VARIABLE,TYPE,NGENES,BETA,BETA_STD,SE,P,FULL_NAME,P_FDR
GOBP_POSITIVE_REGULATION_OF_...728,SET,34,0.62035,0.026658,0.15132,2.0782e-05,GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT,0.214459737692308
GOBP_CAVEOLA_ASSEMBLY,SET,6,1.5061,0.027208,0.36847,2.1913e-05,GOBP_CAVEOLA_ASSEMBLY,0.214459737692308
GOMF_UBIQUITIN_MODIFIED_HIST...,SET,7,1.1578,0.022592,0.28615,2.6147e-05,GOMF_UBIQUITIN_MODIFIED_HISTONE_READER_ACTIVITY,0.214459737692308
GOBP_PROTEIN_LIPID_COMPLEX_A...,SET,28,0.63825,0.024894,0.15959,3.1895e-05,GOBP_PROTEIN_LIPID_COMPLEX_ASSEMBLY,0.214459737692308
GOBP_IMMUNE_COMPLEX_CLEARANCE,SET,5,1.7577,0.028988,0.4445,3.8531e-05,GOBP_IMMUNE_COMPLEX_CLEARANCE,0.214459737692308
GSE23505_IL6_IL1_VS_IL6_IL1_...3,SET,169,0.23955,0.022866,0.060684,3.9641e-05,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.214459737692308
GSE44732_UNSTIM_VS_IL27_STIM...1,SET,183,0.24611,0.024436,0.062913,4.5951e-05,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN,0.214459737692308
GOBP_CHOLESTEROL_EFFLUX,SET,56,0.46676,0.025726,0.12037,5.2903e-05,GOBP_CHOLESTEROL_EFFLUX,0.214459737692308
GOBP_DETECTION_OF_LIPOPOLYSA...,SET,5,1.5866,0.026167,0.41281,6.0869e-05,GOBP_DETECTION_OF_LIPOPOLYSACCHARIDE,0.214459737692308
NFE2L2.V2,SET,396,0.17517,0.025434,0.04615,7.3911e-05,NFE2L2.V2,0.214459737692308
GSE13547_CTRL_VS_ANTI_IGM_ST...2,SET,174,0.23607,0.022861,0.062345,7.6639e-05,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP,0.214459737692308
GSE3982_EOSINOPHIL_VS_BASOPH...1,SET,177,0.23681,0.023128,0.062563,7.7031e-05,GSE3982_EOSINOPHIL_VS_BASOPHIL_DN,0.214459737692308
GOBP_PLASMA_MEMBRANE_RAFT_AS...,SET,7,1.2187,0.023781,0.32283,8.0218e-05,GOBP_PLASMA_MEMBRANE_RAFT_ASSEMBLY,0.214459737692308
GOBP_POSITIVE_REGULATION_OF_...9,SET,7,1.0945,0.021357,0.2953,0.0001054,GOBP_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.231713629411765
HP_DIGESTIVE_SYSTEM_NEOPLASM,SET,343,0.17484,0.023661,0.047195,0.0001062,HP_DIGESTIVE_SYSTEM_NEOPLASM,0.231713629411765
GOMF_PHOSPHATIDYLCHOLINE_STE...,SET,6,1.518,0.027423,0.41005,0.0001073,GOMF_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY,0.231713629411765
ROVERSI_GLIOMA_COPY_NUMBER_UP,SET,94,0.41854,0.029857,0.11349,0.00011334,ROVERSI_GLIOMA_COPY_NUMBER_UP,0.231713629411765
GOBP_REGULATION_OF_SOMATIC_S...,SET,11,1.0023,0.024514,0.27422,0.00012896,GOBP_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.249000266666667
GSE36095_WT_VS_HDAC9_KO_TREG...2,SET,167,0.23514,0.022313,0.064648,0.00013819,GSE36095_WT_VS_HDAC9_KO_TREG_UP,0.252778602631579
ENK_UV_RESPONSE_EPIDERMIS_UP,SET,269,0.18917,0.022718,0.05244,0.00015514,ENK_UV_RESPONSE_EPIDERMIS_UP,0.25961985
BEIER_GLIOMA_STEM_CELL_UP,SET,35,0.56998,0.02485,0.15813,0.00015687,BEIER_GLIOMA_STEM_CELL_UP,0.25961985
GOBP_TRANSCRIPTION_BY_RNA_PO...2,SET,56,0.36186,0.019944,0.1017,0.00018733,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.295938825
GOBP_REGULATION_OF_AGGREPHAGY,SET,7,1.116,0.021777,0.31802,0.00022511,GOBP_REGULATION_OF_AGGREPHAGY,0.340160784782609
GSE19888_ADENOSINE_A3R_INH_P...3,SET,173,0.21077,0.020353,0.060473,0.00024629,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.353958822
GOBP_NEGATIVE_REGULATION_OF_...431,SET,15,0.7903,0.022569,0.22733,0.00025461,GOBP_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.353958822
GTGACTT_MIR224,SET,139,0.24431,0.021167,0.071159,0.00029879,GTGACTT_MIR224,0.398524
REACTOME_VLDL_CLEARANCE,SET,6,1.309,0.023648,0.38234,0.0003096,REACTOME_VLDL_CLEARANCE,0.398524
MIR3913_3P,SET,73,0.35188,0.022133,0.10331,0.00033041,MIR3913_3P,0.4101214125
GOMF_RNA_POLYMERASE_II_ACTIV...,SET,9,0.81566,0.018046,0.24234,0.00038252,GOMF_RNA_POLYMERASE_II_ACTIVITY,0.419961873786408
GOBP_MEMBRANE_RAFT_ASSEMBLY,SET,11,0.82529,0.020185,0.24592,0.00039629,GOBP_MEMBRANE_RAFT_ASSEMBLY,0.419961873786408
GOMF_INOSITOL_BISPHOSPHATE_P...,SET,7,0.98937,0.019305,0.29701,0.00043346,GOMF_INOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.419961873786408
QIU_PBMC_HEPTATITIS_B_SURFAC...4,SET,14,0.82305,0.022708,0.24729,0.00043784,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_UP,0.419961873786408
MIR95_3P,SET,5,1.3773,0.022715,0.41424,0.00044314,MIR95_3P,0.419961873786408
GOBP_PROTEIN_LOCALIZATION_TO...18,SET,14,0.76184,0.021019,0.22969,0.00045625,GOBP_PROTEIN_LOCALIZATION_TO_CONDENSED_CHROMOSOME,0.419961873786408
MAX_01,SET,240,0.18368,0.020852,0.055544,0.00047264,MAX_01,0.419961873786408
chr17q23,SET,51,0.70315,0.036989,0.21294,0.00048082,chr17q23,0.419961873786408
GOCC_SMALL_NUCLEAR_RIBONUCLE...,SET,70,0.29098,0.017924,0.0883,0.00049247,GOCC_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX,0.419961873786408
HP_NEOPLASM_OF_THE_GASTROINT...,SET,285,0.17102,0.021132,0.051911,0.00049386,HP_NEOPLASM_OF_THE_GASTROINTESTINAL_TRACT,0.419961873786408
TAKEDA_TARGETS_OF_NUP98_HOXA...1,SET,131,0.26434,0.022238,0.080593,0.00052024,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,0.419961873786408
HP_OVARIAN_NEOPLASM,SET,73,0.31135,0.019584,0.094949,0.00052168,HP_OVARIAN_NEOPLASM,0.419961873786408
GOBP_STRESS_INDUCED_PREMATUR...,SET,7,0.88484,0.017266,0.27026,0.00053116,GOBP_STRESS_INDUCED_PREMATURE_SENESCENCE,0.419961873786408
GSE20484_MCSG_VS_CXCL4_MONOC...1,SET,174,0.20846,0.020188,0.063817,0.00054534,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN,0.419961873786408
HP_DYSGRAPHIA,SET,52,0.40354,0.021435,0.1238,0.00055868,HP_DYSGRAPHIA,0.419961873786408
CHENG_TAF7L_TARGETS,SET,4,1.2812,0.0189,0.39312,0.00055988,CHENG_TAF7L_TARGETS,0.419961873786408
MIR548AC,SET,545,0.11982,0.020326,0.036807,0.00056723,MIR548AC,0.419961873786408
GOBP_HIGH_DENSITY_LIPOPROTEI...3,SET,17,0.74772,0.022731,0.23063,0.00059452,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.419961873786408
HARALAMBIEVA_PBMC_TIV_AGE_50...3,SET,13,0.71213,0.018933,0.22014,0.00060948,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_POSITIVE,0.419961873786408
MIR3665,SET,73,0.32451,0.020411,0.10037,0.00061352,MIR3665,0.419961873786408
MIR548H_3P_MIR548Z,SET,547,0.11863,0.020159,0.036754,0.00062534,MIR548H_3P_MIR548Z,0.419961873786408
GOBP_OTOLITH_MORPHOGENESIS,SET,5,1.3377,0.022062,0.41542,0.00064181,GOBP_OTOLITH_MORPHOGENESIS,0.419961873786408
GOBP_PROTEIN_LOCALIZATION_TO...13,SET,21,0.60064,0.020292,0.18654,0.00064226,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION,0.419961873786408
REACTOME_INTERLEUKIN_36_PATH...,SET,7,1.5312,0.029878,0.47735,0.00067004,REACTOME_INTERLEUKIN_36_PATHWAY,0.419961873786408
MIR548BB_3P,SET,541,0.11851,0.020032,0.036964,0.0006738,MIR548BB_3P,0.419961873786408
GSE24634_IL4_VS_CTRL_TREATED...3,SET,176,0.21097,0.020547,0.066039,0.00070122,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN,0.419961873786408
GOBP_REGULATION_OF_ANDROGEN_...,SET,25,0.50479,0.018605,0.15828,0.00071434,GOBP_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.419961873786408
HP_NEOPLASM_OF_THE_GENITOURI...,SET,213,0.18528,0.019831,0.058177,0.00072545,HP_NEOPLASM_OF_THE_GENITOURINARY_TRACT,0.419961873786408
REACTOME_RNA_POLYMERASE_III_...3,SET,26,0.44206,0.016616,0.13926,0.00075208,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER,0.419961873786408
GSE14415_TCONV_VS_FOXP3_KO_I...1,SET,159,0.20691,0.019162,0.065215,0.00075654,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN,0.419961873786408
GOMF_QUATERNARY_AMMONIUM_GRO...1,SET,36,0.47645,0.021067,0.15022,0.00075916,GOMF_QUATERNARY_AMMONIUM_GROUP_BINDING,0.419961873786408
GSE22443_IL2_VS_IL12_TREATED...1,SET,188,0.1928,0.0194,0.060823,0.00076405,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN,0.419961873786408
GOBP_REGULATION_OF_PEPTIDYL_...3,SET,7,0.92215,0.017994,0.29099,0.00076606,GOBP_REGULATION_OF_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.419961873786408
GOBP_REGULATION_OF_STEROL_TR...,SET,56,0.37647,0.02075,0.11883,0.00076874,GOBP_REGULATION_OF_STEROL_TRANSPORT,0.419961873786408
GSE11961_MARGINAL_ZONE_BCELL...9,SET,176,0.19993,0.019471,0.063277,0.00079133,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN,0.419961873786408
GOCC_SM_LIKE_PROTEIN_FAMILY_...,SET,78,0.26532,0.017248,0.084064,0.00080066,GOCC_SM_LIKE_PROTEIN_FAMILY_COMPLEX,0.419961873786408
GILMORE_CORE_NFKB_PATHWAY,SET,12,0.77987,0.019922,0.24737,0.0008104,GILMORE_CORE_NFKB_PATHWAY,0.419961873786408
KEGG_N_GLYCAN_BIOSYNTHESIS,SET,44,0.38888,0.019005,0.12348,0.00081987,KEGG_N_GLYCAN_BIOSYNTHESIS,0.419961873786408
MIR1298_3P,SET,41,0.43948,0.020735,0.13956,0.00082045,MIR1298_3P,0.419961873786408
GOBP_NEGATIVE_REGULATION_OF_...554,SET,23,0.52527,0.018571,0.16706,0.00083394,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.419961873786408
GOCC_TRANSCRIPTION_REPRESSOR...,SET,73,0.31704,0.019941,0.10099,0.00084807,GOCC_TRANSCRIPTION_REPRESSOR_COMPLEX,0.419961873786408
HP_BILATERAL_CLEFT_LIP,SET,12,0.88891,0.022707,0.2833,0.00085291,HP_BILATERAL_CLEFT_LIP,0.419961873786408
REACTOME_G2_M_DNA_DAMAGE_CHE...,SET,55,0.34169,0.018664,0.10963,0.00091575,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,0.419961873786408
ARNT_02,SET,217,0.17776,0.019202,0.057116,0.00092971,ARNT_02,0.419961873786408
HP_DISTURBED_PERCEPTION_WITH...,SET,35,0.4289,0.018699,0.13783,0.00093132,HP_DISTURBED_PERCEPTION_WITH_A_STIMULUS,0.419961873786408
GOBP_NEGATIVE_REGULATION_OF_...621,SET,11,0.93106,0.022772,0.29935,0.00093606,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ORGANIZATION,0.419961873786408
HP_ALZHEIMER_DISEASE,SET,9,0.95426,0.021112,0.3071,0.00094549,HP_ALZHEIMER_DISEASE,0.419961873786408
GSE36527_CD62L_HIGH_VS_CD62L...1,SET,188,0.1943,0.019551,0.062578,0.00095321,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN,0.419961873786408
MIR548D_3P,SET,547,0.11416,0.0194,0.036773,0.00095445,MIR548D_3P,0.419961873786408
MYLLYKANGAS_AMPLIFICATION_HO...9,SET,19,0.60692,0.019505,0.19562,0.00096097,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,0.419961873786408
WP_TAR_SYNDROME,SET,49,0.38258,0.019728,0.12386,0.0010065,WP_TAR_SYNDROME,0.419961873786408
PUJANA_CHEK2_PCC_NETWORK,SET,695,0.096575,0.018422,0.031268,0.0010069,PUJANA_CHEK2_PCC_NETWORK,0.419961873786408
GSE16266_LPS_VS_HEATSHOCK_AN...1,SET,176,0.19589,0.019078,0.063434,0.0010087,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.419961873786408
MIR424_5P,SET,476,0.12165,0.019322,0.039396,0.0010097,MIR424_5P,0.419961873786408
GOCC_RNA_POLYMERASE_II_TRANS...2,SET,14,0.68075,0.018782,0.22106,0.0010386,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REPRESSOR_COMPLEX,0.419961873786408
HP_SYNOVIAL_LINING_HYPERPLAS...,SET,8,1.0012,0.020884,0.32547,0.0010506,HP_SYNOVIAL_LINING_HYPERPLASIA,0.419961873786408
MIR6729_5P,SET,9,0.79698,0.017632,0.25964,0.0010734,MIR6729_5P,0.419961873786408
MIR6736_3P,SET,113,0.25734,0.020117,0.083853,0.0010757,MIR6736_3P,0.419961873786408
GSE15750_DAY6_VS_DAY10_EFF_C...2,SET,179,0.1884,0.018503,0.0614,0.0010777,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP,0.419961873786408
AP2_Q6,SET,241,0.16899,0.019225,0.055221,0.0011071,AP2_Q6,0.419961873786408
GOBP_COMPLEMENT_DEPENDENT_CY...,SET,13,0.8081,0.021485,0.26411,0.0011095,GOBP_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.419961873786408
GOBP_POSITIVE_REGULATION_OF_...20,SET,24,0.62171,0.022452,0.20345,0.0011241,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.419961873786408
GOBP_SUGAR_MEDIATED_SIGNALIN...,SET,9,0.90999,0.020133,0.29851,0.0011516,GOBP_SUGAR_MEDIATED_SIGNALING_PATHWAY,0.419961873786408
HELLEBREKERS_SILENCED_DURING...,SET,73,0.32852,0.020664,0.10792,0.001168,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,0.419961873786408
MIR6799_3P,SET,106,0.27541,0.020855,0.090548,0.0011786,MIR6799_3P,0.419961873786408
CARDOSO_RESPONSE_TO_GAMMA_RA...,SET,11,0.68276,0.016699,0.22458,0.0011843,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,0.419961873786408
GOBP_CONVERGENT_EXTENSION_IN...2,SET,9,0.89376,0.019774,0.29425,0.0011946,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_GASTRULATION,0.419961873786408
GNF2_CD97,SET,36,0.46707,0.020652,0.15399,0.0012122,GNF2_CD97,0.419961873786408
HP_SEVERE_EXPRESSIVE_LANGUAG...,SET,9,0.88811,0.019649,0.29283,0.0012131,HP_SEVERE_EXPRESSIVE_LANGUAGE_DELAY,0.419961873786408
GOBP_PLASMA_MEMBRANE_RAFT_OR...,SET,11,0.80968,0.019803,0.267,0.0012146,GOBP_PLASMA_MEMBRANE_RAFT_ORGANIZATION,0.419961873786408
MIR1180_5P,SET,34,0.44289,0.019032,0.14611,0.0012197,MIR1180_5P,0.419961873786408
MIR16_5P,SET,532,0.11295,0.018937,0.037291,0.0012289,MIR16_5P,0.419961873786408
HP_KNEE_CLONUS,SET,5,1.1524,0.019005,0.38057,0.0012329,HP_KNEE_CLONUS,0.419961873786408
HASLINGER_B_CLL_WITH_11Q23_D...,SET,20,0.53433,0.017617,0.17653,0.0012378,HASLINGER_B_CLL_WITH_11Q23_DELETION,0.419961873786408
KEGG_MEDICUS_REFERENCE_RECRU...,SET,9,0.96636,0.02138,0.31945,0.0012446,KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC,0.419961873786408
GOBP_IMPORT_INTO_NUCLEUS,SET,160,0.19851,0.018441,0.065796,0.0012783,GOBP_IMPORT_INTO_NUCLEUS,0.422404400943396
GSE7348_UNSTIM_VS_LPS_STIM_M...1,SET,158,0.22183,0.02048,0.073533,0.0012792,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.422404400943396
REACTOME_CYTOSOLIC_SENSORS_O...,SET,57,0.31888,0.017731,0.10578,0.0012883,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,0.422404400943396
GOBP_REGULATION_OF_COMPLEMEN...4,SET,11,0.87978,0.021518,0.29236,0.0013115,GOBP_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.422882986842105
MIR497_5P,SET,476,0.11795,0.018735,0.039293,0.0013437,MIR497_5P,0.422882986842105
GOBP_B_CELL_DIFFERENTIATION,SET,140,0.23077,0.020065,0.076963,0.0013586,GOBP_B_CELL_DIFFERENTIATION,0.422882986842105
MIR508_5P,SET,86,0.27952,0.019076,0.093227,0.0013594,MIR508_5P,0.422882986842105
MIR10394_5P,SET,162,0.20212,0.018892,0.067439,0.0013649,MIR10394_5P,0.422882986842105
GOBP_NUCLEAR_TRANSPORT,SET,307,0.1396,0.017892,0.046638,0.0013818,GOBP_NUCLEAR_TRANSPORT,0.422882986842105
TANG_SENESCENCE_TP53_TARGETS...1,SET,51,0.37532,0.019744,0.12543,0.001386,TANG_SENESCENCE_TP53_TARGETS_DN,0.422882986842105
GOBP_NEGATIVE_REGULATION_OF_...26,SET,14,0.64005,0.017659,0.21391,0.0013871,GOBP_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.422882986842105
REACTOME_RNA_POLYMERASE_III_...2,SET,39,0.34865,0.016044,0.11691,0.0014329,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION,0.429410950413223
MODULE_315,SET,16,0.63549,0.018743,0.21332,0.0014477,MODULE_315,0.429410950413223
GAJATE_RESPONSE_TO_TRABECTED...2,SET,59,0.3436,0.019437,0.11543,0.0014587,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,0.429410950413223
HP_MILD_POSTNATAL_GROWTH_RET...,SET,16,0.6826,0.020132,0.22951,0.0014708,HP_MILD_POSTNATAL_GROWTH_RETARDATION,0.429410950413223
GOBP_VERY_LOW_DENSITY_LIPOPR...1,SET,11,0.80571,0.019706,0.27129,0.0014915,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.429410950413223
GOCC_NUCLEAR_PROTEIN_CONTAIN...,SET,1120,0.073626,0.017613,0.024794,0.0014932,GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX,0.429410950413223
GOBP_DETECTION_OF_MOLECULE_O...,SET,12,0.79826,0.020391,0.26885,0.001495,GOBP_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN,0.429410950413223
REACTOME_SIGNALLING_TO_P38_V...,SET,5,0.99614,0.016429,0.33589,0.001512,REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN,0.430734098360656
HP_GLOMERULOPATHY,SET,31,0.48568,0.01993,0.16412,0.0015443,HP_GLOMERULOPATHY,0.43388142
REACTOME_NONHOMOLOGOUS_END_J...,SET,29,0.40086,0.015911,0.13557,0.0015557,REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,0.43388142
REACTOME_ACTIVATION_OF_THE_P...2,SET,31,0.42168,0.017304,0.14265,0.0015605,REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,0.43388142
HP_NEOPLASM_OF_THE_BREAST,SET,95,0.24906,0.01786,0.084417,0.0015893,HP_NEOPLASM_OF_THE_BREAST,0.438381916666667
MIR3173_5P,SET,93,0.26675,0.018928,0.09061,0.0016226,MIR3173_5P,0.438990674418605
HP_SINGLE_VENTRICLE,SET,8,0.8766,0.018285,0.2978,0.0016244,HP_SINGLE_VENTRICLE,0.438990674418605
GOBP_REGULATION_OF_PLASMINOG...,SET,17,0.62827,0.0191,0.21351,0.0016294,GOBP_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.438990674418605
GOBP_POSITIVE_REGULATION_OF_...157,SET,26,0.49423,0.018576,0.16826,0.0016577,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.440141564885496
GOBP_POSITIVE_REGULATION_OF_...3,SET,57,0.34327,0.019087,0.11688,0.001659,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.440141564885496
GOBP_POSITIVE_REGULATION_OF_...547,SET,41,0.41539,0.019598,0.14166,0.001685,GOBP_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.443652840909091
GCTNWTTGK_UNKNOWN,SET,279,0.15693,0.019188,0.05372,0.0017454,GCTNWTTGK_UNKNOWN,0.448491711678832
GOMF_RNA_POLYMERASE_ACTIVITY,SET,28,0.40813,0.015918,0.13976,0.0017511,GOMF_RNA_POLYMERASE_ACTIVITY,0.448491711678832
HP_SINGLE_NARIS,SET,19,0.58525,0.018808,0.20045,0.001754,HP_SINGLE_NARIS,0.448491711678832
GOBP_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,0.67426,0.017224,0.23105,0.0017624,GOBP_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT,0.448491711678832
CTIP_DN.V1_DN,SET,115,0.2407,0.018981,0.082509,0.0017679,CTIP_DN.V1_DN,0.448491711678832
GOCC_MYOSIN_FILAMENT,SET,24,0.56768,0.020501,0.19477,0.0017829,GOCC_MYOSIN_FILAMENT,0.449019489130435
GOBP_CHEMOSENSORY_BEHAVIOR,SET,19,0.60515,0.019448,0.20794,0.0018078,GOBP_CHEMOSENSORY_BEHAVIOR,0.451617808510638
MIR6838_5P,SET,489,0.11317,0.018213,0.038938,0.00183,MIR6838_5P,0.451617808510638
GOBP_REGULATION_OF_BILE_ACID...2,SET,14,0.74075,0.020437,0.2549,0.0018322,GOBP_REGULATION_OF_BILE_ACID_METABOLIC_PROCESS,0.451617808510638
MIR5585_3P,SET,77,0.28539,0.018434,0.098375,0.001862,MIR5585_3P,0.453836696078431
GSE30083_SP2_VS_SP3_THYMOCYT...1,SET,183,0.18678,0.018545,0.064424,0.0018726,GSE30083_SP2_VS_SP3_THYMOCYTE_DN,0.453836696078431
HP_ABDOMINAL_PAIN,SET,308,0.14617,0.018764,0.050639,0.0019495,HP_ABDOMINAL_PAIN,0.453836696078431
MIR338_5P,SET,427,0.12394,0.018671,0.042935,0.0019496,MIR338_5P,0.453836696078431
GOBP_MEMBRANE_RAFT_ORGANIZAT...,SET,24,0.52172,0.018841,0.18077,0.0019529,GOBP_MEMBRANE_RAFT_ORGANIZATION,0.453836696078431
GOCC_GAMMA_TUBULIN_COMPLEX,SET,17,0.57591,0.017508,0.19969,0.0019654,GOCC_GAMMA_TUBULIN_COMPLEX,0.453836696078431
MARIADASON_REGULATED_BY_HIST...1,SET,37,0.42914,0.019236,0.14884,0.00197,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,0.453836696078431
GOBP_NEGATIVE_REGULATION_OF_...553,SET,20,0.50491,0.016647,0.17512,0.0019706,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,0.453836696078431
MIR761,SET,209,0.16506,0.017502,0.057262,0.0019743,MIR761,0.453836696078431
WP_ATM_SIGNALING_IN_DEVELOPM...,SET,43,0.34997,0.016909,0.12145,0.0019802,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,0.453836696078431
MIR195_5P,SET,534,0.10704,0.017979,0.037179,0.0019964,MIR195_5P,0.453836696078431
HP_MEDIAN_CLEFT_UPPER_LIP,SET,32,0.4284,0.017861,0.14881,0.0019979,HP_MEDIAN_CLEFT_UPPER_LIP,0.453836696078431
GOBP_REGULATION_OF_CHOLESTER...2,SET,36,0.41333,0.018276,0.14376,0.0020211,GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX,0.456125522727273
GOBP_POSITIVE_REGULATION_OF_...16,SET,6,1.0728,0.019381,0.37383,0.0020565,GOBP_POSITIVE_REGULATION_OF_AGGREPHAGY,0.458000952830189
REACTOME_VLDL_ASSEMBLY,SET,5,0.96124,0.015853,0.33506,0.0020622,REACTOME_VLDL_ASSEMBLY,0.458000952830189
MIR11181_3P,SET,183,0.18396,0.018265,0.0642,0.0020851,MIR11181_3P,0.458000952830189
MIR1205,SET,160,0.19497,0.018113,0.068079,0.0020949,MIR1205,0.458000952830189
TRAVAGLINI_LUNG_SEROUS_CELL,SET,86,0.27389,0.018692,0.095637,0.0020953,TRAVAGLINI_LUNG_SEROUS_CELL,0.458000952830189
GSE46606_IRF4_KO_VS_WT_CD40L...3,SET,169,0.17901,0.017087,0.062705,0.0021554,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN,0.463309274096386
STREICHER_LSM1_TARGETS_DN,SET,18,0.57885,0.018107,0.20286,0.002165,STREICHER_LSM1_TARGETS_DN,0.463309274096386
HP_URIC_ACID_NEPHROLITHIASIS,SET,11,0.671,0.016411,0.2354,0.0021853,HP_URIC_ACID_NEPHROLITHIASIS,0.463309274096386
HP_SHORT_TELOMERE_LENGTH,SET,14,0.63584,0.017543,0.22317,0.0021942,HP_SHORT_TELOMERE_LENGTH,0.463309274096386
GRASEMANN_RETINOBLASTOMA_WIT...,SET,14,0.65745,0.018139,0.23081,0.0021991,GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION,0.463309274096386
MIR15B_5P,SET,532,0.10601,0.017774,0.037226,0.0022039,MIR15B_5P,0.463309274096386
HP_ALBUMINURIA,SET,22,0.49491,0.017113,0.17387,0.0022129,HP_ALBUMINURIA,0.463309274096386
GOCC_SERINE_PROTEASE_INHIBIT...,SET,6,1.1134,0.020114,0.39191,0.0022515,GOCC_SERINE_PROTEASE_INHIBITOR_COMPLEX,0.466046041420118
WP_NEUROINFLAMMATION,SET,11,0.84475,0.020661,0.29752,0.0022634,WP_NEUROINFLAMMATION,0.466046041420118
HP_TYPIFIED_BY_SOMATIC_MOSAI...,SET,162,0.19878,0.018581,0.070021,0.0022662,HP_TYPIFIED_BY_SOMATIC_MOSAICISM,0.466046041420118
HP_NEOPLASM_OF_THE_LARGE_INT...,SET,108,0.22734,0.017376,0.08022,0.0023016,HP_NEOPLASM_OF_THE_LARGE_INTESTINE,0.470541811764706
HP_SEMANTIC_DEMENTIA,SET,7,0.92376,0.018025,0.32748,0.0023978,HP_SEMANTIC_DEMENTIA,0.487342333333333
REACTOME_ACROSOME_REACTION_A...,SET,6,1.1313,0.020438,0.40176,0.0024344,REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING,0.490201352017937
HP_GENITAL_NEOPLASM,SET,146,0.19908,0.017674,0.070897,0.0024947,HP_GENITAL_NEOPLASM,0.490201352017937
KANNAN_TP53_TARGETS_DN,SET,21,0.55849,0.018868,0.19932,0.0025426,KANNAN_TP53_TARGETS_DN,0.490201352017937
GOBP_NEGATIVE_REGULATION_OF_...616,SET,34,0.40869,0.017562,0.1459,0.0025481,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.490201352017937
WP_LDL_INFLUENCE_ON_CD14_AND...,SET,23,0.52953,0.018721,0.18904,0.0025487,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,0.490201352017937
KEGG_MEDICUS_REFERENCE_TELOM...1,SET,3,1.0318,0.013182,0.36847,0.0025551,KEGG_MEDICUS_REFERENCE_TELOMERASE_RNA_MATURATION,0.490201352017937
HP_POLYCYSTIC_LIVER_DISEASE,SET,11,0.67486,0.016505,0.24106,0.0025616,HP_POLYCYSTIC_LIVER_DISEASE,0.490201352017937
HOLLERN_EMT_BREAST_TUMOR_DN,SET,117,0.22745,0.01809,0.081259,0.0025652,HOLLERN_EMT_BREAST_TUMOR_DN,0.490201352017937
HP_PAIN,SET,754,0.090798,0.01801,0.032441,0.0025669,HP_PAIN,0.490201352017937
MODULE_60,SET,382,0.12634,0.018025,0.045143,0.0025684,MODULE_60,0.490201352017937
GSE2405_HEAT_KILLED_LYSATE_V...4,SET,186,0.18089,0.018105,0.064698,0.0025908,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.490201352017937
GSE18893_TCONV_VS_TREG_24H_C...1,SET,179,0.1891,0.018572,0.067702,0.0026125,GSE18893_TCONV_VS_TREG_24H_CULTURE_DN,0.490201352017937
HP_NEOPLASM_OF_THE_LIVER,SET,132,0.21627,0.018263,0.077445,0.0026171,HP_NEOPLASM_OF_THE_LIVER,0.490201352017937
GSE14415_INDUCED_TREG_VS_FOX...4,SET,149,0.19248,0.017261,0.069042,0.0026556,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP,0.490201352017937
MIR1260A_MIR1260B,SET,97,0.23838,0.017272,0.085532,0.0026628,MIR1260A_MIR1260B,0.490201352017937
GOBP_MICROGLIAL_CELL_PROLIFE...,SET,7,1.0241,0.019983,0.36751,0.0026658,GOBP_MICROGLIAL_CELL_PROLIFERATION,0.490201352017937
MIR3136_3P,SET,60,0.29445,0.016797,0.1057,0.002673,MIR3136_3P,0.490201352017937
GOBP_STEROL_TRANSPORT,SET,106,0.23689,0.017939,0.085076,0.0026837,GOBP_STEROL_TRANSPORT,0.490201352017937
HP_ENDOCARDITIS,SET,14,0.61823,0.017057,0.2221,0.0026917,HP_ENDOCARDITIS,0.490201352017937
GOCC_TRANSCRIPTION_REGULATOR...,SET,478,0.10833,0.017243,0.038986,0.0027307,GOCC_TRANSCRIPTION_REGULATOR_COMPLEX,0.490201352017937
HP_DECREASED_CIRCULATING_PAR...,SET,10,0.82596,0.019262,0.29756,0.0027561,HP_DECREASED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.490201352017937
DACOSTA_LOW_DOSE_UV_RESPONSE...1,SET,8,0.83562,0.01743,0.30115,0.0027651,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.490201352017937
MIR7155_3P,SET,61,0.28368,0.016316,0.10227,0.0027722,MIR7155_3P,0.490201352017937
GOBP_SMOOTH_MUSCLE_TISSUE_DE...,SET,24,0.53251,0.019231,0.19203,0.0027798,GOBP_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT,0.490201352017937
GOBP_HAIR_FOLLICLE_PLACODE_F...,SET,4,1.1731,0.017304,0.42331,0.0027961,GOBP_HAIR_FOLLICLE_PLACODE_FORMATION,0.490201352017937
GSE14415_NATURAL_TREG_VS_TCO...1,SET,168,0.1792,0.017055,0.064704,0.00281,GSE14415_NATURAL_TREG_VS_TCONV_DN,0.490201352017937
WP_GANGLIO_SERIES_SPHINGOLIP...,SET,13,0.70014,0.018615,0.25313,0.0028405,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.490201352017937
GOBP_REGULATION_OF_ANATOMICA...1,SET,750,0.090951,0.017995,0.032921,0.0028689,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_MORPHOGENESIS,0.490201352017937
MIR214_3P,SET,222,0.15308,0.016723,0.055415,0.0028714,MIR214_3P,0.490201352017937
HP_SEROSITIS,SET,88,0.25891,0.017873,0.093781,0.0028861,HP_SEROSITIS,0.490201352017937
MORF_FDXR,SET,210,0.15899,0.016898,0.057636,0.0029068,MORF_FDXR,0.490201352017937
HP_NEUROMA,SET,6,0.88559,0.015999,0.32118,0.0029171,HP_NEUROMA,0.490201352017937
HP_MEMORY_IMPAIRMENT,SET,130,0.2031,0.017021,0.073666,0.0029193,HP_MEMORY_IMPAIRMENT,0.490201352017937
GSE3982_MAST_CELL_VS_CENT_ME...2,SET,185,0.17021,0.016992,0.061761,0.0029287,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.490201352017937
MIR662,SET,5,0.89096,0.014694,0.32354,0.0029483,MIR662,0.490201352017937
GAVIN_FOXP3_TARGETS_CLUSTER_...4,SET,84,0.26359,0.01778,0.095728,0.0029505,GAVIN_FOXP3_TARGETS_CLUSTER_P6,0.490201352017937
GCM_RAD21,SET,32,0.37068,0.015454,0.13474,0.002974,GCM_RAD21,0.490201352017937
GOCC_RNA_POLYMERASE_II_CORE_...,SET,13,0.59601,0.015846,0.21678,0.002988,GOCC_RNA_POLYMERASE_II_CORE_COMPLEX,0.490201352017937
GOBP_REGULATION_OF_BILE_ACID...1,SET,11,0.78952,0.01931,0.28723,0.0029942,GOBP_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS,0.490201352017937
GOBP_TOLERANCE_INDUCTION_DEP...,SET,4,1.3134,0.019375,0.47799,0.0030031,GOBP_TOLERANCE_INDUCTION_DEPENDENT_UPON_IMMUNE_RESPONSE,0.490201352017937
MIR4272,SET,180,0.17391,0.017127,0.063403,0.0030474,MIR4272,0.490201352017937
GOBP_REGULATION_OF_RECEPTOR_...8,SET,101,0.25049,0.018519,0.091346,0.0030542,GOBP_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.490201352017937
WU_APOPTOSIS_BY_CDKN1A_NOT_V...,SET,9,0.72308,0.015997,0.26394,0.003079,WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,0.490201352017937
GSE4590_LARGE_PRE_BCELL_VS_V...1,SET,172,0.18531,0.017843,0.067664,0.003088,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.490201352017937
GSE23321_CD8_STEM_CELL_MEMOR...4,SET,178,0.17237,0.016881,0.062944,0.0030898,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.490201352017937
GOCC_GROWTH_CONE_MEMBRANE,SET,7,0.94869,0.018512,0.34663,0.0031044,GOCC_GROWTH_CONE_MEMBRANE,0.490201352017937
GSE32901_NAIVE_VS_TH17_ENRIC...2,SET,137,0.20002,0.017205,0.0731,0.0031107,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP,0.490201352017937
MIR15A_5P,SET,535,0.1015,0.017065,0.0371,0.0031128,MIR15A_5P,0.490201352017937
GOBP_PH_REDUCTION,SET,6,1.0731,0.019387,0.39228,0.0031167,GOBP_PH_REDUCTION,0.490201352017937
GSE12845_IGD_POS_BLOOD_VS_DA...2,SET,166,0.1791,0.016945,0.065507,0.003131,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.490201352017937
GOBP_NUCLEUS_LOCALIZATION,SET,31,0.40884,0.016777,0.14958,0.0031387,GOBP_NUCLEUS_LOCALIZATION,0.490201352017937
HP_GONADAL_NEOPLASM,SET,100,0.22964,0.016893,0.084038,0.0031453,HP_GONADAL_NEOPLASM,0.490201352017937
GOBP_CILIARY_BASAL_BODY_ORGA...,SET,5,1.038,0.01712,0.38083,0.0032107,GOBP_CILIARY_BASAL_BODY_ORGANIZATION,0.497861513333333
GOBP_POLYPRENOL_METABOLIC_PR...,SET,23,0.4356,0.0154,0.15988,0.0032231,GOBP_POLYPRENOL_METABOLIC_PROCESS,0.497861513333333
REACTOME_INTERLEUKIN_35_SIGN...,SET,12,0.74275,0.018973,0.27306,0.0032665,REACTOME_INTERLEUKIN_35_SIGNALLING,0.500992559471366
NICK_RESPONSE_TO_PROC_TREATM...2,SET,4,1.141,0.016831,0.41956,0.0032722,NICK_RESPONSE_TO_PROC_TREATMENT_UP,0.500992559471366
GOMF_SYNDECAN_BINDING,SET,5,1.1809,0.019475,0.43472,0.0033025,GOMF_SYNDECAN_BINDING,0.502995515217391
TFAM_TARGET_GENES,SET,2,1.7078,0.017815,0.62913,0.0033213,TFAM_TARGET_GENES,0.502995515217391
GOBP_ACETATE_ESTER_METABOLIC...,SET,6,0.98598,0.017813,0.36332,0.0033287,GOBP_ACETATE_ESTER_METABOLIC_PROCESS,0.502995515217391
GSE27786_LSK_VS_NEUTROPHIL_DN,SET,181,0.1713,0.016916,0.063193,0.0033597,GSE27786_LSK_VS_NEUTROPHIL_DN,0.504336995689655
GOMF_INTERLEUKIN_17_RECEPTOR...,SET,8,0.88155,0.018389,0.32529,0.0033666,GOMF_INTERLEUKIN_17_RECEPTOR_ACTIVITY,0.504336995689655
GOBP_ESTABLISHMENT_OF_PIGMEN...,SET,21,0.53619,0.018115,0.198,0.0033877,GOBP_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION,0.504636734177215
ALONSO_METASTASIS_EMT_UP,SET,32,0.41357,0.017242,0.15283,0.0034077,ALONSO_METASTASIS_EMT_UP,0.504636734177215
HP_NARROW_NASAL_BRIDGE,SET,41,0.38313,0.018076,0.14166,0.0034218,HP_NARROW_NASAL_BRIDGE,0.504636734177215
GOBP_RENAL_SYSTEM_PROCESS,SET,117,0.23239,0.018483,0.08597,0.0034379,GOBP_RENAL_SYSTEM_PROCESS,0.504636734177215
GOCC_HIGH_DENSITY_LIPOPROTEI...,SET,25,0.5147,0.018971,0.19043,0.0034412,GOCC_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.504636734177215
REACTOME_ACTIVATION_OF_ATR_I...,SET,37,0.35282,0.015815,0.1307,0.0034754,REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,0.507510617647059
GSE5589_WT_VS_IL10_KO_LPS_AN...5,SET,182,0.17144,0.016976,0.063676,0.0035502,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.511268840163934
MODULE_1,SET,336,0.13692,0.018343,0.050889,0.0035707,MODULE_1,0.511268840163934
REACTOME_PROCESSING_OF_DNA_D...,SET,57,0.28314,0.015744,0.10524,0.0035709,REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,0.511268840163934
GSE21033_CTRL_VS_POLYIC_STIM...2,SET,144,0.191,0.016841,0.071001,0.0035745,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP,0.511268840163934
GOBP_RECEPTOR_MEDIATED_ENDOC...3,SET,10,0.80147,0.018691,0.29797,0.0035785,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_OF_VIRUS_BY_HOST_CELL,0.511268840163934
LI_PBMC_MENOMUNE_A_C_Y_W_135...1,SET,16,0.62841,0.018534,0.23372,0.0035894,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN,0.511268840163934
GSE37532_TREG_VS_TCONV_PPARG...2,SET,180,0.16166,0.015921,0.060211,0.0036301,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP,0.514955614285714
GOBP_EMBRYONIC_PROCESS_INVOL...,SET,6,0.96228,0.017384,0.35858,0.0036454,GOBP_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,0.515023890243902
GOMF_PHOSPHATIDYLCHOLINE_BIN...,SET,28,0.45766,0.01785,0.17071,0.0036747,GOMF_PHOSPHATIDYLCHOLINE_BINDING,0.517061532388664
GSE20152_SPHK1_KO_VS_HTNFA_O...2,SET,171,0.16683,0.016017,0.062372,0.0037435,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP,0.522918509881423
AGGGCAG_MIR18A,SET,130,0.20978,0.017581,0.078531,0.0037821,AGGGCAG_MIR18A,0.522918509881423
GOBP_CYTOPLASMIC_SEQUESTERIN...3,SET,7,0.76648,0.014956,0.28696,0.0037843,GOBP_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR,0.522918509881423
HP_INTERHEMISPHERIC_CYST,SET,5,1.0507,0.017328,0.39354,0.0037971,HP_INTERHEMISPHERIC_CYST,0.522918509881423
GOBP_VESICLE_TETHERING_INVOL...,SET,9,0.67903,0.015023,0.25435,0.0038001,GOBP_VESICLE_TETHERING_INVOLVED_IN_EXOCYTOSIS,0.522918509881423
GOBP_PROTEIN_LIPID_COMPLEX_O...,SET,52,0.33082,0.017572,0.12394,0.0038066,GOBP_PROTEIN_LIPID_COMPLEX_ORGANIZATION,0.522918509881423
GSE11961_MARGINAL_ZONE_BCELL...5,SET,185,0.16476,0.016447,0.061798,0.0038407,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.524514282352941
GOBP_NEGATIVE_REGULATION_OF_...620,SET,8,0.95353,0.01989,0.35775,0.0038484,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.524514282352941
HP_HORIZONTAL_PENDULAR_NYSTA...,SET,7,0.90347,0.017629,0.33931,0.0038797,HP_HORIZONTAL_PENDULAR_NYSTAGMUS,0.524934173076923
HP_HYPERMETRIC_SACCADES,SET,11,0.6636,0.01623,0.24929,0.0038882,HP_HYPERMETRIC_SACCADES,0.524934173076923
GOBP_REGULATION_OF_PROTEOLYS...2,SET,197,0.15903,0.016376,0.059765,0.0039001,GOBP_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.524934173076923
MYCMAX_03,SET,231,0.14955,0.01666,0.056228,0.0039148,MYCMAX_03,0.524934173076923
GOMF_LYSOPHOSPHATIDIC_ACID_B...,SET,7,0.80717,0.01575,0.30361,0.003927,GOMF_LYSOPHOSPHATIDIC_ACID_BINDING,0.524934173076923
GOBP_DOUBLE_STRAND_BREAK_REP...5,SET,9,0.72602,0.016063,0.27347,0.0039707,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_CLASSICAL_NONHOMOLOGOUS_END_JOINING,0.528382122137405
WNT_SIGNALING,SET,82,0.26427,0.017613,0.09958,0.0039832,WNT_SIGNALING,0.528382122137405
GSE17301_IFNA2_VS_IFNA2_AND_...2,SET,183,0.16408,0.016292,0.061884,0.0040113,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP,0.528684107954545
GOBP_NEGATIVE_REGULATION_OF_...564,SET,39,0.3516,0.01618,0.13263,0.0040159,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.528684107954545
GSE2124_CTRL_VS_LYMPHOTOXIN_...2,SET,183,0.17459,0.017335,0.065967,0.0040683,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP,0.533561383018868
GOCC_PEPTIDASE_INHIBITOR_COM...,SET,11,0.70951,0.017353,0.26827,0.0040912,GOCC_PEPTIDASE_INHIBITOR_COMPLEX,0.534547578947368
GSE36826_NORMAL_VS_STAPH_AUR...3,SET,187,0.16585,0.016644,0.062786,0.0041313,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN,0.537765286516854
REACTOME_INTERLEUKIN_12_FAMI...,SET,53,0.30051,0.016115,0.1139,0.0041687,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,0.5379701625
GSE5589_IL6_KO_VS_IL10_KO_LP...6,SET,184,0.15563,0.015494,0.059033,0.0041946,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.5379701625
HP_HIPPOCAMPAL_ATROPHY,SET,5,1.0125,0.016698,0.3843,0.0042152,HP_HIPPOCAMPAL_ATROPHY,0.5379701625
GOCC_SPLICEOSOMAL_COMPLEX,SET,178,0.15573,0.015251,0.059114,0.0042183,GOCC_SPLICEOSOMAL_COMPLEX,0.5379701625
MIR133A_3P_MIR133B,SET,222,0.14772,0.016138,0.056123,0.0042463,MIR133A_3P_MIR133B,0.5379701625
GOCC_NEUROMUSCULAR_JUNCTION,SET,70,0.2666,0.016422,0.1013,0.0042508,GOCC_NEUROMUSCULAR_JUNCTION,0.5379701625
GOCC_PROTEASE_INHIBITOR_COMP...,SET,8,0.84154,0.017554,0.32016,0.0042916,GOCC_PROTEASE_INHIBITOR_COMPLEX,0.5379701625
SREBP1_01,SET,140,0.18748,0.016301,0.071349,0.004302,SREBP1_01,0.5379701625
MODULE_206,SET,144,0.18243,0.016085,0.069451,0.0043131,MODULE_206,0.5379701625
GSE10239_NAIVE_VS_KLRG1HIGH_...2,SET,187,0.16129,0.016187,0.061413,0.0043197,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.5379701625
GOBP_MACROPHAGE_PROLIFERATION,SET,10,0.78667,0.018345,0.29956,0.0043224,GOBP_MACROPHAGE_PROLIFERATION,0.5379701625
GSE7460_FOXP3_MUT_VS_WT_ACT_...4,SET,180,0.16786,0.016531,0.063932,0.0043288,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP,0.5379701625
GSE15659_RESTING_VS_ACTIVATE...1,SET,167,0.17381,0.016493,0.066208,0.0043341,GSE15659_RESTING_VS_ACTIVATED_TREG_DN,0.5379701625
GOBP_NEGATIVE_REGULATION_OF_...211,SET,63,0.29764,0.017397,0.1135,0.0043691,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.54038459252669
GSE2585_CTEC_VS_THYMIC_MACRO...2,SET,183,0.1682,0.016701,0.064182,0.0043908,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP,0.54070428975265
GOBP_PRESYNAPSE_ORGANIZATION,SET,46,0.36114,0.018045,0.13785,0.0044028,GOBP_PRESYNAPSE_ORGANIZATION,0.54070428975265
HP_ANTERIOR_UVEITIS,SET,15,0.59516,0.016996,0.2275,0.004451,HP_ANTERIOR_UVEITIS,0.543814231958763
GOBP_POSITIVE_REGULATION_OF_...27,SET,5,0.98034,0.016168,0.37487,0.004463,GOBP_POSITIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.543814231958763
GOBP_NEGATIVE_REGULATION_OF_...205,SET,13,0.60562,0.016102,0.23172,0.0044839,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,0.543814231958763
GOBP_OLFACTORY_BEHAVIOR,SET,11,0.75037,0.018352,0.28747,0.0045281,GOBP_OLFACTORY_BEHAVIOR,0.543814231958763
MIR6804_3P,SET,85,0.25184,0.017088,0.096497,0.0045331,MIR6804_3P,0.543814231958763
MIR4732_5P,SET,18,0.54256,0.016972,0.20791,0.0045357,MIR4732_5P,0.543814231958763
PID_ATM_PATHWAY,SET,29,0.37627,0.014935,0.14425,0.004551,PID_ATM_PATHWAY,0.543814231958763
GOBP_REGULATION_OF_ACTIVIN_R...,SET,26,0.47265,0.017765,0.18121,0.0045533,GOBP_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.543814231958763
DESCARTES_MAIN_FETAL_CHROMAF...,SET,15,0.5306,0.015153,0.20387,0.0046296,DESCARTES_MAIN_FETAL_CHROMAFFIN_CELLS,0.550238917741935
GOMF_UBIQUITIN_LIKE_PROTEIN_...7,SET,19,0.45129,0.014503,0.17355,0.0046608,GOMF_UBIQUITIN_LIKE_PROTEIN_READER_ACTIVITY,0.550238917741935
GSE40274_EOS_VS_FOXP3_AND_EO...2,SET,135,0.18203,0.015544,0.070031,0.004674,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.550238917741935
GOCC_BRCA1_A_COMPLEX,SET,5,0.8381,0.013822,0.32273,0.004707,GOCC_BRCA1_A_COMPLEX,0.550238917741935
REACTOME_FGFR2_ALTERNATIVE_S...,SET,27,0.39936,0.015296,0.15387,0.0047268,REACTOME_FGFR2_ALTERNATIVE_SPLICING,0.550238917741935
NIKOLSKY_BREAST_CANCER_17Q21...,SET,305,0.22191,0.028349,0.085595,0.0047679,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,0.550238917741935
GSE3039_ALPHAALPHA_CD8_TCELL...4,SET,181,0.16703,0.016494,0.064442,0.0047761,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP,0.550238917741935
CCGNMNNTNACG_UNKNOWN,SET,74,0.24198,0.015324,0.093392,0.0047878,CCGNMNNTNACG_UNKNOWN,0.550238917741935
HP_RECURRENT_CORNEAL_EROSIONS,SET,11,0.70638,0.017277,0.27273,0.0048023,HP_RECURRENT_CORNEAL_EROSIONS,0.550238917741935
REACTOME_RNA_POLYMERASE_III_...1,SET,16,0.47687,0.014064,0.18415,0.0048085,REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION,0.550238917741935
GOCC_RNA_POLYMERASE_III_COMP...,SET,16,0.47687,0.014064,0.18415,0.0048085,GOCC_RNA_POLYMERASE_III_COMPLEX,0.550238917741935
GOCC_GATOR1_COMPLEX,SET,5,0.92895,0.01532,0.35884,0.00482,GOCC_GATOR1_COMPLEX,0.550238917741935
GOBP_DETECTION_OF_MUSCLE_STR...,SET,7,0.89668,0.017497,0.34671,0.004855,GOBP_DETECTION_OF_MUSCLE_STRETCH,0.550238917741935
MCCLUNG_COCAIN_REWARD_4WK,SET,68,0.27214,0.016523,0.10524,0.0048586,MCCLUNG_COCAIN_REWARD_4WK,0.550238917741935
GOBP_NEGATIVE_REGULATION_OF_...669,SET,9,0.6326,0.013996,0.24476,0.0048787,GOBP_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.550238917741935
GAO_LARGE_INTESTINE_24W_C8_G...,SET,38,0.39665,0.018018,0.15352,0.0048915,GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL,0.550238917741935
HP_BASAL_CELL_CARCINOMA,SET,61,0.26707,0.015361,0.10339,0.0048993,HP_BASAL_CELL_CARCINOMA,0.550238917741935
HP_ABNORMAL_ATRIOVENTRICULAR...2,SET,14,0.61203,0.016886,0.23697,0.0049053,HP_ABNORMAL_ATRIOVENTRICULAR_CONNECTION,0.550238917741935
GOBP_CELL_SURFACE_RECEPTOR_S...2,SET,167,0.18342,0.017405,0.071024,0.0049079,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.550238917741935
GHANDHI_BYSTANDER_IRRADIATIO...1,SET,11,0.78017,0.019081,0.30258,0.0049679,GHANDHI_BYSTANDER_IRRADIATION_DN,0.555174805466238
AIZARANI_LIVER_C11_HEPATOCYT...,SET,277,0.14519,0.01769,0.056342,0.0049869,AIZARANI_LIVER_C11_HEPATOCYTES_1,0.555511889423077
GSE6674_UNSTIM_VS_PL2_3_STIM...1,SET,152,0.17068,0.015458,0.066394,0.005079,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN,0.561712706896552
GSE18791_CTRL_VS_NEWCASTLE_V...19,SET,179,0.17248,0.016939,0.067149,0.0051092,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN,0.561712706896552
REACTOME_RNA_POLYMERASE_III_...5,SET,21,0.41782,0.014116,0.16272,0.0051232,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION,0.561712706896552
GOBP_REGULATION_OF_AMYLOID_B...,SET,17,0.52728,0.016029,0.20536,0.0051245,GOBP_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.561712706896552
WIKMAN_ASBESTOS_LUNG_CANCER_...1,SET,28,0.40283,0.015712,0.15691,0.0051295,WIKMAN_ASBESTOS_LUNG_CANCER_DN,0.561712706896552
GUTIERREZ_CHRONIC_LYMPHOCYTI...2,SET,11,0.7183,0.017568,0.27998,0.0051549,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.561712706896552
GOBP_NEUROBLAST_DIFFERENTIAT...,SET,6,1.1277,0.020373,0.43957,0.0051557,GOBP_NEUROBLAST_DIFFERENTIATION,0.561712706896552
GSE20198_IL12_VS_IFNA_TREATE...2,SET,181,0.16031,0.015831,0.062556,0.0051964,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.56367310117302
HP_VASCULAR_GRANULAR_OSMIOPH...,SET,12,0.62495,0.015964,0.24411,0.0052357,HP_VASCULAR_GRANULAR_OSMIOPHILIC_MATERIAL_DEPOSITION,0.56367310117302
GSE40273_EOS_KO_VS_WT_TREG_UP,SET,181,0.15917,0.015718,0.062275,0.0053,GSE40273_EOS_KO_VS_WT_TREG_UP,0.56367310117302
HANN_RESISTANCE_TO_BCL2_INHI...1,SET,40,0.38864,0.018111,0.15208,0.0053069,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,0.56367310117302
GOBP_POSITIVE_REGULATION_OF_...731,SET,49,0.32781,0.016904,0.12835,0.0053293,GOBP_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY,0.56367310117302
EGR1_01,SET,242,0.14064,0.016032,0.055085,0.0053407,EGR1_01,0.56367310117302
GOBP_NEGATIVE_REGULATION_OF_...483,SET,40,0.33902,0.015799,0.13293,0.0053849,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.56367310117302
GOBP_CELL_CELL_ADHESION_VIA_...,SET,260,0.16763,0.019797,0.065767,0.005408,GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,0.56367310117302
GOMF_STEROL_TRANSFER_ACTIVITY,SET,24,0.47969,0.017323,0.1882,0.0054087,GOMF_STEROL_TRANSFER_ACTIVITY,0.56367310117302
MARTENS_BOUND_BY_PML_RARA_FU...,SET,412,0.10918,0.016163,0.042838,0.0054095,MARTENS_BOUND_BY_PML_RARA_FUSION,0.56367310117302
REACTOME_RNA_POLYMERASE_III_...4,SET,26,0.36704,0.013796,0.14407,0.0054281,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER,0.56367310117302
CEBP_C,SET,184,0.16095,0.016024,0.063213,0.00545,CEBP_C,0.56367310117302
WP_2Q13_COPY_NUMBER_VARIATIO...,SET,57,0.34854,0.019381,0.13694,0.0054644,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,0.56367310117302
GAVISH_3CA_METAPROGRAM_CD4_T...3,SET,43,0.32965,0.015927,0.12954,0.0054705,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_DYSFUNCTION,0.56367310117302
GSE15624_CTRL_VS_6H_HALOFUGI...1,SET,142,0.1735,0.015192,0.068179,0.0054709,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.56367310117302
GOBP_CONVERGENT_EXTENSION,SET,15,0.59429,0.016972,0.23359,0.0054814,GOBP_CONVERGENT_EXTENSION,0.56367310117302
GSE4748_CTRL_VS_CYANOBACTERI...4,SET,188,0.15594,0.015691,0.061337,0.0055095,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.56367310117302
EVI1_03,SET,54,0.30272,0.016385,0.11909,0.0055173,EVI1_03,0.56367310117302
GSE3982_MEMORY_CD4_TCELL_VS_...3,SET,186,0.15574,0.015588,0.061277,0.0055215,GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN,0.56367310117302
GOBP_OLIGOSACCHARIDE_LIPID_I...,SET,20,0.42722,0.014086,0.16809,0.0055223,GOBP_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS,0.56367310117302
ROYLANCE_BREAST_CANCER_16Q_C...1,SET,24,0.68423,0.02471,0.26922,0.0055226,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,0.56367310117302
GOBP_NEURAL_RETINA_DEVELOPME...,SET,79,0.26222,0.017155,0.1032,0.0055305,GOBP_NEURAL_RETINA_DEVELOPMENT,0.56367310117302
GSE19401_NAIVE_VS_IMMUNIZED_...1,SET,181,0.16054,0.015854,0.063308,0.0056119,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN,0.56886984
MIR6811_3P,SET,55,0.30002,0.016388,0.11843,0.0056536,MIR6811_3P,0.56886984
GSE2770_IL12_ACT_VS_ACT_CD4_...4,SET,181,0.1578,0.015583,0.06234,0.0056869,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP,0.56886984
HP_ABNORMAL_NASAL_CAVITY_MOR...,SET,16,0.55487,0.016365,0.21927,0.0056981,HP_ABNORMAL_NASAL_CAVITY_MORPHOLOGY,0.56886984
GOCC_TRIGLYCERIDE_RICH_PLASM...,SET,18,0.59399,0.01858,0.23478,0.0057084,GOCC_TRIGLYCERIDE_RICH_PLASMA_LIPOPROTEIN_PARTICLE,0.56886984
HP_ENTHESITIS,SET,10,0.80637,0.018805,0.31879,0.0057158,HP_ENTHESITIS,0.56886984
GOBP_PEPTIDYL_SERINE_DEPHOSP...,SET,14,0.50814,0.014019,0.20089,0.0057175,GOBP_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.56886984
MIR6738_3P,SET,137,0.17918,0.015413,0.070852,0.0057249,MIR6738_3P,0.56886984
AML_Q6,SET,238,0.14239,0.016098,0.056308,0.0057288,AML_Q6,0.56886984
GOBP_NEGATIVE_REGULATION_OF_...375,SET,43,0.33244,0.016062,0.13187,0.0058564,GOBP_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,0.571876861643836
WP_SIGNAL_TRANSDUCTION_THROU...,SET,32,0.40691,0.016965,0.16146,0.0058677,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,0.571876861643836
GOMF_PROTEOGLYCAN_BINDING,SET,35,0.40687,0.017739,0.16147,0.0058741,GOMF_PROTEOGLYCAN_BINDING,0.571876861643836
MIR4433B_5P,SET,51,0.32533,0.017114,0.12914,0.005885,MIR4433B_5P,0.571876861643836
GSE7218_UNSTIM_VS_ANTIGEN_ST...2,SET,178,0.15308,0.014992,0.060796,0.0059077,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP,0.571876861643836
IVANOV_MUTATED_IN_COLON_CANC...,SET,13,0.48001,0.012762,0.19078,0.0059377,IVANOV_MUTATED_IN_COLON_CANCER,0.571876861643836
HP_ABNORMALITY_OF_THE_PANCRE...,SET,284,0.1287,0.015874,0.051162,0.0059478,HP_ABNORMALITY_OF_THE_PANCREAS,0.571876861643836
WP_MITOCHONDRIAL_COMPLEX_IV_...,SET,28,0.35556,0.013868,0.14136,0.0059507,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,0.571876861643836
GOBP_POSITIVE_REGULATION_OF_...593,SET,7,0.86094,0.016799,0.34232,0.0059556,GOBP_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.571876861643836
HP_ABNORMAL_SPINAL_CORD_PHYS...,SET,8,0.74634,0.015568,0.29684,0.0059675,HP_ABNORMAL_SPINAL_CORD_PHYSIOLOGY,0.571876861643836
SP3_Q3,SET,212,0.14846,0.015853,0.059074,0.005988,SP3_Q3,0.571876861643836
HP_ABNORMALITY_OF_INTRACRANI...,SET,82,0.22734,0.015151,0.090461,0.0059885,HP_ABNORMALITY_OF_INTRACRANIAL_PRESSURE,0.571876861643836
TCCATTKW_UNKNOWN,SET,217,0.14837,0.016027,0.059041,0.0059889,TCCATTKW_UNKNOWN,0.571876861643836
GSE46606_DAY1_VS_DAY3_CD40L_...1,SET,175,0.16139,0.015674,0.06423,0.0059954,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN,0.571876861643836
GOCC_DYSTROPHIN_ASSOCIATED_G...,SET,17,0.49941,0.015182,0.1988,0.0060059,GOCC_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX,0.571876861643836
WP_PPARALPHA_PATHWAY,SET,26,0.44809,0.016842,0.17867,0.0060772,WP_PPARALPHA_PATHWAY,0.577084934426229
ABRAHAM_ALPC_VS_MULTIPLE_MYE...1,SET,20,0.47817,0.015766,0.19088,0.0061248,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,0.579388516304348
GOCC_PRESPLICEOSOME,SET,17,0.52332,0.015909,0.20895,0.0061348,GOCC_PRESPLICEOSOME,0.579388516304348
GOMF_RNA_POLYMERASE_III_ACTI...,SET,10,0.5912,0.013787,0.23626,0.0061739,GOMF_RNA_POLYMERASE_III_ACTIVITY,0.579995197297297
HP_INHERITANCE_QUALIFIER,SET,302,0.12865,0.016356,0.051415,0.0061746,HP_INHERITANCE_QUALIFIER,0.579995197297297
GSE16385_UNTREATED_VS_12H_IF...2,SET,159,0.1708,0.015818,0.068394,0.0062624,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,0.586656905660377
HE_LIM_SUN_FETAL_LUNG_C1_MID...1,SET,14,0.65295,0.018015,0.26163,0.0062895,HE_LIM_SUN_FETAL_LUNG_C1_MID_AIRWAY_PROGENITOR_CELL,0.587424549465241
GOBP_NEGATIVE_REGULATION_OF_...27,SET,18,0.55955,0.017503,0.2243,0.0063089,GOBP_NEGATIVE_REGULATION_OF_ANOIKIS,0.587424549465241
REACTOME_DNA_DOUBLE_STRAND_B...2,SET,38,0.33619,0.015271,0.1348,0.0063213,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,0.587424549465241
GOBP_THALAMUS_DEVELOPMENT,SET,10,0.70068,0.01634,0.28136,0.0063867,GOBP_THALAMUS_DEVELOPMENT,0.590313675
GOBP_PUTRESCINE_BIOSYNTHETIC...,SET,5,0.84388,0.013917,0.33897,0.0063996,GOBP_PUTRESCINE_BIOSYNTHETIC_PROCESS,0.590313675
REACTOME_EPIGENETIC_REGULATI...,SET,182,0.1486,0.014714,0.059731,0.0064322,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.590313675
HP_NON_MIDLINE_CLEFT_PALATE,SET,26,0.44523,0.016735,0.17899,0.0064371,HP_NON_MIDLINE_CLEFT_PALATE,0.590313675
MIR7114_3P,SET,42,0.33634,0.01606,0.13522,0.0064392,MIR7114_3P,0.590313675
GOMF_PHOSPHATIDYLCHOLINE_TRA...2,SET,18,0.51622,0.016148,0.20761,0.0064543,GOMF_PHOSPHATIDYLCHOLINE_TRANSPORTER_ACTIVITY,0.590313675
GOBP_HETEROPHILIC_CELL_CELL_...,SET,46,0.3601,0.017993,0.14495,0.0064954,GOBP_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.591244417539267
JOSEPH_RESPONSE_TO_SODIUM_BU...2,SET,26,0.42065,0.015811,0.16934,0.0064985,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,0.591244417539267
GOBERT_OLIGODENDROCYTE_DIFFE...2,SET,525,0.091558,0.015252,0.036888,0.0065363,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP,0.59283522265625
SHI_SPARC_TARGETS_UP,SET,24,0.45445,0.016412,0.18315,0.0065501,SHI_SPARC_TARGETS_UP,0.59283522265625
HP_DEXAMETHASONE_SUPPRESSIBL...,SET,5,1.1394,0.018791,0.4596,0.0065917,HP_DEXAMETHASONE_SUPPRESSIBLE_PRIMARY_HYPERALDOSTERONISM,0.595050736363636
MIR615_3P,SET,6,0.85379,0.015424,0.34467,0.0066273,MIR615_3P,0.595358524484536
GSE43955_1H_VS_60H_ACT_CD4_T...4,SET,186,0.14986,0.014999,0.060505,0.0066331,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.595358524484536
REACTOME_DISEASES_ASSOCIATED...3,SET,19,0.42685,0.013718,0.17239,0.0066465,REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS,0.595358524484536
REACTOME_SIGNALING_BY_FGFR_I...,SET,61,0.27474,0.015802,0.11102,0.006673,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,0.596195668380463
GSE11864_UNTREATED_VS_CSF1_I...6,SET,167,0.16348,0.015512,0.066092,0.0066952,GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP,0.596600969465649
chr11q23,SET,107,0.395,0.030052,0.15976,0.0067124,chr11q23,0.596600969465649
GOCC_A_BAND,SET,39,0.31472,0.014482,0.12735,0.006735,GOCC_A_BAND,0.596600969465649
GOCC_SPLICEOSOMAL_TRI_SNRNP_...,SET,36,0.30102,0.01331,0.12183,0.0067462,GOCC_SPLICEOSOMAL_TRI_SNRNP_COMPLEX,0.596600969465649
GOBP_REGULATION_OF_LAMELLIPO...2,SET,11,0.62677,0.015329,0.25419,0.006841,GOBP_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.601252723484848
WP_CYTOKINECYTOKINE_RECEPTOR...,SET,241,0.1571,0.017872,0.06372,0.0068467,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.601252723484848
GSE7460_CTRL_VS_FOXP3_OVEREX...4,SET,181,0.15457,0.015264,0.062699,0.0068507,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP,0.601252723484848
GOBP_ACTIVIN_RECEPTOR_SIGNAL...,SET,44,0.34933,0.017072,0.1418,0.0068818,GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.602460853904282
ABE_VEGFA_TARGETS,SET,15,0.59305,0.016936,0.24085,0.0069058,ABE_VEGFA_TARGETS,0.603042912060301
GOCC_COPI_VESICLE_COAT,SET,12,0.51875,0.013251,0.21089,0.0069562,GOCC_COPI_VESICLE_COAT,0.605921631578947
GOBP_CYTOPLASMIC_SEQUESTERIN...2,SET,13,0.54622,0.014522,0.22223,0.0069917,GOBP_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN,0.60749133375
GOBP_MACROAUTOPHAGY,SET,325,0.11344,0.014952,0.046199,0.0070387,GOBP_MACROAUTOPHAGY,0.609362354477612
GSE3982_CTRL_VS_IGE_STIM_MAS...2,SET,183,0.15266,0.015158,0.062184,0.0070483,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP,0.609362354477612
GOBP_COLLATERAL_SPROUTING_IN...,SET,4,1.1164,0.016469,0.45493,0.007068,GOBP_COLLATERAL_SPROUTING_IN_ABSENCE_OF_INJURY,0.609549230769231
HP_ABNORMAL_BRAIN_FDG_POSITR...,SET,23,0.42318,0.014961,0.17275,0.0071544,HP_ABNORMAL_BRAIN_FDG_POSITRON_EMISSION_TOMOGRAPHY,0.610421864303178
GOMF_AMINO_ACID_PROTON_SYMPO...,SET,6,0.98806,0.01785,0.40344,0.0071657,GOMF_AMINO_ACID_PROTON_SYMPORTER_ACTIVITY,0.610421864303178
KEGG_MEDICUS_REFERENCE_BETA_...3,SET,5,0.84532,0.013941,0.34523,0.0071757,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_PEROXISOME_VLCFA,0.610421864303178
GOMF_ATP_DEPENDENT_ACTIVITY_...2,SET,71,0.23948,0.014856,0.097812,0.0071791,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_RNA,0.610421864303178
GSE43955_1H_VS_10H_ACT_CD4_T...3,SET,182,0.15966,0.015809,0.065209,0.0071795,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.610421864303178
GOBP_PARAXIAL_MESODERM_FORMA...,SET,6,0.97724,0.017655,0.39917,0.0071835,GOBP_PARAXIAL_MESODERM_FORMATION,0.610421864303178
HP_ORCHITIS,SET,14,0.55918,0.015428,0.22855,0.0072142,HP_ORCHITIS,0.610783186131387
GOBP_HYALURONAN_CATABOLIC_PR...,SET,15,0.53412,0.015253,0.21835,0.0072229,GOBP_HYALURONAN_CATABOLIC_PROCESS,0.610783186131387
KAMMINGA_SENESCENCE,SET,38,0.32271,0.014659,0.13207,0.0072792,KAMMINGA_SENESCENCE,0.614049990291262
MIR10526_3P,SET,105,0.20444,0.015409,0.083809,0.0073623,MIR10526_3P,0.617109459677419
GOBP_NEGATIVE_REGULATION_OF_...684,SET,46,0.28597,0.014289,0.11725,0.0073717,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.617109459677419
GSE12963_ENV_NEF_VS_ENV_NEF_...1,SET,132,0.18195,0.015365,0.074637,0.0073939,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.617109459677419
GOBP_POSITIVE_REGULATION_OF_...25,SET,8,0.75415,0.015731,0.30941,0.0074018,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.617109459677419
GSE9988_ANTI_TREM1_VS_LOW_LP...2,SET,174,0.16009,0.015503,0.065742,0.0074496,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP,0.617109459677419
WP_NGLYCAN_BIOSYNTHESIS,SET,53,0.26998,0.014478,0.11091,0.0074665,WP_NGLYCAN_BIOSYNTHESIS,0.617109459677419
GSE9946_IMMATURE_VS_LISTERIA...2,SET,118,0.19322,0.015433,0.07938,0.0074679,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP,0.617109459677419
HP_GANGRENE,SET,52,0.30214,0.016049,0.12416,0.0074804,HP_GANGRENE,0.617109459677419
HP_ABNORMAL_CIRCULATING_CREA...1,SET,10,0.61493,0.01434,0.2528,0.0075028,HP_ABNORMAL_CIRCULATING_CREATINE_CONCENTRATION,0.617109459677419
HP_INTESTINAL_ATRESIA,SET,56,0.28079,0.015476,0.11545,0.0075091,HP_INTESTINAL_ATRESIA,0.617109459677419
GNF2_SPRR1B,SET,23,0.46895,0.016579,0.19285,0.0075209,GNF2_SPRR1B,0.617109459677419
GOBP_CELLULAR_RESPONSE_TO_IN...2,SET,5,0.94265,0.015546,0.38784,0.0075434,GOBP_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL,0.617109459677419
LMO2COM_02,SET,220,0.14426,0.015689,0.05936,0.0075482,LMO2COM_02,0.617109459677419
GSE29949_MICROGLIA_BRAIN_VS_...3,SET,184,0.16105,0.016034,0.066311,0.0075818,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.617109459677419
GOBP_DOPAMINERGIC_NEURON_DIF...,SET,37,0.39424,0.017671,0.16235,0.0075889,GOBP_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.617109459677419
GOBP_DOLICHYL_DIPHOSPHATE_ME...,SET,4,1.0519,0.015516,0.43382,0.0076666,GOBP_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS,0.617109459677419
GOCC_SYNAPTIC_MEMBRANE,SET,369,0.11591,0.016259,0.047807,0.0076675,GOCC_SYNAPTIC_MEMBRANE,0.617109459677419
HP_FLAT_CORNEA,SET,19,0.6413,0.020609,0.26453,0.0076745,HP_FLAT_CORNEA,0.617109459677419
MIR6761_5P,SET,108,0.20332,0.01554,0.083877,0.0076793,MIR6761_5P,0.617109459677419
MIR4518,SET,81,0.22214,0.014715,0.09168,0.0077006,MIR4518,0.617109459677419
BRN2_01,SET,210,0.14822,0.015753,0.061176,0.0077061,BRN2_01,0.617109459677419
GOCC_U2_TYPE_SPLICEOSOMAL_CO...,SET,86,0.19695,0.013441,0.081293,0.0077061,GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX,0.617109459677419
GOBP_NEGATIVE_REGULATION_OF_...496,SET,8,0.7359,0.01535,0.30405,0.0077578,GOBP_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.619821468965517
BIOCARTA_RANBP2_PATHWAY,SET,10,0.64835,0.01512,0.26809,0.0077993,BIOCARTA_RANBP2_PATHWAY,0.621707962155963
HP_HEPATOCELLULAR_CARCINOMA,SET,75,0.24562,0.015659,0.10186,0.0079506,HP_HEPATOCELLULAR_CARCINOMA,0.625474342762063
PID_NFKAPPAB_ATYPICAL_PATHWAY,SET,16,0.50615,0.014928,0.2099,0.007952,PID_NFKAPPAB_ATYPICAL_PATHWAY,0.625474342762063
AP2_Q3,SET,231,0.13483,0.015021,0.055958,0.0079921,AP2_Q3,0.625474342762063
GSE41867_LCMV_ARMSTRONG_VS_C...2,SET,176,0.15306,0.014906,0.063558,0.008023,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP,0.625474342762063
KEGG_MEDICUS_PATHOGEN_HPV_E5...1,SET,6,0.988,0.017849,0.41036,0.0080337,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.625474342762063
KEGG_MEDICUS_PATHOGEN_KSHV_M...1,SET,6,0.988,0.017849,0.41036,0.0080337,KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.625474342762063
GOMF_MANNOSYLTRANSFERASE_ACT...,SET,24,0.38951,0.014067,0.16182,0.0080471,GOMF_MANNOSYLTRANSFERASE_ACTIVITY,0.625474342762063
ATGCTGC_MIR103_MIR107,SET,198,0.1441,0.014876,0.059871,0.0080524,ATGCTGC_MIR103_MIR107,0.625474342762063
MIR6815_5P,SET,54,0.27184,0.014713,0.11298,0.0080677,MIR6815_5P,0.625474342762063
GSE26488_WT_VS_HDAC7_KO_DOUB...1,SET,157,0.1657,0.01525,0.068878,0.0080753,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.625474342762063
GOMF_ACTIVIN_RECEPTOR_BINDING,SET,8,0.75791,0.01581,0.31512,0.0080883,GOMF_ACTIVIN_RECEPTOR_BINDING,0.625474342762063
BIOCARTA_FAS_PATHWAY,SET,30,0.38094,0.015379,0.15839,0.00809,BIOCARTA_FAS_PATHWAY,0.625474342762063
GOBP_VESICLE_TETHERING,SET,30,0.35522,0.01434,0.14771,0.0080941,GOBP_VESICLE_TETHERING,0.625474342762063
HP_NEOPLASM,SET,880,0.071246,0.015212,0.029643,0.0081246,HP_NEOPLASM,0.625474342762063
REACTOME_GPER1_SIGNALING,SET,45,0.31548,0.015592,0.13127,0.0081302,REACTOME_GPER1_SIGNALING,0.625474342762063
GOBP_REGULATION_OF_MACROAUTO...,SET,166,0.157,0.014853,0.065403,0.0081926,GOBP_REGULATION_OF_MACROAUTOPHAGY,0.625474342762063
REACTOME_SIGNALING_BY_FGFR2_...1,SET,19,0.42334,0.013605,0.17639,0.0082006,REACTOME_SIGNALING_BY_FGFR2_IIIA_TM,0.625474342762063
ACEVEDO_LIVER_TUMOR_VS_NORMA...2,SET,752,0.074447,0.014748,0.031042,0.0082418,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP,0.625474342762063
GOBP_NEGATIVE_REGULATION_OF_...491,SET,333,0.11327,0.015108,0.047235,0.008247,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.625474342762063
REACTOME_B_WICH_COMPLEX_POSI...,SET,28,0.35213,0.013734,0.14686,0.008252,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,0.625474342762063
ZHONG_PFC_C8_ORG_PROLIFERATI...,SET,57,0.26152,0.014542,0.10908,0.008258,ZHONG_PFC_C8_ORG_PROLIFERATING,0.625474342762063
MIR3121_3P,SET,590,0.085441,0.015061,0.035637,0.0082582,MIR3121_3P,0.625474342762063
GOBP_PROTEIN_LOCALIZATION_TO...39,SET,297,0.11707,0.014762,0.048842,0.0082726,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.625474342762063
GOCC_MEMBRANE_MICRODOMAIN,SET,270,0.13018,0.015662,0.054338,0.0083002,GOCC_MEMBRANE_MICRODOMAIN,0.625474342762063
GSE9239_CTRL_VS_TNF_INHIBITO...1,SET,177,0.14532,0.014192,0.060702,0.0083396,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN,0.625474342762063
GOBP_RETINA_MORPHOGENESIS_IN...,SET,62,0.27614,0.016012,0.11536,0.0083452,GOBP_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.625474342762063
KEGG_MEDICUS_REFERENCE_HEDGE...1,SET,14,0.52759,0.014556,0.22045,0.0083555,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY,0.625474342762063
TRAVAGLINI_LUNG_MACROPHAGE_C...,SET,191,0.16337,0.016569,0.068292,0.0083773,TRAVAGLINI_LUNG_MACROPHAGE_CELL,0.625474342762063
WP_DYRK1A_INVOLVEMENT_REGARD...,SET,59,0.26505,0.014994,0.11087,0.0084162,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,0.625474342762063
USF_02,SET,237,0.13367,0.015081,0.055944,0.0084458,USF_02,0.625474342762063
GSE22432_UNTREATED_VS_TGFB1_...2,SET,186,0.14813,0.014827,0.062009,0.0084545,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP,0.625474342762063
GSE17721_PAM3CSK4_VS_CPG_1H_...1,SET,176,0.15111,0.014717,0.063262,0.0084609,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN,0.625474342762063
HP_UNILATERAL_CLEFT_PALATE,SET,18,0.52426,0.016399,0.2196,0.0084912,HP_UNILATERAL_CLEFT_PALATE,0.625474342762063
GOMF_PYRIMIDINE_NUCLEOTIDE_S...,SET,10,0.61639,0.014374,0.25824,0.008501,GOMF_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.625474342762063
USF2_Q6,SET,246,0.13551,0.015573,0.056795,0.0085208,USF2_Q6,0.625474342762063
GOBP_PEPTIDYL_SERINE_AUTOPHO...,SET,8,0.71608,0.014937,0.30021,0.0085386,GOBP_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION,0.625474342762063
GOBP_FUCOSYLATION,SET,16,0.50445,0.014878,0.21161,0.0085717,GOBP_FUCOSYLATION,0.625474342762063
GOMF_NUCLEAR_IMPORT_SIGNAL_R...,SET,19,0.42481,0.013652,0.17821,0.0085745,GOMF_NUCLEAR_IMPORT_SIGNAL_RECEPTOR_ACTIVITY,0.625474342762063
MYCMAX_01,SET,235,0.13672,0.015362,0.057363,0.0085801,MYCMAX_01,0.625474342762063
HP_EEG_WITH_GENERALIZED_SLOW...1,SET,32,0.35123,0.014643,0.1476,0.0086719,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY,0.625474342762063
GOBP_REGULATION_OF_COMPLEMEN...1,SET,17,0.56229,0.017094,0.23636,0.0086861,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION,0.625474342762063
GSE41176_UNSTIM_VS_ANTI_IGM_...9,SET,175,0.14923,0.014492,0.062802,0.0087522,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN,0.625474342762063
chr14q22,SET,43,0.63923,0.030884,0.26908,0.0087661,chr14q22,0.625474342762063
GOCC_EXOCYST,SET,16,0.48323,0.014252,0.20345,0.0087761,GOCC_EXOCYST,0.625474342762063
GSE25677_MPL_VS_R848_STIM_BC...2,SET,161,0.16853,0.015705,0.070971,0.0087879,GSE25677_MPL_VS_R848_STIM_BCELL_UP,0.625474342762063
MIR4653_3P,SET,47,0.30381,0.015344,0.12797,0.0088038,MIR4653_3P,0.625474342762063
GAUTAM_EYE_IRIS_CILIARY_BODY...15,SET,83,0.21606,0.014487,0.091048,0.0088265,GAUTAM_EYE_IRIS_CILIARY_BODY_SCHWANN_CELLS,0.625474342762063
GSE22501_PERIPHERAL_BLOOD_VS...2,SET,178,0.15941,0.015612,0.067181,0.0088309,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP,0.625474342762063
GOBP_LEUKOTRIENE_B4_METABOLI...,SET,5,0.92108,0.015191,0.3883,0.0088488,GOBP_LEUKOTRIENE_B4_METABOLIC_PROCESS,0.625474342762063
GSE16385_MONOCYTE_VS_12H_ROS...2,SET,187,0.14891,0.014944,0.062807,0.0088769,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.625474342762063
WP_FARNESOID_X_RECEPTOR_PATH...,SET,19,0.49332,0.015854,0.20828,0.0089331,WP_FARNESOID_X_RECEPTOR_PATHWAY,0.625474342762063
HEN1_02,SET,184,0.14662,0.014597,0.061919,0.0089508,HEN1_02,0.625474342762063
GSE21927_UNTREATED_VS_GMCSF_...3,SET,153,0.16811,0.015274,0.070999,0.0089541,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN,0.625474342762063
GOBP_NEGATIVE_REGULATION_OF_...154,SET,11,0.73643,0.018011,0.31103,0.0089554,GOBP_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.625474342762063
GOMF_GTPASE_BINDING,SET,283,0.11842,0.014581,0.050038,0.008984,GOMF_GTPASE_BINDING,0.625474342762063
VANDESLUIS_COMMD1_TARGETS_GR...5,SET,14,0.5584,0.015406,0.23599,0.0089911,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,0.625474342762063
DURANTE_ADULT_OLFACTORY_NEUR...14,SET,107,0.21188,0.01612,0.089547,0.008993,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_ENSHEATHING_GLIA,0.625474342762063
PUJANA_BRCA1_PCC_NETWORK,SET,1458,0.053438,0.014442,0.022589,0.0090032,PUJANA_BRCA1_PCC_NETWORK,0.625474342762063
chr10q21,SET,41,0.59941,0.02828,0.25338,0.0090044,chr10q21,0.625474342762063
HP_SPASTIC_ATAXIA,SET,18,0.43719,0.013676,0.18483,0.0090114,HP_SPASTIC_ATAXIA,0.625474342762063
GSE41867_NAIVE_VS_DAY30_LCMV...3,SET,180,0.14277,0.014061,0.060379,0.0090291,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN,0.625474342762063
GSE25123_WT_VS_PPARG_KO_MACR...8,SET,173,0.16719,0.016144,0.070724,0.0090468,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP,0.625474342762063
GSE45365_HEALTHY_VS_MCMV_INF...8,SET,184,0.15252,0.015185,0.06455,0.0090723,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN,0.625474342762063
GOCC_STEREOCILIA_COUPLING_LI...,SET,7,0.83775,0.016347,0.35478,0.0091107,GOCC_STEREOCILIA_COUPLING_LINK,0.625474342762063
WP_WNTBETACATENIN_SIGNALING_...1,SET,4,1.1606,0.017121,0.49152,0.009111,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,0.625474342762063
GOBP_LIPID_STORAGE,SET,87,0.2301,0.015794,0.09752,0.0091557,GOBP_LIPID_STORAGE,0.625474342762063
GOBP_TOLERANCE_INDUCTION,SET,27,0.42674,0.016345,0.18096,0.0091888,GOBP_TOLERANCE_INDUCTION,0.625474342762063
GOCC_MEMBRANE_PROTEIN_COMPLEX,SET,1153,0.062425,0.015138,0.026476,0.0091982,GOCC_MEMBRANE_PROTEIN_COMPLEX,0.625474342762063
KEGG_MEDICUS_REFERENCE_IL12_...,SET,10,0.75698,0.017653,0.3211,0.0092059,KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY,0.625474342762063
GOBP_NEGATIVE_REGULATION_OF_...25,SET,19,0.50598,0.016261,0.21483,0.0092598,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.625474342762063
GOBP_REGULATION_OF_VASCULATU...,SET,265,0.13193,0.015728,0.056028,0.009273,GOBP_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.625474342762063
GSE29164_UNTREATED_VS_CD8_TC...1,SET,183,0.14129,0.014029,0.060015,0.0092839,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,0.625474342762063
KEGG_RNA_POLYMERASE,SET,24,0.36531,0.013193,0.15519,0.0092936,KEGG_RNA_POLYMERASE,0.625474342762063
MIR3155A_MIR3155B,SET,71,0.23691,0.014697,0.10068,0.0093138,MIR3155A_MIR3155B,0.625474342762063
YAMASHITA_LIVER_CANCER_WITH_...2,SET,49,0.27668,0.014268,0.11764,0.009345,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,0.625474342762063
GOBP_ODONTOGENESIS_OF_DENTIN...,SET,87,0.23562,0.016173,0.10019,0.0093501,GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.625474342762063
HP_MATURITY_ONSET_DIABETES_O...,SET,19,0.49786,0.016,0.21174,0.0093595,HP_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.625474342762063
REACTOME_RHO_GTPASES_ACTIVAT...9,SET,19,0.46302,0.01488,0.19707,0.0094032,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,0.625474342762063
GOBP_POSITIVE_REGULATION_OF_...171,SET,30,0.3505,0.01415,0.14921,0.0094151,GOBP_POSITIVE_REGULATION_OF_COAGULATION,0.625474342762063
AMBROSINI_FLAVOPIRIDOL_TREAT...,SET,99,0.19604,0.01435,0.083472,0.0094272,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,0.625474342762063
HP_HYPOINSULINEMIA,SET,21,0.46733,0.015788,0.19918,0.0094878,HP_HYPOINSULINEMIA,0.625474342762063
KEGG_MEDICUS_REFERENCE_LPAR_...,SET,22,0.45223,0.015637,0.19281,0.0095075,KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY,0.625474342762063
GOBP_VASCULAR_ENDOTHELIAL_GR...1,SET,34,0.35143,0.015102,0.14987,0.0095201,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.625474342762063
GOMF_PHOSPHATASE_REGULATOR_A...,SET,93,0.20262,0.014377,0.086414,0.0095253,GOMF_PHOSPHATASE_REGULATOR_ACTIVITY,0.625474342762063
DESCARTES_MAIN_FETAL_THYMOCY...,SET,70,0.25177,0.015509,0.10744,0.0095578,DESCARTES_MAIN_FETAL_THYMOCYTES,0.625474342762063
GOBP_CENTROMERIC_SISTER_CHRO...,SET,9,0.68541,0.015164,0.29258,0.0095796,GOBP_CENTROMERIC_SISTER_CHROMATID_COHESION,0.625474342762063
HP_NEOPLASM_OF_THE_COLON,SET,77,0.21866,0.014124,0.093398,0.0096184,HP_NEOPLASM_OF_THE_COLON,0.625474342762063
HP_LARGE_FOR_GESTATIONAL_AGE,SET,49,0.28547,0.014721,0.12194,0.0096185,HP_LARGE_FOR_GESTATIONAL_AGE,0.625474342762063
NATSUME_RESPONSE_TO_INTERFER...1,SET,51,0.28677,0.015086,0.1225,0.0096247,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.625474342762063
YAO_TEMPORAL_RESPONSE_TO_PRO...4,SET,86,0.19909,0.013587,0.085104,0.0096637,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,0.625474342762063
EHLERS_ANEUPLOIDY_DN,SET,10,0.69479,0.016203,0.29719,0.0097036,EHLERS_ANEUPLOIDY_DN,0.625474342762063
GSE21670_UNTREATED_VS_TGFB_I...2,SET,170,0.15247,0.014596,0.065254,0.0097366,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP,0.625474342762063
GOBP_NEGATIVE_REGULATION_OF_...508,SET,2,0.98949,0.010322,0.42363,0.0097583,GOBP_NEGATIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,0.625474342762063
GOBP_REGULATION_OF_UBIQUITIN...1,SET,149,0.16012,0.014359,0.068586,0.009787,GOBP_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.625474342762063
GOMF_LYSOPHOSPHATIDIC_ACID_R...,SET,4,0.9085,0.013402,0.38941,0.0098294,GOMF_LYSOPHOSPHATIDIC_ACID_RECEPTOR_ACTIVITY,0.625474342762063
GSE14415_FOXP3_KO_NATURAL_TR...2,SET,153,0.16082,0.014613,0.068962,0.0098534,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP,0.625474342762063
GOBP_POSITIVE_REGULATION_OF_...101,SET,10,0.75758,0.017667,0.32486,0.0098563,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.625474342762063
ZHONG_PFC_C2_ASCL1_POS_ASTRO...,SET,4,1.192,0.017583,0.51126,0.0098722,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,0.625474342762063
CAGCAGG_MIR370,SET,138,0.16333,0.0141,0.070074,0.0098875,CAGCAGG_MIR370,0.625474342762063
HP_MYOSITIS,SET,34,0.34415,0.014789,0.1477,0.0099079,HP_MYOSITIS,0.625474342762063
MORF_RRM1,SET,89,0.1949,0.01353,0.083659,0.0099156,MORF_RRM1,0.625474342762063
WP_ENDODERM_DIFFERENTIATION,SET,130,0.18384,0.015407,0.07892,0.0099235,WP_ENDODERM_DIFFERENTIATION,0.625474342762063
REACTOME_NEGATIVE_REGULATION...12,SET,15,0.54694,0.015619,0.23484,0.0099348,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS,0.625474342762063
GOBP_MESONEPHRIC_DUCT_DEVELO...,SET,8,0.74346,0.015508,0.31933,0.0099565,GOBP_MESONEPHRIC_DUCT_DEVELOPMENT,0.625474342762063
FARMER_BREAST_CANCER_CLUSTER...5,SET,19,0.46923,0.015079,0.20156,0.0099633,FARMER_BREAST_CANCER_CLUSTER_5,0.625474342762063
GOBP_POSITIVE_REGULATION_OF_...377,SET,4,0.99824,0.014726,0.42891,0.009978,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.625474342762063
HP_PERICARDITIS,SET,33,0.35848,0.015177,0.15404,0.0099838,HP_PERICARDITIS,0.625474342762063
REACTOME_LOSS_OF_FUNCTION_OF...1,SET,11,0.56271,0.013763,0.24183,0.0099916,REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME,0.625474342762063
HP_TEMPORAL_CORTICAL_ATROPHY,SET,17,0.47209,0.014352,0.20292,0.010002,HP_TEMPORAL_CORTICAL_ATROPHY,0.625474342762063
MIR2117,SET,112,0.18722,0.014571,0.080484,0.010011,MIR2117,0.625474342762063
HP_CHOROIDAL_HEMANGIOMA,SET,5,0.80872,0.013338,0.3477,0.010017,HP_CHOROIDAL_HEMANGIOMA,0.625474342762063
GSE41867_NAIVE_VS_DAY8_LCMV_...4,SET,185,0.14233,0.014208,0.061195,0.010019,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.625474342762063
LAKE_ADULT_KIDNEY_C2_PODOCYT...,SET,192,0.15543,0.015804,0.066829,0.010019,LAKE_ADULT_KIDNEY_C2_PODOCYTES,0.625474342762063
GOBP_REGULATION_OF_TYPE_B_PA...2,SET,11,0.64306,0.015728,0.27652,0.010027,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_PROLIFERATION,0.625474342762063
GOBP_SPECIFICATION_OF_ANIMAL...,SET,35,0.38368,0.016728,0.165,0.010033,GOBP_SPECIFICATION_OF_ANIMAL_ORGAN_IDENTITY,0.625474342762063
SENGUPTA_NASOPHARYNGEAL_CARC...2,SET,286,0.1218,0.015076,0.052381,0.010034,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,0.625474342762063
GSE33162_HDAC3_KO_VS_HDAC3_K...1,SET,184,0.15144,0.015077,0.065137,0.010044,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN,0.625474342762063
MIR212_5P,SET,86,0.21161,0.014442,0.091044,0.010062,MIR212_5P,0.625474342762063
GOBP_ENDOCYTOSIS_INVOLVED_IN...,SET,11,0.6058,0.014816,0.26092,0.010128,GOBP_ENDOCYTOSIS_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,0.625474342762063
GSE40274_CTRL_VS_EOS_TRANSDU...2,SET,158,0.15867,0.014649,0.068367,0.010151,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.625474342762063
GOBP_CONVERGENT_EXTENSION_IN...1,SET,5,1.0419,0.017184,0.44916,0.010182,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION,0.625474342762063
GOBP_ESTABLISHMENT_OF_BLOOD_...2,SET,4,1.0961,0.016169,0.47264,0.010199,GOBP_ESTABLISHMENT_OF_BLOOD_RETINAL_BARRIER,0.625474342762063
REACTOME_CDC6_ASSOCIATION_WI...,SET,8,0.71505,0.014915,0.30841,0.010216,REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX,0.625474342762063
REACTOME_ADORA2B_MEDIATED_AN...,SET,42,0.31855,0.015211,0.1374,0.010219,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,0.625474342762063
GSE14308_TH1_VS_INDUCED_TREG...2,SET,180,0.14252,0.014036,0.06148,0.010224,GSE14308_TH1_VS_INDUCED_TREG_UP,0.625474342762063
WP_DOPAMINERGIC_NEUROGENESIS,SET,28,0.42726,0.016664,0.18431,0.010227,WP_DOPAMINERGIC_NEUROGENESIS,0.625474342762063
PGM3_TARGET_GENES,SET,214,0.13414,0.01439,0.057869,0.01023,PGM3_TARGET_GENES,0.625474342762063
MIR130A_5P,SET,307,0.12044,0.015436,0.051994,0.010273,MIR130A_5P,0.625474342762063
HP_NEOPLASM_OF_THE_PANCREAS,SET,86,0.21203,0.01447,0.091545,0.010281,HP_NEOPLASM_OF_THE_PANCREAS,0.625474342762063
GOMF_GLUCOSIDASE_ACTIVITY,SET,13,0.53426,0.014204,0.23069,0.010288,GOMF_GLUCOSIDASE_ACTIVITY,0.625474342762063
GOBP_CELLULAR_RESPONSE_TO_GR...,SET,24,0.44499,0.01607,0.19227,0.010328,GOBP_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS,0.625474342762063
HAHTOLA_SEZARY_SYNDROM_UP,SET,83,0.22087,0.01481,0.095446,0.010336,HAHTOLA_SEZARY_SYNDROM_UP,0.625474342762063
HAY_BONE_MARROW_CD34_POS_PRE...2,SET,96,0.21625,0.015589,0.093449,0.010336,HAY_BONE_MARROW_CD34_POS_PRE_PC,0.625474342762063
GOBP_REGULATION_OF_ENDOPLASM...3,SET,27,0.39091,0.014973,0.16895,0.010345,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.625474342762063
MIR6865_5P,SET,55,0.25921,0.014159,0.11204,0.010353,MIR6865_5P,0.625474342762063
REACTOME_KILLING_MECHANISMS,SET,11,0.61519,0.015046,0.26598,0.01037,REACTOME_KILLING_MECHANISMS,0.625474342762063
GOBP_GOLGI_TO_PLASMA_MEMBRAN...2,SET,61,0.24345,0.014002,0.10526,0.010371,GOBP_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT,0.625474342762063
HP_IMPAIRED_LYMPHOCYTE_TRANS...,SET,11,0.61783,0.015111,0.26725,0.0104,HP_IMPAIRED_LYMPHOCYTE_TRANSFORMATION_WITH_PHYTOHEMAGGLUTININ,0.625474342762063
HP_FOAMY_URINE,SET,29,0.37959,0.015067,0.16434,0.010456,HP_FOAMY_URINE,0.625474342762063
GOBP_POSITIVE_REGULATION_OF_...487,SET,5,0.86075,0.014196,0.37273,0.010469,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.625474342762063
NAKAYA_PBMC_FLUAD_IMUVAC_MAL...,SET,18,0.46114,0.014425,0.19971,0.010476,NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE,0.625474342762063
MIR548G_3P,SET,216,0.13341,0.014378,0.05778,0.01048,MIR548G_3P,0.625474342762063
GSE2770_UNTREATED_VS_IL12_TR...2,SET,178,0.14793,0.014488,0.064071,0.01048,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.625474342762063
GSE30153_LUPUS_VS_HEALTHY_DO...2,SET,184,0.14326,0.014263,0.062056,0.01049,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP,0.625474342762063
HP_IMPOTENCE,SET,47,0.29672,0.014986,0.12859,0.010522,HP_IMPOTENCE,0.625474342762063
MIR218_2_3P,SET,46,0.29059,0.01452,0.12604,0.010572,MIR218_2_3P,0.625474342762063
GSE27786_ERYTHROBLAST_VS_MON...2,SET,174,0.14669,0.014205,0.063629,0.010579,GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP,0.625474342762063
HP_ABNORMAL_NASAL_SEPTUM_MOR...,SET,15,0.57886,0.016531,0.25114,0.01059,HP_ABNORMAL_NASAL_SEPTUM_MORPHOLOGY,0.625474342762063
MODULE_57,SET,55,0.25459,0.013907,0.11047,0.010597,MODULE_57,0.625474342762063
GSE17721_CTRL_VS_GARDIQUIMOD...10,SET,171,0.14947,0.014351,0.064863,0.010604,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP,0.625474342762063
GOBP_NEGATIVE_REGULATION_OF_...281,SET,14,0.62973,0.017374,0.27343,0.010643,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.625474342762063
GSE360_CTRL_VS_L_MAJOR_DC_UP,SET,180,0.14598,0.014376,0.063402,0.010662,GSE360_CTRL_VS_L_MAJOR_DC_UP,0.625474342762063
GOBP_PRIMARY_AMINO_COMPOUND_...1,SET,6,0.67881,0.012263,0.29489,0.010676,GOBP_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS,0.625474342762063
GOMF_GLYCERALDEHYDE_3_PHOSPH...,SET,7,0.82654,0.016128,0.35919,0.010697,GOMF_GLYCERALDEHYDE_3_PHOSPHATE_DEHYDROGENASE_NADPLUS_NON_PHOSPHORYLATING_ACTIVITY,0.625474342762063
QIU_PBMC_HEPTATITIS_B_SURFAC...2,SET,7,0.86118,0.016804,0.37431,0.010711,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0_TO_35DY_JOINTLY_UP,0.625474342762063
GOBP_POSITIVE_REGULATION_OF_...251,SET,9,0.77264,0.017094,0.33587,0.010718,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING,0.625474342762063
GSE1925_CTRL_VS_IFNG_PRIMED_...6,SET,189,0.14736,0.014867,0.064096,0.010755,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP,0.625474342762063
MIR765,SET,257,0.12833,0.015069,0.055818,0.010758,MIR765,0.625474342762063
WALLACE_JAK2_TARGETS_UP,SET,19,0.38334,0.012319,0.16676,0.010767,WALLACE_JAK2_TARGETS_UP,0.625474342762063
MODULE_203,SET,3,1.1839,0.015125,0.51514,0.010778,MODULE_203,0.625474342762063
GOMF_PHOSPHATIDYLINOSITOL_3_...12,SET,11,0.61596,0.015065,0.26802,0.010781,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATORY_SUBUNIT_BINDING,0.625474342762063
GOMF_CORECEPTOR_ACTIVITY,SET,52,0.29081,0.015447,0.12655,0.010787,GOMF_CORECEPTOR_ACTIVITY,0.625474342762063
GOBP_ESTABLISHMENT_OF_LOCALI...,SET,1770,0.047992,0.014158,0.020885,0.01079,GOBP_ESTABLISHMENT_OF_LOCALIZATION_IN_CELL,0.625474342762063
REACTOME_FORMATION_OF_XYLULO...,SET,5,0.92084,0.015187,0.40089,0.010816,REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE,0.625474342762063
GOBP_GLUCURONATE_CATABOLIC_P...,SET,5,0.92084,0.015187,0.40089,0.010816,GOBP_GLUCURONATE_CATABOLIC_PROCESS_TO_XYLULOSE_5_PHOSPHATE,0.625474342762063
GOCC_ENDOPLASMIC_RETICULUM_L...,SET,285,0.1216,0.015025,0.053012,0.010905,GOCC_ENDOPLASMIC_RETICULUM_LUMEN,0.629573546511628
GAVIN_IL2_RESPONSIVE_FOXP3_T...1,SET,5,0.88523,0.014599,0.38625,0.010962,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN,0.631814776119403
GGGTGGRR_PAX4_03,SET,1158,0.060437,0.014685,0.026393,0.011018,GGGTGGRR_PAX4_03,0.633000570247934
SRPK1_TARGET_GENES,SET,304,0.11205,0.014291,0.048931,0.011019,SRPK1_TARGET_GENES,0.633000570247934
GOBP_NEURAL_NUCLEUS_DEVELOPM...,SET,57,0.25891,0.014397,0.11313,0.011055,GOBP_NEURAL_NUCLEUS_DEVELOPMENT,0.634020668316832
GOBP_DIGESTIVE_TRACT_MORPHOG...,SET,48,0.30641,0.015639,0.13401,0.011118,GOBP_DIGESTIVE_TRACT_MORPHOGENESIS,0.63658334431631
HP_NEUROFIBRILLARY_TANGLES,SET,23,0.43459,0.015365,0.19016,0.011149,HP_NEUROFIBRILLARY_TANGLES,0.63708202247191
HAHTOLA_CTCL_CUTANEOUS,SET,21,0.40767,0.013773,0.17861,0.011238,HAHTOLA_CTCL_CUTANEOUS,0.63708202247191
IBRAHIM_NRF3_DOWN,SET,13,0.49885,0.013263,0.2186,0.01125,IBRAHIM_NRF3_DOWN,0.63708202247191
GOBP_OTOLITH_DEVELOPMENT,SET,10,0.6581,0.015347,0.28844,0.011263,GOBP_OTOLITH_DEVELOPMENT,0.63708202247191
GSE24634_IL4_VS_CTRL_TREATED...2,SET,174,0.15223,0.014742,0.066762,0.011306,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP,0.63708202247191
WP_NCRNAS_INVOLVED_IN_WNT_SI...,SET,82,0.23056,0.015366,0.10112,0.011307,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.63708202247191
GOBP_POSITIVE_REGULATION_OF_...397,SET,7,0.72188,0.014086,0.3166,0.011307,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.63708202247191
GOBP_REGULATION_OF_SKELETAL_...11,SET,6,0.87952,0.015889,0.38576,0.011311,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,0.63708202247191
HP_LONG_NECK,SET,3,0.96328,0.012306,0.42252,0.011314,HP_LONG_NECK,0.63708202247191
HP_ABDOMINAL_SITUS_AMBIGUUS,SET,4,1.0111,0.014915,0.44348,0.011315,HP_ABDOMINAL_SITUS_AMBIGUUS,0.63708202247191
GOBP_NEGATIVE_REGULATION_OF_...544,SET,57,0.24675,0.013721,0.10825,0.011329,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.63708202247191
GOCC_RNA_POLYMERASE_COMPLEX,SET,90,0.18431,0.012866,0.080888,0.011354,GOCC_RNA_POLYMERASE_COMPLEX,0.63708202247191
GAVIN_IL2_RESPONSIVE_FOXP3_T...2,SET,15,0.60953,0.017407,0.26756,0.011366,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,0.63708202247191
GOBP_XENOBIOTIC_EXPORT_FROM_...,SET,13,0.53203,0.014145,0.23365,0.011397,GOBP_XENOBIOTIC_EXPORT_FROM_CELL,0.63708202247191
GSE9946_MATURE_STIMULATORY_V...2,SET,117,0.17753,0.01412,0.077977,0.011409,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP,0.63708202247191
HP_ABNORMAL_LYMPH_NODE_MORPH...,SET,228,0.13608,0.015063,0.059782,0.01142,HP_ABNORMAL_LYMPH_NODE_MORPHOLOGY,0.63708202247191
GOBP_RIBOSOMAL_SMALL_SUBUNIT...1,SET,16,0.45587,0.013445,0.20039,0.011463,GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY,0.637302708661417
GOBP_NEGATIVE_REGULATION_OF_...476,SET,7,0.85088,0.016603,0.37406,0.011468,GOBP_NEGATIVE_REGULATION_OF_P38MAPK_CASCADE,0.637302708661417
CHIANG_LIVER_CANCER_SUBCLASS...1,SET,155,0.16804,0.015367,0.073953,0.011539,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,0.637302708661417
GOBP_STRESS_ACTIVATED_PROTEI...,SET,52,0.26953,0.014317,0.11863,0.01155,GOBP_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.637302708661417
ZHENG_GLIOBLASTOMA_PLASTICIT...1,SET,57,0.27365,0.015216,0.12045,0.011551,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,0.637302708661417
KOBAYASHI_EGFR_SIGNALING_24H...2,SET,84,0.21029,0.014185,0.092588,0.011571,KOBAYASHI_EGFR_SIGNALING_24HR_UP,0.637302708661417
GTGCAAA_MIR507,SET,117,0.19061,0.01516,0.083936,0.011582,GTGCAAA_MIR507,0.637302708661417
GOBP_ANDROGEN_RECEPTOR_SIGNA...,SET,43,0.27894,0.013477,0.12285,0.01159,GOBP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.637302708661417
GOMF_AMYLASE_ACTIVITY,SET,2,1.4409,0.015031,0.6346,0.011592,GOMF_AMYLASE_ACTIVITY,0.637302708661417
MIR5580_3P,SET,222,0.13482,0.014728,0.059405,0.011624,MIR5580_3P,0.637302708661417
GSE3982_NEUTROPHIL_VS_BASOPH...2,SET,177,0.14492,0.014153,0.063865,0.011637,GSE3982_NEUTROPHIL_VS_BASOPHIL_UP,0.637302708661417
METTL14_TARGET_GENES,SET,109,0.18697,0.014356,0.082407,0.011644,METTL14_TARGET_GENES,0.637302708661417
GOCC_WASH_COMPLEX,SET,7,0.65687,0.012817,0.28999,0.011758,GOCC_WASH_COMPLEX,0.640623558139535
GOBP_INNER_EAR_RECEPTOR_CELL...3,SET,32,0.36462,0.015202,0.16103,0.011783,GOBP_INNER_EAR_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION,0.640623558139535
MIR6740_3P,SET,146,0.16236,0.014413,0.071738,0.011818,MIR6740_3P,0.640623558139535
GOBP_SENSORY_ORGAN_MORPHOGEN...,SET,261,0.13008,0.015391,0.05748,0.011823,GOBP_SENSORY_ORGAN_MORPHOGENESIS,0.640623558139535
GOBP_REGULATION_OF_RESPONSE_...4,SET,74,0.21326,0.013505,0.094245,0.011828,GOBP_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.640623558139535
GOMF_UBIQUITIN_UBIQUITIN_LIG...,SET,13,0.46833,0.012451,0.20699,0.011836,GOMF_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY,0.640623558139535
GOBP_POSITIVE_REGULATION_OF_...682,SET,70,0.24163,0.014884,0.10686,0.011877,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.640623558139535
WP_THIAMINE_METABOLIC_PATHWA...,SET,8,0.6582,0.01373,0.29109,0.011881,WP_THIAMINE_METABOLIC_PATHWAYS,0.640623558139535
GSE29614_CTRL_VS_TIV_FLU_VAC...1,SET,152,0.15744,0.014259,0.069628,0.011882,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN,0.640623558139535
GOBP_REGULATION_OF_MYOTUBE_D...,SET,40,0.33082,0.015417,0.14632,0.011889,GOBP_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.640623558139535
REACTOME_GENE_AND_PROTEIN_EX...,SET,35,0.30697,0.013383,0.13582,0.011912,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,0.640869287925697
GOMF_STRUCTURAL_CONSTITUENT_...4,SET,40,0.28914,0.013475,0.12801,0.011955,GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE,0.640912096774194
REACTOME_VIRAL_MESSENGER_RNA...,SET,42,0.27631,0.013194,0.12234,0.011959,REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS,0.640912096774194
MIR3529_5P,SET,32,0.34742,0.014485,0.15388,0.011989,MIR3529_5P,0.640912096774194
REACTOME_INHIBITION_OF_DNA_R...,SET,19,0.39945,0.012837,0.17695,0.011998,REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE,0.640912096774194
GSE20198_UNTREATED_VS_IL12_T...2,SET,179,0.13668,0.013424,0.060555,0.012005,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP,0.640912096774194
GSE12392_WT_VS_IFNAR_KO_CD8A...2,SET,174,0.1437,0.013916,0.063688,0.012033,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP,0.641131286370597
REACTOME_MRNA_CAPPING,SET,28,0.31275,0.012198,0.13864,0.012046,REACTOME_MRNA_CAPPING,0.641131286370597
MIR7155_5P,SET,87,0.198,0.013591,0.087817,0.012082,MIR7155_5P,0.641886350531108
CSR_EARLY_UP.V1_UP,SET,143,0.15912,0.013981,0.070608,0.012119,CSR_EARLY_UP.V1_UP,0.641886350531108
GCATTTG_MIR105,SET,153,0.16281,0.014794,0.07228,0.01215,GCATTTG_MIR105,0.641886350531108
HP_KETOSIS,SET,60,0.25414,0.014497,0.11284,0.012163,HP_KETOSIS,0.641886350531108
GOMF_PHOSPHATIDYLCHOLINE_TRA...1,SET,5,0.85995,0.014182,0.38184,0.012164,GOMF_PHOSPHATIDYLCHOLINE_TRANSFER_ACTIVITY,0.641886350531108
HP_BLUE_IRIDES,SET,50,0.30218,0.01574,0.13419,0.012171,HP_BLUE_IRIDES,0.641886350531108
GSE9509_10MIN_VS_30MIN_LPS_A...2,SET,162,0.14343,0.013407,0.063739,0.012221,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.643519583963691
HP_COLON_CANCER,SET,40,0.29475,0.013736,0.13102,0.012239,HP_COLON_CANCER,0.643519583963691
REACTOME_SIGNALING_BY_FGFR2,SET,71,0.22605,0.014023,0.10063,0.012347,REACTOME_SIGNALING_BY_FGFR2,0.645171725663717
TERAO_AOX4_TARGETS_SKIN_UP,SET,25,0.35762,0.013181,0.1592,0.012349,TERAO_AOX4_TARGETS_SKIN_UP,0.645171725663717
GOMF_PHOSPHATASE_INHIBITOR_A...,SET,41,0.29199,0.013776,0.13001,0.012361,GOMF_PHOSPHATASE_INHIBITOR_ACTIVITY,0.645171725663717
E2F2_TARGET_GENES,SET,1188,0.057035,0.014025,0.025408,0.012396,E2F2_TARGET_GENES,0.645171725663717
GSE34217_MIR17_92_OVEREXPRES...1,SET,127,0.16684,0.013821,0.07434,0.012415,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN,0.645171725663717
MIR6813_3P,SET,30,0.36081,0.014566,0.16086,0.012454,MIR6813_3P,0.645171725663717
GSE1460_INTRATHYMIC_T_PROGEN...6,SET,178,0.14082,0.013791,0.062784,0.012458,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.645171725663717
REACTOME_DISSOLUTION_OF_FIBR...,SET,13,0.57987,0.015417,0.25859,0.012474,REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,0.645171725663717
GOBP_REGULATION_OF_EPIDERMAL...,SET,16,0.45732,0.013488,0.20398,0.012486,GOBP_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,0.645171725663717
SMID_BREAST_CANCER_RELAPSE_I...8,SET,21,0.45342,0.015318,0.2023,0.012507,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,0.645171725663717
GNF2_CYP2B6,SET,49,0.27527,0.014195,0.12284,0.012521,GNF2_CYP2B6,0.645171725663717
PAL_PRMT5_TARGETS_DN,SET,27,0.40135,0.015372,0.17911,0.012526,PAL_PRMT5_TARGETS_DN,0.645171725663717
GOMF_RNA_POLYMERASE_I_ACTIVI...,SET,9,0.5334,0.011801,0.23812,0.012551,GOMF_RNA_POLYMERASE_I_ACTIVITY,0.645171725663717
ZNF282_TARGET_GENES,SET,851,0.067025,0.014085,0.029929,0.012568,ZNF282_TARGET_GENES,0.645171725663717
GOBP_NEGATIVE_REGULATION_OF_...645,SET,187,0.1437,0.014422,0.064174,0.012576,GOBP_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,0.645171725663717
HP_OVERWEIGHT,SET,42,0.29525,0.014098,0.13185,0.012577,HP_OVERWEIGHT,0.645171725663717
BIOCARTA_SHH_PATHWAY,SET,16,0.49449,0.014584,0.22086,0.012586,BIOCARTA_SHH_PATHWAY,0.645171725663717
REACTOME_REGULATION_OF_TP53_...5,SET,87,0.1972,0.013536,0.088216,0.0127,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,0.647564454941861
GOCC_CDC73_PAF1_COMPLEX,SET,6,0.82749,0.014949,0.37028,0.012722,GOCC_CDC73_PAF1_COMPLEX,0.647564454941861
HOLLERN_SOLID_NODULAR_BREAST...2,SET,9,0.74539,0.016491,0.33358,0.01273,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP,0.647564454941861
chr2p24,SET,26,0.62354,0.023436,0.27908,0.012739,chr2p24,0.647564454941861
GOCC_FICOLIN_1_RICH_GRANULE_...2,SET,52,0.26959,0.01432,0.1207,0.012761,GOCC_FICOLIN_1_RICH_GRANULE_MEMBRANE,0.647564454941861
MIR3140_5P,SET,121,0.174,0.014072,0.077923,0.012781,MIR3140_5P,0.647564454941861
GOBP_MRNA_CIS_SPLICING_VIA_S...,SET,26,0.33698,0.012666,0.15096,0.012804,GOBP_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.647564454941861
KEGG_MEDICUS_REFERENCE_CDC25...,SET,9,0.54249,0.012002,0.24305,0.012814,KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M,0.647564454941861
HP_BACK_PAIN,SET,68,0.22908,0.013909,0.10264,0.012817,HP_BACK_PAIN,0.647564454941861
GOBP_PROTEIN_AUTOPROCESSING,SET,26,0.36257,0.013628,0.16245,0.012819,GOBP_PROTEIN_AUTOPROCESSING,0.647564454941861
GSE3039_ALPHAALPHA_CD8_TCELL...1,SET,184,0.14319,0.014256,0.064197,0.012863,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN,0.64756669527897
KEGG_MEDICUS_REFERENCE_DNA_E...,SET,13,0.48009,0.012764,0.21527,0.012873,KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING,0.64756669527897
YAMASHITA_LIVER_CANCER_WITH_...1,SET,15,0.48031,0.013716,0.21547,0.01291,YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN,0.64756669527897
GOMF_DEATH_RECEPTOR_ACTIVITY,SET,12,0.62749,0.016029,0.28159,0.012933,GOMF_DEATH_RECEPTOR_ACTIVITY,0.64756669527897
GOBP_NEGATIVE_REGULATION_OF_...320,SET,32,0.32805,0.013677,0.14723,0.012941,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.64756669527897
GOBP_EMBRYONIC_DIGIT_MORPHOG...,SET,53,0.28054,0.015044,0.12591,0.012944,GOBP_EMBRYONIC_DIGIT_MORPHOGENESIS,0.64756669527897
GOBP_SPINDLE_ASSEMBLY,SET,119,0.16161,0.012962,0.072563,0.012975,GOBP_SPINDLE_ASSEMBLY,0.64756669527897
REACTOME_INTERLEUKIN_12_SIGN...,SET,43,0.27684,0.013375,0.12432,0.012983,REACTOME_INTERLEUKIN_12_SIGNALING,0.64756669527897
GOBP_ANGIOGENESIS_INVOLVED_I...2,SET,27,0.39503,0.01513,0.17744,0.013004,GOBP_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING,0.64756669527897
MIR4284,SET,99,0.18544,0.013574,0.083305,0.01301,MIR4284,0.64756669527897
ATF4_Q2,SET,227,0.12672,0.013997,0.056938,0.013024,ATF4_Q2,0.64756669527897
HP_DEPOSITS_IMMUNOREACTIVE_T...,SET,9,0.65384,0.014466,0.29391,0.01306,HP_DEPOSITS_IMMUNOREACTIVE_TO_BETA_AMYLOID_PROTEIN,0.647950206847361
OUYANG_PROSTATE_CANCER_MARKE...,SET,20,0.44144,0.014554,0.19846,0.013069,OUYANG_PROSTATE_CANCER_MARKERS,0.647950206847361
HP_NEOPLASM_OF_THE_PITUITARY...,SET,64,0.23037,0.013571,0.1036,0.013093,HP_NEOPLASM_OF_THE_PITUITARY_GLAND,0.648168425531915
REACTOME_METHIONINE_SALVAGE_...,SET,6,0.8712,0.015739,0.39203,0.013138,REACTOME_METHIONINE_SALVAGE_PATHWAY,0.648168425531915
HP_POIKILODERMA,SET,23,0.36244,0.012814,0.1631,0.013143,HP_POIKILODERMA,0.648168425531915
GSE20727_CTRL_VS_ROS_INH_AND...2,SET,167,0.14302,0.013571,0.064365,0.013148,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.648168425531915
PID_SYNDECAN_4_PATHWAY,SET,31,0.35719,0.014658,0.16079,0.013168,PID_SYNDECAN_4_PATHWAY,0.648234900849858
ALCALAY_AML_BY_NPM1_LOCALIZA...2,SET,123,0.18083,0.014744,0.081444,0.013204,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,0.649087722772277
REACTOME_TRANSCRIPTIONAL_REG...9,SET,337,0.099151,0.013303,0.044671,0.013231,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,0.649496334745763
WTGAAAT_UNKNOWN,SET,529,0.086966,0.014541,0.039222,0.013308,WTGAAAT_UNKNOWN,0.651070491573034
GSE3982_DC_VS_MAC_UP,SET,174,0.14031,0.013588,0.06329,0.013321,GSE3982_DC_VS_MAC_UP,0.651070491573034
GOBP_NEGATIVE_REGULATION_OF_...588,SET,25,0.38609,0.01423,0.1742,0.013337,GOBP_NEGATIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.651070491573034
HP_BREAST_CARCINOMA,SET,68,0.21936,0.013319,0.098972,0.013338,HP_BREAST_CARCINOMA,0.651070491573034
REACTOME_SIGNALING_BY_ALK,SET,26,0.39344,0.014788,0.17762,0.013385,REACTOME_SIGNALING_BY_ALK,0.651546881118881
CAGCACT_MIR5123P,SET,141,0.17238,0.015041,0.077842,0.013403,CAGCACT_MIR5123P,0.651546881118881
GSE5503_LIVER_DC_VS_SPLEEN_D...1,SET,173,0.13672,0.013202,0.061738,0.013404,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.651546881118881
HP_ABNORMALITY_OF_THE_INCISOR,SET,93,0.19929,0.014141,0.090036,0.013439,HP_ABNORMALITY_OF_THE_INCISOR,0.651874073816156
GOBP_ENTERIC_NERVOUS_SYSTEM_...,SET,11,0.58147,0.014221,0.26278,0.013462,GOBP_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT,0.651874073816156
REACTOME_INDUCTION_OF_CELL_C...,SET,12,0.55355,0.01414,0.25018,0.013467,REACTOME_INDUCTION_OF_CELL_CELL_FUSION,0.651874073816156
GSE13547_WT_VS_ZFX_KO_BCELL_...5,SET,164,0.14979,0.014087,0.067739,0.013513,GSE13547_WT_VS_ZFX_KO_BCELL_DN,0.652391359223301
GOBP_NEGATIVE_REGULATION_OF_...462,SET,26,0.3413,0.012828,0.15436,0.01352,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.652391359223301
PUJANA_BREAST_CANCER_WITH_BR...2,SET,52,0.25215,0.013394,0.11406,0.013534,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,0.652391359223301
REACTOME_POSITIVE_EPIGENETIC...,SET,42,0.26457,0.012634,0.11973,0.01357,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.653220706371191
GOBP_TRNA_TRANSCRIPTION,SET,13,0.41805,0.011115,0.18927,0.013601,GOBP_TRNA_TRANSCRIPTION,0.653786549586777
GSE23114_PERITONEAL_CAVITY_B...2,SET,175,0.14005,0.013601,0.063423,0.013621,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN,0.653786549586777
GOCC_FLOTILLIN_COMPLEX,SET,9,0.6392,0.014142,0.28954,0.013641,GOCC_FLOTILLIN_COMPLEX,0.653786549586777
GOBP_MEIOTIC_CELL_CYCLE_PHAS...,SET,13,0.50581,0.013448,0.22917,0.013657,GOBP_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.653786549586777
GOBP_SERINE_PHOSPHORYLATION_...,SET,19,0.50572,0.016252,0.22935,0.013735,GOBP_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.654867309782609
GSE29618_LAIV_VS_TIV_FLU_VAC...6,SET,168,0.14724,0.014013,0.066798,0.013759,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP,0.654867309782609
GOCC_CHLORIDE_CHANNEL_COMPLEX,SET,49,0.30793,0.015879,0.13977,0.013803,GOCC_CHLORIDE_CHANNEL_COMPLEX,0.654867309782609
GSE6092_B_BURGDOFERI_VS_B_BU...1,SET,171,0.14413,0.013838,0.06543,0.013808,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN,0.654867309782609
WELCSH_BRCA1_TARGETS_UP,SET,180,0.13543,0.013338,0.061488,0.013817,WELCSH_BRCA1_TARGETS_UP,0.654867309782609
GOCC_COPI_COATED_VESICLE_MEM...,SET,17,0.40121,0.012197,0.18217,0.013825,GOCC_COPI_COATED_VESICLE_MEMBRANE,0.654867309782609
HE_LIM_SUN_FETAL_LUNG_C2_APO...1,SET,13,0.55392,0.014727,0.25153,0.013832,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M1_MACROPHAGE_CELL,0.654867309782609
GSE17721_PAM3CSK4_VS_CPG_0.5...2,SET,179,0.13703,0.013458,0.062241,0.013853,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP,0.654867309782609
GOBP_RESPONSE_TO_INDOLE_3_ME...,SET,6,0.77499,0.014001,0.35203,0.013858,GOBP_RESPONSE_TO_INDOLE_3_METHANOL,0.654867309782609
GOBP_DENDRITIC_CELL_DIFFEREN...,SET,46,0.30325,0.015152,0.13777,0.013868,GOBP_DENDRITIC_CELL_DIFFERENTIATION,0.654867309782609
GOBP_REGULATION_OF_INTRACELL...5,SET,61,0.23136,0.013307,0.10515,0.013897,GOBP_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.65534631614654
BYSTRYKH_HEMATOPOIESIS_STEM_...8,SET,7,0.82966,0.016189,0.37728,0.013942,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1,0.656577520325203
GSE26488_CTRL_VS_PEPTIDE_INJ...4,SET,148,0.15513,0.013865,0.070571,0.013975,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP,0.657241035182679
GOBP_REGULATION_OF_TRANSCRIP...2,SET,39,0.27592,0.012697,0.12565,0.014055,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.657375559566787
PARK_APL_PATHOGENESIS_UP,SET,14,0.51613,0.01424,0.23509,0.01407,PARK_APL_PATHOGENESIS_UP,0.657375559566787
GAVISH_3CA_METAPROGRAM_B_CEL...11,SET,41,0.30283,0.014288,0.13801,0.014111,GAVISH_3CA_METAPROGRAM_B_CELLS_RESPIRATION,0.657375559566787
KEGG_MEDICUS_VARIANT_MUTATIO...46,SET,7,0.85889,0.016759,0.39151,0.014133,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION,0.657375559566787
BIOCARTA_FIBRINOLYSIS_PATHWAY,SET,12,0.62367,0.015931,0.28431,0.014139,BIOCARTA_FIBRINOLYSIS_PATHWAY,0.657375559566787
BIOCARTA_NPC_PATHWAY,SET,11,0.54838,0.013412,0.25,0.014141,BIOCARTA_NPC_PATHWAY,0.657375559566787
HP_PLEURITIS,SET,26,0.38378,0.014425,0.17501,0.014164,HP_PLEURITIS,0.657375559566787
SESTO_RESPONSE_TO_UV_C1,SET,68,0.21399,0.012992,0.097598,0.014178,SESTO_RESPONSE_TO_UV_C1,0.657375559566787
REACTOME_SYNTHESIS_OF_PC,SET,27,0.35779,0.013704,0.16321,0.014189,REACTOME_SYNTHESIS_OF_PC,0.657375559566787
GSE15659_NAIVE_CD4_TCELL_VS_...1,SET,168,0.14646,0.013939,0.066816,0.014196,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.657375559566787
PDGF_UP.V1_DN,SET,109,0.18614,0.014293,0.084925,0.014202,PDGF_UP.V1_DN,0.657375559566787
HP_OLIGOARTHRITIS,SET,12,0.58801,0.01502,0.26837,0.01423,HP_OLIGOARTHRITIS,0.657375559566787
GSE10325_LUPUS_CD4_TCELL_VS_...2,SET,175,0.14644,0.014222,0.066853,0.014251,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP,0.657375559566787
GOBP_ENAMEL_MINERALIZATION,SET,18,0.44901,0.014045,0.20508,0.014291,GOBP_ENAMEL_MINERALIZATION,0.657375559566787
HP_MINIMAL_CHANGE_GLOMERULON...,SET,34,0.33731,0.014495,0.15407,0.014295,HP_MINIMAL_CHANGE_GLOMERULONEPHRITIS,0.657375559566787
GOBP_MICROAUTOPHAGY,SET,22,0.38172,0.013199,0.17436,0.014297,GOBP_MICROAUTOPHAGY,0.657375559566787
GOMF_TUMOR_NECROSIS_FACTOR_R...1,SET,9,0.70922,0.015691,0.32431,0.014384,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_ACTIVITY,0.657375559566787
SPIELMAN_LYMPHOBLAST_EUROPEA...1,SET,17,0.48549,0.014759,0.22207,0.014407,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,0.657375559566787
GOBP_NEGATIVE_REGULATION_OF_...374,SET,141,0.15936,0.013905,0.072906,0.014418,GOBP_NEGATIVE_REGULATION_OF_MAPK_CASCADE,0.657375559566787
GOBP_STEROL_HOMEOSTASIS,SET,84,0.20808,0.014035,0.095222,0.014445,GOBP_STEROL_HOMEOSTASIS,0.657375559566787
GSE4142_PLASMA_CELL_VS_GC_BC...2,SET,181,0.13431,0.013264,0.061472,0.014452,GSE4142_PLASMA_CELL_VS_GC_BCELL_UP,0.657375559566787
GOBP_REGULATION_OF_NEURON_PR...1,SET,14,0.47091,0.012992,0.21559,0.014476,GOBP_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.657375559566787
GOCC_FACIT_COLLAGEN_TRIMER,SET,6,0.88091,0.015914,0.40331,0.014481,GOCC_FACIT_COLLAGEN_TRIMER,0.657375559566787
MIR664A_3P,SET,359,0.10223,0.014148,0.046807,0.014484,MIR664A_3P,0.657375559566787
GOBP_HUMORAL_IMMUNE_RESPONSE...,SET,42,0.32307,0.015427,0.14797,0.014512,GOBP_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.657375559566787
GSE21063_WT_VS_NFATC1_KO_BCE...1,SET,181,0.13081,0.012918,0.059928,0.014532,GSE21063_WT_VS_NFATC1_KO_BCELL_DN,0.657375559566787
CBX7_TARGET_GENES,SET,726,0.071839,0.013993,0.032915,0.01454,CBX7_TARGET_GENES,0.657375559566787
MIR4514,SET,162,0.14752,0.01379,0.067604,0.014554,MIR4514,0.657375559566787
GOBP_NEGATIVE_REGULATION_OF_...541,SET,19,0.43259,0.013902,0.19825,0.01456,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.657375559566787
GSE27241_WT_VS_RORGT_KO_TH17...4,SET,138,0.15446,0.013335,0.070814,0.014589,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP,0.657375559566787
ABE_VEGFA_TARGETS_2HR,SET,28,0.37218,0.014516,0.17071,0.014629,ABE_VEGFA_TARGETS_2HR,0.657375559566787
LEE_EARLY_T_LYMPHOCYTE_DN,SET,54,0.27129,0.014684,0.12444,0.014629,LEE_EARLY_T_LYMPHOCYTE_DN,0.657375559566787
MIR1266_5P,SET,83,0.19721,0.013223,0.090467,0.014637,MIR1266_5P,0.657375559566787
RUBENSTEIN_SKELETAL_MUSCLE_F...2,SET,256,0.12226,0.014329,0.056093,0.014651,RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS,0.657375559566787
SIRNA_EIF4GI_DN,SET,84,0.2109,0.014226,0.096776,0.014663,SIRNA_EIF4GI_DN,0.657375559566787
RODRIGUES_NTN1_TARGETS_DN,SET,149,0.15806,0.014174,0.072551,0.014686,RODRIGUES_NTN1_TARGETS_DN,0.657375559566787
GOBP_MECHANORECEPTOR_DIFFERE...,SET,65,0.24719,0.014675,0.11353,0.014737,GOBP_MECHANORECEPTOR_DIFFERENTIATION,0.657375559566787
HP_FOCAL_T2_HYPERINTENSE_BAS...,SET,23,0.36906,0.013048,0.16952,0.014745,HP_FOCAL_T2_HYPERINTENSE_BASAL_GANGLIA_LESION,0.657375559566787
PID_ARF6_TRAFFICKING_PATHWAY,SET,47,0.27709,0.013995,0.12732,0.01477,PID_ARF6_TRAFFICKING_PATHWAY,0.657375559566787
MIR376A_2_5P,SET,59,0.25577,0.014469,0.11754,0.014785,MIR376A_2_5P,0.657375559566787
GOBP_NEGATIVE_REGULATION_OF_...246,SET,4,0.75448,0.01113,0.34673,0.014786,GOBP_NEGATIVE_REGULATION_OF_G0_TO_G1_TRANSITION,0.657375559566787
GSE22313_HEALTHY_VS_SLE_MOUS...2,SET,164,0.14697,0.013821,0.067581,0.014832,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP,0.657375559566787
GOMF_HISTONE_READER_ACTIVITY,SET,16,0.42514,0.012539,0.1955,0.014837,GOMF_HISTONE_READER_ACTIVITY,0.657375559566787
GOCC_NF_KAPPAB_COMPLEX,SET,5,0.86734,0.014304,0.39897,0.01486,GOCC_NF_KAPPAB_COMPLEX,0.657375559566787
GSE22935_UNSTIM_VS_48H_MBOVI...2,SET,178,0.14237,0.013943,0.065509,0.014887,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.657375559566787
CUI_DEVELOPING_HEART_LEFT_AT...,SET,16,0.50909,0.015015,0.23428,0.014897,CUI_DEVELOPING_HEART_LEFT_ATRIAL_CARDIOMYOCYTE,0.657375559566787
GOMF_GTPASE_ACTIVATOR_ACTIVI...,SET,240,0.12058,0.013689,0.055494,0.014902,GOMF_GTPASE_ACTIVATOR_ACTIVITY,0.657375559566787
GOMF_SUMO_LIGASE_ACTIVITY,SET,12,0.568,0.014509,0.26142,0.014906,GOMF_SUMO_LIGASE_ACTIVITY,0.657375559566787
GOBP_AUDITORY_RECEPTOR_CELL_...1,SET,24,0.39782,0.014367,0.18317,0.014938,GOBP_AUDITORY_RECEPTOR_CELL_DEVELOPMENT,0.657375559566787
USF_Q6,SET,227,0.12129,0.013397,0.055867,0.01497,USF_Q6,0.657375559566787
GOBP_REGULATION_OF_TOLL_LIKE...2,SET,14,0.454,0.012526,0.20913,0.014974,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.657375559566787
GOBP_POLYAMINE_BIOSYNTHETIC_...,SET,12,0.46599,0.011904,0.21469,0.014991,GOBP_POLYAMINE_BIOSYNTHETIC_PROCESS,0.657375559566787
GOBP_NEGATIVE_REGULATION_OF_...538,SET,7,0.66098,0.012897,0.30501,0.015122,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.657375559566787
GOBP_REGULATION_OF_LEUKOCYTE...9,SET,245,0.12744,0.014615,0.058807,0.015124,GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.657375559566787
HP_CENTRAL_HYPOTHYROIDISM,SET,63,0.24567,0.014359,0.11338,0.015136,HP_CENTRAL_HYPOTHYROIDISM,0.657375559566787
GOBP_NEGATIVE_REGULATION_OF_...230,SET,18,0.40856,0.01278,0.18857,0.01514,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.657375559566787
MIR4784,SET,138,0.1579,0.013631,0.072919,0.015185,MIR4784,0.657375559566787
GERHOLD_ADIPOGENESIS_UP,SET,47,0.28646,0.014468,0.1323,0.015189,GERHOLD_ADIPOGENESIS_UP,0.657375559566787
KEGG_MEDICUS_REFERENCE_BLOOD...1,SET,6,0.80658,0.014571,0.37262,0.015215,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_1_BIOSYNTHESIS,0.657375559566787
WP_LACTO_SERIES_SPHINGOLIPID...,SET,6,0.77959,0.014084,0.36017,0.015219,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.657375559566787
WP_DNA_REPLICATION,SET,40,0.27902,0.013003,0.12901,0.015283,WP_DNA_REPLICATION,0.657375559566787
GOBP_GLYCOSIDE_TRANSPORT,SET,5,0.88485,0.014593,0.40919,0.015298,GOBP_GLYCOSIDE_TRANSPORT,0.657375559566787
GOMF_NUCLEOCYTOPLASMIC_CARRI...,SET,30,0.31078,0.012546,0.14372,0.015302,GOMF_NUCLEOCYTOPLASMIC_CARRIER_ACTIVITY,0.657375559566787
HP_PANCREATIC_ADENOCARCINOMA,SET,35,0.29799,0.012992,0.13781,0.015303,HP_PANCREATIC_ADENOCARCINOMA,0.657375559566787
GOBP_RESPONSE_TO_FRUCTOSE,SET,10,0.495,0.011543,0.22902,0.015339,GOBP_RESPONSE_TO_FRUCTOSE,0.657375559566787
HARALAMBIEVA_PBMC_M_M_R_II_A...5,SET,13,0.59328,0.015774,0.27456,0.01536,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_UP,0.657375559566787
GSE21927_C26GM_VS_4T1_TUMOR_...2,SET,175,0.14083,0.013677,0.065184,0.015374,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,0.657375559566787
GOBP_SYNAPTIC_ASSEMBLY_AT_NE...,SET,8,0.65311,0.013624,0.30249,0.015426,GOBP_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.657375559566787
UBN1_TARGET_GENES,SET,1414,0.051444,0.01371,0.023829,0.015435,UBN1_TARGET_GENES,0.657375559566787
MIR6783_5P,SET,144,0.16231,0.014311,0.075195,0.01545,MIR6783_5P,0.657375559566787
HP_CLEFT_UPPER_LIP,SET,126,0.16583,0.013684,0.076834,0.015458,HP_CLEFT_UPPER_LIP,0.657375559566787
QIU_PBMC_HEPTATITIS_B_SURFAC...5,SET,12,0.5851,0.014946,0.2711,0.01546,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_35DY_UP,0.657375559566787
BMI1_DN.V1_DN,SET,121,0.18366,0.014853,0.0851,0.015466,BMI1_DN.V1_DN,0.657375559566787
GOCC_DNA_DEPENDENT_PROTEIN_K...1,SET,5,0.67462,0.011126,0.31262,0.015472,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.657375559566787
HP_PREMATURE_LOSS_OF_PERMANE...,SET,7,0.70093,0.013677,0.32484,0.015479,HP_PREMATURE_LOSS_OF_PERMANENT_TEETH,0.657375559566787
MIR1283,SET,434,0.09195,0.013962,0.042622,0.015496,MIR1283,0.657375559566787
GOBP_REGULATION_OF_SYNAPSE_P...,SET,6,0.81614,0.014744,0.37831,0.015496,GOBP_REGULATION_OF_SYNAPSE_PRUNING,0.657375559566787
REACTOME_SIGNALING_BY_ERBB4,SET,55,0.23568,0.012873,0.10925,0.015504,REACTOME_SIGNALING_BY_ERBB4,0.657375559566787
NFKB_Q6,SET,237,0.12299,0.013876,0.057034,0.015531,NFKB_Q6,0.657375559566787
GSE6674_UNSTIM_VS_CPG_STIM_B...1,SET,145,0.1502,0.013289,0.06966,0.015542,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN,0.657375559566787
GOBP_REGULATION_OF_MESENCHYM...1,SET,32,0.3775,0.015739,0.1751,0.015551,GOBP_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.657375559566787
REACTOME_DISASSEMBLY_OF_THE_...,SET,29,0.35073,0.013921,0.16268,0.015552,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,0.657375559566787
GOMF_CELL_CELL_ADHESION_MEDI...,SET,50,0.29513,0.015373,0.13694,0.015581,GOMF_CELL_CELL_ADHESION_MEDIATOR_ACTIVITY,0.657375559566787
GSE27786_CD4_TCELL_VS_MONO_M...1,SET,180,0.13913,0.013702,0.064591,0.015624,GSE27786_CD4_TCELL_VS_MONO_MAC_DN,0.657375559566787
GOBP_RENAL_FILTRATION,SET,27,0.40002,0.015321,0.18571,0.015626,GOBP_RENAL_FILTRATION,0.657375559566787
GOBP_REVERSE_CHOLESTEROL_TRA...,SET,17,0.48458,0.014731,0.22501,0.015642,GOBP_REVERSE_CHOLESTEROL_TRANSPORT,0.657375559566787
GSE17186_CD21LOW_VS_CD21HIGH...1,SET,176,0.13411,0.013061,0.062289,0.015663,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.657375559566787
HP_LARGE_CENTRAL_VISUAL_FIEL...,SET,13,0.5226,0.013894,0.24273,0.015668,HP_LARGE_CENTRAL_VISUAL_FIELD_DEFECT,0.657375559566787
LUDWICZEK_TREATING_IRON_OVER...,SET,7,0.79731,0.015558,0.37034,0.01567,LUDWICZEK_TREATING_IRON_OVERLOAD,0.657375559566787
HE_LIM_SUN_FETAL_LUNG_C4_CYC...1,SET,594,0.072478,0.012818,0.033678,0.015703,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL,0.657375559566787
REACTOME_NEGATIVE_EPIGENETIC...,SET,44,0.25276,0.012353,0.11747,0.015716,REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.657375559566787
DESCARTES_MAIN_FETAL_PDE11A_...,SET,37,0.34575,0.015498,0.16069,0.015718,DESCARTES_MAIN_FETAL_PDE11A_FAM19A2_POSITIVE_CELLS,0.657375559566787
WP_DNA_IRDAMAGE_AND_CELLULAR...,SET,74,0.19256,0.012195,0.089543,0.015764,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,0.658506995192308
LMX1B_TARGET_GENES,SET,21,0.42393,0.014322,0.19737,0.015867,LMX1B_TARGET_GENES,0.662013907563025
GOBP_PROTEIN_K6_LINKED_UBIQU...,SET,15,0.46065,0.013155,0.21452,0.015888,GOBP_PROTEIN_K6_LINKED_UBIQUITINATION,0.662095251798561
YAGI_AML_WITH_T_8_21_TRANSLO...,SET,326,0.10313,0.013613,0.048052,0.015936,YAGI_AML_WITH_T_8_21_TRANSLOCATION,0.662335739856802
GOCC_PLASMA_MEMBRANE_PROTEIN...,SET,566,0.084206,0.014548,0.039238,0.015942,GOCC_PLASMA_MEMBRANE_PROTEIN_COMPLEX,0.662335739856802
GSE17721_CPG_VS_GARDIQUIMOD_...7,SET,182,0.13131,0.013003,0.061201,0.01596,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN,0.662335739856802
HP_PAIN_IN_HEAD_AND_NECK_REG...,SET,40,0.30084,0.01402,0.14023,0.01597,HP_PAIN_IN_HEAD_AND_NECK_REGION,0.662335739856802
GOBP_ANIMAL_ORGAN_FORMATION,SET,64,0.2525,0.014875,0.11775,0.016006,GOBP_ANIMAL_ORGAN_FORMATION,0.663024804270463
GOBP_CELLULAR_RESPONSE_TO_VA...,SET,61,0.25771,0.014823,0.12023,0.016043,GOBP_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.663024804270463
HP_ABNORMAL_THALAMIC_MRI_SIG...,SET,32,0.30398,0.012673,0.14182,0.016045,HP_ABNORMAL_THALAMIC_MRI_SIGNAL_INTENSITY,0.663024804270463
MODULE_198,SET,288,0.10388,0.012902,0.048482,0.016077,MODULE_198,0.663024804270463
GOBP_SPINAL_CORD_MOTOR_NEURO...2,SET,27,0.37194,0.014246,0.1736,0.016082,GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION,0.663024804270463
MIR3938,SET,68,0.21224,0.012886,0.099121,0.016136,MIR3938,0.664334627218935
GSE30083_SP1_VS_SP3_THYMOCYT...1,SET,181,0.13938,0.013763,0.065105,0.016152,GSE30083_SP1_VS_SP3_THYMOCYTE_DN,0.664334627218935
MIR489_3P,SET,69,0.22938,0.014029,0.1072,0.016195,MIR489_3P,0.665315868794326
GSE3982_EOSINOPHIL_VS_EFF_ME...2,SET,174,0.13526,0.013099,0.06324,0.016229,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.665925495867769
REACTOME_METALLOPROTEASE_DUBS,SET,15,0.48389,0.013819,0.22633,0.016264,REACTOME_METALLOPROTEASE_DUBS,0.666526395759717
MIR6877_3P,SET,31,0.32661,0.013403,0.15279,0.016282,MIR6877_3P,0.666526395759717
GOBP_VASCULATURE_DEVELOPMENT,SET,691,0.074556,0.014182,0.034906,0.016352,GOBP_VASCULATURE_DEVELOPMENT,0.668565737704918
GOBP_CORTICAL_ACTIN_CYTOSKEL...,SET,42,0.27378,0.013073,0.12821,0.016374,GOBP_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION,0.668565737704918
GSE17974_0H_VS_4H_IN_VITRO_A...2,SET,168,0.14264,0.013575,0.066811,0.01639,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP,0.668565737704918
KEGG_MEDICUS_PATHOGEN_HTLV_1...1,SET,7,0.7707,0.015038,0.36108,0.016412,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.668565737704918
GSE9960_GRAM_POS_VS_GRAM_NEG...1,SET,174,0.1458,0.014119,0.068322,0.016428,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.668565737704918
MIR6082,SET,15,0.46572,0.0133,0.21835,0.016473,MIR6082,0.668658623103851
ROSS_AML_WITH_AML1_ETO_FUSION,SET,67,0.24093,0.014521,0.11296,0.016477,ROSS_AML_WITH_AML1_ETO_FUSION,0.668658623103851
GOBP_VACUOLAR_ACIDIFICATION,SET,32,0.32448,0.013528,0.15216,0.016488,GOBP_VACUOLAR_ACIDIFICATION,0.668658623103851
TOMIDA_METASTASIS_DN,SET,11,0.54915,0.013431,0.25771,0.016557,TOMIDA_METASTASIS_DN,0.669659966216216
MORF_REV3L,SET,55,0.22598,0.012344,0.10609,0.016586,MORF_REV3L,0.669659966216216
BIOCARTA_IL10_PATHWAY,SET,13,0.53745,0.014289,0.25252,0.01666,BIOCARTA_IL10_PATHWAY,0.669659966216216
GSE3982_BASOPHIL_VS_EFF_MEMO...1,SET,172,0.1363,0.013124,0.064052,0.016675,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.669659966216216
GSE17301_CTRL_VS_48H_IFNA2_S...2,SET,182,0.13404,0.013273,0.062992,0.016679,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP,0.669659966216216
GOMF_CELL_ADHESION_MEDIATOR_...,SET,64,0.2523,0.014863,0.1186,0.0167,GOMF_CELL_ADHESION_MEDIATOR_ACTIVITY,0.669659966216216
MIR6165,SET,111,0.16366,0.01268,0.077008,0.016792,MIR6165,0.669659966216216
HP_SENILE_PLAQUES,SET,11,0.54475,0.013323,0.25638,0.016809,HP_SENILE_PLAQUES,0.669659966216216
GSE22045_TREG_VS_TCONV_UP,SET,153,0.15041,0.013666,0.070788,0.016812,GSE22045_TREG_VS_TCONV_UP,0.669659966216216
HP_CONE_SHAPED_METACARPAL_EP...,SET,4,0.88622,0.013073,0.41711,0.016813,HP_CONE_SHAPED_METACARPAL_EPIPHYSES,0.669659966216216
KRAS.DF.V1_UP,SET,176,0.14369,0.013994,0.067632,0.016816,KRAS.DF.V1_UP,0.669659966216216
MODULE_84,SET,492,0.088124,0.014224,0.041493,0.01685,MODULE_84,0.669659966216216
chr15q24,SET,57,0.49045,0.027271,0.23098,0.016871,chr15q24,0.669659966216216
GNF2_RAP1B,SET,32,0.32156,0.013406,0.15148,0.016892,GNF2_RAP1B,0.669659966216216
HP_IRIDOCYCLITIS,SET,10,0.57409,0.013388,0.27046,0.016897,HP_IRIDOCYCLITIS,0.669659966216216
ATOH8_TARGET_GENES,SET,38,0.29659,0.013473,0.13974,0.016905,ATOH8_TARGET_GENES,0.669659966216216
GSE1460_INTRATHYMIC_T_PROGEN...2,SET,173,0.13615,0.013147,0.064151,0.016912,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP,0.669659966216216
GOBP_REGULATION_OF_ASPARTIC_...2,SET,7,0.74892,0.014613,0.35299,0.016941,GOBP_REGULATION_OF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.669659966216216
MIR1296_5P,SET,26,0.34825,0.013089,0.16415,0.016944,MIR1296_5P,0.669659966216216
GSE44649_NAIVE_VS_ACTIVATED_...1,SET,176,0.12981,0.012642,0.061199,0.016966,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.669659966216216
GOMF_SCAFFOLD_PROTEIN_BINDING,SET,65,0.22948,0.013623,0.1082,0.016968,GOMF_SCAFFOLD_PROTEIN_BINDING,0.669659966216216
HP_ABNORMALITY_OF_GLYCOLIPID...,SET,9,0.5693,0.012595,0.26848,0.01699,HP_ABNORMALITY_OF_GLYCOLIPID_METABOLISM,0.669659966216216
chr12p11,SET,31,0.56214,0.023068,0.26513,0.017,chr12p11,0.669659966216216
MODULE_12,SET,324,0.1108,0.014581,0.052267,0.017016,MODULE_12,0.669659966216216
HALLMARK_APOPTOSIS,SET,149,0.15202,0.013633,0.071726,0.017032,HALLMARK_APOPTOSIS,0.669659966216216
ATGGYGGA_UNKNOWN,SET,85,0.19648,0.013332,0.092707,0.017035,ATGGYGGA_UNKNOWN,0.669659966216216
HP_SACCADIC_SMOOTH_PURSUIT,SET,21,0.36076,0.012188,0.17026,0.017057,HP_SACCADIC_SMOOTH_PURSUIT,0.669659966216216
GOBP_COLLATERAL_SPROUTING,SET,25,0.38227,0.01409,0.18041,0.017058,GOBP_COLLATERAL_SPROUTING,0.669659966216216
GSE40274_HELIOS_VS_FOXP3_AND...1,SET,179,0.13303,0.013064,0.062792,0.017072,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.669659966216216
GSE41867_NAIVE_VS_DAY8_LCMV_...2,SET,179,0.13353,0.013114,0.063048,0.017096,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.669659966216216
CHARAFE_BREAST_CANCER_BASAL_...2,SET,108,0.17602,0.013454,0.08312,0.01711,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,0.669659966216216
HP_ABNORMAL_CIRCULATING_ANTI...,SET,8,0.55782,0.011636,0.2635,0.01714,HP_ABNORMAL_CIRCULATING_ANTIMULLERIAN_HORMONE_CONCENTRATION,0.670079527559055
HOFFMANN_LARGE_TO_SMALL_PRE_...1,SET,61,0.23188,0.013337,0.1096,0.017196,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,0.671513460674157
ZHOU_PANCREATIC_BETA_CELL,SET,11,0.62774,0.015353,0.29684,0.017234,ZHOU_PANCREATIC_BETA_CELL,0.672242053872054
REACTOME_GLUCAGON_TYPE_LIGAN...,SET,33,0.3399,0.01439,0.16079,0.017263,REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS,0.672503638320775
GSE16522_ANTI_CD3CD28_STIM_V...3,SET,179,0.13224,0.012988,0.062593,0.017317,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN,0.672503638320775
YTATTTTNR_MEF2_02,SET,627,0.075687,0.013739,0.035839,0.017357,YTATTTTNR_MEF2_02,0.672503638320775
GOMF_CHROMATIN_INSULATOR_SEQ...,SET,4,0.81079,0.01196,0.38396,0.017365,GOMF_CHROMATIN_INSULATOR_SEQUENCE_BINDING,0.672503638320775
HP_ABNORMAL_MACROSCOPIC_URIN...,SET,47,0.26364,0.013315,0.12493,0.017425,HP_ABNORMAL_MACROSCOPIC_URINE_APPEARANCE,0.672503638320775
HP_ABNORMAL_GLOMERULAR_MESAN...,SET,45,0.27239,0.013462,0.1291,0.017438,HP_ABNORMAL_GLOMERULAR_MESANGIUM_MORPHOLOGY,0.672503638320775
GOCC_RNA_POLYMERASE_II_HOLOE...,SET,67,0.1957,0.011795,0.092757,0.017443,GOCC_RNA_POLYMERASE_II_HOLOENZYME,0.672503638320775
HP_SYNCOPE,SET,116,0.18076,0.014316,0.085698,0.017467,HP_SYNCOPE,0.672503638320775
PDGF_ERK_DN.V1_DN,SET,135,0.15215,0.012992,0.072155,0.017498,PDGF_ERK_DN.V1_DN,0.672503638320775
HE_LIM_SUN_FETAL_LUNG_C5_PRO...,SET,407,0.086703,0.012759,0.041119,0.017498,HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL,0.672503638320775
GOBP_INTRACELLULAR_TRANSPORT,SET,1228,0.051145,0.012771,0.02426,0.017515,GOBP_INTRACELLULAR_TRANSPORT,0.672503638320775
ATGCAGT_MIR217,SET,97,0.18144,0.013147,0.086073,0.017522,ATGCAGT_MIR217,0.672503638320775
REACTOME_ALTERNATIVE_COMPLEM...,SET,4,0.97971,0.014452,0.46478,0.017526,REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION,0.672503638320775
HP_CORTICAL_MYOCLONUS,SET,14,0.49008,0.013521,0.23265,0.017586,HP_CORTICAL_MYOCLONUS,0.672503638320775
SUZUKI_RESPONSE_TO_TSA_AND_D...2,SET,15,0.50937,0.014546,0.24195,0.01764,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,0.672503638320775
CTTTAAR_UNKNOWN,SET,878,0.064906,0.013844,0.030834,0.017652,CTTTAAR_UNKNOWN,0.672503638320775
GOBP_SEGMENT_SPECIFICATION,SET,14,0.53451,0.014747,0.25403,0.017693,GOBP_SEGMENT_SPECIFICATION,0.672503638320775
HP_IMPAIRED_DISTAL_PROPRIOCE...,SET,16,0.4064,0.011986,0.19316,0.017698,HP_IMPAIRED_DISTAL_PROPRIOCEPTION,0.672503638320775
HP_HEADACHE,SET,298,0.10757,0.013587,0.051147,0.017729,HP_HEADACHE,0.672503638320775
HP_PROGRESSIVE_LANGUAGE_DETE...,SET,11,0.54463,0.013321,0.25901,0.01775,HP_PROGRESSIVE_LANGUAGE_DETERIORATION,0.672503638320775
HP_ABNORMAL_FALLOPIAN_TUBE_M...,SET,21,0.3775,0.012754,0.17957,0.017775,HP_ABNORMAL_FALLOPIAN_TUBE_MORPHOLOGY,0.672503638320775
COUP_DR1_Q6,SET,218,0.1208,0.013078,0.057468,0.017784,COUP_DR1_Q6,0.672503638320775
HP_FEVER,SET,372,0.096498,0.013589,0.04591,0.017788,HP_FEVER,0.672503638320775
WP_MIR517_RELATIONSHIP_WITH_...,SET,5,0.74244,0.012244,0.35352,0.017865,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,0.672503638320775
GOBP_NEGATIVE_REGULATION_OF_...200,SET,13,0.50422,0.013406,0.24009,0.017865,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.672503638320775
MIR6804_5P,SET,66,0.21632,0.01294,0.10301,0.017874,MIR6804_5P,0.672503638320775
GOBP_ANTERIOR_POSTERIOR_PATT...,SET,199,0.14363,0.014865,0.068411,0.017894,GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION,0.672503638320775
GOBP_POSITIVE_REGULATION_OF_...168,SET,27,0.35345,0.013538,0.16836,0.017897,GOBP_POSITIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.672503638320775
HP_APLASIA_HYPOPLASIA_OF_THE...46,SET,7,0.8569,0.01672,0.40818,0.017902,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_BONE,0.672503638320775
HP_TOTAL_OPHTHALMOPLEGIA,SET,5,0.76104,0.012551,0.36254,0.017908,HP_TOTAL_OPHTHALMOPLEGIA,0.672503638320775
HP_ABNORMAL_CORNEAL_EPITHELI...,SET,95,0.18464,0.013241,0.087959,0.017909,HP_ABNORMAL_CORNEAL_EPITHELIUM_MORPHOLOGY,0.672503638320775
GOBP_FEMALE_GENITALIA_DEVELO...,SET,19,0.45363,0.014578,0.21611,0.017915,GOBP_FEMALE_GENITALIA_DEVELOPMENT,0.672503638320775
GOBP_NEGATIVE_REGULATION_OF_...495,SET,34,0.31128,0.013376,0.14832,0.017926,GOBP_NEGATIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,0.672503638320775
MORF_RAD54L,SET,91,0.17981,0.012621,0.085677,0.017929,MORF_RAD54L,0.672503638320775
HP_IMPAIRED_NEUTROPHIL_BACTE...,SET,8,0.64799,0.013517,0.30879,0.017939,HP_IMPAIRED_NEUTROPHIL_BACTERICIDAL_ACTIVITY,0.672503638320775
GABP_B,SET,240,0.11357,0.012893,0.054129,0.017957,GABP_B,0.672503638320775
GSE15930_NAIVE_VS_24H_IN_VIT...3,SET,188,0.12399,0.012476,0.059105,0.017972,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.672503638320775
HP_ADENOMATOUS_COLONIC_POLYP...,SET,17,0.38511,0.011707,0.18359,0.017976,HP_ADENOMATOUS_COLONIC_POLYPOSIS,0.672503638320775
REACTOME_NEGATIVE_REGULATION...7,SET,40,0.29348,0.013677,0.13998,0.018022,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,0.673499580645161
FEKIR_HEPARG_SPHERE_VS_HEPAR...1,SET,34,0.32939,0.014155,0.1573,0.018138,FEKIR_HEPARG_SPHERE_VS_HEPARG_DN,0.676999210245464
HP_BILATERAL_TONIC_CLONIC_SE...1,SET,322,0.099286,0.013026,0.047443,0.018194,HP_BILATERAL_TONIC_CLONIC_SEIZURE,0.676999210245464
HP_INTRACELLULAR_ACCUMULATIO...,SET,13,0.48369,0.01286,0.23115,0.018204,HP_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,0.676999210245464
VANHARANTA_UTERINE_FIBROID_W...1,SET,35,0.31419,0.013698,0.15017,0.018212,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,0.676999210245464
GOBP_AMYLOID_BETA_METABOLIC_...,SET,52,0.25191,0.013381,0.12044,0.018246,GOBP_AMYLOID_BETA_METABOLIC_PROCESS,0.676999210245464
GOBP_ESTABLISHMENT_OF_ORGANE...,SET,436,0.084916,0.012923,0.040601,0.018249,GOBP_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION,0.676999210245464
GOBP_GENOMIC_IMPRINTING,SET,17,0.40423,0.012288,0.19328,0.018252,GOBP_GENOMIC_IMPRINTING,0.676999210245464
TOMIDA_LUNG_CANCER_POOR_SURV...,SET,5,0.91056,0.015017,0.4355,0.018278,TOMIDA_LUNG_CANCER_POOR_SURVIVAL,0.677154847207587
GOBP_PHOSPHOLIPID_EFFLUX,SET,14,0.50982,0.014066,0.24394,0.01832,GOBP_PHOSPHOLIPID_EFFLUX,0.677154847207587
GSE37605_FOXP3_FUSION_GFP_VS...4,SET,171,0.13703,0.013156,0.065588,0.018352,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP,0.677154847207587
REACTOME_SIGNALING_BY_RNF43_...,SET,8,0.67446,0.014069,0.32285,0.018357,REACTOME_SIGNALING_BY_RNF43_MUTANTS,0.677154847207587
HP_GOUT,SET,16,0.41645,0.012282,0.19937,0.018369,HP_GOUT,0.677154847207587
GOBP_SYNAPTIC_VESICLE_ENDOSO...,SET,8,0.61006,0.012725,0.29208,0.018377,GOBP_SYNAPTIC_VESICLE_ENDOSOMAL_PROCESSING,0.677154847207587
REACTOME_HIV_TRANSCRIPTION_I...,SET,43,0.23587,0.011396,0.11295,0.018395,REACTOME_HIV_TRANSCRIPTION_INITIATION,0.677154847207587
GAGCCTG_MIR484,SET,96,0.18329,0.013212,0.087811,0.018438,GAGCCTG_MIR484,0.677154847207587
MIR2277_3P,SET,15,0.46578,0.013301,0.22316,0.018441,MIR2277_3P,0.677154847207587
HP_EURYBLEPHARON,SET,9,0.58978,0.013048,0.28268,0.018478,HP_EURYBLEPHARON,0.677154847207587
REACTOME_RHO_GTPASES_ACTIVAT...1,SET,19,0.39994,0.012853,0.1917,0.018483,REACTOME_RHO_GTPASES_ACTIVATE_CIT,0.677154847207587
GOMF_5_3_DNA_HELICASE_ACTIVI...,SET,8,0.60439,0.012607,0.28971,0.01849,GOMF_5_3_DNA_HELICASE_ACTIVITY,0.677154847207587
GOBP_RECOGNITION_OF_APOPTOTI...,SET,7,0.72961,0.014237,0.34992,0.01854,GOBP_RECOGNITION_OF_APOPTOTIC_CELL,0.67719369884575
IKEDA_MIR133_TARGETS_UP,SET,40,0.26758,0.01247,0.12835,0.018551,IKEDA_MIR133_TARGETS_UP,0.67719369884575
GOBP_POSITIVE_REGULATION_OF_...847,SET,60,0.24113,0.013755,0.11567,0.018558,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING,0.67719369884575
MIR3150B_3P,SET,137,0.15255,0.013122,0.073185,0.018569,MIR3150B_3P,0.67719369884575
GNF2_CENPE,SET,38,0.28919,0.013137,0.13892,0.018692,GNF2_CENPE,0.680964842767296
GOBP_RENAL_ABSORPTION,SET,33,0.34709,0.014694,0.16688,0.018774,GOBP_RENAL_ABSORPTION,0.682111847826087
chr3q28,SET,12,0.56362,0.014398,0.27103,0.01879,chr3q28,0.682111847826087
GOBP_EMBRYONIC_HINDLIMB_MORP...,SET,27,0.39444,0.015108,0.18973,0.01882,GOBP_EMBRYONIC_HINDLIMB_MORPHOGENESIS,0.682111847826087
MIR4768_3P,SET,174,0.13117,0.012703,0.063128,0.018869,MIR4768_3P,0.682111847826087
GOMF_CHLORIDE_CHANNEL_ACTIVI...,SET,72,0.23462,0.014657,0.11294,0.018886,GOMF_CHLORIDE_CHANNEL_ACTIVITY,0.682111847826087
GOBP_INTRACELLULAR_TRIGLYCER...,SET,9,0.55653,0.012313,0.26792,0.018898,GOBP_INTRACELLULAR_TRIGLYCERIDE_HOMEOSTASIS,0.682111847826087
MIR1909_5P,SET,34,0.29933,0.012863,0.14413,0.018914,MIR1909_5P,0.682111847826087
GOBP_AUDITORY_RECEPTOR_CELL_...2,SET,19,0.42749,0.013738,0.20585,0.01892,GOBP_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS,0.682111847826087
GOBP_CARBOHYDRATE_MEDIATED_S...,SET,11,0.57114,0.013969,0.27502,0.018921,GOBP_CARBOHYDRATE_MEDIATED_SIGNALING,0.682111847826087
GOBP_TRANSCRIPTION_BY_RNA_PO...1,SET,58,0.21536,0.01208,0.10372,0.018932,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.682111847826087
GSE5589_WT_VS_IL6_KO_LPS_AND...4,SET,175,0.13155,0.012776,0.063367,0.018954,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.682111847826087
CHIARETTI_T_ALL_RELAPSE_PROG...,SET,17,0.45206,0.013743,0.21777,0.018959,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,0.682111847826087
GSE32986_CURDLAN_HIGHDOSE_VS...2,SET,177,0.13126,0.012819,0.06325,0.018988,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.682448748707342
KEGG_MEDICUS_REFERENCE_HEDGE...2,SET,6,0.79828,0.014422,0.38483,0.019029,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION,0.68272592879257
HOUNKPE_HOUSEKEEPING_GENES,SET,1054,0.052441,0.012193,0.025282,0.019035,HOUNKPE_HOUSEKEEPING_GENES,0.68272592879257
HP_UPPER_LIMB_MUSCLE_WEAKNESS,SET,131,0.15918,0.013391,0.076765,0.019067,HP_UPPER_LIMB_MUSCLE_WEAKNESS,0.682858795056643
HERNANDEZ_ABERRANT_MITOSIS_B...1,SET,18,0.45503,0.014234,0.21947,0.019078,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,0.682858795056643
GSE27241_WT_VS_RORGT_KO_TH17...3,SET,166,0.12994,0.012293,0.062692,0.01911,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP,0.683300462962963
HP_BRAIN_NEOPLASM,SET,16,0.39435,0.011631,0.19048,0.019219,HP_BRAIN_NEOPLASM,0.684108517241379
WP_APOE_AND_MIR146_IN_INFLAM...,SET,7,0.67925,0.013254,0.3281,0.019221,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.684108517241379
GATA_Q6,SET,177,0.14079,0.01375,0.068021,0.019242,GATA_Q6,0.684108517241379
REACTOME_SEMA4D_INDUCED_CELL...,SET,20,0.39156,0.01291,0.1892,0.019252,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,0.684108517241379
GOBP_GALACTOSE_CATABOLIC_PRO...2,SET,5,0.76305,0.012584,0.36888,0.0193,GOBP_GALACTOSE_CATABOLIC_PROCESS_VIA_UDP_GALACTOSE,0.684108517241379
GOCC_RNA_POLYMERASE_I_COMPLEX,SET,10,0.47636,0.011109,0.23031,0.019311,GOCC_RNA_POLYMERASE_I_COMPLEX,0.684108517241379
REACTOME_DEFECTIVE_CHST6_CAU...,SET,8,0.6334,0.013212,0.30624,0.019313,REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1,0.684108517241379
GSE34006_UNTREATED_VS_A2AR_A...1,SET,182,0.13615,0.013482,0.065847,0.019342,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN,0.684108517241379
GOBP_SPINDLE_LOCALIZATION,SET,61,0.22682,0.013046,0.10971,0.019353,GOBP_SPINDLE_LOCALIZATION,0.684108517241379
GOBP_POSITIVE_REGULATION_OF_...176,SET,4,1.0026,0.01479,0.48501,0.019364,GOBP_POSITIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.684108517241379
GSE15324_ELF4_KO_VS_WT_NAIVE...1,SET,175,0.13709,0.013313,0.066318,0.019368,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN,0.684108517241379
GSE360_L_DONOVANI_VS_B_MALAY...8,SET,186,0.1326,0.013272,0.064163,0.019394,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.684108517241379
GOBP_PROXIMAL_DISTAL_PATTERN...1,SET,34,0.34001,0.014611,0.16457,0.019422,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION,0.684108517241379
HP_STOMACH_CANCER,SET,33,0.30641,0.012972,0.14841,0.01949,HP_STOMACH_CANCER,0.684108517241379
GOBP_RIBOSOME_ASSEMBLY,SET,51,0.23534,0.01238,0.11409,0.019573,GOBP_RIBOSOME_ASSEMBLY,0.684108517241379
GSE1432_CTRL_VS_IFNG_1H_MICR...2,SET,173,0.12885,0.012442,0.062464,0.019577,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.684108517241379
GOBP_SOMATIC_STEM_CELL_DIVIS...,SET,10,0.61772,0.014405,0.29957,0.019612,GOBP_SOMATIC_STEM_CELL_DIVISION,0.684108517241379
REACTOME_ISG15_ANTIVIRAL_MEC...,SET,70,0.20019,0.012332,0.097095,0.019621,REACTOME_ISG15_ANTIVIRAL_MECHANISM,0.684108517241379
GOBP_RENAL_WATER_HOMEOSTASIS,SET,24,0.39831,0.014385,0.19319,0.019621,GOBP_RENAL_WATER_HOMEOSTASIS,0.684108517241379
GSE20198_IL12_IL18_VS_IFNA_T...1,SET,179,0.12931,0.0127,0.062727,0.019635,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.684108517241379
HP_SUDDEN_EPISODIC_APNEA,SET,16,0.45616,0.013454,0.22129,0.01964,HP_SUDDEN_EPISODIC_APNEA,0.684108517241379
CROSBY_E2F4_TARGETS,SET,6,0.6783,0.012254,0.32909,0.019653,CROSBY_E2F4_TARGETS,0.684108517241379
HP_ACUTE_CORONARY_SYNDROME,SET,101,0.19348,0.014304,0.093934,0.019718,HP_ACUTE_CORONARY_SYNDROME,0.684108517241379
GOBP_NEGATIVE_REGULATION_OF_...388,SET,7,0.7733,0.015089,0.37544,0.01972,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.684108517241379
GOBP_ALPHA_BETA_T_CELL_PROLI...,SET,42,0.29991,0.014321,0.14567,0.019763,GOBP_ALPHA_BETA_T_CELL_PROLIFERATION,0.684108517241379
HP_HODGKIN_LYMPHOMA,SET,25,0.34041,0.012547,0.16534,0.019764,HP_HODGKIN_LYMPHOMA,0.684108517241379
ER_Q6_01,SET,240,0.11475,0.013027,0.055739,0.019767,ER_Q6_01,0.684108517241379
WP_ACQUIRED_PARTIAL_LIPODYST...,SET,10,0.53636,0.012508,0.26054,0.01977,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,0.684108517241379
NFMUE1_Q6,SET,216,0.11822,0.012741,0.057433,0.019786,NFMUE1_Q6,0.684108517241379
WP_EDA_SIGNALING_IN_HAIR_FOL...,SET,12,0.53076,0.013558,0.25788,0.019795,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,0.684108517241379
GOMF_SULFATIDE_BINDING,SET,6,0.6923,0.012507,0.33643,0.019812,GOMF_SULFATIDE_BINDING,0.684108517241379
GSE41176_WT_VS_TAK1_KO_ANTI_...6,SET,175,0.13412,0.013025,0.065184,0.019823,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP,0.684108517241379
GOBP_NEGATIVE_REGULATION_OF_...268,SET,5,0.75036,0.012375,0.36471,0.019832,GOBP_NEGATIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.684108517241379
MIR12130,SET,29,0.32283,0.012814,0.15694,0.019847,MIR12130,0.684108517241379
REACTOME_SUMOYLATION_OF_DNA_...1,SET,69,0.20678,0.012646,0.10053,0.019854,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,0.684108517241379
REACTOME_SUMOYLATION_OF_TRAN...2,SET,19,0.40771,0.013103,0.19824,0.019868,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS,0.684108517241379
BIOCARTA_CASPASE_PATHWAY,SET,21,0.37434,0.012647,0.18203,0.019877,BIOCARTA_CASPASE_PATHWAY,0.684108517241379
GOBP_ORGAN_INDUCTION,SET,20,0.44296,0.014605,0.21547,0.01991,GOBP_ORGAN_INDUCTION,0.684108517241379
GOBP_PROTEOLYSIS,SET,1454,0.048734,0.013154,0.023707,0.019913,GOBP_PROTEOLYSIS,0.684108517241379
MORF_CDC2L5,SET,134,0.1481,0.0126,0.072067,0.019944,MORF_CDC2L5,0.684108517241379
PID_FCER1_PATHWAY,SET,56,0.23657,0.013039,0.11514,0.019967,PID_FCER1_PATHWAY,0.684108517241379
MIR4700_3P,SET,86,0.19502,0.013309,0.094925,0.019974,MIR4700_3P,0.684108517241379
GSE29614_CTRL_VS_DAY7_TIV_FL...1,SET,159,0.13985,0.012951,0.068075,0.019979,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,0.684108517241379
GOBP_POSITIVE_REGULATION_OF_...712,SET,16,0.43466,0.012819,0.2117,0.020035,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.685350812007874
FOURNIER_ACINAR_DEVELOPMENT_...2,SET,18,0.45893,0.014355,0.22358,0.020062,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,0.685599616519174
GSE32423_IL7_VS_IL7_IL4_NAIV...2,SET,172,0.13828,0.013315,0.067382,0.020083,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP,0.685643089390963
GOBP_POSITIVE_REGULATION_OF_...411,SET,104,0.18137,0.013605,0.088411,0.020119,GOBP_POSITIVE_REGULATION_OF_LIPID_LOCALIZATION,0.686138661764706
CSR_LATE_UP.V1_UP,SET,154,0.14155,0.012903,0.06901,0.020137,CSR_LATE_UP.V1_UP,0.686138661764706
MIR3127_3P,SET,95,0.17082,0.01225,0.083362,0.02023,MIR3127_3P,0.686603589990375
GOCC_PROTEIN_LIPID_COMPLEX,SET,37,0.32174,0.014422,0.15703,0.020242,GOCC_PROTEIN_LIPID_COMPLEX,0.686603589990375
GSE8685_IL15_ACT_IL2_STARVED...2,SET,149,0.14891,0.013353,0.072689,0.020261,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.686603589990375
GOMF_PHOSPHATIDYLINOSITOL_4_...2,SET,75,0.20804,0.013263,0.10158,0.020285,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING,0.686603589990375
HP_FOCAL_T2_HYPERINTENSE_THA...,SET,14,0.43661,0.012046,0.21326,0.020322,HP_FOCAL_T2_HYPERINTENSE_THALAMIC_LESION,0.686603589990375
GSE25085_FETAL_LIVER_VS_FETA...2,SET,181,0.12391,0.012236,0.06053,0.020335,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP,0.686603589990375
KEGG_BASAL_CELL_CARCINOMA,SET,53,0.25047,0.013431,0.12236,0.020337,KEGG_BASAL_CELL_CARCINOMA,0.686603589990375
GSE3720_VD1_VS_VD2_GAMMADELT...3,SET,183,0.12354,0.012266,0.060361,0.020354,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN,0.686603589990375
HP_PALATE_FISTULA,SET,12,0.57389,0.01466,0.28052,0.020396,HP_PALATE_FISTULA,0.686603589990375
MIR512_5P,SET,49,0.24234,0.012497,0.11849,0.020425,MIR512_5P,0.686603589990375
DCA_UP.V1_UP,SET,161,0.14354,0.013376,0.070191,0.020433,DCA_UP.V1_UP,0.686603589990375
HP_CHRONIC_PAIN,SET,6,0.59973,0.010835,0.29338,0.020474,HP_CHRONIC_PAIN,0.686603589990375
GOCC_DESMOSOME,SET,26,0.37686,0.014165,0.18436,0.020478,GOCC_DESMOSOME,0.686603589990375
HP_PROBOSCIS,SET,16,0.45875,0.01353,0.22445,0.020489,HP_PROBOSCIS,0.686603589990375
GSE16385_UNTREATED_VS_12H_RO...1,SET,173,0.13176,0.012724,0.064467,0.020492,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.686603589990375
GOMF_PHOSPHATIDYLINOSITOL_5_...,SET,18,0.40259,0.012593,0.19701,0.020509,GOMF_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING,0.686603589990375
GOBP_NEGATIVE_REGULATION_OF_...461,SET,18,0.3617,0.011314,0.17701,0.020517,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.686603589990375
HP_PRIMARY_PERITONEAL_CARCIN...,SET,13,0.4912,0.013059,0.2404,0.020522,HP_PRIMARY_PERITONEAL_CARCINOMA,0.686603589990375
chr10q24,SET,109,0.31839,0.024447,0.15583,0.020526,chr10q24,0.686603589990375
GSE15659_NAIVE_VS_PTPRC_NEG_...1,SET,170,0.13685,0.013101,0.066999,0.020554,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN,0.686879105769231
KEGG_MEDICUS_VARIANT_LMO2_RE...1,SET,5,0.81134,0.013381,0.39752,0.020633,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_ACTIVATION,0.688856786743516
GOBP_EQUILIBRIOCEPTION,SET,8,0.73633,0.015359,0.36086,0.020659,GOBP_EQUILIBRIOCEPTION,0.688964813931298
GOMF_PATCHED_BINDING,SET,8,0.644,0.013434,0.31567,0.020678,GOMF_PATCHED_BINDING,0.688964813931298
GOBP_REGULATION_OF_CHRONIC_I...,SET,8,0.61949,0.012922,0.30376,0.020714,GOBP_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE,0.688964813931298
HP_ERECTILE_DYSFUNCTION,SET,60,0.23274,0.013276,0.11415,0.020742,HP_ERECTILE_DYSFUNCTION,0.688964813931298
MIR4489,SET,49,0.24589,0.01268,0.12062,0.020757,MIR4489,0.688964813931298
ZIC2_01,SET,228,0.11822,0.013086,0.058001,0.020769,ZIC2_01,0.688964813931298
FISCHER_G1_S_CELL_CYCLE,SET,172,0.13145,0.012658,0.064497,0.020775,FISCHER_G1_S_CELL_CYCLE,0.688964813931298
CARRILLOREIXACH_HEPATOBLASTO...4,SET,736,0.06743,0.013221,0.033097,0.020816,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP,0.689473
HP_LOSS_OF_SUBCUTANEOUS_ADIP...,SET,9,0.60481,0.013381,0.29691,0.02083,HP_LOSS_OF_SUBCUTANEOUS_ADIPOSE_TISSUE_IN_LIMBS,0.689473
KEGG_MEDICUS_REFERENCE_CD40_...,SET,7,0.68029,0.013274,0.33421,0.020906,KEGG_MEDICUS_REFERENCE_CD40_NFKB_SIGNALING_PATHWAY,0.690739106463878
DYRK1A_TARGET_GENES,SET,600,0.072148,0.012822,0.035445,0.020908,DYRK1A_TARGET_GENES,0.690739106463878
GOBP_VASCULAR_WOUND_HEALING,SET,18,0.43273,0.013536,0.21272,0.020971,GOBP_VASCULAR_WOUND_HEALING,0.692162492877493
GSE43957_UNTREATED_VS_NACL_T...2,SET,181,0.12798,0.012638,0.062931,0.021002,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,0.692527998102467
MGGAAGTG_GABP_B,SET,699,0.066159,0.012655,0.032548,0.02105,MGGAAGTG_GABP_B,0.692707562790698
GSE39820_CTRL_VS_TGFBETA3_IL...3,SET,176,0.13161,0.012818,0.064767,0.021078,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN,0.692707562790698
GOCC_TRANSFERASE_COMPLEX,SET,757,0.061294,0.012181,0.030165,0.021085,GOCC_TRANSFERASE_COMPLEX,0.692707562790698
HP_ABSENT_EARLOBE,SET,20,0.35276,0.011631,0.1737,0.02114,HP_ABSENT_EARLOBE,0.692707562790698
GSE13547_2H_VS_12_H_ANTI_IGM...3,SET,154,0.13994,0.012757,0.068934,0.02118,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN,0.692707562790698
GOBP_ERROR_FREE_TRANSLESION_...,SET,5,0.52625,0.0086789,0.25925,0.021191,GOBP_ERROR_FREE_TRANSLESION_SYNTHESIS,0.692707562790698
GOBP_RESPONSE_TO_HEPATOCYTE_...,SET,17,0.45865,0.013943,0.22604,0.021234,GOBP_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR,0.692707562790698
BONOME_OVARIAN_CANCER_POOR_S...2,SET,28,0.34243,0.013356,0.16877,0.021238,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,0.692707562790698
GAVISH_3CA_METAPROGRAM_MACRO...3,SET,45,0.27415,0.013549,0.13514,0.02126,GAVISH_3CA_METAPROGRAM_MACROPHAGES_LIPID_ASSOCIATED,0.692707562790698
GOBP_IODIDE_TRANSPORT,SET,9,0.51478,0.011389,0.25388,0.021304,GOBP_IODIDE_TRANSPORT,0.692707562790698
GOBP_LOCALIZATION_WITHIN_MEM...,SET,619,0.070153,0.012656,0.034604,0.021323,GOBP_LOCALIZATION_WITHIN_MEMBRANE,0.692707562790698
FOXF2_TARGET_GENES,SET,7,0.61041,0.011911,0.30112,0.021331,FOXF2_TARGET_GENES,0.692707562790698
HP_RHEUMATOID_ARTHRITIS,SET,20,0.41078,0.013544,0.20266,0.021342,HP_RHEUMATOID_ARTHRITIS,0.692707562790698
JACKSON_DNMT1_TARGETS_UP,SET,80,0.19671,0.01295,0.097073,0.021368,JACKSON_DNMT1_TARGETS_UP,0.692707562790698
BLANCO_MELO_COVID19_SARS_COV...2,SET,68,0.22325,0.013555,0.11018,0.021377,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,0.692707562790698
KAMMINGA_EZH2_TARGETS,SET,40,0.26718,0.012451,0.13188,0.021396,KAMMINGA_EZH2_TARGETS,0.692707562790698
GOBP_SUBSTANTIA_NIGRA_DEVELO...,SET,37,0.27034,0.012118,0.13344,0.021397,GOBP_SUBSTANTIA_NIGRA_DEVELOPMENT,0.692707562790698
MIR12116,SET,48,0.22671,0.011571,0.11191,0.021399,MIR12116,0.692707562790698
GOCC_9PLUS0_MOTILE_CILIUM,SET,4,1.0595,0.01563,0.52304,0.021404,GOCC_9PLUS0_MOTILE_CILIUM,0.692707562790698
GSE22886_NAIVE_CD8_TCELL_VS_...2,SET,172,0.12904,0.012425,0.063712,0.02142,GSE22886_NAIVE_CD8_TCELL_VS_DC_UP,0.692707562790698
GSE9946_IMMATURE_VS_MATURE_S...2,SET,124,0.1464,0.011985,0.072284,0.021426,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP,0.692707562790698
chr6q21,SET,46,0.45099,0.022535,0.22294,0.021548,chr6q21,0.694461121323529
KEGG_MEDICUS_VARIANT_FZD7_OV...,SET,36,0.30124,0.01332,0.14893,0.021557,KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.694461121323529
GSE29618_PRE_VS_DAY7_POST_LA...8,SET,178,0.1319,0.012918,0.06523,0.021595,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP,0.694461121323529
GSE6259_33D1_POS_VS_DEC205_P...3,SET,179,0.1392,0.013671,0.068888,0.021663,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN,0.694461121323529
YGTCCTTGR_UNKNOWN,SET,85,0.18193,0.012344,0.090037,0.021665,YGTCCTTGR_UNKNOWN,0.694461121323529
GOBP_VESICLE_TETHERING_TO_GO...,SET,5,0.7558,0.012465,0.37406,0.021671,GOBP_VESICLE_TETHERING_TO_GOLGI,0.694461121323529
GOBP_HIGH_DENSITY_LIPOPROTEI...1,SET,12,0.43509,0.011114,0.21541,0.021708,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.694461121323529
GSE27786_LIN_NEG_VS_ERYTHROB...1,SET,181,0.12541,0.012384,0.062093,0.021713,GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN,0.694461121323529
GOBP_CELL_MIGRATION_INVOLVED...1,SET,13,0.46822,0.012449,0.23183,0.021716,GOBP_CELL_MIGRATION_INVOLVED_IN_GASTRULATION,0.694461121323529
GTF3A_TARGET_GENES,SET,12,0.49481,0.01264,0.245,0.021718,GTF3A_TARGET_GENES,0.694461121323529
MIR11399,SET,68,0.20534,0.012467,0.10167,0.021721,MIR11399,0.694461121323529
GSE27786_LSK_VS_CD4_TCELL_DN,SET,177,0.12954,0.012652,0.064147,0.021725,GSE27786_LSK_VS_CD4_TCELL_DN,0.694461121323529
HP_ABNORMALITY_OF_ABDOMINAL_...,SET,15,0.47023,0.013429,0.23288,0.02174,HP_ABNORMALITY_OF_ABDOMINAL_SITUS,0.694461121323529
GOBP_NUCLEAR_MIGRATION,SET,24,0.34094,0.012313,0.16903,0.021855,GOBP_NUCLEAR_MIGRATION,0.697493595041322
REACTOME_INTERLEUKIN_6_SIGNA...,SET,11,0.56216,0.013749,0.27877,0.02188,REACTOME_INTERLEUKIN_6_SIGNALING,0.697650825688073
HP_RETINOPATHY,SET,128,0.15491,0.012883,0.076857,0.021929,HP_RETINOPATHY,0.698545013157895
BIOCARTA_PS1_PATHWAY,SET,13,0.4349,0.011563,0.21595,0.022015,BIOCARTA_PS1_PATHWAY,0.698545013157895
BENPORATH_MYC_MAX_TARGETS,SET,687,0.062426,0.011842,0.030998,0.02202,BENPORATH_MYC_MAX_TARGETS,0.698545013157895
HP_MEMBRANOPROLIFERATIVE_GLO...,SET,9,0.5939,0.01314,0.29526,0.022146,HP_MEMBRANOPROLIFERATIVE_GLOMERULONEPHRITIS,0.698545013157895
ZNF491_TARGET_GENES,SET,6,0.6581,0.011889,0.32719,0.022151,ZNF491_TARGET_GENES,0.698545013157895
GTGGGTGK_UNKNOWN,SET,265,0.10859,0.012945,0.054,0.022175,GTGGGTGK_UNKNOWN,0.698545013157895
GSE7831_1H_VS_4H_CPG_STIM_PD...1,SET,181,0.1249,0.012334,0.062128,0.022207,GSE7831_1H_VS_4H_CPG_STIM_PDC_DN,0.698545013157895
FAELT_B_CLL_WITH_VH3_21_DN,SET,44,0.26114,0.012762,0.12993,0.02223,FAELT_B_CLL_WITH_VH3_21_DN,0.698545013157895
JINESH_BLEBBISHIELD_VS_LIVE_...2,SET,304,0.097985,0.012498,0.048775,0.022281,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,0.698545013157895
MARZEC_IL2_SIGNALING_UP,SET,109,0.16869,0.012952,0.083973,0.022286,MARZEC_IL2_SIGNALING_UP,0.698545013157895
MIR568,SET,239,0.11399,0.012915,0.056751,0.022293,MIR568,0.698545013157895
GOMF_CYSTEINE_TYPE_ENDOPEPTI...7,SET,18,0.4147,0.012972,0.20653,0.022332,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.698545013157895
HP_LIMB_ATAXIA,SET,82,0.18227,0.012148,0.090775,0.022332,HP_LIMB_ATAXIA,0.698545013157895
GOBP_REGULATION_OF_PROTEASOM...1,SET,164,0.12963,0.012191,0.06457,0.022354,GOBP_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.698545013157895
GOBP_NEGATIVE_REGULATION_OF_...484,SET,7,0.63758,0.012441,0.31766,0.022379,GOBP_NEGATIVE_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.698545013157895
GOBP_NEGATIVE_REGULATION_OF_...533,SET,362,0.09247,0.01285,0.046072,0.022379,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.698545013157895
GSE4590_SMALL_VS_VPREB_POS_L...1,SET,139,0.14844,0.01286,0.073963,0.022386,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.698545013157895
MORF_CUL1,SET,68,0.19344,0.011745,0.096394,0.022393,MORF_CUL1,0.698545013157895
ZHU_CMV_8_HR_UP,SET,39,0.29232,0.013452,0.14567,0.022394,ZHU_CMV_8_HR_UP,0.698545013157895
HP_KNEE_OSTEOARTHRITIS,SET,14,0.50904,0.014044,0.25368,0.022401,HP_KNEE_OSTEOARTHRITIS,0.698545013157895
REACTOME_G2_M_CHECKPOINTS,SET,125,0.14365,0.011806,0.071592,0.022411,REACTOME_G2_M_CHECKPOINTS,0.698545013157895
REACTOME_LRR_FLII_INTERACTIN...,SET,5,0.71582,0.011805,0.35688,0.022448,REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION,0.698545013157895
REACTOME_RHOC_GTPASE_CYCLE,SET,68,0.21939,0.01332,0.10939,0.022455,REACTOME_RHOC_GTPASE_CYCLE,0.698545013157895
GSE12845_IGD_POS_VS_NEG_BLOO...1,SET,171,0.1288,0.012366,0.064223,0.022459,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN,0.698545013157895
HP_EEG_WITH_GENERALIZED_SLOW...2,SET,9,0.56708,0.012546,0.28283,0.022486,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY_GRADE_4,0.698545013157895
KEGG_P53_SIGNALING_PATHWAY,SET,66,0.21002,0.012563,0.10476,0.022503,KEGG_P53_SIGNALING_PATHWAY,0.698545013157895
WP_STATIN_INHIBITION_OF_CHOL...,SET,29,0.34119,0.013542,0.17022,0.022523,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,0.698545013157895
HP_VENOUS_THROMBOSIS,SET,74,0.21157,0.013398,0.10556,0.022533,HP_VENOUS_THROMBOSIS,0.698545013157895
REACTOME_SIGNALING_BY_FGFR,SET,86,0.18766,0.012807,0.093635,0.022534,REACTOME_SIGNALING_BY_FGFR,0.698545013157895
GSE21670_UNTREATED_VS_TGFB_T...3,SET,180,0.13291,0.013089,0.066319,0.02254,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN,0.698545013157895
MIR3912_3P,SET,5,0.72563,0.011967,0.3621,0.022546,MIR3912_3P,0.698545013157895
REACTOME_SUMOYLATION_OF_INTR...,SET,28,0.32205,0.012561,0.16074,0.022568,REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS,0.698545013157895
HP_CALVARIAL_OSTEOSCLEROSIS,SET,7,0.63829,0.012455,0.31869,0.022606,HP_CALVARIAL_OSTEOSCLEROSIS,0.698545013157895
GSE17974_IL4_AND_ANTI_IL12_V...10,SET,155,0.13983,0.012787,0.069836,0.022639,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP,0.698545013157895
HP_ABNORMAL_THROMBOSIS,SET,185,0.1342,0.013397,0.067028,0.022642,HP_ABNORMAL_THROMBOSIS,0.698545013157895
HP_ABNORMAL_URINE_PROTEIN_LE...,SET,213,0.11888,0.012724,0.059381,0.022653,HP_ABNORMAL_URINE_PROTEIN_LEVEL,0.698545013157895
GOBP_INTESTINAL_EPITHELIAL_S...,SET,7,0.70658,0.013787,0.35312,0.022704,GOBP_INTESTINAL_EPITHELIAL_STRUCTURE_MAINTENANCE,0.698545013157895
WU_APOPTOSIS_BY_CDKN1A_VIA_T...,SET,50,0.23501,0.012241,0.11745,0.022712,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,0.698545013157895
GSE12505_WT_VS_E2_2_HET_PDC_...1,SET,143,0.1417,0.012451,0.07085,0.022756,GSE12505_WT_VS_E2_2_HET_PDC_DN,0.698545013157895
GOBP_REGULATION_OF_PROGRAMME...1,SET,1348,0.048883,0.012744,0.024447,0.022783,GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.698545013157895
GSE13485_CTRL_VS_DAY1_YF17D_...2,SET,179,0.11499,0.011293,0.057527,0.02282,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP,0.698545013157895
GOBP_CELLULAR_RESPONSE_TO_NI...1,SET,9,0.59364,0.013134,0.29705,0.02284,GOBP_CELLULAR_RESPONSE_TO_NICOTINE,0.698545013157895
CHANDRAN_METASTASIS_TOP50_DN,SET,35,0.29622,0.012915,0.14824,0.022849,CHANDRAN_METASTASIS_TOP50_DN,0.698545013157895
GSE17721_POLYIC_VS_CPG_8H_BM...1,SET,181,0.12411,0.012256,0.06211,0.022852,GSE17721_POLYIC_VS_CPG_8H_BMDC_DN,0.698545013157895
DESCARTES_MAIN_FETAL_HEMATOP...,SET,38,0.25984,0.011803,0.13004,0.022859,DESCARTES_MAIN_FETAL_HEMATOPOIETIC_STEM_CELLS,0.698545013157895
HP_PRIMARY_ADRENAL_INSUFFICI...,SET,55,0.23032,0.012581,0.11528,0.022874,HP_PRIMARY_ADRENAL_INSUFFICIENCY,0.698545013157895
ZHANG_GATA6_TARGETS_UP,SET,12,0.5368,0.013712,0.26874,0.022895,ZHANG_GATA6_TARGETS_UP,0.698545013157895
GSE22140_HEALTHY_VS_ARTHRITI...3,SET,183,0.12419,0.012331,0.062176,0.022897,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.698545013157895
HP_MYOCLONIC_SPASMS,SET,29,0.31766,0.012609,0.15904,0.022903,HP_MYOCLONIC_SPASMS,0.698545013157895
HP_PATCHY_PALMOPLANTAR_HYPER...,SET,6,0.81986,0.014811,0.41052,0.022913,HP_PATCHY_PALMOPLANTAR_HYPERKERATOSIS,0.698545013157895
GOBP_REGULATION_OF_RESPONSE_...3,SET,4,0.76766,0.011324,0.38446,0.022935,GOBP_REGULATION_OF_RESPONSE_TO_DRUG,0.698602914110429
GCM_Q2,SET,212,0.12029,0.012845,0.060272,0.022988,GCM_Q2,0.698792024760383
GOBP_ESTABLISHMENT_OF_PROTEI...7,SET,416,0.081803,0.012167,0.040992,0.022996,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE,0.698792024760383
GSE13411_PLASMA_CELL_VS_MEMO...2,SET,162,0.13713,0.012817,0.068723,0.023011,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.698792024760383
MIR518E_5P_MIR519A_5P_MIR519...,SET,82,0.18519,0.012342,0.09283,0.023034,MIR518E_5P_MIR519A_5P_MIR519B_5P_MIR519C_5P_MIR522_5P_MIR523_5P,0.698792024760383
NAKAYA_PBMC_FLUMIST_AGE_18_5...6,SET,31,0.30954,0.012702,0.1552,0.023063,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP,0.698792024760383
GOBP_SPINAL_CORD_MOTOR_NEURO...1,SET,9,0.57675,0.01276,0.28923,0.023078,GOBP_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION,0.698792024760383
GOBP_CYTOPLASMIC_SEQUESTERIN...1,SET,4,0.78536,0.011585,0.39406,0.023138,GOBP_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB,0.698792024760383
GOBP_NEGATIVE_REGULATION_OF_...585,SET,2,1.4341,0.01496,0.71969,0.023155,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.698792024760383
KEGG_MEDICUS_REFERENCE_HOMOL...2,SET,12,0.44513,0.011371,0.22344,0.023184,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR,0.698792024760383
GSE3982_MAC_VS_EFF_MEMORY_CD...2,SET,180,0.12715,0.012522,0.063828,0.023186,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP,0.698792024760383
REACTOME_TRANSCRIPTION_OF_E2...1,SET,19,0.3474,0.011164,0.17441,0.023199,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,0.698792024760383
HP_FINGERNAIL_DYSPLASIA,SET,16,0.42875,0.012645,0.21533,0.023243,HP_FINGERNAIL_DYSPLASIA,0.698792024760383
HP_ACCESSORY_ORAL_FRENULUM,SET,16,0.41296,0.012179,0.20754,0.023315,HP_ACCESSORY_ORAL_FRENULUM,0.698792024760383
GOBP_MEIOTIC_DNA_DOUBLE_STRA...,SET,5,0.95167,0.015695,0.47832,0.023324,GOBP_MEIOTIC_DNA_DOUBLE_STRAND_BREAK_FORMATION,0.698792024760383
MIR1244,SET,86,0.17807,0.012152,0.089522,0.023353,MIR1244,0.698792024760383
GOBP_TOLL_LIKE_RECEPTOR_4_SI...,SET,56,0.22497,0.0124,0.11311,0.023357,GOBP_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.698792024760383
HP_2_3_FINGER_SYNDACTYLY,SET,9,0.57788,0.012785,0.29058,0.023373,HP_2_3_FINGER_SYNDACTYLY,0.698792024760383
KEGG_MEDICUS_PATHOGEN_YERSIN...2,SET,6,0.80392,0.014523,0.40437,0.023408,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.698792024760383
HALLMARK_E2F_TARGETS,SET,188,0.11675,0.011748,0.058752,0.023457,HALLMARK_E2F_TARGETS,0.698792024760383
GSE24634_NAIVE_CD4_TCELL_VS_...1,SET,187,0.12494,0.012538,0.062871,0.023459,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN,0.698792024760383
GOBP_REGULATION_OF_COMPLEMEN...3,SET,9,0.69949,0.015476,0.35211,0.023492,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.698792024760383
GOMF_L_ASCORBIC_ACID_BINDING,SET,20,0.37901,0.012496,0.19083,0.023517,GOMF_L_ASCORBIC_ACID_BINDING,0.698792024760383
HP_CHROMOSOMAL_BREAKAGE_INDU...2,SET,13,0.4545,0.012084,0.22885,0.023521,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_IONIZING_RADIATION,0.698792024760383
GOMF_IODIDE_TRANSMEMBRANE_TR...,SET,5,0.66102,0.010902,0.33287,0.023534,GOMF_IODIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.698792024760383
GOBP_B_CELL_ACTIVATION,SET,244,0.11367,0.01301,0.057255,0.023564,GOBP_B_CELL_ACTIVATION,0.698792024760383
GOBP_PUTRESCINE_METABOLIC_PR...,SET,7,0.60024,0.011712,0.30237,0.023573,GOBP_PUTRESCINE_METABOLIC_PROCESS,0.698792024760383
GOBP_VESICLE_MEDIATED_TRANSP...4,SET,138,0.14253,0.012304,0.071807,0.023589,GOBP_VESICLE_MEDIATED_TRANSPORT_TO_THE_PLASMA_MEMBRANE,0.698792024760383
GOMF_SINGLE_STRANDED_DNA_3_5...,SET,6,0.61846,0.011173,0.31159,0.02359,GOMF_SINGLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,0.698792024760383
GSE28237_EARLY_VS_LATE_GC_BC...1,SET,175,0.12539,0.012178,0.063191,0.023618,GSE28237_EARLY_VS_LATE_GC_BCELL_DN,0.698792024760383
GOMF_RETINAL_BINDING,SET,17,0.42792,0.013009,0.21572,0.023653,GOMF_RETINAL_BINDING,0.698792024760383
GSE7460_FOXP3_MUT_VS_WT_ACT_...2,SET,181,0.13063,0.0129,0.065882,0.023702,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP,0.698792024760383
MIR491_3P,SET,108,0.16439,0.012565,0.082915,0.02371,MIR491_3P,0.698792024760383
GSE339_CD8POS_VS_CD4CD8DN_DC...1,SET,185,0.121,0.012079,0.061034,0.023722,GSE339_CD8POS_VS_CD4CD8DN_DC_DN,0.698792024760383
NIKOLSKY_BREAST_CANCER_19Q13...1,SET,21,0.6037,0.020395,0.30454,0.02373,NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON,0.698792024760383
HP_CEREBRAL_CAVERNOUS_MALFOR...,SET,5,0.65791,0.01085,0.33199,0.023764,HP_CEREBRAL_CAVERNOUS_MALFORMATION,0.698792024760383
WP_GENES_CONTROLLING_NEPHROG...,SET,41,0.2973,0.014026,0.15003,0.023774,WP_GENES_CONTROLLING_NEPHROGENESIS,0.698792024760383
MIR1287_5P,SET,58,0.21472,0.012043,0.10837,0.023783,MIR1287_5P,0.698792024760383
SHEDDEN_LUNG_CANCER_POOR_SUR...,SET,417,0.082226,0.012245,0.041502,0.02379,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,0.698792024760383
WP_CYTOSOLIC_DNASENSING_PATH...,SET,62,0.21401,0.012409,0.10804,0.023813,WP_CYTOSOLIC_DNASENSING_PATHWAY,0.698792024760383
GSE2770_TGFB_AND_IL4_VS_TGFB...4,SET,171,0.11958,0.011481,0.060372,0.023816,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.698792024760383
GAO_LARGE_INTESTINE_24W_C7_G...,SET,16,0.43997,0.012976,0.2222,0.023857,GAO_LARGE_INTESTINE_24W_C7_GOBLET_PROGENITOR,0.698792024760383
GOBP_AGGREPHAGY,SET,16,0.38986,0.011498,0.19699,0.023911,GOBP_AGGREPHAGY,0.698792024760383
GOBP_ESTABLISHMENT_OF_MITOTI...1,SET,5,0.70882,0.01169,0.35816,0.023914,GOBP_ESTABLISHMENT_OF_MITOTIC_SISTER_CHROMATID_COHESION,0.698792024760383
GOMF_HELICASE_ACTIVITY,SET,142,0.13897,0.012168,0.070224,0.023917,GOMF_HELICASE_ACTIVITY,0.698792024760383
GSE19374_UNINF_VS_LISTERIA_I...1,SET,182,0.12218,0.012098,0.06175,0.023937,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN,0.698792024760383
GOBP_NEUROMUSCULAR_PROCESS_C...1,SET,50,0.26354,0.013728,0.1332,0.023941,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE,0.698792024760383
GOBP_PLASMINOGEN_ACTIVATION,SET,24,0.37804,0.013652,0.1911,0.02396,GOBP_PLASMINOGEN_ACTIVATION,0.698792024760383
GOBP_REGULATION_OF_OSTEOBLAS...1,SET,116,0.17007,0.013469,0.085998,0.023998,GOBP_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.698792024760383
REACTOME_RHO_GTPASES_ACTIVAT...6,SET,19,0.38789,0.012466,0.19619,0.024024,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,0.698792024760383
GOBP_PIGMENT_GRANULE_LOCALIZ...,SET,23,0.36143,0.012778,0.18285,0.024048,GOBP_PIGMENT_GRANULE_LOCALIZATION,0.698792024760383
GOCC_PRERIBOSOME_SMALL_SUBUN...,SET,14,0.40719,0.011234,0.20605,0.024075,GOCC_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR,0.698792024760383
MORF_UBE2A,SET,39,0.25322,0.011653,0.12815,0.024087,MORF_UBE2A,0.698792024760383
GOBP_REGULATION_OF_AUTOPHAGY,SET,333,0.092814,0.01238,0.046979,0.024106,GOBP_REGULATION_OF_AUTOPHAGY,0.698792024760383
KERLEY_RESPONSE_TO_CISPLATIN...2,SET,44,0.26108,0.012759,0.13216,0.024112,KERLEY_RESPONSE_TO_CISPLATIN_UP,0.698792024760383
GSE15930_STIM_VS_STIM_AND_TR...5,SET,181,0.12559,0.012402,0.0636,0.024164,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN,0.698792024760383
GOBP_RESPONSE_TO_INTERLEUKIN...10,SET,32,0.32734,0.013647,0.16591,0.024257,GOBP_RESPONSE_TO_INTERLEUKIN_6,0.698792024760383
REACTOME_PLASMA_LIPOPROTEIN_...1,SET,18,0.39827,0.012458,0.20196,0.024313,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,0.698792024760383
GOBP_PROPIONATE_METABOLIC_PR...,SET,4,0.79298,0.011698,0.40212,0.024314,GOBP_PROPIONATE_METABOLIC_PROCESS,0.698792024760383
HP_INTERMITTENT_DIARRHEA,SET,21,0.33492,0.011315,0.16989,0.02435,HP_INTERMITTENT_DIARRHEA,0.698792024760383
ALONSO_METASTASIS_NEURAL_UP,SET,15,0.48461,0.013839,0.24583,0.024351,ALONSO_METASTASIS_NEURAL_UP,0.698792024760383
ONGUSAHA_TP53_TARGETS,SET,33,0.29234,0.012377,0.14833,0.024373,ONGUSAHA_TP53_TARGETS,0.698792024760383
IIZUKA_LIVER_CANCER_PROGRESS...4,SET,24,0.33633,0.012146,0.17065,0.024375,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,0.698792024760383
DUTERTRE_ESTRADIOL_RESPONSE_...2,SET,297,0.095174,0.012001,0.048301,0.024403,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,0.698792024760383
GOBP_VIRAL_PROTEIN_PROCESSING,SET,31,0.30001,0.012311,0.15227,0.02441,GOBP_VIRAL_PROTEIN_PROCESSING,0.698792024760383
GOBP_NEGATIVE_REGULATION_OF_...333,SET,157,0.13833,0.012731,0.070209,0.024413,GOBP_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY,0.698792024760383
REACTOME_RAC1_GTPASE_CYCLE,SET,167,0.13625,0.012929,0.06916,0.02442,REACTOME_RAC1_GTPASE_CYCLE,0.698792024760383
GSE17721_0.5H_VS_4H_POLYIC_B...2,SET,183,0.11666,0.011583,0.059217,0.024422,GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP,0.698792024760383
GOBP_ERYTHROCYTE_MATURATION,SET,18,0.38965,0.012188,0.19783,0.024449,GOBP_ERYTHROCYTE_MATURATION,0.698792024760383
CREB_Q2_01,SET,206,0.11706,0.012324,0.059436,0.024455,CREB_Q2_01,0.698792024760383
GOBP_TRANS_SYNAPTIC_SIGNALIN...3,SET,7,0.69678,0.013596,0.35384,0.024474,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_TRANS_SYNAPTIC_COMPLEX,0.698792024760383
CEBPB_01,SET,240,0.11189,0.012703,0.056823,0.024478,CEBPB_01,0.698792024760383
SESTO_RESPONSE_TO_UV_C0,SET,98,0.16585,0.012078,0.084227,0.024482,SESTO_RESPONSE_TO_UV_C0,0.698792024760383
GNF2_PCNA,SET,64,0.20481,0.012065,0.10406,0.024533,GNF2_PCNA,0.698792024760383
WP_EXTRAFOLLICULAR_AND_FOLLI...,SET,65,0.2309,0.013707,0.11733,0.024542,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,0.698792024760383
GOCC_GLYCOPROTEIN_COMPLEX,SET,21,0.36432,0.012308,0.18513,0.024544,GOCC_GLYCOPROTEIN_COMPLEX,0.698792024760383
HP_LIMB_MUSCLE_WEAKNESS,SET,306,0.097045,0.012418,0.049318,0.024556,HP_LIMB_MUSCLE_WEAKNESS,0.698792024760383
GOCC_SET1C_COMPASS_COMPLEX,SET,14,0.44866,0.012378,0.22803,0.024566,GOCC_SET1C_COMPASS_COMPLEX,0.698792024760383
GSE13738_RESTING_VS_BYSTANDE...2,SET,152,0.13561,0.012281,0.068924,0.024572,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.698792024760383
HMGA1_TARGET_GENES,SET,703,0.064712,0.012412,0.032907,0.024626,HMGA1_TARGET_GENES,0.698792024760383
BIOCARTA_IL1R_PATHWAY,SET,30,0.33428,0.013495,0.17,0.024638,BIOCARTA_IL1R_PATHWAY,0.698792024760383
GOMF_PHOSPHATIDIC_ACID_TRANS...,SET,5,0.77397,0.012764,0.39365,0.02465,GOMF_PHOSPHATIDIC_ACID_TRANSFER_ACTIVITY,0.698792024760383
GOBP_PROTEIN_LOCALIZATION_TO...43,SET,6,0.57156,0.010326,0.29074,0.024664,GOBP_PROTEIN_LOCALIZATION_TO_PHOTORECEPTOR_OUTER_SEGMENT,0.698792024760383
GSE2770_UNTREATED_VS_ACT_CD4...2,SET,180,0.13002,0.012804,0.066137,0.024664,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP,0.698792024760383
GSE17721_CPG_VS_GARDIQUIMOD_...11,SET,183,0.12233,0.012146,0.062263,0.02473,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN,0.698792024760383
GOBP_REGULATION_OF_AMYLOID_P...,SET,42,0.26771,0.012783,0.13628,0.024749,GOBP_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.698792024760383
HP_ABNORMAL_NUMBER_OF_INCISO...,SET,51,0.24048,0.012651,0.12243,0.02476,HP_ABNORMAL_NUMBER_OF_INCISORS,0.698792024760383
HP_URINARY_TRACT_NEOPLASM,SET,133,0.14681,0.012444,0.074742,0.024761,HP_URINARY_TRACT_NEOPLASM,0.698792024760383
GOMF_DIACYLGLYCEROL_BINDING,SET,13,0.46462,0.012353,0.2366,0.024788,GOMF_DIACYLGLYCEROL_BINDING,0.698792024760383
GSE37301_MULTIPOTENT_PROGENI...4,SET,153,0.1305,0.011857,0.0665,0.024867,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.698792024760383
WP_15Q112_COPY_NUMBER_VARIAT...,SET,4,0.83878,0.012373,0.42758,0.024906,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,0.698792024760383
GOCC_EQUATORIAL_MICROTUBULE_...,SET,4,0.83878,0.012373,0.42758,0.024906,GOCC_EQUATORIAL_MICROTUBULE_ORGANIZING_CENTER,0.698792024760383
ZHANG_RESPONSE_TO_IKK_INHIBI...2,SET,215,0.12129,0.013042,0.061854,0.024948,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,0.698792024760383
WP_GLYCOSYLATION_AND_RELATED...,SET,20,0.31843,0.010499,0.16242,0.024975,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,0.698792024760383
MIR3162_5P,SET,67,0.19662,0.01185,0.10029,0.024976,MIR3162_5P,0.698792024760383
PID_WNT_SIGNALING_PATHWAY,SET,25,0.37519,0.013828,0.19139,0.024987,PID_WNT_SIGNALING_PATHWAY,0.698792024760383
GOCC_DNA_REPAIR_COMPLEX,SET,20,0.30775,0.010147,0.15701,0.025004,GOCC_DNA_REPAIR_COMPLEX,0.698792024760383
GOMF_NADPLUS_NUCLEOTIDASE_CY...,SET,14,0.57646,0.015904,0.29413,0.025012,GOMF_NADPLUS_NUCLEOTIDASE_CYCLIC_ADP_RIBOSE_GENERATING,0.698792024760383
KRAS.DF.V1_DN,SET,169,0.13507,0.012893,0.068934,0.025039,KRAS.DF.V1_DN,0.698792024760383
MYLLYKANGAS_AMPLIFICATION_HO...11,SET,9,0.58685,0.012983,0.2995,0.025041,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25,0.698792024760383
HP_TRANSIENT_NEONATAL_DIABET...,SET,15,0.46162,0.013183,0.23561,0.025048,HP_TRANSIENT_NEONATAL_DIABETES_MELLITUS,0.698792024760383
CACGTG_MYC_Q2,SET,933,0.056512,0.012406,0.028847,0.02506,CACGTG_MYC_Q2,0.698792024760383
GOCC_PERICENTRIOLAR_MATERIAL,SET,21,0.31847,0.010759,0.16258,0.025071,GOCC_PERICENTRIOLAR_MATERIAL,0.698792024760383
REACTOME_SIGNALING_BY_FGFR2_...2,SET,42,0.24944,0.011911,0.12734,0.025075,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,0.698792024760383
HP_POST_PARTUM_HEMORRHAGE,SET,13,0.48964,0.013018,0.24998,0.025083,HP_POST_PARTUM_HEMORRHAGE,0.698792024760383
DESCARTES_FETAL_EYE_ASTROCYT...,SET,28,0.3578,0.013955,0.18273,0.02512,DESCARTES_FETAL_EYE_ASTROCYTES,0.698792024760383
HP_GLIOBLASTOMA_MULTIFORME,SET,26,0.31053,0.011672,0.1586,0.025125,HP_GLIOBLASTOMA_MULTIFORME,0.698792024760383
GOBP_REGULATION_OF_PROTEOLYS...1,SET,528,0.075504,0.012613,0.03857,0.025147,GOBP_REGULATION_OF_PROTEOLYSIS,0.698792024760383
GOBP_CHOLESTEROL_STORAGE,SET,23,0.36368,0.012858,0.18579,0.025157,GOBP_CHOLESTEROL_STORAGE,0.698792024760383
PITX1_TARGET_GENES,SET,290,0.097397,0.012138,0.049758,0.025159,PITX1_TARGET_GENES,0.698792024760383
MIR3170,SET,47,0.23906,0.012074,0.12214,0.025167,MIR3170,0.698792024760383
GSE23505_UNTREATED_VS_4DAY_I...2,SET,185,0.12465,0.012443,0.063688,0.025173,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.698792024760383
GOMF_METAL_ION_SEQUESTERING_...,SET,5,0.80129,0.013215,0.40955,0.02521,GOMF_METAL_ION_SEQUESTERING_ACTIVITY,0.698897458432304
WP_NEOLACTO_SERIES_SPHINGOLI...,SET,11,0.51046,0.012485,0.26092,0.025218,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.698897458432304
TRAVAGLINI_LUNG_IGSF21_DENDR...,SET,43,0.294,0.014204,0.15032,0.025255,TRAVAGLINI_LUNG_IGSF21_DENDRITIC_CELL,0.698897458432304
GSE2585_CD80_HIGH_VS_LOW_AIR...2,SET,176,0.12985,0.012646,0.066402,0.025271,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP,0.698897458432304
WP_G1_TO_S_CELL_CYCLE_CONTROL,SET,64,0.19921,0.011735,0.10191,0.025316,WP_G1_TO_S_CELL_CYCLE_CONTROL,0.698897458432304
GOCC_DYNEIN_AXONEMAL_PARTICLE,SET,14,0.40468,0.011165,0.20706,0.025336,GOCC_DYNEIN_AXONEMAL_PARTICLE,0.698897458432304
GOMF_CARBOHYDRATE_PROTON_SYM...,SET,7,0.73265,0.014296,0.37494,0.025355,GOMF_CARBOHYDRATE_PROTON_SYMPORTER_ACTIVITY,0.698897458432304
BIOCARTA_PLATELETAPP_PATHWAY,SET,11,0.56786,0.013889,0.29064,0.025371,BIOCARTA_PLATELETAPP_PATHWAY,0.698897458432304
HP_PANHYPOPITUITARISM,SET,25,0.32204,0.011869,0.16484,0.025382,HP_PANHYPOPITUITARISM,0.698897458432304
GOBP_NEGATIVE_REGULATION_OF_...53,SET,18,0.44896,0.014044,0.22982,0.025386,GOBP_NEGATIVE_REGULATION_OF_BONE_REMODELING,0.698897458432304
GSE41176_UNSTIM_VS_ANTI_IGM_...5,SET,170,0.12354,0.011827,0.063246,0.025398,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN,0.698897458432304
GOBP_TUBE_MORPHOGENESIS,SET,812,0.062366,0.012816,0.031947,0.025466,GOBP_TUBE_MORPHOGENESIS,0.700214264240506
STAT6_01,SET,238,0.11353,0.012835,0.05817,0.0255,STAT6_01,0.700594861660079
GOCC_PRESYNAPTIC_ACTIVE_ZONE...2,SET,30,0.31897,0.012877,0.1636,0.02561,GOCC_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,0.703061255924171
GOBP_MORPHOGENESIS_OF_AN_END...,SET,16,0.4419,0.013033,0.2269,0.02574,GOBP_MORPHOGENESIS_OF_AN_ENDOTHELIUM,0.706072375690608
REACTOME_DISEASES_OF_METABOL...,SET,227,0.11353,0.012539,0.058336,0.025826,REACTOME_DISEASES_OF_METABOLISM,0.706648597800471
ZHOU_INFLAMMATORY_RESPONSE_F...1,SET,250,0.10754,0.012457,0.055261,0.025834,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,0.706648597800471
GSE26928_NAIVE_VS_EFF_MEMORY...1,SET,169,0.12393,0.01183,0.063699,0.02586,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,0.706648597800471
GOBP_ESTABLISHMENT_OF_PROTEI...1,SET,1554,0.043283,0.012042,0.022248,0.025867,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.706648597800471
HP_DELAYED_UMBILICAL_CORD_SE...,SET,5,0.91685,0.015121,0.47131,0.025877,HP_DELAYED_UMBILICAL_CORD_SEPARATION,0.706648597800471
GOBP_REGULATION_OF_LIPID_STO...,SET,50,0.24741,0.012887,0.12719,0.025883,GOBP_REGULATION_OF_LIPID_STORAGE,0.706648597800471
GSE1432_6H_VS_24H_IFNG_MICRO...2,SET,178,0.12533,0.012275,0.064465,0.025941,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.70685616251944
MPHOSPH8_TARGET_GENES,SET,7,0.66768,0.013028,0.34346,0.025955,MPHOSPH8_TARGET_GENES,0.70685616251944
REACTOME_DISEASES_OF_DNA_REP...,SET,49,0.23166,0.011946,0.1192,0.025991,REACTOME_DISEASES_OF_DNA_REPAIR,0.70685616251944
TITF1_Q3,SET,213,0.11653,0.012472,0.059984,0.026036,TITF1_Q3,0.70685616251944
GOBP_T_CELL_TOLERANCE_INDUCT...,SET,14,0.47735,0.01317,0.24572,0.026036,GOBP_T_CELL_TOLERANCE_INDUCTION,0.70685616251944
GOMF_BETA_GLUCOSIDASE_ACTIVI...,SET,5,0.74148,0.012229,0.38177,0.026062,GOMF_BETA_GLUCOSIDASE_ACTIVITY,0.70685616251944
GOBP_BLOOD_VESSEL_MORPHOGENE...,SET,579,0.074396,0.012995,0.038312,0.026086,GOBP_BLOOD_VESSEL_MORPHOGENESIS,0.70685616251944
HP_SUBEPENDYMAL_CYSTS,SET,8,0.55539,0.011585,0.28602,0.026089,HP_SUBEPENDYMAL_CYSTS,0.70685616251944
GOBP_PROSTATE_GLANDULAR_ACIN...1,SET,10,0.55963,0.013051,0.28827,0.026118,GOBP_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT,0.70685616251944
NAKAMURA_ADIPOGENESIS_LATE_DN,SET,33,0.30336,0.012843,0.15629,0.026132,NAKAMURA_ADIPOGENESIS_LATE_DN,0.70685616251944
GOBP_POSITIVE_REGULATION_OF_...829,SET,28,0.31876,0.012432,0.16422,0.026139,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.70685616251944
GSE20715_WT_VS_TLR4_KO_LUNG_...1,SET,177,0.12223,0.011937,0.062975,0.026142,GSE20715_WT_VS_TLR4_KO_LUNG_DN,0.70685616251944
NAKAJIMA_MAST_CELL,SET,40,0.28116,0.013102,0.14487,0.026155,NAKAJIMA_MAST_CELL,0.70685616251944
GSE23568_ID3_KO_VS_WT_CD8_TC...1,SET,186,0.12316,0.012327,0.063483,0.026197,GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN,0.70709842901474
REACTOME_REGULATION_OF_INNAT...,SET,13,0.47184,0.012545,0.24326,0.026219,REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA,0.70709842901474
HP_TYPICALLY_DE_NOVO,SET,11,0.50334,0.012311,0.25951,0.026225,HP_TYPICALLY_DE_NOVO,0.70709842901474
WP_NRF2_PATHWAY,SET,133,0.15677,0.013288,0.080902,0.026335,WP_NRF2_PATHWAY,0.709513895348837
HP_RETROBULBAR_OPTIC_NEURITIS,SET,15,0.42926,0.012259,0.22163,0.026392,HP_RETROBULBAR_OPTIC_NEURITIS,0.709887648648649
DACOSTA_UV_RESPONSE_VIA_ERCC...7,SET,79,0.18392,0.012032,0.094994,0.026436,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.709887648648649
GSE22033_WT_VS_PPARG_KO_MEF_...2,SET,174,0.12169,0.011785,0.062855,0.026438,GSE22033_WT_VS_PPARG_KO_MEF_UP,0.709887648648649
KEGG_MEDICUS_VARIANT_MUTATIO...21,SET,28,0.31822,0.012412,0.16438,0.026451,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY,0.709887648648649
KEGG_MEDICUS_VARIANT_MUTATIO...85,SET,28,0.31822,0.012412,0.16438,0.026451,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY,0.709887648648649
GOBP_HOMOPHILIC_CELL_ADHESIO...,SET,157,0.17691,0.016281,0.091452,0.026539,GOBP_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,0.711177872012336
WP_GLYCEROLIPIDS_AND_GLYCERO...,SET,21,0.35062,0.011846,0.18126,0.02654,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,0.711177872012336
GOBP_CELL_ADHESION_MOLECULE_...,SET,11,0.57566,0.014079,0.29769,0.02658,GOBP_CELL_ADHESION_MOLECULE_PRODUCTION,0.711327911538462
GOMF_GLUCOSYLTRANSFERASE_ACT...,SET,16,0.37422,0.011037,0.19355,0.0266,GOMF_GLUCOSYLTRANSFERASE_ACTIVITY,0.711327911538462
HP_CONE_SHAPED_EPIPHYSES_OF_...,SET,27,0.31506,0.012067,0.16296,0.026607,HP_CONE_SHAPED_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.711327911538462
REACTOME_NECTIN_NECL_TRANS_H...,SET,3,1.0438,0.013335,0.54044,0.02673,REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION,0.714066986933128
HP_ABNORMAL_MORPHOLOGY_OF_TH...2,SET,25,0.34074,0.012559,0.17646,0.026753,HP_ABNORMAL_MORPHOLOGY_OF_THE_CHOROIDAL_VASCULATURE,0.7141325
USF_01,SET,229,0.11004,0.012207,0.057005,0.026784,USF_01,0.714411297006907
GSE12507_PDC_CELL_LINE_VS_IM...2,SET,136,0.14087,0.012074,0.072991,0.026811,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP,0.714583055981595
GOBP_ADHERENS_JUNCTION_ASSEM...,SET,13,0.46257,0.012298,0.23987,0.026907,GOBP_ADHERENS_JUNCTION_ASSEMBLY,0.716054047436878
GSE10240_IL22_VS_IL17_STIM_P...1,SET,174,0.11912,0.011536,0.061774,0.026917,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.716054047436878
GSE15930_NAIVE_VS_24H_IN_VIT...1,SET,189,0.1128,0.01138,0.058502,0.026928,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN,0.716054047436878
MANNO_MIDBRAIN_NEUROTYPES_HE...,SET,806,0.063301,0.012963,0.032845,0.026982,MANNO_MIDBRAIN_NEUROTYPES_HENDO,0.716941444954128
REACTOME_Z_DECAY_DEGRADATION...,SET,10,0.50605,0.011801,0.26266,0.02702,REACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS,0.717402673796791
GOBP_STEROID_HORMONE_MEDIATE...,SET,122,0.14714,0.011949,0.076402,0.027066,GOBP_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.717686773455378
HP_CURVILINEAR_INTRACELLULAR...,SET,11,0.50318,0.012307,0.26128,0.027072,HP_CURVILINEAR_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,0.717686773455378
GOMF_RNA_POLYMERASE_I_TRANSC...,SET,9,0.51513,0.011397,0.2677,0.027167,GOMF_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.719000664893617
GOBP_THYROID_STIMULATING_HOR...,SET,6,0.70786,0.012788,0.36788,0.027177,GOBP_THYROID_STIMULATING_HORMONE_SECRETING_CELL_DIFFERENTIATION,0.719000664893617
MIR548B_3P,SET,91,0.17214,0.012083,0.089479,0.0272,MIR548B_3P,0.719000664893617
GSE411_UNSTIM_VS_100MIN_IL6_...3,SET,186,0.12551,0.012562,0.065246,0.02721,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.719000664893617
MIR22_3P,SET,126,0.15034,0.012406,0.078167,0.027225,MIR22_3P,0.719000664893617
GOBP_UDP_GLUCOSE_METABOLIC_P...,SET,6,0.53462,0.0096583,0.27804,0.02726,GOBP_UDP_GLUCOSE_METABOLIC_PROCESS,0.719025352539803
GAVISH_3CA_MALIGNANT_METAPRO...4,SET,48,0.2614,0.013342,0.13596,0.027273,GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2,0.719025352539803
GOMF_CHLORIDE_TRANSMEMBRANE_...,SET,107,0.17209,0.013092,0.089517,0.027288,GOMF_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.719025352539803
GOMF_BETA_GALACTOSIDE_CMP_AL...,SET,7,0.53298,0.0104,0.27743,0.027366,GOMF_BETA_GALACTOSIDE_CMP_ALPHA_2_3_SIALYLTRANSFERASE_ACTIVITY,0.719251779661017
GOBP_REGULATION_OF_PRESYNAPS...,SET,28,0.35862,0.013987,0.1867,0.027383,GOBP_REGULATION_OF_PRESYNAPSE_ORGANIZATION,0.719251779661017
MIR6734_5P,SET,64,0.20196,0.011897,0.10515,0.027392,MIR6734_5P,0.719251779661017
GOBP_OLIGOSACCHARIDE_CATABOL...,SET,16,0.42734,0.012604,0.22251,0.027405,GOBP_OLIGOSACCHARIDE_CATABOLIC_PROCESS,0.719251779661017
REACTOME_TRANSCRIPTIONAL_REG...1,SET,30,0.28668,0.011573,0.14928,0.027413,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6,0.719251779661017
GSE17721_POLYIC_VS_GARDIQUIM...13,SET,191,0.11359,0.011519,0.059164,0.027445,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN,0.719251779661017
REACTOME_SIGNALING_BY_BMP,SET,28,0.32163,0.012544,0.16759,0.027494,REACTOME_SIGNALING_BY_BMP,0.719251779661017
MORI_MATURE_B_LYMPHOCYTE_UP,SET,80,0.19867,0.013079,0.10355,0.027524,MORI_MATURE_B_LYMPHOCYTE_UP,0.719251779661017
GOBP_ODONTOGENESIS,SET,122,0.16484,0.013385,0.085922,0.027537,GOBP_ODONTOGENESIS,0.719251779661017
MIR484,SET,81,0.18171,0.012037,0.094736,0.027559,MIR484,0.719251779661017
GOBP_RESPONSE_TO_UV,SET,142,0.13335,0.011676,0.069532,0.027573,GOBP_RESPONSE_TO_UV,0.719251779661017
ZHAN_MULTIPLE_MYELOMA_CD1_AN...2,SET,78,0.18116,0.011777,0.094479,0.027598,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,0.719251779661017
MIR6128,SET,153,0.13114,0.011916,0.068401,0.027614,MIR6128,0.719251779661017
HP_ELEVATED_URINARY_COLLAGEN...,SET,5,0.73848,0.012179,0.38522,0.027626,HP_ELEVATED_URINARY_COLLAGEN_DEGRADATION_PRODUCTS,0.719251779661017
REACTOME_SEMA4D_IN_SEMAPHORI...,SET,24,0.3368,0.012163,0.17571,0.027636,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,0.719251779661017
GOBP_RENAL_SYSTEM_PROCESS_IN...1,SET,14,0.47733,0.013169,0.24906,0.027656,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME,0.719251779661017
REACTOME_CELL_CYCLE,SET,591,0.064919,0.011453,0.03388,0.02768,REACTOME_CELL_CYCLE,0.719251779661017
HOXC6_TARGET_GENES,SET,949,0.053992,0.011948,0.028187,0.027722,HOXC6_TARGET_GENES,0.719251779661017
GOMF_ALPHA_TUBULIN_BINDING,SET,35,0.26058,0.011361,0.13606,0.027745,GOMF_ALPHA_TUBULIN_BINDING,0.719251779661017
HP_LEG_DYSTONIA,SET,7,0.59949,0.011698,0.31312,0.027782,HP_LEG_DYSTONIA,0.719251779661017
GTF2E2_TARGET_GENES,SET,264,0.10201,0.012138,0.053286,0.027795,GTF2E2_TARGET_GENES,0.719251779661017
GOBP_NEUROBLAST_MIGRATION,SET,6,0.78026,0.014096,0.4076,0.0278,GOBP_NEUROBLAST_MIGRATION,0.719251779661017
GOMF_G_PROTEIN_ACTIVITY,SET,46,0.23143,0.011564,0.1209,0.027809,GOMF_G_PROTEIN_ACTIVITY,0.719251779661017
GOMF_LIPID_PHOSPHATASE_ACTIV...,SET,7,0.62307,0.012158,0.32556,0.027827,GOMF_LIPID_PHOSPHATASE_ACTIVITY,0.719251779661017
STONER_ESOPHAGEAL_CARCINOGEN...2,SET,31,0.28494,0.011693,0.14888,0.027831,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,0.719251779661017
GSE9006_HEALTHY_VS_TYPE_1_DI...2,SET,179,0.11656,0.011447,0.060907,0.027838,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP,0.719251779661017
GSE37605_C57BL6_VS_NOD_FOXP3...1,SET,169,0.12258,0.0117,0.064084,0.027899,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN,0.719251779661017
GOCC_EPSILON_DNA_POLYMERASE_...,SET,5,0.61206,0.010094,0.32001,0.027906,GOCC_EPSILON_DNA_POLYMERASE_COMPLEX,0.719251779661017
REACTOME_TRANSCRIPTIONAL_REG...7,SET,45,0.22691,0.011214,0.1187,0.027969,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,0.719251779661017
SOTIRIOU_BREAST_CANCER_GRADE...2,SET,137,0.13441,0.011562,0.070317,0.02798,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,0.719251779661017
GSE9960_GRAM_POS_VS_GRAM_NEG...2,SET,178,0.11912,0.011667,0.062326,0.027991,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.719251779661017
MIR6756_3P,SET,92,0.16239,0.011461,0.084981,0.02802,MIR6756_3P,0.719251779661017
GSE22886_NAIVE_CD8_TCELL_VS_...6,SET,172,0.1287,0.012392,0.067375,0.02806,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP,0.719251779661017
MORF_SP3,SET,75,0.17871,0.011393,0.09356,0.028066,MORF_SP3,0.719251779661017
BROWNE_HCMV_INFECTION_8HR_DN,SET,40,0.27305,0.012725,0.14295,0.028067,BROWNE_HCMV_INFECTION_8HR_DN,0.719251779661017
GOBP_TONGUE_MORPHOGENESIS,SET,9,0.6136,0.013575,0.32125,0.02807,GOBP_TONGUE_MORPHOGENESIS,0.719251779661017
GSE3982_EFF_MEMORY_CD4_TCELL...4,SET,173,0.12412,0.011985,0.065012,0.02813,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP,0.719251779661017
HP_EMG_IMPAIRED_NEUROMUSCULA...,SET,34,0.26838,0.011533,0.1406,0.028155,HP_EMG_IMPAIRED_NEUROMUSCULAR_TRANSMISSION,0.719251779661017
GOCC_GPI_ANCHOR_TRANSAMIDASE...,SET,5,0.61872,0.010204,0.3243,0.02821,GOCC_GPI_ANCHOR_TRANSAMIDASE_COMPLEX,0.719251779661017
GOBP_HORMONE_MEDIATED_SIGNAL...,SET,178,0.12267,0.012014,0.064313,0.028247,GOBP_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.719251779661017
REACTOME_PLASMA_LIPOPROTEIN_...3,SET,36,0.28389,0.012553,0.14885,0.02825,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,0.719251779661017
GSE30971_WBP7_HET_VS_KO_MACR...1,SET,184,0.12899,0.012842,0.067629,0.02825,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN,0.719251779661017
GOBP_AMYLOID_PRECURSOR_PROTE...2,SET,54,0.22287,0.012063,0.11687,0.028267,GOBP_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.719251779661017
GOBP_INNER_CELL_MASS_CELL_DI...,SET,8,0.6833,0.014253,0.35837,0.028286,GOBP_INNER_CELL_MASS_CELL_DIFFERENTIATION,0.719251779661017
chr1q41,SET,31,0.49853,0.020458,0.26146,0.028288,chr1q41,0.719251779661017
MORF_RAP1A,SET,133,0.13495,0.011439,0.070782,0.028294,MORF_RAP1A,0.719251779661017
REACTOME_REGULATION_OF_FOXO_...,SET,8,0.56999,0.01189,0.29902,0.02832,REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION,0.719251779661017
MODULE_109,SET,35,0.29556,0.012886,0.15506,0.02833,MODULE_109,0.719251779661017
GSE13485_CTRL_VS_DAY1_YF17D_...1,SET,132,0.14733,0.012441,0.077321,0.028369,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN,0.719251779661017
GOBP_L_METHIONINE_SALVAGE_FR...,SET,5,0.80403,0.01326,0.42199,0.028378,GOBP_L_METHIONINE_SALVAGE_FROM_METHYLTHIOADENOSINE,0.719251779661017
GOBP_EPITHELIUM_DEVELOPMENT,SET,1133,0.053212,0.012798,0.027953,0.028487,GOBP_EPITHELIUM_DEVELOPMENT,0.719251779661017
ZHAN_MULTIPLE_MYELOMA_SUBGRO...,SET,30,0.26533,0.010712,0.1394,0.0285,ZHAN_MULTIPLE_MYELOMA_SUBGROUPS,0.719251779661017
HP_RHOMBENCEPHALOSYNAPSIS,SET,15,0.42935,0.012261,0.2256,0.028518,HP_RHOMBENCEPHALOSYNAPSIS,0.719251779661017
GSE17301_IFNA2_VS_IFNA5_STIM...2,SET,176,0.12215,0.011897,0.064218,0.028581,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP,0.719251779661017
GOBP_CELL_DIFFERENTIATION_IN...5,SET,20,0.40574,0.013378,0.21331,0.028587,GOBP_CELL_DIFFERENTIATION_IN_HINDBRAIN,0.719251779661017
GOBP_AMELOGENESIS,SET,23,0.34731,0.012279,0.18265,0.028626,GOBP_AMELOGENESIS,0.719251779661017
GSE37301_COMMON_LYMPHOID_PRO...4,SET,178,0.12058,0.011809,0.06343,0.028656,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,0.719251779661017
GOBP_REGULATION_OF_HUMORAL_I...1,SET,40,0.28408,0.013239,0.14945,0.028668,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.719251779661017
PAL_PRMT5_TARGETS_UP,SET,186,0.11567,0.011577,0.060852,0.028673,PAL_PRMT5_TARGETS_UP,0.719251779661017
OSWALD_HEMATOPOIETIC_STEM_CE...2,SET,208,0.11765,0.012446,0.061908,0.028695,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,0.719251779661017
GOBP_REGULATION_OF_CELLULAR_...14,SET,6,0.75176,0.013581,0.39563,0.028713,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,0.719251779661017
GSE25123_CTRL_VS_IL4_AND_ROS...3,SET,185,0.12033,0.012012,0.063333,0.028729,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.719251779661017
GOBP_MEMBRANE_BIOGENESIS,SET,60,0.20234,0.011543,0.10651,0.028739,GOBP_MEMBRANE_BIOGENESIS,0.719251779661017
HP_ABNORMAL_GLOMERULAR_FILTR...,SET,26,0.30741,0.011554,0.16184,0.028758,HP_ABNORMAL_GLOMERULAR_FILTRATION_RATE,0.719251779661017
GSE2128_C57BL6_VS_NOD_CD4CD8...1,SET,187,0.11804,0.011846,0.062176,0.028823,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN,0.719251779661017
HP_SOLITARY_MEDIAN_MAXILLARY...,SET,22,0.3266,0.011293,0.17205,0.028839,HP_SOLITARY_MEDIAN_MAXILLARY_CENTRAL_INCISOR,0.719251779661017
WP_IL10_ANTIINFLAMMATORY_SIG...,SET,12,0.45181,0.011541,0.23801,0.02884,WP_IL10_ANTIINFLAMMATORY_SIGNALING,0.719251779661017
GOBP_CORNIFICATION,SET,9,0.65209,0.014427,0.34353,0.028844,GOBP_CORNIFICATION,0.719251779661017
MIR3059_5P,SET,275,0.098489,0.011957,0.051903,0.028886,MIR3059_5P,0.719251779661017
REACTOME_TRANSCRIPTION_OF_E2...2,SET,16,0.36958,0.0109,0.19478,0.028891,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1,0.719251779661017
GCM_NPM1,SET,104,0.15365,0.011526,0.08098,0.028894,GCM_NPM1,0.719251779661017
HP_INTESTINAL_LYMPHANGIECTAS...,SET,5,0.80954,0.013351,0.42668,0.028903,HP_INTESTINAL_LYMPHANGIECTASIA,0.719251779661017
GOMF_PHOSPHOLIPID_BINDING,SET,446,0.079256,0.012196,0.041786,0.028941,GOMF_PHOSPHOLIPID_BINDING,0.719251779661017
HP_ABNORMAL_HEART_RATE_VARIA...,SET,22,0.35423,0.012249,0.18678,0.028956,HP_ABNORMAL_HEART_RATE_VARIABILITY,0.719251779661017
MIR6765_3P,SET,88,0.16981,0.011723,0.089548,0.028965,MIR6765_3P,0.719251779661017
GAVISH_3CA_MALIGNANT_METAPRO...24,SET,44,0.24808,0.012124,0.13085,0.02899,GAVISH_3CA_MALIGNANT_METAPROGRAM_32_SKIN_PIGMENTATION,0.719251779661017
KRASNOSELSKAYA_ILF3_TARGETS_...2,SET,37,0.27427,0.012294,0.14467,0.029001,KRASNOSELSKAYA_ILF3_TARGETS_UP,0.719251779661017
YAO_TEMPORAL_RESPONSE_TO_PRO...8,SET,28,0.3044,0.011873,0.16059,0.029024,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,0.719251779661017
GSE17721_POLYIC_VS_CPG_1H_BM...2,SET,189,0.11508,0.011611,0.060726,0.029045,GSE17721_POLYIC_VS_CPG_1H_BMDC_UP,0.719251779661017
BUSSLINGER_GASTRIC_LYZ_POSIT...,SET,101,0.16688,0.012337,0.088071,0.029066,BUSSLINGER_GASTRIC_LYZ_POSITIVE_CELLS,0.719251779661017
LEE_LIVER_CANCER_DENA_DN,SET,71,0.20072,0.012452,0.10595,0.029087,LEE_LIVER_CANCER_DENA_DN,0.719251779661017
GOBP_NETRIN_ACTIVATED_SIGNAL...,SET,8,0.58155,0.012131,0.30699,0.029095,GOBP_NETRIN_ACTIVATED_SIGNALING_PATHWAY,0.719251779661017
HP_VISUAL_ACUITY_TEST_ABNORM...,SET,21,0.35491,0.01199,0.18741,0.029133,HP_VISUAL_ACUITY_TEST_ABNORMALITY,0.719251779661017
GOBP_BLEB_ASSEMBLY,SET,11,0.53682,0.013129,0.28347,0.02914,GOBP_BLEB_ASSEMBLY,0.719251779661017
MIR4271,SET,198,0.11306,0.011672,0.059712,0.029162,MIR4271,0.719251779661017
GOBP_PROTEIN_N_LINKED_GLYCOS...1,SET,69,0.19164,0.011721,0.10122,0.029167,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION,0.719251779661017
HP_LOW_GRADE_FEVER,SET,11,0.54337,0.01329,0.28701,0.029175,HP_LOW_GRADE_FEVER,0.719251779661017
MIR3619_5P,SET,255,0.098494,0.011521,0.052028,0.029181,MIR3619_5P,0.719251779661017
WP_SECRETION_OF_HYDROCHLORIC...,SET,5,0.80178,0.013223,0.42359,0.029198,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,0.719251779661017
HP_NEOPLASM_OF_THE_STOMACH,SET,85,0.1744,0.011833,0.092147,0.029212,HP_NEOPLASM_OF_THE_STOMACH,0.719251779661017
MIR1184,SET,151,0.126,0.011374,0.066579,0.029223,MIR1184,0.719251779661017
GOMF_COBALAMIN_BINDING,SET,8,0.57341,0.011961,0.30307,0.029252,GOMF_COBALAMIN_BINDING,0.719251779661017
GSE37416_CTRL_VS_48H_F_TULAR...1,SET,168,0.11734,0.011168,0.062029,0.029271,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.719251779661017
GSE16385_UNTREATED_VS_12H_RO...4,SET,186,0.1134,0.01135,0.059948,0.029283,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,0.719251779661017
HP_NON_MEDULLARY_THYROID_CAR...,SET,6,0.73587,0.013294,0.38904,0.029287,HP_NON_MEDULLARY_THYROID_CARCINOMA,0.719251779661017
GSE5589_UNSTIM_VS_45MIN_LPS_...2,SET,182,0.11778,0.011663,0.062269,0.029291,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.719251779661017
MIR6883_3P,SET,50,0.24014,0.012509,0.12697,0.029304,MIR6883_3P,0.719251779661017
GOBP_REGULATION_OF_GLOMERULA...,SET,9,0.63171,0.013976,0.33411,0.029338,GOBP_REGULATION_OF_GLOMERULAR_FILTRATION,0.719578115737474
GOMF_NUCLEOSOME_BINDING,SET,52,0.21497,0.011419,0.11373,0.029375,GOMF_NUCLEOSOME_BINDING,0.719977521156558
HP_ABNORMAL_METACARPAL_EPIPH...,SET,16,0.38923,0.01148,0.20623,0.029566,HP_ABNORMAL_METACARPAL_EPIPHYSIS_MORPHOLOGY,0.722787012622721
HP_IRREGULAR_ILIAC_CREST,SET,6,0.70475,0.012732,0.37346,0.029581,HP_IRREGULAR_ILIAC_CREST,0.722787012622721
WP_PGK1_PKM2_KHKCKHKA_ACTING...,SET,10,0.42405,0.009889,0.22474,0.029599,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,0.722787012622721
GOBP_ERYTHROCYTE_DEVELOPMENT,SET,38,0.25906,0.011768,0.1373,0.029604,GOBP_ERYTHROCYTE_DEVELOPMENT,0.722787012622721
REACTOME_STING_MEDIATED_INDU...,SET,13,0.38065,0.01012,0.2018,0.029636,REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES,0.722787012622721
PID_RANBP2_PATHWAY,SET,11,0.4857,0.011879,0.25751,0.029647,PID_RANBP2_PATHWAY,0.722787012622721
HP_EEG_WITH_SERIES_OF_FOCAL_...,SET,10,0.51572,0.012027,0.27344,0.029651,HP_EEG_WITH_SERIES_OF_FOCAL_SPIKES,0.722787012622721
GSE18893_CTRL_VS_TNF_TREATED...5,SET,171,0.12086,0.011604,0.064082,0.029656,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN,0.722787012622721
KOHOUTEK_CCNT2_TARGETS,SET,54,0.22279,0.012059,0.11817,0.029699,KOHOUTEK_CCNT2_TARGETS,0.723186323529412
GSE26488_WT_VS_VP16_TRANSGEN...1,SET,150,0.13739,0.012361,0.07288,0.029714,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.723186323529412
GOBP_REGULATION_OF_TRANSCRIP...3,SET,27,0.29915,0.011458,0.15872,0.029741,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.723268562937063
MIR580_5P,SET,210,0.11233,0.011938,0.059607,0.029759,MIR580_5P,0.723268562937063
HP_ABNORMAL_NASAL_BONE_MORPH...,SET,9,0.63831,0.014122,0.33882,0.029797,HP_ABNORMAL_NASAL_BONE_MORPHOLOGY,0.723686048218029
GOBP_POSITIVE_REGULATION_OF_...485,SET,19,0.37293,0.011985,0.19803,0.029843,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.724297112430168
GOBP_POSITIVE_REGULATION_OF_...406,SET,150,0.13949,0.01255,0.074114,0.029924,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.725353307799443
GOBP_REGULATION_OF_PERK_MEDI...,SET,12,0.49085,0.012539,0.26086,0.02995,GOBP_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.725353307799443
GOBP_POSITIVE_REGULATION_OF_...429,SET,79,0.17946,0.011741,0.09538,0.02996,GOBP_POSITIVE_REGULATION_OF_MACROAUTOPHAGY,0.725353307799443
GOBP_REGULATION_OF_HEART_MOR...,SET,8,0.72751,0.015175,0.3867,0.02997,GOBP_REGULATION_OF_HEART_MORPHOGENESIS,0.725353307799443
COULOUARN_TEMPORAL_TGFB1_SIG...2,SET,102,0.16418,0.012197,0.087362,0.030113,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,0.727634541666667
CHEOK_RESPONSE_TO_MERCAPTOPU...3,SET,17,0.42121,0.012805,0.22414,0.030117,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,0.727634541666667
GSE30083_SP2_VS_SP4_THYMOCYT...1,SET,186,0.12131,0.012142,0.064564,0.030141,GSE30083_SP2_VS_SP4_THYMOCYTE_DN,0.727634541666667
NFKAPPAB_01,SET,234,0.10882,0.012201,0.057923,0.030148,NFKAPPAB_01,0.727634541666667
GOBP_POSITIVE_REGULATION_OF_...245,SET,32,0.29616,0.012348,0.15776,0.030249,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.729422365145228
GOBP_POSITIVE_REGULATION_OF_...241,SET,4,0.92556,0.013653,0.49318,0.030288,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MATRIX_ADHESION_VIA_FIBRONECTIN,0.729422365145228
REACTOME_SULFUR_AMINO_ACID_M...,SET,26,0.33928,0.012752,0.18079,0.03029,REACTOME_SULFUR_AMINO_ACID_METABOLISM,0.729422365145228
HP_UTERINE_LEIOMYOMA,SET,8,0.61832,0.012898,0.32957,0.030327,HP_UTERINE_LEIOMYOMA,0.729422365145228
CCTGTGA_MIR513,SET,116,0.15023,0.011898,0.080078,0.030333,CCTGTGA_MIR513,0.729422365145228
HP_MADELUNG_DEFORMITY,SET,4,0.76971,0.011354,0.41033,0.030348,HP_MADELUNG_DEFORMITY,0.729422365145228
GOBP_SYNAPSE_PRUNING,SET,14,0.50966,0.014062,0.27183,0.030407,GOBP_SYNAPSE_PRUNING,0.730335373185902
GOCC_CELL_SURFACE,SET,818,0.063371,0.013069,0.03382,0.030491,GOCC_CELL_SURFACE,0.731315092975207
MIR324_3P,SET,71,0.18638,0.011562,0.099475,0.030501,MIR324_3P,0.731315092975207
REN_MIF_TARGETS_DN,SET,5,0.70558,0.011636,0.37663,0.030513,REN_MIF_TARGETS_DN,0.731315092975207
LIU_LIVER_CANCER,SET,29,0.28419,0.01128,0.15173,0.030541,LIU_LIVER_CANCER,0.731315092975207
MIR500A_3P,SET,71,0.20225,0.012547,0.10799,0.030553,MIR500A_3P,0.731315092975207
GOBP_PARAXIAL_MESODERM_DEVEL...,SET,17,0.39856,0.012116,0.2129,0.030608,GOBP_PARAXIAL_MESODERM_DEVELOPMENT,0.731483034623218
TSUTSUMI_FBXW8_TARGETS,SET,9,0.51958,0.011495,0.2776,0.030634,TSUTSUMI_FBXW8_TARGETS,0.731483034623218
HP_DECREASED_PROPORTION_OF_C...1,SET,9,0.5475,0.012113,0.29256,0.03065,HP_DECREASED_PROPORTION_OF_CD3_POSITIVE_T_CELLS,0.731483034623218
GOBP_PYRIMIDINE_RIBONUCLEOSI...3,SET,15,0.41821,0.011943,0.2235,0.030668,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.731483034623218
REACTOME_NR1H3_NR1H2_REGULAT...,SET,36,0.25997,0.011495,0.13895,0.030686,REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX,0.731483034623218
GOBP_NEGATIVE_REGULATION_OF_...239,SET,13,0.42298,0.011246,0.22627,0.030793,GOBP_NEGATIVE_REGULATION_OF_FIBRINOLYSIS,0.731483034623218
BOQUEST_STEM_CELL_CULTURED_V...1,SET,30,0.32383,0.013073,0.17323,0.030798,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,0.731483034623218
GOBP_POSITIVE_REGULATION_OF_...414,SET,82,0.1832,0.01221,0.098015,0.030811,GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT,0.731483034623218
HP_ABNORMAL_VISUAL_FIELD_TEST,SET,20,0.35138,0.011585,0.18802,0.030832,HP_ABNORMAL_VISUAL_FIELD_TEST,0.731483034623218
GOBP_MITOTIC_CYTOKINESIS,SET,88,0.15787,0.010898,0.084475,0.030834,GOBP_MITOTIC_CYTOKINESIS,0.731483034623218
ESC_V6.5_UP_LATE.V1_UP,SET,162,0.13388,0.012514,0.071639,0.030835,ESC_V6.5_UP_LATE.V1_UP,0.731483034623218
GOBP_NUCLEOTIDE_BINDING_OLIG...1,SET,7,0.61077,0.011918,0.32693,0.030875,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_1_SIGNALING_PATHWAY,0.731483034623218
IK2_01,SET,238,0.10646,0.012036,0.056985,0.030878,IK2_01,0.731483034623218
GOMF_CARBOXY_LYASE_ACTIVITY,SET,32,0.27421,0.011432,0.14679,0.030885,GOMF_CARBOXY_LYASE_ACTIVITY,0.731483034623218
TTCCGTT_MIR191,SET,28,0.28356,0.01106,0.15181,0.030901,TTCCGTT_MIR191,0.731483034623218
MEISSNER_NPC_HCP_WITH_H3K4ME2,SET,447,0.080553,0.012409,0.043137,0.030931,MEISSNER_NPC_HCP_WITH_H3K4ME2,0.731483034623218
GOBP_ENGULFMENT_OF_APOPTOTIC...,SET,15,0.3956,0.011297,0.21186,0.030941,GOBP_ENGULFMENT_OF_APOPTOTIC_CELL,0.731483034623218
GOBP_RESPONSE_TO_HYPEROXIA,SET,17,0.39205,0.011918,0.20997,0.030948,GOBP_RESPONSE_TO_HYPEROXIA,0.731483034623218
MODULE_2,SET,348,0.093897,0.012798,0.050293,0.03096,MODULE_2,0.731483034623218
GSE26928_EFF_MEM_VS_CENTR_ME...2,SET,165,0.12829,0.012101,0.068733,0.030997,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP,0.731483034623218
DESCARTES_FETAL_EYE_PDE11A_F...,SET,16,0.45745,0.013492,0.2451,0.031002,DESCARTES_FETAL_EYE_PDE11A_FAM19A2_POSITIVE_CELLS,0.731483034623218
KEGG_MEDICUS_PATHOGEN_HCV_CO...3,SET,5,0.73046,0.012047,0.39155,0.03106,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_PPARA_MEDIATED_TRANSCRIPTION,0.731927113821138
GOBP_MONONUCLEAR_CELL_DIFFER...,SET,489,0.077078,0.012404,0.041319,0.031069,GOBP_MONONUCLEAR_CELL_DIFFERENTIATION,0.731927113821138
MIR512_3P,SET,94,0.16698,0.011911,0.089522,0.031084,MIR512_3P,0.731927113821138
GSE360_L_DONOVANI_VS_L_MAJOR...4,SET,180,0.1193,0.011749,0.063993,0.031146,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP,0.732890473933649
REACTOME_REGULATION_OF_SIGNA...2,SET,9,0.53651,0.01187,0.28784,0.031173,REACTOME_REGULATION_OF_SIGNALING_BY_NODAL,0.732956866125761
GOBP_POSITIVE_REGULATION_OF_...212,SET,5,0.72224,0.011911,0.38753,0.031191,GOBP_POSITIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.732956866125761
MORF_RBBP8,SET,200,0.11378,0.011805,0.061097,0.031284,MORF_RBBP8,0.734357672064777
HP_COLORECTAL_POLYPOSIS,SET,23,0.31086,0.01099,0.16694,0.031306,HP_COLORECTAL_POLYPOSIS,0.734357672064777
HP_PAINLESS_FRACTURES_DUE_TO...,SET,7,0.55679,0.010865,0.29904,0.031314,HP_PAINLESS_FRACTURES_DUE_TO_INJURY,0.734357672064777
KEGG_MEDICUS_REFERENCE_REGUL...5,SET,6,0.72487,0.013095,0.3894,0.031344,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI,0.734565556304787
GOBP_REGULATION_OF_HEXOKINAS...,SET,5,0.77714,0.012817,0.41778,0.031438,GOBP_REGULATION_OF_HEXOKINASE_ACTIVITY,0.735869838383838
HP_CYCLOPIA,SET,19,0.36901,0.011859,0.19838,0.031442,HP_CYCLOPIA,0.735869838383838
MIR7850_5P,SET,110,0.15261,0.011771,0.082066,0.03148,MIR7850_5P,0.736263391655451
GNF2_PTPRC,SET,59,0.20877,0.01181,0.11232,0.031547,GNF2_PTPRC,0.737039255033557
GOBP_REGULATION_OF_TRANSMEMB...1,SET,247,0.10713,0.012336,0.057649,0.031575,GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.737039255033557
GSE4984_UNTREATED_VS_VEHICLE...2,SET,136,0.1346,0.011536,0.072439,0.03158,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP,0.737039255033557
WP_DISORDERS_OF_GALACTOSE_ME...,SET,12,0.45066,0.011512,0.24256,0.031598,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.737039255033557
KEGG_PYRIMIDINE_METABOLISM,SET,90,0.15929,0.01112,0.085752,0.031622,KEGG_PYRIMIDINE_METABOLISM,0.737104366197183
GOBP_PROTEIN_LOCALIZATION_TO...40,SET,868,0.053219,0.01129,0.028659,0.031665,GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE,0.737611980563003
NADLER_HYPERGLYCEMIA_AT_OBES...,SET,53,0.22851,0.012253,0.12313,0.031749,NADLER_HYPERGLYCEMIA_AT_OBESITY,0.739073338914936
NAKAYA_MONOCYTE_FLUMIST_AGE_...2,SET,436,0.075125,0.011433,0.040494,0.031793,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP,0.739129182788526
LE_SKI_TARGETS_DN,SET,6,0.80869,0.01461,0.43592,0.031798,LE_SKI_TARGETS_DN,0.739129182788526
AZARE_NEOPLASTIC_TRANSFORMAT...1,SET,17,0.42693,0.012979,0.23026,0.031869,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,0.739129182788526
AP4_Q5,SET,235,0.10427,0.011715,0.056237,0.03187,AP4_Q5,0.739129182788526
HP_BRAIN_STEM_COMPRESSION,SET,14,0.42639,0.011764,0.22997,0.031872,HP_BRAIN_STEM_COMPRESSION,0.739129182788526
SHEPARD_BMYB_TARGETS,SET,71,0.18667,0.01158,0.10069,0.031879,SHEPARD_BMYB_TARGETS,0.739129182788526
PPAR_DR1_Q2,SET,235,0.10313,0.011587,0.055644,0.031923,PPAR_DR1_Q2,0.739518135368281
GOMF_INORGANIC_ANION_TRANSME...,SET,146,0.14016,0.012443,0.075644,0.031952,GOMF_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.739518135368281
GOBP_NEURAL_PLATE_MORPHOGENE...,SET,4,0.74299,0.01096,0.40101,0.031963,GOBP_NEURAL_PLATE_MORPHOGENESIS,0.739518135368281
HP_AMAUROSIS_FUGAX,SET,40,0.24117,0.011239,0.13021,0.032006,HP_AMAUROSIS_FUGAX,0.739518135368281
chr4p16,SET,93,0.31339,0.022237,0.16921,0.032015,chr4p16,0.739518135368281
GOBP_PYRIMIDINE_RIBONUCLEOSI...2,SET,11,0.48163,0.01178,0.26008,0.032035,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.739518135368281
GOCC_CYTOPLASMIC_MICROTUBULE,SET,81,0.17591,0.011653,0.095006,0.032049,GOCC_CYTOPLASMIC_MICROTUBULE,0.739518135368281
GOBP_MESENCHYMAL_CELL_PROLIF...1,SET,42,0.28494,0.013606,0.15391,0.032066,GOBP_MESENCHYMAL_CELL_PROLIFERATION,0.739518135368281
HP_CONICAL_TOOTH,SET,49,0.24392,0.012578,0.1318,0.032115,HP_CONICAL_TOOTH,0.740157045755968
GSE2706_R848_VS_R848_AND_LPS...2,SET,148,0.12302,0.010995,0.066528,0.032227,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP,0.741943695652174
HP_SKIN_VESICLE,SET,24,0.28993,0.01047,0.15682,0.032251,HP_SKIN_VESICLE,0.741943695652174
GOBP_PYRIMIDINE_RIBONUCLEOTI...3,SET,29,0.2985,0.011848,0.1615,0.032288,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS,0.741943695652174
GOMF_LIGAND_GATED_MONOATOMIC...1,SET,42,0.27506,0.013134,0.14882,0.032288,GOMF_LIGAND_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.741943695652174
GOMF_GTPASE_INHIBITOR_ACTIVI...,SET,12,0.4604,0.011761,0.24922,0.032356,GOMF_GTPASE_INHIBITOR_ACTIVITY,0.741943695652174
GOBP_HEART_FORMATION,SET,31,0.32364,0.013281,0.17521,0.032371,GOBP_HEART_FORMATION,0.741943695652174
HP_PITUITARY_ADENOMA,SET,51,0.21264,0.011186,0.11513,0.032379,HP_PITUITARY_ADENOMA,0.741943695652174
MORF_PPP5C,SET,87,0.15647,0.01074,0.084723,0.032396,MORF_PPP5C,0.741943695652174
GOBP_NEGATIVE_REGULATION_OF_...49,SET,32,0.28705,0.011967,0.15544,0.032404,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.741943695652174
GOBP_RECEPTOR_GUANYLYL_CYCLA...,SET,8,0.51998,0.010847,0.28158,0.032406,GOBP_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY,0.741943695652174
GSE25088_ROSIGLITAZONE_VS_IL...3,SET,178,0.11992,0.011745,0.064956,0.032442,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.742278940092166
HOWARD_PBMC_INACT_MONOV_INFL...1,SET,27,0.33699,0.012907,0.18269,0.032557,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN,0.744044911242604
GOBP_CDC42_PROTEIN_SIGNAL_TR...,SET,15,0.47152,0.013465,0.25563,0.032562,GOBP_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.744044911242604
GOBP_REGULATION_OF_RESTING_M...,SET,10,0.4928,0.011492,0.26727,0.032615,GOBP_REGULATION_OF_RESTING_MEMBRANE_POTENTIAL,0.744766310775296
QI_PBMC_ZOSTAVAX_AGE_50_75YO...8,SET,13,0.43295,0.011511,0.23487,0.032646,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_EXPANSION_AND_CONTRACTION_1D_NOT_INFORMATIVE_OF_LONG_TERM_RESPONSES_POSITIVE,0.744801921568627
GSE35685_CD34POS_CD38NEG_VS_...4,SET,182,0.11821,0.011706,0.06416,0.032711,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP,0.744801921568627
MORF_RAGE,SET,136,0.1374,0.011776,0.074583,0.03273,MORF_RAGE,0.744801921568627
HP_APLASIA_HYPOPLASIA_OF_THE...4,SET,6,0.74186,0.013402,0.40272,0.032739,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_FINGER,0.744801921568627
MIR450A_2_3P,SET,115,0.14793,0.011666,0.080325,0.032769,MIR450A_2_3P,0.744801921568627
NFE2L3_TARGET_GENES,SET,10,0.47308,0.011032,0.25689,0.032781,NFE2L3_TARGET_GENES,0.744801921568627
LIM_MAMMARY_LUMINAL_PROGENIT...1,SET,14,0.46464,0.012819,0.25232,0.032785,LIM_MAMMARY_LUMINAL_PROGENITOR_DN,0.744801921568627
GOBP_AMINO_ACID_SALVAGE,SET,7,0.67455,0.013162,0.36632,0.032788,GOBP_AMINO_ACID_SALVAGE,0.744801921568627
XU_AKT1_TARGETS_6HR,SET,25,0.28624,0.01055,0.15563,0.03295,XU_AKT1_TARGETS_6HR,0.74648775
GSE19941_IL10_KO_VS_IL10_KO_...2,SET,177,0.1197,0.011691,0.065092,0.032966,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.74648775
GOMF_OXIDOREDUCTASE_ACTIVITY...33,SET,10,0.46291,0.010795,0.25175,0.032984,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.74648775
BUSSLINGER_ESOPHAGEAL_QUIESC...,SET,70,0.1989,0.012252,0.10818,0.032997,BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS,0.74648775
LI_WILMS_TUMOR_VS_FETAL_KIDN...1,SET,153,0.12543,0.011397,0.06823,0.033012,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,0.74648775
GOCC_MYOSIN_II_COMPLEX,SET,25,0.33657,0.012405,0.18308,0.033015,GOCC_MYOSIN_II_COMPLEX,0.74648775
BLALOCK_ALZHEIMERS_DISEASE_UP,SET,1512,0.041552,0.011418,0.022607,0.033037,BLALOCK_ALZHEIMERS_DISEASE_UP,0.74648775
KEGG_MEDICUS_REFERENCE_ANTIG...2,SET,12,0.46904,0.011981,0.25521,0.033052,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.74648775
GSE26343_UNSTIM_VS_LPS_STIM_...3,SET,188,0.11893,0.011967,0.064718,0.033067,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN,0.74648775
WP_WNT_SIGNALING_IN_KIDNEY_D...,SET,34,0.29806,0.012808,0.16221,0.033077,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,0.74648775
MIR6819_3P,SET,32,0.27639,0.011523,0.15049,0.033138,MIR6819_3P,0.7472325
DI_MARTINO_MATRISOME_HIGHLY_...2,SET,17,0.40007,0.012162,0.21785,0.033153,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED,0.7472325
GOCC_FILOPODIUM,SET,92,0.16998,0.011996,0.092572,0.033176,GOCC_FILOPODIUM,0.747266242718447
GOBP_POSITIVE_REGULATION_OF_...707,SET,38,0.28576,0.012981,0.15567,0.033213,GOBP_POSITIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.747266242718447
GOBP_CELLULAR_METABOLIC_COMP...,SET,30,0.31382,0.012669,0.17097,0.033219,GOBP_CELLULAR_METABOLIC_COMPOUND_SALVAGE,0.747266242718447
GOBP_WOUND_HEALING,SET,399,0.082171,0.011975,0.044774,0.033243,GOBP_WOUND_HEALING,0.747322422380336
MIR4501,SET,73,0.18139,0.011409,0.098863,0.03328,MIR4501,0.747670588235294
KEGG_MEDICUS_REFERENCE_CYTOK...,SET,42,0.26822,0.012807,0.14621,0.033304,KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY,0.747710979349187
HOEGERKORP_CD44_TARGETS_DIRE...1,SET,11,0.4753,0.011625,0.25926,0.033387,HOEGERKORP_CD44_TARGETS_DIRECT_DN,0.747710979349187
MIR330_5P,SET,169,0.12308,0.011749,0.067147,0.033406,MIR330_5P,0.747710979349187
HAY_BONE_MARROW_IMMATURE_NEU...,SET,174,0.12394,0.012002,0.067619,0.033415,HAY_BONE_MARROW_IMMATURE_NEUTROPHIL,0.747710979349187
MIR5581_3P,SET,117,0.14565,0.011585,0.079475,0.033432,MIR5581_3P,0.747710979349187
GOMF_G_PROTEIN_COUPLED_CHEMO...,SET,24,0.36874,0.013317,0.20122,0.033444,GOMF_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY,0.747710979349187
KEGG_MEDICUS_REFERENCE_N_GLY...1,SET,16,0.40755,0.01202,0.22243,0.033465,KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS,0.747710979349187
GSE19941_LPS_VS_LPS_AND_IL10...2,SET,161,0.11977,0.01116,0.065371,0.033477,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.747710979349187
MULLIGAN_NTF3_SIGNALING_VIA_...2,SET,20,0.32704,0.010783,0.17854,0.033504,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,0.747710979349187
ACGCACA_MIR210,SET,8,0.53358,0.01113,0.29135,0.033525,ACGCACA_MIR210,0.747710979349187
GOMF_FRIZZLED_BINDING,SET,35,0.27776,0.01211,0.15168,0.033545,GOMF_FRIZZLED_BINDING,0.747710979349187
ZERBINI_RESPONSE_TO_SULINDAC...1,SET,6,0.53694,0.0097001,0.29332,0.033593,ZERBINI_RESPONSE_TO_SULINDAC_DN,0.747710979349187
GOBP_SCARNA_LOCALIZATION_TO_...,SET,4,0.6087,0.0089791,0.33256,0.033607,GOBP_SCARNA_LOCALIZATION_TO_CAJAL_BODY,0.747710979349187
GOBP_REPRODUCTIVE_SYSTEM_DEV...,SET,284,0.098797,0.012186,0.053998,0.03366,GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT,0.747710979349187
GSE22935_UNSTIM_VS_24H_MBOVI...4,SET,192,0.11102,0.011288,0.060689,0.033684,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.747710979349187
GOBP_GENITALIA_MORPHOGENESIS,SET,11,0.52343,0.012802,0.28616,0.033698,GOBP_GENITALIA_MORPHOGENESIS,0.747710979349187
GSE18203_CTRL_VS_INTRATUMORA...1,SET,176,0.11925,0.011614,0.065202,0.033712,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN,0.747710979349187
EVI1_05,SET,161,0.12877,0.012,0.07041,0.033716,EVI1_05,0.747710979349187
REACTOME_CLASS_B_2_SECRETIN_...,SET,90,0.18205,0.012708,0.099556,0.033739,REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,0.747710979349187
GSE15330_HSC_VS_PRO_BCELL_UP,SET,176,0.11265,0.010971,0.061631,0.033797,GSE15330_HSC_VS_PRO_BCELL_UP,0.747710979349187
REACTOME_WNT_MEDIATED_ACTIVA...,SET,8,0.54574,0.011384,0.29872,0.033864,REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL,0.747710979349187
GOBP_POSITIVE_REGULATION_OF_...458,SET,14,0.42116,0.01162,0.23056,0.033884,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.747710979349187
MATZUK_OVULATION,SET,15,0.43224,0.012344,0.23665,0.033897,MATZUK_OVULATION,0.747710979349187
GOBP_RESPONSE_TO_HYDROSTATIC...,SET,7,0.62762,0.012247,0.34364,0.033905,GOBP_RESPONSE_TO_HYDROSTATIC_PRESSURE,0.747710979349187
GOBP_NEGATIVE_REGULATION_OF_...537,SET,82,0.17334,0.011553,0.094917,0.033913,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.747710979349187
GOBP_INTERLEUKIN_21_PRODUCTI...,SET,2,1.2737,0.013286,0.69746,0.033923,GOBP_INTERLEUKIN_21_PRODUCTION,0.747710979349187
HP_INEFFECTIVE_ESOPHAGEAL_PE...,SET,14,0.41247,0.01138,0.22593,0.03396,HP_INEFFECTIVE_ESOPHAGEAL_PERISTALSIS,0.747710979349187
KEGG_MEDICUS_REFERENCE_TRAPP...,SET,8,0.51617,0.010767,0.28279,0.033987,KEGG_MEDICUS_REFERENCE_TRAPPI_RAB1_SIGNALING_PATHWAY,0.747710979349187
REACTOME_RAC2_GTPASE_CYCLE,SET,78,0.18746,0.012186,0.1027,0.033992,REACTOME_RAC2_GTPASE_CYCLE,0.747710979349187
KEGG_MEDICUS_PATHOGEN_SHIGEL...6,SET,5,0.58201,0.0095985,0.31889,0.034001,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGB1_TO_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.747710979349187
GOBP_ACTIN_FILAMENT_BASED_TR...,SET,10,0.49722,0.011595,0.27246,0.034017,GOBP_ACTIN_FILAMENT_BASED_TRANSPORT,0.747710979349187
KEGG_PORPHYRIN_AND_CHLOROPHY...,SET,35,0.31274,0.013635,0.1714,0.034037,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,0.747710979349187
GOBP_SEGMENTATION,SET,92,0.1726,0.012181,0.094603,0.03405,GOBP_SEGMENTATION,0.747710979349187
GOMF_CYTOSKELETON_NUCLEAR_ME...,SET,5,0.68957,0.011372,0.37802,0.034073,GOMF_CYTOSKELETON_NUCLEAR_MEMBRANE_ANCHOR_ACTIVITY,0.747710979349187
REACTOME_BETA_OXIDATION_OF_P...,SET,9,0.45665,0.010103,0.25044,0.03413,REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA,0.747710979349187
GSE360_HIGH_VS_LOW_DOSE_B_MA...2,SET,179,0.1159,0.011383,0.063564,0.034131,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP,0.747710979349187
MODULE_205,SET,276,0.096241,0.011705,0.0528,0.034179,MODULE_205,0.747710979349187
KANG_DOXORUBICIN_RESISTANCE_...1,SET,16,0.40653,0.01199,0.22303,0.034181,KANG_DOXORUBICIN_RESISTANCE_DN,0.747710979349187
HP_ANOMIC_APHASIA,SET,6,0.60555,0.01094,0.33226,0.034196,HP_ANOMIC_APHASIA,0.747710979349187
GSE20727_CTRL_VS_H2O2_TREATE...1,SET,174,0.11405,0.011045,0.062579,0.034197,GSE20727_CTRL_VS_H2O2_TREATED_DC_DN,0.747710979349187
QIU_PBMC_HEPTATITIS_B_SURFAC...6,SET,13,0.49308,0.01311,0.27056,0.034201,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_3DY_UP,0.747710979349187
HP_DIABETIC_KETOACIDOSIS,SET,19,0.38512,0.012377,0.21136,0.034223,HP_DIABETIC_KETOACIDOSIS,0.747710979349187
GOBP_INTESTINAL_HEXOSE_ABSOR...,SET,5,0.66736,0.011006,0.3663,0.034243,GOBP_INTESTINAL_HEXOSE_ABSORPTION,0.747710979349187
GOBP_MESODERM_DEVELOPMENT,SET,117,0.15271,0.012146,0.083844,0.034287,GOBP_MESODERM_DEVELOPMENT,0.747710979349187
GSE9316_CD4_TCELL_BALBC_VS_T...2,SET,178,0.1171,0.011469,0.064304,0.034307,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP,0.747710979349187
ZHONG_PFC_C2_UNKNOWN_NPC,SET,72,0.16966,0.010599,0.093178,0.034325,ZHONG_PFC_C2_UNKNOWN_NPC,0.747710979349187
KRAS.KIDNEY_UP.V1_DN,SET,121,0.154,0.012454,0.084578,0.03433,KRAS.KIDNEY_UP.V1_DN,0.747710979349187
HP_ABNORMAL_IMMUNE_SYSTEM_MO...,SET,589,0.065237,0.01149,0.035833,0.034345,HP_ABNORMAL_IMMUNE_SYSTEM_MORPHOLOGY,0.747710979349187
HP_HYPOPLASTIC_LABIA_MAJORA,SET,34,0.26978,0.011593,0.14819,0.03435,HP_HYPOPLASTIC_LABIA_MAJORA,0.747710979349187
HP_ABNORMAL_SOCIAL_BEHAVIOR,SET,153,0.12701,0.011541,0.069774,0.034363,HP_ABNORMAL_SOCIAL_BEHAVIOR,0.747710979349187
GOCC_M_BAND,SET,27,0.27458,0.010517,0.15086,0.034379,GOCC_M_BAND,0.747710979349187
WP_CANONICAL_AND_NONCANONICA...1,SET,27,0.30314,0.01161,0.16658,0.034405,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,0.747771504342432
GOMF_RNA_POLYMERASE_II_CORE_...,SET,15,0.40654,0.01161,0.22346,0.03444,GOMF_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.747771504342432
MODULE_7,SET,214,0.10609,0.011382,0.058345,0.034511,MODULE_7,0.747771504342432
GOBP_POSITIVE_REGULATION_OF_...611,SET,47,0.23081,0.011657,0.12693,0.034513,GOBP_POSITIVE_REGULATION_OF_PROTEIN_BINDING,0.747771504342432
GOBP_DENTINOGENESIS,SET,6,0.71098,0.012844,0.39106,0.034535,GOBP_DENTINOGENESIS,0.747771504342432
HP_TYPE_E_BRACHYDACTYLY,SET,5,0.76991,0.012697,0.42358,0.03457,HP_TYPE_E_BRACHYDACTYLY,0.747771504342432
GSE22886_IGA_VS_IGM_MEMORY_B...1,SET,186,0.1139,0.011401,0.062674,0.034584,GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN,0.747771504342432
BIOCARTA_CARM_ER_PATHWAY,SET,22,0.31336,0.010835,0.17245,0.034612,BIOCARTA_CARM_ER_PATHWAY,0.747771504342432
RIGGI_EWING_SARCOMA_PROGENIT...2,SET,389,0.089283,0.012851,0.049145,0.034638,RIGGI_EWING_SARCOMA_PROGENITOR_UP,0.747771504342432
GOBP_NEUROTRANSMITTER_RECEPT...5,SET,7,0.66669,0.013009,0.36697,0.034638,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_POSTSYNAPTIC_ENDOSOME_TO_LYSOSOME,0.747771504342432
MORF_AP3D1,SET,119,0.12941,0.010379,0.071236,0.034648,MORF_AP3D1,0.747771504342432
GOBP_SPLICEOSOMAL_TRI_SNRNP_...,SET,15,0.33639,0.0096065,0.18519,0.034658,GOBP_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY,0.747771504342432
GOBP_NEGATIVE_REGULATION_OF_...216,SET,29,0.29361,0.011654,0.16165,0.034664,GOBP_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.747771504342432
THILLAINADESAN_ZNF217_TARGET...2,SET,38,0.23995,0.0109,0.13212,0.034683,THILLAINADESAN_ZNF217_TARGETS_UP,0.747771504342432
GSE27786_LIN_NEG_VS_MONO_MAC...1,SET,182,0.11189,0.011079,0.061691,0.034869,GSE27786_LIN_NEG_VS_MONO_MAC_DN,0.749773195558297
NKX3A_01,SET,205,0.11742,0.012332,0.06474,0.03487,NKX3A_01,0.749773195558297
HP_PALMOPLANTAR_CUTIS_LAXA,SET,8,0.54646,0.011399,0.30134,0.034893,HP_PALMOPLANTAR_CUTIS_LAXA,0.749773195558297
GOBP_POST_TRANSLATIONAL_PROT...3,SET,8,0.59394,0.012389,0.32754,0.034898,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,0.749773195558297
OISHI_CHOLANGIOMA_STEM_CELL_...1,SET,253,0.10353,0.012064,0.057097,0.034903,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,0.749773195558297
MIR939_5P,SET,114,0.14507,0.01139,0.080018,0.034922,MIR939_5P,0.749773195558297
GOBP_REGULATION_OF_FIBRINOLY...,SET,18,0.36293,0.011353,0.20022,0.034953,GOBP_REGULATION_OF_FIBRINOLYSIS,0.749773195558297
GOBP_PEXOPHAGY,SET,5,0.69092,0.011395,0.38119,0.034961,GOBP_PEXOPHAGY,0.749773195558297
HP_LUPUS_ANTICOAGULANT,SET,4,0.88992,0.013128,0.49102,0.03497,HP_LUPUS_ANTICOAGULANT,0.749773195558297
GOBP_HEART_FIELD_SPECIFICATI...,SET,17,0.46089,0.014011,0.25439,0.035024,GOBP_HEART_FIELD_SPECIFICATION,0.749890484460695
REACTOME_RNA_POLYMERASE_I_TR...3,SET,26,0.25859,0.0097196,0.14277,0.035063,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION,0.749890484460695
GSE17721_0.5H_VS_8H_POLYIC_B...1,SET,184,0.11621,0.01157,0.064192,0.035125,GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN,0.749890484460695
REACTOME_SIGNALING_BY_FGFR1_...,SET,37,0.26689,0.011963,0.14743,0.035129,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,0.749890484460695
GOBP_SPLICEOSOMAL_SNRNP_ASSE...,SET,37,0.22616,0.010137,0.12493,0.035137,GOBP_SPLICEOSOMAL_SNRNP_ASSEMBLY,0.749890484460695
GOMF_CYSTEINE_TYPE_ENDOPEPTI...8,SET,37,0.25258,0.011322,0.13955,0.035156,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.749890484460695
HP_MITRAL_ATRESIA,SET,11,0.5306,0.012977,0.29318,0.03517,HP_MITRAL_ATRESIA,0.749890484460695
GSE43863_NAIVE_VS_TH1_EFF_CD...2,SET,165,0.11952,0.011274,0.066046,0.035186,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP,0.749890484460695
REACTOME_RAF_INDEPENDENT_MAP...,SET,22,0.37309,0.012901,0.20627,0.035255,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,0.749890484460695
HP_ABNORMALITY_OF_THE_FEMALE...,SET,504,0.069912,0.011418,0.038658,0.035273,HP_ABNORMALITY_OF_THE_FEMALE_GENITALIA,0.749890484460695
REACTOME_ABORTIVE_ELONGATION...,SET,23,0.28046,0.0099154,0.15508,0.035275,REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,0.749890484460695
JIANG_MELANOMA_TRM4,SET,186,0.11998,0.012009,0.066348,0.03528,JIANG_MELANOMA_TRM4,0.749890484460695
NCX_01,SET,160,0.1268,0.01178,0.070139,0.035323,NCX_01,0.749890484460695
ONO_FOXP3_TARGETS_UP,SET,21,0.39358,0.013297,0.21774,0.035344,ONO_FOXP3_TARGETS_UP,0.749890484460695
GSE30962_PRIMARY_VS_SECONDAR...2,SET,183,0.11045,0.010966,0.061104,0.035346,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP,0.749890484460695
REACTOME_MATURATION_OF_SARS_...3,SET,5,0.61761,0.010186,0.3417,0.035353,REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,0.749890484460695
GOCC_CONTRACTILE_RING,SET,11,0.40375,0.0098747,0.22338,0.035354,GOCC_CONTRACTILE_RING,0.749890484460695
REACTOME_KERATAN_SULFATE_BIO...,SET,28,0.301,0.01174,0.16656,0.035372,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,0.749890484460695
GOCC_HISTONE_METHYLTRANSFERA...,SET,63,0.17988,0.010514,0.099548,0.035389,GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX,0.749890484460695
GOBP_VENTRICULAR_SEPTUM_DEVE...,SET,70,0.19881,0.012246,0.11004,0.035407,GOBP_VENTRICULAR_SEPTUM_DEVELOPMENT,0.749890484460695
MIR1251_3P,SET,140,0.13606,0.01183,0.075409,0.035606,MIR1251_3P,0.75266231487056
GSE2706_UNSTIM_VS_2H_R848_DC...1,SET,173,0.12709,0.012273,0.070467,0.035659,GSE2706_UNSTIM_VS_2H_R848_DC_DN,0.75266231487056
GSE40274_CTRL_VS_FOXP3_AND_L...1,SET,148,0.12721,0.011369,0.070541,0.035679,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.75266231487056
MIR4779,SET,133,0.13519,0.011459,0.074968,0.035682,MIR4779,0.75266231487056
GOBP_GANGLIOSIDE_CATABOLIC_P...,SET,7,0.6387,0.012463,0.35437,0.035754,GOBP_GANGLIOSIDE_CATABOLIC_PROCESS,0.75266231487056
WP_PHYSICOCHEMICAL_FEATURES_...,SET,62,0.20025,0.011612,0.11113,0.035784,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,0.75266231487056
HP_ABNORMALITY_OF_ADRENAL_PH...,SET,131,0.13745,0.011563,0.076279,0.035789,HP_ABNORMALITY_OF_ADRENAL_PHYSIOLOGY,0.75266231487056
GSE3982_NKCELL_VS_TH1_UP,SET,172,0.12446,0.011984,0.069091,0.035827,GSE3982_NKCELL_VS_TH1_UP,0.75266231487056
PID_HEDGEHOG_GLI_PATHWAY,SET,46,0.23135,0.01156,0.12845,0.035855,PID_HEDGEHOG_GLI_PATHWAY,0.75266231487056
GSE37416_0H_VS_6H_F_TULARENS...1,SET,182,0.11478,0.011365,0.063742,0.035886,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.75266231487056
GSE3982_DC_VS_NKCELL_UP,SET,181,0.11976,0.011826,0.066508,0.035889,GSE3982_DC_VS_NKCELL_UP,0.75266231487056
BAELDE_DIABETIC_NEPHROPATHY_...2,SET,82,0.17971,0.011977,0.09981,0.035899,BAELDE_DIABETIC_NEPHROPATHY_UP,0.75266231487056
BIOCARTA_PLK3_PATHWAY,SET,8,0.46636,0.009728,0.25904,0.035913,BIOCARTA_PLK3_PATHWAY,0.75266231487056
HP_MACRODONTIA,SET,27,0.29865,0.011439,0.1659,0.035923,HP_MACRODONTIA,0.75266231487056
GOMF_DOLICHYL_PHOSPHATE_MANN...,SET,8,0.47239,0.0098537,0.26242,0.035927,GOMF_DOLICHYL_PHOSPHATE_MANNOSE_PROTEIN_MANNOSYLTRANSFERASE_ACTIVITY,0.75266231487056
SANSOM_APC_MYC_TARGETS,SET,223,0.098849,0.010822,0.054919,0.035947,SANSOM_APC_MYC_TARGETS,0.75266231487056
HP_BAND_KERATOPATHY,SET,14,0.47627,0.01314,0.26461,0.035948,HP_BAND_KERATOPATHY,0.75266231487056
GOBP_RIBOSOMAL_LARGE_SUBUNIT...1,SET,19,0.32925,0.010581,0.18293,0.03595,GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY,0.75266231487056
MIR4735_3P,SET,107,0.14918,0.01135,0.082896,0.035968,MIR4735_3P,0.75266231487056
REACTOME_CDH11_HOMOTYPIC_AND...,SET,7,0.63558,0.012402,0.35318,0.035971,REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS,0.75266231487056
NIKOLSKY_MUTATED_AND_AMPLIFI...,SET,87,0.16105,0.011055,0.089517,0.036008,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,0.752983176895307
JI_RESPONSE_TO_FSH_DN,SET,49,0.21211,0.010938,0.11795,0.036077,JI_RESPONSE_TO_FSH_DN,0.753470065940367
GOBP_PYRIMIDINE_DIMER_REPAIR,SET,9,0.40343,0.0089256,0.22439,0.036105,GOBP_PYRIMIDINE_DIMER_REPAIR,0.753470065940367
HP_ABNORMAL_HYPOTHALAMUS_PHY...,SET,49,0.23254,0.011991,0.12934,0.036106,HP_ABNORMAL_HYPOTHALAMUS_PHYSIOLOGY,0.753470065940367
GSE43955_TH0_VS_TGFB_IL6_IL2...1,SET,188,0.11327,0.011398,0.063016,0.036137,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.753470065940367
HALLMARK_G2M_CHECKPOINT,SET,182,0.11111,0.011002,0.061833,0.03618,HALLMARK_G2M_CHECKPOINT,0.753470065940367
GOBP_TUBULIN_COMPLEX_ASSEMBLY,SET,8,0.40788,0.0085082,0.227,0.03619,GOBP_TUBULIN_COMPLEX_ASSEMBLY,0.753470065940367
ITO_PTTG1_TARGETS_UP,SET,11,0.5448,0.013325,0.30331,0.036244,ITO_PTTG1_TARGETS_UP,0.753470065940367
HP_CLEFT_LIP,SET,175,0.11659,0.011323,0.064928,0.036284,HP_CLEFT_LIP,0.753470065940367
HP_GLOMERULONEPHRITIS,SET,86,0.17343,0.011836,0.096594,0.036296,HP_GLOMERULONEPHRITIS,0.753470065940367
GSE29949_CD8_NEG_DC_SPLEEN_V...5,SET,176,0.11799,0.011491,0.065722,0.036308,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,0.753470065940367
REACTOME_SYNTHESIS_OF_DOLICH...,SET,5,0.7145,0.011784,0.39798,0.03631,REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE,0.753470065940367
GSE17186_BLOOD_VS_CORD_BLOOD...4,SET,189,0.10964,0.011061,0.061069,0.036312,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP,0.753470065940367
ROESSLER_LIVER_CANCER_METAST...1,SET,46,0.22975,0.01148,0.12798,0.036322,ROESSLER_LIVER_CANCER_METASTASIS_DN,0.753470065940367
GSE43955_10H_VS_30H_ACT_CD4_...3,SET,182,0.11583,0.011469,0.064534,0.036347,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.753470065940367
REACTOME_OXIDATIVE_STRESS_IN...,SET,60,0.212,0.012094,0.11818,0.036423,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,0.753470065940367
REACTOME_RNA_POLYMERASE_II_T...1,SET,71,0.16025,0.0099413,0.089351,0.036454,REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,0.753470065940367
GOBP_SOMATIC_STEM_CELL_POPUL...,SET,61,0.2057,0.011831,0.1147,0.036459,GOBP_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.753470065940367
PID_HEDGEHOG_2PATHWAY,SET,21,0.34844,0.011772,0.19431,0.03648,PID_HEDGEHOG_2PATHWAY,0.753470065940367
JIANG_MELANOMA_TRM6_CD8,SET,122,0.13331,0.010825,0.074348,0.036493,JIANG_MELANOMA_TRM6_CD8,0.753470065940367
HP_CARDIAC_DIVERTICULUM,SET,20,0.31635,0.01043,0.17645,0.036508,HP_CARDIAC_DIVERTICULUM,0.753470065940367
LEE_CALORIE_RESTRICTION_NEOC...1,SET,60,0.18919,0.010793,0.10553,0.036516,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,0.753470065940367
HP_CRYPTOPHTHALMOS,SET,5,0.8148,0.013438,0.45463,0.036557,HP_CRYPTOPHTHALMOS,0.753470065940367
GOBP_CHORIONIC_TROPHOBLAST_C...2,SET,5,0.70323,0.011598,0.39245,0.036584,GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION,0.753470065940367
MIR1913,SET,139,0.12618,0.010932,0.070425,0.036597,MIR1913,0.753470065940367
ENK_UV_RESPONSE_EPIDERMIS_DN,SET,483,0.073216,0.011712,0.04087,0.036619,ENK_UV_RESPONSE_EPIDERMIS_DN,0.753470065940367
REACTOME_NUCLEAR_SIGNALING_B...,SET,31,0.25703,0.010547,0.14348,0.036623,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,0.753470065940367
SHAFFER_IRF4_TARGETS_IN_PLAS...,SET,64,0.20713,0.012202,0.11563,0.036626,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,0.753470065940367
GOMF_RNA_POLYMERASE_CORE_ENZ...,SET,40,0.24677,0.0115,0.13778,0.036646,GOMF_RNA_POLYMERASE_CORE_ENZYME_BINDING,0.753470065940367
HP_HEPATITIS,SET,82,0.17973,0.011978,0.10039,0.036711,HP_HEPATITIS,0.753470065940367
GSE1460_INTRATHYMIC_T_PROGEN...10,SET,176,0.1125,0.010956,0.062847,0.036735,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP,0.753470065940367
CHENG_RESPONSE_TO_NICKEL_ACE...,SET,40,0.21835,0.010176,0.12199,0.036744,CHENG_RESPONSE_TO_NICKEL_ACETATE,0.753470065940367
GOBP_NEGATIVE_REGULATION_OF_...68,SET,4,0.76753,0.011322,0.42885,0.036756,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.753470065940367
WP_VITAMIN_B6DEPENDENT_AND_R...,SET,6,0.61665,0.01114,0.34464,0.036797,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,0.753470065940367
HP_ADRENAL_HYPERPLASIA,SET,23,0.33682,0.011908,0.18825,0.036797,HP_ADRENAL_HYPERPLASIA,0.753470065940367
REACTOME_FORMATION_OF_WDR5_C...,SET,37,0.23255,0.010424,0.13002,0.036845,REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,0.753470065940367
GOBP_MITOTIC_SISTER_CHROMATI...2,SET,3,0.76742,0.0098041,0.42913,0.036872,GOBP_MITOTIC_SISTER_CHROMATID_COHESION_CENTROMERIC,0.753470065940367
HP_IMMUNODEFICIENCY,SET,194,0.11377,0.011627,0.063622,0.036883,HP_IMMUNODEFICIENCY,0.753470065940367
MIR6891_5P,SET,109,0.14647,0.011246,0.081913,0.03689,MIR6891_5P,0.753470065940367
HP_ESOPHAGEAL_STRICTURE,SET,19,0.34779,0.011177,0.19452,0.0369,HP_ESOPHAGEAL_STRICTURE,0.753470065940367
MIR6083,SET,236,0.10224,0.011511,0.057205,0.036963,MIR6083,0.753470065940367
GOBP_SENSORY_PERCEPTION_OF_B...,SET,43,0.27798,0.01343,0.15555,0.036975,GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE,0.753470065940367
HP_VISUAL_AGNOSIA,SET,7,0.51185,0.0099877,0.28654,0.037029,HP_VISUAL_AGNOSIA,0.753470065940367
MIR4418,SET,118,0.14022,0.0112,0.078515,0.037062,MIR4418,0.753470065940367
GSE21670_STAT3_KO_VS_WT_CD4_...1,SET,187,0.11676,0.011718,0.065381,0.037067,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN,0.753470065940367
GOBP_REGULATION_OF_CHOLESTER...4,SET,17,0.37254,0.011325,0.20866,0.037106,GOBP_REGULATION_OF_CHOLESTEROL_STORAGE,0.753470065940367
GOCC_ACTIN_BASED_CELL_PROJEC...,SET,208,0.10846,0.011473,0.060753,0.037115,GOCC_ACTIN_BASED_CELL_PROJECTION,0.753470065940367
MIR548AR_3P,SET,512,0.068397,0.011256,0.038314,0.037126,MIR548AR_3P,0.753470065940367
GAVISH_3CA_MALIGNANT_METAPRO...15,SET,36,0.23187,0.010252,0.12989,0.03713,GAVISH_3CA_MALIGNANT_METAPROGRAM_24_CILIA,0.753470065940367
ZHAN_VARIABLE_EARLY_DIFFEREN...2,SET,17,0.39517,0.012013,0.22142,0.037162,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,0.753470065940367
KEGG_CYTOKINE_CYTOKINE_RECEP...,SET,245,0.11453,0.013135,0.064184,0.03719,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,0.753470065940367
PKCA_DN.V1_DN,SET,141,0.13275,0.011583,0.074406,0.037213,PKCA_DN.V1_DN,0.753470065940367
LI_PBMC_ZOSTAVAX_AGE_25_40_A...1,SET,7,0.49625,0.0096831,0.27823,0.037256,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_1DY_UP,0.753470065940367
MIR548Q,SET,43,0.22207,0.010729,0.12453,0.037281,MIR548Q,0.753470065940367
GOBP_ANTIVIRAL_INNATE_IMMUNE...,SET,49,0.21138,0.0109,0.11854,0.037284,GOBP_ANTIVIRAL_INNATE_IMMUNE_RESPONSE,0.753470065940367
GSE37301_MULTIPOTENT_PROGENI...1,SET,177,0.11289,0.011025,0.063322,0.037321,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN,0.753470065940367
CROONQUIST_NRAS_SIGNALING_UP,SET,32,0.28993,0.012087,0.16265,0.037341,CROONQUIST_NRAS_SIGNALING_UP,0.753470065940367
MIR4516,SET,272,0.093769,0.011323,0.052612,0.037362,MIR4516,0.753470065940367
GOBP_NEGATIVE_REGULATION_OF_...206,SET,25,0.30588,0.011274,0.17167,0.037402,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.753470065940367
HP_ABNORMALITY_OF_BLOOD_AND_...,SET,1319,0.043494,0.011226,0.024413,0.037415,HP_ABNORMALITY_OF_BLOOD_AND_BLOOD_FORMING_TISSUES,0.753470065940367
GOBP_ADAPTIVE_IMMUNE_MEMORY_...,SET,5,0.802,0.013227,0.45026,0.037449,GOBP_ADAPTIVE_IMMUNE_MEMORY_RESPONSE,0.753470065940367
GSE21379_WT_VS_SAP_KO_TFH_CD...2,SET,175,0.11773,0.011434,0.066108,0.037472,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP,0.753470065940367
MIR3157_5P,SET,97,0.1515,0.010977,0.085068,0.037473,MIR3157_5P,0.753470065940367
HP_PROTRACTED_DIARRHEA,SET,13,0.41499,0.011033,0.23304,0.037485,HP_PROTRACTED_DIARRHEA,0.753470065940367
SMID_BREAST_CANCER_NORMAL_LI...2,SET,422,0.080159,0.012006,0.045016,0.037491,SMID_BREAST_CANCER_NORMAL_LIKE_UP,0.753470065940367
SHAFFER_IRF4_TARGETS_IN_MYEL...,SET,93,0.16046,0.011385,0.090128,0.03752,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,0.753470065940367
GOCC_STEREOCILIA_ANKLE_LINK_...,SET,5,0.71823,0.011845,0.40345,0.037528,GOCC_STEREOCILIA_ANKLE_LINK_COMPLEX,0.753470065940367
GAVISH_3CA_MALIGNANT_METAPRO...10,SET,50,0.24147,0.012578,0.13564,0.037533,GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE,0.753470065940367
GOBP_RESPONSE_TO_PEPTIDOGLYC...,SET,11,0.45763,0.011193,0.25708,0.037537,GOBP_RESPONSE_TO_PEPTIDOGLYCAN,0.753470065940367
HP_CONFUSION,SET,69,0.18056,0.011043,0.10147,0.037589,HP_CONFUSION,0.753470065940367
GOBP_REGULATION_OF_HELICASE_...,SET,9,0.42045,0.009302,0.23636,0.037644,GOBP_REGULATION_OF_HELICASE_ACTIVITY,0.753470065940367
GOBP_CELLULAR_RESPONSE_TO_UV...3,SET,4,0.62991,0.009292,0.35414,0.037653,GOBP_CELLULAR_RESPONSE_TO_UV_C,0.753470065940367
TAKAO_RESPONSE_TO_UVB_RADIAT...2,SET,71,0.17359,0.010769,0.09762,0.037692,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,0.753470065940367
GOMF_MONOATOMIC_ANION_TRANSM...,SET,131,0.1434,0.012064,0.080646,0.037695,GOMF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.753470065940367
LEE_EARLY_T_LYMPHOCYTE_UP,SET,95,0.15942,0.011432,0.089655,0.037701,LEE_EARLY_T_LYMPHOCYTE_UP,0.753470065940367
MIR4455,SET,100,0.16306,0.011995,0.091704,0.037704,MIR4455,0.753470065940367
GOBP_ESTABLISHMENT_OF_PROTEI...5,SET,241,0.096282,0.010953,0.054154,0.037715,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.753470065940367
GOBP_MITOTIC_G2_M_TRANSITION...,SET,46,0.20514,0.01025,0.11542,0.037768,GOBP_MITOTIC_G2_M_TRANSITION_CHECKPOINT,0.753470065940367
MIR1293,SET,55,0.21752,0.011882,0.1224,0.037781,MIR1293,0.753470065940367
LEE_AGING_CEREBELLUM_DN,SET,66,0.19534,0.011685,0.10993,0.037788,LEE_AGING_CEREBELLUM_DN,0.753470065940367
SCHAEFFER_PROSTATE_DEVELOPME...15,SET,10,0.5681,0.013248,0.31971,0.037799,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,0.753470065940367
REACTOME_RHOG_GTPASE_CYCLE,SET,68,0.19708,0.011966,0.11092,0.037806,REACTOME_RHOG_GTPASE_CYCLE,0.753470065940367
GSE9601_UNTREATED_VS_PI3K_IN...1,SET,131,0.13095,0.011017,0.073702,0.037809,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.753470065940367
GSE24726_WT_VS_E2_2_KO_PDC_D...3,SET,177,0.10723,0.010473,0.060367,0.03785,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP,0.753721692439863
GOBP_VERY_LOW_DENSITY_LIPOPR...2,SET,6,0.63,0.011381,0.3547,0.037865,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.753721692439863
GOBP_NEUROTRANSMITTER_RECEPT...3,SET,24,0.32959,0.011903,0.1857,0.037972,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT,0.75541892386949
GOBP_REGULATION_OF_PROTEIN_S...2,SET,239,0.099783,0.011305,0.056265,0.038086,GOBP_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.75670572
GSE15930_STIM_VS_STIM_AND_TR...4,SET,186,0.11806,0.011817,0.066573,0.038092,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP,0.75670572
KOYAMA_SEMA3B_TARGETS_UP,SET,223,0.10306,0.011283,0.058117,0.038102,KOYAMA_SEMA3B_TARGETS_UP,0.75670572
chr9p13,SET,78,0.36217,0.023544,0.20442,0.038231,chr9p13,0.757991887115165
GSE40274_FOXP3_VS_FOXP3_AND_...11,SET,184,0.11261,0.011211,0.063566,0.038242,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.757991887115165
GATA1_02,SET,218,0.10795,0.011687,0.060937,0.038248,GATA1_02,0.757991887115165
MIR5685,SET,58,0.19452,0.01091,0.10981,0.038254,MIR5685,0.757991887115165
GOCC_CHYLOMICRON,SET,13,0.49087,0.013051,0.27716,0.038287,GOCC_CHYLOMICRON,0.758026715017065
GSE7219_WT_VS_NIK_NFKB2_KO_L...1,SET,184,0.11493,0.011442,0.064903,0.038304,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN,0.758026715017065
GOBP_NEURAL_PLATE_DEVELOPMENT,SET,7,0.56673,0.011058,0.32011,0.038335,GOBP_NEURAL_PLATE_DEVELOPMENT,0.758026715017065
GOBP_CHROMOSOME_MOVEMENT_TOW...,SET,7,0.54862,0.010705,0.30989,0.038343,GOBP_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE,0.758026715017065
MIR641,SET,232,0.099907,0.011154,0.056469,0.038437,MIR641,0.758486031161473
MOOTHA_ROS,SET,7,0.64604,0.012606,0.36519,0.038452,MOOTHA_ROS,0.758486031161473
GSE2585_CTEC_VS_THYMIC_DC_UP,SET,178,0.1163,0.01139,0.065744,0.03846,GSE2585_CTEC_VS_THYMIC_DC_UP,0.758486031161473
GOBP_VENTRAL_MIDLINE_DEVELOP...,SET,6,0.68067,0.012297,0.38485,0.038482,GOBP_VENTRAL_MIDLINE_DEVELOPMENT,0.758486031161473
ODONNELL_METASTASIS_DN,SET,23,0.35739,0.012635,0.20209,0.038498,ODONNELL_METASTASIS_DN,0.758486031161473
MODULE_530,SET,15,0.39798,0.011365,0.22507,0.038514,MODULE_530,0.758486031161473
HP_NONPROGRESSIVE,SET,18,0.35294,0.01104,0.1996,0.038519,HP_NONPROGRESSIVE,0.758486031161473
GSE9988_LPS_VS_LPS_AND_ANTI_...1,SET,170,0.11981,0.011469,0.067766,0.038542,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN,0.758509178935447
KIM_MYCL1_AMPLIFICATION_TARG...2,SET,12,0.49535,0.012654,0.28025,0.038578,KIM_MYCL1_AMPLIFICATION_TARGETS_UP,0.758735638778971
GOMF_SIGNAL_SEQUENCE_BINDING,SET,43,0.21664,0.010467,0.12258,0.038601,GOMF_SIGNAL_SEQUENCE_BINDING,0.758735638778971
GOBP_REGULATION_OF_ACTIN_FIL...3,SET,94,0.15999,0.011413,0.090541,0.038619,GOBP_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.758735638778971
HP_LOW_SELF_ESTEEM,SET,10,0.56042,0.013069,0.31724,0.038662,HP_LOW_SELF_ESTEEM,0.75910006097561
MIR8068,SET,353,0.082765,0.01136,0.046871,0.038725,MIR8068,0.75910006097561
GOBP_PROTEIN_DEPHOSPHORYLATI...,SET,187,0.10744,0.010782,0.060863,0.038771,GOBP_PROTEIN_DEPHOSPHORYLATION,0.75910006097561
GSE33292_WT_VS_TCF1_KO_DN3_T...1,SET,189,0.10434,0.010527,0.059126,0.038813,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN,0.75910006097561
HP_DECREASED_CIRCULATING_IGA...,SET,70,0.18253,0.011243,0.10344,0.038823,HP_DECREASED_CIRCULATING_IGA_LEVEL,0.75910006097561
DESCARTES_FETAL_EYE_RETINAL_...1,SET,63,0.21269,0.012431,0.12054,0.038838,DESCARTES_FETAL_EYE_RETINAL_PIGMENT_CELLS,0.75910006097561
MIR7974,SET,80,0.16876,0.01111,0.095645,0.03884,MIR7974,0.75910006097561
GOBP_REGULATION_OF_PLATELET_...3,SET,5,0.70488,0.011625,0.39959,0.038873,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.75910006097561
GSE37532_VISCERAL_ADIPOSE_TI...8,SET,155,0.11941,0.01092,0.067723,0.038941,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP,0.75910006097561
GOBP_DOUBLE_STRAND_BREAK_REP...8,SET,8,0.40952,0.0085423,0.23228,0.038954,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING,0.75910006097561
HOEK_NK_CELL_2011_2012_TIV_7...,SET,14,0.41001,0.011312,0.23259,0.038974,HOEK_NK_CELL_2011_2012_TIV_7D_VS_0DY_ADULT_7D_DN,0.75910006097561
GOBP_REGULATION_OF_INCLUSION...,SET,17,0.37815,0.011496,0.21452,0.038976,GOBP_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,0.75910006097561
GOCC_R2TP_COMPLEX,SET,5,0.60351,0.0099532,0.34242,0.039001,GOCC_R2TP_COMPLEX,0.75910006097561
GSE11973_MIR223_KOVS_WT_BONE...2,SET,179,0.1156,0.011353,0.065591,0.039002,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP,0.75910006097561
GSE36392_TYPE_2_MYELOID_VS_E...2,SET,177,0.1085,0.010597,0.061568,0.039017,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP,0.75910006097561
GOBP_NEGATIVE_REGULATION_OF_...490,SET,5,0.76699,0.012649,0.43522,0.039019,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.75910006097561
GOBP_REGULATION_OF_RESPONSE_...14,SET,161,0.12439,0.011591,0.070583,0.03902,GOBP_REGULATION_OF_RESPONSE_TO_WOUNDING,0.75910006097561
GOMF_CYTOKINE_RECEPTOR_ACTIV...,SET,87,0.18534,0.012722,0.10518,0.039041,GOMF_CYTOKINE_RECEPTOR_ACTIVITY,0.75910006097561
SCHLOSSER_MYC_TARGETS_AND_SE...2,SET,45,0.21063,0.01041,0.11962,0.039139,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,0.75910006097561
GOBP_CELLULAR_RESPONSE_TO_CH...2,SET,17,0.37542,0.011413,0.21321,0.039148,GOBP_CELLULAR_RESPONSE_TO_CHOLESTEROL,0.75910006097561
GSE17721_LPS_VS_POLYIC_24H_B...2,SET,173,0.1109,0.010709,0.062982,0.03915,GSE17721_LPS_VS_POLYIC_24H_BMDC_UP,0.75910006097561
MODULE_293,SET,10,0.53073,0.012377,0.30148,0.039178,MODULE_293,0.75910006097561
MIR518D_5P_MIR518F_5P_MIR520...,SET,85,0.16026,0.010874,0.091037,0.03918,MIR518D_5P_MIR518F_5P_MIR520C_5P_MIR526A_5P,0.75910006097561
GOBP_INTERLEUKIN_17_PRODUCTI...,SET,37,0.27609,0.012375,0.15686,0.0392,GOBP_INTERLEUKIN_17_PRODUCTION,0.75910006097561
GOBP_NEGATIVE_REGULATION_OF_...657,SET,3,0.8652,0.011053,0.49162,0.039223,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.75910006097561
HP_ABNORMAL_RESPONSE_TO_GLUC...,SET,4,0.84056,0.012399,0.47767,0.039238,HP_ABNORMAL_RESPONSE_TO_GLUCAGON_STIMULATION_TEST,0.75910006097561
HP_INCREASED_CIRCULATING_PRO...,SET,26,0.28594,0.010747,0.16254,0.039286,HP_INCREASED_CIRCULATING_PROLACTIN_CONCENTRATION,0.75910006097561
GOBP_TRANSCRIPTION_INITIATIO...1,SET,8,0.42737,0.0089146,0.243,0.039319,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_III_PROMOTER,0.75910006097561
GOCC_TRANSFERASE_COMPLEX_TRA...,SET,263,0.086249,0.010244,0.049051,0.039351,GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,0.75910006097561
GOBP_SYNAPTIC_MEMBRANE_ADHES...,SET,26,0.33339,0.012531,0.18969,0.03942,GOBP_SYNAPTIC_MEMBRANE_ADHESION,0.75910006097561
HNF4_Q6,SET,244,0.096325,0.011025,0.054816,0.039447,HNF4_Q6,0.75910006097561
MORF_EIF3S2,SET,220,0.093377,0.010155,0.053143,0.039459,MORF_EIF3S2,0.75910006097561
MIR6806_5P,SET,63,0.19032,0.011124,0.10833,0.03948,MIR6806_5P,0.75910006097561
GSE43863_TH1_VS_LY6C_INT_CXC...2,SET,179,0.10819,0.010625,0.061584,0.039489,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,0.75910006097561
HP_ABULIA,SET,10,0.45859,0.010694,0.26105,0.039493,HP_ABULIA,0.75910006097561
GSE29949_CD8_NEG_DC_SPLEEN_V...4,SET,168,0.11806,0.011236,0.06721,0.039502,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP,0.75910006097561
GOBP_PYRIMIDINE_NUCLEOSIDE_M...4,SET,20,0.33522,0.011053,0.19085,0.039511,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.75910006097561
HP_DIASTEMA,SET,22,0.28747,0.00994,0.16371,0.039556,HP_DIASTEMA,0.75910006097561
MACAEVA_PBMC_RESPONSE_TO_IR,SET,90,0.15686,0.01095,0.089334,0.03956,MACAEVA_PBMC_RESPONSE_TO_IR,0.75910006097561
HP_HEPATIC_NECROSIS,SET,13,0.39703,0.010556,0.22612,0.039569,HP_HEPATIC_NECROSIS,0.75910006097561
GOBP_FATTY_ACID_BETA_OXIDATI...3,SET,12,0.39529,0.010097,0.22513,0.039571,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE,0.75910006097561
GOBP_IMMUNOLOGICAL_MEMORY_PR...,SET,18,0.41512,0.012985,0.23652,0.03963,GOBP_IMMUNOLOGICAL_MEMORY_PROCESS,0.75910006097561
MIR1207_3P,SET,124,0.13756,0.011261,0.078396,0.039666,MIR1207_3P,0.75910006097561
HP_DECREASED_CIRCULATING_ACT...,SET,28,0.27994,0.010919,0.15956,0.039684,HP_DECREASED_CIRCULATING_ACTH_CONCENTRATION,0.75910006097561
GOBP_POSITIVE_REGULATION_OF_...806,SET,92,0.17427,0.0123,0.099366,0.039735,GOBP_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.75910006097561
REACTOME_SIGNALING_BY_LRP5_M...,SET,6,0.58742,0.010612,0.33493,0.039737,REACTOME_SIGNALING_BY_LRP5_MUTANTS,0.75910006097561
GOBP_PROGESTERONE_RECEPTOR_S...,SET,10,0.50238,0.011716,0.28647,0.039748,GOBP_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY,0.75910006097561
GSE17721_CTRL_VS_PAM3CSK4_1H...1,SET,185,0.11331,0.011311,0.064639,0.039812,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN,0.75910006097561
GOBP_CYTOSKELETON_DEPENDENT_...1,SET,103,0.13767,0.010277,0.078558,0.039857,GOBP_CYTOSKELETON_DEPENDENT_CYTOKINESIS,0.75910006097561
WP_NOTCH_SIGNALING_WP268,SET,45,0.21796,0.010772,0.12443,0.039919,WP_NOTCH_SIGNALING_WP268,0.75910006097561
GSE9960_HEALTHY_VS_GRAM_POS_...2,SET,165,0.10983,0.01036,0.062705,0.03994,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP,0.75910006097561
HMG20B_TARGET_GENES,SET,1493,0.040802,0.011147,0.023303,0.039985,HMG20B_TARGET_GENES,0.75910006097561
WP_MAPK_SIGNALING,SET,235,0.10221,0.011484,0.058375,0.039988,WP_MAPK_SIGNALING,0.75910006097561
GOBP_ORGANELLE_LOCALIZATION,SET,556,0.062976,0.010787,0.035974,0.040018,GOBP_ORGANELLE_LOCALIZATION,0.75910006097561
GOCC_INTERSTITIAL_MATRIX,SET,11,0.5358,0.013105,0.30614,0.040053,GOCC_INTERSTITIAL_MATRIX,0.75910006097561
GSE2197_IMMUNOSUPPRESSIVE_DN...1,SET,179,0.10835,0.010641,0.06191,0.040061,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN,0.75910006097561
GOBP_REGULATION_OF_FAT_CELL_...2,SET,10,0.51385,0.011983,0.29365,0.040082,GOBP_REGULATION_OF_FAT_CELL_PROLIFERATION,0.75910006097561
GOBP_CELL_CYCLE_CHECKPOINT_S...,SET,180,0.10556,0.010396,0.060338,0.040111,GOBP_CELL_CYCLE_CHECKPOINT_SIGNALING,0.75910006097561
GCM_BCL2L1,SET,33,0.23074,0.009769,0.1319,0.040115,GCM_BCL2L1,0.75910006097561
DESCARTES_MAIN_FETAL_GOBLET_...,SET,37,0.28439,0.012748,0.16256,0.040116,DESCARTES_MAIN_FETAL_GOBLET_CELLS,0.75910006097561
WP_DNA_IRDOUBLE_STRAND_BREAK...,SET,52,0.1902,0.010103,0.10872,0.040122,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,0.75910006097561
GSE28726_ACT_CD4_TCELL_VS_AC...1,SET,177,0.1125,0.010987,0.06435,0.040223,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN,0.75910006097561
KEGG_MEDICUS_VARIANT_OLIGOME...,SET,13,0.39311,0.010452,0.22492,0.04026,KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.75910006097561
GOBP_COMPARTMENT_PATTERN_SPE...,SET,5,0.71657,0.011818,0.41005,0.040283,GOBP_COMPARTMENT_PATTERN_SPECIFICATION,0.75910006097561
GOBP_RESPONSE_TO_PHORBOL_13_...,SET,8,0.53632,0.011187,0.30694,0.040299,GOBP_RESPONSE_TO_PHORBOL_13_ACETATE_12_MYRISTATE,0.75910006097561
GSE4811_CLASSSICALY_ACTIVATE...1,SET,177,0.11705,0.011431,0.06699,0.040308,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN,0.75910006097561
PARK_TRETINOIN_RESPONSE_AND_...1,SET,27,0.30622,0.011729,0.17527,0.040318,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,0.75910006097561
GOMF_MONOATOMIC_ANION_CHANNE...,SET,88,0.17948,0.01239,0.10273,0.04032,GOMF_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.75910006097561
HP_SIMPLIFIED_GYRAL_PATTERN,SET,78,0.16359,0.010635,0.093646,0.04034,HP_SIMPLIFIED_GYRAL_PATTERN,0.75910006097561
LI_WILMS_TUMOR_ANAPLASTIC_DN,SET,5,0.73121,0.012059,0.4186,0.040343,LI_WILMS_TUMOR_ANAPLASTIC_DN,0.75910006097561
GOBP_REGULATION_OF_PROTEIN_F...,SET,9,0.51309,0.011352,0.29381,0.040385,GOBP_REGULATION_OF_PROTEIN_FOLDING,0.75910006097561
GSE14415_ACT_TCONV_VS_ACT_NA...2,SET,158,0.12184,0.011248,0.069785,0.040426,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP,0.75910006097561
MODULE_147,SET,101,0.14782,0.010928,0.084671,0.040427,MODULE_147,0.75910006097561
HP_ABNORMAL_CIRCULATING_ADRE...,SET,42,0.23199,0.011078,0.1329,0.040452,HP_ABNORMAL_CIRCULATING_ADRENOCORTICOTROPIN_CONCENTRATION,0.75910006097561
GOMF_GPI_LINKED_EPHRIN_RECEP...,SET,6,0.67744,0.012238,0.38832,0.040543,GOMF_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY,0.75910006097561
TESAR_ALK_TARGETS_HUMAN_ES_5...1,SET,5,0.68776,0.011343,0.39432,0.040574,TESAR_ALK_TARGETS_HUMAN_ES_5D_DN,0.75910006097561
HP_LEFT_BUNDLE_BRANCH_BLOCK,SET,18,0.3704,0.011586,0.21245,0.040631,HP_LEFT_BUNDLE_BRANCH_BLOCK,0.75910006097561
GSE2770_IL12_VS_TGFB_AND_IL1...1,SET,145,0.1276,0.011289,0.073205,0.040669,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.75910006097561
ZSCAN2_TARGET_GENES,SET,677,0.059853,0.011274,0.034343,0.040694,ZSCAN2_TARGET_GENES,0.75910006097561
GSE25123_CTRL_VS_ROSIGLITAZO...3,SET,178,0.11201,0.01097,0.064289,0.040742,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.75910006097561
GOMF_PYRUVATE_DEHYDROGENASE_...1,SET,4,0.70599,0.010414,0.40525,0.040754,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_KINASE_ACTIVITY,0.75910006097561
GOCC_PERINUCLEOLAR_COMPARTME...,SET,5,0.75759,0.012494,0.43499,0.040797,GOCC_PERINUCLEOLAR_COMPARTMENT,0.75910006097561
GOBP_PENETRATION_OF_ZONA_PEL...,SET,9,0.51069,0.011299,0.29325,0.040805,GOBP_PENETRATION_OF_ZONA_PELLUCIDA,0.75910006097561
GSE3982_MAC_VS_NKCELL_UP,SET,180,0.11653,0.011476,0.066911,0.040806,GSE3982_MAC_VS_NKCELL_UP,0.75910006097561
HP_ESOPHAGEAL_CARCINOMA,SET,13,0.42282,0.011242,0.2428,0.040813,HP_ESOPHAGEAL_CARCINOMA,0.75910006097561
GSE23114_PERITONEAL_CAVITY_B...4,SET,164,0.11624,0.010931,0.066749,0.040813,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP,0.75910006097561
GAO_LARGE_INTESTINE_24W_C1_D...,SET,93,0.16665,0.011825,0.095706,0.040823,GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR,0.75910006097561
HP_ABNORMAL_NASAL_SKELETON_M...,SET,11,0.53213,0.013015,0.30561,0.040833,HP_ABNORMAL_NASAL_SKELETON_MORPHOLOGY,0.75910006097561
WP_HEDGEHOG_SIGNALING_WP47,SET,14,0.3696,0.010197,0.21228,0.040839,WP_HEDGEHOG_SIGNALING_WP47,0.75910006097561
GOMF_GLYCOLIPID_BINDING,SET,28,0.27972,0.01091,0.16066,0.040843,GOMF_GLYCOLIPID_BINDING,0.75910006097561
GOBP_SKELETAL_MUSCLE_ACETYLC...,SET,11,0.39975,0.0097769,0.22962,0.040862,GOBP_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.75910006097561
HP_NEUROINFLAMMATION,SET,18,0.34081,0.010661,0.19582,0.040899,HP_NEUROINFLAMMATION,0.75910006097561
GOMF_INTRACELLULARLY_CALCIUM...,SET,20,0.35528,0.011714,0.20415,0.040907,GOMF_INTRACELLULARLY_CALCIUM_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.75910006097561
HP_ABNORMALITY_OF_THE_DIENCE...,SET,122,0.13592,0.011037,0.078115,0.040938,HP_ABNORMALITY_OF_THE_DIENCEPHALON,0.75910006097561
LET_7A_2_3P,SET,265,0.092686,0.011049,0.053282,0.040978,LET_7A_2_3P,0.75910006097561
LET_7G_3P,SET,265,0.092686,0.011049,0.053282,0.040978,LET_7G_3P,0.75910006097561
GOBP_BILE_ACID_BIOSYNTHETIC_...,SET,36,0.25716,0.011371,0.14784,0.040986,GOBP_BILE_ACID_BIOSYNTHETIC_PROCESS,0.75910006097561
HP_DISTICHIASIS,SET,8,0.52067,0.010861,0.29941,0.041026,HP_DISTICHIASIS,0.75910006097561
GSE41176_UNSTIM_VS_ANTI_IGM_...6,SET,180,0.12027,0.011844,0.069166,0.041036,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP,0.75910006097561
REACTOME_REGULATION_OF_MECP2...,SET,29,0.28025,0.011124,0.16118,0.041045,REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY,0.75910006097561
GOBP_COTRANSLATIONAL_PROTEIN...,SET,21,0.30187,0.010199,0.17362,0.041052,GOBP_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.75910006097561
GSE18281_SUBCAPSULAR_VS_PERI...1,SET,184,0.10999,0.01095,0.063275,0.041095,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN,0.75910006097561
MIR6764_5P,SET,213,0.1031,0.011035,0.059316,0.041096,MIR6764_5P,0.75910006097561
LEE_CALORIE_RESTRICTION_MUSC...1,SET,41,0.2162,0.0102,0.12439,0.041102,LEE_CALORIE_RESTRICTION_MUSCLE_DN,0.75910006097561
HP_NEVUS,SET,153,0.12185,0.011072,0.070109,0.041108,HP_NEVUS,0.75910006097561
GOMF_MITOGEN_ACTIVATED_PROTE...3,SET,16,0.34427,0.010153,0.19809,0.041118,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING,0.75910006097561
GSE11057_EFF_MEM_VS_CENT_MEM...2,SET,169,0.11782,0.011246,0.067839,0.041228,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP,0.75910006097561
KEGG_MEDICUS_REFERENCE_GLUTA...,SET,11,0.4441,0.010862,0.25573,0.041239,KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS,0.75910006097561
HP_FEMALE_REPRODUCTIVE_SYSTE...,SET,70,0.17711,0.01091,0.10199,0.04124,HP_FEMALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.75910006097561
GOCC_MISMATCH_REPAIR_COMPLEX,SET,7,0.47724,0.0093123,0.27483,0.041244,GOCC_MISMATCH_REPAIR_COMPLEX,0.75910006097561
GOMF_GPI_ANCHOR_BINDING,SET,8,0.52138,0.010876,0.30026,0.041254,GOMF_GPI_ANCHOR_BINDING,0.75910006097561
HP_PARTIAL_ANOMALOUS_PULMONA...,SET,6,0.63089,0.011398,0.36341,0.04129,HP_PARTIAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,0.75910006097561
GAVISH_3CA_MALIGNANT_METAPRO...6,SET,44,0.25301,0.012365,0.14581,0.041355,GAVISH_3CA_MALIGNANT_METAPROGRAM_15_EMT_4,0.75910006097561
FOXF1_TARGET_GENES,SET,5,0.65977,0.010881,0.38026,0.041374,FOXF1_TARGET_GENES,0.75910006097561
HP_NEONATAL_INSULIN_DEPENDEN...,SET,20,0.34087,0.011239,0.1965,0.041405,HP_NEONATAL_INSULIN_DEPENDENT_DIABETES_MELLITUS,0.75910006097561
GOBP_POSITIVE_REGULATION_OF_...553,SET,61,0.19051,0.010958,0.10985,0.041437,GOBP_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.75910006097561
MIR3129_5P,SET,144,0.12383,0.010919,0.071421,0.04148,MIR3129_5P,0.75910006097561
MODULE_15,SET,319,0.085123,0.011117,0.049095,0.041483,MODULE_15,0.75910006097561
JONES_OVARY_NK_CELL,SET,80,0.17836,0.011742,0.10289,0.04151,JONES_OVARY_NK_CELL,0.75910006097561
HE_LIM_SUN_FETAL_LUNG_C1_LAT...3,SET,6,0.68634,0.012399,0.39599,0.041535,HE_LIM_SUN_FETAL_LUNG_C1_LATE_STALK_CELL,0.75910006097561
DESCARTES_FETAL_PANCREAS_CCL...,SET,44,0.25034,0.012234,0.14445,0.041555,DESCARTES_FETAL_PANCREAS_CCL19_CCL21_POSITIVE_CELLS,0.75910006097561
HUANG_DASATINIB_RESISTANCE_DN,SET,66,0.19773,0.011828,0.1141,0.041566,HUANG_DASATINIB_RESISTANCE_DN,0.75910006097561
CREBL2_TARGET_GENES,SET,7,0.63623,0.012414,0.36723,0.041603,CREBL2_TARGET_GENES,0.75910006097561
DESCARTES_MAIN_FETAL_ERYTHRO...,SET,194,0.10682,0.010917,0.061661,0.041607,DESCARTES_MAIN_FETAL_ERYTHROBLASTS,0.75910006097561
GOBP_NEGATIVE_REGULATION_OF_...332,SET,5,0.80316,0.013246,0.46365,0.041623,GOBP_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.75910006097561
SCIAN_INVERSED_TARGETS_OF_TP...1,SET,26,0.3007,0.011302,0.17361,0.041642,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,0.75910006097561
GSE4590_PRE_BCELL_VS_SMALL_P...2,SET,136,0.12709,0.010892,0.073379,0.041646,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP,0.75910006097561
DIAZ_CHRONIC_MYELOGENOUS_LEU...2,SET,1272,0.041657,0.010573,0.024052,0.041651,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP,0.75910006097561
HP_INCREASED_LEVEL_OF_HIPPUR...,SET,5,0.67416,0.011118,0.38929,0.041667,HP_INCREASED_LEVEL_OF_HIPPURIC_ACID_IN_URINE,0.75910006097561
MIR3616_5P,SET,84,0.16315,0.011005,0.094223,0.041685,MIR3616_5P,0.75910006097561
BIOCARTA_ATM_PATHWAY,SET,19,0.32638,0.010489,0.18852,0.041705,BIOCARTA_ATM_PATHWAY,0.75910006097561
MIR8064,SET,73,0.17751,0.011165,0.10255,0.04174,MIR8064,0.75910006097561
GOBP_RENAL_SYSTEM_PROCESS_IN...2,SET,24,0.32843,0.011861,0.18975,0.041744,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.75910006097561
HP_ARTERIAL_THROMBOSIS,SET,29,0.27162,0.010781,0.15693,0.041748,HP_ARTERIAL_THROMBOSIS,0.75910006097561
GSE34156_NOD2_LIGAND_VS_NOD2...1,SET,158,0.11275,0.01041,0.065148,0.041759,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.75910006097561
SHIRAISHI_PLZF_TARGETS_DN,SET,9,0.53833,0.01191,0.31107,0.041771,SHIRAISHI_PLZF_TARGETS_DN,0.75910006097561
PID_P38_GAMMA_DELTA_PATHWAY,SET,10,0.50919,0.011874,0.29428,0.0418,PID_P38_GAMMA_DELTA_PATHWAY,0.75910006097561
REACTOME_BETA_DEFENSINS,SET,26,0.41202,0.015486,0.23812,0.0418,REACTOME_BETA_DEFENSINS,0.75910006097561
KEGG_BETA_ALANINE_METABOLISM,SET,21,0.36424,0.012305,0.21053,0.041813,KEGG_BETA_ALANINE_METABOLISM,0.75910006097561
GOBP_REGULATION_OF_POLYAMINE...,SET,5,0.5619,0.009267,0.3248,0.041824,GOBP_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT,0.75910006097561
GOMF_ORNITHINE_DECARBOXYLASE...,SET,5,0.5619,0.009267,0.3248,0.041824,GOMF_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY,0.75910006097561
KOHN_EMT_EPITHELIAL,SET,22,0.33364,0.011537,0.19289,0.041852,KOHN_EMT_EPITHELIAL,0.75910006097561
WP_DEVELOPMENT_OF_URETERIC_C...,SET,57,0.22179,0.012333,0.12824,0.041874,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,0.75910006097561
BLANCO_MELO_COVID19_SARS_COV...1,SET,90,0.17174,0.011989,0.099306,0.041879,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,0.75910006097561
WP_MTHFR_DEFICIENCY,SET,22,0.32583,0.011267,0.18842,0.041883,WP_MTHFR_DEFICIENCY,0.75910006097561
GOBP_ARTERY_DEVELOPMENT,SET,100,0.1606,0.011815,0.092874,0.041891,GOBP_ARTERY_DEVELOPMENT,0.75910006097561
GOBP_POSITIVE_REGULATION_OF_...453,SET,25,0.34766,0.012814,0.20107,0.041907,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.75910006097561
GOCC_GAMMA_TUBULIN_RING_COMP...,SET,8,0.57525,0.011999,0.33274,0.041926,GOCC_GAMMA_TUBULIN_RING_COMPLEX,0.75910006097561
MIR7108_3P,SET,12,0.4289,0.010956,0.24809,0.041929,MIR7108_3P,0.75910006097561
GOBP_HEMATOPOIETIC_STEM_CELL...3,SET,9,0.4873,0.010781,0.28187,0.041932,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION,0.75910006097561
REACTOME_SIGNALING_BY_FGFR4,SET,39,0.23741,0.010925,0.13741,0.042025,REACTOME_SIGNALING_BY_FGFR4,0.75910006097561
HNF3ALPHA_Q6,SET,184,0.11315,0.011265,0.065531,0.042122,HNF3ALPHA_Q6,0.75910006097561
HP_ABNORMALITY_OF_JAW_MUSCLES,SET,26,0.27868,0.010474,0.16147,0.042195,HP_ABNORMALITY_OF_JAW_MUSCLES,0.75910006097561
GOBP_ANATOMICAL_STRUCTURE_FO...,SET,1097,0.047558,0.011267,0.027556,0.042197,GOBP_ANATOMICAL_STRUCTURE_FORMATION_INVOLVED_IN_MORPHOGENESIS,0.75910006097561
REACTOME_REGULATION_OF_COMMI...,SET,10,0.54105,0.012617,0.3135,0.042198,REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO,0.75910006097561
GOMF_GROWTH_HORMONE_RECEPTOR...,SET,8,0.58269,0.012155,0.33763,0.042198,GOMF_GROWTH_HORMONE_RECEPTOR_BINDING,0.75910006097561
HP_RADIAL_DEVIATION_OF_THE_H...1,SET,8,0.61723,0.012875,0.35766,0.042206,HP_RADIAL_DEVIATION_OF_THE_HAND,0.75910006097561
HP_CENTRAL_DIABETES_INSIPIDUS,SET,20,0.353,0.011639,0.20455,0.042208,HP_CENTRAL_DIABETES_INSIPIDUS,0.75910006097561
GOCC_SUPRAMOLECULAR_POLYMER,SET,924,0.051575,0.01127,0.029888,0.042218,GOCC_SUPRAMOLECULAR_POLYMER,0.75910006097561
HP_OVARIAN_CARCINOMA,SET,14,0.36818,0.010158,0.21341,0.04225,HP_OVARIAN_CARCINOMA,0.75910006097561
GOBP_OLIGOSACCHARIDE_METABOL...,SET,63,0.19217,0.011232,0.11146,0.042356,GOBP_OLIGOSACCHARIDE_METABOLIC_PROCESS,0.75910006097561
GOBP_PROGRAMMED_NECROTIC_CEL...,SET,47,0.21346,0.010781,0.12383,0.042378,GOBP_PROGRAMMED_NECROTIC_CELL_DEATH,0.75910006097561
MIR3617_5P,SET,232,0.097558,0.010892,0.056604,0.042405,MIR3617_5P,0.75910006097561
MIR6855_5P,SET,61,0.18636,0.010719,0.10814,0.042427,MIR6855_5P,0.75910006097561
HP_INFLAMMATORY_ABNORMALITY_...,SET,189,0.1094,0.011037,0.063485,0.042435,HP_INFLAMMATORY_ABNORMALITY_OF_THE_EYE,0.75910006097561
GOBP_POLYAMINE_METABOLIC_PRO...,SET,15,0.34193,0.0097647,0.19843,0.042439,GOBP_POLYAMINE_METABOLIC_PROCESS,0.75910006097561
GOCC_FILOPODIUM_MEMBRANE,SET,16,0.37789,0.011145,0.21934,0.042466,GOCC_FILOPODIUM_MEMBRANE,0.75910006097561
MIR6507_3P,SET,112,0.13697,0.01066,0.079507,0.042474,MIR6507_3P,0.75910006097561
REACTOME_E2F_MEDIATED_REGULA...,SET,20,0.30657,0.010108,0.17796,0.042478,REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION,0.75910006097561
REACTOME_RHO_GTPASES_ACTIVAT...7,SET,33,0.26417,0.011184,0.15338,0.042513,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,0.75910006097561
GOMF_UBIQUITIN_LIKE_PROTEIN_...3,SET,34,0.24757,0.010639,0.14376,0.042533,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING,0.75910006097561
WANG_CLASSIC_ADIPOGENIC_TARG...,SET,27,0.29374,0.011251,0.17059,0.042548,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,0.75910006097561
GOBP_CORTICOSPINAL_TRACT_MOR...,SET,8,0.56898,0.011869,0.33054,0.042604,GOBP_CORTICOSPINAL_TRACT_MORPHOGENESIS,0.75910006097561
GOBP_NEGATIVE_REGULATION_OF_...686,SET,15,0.37507,0.010711,0.21791,0.042615,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.75910006097561
HP_SMALL_EPIPHYSES,SET,20,0.34937,0.011519,0.20303,0.042656,HP_SMALL_EPIPHYSES,0.75910006097561
MIR7852_3P,SET,66,0.18169,0.010869,0.10559,0.04266,MIR7852_3P,0.75910006097561
GSE15930_NAIVE_VS_24H_IN_VIT...5,SET,189,0.1004,0.010129,0.058348,0.042664,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN,0.75910006097561
GOBP_LACTATE_TRANSMEMBRANE_T...,SET,8,0.58837,0.012273,0.34195,0.042669,GOBP_LACTATE_TRANSMEMBRANE_TRANSPORT,0.75910006097561
QIU_PBMC_HEPTATITIS_B_SURFAC...1,SET,15,0.41765,0.011927,0.24277,0.042689,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP,0.75910006097561
GOBP_TRANSCRIPTION_ELONGATIO...2,SET,8,0.45007,0.0093882,0.26162,0.042695,GOBP_TRANSCRIPTION_ELONGATION_COUPLED_CHROMATIN_REMODELING,0.75910006097561
GOBP_ESTABLISHMENT_OF_LEFT_R...,SET,5,0.71152,0.011734,0.41361,0.0427,GOBP_ESTABLISHMENT_OF_LEFT_RIGHT_ASYMMETRY,0.75910006097561
MIR199A_3P_MIR199B_3P,SET,145,0.12284,0.010868,0.071406,0.042702,MIR199A_3P_MIR199B_3P,0.75910006097561
GOBP_PARAXIAL_MESODERM_MORPH...,SET,9,0.55613,0.012304,0.32335,0.042735,GOBP_PARAXIAL_MESODERM_MORPHOGENESIS,0.75910006097561
GOMF_N_ACETYLGLUCOSAMINE_6_O...,SET,6,0.63989,0.01156,0.37207,0.042744,GOMF_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY,0.75910006097561
GOMF_OXIDATIVE_RNA_DEMETHYLA...,SET,5,0.60276,0.0099408,0.35054,0.042769,GOMF_OXIDATIVE_RNA_DEMETHYLASE_ACTIVITY,0.75910006097561
GSE37301_PRO_BCELL_VS_RAG2_K...2,SET,164,0.11514,0.010828,0.066967,0.042782,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP,0.75910006097561
GOBP_GENITALIA_DEVELOPMENT,SET,46,0.23893,0.011939,0.13898,0.042801,GOBP_GENITALIA_DEVELOPMENT,0.75910006097561
HP_ABNORMALITY_OF_PATTERN_VI...,SET,5,0.79743,0.013151,0.46386,0.042803,HP_ABNORMALITY_OF_PATTERN_VISUAL_EVOKED_POTENTIALS,0.75910006097561
FEVR_CTNNB1_TARGETS_DN,SET,504,0.065375,0.010677,0.038036,0.042839,FEVR_CTNNB1_TARGETS_DN,0.75910006097561
WP_PRIMARY_OVARIAN_INSUFFICI...,SET,159,0.11251,0.01042,0.065473,0.04287,WP_PRIMARY_OVARIAN_INSUFFICIENCY,0.75910006097561
GOBP_FLOOR_PLATE_DEVELOPMENT,SET,10,0.44259,0.010321,0.25758,0.042881,GOBP_FLOOR_PLATE_DEVELOPMENT,0.75910006097561
GSE23321_EFFECTOR_MEMORY_VS_...1,SET,174,0.10245,0.0099218,0.059644,0.042929,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.75910006097561
WP_VITAMIN_B12_DISORDERS,SET,11,0.44459,0.010874,0.25883,0.042934,WP_VITAMIN_B12_DISORDERS,0.75910006097561
GSE40277_EOS_AND_LEF1_TRANSD...4,SET,179,0.11016,0.010819,0.064134,0.042937,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP,0.75910006097561
HP_ABNORMAL_LEUKOCYTE_COUNT,SET,436,0.070785,0.010773,0.041213,0.04295,HP_ABNORMAL_LEUKOCYTE_COUNT,0.75910006097561
RODRIGUES_THYROID_CARCINOMA_...2,SET,636,0.058976,0.01078,0.034342,0.042969,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP,0.75910006097561
DESCARTES_MAIN_FETAL_INTESTI...,SET,71,0.1783,0.011061,0.10383,0.04297,DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS,0.75910006097561
HP_NON_PERIODIC_RECURRENT_FE...,SET,11,0.44584,0.010904,0.25963,0.042978,HP_NON_PERIODIC_RECURRENT_FEVER,0.75910006097561
GSE39820_IL1B_IL6_VS_IL1B_IL...2,SET,181,0.11028,0.01089,0.06422,0.042984,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP,0.75910006097561
REACTOME_FORMATION_OF_THE_BE...,SET,31,0.26849,0.011018,0.1564,0.043027,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,0.759227899797571
HP_EEG_WITH_PHOTOPAROXYSMAL_...,SET,15,0.40639,0.011605,0.23684,0.0431,HP_EEG_WITH_PHOTOPAROXYSMAL_RESPONSE,0.759227899797571
LAMB3_TARGET_GENES,SET,5,0.6518,0.01075,0.37992,0.043125,LAMB3_TARGET_GENES,0.759227899797571
GOBP_RESPONSE_TO_ENDOPLASMIC...,SET,244,0.089836,0.010282,0.052367,0.043137,GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.759227899797571
EPC1_TARGET_GENES,SET,308,0.082757,0.010623,0.048241,0.043138,EPC1_TARGET_GENES,0.759227899797571
GSE10147_IL3_VS_IL3_AND_HIVP...1,SET,131,0.13391,0.011265,0.078061,0.043141,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN,0.759227899797571
REACTOME_RNA_POLYMERASE_I_PR...,SET,27,0.23943,0.0091703,0.13958,0.043154,REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,0.759227899797571
GSE27786_NKTCELL_VS_MONO_MAC...2,SET,175,0.10599,0.010293,0.061796,0.043166,GSE27786_NKTCELL_VS_MONO_MAC_UP,0.759227899797571
GOBP_MICROTUBULE_NUCLEATION_...,SET,5,0.65748,0.010843,0.38349,0.043232,GOBP_MICROTUBULE_NUCLEATION_BY_MICROTUBULE_ORGANIZING_CENTER,0.75963746966633
GOBP_PYRIMIDINE_RIBONUCLEOTI...1,SET,21,0.32106,0.010847,0.18727,0.043233,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.75963746966633
GOBP_REGULATION_OF_NUCLEOTID...6,SET,80,0.15919,0.01048,0.092884,0.043289,GOBP_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.759890618374558
MIR548AA_MIR548AP_3P_MIR548T...,SET,505,0.066532,0.010876,0.038824,0.043303,MIR548AA_MIR548AP_3P_MIR548T_3P,0.759890618374558
GSE3039_CD4_TCELL_VS_NKT_CEL...1,SET,180,0.1049,0.01033,0.061215,0.043313,GSE3039_CD4_TCELL_VS_NKT_CELL_DN,0.759890618374558
GOBP_ACTOMYOSIN_CONTRACTILE_...,SET,10,0.44305,0.010332,0.25868,0.043392,GOBP_ACTOMYOSIN_CONTRACTILE_RING_ORGANIZATION,0.760892512613522
GOBP_NATURAL_KILLER_CELL_PRO...,SET,14,0.44755,0.012348,0.26138,0.043435,GOBP_NATURAL_KILLER_CELL_PROLIFERATION,0.761262443267776
HP_ABNORMAL_SYNOVIAL_MEMBRAN...,SET,15,0.3907,0.011157,0.22824,0.043479,HP_ABNORMAL_SYNOVIAL_MEMBRANE_MORPHOLOGY,0.761649518649194
LI_ESTROGENE_NON_MCF7_T47D_E...1,SET,6,0.64422,0.011638,0.37642,0.043509,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_DN,0.761791080604534
GOBP_NEGATIVE_REGULATION_OF_...74,SET,126,0.13591,0.011214,0.079461,0.04361,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.762103880821232
GOBP_SPINDLE_ORGANIZATION,SET,184,0.10084,0.01004,0.058976,0.043648,GOBP_SPINDLE_ORGANIZATION,0.762103880821232
NELSON_RESPONSE_TO_ANDROGEN_...1,SET,17,0.42312,0.012863,0.24746,0.043654,NELSON_RESPONSE_TO_ANDROGEN_DN,0.762103880821232
CAMP_UP.V1_UP,SET,180,0.10347,0.01019,0.060516,0.043658,CAMP_UP.V1_UP,0.762103880821232
GOCC_ADHERENS_JUNCTION,SET,170,0.12033,0.01152,0.070384,0.04367,GOCC_ADHERENS_JUNCTION,0.762103880821232
HP_ABNORMAL_GRANULOCYTE_COUNT,SET,235,0.094813,0.010653,0.055457,0.043672,HP_ABNORMAL_GRANULOCYTE_COUNT,0.762103880821232
HP_MULTIFOCAL_EPILEPTIFORM_D...,SET,66,0.19326,0.011561,0.11305,0.04369,HP_MULTIFOCAL_EPILEPTIFORM_DISCHARGES,0.762103880821232
PLASARI_NFIC_TARGETS_BASAL_UP,SET,28,0.31648,0.012344,0.18518,0.043736,PLASARI_NFIC_TARGETS_BASAL_UP,0.762103880821232
GOBP_REGULATION_OF_DEVELOPME...1,SET,272,0.094671,0.011432,0.055403,0.043756,GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.762103880821232
GOBP_CALCIUM_INDEPENDENT_CEL...,SET,22,0.35721,0.012352,0.20906,0.043769,GOBP_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.762103880821232
GOCC_BRCA1_C_COMPLEX,SET,5,0.61234,0.010099,0.35842,0.043787,GOCC_BRCA1_C_COMPLEX,0.762103880821232
MIR4509,SET,60,0.19082,0.010886,0.1117,0.04379,MIR4509,0.762103880821232
GCM_RAF1,SET,37,0.21491,0.0096332,0.12583,0.043837,GCM_RAF1,0.762228091545773
GSE5589_UNSTIM_VS_45MIN_LPS_...4,SET,182,0.10523,0.01042,0.061613,0.043841,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP,0.762228091545773
GOBP_REGULATION_OF_NUCLEOCYT...,SET,108,0.13937,0.010652,0.081643,0.043917,GOBP_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.762818156614786
HP_HYPERPHOSPHATEMIA,SET,17,0.37083,0.011273,0.21732,0.043979,HP_HYPERPHOSPHATEMIA,0.762818156614786
GOBP_REGULATION_OF_SYNAPSE_A...,SET,105,0.15814,0.011919,0.092713,0.044038,GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY,0.762818156614786
BOSCO_EPITHELIAL_DIFFERENTIA...,SET,60,0.20601,0.011752,0.12078,0.044043,BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,0.762818156614786
MIR4690_3P,SET,57,0.18823,0.010467,0.11038,0.044077,MIR4690_3P,0.762818156614786
MATTHEWS_AP1_TARGETS,SET,17,0.3892,0.011832,0.22826,0.044098,MATTHEWS_AP1_TARGETS,0.762818156614786
HP_ABNORMAL_ORAL_PHYSIOLOGY,SET,286,0.089319,0.011055,0.052399,0.044145,HP_ABNORMAL_ORAL_PHYSIOLOGY,0.762818156614786
MIR329_3P,SET,106,0.14977,0.011342,0.087874,0.044164,MIR329_3P,0.762818156614786
HP_DUODENAL_ATRESIA,SET,39,0.23935,0.011014,0.14044,0.044174,HP_DUODENAL_ATRESIA,0.762818156614786
ABE_VEGFA_TARGETS_30MIN,SET,26,0.29821,0.011209,0.17503,0.044218,ABE_VEGFA_TARGETS_30MIN,0.762818156614786
GOBP_REGULATION_OF_CARDIOBLA...,SET,5,0.76003,0.012535,0.44612,0.044234,GOBP_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION,0.762818156614786
GOBP_CORPUS_CALLOSUM_DEVELOP...,SET,25,0.30616,0.011284,0.17972,0.044238,GOBP_CORPUS_CALLOSUM_DEVELOPMENT,0.762818156614786
GSE8921_3H_VS_24H_TLR1_2_STI...2,SET,175,0.10877,0.010563,0.063853,0.044252,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP,0.762818156614786
GOBP_CAMERA_TYPE_EYE_MORPHOG...,SET,127,0.13904,0.011518,0.081631,0.044264,GOBP_CAMERA_TYPE_EYE_MORPHOGENESIS,0.762818156614786
HP_CLEFT_SOFT_PALATE,SET,49,0.20202,0.010418,0.11865,0.04432,HP_CLEFT_SOFT_PALATE,0.762818156614786
HP_MALE_SEXUAL_DYSFUNCTION,SET,78,0.16847,0.010952,0.098949,0.044328,HP_MALE_SEXUAL_DYSFUNCTION,0.762818156614786
GOBP_REGULATION_OF_B_CELL_ME...,SET,52,0.20135,0.010695,0.11831,0.044405,GOBP_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.762818156614786
GOBP_PROSTATE_GLANDULAR_ACIN...2,SET,6,0.63664,0.011501,0.37416,0.044429,GOBP_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS,0.762818156614786
DESCARTES_FETAL_STOMACH_LYMP...2,SET,68,0.18258,0.011085,0.10733,0.044477,DESCARTES_FETAL_STOMACH_LYMPHOID_CELLS,0.762818156614786
BEGUM_TARGETS_OF_PAX3_FOXO1_...2,SET,46,0.2366,0.011822,0.1391,0.044488,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.762818156614786
HP_BRISK_REFLEXES,SET,99,0.13708,0.010034,0.080604,0.044512,HP_BRISK_REFLEXES,0.762818156614786
KEGG_MEDICUS_REFERENCE_MODIF...2,SET,5,0.56804,0.0093682,0.33407,0.044542,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_I_SUBUNITS,0.762818156614786
GOBP_CELLULAR_RESPONSE_TO_RA...,SET,161,0.11002,0.010252,0.064704,0.044542,GOBP_CELLULAR_RESPONSE_TO_RADIATION,0.762818156614786
GOBP_RESPONSE_TO_FOLIC_ACID,SET,9,0.58205,0.012877,0.34232,0.044546,GOBP_RESPONSE_TO_FOLIC_ACID,0.762818156614786
MIR4486,SET,34,0.23803,0.010229,0.14001,0.044573,MIR4486,0.762818156614786
GOBP_NEGATIVE_REGULATION_OF_...249,SET,14,0.39469,0.010889,0.23218,0.044577,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_METHYLATION,0.762818156614786
HP_APLASIA_HYPOPLASIA_OF_THE...27,SET,47,0.20869,0.01054,0.12277,0.044583,HP_APLASIA_HYPOPLASIA_OF_THE_EARLOBES,0.762818156614786
GOBP_ENTRY_OF_BACTERIUM_INTO...,SET,9,0.45979,0.010172,0.27048,0.044585,GOBP_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,0.762818156614786
GOBP_RIBOSOMAL_SMALL_SUBUNIT...2,SET,93,0.14411,0.010225,0.084785,0.044603,GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS,0.762818156614786
GOBP_POSITIVE_REGULATION_OF_...839,SET,30,0.24564,0.0099164,0.14452,0.044609,GOBP_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.762818156614786
GOBP_HYALURONAN_METABOLIC_PR...,SET,32,0.26209,0.010927,0.1542,0.044611,GOBP_HYALURONAN_METABOLIC_PROCESS,0.762818156614786
GSE11864_UNTREATED_VS_CSF1_I...2,SET,165,0.11243,0.010605,0.066159,0.04463,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP,0.762818156614786
REACTOME_FORMATION_OF_THE_EA...,SET,32,0.21726,0.009058,0.12786,0.044642,REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX,0.762818156614786
GSE43863_DAY6_EFF_VS_DAY150_...5,SET,184,0.11418,0.011367,0.067207,0.044676,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN,0.762818156614786
KEGG_TGF_BETA_SIGNALING_PATH...,SET,84,0.16156,0.010898,0.095128,0.044727,KEGG_TGF_BETA_SIGNALING_PATHWAY,0.762818156614786
GOBP_SENSORY_PERCEPTION_OF_M...,SET,171,0.12022,0.011543,0.070795,0.044745,GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS,0.762818156614786
GSE21670_UNTREATED_VS_IL6_TR...2,SET,169,0.10707,0.01022,0.063053,0.044754,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP,0.762818156614786
GOBP_NEGATIVE_REGULATION_OF_...506,SET,814,0.052403,0.010782,0.030863,0.04477,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.762818156614786
GSE11057_PBMC_VS_MEM_CD4_TCE...1,SET,165,0.11229,0.010592,0.066144,0.044799,GSE11057_PBMC_VS_MEM_CD4_TCELL_DN,0.762818156614786
GCM_PPM1D,SET,23,0.29335,0.010371,0.17281,0.04481,GCM_PPM1D,0.762818156614786
GOMF_RNA_POLYMERASE_BINDING,SET,56,0.19629,0.010819,0.11566,0.044846,GOMF_RNA_POLYMERASE_BINDING,0.762818156614786
MIZUKAMI_HYPOXIA_DN,SET,6,0.64228,0.011603,0.37854,0.044885,MIZUKAMI_HYPOXIA_DN,0.762818156614786
LANDIS_BREAST_CANCER_PROGRES...2,SET,40,0.22848,0.010648,0.13467,0.0449,LANDIS_BREAST_CANCER_PROGRESSION_UP,0.762818156614786
GOBP_SOMITE_SPECIFICATION,SET,4,0.76137,0.011231,0.44883,0.04492,GOBP_SOMITE_SPECIFICATION,0.762818156614786
HP_CEREBRAL_INCLUSION_BODIES,SET,45,0.22203,0.010973,0.13089,0.044923,HP_CEREBRAL_INCLUSION_BODIES,0.762818156614786
GSE18791_UNSTIM_VS_NEWCATSLE...5,SET,159,0.11455,0.010609,0.067538,0.044941,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN,0.762818156614786
HP_ABNORMAL_DURA_MATER_MORPH...,SET,23,0.29957,0.010591,0.17664,0.044954,HP_ABNORMAL_DURA_MATER_MORPHOLOGY,0.762818156614786
CAR_IGFBP1,SET,55,0.21765,0.011889,0.12834,0.044958,CAR_IGFBP1,0.762818156614786
GOMF_SOLUTE_PROTON_SYMPORTER...,SET,24,0.32324,0.011674,0.1906,0.04496,GOMF_SOLUTE_PROTON_SYMPORTER_ACTIVITY,0.762818156614786
MIR4531,SET,303,0.085839,0.010931,0.050624,0.044987,MIR4531,0.762818156614786
KEGG_MEDICUS_REFERENCE_WNT_S...2,SET,13,0.45291,0.012041,0.26719,0.045038,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4,0.762818156614786
KEGG_MEDICUS_REFERENCE_N_GLY...3,SET,5,0.56321,0.0092885,0.33226,0.045039,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG7_TO_ALG11,0.762818156614786
HWANG_PROSTATE_CANCER_MARKERS,SET,25,0.2898,0.010681,0.17099,0.045064,HWANG_PROSTATE_CANCER_MARKERS,0.762818156614786
GSE3982_MAST_CELL_VS_MAC_UP,SET,175,0.10687,0.010379,0.063056,0.045066,GSE3982_MAST_CELL_VS_MAC_UP,0.762818156614786
WEBER_METHYLATED_IN_COLON_CA...,SET,18,0.37361,0.011687,0.2205,0.045107,WEBER_METHYLATED_IN_COLON_CANCER,0.762818156614786
GSE22601_IMMATURE_CD4_SINGLE...2,SET,179,0.10163,0.0099813,0.059987,0.045118,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.762818156614786
BCAT.100_UP.V1_UP,SET,45,0.24849,0.012281,0.14667,0.045126,BCAT.100_UP.V1_UP,0.762818156614786
REACTOME_PIWI_INTERACTING_RN...,SET,29,0.23906,0.0094887,0.14114,0.045164,REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS,0.763089363150219
GOBP_RNA_SPLICING_VIA_TRANSE...,SET,270,0.080647,0.009703,0.04763,0.045218,GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS,0.76312532038835
MORF_GNB1,SET,272,0.085547,0.01033,0.050525,0.04522,MORF_GNB1,0.76312532038835
MIR3924,SET,306,0.085773,0.010975,0.050662,0.045232,MIR3924,0.76312532038835
HP_NEOPLASM_OF_THE_ENDOCRINE...,SET,150,0.11892,0.0107,0.070281,0.045322,HP_NEOPLASM_OF_THE_ENDOCRINE_SYSTEM,0.763637128378378
GCM_APEX1,SET,102,0.13283,0.009868,0.078501,0.045326,GCM_APEX1,0.763637128378378
AGGTGCA_MIR500,SET,82,0.15879,0.010583,0.093866,0.045364,AGGTGCA_MIR500,0.763637128378378
GSE22886_NAIVE_CD4_TCELL_VS_...5,SET,182,0.10228,0.010128,0.060477,0.045407,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN,0.763637128378378
MIDORIKAWA_AMPLIFIED_IN_LIVE...,SET,51,0.29731,0.01564,0.17583,0.045434,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,0.763637128378378
GOBP_NEPHRIC_DUCT_DEVELOPMENT,SET,14,0.4234,0.011681,0.25048,0.045489,GOBP_NEPHRIC_DUCT_DEVELOPMENT,0.763637128378378
REACTOME_DISEASES_OF_GLYCOSY...,SET,130,0.12904,0.010815,0.076343,0.045491,REACTOME_DISEASES_OF_GLYCOSYLATION,0.763637128378378
GSE26030_TH1_VS_TH17_RESTIMU...4,SET,187,0.10557,0.010595,0.062457,0.045491,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP,0.763637128378378
GOBP_COBALAMIN_TRANSPORT,SET,8,0.50299,0.010492,0.2976,0.045509,GOBP_COBALAMIN_TRANSPORT,0.763637128378378
HP_ONYCHOGRYPOSIS_OF_FINGERN...,SET,9,0.46807,0.010356,0.27695,0.045512,HP_ONYCHOGRYPOSIS_OF_FINGERNAIL,0.763637128378378
PAX4_03,SET,234,0.09652,0.010822,0.057111,0.045518,PAX4_03,0.763637128378378
MIR548AT_3P,SET,56,0.19128,0.010542,0.11318,0.045526,MIR548AT_3P,0.763637128378378
GOMF_PROCOLLAGEN_PROLINE_DIO...,SET,8,0.43203,0.0090119,0.25586,0.045661,GOMF_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY,0.765246170520231
ACACTCC_MIR122A,SET,68,0.16662,0.010117,0.09869,0.045682,ACACTCC_MIR122A,0.765246170520231
GOCC_CEREBELLAR_MOSSY_FIBER,SET,7,0.56879,0.011099,0.33693,0.045699,GOCC_CEREBELLAR_MOSSY_FIBER,0.765246170520231
WP_SOMITOGENESIS_IN_THE_CONT...,SET,9,0.48482,0.010726,0.28721,0.04571,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,0.765246170520231
GSE7568_IL4_VS_IL4_AND_DEXAM...2,SET,149,0.1104,0.0099007,0.065415,0.045739,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP,0.765362997111218
LI_PBMC_MENACTRA_AGE_18_45YO...6,SET,27,0.31335,0.012002,0.18574,0.045805,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_NEGATIVE,0.76609854427334
GSE23502_BM_VS_COLON_TUMOR_M...2,SET,184,0.11517,0.011466,0.068288,0.045856,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.766582626262626
GSE15330_HSC_VS_MEGAKARYOCYT...1,SET,150,0.11778,0.010598,0.069876,0.045943,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.766699279580153
HE_LIM_SUN_FETAL_LUNG_C7_PRO...,SET,909,0.04827,0.010466,0.028645,0.045993,HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL,0.766699279580153
AMIT_EGF_RESPONSE_240_HELA,SET,56,0.19929,0.010984,0.11829,0.04602,AMIT_EGF_RESPONSE_240_HELA,0.766699279580153
HP_ABNORMAL_ORAL_GLUCOSE_TOL...,SET,15,0.39861,0.011383,0.23662,0.046042,HP_ABNORMAL_ORAL_GLUCOSE_TOLERANCE,0.766699279580153
MIR887_3P,SET,5,0.68665,0.011324,0.4077,0.046081,MIR887_3P,0.766699279580153
MODULE_195,SET,138,0.12255,0.010579,0.072763,0.046084,MODULE_195,0.766699279580153
HP_ABNORMAL_PREIMPLANTATION_...,SET,6,0.49401,0.0089247,0.29339,0.046117,HP_ABNORMAL_PREIMPLANTATION_EMBRYONIC_DEVELOPMENT,0.766699279580153
HP_HIP_OSTEOARTHRITIS,SET,17,0.40005,0.012161,0.2376,0.046132,HP_HIP_OSTEOARTHRITIS,0.766699279580153
GNF2_HMMR,SET,47,0.20922,0.010567,0.12426,0.046134,GNF2_HMMR,0.766699279580153
GOCC_DENDRITIC_SHAFT,SET,39,0.23563,0.010843,0.13996,0.046139,GOCC_DENDRITIC_SHAFT,0.766699279580153
GOCC_SEH1_ASSOCIATED_COMPLEX,SET,12,0.39938,0.010202,0.23722,0.046139,GOCC_SEH1_ASSOCIATED_COMPLEX,0.766699279580153
chr1q31,SET,30,0.37364,0.015084,0.22194,0.046146,chr1q31,0.766699279580153
HP_HYDROXYPROLINEMIA,SET,5,0.80656,0.013302,0.47926,0.046206,HP_HYDROXYPROLINEMIA,0.766699279580153
RPS14_DN.V1_DN,SET,167,0.10903,0.010346,0.064792,0.04621,RPS14_DN.V1_DN,0.766699279580153
TESAR_ALK_TARGETS_HUMAN_ES_4...,SET,4,0.72132,0.01064,0.42865,0.046219,TESAR_ALK_TARGETS_HUMAN_ES_4D_DN,0.766699279580153
TSUDA_ALVEOLAR_SOFT_PART_SAR...,SET,10,0.4736,0.011044,0.28146,0.046231,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,0.766699279580153
BIOCARTA_AMAN_PATHWAY,SET,15,0.40082,0.011446,0.23822,0.046238,BIOCARTA_AMAN_PATHWAY,0.766699279580153
HP_POLYURIA,SET,35,0.25677,0.011195,0.15264,0.046267,HP_POLYURIA,0.766814298998569
GSE6092_B_BURGDOFERI_VS_B_BU...2,SET,160,0.11415,0.010605,0.067908,0.046393,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP,0.76790345
MIKKELSEN_ES_ICP_WITH_H3K4ME3,SET,619,0.058732,0.010596,0.034941,0.046398,MIKKELSEN_ES_ICP_WITH_H3K4ME3,0.76790345
MIR6873_3P,SET,340,0.082104,0.011064,0.048845,0.046399,MIR6873_3P,0.76790345
HP_IMPAIRED_OXIDATIVE_BURST,SET,5,0.71659,0.011818,0.42644,0.046448,HP_IMPAIRED_OXIDATIVE_BURST,0.767993084045584
GOBP_HAIR_CELL_DIFFERENTIATI...,SET,50,0.215,0.011199,0.12797,0.046479,GOBP_HAIR_CELL_DIFFERENTIATION,0.767993084045584
REACTOME_SIGNALING_BY_WNT_IN...,SET,32,0.26115,0.010888,0.15546,0.046498,REACTOME_SIGNALING_BY_WNT_IN_CANCER,0.767993084045584
REACTOME_MECP2_REGULATES_TRA...1,SET,4,0.8404,0.012397,0.50031,0.046512,REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS,0.767993084045584
VERNELL_RETINOBLASTOMA_PATHW...1,SET,19,0.33242,0.010683,0.19791,0.046522,VERNELL_RETINOBLASTOMA_PATHWAY_DN,0.767993084045584
GOBP_NEGATIVE_REGULATION_OF_...707,SET,157,0.1194,0.010989,0.071093,0.046537,GOBP_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.767993084045584
GOBP_POSITIVE_REGULATION_OF_...700,SET,28,0.28002,0.010922,0.16677,0.046577,GOBP_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.768284900426743
REACTOME_FGFR2_MUTANT_RECEPT...,SET,32,0.25328,0.01056,0.15087,0.046605,REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,0.768284900426743
GOMF_NADPLUS_NUCLEOSIDASE_AC...,SET,9,0.61556,0.013619,0.36671,0.046621,GOMF_NADPLUS_NUCLEOSIDASE_ACTIVITY,0.768284900426743
GOCC_AXONEMAL_B_TUBULE_INNER...,SET,5,0.74515,0.012289,0.44404,0.046669,GOCC_AXONEMAL_B_TUBULE_INNER_SHEATH,0.76871141943128
SETLUR_PROSTATE_CANCER_TMPRS...2,SET,66,0.17575,0.010513,0.10476,0.046718,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,0.768747889411765
GGCNNMSMYNTTG_UNKNOWN,SET,69,0.17014,0.010405,0.10142,0.046723,GGCNNMSMYNTTG_UNKNOWN,0.768747889411765
MIR4793_3P,SET,68,0.17605,0.010689,0.10497,0.046761,MIR4793_3P,0.768747889411765
GAUCHER_PBMC_YF_VAX_STAMARIL...4,SET,53,0.20139,0.0108,0.12008,0.046762,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_UP,0.768747889411765
GSE360_DC_VS_MAC_B_MALAYI_HI...1,SET,181,0.10669,0.010536,0.063642,0.04684,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN,0.768747889411765
MCLACHLAN_DENTAL_CARIES_UP,SET,214,0.10878,0.01167,0.064899,0.046859,MCLACHLAN_DENTAL_CARIES_UP,0.768747889411765
GOBP_MATURE_B_CELL_DIFFERENT...1,SET,35,0.25196,0.010985,0.15034,0.046883,GOBP_MATURE_B_CELL_DIFFERENTIATION,0.768747889411765
GOBP_POSITIVE_REGULATION_OF_...525,SET,8,0.54365,0.01134,0.32444,0.04691,GOBP_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.768747889411765
GSE29164_DAY3_VS_DAY7_CD8_TC...4,SET,183,0.10502,0.010427,0.062681,0.046938,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP,0.768747889411765
KEGG_MEDICUS_REFERENCE_NOTCH...2,SET,6,0.59284,0.01071,0.35385,0.046939,KEGG_MEDICUS_REFERENCE_NOTCH_MESP2_SIGNALING,0.768747889411765
HP_ABNORMAL_CIRCULATING_IGM_...,SET,94,0.15088,0.010763,0.090067,0.046958,HP_ABNORMAL_CIRCULATING_IGM_LEVEL,0.768747889411765
GOBP_OSTEOBLAST_DEVELOPMENT,SET,16,0.36882,0.010878,0.22019,0.046973,GOBP_OSTEOBLAST_DEVELOPMENT,0.768747889411765
HP_CONGENITAL_LARYNGEAL_STRI...,SET,7,0.52434,0.010231,0.31304,0.046977,HP_CONGENITAL_LARYNGEAL_STRIDOR,0.768747889411765
WEBER_METHYLATED_LCP_IN_SPER...1,SET,6,0.6058,0.010944,0.36169,0.046986,WEBER_METHYLATED_LCP_IN_SPERM_DN,0.768747889411765
GOBP_CELL_DIFFERENTIATION_IN...6,SET,47,0.23079,0.011656,0.13781,0.047003,GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD,0.768747889411765
GOBP_CEREBELLAR_CORTEX_DEVEL...,SET,46,0.21182,0.010584,0.12655,0.04709,GOBP_CEREBELLAR_CORTEX_DEVELOPMENT,0.769556343353687
GSE360_LOW_DOSE_B_MALAYI_VS_...3,SET,181,0.10402,0.010272,0.062149,0.047109,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.769556343353687
GOBP_CELLULAR_RESPONSE_TO_HY...3,SET,4,0.75889,0.011195,0.45352,0.047138,GOBP_CELLULAR_RESPONSE_TO_HYPEROXIA,0.769556343353687
GOBP_REGULATION_OF_ANIMAL_OR...1,SET,26,0.32156,0.012086,0.19217,0.047141,GOBP_REGULATION_OF_ANIMAL_ORGAN_FORMATION,0.769556343353687
GSE13229_IMM_VS_INTMATURE_NK...2,SET,180,0.10863,0.010698,0.06496,0.047242,GSE13229_IMM_VS_INTMATURE_NKCELL_UP,0.770494875703565
GOBP_POSITIVE_REGULATION_OF_...773,SET,9,0.46871,0.01037,0.28029,0.047249,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.770494875703565
HP_ABNORMALITY_OF_THE_SUBUNG...,SET,11,0.39944,0.0097694,0.23889,0.047265,HP_ABNORMALITY_OF_THE_SUBUNGUAL_REGION,0.770494875703565
VALK_AML_WITH_FLT3_ITD,SET,36,0.25755,0.011388,0.1541,0.047337,VALK_AML_WITH_FLT3_ITD,0.771306814345991
GOBP_POSITIVE_REGULATION_OF_...643,SET,4,0.78469,0.011575,0.4696,0.047371,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.771499111996251
GSE360_L_MAJOR_VS_T_GONDII_M...2,SET,179,0.10951,0.010755,0.065551,0.047405,GSE360_L_MAJOR_VS_T_GONDII_MAC_UP,0.771691229508197
KEGG_HEDGEHOG_SIGNALING_PATH...,SET,54,0.20339,0.011009,0.12178,0.047454,KEGG_HEDGEHOG_SIGNALING_PATHWAY,0.771795084190833
MIR4759,SET,46,0.20404,0.010195,0.12218,0.047468,MIR4759,0.771795084190833
GOBP_PHAGOCYTOSIS_RECOGNITION,SET,27,0.30592,0.011717,0.1832,0.047478,GOBP_PHAGOCYTOSIS_RECOGNITION,0.771795084190833
MIR3677_3P,SET,5,0.64565,0.010648,0.38682,0.047555,MIR3677_3P,0.772300882352941
GOBP_CELLULAR_DETOXIFICATION...,SET,9,0.48822,0.010801,0.29254,0.047577,GOBP_CELLULAR_DETOXIFICATION_OF_ALDEHYDE,0.772300882352941
TCGATGG_MIR213,SET,5,0.59844,0.0098696,0.35859,0.047581,TCGATGG_MIR213,0.772300882352941
GOBP_PROTEIN_O_LINKED_FUCOSY...,SET,4,0.60107,0.0088667,0.3602,0.047598,GOBP_PROTEIN_O_LINKED_FUCOSYLATION,0.772300882352941
GOBP_XYLULOSE_5_PHOSPHATE_ME...,SET,6,0.61354,0.011084,0.36778,0.047643,GOBP_XYLULOSE_5_PHOSPHATE_METABOLIC_PROCESS,0.772516965034965
GOBP_POSITIVE_REGULATION_OF_...299,SET,45,0.24613,0.012164,0.14755,0.047658,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.772516965034965
HP_APLASIA_HYPOPLASIA_OF_THE...43,SET,21,0.34736,0.011735,0.20826,0.047678,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_5TH_FINGER,0.772516965034965
PAX6_TARGET_GENES,SET,695,0.05559,0.010604,0.033352,0.047791,PAX6_TARGET_GENES,0.77373561452514
GOBP_COLLAGEN_CATABOLIC_PROC...,SET,39,0.25861,0.011901,0.15517,0.047806,GOBP_COLLAGEN_CATABOLIC_PROCESS,0.77373561452514
GOBP_NEGATIVE_REGULATION_OF_...417,SET,57,0.18771,0.010438,0.11264,0.04782,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.77373561452514
PAX4_01,SET,247,0.090903,0.010467,0.054584,0.047928,PAX4_01,0.775122214983713
HP_ABNORMAL_ANKLE_MORPHOLOGY,SET,87,0.15561,0.010681,0.0935,0.048033,HP_ABNORMAL_ANKLE_MORPHOLOGY,0.776459030232558
BROWNE_HCMV_INFECTION_48HR_UP,SET,168,0.11023,0.010491,0.066257,0.04809,BROWNE_HCMV_INFECTION_48HR_UP,0.77652323269856
GOBP_DIGESTIVE_SYSTEM_DEVELO...,SET,140,0.12806,0.011135,0.076975,0.048093,GOBP_DIGESTIVE_SYSTEM_DEVELOPMENT,0.77652323269856
HP_VAGINAL_ATRESIA,SET,18,0.37916,0.01186,0.22791,0.048104,HP_VAGINAL_ATRESIA,0.77652323269856
GOBP_NUCLEOTIDE_EXCISION_REP...2,SET,6,0.46174,0.0083417,0.27767,0.048176,GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING,0.776554017113784
GOBP_PHOSPHATIDYLINOSITOL_AC...,SET,6,0.67143,0.01213,0.40379,0.048183,GOBP_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING,0.776554017113784
BUYTAERT_PHOTODYNAMIC_THERAP...1,SET,578,0.058772,0.010258,0.035348,0.048199,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN,0.776554017113784
GOMF_VITAMIN_BINDING,SET,133,0.1272,0.010781,0.076511,0.048221,GOMF_VITAMIN_BINDING,0.776554017113784
GOBP_PROCESS_UTILIZING_AUTOP...,SET,541,0.060613,0.010245,0.036472,0.048278,GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM,0.776554017113784
GSE5679_CTRL_VS_RARA_AGONIST...2,SET,179,0.10208,0.010025,0.061429,0.048285,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.776554017113784
GSE44955_MCSF_VS_MCSF_AND_IL...2,SET,175,0.10747,0.010437,0.064672,0.048293,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP,0.776554017113784
KEGG_MEDICUS_REFERENCE_PRE_I...,SET,27,0.25148,0.0096319,0.15134,0.048295,KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION,0.776554017113784
MIR326,SET,115,0.1362,0.01074,0.081968,0.048307,MIR326,0.776554017113784
CAAGGAT_MIR362,SET,59,0.17716,0.010022,0.10665,0.048358,CAAGGAT_MIR362,0.776816007393715
MARSON_BOUND_BY_E2F4_UNSTIMU...,SET,613,0.059408,0.010667,0.035767,0.048368,MARSON_BOUND_BY_E2F4_UNSTIMULATED,0.776816007393715
HP_MULTIPLE_GLOMERULAR_CYSTS,SET,3,0.87846,0.011223,0.52896,0.048394,HP_MULTIPLE_GLOMERULAR_CYSTS,0.776874581986143
chr12q14,SET,32,0.4228,0.017627,0.25467,0.048445,chr12q14,0.777334245152355
MULLIGHAN_NPM1_SIGNATURE_3_DN,SET,143,0.11594,0.010187,0.069857,0.048495,MULLIGHAN_NPM1_SIGNATURE_3_DN,0.777777445777573
BLANCO_MELO_COVID19_BRONCHIA...1,SET,49,0.21665,0.011172,0.13056,0.048529,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,0.777963743081181
GOBP_NEGATIVE_REGULATION_OF_...346,SET,54,0.19585,0.010601,0.11808,0.048607,GOBP_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.778345508982036
GSE39820_CTRL_VS_TGFBETA3_IL...4,SET,173,0.10192,0.0098417,0.061448,0.048608,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP,0.778345508982036
HP_GAIT_ATAXIA,SET,217,0.094853,0.010246,0.057193,0.04862,HP_GAIT_ATAXIA,0.778345508982036
GSE16450_CTRL_VS_IFNA_12H_ST...3,SET,189,0.09987,0.010076,0.060237,0.048672,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.778817119341564
SEITZ_NEOPLASTIC_TRANSFORMAT...2,SET,67,0.19442,0.011718,0.1173,0.048723,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,0.778817119341564
GOCC_B_WICH_COMPLEX,SET,7,0.50683,0.0098896,0.3059,0.048786,GOCC_B_WICH_COMPLEX,0.778817119341564
GSE16266_LPS_VS_HEATSHOCK_AN...2,SET,182,0.10954,0.010846,0.066113,0.048789,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.778817119341564
GSE40225_WT_VS_RIP_B7X_DIABE...2,SET,167,0.10547,0.010008,0.063656,0.048789,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP,0.778817119341564
GSE12392_WT_VS_IFNB_KO_CD8A_...1,SET,185,0.10728,0.01071,0.064756,0.048795,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN,0.778817119341564
GOBP_RENAL_ALBUMIN_ABSORPTION,SET,7,0.61606,0.012021,0.37191,0.048823,GOBP_RENAL_ALBUMIN_ABSORPTION,0.778817119341564
WALLACE_PROSTATE_CANCER_DN,SET,5,0.71865,0.011852,0.4339,0.048841,WALLACE_PROSTATE_CANCER_DN,0.778817119341564
GOBP_MESONEPHROS_DEVELOPMENT,SET,97,0.15644,0.011336,0.094473,0.048873,GOBP_MESONEPHROS_DEVELOPMENT,0.778817119341564
GOBP_TYROSINE_PHOSPHORYLATIO...,SET,74,0.17074,0.010812,0.10311,0.048878,GOBP_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.778817119341564
HP_ABNORMALITY_OF_CIRCULATIN...2,SET,62,0.18314,0.01062,0.11065,0.048953,HP_ABNORMALITY_OF_CIRCULATING_GLUCOCORTICOID_LEVEL,0.778817119341564
GOBP_ATTACHMENT_OF_GPI_ANCHO...,SET,6,0.49359,0.0089171,0.29822,0.048955,GOBP_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN,0.778817119341564
GSE5679_CTRL_VS_PPARG_LIGAND...1,SET,178,0.10882,0.010657,0.065749,0.048968,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.778817119341564
GOBP_REGULATION_OF_ASPARTIC_...1,SET,6,0.63101,0.0114,0.38132,0.048988,GOBP_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.778817119341564
MEIS1_01,SET,225,0.095795,0.010534,0.05789,0.048993,MEIS1_01,0.778817119341564
GSE37301_HEMATOPOIETIC_STEM_...10,SET,185,0.10654,0.010635,0.064388,0.049008,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP,0.778817119341564
GOBP_VESICLE_MEDIATED_TRANSP...1,SET,1412,0.039235,0.010449,0.023717,0.049042,GOBP_VESICLE_MEDIATED_TRANSPORT,0.778835893101873
GSE5455_HEALTHY_VS_TUMOR_BEA...4,SET,178,0.10587,0.010369,0.064001,0.049054,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP,0.778835893101873
MIR24_1_5P_MIR24_2_5P,SET,42,0.20842,0.0099522,0.12605,0.049125,MIR24_1_5P_MIR24_2_5P,0.779607020547945
MODULE_414,SET,8,0.58651,0.012234,0.35478,0.049157,MODULE_414,0.779758801916933
PID_PS1_PATHWAY,SET,42,0.23151,0.011055,0.14007,0.049192,PID_PS1_PATHWAY,0.779958010948905
HP_EMG_DECREMENTAL_RESPONSE_...,SET,28,0.25146,0.0098077,0.15219,0.049248,HP_EMG_DECREMENTAL_RESPONSE_OF_COMPOUND_MUSCLE_ACTION_POTENTIAL_TO_REPETITIVE_NERVE_STIMULATION,0.780023361325465
GOBP_ALCOHOL_CATABOLIC_PROCE...,SET,32,0.27916,0.011639,0.16896,0.049256,GOBP_ALCOHOL_CATABOLIC_PROCESS,0.780023361325465
MIR4433A_5P,SET,43,0.21814,0.010539,0.13207,0.049303,MIR4433A_5P,0.780023361325465
GSE21360_NAIVE_VS_QUATERNARY...2,SET,188,0.10258,0.010322,0.062114,0.049329,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.780023361325465
CDP_02,SET,97,0.15298,0.011085,0.092638,0.049336,CDP_02,0.780023361325465
GSE43863_NAIVE_VS_MEMORY_LY6...2,SET,174,0.10815,0.010473,0.065517,0.049407,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP,0.780023361325465
HP_ABNORMAL_VITREOUS_HUMOR_M...,SET,42,0.21741,0.010381,0.13171,0.049411,HP_ABNORMAL_VITREOUS_HUMOR_MORPHOLOGY,0.780023361325465
GSE26928_EFF_MEMORY_VS_CXCR5...2,SET,164,0.11077,0.010417,0.067109,0.049417,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,0.780023361325465
GOBP_POSITIVE_REGULATION_OF_...768,SET,31,0.24414,0.010019,0.14792,0.049424,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.780023361325465
WP_NUCLEAR_RECEPTORS_METAPAT...,SET,300,0.087858,0.011133,0.053231,0.049427,WP_NUCLEAR_RECEPTORS_METAPATHWAY,0.780023361325465
KAN_RESPONSE_TO_ARSENIC_TRIO...,SET,108,0.14904,0.011392,0.090307,0.049443,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,0.780023361325465
GSE5589_WT_VS_IL6_KO_LPS_STI...1,SET,129,0.12856,0.010733,0.077942,0.049544,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.780453497057492
HP_FLANK_PAIN,SET,14,0.36574,0.010091,0.22178,0.049573,HP_FLANK_PAIN,0.780453497057492
GOBP_LEUKOTRIENE_SIGNALING_P...,SET,4,0.60881,0.0089808,0.36918,0.049574,GOBP_LEUKOTRIENE_SIGNALING_PATHWAY,0.780453497057492
TAGGTCA_MIR192_MIR215,SET,36,0.22471,0.0099358,0.13628,0.049588,TAGGTCA_MIR192_MIR215,0.780453497057492
GOBP_AXON_MIDLINE_CHOICE_POI...,SET,5,0.81487,0.013439,0.49419,0.049594,GOBP_AXON_MIDLINE_CHOICE_POINT_RECOGNITION,0.780453497057492
GSE15659_TREG_VS_TCONV_UP,SET,150,0.11551,0.010393,0.070057,0.049605,GSE15659_TREG_VS_TCONV_UP,0.780453497057492
MIR378G,SET,79,0.15673,0.010254,0.095073,0.049634,MIR378G,0.780556411764706
GAVISH_3CA_METAPROGRAM_FIBRO...4,SET,38,0.25145,0.011422,0.15264,0.049758,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3,0.781774838286713
HP_MYOCLONIC_SEIZURE,SET,210,0.096833,0.010292,0.058791,0.049781,HP_MYOCLONIC_SEIZURE,0.781774838286713
MIR4451,SET,133,0.12341,0.010461,0.07494,0.049804,MIR4451,0.781774838286713
REACTOME_SYNTHESIS_OF_BILE_A...4,SET,23,0.32338,0.011433,0.19639,0.049825,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,0.781774838286713
GOMF_CHEMOATTRACTANT_ACTIVITY,SET,32,0.25997,0.010839,0.15792,0.049867,GOMF_CHEMOATTRACTANT_ACTIVITY,0.781774838286713
GOCC_SCHAFFER_COLLATERAL_CA1...,SET,88,0.15589,0.010762,0.094703,0.049876,GOCC_SCHAFFER_COLLATERAL_CA1_SYNAPSE,0.781774838286713
GOBP_POSITIVE_REGULATION_OF_...321,SET,183,0.11202,0.011122,0.068052,0.049882,GOBP_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY,0.781774838286713
GOBP_EMBRYONIC_PATTERN_SPECI...,SET,63,0.18893,0.011043,0.11478,0.049892,GOBP_EMBRYONIC_PATTERN_SPECIFICATION,0.781774838286713
MIR4692,SET,202,0.099619,0.010387,0.060537,0.049934,MIR4692,0.781774838286713
STONER_ESOPHAGEAL_CARCINOGEN...1,SET,6,0.56504,0.010208,0.34347,0.049983,STONER_ESOPHAGEAL_CARCINOGENESIS_DN,0.781774838286713
REACTOME_DNA_REPLICATION_INI...,SET,7,0.41913,0.0081784,0.25481,0.050006,REACTOME_DNA_REPLICATION_INITIATION,0.781774838286713
GOBP_CIRCULATORY_SYSTEM_DEVE...,SET,1047,0.046632,0.010809,0.028357,0.050049,GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT,0.781774838286713
HOEK_MYELOID_DENDRITIC_CELL_...3,SET,16,0.33703,0.0099401,0.20495,0.050051,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_DN,0.781774838286713
GSE32986_GMCSF_AND_CURDLAN_L...2,SET,178,0.10365,0.010151,0.063045,0.050094,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.781774838286713
GOBP_POSITIVE_REGULATION_OF_...834,SET,156,0.11958,0.01097,0.072739,0.050107,GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.781774838286713
QI_PBMC_ZOSTAVAX_AGE_50_75YO...7,SET,13,0.42501,0.0113,0.25863,0.05017,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_1D_INFORMATIVE_OF_LONG_TERM_RESPONSES_NEGATIVE,0.781774838286713
GOBP_POSITIVE_REGULATION_OF_...416,SET,6,0.60022,0.010843,0.36526,0.050173,GOBP_POSITIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.781774838286713
HP_ABNORMAL_NUMBER_OF_VERTEB...,SET,3,0.73573,0.0093993,0.44785,0.050219,HP_ABNORMAL_NUMBER_OF_VERTEBRAE,0.781774838286713
GOBP_AMINE_BIOSYNTHETIC_PROC...,SET,35,0.23531,0.010259,0.14324,0.050225,GOBP_AMINE_BIOSYNTHETIC_PROCESS,0.781774838286713
REACTOME_PHYSIOLOGICAL_FACTO...,SET,14,0.40168,0.011082,0.24454,0.050243,REACTOME_PHYSIOLOGICAL_FACTORS,0.781774838286713
GAVISH_3CA_MALIGNANT_METAPRO...1,SET,41,0.23775,0.011217,0.14482,0.050334,GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION,0.781774838286713
FAN_OVARY_CL5_HEALTHY_SELECT...,SET,283,0.088485,0.010895,0.053922,0.05041,FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL,0.781774838286713
HP_SUBCORTICAL_CEREBRAL_ATRO...,SET,25,0.29336,0.010812,0.17877,0.050413,HP_SUBCORTICAL_CEREBRAL_ATROPHY,0.781774838286713
SASAKI_TARGETS_OF_TP73_AND_T...,SET,11,0.44931,0.010989,0.27384,0.050432,SASAKI_TARGETS_OF_TP73_AND_TP63,0.781774838286713
GSE34156_UNTREATED_VS_24H_TL...1,SET,160,0.10712,0.0099514,0.065294,0.050452,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.781774838286713
HP_ABNORMALITY_OF_KREBS_CYCL...,SET,8,0.53199,0.011097,0.32434,0.05049,HP_ABNORMALITY_OF_KREBS_CYCLE_METABOLISM,0.781774838286713
GOBP_NEGATIVE_REGULATION_OF_...586,SET,3,0.93398,0.011932,0.56949,0.050509,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.781774838286713
GOMF_CATALYTIC_ACTIVITY_ACTI...6,SET,341,0.071349,0.0096283,0.043513,0.050542,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA,0.781774838286713
REACTOME_INFLUENZA_INFECTION,SET,145,0.11116,0.0098349,0.067806,0.050573,REACTOME_INFLUENZA_INFECTION,0.781774838286713
GOBP_REGULATION_OF_MONOCYTE_...1,SET,25,0.28733,0.01059,0.17526,0.050576,GOBP_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.781774838286713
GSE32901_TH17_EMRICHED_VS_TH...1,SET,158,0.10883,0.010047,0.066387,0.050585,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN,0.781774838286713
MIR885_5P,SET,102,0.13602,0.010105,0.082973,0.050586,MIR885_5P,0.781774838286713
GOCC_XY_BODY,SET,14,0.33823,0.0093317,0.20634,0.050593,GOCC_XY_BODY,0.781774838286713
GSE26343_WT_VS_NFAT5_KO_MACR...1,SET,186,0.10559,0.010568,0.064416,0.050599,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN,0.781774838286713
HP_ABNORMALITY_OF_TEMPERATUR...,SET,490,0.066112,0.01065,0.040334,0.050604,HP_ABNORMALITY_OF_TEMPERATURE_REGULATION,0.781774838286713
chr19q12,SET,9,0.66022,0.014607,0.40285,0.050629,chr19q12,0.781774838286713
HP_FIBROUS_TISSUE_NEOPLASM,SET,78,0.16066,0.010444,0.098055,0.050673,HP_FIBROUS_TISSUE_NEOPLASM,0.781774838286713
GIAROLA_SILVA_BLOOD_INFLUENZ...,SET,4,0.77941,0.011497,0.47577,0.050698,GIAROLA_SILVA_BLOOD_INFLUENZA_A_AGE_21_51YO_3DY_UP,0.781774838286713
BAKER_HEMATOPOESIS_STAT1_TAR...,SET,10,0.41371,0.0096478,0.25254,0.0507,BAKER_HEMATOPOESIS_STAT1_TARGETS,0.781774838286713
HP_ABNORMAL_SHARPEY_FIBER_MO...,SET,31,0.29136,0.011956,0.17786,0.050703,HP_ABNORMAL_SHARPEY_FIBER_MORPHOLOGY,0.781774838286713
GOCC_MCM_COMPLEX,SET,11,0.47907,0.011717,0.2925,0.050736,GOCC_MCM_COMPLEX,0.781774838286713
BIOCARTA_AKAP13_PATHWAY,SET,11,0.407,0.0099544,0.24857,0.050785,BIOCARTA_AKAP13_PATHWAY,0.781774838286713
MIR6127,SET,185,0.10463,0.010444,0.0639,0.050786,MIR6127,0.781774838286713
KEGG_MEDICUS_REFERENCE_CXCR4...5,SET,26,0.2944,0.011065,0.17982,0.050804,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.781774838286713
HP_PECTORAL_MUSCLE_HYPOPLASI...,SET,7,0.55612,0.010851,0.33971,0.050818,HP_PECTORAL_MUSCLE_HYPOPLASIA_APLASIA,0.781774838286713
chr5q13,SET,51,0.36657,0.019283,0.22394,0.050836,chr5q13,0.781774838286713
REACTOME_ACTIVATION_OF_ANTER...,SET,60,0.17948,0.010238,0.10966,0.050856,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,0.781774838286713
GSE40666_STAT1_KO_VS_STAT4_K...2,SET,172,0.09702,0.0093419,0.059279,0.050859,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP,0.781774838286713
GSE40274_CTRL_VS_FOXP3_AND_H...1,SET,172,0.1051,0.01012,0.064218,0.050863,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.781774838286713
HP_DISSEMINATED_INTRAVASCULA...,SET,25,0.28524,0.010513,0.17432,0.050896,HP_DISSEMINATED_INTRAVASCULAR_COAGULATION,0.781774838286713
HP_DECREASED_CIRCULATING_TOT...1,SET,7,0.5873,0.01146,0.35893,0.050905,HP_DECREASED_CIRCULATING_TOTAL_IGA,0.781774838286713
HP_EXERCISE_INDUCED_MYALGIA,SET,31,0.23731,0.0097383,0.14506,0.05093,HP_EXERCISE_INDUCED_MYALGIA,0.781774838286713
GOCC_DNA_POLYMERASE_COMPLEX,SET,19,0.28022,0.0090053,0.1713,0.050944,GOCC_DNA_POLYMERASE_COMPLEX,0.781774838286713
AIZARANI_LIVER_C38_RESIDENT_...,SET,19,0.33533,0.010777,0.20502,0.050973,AIZARANI_LIVER_C38_RESIDENT_B_CELLS_3,0.781774838286713
MORF_ESR1,SET,159,0.10805,0.010006,0.066063,0.050977,MORF_ESR1,0.781774838286713
GSE339_CD4POS_VS_CD8POS_DC_UP,SET,186,0.10486,0.010496,0.06412,0.05099,GSE339_CD4POS_VS_CD8POS_DC_UP,0.781774838286713
GAUCHER_PBMC_YF_VAX_STAMARIL...3,SET,12,0.4233,0.010813,0.25896,0.051072,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_DN,0.781774838286713
HP_MONOCYTOPENIA,SET,5,0.75077,0.012382,0.45931,0.051079,HP_MONOCYTOPENIA,0.781774838286713
GOBP_FERTILIZATION,SET,183,0.10491,0.010416,0.064182,0.05108,GOBP_FERTILIZATION,0.781774838286713
ZHONG_PFC_C1_ASTROCYTE,SET,27,0.27104,0.010381,0.16582,0.05108,ZHONG_PFC_C1_ASTROCYTE,0.781774838286713
HP_ABDOMINAL_SITUS_INVERSUS,SET,12,0.40841,0.010433,0.25,0.051173,HP_ABDOMINAL_SITUS_INVERSUS,0.781774838286713
PID_HDAC_CLASSIII_PATHWAY,SET,23,0.28281,0.0099986,0.17312,0.051174,PID_HDAC_CLASSIII_PATHWAY,0.781774838286713
GSE17721_0.5H_VS_4H_GARDIQUI...2,SET,172,0.10241,0.009861,0.062709,0.051233,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP,0.781774838286713
MIR6872_3P,SET,61,0.18307,0.010529,0.11215,0.051312,MIR6872_3P,0.781774838286713
GOBP_REGULATION_OF_MITOTIC_C...4,SET,16,0.33155,0.0097785,0.20315,0.051339,GOBP_REGULATION_OF_MITOTIC_CYTOKINESIS,0.781774838286713
REACTOME_KIDNEY_DEVELOPMENT,SET,42,0.24554,0.011725,0.15045,0.051343,REACTOME_KIDNEY_DEVELOPMENT,0.781774838286713
REACTOME_VASOPRESSIN_REGULAT...,SET,42,0.23315,0.011133,0.14286,0.051346,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,0.781774838286713
HP_ABNORMAL_CORNEAL_REFLEX,SET,11,0.41204,0.010078,0.2525,0.051363,HP_ABNORMAL_CORNEAL_REFLEX,0.781774838286713
REACTOME_REGULATION_OF_TP53_...1,SET,152,0.11108,0.01006,0.068074,0.051374,REACTOME_REGULATION_OF_TP53_ACTIVITY,0.781774838286713
PATEL_SKIN_OF_BODY_ZOSTAVAX_...1,SET,25,0.2927,0.010788,0.17939,0.051391,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP,0.781774838286713
PR_Q2,SET,239,0.095134,0.010778,0.058309,0.051395,PR_Q2,0.781774838286713
MONTERO_THYROID_CANCER_POOR_...2,SET,12,0.43426,0.011093,0.26617,0.051402,MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP,0.781774838286713
TRAVAGLINI_LUNG_BRONCHIAL_VE...2,SET,243,0.093967,0.010733,0.0576,0.051415,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL,0.781774838286713
HP_AORTIC_REGURGITATION,SET,89,0.14895,0.01034,0.091309,0.051421,HP_AORTIC_REGURGITATION,0.781774838286713
GOBP_LIPID_DROPLET_FORMATION,SET,12,0.39162,0.010004,0.24007,0.051425,GOBP_LIPID_DROPLET_FORMATION,0.781774838286713
REACTOME_IONOTROPIC_ACTIVITY...,SET,9,0.49457,0.010942,0.30322,0.051445,REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS,0.781774838286713
GOBP_DORSAL_VENTRAL_NEURAL_T...,SET,16,0.35312,0.010415,0.21652,0.051463,GOBP_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.781774838286713
GSE19198_CTRL_VS_IL21_TREATE...6,SET,172,0.11246,0.010829,0.068957,0.051466,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP,0.781774838286713
GSE25846_IL10_POS_VS_NEG_CD8...1,SET,176,0.10032,0.0097702,0.061522,0.051493,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN,0.781835731441048
MIR3130_3P,SET,45,0.19785,0.0097783,0.12135,0.051515,MIR3130_3P,0.781835731441048
GSE18791_CTRL_VS_NEWCASTLE_V...9,SET,162,0.11085,0.010361,0.06804,0.051652,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN,0.782995648904168
GSE15659_CD45RA_NEG_CD4_TCEL...5,SET,172,0.10528,0.010138,0.064636,0.051676,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN,0.782995648904168
MIR6875_5P,SET,62,0.17221,0.0099853,0.10572,0.051681,MIR6875_5P,0.782995648904168
GOMF_BIOACTIVE_LIPID_RECEPTO...,SET,13,0.39477,0.010496,0.24238,0.051698,GOMF_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY,0.782995648904168
MIR197_3P,SET,90,0.14037,0.0097993,0.086211,0.051743,MIR197_3P,0.782995648904168
KIM_GLIS2_TARGETS_DN,SET,6,0.55908,0.0101,0.34336,0.051744,KIM_GLIS2_TARGETS_DN,0.782995648904168
GOMF_INTRAMOLECULAR_PHOSPHOT...,SET,10,0.41507,0.0096794,0.25494,0.051764,GOMF_INTRAMOLECULAR_PHOSPHOTRANSFERASE_ACTIVITY,0.782995648904168
TARTE_PLASMA_CELL_VS_PLASMAB...2,SET,354,0.078596,0.010803,0.04828,0.051781,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,0.782995648904168
GOBP_HAIR_FOLLICLE_MATURATION,SET,15,0.37442,0.010692,0.23003,0.051804,GOBP_HAIR_FOLLICLE_MATURATION,0.782995648904168
GTTGNYNNRGNAAC_UNKNOWN,SET,94,0.14726,0.010504,0.090493,0.05185,GTTGNYNNRGNAAC_UNKNOWN,0.782995648904168
GOBP_NEGATIVE_REGULATION_OF_...636,SET,11,0.44207,0.010812,0.27172,0.051885,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.782995648904168
GSE11961_MEMORY_BCELL_DAY7_V...8,SET,186,0.10203,0.010212,0.06272,0.051903,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.782995648904168
GSE45365_NK_CELL_VS_CD8A_DC_...4,SET,181,0.10186,0.010059,0.062619,0.051912,GSE45365_NK_CELL_VS_CD8A_DC_UP,0.782995648904168
WP_MIRNA_ROLE_IN_IMMUNE_RESP...,SET,33,0.25102,0.010627,0.15434,0.051939,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.782995648904168
GSE17186_CD21LOW_VS_CD21HIGH...4,SET,183,0.10748,0.010671,0.066087,0.051951,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.782995648904168
GSE15930_STIM_VS_STIM_AND_IF...1,SET,178,0.10665,0.010445,0.065601,0.052018,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN,0.782995648904168
RICKMAN_METASTASIS_UP,SET,273,0.084893,0.01027,0.052232,0.052059,RICKMAN_METASTASIS_UP,0.782995648904168
HP_CONGENITAL_NYSTAGMUS,SET,19,0.3394,0.010907,0.20888,0.05211,HP_CONGENITAL_NYSTAGMUS,0.782995648904168
PID_P38_ALPHA_BETA_PATHWAY,SET,29,0.26948,0.010696,0.16589,0.052146,PID_P38_ALPHA_BETA_PATHWAY,0.782995648904168
GOMF_BILE_ACID_BINDING,SET,10,0.50027,0.011666,0.30801,0.052176,GOMF_BILE_ACID_BINDING,0.782995648904168
GOCC_COMMITMENT_COMPLEX,SET,5,0.52957,0.0087337,0.32606,0.052181,GOCC_COMMITMENT_COMPLEX,0.782995648904168
GSE15930_NAIVE_VS_48H_IN_VIT...3,SET,182,0.098623,0.0097657,0.060736,0.052218,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.782995648904168
CUI_GLUCOSE_DEPRIVATION,SET,53,0.20447,0.010965,0.12592,0.052221,CUI_GLUCOSE_DEPRIVATION,0.782995648904168
GOBP_NEGATIVE_REGULATION_OF_...685,SET,9,0.49463,0.010943,0.30465,0.052235,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.782995648904168
GSE5960_TH1_VS_ANERGIC_TH1_DN,SET,185,0.10007,0.0099891,0.061635,0.052247,GSE5960_TH1_VS_ANERGIC_TH1_DN,0.782995648904168
GSE40225_WT_VS_RIP_B7X_DIABE...1,SET,169,0.1026,0.0097934,0.063211,0.052291,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN,0.782995648904168
REACTOME_FGFR1_MUTANT_RECEPT...,SET,30,0.28511,0.01151,0.17566,0.052293,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,0.782995648904168
GOBP_MACROMOLECULE_DEPALMITO...,SET,14,0.33143,0.0091442,0.20424,0.052326,GOBP_MACROMOLECULE_DEPALMITOYLATION,0.782995648904168
GOMF_PALMITOYL_HYDROLASE_ACT...,SET,14,0.33143,0.0091442,0.20424,0.052326,GOMF_PALMITOYL_HYDROLASE_ACTIVITY,0.782995648904168
MIR3190_3P,SET,109,0.13243,0.010168,0.081605,0.052327,MIR3190_3P,0.782995648904168
GSE19825_IL2RALOW_VS_IL2RAHI...2,SET,173,0.10181,0.0098316,0.062752,0.052359,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,0.782995648904168
HP_MYALGIA,SET,157,0.11164,0.010275,0.068809,0.05236,HP_MYALGIA,0.782995648904168
HP_BENIGN_NEOPLASM_OF_THE_CE...,SET,100,0.13112,0.009646,0.080824,0.052374,HP_BENIGN_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.782995648904168
MODULE_222,SET,10,0.45821,0.010686,0.28245,0.052382,MODULE_222,0.782995648904168
GOCC_ENDOPLASMIC_RETICULUM_P...3,SET,111,0.12772,0.0098957,0.078734,0.052396,GOCC_ENDOPLASMIC_RETICULUM_PROTEIN_CONTAINING_COMPLEX,0.782995648904168
GOMF_VIRION_BINDING,SET,9,0.48551,0.010741,0.29931,0.052403,GOMF_VIRION_BINDING,0.782995648904168
GOBP_PLATELET_DERIVED_GROWTH...1,SET,7,0.5764,0.011247,0.3554,0.052425,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.782995648904168
GOBP_NEGATIVE_REGULATION_OF_...142,SET,10,0.41442,0.0096643,0.25565,0.052512,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE,0.78319988372093
GOBP_REGULATION_OF_BONE_MINE...2,SET,5,0.66755,0.011009,0.41185,0.052531,GOBP_REGULATION_OF_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,0.78319988372093
GSE15930_STIM_VS_STIM_AND_IL...1,SET,174,0.10642,0.010306,0.065665,0.052549,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN,0.78319988372093
BYSTRYKH_SCP2_QTL,SET,6,0.45992,0.0083088,0.2838,0.052563,BYSTRYKH_SCP2_QTL,0.78319988372093
GOBP_PYRIMIDINE_NUCLEOSIDE_C...,SET,15,0.48028,0.013716,0.29642,0.052594,GOBP_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS,0.78319988372093
DEBIASI_APOPTOSIS_BY_REOVIRU...1,SET,246,0.086574,0.009949,0.05345,0.052655,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,0.78319988372093
BARHL1_TARGET_GENES,SET,1040,0.043542,0.010061,0.026884,0.052662,BARHL1_TARGET_GENES,0.78319988372093
KEGG_UBIQUITIN_MEDIATED_PROT...,SET,120,0.11834,0.0095313,0.073092,0.052725,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,0.78319988372093
MODULE_6,SET,382,0.076486,0.010912,0.047248,0.052753,MODULE_6,0.78319988372093
REACTOME_IRF3_MEDIATED_INDUC...,SET,11,0.34213,0.0083677,0.21136,0.052765,REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN,0.78319988372093
WP_MAMMALIAN_DISORDER_OF_SEX...,SET,24,0.30102,0.010871,0.18597,0.052769,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,0.78319988372093
WP_SMC1SMC3_ROLE_IN_DNA_DAMA...,SET,9,0.44035,0.0097424,0.27211,0.052808,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.78319988372093
GOBP_CERAMIDE_CATABOLIC_PROC...,SET,20,0.33244,0.010961,0.20544,0.052823,GOBP_CERAMIDE_CATABOLIC_PROCESS,0.78319988372093
GOBP_REGULATION_OF_MEMBRANE_...2,SET,5,0.70298,0.011594,0.43445,0.052832,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.78319988372093
GOBP_POSITIVE_REGULATION_OF_...548,SET,6,0.49101,0.0088704,0.30356,0.052892,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.78319988372093
GOBP_LIPOPROTEIN_METABOLIC_P...,SET,127,0.12277,0.010171,0.075909,0.052911,GOBP_LIPOPROTEIN_METABOLIC_PROCESS,0.78319988372093
GOBP_CELL_SURFACE_PATTERN_RE...,SET,71,0.16738,0.010383,0.10349,0.052917,GOBP_CELL_SURFACE_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.78319988372093
GSE23502_BM_VS_COLON_TUMOR_H...2,SET,178,0.11014,0.010787,0.068105,0.05293,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.78319988372093
WP_MRNA_VACCINE_ACTIVATION_O...,SET,7,0.46851,0.009142,0.28976,0.052956,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,0.78319988372093
DHIMAN_PBMC_ATTENUVAX_AGE_15...1,SET,17,0.35131,0.01068,0.21729,0.052972,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_DN,0.78319988372093
GOBP_VITAMIN_TRANSPORT,SET,48,0.20583,0.010505,0.12731,0.052975,GOBP_VITAMIN_TRANSPORT,0.78319988372093
ZHU_CMV_ALL_UP,SET,102,0.1382,0.010267,0.085482,0.052984,ZHU_CMV_ALL_UP,0.78319988372093
HP_VITREORETINOPATHY,SET,21,0.29861,0.010088,0.18478,0.053046,HP_VITREORETINOPATHY,0.78319988372093
HP_ABNORMALITY_OF_OCULAR_SMO...,SET,64,0.15993,0.0094211,0.098961,0.053051,HP_ABNORMALITY_OF_OCULAR_SMOOTH_PURSUIT,0.78319988372093
HP_CRANIOFACIAL_HYPEROSTOSIS,SET,24,0.25565,0.0092325,0.15821,0.053074,HP_CRANIOFACIAL_HYPEROSTOSIS,0.78319988372093
HP_LEUKOCYTOSIS,SET,140,0.11791,0.010252,0.072994,0.05313,HP_LEUKOCYTOSIS,0.78319988372093
HP_PERITONEAL_ABSCESS,SET,11,0.39316,0.0096158,0.24342,0.053146,HP_PERITONEAL_ABSCESS,0.78319988372093
AR_01,SET,142,0.11696,0.010241,0.072412,0.053148,AR_01,0.78319988372093
GSE43863_TH1_VS_LY6C_LOW_CXC...2,SET,180,0.098654,0.0097155,0.0611,0.053205,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.78319988372093
PETRETTO_HEART_MASS_QTL_CIS_...1,SET,24,0.27023,0.0097591,0.16737,0.053207,PETRETTO_HEART_MASS_QTL_CIS_DN,0.78319988372093
HSF2_01,SET,230,0.092674,0.010302,0.057398,0.053211,HSF2_01,0.78319988372093
REACTOME_LATE_SARS_COV_2_INF...,SET,66,0.16756,0.010024,0.10379,0.053218,REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS,0.78319988372093
GOBP_NEGATIVE_REGULATION_OF_...659,SET,12,0.40508,0.010348,0.25093,0.053238,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.78319988372093
GAO_LARGE_INTESTINE_24W_C6_S...,SET,13,0.40061,0.010651,0.24817,0.053248,GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR,0.78319988372093
E2F1_UP.V1_UP,SET,172,0.09962,0.0095923,0.061716,0.053255,E2F1_UP.V1_UP,0.78319988372093
REACTOME_SYNTHESIS_OF_12_EIC...,SET,7,0.54943,0.010721,0.34042,0.053275,REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES,0.78319988372093
GOMF_SH3_DOMAIN_BINDING,SET,112,0.12785,0.0099505,0.07922,0.053281,GOMF_SH3_DOMAIN_BINDING,0.78319988372093
GOBP_REGULATION_OF_PLATELET_...5,SET,22,0.29995,0.010372,0.18587,0.053295,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.78319988372093
GOBP_SPINAL_CORD_DEVELOPMENT,SET,93,0.15523,0.011014,0.096206,0.053331,GOBP_SPINAL_CORD_DEVELOPMENT,0.783397677514793
HP_CEREBRAL_HEMORRHAGE,SET,63,0.16448,0.0096134,0.102,0.053442,HP_CEREBRAL_HEMORRHAGE,0.784040537974684
FAN_EMBRYONIC_CTX_ASTROCYTE_1,SET,73,0.16649,0.010472,0.10325,0.053444,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.784040537974684
MIR3683,SET,5,0.61375,0.010122,0.38068,0.053464,MIR3683,0.784040537974684
GOMF_HISTONE_DECROTONYLASE_A...,SET,4,0.65868,0.0097164,0.40855,0.053465,GOMF_HISTONE_DECROTONYLASE_ACTIVITY,0.784040537974684
GOMF_SOLUTE_MONOATOMIC_CATIO...,SET,114,0.13594,0.010674,0.084334,0.053494,GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.784134951497259
GOBP_ACTIVATION_OF_JANUS_KIN...,SET,13,0.39596,0.010527,0.2457,0.053538,GOBP_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.784359155433867
HP_ADIPOSE_TISSUE_LOSS,SET,27,0.26627,0.010198,0.16526,0.053577,HP_ADIPOSE_TISSUE_LOSS,0.784359155433867
GSE29615_CTRL_VS_DAY3_LAIV_I...2,SET,175,0.10356,0.010057,0.064274,0.053577,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP,0.784359155433867
GOBP_POSITIVE_REGULATION_OF_...201,SET,5,0.69053,0.011388,0.42871,0.053629,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.784743628523349
REACTOME_SULFIDE_OXIDATION_T...,SET,5,0.53321,0.0087937,0.33108,0.053653,REACTOME_SULFIDE_OXIDATION_TO_SULFATE,0.784743628523349
GOBP_LEUKOCYTE_DIFFERENTIATI...,SET,581,0.06132,0.010729,0.038079,0.053671,GOBP_LEUKOCYTE_DIFFERENTIATION,0.784743628523349
HP_MYOPIC_ASTIGMATISM,SET,6,0.55343,0.0099981,0.34375,0.053708,HP_MYOPIC_ASTIGMATISM,0.784878882352941
HP_ABNORMAL_QRS_COMPLEX,SET,9,0.51264,0.011342,0.31846,0.053739,HP_ABNORMAL_QRS_COMPLEX,0.784878882352941
HP_PULMONARY_EMBOLISM,SET,35,0.23929,0.010433,0.14866,0.053748,HP_PULMONARY_EMBOLISM,0.784878882352941
HP_HEMATOLOGICAL_NEOPLASM,SET,277,0.082388,0.010038,0.051196,0.053787,HP_HEMATOLOGICAL_NEOPLASM,0.785118515329693
MODULE_89,SET,2,1.1196,0.011679,0.69581,0.053817,MODULE_89,0.785226630982368
DACOSTA_UV_RESPONSE_VIA_ERCC...8,SET,22,0.28742,0.0099385,0.17868,0.05386,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.785276708542713
GOBP_NODAL_SIGNALING_PATHWAY,SET,16,0.37002,0.010913,0.23006,0.053886,GOBP_NODAL_SIGNALING_PATHWAY,0.785276708542713
MIR3692_5P,SET,128,0.12228,0.010169,0.076035,0.053909,MIR3692_5P,0.785276708542713
NFE2_01,SET,238,0.091272,0.010319,0.056759,0.053919,NFE2_01,0.785276708542713
REACTOME_ACTIVATION_OF_SMO,SET,17,0.33167,0.010083,0.2063,0.053956,REACTOME_ACTIVATION_OF_SMO,0.785276708542713
WP_DENGUE2_INTERACTIONS_WITH...,SET,53,0.20397,0.010938,0.12687,0.053956,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.785276708542713
GOBP_PHAGOSOME_MATURATION,SET,28,0.27923,0.010891,0.17375,0.054026,GOBP_PHAGOSOME_MATURATION,0.785428157894737
MIR125B_5P,SET,298,0.078919,0.0099676,0.049108,0.054029,MIR125B_5P,0.785428157894737
HOEK_PBMC_INACTIVATED_INFLUE...2,SET,2,0.933,0.0097325,0.58062,0.054048,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP,0.785428157894737
GOBP_NEGATIVE_REGULATION_OF_...282,SET,10,0.54789,0.012777,0.34099,0.054062,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.785428157894737
MIR19A_5P,SET,161,0.11338,0.010565,0.070574,0.054092,MIR19A_5P,0.785428157894737
GSE31082_CD4_VS_CD8_SP_THYMO...2,SET,178,0.1033,0.010117,0.064308,0.054102,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP,0.785428157894737
HP_ANKLE_SWELLING,SET,12,0.43921,0.011219,0.27363,0.054241,HP_ANKLE_SWELLING,0.786713658892128
GOMF_HISTONE_H3K4_TRIMETHYLT...,SET,10,0.43995,0.01026,0.27413,0.054268,GOMF_HISTONE_H3K4_TRIMETHYLTRANSFERASE_ACTIVITY,0.786713658892128
GOMF_STEROL_ESTERASE_ACTIVITY,SET,7,0.5358,0.010455,0.33388,0.05428,GOMF_STEROL_ESTERASE_ACTIVITY,0.786713658892128
GSE22611_MUTANT_NOD2_VS_CTRL...1,SET,161,0.10857,0.010117,0.067667,0.054312,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,0.786713658892128
ZHU_SKIL_TARGETS_UP,SET,19,0.35729,0.011482,0.22272,0.054339,ZHU_SKIL_TARGETS_UP,0.786713658892128
HP_JUVENILE_RHEUMATOID_ARTHR...,SET,5,0.62847,0.010365,0.39178,0.054348,HP_JUVENILE_RHEUMATOID_ARTHRITIS,0.786713658892128
GOBP_FUNGIFORM_PAPILLA_MORPH...,SET,4,0.76032,0.011216,0.47397,0.054349,GOBP_FUNGIFORM_PAPILLA_MORPHOGENESIS,0.786713658892128
GOMF_PROTEIN_TYROSINE_PHOSPH...,SET,89,0.14911,0.010351,0.092969,0.054383,GOMF_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.786878087010824
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SET,49,0.2024,0.010437,0.12627,0.05449,SMIRNOV_RESPONSE_TO_IR_2HR_UP,0.787529513513514
QI_PBMC_ZOSTAVAX_AGE_50_75YO...3,SET,159,0.10357,0.0095919,0.064617,0.05449,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE,0.787529513513514
MIR569,SET,69,0.16729,0.010231,0.10437,0.054496,MIR569,0.787529513513514
GOBP_URETER_MORPHOGENESIS,SET,7,0.48542,0.0094719,0.30292,0.054537,GOBP_URETER_MORPHOGENESIS,0.787794445137157
MIR3158_5P,SET,154,0.10995,0.010023,0.068639,0.054605,MIR3158_5P,0.788449013294558
RADAEVA_RESPONSE_TO_IFNA1_UP,SET,46,0.20929,0.010458,0.13071,0.054674,RADAEVA_RESPONSE_TO_IFNA1_UP,0.788804327521793
GOBP_TUBE_DEVELOPMENT,SET,1009,0.046107,0.010503,0.028796,0.054675,GOBP_TUBE_DEVELOPMENT,0.788804327521793
WP_ANDROGEN_RECEPTOR_SIGNALI...,SET,83,0.14708,0.0098617,0.091876,0.054716,WP_ANDROGEN_RECEPTOR_SIGNALING,0.788827503110742
GSE37533_PPARG1_FOXP3_VS_FOX...2,SET,188,0.096058,0.0096656,0.060007,0.054722,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.788827503110742
GSE41867_DAY8_EFFECTOR_VS_DA...2,SET,174,0.1007,0.0097515,0.062926,0.054783,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.789379421641791
GOBP_CELL_SURFACE_RECEPTOR_P...1,SET,333,0.078317,0.010446,0.048961,0.054856,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.789805215410108
GOBP_REGULATION_OF_SIGNALING...,SET,89,0.15424,0.010707,0.096425,0.054858,GOBP_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.789805215410108
YGCGYRCGC_UNKNOWN,SET,287,0.078763,0.0097655,0.049248,0.054883,YGCGYRCGC_UNKNOWN,0.789837956521739
GOBP_REGULATION_OF_CELLULAR_...6,SET,123,0.12371,0.010086,0.077369,0.054932,GOBP_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS,0.790048190830235
KEGG_MEDICUS_REFERENCE_REGUL...12,SET,25,0.30662,0.011301,0.1918,0.054953,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL,0.790048190830235
CORRE_MULTIPLE_MYELOMA_UP,SET,64,0.182,0.010721,0.11386,0.054979,CORRE_MULTIPLE_MYELOMA_UP,0.790048190830235
CALVET_IRINOTECAN_SENSITIVE_...1,SET,4,0.6746,0.0099512,0.4221,0.055009,CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP,0.790048190830235
REACTOME_ACTIVATION_OF_KAINA...,SET,29,0.26602,0.010559,0.16647,0.055033,REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING,0.790048190830235
MIR125A_5P,SET,300,0.078187,0.0099077,0.048929,0.055034,MIR125A_5P,0.790048190830235
REACTOME_IRF3_MEDIATED_ACTIV...,SET,5,0.52092,0.0085911,0.32609,0.055088,REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN,0.790102735148515
GOBP_SPECIFICATION_OF_SYMMET...,SET,131,0.12025,0.010116,0.07528,0.055097,GOBP_SPECIFICATION_OF_SYMMETRY,0.790102735148515
MIR4755_3P,SET,133,0.12057,0.01022,0.075485,0.055106,MIR4755_3P,0.790102735148515
FINETTI_BREAST_CANCER_KINOME...2,SET,16,0.32864,0.0096925,0.20584,0.055191,FINETTI_BREAST_CANCER_KINOME_RED,0.79053381147541
MIR19B_1_5P_MIR19B_2_5P,SET,160,0.11301,0.010498,0.070787,0.055206,MIR19B_1_5P_MIR19B_2_5P,0.79053381147541
GSE5589_LPS_VS_LPS_AND_IL6_S...6,SET,176,0.10079,0.0098155,0.063141,0.055232,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.79053381147541
GSE19888_CTRL_VS_A3R_ACT_TRE...2,SET,185,0.10082,0.010065,0.063181,0.05528,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP,0.79053381147541
GSE30962_ACUTE_VS_CHRONIC_LC...1,SET,185,0.10199,0.010182,0.063917,0.055283,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN,0.79053381147541
GAUTAM_EYE_CORNEA_CONJUNCTIV...,SET,92,0.14697,0.010372,0.092121,0.055323,GAUTAM_EYE_CORNEA_CONJUNCTIVAL_CELLS,0.79053381147541
HP_DECREASED_CIRCULATING_TOT...3,SET,66,0.1697,0.010151,0.10637,0.055329,HP_DECREASED_CIRCULATING_TOTAL_IGM,0.79053381147541
HP_PERITONITIS,SET,41,0.21424,0.010108,0.1343,0.055338,HP_PERITONITIS,0.79053381147541
GSE28737_FOLLICULAR_VS_MARGI...2,SET,176,0.10159,0.0098942,0.063695,0.055366,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP,0.79053381147541
HP_CHROMOSOME_BREAKAGE,SET,36,0.21166,0.0093589,0.13271,0.055374,HP_CHROMOSOME_BREAKAGE,0.79053381147541
JOHNSTONE_PARVB_TARGETS_2_DN,SET,306,0.081085,0.010375,0.050855,0.055427,JOHNSTONE_PARVB_TARGETS_2_DN,0.79053381147541
HP_NON_MIDLINE_CLEFT_OF_THE_...,SET,34,0.22888,0.0098357,0.14356,0.055438,HP_NON_MIDLINE_CLEFT_OF_THE_UPPER_LIP,0.79053381147541
WP_INTERFERON_TYPE_I_SIGNALI...,SET,51,0.19858,0.010446,0.12458,0.055472,WP_INTERFERON_TYPE_I_SIGNALING,0.79053381147541
SARRIO_EPITHELIAL_MESENCHYMA...2,SET,159,0.10453,0.0096802,0.065573,0.055475,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,0.79053381147541
GSE25123_IL4_VS_IL4_AND_ROSI...3,SET,170,0.10933,0.010467,0.068599,0.055498,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,0.79053381147541
MIR4762_3P,SET,242,0.089344,0.010185,0.056057,0.0555,MIR4762_3P,0.79053381147541
HP_ABNORMAL_THALAMUS_MORPHOL...,SET,53,0.17527,0.0093986,0.11,0.055546,HP_ABNORMAL_THALAMUS_MORPHOLOGY,0.79086490372798
chr10q26,SET,91,0.2827,0.019843,0.17747,0.055592,chr10q26,0.790971446991404
GOMF_TRANSCRIPTION_REGULATOR...1,SET,5,0.71483,0.011789,0.44876,0.055599,GOMF_TRANSCRIPTION_REGULATOR_ACTIVATOR_ACTIVITY,0.790971446991404
HP_ABNORMAL_PERITONEUM_MORPH...,SET,59,0.17833,0.010088,0.11197,0.055629,HP_ABNORMAL_PERITONEUM_MORPHOLOGY,0.79107442512275
GOBP_NEGATIVE_REGULATION_OF_...481,SET,23,0.26072,0.0092176,0.16373,0.055662,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.791219963190184
GSE13547_2H_VS_12_H_ANTI_IGM...2,SET,166,0.111,0.010501,0.069724,0.055706,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP,0.791521680294358
HP_COLDNESS,SET,2,1.0579,0.011035,0.66494,0.055821,HP_COLDNESS,0.792354395671703
HP_HAND_APRAXIA,SET,2,1.0579,0.011035,0.66494,0.055821,HP_HAND_APRAXIA,0.792354395671703
GOCC_CALYX_OF_HELD,SET,17,0.34779,0.010573,0.21862,0.055833,GOCC_CALYX_OF_HELD,0.792354395671703
GOCC_MLL3_4_COMPLEX,SET,10,0.38067,0.0088772,0.2394,0.055913,GOCC_MLL3_4_COMPLEX,0.793165842857143
GOMF_CARGO_RECEPTOR_ACTIVITY,SET,71,0.15948,0.0098935,0.10038,0.056059,GOMF_CARGO_RECEPTOR_ACTIVITY,0.793277651302605
KEGG_JAK_STAT_SIGNALING_PATH...,SET,140,0.12856,0.011178,0.080922,0.056072,KEGG_JAK_STAT_SIGNALING_PATHWAY,0.793277651302605
GSE41867_DAY15_EFFECTOR_VS_D...3,SET,154,0.10721,0.0097727,0.067486,0.056084,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.793277651302605
GOBP_REGULATION_OF_MEIOTIC_C...2,SET,10,0.41473,0.0096716,0.26107,0.056085,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.793277651302605
GSE27786_BCELL_VS_ERYTHROBLA...2,SET,179,0.095454,0.0093744,0.060116,0.056172,GSE27786_BCELL_VS_ERYTHROBLAST_UP,0.793277651302605
HP_NEOPLASM_OF_THE_SKIN,SET,198,0.095124,0.0098202,0.059913,0.056188,HP_NEOPLASM_OF_THE_SKIN,0.793277651302605
HP_REDUCED_PROTEIN_S_ACTIVITY,SET,8,0.37466,0.0078152,0.23601,0.05621,HP_REDUCED_PROTEIN_S_ACTIVITY,0.793277651302605
REACTOME_TIGHT_JUNCTION_INTE...,SET,27,0.30051,0.01151,0.1893,0.056211,REACTOME_TIGHT_JUNCTION_INTERACTIONS,0.793277651302605
GOBP_CORPUS_CALLOSUM_MORPHOG...,SET,5,0.56717,0.0093539,0.35731,0.056227,GOBP_CORPUS_CALLOSUM_MORPHOGENESIS,0.793277651302605
GOBP_EPITHELIAL_CELL_MATURAT...,SET,26,0.29834,0.011213,0.18799,0.056265,GOBP_EPITHELIAL_CELL_MATURATION,0.793277651302605
LE_NEURONAL_DIFFERENTIATION_...1,SET,18,0.2894,0.0090527,0.18249,0.056398,LE_NEURONAL_DIFFERENTIATION_DN,0.793277651302605
QIU_PBMC_HEPTATITIS_B_SURFAC...3,SET,7,0.55475,0.010825,0.34987,0.056426,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_DN,0.793277651302605
WP_COMPLEMENT_AND_COAGULATIO...,SET,52,0.20269,0.010766,0.12784,0.056438,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.793277651302605
GOBP_REGULATION_OF_TRANSLATI...7,SET,8,0.45994,0.0095941,0.2901,0.056442,GOBP_REGULATION_OF_TRANSLATIONAL_TERMINATION,0.793277651302605
GOBP_VIRION_ASSEMBLY,SET,34,0.22202,0.0095406,0.14004,0.05645,GOBP_VIRION_ASSEMBLY,0.793277651302605
GOBP_CEREBELLAR_PURKINJE_CEL...2,SET,12,0.40617,0.010376,0.25621,0.056455,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION,0.793277651302605
GSE15659_RESTING_TREG_VS_NON...1,SET,172,0.1033,0.0099462,0.065161,0.056463,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN,0.793277651302605
HP_ABNORMAL_MAST_CELL_MORPHO...,SET,8,0.49532,0.010332,0.3125,0.056491,HP_ABNORMAL_MAST_CELL_MORPHOLOGY,0.793277651302605
KEGG_MEDICUS_PATHOGEN_HCMV_U...3,SET,33,0.24316,0.010295,0.15343,0.056504,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY,0.793277651302605
HP_ABNORMAL_MORPHOLOGY_OF_TH...8,SET,31,0.25793,0.010584,0.16275,0.056507,HP_ABNORMAL_MORPHOLOGY_OF_THE_OLFACTORY_BULB,0.793277651302605
GOCC_MITOTIC_SPINDLE,SET,167,0.099055,0.0093994,0.062501,0.056509,GOCC_MITOTIC_SPINDLE,0.793277651302605
GOBP_REGULATION_OF_OLIGODEND...,SET,46,0.2365,0.011817,0.1493,0.056604,GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.793277651302605
XU_HGF_TARGETS_INDUCED_BY_AK...1,SET,21,0.32043,0.010826,0.20232,0.056632,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,0.793277651302605
MIR4436B_3P,SET,97,0.14018,0.010157,0.088512,0.056639,MIR4436B_3P,0.793277651302605
LIAN_LIPA_TARGETS_3M,SET,52,0.20286,0.010775,0.1281,0.056655,LIAN_LIPA_TARGETS_3M,0.793277651302605
MIR573,SET,86,0.14738,0.010058,0.093071,0.056658,MIR573,0.793277651302605
GNF2_CDC20,SET,52,0.18625,0.0098929,0.11765,0.056714,GNF2_CDC20,0.793277651302605
REACTOME_SYNTHESIS_OF_PIPS_A...4,SET,10,0.34739,0.0081013,0.21946,0.056726,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE,0.793277651302605
HP_GRANULOCYTOPENIA,SET,6,0.52564,0.009496,0.33212,0.056755,HP_GRANULOCYTOPENIA,0.793277651302605
FAN_EMBRYONIC_CTX_IN_5_INTER...,SET,5,0.72716,0.011992,0.45953,0.056788,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.793277651302605
KEGG_GLYCOSAMINOGLYCAN_BIOSY...3,SET,15,0.38437,0.010977,0.24294,0.056812,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,0.793277651302605
HP_ACCESSORY_SPLEEN,SET,33,0.2123,0.008988,0.13418,0.056812,HP_ACCESSORY_SPLEEN,0.793277651302605
HP_ANOREXIA,SET,107,0.1351,0.010278,0.085399,0.056839,HP_ANOREXIA,0.793277651302605
GOBP_CYTOKINESIS,SET,164,0.10206,0.0095978,0.064514,0.056841,GOBP_CYTOKINESIS,0.793277651302605
MIR922,SET,180,0.098262,0.0096769,0.062117,0.056848,MIR922,0.793277651302605
TOMLINS_PROSTATE_CANCER_DN,SET,36,0.23175,0.010247,0.14651,0.056859,TOMLINS_PROSTATE_CANCER_DN,0.793277651302605
GSE19941_IL10_KO_VS_IL10_KO_...6,SET,183,0.10309,0.010236,0.065178,0.056863,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP,0.793277651302605
GSE19401_UNSTIM_VS_RETINOIC_...1,SET,184,0.10174,0.010129,0.064332,0.05689,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.793277651302605
GSE3920_IFNB_VS_IFNG_TREATED...2,SET,144,0.1157,0.010202,0.073164,0.056897,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.793277651302605
HP_EAR_PAIN,SET,15,0.34779,0.0099319,0.21993,0.056908,HP_EAR_PAIN,0.793277651302605
MIR4422,SET,416,0.069578,0.010349,0.044004,0.056929,MIR4422,0.793277651302605
GOBP_EYE_MORPHOGENESIS,SET,155,0.11753,0.010748,0.074336,0.056937,GOBP_EYE_MORPHOGENESIS,0.793277651302605
GOCC_MHC_CLASS_I_PROTEIN_COM...,SET,9,0.49244,0.010895,0.31146,0.056939,GOCC_MHC_CLASS_I_PROTEIN_COMPLEX,0.793277651302605
GOBP_CELLULAR_RESPONSE_TO_UV,SET,81,0.14507,0.0096099,0.091757,0.056941,GOBP_CELLULAR_RESPONSE_TO_UV,0.793277651302605
KEGG_MEDICUS_REFERENCE_IL10_...,SET,13,0.45015,0.011968,0.28473,0.056948,KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.793277651302605
HP_PROGRESSIVE_PERIPHERAL_NE...,SET,4,0.76276,0.011252,0.48254,0.056981,HP_PROGRESSIVE_PERIPHERAL_NEUROPATHY,0.793419332932692
MIR3126_5P,SET,59,0.17122,0.0096855,0.10833,0.057004,MIR3126_5P,0.793421714056868
GSE2706_R848_VS_R848_AND_LPS...4,SET,156,0.11432,0.010488,0.072348,0.057042,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP,0.793522798361935
GSE30971_WBP7_HET_VS_KO_MACR...2,SET,178,0.10385,0.010171,0.065727,0.057061,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP,0.793522798361935
NEUROG3_TARGET_GENES,SET,15,0.3301,0.0094269,0.20902,0.057144,NEUROG3_TARGET_GENES,0.793522798361935
MIR4729,SET,642,0.054787,0.010059,0.034698,0.057179,MIR4729,0.793522798361935
MIR103A_2_5P,SET,140,0.11573,0.010063,0.0733,0.057187,MIR103A_2_5P,0.793522798361935
GOMF_ABC_TYPE_XENOBIOTIC_TRA...,SET,14,0.39877,0.011002,0.25258,0.057203,GOMF_ABC_TYPE_XENOBIOTIC_TRANSPORTER_ACTIVITY,0.793522798361935
GOCC_TRANS_GOLGI_NETWORK,SET,228,0.088349,0.0097793,0.055965,0.057218,GOCC_TRANS_GOLGI_NETWORK,0.793522798361935
LEE_CALORIE_RESTRICTION_NEOC...2,SET,66,0.16683,0.0099797,0.10568,0.057224,LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,0.793522798361935
HP_WEIGHT_LOSS,SET,351,0.072637,0.009942,0.046026,0.057272,HP_WEIGHT_LOSS,0.793522798361935
MIR4319,SET,406,0.066773,0.0098144,0.042313,0.057282,MIR4319,0.793522798361935
GOBP_ACYLGLYCEROL_HOMEOSTASIS,SET,38,0.22203,0.010086,0.1407,0.05729,GOBP_ACYLGLYCEROL_HOMEOSTASIS,0.793522798361935
REACTOME_FORMATION_OF_INTERM...,SET,7,0.57721,0.011263,0.36594,0.05737,REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM,0.793522798361935
LIU_PROSTATE_CANCER_UP,SET,87,0.1534,0.01053,0.097279,0.057416,LIU_PROSTATE_CANCER_UP,0.793522798361935
GOMF_MONOSACCHARIDE_BINDING,SET,69,0.16014,0.0097943,0.10157,0.057436,GOMF_MONOSACCHARIDE_BINDING,0.793522798361935
GOBP_DETERMINATION_OF_LEFT_R...,SET,10,0.46969,0.010953,0.29794,0.057469,GOBP_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM,0.793522798361935
DESCARTES_MAIN_FETAL_RETINAL...1,SET,106,0.14197,0.010751,0.090063,0.05748,DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS,0.793522798361935
GOBP_EMBRYONIC_MORPHOGENESIS,SET,572,0.060068,0.010431,0.038109,0.057496,GOBP_EMBRYONIC_MORPHOGENESIS,0.793522798361935
GOMF_LIPID_TRANSFER_ACTIVITY,SET,50,0.1925,0.010027,0.12213,0.057502,GOMF_LIPID_TRANSFER_ACTIVITY,0.793522798361935
GOBP_POSITIVE_REGULATION_OF_...158,SET,13,0.38475,0.010229,0.24411,0.057505,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.793522798361935
GOBP_ASTRAL_MICROTUBULE_ORGA...,SET,10,0.42157,0.0098312,0.2675,0.057523,GOBP_ASTRAL_MICROTUBULE_ORGANIZATION,0.793522798361935
REACTOME_TRIGLYCERIDE_METABO...,SET,35,0.23849,0.010398,0.15135,0.057553,REACTOME_TRIGLYCERIDE_METABOLISM,0.793522798361935
DESCARTES_FETAL_MUSCLE_SATEL...,SET,41,0.22537,0.010633,0.14303,0.057553,DESCARTES_FETAL_MUSCLE_SATELLITE_CELLS,0.793522798361935
GSE45365_HEALTHY_VS_MCMV_INF...7,SET,181,0.10341,0.010211,0.065648,0.057621,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN,0.793522798361935
GSE11961_MARGINAL_ZONE_BCELL...4,SET,180,0.10204,0.010049,0.064781,0.057623,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.793522798361935
GOMF_OXIDIZED_DNA_BINDING,SET,11,0.39761,0.0097247,0.25244,0.05763,GOMF_OXIDIZED_DNA_BINDING,0.793522798361935
GOBP_NK_T_CELL_ACTIVATION,SET,13,0.4396,0.011688,0.27913,0.057649,GOBP_NK_T_CELL_ACTIVATION,0.793522798361935
REACTOME_AMYLOID_FIBER_FORMA...,SET,48,0.20959,0.010697,0.1331,0.057683,REACTOME_AMYLOID_FIBER_FORMATION,0.793522798361935
HP_X_LINKED_INHERITANCE,SET,11,0.38592,0.0094387,0.24511,0.0577,HP_X_LINKED_INHERITANCE,0.793522798361935
REACTOME_SYNTHESIS_OF_IP2_IP...,SET,13,0.31472,0.0083674,0.19992,0.057729,REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL,0.793522798361935
HP_ABNORMAL_PANCREAS_SIZE,SET,33,0.24329,0.0103,0.15458,0.057766,HP_ABNORMAL_PANCREAS_SIZE,0.793522798361935
HP_ESOPHAGEAL_STENOSIS,SET,29,0.24425,0.0096949,0.1552,0.057778,HP_ESOPHAGEAL_STENOSIS,0.793522798361935
KEGG_GLYCOSPHINGOLIPID_BIOSY...2,SET,13,0.38561,0.010252,0.24512,0.057853,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,0.793522798361935
MIR101_5P,SET,37,0.20738,0.0092957,0.13183,0.057855,MIR101_5P,0.793522798361935
GSE11961_GERMINAL_CENTER_BCE...5,SET,183,0.099184,0.0098479,0.063059,0.057881,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,0.793522798361935
GSE12845_PRE_GC_VS_DARKZONE_...1,SET,176,0.098162,0.0095601,0.062415,0.057901,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.793522798361935
GOBP_FEMALE_SEX_DIFFERENTIAT...,SET,116,0.13437,0.010642,0.08544,0.057905,GOBP_FEMALE_SEX_DIFFERENTIATION,0.793522798361935
KEGG_MEDICUS_REFERENCE_TRANS...2,SET,28,0.22154,0.0086409,0.14087,0.057906,KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER,0.793522798361935
MIR3977,SET,139,0.11092,0.0096103,0.070537,0.057919,MIR3977,0.793522798361935
GSE41867_LCMV_ARMSTRONG_VS_C...4,SET,181,0.094214,0.0093038,0.059945,0.058022,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP,0.793522798361935
TRAVAGLINI_LUNG_CAPILLARY_IN...1,SET,150,0.12072,0.010862,0.076813,0.058029,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_1_CELL,0.793522798361935
GOBP_REGULATION_OF_GROWTH_HO...,SET,6,0.60091,0.010856,0.38251,0.058105,GOBP_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.793522798361935
GSE17721_0.5H_VS_12H_GARDIQU...2,SET,184,0.094108,0.0093692,0.059911,0.058123,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP,0.793522798361935
MANNO_MIDBRAIN_NEUROTYPES_HDA,SET,435,0.070742,0.010754,0.045039,0.058134,MANNO_MIDBRAIN_NEUROTYPES_HDA,0.793522798361935
ATACCTC_MIR202,SET,168,0.10562,0.010052,0.067259,0.058174,ATACCTC_MIR202,0.793522798361935
GOBP_POSITIVE_REGULATION_OF_...668,SET,14,0.34308,0.0094656,0.2185,0.058198,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING,0.793522798361935
REACTOME_MATURATION_OF_SPIKE...,SET,35,0.22643,0.0098721,0.14422,0.058213,REACTOME_MATURATION_OF_SPIKE_PROTEIN,0.793522798361935
REACTOME_E2F_ENABLED_INHIBIT...,SET,9,0.43641,0.0096553,0.27801,0.058241,REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION,0.793522798361935
MIR3920,SET,123,0.12465,0.010164,0.079439,0.058311,MIR3920,0.793522798361935
WP_CELL_DIFFERENTIATION_INDEX,SET,12,0.43346,0.011073,0.27626,0.058326,WP_CELL_DIFFERENTIATION_INDEX,0.793522798361935
HP_PLEURAL_EFFUSION,SET,78,0.15548,0.010108,0.099094,0.058334,HP_PLEURAL_EFFUSION,0.793522798361935
WIEMANN_TELOMERE_SHORTENING_...2,SET,9,0.47808,0.010577,0.30474,0.058352,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP,0.793522798361935
REACTOME_RHOB_GTPASE_CYCLE,SET,65,0.16874,0.010018,0.10756,0.058357,REACTOME_RHOB_GTPASE_CYCLE,0.793522798361935
GOBP_LABYRINTHINE_LAYER_BLOO...,SET,18,0.32184,0.010067,0.20516,0.058367,GOBP_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT,0.793522798361935
HP_ABNORMAL_LOWER_MOTOR_NEUR...,SET,26,0.24644,0.0092629,0.15712,0.058389,HP_ABNORMAL_LOWER_MOTOR_NEURON_MORPHOLOGY,0.793522798361935
CORDENONSI_YAP_CONSERVED_SIG...,SET,52,0.20336,0.010802,0.12965,0.05839,CORDENONSI_YAP_CONSERVED_SIGNATURE,0.793522798361935
RODRIGUES_THYROID_CARCINOMA_...3,SET,73,0.16884,0.01062,0.10765,0.058395,RODRIGUES_THYROID_CARCINOMA_DN,0.793522798361935
GOCC_ORIGIN_RECOGNITION_COMP...,SET,8,0.44194,0.0092186,0.28179,0.058412,GOCC_ORIGIN_RECOGNITION_COMPLEX,0.793522798361935
HP_ABNORMALITY_OF_THE_VERTEB...2,SET,35,0.24307,0.010598,0.15499,0.058414,HP_ABNORMALITY_OF_THE_VERTEBRAL_ENDPLATES,0.793522798361935
GOCC_SEC61_TRANSLOCON_COMPLEX,SET,4,0.56473,0.0083305,0.36012,0.058429,GOCC_SEC61_TRANSLOCON_COMPLEX,0.793522798361935
MORF_CDK2,SET,67,0.14866,0.0089596,0.094822,0.058477,MORF_CDK2,0.793522798361935
GOMF_UBIQUITIN_CONJUGATING_E...,SET,28,0.25514,0.0099512,0.16274,0.058482,GOMF_UBIQUITIN_CONJUGATING_ENZYME_BINDING,0.793522798361935
HP_X_LINKED_RECESSIVE_INHERI...,SET,10,0.40678,0.0094862,0.25948,0.058487,HP_X_LINKED_RECESSIVE_INHERITANCE,0.793522798361935
GOBP_REGULATION_OF_HAIR_CYCLE,SET,28,0.2701,0.010535,0.1723,0.058494,GOBP_REGULATION_OF_HAIR_CYCLE,0.793522798361935
GSE21927_SPLEEN_VS_BONE_MARR...2,SET,168,0.10399,0.0098967,0.066337,0.058501,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP,0.793522798361935
PARENT_MTOR_SIGNALING_UP,SET,504,0.057886,0.0094536,0.036929,0.058508,PARENT_MTOR_SIGNALING_UP,0.793522798361935
HP_ABNORMAL_PERICARDIUM_MORP...,SET,71,0.1627,0.010093,0.1038,0.058527,HP_ABNORMAL_PERICARDIUM_MORPHOLOGY,0.793522798361935
REACTOME_ETHANOL_OXIDATION,SET,12,0.46223,0.011808,0.29494,0.058541,REACTOME_ETHANOL_OXIDATION,0.793522798361935
MIR199A_5P,SET,166,0.10075,0.0095323,0.064299,0.058571,MIR199A_5P,0.793619923976608
MIR7843_5P,SET,86,0.14435,0.0098511,0.092145,0.058624,MIR7843_5P,0.793870245327103
MIR1250_5P,SET,6,0.51277,0.0092636,0.32739,0.058653,MIR1250_5P,0.793870245327103
GOBP_POSITIVE_REGULATION_OF_...559,SET,28,0.29842,0.011639,0.19054,0.058658,GOBP_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.793870245327103
BAELDE_DIABETIC_NEPHROPATHY_...1,SET,402,0.069537,0.010171,0.044411,0.05871,BAELDE_DIABETIC_NEPHROPATHY_DN,0.794144988326848
WP_THYMIC_STROMAL_LYMPHOPOIE...,SET,45,0.21895,0.010821,0.13985,0.058724,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,0.794144988326848
HP_NEOPLASM_OF_HEAD_AND_NECK,SET,35,0.2382,0.010385,0.15225,0.058851,HP_NEOPLASM_OF_HEAD_AND_NECK,0.795459791990669
REACTOME_NEPHRIN_FAMILY_INTE...,SET,21,0.28676,0.0096878,0.1833,0.058867,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,0.795459791990669
GOBP_GOLGI_TO_PLASMA_MEMBRAN...1,SET,40,0.21292,0.0099225,0.13612,0.058894,GOBP_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.795515340069957
TESAR_ALK_TARGETS_EPISC_3D_UP,SET,5,0.6165,0.010167,0.39423,0.05894,TESAR_ALK_TARGETS_EPISC_3D_UP,0.795519823369565
HP_INCREASED_SENSITIVITY_TO_...,SET,12,0.37897,0.0096806,0.24236,0.058959,HP_INCREASED_SENSITIVITY_TO_IONIZING_RADIATION,0.795519823369565
SCHLESINGER_METHYLATED_IN_CO...,SET,10,0.47573,0.011094,0.30425,0.058963,SCHLESINGER_METHYLATED_IN_COLON_CANCER,0.795519823369565
GSE360_L_MAJOR_VS_B_MALAYI_H...2,SET,177,0.10417,0.010174,0.066645,0.059028,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.795834247770454
HP_ABNORMALITY_OF_THE_HYPOTH...2,SET,7,0.5127,0.010004,0.32805,0.05905,HP_ABNORMALITY_OF_THE_HYPOTHENAR_EMINENCE,0.795834247770454
HP_NEOPLASM_BY_HISTOLOGY,SET,331,0.073462,0.0097697,0.047006,0.059055,HP_NEOPLASM_BY_HISTOLOGY,0.795834247770454
GSE13547_CTRL_VS_ANTI_IGM_ST...4,SET,169,0.10381,0.0099092,0.066475,0.059191,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP,0.797251702168861
MORF_IL13,SET,216,0.091062,0.009814,0.05832,0.059221,MORF_IL13,0.797251702168861
GOBP_MYELOID_DENDRITIC_CELL_...3,SET,20,0.32965,0.010869,0.21113,0.059229,GOBP_MYELOID_DENDRITIC_CELL_DIFFERENTIATION,0.797251702168861
VALK_AML_CLUSTER_3,SET,27,0.26947,0.010321,0.17265,0.05929,VALK_AML_CLUSTER_3,0.797437884097035
DAVIES_MULTIPLE_MYELOMA_VS_M...2,SET,12,0.35163,0.0089822,0.2253,0.059306,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP,0.797437884097035
DURANTE_ADULT_OLFACTORY_NEUR...23,SET,28,0.28991,0.011307,0.18576,0.059312,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_SECRETORY_CELLS,0.797437884097035
PID_AVB3_INTEGRIN_PATHWAY,SET,72,0.1661,0.010376,0.10645,0.059337,PID_AVB3_INTEGRIN_PATHWAY,0.797437884097035
GSE7852_LN_VS_FAT_TCONV_DN,SET,176,0.10488,0.010215,0.067222,0.059358,GSE7852_LN_VS_FAT_TCONV_DN,0.797437884097035
BIOCARTA_MCM_PATHWAY,SET,18,0.32934,0.010302,0.21119,0.059452,BIOCARTA_MCM_PATHWAY,0.797437884097035
HP_CONSTITUTIONAL_SYMPTOM,SET,1128,0.04225,0.010141,0.027093,0.059452,HP_CONSTITUTIONAL_SYMPTOM,0.797437884097035
GOBP_NEUROENDOCRINE_CELL_DIF...,SET,16,0.39399,0.01162,0.25265,0.059453,GOBP_NEUROENDOCRINE_CELL_DIFFERENTIATION,0.797437884097035
MIR6865_3P,SET,40,0.2043,0.0095208,0.13103,0.059493,MIR6865_3P,0.797437884097035
GOBP_SECONDARY_HEART_FIELD_S...,SET,11,0.47735,0.011675,0.30617,0.059497,GOBP_SECONDARY_HEART_FIELD_SPECIFICATION,0.797437884097035
DAVIES_MULTIPLE_MYELOMA_VS_M...1,SET,23,0.30633,0.01083,0.19649,0.059505,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,0.797437884097035
GSE24972_MARGINAL_ZONE_BCELL...3,SET,184,0.10225,0.01018,0.065607,0.059565,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP,0.797437884097035
GSE9988_ANTI_TREM1_VS_LPS_MO...2,SET,173,0.10281,0.0099274,0.065966,0.059572,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP,0.797437884097035
TSENG_IRS1_TARGETS_UP,SET,94,0.1374,0.0098012,0.088168,0.059584,TSENG_IRS1_TARGETS_UP,0.797437884097035
KEGG_MEDICUS_REFERENCE_ALTER...,SET,5,0.69215,0.011415,0.44416,0.059587,KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN,0.797437884097035
GSE3982_MAST_CELL_VS_EFF_MEM...1,SET,171,0.10093,0.0096903,0.064792,0.059655,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN,0.797784029567854
REACTOME_HYALURONAN_METABOLI...,SET,17,0.31917,0.0097027,0.2049,0.059667,REACTOME_HYALURONAN_METABOLISM,0.797784029567854
MIR509_5P,SET,141,0.11101,0.009686,0.071281,0.059703,MIR509_5P,0.797784029567854
GOBP_CELLULAR_RESPONSE_TO_FR...,SET,5,0.52606,0.0086758,0.33782,0.05972,GOBP_CELLULAR_RESPONSE_TO_FRUCTOSE_STIMULUS,0.797784029567854
GOMF_CYCLOSPORIN_A_BINDING,SET,17,0.28136,0.0085533,0.18075,0.059786,GOMF_CYCLOSPORIN_A_BINDING,0.797784029567854
URS_ADIPOCYTE_DIFFERENTIATIO...1,SET,31,0.25468,0.010451,0.16363,0.059806,URS_ADIPOCYTE_DIFFERENTIATION_DN,0.797784029567854
GOMF_HISTONE_H3K27_METHYLTRA...,SET,5,0.57698,0.0095157,0.37074,0.059826,GOMF_HISTONE_H3K27_METHYLTRANSFERASE_ACTIVITY,0.797784029567854
GSE41978_ID2_KO_VS_ID2_KO_AN...1,SET,188,0.094029,0.0094615,0.060434,0.059873,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.797784029567854
ZHONG_PFC_MAJOR_TYPES_EXCITA...,SET,8,0.47304,0.0098672,0.30403,0.059877,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.797784029567854
GOBP_NEGATIVE_REGULATION_OF_...463,SET,14,0.43626,0.012036,0.28042,0.059894,GOBP_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.797784029567854
GSE2770_UNTREATED_VS_TGFB_AN...3,SET,176,0.097335,0.0094795,0.062571,0.059913,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.797784029567854
PID_INTEGRIN_A4B1_PATHWAY,SET,32,0.23837,0.009938,0.15325,0.059926,PID_INTEGRIN_A4B1_PATHWAY,0.797784029567854
REACTOME_ATTACHMENT_OF_GPI_A...,SET,7,0.44546,0.0086922,0.28643,0.059957,REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR,0.797784029567854
WP_AMYOTROPHIC_LATERAL_SCLER...,SET,37,0.21101,0.0094583,0.13569,0.059973,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.797784029567854
GOBP_REGULATION_OF_INWARD_RE...,SET,4,0.74554,0.010998,0.47945,0.059982,GOBP_REGULATION_OF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.797784029567854
GOBP_NEGATIVE_REGULATION_OF_...276,SET,21,0.29851,0.010085,0.19203,0.060038,GOBP_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING,0.797784029567854
GOBP_MATURE_B_CELL_DIFFERENT...2,SET,30,0.24932,0.010065,0.1604,0.060055,GOBP_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.797784029567854
ZERBINI_RESPONSE_TO_SULINDAC...2,SET,9,0.52301,0.011571,0.33655,0.060099,ZERBINI_RESPONSE_TO_SULINDAC_UP,0.797784029567854
GSE3982_CENT_MEMORY_CD4_TCEL...4,SET,169,0.10045,0.0095882,0.064647,0.060122,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP,0.797784029567854
E2F_Q6_01,SET,207,0.090622,0.0095634,0.058323,0.060124,E2F_Q6_01,0.797784029567854
TOYOTA_TARGETS_OF_MIR34B_AND...,SET,400,0.062612,0.0091361,0.040302,0.060152,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,0.797784029567854
GOBP_DEVELOPMENTAL_INDUCTION,SET,30,0.26382,0.01065,0.16984,0.060177,GOBP_DEVELOPMENTAL_INDUCTION,0.797784029567854
RASHI_NFKB1_TARGETS,SET,17,0.35702,0.010853,0.22984,0.060183,RASHI_NFKB1_TARGETS,0.797784029567854
KEGG_MEDICUS_REFERENCE_WNT_S...5,SET,44,0.21536,0.010525,0.13869,0.060248,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY,0.797784029567854
HP_MESANGIAL_HYPERCELLULARITY,SET,6,0.54762,0.0098932,0.35267,0.060248,HP_MESANGIAL_HYPERCELLULARITY,0.797784029567854
HP_ABNORMAL_MATERNAL_SERUM_S...,SET,6,0.61202,0.011057,0.39417,0.06026,HP_ABNORMAL_MATERNAL_SERUM_SCREENING,0.797784029567854
HP_CEREBRAL_AMYLOID_ANGIOPAT...,SET,5,0.68121,0.011235,0.43875,0.060268,HP_CEREBRAL_AMYLOID_ANGIOPATHY,0.797784029567854
HARALAMBIEVA_PBMC_DRYVAX_AGE...,SET,14,0.38076,0.010505,0.24527,0.060294,HARALAMBIEVA_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_9_TO_34MO_UP,0.797784029567854
GTACTGT_MIR101,SET,233,0.088557,0.0099079,0.057047,0.060296,GTACTGT_MIR101,0.797784029567854
GSE29614_DAY3_VS_DAY7_TIV_FL...1,SET,158,0.10534,0.0097247,0.067857,0.060302,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,0.797784029567854
GOBP_VESICLE_TRANSPORT_ALONG...1,SET,8,0.48329,0.010081,0.31139,0.060332,GOBP_VESICLE_TRANSPORT_ALONG_ACTIN_FILAMENT,0.797784029567854
LY_AGING_MIDDLE_UP,SET,14,0.41708,0.011507,0.26879,0.060373,LY_AGING_MIDDLE_UP,0.797784029567854
GOBP_WYBUTOSINE_METABOLIC_PR...,SET,6,0.45593,0.0082368,0.29384,0.060385,GOBP_WYBUTOSINE_METABOLIC_PROCESS,0.797784029567854
GOBP_REGULATION_OF_OVARIAN_F...,SET,6,0.49,0.0088522,0.31598,0.060492,GOBP_REGULATION_OF_OVARIAN_FOLLICLE_DEVELOPMENT,0.797784029567854
HAMAI_APOPTOSIS_VIA_TRAIL_UP,SET,596,0.054183,0.009598,0.034943,0.060504,HAMAI_APOPTOSIS_VIA_TRAIL_UP,0.797784029567854
WP_NANOMATERIALINDUCED_INFLA...,SET,5,0.53679,0.0088527,0.34619,0.060512,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,0.797784029567854
WP_METHIONINE_DE_NOVO_AND_SA...,SET,21,0.3112,0.010514,0.20071,0.060521,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,0.797784029567854
GOBP_REGULATION_OF_MONOCYTE_...3,SET,6,0.54198,0.0097913,0.34957,0.060528,GOBP_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.797784029567854
GOBP_MITOTIC_SPINDLE_ASSEMBLY,SET,68,0.14952,0.0090781,0.096448,0.06055,GOBP_MITOTIC_SPINDLE_ASSEMBLY,0.797784029567854
GOBP_POSITIVE_REGULATION_OF_...543,SET,9,0.52987,0.011723,0.34181,0.060554,GOBP_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION,0.797784029567854
GOBP_REGULATION_OF_SKELETAL_...1,SET,5,0.51135,0.0084333,0.32986,0.060554,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.797784029567854
GOCC_NUCLEAR_ENVELOPE_LUMEN,SET,10,0.45182,0.010536,0.2915,0.060584,GOCC_NUCLEAR_ENVELOPE_LUMEN,0.797837886363636
HP_RENAL_STEATOSIS,SET,10,0.48969,0.01142,0.31597,0.060604,HP_RENAL_STEATOSIS,0.797837886363636
REACTOME_TP53_REGULATES_TRAN...6,SET,57,0.14711,0.0081801,0.094945,0.060648,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,0.798114820143885
GOBP_REGULATION_OF_CYSTEINE_...3,SET,11,0.38668,0.0094573,0.24969,0.060746,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.799036254256527
REACTOME_LGI_ADAM_INTERACTIO...,SET,14,0.35844,0.0098893,0.23148,0.060764,REACTOME_LGI_ADAM_INTERACTIONS,0.799036254256527
GOBP_LYMPHOCYTE_ACTIVATION,SET,727,0.052345,0.010203,0.033824,0.060872,GOBP_LYMPHOCYTE_ACTIVATION,0.79995629489603
HP_ABNORMAL_INTERNAL_GENITAL...,SET,467,0.062515,0.009838,0.040398,0.06088,HP_ABNORMAL_INTERNAL_GENITALIA,0.79995629489603
GOBP_POSITIVE_REGULATION_OF_...214,SET,16,0.3273,0.0096531,0.21153,0.060909,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.800034880952381
TESAR_ALK_AND_JAK_TARGETS_MO...1,SET,4,0.65298,0.0096324,0.42212,0.060951,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN,0.800085786199095
GOBP_DETECTION_OF_BIOTIC_STI...,SET,33,0.23803,0.010078,0.1539,0.060984,GOBP_DETECTION_OF_BIOTIC_STIMULUS,0.800085786199095
GSE8685_IL2_ACT_IL2_STARVED_...1,SET,181,0.098137,0.0096911,0.063455,0.060992,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,0.800085786199095
WP_MESODERMAL_COMMITMENT_PAT...,SET,132,0.12192,0.010295,0.078844,0.061021,WP_MESODERMAL_COMMITMENT_PATHWAY,0.800085786199095
CDC73_TARGET_GENES,SET,479,0.058573,0.0093321,0.037881,0.061034,CDC73_TARGET_GENES,0.800085786199095
MODULE_404,SET,25,0.29342,0.010815,0.18978,0.061051,MODULE_404,0.800085786199095
GOBP_REGULATION_OF_HAIR_FOLL...,SET,20,0.30504,0.010057,0.1974,0.06115,GOBP_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.80055577748494
GOBP_BILE_ACID_METABOLIC_PRO...,SET,49,0.20101,0.010365,0.13009,0.061157,GOBP_BILE_ACID_METABOLIC_PROCESS,0.80055577748494
BIOCARTA_IL17_PATHWAY,SET,15,0.37679,0.01076,0.24386,0.061171,BIOCARTA_IL17_PATHWAY,0.80055577748494
HP_DIAPHYSEAL_UNDERTUBULATION,SET,13,0.34876,0.0092726,0.22573,0.061179,HP_DIAPHYSEAL_UNDERTUBULATION,0.80055577748494
REACTOME_GDP_FUCOSE_BIOSYNTH...,SET,4,0.54656,0.0080626,0.35385,0.061229,REACTOME_GDP_FUCOSE_BIOSYNTHESIS,0.800908503951825
DURANTE_ADULT_OLFACTORY_NEUR...18,SET,11,0.42947,0.010504,0.27817,0.061314,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS,0.801271172051089
GOBP_APOPTOTIC_PROCESS_INVOL...1,SET,37,0.21388,0.0095868,0.13855,0.061345,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.801271172051089
HP_ABNORMAL_CIRCULATING_ACYL...,SET,21,0.29,0.0097973,0.18787,0.061349,HP_ABNORMAL_CIRCULATING_ACYLCARNITINE_CONCENTRATION,0.801271172051089
BIOCARTA_RNAPOL3_PATHWAY,SET,7,0.37528,0.0073228,0.24314,0.061366,BIOCARTA_RNAPOL3_PATHWAY,0.801271172051089
PUJANA_ATM_PCC_NETWORK,SET,1244,0.037492,0.0094184,0.024291,0.061372,PUJANA_ATM_PCC_NETWORK,0.801271172051089
GOCC_CILIARY_BASE,SET,35,0.21826,0.0095158,0.14146,0.06143,GOCC_CILIARY_BASE,0.801578532210835
GSE19401_NAIVE_VS_IMMUNIZED_...2,SET,186,0.10074,0.010083,0.065295,0.061442,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP,0.801578532210835
TONKS_TARGETS_OF_RUNX1_RUNX1...4,SET,47,0.20025,0.010114,0.12983,0.061496,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,0.801578532210835
TDRD3_TARGET_GENES,SET,3,0.68936,0.0088069,0.44698,0.061514,TDRD3_TARGET_GENES,0.801578532210835
GOBP_MITOTIC_SISTER_CHROMATI...3,SET,178,0.094506,0.0092556,0.061289,0.061549,GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.801578532210835
GOBP_CELLULAR_RESPONSE_TO_IO...,SET,66,0.15335,0.0091731,0.099469,0.061587,GOBP_CELLULAR_RESPONSE_TO_IONIZING_RADIATION,0.801578532210835
GOBP_REGULATION_OF_GLIAL_CEL...2,SET,74,0.17509,0.011088,0.11358,0.061603,GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.801578532210835
GSE5679_RARA_AGONIST_AM580_V...2,SET,182,0.10114,0.010014,0.065619,0.061638,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP,0.801578532210835
HP_SPOTTY_HYPERPIGMENTATION,SET,9,0.42241,0.0093455,0.27411,0.061665,HP_SPOTTY_HYPERPIGMENTATION,0.801578532210835
GOMF_SCAVENGER_RECEPTOR_ACTI...,SET,25,0.26333,0.0097055,0.1709,0.061689,GOMF_SCAVENGER_RECEPTOR_ACTIVITY,0.801578532210835
FISCHER_DREAM_TARGETS,SET,861,0.043773,0.0092499,0.028418,0.06175,FISCHER_DREAM_TARGETS,0.801578532210835
GSE46606_UNSTIM_VS_CD40L_IL2...5,SET,163,0.1003,0.0094043,0.065148,0.061835,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN,0.801578532210835
GSE25088_WT_VS_STAT6_KO_MACR...8,SET,166,0.10025,0.0094847,0.065114,0.061836,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP,0.801578532210835
GOBP_ATP_EXPORT,SET,6,0.64589,0.011668,0.41952,0.061837,GOBP_ATP_EXPORT,0.801578532210835
REACTOME_BETA_CATENIN_PHOSPH...,SET,16,0.33572,0.0099014,0.21809,0.061863,REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE,0.801578532210835
GSE43957_UNTREATED_VS_NACL_T...1,SET,181,0.098289,0.0097061,0.063853,0.061876,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.801578532210835
GOCC_POSTSYNAPTIC_DENSITY_ME...,SET,94,0.1427,0.010179,0.092723,0.061913,GOCC_POSTSYNAPTIC_DENSITY_MEMBRANE,0.801578532210835
GOBP_EYE_PHOTORECEPTOR_CELL_...2,SET,49,0.19854,0.010238,0.12902,0.061943,GOBP_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.801578532210835
HEN1_01,SET,182,0.098912,0.0097944,0.064308,0.062021,HEN1_01,0.801578532210835
GOBP_RESPONSE_TO_WOUNDING,SET,530,0.059906,0.010026,0.038949,0.062025,GOBP_RESPONSE_TO_WOUNDING,0.801578532210835
GSE41867_DAY8_EFFECTOR_VS_DA...1,SET,179,0.097369,0.0095626,0.063326,0.062083,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.801578532210835
WANG_THOC1_TARGETS_DN,SET,16,0.35763,0.010548,0.2327,0.062167,WANG_THOC1_TARGETS_DN,0.801578532210835
GOBP_REGULATION_OF_CYTOKINET...,SET,7,0.49781,0.0097135,0.32391,0.062175,GOBP_REGULATION_OF_CYTOKINETIC_PROCESS,0.801578532210835
KEGG_MEDICUS_PATHOGEN_HCMV_U...4,SET,8,0.50044,0.010439,0.32563,0.062178,KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.801578532210835
MORF_MT4,SET,234,0.085987,0.0096407,0.055952,0.06218,MORF_MT4,0.801578532210835
SU_SALIVARY_GLAND,SET,10,0.42803,0.0099817,0.27855,0.062203,SU_SALIVARY_GLAND,0.801578532210835
GSE27786_CD8_TCELL_VS_NKTCEL...1,SET,180,0.098767,0.0097266,0.064278,0.062209,GSE27786_CD8_TCELL_VS_NKTCELL_DN,0.801578532210835
GSE32164_ALTERNATIVELY_ACT_M...1,SET,179,0.096015,0.0094296,0.062489,0.062215,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN,0.801578532210835
GOBP_REGULATION_OF_WOUND_HEA...1,SET,126,0.1224,0.0101,0.079675,0.062243,GOBP_REGULATION_OF_WOUND_HEALING,0.801578532210835
HP_DYSGERMINOMA,SET,9,0.43558,0.0096368,0.28354,0.062252,HP_DYSGERMINOMA,0.801578532210835
KYNG_DNA_DAMAGE_BY_4NQO_OR_G...,SET,15,0.32799,0.0093665,0.21358,0.062323,KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION,0.801578532210835
GSE20198_IL12_VS_IFNA_TREATE...1,SET,180,0.098527,0.0097029,0.064167,0.062344,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.801578532210835
REACTOME_EGR2_AND_SOX10_MEDI...,SET,27,0.26566,0.010175,0.17304,0.062366,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,0.801578532210835
GSE32164_ALTERNATIVELY_ACT_M...2,SET,180,0.095957,0.0094499,0.062506,0.062381,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.801578532210835
MATZUK_SPERMATID_DIFFERENTIA...,SET,35,0.22782,0.0099324,0.14841,0.062392,MATZUK_SPERMATID_DIFFERENTIATION,0.801578532210835
HP_DECREASED_CIRCULATING_COR...,SET,32,0.23093,0.0096279,0.15046,0.062418,HP_DECREASED_CIRCULATING_CORTISOL_LEVEL,0.801578532210835
MIR4684_3P,SET,114,0.13142,0.010319,0.085647,0.062467,MIR4684_3P,0.801578532210835
GSE9601_UNTREATED_VS_NFKB_IN...1,SET,162,0.10148,0.0094861,0.066152,0.06251,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.801578532210835
GSE32986_GMCSF_AND_CURDLAN_L...1,SET,165,0.10421,0.0098301,0.067954,0.062576,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.801578532210835
chr3p25,SET,79,0.32015,0.020945,0.20879,0.062599,chr3p25,0.801578532210835
GOMF_MITOGEN_ACTIVATED_PROTE...1,SET,29,0.24047,0.0095449,0.15684,0.062624,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING,0.801578532210835
GOMF_PHOSPHATIDYLINOSITOL_BI...2,SET,98,0.1334,0.0097153,0.087009,0.062626,GOMF_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING,0.801578532210835
LI_PBMC_MENACTRA_AGE_18_45YO...8,SET,16,0.37026,0.01092,0.24154,0.062656,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE,0.801578532210835
GSE7831_CPG_VS_INFLUENZA_STI...3,SET,177,0.095187,0.0092964,0.062105,0.062685,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN,0.801578532210835
GOBP_TRANS_SYNAPTIC_SIGNALIN...4,SET,9,0.50871,0.011255,0.33195,0.062712,GOBP_TRANS_SYNAPTIC_SIGNALING_MODULATING_SYNAPTIC_TRANSMISSION,0.801578532210835
GOBP_POSITIVE_REGULATION_OF_...353,SET,18,0.31043,0.0097106,0.20257,0.062714,GOBP_POSITIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.801578532210835
MIR3190_5P,SET,110,0.12382,0.009551,0.080802,0.062717,MIR3190_5P,0.801578532210835
FRANCO_BLOOD_SANOFI_PASTEUR_...5,SET,19,0.28231,0.0090724,0.18423,0.062724,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_NEGATIVE,0.801578532210835
NAKAYAMA_SOFT_TISSUE_TUMORS_...1,SET,66,0.17952,0.010739,0.11717,0.062748,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,0.801578532210835
MIR216B_3P,SET,115,0.12084,0.0095287,0.078869,0.062756,MIR216B_3P,0.801578532210835
GSE3982_MEMORY_CD4_TCELL_VS_...2,SET,172,0.10344,0.00996,0.067523,0.062782,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP,0.801578532210835
REACTOME_SARS_COV_2_TARGETS_...2,SET,3,0.91458,0.011684,0.59707,0.062795,REACTOME_SARS_COV_2_TARGETS_PDZ_PROTEINS_IN_CELL_CELL_JUNCTION,0.801578532210835
HP_FATIGUE,SET,445,0.065451,0.010061,0.042728,0.062795,HP_FATIGUE,0.801578532210835
MIR670_3P,SET,269,0.080656,0.0096863,0.052656,0.062803,MIR670_3P,0.801578532210835
LEE_TARGETS_OF_PTCH1_AND_SUF...2,SET,51,0.18536,0.0097509,0.12101,0.062808,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,0.801578532210835
GSE2770_TGFB_AND_IL4_VS_IL4_...1,SET,178,0.098947,0.0096906,0.064604,0.06282,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.801578532210835
GOBP_REGULATION_OF_LAMELLIPO...3,SET,43,0.20772,0.010036,0.13563,0.062835,GOBP_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.801578532210835
GOBP_PIECEMEAL_MICROAUTOPHAG...,SET,17,0.31198,0.0094843,0.20372,0.062841,GOBP_PIECEMEAL_MICROAUTOPHAGY_OF_THE_NUCLEUS,0.801578532210835
KEGG_SPLICEOSOME,SET,117,0.10842,0.0086229,0.070797,0.062848,KEGG_SPLICEOSOME,0.801578532210835
HP_SANDWICH_APPEARANCE_OF_VE...,SET,5,0.5346,0.0088167,0.34917,0.062886,HP_SANDWICH_APPEARANCE_OF_VERTEBRAL_BODIES,0.801578532210835
TFIIA_Q6,SET,231,0.089466,0.0099671,0.058435,0.062888,TFIIA_Q6,0.801578532210835
GOMF_ZINC_ION_BINDING,SET,757,0.048764,0.0096908,0.031855,0.062915,GOMF_ZINC_ION_BINDING,0.801578532210835
GOBP_MICROTUBULE_CYTOSKELETO...2,SET,157,0.099429,0.0091506,0.064965,0.062957,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS,0.801578532210835
MIR5705,SET,5,0.62995,0.010389,0.41163,0.06297,MIR5705,0.801578532210835
GOBP_REGULATION_OF_PROTEASOM...2,SET,113,0.11817,0.0092379,0.077221,0.062975,GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.801578532210835
GSE29618_BCELL_VS_MONOCYTE_UP,SET,160,0.10895,0.010122,0.071196,0.06298,GSE29618_BCELL_VS_MONOCYTE_UP,0.801578532210835
chr15q14,SET,23,0.48763,0.01724,0.31866,0.062988,chr15q14,0.801578532210835
GOBP_REGULATION_OF_NUCLEOTID...3,SET,22,0.28248,0.0097677,0.1846,0.062989,GOBP_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.801578532210835
VANLOO_SP3_TARGETS_UP,SET,9,0.45798,0.010132,0.29932,0.063006,VANLOO_SP3_TARGETS_UP,0.801578532210835
HP_BITEMPORAL_HEMIANOPIA,SET,16,0.31193,0.0091997,0.20387,0.06301,HP_BITEMPORAL_HEMIANOPIA,0.801578532210835
NFKB_Q6_01,SET,223,0.0886,0.0097003,0.057922,0.063061,NFKB_Q6_01,0.801933792535675
HP_ABNORMALITY_OF_THE_ANTERI...1,SET,6,0.4817,0.0087023,0.31501,0.063122,HP_ABNORMALITY_OF_THE_ANTERIOR_COMMISSURE,0.80233855393053
GSE43956_WT_VS_SGK1_KO_TH17_...2,SET,183,0.097746,0.0097051,0.063927,0.063139,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP,0.80233855393053
GOBP_ALDITOL_BIOSYNTHETIC_PR...,SET,5,0.74193,0.012236,0.48536,0.063187,GOBP_ALDITOL_BIOSYNTHETIC_PROCESS,0.802655038377193
HP_RADIOULNAR_SYNOSTOSIS,SET,68,0.17017,0.010332,0.11137,0.063271,HP_RADIOULNAR_SYNOSTOSIS,0.8032238458729
GOMF_NERVE_GROWTH_FACTOR_BIN...,SET,5,0.65109,0.010738,0.42613,0.063278,GOMF_NERVE_GROWTH_FACTOR_BINDING,0.8032238458729
GNF2_MCM4,SET,52,0.17324,0.0092019,0.1134,0.063303,GNF2_MCM4,0.803247814895947
GOBP_REGULATION_OF_NEUTROPHI...1,SET,5,0.6492,0.010707,0.42519,0.063409,GOBP_REGULATION_OF_NEUTROPHIL_ACTIVATION,0.804092795404814
REACTOME_GLUCAGON_SIGNALING_...,SET,33,0.24101,0.010204,0.15786,0.063424,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,0.804092795404814
GSE2128_C57BL6_VS_NOD_THYMOC...1,SET,176,0.095114,0.0092632,0.062304,0.063439,GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN,0.804092795404814
BARX2_TARGET_GENES,SET,1491,0.034757,0.0094898,0.022773,0.063483,BARX2_TARGET_GENES,0.804317334183673
GOBP_POSITIVE_REGULATION_OF_...770,SET,17,0.30746,0.0093468,0.20147,0.063503,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.804317334183673
GOBP_NEGATIVE_REGULATION_OF_...222,SET,8,0.45302,0.0094496,0.29695,0.063566,GOBP_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.804821978142076
GOBP_RECEPTOR_DIFFUSION_TRAP...,SET,10,0.4545,0.010599,0.29805,0.06365,GOBP_RECEPTOR_DIFFUSION_TRAPPING,0.805368136363636
HP_CLEFT_ALA_NASI,SET,4,0.77085,0.011371,0.50552,0.063658,HP_CLEFT_ALA_NASI,0.805368136363636
GOBP_UDP_N_ACETYLGLUCOSAMINE...3,SET,5,0.51948,0.0085674,0.34076,0.063704,GOBP_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORT,0.805368136363636
GOMF_UDP_N_ACETYLGLUCOSAMINE...,SET,5,0.51948,0.0085674,0.34076,0.063704,GOMF_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.805368136363636
REACTOME_MRNA_EDITING,SET,9,0.52478,0.01161,0.34427,0.063725,REACTOME_MRNA_EDITING,0.805368136363636
HP_ABNORMAL_LARGE_INTESTINE_...1,SET,295,0.077652,0.0097589,0.05096,0.063789,HP_ABNORMAL_LARGE_INTESTINE_MORPHOLOGY,0.805767901526163
TGCTGAY_UNKNOWN,SET,483,0.061878,0.0098986,0.040611,0.063803,TGCTGAY_UNKNOWN,0.805767901526163
GOBP_LIPID_DROPLET_ORGANIZAT...,SET,33,0.23204,0.0098238,0.15233,0.06386,GOBP_LIPID_DROPLET_ORGANIZATION,0.805867467555876
HALLMARK_MITOTIC_SPINDLE,SET,187,0.090008,0.009033,0.059095,0.063875,HALLMARK_MITOTIC_SPINDLE,0.805867467555876
REACTOME_SIGNALING_BY_CYTOSO...,SET,17,0.371,0.011278,0.24363,0.063909,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,0.805867467555876
REACTOME_FIBRONECTIN_MATRIX_...,SET,6,0.60364,0.010905,0.39639,0.06391,REACTOME_FIBRONECTIN_MATRIX_FORMATION,0.805867467555876
GOBP_EMBRYO_DEVELOPMENT,SET,1048,0.04227,0.009802,0.027769,0.063991,GOBP_EMBRYO_DEVELOPMENT,0.805867467555876
GOBP_ESTABLISHMENT_OF_SISTER...,SET,7,0.43644,0.008516,0.28672,0.063991,GOBP_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,0.805867467555876
WP_KLEEFSTRA_SYNDROME,SET,26,0.26792,0.01007,0.17603,0.064013,WP_KLEEFSTRA_SYNDROME,0.805867467555876
GOBP_REGULATION_OF_ODONTOBLA...,SET,10,0.48446,0.011298,0.31834,0.064034,GOBP_REGULATION_OF_ODONTOBLAST_DIFFERENTIATION,0.805867467555876
GOBP_POSITIVE_REGULATION_OF_...633,SET,6,0.48996,0.0088515,0.322,0.064062,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,0.805867467555876
PPARG_01,SET,45,0.19481,0.009628,0.12804,0.064075,PPARG_01,0.805867467555876
GOBP_EMBRYONIC_CAMERA_TYPE_E...2,SET,11,0.43075,0.010535,0.28312,0.064084,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION,0.805867467555876
GOBP_INNER_EAR_RECEPTOR_CELL...1,SET,44,0.21012,0.010269,0.13814,0.064125,GOBP_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT,0.805867467555876
GOBP_ALDEHYDE_BIOSYNTHETIC_P...,SET,17,0.34791,0.010577,0.22878,0.06417,GOBP_ALDEHYDE_BIOSYNTHETIC_PROCESS,0.805867467555876
HP_INTRAHEPATIC_BILIARY_ATRE...,SET,7,0.44946,0.0087702,0.29564,0.064228,HP_INTRAHEPATIC_BILIARY_ATRESIA,0.805867467555876
WP_COVID19_AND_ENDOTHELIAL_C...,SET,5,0.66855,0.011026,0.43979,0.064242,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,0.805867467555876
VERRECCHIA_RESPONSE_TO_TGFB1...5,SET,20,0.30817,0.010161,0.20273,0.064254,VERRECCHIA_RESPONSE_TO_TGFB1_C5,0.805867467555876
HP_RETROCEREBELLAR_CYST,SET,7,0.44728,0.0087276,0.29427,0.064269,HP_RETROCEREBELLAR_CYST,0.805867467555876
GOMF_AMINO_ACID_MONOATOMIC_C...2,SET,27,0.29283,0.011216,0.19267,0.064288,GOMF_AMINO_ACID_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.805867467555876
MIR4529_5P,SET,45,0.19849,0.0098099,0.13061,0.064294,MIR4529_5P,0.805867467555876
RUTELLA_RESPONSE_TO_HGF_UP,SET,379,0.070573,0.01003,0.046439,0.064302,RUTELLA_RESPONSE_TO_HGF_UP,0.805867467555876
MIR552_3P,SET,53,0.17499,0.0093835,0.11515,0.064317,MIR552_3P,0.805867467555876
GOBP_TRIPARTITE_REGIONAL_SUB...,SET,17,0.34976,0.010633,0.23017,0.064321,GOBP_TRIPARTITE_REGIONAL_SUBDIVISION,0.805867467555876
KEGG_GLYCOSAMINOGLYCAN_DEGRA...,SET,20,0.31273,0.010311,0.20589,0.064404,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,0.806326015850144
GSE17580_UNINFECTED_VS_S_MAN...4,SET,186,0.092792,0.0092878,0.061092,0.064404,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP,0.806326015850144
GOBP_MICROTUBULE_SEVERING,SET,9,0.38465,0.00851,0.25335,0.064487,GOBP_MICROTUBULE_SEVERING,0.806813392664509
GSE32423_CTRL_VS_IL7_IL4_MEM...1,SET,190,0.089894,0.0090929,0.059221,0.064523,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.806813392664509
GOBP_SUCCINYL_COA_METABOLIC_...,SET,9,0.37931,0.008392,0.24989,0.064525,GOBP_SUCCINYL_COA_METABOLIC_PROCESS,0.806813392664509
GOMF_LIPID_BINDING,SET,790,0.048841,0.0099063,0.03218,0.064545,GOMF_LIPID_BINDING,0.806813392664509
GSE39556_CD8A_DC_VS_NK_CELL_...4,SET,181,0.098903,0.0097667,0.065168,0.064559,GSE39556_CD8A_DC_VS_NK_CELL_UP,0.806813392664509
HP_ABNORMAL_ENDOCARDIUM_MORP...,SET,54,0.19106,0.010342,0.12592,0.064607,HP_ABNORMAL_ENDOCARDIUM_MORPHOLOGY,0.807123035585909
GOBP_CELLULAR_RESPONSE_TO_ST...2,SET,193,0.094564,0.0096397,0.062351,0.064686,GOBP_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS,0.807160281261197
HP_ABNORMALITY_OF_THE_EPIPHY...3,SET,5,0.61297,0.010109,0.40423,0.064717,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,0.807160281261197
YOKOE_CANCER_TESTIS_ANTIGENS,SET,33,0.20923,0.0088583,0.13799,0.06473,YOKOE_CANCER_TESTIS_ANTIGENS,0.807160281261197
KRAS.LUNG_UP.V1_DN,SET,128,0.11736,0.0097602,0.077416,0.064773,KRAS.LUNG_UP.V1_DN,0.807160281261197
HP_CEREBRAL_CORTICAL_HEMIATR...,SET,5,0.58306,0.009616,0.38462,0.064774,HP_CEREBRAL_CORTICAL_HEMIATROPHY,0.807160281261197
WP_EUKARYOTIC_TRANSCRIPTION_...,SET,41,0.16956,0.0079998,0.11185,0.06478,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,0.807160281261197
REACTOME_PROSTACYCLIN_SIGNAL...,SET,19,0.32458,0.010431,0.21414,0.064804,REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR,0.807160281261197
MIR6883_5P,SET,373,0.067835,0.0095655,0.044755,0.064807,MIR6883_5P,0.807160281261197
GOBP_MIDBRAIN_DEVELOPMENT,SET,81,0.14631,0.0096918,0.096535,0.064819,GOBP_MIDBRAIN_DEVELOPMENT,0.807160281261197
HP_ANKYLOBLEPHARON,SET,13,0.33469,0.0088984,0.22091,0.064888,HP_ANKYLOBLEPHARON,0.807730100286533
GSE21360_NAIVE_VS_SECONDARY_...2,SET,173,0.10263,0.0099107,0.06776,0.064939,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP,0.808075526315789
GOBP_OBSERVATIONAL_LEARNING,SET,7,0.49714,0.0097006,0.32835,0.065017,GOBP_OBSERVATIONAL_LEARNING,0.808756562276306
BIOCARTA_EFP_PATHWAY,SET,16,0.3102,0.0091488,0.20491,0.065047,BIOCARTA_EFP_PATHWAY,0.808840245080501
BHAT_ESR1_TARGETS_VIA_AKT1_UP,SET,264,0.084254,0.010025,0.055665,0.065073,BHAT_ESR1_TARGETS_VIA_AKT1_UP,0.808874146995708
ROSS_AML_OF_FAB_M7_TYPE,SET,63,0.16369,0.0095674,0.10817,0.065116,ROSS_AML_OF_FAB_M7_TYPE,0.809119263496603
GOBP_REGULATION_OF_GLUCOKINA...,SET,4,0.69181,0.010205,0.45729,0.065171,GOBP_REGULATION_OF_GLUCOKINASE_ACTIVITY,0.809513261258042
MIR376A_3P_MIR376B_3P,SET,133,0.10914,0.0092506,0.07217,0.065247,MIR376A_3P_MIR376B_3P,0.809982516059957
MIR1343_5P,SET,114,0.12042,0.009455,0.079644,0.065275,MIR1343_5P,0.809982516059957
GOCC_PRERIBOSOME,SET,94,0.12306,0.0087783,0.081391,0.065284,GOCC_PRERIBOSOME,0.809982516059957
GOBP_REGULATION_OF_NUCLEOTID...1,SET,13,0.40497,0.010767,0.26787,0.065302,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.809982516059957
GOBP_REGULATION_OF_TOLL_SIGN...,SET,5,0.5882,0.0097007,0.38924,0.065383,GOBP_REGULATION_OF_TOLL_SIGNALING_PATHWAY,0.81039243315508
GOBP_REGULATION_OF_T_CELL_PR...,SET,162,0.11174,0.010445,0.073949,0.0654,GOBP_REGULATION_OF_T_CELL_PROLIFERATION,0.81039243315508
GOBP_REGULATION_OF_STRIATED_...1,SET,78,0.15185,0.0098716,0.1005,0.065405,GOBP_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.81039243315508
HP_FOLLICULITIS,SET,7,0.59936,0.011695,0.39677,0.065453,HP_FOLLICULITIS,0.810458865336658
MIR509_3_5P,SET,140,0.1081,0.0093988,0.071561,0.065457,MIR509_3_5P,0.810458865336658
GOCC_SIDE_OF_MEMBRANE,SET,661,0.055756,0.010382,0.036921,0.065511,GOCC_SIDE_OF_MEMBRANE,0.810472268041237
KEGG_MEDICUS_REFERENCE_BRANC...,SET,30,0.24196,0.0097677,0.16023,0.065521,KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION,0.810472268041237
GSE37532_VISCERAL_ADIPOSE_TI...3,SET,120,0.11495,0.0092586,0.07614,0.065558,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN,0.810472268041237
GSE29618_PRE_VS_DAY7_POST_TI...7,SET,175,0.092907,0.0090228,0.061537,0.065559,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN,0.810472268041237
GSE16385_MONOCYTE_VS_MACROPH...1,SET,171,0.099241,0.0095282,0.06574,0.065583,GSE16385_MONOCYTE_VS_MACROPHAGE_DN,0.810472268041237
REACTOME_UNWINDING_OF_DNA,SET,12,0.35829,0.0091525,0.23736,0.065598,REACTOME_UNWINDING_OF_DNA,0.810472268041237
HP_GLIOMA,SET,48,0.18057,0.0092161,0.11966,0.065649,HP_GLIOMA,0.810814141791045
GOCC_PRESYNAPTIC_ACTIVE_ZONE,SET,73,0.15852,0.0099711,0.10507,0.065686,GOCC_PRESYNAPTIC_ACTIVE_ZONE,0.810900649627263
WP_CALCIUM_MEDIATED_TCELL_AP...,SET,20,0.2877,0.0094858,0.19072,0.06572,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.810900649627263
HP_ABNORMAL_NEUTROPHIL_COUNT,SET,197,0.091076,0.0093789,0.060377,0.065726,HP_ABNORMAL_NEUTROPHIL_COUNT,0.810900649627263
RIZKI_TUMOR_INVASIVENESS_3D_...1,SET,242,0.082908,0.009451,0.054987,0.065813,RIZKI_TUMOR_INVASIVENESS_3D_DN,0.811319259194396
HP_OVARIAN_PAPILLARY_ADENOCA...,SET,6,0.5013,0.0090564,0.33251,0.065831,HP_OVARIAN_PAPILLARY_ADENOCARCINOMA,0.811319259194396
MIR519A_3P_MIR519B_3P,SET,374,0.066288,0.0093596,0.043982,0.065894,MIR519A_3P_MIR519B_3P,0.811319259194396
COLLIS_PRKDC_REGULATORS,SET,13,0.39049,0.010382,0.25914,0.065928,COLLIS_PRKDC_REGULATORS,0.811319259194396
GOBP_RENAL_SYSTEM_DEVELOPMENT,SET,315,0.079406,0.010306,0.0527,0.065944,GOBP_RENAL_SYSTEM_DEVELOPMENT,0.811319259194396
GOBP_MITOTIC_CELL_CYCLE_CHEC...,SET,134,0.10471,0.008908,0.069501,0.065975,GOBP_MITOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.811319259194396
GSE19772_CTRL_VS_HCMV_INF_MO...3,SET,144,0.10863,0.0095784,0.07212,0.066005,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN,0.811319259194396
GSE32986_GMCSF_VS_GMCSF_AND_...4,SET,171,0.099908,0.0095922,0.066331,0.066017,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.811319259194396
GOBP_AMYLOID_BETA_CLEARANCE,SET,36,0.21465,0.009491,0.14254,0.06605,GOBP_AMYLOID_BETA_CLEARANCE,0.811319259194396
GOBP_EPIGENETIC_PROGRAMMING_...2,SET,28,0.23552,0.0091858,0.1564,0.066066,GOBP_EPIGENETIC_PROGRAMMING_OF_GENE_EXPRESSION,0.811319259194396
GOMF_POTASSIUM_ION_BINDING,SET,13,0.38522,0.010242,0.25583,0.066072,GOMF_POTASSIUM_ION_BINDING,0.811319259194396
GSE24574_BCL6_LOW_TFH_VS_NAI...1,SET,171,0.10191,0.0097841,0.067681,0.066084,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN,0.811319259194396
MODULE_72,SET,285,0.076021,0.0093931,0.05049,0.066087,MODULE_72,0.811319259194396
MENON_FETAL_KIDNEY_5_PROXIMA...,SET,89,0.14106,0.0097924,0.093693,0.066102,MENON_FETAL_KIDNEY_5_PROXIMAL_TUBULE_CELLS,0.811319259194396
QIU_PBMC_HEPTATITIS_B_SURFAC...7,SET,28,0.27128,0.010581,0.1802,0.066112,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_7DY_UP,0.811319259194396
DAIRKEE_CANCER_PRONE_RESPONS...2,SET,107,0.1242,0.0094494,0.082514,0.06614,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,0.811319259194396
REACTOME_HOMOLOGOUS_DNA_PAIR...,SET,41,0.19372,0.0091398,0.12873,0.066184,REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,0.811319259194396
GOBP_ADIPOSE_TISSUE_DEVELOPM...,SET,55,0.17479,0.0095478,0.11616,0.066195,GOBP_ADIPOSE_TISSUE_DEVELOPMENT,0.811319259194396
GOBP_NEGATIVE_REGULATION_OF_...124,SET,159,0.10257,0.0094993,0.068174,0.066228,GOBP_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.811319259194396
HP_CEREBRAL_VENOUS_THROMBOSIS,SET,8,0.4432,0.0092449,0.29462,0.06626,HP_CEREBRAL_VENOUS_THROMBOSIS,0.811319259194396
HP_ABNORMAL_URINARY_ORGANIC_...,SET,57,0.17522,0.009743,0.1165,0.066301,HP_ABNORMAL_URINARY_ORGANIC_COMPOUND_LEVEL,0.811319259194396
GSE411_100MIN_VS_400MIN_IL6_...2,SET,179,0.09372,0.0092042,0.062319,0.066314,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.811319259194396
KASLER_HDAC7_TARGETS_1_DN,SET,16,0.34656,0.010221,0.2305,0.066367,KASLER_HDAC7_TARGETS_1_DN,0.811319259194396
REACTOME_SYNTHESIS_OF_15_EIC...,SET,6,0.54622,0.0098679,0.36341,0.06642,REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES,0.811319259194396
HP_GERM_CELL_NEOPLASIA,SET,40,0.20796,0.0096915,0.13836,0.066422,HP_GERM_CELL_NEOPLASIA,0.811319259194396
GSE21063_CTRL_VS_ANTI_IGM_ST...2,SET,180,0.094858,0.0093417,0.063129,0.066479,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP,0.811319259194396
GOBP_EMBRYONIC_APPENDAGE_MOR...,SET,116,0.12948,0.010254,0.086175,0.066496,GOBP_EMBRYONIC_APPENDAGE_MORPHOGENESIS,0.811319259194396
ZHONG_PFC_MAJOR_TYPES_ASTROC...,SET,299,0.079444,0.01005,0.052875,0.066496,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.811319259194396
GOBP_POSITIVE_REGULATION_OF_...722,SET,22,0.28055,0.0097011,0.18674,0.066505,GOBP_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.811319259194396
MORF_PAPSS1,SET,96,0.12839,0.0092553,0.085467,0.066525,MORF_PAPSS1,0.811319259194396
GSE32533_WT_VS_MIR17_KO_ACT_...1,SET,179,0.092825,0.0091162,0.061803,0.066564,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN,0.811319259194396
GOCC_SUPRAMOLECULAR_COMPLEX,SET,1253,0.038103,0.0096039,0.025371,0.066583,GOCC_SUPRAMOLECULAR_COMPLEX,0.811319259194396
OCONNOR_PBMC_MENVEO_ACWYVAX_...2,SET,126,0.10944,0.0090303,0.072871,0.066586,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP,0.811319259194396
GTGACGY_E4F1_Q6,SET,591,0.053785,0.0094888,0.03582,0.06662,GTGACGY_E4F1_Q6,0.811319259194396
CAO_BLOOD_FLUMIST_AGE_05_14Y...6,SET,7,0.49407,0.0096405,0.32906,0.066629,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_UP,0.811319259194396
GSE29618_PRE_VS_DAY7_POST_LA...1,SET,175,0.099802,0.0096924,0.066474,0.06664,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN,0.811319259194396
MIR3173_3P,SET,90,0.13353,0.0093217,0.088944,0.066646,MIR3173_3P,0.811319259194396
GSE40274_CTRL_VS_EOS_TRANSDU...1,SET,134,0.11621,0.0098869,0.077406,0.066647,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.811319259194396
REACTOME_PREGNENOLONE_BIOSYN...,SET,10,0.4305,0.010039,0.28681,0.066691,REACTOME_PREGNENOLONE_BIOSYNTHESIS,0.811570625
GOBP_PLACENTA_BLOOD_VESSEL_D...,SET,29,0.25088,0.009958,0.16721,0.066766,GOBP_PLACENTA_BLOOD_VESSEL_DEVELOPMENT,0.811998764418036
HP_FAILURE_TO_THRIVE_SECONDA...,SET,6,0.55351,0.0099996,0.36895,0.066784,HP_FAILURE_TO_THRIVE_SECONDARY_TO_RECURRENT_INFECTIONS,0.811998764418036
GSE6259_33D1_POS_VS_DEC205_P...1,SET,156,0.10503,0.0096355,0.070025,0.06683,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN,0.811998764418036
GOBP_REGULATION_OF_CENTROMER...2,SET,4,0.68284,0.010073,0.45529,0.066842,GOBP_REGULATION_OF_CENTROMERIC_SISTER_CHROMATID_COHESION,0.811998764418036
GOBP_NON_MEMBRANE_BOUNDED_OR...,SET,385,0.062669,0.0089751,0.041785,0.066843,GOBP_NON_MEMBRANE_BOUNDED_ORGANELLE_ASSEMBLY,0.811998764418036
GOMF_PHOSPHATIDYLINOSITOL_BI...1,SET,253,0.080271,0.0093532,0.053549,0.066944,GOMF_PHOSPHATIDYLINOSITOL_BINDING,0.812934393203884
MIR6854_5P,SET,66,0.15602,0.0093332,0.10411,0.066988,MIR6854_5P,0.812934393203884
GOCC_ENDOPLASMIC_RETICULUM_E...,SET,28,0.23263,0.0090731,0.15523,0.066994,GOCC_ENDOPLASMIC_RETICULUM_EXIT_SITE,0.812934393203884
MIR6829_5P,SET,89,0.13481,0.0093588,0.089983,0.06705,MIR6829_5P,0.812934393203884
HP_ILEAL_ATRESIA,SET,4,0.65739,0.0096974,0.43882,0.067065,HP_ILEAL_ATRESIA,0.812934393203884
WP_INTERACTOME_OF_POLYCOMB_R...,SET,15,0.30374,0.0086741,0.20277,0.067079,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,0.812934393203884
HP_SUBACUTE_PROGRESSIVE_VIRA...,SET,9,0.43367,0.0095946,0.28956,0.067117,HP_SUBACUTE_PROGRESSIVE_VIRAL_HEPATITIS,0.812934393203884
HINATA_NFKB_IMMU_INF,SET,15,0.38552,0.01101,0.25745,0.067142,HINATA_NFKB_IMMU_INF,0.812934393203884
GSE8621_LPS_PRIMED_UNSTIM_VS...2,SET,175,0.09485,0.0092115,0.063344,0.067157,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.812934393203884
HP_SUPERNUMERARY_MAXILLARY_I...,SET,3,0.85558,0.01093,0.57152,0.067202,HP_SUPERNUMERARY_MAXILLARY_INCISOR,0.812934393203884
HP_APLASIA_OF_THE_BLADDER,SET,5,0.59964,0.0098894,0.40056,0.067203,HP_APLASIA_OF_THE_BLADDER,0.812934393203884
REACTOME_INTERLEUKIN_27_SIGN...,SET,11,0.4049,0.0099031,0.27051,0.06723,REACTOME_INTERLEUKIN_27_SIGNALING,0.812934393203884
HP_ABNORMALITY_OF_THE_LYMPHA...,SET,694,0.049585,0.009452,0.033131,0.067254,HP_ABNORMALITY_OF_THE_LYMPHATIC_SYSTEM,0.812934393203884
HP_LONG_PALM,SET,3,0.81472,0.010408,0.54438,0.067257,HP_LONG_PALM,0.812934393203884
MIR4483,SET,85,0.14601,0.0099067,0.097576,0.06729,MIR4483,0.812934393203884
GOBP_EMBRYONIC_BRAIN_DEVELOP...,SET,15,0.3558,0.010161,0.23783,0.067332,GOBP_EMBRYONIC_BRAIN_DEVELOPMENT,0.812934393203884
MEDINA_SMARCA4_TARGETS,SET,35,0.22441,0.0097839,0.15003,0.067362,MEDINA_SMARCA4_TARGETS,0.812934393203884
MODULE_491,SET,68,0.15322,0.0093029,0.10246,0.067402,MODULE_491,0.812934393203884
GSE46606_IRF4MID_VS_WT_CD40L...3,SET,186,0.089597,0.0089679,0.059916,0.067417,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.812934393203884
KEGG_MEDICUS_REFERENCE_LPA_G...1,SET,12,0.34454,0.0088011,0.23041,0.06742,KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,0.812934393203884
CERIBELLI_PROMOTERS_INACTIVE...,SET,30,0.24263,0.0097948,0.16228,0.067447,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,0.812934393203884
ZHANG_RESPONSE_TO_CANTHARIDI...2,SET,14,0.35975,0.0099254,0.24061,0.067447,ZHANG_RESPONSE_TO_CANTHARIDIN_UP,0.812934393203884
E2F1DP1RB_01,SET,208,0.089049,0.0094198,0.059562,0.067458,E2F1DP1RB_01,0.812934393203884
TGACAGNY_MEIS1_01,SET,766,0.048527,0.0096985,0.032467,0.067509,TGACAGNY_MEIS1_01,0.813117671517671
GOBP_MULTICELLULAR_ORGANISMA...4,SET,33,0.24836,0.010515,0.16618,0.06752,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_WATER_HOMEOSTASIS,0.813117671517671
GSE17721_LPS_VS_POLYIC_12H_B...2,SET,185,0.091762,0.0091602,0.061424,0.067609,GSE17721_LPS_VS_POLYIC_12H_BMDC_UP,0.813300637746284
ZHANG_ANTIVIRAL_RESPONSE_TO_...1,SET,43,0.21028,0.01016,0.14077,0.067619,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,0.813300637746284
GOBP_POSITIVE_REGULATION_OF_...26,SET,19,0.29399,0.009448,0.19681,0.067627,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_FORMATION,0.813300637746284
HP_SEVERE_POSTNATAL_GROWTH_R...,SET,32,0.23488,0.0097924,0.15728,0.067681,HP_SEVERE_POSTNATAL_GROWTH_RETARDATION,0.813300637746284
GSE13547_2H_VS_12_H_ANTI_IGM...1,SET,165,0.093909,0.0088582,0.062885,0.067682,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN,0.813300637746284
DANG_BOUND_BY_MYC,SET,942,0.040878,0.0090145,0.027375,0.067696,DANG_BOUND_BY_MYC,0.813300637746284
RAMPON_ENRICHED_LEARNING_ENV...3,SET,21,0.25505,0.0086168,0.17081,0.067699,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,0.813300637746284
SOX11_TARGET_GENES,SET,35,0.20277,0.0088406,0.13583,0.067746,SOX11_TARGET_GENES,0.813584046302695
MIR9899,SET,4,0.58853,0.0086817,0.39436,0.067811,MIR9899,0.813868206409373
MIR4725_3P,SET,260,0.078567,0.0092787,0.052656,0.067846,MIR4725_3P,0.813868206409373
HP_PITUITARY_HYPOTHYROIDISM,SET,35,0.21881,0.0095396,0.14665,0.067857,HP_PITUITARY_HYPOTHYROIDISM,0.813868206409373
MODULE_44,SET,292,0.079777,0.0099756,0.053477,0.067887,MODULE_44,0.813868206409373
DURANTE_ADULT_OLFACTORY_NEUR...9,SET,73,0.16637,0.010465,0.11153,0.067904,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES,0.813868206409373
MIR548BA,SET,159,0.10142,0.0093922,0.067997,0.067929,MIR548BA,0.813868206409373
GOBP_PHAGOSOME_LYSOSOME_FUSI...,SET,13,0.37358,0.0099324,0.25051,0.067952,GOBP_PHAGOSOME_LYSOSOME_FUSION,0.813868206409373
KEGG_MEDICUS_VARIANT_AMPLIFI...10,SET,5,0.55754,0.009195,0.37387,0.067957,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION,0.813868206409373
PARK_APL_PATHOGENESIS_DN,SET,47,0.19744,0.0099718,0.1325,0.068107,PARK_APL_PATHOGENESIS_DN,0.814715312702528
PID_IL3_PATHWAY,SET,25,0.26635,0.0098171,0.17876,0.068119,PID_IL3_PATHWAY,0.814715312702528
GOBP_POSITIVE_REGULATION_OF_...58,SET,48,0.19524,0.0099651,0.13104,0.068121,GOBP_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.814715312702528
GOBP_GOLGI_TO_LYSOSOME_TRANS...,SET,12,0.34449,0.0088,0.23122,0.068136,GOBP_GOLGI_TO_LYSOSOME_TRANSPORT,0.814715312702528
PRKDC_TARGET_GENES,SET,697,0.049188,0.0093957,0.03302,0.068166,PRKDC_TARGET_GENES,0.814715312702528
HE_LIM_SUN_FETAL_LUNG_C5_LAR...,SET,1182,0.036203,0.0088812,0.024316,0.068271,HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL,0.814715312702528
GSE36078_WT_VS_IL1R_KO_LUNG_...3,SET,179,0.095408,0.0093699,0.064098,0.068323,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN,0.814715312702528
ZWANG_EGF_PERSISTENTLY_UP,SET,27,0.24091,0.0092273,0.16187,0.068336,ZWANG_EGF_PERSISTENTLY_UP,0.814715312702528
GENTILE_RESPONSE_CLUSTER_D3,SET,50,0.17865,0.0093057,0.12003,0.068339,GENTILE_RESPONSE_CLUSTER_D3,0.814715312702528
FXR1_TARGET_GENES,SET,979,0.040655,0.00913,0.027316,0.068343,FXR1_TARGET_GENES,0.814715312702528
GRESHOCK_CANCER_COPY_NUMBER_...,SET,310,0.07328,0.0094368,0.049238,0.068346,GRESHOCK_CANCER_COPY_NUMBER_UP,0.814715312702528
KEGG_MEDICUS_VARIANT_MUTATIO...76,SET,20,0.27072,0.0089258,0.1819,0.068347,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.814715312702528
REACTOME_CD163_MEDIATING_AN_...,SET,8,0.45499,0.0094908,0.30585,0.068436,REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE,0.814715312702528
REACTOME_RNA_POLYMERASE_I_TR...2,SET,42,0.17177,0.0082021,0.11547,0.068444,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,0.814715312702528
RASHI_RESPONSE_TO_IONIZING_R...2,SET,117,0.12367,0.0098361,0.083143,0.068458,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,0.814715312702528
GOBP_PYROPTOSIS,SET,33,0.22968,0.009724,0.15447,0.06853,GOBP_PYROPTOSIS,0.814715312702528
GOBP_SOMITE_DEVELOPMENT,SET,74,0.15386,0.0097438,0.10349,0.068556,GOBP_SOMITE_DEVELOPMENT,0.814715312702528
GOBP_G2_MI_TRANSITION_OF_MEI...,SET,6,0.47827,0.0086403,0.32173,0.068574,GOBP_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.814715312702528
GOCC_CORTICAL_GRANULE,SET,6,0.49722,0.0089826,0.33454,0.068613,GOCC_CORTICAL_GRANULE,0.814715312702528
GSE40666_WT_VS_STAT1_KO_CD8_...2,SET,182,0.097741,0.0096784,0.065765,0.06862,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP,0.814715312702528
GOBP_ORGANIC_HYDROXY_COMPOUN...2,SET,51,0.19332,0.01017,0.13009,0.068642,GOBP_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS,0.814715312702528
GOCC_IGM_IMMUNOGLOBULIN_COMP...,SET,3,0.8377,0.010702,0.56384,0.068686,GOCC_IGM_IMMUNOGLOBULIN_COMPLEX,0.814715312702528
ALK_DN.V1_DN,SET,129,0.11631,0.00971,0.078308,0.068749,ALK_DN.V1_DN,0.814715312702528
CAFFAREL_RESPONSE_TO_THC_8HR...1,SET,9,0.34609,0.007657,0.23303,0.068758,CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,0.814715312702528
BOYAULT_LIVER_CANCER_SUBCLAS...16,SET,58,0.16273,0.0091271,0.10958,0.06879,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,0.814715312702528
GOCC_LATERAL_ELEMENT,SET,13,0.32633,0.0086761,0.21984,0.068856,GOCC_LATERAL_ELEMENT,0.814715312702528
SA_CASPASE_CASCADE,SET,18,0.3091,0.0096687,0.20825,0.068881,SA_CASPASE_CASCADE,0.814715312702528
MIR339_3P,SET,6,0.49292,0.008905,0.33215,0.068906,MIR339_3P,0.814715312702528
GOBP_SPINDLE_MIDZONE_ASSEMBLY,SET,13,0.33786,0.0089827,0.2277,0.068944,GOBP_SPINDLE_MIDZONE_ASSEMBLY,0.814715312702528
GOBP_REGULATION_OF_CATABOLIC...,SET,917,0.042537,0.0092616,0.028669,0.068952,GOBP_REGULATION_OF_CATABOLIC_PROCESS,0.814715312702528
BIOCARTA_WNT_PATHWAY,SET,23,0.2776,0.0098144,0.18713,0.068981,BIOCARTA_WNT_PATHWAY,0.814715312702528
GSE21546_WT_VS_SAP1A_KO_AND_...3,SET,183,0.097668,0.0096974,0.065847,0.069012,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.814715312702528
GOBP_POSITIVE_REGULATION_OF_...366,SET,26,0.27471,0.010325,0.18526,0.069062,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.814715312702528
GOBP_REGULATION_OF_MICROVILL...2,SET,7,0.41776,0.0081516,0.28173,0.069069,GOBP_REGULATION_OF_MICROVILLUS_LENGTH,0.814715312702528
HP_LIMITED_KNEE_EXTENSION,SET,17,0.33395,0.010152,0.22524,0.069097,HP_LIMITED_KNEE_EXTENSION,0.814715312702528
GOCC_ESC_E_Z_COMPLEX,SET,14,0.3246,0.0089555,0.21894,0.069105,GOCC_ESC_E_Z_COMPLEX,0.814715312702528
REACTOME_G0_AND_EARLY_G1,SET,27,0.22506,0.00862,0.15181,0.069115,REACTOME_G0_AND_EARLY_G1,0.814715312702528
GOBP_RIGHTING_REFLEX,SET,8,0.4709,0.0098226,0.31768,0.069139,GOBP_RIGHTING_REFLEX,0.814715312702528
GSE17721_CTRL_VS_GARDIQUIMOD...12,SET,184,0.08987,0.0089472,0.060646,0.069195,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP,0.814715312702528
SOBOLEV_T_CELL_PANDEMRIX_AGE...1,SET,23,0.25818,0.0091277,0.17429,0.069268,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP,0.814715312702528
HP_EEG_WITH_SPIKE_WAVE_COMPL...1,SET,88,0.14186,0.0097926,0.09577,0.069284,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES,0.814715312702528
MORF_CCNF,SET,72,0.13661,0.0085339,0.092231,0.069289,MORF_CCNF,0.814715312702528
HP_ABNORMAL_SIZE_OF_PITUITAR...,SET,27,0.24506,0.009386,0.16547,0.069312,HP_ABNORMAL_SIZE_OF_PITUITARY_GLAND,0.814715312702528
WOO_LIVER_CANCER_RECURRENCE_...1,SET,75,0.15364,0.0097951,0.10375,0.069325,WOO_LIVER_CANCER_RECURRENCE_DN,0.814715312702528
WP_FAS_LIGAND_PATHWAY_AND_ST...,SET,42,0.19613,0.0093655,0.13247,0.06936,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.814715312702528
GOBP_POSITIVE_REGULATION_OF_...566,SET,62,0.17458,0.010123,0.11792,0.069391,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.814715312702528
LIU_CDX2_TARGETS_UP,SET,32,0.24255,0.010112,0.16385,0.069402,LIU_CDX2_TARGETS_UP,0.814715312702528
GOBP_NEPHRON_MORPHOGENESIS,SET,75,0.15768,0.010052,0.10652,0.06941,GOBP_NEPHRON_MORPHOGENESIS,0.814715312702528
GAZDA_DIAMOND_BLACKFAN_ANEMI...2,SET,23,0.25741,0.0091006,0.1739,0.069416,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,0.814715312702528
GOBP_REGULATION_OF_ANIMAL_OR...2,SET,82,0.15228,0.010149,0.10288,0.069421,GOBP_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.814715312702528
GOMF_PHOSPHATIDYLINOSITOL_3_...10,SET,24,0.28635,0.010341,0.19352,0.069488,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING,0.814715312702528
NGUYEN_NOTCH1_TARGETS_UP,SET,25,0.26084,0.0096141,0.17632,0.069524,NGUYEN_NOTCH1_TARGETS_UP,0.814715312702528
HP_ABSENCE_OF_SUBCUTANEOUS_F...,SET,13,0.31541,0.0083857,0.21324,0.06956,HP_ABSENCE_OF_SUBCUTANEOUS_FAT,0.814715312702528
IL2_UP.V1_DN,SET,159,0.10562,0.0097814,0.071409,0.069571,IL2_UP.V1_DN,0.814715312702528
WP_PHOTODYNAMIC_THERAPYINDUC...5,SET,25,0.26372,0.0097201,0.17831,0.06958,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,0.814715312702528
GSE24972_WT_VS_IRF8_KO_SPLEE...1,SET,178,0.094322,0.0092376,0.063779,0.069594,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN,0.814715312702528
MORF_DMPK,SET,153,0.10442,0.009488,0.070628,0.069648,MORF_DMPK,0.814715312702528
GOMF_EXTRACELLULAR_MATRIX_ST...3,SET,42,0.21764,0.010393,0.14725,0.0697,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH,0.814715312702528
HP_ABSENT_PHALANGEAL_CREASE,SET,15,0.35398,0.010109,0.23954,0.069752,HP_ABSENT_PHALANGEAL_CREASE,0.814715312702528
CREIGHTON_AKT1_SIGNALING_VIA...1,SET,20,0.26294,0.0086693,0.17794,0.069753,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,0.814715312702528
HP_EXSTROPHY,SET,6,0.54015,0.0097582,0.36553,0.069754,HP_EXSTROPHY,0.814715312702528
HP_REDUCED_CIRCULATING_PROLA...,SET,20,0.28093,0.0092624,0.19012,0.069766,HP_REDUCED_CIRCULATING_PROLACTIN_CONCENTRATION,0.814715312702528
MANNO_MIDBRAIN_NEUROTYPES_HN...4,SET,413,0.067573,0.010015,0.045735,0.069783,MANNO_MIDBRAIN_NEUROTYPES_HNBML5,0.814715312702528
GSE40443_INDUCED_VS_TOTAL_TR...2,SET,181,0.095399,0.0094207,0.064573,0.069794,GSE40443_INDUCED_VS_TOTAL_TREG_UP,0.814715312702528
GSE14308_TH2_VS_INDUCED_TREG...1,SET,180,0.089163,0.0087808,0.060353,0.0698,GSE14308_TH2_VS_INDUCED_TREG_DN,0.814715312702528
GOBP_EXPORT_FROM_CELL,SET,834,0.045877,0.0095488,0.031064,0.069862,GOBP_EXPORT_FROM_CELL,0.814715312702528
GOBP_REPLICATIVE_SENESCENCE,SET,16,0.28964,0.0085425,0.19614,0.06988,GOBP_REPLICATIVE_SENESCENCE,0.814715312702528
WP_ENDOPLASMIC_RETICULUM_STR...,SET,44,0.18855,0.0092145,0.1277,0.069914,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.814715312702528
GSE19923_WT_VS_HEB_AND_E2A_K...2,SET,182,0.090891,0.0090001,0.061559,0.069917,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.814715312702528
GOBP_POSITIVE_REGULATION_OF_...222,SET,13,0.34402,0.0091464,0.23301,0.06993,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.814715312702528
TONKS_TARGETS_OF_RUNX1_RUNX1...11,SET,14,0.36706,0.010127,0.24866,0.069956,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,0.814715312702528
GOBP_MAINTENANCE_OF_BLOOD_BR...,SET,37,0.23193,0.010396,0.15712,0.069969,GOBP_MAINTENANCE_OF_BLOOD_BRAIN_BARRIER,0.814715312702528
GSE3982_EOSINOPHIL_VS_MAC_UP,SET,173,0.098588,0.0095202,0.0668,0.069997,GSE3982_EOSINOPHIL_VS_MAC_UP,0.814715312702528
GSE40184_HEALTHY_VS_HCV_INFE...1,SET,188,0.089773,0.0090332,0.060831,0.070013,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN,0.814715312702528
WP_PLEURAL_MESOTHELIOMA,SET,418,0.066306,0.0098854,0.044938,0.070048,WP_PLEURAL_MESOTHELIOMA,0.814715312702528
GOBP_DETECTION_OF_EXTERNAL_B...,SET,23,0.27572,0.0097479,0.18688,0.070059,GOBP_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS,0.814715312702528
GOMF_VOLTAGE_GATED_MONOATOMI...3,SET,11,0.44128,0.010793,0.29915,0.070103,GOMF_VOLTAGE_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.814715312702528
GSE22589_HEALTHY_VS_SIV_INFE...2,SET,177,0.091914,0.0089767,0.062314,0.070114,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP,0.814715312702528
CEBALLOS_TARGETS_OF_TP53_AND...1,SET,29,0.23751,0.0094273,0.16104,0.070134,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,0.814715312702528
GOBP_POSITIVE_REGULATION_OF_...750,SET,29,0.22345,0.0088691,0.15153,0.070165,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY,0.814715312702528
GOMF_LIPOTEICHOIC_ACID_BINDI...,SET,5,0.58511,0.0096497,0.3968,0.070174,GOMF_LIPOTEICHOIC_ACID_BINDING,0.814715312702528
HSIAO_LIVER_SPECIFIC_GENES,SET,229,0.089959,0.0099791,0.06101,0.070182,HSIAO_LIVER_SPECIFIC_GENES,0.814715312702528
HEIDENBLAD_AMPLIFIED_IN_PANC...,SET,53,0.18439,0.0098877,0.12512,0.070295,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,0.814715312702528
GSE7460_FOXP3_MUT_VS_HET_ACT...2,SET,183,0.095738,0.0095058,0.064973,0.070316,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP,0.814715312702528
ACTGCAG_MIR173P,SET,95,0.12862,0.0092236,0.087297,0.070333,ACTGCAG_MIR173P,0.814715312702528
GOCC_WNT_SIGNALOSOME,SET,13,0.37199,0.0098901,0.25255,0.070391,GOCC_WNT_SIGNALOSOME,0.814715312702528
GOCC_IGA_IMMUNOGLOBULIN_COMP...1,SET,2,0.95127,0.009923,0.6459,0.070415,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX,0.814715312702528
GOCC_IGA_IMMUNOGLOBULIN_COMP...2,SET,2,0.95127,0.009923,0.6459,0.070415,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.814715312702528
WP_G13_SIGNALING,SET,35,0.21765,0.0094891,0.14779,0.070434,WP_G13_SIGNALING,0.814715312702528
BLALOCK_ALZHEIMERS_DISEASE_I...2,SET,350,0.065908,0.0090084,0.044761,0.070461,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,0.814715312702528
GOBP_REGULATION_OF_CDC42_PRO...,SET,8,0.51832,0.010812,0.3521,0.070511,GOBP_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.814715312702528
CUI_DEVELOPING_HEART_C2_CARD...,SET,85,0.14444,0.0098004,0.098124,0.070516,CUI_DEVELOPING_HEART_C2_CARDIOMYOCYTE,0.814715312702528
GOBP_EAR_DEVELOPMENT,SET,209,0.093298,0.0098926,0.063387,0.070537,GOBP_EAR_DEVELOPMENT,0.814715312702528
GOBP_URONIC_ACID_METABOLIC_P...,SET,24,0.37421,0.013514,0.25427,0.070558,GOBP_URONIC_ACID_METABOLIC_PROCESS,0.814715312702528
GOMF_PROTEIN_PHOSPHATASE_2A_...,SET,26,0.25513,0.0095895,0.17337,0.070576,GOMF_PROTEIN_PHOSPHATASE_2A_BINDING,0.814715312702528
PARK_HSC_VS_MULTIPOTENT_PROG...1,SET,14,0.33885,0.0093489,0.23027,0.070585,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,0.814715312702528
ZNF320_TARGET_GENES,SET,1230,0.037598,0.0093956,0.025553,0.070606,ZNF320_TARGET_GENES,0.814715312702528
GCM_CHUK,SET,69,0.14582,0.0089181,0.099122,0.070639,GCM_CHUK,0.814715312702528
HP_DECREASED_CORNEAL_SENSATI...,SET,5,0.6418,0.010585,0.43631,0.070656,HP_DECREASED_CORNEAL_SENSATION,0.814715312702528
WP_MBDNF_AND_PROBDNF_REGULAT...,SET,35,0.23983,0.010456,0.16308,0.070706,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,0.814715312702528
KEGG_MEDICUS_REFERENCE_BREAK...,SET,8,0.4484,0.0093534,0.30491,0.070709,KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION,0.814715312702528
ARNT_01,SET,238,0.083561,0.0094474,0.056821,0.070709,ARNT_01,0.814715312702528
MIR214_5P,SET,49,0.18411,0.0094937,0.12522,0.070754,MIR214_5P,0.814715312702528
GOBP_RESPONSE_TO_STEROID_HOR...,SET,310,0.073587,0.0094763,0.050056,0.070779,GOBP_RESPONSE_TO_STEROID_HORMONE,0.814715312702528
MODULE_356,SET,140,0.10651,0.0092607,0.072454,0.070785,MODULE_356,0.814715312702528
HP_ABNORMALITY_OF_RENAL_EXCR...,SET,62,0.16908,0.0098043,0.11502,0.07079,HP_ABNORMALITY_OF_RENAL_EXCRETION,0.814715312702528
CLASPER_LYMPHATIC_VESSELS_DU...2,SET,18,0.31774,0.009939,0.21616,0.070799,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,0.814715312702528
GOBP_CILIUM_DISASSEMBLY,SET,5,0.54487,0.0089861,0.37073,0.07083,GOBP_CILIUM_DISASSEMBLY,0.814715312702528
GOBP_NEGATIVE_REGULATION_OF_...131,SET,11,0.38043,0.0093045,0.25888,0.070859,GOBP_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION,0.814715312702528
IVANOVA_HEMATOPOIESIS_LATE_P...,SET,466,0.056372,0.008862,0.038369,0.070899,IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,0.814715312702528
GSE3982_MAST_CELL_VS_CENT_ME...1,SET,163,0.095375,0.0089422,0.064918,0.070903,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN,0.814715312702528
GOBP_NEGATIVE_REGULATION_OF_...19,SET,5,0.5459,0.009003,0.3716,0.070917,GOBP_NEGATIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.814715312702528
GOCC_COPI_COATED_VESICLE,SET,24,0.22561,0.0081477,0.15359,0.070933,GOCC_COPI_COATED_VESICLE,0.814715312702528
RIZ_ERYTHROID_DIFFERENTIATION,SET,73,0.14397,0.0090555,0.098017,0.070951,RIZ_ERYTHROID_DIFFERENTIATION,0.814715312702528
GSE43955_10H_VS_30H_ACT_CD4_...2,SET,183,0.094936,0.0094261,0.064645,0.070983,GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP,0.814715312702528
GTTNYYNNGGTNA_UNKNOWN,SET,80,0.136,0.0089532,0.092614,0.071003,GTTNYYNNGGTNA_UNKNOWN,0.814715312702528
GOBP_PLASMA_CELL_DIFFERENTIA...,SET,9,0.41536,0.0091894,0.28287,0.071008,GOBP_PLASMA_CELL_DIFFERENTIATION,0.814715312702528
ABBUD_LIF_SIGNALING_1_DN,SET,21,0.29404,0.009934,0.20027,0.071033,ABBUD_LIF_SIGNALING_1_DN,0.814715312702528
FURUKAWA_DUSP6_TARGETS_PCI35...1,SET,71,0.14921,0.0092564,0.10163,0.071039,FURUKAWA_DUSP6_TARGETS_PCI35_DN,0.814715312702528
GSE18281_SUBCAPSULAR_CORTICA...4,SET,188,0.085478,0.008601,0.058236,0.071089,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.814715312702528
WINTER_HYPOXIA_DN,SET,42,0.20988,0.010022,0.143,0.071099,WINTER_HYPOXIA_DN,0.814715312702528
GOMF_RETROMER_COMPLEX_BINDING,SET,6,0.58515,0.010571,0.39875,0.071133,GOMF_RETROMER_COMPLEX_BINDING,0.814715312702528
GOMF_PHOSPHOPROTEIN_BINDING,SET,87,0.13522,0.0092815,0.092146,0.071136,GOMF_PHOSPHOPROTEIN_BINDING,0.814715312702528
HP_LARGE_INTESTINAL_POLYPOSIS,SET,31,0.20641,0.0084701,0.1407,0.071195,HP_LARGE_INTESTINAL_POLYPOSIS,0.814715312702528
GOBP_NEGATIVE_REGULATION_OF_...501,SET,75,0.14838,0.0094593,0.10115,0.071218,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.814715312702528
GOMF_NUCLEAR_LOCALIZATION_SE...,SET,23,0.26103,0.0092284,0.17797,0.071235,GOMF_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING,0.814715312702528
GOBP_POSITIVE_REGULATION_OF_...688,SET,1685,0.031989,0.0092314,0.02181,0.071238,GOBP_POSITIVE_REGULATION_OF_RNA_METABOLIC_PROCESS,0.814715312702528
GSE12484_HEALTHY_VS_PERIDONT...2,SET,121,0.12086,0.0097746,0.082408,0.071247,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP,0.814715312702528
SCHERER_PBMC_APSV_WETVAX_AGE...7,SET,20,0.29527,0.0097351,0.20135,0.071272,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_DN,0.814715312702528
MIR199B_5P,SET,165,0.094471,0.0089111,0.064432,0.071306,MIR199B_5P,0.814715312702528
MIR3926,SET,160,0.098176,0.0091204,0.066977,0.071359,MIR3926,0.814715312702528
GOBP_RETINA_LAYER_FORMATION,SET,22,0.29528,0.01021,0.20148,0.071386,GOBP_RETINA_LAYER_FORMATION,0.814715312702528
GARCIA_PINERES_PBMC_HPV_16_L...4,SET,305,0.074783,0.0095536,0.051025,0.071387,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP,0.814715312702528
KEGG_MEDICUS_VARIANT_MUTATIO...80,SET,18,0.27559,0.0086206,0.18806,0.071412,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.814715312702528
GOBP_CELL_FATE_SPECIFICATION,SET,101,0.13321,0.0098479,0.090906,0.071423,GOBP_CELL_FATE_SPECIFICATION,0.814715312702528
REACTOME_INTERLEUKIN_23_SIGN...,SET,9,0.44713,0.0098923,0.30514,0.071427,REACTOME_INTERLEUKIN_23_SIGNALING,0.814715312702528
HARALAMBIEVA_PBMC_FLUARIX_AG...8,SET,555,0.049803,0.008523,0.033991,0.071445,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE,0.814715312702528
REACTOME_ADP_SIGNALLING_THRO...1,SET,25,0.27742,0.010225,0.18935,0.071458,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1,0.814715312702528
KEGG_T_CELL_RECEPTOR_SIGNALI...,SET,103,0.12514,0.0093423,0.085443,0.071519,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.814715312702528
WP_GLYCEROPHOSPHOLIPID_BIOSY...,SET,27,0.25065,0.0096001,0.17113,0.071522,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,0.814715312702528
GOBP_REGULATION_OF_BODY_FLUI...,SET,352,0.071514,0.0098019,0.048833,0.071542,GOBP_REGULATION_OF_BODY_FLUID_LEVELS,0.814715312702528
CHESLER_BRAIN_QTL_TRANS,SET,6,0.54148,0.0097823,0.36978,0.071558,CHESLER_BRAIN_QTL_TRANS,0.814715312702528
MIR7157_5P,SET,194,0.092541,0.0094576,0.063203,0.07158,MIR7157_5P,0.814715312702528
GOMF_HISTONE_H3_KINASE_ACTIV...,SET,10,0.40824,0.0095202,0.27888,0.071628,GOMF_HISTONE_H3_KINASE_ACTIVITY,0.814715312702528
WP_DRUG_INDUCTION_OF_BILE_AC...,SET,17,0.31792,0.0096647,0.21723,0.071677,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.814715312702528
BUSSLINGER_ESOPHAGEAL_PROLIF...,SET,67,0.15718,0.0094728,0.10741,0.071696,BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS,0.814715312702528
GOMF_NEUROTROPHIN_RECEPTOR_B...,SET,11,0.36126,0.0088356,0.24689,0.071707,GOMF_NEUROTROPHIN_RECEPTOR_BINDING,0.814715312702528
HP_EXPRESSIVE_APHASIA,SET,11,0.3774,0.0092305,0.25792,0.071708,HP_EXPRESSIVE_APHASIA,0.814715312702528
REACTOME_REGULATION_OF_ENDOG...2,SET,47,0.17585,0.0088814,0.12018,0.071711,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS,0.814715312702528
CROMER_METASTASIS_UP,SET,58,0.16465,0.0092353,0.11254,0.071742,CROMER_METASTASIS_UP,0.814715312702528
KEGG_MEDICUS_REFERENCE_AUTOP...7,SET,5,0.61819,0.010195,0.42256,0.07175,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2,0.814715312702528
GOBP_SRP_DEPENDENT_COTRANSLA...3,SET,8,0.44073,0.0091933,0.30126,0.071751,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,0.814715312702528
HOXA1_TARGET_GENES,SET,955,0.04118,0.0091402,0.02815,0.071756,HOXA1_TARGET_GENES,0.814715312702528
HUMMEL_BURKITTS_LYMPHOMA_UP,SET,38,0.2143,0.0097344,0.14652,0.071799,HUMMEL_BURKITTS_LYMPHOMA_UP,0.814715312702528
GOMF_TRANSITION_METAL_ION_BI...,SET,1008,0.041381,0.0094219,0.028293,0.071801,GOMF_TRANSITION_METAL_ION_BINDING,0.814715312702528
GOMF_TRANSMEMBRANE_RECEPTOR_...4,SET,18,0.30932,0.0096756,0.21152,0.071828,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING,0.814715312702528
GOMF_FERRIC_IRON_BINDING,SET,8,0.48627,0.010143,0.33254,0.071838,GOMF_FERRIC_IRON_BINDING,0.814715312702528
GSE46606_DAY1_VS_DAY3_CD40L_...3,SET,177,0.093733,0.0091544,0.064107,0.071862,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN,0.814715312702528
GOCC_IMMUNOGLOBULIN_COMPLEX,SET,10,0.44993,0.010492,0.30775,0.071883,GOCC_IMMUNOGLOBULIN_COMPLEX,0.814715312702528
HP_ABNORMAL_CIRCULATING_VITA...3,SET,19,0.29768,0.0095665,0.20362,0.07189,HP_ABNORMAL_CIRCULATING_VITAMIN_E_CONCENTRATION,0.814715312702528
FLOTHO_PEDIATRIC_ALL_THERAPY...1,SET,28,0.24401,0.0095172,0.16692,0.071895,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,0.814715312702528
GOBP_MESENCHYMAL_CELL_MIGRAT...,SET,57,0.17737,0.0098625,0.12135,0.071926,GOBP_MESENCHYMAL_CELL_MIGRATION,0.814715312702528
GOMF_CYSTEINE_TYPE_PEPTIDASE...,SET,145,0.10019,0.0088646,0.06855,0.071933,GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY,0.814715312702528
MORF_ATRX,SET,204,0.083635,0.0087625,0.057227,0.071956,MORF_ATRX,0.814715312702528
SCIBETTA_KDM5B_TARGETS_DN,SET,75,0.14524,0.0092594,0.099407,0.072005,SCIBETTA_KDM5B_TARGETS_DN,0.814715312702528
GSE7548_DAY7_VS_DAY28_PCC_IM...1,SET,174,0.093294,0.0090347,0.063859,0.072024,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,0.814715312702528
DAZARD_UV_RESPONSE_CLUSTER_G4,SET,17,0.31247,0.0094991,0.21389,0.07203,DAZARD_UV_RESPONSE_CLUSTER_G4,0.814715312702528
MIR6735_5P,SET,92,0.13206,0.0093205,0.090417,0.07207,MIR6735_5P,0.814715312702528
GSE15930_NAIVE_VS_72H_IN_VIT...3,SET,183,0.090021,0.0089382,0.061638,0.072087,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.814715312702528
OHM_EMBRYONIC_CARCINOMA_UP,SET,6,0.50282,0.0090839,0.3443,0.072099,OHM_EMBRYONIC_CARCINOMA_UP,0.814715312702528
GCM_FANCL,SET,21,0.24597,0.0083099,0.16843,0.072099,GCM_FANCL,0.814715312702528
REACTOME_LIGAND_RECEPTOR_INT...,SET,8,0.50445,0.010523,0.34556,0.072182,REACTOME_LIGAND_RECEPTOR_INTERACTIONS,0.814715312702528
MIR11401,SET,7,0.52655,0.010274,0.36073,0.0722,MIR11401,0.814715312702528
MODULE_98,SET,367,0.062068,0.0086831,0.042522,0.072201,MODULE_98,0.814715312702528
GSE15330_WT_VS_IKAROS_KO_MEG...1,SET,184,0.093155,0.0092743,0.063839,0.072261,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.814715312702528
ZNF19_TARGET_GENES,SET,10,0.36816,0.0085855,0.2523,0.072264,ZNF19_TARGET_GENES,0.814715312702528
MORF_PRKDC,SET,167,0.093019,0.0088267,0.063747,0.072264,MORF_PRKDC,0.814715312702528
REACTOME_HDR_THROUGH_SINGLE_...,SET,36,0.20097,0.0088861,0.13774,0.072285,REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,0.814715312702528
GOBP_PYRIMIDINE_NUCLEOSIDE_M...2,SET,14,0.32937,0.0090872,0.22575,0.072294,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.814715312702528
GOCC_SYNAPSE,SET,1367,0.035997,0.0094454,0.024673,0.072299,GOCC_SYNAPSE,0.814715312702528
HP_ABNORMAL_CORONARY_ARTERY_...2,SET,6,0.50929,0.0092008,0.3491,0.07231,HP_ABNORMAL_CORONARY_ARTERY_ORIGIN,0.814715312702528
GOBP_REGULATION_OF_MEMBRANE_...3,SET,4,0.69745,0.010288,0.47813,0.072331,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.814715312702528
GOBP_POSITIVE_REGULATION_OF_...352,SET,44,0.17888,0.0087424,0.12264,0.072337,GOBP_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.814715312702528
GEORGES_CELL_CYCLE_MIR192_TA...,SET,58,0.16219,0.0090971,0.11119,0.072341,GEORGES_CELL_CYCLE_MIR192_TARGETS,0.814715312702528
GOBP_REGULATION_OF_PROTEIN_C...1,SET,318,0.069243,0.0090292,0.047483,0.072392,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.814941722797927
GOBP_G1_TO_G0_TRANSITION_INV...,SET,6,0.47146,0.0085173,0.32333,0.072408,GOBP_G1_TO_G0_TRANSITION_INVOLVED_IN_CELL_DIFFERENTIATION,0.814941722797927
HP_ANTERIOR_CREASES_OF_EARLO...,SET,3,0.67987,0.0086857,0.46635,0.072448,HP_ANTERIOR_CREASES_OF_EARLOBE,0.815127950793137
GOBP_POSITIVE_REGULATION_OF_...669,SET,51,0.18685,0.0098291,0.12821,0.072523,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.815707723300971
GSE42088_UNINF_VS_LEISHMANIA...1,SET,184,0.09243,0.0092021,0.063458,0.072631,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN,0.815871972098922
KEGG_MEDICUS_VARIANT_MUTATIO...44,SET,5,0.59839,0.0098688,0.4109,0.072663,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_EXTRINSIC_APOPTOTIC_PATHWAY,0.815871972098922
GSE17721_CTRL_VS_POLYIC_24H_...2,SET,177,0.088238,0.0086177,0.060592,0.072667,GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP,0.815871972098922
WESTON_VEGFA_TARGETS,SET,85,0.14374,0.0097526,0.098733,0.072731,WESTON_VEGFA_TARGETS,0.815871972098922
GCGCCTT_MIR525_MIR524,SET,15,0.29443,0.0084082,0.20227,0.072759,GCGCCTT_MIR525_MIR524,0.815871972098922
GOBP_5S_CLASS_RRNA_TRANSCRIP...,SET,6,0.40973,0.007402,0.28149,0.072764,GOBP_5S_CLASS_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.815871972098922
GOCC_TRANSCRIPTION_FACTOR_TF...4,SET,6,0.40973,0.007402,0.28149,0.072764,GOCC_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX,0.815871972098922
REACTOME_PI3K_AKT_ACTIVATION,SET,9,0.44438,0.0098315,0.30543,0.07285,REACTOME_PI3K_AKT_ACTIVATION,0.815871972098922
HP_GENERALIZED_OSTEOSCLEROSIS,SET,8,0.39729,0.0082873,0.27307,0.072852,HP_GENERALIZED_OSTEOSCLEROSIS,0.815871972098922
GSE10325_CD4_TCELL_VS_BCELL_...2,SET,175,0.096132,0.009336,0.066083,0.072881,GSE10325_CD4_TCELL_VS_BCELL_UP,0.815871972098922
SOBOLEV_T_CELL_PANDEMRIX_AGE...2,SET,21,0.26124,0.0088259,0.17966,0.072965,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN,0.815871972098922
REACTOME_UNFOLDED_PROTEIN_RE...,SET,87,0.12565,0.0086245,0.086411,0.072974,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,0.815871972098922
GSE15930_NAIVE_VS_72H_IN_VIT...7,SET,188,0.087451,0.0087996,0.060147,0.072989,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN,0.815871972098922
MIR9851_5P,SET,103,0.11818,0.0088223,0.081282,0.072996,MIR9851_5P,0.815871972098922
GSE27786_NKTCELL_VS_NEUTROPH...1,SET,181,0.094642,0.0093459,0.065097,0.073001,GSE27786_NKTCELL_VS_NEUTROPHIL_DN,0.815871972098922
GOBP_TRANSLATIONAL_TERMINATI...,SET,13,0.34189,0.0090899,0.23518,0.073016,GOBP_TRANSLATIONAL_TERMINATION,0.815871972098922
GSE34179_THPOK_KO_VS_WT_VA14...1,SET,183,0.094862,0.0094189,0.065268,0.073061,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN,0.815871972098922
MIR548AI_MIR570_5P,SET,161,0.098128,0.0091442,0.06752,0.073077,MIR548AI_MIR570_5P,0.815871972098922
MODULE_180,SET,110,0.12622,0.0097358,0.086857,0.073095,MODULE_180,0.815871972098922
GOBP_GLYCOSYLATION,SET,223,0.085217,0.0093299,0.058648,0.073119,GOBP_GLYCOSYLATION,0.815871972098922
GOBP_AUTOPHAGY_OF_PEROXISOME,SET,13,0.35729,0.0094993,0.24591,0.073128,GOBP_AUTOPHAGY_OF_PEROXISOME,0.815871972098922
REACTOME_DEFECTIVE_B4GALT1_C...,SET,8,0.45827,0.0095592,0.31547,0.07317,REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D,0.815871972098922
GSE29618_PRE_VS_DAY7_FLU_VAC...1,SET,175,0.090845,0.0088225,0.062552,0.073218,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN,0.815871972098922
HP_APLASIA_HYPOPLASIA_OF_THE...76,SET,55,0.15976,0.0087264,0.11001,0.073231,HP_APLASIA_HYPOPLASIA_OF_THE_ULNA,0.815871972098922
HP_ADRENAL_OVERACTIVITY,SET,49,0.19347,0.0099768,0.13323,0.073236,HP_ADRENAL_OVERACTIVITY,0.815871972098922
CHEBOTAEV_GR_TARGETS_DN,SET,109,0.12621,0.0096908,0.086917,0.073254,CHEBOTAEV_GR_TARGETS_DN,0.815871972098922
GSE3982_MAC_VS_CENT_MEMORY_C...1,SET,167,0.093145,0.0088387,0.064155,0.073276,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN,0.815871972098922
KEGG_MEDICUS_PATHOGEN_HCMV_U...7,SET,30,0.23156,0.0093482,0.1595,0.073291,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,0.815871972098922
MIR4294,SET,69,0.15126,0.0092509,0.1042,0.073311,MIR4294,0.815871972098922
HP_TYPE_I_TRANSFERRIN_ISOFOR...,SET,17,0.24791,0.0075365,0.1708,0.073332,HP_TYPE_I_TRANSFERRIN_ISOFORM_PROFILE,0.815871972098922
E2F_Q4,SET,212,0.084487,0.0090217,0.058208,0.073335,E2F_Q4,0.815871972098922
HP_FOCAL_TONIC_SEIZURE,SET,28,0.24766,0.0096595,0.17063,0.073338,HP_FOCAL_TONIC_SEIZURE,0.815871972098922
HOFFMANN_SMALL_PRE_BII_TO_IM...1,SET,35,0.20799,0.0090682,0.14332,0.07336,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,0.815871972098922
MCCLUNG_DELTA_FOSB_TARGETS_2...,SET,43,0.20727,0.010014,0.14283,0.073378,MCCLUNG_DELTA_FOSB_TARGETS_2WK,0.815871972098922
GOBP_SENSORY_PERCEPTION_OF_S...3,SET,7,0.45603,0.0088984,0.31428,0.073394,GOBP_SENSORY_PERCEPTION_OF_SWEET_TASTE,0.815871972098922
ACAWNRNSRCGG_UNKNOWN,SET,57,0.16321,0.0090754,0.11249,0.07342,ACAWNRNSRCGG_UNKNOWN,0.815871972098922
GOBP_G_QUADRUPLEX_DNA_UNWIND...,SET,7,0.49751,0.0097078,0.34293,0.07343,GOBP_G_QUADRUPLEX_DNA_UNWINDING,0.815871972098922
GOBP_SENSORY_PERCEPTION_OF_U...,SET,7,0.43379,0.0084644,0.29904,0.073454,GOBP_SENSORY_PERCEPTION_OF_UMAMI_TASTE,0.815871972098922
GSE17974_0H_VS_0.5H_IN_VITRO...1,SET,160,0.094656,0.0087935,0.065278,0.073532,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN,0.815871972098922
GOCC_SARCOLEMMA,SET,136,0.11108,0.0095199,0.076606,0.073542,GOCC_SARCOLEMMA,0.815871972098922
HP_SCHWANNOMA,SET,11,0.35222,0.0086145,0.24295,0.073571,HP_SCHWANNOMA,0.815871972098922
GOBP_REGULATION_OF_CILIUM_AS...,SET,89,0.12934,0.0089786,0.08924,0.073636,GOBP_REGULATION_OF_CILIUM_ASSEMBLY,0.815871972098922
GOBP_REGULATION_OF_PHOSPHORU...,SET,1031,0.040621,0.0093476,0.028032,0.073661,GOBP_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.815871972098922
MIR3675_5P,SET,30,0.21697,0.0087591,0.14973,0.073666,MIR3675_5P,0.815871972098922
GSE15324_ELF4_KO_VS_WT_NAIVE...2,SET,181,0.090808,0.0089673,0.062667,0.07367,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP,0.815871972098922
GOBP_MHC_CLASS_II_BIOSYNTHET...,SET,19,0.29488,0.0094766,0.20353,0.073695,GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.815871972098922
GOBP_NEGATIVE_REGULATION_OF_...179,SET,82,0.14486,0.0096544,0.09999,0.073718,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.815871972098922
GSE14000_TRANSLATED_RNA_VS_M...2,SET,146,0.1027,0.0091173,0.070894,0.073725,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP,0.815871972098922
GAZDA_DIAMOND_BLACKFAN_ANEMI...3,SET,31,0.22699,0.0093146,0.15677,0.073829,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,0.815871972098922
REACTOME_COLLAGEN_DEGRADATION,SET,61,0.17349,0.0099785,0.11983,0.073853,REACTOME_COLLAGEN_DEGRADATION,0.815871972098922
GOBP_REGULATION_OF_MONOCYTE_...2,SET,18,0.31933,0.0099887,0.22059,0.073869,GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.815871972098922
GOBP_NEGATIVE_REGULATION_OF_...634,SET,21,0.30522,0.010312,0.21086,0.073882,GOBP_NEGATIVE_REGULATION_OF_TISSUE_REMODELING,0.815871972098922
MIR519C_3P,SET,375,0.063573,0.008988,0.043934,0.073954,MIR519C_3P,0.815871972098922
KAYO_CALORIE_RESTRICTION_MUS...2,SET,89,0.13121,0.0091086,0.090677,0.073961,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,0.815871972098922
REACTOME_DDX58_IFIH1_MEDIATE...,SET,74,0.15033,0.0095202,0.1039,0.073962,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,0.815871972098922
NIKOLSKY_BREAST_CANCER_17P11...,SET,9,0.58682,0.012983,0.40557,0.073971,NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,0.815871972098922
ACTGTGA_MIR27A_MIR27B,SET,435,0.061252,0.0093114,0.042335,0.073977,ACTGTGA_MIR27A_MIR27B,0.815871972098922
CREB_Q4_01,SET,192,0.091626,0.0093163,0.063334,0.073998,CREB_Q4_01,0.815871972098922
GOBP_RESPONSE_TO_UV_C,SET,13,0.34185,0.0090888,0.2363,0.073998,GOBP_RESPONSE_TO_UV_C,0.815871972098922
HP_MUTISM,SET,46,0.17771,0.0088799,0.12285,0.074008,HP_MUTISM,0.815871972098922
MIR4749_5P,SET,4,0.64879,0.0095705,0.44851,0.074022,MIR4749_5P,0.815871972098922
CARRILLOREIXACH_HEPATOBLASTO...1,SET,974,0.043108,0.0096575,0.029801,0.074024,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN,0.815871972098922
REACTOME_CHROMATIN_MODIFYING...,SET,183,0.085875,0.0085265,0.059369,0.074033,REACTOME_CHROMATIN_MODIFYING_ENZYMES,0.815871972098922
HP_RECURRENT_THROMBOPHLEBITIS,SET,6,0.5333,0.0096344,0.36871,0.07404,HP_RECURRENT_THROMBOPHLEBITIS,0.815871972098922
GSE2770_IL12_AND_TGFB_ACT_VS...4,SET,178,0.090272,0.008841,0.062445,0.07415,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP,0.816234575559701
GOMF_CHROMATIN_PROTEIN_ADAPT...,SET,24,0.23677,0.0085507,0.16381,0.074178,GOMF_CHROMATIN_PROTEIN_ADAPTOR_ACTIVITY,0.816234575559701
SIPA1_TARGET_GENES,SET,102,0.12092,0.0089833,0.083686,0.07425,SIPA1_TARGET_GENES,0.816234575559701
GSE9006_HEALTHY_VS_TYPE_1_DI...4,SET,183,0.091245,0.0090597,0.063152,0.074259,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP,0.816234575559701
GSE21774_CD62L_POS_CD56_BRIG...1,SET,173,0.096421,0.009311,0.066737,0.074265,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,0.816234575559701
GOMF_MISFOLDED_PROTEIN_BINDI...,SET,15,0.28241,0.0080648,0.19555,0.074352,GOMF_MISFOLDED_PROTEIN_BINDING,0.816234575559701
GSE37532_VISCERAL_ADIPOSE_TI...6,SET,112,0.12227,0.0095163,0.084667,0.074352,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP,0.816234575559701
WP_TGIF_DISRUPTION_OF_SHH_SI...,SET,9,0.41279,0.0091327,0.28586,0.074371,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,0.816234575559701
GOBP_POSITIVE_REGULATION_OF_...69,SET,73,0.13994,0.0088019,0.096906,0.074372,GOBP_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION,0.816234575559701
GOMF_IGE_BINDING,SET,5,0.53817,0.0088755,0.37273,0.074397,GOMF_IGE_BINDING,0.816234575559701
DESCARTES_FETAL_LUNG_STROMAL...,SET,37,0.22044,0.0098809,0.15269,0.074423,DESCARTES_FETAL_LUNG_STROMAL_CELLS,0.816234575559701
GOBP_NEGATIVE_REGULATION_OF_...510,SET,33,0.20036,0.0084825,0.13881,0.074466,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.816234575559701
WEST_ADRENOCORTICAL_TUMOR_MA...1,SET,18,0.3238,0.010129,0.22435,0.074478,WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,0.816234575559701
GSE4984_UNTREATED_VS_LPS_TRE...2,SET,144,0.10046,0.0088573,0.069616,0.074518,GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP,0.816234575559701
NUTT_GBM_VS_AO_GLIOMA_DN,SET,44,0.17228,0.0084195,0.1194,0.074534,NUTT_GBM_VS_AO_GLIOMA_DN,0.816234575559701
GOBP_SALIVA_SECRETION,SET,13,0.38374,0.010203,0.26605,0.074611,GOBP_SALIVA_SECRETION,0.816234575559701
HP_CALF_MUSCLE_HYPERTROPHY,SET,42,0.19629,0.0093729,0.13611,0.074636,HP_CALF_MUSCLE_HYPERTROPHY,0.816234575559701
GOMF_CALCIUM_DEPENDENT_PHOSP...2,SET,52,0.18937,0.010059,0.13133,0.07466,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING,0.816234575559701
GSE46606_DAY1_VS_DAY3_CD40L_...7,SET,179,0.089367,0.0087767,0.061982,0.074685,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN,0.816234575559701
GOBP_PLANAR_CELL_POLARITY_PA...1,SET,6,0.6084,0.010991,0.42204,0.074721,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_AXIS_ELONGATION,0.816234575559701
MIR4722_5P,SET,127,0.1095,0.0090712,0.075978,0.074769,MIR4722_5P,0.816234575559701
GOBP_APOPTOTIC_PROCESS_INVOL...2,SET,4,0.77203,0.011388,0.53575,0.074797,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_HEART_MORPHOGENESIS,0.816234575559701
MIR2392,SET,68,0.15232,0.0092485,0.10572,0.074819,MIR2392,0.816234575559701
GOBP_NEGATIVE_REGULATION_OF_...110,SET,59,0.1504,0.008508,0.1044,0.07486,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.816234575559701
HP_INABILITY_TO_WALK,SET,327,0.066368,0.0087737,0.046074,0.074879,HP_INABILITY_TO_WALK,0.816234575559701
GOMF_SUMO_TRANSFERASE_ACTIVI...,SET,24,0.26889,0.0097107,0.18669,0.074897,GOMF_SUMO_TRANSFERASE_ACTIVITY,0.816234575559701
GOBP_POSITIVE_REGULATION_OF_...28,SET,24,0.26021,0.0093971,0.18068,0.074923,GOBP_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.816234575559701
HP_DECREASED_CORNEAL_REFLEX,SET,9,0.38724,0.0085674,0.2689,0.074933,HP_DECREASED_CORNEAL_REFLEX,0.816234575559701
GOBP_MONOUBIQUITINATED_PROTE...,SET,8,0.41972,0.0087551,0.29148,0.07495,GOBP_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION,0.816234575559701
GSE17721_POLYIC_VS_CPG_1H_BM...1,SET,183,0.089981,0.0089342,0.062498,0.074978,GSE17721_POLYIC_VS_CPG_1H_BMDC_DN,0.816234575559701
HP_INTEROSSEUS_MUSCLE_ATROPHY,SET,4,0.53872,0.0079469,0.37424,0.075011,HP_INTEROSSEUS_MUSCLE_ATROPHY,0.816234575559701
AP1_Q4_01,SET,241,0.079631,0.0090589,0.055321,0.075023,AP1_Q4_01,0.816234575559701
HP_RECURRENT_KLEBSIELLA_INFE...,SET,4,0.71934,0.010611,0.49976,0.075032,HP_RECURRENT_KLEBSIELLA_INFECTIONS,0.816234575559701
MORF_LTK,SET,137,0.10846,0.0093299,0.075382,0.075104,MORF_LTK,0.816234575559701
GOBP_NEGATIVE_REGULATION_OF_...520,SET,6,0.48305,0.0087267,0.33574,0.075116,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.816234575559701
REACTOME_RESOLUTION_OF_D_LOO...2,SET,25,0.23798,0.0087714,0.16543,0.075139,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA,0.816234575559701
MIR548AG,SET,158,0.097989,0.0090465,0.068131,0.075191,MIR548AG,0.816234575559701
CROONQUIST_NRAS_VS_STROMAL_S...1,SET,86,0.13745,0.0093804,0.095581,0.075221,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,0.816234575559701
GOBP_MITOTIC_G2_DNA_DAMAGE_C...,SET,29,0.20023,0.0079477,0.13926,0.075248,GOBP_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT_SIGNALING,0.816234575559701
GSE8921_3H_VS_24H_TLR1_2_STI...1,SET,184,0.091961,0.0091554,0.063963,0.075267,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN,0.816234575559701
HP_PELVIC_KIDNEY,SET,30,0.25877,0.010446,0.18001,0.075291,HP_PELVIC_KIDNEY,0.816234575559701
GOBP_AORTA_DEVELOPMENT,SET,60,0.17057,0.0097304,0.11866,0.075298,GOBP_AORTA_DEVELOPMENT,0.816234575559701
HP_MELANOMA,SET,74,0.13413,0.0084944,0.093323,0.075323,HP_MELANOMA,0.816234575559701
ISHIDA_TARGETS_OF_SYT_SSX_FU...,SET,6,0.58739,0.010612,0.40868,0.075325,ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS,0.816234575559701
HP_DECREASED_ACTIVITY_OF_MIT...4,SET,41,0.17502,0.0082572,0.12177,0.07533,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_III,0.816234575559701
REACTOME_REGULATION_OF_GENE_...3,SET,8,0.50762,0.010589,0.35321,0.075343,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS,0.816234575559701
WP_RANKLRANK_SIGNALING,SET,54,0.16948,0.0091734,0.11793,0.075349,WP_RANKLRANK_SIGNALING,0.816234575559701
GSE15324_NAIVE_VS_ACTIVATED_...4,SET,184,0.086962,0.0086577,0.060514,0.075358,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP,0.816234575559701
WP_WNT_SIGNALING_WP428,SET,109,0.12464,0.0095702,0.086737,0.075373,WP_WNT_SIGNALING_WP428,0.816234575559701
GOBP_REGULATION_OF_ORGAN_GRO...,SET,80,0.14904,0.0098122,0.10374,0.075413,GOBP_REGULATION_OF_ORGAN_GROWTH,0.816234575559701
GOBP_INTERLEUKIN_8_PRODUCTION,SET,78,0.14687,0.0095476,0.10223,0.075418,GOBP_INTERLEUKIN_8_PRODUCTION,0.816234575559701
GOBP_PROTEOLYSIS_INVOLVED_IN...,SET,698,0.045724,0.0087402,0.031828,0.075426,GOBP_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.816234575559701
ZIRN_TRETINOIN_RESPONSE_WT1_...1,SET,5,0.57636,0.0095054,0.40123,0.075439,ZIRN_TRETINOIN_RESPONSE_WT1_DN,0.816234575559701
GOBP_POSITIVE_REGULATION_OF_...769,SET,1153,0.037675,0.0091358,0.026228,0.075446,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.816234575559701
GOBP_POSITIVE_REGULATION_OF_...386,SET,22,0.24167,0.0083564,0.16825,0.075458,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING,0.816234575559701
ZNF626_TARGET_GENES,SET,12,0.34922,0.0089206,0.24315,0.075475,ZNF626_TARGET_GENES,0.816234575559701
GOBP_BRANCHING_INVOLVED_IN_P...,SET,12,0.40376,0.010314,0.28114,0.075487,GOBP_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,0.816234575559701
GAVISH_3CA_METAPROGRAM_FIBRO...13,SET,48,0.19848,0.01013,0.13821,0.075496,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA,0.816234575559701
GSE46242_CTRL_VS_EGR2_DELETE...4,SET,168,0.091274,0.0086868,0.063562,0.075511,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP,0.816234575559701
HP_ADRENAL_INSUFFICIENCY,SET,93,0.12843,0.009113,0.089439,0.075514,HP_ADRENAL_INSUFFICIENCY,0.816234575559701
GOBP_VITAMIN_K_METABOLIC_PRO...,SET,11,0.36781,0.0089958,0.25616,0.075527,GOBP_VITAMIN_K_METABOLIC_PROCESS,0.816234575559701
TAKAO_RESPONSE_TO_UVB_RADIAT...1,SET,87,0.13076,0.0089755,0.091068,0.075529,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,0.816234575559701
HP_SHORT_TIBIA,SET,23,0.2614,0.0092418,0.18211,0.075596,HP_SHORT_TIBIA,0.816645298321939
GSE43700_UNTREATED_VS_IL10_T...2,SET,184,0.092016,0.0091609,0.064111,0.075614,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP,0.816645298321939
GSE17721_CPG_VS_GARDIQUIMOD_...10,SET,186,0.090452,0.0090536,0.063038,0.075669,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP,0.816677859578425
GOBP_PIGMENT_GRANULE_MATURAT...,SET,10,0.40309,0.0094001,0.28093,0.075679,GOBP_PIGMENT_GRANULE_MATURATION,0.816677859578425
GOBP_REGULATION_OF_PROTEIN_M...2,SET,1099,0.038497,0.0091283,0.026839,0.075741,GOBP_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.816677859578425
DORSAM_HOXA9_TARGETS_DN,SET,29,0.23123,0.0091781,0.16121,0.075746,DORSAM_HOXA9_TARGETS_DN,0.816677859578425
GOBP_EPITHELIAL_MESENCHYMAL_...,SET,5,0.66817,0.01102,0.46591,0.075776,GOBP_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING,0.816677859578425
HP_STIFF_NECK,SET,5,0.54566,0.0089992,0.3805,0.075785,HP_STIFF_NECK,0.816677859578425
GSE25088_IL4_VS_IL4_AND_ROSI...1,SET,185,0.089583,0.0089427,0.062473,0.075801,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.816677859578425
GOCC_AXONAL_GROWTH_CONE,SET,23,0.25883,0.0091507,0.1805,0.075805,GOCC_AXONAL_GROWTH_CONE,0.816677859578425
HP_ADENOCARCINOMA_OF_THE_COL...,SET,30,0.21008,0.0084809,0.14654,0.075845,HP_ADENOCARCINOMA_OF_THE_COLON,0.816677979579208
REACTOME_P75_NTR_RECEPTOR_ME...,SET,87,0.13231,0.0090815,0.0923,0.075877,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,0.816677979579208
GSE13738_RESTING_VS_TCR_ACTI...2,SET,155,0.09745,0.0089117,0.067989,0.075891,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP,0.816677979579208
E2F5_TARGET_GENES,SET,1007,0.040263,0.0091629,0.028093,0.075909,E2F5_TARGET_GENES,0.816677979579208
FAN_OVARY_CL6_PUTATIVE_EARLY...,SET,260,0.078922,0.0093205,0.055076,0.075942,FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2,0.816677979579208
GSE21774_CD56_BRIGHT_VS_DIM_...2,SET,176,0.096845,0.0094318,0.067584,0.075946,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP,0.816677979579208
PID_NETRIN_PATHWAY,SET,32,0.21906,0.009133,0.15291,0.075986,PID_NETRIN_PATHWAY,0.816855375811939
CERIBELLI_GENES_INACTIVE_AND...,SET,29,0.25498,0.010121,0.178,0.076016,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,0.816925194805195
GOCC_LSM2_8_COMPLEX,SET,7,0.44376,0.0086589,0.30983,0.076043,GOCC_LSM2_8_COMPLEX,0.816957302224969
VAN_DEN_BIGGELAAR_PBMC_PREVN...2,SET,4,0.65744,0.0096982,0.45907,0.076066,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_DN,0.816957302224969
SATO_SILENCED_BY_DEACETYLATI...,SET,36,0.21827,0.0096511,0.15245,0.076113,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,0.817139148673658
REACTOME_ANTIVIRAL_MECHANISM...,SET,135,0.10394,0.0088757,0.072615,0.076168,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,0.817139148673658
GSE12366_GC_VS_NAIVE_BCELL_DN,SET,170,0.095396,0.0091324,0.066646,0.076169,GSE12366_GC_VS_NAIVE_BCELL_DN,0.817139148673658
GOMF_UDP_GLUCOSYLTRANSFERASE...,SET,8,0.36992,0.0077163,0.25849,0.076215,GOMF_UDP_GLUCOSYLTRANSFERASE_ACTIVITY,0.817139148673658
GOBP_APOPTOTIC_PROCESS,SET,1731,0.031226,0.0091209,0.021821,0.07622,GOBP_APOPTOTIC_PROCESS,0.817139148673658
HP_WEAKNESS_OF_MUSCLES_OF_RE...,SET,99,0.12269,0.0089807,0.085739,0.076224,HP_WEAKNESS_OF_MUSCLES_OF_RESPIRATION,0.817139148673658
THEODOROU_MAMMARY_TUMORIGENE...,SET,27,0.26799,0.010264,0.18733,0.076281,THEODOROU_MAMMARY_TUMORIGENESIS,0.817331749383477
GOBP_NEPHRON_DEVELOPMENT,SET,150,0.1086,0.0097709,0.075913,0.076289,GOBP_NEPHRON_DEVELOPMENT,0.817331749383477
GOBP_ERYTHROCYTE_HOMEOSTASIS,SET,133,0.10637,0.0090161,0.074365,0.076313,GOBP_ERYTHROCYTE_HOMEOSTASIS,0.817336922958398
GSE3982_MAC_VS_TH1_DN,SET,180,0.088622,0.0087275,0.06198,0.076389,GSE3982_MAC_VS_TH1_DN,0.817759040948276
GSE42021_TREG_PLN_VS_CD24HI_...2,SET,185,0.094484,0.0094319,0.066085,0.076406,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP,0.817759040948276
WANG_NFKB_TARGETS,SET,24,0.24725,0.0089292,0.17295,0.076423,WANG_NFKB_TARGETS,0.817759040948276
GOMF_ACTIVIN_RECEPTOR_ACTIVI...2,SET,5,0.67494,0.011131,0.47225,0.076484,GOMF_ACTIVIN_RECEPTOR_ACTIVITY_TYPE_I,0.817776621165644
GAVISH_3CA_METAPROGRAM_MACRO...11,SET,42,0.18027,0.0086082,0.12616,0.076518,GAVISH_3CA_METAPROGRAM_MACROPHAGES_RESPIRATION,0.817776621165644
MIR1264,SET,109,0.1126,0.0086461,0.078822,0.076573,MIR1264,0.817776621165644
E2F1_Q4,SET,222,0.08374,0.009148,0.058619,0.076574,E2F1_Q4,0.817776621165644
HP_SWAN_NECK_LIKE_DEFORMITIE...,SET,8,0.46061,0.009608,0.32246,0.076598,HP_SWAN_NECK_LIKE_DEFORMITIES_OF_THE_FINGERS,0.817776621165644
GOBP_ESTABLISHMENT_OF_PROTEI...4,SET,38,0.18729,0.0085077,0.13115,0.076649,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,0.817776621165644
MIR147B_5P,SET,285,0.074674,0.0092267,0.052292,0.076652,MIR147B_5P,0.817776621165644
REACTOME_MALATE_ASPARTATE_SH...,SET,9,0.37455,0.0082865,0.26229,0.076654,REACTOME_MALATE_ASPARTATE_SHUTTLE,0.817776621165644
GOBP_PROSTATE_GLAND_MORPHOGE...,SET,26,0.27973,0.010514,0.19589,0.076663,GOBP_PROSTATE_GLAND_MORPHOGENESIS,0.817776621165644
GSE25123_ROSIGLITAZONE_VS_IL...4,SET,178,0.090083,0.0088225,0.063095,0.076692,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.817776621165644
GOMF_CDP_ALCOHOL_PHOSPHATIDY...,SET,7,0.41732,0.008143,0.2923,0.076697,GOMF_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY,0.817776621165644
GOMF_CYSTEINE_TYPE_ENDOPEPTI...2,SET,80,0.13821,0.0090991,0.096813,0.076707,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.817776621165644
GOBP_DEVELOPMENTAL_MATURATION,SET,310,0.072255,0.0093048,0.050622,0.076751,GOBP_DEVELOPMENTAL_MATURATION,0.817927208804647
GOCC_AMPA_GLUTAMATE_RECEPTOR...,SET,23,0.26367,0.009322,0.18475,0.076769,GOCC_AMPA_GLUTAMATE_RECEPTOR_COMPLEX,0.817927208804647
GOMF_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,0.3409,0.0087082,0.23888,0.076792,GOMF_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.817927208804647
MIR103A_3P_MIR107,SET,234,0.081017,0.0090835,0.056786,0.076841,MIR103A_3P_MIR107,0.817927208804647
HP_SUDDEN_DEATH,SET,123,0.12134,0.0098935,0.08505,0.076844,HP_SUDDEN_DEATH,0.817927208804647
GOBP_MIDBRAIN_DOPAMINERGIC_N...,SET,15,0.37362,0.01067,0.2619,0.076863,GOBP_MIDBRAIN_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.817927208804647
GOBP_NEUTRAL_LIPID_BIOSYNTHE...,SET,45,0.1797,0.0088813,0.12601,0.076936,GOBP_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS,0.817927208804647
REACTOME_RNA_POLYMERASE_I_TR...1,SET,45,0.15995,0.0079053,0.11217,0.076953,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,0.817927208804647
GSE24142_ADULT_VS_FETAL_EARL...1,SET,177,0.094219,0.0092018,0.066079,0.076963,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN,0.817927208804647
GOCC_TRANSLOCON_COMPLEX,SET,5,0.48831,0.0080532,0.34248,0.076974,GOCC_TRANSLOCON_COMPLEX,0.817927208804647
GOBP_CELLULAR_RESPONSE_TO_PE...3,SET,5,0.53031,0.0087459,0.37195,0.07698,GOBP_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN,0.817927208804647
MIR4649_5P,SET,8,0.41883,0.0087366,0.29383,0.077025,MIR4649_5P,0.818022053162237
GOBP_CELL_CELL_ADHESION_MEDI...1,SET,48,0.187,0.0095442,0.13119,0.077036,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.818022053162237
GOBP_GASTRULATION,SET,177,0.094218,0.0092017,0.066128,0.07712,GOBP_GASTRULATION,0.818190183094294
HP_ADDICTIVE_BEHAVIOR,SET,29,0.23938,0.0095016,0.16802,0.077122,HP_ADDICTIVE_BEHAVIOR,0.818190183094294
DESCARTES_MAIN_FETAL_INHIBIT...1,SET,25,0.27687,0.010205,0.19433,0.077128,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.818190183094294
HP_INCREASED_CEREBRAL_LIPOFU...,SET,11,0.36222,0.0088591,0.25426,0.077146,HP_INCREASED_CEREBRAL_LIPOFUSCIN,0.818190183094294
HP_MILD_MYOPIA,SET,4,0.73976,0.010913,0.51944,0.07721,HP_MILD_MYOPIA,0.818380086916743
GOBP_NEGATIVE_REGULATION_OF_...434,SET,124,0.11274,0.0092297,0.079166,0.077211,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.818380086916743
GOCC_CLUSTER_OF_ACTIN_BASED_...,SET,155,0.09843,0.0090013,0.069135,0.077269,GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS,0.818745150914634
SMID_BREAST_CANCER_LUMINAL_B...1,SET,494,0.060987,0.0098636,0.042845,0.077311,SMID_BREAST_CANCER_LUMINAL_B_DN,0.818940507467236
GOBP_REGULATION_OF_NATURAL_K...6,SET,12,0.40504,0.010347,0.28462,0.077366,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.81910855010661
GSE35543_IN_VITRO_ITREG_VS_C...2,SET,183,0.089568,0.0088932,0.062942,0.077374,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP,0.81910855010661
GOBP_ACTIN_FILAMENT_BASED_MO...,SET,130,0.11348,0.0095103,0.079784,0.077477,GOBP_ACTIN_FILAMENT_BASED_MOVEMENT,0.819608782714547
HP_APLASIA_OF_THE_NASAL_BONE,SET,5,0.70258,0.011587,0.494,0.077491,HP_APLASIA_OF_THE_NASAL_BONE,0.819608782714547
GOBP_POSITIVE_REGULATION_OF_...567,SET,11,0.385,0.0094162,0.2707,0.077492,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.819608782714547
SASAKI_ADULT_T_CELL_LEUKEMIA,SET,154,0.098848,0.0090106,0.069527,0.077561,SASAKI_ADULT_T_CELL_LEUKEMIA,0.820089003650745
GOCC_CD95_DEATH_INDUCING_SIG...,SET,6,0.56607,0.010226,0.39828,0.077623,GOCC_CD95_DEATH_INDUCING_SIGNALING_COMPLEX,0.820494940693431
MEL18_DN.V1_DN,SET,135,0.11641,0.0099406,0.081922,0.077668,MEL18_DN.V1_DN,0.820557330200121
GOBP_CARDIAC_FIBROBLAST_CELL...,SET,4,0.58975,0.0086997,0.41506,0.077684,GOBP_CARDIAC_FIBROBLAST_CELL_DIFFERENTIATION,0.820557330200121
HE_LIM_SUN_FETAL_LUNG_C5_CD5...1,SET,46,0.18735,0.0093613,0.1319,0.077751,HE_LIM_SUN_FETAL_LUNG_C5_CD5_NEG_MATURE_B_CELL,0.820557330200121
WP_REGULATION_OF_SISTER_CHRO...,SET,13,0.37433,0.0099522,0.26355,0.077763,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,0.820557330200121
HP_PULMONARY_INFILTRATES,SET,52,0.17958,0.009539,0.12645,0.077792,HP_PULMONARY_INFILTRATES,0.820557330200121
HASLINGER_B_CLL_WITH_17P13_D...,SET,20,0.25782,0.0085005,0.18155,0.077799,HASLINGER_B_CLL_WITH_17P13_DELETION,0.820557330200121
REACTOME_PEROXISOMAL_LIPID_M...,SET,28,0.22809,0.0088961,0.16063,0.077817,REACTOME_PEROXISOMAL_LIPID_METABOLISM,0.820557330200121
GOBP_VITAMIN_B6_METABOLIC_PR...,SET,5,0.56614,0.0093368,0.39875,0.077844,GOBP_VITAMIN_B6_METABOLIC_PROCESS,0.820557330200121
GSE360_T_GONDII_VS_B_MALAYI_...5,SET,183,0.090134,0.0089494,0.063484,0.077844,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN,0.820557330200121
GOBP_POSITIVE_REGULATION_OF_...617,SET,39,0.19818,0.0091197,0.1396,0.077865,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.820557330200121
HP_CRANIOSYNOSTOSIS,SET,162,0.093301,0.0087211,0.065748,0.077949,HP_CRANIOSYNOSTOSIS,0.821107913135593
PID_RB_1PATHWAY,SET,60,0.1567,0.0089388,0.11043,0.077966,PID_RB_1PATHWAY,0.821107913135593
GOBP_POSITIVE_REGULATION_OF_...782,SET,95,0.13308,0.0095434,0.093799,0.07799,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.821107913135593
GOBP_NEGATIVE_REGULATION_OF_...379,SET,17,0.30599,0.0093022,0.21572,0.078034,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.821107913135593
GOBP_NEGATIVE_REGULATION_OF_...148,SET,19,0.26279,0.0084452,0.18528,0.078051,GOBP_NEGATIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.821107913135593
REACTOME_INITIATION_OF_NUCLE...,SET,18,0.27201,0.0085086,0.19178,0.078059,REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,0.821107913135593
GOBP_ENTEROENDOCRINE_CELL_DI...,SET,33,0.23046,0.0097568,0.16253,0.078115,GOBP_ENTEROENDOCRINE_CELL_DIFFERENTIATION,0.821448358547655
PID_HNF3B_PATHWAY,SET,43,0.20462,0.009886,0.14435,0.078177,PID_HNF3B_PATHWAY,0.821771307831872
GCGCTTT_MIR518B_MIR518C_MIR5...,SET,17,0.27585,0.0083859,0.19462,0.078193,GCGCTTT_MIR518B_MIR518C_MIR518D,0.821771307831872
YY1_01,SET,225,0.08178,0.0089932,0.057731,0.078313,YY1_01,0.821901682175051
GOCC_VESICLE_COAT,SET,59,0.15251,0.0086271,0.10768,0.078352,GOCC_VESICLE_COAT,0.821901682175051
MODULE_214,SET,26,0.25677,0.0096509,0.1813,0.078363,MODULE_214,0.821901682175051
GOBP_EPIDERMAL_CELL_DIFFEREN...,SET,225,0.092064,0.010124,0.065008,0.078367,GOBP_EPIDERMAL_CELL_DIFFERENTIATION,0.821901682175051
LXR_DR4_Q3,SET,81,0.13953,0.0092424,0.098534,0.078396,LXR_DR4_Q3,0.821901682175051
GOBP_PEPTIDYL_PROLINE_HYDROX...1,SET,11,0.32014,0.0078299,0.2261,0.078408,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION,0.821901682175051
GSE9650_NAIVE_VS_EXHAUSTED_C...1,SET,176,0.09545,0.009296,0.067412,0.078408,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN,0.821901682175051
GOBP_CELLULAR_RESPONSE_TO_MA...1,SET,13,0.38796,0.010315,0.27404,0.078445,GOBP_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,0.821901682175051
GOBP_PYRIMIDINE_RIBONUCLEOSI...1,SET,7,0.44678,0.008718,0.31566,0.078486,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.821901682175051
HP_GERMINOMA,SET,12,0.3691,0.0094286,0.26079,0.078493,HP_GERMINOMA,0.821901682175051
HP_IRRITABILITY,SET,243,0.078027,0.0089127,0.05513,0.078494,HP_IRRITABILITY,0.821901682175051
REACTOME_PHOSPHOLIPASE_C_MED...3,SET,14,0.34811,0.0096043,0.24602,0.078547,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4,0.821901682175051
GOBP_RESPONSE_TO_LIPOTEICHOI...,SET,10,0.38103,0.0088857,0.26931,0.078563,GOBP_RESPONSE_TO_LIPOTEICHOIC_ACID,0.821901682175051
GSE43955_TH0_VS_TGFB_IL6_TH1...7,SET,177,0.090382,0.0088271,0.063886,0.078583,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN,0.821901682175051
GOBP_SOMATIC_MOTOR_NEURON_DI...,SET,5,0.55433,0.0091421,0.39187,0.078603,GOBP_SOMATIC_MOTOR_NEURON_DIFFERENTIATION,0.821901682175051
GOCC_FC_RECEPTOR_COMPLEX,SET,5,0.60782,0.010024,0.4298,0.078664,GOCC_FC_RECEPTOR_COMPLEX,0.821901682175051
CUI_DEVELOPING_HEART_5TH_WEE...2,SET,64,0.1599,0.0094198,0.11309,0.078692,CUI_DEVELOPING_HEART_5TH_WEEK_VENTRICULAR_CARDIOMYOCYTE,0.821901682175051
MARSON_FOXP3_TARGETS_DN,SET,48,0.19391,0.0098968,0.13716,0.078725,MARSON_FOXP3_TARGETS_DN,0.821901682175051
HP_CORONAL_CRANIOSYNOSTOSIS,SET,26,0.21997,0.008268,0.1556,0.07874,HP_CORONAL_CRANIOSYNOSTOSIS,0.821901682175051
SCHAEFFER_SOX9_TARGETS_IN_PR...2,SET,19,0.31122,0.010002,0.22017,0.078755,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,0.821901682175051
MODULE_415,SET,11,0.37002,0.0090498,0.26179,0.078779,MODULE_415,0.821901682175051
HP_ABNORMAL_PANCREAS_MORPHOL...,SET,99,0.12078,0.0088406,0.085466,0.078813,HP_ABNORMAL_PANCREAS_MORPHOLOGY,0.821901682175051
REACTOME_UPTAKE_AND_FUNCTION...1,SET,11,0.40822,0.0099842,0.28892,0.078847,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,0.821901682175051
REACTOME_NEF_MEDIATED_CD8_DO...,SET,7,0.45013,0.0087833,0.3186,0.078858,REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION,0.821901682175051
GOBP_NEGATIVE_REGULATION_OF_...539,SET,4,0.64272,0.009481,0.45495,0.078875,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.821901682175051
WP_CELL_LINEAGE_MAP_FOR_NEUR...,SET,122,0.11874,0.0096423,0.084059,0.0789,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.821901682175051
GOBP_KIDNEY_EPITHELIUM_DEVEL...,SET,143,0.11182,0.0098255,0.079189,0.078967,GOBP_KIDNEY_EPITHELIUM_DEVELOPMENT,0.821901682175051
GOMF_OXIDOREDUCTASE_ACTIVITY...27,SET,51,0.17927,0.0094308,0.12697,0.078996,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR,0.821901682175051
GSE20198_IL12_IL18_VS_IFNA_T...2,SET,186,0.084856,0.0084934,0.060106,0.079016,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.821901682175051
KEGG_LEUKOCYTE_TRANSENDOTHEL...,SET,108,0.12544,0.0095877,0.088861,0.079038,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,0.821901682175051
GOBP_HEME_TRANSPORT,SET,8,0.43202,0.0090116,0.30604,0.079038,GOBP_HEME_TRANSPORT,0.821901682175051
GOMF_HEME_TRANSMEMBRANE_TRAN...,SET,8,0.43202,0.0090116,0.30604,0.079038,GOMF_HEME_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.821901682175051
LI_PBMC_MENOMUNE_A_C_Y_W_135...4,SET,42,0.20715,0.0098916,0.14682,0.079143,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE,0.821901682175051
GOMF_INTERLEUKIN_1_RECEPTOR_...2,SET,17,0.34352,0.010443,0.2435,0.079169,GOMF_INTERLEUKIN_1_RECEPTOR_BINDING,0.821901682175051
REACTOME_DETOXIFICATION_OF_R...,SET,33,0.20564,0.0087059,0.14577,0.079178,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,0.821901682175051
GSE17721_CTRL_VS_CPG_24H_BMD...1,SET,183,0.087833,0.0087209,0.062265,0.079186,GSE17721_CTRL_VS_CPG_24H_BMDC_DN,0.821901682175051
GOBP_SMALL_NUCLEOLAR_RIBONUC...,SET,10,0.3726,0.008689,0.2642,0.079234,GOBP_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY,0.821901682175051
GSE3982_EOSINOPHIL_VS_EFF_ME...1,SET,171,0.089691,0.0086113,0.0636,0.079243,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.821901682175051
GOMF_GLUTAMATE_RECEPTOR_ACTI...,SET,25,0.26173,0.0096467,0.18561,0.079265,GOMF_GLUTAMATE_RECEPTOR_ACTIVITY,0.821901682175051
NIKOLSKY_BREAST_CANCER_7P22_...,SET,37,0.36102,0.016183,0.25608,0.079305,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,0.821901682175051
GOCC_EARLY_ENDOSOME_MEMBRANE,SET,175,0.088402,0.0085853,0.06271,0.079324,GOCC_EARLY_ENDOSOME_MEMBRANE,0.821901682175051
GSE9946_MATURE_STIMULATORY_V...4,SET,120,0.10906,0.0087841,0.07737,0.079333,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.821901682175051
GOBP_POSITIVE_REGULATION_OF_...71,SET,34,0.19865,0.0085362,0.14094,0.079365,GOBP_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.821901682175051
MIR12125,SET,101,0.12225,0.0090375,0.08674,0.079378,MIR12125,0.821901682175051
GSE19198_1H_VS_24H_IL21_TREA...1,SET,182,0.09363,0.0092713,0.066436,0.079378,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN,0.821901682175051
HP_MICROSCOPIC_HEMATURIA,SET,18,0.29949,0.0093681,0.21251,0.079386,HP_MICROSCOPIC_HEMATURIA,0.821901682175051
MIR379_5P,SET,41,0.19474,0.009188,0.1382,0.079399,MIR379_5P,0.821901682175051
GOBP_REGULATION_OF_DENDRITIC...3,SET,14,0.34294,0.0094617,0.24337,0.07941,GOBP_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.821901682175051
HP_GENERALIZED_ONSET_MOTOR_S...,SET,158,0.099335,0.0091708,0.070501,0.079428,HP_GENERALIZED_ONSET_MOTOR_SEIZURE,0.821901682175051
GSE29949_MICROGLIA_BRAIN_VS_...1,SET,176,0.092851,0.0090428,0.0659,0.079432,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.821901682175051
GSE37532_WT_VS_PPARG_KO_VISC...4,SET,167,0.090687,0.0086054,0.064378,0.079477,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP,0.821901682175051
HP_IMPAIRED_VISUOSPATIAL_CON...,SET,19,0.27689,0.0088985,0.19658,0.079491,HP_IMPAIRED_VISUOSPATIAL_CONSTRUCTIVE_COGNITION,0.821901682175051
HP_EMG_MYOPATHIC_ABNORMALITI...,SET,116,0.10853,0.0085948,0.077053,0.079509,HP_EMG_MYOPATHIC_ABNORMALITIES,0.821901682175051
HP_HYPERGALACTOSEMIA,SET,6,0.499,0.0090147,0.35435,0.079546,HP_HYPERGALACTOSEMIA,0.821901682175051
GSE3982_BCELL_VS_TH1_UP,SET,163,0.094808,0.008889,0.067327,0.07955,GSE3982_BCELL_VS_TH1_UP,0.821901682175051
GOBP_REGULATION_OF_BONE_DEVE...,SET,8,0.43179,0.0090068,0.30674,0.079624,GOBP_REGULATION_OF_BONE_DEVELOPMENT,0.821901682175051
PUJANA_XPRSS_INT_NETWORK,SET,155,0.09054,0.0082798,0.064346,0.07971,PUJANA_XPRSS_INT_NETWORK,0.821901682175051
GOBP_MESENCHYMAL_CELL_APOPTO...,SET,15,0.36463,0.010413,0.25917,0.079739,GOBP_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.821901682175051
KEGG_MEDICUS_REFERENCE_COHES...3,SET,14,0.30249,0.0083456,0.21503,0.079767,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE,0.821901682175051
MODULE_252,SET,226,0.077252,0.0085139,0.05492,0.079776,MODULE_252,0.821901682175051
KEGG_MEDICUS_VARIANT_LMO2_RE...2,SET,5,0.5412,0.0089255,0.38476,0.079787,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_REPRESSION,0.821901682175051
KEGG_MEDICUS_VARIANT_MUTATIO...51,SET,9,0.34384,0.0076071,0.24446,0.079792,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.821901682175051
HEBERT_MATRISOME_TNBC_BRAIN_...2,SET,9,0.43765,0.0096827,0.31117,0.079802,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED,0.821901682175051
HP_MENINGIOMA,SET,42,0.17611,0.0084093,0.12522,0.079807,HP_MENINGIOMA,0.821901682175051
GSE23308_WT_VS_MINERALCORTIC...4,SET,187,0.085476,0.0085781,0.060775,0.079807,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP,0.821901682175051
REACTOME_SMOOTH_MUSCLE_CONTR...,SET,40,0.19591,0.0091299,0.13932,0.07984,REACTOME_SMOOTH_MUSCLE_CONTRACTION,0.821901682175051
REACTOME_CELL_DEATH_SIGNALLI...,SET,67,0.15105,0.0091038,0.10742,0.079851,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,0.821901682175051
GSE24142_ADULT_VS_FETAL_DN3_...2,SET,180,0.091388,0.0089999,0.065012,0.079915,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP,0.821901682175051
PID_FGF_PATHWAY,SET,54,0.16976,0.0091885,0.12077,0.079931,PID_FGF_PATHWAY,0.821901682175051
GOMF_PHOSPHATIDYLINOSITOL_PH...3,SET,162,0.094958,0.008876,0.06757,0.079971,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING,0.821901682175051
KEGG_MEDICUS_PATHOGEN_HPV_E6...3,SET,13,0.32887,0.0087436,0.23404,0.079989,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382,0.821901682175051
GOBP_INFLAMMATORY_RESPONSE_T...2,SET,24,0.26351,0.0095164,0.18754,0.080011,GOBP_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.821901682175051
REACTOME_SYNTHESIS_OF_PI,SET,5,0.52834,0.0087135,0.3761,0.08005,REACTOME_SYNTHESIS_OF_PI,0.821901682175051
KEGG_MEDICUS_REFERENCE_CCR_C...,SET,31,0.24229,0.0099424,0.17247,0.080051,KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY,0.821901682175051
GSE9509_10MIN_VS_30MIN_LPS_S...2,SET,174,0.088553,0.0085756,0.063037,0.080051,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.821901682175051
GSE32986_CURDLAN_LOWDOSE_VS_...1,SET,190,0.09093,0.0091977,0.064734,0.080068,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,0.821901682175051
GSE32986_UNSTIM_VS_CURDLAN_L...1,SET,176,0.090936,0.0088563,0.064752,0.080114,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN,0.821901682175051
BIOCARTA_NO2IL12_PATHWAY,SET,14,0.34922,0.009635,0.24867,0.080115,BIOCARTA_NO2IL12_PATHWAY,0.821901682175051
GOBP_MOLTING_CYCLE,SET,114,0.12355,0.0097007,0.087979,0.080119,GOBP_MOLTING_CYCLE,0.821901682175051
GSE21774_CD56_BRIGHT_VS_DIM_...1,SET,178,0.090596,0.0088727,0.064524,0.080159,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN,0.821901682175051
HP_TRANSIENT_GLOBAL_AMNESIA,SET,20,0.27014,0.0089068,0.19244,0.080202,HP_TRANSIENT_GLOBAL_AMNESIA,0.821901682175051
GOCC_RECYCLING_ENDOSOME_MEMB...,SET,97,0.12197,0.0088377,0.086894,0.08022,GOCC_RECYCLING_ENDOSOME_MEMBRANE,0.821901682175051
GSE39820_TGFBETA1_IL6_VS_TGF...1,SET,181,0.088637,0.008753,0.063151,0.080232,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN,0.821901682175051
MIR3150A_3P,SET,86,0.12607,0.0086038,0.089827,0.080249,MIR3150A_3P,0.821901682175051
KEGG_MEDICUS_PATHOGEN_HCV_CO...2,SET,6,0.47491,0.0085797,0.33841,0.080262,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_LXRA_MEDIATED_TRANSCRIPTION,0.821901682175051
GOBP_POSITIVE_REGULATION_OF_...118,SET,10,0.35039,0.0081712,0.24977,0.080339,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.821901682175051
FINAK_BREAST_CANCER_SDPP_SIG...,SET,20,0.29214,0.0096321,0.20827,0.080364,FINAK_BREAST_CANCER_SDPP_SIGNATURE,0.821901682175051
KEGG_MEDICUS_REFERENCE_CENPE...,SET,12,0.32833,0.008387,0.23424,0.080513,KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX,0.821901682175051
REACTOME_SIGNALING_BY_FGFR4_...,SET,11,0.32354,0.0079131,0.23083,0.080518,REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE,0.821901682175051
GOCC_FAR_SIN_STRIPAK_COMPLEX,SET,16,0.30594,0.0090232,0.21827,0.080518,GOCC_FAR_SIN_STRIPAK_COMPLEX,0.821901682175051
HP_VERTIGO,SET,136,0.10592,0.0090783,0.075584,0.080554,HP_VERTIGO,0.821901682175051
GOCC_POSTSYNAPTIC_MEMBRANE,SET,257,0.081736,0.0095978,0.058325,0.080558,GOCC_POSTSYNAPTIC_MEMBRANE,0.821901682175051
GSE19401_PAM2CSK4_VS_RETINOI...1,SET,180,0.088568,0.0087222,0.063208,0.080583,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.821901682175051
MIR510_5P,SET,59,0.14906,0.0084324,0.10639,0.080607,MIR510_5P,0.821901682175051
GOBP_REGULATION_OF_PROTEIN_S...4,SET,20,0.24258,0.0079982,0.17317,0.080636,GOBP_REGULATION_OF_PROTEIN_SUMOYLATION,0.821901682175051
NPAT_TARGET_GENES,SET,190,0.087027,0.0088029,0.062128,0.080649,NPAT_TARGET_GENES,0.821901682175051
REACTOME_SUMOYLATION,SET,162,0.094274,0.0088121,0.067306,0.080665,REACTOME_SUMOYLATION,0.821901682175051
HP_ABNORMAL_URINARY_ELECTROL...,SET,104,0.12499,0.0093762,0.08924,0.080668,HP_ABNORMAL_URINARY_ELECTROLYTE_CONCENTRATION,0.821901682175051
GOBP_AUTONOMIC_NERVOUS_SYSTE...,SET,40,0.20701,0.009647,0.14785,0.080749,GOBP_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,0.821901682175051
MIR4425,SET,84,0.12725,0.008583,0.090897,0.080782,MIR4425,0.821901682175051
GSE4984_GALECTIN1_VS_VEHICLE...2,SET,164,0.091005,0.0085584,0.065015,0.080803,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP,0.821901682175051
HUMMEL_BURKITTS_LYMPHOMA_DN,SET,15,0.34443,0.0098361,0.24609,0.080825,HUMMEL_BURKITTS_LYMPHOMA_DN,0.821901682175051
KAYO_AGING_MUSCLE_UP,SET,208,0.082003,0.0086744,0.058593,0.080837,KAYO_AGING_MUSCLE_UP,0.821901682175051
GOBP_RESPONSE_TO_TESTOSTERONE,SET,39,0.19333,0.0088963,0.13814,0.080846,GOBP_RESPONSE_TO_TESTOSTERONE,0.821901682175051
GOMF_MONOATOMIC_CATION_BICAR...,SET,13,0.30791,0.0081863,0.22004,0.080871,GOMF_MONOATOMIC_CATION_BICARBONATE_SYMPORTER_ACTIVITY,0.821901682175051
GOBP_POSITIVE_REGULATION_OF_...604,SET,497,0.055718,0.009038,0.039819,0.080873,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.821901682175051
PID_SYNDECAN_1_PATHWAY,SET,43,0.19331,0.0093399,0.13816,0.080886,PID_SYNDECAN_1_PATHWAY,0.821901682175051
GOBP_NECROPTOTIC_PROCESS,SET,36,0.20829,0.0092095,0.14889,0.080927,GOBP_NECROPTOTIC_PROCESS,0.821901682175051
KEGG_MEDICUS_VARIANT_DELETED...,SET,9,0.42752,0.0094584,0.30561,0.08093,KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX,0.821901682175051
MIR4481,SET,121,0.11144,0.0090126,0.07967,0.08095,MIR4481,0.821901682175051
GSE24634_IL4_VS_CTRL_TREATED...4,SET,184,0.090822,0.0090421,0.064937,0.080971,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP,0.821901682175051
KEGG_MEDICUS_REFERENCE_LIGHT...,SET,9,0.37291,0.0082502,0.26663,0.080974,KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY,0.821901682175051
MIR4457,SET,112,0.1114,0.0086702,0.079664,0.081003,MIR4457,0.821901682175051
SRY_02,SET,229,0.084012,0.0093194,0.06008,0.081013,SRY_02,0.821901682175051
GSE36078_UNTREATED_VS_AD5_IN...4,SET,185,0.089869,0.0089712,0.064273,0.081029,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP,0.821901682175051
HP_ABSENT_HAND,SET,17,0.31009,0.0094269,0.22179,0.081047,HP_ABSENT_HAND,0.821901682175051
GSE20152_SPHK1_KO_VS_HTNFA_O...1,SET,177,0.085796,0.0083793,0.061372,0.081068,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN,0.821901682175051
GOBP_NEGATIVE_REGULATION_OF_...511,SET,6,0.46822,0.0084587,0.33493,0.081073,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION,0.821901682175051
GOBP_MYELOID_CELL_HOMEOSTASIS,SET,163,0.094581,0.0088678,0.067663,0.08109,GOBP_MYELOID_CELL_HOMEOSTASIS,0.821901682175051
ZHAN_MULTIPLE_MYELOMA_CD2_DN,SET,44,0.18904,0.0092387,0.13524,0.081099,ZHAN_MULTIPLE_MYELOMA_CD2_DN,0.821901682175051
GOBP_FIBRINOLYSIS,SET,27,0.23369,0.0089507,0.1672,0.081118,GOBP_FIBRINOLYSIS,0.821901682175051
REACTOME_SIGNALING_BY_CTNNB1...,SET,14,0.32062,0.0088459,0.22941,0.081127,REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS,0.821901682175051
GNF2_VAV1,SET,33,0.21526,0.0091136,0.15404,0.081149,GNF2_VAV1,0.821901682175051
GOBP_C_X_C_CHEMOKINE_RECEPTO...,SET,5,0.5776,0.0095259,0.41335,0.081157,GOBP_C_X_C_CHEMOKINE_RECEPTOR_CXCR4_SIGNALING_PATHWAY,0.821901682175051
GOMF_OXIDOREDUCTASE_ACTIVITY...30,SET,7,0.47906,0.0093478,0.34297,0.081244,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,0.821901682175051
GSE3982_EFF_MEMORY_CD4_TCELL...3,SET,181,0.08629,0.0085213,0.061779,0.081251,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN,0.821901682175051
HP_NAEVUS_FLAMMEUS_OF_THE_EY...,SET,7,0.47602,0.0092885,0.34084,0.081272,HP_NAEVUS_FLAMMEUS_OF_THE_EYELID,0.821901682175051
GOBP_PATTERN_SPECIFICATION_P...,SET,432,0.062869,0.009525,0.045021,0.081298,GOBP_PATTERN_SPECIFICATION_PROCESS,0.821901682175051
SERVITJA_LIVER_HNF1A_TARGETS...2,SET,132,0.1087,0.0091794,0.077846,0.081307,SERVITJA_LIVER_HNF1A_TARGETS_UP,0.821901682175051
GOBP_NEGATIVE_REGULATION_OF_...492,SET,274,0.073679,0.0089291,0.052766,0.081317,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORYLATION,0.821901682175051
chr2p15,SET,15,0.38469,0.010986,0.27551,0.081326,chr2p15,0.821901682175051
HP_EXCESSIVE_WRINKLING_OF_PA...,SET,11,0.3465,0.0084746,0.24816,0.081327,HP_EXCESSIVE_WRINKLING_OF_PALMAR_SKIN,0.821901682175051
GOMF_CYTOKINE_ACTIVITY,SET,217,0.09591,0.01036,0.068707,0.081377,GOMF_CYTOKINE_ACTIVITY,0.822167917151163
GOBP_NEGATIVE_REGULATION_OF_...356,SET,294,0.072886,0.0091446,0.052233,0.081457,GOBP_NEGATIVE_REGULATION_OF_LOCOMOTION,0.822602295962823
GSE2770_UNTREATED_VS_IL12_TR...6,SET,178,0.090307,0.0088444,0.064725,0.081481,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.822602295962823
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SET,157,0.09494,0.0087375,0.068049,0.081491,SMIRNOV_RESPONSE_TO_IR_6HR_UP,0.822602295962823
PID_IL23_PATHWAY,SET,37,0.22343,0.010015,0.1602,0.081567,PID_IL23_PATHWAY,0.822837480417755
MODULE_103,SET,10,0.32499,0.0075788,0.23303,0.081571,MODULE_103,0.822837480417755
GOCC_PLASMA_MEMBRANE_RAFT,SET,106,0.1202,0.0091027,0.0862,0.081593,GOCC_PLASMA_MEMBRANE_RAFT,0.822837480417755
GOMF_PHOSPHOLIPID_TRANSFER_A...,SET,20,0.24115,0.0079508,0.17294,0.081609,GOMF_PHOSPHOLIPID_TRANSFER_ACTIVITY,0.822837480417755
GSE25088_WT_VS_STAT6_KO_MACR...6,SET,180,0.088199,0.0086859,0.063268,0.081661,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,0.822975021745433
GOBP_ACTOMYOSIN_STRUCTURE_OR...,SET,205,0.084295,0.0088531,0.060471,0.08167,GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION,0.822975021745433
GOBP_METAPHASE_ANAPHASE_TRAN...,SET,6,0.48862,0.0088273,0.35061,0.081725,GOBP_METAPHASE_ANAPHASE_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.823211349710983
MIR7854_3P,SET,99,0.11888,0.0087014,0.085306,0.081741,MIR7854_3P,0.823211349710983
GSE14908_RESTING_VS_HDM_STIM...3,SET,177,0.087233,0.0085196,0.062613,0.081787,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN,0.823211349710983
LI_PBMC_MENACTRA_AGE_18_45YO...9,SET,54,0.18707,0.010125,0.1343,0.081831,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE,0.823211349710983
REACTOME_NR1H2_AND_NR1H3_MED...,SET,46,0.17587,0.0087879,0.12627,0.081847,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,0.823211349710983
HP_ABNORMAL_CALF_MUSCULATURE...,SET,60,0.15373,0.0087694,0.11038,0.081863,HP_ABNORMAL_CALF_MUSCULATURE_MORPHOLOGY,0.823211349710983
GOBP_NEGATIVE_REGULATION_OF_...499,SET,12,0.35308,0.0090194,0.25353,0.081871,GOBP_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.823211349710983
PURBEY_TARGETS_OF_CTBP1_AND_...1,SET,150,0.094347,0.0084888,0.067762,0.081919,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,0.823211349710983
GOBP_REGULATION_OF_PLATELET_...1,SET,51,0.18763,0.0098705,0.13477,0.081929,GOBP_REGULATION_OF_PLATELET_ACTIVATION,0.823211349710983
HOFMANN_MYELODYSPLASTIC_SYND...6,SET,19,0.24653,0.0079227,0.17707,0.081932,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,0.823211349710983
GOBP_PROTEIN_TRANSPORT,SET,1301,0.033638,0.0086272,0.024163,0.081954,GOBP_PROTEIN_TRANSPORT,0.823211349710983
GOBP_PROTECTION_FROM_NATURAL...,SET,6,0.54356,0.0098198,0.39061,0.082038,GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.823651506041427
MIR222_5P,SET,174,0.089279,0.0086459,0.064168,0.082072,MIR222_5P,0.823651506041427
GSE36392_MAC_VS_NEUTROPHIL_I...2,SET,186,0.085251,0.0085329,0.061276,0.082081,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.823651506041427
GOCC_CELL_CELL_JUNCTION,SET,471,0.058575,0.0092563,0.042115,0.082144,GOCC_CELL_CELL_JUNCTION,0.823651506041427
GSE9037_CTRL_VS_LPS_4H_STIM_...2,SET,177,0.088975,0.0086897,0.063973,0.082148,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP,0.823651506041427
HP_AORTIC_ATHEROSCLEROTIC_LE...,SET,9,0.4574,0.01012,0.32898,0.08222,HP_AORTIC_ATHEROSCLEROTIC_LESION,0.823651506041427
REACTOME_G_ALPHA_12_13_SIGNA...,SET,74,0.14331,0.0090753,0.10309,0.082257,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,0.823651506041427
GOMF_TYPE_I_TRANSFORMING_GRO...,SET,11,0.40347,0.009868,0.29027,0.082277,GOMF_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.823651506041427
GOBP_REGULATION_OF_CAMP_DEPE...,SET,13,0.33676,0.0089533,0.24228,0.082284,GOBP_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.823651506041427
HP_ABNORMAL_PROSTATE_MORPHOL...,SET,38,0.2069,0.0093983,0.14886,0.082294,HP_ABNORMAL_PROSTATE_MORPHOLOGY,0.823651506041427
GOMF_CONNEXIN_BINDING,SET,5,0.62026,0.010229,0.44635,0.08233,GOMF_CONNEXIN_BINDING,0.823651506041427
GOBP_NEGATIVE_REGULATION_OF_...40,SET,44,0.17607,0.0086049,0.12671,0.08234,GOBP_NEGATIVE_REGULATION_OF_AXONOGENESIS,0.823651506041427
GSE25123_ROSIGLITAZONE_VS_IL...1,SET,105,0.11644,0.0087759,0.083796,0.082346,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.823651506041427
REACTOME_DOWNSTREAM_SIGNALIN...5,SET,26,0.22592,0.0084916,0.1626,0.082359,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,0.823651506041427
WESTON_VEGFA_TARGETS_6HR,SET,43,0.19536,0.0094388,0.14061,0.082365,WESTON_VEGFA_TARGETS_6HR,0.823651506041427
GAVISH_3CA_METAPROGRAM_EPITH...14,SET,45,0.18664,0.0092241,0.13434,0.082377,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1,0.823651506041427
HP_ABNORMAL_ARACHNOID_MATER_...,SET,48,0.16099,0.008217,0.1159,0.082413,HP_ABNORMAL_ARACHNOID_MATER_MORPHOLOGY,0.823774465056083
REACTOME_SPHINGOLIPID_CATABO...,SET,9,0.43349,0.0095905,0.31215,0.082469,REACTOME_SPHINGOLIPID_CATABOLISM,0.824015989658144
HNF3_Q6,SET,165,0.097615,0.0092077,0.070306,0.082511,HNF3_Q6,0.824015989658144
HASEGAWA_TUMORIGENESIS_BY_RE...,SET,9,0.37046,0.008196,0.26683,0.082525,HASEGAWA_TUMORIGENESIS_BY_RET_C634R,0.824015989658144
GOBP_DNA_DEAMINATION,SET,11,0.46857,0.01146,0.33751,0.082532,GOBP_DNA_DEAMINATION,0.824015989658144
HP_ABNORMAL_METACARPOPHALANG...,SET,19,0.29951,0.0096252,0.21576,0.082558,HP_ABNORMAL_METACARPOPHALANGEAL_JOINT_MORPHOLOGY,0.824038854106835
GSE11864_CSF1_IFNG_VS_CSF1_P...1,SET,161,0.093589,0.0087212,0.067437,0.08261,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN,0.824321145564169
GCM_HBP1,SET,63,0.14291,0.008353,0.10301,0.08267,GCM_HBP1,0.824683079793341
GOBP_APPENDAGE_MORPHOGENESIS,SET,139,0.10915,0.0094566,0.078735,0.082835,GOBP_APPENDAGE_MORPHOGENESIS,0.825889579124579
GSE36888_UNTREATED_VS_IL2_TR...10,SET,177,0.087897,0.0085844,0.063417,0.082881,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP,0.825889579124579
GOBP_REGULATION_OF_TOLERANCE...,SET,17,0.31385,0.0095412,0.2265,0.082937,GOBP_REGULATION_OF_TOLERANCE_INDUCTION,0.825889579124579
MIR6073,SET,96,0.12253,0.0088328,0.088431,0.08294,MIR6073,0.825889579124579
GSE360_LOW_DOSE_B_MALAYI_VS_...2,SET,184,0.084211,0.0083838,0.060781,0.08296,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.825889579124579
HP_DELAYED_EARLY_CHILDHOOD_S...,SET,20,0.25032,0.0082531,0.18071,0.083005,HP_DELAYED_EARLY_CHILDHOOD_SOCIAL_MILESTONE_DEVELOPMENT,0.825889579124579
GOBP_INTERLEUKIN_10_MEDIATED...,SET,11,0.46362,0.011339,0.33473,0.083029,GOBP_INTERLEUKIN_10_MEDIATED_SIGNALING_PATHWAY,0.825889579124579
ONGUSAHA_BRCA1_TARGETS_UP,SET,11,0.40091,0.0098054,0.28946,0.08303,ONGUSAHA_BRCA1_TARGETS_UP,0.825889579124579
GOBP_RENAL_RESPONSE_TO_BLOOD...,SET,7,0.55768,0.010882,0.40284,0.083129,GOBP_RENAL_RESPONSE_TO_BLOOD_FLOW_INVOLVED_IN_CIRCULATORY_RENIN_ANGIOTENSIN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.825889579124579
CHEN_ETV5_TARGETS_SERTOLI,SET,24,0.2864,0.010343,0.2069,0.083146,CHEN_ETV5_TARGETS_SERTOLI,0.825889579124579
MIR10400_3P_MIR4674,SET,34,0.20382,0.0087585,0.14727,0.083186,MIR10400_3P_MIR4674,0.825889579124579
MIR4323,SET,37,0.18799,0.0084267,0.13588,0.083254,MIR4323,0.825889579124579
GOCC_ORGANELLE_ENVELOPE_LUMEN,SET,83,0.13075,0.0087669,0.094502,0.083256,GOCC_ORGANELLE_ENVELOPE_LUMEN,0.825889579124579
PUIFFE_INVASION_INHIBITED_BY...2,SET,65,0.14558,0.0086427,0.10523,0.083264,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,0.825889579124579
REACTOME_REPRESSION_OF_WNT_T...,SET,13,0.34978,0.0092996,0.25284,0.083278,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,0.825889579124579
KEGG_MEDICUS_REFERENCE_NODAL...,SET,8,0.40523,0.0084528,0.29297,0.083312,KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY,0.825889579124579
HP_MODERATE_ALBUMINURIA,SET,10,0.39979,0.0093233,0.28923,0.083457,HP_MODERATE_ALBUMINURIA,0.825889579124579
GSE18281_SUBCAPSULAR_VS_CENT...2,SET,168,0.088926,0.0084633,0.064343,0.083484,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP,0.825889579124579
GSE22601_DOUBLE_NEGATIVE_VS_...3,SET,165,0.093885,0.0088559,0.067935,0.083496,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.825889579124579
GSE17721_PAM3CSK4_VS_GADIQUI...14,SET,184,0.085585,0.0085206,0.061943,0.083545,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP,0.825889579124579
GOMF_RNA_POLYMERASE_II_CTD_H...1,SET,10,0.36119,0.0084229,0.26149,0.083612,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_KINASE_ACTIVITY,0.825889579124579
GOBP_POSITIVE_REGULATION_OF_...302,SET,68,0.1566,0.0095081,0.11338,0.08362,GOBP_POSITIVE_REGULATION_OF_GLIOGENESIS,0.825889579124579
GOMF_ACTIVIN_BINDING,SET,11,0.38839,0.0094992,0.28121,0.083624,GOMF_ACTIVIN_BINDING,0.825889579124579
CHARAFE_BREAST_CANCER_LUMINA...2,SET,341,0.065199,0.0087984,0.047214,0.083657,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,0.825889579124579
GOBP_REGULATION_OF_CELLULAR_...7,SET,905,0.039955,0.0086454,0.028938,0.08369,GOBP_REGULATION_OF_CELLULAR_LOCALIZATION,0.825889579124579
GSE8685_IL2_STARVED_VS_IL21_...2,SET,182,0.085866,0.0085025,0.062192,0.083702,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.825889579124579
GOBP_KIDNEY_MORPHOGENESIS,SET,92,0.13423,0.009473,0.097234,0.083734,GOBP_KIDNEY_MORPHOGENESIS,0.825889579124579
HP_ABNORMALITY_OF_THE_ADRENA...,SET,199,0.084853,0.0087817,0.061477,0.083766,HP_ABNORMALITY_OF_THE_ADRENAL_GLANDS,0.825889579124579
WP_TROP2_REGULATORY_SIGNALING,SET,48,0.17434,0.0088979,0.12631,0.083775,WP_TROP2_REGULATORY_SIGNALING,0.825889579124579
GOMF_R_SMAD_BINDING,SET,25,0.23654,0.0087182,0.17139,0.08378,GOMF_R_SMAD_BINDING,0.825889579124579
MIR548L,SET,333,0.064901,0.0086567,0.047035,0.083827,MIR548L,0.825889579124579
HALLMARK_APICAL_JUNCTION,SET,183,0.089685,0.0089048,0.064998,0.083831,HALLMARK_APICAL_JUNCTION,0.825889579124579
GOBP_SPERMIDINE_METABOLIC_PR...,SET,6,0.42641,0.0077034,0.30904,0.083834,GOBP_SPERMIDINE_METABOLIC_PROCESS,0.825889579124579
GSE16266_CTRL_VS_LPS_STIM_ME...1,SET,179,0.090788,0.0089163,0.065799,0.083836,GSE16266_CTRL_VS_LPS_STIM_MEF_DN,0.825889579124579
MATTIOLI_MGUS_VS_MULTIPLE_MY...,SET,13,0.34773,0.0092452,0.25203,0.083842,MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,0.825889579124579
HP_INTERVERTEBRAL_DISK_DEGEN...,SET,6,0.50726,0.009164,0.36769,0.083867,HP_INTERVERTEBRAL_DISK_DEGENERATION,0.825889579124579
REACTOME_INTERLEUKIN_3_INTER...,SET,43,0.19199,0.0092758,0.13917,0.08388,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,0.825889579124579
WHITE_NEUROBLASTOMA_WITH_1P3...,SET,19,0.37256,0.011973,0.27008,0.08389,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,0.825889579124579
MIR362_3P,SET,107,0.12155,0.0092477,0.088136,0.083935,MIR362_3P,0.825889579124579
HP_NEOPLASM_OF_THE_ORAL_CAVI...,SET,63,0.1428,0.0083466,0.10355,0.083944,HP_NEOPLASM_OF_THE_ORAL_CAVITY,0.825889579124579
GSE27291_0H_VS_7D_STIM_GAMMA...1,SET,159,0.092641,0.0085796,0.067178,0.083951,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN,0.825889579124579
GOBP_CELLULAR_PROCESS_INVOLV...,SET,356,0.06276,0.0086499,0.045511,0.083957,GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM,0.825889579124579
GOBP_WATER_SOLUBLE_VITAMIN_B...,SET,11,0.3559,0.0087044,0.25809,0.083959,GOBP_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,0.825889579124579
MIR6889_5P,SET,11,0.38213,0.0093461,0.27717,0.084002,MIR6889_5P,0.825889579124579
LU_IL4_SIGNALING,SET,86,0.12649,0.0086325,0.09178,0.084081,LU_IL4_SIGNALING,0.825889579124579
GOBP_ENDOTHELIAL_CELL_MATRIX...,SET,6,0.56312,0.010173,0.4086,0.084085,GOBP_ENDOTHELIAL_CELL_MATRIX_ADHESION,0.825889579124579
DESCARTES_FETAL_KIDNEY_MESAN...,SET,42,0.20466,0.0097724,0.14852,0.08412,DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS,0.825889579124579
GOMF_QUATERNARY_AMMONIUM_GRO...2,SET,13,0.38419,0.010215,0.27884,0.084136,GOMF_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.825889579124579
WP_MIRNA_REGULATION_OF_DNA_D...,SET,67,0.13163,0.007933,0.095536,0.084146,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,0.825889579124579
MIR587,SET,337,0.067165,0.0090113,0.048754,0.084167,MIR587,0.825889579124579
MIR924,SET,44,0.17034,0.0083248,0.12365,0.084168,MIR924,0.825889579124579
GSE14415_INDUCED_TREG_VS_TCO...2,SET,158,0.090417,0.0083475,0.065642,0.084198,GSE14415_INDUCED_TREG_VS_TCONV_UP,0.825889579124579
MIR6777_3P,SET,45,0.17487,0.0086424,0.12695,0.084199,MIR6777_3P,0.825889579124579
GSE24026_PD1_LIGATION_VS_CTR...1,SET,182,0.086674,0.0085825,0.062938,0.084246,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN,0.825889579124579
GOBP_TRIGLYCERIDE_BIOSYNTHET...,SET,37,0.19079,0.0085521,0.13855,0.084254,GOBP_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.825889579124579
REACTOME_GABA_B_RECEPTOR_ACT...,SET,43,0.19643,0.0094905,0.14267,0.084293,REACTOME_GABA_B_RECEPTOR_ACTIVATION,0.825889579124579
FARMER_BREAST_CANCER_CLUSTER...1,SET,38,0.21838,0.0099199,0.15862,0.084296,FARMER_BREAST_CANCER_CLUSTER_1,0.825889579124579
ZNF837_TARGET_GENES,SET,5,0.52096,0.0085918,0.37841,0.084307,ZNF837_TARGET_GENES,0.825889579124579
MIR3192_5P,SET,142,0.10028,0.0087804,0.072855,0.084358,MIR3192_5P,0.825889579124579
CACCCBINDINGFACTOR_Q6,SET,244,0.075653,0.008659,0.054965,0.08436,CACCCBINDINGFACTOR_Q6,0.825889579124579
GOBP_RESPONSE_TO_BILE_ACID,SET,7,0.4888,0.0095378,0.35519,0.084393,GOBP_RESPONSE_TO_BILE_ACID,0.825889579124579
GOBP_RENAL_PROTEIN_ABSORPTION,SET,9,0.44779,0.0099069,0.3254,0.084403,GOBP_RENAL_PROTEIN_ABSORPTION,0.825889579124579
NAKAMURA_ADIPOGENESIS_EARLY_...1,SET,33,0.21818,0.0092372,0.15855,0.084407,NAKAMURA_ADIPOGENESIS_EARLY_DN,0.825889579124579
GOBP_REGULATION_OF_PROTEIN_B...,SET,112,0.10899,0.0084823,0.079203,0.084409,GOBP_REGULATION_OF_PROTEIN_BINDING,0.825889579124579
GCM_AQP4,SET,41,0.1899,0.0089597,0.13801,0.084413,GCM_AQP4,0.825889579124579
GSE18281_MEDULLARY_THYMOCYTE...2,SET,164,0.0914,0.0085955,0.066423,0.084416,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP,0.825889579124579
GOMF_MANNOSYL_OLIGOSACCHARID...2,SET,9,0.41929,0.0092765,0.30472,0.084421,GOMF_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY,0.825889579124579
REACTOME_FERTILIZATION,SET,26,0.22328,0.0083924,0.16231,0.084471,REACTOME_FERTILIZATION,0.825889579124579
GSE28726_NAIVE_VS_ACTIVATED_...2,SET,173,0.092495,0.0089318,0.067238,0.084477,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP,0.825889579124579
GSE40274_FOXP3_VS_FOXP3_AND_...3,SET,183,0.085044,0.008444,0.061842,0.084544,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.825889579124579
GSE19401_PLN_VS_PEYERS_PATCH...2,SET,171,0.088467,0.0084938,0.064338,0.084567,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP,0.825889579124579
chr19p13,SET,517,0.11964,0.019782,0.087008,0.084568,chr19p13,0.825889579124579
GSE12392_CD8A_POS_VS_NEG_SPL...1,SET,185,0.085337,0.0085187,0.062063,0.084573,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN,0.825889579124579
GOMF_THIAMINE_PYROPHOSPHATE_...,SET,6,0.4929,0.0089045,0.35848,0.084579,GOMF_THIAMINE_PYROPHOSPHATE_BINDING,0.825889579124579
HP_EEG_WITH_SPIKE_WAVE_COMPL...2,SET,8,0.48487,0.010114,0.3527,0.084614,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES_2_5_3_5_HZ,0.825889579124579
MIR6775_3P,SET,69,0.14446,0.0088349,0.10509,0.084623,MIR6775_3P,0.825889579124579
GOBP_POSITIVE_REGULATION_OF_...87,SET,9,0.46625,0.010315,0.33926,0.084682,GOBP_POSITIVE_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.825889579124579
HP_IRON_DEFICIENCY_ANEMIA,SET,27,0.22812,0.0087372,0.16599,0.084686,HP_IRON_DEFICIENCY_ANEMIA,0.825889579124579
BIOCARTA_EIF_PATHWAY,SET,13,0.30159,0.0080183,0.21946,0.084692,BIOCARTA_EIF_PATHWAY,0.825889579124579
HP_ABNORMAL_ASTROCYTE_MORPHO...,SET,45,0.17663,0.0087297,0.12853,0.084692,HP_ABNORMAL_ASTROCYTE_MORPHOLOGY,0.825889579124579
GSE22886_NAIVE_TCELL_VS_DC_UP,SET,178,0.085158,0.0083402,0.061991,0.084773,GSE22886_NAIVE_TCELL_VS_DC_UP,0.826352267246214
GOMF_MAP_KINASE_PHOSPHATASE_...,SET,13,0.34441,0.0091567,0.25073,0.084787,GOMF_MAP_KINASE_PHOSPHATASE_ACTIVITY,0.826352267246214
AACTGGA_MIR145,SET,216,0.077865,0.0083917,0.056693,0.084815,AACTGGA_MIR145,0.826393418839361
GOBP_BICARBONATE_TRANSPORT,SET,36,0.19072,0.0084329,0.13889,0.084862,GOBP_BICARBONATE_TRANSPORT,0.826619621636771
GSE6092_CTRL_VS_BORRELIA_BIR...2,SET,143,0.09445,0.008299,0.068804,0.084926,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP,0.826745963149079
GSE360_CTRL_VS_B_MALAYI_HIGH...4,SET,178,0.085042,0.0083287,0.061965,0.084975,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.826745963149079
HE_LIM_SUN_FETAL_LUNG_C1_EAR...2,SET,498,0.052375,0.008504,0.038167,0.084998,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL,0.826745963149079
MIR6894_5P,SET,38,0.18227,0.0082794,0.13289,0.085108,MIR6894_5P,0.826745963149079
GOBP_OSTEOBLAST_DIFFERENTIAT...,SET,209,0.085866,0.0091047,0.062605,0.085108,GOBP_OSTEOBLAST_DIFFERENTIATION,0.826745963149079
HP_POLYMORPHIC_VENTRICULAR_T...,SET,6,0.56796,0.010261,0.4141,0.08511,HP_POLYMORPHIC_VENTRICULAR_TACHYCARDIA,0.826745963149079
GOBP_COMPLEMENT_ACTIVATION_C...,SET,29,0.2489,0.0098795,0.18149,0.085133,GOBP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.826745963149079
MIR103A_1_5P,SET,136,0.1019,0.0087334,0.074312,0.085157,MIR103A_1_5P,0.826745963149079
MIR4313,SET,26,0.23075,0.0086732,0.16829,0.085164,MIR4313,0.826745963149079
GOBP_PHAGOLYSOSOME_ASSEMBLY,SET,17,0.31104,0.0094556,0.22685,0.085176,GOBP_PHAGOLYSOSOME_ASSEMBLY,0.826745963149079
GOBP_ENDONUCLEOLYTIC_CLEAVAG...1,SET,7,0.43474,0.008483,0.31707,0.085178,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_5_ETS_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.826745963149079
GOBP_BOX_C_D_SNORNP_ASSEMBLY,SET,8,0.38756,0.0080843,0.28266,0.08518,GOBP_BOX_C_D_SNORNP_ASSEMBLY,0.826745963149079
GOBP_CDP_CHOLINE_PATHWAY,SET,6,0.43555,0.0078685,0.31768,0.08519,GOBP_CDP_CHOLINE_PATHWAY,0.826745963149079
HP_NATAL_TOOTH,SET,31,0.21076,0.0086489,0.15374,0.085208,HP_NATAL_TOOTH,0.826745963149079
FERRANDO_LYL1_NEIGHBORS,SET,15,0.33639,0.0096064,0.24542,0.085245,FERRANDO_LYL1_NEIGHBORS,0.826829690376569
MORF_JAG1,SET,91,0.1266,0.0088867,0.092383,0.085287,MORF_JAG1,0.826829690376569
WP_INTEGRATED_CANCER_PATHWAY,SET,43,0.17082,0.0082528,0.12465,0.085288,WP_INTEGRATED_CANCER_PATHWAY,0.826829690376569
GOBP_POSITIVE_REGULATION_OF_...49,SET,147,0.097088,0.0086483,0.070888,0.085415,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY,0.827829984662577
HP_MYOCLONIC_ABSENCE_SEIZURE,SET,14,0.31955,0.0088164,0.23335,0.085446,HP_MYOCLONIC_ABSENCE_SEIZURE,0.827899562308336
GOMF_AMINOACYL_TRNA_HYDROLAS...,SET,4,0.45675,0.0067378,0.33362,0.085492,GOMF_AMINOACYL_TRNA_HYDROLASE_ACTIVITY,0.827966275055679
REACTOME_REGULATION_OF_CDH19...,SET,7,0.44623,0.0087071,0.32598,0.08553,REACTOME_REGULATION_OF_CDH19_EXPRESSION_AND_FUNCTION,0.827966275055679
KEGG_MEDICUS_REFERENCE_LPA_G...2,SET,8,0.42761,0.0089196,0.31241,0.085549,KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY,0.827966275055679
REACTOME_ANTIGEN_PRESENTATIO...,SET,28,0.22293,0.008695,0.16289,0.085567,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.827966275055679
GOBP_COLUMNAR_CUBOIDAL_EPITH...2,SET,119,0.1174,0.0094164,0.085782,0.085572,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION,0.827966275055679
HP_INCREASED_PROPORTION_OF_C...,SET,6,0.48082,0.0086863,0.35139,0.085615,HP_INCREASED_PROPORTION_OF_CD25_MAST_CELLS,0.828002114849833
GOCC_PRECATALYTIC_SPLICEOSOME,SET,48,0.14919,0.0076146,0.10905,0.085652,GOCC_PRECATALYTIC_SPLICEOSOME,0.828002114849833
MODULE_495,SET,13,0.36171,0.0096169,0.2644,0.085659,MODULE_495,0.828002114849833
GSE20198_UNTREATED_VS_IL12_I...2,SET,183,0.08846,0.0087831,0.064665,0.085671,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,0.828002114849833
CREB3L2_TARGET_GENES,SET,115,0.11191,0.008825,0.081844,0.085761,CREB3L2_TARGET_GENES,0.828242245209664
GSE45365_HEALTHY_VS_MCMV_INF...9,SET,172,0.089607,0.0086281,0.065537,0.085779,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP,0.828242245209664
GOBP_NEGATIVE_REGULATION_OF_...244,SET,33,0.19657,0.008322,0.14378,0.085802,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.828242245209664
HP_ABNORMALITY_OF_THE_ACOUST...,SET,4,0.62962,0.0092878,0.46057,0.085815,HP_ABNORMALITY_OF_THE_ACOUSTIC_REFLEX,0.828242245209664
HP_ABNORMAL_MIDDLE_EAR_REFLE...,SET,4,0.62962,0.0092878,0.46057,0.085815,HP_ABNORMAL_MIDDLE_EAR_REFLEXES,0.828242245209664
GOMF_PEPTIDYL_PROLINE_DIOXYG...,SET,12,0.29833,0.0076207,0.21827,0.085857,GOMF_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY,0.828322676935887
KEGG_MEDICUS_PATHOGEN_KSHV_V...6,SET,29,0.23796,0.009445,0.17411,0.085871,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY,0.828322676935887
REACTOME_SARS_COV_2_INFECTION,SET,269,0.070558,0.0084737,0.051636,0.085906,REACTOME_SARS_COV_2_INFECTION,0.828422300970874
HP_DUANE_ANOMALY,SET,22,0.26012,0.0089944,0.19038,0.085929,HP_DUANE_ANOMALY,0.828422300970874
GSE22601_IMMATURE_CD4_SINGLE...4,SET,184,0.088532,0.008814,0.064803,0.085953,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.828423881031614
MIR618,SET,59,0.14632,0.0082774,0.10715,0.086046,MIR618,0.828580715449362
GOCC_NUCLEAR_MEMBRANE,SET,282,0.068866,0.0084649,0.050436,0.086069,GOCC_NUCLEAR_MEMBRANE,0.828580715449362
GOBP_PROTEIN_DEUBIQUITINATION,SET,71,0.13294,0.0082469,0.097364,0.086075,GOBP_PROTEIN_DEUBIQUITINATION,0.828580715449362
GOCC_TRANSCRIPTION_FACTOR_TF...1,SET,5,0.45336,0.007477,0.33205,0.086082,GOCC_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX,0.828580715449362
GOBP_ANATOMICAL_STRUCTURE_MA...,SET,247,0.077886,0.0089685,0.057055,0.086118,GOBP_ANATOMICAL_STRUCTURE_MATURATION,0.828580715449362
GSE3982_BCELL_VS_BASOPHIL_UP,SET,164,0.087875,0.008264,0.064375,0.086126,GSE3982_BCELL_VS_BASOPHIL_UP,0.828580715449362
REACTOME_DEFECTIVE_ST3GAL3_C...,SET,8,0.40562,0.0084609,0.29718,0.086154,REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15,0.828580715449362
AMEF2_Q6,SET,229,0.081162,0.0090033,0.059472,0.086178,AMEF2_Q6,0.828580715449362
GCM_PPP1CC,SET,51,0.14369,0.0075591,0.10532,0.086246,GCM_PPP1CC,0.828580715449362
HP_PERIORBITAL_EDEMA,SET,99,0.12961,0.0094868,0.095026,0.086309,HP_PERIORBITAL_EDEMA,0.828580715449362
HP_ANTI_SMOOTH_MUSCLE_ANTIBO...,SET,5,0.48583,0.0080125,0.3563,0.086363,HP_ANTI_SMOOTH_MUSCLE_ANTIBODY_POSITIVITY,0.828580715449362
GOBP_INTRACELLULAR_PH_ELEVAT...,SET,7,0.43527,0.0084933,0.31928,0.086403,GOBP_INTRACELLULAR_PH_ELEVATION,0.828580715449362
GOBP_SPINDLE_ELONGATION,SET,13,0.33802,0.0089869,0.24795,0.086413,GOBP_SPINDLE_ELONGATION,0.828580715449362
GOMF_STRUCTURAL_CONSTITUENT_...6,SET,22,0.23232,0.0080331,0.17045,0.08646,GOMF_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE,0.828580715449362
GOMF_PROTEIN_TRANSMEMBRANE_T...,SET,25,0.21952,0.008091,0.16108,0.086475,GOMF_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.828580715449362
GOMF_EPHRIN_RECEPTOR_BINDING,SET,26,0.23938,0.0089974,0.17567,0.086508,GOMF_EPHRIN_RECEPTOR_BINDING,0.828580715449362
GSE32986_GMCSF_VS_GMCSF_AND_...2,SET,182,0.086954,0.0086103,0.063818,0.086522,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.828580715449362
WP_ETHANOL_METABOLISM_PRODUC...,SET,9,0.42355,0.0093707,0.31088,0.086541,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.828580715449362
HP_HYPOPLASIA_OF_THE_FOVEA,SET,25,0.25197,0.009287,0.18499,0.086593,HP_HYPOPLASIA_OF_THE_FOVEA,0.828580715449362
GOBP_PYRIMIDINE_NUCLEOTIDE_B...,SET,28,0.21998,0.0085801,0.16151,0.086594,GOBP_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.828580715449362
GOMF_ATP_DEPENDENT_ACTIVITY_...1,SET,109,0.10558,0.0081071,0.07753,0.086634,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_DNA,0.828580715449362
GOBP_REGULATION_OF_BMP_SIGNA...,SET,93,0.13046,0.0092568,0.095805,0.086654,GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.828580715449362
GSE6269_FLU_VS_E_COLI_INF_PB...1,SET,122,0.10908,0.0088582,0.080128,0.086706,GSE6269_FLU_VS_E_COLI_INF_PBMC_DN,0.828580715449362
REACTOME_INTERLEUKIN_21_SIGN...,SET,9,0.4723,0.010449,0.34699,0.086747,REACTOME_INTERLEUKIN_21_SIGNALING,0.828580715449362
LI_WILMS_TUMOR_VS_FETAL_KIDN...4,SET,25,0.24231,0.0089309,0.17805,0.086781,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,0.828580715449362
GOBP_REGULATION_OF_HUMORAL_I...2,SET,17,0.33523,0.010191,0.24635,0.086803,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.828580715449362
GOBP_CAMERA_TYPE_EYE_PHOTORE...,SET,31,0.21551,0.0088438,0.15839,0.086818,GOBP_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.828580715449362
GOBP_COPII_COATED_VESICLE_CA...,SET,18,0.24799,0.0077573,0.18226,0.086818,GOBP_COPII_COATED_VESICLE_CARGO_LOADING,0.828580715449362
KEGG_MEDICUS_REFERENCE_CXCR4...4,SET,31,0.22247,0.0091294,0.16354,0.086863,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.828580715449362
MOROSETTI_FACIOSCAPULOHUMERA...2,SET,19,0.26801,0.0086128,0.19702,0.086881,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,0.828580715449362
HP_ABNORMALITY_OF_THE_MUSCUL...3,SET,89,0.12201,0.00847,0.089704,0.086903,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LOWER_LIMBS,0.828580715449362
HP_NEOPLASM_OF_THE_PERIPHERA...,SET,68,0.13607,0.0082618,0.10006,0.086934,HP_NEOPLASM_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,0.828580715449362
LI_ESTROGENE_MID_E2_RESPONSE...1,SET,40,0.20072,0.009354,0.1476,0.086947,LI_ESTROGENE_MID_E2_RESPONSE_DN,0.828580715449362
ABBUD_LIF_SIGNALING_1_UP,SET,39,0.1982,0.0091208,0.14578,0.086982,ABBUD_LIF_SIGNALING_1_UP,0.828580715449362
GOBP_CAMP_CATABOLIC_PROCESS,SET,9,0.41027,0.0090768,0.30176,0.086991,GOBP_CAMP_CATABOLIC_PROCESS,0.828580715449362
HP_CHRONIC_INFECTION,SET,21,0.25735,0.0086945,0.18929,0.086994,HP_CHRONIC_INFECTION,0.828580715449362
RFX1_02,SET,252,0.071693,0.0083374,0.052742,0.087031,RFX1_02,0.828580715449362
HP_PROTEIN_LOSING_ENTEROPATHY,SET,20,0.25823,0.0085141,0.19,0.087069,HP_PROTEIN_LOSING_ENTEROPATHY,0.828580715449362
HP_ABNORMALITY_OF_SALIVATION,SET,178,0.09018,0.008832,0.066354,0.087071,HP_ABNORMALITY_OF_SALIVATION,0.828580715449362
MIR4764_3P,SET,62,0.14775,0.0085671,0.10873,0.087106,MIR4764_3P,0.828580715449362
MIR5590_5P,SET,106,0.11227,0.0085016,0.082621,0.08711,MIR5590_5P,0.828580715449362
KEGG_MEDICUS_PATHOGEN_HIV_GP...3,SET,26,0.24257,0.0091175,0.17852,0.087111,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.828580715449362
GOBP_HINDBRAIN_MATURATION,SET,5,0.55284,0.0091175,0.40691,0.087142,GOBP_HINDBRAIN_MATURATION,0.828580715449362
GOBP_EPITHELIAL_CELL_DIFFERE...3,SET,10,0.41875,0.0097653,0.30823,0.087149,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.828580715449362
GOBP_TRIGLYCERIDE_METABOLIC_...,SET,96,0.12283,0.0088546,0.090429,0.087186,GOBP_TRIGLYCERIDE_METABOLIC_PROCESS,0.828580715449362
GSE37605_NOD_VS_C57BL6_IRES_...2,SET,140,0.10062,0.0087484,0.074074,0.087188,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP,0.828580715449362
BENPORATH_SOX2_TARGETS,SET,663,0.046426,0.0086574,0.034183,0.087219,BENPORATH_SOX2_TARGETS,0.828580715449362
HP_ELEVATED_MATERNAL_CIRCULA...,SET,4,0.66375,0.0097912,0.48877,0.08724,HP_ELEVATED_MATERNAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,0.828580715449362
GOMF_NMDA_GLUTAMATE_RECEPTOR...,SET,7,0.46054,0.0089864,0.33921,0.087288,GOMF_NMDA_GLUTAMATE_RECEPTOR_ACTIVITY,0.828580715449362
GSE2826_WT_VS_XID_BCELL_UP,SET,183,0.085901,0.0085291,0.063282,0.08733,GSE2826_WT_VS_XID_BCELL_UP,0.828580715449362
REACTOME_FORMATION_OF_THE_UR...,SET,19,0.31302,0.01006,0.23063,0.087359,REACTOME_FORMATION_OF_THE_URETERIC_BUD,0.828580715449362
HP_ABNORMAL_CIRCULATING_INSU...,SET,144,0.10023,0.0088377,0.073851,0.087361,HP_ABNORMAL_CIRCULATING_INSULIN_CONCENTRATION,0.828580715449362
GSE11961_UNSTIM_VS_ANTI_IGM_...2,SET,182,0.086883,0.0086033,0.064032,0.087419,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP,0.828580715449362
chr7q31,SET,58,0.28516,0.015994,0.21018,0.087443,chr7q31,0.828580715449362
FAN_EMBRYONIC_CTX_ASTROCYTE_2,SET,139,0.11161,0.0096694,0.082266,0.087453,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.828580715449362
HP_MICRONODULAR_CIRRHOSIS,SET,21,0.24904,0.0084134,0.18357,0.087454,HP_MICRONODULAR_CIRRHOSIS,0.828580715449362
GSE1791_CTRL_VS_NEUROMEDINU_...6,SET,160,0.094546,0.0087832,0.069692,0.087461,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP,0.828580715449362
REACTOME_TRANSPORT_OF_RCBL_W...,SET,8,0.4052,0.0084522,0.29869,0.087468,REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY,0.828580715449362
GSE22432_MULTIPOTENT_VS_COMM...1,SET,187,0.083737,0.0084036,0.061735,0.087495,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN,0.828580715449362
GOBP_OVIDUCT_DEVELOPMENT,SET,6,0.49681,0.0089752,0.3663,0.087512,GOBP_OVIDUCT_DEVELOPMENT,0.828580715449362
HOFT_PBMC_TICE_BCG_RBCG_AG85...,SET,35,0.20963,0.0091397,0.15459,0.087543,HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE,0.828580715449362
GSE1740_UNSTIM_VS_IFNA_STIMU...2,SET,154,0.092541,0.0084357,0.068246,0.08756,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP,0.828580715449362
GSE6269_FLU_VS_E_COLI_INF_PB...2,SET,147,0.090614,0.0080716,0.066833,0.087586,GSE6269_FLU_VS_E_COLI_INF_PBMC_UP,0.828580715449362
ZNF579_TARGET_GENES,SET,613,0.047608,0.0085485,0.035115,0.087598,ZNF579_TARGET_GENES,0.828580715449362
MIR548AZ_3P,SET,436,0.055972,0.0085183,0.04129,0.087625,MIR548AZ_3P,0.828580715449362
GOBP_POSITIVE_REGULATION_OF_...655,SET,304,0.067716,0.0086369,0.049956,0.087636,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS,0.828580715449362
GOBP_ETHANOL_METABOLIC_PROCE...,SET,11,0.39029,0.0095455,0.28793,0.087641,GOBP_ETHANOL_METABOLIC_PROCESS,0.828580715449362
GOMF_INTERLEUKIN_6_RECEPTOR_...,SET,6,0.44306,0.0080042,0.3269,0.087661,GOMF_INTERLEUKIN_6_RECEPTOR_BINDING,0.828580715449362
GAUSSMANN_MLL_AF4_FUSION_TAR...2,SET,165,0.094953,0.0089566,0.070061,0.087671,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,0.828580715449362
GOCC_ENDOLYSOSOME_LUMEN,SET,5,0.58264,0.009609,0.42994,0.087692,GOCC_ENDOLYSOSOME_LUMEN,0.828580715449362
GOBP_CYTOKINETIC_PROCESS,SET,46,0.16378,0.0081837,0.12087,0.087712,GOBP_CYTOKINETIC_PROCESS,0.828580715449362
HP_INAPPROPRIATE_CRYING,SET,14,0.30099,0.0083042,0.22213,0.08772,HP_INAPPROPRIATE_CRYING,0.828580715449362
HP_KERATITIS,SET,70,0.13634,0.0083981,0.10063,0.08775,HP_KERATITIS,0.828580715449362
GSE14308_TH17_VS_INDUCED_TRE...1,SET,186,0.081484,0.0081559,0.06015,0.087767,GSE14308_TH17_VS_INDUCED_TREG_DN,0.828580715449362
GOBP_NEGATIVE_REGULATION_OF_...245,SET,4,0.64174,0.0094666,0.47376,0.087784,GOBP_NEGATIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.828580715449362
TRAVAGLINI_LUNG_MUCOUS_CELL,SET,116,0.12069,0.0095581,0.089105,0.087803,TRAVAGLINI_LUNG_MUCOUS_CELL,0.828580715449362
MIR32_3P,SET,306,0.068005,0.0087018,0.050209,0.087805,MIR32_3P,0.828580715449362
HP_MUSCULAR_DYSTROPHY,SET,69,0.13626,0.0083335,0.10065,0.087901,HP_MUSCULAR_DYSTROPHY,0.828672478343259
GOMF_IMMUNOGLOBULIN_BINDING,SET,25,0.24426,0.0090027,0.1805,0.088,GOMF_IMMUNOGLOBULIN_BINDING,0.828672478343259
GOBP_REGULATION_OF_CELL_CELL...3,SET,11,0.32556,0.0079624,0.24059,0.088006,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.828672478343259
GSE5589_WT_VS_IL6_KO_LPS_AND...3,SET,178,0.085307,0.0083547,0.063042,0.088008,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.828672478343259
GOBP_REGULATION_OF_ENDOPLASM...1,SET,29,0.19685,0.0078134,0.14548,0.088018,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.828672478343259
DACOSTA_LOW_DOSE_UV_RESPONSE...2,SET,11,0.37579,0.0091909,0.27773,0.088024,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.828672478343259
GOBP_GOLGI_TO_VACUOLE_TRANSP...,SET,20,0.24204,0.0079802,0.17889,0.088035,GOBP_GOLGI_TO_VACUOLE_TRANSPORT,0.828672478343259
SCGGAAGY_ELK1_02,SET,1127,0.034736,0.008334,0.025674,0.088044,SCGGAAGY_ELK1_02,0.828672478343259
GSE25502_WT_VS_KLF13_KO_THYM...2,SET,158,0.090793,0.0083822,0.06711,0.088051,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP,0.828672478343259
GOBP_POSITIVE_REGULATION_OF_...448,SET,10,0.40845,0.009525,0.30192,0.088062,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.828672478343259
GSE2770_IL12_VS_IL4_TREATED_...1,SET,151,0.097398,0.0087922,0.072,0.088077,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.828672478343259
MODULE_130,SET,18,0.30474,0.0095324,0.22541,0.088209,MODULE_130,0.829689795669824
GOMF_CADHERIN_BINDING_INVOLV...,SET,18,0.31053,0.0097135,0.22976,0.088273,GOMF_CADHERIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION,0.82994714440238
WP_INITIATION_OF_TRANSCRIPTI...,SET,31,0.19182,0.0078716,0.14194,0.088293,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,0.82994714440238
GOBP_PERICARDIUM_DEVELOPMENT,SET,18,0.29582,0.0092535,0.21892,0.088308,GOBP_PERICARDIUM_DEVELOPMENT,0.82994714440238
GSE39916_B_CELL_SPLEEN_VS_PL...2,SET,181,0.089694,0.0088573,0.066394,0.088367,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP,0.830277124898621
GOBP_3_PHOSPHOADENOSINE_5_PH...,SET,15,0.33961,0.0096983,0.25148,0.088448,GOBP_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS,0.830813578378378
RP58_01,SET,191,0.086897,0.0088126,0.064357,0.088479,RP58_01,0.830880206700892
IGLV5_37_TARGET_GENES,SET,473,0.055655,0.008813,0.041225,0.088512,IGLV5_37_TARGET_GENES,0.830965575364668
GSE9960_GRAM_NEG_VS_GRAM_NEG...1,SET,167,0.081948,0.0077762,0.060721,0.088583,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.831006492174852
GSE22886_NAIVE_CD8_TCELL_VS_...4,SET,182,0.083028,0.0082215,0.061522,0.088584,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP,0.831006492174852
GOBP_REGULATION_OF_SKELETAL_...4,SET,14,0.29894,0.0082478,0.22153,0.088608,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.831006492174852
GSE20727_DNFB_ALLERGEN_VS_RO...2,SET,162,0.09341,0.0087313,0.069223,0.088612,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.831006492174852
GOBP_CEREBELLAR_PURKINJE_CEL...3,SET,15,0.29084,0.0083056,0.21558,0.088658,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS,0.83121359320205
HP_SECONDARY_GROWTH_HORMONE_...,SET,15,0.28328,0.0080899,0.21001,0.088692,HP_SECONDARY_GROWTH_HORMONE_DEFICIENCY,0.831280753572392
GSE25088_CTRL_VS_IL4_AND_ROS...3,SET,152,0.092401,0.0083685,0.068508,0.088713,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,0.831280753572392
PID_ECADHERIN_NASCENT_AJ_PAT...,SET,38,0.19749,0.0089707,0.14648,0.088798,PID_ECADHERIN_NASCENT_AJ_PATHWAY,0.831769284559418
MYLLYKANGAS_AMPLIFICATION_HO...7,SET,6,0.46001,0.0083105,0.34122,0.088813,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21,0.831769284559418
GOBP_PROTON_TRANSPORTING_V_T...,SET,6,0.46279,0.0083607,0.34346,0.088929,GOBP_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.832441727248607
REACTOME_SIGNALING_BY_PDGF,SET,57,0.15865,0.0088219,0.11775,0.088933,REACTOME_SIGNALING_BY_PDGF,0.832441727248607
GOBP_POSITIVE_REGULATION_OF_...531,SET,8,0.42086,0.0087789,0.3125,0.089037,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.832441727248607
PARK_TRETINOIN_RESPONSE_AND_...2,SET,20,0.28407,0.0093661,0.21099,0.089095,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,0.832441727248607
REACTOME_MISCELLANEOUS_SUBST...,SET,12,0.36742,0.0093856,0.2729,0.089105,REACTOME_MISCELLANEOUS_SUBSTRATES,0.832441727248607
GOBP_T_TUBULE_ORGANIZATION,SET,6,0.44248,0.0079938,0.32869,0.08913,GOBP_T_TUBULE_ORGANIZATION,0.832441727248607
GSE26669_CTRL_VS_COSTIM_BLOC...3,SET,179,0.084098,0.0082592,0.062472,0.089131,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN,0.832441727248607
HP_SENSORIMOTOR_NEUROPATHY,SET,73,0.13545,0.0085196,0.10063,0.08917,HP_SENSORIMOTOR_NEUROPATHY,0.832441727248607
LEI_MYB_TARGETS,SET,297,0.068913,0.0086895,0.051201,0.089172,LEI_MYB_TARGETS,0.832441727248607
MULLIGHAN_NPM1_MUTATED_SIGNA...1,SET,110,0.10348,0.0079817,0.076888,0.089187,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,0.832441727248607
HP_APLASIA_HYPOPLASIA_OF_THE...73,SET,27,0.23097,0.0088463,0.17163,0.089204,HP_APLASIA_HYPOPLASIA_OF_THE_TIBIA,0.832441727248607
EGFR_TARGET_GENES,SET,20,0.26998,0.0089016,0.20065,0.089231,EGFR_TARGET_GENES,0.832441727248607
GOBP_PERK_MEDIATED_UNFOLDED_...,SET,20,0.26912,0.0088732,0.20001,0.089232,GOBP_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.832441727248607
GSE37533_PPARG2_FOXP3_VS_FOX...3,SET,175,0.087631,0.0085104,0.065138,0.089269,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.832441727248607
MIR5001_3P,SET,139,0.096237,0.0083378,0.071535,0.089272,MIR5001_3P,0.832441727248607
GOCC_GTPASE_COMPLEX,SET,38,0.19042,0.0086496,0.14155,0.089291,GOCC_GTPASE_COMPLEX,0.832441727248607
GOBP_CELL_JUNCTION_DISASSEMB...,SET,27,0.26029,0.0099696,0.19353,0.08932,GOBP_CELL_JUNCTION_DISASSEMBLY,0.832441727248607
GOCC_NUCLEAR_ENVELOPE,SET,450,0.054291,0.0083907,0.040368,0.089339,GOCC_NUCLEAR_ENVELOPE,0.832441727248607
HE_LIM_SUN_FETAL_LUNG_C5_DEL...,SET,3,0.75394,0.009632,0.56081,0.089421,HE_LIM_SUN_FETAL_LUNG_C5_DELTA_SMALL_PRE_B_CELL,0.832441727248607
GSE21670_TGFB_VS_TGFB_AND_IL...3,SET,184,0.079931,0.0079577,0.059459,0.089434,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.832441727248607
HP_ABNORMAL_CIRCULATING_ALBU...,SET,108,0.10875,0.0083119,0.080901,0.089449,HP_ABNORMAL_CIRCULATING_ALBUMIN_CONCENTRATION,0.832441727248607
GSE13306_RA_VS_UNTREATED_TRE...1,SET,190,0.086605,0.0087602,0.06443,0.089455,GSE13306_RA_VS_UNTREATED_TREG_DN,0.832441727248607
GSE36392_EOSINOPHIL_VS_NEUTR...2,SET,183,0.084793,0.008419,0.063089,0.08948,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.832441727248607
PURBEY_TARGETS_OF_CTBP1_NOT_...2,SET,262,0.069866,0.0082822,0.051994,0.089528,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,0.832441727248607
MODULE_165,SET,77,0.14215,0.0091816,0.10581,0.089571,MODULE_165,0.832441727248607
GOBP_MOTOR_LEARNING,SET,8,0.43377,0.0090481,0.32301,0.089663,GOBP_MOTOR_LEARNING,0.832441727248607
WEBER_METHYLATED_HCP_IN_SPER...2,SET,16,0.27177,0.0080154,0.20241,0.089694,WEBER_METHYLATED_HCP_IN_SPERM_UP,0.832441727248607
GAVISH_3CA_METAPROGRAM_MACRO...7,SET,46,0.17638,0.0088133,0.13139,0.089732,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS,0.832441727248607
HP_INTRAVENTRICULAR_HEMORRHA...,SET,7,0.48008,0.0093677,0.35772,0.089799,HP_INTRAVENTRICULAR_HEMORRHAGE,0.832441727248607
FREAC3_01,SET,232,0.080116,0.0089445,0.059698,0.089802,FREAC3_01,0.832441727248607
GSE30962_ACUTE_VS_CHRONIC_LC...2,SET,176,0.085995,0.0083751,0.064078,0.089802,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP,0.832441727248607
HP_NYSTAGMUS_INDUCED_HEAD_NO...,SET,15,0.43867,0.012527,0.3269,0.089824,HP_NYSTAGMUS_INDUCED_HEAD_NODDING,0.832441727248607
GCM_DPF2,SET,27,0.19601,0.0075073,0.14609,0.089862,GCM_DPF2,0.832441727248607
GOMF_NUCLEOSIDE_KINASE_ACTIV...,SET,9,0.3644,0.0080621,0.27161,0.089865,GOMF_NUCLEOSIDE_KINASE_ACTIVITY,0.832441727248607
HP_RECURRENT_SYSTEMIC_PYOGEN...,SET,5,0.52221,0.0086123,0.3893,0.089904,HP_RECURRENT_SYSTEMIC_PYOGENIC_INFECTIONS,0.832441727248607
KRAS.50_UP.V1_DN,SET,44,0.17803,0.0087008,0.13273,0.089922,KRAS.50_UP.V1_DN,0.832441727248607
HALLMARK_REACTIVE_OXYGEN_SPE...,SET,45,0.18004,0.0088979,0.13423,0.089933,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.832441727248607
GSE6674_ANTI_IGM_VS_CPG_STIM...1,SET,179,0.084203,0.0082695,0.062784,0.089944,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN,0.832441727248607
HP_ELEVATED_CIRCULATING_ACYL...,SET,17,0.28004,0.0085134,0.20883,0.089962,HP_ELEVATED_CIRCULATING_ACYLCARNITINE_CONCENTRATION,0.832441727248607
GOBP_ACTIVATION_OF_CYSTEINE_...3,SET,5,0.43855,0.0072326,0.32703,0.089965,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C,0.832441727248607
GSE19941_UNSTIM_VS_LPS_AND_I...1,SET,184,0.082466,0.0082101,0.061496,0.089971,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.832441727248607
GOBP_FAT_CELL_PROLIFERATION,SET,15,0.31883,0.009105,0.23777,0.089978,GOBP_FAT_CELL_PROLIFERATION,0.832441727248607
GOCC_ENDOPLASMIC_RETICULUM_G...2,SET,72,0.13084,0.0081736,0.097586,0.090002,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE,0.832441727248607
KEGG_MEDICUS_REFERENCE_CGAS_...,SET,13,0.40234,0.010697,0.30009,0.090012,KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY,0.832441727248607
HP_LONG_UPPER_LIP,SET,6,0.58758,0.010615,0.43827,0.090022,HP_LONG_UPPER_LIP,0.832441727248607
HP_APLASIA_HYPOPLASIA_OF_THE...47,SET,4,0.6716,0.0099071,0.50104,0.090063,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_SEPTUM,0.832441727248607
MORF_DNMT1,SET,104,0.1056,0.0079211,0.078794,0.090105,MORF_DNMT1,0.832441727248607
GSE11924_TFH_VS_TH17_CD4_TCE...2,SET,177,0.080563,0.0078681,0.060115,0.090108,GSE11924_TFH_VS_TH17_CD4_TCELL_UP,0.832441727248607
HP_ABNORMAL_CENTRAL_SENSORY_...,SET,12,0.32636,0.0083368,0.24353,0.090113,HP_ABNORMAL_CENTRAL_SENSORY_FUNCTION,0.832441727248607
GSE43955_TH0_VS_TGFB_IL6_TH1...13,SET,184,0.089321,0.0088926,0.066652,0.090114,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN,0.832441727248607
GSE27786_ERYTHROBLAST_VS_NEU...1,SET,176,0.082067,0.0079926,0.061242,0.090123,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN,0.832441727248607
GOBP_SKELETAL_MUSCLE_TISSUE_...1,SET,10,0.38091,0.0088829,0.28428,0.090149,GOBP_SKELETAL_MUSCLE_TISSUE_GROWTH,0.832441727248607
GSE24142_DN2_VS_DN3_THYMOCYT...4,SET,186,0.086171,0.008625,0.064328,0.090204,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN,0.832441727248607
GSE30962_ACUTE_VS_CHRONIC_LC...3,SET,185,0.087627,0.0087474,0.065425,0.090237,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN,0.832441727248607
GOMF_CYSTEINE_TYPE_ENDOPEPTI...3,SET,12,0.33289,0.0085036,0.24856,0.090246,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.832441727248607
CEBPZ_TARGET_GENES,SET,1239,0.03338,0.0083698,0.024925,0.090261,CEBPZ_TARGET_GENES,0.832441727248607
GOCC_DISTAL_AXON,SET,249,0.075722,0.008754,0.056544,0.090267,GOCC_DISTAL_AXON,0.832441727248607
MIR150_3P,SET,119,0.10604,0.0085048,0.079182,0.090274,MIR150_3P,0.832441727248607
GSE24634_TREG_VS_TCONV_POST_...5,SET,177,0.089173,0.008709,0.066602,0.09031,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN,0.832552798408488
GOBP_NEGATIVE_REGULATION_OF_...18,SET,23,0.2405,0.0085027,0.17968,0.090378,GOBP_NEGATIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.832630105848108
STAT5A_03,SET,233,0.079272,0.0088691,0.059231,0.0904,STAT5A_03,0.832630105848108
HP_ABNORMAL_ILEUM_MORPHOLOGY,SET,33,0.18745,0.007936,0.14011,0.090483,HP_ABNORMAL_ILEUM_MORPHOLOGY,0.832630105848108
GOMF_KINASE_BINDING,SET,732,0.043221,0.0084523,0.032309,0.090499,GOMF_KINASE_BINDING,0.832630105848108
MODULE_47,SET,208,0.084739,0.0089639,0.063345,0.0905,MODULE_47,0.832630105848108
KEGG_MEDICUS_REFERENCE_NOTCH...3,SET,10,0.32914,0.0076755,0.24606,0.090517,KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION,0.832630105848108
GOBP_HEMOSTASIS,SET,221,0.082001,0.0089379,0.061303,0.090518,GOBP_HEMOSTASIS,0.832630105848108
GATA3_01,SET,220,0.080439,0.0087481,0.060136,0.090521,GATA3_01,0.832630105848108
MIR4437,SET,97,0.11833,0.0085737,0.088466,0.090534,MIR4437,0.832630105848108
GSE22229_RENAL_TRANSPLANT_VS...2,SET,183,0.084219,0.0083621,0.063002,0.090659,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP,0.833092125693161
FAN_EMBRYONIC_CTX_BIG_GROUPS...1,SET,341,0.068307,0.0092178,0.051112,0.090716,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL,0.833092125693161
WANG_RESPONSE_TO_BEXAROTENE_...2,SET,31,0.19373,0.0079497,0.14497,0.090729,WANG_RESPONSE_TO_BEXAROTENE_UP,0.833092125693161
HP_ABNORMALITY_OF_THE_EXTRIN...,SET,20,0.22493,0.0074162,0.16832,0.090731,HP_ABNORMALITY_OF_THE_EXTRINSIC_PATHWAY,0.833092125693161
MORI_SMALL_PRE_BII_LYMPHOCYT...1,SET,73,0.13024,0.0081921,0.097467,0.090742,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,0.833092125693161
MIR516B_5P,SET,114,0.10379,0.0081493,0.077675,0.090744,MIR516B_5P,0.833092125693161
MIR2052,SET,220,0.07663,0.0083339,0.057355,0.09077,MIR2052,0.833092125693161
GOMF_ENDOPEPTIDASE_ACTIVITY,SET,362,0.063668,0.0088472,0.047654,0.090776,GOMF_ENDOPEPTIDASE_ACTIVITY,0.833092125693161
GSE12366_PLASMA_CELL_VS_MEMO...2,SET,168,0.088473,0.0084202,0.066239,0.090838,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.833432054631829
MIR766_3P,SET,142,0.098153,0.0085944,0.073494,0.090861,MIR766_3P,0.833432054631829
HP_APLASIA_OF_THE_PECTORALIS...,SET,4,0.62913,0.0092805,0.47139,0.091011,HP_APLASIA_OF_THE_PECTORALIS_MAJOR_MUSCLE,0.833599086247699
GSE18791_CTRL_VS_NEWCASTLE_V...1,SET,170,0.091167,0.0087276,0.068313,0.09102,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN,0.833599086247699
MIR651_5P,SET,107,0.11231,0.008545,0.08416,0.091024,MIR651_5P,0.833599086247699
MODULE_90,SET,3,0.52681,0.0067302,0.39476,0.091028,MODULE_90,0.833599086247699
BIOCARTA_INFLAM_PATHWAY,SET,25,0.24979,0.0092065,0.18723,0.091085,BIOCARTA_INFLAM_PATHWAY,0.833599086247699
GOMF_HISTONE_H2AX_KINASE_ACT...,SET,5,0.45929,0.0075747,0.34426,0.091091,GOMF_HISTONE_H2AX_KINASE_ACTIVITY,0.833599086247699
REACTOME_TRIGLYCERIDE_BIOSYN...,SET,12,0.35444,0.0090541,0.26572,0.091126,REACTOME_TRIGLYCERIDE_BIOSYNTHESIS,0.833599086247699
HP_ABNORMAL_MORPHOLOGY_OF_TH...5,SET,43,0.17876,0.0086368,0.13402,0.091143,HP_ABNORMAL_MORPHOLOGY_OF_THE_LIMBIC_SYSTEM,0.833599086247699
GSE45365_WT_VS_IFNAR_KO_CD8A...2,SET,171,0.089165,0.0085608,0.066852,0.091148,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN,0.833599086247699
HP_ELEVATED_URINARY_DELTA_AM...,SET,5,0.59459,0.009806,0.44585,0.091175,HP_ELEVATED_URINARY_DELTA_AMINOLEVULINIC_ACID,0.833599086247699
ARGGGTTAA_UNKNOWN,SET,110,0.11615,0.0089594,0.087103,0.091187,ARGGGTTAA_UNKNOWN,0.833599086247699
HE_LIM_SUN_FETAL_LUNG_C0_MES...3,SET,156,0.10031,0.0092028,0.075227,0.091196,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL,0.833599086247699
GOBP_NEGATIVE_REGULATION_OF_...614,SET,7,0.50237,0.0098026,0.37674,0.091198,GOBP_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.833599086247699
CCAWYNNGAAR_UNKNOWN,SET,123,0.10241,0.0083498,0.076804,0.091215,CCAWYNNGAAR_UNKNOWN,0.833599086247699
GNF2_SMC2L1,SET,32,0.20438,0.0085207,0.15335,0.091312,GNF2_SMC2L1,0.834101760692732
DESCARTES_MAIN_FETAL_THYMIC_...,SET,139,0.097485,0.008446,0.073157,0.09135,DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS,0.834101760692732
MIYAGAWA_TARGETS_OF_EWSR1_ET...2,SET,239,0.081734,0.0092599,0.061339,0.091359,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,0.834101760692732
GOBP_ESTABLISHMENT_OF_CENTRO...,SET,10,0.40543,0.0094546,0.30427,0.091368,GOBP_ESTABLISHMENT_OF_CENTROSOME_LOCALIZATION,0.834101760692732
HP_PALMAR_PITS,SET,8,0.2991,0.006239,0.22454,0.091436,HP_PALMAR_PITS,0.834101760692732
MOROSETTI_FACIOSCAPULOHUMERA...1,SET,12,0.33983,0.0086808,0.25513,0.091442,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN,0.834101760692732
GOBP_SRP_DEPENDENT_COTRANSLA...1,SET,16,0.25987,0.0076644,0.1951,0.091444,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.834101760692732
REACTOME_DNA_REPAIR,SET,264,0.063299,0.007532,0.047527,0.091462,REACTOME_DNA_REPAIR,0.834101760692732
GSE45382_UNTREATED_VS_TGFB_T...2,SET,179,0.087161,0.00856,0.065459,0.091513,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP,0.834347931532004
LI_WILMS_TUMOR_ANAPLASTIC_UP,SET,17,0.26941,0.00819,0.20237,0.091565,LI_WILMS_TUMOR_ANAPLASTIC_UP,0.83441152293578
TESAR_ALK_AND_JAK_TARGETS_MO...2,SET,4,0.56841,0.0083849,0.42702,0.091583,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP,0.83441152293578
GSE32901_NAIVE_VS_TH1_CD4_TC...1,SET,152,0.093067,0.0084288,0.069919,0.091592,GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN,0.83441152293578
HP_ABNORMAL_FOVEAL_MORPHOLOGY,SET,46,0.18433,0.0092104,0.13852,0.09165,HP_ABNORMAL_FOVEAL_MORPHOLOGY,0.834721108490566
GSE20366_EX_VIVO_VS_HOMEOSTA...2,SET,180,0.081398,0.0080161,0.061177,0.091681,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP,0.834784688236835
HP_ABNORMALITY_OF_THE_ABDOMI...1,SET,1202,0.033897,0.0083807,0.025482,0.091726,HP_ABNORMALITY_OF_THE_ABDOMINAL_ORGANS,0.834902237634127
DESCARTES_FETAL_PLACENTA_IGF...,SET,94,0.12433,0.0088693,0.093483,0.091766,DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS,0.834902237634127
GALE_APL_WITH_FLT3_MUTATED_UP,SET,55,0.15287,0.0083504,0.11494,0.091768,GALE_APL_WITH_FLT3_MUTATED_UP,0.834902237634127
WP_GLUCURONIDATION,SET,24,0.32576,0.011765,0.24496,0.09179,WP_GLUCURONIDATION,0.834902237634127
REACTOME_NOTCH_HLH_TRANSCRIP...,SET,24,0.21884,0.0079032,0.16458,0.09182,REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY,0.834956593406593
GOBP_INORGANIC_ANION_TRANSME...,SET,120,0.1114,0.0089722,0.083802,0.091883,GOBP_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT,0.83525430156658
WP_DOPAMINE_METABOLISM,SET,11,0.33995,0.0083145,0.2558,0.091939,WP_DOPAMINE_METABOLISM,0.83525430156658
GOBP_GLYCOSIDE_METABOLIC_PRO...,SET,19,0.28657,0.0092093,0.21564,0.091945,GOBP_GLYCOSIDE_METABOLIC_PROCESS,0.83525430156658
HP_CONICAL_INCISOR,SET,34,0.20939,0.0089979,0.15757,0.091959,HP_CONICAL_INCISOR,0.83525430156658
GSE557_CIITA_KO_VS_I_AB_KO_D...2,SET,179,0.083886,0.0082384,0.063147,0.092026,GSE557_CIITA_KO_VS_I_AB_KO_DC_UP,0.83525430156658
GOBP_POSITIVE_REGULATION_OF_...325,SET,5,0.51816,0.0085456,0.39007,0.092032,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_MATURATION,0.83525430156658
GSE5589_WT_VS_IL6_KO_LPS_AND...2,SET,91,0.1224,0.0085918,0.092146,0.092041,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.83525430156658
HP_ABNORMAL_LABIA_MAJORA_MOR...,SET,40,0.1812,0.0084444,0.13641,0.092045,HP_ABNORMAL_LABIA_MAJORA_MORPHOLOGY,0.83525430156658
GOBP_ANATOMICAL_STRUCTURE_RE...,SET,15,0.30525,0.0087173,0.22985,0.092085,GOBP_ANATOMICAL_STRUCTURE_REGRESSION,0.835271848903967
GSE3982_MAC_VS_NEUTROPHIL_DN,SET,174,0.088293,0.0085504,0.066485,0.092095,GSE3982_MAC_VS_NEUTROPHIL_DN,0.835271848903967
REACTOME_ANTIMICROBIAL_PEPTI...,SET,74,0.16342,0.010349,0.12308,0.092136,REACTOME_ANTIMICROBIAL_PEPTIDES,0.835316572769953
HP_ABNORMAL_EUSTACHIAN_TUBE_...,SET,4,0.72775,0.010735,0.54813,0.092148,HP_ABNORMAL_EUSTACHIAN_TUBE_MORPHOLOGY,0.835316572769953
HP_KETOACIDOSIS,SET,35,0.20061,0.0087462,0.15112,0.092188,HP_KETOACIDOSIS,0.835424331508991
REACTOME_HOMOLOGY_DIRECTED_R...,SET,96,0.10569,0.0076188,0.079632,0.092224,REACTOME_HOMOLOGY_DIRECTED_REPAIR,0.835424331508991
XU_GH1_AUTOCRINE_TARGETS_UP,SET,158,0.090692,0.0083729,0.068334,0.092232,XU_GH1_AUTOCRINE_TARGETS_UP,0.835424331508991
PID_NFAT_TFPATHWAY,SET,42,0.18363,0.0087685,0.13838,0.09226,PID_NFAT_TFPATHWAY,0.835460213652944
BOYLAN_MULTIPLE_MYELOMA_PCA1...1,SET,8,0.44352,0.0092515,0.33431,0.092319,BOYLAN_MULTIPLE_MYELOMA_PCA1_DN,0.835532512296143
GOBP_MEMBRANE_ORGANIZATION,SET,723,0.042635,0.0082885,0.032148,0.092389,GOBP_MEMBRANE_ORGANIZATION,0.835532512296143
GOBP_NEGATIVE_REGULATION_OF_...353,SET,5,0.57566,0.0094938,0.43406,0.092393,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.835532512296143
REACTOME_INTERLEUKIN_RECEPTO...,SET,23,0.2553,0.009026,0.19252,0.09241,REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,0.835532512296143
GOCC_NUCLEAR_STRESS_GRANULE,SET,6,0.44905,0.0081123,0.33868,0.09245,GOCC_NUCLEAR_STRESS_GRANULE,0.835532512296143
KEGG_MEDICUS_REFERENCE_TLR4_...,SET,9,0.35679,0.0078937,0.26914,0.092483,KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY,0.835532512296143
GOBP_COPII_COATED_VESICLE_BU...,SET,42,0.16209,0.00774,0.1223,0.092534,GOBP_COPII_COATED_VESICLE_BUDDING,0.835532512296143
GOMF_CHROMATIN_BINDING,SET,521,0.049929,0.0082866,0.037673,0.092541,GOMF_CHROMATIN_BINDING,0.835532512296143
GSE9650_EXHAUSTED_VS_MEMORY_...2,SET,183,0.086426,0.0085812,0.065212,0.092544,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP,0.835532512296143
REACTOME_COBALAMIN_CBL_VITAM...,SET,20,0.26523,0.008745,0.20015,0.09257,REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,0.835532512296143
GSE10240_CTRL_VS_IL22_STIM_P...1,SET,175,0.08127,0.0078926,0.06133,0.092574,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.835532512296143
LIU_COMMON_CANCER_GENES,SET,59,0.13787,0.0077989,0.10404,0.092582,LIU_COMMON_CANCER_GENES,0.835532512296143
GOBP_LYMPHOCYTE_DIFFERENTIAT...,SET,404,0.059868,0.0087783,0.045199,0.09267,GOBP_LYMPHOCYTE_DIFFERENTIATION,0.835532512296143
MIR1236_5P,SET,73,0.13467,0.0084704,0.10168,0.092703,MIR1236_5P,0.835532512296143
ZNF547_TARGET_GENES,SET,263,0.071776,0.0085246,0.0542,0.092714,ZNF547_TARGET_GENES,0.835532512296143
GOBP_CXCL12_ACTIVATED_CXCR4_...,SET,4,0.60299,0.0088949,0.45534,0.092718,GOBP_CXCL12_ACTIVATED_CXCR4_SIGNALING_PATHWAY,0.835532512296143
MIR3973,SET,233,0.07553,0.0084504,0.057038,0.092727,MIR3973,0.835532512296143
REACTOME_TP53_REGULATES_TRAN...2,SET,12,0.28645,0.0073173,0.21634,0.092743,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES,0.835532512296143
GOBP_URETER_DEVELOPMENT,SET,17,0.28944,0.0087989,0.21862,0.092774,GOBP_URETER_DEVELOPMENT,0.835532512296143
MIR6794_3P,SET,77,0.13807,0.0089183,0.1043,0.092792,MIR6794_3P,0.835532512296143
AIZARANI_LIVER_C1_NK_NKT_CEL...,SET,136,0.10362,0.008881,0.078282,0.092811,AIZARANI_LIVER_C1_NK_NKT_CELLS_1,0.835532512296143
GOBP_REGULATION_OF_PROTEIN_T...4,SET,40,0.18322,0.0085384,0.13843,0.092829,GOBP_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.835532512296143
GOBP_NEGATIVE_REGULATION_OF_...235,SET,5,0.5646,0.0093114,0.42657,0.092833,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION,0.835532512296143
CYCLIN_D1_UP.V1_DN,SET,175,0.08489,0.0082442,0.064145,0.092858,CYCLIN_D1_UP.V1_DN,0.835532512296143
REACTOME_POLO_LIKE_KINASE_ME...,SET,16,0.24882,0.0073386,0.18803,0.092869,REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS,0.835532512296143
KEGG_MEDICUS_REFERENCE_REGUL...10,SET,6,0.40383,0.0072955,0.30521,0.092906,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX,0.835593202377875
HP_PITUITARY_GROWTH_HORMONE_...,SET,16,0.25838,0.0076206,0.1953,0.092928,HP_PITUITARY_GROWTH_HORMONE_CELL_ADENOMA,0.835593202377875
HP_DIGENIC_INHERITANCE,SET,13,0.34554,0.0091868,0.26126,0.092993,HP_DIGENIC_INHERITANCE,0.835593202377875
SP1_Q6_01,SET,231,0.071719,0.00799,0.054229,0.093007,SP1_Q6_01,0.835593202377875
HP_INCREASED_C_PEPTIDE_LEVEL,SET,13,0.3668,0.0097522,0.27736,0.093011,HP_INCREASED_C_PEPTIDE_LEVEL,0.835593202377875
GOMF_INTERLEUKIN_1_RECEPTOR_...1,SET,6,0.53866,0.0097312,0.40732,0.09302,GOMF_INTERLEUKIN_1_RECEPTOR_ACTIVITY,0.835593202377875
HP_BIFID_URETER,SET,4,0.5472,0.0080719,0.41401,0.093142,HP_BIFID_URETER,0.83647292248062
GOMF_MITOGEN_ACTIVATED_PROTE...2,SET,10,0.35923,0.0083773,0.27184,0.093177,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING,0.836571075949367
PID_EPHA2_FWD_PATHWAY,SET,19,0.25842,0.0083047,0.19558,0.093208,PID_EPHA2_FWD_PATHWAY,0.836633274793388
GOMF_POTASSIUM_ION_LEAK_CHAN...,SET,16,0.29737,0.0087704,0.22513,0.093277,GOMF_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY,0.836869944587629
MODULE_227,SET,14,0.30671,0.0084622,0.23223,0.093305,MODULE_227,0.836869944587629
JEON_SMAD6_TARGETS_UP,SET,23,0.27537,0.0097356,0.20855,0.093357,JEON_SMAD6_TARGETS_UP,0.836869944587629
GOCC_JUNCTIONAL_MEMBRANE_COM...,SET,6,0.46792,0.0084533,0.35443,0.093391,GOCC_JUNCTIONAL_MEMBRANE_COMPLEX,0.836869944587629
GOMF_PRE_MRNA_5_SPLICE_SITE_...,SET,2,0.6377,0.0066521,0.48305,0.093402,GOMF_PRE_MRNA_5_SPLICE_SITE_BINDING,0.836869944587629
HP_IMPAIRED_VIBRATION_SENSAT...1,SET,10,0.32562,0.0075935,0.24666,0.093413,HP_IMPAIRED_VIBRATION_SENSATION_AT_ANKLES,0.836869944587629
GSE37533_UNTREATED_VS_PIOGLI...5,SET,144,0.090626,0.0079905,0.068654,0.093419,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN,0.836869944587629
GOBP_DNA_TEMPLATED_DNA_REPLI...2,SET,54,0.15134,0.0081914,0.11465,0.093427,GOBP_DNA_TEMPLATED_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY,0.836869944587629
TAKEDA_TARGETS_OF_NUP98_HOXA...3,SET,112,0.11252,0.0087569,0.085259,0.093476,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,0.837093115176501
SF1_Q6,SET,236,0.074448,0.0083821,0.056432,0.093551,SF1_Q6,0.837548945131376
GSE46606_IRF4HIGH_VS_WT_CD40...1,SET,185,0.08344,0.0083294,0.063257,0.093585,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.837618765447992
GNF2_BUB1,SET,26,0.20265,0.0076171,0.15365,0.093607,GNF2_BUB1,0.837618765447992
AIZARANI_LIVER_C17_HEPATOCYT...,SET,99,0.12592,0.0092171,0.095507,0.093684,AIZARANI_LIVER_C17_HEPATOCYTES_3,0.837773249807248
GOBP_REGULATION_OF_B_CELL_AC...,SET,115,0.10609,0.0083661,0.080479,0.093715,GOBP_REGULATION_OF_B_CELL_ACTIVATION,0.837773249807248
GOBP_PROTEIN_LOCALIZATION_TO...1,SET,6,0.50825,0.0091819,0.38559,0.093741,GOBP_PROTEIN_LOCALIZATION_TO_ADHERENS_JUNCTION,0.837773249807248
ZHAN_MULTIPLE_MYELOMA_HP_UP,SET,39,0.18028,0.008296,0.13677,0.093744,ZHAN_MULTIPLE_MYELOMA_HP_UP,0.837773249807248
GOBP_REGULATION_OF_SPROUTING...,SET,40,0.18305,0.0085305,0.13889,0.093766,GOBP_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.837773249807248
GOMF_GALACTOSYLCERAMIDASE_AC...,SET,4,0.51931,0.0076605,0.39407,0.093791,GOMF_GALACTOSYLCERAMIDASE_ACTIVITY,0.837773249807248
GSE22313_HEALTHY_VS_SLE_MOUS...1,SET,179,0.084818,0.0083299,0.064363,0.093793,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN,0.837773249807248
HOEK_NEUTROPHIL_2011_2012_TI...6,SET,17,0.29488,0.0089642,0.22381,0.093843,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP,0.838004487410072
FISCHER_DIRECT_P53_TARGETS_M...,SET,290,0.065575,0.0081721,0.049807,0.094,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,0.838607376881858
GOMF_PROTEIN_TRANSPORTER_ACT...,SET,37,0.18126,0.0081251,0.13769,0.094016,GOMF_PROTEIN_TRANSPORTER_ACTIVITY,0.838607376881858
TIAN_TNF_SIGNALING_VIA_NFKB,SET,25,0.2531,0.0093287,0.19229,0.094053,TIAN_TNF_SIGNALING_VIA_NFKB,0.838607376881858
GOCC_POLYPRENYL_DIPHOSPHATE_...,SET,10,0.3272,0.0076303,0.24858,0.094053,GOCC_POLYPRENYL_DIPHOSPHATE_SYNTHASE_COMPLEX,0.838607376881858
BYSTRYKH_HEMATOPOIESIS_STEM_...3,SET,7,0.45424,0.0088635,0.34513,0.094068,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3,0.838607376881858
GOBP_PIGMENT_ACCUMULATION,SET,11,0.35635,0.0087156,0.27075,0.094068,GOBP_PIGMENT_ACCUMULATION,0.838607376881858
HE_LIM_SUN_FETAL_LUNG_C0_EAR...1,SET,71,0.13392,0.0083078,0.10176,0.094087,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST,0.838607376881858
DESCARTES_FETAL_CEREBRUM_SKO...,SET,48,0.17673,0.00902,0.13432,0.094142,DESCARTES_FETAL_CEREBRUM_SKOR2_NPSR1_POSITIVE_CELLS,0.838607376881858
GSE3920_UNTREATED_VS_IFNG_TR...4,SET,156,0.08991,0.0082484,0.068351,0.094192,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP,0.838607376881858
HP_RETICULAR_HYPERPIGMENTATI...,SET,9,0.33272,0.0073611,0.25294,0.094196,HP_RETICULAR_HYPERPIGMENTATION,0.838607376881858
REACTOME_PKA_ACTIVATION_IN_G...,SET,17,0.28519,0.0086697,0.21684,0.094232,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,0.838607376881858
GOBP_NEGATIVE_REGULATION_OF_...5,SET,6,0.52207,0.0094315,0.397,0.094259,GOBP_NEGATIVE_REGULATION_OF_ACTION_POTENTIAL,0.838607376881858
MIR548AY_3P,SET,54,0.15228,0.0082423,0.11581,0.094288,MIR548AY_3P,0.838607376881858
GSE18791_CTRL_VS_NEWCASTLE_V...17,SET,176,0.088942,0.0086621,0.067644,0.094288,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN,0.838607376881858
GOBP_NUCLEOTIDE_BINDING_DOMA...,SET,26,0.22355,0.0084023,0.17002,0.094295,GOBP_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.838607376881858
GOMF_MITOGEN_ACTIVATED_PROTE...4,SET,7,0.47544,0.0092771,0.36163,0.094314,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_P38_BINDING,0.838607376881858
GOBP_DNA_INTEGRITY_CHECKPOIN...,SET,125,0.092458,0.0075992,0.070341,0.094361,GOBP_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.838607376881858
ARP1_01,SET,142,0.091358,0.0079994,0.069515,0.094395,ARP1_01,0.838607376881858
GSE27859_DC_VS_CD11C_INT_F48...1,SET,144,0.088784,0.0078282,0.067557,0.094397,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,0.838607376881858
GOBP_REGULATION_OF_MULTICELL...1,SET,1271,0.033829,0.0085831,0.025746,0.094445,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISMAL_DEVELOPMENT,0.838607376881858
GOBP_DNA_STRAND_RESECTION_IN...,SET,9,0.3819,0.0084492,0.29074,0.094508,GOBP_DNA_STRAND_RESECTION_INVOLVED_IN_REPLICATION_FORK_PROCESSING,0.838607376881858
GOBP_REGULATION_OF_TOLL_LIKE...3,SET,28,0.21117,0.0082362,0.16077,0.094524,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.838607376881858
GAUCHER_PBMC_YF_VAX_STAMARIL...5,SET,12,0.34031,0.0086931,0.25912,0.094541,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN,0.838607376881858
RICKMAN_TUMOR_DIFFERENTIATED...6,SET,213,0.074357,0.0079585,0.05662,0.094553,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,0.838607376881858
LUI_THYROID_CANCER_CLUSTER_5,SET,14,0.28716,0.0079226,0.21866,0.094558,LUI_THYROID_CANCER_CLUSTER_5,0.838607376881858
GSE360_CTRL_VS_L_MAJOR_MAC_UP,SET,182,0.081401,0.0080604,0.061984,0.094558,GSE360_CTRL_VS_L_MAJOR_MAC_UP,0.838607376881858
GENTILE_UV_RESPONSE_CLUSTER_...4,SET,35,0.18161,0.007918,0.13829,0.094562,GENTILE_UV_RESPONSE_CLUSTER_D5,0.838607376881858
GOBP_UBIQUITIN_DEPENDENT_GLY...,SET,7,0.45584,0.0088946,0.34741,0.094748,GOBP_UBIQUITIN_DEPENDENT_GLYCOPROTEIN_ERAD_PATHWAY,0.839623022692504
GOMF_MANNOSYL_OLIGOSACCHARID...1,SET,7,0.45584,0.0088946,0.34741,0.094748,GOMF_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY,0.839623022692504
GSE17721_CPG_VS_GARDIQUIMOD_...15,SET,172,0.082182,0.0079131,0.062633,0.094749,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN,0.839623022692504
GTAAACC_MIR2995P,SET,42,0.1782,0.0085092,0.13588,0.094869,GTAAACC_MIR2995P,0.840230866412214
GOBP_DETECTION_OF_TEMPERATUR...1,SET,26,0.23359,0.0087796,0.17816,0.094916,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS,0.840230866412214
AACWWCAANK_UNKNOWN,SET,132,0.099238,0.0083801,0.075698,0.09494,AACWWCAANK_UNKNOWN,0.840230866412214
GOBP_NEGATIVE_REGULATION_OF_...116,SET,151,0.091811,0.0082879,0.070034,0.094947,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH,0.840230866412214
GSE27434_WT_VS_DNMT1_KO_TREG...2,SET,182,0.078641,0.0077871,0.05999,0.094953,GSE27434_WT_VS_DNMT1_KO_TREG_UP,0.840230866412214
HP_FUNCTIONAL_INTESTINAL_OBS...,SET,10,0.32318,0.0075365,0.24654,0.094965,HP_FUNCTIONAL_INTESTINAL_OBSTRUCTION,0.840230866412214
GSE37301_PRO_BCELL_VS_CD4_TC...2,SET,155,0.090476,0.0082739,0.069028,0.094987,GSE37301_PRO_BCELL_VS_CD4_TCELL_UP,0.840230866412214
REACTOME_BBSOME_MEDIATED_CAR...,SET,23,0.225,0.0079546,0.17168,0.095011,REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM,0.840230866412214
GSE22432_UNTREATED_VS_TGFB1_...1,SET,174,0.082354,0.0079753,0.062848,0.095045,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN,0.840317724497583
GSE26351_WNT_VS_BMP_PATHWAY_...2,SET,182,0.082954,0.0082142,0.063322,0.095099,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.840581318667345
GOBP_CMP_METABOLIC_PROCESS,SET,8,0.42582,0.0088823,0.32516,0.095184,GOBP_CMP_METABOLIC_PROCESS,0.841072766903915
GSE360_CTRL_VS_T_GONDII_MAC_...2,SET,180,0.081607,0.0080367,0.062323,0.095203,GSE360_CTRL_VS_T_GONDII_MAC_UP,0.841072766903915
HP_AV_NODAL_TACHYCARDIA,SET,2,0.91349,0.0095289,0.69791,0.095295,HP_AV_NODAL_TACHYCARDIA,0.841258054074638
GOCC_T_TUBULE,SET,52,0.16336,0.0086774,0.12481,0.0953,GOCC_T_TUBULE,0.841258054074638
GOBP_BIOLOGICAL_PHASE,SET,11,0.35243,0.0086196,0.26929,0.095323,GOBP_BIOLOGICAL_PHASE,0.841258054074638
GSE37301_MULTIPOTENT_PROGENI...12,SET,182,0.082158,0.0081353,0.06278,0.095334,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.841258054074638
AP4_Q6,SET,199,0.081003,0.0083833,0.061901,0.095345,AP4_Q6,0.841258054074638
HP_ABNORMAL_CIRCULATING_SERI...1,SET,5,0.5126,0.0084538,0.39183,0.09541,HP_ABNORMAL_CIRCULATING_SERINE_CONCENTRATION,0.841617906091371
CUI_DEVELOPING_HEART_TRABECU...1,SET,161,0.088925,0.0082866,0.068001,0.095497,CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE,0.842066517110266
GSE41867_DAY8_EFFECTOR_VS_DA...3,SET,186,0.079476,0.0079549,0.060788,0.095542,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.842066517110266
GOCC_DENDRITE_TERMINUS,SET,11,0.3327,0.008137,0.25447,0.095544,GOCC_DENDRITE_TERMINUS,0.842066517110266
KEGG_MEDICUS_VARIANT_MUTATIO...29,SET,15,0.26312,0.007514,0.20128,0.095574,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.842066517110266
GOBP_PROTEIN_LOCALIZATION_TO...2,SET,9,0.37006,0.0081873,0.2831,0.095582,GOBP_PROTEIN_LOCALIZATION_TO_AXON,0.842066517110266
GOBP_NEGATIVE_REGULATION_OF_...350,SET,21,0.24878,0.0084048,0.19039,0.095667,GOBP_NEGATIVE_REGULATION_OF_LIPID_STORAGE,0.842151876106195
PEDERSEN_METASTASIS_BY_ERBB2...4,SET,11,0.3787,0.009262,0.28982,0.095676,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,0.842151876106195
HP_DECREASED_CIRCULATING_IGE,SET,5,0.49304,0.0081314,0.3774,0.095712,HP_DECREASED_CIRCULATING_IGE,0.842151876106195
GSE3982_MAC_VS_NEUTROPHIL_UP,SET,181,0.078533,0.0077552,0.060117,0.095728,GSE3982_MAC_VS_NEUTROPHIL_UP,0.842151876106195
HP_LEG_MUSCLE_STIFFNESS,SET,14,0.26236,0.0072385,0.20085,0.095735,HP_LEG_MUSCLE_STIFFNESS,0.842151876106195
GSE10240_CTRL_VS_IL17_AND_IL...2,SET,182,0.078444,0.0077675,0.060063,0.09578,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.842151876106195
GSE27786_LIN_NEG_VS_NEUTROPH...1,SET,185,0.079229,0.0079091,0.060665,0.095781,GSE27786_LIN_NEG_VS_NEUTROPHIL_DN,0.842151876106195
GOTZMANN_EPITHELIAL_TO_MESEN...2,SET,65,0.1417,0.0084124,0.10851,0.095798,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.842151876106195
RTTTNNNYTGGM_UNKNOWN,SET,141,0.10134,0.008842,0.077601,0.09581,RTTTNNNYTGGM_UNKNOWN,0.842151876106195
HP_ARTHRITIS,SET,207,0.080345,0.0084788,0.061534,0.095834,HP_ARTHRITIS,0.842151876106195
TCTCTCC_MIR185,SET,115,0.10789,0.0085076,0.082639,0.095864,TCTCTCC_MIR185,0.842202558139535
BIOCARTA_VIP_PATHWAY,SET,26,0.23459,0.0088173,0.17976,0.095951,BIOCARTA_VIP_PATHWAY,0.842753855193328
MODULE_236,SET,17,0.28801,0.0087556,0.22074,0.095999,MODULE_236,0.842813136042403
GSE42088_UNINF_VS_LEISHMANIA...5,SET,178,0.085063,0.0083308,0.065199,0.096013,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN,0.842813136042403
FREAC2_01,SET,235,0.077696,0.0087295,0.059559,0.096037,FREAC2_01,0.842813136042403
WP_NAD_METABOLISM_SIRTUINS_A...,SET,11,0.35631,0.0087145,0.27316,0.096057,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.842813136042403
GSE11924_TFH_VS_TH2_CD4_TCEL...1,SET,176,0.081941,0.0079803,0.062826,0.096079,GSE11924_TFH_VS_TH2_CD4_TCELL_DN,0.842813136042403
GOMF_CORE_PROMOTER_SEQUENCE_...,SET,35,0.19033,0.0082981,0.14595,0.096109,GOMF_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.842863561695685
GSE24671_CTRL_VS_SENDAI_VIRU...1,SET,177,0.078502,0.0076669,0.060205,0.096141,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.842931497225025
HP_EARLY_ONSET_OF_SEXUAL_MAT...,SET,150,0.09589,0.0086276,0.073553,0.096178,HP_EARLY_ONSET_OF_SEXUAL_MATURATION,0.843043225725095
GSE17721_LPS_VS_POLYIC_0.5H_...2,SET,181,0.079702,0.0078706,0.06116,0.096268,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP,0.843562008568549
GOBP_REGULATION_OF_NEUROTRAN...3,SET,72,0.1328,0.0082958,0.10192,0.096308,GOBP_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.843562008568549
FAC1_01,SET,189,0.087086,0.0087859,0.066839,0.09631,FAC1_01,0.843562008568549
GOBP_NEGATIVE_REGULATION_OF_...265,SET,200,0.081992,0.0085067,0.062937,0.096337,GOBP_NEGATIVE_REGULATION_OF_GROWTH,0.843585899470899
GSE20366_TREG_VS_NAIVE_CD4_T...2,SET,186,0.083041,0.0083118,0.063754,0.096376,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP,0.843624892974062
MODULE_45,SET,528,0.051349,0.0085776,0.039425,0.09639,MODULE_45,0.843624892974062
GOBP_MACROPHAGE_COLONY_STIMU...2,SET,7,0.47267,0.0092232,0.36309,0.096499,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,0.843821094963668
GSE3982_DC_VS_CENT_MEMORY_CD...2,SET,186,0.082704,0.008278,0.063539,0.096531,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP,0.843821094963668
GSE27786_LSK_VS_ERYTHROBLAST...1,SET,178,0.081681,0.0079996,0.062761,0.096557,GSE27786_LSK_VS_ERYTHROBLAST_DN,0.843821094963668
GOBP_ERAD_PATHWAY,SET,104,0.10248,0.007687,0.078744,0.096573,GOBP_ERAD_PATHWAY,0.843821094963668
WP_GPCRS_OTHER,SET,86,0.12816,0.0087467,0.098488,0.096584,WP_GPCRS_OTHER,0.843821094963668
GOCC_RETROMER_COMPLEX,SET,19,0.23349,0.0075037,0.17945,0.096616,GOCC_RETROMER_COMPLEX,0.843821094963668
GSE11386_NAIVE_VS_MEMORY_BCE...2,SET,160,0.085239,0.0079187,0.065523,0.096654,GSE11386_NAIVE_VS_MEMORY_BCELL_UP,0.843821094963668
GOBP_ACTIN_MYOSIN_FILAMENT_S...,SET,15,0.29932,0.0085479,0.2301,0.096665,GOBP_ACTIN_MYOSIN_FILAMENT_SLIDING,0.843821094963668
MIR448,SET,327,0.063597,0.0084074,0.048897,0.096701,MIR448,0.843821094963668
HP_CENTRAL_OPACIFICATION_OF_...,SET,21,0.28081,0.0094869,0.21595,0.096748,HP_CENTRAL_OPACIFICATION_OF_THE_CORNEA,0.843821094963668
GOCC_WEIBEL_PALADE_BODY,SET,5,0.47248,0.0077921,0.36341,0.096788,GOCC_WEIBEL_PALADE_BODY,0.843821094963668
FEV_TARGET_GENES,SET,1339,0.031339,0.0081452,0.024106,0.096799,FEV_TARGET_GENES,0.843821094963668
REACTOME_PKA_MEDIATED_PHOSPH...1,SET,19,0.27623,0.0088771,0.21248,0.096802,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,0.843821094963668
HP_CONGENITAL_HEMOLYTIC_ANEM...,SET,8,0.40164,0.008378,0.30899,0.096835,HP_CONGENITAL_HEMOLYTIC_ANEMIA,0.843821094963668
MORF_PPP2R5E,SET,72,0.11822,0.007385,0.090955,0.096853,MORF_PPP2R5E,0.843821094963668
HP_MALIGNANT_GASTROINTESTINA...,SET,70,0.13088,0.008062,0.1007,0.09686,HP_MALIGNANT_GASTROINTESTINAL_TRACT_TUMORS,0.843821094963668
GSE42724_NAIVE_VS_MEMORY_BCE...1,SET,172,0.086672,0.0083455,0.066691,0.096876,GSE42724_NAIVE_VS_MEMORY_BCELL_DN,0.843821094963668
GOBP_ANTERIOR_POSTERIOR_AXIS...,SET,51,0.16781,0.008828,0.12913,0.096887,GOBP_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,0.843821094963668
REACTOME_COMPLEMENT_CASCADE,SET,49,0.18146,0.0093571,0.13963,0.096893,REACTOME_COMPLEMENT_CASCADE,0.843821094963668
HP_VIRAL_HEPATITIS,SET,13,0.31916,0.0084854,0.2456,0.096898,HP_VIRAL_HEPATITIS,0.843821094963668
GOBP_NEGATIVE_REGULATION_OF_...130,SET,7,0.39633,0.0077335,0.30506,0.096949,GOBP_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.843854879849812
REACTOME_HYALURONAN_UPTAKE_A...,SET,12,0.30854,0.0078816,0.23753,0.096993,REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,0.843854879849812
HP_ABNORMAL_PROLACTIN_LEVEL,SET,26,0.22385,0.0084136,0.17234,0.096998,HP_ABNORMAL_PROLACTIN_LEVEL,0.843854879849812
REACTOME_SIGNAL_AMPLIFICATION,SET,33,0.20995,0.0088888,0.16164,0.096999,REACTOME_SIGNAL_AMPLIFICATION,0.843854879849812
MIR6834_5P,SET,53,0.14881,0.0079797,0.11458,0.097026,MIR6834_5P,0.843878536036036
HP_MEGALENCEPHALY,SET,40,0.18522,0.0086318,0.14264,0.097066,HP_MEGALENCEPHALY,0.844015218914186
HP_SUDDEN_UNEXPECTED_DEATH_I...,SET,9,0.35602,0.0078767,0.27423,0.097108,HP_SUDDEN_UNEXPECTED_DEATH_IN_EPILEPSY,0.844169219609805
GSE360_DC_VS_MAC_T_GONDII_DN,SET,182,0.083263,0.0082447,0.064155,0.097179,GSE360_DC_VS_MAC_T_GONDII_DN,0.844225164233577
GOBP_POSITIVE_REGULATION_OF_...343,SET,20,0.27338,0.0090134,0.21066,0.0972,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.844225164233577
KLEIN_PRIMARY_EFFUSION_LYMPH...2,SET,46,0.15978,0.0079839,0.12314,0.097219,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,0.844225164233577
GOBP_REGULATION_OF_HIPPO_SIG...,SET,36,0.20083,0.00888,0.15479,0.097247,GOBP_REGULATION_OF_HIPPO_SIGNALING,0.844225164233577
HP_CRANIOFACIAL_OSTEOSCLEROS...,SET,13,0.29717,0.0079009,0.2292,0.097401,HP_CRANIOFACIAL_OSTEOSCLEROSIS,0.844225164233577
REACTOME_G_BETA_GAMMA_SIGNAL...1,SET,19,0.2687,0.0086353,0.20725,0.097413,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42,0.844225164233577
BURTON_ADIPOGENESIS_9,SET,73,0.13995,0.008803,0.10796,0.097428,BURTON_ADIPOGENESIS_9,0.844225164233577
GSE10211_UV_INACT_SENDAI_VS_...1,SET,141,0.094624,0.0082563,0.073003,0.097469,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN,0.844225164233577
GSE7219_UNSTIM_VS_LPS_AND_AN...2,SET,159,0.092005,0.0085207,0.071012,0.097561,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP,0.844225164233577
GSE11057_CD4_CENT_MEM_VS_PBM...2,SET,178,0.082006,0.0080314,0.063311,0.097619,GSE11057_CD4_CENT_MEM_VS_PBMC_UP,0.844225164233577
LIU_TARGETS_OF_VMYB_VS_CMYB_...1,SET,38,0.18744,0.0085144,0.14475,0.097687,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,0.844225164233577
HP_ABNORMAL_LYMPHOCYTE_MORPH...,SET,222,0.075841,0.008285,0.058581,0.097731,HP_ABNORMAL_LYMPHOCYTE_MORPHOLOGY,0.844225164233577
GOMF_STRUCTURAL_CONSTITUENT_...12,SET,4,0.60839,0.0089746,0.46994,0.097734,GOMF_STRUCTURAL_CONSTITUENT_OF_TOOTH_ENAMEL,0.844225164233577
HP_COUGH,SET,136,0.096849,0.0083005,0.074811,0.097739,HP_COUGH,0.844225164233577
CROONQUIST_NRAS_VS_STROMAL_S...2,SET,36,0.18346,0.0081116,0.14171,0.097746,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,0.844225164233577
GOBP_SOMITOGENESIS,SET,59,0.14984,0.0084763,0.11576,0.097764,GOBP_SOMITOGENESIS,0.844225164233577
GOBP_LYSOSOMAL_LUMEN_ACIDIFI...,SET,20,0.24364,0.008033,0.18823,0.097778,GOBP_LYSOSOMAL_LUMEN_ACIDIFICATION,0.844225164233577
HP_PARESTHESIA,SET,119,0.10192,0.0081746,0.078751,0.097807,HP_PARESTHESIA,0.844225164233577
REACTOME_DEATH_RECEPTOR_SIGN...,SET,139,0.093827,0.008129,0.072505,0.097826,REACTOME_DEATH_RECEPTOR_SIGNALING,0.844225164233577
GOMF_PDZ_DOMAIN_BINDING,SET,80,0.13073,0.0086066,0.10104,0.097859,GOMF_PDZ_DOMAIN_BINDING,0.844225164233577
CROMER_TUMORIGENESIS_DN,SET,46,0.17209,0.0085988,0.133,0.097861,CROMER_TUMORIGENESIS_DN,0.844225164233577
REACTOME_VXPX_CARGO_TARGETIN...,SET,20,0.23372,0.0077061,0.18067,0.097899,REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,0.844225164233577
GSE3982_MAST_CELL_VS_NKCELL_...1,SET,179,0.08437,0.0082859,0.065236,0.097962,GSE3982_MAST_CELL_VS_NKCELL_DN,0.844225164233577
GOMF_C4_DICARBOXYLATE_TRANSM...,SET,15,0.28437,0.0081209,0.21994,0.098023,GOMF_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.844225164233577
MIR4661_5P,SET,36,0.17488,0.0077322,0.13526,0.09804,MIR4661_5P,0.844225164233577
GSE17186_MEMORY_VS_NAIVE_BCE...1,SET,183,0.081387,0.0080808,0.062952,0.098042,GSE17186_MEMORY_VS_NAIVE_BCELL_DN,0.844225164233577
GSE20366_EX_VIVO_VS_DEC205_C...3,SET,181,0.082589,0.0081557,0.063885,0.098054,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP,0.844225164233577
GOBP_REGULATION_OF_STRESS_AC...,SET,36,0.18752,0.0082914,0.14506,0.098057,GOBP_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.844225164233577
REACTOME_HATS_ACETYLATE_HIST...,SET,71,0.12465,0.0077328,0.096436,0.098086,REACTOME_HATS_ACETYLATE_HISTONES,0.844225164233577
GOBP_NEGATIVE_REGULATION_OF_...315,SET,16,0.2748,0.0081048,0.21261,0.098096,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.844225164233577
GOBP_REGULATION_OF_CHOLESTER...1,SET,17,0.26535,0.0080667,0.2053,0.098099,GOBP_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.844225164233577
ZNF582_TARGET_GENES,SET,51,0.15346,0.008073,0.11874,0.098113,ZNF582_TARGET_GENES,0.844225164233577
HP_ABNORMAL_CIRCULATING_INTE...1,SET,23,0.23637,0.0083569,0.18292,0.098145,HP_ABNORMAL_CIRCULATING_INTERFERON_CONCENTRATION,0.844225164233577
GOCC_B_CELL_RECEPTOR_COMPLEX,SET,5,0.53357,0.0087997,0.41292,0.098155,GOCC_B_CELL_RECEPTOR_COMPLEX,0.844225164233577
GSE11057_NAIVE_VS_EFF_MEMORY...2,SET,165,0.088306,0.0083296,0.068341,0.098161,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,0.844225164233577
BIOCARTA_PCAF_PATHWAY,SET,13,0.28801,0.0076573,0.22293,0.098195,BIOCARTA_PCAF_PATHWAY,0.844225164233577
GOBP_PROTEIN_CATABOLIC_PROCE...1,SET,911,0.036677,0.0079608,0.028391,0.098213,GOBP_PROTEIN_CATABOLIC_PROCESS,0.844225164233577
GOBP_PROTEIN_TARGETING_TO_ME...,SET,107,0.10345,0.0078702,0.080083,0.098234,GOBP_PROTEIN_TARGETING_TO_MEMBRANE,0.844225164233577
LOPEZ_MESOTHELIOMA_SURVIVAL_...1,SET,10,0.36067,0.0084108,0.27927,0.098278,LOPEZ_MESOTHELIOMA_SURVIVAL_DN,0.844225164233577
GSE45365_NK_CELL_VS_CD8A_DC_...1,SET,182,0.085096,0.0084263,0.065896,0.098295,GSE45365_NK_CELL_VS_CD8A_DC_DN,0.844225164233577
HOEK_T_CELL_2011_2012_TIV_AD...3,SET,8,0.46087,0.0096134,0.35688,0.098295,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_DN,0.844225164233577
GOBP_EPITHELIAL_CELL_DIFFERE...1,SET,681,0.047511,0.0089747,0.036797,0.098329,GOBP_EPITHELIAL_CELL_DIFFERENTIATION,0.844225164233577
HP_ENTROPION,SET,20,0.21692,0.007152,0.16801,0.098336,HP_ENTROPION,0.844225164233577
GOBP_THIAMINE_TRANSPORT,SET,8,0.41859,0.0087315,0.32421,0.098338,GOBP_THIAMINE_TRANSPORT,0.844225164233577
KEGG_MEDICUS_REFERENCE_PKA_H...,SET,7,0.41891,0.008174,0.3245,0.098372,KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME,0.844225164233577
GOCC_CAMP_DEPENDENT_PROTEIN_...,SET,7,0.41891,0.008174,0.3245,0.098372,GOCC_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.844225164233577
GSE14308_TH17_VS_INDUCED_TRE...2,SET,178,0.078612,0.007699,0.060901,0.098392,GSE14308_TH17_VS_INDUCED_TREG_UP,0.844225164233577
MANNO_MIDBRAIN_NEUROTYPES_HP...5,SET,269,0.070221,0.0084333,0.054406,0.098415,MANNO_MIDBRAIN_NEUROTYPES_HPROGM,0.844225164233577
GOCC_AXONEMAL_MICROTUBULE,SET,26,0.2137,0.0080323,0.16559,0.098434,GOCC_AXONEMAL_MICROTUBULE,0.844225164233577
BIOCARTA_PGC1A_PATHWAY,SET,15,0.2904,0.008293,0.22502,0.098439,BIOCARTA_PGC1A_PATHWAY,0.844225164233577
GOCC_AXONEMAL_OUTER_DOUBLET,SET,14,0.33444,0.0092271,0.2592,0.098485,GOCC_AXONEMAL_OUTER_DOUBLET,0.844225164233577
GOMF_MAP_KINASE_TYROSINE_SER...,SET,11,0.3684,0.0090103,0.28553,0.098493,GOMF_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.844225164233577
GSE3565_DUSP1_VS_WT_SPLENOCY...1,SET,164,0.086116,0.0080986,0.066747,0.098503,GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN,0.844225164233577
GAUTSCHI_SRC_SIGNALING,SET,8,0.4234,0.0088318,0.32821,0.098532,GAUTSCHI_SRC_SIGNALING,0.844225164233577
GSE32423_CTRL_VS_IL7_MEMORY_...2,SET,179,0.08628,0.0084735,0.066889,0.098553,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP,0.844225164233577
GOBP_INTERLEUKIN_6_MEDIATED_...,SET,18,0.29032,0.0090814,0.22508,0.098557,GOBP_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,0.844225164233577
SCHEIDEREIT_IKK_TARGETS,SET,17,0.29537,0.0089792,0.22899,0.098561,SCHEIDEREIT_IKK_TARGETS,0.844225164233577
GSE21360_PRIMARY_VS_SECONDAR...1,SET,179,0.08126,0.0079805,0.063003,0.098572,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN,0.844225164233577
GSE7460_CTRL_VS_TGFB_TREATED...2,SET,184,0.08179,0.0081428,0.063427,0.098618,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP,0.844225164233577
HP_CONGENITAL_FINGER_FLEXION...,SET,11,0.35751,0.0087438,0.27728,0.098649,HP_CONGENITAL_FINGER_FLEXION_CONTRACTURES,0.844225164233577
GOBP_GANGLIOSIDE_METABOLIC_P...,SET,28,0.21636,0.0084389,0.16782,0.098662,GOBP_GANGLIOSIDE_METABOLIC_PROCESS,0.844225164233577
WP_NEURAL_CREST_DIFFERENTIAT...,SET,94,0.12297,0.0087722,0.095421,0.098755,WP_NEURAL_CREST_DIFFERENTIATION,0.844225164233577
REACTOME_NUCLEAR_PORE_COMPLE...,SET,34,0.17504,0.0075219,0.13583,0.098769,REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY,0.844225164233577
HP_GENERALIZED_MYOCLONIC_ATO...,SET,9,0.3575,0.0079094,0.27745,0.098788,HP_GENERALIZED_MYOCLONIC_ATONIC_SEIZURE,0.844225164233577
GOBP_POSITIVE_REGULATION_OF_...594,SET,12,0.36917,0.0094304,0.28653,0.09881,GOBP_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION,0.844225164233577
GOBP_POSITIVE_REGULATION_OF_...204,SET,49,0.16115,0.0083101,0.12509,0.098833,GOBP_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION,0.844225164233577
GOBP_REGULATION_OF_CELL_CYCL...3,SET,103,0.10457,0.0078064,0.081173,0.098844,GOBP_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.844225164233577
HP_ABNORMAL_ENDOCRINE_MORPHO...,SET,101,0.11131,0.008229,0.08641,0.098855,HP_ABNORMAL_ENDOCRINE_MORPHOLOGY,0.844225164233577
ODONNELL_TFRC_TARGETS_DN,SET,116,0.095974,0.0076008,0.074509,0.098865,ODONNELL_TFRC_TARGETS_DN,0.844225164233577
CCTNTMAGA_UNKNOWN,SET,120,0.10374,0.0083556,0.08055,0.098892,CCTNTMAGA_UNKNOWN,0.844225164233577
HP_ABNORMALITY_OF_CHROMOSOME...2,SET,49,0.14578,0.0075171,0.1132,0.098929,HP_ABNORMALITY_OF_CHROMOSOME_STABILITY,0.844225164233577
SARTIPY_BLUNTED_BY_INSULIN_R...2,SET,18,0.26747,0.0083667,0.20774,0.098958,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,0.844225164233577
GSE16450_IMMATURE_VS_MATURE_...5,SET,184,0.078621,0.0078273,0.061073,0.098999,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.844225164233577
GOBP_DNA_REPLICATION_INITIAT...,SET,35,0.17987,0.007842,0.13973,0.099004,GOBP_DNA_REPLICATION_INITIATION,0.844225164233577
WP_MITOCHONDRIAL_FATTY_ACID_...1,SET,18,0.25598,0.0080071,0.19885,0.099011,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,0.844225164233577
GOBP_POSITIVE_REGULATION_OF_...564,SET,41,0.18944,0.008938,0.14721,0.099075,GOBP_POSITIVE_REGULATION_OF_ORGAN_GROWTH,0.844225164233577
HP_SPONTANEOUS_HEMOLYTIC_CRI...,SET,7,0.37946,0.0074044,0.29488,0.099079,HP_SPONTANEOUS_HEMOLYTIC_CRISES,0.844225164233577
GOMF_11_CIS_RETINAL_BINDING,SET,7,0.42408,0.008275,0.32961,0.099121,GOMF_11_CIS_RETINAL_BINDING,0.844225164233577
GSE10325_MYELOID_VS_LUPUS_MY...2,SET,170,0.085927,0.008226,0.066794,0.099151,GSE10325_MYELOID_VS_LUPUS_MYELOID_UP,0.844225164233577
GROSS_ELK3_TARGETS_DN,SET,32,0.20675,0.0086197,0.16072,0.099154,GROSS_ELK3_TARGETS_DN,0.844225164233577
HP_ENLARGED_EPIPHYSES,SET,12,0.30813,0.0078711,0.23955,0.099179,HP_ENLARGED_EPIPHYSES,0.844225164233577
HP_MYELODYSPLASIA,SET,100,0.10544,0.0077564,0.08198,0.099208,HP_MYELODYSPLASIA,0.844225164233577
GOBP_REGULATION_OF_GTP_BINDI...,SET,8,0.419,0.0087401,0.32582,0.099228,GOBP_REGULATION_OF_GTP_BINDING,0.844225164233577
GOBP_CARDIAC_VENTRICLE_DEVEL...,SET,121,0.10901,0.0088164,0.084775,0.099245,GOBP_CARDIAC_VENTRICLE_DEVELOPMENT,0.844225164233577
chr15q12,SET,4,0.67384,0.00994,0.52405,0.099261,chr15q12,0.844225164233577
PUJANA_BREAST_CANCER_LIT_INT...,SET,91,0.10604,0.0074433,0.082502,0.09935,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,0.844225164233577
GNF2_CKS2,SET,49,0.15137,0.0078058,0.11777,0.099351,GNF2_CKS2,0.844225164233577
GOBP_NEGATIVE_REGULATION_OF_...509,SET,44,0.15979,0.0078092,0.12432,0.099353,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.844225164233577
MATSUMIYA_PBMC_MODIFIED_VACC...4,SET,81,0.1231,0.0081544,0.095783,0.099369,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP,0.844225164233577
TGFB_UP.V1_UP,SET,176,0.089665,0.0087326,0.06977,0.099377,TGFB_UP.V1_UP,0.844225164233577
HP_MENINGITIS,SET,65,0.14023,0.0083246,0.10913,0.099406,HP_MENINGITIS,0.844225164233577
KEGG_LIMONENE_AND_PINENE_DEG...,SET,9,0.40001,0.0088498,0.31132,0.099426,KEGG_LIMONENE_AND_PINENE_DEGRADATION,0.844225164233577
GOBP_REGULATION_OF_NK_T_CELL...1,SET,11,0.38618,0.0094451,0.30057,0.099432,GOBP_REGULATION_OF_NK_T_CELL_ACTIVATION,0.844225164233577
HP_ABNORMAL_NATURAL_KILLER_C...,SET,38,0.17072,0.0077549,0.13288,0.099442,HP_ABNORMAL_NATURAL_KILLER_CELL_MORPHOLOGY,0.844225164233577
GSE17721_CTRL_VS_POLYIC_6H_B...2,SET,174,0.079203,0.0076701,0.061651,0.099458,GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP,0.844225164233577
CASTELLANO_NRAS_TARGETS_UP,SET,67,0.14349,0.008648,0.11171,0.099501,CASTELLANO_NRAS_TARGETS_UP,0.844225164233577
MIR10397_5P,SET,67,0.12744,0.0076805,0.099249,0.099577,MIR10397_5P,0.844225164233577
COLLIS_PRKDC_SUBSTRATES,SET,15,0.29093,0.0083083,0.22661,0.099603,COLLIS_PRKDC_SUBSTRATES,0.844225164233577
GOBP_OVULATION_CYCLE_PROCESS,SET,49,0.17127,0.0088319,0.13342,0.099629,GOBP_OVULATION_CYCLE_PROCESS,0.844225164233577
BYSTRYKH_HEMATOPOIESIS_STEM_...4,SET,8,0.35858,0.0074797,0.27933,0.09963,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1,0.844225164233577
GOCC_METHYLTRANSFERASE_COMPL...,SET,92,0.10639,0.0075083,0.082877,0.099639,GOCC_METHYLTRANSFERASE_COMPLEX,0.844225164233577
MIR7151_5P,SET,42,0.17697,0.0084506,0.13787,0.09965,MIR7151_5P,0.844225164233577
HP_BIFID_NOSE,SET,11,0.32721,0.0080029,0.25493,0.099662,HP_BIFID_NOSE,0.844225164233577
GOBP_POST_GOLGI_VESICLE_MEDI...,SET,103,0.10253,0.0076543,0.079895,0.099696,GOBP_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.844225164233577
HP_ABNORMALITY_OF_THE_ANKLE,SET,159,0.089528,0.0082913,0.069779,0.099752,HP_ABNORMALITY_OF_THE_ANKLE,0.844225164233577
MIR31_3P,SET,51,0.15846,0.0083361,0.12352,0.099776,MIR31_3P,0.844225164233577
CONCANNON_APOPTOSIS_BY_EPOXO...1,SET,146,0.094512,0.0083904,0.073673,0.099778,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,0.844225164233577
MIR1915_5P,SET,42,0.18399,0.0087854,0.14342,0.09978,MIR1915_5P,0.844225164233577
GOBP_ESTABLISHMENT_OF_SPINDL...,SET,42,0.16776,0.0080107,0.13078,0.099786,GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION,0.844225164233577
GOBP_UROGENITAL_SYSTEM_DEVEL...,SET,64,0.15751,0.0092786,0.12279,0.099797,GOBP_UROGENITAL_SYSTEM_DEVELOPMENT,0.844225164233577
BONOME_OVARIAN_CANCER_SURVIV...2,SET,453,0.052092,0.008077,0.040615,0.099831,BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,0.844225164233577
GSE1925_CTRL_VS_IFNG_PRIMED_...5,SET,186,0.07973,0.0079803,0.062165,0.099835,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN,0.844225164233577
GSE37532_WT_VS_PPARG_KO_VISC...3,SET,180,0.084085,0.0082807,0.065569,0.099862,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN,0.844248068596449
MIR548P,SET,541,0.04827,0.008159,0.037651,0.099925,MIR548P,0.844575237110895
HP_RESPONSE_TO_DRUGS_ACTING_...,SET,6,0.46521,0.0084043,0.36294,0.099971,HP_RESPONSE_TO_DRUGS_ACTING_ON_NEUROMUSCULAR_TRANSMISSION,0.84475859591539
TCTATGA_MIR376A_MIR376B,SET,79,0.12388,0.0081047,0.096684,0.10005,TCTATGA_MIR376A_MIR376B,0.8450152490887
GOBP_REGULATION_OF_MAP_KINAS...,SET,124,0.10089,0.0082595,0.078742,0.10005,GOBP_REGULATION_OF_MAP_KINASE_ACTIVITY,0.8450152490887
GSE43955_10H_VS_30H_ACT_CD4_...4,SET,183,0.080646,0.0080073,0.062963,0.10013,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.845485459183673
REACTOME_CARNITINE_METABOLISM,SET,13,0.29491,0.0078409,0.2303,0.10018,REACTOME_CARNITINE_METABOLISM,0.845702186057809
ONDER_CDH1_TARGETS_1_UP,SET,123,0.10097,0.0082322,0.07887,0.10025,ONDER_CDH1_TARGETS_1_UP,0.845893351128367
GSE22432_PDC_VS_TGFB1_TREATE...1,SET,176,0.086473,0.0084217,0.067561,0.10029,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN,0.845893351128367
MORF_PRKACA,SET,109,0.10361,0.0079558,0.080953,0.1003,MORF_PRKACA,0.845893351128367
GSE10273_HIGH_IL7_VS_HIGH_IL...2,SET,182,0.079729,0.0078948,0.062295,0.1003,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.845893351128367
HAY_BONE_MARROW_CD34_POS_MUL...,SET,17,0.27331,0.0083085,0.21357,0.10033,HAY_BONE_MARROW_CD34_POS_MULTILIN,0.845941084425036
GOBP_SHORT_CHAIN_FATTY_ACID_...2,SET,15,0.27793,0.007937,0.21722,0.10037,GOBP_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.84604755210858
GOBP_LONG_CHAIN_FATTY_ACID_C...,SET,8,0.39254,0.0081882,0.30685,0.10041,GOBP_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.84604755210858
REACTOME_PROCESSING_OF_CAPPE...2,SET,255,0.06234,0.0072921,0.048732,0.10042,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,0.84604755210858
GSE11961_FOLLICULAR_BCELL_VS...3,SET,183,0.080967,0.0080392,0.063299,0.10044,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.84604755210858
GSE360_HIGH_DOSE_B_MALAYI_VS...3,SET,179,0.085965,0.0084425,0.067229,0.10051,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.846432045069057
GCGNNANTTCC_UNKNOWN,SET,115,0.098286,0.0077505,0.076886,0.10057,GCGNNANTTCC_UNKNOWN,0.846527088883507
GSE2770_TGFB_AND_IL4_VS_IL4_...2,SET,184,0.08003,0.0079676,0.062605,0.10057,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.846527088883507
GOCC_CASPASE_COMPLEX,SET,10,0.31291,0.0072971,0.24482,0.10061,GOCC_CASPASE_COMPLEX,0.846537908496732
HP_PILI_TORTI,SET,12,0.33101,0.0084555,0.25899,0.10062,HP_PILI_TORTI,0.846537908496732
YAO_TEMPORAL_RESPONSE_TO_PRO...5,SET,70,0.13165,0.0081094,0.10305,0.10073,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,0.847258264762827
GSE8678_IL7R_LOW_VS_HIGH_EFF...2,SET,183,0.080125,0.0079556,0.062745,0.10081,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP,0.847300036231884
HP_LENS_SUBLUXATION,SET,13,0.31944,0.0084928,0.25018,0.10084,HP_LENS_SUBLUXATION,0.847300036231884
RIZ_ERYTHROID_DIFFERENTIATIO...2,SET,38,0.1822,0.0082764,0.14271,0.10086,RIZ_ERYTHROID_DIFFERENTIATION_6HR,0.847300036231884
PID_CDC42_REG_PATHWAY,SET,25,0.2205,0.008127,0.17272,0.10088,PID_CDC42_REG_PATHWAY,0.847300036231884
REACTOME_DISEASES_ASSOCIATED...1,SET,38,0.18092,0.0082185,0.14172,0.10088,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,0.847300036231884
GSE32986_CURDLAN_LOWDOSE_VS_...2,SET,175,0.080835,0.0078504,0.063323,0.10089,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,0.847300036231884
GSE43863_TFH_VS_LY6C_INT_CXC...1,SET,182,0.084654,0.0083825,0.066323,0.10092,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.847300036231884
HP_DECREASED_CERVICAL_SPINE_...1,SET,5,0.51642,0.0085169,0.40462,0.10093,HP_DECREASED_CERVICAL_SPINE_FLEXION_DUE_TO_CONTRACTURES_OF_POSTERIOR_CERVICAL_MUSCLES,0.847300036231884
TRAVAGLINI_LUNG_MYOFIBROBLAS...,SET,60,0.15422,0.0087977,0.12085,0.10097,TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL,0.847325728389116
KEGG_ARGININE_AND_PROLINE_ME...,SET,47,0.15096,0.0076244,0.11833,0.10102,KEGG_ARGININE_AND_PROLINE_METABOLISM,0.847325728389116
PID_BETA_CATENIN_DEG_PATHWAY,SET,17,0.25046,0.0076139,0.19636,0.10107,PID_BETA_CATENIN_DEG_PATHWAY,0.847325728389116
GOBP_NEGATIVE_REGULATION_OF_...596,SET,50,0.15935,0.0083003,0.12493,0.10108,GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.847325728389116
MIR24_3P,SET,246,0.069708,0.0080107,0.054664,0.10113,MIR24_3P,0.847325728389116
GOBP_DETECTION_OF_MECHANICAL...1,SET,51,0.16009,0.0084215,0.12554,0.10113,GOBP_DETECTION_OF_MECHANICAL_STIMULUS,0.847325728389116
GOMF_INOSITOL_PHOSPHATE_PHOS...,SET,18,0.23077,0.0072185,0.18101,0.10118,GOMF_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.847325728389116
GSE9988_ANTI_TREM1_VS_VEHICL...2,SET,166,0.092937,0.0087927,0.072901,0.10119,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP,0.847325728389116
GSE10239_MEMORY_VS_DAY4.5_EF...1,SET,181,0.07984,0.0078843,0.06263,0.1012,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN,0.847325728389116
MYC_Q2,SET,180,0.082612,0.0081357,0.064813,0.10123,MYC_Q2,0.847325728389116
GOBP_MESODERMAL_CELL_MIGRATI...,SET,5,0.52749,0.0086994,0.41385,0.10124,GOBP_MESODERMAL_CELL_MIGRATION,0.847325728389116
GSE4984_GALECTIN1_VS_LPS_STI...2,SET,144,0.087354,0.007702,0.068535,0.10124,GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP,0.847325728389116
GSE2706_2H_VS_8H_R848_STIM_D...1,SET,166,0.085038,0.0080454,0.066723,0.10125,GSE2706_2H_VS_8H_R848_STIM_DC_DN,0.847325728389116
GSE28726_NAIVE_VS_ACTIVATED_...1,SET,186,0.078863,0.0078935,0.061926,0.10143,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN,0.848249135031235
GOMF_ALKALI_METAL_ION_BINDING,SET,19,0.24718,0.0079435,0.1941,0.10144,GOMF_ALKALI_METAL_ION_BINDING,0.848249135031235
GSE26495_PD1HIGH_VS_PD1LOW_C...1,SET,148,0.089303,0.0079817,0.070139,0.10147,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN,0.848249135031235
GOBP_NEUROTRANSMITTER_RECEPT...6,SET,15,0.28668,0.0081868,0.22518,0.1015,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_TO_PLASMA_MEMBRANE,0.848249135031235
KEGG_MEDICUS_REFERENCE_ATR_P...,SET,8,0.31595,0.0065906,0.2482,0.10152,KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M,0.848249135031235
GOMF_PROTEIN_TYROSINE_THREON...,SET,9,0.43503,0.0096245,0.34174,0.10152,GOMF_PROTEIN_TYROSINE_THREONINE_PHOSPHATASE_ACTIVITY,0.848249135031235
GSE27670_BLIMP1_VS_LMP1_TRAN...2,SET,180,0.082836,0.0081577,0.065083,0.10156,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.848249135031235
MIR4733_5P,SET,83,0.12372,0.0082957,0.09721,0.10157,MIR4733_5P,0.848249135031235
GOMF_PHOSPHOLIPASE_INHIBITOR...,SET,12,0.34886,0.0089115,0.27413,0.10158,GOMF_PHOSPHOLIPASE_INHIBITOR_ACTIVITY,0.848249135031235
MIR6760_5P,SET,105,0.10654,0.0080303,0.083729,0.10161,MIR6760_5P,0.848295832332453
HP_CHIN_WITH_HORIZONTAL_CREA...,SET,8,0.457,0.0095328,0.35925,0.10168,HP_CHIN_WITH_HORIZONTAL_CREASE,0.848528982725528
GSE3039_CD4_TCELL_VS_NKT_CEL...2,SET,183,0.074594,0.0074064,0.058644,0.1017,GSE3039_CD4_TCELL_VS_NKT_CELL_UP,0.848528982725528
STEINER_ERYTHROCYTE_MEMBRANE...,SET,14,0.27408,0.0075618,0.21552,0.10175,STEINER_ERYTHROCYTE_MEMBRANE_GENES,0.848528982725528
GSE37319_WT_VS_RC3H1_KO_CD44...1,SET,122,0.1011,0.0082097,0.0795,0.10175,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN,0.848528982725528
GUENTHER_GROWTH_SPHERICAL_VS...1,SET,24,0.23519,0.0084935,0.18495,0.10176,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,0.848528982725528
PAX7_TARGET_GENES,SET,514,0.04859,0.0080116,0.038221,0.10182,PAX7_TARGET_GENES,0.848825641640681
GSE27786_NKTCELL_VS_ERYTHROB...2,SET,185,0.078531,0.0078394,0.061793,0.1019,GSE27786_NKTCELL_VS_ERYTHROBLAST_UP,0.849030452477855
ROSS_ACUTE_MYELOID_LEUKEMIA_...,SET,77,0.13771,0.008895,0.10836,0.10191,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,0.849030452477855
LANDIS_ERBB2_BREAST_PRENEOPL...2,SET,17,0.25812,0.0078468,0.20317,0.10197,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,0.849030452477855
GOBP_PROTEIN_DEGLUTAMYLATION,SET,7,0.46286,0.0090316,0.36435,0.10199,GOBP_PROTEIN_DEGLUTAMYLATION,0.849030452477855
PAX_Q6,SET,227,0.076023,0.0083967,0.059848,0.102,PAX_Q6,0.849030452477855
HP_ABNORMAL_EMOTION,SET,598,0.045722,0.0081123,0.035995,0.10201,HP_ABNORMAL_EMOTION,0.849030452477855
HP_CORNEAL_EROSION,SET,40,0.18886,0.0088014,0.1487,0.10203,HP_CORNEAL_EROSION,0.849030452477855
GSE40274_CTRL_VS_FOXP3_AND_H...2,SET,187,0.077782,0.007806,0.061242,0.10204,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.849030452477855
WP_LNCRNA_IN_CANONICAL_WNT_S...,SET,89,0.1224,0.0084969,0.096387,0.10208,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,0.849039949748744
JOSEPH_RESPONSE_TO_SODIUM_BU...1,SET,57,0.15164,0.0084322,0.11943,0.10209,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,0.849039949748744
XU_HGF_SIGNALING_NOT_VIA_AKT...1,SET,18,0.25048,0.0078351,0.19733,0.10217,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,0.84914200334688
GOCC_EXON_EXON_JUNCTION_COMP...,SET,16,0.25939,0.0076502,0.20435,0.10217,GOCC_EXON_EXON_JUNCTION_COMPLEX,0.84914200334688
HP_ABNORMAL_MYELOID_LEUKOCYT...,SET,302,0.062915,0.0079986,0.049571,0.10219,HP_ABNORMAL_MYELOID_LEUKOCYTE_MORPHOLOGY,0.84914200334688
GOMF_CYCLIN_BINDING,SET,33,0.17738,0.0075097,0.13976,0.1022,GOMF_CYCLIN_BINDING,0.84914200334688
GOBP_APPENDAGE_DEVELOPMENT,SET,173,0.087582,0.0084574,0.069025,0.10226,GOBP_APPENDAGE_DEVELOPMENT,0.849197658862876
REACTOME_CREB1_PHOSPHORYLATI...2,SET,11,0.35417,0.0086621,0.27915,0.10227,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,0.849197658862876
GCM_PTPRU,SET,50,0.14647,0.0076294,0.11545,0.10228,GCM_PTPRU,0.849197658862876
GSE26030_UNSTIM_VS_RESTIM_TH...7,SET,180,0.081619,0.0080378,0.064356,0.10237,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN,0.849741903510867
GSE12392_CD8A_POS_VS_NEG_SPL...4,SET,188,0.075813,0.0076285,0.059814,0.1025,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP,0.850240160263964
GSE12507_PDC_CELL_LINE_VS_IM...1,SET,119,0.10362,0.0083109,0.081759,0.10252,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN,0.850240160263964
HP_IMPAIRED_GLUCOSE_TOLERANCE,SET,36,0.19508,0.0086256,0.15393,0.10253,HP_IMPAIRED_GLUCOSE_TOLERANCE,0.850240160263964
MIR3612,SET,110,0.10386,0.0080113,0.08198,0.1026,MIR3612,0.850240160263964
GOBP_DORSAL_VENTRAL_PATTERN_...,SET,88,0.12209,0.008428,0.096368,0.1026,GOBP_DORSAL_VENTRAL_PATTERN_FORMATION,0.850240160263964
GCM_ANP32B,SET,31,0.18716,0.0076804,0.14777,0.10266,GCM_ANP32B,0.850240160263964
HP_HEREDITARY_NONPOLYPOSIS_C...,SET,32,0.19616,0.0081782,0.15487,0.10266,HP_HEREDITARY_NONPOLYPOSIS_COLORECTAL_CARCINOMA,0.850240160263964
GOBP_NEGATIVE_REGULATION_OF_...601,SET,22,0.24812,0.0085796,0.19593,0.1027,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,0.850240160263964
HP_MENORRHAGIA,SET,34,0.18964,0.0081493,0.14975,0.1027,HP_MENORRHAGIA,0.850240160263964
GOBP_MULTI_CILIATED_EPITHELI...,SET,8,0.36256,0.0075628,0.28642,0.1028,GOBP_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.850240160263964
TIEN_INTESTINE_PROBIOTICS_2H...2,SET,28,0.20704,0.0080751,0.16358,0.10282,TIEN_INTESTINE_PROBIOTICS_2HR_UP,0.850240160263964
TBK1.DN.48HRS_UP,SET,48,0.15224,0.0077704,0.12032,0.10288,TBK1.DN.48HRS_UP,0.850240160263964
MODULE_129,SET,204,0.081148,0.008502,0.064133,0.10289,MODULE_129,0.850240160263964
KRAS.LUNG.BREAST_UP.V1_DN,SET,129,0.10077,0.0084128,0.079641,0.10289,KRAS.LUNG.BREAST_UP.V1_DN,0.850240160263964
GOBP_MUSCLE_HYPERTROPHY,SET,84,0.12489,0.0084241,0.098725,0.10294,GOBP_MUSCLE_HYPERTROPHY,0.850240160263964
GOBP_NUCLEOPHAGY,SET,21,0.23884,0.0080689,0.1888,0.10294,GOBP_NUCLEOPHAGY,0.850240160263964
VAN_DEN_BIGGELAAR_PBMC_PREVN...1,SET,62,0.13826,0.0080172,0.1093,0.10295,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP,0.850240160263964
GSE32034_LY6C_HIGH_VS_LOW_RO...1,SET,183,0.082192,0.0081608,0.064978,0.10296,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN,0.850240160263964
REACTOME_INITIAL_TRIGGERING_...,SET,17,0.30828,0.0093718,0.24374,0.10298,REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT,0.850240160263964
EBNA1BP2_TARGET_GENES,SET,291,0.064461,0.0080469,0.050966,0.10298,EBNA1BP2_TARGET_GENES,0.850240160263964
HP_ABNORMAL_BLOOD_UREA_NITRO...,SET,17,0.26336,0.0080061,0.20826,0.10302,HP_ABNORMAL_BLOOD_UREA_NITROGEN_CONCENTRATION,0.850240160263964
GOBP_NEURON_FATE_SPECIFICATI...,SET,32,0.20772,0.0086601,0.16429,0.10306,GOBP_NEURON_FATE_SPECIFICATION,0.850240160263964
HP_SYNOSTOSIS_INVOLVING_BONE...3,SET,106,0.11312,0.0085662,0.089475,0.10308,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.850240160263964
GOBP_POSITIVE_REGULATION_OF_...205,SET,145,0.094547,0.0083649,0.07479,0.10309,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.850240160263964
GOBP_REGULATION_OF_FATTY_ACI...2,SET,41,0.16154,0.0076215,0.1278,0.10312,GOBP_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.850240160263964
GOBP_POSITIVE_REGULATION_OF_...269,SET,47,0.17122,0.0086479,0.13546,0.10313,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.850240160263964
GOBP_EPIDERMIS_DEVELOPMENT,SET,356,0.064035,0.0088257,0.050665,0.10314,GOBP_EPIDERMIS_DEVELOPMENT,0.850240160263964
GSE23114_PERITONEAL_CAVITY_B...3,SET,178,0.082724,0.0081018,0.065461,0.10318,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP,0.850240160263964
HP_ORAL_CAVITY_BLEEDING,SET,19,0.26443,0.0084978,0.20934,0.10328,HP_ORAL_CAVITY_BLEEDING,0.850240160263964
GSE17721_0.5H_VS_4H_POLYIC_B...1,SET,178,0.081155,0.007948,0.064248,0.10328,GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN,0.850240160263964
PID_EPO_PATHWAY,SET,31,0.2027,0.0083181,0.16051,0.10333,PID_EPO_PATHWAY,0.850240160263964
GOCC_EXTERNAL_SIDE_OF_PLASMA...,SET,362,0.064894,0.0090176,0.051388,0.10333,GOCC_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,0.850240160263964
FAELT_B_CLL_WITH_VH3_21_UP,SET,39,0.15981,0.0073541,0.12657,0.10336,FAELT_B_CLL_WITH_VH3_21_UP,0.850240160263964
KOBAYASHI_EGFR_SIGNALING_24H...1,SET,240,0.067677,0.0076832,0.053607,0.1034,KOBAYASHI_EGFR_SIGNALING_24HR_DN,0.850240160263964
THRA_TARGET_GENES,SET,67,0.12638,0.0076168,0.10011,0.1034,THRA_TARGET_GENES,0.850240160263964
MODULE_143,SET,12,0.34041,0.0086956,0.26966,0.10342,MODULE_143,0.850240160263964
GOBP_CARDIAC_MUSCLE_CELL_FAT...,SET,7,0.48052,0.0093763,0.38067,0.10342,GOBP_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT,0.850240160263964
GOMF_L_PROLINE_TRANSMEMBRANE...,SET,7,0.46394,0.0090526,0.36762,0.10348,GOMF_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.850240160263964
APPEL_IMATINIB_RESPONSE,SET,30,0.21081,0.0085103,0.16706,0.10351,APPEL_IMATINIB_RESPONSE,0.850240160263964
HP_WRIST_FLEXION_CONTRACTURE,SET,33,0.20598,0.0087204,0.16324,0.10352,HP_WRIST_FLEXION_CONTRACTURE,0.850240160263964
BIOCARTA_41BB_PATHWAY,SET,18,0.24843,0.0077711,0.1969,0.10353,BIOCARTA_41BB_PATHWAY,0.850240160263964
REACTOME_DAP12_INTERACTIONS,SET,36,0.17217,0.0076127,0.13646,0.10353,REACTOME_DAP12_INTERACTIONS,0.850240160263964
GOBP_NEGATIVE_REGULATION_OF_...344,SET,88,0.12687,0.0087578,0.10056,0.10356,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.850240160263964
WP_DNA_DAMAGE_RESPONSE,SET,65,0.12248,0.0072709,0.097089,0.10358,WP_DNA_DAMAGE_RESPONSE,0.850240160263964
GOBP_CEREBELLAR_CORTEX_MORPH...,SET,32,0.19697,0.0082121,0.15618,0.10363,GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS,0.850240160263964
WP_MAMMARY_GLAND_DEVELOPMENT...3,SET,32,0.21058,0.0087794,0.16699,0.10365,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,0.850240160263964
GOBP_PROTEIN_DE_ADP_RIBOSYLA...,SET,4,0.64695,0.0095434,0.51309,0.10368,GOBP_PROTEIN_DE_ADP_RIBOSYLATION,0.850240160263964
GSE13522_WT_VS_IFNG_KO_SKIN_...2,SET,119,0.10512,0.0084311,0.08337,0.10369,GSE13522_WT_VS_IFNG_KO_SKIN_UP,0.850240160263964
GSE18804_SPLEEN_MACROPHAGE_V...6,SET,170,0.082977,0.0079435,0.06581,0.10369,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP,0.850240160263964
GSE6259_FLT3L_INDUCED_33D1_P...3,SET,149,0.086029,0.0077147,0.068238,0.10371,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN,0.850240160263964
GOBP_VESICLE_BUDDING_FROM_ME...,SET,82,0.11276,0.0075152,0.089463,0.10377,GOBP_VESICLE_BUDDING_FROM_MEMBRANE,0.850240160263964
HP_HEMIMEGALENCEPHALY,SET,14,0.30532,0.0084238,0.24224,0.10377,HP_HEMIMEGALENCEPHALY,0.850240160263964
HE_LIM_SUN_FETAL_LUNG_C7_SST...,SET,333,0.061636,0.0082213,0.048902,0.10377,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.850240160263964
REACTOME_AMINO_ACIDS_REGULAT...,SET,49,0.15085,0.0077788,0.11969,0.10379,REACTOME_AMINO_ACIDS_REGULATE_MTORC1,0.850240160263964
REACTOME_MET_ACTIVATES_PI3K_...,SET,6,0.47625,0.0086037,0.37788,0.10379,REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING,0.850240160263964
REACTOME_CD209_DC_SIGN_SIGNA...,SET,20,0.23531,0.0077584,0.18672,0.1038,REACTOME_CD209_DC_SIGN_SIGNALING,0.850240160263964
HP_RECURRENT_HYPOGLYCEMIA,SET,21,0.24879,0.008405,0.19746,0.10386,HP_RECURRENT_HYPOGLYCEMIA,0.850494558303887
GOMF_ANKYRIN_REPEAT_BINDING,SET,6,0.37468,0.0067689,0.29742,0.10388,GOMF_ANKYRIN_REPEAT_BINDING,0.850494558303887
HP_ABNORMALITY_OF_NEUTROPHILS,SET,231,0.0706,0.0078653,0.056052,0.10392,HP_ABNORMALITY_OF_NEUTROPHILS,0.850572167487685
GOMF_ALDEHYDE_DEHYDROGENASE_...,SET,17,0.28196,0.0085716,0.2239,0.10397,GOMF_ALDEHYDE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.850572167487685
HP_LOWER_LIMB_MUSCLE_WEAKNESS,SET,196,0.077677,0.0079789,0.061683,0.10397,HP_LOWER_LIMB_MUSCLE_WEAKNESS,0.850572167487685
WP_MITOCHONDRIAL_LONG_CHAIN_...,SET,16,0.27909,0.0082312,0.2217,0.10405,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,0.850572167487685
GSE3691_IFN_PRODUCING_KILLER...4,SET,177,0.08095,0.0079059,0.064323,0.10411,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP,0.850572167487685
LEF1_UP.V1_DN,SET,166,0.087664,0.0082938,0.069672,0.10416,LEF1_UP.V1_DN,0.850572167487685
BIOCARTA_AKAP95_PATHWAY,SET,11,0.29548,0.0072267,0.23484,0.10417,BIOCARTA_AKAP95_PATHWAY,0.850572167487685
GSE20366_TREG_VS_NAIVE_CD4_T...6,SET,181,0.082022,0.0080998,0.065195,0.10418,GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP,0.850572167487685
BIOCARTA_TERT_PATHWAY,SET,8,0.35775,0.0074625,0.28436,0.10419,BIOCARTA_TERT_PATHWAY,0.850572167487685
GNF2_BUB1B,SET,49,0.1408,0.0072607,0.11193,0.10421,GNF2_BUB1B,0.850572167487685
WP_PYRIMIDINE_METABOLISM,SET,75,0.11885,0.0075772,0.094496,0.10425,WP_PYRIMIDINE_METABOLISM,0.850572167487685
GOCC_NATA_COMPLEX,SET,4,0.43916,0.0064782,0.34921,0.10428,GOCC_NATA_COMPLEX,0.850572167487685
GOMF_OXIDOREDUCTASE_ACTIVITY...3,SET,9,0.36084,0.0079833,0.28694,0.10429,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,0.850572167487685
MODULE_325,SET,53,0.14574,0.007815,0.1159,0.10431,MODULE_325,0.850572167487685
GOMF_BICARBONATE_TRANSMEMBRA...,SET,31,0.18824,0.0077245,0.1497,0.10431,GOMF_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.850572167487685
GOBP_MAINTENANCE_OF_LOCATION,SET,312,0.063083,0.0081494,0.050172,0.10432,GOBP_MAINTENANCE_OF_LOCATION,0.850572167487685
GSE1460_NAIVE_CD4_TCELL_CORD...2,SET,162,0.080331,0.0075087,0.063888,0.10432,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.850572167487685
HP_POSTNATAL_GROWTH_RETARDAT...,SET,219,0.072625,0.0078806,0.057763,0.10433,HP_POSTNATAL_GROWTH_RETARDATION,0.850572167487685
GOCC_KATANIN_COMPLEX,SET,5,0.53186,0.0087715,0.42344,0.10456,GOCC_KATANIN_COMPLEX,0.851711538461538
WIELAND_UP_BY_HBV_INFECTION,SET,93,0.1155,0.0081953,0.091961,0.10458,WIELAND_UP_BY_HBV_INFECTION,0.851711538461538
GOBP_NEGATIVE_REGULATION_OF_...31,SET,212,0.074016,0.0079036,0.058937,0.10459,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.851711538461538
GSE24081_CONTROLLER_VS_PROGR...1,SET,173,0.083604,0.0080733,0.066583,0.10463,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN,0.851711538461538
TFDP2_TARGET_GENES,SET,4,0.44722,0.0065971,0.35621,0.10466,TFDP2_TARGET_GENES,0.851711538461538
HP_LIMB_GIRDLE_MUSCULAR_DYST...,SET,13,0.29079,0.0077311,0.23161,0.10466,HP_LIMB_GIRDLE_MUSCULAR_DYSTROPHY,0.851711538461538
PID_P38_MKK3_6PATHWAY,SET,26,0.20989,0.007889,0.16723,0.10474,PID_P38_MKK3_6PATHWAY,0.851711538461538
GSE23925_DARK_ZONE_VS_NAIVE_...1,SET,188,0.077674,0.0078158,0.061895,0.10476,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN,0.851711538461538
GOBP_POSITIVE_REGULATION_OF_...517,SET,5,0.53472,0.0088186,0.42611,0.10477,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.851711538461538
GSE24142_EARLY_THYMIC_PROGEN...4,SET,179,0.08147,0.0080011,0.064922,0.10477,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN,0.851711538461538
GSE3920_UNTREATED_VS_IFNB_TR...1,SET,157,0.084047,0.007735,0.066978,0.10478,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.851711538461538
GOMF_AMINOACYLTRANSFERASE_AC...,SET,444,0.050543,0.0077605,0.040281,0.10479,GOMF_AMINOACYLTRANSFERASE_ACTIVITY,0.851711538461538
GAO_LARGE_INTESTINE_24W_C2_M...,SET,104,0.11279,0.0084605,0.089894,0.10481,GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR,0.851711538461538
GOMF_PHOSPHATASE_ACTIVATOR_A...,SET,16,0.27309,0.0080542,0.21769,0.10484,GOMF_PHOSPHATASE_ACTIVATOR_ACTIVITY,0.851711538461538
HP_HYPOTHALAMIC_HYPOTHYROIDI...,SET,12,0.30539,0.0078012,0.24348,0.10487,HP_HYPOTHALAMIC_HYPOTHYROIDISM,0.851711538461538
HP_PRIMARY_HYPERALDOSTERONISM,SET,10,0.39278,0.0091597,0.31315,0.10488,HP_PRIMARY_HYPERALDOSTERONISM,0.851711538461538
HP_INCREASED_MEGAKARYOCYTE_C...,SET,7,0.38109,0.0074361,0.30391,0.10494,HP_INCREASED_MEGAKARYOCYTE_COUNT,0.851711538461538
GSE22611_NOD2_TRANSD_VS_CTRL...3,SET,178,0.083877,0.0082147,0.066909,0.105,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN,0.851711538461538
GSE32034_UNTREATED_VS_ROSIGL...2,SET,178,0.08243,0.008073,0.065771,0.10506,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP,0.851711538461538
GOBP_REGULATION_OF_SMAD_PROT...,SET,59,0.15686,0.0088732,0.12516,0.10507,GOBP_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.851711538461538
GOMF_CYCLIN_DEPENDENT_PROTEI...1,SET,26,0.19325,0.0072636,0.15422,0.10509,GOMF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.851711538461538
HP_PALMAR_HYPERHIDROSIS,SET,15,0.29896,0.0085375,0.23857,0.10509,HP_PALMAR_HYPERHIDROSIS,0.851711538461538
MOOTHA_PYR,SET,5,0.61934,0.010214,0.4943,0.10512,MOOTHA_PYR,0.851711538461538
GOBP_LAMELLIPODIUM_MORPHOGEN...,SET,18,0.23499,0.0073507,0.18756,0.10514,GOBP_LAMELLIPODIUM_MORPHOGENESIS,0.851711538461538
KEGG_COMPLEMENT_AND_COAGULAT...,SET,61,0.15314,0.0088079,0.12224,0.10515,KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,0.851711538461538
HP_PULMONARY_HEMORRHAGE,SET,29,0.21372,0.0084829,0.1706,0.10516,HP_PULMONARY_HEMORRHAGE,0.851711538461538
GSE12839_CTRL_VS_IL12_TREATE...2,SET,135,0.092695,0.0079154,0.07402,0.10524,GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP,0.851711538461538
GNF2_CCNB2,SET,53,0.14806,0.0079397,0.11824,0.10526,GNF2_CCNB2,0.851711538461538
GSE14308_NAIVE_CD4_TCELL_VS_...1,SET,182,0.077574,0.0076814,0.06195,0.10526,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN,0.851711538461538
REACTOME_DISEASES_ASSOCIATED...2,SET,13,0.27145,0.0072171,0.2168,0.10528,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,0.851711538461538
DING_LUNG_CANCER_EXPRESSION_...,SET,96,0.11016,0.0079407,0.087991,0.10531,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,0.851711538461538
MODULE_540,SET,10,0.38666,0.009017,0.30888,0.10533,MODULE_540,0.851711538461538
GOBP_ASTROCYTE_ACTIVATION,SET,23,0.24743,0.0087476,0.19765,0.10533,GOBP_ASTROCYTE_ACTIVATION,0.851711538461538
KARLSSON_TGFB1_TARGETS_UP,SET,113,0.099995,0.0078168,0.079892,0.10536,KARLSSON_TGFB1_TARGETS_UP,0.851711538461538
CYCLIN_D1_KE_.V1_UP,SET,178,0.08034,0.0078683,0.064189,0.10536,CYCLIN_D1_KE_.V1_UP,0.851711538461538
MIR3922_3P,SET,89,0.10837,0.0075234,0.086602,0.1054,MIR3922_3P,0.851711538461538
MIR3942_3P,SET,299,0.062663,0.0079274,0.05008,0.10543,MIR3942_3P,0.851711538461538
MIR4252,SET,86,0.1192,0.0081352,0.095277,0.10545,MIR4252,0.851711538461538
GOBP_NEGATIVE_REGULATION_OF_...35,SET,16,0.26736,0.0078853,0.21369,0.10545,GOBP_NEGATIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.851711538461538
GOBP_RESPONSE_TO_MUSCLE_STRE...,SET,24,0.22405,0.0080913,0.17908,0.10545,GOBP_RESPONSE_TO_MUSCLE_STRETCH,0.851711538461538
REACTOME_SYNTHESIS_OF_5_EICO...,SET,9,0.39344,0.0087045,0.31459,0.10554,REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS,0.852047700485325
GOBP_GROWTH_HORMONE_RECEPTOR...,SET,10,0.42647,0.0099454,0.3411,0.10561,GOBP_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,0.852047700485325
GSE12392_WT_VS_IFNB_KO_CD8A_...3,SET,184,0.078819,0.007847,0.063052,0.10565,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN,0.852047700485325
WP_NAD_METABOLISM_IN_ONCOGEN...,SET,22,0.21453,0.0074181,0.17165,0.10569,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.852047700485325
HP_INCREASED_NEURONAL_AUTOFL...,SET,9,0.36106,0.0079882,0.2889,0.1057,HP_INCREASED_NEURONAL_AUTOFLUORESCENT_LIPOPIGMENT,0.852047700485325
GOBP_REGULATION_OF_SYNAPSE_S...2,SET,231,0.073998,0.0082439,0.059234,0.10579,GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY,0.852047700485325
E2F1DP1_01,SET,209,0.073459,0.0077891,0.058811,0.10583,E2F1DP1_01,0.852047700485325
E2F1DP2_01,SET,209,0.073459,0.0077891,0.058811,0.10583,E2F1DP2_01,0.852047700485325
E2F4DP2_01,SET,209,0.073459,0.0077891,0.058811,0.10583,E2F4DP2_01,0.852047700485325
E2F_02,SET,209,0.073459,0.0077891,0.058811,0.10583,E2F_02,0.852047700485325
GOBP_POSITIVE_REGULATION_OF_...678,SET,35,0.16709,0.007285,0.13377,0.10583,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.852047700485325
MIKKELSEN_MEF_LCP_WITH_H3K27...,SET,61,0.14916,0.0085794,0.11944,0.10586,MIKKELSEN_MEF_LCP_WITH_H3K27ME3,0.852047700485325
KUMAMOTO_RESPONSE_TO_NUTLIN_...2,SET,9,0.35799,0.0079201,0.28671,0.10591,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP,0.852047700485325
MIR301A_5P,SET,75,0.12351,0.0078742,0.098922,0.10592,MIR301A_5P,0.852047700485325
MIR301B_5P,SET,75,0.12351,0.0078742,0.098922,0.10592,MIR301B_5P,0.852047700485325
GOBP_CELLULAR_RESPONSE_TO_LI...1,SET,106,0.1001,0.0075802,0.08019,0.10597,GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS,0.852047700485325
WP_SULFATION_BIOTRANSFORMATI...,SET,14,0.33376,0.0092085,0.26739,0.10598,WP_SULFATION_BIOTRANSFORMATION_REACTION,0.852047700485325
GSE22611_UNSTIM_VS_6H_MDP_ST...4,SET,177,0.07925,0.0077399,0.063491,0.10599,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.852047700485325
GOBP_REGULATION_OF_ALTERNATI...,SET,50,0.14057,0.0073224,0.11264,0.10603,GOBP_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.852047700485325
HP_INSPIRATORY_STRIDOR,SET,14,0.291,0.0080287,0.2332,0.10605,HP_INSPIRATORY_STRIDOR,0.852047700485325
GOBP_REGULATION_OF_ANION_CHA...,SET,5,0.54423,0.0089755,0.43616,0.10606,GOBP_REGULATION_OF_ANION_CHANNEL_ACTIVITY,0.852047700485325
GOBP_RRNA_TRANSCRIPTION,SET,33,0.17759,0.0075184,0.14232,0.10606,GOBP_RRNA_TRANSCRIPTION,0.852047700485325
PID_NECTIN_PATHWAY,SET,26,0.22526,0.0084665,0.18053,0.10607,PID_NECTIN_PATHWAY,0.852047700485325
KEGG_MEDICUS_VARIANT_MUTATIO...40,SET,6,0.40196,0.0072617,0.32217,0.10608,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION,0.852047700485325
MOTAMED_RESPONSE_TO_ANDROGEN...1,SET,6,0.43502,0.007859,0.34878,0.10616,MOTAMED_RESPONSE_TO_ANDROGEN_DN,0.852296327096327
SHAFFER_IRF4_TARGETS_IN_ACTI...2,SET,57,0.14543,0.0080868,0.1166,0.10616,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,0.852296327096327
GOMF_3_5_DNA_EXONUCLEASE_ACT...,SET,13,0.2913,0.0077447,0.23359,0.1062,GOMF_3_5_DNA_EXONUCLEASE_ACTIVITY,0.852420554272517
GOBP_OPTIC_CUP_MORPHOGENESIS...,SET,7,0.47235,0.0092167,0.37883,0.10624,GOBP_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT,0.852544724082198
REACTOME_TOLL_LIKE_RECEPTOR_...1,SET,101,0.10579,0.007821,0.084882,0.10633,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,0.853069979224377
KIM_WT1_TARGETS_UP,SET,212,0.076984,0.0082206,0.061789,0.1064,KIM_WT1_TARGETS_UP,0.853244868542435
GOBP_DETECTION_OF_TEMPERATUR...2,SET,19,0.25144,0.0080805,0.20183,0.10642,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.853244868542435
GSE21927_SPLEEN_VS_TUMOR_MON...3,SET,149,0.088331,0.0079211,0.070907,0.10644,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN,0.853244868542435
GOBP_LEUKOCYTE_PROLIFERATION,SET,322,0.063709,0.0083588,0.051145,0.10645,GOBP_LEUKOCYTE_PROLIFERATION,0.853244868542435
GOMF_P53_BINDING,SET,64,0.13238,0.0077986,0.10633,0.10657,GOMF_P53_BINDING,0.854009764814388
KEGG_VIBRIO_CHOLERAE_INFECTI...,SET,50,0.15322,0.0079809,0.1231,0.10664,KEGG_VIBRIO_CHOLERAE_INFECTION,0.854130696711888
GOBP_MIGRACYTOSIS,SET,5,0.56646,0.0093422,0.45535,0.10675,GOBP_MIGRACYTOSIS,0.854130696711888
WP_REGULATION_OF_WNT_BCATENI...,SET,16,0.29191,0.0086093,0.23466,0.10677,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,0.854130696711888
AUNG_GASTRIC_CANCER,SET,47,0.14719,0.0074341,0.11835,0.1068,AUNG_GASTRIC_CANCER,0.854130696711888
CONRAD_GERMLINE_STEM_CELL,SET,8,0.35312,0.0073658,0.28393,0.10682,CONRAD_GERMLINE_STEM_CELL,0.854130696711888
GOBP_INTEGRIN_ACTIVATION,SET,26,0.21354,0.0080262,0.17171,0.10683,GOBP_INTEGRIN_ACTIVATION,0.854130696711888
CUI_TCF21_TARGETS_2_UP,SET,390,0.055672,0.0080235,0.044768,0.10684,CUI_TCF21_TARGETS_2_UP,0.854130696711888
HP_ABNORMALITY_OF_FUNDUS_PIG...,SET,39,0.16831,0.0077454,0.13535,0.10685,HP_ABNORMALITY_OF_FUNDUS_PIGMENTATION,0.854130696711888
REACTOME_PRE_NOTCH_PROCESSIN...1,SET,18,0.22963,0.0071829,0.18467,0.10686,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,0.854130696711888
MODULE_312,SET,46,0.15543,0.0077662,0.125,0.10687,MODULE_312,0.854130696711888
HP_DEFICIT_IN_GRAMMAR,SET,9,0.31528,0.0069753,0.25357,0.10688,HP_DEFICIT_IN_GRAMMAR,0.854130696711888
GSE17721_LPS_VS_PAM3CSK4_0.5...1,SET,174,0.079117,0.0076617,0.063632,0.10688,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN,0.854130696711888
GOMF_SPECTRIN_BINDING,SET,26,0.21728,0.0081668,0.1748,0.10694,GOMF_SPECTRIN_BINDING,0.854274070247934
MODULE_322,SET,51,0.14236,0.0074892,0.11455,0.10697,MODULE_322,0.854274070247934
GOBP_MODIFICATION_DEPENDENT_...,SET,566,0.04374,0.0075569,0.0352,0.10701,GOBP_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS,0.854274070247934
KEGG_ASCORBATE_AND_ALDARATE_...,SET,23,0.32485,0.011485,0.26145,0.10704,KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,0.854274070247934
GOBP_FUCOSE_METABOLIC_PROCESS,SET,15,0.26677,0.0076182,0.21472,0.10706,GOBP_FUCOSE_METABOLIC_PROCESS,0.854274070247934
GSE21927_SPLEEN_VS_C26GM_TUM...2,SET,137,0.094486,0.0081275,0.076054,0.10706,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP,0.854274070247934
BIOCARTA_FCER1_PATHWAY,SET,37,0.1778,0.0079698,0.14312,0.10707,BIOCARTA_FCER1_PATHWAY,0.854274070247934
HP_CLUMSINESS,SET,84,0.11597,0.0078225,0.093381,0.10714,HP_CLUMSINESS,0.85445664
GOBP_RESPONSE_TO_LITHIUM_ION,SET,16,0.27793,0.0081969,0.2238,0.10715,GOBP_RESPONSE_TO_LITHIUM_ION,0.85445664
GOCC_SMALL_SUBUNIT_PROCESSOME,SET,63,0.12586,0.0073562,0.10136,0.10719,GOCC_SMALL_SUBUNIT_PROCESSOME,0.85445664
HP_MATERNAL_DIABETES,SET,39,0.18177,0.0083646,0.14644,0.10726,HP_MATERNAL_DIABETES,0.85445664
KEGG_MEDICUS_PATHOGEN_SALMON...2,SET,24,0.21504,0.007766,0.17327,0.1073,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.85445664
HP_MESOMELIC_LEG_SHORTENING,SET,5,0.47518,0.0078367,0.38291,0.10732,HP_MESOMELIC_LEG_SHORTENING,0.85445664
HP_PICA,SET,8,0.33832,0.0070572,0.2727,0.10737,HP_PICA,0.85445664
REACTOME_DCC_MEDIATED_ATTRAC...,SET,14,0.27068,0.007468,0.21818,0.10738,REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,0.85445664
GOBP_HINDLIMB_MORPHOGENESIS,SET,34,0.20886,0.0089753,0.16836,0.10739,GOBP_HINDLIMB_MORPHOGENESIS,0.85445664
HP_MICROVESICULAR_HEPATIC_ST...,SET,19,0.23111,0.0074271,0.18629,0.10739,HP_MICROVESICULAR_HEPATIC_STEATOSIS,0.85445664
MIR1915_3P,SET,156,0.085866,0.0078774,0.069218,0.1074,MIR1915_3P,0.85445664
GOMF_RECEPTOR_SERINE_THREONI...,SET,24,0.23341,0.0084294,0.18816,0.1074,GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING,0.85445664
HP_DIFFUSE_MESANGIAL_SCLEROS...,SET,38,0.17297,0.007857,0.13945,0.10743,HP_DIFFUSE_MESANGIAL_SCLEROSIS,0.85445664
HP_ABNORMAL_AORTIC_VALVE_PHY...,SET,148,0.091218,0.0081528,0.073545,0.10744,HP_ABNORMAL_AORTIC_VALVE_PHYSIOLOGY,0.85445664
GSE42021_CD24HI_TREG_VS_CD24...1,SET,187,0.081282,0.0081573,0.065546,0.10748,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN,0.85445664
KEGG_MEDICUS_ENV_FACTOR_BENZ...,SET,11,0.36809,0.0090026,0.29688,0.10752,KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM,0.85445664
KEGG_PRIMARY_IMMUNODEFICIENCY,SET,30,0.21473,0.0086686,0.1732,0.10753,KEGG_PRIMARY_IMMUNODEFICIENCY,0.85445664
GSE3691_IFN_PRODUCING_KILLER...1,SET,177,0.079544,0.0077686,0.064163,0.10755,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN,0.85445664
GOBP_NEGATIVE_REGULATION_OF_...105,SET,5,0.53632,0.008845,0.43263,0.10756,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,0.85445664
GOBP_RAP_PROTEIN_SIGNAL_TRAN...,SET,12,0.33935,0.0086686,0.27389,0.10768,GOBP_RAP_PROTEIN_SIGNAL_TRANSDUCTION,0.854862164009112
MIR1208,SET,119,0.096094,0.0077074,0.077561,0.10769,MIR1208,0.854862164009112
GSE37605_C57BL6_VS_NOD_FOXP3...3,SET,179,0.079863,0.0078432,0.064463,0.1077,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN,0.854862164009112
IWANAGA_CARCINOGENESIS_BY_KR...1,SET,115,0.099377,0.0078365,0.080235,0.10776,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,0.854862164009112
GOBP_NEUROTRANSMITTER_LOADIN...,SET,7,0.45179,0.0088157,0.36483,0.1078,GOBP_NEUROTRANSMITTER_LOADING_INTO_SYNAPTIC_VESICLE,0.854862164009112
GOBP_REGULATION_OF_CARDIAC_E...,SET,11,0.37196,0.0090973,0.30039,0.10782,GOBP_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.854862164009112
GOMF_CALCIUM_ION_BINDING,SET,661,0.045552,0.0084821,0.036787,0.10782,GOMF_CALCIUM_ION_BINDING,0.854862164009112
GSE360_L_DONOVANI_VS_M_TUBER...4,SET,184,0.079838,0.0079485,0.064476,0.10782,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP,0.854862164009112
GOBP_MOLTING_CYCLE_PROCESS,SET,95,0.11979,0.0085903,0.096754,0.10785,GOBP_MOLTING_CYCLE_PROCESS,0.854862164009112
GSE13522_WT_VS_IFNAR_KO_SKIN...1,SET,178,0.078854,0.0077228,0.063703,0.10789,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,0.854862164009112
HP_BREAST_APLASIA,SET,16,0.27886,0.0082245,0.22531,0.10792,HP_BREAST_APLASIA,0.854862164009112
MIR7159_3P,SET,199,0.076565,0.007924,0.061864,0.10793,MIR7159_3P,0.854862164009112
GOBP_POSITIVE_REGULATION_OF_...623,SET,39,0.16687,0.0076791,0.13485,0.10797,GOBP_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.854862164009112
PID_INSULIN_PATHWAY,SET,44,0.15832,0.0077372,0.12795,0.10798,PID_INSULIN_PATHWAY,0.854862164009112
HP_PANCREATIC_HYPOPLASIA,SET,24,0.23224,0.0083872,0.18769,0.10798,HP_PANCREATIC_HYPOPLASIA,0.854862164009112
GOBP_REGULATION_OF_NUCLEOTID...2,SET,9,0.3995,0.0088386,0.32294,0.10804,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.855105942622951
KEGG_MEDICUS_REFERENCE_N_GLY...2,SET,11,0.30647,0.0074957,0.24776,0.10806,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST,0.855105942622951
GSE17186_NAIVE_VS_CD21HIGH_T...1,SET,178,0.07975,0.0078105,0.064487,0.10811,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.855244826815643
HP_OVERHANGING_NASAL_TIP,SET,7,0.33143,0.0064671,0.26804,0.10814,HP_OVERHANGING_NASAL_TIP,0.855244826815643
HP_ABNORMAL_TIBIA_MORPHOLOGY,SET,90,0.11591,0.0080914,0.093766,0.10821,HP_ABNORMAL_TIBIA_MORPHOLOGY,0.855244826815643
GOMF_LOW_DENSITY_LIPOPROTEIN...3,SET,23,0.21844,0.0077227,0.17674,0.10825,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,0.855244826815643
KIM_PTEN_TARGETS_DN,SET,4,0.48154,0.0071034,0.3897,0.1083,KIM_PTEN_TARGETS_DN,0.855244826815643
GOBP_POSITIVE_REGULATION_OF_...236,SET,13,0.32412,0.0086174,0.26232,0.10831,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.855244826815643
REACTOME_MRNA_EDITING_C_TO_U...,SET,7,0.48986,0.0095585,0.39651,0.10834,REACTOME_MRNA_EDITING_C_TO_U_CONVERSION,0.855244826815643
GOBP_ANTERIOR_POSTERIOR_AXON...,SET,7,0.4551,0.0088803,0.36838,0.10835,GOBP_ANTERIOR_POSTERIOR_AXON_GUIDANCE,0.855244826815643
MORF_RAD23B,SET,158,0.076598,0.0070717,0.062012,0.10838,MORF_RAD23B,0.855244826815643
GOMF_PEROXIREDOXIN_ACTIVITY,SET,6,0.39554,0.0071456,0.32021,0.10838,GOMF_PEROXIREDOXIN_ACTIVITY,0.855244826815643
HP_ABNORMALITY_OF_SKIN_PIGME...,SET,435,0.050536,0.0076823,0.040932,0.10849,HP_ABNORMALITY_OF_SKIN_PIGMENTATION,0.855244826815643
ASTIER_INTEGRIN_SIGNALING,SET,54,0.15348,0.0083074,0.12434,0.10855,ASTIER_INTEGRIN_SIGNALING,0.855244826815643
GOMF_PROTEIN_SERINE_THREONIN...7,SET,42,0.16821,0.0080322,0.13628,0.10855,GOMF_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY,0.855244826815643
CHANG_IMMORTALIZED_BY_HPV31_...2,SET,65,0.13175,0.0078214,0.10675,0.10858,CHANG_IMMORTALIZED_BY_HPV31_UP,0.855244826815643
DESCARTES_MAIN_FETAL_CARDIOM...,SET,24,0.22019,0.007952,0.17841,0.10858,DESCARTES_MAIN_FETAL_CARDIOMYOCYTES,0.855244826815643
HP_INCREASED_CIRCULATING_CRE...,SET,3,0.47345,0.0060485,0.38366,0.1086,HP_INCREASED_CIRCULATING_CREATINE_KINASE_MB_ISOFORM,0.855244826815643
WP_VITAMIN_D_IN_INFLAMMATORY...,SET,20,0.23685,0.0078091,0.19194,0.10861,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,0.855244826815643
GOBP_CARDIOBLAST_DIFFERENTIA...,SET,16,0.30591,0.0090223,0.2479,0.10861,GOBP_CARDIOBLAST_DIFFERENTIATION,0.855244826815643
chr4q33,SET,5,0.67752,0.011174,0.54915,0.10865,chr4q33,0.855244826815643
AML1_01,SET,251,0.069437,0.0080593,0.056288,0.10868,AML1_01,0.855244826815643
AML1_Q6,SET,251,0.069437,0.0080593,0.056288,0.10868,AML1_Q6,0.855244826815643
GOCC_CHROMAFFIN_GRANULE_MEMB...,SET,9,0.39769,0.0087985,0.32239,0.10869,GOCC_CHROMAFFIN_GRANULE_MEMBRANE,0.855244826815643
GSE27859_DC_VS_CD11C_INT_F48...3,SET,183,0.072731,0.0072215,0.058966,0.10871,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN,0.855244826815643
MIR6879_5P,SET,99,0.10889,0.0079708,0.08829,0.10873,MIR6879_5P,0.855244826815643
GOMF_NUCLEOSIDE_BINDING,SET,8,0.38859,0.0081058,0.31512,0.10876,GOMF_NUCLEOSIDE_BINDING,0.855244826815643
EBAUER_TARGETS_OF_PAX3_FOXO1...1,SET,46,0.15941,0.0079652,0.12929,0.10881,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.855244826815643
GSE34156_UNTREATED_VS_6H_TLR...1,SET,163,0.080874,0.0075826,0.065596,0.10881,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.855244826815643
TRAVAGLINI_LUNG_MESOTHELIAL_...,SET,582,0.04542,0.0079537,0.03684,0.10881,TRAVAGLINI_LUNG_MESOTHELIAL_CELL,0.855244826815643
ITO_PTTG1_TARGETS_DN,SET,9,0.36463,0.008067,0.29576,0.10882,ITO_PTTG1_TARGETS_DN,0.855244826815643
GOBP_POLY_A_DEPENDENT_SNORNA...,SET,6,0.4353,0.007864,0.35313,0.10886,GOBP_POLY_A_DEPENDENT_SNORNA_3_END_PROCESSING,0.855244826815643
GSE17721_CTRL_VS_CPG_6H_BMDC...2,SET,181,0.074297,0.0073369,0.060281,0.10889,GSE17721_CTRL_VS_CPG_6H_BMDC_UP,0.855244826815643
GSE27670_CTRL_VS_BLIMP1_TRAN...2,SET,186,0.079668,0.0079741,0.064647,0.10892,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP,0.855244826815643
ATACTGT_MIR144,SET,181,0.080701,0.0079693,0.065491,0.10894,ATACTGT_MIR144,0.855244826815643
GSE40274_GATA1_VS_FOXP3_AND_...1,SET,183,0.07887,0.0078309,0.064018,0.10899,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.855244826815643
KAYO_AGING_MUSCLE_DN,SET,106,0.096725,0.0073247,0.078515,0.109,KAYO_AGING_MUSCLE_DN,0.855244826815643
GOBP_PYRAMIDAL_NEURON_DEVELO...,SET,9,0.35492,0.0078523,0.28825,0.10911,GOBP_PYRAMIDAL_NEURON_DEVELOPMENT,0.855244826815643
GSE3203_INFLUENZA_INF_VS_IFN...1,SET,172,0.081591,0.0078563,0.066263,0.10911,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN,0.855244826815643
TTGCWCAAY_CEBPB_02,SET,60,0.14174,0.0080854,0.11513,0.10915,TTGCWCAAY_CEBPB_02,0.855244826815643
REACTOME_INSULIN_PROCESSING,SET,23,0.21801,0.0077076,0.17709,0.10916,REACTOME_INSULIN_PROCESSING,0.855244826815643
HP_MINIMAL_SUBCUTANEOUS_FAT,SET,4,0.55541,0.008193,0.45116,0.10916,HP_MINIMAL_SUBCUTANEOUS_FAT,0.855244826815643
HP_INAPPROPRIATE_ANTIDIURETI...,SET,8,0.35292,0.0073617,0.28672,0.10919,HP_INAPPROPRIATE_ANTIDIURETIC_HORMONE_SECRETION,0.855244826815643
GSE6259_BCELL_VS_CD8_TCELL_UP,SET,174,0.085678,0.0082972,0.069627,0.10926,GSE6259_BCELL_VS_CD8_TCELL_UP,0.855244826815643
HP_HYPOKETOTIC_HYPOGLYCEMIA,SET,14,0.28674,0.0079112,0.23304,0.10928,HP_HYPOKETOTIC_HYPOGLYCEMIA,0.855244826815643
REACTOME_CHEMOKINE_RECEPTORS...,SET,54,0.17333,0.0093817,0.14089,0.1093,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,0.855244826815643
TESAR_ALK_TARGETS_EPISC_4D_UP,SET,5,0.48409,0.0079837,0.39351,0.10932,TESAR_ALK_TARGETS_EPISC_4D_UP,0.855244826815643
GAVISH_3CA_MALIGNANT_METAPRO...29,SET,42,0.16825,0.008034,0.13677,0.10933,GAVISH_3CA_MALIGNANT_METAPROGRAM_37_HEMATO_RELATED_2,0.855244826815643
GOCC_HOST_CELLULAR_COMPONENT,SET,9,0.34163,0.0075583,0.27772,0.10933,GOCC_HOST_CELLULAR_COMPONENT,0.855244826815643
HP_ABNORMAL_LUNG_LOBATION,SET,37,0.17869,0.0080099,0.1453,0.10939,HP_ABNORMAL_LUNG_LOBATION,0.855244826815643
GOMF_UDP_GALACTOSE_BETA_N_AC...,SET,12,0.33061,0.0084454,0.26884,0.1094,GOMF_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.855244826815643
BIOCARTA_TCR_PATHWAY,SET,43,0.15754,0.0076114,0.12811,0.10941,BIOCARTA_TCR_PATHWAY,0.855244826815643
chr17p11,SET,61,0.23557,0.013549,0.19157,0.10942,chr17p11,0.855244826815643
ZHAN_V1_LATE_DIFFERENTIATION...1,SET,11,0.32419,0.007929,0.26364,0.10942,ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,0.855244826815643
GOMF_TRANSLATION_ACTIVATOR_A...,SET,9,0.33635,0.0074415,0.27359,0.10947,GOMF_TRANSLATION_ACTIVATOR_ACTIVITY,0.855244826815643
GSE16266_CTRL_VS_LPS_STIM_ME...2,SET,182,0.082173,0.0081368,0.06684,0.10947,GSE16266_CTRL_VS_LPS_STIM_MEF_UP,0.855244826815643
GEORGES_TARGETS_OF_MIR192_AN...,SET,796,0.03796,0.0077272,0.030878,0.10948,GEORGES_TARGETS_OF_MIR192_AND_MIR215,0.855244826815643
SEAVEY_EPITHELIOID_HEMANGIOE...,SET,87,0.11987,0.0082276,0.097513,0.1095,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,0.855244826815643
GSE46242_TH1_VS_ANERGIC_TH1_...2,SET,168,0.080623,0.0076731,0.065603,0.10955,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP,0.855244826815643
GSE9946_IMMATURE_VS_LISTERIA...1,SET,112,0.099145,0.0077162,0.080674,0.10955,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN,0.855244826815643
GSE26669_CD4_VS_CD8_TCELL_IN...2,SET,181,0.078439,0.0077459,0.06383,0.10957,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP,0.855244826815643
GOBP_REGULATION_OF_PLASMA_CE...,SET,6,0.4124,0.0074503,0.33569,0.10964,GOBP_REGULATION_OF_PLASMA_CELL_DIFFERENTIATION,0.855244826815643
GOBP_RENAL_WATER_ABSORPTION,SET,6,0.48625,0.0087845,0.39593,0.10971,GOBP_RENAL_WATER_ABSORPTION,0.855244826815643
GCM_LTK,SET,41,0.15519,0.0073218,0.12637,0.10973,GCM_LTK,0.855244826815643
HALLMARK_WNT_BETA_CATENIN_SI...,SET,41,0.16416,0.007745,0.13368,0.10973,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.855244826815643
PAX4_04,SET,195,0.079112,0.0081058,0.064425,0.10974,PAX4_04,0.855244826815643
BIOCARTA_P38MAPK_PATHWAY,SET,35,0.17929,0.0078167,0.14602,0.10976,BIOCARTA_P38MAPK_PATHWAY,0.855244826815643
GSE20727_CTRL_VS_DNFB_ALLERG...2,SET,179,0.077427,0.007604,0.063058,0.10976,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP,0.855244826815643
GSE3982_DC_VS_NEUTROPHIL_LPS...1,SET,176,0.080237,0.0078143,0.065355,0.10979,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN,0.855244826815643
KEGG_MEDICUS_REFERENCE_GLYCO...3,SET,5,0.46027,0.0075908,0.37503,0.10987,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_,0.855244826815643
GOMF_MACROMOLECULE_TRANSMEMB...,SET,30,0.17837,0.0072009,0.14534,0.10987,GOMF_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.855244826815643
GOBP_FERMENTATION,SET,3,0.60221,0.0076935,0.49079,0.10991,GOBP_FERMENTATION,0.855244826815643
MODULE_189,SET,9,0.31954,0.0070696,0.26043,0.10992,MODULE_189,0.855244826815643
GOBP_NEGATIVE_REGULATION_OF_...591,SET,13,0.3424,0.0091035,0.27907,0.10993,GOBP_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,0.855244826815643
WEIGEL_OXIDATIVE_STRESS_BY_H...1,SET,31,0.18552,0.007613,0.15122,0.10995,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,0.855244826815643
GSE22886_UNSTIM_VS_IL15_STIM...2,SET,171,0.078205,0.0075085,0.063751,0.10997,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP,0.855244826815643
MIR5002_5P,SET,233,0.071884,0.0080425,0.058601,0.10998,MIR5002_5P,0.855244826815643
REACTOME_EICOSANOIDS,SET,12,0.3672,0.00938,0.29936,0.10999,REACTOME_EICOSANOIDS,0.855244826815643
GOBP_PODOCYTE_CELL_MIGRATION,SET,7,0.43298,0.0084486,0.35305,0.11003,GOBP_PODOCYTE_CELL_MIGRATION,0.855244826815643
GOBP_POSITIVE_REGULATION_OF_...467,SET,8,0.40817,0.0085142,0.33281,0.11003,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,0.855244826815643
REACTOME_MUSCLE_CONTRACTION,SET,194,0.077809,0.007952,0.063456,0.11007,REACTOME_MUSCLE_CONTRACTION,0.855244826815643
GSE10856_CTRL_VS_TNFRSF6B_IN...2,SET,157,0.085624,0.0078801,0.06983,0.11008,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP,0.855244826815643
VDR_Q3,SET,213,0.073544,0.0078715,0.059984,0.1101,VDR_Q3,0.855244826815643
BIOCARTA_ERYTH_PATHWAY,SET,15,0.30563,0.0087279,0.2493,0.11012,BIOCARTA_ERYTH_PATHWAY,0.855244826815643
LI_PBMC_MENACTRA_AGE_18_45YO...5,SET,30,0.20775,0.008387,0.16946,0.11012,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.855244826815643
GSE1460_INTRATHYMIC_T_PROGEN...9,SET,174,0.085301,0.0082607,0.069604,0.1102,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN,0.855639066339066
HP_PERSISTENCE_OF_PRIMARY_TE...,SET,22,0.2125,0.007348,0.17342,0.11022,HP_PERSISTENCE_OF_PRIMARY_TEETH,0.855639066339066
REACTOME_COMPLEX_IV_ASSEMBLY,SET,41,0.13984,0.0065975,0.11413,0.11025,REACTOME_COMPLEX_IV_ASSEMBLY,0.855680828494864
HP_ABSENT_TESTIS,SET,24,0.19023,0.0068701,0.1553,0.1103,HP_ABSENT_TESTIS,0.855791917986548
HP_ELEVATED_URINARY_MONOCARB...,SET,11,0.31457,0.0076938,0.25691,0.1104,HP_ELEVATED_URINARY_MONOCARBOXYLIC_ACID_LEVEL,0.855791917986548
GOBP_ACTIN_FILAMENT_SEVERING,SET,16,0.26174,0.0077195,0.2138,0.11044,GOBP_ACTIN_FILAMENT_SEVERING,0.855791917986548
CHIARETTI_T_ALL_REFRACTORY_T...,SET,25,0.20923,0.0077118,0.17091,0.11045,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,0.855791917986548
GSE6269_HEALTHY_VS_STAPH_PNE...2,SET,165,0.077663,0.0073257,0.063442,0.11045,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP,0.855791917986548
GOBP_POSITIVE_REGULATION_OF_...656,SET,115,0.095492,0.0075301,0.078028,0.11052,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.855791917986548
GOBP_GLYCOSIDE_CATABOLIC_PRO...,SET,7,0.37209,0.0072604,0.30405,0.11053,GOBP_GLYCOSIDE_CATABOLIC_PROCESS,0.855791917986548
MOREIRA_RESPONSE_TO_TSA_UP,SET,25,0.20764,0.0076529,0.16968,0.11055,MOREIRA_RESPONSE_TO_TSA_UP,0.855791917986548
REACTOME_LYSOSPHINGOLIPID_AN...,SET,9,0.38648,0.0085506,0.31585,0.11055,REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS,0.855791917986548
MIR4697_3P,SET,99,0.10522,0.0077018,0.086,0.11058,MIR4697_3P,0.855791917986548
HNF4_01,SET,244,0.066478,0.0076088,0.054334,0.11058,HNF4_01,0.855791917986548
REACTOME_FATTY_ACIDS,SET,15,0.30688,0.0087638,0.25083,0.11059,REACTOME_FATTY_ACIDS,0.855791917986548
GOBP_IRON_COORDINATION_ENTIT...,SET,11,0.32222,0.0078808,0.26337,0.11059,GOBP_IRON_COORDINATION_ENTITY_TRANSPORT,0.855791917986548
GOBP_EPITHELIAL_CELL_APOPTOT...,SET,128,0.096607,0.0080343,0.078974,0.11062,GOBP_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.855791917986548
GOBP_HAIR_CYCLE_PHASE,SET,9,0.3631,0.0080334,0.2969,0.11068,GOBP_HAIR_CYCLE_PHASE,0.855791917986548
GSE23308_CTRL_VS_CORTICOSTER...1,SET,186,0.077086,0.0077157,0.063038,0.1107,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN,0.855791917986548
WP_MFAP5MEDIATED_OVARIAN_CAN...,SET,12,0.31532,0.0080547,0.25792,0.11076,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,0.855791917986548
GOCC_CYTOPLASMIC_SIDE_OF_MEM...,SET,186,0.076713,0.0076783,0.062754,0.11078,GOCC_CYTOPLASMIC_SIDE_OF_MEMBRANE,0.855791917986548
GOBP_AMINO_ACID_BETAINE_BIOS...,SET,5,0.53127,0.0087618,0.43467,0.11081,GOBP_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS,0.855791917986548
GOBP_GOLGI_RIBBON_FORMATION,SET,11,0.3011,0.0073642,0.24639,0.11086,GOBP_GOLGI_RIBBON_FORMATION,0.855791917986548
GOBP_NEGATIVE_REGULATION_OF_...652,SET,137,0.092788,0.0079814,0.075934,0.11087,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.855791917986548
GSE29615_DAY3_VS_DAY7_LAIV_F...2,SET,145,0.088806,0.007857,0.072692,0.11092,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,0.855791917986548
GOBP_POSITIVE_REGULATION_OF_...21,SET,28,0.19727,0.007694,0.16148,0.11093,GOBP_POSITIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.855791917986548
GOMF_RNA_POLYMERASE_III_GENE...,SET,12,0.23424,0.0059835,0.19175,0.11094,GOMF_RNA_POLYMERASE_III_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.855791917986548
REACTOME_WNT_LIGAND_BIOGENES...,SET,24,0.23196,0.0083768,0.18995,0.11103,REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING,0.855791917986548
GOBP_MEMBRANE_DEPOLARIZATION...4,SET,5,0.49144,0.0081049,0.40247,0.11104,GOBP_MEMBRANE_DEPOLARIZATION_DURING_SA_NODE_CELL_ACTION_POTENTIAL,0.855791917986548
GOMF_BETA_CATENIN_BINDING,SET,98,0.11115,0.0080949,0.091029,0.11105,GOMF_BETA_CATENIN_BINDING,0.855791917986548
chr2q11,SET,69,0.28083,0.017175,0.23,0.11106,chr2q11,0.855791917986548
GOBP_NEUROEPITHELIAL_CELL_DI...,SET,42,0.18016,0.0086026,0.14756,0.11106,GOBP_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.855791917986548
GOMF_5S_RRNA_BINDING,SET,8,0.35994,0.0075081,0.29482,0.11107,GOMF_5S_RRNA_BINDING,0.855791917986548
GCM_DENR,SET,49,0.13416,0.0069184,0.10989,0.11108,GCM_DENR,0.855791917986548
GOMF_DIOXYGENASE_ACTIVITY,SET,82,0.10937,0.0072895,0.089592,0.11109,GOMF_DIOXYGENASE_ACTIVITY,0.855791917986548
GENTILE_UV_RESPONSE_CLUSTER_...7,SET,36,0.1811,0.0080075,0.14836,0.11111,GENTILE_UV_RESPONSE_CLUSTER_D8,0.855791917986548
GOBP_IMMUNE_RESPONSE_INHIBIT...1,SET,8,0.40161,0.0083774,0.32911,0.11118,GOBP_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.855791917986548
GSE21033_1H_VS_12H_POLYIC_ST...1,SET,124,0.092875,0.0076031,0.076115,0.1112,GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN,0.855791917986548
KEGG_MEDICUS_REFERENCE_HEDGE...3,SET,9,0.37441,0.0082834,0.30686,0.11122,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR,0.855791917986548
WP_PATHWAYS_AFFECTED_IN_ADEN...,SET,56,0.12856,0.0070857,0.10537,0.11123,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,0.855791917986548
NCOA2_TARGET_GENES,SET,380,0.055212,0.0078567,0.045258,0.11125,NCOA2_TARGET_GENES,0.855791917986548
REACTOME_DNA_DOUBLE_STRAND_B...1,SET,126,0.085523,0.0070571,0.070107,0.11126,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,0.855791917986548
REACTOME_ESTROGEN_DEPENDENT_...1,SET,87,0.10967,0.0075281,0.089908,0.11127,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,0.855791917986548
GOBP_CEREBELLAR_PURKINJE_CEL...1,SET,23,0.20933,0.0074006,0.17164,0.11133,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT,0.855791917986548
ZF5_B,SET,214,0.073879,0.0079257,0.060596,0.11139,ZF5_B,0.855791917986548
THAKAR_PBMC_INACTIVATED_INFL...1,SET,56,0.13876,0.0076479,0.11385,0.11147,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_DN,0.855791917986548
GOBP_REGULATION_OF_B_CELL_PR...,SET,61,0.13686,0.0078718,0.1123,0.11148,GOBP_REGULATION_OF_B_CELL_PROLIFERATION,0.855791917986548
MORF_TNFRSF25,SET,244,0.068059,0.0077899,0.055848,0.1115,MORF_TNFRSF25,0.855791917986548
HP_NEOPLASM_OF_THE_HEART,SET,15,0.24563,0.0070144,0.20161,0.11156,HP_NEOPLASM_OF_THE_HEART,0.855791917986548
GOBP_NEGATIVE_REGULATION_OF_...635,SET,6,0.44813,0.0080959,0.36788,0.11159,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.855791917986548
MTOR_UP.N4.V1_DN,SET,155,0.081381,0.0074422,0.066807,0.11159,MTOR_UP.N4.V1_DN,0.855791917986548
GOBP_REGULATION_OF_CELLULAR_...2,SET,416,0.051589,0.0076733,0.042361,0.11165,GOBP_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.855791917986548
GOCC_ROUGH_ENDOPLASMIC_RETIC...2,SET,20,0.22832,0.0075279,0.18749,0.11167,GOCC_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.855791917986548
GOBP_POSITIVE_REGULATION_OF_...486,SET,9,0.39384,0.0087135,0.32344,0.11168,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.855791917986548
GAO_LARGE_INTESTINE_ADULT_CH...,SET,92,0.10353,0.0073069,0.085024,0.11168,GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS,0.855791917986548
ZNF16_TARGET_GENES,SET,66,0.13517,0.0080858,0.11105,0.11178,ZNF16_TARGET_GENES,0.855791917986548
GOCC_RESPIRATORY_CHAIN_COMPL...,SET,21,0.22143,0.0074807,0.18192,0.11178,GOCC_RESPIRATORY_CHAIN_COMPLEX_IV,0.855791917986548
GOBP_ORGANELLE_FUSION,SET,152,0.083326,0.0075465,0.06847,0.11182,GOBP_ORGANELLE_FUSION,0.855791917986548
GSE17721_CTRL_VS_GARDIQUIMOD...1,SET,176,0.075434,0.0073466,0.062004,0.11189,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.855791917986548
GSE17721_PAM3CSK4_VS_GADIQUI...2,SET,187,0.074839,0.0075107,0.061516,0.11189,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP,0.855791917986548
HP_HYPOGONADISM,SET,377,0.054084,0.0076663,0.044458,0.11191,HP_HYPOGONADISM,0.855791917986548
GOBP_LIPID_HOMEOSTASIS,SET,150,0.084906,0.0076393,0.069814,0.11197,GOBP_LIPID_HOMEOSTASIS,0.855791917986548
GOBP_ZYMOGEN_ACTIVATION,SET,51,0.1561,0.0082116,0.12835,0.11197,GOBP_ZYMOGEN_ACTIVATION,0.855791917986548
TBX3_TARGET_GENES,SET,628,0.04195,0.0076211,0.034501,0.11202,TBX3_TARGET_GENES,0.855791917986548
GOBP_CEREBELLAR_CORTEX_FORMA...,SET,22,0.23334,0.0080686,0.19192,0.11203,GOBP_CEREBELLAR_CORTEX_FORMATION,0.855791917986548
HP_LOWER_LIMB_METAPHYSEAL_IR...,SET,9,0.32797,0.0072559,0.26976,0.11204,HP_LOWER_LIMB_METAPHYSEAL_IRREGULARITY,0.855791917986548
QI_PLASMACYTOMA_UP,SET,246,0.070007,0.0080452,0.057587,0.11206,QI_PLASMACYTOMA_UP,0.855791917986548
GSE22140_GERMFREE_VS_SPF_MOU...1,SET,187,0.077212,0.0077488,0.063512,0.11206,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN,0.855791917986548
REACTOME_DEADENYLATION_DEPEN...,SET,49,0.14322,0.0073852,0.11782,0.11209,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,0.855791917986548
GOBP_AXIAL_MESODERM_DEVELOPM...,SET,7,0.33287,0.0064952,0.27386,0.1121,GOBP_AXIAL_MESODERM_DEVELOPMENT,0.855791917986548
NOJIMA_SFRP2_TARGETS_UP,SET,29,0.208,0.0082562,0.17118,0.11217,NOJIMA_SFRP2_TARGETS_UP,0.855791917986548
PEPPER_CHRONIC_LYMPHOCYTIC_L...1,SET,21,0.24556,0.008296,0.20209,0.11217,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.855791917986548
MIR12118,SET,90,0.10897,0.007607,0.089687,0.11219,MIR12118,0.855791917986548
ZHENG_CORD_BLOOD_C3_MEGAKARY...,SET,90,0.10846,0.0075712,0.08927,0.1122,ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR,0.855791917986548
GOCC_MEMBRANE_COAT,SET,93,0.10345,0.0073404,0.08515,0.11221,GOCC_MEMBRANE_COAT,0.855791917986548
GSE29615_CTRL_VS_DAY7_LAIV_F...2,SET,153,0.086133,0.0078262,0.070902,0.11222,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,0.855791917986548
HP_MICROTIA_THIRD_DEGREE,SET,10,0.32734,0.0076337,0.26953,0.11228,HP_MICROTIA_THIRD_DEGREE,0.855791917986548
HIRSCH_CELLULAR_TRANSFORMATI...1,SET,91,0.11135,0.0078161,0.091697,0.11232,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,0.855791917986548
GOBP_REGULATION_OF_VIRAL_GEN...,SET,80,0.12134,0.0079884,0.099925,0.11232,GOBP_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.855791917986548
GSE8515_CTRL_VS_IL1_4H_STIM_...1,SET,174,0.077624,0.0075172,0.063922,0.11232,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN,0.855791917986548
GOMF_MOLECULAR_CARRIER_ACTIV...,SET,84,0.10952,0.0073872,0.090205,0.11236,GOMF_MOLECULAR_CARRIER_ACTIVITY,0.855791917986548
GOBP_DEVELOPMENT_OF_PRIMARY_...2,SET,213,0.07476,0.0080016,0.061581,0.11238,GOBP_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS,0.855791917986548
GRYDER_PAX3FOXO1_ENHANCERS_I...,SET,942,0.036288,0.0080023,0.029893,0.11239,GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS,0.855791917986548
GSE21670_UNTREATED_VS_TGFB_I...1,SET,160,0.083597,0.0077661,0.068868,0.11241,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN,0.855791917986548
KEGG_THYROID_CANCER,SET,29,0.18415,0.0073092,0.15173,0.11245,KEGG_THYROID_CANCER,0.855791917986548
GOBP_RESPONSE_TO_MACROPHAGE_...,SET,16,0.29552,0.0087159,0.24357,0.11251,GOBP_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR,0.855791917986548
ZNF250_TARGET_GENES,SET,444,0.049189,0.0075526,0.040543,0.11252,ZNF250_TARGET_GENES,0.855791917986548
GOBP_EXOCYTOSIS,SET,322,0.057518,0.0075465,0.047411,0.11254,GOBP_EXOCYTOSIS,0.855791917986548
REACTOME_CS_DS_DEGRADATION,SET,12,0.28201,0.0072039,0.2325,0.11258,REACTOME_CS_DS_DEGRADATION,0.855791917986548
HP_ONYCHOGRYPOSIS_OF_TOENAILS,SET,7,0.38487,0.0075098,0.31729,0.11258,HP_ONYCHOGRYPOSIS_OF_TOENAILS,0.855791917986548
GOCC_CAJAL_BODY,SET,56,0.12622,0.0069568,0.10409,0.11265,GOCC_CAJAL_BODY,0.855791917986548
WP_ESTROGEN_RECEPTOR_PATHWAY,SET,13,0.3136,0.0083377,0.25869,0.11271,WP_ESTROGEN_RECEPTOR_PATHWAY,0.855791917986548
ZNF740_TARGET_GENES,SET,1190,0.030886,0.0076008,0.02548,0.11273,ZNF740_TARGET_GENES,0.855791917986548
GOCC_VESICLE_MEMBRANE,SET,1142,0.032118,0.0077537,0.026498,0.11274,GOCC_VESICLE_MEMBRANE,0.855791917986548
GOCC_CHROMAFFIN_GRANULE,SET,14,0.32063,0.0088462,0.26454,0.11276,GOCC_CHROMAFFIN_GRANULE,0.855791917986548
GSE2405_0H_VS_9H_A_PHAGOCYTO...1,SET,182,0.072938,0.0072223,0.060193,0.11282,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.855791917986548
GSE29949_CD8_POS_DC_SPLEEN_V...2,SET,184,0.075581,0.0075247,0.062387,0.11286,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP,0.855791917986548
KEGG_NOTCH_SIGNALING_PATHWAY,SET,46,0.1463,0.0073102,0.12078,0.11289,KEGG_NOTCH_SIGNALING_PATHWAY,0.855791917986548
GSE45365_HEALTHY_VS_MCMV_INF...10,SET,182,0.074405,0.0073676,0.061423,0.11289,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP,0.855791917986548
GOBP_CARNITINE_METABOLIC_PRO...,SET,11,0.28641,0.007005,0.23648,0.11293,GOBP_CARNITINE_METABOLIC_PROCESS,0.855791917986548
GOCC_PLATELET_ALPHA_GRANULE_...1,SET,59,0.14054,0.0079504,0.11604,0.11293,GOCC_PLATELET_ALPHA_GRANULE_LUMEN,0.855791917986548
GOMF_L_ASPARTATE_TRANSMEMBRA...,SET,9,0.33605,0.0074349,0.27749,0.11295,GOMF_L_ASPARTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.855791917986548
KRAS.300_UP.V1_DN,SET,125,0.09604,0.0078937,0.079306,0.11295,KRAS.300_UP.V1_DN,0.855791917986548
GSE3565_CTRL_VS_LPS_INJECTED...1,SET,155,0.085703,0.0078374,0.07077,0.11296,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN,0.855791917986548
GOBP_AMEBOIDAL_TYPE_CELL_MIG...,SET,402,0.054591,0.0079852,0.045088,0.113,GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION,0.855791917986548
GOBP_REGULATION_OF_PROTEIN_D...2,SET,69,0.12294,0.007519,0.10155,0.11301,GOBP_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.855791917986548
RICHERT_PBMC_HIV_LIPO_5_AGE_...4,SET,25,0.23542,0.0086769,0.19445,0.11302,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP,0.855791917986548
GOBP_RETICULOPHAGY,SET,17,0.24644,0.0074919,0.20357,0.11303,GOBP_RETICULOPHAGY,0.855791917986548
BIOCARTA_IL12_PATHWAY,SET,18,0.25021,0.0078268,0.20672,0.11307,BIOCARTA_IL12_PATHWAY,0.855791917986548
MODULE_253,SET,20,0.23216,0.0076546,0.19181,0.11308,MODULE_253,0.855791917986548
GSE16385_MONOCYTE_VS_12H_IL4...2,SET,175,0.080177,0.0077865,0.066244,0.11308,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP,0.855791917986548
HP_MALAR_FLATTENING,SET,175,0.078794,0.0076522,0.065105,0.1131,HP_MALAR_FLATTENING,0.855791917986548
GOBP_MUSCLE_CELL_MIGRATION,SET,80,0.12502,0.0082305,0.1033,0.11311,GOBP_MUSCLE_CELL_MIGRATION,0.855791917986548
GOCC_IMMUNOGLOBULIN_COMPLEX_...,SET,3,0.72598,0.0092747,0.59988,0.11311,GOCC_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.855791917986548
REACTOME_ACTIVATION_OF_PPARG...,SET,10,0.34242,0.0079854,0.28296,0.11312,REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,0.855791917986548
GOBP_TISSUE_HOMEOSTASIS,SET,247,0.070404,0.008107,0.058187,0.11315,GOBP_TISSUE_HOMEOSTASIS,0.855791917986548
GOBP_POSITIVE_REGULATION_OF_...754,SET,37,0.15653,0.0070161,0.12937,0.11316,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.855791917986548
GOBP_VACUOLAR_TRANSPORT,SET,161,0.079194,0.0073798,0.065453,0.11316,GOBP_VACUOLAR_TRANSPORT,0.855791917986548
GOBP_SNRNA_METABOLIC_PROCESS,SET,50,0.13509,0.0070366,0.11167,0.1132,GOBP_SNRNA_METABOLIC_PROCESS,0.855791917986548
GOBP_NEGATIVE_REGULATION_OF_...696,SET,88,0.11926,0.0082325,0.098605,0.11326,GOBP_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.855791917986548
REACTOME_ANTI_INFLAMMATORY_R...,SET,74,0.12361,0.0078277,0.10221,0.11328,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,0.855791917986548
SFMBT1_TARGET_GENES,SET,1310,0.029781,0.0076624,0.024626,0.11328,SFMBT1_TARGET_GENES,0.855791917986548
E2F_Q6,SET,209,0.070851,0.0075125,0.058588,0.11328,E2F_Q6,0.855791917986548
GSE22342_CD11C_HIGH_VS_LOW_D...2,SET,174,0.078415,0.0075938,0.064849,0.1133,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP,0.855791917986548
GOBP_RECEPTOR_CLUSTERING,SET,55,0.14014,0.0076552,0.11591,0.11332,GOBP_RECEPTOR_CLUSTERING,0.855791917986548
GSE22196_HEALTHY_VS_OBESE_MO...1,SET,182,0.07663,0.007588,0.063384,0.11334,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN,0.855791917986548
KEGG_MEDICUS_REFERENCE_ELECT...3,SET,14,0.24773,0.0068348,0.20491,0.11335,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.855791917986548
REACTOME_ROLE_OF_LAT2_NTAL_L...,SET,16,0.26053,0.007684,0.21557,0.11342,REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,0.855791917986548
MORF_MSH2,SET,58,0.12065,0.0067671,0.099828,0.11342,MORF_MSH2,0.855791917986548
GOBP_ENDOCRINE_PANCREAS_DEVE...,SET,42,0.17545,0.008378,0.14517,0.11342,GOBP_ENDOCRINE_PANCREAS_DEVELOPMENT,0.855791917986548
CTGTTAC_MIR194,SET,92,0.10396,0.0073368,0.086023,0.11344,CTGTTAC_MIR194,0.855791917986548
MIR3677_5P,SET,24,0.20262,0.0073173,0.16767,0.11345,MIR3677_5P,0.855791917986548
HP_RIDGED_FINGERNAIL,SET,7,0.40409,0.007885,0.33445,0.11348,HP_RIDGED_FINGERNAIL,0.855791917986548
GOBP_REGULATION_OF_METALLOEN...,SET,4,0.59878,0.0088328,0.4956,0.11349,GOBP_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.855791917986548
GOBP_GLANDULAR_EPITHELIAL_CE...2,SET,68,0.13786,0.00837,0.11412,0.11353,GOBP_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION,0.85590784164859
GOBP_REGULATION_OF_GLIOGENES...,SET,101,0.11117,0.0082185,0.092043,0.11358,GOBP_REGULATION_OF_GLIOGENESIS,0.856099089134678
WP_GENES_TARGETED_BY_MIRNAS_...,SET,11,0.33845,0.0082778,0.28036,0.11368,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,0.856532384148982
HP_DEVIATED_NASAL_SEPTUM,SET,6,0.45347,0.0081922,0.37566,0.1137,HP_DEVIATED_NASAL_SEPTUM,0.856532384148982
GOBP_POSITIVE_REGULATION_OF_...232,SET,4,0.50469,0.0074449,0.41815,0.11373,GOBP_POSITIVE_REGULATION_OF_ENAMEL_MINERALIZATION,0.856532384148982
GOCC_NUCLEOLUS,SET,908,0.033592,0.0072799,0.027833,0.11374,GOCC_NUCLEOLUS,0.856532384148982
WP_GENE_REGULATORY_NETWORK_M...,SET,11,0.3149,0.0077017,0.26094,0.11377,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,0.856532384148982
REACTOME_MAPK3_ERK1_ACTIVATI...,SET,10,0.36825,0.0085877,0.30519,0.1138,REACTOME_MAPK3_ERK1_ACTIVATION,0.856532384148982
PID_NFKAPPAB_CANONICAL_PATHW...,SET,21,0.23607,0.0079756,0.19566,0.11381,PID_NFKAPPAB_CANONICAL_PATHWAY,0.856532384148982
GOCC_NUCLEAR_PORE_CENTRAL_TR...,SET,5,0.45386,0.0074851,0.37623,0.11385,GOCC_NUCLEAR_PORE_CENTRAL_TRANSPORT_CHANNEL,0.856647921628058
PID_HDAC_CLASSI_PATHWAY,SET,60,0.12739,0.007267,0.10562,0.1139,PID_HDAC_CLASSI_PATHWAY,0.856838636363636
GOBP_REGULATION_OF_CELL_FATE...2,SET,23,0.21153,0.0074786,0.17542,0.11395,GOBP_REGULATION_OF_CELL_FATE_SPECIFICATION,0.856959214795587
NIKOLSKY_OVERCONNECTED_IN_BR...,SET,21,0.22514,0.0076061,0.18672,0.11397,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,0.856959214795587
MIR516A_3P_MIR516B_3P,SET,160,0.081634,0.0075838,0.06771,0.11399,MIR516A_3P_MIR516B_3P,0.856959214795587
HP_ASTROCYTOMA,SET,22,0.21316,0.0073708,0.17683,0.11402,HP_ASTROCYTOMA,0.85699937283737
GOBP_CELLULAR_RESPONSE_TO_ST...3,SET,22,0.23091,0.0079844,0.1916,0.11408,GOBP_CELLULAR_RESPONSE_TO_STEROL,0.85725
REACTOME_COLLAGEN_BIOSYNTHES...,SET,65,0.13812,0.0081995,0.11465,0.11416,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,0.85725
HP_ABNORMAL_MALE_INTERNAL_GE...,SET,69,0.13231,0.0080921,0.10983,0.11416,HP_ABNORMAL_MALE_INTERNAL_GENITALIA_MORPHOLOGY,0.85725
HP_FACIAL_EDEMA,SET,122,0.10209,0.0082902,0.084753,0.1142,HP_FACIAL_EDEMA,0.85725
HP_COMPLETE_ATRIOVENTRICULAR...,SET,16,0.23867,0.0070392,0.19815,0.11421,HP_COMPLETE_ATRIOVENTRICULAR_CANAL_DEFECT,0.85725
MODULE_139,SET,74,0.12711,0.0080493,0.10554,0.11423,MODULE_139,0.85725
GOBP_LIPOXIN_METABOLIC_PROCE...,SET,5,0.49589,0.0081783,0.41177,0.11424,GOBP_LIPOXIN_METABOLIC_PROCESS,0.85725
REACTOME_IKK_COMPLEX_RECRUIT...,SET,21,0.23552,0.0079569,0.19558,0.11426,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,0.85725
SCIBETTA_KDM5B_TARGETS_UP,SET,18,0.23743,0.0074269,0.19719,0.1143,SCIBETTA_KDM5B_TARGETS_UP,0.85725
MIR548BC,SET,433,0.049956,0.0075771,0.041492,0.1143,MIR548BC,0.85725
GAVISH_3CA_METAPROGRAM_B_CEL...3,SET,48,0.15268,0.0077926,0.12683,0.11434,GAVISH_3CA_METAPROGRAM_B_CELLS_GERMINAL_CENTER,0.857255015099223
GOBP_MULTINUCLEAR_OSTEOCLAST...,SET,8,0.40683,0.0084863,0.33798,0.11435,GOBP_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION,0.857255015099223
MIR640,SET,46,0.13687,0.006839,0.11372,0.11439,MIR640,0.857369948242398
HP_FRONTOTEMPORAL_DEMENTIA,SET,51,0.143,0.0075226,0.11886,0.11449,HP_FRONTOTEMPORAL_DEMENTIA,0.857604524886878
GSE411_UNSTIM_VS_400MIN_IL6_...2,SET,183,0.074791,0.0074259,0.062168,0.11449,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.857604524886878
GOMF_SPHINGOLIPID_TRANSFER_A...,SET,7,0.35696,0.0069652,0.29673,0.1145,GOMF_SPHINGOLIPID_TRANSFER_ACTIVITY,0.857604524886878
MIR208A_5P,SET,228,0.069417,0.0076838,0.057708,0.11452,MIR208A_5P,0.857604524886878
REACTOME_NEGATIVE_REGULATION...5,SET,29,0.20132,0.0079907,0.16738,0.11455,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,0.857644388194744
HOEGERKORP_CD44_TARGETS_TEMP...1,SET,23,0.21285,0.0075252,0.177,0.11459,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,0.857759088951109
GR_01,SET,183,0.078399,0.0077842,0.065213,0.11465,GR_01,0.857953282393457
HP_BASAL_GANGLIA_GLIOSIS,SET,8,0.3888,0.00811,0.32343,0.11467,HP_BASAL_GANGLIA_GLIOSIS,0.857953282393457
REACTOME_PI_3K_CASCADE_FGFR4,SET,19,0.24624,0.0079135,0.20486,0.11469,REACTOME_PI_3K_CASCADE_FGFR4,0.857953282393457
GOBP_CELL_DIVISION,SET,577,0.042491,0.0074098,0.035356,0.11473,GOBP_CELL_DIVISION,0.858067817947063
GOBP_LIPID_DROPLET_FUSION,SET,5,0.53319,0.0087934,0.44375,0.11478,GOBP_LIPID_DROPLET_FUSION,0.858257078313253
MORF_RAB6A,SET,60,0.1368,0.0078036,0.11389,0.11486,MORF_RAB6A,0.858494800171895
GSE12845_NAIVE_VS_DARKZONE_G...2,SET,170,0.080654,0.0077212,0.067161,0.1149,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.858494800171895
GOBP_POSITIVE_REGULATION_OF_...187,SET,26,0.20833,0.0078303,0.17348,0.11491,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.858494800171895
CC2D1A_TARGET_GENES,SET,1191,0.030742,0.0075681,0.025603,0.11494,CC2D1A_TARGET_GENES,0.858494800171895
REACTOME_THROMBOXANE_SIGNALL...,SET,24,0.22803,0.0082349,0.18991,0.11495,REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR,0.858494800171895
GSE11961_PLASMA_CELL_DAY7_VS...4,SET,175,0.077803,0.007556,0.064803,0.11496,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.858494800171895
HP_CHRONIC_OTITIS_MEDIA,SET,136,0.092875,0.0079599,0.077382,0.11503,HP_CHRONIC_OTITIS_MEDIA,0.858543238892466
GOCC_RNA_POLYMERASE_III_TRAN...,SET,9,0.28485,0.0063021,0.23734,0.11504,GOCC_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATOR_COMPLEX,0.858543238892466
GAO_STOMACH_24W_C1_PROCRPOS_...,SET,37,0.152,0.0068135,0.12667,0.11507,GAO_STOMACH_24W_C1_PROCRPOS_MULTIPOTENT_PROGENITOR,0.858543238892466
REACTOME_MRNA_SPLICING,SET,191,0.067128,0.0068077,0.05594,0.11508,REACTOME_MRNA_SPLICING,0.858543238892466
GSE22886_CD8_VS_CD4_NAIVE_TC...2,SET,176,0.072811,0.0070911,0.06068,0.11509,GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP,0.858543238892466
REACTOME_KERATAN_SULFATE_KER...,SET,36,0.17738,0.007843,0.14788,0.11517,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,0.858740608919383
FAN_EMBRYONIC_CTX_BIG_GROUPS...4,SET,43,0.16663,0.0080506,0.13892,0.11518,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.858740608919383
GOMF_PROTEIN_PHOSPHATASE_1_B...,SET,23,0.20298,0.0071764,0.16924,0.1152,GOMF_PROTEIN_PHOSPHATASE_1_BINDING,0.858740608919383
HP_ABNORMAL_RESPONSE_TO_ENDO...,SET,130,0.091414,0.0076612,0.076224,0.11522,HP_ABNORMAL_RESPONSE_TO_ENDOCRINE_STIMULATION_TEST,0.858740608919383
GSE40274_CTRL_VS_FOXP3_AND_I...1,SET,148,0.08203,0.0073316,0.068405,0.11524,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.858740608919383
GOMF_VOLTAGE_GATED_CHLORIDE_...,SET,9,0.37687,0.008338,0.31432,0.11527,GOMF_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.858780032154341
GOBP_SIGNAL_TRANSDUCTION_IN_...2,SET,171,0.075099,0.0072103,0.062655,0.11535,GOBP_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE,0.85878868065967
REACTOME_ABERRANT_REGULATION...2,SET,17,0.24366,0.0074074,0.2033,0.11536,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,0.85878868065967
GOCC_GOLGI_ASSOCIATED_VESICL...,SET,52,0.13277,0.0070525,0.11078,0.11537,GOCC_GOLGI_ASSOCIATED_VESICLE_MEMBRANE,0.85878868065967
HP_SHORT_MIDDLE_PHALANX_OF_T...1,SET,7,0.40283,0.0078603,0.33611,0.11537,HP_SHORT_MIDDLE_PHALANX_OF_THE_2ND_FINGER,0.85878868065967
FONTAINE_THYROID_TUMOR_UNCER...2,SET,33,0.19069,0.0080734,0.15919,0.11548,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,0.859028864656831
RODWELL_AGING_KIDNEY_UP,SET,422,0.051979,0.0077856,0.043396,0.11551,RODWELL_AGING_KIDNEY_UP,0.859028864656831
GSE32901_NAIVE_VS_TH1_CD4_TC...2,SET,113,0.099122,0.0077485,0.082754,0.11551,GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP,0.859028864656831
IK1_01,SET,253,0.06558,0.0076414,0.054756,0.11553,IK1_01,0.859028864656831
REACTOME_DEFECTS_IN_COBALAMI...,SET,12,0.29488,0.0075326,0.24625,0.11557,REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,0.859028864656831
HP_INFECTIOUS_ENCEPHALITIS,SET,39,0.1655,0.0076159,0.13821,0.11557,HP_INFECTIOUS_ENCEPHALITIS,0.859028864656831
GOBP_REGULATION_OF_MACROPHAG...8,SET,6,0.45306,0.0081848,0.37839,0.1156,GOBP_REGULATION_OF_MACROPHAGE_PROLIFERATION,0.859028864656831
GSE3982_MAST_CELL_VS_NKCELL_...2,SET,176,0.078023,0.0075988,0.065164,0.1156,GSE3982_MAST_CELL_VS_NKCELL_UP,0.859028864656831
TGACATY_UNKNOWN,SET,613,0.04372,0.0078504,0.036527,0.11568,TGACATY_UNKNOWN,0.859185772270882
GOBP_AUTOSOME_GENOMIC_IMPRIN...,SET,5,0.43379,0.007154,0.36243,0.11569,GOBP_AUTOSOME_GENOMIC_IMPRINTING,0.859185772270882
HP_RETINAL_ARTERIOLAR_TORTUO...,SET,27,0.25469,0.0097548,0.21281,0.1157,HP_RETINAL_ARTERIOLAR_TORTUOSITY,0.859185772270882
GSE2770_UNTREATED_VS_TGFB_AN...5,SET,178,0.075177,0.0073626,0.062819,0.11572,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.859185772270882
ZIC3_01,SET,236,0.06774,0.0076269,0.056616,0.11576,ZIC3_01,0.859299188381034
MIR1265,SET,40,0.15999,0.0074561,0.13375,0.11581,MIR1265,0.859486771300448
GOBP_TRANSPORT_OF_VIRUS,SET,20,0.23129,0.0076259,0.1934,0.11587,GOBP_TRANSPORT_OF_VIRUS,0.859721145233525
GSE36009_UNSTIM_VS_LPS_STIM_...4,SET,181,0.076212,0.007526,0.063741,0.11593,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP,0.859721145233525
MATZUK_MATERNAL_EFFECT,SET,7,0.37597,0.0073362,0.31447,0.11594,MATZUK_MATERNAL_EFFECT,0.859721145233525
GOCC_INCLUSION_BODY,SET,66,0.11969,0.0071595,0.10011,0.11595,GOCC_INCLUSION_BODY,0.859721145233525
chr19q13,SET,730,0.094626,0.018481,0.079157,0.11597,chr19q13,0.859721145233525
BHATI_G2M_ARREST_BY_2METHOXY...2,SET,107,0.099361,0.0075595,0.083125,0.11599,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,0.859721145233525
GOBP_REGULATION_OF_PROTEIN_A...3,SET,34,0.17968,0.0077213,0.15035,0.11604,GOBP_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.859908358208955
GOBP_ANTIGEN_PROCESSING_AND_...2,SET,5,0.74581,0.0123,0.62423,0.1161,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_ENDOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.859958718330849
GOMF_LIPID_ANTIGEN_BINDING,SET,5,0.74581,0.0123,0.62423,0.1161,GOMF_LIPID_ANTIGEN_BINDING,0.859958718330849
GSE27786_NKCELL_VS_ERYTHROBL...2,SET,181,0.074786,0.0073852,0.062616,0.11618,GSE27786_NKCELL_VS_ERYTHROBLAST_UP,0.859958718330849
GOBP_PYRIMIDINE_CONTAINING_C...4,SET,7,0.40108,0.0078261,0.33585,0.1162,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE,0.859958718330849
KAECH_DAY8_EFF_VS_MEMORY_CD8...2,SET,183,0.072827,0.007231,0.060983,0.11621,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP,0.859958718330849
GOMF_GLYCOLIPID_MANNOSYLTRAN...,SET,5,0.37587,0.0061989,0.31476,0.11622,GOMF_GLYCOLIPID_MANNOSYLTRANSFERASE_ACTIVITY,0.859958718330849
GOMF_TAP_BINDING,SET,7,0.39363,0.0076807,0.32963,0.11622,GOMF_TAP_BINDING,0.859958718330849
GOBP_ER_NUCLEUS_SIGNALING_PA...,SET,44,0.156,0.007624,0.13068,0.1163,GOBP_ER_NUCLEUS_SIGNALING_PATHWAY,0.860258363481592
ZHENG_CORD_BLOOD_C6_HSC_MULT...,SET,81,0.12343,0.0081764,0.10341,0.11631,ZHENG_CORD_BLOOD_C6_HSC_MULTIPOTENT_PROGENITOR,0.860258363481592
GSE30971_CTRL_VS_LPS_STIM_MA...6,SET,168,0.088949,0.0084655,0.074536,0.11637,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP,0.860519010638298
GOCC_DNA_REPLICATION_PREINIT...,SET,13,0.27893,0.007416,0.23385,0.11648,GOCC_DNA_REPLICATION_PREINITIATION_COMPLEX,0.861039972352191
BLANCO_MELO_HUMAN_PARAINFLUE...1,SET,101,0.10518,0.0077758,0.08818,0.11649,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,0.861039972352191
MIR4490,SET,95,0.10277,0.0073699,0.08619,0.11656,MIR4490,0.861245853658537
GOBP_DETECTION_OF_ABIOTIC_ST...,SET,130,0.093607,0.007845,0.078506,0.11657,GOBP_DETECTION_OF_ABIOTIC_STIMULUS,0.861245853658537
HP_PULMONARY_FIBROSIS,SET,68,0.12425,0.0075441,0.10424,0.11663,HP_PULMONARY_FIBROSIS,0.861245853658537
PID_EPHA_FWDPATHWAY,SET,34,0.1866,0.0080188,0.15657,0.11668,PID_EPHA_FWDPATHWAY,0.861245853658537
GOBP_NEGATIVE_REGULATION_OF_...465,SET,312,0.056223,0.0072631,0.047177,0.11669,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,0.861245853658537
GOBP_NEGATIVE_REGULATION_OF_...380,SET,6,0.44337,0.0080098,0.37212,0.11674,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.861245853658537
WP_GLYCOSAMINOGLYCAN_DEGRADA...,SET,16,0.26975,0.0079558,0.22641,0.11675,WP_GLYCOSAMINOGLYCAN_DEGRADATION,0.861245853658537
HNF4_01_B,SET,233,0.065978,0.0073817,0.05538,0.11676,HNF4_01_B,0.861245853658537
GOBP_POSITIVE_REGULATION_OF_...572,SET,61,0.12999,0.0074767,0.10913,0.1168,GOBP_POSITIVE_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.861245853658537
GOBP_POSITIVE_REGULATION_OF_...621,SET,19,0.2223,0.0071442,0.18663,0.1168,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.861245853658537
GOMF_CARBON_CARBON_LYASE_ACT...,SET,50,0.13892,0.007236,0.11662,0.1168,GOMF_CARBON_CARBON_LYASE_ACTIVITY,0.861245853658537
MIR642A_3P_MIR642B_3P,SET,126,0.091001,0.0075091,0.076408,0.11684,MIR642A_3P_MIR642B_3P,0.861245853658537
HP_ABNORMALITY_OF_BLOOD_CIRC...,SET,334,0.057506,0.0076817,0.048285,0.11684,HP_ABNORMALITY_OF_BLOOD_CIRCULATION,0.861245853658537
HP_ABNORMAL_URINARY_NUCLEOBA...,SET,11,0.36661,0.0089665,0.30786,0.11687,HP_ABNORMAL_URINARY_NUCLEOBASE_CONCENTRATION,0.861249088403646
GOBP_TRANSMISSION_OF_NERVE_I...,SET,71,0.13198,0.0081874,0.11084,0.11689,GOBP_TRANSMISSION_OF_NERVE_IMPULSE,0.861249088403646
MIR3156_3P,SET,86,0.10377,0.0070819,0.087172,0.11695,MIR3156_3P,0.86150853115727
GLINSKY_CANCER_DEATH_UP,SET,5,0.40561,0.0066894,0.34085,0.11703,GLINSKY_CANCER_DEATH_UP,0.861732552966102
HP_SQUAMOUS_CELL_CARCINOMA_O...,SET,22,0.20023,0.0069234,0.16826,0.11703,HP_SQUAMOUS_CELL_CARCINOMA_OF_THE_SKIN,0.861732552966102
GOMF_NODAL_BINDING,SET,2,0.83937,0.0087558,0.70561,0.11712,GOMF_NODAL_BINDING,0.862212582080068
HP_VITREOUS_FLOATERS,SET,11,0.31821,0.0077827,0.26757,0.11718,HP_VITREOUS_FLOATERS,0.862471601016518
WILSON_PROTEASES_AT_TUMOR_BO...2,SET,20,0.22643,0.0074656,0.19047,0.11727,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,0.862697640710961
GOBP_SEX_DIFFERENTIATION,SET,260,0.066875,0.0078978,0.056259,0.11729,GOBP_SEX_DIFFERENTIATION,0.862697640710961
GOMF_RETINOL_BINDING,SET,14,0.29049,0.0080147,0.24438,0.11729,GOMF_RETINOL_BINDING,0.862697640710961
GOBP_INTEGRIN_MEDIATED_SIGNA...,SET,102,0.10559,0.0078444,0.088837,0.11731,GOBP_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.862697640710961
HP_PARKINSONISM,SET,125,0.09087,0.0074687,0.076469,0.11736,HP_PARKINSONISM,0.86288275862069
GOBP_POSITIVE_REGULATION_OF_...329,SET,6,0.35753,0.006459,0.30092,0.1174,GOBP_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY,0.862994289340102
GCCATNTTG_YY1_Q6,SET,385,0.050406,0.0072188,0.042433,0.11744,GCCATNTTG_YY1_Q6,0.86299677589852
REACTOME_REGULATION_OF_NFE2L...,SET,8,0.37991,0.0079246,0.31982,0.11745,REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION,0.86299677589852
GSE19941_LPS_VS_LPS_AND_IL10...4,SET,183,0.076299,0.0075757,0.064243,0.11749,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.863108211794547
WANG_CISPLATIN_RESPONSE_AND_...1,SET,207,0.070087,0.0073963,0.059023,0.11753,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,0.863113083421331
CARRILLOREIXACH_MRS3_VS_LOWE...1,SET,144,0.091468,0.0080648,0.077035,0.11755,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN,0.863113083421331
GOBP_REGULATION_OF_ISOTYPE_S...1,SET,30,0.17172,0.0069324,0.14464,0.11758,GOBP_REGULATION_OF_ISOTYPE_SWITCHING,0.863113083421331
KEGG_CYTOSOLIC_DNA_SENSING_P...,SET,45,0.15376,0.0075993,0.12952,0.11759,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,0.863113083421331
GOBP_AMYLOID_PRECURSOR_PROTE...3,SET,71,0.11877,0.0073681,0.10008,0.11766,GOBP_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS,0.863408993033566
GOCC_NONHOMOLOGOUS_END_JOINI...,SET,7,0.30504,0.0059522,0.25706,0.11768,GOCC_NONHOMOLOGOUS_END_JOINING_COMPLEX,0.863408993033566
REACTOME_INACTIVATION_OF_CDC...,SET,8,0.38288,0.0079865,0.32272,0.11774,REACTOME_INACTIVATION_OF_CDC42_AND_RAC1,0.863666884761503
GSE30971_2H_VS_4H_LPS_STIM_M...2,SET,160,0.0788,0.0073205,0.06643,0.11778,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP,0.863777991137371
CHEN_ETV5_TARGETS_TESTIS,SET,21,0.22605,0.007637,0.19062,0.11785,CHEN_ETV5_TARGETS_TESTIS,0.864109018987342
GOMF_NEUROTROPHIN_TRK_RECEPT...,SET,6,0.35599,0.0064312,0.30028,0.11792,GOMF_NEUROTROPHIN_TRK_RECEPTOR_BINDING,0.864330904681569
MODULE_58,SET,17,0.2732,0.0083052,0.23046,0.11793,MODULE_58,0.864330904681569
REACTOME_TNFS_BIND_THEIR_PHY...,SET,27,0.225,0.008618,0.18984,0.11797,REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS,0.864441777356104
GOMF_ALPHA_CATENIN_BINDING,SET,10,0.34291,0.0079967,0.28943,0.11806,GOMF_ALPHA_CATENIN_BINDING,0.864918908094435
GOBP_GALACTOSE_CATABOLIC_PRO...1,SET,6,0.40819,0.0073742,0.34464,0.11814,GOBP_GALACTOSE_CATABOLIC_PROCESS,0.864938821308725
GOBP_REGULATION_OF_PINOCYTOS...,SET,12,0.25991,0.0066394,0.21947,0.11816,GOBP_REGULATION_OF_PINOCYTOSIS,0.864938821308725
GOBP_GLYCOSYL_COMPOUND_CATAB...,SET,31,0.2039,0.0083673,0.17218,0.11817,GOBP_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS,0.864938821308725
HP_GENERALIZED_AMYOTROPHY,SET,78,0.105,0.0068256,0.088667,0.11819,HP_GENERALIZED_AMYOTROPHY,0.864938821308725
chr11q11,SET,10,0.46511,0.010846,0.39285,0.11823,chr11q11,0.864938821308725
GOMF_HYALURONONGLUCOSAMINIDA...,SET,6,0.43865,0.0079245,0.37051,0.11823,GOMF_HYALURONONGLUCOSAMINIDASE_ACTIVITY,0.864938821308725
GOBP_ISOPRENOID_TRANSPORT,SET,5,0.50262,0.0082893,0.42461,0.11827,GOBP_ISOPRENOID_TRANSPORT,0.864938821308725
chr16p12,SET,78,0.21961,0.014277,0.18554,0.11829,chr16p12,0.864938821308725
GOBP_SIGNAL_COMPLEX_ASSEMBLY,SET,8,0.32695,0.00682,0.27635,0.11839,GOBP_SIGNAL_COMPLEX_ASSEMBLY,0.864938821308725
HOEK_MONOCYTE_2011_2012_TIV_...1,SET,13,0.27362,0.0072747,0.23129,0.11841,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_DN,0.864938821308725
GOBP_DETOXIFICATION_OF_INORG...,SET,20,0.28893,0.0095264,0.24427,0.11844,GOBP_DETOXIFICATION_OF_INORGANIC_COMPOUND,0.864938821308725
GSE26928_CENTR_MEMORY_VS_CXC...1,SET,158,0.079468,0.0073367,0.067187,0.11845,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,0.864938821308725
GOBP_ISG15_PROTEIN_CONJUGATI...,SET,6,0.39911,0.0072102,0.33745,0.11847,GOBP_ISG15_PROTEIN_CONJUGATION,0.864938821308725
GOBP_REGULATION_OF_INTRACELL...2,SET,9,0.3317,0.0073385,0.28045,0.11847,GOBP_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.864938821308725
WP_17Q12_COPY_NUMBER_VARIATI...,SET,84,0.21128,0.014251,0.17868,0.11853,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,0.864938821308725
MIR6819_5P,SET,75,0.11439,0.0072924,0.096746,0.11854,MIR6819_5P,0.864938821308725
BIOCARTA_RB_PATHWAY,SET,13,0.24777,0.0065875,0.20957,0.11855,BIOCARTA_RB_PATHWAY,0.864938821308725
GOCC_CYTOPLASMIC_SIDE_OF_PLA...,SET,152,0.083662,0.007577,0.070765,0.11856,GOCC_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,0.864938821308725
GSE33425_CD161_HIGH_VS_NEG_C...1,SET,178,0.07966,0.0078017,0.067386,0.11858,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.864938821308725
HP_OLIGURIA,SET,13,0.29326,0.0077968,0.24812,0.11863,HP_OLIGURIA,0.864938821308725
GOBP_WATER_TRANSPORT,SET,25,0.23437,0.0086384,0.19831,0.11864,GOBP_WATER_TRANSPORT,0.864938821308725
GOMF_PEPTIDE_ALPHA_N_ACETYLT...,SET,6,0.34998,0.0063226,0.29613,0.11864,GOMF_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY,0.864938821308725
DR3_Q4,SET,133,0.09063,0.0076819,0.076687,0.11865,DR3_Q4,0.864938821308725
GOBP_POSTSYNAPTIC_MEMBRANE_O...,SET,36,0.16721,0.0073933,0.1415,0.11866,GOBP_POSTSYNAPTIC_MEMBRANE_ORGANIZATION,0.864938821308725
MODULE_500,SET,28,0.18813,0.0073378,0.15923,0.11871,MODULE_500,0.865050565919094
ETS2_B,SET,257,0.063814,0.0074934,0.054018,0.11874,ETS2_B,0.865050565919094
GSE9006_1MONTH_VS_4MONTH_POS...2,SET,177,0.076151,0.0074372,0.064462,0.11875,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP,0.865050565919094
KRIEG_HYPOXIA_NOT_VIA_KDM3A,SET,665,0.040577,0.0075778,0.034356,0.11879,KRIEG_HYPOXIA_NOT_VIA_KDM3A,0.865160613998324
GOBP_DETECTION_OF_STIMULUS,SET,532,0.055787,0.0093532,0.047249,0.11887,GOBP_DETECTION_OF_STIMULUS,0.865350815387832
GOBP_EPOXIDE_METABOLIC_PROCE...,SET,5,0.50791,0.0083765,0.43027,0.11892,GOBP_EPOXIDE_METABOLIC_PROCESS,0.865350815387832
WP_NCRNAS_INVOLVED_IN_STAT3_...,SET,13,0.30506,0.0081105,0.25846,0.11895,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.865350815387832
MIR6763_5P,SET,93,0.10222,0.0072531,0.086611,0.11897,MIR6763_5P,0.865350815387832
MCBRYAN_PUBERTAL_TGFB1_TARGE...1,SET,59,0.1428,0.0080781,0.12101,0.11899,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,0.865350815387832
ALCALA_APOPTOSIS,SET,80,0.10937,0.0072003,0.092683,0.119,ALCALA_APOPTOSIS,0.865350815387832
REACTOME_INNATE_IMMUNE_SYSTEM,SET,962,0.033825,0.0075336,0.028664,0.119,REACTOME_INNATE_IMMUNE_SYSTEM,0.865350815387832
GOBP_NEGATIVE_REGULATION_OF_...199,SET,17,0.22659,0.0068883,0.19203,0.11902,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.865350815387832
HP_ABNORMALITY_OF_THE_MUSCUL...2,SET,564,0.042871,0.0073942,0.036338,0.11905,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LIMBS,0.865350815387832
GSE12707_AT16L1_HYPOMORPH_VS...1,SET,114,0.095168,0.0074721,0.080674,0.11908,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN,0.865350815387832
GOBP_ESTABLISHMENT_OF_MITOTI...2,SET,40,0.15936,0.0074263,0.13509,0.11909,GOBP_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION,0.865350815387832
HP_URETHRAL_ATRESIA,SET,22,0.19549,0.0067597,0.16575,0.11912,HP_URETHRAL_ATRESIA,0.865387876254181
GSE17186_NAIVE_VS_CD21LOW_TR...3,SET,180,0.073948,0.0072824,0.062722,0.11921,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN,0.865817583878887
HOLLEMAN_PREDNISOLONE_RESIST...3,SET,9,0.34656,0.0076673,0.29398,0.11924,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,0.865817583878887
MODULE_303,SET,27,0.19488,0.0074642,0.16535,0.11929,MODULE_303,0.865817583878887
HP_ABNORMAL_GLUCOSE_HOMEOSTA...,SET,623,0.041566,0.0075222,0.035268,0.11929,HP_ABNORMAL_GLUCOSE_HOMEOSTASIS,0.865817583878887
GOBP_NEURON_FATE_COMMITMENT,SET,67,0.13977,0.0084238,0.11862,0.11934,GOBP_NEURON_FATE_COMMITMENT,0.865817583878887
GOBP_ENDOSOMAL_VESICLE_FUSION,SET,15,0.2383,0.0068051,0.20232,0.11944,GOBP_ENDOSOMAL_VESICLE_FUSION,0.865817583878887
GOBP_RESPONSE_TO_INTERLEUKIN...8,SET,6,0.41453,0.0074889,0.35194,0.11944,GOBP_RESPONSE_TO_INTERLEUKIN_3,0.865817583878887
GOBP_NEGATIVE_REGULATION_OF_...166,SET,135,0.085561,0.0073062,0.072654,0.11948,GOBP_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.865817583878887
MIR183_5P,SET,210,0.071486,0.0075978,0.060708,0.1195,MIR183_5P,0.865817583878887
GOBP_CORTICAL_CYTOSKELETON_O...,SET,51,0.13877,0.0073,0.11785,0.11951,GOBP_CORTICAL_CYTOSKELETON_ORGANIZATION,0.865817583878887
GSE339_CD4POS_VS_CD4CD8DN_DC...4,SET,187,0.070604,0.0070856,0.059963,0.11951,GSE339_CD4POS_VS_CD4CD8DN_DC_UP,0.865817583878887
GSE41978_WT_VS_BIM_KO_KLRG1_...2,SET,185,0.071127,0.0071003,0.060409,0.11952,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.865817583878887
HP_FOCAL_CORTICAL_DYSPLASIA_...,SET,5,0.49415,0.0081496,0.4197,0.11953,HP_FOCAL_CORTICAL_DYSPLASIA_TYPE_II,0.865817583878887
MORF_NF1,SET,160,0.079121,0.0073503,0.067206,0.11955,MORF_NF1,0.865817583878887
GOBP_FRUCTOSE_TRANSMEMBRANE_...,SET,9,0.33825,0.0074834,0.28734,0.11957,GOBP_FRUCTOSE_TRANSMEMBRANE_TRANSPORT,0.865817583878887
HP_OLIGODACTYLY,SET,24,0.20861,0.0075336,0.17728,0.11966,HP_OLIGODACTYLY,0.865817583878887
MURAKAMI_UV_RESPONSE_6HR_DN,SET,21,0.22548,0.0076175,0.19162,0.11967,MURAKAMI_UV_RESPONSE_6HR_DN,0.865817583878887
GOBP_SPONTANEOUS_SYNAPTIC_TR...,SET,13,0.2948,0.0078379,0.25058,0.11971,GOBP_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.865817583878887
GSE17721_0.5H_VS_8H_PAM3CSK4...1,SET,186,0.072673,0.007274,0.061796,0.1198,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN,0.865817583878887
HP_RIDGED_NAIL,SET,20,0.2011,0.0066304,0.17107,0.11989,HP_RIDGED_NAIL,0.865817583878887
GOBP_REGULATION_OF_VASCULAR_...6,SET,9,0.32766,0.0072491,0.27875,0.11992,GOBP_REGULATION_OF_VASCULAR_WOUND_HEALING,0.865817583878887
HP_CENTRALLY_NUCLEATED_SKELE...,SET,47,0.14194,0.0071686,0.12077,0.11994,HP_CENTRALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,0.865817583878887
MURAKAMI_UV_RESPONSE_1HR_DN,SET,10,0.32319,0.0075369,0.27501,0.11997,MURAKAMI_UV_RESPONSE_1HR_DN,0.865817583878887
GOBP_POSITIVE_REGULATION_OF_...545,SET,14,0.3048,0.0084093,0.25936,0.11997,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.865817583878887
GOBP_FORMATION_OF_PRIMARY_GE...,SET,118,0.098759,0.007888,0.084043,0.11999,GOBP_FORMATION_OF_PRIMARY_GERM_LAYER,0.865817583878887
GOBP_REGULATION_OF_INFLAMMAT...2,SET,39,0.16888,0.0077716,0.14374,0.12002,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.865817583878887
REACTOME_NRAGE_SIGNALS_DEATH...,SET,53,0.14468,0.0077583,0.12315,0.12004,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,0.865817583878887
GOBP_OUTER_DYNEIN_ARM_ASSEMB...,SET,15,0.23769,0.0067877,0.20232,0.12004,GOBP_OUTER_DYNEIN_ARM_ASSEMBLY,0.865817583878887
HP_GAZE_EVOKED_NYSTAGMUS,SET,53,0.12862,0.0068971,0.10952,0.12013,HP_GAZE_EVOKED_NYSTAGMUS,0.865817583878887
GOBP_EPIGENETIC_REGULATION_O...,SET,209,0.067801,0.0071892,0.057742,0.12016,GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.865817583878887
GOBP_ESTABLISHMENT_OF_PLANAR...1,SET,12,0.30208,0.0077165,0.25731,0.12021,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.865817583878887
GOBP_POSITIVE_REGULATION_OF_...400,SET,27,0.21085,0.0080757,0.17963,0.12024,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.865817583878887
MODULE_134,SET,29,0.21697,0.0086119,0.18485,0.12025,MODULE_134,0.865817583878887
HP_ABNORMAL_CIRCULATING_VITA...1,SET,17,0.24813,0.007543,0.2114,0.12026,HP_ABNORMAL_CIRCULATING_VITAMIN_A_CONCENTRATION,0.865817583878887
HP_EUNUCHOID_HABITUS,SET,21,0.23857,0.0080598,0.20329,0.1203,HP_EUNUCHOID_HABITUS,0.865817583878887
GOBP_MEMBRANE_LIPID_CATABOLI...,SET,44,0.15336,0.0074949,0.13069,0.12032,GOBP_MEMBRANE_LIPID_CATABOLIC_PROCESS,0.865817583878887
HP_ABNORMAL_BOWMAN_CAPSULE_M...,SET,9,0.32392,0.0071664,0.27604,0.12032,HP_ABNORMAL_BOWMAN_CAPSULE_MORPHOLOGY,0.865817583878887
MOTAMED_RESPONSE_TO_ANDROGEN...2,SET,4,0.59965,0.0088457,0.51113,0.12037,MOTAMED_RESPONSE_TO_ANDROGEN_UP,0.865817583878887
GSE37301_COMMON_LYMPHOID_PRO...3,SET,170,0.078093,0.007476,0.066567,0.12038,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,0.865817583878887
LI_PBMC_ZOSTAVAX_AGE_25_40_A...2,SET,7,0.40811,0.0079634,0.34796,0.12043,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_3DY_UP,0.865817583878887
WP_8Q1123_RB1CC1_COPY_NUMBER...,SET,16,0.23613,0.0069643,0.20134,0.12044,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,0.865817583878887
GSE37605_C57BL6_VS_NOD_FOXP3...4,SET,109,0.10145,0.0077894,0.086496,0.12044,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP,0.865817583878887
GSE8685_IL2_STARVED_VS_IL2_A...2,SET,183,0.073611,0.0073088,0.062769,0.12046,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP,0.865817583878887
GOBP_POST_TRANSLATIONAL_PROT...2,SET,14,0.26153,0.0072156,0.22303,0.12048,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_ENDOPLASMIC_RETICULUM_MEMBRANE,0.865817583878887
GOBP_CELLULAR_ALDEHYDE_METAB...,SET,74,0.12012,0.0076071,0.10246,0.12052,GOBP_CELLULAR_ALDEHYDE_METABOLIC_PROCESS,0.865817583878887
GOBP_NEGATIVE_REGULATION_OF_...543,SET,193,0.075578,0.0077043,0.064464,0.12053,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS,0.865817583878887
BROWNE_HCMV_INFECTION_16HR_DN,SET,77,0.11894,0.0076825,0.10148,0.1206,BROWNE_HCMV_INFECTION_16HR_DN,0.865817583878887
HP_INCREASED_JITTER_AT_SINGL...,SET,7,0.43896,0.0085653,0.37455,0.12061,HP_INCREASED_JITTER_AT_SINGLE_FIBER_EMG,0.865817583878887
GAVIN_FOXP3_TARGETS_CLUSTER_...7,SET,91,0.10116,0.0071008,0.086321,0.12062,GAVIN_FOXP3_TARGETS_CLUSTER_T7,0.865817583878887
GSE43863_NAIVE_VS_MEMORY_TH1...1,SET,140,0.083581,0.0072671,0.07132,0.12062,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN,0.865817583878887
ZNF493_TARGET_GENES,SET,6,0.40784,0.007368,0.34807,0.12066,ZNF493_TARGET_GENES,0.865817583878887
GOMF_CARGO_ADAPTOR_ACTIVITY,SET,20,0.22347,0.0073679,0.19074,0.12069,GOMF_CARGO_ADAPTOR_ACTIVITY,0.865817583878887
GSE6674_UNSTIM_VS_ANTI_IGM_S...1,SET,117,0.09557,0.0076011,0.081574,0.12069,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN,0.865817583878887
MIR5006_5P,SET,109,0.091863,0.0070536,0.078424,0.12074,MIR5006_5P,0.865817583878887
MORF_FANCG,SET,156,0.077541,0.0071137,0.066204,0.12076,MORF_FANCG,0.865817583878887
GNF2_RRM2,SET,38,0.15892,0.007219,0.13569,0.12077,GNF2_RRM2,0.865817583878887
GALI_TP53_TARGETS_APOPTOTIC_...2,SET,8,0.38311,0.0079915,0.32713,0.12078,GALI_TP53_TARGETS_APOPTOTIC_UP,0.865817583878887
GSE360_T_GONDII_VS_M_TUBERCU...3,SET,176,0.074728,0.0072778,0.063816,0.12081,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN,0.865817583878887
GOMF_HEXOSAMINIDASE_ACTIVITY,SET,12,0.28948,0.0073947,0.24722,0.12082,GOMF_HEXOSAMINIDASE_ACTIVITY,0.865817583878887
HE_LIM_SUN_FETAL_LUNG_C4_CYC...2,SET,809,0.034244,0.0070248,0.029247,0.12084,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL,0.865817583878887
BURTON_ADIPOGENESIS_PEAK_AT_...3,SET,42,0.15254,0.0072838,0.13032,0.12091,BURTON_ADIPOGENESIS_PEAK_AT_24HR,0.865817583878887
GOBP_ESTABLISHMENT_OF_PROTEI...9,SET,58,0.13123,0.0073604,0.11212,0.12092,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.865817583878887
MIR6852_3P,SET,134,0.088118,0.0074969,0.075294,0.12094,MIR6852_3P,0.865817583878887
GOMF_DNA_BINDING_TRANSCRIPTI...2,SET,1331,0.032157,0.0083346,0.027478,0.12095,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.865817583878887
REACTOME_STIMULI_SENSING_CHA...,SET,99,0.10519,0.0076998,0.089896,0.12097,REACTOME_STIMULI_SENSING_CHANNELS,0.865817583878887
GOMF_KINETOCHORE_BINDING,SET,6,0.40332,0.0072862,0.34468,0.12098,GOMF_KINETOCHORE_BINDING,0.865817583878887
KEGG_MEDICUS_VARIANT_LRP6_OV...,SET,43,0.16405,0.0079262,0.14021,0.121,KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.865817583878887
MIR548F_3P,SET,434,0.048596,0.0073792,0.041538,0.12103,MIR548F_3P,0.865817583878887
GOMF_TAU_PROTEIN_BINDING,SET,42,0.14693,0.0070158,0.1256,0.12105,GOMF_TAU_PROTEIN_BINDING,0.865817583878887
BIOCARTA_ETS_PATHWAY,SET,17,0.2601,0.0079072,0.22236,0.12106,BIOCARTA_ETS_PATHWAY,0.865817583878887
GOBP_RESPONSE_TO_ORGANIC_CYC...,SET,826,0.036781,0.0076205,0.031447,0.12109,GOBP_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.865817583878887
GOBP_DEFENSE_RESPONSE_TO_GRA...1,SET,77,0.13216,0.0085364,0.11301,0.12112,GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM,0.865817583878887
GSE26030_TH1_VS_TH17_DAY5_PO...2,SET,183,0.073384,0.0072863,0.062765,0.12117,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP,0.865817583878887
HNF4ALPHA_Q6,SET,236,0.065742,0.0074019,0.056234,0.12119,HNF4ALPHA_Q6,0.865817583878887
GOBP_DUCTUS_ARTERIOSUS_CLOSU...,SET,5,0.52551,0.0086668,0.4495,0.12119,GOBP_DUCTUS_ARTERIOSUS_CLOSURE,0.865817583878887
GOBP_PROTEIN_LOCALIZATION_TO...12,SET,95,0.096102,0.0068916,0.0822,0.12119,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME,0.865817583878887
MYAATNNNNNNNGGC_UNKNOWN,SET,103,0.099615,0.0074366,0.085214,0.12121,MYAATNNNNNNNGGC_UNKNOWN,0.865817583878887
BIOCARTA_IL22BP_PATHWAY,SET,9,0.43002,0.0095138,0.36794,0.12127,BIOCARTA_IL22BP_PATHWAY,0.865817583878887
GOBP_IRE1_MEDIATED_UNFOLDED_...,SET,20,0.23313,0.0076866,0.1995,0.12129,GOBP_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.865817583878887
MIR4529_3P,SET,43,0.15324,0.0074036,0.13117,0.12137,MIR4529_3P,0.865817583878887
HP_HYPOGONADOTROPIC_HYPOGONA...,SET,146,0.086247,0.0076567,0.073832,0.12138,HP_HYPOGONADOTROPIC_HYPOGONADISM,0.865817583878887
GOBP_POSITIVE_REGULATION_OF_...129,SET,13,0.28458,0.0075662,0.24363,0.12139,GOBP_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.865817583878887
HP_DEPRESSION,SET,380,0.053008,0.007543,0.045389,0.12144,HP_DEPRESSION,0.865817583878887
HP_METABOLIC_ALKALOSIS,SET,18,0.25918,0.0081072,0.22195,0.12146,HP_METABOLIC_ALKALOSIS,0.865817583878887
REACTOME_MITOPHAGY,SET,35,0.16305,0.0071088,0.13964,0.12147,REACTOME_MITOPHAGY,0.865817583878887
GOBP_MYOFIBROBLAST_DIFFERENT...,SET,10,0.28663,0.0066842,0.24547,0.12148,GOBP_MYOFIBROBLAST_DIFFERENTIATION,0.865817583878887
GOBP_MATERNAL_PROCESS_INVOLV...1,SET,52,0.14499,0.0077013,0.12418,0.1215,GOBP_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,0.865817583878887
MIR122_3P,SET,8,0.33404,0.0069679,0.28616,0.12155,MIR122_3P,0.865817583878887
HP_ABNORMALITY_OF_THE_MUSCUL...5,SET,243,0.063361,0.0072374,0.05428,0.12155,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_LIMBS,0.865817583878887
GOBP_MEMBRANE_INVAGINATION,SET,65,0.12789,0.0075925,0.10957,0.12157,GOBP_MEMBRANE_INVAGINATION,0.865817583878887
CHICAS_RB1_TARGETS_GROWING,SET,221,0.069105,0.0075323,0.059214,0.12161,CHICAS_RB1_TARGETS_GROWING,0.865817583878887
MIR4492,SET,388,0.051428,0.0073932,0.044068,0.12161,MIR4492,0.865817583878887
GOBP_SELF_PROTEOLYSIS,SET,12,0.30406,0.0077671,0.26055,0.12161,GOBP_SELF_PROTEOLYSIS,0.865817583878887
MODULE_131,SET,31,0.1929,0.007916,0.1653,0.12162,MODULE_131,0.865817583878887
KEGG_BASAL_TRANSCRIPTION_FAC...,SET,31,0.16024,0.0065756,0.13732,0.12163,KEGG_BASAL_TRANSCRIPTION_FACTORS,0.865817583878887
MIR548E_3P,SET,433,0.048413,0.0073431,0.041495,0.12167,MIR548E_3P,0.865817583878887
GOBP_RESPONSE_TO_OSMOTIC_STR...,SET,79,0.11254,0.0073625,0.096462,0.12168,GOBP_RESPONSE_TO_OSMOTIC_STRESS,0.865817583878887
HP_DYSPHAGIA,SET,466,0.046681,0.0073384,0.040015,0.1217,HP_DYSPHAGIA,0.865817583878887
GOBP_REGULATION_OF_MIRNA_TRA...,SET,72,0.11951,0.0074659,0.10245,0.12171,GOBP_REGULATION_OF_MIRNA_TRANSCRIPTION,0.865817583878887
GSE10240_IL22_VS_IL17_STIM_P...2,SET,171,0.073288,0.0070365,0.062828,0.12171,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.865817583878887
chr2q12,SET,24,0.34093,0.012312,0.29227,0.12172,chr2q12,0.865817583878887
REACTOME_SIGNALING_BY_NUCLEA...,SET,229,0.067899,0.007532,0.058216,0.12175,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,0.865817583878887
GOCC_PROTON_TRANSPORTING_TWO...3,SET,10,0.29047,0.0067738,0.24907,0.12177,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN,0.865817583878887
GOCC_PROTON_TRANSPORTING_V_T...2,SET,10,0.29047,0.0067738,0.24907,0.12177,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,0.865817583878887
GSE3039_ALPHABETA_CD8_TCELL_...3,SET,184,0.07136,0.0071044,0.061196,0.1218,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN,0.865853753323788
GOMF_PROCOLLAGEN_PROLINE_4_D...,SET,5,0.33826,0.0055786,0.29019,0.12189,GOMF_PROCOLLAGEN_PROLINE_4_DIOXYGENASE_ACTIVITY,0.865972851323829
GOMF_PRERIBOSOME_BINDING,SET,6,0.44937,0.0081182,0.38569,0.122,GOMF_PRERIBOSOME_BINDING,0.865972851323829
HP_DECREASED_LDL_CHOLESTEROL...,SET,13,0.27403,0.0072856,0.23526,0.12206,HP_DECREASED_LDL_CHOLESTEROL_CONCENTRATION,0.865972851323829
GSE3982_EOSINOPHIL_VS_DC_UP,SET,174,0.077865,0.0075405,0.066848,0.12206,GSE3982_EOSINOPHIL_VS_DC_UP,0.865972851323829
GSE28783_ANTI_MIR33_VS_UNTRE...1,SET,177,0.077251,0.0075447,0.066324,0.12207,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,0.865972851323829
MIR5703,SET,150,0.081636,0.0073451,0.070092,0.12208,MIR5703,0.865972851323829
GOMF_RNA_POLYMERASE_II_C_TER...,SET,10,0.27043,0.0063066,0.23219,0.12208,GOMF_RNA_POLYMERASE_II_C_TERMINAL_DOMAIN_BINDING,0.865972851323829
GSE37301_COMMON_LYMPHOID_PRO...8,SET,166,0.077264,0.0073099,0.066345,0.1221,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.865972851323829
REACTOME_GABA_RECEPTOR_ACTIV...,SET,57,0.148,0.0082294,0.12709,0.12211,REACTOME_GABA_RECEPTOR_ACTIVATION,0.865972851323829
MODULE_354,SET,17,0.27308,0.0083016,0.23452,0.12213,MODULE_354,0.865972851323829
DESCARTES_MAIN_FETAL_IGFBP1_...,SET,128,0.091358,0.0075977,0.078465,0.12216,DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS,0.865972851323829
KEGG_MEDICUS_VARIANT_MUTATIO...18,SET,17,0.22732,0.0069107,0.19528,0.1222,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.865972851323829
NAKAMURA_ALVEOLAR_EPITHELIUM,SET,5,0.4671,0.0077034,0.40126,0.12221,NAKAMURA_ALVEOLAR_EPITHELIUM,0.865972851323829
REACTOME_RHOT1_GTPASE_CYCLE,SET,5,0.43685,0.0072045,0.37532,0.12223,REACTOME_RHOT1_GTPASE_CYCLE,0.865972851323829
GOBP_SNRNA_TRANSCRIPTION,SET,20,0.20796,0.0068566,0.17867,0.12223,GOBP_SNRNA_TRANSCRIPTION,0.865972851323829
MIR513A_5P,SET,346,0.0549,0.0074616,0.047171,0.12225,MIR513A_5P,0.865972851323829
GOMF_NUCLEOSIDE_DIPHOSPHATE_...1,SET,17,0.23178,0.0070462,0.19915,0.12225,GOMF_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY,0.865972851323829
GOBP_REGULATION_OF_ALDOSTERO...,SET,8,0.39588,0.0082579,0.34017,0.12227,GOBP_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS,0.865972851323829
REACTOME_SARS_COV_2_ACTIVATE...,SET,111,0.094066,0.0072884,0.080844,0.12231,REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,0.865972851323829
MIR4267,SET,203,0.06874,0.0071845,0.05908,0.12232,MIR4267,0.865972851323829
KEGG_MEDICUS_VARIANT_FUS_DDI...,SET,5,0.51433,0.0084824,0.4421,0.12234,KEGG_MEDICUS_VARIANT_FUS_DDIT3_FUSION_TO_NFKB_MEDIATED_TRANSCRIPTION,0.865972851323829
GOMF_ABC_TYPE_GLUTATHIONE_S_...,SET,8,0.38306,0.0079905,0.32931,0.12238,GOMF_ABC_TYPE_GLUTATHIONE_S_CONJUGATE_TRANSPORTER_ACTIVITY,0.866079596823458
GOCC_PRESYNAPSE,SET,524,0.045512,0.0075747,0.039132,0.12241,GOCC_PRESYNAPSE,0.866115543566775
GOBP_NUCLEAR_MEMBRANE_REASSE...,SET,25,0.19198,0.0070757,0.1651,0.12246,GOBP_NUCLEAR_MEMBRANE_REASSEMBLY,0.866187393162393
GOBP_REGULATION_OF_SOMITOGEN...,SET,6,0.4509,0.0081459,0.38779,0.12247,GOBP_REGULATION_OF_SOMITOGENESIS,0.866187393162393
GSE9988_LOW_LPS_VS_ANTI_TREM...1,SET,171,0.077561,0.0074467,0.066732,0.12257,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.866718280773143
ZNF419_TARGET_GENES,SET,5,0.42549,0.0070173,0.36623,0.12266,ZNF419_TARGET_GENES,0.867073307582842
HP_RENAL_CELL_CARCINOMA,SET,70,0.11919,0.007342,0.1026,0.12269,HP_RENAL_CELL_CARCINOMA,0.867073307582842
GSE360_L_MAJOR_VS_B_MALAYI_L...1,SET,178,0.072545,0.0071049,0.062454,0.12271,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN,0.867073307582842
GOBP_POSITIVE_REGULATION_OF_...825,SET,6,0.43529,0.0078638,0.37475,0.12272,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.867073307582842
KEGG_MEDICUS_REFERENCE_CXCR_...1,SET,27,0.20055,0.0076814,0.17271,0.12279,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY,0.867391554878049
SALL4_TARGET_GENES,SET,1444,0.026991,0.0072625,0.023256,0.12291,SALL4_TARGET_GENES,0.867605024360536
GOBP_CYTOSOL_TO_ENDOPLASMIC_...,SET,4,0.45773,0.0067522,0.39441,0.12292,GOBP_CYTOSOL_TO_ENDOPLASMIC_RETICULUM_TRANSPORT,0.867605024360536
HP_HYPERCHLOREMIC_ACIDOSIS,SET,13,0.27199,0.0072314,0.23436,0.12292,HP_HYPERCHLOREMIC_ACIDOSIS,0.867605024360536
PATIL_LIVER_CANCER,SET,585,0.040759,0.0071553,0.035122,0.12294,PATIL_LIVER_CANCER,0.867605024360536
MIR6757_3P,SET,96,0.099104,0.007144,0.085408,0.12296,MIR6757_3P,0.867605024360536
MORF_BUB1B,SET,56,0.12797,0.0070531,0.11029,0.12297,MORF_BUB1B,0.867605024360536
GOCC_NEUROTRANSMITTER_RECEPT...,SET,43,0.16161,0.0078083,0.13931,0.12302,GOCC_NEUROTRANSMITTER_RECEPTOR_COMPLEX,0.867713919821826
GSE4748_CTRL_VS_LPS_AND_CYAN...2,SET,180,0.07431,0.0073181,0.064068,0.12306,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.867713919821826
GOBP_LIPOPROTEIN_CATABOLIC_P...,SET,15,0.26071,0.0074451,0.22478,0.12307,GOBP_LIPOPROTEIN_CATABOLIC_PROCESS,0.867713919821826
REACTOME_TRANSPORT_OF_NUCLEO...2,SET,8,0.32578,0.0067956,0.28093,0.1231,REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS,0.867713919821826
GOBP_CELL_CELL_SIGNALING_INV...,SET,30,0.20084,0.0081078,0.17323,0.12316,GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION,0.867713919821826
HP_ABNORMAL_BLISTERING_OF_TH...,SET,103,0.10091,0.0075335,0.08705,0.12318,HP_ABNORMAL_BLISTERING_OF_THE_SKIN,0.867713919821826
GOBP_NEGATIVE_REGULATION_OF_...75,SET,47,0.13651,0.0068947,0.11777,0.1232,GOBP_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,0.867713919821826
GOBP_CELLULAR_RESPONSE_TO_GL...1,SET,12,0.29718,0.0075914,0.25642,0.12325,GOBP_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS,0.867713919821826
GOBP_MEMBRANE_FISSION,SET,44,0.13962,0.0068235,0.12048,0.12326,GOBP_MEMBRANE_FISSION,0.867713919821826
REACTOME_INWARDLY_RECTIFYING...,SET,35,0.19079,0.0083183,0.16465,0.12328,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,0.867713919821826
MIR412_5P,SET,5,0.43398,0.0071573,0.37452,0.12328,MIR412_5P,0.867713919821826
MIR4804_5P,SET,8,0.37332,0.0077873,0.32219,0.1233,MIR4804_5P,0.867713919821826
GOBP_STORE_OPERATED_CALCIUM_...,SET,20,0.23065,0.0076048,0.19907,0.12331,GOBP_STORE_OPERATED_CALCIUM_ENTRY,0.867713919821826
GOMF_NARROW_PORE_CHANNEL_ACT...,SET,19,0.24415,0.0078461,0.21076,0.12336,GOMF_NARROW_PORE_CHANNEL_ACTIVITY,0.867784729811779
HP_FOCAL_SEGMENTAL_GLOMERULO...,SET,51,0.13881,0.007302,0.11983,0.12337,HP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS,0.867784729811779
MIR1224_3P,SET,63,0.1248,0.0072943,0.10775,0.1234,MIR1224_3P,0.867820113314448
GOBP_NEUROMUSCULAR_PROCESS,SET,153,0.082617,0.0075067,0.071364,0.1235,GOBP_NEUROMUSCULAR_PROCESS,0.867928474884002
HP_HYPOPLASTIC_SPLEEN,SET,8,0.36744,0.0076646,0.31739,0.1235,HP_HYPOPLASTIC_SPLEEN,0.867928474884002
GOBP_POSITIVE_CHEMOTAXIS,SET,60,0.13641,0.0077816,0.11784,0.12353,GOBP_POSITIVE_CHEMOTAXIS,0.867928474884002
SHIN_B_CELL_LYMPHOMA_CLUSTER...5,SET,10,0.36653,0.0085475,0.31665,0.12354,SHIN_B_CELL_LYMPHOMA_CLUSTER_6,0.867928474884002
GOBP_LATE_ENDOSOME_TO_VACUOL...2,SET,26,0.18102,0.006804,0.1564,0.12355,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.867928474884002
HP_APLASIA_HYPOPLASIA_OF_THE...71,SET,36,0.17457,0.0077186,0.15084,0.12359,HP_APLASIA_HYPOPLASIA_OF_THE_THYMUS,0.867928474884002
MIR141_5P,SET,91,0.10615,0.007451,0.091746,0.12365,MIR141_5P,0.867928474884002
GOBP_REGULATION_OF_CELL_PROJ...2,SET,615,0.041261,0.0074205,0.035666,0.12367,GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.867928474884002
WP_AMINO_ACID_METABOLISM_PAT...,SET,6,0.42038,0.0075944,0.3634,0.12369,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,0.867928474884002
GOBP_RESPONSE_TO_STILBENOID,SET,7,0.48233,0.0094116,0.41697,0.12369,GOBP_RESPONSE_TO_STILBENOID,0.867928474884002
GOBP_PANCREAS_DEVELOPMENT,SET,74,0.12415,0.007862,0.10735,0.12374,GOBP_PANCREAS_DEVELOPMENT,0.867928474884002
HP_PULMONARY_ARTERY_ATRESIA,SET,29,0.18884,0.0074957,0.16328,0.12374,HP_PULMONARY_ARTERY_ATRESIA,0.867928474884002
MIR541_5P,SET,113,0.092771,0.0072521,0.080226,0.12377,MIR541_5P,0.867928474884002
GSE17721_CTRL_VS_LPS_12H_BMD...2,SET,173,0.071878,0.0069409,0.062159,0.12377,GSE17721_CTRL_VS_LPS_12H_BMDC_UP,0.867928474884002
GOCC_PRERIBOSOME_LARGE_SUBUN...,SET,18,0.205,0.0064126,0.17729,0.12379,GOCC_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR,0.867928474884002
GOMF_MANNOSIDASE_ACTIVITY,SET,15,0.27141,0.0077508,0.23475,0.12382,GOMF_MANNOSIDASE_ACTIVITY,0.86792885662432
GSE22443_NAIVE_VS_ACT_AND_IL...1,SET,185,0.073173,0.0073045,0.063297,0.12384,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN,0.86792885662432
HP_DECREASED_AMPLITUDE_OF_SE...,SET,24,0.20218,0.0073016,0.17495,0.12391,HP_DECREASED_AMPLITUDE_OF_SENSORY_ACTION_POTENTIALS,0.868209463817779
TARTE_PLASMA_CELL_VS_B_LYMPH...2,SET,75,0.11369,0.0072481,0.098382,0.12393,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,0.868209463817779
GOBP_REGULATION_OF_G2_MI_TRA...,SET,4,0.44777,0.0066053,0.38752,0.12396,GOBP_REGULATION_OF_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.868244619105199
GSE29164_CD8_TCELL_VS_CD8_TC...1,SET,184,0.074795,0.0074464,0.064748,0.12402,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,0.86828
ZNF622_TARGET_GENES,SET,55,0.13274,0.0072509,0.11492,0.12404,ZNF622_TARGET_GENES,0.86828
HP_DELUSION,SET,28,0.20382,0.0079497,0.17646,0.12404,HP_DELUSION,0.86828
GOMF_IONOTROPIC_GLUTAMATE_RE...,SET,23,0.20594,0.0072807,0.17831,0.12407,GOMF_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING,0.868315112766814
KEGG_MEDICUS_VARIANT_TEL_AML...,SET,10,0.31759,0.0074063,0.27506,0.12413,KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION,0.868350422620246
MIR9718,SET,95,0.10743,0.0077041,0.093051,0.12415,MIR9718,0.868350422620246
GOMF_PHOSPHATIDYLINOSITOL_3_...9,SET,6,0.46777,0.0084505,0.40515,0.12415,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVATOR_ACTIVITY,0.868350422620246
GSE6674_ANTI_IGM_VS_CPG_STIM...2,SET,180,0.074664,0.007353,0.064701,0.12426,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP,0.868944929577465
HP_URETHRAL_STENOSIS,SET,49,0.15607,0.0080478,0.13527,0.1243,HP_URETHRAL_STENOSIS,0.86901474668275
GOBP_REGULATION_OF_CHONDROCY...1,SET,4,0.61667,0.0090967,0.53453,0.12433,GOBP_REGULATION_OF_CHONDROCYTE_DEVELOPMENT,0.86901474668275
HP_PRIMARY_HYPERCORTISOLISM,SET,9,0.30604,0.0067709,0.2653,0.12435,HP_PRIMARY_HYPERCORTISOLISM,0.86901474668275
REACTOME_IRE1ALPHA_ACTIVATES...,SET,47,0.13369,0.0067524,0.11591,0.12437,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,0.86901474668275
GOBP_RRNA_5_END_PROCESSING,SET,5,0.42282,0.0069732,0.36664,0.12441,GOBP_RRNA_5_END_PROCESSING,0.869047224975223
GSE15930_STIM_VS_STIM_AND_IF...6,SET,171,0.075021,0.0072028,0.065111,0.12463,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP,0.869047224975223
GOBP_DETOXIFICATION,SET,130,0.091606,0.0076772,0.079509,0.12464,GOBP_DETOXIFICATION,0.869047224975223
GOBP_INTRINSIC_APOPTOTIC_SIG...5,SET,58,0.12294,0.0068958,0.10674,0.12471,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.869047224975223
RADAEVA_RESPONSE_TO_IFNA1_DN,SET,10,0.37126,0.0086578,0.32234,0.12472,RADAEVA_RESPONSE_TO_IFNA1_DN,0.869047224975223
HP_POSITIVE_ROMBERG_SIGN,SET,26,0.18071,0.0067922,0.1569,0.12472,HP_POSITIVE_ROMBERG_SIGN,0.869047224975223
GOBP_REGULATION_OF_PLATELET_...4,SET,8,0.35401,0.0073844,0.30738,0.12473,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,0.869047224975223
GSE36476_YOUNG_VS_OLD_DONOR_...1,SET,166,0.078238,0.0074021,0.067934,0.12473,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN,0.869047224975223
HP_CORONARY_ARTERY_STENOSIS,SET,6,0.37798,0.0068284,0.32823,0.12476,HP_CORONARY_ARTERY_STENOSIS,0.869047224975223
GSE36826_WT_VS_IL1R_KO_SKIN_...2,SET,176,0.077887,0.0075854,0.067649,0.12481,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN,0.869047224975223
MARTORIATI_MDM4_TARGETS_FETA...1,SET,467,0.045408,0.0071459,0.039442,0.12482,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,0.869047224975223
KEGG_MEDICUS_REFERENCE_WNT_S...4,SET,27,0.20565,0.0078766,0.17867,0.12487,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR,0.869047224975223
GSE39820_CTRL_VS_TGFBETA1_IL...4,SET,172,0.074337,0.0071578,0.064587,0.12488,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP,0.869047224975223
HOLLEMAN_DAUNORUBICIN_B_ALL_...2,SET,10,0.31135,0.0072607,0.27053,0.1249,HOLLEMAN_DAUNORUBICIN_B_ALL_UP,0.869047224975223
KAT5_TARGET_GENES,SET,709,0.036659,0.0070601,0.031855,0.12491,KAT5_TARGET_GENES,0.869047224975223
GSE19888_ADENOSINE_A3R_INH_V...8,SET,183,0.074325,0.0073797,0.064603,0.12498,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.869047224975223
BOYAULT_LIVER_CANCER_SUBCLAS...5,SET,37,0.16737,0.0075025,0.14552,0.12504,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,0.869047224975223
GOMF_PROTEIN_TYROSINE_SERINE...,SET,22,0.21421,0.0074071,0.18628,0.12509,GOMF_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.869047224975223
HP_ABNORMALITY_OF_THE_UTERUS,SET,225,0.06612,0.0072711,0.057503,0.12511,HP_ABNORMALITY_OF_THE_UTERUS,0.869047224975223
GOMF_TRANSCRIPTION_ELONGATIO...,SET,7,0.38647,0.0075411,0.33614,0.12513,GOMF_TRANSCRIPTION_ELONGATION_FACTOR_ACTIVITY,0.869047224975223
MODULE_254,SET,59,0.1282,0.0072521,0.11151,0.12516,MODULE_254,0.869047224975223
DITTMER_PTHLH_TARGETS_DN,SET,69,0.1222,0.0074735,0.10631,0.12519,DITTMER_PTHLH_TARGETS_DN,0.869047224975223
MIR3679_5P,SET,71,0.11454,0.0071056,0.099649,0.12519,MIR3679_5P,0.869047224975223
MIR4465,SET,395,0.050888,0.0073799,0.044272,0.1252,MIR4465,0.869047224975223
XU_CREBBP_TARGETS_UP,SET,20,0.21105,0.0069585,0.18362,0.12521,XU_CREBBP_TARGETS_UP,0.869047224975223
KEGG_MEDICUS_REFERENCE_ACTIV...3,SET,8,0.36637,0.0076423,0.31875,0.12521,KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY,0.869047224975223
REACTOME_REGULATION_OF_INSUL...1,SET,116,0.10077,0.0079802,0.08767,0.12521,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,0.869047224975223
ZHU_CMV_8_HR_DN,SET,45,0.16612,0.0082102,0.14454,0.12522,ZHU_CMV_8_HR_DN,0.869047224975223
BROWNE_HCMV_INFECTION_6HR_UP,SET,57,0.1287,0.0071565,0.11201,0.12528,BROWNE_HCMV_INFECTION_6HR_UP,0.869047224975223
GSE5589_WT_VS_IL10_KO_LPS_AN...2,SET,140,0.079675,0.0069275,0.069342,0.12528,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.869047224975223
HOFMANN_MYELODYSPLASTIC_SYND...4,SET,20,0.21817,0.0071931,0.18987,0.12529,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,0.869047224975223
GOBP_VENTRAL_SPINAL_CORD_DEV...,SET,44,0.15853,0.0077476,0.13799,0.12531,GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT,0.869047224975223
GOBP_DEVELOPMENT_OF_PRIMARY_...1,SET,101,0.10451,0.0077261,0.090966,0.12532,GOBP_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS,0.869047224975223
BOYAULT_LIVER_CANCER_SUBCLAS...1,SET,45,0.15105,0.0074652,0.13152,0.12539,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,0.869047224975223
MODULE_363,SET,41,0.14293,0.0067435,0.12446,0.12541,MODULE_363,0.869047224975223
GSE2770_IL12_VS_IL4_TREATED_...6,SET,182,0.070745,0.0070052,0.061616,0.12546,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.869047224975223
REACTOME_SYNTHESIS_OF_PE,SET,12,0.28463,0.0072708,0.24792,0.12547,REACTOME_SYNTHESIS_OF_PE,0.869047224975223
GOBP_ANTIGEN_PROCESSING_AND_...14,SET,24,0.2522,0.009108,0.21969,0.1255,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB,0.869047224975223
HP_ABNORMAL_CIRCULATING_C_PE...,SET,26,0.2076,0.0078029,0.18088,0.12554,HP_ABNORMAL_CIRCULATING_C_PEPTIDE_CONCENTRATION,0.869047224975223
HP_EUTHYROID_GOITER,SET,4,0.50588,0.0074625,0.44078,0.12555,HP_EUTHYROID_GOITER,0.869047224975223
MIR4434,SET,148,0.08103,0.0072422,0.070605,0.12556,MIR4434,0.869047224975223
HP_MEDIAN_CLEFT_PALATE,SET,24,0.21395,0.0077266,0.18642,0.12556,HP_MEDIAN_CLEFT_PALATE,0.869047224975223
HP_RENAL_MALROTATION,SET,6,0.41838,0.0075583,0.36458,0.12559,HP_RENAL_MALROTATION,0.869047224975223
SERVITJA_ISLET_HNF1A_TARGETS...2,SET,155,0.085447,0.007814,0.07447,0.12561,SERVITJA_ISLET_HNF1A_TARGETS_UP,0.869047224975223
MIR8055,SET,64,0.1246,0.0073402,0.1086,0.12562,MIR8055,0.869047224975223
MIR16_1_3P,SET,173,0.075341,0.0072753,0.065668,0.12564,MIR16_1_3P,0.869047224975223
GSE25123_CTRL_VS_IL4_AND_ROS...1,SET,172,0.072865,0.0070161,0.063513,0.12565,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.869047224975223
HP_MELANOCYTIC_NEVUS,SET,64,0.11401,0.0067164,0.099399,0.12569,HP_MELANOCYTIC_NEVUS,0.869047224975223
AFP1_Q6,SET,237,0.068012,0.0076735,0.059298,0.12571,AFP1_Q6,0.869047224975223
HP_PROSTATE_CANCER,SET,32,0.18093,0.0075431,0.15775,0.12572,HP_PROSTATE_CANCER,0.869047224975223
GOBP_NEGATIVE_REGULATION_OF_...648,SET,89,0.10453,0.0072567,0.091145,0.12573,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.869047224975223
MIR6803_5P,SET,52,0.13864,0.007364,0.12089,0.12575,MIR6803_5P,0.869047224975223
HP_AORTIC_TORTUOSITY,SET,6,0.45814,0.0082767,0.39958,0.12579,HP_AORTIC_TORTUOSITY,0.869047224975223
GOBP_NEGATIVE_REGULATION_OF_...578,SET,7,0.40503,0.0079033,0.35329,0.12581,GOBP_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.869047224975223
MORF_JAK3,SET,90,0.10401,0.0072604,0.090726,0.12583,MORF_JAK3,0.869047224975223
GOBP_NEURONAL_ACTION_POTENTI...1,SET,33,0.18542,0.0078502,0.16175,0.12583,GOBP_NEURONAL_ACTION_POTENTIAL,0.869047224975223
ZHENG_CORD_BLOOD_C7_PUTATIVE...,SET,81,0.1121,0.0074256,0.097785,0.12583,ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1,0.869047224975223
REACTOME_CELLULAR_RESPONSE_T...5,SET,140,0.081545,0.0070901,0.071156,0.1259,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,0.869047224975223
HP_LOSS_OF_PURKINJE_CELLS_IN...,SET,5,0.44843,0.0073956,0.39131,0.12591,HP_LOSS_OF_PURKINJE_CELLS_IN_THE_CEREBELLAR_VERMIS,0.869047224975223
GSE3720_UNSTIM_VS_PMA_STIM_V...4,SET,148,0.07807,0.0069777,0.068139,0.12596,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,0.869047224975223
DESCARTES_FETAL_LUNG_CSH1_CS...,SET,180,0.073328,0.0072214,0.064,0.12596,DESCARTES_FETAL_LUNG_CSH1_CSH2_POSITIVE_CELLS,0.869047224975223
GOBP_POSITIVE_REGULATION_OF_...29,SET,33,0.187,0.007917,0.16323,0.12598,GOBP_POSITIVE_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.869047224975223
HP_PREGNANCY_EXPOSURE,SET,5,0.45614,0.0075227,0.39819,0.126,HP_PREGNANCY_EXPOSURE,0.869047224975223
GOBP_POSITIVE_REGULATION_OF_...355,SET,11,0.28414,0.0069493,0.24807,0.12603,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.869047224975223
GRAESSMANN_RESPONSE_TO_MC_AN...3,SET,76,0.11405,0.0073187,0.099582,0.12606,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,0.869047224975223
YAP1_DN,SET,37,0.17832,0.0079929,0.1557,0.12606,YAP1_DN,0.869047224975223
GOBP_SINGLE_STRAND_BREAK_REP...,SET,11,0.27671,0.0067677,0.24168,0.12613,GOBP_SINGLE_STRAND_BREAK_REPAIR,0.869047224975223
GSE24634_TEFF_VS_TCONV_DAY10...1,SET,186,0.074188,0.0074256,0.064798,0.12613,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN,0.869047224975223
REACTOME_REGULATED_PROTEOLYS...,SET,10,0.28473,0.00664,0.2487,0.12614,REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,0.869047224975223
GGTAACC_MIR4095P,SET,28,0.19205,0.0074905,0.16775,0.12614,GGTAACC_MIR4095P,0.869047224975223
PID_P73PATHWAY,SET,76,0.10538,0.0067625,0.092047,0.12615,PID_P73PATHWAY,0.869047224975223
REACTOME_RNA_POLYMERASE_II_P...,SET,72,0.098344,0.0061434,0.085931,0.12622,REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,0.869322607489598
KEGG_MEDICUS_VARIANT_MUTATIO...53,SET,5,0.44071,0.0072683,0.38511,0.12624,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.869322607489598
GOLDRATH_NAIVE_VS_EFF_CD8_TC...1,SET,180,0.073132,0.0072021,0.063923,0.12631,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN,0.869459869332805
GOBP_DE_NOVO_PYRIMIDINE_NUCL...,SET,6,0.39937,0.0072149,0.34913,0.12634,GOBP_DE_NOVO_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.869459869332805
GSE12845_IGD_POS_BLOOD_VS_PR...2,SET,170,0.074584,0.0071401,0.065203,0.12634,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.869459869332805
GSE29615_CTRL_VS_LAIV_FLU_VA...2,SET,175,0.076371,0.0074168,0.066769,0.12636,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP,0.869459869332805
REACTOME_CONSTITUTIVE_SIGNAL...3,SET,15,0.22865,0.0065298,0.19998,0.12645,REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,0.869906918052257
COLE_BLOOD_FLUMIST_QUADRIVAL...,SET,5,0.51786,0.0085406,0.45305,0.12651,COLE_BLOOD_FLUMIST_QUADRIVALENT_AGE_03_17YO_7DY_UP,0.870146943620178
GOBP_PHAGOCYTOSIS,SET,221,0.069773,0.0076052,0.061052,0.12656,GOBP_PHAGOCYTOSIS,0.870146943620178
HP_APLASIA_HYPOPLASIA_OF_THE...69,SET,6,0.40993,0.0074058,0.3587,0.12656,HP_APLASIA_HYPOPLASIA_OF_THE_SWEAT_GLANDS,0.870146943620178
MIR6808_5P,SET,164,0.076518,0.0071959,0.066968,0.12661,MIR6808_5P,0.870317401185771
GOBP_POSTSYNAPTIC_MEMBRANE_A...,SET,7,0.35096,0.0068481,0.30723,0.12666,GOBP_POSTSYNAPTIC_MEMBRANE_ASSEMBLY,0.870317401185771
HP_FAVORABLE_RESPONSE_OF_WEA...,SET,4,0.52238,0.0077058,0.4573,0.12667,HP_FAVORABLE_RESPONSE_OF_WEAKNESS_TO_ACETYLCHOLINE_ESTERASE_INHIBITORS,0.870317401185771
LFA1_Q6,SET,237,0.064279,0.0072523,0.056279,0.1267,LFA1_Q6,0.870317401185771
BUSSLINGER_DUODENAL_EC_CELLS,SET,27,0.21498,0.0082341,0.18823,0.12671,BUSSLINGER_DUODENAL_EC_CELLS,0.870317401185771
HP_PANCREATIC_APLASIA,SET,6,0.38932,0.0070333,0.34094,0.12676,HP_PANCREATIC_APLASIA,0.870347959787108
GSE5542_IFNA_VS_IFNA_AND_IFN...4,SET,178,0.069788,0.0068349,0.061121,0.12678,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.870347959787108
KEGG_MEDICUS_REFERENCE_BCR_P...1,SET,16,0.23781,0.0070137,0.20836,0.12687,KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.870347959787108
REACTOME_CLASS_C_3_METABOTRO...,SET,37,0.19209,0.0086104,0.16833,0.12691,REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS,0.870347959787108
GOBP_REGULATION_OF_HIGH_DENS...,SET,4,0.46643,0.0068805,0.40877,0.12693,GOBP_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.870347959787108
LUI_THYROID_CANCER_CLUSTER_2,SET,43,0.14948,0.007222,0.13102,0.12697,LUI_THYROID_CANCER_CLUSTER_2,0.870347959787108
MODULE_196,SET,22,0.21175,0.007322,0.18561,0.12697,MODULE_196,0.870347959787108
GSE21063_WT_VS_NFATC1_KO_8H_...1,SET,180,0.071066,0.0069986,0.062294,0.12698,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN,0.870347959787108
GOBP_DUMP_METABOLIC_PROCESS,SET,7,0.40198,0.0078437,0.35238,0.12699,GOBP_DUMP_METABOLIC_PROCESS,0.870347959787108
CEBALLOS_TARGETS_OF_TP53_AND...2,SET,18,0.2549,0.0079735,0.22346,0.127,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,0.870347959787108
GOBP_APICAL_JUNCTION_ASSEMBLY,SET,71,0.12109,0.007512,0.10616,0.12701,GOBP_APICAL_JUNCTION_ASSEMBLY,0.870347959787108
REACTOME_HDR_THROUGH_HOMOLOG...,SET,64,0.11256,0.006631,0.098689,0.12703,REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,0.870347959787108
GOBP_REGULATION_OF_BINDING,SET,206,0.067767,0.0071344,0.059416,0.12704,GOBP_REGULATION_OF_BINDING,0.870347959787108
GOBP_EMBRYONIC_AXIS_SPECIFIC...,SET,35,0.1767,0.0077039,0.15498,0.12711,GOBP_EMBRYONIC_AXIS_SPECIFICATION,0.870483710852866
GSE22886_NAIVE_BCELL_VS_BM_P...1,SET,182,0.073772,0.0073049,0.064703,0.12712,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN,0.870483710852866
MIR936,SET,127,0.085714,0.0071007,0.075189,0.12715,MIR936,0.870483710852866
HP_EVERTED_UPPER_LIP_VERMILI...,SET,19,0.22546,0.0072454,0.19778,0.12716,HP_EVERTED_UPPER_LIP_VERMILION,0.870483710852866
MIR5191,SET,27,0.1986,0.0076066,0.17426,0.12723,MIR5191,0.870791384403308
GOCC_POSTSYNAPTIC_CYTOSKELET...,SET,13,0.26597,0.0070713,0.23341,0.12726,GOCC_POSTSYNAPTIC_CYTOSKELETON,0.870825221500295
GSE30962_PRIMARY_VS_SECONDAR...4,SET,180,0.070692,0.0069618,0.06208,0.12742,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP,0.871713678409762
REACTOME_NUCLEAR_RECEPTOR_TR...,SET,50,0.14104,0.0073467,0.12387,0.12744,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,0.871713678409762
GOBP_B_CELL_MEDIATED_IMMUNITY,SET,118,0.092827,0.0074142,0.081544,0.12749,GOBP_B_CELL_MEDIATED_IMMUNITY,0.871780936454849
WP_T_CELL_MODULATION_IN_PANC...,SET,43,0.15739,0.0076043,0.13827,0.1275,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,0.871780936454849
GSE3982_EFF_MEMORY_VS_CENT_M...2,SET,174,0.074495,0.0072142,0.065456,0.12755,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP,0.871951268686074
REACTOME_INTEGRIN_CELL_SURFA...,SET,81,0.11812,0.0078248,0.1038,0.12758,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,0.871983615097307
HP_ANTERIOR_CHAMBER_SYNECHIAE,SET,27,0.21233,0.0081324,0.18661,0.12761,HP_ANTERIOR_CHAMBER_SYNECHIAE,0.871983615097307
chr6p23,SET,7,0.4655,0.0090832,0.40917,0.12763,chr6p23,0.871983615097307
HERNANDEZ_ABERRANT_MITOSIS_B...2,SET,65,0.12586,0.0074717,0.11066,0.12771,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,0.872358696933962
GOBP_POSITIVE_REGULATION_OF_...772,SET,7,0.40541,0.0079107,0.35654,0.12776,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET,0.87245763793442
WU_HBX_TARGETS_2_UP,SET,21,0.22546,0.007617,0.19833,0.12782,WU_HBX_TARGETS_2_UP,0.87245763793442
GOBP_NEGATIVE_REGULATION_OF_...38,SET,82,0.10637,0.0070896,0.093578,0.12783,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY,0.87245763793442
HP_LEIOMYOSARCOMA,SET,28,0.19189,0.0074843,0.16881,0.12784,HP_LEIOMYOSARCOMA,0.87245763793442
MANNO_MIDBRAIN_NEUROTYPES_HS...,SET,389,0.05303,0.0076331,0.046654,0.12785,MANNO_MIDBRAIN_NEUROTYPES_HSERT,0.87245763793442
HP_HYPOPLASIA_OF_THE_OLFACTO...,SET,6,0.44341,0.0080106,0.39022,0.12792,HP_HYPOPLASIA_OF_THE_OLFACTORY_BULB,0.872763957597173
GOBP_POSITIVE_REGULATION_OF_...671,SET,20,0.23399,0.0077149,0.20598,0.12798,GOBP_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.872785022500489
MIR4445_3P,SET,9,0.33788,0.0074753,0.29751,0.12805,MIR4445_3P,0.872785022500489
HP_OCULAR_PAIN,SET,20,0.22476,0.0074107,0.19795,0.1281,HP_OCULAR_PAIN,0.872785022500489
HP_WHITE_LESION_OF_THE_ORAL_...,SET,26,0.20461,0.0076906,0.18022,0.12812,HP_WHITE_LESION_OF_THE_ORAL_MUCOSA,0.872785022500489
GOBP_SNRNA_MODIFICATION,SET,6,0.33064,0.0059732,0.29123,0.12813,GOBP_SNRNA_MODIFICATION,0.872785022500489
BUSSLINGER_DUODENAL_MX_CELLS,SET,10,0.31408,0.0073244,0.27666,0.12814,BUSSLINGER_DUODENAL_MX_CELLS,0.872785022500489
GSE19941_UNSTIM_VS_LPS_AND_I...4,SET,158,0.078072,0.0072077,0.068773,0.12815,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.872785022500489
PID_IL6_7_PATHWAY,SET,43,0.15932,0.0076976,0.14037,0.12819,PID_IL6_7_PATHWAY,0.872785022500489
TURASHVILI_BREAST_NORMAL_DUC...1,SET,5,0.40521,0.0066827,0.35705,0.12822,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN,0.872785022500489
BIOCARTA_TOB1_PATHWAY,SET,19,0.23668,0.0076063,0.20855,0.12822,BIOCARTA_TOB1_PATHWAY,0.872785022500489
GOMF_UBIQUITIN_LIKE_MODIFIER...,SET,9,0.28053,0.0062065,0.2472,0.12823,GOMF_UBIQUITIN_LIKE_MODIFIER_ACTIVATING_ENZYME_ACTIVITY,0.872785022500489
GSE14350_TREG_VS_TEFF_DN,SET,186,0.073302,0.0073369,0.064592,0.12823,GSE14350_TREG_VS_TEFF_DN,0.872785022500489
HP_SOFT_TISSUE_SARCOMA,SET,124,0.089426,0.0073207,0.078818,0.12828,HP_SOFT_TISSUE_SARCOMA,0.872785022500489
ZHONG_SECRETOME_OF_LUNG_CANC...2,SET,122,0.086805,0.007049,0.076518,0.12831,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,0.872785022500489
GSE3982_MAST_CELL_VS_DC_UP,SET,161,0.075437,0.0070297,0.066498,0.12831,GSE3982_MAST_CELL_VS_DC_UP,0.872785022500489
KEGG_MEDICUS_PATHOGEN_SALMON...6,SET,5,0.36958,0.0060952,0.32583,0.12835,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOG_SIGNALING_PATHWAY,0.872785022500489
IPF1_Q4,SET,215,0.070354,0.0075649,0.062025,0.12835,IPF1_Q4,0.872785022500489
BIOCARTA_STATHMIN_PATHWAY,SET,20,0.21952,0.0072379,0.19356,0.12838,BIOCARTA_STATHMIN_PATHWAY,0.872818251173709
GSE2770_UNTREATED_VS_IL12_TR...3,SET,180,0.068911,0.0067864,0.060772,0.12842,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.872884669534611
GOBP_ATRIAL_CARDIAC_MUSCLE_C...1,SET,8,0.375,0.0078223,0.33074,0.12844,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.872884669534611
GAVISH_3CA_METAPROGRAM_FIBRO...10,SET,48,0.15387,0.0078534,0.13572,0.12847,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9,0.872917859237537
GROSS_HYPOXIA_VIA_ELK3_AND_H...1,SET,98,0.098016,0.0071384,0.086476,0.12852,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,0.873086903831118
MANNO_MIDBRAIN_NEUROTYPES_HO...1,SET,339,0.055743,0.0075007,0.0492,0.12862,MANNO_MIDBRAIN_NEUROTYPES_HOMTN,0.873448917917723
REACTOME_VITAMIN_D_CALCIFERO...,SET,12,0.29818,0.0076169,0.26326,0.12869,REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM,0.873448917917723
GOMF_SPHINGOSINE_1_PHOSPHATE...1,SET,2,0.68586,0.0071545,0.60555,0.12869,GOMF_SPHINGOSINE_1_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.873448917917723
GSE20727_DNFB_ALLERGEN_VS_RO...1,SET,188,0.070654,0.0071094,0.062382,0.1287,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.873448917917723
REICHERT_MITOSIS_LIN9_TARGETS,SET,25,0.18065,0.0066581,0.15952,0.12873,REICHERT_MITOSIS_LIN9_TARGETS,0.873448917917723
GOBP_POTASSIUM_ION_HOMEOSTAS...,SET,34,0.17699,0.0076059,0.15631,0.12876,GOBP_POTASSIUM_ION_HOMEOSTASIS,0.873448917917723
GOCC_EUKARYOTIC_TRANSLATION_...2,SET,3,0.56871,0.0072656,0.50233,0.12879,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2_COMPLEX,0.873448917917723
HP_ABNORMALITY_OF_THE_DORSAL...,SET,5,0.35311,0.0058236,0.3119,0.12879,HP_ABNORMALITY_OF_THE_DORSAL_COLUMN_OF_THE_SPINAL_CORD,0.873448917917723
KEGG_MEDICUS_REFERENCE_DOUBL...2,SET,11,0.28268,0.0069138,0.24972,0.12883,KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING,0.873448917917723
chr21q22,SET,149,0.16693,0.014969,0.1475,0.12889,chr21q22,0.873448917917723
GOCC_ACTIVIN_RECEPTOR_COMPLEX,SET,6,0.41905,0.0075705,0.37028,0.12889,GOCC_ACTIVIN_RECEPTOR_COMPLEX,0.873448917917723
GSE9960_HEALTHY_VS_GRAM_NEG_...1,SET,163,0.072649,0.0068115,0.064194,0.12889,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.873448917917723
WP_TOLLLIKE_RECEPTOR_SIGNALI...2,SET,27,0.17779,0.0068097,0.15711,0.1289,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,0.873448917917723
ZWANG_DOWN_BY_2ND_EGF_PULSE,SET,210,0.06474,0.0068808,0.057224,0.12897,ZWANG_DOWN_BY_2ND_EGF_PULSE,0.873547827357755
HP_ABNORMAL_EYELASH_MORPHOLO...,SET,250,0.061777,0.0071561,0.05461,0.12898,HP_ABNORMAL_EYELASH_MORPHOLOGY,0.873547827357755
GSE28783_ANTI_MIR33_VS_UNTRE...2,SET,177,0.072687,0.007099,0.064255,0.12899,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.873547827357755
RLF_TARGET_GENES,SET,268,0.059918,0.0071826,0.052982,0.12905,RLF_TARGET_GENES,0.873657180232558
MARIADASON_RESPONSE_TO_BUTYR...1,SET,6,0.45861,0.0082851,0.40562,0.12911,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1,0.873657180232558
WP_INDUCTION_OF_AUTOPHAGY_AN...,SET,11,0.28545,0.0069816,0.25248,0.12912,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,0.873657180232558
GSE34205_HEALTHY_VS_FLU_INF_...2,SET,173,0.07217,0.0069691,0.063853,0.12919,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP,0.873657180232558
GOMF_METALLOCARBOXYPEPTIDASE...,SET,29,0.20669,0.008204,0.18287,0.1292,GOMF_METALLOCARBOXYPEPTIDASE_ACTIVITY,0.873657180232558
GOMF_NUCLEOSIDE_TRIPHOSPHATA...,SET,445,0.045904,0.007056,0.040639,0.12934,GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY,0.873657180232558
MIR511_5P,SET,291,0.057698,0.0072026,0.051083,0.12935,MIR511_5P,0.873657180232558
GOBP_POSITIVE_REGULATION_OF_...257,SET,29,0.19014,0.0075469,0.16834,0.12936,GOBP_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.873657180232558
REACTOME_TYSND1_CLEAVES_PERO...,SET,7,0.35678,0.0069617,0.31589,0.12937,REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS,0.873657180232558
KEGG_MEDICUS_REFERENCE_DNA_R...1,SET,24,0.18171,0.0065622,0.1609,0.12939,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING,0.873657180232558
RICKMAN_HEAD_AND_NECK_CANCER...4,SET,30,0.20348,0.0082145,0.18021,0.12943,RICKMAN_HEAD_AND_NECK_CANCER_D,0.873657180232558
GOBP_POSITIVE_REGULATION_OF_...324,SET,12,0.29771,0.0076048,0.26367,0.12944,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.873657180232558
HP_TOTAL_ANOMALOUS_PULMONARY...,SET,11,0.26314,0.0064358,0.23308,0.12946,HP_TOTAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,0.873657180232558
REACTOME_FORMATION_OF_AXIAL_...,SET,13,0.28143,0.0074823,0.24929,0.12947,REACTOME_FORMATION_OF_AXIAL_MESODERM,0.873657180232558
GSE14308_TH2_VS_TH17_DN,SET,185,0.067577,0.0067458,0.059858,0.12947,GSE14308_TH2_VS_TH17_DN,0.873657180232558
PEART_HDAC_PROLIFERATION_CLU...2,SET,51,0.13882,0.0073029,0.12299,0.12952,PEART_HDAC_PROLIFERATION_CLUSTER_UP,0.873657180232558
MIR18A_5P_MIR18B_5P,SET,117,0.089546,0.007122,0.079334,0.12952,MIR18A_5P_MIR18B_5P,0.873657180232558
DESERT_PERIVENOUS_HEPATOCELL...,SET,144,0.081741,0.0072072,0.072427,0.12954,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.873657180232558
ROAZ_01,SET,8,0.31219,0.0065121,0.27662,0.12954,ROAZ_01,0.873657180232558
CAVARD_LIVER_CANCER_MALIGNAN...,SET,28,0.19967,0.0077878,0.17693,0.12955,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,0.873657180232558
MIR6858_5P,SET,56,0.13119,0.0072308,0.11626,0.12958,MIR6858_5P,0.873657180232558
HP_MICROCEPHALIC_SPERM_HEAD,SET,2,0.73204,0.0076362,0.64891,0.12964,HP_MICROCEPHALIC_SPERM_HEAD,0.873657180232558
WP_KENNEDY_PATHWAY_FROM_SPHI...,SET,13,0.25312,0.0067298,0.22439,0.12965,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,0.873657180232558
REACTOME_PROTEIN_REPAIR,SET,6,0.39326,0.0071046,0.34863,0.12966,REACTOME_PROTEIN_REPAIR,0.873657180232558
GOBP_RESPONSE_TO_GROWTH_HORM...,SET,35,0.1767,0.0077039,0.15664,0.12966,GOBP_RESPONSE_TO_GROWTH_HORMONE,0.873657180232558
GOCC_NODE_OF_RANVIER,SET,16,0.26274,0.007749,0.23292,0.12966,GOCC_NODE_OF_RANVIER,0.873657180232558
GOBP_BLOOD_VESSEL_ENDOTHELIA...2,SET,109,0.096618,0.0074188,0.085666,0.1297,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.873657180232558
REACTOME_NONCANONICAL_ACTIVA...,SET,7,0.32158,0.0062749,0.28515,0.12971,REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3,0.873657180232558
REACTOME_AQUAPORIN_MEDIATED_...,SET,50,0.15009,0.0078179,0.1331,0.12975,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,0.873757266033715
GSE24574_BCL6_HIGH_VS_LOW_TF...2,SET,183,0.07324,0.007272,0.064978,0.12985,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP,0.874226583381755
GOBP_CYTIDINE_TO_URIDINE_EDI...,SET,10,0.42665,0.0099496,0.37855,0.12987,GOBP_CYTIDINE_TO_URIDINE_EDITING,0.874226583381755
BIOCARTA_MRP_PATHWAY,SET,6,0.45096,0.008147,0.40023,0.12993,BIOCARTA_MRP_PATHWAY,0.874257113821138
GOBP_POSITIVE_REGULATION_OF_...83,SET,7,0.36249,0.0070732,0.32175,0.12995,GOBP_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.874257113821138
HP_INCREASED_CIRCULATING_COR...,SET,29,0.18998,0.0075407,0.16862,0.12995,HP_INCREASED_CIRCULATING_CORTISOL_LEVEL,0.874257113821138
BLANCO_MELO_SARS_COV_1_INFEC...1,SET,9,0.35982,0.0079607,0.31948,0.13003,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_DN,0.874521847195358
CAR_TNFRSF25,SET,29,0.17987,0.0071395,0.15972,0.13006,CAR_TNFRSF25,0.874521847195358
chr16q12,SET,35,0.27932,0.012178,0.24804,0.13007,chr16q12,0.874521847195358
GOCC_EXTRINSIC_COMPONENT_OF_...1,SET,47,0.14499,0.0073229,0.12877,0.13009,GOCC_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,0.874521847195358
MIR577,SET,300,0.055883,0.0070814,0.049644,0.13016,MIR577,0.874654060324826
ATGTCAC_MIR489,SET,77,0.11738,0.0075818,0.10427,0.13016,ATGTCAC_MIR489,0.874654060324826
GSE29618_LAIV_VS_TIV_FLU_VAC...8,SET,171,0.06961,0.0066833,0.061858,0.13023,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP,0.874684289855072
MODULE_368,SET,17,0.24151,0.0073419,0.21462,0.13024,MODULE_368,0.874684289855072
HP_ABNORMAL_BONE_MARROW_CELL...,SET,199,0.067383,0.0069737,0.059881,0.13024,HP_ABNORMAL_BONE_MARROW_CELL_MORPHOLOGY,0.874684289855072
DURANTE_ADULT_OLFACTORY_NEUR...17,SET,70,0.12807,0.0078889,0.11385,0.13032,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PERICYTES,0.874846418918919
MIR5001_5P,SET,160,0.072605,0.006745,0.064552,0.13035,MIR5001_5P,0.874846418918919
GOBP_HISTONE_MRNA_METABOLIC_...,SET,20,0.18941,0.006245,0.16841,0.13037,GOBP_HISTONE_MRNA_METABOLIC_PROCESS,0.874846418918919
GOBP_REGULATION_OF_ATP_METAB...,SET,63,0.1157,0.0067623,0.10288,0.13039,GOBP_REGULATION_OF_ATP_METABOLIC_PROCESS,0.874846418918919
GOBP_REGULATION_OF_NUCLEOTID...4,SET,49,0.12833,0.0066176,0.11412,0.13039,GOBP_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.874846418918919
KEGG_ABC_TRANSPORTERS,SET,42,0.1617,0.0077212,0.14381,0.13044,KEGG_ABC_TRANSPORTERS,0.874876490449547
MIR6890_3P,SET,82,0.10977,0.0073162,0.097646,0.13047,MIR6890_3P,0.874876490449547
GOBP_NEGATIVE_REGULATION_OF_...371,SET,13,0.27256,0.0072466,0.24245,0.13047,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,0.874876490449547
GNF2_FBL,SET,129,0.080351,0.0067083,0.07149,0.13052,GNF2_FBL,0.874938866396761
GOBP_QUATERNARY_AMMONIUM_GRO...,SET,16,0.27862,0.0082175,0.24791,0.13053,GOBP_QUATERNARY_AMMONIUM_GROUP_TRANSPORT,0.874938866396761
GOBP_CYTOCHROME_METABOLIC_PR...,SET,5,0.48019,0.0079193,0.42732,0.13057,GOBP_CYTOCHROME_METABOLIC_PROCESS,0.874938866396761
GOCC_NUCLEOSOME,SET,37,0.15472,0.0069353,0.13769,0.13058,GOCC_NUCLEOSOME,0.874938866396761
GOMF_K63_LINKED_DEUBIQUITINA...,SET,11,0.27789,0.0067967,0.24753,0.13079,GOMF_K63_LINKED_DEUBIQUITINASE_ACTIVITY,0.875785936599424
HP_MICROANGIOPATHIC_HEMOLYTI...,SET,9,0.3381,0.0074801,0.30117,0.13081,HP_MICROANGIOPATHIC_HEMOLYTIC_ANEMIA,0.875785936599424
GSE21380_NON_TFH_VS_TFH_CD4_...2,SET,183,0.07234,0.0071826,0.064442,0.13082,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP,0.875785936599424
GOBP_LEUKOCYTE_ADHESION_TO_V...,SET,47,0.1514,0.0076469,0.1349,0.13087,GOBP_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.875785936599424
BARIS_THYROID_CANCER_UP,SET,23,0.18328,0.0064796,0.16336,0.13096,BARIS_THYROID_CANCER_UP,0.875785936599424
REACTOME_NUCLEAR_IMPORT_OF_R...,SET,32,0.159,0.0066289,0.14172,0.13096,REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN,0.875785936599424
GOMF_PROTEIN_SERINE_THREONIN...6,SET,11,0.27009,0.0066059,0.24076,0.13098,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY,0.875785936599424
GOBP_GALACTOSE_METABOLIC_PRO...,SET,9,0.32062,0.0070934,0.28582,0.13099,GOBP_GALACTOSE_METABOLIC_PROCESS,0.875785936599424
GOMF_PROTEIN_ARGININE_OMEGA_...2,SET,5,0.41855,0.0069028,0.37314,0.131,GOMF_PROTEIN_ARGININE_OMEGA_N_MONOMETHYLTRANSFERASE_ACTIVITY,0.875785936599424
GOBP_CERAMIDE_TRANSPORT,SET,15,0.25326,0.0072325,0.22583,0.13106,GOBP_CERAMIDE_TRANSPORT,0.875785936599424
GOBP_POSITIVE_REGULATION_OF_...66,SET,40,0.16299,0.0075956,0.14537,0.13112,GOBP_POSITIVE_REGULATION_OF_BONE_MINERALIZATION,0.875785936599424
RICHERT_PBMC_HIV_LIPO_5_AGE_...3,SET,5,0.44421,0.0073259,0.3962,0.13112,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_SIGNIFICANT_VARIATION_UP,0.875785936599424
GOBP_SIGNAL_TRANSDUCTION_INV...,SET,23,0.21416,0.0075716,0.19103,0.13113,GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION,0.875785936599424
GSE22611_MUTANT_NOD2_TRANSDU...1,SET,184,0.069959,0.006965,0.062402,0.13113,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN,0.875785936599424
WP_RETT_SYNDROME,SET,41,0.14804,0.0069847,0.13206,0.13114,WP_RETT_SYNDROME,0.875785936599424
MIR4774_5P,SET,87,0.099953,0.0068608,0.089168,0.13116,MIR4774_5P,0.875785936599424
GOBP_REGULATION_OF_DEPHOSPHO...,SET,92,0.098627,0.0069607,0.087983,0.13116,GOBP_REGULATION_OF_DEPHOSPHORYLATION,0.875785936599424
HP_ABNORMAL_CORTICOSPINAL_TR...,SET,44,0.15272,0.0074639,0.13625,0.13116,HP_ABNORMAL_CORTICOSPINAL_TRACT_MORPHOLOGY,0.875785936599424
REACTOME_ACTIVATED_PKN1_STIM...,SET,6,0.41673,0.0075285,0.3719,0.13125,REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,0.876218545908567
MODULE_41,SET,510,0.043521,0.0071487,0.038856,0.13135,MODULE_41,0.87631154289004
GOBP_POSITIVE_REGULATION_OF_...705,SET,4,0.52525,0.0077481,0.46895,0.13135,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,0.87631154289004
GSE12392_WT_VS_IFNB_KO_CD8A_...4,SET,176,0.069247,0.006744,0.061823,0.13135,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP,0.87631154289004
BOSCO_TH1_CYTOTOXIC_MODULE,SET,107,0.10157,0.0077274,0.090695,0.13139,BOSCO_TH1_CYTOTOXIC_MODULE,0.87631154289004
GOBP_MAINTENANCE_OF_PROTEIN_...3,SET,81,0.10588,0.0070139,0.094549,0.13139,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION,0.87631154289004
KYNG_WERNER_SYNDROM_AND_NORM...2,SET,74,0.10547,0.0066792,0.094218,0.13148,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,0.87674355333845
GOMF_1_ALKYL_2_ACETYLGLYCERO...,SET,8,0.30093,0.0062772,0.26885,0.13151,GOMF_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY,0.876775378860541
GOBP_NEGATIVE_REGULATION_OF_...159,SET,5,0.39331,0.0064865,0.35151,0.1316,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.876808567335244
LEE_AGING_CEREBELLUM_UP,SET,78,0.10666,0.0069339,0.095369,0.13171,LEE_AGING_CEREBELLUM_UP,0.876808567335244
WP_TLR4_SIGNALING_AND_TOLERA...,SET,26,0.17899,0.0067276,0.16005,0.13171,WP_TLR4_SIGNALING_AND_TOLERANCE,0.876808567335244
NFY_Q6_01,SET,231,0.062605,0.0069746,0.055982,0.13173,NFY_Q6_01,0.876808567335244
GSE15330_WT_VS_IKAROS_KO_GRA...1,SET,185,0.070614,0.0070491,0.063146,0.13173,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.876808567335244
HP_HYPOPLASTIC_PUBIC_RAMUS,SET,6,0.4181,0.0075533,0.37391,0.13175,HP_HYPOPLASTIC_PUBIC_RAMUS,0.876808567335244
GSE15735_CTRL_VS_HDAC_INHIBI...1,SET,185,0.071225,0.0071101,0.063698,0.13175,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN,0.876808567335244
HP_METAPHYSEAL_STRIATIONS,SET,11,0.29589,0.0072369,0.26475,0.13187,HP_METAPHYSEAL_STRIATIONS,0.876808567335244
GOBP_REGULATION_OF_EATING_BE...,SET,7,0.41456,0.0080891,0.37094,0.13188,GOBP_REGULATION_OF_EATING_BEHAVIOR,0.876808567335244
HP_CHRONIC_NONINFECTIOUS_LYM...,SET,11,0.28674,0.007013,0.2566,0.1319,HP_CHRONIC_NONINFECTIOUS_LYMPHADENOPATHY,0.876808567335244
HP_LYMPHANGIECTASIS,SET,10,0.31677,0.0073873,0.28349,0.13192,HP_LYMPHANGIECTASIS,0.876808567335244
GOCC_NUCLEAR_PORE,SET,87,0.09874,0.0067775,0.088371,0.13193,GOCC_NUCLEAR_PORE,0.876808567335244
REACTOME_SARS_COV_INFECTIONS,SET,379,0.048419,0.0068812,0.043338,0.13195,REACTOME_SARS_COV_INFECTIONS,0.876808567335244
GOBP_MOTOR_NEURON_AXON_GUIDA...,SET,23,0.21558,0.0076217,0.19295,0.13195,GOBP_MOTOR_NEURON_AXON_GUIDANCE,0.876808567335244
GOBP_CHOLESTEROL_CATABOLIC_P...,SET,9,0.34761,0.0076906,0.31117,0.13198,GOBP_CHOLESTEROL_CATABOLIC_PROCESS,0.876808567335244
GOBP_RESPONSE_TO_PROGESTERONE,SET,42,0.14942,0.0071349,0.13376,0.13198,GOBP_RESPONSE_TO_PROGESTERONE,0.876808567335244
GOBP_MITOTIC_SPINDLE_ELONGAT...,SET,11,0.30752,0.0075214,0.2753,0.13199,GOBP_MITOTIC_SPINDLE_ELONGATION,0.876808567335244
MIZUKAMI_HYPOXIA_UP,SET,11,0.32087,0.0078478,0.28725,0.132,MIZUKAMI_HYPOXIA_UP,0.876808567335244
GOBP_PYRIMIDINE_NUCLEOSIDE_M...3,SET,8,0.35665,0.0074396,0.31929,0.132,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.876808567335244
MIR8085,SET,208,0.069201,0.0073202,0.061961,0.13204,MIR8085,0.876808567335244
HP_CHRONIC_LUNG_DISEASE,SET,39,0.15088,0.0069431,0.1351,0.13205,HP_CHRONIC_LUNG_DISEASE,0.876808567335244
SEITZ_NEOPLASTIC_TRANSFORMAT...1,SET,30,0.17541,0.0070813,0.15708,0.13207,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,0.876808567335244
STK33_NOMO_DN,SET,233,0.063862,0.007145,0.057205,0.13214,STK33_NOMO_DN,0.877105748663102
MODULE_125,SET,42,0.14259,0.0068086,0.12774,0.13218,MODULE_125,0.877165791984733
BIOCARTA_MITOCHONDRIA_PATHWAY,SET,17,0.2285,0.0069463,0.20476,0.13223,BIOCARTA_MITOCHONDRIA_PATHWAY,0.877165791984733
HP_PARTIAL_ATRIOVENTRICULAR_...,SET,5,0.40323,0.0066502,0.36137,0.13225,HP_PARTIAL_ATRIOVENTRICULAR_CANAL_DEFECT,0.877165791984733
GSE3982_DC_VS_TH1_UP,SET,186,0.071401,0.0071467,0.063987,0.13225,GSE3982_DC_VS_TH1_UP,0.877165791984733
HP_PAPILLARY_RENAL_CELL_CARC...,SET,8,0.38621,0.0080561,0.34616,0.13228,HP_PAPILLARY_RENAL_CELL_CARCINOMA,0.877197366914711
GSE29618_LAIV_VS_TIV_FLU_VAC...7,SET,174,0.073524,0.0071201,0.065913,0.13233,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN,0.877200342205323
GOBP_REGULATION_OF_SYNAPTIC_...1,SET,5,0.44512,0.007341,0.39915,0.1324,GOBP_REGULATION_OF_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.877200342205323
EIF4E_DN,SET,90,0.10126,0.0070685,0.090826,0.13247,EIF4E_DN,0.877200342205323
REACTOME_DISEASES_OF_MISMATC...,SET,5,0.34165,0.0056346,0.30648,0.13248,REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR,0.877200342205323
MIR8088,SET,5,0.38241,0.0063067,0.34309,0.13252,MIR8088,0.877200342205323
GOMF_ISOPRENOID_BINDING,SET,42,0.17339,0.0082795,0.15558,0.13255,GOMF_ISOPRENOID_BINDING,0.877200342205323
GSE40666_UNTREATED_VS_IFNA_S...1,SET,174,0.067934,0.0065789,0.060958,0.13255,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN,0.877200342205323
WP_UNFOLDED_PROTEIN_RESPONSE,SET,22,0.20902,0.0072274,0.18758,0.13258,WP_UNFOLDED_PROTEIN_RESPONSE,0.877200342205323
HP_PREMATURE_GRAYING_OF_HAIR,SET,46,0.13846,0.0069184,0.12426,0.13259,HP_PREMATURE_GRAYING_OF_HAIR,0.877200342205323
GOBP_CALCIUM_ION_REGULATED_E...1,SET,62,0.12249,0.0071027,0.10993,0.1326,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS,0.877200342205323
GOBP_MESONEPHRIC_TUBULE_MORP...,SET,62,0.12971,0.0075215,0.11643,0.13262,GOBP_MESONEPHRIC_TUBULE_MORPHOGENESIS,0.877200342205323
GOCC_MITOCHONDRIA_ASSOCIATED...,SET,19,0.20375,0.0065477,0.18291,0.13267,GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE_CONTACT_SITE,0.877200342205323
KEGG_PURINE_METABOLISM,SET,144,0.078186,0.0068937,0.070195,0.13268,KEGG_PURINE_METABOLISM,0.877200342205323
WP_BLOOD_CLOTTING_CASCADE,SET,20,0.23843,0.0078613,0.21406,0.13268,WP_BLOOD_CLOTTING_CASCADE,0.877200342205323
KEGG_MEDICUS_VARIANT_EWSR1_W...,SET,5,0.46183,0.0076165,0.41464,0.13269,KEGG_MEDICUS_VARIANT_EWSR1_WT1_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.877200342205323
HP_IRIS_ATROPHY,SET,8,0.40575,0.0084637,0.36432,0.13271,HP_IRIS_ATROPHY,0.877200342205323
REACTOME_SENSING_OF_DNA_DOUB...,SET,5,0.37071,0.0061138,0.33292,0.13275,REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS,0.877200342205323
GOBP_RESPONSE_TO_GROWTH_FACT...,SET,663,0.039563,0.0073777,0.035531,0.13275,GOBP_RESPONSE_TO_GROWTH_FACTOR,0.877200342205323
GSE24634_NAIVE_CD4_TCELL_VS_...6,SET,184,0.069129,0.0068823,0.062084,0.13276,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP,0.877200342205323
LU_EZH2_TARGETS_DN,SET,343,0.051911,0.0070253,0.046642,0.13287,LU_EZH2_TARGETS_DN,0.877277164542729
GSE17721_POLYIC_VS_PAM3CSK4_...13,SET,182,0.068131,0.0067464,0.061221,0.13289,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN,0.877277164542729
HP_MOON_FACIES,SET,12,0.26441,0.0067541,0.23765,0.13295,HP_MOON_FACIES,0.877277164542729
MORF_RPA2,SET,173,0.067273,0.0064962,0.060469,0.13296,MORF_RPA2,0.877277164542729
HP_ABNORMALITY_OF_THE_HAMATE...,SET,9,0.32188,0.0071213,0.28933,0.13297,HP_ABNORMALITY_OF_THE_HAMATE_BONE,0.877277164542729
GSE44649_WT_VS_MIR155_KO_ACT...2,SET,190,0.07067,0.0071484,0.063529,0.13299,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP,0.877277164542729
GOBP_NEGATIVE_REGULATION_OF_...597,SET,97,0.097503,0.0070649,0.087653,0.133,GOBP_NEGATIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.877277164542729
KEGG_MEDICUS_REFERENCE_REGUL...4,SET,4,0.49836,0.0073515,0.44804,0.13301,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH,0.877277164542729
MIR1539,SET,5,0.43038,0.0070979,0.38699,0.13305,MIR1539,0.877277164542729
GU_PDEF_TARGETS_UP,SET,68,0.12951,0.0078633,0.11647,0.13308,GU_PDEF_TARGETS_UP,0.877277164542729
GSE26030_TH1_VS_TH17_DAY15_P...1,SET,176,0.073048,0.0071142,0.0657,0.13311,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN,0.877277164542729
GOMF_MICROTUBULE_MINUS_END_B...,SET,12,0.25422,0.006494,0.22872,0.13318,GOMF_MICROTUBULE_MINUS_END_BINDING,0.877277164542729
TONKS_TARGETS_OF_RUNX1_RUNX1...2,SET,143,0.086022,0.0075584,0.077394,0.13319,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,0.877277164542729
DESCARTES_MAIN_FETAL_EXTRAVI...,SET,97,0.10099,0.0073175,0.09086,0.13319,DESCARTES_MAIN_FETAL_EXTRAVILLOUS_TROPHOBLASTS,0.877277164542729
BOYAULT_LIVER_CANCER_SUBCLAS...14,SET,27,0.21587,0.0082683,0.19432,0.1333,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,0.877277164542729
BIOCARTA_SLRP_PATHWAY,SET,5,0.61503,0.010143,0.55362,0.13331,BIOCARTA_SLRP_PATHWAY,0.877277164542729
HP_TENDON_XANTHOMATOSIS,SET,15,0.28564,0.0081571,0.25716,0.13335,HP_TENDON_XANTHOMATOSIS,0.877277164542729
GSE9006_HEALTHY_VS_TYPE_1_DI...6,SET,169,0.071418,0.006817,0.06431,0.13339,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP,0.877277164542729
GSE10239_NAIVE_VS_DAY4.5_EFF...2,SET,187,0.070753,0.0071006,0.063726,0.13345,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP,0.877277164542729
MODULE_120,SET,67,0.11603,0.0069933,0.10452,0.13347,MODULE_120,0.877277164542729
DOANE_BREAST_CANCER_ESR1_DN,SET,42,0.15986,0.0076332,0.14401,0.1335,DOANE_BREAST_CANCER_ESR1_DN,0.877277164542729
MIR23A_5P,SET,30,0.18191,0.0073436,0.16389,0.13353,MIR23A_5P,0.877277164542729
GSE39110_UNTREATED_VS_IL2_TR...1,SET,183,0.068189,0.0067705,0.061437,0.13353,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN,0.877277164542729
GOBP_PHAGOCYTOSIS_ENGULFMENT,SET,49,0.14537,0.0074961,0.13103,0.13364,GOBP_PHAGOCYTOSIS_ENGULFMENT,0.877277164542729
GOBP_LATE_ENDOSOME_TO_VACUOL...1,SET,36,0.14892,0.0065848,0.13426,0.13367,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT,0.877277164542729
FOSTER_KDM1A_TARGETS_DN,SET,186,0.06556,0.006562,0.059107,0.13368,FOSTER_KDM1A_TARGETS_DN,0.877277164542729
GOCC_SCHMIDT_LANTERMAN_INCIS...,SET,10,0.32254,0.0075218,0.29078,0.13368,GOCC_SCHMIDT_LANTERMAN_INCISURE,0.877277164542729
HP_INTESTINAL_POLYP,SET,63,0.11777,0.0068833,0.10617,0.13368,HP_INTESTINAL_POLYP,0.877277164542729
GOBP_PRIMARY_ALCOHOL_CATABOL...,SET,13,0.29825,0.0079297,0.26892,0.1337,GOBP_PRIMARY_ALCOHOL_CATABOLIC_PROCESS,0.877277164542729
GOBP_REGULATION_OF_KINASE_AC...,SET,468,0.045519,0.0071707,0.041041,0.1337,GOBP_REGULATION_OF_KINASE_ACTIVITY,0.877277164542729
STEGER_ADIPOGENESIS_DN,SET,22,0.21341,0.0073795,0.19244,0.13372,STEGER_ADIPOGENESIS_DN,0.877277164542729
MIR7973,SET,43,0.14199,0.0068599,0.12803,0.13372,MIR7973,0.877277164542729
GOBP_BLOOD_VESSEL_ENDOTHELIA...3,SET,23,0.22119,0.0078201,0.19945,0.13372,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.877277164542729
GSE43955_1H_VS_60H_ACT_CD4_T...2,SET,184,0.071047,0.0070733,0.064064,0.13372,GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP,0.877277164542729
BCL6B_TARGET_GENES,SET,129,0.086094,0.0071877,0.077634,0.13373,BCL6B_TARGET_GENES,0.877277164542729
HOEGERKORP_CD44_TARGETS_TEMP...2,SET,10,0.3173,0.0073996,0.28617,0.13377,HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,0.877277164542729
REACTOME_BIOSYNTHESIS_OF_THE...,SET,72,0.10632,0.0066418,0.095903,0.1338,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,0.877277164542729
GSE18281_CORTICAL_VS_MEDULLA...2,SET,183,0.072804,0.0072287,0.065674,0.13382,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP,0.877277164542729
GOBP_EMBRYONIC_SKELETAL_JOIN...1,SET,14,0.28549,0.0078767,0.25755,0.13383,GOBP_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT,0.877277164542729
NUYTTEN_NIPP1_TARGETS_DN,SET,766,0.034979,0.0069908,0.031559,0.13386,NUYTTEN_NIPP1_TARGETS_DN,0.877277164542729
GOBP_REGULATION_OF_OPSONIZAT...,SET,10,0.36036,0.0084036,0.32522,0.13393,GOBP_REGULATION_OF_OPSONIZATION,0.877277164542729
chr5q32,SET,44,0.25106,0.01227,0.22659,0.13394,chr5q32,0.877277164542729
GOCC_SYNAPTIC_CLEFT,SET,22,0.22425,0.0077542,0.2024,0.13395,GOCC_SYNAPTIC_CLEFT,0.877277164542729
GSE29949_CD8_POS_DC_SPLEEN_V...4,SET,171,0.073594,0.0070658,0.066424,0.13395,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,0.877277164542729
GSE13485_DAY1_VS_DAY3_YF17D_...2,SET,141,0.084903,0.0074082,0.076635,0.13396,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP,0.877277164542729
GSE17721_CTRL_VS_GARDIQUIMOD...15,SET,184,0.069387,0.006908,0.06263,0.13397,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN,0.877277164542729
GAVISH_3CA_MALIGNANT_METAPRO...9,SET,41,0.15757,0.007434,0.14225,0.13401,GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2,0.877277164542729
GOBP_GLYCEROLIPID_BIOSYNTHET...,SET,226,0.061813,0.0068124,0.055804,0.13401,GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS,0.877277164542729
HP_POOR_FINE_MOTOR_COORDINAT...,SET,64,0.12169,0.0071685,0.10987,0.13403,HP_POOR_FINE_MOTOR_COORDINATION,0.877277164542729
GOBP_CELL_CYCLE_DNA_REPLICAT...2,SET,4,0.4624,0.006821,0.41751,0.13404,GOBP_CELL_CYCLE_DNA_REPLICATION_INITIATION,0.877277164542729
GOBP_GASTRIC_MOTILITY,SET,5,0.42164,0.0069538,0.38077,0.13408,GOBP_GASTRIC_MOTILITY,0.877277164542729
GSE2128_C57BL6_VS_NOD_CD4CD8...2,SET,175,0.07109,0.006904,0.064203,0.1341,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP,0.877277164542729
REACTOME_RAF_ACTIVATION,SET,32,0.16402,0.0068382,0.14815,0.13412,REACTOME_RAF_ACTIVATION,0.877277164542729
GSE22886_NAIVE_CD8_TCELL_VS_...7,SET,171,0.080157,0.0076959,0.072409,0.13415,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN,0.877277164542729
GOBP_POSITIVE_REGULATION_OF_...477,SET,13,0.24967,0.0066381,0.22554,0.13416,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CYTOKINESIS,0.877277164542729
GOBP_REGULATION_OF_VENTRICUL...1,SET,12,0.31865,0.0081399,0.28806,0.13433,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.877277164542729
GAUSSMANN_MLL_AF4_FUSION_TAR...3,SET,6,0.42881,0.0077467,0.38768,0.13435,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN,0.877277164542729
WU_HBX_TARGETS_3_UP,SET,18,0.23612,0.007386,0.21348,0.13436,WU_HBX_TARGETS_3_UP,0.877277164542729
GOCC_STEREOCILIUM_BASE,SET,7,0.36042,0.0070327,0.32589,0.13438,GOCC_STEREOCILIUM_BASE,0.877277164542729
PTEN_DN.V2_DN,SET,119,0.089133,0.0071491,0.080594,0.13438,PTEN_DN.V2_DN,0.877277164542729
GOBP_INTESTINAL_EPITHELIAL_C...1,SET,16,0.2547,0.0075119,0.23036,0.13444,GOBP_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT,0.877277164542729
REACTOME_SIGNALING_BY_LTK,SET,10,0.29384,0.0068525,0.26577,0.13445,REACTOME_SIGNALING_BY_LTK,0.877277164542729
GOBP_CD4_POSITIVE_ALPHA_BETA...4,SET,19,0.24122,0.0077521,0.21817,0.13445,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.877277164542729
GOBP_REGULATION_OF_TRIGLYCER...1,SET,18,0.20895,0.0065359,0.18899,0.13446,GOBP_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.877277164542729
GAVISH_3CA_METAPROGRAM_ENDOT...8,SET,46,0.15365,0.0076776,0.13898,0.13447,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_6,0.877277164542729
GOBP_VASCULAR_ENDOTHELIAL_GR...4,SET,40,0.16349,0.0076189,0.1479,0.13449,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.877277164542729
REACTOME_ADP_SIGNALLING_THRO...2,SET,22,0.21372,0.0073899,0.19335,0.13451,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12,0.877277164542729
HP_TYPE_A_BRACHYDACTYLY,SET,20,0.22908,0.0075529,0.20725,0.13451,HP_TYPE_A_BRACHYDACTYLY,0.877277164542729
MODULE_16,SET,462,0.044341,0.0069414,0.040123,0.13456,MODULE_16,0.877277164542729
CACCAGC_MIR138,SET,208,0.067447,0.0071347,0.061034,0.13457,CACCAGC_MIR138,0.877277164542729
WP_CALORIC_RESTRICTION_AND_A...,SET,8,0.34511,0.0071989,0.31233,0.13459,WP_CALORIC_RESTRICTION_AND_AGING,0.877277164542729
GSE11961_FOLLICULAR_BCELL_VS...7,SET,178,0.070357,0.0068905,0.063675,0.1346,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.877277164542729
GOBP_NEGATIVE_REGULATION_OF_...55,SET,29,0.19441,0.0077165,0.17597,0.13464,GOBP_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION,0.877277164542729
MIR208B_5P,SET,232,0.063271,0.0070638,0.057275,0.13466,MIR208B_5P,0.877277164542729
ISRE_01,SET,227,0.065873,0.0072756,0.059636,0.13468,ISRE_01,0.877277164542729
HP_CORPUS_CALLOSUM_ATROPHY,SET,37,0.1499,0.0067191,0.13571,0.13469,HP_CORPUS_CALLOSUM_ATROPHY,0.877277164542729
ZHONG_PFC_MAJOR_TYPES_INTERN...,SET,13,0.29673,0.0078892,0.26873,0.13476,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.877431979030144
GSE41867_NAIVE_VS_DAY6_LCMV_...2,SET,177,0.071244,0.006958,0.064526,0.13478,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.877431979030144
GSE36891_UNSTIM_VS_PAM_TLR2_...2,SET,174,0.073734,0.0071404,0.066792,0.13482,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.877431979030144
GOMF_SYMPORTER_ACTIVITY,SET,144,0.084606,0.0074597,0.076644,0.13483,GOMF_SYMPORTER_ACTIVITY,0.877431979030144
GOBP_TRANSITION_BETWEEN_FAST...,SET,7,0.34488,0.0067295,0.31244,0.13484,GOBP_TRANSITION_BETWEEN_FAST_AND_SLOW_FIBER,0.877431979030144
GSE36527_CD69_NEG_VS_POS_TRE...1,SET,185,0.066983,0.0066866,0.060707,0.13494,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN,0.877515028037383
GOBP_CARDIAC_EPITHELIAL_TO_M...,SET,36,0.17374,0.007682,0.15747,0.13495,GOBP_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.877515028037383
GOBP_OSTEOCLAST_FUSION,SET,6,0.42895,0.0077493,0.38878,0.13495,GOBP_OSTEOCLAST_FUSION,0.877515028037383
GSE45739_UNSTIM_VS_ACD3_ACD2...4,SET,181,0.071762,0.0070866,0.065058,0.13501,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP,0.877515028037383
AFFAR_YY1_TARGETS_DN,SET,237,0.062784,0.0070837,0.056926,0.13504,AFFAR_YY1_TARGETS_DN,0.877515028037383
GOMF_NFAT_PROTEIN_BINDING,SET,5,0.40569,0.0066907,0.36783,0.13504,GOMF_NFAT_PROTEIN_BINDING,0.877515028037383
GOMF_DNA_HELICASE_ACTIVITY,SET,55,0.12509,0.0068329,0.11342,0.13505,GOMF_DNA_HELICASE_ACTIVITY,0.877515028037383
WP_DEREGULATION_OF_RAB_AND_R...,SET,14,0.22953,0.0063328,0.20814,0.13507,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,0.877515028037383
REACTOME_SRP_DEPENDENT_COTRA...,SET,102,0.090291,0.0067079,0.081881,0.13508,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.877515028037383
HP_ABNORMAL_UTERUS_MORPHOLOGY,SET,138,0.078928,0.0068137,0.071609,0.13519,HP_ABNORMAL_UTERUS_MORPHOLOGY,0.878065492431321
GOMF_C_C_CHEMOKINE_BINDING,SET,22,0.23347,0.008073,0.21191,0.13529,GOMF_C_C_CHEMOKINE_BINDING,0.878191306775875
GSE2405_0H_VS_6H_A_PHAGOCYTO...1,SET,170,0.073902,0.0070748,0.067077,0.13529,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.878191306775875
HP_SLEEP_WAKE_CYCLE_DISTURBA...,SET,36,0.16686,0.007378,0.1515,0.13537,HP_SLEEP_WAKE_CYCLE_DISTURBANCE,0.878191306775875
HP_NEPHRITIS,SET,113,0.090586,0.0070813,0.082253,0.13539,HP_NEPHRITIS,0.878191306775875
GSE18281_SUBCAPSULAR_CORTICA...2,SET,189,0.067486,0.0068085,0.061286,0.13542,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.878191306775875
HP_ABNORMAL_MEGAKARYOCYTE_MO...,SET,23,0.1952,0.0069013,0.17727,0.13543,HP_ABNORMAL_MEGAKARYOCYTE_MORPHOLOGY,0.878191306775875
GOCC_OUTER_DENSE_FIBER,SET,4,0.49772,0.0073421,0.45204,0.13544,GOCC_OUTER_DENSE_FIBER,0.878191306775875
REACTOME_SIGNALING_BY_FGFR3,SET,38,0.15333,0.006965,0.13926,0.13546,REACTOME_SIGNALING_BY_FGFR3,0.878191306775875
BIOCARTA_PTC1_PATHWAY,SET,11,0.25513,0.00624,0.23174,0.13547,BIOCARTA_PTC1_PATHWAY,0.878191306775875
GSE13484_UNSTIM_VS_3H_YF17D_...2,SET,179,0.065289,0.006412,0.059312,0.1355,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.878191306775875
GSE40666_WT_VS_STAT4_KO_CD8_...2,SET,148,0.081419,0.007277,0.073968,0.13551,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP,0.878191306775875
MODULE_429,SET,14,0.24821,0.006848,0.22552,0.13554,MODULE_429,0.878191306775875
GSE15930_STIM_VS_STIM_AND_TR...1,SET,177,0.068172,0.006658,0.061953,0.13559,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN,0.878191306775875
MIR1286,SET,80,0.10327,0.0067986,0.09386,0.13562,MIR1286,0.878191306775875
KEGG_MEDICUS_VARIANT_AMPLIFI...3,SET,8,0.3141,0.0065519,0.28552,0.13566,KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S,0.878191306775875
HP_MOTOR_DETERIORATION,SET,27,0.17813,0.0068226,0.16193,0.13566,HP_MOTOR_DETERIORATION,0.878191306775875
TRAVAGLINI_LUNG_GOBLET_CELL,SET,138,0.084094,0.0072597,0.076446,0.13566,TRAVAGLINI_LUNG_GOBLET_CELL,0.878191306775875
BIOCARTA_CALCINEURIN_PATHWAY,SET,18,0.21784,0.0068143,0.19804,0.13567,BIOCARTA_CALCINEURIN_PATHWAY,0.878191306775875
GOBP_DETECTION_OF_STIMULUS_I...2,SET,27,0.18879,0.007231,0.17165,0.1357,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.878191306775875
GOBP_REGULATION_OF_MITOTIC_C...3,SET,9,0.28291,0.0062591,0.25725,0.13573,GOBP_REGULATION_OF_MITOTIC_CENTROSOME_SEPARATION,0.878191306775875
MIR4536_3P,SET,19,0.22415,0.0072036,0.20383,0.13574,MIR4536_3P,0.878191306775875
AP2_Q6_01,SET,248,0.059369,0.0068499,0.054003,0.13582,AP2_Q6_01,0.878242053903346
GOBP_MYELOID_DENDRITIC_CELL_...1,SET,27,0.20151,0.007718,0.1833,0.13582,GOBP_MYELOID_DENDRITIC_CELL_ACTIVATION,0.878242053903346
HALLMARK_TGF_BETA_SIGNALING,SET,52,0.13328,0.0070796,0.12125,0.13585,HALLMARK_TGF_BETA_SIGNALING,0.878242053903346
HP_ANKLE_CONTRACTURE,SET,52,0.12799,0.0067983,0.11644,0.13586,HP_ANKLE_CONTRACTURE,0.878242053903346
REACTOME_RNA_POLYMERASE_II_T...2,SET,1234,0.028211,0.0070604,0.02567,0.1359,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION,0.878242053903346
HP_FREQUENT_TEMPER_TANTRUMS,SET,8,0.33093,0.006903,0.30117,0.13593,HP_FREQUENT_TEMPER_TANTRUMS,0.878242053903346
WEBER_METHYLATED_LCP_IN_FIBR...1,SET,9,0.33441,0.0073985,0.30434,0.13594,WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN,0.878242053903346
MIR215_3P,SET,119,0.087025,0.00698,0.079205,0.13595,MIR215_3P,0.878242053903346
HP_ABNORMAL_LIVER_MORPHOLOGY,SET,792,0.034175,0.00694,0.031109,0.13599,HP_ABNORMAL_LIVER_MORPHOLOGY,0.878299647102526
HP_HEPATOCELLULAR_ADENOMA,SET,17,0.24293,0.007385,0.22117,0.13603,HP_HEPATOCELLULAR_ADENOMA,0.878299647102526
MADAN_DPPA4_TARGETS,SET,49,0.13611,0.0070185,0.12393,0.13605,MADAN_DPPA4_TARGETS,0.878299647102526
GSE39152_SPLEEN_CD103_NEG_VS...1,SET,189,0.069038,0.006965,0.062862,0.13606,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN,0.878299647102526
GSE17186_MEMORY_VS_CD21LOW_T...2,SET,176,0.067112,0.0065361,0.06112,0.1361,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP,0.878312641334569
GSE26488_CTRL_VS_PEPTIDE_INJ...1,SET,178,0.071908,0.0070425,0.065513,0.13619,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN,0.878312641334569
GSE8921_UNSTIM_0H_VS_TLR1_2_...8,SET,182,0.06976,0.0069076,0.063556,0.13619,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP,0.878312641334569
GSE37534_UNTREATED_VS_GW1929...1,SET,186,0.066249,0.006631,0.060364,0.13622,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.878312641334569
HP_ABNORMAL_LABIA_MORPHOLOGY,SET,72,0.11836,0.007394,0.10786,0.13624,HP_ABNORMAL_LABIA_MORPHOLOGY,0.878312641334569
HP_HYPOPIGMENTATION_OF_THE_S...,SET,180,0.068313,0.0067275,0.06225,0.13624,HP_HYPOPIGMENTATION_OF_THE_SKIN,0.878312641334569
HP_HAMSTRING_CONTRACTURES,SET,5,0.41602,0.006861,0.37911,0.13625,HP_HAMSTRING_CONTRACTURES,0.878312641334569
MATZUK_SPERMATOCYTE,SET,67,0.10658,0.0064232,0.097131,0.13628,MATZUK_SPERMATOCYTE,0.878312641334569
GOBP_REGULATION_OF_ALCOHOL_B...,SET,45,0.14674,0.0072525,0.13375,0.13629,GOBP_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.878312641334569
DESCARTES_FETAL_SPLEEN_MESOT...,SET,177,0.075288,0.007353,0.068631,0.13633,DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS,0.878312641334569
GOMF_TRANSFORMING_GROWTH_FAC...4,SET,26,0.20139,0.0075696,0.18359,0.13634,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.878312641334569
GSE45365_NK_CELL_VS_CD8A_DC_...3,SET,154,0.076867,0.0070069,0.070087,0.13638,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP,0.878407505559674
GOBP_RIBONUCLEOSIDE_DIPHOSPH...,SET,10,0.29564,0.0068943,0.26959,0.13641,GOBP_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.878437937743191
GNF2_SPINK1,SET,24,0.22343,0.0080688,0.20377,0.13645,GNF2_SPINK1,0.878532743608744
GSE12845_IGD_NEG_BLOOD_VS_PR...1,SET,182,0.066928,0.0066273,0.061054,0.1365,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,0.878691887386553
MIR9985,SET,570,0.040817,0.0070759,0.037246,0.13658,MIR9985,0.878964746671598
HP_PARATHYROID_ADENOMA,SET,15,0.26901,0.0076823,0.24555,0.13665,HP_PARATHYROID_ADENOMA,0.878964746671598
GOBP_REGULATION_OF_GLYCOGEN_...4,SET,4,0.43413,0.0064041,0.39637,0.13671,GOBP_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY,0.878964746671598
GOCC_BLOC_1_COMPLEX,SET,14,0.25353,0.0069948,0.23148,0.13671,GOCC_BLOC_1_COMPLEX,0.878964746671598
GSE22886_UNSTIM_VS_STIM_MEMO...1,SET,182,0.064653,0.0064019,0.059031,0.13672,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN,0.878964746671598
KEGG_AXON_GUIDANCE,SET,122,0.087645,0.0071172,0.080037,0.13675,KEGG_AXON_GUIDANCE,0.878964746671598
GOBP_POSITIVE_REGULATION_OF_...11,SET,7,0.31829,0.0062108,0.29067,0.13675,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.878964746671598
PBXIP1_TARGET_GENES,SET,196,0.067889,0.0069735,0.061998,0.13676,PBXIP1_TARGET_GENES,0.878964746671598
GSE15324_NAIVE_VS_ACTIVATED_...2,SET,171,0.069479,0.0066707,0.063452,0.13677,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.878964746671598
HP_LYMPHOMA,SET,112,0.090549,0.0070472,0.082724,0.13686,HP_LYMPHOMA,0.879380532445924
GOBP_TIGHT_JUNCTION_ORGANIZA...,SET,75,0.11402,0.0072691,0.10419,0.1369,GOBP_TIGHT_JUNCTION_ORGANIZATION,0.879474953789279
GSE14415_INDUCED_TREG_VS_FOX...3,SET,161,0.076742,0.0071513,0.070143,0.13697,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP,0.879626271342023
GOCC_BLEB,SET,9,0.32525,0.0071958,0.29735,0.13702,GOCC_BLEB,0.879626271342023
MORF_DDB1,SET,224,0.058495,0.0064184,0.053479,0.13703,MORF_DDB1,0.879626271342023
GOBP_CARBOHYDRATE_DERIVATIVE...4,SET,88,0.1037,0.0071587,0.094808,0.13703,GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT,0.879626271342023
GOBP_REGULATION_OF_CARDIAC_M...1,SET,10,0.3279,0.0076466,0.29982,0.13706,GOBP_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.879626271342023
GSE11924_TFH_VS_TH1_CD4_TCEL...2,SET,186,0.06689,0.0066951,0.061183,0.13714,GSE11924_TFH_VS_TH1_CD4_TCELL_UP,0.879626271342023
HP_ANTERIOR_PITUITARY_AGENES...,SET,10,0.31647,0.0073802,0.2896,0.13725,HP_ANTERIOR_PITUITARY_AGENESIS,0.879626271342023
MIR1249_5P,SET,177,0.071159,0.0069497,0.065119,0.13726,MIR1249_5P,0.879626271342023
LEE_LIVER_CANCER_ACOX1_DN,SET,62,0.12433,0.0072093,0.11379,0.13728,LEE_LIVER_CANCER_ACOX1_DN,0.879626271342023
GOBP_REGULATION_OF_MACROPHAG...7,SET,42,0.1492,0.0071244,0.13655,0.13729,GOBP_REGULATION_OF_MACROPHAGE_MIGRATION,0.879626271342023
GAUTAM_EYE_IRIS_CILIARY_BODY...3,SET,316,0.050719,0.0065932,0.046422,0.1373,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS,0.879626271342023
HP_ABNORMAL_SHOULDER_MORPHOL...,SET,79,0.11338,0.0074174,0.10378,0.13732,HP_ABNORMAL_SHOULDER_MORPHOLOGY,0.879626271342023
HP_MALAR_RASH,SET,29,0.18723,0.0074316,0.17142,0.13737,HP_MALAR_RASH,0.879626271342023
MIR3120_3P,SET,320,0.052457,0.0068614,0.048035,0.13741,MIR3120_3P,0.879626271342023
HP_EPISPADIAS,SET,25,0.17902,0.0065983,0.16393,0.13742,HP_EPISPADIAS,0.879626271342023
FRASOR_RESPONSE_TO_SERM_OR_F...2,SET,21,0.20584,0.0069541,0.18851,0.13744,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,0.879626271342023
HP_APLASIA_HYPOPLASIA_OF_THE...41,SET,51,0.13173,0.0069295,0.12064,0.13744,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_HAND,0.879626271342023
KEGG_MEDICUS_REFERENCE_ACTIV...2,SET,23,0.19198,0.0067873,0.17583,0.13745,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES,0.879626271342023
BIOCARTA_PLCE_PATHWAY,SET,11,0.31589,0.007726,0.28932,0.13746,BIOCARTA_PLCE_PATHWAY,0.879626271342023
GOBP_IMMUNE_RESPONSE_INHIBIT...2,SET,10,0.32441,0.0075654,0.29718,0.13751,GOBP_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION,0.879626271342023
SOX10_TARGET_GENES,SET,205,0.066484,0.0069824,0.060925,0.13759,SOX10_TARGET_GENES,0.879626271342023
GSE14415_INDUCED_VS_NATURAL_...1,SET,162,0.071213,0.0066565,0.065259,0.13759,GSE14415_INDUCED_VS_NATURAL_TREG_DN,0.879626271342023
REACTOME_CYTOSOLIC_SULFONATI...,SET,21,0.22039,0.0074457,0.20197,0.1376,REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,0.879626271342023
GOMF_ATPASE_COUPLED_INORGANI...,SET,10,0.31771,0.007409,0.29118,0.13762,GOMF_ATPASE_COUPLED_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.879626271342023
HFH4_01,SET,180,0.073184,0.0072072,0.067075,0.13763,HFH4_01,0.879626271342023
MIR3120_5P,SET,77,0.10578,0.0068329,0.096996,0.13773,MIR3120_5P,0.879626271342023
MIR4650_3P,SET,119,0.089116,0.0071477,0.081719,0.13775,MIR4650_3P,0.879626271342023
TRAVAGLINI_LUNG_LIPOFIBROBLA...,SET,138,0.085416,0.0073738,0.078325,0.13775,TRAVAGLINI_LUNG_LIPOFIBROBLAST_CELL,0.879626271342023
GOBP_5_PHOSPHORIBOSE_1_DIPHO...,SET,4,0.42277,0.0062365,0.3877,0.13776,GOBP_5_PHOSPHORIBOSE_1_DIPHOSPHATE_METABOLIC_PROCESS,0.879626271342023
GOMF_ATP_ADP_ANTIPORTER_ACTI...,SET,3,0.51442,0.006572,0.4718,0.13779,GOMF_ATP_ADP_ANTIPORTER_ACTIVITY,0.879626271342023
GSE29164_DAY3_VS_DAY7_CD8_TC...3,SET,184,0.069459,0.0069152,0.063709,0.13781,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN,0.879626271342023
CHEN_HOXA5_TARGETS_9HR_UP,SET,206,0.065582,0.0069044,0.060155,0.13782,CHEN_HOXA5_TARGETS_9HR_UP,0.879626271342023
SHIN_B_CELL_LYMPHOMA_CLUSTER...1,SET,13,0.26297,0.0069916,0.24121,0.13782,SHIN_B_CELL_LYMPHOMA_CLUSTER_1,0.879626271342023
KTGGYRSGAA_UNKNOWN,SET,68,0.11343,0.0068869,0.10406,0.13785,KTGGYRSGAA_UNKNOWN,0.879626271342023
GOMF_NITRITE_REDUCTASE_ACTIV...,SET,5,0.47286,0.0077984,0.43379,0.13785,GOMF_NITRITE_REDUCTASE_ACTIVITY,0.879626271342023
HP_PUBERTY_AND_GONADAL_DISOR...,SET,561,0.039923,0.0068679,0.036624,0.13785,HP_PUBERTY_AND_GONADAL_DISORDERS,0.879626271342023
MIR1228_3P,SET,70,0.11448,0.0070518,0.10503,0.13786,MIR1228_3P,0.879626271342023
CUI_DEVELOPING_HEART_RIGHT_A...,SET,36,0.16305,0.0072093,0.14966,0.13799,CUI_DEVELOPING_HEART_RIGHT_ATRIAL_CARDIOMYOCYTE,0.879649302030457
GSE2405_S_AUREUS_VS_A_PHAGOC...2,SET,183,0.072838,0.0072321,0.066871,0.13803,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP,0.879649302030457
HP_EXTRAHEPATIC_CHOLESTASIS,SET,10,0.27024,0.006302,0.24811,0.13804,HP_EXTRAHEPATIC_CHOLESTASIS,0.879649302030457
REACTOME_MITOTIC_PROPHASE,SET,77,0.099753,0.0064433,0.091589,0.13805,REACTOME_MITOTIC_PROPHASE,0.879649302030457
KEGG_MEDICUS_REFERENCE_AVP_V...,SET,9,0.32117,0.0071056,0.29491,0.13807,KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY,0.879649302030457
FAN_EMBRYONIC_CTX_MICROGLIA_1,SET,137,0.075939,0.0065321,0.069741,0.13811,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.879649302030457
HP_TESTICULAR_ADRENAL_REST_T...,SET,8,0.35473,0.0073994,0.32585,0.13817,HP_TESTICULAR_ADRENAL_REST_TUMOR,0.879649302030457
HP_ABNORMAL_INCISOR_MORPHOLO...,SET,55,0.13379,0.0073081,0.12294,0.13825,HP_ABNORMAL_INCISOR_MORPHOLOGY,0.879649302030457
MIR6821_3P,SET,47,0.13141,0.0066369,0.12075,0.13826,MIR6821_3P,0.879649302030457
GOBP_VITAMIN_E_METABOLIC_PRO...,SET,6,0.37084,0.0066994,0.34084,0.1383,GOBP_VITAMIN_E_METABOLIC_PROCESS,0.879649302030457
GSE369_PRE_VS_POST_IL6_INJEC...3,SET,193,0.067091,0.0068392,0.061684,0.13838,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN,0.879649302030457
GSE39556_CD8A_DC_VS_NK_CELL_...3,SET,179,0.065184,0.0064016,0.059933,0.13839,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP,0.879649302030457
REACTOME_MIRO_GTPASE_CYCLE,SET,8,0.30993,0.0064649,0.28497,0.1384,REACTOME_MIRO_GTPASE_CYCLE,0.879649302030457
chr3q13,SET,80,0.19875,0.013084,0.18277,0.13843,chr3q13,0.879649302030457
BIOCARTA_EGFR_SMRTE_PATHWAY,SET,11,0.3067,0.0075013,0.28212,0.13849,BIOCARTA_EGFR_SMRTE_PATHWAY,0.879649302030457
GOBP_CENTRAL_NERVOUS_SYSTEM_...4,SET,4,0.53055,0.0078264,0.48824,0.1386,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,0.879649302030457
GSE42021_TREG_PLN_VS_CD24HI_...1,SET,183,0.065366,0.0064902,0.060155,0.13861,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN,0.879649302030457
HP_ABNORMAL_CONUS_TERMINALIS...,SET,29,0.17632,0.0069987,0.16228,0.13862,HP_ABNORMAL_CONUS_TERMINALIS_MORPHOLOGY,0.879649302030457
KEGG_MEDICUS_VARIANT_MUTATIO...7,SET,29,0.17288,0.0068621,0.15913,0.13865,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.879649302030457
GAO_STOMACH_24W_C6_PIT_CELL,SET,12,0.26828,0.006853,0.24693,0.13865,GAO_STOMACH_24W_C6_PIT_CELL,0.879649302030457
GOCC_EXTRINSIC_COMPONENT_OF_...5,SET,97,0.09834,0.0071255,0.090535,0.1387,GOCC_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE,0.879649302030457
GOMF_MOLECULAR_FUNCTION_INHI...,SET,457,0.046159,0.0071879,0.042498,0.13871,GOMF_MOLECULAR_FUNCTION_INHIBITOR_ACTIVITY,0.879649302030457
GOMF_MAP_KINASE_KINASE_ACTIV...,SET,15,0.24596,0.0070239,0.22645,0.13872,GOMF_MAP_KINASE_KINASE_ACTIVITY,0.879649302030457
GSE15659_NAIVE_CD4_TCELL_VS_...6,SET,157,0.073994,0.0068098,0.06813,0.13873,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP,0.879649302030457
GOBP_FAT_SOLUBLE_VITAMIN_MET...,SET,47,0.14121,0.0071319,0.13003,0.13874,GOBP_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.879649302030457
GOBP_INTRACELLULAR_GLUTAMATE...,SET,6,0.41456,0.0074893,0.38176,0.13876,GOBP_INTRACELLULAR_GLUTAMATE_HOMEOSTASIS,0.879649302030457
GSE5589_LPS_VS_LPS_AND_IL10_...8,SET,179,0.069572,0.0068326,0.06407,0.13878,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.879649302030457
SA_G2_AND_M_PHASES,SET,8,0.27551,0.0057469,0.25374,0.1388,SA_G2_AND_M_PHASES,0.879649302030457
KEGG_TIGHT_JUNCTION,SET,125,0.086086,0.0070755,0.079289,0.13881,KEGG_TIGHT_JUNCTION,0.879649302030457
HP_HYPOPLASTIC_FEMALE_EXTERN...,SET,55,0.13118,0.0071656,0.12084,0.13884,HP_HYPOPLASTIC_FEMALE_EXTERNAL_GENITALIA,0.879649302030457
HP_HEMATURIA,SET,164,0.075329,0.0070842,0.069401,0.13888,HP_HEMATURIA,0.879649302030457
REACTOME_TRAFFICKING_AND_PRO...,SET,11,0.29439,0.0072002,0.27124,0.13889,REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,0.879649302030457
GSE369_PRE_VS_POST_IL6_INJEC...1,SET,177,0.069214,0.0067597,0.063774,0.1389,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN,0.879649302030457
KEGG_MEDICUS_REFERENCE_CCR2_...,SET,30,0.17238,0.0069591,0.15886,0.13893,KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,0.879649302030457
KEGG_MEDICUS_PATHOGEN_HIV_VP...2,SET,8,0.26567,0.0055417,0.24485,0.13896,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M,0.879649302030457
ZID_01,SET,233,0.059832,0.0066941,0.055147,0.13898,ZID_01,0.879649302030457
GOMF_SPLICING_FACTOR_BINDING,SET,5,0.37056,0.0061114,0.34156,0.13899,GOMF_SPLICING_FACTOR_BINDING,0.879649302030457
HP_EEG_WITH_CONTINUOUS_SLOW_...,SET,8,0.30392,0.0063395,0.28016,0.13901,HP_EEG_WITH_CONTINUOUS_SLOW_ACTIVITY,0.879649302030457
GSE8515_IL1_VS_IL6_4H_STIM_M...1,SET,172,0.071685,0.0069025,0.066085,0.13902,GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN,0.879649302030457
GOMF_NITRIC_OXIDE_SYNTHASE_B...,SET,10,0.31713,0.0073956,0.2924,0.13906,GOMF_NITRIC_OXIDE_SYNTHASE_BINDING,0.879649302030457
GSE5589_WT_VS_IL10_KO_LPS_ST...4,SET,179,0.067013,0.0065813,0.061787,0.13906,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.879649302030457
HENDRICKS_SMARCA4_TARGETS_UP,SET,51,0.14175,0.0074567,0.13071,0.1391,HENDRICKS_SMARCA4_TARGETS_UP,0.879649302030457
HP_ELFIN_FACIES,SET,18,0.27894,0.0087254,0.25726,0.13913,HP_ELFIN_FACIES,0.879649302030457
MULLIGHAN_NPM1_MUTATED_SIGNA...4,SET,114,0.088353,0.006937,0.081502,0.13918,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,0.879649302030457
HP_PANCREATIC_CALCIFICATION,SET,8,0.37433,0.0078083,0.34532,0.13919,HP_PANCREATIC_CALCIFICATION,0.879649302030457
BUSSLINGER_GASTRIC_PPP1R1B_P...,SET,114,0.086427,0.0067858,0.079734,0.1392,BUSSLINGER_GASTRIC_PPP1R1B_POSITIVE_CELLS,0.879649302030457
REACTOME_BETA_OXIDATION_OF_B...,SET,5,0.43074,0.0071037,0.39744,0.13924,REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA,0.879649302030457
GOMF_LIPOPROTEIN_PARTICLE_RE...2,SET,28,0.17965,0.007007,0.16576,0.13924,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,0.879649302030457
GOBP_SMOOTH_MUSCLE_CELL_MIGR...,SET,67,0.12468,0.0075145,0.11505,0.13926,GOBP_SMOOTH_MUSCLE_CELL_MIGRATION,0.879649302030457
WP_IMMUNE_INFILTRATION_IN_PA...,SET,38,0.161,0.0073134,0.14857,0.13927,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.879649302030457
HP_ACUTE_RHABDOMYOLYSIS,SET,5,0.39377,0.0064941,0.36338,0.13928,HP_ACUTE_RHABDOMYOLYSIS,0.879649302030457
HP_DISCOID_LUPUS_RASH,SET,28,0.19481,0.0075981,0.1798,0.1393,HP_DISCOID_LUPUS_RASH,0.879649302030457
GNF2_BUB3,SET,26,0.16911,0.0063561,0.15608,0.13931,GNF2_BUB3,0.879649302030457
REACTOME_RAC3_GTPASE_CYCLE,SET,82,0.1089,0.0072581,0.10052,0.13932,REACTOME_RAC3_GTPASE_CYCLE,0.879649302030457
HP_ABNORMAL_ERYTHROCYTE_PHYS...,SET,15,0.25497,0.0072812,0.23533,0.13932,HP_ABNORMAL_ERYTHROCYTE_PHYSIOLOGY,0.879649302030457
REACTOME_DEFECTIVE_LFNG_CAUS...,SET,5,0.44645,0.0073629,0.41216,0.13937,REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3,0.879649302030457
CTCAGGG_MIR125B_MIR125A,SET,303,0.052559,0.0066929,0.048528,0.1394,CTCAGGG_MIR125B_MIR125A,0.879649302030457
GOBP_AMINO_ACID_BETAINE_META...,SET,16,0.23268,0.0068626,0.21485,0.13941,GOBP_AMINO_ACID_BETAINE_METABOLIC_PROCESS,0.879649302030457
MIR7162_5P,SET,162,0.073059,0.006829,0.067464,0.13943,MIR7162_5P,0.879649302030457
REACTOME_GLUCURONIDATION,SET,23,0.27189,0.0096124,0.25109,0.13945,REACTOME_GLUCURONIDATION,0.879649302030457
GOCC_CHITOSOME,SET,20,0.2243,0.0073955,0.20717,0.13948,GOCC_CHITOSOME,0.879649302030457
GOBP_CENTRIOLE_ELONGATION,SET,7,0.33349,0.0065073,0.30804,0.13949,GOBP_CENTRIOLE_ELONGATION,0.879649302030457
GOBP_MYELOID_DENDRITIC_CELL_...2,SET,6,0.37702,0.0068112,0.34823,0.13949,GOBP_MYELOID_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.879649302030457
HP_PROTRUSIO_ACETABULI,SET,12,0.29901,0.0076382,0.27619,0.13949,HP_PROTRUSIO_ACETABULI,0.879649302030457
MIR1976,SET,79,0.10354,0.0067736,0.095646,0.13952,MIR1976,0.879649302030457
HMEF2_Q6,SET,129,0.083533,0.0069739,0.077175,0.13955,HMEF2_Q6,0.879649302030457
GOMF_HISTONE_H3K4_MONOMETHYL...,SET,8,0.31855,0.0066447,0.29435,0.13959,GOMF_HISTONE_H3K4_MONOMETHYLTRANSFERASE_ACTIVITY,0.879649302030457
HP_ADRENAL_HYPOPLASIA,SET,28,0.18191,0.0070951,0.16809,0.13959,HP_ADRENAL_HYPOPLASIA,0.879649302030457
KANG_FLUOROURACIL_RESISTANCE...2,SET,19,0.20289,0.0065201,0.18749,0.13961,KANG_FLUOROURACIL_RESISTANCE_UP,0.879649302030457
KIM_MYC_AMPLIFICATION_TARGET...1,SET,87,0.10642,0.0073048,0.098361,0.13964,KIM_MYC_AMPLIFICATION_TARGETS_DN,0.879678847199565
GOBP_ATF6_MEDIATED_UNFOLDED_...,SET,8,0.30769,0.0064182,0.28442,0.13968,GOBP_ATF6_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.879771366437115
GSE1460_INTRATHYMIC_T_PROGEN...3,SET,174,0.070376,0.0068153,0.065092,0.13981,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN,0.880204047446577
ATF6_01,SET,118,0.083562,0.0066742,0.077289,0.13982,ATF6_01,0.880204047446577
GOBP_OVULATION_FROM_OVARIAN_...,SET,9,0.32954,0.0072909,0.30482,0.13983,GOBP_OVULATION_FROM_OVARIAN_FOLLICLE,0.880204047446577
MIR584_5P,SET,79,0.10437,0.0068283,0.096547,0.13985,MIR584_5P,0.880204047446577
ZHU_CMV_24_HR_UP,SET,79,0.10287,0.0067302,0.095172,0.13988,ZHU_CMV_24_HR_UP,0.880233460076046
chr1p33,SET,28,0.28433,0.01109,0.2631,0.13993,chr1p33,0.880288121946807
GOMF_FUCOSE_BINDING,SET,8,0.33772,0.0070446,0.31252,0.13994,GOMF_FUCOSE_BINDING,0.880288121946807
HP_EPISODIC_TACHYPNEA,SET,48,0.11441,0.0058393,0.10589,0.13997,HP_EPISODIC_TACHYPNEA,0.880288121946807
MIR6815_3P,SET,187,0.068095,0.0068339,0.063027,0.13999,MIR6815_3P,0.880288121946807
GOCC_L_TYPE_VOLTAGE_GATED_CA...,SET,12,0.29751,0.0075999,0.27554,0.14013,GOCC_L_TYPE_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.880329671295483
HP_CHRONIC_NEUTROPENIA,SET,9,0.2765,0.0061174,0.25609,0.14015,HP_CHRONIC_NEUTROPENIA,0.880329671295483
PID_NCADHERIN_PATHWAY,SET,33,0.16848,0.0071331,0.15606,0.14017,PID_NCADHERIN_PATHWAY,0.880329671295483
GOMF_HYDROLASE_ACTIVITY_HYDR...1,SET,37,0.16693,0.0074826,0.15465,0.14021,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS,0.880329671295483
GSE32255_UNSTIM_VS_4H_LPS_ST...1,SET,140,0.077599,0.006747,0.071898,0.14023,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN,0.880329671295483
DEMAGALHAES_AGING_DN,SET,13,0.24601,0.0065406,0.22796,0.14026,DEMAGALHAES_AGING_DN,0.880329671295483
GOBP_RETINA_DEVELOPMENT_IN_C...,SET,155,0.078464,0.0071755,0.072706,0.14026,GOBP_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.880329671295483
GOBP_POSITIVE_REGULATION_OF_...296,SET,1057,0.029988,0.0069818,0.027792,0.1403,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION,0.880329671295483
HP_ABNORMAL_MORPHOLOGY_OF_MU...,SET,4,0.418,0.0061661,0.38741,0.14031,HP_ABNORMAL_MORPHOLOGY_OF_MUSCULATURE_OF_PHARYNX,0.880329671295483
HP_ABNORMAL_VOCAL_CORD_MORPH...,SET,4,0.418,0.0061661,0.38741,0.14031,HP_ABNORMAL_VOCAL_CORD_MORPHOLOGY,0.880329671295483
HAY_BONE_MARROW_CD34_POS_GRAN,SET,24,0.19451,0.0070243,0.18028,0.14033,HAY_BONE_MARROW_CD34_POS_GRAN,0.880329671295483
GOMF_INORGANIC_DIPHOSPHATE_P...,SET,4,0.52565,0.007754,0.48723,0.14034,GOMF_INORGANIC_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,0.880329671295483
HP_ABNORMALITY_OF_URINE_CALC...,SET,63,0.13237,0.0077367,0.12274,0.14042,HP_ABNORMALITY_OF_URINE_CALCIUM_CONCENTRATION,0.880329671295483
REACTOME_PKMTS_METHYLATE_HIS...,SET,36,0.1447,0.0063978,0.13418,0.14044,REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,0.880329671295483
GSE14908_ATOPIC_VS_NONATOPIC...3,SET,180,0.064147,0.0063173,0.059488,0.14045,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN,0.880329671295483
HP_CURLY_EYELASHES,SET,12,0.29631,0.0075691,0.27488,0.14053,HP_CURLY_EYELASHES,0.880329671295483
GSE16522_MEMORY_VS_NAIVE_ANT...1,SET,183,0.068635,0.0068147,0.063676,0.14055,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN,0.880329671295483
GSE360_CTRL_VS_T_GONDII_DC_DN,SET,176,0.072613,0.0070718,0.06737,0.14057,GSE360_CTRL_VS_T_GONDII_DC_DN,0.880329671295483
GSE22045_TREG_VS_TCONV_DN,SET,157,0.07353,0.0067671,0.068225,0.14058,GSE22045_TREG_VS_TCONV_DN,0.880329671295483
GOBP_REGULATION_OF_SERINE_TY...,SET,5,0.44737,0.007378,0.41524,0.14067,GOBP_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.880329671295483
KEGG_ENDOCYTOSIS,SET,175,0.070684,0.0068646,0.065613,0.14068,KEGG_ENDOCYTOSIS,0.880329671295483
FERRANDO_T_ALL_WITH_MLL_ENL_...2,SET,76,0.10825,0.0069467,0.10049,0.1407,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,0.880329671295483
GSE20366_CD103_KLRG1_DP_VS_D...2,SET,180,0.068246,0.0067209,0.063354,0.1407,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP,0.880329671295483
GSE12198_CTRL_VS_LOW_IL2_STI...1,SET,193,0.064555,0.0065806,0.059929,0.14071,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN,0.880329671295483
HP_SEPSIS,SET,106,0.093089,0.0070493,0.086434,0.14075,HP_SEPSIS,0.880329671295483
GOBP_NUCLEAR_EXPORT,SET,153,0.069488,0.0063138,0.064528,0.14078,GOBP_NUCLEAR_EXPORT,0.880329671295483
GOCC_TRANS_GOLGI_NETWORK_MEM...,SET,95,0.095389,0.0068405,0.0886,0.14083,GOCC_TRANS_GOLGI_NETWORK_MEMBRANE,0.880329671295483
HP_LACRIMAL_DUCT_ATRESIA,SET,5,0.47566,0.0078447,0.44181,0.14083,HP_LACRIMAL_DUCT_ATRESIA,0.880329671295483
FARMER_BREAST_CANCER_CLUSTER...4,SET,18,0.23957,0.0074937,0.22253,0.14085,FARMER_BREAST_CANCER_CLUSTER_4,0.880329671295483
GOBP_PURINE_RIBONUCLEOSIDE_S...,SET,6,0.41754,0.0075432,0.38787,0.14086,GOBP_PURINE_RIBONUCLEOSIDE_SALVAGE,0.880329671295483
GCM_TPR,SET,29,0.15656,0.0062141,0.14549,0.14095,GCM_TPR,0.880329671295483
HP_COARCTATION_OF_AORTA,SET,128,0.080443,0.00669,0.074755,0.14095,HP_COARCTATION_OF_AORTA,0.880329671295483
GOMF_C_X_C_CHEMOKINE_RECEPTO...,SET,7,0.35965,0.0070178,0.33429,0.141,GOMF_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY,0.880329671295483
HP_COGNITIVE_DISTORTION,SET,29,0.17298,0.0068659,0.16079,0.14101,HP_COGNITIVE_DISTORTION,0.880329671295483
HP_CLAW_HAND_DEFORMITY,SET,8,0.3326,0.0069377,0.30919,0.14104,HP_CLAW_HAND_DEFORMITY,0.880329671295483
GOMF_BITTER_TASTE_RECEPTOR_A...,SET,22,0.26493,0.0091609,0.24631,0.14106,GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY,0.880329671295483
HP_FRAGMENTED_EPIPHYSES,SET,5,0.48493,0.0079975,0.45089,0.14108,HP_FRAGMENTED_EPIPHYSES,0.880329671295483
TESAR_JAK_TARGETS_MOUSE_ES_D...,SET,7,0.39152,0.0076396,0.36405,0.1411,TESAR_JAK_TARGETS_MOUSE_ES_D3_DN,0.880329671295483
GOCC_HISTONE_DEACETYLASE_COM...,SET,73,0.098343,0.0061858,0.091447,0.1411,GOCC_HISTONE_DEACETYLASE_COMPLEX,0.880329671295483
GSE30971_CTRL_VS_LPS_STIM_MA...2,SET,167,0.079273,0.0075224,0.073721,0.14112,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP,0.880329671295483
FRASOR_RESPONSE_TO_ESTRADIOL...2,SET,33,0.17026,0.0072083,0.15835,0.14114,FRASOR_RESPONSE_TO_ESTRADIOL_UP,0.880329671295483
GSE45365_HEALTHY_VS_MCMV_INF...3,SET,162,0.074891,0.0070003,0.069659,0.14117,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN,0.880329671295483
GOBP_REGULATION_OF_COAGULATI...,SET,73,0.11162,0.007021,0.10385,0.14122,GOBP_REGULATION_OF_COAGULATION,0.880329671295483
HP_ABNORMAL_PUTAMEN_MORPHOLO...,SET,5,0.42439,0.006999,0.39481,0.14122,HP_ABNORMAL_PUTAMEN_MORPHOLOGY,0.880329671295483
TBP_01,SET,223,0.064116,0.0070197,0.059654,0.14124,TBP_01,0.880329671295483
HP_SUBUNGUAL_HYPERKERATOSIS,SET,6,0.38246,0.0069093,0.35593,0.1413,HP_SUBUNGUAL_HYPERKERATOSIS,0.880329671295483
GOBP_REGULATION_OF_AMPA_RECE...,SET,19,0.22162,0.0071223,0.20626,0.14131,GOBP_REGULATION_OF_AMPA_RECEPTOR_ACTIVITY,0.880329671295483
GOBP_ENDOTHELIAL_CELL_CHEMOT...,SET,26,0.19415,0.0072975,0.1807,0.14132,GOBP_ENDOTHELIAL_CELL_CHEMOTAXIS,0.880329671295483
GSE7548_NAIVE_VS_DAY7_PCC_IM...2,SET,184,0.06397,0.0063687,0.059539,0.14132,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP,0.880329671295483
HP_TIBIAL_TORSION,SET,20,0.20247,0.0066756,0.18846,0.14134,HP_TIBIAL_TORSION,0.880329671295483
GSE13411_NAIVE_VS_IGM_MEMORY...1,SET,183,0.066877,0.0066402,0.062255,0.14136,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.880329671295483
GSE1432_CTRL_VS_IFNG_24H_MIC...2,SET,186,0.067949,0.0068012,0.063256,0.14137,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.880329671295483
REACTOME_DEFENSINS,SET,32,0.22125,0.0092241,0.20598,0.14139,REACTOME_DEFENSINS,0.880329671295483
HP_SINGLE_LINEAGE_MYELODYSPL...,SET,5,0.3692,0.0060889,0.34385,0.14148,HP_SINGLE_LINEAGE_MYELODYSPLASIA,0.880329671295483
GOBP_CELLULAR_RESPONSE_TO_HI...,SET,6,0.38425,0.0069418,0.35788,0.14149,GOBP_CELLULAR_RESPONSE_TO_HISTAMINE,0.880329671295483
GOBP_GLYCOSYL_COMPOUND_METAB...,SET,75,0.11249,0.0071715,0.10477,0.1415,GOBP_GLYCOSYL_COMPOUND_METABOLIC_PROCESS,0.880329671295483
GSE43955_TGFB_IL6_VS_TGFB_IL...1,SET,176,0.073418,0.0071503,0.068391,0.14153,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.880329671295483
GSE34515_CD16_NEG_VS_POS_MON...2,SET,181,0.069632,0.0068762,0.064867,0.14154,GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP,0.880329671295483
GSE22886_CD8_VS_CD4_NAIVE_TC...1,SET,176,0.070986,0.0069134,0.066134,0.14156,GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN,0.880329671295483
GSE5679_CTRL_VS_PPARG_LIGAND...4,SET,179,0.06374,0.0062598,0.05939,0.14159,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP,0.880329671295483
SIRT3_TARGET_GENES,SET,38,0.14548,0.0066083,0.13556,0.1416,SIRT3_TARGET_GENES,0.880329671295483
HP_OVERTUBULATED_LONG_BONES,SET,7,0.34514,0.0067345,0.32162,0.14162,HP_OVERTUBULATED_LONG_BONES,0.880329671295483
HP_NEOPLASM_OF_THE_AUTONOMIC...,SET,10,0.34313,0.0080018,0.31979,0.14165,HP_NEOPLASM_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,0.880329671295483
HP_RED_EYE,SET,99,0.091351,0.0066866,0.085146,0.14167,HP_RED_EYE,0.880329671295483
MATZUK_SPERMATOGONIA,SET,25,0.1955,0.0072057,0.18228,0.14174,MATZUK_SPERMATOGONIA,0.880329671295483
GOBP_RENAL_WATER_TRANSPORT,SET,9,0.34447,0.0076212,0.32117,0.14174,GOBP_RENAL_WATER_TRANSPORT,0.880329671295483
GSE10239_KLRG1INT_VS_KLRG1HI...2,SET,183,0.065548,0.0065083,0.06112,0.14176,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.880329671295483
WILSON_PROTEASES_AT_TUMOR_BO...1,SET,5,0.4653,0.0076737,0.43393,0.14181,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN,0.880329671295483
MODULE_61,SET,47,0.13365,0.0067502,0.12468,0.14188,MODULE_61,0.880329671295483
GARGALOVIC_RESPONSE_TO_OXIDI...15,SET,30,0.18709,0.007553,0.17454,0.14189,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,0.880329671295483
HP_ELEVATED_SERUM_ANION_GAP,SET,4,0.45721,0.0067444,0.42663,0.14194,HP_ELEVATED_SERUM_ANION_GAP,0.880329671295483
DACOSTA_UV_RESPONSE_VIA_ERCC...4,SET,78,0.10462,0.0068012,0.097626,0.14195,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,0.880329671295483
HP_ABNORMAL_VISUAL_ACCOMMODA...,SET,5,0.38633,0.0063713,0.36051,0.14195,HP_ABNORMAL_VISUAL_ACCOMMODATION,0.880329671295483
GSE21927_EL4_VS_MCA203_TUMOR...1,SET,153,0.072017,0.0065436,0.067205,0.14196,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN,0.880329671295483
HP_PAPILLOMA,SET,46,0.12832,0.0064118,0.11976,0.14198,HP_PAPILLOMA,0.880329671295483
GOBP_VOCALIZATION_BEHAVIOR,SET,15,0.25681,0.0073338,0.23974,0.14205,GOBP_VOCALIZATION_BEHAVIOR,0.880329671295483
GSE27786_NKTCELL_VS_MONO_MAC...1,SET,179,0.069667,0.0068419,0.065036,0.14205,GSE27786_NKTCELL_VS_MONO_MAC_DN,0.880329671295483
GOBP_REGULATION_OF_BRANCHING...2,SET,5,0.49825,0.0082172,0.46524,0.14211,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,0.880329671295483
GOBP_POSITIVE_REGULATION_OF_...183,SET,6,0.37987,0.0068627,0.35474,0.14213,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.880329671295483
FEKIR_HEPARG_SIDE_POP_VS_HEP...2,SET,77,0.10271,0.0066344,0.095962,0.14224,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP,0.880329671295483
HAY_BONE_MARROW_EARLY_ERYTHR...,SET,82,0.10074,0.0067143,0.094124,0.14224,HAY_BONE_MARROW_EARLY_ERYTHROBLAST,0.880329671295483
GOCC_TRANSPORT_VESICLE,SET,397,0.04703,0.0068372,0.043941,0.14225,GOCC_TRANSPORT_VESICLE,0.880329671295483
GOBP_POSITIVE_REGULATION_OF_...424,SET,17,0.24249,0.0073716,0.22658,0.14227,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.880329671295483
MORF_RAC1,SET,186,0.064123,0.0064182,0.059922,0.14229,MORF_RAC1,0.880329671295483
GOCC_MANNOSYLTRANSFERASE_COM...,SET,4,0.35886,0.0052936,0.33535,0.1423,GOCC_MANNOSYLTRANSFERASE_COMPLEX,0.880329671295483
MIR142_3P,SET,163,0.074194,0.0069563,0.069346,0.14234,MIR142_3P,0.880329671295483
GOBP_CORONARY_VASCULATURE_DE...,SET,45,0.14002,0.00692,0.13092,0.14243,GOBP_CORONARY_VASCULATURE_DEVELOPMENT,0.880329671295483
GOBP_MITOTIC_SPINDLE_ORGANIZ...,SET,124,0.076261,0.006243,0.071307,0.14243,GOBP_MITOTIC_SPINDLE_ORGANIZATION,0.880329671295483
HAHTOLA_MYCOSIS_FUNGOIDES_DN,SET,13,0.25816,0.0068637,0.24139,0.14244,HAHTOLA_MYCOSIS_FUNGOIDES_DN,0.880329671295483
GSE22886_NAIVE_CD4_TCELL_VS_...7,SET,188,0.063814,0.0064211,0.059687,0.14251,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN,0.880329671295483
LAU_APOPTOSIS_CDKN2A_UP,SET,55,0.11853,0.0064748,0.11088,0.14254,LAU_APOPTOSIS_CDKN2A_UP,0.880329671295483
GSE19198_1H_VS_6H_IL21_TREAT...2,SET,145,0.078968,0.0069866,0.073878,0.14256,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP,0.880329671295483
GOBP_SINOATRIAL_NODE_DEVELOP...,SET,12,0.30254,0.0077283,0.28305,0.14257,GOBP_SINOATRIAL_NODE_DEVELOPMENT,0.880329671295483
GSE20727_CTRL_VS_ROS_INHIBIT...1,SET,180,0.067117,0.0066097,0.062796,0.14259,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN,0.880329671295483
MIR6860,SET,102,0.087601,0.0065081,0.081975,0.14263,MIR6860,0.880329671295483
GOMF_BASAL_TRANSCRIPTION_MAC...,SET,56,0.11909,0.0065641,0.11147,0.14267,GOMF_BASAL_TRANSCRIPTION_MACHINERY_BINDING,0.880329671295483
TRAVAGLINI_LUNG_CD4_NAIVE_T_...,SET,118,0.086586,0.0069158,0.081039,0.14267,TRAVAGLINI_LUNG_CD4_NAIVE_T_CELL,0.880329671295483
HP_LIMB_DYSMETRIA,SET,14,0.25006,0.0068991,0.23408,0.1427,HP_LIMB_DYSMETRIA,0.880329671295483
REACTOME_DEGRADATION_OF_CYST...,SET,14,0.25454,0.0070228,0.23836,0.14279,REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE,0.880329671295483
GOBP_INNER_EAR_RECEPTOR_CELL...2,SET,4,0.48111,0.0070971,0.45053,0.14279,GOBP_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT,0.880329671295483
GOBP_CALCIUM_ACTIVATED_PHOSP...,SET,5,0.453,0.0074709,0.42439,0.1429,GOBP_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING,0.880329671295483
GSE15330_HSC_VS_GRANULOCYTE_...3,SET,173,0.070254,0.0067841,0.065824,0.14292,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.880329671295483
GOBP_ENDOSOMAL_TRANSPORT,SET,255,0.05499,0.0064324,0.051532,0.14297,GOBP_ENDOSOMAL_TRANSPORT,0.880329671295483
HP_SLOW_PUPILLARY_LIGHT_RESP...,SET,17,0.21779,0.0066208,0.2041,0.14298,HP_SLOW_PUPILLARY_LIGHT_RESPONSE,0.880329671295483
MIR12123,SET,428,0.045117,0.0068044,0.042284,0.14299,MIR12123,0.880329671295483
HP_THICKENED_CORTEX_OF_LONG_...,SET,14,0.25508,0.0070376,0.23907,0.14301,HP_THICKENED_CORTEX_OF_LONG_BONES,0.880329671295483
WP_INCLUSION_BODY_MYOSITIS,SET,10,0.28603,0.0066703,0.26812,0.14303,WP_INCLUSION_BODY_MYOSITIS,0.880329671295483
LAKE_ADULT_KIDNEY_C1_EPITHEL...,SET,27,0.18699,0.0071618,0.17527,0.14303,LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED,0.880329671295483
HP_ABNORMALITY_OF_THE_OVARY,SET,216,0.061961,0.0066777,0.058083,0.14305,HP_ABNORMALITY_OF_THE_OVARY,0.880329671295483
HP_GENERALIZED_HYPERTRICHOSIS,SET,8,0.3412,0.0071173,0.31985,0.14305,HP_GENERALIZED_HYPERTRICHOSIS,0.880329671295483
HOEK_MYELOID_DENDRITIC_CELL_...1,SET,5,0.41286,0.0068089,0.38708,0.14308,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_DN,0.880329671295483
SCHERER_PBMC_APSV_WETVAX_AGE...9,SET,55,0.13712,0.0074898,0.12858,0.14314,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.880329671295483
SCHERER_PBMC_YF_VAX_AGE_18_4...5,SET,55,0.13712,0.0074898,0.12858,0.14314,SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.880329671295483
GOBP_POSITIVE_REGULATION_OF_...565,SET,50,0.13581,0.0070741,0.12738,0.14319,GOBP_POSITIVE_REGULATION_OF_OSSIFICATION,0.880329671295483
GOMF_BETA_N_ACETYLHEXOSAMINI...,SET,3,0.56337,0.0071974,0.52847,0.14321,GOMF_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY,0.880329671295483
TRAVAGLINI_LUNG_CAPILLARY_IN...2,SET,353,0.048722,0.0066874,0.045706,0.14322,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL,0.880329671295483
LIU_SOX4_TARGETS_DN,SET,286,0.053655,0.0066411,0.050343,0.14326,LIU_SOX4_TARGETS_DN,0.880329671295483
GRE_C,SET,112,0.089154,0.0069386,0.083647,0.14326,GRE_C,0.880329671295483
KEGG_MEDICUS_REFERENCE_FE3_F...,SET,5,0.45263,0.0074648,0.42469,0.14327,KEGG_MEDICUS_REFERENCE_FE3_FERRITIN_TRANSPORT,0.880329671295483
NAKAYA_MYELOID_DENDRITIC_CEL...1,SET,238,0.056159,0.0063493,0.052693,0.14327,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.880329671295483
HP_TETRALOGY_OF_FALLOT,SET,156,0.074954,0.0068763,0.070334,0.14329,HP_TETRALOGY_OF_FALLOT,0.880329671295483
MAYBURD_RESPONSE_TO_L663536_...2,SET,22,0.1805,0.0062413,0.16939,0.14331,MAYBURD_RESPONSE_TO_L663536_UP,0.880329671295483
MORI_EMU_MYC_LYMPHOMA_BY_ONS...1,SET,16,0.21619,0.0063763,0.20288,0.14331,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,0.880329671295483
MIR1290,SET,241,0.059849,0.0068084,0.056172,0.14334,MIR1290,0.880329671295483
GSE5589_UNSTIM_VS_45MIN_LPS_...1,SET,181,0.065452,0.0064635,0.061435,0.14336,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.880329671295483
E2F3_UP.V1_UP,SET,175,0.069189,0.0067194,0.064951,0.14339,E2F3_UP.V1_UP,0.880329671295483
LI_CISPLATIN_RESISTANCE_DN,SET,28,0.19264,0.0075137,0.18085,0.1434,LI_CISPLATIN_RESISTANCE_DN,0.880329671295483
GOBP_CELL_PROLIFERATION_IN_M...,SET,7,0.37899,0.0073951,0.35583,0.14343,GOBP_CELL_PROLIFERATION_IN_MIDBRAIN,0.880329671295483
MIR4671_5P,SET,7,0.35186,0.0068658,0.33039,0.14345,MIR4671_5P,0.880329671295483
GOCC_CATALYTIC_COMPLEX,SET,1515,0.023322,0.0064143,0.0219,0.14346,GOCC_CATALYTIC_COMPLEX,0.880329671295483
GOCC_BETA_CATENIN_DESTRUCTIO...,SET,12,0.25717,0.0065694,0.24155,0.14352,GOCC_BETA_CATENIN_DESTRUCTION_COMPLEX,0.880329671295483
GSE28237_FOLLICULAR_VS_LATE_...2,SET,180,0.071813,0.0070722,0.067478,0.14361,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP,0.880329671295483
REACTOME_SIGNALLING_TO_ERKS,SET,34,0.15723,0.0067565,0.14775,0.14364,REACTOME_SIGNALLING_TO_ERKS,0.880329671295483
GOMF_ABC_TYPE_TRANSPORTER_AC...,SET,46,0.14493,0.0072417,0.13619,0.14364,GOMF_ABC_TYPE_TRANSPORTER_ACTIVITY,0.880329671295483
GAVISH_3CA_MALIGNANT_METAPRO...27,SET,46,0.14972,0.0074809,0.1407,0.14365,GAVISH_3CA_MALIGNANT_METAPROGRAM_35_HEMATO_RELATED_1,0.880329671295483
HP_ORAL_ULCER,SET,57,0.12231,0.0068008,0.11495,0.14366,HP_ORAL_ULCER,0.880329671295483
CAIRO_HEPATOBLASTOMA_CLASSES...2,SET,559,0.036935,0.006343,0.034713,0.14367,CAIRO_HEPATOBLASTOMA_CLASSES_UP,0.880329671295483
GOCC_MANCHETTE,SET,20,0.20924,0.0068988,0.19667,0.14369,GOCC_MANCHETTE,0.880329671295483
XBP1_01,SET,113,0.085467,0.0066811,0.080339,0.14371,XBP1_01,0.880329671295483
GSE15659_NAIVE_CD4_TCELL_VS_...3,SET,175,0.07072,0.0068681,0.066476,0.14371,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,0.880329671295483
GSE28783_ANTI_MIR33_VS_CTRL_...2,SET,184,0.071557,0.0071241,0.067276,0.14375,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP,0.880329671295483
ANDERSON_BLOOD_CN54GP140_ADJ...2,SET,63,0.11871,0.0069383,0.11162,0.14378,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP,0.880329671295483
GSE360_L_MAJOR_VS_B_MALAYI_L...3,SET,177,0.066619,0.0065063,0.062644,0.1438,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.880329671295483
HP_VENTRICULAR_ESCAPE_RHYTHM,SET,8,0.34105,0.0071141,0.32073,0.14382,HP_VENTRICULAR_ESCAPE_RHYTHM,0.880329671295483
GOBP_REGULATION_OF_DOPAMINER...,SET,9,0.34829,0.0077056,0.32756,0.14383,GOBP_REGULATION_OF_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.880329671295483
GOBP_REGULATION_OF_MYOFIBROB...,SET,6,0.31319,0.005658,0.29455,0.14384,GOBP_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,0.880329671295483
HALLMARK_PANCREAS_BETA_CELLS,SET,38,0.1695,0.0076994,0.15942,0.14385,HALLMARK_PANCREAS_BETA_CELLS,0.880329671295483
ATGTACA_MIR493,SET,294,0.055293,0.0069373,0.052007,0.14386,ATGTACA_MIR493,0.880329671295483
GSE10147_IL3_AND_HIVP17_VS_I...2,SET,132,0.0836,0.0070596,0.078632,0.14386,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP,0.880329671295483
GOBP_PHOSPHATIDYLCHOLINE_ACY...,SET,13,0.25562,0.0067961,0.24047,0.1439,GOBP_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING,0.880329671295483
MORF_RBM8A,SET,77,0.10242,0.0066156,0.096362,0.14393,MORF_RBM8A,0.880329671295483
GSE21033_1H_VS_24H_POLYIC_ST...1,SET,152,0.072791,0.0065925,0.068486,0.14393,GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN,0.880329671295483
GSE45365_WT_VS_IFNAR_KO_BCEL...1,SET,149,0.075469,0.0067677,0.071009,0.14394,GSE45365_WT_VS_IFNAR_KO_BCELL_DN,0.880329671295483
REACTOME_DIGESTION_OF_DIETAR...1,SET,7,0.34856,0.0068014,0.32798,0.14395,REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE,0.880329671295483
HP_APLASIA_HYPOPLASIA_OF_THE...53,SET,27,0.19064,0.0073016,0.17939,0.14397,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_FINGER,0.880329671295483
MIR6798_5P,SET,42,0.13697,0.0065402,0.1289,0.144,MIR6798_5P,0.880329671295483
DURANTE_ADULT_OLFACTORY_NEUR...15,SET,18,0.24005,0.007509,0.22596,0.14404,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS,0.880329671295483
MIR6878_5P,SET,197,0.067255,0.0069257,0.063307,0.14405,MIR6878_5P,0.880329671295483
GOBP_RIBOSOMAL_LARGE_SUBUNIT...3,SET,7,0.31658,0.0061773,0.29803,0.14407,GOBP_RIBOSOMAL_LARGE_SUBUNIT_EXPORT_FROM_NUCLEUS,0.880329671295483
GOBP_RAS_PROTEIN_SIGNAL_TRAN...,SET,116,0.083151,0.0065852,0.078281,0.14408,GOBP_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.880329671295483
GSE369_PRE_VS_POST_IL6_INJEC...5,SET,185,0.06426,0.0064147,0.060498,0.14409,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN,0.880329671295483
MIR1277_3P,SET,14,0.24211,0.0066799,0.22795,0.1441,MIR1277_3P,0.880329671295483
GOCC_HAUS_COMPLEX,SET,7,0.28113,0.0054855,0.26478,0.14418,GOCC_HAUS_COMPLEX,0.880663602811951
CARRILLOREIXACH_MRS3_VS_LOWE...2,SET,38,0.14532,0.0066011,0.13691,0.14426,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_UP,0.880903698172874
MIR598_5P,SET,4,0.46729,0.0068932,0.44027,0.14427,MIR598_5P,0.880903698172874
GOMF_PHOSPHATIDYLETHANOLAMIN...1,SET,16,0.22836,0.006735,0.21518,0.1443,GOMF_PHOSPHATIDYLETHANOLAMINE_BINDING,0.880932109608291
GOBP_INTRACELLULAR_PROTEIN_T...1,SET,29,0.16764,0.0066538,0.158,0.14435,GOBP_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.881082586933614
HP_NEOPLASM_OF_THE_LARYNX,SET,18,0.20694,0.0064732,0.19512,0.14444,HP_NEOPLASM_OF_THE_LARYNX,0.881383383075843
WP_FOXP3_IN_COVID19,SET,13,0.30759,0.008178,0.29002,0.14445,WP_FOXP3_IN_COVID19,0.881383383075843
GOBP_HEPATICOBILIARY_SYSTEM_...,SET,141,0.080089,0.0069882,0.075528,0.14449,GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT,0.881439987714988
HP_FETAL_PYELECTASIS,SET,9,0.32411,0.0071705,0.30568,0.14451,HP_FETAL_PYELECTASIS,0.881439987714988
GOBP_ALPHA_KETOGLUTARATE_TRA...,SET,7,0.33904,0.0066156,0.31984,0.14457,GOBP_ALPHA_KETOGLUTARATE_TRANSPORT,0.881651228285664
GSE17721_POLYIC_VS_GARDIQUIM...4,SET,181,0.066385,0.0065556,0.062634,0.1446,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP,0.881679473684211
GOMF_RNA_POLYMERASE_II_CTD_H...2,SET,17,0.20747,0.0063071,0.19577,0.14464,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_MODIFYING_ACTIVITY,0.881768672162778
MIR4646_3P,SET,54,0.12845,0.0069524,0.12125,0.14472,MIR4646_3P,0.882041154855643
VALK_AML_CLUSTER_13,SET,29,0.18662,0.0074074,0.1762,0.14477,VALK_AML_CLUSTER_13,0.882041154855643
ZHAN_EARLY_DIFFERENTIATION_G...2,SET,6,0.37379,0.0067528,0.35294,0.14479,ZHAN_EARLY_DIFFERENTIATION_GENES_UP,0.882041154855643
HP_HYDROXYPROLINURIA,SET,9,0.37073,0.0082021,0.3501,0.14483,HP_HYDROXYPROLINURIA,0.882041154855643
NAKAJIMA_EOSINOPHIL,SET,22,0.22331,0.0077217,0.2109,0.14484,NAKAJIMA_EOSINOPHIL,0.882041154855643
GOMF_HYDROLASE_ACTIVITY_ACTI...9,SET,121,0.086796,0.0070195,0.081979,0.14486,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS,0.882041154855643
GOBP_EPITHELIAL_CELL_DEVELOP...,SET,205,0.067928,0.0071341,0.064159,0.14487,GOBP_EPITHELIAL_CELL_DEVELOPMENT,0.882041154855643
HP_TYPE_I_DIABETES_MELLITUS,SET,51,0.12863,0.0067669,0.12152,0.14491,HP_TYPE_I_DIABETES_MELLITUS,0.882041154855643
HP_SIMPLE_FEBRILE_SEIZURE,SET,25,0.19689,0.0072568,0.18604,0.14496,HP_SIMPLE_FEBRILE_SEIZURE,0.882041154855643
GSE1740_UNSTIM_VS_IFNA_STIMU...3,SET,166,0.068523,0.006483,0.064746,0.14496,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN,0.882041154855643
HP_HYPOPIGMENTED_SKIN_PATCHES,SET,105,0.08474,0.0063869,0.080077,0.14498,HP_HYPOPIGMENTED_SKIN_PATCHES,0.882041154855643
GOBP_AXIS_ELONGATION,SET,28,0.19176,0.0074793,0.18122,0.14499,GOBP_AXIS_ELONGATION,0.882041154855643
GOBP_NEGATIVE_REGULATION_OF_...602,SET,45,0.1413,0.0069836,0.13355,0.14502,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.882041154855643
BROWNE_HCMV_INFECTION_14HR_UP,SET,138,0.072819,0.0062863,0.068829,0.14504,BROWNE_HCMV_INFECTION_14HR_UP,0.882041154855643
GOBP_PROTEIN_SUMOYLATION,SET,59,0.11448,0.0064758,0.10823,0.14511,GOBP_PROTEIN_SUMOYLATION,0.882312465010497
ONDER_CDH1_TARGETS_3_DN,SET,55,0.1333,0.0072814,0.12606,0.14516,ONDER_CDH1_TARGETS_3_DN,0.882359113946173
GOBP_NEGATIVE_REGULATION_OF_...691,SET,20,0.20026,0.0066027,0.18943,0.14522,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.882359113946173
GOBP_RNA_SPLICING,SET,398,0.042881,0.0062417,0.040562,0.14522,GOBP_RNA_SPLICING,0.882359113946173
NFKB_C,SET,244,0.05917,0.0067725,0.055976,0.14525,NFKB_C,0.882359113946173
GOBP_PARACRINE_SIGNALING,SET,6,0.39872,0.0072031,0.37719,0.14525,GOBP_PARACRINE_SIGNALING,0.882359113946173
GOBP_CARDIAC_MUSCLE_CELL_ACT...1,SET,77,0.1144,0.0073895,0.10823,0.14527,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.882359113946173
GOBP_NEGATIVE_REGULATION_OF_...335,SET,5,0.39797,0.0065633,0.37661,0.14533,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.882536556603774
HP_CUBITUS_VALGUS,SET,45,0.12945,0.0063977,0.12251,0.14535,HP_CUBITUS_VALGUS,0.882536556603774
FULCHER_INFLAMMATORY_RESPONS...1,SET,405,0.046704,0.0068563,0.04421,0.1454,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,0.882685938864629
RODRIGUES_NTN1_AND_DCC_TARGE...,SET,29,0.17924,0.0071144,0.16971,0.14545,RODRIGUES_NTN1_AND_DCC_TARGETS,0.882835268948655
GOLDRATH_EFF_VS_MEMORY_CD8_T...2,SET,183,0.066679,0.0066205,0.06315,0.14552,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP,0.883091025641026
LIU_IL13_MEMORY_MODEL_DN,SET,4,0.43112,0.0063596,0.40836,0.14555,LIU_IL13_MEMORY_MODEL_DN,0.883091025641026
GSE39382_IL3_VS_IL3_IL33_TRE...1,SET,177,0.068404,0.0066807,0.064799,0.14557,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN,0.883091025641026
GOMF_GDP_BINDING,SET,70,0.11055,0.0068099,0.10474,0.14562,GOMF_GDP_BINDING,0.883091025641026
GOBP_REGULATION_OF_GUANYLATE...,SET,6,0.38812,0.0070117,0.36775,0.14563,GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,0.883091025641026
MODULE_38,SET,424,0.046295,0.0069503,0.04387,0.14566,MODULE_38,0.883091025641026
HP_ABNORMAL_SPERM_MOTILITY,SET,93,0.092213,0.0065431,0.087389,0.14567,HP_ABNORMAL_SPERM_MOTILITY,0.883091025641026
PID_TCPTP_PATHWAY,SET,42,0.14898,0.0071138,0.14124,0.14576,PID_TCPTP_PATHWAY,0.883295658995816
GSE19888_ADENOSINE_A3R_ACT_V...3,SET,182,0.065527,0.0064886,0.062127,0.14578,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN,0.883295658995816
DESCARTES_MAIN_FETAL_SATELLI...,SET,44,0.13413,0.0065552,0.12717,0.14578,DESCARTES_MAIN_FETAL_SATELLITE_CELLS,0.883295658995816
HP_ENTEROCOLITIS,SET,19,0.20017,0.0064328,0.18987,0.14589,HP_ENTEROCOLITIS,0.883321137859369
MIR6502_3P,SET,50,0.13104,0.0068255,0.1243,0.1459,MIR6502_3P,0.883321137859369
REACTOME_TRANSCRIPTION_OF_TH...,SET,62,0.096564,0.0055992,0.091607,0.14592,REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME,0.883321137859369
JI_CARCINOGENESIS_BY_KRAS_AN...1,SET,16,0.26221,0.0077334,0.24876,0.14593,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,0.883321137859369
MIR1229_5P,SET,30,0.18077,0.0072975,0.17151,0.14595,MIR1229_5P,0.883321137859369
GSE17721_LPS_VS_CPG_24H_BMDC...1,SET,190,0.064369,0.006511,0.06108,0.14598,GSE17721_LPS_VS_CPG_24H_BMDC_DN,0.883321137859369
SENGUPTA_NASOPHARYNGEAL_CARC...1,SET,293,0.05358,0.0067112,0.050866,0.1461,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,0.883321137859369
HP_EMBRYONAL_RENAL_NEOPLASM,SET,41,0.15799,0.0074538,0.14999,0.14611,HP_EMBRYONAL_RENAL_NEOPLASM,0.883321137859369
PID_CD40_PATHWAY,SET,30,0.17474,0.007054,0.1659,0.14612,PID_CD40_PATHWAY,0.883321137859369
GOBP_RIBOSOME_BIOGENESIS,SET,272,0.051188,0.0061811,0.048607,0.14615,GOBP_RIBOSOME_BIOGENESIS,0.883321137859369
HP_ABNORMAL_STOMACH_MORPHOLO...,SET,244,0.059545,0.0068154,0.056543,0.14616,HP_ABNORMAL_STOMACH_MORPHOLOGY,0.883321137859369
MATZUK_IMPLANTATION_AND_UTER...,SET,18,0.22618,0.0070749,0.21479,0.14617,MATZUK_IMPLANTATION_AND_UTERINE,0.883321137859369
HP_BILIARY_TRACT_NEOPLASM,SET,15,0.2379,0.0067937,0.22593,0.14618,HP_BILIARY_TRACT_NEOPLASM,0.883321137859369
ATXN7L3_TARGET_GENES,SET,516,0.04068,0.00672,0.03864,0.14622,ATXN7L3_TARGET_GENES,0.883321137859369
GSE30971_CTRL_VS_LPS_STIM_MA...8,SET,173,0.075954,0.0073345,0.072149,0.14624,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP,0.883321137859369
GSE27434_WT_VS_DNMT1_KO_TREG...1,SET,183,0.069617,0.0069123,0.066136,0.14626,GSE27434_WT_VS_DNMT1_KO_TREG_DN,0.883321137859369
GSE16450_IMMATURE_VS_MATURE_...2,SET,180,0.068092,0.0067058,0.06469,0.14627,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.883321137859369
GSE42021_CD24LO_TREG_VS_CD24...2,SET,186,0.068423,0.0068486,0.065018,0.14632,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP,0.883321137859369
GSE19923_WT_VS_HEB_KO_DP_THY...2,SET,184,0.067144,0.0066847,0.063804,0.14633,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP,0.883321137859369
PID_AR_TF_PATHWAY,SET,49,0.12847,0.0066249,0.12209,0.14634,PID_AR_TF_PATHWAY,0.883321137859369
HP_EROSION_OF_ORAL_MUCOSA,SET,89,0.098311,0.0068249,0.093425,0.14634,HP_EROSION_OF_ORAL_MUCOSA,0.883321137859369
chr10q25,SET,51,0.22281,0.011721,0.21175,0.14635,chr10q25,0.883321137859369
GOBP_RESPONSE_TO_SODIUM_ARSE...,SET,6,0.36652,0.0066214,0.34837,0.14639,GOBP_RESPONSE_TO_SODIUM_ARSENITE,0.883321137859369
GOBP_LEARNED_VOCALIZATION_BE...,SET,10,0.31899,0.007439,0.30324,0.14642,GOBP_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING,0.883321137859369
MODULE_19,SET,283,0.057162,0.0070386,0.054342,0.14643,MODULE_19,0.883321137859369
GNF2_G22P1,SET,31,0.15056,0.0061785,0.14315,0.14645,GNF2_G22P1,0.883321137859369
GOMF_SODIUM_BICARBONATE_SYMP...,SET,6,0.34185,0.0061759,0.32511,0.14652,GOMF_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY,0.883321137859369
GOBP_POSITIVE_REGULATION_OF_...465,SET,52,0.13067,0.0069406,0.12428,0.14655,GOBP_POSITIVE_REGULATION_OF_MIRNA_TRANSCRIPTION,0.883321137859369
MEISSNER_NPC_HCP_WITH_H3_UNM...,SET,489,0.043176,0.0069485,0.041071,0.14658,MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,0.883321137859369
GSE25087_TREG_VS_TCONV_ADULT...2,SET,174,0.070702,0.0068468,0.067265,0.14662,GSE25087_TREG_VS_TCONV_ADULT_UP,0.883321137859369
WP_MAMMARY_GLAND_DEVELOPMENT...2,SET,10,0.31361,0.0073135,0.29842,0.14666,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,0.883321137859369
LI_PBMC_MENACTRA_AGE_18_45YO...4,SET,14,0.25508,0.0070376,0.24273,0.14666,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.883321137859369
HP_ABNORMAL_FLASH_VISUAL_EVO...,SET,13,0.24845,0.0066055,0.23643,0.14668,HP_ABNORMAL_FLASH_VISUAL_EVOKED_POTENTIALS,0.883321137859369
BIOCARTA_G2_PATHWAY,SET,24,0.1652,0.0059661,0.15723,0.1467,BIOCARTA_G2_PATHWAY,0.883321137859369
GOBP_NUCLEOSIDE_SALVAGE,SET,10,0.30084,0.0070157,0.28633,0.14671,GOBP_NUCLEOSIDE_SALVAGE,0.883321137859369
GSE11864_UNTREATED_VS_CSF1_P...1,SET,176,0.064434,0.0062753,0.061336,0.14675,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN,0.883321137859369
GSE11961_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.068375,0.0066778,0.065088,0.14675,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN,0.883321137859369
GSE17721_PAM3CSK4_VS_CPG_6H_...1,SET,187,0.064787,0.0065019,0.061672,0.14675,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN,0.883321137859369
HP_APATHY,SET,82,0.10125,0.006748,0.096404,0.14681,HP_APATHY,0.883529272727273
CGGAARNGGCNG_UNKNOWN,SET,52,0.11401,0.0060561,0.10858,0.14686,CGGAARNGGCNG_UNKNOWN,0.883677164127424
WP_ADIPOGENESIS,SET,125,0.086267,0.0070904,0.082169,0.14689,WP_ADIPOGENESIS,0.883704682361087
BERTUCCI_MEDULLARY_VS_DUCTAL...2,SET,173,0.069487,0.00671,0.066199,0.14694,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,0.88375969025783
GSE42088_UNINF_VS_LEISHMANIA...4,SET,184,0.069156,0.006885,0.065886,0.14695,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP,0.88375969025783
KAMIKUBO_MYELOID_MN1_NETWORK,SET,18,0.22059,0.0069003,0.2102,0.14699,KAMIKUBO_MYELOID_MN1_NETWORK,0.883842130750605
GOBP_CELLULAR_RESPONSE_TO_AB...,SET,308,0.051204,0.006573,0.048801,0.14704,GOBP_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS,0.883842130750605
HP_MOTOR_TICS,SET,11,0.28729,0.0070266,0.27381,0.14704,HP_MOTOR_TICS,0.883842130750605
GSE37301_COMMON_LYMPHOID_PRO...7,SET,177,0.067486,0.006591,0.064337,0.14711,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.884017219917013
WU_SILENCED_BY_METHYLATION_I...,SET,46,0.14659,0.0073248,0.13976,0.14712,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,0.884017219917013
HP_RECURRENT_STAPHYLOCOCCAL_...,SET,32,0.16511,0.0068836,0.15743,0.14715,HP_RECURRENT_STAPHYLOCOCCAL_INFECTIONS,0.884044641313742
GSE25088_IL4_VS_IL4_AND_ROSI...3,SET,178,0.067093,0.0065709,0.063992,0.14722,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.884214268440145
GOBP_SUCCINYL_COA_CATABOLIC_...,SET,6,0.36083,0.0065186,0.34416,0.14723,GOBP_SUCCINYL_COA_CATABOLIC_PROCESS,0.884214268440145
KEGG_AMYOTROPHIC_LATERAL_SCL...,SET,53,0.12041,0.0064567,0.11487,0.14728,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.884214268440145
GSE22025_UNTREATED_VS_TGFB1_...2,SET,178,0.069116,0.006769,0.065937,0.14728,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.884214268440145
GSE360_T_GONDII_VS_B_MALAYI_...6,SET,174,0.069781,0.0067577,0.066589,0.14734,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP,0.884236325966851
HP_ABNORMAL_EPIPHYSIS_MORPHO...2,SET,36,0.15387,0.0068033,0.14683,0.14735,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY_OF_THE_PHALANGES_OF_THE_HAND,0.884236325966851
GSE26495_NAIVE_VS_PD1HIGH_CD...2,SET,151,0.075734,0.0068366,0.072275,0.14736,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP,0.884236325966851
GOBP_OSTEOCLAST_DIFFERENTIAT...,SET,100,0.10051,0.007394,0.095937,0.1474,GOBP_OSTEOCLAST_DIFFERENTIATION,0.884323666494044
GSE27786_BCELL_VS_NKTCELL_UP,SET,180,0.063161,0.0062201,0.060309,0.14749,GSE27786_BCELL_VS_NKTCELL_UP,0.884710899206075
GSE40274_HELIOS_VS_FOXP3_AND...2,SET,182,0.067879,0.0067215,0.064841,0.14759,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.884765048126504
E2F1_Q6_01,SET,214,0.060409,0.0064806,0.057708,0.1476,E2F1_Q6_01,0.884765048126504
GAANYNYGACNY_UNKNOWN,SET,65,0.11232,0.0066678,0.10731,0.14763,GAANYNYGACNY_UNKNOWN,0.884765048126504
MIR4432,SET,62,0.11404,0.0066126,0.10896,0.14765,MIR4432,0.884765048126504
IIZUKA_LIVER_CANCER_PROGRESS...6,SET,13,0.24992,0.0066447,0.2388,0.14766,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,0.884765048126504
DUTTA_APOPTOSIS_VIA_NFKB,SET,32,0.16565,0.0069062,0.15831,0.14771,DUTTA_APOPTOSIS_VIA_NFKB,0.884765048126504
GOBP_VASCULOGENESIS,SET,79,0.10743,0.0070283,0.10268,0.14774,GOBP_VASCULOGENESIS,0.884765048126504
GOBP_MITOTIC_DNA_REPLICATION...,SET,11,0.24117,0.0058984,0.23053,0.14776,GOBP_MITOTIC_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.884765048126504
DESCARTES_FETAL_HEART_CLC_IL...,SET,17,0.23014,0.0069963,0.22002,0.14778,DESCARTES_FETAL_HEART_CLC_IL5RA_POSITIVE_CELLS,0.884765048126504
TRAVAGLINI_LUNG_PROXIMAL_BAS...,SET,557,0.038691,0.0066329,0.036988,0.14778,TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL,0.884765048126504
GOBP_APOPTOTIC_CHROMOSOME_CO...,SET,6,0.36723,0.0066343,0.35112,0.14781,GOBP_APOPTOTIC_CHROMOSOME_CONDENSATION,0.884765048126504
GSE27786_BCELL_VS_CD4_TCELL_...1,SET,177,0.067575,0.0065997,0.064625,0.14787,GSE27786_BCELL_VS_CD4_TCELL_DN,0.884765048126504
HP_SYNOSTOSIS_OF_CARPAL_BONES,SET,23,0.19556,0.006914,0.18707,0.14792,HP_SYNOSTOSIS_OF_CARPAL_BONES,0.884765048126504
GOBP_NEPHRON_EPITHELIUM_DEVE...,SET,113,0.092562,0.0072358,0.088542,0.14793,GOBP_NEPHRON_EPITHELIUM_DEVELOPMENT,0.884765048126504
SU_LIVER,SET,55,0.13187,0.0072032,0.12616,0.14795,SU_LIVER,0.884765048126504
DANG_REGULATED_BY_MYC_DN,SET,225,0.060366,0.0066384,0.057752,0.14796,DANG_REGULATED_BY_MYC_DN,0.884765048126504
GSE17721_LPS_VS_GARDIQUIMOD_...14,SET,179,0.065677,0.0064501,0.062847,0.14801,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP,0.884765048126504
HALLMARK_MTORC1_SIGNALING,SET,185,0.064387,0.0064275,0.061611,0.14801,HALLMARK_MTORC1_SIGNALING,0.884765048126504
HP_ABNORMAL_URINE_METABOLITE...,SET,522,0.039492,0.0065606,0.037797,0.14805,HP_ABNORMAL_URINE_METABOLITE_LEVEL,0.884765048126504
GSE17974_2.5H_VS_72H_IL4_AND...1,SET,177,0.064681,0.006317,0.06191,0.14808,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.884765048126504
GOBP_MRNA_PROCESSING,SET,425,0.040411,0.0060738,0.038682,0.14809,GOBP_MRNA_PROCESSING,0.884765048126504
GCM_RBM8A,SET,70,0.1023,0.0063017,0.097931,0.1481,GCM_RBM8A,0.884765048126504
GOCC_MICROFIBRIL,SET,11,0.27063,0.006619,0.25906,0.1481,GOCC_MICROFIBRIL,0.884765048126504
HOFT_CD4_POSITIVE_ALPHA_BETA...1,SET,43,0.13207,0.0063811,0.12643,0.14811,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,0.884765048126504
DURANTE_ADULT_OLFACTORY_NEUR...1,SET,32,0.15988,0.0066656,0.15311,0.1482,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_BOWMANS_GLAND,0.88478649691358
MIR3688_5P,SET,126,0.080692,0.0066584,0.077309,0.14831,MIR3688_5P,0.88478649691358
GOBP_REGULATION_OF_MYELOID_D...,SET,4,0.51797,0.0076408,0.49626,0.14831,GOBP_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION,0.88478649691358
GOCC_HIPPOCAMPAL_MOSSY_FIBER...,SET,41,0.14552,0.0068655,0.13943,0.14833,GOCC_HIPPOCAMPAL_MOSSY_FIBER_TO_CA3_SYNAPSE,0.88478649691358
HP_NAUSEA_AND_VOMITING,SET,487,0.040655,0.0065297,0.03896,0.14837,HP_NAUSEA_AND_VOMITING,0.88478649691358
GOBP_RESPONSE_TO_XENOBIOTIC_...,SET,417,0.046411,0.0069112,0.044481,0.14839,GOBP_RESPONSE_TO_XENOBIOTIC_STIMULUS,0.88478649691358
HP_AXONAL_DEGENERATION,SET,20,0.19417,0.0064018,0.18609,0.14839,HP_AXONAL_DEGENERATION,0.88478649691358
REACTOME_CALNEXIN_CALRETICUL...,SET,24,0.17853,0.0064475,0.17112,0.14841,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,0.88478649691358
GSE14415_TCONV_VS_FOXP3_KO_I...2,SET,151,0.071664,0.0064691,0.068688,0.14841,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP,0.88478649691358
GSE17301_ACD3_ACD28_VS_ACD3_...2,SET,171,0.065709,0.0063087,0.06299,0.14844,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP,0.88478649691358
KEGG_MEDICUS_REFERENCE_ACTH_...,SET,32,0.1591,0.0066329,0.15251,0.14845,KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY,0.88478649691358
ACAWYAAAG_UNKNOWN,SET,91,0.097661,0.0068552,0.093624,0.14845,ACAWYAAAG_UNKNOWN,0.88478649691358
MIR4632_5P,SET,91,0.094534,0.0066356,0.090634,0.14847,MIR4632_5P,0.88478649691358
GOBP_RESPONSE_TO_MURAMYL_DIP...,SET,18,0.20009,0.006259,0.19183,0.14847,GOBP_RESPONSE_TO_MURAMYL_DIPEPTIDE,0.88478649691358
MIR505_5P,SET,50,0.12353,0.0064343,0.11849,0.14861,MIR505_5P,0.885146955483541
GSE37533_UNTREATED_VS_PIOGLI...2,SET,149,0.072363,0.0064893,0.069419,0.14862,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP,0.885146955483541
CUI_DEVELOPING_HEART_CORONAR...,SET,37,0.1651,0.0074007,0.1584,0.14864,CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL,0.885146955483541
HP_ABNORMAL_RENAL_CORPUSCLE_...,SET,165,0.070144,0.0066165,0.067301,0.14866,HP_ABNORMAL_RENAL_CORPUSCLE_MORPHOLOGY,0.885146955483541
GOBP_ALTERNATIVE_MRNA_SPLICI...,SET,67,0.10226,0.0061629,0.098122,0.14868,GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.885146955483541
GOMF_CYTIDINE_DEAMINASE_ACTI...,SET,10,0.40942,0.0095479,0.39288,0.14869,GOMF_CYTIDINE_DEAMINASE_ACTIVITY,0.885146955483541
GSE32901_TH1_VS_TH17_NEG_CD4...1,SET,104,0.086805,0.0065115,0.083311,0.14873,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN,0.885146955483541
HP_APLASIA_HYPOPLASIA_OF_THE...6,SET,4,0.50349,0.0074273,0.48325,0.14874,HP_APLASIA_HYPOPLASIA_OF_THE_4TH_FINGER,0.885146955483541
MIR6737_5P,SET,72,0.10262,0.0064103,0.098499,0.14876,MIR6737_5P,0.885146955483541
KOKKINAKIS_METHIONINE_DEPRIV...1,SET,57,0.12058,0.0067046,0.11575,0.14879,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,0.885146955483541
GOMF_BETA_1_3_GALACTOSYLTRAN...,SET,14,0.26092,0.0071987,0.25054,0.14884,GOMF_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.885146955483541
GOBP_POTASSIUM_ION_IMPORT_AC...,SET,44,0.15147,0.0074025,0.14546,0.14888,GOBP_POTASSIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.885146955483541
GOBP_CELL_CYCLE_G2_M_PHASE_T...,SET,139,0.074618,0.0064648,0.07167,0.14891,GOBP_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.885146955483541
REACTOME_HIV_ELONGATION_ARRE...,SET,29,0.14092,0.0055933,0.13536,0.14893,REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY,0.885146955483541
GSE2935_UV_INACTIVATED_VS_LI...2,SET,163,0.074252,0.0069618,0.071331,0.14895,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP,0.885146955483541
GOCC_TRAMP_COMPLEX,SET,2,0.54569,0.0056923,0.52423,0.14896,GOCC_TRAMP_COMPLEX,0.885146955483541
HP_CARCINOMA,SET,6,0.32839,0.0059325,0.31552,0.14899,HP_CARCINOMA,0.885146955483541
GOBP_ENDODERMAL_CELL_FATE_CO...,SET,14,0.272,0.0075045,0.26136,0.14901,GOBP_ENDODERMAL_CELL_FATE_COMMITMENT,0.885146955483541
REACTOME_ALK_MUTANTS_BIND_TK...,SET,12,0.24544,0.0062697,0.23589,0.14906,REACTOME_ALK_MUTANTS_BIND_TKIS,0.885146955483541
GOBP_NK_T_CELL_PROLIFERATION,SET,8,0.36538,0.0076217,0.35116,0.14906,GOBP_NK_T_CELL_PROLIFERATION,0.885146955483541
GSE17721_CTRL_VS_CPG_1H_BMDC...2,SET,186,0.06195,0.0062007,0.059551,0.14911,GSE17721_CTRL_VS_CPG_1H_BMDC_UP,0.885146955483541
GOBP_ORGANIC_HYDROXY_COMPOUN...4,SET,254,0.058617,0.0068434,0.056356,0.14915,GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT,0.885146955483541
GOBP_NEGATIVE_REGULATION_OF_...241,SET,3,0.59335,0.0075803,0.57048,0.14916,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.885146955483541
GOMF_ENZYME_ACTIVATOR_ACTIVI...,SET,542,0.038717,0.0065501,0.037226,0.14917,GOMF_ENZYME_ACTIVATOR_ACTIVITY,0.885146955483541
GOBP_TONIC_SMOOTH_MUSCLE_CON...,SET,11,0.3144,0.0076895,0.30239,0.14924,GOBP_TONIC_SMOOTH_MUSCLE_CONTRACTION,0.885146955483541
MIR6797_5P,SET,181,0.066788,0.0065953,0.064241,0.14926,MIR6797_5P,0.885146955483541
COLIN_PILOCYTIC_ASTROCYTOMA_...1,SET,26,0.1839,0.0069122,0.1769,0.14927,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,0.885146955483541
NUMATA_CSF3_SIGNALING_VIA_ST...,SET,21,0.21514,0.0072683,0.20695,0.14927,NUMATA_CSF3_SIGNALING_VIA_STAT3,0.885146955483541
GOBP_REGULATION_OF_AUTOPHAGO...1,SET,43,0.13475,0.0065105,0.12964,0.14931,GOBP_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.885146955483541
HP_PARTIAL_ABSENCE_OF_SPECIF...2,SET,6,0.40029,0.0072316,0.38511,0.14931,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,0.885146955483541
HP_PACE_OF_PROGRESSION,SET,401,0.043915,0.0064157,0.04225,0.14932,HP_PACE_OF_PROGRESSION,0.885146955483541
AIZARANI_LIVER_C8_RESIDENT_B...,SET,30,0.1628,0.006572,0.15668,0.1494,AIZARANI_LIVER_C8_RESIDENT_B_CELLS_1,0.885246604990664
HP_GENERALIZED_MYOCLONIC_SEI...,SET,114,0.085814,0.0067377,0.082598,0.14942,HP_GENERALIZED_MYOCLONIC_SEIZURE,0.885246604990664
GOBP_ANIMAL_ORGAN_MORPHOGENE...,SET,952,0.031499,0.006981,0.030324,0.14946,GOBP_ANIMAL_ORGAN_MORPHOGENESIS,0.885246604990664
GSE42021_CD24HI_VS_CD24INT_T...2,SET,182,0.06656,0.0065908,0.06408,0.14948,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP,0.885246604990664
HP_EXCESSIVE_SALIVATION,SET,106,0.088152,0.0066754,0.084886,0.14953,HP_EXCESSIVE_SALIVATION,0.885246604990664
MIR4774_3P,SET,75,0.10521,0.0067075,0.10132,0.14954,MIR4774_3P,0.885246604990664
GSE4142_PLASMA_CELL_VS_MEMOR...1,SET,184,0.065345,0.0065056,0.062941,0.1496,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.885246604990664
HP_ALEXIA,SET,7,0.31043,0.0060574,0.29903,0.14961,HP_ALEXIA,0.885246604990664
MIR548A_3P,SET,431,0.04328,0.0065497,0.041695,0.14964,MIR548A_3P,0.885246604990664
GSE17974_IL4_AND_ANTI_IL12_V...8,SET,143,0.077481,0.006808,0.074647,0.14965,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP,0.885246604990664
GOMF_IMMUNE_RECEPTOR_ACTIVITY,SET,131,0.091843,0.0077264,0.088488,0.14966,GOMF_IMMUNE_RECEPTOR_ACTIVITY,0.885246604990664
HP_COLLECTIONISM,SET,10,0.25962,0.0060543,0.25015,0.14968,HP_COLLECTIONISM,0.885246604990664
REACTOME_ADRENALINE_NORADREN...,SET,28,0.18315,0.0071436,0.1765,0.14971,REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION,0.885246604990664
BENPORATH_ES_CORE_NINE_CORRE...,SET,95,0.091994,0.006597,0.088664,0.14975,BENPORATH_ES_CORE_NINE_CORRELATED,0.885246604990664
PID_ERBB4_PATHWAY,SET,38,0.13578,0.0061676,0.13087,0.14976,PID_ERBB4_PATHWAY,0.885246604990664
HE_LIM_SUN_FETAL_LUNG_C7_PCP...,SET,48,0.13975,0.0071327,0.13474,0.14984,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.885246604990664
STAMBOLSKY_TARGETS_OF_MUTATE...1,SET,47,0.13192,0.0066627,0.1272,0.14985,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,0.885246604990664
MIR510_3P,SET,337,0.049453,0.006635,0.047684,0.14985,MIR510_3P,0.885246604990664
MODULE_135,SET,25,0.19358,0.007135,0.18669,0.14989,MODULE_135,0.885246604990664
GOBP_CYTIDINE_METABOLIC_PROC...,SET,11,0.38309,0.0093694,0.36952,0.14994,GOBP_CYTIDINE_METABOLIC_PROCESS,0.885246604990664
GOMF_PROTEIN_DOMAIN_SPECIFIC...,SET,599,0.036402,0.0064639,0.035114,0.14995,GOMF_PROTEIN_DOMAIN_SPECIFIC_BINDING,0.885246604990664
HP_ABNORMAL_EPIDIDYMIS_MORPH...,SET,10,0.28773,0.0067099,0.27756,0.14996,HP_ABNORMAL_EPIDIDYMIS_MORPHOLOGY,0.885246604990664
GOBP_DETECTION_OF_CHEMICAL_S...,SET,45,0.15418,0.0076199,0.14874,0.14998,GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE,0.885246604990664
GOBP_REGULATION_OF_BILE_ACID...3,SET,5,0.37694,0.0062165,0.36366,0.14999,GOBP_REGULATION_OF_BILE_ACID_SECRETION,0.885246604990664
GSE43955_1H_VS_20H_ACT_CD4_T...4,SET,185,0.064876,0.0064763,0.062598,0.15001,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.885246604990664
GOBP_ENDODERM_FORMATION,SET,56,0.12649,0.0069717,0.12205,0.15003,GOBP_ENDODERM_FORMATION,0.885246604990664
HOFMANN_CELL_LYMPHOMA_UP,SET,44,0.12699,0.0062063,0.12254,0.15004,HOFMANN_CELL_LYMPHOMA_UP,0.885246604990664
REACTOME_SUMOYLATION_OF_IMMU...,SET,10,0.2793,0.0065134,0.26953,0.15005,REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS,0.885246604990664
GOBP_MRNA_3_END_PROCESSING_B...,SET,6,0.30273,0.005469,0.29219,0.15009,GOBP_MRNA_3_END_PROCESSING_BY_STEM_LOOP_BINDING_AND_CLEAVAGE,0.885332306517312
WANG_RESPONSE_TO_FORSKOLIN_DN,SET,9,0.26242,0.0058057,0.25341,0.15022,WANG_RESPONSE_TO_FORSKOLIN_DN,0.885475457317073
HP_IRREGULAR_VERTEBRAL_ENDPL...,SET,27,0.17826,0.0068274,0.17214,0.15022,HP_IRREGULAR_VERTEBRAL_ENDPLATES,0.885475457317073
MIR6840_3P,SET,154,0.071061,0.0064776,0.068635,0.15026,MIR6840_3P,0.885475457317073
REACTOME_INTERACTIONS_OF_REV...,SET,35,0.13837,0.0060329,0.13366,0.15027,REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS,0.885475457317073
HMGIY_Q6,SET,237,0.060786,0.0068582,0.058724,0.15031,HMGIY_Q6,0.885475457317073
GOBP_NEGATIVE_REGULATION_OF_...137,SET,6,0.34721,0.0062726,0.33542,0.15031,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,0.885475457317073
KEGG_MEDICUS_REFERENCE_CA2_C...2,SET,12,0.23888,0.0061022,0.23078,0.15032,KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY,0.885475457317073
HP_MULTIPLE_CAFE_AU_LAIT_SPO...,SET,61,0.10359,0.0059579,0.10008,0.15034,HP_MULTIPLE_CAFE_AU_LAIT_SPOTS,0.885475457317073
HP_SEVERE_B_LYMPHOCYTOPENIA,SET,6,0.33466,0.0060459,0.32343,0.15041,HP_SEVERE_B_LYMPHOCYTOPENIA,0.885475457317073
MIR147A,SET,57,0.11373,0.0063242,0.10993,0.15042,MIR147A,0.885475457317073
GOCC_EXTRINSIC_COMPONENT_OF_...2,SET,167,0.071718,0.0068054,0.069316,0.15042,GOCC_EXTRINSIC_COMPONENT_OF_MEMBRANE,0.885475457317073
FAN_OVARY_CL9_PUTATIVE_APOPT...,SET,329,0.049069,0.0065062,0.047426,0.15042,FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL,0.885475457317073
GOBP_HIS_PURKINJE_SYSTEM_DEV...,SET,7,0.42474,0.0082879,0.41056,0.15045,GOBP_HIS_PURKINJE_SYSTEM_DEVELOPMENT,0.885502074513125
MARSON_BOUND_BY_FOXP3_UNSTIM...,SET,1068,0.028996,0.0067839,0.028038,0.15053,MARSON_BOUND_BY_FOXP3_UNSTIMULATED,0.88574122421373
GSE11057_NAIVE_CD4_VS_PBMC_C...2,SET,163,0.068237,0.0063978,0.065988,0.15055,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP,0.88574122421373
GSE2585_CTEC_VS_THYMIC_DC_DN,SET,188,0.066488,0.0066902,0.064316,0.15063,GSE2585_CTEC_VS_THYMIC_DC_DN,0.88574122421373
ERWIN_COHEN_PBMC_TC_83_AGE_1...2,SET,14,0.25307,0.0069822,0.24482,0.15064,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_DN,0.88574122421373
HP_URETEROCELE,SET,25,0.18829,0.0069399,0.18216,0.15065,HP_URETEROCELE,0.88574122421373
GSE5542_IFNG_VS_IFNA_TREATED...4,SET,176,0.063147,0.00615,0.061092,0.15066,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,0.88574122421373
HP_ABNORMALITY_OF_PANCREAS_P...,SET,149,0.073948,0.0066313,0.071549,0.15069,HP_ABNORMALITY_OF_PANCREAS_PHYSIOLOGY,0.88574122421373
GSE3337_CTRL_VS_4H_IFNG_IN_C...1,SET,187,0.065069,0.0065302,0.062964,0.15071,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN,0.88574122421373
GSE2706_UNSTIM_VS_8H_LPS_DC_...1,SET,171,0.069431,0.0066661,0.067189,0.15072,GSE2706_UNSTIM_VS_8H_LPS_DC_DN,0.88574122421373
KEGG_MEDICUS_REFERENCE_GPCR_...1,SET,31,0.16624,0.006822,0.1609,0.15075,KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY,0.88576775147929
GSE10239_NAIVE_VS_DAY4.5_EFF...1,SET,186,0.064658,0.0064717,0.062597,0.15083,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN,0.885938254182863
GSE10240_IL22_VS_IL22_AND_IL...2,SET,185,0.0641,0.0063988,0.062057,0.15083,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.885938254182863
HP_BICORONAL_SYNOSTOSIS,SET,9,0.27577,0.0061012,0.26702,0.15086,HP_BICORONAL_SYNOSTOSIS,0.885964734707671
GOBP_PHENOTYPIC_SWITCHING,SET,7,0.36511,0.0071243,0.35365,0.15094,GOBP_PHENOTYPIC_SWITCHING,0.886240766374072
MODULE_352,SET,17,0.19422,0.0059042,0.18815,0.15098,MODULE_352,0.886240766374072
GOBP_MONOCYTE_EXTRAVASATION,SET,9,0.31149,0.0068914,0.30176,0.15099,GOBP_MONOCYTE_EXTRAVASATION,0.886240766374072
HP_CRANIOFACIAL_DYSOSTOSIS,SET,8,0.29363,0.006125,0.28449,0.15101,HP_CRANIOFACIAL_DYSOSTOSIS,0.886240766374072
WP_MEASLES_VIRUS_INFECTION,SET,123,0.086281,0.007035,0.083604,0.15104,WP_MEASLES_VIRUS_INFECTION,0.886240766374072
HP_PERIPHERAL_RETINAL_DEGENE...,SET,6,0.40958,0.0073993,0.3969,0.15106,HP_PERIPHERAL_RETINAL_DEGENERATION,0.886240766374072
GOBP_NEGATIVE_REGULATION_OF_...42,SET,8,0.3234,0.0067458,0.31356,0.15119,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.886580819838057
GOBP_TETRAPYRROLE_BIOSYNTHET...,SET,29,0.15503,0.0061536,0.15033,0.15121,GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS,0.886580819838057
REACTOME_FORMATION_OF_RNA_PO...,SET,52,0.10374,0.0055106,0.1006,0.15122,REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,0.886580819838057
DESCARTES_FETAL_LIVER_ERYTHR...,SET,55,0.12247,0.0066898,0.11876,0.15122,DESCARTES_FETAL_LIVER_ERYTHROBLASTS,0.886580819838057
GOBP_ANTIGEN_PROCESSING_AND_...12,SET,17,0.25749,0.0078277,0.24976,0.15129,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_IB,0.886615507075472
GSE16266_CTRL_VS_HEATSHOCK_A...2,SET,173,0.065828,0.0063567,0.063862,0.15133,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.886615507075472
GSE5503_MLN_DC_VS_PLN_DC_ACT...2,SET,179,0.064655,0.0063498,0.062735,0.15137,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.886615507075472
GOMF_NUCLEAR_STEROID_RECEPTO...,SET,25,0.18444,0.0067982,0.17898,0.15138,GOMF_NUCLEAR_STEROID_RECEPTOR_ACTIVITY,0.886615507075472
TGAYRTCA_ATF3_Q6,SET,497,0.04113,0.0066717,0.039913,0.15139,TGAYRTCA_ATF3_Q6,0.886615507075472
GSE3982_MAC_VS_BASOPHIL_DN,SET,167,0.068905,0.0065385,0.066864,0.15139,GSE3982_MAC_VS_BASOPHIL_DN,0.886615507075472
GOBP_DIADENOSINE_POLYPHOSPHA...1,SET,3,0.58939,0.0075298,0.57204,0.15143,GOBP_DIADENOSINE_POLYPHOSPHATE_CATABOLIC_PROCESS,0.886615507075472
GOBP_DIADENOSINE_POLYPHOSPHA...2,SET,3,0.58939,0.0075298,0.57204,0.15143,GOBP_DIADENOSINE_POLYPHOSPHATE_METABOLIC_PROCESS,0.886615507075472
GOBP_LUNG_ASSOCIATED_MESENCH...,SET,9,0.32821,0.0072614,0.3186,0.15147,GOBP_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT,0.886700328448711
HP_MIDLINE_DEFECT_OF_THE_NOSE,SET,15,0.22752,0.0064974,0.22094,0.15156,HP_MIDLINE_DEFECT_OF_THE_NOSE,0.887062789332439
E2F1_Q3,SET,221,0.057764,0.0062962,0.056105,0.15161,E2F1_Q3,0.887062789332439
PID_INTEGRIN3_PATHWAY,SET,39,0.1615,0.0074316,0.15686,0.15162,PID_INTEGRIN3_PATHWAY,0.887062789332439
MODULE_5,SET,401,0.047366,0.00692,0.046016,0.15167,MODULE_5,0.887062789332439
REACTOME_SYNTHESIS_OF_PG,SET,8,0.31047,0.0064762,0.30166,0.1517,REACTOME_SYNTHESIS_OF_PG,0.887062789332439
GOBP_MESENCHYMAL_EPITHELIAL_...,SET,9,0.33646,0.0074439,0.32698,0.15174,GOBP_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING,0.887062789332439
HP_NEOPLASM_OF_THE_RECTUM,SET,46,0.12469,0.0062305,0.12117,0.15174,HP_NEOPLASM_OF_THE_RECTUM,0.887062789332439
GOBP_KERATAN_SULFATE_METABOL...,SET,18,0.21261,0.0066504,0.20661,0.15175,GOBP_KERATAN_SULFATE_METABOLIC_PROCESS,0.887062789332439
GOMF_MOLECULAR_FUNCTION_ACTI...,SET,1020,0.029413,0.0067343,0.02859,0.1518,GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY,0.887062789332439
GSE3039_NKT_CELL_VS_B2_BCELL...2,SET,190,0.067766,0.0068546,0.065874,0.15181,GSE3039_NKT_CELL_VS_B2_BCELL_UP,0.887062789332439
HP_FRONTAL_POLYMICROGYRIA,SET,5,0.43072,0.0071034,0.41884,0.1519,HP_FRONTAL_POLYMICROGYRIA,0.887062789332439
GSE4590_PRE_BCELL_VS_VPREB_P...2,SET,140,0.076694,0.0066683,0.074579,0.1519,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.887062789332439
HP_HYPERPIGMENTATION_IN_SUN_...,SET,7,0.26679,0.0052058,0.25947,0.15193,HP_HYPERPIGMENTATION_IN_SUN_EXPOSED_AREAS,0.887062789332439
GSE27786_NKCELL_VS_MONO_MAC_...2,SET,179,0.063135,0.0062004,0.061417,0.15199,GSE27786_NKCELL_VS_MONO_MAC_UP,0.887062789332439
GSE360_T_GONDII_VS_B_MALAYI_...8,SET,174,0.06607,0.0063983,0.064271,0.15199,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.887062789332439
GOBP_COMPLEMENT_ACTIVATION,SET,46,0.15054,0.0075219,0.14646,0.15202,GOBP_COMPLEMENT_ACTIVATION,0.887062789332439
GOBP_TYPE_B_PANCREATIC_CELL_...4,SET,23,0.19642,0.0069445,0.19111,0.15202,GOBP_TYPE_B_PANCREATIC_CELL_PROLIFERATION,0.887062789332439
GOBP_POSITIVE_REGULATION_OF_...184,SET,46,0.13349,0.0066703,0.12992,0.15209,GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS,0.887062789332439
GOBP_NEUROTRANSMITTER_SECRET...,SET,135,0.075139,0.0064163,0.073129,0.1521,GOBP_NEUROTRANSMITTER_SECRETION,0.887062789332439
GNF2_CCNA2,SET,64,0.10864,0.0063998,0.10574,0.15211,GNF2_CCNA2,0.887062789332439
HP_ECTOPIC_THYROID,SET,5,0.46831,0.0077234,0.45585,0.15214,HP_ECTOPIC_THYROID,0.887062789332439
REACTOME_SUMOYLATION_OF_UBIQ...,SET,37,0.13642,0.006115,0.1328,0.15215,REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,0.887062789332439
HP_ABNORMAL_CORNEA_MORPHOLOGY,SET,640,0.03552,0.0065121,0.034579,0.15216,HP_ABNORMAL_CORNEA_MORPHOLOGY,0.887062789332439
PUJANA_BRCA2_PCC_NETWORK,SET,394,0.042282,0.0061242,0.041162,0.15217,PUJANA_BRCA2_PCC_NETWORK,0.887062789332439
MIR365A_3P_MIR365B_3P,SET,106,0.086741,0.0065686,0.084443,0.15217,MIR365A_3P_MIR365B_3P,0.887062789332439
REACTOME_CONDENSATION_OF_PRO...1,SET,11,0.24489,0.0059895,0.23844,0.1522,REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES,0.887088881435519
GOBP_FUNGIFORM_PAPILLA_DEVEL...,SET,5,0.4104,0.0067684,0.39969,0.15227,GOBP_FUNGIFORM_PAPILLA_DEVELOPMENT,0.887315834031853
GARGALOVIC_RESPONSE_TO_OXIDI...14,SET,25,0.17408,0.0064163,0.16956,0.15229,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,0.887315834031853
GSE17721_CTRL_VS_CPG_1H_BMDC...1,SET,187,0.064681,0.0064913,0.063013,0.15234,GSE17721_CTRL_VS_CPG_1H_BMDC_DN,0.887458380824673
HP_PROXIMAL_MUSCLE_WEAKNESS_...2,SET,54,0.1174,0.0063544,0.11438,0.15237,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_UPPER_LIMBS,0.887484389140272
REACTOME_RHO_GTPASES_ACTIVAT...8,SET,9,0.28887,0.0063911,0.28151,0.15242,REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS,0.887626859919571
GOBP_REGULATION_OF_CHAPERONE...,SET,8,0.27636,0.0057647,0.26943,0.15252,GOBP_REGULATION_OF_CHAPERONE_MEDIATED_AUTOPHAGY,0.887795810336177
ONO_AML1_TARGETS_DN,SET,37,0.16464,0.00738,0.16052,0.15253,ONO_AML1_TARGETS_DN,0.887795810336177
GOBP_MONOCARBOXYLIC_ACID_CAT...,SET,125,0.076542,0.0062911,0.074633,0.15255,GOBP_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS,0.887795810336177
GOBP_REGULATION_OF_MAST_CELL...3,SET,7,0.32596,0.0063603,0.31789,0.1526,GOBP_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.887795810336177
GOBP_PHOTORECEPTOR_CELL_DIFF...,SET,63,0.11761,0.0068741,0.11471,0.15263,GOBP_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.887795810336177
GOBP_DEPHOSPHORYLATION,SET,243,0.054603,0.006237,0.05327,0.15268,GOBP_DEPHOSPHORYLATION,0.887795810336177
GOBP_CARDIAC_MUSCLE_CELL_MYO...,SET,11,0.30381,0.0074305,0.29643,0.15272,GOBP_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION,0.887795810336177
GOMF_VASOPRESSIN_RECEPTOR_AC...,SET,6,0.39669,0.0071666,0.38706,0.15272,GOMF_VASOPRESSIN_RECEPTOR_ACTIVITY,0.887795810336177
REACTOME_CONSTITUTIVE_SIGNAL...4,SET,18,0.19595,0.0061295,0.1912,0.15273,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,0.887795810336177
GOBP_COBALAMIN_METABOLIC_PRO...,SET,9,0.3229,0.0071438,0.31508,0.15273,GOBP_COBALAMIN_METABOLIC_PROCESS,0.887795810336177
GOMF_GLYCINE_BINDING,SET,10,0.31246,0.0072866,0.30488,0.15273,GOMF_GLYCINE_BINDING,0.887795810336177
HP_ABNORMALITY_OF_THE_LIVER,SET,986,0.028702,0.0064675,0.028013,0.15278,HP_ABNORMALITY_OF_THE_LIVER,0.88781537111334
HINATA_NFKB_TARGETS_KERATINO...1,SET,22,0.21049,0.0072783,0.20544,0.15279,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,0.88781537111334
HP_HERPES_SIMPLEX_ENCEPHALIT...,SET,9,0.29176,0.006455,0.28479,0.15281,HP_HERPES_SIMPLEX_ENCEPHALITIS,0.88781537111334
HP_PRURITIS_ON_HAND,SET,5,0.41479,0.0068407,0.40501,0.15289,HP_PRURITIS_ON_HAND,0.887983280414438
GSE1112_OT1_VS_HY_CD8AB_THYM...2,SET,180,0.063077,0.0062118,0.06159,0.15289,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP,0.887983280414438
GSE5589_WT_VS_IL10_KO_LPS_AN...1,SET,103,0.092693,0.0069199,0.090546,0.15299,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.888292984800401
SHEPARD_BMYB_MORPHOLINO_DN,SET,188,0.064061,0.006446,0.062578,0.153,SHEPARD_BMYB_MORPHOLINO_DN,0.888292984800401
GOBP_PROTEIN_CONTAINING_COMP...4,SET,37,0.15389,0.0068979,0.15034,0.15302,GOBP_PROTEIN_CONTAINING_COMPLEX_REMODELING,0.888292984800401
HP_ELEVATED_CREATINE_KINASE_...,SET,10,0.26606,0.0062045,0.25996,0.15305,HP_ELEVATED_CREATINE_KINASE_AFTER_EXERCISE,0.88831876252505
GOBP_BONE_RESORPTION,SET,65,0.1148,0.0068151,0.1122,0.15312,GOBP_BONE_RESORPTION,0.888396044066099
HP_ESOPHAGEAL_NEOPLASM,SET,27,0.17258,0.0066099,0.16867,0.15312,HP_ESOPHAGEAL_NEOPLASM,0.888396044066099
MIR769_3P,SET,27,0.17236,0.0066016,0.16847,0.15314,MIR769_3P,0.888396044066099
GOBP_NEGATIVE_REGULATION_OF_...178,SET,29,0.15197,0.0060319,0.14856,0.15318,GOBP_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION,0.888479789719626
GOBP_INTERLEUKIN_4_PRODUCTION,SET,29,0.17747,0.0070441,0.17359,0.15332,GOBP_INTERLEUKIN_4_PRODUCTION,0.888529671150972
WP_GENES_ASSOCIATED_WITH_THE...,SET,17,0.23469,0.0071346,0.22957,0.15333,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,0.888529671150972
MODULE_158,SET,41,0.13208,0.0062317,0.1292,0.15333,MODULE_158,0.888529671150972
HP_REDUCED_DELAYED_HYPERSENS...,SET,4,0.44298,0.0065346,0.43331,0.15333,HP_REDUCED_DELAYED_HYPERSENSITIVITY,0.888529671150972
GSE36476_CTRL_VS_TSST_ACT_40...3,SET,181,0.062185,0.0061408,0.060831,0.15334,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN,0.888529671150972
MIR4482_3P,SET,427,0.043628,0.0065724,0.042694,0.15343,MIR4482_3P,0.888529671150972
ZNF524_TARGET_GENES,SET,277,0.051181,0.0062359,0.050089,0.15345,ZNF524_TARGET_GENES,0.888529671150972
GOBP_PRONEPHROS_DEVELOPMENT,SET,9,0.28512,0.006308,0.27907,0.15347,GOBP_PRONEPHROS_DEVELOPMENT,0.888529671150972
GOBP_ORNITHINE_METABOLIC_PRO...,SET,9,0.24568,0.0054355,0.2405,0.1535,GOBP_ORNITHINE_METABOLIC_PROCESS,0.888529671150972
TIEN_INTESTINE_PROBIOTICS_6H...2,SET,46,0.13025,0.0065081,0.12752,0.15355,TIEN_INTESTINE_PROBIOTICS_6HR_UP,0.888529671150972
GOBP_ACTIN_FILAMENT_ORGANIZA...,SET,412,0.044548,0.0065948,0.043619,0.15356,GOBP_ACTIN_FILAMENT_ORGANIZATION,0.888529671150972
ASGHARZADEH_NEUROBLASTOMA_PO...,SET,37,0.14405,0.0064568,0.14105,0.15358,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,0.888529671150972
REACTOME_RECYCLING_OF_EIF2_G...,SET,7,0.28771,0.005614,0.28178,0.15363,REACTOME_RECYCLING_OF_EIF2_GDP,0.888529671150972
GOBP_VENTRAL_SPINAL_CORD_INT...,SET,13,0.26377,0.0070129,0.25834,0.15363,GOBP_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION,0.888529671150972
HP_MACULAR_DYSTROPHY,SET,18,0.21206,0.0066333,0.20773,0.15368,HP_MACULAR_DYSTROPHY,0.888529671150972
GOBP_POSITIVE_REGULATION_OF_...833,SET,4,0.3721,0.005489,0.36453,0.15369,GOBP_POSITIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.888529671150972
GSE22140_HEALTHY_VS_ARTHRITI...1,SET,188,0.066514,0.0066928,0.065167,0.15371,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN,0.888529671150972
GOBP_REGULATION_OF_SMOOTH_MU...1,SET,6,0.3573,0.0064549,0.35007,0.15372,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.888529671150972
CAO_BLOOD_FLUZONE_AGE_05_14Y...1,SET,6,0.34031,0.006148,0.33344,0.15372,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_DN,0.888529671150972
GOBP_MULTICELLULAR_ORGANISMA...6,SET,820,0.031202,0.0064421,0.030573,0.15374,GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS,0.888529671150972
GOBP_REGULATION_OF_CARDIAC_M...2,SET,27,0.17792,0.0068147,0.17436,0.15377,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.888529671150972
HP_ANTINUCLEAR_ANTIBODY_POSI...,SET,62,0.11926,0.0069154,0.1169,0.15382,HP_ANTINUCLEAR_ANTIBODY_POSITIVITY,0.888529671150972
DESCARTES_FETAL_MUSCLE_SKELE...,SET,181,0.065971,0.0065147,0.064664,0.15382,DESCARTES_FETAL_MUSCLE_SKELETAL_MUSCLE_CELLS,0.888529671150972
MIR2113,SET,234,0.058694,0.0065807,0.057534,0.15383,MIR2113,0.888529671150972
GOMF_ALPHA_KETOGLUTARATE_TRA...,SET,6,0.34423,0.0062188,0.33746,0.15385,GOMF_ALPHA_KETOGLUTARATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.888529671150972
GOBP_TRANSDIFFERENTIATION,SET,7,0.37922,0.0073996,0.37177,0.15386,GOBP_TRANSDIFFERENTIATION,0.888529671150972
GOBP_REGULATION_OF_PLASMA_LI...,SET,75,0.1047,0.0066746,0.10265,0.15388,GOBP_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS,0.888529671150972
HALLMARK_HYPOXIA,SET,178,0.069235,0.0067807,0.067888,0.15391,HALLMARK_HYPOXIA,0.888529671150972
GOBP_REGULATION_OF_CELL_COMM...1,SET,16,0.25746,0.0075933,0.25248,0.15393,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.888529671150972
HE_LIM_SUN_FETAL_LUNG_C3_CYC...,SET,388,0.043286,0.0062228,0.042464,0.15402,HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST,0.888785218040126
HP_ABNORMAL_FETAL_GENITOURIN...,SET,11,0.28114,0.006876,0.27583,0.15405,HP_ABNORMAL_FETAL_GENITOURINARY_SYSTEM_MORPHOLOGY,0.888785218040126
GSE45365_CD8A_DC_VS_CD11B_DC...3,SET,142,0.076948,0.0067377,0.075513,0.15411,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN,0.888785218040126
REACTOME_RORA_ACTIVATES_GENE...,SET,17,0.20759,0.0063108,0.20376,0.15416,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,0.888785218040126
MIR1269A_MIR1269B,SET,48,0.1594,0.0081355,0.15647,0.15417,MIR1269A_MIR1269B,0.888785218040126
MIR3169,SET,54,0.11795,0.006384,0.11578,0.15419,MIR3169,0.888785218040126
GOBP_NEGATIVE_REGULATION_OF_...39,SET,7,0.33314,0.0065005,0.32705,0.15419,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.888785218040126
GOMF_AMINO_ACID_MONOATOMIC_C...1,SET,4,0.37794,0.0055752,0.37104,0.1542,GOMF_AMINO_ACID_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.888785218040126
GOBP_SPINAL_CORD_PATTERNING,SET,18,0.20993,0.0065668,0.20611,0.15421,GOBP_SPINAL_CORD_PATTERNING,0.888785218040126
GOBP_INTERLEUKIN_10_PRODUCTI...,SET,52,0.13557,0.0072009,0.13311,0.15423,GOBP_INTERLEUKIN_10_PRODUCTION,0.888785218040126
CTGRYYYNATT_UNKNOWN,SET,63,0.11126,0.006503,0.10927,0.1543,CTGRYYYNATT_UNKNOWN,0.888970253479125
GOCC_ENDOPLASMIC_RETICULUM_G...1,SET,121,0.077386,0.0062585,0.07601,0.15432,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT,0.888970253479125
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...4,SET,7,0.36303,0.0070837,0.35664,0.15437,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_DN,0.888970253479125
HP_VACUOLATED_LYMPHOCYTES,SET,11,0.28234,0.0069054,0.2774,0.15439,HP_VACUOLATED_LYMPHOCYTES,0.888970253479125
P53_DN.V1_DN,SET,179,0.068897,0.0067663,0.067692,0.15439,P53_DN.V1_DN,0.888970253479125
MARTINELLI_IMMATURE_NEUTROPH...2,SET,8,0.35928,0.0074943,0.35308,0.15445,MARTINELLI_IMMATURE_NEUTROPHIL_UP,0.889014486754967
HP_ALOBAR_HOLOPROSENCEPHALY,SET,6,0.41288,0.007459,0.4058,0.15448,HP_ALOBAR_HOLOPROSENCEPHALY,0.889014486754967
RB_DN.V1_UP,SET,111,0.079435,0.0061548,0.078075,0.15448,RB_DN.V1_UP,0.889014486754967
REACTOME_VITAMIN_B2_RIBOFLAV...,SET,7,0.33866,0.0066081,0.33289,0.1545,REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM,0.889014486754967
GOBP_INTRACELLULAR_PH_REDUCT...,SET,51,0.12532,0.0065925,0.12322,0.15458,GOBP_INTRACELLULAR_PH_REDUCTION,0.889184128425223
XU_RESPONSE_TO_TRETINOIN_AND...2,SET,14,0.2586,0.0071347,0.25429,0.1546,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,0.889184128425223
GSE39820_CTRL_VS_TGFBETA1_IL...3,SET,180,0.062527,0.0061577,0.061502,0.15466,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN,0.889184128425223
BIOCARTA_PITX2_PATHWAY,SET,15,0.22104,0.0063123,0.21745,0.15471,BIOCARTA_PITX2_PATHWAY,0.889184128425223
GOBP_PROTEIN_INSERTION_INTO_...6,SET,6,0.32888,0.0059414,0.32357,0.15472,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE,0.889184128425223
GOBP_BARBED_END_ACTIN_FILAME...,SET,21,0.18616,0.0062892,0.18316,0.15473,GOBP_BARBED_END_ACTIN_FILAMENT_CAPPING,0.889184128425223
HP_MICROMELIA,SET,86,0.091668,0.006256,0.090189,0.15473,HP_MICROMELIA,0.889184128425223
HOXD11_TARGET_GENES,SET,117,0.081534,0.0064848,0.080227,0.15475,HOXD11_TARGET_GENES,0.889184128425223
GSE24574_NAIVE_VS_TCONV_CD4_...2,SET,181,0.067592,0.0066747,0.06651,0.15476,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP,0.889184128425223
GSE5463_CTRL_VS_DEXAMETHASON...2,SET,187,0.064009,0.0064238,0.063001,0.15482,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP,0.889184128425223
GSE46606_DAY1_VS_DAY3_CD40L_...5,SET,180,0.063996,0.0063023,0.062993,0.15484,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN,0.889184128425223
FIGUEROA_AML_METHYLATION_CLU...12,SET,127,0.079271,0.006567,0.07806,0.15494,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,0.889184128425223
KEGG_WNT_SIGNALING_PATHWAY,SET,144,0.076195,0.0067182,0.07503,0.15494,KEGG_WNT_SIGNALING_PATHWAY,0.889184128425223
KEGG_MEDICUS_PATHOGEN_KSHV_V...3,SET,6,0.313,0.0056546,0.30823,0.15495,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY,0.889184128425223
TIEN_INTESTINE_PROBIOTICS_2H...1,SET,83,0.099921,0.0066998,0.098412,0.15498,TIEN_INTESTINE_PROBIOTICS_2HR_DN,0.889184128425223
GAVISH_3CA_METAPROGRAM_MACRO...5,SET,47,0.1382,0.0069801,0.13612,0.15499,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_2,0.889184128425223
GOCC_LATERAL_PLASMA_MEMBRANE,SET,65,0.11039,0.0065534,0.10873,0.15499,GOCC_LATERAL_PLASMA_MEMBRANE,0.889184128425223
HP_RECURRENT_PATELLAR_DISLOC...,SET,3,0.58546,0.0074795,0.57665,0.15499,HP_RECURRENT_PATELLAR_DISLOCATION,0.889184128425223
WP_ENERGY_METABOLISM,SET,47,0.12672,0.0064,0.12483,0.15503,WP_ENERGY_METABOLISM,0.889234777227723
GSE22886_DAY1_VS_DAY7_MONOCY...1,SET,177,0.062958,0.0061487,0.062026,0.15505,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.889234777227723
GSE28737_WT_VS_BCL6_KO_MARGI...1,SET,174,0.064452,0.0062416,0.063506,0.15509,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,0.8892853926097
ZHOU_PANCREATIC_EXOCRINE_PRO...,SET,11,0.30012,0.0073403,0.29575,0.15511,ZHOU_PANCREATIC_EXOCRINE_PROGENITOR,0.8892853926097
AIZARANI_LIVER_C14_HEPATOCYT...,SET,211,0.065631,0.0069918,0.064693,0.15518,AIZARANI_LIVER_C14_HEPATOCYTES_2,0.889539980207818
GSE24142_EARLY_THYMIC_PROGEN...10,SET,187,0.063834,0.0064062,0.062938,0.15524,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN,0.889737170184696
GSE27786_CD4_TCELL_VS_NKCELL...1,SET,180,0.06397,0.0062998,0.063084,0.15529,GSE27786_CD4_TCELL_VS_NKCELL_DN,0.889876990931575
GOBP_REGULATION_OF_PROTEIN_L...8,SET,10,0.23965,0.0055887,0.23642,0.15538,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,0.889975024679171
GSE17974_CTRL_VS_ACT_IL4_AND...5,SET,176,0.061997,0.006038,0.061179,0.15545,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN,0.889975024679171
PID_LYSOPHOSPHOLIPID_PATHWAY,SET,63,0.11437,0.0066851,0.11288,0.15547,PID_LYSOPHOSPHOLIPID_PATHWAY,0.889975024679171
REACTOME_MET_RECEPTOR_RECYCL...,SET,10,0.28454,0.0066355,0.28087,0.15552,REACTOME_MET_RECEPTOR_RECYCLING,0.889975024679171
GOBP_REGULATION_OF_VASCULAR_...2,SET,14,0.23452,0.0064703,0.23149,0.15552,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.889975024679171
GOCC_CMG_COMPLEX,SET,11,0.25035,0.0061231,0.24715,0.15555,GOCC_CMG_COMPLEX,0.889975024679171
GOBP_MEMBRANE_FUSION,SET,166,0.067378,0.0063746,0.066526,0.15558,GOBP_MEMBRANE_FUSION,0.889975024679171
GOMF_OXIDOREDUCTASE_ACTIVITY...17,SET,10,0.28619,0.0066741,0.28257,0.15558,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS,0.889975024679171
GOMF_CARNITINE_O_ACYLTRANSFE...,SET,6,0.31109,0.0056201,0.30718,0.1556,GOMF_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY,0.889975024679171
GSE7509_DC_VS_MONOCYTE_WITH_...1,SET,185,0.064672,0.0064558,0.063861,0.15561,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN,0.889975024679171
TERAO_AOX4_TARGETS_HG_DN,SET,6,0.39227,0.0070866,0.38737,0.15562,TERAO_AOX4_TARGETS_HG_DN,0.889975024679171
GSE27670_CTRL_VS_LMP1_TRANSD...2,SET,181,0.064418,0.0063614,0.063617,0.15564,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.889975024679171
DURANTE_ADULT_OLFACTORY_NEUR...10,SET,66,0.12041,0.0072026,0.11891,0.15564,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MAST_CELLS,0.889975024679171
MIR3154,SET,107,0.080676,0.0061379,0.079684,0.15567,MIR3154,0.890000139825629
GOBP_IMMUNE_RESPONSE_REGULAT...1,SET,307,0.052106,0.0066781,0.051485,0.15576,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.890218793103448
RYCACNNRNNRNCAG_UNKNOWN,SET,63,0.11042,0.0064539,0.10911,0.15577,RYCACNNRNNRNCAG_UNKNOWN,0.890218793103448
GOBP_APOPTOTIC_CELL_CLEARANCE,SET,46,0.13174,0.0065828,0.13019,0.1558,GOBP_APOPTOTIC_CELL_CLEARANCE,0.890218793103448
GOBP_CORNEA_DEVELOPMENT_IN_C...,SET,12,0.29882,0.0076333,0.29537,0.15585,GOBP_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.890218793103448
CENPT_TARGET_GENES,SET,49,0.12184,0.0062828,0.12044,0.15587,CENPT_TARGET_GENES,0.890218793103448
HP_PUNCTATE_OPACIFICATION_OF...,SET,5,0.40294,0.0066454,0.39842,0.15593,HP_PUNCTATE_OPACIFICATION_OF_THE_CORNEA,0.890218793103448
CGCAAAA_MIR450,SET,9,0.28519,0.0063095,0.282,0.15595,CGCAAAA_MIR450,0.890218793103448
GOBP_REGULATION_OF_GTPASE_AC...,SET,245,0.058983,0.0067647,0.058326,0.15595,GOBP_REGULATION_OF_GTPASE_ACTIVITY,0.890218793103448
MIR27A_3P_MIR27B_3P,SET,570,0.037616,0.0065211,0.037199,0.15596,MIR27A_3P_MIR27B_3P,0.890218793103448
HP_UNDETECTABLE_LIGHT_AND_DA...,SET,13,0.26729,0.0071064,0.26434,0.15598,HP_UNDETECTABLE_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,0.890218793103448
GOBP_NEURON_APOPTOTIC_PROCESS,SET,263,0.054718,0.0064988,0.054117,0.15599,GOBP_NEURON_APOPTOTIC_PROCESS,0.890218793103448
GOBP_POSITIVE_REGULATION_OF_...665,SET,9,0.27577,0.0061012,0.27292,0.15615,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CLUSTERING,0.890461602753196
DURANTE_ADULT_OLFACTORY_NEUR...4,SET,58,0.12134,0.0068057,0.12009,0.15617,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD8_T_CELLS,0.890461602753196
GOBP_PERIPHERAL_NERVOUS_SYST...2,SET,8,0.37051,0.0077286,0.36682,0.15624,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION,0.890461602753196
GOBP_REGULATION_OF_POSTSYNAP...5,SET,17,0.22017,0.0066932,0.21798,0.15624,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ORGANIZATION,0.890461602753196
GOMF_TRNA_CYTIDINE_5_METHYLT...,SET,5,0.32325,0.0053311,0.32005,0.15625,GOMF_TRNA_CYTIDINE_5_METHYLTRANSFERASE_ACTIVITY,0.890461602753196
MORF_TPR,SET,131,0.069914,0.0058817,0.069228,0.15627,MORF_TPR,0.890461602753196
GOCC_CATENIN_COMPLEX,SET,31,0.17812,0.0073094,0.17639,0.1563,GOCC_CATENIN_COMPLEX,0.890461602753196
HP_ABNORMAL_PERIPHERAL_ACTIO...,SET,37,0.14276,0.0063992,0.14138,0.1563,HP_ABNORMAL_PERIPHERAL_ACTION_POTENTIAL_AMPLITUDE,0.890461602753196
GOMF_3_5_CYCLIC_AMP_PHOSPHOD...,SET,22,0.1973,0.0068223,0.19539,0.15631,GOMF_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY,0.890461602753196
HIRSCH_CELLULAR_TRANSFORMATI...2,SET,228,0.058872,0.0065165,0.058304,0.15632,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,0.890461602753196
GSE36826_WT_VS_IL1R_KO_SKIN_...1,SET,170,0.064965,0.0062192,0.064342,0.15633,GSE36826_WT_VS_IL1R_KO_SKIN_DN,0.890461602753196
GSE40666_WT_VS_STAT1_KO_CD8_...4,SET,178,0.064311,0.0062984,0.063696,0.15634,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.890461602753196
GSE17721_LPS_VS_GARDIQUIMOD_...5,SET,180,0.064547,0.0063566,0.063963,0.15646,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN,0.890476079489696
GAUSSMANN_MLL_AF4_FUSION_TAR...4,SET,23,0.18276,0.0064614,0.18112,0.15648,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,0.890476079489696
HP_RECTAL_ABSCESS,SET,7,0.38483,0.0075091,0.38137,0.15648,HP_RECTAL_ABSCESS,0.890476079489696
HP_RECURRENT_APHTHOUS_STOMAT...,SET,44,0.13037,0.0063712,0.12923,0.15654,HP_RECURRENT_APHTHOUS_STOMATITIS,0.890476079489696
HP_CEREBRAL_CORTICAL_ATROPHY,SET,278,0.051675,0.0063072,0.051225,0.15655,HP_CEREBRAL_CORTICAL_ATROPHY,0.890476079489696
HP_ABNORMAL_BRAINSTEM_MORPHO...,SET,249,0.05354,0.0061897,0.053081,0.15658,HP_ABNORMAL_BRAINSTEM_MORPHOLOGY,0.890476079489696
GOBP_RHODOPSIN_MEDIATED_SIGN...,SET,10,0.25758,0.0060067,0.25542,0.15663,GOBP_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY,0.890476079489696
MYCMAX_02,SET,241,0.056283,0.0064028,0.055814,0.15664,MYCMAX_02,0.890476079489696
HP_ABNORMAL_CIRCULATING_IGA_...,SET,95,0.090994,0.0065253,0.090236,0.15664,HP_ABNORMAL_CIRCULATING_IGA_LEVEL,0.890476079489696
HP_ARTHRALGIA,SET,178,0.069541,0.0068106,0.068962,0.15664,HP_ARTHRALGIA,0.890476079489696
HP_WEAK_EXTRAOCULAR_MUSCLES,SET,12,0.24437,0.0062424,0.24234,0.15664,HP_WEAK_EXTRAOCULAR_MUSCLES,0.890476079489696
HP_PETECHIAE,SET,55,0.1208,0.0065985,0.1198,0.15665,HP_PETECHIAE,0.890476079489696
GOBP_POSITIVE_REGULATION_OF_...802,SET,37,0.17481,0.0078357,0.17341,0.15672,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.89072830744072
HP_HYPOKINESIA,SET,46,0.11703,0.0058475,0.1161,0.15675,HP_HYPOKINESIA,0.890753147482014
GOBP_MYOSIN_FILAMENT_ORGANIZ...,SET,6,0.33574,0.0060654,0.33314,0.15678,GOBP_MYOSIN_FILAMENT_ORGANIZATION,0.890777979401667
MIR376B_5P_MIR376C_5P,SET,44,0.13577,0.0066351,0.13475,0.15684,MIR376B_5P_MIR376C_5P,0.890836817738791
ENGELMANN_CANCER_PROGENITORS...1,SET,59,0.11784,0.006666,0.117,0.15693,ENGELMANN_CANCER_PROGENITORS_DN,0.890836817738791
JOHNSTONE_PARVB_TARGETS_3_DN,SET,757,0.031091,0.0061787,0.030869,0.15693,JOHNSTONE_PARVB_TARGETS_3_DN,0.890836817738791
GSE17721_CTRL_VS_PAM3CSK4_6H...1,SET,181,0.062753,0.0061969,0.062306,0.15693,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN,0.890836817738791
GOBP_DEVELOPMENTAL_PROCESS_I...,SET,869,0.030185,0.0064067,0.029973,0.15696,GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION,0.890836817738791
MIR6731_5P,SET,207,0.062165,0.0065603,0.061739,0.157,MIR6731_5P,0.890836817738791
GOBP_ROOF_OF_MOUTH_DEVELOPME...,SET,89,0.10375,0.0072023,0.10304,0.15701,GOBP_ROOF_OF_MOUTH_DEVELOPMENT,0.890836817738791
STAT3_02,SET,137,0.073986,0.0063641,0.073486,0.15702,STAT3_02,0.890836817738791
GSE40277_GATA1_AND_SATB1_TRA...1,SET,181,0.064638,0.006383,0.064216,0.15708,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.890836817738791
KEGG_MEDICUS_VARIANT_AMPLIFI...12,SET,11,0.24483,0.0059881,0.24327,0.15711,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S,0.890836817738791
ZF5_01,SET,225,0.057982,0.0063762,0.057614,0.15712,ZF5_01,0.890836817738791
ATCMNTCCGY_UNKNOWN,SET,47,0.12388,0.0062567,0.1231,0.15713,ATCMNTCCGY_UNKNOWN,0.890836817738791
HP_DYSARTHRIA,SET,538,0.03695,0.0062289,0.036722,0.15716,HP_DYSARTHRIA,0.890836817738791
GOBP_POST_TRANSLATIONAL_PROT...1,SET,870,0.029005,0.0061596,0.028826,0.15717,GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.890836817738791
BUSSLINGER_GASTRIC_NECK_CELLS,SET,34,0.16133,0.0069329,0.16035,0.15719,BUSSLINGER_GASTRIC_NECK_CELLS,0.890836817738791
HP_SPINAL_CORD_TUMOR,SET,9,0.30606,0.0067713,0.30422,0.15721,HP_SPINAL_CORD_TUMOR,0.890836817738791
GOBP_UBIQUITIN_DEPENDENT_END...,SET,7,0.31089,0.0060664,0.30914,0.15729,GOBP_UBIQUITIN_DEPENDENT_ENDOCYTOSIS,0.890836817738791
GOBP_REGULATION_OF_PROTEIN_I...,SET,56,0.1145,0.0063109,0.11387,0.15732,GOBP_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.890836817738791
GOBP_REGULATION_OF_PROTEIN_L...1,SET,10,0.25351,0.005912,0.25213,0.15734,GOBP_REGULATION_OF_PROTEIN_LIPIDATION,0.890836817738791
QI_PBMC_ZOSTAVAX_AGE_50_75YO...2,SET,35,0.13684,0.0059659,0.13614,0.15742,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE,0.890836817738791
GOBP_EMBRYONIC_SKELETAL_JOIN...2,SET,10,0.31138,0.0072614,0.30984,0.15746,GOBP_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS,0.890836817738791
GSE17974_0H_VS_1H_IN_VITRO_A...2,SET,159,0.066806,0.0061869,0.066475,0.15746,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP,0.890836817738791
GOMF_ANTIOXIDANT_ACTIVITY,SET,73,0.10426,0.006558,0.10375,0.15748,GOMF_ANTIOXIDANT_ACTIVITY,0.890836817738791
MORF_RAD23A,SET,303,0.046257,0.0058904,0.046037,0.15751,MORF_RAD23A,0.890836817738791
GSE1448_CTRL_VS_ANTI_VALPHA2...2,SET,178,0.063175,0.0061872,0.062882,0.15754,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP,0.890836817738791
GSE12003_MIR223_KO_VS_WT_BM_...3,SET,125,0.074469,0.0061207,0.074129,0.15755,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN,0.890836817738791
GOBP_PROTEIN_MODIFICATION_BY...1,SET,745,0.031088,0.006131,0.030946,0.15756,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION,0.890836817738791
WP_NEPHROTIC_SYNDROME,SET,42,0.13711,0.006547,0.1365,0.15758,WP_NEPHROTIC_SYNDROME,0.890836817738791
LEE_LIVER_CANCER_MYC_E2F1_UP,SET,55,0.1273,0.0069537,0.12675,0.1576,LEE_LIVER_CANCER_MYC_E2F1_UP,0.890836817738791
GOBP_CELL_COMMUNICATION_INVO...,SET,55,0.12992,0.0070966,0.12935,0.1576,GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION,0.890836817738791
AZARE_NEOPLASTIC_TRANSFORMAT...2,SET,116,0.085451,0.0067674,0.085085,0.15762,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,0.890836817738791
KHETCHOUMIAN_TRIM24_TARGETS_...1,SET,7,0.35403,0.0069081,0.35251,0.15762,KHETCHOUMIAN_TRIM24_TARGETS_DN,0.890836817738791
HP_BIRD_LIKE_FACIES,SET,13,0.20423,0.0054298,0.20342,0.15771,HP_BIRD_LIKE_FACIES,0.890836817738791
LIU_PROSTATE_CANCER_DN,SET,435,0.044127,0.0067081,0.043956,0.15772,LIU_PROSTATE_CANCER_DN,0.890836817738791
MORI_PLASMA_CELL_UP,SET,45,0.12694,0.0062738,0.12645,0.15772,MORI_PLASMA_CELL_UP,0.890836817738791
GOBP_POSITIVE_REGULATION_OF_...591,SET,7,0.31016,0.0060521,0.30898,0.15774,GOBP_POSITIVE_REGULATION_OF_PINOCYTOSIS,0.890836817738791
GSE1460_CD4_THYMOCYTE_VS_NAI...2,SET,182,0.064994,0.0064358,0.064748,0.15774,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.890836817738791
GOBP_NLS_BEARING_PROTEIN_IMP...,SET,18,0.20607,0.0064461,0.20533,0.15778,GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS,0.890836817738791
GSE26343_UNSTIM_VS_LPS_STIM_...1,SET,182,0.061741,0.0061136,0.061518,0.15779,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.890836817738791
GSE15930_STIM_VS_STIM_AND_IF...4,SET,180,0.062812,0.0061857,0.0626,0.15784,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP,0.89097437063505
GOBP_GANGLIOSIDE_BIOSYNTHETI...2,SET,6,0.31893,0.0057616,0.31789,0.15787,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS_VIA_LACTOSYLCERAMIDE,0.890999001299123
GSE24210_RESTING_TREG_VS_TCO...1,SET,178,0.060583,0.0059334,0.060398,0.15792,GSE24210_RESTING_TREG_VS_TCONV_DN,0.891136483195324
BIOCARTA_MAPK_PATHWAY,SET,79,0.097742,0.0063946,0.097457,0.15796,BIOCARTA_MAPK_PATHWAY,0.891186782902137
HP_EOSINOPHILIA,SET,52,0.11987,0.0063672,0.11962,0.15816,HP_EOSINOPHILIA,0.891186782902137
GOMF_POTASSIUM_CHANNEL_INHIB...,SET,5,0.40232,0.0066351,0.40155,0.1582,GOMF_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY,0.891186782902137
GSE17721_12H_VS_24H_LPS_BMDC...2,SET,190,0.063695,0.0064428,0.063574,0.1582,GSE17721_12H_VS_24H_LPS_BMDC_UP,0.891186782902137
GSE21379_WT_VS_SAP_KO_CD4_TC...2,SET,185,0.062917,0.0062807,0.062797,0.1582,GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP,0.891186782902137
GOBP_OPSONIZATION,SET,15,0.26216,0.0074867,0.26168,0.15821,GOBP_OPSONIZATION,0.891186782902137
HP_IMPAIRED_EPINEPHRINE_INDU...,SET,9,0.28258,0.0062518,0.28206,0.15822,HP_IMPAIRED_EPINEPHRINE_INDUCED_PLATELET_AGGREGATION,0.891186782902137
GSE43863_TFH_VS_LY6C_INT_CXC...3,SET,178,0.065803,0.0064445,0.065682,0.15822,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.891186782902137
RAMPON_ENRICHED_LEARNING_ENV...1,SET,10,0.29302,0.0068332,0.29249,0.15823,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN,0.891186782902137
DESCARTES_FETAL_CEREBELLUM_P...,SET,43,0.14322,0.0069194,0.14296,0.15823,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.891186782902137
MIR4678,SET,100,0.086892,0.0063921,0.086747,0.15826,MIR4678,0.891186782902137
GOMF_DOUBLE_STRANDED_TELOMER...,SET,9,0.26872,0.0059451,0.26827,0.15826,GOMF_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING,0.891186782902137
GSE44649_NAIVE_VS_ACTIVATED_...2,SET,175,0.058839,0.0057142,0.058754,0.15831,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN,0.891186782902137
PROVENZANI_METASTASIS_DN,SET,135,0.07489,0.006395,0.074793,0.15835,PROVENZANI_METASTASIS_DN,0.891186782902137
GOBP_REGULATION_OF_HEPATOCYT...2,SET,16,0.20793,0.0061325,0.20767,0.15836,GOBP_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.891186782902137
GARCIA_PINERES_PBMC_HPV_16_L...5,SET,12,0.25354,0.0064765,0.25326,0.1584,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.891186782902137
CROONQUIST_NRAS_SIGNALING_DN,SET,68,0.10073,0.0061159,0.10066,0.15849,CROONQUIST_NRAS_SIGNALING_DN,0.891186782902137
GOMF_TRIPEPTIDE_TRANSMEMBRAN...,SET,9,0.30044,0.006647,0.30025,0.15851,GOMF_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.891186782902137
HP_RENAL_DYSPLASIA,SET,62,0.10993,0.0063744,0.10987,0.15852,HP_RENAL_DYSPLASIA,0.891186782902137
HP_INTRAMUSCULAR_HEMATOMA,SET,7,0.33961,0.0066267,0.33946,0.15856,HP_INTRAMUSCULAR_HEMATOMA,0.891186782902137
GSE46242_CTRL_VS_EGR2_DELETE...1,SET,168,0.068079,0.0064792,0.068057,0.15858,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN,0.891186782902137
GSE45365_HEALTHY_VS_MCMV_INF...1,SET,167,0.06528,0.0061945,0.065264,0.1586,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN,0.891186782902137
DESCARTES_FETAL_SPLEEN_ERYTH...,SET,53,0.11972,0.0064199,0.11971,0.15865,DESCARTES_FETAL_SPLEEN_ERYTHROBLASTS,0.891186782902137
LEE_LIVER_CANCER_MYC_UP,SET,49,0.12599,0.006497,0.12599,0.15866,LEE_LIVER_CANCER_MYC_UP,0.891186782902137
GOBP_REGULATION_OF_CAMP_MEDI...,SET,19,0.19999,0.006427,0.2,0.15868,GOBP_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.891186782902137
DOANE_BREAST_CANCER_CLASSES_...2,SET,66,0.10859,0.0064955,0.10861,0.15872,DOANE_BREAST_CANCER_CLASSES_UP,0.891186782902137
HE_LIM_SUN_FETAL_LUNG_C2_APO...2,SET,436,0.04125,0.0062778,0.041261,0.15872,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL,0.891186782902137
HP_THORACIC_AORTA_CALCIFICAT...,SET,5,0.43077,0.0071043,0.43089,0.15873,HP_THORACIC_AORTA_CALCIFICATION,0.891186782902137
REACTOME_PRC2_METHYLATES_HIS...,SET,12,0.24496,0.0062573,0.24507,0.15877,REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA,0.891186782902137
HP_ACRAL_ULCERATION,SET,8,0.3033,0.0063266,0.30354,0.15885,HP_ACRAL_ULCERATION,0.891186782902137
HP_CERVICAL_SPINAL_CORD_ATRO...,SET,5,0.38199,0.0062999,0.38232,0.15887,HP_CERVICAL_SPINAL_CORD_ATROPHY,0.891186782902137
HP_HEMOGLOBINURIA,SET,8,0.28328,0.0059091,0.28352,0.15887,HP_HEMOGLOBINURIA,0.891186782902137
GOBP_MAMMARY_GLAND_EPITHELIU...,SET,67,0.1146,0.0069066,0.11472,0.15892,GOBP_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT,0.891186782902137
GOBP_PYRIMIDINE_CONTAINING_C...1,SET,37,0.14092,0.0063167,0.14108,0.15894,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.891186782902137
HP_PEG_SHAPED_MAXILLARY_LATE...,SET,24,0.19327,0.0069796,0.19349,0.15894,HP_PEG_SHAPED_MAXILLARY_LATERAL_INCISORS,0.891186782902137
GSE21063_WT_VS_NFATC1_KO_16H...2,SET,176,0.062872,0.0061232,0.062944,0.15894,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP,0.891186782902137
TRAVAGLINI_LUNG_EREG_DENDRIT...,SET,526,0.040022,0.0066733,0.040069,0.15894,TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL,0.891186782902137
GOBP_ESTABLISHMENT_OF_ENDOTH...2,SET,13,0.25187,0.0066965,0.25221,0.15898,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER,0.891186782902137
GOBP_NEGATIVE_REGULATION_OF_...594,SET,5,0.36007,0.0059384,0.36058,0.159,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.891186782902137
HP_ISOMERISM,SET,4,0.43909,0.0064773,0.43973,0.15901,HP_ISOMERISM,0.891186782902137
REACTOME_E3_UBIQUITIN_LIGASE...,SET,39,0.12985,0.0059756,0.1301,0.15912,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,0.891186782902137
GSE40666_WT_VS_STAT1_KO_CD8_...3,SET,186,0.061093,0.0061149,0.061211,0.15913,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.891186782902137
MIR135A_2_3P,SET,48,0.11586,0.0059133,0.11613,0.15923,MIR135A_2_3P,0.891186782902137
MIR135B_3P,SET,48,0.11586,0.0059133,0.11613,0.15923,MIR135B_3P,0.891186782902137
REACTOME_ACTIVATION_OF_RAC1,SET,11,0.25684,0.0062818,0.25749,0.15927,REACTOME_ACTIVATION_OF_RAC1,0.891186782902137
GSE14026_TH1_VS_TH17_DN,SET,179,0.062167,0.0061054,0.062325,0.15928,GSE14026_TH1_VS_TH17_DN,0.891186782902137
GOBP_MITOTIC_NUCLEAR_DIVISION,SET,265,0.050453,0.0060146,0.050584,0.15929,GOBP_MITOTIC_NUCLEAR_DIVISION,0.891186782902137
GSE10240_IL17_VS_IL17_AND_IL...2,SET,180,0.061638,0.0060702,0.061807,0.15932,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.891186782902137
GSE18893_CTRL_VS_TNF_TREATED...7,SET,179,0.063676,0.0062536,0.06385,0.15932,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN,0.891186782902137
GSE8685_IL15_ACT_IL2_STARVED...1,SET,141,0.070334,0.006137,0.07053,0.15934,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,0.891186782902137
GOBP_INTRACELLULAR_MRNA_LOCA...,SET,15,0.21423,0.0061177,0.21484,0.15935,GOBP_INTRACELLULAR_MRNA_LOCALIZATION,0.891186782902137
GOBP_REGULATION_OF_TRIGLYCER...3,SET,39,0.13593,0.0062552,0.13634,0.15938,GOBP_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.891186782902137
GOBP_REGULATION_OF_NK_T_CELL...3,SET,7,0.37032,0.007226,0.37144,0.15939,GOBP_REGULATION_OF_NK_T_CELL_PROLIFERATION,0.891186782902137
GSE12845_IGD_NEG_BLOOD_VS_DA...2,SET,162,0.067623,0.0063209,0.067831,0.1594,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.891186782902137
GOBP_AXON_CHOICE_POINT_RECOG...,SET,7,0.40656,0.0079332,0.40785,0.15943,GOBP_AXON_CHOICE_POINT_RECOGNITION,0.891186782902137
HP_DIGITAL_FLEXOR_TENOSYNOVI...,SET,7,0.33082,0.0064551,0.33189,0.15944,HP_DIGITAL_FLEXOR_TENOSYNOVITIS,0.891186782902137
GSE11961_FOLLICULAR_BCELL_VS...1,SET,180,0.0636,0.0062634,0.06381,0.15946,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.891186782902137
GOBP_PROTEIN_K29_LINKED_DEUB...,SET,4,0.4477,0.0066042,0.44921,0.15947,GOBP_PROTEIN_K29_LINKED_DEUBIQUITINATION,0.891186782902137
HP_PHONOPHOBIA,SET,22,0.23641,0.0081745,0.2372,0.15947,HP_PHONOPHOBIA,0.891186782902137
CHIARADONNA_NEOPLASTIC_TRANS...3,SET,49,0.1296,0.0066832,0.13005,0.15949,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,0.891186782902137
HP_HALLUCINATIONS,SET,146,0.070757,0.0062815,0.071004,0.1595,HP_HALLUCINATIONS,0.891186782902137
RAY_TUMORIGENESIS_BY_ERBB2_C...2,SET,176,0.064928,0.0063234,0.06517,0.15956,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,0.891186782902137
GSE29614_CTRL_VS_DAY3_TIV_FL...1,SET,139,0.077116,0.0066812,0.077403,0.15956,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN,0.891186782902137
MIR664B_5P,SET,53,0.11495,0.0061641,0.11538,0.15957,MIR664B_5P,0.891186782902137
GOBP_PYRIMIDINE_RIBONUCLEOSI...5,SET,16,0.22041,0.0065006,0.22135,0.15969,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.891475794797688
BIOCARTA_RANMS_PATHWAY,SET,10,0.25272,0.0058936,0.25381,0.1597,BIOCARTA_RANMS_PATHWAY,0.891475794797688
KEGG_MEDICUS_REFERENCE_GATOR...,SET,13,0.23405,0.0062226,0.23506,0.15971,KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY,0.891475794797688
MIR6873_5P,SET,94,0.088637,0.0063229,0.089038,0.15975,MIR6873_5P,0.891475794797688
VEGF_A_UP.V1_DN,SET,181,0.061116,0.0060352,0.061392,0.15975,VEGF_A_UP.V1_DN,0.891475794797688
ZHONG_PFC_C3_PROX1_CCK_POS_I...,SET,10,0.32615,0.0076058,0.32767,0.15979,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.891555859688554
GSE41176_UNSTIM_VS_ANTI_IGM_...3,SET,180,0.064283,0.0063306,0.064597,0.15984,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN,0.891604357246028
HP_HYPOGLYCEMIC_COMA,SET,20,0.19428,0.0064054,0.19523,0.15985,HP_HYPOGLYCEMIC_COMA,0.891604357246028
HP_SYMPTOMATIC_SEIZURES,SET,35,0.15497,0.0067565,0.15576,0.15989,HP_SYMPTOMATIC_SEIZURES,0.891677045235804
GOBP_UTERUS_DEVELOPMENT,SET,25,0.18101,0.0066717,0.18196,0.15992,GOBP_UTERUS_DEVELOPMENT,0.891677045235804
GSE9988_ANTI_TREM1_VS_CTRL_T...2,SET,172,0.070861,0.0068231,0.071237,0.15994,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP,0.891677045235804
HP_EPISTAXIS,SET,96,0.092855,0.0066935,0.093374,0.16001,HP_EPISTAXIS,0.891881987527982
MIR6717_5P,SET,4,0.42924,0.0063318,0.43167,0.16003,MIR6717_5P,0.891881987527982
MYLLYKANGAS_AMPLIFICATION_HO...13,SET,8,0.32782,0.0068381,0.32975,0.16008,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29,0.891881987527982
GOBP_REGULATION_OF_NK_T_CELL...2,SET,6,0.40083,0.0072413,0.40327,0.16013,GOBP_REGULATION_OF_NK_T_CELL_DIFFERENTIATION,0.891881987527982
GSE2770_IL12_ACT_VS_ACT_CD4_...3,SET,178,0.061326,0.0060061,0.061715,0.16019,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN,0.891881987527982
HP_FASCICULATIONS,SET,123,0.076783,0.0062605,0.077272,0.1602,HP_FASCICULATIONS,0.891881987527982
GOBP_PROLINE_TRANSPORT,SET,11,0.28253,0.0069101,0.28441,0.16027,GOBP_PROLINE_TRANSPORT,0.891881987527982
GOBP_RESPONSE_TO_CGMP,SET,8,0.29207,0.0060924,0.29407,0.16031,GOBP_RESPONSE_TO_CGMP,0.891881987527982
GSE4142_GC_BCELL_VS_MEMORY_B...1,SET,180,0.059971,0.005906,0.060383,0.16032,GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN,0.891881987527982
GSE17974_CTRL_VS_ACT_IL4_AND...11,SET,177,0.060818,0.0059397,0.061239,0.16033,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN,0.891881987527982
GSE1460_CD4_THYMOCYTE_VS_NAI...4,SET,191,0.061479,0.0062348,0.061905,0.16034,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.891881987527982
HP_ABNORMAL_NEPHRON_MORPHOLO...,SET,220,0.058383,0.0063495,0.058794,0.16036,HP_ABNORMAL_NEPHRON_MORPHOLOGY,0.891881987527982
GSE11961_GERMINAL_CENTER_BCE...6,SET,181,0.063635,0.006284,0.064085,0.16037,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.891881987527982
REACTOME_SUMOYLATION_OF_TRAN...1,SET,40,0.12723,0.005929,0.12815,0.16041,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,0.891881987527982
GOBP_REGULATION_OF_ACTOMYOSI...,SET,94,0.089978,0.0064186,0.090631,0.16041,GOBP_REGULATION_OF_ACTOMYOSIN_STRUCTURE_ORGANIZATION,0.891881987527982
GSE39820_CTRL_VS_IL1B_IL6_IL...1,SET,186,0.064704,0.0064764,0.065175,0.16042,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN,0.891881987527982
GOBP_REGULATION_OF_INTEGRIN_...3,SET,18,0.21032,0.006579,0.21189,0.16046,GOBP_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.891881987527982
REACTOME_TRIGLYCERIDE_CATABO...,SET,23,0.18277,0.0064617,0.18414,0.16047,REACTOME_TRIGLYCERIDE_CATABOLISM,0.891881987527982
LEE_LIVER_CANCER_CIPROFIBRAT...1,SET,63,0.1176,0.0068737,0.11849,0.16048,LEE_LIVER_CANCER_CIPROFIBRATE_DN,0.891881987527982
HP_ADENOCARCINOMA_OF_THE_INT...,SET,38,0.1295,0.0058824,0.13048,0.16049,HP_ADENOCARCINOMA_OF_THE_INTESTINES,0.891881987527982
MIR7845_5P,SET,55,0.10941,0.0059764,0.11026,0.16053,MIR7845_5P,0.891954275211763
GSE18281_CORTICAL_THYMOCYTE_...2,SET,173,0.069341,0.006696,0.069887,0.16056,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP,0.891954275211763
GOBP_REGULATION_OF_PHENOTYPI...,SET,3,0.58045,0.0074155,0.58507,0.16058,GOBP_REGULATION_OF_PHENOTYPIC_SWITCHING,0.891954275211763
GSE15330_MEGAKARYOCYTE_ERYTH...3,SET,181,0.064113,0.0063312,0.064663,0.16073,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.892644798657718
GSE36476_CTRL_VS_TSST_ACT_40...1,SET,181,0.058837,0.0058102,0.05936,0.1608,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN,0.892678655716792
OHM_METHYLATED_IN_ADULT_CANC...,SET,26,0.17393,0.0065373,0.17547,0.16081,OHM_METHYLATED_IN_ADULT_CANCERS,0.892678655716792
REACTOME_CARGO_TRAFFICKING_T...,SET,49,0.11108,0.0057281,0.1121,0.16086,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,0.892678655716792
SAMOLS_TARGETS_OF_KHSV_MIRNA...1,SET,47,0.1373,0.0069345,0.13857,0.16089,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,0.892678655716792
GOBP_RESPONSE_TO_BMP,SET,147,0.074154,0.0066054,0.074864,0.16097,GOBP_RESPONSE_TO_BMP,0.892678655716792
REACTOME_NS1_MEDIATED_EFFECT...,SET,39,0.12295,0.0056577,0.12413,0.16098,REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,0.892678655716792
GOBP_ADHERENS_JUNCTION_ORGAN...,SET,56,0.1229,0.006774,0.12409,0.16099,GOBP_ADHERENS_JUNCTION_ORGANIZATION,0.892678655716792
PID_FOXM1_PATHWAY,SET,39,0.13383,0.0061587,0.13514,0.16101,PID_FOXM1_PATHWAY,0.892678655716792
GOBP_NEGATIVE_REGULATION_OF_...234,SET,48,0.13575,0.0069283,0.13707,0.16101,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.892678655716792
MODULE_568,SET,62,0.10523,0.006102,0.10627,0.16102,MODULE_568,0.892678655716792
GOBP_RENAL_SODIUM_ION_TRANSP...,SET,14,0.25112,0.0069284,0.25359,0.16103,GOBP_RENAL_SODIUM_ION_TRANSPORT,0.892678655716792
MIR4261,SET,387,0.044591,0.0064023,0.045038,0.16107,MIR4261,0.892678655716792
HP_PROGRESSIVE_PULMONARY_FUN...,SET,13,0.23482,0.006243,0.23717,0.16107,HP_PROGRESSIVE_PULMONARY_FUNCTION_IMPAIRMENT,0.892678655716792
HP_ORTHOSTATIC_HYPOTENSION,SET,38,0.14604,0.0066339,0.14753,0.16112,HP_ORTHOSTATIC_HYPOTENSION,0.892726470588235
GOMF_2_OXOGLUTARATE_DEPENDEN...,SET,52,0.10355,0.0055006,0.10462,0.16113,GOMF_2_OXOGLUTARATE_DEPENDENT_DIOXYGENASE_ACTIVITY,0.892726470588235
MODULE_316,SET,63,0.11865,0.006935,0.11994,0.16127,MODULE_316,0.892751223941882
LIEN_BREAST_CARCINOMA_METAPL...3,SET,73,0.10952,0.0068888,0.11071,0.16128,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,0.892751223941882
GOBP_POSITIVE_REGULATION_OF_...442,SET,5,0.35224,0.0058091,0.35612,0.16131,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.892751223941882
GOBP_CELLULAR_RESPONSE_TO_TE...1,SET,5,0.35484,0.0058521,0.35879,0.16134,GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS,0.892751223941882
HALLMARK_UNFOLDED_PROTEIN_RE...,SET,104,0.08207,0.0061563,0.082994,0.16137,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.892751223941882
HP_ABNORMAL_EARLOBE_MORPHOLO...,SET,107,0.081497,0.0062004,0.082418,0.16138,HP_ABNORMAL_EARLOBE_MORPHOLOGY,0.892751223941882
GOBP_SINGLE_STRANDED_VIRAL_R...,SET,17,0.24711,0.0075123,0.24994,0.16141,GOBP_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,0.892751223941882
GSE41867_DAY8_VS_DAY15_LCMV_...2,SET,148,0.070356,0.0062882,0.071164,0.16142,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.892751223941882
TAKADA_GASTRIC_CANCER_COPY_N...1,SET,28,0.18768,0.0073203,0.18985,0.16144,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,0.892751223941882
GOBP_ACTIVATION_OF_GTPASE_AC...,SET,81,0.096642,0.0064018,0.097756,0.16144,GOBP_ACTIVATION_OF_GTPASE_ACTIVITY,0.892751223941882
GOBP_REGULATION_OF_PROTEIN_L...6,SET,9,0.24788,0.0054842,0.25079,0.16148,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.892751223941882
GOBP_POSITIVE_REGULATION_OF_...607,SET,96,0.082827,0.0059706,0.083817,0.16154,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.892751223941882
KEGG_MEDICUS_VARIANT_AMPLIFI...8,SET,12,0.23394,0.005976,0.23677,0.16157,KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S,0.892751223941882
REACTOME_PLATELET_SENSITIZAT...,SET,16,0.21421,0.0063179,0.2168,0.16157,REACTOME_PLATELET_SENSITIZATION_BY_LDL,0.892751223941882
GOMF_OXIDOREDUCTASE_ACTIVITY...18,SET,2,0.57574,0.0060057,0.58274,0.16159,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS_CYTOCHROME_AS_ACCEPTOR,0.892751223941882
WANG_CLIM2_TARGETS_UP,SET,214,0.05592,0.005999,0.056612,0.16164,WANG_CLIM2_TARGETS_UP,0.892751223941882
HP_ULNAR_CLAW,SET,9,0.31432,0.006954,0.31821,0.16164,HP_ULNAR_CLAW,0.892751223941882
GSE17721_CTRL_VS_PAM3CSK4_0....1,SET,181,0.061543,0.0060775,0.06233,0.16174,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN,0.892751223941882
HP_ABNORMALITY_OF_THE_TEMPOR...,SET,18,0.2168,0.0067816,0.21958,0.16175,HP_ABNORMALITY_OF_THE_TEMPOROMANDIBULAR_JOINT,0.892751223941882
REACTOME_EPHA_MEDIATED_GROWT...,SET,29,0.16883,0.0067011,0.171,0.16176,REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,0.892751223941882
HP_INTERPHALANGEAL_JOINT_ERO...,SET,7,0.32729,0.0063863,0.33151,0.16176,HP_INTERPHALANGEAL_JOINT_EROSIONS,0.892751223941882
GOBP_GAP_JUNCTION_MEDIATED_I...,SET,6,0.42483,0.0076749,0.43032,0.16177,GOBP_GAP_JUNCTION_MEDIATED_INTERCELLULAR_TRANSPORT,0.892751223941882
NIKOLSKY_BREAST_CANCER_11Q12...,SET,144,0.1171,0.010325,0.11863,0.1618,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,0.892751223941882
MIR6780B_5P,SET,258,0.052221,0.0061438,0.052913,0.16185,MIR6780B_5P,0.892751223941882
GSE36891_UNSTIM_VS_POLYIC_TL...2,SET,141,0.077087,0.0067262,0.07811,0.16185,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP,0.892751223941882
HP_ABNORMALITY_OF_REPRODUCTI...,SET,755,0.031389,0.0062301,0.03181,0.16189,HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.892751223941882
MIR6126,SET,106,0.079179,0.0059959,0.080251,0.16192,MIR6126,0.892751223941882
GOBP_SEXUAL_REPRODUCTION,SET,923,0.028051,0.0061265,0.028438,0.16197,GOBP_SEXUAL_REPRODUCTION,0.892751223941882
GOBP_NEGATIVE_REGULATION_OF_...512,SET,9,0.29557,0.0065392,0.29965,0.16198,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.892751223941882
GOBP_MYOTUBE_CELL_DEVELOPMENT,SET,37,0.14512,0.006505,0.14713,0.16199,GOBP_MYOTUBE_CELL_DEVELOPMENT,0.892751223941882
HP_ANTIPHOSPHOLIPID_ANTIBODY...,SET,16,0.21206,0.0062544,0.21501,0.162,HP_ANTIPHOSPHOLIPID_ANTIBODY_POSITIVITY,0.892751223941882
GOMF_CYTOKINE_BINDING,SET,130,0.078736,0.0065986,0.079843,0.16204,GOMF_CYTOKINE_BINDING,0.892751223941882
KIM_LIVER_CANCER_POOR_SURVIV...1,SET,41,0.13404,0.0063238,0.13593,0.16206,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,0.892751223941882
GOBP_INTERLEUKIN_27_MEDIATED...,SET,7,0.33951,0.0066247,0.34433,0.16207,GOBP_INTERLEUKIN_27_MEDIATED_SIGNALING_PATHWAY,0.892751223941882
WP_MIRNA_REGULATION_OF_P53_P...,SET,24,0.17856,0.0064485,0.18114,0.16214,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,0.892751223941882
NFAT_Q4_01,SET,243,0.056861,0.006495,0.057689,0.16216,NFAT_Q4_01,0.892751223941882
GOBP_CHEMOREPULSION_OF_AXON,SET,6,0.38118,0.0068862,0.38675,0.16217,GOBP_CHEMOREPULSION_OF_AXON,0.892751223941882
GSE22196_HEALTHY_VS_OBESE_MO...2,SET,180,0.06448,0.00635,0.065423,0.16218,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP,0.892751223941882
GOCC_TRANSPORT_VESICLE_MEMBR...,SET,221,0.057491,0.0062664,0.058334,0.16219,GOCC_TRANSPORT_VESICLE_MEMBRANE,0.892751223941882
HP_BLADDER_DIVERTICULUM,SET,29,0.1852,0.0073511,0.18792,0.16219,HP_BLADDER_DIVERTICULUM,0.892751223941882
KEGG_MEDICUS_ENV_FACTOR_ARSE...,SET,16,0.18923,0.005581,0.19205,0.16224,KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.892751223941882
HUPER_BREAST_BASAL_VS_LUMINA...2,SET,51,0.12704,0.0066832,0.12894,0.16225,HUPER_BREAST_BASAL_VS_LUMINAL_UP,0.892751223941882
BIOCARTA_STEM_PATHWAY,SET,15,0.22956,0.0065555,0.233,0.16226,BIOCARTA_STEM_PATHWAY,0.892751223941882
MIR5189_5P,SET,139,0.071999,0.0062379,0.073086,0.16229,MIR5189_5P,0.892751223941882
FLORIO_NEOCORTEX_BASAL_RADIA...1,SET,170,0.064817,0.0062051,0.065804,0.16232,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,0.892751223941882
GUTIERREZ_WALDENSTROEMS_MACR...2,SET,10,0.28231,0.0065835,0.28662,0.16233,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,0.892751223941882
BURTON_ADIPOGENESIS_3,SET,95,0.084722,0.0060755,0.086041,0.1624,BURTON_ADIPOGENESIS_3,0.892751223941882
GOBP_EPITHELIAL_STRUCTURE_MA...,SET,32,0.16293,0.0067929,0.16547,0.16241,GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE,0.892751223941882
HP_APLASIA_OF_THE_SEMICIRCUL...,SET,16,0.19174,0.005655,0.19473,0.16241,HP_APLASIA_OF_THE_SEMICIRCULAR_CANAL,0.892751223941882
HP_OPHTHALMOPARESIS,SET,244,0.052574,0.0060175,0.053411,0.16249,HP_OPHTHALMOPARESIS,0.892751223941882
GOBP_DOPAMINE_SECRETION,SET,29,0.16711,0.0066331,0.16978,0.1625,GOBP_DOPAMINE_SECRETION,0.892751223941882
GOMF_CYCLASE_INHIBITOR_ACTIV...,SET,4,0.38952,0.0057459,0.39579,0.16253,GOMF_CYCLASE_INHIBITOR_ACTIVITY,0.892751223941882
GOMF_PROTEIN_HORMONE_RECEPTO...,SET,18,0.21661,0.0067758,0.22011,0.16254,GOMF_PROTEIN_HORMONE_RECEPTOR_ACTIVITY,0.892751223941882
GOBP_REGULATION_OF_GLUCAGON_...,SET,8,0.29501,0.0061537,0.29982,0.16258,GOBP_REGULATION_OF_GLUCAGON_SECRETION,0.892751223941882
HP_SMALL_CEREBRAL_CORTEX,SET,8,0.29187,0.0060883,0.29668,0.16261,HP_SMALL_CEREBRAL_CORTEX,0.892751223941882
MIKKELSEN_IPS_LCP_WITH_H3K4M...2,SET,5,0.45481,0.0075008,0.46231,0.16262,MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.892751223941882
GSE14000_UNSTIM_VS_16H_LPS_D...1,SET,174,0.063966,0.0061945,0.06502,0.16262,GSE14000_UNSTIM_VS_16H_LPS_DC_DN,0.892751223941882
BIOCARTA_BCR_PATHWAY,SET,31,0.15067,0.0061827,0.15316,0.16264,BIOCARTA_BCR_PATHWAY,0.892751223941882
FULLER_PBMC_F_TULARENSIS_VAC...5,SET,54,0.12487,0.0067587,0.12695,0.16265,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP,0.892751223941882
MANNE_COVID19_COMBINED_COHOR...2,SET,162,0.065491,0.0061216,0.066589,0.16268,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,0.892774893415443
GOBP_POSITIVE_REGULATION_OF_...41,SET,5,0.40116,0.0066159,0.40792,0.16271,GOBP_POSITIVE_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.892798555415219
GSE1460_NAIVE_CD4_TCELL_ADUL...2,SET,170,0.060143,0.0057576,0.061182,0.1628,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.893120123106061
GOBP_NEGATIVE_REGULATION_OF_...663,SET,57,0.1191,0.0066228,0.12117,0.16282,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.893120123106061
HP_FLAT_NASAL_ALAE,SET,8,0.25101,0.0052358,0.25541,0.16287,HP_FLAT_NASAL_ALAE,0.893167308299148
WP_HEDGEHOG_SIGNALING_WP4249,SET,41,0.13469,0.0063548,0.13706,0.16288,WP_HEDGEHOG_SIGNALING_WP4249,0.893167308299148
GOBP_REGULATION_OF_CELLULAR_...18,SET,137,0.073875,0.0063545,0.075202,0.16297,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.893519853289162
HU_FETAL_RETINA_RPE,SET,253,0.057973,0.006755,0.059054,0.16313,HU_FETAL_RETINA_RPE,0.894256017350158
GSE15750_DAY6_VS_DAY10_TRAF6...2,SET,180,0.061197,0.0060267,0.062366,0.16324,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP,0.894717899384955
HP_URETHRAL_OBSTRUCTION,SET,60,0.1175,0.0067025,0.11978,0.16332,HP_URETHRAL_OBSTRUCTION,0.895015231788079
HP_RETINAL_VEIN_OCCLUSION,SET,6,0.35898,0.0064853,0.36606,0.16339,HP_RETINAL_VEIN_OCCLUSION,0.895212816082928
HP_WEAK_VOICE,SET,24,0.16412,0.005927,0.16738,0.16342,HP_WEAK_VOICE,0.895212816082928
MARIADASON_REGULATED_BY_HIST...2,SET,55,0.11351,0.0062003,0.11578,0.16345,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,0.895212816082928
GOMF_PHOSPHATIDYLINOSITOL_3_...5,SET,8,0.25951,0.0054132,0.26478,0.16352,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.895212816082928
GOBP_CELLULAR_RESPONSE_TO_CG...,SET,7,0.30119,0.0058769,0.30735,0.16356,GOBP_CELLULAR_RESPONSE_TO_CGMP,0.895212816082928
GSE45365_NK_CELL_VS_CD8_TCEL...4,SET,143,0.068306,0.0060018,0.069704,0.16356,GSE45365_NK_CELL_VS_CD8_TCELL_UP,0.895212816082928
KEGG_MEDICUS_REFERENCE_ORIGI...,SET,29,0.14164,0.0056221,0.14458,0.16363,KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION,0.895212816082928
MORF_ESPL1,SET,54,0.10468,0.0056661,0.10685,0.16363,MORF_ESPL1,0.895212816082928
GOMF_ASPARTIC_TYPE_ENDOPEPTI...,SET,7,0.34652,0.0067615,0.35374,0.16365,GOMF_ASPARTIC_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.895212816082928
HP_PENDULAR_NYSTAGMUS,SET,37,0.14101,0.0063207,0.14396,0.16368,HP_PENDULAR_NYSTAGMUS,0.895212816082928
HP_CORTICAL_SCLEROSIS,SET,5,0.34857,0.0057486,0.35607,0.16382,HP_CORTICAL_SCLEROSIS,0.895212816082928
GOMF_INOSITOL_TETRAKISPHOSPH...2,SET,7,0.30837,0.0060171,0.31503,0.16383,GOMF_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.895212816082928
AMIT_EGF_RESPONSE_60_HELA,SET,42,0.12959,0.0061881,0.1324,0.16385,AMIT_EGF_RESPONSE_60_HELA,0.895212816082928
HP_DECREASED_CIRCULATING_ANT...,SET,175,0.063044,0.0061226,0.064417,0.16388,HP_DECREASED_CIRCULATING_ANTIBODY_LEVEL,0.895212816082928
GSE22886_IGM_MEMORY_BCELL_VS...4,SET,180,0.062193,0.0061248,0.063553,0.16389,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,0.895212816082928
GOBP_MIDGUT_DEVELOPMENT,SET,11,0.30379,0.00743,0.31046,0.16391,GOBP_MIDGUT_DEVELOPMENT,0.895212816082928
GSE17721_POLYIC_VS_PAM3CSK4_...15,SET,178,0.060192,0.0058951,0.061512,0.16391,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN,0.895212816082928
REACTOME_RESOLUTION_OF_D_LOO...1,SET,32,0.14064,0.0058637,0.14374,0.16392,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES,0.895212816082928
HP_PREAXIAL_FOOT_POLYDACTYLY,SET,16,0.2061,0.0060786,0.21065,0.16394,HP_PREAXIAL_FOOT_POLYDACTYLY,0.895212816082928
GSE2770_IL12_VS_IL4_TREATED_...5,SET,184,0.059714,0.005945,0.061032,0.16394,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.895212816082928
GSE17721_0.5H_VS_12H_POLYIC_...2,SET,180,0.060699,0.0059777,0.062043,0.16396,GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP,0.895212816082928
chr8p23,SET,42,0.23729,0.011331,0.24255,0.16397,chr8p23,0.895212816082928
GOBP_NEGATIVE_REGULATION_OF_...152,SET,8,0.34651,0.0072279,0.35421,0.16398,GOBP_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.895212816082928
GOBP_REGULATION_OF_MEIOSIS_I,SET,5,0.34646,0.0057139,0.35417,0.16398,GOBP_REGULATION_OF_MEIOSIS_I,0.895212816082928
MORF_PRKAR1A,SET,125,0.070838,0.0058222,0.072418,0.164,MORF_PRKAR1A,0.895212816082928
TRAVAGLINI_LUNG_ALVEOLAR_FIB...,SET,149,0.074871,0.0067141,0.076566,0.16408,TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL,0.89550885678392
KEGG_MEDICUS_VARIANT_AMPLIFI...1,SET,6,0.30709,0.0055479,0.3141,0.16412,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCND1_TO_CELL_CYCLE_G1_S,0.895578143148642
GOBP_NITROGEN_UTILIZATION,SET,5,0.36803,0.0060697,0.37648,0.16415,GOBP_NITROGEN_UTILIZATION,0.895578143148642
HP_INCREASED_CIRCULATING_INT...1,SET,20,0.19403,0.0063973,0.1985,0.16417,HP_INCREASED_CIRCULATING_INTERFERON_GAMMA_CONCENTRATION,0.895578143148642
GOBP_BLOOD_VESSEL_MATURATION,SET,8,0.32144,0.006705,0.32899,0.16428,GOBP_BLOOD_VESSEL_MATURATION,0.895943011764706
FOXO4_01,SET,229,0.057304,0.0063567,0.058653,0.16429,FOXO4_01,0.895943011764706
GSE7460_CTRL_VS_TGFB_TREATED...8,SET,181,0.065085,0.0064272,0.066626,0.16432,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP,0.895943011764706
GOBP_HEAD_MORPHOGENESIS,SET,35,0.14798,0.0064516,0.15149,0.16434,GOBP_HEAD_MORPHOGENESIS,0.895943011764706
GSE17721_POLYIC_VS_GARDIQUIM...14,SET,181,0.058206,0.0057479,0.0596,0.16438,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP,0.896020530112923
HP_PECTUS_CARINATUM,SET,158,0.065106,0.0060107,0.066674,0.16442,HP_PECTUS_CARINATUM,0.896089488948111
JIANG_MELANOMA_TRM2_CD8,SET,127,0.082023,0.0067949,0.084008,0.16445,JIANG_MELANOMA_TRM2_CD8,0.896089488948111
MIR548AL,SET,10,0.27939,0.0065154,0.28618,0.16447,MIR548AL,0.896089488948111
WP_VITAMIN_K_METABOLISM_AND_...,SET,12,0.22341,0.0057068,0.22902,0.16466,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.896880399373532
GOBP_LAMELLIPODIUM_ORGANIZAT...,SET,79,0.096133,0.0062893,0.098553,0.16468,GOBP_LAMELLIPODIUM_ORGANIZATION,0.896880399373532
YAO_TEMPORAL_RESPONSE_TO_PRO...3,SET,63,0.10357,0.0060535,0.1062,0.16472,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,0.896880399373532
REACTOME_PINK1_PRKN_MEDIATED...,SET,29,0.14864,0.0058999,0.15241,0.16472,REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,0.896880399373532
ACEVEDO_METHYLATED_IN_LIVER_...,SET,684,0.035658,0.00675,0.03657,0.16477,ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN,0.896880399373532
GOBP_NEGATIVE_REGULATION_OF_...507,SET,16,0.20586,0.0060715,0.21113,0.16477,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.896880399373532
MIR5004_5P,SET,114,0.077828,0.0061107,0.079831,0.16481,MIR5004_5P,0.896926045091592
GSE11864_CSF1_IFNG_VS_CSF1_P...2,SET,174,0.062651,0.0060672,0.064268,0.16483,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP,0.896926045091592
HP_UNDERFOLDED_HELIX,SET,4,0.50642,0.0074704,0.51968,0.16491,HP_UNDERFOLDED_HELIX,0.896954082590333
HP_ERYTHEMATOUS_PAPULE,SET,10,0.21149,0.0049321,0.21704,0.16492,HP_ERYTHEMATOUS_PAPULE,0.896954082590333
GSE17721_CTRL_VS_POLYIC_8H_B...1,SET,183,0.061841,0.0061401,0.06347,0.16495,GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN,0.896954082590333
GOBP_POSITIVE_REGULATION_OF_...519,SET,10,0.29987,0.0069929,0.30778,0.16496,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.896954082590333
LI_ADIPOGENESIS_BY_ACTIVATED...,SET,18,0.20691,0.0064722,0.21239,0.16499,LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,0.896954082590333
HP_RIB_SEGMENTATION_ABNORMAL...,SET,11,0.27429,0.0067085,0.28156,0.16499,HP_RIB_SEGMENTATION_ABNORMALITIES,0.896954082590333
GOMF_PHOSPHATIDIC_ACID_BINDI...,SET,23,0.18163,0.0064214,0.18648,0.16503,GOMF_PHOSPHATIDIC_ACID_BINDING,0.897030607003891
REACTOME_P130CAS_LINKAGE_TO_...,SET,15,0.23973,0.006846,0.24626,0.16517,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.897030607003891
YATTNATC_UNKNOWN,SET,340,0.048707,0.0065634,0.050037,0.16518,YATTNATC_UNKNOWN,0.897030607003891
MIR219B_3P,SET,54,0.11651,0.0063062,0.1197,0.16519,MIR219B_3P,0.897030607003891
SINGH_NFE2L2_TARGETS,SET,13,0.25248,0.0067127,0.25944,0.16524,SINGH_NFE2L2_TARGETS,0.897030607003891
GOBP_NEGATIVE_REGULATION_OF_...57,SET,6,0.39211,0.0070837,0.40299,0.16528,GOBP_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.897030607003891
GSE339_EX_VIVO_VS_IN_CULTURE...5,SET,188,0.062785,0.0063177,0.06453,0.16529,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN,0.897030607003891
GOBP_REGULATION_OF_OSTEOBLAS...2,SET,26,0.17491,0.0065741,0.17979,0.16532,GOBP_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.897030607003891
HP_INTRACTABLE_DIARRHEA,SET,6,0.38668,0.0069856,0.39748,0.16532,HP_INTRACTABLE_DIARRHEA,0.897030607003891
GOCC_DENDRITIC_SPINE_HEAD,SET,7,0.33678,0.0065716,0.34625,0.16537,GOCC_DENDRITIC_SPINE_HEAD,0.897030607003891
HP_UPLIFTED_EARLOBE,SET,20,0.19012,0.0062682,0.19548,0.16539,HP_UPLIFTED_EARLOBE,0.897030607003891
GOBP_REGULATION_OF_ATRIAL_CA...2,SET,5,0.39403,0.0064983,0.40526,0.16546,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.897030607003891
GSE3039_CD4_TCELL_VS_B1_BCEL...1,SET,175,0.064614,0.0062751,0.066464,0.16549,GSE3039_CD4_TCELL_VS_B1_BCELL_DN,0.897030607003891
YAO_TEMPORAL_RESPONSE_TO_PRO...17,SET,46,0.12324,0.006158,0.12678,0.16551,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,0.897030607003891
HP_AVASCULAR_NECROSIS,SET,83,0.09281,0.006223,0.095478,0.16552,HP_AVASCULAR_NECROSIS,0.897030607003891
GABRIELY_MIR21_TARGETS,SET,261,0.052605,0.0062244,0.054126,0.16556,GABRIELY_MIR21_TARGETS,0.897030607003891
GOMF_TRANSCRIPTION_REGULATOR...2,SET,1783,0.022255,0.0065871,0.0229,0.16557,GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY,0.897030607003891
HEBERT_MATRISOME_TNBC_BRAIN_...1,SET,23,0.18895,0.0066804,0.19445,0.1656,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS,0.897030607003891
GSE369_SOCS3_KO_VS_IFNG_KO_L...2,SET,170,0.066929,0.0064073,0.068886,0.16563,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP,0.897030607003891
GSE5542_UNTREATED_VS_IFNA_AN...2,SET,180,0.059888,0.0058978,0.061639,0.16563,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.897030607003891
RCGCANGCGY_NRF1_Q6,SET,852,0.027944,0.0058756,0.028765,0.16566,RCGCANGCGY_NRF1_Q6,0.897030607003891
GOBP_ANIMAL_ORGAN_REGENERATI...,SET,61,0.11279,0.0064873,0.1161,0.16567,GOBP_ANIMAL_ORGAN_REGENERATION,0.897030607003891
GOBP_TRNA_AMINOACYLATION_FOR...,SET,7,0.27878,0.0054398,0.28702,0.16571,GOBP_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION,0.897030607003891
GSE22886_NAIVE_CD4_TCELL_VS_...18,SET,181,0.060968,0.0060207,0.062776,0.16573,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP,0.897030607003891
MIR559,SET,496,0.037775,0.0061214,0.038898,0.16575,MIR559,0.897030607003891
MIR148A_5P,SET,102,0.082563,0.0061338,0.085023,0.16576,MIR148A_5P,0.897030607003891
HP_FEMALE_HYPOGONADISM,SET,28,0.16472,0.0064246,0.16964,0.16578,HP_FEMALE_HYPOGONADISM,0.897030607003891
MARTIN_VIRAL_GPCR_SIGNALING_...1,SET,47,0.11872,0.0059963,0.12228,0.1658,MARTIN_VIRAL_GPCR_SIGNALING_DN,0.897030607003891
MIR4698,SET,572,0.036099,0.0062687,0.03718,0.1658,MIR4698,0.897030607003891
GOBP_RESPONSE_TO_INTERLEUKIN...7,SET,9,0.34354,0.0076005,0.35385,0.16581,GOBP_RESPONSE_TO_INTERLEUKIN_2,0.897030607003891
LUCAS_HNF4A_TARGETS_DN,SET,7,0.31589,0.0061638,0.32537,0.16582,LUCAS_HNF4A_TARGETS_DN,0.897030607003891
GOBP_NEGATIVE_REGULATION_OF_...59,SET,15,0.24073,0.0068745,0.24796,0.16583,GOBP_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION,0.897030607003891
GARGALOVIC_RESPONSE_TO_OXIDI...2,SET,32,0.15354,0.0064012,0.15829,0.16603,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,0.897447594917562
AIZARANI_LIVER_C29_MVECS_2,SET,287,0.053362,0.0066162,0.055015,0.16604,AIZARANI_LIVER_C29_MVECS_2,0.897447594917562
BILANGES_RAPAMYCIN_SENSITIVE...1,SET,35,0.13926,0.0060716,0.14361,0.1661,BILANGES_RAPAMYCIN_SENSITIVE_GENES,0.897447594917562
HP_PROXIMAL_MUSCLE_WEAKNESS_...1,SET,62,0.1056,0.0061232,0.10891,0.16612,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_LOWER_LIMBS,0.897447594917562
GSE45365_NK_CELL_VS_CD8_TCEL...1,SET,144,0.072451,0.006388,0.07473,0.16615,GSE45365_NK_CELL_VS_CD8_TCELL_DN,0.897447594917562
INGRAM_SHH_TARGETS_DN,SET,57,0.11065,0.0061529,0.11415,0.16619,INGRAM_SHH_TARGETS_DN,0.897447594917562
GOBP_SECONDARY_PALATE_DEVELO...,SET,26,0.186,0.006991,0.19188,0.1662,GOBP_SECONDARY_PALATE_DEVELOPMENT,0.897447594917562
GSE25502_WT_VS_KLF13_KO_THYM...1,SET,154,0.070511,0.0064275,0.072753,0.16623,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN,0.897447594917562
GOMF_TRANSCRIPTION_COREPRESS...2,SET,42,0.12737,0.0060819,0.13145,0.16628,GOMF_TRANSCRIPTION_COREPRESSOR_BINDING,0.897447594917562
BIOCARTA_HIVNEF_PATHWAY,SET,54,0.11151,0.0060354,0.11508,0.1663,BIOCARTA_HIVNEF_PATHWAY,0.897447594917562
GSE360_L_MAJOR_VS_B_MALAYI_H...4,SET,181,0.063032,0.0062245,0.065061,0.16632,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.897447594917562
GOBP_POSITIVE_REGULATION_OF_...776,SET,4,0.47929,0.0070701,0.49481,0.16637,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.897447594917562
MIR4708_3P,SET,91,0.085892,0.006029,0.088685,0.1664,MIR4708_3P,0.897447594917562
WHN_B,SET,229,0.055702,0.006179,0.057517,0.16642,WHN_B,0.897447594917562
GSE8921_UNSTIM_0H_VS_TLR1_2_...3,SET,184,0.060568,0.00603,0.062548,0.16644,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN,0.897447594917562
HMCES_TARGET_GENES,SET,6,0.31973,0.0057762,0.33021,0.16646,HMCES_TARGET_GENES,0.897447594917562
GSE3565_CTRL_VS_LPS_INJECTED...3,SET,155,0.067202,0.0061456,0.069406,0.16647,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN,0.897447594917562
HP_ANORECTAL_ANOMALY,SET,149,0.07025,0.0062997,0.072559,0.16648,HP_ANORECTAL_ANOMALY,0.897447594917562
GSE15930_NAIVE_VS_72H_IN_VIT...1,SET,182,0.060603,0.0060009,0.062593,0.16648,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN,0.897447594917562
GOBP_REGULATION_OF_DEVELOPME...2,SET,13,0.24707,0.0065687,0.25522,0.16651,GOBP_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC,0.897447594917562
PUJANA_BREAST_CANCER_WITH_BR...1,SET,8,0.25789,0.0053794,0.2664,0.16652,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN,0.897447594917562
GOBP_PRESYNAPTIC_MEMBRANE_OR...,SET,6,0.32806,0.0059267,0.33894,0.16655,GOBP_PRESYNAPTIC_MEMBRANE_ORGANIZATION,0.897447594917562
HP_ABNORMAL_PEER_RELATIONSHI...,SET,6,0.32732,0.0059133,0.33824,0.1666,HP_ABNORMAL_PEER_RELATIONSHIPS,0.897447594917562
GOBP_RIBOSOMAL_SUBUNIT_EXPOR...,SET,15,0.21215,0.0060583,0.21923,0.16661,GOBP_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS,0.897447594917562
HP_TELANGIECTASIA_OF_THE_SKIN,SET,70,0.091904,0.0056611,0.095002,0.16668,HP_TELANGIECTASIA_OF_THE_SKIN,0.897447594917562
GSE21670_UNTREATED_VS_TGFB_I...4,SET,180,0.060566,0.0059646,0.062623,0.16674,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.897447594917562
NAKAYA_MYELOID_DENDRITIC_CEL...4,SET,337,0.044644,0.0059898,0.046164,0.16676,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.897447594917562
GSE2706_UNSTIM_VS_2H_LPS_AND...1,SET,170,0.067965,0.0065064,0.070289,0.1668,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN,0.897447594917562
MANNO_MIDBRAIN_NEUROTYPES_HD...1,SET,516,0.039887,0.006589,0.041271,0.16691,MANNO_MIDBRAIN_NEUROTYPES_HDA1,0.897447594917562
REACTOME_G1_S_SPECIFIC_TRANS...,SET,28,0.14254,0.0055596,0.1475,0.16694,REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,0.897447594917562
GOBP_CAMP_METABOLIC_PROCESS,SET,23,0.18569,0.0065648,0.19218,0.16698,GOBP_CAMP_METABOLIC_PROCESS,0.897447594917562
MIR6845_5P,SET,57,0.10936,0.0060808,0.11322,0.16705,MIR6845_5P,0.897447594917562
KEGG_PENTOSE_AND_GLUCURONATE...,SET,26,0.21218,0.0079749,0.2197,0.16709,KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,0.897447594917562
GSE6269_FLU_VS_STREP_PNEUMO_...2,SET,162,0.064113,0.0059928,0.06639,0.1671,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP,0.897447594917562
GOBP_ADENYLATE_CYCLASE_ACTIV...3,SET,162,0.070706,0.0066091,0.073221,0.16712,GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.897447594917562
GOBP_RNA_POLYMERASE_I_PREINI...,SET,9,0.26512,0.0058655,0.27458,0.16714,GOBP_RNA_POLYMERASE_I_PREINITIATION_COMPLEX_ASSEMBLY,0.897447594917562
GOBP_TRANSCRIPTION_INITIATIO...3,SET,9,0.26512,0.0058655,0.27458,0.16714,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_I_PROMOTER,0.897447594917562
GATA6_01,SET,236,0.057424,0.0064654,0.059481,0.16717,GATA6_01,0.897447594917562
HP_UNUSUAL_VIRUS_REACTIVATION,SET,21,0.19083,0.006447,0.19767,0.16718,HP_UNUSUAL_VIRUS_REACTIVATION,0.897447594917562
GOBP_GROWTH_INVOLVED_IN_HEAR...,SET,4,0.49231,0.0072623,0.50997,0.16719,GOBP_GROWTH_INVOLVED_IN_HEART_MORPHOGENESIS,0.897447594917562
GSE19923_E2A_KO_VS_HEB_AND_E...2,SET,180,0.062465,0.0061516,0.064708,0.16719,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.897447594917562
HP_INCREASED_ENDOMYSIAL_CONN...,SET,27,0.16534,0.0063328,0.17129,0.16721,HP_INCREASED_ENDOMYSIAL_CONNECTIVE_TISSUE,0.897447594917562
GOMF_UBIQUITIN_LIKE_PROTEIN_...4,SET,333,0.045138,0.0060206,0.046769,0.16725,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY,0.897447594917562
HP_DISTAL_JOINT_HYPERMOBILITY,SET,7,0.34527,0.0067372,0.35777,0.16726,HP_DISTAL_JOINT_HYPERMOBILITY,0.897447594917562
HP_BASAL_GANGLIA_CYSTS,SET,6,0.29097,0.0052565,0.3016,0.16735,HP_BASAL_GANGLIA_CYSTS,0.897447594917562
BIOCARTA_BARD1_PATHWAY,SET,8,0.23408,0.0048827,0.2427,0.16741,BIOCARTA_BARD1_PATHWAY,0.897447594917562
GOBP_REGULATION_OF_PRESYNAPT...2,SET,28,0.1723,0.0067201,0.17865,0.16741,GOBP_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.897447594917562
HP_HEMIFACIAL_SPASM,SET,12,0.22209,0.0056732,0.23028,0.16742,HP_HEMIFACIAL_SPASM,0.897447594917562
WP_FIBRIN_COMPLEMENT_RECEPTO...,SET,41,0.13271,0.0062611,0.13761,0.16744,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.897447594917562
GOCC_PROCENTRIOLE_REPLICATIO...,SET,6,0.27657,0.0049964,0.28679,0.16744,GOCC_PROCENTRIOLE_REPLICATION_COMPLEX,0.897447594917562
GOBP_PROTEIN_HYDROXYLATION,SET,23,0.16095,0.0056904,0.16692,0.16746,GOBP_PROTEIN_HYDROXYLATION,0.897447594917562
GOCC_IMMUNOLOGICAL_SYNAPSE,SET,43,0.12926,0.0062453,0.13408,0.16752,GOCC_IMMUNOLOGICAL_SYNAPSE,0.897447594917562
REACTOME_INTERLEUKIN_20_FAMI...,SET,26,0.17907,0.0067307,0.18577,0.16754,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,0.897447594917562
GOMF_PROFILIN_BINDING,SET,10,0.26921,0.0062779,0.27929,0.16756,GOMF_PROFILIN_BINDING,0.897447594917562
WP_COHESIN_COMPLEX_CORNELIA_...,SET,27,0.14375,0.005506,0.14917,0.1676,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,0.897447594917562
MIR1910_5P,SET,76,0.095326,0.0061174,0.098917,0.16761,MIR1910_5P,0.897447594917562
REACTOME_RAS_PROCESSING,SET,21,0.17415,0.0058836,0.18073,0.16763,REACTOME_RAS_PROCESSING,0.897447594917562
GOBP_POSITIVE_REGULATION_OF_...337,SET,3,0.446,0.0056979,0.46295,0.16768,GOBP_POSITIVE_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.897447594917562
MODULE_59,SET,22,0.18657,0.0064513,0.19367,0.1677,MODULE_59,0.897447594917562
BIOCARTA_IRES_PATHWAY,SET,7,0.28809,0.0056214,0.29909,0.16773,BIOCARTA_IRES_PATHWAY,0.897447594917562
ELK1_02,SET,236,0.051039,0.0057465,0.052995,0.16776,ELK1_02,0.897447594917562
MCGOWAN_RSP6_TARGETS_UP,SET,20,0.19308,0.006366,0.2005,0.16779,MCGOWAN_RSP6_TARGETS_UP,0.897447594917562
HP_MILD_HEARING_IMPAIRMENT,SET,7,0.27037,0.0052757,0.2808,0.16781,HP_MILD_HEARING_IMPAIRMENT,0.897447594917562
REACTOME_HIV_TRANSCRIPTION_E...,SET,38,0.11138,0.0050595,0.11569,0.16784,REACTOME_HIV_TRANSCRIPTION_ELONGATION,0.897447594917562
GCM_ERBB2IP,SET,59,0.10464,0.0059193,0.10869,0.16785,GCM_ERBB2IP,0.897447594917562
GOMF_RETINAL_DEHYDROGENASE_A...,SET,9,0.33808,0.0074797,0.35117,0.16785,GOMF_RETINAL_DEHYDROGENASE_ACTIVITY,0.897447594917562
MIR149_3P,SET,397,0.041901,0.0060915,0.043526,0.16786,MIR149_3P,0.897447594917562
GOBP_IMMUNOLOGICAL_MEMORY_FO...,SET,13,0.26743,0.00711,0.27785,0.16791,GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS,0.897447594917562
NAKAMURA_BRONCHIAL_AND_BRONC...,SET,5,0.38879,0.006412,0.40397,0.16793,NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA,0.897447594917562
GOBP_PROTEASOMAL_PROTEIN_CAT...,SET,482,0.036389,0.0058154,0.037818,0.16798,GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.897447594917562
GOBP_SERTOLI_CELL_DEVELOPMENT,SET,12,0.22217,0.0056754,0.2309,0.16798,GOBP_SERTOLI_CELL_DEVELOPMENT,0.897447594917562
TBK1.DF_UP,SET,261,0.051652,0.0061116,0.053684,0.16799,TBK1.DF_UP,0.897447594917562
GSE20151_CTRL_VS_FUSOBACT_NU...2,SET,178,0.060665,0.0059413,0.063057,0.16802,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP,0.897447594917562
MIR106A_3P,SET,99,0.087433,0.0063999,0.090886,0.16803,MIR106A_3P,0.897447594917562
HP_ACCELERATED_ATHEROSCLEROS...,SET,8,0.29534,0.0061605,0.307,0.16803,HP_ACCELERATED_ATHEROSCLEROSIS,0.897447594917562
WP_TRANSCRIPTION_FACTOR_REGU...,SET,21,0.20982,0.0070886,0.21813,0.16806,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,0.897447594917562
GOBP_ENDOTHELIAL_CELL_MIGRAT...,SET,203,0.060948,0.0063701,0.06337,0.16809,GOBP_ENDOTHELIAL_CELL_MIGRATION,0.897447594917562
GSE34392_ST2_KO_VS_WT_DAY8_L...2,SET,182,0.05867,0.0058096,0.061003,0.16809,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,0.897447594917562
GSE22935_WT_VS_MYD88_KO_MACR...8,SET,181,0.063526,0.0062732,0.066063,0.16813,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP,0.897447594917562
HP_HYPOPITUITARISM,SET,159,0.066435,0.0061527,0.069095,0.16815,HP_HYPOPITUITARISM,0.897447594917562
GOCC_RECYCLING_ENDOSOME,SET,187,0.05914,0.0059351,0.061511,0.16817,GOCC_RECYCLING_ENDOSOME,0.897447594917562
HP_HYPERTENSIVE_CRISIS,SET,14,0.24217,0.0066813,0.25191,0.1682,HP_HYPERTENSIVE_CRISIS,0.897447594917562
GSE15330_HSC_VS_GRANULOCYTE_...1,SET,175,0.061317,0.0059548,0.063784,0.1682,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.897447594917562
GSE43955_TH0_VS_TGFB_IL6_IL2...3,SET,187,0.05999,0.0060205,0.062403,0.1682,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,0.897447594917562
GOBP_BRAIN_DERIVED_NEUROTROP...,SET,6,0.37732,0.0068166,0.39251,0.16821,GOBP_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.897447594917562
CUI_DEVELOPING_HEART_VASCULA...,SET,179,0.065088,0.0063922,0.067714,0.16823,CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL,0.897447594917562
REACTOME_METABOLISM_OF_RNA,SET,647,0.030599,0.0056394,0.031842,0.16829,REACTOME_METABOLISM_OF_RNA,0.897447594917562
GOBP_REGULATION_OF_GUANYL_NU...,SET,6,0.36245,0.006548,0.37725,0.16834,GOBP_REGULATION_OF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,0.897447594917562
HP_PAPULE,SET,92,0.083055,0.0058616,0.086462,0.16839,HP_PAPULE,0.897447594917562
GOBP_RESPONSE_TO_BACTERIUM,SET,612,0.036643,0.0065745,0.038149,0.1684,GOBP_RESPONSE_TO_BACTERIUM,0.897447594917562
GOBP_DNA_ALKYLATION_REPAIR,SET,11,0.2231,0.0054566,0.23229,0.16843,GOBP_DNA_ALKYLATION_REPAIR,0.897447594917562
GOBP_TETRAPYRROLE_METABOLIC_...,SET,57,0.10806,0.0060088,0.11253,0.16847,GOBP_TETRAPYRROLE_METABOLIC_PROCESS,0.897447594917562
HP_REACTIVE_HYPOGLYCEMIA,SET,7,0.29148,0.0056875,0.30355,0.16847,HP_REACTIVE_HYPOGLYCEMIA,0.897447594917562
GOBP_RESPONSE_TO_INTERLEUKIN...12,SET,5,0.41327,0.0068158,0.43044,0.1685,GOBP_RESPONSE_TO_INTERLEUKIN_9,0.897447594917562
GOMF_CARBOXYPEPTIDASE_ACTIVI...,SET,42,0.13453,0.0064237,0.14012,0.16851,GOMF_CARBOXYPEPTIDASE_ACTIVITY,0.897447594917562
BLANCO_MELO_COVID19_SARS_COV...5,SET,69,0.10657,0.0065174,0.111,0.16852,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN,0.897447594917562
HP_ELEVATED_TOTAL_SERUM_TRYP...,SET,6,0.34257,0.0061888,0.35683,0.16852,HP_ELEVATED_TOTAL_SERUM_TRYPTASE,0.897447594917562
GOCC_CONTRACTILE_MUSCLE_FIBER,SET,237,0.054896,0.0061937,0.057183,0.16853,GOCC_CONTRACTILE_MUSCLE_FIBER,0.897447594917562
GOMF_PROTEIN_DIMERIZATION_AC...,SET,894,0.028699,0.0061738,0.029894,0.16853,GOMF_PROTEIN_DIMERIZATION_ACTIVITY,0.897447594917562
GOMF_THIOREDOXIN_DEPENDENT_P...,SET,4,0.38998,0.0057528,0.40626,0.16855,GOMF_THIOREDOXIN_DEPENDENT_PEROXIREDOXIN_ACTIVITY,0.897447594917562
MIR6884_3P,SET,60,0.11124,0.0063455,0.11589,0.16857,MIR6884_3P,0.897447594917562
HOWARD_DENDRITIC_CELL_INACT_...1,SET,39,0.14049,0.0064648,0.14638,0.1686,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.897447594917562
GOBP_NEGATIVE_REGULATION_OF_...295,SET,26,0.17246,0.0064821,0.1797,0.16862,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.897447594917562
GOBP_NEGATIVE_REGULATION_OF_...180,SET,797,0.031095,0.0063335,0.032404,0.16864,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.897447594917562
EPPERT_LSC_R,SET,36,0.12648,0.0055923,0.13184,0.1687,EPPERT_LSC_R,0.897447594917562
REACTOME_ERYTHROPOIETIN_ACTI...2,SET,7,0.33901,0.006615,0.35344,0.16874,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG,0.897447594917562
GOMF_RECEPTOR_ANTAGONIST_ACT...,SET,16,0.19688,0.0058065,0.20528,0.16877,GOMF_RECEPTOR_ANTAGONIST_ACTIVITY,0.897447594917562
MIR6785_5P,SET,470,0.038301,0.0060462,0.039939,0.16879,MIR6785_5P,0.897447594917562
PAX5_02,SET,16,0.19589,0.0057774,0.20428,0.1688,PAX5_02,0.897447594917562
ONGUSAHA_BRCA1_TARGETS_DN,SET,11,0.24015,0.0058736,0.25047,0.16883,ONGUSAHA_BRCA1_TARGETS_DN,0.897447594917562
GSE29164_UNTREATED_VS_CD8_TC...5,SET,184,0.061512,0.006124,0.064152,0.16883,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN,0.897447594917562
MODULE_86,SET,42,0.12427,0.0059342,0.12962,0.16884,MODULE_86,0.897447594917562
GSE7460_CTRL_VS_TGFB_TREATED...6,SET,177,0.062281,0.0060827,0.064958,0.16884,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP,0.897447594917562
ZNF507_TARGET_GENES,SET,512,0.03624,0.005964,0.03781,0.16891,ZNF507_TARGET_GENES,0.897447594917562
MORF_TTN,SET,45,0.12486,0.0061708,0.13029,0.16895,MORF_TTN,0.897447594917562
HP_GENERALIZED_HYPOPIGMENTAT...1,SET,28,0.17285,0.0067418,0.18037,0.16896,HP_GENERALIZED_HYPOPIGMENTATION,0.897447594917562
HP_FEMALE_PSEUDOHERMAPHRODIT...,SET,7,0.35723,0.0069706,0.3729,0.16904,HP_FEMALE_PSEUDOHERMAPHRODITISM,0.897447594917562
GOBP_RESPONSE_TO_MERCURY_ION,SET,10,0.26305,0.0061344,0.27461,0.16906,GOBP_RESPONSE_TO_MERCURY_ION,0.897447594917562
GOBP_POSITIVE_REGULATION_OF_...455,SET,2,0.64235,0.0067006,0.67061,0.16907,GOBP_POSITIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.897447594917562
GOBP_VASCULAR_ASSOCIATED_SMO...3,SET,28,0.15661,0.0061084,0.1635,0.16907,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.897447594917562
GSE8621_UNSTIM_VS_LPS_PRIMED...4,SET,176,0.060922,0.0059333,0.063624,0.16915,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP,0.897447594917562
GOBP_INTRACELLULAR_ESTROGEN_...,SET,45,0.11465,0.0056663,0.11974,0.16917,GOBP_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.897447594917562
HP_ABNORMAL_RENAL_CORTEX_MOR...,SET,201,0.058351,0.0060689,0.060968,0.16927,HP_ABNORMAL_RENAL_CORTEX_MORPHOLOGY,0.897447594917562
GOBP_VESICLE_ORGANIZATION,SET,337,0.04408,0.0059142,0.046072,0.16935,GOBP_VESICLE_ORGANIZATION,0.897447594917562
REACTOME_PRE_NOTCH_EXPRESSIO...,SET,48,0.11069,0.0056496,0.1157,0.16936,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,0.897447594917562
GOBP_SNRNA_TRANSCRIPTION_BY_...2,SET,9,0.24475,0.0054149,0.25588,0.16941,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.897447594917562
HP_PREMATURE_ATRIAL_CONTRACT...,SET,6,0.40483,0.0073135,0.42326,0.16943,HP_PREMATURE_ATRIAL_CONTRACTIONS,0.897447594917562
REACTOME_NADE_MODULATES_DEAT...,SET,5,0.44018,0.0072595,0.46032,0.16948,REACTOME_NADE_MODULATES_DEATH_SIGNALLING,0.897447594917562
RUTELLA_RESPONSE_TO_CSF2RB_A...2,SET,301,0.048676,0.0061782,0.050919,0.16956,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,0.897447594917562
BIOCARTA_GSK3_PATHWAY,SET,19,0.19598,0.0062982,0.20503,0.16958,BIOCARTA_GSK3_PATHWAY,0.897447594917562
GOBP_SKIN_EPIDERMIS_DEVELOPM...,SET,127,0.079579,0.0065924,0.083259,0.16959,GOBP_SKIN_EPIDERMIS_DEVELOPMENT,0.897447594917562
MANNO_MIDBRAIN_NEUROTYPES_HRN,SET,300,0.051122,0.006478,0.053492,0.16962,MANNO_MIDBRAIN_NEUROTYPES_HRN,0.897447594917562
HP_HEPATOMEGALY,SET,574,0.03462,0.006022,0.03623,0.16965,HP_HEPATOMEGALY,0.897447594917562
BERNARD_PPAPDC1B_TARGETS_DN,SET,53,0.11859,0.0063591,0.12412,0.16968,BERNARD_PPAPDC1B_TARGETS_DN,0.897447594917562
GOCC_KERATIN_FILAMENT,SET,81,0.12818,0.0084907,0.13415,0.16968,GOCC_KERATIN_FILAMENT,0.897447594917562
GSE11961_GERMINAL_CENTER_BCE...4,SET,176,0.061536,0.0059931,0.064409,0.16969,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.897447594917562
REACTOME_SCAVENGING_BY_CLASS...2,SET,6,0.38604,0.0069741,0.40413,0.16973,REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS,0.897447594917562
GOBP_VITAMIN_TRANSMEMBRANE_T...,SET,20,0.18088,0.0059638,0.18938,0.16976,GOBP_VITAMIN_TRANSMEMBRANE_TRANSPORT,0.897447594917562
REACTOME_REGULATION_OF_GENE_...4,SET,5,0.42077,0.0069394,0.44057,0.16978,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS,0.897447594917562
GOMF_AXON_GUIDANCE_RECEPTOR_...,SET,10,0.28868,0.0067321,0.30229,0.1698,GOMF_AXON_GUIDANCE_RECEPTOR_ACTIVITY,0.897447594917562
GSE21360_PRIMARY_VS_SECONDAR...2,SET,176,0.060455,0.0058877,0.063313,0.16983,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP,0.897447594917562
GOBP_REGULATION_OF_GASTRULAT...,SET,15,0.18864,0.0053869,0.19758,0.16986,GOBP_REGULATION_OF_GASTRULATION,0.897447594917562
MIR7106_3P,SET,38,0.12845,0.0058349,0.13454,0.16987,MIR7106_3P,0.897447594917562
ZHANG_RESPONSE_TO_CANTHARIDI...1,SET,60,0.09783,0.0055807,0.10248,0.16989,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,0.897447594917562
GARGALOVIC_RESPONSE_TO_OXIDI...17,SET,24,0.17341,0.0062626,0.18166,0.1699,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,0.897447594917562
KEGG_MEDICUS_PATHOGEN_HPV_E6...2,SET,12,0.2467,0.006302,0.25845,0.16991,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381,0.897447594917562
HP_HYPERPIGMENTATION_OF_THE_...1,SET,6,0.3645,0.006585,0.3819,0.16994,HP_HYPERPIGMENTATION_OF_THE_FUNDUS,0.897447594917562
GOMF_CYSTEINE_TYPE_ENDOPEPTI...5,SET,5,0.36194,0.0059691,0.37926,0.16997,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.897447594917562
HP_CEREBELLAR_VERMIS_ATROPHY,SET,49,0.11348,0.0058517,0.11891,0.16997,HP_CEREBELLAR_VERMIS_ATROPHY,0.897447594917562
GOBP_NEGATIVE_REGULATION_OF_...660,SET,5,0.36268,0.0059813,0.38006,0.16998,GOBP_NEGATIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,0.897447594917562
HALLMARK_IL2_STAT5_SIGNALING,SET,187,0.063619,0.0063847,0.066669,0.16998,HALLMARK_IL2_STAT5_SIGNALING,0.897447594917562
SANSOM_APC_TARGETS_DN,SET,333,0.046472,0.0061986,0.0487,0.16999,SANSOM_APC_TARGETS_DN,0.897447594917562
GSE3720_LPS_VS_PMA_STIM_VD2_...1,SET,138,0.072357,0.0062464,0.075832,0.17,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.897447594917562
GOBP_METANEPHRIC_PART_OF_URE...,SET,6,0.3987,0.0072028,0.4179,0.17003,GOBP_METANEPHRIC_PART_OF_URETERIC_BUD_DEVELOPMENT,0.897447594917562
GOCC_PROTEIN_PHOSPHATASE_TYP...2,SET,16,0.20022,0.0059052,0.20993,0.1701,GOCC_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX,0.897447594917562
GSE36392_TYPE_2_MYELOID_VS_M...1,SET,181,0.056276,0.0055573,0.059003,0.1701,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN,0.897447594917562
HP_LOSS_OF_SPEECH,SET,45,0.12102,0.0059811,0.12691,0.17014,HP_LOSS_OF_SPEECH,0.897447594917562
STAT1_03,SET,239,0.053064,0.0060119,0.055645,0.17015,STAT1_03,0.897447594917562
GOMF_NEUROPEPTIDE_RECEPTOR_B...,SET,29,0.15916,0.0063172,0.1669,0.17015,GOMF_NEUROPEPTIDE_RECEPTOR_BINDING,0.897447594917562
WP_IRON_METABOLISM_DISORDERS,SET,15,0.22558,0.006442,0.23662,0.17021,WP_IRON_METABOLISM_DISORDERS,0.897447594917562
BYSTRYKH_HEMATOPOIESIS_STEM_...7,SET,719,0.030747,0.0059614,0.032257,0.17026,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS,0.897447594917562
KEGG_MEDICUS_VARIANT_DUPLICA...1,SET,4,0.53218,0.0078504,0.55836,0.17027,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY,0.897447594917562
GOCC_SMOOTH_ENDOPLASMIC_RETI...1,SET,28,0.15777,0.0061535,0.16554,0.17029,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM,0.897447594917562
GOCC_PIGMENT_GRANULE,SET,107,0.08032,0.0061108,0.084296,0.17034,GOCC_PIGMENT_GRANULE,0.897447594917562
GOMF_CARBOHYDRATE_MONOATOMIC...,SET,16,0.21,0.0061935,0.22039,0.17034,GOMF_CARBOHYDRATE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.897447594917562
RGAANNTTC_HSF1_01,SET,407,0.041132,0.0060529,0.043173,0.17037,RGAANNTTC_HSF1_01,0.897447594917562
KEGG_MEDICUS_REFERENCE_RIG_I...2,SET,17,0.24409,0.0074204,0.25624,0.1704,KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY,0.897447594917562
GOCC_NUCLEAR_OUTER_MEMBRANE,SET,26,0.15557,0.0058473,0.16334,0.17045,GOCC_NUCLEAR_OUTER_MEMBRANE,0.897447594917562
MODULE_239,SET,108,0.077787,0.0059455,0.081679,0.17047,MODULE_239,0.897447594917562
GSE360_LOW_DOSE_B_MALAYI_VS_...4,SET,184,0.058864,0.0058603,0.061809,0.17047,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,0.897447594917562
TATAAA_TATA_01,SET,1142,0.026261,0.0063397,0.027577,0.17048,TATAAA_TATA_01,0.897447594917562
FOXM1_01,SET,226,0.056547,0.006232,0.059382,0.17049,FOXM1_01,0.897447594917562
REACTOME_STAT3_NUCLEAR_EVENT...,SET,10,0.29357,0.006846,0.3083,0.1705,REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING,0.897447594917562
GSE3920_IFNB_VS_IFNG_TREATED...1,SET,158,0.061771,0.0057028,0.064878,0.17053,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.897447594917562
CHAMP1_TARGET_GENES,SET,145,0.066761,0.0059066,0.070129,0.17056,CHAMP1_TARGET_GENES,0.897447594917562
GOBP_NUCLEOBASE_CONTAINING_S...3,SET,8,0.31007,0.0064679,0.32572,0.17056,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION,0.897447594917562
MORF_RUNX1,SET,139,0.067119,0.0058151,0.070518,0.1706,MORF_RUNX1,0.897447594917562
HP_EEG_WITH_ABNORMALLY_SLOW_...,SET,86,0.085913,0.0058633,0.090266,0.17061,HP_EEG_WITH_ABNORMALLY_SLOW_FREQUENCIES,0.897447594917562
MIR6878_3P,SET,59,0.10534,0.0059589,0.11069,0.17064,MIR6878_3P,0.897447594917562
GOBP_TELOMERASE_RNA_LOCALIZA...,SET,18,0.17372,0.0054339,0.18253,0.17064,GOBP_TELOMERASE_RNA_LOCALIZATION,0.897447594917562
BIOCARTA_TRKA_PATHWAY,SET,14,0.20494,0.0056542,0.21538,0.17067,BIOCARTA_TRKA_PATHWAY,0.897447594917562
GOBP_FEEDING_BEHAVIOR,SET,97,0.093254,0.0067571,0.098008,0.17068,GOBP_FEEDING_BEHAVIOR,0.897447594917562
GOBP_NEGATIVE_REGULATION_OF_...127,SET,53,0.11803,0.0063291,0.12404,0.17068,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.897447594917562
KEGG_MEDICUS_REFERENCE_TRANS...3,SET,72,0.094034,0.0058742,0.098835,0.1707,KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION,0.897447594917562
GOBP_REGULATION_OF_AMIDE_MET...,SET,64,0.10093,0.0059457,0.10609,0.17071,GOBP_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.897447594917562
HP_LOSS_OF_AMBULATION,SET,114,0.073075,0.0057375,0.076808,0.17071,HP_LOSS_OF_AMBULATION,0.897447594917562
GSE21546_SAP1A_KO_VS_SAP1A_K...2,SET,178,0.061605,0.0060334,0.064784,0.17083,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.897780719348515
GSE3691_CONVENTIONAL_VS_PLAS...2,SET,188,0.060061,0.0060436,0.063177,0.17089,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP,0.897780719348515
GOMF_CLATHRIN_BINDING,SET,53,0.11126,0.005966,0.11705,0.17093,GOMF_CLATHRIN_BINDING,0.897780719348515
GOMF_MORPHOGEN_ACTIVITY,SET,6,0.33191,0.0059962,0.34918,0.17093,GOMF_MORPHOGEN_ACTIVITY,0.897780719348515
ZHONG_SECRETOME_OF_LUNG_CANC...1,SET,63,0.10545,0.0061636,0.11097,0.171,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,0.897780719348515
HP_HYPERALDOSTERONISM,SET,30,0.16704,0.0067435,0.17581,0.17102,HP_HYPERALDOSTERONISM,0.897780719348515
HE_LIM_SUN_FETAL_LUNG_C2_DC3...,SET,6,0.32796,0.0059248,0.34518,0.17104,HE_LIM_SUN_FETAL_LUNG_C2_DC3_CELL,0.897780719348515
VERHAAK_AML_WITH_NPM1_MUTATE...1,SET,224,0.059055,0.0064799,0.062161,0.17105,VERHAAK_AML_WITH_NPM1_MUTATED_DN,0.897780719348515
GOBP_PYRIMIDINE_NUCLEOSIDE_M...1,SET,22,0.1944,0.0067218,0.20464,0.17108,GOBP_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS,0.897780719348515
HP_GLYCOSURIA,SET,40,0.12809,0.0059692,0.13484,0.17109,HP_GLYCOSURIA,0.897780719348515
MIR4703_5P,SET,225,0.05792,0.0063693,0.060982,0.17112,MIR4703_5P,0.897780719348515
REACTOME_TRANSCRIPTIONAL_AND...,SET,42,0.13035,0.0062244,0.13727,0.17117,REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY,0.897780719348515
GOMF_PROTEIN_SERINE_THREONIN...5,SET,90,0.079344,0.0055389,0.083559,0.17117,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.897780719348515
HP_LYMPHOCYTOSIS,SET,22,0.17485,0.0060461,0.18414,0.17117,HP_LYMPHOCYTOSIS,0.897780719348515
GAVISH_3CA_MALIGNANT_METAPRO...28,SET,19,0.21773,0.0069972,0.22933,0.1712,GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG,0.897780719348515
GSE13887_HEALTHY_VS_LUPUS_RE...1,SET,114,0.076058,0.0059717,0.080109,0.17121,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN,0.897780719348515
BIOCARTA_NGF_PATHWAY,SET,19,0.18675,0.0060014,0.19673,0.17125,BIOCARTA_NGF_PATHWAY,0.897780719348515
GOMF_ENZYME_INHIBITOR_ACTIVI...,SET,355,0.045692,0.0062888,0.048139,0.17128,GOMF_ENZYME_INHIBITOR_ACTIVITY,0.897780719348515
GCTGAGT_MIR5125P,SET,42,0.12135,0.0057943,0.12785,0.17129,GCTGAGT_MIR5125P,0.897780719348515
GOBP_NATURAL_KILLER_CELL_CYT...,SET,8,0.31327,0.0065346,0.33008,0.17129,GOBP_NATURAL_KILLER_CELL_CYTOKINE_PRODUCTION,0.897780719348515
REACTOME_ZBP1_DAI_MEDIATED_I...,SET,20,0.17493,0.0057677,0.18435,0.17133,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,0.897854968335344
HP_ABNORMALITY_OF_THE_EXTRAO...,SET,11,0.21239,0.0051945,0.22388,0.1714,HP_ABNORMALITY_OF_THE_EXTRAOCULAR_MUSCLES,0.898086386250565
BUCASAS_PBMC_FLUARIX_FLUVIRI...3,SET,5,0.35078,0.0057851,0.36988,0.17148,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_LOW_RESPONDERS_1DY_POSITIVE_PREDICTIVE_OF_TITER,0.898164685946679
CAGNWMCNNNGAC_UNKNOWN,SET,79,0.096053,0.0062841,0.1013,0.17152,CAGNWMCNNNGAC_UNKNOWN,0.898164685946679
GOBP_NUCLEOTIDE_BINDING_OLIG...2,SET,16,0.21998,0.0064878,0.23199,0.17152,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.898164685946679
KUROZUMI_RESPONSE_TO_ONCOCYT...2,SET,20,0.20036,0.006606,0.21132,0.17153,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,0.898164685946679
GOBP_MONOATOMIC_ANION_TRANSP...,SET,159,0.06949,0.0064355,0.073295,0.17155,GOBP_MONOATOMIC_ANION_TRANSPORT,0.898164685946679
PATEL_SKIN_OF_BODY_ZOSTAVAX_...4,SET,91,0.085956,0.0060335,0.090671,0.17157,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_DN,0.898164685946679
MIR1253,SET,158,0.06698,0.0061837,0.070673,0.17164,MIR1253,0.898386924119241
HUTTMANN_B_CLL_POOR_SURVIVAL...2,SET,241,0.054218,0.0061678,0.057215,0.17167,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,0.898386924119241
HU_FETAL_RETINA_AMACRINE,SET,57,0.121,0.0067281,0.1277,0.17169,HU_FETAL_RETINA_AMACRINE,0.898386924119241
HP_GLAUCOMA,SET,316,0.047228,0.0061394,0.049857,0.17176,HP_GLAUCOMA,0.898582138024357
GSE15659_CD45RA_NEG_CD4_TCEL...1,SET,164,0.063105,0.0059346,0.066629,0.1718,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.898582138024357
KEGG_MEDICUS_VARIANT_MUTATIO...58,SET,6,0.37958,0.0068574,0.4008,0.17181,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_PERK_ATF4_SIGNALING_PATHWAY,0.898582138024357
NAKAMURA_METASTASIS_MODEL_DN,SET,43,0.135,0.0065226,0.14259,0.17189,NAKAMURA_METASTASIS_MODEL_DN,0.898582138024357
GAVISH_3CA_METAPROGRAM_MACRO...13,SET,42,0.12534,0.0059852,0.1324,0.17191,GAVISH_3CA_METAPROGRAM_MACROPHAGES_UNFOLDED_PROTEIN_RESPONSE,0.898582138024357
GOBP_CELLULAR_RESPONSE_TO_FO...,SET,9,0.31811,0.0070378,0.33602,0.17191,GOBP_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS,0.898582138024357
GOBP_TYPE_B_PANCREATIC_CELL_...3,SET,27,0.17036,0.0065252,0.17998,0.17193,GOBP_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION,0.898582138024357
MIR4310,SET,262,0.051147,0.0060632,0.054037,0.17195,MIR4310,0.898582138024357
CHIARADONNA_NEOPLASTIC_TRANS...2,SET,102,0.084721,0.0062941,0.089513,0.17196,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,0.898582138024357
GOMF_MOLECULAR_CONDENSATE_SC...,SET,33,0.12519,0.0053,0.13228,0.17199,GOMF_MOLECULAR_CONDENSATE_SCAFFOLD_ACTIVITY,0.898590784753363
GOBP_REGULATION_OF_PHOSPHOLI...1,SET,7,0.32824,0.0064049,0.34691,0.17203,GOBP_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.898590784753363
BIOCARTA_RNA_PATHWAY,SET,10,0.25653,0.0059824,0.27118,0.17208,BIOCARTA_RNA_PATHWAY,0.898590784753363
GOMF_NUCLEOBASE_CONTAINING_C...1,SET,40,0.12679,0.0059087,0.13404,0.1721,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY,0.898590784753363
KEGG_MEDICUS_PATHOGEN_SARS_C...3,SET,3,0.71439,0.0091267,0.75533,0.17213,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE,0.898590784753363
GOBP_REGULATION_OF_KETONE_BI...,SET,19,0.18799,0.0060414,0.19877,0.17214,GOBP_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS,0.898590784753363
GOBP_POSITIVE_REGULATION_OF_...346,SET,413,0.042419,0.0062871,0.044869,0.17224,GOBP_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY,0.898590784753363
GOBP_RESPONSE_TO_ALDOSTERONE,SET,17,0.20631,0.0062718,0.21824,0.17225,GOBP_RESPONSE_TO_ALDOSTERONE,0.898590784753363
GOCC_BASOLATERAL_PLASMA_MEMB...,SET,246,0.055348,0.0063605,0.05855,0.17226,GOCC_BASOLATERAL_PLASMA_MEMBRANE,0.898590784753363
GOMF_CYTIDYLYLTRANSFERASE_AC...,SET,8,0.29547,0.0061634,0.31269,0.17235,GOMF_CYTIDYLYLTRANSFERASE_ACTIVITY,0.898590784753363
GSE3982_NEUTROPHIL_VS_TH1_DN,SET,179,0.057523,0.0056492,0.060875,0.17235,GSE3982_NEUTROPHIL_VS_TH1_DN,0.898590784753363
HP_ABNORMAL_THOUGHT_PATTERN,SET,63,0.098936,0.0057827,0.10473,0.17242,HP_ABNORMAL_THOUGHT_PATTERN,0.898590784753363
KAAB_FAILED_HEART_ATRIUM_UP,SET,32,0.14339,0.005978,0.15179,0.17243,KAAB_FAILED_HEART_ATRIUM_UP,0.898590784753363
GOBP_REGULATION_OF_MEMBRANE_...1,SET,41,0.14047,0.0066275,0.14871,0.17244,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.898590784753363
GSE17721_LPS_VS_GARDIQUIMOD_...16,SET,187,0.059645,0.0059859,0.063143,0.17244,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP,0.898590784753363
GSE2128_CTRL_VS_MIMETOPE_NEG...2,SET,158,0.06674,0.0061616,0.070659,0.17245,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP,0.898590784753363
GOBP_TRANS_SYNAPTIC_SIGNALIN...1,SET,4,0.46081,0.0067975,0.48787,0.17246,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_BDNF,0.898590784753363
HP_ALOPECIA_UNIVERSALIS,SET,11,0.27255,0.0066659,0.28861,0.1725,HP_ALOPECIA_UNIVERSALIS,0.898590784753363
GOBP_REDUCTION_OF_FOOD_INTAK...,SET,6,0.33743,0.0060959,0.35737,0.17254,GOBP_REDUCTION_OF_FOOD_INTAKE_IN_RESPONSE_TO_DIETARY_EXCESS,0.898590784753363
HP_PATCHY_HYPOPIGMENTATION_O...,SET,21,0.19518,0.0065941,0.20672,0.17254,HP_PATCHY_HYPOPIGMENTATION_OF_HAIR,0.898590784753363
GOBP_POSITIVE_REGULATION_OF_...295,SET,5,0.44401,0.0073226,0.47026,0.17255,GOBP_POSITIVE_REGULATION_OF_GASTRULATION,0.898590784753363
WP_B_CELL_RECEPTOR_SIGNALING,SET,93,0.085527,0.0060687,0.090605,0.1726,WP_B_CELL_RECEPTOR_SIGNALING,0.898590784753363
GOMF_ACYL_COA_OXIDASE_ACTIVI...,SET,7,0.26671,0.0052042,0.28255,0.17261,GOMF_ACYL_COA_OXIDASE_ACTIVITY,0.898590784753363
GOMF_HISTONE_H3K27ME2_H3K27M...,SET,2,0.49878,0.005203,0.5285,0.17265,GOMF_HISTONE_H3K27ME2_H3K27ME3_DEMETHYLASE_ACTIVITY,0.898590784753363
HP_THUMB_CONTRACTURE,SET,4,0.48045,0.0070873,0.50914,0.17268,HP_THUMB_CONTRACTURE,0.898590784753363
GOBP_POSITIVE_REGULATION_OF_...72,SET,42,0.12299,0.0058728,0.13035,0.17271,GOBP_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION,0.898590784753363
GSE37532_VISCERAL_ADIPOSE_TI...1,SET,89,0.088009,0.0061097,0.093275,0.17271,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN,0.898590784753363
GOCC_MALE_GERM_CELL_NUCLEUS,SET,48,0.11034,0.0056319,0.11697,0.17275,GOCC_MALE_GERM_CELL_NUCLEUS,0.898590784753363
GOCC_ASTER,SET,10,0.25037,0.0058387,0.26542,0.17277,GOCC_ASTER,0.898590784753363
GOBP_ARTERY_MORPHOGENESIS,SET,69,0.10914,0.0066752,0.11573,0.17281,GOBP_ARTERY_MORPHOGENESIS,0.898590784753363
IGLESIAS_E2F_TARGETS_UP,SET,136,0.074379,0.0063747,0.078871,0.17284,IGLESIAS_E2F_TARGETS_UP,0.898590784753363
GOBP_NUCLEOSIDE_DIPHOSPHATE_...1,SET,13,0.2229,0.0059263,0.23638,0.17285,GOBP_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.898590784753363
GSE17721_PAM3CSK4_VS_GADIQUI...10,SET,185,0.059952,0.0059847,0.063591,0.1729,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP,0.898590784753363
REACTOME_NEGATIVE_REGULATION...8,SET,19,0.1886,0.0060609,0.20005,0.17291,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,0.898590784753363
GOBP_NUCLEOBASE_CONTAINING_S...2,SET,28,0.17735,0.0069172,0.18812,0.17291,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS,0.898590784753363
GOBP_POSITIVE_REGULATION_OF_...673,SET,42,0.13717,0.0065499,0.1455,0.17292,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.898590784753363
GOMF_POLY_A_BINDING,SET,21,0.17751,0.0059971,0.18833,0.17296,GOMF_POLY_A_BINDING,0.898590784753363
JONES_OVARY_PERICYTE,SET,152,0.070553,0.0063898,0.074854,0.17296,JONES_OVARY_PERICYTE,0.898590784753363
MORF_MYC,SET,75,0.093259,0.0059454,0.098948,0.17297,MORF_MYC,0.898590784753363
STAT5A_01,SET,227,0.055348,0.0061132,0.058739,0.17303,STAT5A_01,0.898655356342447
MIR6893_5P,SET,163,0.063273,0.0059324,0.067155,0.17305,MIR6893_5P,0.898655356342447
XU_AKT1_TARGETS_48HR,SET,9,0.26866,0.0059438,0.28515,0.17306,XU_AKT1_TARGETS_48HR,0.898655356342447
REACTOME_PHASE_1_INACTIVATIO...,SET,6,0.32828,0.0059306,0.34855,0.17314,REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS,0.898710958495073
REACTOME_LEUKOTRIENE_RECEPTO...,SET,4,0.34123,0.0050336,0.36233,0.17317,REACTOME_LEUKOTRIENE_RECEPTORS,0.898710958495073
GOBP_RESPONSE_TO_GLYCOPROTEIN,SET,11,0.27252,0.0066652,0.28938,0.17317,GOBP_RESPONSE_TO_GLYCOPROTEIN,0.898710958495073
BASSO_B_LYMPHOCYTE_NETWORK,SET,130,0.066875,0.0056046,0.071019,0.17319,BASSO_B_LYMPHOCYTE_NETWORK,0.898710958495073
KEGG_MEDICUS_REFERENCE_MDM2_...1,SET,13,0.21768,0.0057874,0.23118,0.1732,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066,0.898710958495073
GSE5679_PPARG_LIGAND_ROSIGLI...2,SET,181,0.058637,0.0057905,0.06229,0.17327,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.89877539919415
GOBP_MITOCHONDRIAL_FUSION,SET,30,0.14425,0.0058232,0.15324,0.17328,GOBP_MITOCHONDRIAL_FUSION,0.89877539919415
GSE20715_0H_VS_48H_OZONE_LUN...2,SET,180,0.060871,0.0059946,0.064668,0.17329,GSE20715_0H_VS_48H_OZONE_LUNG_UP,0.89877539919415
GAVISH_3CA_MALIGNANT_METAPRO...23,SET,48,0.12751,0.006508,0.1355,0.17335,GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR,0.898818327614501
GSE7509_DC_VS_MONOCYTE_DN,SET,186,0.059974,0.0060029,0.063732,0.17335,GSE7509_DC_VS_MONOCYTE_DN,0.898818327614501
GOBP_POSITIVE_REGULATION_OF_...398,SET,30,0.15136,0.0061103,0.1609,0.17344,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.898968375558867
GOBP_MINERALOCORTICOID_BIOSY...,SET,12,0.27366,0.0069906,0.29097,0.17348,GOBP_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS,0.898968375558867
BIOCARTA_PEPI_PATHWAY,SET,8,0.30985,0.0064633,0.32946,0.17349,BIOCARTA_PEPI_PATHWAY,0.898968375558867
PID_MET_PATHWAY,SET,77,0.091082,0.0058833,0.096849,0.1735,PID_MET_PATHWAY,0.898968375558867
DESCARTES_FETAL_INTESTINE_VA...,SET,38,0.14118,0.0064129,0.15012,0.17351,DESCARTES_FETAL_INTESTINE_VASCULAR_ENDOTHELIAL_CELLS,0.898968375558867
GOMF_HISTONE_H3K9ME2_METHYLT...,SET,7,0.30094,0.0058722,0.32004,0.17354,GOMF_HISTONE_H3K9ME2_METHYLTRANSFERASE_ACTIVITY,0.898968375558867
PID_HIV_NEF_PATHWAY,SET,35,0.13475,0.0058749,0.14332,0.17356,PID_HIV_NEF_PATHWAY,0.898968375558867
GAUTAM_EYE_CHOROID_SCLERA_ME...,SET,136,0.065702,0.005631,0.069888,0.17359,GAUTAM_EYE_CHOROID_SCLERA_MELANOCYTES,0.898989785426911
LENAOUR_DENDRITIC_CELL_MATUR...2,SET,110,0.084138,0.0064899,0.089524,0.17366,LENAOUR_DENDRITIC_CELL_MATURATION_UP,0.899187904066736
GSE41176_WT_VS_TAK1_KO_ANTI_...1,SET,174,0.062364,0.0060394,0.066362,0.17368,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN,0.899187904066736
GSE14350_TREG_VS_TEFF_IN_IL2...1,SET,184,0.058781,0.0058521,0.062577,0.17378,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN,0.899571626452189
GOBP_STRESS_FIBER_ASSEMBLY,SET,103,0.082359,0.0061484,0.087708,0.17387,GOBP_STRESS_FIBER_ASSEMBLY,0.89990347728965
GOBP_DNA_TEMPLATED_DNA_REPLI...1,SET,154,0.062953,0.0057385,0.067055,0.17392,GOBP_DNA_TEMPLATED_DNA_REPLICATION,0.89999772219741
GOBP_NEUTROPHIL_CLEARANCE,SET,6,0.37661,0.0068037,0.40118,0.17394,GOBP_NEUTROPHIL_CLEARANCE,0.89999772219741
KONG_E2F3_TARGETS,SET,90,0.084404,0.0058921,0.089939,0.17401,KONG_E2F3_TARGETS,0.900219100371747
GSE3039_ALPHABETA_CD8_TCELL_...2,SET,178,0.058205,0.0057004,0.06203,0.17404,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP,0.900219100371747
GOBP_INHIBITION_OF_NEUROEPIT...,SET,6,0.32694,0.0059063,0.34848,0.17408,GOBP_INHIBITION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.900219100371747
XIE_ST_HSC_S1PR3_OE_UP,SET,176,0.066867,0.0065122,0.071279,0.1741,XIE_ST_HSC_S1PR3_OE_UP,0.900219100371747
HP_LINEAR_ARRAYS_OF_MACULAR_...,SET,5,0.39607,0.006532,0.42225,0.17413,HP_LINEAR_ARRAYS_OF_MACULAR_HYPERKERATOSES_IN_FLEXURAL_AREAS,0.900219100371747
GSE32423_CTRL_VS_IL4_MEMORY_...1,SET,178,0.058404,0.00572,0.062268,0.17414,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN,0.900219100371747
WP_PPAR_SIGNALING,SET,66,0.1003,0.0059996,0.10694,0.17417,WP_PPAR_SIGNALING,0.900219100371747
GSE27241_CTRL_VS_DIGOXIN_TRE...3,SET,164,0.062776,0.0059036,0.066943,0.17419,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.900219100371747
AMIT_EGF_RESPONSE_480_HELA,SET,154,0.067435,0.0061471,0.071941,0.17429,AMIT_EGF_RESPONSE_480_HELA,0.900479843982169
GENTLES_LEUKEMIC_STEM_CELL_UP,SET,28,0.16751,0.0065336,0.17872,0.17431,GENTLES_LEUKEMIC_STEM_CELL_UP,0.900479843982169
GOBP_DE_NOVO_CENTRIOLE_ASSEM...2,SET,4,0.34541,0.0050952,0.36854,0.17433,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY_INVOLVED_IN_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.900479843982169
MIR6820_3P,SET,88,0.084694,0.0058466,0.090382,0.17437,MIR6820_3P,0.900479843982169
GOBP_ESTABLISHMENT_OF_PROTEI...2,SET,5,0.31899,0.0052608,0.34041,0.17437,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.900479843982169
chr4q28,SET,19,0.28923,0.0092948,0.30871,0.17442,chr4q28,0.900604234140544
GOBP_NEGATIVE_REGULATION_OF_...584,SET,6,0.33923,0.0061284,0.36214,0.17446,GOBP_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.900676960784314
GSE25088_CTRL_VS_ROSIGLITAZO...1,SET,138,0.06745,0.0058229,0.072043,0.17458,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.901070843230404
BIOCARTA_DREAM_PATHWAY,SET,13,0.26506,0.0070473,0.28316,0.17461,BIOCARTA_DREAM_PATHWAY,0.901070843230404
MODULE_308,SET,63,0.098657,0.0057664,0.10539,0.17462,MODULE_308,0.901070843230404
BIOCARTA_TCYTOTOXIC_PATHWAY,SET,12,0.255,0.0065138,0.27243,0.17464,BIOCARTA_TCYTOTOXIC_PATHWAY,0.901070843230404
HP_VIRAL_INFECTION_INDUCED_R...,SET,9,0.24724,0.00547,0.26418,0.17468,HP_VIRAL_INFECTION_INDUCED_RHABDOMYOLYSIS,0.901143446637969
REACTOME_TRANSPORT_OF_MATURE...1,SET,40,0.11256,0.0052457,0.12033,0.17479,REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS,0.901577092609083
MIR5011_3P,SET,46,0.11817,0.0059045,0.12635,0.17484,MIR5011_3P,0.901670519287834
UNTERMAN_IPF_VS_CTRL_CD8T_DN,SET,2,0.66939,0.0069827,0.71581,0.17486,UNTERMAN_IPF_VS_CTRL_CD8T_DN,0.901670519287834
HP_ANKLE_WEAKNESS,SET,17,0.17382,0.0052842,0.18591,0.1749,HP_ANKLE_WEAKNESS,0.901742990654206
FOXN3_TARGET_GENES,SET,1155,0.02534,0.0061497,0.027105,0.17493,FOXN3_TARGET_GENES,0.901763890536933
GNF2_CDKN1C,SET,25,0.17522,0.0064581,0.18745,0.17496,GNF2_CDKN1C,0.901784784220673
BANDRES_RESPONSE_TO_CARMUSTI...4,SET,18,0.19165,0.0059948,0.20509,0.17505,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,0.901981134173462
GTAAGAT_MIR200A,SET,44,0.12355,0.0060379,0.13222,0.17505,GTAAGAT_MIR200A,0.901981134173462
REACTOME_INHIBITION_OF_REPLI...,SET,11,0.21642,0.0052933,0.23164,0.17508,REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1,0.902001986362289
HALLMARK_PROTEIN_SECRETION,SET,85,0.084049,0.0057028,0.089984,0.17515,HALLMARK_PROTEIN_SECRETION,0.902228879502001
GOBP_RESPONSE_TO_PLATELET_DE...,SET,19,0.19831,0.0063732,0.21236,0.17519,GOBP_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR,0.90227049192473
HE_LIM_SUN_FETAL_LUNG_C2_BAS...,SET,100,0.086114,0.0063349,0.09222,0.17521,HE_LIM_SUN_FETAL_LUNG_C2_BASOPHIL_CELL,0.90227049192473
GOCC_NEUROFIBRILLARY_TANGLE,SET,5,0.44685,0.0073695,0.47873,0.17531,GOCC_NEUROFIBRILLARY_TANGLE,0.902620967264109
GOBP_INTERLEUKIN_2_MEDIATED_...,SET,8,0.32326,0.006743,0.34634,0.17533,GOBP_INTERLEUKIN_2_MEDIATED_SIGNALING_PATHWAY,0.902620967264109
REACTOME_SIGNALING_BY_RHO_GT...,SET,608,0.032564,0.0058243,0.034901,0.1754,REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,0.902847600710901
MIR3660,SET,96,0.083583,0.0060251,0.089591,0.17543,MIR3660,0.902868302976455
GSE8621_LPS_STIM_VS_LPS_PRIM...1,SET,183,0.059782,0.0059357,0.064096,0.17549,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.903043374296713
CUI_DEVELOPING_HEART_SMOOTH_...,SET,41,0.13282,0.0062666,0.14243,0.17554,CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL,0.903053921858813
GOBP_SKIN_MORPHOGENESIS,SET,13,0.21587,0.0057394,0.23152,0.17557,GOBP_SKIN_MORPHOGENESIS,0.903053921858813
HP_HOODED_EYELID,SET,6,0.30389,0.0054899,0.32592,0.17557,HP_HOODED_EYELID,0.903053921858813
SP1_Q2_01,SET,238,0.052729,0.0059616,0.056563,0.17561,SP1_Q2_01,0.903126006214857
GSE17721_12H_VS_24H_PAM3CSK4...1,SET,185,0.057367,0.0057266,0.061567,0.17573,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN,0.903362732919255
chr4q32,SET,38,0.22052,0.010017,0.23669,0.17575,chr4q32,0.903362732919255
GOBP_PROTEIN_N_LINKED_GLYCOS...2,SET,23,0.17236,0.0060936,0.18499,0.17575,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE,0.903362732919255
HP_ABNORMAL_DELAYED_HYPERSEN...,SET,10,0.26323,0.0061387,0.28254,0.17576,HP_ABNORMAL_DELAYED_HYPERSENSITIVITY_SKIN_TEST,0.903362732919255
GOCC_STEREOCILIUM_BUNDLE,SET,60,0.10689,0.0060973,0.11474,0.1758,GOCC_STEREOCILIUM_BUNDLE,0.903434718320272
GSE22103_UNSTIM_VS_GMCSF_AND...2,SET,185,0.056421,0.0056322,0.060588,0.17588,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,0.903712211709048
HP_HYPERNATRIURIA,SET,9,0.30256,0.006694,0.32497,0.17592,HP_HYPERNATRIURIA,0.903783896678967
GOBP_RESPONSE_TO_LAMINAR_FLU...,SET,14,0.22533,0.0062169,0.24211,0.17601,GOBP_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.903783896678967
GOMF_COMPLEMENT_COMPONENT_C3...,SET,7,0.38705,0.0075524,0.41589,0.17602,GOMF_COMPLEMENT_COMPONENT_C3B_BINDING,0.903783896678967
HP_EMG_ABNORMALITY,SET,250,0.050511,0.005851,0.054281,0.17605,HP_EMG_ABNORMALITY,0.903783896678967
HOUSTIS_ROS,SET,34,0.15018,0.0064536,0.16139,0.17606,HOUSTIS_ROS,0.903783896678967
GSE41176_WT_VS_TAK1_KO_ANTI_...8,SET,180,0.058199,0.0057315,0.062552,0.17608,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP,0.903783896678967
GSE6092_UNSTIM_VS_IFNG_STIM_...2,SET,180,0.05805,0.0057168,0.062393,0.17609,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.903783896678967
GOBP_DNA_UNWINDING_INVOLVED_...,SET,20,0.18558,0.0061188,0.19951,0.17614,GOBP_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION,0.903783896678967
HP_INFANTILE_AXIAL_HYPOTONIA,SET,42,0.12981,0.0061984,0.13956,0.17616,HP_INFANTILE_AXIAL_HYPOTONIA,0.903783896678967
HP_NEOPLASM_OF_THE_SKELETAL_...,SET,97,0.079511,0.0057612,0.085487,0.17617,HP_NEOPLASM_OF_THE_SKELETAL_SYSTEM,0.903783896678967
GOMF_LIPOPOLYSACCHARIDE_IMMU...,SET,6,0.3144,0.0056799,0.33805,0.17618,GOMF_LIPOPOLYSACCHARIDE_IMMUNE_RECEPTOR_ACTIVITY,0.903783896678967
GSE28726_ACT_CD4_TCELL_VS_AC...4,SET,183,0.058319,0.0057905,0.062715,0.17621,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP,0.903804390495868
REACTOME_SIGNALING_BY_ALK_IN...,SET,86,0.083961,0.0057301,0.090329,0.17632,REACTOME_SIGNALING_BY_ALK_IN_CANCER,0.904048919594297
UROSEVIC_RESPONSE_TO_IMIQUIM...,SET,18,0.19052,0.0059596,0.20499,0.17634,UROSEVIC_RESPONSE_TO_IMIQUIMOD,0.904048919594297
GOBP_SPERM_MOTILITY,SET,122,0.070122,0.0056943,0.075457,0.17637,GOBP_SPERM_MOTILITY,0.904048919594297
GOBP_REGULATION_OF_KIDNEY_DE...,SET,31,0.15989,0.0065613,0.1721,0.17643,GOBP_REGULATION_OF_KIDNEY_DEVELOPMENT,0.904048919594297
HP_PROSTATITIS,SET,6,0.41766,0.0075453,0.44963,0.17648,HP_PROSTATITIS,0.904048919594297
GOMF_OLIGOSACCHARYL_TRANSFER...,SET,5,0.37159,0.0061283,0.40013,0.17653,GOMF_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY,0.904048919594297
REACTOME_DARPP_32_EVENTS,SET,24,0.15516,0.0056033,0.16708,0.17654,REACTOME_DARPP_32_EVENTS,0.904048919594297
LASTOWSKA_NEUROBLASTOMA_COPY...2,SET,169,0.065772,0.0062781,0.070831,0.17656,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,0.904048919594297
GSE7568_CTRL_VS_24H_TGFB_TRE...2,SET,180,0.058644,0.0057753,0.063155,0.17656,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,0.904048919594297
GOMF_MODIFIED_AMINO_ACID_TRA...,SET,30,0.14801,0.0059751,0.1594,0.17657,GOMF_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.904048919594297
CAO_BLOOD_FLUZONE_AGE_05_14Y...4,SET,7,0.30179,0.0058888,0.32504,0.17659,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_UP,0.904048919594297
GOMF_ER_RETENTION_SEQUENCE_B...,SET,5,0.32366,0.0053378,0.34864,0.17662,GOMF_ER_RETENTION_SEQUENCE_BINDING,0.904048919594297
GOBP_REGULATION_OF_CYSTEINE_...4,SET,5,0.3215,0.0053022,0.3464,0.17668,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.904048919594297
HP_RECURRENT_PNEUMONIA,SET,114,0.075445,0.0059236,0.081287,0.17668,HP_RECURRENT_PNEUMONIA,0.904048919594297
GSE20366_EX_VIVO_VS_DEC205_C...2,SET,182,0.059441,0.0058859,0.064044,0.17668,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN,0.904048919594297
CTTGTAT_MIR381,SET,185,0.058754,0.0058651,0.063318,0.17673,CTTGTAT_MIR381,0.904048919594297
GSE14415_INDUCED_TREG_VS_FOX...2,SET,124,0.075322,0.0061662,0.081172,0.17673,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN,0.904048919594297
DESCARTES_MAIN_FETAL_UNIPOLA...,SET,22,0.18735,0.0064782,0.20192,0.17675,DESCARTES_MAIN_FETAL_UNIPOLAR_BRUSH_CELLS,0.904048919594297
NUNODA_RESPONSE_TO_DASATINIB...2,SET,29,0.14384,0.0057094,0.15505,0.17678,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,0.904048919594297
GOBP_MRNA_3_END_PROCESSING,SET,36,0.12017,0.0053134,0.12953,0.17678,GOBP_MRNA_3_END_PROCESSING,0.904048919594297
FAN_EMBRYONIC_CTX_EX_1_EXCIT...,SET,5,0.34082,0.0056208,0.36744,0.17683,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.904048919594297
GOBP_PROTEIN_LOCALIZATION_TO...22,SET,65,0.091229,0.0054159,0.098366,0.17686,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,0.904048919594297
GOMF_C_X_C_CHEMOKINE_BINDING,SET,4,0.39285,0.0057952,0.42368,0.17691,GOMF_C_X_C_CHEMOKINE_BINDING,0.904048919594297
GSE5589_LPS_VS_LPS_AND_IL10_...9,SET,177,0.059518,0.0058128,0.064189,0.17691,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.904048919594297
chr7q11,SET,71,0.19555,0.012131,0.21092,0.17694,chr7q11,0.904048919594297
HP_ARTHRALGIA_OF_THE_HIP,SET,8,0.28549,0.0059552,0.30794,0.17694,HP_ARTHRALGIA_OF_THE_HIP,0.904048919594297
KEGG_MEDICUS_PATHOGEN_HSV_GD...,SET,11,0.23102,0.0056502,0.24921,0.17696,KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY,0.904048919594297
REACTOME_SYNTHESIS_OF_BILE_A...3,SET,14,0.25542,0.0070469,0.27559,0.17702,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL,0.904222530864198
GOCC_MITOTIC_SPINDLE_POLE,SET,36,0.12961,0.0057308,0.13989,0.1771,GOCC_MITOTIC_SPINDLE_POLE,0.904225050783517
HP_ABNORMAL_PULMONARY_THORAC...,SET,132,0.072167,0.0060941,0.077911,0.17716,HP_ABNORMAL_PULMONARY_THORACIC_IMAGING_FINDING,0.904225050783517
MIR3911,SET,81,0.087984,0.0058283,0.094994,0.17718,MIR3911,0.904225050783517
MIR204_3P,SET,128,0.069325,0.0057654,0.074852,0.17719,MIR204_3P,0.904225050783517
LINDSTEDT_DENDRITIC_CELL_MAT...3,SET,60,0.10466,0.0059706,0.11302,0.17721,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,0.904225050783517
GOMF_TRANSLATION_TERMINATION...,SET,4,0.35511,0.0052383,0.38359,0.17729,GOMF_TRANSLATION_TERMINATION_FACTOR_ACTIVITY,0.904225050783517
GOBP_HEME_B_METABOLIC_PROCESS,SET,9,0.25665,0.0056782,0.27728,0.17733,GOBP_HEME_B_METABOLIC_PROCESS,0.904225050783517
XU_CREBBP_TARGETS_DN,SET,36,0.12612,0.0055765,0.13627,0.17736,XU_CREBBP_TARGETS_DN,0.904225050783517
REACTOME_SYNTHESIS_SECRETION...3,SET,12,0.222,0.005671,0.23991,0.1774,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP,0.904225050783517
HP_SPLANCHNIC_VEIN_THROMBOSIS,SET,22,0.18066,0.0062468,0.19524,0.17741,HP_SPLANCHNIC_VEIN_THROMBOSIS,0.904225050783517
GSE2770_UNTREATED_VS_TGFB_AN...9,SET,184,0.05931,0.0059048,0.064098,0.17741,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.904225050783517
GOBP_REGULATION_OF_TRANSFERA...,SET,564,0.034384,0.0059303,0.037162,0.17743,GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY,0.904225050783517
REACTOME_DISEASES_OF_CARBOHY...,SET,30,0.14003,0.0056529,0.15138,0.17749,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,0.904225050783517
GOCC_NETWORK_FORMING_COLLAGE...,SET,6,0.3552,0.006417,0.38409,0.17754,GOCC_NETWORK_FORMING_COLLAGEN_TRIMER,0.904225050783517
JIANG_MELANOMA_TRM9_CD8,SET,459,0.037053,0.0057822,0.040071,0.17757,JIANG_MELANOMA_TRM9_CD8,0.904225050783517
TGTTTGY_HNF3_Q6,SET,650,0.032393,0.0059832,0.035032,0.17758,TGTTTGY_HNF3_Q6,0.904225050783517
GSE5589_UNSTIM_VS_45MIN_LPS_...3,SET,178,0.05712,0.0055942,0.061796,0.17766,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN,0.904225050783517
GOBP_POSITIVE_REGULATION_OF_...92,SET,13,0.22046,0.0058613,0.23855,0.1777,GOBP_POSITIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.904225050783517
SANSOM_APC_TARGETS_UP,SET,120,0.074778,0.0060227,0.080931,0.17776,SANSOM_APC_TARGETS_UP,0.904225050783517
GOBP_POSITIVE_REGULATION_OF_...533,SET,9,0.27327,0.0060458,0.29581,0.1778,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.904225050783517
GSE22601_DOUBLE_NEGATIVE_VS_...2,SET,183,0.060528,0.0060098,0.065534,0.17785,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.904225050783517
GSE27786_CD4_TCELL_VS_ERYTHT...2,SET,182,0.053968,0.0053439,0.05843,0.17785,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP,0.904225050783517
GSE15330_MEGAKARYOCYTE_ERYTH...2,SET,188,0.058769,0.0059135,0.063632,0.17786,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP,0.904225050783517
GOMF_RDNA_BINDING,SET,8,0.25649,0.0053502,0.27773,0.17787,GOMF_RDNA_BINDING,0.904225050783517
GSE43863_TH1_VS_LY6C_LOW_CXC...1,SET,184,0.057625,0.005737,0.062401,0.17789,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.904225050783517
MIR6511A_3P_MIR6511B_3P,SET,55,0.10337,0.0056465,0.11196,0.17793,MIR6511A_3P_MIR6511B_3P,0.904225050783517
NIKOLSKY_BREAST_CANCER_1Q32_...,SET,13,0.33099,0.0088,0.3585,0.17794,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,0.904225050783517
REACTOME_SHC_MEDIATED_CASCAD...3,SET,19,0.18141,0.00583,0.19649,0.17794,REACTOME_SHC_MEDIATED_CASCADE_FGFR4,0.904225050783517
GOBP_REGULATION_OF_PEPTIDYL_...1,SET,8,0.32104,0.0066967,0.3478,0.178,GOBP_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.904225050783517
GOBP_METANEPHRIC_S_SHAPED_BO...,SET,5,0.43532,0.0071794,0.47164,0.17801,GOBP_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS,0.904225050783517
HE_LIM_SUN_FETAL_LUNG_C3_OMD...,SET,323,0.047288,0.0062137,0.051235,0.17802,HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL,0.904225050783517
HP_GRANULOMA,SET,6,0.34852,0.0062962,0.37764,0.17804,HP_GRANULOMA,0.904225050783517
GOBP_SISTER_CHROMATID_SEGREG...,SET,218,0.051381,0.0055628,0.055678,0.17805,GOBP_SISTER_CHROMATID_SEGREGATION,0.904225050783517
GSE36476_CTRL_VS_TSST_ACT_16...3,SET,185,0.056734,0.0056635,0.06148,0.17806,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN,0.904225050783517
KRIGE_RESPONSE_TO_TOSEDOSTAT...2,SET,645,0.031917,0.0058734,0.034595,0.17812,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,0.904225050783517
REACTOME_SYNTHESIS_OF_WYBUTO...,SET,6,0.26398,0.0047691,0.28618,0.17815,REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE,0.904225050783517
GSE22432_CONVENTIONAL_CDC_VS...1,SET,185,0.056502,0.0056403,0.061266,0.17821,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN,0.904225050783517
MODULE_213,SET,75,0.096514,0.006153,0.10466,0.17822,MODULE_213,0.904225050783517
REACTOME_MATURATION_OF_PROTE...,SET,9,0.27141,0.0060047,0.29434,0.17824,REACTOME_MATURATION_OF_PROTEIN_3A,0.904225050783517
CYTAGCAAY_UNKNOWN,SET,135,0.067239,0.0057417,0.072921,0.17825,CYTAGCAAY_UNKNOWN,0.904225050783517
GOBP_CHRONIC_INFLAMMATORY_RE...,SET,18,0.19633,0.0061412,0.21292,0.17825,GOBP_CHRONIC_INFLAMMATORY_RESPONSE,0.904225050783517
GOCC_STEREOCILIUM_MEMBRANE,SET,5,0.36559,0.0060294,0.39649,0.17825,GOCC_STEREOCILIUM_MEMBRANE,0.904225050783517
GOBP_N_ACYLPHOSPHATIDYLETHAN...,SET,4,0.40385,0.0059574,0.43802,0.17827,GOBP_N_ACYLPHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,0.904225050783517
GOCC_GLUTAMATERGIC_SYNAPSE,SET,390,0.040952,0.0059021,0.044419,0.17828,GOCC_GLUTAMATERGIC_SYNAPSE,0.904225050783517
REACTOME_RHO_GTPASE_EFFECTORS,SET,244,0.050215,0.0057475,0.054479,0.17834,REACTOME_RHO_GTPASE_EFFECTORS,0.904225050783517
GSE360_DC_VS_MAC_M_TUBERCULO...2,SET,179,0.059735,0.0058666,0.064807,0.17834,GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP,0.904225050783517
GOCC_H4_H2A_HISTONE_ACETYLTR...,SET,26,0.1527,0.0057393,0.16568,0.17836,GOCC_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.904225050783517
REACTOME_RECOGNITION_AND_ASS...,SET,10,0.2405,0.0056086,0.26097,0.17838,REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE,0.904225050783517
MIR767_5P,SET,174,0.061691,0.0059742,0.066949,0.17841,MIR767_5P,0.904225050783517
GSE44955_MCSF_VS_MCSF_AND_IL...1,SET,180,0.059031,0.0058134,0.064061,0.17841,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN,0.904225050783517
KEGG_MEDICUS_PATHOGEN_SALMON...7,SET,8,0.24237,0.0050557,0.2631,0.17848,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY,0.904225050783517
WILLIAMS_ESR1_TARGETS_UP,SET,25,0.16881,0.006222,0.18326,0.17849,WILLIAMS_ESR1_TARGETS_UP,0.904225050783517
GOBP_TYPE_II_HYPERSENSITIVITY,SET,8,0.33543,0.0069968,0.3642,0.17853,GOBP_TYPE_II_HYPERSENSITIVITY,0.904225050783517
HP_NEOPLASM_OF_THE_GALLBLADD...,SET,6,0.33679,0.0060844,0.36571,0.17855,HP_NEOPLASM_OF_THE_GALLBLADDER,0.904225050783517
SOTIRIOU_BREAST_CANCER_GRADE...1,SET,48,0.10926,0.0055764,0.11865,0.17857,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,0.904225050783517
GOBP_LIPID_GLYCOSYLATION,SET,11,0.24411,0.0059703,0.26512,0.1786,GOBP_LIPID_GLYCOSYLATION,0.904225050783517
REACTOME_EPH_EPHRIN_SIGNALING,SET,89,0.08575,0.0059528,0.09314,0.17862,REACTOME_EPH_EPHRIN_SIGNALING,0.904225050783517
GSE3920_UNTREATED_VS_IFNG_TR...2,SET,137,0.068305,0.0058754,0.074201,0.17865,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.904225050783517
GOBP_VESICLE_LOCALIZATION,SET,202,0.053023,0.0055283,0.057605,0.17867,GOBP_VESICLE_LOCALIZATION,0.904225050783517
GOBP_NEGATIVE_REGULATION_OF_...255,SET,5,0.41184,0.0067921,0.4475,0.17871,GOBP_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.904225050783517
MIR409_3P,SET,88,0.086506,0.0059717,0.094001,0.17872,MIR409_3P,0.904225050783517
GOBP_SECRETION,SET,899,0.027573,0.0059473,0.029964,0.17874,GOBP_SECRETION,0.904225050783517
MIR4728_5P,SET,517,0.034901,0.0057708,0.03793,0.17876,MIR4728_5P,0.904225050783517
KEGG_MEDICUS_REFERENCE_COHES...4,SET,6,0.34928,0.00631,0.37968,0.17881,KEGG_MEDICUS_REFERENCE_COHESIN_LOADING,0.904225050783517
GOBP_HISTONE_MRNA_CATABOLIC_...,SET,11,0.22155,0.0054187,0.24085,0.17882,GOBP_HISTONE_MRNA_CATABOLIC_PROCESS,0.904225050783517
chr7p15,SET,40,0.22026,0.010265,0.23945,0.17883,chr7p15,0.904225050783517
chr1q23,SET,130,0.14521,0.01217,0.15789,0.17887,chr1q23,0.904225050783517
GOBP_REGULATION_OF_EXCITATOR...,SET,17,0.1989,0.0060466,0.21627,0.17887,GOBP_REGULATION_OF_EXCITATORY_SYNAPSE_ASSEMBLY,0.904225050783517
HP_DEJA_VU_AURA,SET,7,0.28836,0.0056266,0.3136,0.17892,HP_DEJA_VU_AURA,0.904225050783517
GOCC_MPP7_DLG1_LIN7_COMPLEX,SET,5,0.40828,0.0067334,0.44403,0.17893,GOCC_MPP7_DLG1_LIN7_COMPLEX,0.904225050783517
HP_ABNORMAL_PERISTALSIS,SET,21,0.17073,0.005768,0.18568,0.17893,HP_ABNORMAL_PERISTALSIS,0.904225050783517
GOMF_HORMONE_RECEPTOR_BINDING,SET,29,0.16184,0.0064237,0.17602,0.17895,GOMF_HORMONE_RECEPTOR_BINDING,0.904225050783517
GSE23568_ID3_KO_VS_WT_CD8_TC...2,SET,174,0.0587,0.0056846,0.063855,0.17898,GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP,0.904225050783517
WP_LTF_DANGER_SIGNAL_RESPONS...,SET,18,0.20385,0.0063766,0.22177,0.179,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,0.904225050783517
GOBP_REGULATION_OF_MESODERM_...,SET,5,0.37469,0.0061795,0.40767,0.17902,GOBP_REGULATION_OF_MESODERM_DEVELOPMENT,0.904225050783517
GOMF_DISACCHARIDE_BINDING,SET,5,0.33258,0.0054849,0.36184,0.17902,GOMF_DISACCHARIDE_BINDING,0.904225050783517
GOMF_HISTONE_KINASE_ACTIVITY,SET,21,0.17163,0.0057985,0.18675,0.17904,GOMF_HISTONE_KINASE_ACTIVITY,0.904225050783517
GOBP_SENSORY_PERCEPTION_OF_T...2,SET,29,0.15367,0.0060995,0.16724,0.17909,GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS,0.904225050783517
GSE17721_PAM3CSK4_VS_CPG_8H_...2,SET,183,0.057449,0.0057041,0.062523,0.1791,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP,0.904225050783517
MIR4498,SET,232,0.052261,0.0058347,0.056885,0.17913,MIR4498,0.904225050783517
GOMF_SMAD_BINDING,SET,74,0.095825,0.0060684,0.10431,0.17913,GOMF_SMAD_BINDING,0.904225050783517
REACTOME_OPSINS,SET,7,0.27653,0.0053959,0.30104,0.17917,REACTOME_OPSINS,0.904225050783517
MODULE_284,SET,40,0.12668,0.0059038,0.13794,0.17921,MODULE_284,0.904225050783517
GOMF_MINOR_GROOVE_OF_ADENINE...,SET,8,0.28068,0.0058549,0.30564,0.17922,GOMF_MINOR_GROOVE_OF_ADENINE_THYMINE_RICH_DNA_BINDING,0.904225050783517
BOGNI_TREATMENT_RELATED_MYEL...2,SET,25,0.15955,0.0058807,0.17376,0.17925,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,0.904225050783517
GSE24210_IL35_TREATED_VS_RES...1,SET,181,0.062069,0.0061294,0.06761,0.1793,GSE24210_IL35_TREATED_VS_RESTING_TREG_DN,0.904225050783517
PID_P75_NTR_PATHWAY,SET,59,0.10166,0.005751,0.11074,0.17931,PID_P75_NTR_PATHWAY,0.904225050783517
GSE42021_CD24INT_TREG_VS_CD2...2,SET,178,0.056477,0.0055312,0.061522,0.17931,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP,0.904225050783517
REACTOME_FORMYL_PEPTIDE_RECE...,SET,8,0.33722,0.0070341,0.36737,0.17934,REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS,0.904245132743363
GOBP_LUTEOLYSIS,SET,6,0.37903,0.0068474,0.41308,0.17943,GOBP_LUTEOLYSIS,0.904486903553299
GSE10240_CTRL_VS_IL17_STIM_P...2,SET,177,0.059839,0.0058442,0.065219,0.17944,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.904486903553299
WELCH_GATA1_TARGETS,SET,21,0.1763,0.0059562,0.19226,0.17958,WELCH_GATA1_TARGETS,0.904551325457427
GOBP_NEGATIVE_REGULATION_OF_...77,SET,8,0.27259,0.0056861,0.29728,0.17959,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.904551325457427
GOBP_MYOBLAST_MIGRATION,SET,12,0.2223,0.0056785,0.24248,0.17963,GOBP_MYOBLAST_MIGRATION,0.904551325457427
GOBP_CENTRAL_NERVOUS_SYSTEM_...7,SET,163,0.06787,0.0063633,0.074033,0.17964,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,0.904551325457427
REACTOME_ACTIVATION_OF_TRKA_...,SET,6,0.35228,0.0063642,0.38429,0.17966,REACTOME_ACTIVATION_OF_TRKA_RECEPTORS,0.904551325457427
WEINBERGER_BLOOD_TWINRIX_AGE...3,SET,6,0.38509,0.0069568,0.4201,0.17967,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_4_POST_BOOSTER_VACC_1DY_POSITIVE,0.904551325457427
GOBP_MODIFIED_AMINO_ACID_TRA...,SET,38,0.13813,0.0062744,0.15069,0.17968,GOBP_MODIFIED_AMINO_ACID_TRANSPORT,0.904551325457427
GOCC_GAMMA_SECRETASE_COMPLEX,SET,6,0.26523,0.0047916,0.28937,0.17968,GOCC_GAMMA_SECRETASE_COMPLEX,0.904551325457427
GOBP_POSITIVE_REGULATION_OF_...119,SET,6,0.31288,0.0056524,0.34145,0.17975,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.904551325457427
REACTOME_MECP2_REGULATES_TRA...2,SET,7,0.36046,0.0070336,0.3934,0.17977,REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS,0.904551325457427
GOBP_CHLORIDE_TRANSPORT,SET,113,0.079662,0.0062273,0.086958,0.17982,GOBP_CHLORIDE_TRANSPORT,0.904551325457427
WAKASUGI_HAVE_ZNF143_BINDING...,SET,51,0.09426,0.0049586,0.10293,0.1799,WAKASUGI_HAVE_ZNF143_BINDING_SITES,0.904551325457427
REACTOME_G_ALPHA_S_SIGNALLIN...,SET,152,0.069389,0.0062843,0.075776,0.17992,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,0.904551325457427
KEGG_MEDICUS_REFERENCE_HEME_...,SET,8,0.26942,0.0056199,0.29423,0.17993,KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS,0.904551325457427
WP_HEMESYNTHESIS_DEFECTS_AND...,SET,8,0.26942,0.0056199,0.29423,0.17993,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,0.904551325457427
WP_HEME_BIOSYNTHESIS,SET,8,0.26942,0.0056199,0.29423,0.17993,WP_HEME_BIOSYNTHESIS,0.904551325457427
GSE360_HIGH_DOSE_B_MALAYI_VS...4,SET,187,0.055141,0.0055338,0.060222,0.17994,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,0.904551325457427
GSE9316_IL6_KO_VS_IFNG_KO_IN...1,SET,188,0.058225,0.0058587,0.063589,0.17994,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN,0.904551325457427
GOBP_OVULATION,SET,16,0.2202,0.0064944,0.2406,0.18004,GOBP_OVULATION,0.904551325457427
REACTOME_CALCINEURIN_ACTIVAT...,SET,9,0.23326,0.0051607,0.2549,0.18007,REACTOME_CALCINEURIN_ACTIVATES_NFAT,0.904551325457427
GOBP_SYNAPTIC_VESICLE_CYTOSK...,SET,18,0.18656,0.0058358,0.20388,0.18008,GOBP_SYNAPTIC_VESICLE_CYTOSKELETAL_TRANSPORT,0.904551325457427
GSE32901_NAIVE_VS_TH17_NEG_C...2,SET,157,0.061838,0.005691,0.067589,0.18013,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP,0.904551325457427
SCHWAB_TARGETS_OF_BMYB_POLYM...1,SET,14,0.22409,0.0061826,0.24494,0.18014,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,0.904551325457427
HP_PANCREATIC_FIBROSIS,SET,21,0.14691,0.0049631,0.1606,0.18017,HP_PANCREATIC_FIBROSIS,0.904551325457427
GOBP_NEUROMUSCULAR_PROCESS_C...2,SET,16,0.1943,0.0057306,0.21243,0.18019,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE,0.904551325457427
GOBP_POSITIVE_REGULATION_OF_...560,SET,8,0.33218,0.0069291,0.3632,0.18021,GOBP_POSITIVE_REGULATION_OF_OPSONIZATION,0.904551325457427
GSE3039_CD4_TCELL_VS_ALPHABE...2,SET,175,0.059646,0.0057926,0.065262,0.18038,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP,0.904551325457427
HP_ENAMEL_HYPOMINERALIZATION,SET,8,0.27221,0.0056781,0.29787,0.1804,HP_ENAMEL_HYPOMINERALIZATION,0.904551325457427
GOCC_CUTICULAR_PLATE,SET,8,0.29207,0.0060923,0.31964,0.18044,GOCC_CUTICULAR_PLATE,0.904551325457427
HP_LIMITED_EXTRAOCULAR_MOVEM...,SET,14,0.20144,0.0055576,0.22046,0.18044,HP_LIMITED_EXTRAOCULAR_MOVEMENTS,0.904551325457427
SRF_01,SET,45,0.12231,0.006045,0.13387,0.18046,SRF_01,0.904551325457427
GSE12963_ENV_NEF_VS_ENV_NEF_...2,SET,117,0.069283,0.0055104,0.075835,0.18047,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.904551325457427
POMEROY_MEDULLOBLASTOMA_DESM...2,SET,56,0.10066,0.005548,0.11018,0.18048,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,0.904551325457427
HP_GALACTOSURIA,SET,4,0.366,0.0053991,0.40064,0.18048,HP_GALACTOSURIA,0.904551325457427
GOBP_MEIOTIC_CELL_CYCLE_CHEC...,SET,9,0.27848,0.0061611,0.30484,0.18049,GOBP_MEIOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.904551325457427
GSE27786_BCELL_VS_CD4_TCELL_...2,SET,180,0.056865,0.0056001,0.062254,0.18051,GSE27786_BCELL_VS_CD4_TCELL_UP,0.904551325457427
LIU_BREAST_CANCER,SET,25,0.14834,0.0054674,0.1624,0.18052,LIU_BREAST_CANCER,0.904551325457427
GOBP_DISTAL_TUBULE_DEVELOPME...,SET,11,0.26755,0.0065437,0.29296,0.18056,GOBP_DISTAL_TUBULE_DEVELOPMENT,0.904551325457427
GSE20727_H2O2_VS_ROS_INHIBIT...1,SET,174,0.060333,0.0058427,0.066063,0.18056,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN,0.904551325457427
WP_EFFECT_OF_INTESTINAL_MICR...,SET,8,0.27545,0.0057457,0.30164,0.18058,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,0.904551325457427
GOBP_INNER_EAR_MORPHOGENESIS,SET,98,0.084289,0.0061387,0.092301,0.18058,GOBP_INNER_EAR_MORPHOGENESIS,0.904551325457427
ZHONG_PFC_C1_OPC,SET,218,0.051154,0.0055382,0.056025,0.18061,ZHONG_PFC_C1_OPC,0.904551325457427
GOBP_UV_DAMAGE_EXCISION_REPA...,SET,11,0.19906,0.0048686,0.21804,0.18064,GOBP_UV_DAMAGE_EXCISION_REPAIR,0.904551325457427
HP_ABNORMAL_VESTIBULAR_FUNCT...,SET,194,0.057503,0.0058768,0.062987,0.18064,HP_ABNORMAL_VESTIBULAR_FUNCTION,0.904551325457427
GSE43955_TH0_VS_TGFB_IL6_TH1...14,SET,183,0.058616,0.00582,0.064204,0.18064,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP,0.904551325457427
GRAHAM_CML_DIVIDING_VS_NORMA...2,SET,9,0.2507,0.0055465,0.27462,0.18065,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,0.904551325457427
GOMF_MAP_KINASE_SCAFFOLD_ACT...,SET,12,0.22836,0.0058332,0.25022,0.18073,GOMF_MAP_KINASE_SCAFFOLD_ACTIVITY,0.90482154278306
GOBP_PROTEIN_LOCALIZATION_TO...50,SET,81,0.083965,0.005562,0.092044,0.18083,GOBP_PROTEIN_LOCALIZATION_TO_VACUOLE,0.904931123110151
HP_APNEIC_EPISODES_PRECIPITA...,SET,11,0.23157,0.0056638,0.25385,0.18083,HP_APNEIC_EPISODES_PRECIPITATED_BY_ILLNESS_FATIGUE_STRESS,0.904931123110151
HP_NARROW_FACE,SET,83,0.088274,0.0059189,0.096767,0.18083,HP_NARROW_FACE,0.904931123110151
GOBP_POSITIVE_REGULATION_OF_...758,SET,10,0.25553,0.0059591,0.28035,0.18103,GOBP_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION,0.905129137311287
ATF_01,SET,240,0.051934,0.0058959,0.056988,0.18107,ATF_01,0.905129137311287
GSE22886_CTRL_VS_LPS_24H_DC_...2,SET,178,0.055403,0.005426,0.060794,0.18107,GSE22886_CTRL_VS_LPS_24H_DC_UP,0.905129137311287
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,SET,28,0.1373,0.005355,0.15067,0.18108,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,0.905129137311287
GSE21927_SPLENIC_C26GM_TUMOR...2,SET,151,0.061686,0.0055684,0.067691,0.18108,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP,0.905129137311287
HP_LARYNGOMALACIA,SET,77,0.086474,0.0055856,0.094903,0.1811,HP_LARYNGOMALACIA,0.905129137311287
CAFFAREL_RESPONSE_TO_THC_24H...1,SET,12,0.23464,0.0059939,0.25752,0.18111,CAFFAREL_RESPONSE_TO_THC_24HR_3_DN,0.905129137311287
WANG_HCP_PROSTATE_CANCER,SET,100,0.077986,0.005737,0.085598,0.18113,WANG_HCP_PROSTATE_CANCER,0.905129137311287
GOBP_RESPONSE_TO_INTERLEUKIN...2,SET,12,0.24041,0.0061411,0.26387,0.18113,GOBP_RESPONSE_TO_INTERLEUKIN_12,0.905129137311287
HP_TIBIALIS_ANTERIOR_MUSCLE_...,SET,4,0.41624,0.0061401,0.45686,0.18113,HP_TIBIALIS_ANTERIOR_MUSCLE_ATROPHY,0.905129137311287
HP_ABNORMAL_AFFECT,SET,37,0.14076,0.0063095,0.15455,0.18122,HP_ABNORMAL_AFFECT,0.905326582914573
GOBP_REGULATION_OF_SYNAPTIC_...10,SET,37,0.13029,0.0058403,0.14307,0.18124,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,0.905326582914573
VALK_AML_CLUSTER_2,SET,26,0.17803,0.0066914,0.1955,0.18125,VALK_AML_CLUSTER_2,0.905326582914573
HP_MALABSORPTION,SET,212,0.056056,0.0059858,0.061564,0.18128,HP_MALABSORPTION,0.905326582914573
GSE1791_CTRL_VS_NEUROMEDINU_...2,SET,170,0.058522,0.0056024,0.064286,0.18133,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP,0.905326582914573
GOBP_SMAD_PROTEIN_SIGNAL_TRA...,SET,76,0.099655,0.0063953,0.10949,0.18137,GOBP_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.905326582914573
WP_HYPOTHETICAL_CRANIOFACIAL...,SET,7,0.29631,0.0057819,0.32558,0.18138,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,0.905326582914573
GOBP_RESPONSE_TO_FUNGICIDE,SET,7,0.26255,0.0051231,0.28848,0.18139,GOBP_RESPONSE_TO_FUNGICIDE,0.905326582914573
HARALAMBIEVA_PBMC_M_M_R_II_A...6,SET,40,0.1364,0.0063568,0.14989,0.18141,HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_16YO_STIMULATED_VS_UNSTIMULATED_3_TO_7YR_POST_TOP_DEG_UP,0.905326582914573
GAVISH_3CA_MALIGNANT_METAPRO...7,SET,45,0.12734,0.0062934,0.13994,0.18143,GAVISH_3CA_MALIGNANT_METAPROGRAM_16_MES_GLIOMA,0.905326582914573
GOCC_AZUROPHIL_GRANULE_MEMBR...,SET,51,0.10598,0.0055752,0.1165,0.1815,GOCC_AZUROPHIL_GRANULE_MEMBRANE,0.905435584098737
HOFT_CD4_POSITIVE_ALPHA_BETA...7,SET,12,0.22671,0.0057911,0.24923,0.18152,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_DN,0.905435584098737
GOBP_PRIMITIVE_STREAK_FORMAT...,SET,8,0.29715,0.0061985,0.3267,0.18153,GOBP_PRIMITIVE_STREAK_FORMATION,0.905435584098737
TGCGCANK_UNKNOWN,SET,491,0.03478,0.0056084,0.038252,0.18162,TGCGCANK_UNKNOWN,0.905564156626506
GSE26023_PHD3_KO_VS_WT_NEUTR...1,SET,179,0.057067,0.0056046,0.062772,0.18165,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN,0.905564156626506
STEARMAN_LUNG_CANCER_EARLY_V...1,SET,56,0.1068,0.0058865,0.11748,0.18166,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,0.905564156626506
GSE23114_PERITONEAL_CAVITY_B...1,SET,183,0.055138,0.0054746,0.060652,0.18166,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN,0.905564156626506
FLECHNER_PBL_KIDNEY_TRANSPLA...2,SET,137,0.064416,0.0055409,0.070882,0.18174,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,0.905643201597946
GSE29618_PRE_VS_DAY7_FLU_VAC...7,SET,177,0.054974,0.005369,0.060506,0.1818,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN,0.905643201597946
GSE360_T_GONDII_VS_B_MALAYI_...1,SET,187,0.05737,0.0057575,0.063156,0.18184,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.905643201597946
MIR17_3P,SET,121,0.071701,0.0057988,0.078935,0.18185,MIR17_3P,0.905643201597946
HP_PAPILLARY_CYSTADENOMA_OF_...,SET,5,0.36907,0.0060867,0.40635,0.18188,HP_PAPILLARY_CYSTADENOMA_OF_THE_EPIDIDYMIS,0.905643201597946
GOMF_AMMONIA_LYASE_ACTIVITY,SET,5,0.40401,0.0066631,0.445,0.18197,GOMF_AMMONIA_LYASE_ACTIVITY,0.905643201597946
GSE6875_TCONV_VS_FOXP3_KO_TR...1,SET,177,0.056912,0.0055582,0.062685,0.18197,GSE6875_TCONV_VS_FOXP3_KO_TREG_DN,0.905643201597946
GENTILE_UV_RESPONSE_CLUSTER_...6,SET,30,0.1382,0.0055789,0.15224,0.182,GENTILE_UV_RESPONSE_CLUSTER_D7,0.905643201597946
GOCC_U1_SNRNP,SET,18,0.18181,0.005687,0.20028,0.182,GOCC_U1_SNRNP,0.905643201597946
MYLLYKANGAS_AMPLIFICATION_HO...17,SET,7,0.31445,0.0061358,0.34646,0.18205,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7,0.905643201597946
HP_ABNORMAL_CELL_MORPHOLOGY,SET,42,0.11334,0.0054121,0.1249,0.1821,HP_ABNORMAL_CELL_MORPHOLOGY,0.905643201597946
SAGIV_CD24_TARGETS_DN,SET,44,0.11866,0.005799,0.13077,0.18212,SAGIV_CD24_TARGETS_DN,0.905643201597946
GOCC_ENDOSOME_MEMBRANE,SET,518,0.034365,0.0056876,0.037885,0.18218,GOCC_ENDOSOME_MEMBRANE,0.905643201597946
GSE21546_UNSTIM_VS_ANTI_CD3_...7,SET,132,0.069128,0.0058375,0.076208,0.18218,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN,0.905643201597946
MODULE_543,SET,14,0.21815,0.0060187,0.24052,0.18221,MODULE_543,0.905643201597946
GSE45739_NRAS_KO_VS_WT_UNSTI...1,SET,169,0.060295,0.0057553,0.066486,0.18224,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN,0.905643201597946
GSE5589_UNSTIM_VS_180MIN_LPS...2,SET,183,0.055568,0.0055173,0.061276,0.18225,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.905643201597946
GOBP_NEGATIVE_REGULATION_OF_...383,SET,6,0.33597,0.0060695,0.37052,0.18228,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.905643201597946
GOBP_PEPTIDYL_PROLINE_MODIFI...,SET,29,0.12637,0.0050159,0.13938,0.1823,GOBP_PEPTIDYL_PROLINE_MODIFICATION,0.905643201597946
HP_NEOPLASM_OF_THE_NERVOUS_S...,SET,184,0.056113,0.0055865,0.061891,0.1823,HP_NEOPLASM_OF_THE_NERVOUS_SYSTEM,0.905643201597946
REACTOME_FORMATION_OF_TC_NER...,SET,48,0.099035,0.0050546,0.10923,0.18231,REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,0.905643201597946
ROZANOV_MMP14_TARGETS_DN,SET,30,0.15337,0.0061915,0.16918,0.18233,ROZANOV_MMP14_TARGETS_DN,0.905643201597946
HMX1_01,SET,39,0.13029,0.0059957,0.14373,0.18235,HMX1_01,0.905643201597946
MIR6802_5P,SET,22,0.16164,0.0055891,0.17834,0.18239,MIR6802_5P,0.905643201597946
HP_HYPOGLYCEMIA,SET,230,0.051534,0.005729,0.056862,0.18239,HP_HYPOGLYCEMIA,0.905643201597946
GOBP_MRNA_5_SPLICE_SITE_RECO...,SET,6,0.26098,0.0047147,0.28798,0.18241,GOBP_MRNA_5_SPLICE_SITE_RECOGNITION,0.905643201597946
GOCC_KINETOCHORE_MICROTUBULE,SET,19,0.16497,0.0053015,0.18206,0.18244,GOCC_KINETOCHORE_MICROTUBULE,0.905643201597946
GOBP_LIVER_MORPHOGENESIS,SET,25,0.15756,0.0058072,0.17388,0.18245,GOBP_LIVER_MORPHOGENESIS,0.905643201597946
GOMF_CALCIUM_SENSITIVE_GUANY...,SET,5,0.34088,0.0056218,0.37628,0.1825,GOMF_CALCIUM_SENSITIVE_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY,0.905643201597946
HP_SELF_BITING,SET,8,0.28445,0.0059335,0.31403,0.18252,HP_SELF_BITING,0.905643201597946
GSE37416_CTRL_VS_6H_F_TULARE...2,SET,164,0.059582,0.0056032,0.065779,0.18253,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.905643201597946
DURANTE_ADULT_OLFACTORY_NEUR...13,SET,72,0.10068,0.0062894,0.11116,0.18254,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS,0.905643201597946
TFIII_Q6,SET,201,0.057058,0.0059344,0.063007,0.18259,TFIII_Q6,0.905643201597946
GOBP_MANNOSYLATION,SET,20,0.17193,0.0056685,0.18986,0.18259,GOBP_MANNOSYLATION,0.905643201597946
HP_APLASIA_HYPOPLASIA_OF_THE...32,SET,4,0.41006,0.006049,0.45285,0.1826,HP_APLASIA_HYPOPLASIA_OF_THE_FALLOPIAN_TUBE,0.905643201597946
GOBP_KERATINOCYTE_DEVELOPMENT,SET,13,0.23586,0.0062708,0.26051,0.18264,GOBP_KERATINOCYTE_DEVELOPMENT,0.905643201597946
GSE17721_CTRL_VS_GARDIQUIMOD...14,SET,185,0.056476,0.0056377,0.062377,0.18264,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP,0.905643201597946
HP_DEFORMED_TARSAL_BONES,SET,13,0.25495,0.0067783,0.2817,0.18273,HP_DEFORMED_TARSAL_BONES,0.905960221112696
GOCC_FILTRATION_DIAPHRAGM,SET,9,0.27543,0.0060937,0.30439,0.18278,GOCC_FILTRATION_DIAPHRAGM,0.906078861788618
HALLMARK_COAGULATION,SET,129,0.073048,0.0060985,0.080757,0.18286,HALLMARK_COAGULATION,0.906266483673178
KEGG_MEDICUS_REFERENCE_HEPAR...2,SET,6,0.31424,0.0056769,0.34742,0.18287,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION,0.906266483673178
GOCC_MUSCLE_MYOSIN_COMPLEX,SET,14,0.24409,0.0067345,0.26993,0.18293,GOCC_MUSCLE_MYOSIN_COMPLEX,0.906417913525814
WP_PREGNANE_X_RECEPTOR_PATHW...,SET,31,0.15586,0.0063959,0.17239,0.18297,WP_PREGNANE_X_RECEPTOR_PATHWAY,0.906417913525814
MIR4423_5P,SET,26,0.14817,0.0055693,0.16389,0.18298,MIR4423_5P,0.906417913525814
HP_RESTRICTIVE_CARDIOMYOPATHY,SET,22,0.17493,0.0060489,0.19359,0.1831,HP_RESTRICTIVE_CARDIOMYOPATHY,0.906417913525814
HP_BICONVEX_VERTEBRAL_BODIES,SET,3,0.44375,0.0056692,0.49122,0.18317,HP_BICONVEX_VERTEBRAL_BODIES,0.906417913525814
GSE17721_0.5H_VS_24H_POLYIC_...2,SET,183,0.056272,0.0055873,0.062293,0.18317,GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP,0.906417913525814
KEGG_PPAR_SIGNALING_PATHWAY,SET,67,0.096513,0.0058168,0.10686,0.18323,KEGG_PPAR_SIGNALING_PATHWAY,0.906417913525814
GSE27859_DC_VS_CD11C_INT_F48...4,SET,184,0.05694,0.0056688,0.063046,0.18323,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP,0.906417913525814
GOBP_REGULATION_OF_MUSCLE_CE...,SET,132,0.067627,0.0057108,0.074888,0.18326,GOBP_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.906417913525814
HP_BROAD_FOREHEAD,SET,167,0.06105,0.0057931,0.067606,0.18326,HP_BROAD_FOREHEAD,0.906417913525814
GOBP_CARDIAC_MUSCLE_CELL_ACT...2,SET,57,0.11916,0.0066261,0.13196,0.18327,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION,0.906417913525814
GSE45365_WT_VS_IFNAR_KO_CD8A...3,SET,186,0.056109,0.0056161,0.062144,0.1833,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP,0.906417913525814
GOBP_CELLULAR_RESPONSE_TO_X_...,SET,11,0.20067,0.0049079,0.22227,0.18332,GOBP_CELLULAR_RESPONSE_TO_X_RAY,0.906417913525814
GOBP_ENDOCARDIAL_CUSHION_FUS...,SET,4,0.47134,0.0069529,0.52209,0.18332,GOBP_ENDOCARDIAL_CUSHION_FUSION,0.906417913525814
GOCC_RAGULATOR_COMPLEX,SET,6,0.26233,0.0047392,0.29059,0.18334,GOCC_RAGULATOR_COMPLEX,0.906417913525814
GSE16451_CTRL_VS_WEST_EQUINE...1,SET,178,0.055101,0.0053964,0.061038,0.18334,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.906417913525814
GOBP_RESPONSE_TO_IRON_II_ION,SET,6,0.33799,0.006106,0.37442,0.18335,GOBP_RESPONSE_TO_IRON_II_ION,0.906417913525814
GOBP_REGULATION_OF_NEUROMUSC...,SET,7,0.30181,0.0058891,0.33436,0.18337,GOBP_REGULATION_OF_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.906417913525814
GSE20151_CTRL_VS_FUSOBACT_NU...1,SET,174,0.05785,0.0056022,0.064113,0.18345,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN,0.906603112648221
GSE45739_UNSTIM_VS_ACD3_ACD2...3,SET,178,0.060345,0.00591,0.066893,0.18351,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN,0.906603112648221
GOBP_AMELOBLAST_DIFFERENTIAT...,SET,5,0.41691,0.0068758,0.46225,0.18355,GOBP_AMELOBLAST_DIFFERENTIATION,0.906603112648221
BENPORATH_CYCLING_GENES,SET,589,0.031266,0.0055069,0.034667,0.18356,BENPORATH_CYCLING_GENES,0.906603112648221
GSE22025_UNTREATED_VS_TGFB1_...4,SET,185,0.059107,0.0059004,0.065543,0.18359,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP,0.906603112648221
GOBP_WNT_SIGNALING_PATHWAY_C...,SET,5,0.43269,0.0071359,0.47983,0.1836,GOBP_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY,0.906603112648221
MIR4758_3P,SET,50,0.099902,0.0052038,0.1108,0.18362,MIR4758_3P,0.906603112648221
HP_ABDOMINAL_OBESITY,SET,24,0.16094,0.0058123,0.1785,0.18362,HP_ABDOMINAL_OBESITY,0.906603112648221
GOBP_ACROSOMAL_VESICLE_EXOCY...,SET,9,0.26142,0.0057838,0.28997,0.18365,GOBP_ACROSOMAL_VESICLE_EXOCYTOSIS,0.906603112648221
HP_ABNORMAL_IMMUNE_SERUM_PRO...,SET,42,0.12486,0.0059623,0.13855,0.18374,HP_ABNORMAL_IMMUNE_SERUM_PROTEIN_PHYSIOLOGY,0.906603112648221
BIOCARTA_DEATH_PATHWAY,SET,28,0.1502,0.0058584,0.16669,0.18377,BIOCARTA_DEATH_PATHWAY,0.906603112648221
MIR299_5P,SET,134,0.069871,0.0059444,0.077542,0.18378,MIR299_5P,0.906603112648221
GSE29164_UNTREATED_VS_CD8_TC...2,SET,174,0.056523,0.0054737,0.062763,0.18391,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.906603112648221
GOBP_MEIOTIC_CHROMOSOME_SEPA...,SET,9,0.24528,0.0054265,0.27239,0.18394,GOBP_MEIOTIC_CHROMOSOME_SEPARATION,0.906603112648221
HP_ELEVATED_CIRCULATING_GLUT...,SET,6,0.3253,0.0058768,0.36126,0.18394,HP_ELEVATED_CIRCULATING_GLUTARIC_ACID_CONCENTRATION,0.906603112648221
MIR7706,SET,10,0.24907,0.0058084,0.27665,0.18398,MIR7706,0.906603112648221
GSE2770_TGFB_AND_IL4_ACT_VS_...5,SET,175,0.055994,0.0054379,0.062193,0.18398,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.906603112648221
MODULE_576,SET,102,0.078483,0.0058307,0.087174,0.18399,MODULE_576,0.906603112648221
GOBP_CELLULAR_RESPONSE_TO_UV...1,SET,10,0.28397,0.0066222,0.31544,0.18401,GOBP_CELLULAR_RESPONSE_TO_UV_A,0.906603112648221
GOBP_RESPONSE_TO_LIPID,SET,853,0.028326,0.0059593,0.031466,0.18401,GOBP_RESPONSE_TO_LIPID,0.906603112648221
YTAAYNGCT_UNKNOWN,SET,130,0.072625,0.0060865,0.080696,0.18407,YTAAYNGCT_UNKNOWN,0.906603112648221
chr3q25,SET,61,0.18375,0.010569,0.2042,0.1841,chr3q25,0.906603112648221
HP_ABNORMAL_CIRCULATING_INTE...3,SET,31,0.15161,0.0062215,0.16851,0.18414,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_CONCENTRATION,0.906603112648221
AUJLA_IL22_AND_IL17A_SIGNALI...,SET,10,0.24556,0.0057266,0.27294,0.18415,AUJLA_IL22_AND_IL17A_SIGNALING,0.906603112648221
SMID_BREAST_CANCER_BASAL_DN,SET,631,0.032758,0.0059648,0.036417,0.18419,SMID_BREAST_CANCER_BASAL_DN,0.906603112648221
MUNSHI_MULTIPLE_MYELOMA_UP,SET,71,0.093031,0.0057712,0.10344,0.18423,MUNSHI_MULTIPLE_MYELOMA_UP,0.906603112648221
GOCC_POSTSYNAPTIC_ACTIN_CYTO...,SET,8,0.2722,0.0056779,0.30265,0.18423,GOCC_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.906603112648221
GSE21670_IL6_VS_TGFB_AND_IL6...2,SET,173,0.059848,0.0057792,0.066554,0.18427,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,0.906603112648221
WYAAANNRNNNGCG_UNKNOWN,SET,62,0.10002,0.0057998,0.11124,0.18428,WYAAANNRNNNGCG_UNKNOWN,0.906603112648221
GOBP_MACROMOLECULE_DEACYLATI...,SET,53,0.098018,0.0052561,0.10902,0.18431,GOBP_MACROMOLECULE_DEACYLATION,0.906603112648221
chr22q11,SET,98,0.14244,0.010373,0.15845,0.18436,chr22q11,0.906603112648221
GOBP_NEGATIVE_REGULATION_OF_...523,SET,6,0.31237,0.0056432,0.34752,0.18437,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION,0.906603112648221
HP_CHRONIC_FATIGUE,SET,24,0.16065,0.0058017,0.17873,0.18438,HP_CHRONIC_FATIGUE,0.906603112648221
GOBP_EXTRACELLULAR_EXOSOME_A...,SET,7,0.30266,0.0059056,0.33674,0.18439,GOBP_EXTRACELLULAR_EXOSOME_ASSEMBLY,0.906603112648221
KEGG_MEDICUS_REFERENCE_ESTAB...,SET,5,0.32144,0.0053013,0.3577,0.18443,KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION,0.906603112648221
GSE22886_NAIVE_CD8_TCELL_VS_...1,SET,185,0.055964,0.0055866,0.062275,0.18443,GSE22886_NAIVE_CD8_TCELL_VS_DC_DN,0.906603112648221
GOMF_ACYLTRANSFERASE_ACTIVITY,SET,651,0.030064,0.0055572,0.033458,0.18445,GOMF_ACYLTRANSFERASE_ACTIVITY,0.906603112648221
MIR216A_5P,SET,118,0.071684,0.0057255,0.079795,0.18451,MIR216A_5P,0.906603112648221
REACTOME_SIGNALING_BY_NODAL,SET,19,0.18783,0.0060363,0.2091,0.18452,REACTOME_SIGNALING_BY_NODAL,0.906603112648221
GSE13306_LAMINA_PROPRIA_VS_S...2,SET,182,0.057319,0.0056758,0.063818,0.18456,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP,0.906603112648221
GOCC_DNA_DEPENDENT_PROTEIN_K...2,SET,6,0.24122,0.0043579,0.26865,0.18462,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_DNA_LIGASE_4_COMPLEX,0.906603112648221
GOCC_CORNIFIED_ENVELOPE,SET,58,0.12274,0.0068841,0.13671,0.18466,GOCC_CORNIFIED_ENVELOPE,0.906603112648221
HP_ESOPHAGEAL_ULCERATION,SET,7,0.27665,0.0053981,0.30814,0.18466,HP_ESOPHAGEAL_ULCERATION,0.906603112648221
HP_RETINAL_VASCULAR_TORTUOSI...,SET,38,0.14539,0.0066044,0.16196,0.18468,HP_RETINAL_VASCULAR_TORTUOSITY,0.906603112648221
HP_CHIN_WITH_H_SHAPED_CREASE,SET,4,0.47645,0.0070283,0.53079,0.1847,HP_CHIN_WITH_H_SHAPED_CREASE,0.906603112648221
MIR4268,SET,54,0.10911,0.005906,0.12157,0.18472,MIR4268,0.906603112648221
REACTOME_DEX_H_BOX_HELICASES...,SET,7,0.2917,0.0056918,0.32501,0.18473,REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION,0.906603112648221
GSE9946_IMMATURE_VS_MATURE_S...1,SET,124,0.071087,0.0058194,0.079207,0.18474,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN,0.906603112648221
GOMF_STRUCTURAL_MOLECULE_ACT...1,SET,652,0.031323,0.0057941,0.034903,0.18475,GOMF_STRUCTURAL_MOLECULE_ACTIVITY,0.906603112648221
HP_ABNORMAL_NUMBER_OF_GRANUL...,SET,9,0.25837,0.0057161,0.28789,0.18475,HP_ABNORMAL_NUMBER_OF_GRANULOCYTE_PRECURSORS,0.906603112648221
HOLLERN_MICROACINAR_BREAST_T...2,SET,40,0.12515,0.0058325,0.13947,0.18478,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,0.906603112648221
HP_BROAD_PALM,SET,24,0.15916,0.005748,0.17738,0.18479,HP_BROAD_PALM,0.906603112648221
GSE31082_DN_VS_DP_THYMOCYTE_...1,SET,184,0.053856,0.0053618,0.060023,0.18479,GSE31082_DN_VS_DP_THYMOCYTE_DN,0.906603112648221
GOBP_MULTIVESICULAR_BODY_SOR...,SET,45,0.1088,0.0053772,0.1213,0.18487,GOBP_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.906867586450247
GOBP_POSITIVE_REGULATION_OF_...38,SET,123,0.072559,0.0059161,0.080948,0.18503,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.907385442234448
MIR4638_3P,SET,56,0.10147,0.0055928,0.11322,0.18506,MIR4638_3P,0.907385442234448
GOCC_UBIQUITIN_CONJUGATING_E...,SET,7,0.22682,0.0044259,0.2531,0.18508,GOCC_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX,0.907385442234448
HP_FRAGILE_NAILS,SET,23,0.15595,0.0055136,0.17402,0.18508,HP_FRAGILE_NAILS,0.907385442234448
HP_ABNORMAL_SWEAT_GLAND_MORP...,SET,18,0.19653,0.0061477,0.21938,0.18517,HP_ABNORMAL_SWEAT_GLAND_MORPHOLOGY,0.907570631786772
HP_DECREASED_URINE_OUTPUT,SET,24,0.16853,0.0060863,0.18812,0.18517,HP_DECREASED_URINE_OUTPUT,0.907570631786772
GOBP_DETECTION_OF_CALCIUM_ION,SET,13,0.2249,0.0059794,0.2511,0.18522,GOBP_DETECTION_OF_CALCIUM_ION,0.90768769035533
MODULE_298,SET,26,0.16072,0.0060409,0.17948,0.18527,MODULE_298,0.907774732168029
HP_AMYOTROPHIC_LATERAL_SCLER...,SET,48,0.10591,0.0054054,0.11828,0.18529,HP_AMYOTROPHIC_LATERAL_SCLEROSIS,0.907774732168029
HP_WRIST_HYPERMOBILITY,SET,7,0.33155,0.0064693,0.37049,0.18543,HP_WRIST_HYPERMOBILITY,0.907972541156606
GOBP_REGULATION_OF_MONOATOMI...1,SET,6,0.35249,0.006368,0.39402,0.1855,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORT,0.907972541156606
GOCC_EUKARYOTIC_TRANSLATION_...5,SET,13,0.20491,0.0054479,0.22908,0.18554,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX,0.907972541156606
GSE9037_CTRL_VS_LPS_1H_STIM_...1,SET,177,0.057415,0.0056074,0.064191,0.18555,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN,0.907972541156606
GARGALOVIC_RESPONSE_TO_OXIDI...12,SET,11,0.21774,0.0053254,0.24344,0.18556,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,0.907972541156606
GOBP_MUSCLE_CELL_DEVELOPMENT,SET,185,0.057156,0.0057056,0.063905,0.18556,GOBP_MUSCLE_CELL_DEVELOPMENT,0.907972541156606
HP_TIBIAL_BOWING,SET,33,0.14189,0.0060073,0.15868,0.18561,HP_TIBIAL_BOWING,0.907972541156606
GOCC_PRESYNAPTIC_MEMBRANE,SET,159,0.065651,0.00608,0.073424,0.18563,GOCC_PRESYNAPTIC_MEMBRANE,0.907972541156606
GOMF_VOLTAGE_GATED_CHANNEL_A...,SET,165,0.065796,0.0062063,0.07359,0.18564,GOMF_VOLTAGE_GATED_CHANNEL_ACTIVITY,0.907972541156606
NABA_COLLAGENS,SET,42,0.13142,0.0062753,0.147,0.18567,NABA_COLLAGENS,0.907972541156606
REACTOME_COLLAGEN_CHAIN_TRIM...,SET,42,0.13142,0.0062753,0.147,0.18567,REACTOME_COLLAGEN_CHAIN_TRIMERIZATION,0.907972541156606
REACTOME_PTK6_REGULATES_RTKS...,SET,8,0.29508,0.0061551,0.33006,0.18567,REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1,0.907972541156606
GOBP_REGULATION_OF_CELL_FATE...1,SET,38,0.12879,0.0058501,0.14406,0.18567,GOBP_REGULATION_OF_CELL_FATE_COMMITMENT,0.907972541156606
GOBP_PLASMA_MEMBRANE_FUSION,SET,25,0.16582,0.0061117,0.18561,0.18583,GOBP_PLASMA_MEMBRANE_FUSION,0.908420421940928
GSE40068_CXCR5NEG_BCL6NEG_CD...1,SET,183,0.056447,0.0056046,0.063183,0.18583,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN,0.908420421940928
REACTOME_DRUG_MEDIATED_INHIB...,SET,5,0.35207,0.0058064,0.39411,0.18584,REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY,0.908420421940928
GSE16522_MEMORY_VS_NAIVE_CD8...2,SET,170,0.056432,0.0054023,0.063181,0.18589,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.908458169291339
GSE4535_BM_DERIVED_DC_VS_FOL...2,SET,179,0.059671,0.0058602,0.066811,0.1859,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP,0.908458169291339
HP_ABNORMAL_NEURON_MORPHOLOGY,SET,79,0.084198,0.0055085,0.094341,0.18607,HP_ABNORMAL_NEURON_MORPHOLOGY,0.9088942812983
KEGG_MEDICUS_REFERENCE_ANGII...,SET,7,0.32835,0.0064071,0.36793,0.18608,KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,0.9088942812983
GSE45365_CD8A_DC_VS_CD11B_DC...1,SET,173,0.057837,0.0055851,0.06481,0.18609,GSE45365_CD8A_DC_VS_CD11B_DC_DN,0.9088942812983
KEGG_MEDICUS_VARIANT_TMPRSS2...,SET,7,0.31212,0.0060903,0.34979,0.18612,KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.9088942812983
WP_16P112_DISTAL_DELETION_SY...,SET,31,0.15013,0.0061606,0.16825,0.18612,WP_16P112_DISTAL_DELETION_SYNDROME,0.9088942812983
REACTOME_CELL_CYCLE_MITOTIC,SET,469,0.033913,0.005348,0.038034,0.18629,REACTOME_CELL_CYCLE_MITOTIC,0.909201709641256
GOBP_TOOTH_MINERALIZATION,SET,28,0.15281,0.0059602,0.17138,0.18629,GOBP_TOOTH_MINERALIZATION,0.909201709641256
HP_ATROPHY_DEGENERATION_INVO...2,SET,34,0.13895,0.0059711,0.15591,0.1864,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.909201709641256
LIU_OVARIAN_CANCER_TUMORS_AN...3,SET,74,0.089254,0.0056522,0.10015,0.18641,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP,0.909201709641256
GOBP_POSITIVE_REGULATION_OF_...373,SET,23,0.16869,0.0059638,0.18927,0.18641,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.909201709641256
GOBP_REGULATION_OF_APOPTOTIC...5,SET,346,0.041379,0.005624,0.046429,0.18641,GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.909201709641256
MIR8078,SET,28,0.14432,0.0056291,0.16194,0.18642,MIR8078,0.909201709641256
GOCC_GINS_COMPLEX,SET,5,0.34698,0.0057225,0.3894,0.18645,GOCC_GINS_COMPLEX,0.909201709641256
GOBP_POSITIVE_REGULATION_OF_...811,SET,18,0.18938,0.005924,0.21254,0.18646,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.909201709641256
MODULE_503,SET,103,0.077104,0.0057561,0.086555,0.18652,MODULE_503,0.909201709641256
GSE6674_ANTI_IGM_VS_ANTI_IGM...2,SET,183,0.055784,0.0055387,0.062623,0.18653,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.909201709641256
DESCARTES_FETAL_INTESTINE_IN...,SET,208,0.055589,0.0058803,0.062419,0.18658,DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS,0.909201709641256
HP_ABNORMAL_MORPHOLOGY_OF_UL...,SET,140,0.066366,0.0057703,0.074523,0.18659,HP_ABNORMAL_MORPHOLOGY_OF_ULNA,0.909201709641256
GOBP_ENDOPLASMIC_RETICULUM_T...4,SET,19,0.16955,0.0054487,0.19039,0.1866,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.909201709641256
GOMF_CHEMOKINE_BINDING,SET,29,0.15947,0.0063296,0.17908,0.18661,GOMF_CHEMOKINE_BINDING,0.909201709641256
GSE44649_NAIVE_VS_ACTIVATED_...4,SET,186,0.056324,0.0056375,0.063256,0.18663,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.909201709641256
HP_MISALIGNMENT_OF_INCISORS,SET,14,0.18508,0.0051062,0.20786,0.18664,HP_MISALIGNMENT_OF_INCISORS,0.909201709641256
MARZEC_IL2_SIGNALING_DN,SET,36,0.1267,0.0056023,0.14233,0.18667,MARZEC_IL2_SIGNALING_DN,0.909201709641256
GSE22432_CONVENTIONAL_CDC_VS...2,SET,181,0.055268,0.0054578,0.062083,0.18668,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP,0.909201709641256
CRX_DN.V1_DN,SET,122,0.072942,0.0059233,0.081952,0.18672,CRX_DN.V1_DN,0.909269104665826
HP_MACULAR_DRUSEN,SET,6,0.36551,0.0066032,0.41071,0.18675,HP_MACULAR_DRUSEN,0.909287790697674
GUTIERREZ_WALDENSTROEMS_MACR...1,SET,8,0.26757,0.0055814,0.3007,0.18678,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN,0.909306471494607
GSE7219_UNSTIM_VS_LPS_AND_AN...4,SET,168,0.058674,0.0055841,0.065965,0.18688,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP,0.909433030345406
GOMF_MANGANESE_ION_BINDING,SET,61,0.099913,0.0057467,0.11233,0.18689,GOMF_MANGANESE_ION_BINDING,0.909433030345406
MATSUMIYA_PBMC_MODIFIED_VACC...6,SET,9,0.25444,0.0056292,0.28609,0.18691,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP,0.909433030345406
GOMF_PHOSPHOSERINE_RESIDUE_B...,SET,10,0.24235,0.0056516,0.27255,0.18696,GOMF_PHOSPHOSERINE_RESIDUE_BINDING,0.909433030345406
REACTOME_NRIF_SIGNALS_CELL_D...,SET,14,0.19704,0.0054363,0.2216,0.18697,REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,0.909433030345406
GOMF_UBIQUITIN_BINDING,SET,94,0.077549,0.005532,0.08723,0.187,GOMF_UBIQUITIN_BINDING,0.909433030345406
HP_SPARSE_OR_ABSENT_EYELASHES,SET,80,0.087552,0.0057639,0.098494,0.18703,HP_SPARSE_OR_ABSENT_EYELASHES,0.909433030345406
PAX4_02,SET,217,0.054679,0.0059064,0.06152,0.18706,PAX4_02,0.909433030345406
REACTOME_MAPK1_ERK2_ACTIVATI...,SET,9,0.28561,0.0063188,0.32135,0.18707,REACTOME_MAPK1_ERK2_ACTIVATION,0.909433030345406
MIR4740_3P,SET,7,0.28641,0.0055886,0.32226,0.18707,MIR4740_3P,0.909433030345406
HP_ABNORMAL_DUODENUM_MORPHOL...,SET,81,0.082041,0.0054345,0.092321,0.1871,HP_ABNORMAL_DUODENUM_MORPHOLOGY,0.909433030345406
KEGG_MEDICUS_REFERENCE_ARL8_...,SET,30,0.13949,0.0056311,0.15698,0.18712,KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.909433030345406
GOBP_POSITIVE_REGULATION_OF_...595,SET,12,0.25,0.006386,0.28148,0.18724,GOBP_POSITIVE_REGULATION_OF_PLATELET_AGGREGATION,0.909824633328677
GSE22601_DOUBLE_NEGATIVE_VS_...5,SET,184,0.052668,0.0052435,0.059315,0.1873,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,0.909824633328677
REACTOME_RHOD_GTPASE_CYCLE,SET,48,0.11547,0.0058934,0.13009,0.18739,REACTOME_RHOD_GTPASE_CYCLE,0.909824633328677
HP_LOSS_OF_CONSCIOUSNESS,SET,23,0.16315,0.005768,0.18382,0.1874,HP_LOSS_OF_CONSCIOUSNESS,0.909824633328677
SASSON_RESPONSE_TO_FORSKOLIN...2,SET,78,0.084689,0.0055056,0.095423,0.18741,SASSON_RESPONSE_TO_FORSKOLIN_UP,0.909824633328677
PBRM1_TARGET_GENES,SET,5,0.39731,0.0065525,0.44766,0.18741,PBRM1_TARGET_GENES,0.909824633328677
HP_DECREASED_CIRCULATING_DEH...,SET,7,0.30255,0.0059036,0.3409,0.18741,HP_DECREASED_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.909824633328677
HP_HYPERECHOGENIC_PANCREAS,SET,4,0.3601,0.005312,0.40574,0.18741,HP_HYPERECHOGENIC_PANCREAS,0.909824633328677
GOBP_GTP_METABOLIC_PROCESS,SET,22,0.16687,0.0057701,0.18808,0.18748,GOBP_GTP_METABOLIC_PROCESS,0.910037346368715
LI_PBMC_MENACTRA_AGE_18_45YO...3,SET,25,0.15736,0.0058,0.17738,0.18751,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.910055865102639
KEGG_MEDICUS_VARIANT_CYP11B1...,SET,31,0.13646,0.0055997,0.15386,0.18758,KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.910060909850913
GOBP_REGULATION_OF_B_CELL_DI...,SET,31,0.13891,0.0057002,0.15664,0.1876,GOBP_REGULATION_OF_B_CELL_DIFFERENTIATION,0.910060909850913
GOBP_NEGATIVE_REGULATION_OF_...248,SET,127,0.065335,0.0054124,0.07369,0.18765,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.910060909850913
HP_OVERRIDING_AORTA,SET,21,0.21948,0.0074149,0.24758,0.18768,HP_OVERRIDING_AORTA,0.910060909850913
GOBP_VENOUS_BLOOD_VESSEL_MOR...,SET,9,0.27684,0.0061248,0.31232,0.18771,GOBP_VENOUS_BLOOD_VESSEL_MORPHOGENESIS,0.910060909850913
GSE9946_IMMATURE_VS_PROSTAGL...1,SET,124,0.068115,0.0055761,0.076851,0.18773,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.910060909850913
GCM_DEAF1,SET,24,0.14153,0.0051111,0.15969,0.18774,GCM_DEAF1,0.910060909850913
GOBP_NEGATIVE_REGULATION_OF_...413,SET,1003,0.025623,0.0058204,0.028911,0.18774,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.910060909850913
REACTOME_TP53_REGULATES_TRAN...4,SET,42,0.11427,0.0054564,0.12896,0.1878,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,0.910060909850913
GOBP_CHONDROBLAST_DIFFERENTI...,SET,4,0.36015,0.0053127,0.40652,0.18783,GOBP_CHONDROBLAST_DIFFERENTIATION,0.910060909850913
GOBP_REGULATION_OF_GLIAL_CEL...3,SET,18,0.19081,0.0059685,0.21539,0.18785,GOBP_REGULATION_OF_GLIAL_CELL_MIGRATION,0.910060909850913
GOBP_REGULATION_OF_ENDOPLASM...2,SET,5,0.29529,0.0048699,0.33334,0.18786,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.910060909850913
GOBP_VESICLE_TARGETING,SET,62,0.086416,0.0050108,0.097554,0.18786,GOBP_VESICLE_TARGETING,0.910060909850913
HP_ABNORMALITY_OF_THE_SPLEEN,SET,557,0.032783,0.0056202,0.037012,0.18788,HP_ABNORMALITY_OF_THE_SPLEEN,0.910060909850913
WP_MINERALOCORTICOID_BIOSYNT...,SET,14,0.24363,0.0067217,0.2751,0.18792,WP_MINERALOCORTICOID_BIOSYNTHESIS,0.910060909850913
GOBP_REGULATION_OF_CYTOKINES...,SET,87,0.080122,0.0054996,0.090474,0.18793,GOBP_REGULATION_OF_CYTOKINESIS,0.910060909850913
GSE17721_LPS_VS_POLYIC_1H_BM...1,SET,180,0.055061,0.0054224,0.062191,0.18799,GSE17721_LPS_VS_POLYIC_1H_BMDC_DN,0.910123277182236
GOCC_SEPTIN_CYTOSKELETON,SET,2,0.46796,0.0048814,0.52861,0.18801,GOCC_SEPTIN_CYTOSKELETON,0.910123277182236
MIR496,SET,95,0.079394,0.0056934,0.089699,0.18805,MIR496,0.910123277182236
GOCC_PHAGOPHORE_ASSEMBLY_SIT...,SET,20,0.16227,0.00535,0.18335,0.18808,GOCC_PHAGOPHORE_ASSEMBLY_SITE_MEMBRANE,0.910123277182236
GSE17974_IL4_AND_ANTI_IL12_V...7,SET,163,0.062291,0.0058403,0.070387,0.18809,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN,0.910123277182236
HP_MEDULLOBLASTOMA,SET,18,0.18469,0.0057772,0.20871,0.1881,HP_MEDULLOBLASTOMA,0.910123277182236
GOMF_PHOSPHATIDYLINOSITOL_3_...14,SET,41,0.11979,0.0056517,0.1354,0.18817,GOMF_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING,0.910148678168916
HP_CEREBRAL_VISUAL_IMPAIRMENT,SET,140,0.063419,0.0055141,0.071688,0.18818,HP_CEREBRAL_VISUAL_IMPAIRMENT,0.910148678168916
GSE17721_LPS_VS_PAM3CSK4_2H_...1,SET,179,0.055479,0.0054486,0.062718,0.1882,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN,0.910148678168916
GSE22601_DOUBLE_NEGATIVE_VS_...1,SET,179,0.0551,0.0054114,0.062294,0.18821,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.910148678168916
HAY_BONE_MARROW_CD34_POS_ERP,SET,8,0.2844,0.0059323,0.32157,0.18825,HAY_BONE_MARROW_CD34_POS_ERP,0.910185540408958
GSE15930_STIM_VS_STIM_AND_IL...5,SET,174,0.05723,0.0055422,0.064716,0.18827,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN,0.910185540408958
IWANAGA_CARCINOGENESIS_BY_KR...4,SET,158,0.061766,0.0057023,0.069868,0.18834,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,0.910397315716273
MIR4253,SET,45,0.1181,0.0058368,0.13364,0.18843,MIR4253,0.910429366402668
GOMF_1_PHOSPHATIDYLINOSITOL_...6,SET,15,0.19726,0.0056332,0.22321,0.18843,GOMF_1_PHOSPHATIDYLINOSITOL_BINDING,0.910429366402668
GOBP_GAMETE_GENERATION,SET,676,0.029044,0.005467,0.032867,0.18844,GOBP_GAMETE_GENERATION,0.910429366402668
KEGG_MEDICUS_VARIANT_MUTATIO...56,SET,24,0.15546,0.0056143,0.17594,0.18846,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.910429366402668
REACTOME_REGULATION_OF_TP53_...4,SET,17,0.19456,0.0059146,0.22023,0.18851,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION,0.910429366402668
GSE45739_NRAS_KO_VS_WT_ACD3_...2,SET,180,0.053545,0.0052732,0.06061,0.18851,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP,0.910429366402668
MIR940,SET,164,0.059232,0.0055704,0.067055,0.18853,MIR940,0.910429366402668
BIOCARTA_CDC25_PATHWAY,SET,9,0.23095,0.0051096,0.26159,0.18865,BIOCARTA_CDC25_PATHWAY,0.910822354166667
GOMF_3_PHOSPHOADENOSINE_5_PH...,SET,9,0.25711,0.0056884,0.29124,0.18867,GOMF_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING,0.910822354166667
DESCARTES_FETAL_CEREBRUM_VAS...,SET,437,0.039574,0.0060295,0.044831,0.18869,DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS,0.910822354166667
GSE3982_EOSINOPHIL_VS_TH2_UP,SET,174,0.056602,0.0054814,0.064143,0.18878,GSE3982_EOSINOPHIL_VS_TH2_UP,0.911130245799195
GOBP_NEGATIVE_REGULATION_OF_...587,SET,1300,0.021799,0.0055889,0.02471,0.18884,GOBP_NEGATIVE_REGULATION_OF_SIGNALING,0.911293279644543
GOBP_PYRIMIDINE_NUCLEOBASE_B...,SET,7,0.27548,0.0053754,0.31231,0.18888,GOBP_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.911359766763848
GOBP_POSITIVE_REGULATION_OF_...624,SET,7,0.295,0.0057562,0.33457,0.18897,GOBP_POSITIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.911499965354767
WAMUNYOKOLI_OVARIAN_CANCER_L...1,SET,173,0.059283,0.0057247,0.067245,0.189,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,0.911499965354767
GOBP_CLEARANCE_OF_FOREIGN_IN...,SET,6,0.4454,0.0080466,0.5053,0.18904,GOBP_CLEARANCE_OF_FOREIGN_INTRACELLULAR_NUCLEIC_ACIDS,0.911499965354767
GSE10147_IL3_VS_IL3_AND_CPG_...1,SET,147,0.059611,0.0053099,0.067626,0.18904,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN,0.911499965354767
GOBP_DIGESTIVE_SYSTEM_PROCESS,SET,102,0.078801,0.0058543,0.089424,0.18911,GOBP_DIGESTIVE_SYSTEM_PROCESS,0.911499965354767
HP_JOINT_CONTRACTURE_OF_THE_...2,SET,14,0.20158,0.0055616,0.22875,0.18911,HP_JOINT_CONTRACTURE_OF_THE_5TH_FINGER,0.911499965354767
GOMF_PHOSPHOPROTEIN_PHOSPHAT...,SET,159,0.057775,0.0053506,0.065569,0.18913,GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.911499965354767
GSE13547_WT_VS_ZFX_KO_BCELL_...3,SET,148,0.060128,0.0053741,0.068246,0.18915,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN,0.911499965354767
HP_DEFECTIVE_DNA_REPAIR_AFTE...,SET,10,0.19463,0.0045388,0.22092,0.18916,HP_DEFECTIVE_DNA_REPAIR_AFTER_ULTRAVIOLET_RADIATION_DAMAGE,0.911499965354767
REACTOME_SARS_COV_1_MODULATE...,SET,32,0.127,0.0052946,0.14416,0.18918,REACTOME_SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,0.911499965354767
chr6q26,SET,6,0.4098,0.0074033,0.46529,0.18924,chr6q26,0.911499965354767
GOBP_CELLULAR_KETONE_METABOL...,SET,198,0.054068,0.0055817,0.06139,0.18924,GOBP_CELLULAR_KETONE_METABOLIC_PROCESS,0.911499965354767
HP_ACUTE_KIDNEY_INJURY,SET,34,0.12657,0.0054391,0.14372,0.18925,HP_ACUTE_KIDNEY_INJURY,0.911499965354767
HP_ABNORMAL_BLEEDING,SET,498,0.034393,0.0055844,0.039062,0.1893,HP_ABNORMAL_BLEEDING,0.911614451988361
GOBP_REGULATION_OF_BONE_REMO...,SET,50,0.11752,0.0061216,0.13351,0.18937,GOBP_REGULATION_OF_BONE_REMODELING,0.911760102599179
GSE34515_CD16_NEG_MONOCYTE_V...2,SET,180,0.057487,0.0056614,0.065316,0.1894,GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP,0.911760102599179
RODWELL_AGING_KIDNEY_NO_BLOO...2,SET,196,0.057395,0.0058955,0.065228,0.18946,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,0.911760102599179
HP_ABNORMAL_FETAL_CENTRAL_NE...,SET,5,0.31334,0.0051677,0.35618,0.1895,HP_ABNORMAL_FETAL_CENTRAL_NERVOUS_SYSTEM_MORPHOLOGY,0.911760102599179
MIR7853_5P,SET,198,0.054538,0.0056303,0.061993,0.18951,MIR7853_5P,0.911760102599179
HALLMARK_DNA_REPAIR,SET,137,0.059253,0.0050968,0.067371,0.18957,HALLMARK_DNA_REPAIR,0.911760102599179
GSE6259_FLT3L_INDUCED_DEC205...4,SET,147,0.058955,0.0052516,0.067047,0.18962,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP,0.911760102599179
GOCC_LAMELLIPODIUM,SET,187,0.05462,0.0054815,0.062128,0.18967,GOCC_LAMELLIPODIUM,0.911760102599179
WP_CONSTITUTIVE_ANDROSTANE_R...,SET,29,0.14702,0.0058355,0.16726,0.18971,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,0.911760102599179
GOBP_POSITIVE_REGULATION_OF_...175,SET,9,0.25414,0.0056225,0.28918,0.18976,GOBP_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.911760102599179
REACTOME_EVASION_BY_RSV_OF_H...,SET,28,0.15781,0.006155,0.17958,0.18977,REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,0.911760102599179
GOBP_POSITIVE_REGULATION_OF_...90,SET,23,0.1778,0.006286,0.20235,0.18979,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.911760102599179
HP_CONGENITAL_HYPOPLASTIC_AN...,SET,4,0.36253,0.0053479,0.41263,0.18982,HP_CONGENITAL_HYPOPLASTIC_ANEMIA,0.911760102599179
KYNG_DNA_DAMAGE_BY_4NQO,SET,33,0.12004,0.0050821,0.13666,0.18988,KYNG_DNA_DAMAGE_BY_4NQO,0.911760102599179
GOBP_SPERMINE_METABOLIC_PROC...,SET,4,0.32631,0.0048136,0.37154,0.1899,GOBP_SPERMINE_METABOLIC_PROCESS,0.911760102599179
SAKAI_TUMOR_INFILTRATING_MON...1,SET,75,0.079223,0.0050506,0.090213,0.18993,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,0.911760102599179
GSE7509_UNSTIM_VS_TNFA_IL1B_...2,SET,175,0.055206,0.0053614,0.062867,0.18994,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,0.911760102599179
GOBP_NEGATIVE_REGULATION_OF_...111,SET,272,0.0444,0.0053615,0.050566,0.18996,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.911760102599179
GOBP_HEMOPOIESIS,SET,880,0.026814,0.0057252,0.03054,0.18999,GOBP_HEMOPOIESIS,0.911760102599179
GOMF_PROTEIN_BINDING_INVOLVE...,SET,12,0.24887,0.0063574,0.28351,0.19003,GOMF_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION,0.911760102599179
HP_ASTROCYTOSIS,SET,21,0.17077,0.0057694,0.19459,0.19008,HP_ASTROCYTOSIS,0.911760102599179
HP_LOW_FRUSTRATION_TOLERANCE,SET,22,0.16229,0.0056118,0.18498,0.19015,HP_LOW_FRUSTRATION_TOLERANCE,0.911760102599179
GOBP_NEGATIVE_REGULATION_OF_...60,SET,7,0.29478,0.005752,0.33602,0.19017,GOBP_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.911760102599179
GOBP_POSITIVE_REGULATION_OF_...128,SET,91,0.08365,0.0058717,0.095351,0.19017,GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION,0.911760102599179
GOBP_T_HELPER_17_TYPE_IMMUNE...,SET,45,0.12044,0.0059525,0.13729,0.19017,GOBP_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.911760102599179
WANG_SMARCE1_TARGETS_UP,SET,259,0.051227,0.0060383,0.058409,0.19024,WANG_SMARCE1_TARGETS_UP,0.911760102599179
GOBP_REGULATION_OF_INSULIN_R...,SET,65,0.090909,0.0053969,0.10368,0.19029,GOBP_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.911760102599179
GSE23695_CD57_POS_VS_NEG_NK_...1,SET,185,0.052537,0.0052445,0.059915,0.19029,GSE23695_CD57_POS_VS_NEG_NK_CELL_DN,0.911760102599179
MIR1179,SET,108,0.071458,0.0054618,0.081509,0.19033,MIR1179,0.911760102599179
GSE46606_DAY1_VS_DAY3_CD40L_...6,SET,176,0.057997,0.0056484,0.066173,0.1904,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP,0.911760102599179
FUJIWARA_PARK2_IN_LIVER_CANC...2,SET,8,0.27623,0.0057619,0.31519,0.19041,FUJIWARA_PARK2_IN_LIVER_CANCER_UP,0.911760102599179
HP_REPETITIVE_COMPULSIVE_BEH...,SET,12,0.24793,0.0063334,0.28291,0.19042,HP_REPETITIVE_COMPULSIVE_BEHAVIOR,0.911760102599179
TSENG_ADIPOGENIC_POTENTIAL_DN,SET,38,0.13376,0.0060761,0.15264,0.19043,TSENG_ADIPOGENIC_POTENTIAL_DN,0.911760102599179
GOMF_ADP_TRANSMEMBRANE_TRANS...,SET,9,0.26577,0.0058799,0.30332,0.19046,GOMF_ADP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.911760102599179
HP_AORTIC_VALVE_CALCIFICATION,SET,8,0.29018,0.006053,0.33118,0.19046,HP_AORTIC_VALVE_CALCIFICATION,0.911760102599179
REACTOME_DOWNREGULATION_OF_E...3,SET,8,0.24937,0.0052017,0.28464,0.1905,REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING,0.911760102599179
DESCARTES_MAIN_FETAL_PHOTORE...,SET,67,0.10093,0.0060828,0.11521,0.19052,DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS,0.911760102599179
GARGALOVIC_RESPONSE_TO_OXIDI...5,SET,13,0.19019,0.0050566,0.21715,0.19056,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,0.911760102599179
REACTOME_RHO_GTPASE_CYCLE,SET,412,0.037213,0.005509,0.042495,0.1906,REACTOME_RHO_GTPASE_CYCLE,0.911760102599179
GOCC_SITE_OF_POLARIZED_GROWTH,SET,153,0.061352,0.0055745,0.070067,0.19063,GOCC_SITE_OF_POLARIZED_GROWTH,0.911760102599179
GSE20198_UNTREATED_VS_IL12_I...1,SET,176,0.053582,0.0052184,0.061205,0.19067,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,0.911760102599179
HP_TRUNCAL_ATAXIA,SET,66,0.09129,0.0054609,0.1043,0.19073,HP_TRUNCAL_ATAXIA,0.911760102599179
HP_SUPERNUMERARY_SPLEENS,SET,81,0.076366,0.0050587,0.087256,0.19074,HP_SUPERNUMERARY_SPLEENS,0.911760102599179
GSE27786_CD8_TCELL_VS_MONO_M...2,SET,171,0.055042,0.0052846,0.062895,0.19075,GSE27786_CD8_TCELL_VS_MONO_MAC_UP,0.911760102599179
EMX1_TARGET_GENES,SET,183,0.055928,0.0055531,0.063913,0.19078,EMX1_TARGET_GENES,0.911760102599179
GSE41867_NAIVE_VS_DAY15_LCMV...2,SET,179,0.052619,0.0051677,0.060134,0.19078,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.911760102599179
REACTOME_RUNX1_REGULATES_GEN...,SET,35,0.13023,0.0056777,0.14884,0.1908,REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,0.911760102599179
HP_ACNE,SET,60,0.096018,0.0054773,0.10974,0.1908,HP_ACNE,0.911760102599179
GSE32128_INOS_DEPENDENT_VS_I...2,SET,186,0.055501,0.0055552,0.063435,0.19081,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP,0.911760102599179
HP_ABNORMAL_HARD_PALATE_MORP...,SET,71,0.088129,0.0054671,0.10074,0.19083,HP_ABNORMAL_HARD_PALATE_MORPHOLOGY,0.911760102599179
HP_HYPERKALEMIA,SET,35,0.12811,0.0055853,0.14643,0.19083,HP_HYPERKALEMIA,0.911760102599179
BIOCARTA_EIF2_PATHWAY,SET,9,0.24896,0.005508,0.28462,0.19088,BIOCARTA_EIF2_PATHWAY,0.911760102599179
DAUER_STAT3_TARGETS_DN,SET,46,0.11662,0.0058269,0.13333,0.1909,DAUER_STAT3_TARGETS_DN,0.911760102599179
ZNF486_TARGET_GENES,SET,160,0.060516,0.0056219,0.069194,0.1909,ZNF486_TARGET_GENES,0.911760102599179
GOCC_TOM_COMPLEX,SET,6,0.27756,0.0050144,0.31737,0.19091,GOCC_TOM_COMPLEX,0.911760102599179
GGCAGTG_MIR3243P,SET,87,0.077577,0.0053249,0.088706,0.19092,GGCAGTG_MIR3243P,0.911760102599179
RATTENBACHER_BOUND_BY_CELF1,SET,365,0.039036,0.0054464,0.04464,0.19094,RATTENBACHER_BOUND_BY_CELF1,0.911760102599179
GOBP_REGULATION_OF_EPITHELIA...4,SET,213,0.05398,0.0057776,0.061739,0.19097,GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.911760102599179
GSE41867_DAY6_VS_DAY15_LCMV_...2,SET,161,0.064633,0.006023,0.073923,0.19097,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.911760102599179
GOCC_PARALLEL_FIBER_TO_PURKI...,SET,17,0.17804,0.0054123,0.20364,0.19099,GOCC_PARALLEL_FIBER_TO_PURKINJE_CELL_SYNAPSE,0.911760102599179
HP_INTRAHEPATIC_BILE_DUCT_DI...,SET,3,0.44223,0.0056497,0.50594,0.19104,HP_INTRAHEPATIC_BILE_DUCT_DILATATION,0.911760102599179
GSE19941_UNSTIM_VS_LPS_STIM_...2,SET,178,0.056954,0.0055779,0.065158,0.19104,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.911760102599179
MIR4751,SET,31,0.13185,0.0054106,0.1509,0.19113,MIR4751,0.911760102599179
GOBP_CAMP_MEDIATED_SIGNALING,SET,53,0.10847,0.0058164,0.12415,0.19115,GOBP_CAMP_MEDIATED_SIGNALING,0.911760102599179
GSE2706_UNSTIM_VS_8H_LPS_AND...1,SET,174,0.059239,0.0057368,0.067813,0.19118,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN,0.911760102599179
GOBP_GRANULOCYTE_COLONY_STIM...2,SET,5,0.30588,0.0050447,0.35021,0.19122,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,0.911760102599179
BIOCARTA_FXR_PATHWAY,SET,7,0.29678,0.005791,0.3398,0.19123,BIOCARTA_FXR_PATHWAY,0.911760102599179
REACTOME_PRE_NOTCH_PROCESSIN...2,SET,6,0.24911,0.0045003,0.28524,0.19125,REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM,0.911760102599179
HP_ABNORMALITY_OF_THE_FIFTH_...,SET,8,0.29532,0.0061602,0.33815,0.19125,HP_ABNORMALITY_OF_THE_FIFTH_METATARSAL_BONE,0.911760102599179
MIR6870_3P,SET,42,0.11241,0.0053675,0.12873,0.19128,MIR6870_3P,0.911760102599179
MIR6768_5P,SET,186,0.056545,0.0056597,0.064765,0.19132,MIR6768_5P,0.911760102599179
HP_DECREASED_CIRCULATING_COM...1,SET,33,0.13747,0.0058198,0.15746,0.19133,HP_DECREASED_CIRCULATING_COMPLEMENT_C3_CONCENTRATION,0.911760102599179
GOBP_POSITIVE_REGULATION_OF_...672,SET,23,0.16523,0.0058415,0.18926,0.19134,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.911760102599179
HP_ABNORMAL_PROTEIN_GLYCOSYL...,SET,39,0.10955,0.0050414,0.1255,0.19135,HP_ABNORMAL_PROTEIN_GLYCOSYLATION,0.911760102599179
WP_AUTOPHAGY,SET,30,0.12961,0.0052321,0.14848,0.19137,WP_AUTOPHAGY,0.911760102599179
HP_POOR_MOTOR_COORDINATION,SET,77,0.087292,0.0056385,0.10002,0.19141,HP_POOR_MOTOR_COORDINATION,0.911760102599179
GOBP_REGULATION_OF_OPSIN_MED...,SET,8,0.24659,0.0051437,0.28257,0.19143,GOBP_REGULATION_OF_OPSIN_MEDIATED_SIGNALING_PATHWAY,0.911760102599179
P53_DECAMER_Q2,SET,233,0.049272,0.0055126,0.056471,0.19147,P53_DECAMER_Q2,0.911760102599179
GOMF_SPHINGOSINE_N_ACYLTRANS...,SET,6,0.32094,0.005798,0.36784,0.19147,GOMF_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY,0.911760102599179
HE_LIM_SUN_FETAL_LUNG_C2_GMP...,SET,33,0.14173,0.0060004,0.16246,0.1915,HE_LIM_SUN_FETAL_LUNG_C2_GMP_CELL,0.911760102599179
HE_LIM_SUN_FETAL_LUNG_C7_TM4...2,SET,107,0.076242,0.0058005,0.087392,0.1915,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.911760102599179
HP_OVERGROWTH_OF_EXTERNAL_GE...,SET,9,0.29784,0.0065895,0.34148,0.19155,HP_OVERGROWTH_OF_EXTERNAL_GENITALIA,0.911760102599179
GSE19941_IL10_KO_VS_IL10_KO_...5,SET,179,0.057188,0.0056164,0.065569,0.19156,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN,0.911760102599179
GOBP_PROTEIN_LOCALIZATION_TO...23,SET,6,0.24822,0.0044843,0.28468,0.19163,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM_EXIT_SITE,0.911760102599179
GOBP_POSITIVE_REGULATION_OF_...221,SET,40,0.11438,0.0053301,0.13119,0.19165,GOBP_POSITIVE_REGULATION_OF_DNA_REPLICATION,0.911760102599179
GSE26030_UNSTIM_VS_RESTIM_TH...1,SET,178,0.055882,0.0054729,0.064097,0.19166,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN,0.911760102599179
GOBP_MUSCLE_CELL_FATE_COMMIT...,SET,16,0.22629,0.006674,0.2596,0.19169,GOBP_MUSCLE_CELL_FATE_COMMITMENT,0.911760102599179
GOBP_RIBOSOMAL_LARGE_SUBUNIT...2,SET,60,0.088976,0.0050756,0.10208,0.19172,GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS,0.911760102599179
GSE22601_DOUBLE_NEGATIVE_VS_...8,SET,172,0.054591,0.0052564,0.062637,0.19173,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP,0.911760102599179
MIR371B_3P,SET,36,0.12848,0.0056808,0.14742,0.19174,MIR371B_3P,0.911760102599179
MCCOLLUM_GELDANAMYCIN_RESIST...1,SET,7,0.30266,0.0059056,0.34729,0.19176,MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN,0.911760102599179
KEGG_MEDICUS_REFERENCE_KERAT...,SET,5,0.3623,0.0059751,0.41577,0.19177,KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION,0.911760102599179
GSE1432_6H_VS_24H_IFNG_MICRO...1,SET,179,0.053401,0.0052445,0.061282,0.19177,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.911760102599179
HP_CHOROIDAL_NEOVASCULARIZAT...,SET,20,0.17834,0.0058798,0.20477,0.19191,HP_CHOROIDAL_NEOVASCULARIZATION,0.911927151051625
REACTOME_SENSORY_PERCEPTION_...2,SET,45,0.13154,0.0065013,0.15105,0.19193,REACTOME_SENSORY_PERCEPTION_OF_TASTE,0.911927151051625
HARALAMBIEVA_PBMC_M_M_R_II_A...1,SET,642,0.031653,0.0058118,0.036349,0.19193,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN,0.911927151051625
GCM_ATM,SET,24,0.14614,0.0052776,0.16784,0.19196,GCM_ATM,0.911927151051625
BIOCARTA_BLYMPHOCYTE_PATHWAY,SET,10,0.27568,0.0064289,0.31664,0.19198,BIOCARTA_BLYMPHOCYTE_PATHWAY,0.911927151051625
HP_ABNORMAL_SPACED_INCISORS,SET,12,0.19843,0.0050688,0.22792,0.19199,HP_ABNORMAL_SPACED_INCISORS,0.911927151051625
HP_AGENESIS_OF_LATERAL_INCIS...,SET,23,0.16835,0.0059518,0.19342,0.19206,HP_AGENESIS_OF_LATERAL_INCISOR,0.911927151051625
MIR6129,SET,170,0.058026,0.005555,0.066672,0.19207,MIR6129,0.911927151051625
GSE5589_WT_VS_IL10_KO_LPS_ST...2,SET,140,0.061223,0.0053232,0.070346,0.19207,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.911927151051625
MIR4727_5P,SET,103,0.074998,0.0055988,0.086175,0.19208,MIR4727_5P,0.911927151051625
MODULE_52,SET,394,0.039264,0.005687,0.045125,0.19212,MODULE_52,0.911927151051625
HE_LIM_SUN_FETAL_LUNG_C3_AER...,SET,84,0.088075,0.0059408,0.10122,0.19212,HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE,0.911927151051625
GOCC_ROUGH_ENDOPLASMIC_RETIC...1,SET,52,0.10019,0.005322,0.11518,0.19218,GOCC_ROUGH_ENDOPLASMIC_RETICULUM,0.911993173456874
KRAS.600_UP.V1_DN,SET,254,0.049662,0.0057979,0.057096,0.19221,KRAS.600_UP.V1_DN,0.911993173456874
WP_ATM_SIGNALING,SET,36,0.11054,0.0048876,0.12711,0.19225,WP_ATM_SIGNALING,0.911993173456874
GSE17721_POLYIC_VS_PAM3CSK4_...6,SET,187,0.054376,0.0054571,0.062534,0.19228,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP,0.911993173456874
GOBP_MORPHOGENESIS_OF_AN_EPI...2,SET,22,0.17632,0.0060968,0.20279,0.1923,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD,0.911993173456874
GOBP_ESTABLISHMENT_OF_PROTEI...11,SET,61,0.093315,0.0053672,0.10733,0.19231,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE,0.911993173456874
HP_GENERALIZED_HYPERPIGMENTA...,SET,37,0.124,0.0055582,0.14268,0.19241,HP_GENERALIZED_HYPERPIGMENTATION,0.911993173456874
GSE37533_UNTREATED_VS_PIOGLI...4,SET,182,0.057402,0.005684,0.066054,0.19242,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.911993173456874
MARTINEZ_RB1_TARGETS_DN,SET,497,0.034047,0.0055228,0.039184,0.19246,MARTINEZ_RB1_TARGETS_DN,0.911993173456874
MIR4689,SET,78,0.084992,0.0055253,0.097826,0.19248,MIR4689,0.911993173456874
BMI1_DN_MEL18_DN.V1_DN,SET,129,0.070267,0.0058663,0.080886,0.19251,BMI1_DN_MEL18_DN.V1_DN,0.911993173456874
BIOCARTA_CSK_PATHWAY,SET,18,0.18396,0.0057544,0.21177,0.19252,BIOCARTA_CSK_PATHWAY,0.911993173456874
GOBP_POSITIVE_REGULATION_OF_...817,SET,92,0.077412,0.0054634,0.089123,0.19254,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.911993173456874
GSE3565_DUSP1_VS_WT_SPLENOCY...3,SET,141,0.061428,0.0053599,0.070728,0.19256,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP,0.911993173456874
GOBP_NUCLEOTIDE_SUGAR_METABO...,SET,34,0.11843,0.0050892,0.13636,0.19257,GOBP_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS,0.911993173456874
HP_OROMOTOR_APRAXIA,SET,24,0.15818,0.0057124,0.18213,0.19257,HP_OROMOTOR_APRAXIA,0.911993173456874
HP_ABNORMAL_PUPILLARY_LIGHT_...,SET,28,0.14505,0.0056573,0.16702,0.19258,HP_ABNORMAL_PUPILLARY_LIGHT_REFLEX,0.911993173456874
GSE17721_LPS_VS_CPG_6H_BMDC_...1,SET,181,0.054984,0.0054298,0.063324,0.19262,GSE17721_LPS_VS_CPG_6H_BMDC_DN,0.912024016282225
CHIARETTI_ACUTE_LYMPHOBLASTI...,SET,63,0.086694,0.0050672,0.099855,0.19265,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,0.912024016282225
GOBP_NUCLEOSIDE_MONOPHOSPHAT...4,SET,11,0.21647,0.0052944,0.2494,0.19271,GOBP_NUCLEOSIDE_MONOPHOSPHATE_PHOSPHORYLATION,0.912024016282225
REACTOME_REGULATION_OF_GLUCO...,SET,30,0.12566,0.0050729,0.14479,0.19273,REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN,0.912024016282225
KEGG_MAPK_SIGNALING_PATHWAY,SET,256,0.048604,0.0056963,0.056005,0.19274,KEGG_MAPK_SIGNALING_PATHWAY,0.912024016282225
PID_IL1_PATHWAY,SET,32,0.12954,0.0054008,0.1493,0.1928,PID_IL1_PATHWAY,0.912024016282225
HP_DILATATION_OF_THE_BLADDER,SET,11,0.24551,0.0060046,0.28298,0.19282,HP_DILATATION_OF_THE_BLADDER,0.912024016282225
GOBP_CELLULAR_RESPONSE_TO_SO...,SET,5,0.31911,0.0052628,0.36787,0.19286,GOBP_CELLULAR_RESPONSE_TO_SODIUM_ARSENITE,0.912024016282225
AP1_Q2,SET,242,0.048994,0.005585,0.056496,0.19292,AP1_Q2,0.912024016282225
REACTOME_REGULATION_OF_CDH11...1,SET,10,0.25075,0.0058475,0.28919,0.19296,REACTOME_REGULATION_OF_CDH11_FUNCTION,0.912024016282225
HP_ATROPHY_DEGENERATION_AFFE...1,SET,36,0.13093,0.0057893,0.15101,0.19296,HP_ATROPHY_DEGENERATION_AFFECTING_THE_BRAINSTEM,0.912024016282225
GOBP_REGULATION_OF_CHEMOKINE...,SET,9,0.24933,0.0055162,0.28764,0.19303,GOBP_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,0.912024016282225
LAKE_ADULT_KIDNEY_C3_PROXIMA...,SET,194,0.057053,0.0058307,0.065826,0.19305,LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2,0.912024016282225
AMIT_SERUM_RESPONSE_60_MCF10A,SET,54,0.11667,0.0063151,0.13463,0.19307,AMIT_SERUM_RESPONSE_60_MCF10A,0.912024016282225
BOYAULT_LIVER_CANCER_SUBCLAS...6,SET,106,0.070216,0.0053172,0.081032,0.19311,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,0.912024016282225
GOCC_CELL_DIVISION_SITE,SET,58,0.097106,0.0054466,0.11206,0.19311,GOCC_CELL_DIVISION_SITE,0.912024016282225
HP_ACHOLIC_STOOLS,SET,8,0.28895,0.0060273,0.33346,0.19311,HP_ACHOLIC_STOOLS,0.912024016282225
WP_SARSCOV2_B117_VARIANT_ANT...,SET,7,0.27357,0.0053381,0.31572,0.19312,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.912024016282225
E2F4DP1_01,SET,209,0.051229,0.005432,0.059139,0.19318,E2F4DP1_01,0.912024016282225
GSE1925_CTRL_VS_3H_IFNG_STIM...1,SET,181,0.056426,0.0055721,0.06515,0.19323,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.912024016282225
REACTOME_TP53_REGULATES_TRAN...7,SET,19,0.17535,0.0056351,0.20247,0.19324,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE,0.912024016282225
VANDESLUIS_COMMD1_TARGETS_GR...3,SET,71,0.088677,0.0055011,0.1024,0.19326,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,0.912024016282225
RAAGNYNNCTTY_UNKNOWN,SET,135,0.068969,0.0058894,0.079653,0.19329,RAAGNYNNCTTY_UNKNOWN,0.912024016282225
FULLER_PBMC_F_TULARENSIS_VAC...6,SET,31,0.14882,0.0061068,0.17187,0.19329,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_DN,0.912024016282225
GSE13411_IGM_MEMORY_BCELL_VS...2,SET,178,0.056967,0.0055792,0.065797,0.19331,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.912024016282225
MORF_GPX4,SET,47,0.10227,0.0051651,0.11812,0.19332,MORF_GPX4,0.912024016282225
GSE21670_STAT3_KO_VS_WT_CD4_...7,SET,180,0.053208,0.0052399,0.061461,0.19333,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP,0.912024016282225
MORF_G22P1,SET,152,0.055256,0.0050043,0.063838,0.19337,MORF_G22P1,0.912024016282225
KEGG_MEDICUS_PATHOGEN_SHIGEL...2,SET,10,0.23841,0.0055597,0.27545,0.19338,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,0.912024016282225
AP1_C,SET,249,0.047067,0.0054414,0.054383,0.19339,AP1_C,0.912024016282225
GCM_MLL,SET,157,0.0545,0.0050157,0.062971,0.1934,GCM_MLL,0.912024016282225
GSE14350_IL2RB_KO_VS_WT_TEFF...2,SET,181,0.054948,0.0054262,0.063497,0.19343,GSE14350_IL2RB_KO_VS_WT_TEFF_UP,0.912041737891738
BERTUCCI_INVASIVE_CARCINOMA_...2,SET,20,0.16014,0.0052799,0.18515,0.19355,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.912277537606722
HUMMERICH_MALIGNANT_SKIN_TUM...1,SET,19,0.16181,0.0052001,0.18711,0.19358,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,0.912277537606722
KOMMAGANI_TP63_GAMMA_TARGETS,SET,9,0.24036,0.0053178,0.27795,0.19359,KOMMAGANI_TP63_GAMMA_TARGETS,0.912277537606722
ZNF418_TARGET_GENES,SET,26,0.1551,0.0058295,0.17935,0.19359,ZNF418_TARGET_GENES,0.912277537606722
WP_SUPPRESSION_OF_HMGB1MEDIA...,SET,8,0.25926,0.005408,0.29984,0.19362,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.912277537606722
GOBP_CENTRAL_NERVOUS_SYSTEM_...2,SET,6,0.32948,0.0059523,0.38109,0.19364,GOBP_CENTRAL_NERVOUS_SYSTEM_MATURATION,0.912277537606722
GOBP_HOMEOSTASIS_OF_NUMBER_O...2,SET,33,0.13401,0.0056735,0.15502,0.19367,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE,0.912277537606722
GOCC_LYSOSOMAL_LUMEN,SET,89,0.081125,0.0056318,0.093852,0.19369,GOCC_LYSOSOMAL_LUMEN,0.912277537606722
AMUNDSON_RESPONSE_TO_ARSENITE,SET,195,0.053127,0.0054434,0.061482,0.19377,AMUNDSON_RESPONSE_TO_ARSENITE,0.912407038341688
GOBP_REGULATION_OF_LIPID_BIO...,SET,162,0.059432,0.0055553,0.068777,0.19377,GOBP_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.912407038341688
GOMF_ENONE_REDUCTASE_ACTIVITY,SET,5,0.34572,0.0057016,0.40022,0.19385,GOMF_ENONE_REDUCTASE_ACTIVITY,0.912536468915075
GSE7218_UNSTIM_VS_ANTIGEN_ST...4,SET,109,0.070313,0.0053989,0.081398,0.19385,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP,0.912536468915075
KEGG_MEDICUS_REFERENCE_P300_...,SET,15,0.17925,0.0051188,0.20756,0.19392,KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S,0.912742361863489
GOMF_O_ACETYLTRANSFERASE_ACT...,SET,9,0.25468,0.0056345,0.29506,0.19403,GOMF_O_ACETYLTRANSFERASE_ACTIVITY,0.91313644549763
GOMF_NUCLEOSOMAL_DNA_BINDING,SET,24,0.15242,0.0055044,0.17661,0.19406,GOMF_NUCLEOSOMAL_DNA_BINDING,0.913153980503656
BIOCARTA_PDZS_PATHWAY,SET,15,0.1894,0.0054089,0.2195,0.19411,BIOCARTA_PDZS_PATHWAY,0.91318903627504
GOBP_NEGATIVE_REGULATION_OF_...570,SET,7,0.23828,0.0046494,0.27615,0.19412,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.91318903627504
GOBP_NEGATIVE_REGULATION_OF_...493,SET,6,0.33727,0.0060931,0.39102,0.1942,GOBP_NEGATIVE_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.913335631173048
MIR10395_5P,SET,66,0.094361,0.0056446,0.1094,0.19421,MIR10395_5P,0.913335631173048
AGCYRWTTC_UNKNOWN,SET,107,0.071666,0.0054524,0.083099,0.19423,AGCYRWTTC_UNKNOWN,0.913335631173048
GOBP_POSITIVE_REGULATION_OF_...844,SET,9,0.2536,0.0056107,0.29416,0.19432,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.913511646151765
GSE7831_UNSTIM_VS_INFLUENZA_...4,SET,186,0.055319,0.005537,0.064166,0.19432,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP,0.913511646151765
GOBP_REGULATION_OF_CLATHRIN_...,SET,16,0.17481,0.0051557,0.20282,0.19438,GOBP_REGULATION_OF_CLATHRIN_DEPENDENT_ENDOCYTOSIS,0.913546572008114
GSE9988_ANTI_TREM1_AND_LPS_V...1,SET,185,0.051662,0.0051572,0.05994,0.19438,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN,0.913546572008114
OVSYANNIKOVA_PBMC_FLUARIX_AG...4,SET,23,0.15931,0.0056322,0.18487,0.19442,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,0.913581478977964
HP_SEVERE_PLATYSPONDYLY,SET,8,0.25928,0.0054084,0.30091,0.19444,HP_SEVERE_PLATYSPONDYLY,0.913581478977964
AATGGAG_MIR136,SET,68,0.08941,0.0054286,0.10378,0.19449,AATGGAG_MIR136,0.913692883211679
GOMF_CYSTEINE_TYPE_EXOPEPTID...,SET,4,0.36534,0.0053892,0.42421,0.19456,GOMF_CYSTEINE_TYPE_EXOPEPTIDASE_ACTIVITY,0.913774702702703
GSE19401_RETINOIC_ACID_VS_RE...2,SET,177,0.057056,0.0055724,0.066248,0.19456,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.913774702702703
chr2q36,SET,34,0.19891,0.0085476,0.23106,0.19467,chr2q36,0.914167794892582
RIZKI_TUMOR_INVASIVENESS_3D_...2,SET,186,0.053862,0.0053911,0.062591,0.19475,RIZKI_TUMOR_INVASIVENESS_3D_UP,0.914242285367171
HP_ABNORMAL_CIRCULATING_ATRI...,SET,8,0.21686,0.0045236,0.252,0.19475,HP_ABNORMAL_CIRCULATING_ATRIAL_NATRIURETIC_PEPTIDE_PRO_HORMONE_CONCENTRATION,0.914242285367171
WP_JOUBERT_SYNDROME,SET,69,0.080775,0.0049401,0.093884,0.1948,WP_JOUBERT_SYNDROME,0.914242285367171
GOBP_MYOTUBE_DIFFERENTIATION,SET,117,0.071674,0.0057006,0.083308,0.1948,GOBP_MYOTUBE_DIFFERENTIATION,0.914242285367171
REACTOME_HYALURONAN_BIOSYNTH...,SET,5,0.34696,0.0057222,0.40331,0.19482,REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT,0.914242285367171
MILI_PSEUDOPODIA_HAPTOTAXIS_...1,SET,632,0.02935,0.0053484,0.034123,0.19486,MILI_PSEUDOPODIA_HAPTOTAXIS_DN,0.914242285367171
WEI_MIR34A_TARGETS,SET,136,0.063081,0.0054064,0.073342,0.19487,WEI_MIR34A_TARGETS,0.914242285367171
GOMF_MANNOSE_BINDING,SET,22,0.16572,0.0057302,0.19276,0.19499,GOMF_MANNOSE_BINDING,0.914330942269409
GSE2405_0H_VS_9H_A_PHAGOCYTO...2,SET,176,0.05505,0.0053614,0.064037,0.19499,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.914330942269409
KEGG_GLYCOSPHINGOLIPID_BIOSY...3,SET,26,0.15496,0.0058244,0.18028,0.19502,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,0.914330942269409
GOBP_REGULATION_OF_GROWTH,SET,527,0.033588,0.0056055,0.039085,0.19508,GOBP_REGULATION_OF_GROWTH,0.914330942269409
DESCARTES_FETAL_MUSCLE_ERYTH...,SET,101,0.0721,0.0053303,0.083915,0.19512,DESCARTES_FETAL_MUSCLE_ERYTHROBLASTS,0.914330942269409
HP_DECREASED_CIRCULATING_FOL...,SET,30,0.13876,0.0056017,0.1615,0.19513,HP_DECREASED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,0.914330942269409
GSE41978_WT_VS_ID2_KO_AND_BI...2,SET,179,0.052013,0.0051081,0.060549,0.19517,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.914330942269409
HP_CRANIOFACIAL_ASYMMETRY,SET,5,0.34855,0.0057484,0.4058,0.1952,HP_CRANIOFACIAL_ASYMMETRY,0.914330942269409
GOBP_NEGATIVE_REGULATION_OF_...690,SET,10,0.25105,0.0058546,0.29234,0.19524,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.914330942269409
GSE41176_WT_VS_TAK1_KO_ANTI_...5,SET,177,0.05578,0.0054477,0.064959,0.19526,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN,0.914330942269409
HP_ABNORMAL_PHAGOCYTOSIS,SET,3,0.44419,0.0056747,0.51733,0.19528,HP_ABNORMAL_PHAGOCYTOSIS,0.914330942269409
PIT1_Q6,SET,202,0.055522,0.0057889,0.064672,0.19531,PIT1_Q6,0.914330942269409
GOCC_N_TERMINAL_PROTEIN_ACET...,SET,9,0.20824,0.0046071,0.24261,0.19536,GOCC_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX,0.914330942269409
REACTOME_ERYTHROPOIETIN_ACTI...4,SET,7,0.35458,0.0069188,0.41319,0.19541,REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5,0.914330942269409
GOMF_MONOCARBOXYLIC_ACID_BIN...,SET,83,0.087862,0.0058913,0.1024,0.19543,GOMF_MONOCARBOXYLIC_ACID_BINDING,0.914330942269409
HP_CUTANEOUS_CYST,SET,21,0.15241,0.0051489,0.17762,0.19544,HP_CUTANEOUS_CYST,0.914330942269409
HP_PROMINENT_CALCANEUS,SET,9,0.24787,0.0054839,0.2889,0.19546,HP_PROMINENT_CALCANEUS,0.914330942269409
HP_ABNORMAL_RECTUM_MORPHOLOGY,SET,124,0.067738,0.0055453,0.078954,0.19547,HP_ABNORMAL_RECTUM_MORPHOLOGY,0.914330942269409
CAO_BLOOD_FLUMIST_AGE_05_14Y...3,SET,7,0.3159,0.0061641,0.36822,0.19548,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_DN,0.914330942269409
HP_ABNORMAL_DERMOEPIDERMAL_J...,SET,12,0.23043,0.0058863,0.26866,0.19553,HP_ABNORMAL_DERMOEPIDERMAL_JUNCTION_MORPHOLOGY,0.914330942269409
LEE_LIVER_CANCER_MYC_TGFA_DN,SET,57,0.10251,0.0057001,0.11954,0.19559,LEE_LIVER_CANCER_MYC_TGFA_DN,0.914330942269409
GSE13547_CTRL_VS_ANTI_IGM_ST...8,SET,139,0.058986,0.0051105,0.068788,0.19559,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP,0.914330942269409
GOBP_NEGATIVE_REGULATION_OF_...58,SET,13,0.24367,0.0064785,0.28417,0.1956,GOBP_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.914330942269409
HP_SALIVARY_GLAND_NEOPLASM,SET,12,0.19656,0.0050209,0.22923,0.1956,HP_SALIVARY_GLAND_NEOPLASM,0.914330942269409
GOBP_RESPONSE_TO_UV_B,SET,19,0.16451,0.0052868,0.19188,0.19563,GOBP_RESPONSE_TO_UV_B,0.914330942269409
REACTOME_CONSTITUTIVE_SIGNAL...2,SET,25,0.14165,0.0052209,0.16524,0.19565,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,0.914330942269409
GSE22611_UNSTIM_VS_6H_MDP_ST...2,SET,177,0.055232,0.0053942,0.064435,0.19568,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.914330942269409
REACTOME_SIGNALING_BY_CSF1_M...,SET,29,0.13793,0.0054748,0.16094,0.19571,REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS,0.914330942269409
HP_INSULIN_RESISTANT_DIABETE...,SET,38,0.12402,0.0056335,0.14471,0.19573,HP_INSULIN_RESISTANT_DIABETES_MELLITUS,0.914330942269409
KYNG_DNA_DAMAGE_BY_UV,SET,51,0.10183,0.005357,0.11885,0.19577,KYNG_DNA_DAMAGE_BY_UV,0.914330942269409
MIR6762_5P,SET,55,0.098995,0.0054075,0.11554,0.19578,MIR6762_5P,0.914330942269409
BENPORATH_NOS_TARGETS,SET,160,0.060877,0.0056555,0.071065,0.19583,BENPORATH_NOS_TARGETS,0.914330942269409
GSE27241_CTRL_VS_DIGOXIN_TRE...2,SET,146,0.060558,0.0053761,0.070707,0.19587,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.914330942269409
GSE37605_C57BL6_VS_NOD_FOXP3...5,SET,149,0.059784,0.0053612,0.069812,0.1959,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN,0.914330942269409
GOBP_SYNAPTIC_VESICLE_LOCALI...,SET,53,0.10133,0.0054338,0.11835,0.19595,GOBP_SYNAPTIC_VESICLE_LOCALIZATION,0.914330942269409
REACTOME_RETROGRADE_NEUROTRO...,SET,14,0.19078,0.0052635,0.22284,0.19597,REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,0.914330942269409
GSE8921_UNSTIM_0H_VS_TLR1_2_...4,SET,171,0.05753,0.0055235,0.067199,0.19597,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP,0.914330942269409
MIR1973,SET,6,0.32202,0.0058176,0.37615,0.19598,MIR1973,0.914330942269409
GOBP_CELL_ACTIVATION,SET,1024,0.024607,0.0056444,0.028746,0.196,GOBP_CELL_ACTIVATION,0.914330942269409
GOBP_NEGATIVE_REGULATION_OF_...202,SET,4,0.41248,0.0060847,0.48204,0.19609,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.914330942269409
HP_ABNORMAL_SALIVARY_GLAND_M...,SET,27,0.1372,0.0052549,0.16034,0.19609,HP_ABNORMAL_SALIVARY_GLAND_MORPHOLOGY,0.914330942269409
GOBP_CELL_CELL_JUNCTION_DISA...,SET,5,0.40757,0.0067218,0.47633,0.1961,GOBP_CELL_CELL_JUNCTION_DISASSEMBLY,0.914330942269409
GOBP_EGG_ACTIVATION,SET,11,0.19971,0.0048845,0.23342,0.19612,GOBP_EGG_ACTIVATION,0.914330942269409
MIR3941,SET,303,0.042232,0.0053777,0.049367,0.19615,MIR3941,0.914330942269409
GAVISH_3CA_MALIGNANT_METAPRO...39,SET,41,0.11314,0.0053377,0.13225,0.19615,GAVISH_3CA_MALIGNANT_METAPROGRAM_9_UNFOLDED_PROTEIN_RESPONSE,0.914330942269409
GSE18804_SPLEEN_MACROPHAGE_V...2,SET,170,0.057709,0.0055246,0.067458,0.19615,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP,0.914330942269409
GOBP_RETINAL_METABOLIC_PROCE...,SET,18,0.18595,0.0058165,0.21741,0.1962,GOBP_RETINAL_METABOLIC_PROCESS,0.914330942269409
REACTOME_SUMOYLATION_OF_CHRO...,SET,52,0.098249,0.0052188,0.11488,0.19621,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,0.914330942269409
GOBP_ENDOTHELIAL_CELL_APOPTO...,SET,55,0.1071,0.0058501,0.12523,0.19622,GOBP_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.914330942269409
GSE17721_POLYIC_VS_PAM3CSK4_...3,SET,182,0.054335,0.0053803,0.063532,0.19622,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN,0.914330942269409
GOBP_POSITIVE_REGULATION_OF_...199,SET,6,0.29026,0.0052437,0.33944,0.19625,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.914330942269409
GOBP_ACINAR_CELL_DIFFERENTIA...,SET,5,0.37089,0.0061168,0.4339,0.19634,GOBP_ACINAR_CELL_DIFFERENTIATION,0.914330942269409
GOMF_CAMP_DEPENDENT_PROTEIN_...3,SET,12,0.21271,0.0054337,0.2489,0.19639,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY,0.914330942269409
GOBP_MITOCHONDRIAL_ELECTRON_...1,SET,16,0.16719,0.004931,0.19566,0.19642,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_CYTOCHROME_C_TO_OXYGEN,0.914330942269409
HP_ABNORMAL_HIP_JOINT_MORPHO...,SET,336,0.039497,0.0052915,0.046236,0.19649,HP_ABNORMAL_HIP_JOINT_MORPHOLOGY,0.914330942269409
GSE41176_UNSTIM_VS_ANTI_IGM_...12,SET,182,0.051236,0.0050734,0.059977,0.19649,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP,0.914330942269409
GSE17301_IFNA2_VS_IFNA2_AND_...1,SET,182,0.056141,0.0055592,0.065729,0.19652,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN,0.914330942269409
REACTOME_CELL_CELL_JUNCTION_...,SET,80,0.092088,0.0060625,0.10782,0.19653,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,0.914330942269409
HP_ABNORMAL_NECK_PHYSIOLOGY,SET,29,0.14194,0.0056338,0.16621,0.19657,HP_ABNORMAL_NECK_PHYSIOLOGY,0.914330942269409
GAVISH_3CA_METAPROGRAM_EPITH...18,SET,47,0.12332,0.0062285,0.14443,0.19659,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_1,0.914330942269409
HP_DECREASED_NUMBER_OF_PERIP...,SET,45,0.11035,0.0054537,0.12923,0.19659,HP_DECREASED_NUMBER_OF_PERIPHERAL_MYELINATED_NERVE_FIBERS,0.914330942269409
KEGG_MEDICUS_ENV_FACTOR_E2_T...1,SET,7,0.30033,0.0058602,0.35173,0.1966,KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.914330942269409
MIR6757_5P,SET,53,0.098851,0.0053008,0.1158,0.19666,MIR6757_5P,0.914330942269409
GOBP_ARGININE_METABOLIC_PROC...,SET,17,0.17866,0.0054313,0.20932,0.19669,GOBP_ARGININE_METABOLIC_PROCESS,0.914330942269409
SCHAEFFER_PROSTATE_DEVELOPME...2,SET,102,0.074707,0.0055501,0.087531,0.1967,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,0.914330942269409
MIR3199,SET,41,0.11401,0.0053791,0.13358,0.1967,MIR3199,0.914330942269409
HP_DECREASED_CIRCULATING_AND...,SET,62,0.097483,0.0056525,0.11423,0.19672,HP_DECREASED_CIRCULATING_ANDROGEN_CONCENTRATION,0.914330942269409
GCM_PFN1,SET,44,0.10642,0.0052011,0.12471,0.19673,GCM_PFN1,0.914330942269409
MODULE_201,SET,48,0.10563,0.0053913,0.12378,0.19674,MODULE_201,0.914330942269409
GSE7219_UNSTIM_VS_LPS_AND_AN...3,SET,185,0.05582,0.0055723,0.06542,0.19677,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN,0.914330942269409
SPIELMAN_LYMPHOBLAST_EUROPEA...3,SET,545,0.030692,0.0052065,0.035976,0.1968,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN,0.914330942269409
REACTOME_FORMATION_OF_THE_NE...,SET,17,0.19899,0.0060492,0.23331,0.19686,REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT,0.914330942269409
HP_ABNORMALITY_OF_THE_EPIPHY...2,SET,6,0.32034,0.0057872,0.37567,0.19691,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_FEET,0.914330942269409
MODULE_106,SET,14,0.21328,0.0058845,0.25016,0.19695,MODULE_106,0.914330942269409
HP_SUPRAVALVULAR_AORTIC_STEN...,SET,26,0.19138,0.0071932,0.22457,0.19706,HP_SUPRAVALVULAR_AORTIC_STENOSIS,0.914330942269409
GSE17721_POLYIC_VS_PAM3CSK4_...1,SET,185,0.053039,0.0052947,0.062245,0.19708,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN,0.914330942269409
REACTOME_HEME_BIOSYNTHESIS,SET,13,0.1958,0.0052056,0.22978,0.19709,REACTOME_HEME_BIOSYNTHESIS,0.914330942269409
HP_BROAD_METATARSAL,SET,12,0.21699,0.0055428,0.25467,0.19711,HP_BROAD_METATARSAL,0.914330942269409
HP_POOR_COORDINATION,SET,32,0.12928,0.00539,0.15177,0.19715,HP_POOR_COORDINATION,0.914330942269409
CAFFAREL_RESPONSE_TO_THC_24H...4,SET,29,0.12969,0.0051477,0.15228,0.19721,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,0.914330942269409
GROSS_ELK3_TARGETS_UP,SET,25,0.15477,0.0057046,0.18173,0.19721,GROSS_ELK3_TARGETS_UP,0.914330942269409
HE_LIM_SUN_FETAL_LUNG_C4_T_A...,SET,66,0.092703,0.0055455,0.10886,0.19723,HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL,0.914330942269409
WP_FGF23_SIGNALING_IN_HYPOPH...,SET,22,0.16923,0.0058518,0.19874,0.19724,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,0.914330942269409
TONKS_TARGETS_OF_RUNX1_RUNX1...8,SET,192,0.053583,0.0054481,0.062938,0.19729,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,0.914330942269409
MIR185_3P,SET,138,0.063624,0.0054925,0.074745,0.19733,MIR185_3P,0.914330942269409
TRAVAGLINI_LUNG_ADVENTITIAL_...,SET,279,0.048013,0.0058707,0.056409,0.19735,TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL,0.914330942269409
MIR4636,SET,3,0.64779,0.0082758,0.76124,0.1974,MIR4636,0.914330942269409
GSE22432_MULTIPOTENT_PROGENI...4,SET,187,0.052559,0.0052747,0.061769,0.19742,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP,0.914330942269409
WP_ALSTROM_SYNDROME,SET,30,0.13429,0.0054215,0.15787,0.19748,WP_ALSTROM_SYNDROME,0.914330942269409
GSE2826_XID_VS_BTK_KO_BCELL_...2,SET,187,0.053936,0.0054129,0.063405,0.19748,GSE2826_XID_VS_BTK_KO_BCELL_UP,0.914330942269409
HADDAD_B_LYMPHOCYTE_PROGENIT...,SET,248,0.048915,0.0056438,0.057507,0.1975,HADDAD_B_LYMPHOCYTE_PROGENITOR,0.914330942269409
KYNG_RESPONSE_TO_H2O2,SET,64,0.089801,0.0052901,0.10558,0.19751,KYNG_RESPONSE_TO_H2O2,0.914330942269409
GSE16385_IFNG_TNF_VS_UNSTIM_...2,SET,154,0.057339,0.0052268,0.067414,0.19751,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,0.914330942269409
XIE_ST_HSC_S1PR3_OE_DN,SET,23,0.16716,0.0059098,0.19653,0.19752,XIE_ST_HSC_S1PR3_OE_DN,0.914330942269409
GOBP_POSITIVE_REGULATION_OF_...756,SET,5,0.32645,0.0053839,0.38383,0.19753,GOBP_POSITIVE_REGULATION_OF_THYROID_HORMONE_GENERATION,0.914330942269409
GSE45382_UNTREATED_VS_TGFB_T...1,SET,167,0.055549,0.0052711,0.065326,0.19758,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN,0.914330942269409
HP_SKIN_RASH,SET,148,0.062646,0.0055992,0.073678,0.19759,HP_SKIN_RASH,0.914330942269409
HP_APHASIA,SET,71,0.090831,0.0056347,0.10685,0.19764,HP_APHASIA,0.914330942269409
GOMF_SOMATOSTATIN_RECEPTOR_A...,SET,5,0.31578,0.0052078,0.37151,0.19768,GOMF_SOMATOSTATIN_RECEPTOR_ACTIVITY,0.914330942269409
GSE9601_NFKB_INHIBITOR_VS_PI...1,SET,185,0.057177,0.0057077,0.06727,0.19768,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.914330942269409
HP_DEEP_PHILTRUM,SET,63,0.090694,0.005301,0.10672,0.19772,HP_DEEP_PHILTRUM,0.914330942269409
FARMER_BREAST_CANCER_CLUSTER...8,SET,7,0.31377,0.0061225,0.36923,0.19773,FARMER_BREAST_CANCER_CLUSTER_8,0.914330942269409
GSE22589_HIV_VS_HIV_AND_SIV_...2,SET,181,0.053461,0.0052793,0.062914,0.19774,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP,0.914330942269409
MIR7158_5P,SET,63,0.091237,0.0053327,0.10737,0.19775,MIR7158_5P,0.914330942269409
MENON_FETAL_KIDNEY_6_COLLECT...,SET,84,0.085152,0.0057437,0.10022,0.19776,MENON_FETAL_KIDNEY_6_COLLECTING_DUCT_CELLS,0.914330942269409
GSE1460_CD4_THYMOCYTE_VS_THY...1,SET,174,0.056817,0.0055022,0.066871,0.19777,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.914330942269409
MIR4648,SET,37,0.11449,0.0051318,0.13475,0.19778,MIR4648,0.914330942269409
GOBP_INNER_CELL_MASS_CELL_PR...,SET,14,0.17965,0.0049566,0.21148,0.19781,GOBP_INNER_CELL_MASS_CELL_PROLIFERATION,0.914330942269409
HP_RECURRENT_SPONTANEOUS_ABO...,SET,11,0.22736,0.0055608,0.26766,0.19782,HP_RECURRENT_SPONTANEOUS_ABORTION,0.914330942269409
GOCC_JUNCTIONAL_SARCOPLASMIC...,SET,9,0.27753,0.0061401,0.32674,0.19783,GOCC_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE,0.914330942269409
HP_CHOROID_PLEXUS_CARCINOMA,SET,5,0.38586,0.0063637,0.45429,0.19784,HP_CHOROID_PLEXUS_CARCINOMA,0.914330942269409
HP_ABNORMAL_ESOPHAGUS_MORPHO...,SET,207,0.052476,0.0055378,0.061783,0.19785,HP_ABNORMAL_ESOPHAGUS_MORPHOLOGY,0.914330942269409
NIKOLSKY_BREAST_CANCER_7Q21_...,SET,72,0.15258,0.0095313,0.17969,0.19792,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,0.914330942269409
REACTOME_RESPIRATORY_SYNCYTI...2,SET,21,0.16813,0.00568,0.19804,0.19796,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY,0.914330942269409
GOMF_GENERAL_TRANSCRIPTION_I...1,SET,46,0.093016,0.0046477,0.10958,0.198,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.914330942269409
REACTOME_ACTIVATION_OF_IRF3_...,SET,17,0.17144,0.0052116,0.20198,0.19801,REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE,0.914330942269409
MORF_RFC1,SET,99,0.070785,0.0051813,0.083407,0.19804,MORF_RFC1,0.914330942269409
GOBP_FAT_SOLUBLE_VITAMIN_CAT...,SET,12,0.23762,0.00607,0.28,0.19804,GOBP_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS,0.914330942269409
MIR6781_3P,SET,72,0.085178,0.005321,0.10039,0.19809,MIR6781_3P,0.914330942269409
MIR6752_3P,SET,131,0.061765,0.0051961,0.072796,0.1981,MIR6752_3P,0.914330942269409
GOMF_PHOSPHATIDATE_PHOSPHATA...,SET,3,0.41022,0.0052407,0.48349,0.1981,GOMF_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY,0.914330942269409
GOBP_NAIL_DEVELOPMENT,SET,11,0.24543,0.0060027,0.28931,0.19813,GOBP_NAIL_DEVELOPMENT,0.914330942269409
HP_MALIGNANT_GENITOURINARY_T...,SET,33,0.11739,0.0049699,0.13838,0.19814,HP_MALIGNANT_GENITOURINARY_TRACT_TUMOR,0.914330942269409
GRATIAS_RETINOBLASTOMA_16Q24,SET,17,0.21483,0.0065309,0.25329,0.19818,GRATIAS_RETINOBLASTOMA_16Q24,0.914330942269409
ATF6_TARGET_GENES,SET,865,0.024902,0.0052738,0.029365,0.19822,ATF6_TARGET_GENES,0.914330942269409
MIR342_3P,SET,111,0.068715,0.0053241,0.081034,0.19823,MIR342_3P,0.914330942269409
GSE14769_UNSTIM_VS_60MIN_LPS...2,SET,180,0.052044,0.0051253,0.061375,0.19823,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP,0.914330942269409
WP_METABOLIC_PATHWAYS_OF_FIB...,SET,32,0.12368,0.0051562,0.14591,0.19834,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,0.914491225626741
GOBP_PHOTORECEPTOR_CELL_MAIN...,SET,43,0.11563,0.0055865,0.13643,0.19835,GOBP_PHOTORECEPTOR_CELL_MAINTENANCE,0.914491225626741
BOYAULT_LIVER_CANCER_SUBCLAS...11,SET,177,0.053003,0.0051765,0.062538,0.19836,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,0.914491225626741
GSE2770_UNTREATED_VS_TGFB_AN...10,SET,131,0.065084,0.0054753,0.076797,0.19837,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.914491225626741
GOBP_PLATELET_ACTIVATION,SET,131,0.06809,0.0057281,0.080366,0.19843,GOBP_PLATELET_ACTIVATION,0.91464650530504
WP_GASTRIN_SIGNALING,SET,113,0.070845,0.0055381,0.083684,0.19862,WP_GASTRIN_SIGNALING,0.914800758675287
GAVISH_3CA_METAPROGRAM_FIBRO...16,SET,46,0.116,0.0057962,0.13703,0.19863,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE,0.914800758675287
HP_RETINOSCHISIS,SET,7,0.3389,0.0066129,0.40036,0.19864,HP_RETINOSCHISIS,0.914800758675287
KEGG_MEDICUS_REFERENCE_CA2_E...2,SET,5,0.32365,0.0053377,0.38247,0.19872,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_STORE_OPERATED_CA2_CHANNEL,0.914800758675287
MIR3688_3P,SET,368,0.038798,0.0054349,0.045853,0.19875,MIR3688_3P,0.914800758675287
GOBP_REGULATION_BY_VIRUS_OF_...,SET,7,0.25598,0.0049949,0.30261,0.1988,GOBP_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL,0.914800758675287
GOMF_PHOSPHATASE_ACTIVITY,SET,231,0.046111,0.005137,0.054511,0.19881,GOMF_PHOSPHATASE_ACTIVITY,0.914800758675287
MIKHAYLOVA_OXIDATIVE_STRESS_...2,SET,6,0.26492,0.004786,0.31319,0.19882,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP,0.914800758675287
GNF2_NPM1,SET,65,0.081392,0.0048319,0.096222,0.19882,GNF2_NPM1,0.914800758675287
GOCC_CIS_GOLGI_NETWORK,SET,56,0.088757,0.004892,0.10493,0.19883,GOCC_CIS_GOLGI_NETWORK,0.914800758675287
REACTOME_ESR_MEDIATED_SIGNAL...,SET,157,0.059089,0.0054381,0.069871,0.19887,REACTOME_ESR_MEDIATED_SIGNALING,0.914800758675287
GOBP_NEGATIVE_REGULATION_OF_...678,SET,65,0.09853,0.0058493,0.11652,0.19889,GOBP_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.914800758675287
GOBP_NEGATIVE_REGULATION_OF_...71,SET,8,0.25204,0.0052573,0.29809,0.19892,GOBP_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.914800758675287
GOBP_MEMBRANE_REPOLARIZATION...2,SET,5,0.36073,0.0059493,0.42668,0.19893,GOBP_MEMBRANE_REPOLARIZATION_DURING_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.914800758675287
GOMF_RS_DOMAIN_BINDING,SET,4,0.3074,0.0045346,0.36364,0.19897,GOMF_RS_DOMAIN_BINDING,0.914800758675287
REACTOME_SARS_COV_2_HOST_INT...,SET,179,0.053538,0.005258,0.063337,0.19898,REACTOME_SARS_COV_2_HOST_INTERACTIONS,0.914800758675287
HP_ABNORMAL_HEAD_BLOOD_VESSE...,SET,64,0.1026,0.0060442,0.12138,0.19898,HP_ABNORMAL_HEAD_BLOOD_VESSEL_MORPHOLOGY,0.914800758675287
HOEK_B_CELL_2011_2012_TIV_AD...3,SET,30,0.13377,0.0054002,0.1583,0.19905,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_UP,0.914800758675287
KEGG_PROTEIN_EXPORT,SET,22,0.14511,0.0050176,0.17173,0.19907,KEGG_PROTEIN_EXPORT,0.914800758675287
NR0B1_TARGET_GENES,SET,278,0.044627,0.005447,0.052818,0.19908,NR0B1_TARGET_GENES,0.914800758675287
RICKMAN_TUMOR_DIFFERENTIATED...1,SET,15,0.18757,0.0053565,0.22201,0.19909,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN,0.914800758675287
MIR650,SET,108,0.07044,0.0053839,0.083378,0.19911,MIR650,0.914800758675287
chr16p11,SET,88,0.15152,0.01046,0.17937,0.19914,chr16p11,0.914800758675287
RAO_BOUND_BY_SALL4_ISOFORM_A,SET,166,0.057799,0.0054683,0.068437,0.19918,RAO_BOUND_BY_SALL4_ISOFORM_A,0.914800758675287
MIR325,SET,28,0.13397,0.0052251,0.15865,0.19923,MIR325,0.914800758675287
GOBP_CELLULAR_RESPONSE_TO_GL...3,SET,43,0.10833,0.0052339,0.12829,0.19923,GOBP_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION,0.914800758675287
GOBP_TRIPEPTIDE_TRANSPORT,SET,11,0.23599,0.0057719,0.27948,0.19923,GOBP_TRIPEPTIDE_TRANSPORT,0.914800758675287
GOMF_OXYGEN_CARRIER_ACTIVITY,SET,10,0.28162,0.0065675,0.33354,0.19924,GOMF_OXYGEN_CARRIER_ACTIVITY,0.914800758675287
WP_METABOLISM_OF_SPHINGOLIPI...,SET,21,0.16677,0.0056342,0.19752,0.19926,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.914800758675287
MIR645,SET,35,0.11921,0.0051972,0.1412,0.19927,MIR645,0.914800758675287
TGGAAA_NFAT_Q4_01,SET,1694,0.019118,0.0055304,0.022649,0.19931,TGGAAA_NFAT_Q4_01,0.914800758675287
GSE13411_SWITCHED_MEMORY_BCE...1,SET,160,0.058308,0.0054167,0.069082,0.19933,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN,0.914800758675287
MIR6845_3P,SET,124,0.066476,0.005442,0.078774,0.19937,MIR6845_3P,0.914800758675287
GOBP_ADIPONECTIN_ACTIVATED_S...,SET,7,0.27179,0.0053033,0.32211,0.1994,GOBP_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY,0.914800758675287
GSE29164_DAY3_VS_DAY7_UNTREA...1,SET,175,0.055812,0.0054202,0.066149,0.19942,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN,0.914800758675287
GSE17721_CTRL_VS_GARDIQUIMOD...11,SET,180,0.054044,0.0053222,0.064061,0.19944,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN,0.914800758675287
GSE27896_HDAC6_KO_VS_WT_TREG...1,SET,150,0.058076,0.0052253,0.068846,0.19946,GSE27896_HDAC6_KO_VS_WT_TREG_DN,0.914800758675287
HP_EMOTIONAL_LABILITY,SET,154,0.05845,0.005328,0.069293,0.19948,HP_EMOTIONAL_LABILITY,0.914800758675287
WANG_BARRETTS_ESOPHAGUS_AND_...1,SET,33,0.12773,0.0054076,0.15143,0.19949,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,0.914800758675287
GOBP_REGULATION_OF_LYSOSOMAL...,SET,27,0.1334,0.0051095,0.1582,0.19956,GOBP_REGULATION_OF_LYSOSOMAL_LUMEN_PH,0.915001029023747
GOBP_PROTEIN_LOCALIZATION_TO...3,SET,7,0.28506,0.0055624,0.33823,0.19968,GOBP_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE,0.91530973357953
HP_INCREASED_LEFT_VENTRICULA...,SET,21,0.15695,0.0053024,0.18622,0.19968,HP_INCREASED_LEFT_VENTRICULAR_END_DIASTOLIC_VOLUME,0.91530973357953
GHANDHI_DIRECT_IRRADIATION_UP,SET,98,0.080405,0.0058558,0.095434,0.19976,GHANDHI_DIRECT_IRRADIATION_UP,0.915555690360016
GOBP_PROTEIN_DNA_COMPLEX_ORG...,SET,725,0.025935,0.0050486,0.030792,0.19982,GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION,0.915562184542587
REACTOME_BICARBONATE_TRANSPO...,SET,10,0.22246,0.0051879,0.26423,0.19992,REACTOME_BICARBONATE_TRANSPORTERS,0.915562184542587
GSE13547_CTRL_VS_ANTI_IGM_ST...3,SET,149,0.059588,0.0053436,0.070787,0.19996,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN,0.915562184542587
GOBP_LABYRINTHINE_LAYER_DEVE...,SET,42,0.11608,0.0055428,0.13792,0.2,GOBP_LABYRINTHINE_LAYER_DEVELOPMENT,0.915562184542587
GSE17974_IL4_AND_ANTI_IL12_V...14,SET,164,0.054198,0.0050969,0.064397,0.20001,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP,0.915562184542587
VERRECCHIA_RESPONSE_TO_TGFB1...4,SET,11,0.23803,0.0058216,0.28285,0.20003,VERRECCHIA_RESPONSE_TO_TGFB1_C4,0.915562184542587
GOCC_NUCLEOLAR_EXOSOME_RNASE...,SET,9,0.22473,0.0049719,0.26706,0.20004,GOCC_NUCLEOLAR_EXOSOME_RNASE_COMPLEX,0.915562184542587
HP_LACTICACIDURIA,SET,20,0.16039,0.0052881,0.19061,0.20006,HP_LACTICACIDURIA,0.915562184542587
REACTOME_NUCLEAR_ENVELOPE_BR...,SET,50,0.095657,0.0049826,0.11369,0.20008,REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,0.915562184542587
WP_GLUCOCORTICOID_BIOSYNTHES...,SET,14,0.22373,0.0061727,0.26599,0.20015,WP_GLUCOCORTICOID_BIOSYNTHESIS,0.915562184542587
GOBP_POSITIVE_REGULATION_OF_...674,SET,85,0.081367,0.0055208,0.096742,0.20016,GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.915562184542587
MIR186_3P,SET,131,0.062566,0.0052635,0.074407,0.20022,MIR186_3P,0.915562184542587
GSE17721_CTRL_VS_LPS_4H_BMDC...2,SET,185,0.051512,0.0051422,0.061261,0.20022,GSE17721_CTRL_VS_LPS_4H_BMDC_UP,0.915562184542587
GSE19923_WT_VS_HEB_AND_E2A_K...1,SET,186,0.053709,0.0053758,0.063875,0.20022,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.915562184542587
HP_ACUTE_LEUKEMIA,SET,110,0.068794,0.0053063,0.081827,0.20026,HP_ACUTE_LEUKEMIA,0.915562184542587
GOBP_ACUTE_PHASE_RESPONSE,SET,44,0.12349,0.006035,0.14693,0.20033,GOBP_ACUTE_PHASE_RESPONSE,0.915562184542587
HP_ABNORMAL_LIMB_EPIPHYSIS_M...,SET,120,0.066748,0.005376,0.079419,0.20033,HP_ABNORMAL_LIMB_EPIPHYSIS_MORPHOLOGY,0.915562184542587
HP_MOTOR_NEURON_ATROPHY,SET,61,0.089033,0.0051209,0.10593,0.20033,HP_MOTOR_NEURON_ATROPHY,0.915562184542587
MISSIAGLIA_REGULATED_BY_METH...2,SET,109,0.071899,0.0055207,0.085552,0.20034,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,0.915562184542587
VERRECCHIA_DELAYED_RESPONSE_...,SET,36,0.12739,0.0056326,0.15157,0.20034,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,0.915562184542587
MIR3126_3P,SET,43,0.10999,0.0053143,0.13088,0.20035,MIR3126_3P,0.915562184542587
BOYAULT_LIVER_CANCER_SUBCLAS...3,SET,14,0.22244,0.0061372,0.26474,0.2004,BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN,0.915562184542587
NGFIC_01,SET,224,0.047878,0.0052535,0.056982,0.2004,NGFIC_01,0.915562184542587
GSE22140_HEALTHY_VS_ARTHRITI...2,SET,175,0.05192,0.0050423,0.061793,0.2004,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP,0.915562184542587
HP_OVERFRIENDLINESS,SET,23,0.20362,0.0071988,0.24236,0.20042,HP_OVERFRIENDLINESS,0.915562184542587
ACEVEDO_LIVER_CANCER_WITH_H3...4,SET,111,0.074066,0.0057387,0.088192,0.20051,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,0.915852943882245
GOBP_CELLULAR_RESPONSE_TO_AL...2,SET,16,0.19064,0.0056225,0.2271,0.20061,GOBP_CELLULAR_RESPONSE_TO_ALDEHYDE,0.916189296977661
GOBP_SKIN_DEVELOPMENT,SET,301,0.046753,0.0059342,0.055707,0.20066,GOBP_SKIN_DEVELOPMENT,0.916297240835633
LEE_AGING_NEOCORTEX_UP,SET,72,0.08658,0.0054086,0.10321,0.20078,LEE_AGING_NEOCORTEX_UP,0.916380193014706
GSE1460_NAIVE_CD4_TCELL_ADUL...1,SET,182,0.05356,0.0053036,0.06385,0.20078,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.916380193014706
GAUSSMANN_MLL_AF4_FUSION_TAR...7,SET,10,0.23563,0.005495,0.28091,0.20079,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN,0.916380193014706
GSE41867_NAIVE_VS_DAY6_LCMV_...1,SET,187,0.05357,0.0053762,0.063862,0.20079,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.916380193014706
GOBP_LOW_DENSITY_LIPOPROTEIN...3,SET,6,0.32217,0.0058202,0.38411,0.20081,GOBP_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_PARTICLE_METABOLIC_PROCESS,0.916380193014706
REACTOME_SCAVENGING_BY_CLASS...3,SET,6,0.30041,0.005427,0.3583,0.20091,REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS,0.916595832239433
GOBP_METENCEPHALON_DEVELOPME...,SET,101,0.073311,0.0054198,0.08744,0.20091,GOBP_METENCEPHALON_DEVELOPMENT,0.916595832239433
MORF_PRDX3,SET,72,0.079863,0.004989,0.095298,0.20101,MORF_PRDX3,0.916632920110193
GOBP_REGULATION_OF_ACYL_COA_...,SET,4,0.39714,0.0058584,0.47389,0.20101,GOBP_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS,0.916632920110193
HP_ABNORMAL_NONVERBAL_COMMUN...,SET,89,0.072881,0.0050595,0.086966,0.20101,HP_ABNORMAL_NONVERBAL_COMMUNICATIVE_BEHAVIOR,0.916632920110193
KORKOLA_EMBRYONIC_CARCINOMA_...2,SET,16,0.18101,0.0053386,0.21604,0.20105,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,0.916632920110193
MIR125A_3P,SET,68,0.087041,0.0052848,0.10388,0.20105,MIR125A_3P,0.916632920110193
HP_GLUCOSE_INTOLERANCE,SET,421,0.03588,0.0053679,0.042833,0.20112,HP_GLUCOSE_INTOLERANCE,0.916640379581152
GOBP_ENDOSOME_TRANSPORT_VIA_...,SET,39,0.10677,0.0049134,0.12748,0.20114,GOBP_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.916640379581152
PID_ERBB1_INTERNALIZATION_PA...,SET,40,0.10902,0.0050804,0.13018,0.20118,PID_ERBB1_INTERNALIZATION_PATHWAY,0.916640379581152
HP_ABNORMAL_LDL_CHOLESTEROL_...,SET,42,0.11557,0.0055184,0.13802,0.2012,HP_ABNORMAL_LDL_CHOLESTEROL_CONCENTRATION,0.916640379581152
HP_KETOTIC_HYPOGLYCEMIA,SET,12,0.21803,0.0055695,0.26038,0.2012,HP_KETOTIC_HYPOGLYCEMIA,0.916640379581152
DESCARTES_FETAL_LUNG_NEUROEN...,SET,76,0.090972,0.005838,0.10867,0.20127,DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS,0.916640379581152
HP_ABNORMALLY_LOW_T_CELL_REC...,SET,6,0.3288,0.0059401,0.39282,0.20129,HP_ABNORMALLY_LOW_T_CELL_RECEPTOR_EXCISION_CIRCLE_LEVEL,0.916640379581152
HP_11_PAIRS_OF_RIBS,SET,44,0.10781,0.0052688,0.12883,0.20135,HP_11_PAIRS_OF_RIBS,0.916640379581152
GSE12003_MIR223_KO_VS_WT_BM_...4,SET,105,0.07032,0.0053001,0.084032,0.20135,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP,0.916640379581152
GOBP_MONOCYTE_CHEMOTAXIS,SET,47,0.11136,0.0056245,0.13309,0.20136,GOBP_MONOCYTE_CHEMOTAXIS,0.916640379581152
HP_PROGRESSIVE_CEREBELLAR_AT...,SET,57,0.090608,0.0050383,0.10828,0.20136,HP_PROGRESSIVE_CEREBELLAR_ATAXIA,0.916640379581152
GSE37416_CTRL_VS_0H_F_TULARE...2,SET,149,0.057388,0.0051464,0.068583,0.20137,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.916640379581152
HP_ABDOMINAL_COLIC,SET,5,0.36566,0.0060305,0.43705,0.2014,HP_ABDOMINAL_COLIC,0.916640379581152
GSE2770_UNTREATED_VS_TGFB_AN...6,SET,176,0.050784,0.0049459,0.060713,0.20145,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.916640379581152
GOCC_SYNAPSE_ASSOCIATED_EXTR...,SET,12,0.20942,0.0053496,0.25038,0.20146,GOCC_SYNAPSE_ASSOCIATED_EXTRACELLULAR_MATRIX,0.916640379581152
GGCGGCA_MIR371,SET,5,0.29286,0.0048298,0.35018,0.2015,GGCGGCA_MIR371,0.916640379581152
HP_PAPILLEDEMA,SET,26,0.14375,0.0054029,0.17188,0.2015,HP_PAPILLEDEMA,0.916640379581152
HP_PUNDING,SET,6,0.34079,0.0061567,0.40763,0.20157,HP_PUNDING,0.916824657534246
GOBP_DNA_REPLICATION_CHECKPO...,SET,20,0.1434,0.004728,0.17158,0.20165,GOBP_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.916824657534246
EBAUER_MYOGENIC_TARGETS_OF_P...,SET,43,0.10989,0.0053095,0.13149,0.20166,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,0.916824657534246
GOBP_PYRIMIDINE_NUCLEOSIDE_D...2,SET,9,0.23186,0.0051296,0.27743,0.20166,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.916824657534246
REACTOME_REGULATION_OF_FZD_B...,SET,20,0.17318,0.0057099,0.20729,0.20174,REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION,0.916824657534246
MODULE_433,SET,59,0.10575,0.0059821,0.1266,0.20178,MODULE_433,0.916824657534246
MIR133A_5P,SET,122,0.063049,0.0051199,0.075499,0.20184,MIR133A_5P,0.916824657534246
MEISSNER_BRAIN_HCP_WITH_H3K2...,SET,253,0.050133,0.0058415,0.060035,0.20185,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,0.916824657534246
WP_SRF_AND_MIRS_IN_SMOOTH_MU...,SET,10,0.25629,0.0059768,0.30698,0.2019,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,0.916824657534246
WP_FAMILIAL_HYPERLIPIDEMIA_T...3,SET,13,0.21533,0.0057249,0.25792,0.20191,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,0.916824657534246
GOMF_HISTONE_CHAPERONE_ACTIV...,SET,12,0.19452,0.004969,0.23304,0.20195,GOMF_HISTONE_CHAPERONE_ACTIVITY,0.916824657534246
PID_MYC_REPRESS_PATHWAY,SET,60,0.090991,0.0051906,0.10902,0.20197,PID_MYC_REPRESS_PATHWAY,0.916824657534246
GOCC_FIBRINOGEN_COMPLEX,SET,8,0.27484,0.0057331,0.3293,0.20197,GOCC_FIBRINOGEN_COMPLEX,0.916824657534246
BERTUCCI_INVASIVE_CARCINOMA_...1,SET,41,0.11597,0.0054713,0.13895,0.20198,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,0.916824657534246
MIR6089,SET,16,0.18199,0.0053676,0.21807,0.20199,MIR6089,0.916824657534246
PID_ERA_GENOMIC_PATHWAY,SET,61,0.090906,0.0052286,0.10894,0.20202,PID_ERA_GENOMIC_PATHWAY,0.916824657534246
MIR5196_3P,SET,60,0.092397,0.0052708,0.11073,0.20202,MIR5196_3P,0.916824657534246
COLIN_PILOCYTIC_ASTROCYTOMA_...2,SET,33,0.13382,0.0056653,0.16039,0.20206,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,0.916824657534246
LIAN_LIPA_TARGETS_6M,SET,65,0.09645,0.0057258,0.11561,0.20207,LIAN_LIPA_TARGETS_6M,0.916824657534246
VILIMAS_NOTCH1_TARGETS_UP,SET,50,0.1059,0.005516,0.12696,0.20213,VILIMAS_NOTCH1_TARGETS_UP,0.916824657534246
GSE24634_NAIVE_CD4_TCELL_VS_...8,SET,181,0.050886,0.0050251,0.061014,0.20214,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP,0.916824657534246
REACTOME_SIGNALING_BY_RECEPT...,SET,509,0.032939,0.0054053,0.039499,0.20217,REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,0.916824657534246
WP_TYPE_I_COLLAGEN_SYNTHESIS...,SET,31,0.12842,0.0052697,0.15399,0.20217,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,0.916824657534246
MENON_FETAL_KIDNEY_9_ENDOTHE...,SET,91,0.084581,0.005937,0.10143,0.20219,MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS,0.916824657534246
GOBP_APOPTOTIC_PROCESS_INVOL...3,SET,23,0.15837,0.0055992,0.18994,0.2022,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,0.916824657534246
GOBP_CELLULAR_RESPONSE_TO_OS...,SET,52,0.098572,0.0052359,0.11825,0.20225,GOBP_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,0.916931744064701
HP_ABNORMALITY_OF_THE_CURVAT...,SET,305,0.041046,0.0052437,0.049261,0.20236,HP_ABNORMALITY_OF_THE_CURVATURE_OF_THE_CORNEA,0.917240222917481
GOMF_HISTONE_H3K9ME2_H3K9ME3...,SET,5,0.27102,0.0044696,0.32529,0.20239,GOMF_HISTONE_H3K9ME2_H3K9ME3_DEMETHYLASE_ACTIVITY,0.917240222917481
GOBP_STEM_CELL_DEVELOPMENT,SET,82,0.084175,0.0056101,0.10104,0.2024,GOBP_STEM_CELL_DEVELOPMENT,0.917240222917481
BREUHAHN_GROWTH_FACTOR_SIGNA...,SET,15,0.21155,0.0060412,0.25396,0.20243,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,0.917240222917481
HP_APLASIA_HYPOPLASIA_OF_THE...12,SET,66,0.089569,0.005358,0.10754,0.20245,HP_APLASIA_HYPOPLASIA_OF_THE_BREASTS,0.917240222917481
GOMF_AP_1_ADAPTOR_COMPLEX_BI...,SET,5,0.28907,0.0047673,0.3471,0.20248,GOMF_AP_1_ADAPTOR_COMPLEX_BINDING,0.917256569343066
GOBP_IMMUNOGLOBULIN_V_D_J_RE...,SET,7,0.24405,0.004762,0.29328,0.20267,GOBP_IMMUNOGLOBULIN_V_D_J_RECOMBINATION,0.917287787898504
REACTOME_NEF_AND_SIGNAL_TRAN...,SET,8,0.26683,0.005566,0.32068,0.20268,REACTOME_NEF_AND_SIGNAL_TRANSDUCTION,0.917287787898504
GOBP_NEGATIVE_REGULATION_OF_...243,SET,8,0.25689,0.0053586,0.30877,0.20271,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION,0.917287787898504
MIR885_3P,SET,26,0.13405,0.0050384,0.16113,0.20273,MIR885_3P,0.917287787898504
GOBP_NEGATIVE_REGULATION_OF_...51,SET,52,0.10523,0.0055894,0.12649,0.20273,GOBP_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.917287787898504
GSE14415_NATURAL_TREG_VS_FOX...2,SET,141,0.059391,0.0051821,0.071394,0.20275,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP,0.917287787898504
REACTOME_PLASMA_LIPOPROTEIN_...2,SET,71,0.087304,0.0054159,0.10496,0.20277,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,0.917287787898504
MIR6529_3P,SET,80,0.084669,0.0055741,0.10179,0.20277,MIR6529_3P,0.917287787898504
HP_OBSESSIVE_COMPULSIVE_TRAIT,SET,36,0.12017,0.0053134,0.14448,0.20278,HP_OBSESSIVE_COMPULSIVE_TRAIT,0.917287787898504
GSE46606_UNSTIM_VS_CD40L_IL2...14,SET,174,0.054558,0.0052835,0.065595,0.20278,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.917287787898504
KEGG_MEDICUS_REFERENCE_MDM2_...2,SET,11,0.20357,0.004979,0.24478,0.2028,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536,0.917287787898504
WP_VEGFAVEGFR2_SIGNALING,SET,404,0.036111,0.0052948,0.043421,0.20281,WP_VEGFAVEGFR2_SIGNALING,0.917287787898504
E2F_Q2,SET,169,0.057592,0.0054973,0.069256,0.20283,E2F_Q2,0.917287787898504
GOBP_REGULATION_OF_MRNA_CIS_...,SET,3,0.37746,0.0048223,0.45401,0.20288,GOBP_REGULATION_OF_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.917298914738757
GOBP_REGULATION_OF_EXOCYTOSIS,SET,155,0.057798,0.0052855,0.069528,0.20291,GOBP_REGULATION_OF_EXOCYTOSIS,0.917298914738757
GOBP_PROTEIN_EXPORT_FROM_NUC...,SET,58,0.088768,0.0049789,0.10679,0.20293,GOBP_PROTEIN_EXPORT_FROM_NUCLEUS,0.917298914738757
HP_PILL_ROLLING_TREMOR,SET,4,0.39414,0.0058141,0.47422,0.20295,HP_PILL_ROLLING_TREMOR,0.917298914738757
GOMF_DNA_INSERTION_OR_DELETI...,SET,6,0.22335,0.004035,0.26875,0.20297,GOMF_DNA_INSERTION_OR_DELETION_BINDING,0.917298914738757
HP_SILVER_GRAY_HAIR,SET,6,0.29439,0.0053184,0.35427,0.203,HP_SILVER_GRAY_HAIR,0.917298914738757
MORF_DDX11,SET,145,0.055987,0.0049534,0.067384,0.20303,MORF_DDX11,0.917298914738757
GOBP_CELLULAR_RESPONSE_TO_OR...1,SET,483,0.033724,0.0053949,0.040594,0.20306,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.917298914738757
AATGTGA_MIR23A_MIR23B,SET,381,0.037101,0.0052862,0.044661,0.20307,AATGTGA_MIR23A_MIR23B,0.917298914738757
GOCC_MIDBODY,SET,186,0.049241,0.0049286,0.059287,0.20312,GOCC_MIDBODY,0.917396590909091
WP_ALTERED_GLYCOSYLATION_OF_...,SET,8,0.22622,0.0047188,0.2724,0.20315,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,0.917396590909091
GOMF_MISMATCHED_DNA_BINDING,SET,14,0.1526,0.0042103,0.1838,0.2032,GOMF_MISMATCHED_DNA_BINDING,0.917396590909091
FIGUEROA_AML_METHYLATION_CLU...4,SET,47,0.10582,0.0053445,0.12746,0.20321,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,0.917396590909091
OCT1_04,SET,201,0.05446,0.0056642,0.0656,0.20323,OCT1_04,0.917396590909091
HP_NEVUS_SEBACEOUS,SET,5,0.2857,0.0047118,0.34418,0.20325,HP_NEVUS_SEBACEOUS,0.917396590909091
MIR1296_3P,SET,34,0.11776,0.0050604,0.14191,0.20333,MIR1296_3P,0.917515801398239
MIR145_3P,SET,64,0.090302,0.0053196,0.10884,0.20337,MIR145_3P,0.917515801398239
HP_PHOTOPSIA,SET,90,0.074642,0.0052107,0.089984,0.20341,HP_PHOTOPSIA,0.917515801398239
RIZKI_TUMOR_INVASIVENESS_2D_...1,SET,53,0.095717,0.0051328,0.11544,0.20352,RIZKI_TUMOR_INVASIVENESS_2D_DN,0.917515801398239
UNTERMAN_PROGRESSIVE_VS_STAB...1,SET,4,0.42284,0.0062375,0.50999,0.20352,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN,0.917515801398239
GOBP_NEGATIVE_REGULATION_OF_...91,SET,104,0.069818,0.0052372,0.084214,0.20354,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.917515801398239
ATCTTGC_MIR31,SET,70,0.080544,0.0049614,0.097165,0.20357,ATCTTGC_MIR31,0.917515801398239
GOMF_PEPTIDE_TRANSMEMBRANE_T...,SET,9,0.25069,0.0055463,0.30243,0.20358,GOMF_PEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.917515801398239
WP_STRIATED_MUSCLE_CONTRACTI...,SET,37,0.11567,0.0051848,0.13955,0.20359,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,0.917515801398239
GOCC_CILIARY_ROOTLET,SET,12,0.20498,0.005236,0.24729,0.20359,GOCC_CILIARY_ROOTLET,0.917515801398239
GSE37532_WT_VS_PPARG_KO_LN_T...4,SET,156,0.054647,0.0050133,0.065928,0.20359,GSE37532_WT_VS_PPARG_KO_LN_TREG_UP,0.917515801398239
BUCKANOVICH_T_LYMPHOCYTE_HOM...2,SET,18,0.17276,0.005404,0.20845,0.20362,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,0.917515801398239
CUI_DEVELOPING_HEART_CARDIAC...,SET,100,0.073648,0.0054178,0.088874,0.20365,CUI_DEVELOPING_HEART_CARDIAC_FIBROBLASTS,0.917515801398239
GOBP_POSITIVE_REGULATION_OF_...335,SET,10,0.21325,0.0049731,0.25738,0.20369,GOBP_POSITIVE_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.917515801398239
KEGG_RIG_I_LIKE_RECEPTOR_SIG...,SET,61,0.098267,0.005652,0.11862,0.20372,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.917515801398239
GOBP_ACTIVATION_OF_MEIOSIS,SET,5,0.33471,0.0055201,0.40412,0.20377,GOBP_ACTIVATION_OF_MEIOSIS,0.917515801398239
FRIDMAN_SENESCENCE_DN,SET,10,0.20817,0.0048546,0.25134,0.20378,FRIDMAN_SENESCENCE_DN,0.917515801398239
GSE8835_HEALTHY_VS_CLL_CD8_T...1,SET,181,0.053669,0.0052999,0.064807,0.2038,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN,0.917515801398239
PID_CDC42_PATHWAY,SET,68,0.089597,0.00544,0.1082,0.20381,PID_CDC42_PATHWAY,0.917515801398239
GOCC_INTEGRATOR_COMPLEX,SET,13,0.18371,0.0048842,0.22185,0.20382,GOCC_INTEGRATOR_COMPLEX,0.917515801398239
MIR1285_3P,SET,151,0.056935,0.0051396,0.068771,0.20387,MIR1285_3P,0.917515801398239
KEGG_APOPTOSIS,SET,81,0.079531,0.0052683,0.096068,0.20388,KEGG_APOPTOSIS,0.917515801398239
GSE7548_DAY7_VS_DAY28_PCC_IM...2,SET,187,0.053054,0.0053244,0.064088,0.20389,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,0.917515801398239
GAO_LARGE_INTESTINE_24W_C4_P...,SET,5,0.32427,0.0053479,0.39174,0.20391,GAO_LARGE_INTESTINE_24W_C4_PROM1LOW_PROGENITOR,0.917515801398239
GOMF_CELL_ADHESION_MOLECULE_...,SET,502,0.032304,0.0052656,0.03904,0.20399,GOMF_CELL_ADHESION_MOLECULE_BINDING,0.917585848934797
GUILLAUMOND_KLF10_TARGETS_UP,SET,48,0.10345,0.00528,0.12502,0.204,GUILLAUMOND_KLF10_TARGETS_UP,0.917585848934797
GOBP_CARDIAC_MUSCLE_CELL_CAR...,SET,7,0.31941,0.0062326,0.38609,0.20404,GOBP_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION,0.917585848934797
MIR6752_5P,SET,112,0.069409,0.0054019,0.083906,0.20406,MIR6752_5P,0.917585848934797
GOBP_RRNA_CATABOLIC_PROCESS,SET,12,0.1856,0.004741,0.22442,0.20413,GOBP_RRNA_CATABOLIC_PROCESS,0.917585848934797
GCCNNNWTAAR_UNKNOWN,SET,132,0.062963,0.0053169,0.076154,0.20418,GCCNNNWTAAR_UNKNOWN,0.917585848934797
GOBP_NEPHRIC_DUCT_MORPHOGENE...,SET,10,0.26175,0.0061042,0.31658,0.20418,GOBP_NEPHRIC_DUCT_MORPHOGENESIS,0.917585848934797
GOBP_REGULATION_OF_CARDIAC_M...7,SET,35,0.13547,0.0059064,0.16387,0.20421,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.917585848934797
GSE11864_CSF1_IFNG_VS_CSF1_I...1,SET,167,0.05313,0.0050415,0.064279,0.20425,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.917585848934797
GOMF_ALPHA_GLUCOSIDASE_ACTIV...,SET,7,0.26906,0.0052502,0.32553,0.20426,GOMF_ALPHA_GLUCOSIDASE_ACTIVITY,0.917585848934797
HP_PANCREATITIS,SET,73,0.086311,0.005429,0.10443,0.20427,HP_PANCREATITIS,0.917585848934797
GOBP_REGULATION_OF_PROTEIN_T...1,SET,72,0.081287,0.0050779,0.098357,0.20428,GOBP_REGULATION_OF_PROTEIN_TARGETING,0.917585848934797
GOBP_RESPONSE_TO_MINERALOCOR...,SET,36,0.12649,0.005593,0.15306,0.20429,GOBP_RESPONSE_TO_MINERALOCORTICOID,0.917585848934797
GOBP_POSITIVE_REGULATION_OF_...479,SET,6,0.24265,0.0043836,0.29365,0.20432,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.917585848934797
GOBP_PANCREATIC_A_CELL_DIFFE...,SET,10,0.27729,0.0064666,0.33563,0.20436,GOBP_PANCREATIC_A_CELL_DIFFERENTIATION,0.917585848934797
FARMER_BREAST_CANCER_CLUSTER...2,SET,32,0.1273,0.0053071,0.15411,0.2044,FARMER_BREAST_CANCER_CLUSTER_2,0.917585848934797
GOCC_NUCLEAR_BODY,SET,747,0.024995,0.0049359,0.030267,0.20445,GOCC_NUCLEAR_BODY,0.917585848934797
HP_RETICULOCYTOSIS,SET,41,0.11179,0.0052743,0.13536,0.20445,HP_RETICULOCYTOSIS,0.917585848934797
NABA_ECM_REGULATORS,SET,229,0.052223,0.005793,0.063237,0.20446,NABA_ECM_REGULATORS,0.917585848934797
GSE21380_NON_TFH_VS_GERMINAL...2,SET,176,0.054726,0.0053298,0.066272,0.20447,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,0.917585848934797
HP_DIFFICULTY_CLIMBING_STAIRS,SET,58,0.093229,0.0052291,0.1129,0.20448,HP_DIFFICULTY_CLIMBING_STAIRS,0.917585848934797
GOBP_CONVERGENT_EXTENSION_IN...3,SET,5,0.32317,0.0053297,0.39149,0.20455,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS,0.917781467854377
GOBP_NEGATIVE_REGULATION_OF_...514,SET,101,0.068749,0.0050825,0.083301,0.2046,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.917887311217245
REACTOME_LDL_REMODELING,SET,6,0.26522,0.0047914,0.3215,0.2047,REACTOME_LDL_REMODELING,0.918191031390134
REACTOME_CDC42_GTPASE_CYCLE,SET,142,0.061243,0.0053625,0.074256,0.20476,REACTOME_CDC42_GTPASE_CYCLE,0.918191031390134
WP_CARDIAC_PROGENITOR_DIFFER...,SET,50,0.1131,0.0058911,0.13714,0.20478,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,0.918191031390134
HP_COMBINED_IMMUNODEFICIENCY,SET,35,0.12559,0.0054755,0.15233,0.20485,HP_COMBINED_IMMUNODEFICIENCY,0.918191031390134
MIR3915,SET,197,0.04954,0.0051015,0.060122,0.20498,MIR3915,0.918191031390134
HP_FUSED_CERVICAL_VERTEBRAE,SET,30,0.12891,0.0052043,0.15645,0.20498,HP_FUSED_CERVICAL_VERTEBRAE,0.918191031390134
GOBP_NEGATIVE_REGULATION_OF_...99,SET,4,0.37649,0.0055538,0.45696,0.205,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.918191031390134
GOBP_POSITIVE_REGULATION_OF_...542,SET,16,0.20791,0.0061319,0.25237,0.20502,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.918191031390134
GOBP_REGULATION_OF_RECEPTOR_...1,SET,13,0.1974,0.0052482,0.23966,0.20507,GOBP_REGULATION_OF_RECEPTOR_BINDING,0.918191031390134
GSE32423_IL7_VS_IL4_MEMORY_C...1,SET,181,0.050228,0.00496,0.06099,0.20511,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN,0.918191031390134
KEGG_MEDICUS_PATHOGEN_KSHV_V...2,SET,5,0.28722,0.0047369,0.34879,0.20512,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY,0.918191031390134
GOBP_T_HELPER_1_TYPE_IMMUNE_...,SET,47,0.11538,0.0058276,0.14013,0.20514,GOBP_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.918191031390134
GRAESSMANN_RESPONSE_TO_MC_AN...1,SET,698,0.026182,0.0050046,0.0318,0.20517,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN,0.918191031390134
PID_ATF2_PATHWAY,SET,58,0.099948,0.005606,0.12142,0.20521,PID_ATF2_PATHWAY,0.918191031390134
HP_INCREASED_BODY_WEIGHT,SET,425,0.035255,0.0052989,0.042829,0.20522,HP_INCREASED_BODY_WEIGHT,0.918191031390134
GOBP_INNATE_IMMUNE_RESPONSE_...1,SET,88,0.077802,0.0053708,0.094531,0.20525,GOBP_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.918191031390134
GSE3039_CD4_TCELL_VS_B2_BCEL...1,SET,181,0.053607,0.0052937,0.065134,0.20525,GSE3039_CD4_TCELL_VS_B2_BCELL_DN,0.918191031390134
GOBP_SA_NODE_CELL_TO_ATRIAL_...1,SET,11,0.23107,0.0056516,0.28077,0.20526,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.918191031390134
HP_CATAPLEXY,SET,10,0.22993,0.0053621,0.2794,0.20527,HP_CATAPLEXY,0.918191031390134
HP_SKIN_ULCER,SET,122,0.06551,0.0053198,0.079642,0.20538,HP_SKIN_ULCER,0.918191031390134
WANG_IMMORTALIZED_BY_HOXA9_A...2,SET,29,0.14563,0.0057805,0.17706,0.20541,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,0.918191031390134
MODULE_207,SET,207,0.049602,0.0052345,0.060316,0.20544,MODULE_207,0.918191031390134
HE_LIM_SUN_FETAL_LUNG_C0_MYO...1,SET,46,0.12031,0.0060118,0.14633,0.20548,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL,0.918191031390134
TRAVAGLINI_LUNG_PROLIFERATIN...2,SET,874,0.023912,0.0050892,0.029086,0.20551,TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL,0.918191031390134
MODULE_65,SET,7,0.26061,0.0050853,0.31702,0.20552,MODULE_65,0.918191031390134
GSE360_DC_VS_MAC_M_TUBERCULO...1,SET,180,0.052686,0.0051885,0.064089,0.20552,GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN,0.918191031390134
GOBP_INTRACELLULAR_RECEPTOR_...,SET,335,0.038224,0.0051135,0.046501,0.20554,GOBP_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY,0.918191031390134
GSE11961_FOLLICULAR_BCELL_VS...10,SET,182,0.051076,0.0050575,0.06214,0.20556,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP,0.918191031390134
MIR6817_3P,SET,203,0.051041,0.0053346,0.0621,0.20557,MIR6817_3P,0.918191031390134
INAMURA_LUNG_CANCER_SCC_SUBT...,SET,12,0.17803,0.0045477,0.21662,0.20559,INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP,0.918191031390134
WANG_BARRETTS_ESOPHAGUS_DN,SET,24,0.15775,0.0056968,0.19195,0.2056,WANG_BARRETTS_ESOPHAGUS_DN,0.918191031390134
PRC2_SUZ12_UP.V1_DN,SET,168,0.056207,0.0053494,0.068395,0.2056,PRC2_SUZ12_UP.V1_DN,0.918191031390134
MIR8066,SET,142,0.058981,0.0051644,0.071775,0.20562,MIR8066,0.918191031390134
HP_ABNORMAL_SEMICIRCULAR_CAN...,SET,21,0.14252,0.004815,0.17344,0.20562,HP_ABNORMAL_SEMICIRCULAR_CANAL_MORPHOLOGY,0.918191031390134
MORF_RFC4,SET,132,0.059166,0.0049963,0.072005,0.20563,MORF_RFC4,0.918191031390134
GSE11961_MARGINAL_ZONE_BCELL...10,SET,185,0.05095,0.0050861,0.06202,0.20568,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP,0.918191031390134
HP_ABNORMAL_EOSINOPHIL_MORPH...,SET,65,0.088194,0.0052357,0.10736,0.2057,HP_ABNORMAL_EOSINOPHIL_MORPHOLOGY,0.918191031390134
DESERT_STEM_CELL_HEPATOCELLU...,SET,229,0.047163,0.0052317,0.057418,0.20572,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.918191031390134
GOBP_OLFACTORY_BULB_INTERNEU...1,SET,7,0.31141,0.0060764,0.37915,0.20574,GOBP_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT,0.918191031390134
ETF_Q6,SET,110,0.069096,0.0053296,0.084131,0.20575,ETF_Q6,0.918191031390134
HP_INTRACRANIAL_HEMORRHAGE,SET,141,0.060765,0.005302,0.074004,0.2058,HP_INTRACRANIAL_HEMORRHAGE,0.918191031390134
GSE11818_WT_VS_DICER_KO_TREG...1,SET,143,0.057549,0.0050566,0.07009,0.20581,GSE11818_WT_VS_DICER_KO_TREG_DN,0.918191031390134
HP_HYPOPLASIA_OF_THE_PONS,SET,82,0.07472,0.00498,0.091013,0.20583,HP_HYPOPLASIA_OF_THE_PONS,0.918191031390134
MIR1226_3P,SET,99,0.070622,0.0051694,0.08603,0.20586,MIR1226_3P,0.918191031390134
HP_ABNORMAL_URINE_POTASSIUM_...,SET,16,0.19083,0.0056283,0.23247,0.20586,HP_ABNORMAL_URINE_POTASSIUM_CONCENTRATION,0.918191031390134
HOXA3_01,SET,14,0.19245,0.0053098,0.23455,0.20597,HOXA3_01,0.918191031390134
HP_CHRONIC_HEMOLYTIC_ANEMIA,SET,5,0.32881,0.0054228,0.40075,0.20597,HP_CHRONIC_HEMOLYTIC_ANEMIA,0.918191031390134
GOBP_ACTIN_MEDIATED_CELL_CON...,SET,106,0.073121,0.0055372,0.089126,0.20599,GOBP_ACTIN_MEDIATED_CELL_CONTRACTION,0.918191031390134
HP_INTERRUPTED_AORTIC_ARCH,SET,18,0.17339,0.0054237,0.21134,0.20599,HP_INTERRUPTED_AORTIC_ARCH,0.918191031390134
REACTOME_APOPTOTIC_EXECUTION...,SET,43,0.10811,0.0052232,0.1318,0.20605,REACTOME_APOPTOTIC_EXECUTION_PHASE,0.918191031390134
NAKAYAMA_SOFT_TISSUE_TUMORS_...4,SET,78,0.081762,0.0053153,0.09971,0.20611,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,0.918191031390134
HP_HYPOGLYCEMIC_SEIZURES,SET,23,0.16028,0.0056667,0.19547,0.20612,HP_HYPOGLYCEMIC_SEIZURES,0.918191031390134
GOMF_PHOSPHORIC_ESTER_HYDROL...,SET,318,0.038759,0.0050541,0.04727,0.20613,GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY,0.918191031390134
GSE25088_IL4_VS_IL4_AND_ROSI...2,SET,183,0.051211,0.0050847,0.062456,0.20613,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.918191031390134
GSE15930_STIM_VS_STIM_AND_IL...6,SET,181,0.049384,0.0048767,0.060233,0.20615,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP,0.918191031390134
TAGAACC_MIR182,SET,34,0.11668,0.0050139,0.14233,0.20618,TAGAACC_MIR182,0.918191031390134
GOBP_RESPONSE_TO_ZINC_ION_ST...,SET,8,0.22279,0.0046473,0.2718,0.2062,GOBP_RESPONSE_TO_ZINC_ION_STARVATION,0.918191031390134
GSE40068_CXCR5NEG_BCL6NEG_CD...2,SET,184,0.050853,0.0050628,0.062038,0.2062,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP,0.918191031390134
GOBP_LENS_MORPHOGENESIS_IN_C...,SET,19,0.18237,0.0058608,0.22252,0.20624,GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.918196693794507
GOBP_REGULATION_OF_COMPLEMEN...2,SET,3,0.45804,0.0058517,0.55904,0.2063,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.918196693794507
GOBP_MEDIUM_CHAIN_FATTY_ACID...3,SET,15,0.17123,0.0048898,0.20901,0.20633,GOBP_MEDIUM_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.918196693794507
GOBP_NEGATIVE_REGULATION_OF_...204,SET,36,0.12808,0.0056631,0.15639,0.20641,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,0.918196693794507
PID_PLK1_PATHWAY,SET,42,0.10235,0.0048874,0.125,0.20646,PID_PLK1_PATHWAY,0.918196693794507
HP_TEMPERATURE_INSTABILITY,SET,34,0.12538,0.0053878,0.15313,0.20647,HP_TEMPERATURE_INSTABILITY,0.918196693794507
YAMASHITA_METHYLATED_IN_PROS...,SET,59,0.098073,0.0055479,0.11979,0.20648,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,0.918196693794507
MIR6759_5P,SET,56,0.099399,0.0054786,0.12141,0.20648,MIR6759_5P,0.918196693794507
GREGORY_SYNTHETIC_LETHAL_WIT...,SET,128,0.060583,0.0050383,0.074006,0.20651,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,0.918196693794507
MIR7704,SET,5,0.34021,0.0056109,0.41562,0.20652,MIR7704,0.918196693794507
REACTOME_NR1H2_NR1H3_REGULAT...4,SET,9,0.18882,0.0041775,0.23078,0.20663,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS,0.918196693794507
REACTOME_SIGNALING_BY_MAPK_M...,SET,6,0.33873,0.0061195,0.41401,0.20663,REACTOME_SIGNALING_BY_MAPK_MUTANTS,0.918196693794507
GOBP_PYRIMIDINE_RIBONUCLEOTI...2,SET,8,0.26076,0.0054394,0.31873,0.20665,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_CATABOLIC_PROCESS,0.918196693794507
GOBP_AXIS_SPECIFICATION,SET,87,0.080311,0.0055126,0.098173,0.20667,GOBP_AXIS_SPECIFICATION,0.918196693794507
GOBP_TISSUE_MIGRATION,SET,295,0.043053,0.0054107,0.052657,0.20679,GOBP_TISSUE_MIGRATION,0.918196693794507
GOMF_SECONDARY_ACTIVE_TRANSM...,SET,274,0.044318,0.0053709,0.05422,0.20686,GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.918196693794507
GOBP_ANTIMICROBIAL_PEPTIDE_P...,SET,12,0.22976,0.0058691,0.28111,0.20688,GOBP_ANTIMICROBIAL_PEPTIDE_PRODUCTION,0.918196693794507
ROSS_LEUKEMIA_WITH_MLL_FUSIO...,SET,75,0.083947,0.0053518,0.10272,0.20689,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,0.918196693794507
HP_AGENESIS_OF_INCISOR,SET,31,0.13757,0.0056454,0.16835,0.20692,HP_AGENESIS_OF_INCISOR,0.918196693794507
GOBP_PHOSPHATIDYLGLYCEROL_AC...,SET,9,0.25911,0.0057326,0.31713,0.20695,GOBP_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING,0.918196693794507
GOBP_REGULATION_OF_ANTIMICRO...2,SET,9,0.26094,0.005773,0.31935,0.20695,GOBP_REGULATION_OF_ANTIMICROBIAL_PEPTIDE_PRODUCTION,0.918196693794507
GSE41867_DAY6_VS_DAY8_LCMV_A...2,SET,176,0.052825,0.0051447,0.064655,0.20696,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.918196693794507
REACTOME_POTASSIUM_CHANNELS,SET,102,0.077976,0.005793,0.095452,0.207,REACTOME_POTASSIUM_CHANNELS,0.918196693794507
HP_SMOOTH_TONGUE,SET,5,0.35033,0.0057778,0.4289,0.20702,HP_SMOOTH_TONGUE,0.918196693794507
ABBUD_LIF_SIGNALING_2_DN,SET,7,0.31225,0.0060928,0.38231,0.20704,ABBUD_LIF_SIGNALING_2_DN,0.918196693794507
REACTOME_POST_TRANSLATIONAL_...1,SET,87,0.077526,0.0053214,0.094932,0.20707,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,0.918196693794507
MIR4667_3P,SET,118,0.064364,0.0051409,0.078822,0.20709,MIR4667_3P,0.918196693794507
GOCC_GTPASE_ACTIVATOR_COMPLEX,SET,11,0.18565,0.0045405,0.22737,0.20711,GOCC_GTPASE_ACTIVATOR_COMPLEX,0.918196693794507
KEGG_MEDICUS_REFERENCE_BASE_...2,SET,8,0.21691,0.0045246,0.26567,0.20712,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_MONOFUNCTIONAL_GLYCOSYLASE,0.918196693794507
MODULE_310,SET,19,0.1753,0.0056336,0.21471,0.20713,MODULE_310,0.918196693794507
GOCC_PARASPECKLES,SET,7,0.22717,0.0044326,0.27826,0.20715,GOCC_PARASPECKLES,0.918196693794507
LIANG_HEMATOPOIESIS_STEM_CEL...3,SET,15,0.16612,0.004744,0.2035,0.20716,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,0.918196693794507
HP_ABNORMALITY_OF_THE_THENAR...,SET,30,0.12299,0.004965,0.15066,0.20716,HP_ABNORMALITY_OF_THE_THENAR_EMINENCE,0.918196693794507
GOMF_ADENYLATE_CYCLASE_REGUL...,SET,8,0.25211,0.0052588,0.30888,0.2072,GOMF_ADENYLATE_CYCLASE_REGULATOR_ACTIVITY,0.918196693794507
REACTOME_PYRIMIDINE_SALVAGE,SET,10,0.225,0.0052471,0.27571,0.20723,REACTOME_PYRIMIDINE_SALVAGE,0.918196693794507
HOWARD_NEUTROPHIL_INACT_MONO...3,SET,8,0.23926,0.0049908,0.29319,0.20724,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_DN,0.918196693794507
WP_VITAMIN_B12_METABOLISM,SET,49,0.11077,0.005712,0.13576,0.20728,WP_VITAMIN_B12_METABOLISM,0.918196693794507
WP_FLUOROACETIC_ACID_TOXICITY,SET,6,0.26671,0.0048184,0.32691,0.20729,WP_FLUOROACETIC_ACID_TOXICITY,0.918196693794507
GOBP_REGULATION_OF_APOPTOTIC...3,SET,11,0.25022,0.0061198,0.30672,0.20732,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.918196693794507
REACTOME_PROTON_COUPLED_MONO...,SET,6,0.3209,0.0057973,0.39339,0.20733,REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT,0.918196693794507
GOBP_POSITIVE_REGULATION_OF_...376,SET,58,0.097014,0.0054414,0.11893,0.20734,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.918196693794507
GSE22935_UNSTIM_VS_48H_MBOVI...1,SET,180,0.052578,0.0051779,0.064461,0.20735,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.918196693794507
ZHENG_CORD_BLOOD_C8_PUTATIVE...,SET,75,0.08369,0.0053354,0.1026,0.20735,ZHENG_CORD_BLOOD_C8_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_2,0.918196693794507
GOMF_NETRIN_RECEPTOR_ACTIVITY,SET,5,0.31274,0.0051577,0.38345,0.20737,GOMF_NETRIN_RECEPTOR_ACTIVITY,0.918196693794507
GUTIERREZ_CHRONIC_LYMPHOCYTI...1,SET,50,0.10429,0.0054322,0.12792,0.20747,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.918196693794507
GOBP_REGULATION_OF_NEURON_AP...,SET,220,0.049306,0.0053623,0.060488,0.2075,GOBP_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.918196693794507
HP_ABNORMAL_CIRCULATING_ANDR...1,SET,89,0.0759,0.0052691,0.093119,0.20751,HP_ABNORMAL_CIRCULATING_ANDROGEN_LEVEL,0.918196693794507
PID_AR_PATHWAY,SET,57,0.091383,0.0050814,0.11212,0.20752,PID_AR_PATHWAY,0.918196693794507
GSE24142_EARLY_THYMIC_PROGEN...11,SET,181,0.054786,0.0054101,0.067218,0.20753,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP,0.918196693794507
GOMF_ENZYME_REGULATOR_ACTIVI...,SET,1190,0.021105,0.0051938,0.025902,0.2076,GOMF_ENZYME_REGULATOR_ACTIVITY,0.918196693794507
GOBP_NEUROTRANSMITTER_RECEPT...1,SET,33,0.12354,0.0052304,0.15164,0.20762,GOBP_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.918196693794507
WANG_RESPONSE_TO_GSK3_INHIBI...1,SET,313,0.038392,0.0049674,0.047131,0.20766,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,0.918196693794507
GSE29618_PRE_VS_DAY7_FLU_VAC...8,SET,175,0.051603,0.0050115,0.063349,0.20766,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP,0.918196693794507
HP_ABNORMALITY_OF_URINE_HOME...,SET,658,0.027922,0.0051878,0.034282,0.20769,HP_ABNORMALITY_OF_URINE_HOMEOSTASIS,0.918196693794507
REACTOME_BMAL1_CLOCK_NPAS2_A...,SET,23,0.15659,0.0055361,0.19227,0.2077,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,0.918196693794507
HP_BILIARY_ATRESIA,SET,11,0.2006,0.0049063,0.2463,0.2077,HP_BILIARY_ATRESIA,0.918196693794507
MAP2K1_TARGET_GENES,SET,5,0.29119,0.0048024,0.3576,0.20774,MAP2K1_TARGET_GENES,0.918196693794507
GOBP_MUSCLE_HYPERTROPHY_IN_R...,SET,24,0.14308,0.0051671,0.17572,0.20775,GOBP_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS,0.918196693794507
GSE17721_POLYIC_VS_PAM3CSK4_...17,SET,180,0.049243,0.0048494,0.060477,0.20776,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN,0.918196693794507
PIEPOLI_LGI1_TARGETS_UP,SET,12,0.23418,0.005982,0.28771,0.20785,PIEPOLI_LGI1_TARGETS_UP,0.918332027331996
MIR184,SET,7,0.2726,0.0053191,0.33497,0.20788,MIR184,0.918332027331996
GSE2405_0H_VS_12H_A_PHAGOCYT...1,SET,178,0.051987,0.0050914,0.06389,0.20792,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.918332027331996
GOBP_REGULATION_OF_IMMUNOGLO...,SET,62,0.083916,0.0048658,0.10315,0.20795,GOBP_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.918332027331996
HP_OSTEOSARCOMA,SET,32,0.1182,0.0049278,0.14532,0.20801,HP_OSTEOSARCOMA,0.918332027331996
HOWARD_DENDRITIC_CELL_INACT_...3,SET,9,0.25952,0.0057416,0.31909,0.20803,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.918332027331996
HP_HYPOREFLEXIA_OF_LOWER_LIM...,SET,33,0.12245,0.005184,0.1506,0.20809,HP_HYPOREFLEXIA_OF_LOWER_LIMBS,0.918332027331996
GOBP_NEGATIVE_REGULATION_OF_...419,SET,27,0.1431,0.0054807,0.17602,0.20813,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,0.918332027331996
REACTOME_TANDEM_PORE_DOMAIN_...,SET,12,0.21415,0.0054703,0.26348,0.20818,REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS,0.918332027331996
GOBP_SEMICIRCULAR_CANAL_MORP...,SET,7,0.29896,0.0058335,0.36787,0.20821,GOBP_SEMICIRCULAR_CANAL_MORPHOGENESIS,0.918332027331996
GOBP_POSITIVE_REGULATION_OF_...452,SET,8,0.30193,0.006298,0.37158,0.20824,GOBP_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION,0.918332027331996
GSE10147_IL3_AND_HIVP17_VS_I...1,SET,134,0.058311,0.004961,0.071775,0.20828,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN,0.918332027331996
DESERT_EXTRACELLULAR_MATRIX_...,SET,19,0.17161,0.0055151,0.21129,0.20834,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.918332027331996
HP_HYPOPIGMENTED_MACULE,SET,24,0.13544,0.0048914,0.16676,0.20835,HP_HYPOPIGMENTED_MACULE,0.918332027331996
GSE21670_STAT3_KO_VS_WT_CD4_...6,SET,174,0.055812,0.0054049,0.068734,0.2084,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN,0.918332027331996
GCM_HMGA2,SET,107,0.065139,0.0049558,0.080241,0.20846,GCM_HMGA2,0.918332027331996
WP_PROLACTIN_SIGNALING,SET,72,0.088141,0.0055061,0.10858,0.20848,WP_PROLACTIN_SIGNALING,0.918332027331996
GOCC_CYTOPLASMIC_SIDE_OF_END...1,SET,18,0.14288,0.0044694,0.17605,0.20851,GOCC_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.918332027331996
HP_UPPER_LIMB_ASYMMETRY,SET,10,0.24258,0.0056571,0.2989,0.20852,HP_UPPER_LIMB_ASYMMETRY,0.918332027331996
PID_IL12_2PATHWAY,SET,61,0.096742,0.0055643,0.11921,0.20853,PID_IL12_2PATHWAY,0.918332027331996
GOMF_CAMP_DEPENDENT_PROTEIN_...2,SET,10,0.23145,0.0053975,0.28519,0.20853,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY,0.918332027331996
GNF2_CASP8,SET,24,0.15352,0.0055441,0.18917,0.20854,GNF2_CASP8,0.918332027331996
REACTOME_GLUCAGON_LIKE_PEPTI...,SET,42,0.11187,0.0053417,0.13787,0.20858,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,0.918332027331996
GSE15735_2H_VS_12H_HDAC_INHI...1,SET,189,0.050775,0.0051225,0.062578,0.20858,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN,0.918332027331996
GOBP_POSITIVE_REGULATION_OF_...172,SET,8,0.2758,0.0057529,0.34008,0.2087,GOBP_POSITIVE_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,0.918332027331996
GOBP_REGULATION_OF_COA_TRANS...,SET,8,0.2758,0.0057529,0.34008,0.2087,GOBP_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,0.918332027331996
GSE22886_CD8_TCELL_VS_BCELL_...2,SET,183,0.049442,0.0049091,0.060971,0.20872,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP,0.918332027331996
WEST_ADRENOCORTICAL_CARCINOM...1,SET,23,0.16056,0.0056764,0.19801,0.20873,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,0.918332027331996
HP_ABNORMAL_NUMBER_OF_PERMAN...,SET,30,0.1307,0.0052765,0.1612,0.20874,HP_ABNORMAL_NUMBER_OF_PERMANENT_TEETH,0.918332027331996
HP_GASTROINTESTINAL_ATRESIA,SET,75,0.078016,0.0049737,0.096223,0.20875,HP_GASTROINTESTINAL_ATRESIA,0.918332027331996
REACTOME_TOLL_LIKE_RECEPTOR_...3,SET,108,0.068052,0.0052015,0.083941,0.20877,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,0.918332027331996
MIR449A,SET,280,0.040631,0.0049769,0.05013,0.20883,MIR449A,0.918332027331996
GOBP_REGULATION_OF_CELL_PROJ...3,SET,11,0.19665,0.0048097,0.24266,0.20886,GOBP_REGULATION_OF_CELL_PROJECTION_SIZE,0.918332027331996
GTATTAT_MIR3693P,SET,192,0.053818,0.005472,0.066413,0.20887,GTATTAT_MIR3693P,0.918332027331996
HP_SEVERE_COMBINED_IMMUNODEF...,SET,19,0.16378,0.0052635,0.20212,0.20888,HP_SEVERE_COMBINED_IMMUNODEFICIENCY,0.918332027331996
HP_CONGENITAL_MALFORMATION_O...2,SET,76,0.079211,0.0050833,0.097755,0.20889,HP_CONGENITAL_MALFORMATION_OF_THE_RIGHT_HEART,0.918332027331996
GOBP_NEGATIVE_REGULATION_OF_...469,SET,43,0.1182,0.0057105,0.14589,0.20893,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.918332027331996
HP_SELECTIVE_TOOTH_AGENESIS,SET,40,0.12406,0.0057816,0.15313,0.20893,HP_SELECTIVE_TOOTH_AGENESIS,0.918332027331996
HP_SUBMUCOUS_CLEFT_SOFT_PALA...,SET,9,0.2167,0.0047943,0.26753,0.20897,HP_SUBMUCOUS_CLEFT_SOFT_PALATE,0.918332027331996
GSE17721_LPS_VS_PAM3CSK4_2H_...2,SET,184,0.053359,0.0053123,0.065875,0.20897,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP,0.918332027331996
GAVISH_3CA_MALIGNANT_METAPRO...16,SET,47,0.11166,0.0056396,0.13786,0.20899,GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES,0.918332027331996
GOBP_XENOBIOTIC_TRANSPORT,SET,47,0.10914,0.0055122,0.13481,0.20909,GOBP_XENOBIOTIC_TRANSPORT,0.918332027331996
REACTOME_GENE_SILENCING_BY_R...,SET,77,0.074122,0.0047877,0.091567,0.20912,REACTOME_GENE_SILENCING_BY_RNA,0.918332027331996
NAKAYA_PBMC_FLUMIST_AGE_18_5...2,SET,30,0.12332,0.0049785,0.15237,0.20915,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP,0.918332027331996
GOBP_POSITIVE_REGULATION_OF_...431,SET,18,0.16549,0.0051765,0.20448,0.20917,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.918332027331996
GOBP_REGULATION_OF_MITOTIC_S...1,SET,53,0.091684,0.0049165,0.11328,0.20917,GOBP_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.918332027331996
PID_IL27_PATHWAY,SET,26,0.14083,0.0052933,0.17404,0.20921,PID_IL27_PATHWAY,0.918332027331996
GOBP_L_ASPARTATE_TRANSMEMBRA...,SET,11,0.2098,0.0051313,0.25928,0.20921,GOBP_L_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.918332027331996
GOCC_DENDRITIC_SPINE_MEMBRANE,SET,14,0.18805,0.0051882,0.23239,0.20921,GOCC_DENDRITIC_SPINE_MEMBRANE,0.918332027331996
GOBP_NEGATIVE_REGULATION_OF_...362,SET,35,0.11745,0.0051209,0.14516,0.20922,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.918332027331996
GOBP_REGULATION_OF_CELL_MORP...,SET,222,0.046654,0.0050966,0.057674,0.20928,GOBP_REGULATION_OF_CELL_MORPHOGENESIS,0.918332027331996
GNF2_EIF3S6,SET,106,0.064044,0.0048498,0.079171,0.20929,GNF2_EIF3S6,0.918332027331996
RAY_ALZHEIMERS_DISEASE,SET,13,0.20072,0.0053366,0.24827,0.20941,RAY_ALZHEIMERS_DISEASE,0.918332027331996
HP_INCREASED_ADIPOSE_TISSUE,SET,9,0.22928,0.0050727,0.28361,0.20943,HP_INCREASED_ADIPOSE_TISSUE,0.918332027331996
GOMF_VOLTAGE_GATED_MONOATOMI...1,SET,14,0.20223,0.0055794,0.25017,0.20945,GOMF_VOLTAGE_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.918332027331996
GOBP_NEGATIVE_REGULATION_OF_...173,SET,6,0.2788,0.0050366,0.345,0.20952,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.918332027331996
ZHENG_FOXP3_TARGETS_IN_THYMU...1,SET,12,0.18874,0.0048212,0.23363,0.20959,ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,0.918332027331996
MIR4497,SET,8,0.27825,0.0058042,0.34444,0.20959,MIR4497,0.918332027331996
GOBP_MAMMARY_GLAND_EPITHELIA...1,SET,17,0.1819,0.0055299,0.22517,0.20959,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION,0.918332027331996
PTEN_DN.V1_DN,SET,152,0.059742,0.0054106,0.073949,0.20959,PTEN_DN.V1_DN,0.918332027331996
GOBP_PROTEIN_LOCALIZATION_TO...44,SET,260,0.043204,0.0051023,0.053485,0.20961,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.918332027331996
HP_TALL_CHIN,SET,5,0.23551,0.0038841,0.29156,0.20962,HP_TALL_CHIN,0.918332027331996
MIR6771_3P,SET,89,0.072714,0.0050479,0.090028,0.20964,MIR6771_3P,0.918332027331996
GOBP_MONOCYTE_DIFFERENTIATION,SET,32,0.13338,0.0055609,0.16516,0.20966,GOBP_MONOCYTE_DIFFERENTIATION,0.918332027331996
WP_EPAC1_AND_PKA_REDUCTION_O...,SET,8,0.25952,0.0054135,0.32135,0.20967,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,0.918332027331996
MODULE_194,SET,15,0.18934,0.0054071,0.23446,0.20967,MODULE_194,0.918332027331996
GOBP_AXONOGENESIS_INVOLVED_I...,SET,9,0.24486,0.0054173,0.30319,0.20967,GOBP_AXONOGENESIS_INVOLVED_IN_INNERVATION,0.918332027331996
GSE27786_ERYTHROBLAST_VS_MON...1,SET,184,0.049688,0.0049468,0.061541,0.20972,GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN,0.918332027331996
HP_SYNOSTOSIS_OF_METACARPALS...,SET,15,0.18475,0.0052759,0.22885,0.20976,HP_SYNOSTOSIS_OF_METACARPALS_METATARSALS,0.918332027331996
PUJANA_BRCA_CENTERED_NETWORK,SET,110,0.06056,0.0046712,0.075021,0.20977,PUJANA_BRCA_CENTERED_NETWORK,0.918332027331996
GOBP_POSITIVE_REGULATION_OF_...42,SET,12,0.22793,0.0058224,0.2824,0.20981,GOBP_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.918332027331996
REACTOME_ARACHIDONATE_PRODUC...,SET,5,0.25914,0.0042737,0.32109,0.20982,REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG,0.918332027331996
TCGA_GLIOBLASTOMA_COPY_NUMBE...2,SET,67,0.10945,0.0065964,0.13565,0.20988,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,0.918332027331996
GOBP_INFLAMMATORY_RESPONSE_T...1,SET,70,0.091761,0.0056524,0.11373,0.20988,GOBP_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.918332027331996
MIR4753_3P,SET,513,0.031501,0.0051891,0.039044,0.2099,MIR4753_3P,0.918332027331996
DER_IFN_ALPHA_RESPONSE_UP,SET,72,0.080798,0.0050474,0.10015,0.20991,DER_IFN_ALPHA_RESPONSE_UP,0.918332027331996
GALIE_TUMOR_STEMNESS_GENES,SET,6,0.327,0.0059074,0.40542,0.20997,GALIE_TUMOR_STEMNESS_GENES,0.918332027331996
GOBP_REGULATION_OF_LIPID_LOC...,SET,154,0.058507,0.0053332,0.072547,0.20999,GOBP_REGULATION_OF_LIPID_LOCALIZATION,0.918332027331996
REACTOME_RECYCLING_OF_BILE_A...,SET,18,0.17192,0.0053776,0.21319,0.21001,REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,0.918332027331996
REACTOME_ASSEMBLY_OF_THE_ORC...,SET,9,0.21751,0.0048121,0.26978,0.21006,REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION,0.918332027331996
GOBP_B_CELL_ACTIVATION_INVOL...,SET,76,0.07765,0.0049831,0.096327,0.21009,GOBP_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.918332027331996
HP_ABNORMAL_OPTIC_CHIASM_MOR...,SET,6,0.33304,0.0060166,0.41317,0.21011,HP_ABNORMAL_OPTIC_CHIASM_MORPHOLOGY,0.918332027331996
HP_LYMPHOPENIA,SET,163,0.054863,0.0051439,0.068076,0.21015,HP_LYMPHOPENIA,0.918332027331996
REACTOME_PYRIMIDINE_CATABOLI...,SET,12,0.21377,0.0054606,0.26526,0.21016,REACTOME_PYRIMIDINE_CATABOLISM,0.918332027331996
GOBP_CELLULAR_RESPONSE_TO_NU...1,SET,45,0.10753,0.0053146,0.13345,0.21019,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT,0.918332027331996
GOBP_PROTEIN_O_LINKED_GLYCOS...2,SET,8,0.24044,0.0050154,0.2984,0.2102,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_SERINE,0.918332027331996
GSE27786_LSK_VS_MONO_MAC_UP,SET,174,0.05033,0.004874,0.06247,0.21022,GSE27786_LSK_VS_MONO_MAC_UP,0.918332027331996
REACTOME_SIGNALING_BY_FLT3_F...,SET,19,0.15592,0.0050108,0.19356,0.21025,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,0.918332027331996
STAMBOLSKY_TARGETS_OF_MUTATE...2,SET,45,0.10536,0.0052074,0.1308,0.21026,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,0.918332027331996
SU_PANCREAS,SET,39,0.10881,0.0050074,0.13509,0.21028,SU_PANCREAS,0.918332027331996
HP_DECREASED_SPECIFIC_ANTIBO...3,SET,13,0.21481,0.0057112,0.2667,0.21029,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_VACCINE,0.918332027331996
HP_DELAYED_FINE_MOTOR_DEVELO...,SET,45,0.10212,0.0050472,0.1268,0.2103,HP_DELAYED_FINE_MOTOR_DEVELOPMENT,0.918332027331996
REACTOME_SYNTHESIS_OF_LIPOXI...,SET,6,0.30124,0.0054422,0.37405,0.21031,REACTOME_SYNTHESIS_OF_LIPOXINS_LX,0.918332027331996
GOCC_MITOCHONDRIAL_PERMEABIL...,SET,6,0.28527,0.0051536,0.35423,0.21032,GOCC_MITOCHONDRIAL_PERMEABILITY_TRANSITION_PORE_COMPLEX,0.918332027331996
GSE4984_LPS_VS_VEHICLE_CTRL_...1,SET,177,0.052783,0.005155,0.065544,0.21033,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN,0.918332027331996
REACTOME_TRAF6_MEDIATED_NF_K...,SET,23,0.14534,0.0051383,0.18051,0.21037,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,0.918332027331996
GSE9650_GP33_VS_GP276_LCMV_S...1,SET,185,0.04838,0.0048296,0.0601,0.21042,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN,0.918332027331996
MIR6880_5P,SET,87,0.074665,0.005125,0.092762,0.21044,MIR6880_5P,0.918332027331996
GOBP_METHIONINE_BIOSYNTHETIC...,SET,12,0.21819,0.0055735,0.27116,0.21052,GOBP_METHIONINE_BIOSYNTHETIC_PROCESS,0.918332027331996
GOBP_RESPONSE_TO_AMYLOID_BETA,SET,50,0.10665,0.005555,0.13254,0.21053,GOBP_RESPONSE_TO_AMYLOID_BETA,0.918332027331996
GAVISH_3CA_METAPROGRAM_EPITH...5,SET,47,0.1098,0.0055456,0.13647,0.21054,GAVISH_3CA_METAPROGRAM_EPITHELIAL_COLON_RELATED,0.918332027331996
GOBP_NEGATIVE_REGULATION_OF_...546,SET,21,0.16094,0.005437,0.20005,0.21056,GOBP_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.918332027331996
GSE24292_WT_VS_PPARG_KO_MACR...1,SET,178,0.049588,0.0048565,0.061647,0.2106,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN,0.918332027331996
KEGG_MEDICUS_PATHOGEN_SALMON...5,SET,9,0.23459,0.0051901,0.29166,0.21061,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY,0.918332027331996
REACTOME_DEADENYLATION_OF_MR...,SET,22,0.14627,0.0050578,0.18186,0.21061,REACTOME_DEADENYLATION_OF_MRNA,0.918332027331996
GSE360_L_MAJOR_VS_B_MALAYI_L...2,SET,177,0.050806,0.004962,0.063169,0.21062,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP,0.918332027331996
BLANCO_MELO_RESPIRATORY_SYNC...1,SET,104,0.068815,0.005162,0.085583,0.21068,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,0.918332027331996
GCM_CDH5,SET,31,0.11911,0.0048876,0.14814,0.2107,GCM_CDH5,0.918332027331996
KYNG_DNA_DAMAGE_DN,SET,171,0.050924,0.0048892,0.063344,0.21072,KYNG_DNA_DAMAGE_DN,0.918332027331996
GOBP_POSITIVE_REGULATION_OF_...159,SET,7,0.29174,0.0056926,0.36291,0.21073,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE,0.918332027331996
MANNO_MIDBRAIN_NEUROTYPES_HG...,SET,972,0.023833,0.0053341,0.029647,0.21074,MANNO_MIDBRAIN_NEUROTYPES_HGABA,0.918332027331996
HP_ABNORMAL_URINE_CARBOHYDRA...,SET,37,0.10957,0.0049113,0.13631,0.21075,HP_ABNORMAL_URINE_CARBOHYDRATE_LEVEL,0.918332027331996
GSE29618_BCELL_VS_PDC_UP,SET,169,0.057489,0.0054875,0.071557,0.21088,GSE29618_BCELL_VS_PDC_UP,0.918783301993231
KEGG_MEDICUS_REFERENCE_BILE_...,SET,14,0.19236,0.0053073,0.2395,0.21093,KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS,0.918814350169194
GOBP_REGULATION_OF_CARDIAC_M...6,SET,25,0.14816,0.0054607,0.18446,0.21094,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.918814350169194
GSE7219_UNSTIM_VS_LPS_AND_AN...1,SET,162,0.054371,0.0050822,0.067735,0.21108,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN,0.919209227010774
KEGG_STARCH_AND_SUCROSE_META...,SET,45,0.11369,0.005619,0.14165,0.2111,KEGG_STARCH_AND_SUCROSE_METABOLISM,0.919209227010774
MIR200B_5P,SET,95,0.067516,0.0048416,0.084123,0.21111,MIR200B_5P,0.919209227010774
GNF2_CD53,SET,52,0.099095,0.0052637,0.1235,0.21118,GNF2_CD53,0.919280237714004
WP_HISTONE_MODIFICATIONS,SET,35,0.10831,0.004722,0.13499,0.21119,WP_HISTONE_MODIFICATIONS,0.919280237714004
LANDIS_BREAST_CANCER_PROGRES...1,SET,68,0.090132,0.0054724,0.11238,0.21128,LANDIS_BREAST_CANCER_PROGRESSION_DN,0.919280237714004
GOCC_PHOSPHATIDYLINOSITOL_3_...3,SET,8,0.23423,0.0048859,0.29207,0.21129,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III,0.919280237714004
HP_VENOUS_MALFORMATION,SET,11,0.2063,0.0050456,0.25724,0.21129,HP_VENOUS_MALFORMATION,0.919280237714004
GSE37416_0H_VS_12H_F_TULAREN...1,SET,178,0.051284,0.0050226,0.063954,0.21131,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.919280237714004
BIOCARTA_VDR_PATHWAY,SET,24,0.13008,0.0046978,0.16224,0.21134,BIOCARTA_VDR_PATHWAY,0.919280237714004
REACTOME_DAG_AND_IP3_SIGNALI...,SET,39,0.11686,0.0053775,0.14576,0.21136,REACTOME_DAG_AND_IP3_SIGNALING,0.919280237714004
KEGG_ETHER_LIPID_METABOLISM,SET,30,0.13352,0.0053903,0.16659,0.21142,KEGG_ETHER_LIPID_METABOLISM,0.919280237714004
REACTOME_NFE2L2_REGULATES_PE...,SET,7,0.28209,0.0055044,0.35204,0.21148,REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES,0.919280237714004
GOMF_PROTEIN_PHOSPHATASE_BIN...,SET,136,0.058555,0.0050185,0.073074,0.21148,GOMF_PROTEIN_PHOSPHATASE_BINDING,0.919280237714004
GSE34156_NOD2_LIGAND_VS_NOD2...3,SET,182,0.051531,0.0051027,0.064312,0.21149,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,0.919280237714004
MIR4668_5P,SET,425,0.033512,0.0050369,0.041827,0.21151,MIR4668_5P,0.919280237714004
MORF_MBD4,SET,75,0.070817,0.0045147,0.088389,0.21151,MORF_MBD4,0.919280237714004
GSE17721_PAM3CSK4_VS_GADIQUI...12,SET,184,0.052449,0.0052217,0.065466,0.21153,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP,0.919280237714004
GOBP_AMINO_ACID_BETAINE_TRAN...,SET,12,0.23744,0.0060652,0.29639,0.21155,GOBP_AMINO_ACID_BETAINE_TRANSPORT,0.919280237714004
GSE16450_CTRL_VS_IFNA_6H_STI...1,SET,157,0.055235,0.0050834,0.068966,0.2116,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.919280237714004
MIR6746_5P,SET,5,0.31516,0.0051976,0.39356,0.21163,MIR6746_5P,0.919280237714004
HP_ADRENOCORTICOTROPIN_DEFIC...,SET,6,0.27449,0.0049589,0.34278,0.21164,HP_ADRENOCORTICOTROPIN_DEFICIENT_ADRENAL_INSUFFICIENCY,0.919280237714004
HP_DEATH_IN_ADULTHOOD,SET,42,0.11396,0.0054418,0.14234,0.21168,HP_DEATH_IN_ADULTHOOD,0.919280237714004
KEGG_MEDICUS_REFERENCE_GLUCO...,SET,5,0.28428,0.0046884,0.35526,0.2118,KEGG_MEDICUS_REFERENCE_GLUCONEOGENESIS,0.919280237714004
GOBP_GASTRULATION_WITH_MOUTH...,SET,23,0.1373,0.0048541,0.17165,0.2119,GOBP_GASTRULATION_WITH_MOUTH_FORMING_SECOND,0.919280237714004
GOBP_REGULATION_OF_AUTOPHAGO...2,SET,15,0.16979,0.0048489,0.21228,0.2119,GOBP_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.919280237714004
GOBP_VESICLE_DOCKING_INVOLVE...,SET,35,0.11187,0.0048775,0.13988,0.21192,GOBP_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS,0.919280237714004
BRUNO_HEMATOPOIESIS,SET,61,0.09204,0.0052938,0.11508,0.21193,BRUNO_HEMATOPOIESIS,0.919280237714004
GOCC_POLYMERIC_CYTOSKELETAL_...,SET,687,0.027575,0.0052309,0.034479,0.21193,GOCC_POLYMERIC_CYTOSKELETAL_FIBER,0.919280237714004
GOBP_REGULATION_OF_NEURON_PR...2,SET,404,0.035219,0.0051641,0.044043,0.21196,GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.919280237714004
MIR4324,SET,238,0.045071,0.0050958,0.056371,0.21199,MIR4324,0.919280237714004
BLUM_RESPONSE_TO_SALIRASIB_UP,SET,221,0.04538,0.0049463,0.056765,0.21202,BLUM_RESPONSE_TO_SALIRASIB_UP,0.919280237714004
DELLA_RESPONSE_TO_TSA_AND_BU...,SET,20,0.15497,0.0051096,0.19385,0.21202,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,0.919280237714004
REACTOME_PLATELET_HOMEOSTASIS,SET,81,0.079334,0.0052553,0.099243,0.21204,REACTOME_PLATELET_HOMEOSTASIS,0.919280237714004
HP_SMALL_BASAL_GANGLIA,SET,13,0.18416,0.0048962,0.23042,0.21208,HP_SMALL_BASAL_GANGLIA,0.919280237714004
GOCC_POTASSIUM_CHANNEL_COMPL...,SET,99,0.075601,0.0055338,0.0946,0.2121,GOCC_POTASSIUM_CHANNEL_COMPLEX,0.919280237714004
GSE360_L_MAJOR_VS_B_MALAYI_L...4,SET,178,0.050514,0.0049472,0.063213,0.21212,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.919280237714004
GSE34156_UNTREATED_VS_24H_TL...2,SET,149,0.058111,0.0052112,0.072722,0.21213,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.919280237714004
GOMF_FOUR_WAY_JUNCTION_HELIC...,SET,6,0.31829,0.0057502,0.39849,0.21222,GOMF_FOUR_WAY_JUNCTION_HELICASE_ACTIVITY,0.919280237714004
HP_CORNEAL_OPACITY,SET,247,0.044971,0.0051784,0.056306,0.21224,HP_CORNEAL_OPACITY,0.919280237714004
GOCC_GERM_CELL_NUCLEUS,SET,62,0.08493,0.0049246,0.10635,0.21228,GOCC_GERM_CELL_NUCLEUS,0.919280237714004
MIR337_3P,SET,110,0.06443,0.0049697,0.080697,0.21232,MIR337_3P,0.919280237714004
HP_REDUCED_FACTOR_VII_ACTIVI...,SET,5,0.2965,0.0048898,0.37136,0.21232,HP_REDUCED_FACTOR_VII_ACTIVITY,0.919280237714004
GOBP_TONGUE_DEVELOPMENT,SET,19,0.17574,0.0056478,0.22014,0.21234,GOBP_TONGUE_DEVELOPMENT,0.919280237714004
FOXJ2_01,SET,168,0.056703,0.0053966,0.071036,0.21237,FOXJ2_01,0.919280237714004
HILLION_HMGA1B_TARGETS,SET,78,0.081636,0.0053071,0.10229,0.21242,HILLION_HMGA1B_TARGETS,0.919280237714004
GOBP_CD8_POSITIVE_ALPHA_BETA...3,SET,7,0.26423,0.0051559,0.33117,0.21248,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.919280237714004
GOBP_ZYGOTIC_DETERMINATION_O...,SET,6,0.3717,0.0067151,0.46588,0.21248,GOBP_ZYGOTIC_DETERMINATION_OF_ANTERIOR_POSTERIOR_AXIS_EMBRYO,0.919280237714004
GSE6674_ANTI_IGM_VS_PL2_3_ST...2,SET,178,0.048927,0.0047917,0.061325,0.21249,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP,0.919280237714004
MISHRA_CARCINOMA_ASSOCIATED_...1,SET,20,0.16363,0.0053949,0.20512,0.21253,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,0.919280237714004
HP_GLOMUS_JUGULAR_TUMOR,SET,5,0.24199,0.0039909,0.30344,0.21259,HP_GLOMUS_JUGULAR_TUMOR,0.919280237714004
GSE2706_2H_VS_8H_LPS_STIM_DC...2,SET,178,0.051219,0.0050163,0.064227,0.21259,GSE2706_2H_VS_8H_LPS_STIM_DC_UP,0.919280237714004
MIKKELSEN_IPS_WITH_HCP_H3K27...,SET,97,0.08082,0.0058561,0.10135,0.2126,MIKKELSEN_IPS_WITH_HCP_H3K27ME3,0.919280237714004
GOCC_BASEMENT_MEMBRANE_COLLA...,SET,6,0.30527,0.0055149,0.38285,0.21262,GOCC_BASEMENT_MEMBRANE_COLLAGEN_TRIMER,0.919280237714004
GOCC_PROXIMAL_DENDRITE,SET,6,0.29465,0.0053231,0.36952,0.21262,GOCC_PROXIMAL_DENDRITE,0.919280237714004
CHIANG_LIVER_CANCER_SUBCLASS...8,SET,161,0.05499,0.0051243,0.068967,0.21263,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,0.919280237714004
GOBP_REGULATION_OF_CHOLESTER...3,SET,33,0.12267,0.0051934,0.15385,0.21264,GOBP_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.919280237714004
REACTOME_NGF_INDEPENDANT_TRK...,SET,5,0.32995,0.0054416,0.41384,0.21265,REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION,0.919280237714004
GOBP_HEMOGLOBIN_METABOLIC_PR...,SET,17,0.16943,0.0051507,0.21253,0.21267,GOBP_HEMOGLOBIN_METABOLIC_PROCESS,0.919280237714004
GOBP_NEUTROPHIL_HOMEOSTASIS,SET,19,0.16453,0.0052874,0.20643,0.21273,GOBP_NEUTROPHIL_HOMEOSTASIS,0.919280237714004
GSE9509_LPS_VS_LPS_AND_IL10_...3,SET,173,0.050519,0.0048784,0.063385,0.21273,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN,0.919280237714004
ISHIKAWA_STING_SIGNALING,SET,10,0.20718,0.0048316,0.25997,0.21275,ISHIKAWA_STING_SIGNALING,0.919280237714004
KRAS.600.LUNG.BREAST_UP.V1_UP,SET,248,0.047825,0.005518,0.06002,0.21278,KRAS.600.LUNG.BREAST_UP.V1_UP,0.919280237714004
GOBP_PROSTATE_GLAND_GROWTH,SET,10,0.25797,0.006016,0.3238,0.21282,GOBP_PROSTATE_GLAND_GROWTH,0.919280237714004
GOCC_VACUOLAR_PROTON_TRANSPO...,SET,8,0.21506,0.0044861,0.26994,0.21282,GOCC_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,0.919280237714004
GOBP_POSITIVE_REGULATION_OF_...43,SET,8,0.23779,0.0049602,0.2985,0.21284,GOBP_POSITIVE_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.919280237714004
GOBP_ISOLEUCINE_TRANSPORT,SET,5,0.31818,0.0052474,0.3996,0.21295,GOBP_ISOLEUCINE_TRANSPORT,0.919280237714004
TGCTGCT_MIR15A_MIR16_MIR15B_...,SET,555,0.028945,0.0049536,0.036356,0.21297,TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497,0.919280237714004
HP_ANEMIA_DUE_TO_REDUCED_LIF...,SET,139,0.058345,0.0050549,0.073301,0.21303,HP_ANEMIA_DUE_TO_REDUCED_LIFE_SPAN_OF_RED_CELLS,0.919280237714004
HP_ARM_DYSTONIA,SET,12,0.18878,0.0048222,0.23718,0.21304,HP_ARM_DYSTONIA,0.919280237714004
BASAKI_YBX1_TARGETS_DN,SET,350,0.037936,0.0051851,0.047665,0.21305,BASAKI_YBX1_TARGETS_DN,0.919280237714004
WP_WNTBETACATENIN_SIGNALING_...2,SET,25,0.14906,0.005494,0.18729,0.21305,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,0.919280237714004
REACTOME_TRANSLATION_OF_REPL...,SET,14,0.1829,0.0050462,0.22981,0.21306,REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX,0.919280237714004
GSE15330_LYMPHOID_MULTIPOTEN...8,SET,181,0.049876,0.0049253,0.062695,0.21315,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.919280237714004
GSE25146_UNSTIM_VS_HELIOBACT...2,SET,165,0.049477,0.004667,0.062209,0.21321,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP,0.919280237714004
THAKAR_PBMC_INACTIVATED_INFL...12,SET,5,0.22838,0.0037665,0.28718,0.21324,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_VS_21_30YO_0DY_UP,0.919280237714004
GGCACTT_MIR519E,SET,109,0.064454,0.004949,0.081053,0.21325,GGCACTT_MIR519E,0.919280237714004
ZA_UNIPROT_Q9UM89_UNREVIEWED...,SET,60,0.089996,0.0051338,0.11321,0.21333,ZA_UNIPROT_Q9UM89_UNREVIEWED_GENES_TARGET_GENES,0.919280237714004
HAN_SATB1_TARGETS_DN,SET,346,0.037963,0.0051597,0.047762,0.21336,HAN_SATB1_TARGETS_DN,0.919280237714004
GOBP_REGULATION_OF_PH,SET,95,0.070101,0.005027,0.0882,0.21337,GOBP_REGULATION_OF_PH,0.919280237714004
GOBP_FOREBRAIN_MORPHOGENESIS,SET,13,0.19456,0.0051728,0.24482,0.2134,GOBP_FOREBRAIN_MORPHOGENESIS,0.919280237714004
GSE46143_CTRL_VS_LMP2A_TRANS...2,SET,182,0.051363,0.005086,0.064631,0.2134,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP,0.919280237714004
GSE3920_UNTREATED_VS_IFNA_TR...2,SET,164,0.054812,0.0051547,0.06898,0.21343,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP,0.919280237714004
GOBP_REGULATION_OF_BONE_RESO...,SET,42,0.11491,0.0054868,0.14464,0.21348,GOBP_REGULATION_OF_BONE_RESORPTION,0.919280237714004
NIKOLSKY_BREAST_CANCER_10Q22...,SET,8,0.32702,0.0068215,0.4117,0.21351,NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON,0.919280237714004
GOBP_CELLULAR_HYPEROSMOTIC_R...,SET,19,0.15419,0.0049552,0.19411,0.21351,GOBP_CELLULAR_HYPEROSMOTIC_RESPONSE,0.919280237714004
KRIEG_KDM3A_TARGETS_NOT_HYPO...,SET,176,0.049956,0.0048652,0.062898,0.21354,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,0.919280237714004
GOBP_NEGATIVE_REGULATION_OF_...252,SET,5,0.35603,0.0058717,0.44838,0.21359,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,0.919280237714004
GSE24634_NAIVE_CD4_TCELL_VS_...4,SET,172,0.050144,0.0048283,0.06315,0.21359,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP,0.919280237714004
LIU_NASOPHARYNGEAL_CARCINOMA,SET,62,0.084409,0.0048944,0.10632,0.21362,LIU_NASOPHARYNGEAL_CARCINOMA,0.919280237714004
HP_SARCOMA,SET,167,0.053529,0.0050795,0.067441,0.21368,HP_SARCOMA,0.919280237714004
GSE2405_0H_VS_3H_A_PHAGOCYTO...2,SET,188,0.053066,0.0053397,0.066856,0.21368,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.919280237714004
HP_COLITIS,SET,62,0.089937,0.005215,0.11332,0.2137,HP_COLITIS,0.919280237714004
GOMF_SERINE_TYPE_CARBOXYPEPT...,SET,5,0.27268,0.0044971,0.34359,0.21371,GOMF_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY,0.919280237714004
MIR7847_3P,SET,65,0.087062,0.0051685,0.10971,0.21372,MIR7847_3P,0.919280237714004
HALMOS_CEBPA_TARGETS_DN,SET,40,0.11992,0.0055887,0.15112,0.21373,HALMOS_CEBPA_TARGETS_DN,0.919280237714004
STAMBOLSKY_RESPONSE_TO_VITAM...2,SET,75,0.081516,0.0051968,0.10272,0.21373,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,0.919280237714004
GSE3982_BASOPHIL_VS_CENT_MEM...1,SET,172,0.051514,0.0049602,0.064919,0.21374,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.919280237714004
HP_SMALL_THENAR_EMINENCE,SET,10,0.22162,0.0051681,0.2793,0.21376,HP_SMALL_THENAR_EMINENCE,0.919280237714004
MORF_EI24,SET,118,0.060713,0.0048492,0.076528,0.2138,MORF_EI24,0.919280237714004
REACTOME_MYOGENESIS,SET,28,0.14185,0.0055327,0.17885,0.21385,REACTOME_MYOGENESIS,0.919280237714004
REACTOME_METABOLISM_OF_ANGIO...,SET,15,0.21206,0.0060559,0.26737,0.21386,REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS,0.919280237714004
GOBP_INTRACELLULAR_AMINO_ACI...,SET,8,0.25632,0.0053466,0.32333,0.21397,GOBP_INTRACELLULAR_AMINO_ACID_HOMEOSTASIS,0.919280237714004
HASINA_NOL7_TARGETS_DN,SET,13,0.20968,0.0055749,0.26452,0.21399,HASINA_NOL7_TARGETS_DN,0.919280237714004
GOBP_HEMATOPOIETIC_STEM_CELL...4,SET,5,0.27357,0.0045117,0.34517,0.21402,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION_TO_BONE_MARROW,0.919280237714004
GSE46606_UNSTIM_VS_CD40L_IL2...6,SET,180,0.051082,0.0050306,0.064462,0.21406,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP,0.919280237714004
HP_APLASIA_HYPOPLASIA_OF_THE...78,SET,27,0.11692,0.0044781,0.14756,0.21409,HP_APLASIA_HYPOPLASIA_OF_THE_UVULA,0.919280237714004
GSE11864_UNTREATED_VS_CSF1_P...2,SET,164,0.051787,0.0048702,0.06536,0.21409,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP,0.919280237714004
WP_THYROID_STIMULATING_HORMO...,SET,66,0.089463,0.0053516,0.11292,0.2141,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,0.919280237714004
GSE23568_CTRL_TRANSDUCED_VS_...2,SET,185,0.052534,0.0052442,0.066311,0.21412,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP,0.919280237714004
MORF_PSMF1,SET,159,0.051218,0.0047433,0.064655,0.21413,MORF_PSMF1,0.919280237714004
REACTOME_GOLGI_CISTERNAE_PER...,SET,14,0.15624,0.0043106,0.19723,0.21414,REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION,0.919280237714004
HP_CONGENITAL_FIBROSIS_OF_EX...,SET,6,0.27236,0.0049203,0.34385,0.21416,HP_CONGENITAL_FIBROSIS_OF_EXTRAOCULAR_MUSCLES,0.919280237714004
GCNP_SHH_UP_EARLY.V1_UP,SET,156,0.052599,0.0048255,0.066407,0.21416,GCNP_SHH_UP_EARLY.V1_UP,0.919280237714004
GSE17721_CTRL_VS_POLYIC_24H_...1,SET,186,0.0497,0.0049745,0.062745,0.21416,GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN,0.919280237714004
MIR1291,SET,97,0.070845,0.0051333,0.089444,0.21417,MIR1291,0.919280237714004
WP_SELENIUM_METABOLISM_AND_S...,SET,34,0.1208,0.005191,0.15254,0.2142,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.919280237714004
GSE30083_SP1_VS_SP2_THYMOCYT...1,SET,184,0.052024,0.0051794,0.06569,0.2142,GSE30083_SP1_VS_SP2_THYMOCYTE_DN,0.919280237714004
GSE8685_IL2_STARVED_VS_IL15_...2,SET,182,0.050445,0.0049951,0.063717,0.21427,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,0.919280237714004
BASSO_CD40_SIGNALING_DN,SET,64,0.087571,0.0051587,0.11062,0.21429,BASSO_CD40_SIGNALING_DN,0.919280237714004
HP_ABNORMALITY_OF_THE_SHOULD...,SET,128,0.057686,0.0047974,0.072869,0.21429,HP_ABNORMALITY_OF_THE_SHOULDER_GIRDLE_MUSCULATURE,0.919280237714004
BIOCARTA_CFTR_PATHWAY,SET,10,0.23787,0.0055471,0.30054,0.21434,BIOCARTA_CFTR_PATHWAY,0.919280237714004
KEGG_MEDICUS_REFERENCE_CCR5_...,SET,26,0.13627,0.0051217,0.17219,0.21436,KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY,0.919280237714004
HP_CAROTID_ARTERY_STENOSIS,SET,6,0.2739,0.0049483,0.34612,0.21437,HP_CAROTID_ARTERY_STENOSIS,0.919280237714004
GOBP_L_LYSINE_TRANSMEMBRANE_...,SET,6,0.31436,0.0056792,0.39733,0.21442,GOBP_L_LYSINE_TRANSMEMBRANE_TRANSPORT,0.919280237714004
GOBP_ORNITHINE_TRANSPORT,SET,6,0.31436,0.0056792,0.39733,0.21442,GOBP_ORNITHINE_TRANSPORT,0.919280237714004
GOMF_L_LYSINE_TRANSMEMBRANE_...,SET,6,0.31436,0.0056792,0.39733,0.21442,GOMF_L_LYSINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.919280237714004
GSE13485_DAY1_VS_DAY21_YF17D...1,SET,165,0.049375,0.0046574,0.062417,0.21446,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.919280237714004
GOBP_POSITIVE_REGULATION_OF_...706,SET,5,0.28752,0.0047419,0.36355,0.21452,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.919280237714004
GOMF_PEPTIDASE_ACTIVITY,SET,534,0.030443,0.0051134,0.038499,0.21455,GOMF_PEPTIDASE_ACTIVITY,0.919280237714004
GOMF_3_BETA_HYDROXY_DELTA5_S...,SET,5,0.33589,0.0055395,0.42479,0.21456,GOMF_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY,0.919280237714004
REACTOME_RHOF_GTPASE_CYCLE,SET,39,0.1126,0.0051814,0.14244,0.21463,REACTOME_RHOF_GTPASE_CYCLE,0.919280237714004
GOBP_REGULATION_OF_MUSCLE_HY...,SET,53,0.10075,0.0054028,0.12748,0.21466,GOBP_REGULATION_OF_MUSCLE_HYPERTROPHY,0.919280237714004
GSE32986_UNSTIM_VS_GMCSF_AND...2,SET,181,0.049685,0.0049064,0.062862,0.21466,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.919280237714004
GOMF_CALCIUM_INDEPENDENT_PHO...,SET,9,0.22335,0.0049414,0.28262,0.21469,GOMF_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,0.919280237714004
GAUTAM_EYE_CHOROID_SCLERA_FI...,SET,185,0.050605,0.0050517,0.064036,0.21469,GAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS,0.919280237714004
HP_ABNORMAL_LOWER_LIMB_EPIPH...,SET,84,0.074571,0.0050299,0.094373,0.21472,HP_ABNORMAL_LOWER_LIMB_EPIPHYSIS_MORPHOLOGY,0.919280237714004
HP_URETHRAL_STRICTURE,SET,16,0.17379,0.0051256,0.21995,0.21473,HP_URETHRAL_STRICTURE,0.919280237714004
MIR3187_5P,SET,109,0.063003,0.0048377,0.07974,0.21474,MIR3187_5P,0.919280237714004
HOXB4_TARGET_GENES,SET,931,0.021865,0.0047951,0.027676,0.21475,HOXB4_TARGET_GENES,0.919280237714004
GSE13946_CTRL_VS_DSS_COLITIS...1,SET,157,0.054351,0.0050021,0.068848,0.21493,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN,0.919937456896552
LE_EGR2_TARGETS_DN,SET,103,0.068171,0.0050892,0.086386,0.21502,LE_EGR2_TARGETS_DN,0.920181630140359
GOBP_REGULATION_OF_CATALYTIC...,SET,1229,0.020524,0.0051268,0.02601,0.21504,GOBP_REGULATION_OF_CATALYTIC_ACTIVITY,0.920181630140359
GOBP_POSITIVE_REGULATION_OF_...647,SET,140,0.059492,0.0051726,0.075409,0.21508,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SECRETION,0.920239492798227
GOMF_CULLIN_FAMILY_PROTEIN_B...,SET,21,0.13073,0.0044165,0.16578,0.21518,GOMF_CULLIN_FAMILY_PROTEIN_BINDING,0.920440726153846
GSE6269_FLU_VS_STREP_PNEUMO_...1,SET,146,0.05616,0.0049856,0.071215,0.21518,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN,0.920440726153846
GOBP_REGULATION_OF_LENS_FIBE...,SET,8,0.26058,0.0054355,0.33054,0.21525,GOBP_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.920505507068224
HP_MODERATELY_REDUCED_VISUAL...,SET,7,0.29305,0.0057181,0.3718,0.2153,HP_MODERATELY_REDUCED_VISUAL_ACUITY,0.920505507068224
GSE3982_EOSINOPHIL_VS_BASOPH...2,SET,173,0.051772,0.0049994,0.065689,0.21531,GSE3982_EOSINOPHIL_VS_BASOPHIL_UP,0.920505507068224
GOBP_SIALYLATION,SET,10,0.21877,0.0051018,0.27759,0.21532,GOBP_SIALYLATION,0.920505507068224
GOBP_NEGATIVE_REGULATION_OF_...86,SET,28,0.13736,0.0053573,0.17429,0.21533,GOBP_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.920505507068224
GOBP_NEGATIVE_REGULATION_OF_...414,SET,12,0.2357,0.0060209,0.29912,0.21536,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.920505507068224
GOBP_REGULATION_OF_PHOSPHORY...,SET,890,0.023842,0.005118,0.030264,0.21542,GOBP_REGULATION_OF_PHOSPHORYLATION,0.920505507068224
MODULE_168,SET,10,0.23685,0.0055234,0.30067,0.21543,MODULE_168,0.920505507068224
SMID_BREAST_CANCER_RELAPSE_I...7,SET,37,0.11627,0.0052119,0.14762,0.21546,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,0.920505507068224
YY1_02,SET,228,0.043688,0.0048358,0.055467,0.21546,YY1_02,0.920505507068224
REACTOME_RETINOID_CYCLE_DISE...,SET,11,0.20717,0.0050669,0.26308,0.21551,REACTOME_RETINOID_CYCLE_DISEASE_EVENTS,0.920544753957541
GOBP_NEGATIVE_REGULATION_OF_...391,SET,5,0.3446,0.0056833,0.43767,0.21554,GOBP_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.920544753957541
GHANDHI_BYSTANDER_IRRADIATIO...2,SET,72,0.089368,0.0055827,0.11351,0.21555,GHANDHI_BYSTANDER_IRRADIATION_UP,0.920544753957541
HP_NAIL_PITS,SET,9,0.22494,0.0049766,0.2858,0.21563,HP_NAIL_PITS,0.920544753957541
KYNG_ENVIRONMENTAL_STRESS_RE...8,SET,48,0.0923,0.0047109,0.11728,0.21565,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,0.920544753957541
GOBP_PEPTIDYL_TYROSINE_MODIF...,SET,248,0.045022,0.0051946,0.05722,0.2157,GOBP_PEPTIDYL_TYROSINE_MODIFICATION,0.920544753957541
HP_ABNORMAL_CIRCULATING_IRON...,SET,17,0.16042,0.0048768,0.2039,0.21571,HP_ABNORMAL_CIRCULATING_IRON_CONCENTRATION,0.920544753957541
HP_DARK_URINE,SET,9,0.22151,0.0049007,0.28157,0.21574,HP_DARK_URINE,0.920544753957541
NOTCH_DN.V1_DN,SET,161,0.054745,0.0051015,0.069589,0.21574,NOTCH_DN.V1_DN,0.920544753957541
RICKMAN_TUMOR_DIFFERENTIATED...4,SET,97,0.067411,0.0048845,0.085701,0.21577,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,0.920544753957541
GSE45365_CD8A_DC_VS_CD11B_DC...6,SET,166,0.052081,0.0049273,0.066211,0.21577,GSE45365_CD8A_DC_VS_CD11B_DC_UP,0.920544753957541
GOBP_HEMIDESMOSOME_ASSEMBLY,SET,6,0.31058,0.0056109,0.39491,0.21581,GOBP_HEMIDESMOSOME_ASSEMBLY,0.920544753957541
GOBP_MITOTIC_DNA_INTEGRITY_C...,SET,79,0.068698,0.0044944,0.087357,0.21582,GOBP_MITOTIC_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.920544753957541
UNTERMAN_IPF_VS_CTRL_NK_CELL...2,SET,2,0.40188,0.0041922,0.51108,0.21584,UNTERMAN_IPF_VS_CTRL_NK_CELL_UP,0.920544753957541
MIR762,SET,164,0.049824,0.0046856,0.0634,0.21598,MIR762,0.920860431742917
MIR938,SET,69,0.076338,0.0046687,0.097144,0.21599,MIR938,0.920860431742917
GNF2_ELAC2,SET,40,0.097408,0.0045394,0.12396,0.216,GNF2_ELAC2,0.920860431742917
GOBP_REGULATION_OF_STEROID_H...1,SET,15,0.19707,0.0056279,0.25082,0.21602,GOBP_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.920860431742917
MINGUEZ_LIVER_CANCER_VASCULA...1,SET,21,0.1575,0.0053209,0.20057,0.21615,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,0.921188626609442
GOBP_REGULATION_OF_RESPONSE_...6,SET,15,0.18783,0.0053641,0.2392,0.21615,GOBP_REGULATION_OF_RESPONSE_TO_FOOD,0.921188626609442
GOBP_RESPONSE_TO_SORBITOL,SET,6,0.30198,0.0054555,0.38461,0.21618,GOBP_RESPONSE_TO_SORBITOL,0.921203518881805
BROWNE_HCMV_INFECTION_1HR_DN,SET,186,0.048166,0.004821,0.061356,0.21622,BROWNE_HCMV_INFECTION_1HR_DN,0.921233292473645
KEGG_MEDICUS_PATHOGEN_EBV_EB...3,SET,9,0.21602,0.0047793,0.27519,0.21624,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483,0.921233292473645
HP_HIGH_FREQUENCY_HEARING_IM...,SET,5,0.34648,0.0057142,0.44148,0.21628,HP_HIGH_FREQUENCY_HEARING_IMPAIRMENT,0.92129077092781
HP_DECREASED_CIRCULATING_COM...2,SET,27,0.13934,0.005337,0.17758,0.21633,HP_DECREASED_CIRCULATING_COMPLEMENT_C4_CONCENTRATION,0.921350238882764
MIR5089_3P,SET,62,0.084002,0.0048708,0.10706,0.21635,MIR5089_3P,0.921350238882764
GOBP_POSITIVE_REGULATION_OF_...76,SET,23,0.13531,0.0047839,0.17249,0.21639,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT,0.921350238882764
HP_STENOSIS_OF_THE_EXTERNAL_...,SET,32,0.12282,0.0051207,0.15658,0.2164,HP_STENOSIS_OF_THE_EXTERNAL_AUDITORY_CANAL,0.921350238882764
GOCC_NURD_COMPLEX,SET,14,0.16405,0.0045261,0.2092,0.21647,GOCC_NURD_COMPLEX,0.921452203991674
GOBP_CELL_CYCLE_DNA_REPLICAT...1,SET,41,0.098521,0.0046482,0.12564,0.21649,GOBP_CELL_CYCLE_DNA_REPLICATION,0.921452203991674
GOBP_ADP_TRANSPORT,SET,10,0.22162,0.0051682,0.28268,0.21653,GOBP_ADP_TRANSPORT,0.921452203991674
GOBP_SEMICIRCULAR_CANAL_DEVE...,SET,9,0.25344,0.0056071,0.32327,0.21653,GOBP_SEMICIRCULAR_CANAL_DEVELOPMENT,0.921452203991674
GOCC_EXTRINSIC_COMPONENT_OF_...8,SET,6,0.29548,0.0053381,0.377,0.21659,GOCC_EXTRINSIC_COMPONENT_OF_PRESYNAPTIC_MEMBRANE,0.921456129940046
WESTON_VEGFA_TARGETS_3HR,SET,59,0.094445,0.0053426,0.12052,0.21662,WESTON_VEGFA_TARGETS_3HR,0.921456129940046
GOBP_PLANAR_CELL_POLARITY_PA...2,SET,10,0.2228,0.0051957,0.28433,0.21664,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.921456129940046
chr3q24,SET,15,0.26781,0.007648,0.34178,0.21665,chr3q24,0.921456129940046
GTAGGCA_MIR189,SET,25,0.12709,0.0046841,0.16222,0.21669,GTAGGCA_MIR189,0.921456129940046
GOBP_SNRNA_TRANSCRIPTION_BY_...1,SET,16,0.14947,0.0044082,0.19078,0.21669,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.921456129940046
MIR4433A_3P,SET,53,0.089472,0.0047979,0.11424,0.21677,MIR4433A_3P,0.921613321100918
GOCC_PERINUCLEAR_THECA,SET,4,0.31185,0.0046002,0.39821,0.21678,GOCC_PERINUCLEAR_THECA,0.921613321100918
GSE41978_ID2_KO_AND_BIM_KO_V...2,SET,175,0.050788,0.0049323,0.064868,0.21683,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.921700220102714
GOBP_NEGATIVE_REGULATION_OF_...83,SET,308,0.037493,0.0048129,0.047894,0.21687,GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS,0.921700220102714
GSE2585_THYMIC_DC_VS_THYMIC_...1,SET,177,0.049892,0.0048727,0.063738,0.21688,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN,0.921700220102714
GOBP_CELL_RECOGNITION,SET,152,0.058097,0.0052617,0.074234,0.21693,GOBP_CELL_RECOGNITION,0.921799993886783
SMID_BREAST_CANCER_LUMINAL_B...2,SET,155,0.056612,0.0051771,0.072384,0.21708,SMID_BREAST_CANCER_LUMINAL_B_UP,0.921864495849609
HP_POSTEXERTIONAL_SYMPTOM_EX...,SET,14,0.17942,0.0049501,0.22941,0.21709,HP_POSTEXERTIONAL_SYMPTOM_EXACERBATION,0.921864495849609
GOBP_OXYGEN_TRANSPORT,SET,11,0.24921,0.0060951,0.31871,0.21713,GOBP_OXYGEN_TRANSPORT,0.921864495849609
GOCC_HEMIDESMOSOME,SET,7,0.28806,0.0056209,0.36839,0.21713,GOCC_HEMIDESMOSOME,0.921864495849609
MIR580_3P,SET,190,0.050165,0.0050743,0.064166,0.21717,MIR580_3P,0.921864495849609
GSE9946_MATURE_STIMULATORY_V...3,SET,117,0.063909,0.005083,0.08175,0.21718,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.921864495849609
GSE45739_NRAS_KO_VS_WT_UNSTI...2,SET,178,0.050066,0.0049033,0.064047,0.2172,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP,0.921864495849609
GSE17721_CTRL_VS_CPG_4H_BMDC...2,SET,188,0.047705,0.0048002,0.061037,0.21724,GSE17721_CTRL_VS_CPG_4H_BMDC_UP,0.921864495849609
HP_PERSEVERATIVE_THOUGHT,SET,19,0.14529,0.0046693,0.18591,0.21725,HP_PERSEVERATIVE_THOUGHT,0.921864495849609
GOBP_UTP_METABOLIC_PROCESS,SET,11,0.21467,0.0052504,0.27469,0.21726,GOBP_UTP_METABOLIC_PROCESS,0.921864495849609
GOCC_CELL_CORTEX,SET,288,0.040147,0.0049862,0.051374,0.21727,GOCC_CELL_CORTEX,0.921864495849609
AREB6_01,SET,248,0.043608,0.0050314,0.055809,0.21729,AREB6_01,0.921864495849609
GOBP_PYRIMIDINE_NUCLEOSIDE_D...1,SET,6,0.25565,0.0046185,0.32717,0.21729,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.921864495849609
GLI1_TARGET_GENES,SET,421,0.033234,0.0049722,0.042549,0.21738,GLI1_TARGET_GENES,0.922133760527279
MIR2682_3P,SET,59,0.086946,0.0049184,0.11136,0.21748,MIR2682_3P,0.922300970873786
GOBP_UMP_CATABOLIC_PROCESS,SET,5,0.3137,0.0051736,0.40184,0.2175,GOBP_UMP_CATABOLIC_PROCESS,0.922300970873786
REACTOME_CASPASE_ACTIVATION_...3,SET,25,0.13621,0.0050203,0.1745,0.21753,REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,0.922300970873786
YYCATTCAWW_UNKNOWN,SET,178,0.050598,0.0049555,0.064842,0.2176,YYCATTCAWW_UNKNOWN,0.922300970873786
GSE23505_UNTREATED_VS_4DAY_I...1,SET,178,0.05145,0.0050389,0.06595,0.21766,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,0.922300970873786
KEGG_PHENYLALANINE_METABOLISM,SET,15,0.19557,0.0055849,0.25073,0.2177,KEGG_PHENYLALANINE_METABOLISM,0.922300970873786
GOBP_EMBRYONIC_RETINA_MORPHO...,SET,6,0.30896,0.0055816,0.39621,0.21776,GOBP_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.922300970873786
HP_ABNORMAL_CIRCULATING_IGG_...,SET,107,0.064781,0.0049286,0.083081,0.21778,HP_ABNORMAL_CIRCULATING_IGG_LEVEL,0.922300970873786
HP_RESTRICTIVE_BEHAVIOR,SET,12,0.18902,0.0048285,0.24244,0.2178,HP_RESTRICTIVE_BEHAVIOR,0.922300970873786
MIR6820_5P,SET,11,0.20006,0.004893,0.25665,0.21784,MIR6820_5P,0.922300970873786
GOBP_TOLL_LIKE_RECEPTOR_3_SI...,SET,28,0.12149,0.0047385,0.15586,0.21785,GOBP_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.922300970873786
GOBP_TRIPEPTIDE_TRANSMEMBRAN...,SET,10,0.22547,0.0052581,0.28928,0.21787,GOBP_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORT,0.922300970873786
HP_ABNORMAL_PARATHYROID_MORP...,SET,22,0.15517,0.0053654,0.19911,0.2179,HP_ABNORMAL_PARATHYROID_MORPHOLOGY,0.922300970873786
GOMF_OMEGA_PEPTIDASE_ACTIVITY,SET,12,0.2037,0.0052035,0.26141,0.21792,GOMF_OMEGA_PEPTIDASE_ACTIVITY,0.922300970873786
HP_ABNORMALITY_OF_VITAMIN_B1...,SET,30,0.12614,0.0050923,0.16187,0.21792,HP_ABNORMALITY_OF_VITAMIN_B12_METABOLISM,0.922300970873786
RODRIGUES_DCC_TARGETS_DN,SET,110,0.063822,0.0049228,0.081905,0.21793,RODRIGUES_DCC_TARGETS_DN,0.922300970873786
HESSON_TUMOR_SUPPRESSOR_CLUS...,SET,8,0.27329,0.0057007,0.35082,0.21799,HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3,0.922300970873786
NAISHIRO_CTNNB1_TARGETS_WITH...,SET,8,0.26805,0.0055914,0.34409,0.21799,NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF,0.922300970873786
LEE_LIVER_CANCER_MYC_E2F1_DN,SET,59,0.095482,0.0054013,0.12257,0.218,LEE_LIVER_CANCER_MYC_E2F1_DN,0.922300970873786
GOMF_HYDROLASE_ACTIVITY_HYDR...2,SET,83,0.075508,0.0050629,0.096938,0.21801,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS,0.922300970873786
HP_FRONTOTEMPORAL_CEREBRAL_A...,SET,14,0.16577,0.0045737,0.21289,0.21809,HP_FRONTOTEMPORAL_CEREBRAL_ATROPHY,0.922300970873786
CHEOK_RESPONSE_TO_MERCAPTOPU...6,SET,11,0.18391,0.0044981,0.23619,0.2181,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,0.922300970873786
REACTOME_CELL_CELL_COMMUNICA...,SET,139,0.061256,0.0053071,0.078678,0.21812,REACTOME_CELL_CELL_COMMUNICATION,0.922300970873786
GOBP_REGULATION_OF_TRANSLATI...11,SET,8,0.21651,0.0045163,0.27809,0.21812,GOBP_REGULATION_OF_TRANSLATION_INITIATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.922300970873786
GSE26290_CTRL_VS_AKT_INHIBIT...1,SET,181,0.050821,0.0050186,0.065288,0.21817,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,0.922300970873786
MIR5704,SET,47,0.097157,0.004907,0.12482,0.21819,MIR5704,0.922300970873786
GAVISH_3CA_METAPROGRAM_ENDOT...7,SET,48,0.10516,0.0053671,0.13513,0.21824,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_5,0.922300970873786
HP_RECURRENT_ABSCESS_FORMATI...,SET,16,0.19039,0.0056153,0.24472,0.21829,HP_RECURRENT_ABSCESS_FORMATION,0.922300970873786
MIR31_5P,SET,129,0.059403,0.0049594,0.076362,0.21832,MIR31_5P,0.922300970873786
GSE12392_IFNAR_KO_VS_IFNB_KO...1,SET,185,0.051591,0.00515,0.066334,0.21837,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN,0.922300970873786
GSE22886_IL2_VS_IL15_STIM_NK...1,SET,166,0.050145,0.0047442,0.064475,0.21837,GSE22886_IL2_VS_IL15_STIM_NKCELL_DN,0.922300970873786
WOOD_EBV_EBNA1_TARGETS_DN,SET,43,0.10556,0.0051,0.13574,0.21839,WOOD_EBV_EBNA1_TARGETS_DN,0.922300970873786
E2F_03,SET,218,0.044751,0.004845,0.05755,0.21841,E2F_03,0.922300970873786
IWANAGA_CARCINOGENESIS_BY_KR...2,SET,333,0.036962,0.0049302,0.047536,0.21842,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,0.922300970873786
MODULE_497,SET,29,0.13507,0.0053611,0.17371,0.21842,MODULE_497,0.922300970873786
GOBP_THYROID_HORMONE_MEDIATE...,SET,7,0.27393,0.0053451,0.3523,0.21843,GOBP_THYROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.922300970873786
GOMF_HEPARAN_SULFATE_PROTEOG...,SET,18,0.17962,0.0056186,0.23105,0.21846,GOMF_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING,0.922300970873786
HP_LIP_PIT,SET,9,0.22951,0.0050777,0.29533,0.21855,HP_LIP_PIT,0.922300970873786
HP_UPPER_LIMB_UNDERGROWTH,SET,78,0.071149,0.0046254,0.091559,0.21856,HP_UPPER_LIMB_UNDERGROWTH,0.922300970873786
BIOCARTA_TOLL_PATHWAY,SET,22,0.14985,0.0051816,0.19286,0.21858,BIOCARTA_TOLL_PATHWAY,0.922300970873786
HP_TINNITUS,SET,65,0.079911,0.004744,0.10286,0.21862,HP_TINNITUS,0.922300970873786
GOBP_CELLULAR_RESPONSE_TO_AM...2,SET,40,0.11203,0.0052206,0.14426,0.21872,GOBP_CELLULAR_RESPONSE_TO_AMYLOID_BETA,0.922300970873786
GOCC_NEUROFILAMENT,SET,10,0.24347,0.0056777,0.31354,0.21873,GOCC_NEUROFILAMENT,0.922300970873786
HP_SPASTIC_PARAPARETIC_GAIT,SET,9,0.22679,0.0050176,0.2921,0.21875,HP_SPASTIC_PARAPARETIC_GAIT,0.922300970873786
GOBP_POSITIVE_REGULATION_OF_...809,SET,11,0.20768,0.0050793,0.26749,0.21876,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.922300970873786
GOBP_REGULATION_OF_ANTIMICRO...1,SET,11,0.2176,0.005322,0.28028,0.21877,GOBP_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,0.922300970873786
GOBP_REGULATION_OF_CELL_ADHE...2,SET,46,0.098135,0.0049035,0.12644,0.21883,GOBP_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.922300970873786
WP_CORTICOTROPINRELEASING_HO...,SET,89,0.074056,0.005141,0.095423,0.21886,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,0.922300970873786
GSE1448_ANTI_VALPHA2_VS_VBET...1,SET,177,0.051262,0.0050065,0.06607,0.21892,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN,0.922300970873786
HP_GENERALIZED_CEREBRAL_ATRO...,SET,11,0.19328,0.0047272,0.24925,0.21905,HP_GENERALIZED_CEREBRAL_ATROPHY_HYPOPLASIA,0.922300970873786
HE_LIM_SUN_FETAL_LUNG_C1_PRO...1,SET,176,0.054639,0.0053213,0.070471,0.21907,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL,0.922300970873786
CROONQUIST_IL6_DEPRIVATION_DN,SET,91,0.066512,0.0046687,0.085797,0.21911,CROONQUIST_IL6_DEPRIVATION_DN,0.922300970873786
GOBP_COMPLEMENT_RECEPTOR_MED...,SET,13,0.21622,0.0057486,0.27896,0.21915,GOBP_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.922300970873786
BOYLAN_MULTIPLE_MYELOMA_D_DN,SET,73,0.083353,0.0052428,0.10759,0.21925,BOYLAN_MULTIPLE_MYELOMA_D_DN,0.922300970873786
ROVERSI_GLIOMA_LOH_REGIONS,SET,45,0.12666,0.00626,0.16352,0.21929,ROVERSI_GLIOMA_LOH_REGIONS,0.922300970873786
KEGG_MEDICUS_PATHOGEN_EBV_LM...3,SET,5,0.32246,0.005318,0.41636,0.21933,KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY,0.922300970873786
GSE11961_MEMORY_BCELL_DAY7_V...5,SET,181,0.048194,0.0047592,0.06223,0.21934,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.922300970873786
HP_TRISMUS,SET,13,0.16511,0.0043898,0.21324,0.21938,HP_TRISMUS,0.922300970873786
HP_ACUTE_MYELOID_LEUKEMIA,SET,68,0.079986,0.0048564,0.10332,0.21942,HP_ACUTE_MYELOID_LEUKEMIA,0.922300970873786
GOBP_POSITIVE_REGULATION_OF_...363,SET,37,0.1219,0.0054642,0.15752,0.2195,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.922300970873786
MODULE_177,SET,95,0.067038,0.0048074,0.086633,0.21952,MODULE_177,0.922300970873786
GOBP_VACUOLAR_PROTON_TRANSPO...,SET,5,0.28081,0.0046311,0.36289,0.21953,GOBP_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.922300970873786
WP_COVID19_ADVERSE_OUTCOME_P...,SET,14,0.19006,0.0052437,0.24573,0.21963,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,0.922300970873786
JOHNSTONE_PARVB_TARGETS_2_UP,SET,126,0.061843,0.0051031,0.079966,0.21966,JOHNSTONE_PARVB_TARGETS_2_UP,0.922300970873786
GSE32986_UNSTIM_VS_GMCSF_STI...2,SET,166,0.050297,0.0047586,0.065039,0.21967,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP,0.922300970873786
REACTOME_ACETYLCHOLINE_NEURO...,SET,16,0.18274,0.0053895,0.23631,0.21968,REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.922300970873786
GSE21678_WT_VS_FOXO1_FOXO3_K...2,SET,161,0.053592,0.0049941,0.069308,0.21969,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP,0.922300970873786
HP_ACANTHOSIS_NIGRICANS,SET,57,0.092639,0.0051512,0.11985,0.21977,HP_ACANTHOSIS_NIGRICANS,0.922300970873786
GSE32423_IL7_VS_IL7_IL4_NAIV...1,SET,172,0.049375,0.0047542,0.063876,0.21977,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN,0.922300970873786
GOBP_DNA_DOUBLE_STRAND_BREAK...,SET,19,0.14461,0.0046472,0.18717,0.21989,GOBP_DNA_DOUBLE_STRAND_BREAK_PROCESSING,0.922300970873786
MIR8074,SET,17,0.14597,0.0044374,0.18895,0.21991,MIR8074,0.922300970873786
YAO_TEMPORAL_RESPONSE_TO_PRO...10,SET,169,0.047794,0.0045621,0.061872,0.21992,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,0.922300970873786
MIR34A_5P,SET,283,0.038413,0.0047299,0.049727,0.21992,MIR34A_5P,0.922300970873786
GSE21063_3H_VS_16H_ANTI_IGM_...3,SET,182,0.047728,0.0047261,0.06179,0.21994,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN,0.922300970873786
GSE2706_UNSTIM_VS_2H_LPS_DC_...1,SET,169,0.054,0.0051545,0.069913,0.21995,GSE2706_UNSTIM_VS_2H_LPS_DC_DN,0.922300970873786
WP_PHOSPHODIESTERASES_IN_NEU...,SET,52,0.096409,0.005121,0.12483,0.21997,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.922300970873786
GOCC_ENDOPLASMIC_RETICULUM_C...,SET,11,0.18185,0.0044477,0.23546,0.21997,GOCC_ENDOPLASMIC_RETICULUM_CHAPERONE_COMPLEX,0.922300970873786
GOBP_NEGATIVE_REGULATION_OF_...95,SET,92,0.07331,0.0051739,0.094936,0.22,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,0.922300970873786
HP_CYSTIC_LIVER_DISEASE,SET,40,0.095462,0.0044488,0.12363,0.22001,HP_CYSTIC_LIVER_DISEASE,0.922300970873786
GSE5589_IL6_KO_VS_IL10_KO_LP...1,SET,179,0.049741,0.004885,0.064439,0.22009,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.922300970873786
GOMF_MITOCHONDRION_TARGETING...,SET,5,0.24992,0.0041217,0.3238,0.22011,GOMF_MITOCHONDRION_TARGETING_SEQUENCE_BINDING,0.922300970873786
MIR383_5P,SET,70,0.078038,0.0048071,0.10111,0.22012,MIR383_5P,0.922300970873786
GSE22886_NAIVE_TCELL_VS_DC_DN,SET,189,0.047985,0.0048411,0.062178,0.22014,GSE22886_NAIVE_TCELL_VS_DC_DN,0.922300970873786
REACTOME_NEGATIVE_REGULATORS...,SET,32,0.11917,0.0049682,0.15443,0.22017,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,0.922300970873786
TATA_C,SET,258,0.04397,0.0051731,0.056989,0.22019,TATA_C,0.922300970873786
GOMF_FUCOSYLTRANSFERASE_ACTI...,SET,13,0.19818,0.0052689,0.25686,0.2202,GOMF_FUCOSYLTRANSFERASE_ACTIVITY,0.922300970873786
GOBP_MATERNAL_PLACENTA_DEVEL...,SET,33,0.11824,0.0050058,0.15327,0.22024,GOBP_MATERNAL_PLACENTA_DEVELOPMENT,0.922300970873786
KEGG_MEDICUS_REFERENCE_THYRO...,SET,8,0.22064,0.0046025,0.28607,0.22027,KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY,0.922300970873786
GSE24634_IL4_VS_CTRL_TREATED...5,SET,183,0.050917,0.0050555,0.066027,0.22031,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN,0.922300970873786
MIR33A_5P_MIR33B_5P,SET,106,0.065871,0.0049882,0.085432,0.22035,MIR33A_5P_MIR33B_5P,0.922300970873786
CATRRAGC_UNKNOWN,SET,122,0.058903,0.0047833,0.076407,0.22038,CATRRAGC_UNKNOWN,0.922300970873786
GOCC_CONNEXIN_COMPLEX,SET,18,0.18945,0.0059262,0.24576,0.22039,GOCC_CONNEXIN_COMPLEX,0.922300970873786
GOBP_REGULATION_OF_ANOIKIS,SET,22,0.1462,0.0050553,0.18966,0.2204,GOBP_REGULATION_OF_ANOIKIS,0.922300970873786
MIR548T_5P,SET,389,0.034863,0.0050181,0.045227,0.22041,MIR548T_5P,0.922300970873786
KEGG_MEDICUS_REFERENCE_DERMA...,SET,7,0.27063,0.0052807,0.35114,0.22044,KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION,0.922300970873786
GOBP_LIPOPROTEIN_BIOSYNTHETI...,SET,91,0.067098,0.0047098,0.087059,0.22044,GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS,0.922300970873786
GOBP_TORC1_SIGNALING,SET,92,0.067946,0.0047954,0.088162,0.22045,GOBP_TORC1_SIGNALING,0.922300970873786
GSE15330_HSC_VS_GRANULOCYTE_...2,SET,173,0.048699,0.0047026,0.063189,0.22045,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.922300970873786
HP_SPIDER_HEMANGIOMA,SET,5,0.29033,0.0047882,0.37676,0.22048,HP_SPIDER_HEMANGIOMA,0.922300970873786
GSE14386_UNTREATED_VS_IFNA_T...2,SET,126,0.061217,0.0050514,0.079443,0.22048,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP,0.922300970873786
chr6q13,SET,19,0.23877,0.0076734,0.3099,0.22051,chr6q13,0.922300970873786
ROPERO_HDAC2_TARGETS,SET,98,0.067219,0.0048954,0.087246,0.22052,ROPERO_HDAC2_TARGETS,0.922300970873786
GOCC_TRANSCRIPTION_FACTOR_TF...2,SET,30,0.10085,0.0040714,0.1309,0.22053,GOCC_TRANSCRIPTION_FACTOR_TFIID_COMPLEX,0.922300970873786
HP_BIVENTRICULAR_HYPERTROPHY,SET,13,0.17473,0.0046454,0.22681,0.22054,HP_BIVENTRICULAR_HYPERTROPHY,0.922300970873786
MIR1245A,SET,34,0.12179,0.0052337,0.15811,0.22057,MIR1245A,0.922300970873786
ROETH_TERT_TARGETS_UP,SET,14,0.19773,0.0054552,0.25671,0.22059,ROETH_TERT_TARGETS_UP,0.922300970873786
HP_RAPIDLY_PROGRESSIVE,SET,35,0.10664,0.0046494,0.13847,0.22061,HP_RAPIDLY_PROGRESSIVE,0.922300970873786
HP_LONG_THORAX,SET,6,0.26782,0.0048383,0.34778,0.22063,HP_LONG_THORAX,0.922300970873786
GRYDER_PAX3FOXO1_ENHANCERS_K...,SET,412,0.034964,0.005176,0.045405,0.22064,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,0.922300970873786
GSE27859_CD11C_INT_F480_HI_M...1,SET,179,0.048976,0.0048099,0.0636,0.22064,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN,0.922300970873786
MIR4693_5P,SET,100,0.067019,0.0049302,0.087041,0.22066,MIR4693_5P,0.922300970873786
HP_NEOPLASM_OF_THE_TONGUE,SET,42,0.098717,0.0047138,0.12822,0.22068,HP_NEOPLASM_OF_THE_TONGUE,0.922300970873786
GSE3982_CTRL_VS_LPS_48H_DC_DN,SET,180,0.052333,0.0051538,0.067982,0.22071,GSE3982_CTRL_VS_LPS_48H_DC_DN,0.922300970873786
YWATTWNNRGCT_UNKNOWN,SET,63,0.087272,0.0051009,0.11337,0.22072,YWATTWNNRGCT_UNKNOWN,0.922300970873786
HP_FEMORAL_HERNIA,SET,17,0.1699,0.0051651,0.22074,0.22074,HP_FEMORAL_HERNIA,0.922300970873786
REACTOME_TCF_DEPENDENT_SIGNA...,SET,165,0.050841,0.0047957,0.066059,0.22076,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,0.922300970873786
CDPCR3_01,SET,50,0.10379,0.0054063,0.13488,0.2208,CDPCR3_01,0.922300970873786
GOCC_POSTSYNAPTIC_SPECIALIZA...3,SET,121,0.063924,0.0051698,0.083081,0.22083,GOCC_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.922300970873786
ZHU_CMV_ALL_DN,SET,109,0.068037,0.0052242,0.088432,0.22084,ZHU_CMV_ALL_DN,0.922300970873786
HP_DIAPHRAGMATIC_EVENTRATION,SET,18,0.14507,0.0045379,0.18855,0.22084,HP_DIAPHRAGMATIC_EVENTRATION,0.922300970873786
HP_ENCEPHALOCELE,SET,110,0.060682,0.0046807,0.078894,0.2209,HP_ENCEPHALOCELE,0.922300970873786
GOBP_PYRIMIDINE_RIBONUCLEOSI...4,SET,13,0.18075,0.0048057,0.235,0.22091,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.922300970873786
GSE37301_LYMPHOID_PRIMED_MPP...4,SET,187,0.048404,0.0048578,0.062934,0.22091,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.922300970873786
GSE27786_NKCELL_VS_NEUTROPHI...1,SET,180,0.050027,0.0049267,0.065059,0.22097,GSE27786_NKCELL_VS_NEUTROPHIL_DN,0.922300970873786
REACTOME_IKBA_VARIANT_LEADS_...,SET,6,0.24807,0.0044816,0.32273,0.22105,REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID,0.922300970873786
HNF1_C,SET,225,0.047316,0.0052033,0.061559,0.22106,HNF1_C,0.922300970873786
GSE22025_TGFB1_VS_TGFB1_AND_...1,SET,180,0.051959,0.005117,0.067602,0.22107,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.922300970873786
GOBP_POSITIVE_REGULATION_OF_...689,SET,40,0.09749,0.0045433,0.12685,0.22108,GOBP_POSITIVE_REGULATION_OF_RNA_SPLICING,0.922300970873786
GOMF_7SK_SNRNA_BINDING,SET,9,0.17654,0.0039057,0.22969,0.22108,GOMF_7SK_SNRNA_BINDING,0.922300970873786
GOMF_ALL_TRANS_RETINAL_BINDI...,SET,5,0.29548,0.0048731,0.38447,0.22109,GOMF_ALL_TRANS_RETINAL_BINDING,0.922300970873786
GOBP_NEGATIVE_REGULATION_BY_...2,SET,13,0.1862,0.0049506,0.24229,0.2211,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.922300970873786
REACTOME_SEROTONIN_NEUROTRAN...,SET,16,0.16683,0.0049204,0.2171,0.22111,REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE,0.922300970873786
HP_INCREASED_CIRCULATING_IRO...,SET,11,0.20588,0.0050354,0.26792,0.22112,HP_INCREASED_CIRCULATING_IRON_CONCENTRATION,0.922300970873786
GOBP_INTRACELLULAR_PROTEIN_T...2,SET,630,0.025447,0.00463,0.033118,0.22114,GOBP_INTRACELLULAR_PROTEIN_TRANSPORT,0.922300970873786
GOBP_POSITIVE_REGULATION_OF_...836,SET,30,0.13415,0.0054157,0.17461,0.22116,GOBP_POSITIVE_REGULATION_OF_VASOCONSTRICTION,0.922300970873786
REACTOME_ZINC_INFLUX_INTO_CE...,SET,10,0.18729,0.0043677,0.24378,0.22117,REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,0.922300970873786
HP_DECREASED_SPECIFIC_ANTI_P...,SET,7,0.27476,0.0053613,0.35764,0.22117,HP_DECREASED_SPECIFIC_ANTI_POLYSACCHARIDE_ANTIBODY_LEVEL,0.922300970873786
GOBP_POSITIVE_REGULATION_OF_...105,SET,459,0.031102,0.0048536,0.040489,0.2212,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.922300970873786
HP_FOLLICULAR_HYPERPLASIA,SET,14,0.18809,0.0051892,0.24485,0.2212,HP_FOLLICULAR_HYPERPLASIA,0.922300970873786
GOBP_DIACYLGLYCEROL_CATABOLI...,SET,5,0.31959,0.0052707,0.41607,0.22121,GOBP_DIACYLGLYCEROL_CATABOLIC_PROCESS,0.922300970873786
ALCALAY_AML_BY_NPM1_LOCALIZA...1,SET,168,0.051865,0.0049362,0.067538,0.22126,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,0.922300970873786
GSE15930_STIM_VS_STIM_AND_IF...5,SET,181,0.046752,0.0046168,0.060882,0.22128,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN,0.922300970873786
GGGCATT_MIR365,SET,100,0.06585,0.0048442,0.085758,0.22129,GGGCATT_MIR365,0.922300970873786
GSE22886_TH1_VS_TH2_48H_ACT_...1,SET,182,0.049712,0.0049225,0.064744,0.2213,GSE22886_TH1_VS_TH2_48H_ACT_DN,0.922300970873786
GOBP_ATRIAL_SEPTUM_DEVELOPME...,SET,21,0.1634,0.0055204,0.21282,0.22131,GOBP_ATRIAL_SEPTUM_DEVELOPMENT,0.922300970873786
GSE5589_LPS_AND_IL10_VS_LPS_...1,SET,178,0.04859,0.0047588,0.063292,0.22133,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.922300970873786
HP_HEPATOSPLENOMEGALY,SET,152,0.053357,0.0048324,0.069511,0.22137,HP_HEPATOSPLENOMEGALY,0.922300970873786
SCHERER_PBMC_APSV_WETVAX_AGE...1,SET,31,0.11327,0.004648,0.14756,0.22137,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_DN,0.922300970873786
MIR6830_3P,SET,191,0.051886,0.005262,0.067602,0.22139,MIR6830_3P,0.922300970873786
KEGG_TOLL_LIKE_RECEPTOR_SIGN...,SET,95,0.072653,0.0052101,0.094661,0.2214,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.922300970873786
GSE21379_TFH_VS_NON_TFH_SAP_...2,SET,179,0.047536,0.0046685,0.061954,0.22146,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP,0.922305818965517
GOBP_REGULATION_OF_PROTEIN_E...2,SET,34,0.11059,0.0047522,0.14413,0.22147,GOBP_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.922305818965517
GOBP_CARDIAC_ATRIUM_DEVELOPM...,SET,34,0.12788,0.0054952,0.16668,0.22149,GOBP_CARDIAC_ATRIUM_DEVELOPMENT,0.922305818965517
GOBP_REGULATION_OF_CELL_JUNC...,SET,198,0.049599,0.0051204,0.064668,0.22155,GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.922305818965517
REACTOME_TRANSLATION_OF_SARS...2,SET,54,0.087623,0.0047427,0.11426,0.22158,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,0.922305818965517
GSE4590_PRE_BCELL_VS_LARGE_P...1,SET,147,0.05245,0.0046721,0.068407,0.22162,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN,0.922305818965517
HP_NEUROPATHIC_ARTHROPATHY,SET,5,0.26076,0.0043005,0.34011,0.22163,HP_NEUROPATHIC_ARTHROPATHY,0.922305818965517
HP_TROPHIC_CHANGES_RELATED_T...,SET,5,0.26076,0.0043005,0.34011,0.22163,HP_TROPHIC_CHANGES_RELATED_TO_PAIN,0.922305818965517
MIR1247_5P,SET,4,0.3412,0.0050331,0.44502,0.22164,MIR1247_5P,0.922305818965517
MINGUEZ_LIVER_CANCER_VASCULA...2,SET,13,0.16825,0.0044731,0.21947,0.22167,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,0.922320226266012
KEGG_MEDICUS_REFERENCE_AUTOP...4,SET,7,0.22387,0.0043683,0.29207,0.2217,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN,0.922334630117309
GSE17721_PAM3CSK4_VS_GADIQUI...17,SET,183,0.04756,0.0047222,0.062066,0.22176,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN,0.922473824057451
PID_SHP2_PATHWAY,SET,55,0.093878,0.0051279,0.12256,0.22185,PID_SHP2_PATHWAY,0.92257975
HP_INAPPROPRIATE_LAUGHTER,SET,27,0.12705,0.0048662,0.16593,0.22194,HP_INAPPROPRIATE_LAUGHTER,0.92257975
GOBP_POSITIVE_REGULATION_OF_...841,SET,60,0.080986,0.0046198,0.10578,0.22196,GOBP_POSITIVE_REGULATION_OF_VIRAL_PROCESS,0.92257975
HP_LIMB_MYOCLONUS,SET,25,0.13563,0.0049988,0.17714,0.22196,HP_LIMB_MYOCLONUS,0.92257975
OKAWA_NEUROBLASTOMA_1P36_31_...,SET,22,0.21193,0.0073283,0.27684,0.22198,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,0.92257975
MIR3164,SET,93,0.066906,0.0047474,0.087403,0.222,MIR3164,0.92257975
GOCC_NEURON_PROJECTION_TERMI...,SET,117,0.064782,0.0051524,0.084631,0.222,GOCC_NEURON_PROJECTION_TERMINUS,0.92257975
GOBP_FATTY_ACID_HOMEOSTASIS,SET,15,0.16423,0.0046901,0.21459,0.22204,GOBP_FATTY_ACID_HOMEOSTASIS,0.92257975
REACTOME_TOLL_LIKE_RECEPTOR_...2,SET,159,0.053356,0.0049413,0.069739,0.22212,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,0.92257975
BIOCARTA_NOTCH_PATHWAY,SET,6,0.22682,0.0040976,0.29649,0.22214,BIOCARTA_NOTCH_PATHWAY,0.92257975
LIN_TUMOR_ESCAPE_FROM_IMMUNE...,SET,17,0.16097,0.0048936,0.21047,0.22219,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,0.92257975
HP_LEUKEMIA,SET,162,0.050863,0.0047543,0.066516,0.22224,HP_LEUKEMIA,0.92257975
GSE37301_RAG2_KO_VS_RAG2_AND...1,SET,182,0.047436,0.0046971,0.062037,0.22225,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN,0.92257975
HP_FOCAL_ONSET_SEIZURE,SET,296,0.038033,0.0047877,0.049744,0.22227,HP_FOCAL_ONSET_SEIZURE,0.92257975
GOBP_REGULATION_OF_NEUROTRAN...4,SET,88,0.070211,0.0048468,0.091835,0.22228,GOBP_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.92257975
GOBP_ESTABLISHMENT_OF_PLANAR...2,SET,15,0.17684,0.0050501,0.23133,0.22231,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_OF_EMBRYONIC_EPITHELIUM,0.92257975
ZNF704_TARGET_GENES,SET,61,0.08175,0.004702,0.10695,0.22233,ZNF704_TARGET_GENES,0.92257975
PGBD5_TARGET_GENES,SET,14,0.16309,0.0044995,0.21339,0.22236,PGBD5_TARGET_GENES,0.92257975
GOCC_NUCLEAR_EXOSOME_RNASE_C...,SET,14,0.16595,0.0045786,0.21719,0.22241,GOCC_NUCLEAR_EXOSOME_RNASE_COMPLEX,0.92257975
GOBP_CAMP_PKA_SIGNAL_TRANSDU...,SET,5,0.32108,0.0052952,0.42022,0.22242,GOBP_CAMP_PKA_SIGNAL_TRANSDUCTION,0.92257975
ZHENG_CORD_BLOOD_C2_PUTATIVE...,SET,86,0.072137,0.0049231,0.094421,0.22244,ZHENG_CORD_BLOOD_C2_PUTATIVE_BASOPHIL_EOSINOPHIL_MAST_CELL_PROGENITOR,0.92257975
GOBP_GERMINAL_CENTER_B_CELL_...,SET,8,0.28338,0.0059111,0.37093,0.22245,GOBP_GERMINAL_CENTER_B_CELL_DIFFERENTIATION,0.92257975
HE_LIM_SUN_FETAL_LUNG_C2_DC2...,SET,49,0.098542,0.0050815,0.12899,0.22245,HE_LIM_SUN_FETAL_LUNG_C2_DC2_CELL,0.92257975
GSE3039_CD4_TCELL_VS_ALPHAAL...1,SET,179,0.049468,0.0048583,0.064777,0.22254,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN,0.92257975
KEGG_MEDICUS_PATHOGEN_HIV_GP...2,SET,17,0.1522,0.004627,0.19932,0.22255,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN,0.92257975
GOBP_POSITIVE_REGULATION_OF_...347,SET,5,0.26202,0.0043213,0.34317,0.22258,GOBP_POSITIVE_REGULATION_OF_HYPERSENSITIVITY,0.92257975
DESCARTES_MAIN_FETAL_ADRENOC...,SET,62,0.087715,0.0050861,0.11489,0.2226,DESCARTES_MAIN_FETAL_ADRENOCORTICAL_CELLS,0.92257975
GOBP_RIBOSOMAL_SMALL_SUBUNIT...3,SET,8,0.26271,0.0054799,0.34417,0.22265,GOBP_RIBOSOMAL_SMALL_SUBUNIT_EXPORT_FROM_NUCLEUS,0.92257975
GOBP_CELLULAR_RESPONSE_TO_AL...1,SET,96,0.072339,0.0052146,0.09478,0.22267,GOBP_CELLULAR_RESPONSE_TO_ALCOHOL,0.92257975
GOBP_MALONYL_COA_METABOLIC_P...,SET,6,0.26589,0.0048034,0.34839,0.22268,GOBP_MALONYL_COA_METABOLIC_PROCESS,0.92257975
REACTOME_SIGNALING_BY_SCF_KIT,SET,42,0.10595,0.0050593,0.13886,0.22274,REACTOME_SIGNALING_BY_SCF_KIT,0.92257975
BIOCARTA_HSP27_PATHWAY,SET,14,0.17334,0.0047825,0.2272,0.22275,BIOCARTA_HSP27_PATHWAY,0.92257975
TURJANSKI_MAPK14_TARGETS,SET,9,0.23603,0.0052219,0.30939,0.22277,TURJANSKI_MAPK14_TARGETS,0.92257975
GOMF_POLY_PYRIMIDINE_TRACT_B...,SET,25,0.13371,0.0049281,0.17527,0.22277,GOMF_POLY_PYRIMIDINE_TRACT_BINDING,0.92257975
GSE17301_CTRL_VS_48H_ACD3_AC...4,SET,176,0.047893,0.0046643,0.062784,0.22279,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP,0.92257975
HP_UNUSUAL_INFECTION_BY_ANAT...,SET,95,0.068329,0.0049,0.089577,0.2228,HP_UNUSUAL_INFECTION_BY_ANATOMICAL_SITE,0.92257975
HP_ABNORMALITY_OF_HUMORAL_IM...,SET,280,0.039643,0.0048558,0.05198,0.22284,HP_ABNORMALITY_OF_HUMORAL_IMMUNITY,0.92257975
HP_LACK_OF_INSIGHT,SET,10,0.18076,0.0042153,0.23701,0.22284,HP_LACK_OF_INSIGHT,0.92257975
GOBP_REGULATION_OF_CELL_DIVI...,SET,171,0.050821,0.0048793,0.066642,0.22286,GOBP_REGULATION_OF_CELL_DIVISION,0.92257975
GOBP_ALDITOL_METABOLIC_PROCE...,SET,21,0.15584,0.0052648,0.20436,0.22287,GOBP_ALDITOL_METABOLIC_PROCESS,0.92257975
GOBP_INTRINSIC_APOPTOTIC_SIG...1,SET,283,0.037815,0.0046562,0.049592,0.22288,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.92257975
HP_ANISOCORIA,SET,15,0.17279,0.0049344,0.22667,0.22295,HP_ANISOCORIA,0.92257975
GOBP_CARDIAC_MUSCLE_CELL_MEM...,SET,36,0.11765,0.0052019,0.15434,0.22296,GOBP_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.92257975
GOMF_CATALYTIC_ACTIVITY_ACTI...2,SET,541,0.026475,0.0044751,0.034735,0.22297,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_NUCLEIC_ACID,0.92257975
GSE40655_FOXO1_KO_VS_WT_NTRE...1,SET,170,0.048334,0.0046271,0.063416,0.22298,GSE40655_FOXO1_KO_VS_WT_NTREG_DN,0.92257975
KEGG_MEDICUS_REFERENCE_DEPHO...,SET,12,0.18323,0.0046806,0.24043,0.22301,KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE,0.922594042375908
KEGG_EPITHELIAL_CELL_SIGNALI...,SET,65,0.079059,0.0046934,0.1038,0.22315,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,0.922894789317507
HP_MALIGNANT_NEOPLASM_OF_THE...,SET,95,0.067719,0.0048562,0.08892,0.22316,HP_MALIGNANT_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.922894789317507
HP_ABNORMALITY_OF_THE_PHALAN...2,SET,3,0.39511,0.0050477,0.51907,0.22328,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_3RD_TOE,0.922894789317507
FOSTER_KDM1A_TARGETS_UP,SET,225,0.046689,0.0051343,0.061343,0.2233,FOSTER_KDM1A_TARGETS_UP,0.922894789317507
MIR200A_5P,SET,96,0.063783,0.0045979,0.08381,0.22332,MIR200A_5P,0.922894789317507
HP_ABNORMAL_VENTRICULAR_AXIS,SET,5,0.32621,0.0053798,0.42863,0.22332,HP_ABNORMAL_VENTRICULAR_AXIS,0.922894789317507
GOBP_REGULATION_OF_CELL_CELL...2,SET,19,0.14493,0.0046577,0.19047,0.22335,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.922894789317507
UNTERMAN_PROGRESSIVE_VS_STAB...4,SET,26,0.15517,0.0058323,0.20394,0.22337,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_MONOCYTE_DN,0.922894789317507
HP_FRONTAL_CORTICAL_ATROPHY,SET,10,0.20916,0.0048776,0.275,0.22346,HP_FRONTAL_CORTICAL_ATROPHY,0.922894789317507
HP_MUSCLE_FIBER_TUBULAR_INCL...,SET,7,0.24968,0.004872,0.32828,0.22346,HP_MUSCLE_FIBER_TUBULAR_INCLUSIONS,0.922894789317507
GOBP_PYRIMIDINE_NUCLEOTIDE_M...,SET,49,0.09359,0.0048261,0.12307,0.22349,GOBP_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS,0.922894789317507
GOMF_ADENYLATE_KINASE_ACTIVI...,SET,9,0.22018,0.0048712,0.28956,0.22352,GOMF_ADENYLATE_KINASE_ACTIVITY,0.922894789317507
GOBP_REGULATION_OF_COLLATERA...,SET,18,0.1645,0.0051456,0.21634,0.22353,GOBP_REGULATION_OF_COLLATERAL_SPROUTING,0.922894789317507
MIR6895_3P,SET,85,0.073387,0.0049794,0.096528,0.22355,MIR6895_3P,0.922894789317507
GOBP_REGULATION_OF_PRIMARY_M...,SET,5,0.32868,0.0054206,0.4323,0.22355,GOBP_REGULATION_OF_PRIMARY_MIRNA_PROCESSING,0.922894789317507
GOMF_DNA_REPLICATION_ORIGIN_...,SET,15,0.18212,0.0052009,0.23962,0.22362,GOMF_DNA_REPLICATION_ORIGIN_BINDING,0.922894789317507
GSE2585_CD80_HIGH_VS_LOW_MTE...1,SET,171,0.049833,0.0047845,0.065567,0.22362,GSE2585_CD80_HIGH_VS_LOW_MTEC_DN,0.922894789317507
MIR122B_5P,SET,195,0.046072,0.0047205,0.060624,0.22364,MIR122B_5P,0.922894789317507
GOBP_RESPONSE_TO_MISFOLDED_P...,SET,17,0.14767,0.0044893,0.19432,0.22364,GOBP_RESPONSE_TO_MISFOLDED_PROTEIN,0.922894789317507
HP_CARPAL_SYNOSTOSIS,SET,33,0.12268,0.0051937,0.16142,0.22364,HP_CARPAL_SYNOSTOSIS,0.922894789317507
NADERI_BREAST_CANCER_PROGNOS...1,SET,14,0.17607,0.0048577,0.23169,0.22365,NADERI_BREAST_CANCER_PROGNOSIS_DN,0.922894789317507
MIR511_3P,SET,154,0.053081,0.0048386,0.069853,0.22367,MIR511_3P,0.922894789317507
GOBP_NEGATIVE_REGULATION_OF_...545,SET,4,0.34319,0.0050625,0.45174,0.22372,GOBP_NEGATIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.922894789317507
GOMF_ATP_DEPENDENT_CHROMATIN...,SET,33,0.10505,0.0044475,0.13827,0.22372,GOMF_ATP_DEPENDENT_CHROMATIN_REMODELER_ACTIVITY,0.922894789317507
REACTOME_PERK_REGULATES_GENE...,SET,30,0.11907,0.0048069,0.15677,0.22377,REACTOME_PERK_REGULATES_GENE_EXPRESSION,0.922991496558272
E47_02,SET,222,0.046111,0.0050372,0.06072,0.22381,E47_02,0.923046938412246
HP_STUTTERING,SET,9,0.20615,0.0045608,0.2715,0.22385,HP_STUTTERING,0.923102367109635
HP_SPONDYLOMETAPHYSEAL_DYSPL...,SET,8,0.22914,0.0047796,0.30193,0.22396,HP_SPONDYLOMETAPHYSEAL_DYSPLASIA,0.923269830448186
GOBP_DE_NOVO_CENTRIOLE_ASSEM...1,SET,5,0.24187,0.0039889,0.31873,0.22398,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY,0.923269830448186
REACTOME_REGULATION_OF_TP53_...6,SET,36,0.1092,0.0048285,0.14393,0.22401,REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION,0.923269830448186
GSE34205_HEALTHY_VS_FLU_INF_...1,SET,175,0.050925,0.0049456,0.067118,0.22401,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN,0.923269830448186
REACTOME_CA_DEPENDENT_EVENTS,SET,35,0.12039,0.005249,0.1587,0.22404,REACTOME_CA_DEPENDENT_EVENTS,0.923269830448186
LANDIS_ERBB2_BREAST_TUMORS_3...2,SET,140,0.055818,0.0048532,0.073582,0.22405,LANDIS_ERBB2_BREAST_TUMORS_324_UP,0.923269830448186
MODULE_36,SET,146,0.052048,0.0046206,0.068621,0.22408,MODULE_36,0.92328398340249
GOBP_LYMPHOCYTE_AGGREGATION,SET,4,0.33499,0.0049416,0.44171,0.22411,GOBP_LYMPHOCYTE_AGGREGATION,0.923298133001423
GOBP_ENDOLYSOSOMAL_TOLL_LIKE...,SET,45,0.095715,0.0047305,0.12623,0.22415,GOBP_ENDOLYSOSOMAL_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.923299377888375
RIGGI_EWING_SARCOMA_PROGENIT...1,SET,172,0.05487,0.0052833,0.072372,0.22418,RIGGI_EWING_SARCOMA_PROGENITOR_DN,0.923299377888375
GOBP_NEGATIVE_REGULATION_OF_...260,SET,6,0.24272,0.0043849,0.32016,0.22419,GOBP_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,0.923299377888375
WP_IL26_SIGNALING,SET,44,0.10893,0.0053238,0.14374,0.22428,WP_IL26_SIGNALING,0.923301865008881
GOBP_AUTOPHAGOSOME_LYSOSOME_...,SET,11,0.18717,0.0045779,0.24701,0.2243,GOBP_AUTOPHAGOSOME_LYSOSOME_FUSION,0.923301865008881
ZNF292_TARGET_GENES,SET,21,0.13454,0.0045453,0.17756,0.22432,ZNF292_TARGET_GENES,0.923301865008881
GSE26290_WT_VS_PDK1_KO_ANTI_...2,SET,169,0.051228,0.0048898,0.067609,0.22432,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,0.923301865008881
GCNF_01,SET,67,0.082808,0.0049907,0.10929,0.22433,GCNF_01,0.923301865008881
GOMF_OXIDOREDUCTASE_ACTIVITY...4,SET,10,0.19104,0.0044552,0.25217,0.22435,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR,0.923301865008881
GOBP_SYNAPSE_ASSEMBLY,SET,190,0.051336,0.0051927,0.067769,0.22438,GOBP_SYNAPSE_ASSEMBLY,0.923315995737627
GOBP_POSITIVE_REGULATION_OF_...683,SET,5,0.33132,0.0054642,0.43753,0.22446,GOBP_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.923386599219027
HP_LARYNGEAL_DYSTONIA,SET,13,0.17517,0.0046574,0.23136,0.22449,HP_LARYNGEAL_DYSTONIA,0.923386599219027
GOBP_REGULATION_OF_PROTEIN_S...1,SET,246,0.043481,0.0049968,0.057438,0.22452,GOBP_REGULATION_OF_PROTEIN_SECRETION,0.923386599219027
GAVISH_3CA_METAPROGRAM_CD8_T...2,SET,42,0.089826,0.0042893,0.11866,0.22453,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN,0.923386599219027
GSE41978_KLRG1_HIGH_VS_LOW_E...2,SET,183,0.050056,0.00497,0.066123,0.22453,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP,0.923386599219027
GSE2405_HEAT_KILLED_VS_LIVE_...4,SET,178,0.045983,0.0045034,0.06075,0.22456,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.92340070989115
GOBP_NUCLEOTIDE_SALVAGE,SET,16,0.17269,0.0050932,0.22821,0.22461,GOBP_NUCLEOTIDE_SALVAGE,0.923497048385189
GOBP_LEPTIN_MEDIATED_SIGNALI...,SET,10,0.20633,0.0048117,0.27277,0.2247,GOBP_LEPTIN_MEDIATED_SIGNALING_PATHWAY,0.923676693863072
GOBP_ACTION_POTENTIAL,SET,158,0.057351,0.0052948,0.075821,0.22471,GOBP_ACTION_POTENTIAL,0.923676693863072
RIGGINS_TAMOXIFEN_RESISTANCE...2,SET,53,0.094768,0.0050819,0.12531,0.22475,RIGGINS_TAMOXIFEN_RESISTANCE_UP,0.923676693863072
GOCC_INNER_KINETOCHORE,SET,14,0.16248,0.0044827,0.21485,0.22476,GOCC_INNER_KINETOCHORE,0.923676693863072
P53_DN.V2_UP,SET,133,0.060796,0.0051532,0.080417,0.22483,P53_DN.V2_UP,0.923855125325136
HP_APLASIA_HYPOPLASIA_OF_THE...61,SET,74,0.072595,0.0045972,0.09606,0.22491,HP_APLASIA_HYPOPLASIA_OF_THE_RADIUS,0.924074601016669
REACTOME_FGFR1C_LIGAND_BINDI...,SET,13,0.20041,0.0053282,0.26526,0.22498,REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION,0.924252943262411
HP_PROLONGED_QT_INTERVAL,SET,45,0.10294,0.0050875,0.13628,0.22502,HP_PROLONGED_QT_INTERVAL,0.924308013237206
GOBP_CELLULAR_RESPONSE_TO_UV...2,SET,10,0.20399,0.004757,0.2701,0.22506,GOBP_CELLULAR_RESPONSE_TO_UV_B,0.924349958648393
HP_ABNORMAL_CIRCULATING_CALC...,SET,46,0.094878,0.0047408,0.12564,0.22509,HP_ABNORMAL_CIRCULATING_CALCIUM_PHOSPHATE_REGULATING_HORMONE_CONCENTRATION,0.924349958648393
HP_CHEILITIS,SET,48,0.10232,0.0052225,0.13552,0.22511,HP_CHEILITIS,0.924349958648393
CHOI_ATL_STAGE_PREDICTOR,SET,39,0.10742,0.0049433,0.14234,0.22523,CHOI_ATL_STAGE_PREDICTOR,0.924679207511515
GOBP_NEURON_PROJECTION_ARBOR...,SET,32,0.11038,0.0046019,0.14629,0.22527,GOBP_NEURON_PROJECTION_ARBORIZATION,0.924679207511515
HU_FETAL_RETINA_BLOOD,SET,244,0.043021,0.0049241,0.057018,0.22527,HU_FETAL_RETINA_BLOOD,0.924679207511515
HP_ABSENT_EYEBROW,SET,31,0.12525,0.0051399,0.16605,0.22533,HP_ABSENT_EYEBROW,0.924694630634883
LI_INDUCED_T_TO_NATURAL_KILL...1,SET,127,0.057546,0.0047672,0.076301,0.22537,LI_INDUCED_T_TO_NATURAL_KILLER_DN,0.924694630634883
GOBP_RECEPTOR_RECYCLING,SET,43,0.095921,0.0046344,0.12719,0.22538,GOBP_RECEPTOR_RECYCLING,0.924694630634883
GOBP_REGULATION_OF_LIPOPROTE...1,SET,12,0.18809,0.0048046,0.24943,0.22541,GOBP_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.924694630634883
MAINA_HYPOXIA_VHL_TARGETS_UP,SET,6,0.32473,0.0058665,0.4307,0.22544,MAINA_HYPOXIA_VHL_TARGETS_UP,0.924694630634883
GOBP_NEGATIVE_REGULATION_OF_...327,SET,5,0.30561,0.0050401,0.40535,0.22545,GOBP_NEGATIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.924694630634883
GOBP_POSITIVE_REGULATION_OF_...808,SET,8,0.23053,0.0048087,0.30579,0.22546,GOBP_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION,0.924694630634883
GNF2_DENR,SET,46,0.083061,0.0041503,0.11025,0.22562,GNF2_DENR,0.92513309352518
GOMF_SPHINGOLIPID_TRANSPORTE...,SET,18,0.1537,0.0048079,0.20403,0.22563,GOMF_SPHINGOLIPID_TRANSPORTER_ACTIVITY,0.92513309352518
MIR1238_3P,SET,30,0.11416,0.0046088,0.15158,0.22568,MIR1238_3P,0.92513309352518
MIR6130,SET,164,0.051026,0.0047986,0.06775,0.22568,MIR6130,0.92513309352518
GOMF_BUBBLE_DNA_BINDING,SET,8,0.24592,0.0051298,0.32655,0.2257,GOMF_BUBBLE_DNA_BINDING,0.92513309352518
REACTOME_SUMOYLATION_OF_SUMO...,SET,33,0.10455,0.0044265,0.13889,0.22579,REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS,0.925134272245138
HP_ANARTHRIA,SET,15,0.14938,0.0042658,0.19843,0.22579,HP_ANARTHRIA,0.925134272245138
HP_GAIT_DISTURBANCE,SET,1053,0.020203,0.0046953,0.026836,0.22579,HP_GAIT_DISTURBANCE,0.925134272245138
GSE23925_LIGHT_ZONE_VS_NAIVE...2,SET,181,0.049654,0.0049034,0.065969,0.22583,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP,0.925134272245138
HP_RHEUMATOID_FACTOR_POSITIVE,SET,18,0.15756,0.0049286,0.20937,0.22586,HP_RHEUMATOID_FACTOR_POSITIVE,0.925134272245138
GSE2405_HEAT_KILLED_LYSATE_V...2,SET,189,0.050289,0.0050735,0.066823,0.22586,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,0.925134272245138
GOBP_REGULATION_OF_ANTIGEN_P...3,SET,4,0.34145,0.0050369,0.45387,0.22594,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,0.925352898892293
GSE25087_FETAL_VS_ADULT_TREG...2,SET,176,0.047169,0.0045938,0.062718,0.22601,GSE25087_FETAL_VS_ADULT_TREG_UP,0.92543529273177
LEE_RECENT_THYMIC_EMIGRANT,SET,197,0.04694,0.0048338,0.06242,0.22603,LEE_RECENT_THYMIC_EMIGRANT,0.92543529273177
GSE7459_UNTREATED_VS_IL6_TRE...1,SET,125,0.059348,0.0048779,0.078922,0.22604,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN,0.92543529273177
GOBP_MAINTENANCE_OF_POSTSYNA...,SET,8,0.22566,0.0047071,0.30017,0.2261,GOBP_MAINTENANCE_OF_POSTSYNAPTIC_SPECIALIZATION_STRUCTURE,0.925571908127208
GOBP_CELLULAR_RESPONSE_TO_CA...2,SET,10,0.19461,0.0045383,0.25892,0.22615,GOBP_CELLULAR_RESPONSE_TO_CAFFEINE,0.925572341928647
REACTOME_EXPORT_OF_VIRAL_RIB...,SET,31,0.10876,0.0044631,0.14472,0.22618,REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS,0.925572341928647
GSE7460_CD8_TCELL_VS_TREG_AC...2,SET,179,0.047463,0.0046613,0.063156,0.22618,GSE7460_CD8_TCELL_VS_TREG_ACT_UP,0.925572341928647
HP_RECURRENT_PHARYNGITIS,SET,7,0.29697,0.0057948,0.3953,0.22625,HP_RECURRENT_PHARYNGITIS,0.925662622720898
KEGG_MEDICUS_PATHOGEN_SHIGEL...3,SET,9,0.23049,0.0050995,0.30693,0.22634,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.925662622720898
GOMF_GLYCOSYLTRANSFERASE_ACT...,SET,254,0.042442,0.0049549,0.056524,0.22637,GOMF_GLYCOSYLTRANSFERASE_ACTIVITY,0.925662622720898
GSE32255_WT_VS_JMJD2D_KNOCKD...2,SET,129,0.057376,0.0047901,0.076421,0.2264,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.925662622720898
PID_BARD1_PATHWAY,SET,28,0.10676,0.0041641,0.14224,0.22645,PID_BARD1_PATHWAY,0.925662622720898
MODULE_464,SET,14,0.18526,0.0051113,0.24682,0.22645,MODULE_464,0.925662622720898
GOCC_ACETYLTRANSFERASE_COMPL...,SET,89,0.062777,0.004358,0.083639,0.22646,GOCC_ACETYLTRANSFERASE_COMPLEX,0.925662622720898
HP_CYANOTIC_EPISODE,SET,7,0.27682,0.0054016,0.36882,0.22646,HP_CYANOTIC_EPISODE,0.925662622720898
GOBP_POSITIVE_REGULATION_OF_...207,SET,1216,0.019788,0.0049188,0.026366,0.22648,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.925662622720898
GOBP_AUTOPHAGOSOME_ORGANIZAT...,SET,112,0.058548,0.0045567,0.078017,0.2265,GOBP_AUTOPHAGOSOME_ORGANIZATION,0.925662622720898
HP_OPEN_OPERCULUM,SET,6,0.26458,0.0047799,0.35284,0.22667,HP_OPEN_OPERCULUM,0.925662622720898
GOBP_DCMP_CATABOLIC_PROCESS,SET,6,0.27973,0.0050535,0.37305,0.22668,GOBP_DCMP_CATABOLIC_PROCESS,0.925662622720898
KEGG_MEDICUS_VARIANT_SCRAPIE...5,SET,5,0.31807,0.0052456,0.42432,0.22675,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.925662622720898
GTTAAAG_MIR302B,SET,63,0.077985,0.0045581,0.10406,0.2268,GTTAAAG_MIR302B,0.925662622720898
GSE4142_NAIVE_VS_MEMORY_BCEL...1,SET,189,0.046808,0.0047224,0.062469,0.22684,GSE4142_NAIVE_VS_MEMORY_BCELL_DN,0.925662622720898
BOYLAN_MULTIPLE_MYELOMA_D_UP,SET,82,0.072735,0.0048477,0.097086,0.22688,BOYLAN_MULTIPLE_MYELOMA_D_UP,0.925662622720898
GSE17721_CTRL_VS_POLYIC_12H_...1,SET,188,0.045218,0.0045499,0.060371,0.22693,GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN,0.925662622720898
HP_DYSMETRIA,SET,158,0.050679,0.0046788,0.067666,0.22694,HP_DYSMETRIA,0.925662622720898
MIR6133,SET,169,0.049898,0.0047629,0.066624,0.22695,MIR6133,0.925662622720898
GSE19923_HEB_KO_VS_HEB_AND_E...1,SET,191,0.047126,0.0047792,0.062923,0.22695,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.925662622720898
REACTOME_NEF_MEDIATED_CD4_DO...,SET,9,0.20709,0.0045816,0.27652,0.22696,REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION,0.925662622720898
chr16q22,SET,105,0.13084,0.0098613,0.17472,0.22698,chr16q22,0.925662622720898
HP_PAST_MEDICAL_HISTORY,SET,156,0.053454,0.0049039,0.071385,0.22699,HP_PAST_MEDICAL_HISTORY,0.925662622720898
MIR9983_3P,SET,424,0.031933,0.0047941,0.042649,0.22701,MIR9983_3P,0.925662622720898
GSE2770_TGFB_AND_IL4_ACT_VS_...4,SET,184,0.046667,0.004646,0.062331,0.22703,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,0.925662622720898
chr7q21,SET,73,0.1347,0.0084724,0.17993,0.22705,chr7q21,0.925662622720898
MIR6081,SET,97,0.065278,0.0047299,0.087214,0.22709,MIR6081,0.925662622720898
HP_IMPAIRED_DISTAL_VIBRATION...,SET,47,0.090357,0.0045636,0.12075,0.22715,HP_IMPAIRED_DISTAL_VIBRATION_SENSATION,0.925662622720898
NAKAMURA_METASTASIS_MODEL_UP,SET,39,0.096763,0.0044528,0.12933,0.22717,NAKAMURA_METASTASIS_MODEL_UP,0.925662622720898
DAZARD_RESPONSE_TO_UV_SCC_UP,SET,88,0.067042,0.0046281,0.08961,0.22719,DAZARD_RESPONSE_TO_UV_SCC_UP,0.925662622720898
CHOP_01,SET,207,0.046287,0.0048847,0.061881,0.22723,CHOP_01,0.925662622720898
GSE20754_WT_VS_TCF1_KO_MEMOR...1,SET,179,0.048527,0.0047658,0.064884,0.22726,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN,0.925662622720898
JINESH_BLEBBISHIELD_TRANSFOR...2,SET,154,0.056479,0.0051484,0.075518,0.22727,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,0.925662622720898
GSE2770_UNTREATED_VS_TGFB_AN...12,SET,183,0.046235,0.0045907,0.061823,0.22727,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP,0.925662622720898
GOBP_NEGATIVE_REGULATION_OF_...670,SET,23,0.13685,0.0048384,0.183,0.22728,GOBP_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.925662622720898
HP_ABNORMAL_UPPER_LIMB_EPIPH...,SET,54,0.089256,0.0048311,0.11937,0.22732,HP_ABNORMAL_UPPER_LIMB_EPIPHYSIS_MORPHOLOGY,0.925662622720898
DESCARTES_FETAL_CEREBELLUM_G...,SET,26,0.13735,0.0051624,0.18369,0.22732,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.925662622720898
GOBP_NEGATIVE_REGULATION_OF_...147,SET,49,0.0869,0.0044811,0.11622,0.22733,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,0.925662622720898
NAKAYA_PBMC_FLUAD_MALE_AGE_1...3,SET,17,0.17959,0.0054594,0.24022,0.22736,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_UP,0.925662622720898
GSE39820_TGFBETA1_VS_TGFBETA...3,SET,179,0.047146,0.0046302,0.06307,0.22738,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN,0.925662622720898
MIR7705,SET,45,0.096373,0.004763,0.12894,0.22741,MIR7705,0.925662622720898
GOBP_RESPONSE_TO_L_LEUCINE,SET,14,0.17441,0.004812,0.23337,0.22743,GOBP_RESPONSE_TO_L_LEUCINE,0.925662622720898
HP_THROMBOEMBOLISM,SET,91,0.071794,0.0050395,0.096066,0.22743,HP_THROMBOEMBOLISM,0.925662622720898
HP_URINARY_INCONTINENCE,SET,134,0.055182,0.0046948,0.073849,0.22747,HP_URINARY_INCONTINENCE,0.925662622720898
MORF_MAP2K2,SET,116,0.055798,0.004419,0.0747,0.22755,MORF_MAP2K2,0.925662622720898
MIR4710,SET,72,0.076965,0.004808,0.10305,0.22756,MIR4710,0.925662622720898
HP_BCGITIS,SET,10,0.21731,0.0050678,0.29095,0.22756,HP_BCGITIS,0.925662622720898
GOBP_BILE_ACID_SIGNALING_PAT...,SET,11,0.20327,0.0049715,0.27221,0.22762,GOBP_BILE_ACID_SIGNALING_PATHWAY,0.925662622720898
TOOKER_GEMCITABINE_RESISTANC...1,SET,115,0.06091,0.0048031,0.081579,0.22765,TOOKER_GEMCITABINE_RESISTANCE_DN,0.925662622720898
HP_NEONATAL_ASPHYXIA,SET,12,0.18048,0.0046104,0.24174,0.22766,HP_NEONATAL_ASPHYXIA,0.925662622720898
GSE28237_FOLLICULAR_VS_EARLY...1,SET,181,0.046947,0.004636,0.062883,0.22766,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN,0.925662622720898
GSE369_PRE_VS_POST_IL6_INJEC...4,SET,178,0.050383,0.0049344,0.067483,0.22766,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP,0.925662622720898
MIR5010_3P,SET,269,0.039929,0.0047952,0.053483,0.22767,MIR5010_3P,0.925662622720898
YKACATTT_UNKNOWN,SET,257,0.041138,0.0048306,0.055111,0.2277,YKACATTT_UNKNOWN,0.925662622720898
GSE24634_TREG_VS_TCONV_POST_...1,SET,189,0.048719,0.0049151,0.065266,0.2277,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN,0.925662622720898
HU_ANGIOGENESIS_DN,SET,32,0.10636,0.0044344,0.14253,0.22776,HU_ANGIOGENESIS_DN,0.925662622720898
MIR630,SET,71,0.074781,0.004639,0.10021,0.22776,MIR630,0.925662622720898
CTACTGT_MIR199A,SET,172,0.048726,0.0046918,0.065303,0.22779,CTACTGT_MIR199A,0.925662622720898
MIR1284,SET,214,0.045186,0.0048475,0.060571,0.22784,MIR1284,0.925662622720898
GOBP_ATRIAL_CARDIAC_MUSCLE_T...1,SET,20,0.16472,0.0054308,0.2208,0.22784,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.925662622720898
GOMF_DNA_DEMETHYLASE_ACTIVITY,SET,5,0.24688,0.0040716,0.33101,0.22788,GOMF_DNA_DEMETHYLASE_ACTIVITY,0.925662622720898
HP_ABNORMALITY_OF_MULTIPLE_C...,SET,165,0.048668,0.0045907,0.065249,0.22788,HP_ABNORMALITY_OF_MULTIPLE_CELL_LINEAGES_IN_THE_BONE_MARROW,0.925662622720898
HP_ELEVATED_CIRCULATING_LONG...,SET,3,0.30438,0.0038886,0.40808,0.22788,HP_ELEVATED_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.925662622720898
GSE32423_IL7_VS_IL4_MEMORY_C...2,SET,182,0.045695,0.0045248,0.061279,0.22793,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP,0.925757526002103
GOBP_REGULATION_OF_PHOSPHATI...3,SET,4,0.30107,0.0044412,0.40378,0.22796,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.925771184856275
GSE21063_WT_VS_NFATC1_KO_8H_...2,SET,179,0.045232,0.0044422,0.060684,0.22803,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP,0.925825788367204
MIR873_3P,SET,55,0.08594,0.0046944,0.1153,0.22804,MIR873_3P,0.925825788367204
MIR589_3P,SET,229,0.043074,0.0047782,0.057799,0.22807,MIR589_3P,0.925825788367204
GSE3982_MAC_VS_CENT_MEMORY_C...2,SET,179,0.046491,0.0045659,0.062389,0.22808,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP,0.925825788367204
VALK_AML_WITH_CEBPA,SET,31,0.12523,0.0051388,0.16812,0.22819,VALK_AML_WITH_CEBPA,0.926002060471632
GOCC_VESICLE_TETHERING_COMPL...,SET,62,0.075773,0.0043937,0.10174,0.22821,GOCC_VESICLE_TETHERING_COMPLEX,0.926002060471632
ONDER_CDH1_TARGETS_1_DN,SET,157,0.05085,0.0046798,0.068282,0.22823,ONDER_CDH1_TARGETS_1_DN,0.926002060471632
GOCC_SECRETORY_GRANULE_MEMBR...,SET,291,0.038576,0.0048156,0.051801,0.22823,GOCC_SECRETORY_GRANULE_MEMBRANE,0.926002060471632
KEGG_MATURITY_ONSET_DIABETES...,SET,25,0.14696,0.0054167,0.19737,0.22826,KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.926015676432824
HP_SPARSE_EYELASHES,SET,61,0.083004,0.0047741,0.11149,0.22829,HP_SPARSE_EYELASHES,0.926029289215686
HP_DERMOID_CYST,SET,6,0.28028,0.0050634,0.37655,0.22834,HP_DERMOID_CYST,0.926124016804761
GSE28449_WT_VS_LRF_KO_GERMIN...1,SET,171,0.050647,0.0048627,0.068062,0.2284,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN,0.926259276546091
GOMF_CALCIUM_DEPENDENT_PROTE...2,SET,10,0.20495,0.0047795,0.27552,0.22848,GOMF_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.926287329684407
CROONQUIST_STROMAL_STIMULATI...1,SET,11,0.21108,0.0051625,0.28379,0.22851,CROONQUIST_STROMAL_STIMULATION_DN,0.926287329684407
CTCAAGA_MIR526B,SET,61,0.078287,0.0045028,0.10527,0.22853,CTCAAGA_MIR526B,0.926287329684407
GOBP_VENTRICULAR_CARDIAC_MUS...1,SET,33,0.12835,0.005434,0.1726,0.22855,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.926287329684407
HP_DYSGENESIS_OF_THE_HIPPOCA...,SET,15,0.16717,0.004774,0.2248,0.22855,HP_DYSGENESIS_OF_THE_HIPPOCAMPUS,0.926287329684407
HP_ABNORMALITY_OF_THE_MUSCUL...1,SET,111,0.057911,0.0044871,0.077903,0.22863,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_HAND,0.926287329684407
GOBP_CELLULAR_RESPONSE_TO_OR...2,SET,1775,0.016534,0.0048841,0.022245,0.22866,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_SUBSTANCE,0.926287329684407
GOMF_ANTIPORTER_ACTIVITY,SET,126,0.056402,0.0046541,0.075893,0.22869,GOMF_ANTIPORTER_ACTIVITY,0.926287329684407
FOURNIER_ACINAR_DEVELOPMENT_...4,SET,22,0.13603,0.0047037,0.18305,0.22871,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,0.926287329684407
GOBP_PYRIMIDINE_DEOXYRIBONUC...2,SET,11,0.19433,0.0047528,0.26151,0.22871,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.926287329684407
DESCARTES_FETAL_STOMACH_ERYT...,SET,86,0.06882,0.0046968,0.092621,0.22873,DESCARTES_FETAL_STOMACH_ERYTHROBLASTS,0.926287329684407
MIR4666B,SET,111,0.063158,0.0048936,0.085003,0.22874,MIR4666B,0.926287329684407
HP_VERRUCAE,SET,25,0.13056,0.004812,0.17575,0.22879,HP_VERRUCAE,0.926287329684407
GNF2_JAK1,SET,30,0.10978,0.0044319,0.14779,0.2288,GNF2_JAK1,0.926287329684407
REACTOME_MITOCHONDRIAL_FATTY...3,SET,6,0.2616,0.004726,0.35223,0.22884,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS,0.926287329684407
GOBP_NEGATIVE_REGULATION_OF_...389,SET,2,0.54633,0.005699,0.73568,0.22886,GOBP_NEGATIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.926287329684407
GSE21033_3H_VS_24H_POLYIC_ST...2,SET,148,0.052692,0.0047094,0.070954,0.22886,GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP,0.926287329684407
GOMF_OPSONIN_RECEPTOR_ACTIVI...,SET,4,0.365,0.0053842,0.49165,0.22893,GOMF_OPSONIN_RECEPTOR_ACTIVITY,0.926462756171402
GOBP_SPONTANEOUS_NEUROTRANSM...,SET,7,0.25139,0.0049052,0.33866,0.22896,GOBP_SPONTANEOUS_NEUROTRANSMITTER_SECRETION,0.926476283618582
KEGG_HUNTINGTONS_DISEASE,SET,153,0.047469,0.0043131,0.063968,0.22903,KEGG_HUNTINGTONS_DISEASE,0.926638705186216
GSE21927_UNTREATED_VS_GMCSF_...4,SET,154,0.051198,0.004667,0.069011,0.22908,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP,0.926638705186216
MIR8076,SET,116,0.055385,0.0043863,0.074664,0.22911,MIR8076,0.926638705186216
GOBP_HUMORAL_IMMUNE_RESPONSE,SET,231,0.048539,0.0054076,0.065457,0.22919,GOBP_HUMORAL_IMMUNE_RESPONSE,0.926638705186216
GOBP_RESPONSE_TO_INTERLEUKIN...9,SET,35,0.10753,0.0046881,0.14503,0.22922,GOBP_RESPONSE_TO_INTERLEUKIN_4,0.926638705186216
MIR6824_5P,SET,73,0.081422,0.0051214,0.10984,0.22927,MIR6824_5P,0.926638705186216
NFE2L1_TARGET_GENES,SET,1475,0.016967,0.0046099,0.022891,0.22929,NFE2L1_TARGET_GENES,0.926638705186216
MIR6788_5P,SET,115,0.062113,0.004898,0.083805,0.2293,MIR6788_5P,0.926638705186216
HP_DECREASED_LYMPHOCYTE_APOP...,SET,6,0.25069,0.0045288,0.33835,0.22938,HP_DECREASED_LYMPHOCYTE_APOPTOSIS,0.926638705186216
REACTOME_PROLONGED_ERK_ACTIV...,SET,14,0.17919,0.0049438,0.2419,0.22943,REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,0.926638705186216
MIR5697,SET,139,0.052903,0.0045834,0.071434,0.22948,MIR5697,0.926638705186216
GOBP_NEGATIVE_REGULATION_OF_...618,SET,13,0.18318,0.0048702,0.24735,0.22948,GOBP_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.926638705186216
HOSHIDA_LIVER_CANCER_SUBCLAS...2,SET,109,0.059412,0.0045619,0.080227,0.22949,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,0.926638705186216
GSE10239_NAIVE_VS_KLRG1INT_E...1,SET,184,0.044725,0.0044527,0.060395,0.22949,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN,0.926638705186216
HP_CROSSED_FUSED_RENAL_ECTOP...,SET,9,0.19788,0.004378,0.26724,0.22951,HP_CROSSED_FUSED_RENAL_ECTOPIA,0.926638705186216
GOBP_NEGATIVE_REGULATION_OF_...518,SET,25,0.11813,0.0043542,0.15955,0.22952,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.926638705186216
HP_PURSED_LIPS,SET,4,0.37578,0.0055433,0.5075,0.22952,HP_PURSED_LIPS,0.926638705186216
GOBP_NEUTRAL_LIPID_METABOLIC...,SET,122,0.058268,0.0047317,0.078697,0.22953,GOBP_NEUTRAL_LIPID_METABOLIC_PROCESS,0.926638705186216
REACTOME_GLYCOGEN_SYNTHESIS,SET,12,0.1839,0.0046976,0.24848,0.22963,REACTOME_GLYCOGEN_SYNTHESIS,0.926638705186216
GOBP_POSITIVE_REGULATION_OF_...271,SET,12,0.19617,0.0050112,0.26508,0.22964,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.926638705186216
YAGI_AML_WITH_T_9_11_TRANSLO...,SET,115,0.061329,0.0048362,0.082874,0.22965,YAGI_AML_WITH_T_9_11_TRANSLOCATION,0.926638705186216
GSE9988_ANTI_TREM1_AND_LPS_V...4,SET,162,0.053768,0.0050258,0.072657,0.22965,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP,0.926638705186216
MEISSNER_BRAIN_HCP_WITH_H3K4...2,SET,54,0.092167,0.0049887,0.12455,0.22966,MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,0.926638705186216
GSE14699_DELETIONAL_TOLERANC...2,SET,169,0.049687,0.0047428,0.067153,0.22968,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.926638705186216
GSE19825_NAIVE_VS_IL2RALOW_D...1,SET,179,0.044906,0.0044102,0.060696,0.2297,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN,0.926638705186216
GSE30971_WBP7_HET_VS_KO_MACR...5,SET,179,0.051811,0.0050884,0.07003,0.2297,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN,0.926638705186216
GSE27786_NKCELL_VS_ERYTHROBL...1,SET,185,0.046443,0.0046362,0.062793,0.22977,GSE27786_NKCELL_VS_ERYTHROBLAST_DN,0.926638705186216
GOBP_REGULATION_OF_TOLL_LIKE...1,SET,11,0.19843,0.0048532,0.2683,0.22978,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.926638705186216
HP_ABNORMAL_BLADDER_MORPHOLO...,SET,66,0.083988,0.0050241,0.11357,0.22979,HP_ABNORMAL_BLADDER_MORPHOLOGY,0.926638705186216
GOBP_RESPONSE_TO_FOLLICLE_ST...,SET,15,0.18241,0.0052091,0.24666,0.2298,GOBP_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE,0.926638705186216
KEGG_MEDICUS_REFERENCE_BLOOD...2,SET,7,0.2644,0.0051592,0.35776,0.22994,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS,0.927041858037578
GSE21063_CTRL_VS_ANTI_IGM_ST...9,SET,164,0.04878,0.0045874,0.066008,0.22996,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN,0.927041858037578
GOBP_GLYCOSAMINOGLYCAN_CATAB...,SET,26,0.1267,0.0047622,0.17147,0.22998,GOBP_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS,0.927041858037578
TEAD2_TARGET_GENES,SET,1172,0.019087,0.0046638,0.025838,0.23005,TEAD2_TARGET_GENES,0.927149269480519
PHESSE_TARGETS_OF_APC_AND_MB...2,SET,15,0.18076,0.0051621,0.24472,0.23006,PHESSE_TARGETS_OF_APC_AND_MBD2_UP,0.927149269480519
GOBP_SUCCINATE_METABOLIC_PRO...,SET,7,0.26534,0.0051775,0.35933,0.23013,GOBP_SUCCINATE_METABOLIC_PROCESS,0.927256631115233
GOCC_SIN3_TYPE_COMPLEX,SET,19,0.13803,0.004436,0.18694,0.23014,GOCC_SIN3_TYPE_COMPLEX,0.927256631115233
GOMF_SODIUM_ION_BINDING,SET,8,0.21273,0.0044375,0.28815,0.23018,GOMF_SODIUM_ION_BINDING,0.927272857142857
GSE21670_TGFB_VS_TGFB_AND_IL...1,SET,175,0.046108,0.0044778,0.062468,0.23023,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,0.927272857142857
GRAHAM_CML_QUIESCENT_VS_CML_...1,SET,10,0.22906,0.0053418,0.31042,0.23029,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,0.927272857142857
MORF_BMI1,SET,73,0.068368,0.0043003,0.092654,0.2303,MORF_BMI1,0.927272857142857
GOBP_REGULATION_OF_POTASSIUM...1,SET,7,0.24998,0.0048777,0.33886,0.23035,GOBP_REGULATION_OF_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.927272857142857
GOBP_NEGATIVE_REGULATION_OF_...305,SET,13,0.19828,0.0052717,0.26878,0.23036,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.927272857142857
NAKAMURA_LUNG_CANCER_DIFFERE...,SET,12,0.19306,0.0049317,0.26174,0.23038,NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS,0.927272857142857
REACTOME_DOWNSTREAM_SIGNALIN...4,SET,24,0.12369,0.0044668,0.16773,0.23044,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,0.927272857142857
MIR648,SET,47,0.096252,0.0048613,0.13055,0.23048,MIR648,0.927272857142857
GOBP_REGULATION_OF_ENTRY_OF_...,SET,7,0.22668,0.0044231,0.30746,0.23049,GOBP_REGULATION_OF_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,0.927272857142857
REACTOME_MYD88_INDEPENDENT_T...,SET,103,0.0622,0.0046434,0.08437,0.2305,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,0.927272857142857
MATZUK_STEROIDOGENESIS,SET,6,0.28665,0.0051786,0.38884,0.23051,MATZUK_STEROIDOGENESIS,0.927272857142857
HP_OSTEOLYTIC_DEFECTS_OF_THE...,SET,5,0.24474,0.0040362,0.33207,0.23057,HP_OSTEOLYTIC_DEFECTS_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.927272857142857
MIR4487,SET,73,0.076237,0.0047953,0.10345,0.23059,MIR4487,0.927272857142857
MIR7107_3P,SET,49,0.093782,0.004836,0.12727,0.2306,MIR7107_3P,0.927272857142857
HP_ABNORMALITY_OF_VITAMIN_D_...,SET,45,0.093728,0.0046323,0.12722,0.23064,HP_ABNORMALITY_OF_VITAMIN_D_METABOLISM,0.927272857142857
MIR4672,SET,335,0.035391,0.0047345,0.048044,0.23068,MIR4672,0.927272857142857
HP_ABNORMAL_MITOCHONDRIAL_SH...,SET,10,0.19042,0.0044406,0.25853,0.23071,HP_ABNORMAL_MITOCHONDRIAL_SHAPE,0.927272857142857
YBX3_TARGET_GENES,SET,52,0.085562,0.0045448,0.11619,0.23075,YBX3_TARGET_GENES,0.927272857142857
REACTOME_HDACS_DEACETYLATE_H...,SET,29,0.10447,0.0041467,0.14189,0.23079,REACTOME_HDACS_DEACETYLATE_HISTONES,0.927272857142857
GSE7831_UNSTIM_VS_CPG_STIM_P...2,SET,180,0.047446,0.0046725,0.064443,0.2308,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP,0.927272857142857
GOBP_ODONTOBLAST_DIFFERENTIA...,SET,16,0.17988,0.0053053,0.2444,0.23087,GOBP_ODONTOBLAST_DIFFERENTIATION,0.927272857142857
HP_OCULAR_ALBINISM,SET,27,0.12478,0.0047793,0.16954,0.23088,HP_OCULAR_ALBINISM,0.927272857142857
HP_AMBIGUOUS_GENITALIA,SET,109,0.059304,0.0045536,0.080582,0.23089,HP_AMBIGUOUS_GENITALIA,0.927272857142857
HP_DIMINISHED_MOTIVATION,SET,563,0.027363,0.0047154,0.037181,0.23089,HP_DIMINISHED_MOTIVATION,0.927272857142857
GOBP_NEGATIVE_REGULATION_OF_...92,SET,626,0.025307,0.0045904,0.03439,0.23091,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,0.927272857142857
GOBP_PROPRIOCEPTION,SET,4,0.35803,0.0052815,0.48669,0.23098,GOBP_PROPRIOCEPTION,0.927272857142857
WP_ARACHIDONATE_EPOXYGENASE_...,SET,7,0.21633,0.0042212,0.29409,0.23099,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,0.927272857142857
MIR4772_5P,SET,48,0.092735,0.0047331,0.12606,0.23099,MIR4772_5P,0.927272857142857
GOMF_DAMAGED_DNA_BINDING,SET,71,0.065659,0.0040732,0.089263,0.231,GOMF_DAMAGED_DNA_BINDING,0.927272857142857
HP_IMMOTILE_CILIA,SET,9,0.21896,0.0048444,0.29768,0.231,HP_IMMOTILE_CILIA,0.927272857142857
HP_LIVEDO,SET,6,0.21349,0.0038568,0.29031,0.23106,HP_LIVEDO,0.927272857142857
GOBP_DOPAMINE_BIOSYNTHETIC_P...,SET,12,0.19331,0.004938,0.2629,0.23108,GOBP_DOPAMINE_BIOSYNTHETIC_PROCESS,0.927272857142857
HP_HYPERPIGMENTATION_OF_THE_...2,SET,290,0.036092,0.0044979,0.049085,0.23108,HP_HYPERPIGMENTATION_OF_THE_SKIN,0.927272857142857
GSE2706_UNSTIM_VS_8H_R848_DC...1,SET,175,0.051939,0.0050441,0.070644,0.23111,GSE2706_UNSTIM_VS_8H_R848_DC_DN,0.927272857142857
GSE32423_MEMORY_VS_NAIVE_CD8...2,SET,177,0.04641,0.0045326,0.06313,0.23113,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN,0.927272857142857
MIR5589_3P,SET,149,0.053105,0.0047623,0.072256,0.23119,MIR5589_3P,0.927272857142857
BIOCARTA_HDAC_PATHWAY,SET,25,0.13295,0.0049003,0.1809,0.2312,BIOCARTA_HDAC_PATHWAY,0.927272857142857
GOMF_TRANSCRIPTION_REGULATOR...3,SET,26,0.13182,0.0049547,0.17942,0.23126,GOMF_TRANSCRIPTION_REGULATOR_INHIBITOR_ACTIVITY,0.927272857142857
REACTOME_INTERLEUKIN_9_SIGNA...,SET,7,0.30128,0.0058787,0.41021,0.23134,REACTOME_INTERLEUKIN_9_SIGNALING,0.927272857142857
GSE21927_SPLEEN_VS_TUMOR_MON...4,SET,157,0.049928,0.0045949,0.067984,0.23135,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP,0.927272857142857
DORMOY_ELAVL1_TARGETS,SET,17,0.16575,0.0050389,0.2257,0.23136,DORMOY_ELAVL1_TARGETS,0.927272857142857
HP_PETERS_ANOMALY,SET,18,0.15603,0.0048806,0.21246,0.23136,HP_PETERS_ANOMALY,0.927272857142857
GOBP_PROTEIN_DEPALMITOYLATION,SET,8,0.21442,0.0044726,0.29199,0.23138,GOBP_PROTEIN_DEPALMITOYLATION,0.927272857142857
JAZAG_TGFB1_SIGNALING_DN,SET,32,0.10668,0.0044478,0.1453,0.23141,JAZAG_TGFB1_SIGNALING_DN,0.927272857142857
GSE1566_WT_VS_EZH2_KO_LN_TCE...1,SET,178,0.047587,0.0046605,0.06484,0.23151,GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN,0.927272857142857
chr1p22,SET,59,0.15505,0.0087712,0.21129,0.23153,chr1p22,0.927272857142857
ZNF138_TARGET_GENES,SET,3,0.30082,0.0038431,0.40999,0.23156,ZNF138_TARGET_GENES,0.927272857142857
KEGG_MEDICUS_REFERENCE_P16_C...,SET,10,0.19552,0.0045595,0.26652,0.2316,KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S,0.927272857142857
GOBP_POSITIVE_REGULATION_OF_...219,SET,65,0.075454,0.0044794,0.10286,0.23161,GOBP_POSITIVE_REGULATION_OF_DNA_RECOMBINATION,0.927272857142857
CACTGTG_MIR128A_MIR128B,SET,305,0.035842,0.0045789,0.048886,0.23173,CACTGTG_MIR128A_MIR128B,0.927272857142857
SYNCRIP_TARGET_GENES,SET,16,0.15084,0.0044489,0.20576,0.23176,SYNCRIP_TARGET_GENES,0.927272857142857
MIR3668,SET,95,0.065,0.0046612,0.088684,0.2318,MIR3668,0.927272857142857
GOMF_NEUROLIGIN_FAMILY_PROTE...,SET,5,0.27325,0.0045065,0.37281,0.2318,GOMF_NEUROLIGIN_FAMILY_PROTEIN_BINDING,0.927272857142857
WONG_ADULT_TISSUE_STEM_MODULE,SET,660,0.026232,0.004881,0.035792,0.23182,WONG_ADULT_TISSUE_STEM_MODULE,0.927272857142857
ZHOU_CELL_CYCLE_GENES_IN_IR_...2,SET,8,0.21156,0.0044131,0.28873,0.23186,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR,0.927272857142857
GOBP_MESANGIAL_CELL_DIFFEREN...,SET,6,0.28081,0.0050731,0.38327,0.23188,GOBP_MESANGIAL_CELL_DIFFERENTIATION,0.927272857142857
TAATTA_CHX10_01,SET,730,0.025023,0.0048871,0.034156,0.2319,TAATTA_CHX10_01,0.927272857142857
HP_PARIETAL_FORAMINA,SET,12,0.19003,0.0048543,0.25939,0.2319,HP_PARIETAL_FORAMINA,0.927272857142857
FRIDMAN_SENESCENCE_UP,SET,75,0.07554,0.0048158,0.10311,0.23191,FRIDMAN_SENESCENCE_UP,0.927272857142857
RSRFC4_01,SET,219,0.044015,0.004776,0.060086,0.23193,RSRFC4_01,0.927272857142857
GSE22611_NOD2_TRANSD_VS_CTRL...1,SET,114,0.059955,0.0047073,0.08187,0.23199,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN,0.927272857142857
BIOCARTA_IL5_PATHWAY,SET,9,0.22539,0.0049866,0.30779,0.232,BIOCARTA_IL5_PATHWAY,0.927272857142857
HP_ADRENOCORTICAL_ABNORMALITY,SET,9,0.21268,0.0047053,0.29043,0.232,HP_ADRENOCORTICAL_ABNORMALITY,0.927272857142857
GOBP_HEME_A_METABOLIC_PROCESS,SET,10,0.19302,0.0045014,0.26364,0.23204,GOBP_HEME_A_METABOLIC_PROCESS,0.927272857142857
KRAS.PROSTATE_UP.V1_DN,SET,124,0.058994,0.0048295,0.080606,0.23212,KRAS.PROSTATE_UP.V1_DN,0.927272857142857
GOBP_SYNAPTIC_VESICLE_RECYCL...2,SET,4,0.2793,0.00412,0.38161,0.23213,GOBP_SYNAPTIC_VESICLE_RECYCLING_VIA_ENDOSOME,0.927272857142857
HP_INCREASED_HEPATIC_ECHOGEN...,SET,5,0.28925,0.0047704,0.39525,0.23214,HP_INCREASED_HEPATIC_ECHOGENICITY,0.927272857142857
HP_PURPURA,SET,117,0.060318,0.0047974,0.082432,0.23217,HP_PURPURA,0.927272857142857
GSE19941_LPS_VS_LPS_AND_IL10...3,SET,178,0.046382,0.0045425,0.063396,0.2322,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.927272857142857
GOMF_SIGNALING_RECEPTOR_BIND...,SET,1327,0.018841,0.0048766,0.025753,0.23221,GOMF_SIGNALING_RECEPTOR_BINDING,0.927272857142857
VAN_DEN_BIGGELAAR_PBMC_PREVN...3,SET,102,0.059898,0.0044499,0.081872,0.23221,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP,0.927272857142857
GSE42724_NAIVE_BCELL_VS_PLAS...1,SET,179,0.047966,0.0047107,0.065572,0.23224,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN,0.927272857142857
GOMF_KETOSTEROID_MONOOXYGENA...,SET,5,0.39851,0.0065722,0.5448,0.23225,GOMF_KETOSTEROID_MONOOXYGENASE_ACTIVITY,0.927272857142857
GSE45365_WT_VS_IFNAR_KO_CD8A...4,SET,174,0.047533,0.0046032,0.064984,0.23225,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP,0.927272857142857
GOMF_4_IRON_4_SULFUR_CLUSTER...,SET,44,0.094777,0.0046319,0.1296,0.2323,GOMF_4_IRON_4_SULFUR_CLUSTER_BINDING,0.927272857142857
GOBP_DNA_STRAND_INVASION,SET,6,0.24386,0.0044055,0.33352,0.23234,GOBP_DNA_STRAND_INVASION,0.927272857142857
RODRIGUES_NTN1_TARGETS_UP,SET,14,0.18736,0.0051692,0.25625,0.23235,RODRIGUES_NTN1_TARGETS_UP,0.927272857142857
MODULE_73,SET,20,0.15832,0.00522,0.21654,0.23235,MODULE_73,0.927272857142857
HP_APLASIA_OF_THE_UTERUS,SET,18,0.15547,0.0048631,0.21271,0.23243,HP_APLASIA_OF_THE_UTERUS,0.927272857142857
GOCC_CILIARY_TRANSITION_FIBER,SET,8,0.22296,0.0046508,0.30509,0.23245,GOCC_CILIARY_TRANSITION_FIBER,0.927272857142857
PID_P53_DOWNSTREAM_PATHWAY,SET,134,0.052989,0.0045081,0.072511,0.23247,PID_P53_DOWNSTREAM_PATHWAY,0.927272857142857
GSE1460_DP_VS_CD4_THYMOCYTE_...2,SET,176,0.046425,0.0045214,0.063536,0.23249,GSE1460_DP_VS_CD4_THYMOCYTE_UP,0.927272857142857
GOMF_ARGININE_BINDING,SET,6,0.29015,0.0052418,0.39721,0.23256,GOMF_ARGININE_BINDING,0.927272857142857
MIR633,SET,128,0.054382,0.0045226,0.074455,0.23258,MIR633,0.927272857142857
STAT1_02,SET,233,0.040206,0.0044983,0.05506,0.23263,STAT1_02,0.927272857142857
GOMF_TAT_PROTEIN_BINDING,SET,10,0.19621,0.0045757,0.26877,0.23269,GOMF_TAT_PROTEIN_BINDING,0.927272857142857
WP_TYPE_2_PAPILLARY_RENAL_CE...,SET,31,0.11402,0.0046789,0.1562,0.23272,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,0.927272857142857
GOBP_MINERALOCORTICOID_METAB...,SET,14,0.19818,0.0054677,0.27152,0.23273,GOBP_MINERALOCORTICOID_METABOLIC_PROCESS,0.927272857142857
GSE27291_0H_VS_6H_STIM_GAMMA...1,SET,157,0.049298,0.004537,0.067548,0.23275,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN,0.927272857142857
HP_PANCREATIC_CYSTS,SET,33,0.098157,0.0041557,0.1345,0.23276,HP_PANCREATIC_CYSTS,0.927272857142857
MIR2278,SET,95,0.061897,0.0044387,0.084821,0.23278,MIR2278,0.927272857142857
GOBP_SENSORY_ORGAN_DEVELOPME...,SET,554,0.028802,0.0049248,0.039476,0.23282,GOBP_SENSORY_ORGAN_DEVELOPMENT,0.927272857142857
GSE29618_PRE_VS_DAY7_POST_TI...2,SET,168,0.052466,0.0049933,0.071931,0.23289,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP,0.927272857142857
GSE9006_HEALTHY_VS_TYPE_2_DI...1,SET,179,0.046899,0.004606,0.064312,0.23293,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.927272857142857
GOBP_REGULATION_OF_L_GLUTAMA...,SET,8,0.20624,0.0043021,0.28287,0.23297,GOBP_REGULATION_OF_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.927272857142857
MIR6784_3P,SET,35,0.096582,0.0042108,0.13247,0.23298,MIR6784_3P,0.927272857142857
HP_RENAL_HYPOPLASIA_APLASIA,SET,298,0.036111,0.0045609,0.04953,0.23298,HP_RENAL_HYPOPLASIA_APLASIA,0.927272857142857
ALTEMEIER_RESPONSE_TO_LPS_WI...,SET,114,0.061377,0.004819,0.084192,0.233,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,0.927272857142857
XU_HGF_SIGNALING_NOT_VIA_AKT...3,SET,23,0.13856,0.0048986,0.19009,0.23304,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,0.927272857142857
GOBP_VASCULAR_ASSOCIATED_SMO...4,SET,26,0.1418,0.0053296,0.19455,0.23306,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.927272857142857
GOBP_SA_NODE_CELL_TO_ATRIAL_...2,SET,9,0.22839,0.005053,0.31344,0.23311,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALING,0.927272857142857
SCHAEFFER_PROSTATE_DEVELOPME...4,SET,404,0.033383,0.0048949,0.045818,0.23313,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,0.927272857142857
REACTOME_HDL_REMODELING,SET,10,0.19963,0.0046553,0.27402,0.23315,REACTOME_HDL_REMODELING,0.927272857142857
GSE21063_CTRL_VS_ANTI_IGM_ST...5,SET,178,0.046878,0.0045911,0.064346,0.23315,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN,0.927272857142857
GOCC_MONOATOMIC_ION_CHANNEL_...,SET,319,0.038518,0.0050305,0.052873,0.23316,GOCC_MONOATOMIC_ION_CHANNEL_COMPLEX,0.927272857142857
GSE43863_DAY6_EFF_VS_DAY150_...6,SET,180,0.048304,0.004757,0.066307,0.23316,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP,0.927272857142857
ABRAMSON_INTERACT_WITH_AIRE,SET,39,0.091981,0.0042327,0.12627,0.23317,ABRAMSON_INTERACT_WITH_AIRE,0.927272857142857
GOBP_CONSTITUTIVE_HETEROCHRO...,SET,8,0.20773,0.0043331,0.28517,0.23318,GOBP_CONSTITUTIVE_HETEROCHROMATIN_FORMATION,0.927272857142857
MIR4780,SET,38,0.10486,0.0047633,0.14396,0.23319,MIR4780,0.927272857142857
GOBP_OSTEOBLAST_PROLIFERATION,SET,32,0.11575,0.0048258,0.15894,0.23324,GOBP_OSTEOBLAST_PROLIFERATION,0.927272857142857
GOBP_REGULATION_OF_WNT_SIGNA...1,SET,302,0.037804,0.0048061,0.051917,0.23326,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.927272857142857
GOBP_RESPONSE_TO_GONADOTROPIN,SET,27,0.13387,0.0051273,0.18388,0.23331,GOBP_RESPONSE_TO_GONADOTROPIN,0.927272857142857
HP_SOFT_TISSUE_NEOPLASM,SET,5,0.31772,0.0052399,0.43648,0.23334,HP_SOFT_TISSUE_NEOPLASM,0.927272857142857
MODULE_218,SET,18,0.16494,0.0051595,0.22661,0.23335,MODULE_218,0.927272857142857
GOBP_DETECTION_OF_CELL_DENSI...,SET,8,0.21295,0.0044419,0.29256,0.23335,GOBP_DETECTION_OF_CELL_DENSITY,0.927272857142857
GATAAGR_GATA_C,SET,277,0.038681,0.0047129,0.053144,0.23336,GATAAGR_GATA_C,0.927272857142857
GOBP_REPRODUCTIVE_PROCESS,SET,1329,0.017973,0.0046552,0.024706,0.23347,GOBP_REPRODUCTIVE_PROCESS,0.927272857142857
KEGG_MEDICUS_REFERENCE_ANTER...,SET,23,0.1302,0.0046033,0.17899,0.23349,KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT,0.927272857142857
GOBP_EYE_PIGMENTATION,SET,4,0.3111,0.0045892,0.42778,0.23355,GOBP_EYE_PIGMENTATION,0.927272857142857
GOBP_TRIGLYCERIDE_RICH_LIPOP...1,SET,7,0.25366,0.0049496,0.34883,0.23357,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE,0.927272857142857
GOBP_SEBACEOUS_GLAND_DEVELOP...,SET,10,0.21314,0.0049706,0.29327,0.23368,GOBP_SEBACEOUS_GLAND_DEVELOPMENT,0.927272857142857
GOCC_BASEMENT_MEMBRANE,SET,85,0.071937,0.004881,0.099002,0.23373,GOCC_BASEMENT_MEMBRANE,0.927272857142857
GSE15330_LYMPHOID_MULTIPOTEN...1,SET,181,0.044934,0.0044373,0.061847,0.23376,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.927272857142857
GOBP_PROTEIN_RNA_COMPLEX_ORG...,SET,182,0.041771,0.0041362,0.057506,0.23381,GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION,0.927272857142857
HP_SUBCUTANEOUS_HEMORRHAGE,SET,234,0.041742,0.00468,0.057469,0.23382,HP_SUBCUTANEOUS_HEMORRHAGE,0.927272857142857
GOBP_CAVEOLIN_MEDIATED_ENDOC...,SET,11,0.18641,0.0045592,0.25665,0.23383,GOBP_CAVEOLIN_MEDIATED_ENDOCYTOSIS,0.927272857142857
GOBP_POSITIVE_REGULATION_OF_...390,SET,27,0.12284,0.004705,0.16913,0.23383,GOBP_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,0.927272857142857
MODULE_412,SET,13,0.19425,0.0051645,0.26748,0.23385,MODULE_412,0.927272857142857
GCM_TPT1,SET,60,0.07647,0.0043622,0.1053,0.23387,GCM_TPT1,0.927272857142857
MIR660_3P,SET,91,0.065269,0.0045814,0.089887,0.23389,MIR660_3P,0.927272857142857
GOBP_MUSCLE_CELL_PROLIFERATI...,SET,189,0.047473,0.0047895,0.065382,0.2339,GOBP_MUSCLE_CELL_PROLIFERATION,0.927272857142857
MODULE_221,SET,29,0.11213,0.0044509,0.15446,0.23392,MODULE_221,0.927272857142857
GSE16385_ROSIGLITAZONE_IFNG_...1,SET,174,0.04681,0.0045332,0.064482,0.23394,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,0.927272857142857
WP_MICRORNAS_IN_CARDIOMYOCYT...,SET,81,0.071343,0.0047259,0.098282,0.23396,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,0.927272857142857
QI_HYPOXIA_TARGETS_OF_HIF1A_...,SET,32,0.11266,0.0046971,0.15525,0.23402,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,0.927272857142857
GSE16697_CD4_TCELL_VS_TFH_CD...2,SET,181,0.047505,0.0046912,0.065475,0.23406,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP,0.927272857142857
MIR6864_5P,SET,77,0.072362,0.0046741,0.099737,0.23407,MIR6864_5P,0.927272857142857
LCORL_TARGET_GENES,SET,359,0.032357,0.0044779,0.044617,0.23417,LCORL_TARGET_GENES,0.927272857142857
CTGAGCC_MIR24,SET,201,0.043749,0.0045502,0.06033,0.23418,CTGAGCC_MIR24,0.927272857142857
MIR4314,SET,121,0.056103,0.0045373,0.077376,0.23421,MIR4314,0.927272857142857
GOBP_REGULATION_OF_SKELETAL_...12,SET,7,0.23144,0.004516,0.31921,0.23422,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.927272857142857
HP_ABNORMAL_PROTEIN_O_LINKED...,SET,5,0.24789,0.0040883,0.3419,0.23422,HP_ABNORMAL_PROTEIN_O_LINKED_GLYCOSYLATION,0.927272857142857
GOBP_EMBRYO_DEVELOPMENT_ENDI...,SET,641,0.025512,0.0046807,0.035189,0.23423,GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING,0.927272857142857
GOBP_PROTEIN_LOCALIZATION_TO...9,SET,318,0.034711,0.0045262,0.047881,0.23425,GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.927272857142857
WP_PENTOSE_PHOSPHATE_PATHWAY...,SET,7,0.24519,0.0047844,0.33824,0.23426,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,0.927272857142857
GSE40274_FOXP3_VS_FOXP3_AND_...13,SET,164,0.046669,0.0043889,0.064383,0.23427,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.927272857142857
NFKAPPAB65_01,SET,230,0.041472,0.0046104,0.057219,0.23429,NFKAPPAB65_01,0.927272857142857
GOBP_NEGATIVE_REGULATION_OF_...160,SET,7,0.22741,0.0044373,0.31376,0.2343,GOBP_NEGATIVE_REGULATION_OF_CYTOKINESIS,0.927272857142857
REACTOME_INTERLEUKIN_2_FAMIL...,SET,39,0.11325,0.0052114,0.15627,0.23432,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,0.927272857142857
GOBP_REGULATION_OF_AMINO_ACI...1,SET,14,0.16843,0.0046469,0.23241,0.23432,GOBP_REGULATION_OF_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,0.927272857142857
KEGG_MEDICUS_REFERENCE_AUTOP...8,SET,9,0.19315,0.0042732,0.26653,0.23433,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1,0.927272857142857
FAN_EMBRYONIC_CTX_EX_2_EXCIT...,SET,15,0.17996,0.0051393,0.24836,0.23435,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.927272857142857
AAAGACA_MIR511,SET,185,0.046222,0.0046141,0.063791,0.23436,AAAGACA_MIR511,0.927272857142857
WP_POSTCOVID_NEUROINFLAMMATI...,SET,20,0.15484,0.0051053,0.21372,0.23438,WP_POSTCOVID_NEUROINFLAMMATION,0.927272857142857
HP_ELEVATED_LACTATE_PYRUVATE...,SET,18,0.13514,0.0042273,0.18655,0.23441,HP_ELEVATED_LACTATE_PYRUVATE_RATIO,0.927272857142857
GOBP_REGULATION_OF_FC_RECEPT...,SET,10,0.1986,0.0046314,0.27421,0.23445,GOBP_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.927272857142857
GOMF_GLUTATHIONE_TRANSMEMBRA...,SET,7,0.24092,0.0047009,0.33275,0.23453,GOMF_GLUTATHIONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.927272857142857
KEGG_MEDICUS_PATHOGEN_HTLV_1...6,SET,8,0.19585,0.0040853,0.27053,0.23455,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498,0.927272857142857
GAVISH_3CA_METAPROGRAM_B_CEL...10,SET,44,0.10181,0.0049757,0.14064,0.23457,GAVISH_3CA_METAPROGRAM_B_CELLS_PROGENITOR,0.927272857142857
MEF2_02,SET,201,0.044625,0.0046413,0.061649,0.23458,MEF2_02,0.927272857142857
GOBP_POSITIVE_REGULATION_OF_...34,SET,7,0.26929,0.0052546,0.37206,0.2346,GOBP_POSITIVE_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,0.927272857142857
KEGG_MEDICUS_VARIANT_MUTATIO...81,SET,5,0.25671,0.0042336,0.35481,0.23469,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.927272857142857
GOBP_REGULATION_OF_MICROVILL...3,SET,13,0.16569,0.0044051,0.22903,0.23471,GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION,0.927272857142857
REACTOME_CYTOSOLIC_TRNA_AMIN...,SET,6,0.20537,0.0037102,0.28392,0.23473,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,0.927272857142857
GSE28130_ACTIVATED_VS_INDUCE...2,SET,175,0.04801,0.0046625,0.066373,0.23474,GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP,0.927272857142857
HP_CUPPED_RIBS,SET,23,0.12756,0.0045098,0.17636,0.23475,HP_CUPPED_RIBS,0.927272857142857
TOP2B_TARGET_GENES,SET,483,0.028664,0.0045854,0.03963,0.23476,TOP2B_TARGET_GENES,0.927272857142857
GOBP_CARDIAC_PACEMAKER_CELL_...1,SET,9,0.22441,0.0049648,0.31027,0.23477,GOBP_CARDIAC_PACEMAKER_CELL_DEVELOPMENT,0.927272857142857
GOBP_REGULATION_OF_DNA_TEMPL...2,SET,15,0.15755,0.0044992,0.21785,0.23478,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION_INITIATION,0.927272857142857
SMID_BREAST_CANCER_RELAPSE_I...2,SET,87,0.070444,0.0048353,0.097414,0.2348,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,0.927272857142857
HP_LOW_PLASMA_CITRULLINE,SET,5,0.24763,0.004084,0.34247,0.23482,HP_LOW_PLASMA_CITRULLINE,0.927272857142857
HP_JOINT_HEMORRHAGE,SET,14,0.17123,0.0047243,0.23682,0.23483,HP_JOINT_HEMORRHAGE,0.927272857142857
MIR3161,SET,69,0.079774,0.0048789,0.11034,0.23485,MIR3161,0.927272857142857
MIR6125,SET,8,0.24249,0.0050581,0.33539,0.23485,MIR6125,0.927272857142857
GSE35825_UNTREATED_VS_IFNA_S...1,SET,159,0.050769,0.0047018,0.070226,0.23486,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN,0.927272857142857
FIGUEROA_AML_METHYLATION_CLU...14,SET,104,0.063351,0.0047521,0.087631,0.23487,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,0.927272857142857
GOBP_LIPID_LOCALIZATION,SET,453,0.030617,0.0047472,0.042361,0.23492,GOBP_LIPID_LOCALIZATION,0.927272857142857
MODULE_522,SET,31,0.11582,0.0047529,0.16026,0.23494,MODULE_522,0.927272857142857
IM_SREBF1A_TARGETS,SET,5,0.26842,0.0044268,0.37152,0.235,IM_SREBF1A_TARGETS,0.927272857142857
REACTOME_SIGNALING_BY_ACTIVA...,SET,11,0.20659,0.0050527,0.28607,0.2351,REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1,0.927272857142857
GSE3982_BCELL_VS_CENT_MEMORY...1,SET,175,0.048149,0.0046761,0.066675,0.23511,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN,0.927272857142857
MIR500B_5P,SET,51,0.084816,0.0044618,0.11747,0.23514,MIR500B_5P,0.927272857142857
HP_HYPERESTHESIA,SET,9,0.20507,0.0045371,0.28403,0.23515,HP_HYPERESTHESIA,0.927272857142857
KORKOLA_TERATOMA,SET,38,0.10692,0.004857,0.14811,0.23518,KORKOLA_TERATOMA,0.927272857142857
TRAVAGLINI_LUNG_ALVEOLAR_EPI...1,SET,363,0.035134,0.0048888,0.048669,0.23518,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL,0.927272857142857
GOBP_NEGATIVE_REGULATION_OF_...542,SET,63,0.080604,0.0047112,0.11166,0.2352,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.927272857142857
HP_ABNORMALITY_OF_THE_EPIPHY...1,SET,5,0.28675,0.0047291,0.39726,0.23521,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_DISTAL_PHALANX_OF_FINGER,0.927272857142857
HP_ABNORMAL_ARM_SPAN,SET,11,0.18145,0.0044378,0.2514,0.23523,HP_ABNORMAL_ARM_SPAN,0.927272857142857
HP_HEAD_BANGING,SET,9,0.20703,0.0045804,0.28686,0.23524,HP_HEAD_BANGING,0.927272857142857
WP_DNA_REPAIR_PATHWAYS_FULL_...,SET,109,0.050597,0.0038851,0.070109,0.23525,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,0.927272857142857
GOMF_CYCLASE_REGULATOR_ACTIV...,SET,15,0.16585,0.0047362,0.22983,0.23527,GOMF_CYCLASE_REGULATOR_ACTIVITY,0.927272857142857
HP_MUSCLE_FLACCIDITY,SET,13,0.1848,0.0049132,0.25612,0.2353,HP_MUSCLE_FLACCIDITY,0.927272857142857
DESCARTES_MAIN_FETAL_STC2_TL...,SET,16,0.16612,0.0048994,0.23025,0.23532,DESCARTES_MAIN_FETAL_STC2_TLX1_POSITIVE_CELLS,0.927272857142857
GSE40666_UNTREATED_VS_IFNA_S...4,SET,186,0.047548,0.0047592,0.065926,0.23539,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP,0.927443538147602
GSE13485_CTRL_VS_DAY21_YF17D...2,SET,177,0.044717,0.0043672,0.062035,0.23551,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.927493399209486
MIR4427,SET,211,0.0435,0.0046341,0.060349,0.23552,MIR4427,0.927493399209486
XU_GH1_EXOGENOUS_TARGETS_DN,SET,90,0.063966,0.0044654,0.088767,0.23558,XU_GH1_EXOGENOUS_TARGETS_DN,0.927493399209486
HE_LIM_SUN_FETAL_LUNG_C1_MID...2,SET,136,0.057914,0.0049635,0.080376,0.2356,HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL,0.927493399209486
HP_ANTIMITOCHONDRIAL_ANTIBOD...,SET,11,0.22248,0.0054414,0.30884,0.23566,HP_ANTIMITOCHONDRIAL_ANTIBODY_POSITIVITY,0.927493399209486
FEKIR_HEPARG_SIDE_POP_VS_HEP...1,SET,77,0.071404,0.0046122,0.099129,0.23567,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_DN,0.927493399209486
GOMF_SIGNAL_RECOGNITION_PART...,SET,7,0.19801,0.0038637,0.27501,0.23577,GOMF_SIGNAL_RECOGNITION_PARTICLE_BINDING,0.927493399209486
TGIF_01,SET,229,0.0417,0.0046257,0.057923,0.23579,TGIF_01,0.927493399209486
HP_VITREOUS_HEMORRHAGE,SET,16,0.15387,0.0045381,0.21372,0.23579,HP_VITREOUS_HEMORRHAGE,0.927493399209486
GSE17721_LPS_VS_POLYIC_6H_BM...2,SET,182,0.046523,0.0046067,0.064625,0.2358,GSE17721_LPS_VS_POLYIC_6H_BMDC_UP,0.927493399209486
HP_SPINAL_CANAL_STENOSIS,SET,35,0.10593,0.0046186,0.14717,0.23583,HP_SPINAL_CANAL_STENOSIS,0.927493399209486
HALLMARK_GLYCOLYSIS,SET,182,0.045389,0.0044945,0.063058,0.23583,HALLMARK_GLYCOLYSIS,0.927493399209486
KEGG_MEDICUS_VARIANT_MUTATIO...49,SET,17,0.14702,0.0044695,0.20427,0.23584,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM,0.927493399209486
MODULE_332,SET,42,0.089382,0.004268,0.12418,0.23584,MODULE_332,0.927493399209486
GOBP_REGULATION_OF_AXONOGENE...,SET,125,0.056082,0.0046094,0.077934,0.23589,GOBP_REGULATION_OF_AXONOGENESIS,0.927493399209486
HP_TETANY,SET,21,0.14883,0.005028,0.20682,0.23589,HP_TETANY,0.927493399209486
GOMF_RIBOSOMAL_PROTEIN_S6_KI...,SET,5,0.27333,0.0045077,0.37986,0.23591,GOMF_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY,0.927493399209486
MIR34A_3P,SET,64,0.078853,0.0046452,0.1096,0.23592,MIR34A_3P,0.927493399209486
CACBINDINGPROTEIN_Q6,SET,231,0.040491,0.004511,0.056278,0.23593,CACBINDINGPROTEIN_Q6,0.927493399209486
WP_SPLICING_FACTOR_NOVA_REGU...,SET,41,0.094297,0.0044489,0.13113,0.23604,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,0.927493399209486
KEGG_MEDICUS_REFERENCE_PTH_P...,SET,15,0.1651,0.0047149,0.2296,0.23605,KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY,0.927493399209486
GSE10239_NAIVE_VS_KLRG1HIGH_...1,SET,180,0.045913,0.0045216,0.063853,0.23606,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.927493399209486
RUBENSTEIN_SKELETAL_MUSCLE_T...,SET,157,0.048666,0.0044788,0.067682,0.23606,RUBENSTEIN_SKELETAL_MUSCLE_T_CELLS,0.927493399209486
GOBP_COLUMNAR_CUBOIDAL_EPITH...1,SET,49,0.095314,0.004915,0.13258,0.23609,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT,0.927493399209486
REACTOME_ADVANCED_GLYCOSYLAT...,SET,13,0.16544,0.0043986,0.23016,0.23613,REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,0.927493399209486
GOBP_PROTEASOME_ASSEMBLY,SET,11,0.17557,0.0042939,0.24425,0.23614,GOBP_PROTEASOME_ASSEMBLY,0.927493399209486
GOMF_PHOSPHATIDYLINOSITOL_TR...1,SET,10,0.17297,0.0040338,0.24066,0.23616,GOMF_PHOSPHATIDYLINOSITOL_TRANSFER_ACTIVITY,0.927493399209486
MIR4540,SET,47,0.087197,0.004404,0.12133,0.23617,MIR4540,0.927493399209486
HP_INTRA_EPIDERMAL_BLISTERING,SET,6,0.22936,0.0041435,0.31922,0.23623,HP_INTRA_EPIDERMAL_BLISTERING,0.927493399209486
GSE24726_WT_VS_E2_2_KO_PDC_D...1,SET,186,0.045725,0.0045767,0.06364,0.23623,GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP,0.927493399209486
HP_ASYMMETRY_OF_THE_THORAX,SET,6,0.24579,0.0044405,0.34212,0.23624,HP_ASYMMETRY_OF_THE_THORAX,0.927493399209486
KEGG_MEDICUS_PATHOGEN_HTLV_1...5,SET,9,0.18574,0.0041094,0.2586,0.2363,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497,0.927493399209486
WP_ALZHEIMERS_DISEASE,SET,248,0.039031,0.0045034,0.054343,0.23631,WP_ALZHEIMERS_DISEASE,0.927493399209486
WP_ALZHEIMERS_DISEASE_AND_MI...,SET,248,0.039031,0.0045034,0.054343,0.23631,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,0.927493399209486
GOBP_POSITIVE_REGULATION_OF_...394,SET,8,0.23843,0.0049734,0.33203,0.23636,GOBP_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.927584891598916
IIZUKA_LIVER_CANCER_PROGRESS...3,SET,8,0.23751,0.0049542,0.3308,0.23639,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN,0.927597883030371
MIR185_5P,SET,267,0.038539,0.0046114,0.053689,0.23644,MIR185_5P,0.92768934296681
MIR3714,SET,404,0.031153,0.0045679,0.043436,0.23662,MIR3714,0.928238155964338
HP_VASCULAR_NEOPLASM,SET,143,0.050758,0.0044599,0.070779,0.23665,HP_VASCULAR_NEOPLASM,0.928238155964338
TAXCREB_02,SET,25,0.12631,0.0046553,0.17613,0.23666,TAXCREB_02,0.928238155964338
MCCOLLUM_GELDANAMYCIN_RESIST...2,SET,9,0.22526,0.0049837,0.31431,0.23679,MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,0.928551342509025
GOBP_FERROPTOSIS,SET,9,0.22241,0.0049206,0.31035,0.2368,GOBP_FERROPTOSIS,0.928551342509025
MIR3649,SET,18,0.15274,0.0047778,0.21315,0.23682,MIR3649,0.928551342509025
BIOCARTA_ERK5_PATHWAY,SET,14,0.16214,0.0044734,0.22632,0.23687,BIOCARTA_ERK5_PATHWAY,0.928642622673435
HP_ABNORMAL_HALLUX_PHALANX_M...,SET,37,0.095478,0.0042798,0.13329,0.2369,HP_ABNORMAL_HALLUX_PHALANX_MORPHOLOGY,0.928655481615159
HP_PULMONARY_LYMPHANGIECTASIA,SET,5,0.33125,0.0054631,0.46255,0.23695,HP_PULMONARY_LYMPHANGIECTASIA,0.928746729446261
BARRIER_CANCER_RELAPSE_NORMA...1,SET,27,0.11374,0.0043563,0.15885,0.237,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,0.928798089279675
SETBP1_TARGET_GENES,SET,149,0.050664,0.0045434,0.070768,0.23702,SETBP1_TARGET_GENES,0.928798089279675
GOBP_FC_RECEPTOR_MEDIATED_IN...,SET,5,0.32055,0.0052865,0.44779,0.23705,GOBP_FC_RECEPTOR_MEDIATED_INHIBITORY_SIGNALING_PATHWAY,0.928798089279675
KAUFFMANN_MELANOMA_RELAPSE_DN,SET,6,0.24095,0.004353,0.33662,0.23707,KAUFFMANN_MELANOMA_RELAPSE_DN,0.928798089279675
GSE2585_THYMIC_MACROPHAGE_VS...2,SET,173,0.046839,0.004523,0.065468,0.23717,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP,0.929019598782824
REACTOME_COBALAMIN_CBL_METAB...,SET,6,0.26207,0.0047345,0.36632,0.23718,REACTOME_COBALAMIN_CBL_METABOLISM,0.929019598782824
HP_VENTRICULAR_TACHYCARDIA,SET,62,0.080764,0.0046831,0.11292,0.23723,HP_VENTRICULAR_TACHYCARDIA,0.929084366197183
GOBP_MORPHOGENESIS_OF_AN_EPI...1,SET,13,0.19652,0.0052247,0.27477,0.23725,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD,0.929084366197183
GSE22886_IGG_IGA_MEMORY_BCEL...1,SET,170,0.045782,0.0043828,0.064022,0.23728,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.929097160883281
GOBP_INCLUSION_BODY_ASSEMBLY,SET,22,0.13521,0.0046752,0.18915,0.23736,GOBP_INCLUSION_BODY_ASSEMBLY,0.929265726351351
HP_SUBCUTANEOUS_NODULE,SET,88,0.065366,0.0045123,0.091455,0.23739,HP_SUBCUTANEOUS_NODULE,0.929265726351351
ZBTB49_TARGET_GENES,SET,7,0.1982,0.0038674,0.27734,0.23742,ZBTB49_TARGET_GENES,0.929265726351351
MIR100_5P_MIR99A_5P_MIR99B_5P,SET,17,0.16125,0.0049019,0.22564,0.23743,MIR100_5P_MIR99A_5P_MIR99B_5P,0.929265726351351
HP_POSTERIOR_STAPHYLOMA,SET,7,0.26424,0.005156,0.36981,0.23746,HP_POSTERIOR_STAPHYLOMA,0.929278493412904
GOBP_MULTI_MULTICELLULAR_ORG...,SET,191,0.0474,0.0048071,0.066356,0.23752,GOBP_MULTI_MULTICELLULAR_ORGANISM_PROCESS,0.929408646701193
GOBP_COLLAGEN_METABOLIC_PROC...,SET,90,0.071078,0.0049619,0.099559,0.23764,GOBP_COLLAGEN_METABOLIC_PROCESS,0.929642464828363
GSE31082_CD4_VS_CD8_SP_THYMO...1,SET,179,0.045349,0.0044537,0.063521,0.23764,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN,0.929642464828363
BIOCARTA_CDC42RAC_PATHWAY,SET,8,0.20317,0.0042381,0.28462,0.23766,BIOCARTA_CDC42RAC_PATHWAY,0.929642464828363
PEDRIOLI_MIR31_TARGETS_DN,SET,368,0.033143,0.0046428,0.046442,0.23773,PEDRIOLI_MIR31_TARGETS_DN,0.929811630654963
GSE17721_CTRL_VS_PAM3CSK4_6H...2,SET,178,0.045804,0.0044859,0.064203,0.2378,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP,0.92989627175744
BENPORATH_OCT4_TARGETS,SET,258,0.039449,0.0046411,0.055323,0.23791,BENPORATH_OCT4_TARGETS,0.92989627175744
PID_SYNDECAN_2_PATHWAY,SET,31,0.11212,0.0046011,0.15724,0.23791,PID_SYNDECAN_2_PATHWAY,0.92989627175744
GSE17721_LPS_VS_PAM3CSK4_1H_...1,SET,190,0.045941,0.004647,0.064432,0.23792,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN,0.92989627175744
GOBP_NEGATIVE_REGULATION_OF_...345,SET,11,0.20334,0.0049732,0.28518,0.23793,GOBP_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY,0.92989627175744
GSE10240_CTRL_VS_IL17_AND_IL...1,SET,191,0.043044,0.0043653,0.060382,0.23797,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.92989627175744
HP_ABNORMAL_BLOOD_GLUCOSE_CO...,SET,285,0.036437,0.0045022,0.051119,0.238,HP_ABNORMAL_BLOOD_GLUCOSE_CONCENTRATION,0.92989627175744
GOBP_NUCLEAR_ENVELOPE_ORGANI...,SET,54,0.08105,0.0043869,0.11372,0.23801,GOBP_NUCLEAR_ENVELOPE_ORGANIZATION,0.92989627175744
GSE21063_CTRL_VS_ANTI_IGM_ST...11,SET,174,0.043782,0.0042399,0.061431,0.23802,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN,0.92989627175744
HP_FATIGABLE_WEAKNESS_OF_SWA...,SET,37,0.09736,0.0043641,0.13665,0.23808,HP_FATIGABLE_WEAKNESS_OF_SWALLOWING_MUSCLES,0.92989627175744
CTR9_TARGET_GENES,SET,46,0.082784,0.0041365,0.11619,0.23809,CTR9_TARGET_GENES,0.92989627175744
GSE1432_1H_VS_24H_IFNG_MICRO...1,SET,181,0.046182,0.0045605,0.064818,0.23809,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.92989627175744
KEGG_MEDICUS_REFERENCE_TSH_T...,SET,29,0.11258,0.0044687,0.15806,0.23815,KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY,0.92989627175744
GSE32034_UNTREATED_VS_ROSIGL...4,SET,154,0.048171,0.0043911,0.06763,0.23815,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP,0.92989627175744
GOMF_2_ACYLGLYCEROL_O_ACYLTR...,SET,6,0.26401,0.0047695,0.37071,0.23818,GOMF_2_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.92989627175744
GOBP_NUCLEOSIDE_MONOPHOSPHAT...1,SET,36,0.10179,0.0045005,0.14293,0.2382,GOBP_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.92989627175744
MIR549A_3P,SET,69,0.074996,0.0045866,0.10532,0.23821,MIR549A_3P,0.92989627175744
RUBENSTEIN_SKELETAL_MUSCLE_B...,SET,154,0.048924,0.0044597,0.068715,0.23824,RUBENSTEIN_SKELETAL_MUSCLE_B_CELLS,0.92989627175744
JAEGER_METASTASIS_DN,SET,236,0.042122,0.0047426,0.059168,0.23826,JAEGER_METASTASIS_DN,0.92989627175744
MORF_SMC1L1,SET,54,0.074548,0.004035,0.10473,0.2383,MORF_SMC1L1,0.929947956433865
GOCC_CYTOSOLIC_SMALL_RIBOSOM...,SET,35,0.10014,0.0043661,0.14073,0.23836,GOCC_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT,0.929970057194124
VECCHI_GASTRIC_CANCER_EARLY_...1,SET,306,0.038357,0.0049081,0.053914,0.23841,VECCHI_GASTRIC_CANCER_EARLY_DN,0.929970057194124
GSE43955_TGFB_IL6_VS_TGFB_IL...4,SET,183,0.043894,0.0043583,0.061707,0.23844,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.929970057194124
REACTOME_PROTEIN_PROTEIN_INT...,SET,77,0.073004,0.0047156,0.10265,0.23848,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,0.929970057194124
GOBP_MESODERM_MORPHOGENESIS,SET,68,0.077614,0.0047124,0.10914,0.2385,GOBP_MESODERM_MORPHOGENESIS,0.929970057194124
GAVISH_3CA_METAPROGRAM_CD8_T...4,SET,46,0.094451,0.0047195,0.13284,0.23854,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_DYSFUNCTION,0.929970057194124
WP_CANONICAL_NFKB_PATHWAY,SET,7,0.21904,0.004274,0.30813,0.23859,WP_CANONICAL_NFKB_PATHWAY,0.929970057194124
LAKE_ADULT_KIDNEY_C24_ENDOTH...,SET,144,0.054552,0.0048099,0.07674,0.23859,LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR,0.929970057194124
GAZDA_DIAMOND_BLACKFAN_ANEMI...5,SET,55,0.07623,0.004164,0.10724,0.2386,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,0.929970057194124
GOCC_EXOCYTIC_VESICLE,SET,217,0.042445,0.0045849,0.059711,0.2386,GOCC_EXOCYTIC_VESICLE,0.929970057194124
HP_ABNORMAL_EKG,SET,120,0.058801,0.0047359,0.082721,0.2386,HP_ABNORMAL_EKG,0.929970057194124
KEGG_TASTE_TRANSDUCTION,SET,48,0.10343,0.0052789,0.14556,0.23868,KEGG_TASTE_TRANSDUCTION,0.930085880044843
GOBP_REGULATION_OF_ESTABLISH...1,SET,13,0.17883,0.0047545,0.25168,0.23869,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY,0.930085880044843
GOBP_RESPONSE_TO_SELENIUM_ION,SET,5,0.25141,0.0041463,0.35386,0.23871,GOBP_RESPONSE_TO_SELENIUM_ION,0.930085880044843
NAKAYA_PBMC_FLUMIST_AGE_18_5...3,SET,504,0.026599,0.0043441,0.037453,0.23879,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP,0.930266930060525
GOCC_PHAGOCYTIC_CUP,SET,26,0.12044,0.004527,0.1696,0.23881,GOCC_PHAGOCYTIC_CUP,0.930266930060525
WGTTNNNNNAAA_UNKNOWN,SET,484,0.029483,0.0047212,0.041545,0.23896,WGTTNNNNNAAA_UNKNOWN,0.930367609182531
GOBP_PULMONARY_ARTERY_MORPHO...,SET,6,0.28641,0.0051742,0.4036,0.23897,GOBP_PULMONARY_ARTERY_MORPHOGENESIS,0.930367609182531
HP_ABNORMALITY_OF_THE_PROTEI...,SET,13,0.14569,0.0038736,0.20534,0.239,HP_ABNORMALITY_OF_THE_PROTEIN_C_ANTICOAGULANT_PATHWAY,0.930367609182531
GOBP_NITROGEN_COMPOUND_TRANS...,SET,1731,0.015195,0.0044382,0.021416,0.23902,GOBP_NITROGEN_COMPOUND_TRANSPORT,0.930367609182531
GOBP_CELLULAR_RESPONSE_TO_ZI...,SET,20,0.1568,0.00517,0.22102,0.23903,GOBP_CELLULAR_RESPONSE_TO_ZINC_ION,0.930367609182531
GOBP_CELL_MATURATION,SET,188,0.046297,0.0046585,0.065262,0.23904,GOBP_CELL_MATURATION,0.930367609182531
GOMF_TELOMERIC_DNA_BINDING,SET,37,0.094418,0.0042322,0.1331,0.23904,GOMF_TELOMERIC_DNA_BINDING,0.930367609182531
GSE3920_IFNA_VS_IFNG_TREATED...2,SET,154,0.048534,0.0044241,0.068418,0.23905,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.930367609182531
GOLDRATH_ANTIGEN_RESPONSE,SET,322,0.034187,0.0044854,0.048209,0.23912,GOLDRATH_ANTIGEN_RESPONSE,0.930535841451125
HP_LONG_FOOT,SET,22,0.11841,0.0040943,0.16704,0.23921,HP_LONG_FOOT,0.93065
GOBP_POSITIVE_REGULATION_OF_...237,SET,16,0.15613,0.0046048,0.22027,0.23923,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.93065
chr17q12,SET,86,0.13359,0.0091169,0.18848,0.23924,chr17q12,0.93065
GOBP_REGULATION_OF_CYCLASE_A...,SET,51,0.091588,0.004818,0.12925,0.23929,GOBP_REGULATION_OF_CYCLASE_ACTIVITY,0.93065
SMID_BREAST_CANCER_LUMINAL_A...2,SET,78,0.073333,0.0047673,0.10349,0.2393,SMID_BREAST_CANCER_LUMINAL_A_UP,0.93065
STK33_UP,SET,254,0.038773,0.0045266,0.054722,0.23931,STK33_UP,0.93065
HP_ECTROPION_OF_LOWER_EYELIDS,SET,7,0.18294,0.0035696,0.25825,0.23937,HP_ECTROPION_OF_LOWER_EYELIDS,0.930779184381293
GOBP_NOSE_DEVELOPMENT,SET,15,0.16485,0.0047077,0.23283,0.23947,GOBP_NOSE_DEVELOPMENT,0.930919456558202
GSE2585_CTEC_VS_MTEC_THYMUS_...2,SET,176,0.045741,0.0044547,0.064606,0.23948,GSE2585_CTEC_VS_MTEC_THYMUS_UP,0.930919456558202
GOBP_ENUCLEATE_ERYTHROCYTE_D...2,SET,12,0.17555,0.0044842,0.24797,0.23949,GOBP_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION,0.930919456558202
KEGG_MEDICUS_REFERENCE_HOMOL...1,SET,31,0.094965,0.003897,0.13416,0.23952,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION,0.930919456558202
HP_CENTRAL_ADRENAL_INSUFFICI...,SET,18,0.14037,0.004391,0.19832,0.23954,HP_CENTRAL_ADRENAL_INSUFFICIENCY,0.930919456558202
GOMF_CYCLIC_NUCLEOTIDE_PHOSP...,SET,26,0.12366,0.004648,0.17476,0.23959,GOMF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,0.93094443823365
MIR4660,SET,124,0.054632,0.0044724,0.077208,0.2396,MIR4660,0.93094443823365
GSE9960_HEALTHY_VS_SEPSIS_PB...2,SET,166,0.04639,0.0043889,0.065592,0.23971,GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP,0.93121554663992
MIR6888_3P,SET,87,0.066011,0.004531,0.093361,0.23977,MIR6888_3P,0.93121554663992
GSE5542_IFNA_VS_IFNA_AND_IFN...1,SET,182,0.04291,0.0042489,0.060692,0.23979,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.93121554663992
KEGG_MEDICUS_PATHOGEN_KSHV_V...4,SET,31,0.11485,0.0047131,0.16247,0.23981,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY,0.93121554663992
HP_MESOMELIC_ARM_SHORTENING,SET,3,0.41725,0.0053306,0.59037,0.23986,HP_MESOMELIC_ARM_SHORTENING,0.93121554663992
GOMF_ACTIVIN_RECEPTOR_ACTIVI...1,SET,9,0.2195,0.0048563,0.31069,0.23995,GOMF_ACTIVIN_RECEPTOR_ACTIVITY,0.93121554663992
GOBP_PLATELET_DERIVED_GROWTH...3,SET,53,0.088794,0.0047615,0.12569,0.23996,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.93121554663992
MIR297,SET,130,0.054895,0.0046006,0.077728,0.24002,MIR297,0.93121554663992
MODULE_534,SET,9,0.21882,0.0048413,0.30992,0.24008,MODULE_534,0.93121554663992
GOCC_NLS_DEPENDENT_PROTEIN_N...,SET,10,0.17692,0.0041259,0.25061,0.24011,GOCC_NLS_DEPENDENT_PROTEIN_NUCLEAR_IMPORT_COMPLEX,0.93121554663992
MILI_PSEUDOPODIA_CHEMOTAXIS_...1,SET,419,0.028508,0.0042552,0.040386,0.24014,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,0.93121554663992
GOBP_REGULATION_OF_CELLULAR_...19,SET,24,0.13236,0.00478,0.18752,0.24015,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.93121554663992
OVSYANNIKOVA_PBMC_FLUARIX_AG...7,SET,6,0.24156,0.004364,0.34226,0.24017,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_DN,0.93121554663992
GOBP_POSITIVE_REGULATION_OF_...510,SET,14,0.16628,0.0045875,0.23563,0.2402,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION,0.93121554663992
IVANOVA_HEMATOPOIESIS_STEM_C...2,SET,515,0.027231,0.0044941,0.038591,0.24021,IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR,0.93121554663992
HP_COMPLETE_OR_NEAR_COMPLETE...1,SET,7,0.27316,0.00533,0.3871,0.24021,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.93121554663992
GSE11367_CTRL_VS_IL17_TREATE...2,SET,119,0.056998,0.0045717,0.080788,0.24025,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP,0.93121554663992
ULE_SPLICING_VIA_NOVA2,SET,42,0.094104,0.0044935,0.13339,0.24026,ULE_SPLICING_VIA_NOVA2,0.93121554663992
ZNF140_TARGET_GENES,SET,550,0.025702,0.0043792,0.036436,0.24028,ZNF140_TARGET_GENES,0.93121554663992
GSE24634_TREG_VS_TCONV_POST_...2,SET,180,0.044181,0.004351,0.06263,0.24028,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP,0.93121554663992
JAZAG_TGFB1_SIGNALING_UP,SET,93,0.060223,0.0042732,0.085383,0.24031,JAZAG_TGFB1_SIGNALING_UP,0.93121554663992
HP_ABNORMAL_CIRCULATING_GLOB...,SET,10,0.19933,0.0046483,0.2826,0.24031,HP_ABNORMAL_CIRCULATING_GLOBULIN_CONCENTRATION,0.93121554663992
GOBP_TRACHEA_MORPHOGENESIS,SET,11,0.21287,0.0052064,0.30182,0.24032,GOBP_TRACHEA_MORPHOGENESIS,0.93121554663992
DESCARTES_MAIN_FETAL_PAEP_ME...,SET,109,0.058693,0.0045067,0.083225,0.24034,DESCARTES_MAIN_FETAL_PAEP_MECOM_POSITIVE_CELLS,0.93121554663992
GOBP_INTRACELLULAR_WATER_HOM...,SET,6,0.28163,0.0050878,0.39941,0.24037,GOBP_INTRACELLULAR_WATER_HOMEOSTASIS,0.93121554663992
GOBP_PATTERN_SPECIFICATION_I...,SET,8,0.26393,0.0055055,0.37431,0.24038,GOBP_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.93121554663992
GOBP_PRIMARY_ALCOHOL_BIOSYNT...,SET,14,0.17673,0.004876,0.25068,0.2404,GOBP_PRIMARY_ALCOHOL_BIOSYNTHETIC_PROCESS,0.93121554663992
WP_APOPTOSIS,SET,82,0.068083,0.0045376,0.096577,0.24042,WP_APOPTOSIS,0.93121554663992
MIR3675_3P,SET,78,0.071213,0.0046295,0.10106,0.24051,MIR3675_3P,0.931291510695187
GOBP_VASCULAR_ASSOCIATED_SMO...6,SET,24,0.13359,0.0048244,0.18957,0.24051,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,0.931291510695187
HE_LIM_SUN_FETAL_LUNG_C2_NEU...,SET,58,0.085523,0.0047969,0.12137,0.24052,HE_LIM_SUN_FETAL_LUNG_C2_NEUTROPHIL_CELL,0.931291510695187
NAKAYA_PBMC_FLUAD_MALE_AGE_1...2,SET,49,0.093312,0.0048118,0.13247,0.24059,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN,0.931367423989308
HP_DECREASED_CIRCULATING_COM...4,SET,3,0.40405,0.0051619,0.57361,0.2406,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_I_CONCENTRATION,0.931367423989308
GOBP_MULTICELLULAR_ORGANISMA...1,SET,75,0.072386,0.0046147,0.10278,0.24062,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_CHEMICAL_HOMEOSTASIS,0.931367423989308
CHX10_01,SET,203,0.045496,0.0047551,0.064626,0.24072,CHX10_01,0.931461739275025
GOBP_CELLULAR_RESPONSE_TO_SA...1,SET,6,0.24502,0.0044265,0.34806,0.24073,GOBP_CELLULAR_RESPONSE_TO_SALT,0.931461739275025
GOBP_POSITIVE_REGULATION_OF_...837,SET,10,0.21259,0.0049577,0.30215,0.24085,GOBP_POSITIVE_REGULATION_OF_VESICLE_FUSION,0.931461739275025
HP_ARTERIAL_STENOSIS,SET,95,0.066696,0.0047829,0.094814,0.2409,HP_ARTERIAL_STENOSIS,0.931461739275025
WP_BREAST_CANCER_PATHWAY,SET,149,0.051974,0.0046609,0.07389,0.24091,WP_BREAST_CANCER_PATHWAY,0.931461739275025
MODULE_264,SET,10,0.18655,0.0043504,0.26524,0.24092,MODULE_264,0.931461739275025
GOBP_APOPTOTIC_PROCESS_IN_BO...,SET,5,0.29878,0.0049275,0.42483,0.24094,GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,0.931461739275025
HP_ABNORMALITY_OF_THE_THYROI...,SET,462,0.029236,0.0045768,0.041586,0.24103,HP_ABNORMALITY_OF_THE_THYROID_GLAND,0.931461739275025
HP_INCREASED_CIRCULATING_INS...,SET,5,0.24427,0.0040286,0.34747,0.24103,HP_INCREASED_CIRCULATING_INSULIN_LIKE_GROWTH_FACTOR_1_CONCENTRATION,0.931461739275025
GOBP_GLUCOSYLCERAMIDE_CATABO...,SET,4,0.33158,0.0048912,0.47172,0.24106,GOBP_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,0.931461739275025
GCM_PRKAG1,SET,44,0.083957,0.0041031,0.11945,0.24108,GCM_PRKAG1,0.931461739275025
REACTOME_PHASE_4_RESTING_MEM...,SET,19,0.14807,0.0047585,0.2107,0.24111,REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL,0.931461739275025
MIR378B,SET,37,0.093083,0.0041724,0.13246,0.24111,MIR378B,0.931461739275025
MORF_HDAC2,SET,248,0.036363,0.0041956,0.051755,0.24116,MORF_HDAC2,0.931461739275025
MODULE_172,SET,91,0.066118,0.004641,0.094121,0.2412,MODULE_172,0.931461739275025
SGCGSSAAA_E2F1DP2_01,SET,147,0.048883,0.0043544,0.069591,0.24121,SGCGSSAAA_E2F1DP2_01,0.931461739275025
PID_RET_PATHWAY,SET,39,0.096564,0.0044436,0.13749,0.24124,PID_RET_PATHWAY,0.931461739275025
GSE17721_4_VS_24H_GARDIQUIMO...1,SET,176,0.043928,0.0042782,0.062549,0.24125,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN,0.931461739275025
GOMF_INOSITOL_TRISPHOSPHATE_...,SET,12,0.1531,0.003911,0.21806,0.24131,GOMF_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.931461739275025
MIR8052,SET,40,0.095452,0.0044483,0.13596,0.24133,MIR8052,0.931461739275025
GAUTAM_EYE_IRIS_CILIARY_BODY...14,SET,11,0.17754,0.0043423,0.2529,0.24133,GAUTAM_EYE_IRIS_CILIARY_BODY_RIBOSOMAL_GENES_HIGH_FIBROBLASTS,0.931461739275025
REACTOME_NEUROTRANSMITTER_RE...1,SET,191,0.046622,0.0047281,0.066416,0.24136,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,0.931461739275025
BYSTROEM_CORRELATED_WITH_IL5...2,SET,38,0.093297,0.004238,0.13295,0.24143,BYSTROEM_CORRELATED_WITH_IL5_UP,0.931461739275025
HP_ATYPICAL_NEVI_IN_NON_SUN_...,SET,5,0.24011,0.0039599,0.34217,0.24143,HP_ATYPICAL_NEVI_IN_NON_SUN_EXPOSED_AREAS,0.931461739275025
ZNF501_TARGET_GENES,SET,13,0.18416,0.0048961,0.26247,0.24146,ZNF501_TARGET_GENES,0.931461739275025
BIOCARTA_FMLP_PATHWAY,SET,32,0.10958,0.0045687,0.1562,0.24148,BIOCARTA_FMLP_PATHWAY,0.931461739275025
MIR5582_5P,SET,357,0.0323,0.0044579,0.046041,0.24148,MIR5582_5P,0.931461739275025
GSE21063_3H_VS_16H_ANTI_IGM_...4,SET,180,0.043573,0.0042911,0.06211,0.24148,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP,0.931461739275025
HP_VARIABLE_EXPRESSIVITY,SET,63,0.073756,0.004311,0.10513,0.24149,HP_VARIABLE_EXPRESSIVITY,0.931461739275025
IZADPANAH_STEM_CELL_ADIPOSE_...2,SET,117,0.057842,0.0046004,0.082466,0.24153,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,0.931461739275025
HP_TACHYPNEA,SET,88,0.059811,0.0041289,0.085285,0.24156,HP_TACHYPNEA,0.931461739275025
BROWNE_HCMV_INFECTION_24HR_UP,SET,136,0.051364,0.0044021,0.073246,0.24158,BROWNE_HCMV_INFECTION_24HR_UP,0.931461739275025
REACTOME_TRANSPORT_OF_THE_SL...,SET,33,0.094023,0.0039806,0.13409,0.24159,REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA,0.931461739275025
GSE3337_CTRL_VS_16H_IFNG_IN_...1,SET,181,0.04503,0.0044467,0.064219,0.2416,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN,0.931461739275025
GSE17186_BLOOD_VS_CORD_BLOOD...1,SET,182,0.044227,0.0043793,0.063096,0.24167,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN,0.931461739275025
HP_ACANTHOLYSIS,SET,10,0.19293,0.0044992,0.27525,0.24168,HP_ACANTHOLYSIS,0.931461739275025
GOBP_RESPONSE_TO_COBALT_ION,SET,9,0.19092,0.0042239,0.27243,0.24172,GOBP_RESPONSE_TO_COBALT_ION,0.931461739275025
HP_SHAWL_SCROTUM,SET,18,0.14183,0.0044365,0.2024,0.24173,HP_SHAWL_SCROTUM,0.931461739275025
GSE2197_IMMUNOSUPPRESSIVE_DN...2,SET,179,0.045308,0.0044496,0.064656,0.24173,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP,0.931461739275025
GOBP_NOTCH_RECEPTOR_PROCESSI...,SET,8,0.18918,0.0039461,0.26999,0.24176,GOBP_NOTCH_RECEPTOR_PROCESSING,0.931461739275025
GOBP_PYRIMIDINE_NUCLEOSIDE_T...1,SET,17,0.14496,0.0044067,0.20689,0.24177,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.931461739275025
CAO_BLOOD_FLUZONE_AGE_05_14Y...2,SET,5,0.27627,0.0045563,0.39431,0.24177,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP,0.931461739275025
REACTOME_KSRP_KHSRP_BINDS_AN...,SET,16,0.14562,0.0042947,0.20787,0.24181,REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,0.931512585901131
HP1SITEFACTOR_Q6,SET,204,0.043299,0.0045365,0.06182,0.24184,HP1SITEFACTOR_Q6,0.931524903025601
WP_GPCRS_CLASS_C_METABOTROPI...,SET,15,0.17311,0.0049435,0.24725,0.24192,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.931626548476454
MIR8065,SET,134,0.049034,0.0041717,0.070034,0.24192,MIR8065,0.931626548476454
PHONG_TNF_RESPONSE_VIA_P38_P...,SET,155,0.052571,0.0048076,0.0751,0.24196,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,0.931677354309772
GOBP_NEGATIVE_REGULATION_OF_...61,SET,15,0.15509,0.0044291,0.22166,0.24207,GOBP_NEGATIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.931932919805051
GSE10239_MEMORY_VS_KLRG1HIGH...1,SET,182,0.043522,0.0043096,0.062205,0.24208,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.931932919805051
GOBP_CELL_FATE_SPECIFICATION...,SET,7,0.22359,0.0043628,0.31975,0.2422,GOBP_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION,0.932135872453499
HP_HYPERKERATOTIC_PAPULE,SET,12,0.15359,0.0039234,0.21966,0.24222,HP_HYPERKERATOTIC_PAPULE,0.932135872453499
SCHERER_PBMC_YF_VAX_OR_APSV_...,SET,21,0.13355,0.0045119,0.19101,0.24222,SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_DN,0.932135872453499
GOBP_NEGATIVE_REGULATION_OF_...555,SET,21,0.13586,0.00459,0.19433,0.24224,GOBP_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.932135872453499
HP_INCREASED_SERUM_TESTOSTER...,SET,10,0.20017,0.0046681,0.28637,0.24228,HP_INCREASED_SERUM_TESTOSTERONE_LEVEL,0.932186582530721
AGCATTA_MIR155,SET,124,0.054753,0.0044823,0.078346,0.24233,AGCATTA_MIR155,0.932249501936912
HP_TRACHEOBRONCHOMALACIA,SET,7,0.20319,0.0039647,0.29077,0.24235,HP_TRACHEOBRONCHOMALACIA,0.932249501936912
GOCC_POLAR_MICROTUBULE,SET,5,0.24832,0.0040954,0.35544,0.2424,GOCC_POLAR_MICROTUBULE,0.93227393493416
GOBP_CARDIAC_MUSCLE_CELL_PRO...,SET,45,0.098641,0.0048751,0.1412,0.24241,GOBP_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.93227393493416
GERHOLD_RESPONSE_TO_TZD_DN,SET,12,0.18462,0.004716,0.26432,0.24245,GERHOLD_RESPONSE_TO_TZD_DN,0.93229835711915
KARAKAS_TGFB1_SIGNALING,SET,18,0.13976,0.0043718,0.20012,0.24247,KARAKAS_TGFB1_SIGNALING,0.93229835711915
HP_SMALL_INTESTINAL_STENOSIS,SET,27,0.10391,0.0039798,0.14883,0.24254,HP_SMALL_INTESTINAL_STENOSIS,0.932464347345133
GNF2_CEBPA,SET,63,0.077589,0.004535,0.11116,0.2426,GNF2_CEBPA,0.932527156602522
GOBP_NEGATIVE_REGULATION_OF_...171,SET,7,0.25341,0.0049448,0.36309,0.24261,GOBP_NEGATIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.932527156602522
GOBP_NEGATIVE_REGULATION_OF_...41,SET,28,0.11054,0.0043114,0.1584,0.24264,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION,0.932539334291717
GOBP_REGULATION_OF_PROTEIN_A...1,SET,17,0.13558,0.0041216,0.19432,0.24268,GOBP_REGULATION_OF_PROTEIN_ACETYLATION,0.932588018127556
REACTOME_MET_RECEPTOR_ACTIVA...,SET,6,0.2566,0.0046357,0.36782,0.24271,REACTOME_MET_RECEPTOR_ACTIVATION,0.932588018127556
GOBP_PEPTIDYL_SERINE_MODIFIC...,SET,256,0.037708,0.0044194,0.05406,0.24274,GOBP_PEPTIDYL_SERINE_MODIFICATION,0.932588018127556
GSE14413_UNSTIM_VS_IFNB_STIM...5,SET,105,0.05869,0.0044235,0.084147,0.24276,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN,0.932588018127556
DESCARTES_FETAL_CEREBELLUM_A...,SET,112,0.063009,0.0049038,0.090369,0.24283,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.932660963216613
GOMF_C2H2_ZINC_FINGER_DOMAIN...,SET,12,0.17921,0.0045779,0.25709,0.24288,GOMF_C2H2_ZINC_FINGER_DOMAIN_BINDING,0.932660963216613
KEGG_MEDICUS_VARIANT_MUTATIO...39,SET,25,0.12028,0.0044333,0.17256,0.2429,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.932660963216613
WP_ATR_SIGNALING,SET,11,0.15819,0.0038689,0.22697,0.24292,WP_ATR_SIGNALING,0.932660963216613
GSE34205_HEALTHY_VS_RSV_INF_...1,SET,170,0.046629,0.0044639,0.066906,0.24292,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN,0.932660963216613
GOBP_NEGATIVE_REGULATION_OF_...460,SET,23,0.1188,0.0042,0.17047,0.24294,GOBP_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.932660963216613
TCOF1_TARGET_GENES,SET,12,0.17349,0.0044317,0.249,0.24299,TCOF1_TARGET_GENES,0.932749884029158
GSE1460_DP_THYMOCYTE_VS_NAIV...3,SET,173,0.046745,0.0045139,0.067168,0.24324,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.933606427388183
GOMF_HEXOSYLTRANSFERASE_ACTI...,SET,184,0.046782,0.0046575,0.067236,0.24329,GOMF_HEXOSYLTRANSFERASE_ACTIVITY,0.933625984773254
STK33_SKM_UP,SET,230,0.039228,0.0043609,0.056385,0.24331,STK33_SKM_UP,0.933625984773254
BACH2_01,SET,242,0.03896,0.0044411,0.056014,0.24336,BACH2_01,0.933625984773254
GOBP_REGULATION_OF_TOLL_LIKE...4,SET,4,0.36391,0.0053682,0.52324,0.24338,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.933625984773254
GRAHAM_CML_DIVIDING_VS_NORMA...4,SET,170,0.044553,0.0042651,0.064077,0.24344,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,0.933625984773254
GOBP_WOUND_HEALING_INVOLVED_...,SET,7,0.25476,0.004971,0.3664,0.24344,GOBP_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.933625984773254
GU_PDEF_TARGETS_DN,SET,37,0.10839,0.0048584,0.15589,0.24345,GU_PDEF_TARGETS_DN,0.933625984773254
PLASARI_TGFB1_SIGNALING_VIA_...2,SET,51,0.087322,0.0045936,0.1256,0.24346,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,0.933625984773254
REACTOME_TRANSPORT_OF_VITAMI...,SET,38,0.095596,0.0043424,0.13755,0.24354,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,0.933765057915058
GOBP_MALATE_METABOLIC_PROCESS,SET,9,0.20419,0.0045176,0.29383,0.24355,GOBP_MALATE_METABOLIC_PROCESS,0.933765057915058
MIR4446_5P,SET,271,0.036967,0.0044557,0.053209,0.24361,MIR4446_5P,0.933798765295998
CTGCAGY_UNKNOWN,SET,678,0.023822,0.0044905,0.034291,0.24362,CTGCAGY_UNKNOWN,0.933798765295998
MCCLUNG_CREB1_TARGETS_UP,SET,91,0.067664,0.0047496,0.097421,0.24367,MCCLUNG_CREB1_TARGETS_UP,0.933798765295998
GOBP_SINGLE_FERTILIZATION,SET,150,0.049517,0.0044553,0.071296,0.24368,GOBP_SINGLE_FERTILIZATION,0.933798765295998
GOBP_NEGATIVE_REGULATION_OF_...210,SET,46,0.098243,0.004909,0.14148,0.24371,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.933798765295998
WP_EBOLA_VIRUS_INFECTION_IN_...,SET,123,0.056585,0.0046137,0.081487,0.24372,WP_EBOLA_VIRUS_INFECTION_IN_HOST,0.933798765295998
GSE17721_0.5H_VS_4H_LPS_BMDC...2,SET,183,0.042647,0.0042344,0.061424,0.24375,GSE17721_0.5H_VS_4H_LPS_BMDC_UP,0.933810763888889
GOBP_REGULATION_OF_GAMMA_DEL...2,SET,9,0.20255,0.0044812,0.29186,0.24385,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.934090901576105
MIR495_3P,SET,639,0.024553,0.0044979,0.035386,0.24389,MIR495_3P,0.934114826446281
GNF2_CDC2,SET,58,0.078128,0.0043821,0.11261,0.24391,GNF2_CDC2,0.934114826446281
GOBP_RESPONSE_TO_MECHANICAL_...,SET,209,0.042964,0.0045556,0.061941,0.24396,GOBP_RESPONSE_TO_MECHANICAL_STIMULUS,0.934188978849967
GOCC_BRUSH_BORDER,SET,100,0.058671,0.0043161,0.084604,0.24401,GOCC_BRUSH_BORDER,0.934188978849967
GSE17721_LPS_VS_CPG_0.5H_BMD...1,SET,179,0.043722,0.0042939,0.063048,0.24401,GSE17721_LPS_VS_CPG_0.5H_BMDC_DN,0.934188978849967
GSE10463_CD40L_AND_VA347_VS_...2,SET,167,0.045999,0.0043649,0.066394,0.24422,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP,0.934711893764434
chr2p22,SET,40,0.18156,0.0084612,0.26208,0.24423,chr2p22,0.934711893764434
GSE40666_UNTREATED_VS_IFNA_S...8,SET,188,0.043905,0.0044178,0.063384,0.24426,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP,0.934711893764434
HP_ATRESIA_OF_THE_EXTERNAL_A...,SET,45,0.087983,0.0043483,0.12703,0.24429,HP_ATRESIA_OF_THE_EXTERNAL_AUDITORY_CANAL,0.934711893764434
HP_ACETABULAR_DYSPLASIA,SET,23,0.11656,0.004121,0.16831,0.24431,HP_ACETABULAR_DYSPLASIA,0.934711893764434
GOBP_REGULATION_OF_CELL_CYCLE,SET,997,0.019225,0.0043547,0.027765,0.24434,GOBP_REGULATION_OF_CELL_CYCLE,0.934711893764434
E2F1_Q6,SET,207,0.040703,0.0042954,0.058794,0.24438,E2F1_Q6,0.934711893764434
GOBP_STABILIZATION_OF_MEMBRA...,SET,17,0.15163,0.0046096,0.21907,0.24442,GOBP_STABILIZATION_OF_MEMBRANE_POTENTIAL,0.934711893764434
KANG_DOXORUBICIN_RESISTANCE_...2,SET,49,0.081443,0.0041997,0.11769,0.24447,KANG_DOXORUBICIN_RESISTANCE_UP,0.934711893764434
GSE3337_CTRL_VS_4H_IFNG_IN_C...2,SET,185,0.042778,0.0042703,0.061819,0.24447,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP,0.934711893764434
MODULE_444,SET,17,0.16083,0.0048893,0.23242,0.24448,MODULE_444,0.934711893764434
BIOCARTA_PPARA_PATHWAY,SET,52,0.085271,0.0045294,0.12324,0.2445,BIOCARTA_PPARA_PATHWAY,0.934711893764434
GSE2585_CTEC_VS_THYMIC_MACRO...1,SET,187,0.04194,0.004209,0.060622,0.24453,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN,0.934711893764434
GSE37416_CTRL_VS_24H_F_TULAR...1,SET,177,0.042844,0.0041844,0.061933,0.24454,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.934711893764434
GHO_ATF5_TARGETS_UP,SET,12,0.19226,0.0049112,0.27793,0.24455,GHO_ATF5_TARGETS_UP,0.934711893764434
REACTOME_MRNA_DECAY_BY_3_TO_...,SET,12,0.15211,0.0038857,0.22003,0.24468,REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,0.93488581556386
ACAACCT_MIR453,SET,36,0.096541,0.0042686,0.13966,0.2447,ACAACCT_MIR453,0.93488581556386
GOBP_CELLULAR_RESPONSE_TO_MU...,SET,8,0.18013,0.0037573,0.26057,0.2447,GOBP_CELLULAR_RESPONSE_TO_MURAMYL_DIPEPTIDE,0.93488581556386
FERRANDO_TAL1_NEIGHBORS,SET,17,0.14317,0.0043524,0.20713,0.24472,FERRANDO_TAL1_NEIGHBORS,0.93488581556386
MIR4716_5P,SET,107,0.055904,0.0042532,0.08088,0.24473,MIR4716_5P,0.93488581556386
GOBP_POSITIVE_REGULATION_OF_...605,SET,7,0.23362,0.0045586,0.33808,0.24478,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.934974052093637
GAO_SMALL_INTESTINE_24W_C2_P...,SET,17,0.14742,0.0044817,0.2134,0.24485,GAO_SMALL_INTESTINE_24W_C2_PROCRPOS_PROGENITOR,0.935138653846154
GOBP_REGULATION_OF_TRANSLATI...13,SET,20,0.12919,0.0042595,0.18707,0.24491,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,0.93526503131524
GOMF_VOLTAGE_GATED_CALCIUM_C...2,SET,5,0.30021,0.0049511,0.43479,0.24496,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.935353197099539
FONTAINE_PAPILLARY_THYROID_C...2,SET,61,0.079924,0.004597,0.11577,0.24499,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,0.935364984071185
GOBP_REGULATION_OF_SEQUESTER...,SET,15,0.16389,0.0046804,0.2375,0.24508,GOBP_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.935582484914975
HP_ABNORMAL_RESPONSE_TO_SOCI...,SET,61,0.082379,0.0047382,0.1194,0.24512,HP_ABNORMAL_RESPONSE_TO_SOCIAL_NORMS,0.935582484914975
GOBP_BRANCHED_CHAIN_AMINO_AC...4,SET,13,0.17389,0.0046232,0.25206,0.24514,GOBP_BRANCHED_CHAIN_AMINO_ACID_TRANSPORT,0.935582484914975
THUM_SYSTOLIC_HEART_FAILURE_...2,SET,366,0.031065,0.0043401,0.045035,0.24516,THUM_SYSTOLIC_HEART_FAILURE_UP,0.935582484914975
HP_HETEROTAXY,SET,21,0.12991,0.0043888,0.18835,0.24519,HP_HETEROTAXY,0.935582484914975
GOBP_CELL_CYCLE,SET,1476,0.015728,0.0042745,0.02281,0.24525,GOBP_CELL_CYCLE,0.935582484914975
KEGG_MEDICUS_ENV_FACTOR_META...2,SET,9,0.22975,0.005083,0.33326,0.24529,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY,0.935582484914975
GOCC_ALPHA_BETA_T_CELL_RECEP...,SET,4,0.28154,0.0041532,0.40841,0.2453,GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX,0.935582484914975
SHARMA_PILOCYTIC_ASTROCYTOMA...1,SET,6,0.28778,0.005199,0.41753,0.24534,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN,0.935582484914975
HP_DYSPHONIA,SET,111,0.056137,0.0043496,0.081447,0.24534,HP_DYSPHONIA,0.935582484914975
GOBP_NEGATIVE_REGULATION_OF_...406,SET,7,0.2592,0.0050577,0.3761,0.24536,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.935582484914975
GSE2585_AIRE_KO_VS_WT_CD80_H...2,SET,182,0.042876,0.0042456,0.062215,0.24537,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP,0.935582484914975
HINATA_NFKB_TARGETS_KERATINO...2,SET,84,0.067405,0.0045466,0.097845,0.24545,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,0.935784856296621
XPO1_TARGET_GENES,SET,19,0.14763,0.0047445,0.21441,0.24556,XPO1_TARGET_GENES,0.935989810452504
GSE43955_1H_VS_42H_ACT_CD4_T...1,SET,186,0.04367,0.004371,0.063424,0.24556,GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN,0.935989810452504
GOBP_CELL_CELL_ADHESION_MEDI...2,SET,17,0.14112,0.0042899,0.20503,0.24565,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.935989810452504
TESAR_ALK_TARGETS_HUMAN_ES_5...2,SET,4,0.31364,0.0046267,0.45575,0.24567,TESAR_ALK_TARGETS_HUMAN_ES_5D_UP,0.935989810452504
GOCC_ALPHA_DNA_POLYMERASE_PR...,SET,4,0.25158,0.0037111,0.36557,0.24568,GOCC_ALPHA_DNA_POLYMERASE_PRIMASE_COMPLEX,0.935989810452504
chr2q34,SET,15,0.27812,0.0079423,0.40421,0.24572,chr2q34,0.935989810452504
GSE7509_DC_VS_MONOCYTE_WITH_...2,SET,182,0.042809,0.004239,0.062222,0.24573,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP,0.935989810452504
GOBP_PROTEIN_LOCALIZATION_TO...17,SET,67,0.066922,0.0040333,0.09728,0.24575,GOBP_PROTEIN_LOCALIZATION_TO_CILIUM,0.935989810452504
HP_SKIN_NODULE,SET,121,0.055126,0.0044583,0.080139,0.24577,HP_SKIN_NODULE,0.935989810452504
LIANG_SILENCED_BY_METHYLATIO...2,SET,9,0.19854,0.0043925,0.28867,0.2458,LIANG_SILENCED_BY_METHYLATION_DN,0.935989810452504
GOBP_POSITIVE_REGULATION_OF_...779,SET,22,0.1178,0.0040732,0.17127,0.2458,GOBP_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,0.935989810452504
GSE5589_WT_VS_IL6_KO_LPS_AND...1,SET,133,0.049485,0.0041944,0.071972,0.24587,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.936127390732829
REACTOME_DISEASES_OF_BASE_EX...,SET,5,0.28362,0.0046775,0.41255,0.24589,REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR,0.936127390732829
KEGG_MEDICUS_REFERENCE_C9ORF...,SET,8,0.21333,0.0044499,0.31042,0.24597,KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION,0.936140904621436
GSE10325_LUPUS_CD4_TCELL_VS_...4,SET,172,0.045669,0.0043974,0.066469,0.24602,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP,0.936140904621436
GOBP_GROOMING_BEHAVIOR,SET,18,0.15909,0.0049765,0.23156,0.24603,GOBP_GROOMING_BEHAVIOR,0.936140904621436
GOBP_RECEPTOR_METABOLIC_PROC...,SET,67,0.070455,0.0042463,0.10255,0.24604,GOBP_RECEPTOR_METABOLIC_PROCESS,0.936140904621436
WP_CONVERSION_OF_ANGIOTENSIN...,SET,5,0.32735,0.0053987,0.47652,0.24606,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,0.936140904621436
GOCC_PHAGOPHORE_ASSEMBLY_SITE,SET,35,0.099985,0.0043592,0.14555,0.24606,GOCC_PHAGOPHORE_ASSEMBLY_SITE,0.936140904621436
MIR105_5P,SET,198,0.042582,0.004396,0.062001,0.24611,MIR105_5P,0.936140904621436
PID_NOTCH_PATHWAY,SET,56,0.074523,0.0041074,0.10852,0.24613,PID_NOTCH_PATHWAY,0.936140904621436
HE_LIM_SUN_FETAL_LUNG_C0_INT...2,SET,9,0.2159,0.0047765,0.31443,0.24616,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_FIBROBLAST,0.936140904621436
GOMF_TELETHONIN_BINDING,SET,7,0.25253,0.0049276,0.36785,0.2462,GOMF_TELETHONIN_BINDING,0.936140904621436
GOBP_PROTEIN_TARGETING_TO_VA...2,SET,5,0.26846,0.0044274,0.39108,0.24622,GOBP_PROTEIN_TARGETING_TO_VACUOLE_INVOLVED_IN_AUTOPHAGY,0.936140904621436
GOBP_SYNAPTIC_VESICLE_TRANSP...,SET,40,0.091617,0.0042696,0.13348,0.24624,GOBP_SYNAPTIC_VESICLE_TRANSPORT,0.936140904621436
GOBP_NEGATIVE_REGULATION_OF_...279,SET,12,0.18549,0.0047384,0.27026,0.24625,GOBP_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.936140904621436
GOCC_UNCONVENTIONAL_MYOSIN_C...,SET,9,0.19535,0.004322,0.2847,0.2463,GOCC_UNCONVENTIONAL_MYOSIN_COMPLEX,0.936140904621436
DESCARTES_FETAL_CEREBELLUM_V...,SET,507,0.028689,0.0046989,0.041809,0.2463,DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS,0.936140904621436
FERREIRA_EWINGS_SARCOMA_UNST...2,SET,148,0.044823,0.0040061,0.065342,0.24637,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,0.936140904621436
HP_EEG_WITH_FOCAL_EPILEPTIFO...,SET,108,0.059541,0.0045509,0.08682,0.24643,HP_EEG_WITH_FOCAL_EPILEPTIFORM_DISCHARGES,0.936140904621436
BARX1_TARGET_GENES,SET,1026,0.018446,0.0042349,0.0269,0.24645,BARX1_TARGET_GENES,0.936140904621436
GOMF_ATPASE_COUPLED_LIPID_TR...,SET,8,0.22169,0.0046244,0.32332,0.24646,GOMF_ATPASE_COUPLED_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.936140904621436
GSE41867_DAY15_EFFECTOR_VS_D...4,SET,178,0.044517,0.0043598,0.064925,0.24647,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.936140904621436
HP_SMALL_JOINT_HYPERMOBILTY,SET,52,0.083546,0.0044378,0.12187,0.2465,HP_SMALL_JOINT_HYPERMOBILTY,0.936140904621436
LIANG_HEMATOPOIESIS_STEM_CEL...1,SET,37,0.096575,0.0043289,0.14088,0.24651,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,0.936140904621436
REACTOME_FRUCTOSE_METABOLISM,SET,7,0.17722,0.003458,0.25853,0.24652,REACTOME_FRUCTOSE_METABOLISM,0.936140904621436
GOBP_RIBOFLAVIN_METABOLIC_PR...,SET,5,0.26803,0.0044203,0.39103,0.24654,GOBP_RIBOFLAVIN_METABOLIC_PROCESS,0.936140904621436
GOBP_INTRACELLULAR_POTASSIUM...,SET,15,0.17259,0.0049289,0.25185,0.24658,GOBP_INTRACELLULAR_POTASSIUM_ION_HOMEOSTASIS,0.936190506882237
MARTINEZ_TP53_TARGETS_DN,SET,553,0.025345,0.0043299,0.036993,0.24663,MARTINEZ_TP53_TARGETS_DN,0.936237113066145
HP_ABNORMAL_RENAL_ECHOGENICI...,SET,31,0.10638,0.0043655,0.15528,0.24665,HP_ABNORMAL_RENAL_ECHOGENICITY,0.936237113066145
RNCTGNYNRNCTGNY_UNKNOWN,SET,65,0.073396,0.0043572,0.10715,0.24668,RNCTGNYNRNCTGNY_UNKNOWN,0.936237113066145
REACTOME_G_ALPHA_Z_SIGNALLIN...,SET,48,0.089475,0.0045667,0.13066,0.24674,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,0.936237113066145
GOBP_POSITIVE_REGULATION_OF_...326,SET,31,0.1196,0.0049081,0.17474,0.24685,GOBP_POSITIVE_REGULATION_OF_HEART_GROWTH,0.936237113066145
HP_EPIDERMAL_NEVUS,SET,11,0.15909,0.0038911,0.23245,0.24686,HP_EPIDERMAL_NEVUS,0.936237113066145
GOBP_REGULATION_OF_RECEPTOR_...7,SET,25,0.11142,0.0041066,0.16283,0.24691,GOBP_REGULATION_OF_RECEPTOR_RECYCLING,0.936237113066145
MIR6769A_3P,SET,17,0.14965,0.0045494,0.21871,0.24692,MIR6769A_3P,0.936237113066145
GOBP_MITOTIC_CYTOKINETIC_PRO...,SET,31,0.10115,0.0041508,0.14787,0.24698,GOBP_MITOTIC_CYTOKINETIC_PROCESS,0.936237113066145
REACTOME_MEIOTIC_RECOMBINATI...,SET,26,0.10767,0.0040468,0.15742,0.24701,REACTOME_MEIOTIC_RECOMBINATION,0.936237113066145
GSE21360_SECONDARY_VS_QUATER...2,SET,174,0.049123,0.0047571,0.071832,0.24704,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.936237113066145
REACTOME_INTERLEUKIN_37_SIGN...,SET,19,0.12297,0.0039517,0.17985,0.24708,REACTOME_INTERLEUKIN_37_SIGNALING,0.936237113066145
ZWANG_CLASS_3_TRANSIENTLY_IN...,SET,206,0.044332,0.0046672,0.064849,0.24711,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,0.936237113066145
GOBP_REGULATION_OF_POSTSYNAP...4,SET,13,0.16385,0.0043562,0.23968,0.24711,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.936237113066145
GAVISH_3CA_METAPROGRAM_FIBRO...11,SET,44,0.09037,0.0044165,0.1322,0.24713,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE,0.936237113066145
GSE24574_BCL6_HIGH_TFH_VS_TF...1,SET,185,0.044186,0.0044108,0.064651,0.24717,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN,0.936237113066145
GSE29618_BCELL_VS_MDC_DN,SET,183,0.045215,0.0044894,0.066158,0.24717,GSE29618_BCELL_VS_MDC_DN,0.936237113066145
WP_EICOSANOID_METABOLISM_VIA...2,SET,9,0.19508,0.0043159,0.28546,0.24719,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.936237113066145
KEGG_RIBOSOME,SET,79,0.063576,0.0041593,0.093056,0.24724,KEGG_RIBOSOME,0.936237113066145
GOBP_ALDEHYDE_CATABOLIC_PROC...,SET,13,0.1545,0.0041077,0.22616,0.24726,GOBP_ALDEHYDE_CATABOLIC_PROCESS,0.936237113066145
CHANDRAN_METASTASIS_DN,SET,288,0.035728,0.0044374,0.052307,0.24729,CHANDRAN_METASTASIS_DN,0.936237113066145
GOBP_NEGATIVE_REGULATION_OF_...292,SET,12,0.18673,0.00477,0.27338,0.2473,GOBP_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,0.936237113066145
GOBP_REGULATION_OF_CARDIAC_M...3,SET,7,0.18489,0.0036077,0.27073,0.24733,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION,0.936237113066145
GOBP_CELLULAR_RESPONSE_TO_EP...,SET,11,0.18026,0.0044088,0.26397,0.24734,GOBP_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS,0.936237113066145
DESCARTES_MAIN_FETAL_MICROGL...,SET,121,0.055444,0.0044839,0.081187,0.24734,DESCARTES_MAIN_FETAL_MICROGLIA,0.936237113066145
GOBP_INTERMEMBRANE_LIPID_TRA...,SET,28,0.1044,0.0040718,0.15288,0.24735,GOBP_INTERMEMBRANE_LIPID_TRANSFER,0.936237113066145
KEGG_MEDICUS_REFERENCE_GENE_...,SET,25,0.11748,0.0043302,0.17205,0.24736,KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119,0.936237113066145
GOBP_LYMPH_NODE_DEVELOPMENT,SET,19,0.1362,0.004377,0.19947,0.24737,GOBP_LYMPH_NODE_DEVELOPMENT,0.936237113066145
GSE12198_CTRL_VS_HIGH_IL2_ST...2,SET,181,0.043367,0.0042825,0.063526,0.24741,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.936237113066145
GSE12845_NAIVE_VS_DARKZONE_G...1,SET,176,0.040525,0.0039468,0.059369,0.24743,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.936237113066145
HP_HYPERACUSIS,SET,23,0.1523,0.0053846,0.22317,0.24748,HP_HYPERACUSIS,0.936237113066145
HP_SMALL_EARLOBE,SET,23,0.12602,0.0044555,0.18468,0.2475,HP_SMALL_EARLOBE,0.936237113066145
HP_URETHROVESICAL_OCCLUSION,SET,10,0.18017,0.0042016,0.26402,0.2475,HP_URETHROVESICAL_OCCLUSION,0.936237113066145
SHARMA_PILOCYTIC_ASTROCYTOMA...2,SET,26,0.12808,0.0048139,0.18774,0.24756,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,0.936237113066145
GKCGCNNNNNNNTGAYG_UNKNOWN,SET,54,0.071789,0.0038857,0.10525,0.24761,GKCGCNNNNNNNTGAYG_UNKNOWN,0.936237113066145
GSE40655_FOXO1_KO_VS_WT_NTRE...2,SET,178,0.041498,0.0040642,0.060844,0.24761,GSE40655_FOXO1_KO_VS_WT_NTREG_UP,0.936237113066145
WP_BMP2WNT4FOXO1_PATHWAY_IN_...,SET,13,0.19339,0.0051415,0.2837,0.24773,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,0.936237113066145
MIR139_3P,SET,14,0.16984,0.0046857,0.2492,0.24778,MIR139_3P,0.936237113066145
HP_CENTRAL_PRIMITIVE_NEUROEC...,SET,6,0.27085,0.0048931,0.39745,0.24779,HP_CENTRAL_PRIMITIVE_NEUROECTODERMAL_TUMOR,0.936237113066145
BIOCARTA_THELPER_PATHWAY,SET,12,0.18599,0.0047509,0.27295,0.24782,BIOCARTA_THELPER_PATHWAY,0.936237113066145
GOMF_HISTONE_BINDING,SET,204,0.039525,0.0041411,0.058011,0.24783,GOMF_HISTONE_BINDING,0.936237113066145
GOMF_GAP_JUNCTION_CHANNEL_AC...2,SET,5,0.30317,0.0049999,0.44501,0.24785,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_CONDUCTION_ELECTRICAL_COUPLING,0.936237113066145
GOCC_INTERCALATED_DISC,SET,50,0.088843,0.0046277,0.13042,0.24787,GOCC_INTERCALATED_DISC,0.936237113066145
REACTOME_TRAF3_DEPENDENT_IRF...,SET,14,0.15322,0.0042274,0.22497,0.24792,REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,0.936237113066145
VANTVEER_BREAST_CANCER_ESR1_...2,SET,136,0.051241,0.0043916,0.075241,0.24793,VANTVEER_BREAST_CANCER_ESR1_UP,0.936237113066145
GOBP_LYMPH_VESSEL_DEVELOPMENT,SET,29,0.11529,0.004576,0.16928,0.24793,GOBP_LYMPH_VESSEL_DEVELOPMENT,0.936237113066145
GSE33424_CD161_INT_VS_NEG_CD...2,SET,181,0.043238,0.0042698,0.063493,0.24794,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP,0.936237113066145
REACTOME_SIGNALING_BY_PDGFR_...,SET,20,0.12643,0.0041685,0.18567,0.24796,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,0.936237113066145
GTGGTGA_MIR197,SET,64,0.069775,0.0041104,0.10247,0.24796,GTGGTGA_MIR197,0.936237113066145
GOBP_PLATELET_ACTIVATING_FAC...,SET,8,0.20813,0.0043414,0.30565,0.24796,GOBP_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS,0.936237113066145
GOBP_PLATELET_DERIVED_GROWTH...2,SET,14,0.16571,0.0045719,0.24338,0.24798,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,0.936237113066145
MIR6869_5P,SET,37,0.092328,0.0041385,0.13562,0.24801,MIR6869_5P,0.936237113066145
GOBP_MELANOCYTE_PROLIFERATION,SET,5,0.28053,0.0046266,0.41209,0.24802,GOBP_MELANOCYTE_PROLIFERATION,0.936237113066145
GSE6259_FLT3L_INDUCED_VS_WT_...2,SET,165,0.047361,0.0044674,0.069588,0.24807,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP,0.936294870820669
HP_WRIST_DROP,SET,7,0.23725,0.0046294,0.34864,0.2481,HP_WRIST_DROP,0.936294870820669
GSE22886_DAY0_VS_DAY1_MONOCY...1,SET,185,0.044418,0.004434,0.065277,0.24812,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN,0.936294870820669
GOBP_INTERLEUKIN_11_MEDIATED...,SET,6,0.24901,0.0044985,0.36602,0.24816,GOBP_INTERLEUKIN_11_MEDIATED_SIGNALING_PATHWAY,0.936294870820669
TAXCREB_01,SET,121,0.053327,0.0043128,0.078391,0.24817,TAXCREB_01,0.936294870820669
HP_SUPERNUMERARY_CUSP,SET,4,0.28476,0.0042006,0.41882,0.24829,HP_SUPERNUMERARY_CUSP,0.936307828064097
GSE43955_TH0_VS_TGFB_IL6_TH1...9,SET,184,0.0436,0.0043408,0.064131,0.2483,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN,0.936307828064097
GSE17721_0.5H_VS_8H_CPG_BMDC...1,SET,183,0.041888,0.0041591,0.061623,0.24833,GSE17721_0.5H_VS_8H_CPG_BMDC_DN,0.936307828064097
HP_ABNORMAL_CIRCULATING_RENIN,SET,29,0.11908,0.0047267,0.17519,0.24834,HP_ABNORMAL_CIRCULATING_RENIN,0.936307828064097
SCHAEFFER_PROSTATE_DEVELOPME...14,SET,8,0.21435,0.0044712,0.31539,0.24837,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN,0.936307828064097
GSE36476_CTRL_VS_TSST_ACT_72...1,SET,181,0.041306,0.004079,0.060789,0.24841,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN,0.936307828064097
HP_INCREASED_CORNEAL_THICKNE...,SET,5,0.30363,0.0050074,0.4469,0.24845,HP_INCREASED_CORNEAL_THICKNESS,0.936307828064097
GSE37301_COMMON_LYMPHOID_PRO...2,SET,168,0.043687,0.0041578,0.064304,0.24845,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP,0.936307828064097
HP_LIMITED_HIP_EXTENSION,SET,5,0.28697,0.0047328,0.42248,0.24849,HP_LIMITED_HIP_EXTENSION,0.936307828064097
LEONARD_HYPOXIA,SET,38,0.091707,0.0041658,0.13503,0.24852,LEONARD_HYPOXIA,0.936307828064097
GOBP_RESPONSE_TO_NITROGEN_CO...,SET,992,0.019235,0.0043465,0.028327,0.24857,GOBP_RESPONSE_TO_NITROGEN_COMPOUND,0.936307828064097
MIR101_2_5P,SET,6,0.21858,0.0039487,0.32195,0.2486,MIR101_2_5P,0.936307828064097
GOBP_TOLL_SIGNALING_PATHWAY,SET,11,0.1746,0.0042703,0.2572,0.24862,GOBP_TOLL_SIGNALING_PATHWAY,0.936307828064097
GOBP_POSITIVE_REGULATION_OF_...413,SET,24,0.12839,0.0046367,0.18914,0.24863,GOBP_POSITIVE_REGULATION_OF_LIPID_STORAGE,0.936307828064097
PID_CASPASE_PATHWAY,SET,50,0.081393,0.0042396,0.11991,0.24864,PID_CASPASE_PATHWAY,0.936307828064097
GOBP_GLUTAMATE_CATABOLIC_PRO...,SET,7,0.22809,0.0044507,0.33604,0.24864,GOBP_GLUTAMATE_CATABOLIC_PROCESS,0.936307828064097
GOBP_CENTRIOLE_CENTRIOLE_COH...,SET,14,0.1616,0.0044586,0.23818,0.24873,GOBP_CENTRIOLE_CENTRIOLE_COHESION,0.936307828064097
GSE5589_WT_VS_IL6_KO_LPS_STI...2,SET,119,0.052427,0.004205,0.077268,0.24873,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.936307828064097
GSE17721_LPS_VS_GARDIQUIMOD_...2,SET,185,0.041856,0.0041783,0.061699,0.24877,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.936307828064097
DANG_MYC_TARGETS_DN,SET,27,0.11959,0.0045805,0.17629,0.24878,DANG_MYC_TARGETS_DN,0.936307828064097
GOBP_POSITIVE_REGULATION_OF_...627,SET,9,0.21502,0.0047572,0.31699,0.24878,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.936307828064097
MIR3200_5P,SET,58,0.078832,0.0044216,0.11621,0.24879,MIR3200_5P,0.936307828064097
HP_ACUTE_HEPATIC_FAILURE,SET,31,0.098932,0.0040598,0.14586,0.24881,HP_ACUTE_HEPATIC_FAILURE,0.936307828064097
LINDVALL_IMMORTALIZED_BY_TER...2,SET,59,0.0833,0.0047122,0.12282,0.24882,LINDVALL_IMMORTALIZED_BY_TERT_UP,0.936307828064097
GSE22886_NAIVE_CD4_TCELL_VS_...8,SET,181,0.04411,0.0043559,0.065055,0.24888,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP,0.936432218252679
BRUINS_UVC_RESPONSE_VIA_TP53...2,SET,493,0.026433,0.0042709,0.039001,0.24897,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,0.936463567023694
GOBP_REGULATION_OF_PROGRAMME...2,SET,27,0.11181,0.0042826,0.165,0.249,GOBP_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.936463567023694
MODULE_492,SET,16,0.1493,0.0044033,0.22033,0.24902,MODULE_492,0.936463567023694
GSE17974_CTRL_VS_ACT_IL4_AND...6,SET,173,0.043391,0.0041901,0.064037,0.24902,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP,0.936463567023694
HP_FLAT_OCCIPUT,SET,52,0.076571,0.0040672,0.11301,0.24904,HP_FLAT_OCCIPUT,0.936463567023694
GOBP_HORMONE_CATABOLIC_PROCE...,SET,12,0.18052,0.0046113,0.26646,0.24905,GOBP_HORMONE_CATABOLIC_PROCESS,0.936463567023694
KEGG_MEDICUS_REFERENCE_EGF_E...4,SET,16,0.13817,0.0040751,0.204,0.24911,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.936587846170489
GOMF_1_PHOSPHATIDYLINOSITOL_...3,SET,7,0.24115,0.0047056,0.35624,0.24922,GOMF_1_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY,0.936746464100346
HP_CENTRAL_SLEEP_APNEA,SET,37,0.1027,0.0046035,0.15172,0.24923,HP_CENTRAL_SLEEP_APNEA,0.936746464100346
GENTILE_UV_HIGH_DOSE_DN,SET,268,0.035235,0.0042238,0.052058,0.24926,GENTILE_UV_HIGH_DOSE_DN,0.936746464100346
BIOCARTA_MPR_PATHWAY,SET,21,0.13049,0.0044083,0.19279,0.24926,BIOCARTA_MPR_PATHWAY,0.936746464100346
HP_HYPERHIDROSIS,SET,149,0.047959,0.0043008,0.070881,0.24933,HP_HYPERHIDROSIS,0.936766129903815
GSE21063_WT_VS_NFATC1_KO_3H_...2,SET,184,0.041288,0.0041106,0.061027,0.24935,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP,0.936766129903815
MIR6501_5P,SET,65,0.073153,0.0043428,0.10814,0.24938,MIR6501_5P,0.936766129903815
HP_GENERALIZED_DYSTONIA,SET,27,0.10416,0.0039893,0.15398,0.24939,HP_GENERALIZED_DYSTONIA,0.936766129903815
GOMF_PHOSPHOLIPID_TRANSPORTE...,SET,58,0.076753,0.004305,0.11347,0.2494,GOMF_PHOSPHOLIPID_TRANSPORTER_ACTIVITY,0.936766129903815
GOBP_OOCYTE_MATURATION,SET,30,0.10859,0.0043839,0.16057,0.24943,GOBP_OOCYTE_MATURATION,0.936777571860817
HP_DECREASED_CIRCULATING_VIT...2,SET,31,0.09951,0.0040835,0.14716,0.24946,HP_DECREASED_CIRCULATING_VITAMIN_D_CONCENTRATION,0.936789011345219
MIR4786_5P,SET,85,0.064115,0.0043503,0.094844,0.24952,MIR4786_5P,0.936834744572848
BIOCARTA_ARENRF2_PATHWAY,SET,20,0.14235,0.0046933,0.21058,0.24953,BIOCARTA_ARENRF2_PATHWAY,0.936834744572848
HP_POSTERIOR_HELIX_PIT,SET,4,0.31298,0.0046168,0.46307,0.24956,HP_POSTERIOR_HELIX_PIT,0.936834744572848
CEBPA_01,SET,223,0.040824,0.0044696,0.060406,0.24958,CEBPA_01,0.936834744572848
HP_HYPERPIGMENTED_PAPULE,SET,5,0.21261,0.0035064,0.31472,0.24966,HP_HYPERPIGMENTED_PAPULE,0.936932653061224
GSE39152_BRAIN_VS_SPLEEN_CD1...1,SET,186,0.041653,0.0041692,0.061657,0.24966,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN,0.936932653061224
GOBP_NEGATIVE_REGULATION_OF_...708,SET,70,0.071843,0.0044255,0.1064,0.24977,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING,0.937096945701357
GOBP_NEGATIVE_REGULATION_OF_...571,SET,92,0.062634,0.0044204,0.092785,0.24983,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.937096945701357
GOBP_RENAL_TUBULE_DEVELOPMENT,SET,96,0.064419,0.0046437,0.095445,0.24986,GOBP_RENAL_TUBULE_DEVELOPMENT,0.937096945701357
WU_HBX_TARGETS_1_UP,SET,13,0.17779,0.0047269,0.26344,0.24988,WU_HBX_TARGETS_1_UP,0.937096945701357
MODULE_107,SET,74,0.070746,0.0044801,0.10484,0.24991,MODULE_107,0.937096945701357
GOMF_CARBOHYDRATE_DERIVATIVE...,SET,54,0.083063,0.0044959,0.1231,0.24991,GOMF_CARBOHYDRATE_DERIVATIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.937096945701357
GSE42021_TCONV_PLN_VS_CD24LO...2,SET,182,0.041801,0.0041391,0.061946,0.24991,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP,0.937096945701357
GOBP_DNA_REPLICATION,SET,260,0.034811,0.0041111,0.05159,0.24992,GOBP_DNA_REPLICATION,0.937096945701357
WP_LDLRAD4_AND_WHAT_WE_KNOW_...,SET,7,0.26441,0.0051594,0.39202,0.25,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,0.937096945701357
MIR10399_3P,SET,8,0.19593,0.004087,0.29052,0.25003,MIR10399_3P,0.937096945701357
GOBP_RESPONSE_TO_MOLECULE_OF...1,SET,326,0.034403,0.0045412,0.051022,0.25007,GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.937096945701357
GOMF_STRUCTURAL_CONSTITUENT_...2,SET,100,0.05943,0.0043719,0.088142,0.25008,GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON,0.937096945701357
GSE23321_CD8_STEM_CELL_MEMOR...2,SET,174,0.045584,0.0044145,0.067615,0.2501,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP,0.937096945701357
CAR_HPX,SET,70,0.075746,0.0046659,0.11237,0.25013,CAR_HPX,0.937096945701357
REACTOME_PHASE_2_PLATEAU_PHA...,SET,14,0.15754,0.0043465,0.23378,0.25019,REACTOME_PHASE_2_PLATEAU_PHASE,0.937096945701357
GHO_ATF5_TARGETS_DN,SET,16,0.15872,0.004681,0.23553,0.2502,GHO_ATF5_TARGETS_DN,0.937096945701357
PURBEY_TARGETS_OF_CTBP1_NOT_...1,SET,353,0.030931,0.0042455,0.0459,0.2502,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,0.937096945701357
GOBP_ORGANONITROGEN_COMPOUND...2,SET,1308,0.016422,0.0042224,0.02437,0.2502,GOBP_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS,0.937096945701357
REACTOME_P75NTR_NEGATIVELY_R...,SET,6,0.23466,0.0042393,0.34826,0.25022,REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1,0.937096945701357
GOMF_NUCLEAR_RECEPTOR_BINDING,SET,126,0.049909,0.0041183,0.074085,0.25027,GOMF_NUCLEAR_RECEPTOR_BINDING,0.937096945701357
GARCIA_PINERES_PBMC_HPV_16_L...1,SET,20,0.13365,0.0044064,0.19839,0.25027,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.937096945701357
GOMF_SEMAPHORIN_RECEPTOR_BIN...,SET,23,0.12263,0.0043356,0.1821,0.25034,GOMF_SEMAPHORIN_RECEPTOR_BINDING,0.937258073898524
REACTOME_PRESYNAPTIC_FUNCTIO...,SET,21,0.13128,0.0044352,0.19497,0.25038,REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS,0.937259286559776
GOBP_PROTEIN_LOCALIZATION_TO...45,SET,5,0.28124,0.0046382,0.41778,0.25042,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE_RAFT,0.937259286559776
MIR3117_5P,SET,54,0.077232,0.0041803,0.11476,0.25048,MIR3117_5P,0.937259286559776
GOBP_PROTEIN_K11_LINKED_DEUB...,SET,9,0.17963,0.0039741,0.26697,0.25053,GOBP_PROTEIN_K11_LINKED_DEUBIQUITINATION,0.937259286559776
GSE17721_CPG_VS_GARDIQUIMOD_...2,SET,185,0.040749,0.0040678,0.060566,0.25054,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.937259286559776
MIR4786_3P,SET,149,0.049471,0.0044364,0.073536,0.25056,MIR4786_3P,0.937259286559776
GOBP_PROTEIN_REPAIR,SET,7,0.20051,0.0039126,0.29805,0.25056,GOBP_PROTEIN_REPAIR,0.937259286559776
HP_IMPAIRMENT_IN_PERSONALITY...,SET,200,0.041081,0.0042621,0.061072,0.25058,HP_IMPAIRMENT_IN_PERSONALITY_FUNCTIONING,0.937259286559776
HP_PROGRESSIVE_NIGHT_BLINDNE...,SET,85,0.06257,0.0042454,0.093019,0.25059,HP_PROGRESSIVE_NIGHT_BLINDNESS,0.937259286559776
GSE1460_CD4_THYMOCYTE_VS_NAI...3,SET,176,0.043551,0.0042414,0.064751,0.25061,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.937259286559776
GOMF_GLYCINE_N_ACYLTRANSFERA...,SET,4,0.40092,0.0059141,0.59633,0.2507,GOMF_GLYCINE_N_ACYLTRANSFERASE_ACTIVITY,0.937361255643947
HP_ABNORMAL_BLOOD_POTASSIUM_...,SET,105,0.058579,0.0044152,0.087137,0.25071,HP_ABNORMAL_BLOOD_POTASSIUM_CONCENTRATION,0.937361255643947
GOBP_FIBROBLAST_GROWTH_FACTO...1,SET,7,0.23802,0.0046444,0.35412,0.25075,GOBP_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.937361255643947
SOBOLEV_PBMC_PANDEMRIX_AGE_1...1,SET,15,0.15781,0.0045065,0.23479,0.25076,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP,0.937361255643947
HP_ABDOMINAL_CRAMPS,SET,7,0.19524,0.0038097,0.29052,0.25078,HP_ABDOMINAL_CRAMPS,0.937361255643947
MORF_FLT1,SET,116,0.055281,0.004378,0.082268,0.25081,MORF_FLT1,0.937361255643947
GOCC_ELONGATOR_HOLOENZYME_CO...,SET,5,0.27877,0.0045974,0.41491,0.25084,GOCC_ELONGATOR_HOLOENZYME_COMPLEX,0.937361255643947
HE_LIM_SUN_FETAL_LUNG_C0_ASP...,SET,105,0.060003,0.0045224,0.089321,0.25087,HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE,0.937361255643947
REACTOME_ERYTHROPOIETIN_ACTI...1,SET,12,0.19173,0.0048977,0.28543,0.25088,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,0.937361255643947
GOBP_ENDOCYTOSIS,SET,646,0.023407,0.0043106,0.034854,0.25093,GOBP_ENDOCYTOSIS,0.937447291196388
VERRECCHIA_RESPONSE_TO_TGFB1...1,SET,19,0.1285,0.0041296,0.19139,0.25098,VERRECCHIA_RESPONSE_TO_TGFB1_C1,0.937533308254514
GOMF_DNA_TRANSLOCASE_ACTIVITY,SET,2,0.28862,0.0030107,0.42997,0.25104,GOMF_DNA_TRANSLOCASE_ACTIVITY,0.937575008054989
MORF_DEAF1,SET,46,0.081872,0.0040909,0.12199,0.25107,MORF_DEAF1,0.937575008054989
HOWARD_B_CELL_INACT_MONOV_IN...,SET,14,0.15319,0.0042266,0.22828,0.25108,HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.937575008054989
GOCC_POSTSYNAPTIC_SPECIALIZA...2,SET,19,0.12962,0.0041656,0.1932,0.25114,GOCC_POSTSYNAPTIC_SPECIALIZATION_INTRACELLULAR_COMPONENT,0.937575008054989
HP_KERATOCONJUNCTIVITIS,SET,43,0.086125,0.0041611,0.12837,0.25115,HP_KERATOCONJUNCTIVITIS,0.937575008054989
GOBP_NEGATIVE_REGULATION_OF_...400,SET,166,0.043641,0.0041289,0.065053,0.25116,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,0.937575008054989
GOBP_ACTIN_FILAMENT_BUNDLE_O...,SET,152,0.0478,0.0043291,0.07126,0.25118,GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION,0.937575008054989
GOCC_CARDIAC_MYOFIBRIL,SET,6,0.21347,0.0038565,0.31844,0.25132,GOCC_CARDIAC_MYOFIBRIL,0.937996842783505
GOBP_NEGATIVE_REGULATION_OF_...78,SET,9,0.21606,0.0047801,0.3225,0.25145,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.93830292507514
MORF_XPC,SET,53,0.071393,0.0038284,0.10658,0.25148,MORF_XPC,0.93830292507514
GOBP_NEGATIVE_REGULATION_OF_...82,SET,26,0.12089,0.0045439,0.18048,0.25149,GOBP_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.93830292507514
ZNF23_TARGET_GENES,SET,14,0.1541,0.0042516,0.23009,0.25151,ZNF23_TARGET_GENES,0.93830292507514
DE_YY1_TARGETS_DN,SET,88,0.060851,0.0042007,0.090886,0.25158,DE_YY1_TARGETS_DN,0.938407345692242
MIR23B_5P,SET,43,0.092264,0.0044577,0.13782,0.2516,MIR23B_5P,0.938407345692242
MORF_STK17A,SET,158,0.046005,0.0042473,0.068758,0.25172,MORF_STK17A,0.938407345692242
GOCC_NUCLEOCYTOPLASMIC_TRANS...,SET,12,0.15365,0.0039249,0.22965,0.25173,GOCC_NUCLEOCYTOPLASMIC_TRANSPORT_COMPLEX,0.938407345692242
MIR6134,SET,122,0.051245,0.0041614,0.076598,0.25175,MIR6134,0.938407345692242
GOMF_VINCULIN_BINDING,SET,11,0.1812,0.0044318,0.27088,0.25177,GOMF_VINCULIN_BINDING,0.938407345692242
GOBP_MEIOTIC_SPINDLE_ORGANIZ...,SET,16,0.14464,0.0042659,0.21624,0.25178,GOBP_MEIOTIC_SPINDLE_ORGANIZATION,0.938407345692242
HP_ABNORMAL_AMPLITUDE_OF_PAT...,SET,6,0.25179,0.0045487,0.37641,0.25178,HP_ABNORMAL_AMPLITUDE_OF_PATTERN_ELECTRORETINOGRAM,0.938407345692242
HP_LUPUS_NEPHRITIS,SET,25,0.12594,0.0046416,0.18829,0.2518,HP_LUPUS_NEPHRITIS,0.938407345692242
GSE40685_NAIVE_CD4_TCELL_VS_...3,SET,179,0.042679,0.0041914,0.063825,0.25185,GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN,0.938407345692242
WP_5Q35_COPY_NUMBER_VARIATION,SET,97,0.062672,0.0045411,0.093736,0.25188,WP_5Q35_COPY_NUMBER_VARIATION,0.938407345692242
KEGG_MEDICUS_PATHOGEN_KSHV_V...1,SET,6,0.21302,0.0038484,0.31865,0.2519,KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S,0.938407345692242
MARSHALL_VIRAL_INFECTION_RES...1,SET,27,0.11134,0.0042644,0.16659,0.25196,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,0.938407345692242
RUBENSTEIN_SKELETAL_MUSCLE_P...1,SET,203,0.042796,0.0044729,0.064033,0.25196,RUBENSTEIN_SKELETAL_MUSCLE_PCV_ENDOTHELIAL_CELLS,0.938407345692242
GOBP_POSITIVE_REGULATION_OF_...658,SET,5,0.30235,0.0049864,0.45241,0.25197,GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS,0.938407345692242
GSE26928_NAIVE_VS_CENT_MEMOR...1,SET,170,0.043149,0.0041308,0.064565,0.25197,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,0.938407345692242
GSE7831_UNSTIM_VS_CPG_STIM_P...1,SET,175,0.043612,0.0042354,0.065268,0.25201,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN,0.938414781491003
GSE40274_FOXP3_VS_FOXP3_AND_...10,SET,185,0.041551,0.0041479,0.062196,0.25205,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.938414781491003
KEGG_MEDICUS_REFERENCE_RIG_I...1,SET,20,0.14452,0.0047649,0.21633,0.25206,KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY,0.938414781491003
LINDSTEDT_DENDRITIC_CELL_MAT...1,SET,61,0.079937,0.0045977,0.11967,0.25208,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,0.938414781491003
PTEN_DN.V2_UP,SET,126,0.05424,0.0044757,0.081215,0.25212,PTEN_DN.V2_UP,0.938437106446776
GOBP_NEGATIVE_REGULATION_OF_...494,SET,5,0.2077,0.0034255,0.31103,0.25214,GOBP_NEGATIVE_REGULATION_OF_PINOCYTOSIS,0.938437106446776
chr5p13,SET,54,0.15071,0.0081572,0.22576,0.25222,chr5p13,0.938455527074656
HP_PROMINENT_ANTITRAGUS,SET,6,0.22666,0.0040947,0.33956,0.25223,HP_PROMINENT_ANTITRAGUS,0.938455527074656
GOBP_SMOOTH_MUSCLE_ADAPTATION,SET,4,0.34689,0.0051171,0.5198,0.25228,GOBP_SMOOTH_MUSCLE_ADAPTATION,0.938455527074656
MELLMAN_TUT1_TARGETS_UP,SET,19,0.13056,0.0041957,0.19564,0.25229,MELLMAN_TUT1_TARGETS_UP,0.938455527074656
MIR619_5P,SET,130,0.049507,0.004149,0.074188,0.25229,MIR619_5P,0.938455527074656
REACTOME_PTK6_REGULATES_CELL...,SET,6,0.2382,0.0043032,0.35712,0.25239,REACTOME_PTK6_REGULATES_CELL_CYCLE,0.938455527074656
MIR378A_3P_MIR378C_MIR378D_M...,SET,38,0.087488,0.0039741,0.13117,0.2524,MIR378A_3P_MIR378C_MIR378D_MIR378I,0.938455527074656
GCM_RING1,SET,98,0.054589,0.0039756,0.081865,0.25245,GCM_RING1,0.938455527074656
HP_DECREASED_MINIATURE_ENDPL...,SET,13,0.13916,0.0036998,0.20876,0.25252,HP_DECREASED_MINIATURE_ENDPLATE_POTENTIALS,0.938455527074656
PID_P38_ALPHA_BETA_DOWNSTREA...,SET,37,0.095946,0.0043007,0.14398,0.25258,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,0.938455527074656
GOBP_SCHWANN_CELL_MIGRATION,SET,5,0.30295,0.0049963,0.45468,0.25262,GOBP_SCHWANN_CELL_MIGRATION,0.938455527074656
HP_ABNORMAL_ABDOMEN_MORPHOLO...,SET,723,0.021674,0.0042135,0.03253,0.25262,HP_ABNORMAL_ABDOMEN_MORPHOLOGY,0.938455527074656
GARGALOVIC_RESPONSE_TO_OXIDI...9,SET,71,0.074385,0.0046145,0.11164,0.25263,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,0.938455527074656
GOBP_GERMINAL_CENTER_FORMATI...,SET,14,0.15522,0.0042826,0.23299,0.25264,GOBP_GERMINAL_CENTER_FORMATION,0.938455527074656
GSE40666_STAT1_KO_VS_STAT4_K...4,SET,168,0.040778,0.003881,0.061214,0.25266,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.938455527074656
GSE9601_NFKB_INHIBITOR_VS_PI...2,SET,177,0.041987,0.0041006,0.063035,0.25268,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.938455527074656
GOMF_GAMMA_TUBULIN_BINDING,SET,28,0.10535,0.0041089,0.15817,0.25269,GOMF_GAMMA_TUBULIN_BINDING,0.938455527074656
GSE10856_CTRL_VS_TNFRSF6B_IN...1,SET,164,0.042702,0.0040158,0.064116,0.25271,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN,0.938455527074656
WP_COMPLEMENT_SYSTEM,SET,89,0.066049,0.0045852,0.09918,0.25273,WP_COMPLEMENT_SYSTEM,0.938455527074656
MIR5682,SET,205,0.04091,0.0042966,0.061431,0.25273,MIR5682,0.938455527074656
GSE46242_TH1_VS_ANERGIC_TH1_...4,SET,166,0.04468,0.0042272,0.067108,0.25277,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP,0.938455527074656
SHEPARD_CRASH_AND_BURN_MUTAN...1,SET,179,0.043409,0.0042631,0.065199,0.25278,SHEPARD_CRASH_AND_BURN_MUTANT_DN,0.938455527074656
ZHANG_PROLIFERATING_VS_QUIES...,SET,45,0.088088,0.0043535,0.13232,0.2528,ZHANG_PROLIFERATING_VS_QUIESCENT,0.938455527074656
REACTOME_SIGNALING_BY_PDGFRA...,SET,12,0.16057,0.0041016,0.24121,0.25281,REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,0.938455527074656
GOBP_FORELIMB_MORPHOGENESIS,SET,38,0.10066,0.0045724,0.15122,0.25282,GOBP_FORELIMB_MORPHOGENESIS,0.938455527074656
GOCC_CCR4_NOT_CORE_COMPLEX,SET,5,0.2114,0.0034864,0.31779,0.25296,GOCC_CCR4_NOT_CORE_COMPLEX,0.938566497921773
MIR4312,SET,42,0.091753,0.0043813,0.13795,0.25299,MIR4312,0.938566497921773
GOBP_REGULATION_OF_RELEASE_O...1,SET,41,0.09149,0.0043165,0.13756,0.253,GOBP_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.938566497921773
BIOCARTA_HCMV_PATHWAY,SET,17,0.14343,0.0043604,0.21573,0.25306,BIOCARTA_HCMV_PATHWAY,0.938566497921773
HP_EPENDYMOMA,SET,19,0.13456,0.0043243,0.20241,0.2531,HP_EPENDYMOMA,0.938566497921773
DESCARTES_FETAL_MUSCLE_LYMPH...2,SET,96,0.057895,0.0041734,0.087088,0.2531,DESCARTES_FETAL_MUSCLE_LYMPHOID_CELLS,0.938566497921773
GSE21063_3H_VS_16H_ANTI_IGM_...1,SET,168,0.040508,0.0038552,0.060942,0.25313,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN,0.938566497921773
PID_AJDISS_2PATHWAY,SET,46,0.086309,0.0043126,0.12986,0.25315,PID_AJDISS_2PATHWAY,0.938566497921773
GSE43955_10H_VS_60H_ACT_CD4_...2,SET,177,0.042003,0.0041022,0.06321,0.25319,GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP,0.938566497921773
MODULE_524,SET,27,0.11644,0.0044598,0.17523,0.2532,MODULE_524,0.938566497921773
GSE2706_2H_VS_8H_LPS_STIM_DC...1,SET,162,0.046074,0.0043066,0.069344,0.25322,GSE2706_2H_VS_8H_LPS_STIM_DC_DN,0.938566497921773
DESCARTES_FETAL_HEART_VISCER...,SET,73,0.071363,0.0044887,0.10742,0.25324,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.938566497921773
GOBP_NEGATIVE_REGULATION_OF_...224,SET,3,0.32851,0.0041969,0.49456,0.25327,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.938566497921773
GSE14415_FOXP3_KO_NATURAL_TR...1,SET,158,0.045668,0.0042161,0.068756,0.25328,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN,0.938566497921773
GOBP_PEPTIDYL_PROLINE_HYDROX...2,SET,8,0.16075,0.0033531,0.24203,0.25329,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE,0.938566497921773
GOMF_PEPTIDYL_PROLINE_4_DIOX...,SET,8,0.16075,0.0033531,0.24203,0.25329,GOMF_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY,0.938566497921773
HP_INTERMITTENT_EPISODES_OF_...,SET,13,0.1684,0.0044772,0.2536,0.25334,HP_INTERMITTENT_EPISODES_OF_RESPIRATORY_INSUFFICIENCY_DUE_TO_MUSCLE_WEAKNESS,0.938566497921773
HP_ABNORMAL_ZYGOMATIC_BONE_M...,SET,206,0.040368,0.0042499,0.060804,0.25338,HP_ABNORMAL_ZYGOMATIC_BONE_MORPHOLOGY,0.938566497921773
GSE22886_NAIVE_CD4_TCELL_VS_...1,SET,184,0.039106,0.0038933,0.058904,0.25338,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN,0.938566497921773
JONES_OVARY_T_CELL,SET,83,0.06917,0.0046379,0.10419,0.25339,JONES_OVARY_T_CELL,0.938566497921773
GOBP_POSITIVE_REGULATION_OF_...744,SET,33,0.10799,0.004572,0.16271,0.25344,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.938651662404092
YAGI_AML_WITH_11Q23_REARRANG...,SET,304,0.032916,0.0041983,0.049613,0.25353,YAGI_AML_WITH_11Q23_REARRANGED,0.938762369597616
GOBP_RELAXATION_OF_SMOOTH_MU...,SET,6,0.252,0.0045526,0.37999,0.25361,GOBP_RELAXATION_OF_SMOOTH_MUSCLE,0.938762369597616
GGCNRNWCTTYS_UNKNOWN,SET,77,0.064356,0.004157,0.09706,0.25365,GGCNRNWCTTYS_UNKNOWN,0.938762369597616
HP_ENLARGED_JOINTS,SET,12,0.1563,0.0039926,0.23574,0.25366,HP_ENLARGED_JOINTS,0.938762369597616
GOBP_REGULATION_OF_MULTICELL...2,SET,61,0.080752,0.0046446,0.1218,0.25367,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.938762369597616
MIR7_5P,SET,241,0.037353,0.0042493,0.056341,0.25368,MIR7_5P,0.938762369597616
GSE6269_E_COLI_VS_STAPH_AURE...2,SET,127,0.051304,0.0042501,0.07739,0.25369,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP,0.938762369597616
HP_PSYCHIC_EPILEPTIC_AURA,SET,10,0.17573,0.0040981,0.2651,0.2537,HP_PSYCHIC_EPILEPTIC_AURA,0.938762369597616
MIR223_3P,SET,112,0.053853,0.0041913,0.081245,0.25372,MIR223_3P,0.938762369597616
GOBP_NEGATIVE_REGULATION_OF_...381,SET,4,0.30137,0.0044456,0.45471,0.25374,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CHROMOSOME_SEPARATION,0.938762369597616
GOMF_PHOSPHATIDYLINOSITOL_PH...4,SET,23,0.10318,0.0036479,0.15577,0.25387,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.938917796433413
GOBP_MITOTIC_RECOMBINATION,SET,24,0.10396,0.0037544,0.15699,0.25392,GOBP_MITOTIC_RECOMBINATION,0.938917796433413
GOBP_RESPONSE_TO_FIBROBLAST_...,SET,107,0.059619,0.0045359,0.090058,0.25399,GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR,0.938917796433413
HP_ABNORMAL_CIRCULATING_HORM...,SET,434,0.027904,0.0042372,0.042155,0.25401,HP_ABNORMAL_CIRCULATING_HORMONE_CONCENTRATION,0.938917796433413
MAGRANGEAS_MULTIPLE_MYELOMA_...2,SET,16,0.14516,0.0042813,0.21935,0.25406,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,0.938917796433413
PID_ANGIOPOIETIN_RECEPTOR_PA...,SET,47,0.083517,0.0042181,0.12621,0.25407,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,0.938917796433413
GOBP_INTERLEUKIN_18_PRODUCTI...,SET,12,0.15354,0.0039222,0.23204,0.25408,GOBP_INTERLEUKIN_18_PRODUCTION,0.938917796433413
GSE27786_NEUTROPHIL_VS_MONO_...2,SET,176,0.043213,0.0042085,0.065316,0.25412,GSE27786_NEUTROPHIL_VS_MONO_MAC_UP,0.938917796433413
HP_SHORT_SPERM_FLAGELLA,SET,27,0.10674,0.0040882,0.16136,0.25415,HP_SHORT_SPERM_FLAGELLA,0.938917796433413
GSE37605_TREG_VS_TCONV_C57BL...3,SET,136,0.046893,0.004019,0.070892,0.25416,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN,0.938917796433413
GOBP_REGULATION_OF_LIGASE_AC...,SET,5,0.20425,0.0033686,0.30881,0.25417,GOBP_REGULATION_OF_LIGASE_ACTIVITY,0.938917796433413
HP_RECURRENT_STREPTOCOCCAL_I...,SET,3,0.29577,0.0037786,0.4472,0.25419,HP_RECURRENT_STREPTOCOCCAL_INFECTIONS,0.938917796433413
GOMF_MRNA_CDS_BINDING,SET,3,0.32193,0.0041128,0.48692,0.25426,GOMF_MRNA_CDS_BINDING,0.938917796433413
MIR8079,SET,30,0.11366,0.0045883,0.17195,0.25431,MIR8079,0.938917796433413
GSE2826_XID_VS_BTK_KO_BCELL_...1,SET,185,0.04176,0.0041687,0.063178,0.25431,GSE2826_XID_VS_BTK_KO_BCELL_DN,0.938917796433413
GOBP_T_CELL_APOPTOTIC_PROCESS,SET,57,0.077385,0.004303,0.11708,0.25433,GOBP_T_CELL_APOPTOTIC_PROCESS,0.938917796433413
MIR8082,SET,104,0.056367,0.0042283,0.085294,0.25436,MIR8082,0.938917796433413
GSE13547_CTRL_VS_ANTI_IGM_ST...7,SET,149,0.04524,0.0040569,0.068458,0.25436,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN,0.938917796433413
BYSTRYKH_HEMATOPOIESIS_STEM_...1,SET,64,0.062922,0.0037067,0.095219,0.25437,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,0.938917796433413
GSE32901_NAIVE_VS_TH17_NEG_C...1,SET,112,0.055594,0.0043267,0.084131,0.25437,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN,0.938917796433413
GOCC_POST_MRNA_RELEASE_SPLIC...,SET,10,0.16926,0.0039472,0.25616,0.25439,GOCC_POST_MRNA_RELEASE_SPLICEOSOMAL_COMPLEX,0.938917796433413
MIR1273C,SET,6,0.21488,0.0038821,0.32524,0.25441,MIR1273C,0.938917796433413
GOBP_REGULATION_OF_SECRETION,SET,560,0.025255,0.0043409,0.038236,0.25447,GOBP_REGULATION_OF_SECRETION,0.938917796433413
GSE411_UNSTIM_VS_100MIN_IL6_...2,SET,185,0.042341,0.0042267,0.064109,0.25448,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP,0.938917796433413
GOBP_NEGATIVE_REGULATION_OF_...401,SET,620,0.02367,0.0042736,0.035858,0.25459,GOBP_NEGATIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.938917796433413
HP_ABNORMALITY_OF_COMPLEMENT...,SET,49,0.086417,0.0044563,0.13091,0.25459,HP_ABNORMALITY_OF_COMPLEMENT_SYSTEM,0.938917796433413
HP_NEPHROCALCINOSIS,SET,86,0.067897,0.0046337,0.10286,0.25461,HP_NEPHROCALCINOSIS,0.938917796433413
HP_ABSENT_DISTAL_INTERPHALAN...,SET,7,0.21877,0.0042687,0.33148,0.25464,HP_ABSENT_DISTAL_INTERPHALANGEAL_CREASES,0.938917796433413
HP_PROGRESSIVE_MACROCEPHALY,SET,7,0.21223,0.0041412,0.3216,0.25465,HP_PROGRESSIVE_MACROCEPHALY,0.938917796433413
REACTOME_SELENOAMINO_ACID_ME...,SET,99,0.056324,0.0041228,0.08536,0.25468,REACTOME_SELENOAMINO_ACID_METABOLISM,0.938917796433413
HP_HEPATIC_CYSTS,SET,23,0.11218,0.0039661,0.17005,0.25473,HP_HEPATIC_CYSTS,0.938917796433413
GOBP_POSITIVE_REGULATION_OF_...663,SET,5,0.2676,0.0044133,0.40571,0.25477,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_BINDING,0.938917796433413
GOBP_RETINAL_CELL_PROGRAMMED...,SET,6,0.24335,0.0043964,0.36902,0.2548,GOBP_RETINAL_CELL_PROGRAMMED_CELL_DEATH,0.938917796433413
GOBP_ENDOPLASMIC_RETICULUM_O...,SET,84,0.059176,0.0039915,0.089738,0.25481,GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION,0.938917796433413
GOBP_INSULIN_SECRETION,SET,187,0.042644,0.0042797,0.06468,0.25485,GOBP_INSULIN_SECRETION,0.938917796433413
GSE3982_DC_VS_MAC_DN,SET,178,0.043452,0.0042556,0.06591,0.25487,GSE3982_DC_VS_MAC_DN,0.938917796433413
STEGMEIER_PREMITOTIC_CELL_CY...,SET,11,0.16224,0.0039681,0.24617,0.25493,STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS,0.938917796433413
GOBP_PONS_DEVELOPMENT,SET,11,0.17255,0.0042202,0.26183,0.25494,GOBP_PONS_DEVELOPMENT,0.938917796433413
GOMF_EXOGENOUS_PROTEIN_BINDI...,SET,78,0.068798,0.0044725,0.10441,0.25497,GOMF_EXOGENOUS_PROTEIN_BINDING,0.938917796433413
ONDER_CDH1_TARGETS_3_UP,SET,15,0.15468,0.0044171,0.23478,0.25501,ONDER_CDH1_TARGETS_3_UP,0.938917796433413
HP_TORSION_DYSTONIA,SET,7,0.19919,0.0038867,0.30234,0.25501,HP_TORSION_DYSTONIA,0.938917796433413
GOBP_PIGMENTATION,SET,105,0.05693,0.0042908,0.086416,0.25502,GOBP_PIGMENTATION,0.938917796433413
HP_GRANULOMATOSIS,SET,8,0.25055,0.0052263,0.38038,0.25505,HP_GRANULOMATOSIS,0.938917796433413
REACTOME_ARMS_MEDIATED_ACTIV...,SET,7,0.22703,0.0044299,0.3447,0.25507,REACTOME_ARMS_MEDIATED_ACTIVATION,0.938917796433413
GOBP_REGULATION_OF_TRANSMISS...,SET,13,0.17129,0.004554,0.2601,0.2551,GOBP_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.938917796433413
REACTOME_NOD1_2_SIGNALING_PA...,SET,32,0.096352,0.0040171,0.1464,0.25523,REACTOME_NOD1_2_SIGNALING_PATHWAY,0.938917796433413
DPPA3_TARGET_GENES,SET,16,0.12761,0.0037637,0.1939,0.25523,DPPA3_TARGET_GENES,0.938917796433413
MANNO_MIDBRAIN_NEUROTYPES_HN...3,SET,287,0.035336,0.0043812,0.053692,0.25523,MANNO_MIDBRAIN_NEUROTYPES_HNBML1,0.938917796433413
KANG_IMMORTALIZED_BY_TERT_UP,SET,82,0.065612,0.0043729,0.099705,0.25525,KANG_IMMORTALIZED_BY_TERT_UP,0.938917796433413
MIR6500_3P,SET,73,0.064917,0.0040833,0.098645,0.25525,MIR6500_3P,0.938917796433413
HP_LARYNGEAL_CARCINOMA,SET,12,0.14887,0.0038028,0.22636,0.25539,HP_LARYNGEAL_CARCINOMA,0.938917796433413
GOBP_NEGATIVE_REGULATION_OF_...394,SET,33,0.09444,0.0039983,0.14364,0.25544,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.938917796433413
GOCC_ZONA_PELLUCIDA_RECEPTOR...,SET,8,0.16742,0.0034923,0.25483,0.2556,GOCC_ZONA_PELLUCIDA_RECEPTOR_COMPLEX,0.938917796433413
GOBP_ENDOPLASMIC_RETICULUM_T...3,SET,5,0.22603,0.0037277,0.34407,0.25562,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_FORMATION,0.938917796433413
GSE16385_UNTREATED_VS_12H_RO...6,SET,142,0.050348,0.0044085,0.076649,0.25564,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.938917796433413
BIOCARTA_RHO_PATHWAY,SET,18,0.13259,0.0041475,0.20186,0.25565,BIOCARTA_RHO_PATHWAY,0.938917796433413
GOBP_REGULATION_OF_HEART_GRO...,SET,55,0.083965,0.0045865,0.12786,0.25569,GOBP_REGULATION_OF_HEART_GROWTH,0.938917796433413
GOBP_OVARIAN_FOLLICLE_DEVELO...,SET,55,0.079398,0.004337,0.12091,0.2557,GOBP_OVARIAN_FOLLICLE_DEVELOPMENT,0.938917796433413
HP_LABIAL_HYPERTROPHY,SET,7,0.25633,0.0050016,0.39036,0.25571,HP_LABIAL_HYPERTROPHY,0.938917796433413
GSE21360_NAIVE_VS_TERTIARY_M...1,SET,178,0.041309,0.0040457,0.062913,0.25572,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.938917796433413
GSE18281_PERIMEDULLARY_CORTI...2,SET,186,0.040481,0.0040518,0.061655,0.25573,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.938917796433413
MORI_MATURE_B_LYMPHOCYTE_DN,SET,69,0.065001,0.0039754,0.099003,0.25574,MORI_MATURE_B_LYMPHOCYTE_DN,0.938917796433413
GOBP_POSITIVE_REGULATION_OF_...435,SET,25,0.1164,0.0042901,0.17729,0.25574,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_MIGRATION,0.938917796433413
DURANTE_ADULT_OLFACTORY_NEUR...21,SET,15,0.15303,0.0043701,0.23309,0.25575,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_EPITHELIAL_CELLS,0.938917796433413
GOBP_PHOSPHATIDYLSERINE_EXPO...,SET,8,0.1881,0.0039237,0.28658,0.2558,GOBP_PHOSPHATIDYLSERINE_EXPOSURE_ON_APOPTOTIC_CELL_SURFACE,0.938917796433413
DELYS_THYROID_CANCER_DN,SET,213,0.042037,0.0044993,0.064065,0.25586,DELYS_THYROID_CANCER_DN,0.938917796433413
GOBP_MYELOID_CELL_DIFFERENTI...,SET,393,0.029624,0.0042854,0.045149,0.25587,GOBP_MYELOID_CELL_DIFFERENTIATION,0.938917796433413
MIR26A_5P,SET,455,0.027106,0.004212,0.041342,0.25602,MIR26A_5P,0.938917796433413
HE_LIM_SUN_FETAL_LUNG_C1_AT1...,SET,37,0.096327,0.0043178,0.14693,0.25604,HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL,0.938917796433413
REACTOME_REGULATION_OF_SIGNA...1,SET,21,0.13357,0.0045127,0.20376,0.25606,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,0.938917796433413
HP_CEREBELLAR_HEMORRHAGE,SET,5,0.29416,0.0048514,0.44878,0.25609,HP_CEREBELLAR_HEMORRHAGE,0.938917796433413
GOBP_MYELOID_PROGENITOR_CELL...,SET,9,0.17156,0.0037956,0.26177,0.25611,GOBP_MYELOID_PROGENITOR_CELL_DIFFERENTIATION,0.938917796433413
MCGOWAN_RSP6_TARGETS_DN,SET,4,0.28419,0.0041922,0.43368,0.25614,MCGOWAN_RSP6_TARGETS_DN,0.938917796433413
GOBP_POSITIVE_REGULATION_OF_...63,SET,8,0.23707,0.0049452,0.3618,0.25615,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.938917796433413
GSE3982_DC_VS_BASOPHIL_UP,SET,182,0.042284,0.004187,0.06453,0.25615,GSE3982_DC_VS_BASOPHIL_UP,0.938917796433413
GOBP_HEXOSE_PHOSPHATE_TRANSP...,SET,6,0.23244,0.0041992,0.35481,0.2562,GOBP_HEXOSE_PHOSPHATE_TRANSPORT,0.938917796433413
GSE18281_CORTEX_VS_MEDULLA_T...2,SET,162,0.042056,0.0039311,0.064207,0.25623,GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP,0.938917796433413
GOBP_POSITIVE_REGULATION_OF_...18,SET,67,0.075028,0.0045219,0.11455,0.25625,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.938917796433413
MIR2276_5P,SET,63,0.072912,0.0042616,0.11133,0.25626,MIR2276_5P,0.938917796433413
KEGG_MEDICUS_REFERENCE_TLR3_...1,SET,9,0.18382,0.0040668,0.28068,0.25627,KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY,0.938917796433413
MODULE_244,SET,172,0.040544,0.0039039,0.061914,0.25629,MODULE_244,0.938917796433413
chr8q12,SET,27,0.20038,0.0076749,0.30603,0.25631,chr8q12,0.938917796433413
BIOCARTA_NOS1_PATHWAY,SET,21,0.12717,0.0042962,0.19431,0.25641,BIOCARTA_NOS1_PATHWAY,0.938917796433413
MIR4640_5P,SET,118,0.048803,0.003898,0.074576,0.25643,MIR4640_5P,0.938917796433413
GOBP_POSITIVE_REGULATION_OF_...13,SET,6,0.22469,0.0040592,0.34335,0.25643,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.938917796433413
GOCC_GATOR2_COMPLEX,SET,8,0.176,0.0036712,0.26905,0.25651,GOCC_GATOR2_COMPLEX,0.938917796433413
REACTOME_INTERLEUKIN_7_SIGNA...,SET,21,0.12973,0.0043828,0.19834,0.25654,REACTOME_INTERLEUKIN_7_SIGNALING,0.938917796433413
GSE29618_LAIV_VS_TIV_FLU_VAC...4,SET,180,0.042994,0.0042341,0.065733,0.25654,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP,0.938917796433413
GOCC_PERINEURONAL_NET,SET,10,0.17697,0.004127,0.27058,0.25655,GOCC_PERINEURONAL_NET,0.938917796433413
GSE24726_WT_VS_E2_2_KO_PDC_D...2,SET,177,0.041258,0.0040294,0.063081,0.25655,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN,0.938917796433413
AMIT_EGF_RESPONSE_60_MCF10A,SET,36,0.09898,0.0043765,0.15135,0.25656,AMIT_EGF_RESPONSE_60_MCF10A,0.938917796433413
GSE21670_IL6_VS_TGFB_AND_IL6...3,SET,179,0.040441,0.0039716,0.061836,0.25656,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.938917796433413
REACTOME_PEXOPHAGY,SET,9,0.20197,0.0044684,0.30884,0.25657,REACTOME_PEXOPHAGY,0.938917796433413
HP_INTERSTITIAL_CARDIAC_FIBR...,SET,9,0.20193,0.0044676,0.30879,0.25658,HP_INTERSTITIAL_CARDIAC_FIBROSIS,0.938917796433413
MIR450B_3P,SET,42,0.086681,0.0041391,0.13256,0.25659,MIR450B_3P,0.938917796433413
GSE36476_CTRL_VS_TSST_ACT_72...3,SET,179,0.040622,0.0039895,0.062126,0.2566,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN,0.938917796433413
GOMF_DEUBIQUITINASE_ACTIVITY,SET,81,0.057776,0.0038272,0.088377,0.25664,GOMF_DEUBIQUITINASE_ACTIVITY,0.938917796433413
GSE41978_ID2_KO_VS_ID2_KO_AN...2,SET,175,0.044796,0.0043504,0.068523,0.25665,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.938917796433413
GOBP_NEGATIVE_REGULATION_OF_...706,SET,10,0.19999,0.0046639,0.30599,0.25669,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.938917796433413
HOWARD_NEUTROPHIL_INACT_MONO...4,SET,113,0.054677,0.0042742,0.083684,0.25676,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.938917796433413
HAY_BONE_MARROW_DENDRITIC_CE...,SET,167,0.044851,0.004256,0.068644,0.25676,HAY_BONE_MARROW_DENDRITIC_CELL,0.938917796433413
GOBP_CARDIAC_MUSCLE_CONTRACT...,SET,131,0.052067,0.0043802,0.079713,0.25682,GOBP_CARDIAC_MUSCLE_CONTRACTION,0.938917796433413
HP_HYPERACTIVE_PATELLAR_REFL...,SET,16,0.12426,0.0036648,0.19026,0.25685,HP_HYPERACTIVE_PATELLAR_REFLEX,0.938917796433413
MIR7154_5P,SET,239,0.037244,0.0042195,0.057034,0.25688,MIR7154_5P,0.938917796433413
HP_ABNORMAL_MORPHOLOGY_OF_TH...6,SET,82,0.058869,0.0039235,0.09017,0.25692,HP_ABNORMAL_MORPHOLOGY_OF_THE_MUSCULATURE_OF_THE_NECK,0.938917796433413
GGGYGTGNY_UNKNOWN,SET,598,0.023178,0.0041124,0.035517,0.25701,GGGYGTGNY_UNKNOWN,0.938917796433413
KEGG_MEDICUS_REFERENCE_TLR1_...,SET,18,0.12856,0.0040213,0.19704,0.25707,KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY,0.938917796433413
GOBP_ENDOMEMBRANE_SYSTEM_ORG...,SET,531,0.024022,0.0040239,0.036821,0.25708,GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION,0.938917796433413
REACTOME_PHENYLALANINE_METAB...,SET,5,0.29484,0.0048625,0.45197,0.25709,REACTOME_PHENYLALANINE_METABOLISM,0.938917796433413
MIR5688,SET,714,0.021861,0.0042243,0.033511,0.25709,MIR5688,0.938917796433413
GOBP_NEGATIVE_REGULATION_OF_...302,SET,17,0.15695,0.0047714,0.2406,0.25709,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.938917796433413
MIR6131,SET,89,0.058091,0.0040327,0.089062,0.25712,MIR6131,0.938917796433413
HP_DIFFICULTY_WALKING,SET,277,0.032396,0.0039471,0.049666,0.25712,HP_DIFFICULTY_WALKING,0.938917796433413
TURASHVILI_BREAST_DUCTAL_CAR...4,SET,71,0.067024,0.0041579,0.10278,0.25716,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,0.938917796433413
GSE24634_TEFF_VS_TCONV_DAY7_...2,SET,181,0.040053,0.0039553,0.061434,0.25722,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP,0.938917796433413
GOBP_NEGATIVE_REGULATION_OF_...532,SET,725,0.021174,0.0041218,0.032489,0.25729,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,0.938917796433413
GOBP_RESPONSE_TO_PROTOZOAN,SET,28,0.12006,0.0046827,0.18421,0.25729,GOBP_RESPONSE_TO_PROTOZOAN,0.938917796433413
HP_CALCIUM_NEPHROLITHIASIS,SET,18,0.12724,0.00398,0.19524,0.2573,HP_CALCIUM_NEPHROLITHIASIS,0.938917796433413
FULLER_PBMC_F_TULARENSIS_VAC...9,SET,43,0.087562,0.0042305,0.13439,0.25735,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_UP,0.938917796433413
BOYAULT_LIVER_CANCER_SUBCLAS...12,SET,15,0.1578,0.0045063,0.24222,0.25738,BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,0.938917796433413
GSE3039_NKT_CELL_VS_B1_BCELL...1,SET,173,0.042952,0.0041476,0.06595,0.25744,GSE3039_NKT_CELL_VS_B1_BCELL_DN,0.938917796433413
GOMF_METALLOENDOPEPTIDASE_AC...,SET,102,0.058734,0.0043635,0.090191,0.25746,GOMF_METALLOENDOPEPTIDASE_ACTIVITY,0.938917796433413
GOBP_NEGATIVE_REGULATION_OF_...557,SET,6,0.27291,0.0049303,0.41912,0.25748,GOBP_NEGATIVE_REGULATION_OF_RELAXATION_OF_MUSCLE,0.938917796433413
HP_HYPOTENSION,SET,103,0.058074,0.0043355,0.089207,0.25753,HP_HYPOTENSION,0.938917796433413
MIR554,SET,16,0.13347,0.0039365,0.20506,0.25756,MIR554,0.938917796433413
WP_INTERACTIONS_BETWEEN_IMMU...,SET,24,0.12274,0.0044326,0.18859,0.25758,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.938917796433413
GOBP_NEGATIVE_REGULATION_OF_...429,SET,4,0.20824,0.0030718,0.31996,0.25759,GOBP_NEGATIVE_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,0.938917796433413
MIKHAYLOVA_OXIDATIVE_STRESS_...1,SET,6,0.27677,0.0050001,0.42529,0.2576,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN,0.938917796433413
HP_MOTTLED_PIGMENTATION,SET,8,0.21922,0.0045727,0.33691,0.25764,HP_MOTTLED_PIGMENTATION,0.938917796433413
GOBP_PHOSPHATIDYLINOSITOL_ME...2,SET,147,0.043873,0.0039081,0.067434,0.25765,GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS,0.938917796433413
MODULE_320,SET,19,0.12879,0.004139,0.19797,0.25766,MODULE_320,0.938917796433413
MIR6741_5P,SET,22,0.10695,0.0036982,0.16442,0.25769,MIR6741_5P,0.938917796433413
MIR7158_3P,SET,57,0.075759,0.0042126,0.11646,0.25769,MIR7158_3P,0.938917796433413
GOBP_REGULATION_OF_GAP_JUNCT...,SET,9,0.22111,0.0048918,0.34001,0.25775,GOBP_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,0.938917796433413
GSE23505_UNTREATED_VS_4DAY_I...3,SET,183,0.038823,0.0038547,0.059706,0.25777,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.938917796433413
HP_NEONATAL_OMPHALITIS,SET,10,0.20027,0.0046704,0.30803,0.2578,HP_NEONATAL_OMPHALITIS,0.938917796433413
GSE19888_NO_PRETREAT_VS_ADEN...2,SET,177,0.041202,0.0040239,0.063372,0.2578,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP,0.938917796433413
FERNANDEZ_BOUND_BY_MYC,SET,170,0.042925,0.0041093,0.066031,0.25783,FERNANDEZ_BOUND_BY_MYC,0.938917796433413
GOBP_POSITIVE_REGULATION_OF_...558,SET,8,0.2294,0.0047851,0.35289,0.25783,GOBP_POSITIVE_REGULATION_OF_ODONTOGENESIS,0.938917796433413
TCCCRNNRTGC_UNKNOWN,SET,189,0.039575,0.0039926,0.06088,0.25784,TCCCRNNRTGC_UNKNOWN,0.938917796433413
GOBP_TRICARBOXYLIC_ACID_TRAN...,SET,5,0.2668,0.0044001,0.41055,0.2579,GOBP_TRICARBOXYLIC_ACID_TRANSPORT,0.938917796433413
DESCARTES_FETAL_STOMACH_MUC1...,SET,81,0.065457,0.004336,0.10074,0.25793,DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS,0.938917796433413
GOBP_CYTOLYSIS,SET,6,0.30778,0.0055603,0.47373,0.25795,GOBP_CYTOLYSIS,0.938917796433413
GSE38697_LIGHT_ZONE_VS_DARK_...1,SET,113,0.053872,0.0042113,0.082924,0.25796,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.938917796433413
chr1p35,SET,77,0.12783,0.0082569,0.1968,0.25799,chr1p35,0.938917796433413
GSE14415_ACT_VS_CTRL_NATURAL...1,SET,157,0.044602,0.0041048,0.068683,0.25805,GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN,0.938917796433413
BIOCARTA_CTCF_PATHWAY,SET,24,0.12939,0.0046726,0.19932,0.25813,BIOCARTA_CTCF_PATHWAY,0.938917796433413
HE_LIM_SUN_FETAL_LUNG_C4_ILC...1,SET,136,0.051591,0.0044216,0.079475,0.25813,HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL,0.938917796433413
GOMF_TRANSCRIPTION_COACTIVAT...1,SET,251,0.03379,0.0039219,0.052069,0.25819,GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY,0.938917796433413
GSE29949_MICROGLIA_BRAIN_VS_...5,SET,182,0.040349,0.0039953,0.062177,0.25819,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.938917796433413
ZHOU_PANCREATIC_ENDOCRINE_PR...,SET,12,0.18115,0.0046275,0.27917,0.2582,ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR,0.938917796433413
YATGNWAAT_OCT_C,SET,315,0.033291,0.004321,0.05132,0.25827,YATGNWAAT_OCT_C,0.938917796433413
NAKAMURA_METASTASIS,SET,42,0.08297,0.0039619,0.12792,0.25829,NAKAMURA_METASTASIS,0.938917796433413
WP_RETINOBLASTOMA_GENE_IN_CA...,SET,81,0.057975,0.0038404,0.08938,0.25829,WP_RETINOBLASTOMA_GENE_IN_CANCER,0.938917796433413
KEGG_MEDICUS_PATHOGEN_HPV_E7...2,SET,7,0.19322,0.0037703,0.29791,0.2583,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S,0.938917796433413
LEE_METASTASIS_AND_ALTERNATI...1,SET,44,0.085243,0.0041659,0.13144,0.25832,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,0.938917796433413
GOBP_POSITIVE_REGULATION_OF_...602,SET,39,0.094926,0.0043683,0.14638,0.25834,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.938917796433413
HP_BLADDER_NEOPLASM,SET,33,0.095296,0.0040345,0.14695,0.25834,HP_BLADDER_NEOPLASM,0.938917796433413
HP_HYPERKETONEMIA,SET,4,0.27468,0.004052,0.42372,0.25841,HP_HYPERKETONEMIA,0.938917796433413
GOMF_TRANSMEMBRANE_EPHRIN_RE...,SET,15,0.16362,0.0046725,0.25241,0.25842,GOMF_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY,0.938917796433413
KEGG_MEDICUS_REFERENCE_NOD_N...,SET,8,0.17146,0.0035765,0.26455,0.25846,KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY,0.938917796433413
HP_REDUCED_PANCREATIC_BETA_C...,SET,7,0.25994,0.0050722,0.40118,0.25851,HP_REDUCED_PANCREATIC_BETA_CELLS,0.938917796433413
LEE_SP4_THYMOCYTE,SET,15,0.1549,0.0044237,0.23911,0.25855,LEE_SP4_THYMOCYTE,0.938917796433413
chr6p22,SET,103,0.090215,0.0067348,0.13927,0.25857,chr6p22,0.938917796433413
GOBP_CELL_CELL_JUNCTION_ORGA...,SET,199,0.042611,0.00441,0.065782,0.25857,GOBP_CELL_CELL_JUNCTION_ORGANIZATION,0.938917796433413
GOBP_MESANGIAL_CELL_DEVELOPM...,SET,5,0.26903,0.0044369,0.41534,0.25859,GOBP_MESANGIAL_CELL_DEVELOPMENT,0.938917796433413
WP_PEROXIREDOXIN_2_INDUCED_O...,SET,8,0.20003,0.0041725,0.30888,0.25863,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,0.938917796433413
GOBP_ADENYLATE_CYCLASE_INHIB...3,SET,9,0.2007,0.0044404,0.30993,0.25864,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.938917796433413
GOMF_G_PROTEIN_COUPLED_GLUTA...1,SET,9,0.2007,0.0044404,0.30993,0.25864,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY,0.938917796433413
HP_CHORDEE,SET,13,0.16078,0.0042746,0.24831,0.25866,HP_CHORDEE,0.938917796433413
HSF1_01,SET,246,0.035682,0.0041005,0.055113,0.25868,HSF1_01,0.938917796433413
BURTON_ADIPOGENESIS_PEAK_AT_...4,SET,40,0.09346,0.0043555,0.14436,0.25869,BURTON_ADIPOGENESIS_PEAK_AT_2HR,0.938917796433413
BIOCARTA_TALL1_PATHWAY,SET,15,0.15764,0.0045019,0.24352,0.25871,BIOCARTA_TALL1_PATHWAY,0.938917796433413
PYEON_CANCER_HEAD_AND_NECK_V...1,SET,19,0.13347,0.0042893,0.20621,0.25873,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,0.938917796433413
WP_ANTIVIRAL_AND_ANTIINFLAMM...,SET,26,0.11313,0.0042521,0.17481,0.25877,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,0.938917796433413
GOBP_MONOACYLGLYCEROL_BIOSYN...,SET,7,0.22521,0.0043944,0.34803,0.25879,GOBP_MONOACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.938917796433413
GOMF_EPINEPHRINE_BINDING,SET,6,0.25269,0.004565,0.39053,0.25881,GOMF_EPINEPHRINE_BINDING,0.938917796433413
GOBP_NEGATIVE_REGULATION_OF_...517,SET,70,0.062584,0.0038551,0.09673,0.25882,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.938917796433413
GSE10240_CTRL_VS_IL17_STIM_P...1,SET,182,0.040403,0.0040007,0.062456,0.25885,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.938917796433413
HP_SEVERE_TEMPER_TANTRUMS,SET,6,0.24233,0.004378,0.37462,0.25886,HP_SEVERE_TEMPER_TANTRUMS,0.938917796433413
KREPPEL_CD99_TARGETS_DN,SET,7,0.21735,0.004241,0.336,0.25887,KREPPEL_CD99_TARGETS_DN,0.938917796433413
GOBP_DENDRITIC_CELL_CYTOKINE...,SET,17,0.14342,0.00436,0.22172,0.25887,GOBP_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.938917796433413
GOBP_POLYKETIDE_METABOLIC_PR...,SET,10,0.22115,0.0051572,0.34189,0.25887,GOBP_POLYKETIDE_METABOLIC_PROCESS,0.938917796433413
GALINDO_IMMUNE_RESPONSE_TO_E...,SET,73,0.069098,0.0043462,0.10684,0.2589,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,0.938917796433413
HP_ABNORMALITY_OF_COORDINATI...,SET,1042,0.017273,0.0039946,0.026708,0.25891,HP_ABNORMALITY_OF_COORDINATION,0.938917796433413
GOCC_PLASMA_MEMBRANE_SIGNALI...,SET,180,0.044413,0.0043738,0.068697,0.25898,GOCC_PLASMA_MEMBRANE_SIGNALING_RECEPTOR_COMPLEX,0.938917796433413
DESCARTES_FETAL_INTESTINE_ER...,SET,132,0.048818,0.0041225,0.075516,0.25899,DESCARTES_FETAL_INTESTINE_ERYTHROBLASTS,0.938917796433413
JOHNSTONE_PARVB_TARGETS_1_UP,SET,6,0.23715,0.0042842,0.36685,0.259,JOHNSTONE_PARVB_TARGETS_1_UP,0.938917796433413
BLANCO_MELO_BRONCHIAL_EPITHE...1,SET,159,0.04234,0.0039211,0.065499,0.25901,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,0.938917796433413
HARALAMBIEVA_PBMC_FLUARIX_AG...1,SET,376,0.029498,0.0041759,0.045633,0.25901,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE,0.938917796433413
REACTOME_RRNA_MODIFICATION_I...2,SET,51,0.071998,0.0037875,0.11139,0.25902,REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.938917796433413
MIR4287,SET,115,0.051447,0.0040569,0.079597,0.25903,MIR4287,0.938917796433413
BIOCARTA_CYTOKINE_PATHWAY,SET,19,0.13808,0.0044375,0.21364,0.25904,BIOCARTA_CYTOKINE_PATHWAY,0.938917796433413
HFH3_01,SET,176,0.04325,0.0042122,0.066919,0.25905,HFH3_01,0.938917796433413
GSE18804_SPLEEN_MACROPHAGE_V...5,SET,174,0.043249,0.0041883,0.066919,0.25905,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN,0.938917796433413
BOHN_PRIMARY_IMMUNODEFICIENC...2,SET,44,0.08859,0.0043295,0.13713,0.25913,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,0.939105967893256
TBX1_TARGET_GENES,SET,166,0.041903,0.0039644,0.064869,0.25916,TBX1_TARGET_GENES,0.939105967893256
GOBP_INTERLEUKIN_12_MEDIATED...,SET,9,0.18906,0.0041828,0.29275,0.25921,GOBP_INTERLEUKIN_12_MEDIATED_SIGNALING_PATHWAY,0.939105967893256
HP_PULMONARY_VENOUS_HYPERTEN...,SET,9,0.19359,0.0042831,0.29978,0.25921,HP_PULMONARY_VENOUS_HYPERTENSION,0.939105967893256
GOMF_OXIDOREDUCTASE_ACTIVITY...24,SET,9,0.22053,0.0048789,0.34156,0.25926,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.939149124726477
GOBP_ENDOTHELIAL_CELL_DEVELO...,SET,64,0.074007,0.0043597,0.11465,0.2593,GOBP_ENDOTHELIAL_CELL_DEVELOPMENT,0.939149124726477
GOMF_PHOSPHATIDYLINOSITOL_3_...13,SET,10,0.16623,0.0038766,0.25756,0.25933,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,0.939149124726477
HARALAMBIEVA_PBMC_FLUARIX_AG...7,SET,1114,0.01774,0.0042332,0.027485,0.25933,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE,0.939149124726477
REACTOME_TRAF6_MEDIATED_IRF7...1,SET,26,0.12187,0.0045808,0.18888,0.25938,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,0.939170689655172
GOBP_REGULATION_OF_ENDOTHELI...4,SET,154,0.046793,0.0042655,0.072521,0.25939,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,0.939170689655172
GOBP_CELLULAR_RESPONSE_TO_HO...,SET,568,0.02439,0.0042211,0.037814,0.25946,GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS,0.93921680541103
GOCC_CATALYTIC_STEP_2_SPLICE...,SET,83,0.054871,0.0036792,0.085067,0.25946,GOCC_CATALYTIC_STEP_2_SPLICEOSOME,0.93921680541103
GSE22886_NAIVE_VS_IGM_MEMORY...1,SET,176,0.042732,0.0041617,0.066262,0.2595,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.93921680541103
HP_HYPERTHYROIDISM,SET,30,0.10631,0.0042916,0.16486,0.25953,HP_HYPERTHYROIDISM,0.93921680541103
BOYLAN_MULTIPLE_MYELOMA_PCA3...1,SET,63,0.070704,0.0041326,0.10968,0.25958,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,0.93921680541103
FAN_EMBRYONIC_CTX_MICROGLIA_2,SET,8,0.21591,0.0045037,0.33492,0.25958,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.93921680541103
GOCC_SYNAPTIC_VESICLE_MEMBRA...,SET,124,0.051204,0.0041918,0.079443,0.25962,GOCC_SYNAPTIC_VESICLE_MEMBRANE,0.93921680541103
GSE5463_CTRL_VS_DEXAMETHASON...1,SET,177,0.042849,0.0041848,0.066492,0.25965,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN,0.93921680541103
HP_ABNORMALITY_OF_THE_PROXIM...1,SET,4,0.27185,0.0040102,0.42191,0.25968,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_5TH_FINGER,0.93921680541103
HP_CELLULAR_IMMUNODEFICIENCY,SET,33,0.091049,0.0038547,0.14131,0.25968,HP_CELLULAR_IMMUNODEFICIENCY,0.93921680541103
GOBP_REGULATION_OF_SKELETAL_...9,SET,11,0.15635,0.003824,0.24268,0.2597,GOBP_REGULATION_OF_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.93921680541103
GSE11961_FOLLICULAR_BCELL_VS...9,SET,179,0.041319,0.0040579,0.064142,0.25973,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.939227567370721
GSE36888_STAT5_AB_KNOCKIN_VS...3,SET,186,0.0412,0.0041238,0.063967,0.25976,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN,0.939238327091136
GOBP_REGULATION_OF_SPERM_CAP...,SET,4,0.32476,0.0047907,0.5044,0.25984,GOBP_REGULATION_OF_SPERM_CAPACITATION,0.93942985540414
GOBP_POSITIVE_REGULATION_OF_...300,SET,11,0.18449,0.0045121,0.2866,0.25988,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,0.939476742250884
REACTOME_CYTOKINE_SIGNALING_...,SET,715,0.021476,0.0041528,0.033385,0.26002,REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,0.939711030252625
GOBP_MITOTIC_CELL_CYCLE,SET,838,0.019069,0.003978,0.029644,0.26003,GOBP_MITOTIC_CELL_CYCLE,0.939711030252625
BIOCARTA_EPHA4_PATHWAY,SET,8,0.20806,0.0043399,0.32346,0.26004,BIOCARTA_EPHA4_PATHWAY,0.939711030252625
SREBP_Q3,SET,229,0.036556,0.0040551,0.056837,0.26006,SREBP_Q3,0.939711030252625
GSE17721_LPS_VS_POLYIC_2H_BM...2,SET,187,0.041918,0.0042068,0.065181,0.26008,GSE17721_LPS_VS_POLYIC_2H_BMDC_UP,0.939711030252625
GOBP_REFLEX,SET,22,0.12242,0.0042332,0.19045,0.26017,GOBP_REFLEX,0.939883527272727
MORF_PCNA,SET,71,0.060064,0.0037261,0.093454,0.26021,MORF_PCNA,0.939883527272727
MIR616_3P,SET,41,0.088359,0.0041688,0.1375,0.26024,MIR616_3P,0.939883527272727
GOBP_REGULATION_OF_ACTIN_FIL...5,SET,233,0.036765,0.0041133,0.057219,0.26027,GOBP_REGULATION_OF_ACTIN_FILAMENT_ORGANIZATION,0.939883527272727
GSE6259_DEC205_POS_DC_VS_CD4...1,SET,181,0.039154,0.0038665,0.060939,0.26027,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN,0.939883527272727
GOBP_REGULATION_OF_CALCIUM_I...2,SET,29,0.10055,0.0039911,0.15651,0.26029,GOBP_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.939883527272727
GOBP_COLUMNAR_CUBOIDAL_EPITH...3,SET,14,0.15526,0.0042835,0.24173,0.26035,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION,0.940002519218783
GOBP_REGULATION_OF_LIPID_TRA...1,SET,125,0.050701,0.0041671,0.078971,0.26044,GOBP_REGULATION_OF_LIPID_TRANSPORT,0.940229791212216
NFKBIA_TARGET_GENES,SET,967,0.018206,0.0040649,0.028365,0.26049,NFKBIA_TARGET_GENES,0.940312624636477
GOBP_NEGATIVE_REGULATION_OF_...37,SET,4,0.24861,0.0036673,0.38741,0.26053,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.940359346764981
GOMF_HYDROPEROXY_ICOSATETRAE...,SET,7,0.22628,0.0044154,0.35273,0.2606,GOMF_HYDROPEROXY_ICOSATETRAENOATE_DEHYDRATASE_ACTIVITY,0.940514330218069
WHITEFORD_PEDIATRIC_CANCER_M...,SET,111,0.051999,0.0040289,0.081076,0.26065,WHITEFORD_PEDIATRIC_CANCER_MARKERS,0.940571620639535
REN_ALVEOLAR_RHABDOMYOSARCOM...2,SET,93,0.0621,0.0044064,0.096834,0.26067,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,0.940571620639535
ZHONG_PFC_C6_PLXNA4_POS_EXCI...,SET,6,0.2433,0.0043954,0.37949,0.26073,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.940660646466743
GSE5099_MONOCYTE_VS_CLASSICA...1,SET,177,0.039386,0.0038466,0.061449,0.26078,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN,0.940660646466743
MODULE_346,SET,17,0.146,0.0044383,0.22779,0.26079,MODULE_346,0.940660646466743
CAHOY_NEURONAL,SET,97,0.060597,0.0043907,0.094555,0.26081,CAHOY_NEURONAL,0.940660646466743
HP_3_4_TOE_SYNDACTYLY,SET,6,0.23814,0.0043023,0.37164,0.26083,HP_3_4_TOE_SYNDACTYLY,0.940660646466743
NOUSHMEHR_GBM_SOMATIC_MUTATED,SET,9,0.20706,0.004581,0.32317,0.26086,NOUSHMEHR_GBM_SOMATIC_MUTATED,0.940671228470637
SCHMIDT_POR_TARGETS_IN_LIMB_...1,SET,8,0.20892,0.004358,0.32615,0.26091,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN,0.940753921568627
FIGUEROA_AML_METHYLATION_CLU...8,SET,99,0.057001,0.0041723,0.089015,0.26098,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,0.940883207136189
GOMF_SOLUTE_SODIUM_SYMPORTER...,SET,77,0.067003,0.0043279,0.10465,0.261,GOMF_SOLUTE_SODIUM_SYMPORTER_ACTIVITY,0.940883207136189
DANG_REGULATED_BY_MYC_UP,SET,65,0.068445,0.0040633,0.10696,0.26111,DANG_REGULATED_BY_MYC_UP,0.941116110304789
HASLINGER_B_CLL_WITH_6Q21_DE...,SET,11,0.15141,0.003703,0.23665,0.26116,HASLINGER_B_CLL_WITH_6Q21_DELETION,0.941116110304789
HP_ABNORMAL_CIRCULATING_GABA...,SET,6,0.21856,0.0039484,0.34161,0.26116,HP_ABNORMAL_CIRCULATING_GABA_CONCENTRATION,0.941116110304789
GOMF_ORGANIC_ACID_BINDING,SET,189,0.04297,0.0043351,0.067175,0.2612,GOMF_ORGANIC_ACID_BINDING,0.941116110304789
HP_INCREASED_CONNECTIVE_TISS...,SET,24,0.10739,0.0038784,0.16789,0.2612,HP_INCREASED_CONNECTIVE_TISSUE,0.941116110304789
MIR3622A_5P,SET,37,0.098213,0.0044023,0.15358,0.26126,MIR3622A_5P,0.941158196891192
HP_ABNORMAL_TALUS_MORPHOLOGY,SET,61,0.06906,0.0039721,0.10801,0.26129,HP_ABNORMAL_TALUS_MORPHOLOGY,0.941158196891192
GOCC_PHAGOCYTIC_VESICLE_MEMB...,SET,67,0.066318,0.0039969,0.10373,0.2613,GOCC_PHAGOCYTIC_VESICLE_MEMBRANE,0.941158196891192
HP_VAGINAL_NEOPLASM,SET,8,0.23681,0.0049397,0.37043,0.26132,HP_VAGINAL_NEOPLASM,0.941158196891192
GSE3982_MAST_CELL_VS_TH2_DN,SET,182,0.03883,0.0038449,0.060756,0.26138,GSE3982_MAST_CELL_VS_TH2_DN,0.94126174764322
HP_LONG_EYELASHES,SET,115,0.050089,0.0039498,0.07839,0.26143,HP_LONG_EYELASHES,0.94126174764322
GSE17721_PAM3CSK4_VS_GADIQUI...8,SET,181,0.04289,0.0042354,0.067124,0.26143,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP,0.94126174764322
CATGTAA_MIR496,SET,161,0.042977,0.0040049,0.067272,0.26146,CATGTAA_MIR496,0.941272249844624
WP_BURN_WOUND_HEALING,SET,95,0.061642,0.0044204,0.096511,0.26151,WP_BURN_WOUND_HEALING,0.941309729841631
HP_REDUCED_SPERM_MOTILITY,SET,58,0.069465,0.0038962,0.10877,0.26154,HP_REDUCED_SPERM_MOTILITY,0.941309729841631
GARGALOVIC_RESPONSE_TO_OXIDI...6,SET,15,0.1279,0.0036524,0.20031,0.26158,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP,0.941309729841631
GSE17721_CTRL_VS_CPG_12H_BMD...1,SET,184,0.0403,0.0040121,0.063127,0.26161,GSE17721_CTRL_VS_CPG_12H_BMDC_DN,0.941309729841631
HP_INCOORDINATION,SET,251,0.03441,0.0039938,0.053911,0.26165,HP_INCOORDINATION,0.941309729841631
GOBP_POST_CHAPERONIN_TUBULIN...,SET,6,0.18149,0.0032787,0.28435,0.26166,GOBP_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,0.941309729841631
GSE43863_TH1_VS_TFH_EFFECTOR...1,SET,173,0.041835,0.0040398,0.065548,0.26166,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN,0.941309729841631
FRANCO_BLOOD_SANOFI_PASTEUR_...2,SET,19,0.12946,0.0041604,0.20291,0.26174,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_POSITIVE,0.941436833677686
BOYAULT_LIVER_CANCER_SUBCLAS...2,SET,43,0.077621,0.0037502,0.12168,0.26177,BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,0.941436833677686
EN1_01,SET,98,0.058794,0.0042819,0.0922,0.26184,EN1_01,0.941436833677686
KANG_AR_TARGETS_UP,SET,16,0.15903,0.0046904,0.2494,0.26185,KANG_AR_TARGETS_UP,0.941436833677686
GOBP_RESPONSE_TO_ERYTHROPOIE...,SET,6,0.26512,0.0047896,0.41577,0.26185,GOBP_RESPONSE_TO_ERYTHROPOIETIN,0.941436833677686
HP_DECREASED_CIRCULATING_TOT...2,SET,8,0.21264,0.0044356,0.33351,0.26187,HP_DECREASED_CIRCULATING_TOTAL_IGG,0.941436833677686
SCHAVOLT_TARGETS_OF_TP53_AND...,SET,15,0.12229,0.0034924,0.19183,0.2619,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,0.941436833677686
HP_BLUE_NEVUS,SET,11,0.16119,0.0039424,0.25289,0.26194,HP_BLUE_NEVUS,0.941436833677686
GOBP_REGULATION_OF_MITOCHOND...3,SET,6,0.20617,0.0037247,0.32352,0.26197,GOBP_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,0.941436833677686
POU2AF1_TARGET_GENES,SET,664,0.021524,0.0040167,0.033776,0.26199,POU2AF1_TARGET_GENES,0.941436833677686
GOBP_VASCULAR_ASSOCIATED_SMO...5,SET,57,0.076707,0.0042653,0.12039,0.26202,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.941436833677686
MORF_RAB5A,SET,85,0.05119,0.0034733,0.080368,0.26209,MORF_RAB5A,0.941436833677686
NRL_DN.V1_DN,SET,120,0.05146,0.0041447,0.080799,0.2621,NRL_DN.V1_DN,0.941436833677686
MIR10398_3P,SET,5,0.25875,0.0042674,0.4063,0.26212,MIR10398_3P,0.941436833677686
GOCC_9PLUS2_MOTILE_CILIUM,SET,158,0.043223,0.0039904,0.067871,0.26212,GOCC_9PLUS2_MOTILE_CILIUM,0.941436833677686
KEGG_MEDICUS_REFERENCE_BASE_...1,SET,8,0.18136,0.003783,0.28479,0.26213,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE,0.941436833677686
SHIN_B_CELL_LYMPHOMA_CLUSTER...7,SET,36,0.089828,0.0039718,0.14108,0.26216,SHIN_B_CELL_LYMPHOMA_CLUSTER_8,0.941436833677686
GOMF_XENOBIOTIC_TRANSMEMBRAN...,SET,32,0.10678,0.0044517,0.16774,0.26221,GOMF_XENOBIOTIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.941436833677686
HP_UVEITIS,SET,47,0.085243,0.0043053,0.13392,0.26221,HP_UVEITIS,0.941436833677686
GAO_SMALL_INTESTINE_24W_C7_S...,SET,39,0.088032,0.004051,0.13835,0.26229,GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR,0.94145320082602
GSE23568_CTRL_VS_ID3_TRANSDU...1,SET,179,0.039584,0.0038875,0.062217,0.26232,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN,0.94145320082602
GOMF_RRNA_BINDING,SET,56,0.069084,0.0038077,0.10859,0.26233,GOMF_RRNA_BINDING,0.94145320082602
MIR26B_5P,SET,455,0.026374,0.0040981,0.041458,0.26234,MIR26B_5P,0.94145320082602
HP_ABNORMAL_ERYTHROCYTE_MORP...,SET,599,0.022455,0.0039873,0.035299,0.26235,HP_ABNORMAL_ERYTHROCYTE_MORPHOLOGY,0.94145320082602
GOBP_GLANDULAR_EPITHELIAL_CE...3,SET,8,0.22237,0.0046386,0.34989,0.26254,GOBP_GLANDULAR_EPITHELIAL_CELL_MATURATION,0.941791934989267
GSE9650_EFFECTOR_VS_EXHAUSTE...1,SET,177,0.042663,0.0041666,0.067129,0.26254,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN,0.941791934989267
GOBP_PROTEIN_LOCALIZATION_TO...34,SET,11,0.13157,0.0032178,0.20707,0.26259,GOBP_PROTEIN_LOCALIZATION_TO_NON_MOTILE_CILIUM,0.941791934989267
GOBP_REGULATION_OF_TOLL_LIKE...5,SET,11,0.17608,0.0043065,0.27716,0.26262,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.941791934989267
GAZDA_DIAMOND_BLACKFAN_ANEMI...6,SET,36,0.095954,0.0042427,0.15104,0.26263,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,0.941791934989267
GOBP_DEVELOPMENTAL_PIGMENTAT...,SET,45,0.087162,0.0043077,0.13723,0.26267,GOBP_DEVELOPMENTAL_PIGMENTATION,0.941791934989267
GSE6674_CPG_VS_PL2_3_STIM_BC...2,SET,171,0.038798,0.003725,0.061088,0.26268,GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP,0.941791934989267
PATEL_SKIN_OF_BODY_ZOSTAVAX_...6,SET,260,0.035514,0.0041941,0.055919,0.26269,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP,0.941791934989267
HP_VELOPHARYNGEAL_INSUFFICIE...,SET,26,0.10765,0.0040462,0.16952,0.26271,HP_VELOPHARYNGEAL_INSUFFICIENCY,0.941791934989267
MIR548AZ_5P,SET,393,0.028584,0.0041349,0.045016,0.26273,MIR548AZ_5P,0.941791934989267
GOBP_PORPHYRIN_CONTAINING_CO...,SET,48,0.076339,0.0038963,0.12024,0.26275,GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.941791934989267
HP_ABNORMAL_HEPATIC_ECHOGENI...,SET,7,0.22361,0.0043632,0.35238,0.26286,HP_ABNORMAL_HEPATIC_ECHOGENICITY,0.941791934989267
HP_RENAL_CORTICAL_MICROCYSTS,SET,4,0.26474,0.0039052,0.41721,0.26287,HP_RENAL_CORTICAL_MICROCYSTS,0.941791934989267
GOBP_INTERLEUKIN_33_MEDIATED...,SET,7,0.20624,0.0040242,0.32503,0.26288,GOBP_INTERLEUKIN_33_MEDIATED_SIGNALING_PATHWAY,0.941791934989267
GSE23321_CENTRAL_VS_EFFECTOR...2,SET,182,0.040281,0.0039887,0.063505,0.26294,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.941791934989267
GOBP_POSITIVE_REGULATION_OF_...138,SET,851,0.019982,0.0041991,0.031503,0.26295,GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.941791934989267
HP_ONYCHOGRYPOSIS,SET,27,0.10769,0.0041247,0.16982,0.26299,HP_ONYCHOGRYPOSIS,0.941791934989267
GSE43955_TH0_VS_TGFB_IL6_IL2...4,SET,186,0.03987,0.0039906,0.062869,0.26299,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.941791934989267
GOMF_ATPASE_COUPLED_TRANSMEM...,SET,91,0.058881,0.0041331,0.092854,0.263,GOMF_ATPASE_COUPLED_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.941791934989267
KEGG_MEDICUS_REFERENCE_HORMO...,SET,17,0.14778,0.0044925,0.23311,0.26306,KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.941791934989267
HP_HYPERCALCEMIA,SET,63,0.072103,0.0042143,0.11376,0.2631,HP_HYPERCALCEMIA,0.941791934989267
MILICIC_FAMILIAL_ADENOMATOUS...1,SET,9,0.19959,0.0044156,0.31495,0.26314,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN,0.941791934989267
GOBP_CHAPERONE_MEDIATED_AUTO...,SET,14,0.12907,0.003561,0.20368,0.26314,GOBP_CHAPERONE_MEDIATED_AUTOPHAGY,0.941791934989267
GOBP_CARDIAC_SEPTUM_CELL_DIF...,SET,5,0.25819,0.0042582,0.40745,0.26315,GOBP_CARDIAC_SEPTUM_CELL_DIFFERENTIATION,0.941791934989267
GOBP_POSITIVE_REGULATION_OF_...238,SET,13,0.1657,0.0044054,0.26149,0.26315,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.941791934989267
GOCC_U6_SNRNP,SET,8,0.17021,0.0035505,0.26865,0.26318,GOCC_U6_SNRNP,0.941791934989267
HP_INCREASED_WAIST_TO_HIP_RA...,SET,36,0.10026,0.004433,0.15825,0.26319,HP_INCREASED_WAIST_TO_HIP_RATIO,0.941791934989267
chr8q23,SET,16,0.24883,0.0073387,0.39283,0.26323,chr8q23,0.941791934989267
GOBP_FORMATION_OF_TRANSLATIO...,SET,5,0.1882,0.0031038,0.29715,0.26325,GOBP_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX,0.941791934989267
GOBP_REGULATION_OF_MITOCHOND...2,SET,17,0.13866,0.0042154,0.21905,0.26336,GOBP_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,0.941791934989267
RPS14_DN.V1_UP,SET,180,0.04246,0.0041814,0.067082,0.26339,RPS14_DN.V1_UP,0.941791934989267
HP_ACUTE_OTITIS_MEDIA,SET,5,0.26546,0.004378,0.41945,0.26341,HP_ACUTE_OTITIS_MEDIA,0.941791934989267
GSE25846_IL10_POS_VS_NEG_CD8...2,SET,175,0.041775,0.0040571,0.066009,0.26341,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP,0.941791934989267
ATF1_Q6,SET,219,0.038971,0.0042287,0.061588,0.26345,ATF1_Q6,0.941791934989267
HP_SPLENOMEGALY,SET,431,0.026877,0.0040674,0.042483,0.26348,HP_SPLENOMEGALY,0.941791934989267
MIR6727_3P,SET,102,0.054103,0.0040194,0.085538,0.26353,MIR6727_3P,0.941791934989267
GOBP_BRANCHED_CHAIN_AMINO_AC...1,SET,5,0.27053,0.0044616,0.42789,0.26362,GOBP_BRANCHED_CHAIN_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.941791934989267
GOBP_POSITIVE_REGULATION_OF_...760,SET,8,0.1852,0.0038632,0.29294,0.26362,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.941791934989267
GOBP_NEGATIVE_REGULATION_OF_...228,SET,28,0.098192,0.0038298,0.15532,0.26363,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.941791934989267
GOBP_CELLULAR_RESPONSE_TO_CO...3,SET,22,0.13817,0.0047775,0.21866,0.26374,GOBP_CELLULAR_RESPONSE_TO_COPPER_ION,0.941791934989267
GOBP_POSITIVE_REGULATION_OF_...383,SET,5,0.25823,0.0042588,0.40872,0.26376,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.941791934989267
HP_ABNORMALITY_OF_THE_COMMON...,SET,61,0.07146,0.0041101,0.11312,0.2638,HP_ABNORMALITY_OF_THE_COMMON_COAGULATION_PATHWAY,0.941791934989267
REACTOME_INOSITOL_PHOSPHATE_...,SET,45,0.075166,0.0037149,0.11903,0.26387,REACTOME_INOSITOL_PHOSPHATE_METABOLISM,0.941791934989267
YY1_Q6,SET,221,0.03596,0.0039196,0.056949,0.26388,YY1_Q6,0.941791934989267
GOBP_REGULATION_OF_HYPERSENS...,SET,9,0.18151,0.0040157,0.28745,0.26388,GOBP_REGULATION_OF_HYPERSENSITIVITY,0.941791934989267
KEGG_MEDICUS_PATHOGEN_HTLV_1...3,SET,5,0.24014,0.0039604,0.38048,0.26397,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_E47_MEDIATED_TRANSCRIPTION,0.941791934989267
GOBP_CELLULAR_RESPONSE_TO_LA...,SET,7,0.20484,0.003997,0.32458,0.26399,GOBP_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.941791934989267
MIKKELSEN_ES_LCP_WITH_H3K4ME...,SET,7,0.21121,0.0041213,0.33483,0.26409,MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.941791934989267
ZZZ3_TARGET_GENES,SET,234,0.034597,0.003879,0.054845,0.26409,ZZZ3_TARGET_GENES,0.941791934989267
GOBP_L_HISTIDINE_TRANSMEMBRA...,SET,4,0.29655,0.0043745,0.47036,0.2642,GOBP_L_HISTIDINE_TRANSMEMBRANE_TRANSPORT,0.941791934989267
KEGG_MEDICUS_REFERENCE_COPII...,SET,12,0.14793,0.0037788,0.23464,0.26421,KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION,0.941791934989267
HP_HYPOPLASTIC_HEART,SET,43,0.086584,0.0041832,0.13735,0.26423,HP_HYPOPLASTIC_HEART,0.941791934989267
GOBP_BLOOD_VESSEL_ENDOTHELIA...1,SET,11,0.17657,0.0043186,0.28013,0.26424,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.941791934989267
GOBP_POSITIVE_REGULATION_OF_...132,SET,99,0.058455,0.0042787,0.092738,0.26425,GOBP_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.941791934989267
HP_LOW_1_MINUTE_APGAR_SCORE,SET,6,0.27664,0.0049977,0.43891,0.26426,HP_LOW_1_MINUTE_APGAR_SCORE,0.941791934989267
KEGG_MEDICUS_PATHOGEN_HPV_E6...1,SET,12,0.16432,0.0041974,0.26076,0.2643,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380,0.941791934989267
LAKE_ADULT_KIDNEY_C6_PROXIMA...,SET,171,0.043079,0.004136,0.068362,0.2643,LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3,0.941791934989267
GOBP_NEGATIVE_REGULATION_OF_...387,SET,10,0.20166,0.0047028,0.32013,0.26437,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.941791934989267
GOBP_CELLULAR_RESPONSE_TO_SA...2,SET,14,0.14091,0.0038878,0.22374,0.26441,GOBP_CELLULAR_RESPONSE_TO_SALT_STRESS,0.941791934989267
MODULE_402,SET,12,0.17202,0.0043941,0.27315,0.26443,MODULE_402,0.941791934989267
HP_UNCOMBABLE_HAIR,SET,4,0.31496,0.0046461,0.50012,0.26443,HP_UNCOMBABLE_HAIR,0.941791934989267
MEF2_03,SET,204,0.038909,0.0040766,0.061786,0.26444,MEF2_03,0.941791934989267
BIOCARTA_ASBCELL_PATHWAY,SET,10,0.19355,0.0045137,0.30739,0.26446,BIOCARTA_ASBCELL_PATHWAY,0.941791934989267
MODULE_273,SET,40,0.081682,0.0038066,0.12972,0.26446,MODULE_273,0.941791934989267
CUI_DEVELOPING_HEART_C9_B_T_...,SET,133,0.048184,0.0040842,0.076525,0.26446,CUI_DEVELOPING_HEART_C9_B_T_CELL,0.941791934989267
PTF1BETA_Q6,SET,214,0.037823,0.0040576,0.06007,0.26447,PTF1BETA_Q6,0.941791934989267
HP_THYROID_DYSGENESIS,SET,7,0.23787,0.0046414,0.37786,0.26451,HP_THYROID_DYSGENESIS,0.941791934989267
GOBP_B_1_B_CELL_DIFFERENTIAT...,SET,5,0.27208,0.0044872,0.43225,0.26453,GOBP_B_1_B_CELL_DIFFERENTIATION,0.941791934989267
GOMF_NUCLEAR_ANDROGEN_RECEPT...,SET,25,0.097699,0.0036009,0.15521,0.26453,GOMF_NUCLEAR_ANDROGEN_RECEPTOR_BINDING,0.941791934989267
GOCC_OTHER_ORGANISM_PART,SET,4,0.29908,0.0044118,0.47516,0.26454,GOCC_OTHER_ORGANISM_PART,0.941791934989267
REACTOME_APOPTOTIC_CLEAVAGE_...1,SET,35,0.091243,0.0039781,0.14497,0.26455,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,0.941791934989267
DR1_Q3,SET,230,0.035133,0.0039057,0.055824,0.26456,DR1_Q3,0.941791934989267
GOBP_NEGATIVE_REGULATION_OF_...184,SET,30,0.094763,0.0038256,0.15057,0.26456,GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.941791934989267
BIOCARTA_EICOSANOID_PATHWAY,SET,21,0.13165,0.0044476,0.20922,0.26461,BIOCARTA_EICOSANOID_PATHWAY,0.941791934989267
MODULE_24,SET,412,0.028462,0.0042136,0.045252,0.26469,MODULE_24,0.941791934989267
MODULE_220,SET,310,0.03376,0.0043475,0.053683,0.26472,MODULE_220,0.941791934989267
MIKKELSEN_NPC_WITH_LCP_H3K27...,SET,7,0.20099,0.0039219,0.31965,0.26474,MIKKELSEN_NPC_WITH_LCP_H3K27ME3,0.941791934989267
GSE2770_TGFB_AND_IL4_VS_IL4_...3,SET,174,0.041747,0.0040428,0.066396,0.26476,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.941791934989267
LEE_AGING_MUSCLE_UP,SET,34,0.097846,0.0042047,0.15563,0.26478,LEE_AGING_MUSCLE_UP,0.941791934989267
HP_INTESTINAL_PERFORATION,SET,5,0.21506,0.0035468,0.34209,0.26479,HP_INTESTINAL_PERFORATION,0.941791934989267
GOBP_ENDODERM_DEVELOPMENT,SET,80,0.064705,0.0042598,0.10294,0.26481,GOBP_ENDODERM_DEVELOPMENT,0.941791934989267
GOMF_NEUROTROPHIN_BINDING,SET,9,0.2002,0.0044293,0.31848,0.26481,GOMF_NEUROTROPHIN_BINDING,0.941791934989267
MODULE_512,SET,36,0.086385,0.0038196,0.13743,0.26482,MODULE_512,0.941791934989267
GOBP_REGULATION_OF_REGULATED...,SET,104,0.052801,0.0039608,0.084008,0.26483,GOBP_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.941791934989267
GOBP_TANGENTIAL_MIGRATION_FR...,SET,7,0.21227,0.004142,0.33772,0.26483,GOBP_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB,0.941791934989267
GSE17721_4_VS_24H_CPG_BMDC_DN,SET,177,0.038885,0.0037977,0.061868,0.26484,GSE17721_4_VS_24H_CPG_BMDC_DN,0.941791934989267
LI_DCP2_BOUND_MRNA,SET,78,0.057729,0.0037529,0.091864,0.26487,LI_DCP2_BOUND_MRNA,0.941791934989267
BIOCARTA_TCAPOPTOSIS_PATHWAY,SET,9,0.18599,0.0041148,0.296,0.26489,BIOCARTA_TCAPOPTOSIS_PATHWAY,0.941791934989267
BIOCARTA_PPARG_PATHWAY,SET,8,0.20675,0.0043127,0.32905,0.2649,BIOCARTA_PPARG_PATHWAY,0.941791934989267
GOBP_POSITIVE_REGULATION_OF_...139,SET,320,0.030778,0.0040257,0.048987,0.26492,GOBP_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.941791934989267
chr13q14,SET,81,0.12281,0.008135,0.19555,0.265,chr13q14,0.941791934989267
HP_MENTAL_DETERIORATION,SET,335,0.029452,0.00394,0.046899,0.26501,HP_MENTAL_DETERIORATION,0.941791934989267
MIR3606_5P,SET,141,0.047167,0.0041155,0.07512,0.26504,MIR3606_5P,0.941791934989267
BIOCARTA_GPCR_PATHWAY,SET,28,0.10633,0.0041473,0.16936,0.26505,BIOCARTA_GPCR_PATHWAY,0.941791934989267
GOBP_CARDIAC_CONDUCTION_SYST...,SET,36,0.10023,0.0044317,0.15963,0.26505,GOBP_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT,0.941791934989267
REACTOME_SPERM_MOTILITY_AND_...,SET,9,0.16141,0.003571,0.25711,0.26508,REACTOME_SPERM_MOTILITY_AND_TAXES,0.941791934989267
GSE12198_NK_VS_NK_ACT_EXPANS...2,SET,182,0.040705,0.0040306,0.064842,0.26509,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP,0.941791934989267
MIR1193,SET,32,0.093295,0.0038896,0.14863,0.2651,MIR1193,0.941791934989267
GOBP_PINOCYTOSIS,SET,20,0.11245,0.0037076,0.17927,0.26524,GOBP_PINOCYTOSIS,0.942192988552739
SWEET_LUNG_CANCER_KRAS_DN,SET,387,0.029887,0.0042911,0.047652,0.26527,SWEET_LUNG_CANCER_KRAS_DN,0.942203254982116
GSE15330_WT_VS_IKAROS_KO_LYM...2,SET,188,0.037994,0.0038231,0.060596,0.26533,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP,0.942259292939614
GOBP_MULTICELLULAR_ORGANISMA...2,SET,758,0.020789,0.004134,0.033158,0.26534,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS,0.942259292939614
REACTOME_ER_QUALITY_CONTROL_...,SET,19,0.12147,0.0039036,0.19389,0.26551,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,0.9425487845981
REACTOME_SYNTHESIS_OF_BILE_A...1,SET,33,0.10044,0.0042524,0.16033,0.26551,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,0.9425487845981
GOMF_CYCLIN_DEPENDENT_PROTEI...2,SET,14,0.12981,0.0035814,0.20721,0.26551,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.9425487845981
HP_POPLITEAL_PTERYGIUM,SET,8,0.20814,0.0043416,0.33228,0.26553,HP_POPLITEAL_PTERYGIUM,0.9425487845981
GOMF_PHOSPHATIDYLINOSITOL_4_...4,SET,27,0.10076,0.0038594,0.16093,0.26561,GOMF_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING,0.942713007840342
GOBP_RESPONSE_TO_OXYGEN_GLUC...,SET,9,0.17256,0.0038178,0.27568,0.26568,GOBP_RESPONSE_TO_OXYGEN_GLUCOSE_DEPRIVATION,0.942713007840342
GOBP_STRIATED_MUSCLE_CONTRAC...,SET,173,0.04232,0.0040866,0.067618,0.26571,GOBP_STRIATED_MUSCLE_CONTRACTION,0.942713007840342
HP_REDUCED_SOCIAL_RECIPROCITY,SET,52,0.070262,0.0037321,0.1123,0.26577,HP_REDUCED_SOCIAL_RECIPROCITY,0.942713007840342
GIAROLA_SILVA_BLOOD_PANDEMRI...1,SET,5,0.20635,0.0034032,0.32987,0.2658,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_30DY_UP,0.942713007840342
KOKKINAKIS_METHIONINE_DEPRIV...3,SET,69,0.064684,0.003956,0.10341,0.26582,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,0.942713007840342
REACTOME_INTEGRIN_SIGNALING,SET,27,0.104,0.0039833,0.16628,0.26584,REACTOME_INTEGRIN_SIGNALING,0.942713007840342
GSE12003_4D_VS_8D_CULTURE_MI...1,SET,153,0.04426,0.0040215,0.070778,0.26588,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN,0.942713007840342
GOMF_PROTEIN_HOMODIMERIZATIO...,SET,641,0.021732,0.0039873,0.034756,0.26589,GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY,0.942713007840342
HOWARD_NK_CELL_INACT_MONOV_I...3,SET,66,0.063738,0.0038127,0.10194,0.26592,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.942713007840342
DESCARTES_MAIN_FETAL_SKELETA...,SET,134,0.045513,0.0038721,0.072798,0.26592,DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS,0.942713007840342
HP_ABNORMALITY_OF_THE_FOOT_M...,SET,11,0.17077,0.0041765,0.27315,0.26594,HP_ABNORMALITY_OF_THE_FOOT_MUSCULATURE,0.942713007840342
GSE16266_CTRL_VS_HEATSHOCK_A...1,SET,186,0.038071,0.0038106,0.060925,0.26603,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.942713007840342
ACACTAC_MIR1423P,SET,118,0.050492,0.0040329,0.080811,0.26605,ACACTAC_MIR1423P,0.942713007840342
KEGG_MEDICUS_VARIANT_MUTATIO...35,SET,8,0.19606,0.0040898,0.31383,0.26607,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006,0.942713007840342
HES4_TARGET_GENES,SET,490,0.024637,0.0039689,0.039442,0.26611,HES4_TARGET_GENES,0.942713007840342
MIR433_5P,SET,7,0.19956,0.003894,0.3195,0.26612,MIR433_5P,0.942713007840342
CREIGHTON_ENDOCRINE_THERAPY_...4,SET,266,0.034064,0.0040684,0.054543,0.26614,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,0.942713007840342
GOBP_REGULATION_OF_PROTEIN_M...3,SET,5,0.24291,0.004006,0.38894,0.26614,GOBP_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.942713007840342
HOLLERN_SQUAMOUS_BREAST_TUMOR,SET,169,0.045291,0.0043231,0.072535,0.26619,HOLLERN_SQUAMOUS_BREAST_TUMOR,0.942713007840342
HP_ABNORMAL_LEFT_VENTRICULAR...,SET,26,0.10843,0.0040753,0.17366,0.2662,HP_ABNORMAL_LEFT_VENTRICULAR_OUTFLOW_TRACT_MORPHOLOGY,0.942713007840342
GOBP_FLUID_TRANSPORT,SET,35,0.10184,0.0044402,0.16313,0.26622,GOBP_FLUID_TRANSPORT,0.942713007840342
GOBP_NEGATIVE_REGULATION_OF_...316,SET,13,0.14616,0.003886,0.23416,0.26625,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.942713007840342
MULLIGHAN_MLL_SIGNATURE_1_UP,SET,353,0.028542,0.0039176,0.045733,0.26628,MULLIGHAN_MLL_SIGNATURE_1_UP,0.942713007840342
GOMF_STRUCTURAL_CONSTITUENT_...11,SET,23,0.11681,0.0041298,0.18718,0.2663,GOMF_STRUCTURAL_CONSTITUENT_OF_SYNAPSE,0.942713007840342
MIR8485,SET,922,0.018151,0.0039623,0.029092,0.26634,MIR8485,0.942713007840342
GSE43700_UNTREATED_VS_IL10_T...1,SET,187,0.03989,0.0040033,0.063939,0.26636,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN,0.942713007840342
BROWNE_HCMV_INFECTION_20HR_DN,SET,90,0.059069,0.0041235,0.094692,0.26638,BROWNE_HCMV_INFECTION_20HR_DN,0.942713007840342
GSE21670_UNTREATED_VS_IL6_TR...1,SET,183,0.038831,0.0038555,0.062248,0.26638,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN,0.942713007840342
GOBP_NUCLEOSIDE_BISPHOSPHATE...2,SET,11,0.16155,0.0039513,0.259,0.26639,GOBP_NUCLEOSIDE_BISPHOSPHATE_CATABOLIC_PROCESS,0.942713007840342
GSE1460_DP_VS_CD4_THYMOCYTE_...1,SET,189,0.042508,0.0042886,0.068165,0.26645,GSE1460_DP_VS_CD4_THYMOCYTE_DN,0.942829337202199
GOBP_NEGATIVE_REGULATION_OF_...114,SET,14,0.14937,0.0041211,0.23963,0.26654,GOBP_NEGATIVE_REGULATION_OF_CELL_DIVISION,0.94298674423331
MIR4796_5P,SET,89,0.06087,0.0042257,0.097669,0.26657,MIR4796_5P,0.94298674423331
KEGG_MEDICUS_REFERENCE_ITGA_...2,SET,29,0.10544,0.0041852,0.1692,0.26658,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY,0.94298674423331
FREDERICK_PRKCI_TARGETS,SET,9,0.17645,0.0039039,0.28321,0.26663,FREDERICK_PRKCI_TARGETS,0.94298674423331
TAANNYSGCG_UNKNOWN,SET,72,0.06368,0.003978,0.10222,0.26666,TAANNYSGCG_UNKNOWN,0.94298674423331
HP_DECREASED_LYMPHOCYTE_PROL...2,SET,27,0.10957,0.0041967,0.17592,0.2667,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_MITOGEN,0.94298674423331
BIOCARTA_MAL_PATHWAY,SET,19,0.12127,0.0038974,0.19476,0.26675,BIOCARTA_MAL_PATHWAY,0.94298674423331
GOBP_REGULATION_OF_HEART_RAT...1,SET,39,0.095661,0.004402,0.15366,0.26679,GOBP_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION,0.94298674423331
TIAN_TNF_SIGNALING_NOT_VIA_N...,SET,21,0.12948,0.0043744,0.20799,0.2668,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,0.94298674423331
HP_ABNORMAL_QT_INTERVAL,SET,55,0.077117,0.0042124,0.12388,0.2668,HP_ABNORMAL_QT_INTERVAL,0.94298674423331
HP_DECREASED_PATELLAR_REFLEX,SET,9,0.18378,0.0040659,0.29523,0.26681,HP_DECREASED_PATELLAR_REFLEX,0.94298674423331
chr14q32,SET,129,0.093652,0.0078187,0.15047,0.26685,chr14q32,0.94298674423331
LAKE_ADULT_KIDNEY_C5_PROXIMA...,SET,359,0.028963,0.0040083,0.046543,0.26688,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.94298674423331
GOBP_VITAMIN_METABOLIC_PROCE...,SET,109,0.051022,0.0039177,0.082007,0.26692,GOBP_VITAMIN_METABOLIC_PROCESS,0.94298674423331
GOBP_RESPONSE_TO_HYDROPEROXI...,SET,19,0.13186,0.0042374,0.21194,0.26693,GOBP_RESPONSE_TO_HYDROPEROXIDE,0.94298674423331
GOBP_PROTEIN_TRANSMEMBRANE_T...,SET,69,0.062463,0.0038201,0.10042,0.26698,GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.94298674423331
HP_ABNORMAL_ANTITRAGUS_MORPH...,SET,10,0.17073,0.0039815,0.27449,0.26698,HP_ABNORMAL_ANTITRAGUS_MORPHOLOGY,0.94298674423331
BIOCARTA_PML_PATHWAY,SET,17,0.12153,0.0036944,0.1954,0.267,BIOCARTA_PML_PATHWAY,0.94298674423331
CHEN_LVAD_SUPPORT_OF_FAILING...1,SET,42,0.090177,0.004306,0.14501,0.26701,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,0.94298674423331
WATANABE_COLON_CANCER_MSI_VS...2,SET,28,0.10475,0.0040857,0.16851,0.26709,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,0.943078193430657
DESCARTES_MAIN_FETAL_ENS_NEU...,SET,27,0.10693,0.0040954,0.17207,0.26717,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.943078193430657
GOBP_NEGATIVE_REGULATION_OF_...113,SET,581,0.023484,0.004109,0.037793,0.26718,GOBP_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION,0.943078193430657
MIR33A_3P,SET,393,0.027148,0.0039273,0.043696,0.26721,MIR33A_3P,0.943078193430657
KORKOLA_CHORIOCARCINOMA_UP,SET,3,0.34554,0.0044145,0.55629,0.26725,KORKOLA_CHORIOCARCINOMA_UP,0.943078193430657
GOBP_REGULATION_OF_OOCYTE_MA...,SET,7,0.19383,0.0037821,0.31204,0.26725,GOBP_REGULATION_OF_OOCYTE_MATURATION,0.943078193430657
GOCC_MICROTUBULE_ORGANIZING_...2,SET,10,0.17063,0.0039791,0.27469,0.26725,GOCC_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE,0.943078193430657
REACTOME_GAMMA_CARBOXYLATION...2,SET,9,0.17154,0.0037952,0.27623,0.2673,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,0.943078193430657
GSE41176_UNSTIM_VS_ANTI_IGM_...14,SET,179,0.039215,0.0038513,0.063147,0.2673,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP,0.943078193430657
GSE37416_0H_VS_6H_F_TULARENS...2,SET,166,0.041379,0.0039148,0.066643,0.26734,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.943078193430657
HP_NONKETOTIC_HYPOGLYCEMIA,SET,13,0.13963,0.0037124,0.22491,0.26736,HP_NONKETOTIC_HYPOGLYCEMIA,0.943078193430657
GOBP_BASE_CONVERSION_OR_SUBS...,SET,16,0.16792,0.0049525,0.27051,0.26739,GOBP_BASE_CONVERSION_OR_SUBSTITUTION_EDITING,0.943078193430657
HE_LIM_SUN_FETAL_LUNG_C7_MID...,SET,237,0.037673,0.0042504,0.060691,0.26739,HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL,0.943078193430657
HP_Y_SHAPED_METACARPALS,SET,12,0.13252,0.0033851,0.21354,0.26744,HP_Y_SHAPED_METACARPALS,0.943078193430657
HEIDENBLAD_AMPLIFIED_IN_BONE...,SET,7,0.22924,0.004473,0.3694,0.26745,HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER,0.943078193430657
MIR4700_5P,SET,200,0.039084,0.004055,0.063012,0.26755,MIR4700_5P,0.943078193430657
MIR494_3P,SET,346,0.028918,0.0039303,0.046624,0.26756,MIR494_3P,0.943078193430657
GSE9509_LPS_VS_LPS_AND_IL10_...5,SET,169,0.04163,0.0039737,0.067134,0.2676,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN,0.943078193430657
CHIANG_LIVER_CANCER_SUBCLASS...5,SET,24,0.11761,0.0042473,0.18967,0.26761,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,0.943078193430657
GSE360_CTRL_VS_T_GONDII_DC_UP,SET,179,0.040522,0.0039797,0.065353,0.26761,GSE360_CTRL_VS_T_GONDII_DC_UP,0.943078193430657
DESCARTES_FETAL_PLACENTA_SMO...,SET,74,0.070636,0.0044732,0.11392,0.26761,DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS,0.943078193430657
HP_BRONCHOMALACIA,SET,23,0.1074,0.0037969,0.17324,0.26766,HP_BRONCHOMALACIA,0.943078193430657
GSE20366_TREG_VS_NAIVE_CD4_T...5,SET,179,0.038935,0.0038237,0.062805,0.26766,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP,0.943078193430657
GOMF_GANGLIOSIDE_BINDING,SET,5,0.27245,0.0044934,0.43957,0.26769,GOMF_GANGLIOSIDE_BINDING,0.943088286872782
GOBP_ORGANELLE_MEMBRANE_FUSI...,SET,114,0.048373,0.003798,0.078063,0.26774,GOBP_ORGANELLE_MEMBRANE_FUSION,0.943168832353537
HP_ABNORMAL_ODONTOID_TISSUE_...,SET,207,0.037781,0.003987,0.060979,0.26777,HP_ABNORMAL_ODONTOID_TISSUE_MORPHOLOGY,0.943178914563697
HP_KNEE_PAIN,SET,15,0.15741,0.0044952,0.25413,0.26783,HP_KNEE_PAIN,0.943214330533347
GSE22935_UNSTIM_VS_48H_MBOVI...4,SET,179,0.039052,0.0038352,0.063053,0.26785,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.943214330533347
GOCC_SPERM_FIBROUS_SHEATH,SET,5,0.25835,0.0042607,0.41719,0.26788,GOCC_SPERM_FIBROUS_SHEATH,0.943214330533347
REACTOME_TRANSCRIPTIONAL_REG...2,SET,57,0.072726,0.0040439,0.1175,0.26797,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,0.943214330533347
GSE369_PRE_VS_POST_IL6_INJEC...6,SET,175,0.041039,0.0039856,0.066311,0.268,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP,0.943214330533347
GOMF_AMP_BINDING,SET,15,0.12346,0.0035257,0.19949,0.26801,GOMF_AMP_BINDING,0.943214330533347
GSE21379_WT_VS_SAP_KO_CD4_TC...1,SET,183,0.040392,0.0040105,0.065272,0.26802,GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN,0.943214330533347
GOBP_CLATHRIN_DEPENDENT_ENDO...,SET,47,0.075976,0.0038373,0.12278,0.26803,GOBP_CLATHRIN_DEPENDENT_ENDOCYTOSIS,0.943214330533347
HP_ABNORMALITY_OF_EXTRAPYRAM...,SET,270,0.032502,0.0039104,0.052542,0.2681,HP_ABNORMALITY_OF_EXTRAPYRAMIDAL_MOTOR_FUNCTION,0.943214330533347
GSE41867_DAY6_VS_DAY15_LCMV_...4,SET,147,0.046395,0.0041328,0.075006,0.26811,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.943214330533347
HP_CERVICAL_SPINAL_CANAL_STE...,SET,9,0.18292,0.0040469,0.29576,0.26814,HP_CERVICAL_SPINAL_CANAL_STENOSIS,0.943214330533347
GOBP_DEFENSE_RESPONSE_TO_VIR...,SET,280,0.033578,0.0041129,0.054296,0.26815,GOBP_DEFENSE_RESPONSE_TO_VIRUS,0.943214330533347
GOBP_PHOSPHATIDYLINOSITOL_BI...,SET,117,0.04651,0.0036992,0.07521,0.26816,GOBP_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.943214330533347
GOBP_REGULATION_OF_MEMBRANE_...10,SET,33,0.10027,0.0042449,0.16214,0.26816,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION,0.943214330533347
GOBP_RETINA_HOMEOSTASIS,SET,53,0.077078,0.0041332,0.12466,0.26819,GOBP_RETINA_HOMEOSTASIS,0.943224392835458
GSE8384_CTRL_VS_B_ABORTUS_4H...1,SET,179,0.040584,0.0039857,0.065677,0.26832,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN,0.9433550176857
KEGG_HYPERTROPHIC_CARDIOMYOP...,SET,79,0.062117,0.0040638,0.10054,0.26835,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,0.9433550176857
GOBP_BONE_REMODELING,SET,89,0.059622,0.0041391,0.096503,0.26835,GOBP_BONE_REMODELING,0.9433550176857
HELLER_HDAC_TARGETS_UP,SET,252,0.033035,0.0038417,0.053477,0.26838,HELLER_HDAC_TARGETS_UP,0.9433550176857
OUELLET_CULTURED_OVARIAN_CAN...2,SET,60,0.066085,0.0037698,0.10698,0.26838,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.9433550176857
FLETCHER_PBMC_BCG_10W_INFANT...4,SET,89,0.064776,0.0044968,0.10487,0.2684,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP,0.9433550176857
HP_VISUAL_FIELD_DEFECT,SET,256,0.033241,0.0038959,0.053829,0.26845,HP_VISUAL_FIELD_DEFECT,0.9433550176857
BIOCARTA_CPSF_PATHWAY,SET,9,0.16947,0.0037493,0.27444,0.26846,BIOCARTA_CPSF_PATHWAY,0.9433550176857
GOBP_NEGATIVE_REGULATION_OF_...6,SET,13,0.15224,0.0040476,0.24657,0.26848,GOBP_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,0.9433550176857
GOBP_PROTEIN_POLYMERIZATION,SET,253,0.033299,0.0038801,0.053938,0.2685,GOBP_PROTEIN_POLYMERIZATION,0.9433550176857
HP_HYPOPLASIA_OF_THE_RADIUS,SET,38,0.081808,0.0037161,0.13255,0.26856,HP_HYPOPLASIA_OF_THE_RADIUS,0.9433550176857
HP_INCREASED_MEAN_CORPUSCULA...,SET,11,0.13932,0.0034074,0.22576,0.26858,HP_INCREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.9433550176857
GSE29618_MONOCYTE_VS_MDC_DN,SET,170,0.042255,0.0040451,0.06847,0.26858,GSE29618_MONOCYTE_VS_MDC_DN,0.9433550176857
GOCC_ENDOLYSOSOME,SET,26,0.10272,0.0038609,0.16653,0.26868,GOCC_ENDOLYSOSOME,0.943584292168675
QUINTENS_EMBRYONIC_BRAIN_RES...,SET,73,0.062922,0.0039578,0.10204,0.26875,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,0.943584292168675
KEGG_MEDICUS_VARIANT_MUTATIO...79,SET,6,0.19989,0.0036112,0.32421,0.26877,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050,0.943584292168675
GOBP_POSITIVE_REGULATION_OF_...499,SET,66,0.066974,0.0040063,0.10864,0.2688,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.943584292168675
GOBP_REGULATION_OF_MACROPHAG...3,SET,27,0.10185,0.0039009,0.16523,0.26882,GOBP_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.943584292168675
HP_PREMATURE_VENTRICULAR_CON...,SET,27,0.11292,0.004325,0.1832,0.26883,HP_PREMATURE_VENTRICULAR_CONTRACTION,0.943584292168675
HP_ABNORMAL_URETER_MORPHOLOGY,SET,136,0.044433,0.0038081,0.072091,0.26884,HP_ABNORMAL_URETER_MORPHOLOGY,0.943584292168675
KEGG_MEDICUS_REFERENCE_GH_JA...,SET,7,0.23547,0.0045946,0.38221,0.26893,KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY,0.943584292168675
WP_PATHWAYS_OF_NUCLEIC_ACID_...,SET,13,0.13961,0.0037118,0.22666,0.26897,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,0.943584292168675
GOMF_NON_MEMBRANE_SPANNING_P...2,SET,10,0.16357,0.0038145,0.26568,0.26906,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.943584292168675
HP_ABNORMAL_SEXUAL_BEHAVIOR,SET,7,0.19596,0.0038237,0.31846,0.26917,HP_ABNORMAL_SEXUAL_BEHAVIOR,0.943584292168675
GSE17301_ACD3_ACD28_VS_ACD3_...3,SET,183,0.040781,0.0040492,0.066282,0.26919,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN,0.943584292168675
GSE46606_UNSTIM_VS_CD40L_IL2...9,SET,189,0.038829,0.0039174,0.063126,0.26925,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.943584292168675
MIR6837_5P,SET,116,0.048461,0.003838,0.078792,0.26926,MIR6837_5P,0.943584292168675
GOMF_INTRAMOLECULAR_TRANSFER...,SET,26,0.094981,0.00357,0.15444,0.26928,GOMF_INTRAMOLECULAR_TRANSFERASE_ACTIVITY,0.943584292168675
GSE13493_DP_VS_CD4INTCD8POS_...2,SET,178,0.038572,0.0037776,0.062719,0.26928,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP,0.943584292168675
MORF_BUB1,SET,43,0.075354,0.0036407,0.12255,0.26932,MORF_BUB1,0.943584292168675
WP_NEUROTRANSMITTER_DISORDERS,SET,9,0.1877,0.0041527,0.3053,0.26935,WP_NEUROTRANSMITTER_DISORDERS,0.943584292168675
GOMF_AP_2_ADAPTOR_COMPLEX_BI...,SET,10,0.16163,0.0037692,0.26297,0.2694,GOMF_AP_2_ADAPTOR_COMPLEX_BINDING,0.943584292168675
HP_EBSTEIN_ANOMALY_OF_THE_TR...,SET,5,0.27386,0.0045166,0.44568,0.26945,HP_EBSTEIN_ANOMALY_OF_THE_TRICUSPID_VALVE,0.943584292168675
GOBP_SOMATOSTATIN_RECEPTOR_S...,SET,6,0.21622,0.0039062,0.35207,0.26956,GOBP_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY,0.943584292168675
MIR11181_5P,SET,65,0.064222,0.0038126,0.10458,0.26958,MIR11181_5P,0.943584292168675
FOROUTAN_PRODRANK_TGFB_EMT_DN,SET,76,0.066107,0.0042424,0.10766,0.2696,FOROUTAN_PRODRANK_TGFB_EMT_DN,0.943584292168675
TAKEDA_TARGETS_OF_NUP98_HOXA...9,SET,176,0.042467,0.0041359,0.069163,0.26961,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,0.943584292168675
REACTOME_POST_CHAPERONIN_TUB...,SET,21,0.1129,0.0038141,0.18389,0.26963,REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,0.943584292168675
GOBP_BLASTODERM_SEGMENTATION,SET,22,0.12244,0.0042339,0.19945,0.26964,GOBP_BLASTODERM_SEGMENTATION,0.943584292168675
GOCC_EXTRINSIC_COMPONENT_OF_...10,SET,11,0.16626,0.0040663,0.27082,0.26965,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE,0.943584292168675
OCT1_03,SET,206,0.037761,0.0039754,0.06152,0.26968,OCT1_03,0.943584292168675
GOBP_MAST_CELL_CHEMOTAXIS,SET,11,0.16625,0.004066,0.27089,0.26971,GOBP_MAST_CELL_CHEMOTAXIS,0.943584292168675
MIR8083,SET,49,0.07279,0.0037536,0.11861,0.26972,MIR8083,0.943584292168675
GOBP_REGULATION_OF_RENAL_SYS...,SET,20,0.13187,0.0043479,0.21489,0.26972,GOBP_REGULATION_OF_RENAL_SYSTEM_PROCESS,0.943584292168675
REACTOME_VITAMIN_B5_PANTOTHE...,SET,19,0.11448,0.0036791,0.18659,0.26977,REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,0.943584292168675
WP_PROSTAGLANDIN_SYNTHESIS_A...,SET,45,0.090291,0.0044624,0.14717,0.26977,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,0.943584292168675
GOBP_ENDOCYTIC_RECYCLING,SET,74,0.062237,0.0039413,0.10144,0.26977,GOBP_ENDOCYTIC_RECYCLING,0.943584292168675
WP_IL18_SIGNALING,SET,260,0.03408,0.0040248,0.055552,0.26978,WP_IL18_SIGNALING,0.943584292168675
MIR4477B,SET,242,0.034136,0.0038913,0.055644,0.26978,MIR4477B,0.943584292168675
GOBP_POSITIVE_REGULATION_OF_...649,SET,11,0.13786,0.0033719,0.22474,0.26979,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.943584292168675
GOBP_POSITIVE_REGULATION_OF_...518,SET,31,0.10585,0.0043437,0.17256,0.26981,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.943584292168675
GOMF_ATP_DEPENDENT_DNA_DNA_A...,SET,4,0.25607,0.0037773,0.4175,0.26983,GOMF_ATP_DEPENDENT_DNA_DNA_ANNEALING_ACTIVITY,0.943584292168675
MIR6859_3P,SET,33,0.097323,0.0041203,0.15868,0.26984,MIR6859_3P,0.943584292168675
LIN_MELANOMA_COPY_NUMBER_DN,SET,38,0.083909,0.0038115,0.13682,0.26985,LIN_MELANOMA_COPY_NUMBER_DN,0.943584292168675
GOBP_MYELOID_CELL_APOPTOTIC_...,SET,36,0.085131,0.0037641,0.13881,0.26985,GOBP_MYELOID_CELL_APOPTOTIC_PROCESS,0.943584292168675
WP_EXTRACELLULAR_VESICLES_IN...,SET,19,0.13887,0.0044629,0.22648,0.26988,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,0.943584292168675
BILD_E2F3_ONCOGENIC_SIGNATURE,SET,223,0.035627,0.0039006,0.058124,0.26996,BILD_E2F3_ONCOGENIC_SIGNATURE,0.943584292168675
REACTOME_RELAXIN_RECEPTORS,SET,7,0.22636,0.0044169,0.36935,0.26998,REACTOME_RELAXIN_RECEPTORS,0.943584292168675
GOBP_SKELETAL_MYOFIBRIL_ASSE...,SET,10,0.17137,0.0039965,0.27963,0.26999,GOBP_SKELETAL_MYOFIBRIL_ASSEMBLY,0.943584292168675
REACTOME_MASTL_FACILITATES_M...,SET,10,0.15585,0.0036344,0.25431,0.27,REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION,0.943584292168675
GSE42088_UNINF_VS_LEISHMANIA...8,SET,183,0.041388,0.0041094,0.067549,0.27004,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP,0.943584292168675
NAKAYAMA_SOFT_TISSUE_TUMORS_...3,SET,71,0.068728,0.0042636,0.11219,0.27007,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,0.943584292168675
GSE4748_CYANOBACTERIUM_LPSLI...2,SET,166,0.042766,0.004046,0.06981,0.27007,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.943584292168675
GSE5589_WT_VS_IL10_KO_LPS_ST...3,SET,185,0.038604,0.0038537,0.063019,0.27008,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.943584292168675
REACTOME_CASPASE_ACTIVATION_...2,SET,9,0.17123,0.0037883,0.27953,0.27009,REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND,0.943584292168675
GOCC_NUCLEAR_INCLUSION_BODY,SET,11,0.12538,0.0030665,0.20472,0.27013,GOCC_NUCLEAR_INCLUSION_BODY,0.943584292168675
GOMF_TRANSFERRIN_RECEPTOR_BI...,SET,9,0.15602,0.0034517,0.25476,0.27014,GOMF_TRANSFERRIN_RECEPTOR_BINDING,0.943584292168675
GSE13485_DAY1_VS_DAY21_YF17D...2,SET,160,0.039855,0.0037025,0.065082,0.27015,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.943584292168675
WP_PRION_DISEASE_PATHWAY,SET,31,0.097122,0.0039855,0.15866,0.27022,WP_PRION_DISEASE_PATHWAY,0.943584292168675
HP_MODERATE_MYOPIA,SET,3,0.32498,0.0041518,0.53089,0.27022,HP_MODERATE_MYOPIA,0.943584292168675
GENTILE_UV_RESPONSE_CLUSTER_...8,SET,24,0.11084,0.0040028,0.18108,0.27024,GENTILE_UV_RESPONSE_CLUSTER_D9,0.943584292168675
MIR5094,SET,85,0.058779,0.0039882,0.096066,0.27032,MIR5094,0.943584292168675
DESCARTES_FETAL_INTESTINE_EN...1,SET,46,0.084297,0.0042121,0.13777,0.27032,DESCARTES_FETAL_INTESTINE_ENS_GLIA,0.943584292168675
GOBP_S_ADENOSYLMETHIONINE_CY...,SET,7,0.20518,0.0040036,0.33535,0.27033,GOBP_S_ADENOSYLMETHIONINE_CYCLE,0.943584292168675
GOBP_REGULATION_OF_NERVOUS_S...1,SET,417,0.026788,0.0039891,0.043789,0.27035,GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.943584292168675
ZNF530_TARGET_GENES,SET,23,0.11669,0.0041257,0.19081,0.27041,ZNF530_TARGET_GENES,0.943584292168675
GOBP_POSITIVE_REGULATION_OF_...445,SET,26,0.10432,0.0039212,0.17058,0.27041,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.943584292168675
GOBP_PROTEIN_DNA_COMPLEX_ASS...,SET,147,0.040371,0.0035962,0.066011,0.27041,GOBP_PROTEIN_DNA_COMPLEX_ASSEMBLY,0.943584292168675
GOCC_MITOTIC_SPINDLE_MICROTU...,SET,13,0.11771,0.0031294,0.19249,0.27044,GOCC_MITOTIC_SPINDLE_MICROTUBULE,0.943594237526353
GCTCTTG_MIR335,SET,80,0.055742,0.0036697,0.091174,0.27048,GCTCTTG_MIR335,0.943639068460149
OHASHI_AURKA_TARGETS,SET,5,0.22184,0.0036586,0.36302,0.27057,OHASHI_AURKA_TARGETS,0.943858310749774
GSE27670_BLIMP1_VS_LMP1_TRAN...1,SET,184,0.038166,0.0037997,0.062474,0.27063,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN,0.94397286732236
PID_MAPK_TRK_PATHWAY,SET,33,0.095202,0.0040305,0.1559,0.27071,PID_MAPK_TRK_PATHWAY,0.944057222389407
GOBP_RESPONSE_TO_INCREASED_O...,SET,23,0.10399,0.0036765,0.17032,0.27075,GOBP_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,0.944057222389407
MIR7978,SET,78,0.057083,0.0037109,0.093499,0.27076,MIR7978,0.944057222389407
GSE18281_CORTEX_VS_MEDULLA_T...1,SET,160,0.042065,0.0039078,0.068908,0.27078,GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN,0.944057222389407
GOBP_PROTEIN_LOCALIZATION_TO...25,SET,350,0.029049,0.0039704,0.047586,0.27079,GOBP_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION,0.944057222389407
HE_LIM_SUN_FETAL_LUNG_C0_ADV...,SET,62,0.06974,0.0040438,0.11428,0.27084,HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST,0.944136830491475
ZHENG_FOXP3_TARGETS_DN,SET,6,0.254,0.0045886,0.41631,0.2709,ZHENG_FOXP3_TARGETS_DN,0.944191441034898
E2F_Q4_01,SET,211,0.035305,0.0037612,0.057872,0.27091,E2F_Q4_01,0.944191441034898
GOMF_1_PHOSPHATIDYLINOSITOL_...1,SET,10,0.17514,0.0040844,0.28713,0.27094,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY,0.944201313546576
GSE26727_WT_VS_KLF2_KO_LPS_S...2,SET,179,0.039492,0.0038785,0.064761,0.27099,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP,0.944270365731463
REACTOME_SIGNALING_BY_KIT_IN...,SET,20,0.12563,0.0041421,0.20609,0.27107,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,0.944270365731463
HOEK_MYELOID_DENDRITIC_CELL_...2,SET,16,0.13601,0.0040112,0.22312,0.27108,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_UP,0.944270365731463
GOCC_CELL_BODY_FIBER,SET,8,0.20648,0.004307,0.33874,0.27109,GOCC_CELL_BODY_FIBER,0.944270365731463
GOCC_BARR_BODY,SET,2,0.43683,0.0045567,0.71679,0.27113,GOCC_BARR_BODY,0.944270365731463
GOBP_POSITIVE_REGULATION_OF_...259,SET,32,0.088282,0.0036806,0.14488,0.27115,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.944270365731463
GSE11961_MARGINAL_ZONE_BCELL...7,SET,175,0.040689,0.0039515,0.066772,0.27115,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.944270365731463
GOBP_NEGATIVE_REGULATION_OF_...573,SET,20,0.11197,0.0036919,0.18383,0.27123,GOBP_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.94428286028383
GOBP_REGULATION_OF_LYMPHOCYT...2,SET,56,0.071233,0.0039261,0.11696,0.27125,GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.94428286028383
PID_CD8_TCR_PATHWAY,SET,51,0.071038,0.003737,0.11665,0.27128,PID_CD8_TCR_PATHWAY,0.94428286028383
GOBP_POSITIVE_REGULATION_OF_...796,SET,18,0.12241,0.0038292,0.20109,0.27135,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.94428286028383
GOBP_VASCULOGENESIS_INVOLVED...,SET,4,0.31234,0.0046075,0.51311,0.27136,GOBP_VASCULOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.94428286028383
CMYB_01,SET,232,0.033914,0.0037863,0.055721,0.27139,CMYB_01,0.94428286028383
GSE6269_E_COLI_VS_STAPH_AURE...1,SET,162,0.040712,0.0038055,0.066892,0.27139,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN,0.94428286028383
GOBP_TYPE_B_PANCREATIC_CELL_...2,SET,22,0.11872,0.0041053,0.19511,0.27143,GOBP_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,0.94428286028383
GOBP_ORGAN_GROWTH,SET,151,0.045248,0.0040846,0.074364,0.27144,GOBP_ORGAN_GROWTH,0.94428286028383
GOMF_FRUCTOSE_TRANSMEMBRANE_...,SET,8,0.18583,0.0038763,0.30543,0.27146,GOMF_FRUCTOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.94428286028383
GSE6259_FLT3L_INDUCED_DEC205...3,SET,111,0.051739,0.0040088,0.085041,0.27146,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN,0.94428286028383
GSE8621_UNSTIM_VS_LPS_PRIMED...3,SET,179,0.03671,0.0036053,0.060362,0.27154,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN,0.94428286028383
GOBP_REGULATION_OF_CARDIOCYT...,SET,25,0.10642,0.0039225,0.17503,0.27158,GOBP_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.94428286028383
MODULE_400,SET,18,0.13189,0.0041256,0.21698,0.27165,MODULE_400,0.94428286028383
KRAS.BREAST_UP.V1_UP,SET,118,0.053508,0.0042737,0.088034,0.27166,KRAS.BREAST_UP.V1_UP,0.94428286028383
GSE20715_0H_VS_48H_OZONE_TLR...1,SET,190,0.037613,0.0038046,0.061892,0.27169,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN,0.94428286028383
GOBP_NEUROTROPHIN_TRK_RECEPT...,SET,24,0.10242,0.0036988,0.16854,0.2717,GOBP_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.94428286028383
MIR6856_3P,SET,65,0.061797,0.0036687,0.10172,0.27176,MIR6856_3P,0.94428286028383
HP_PYRIDOXINE_RESPONSIVE_SID...,SET,22,0.09775,0.00338,0.16091,0.27177,HP_PYRIDOXINE_RESPONSIVE_SIDEROBLASTIC_ANEMIA,0.94428286028383
REACTOME_NOTCH3_INTRACELLULA...,SET,24,0.10558,0.003813,0.17381,0.27178,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.94428286028383
HP_DIFFICULTY_STANDING,SET,28,0.097698,0.0038105,0.16084,0.27179,HP_DIFFICULTY_STANDING,0.94428286028383
GSE9037_WT_VS_IRAK4_KO_LPS_1...2,SET,181,0.038837,0.0038352,0.063937,0.27179,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP,0.94428286028383
MIR646,SET,225,0.035026,0.0038518,0.057676,0.27183,MIR646,0.94428286028383
GOBP_REGULATION_OF_METAPHASE...,SET,14,0.14214,0.0039217,0.23406,0.27183,GOBP_REGULATION_OF_METAPHASE_PLATE_CONGRESSION,0.94428286028383
REACTOME_INTERLEUKIN_2_SIGNA...,SET,11,0.17136,0.004191,0.28218,0.27185,REACTOME_INTERLEUKIN_2_SIGNALING,0.94428286028383
WALLACE_PROSTATE_CANCER_RACE...2,SET,257,0.035414,0.0041584,0.058322,0.27186,WALLACE_PROSTATE_CANCER_RACE_UP,0.94428286028383
GSE1460_INTRATHYMIC_T_PROGEN...8,SET,184,0.037299,0.0037134,0.061451,0.27194,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.944405961058412
GOCC_SAGA_TYPE_COMPLEX,SET,33,0.078763,0.0033346,0.1298,0.272,GOCC_SAGA_TYPE_COMPLEX,0.944405961058412
SCHERER_PBMC_APSV_WETVAX_AGE...3,SET,130,0.045292,0.0037958,0.074646,0.27201,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN,0.944405961058412
GOBP_REGULATION_OF_LEUKOCYTE...2,SET,30,0.098881,0.0039918,0.16298,0.27202,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.944405961058412
GOBP_NEGATIVE_REGULATION_OF_...467,SET,26,0.1078,0.0040517,0.17768,0.27204,GOBP_NEGATIVE_REGULATION_OF_ORGAN_GROWTH,0.944405961058412
MIR4708_5P,SET,80,0.056076,0.0036917,0.092453,0.27209,MIR4708_5P,0.944405961058412
MIR1229_3P,SET,75,0.057628,0.0036739,0.095034,0.27213,MIR1229_3P,0.944405961058412
HOWARD_NEUTROPHIL_INACT_MONO...1,SET,102,0.051851,0.0038521,0.085507,0.27213,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.944405961058412
GOBP_PROTEIN_O_LINKED_MANNOS...,SET,14,0.13104,0.0036153,0.2161,0.27214,GOBP_PROTEIN_O_LINKED_MANNOSYLATION,0.944405961058412
HP_ABNORMAL_BOWEL_SOUNDS,SET,8,0.15704,0.0032759,0.25911,0.27223,HP_ABNORMAL_BOWEL_SOUNDS,0.94454841412328
GOBP_NUCLEAR_CHROMOSOME_SEGR...,SET,293,0.029132,0.0036489,0.048071,0.27225,GOBP_NUCLEAR_CHROMOSOME_SEGREGATION,0.94454841412328
REACTOME_SODIUM_COUPLED_PHOS...,SET,5,0.26141,0.0043113,0.43148,0.27231,REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS,0.94454841412328
GOMF_ADP_BINDING,SET,32,0.091047,0.0037959,0.15028,0.27232,GOMF_ADP_BINDING,0.94454841412328
KEGG_MEDICUS_REFERENCE_PRNP_...,SET,27,0.10343,0.0039616,0.17076,0.27236,KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY,0.94454841412328
GOBP_REGULATION_OF_PROTEIN_K...2,SET,12,0.15669,0.0040026,0.25873,0.27239,GOBP_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.94454841412328
HP_APLASIA_HYPOPLASIA_OF_THE...13,SET,18,0.13788,0.004313,0.22768,0.27239,HP_APLASIA_HYPOPLASIA_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,0.94454841412328
WP_PTDINS45P2_IN_CYTOKINESIS...,SET,9,0.17179,0.0038006,0.2837,0.27242,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.94454841412328
MIR4308,SET,133,0.044446,0.0037673,0.073421,0.27247,MIR4308,0.94454841412328
GOBP_ENUCLEATE_ERYTHROCYTE_D...1,SET,5,0.25859,0.0042647,0.42718,0.27248,GOBP_ENUCLEATE_ERYTHROCYTE_DEVELOPMENT,0.94454841412328
HP_AGITATION,SET,96,0.053642,0.0038668,0.088613,0.27248,HP_AGITATION,0.94454841412328
WP_SOMATIC_SEX_DETERMINATION,SET,13,0.14904,0.0039625,0.24624,0.27251,WP_SOMATIC_SEX_DETERMINATION,0.944550373097204
GSE39820_CTRL_VS_IL1B_IL6_CD...1,SET,182,0.039563,0.0039175,0.065378,0.27255,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN,0.944550373097204
RICKMAN_HEAD_AND_NECK_CANCER...3,SET,101,0.05591,0.0041334,0.092421,0.27261,RICKMAN_HEAD_AND_NECK_CANCER_C,0.944550373097204
CHIARADONNA_NEOPLASTIC_TRANS...6,SET,113,0.051207,0.004003,0.08465,0.27262,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,0.944550373097204
GSE360_T_GONDII_VS_B_MALAYI_...4,SET,179,0.038931,0.0038234,0.064364,0.27264,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.944550373097204
GOMF_PROTEIN_KINASE_A_CATALY...,SET,14,0.14005,0.0038641,0.23158,0.27266,GOMF_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING,0.944550373097204
AIYAR_COBRA1_TARGETS_DN,SET,27,0.10346,0.0039626,0.1711,0.27271,AIYAR_COBRA1_TARGETS_DN,0.944550373097204
HP_ABNORMAL_CIRCULATING_FATT...1,SET,39,0.079495,0.0036581,0.13149,0.27274,HP_ABNORMAL_CIRCULATING_FATTY_ACID_ANION_CONCENTRATION,0.944550373097204
KEGG_DNA_REPLICATION,SET,34,0.080685,0.0034672,0.13348,0.27277,KEGG_DNA_REPLICATION,0.944550373097204
GOBP_ESTABLISHMENT_OF_MITOCH...1,SET,27,0.10461,0.0040068,0.17307,0.27278,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION,0.944550373097204
KEGG_MEDICUS_REFERENCE_EP_NE...,SET,15,0.13468,0.0038461,0.22283,0.2728,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY,0.944550373097204
REACTOME_PTK6_REGULATES_PROT...,SET,5,0.25393,0.0041878,0.42018,0.27281,REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING,0.944550373097204
GOBP_POSITIVE_REGULATION_OF_...520,SET,5,0.23832,0.0039304,0.39443,0.27286,GOBP_POSITIVE_REGULATION_OF_NECROPTOTIC_PROCESS,0.944550373097204
OUELLET_OVARIAN_CANCER_INVAS...2,SET,104,0.047551,0.003567,0.078735,0.27294,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.944550373097204
GOBP_RESPONSE_TO_RADIATION,SET,391,0.025697,0.0037081,0.042552,0.27296,GOBP_RESPONSE_TO_RADIATION,0.944550373097204
GOMF_3_5_DNA_HELICASE_ACTIVI...,SET,14,0.14022,0.0038687,0.23223,0.27299,GOMF_3_5_DNA_HELICASE_ACTIVITY,0.944550373097204
GSE17974_0H_VS_72H_IN_VITRO_...1,SET,170,0.038167,0.0036538,0.063215,0.273,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN,0.944550373097204
MIR5590_3P,SET,317,0.029083,0.0037866,0.048175,0.27303,MIR5590_3P,0.944550373097204
HP_RIGHT_AORTIC_ARCH_WITH_MI...,SET,5,0.21139,0.0034863,0.35017,0.27303,HP_RIGHT_AORTIC_ARCH_WITH_MIRROR_IMAGE_BRANCHING,0.944550373097204
MORF_DAP,SET,69,0.057298,0.0035043,0.094932,0.27307,MORF_DAP,0.944550373097204
ROESSLER_LIVER_CANCER_METAST...2,SET,100,0.049586,0.0036477,0.082166,0.2731,ROESSLER_LIVER_CANCER_METASTASIS_UP,0.944550373097204
HSF_Q6,SET,183,0.038189,0.0037918,0.063289,0.27312,HSF_Q6,0.944550373097204
GOBP_POSITIVE_REGULATION_OF_...235,SET,9,0.14959,0.0033095,0.2479,0.27312,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.944550373097204
MIR362_5P,SET,50,0.071413,0.0037198,0.11836,0.27314,MIR362_5P,0.944550373097204
REACTOME_RND2_GTPASE_CYCLE,SET,40,0.082388,0.0038395,0.13656,0.27316,REACTOME_RND2_GTPASE_CYCLE,0.944550373097204
MIR422A,SET,37,0.079829,0.0035783,0.13242,0.27331,MIR422A,0.94480651849642
GOBP_EMBRYONIC_FORELIMB_MORP...,SET,32,0.10066,0.0041967,0.16698,0.27331,GOBP_EMBRYONIC_FORELIMB_MORPHOGENESIS,0.94480651849642
GOBP_POSITIVE_REGULATION_OF_...502,SET,21,0.1264,0.0042704,0.20972,0.27335,GOBP_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.94480651849642
HP_HYPOPLASTIC_ILIAC_WING,SET,27,0.10031,0.003842,0.16643,0.27335,HP_HYPOPLASTIC_ILIAC_WING,0.94480651849642
GOCC_RNA_CAP_BINDING_COMPLEX,SET,15,0.12187,0.0034802,0.20222,0.27337,GOCC_RNA_CAP_BINDING_COMPLEX,0.94480651849642
GOBP_NEGATIVE_REGULATION_OF_...237,SET,8,0.19638,0.0040964,0.32603,0.27348,GOBP_NEGATIVE_REGULATION_OF_FERROPTOSIS,0.945018161033797
GSE21360_TERTIARY_VS_QUATERN...2,SET,173,0.040621,0.0039225,0.067455,0.27353,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.945018161033797
MIR6824_3P,SET,99,0.050749,0.0037147,0.08428,0.27354,MIR6824_3P,0.945018161033797
HP_ABNORMALITY_OF_NEUTROPHIL...,SET,14,0.13992,0.0038605,0.23237,0.27354,HP_ABNORMALITY_OF_NEUTROPHIL_PHYSIOLOGY,0.945018161033797
HP_FOLLICULAR_THYROID_CARCIN...,SET,16,0.12355,0.0036439,0.20529,0.27365,HP_FOLLICULAR_THYROID_CARCINOMA,0.945304219262499
REACTOME_SODIUM_CALCIUM_EXCH...,SET,11,0.18312,0.0044787,0.30432,0.27368,REACTOME_SODIUM_CALCIUM_EXCHANGERS,0.94531389385808
HP_TISSUE_ISCHEMIA,SET,108,0.053558,0.0040936,0.089031,0.27374,HP_TISSUE_ISCHEMIA,0.945427178773725
GSE26559_TCF1_KO_VS_WT_LIN_N...1,SET,174,0.039284,0.0038043,0.065316,0.27378,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN,0.945471373211447
HP_COLD_INDUCED_MUSCLE_CRAMPS,SET,6,0.2332,0.004213,0.38788,0.27385,HP_COLD_INDUCED_MUSCLE_CRAMPS,0.945559735744089
GOMF_NEUTRAL_L_AMINO_ACID_SO...,SET,8,0.21048,0.0043904,0.3501,0.27386,GOMF_NEUTRAL_L_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.945559735744089
HP_ABNORMAL_CEREBRAL_CORTEX_...,SET,678,0.019885,0.0037483,0.033084,0.27391,HP_ABNORMAL_CEREBRAL_CORTEX_MORPHOLOGY,0.945588663223756
GOBP_REGULATION_OF_SPONTANEO...,SET,5,0.23858,0.0039347,0.39699,0.27393,GOBP_REGULATION_OF_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.945588663223756
GOBP_RESPIRATORY_CHAIN_COMPL...1,SET,8,0.17881,0.00373,0.29757,0.27395,GOBP_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY,0.945588663223756
LEE_BMP2_TARGETS_DN,SET,824,0.017726,0.0036684,0.029518,0.27408,LEE_BMP2_TARGETS_DN,0.945651297415074
HP_ABNORMAL_CIRCULATING_IGE_...,SET,44,0.077911,0.0038077,0.12976,0.27411,HP_ABNORMAL_CIRCULATING_IGE_LEVEL,0.945651297415074
KAZMIN_PBMC_P_FALCIPARUM_RTS...1,SET,39,0.090801,0.0041784,0.15124,0.27413,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE,0.945651297415074
GSE2770_IL12_VS_TGFB_AND_IL1...3,SET,184,0.037653,0.0037486,0.062735,0.27419,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.945651297415074
REACTOME_SLC_TRANSPORTER_DIS...,SET,92,0.054063,0.0038155,0.090088,0.27422,REACTOME_SLC_TRANSPORTER_DISORDERS,0.945651297415074
GSE41087_WT_VS_FOXP3_MUT_ANT...1,SET,173,0.037516,0.0036227,0.062519,0.27423,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.945651297415074
HP_NEOPLASM_OF_THE_THYROID_G...,SET,87,0.055483,0.0038084,0.092462,0.27424,HP_NEOPLASM_OF_THE_THYROID_GLAND,0.945651297415074
SARTIPY_NORMAL_AT_INSULIN_RE...2,SET,27,0.099675,0.0038177,0.16616,0.2743,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,0.945651297415074
GSE7764_IL15_TREATED_VS_CTRL...1,SET,181,0.039716,0.003922,0.066212,0.27431,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN,0.945651297415074
MIR3922_5P,SET,92,0.054965,0.0038792,0.091648,0.27434,MIR3922_5P,0.945651297415074
WILCOX_RESPONSE_TO_PROGESTER...1,SET,57,0.071478,0.0039746,0.11919,0.27436,WILCOX_RESPONSE_TO_PROGESTERONE_DN,0.945651297415074
MIR888_3P,SET,105,0.050645,0.0038172,0.084464,0.27439,MIR888_3P,0.945651297415074
GSE2706_UNSTIM_VS_2H_LPS_AND...2,SET,162,0.038167,0.0035676,0.063655,0.27439,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP,0.945651297415074
KEGG_MEDICUS_REFERENCE_ATR_S...,SET,11,0.13753,0.0033636,0.22937,0.2744,KEGG_MEDICUS_REFERENCE_ATR_SIGNALING,0.945651297415074
GOBP_IONOTROPIC_GLUTAMATE_RE...,SET,21,0.12344,0.0041705,0.20589,0.2744,GOBP_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.945651297415074
KANG_IMMORTALIZED_BY_TERT_DN,SET,95,0.054934,0.0039394,0.091632,0.27442,KANG_IMMORTALIZED_BY_TERT_DN,0.945651297415074
GOBP_BUD_ELONGATION_INVOLVED...,SET,7,0.22169,0.0043257,0.36983,0.27444,GOBP_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING,0.945651297415074
GOMF_SEQUENCE_SPECIFIC_DNA_B...,SET,1524,0.014834,0.0040907,0.024749,0.27447,GOMF_SEQUENCE_SPECIFIC_DNA_BINDING,0.945651297415074
HE_PTEN_TARGETS_UP,SET,18,0.11926,0.0037304,0.19901,0.27451,HE_PTEN_TARGETS_UP,0.945651297415074
KONDO_PROSTATE_CANCER_HCP_WI...,SET,87,0.061073,0.0041921,0.10193,0.27454,KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,0.945651297415074
TFEB_TARGET_GENES,SET,1068,0.016429,0.0038438,0.027422,0.27455,TFEB_TARGET_GENES,0.945651297415074
PHF21A_TARGET_GENES,SET,224,0.034875,0.0038267,0.058237,0.27464,PHF21A_TARGET_GENES,0.945651297415074
GOBP_CELLULAR_RESPONSE_TO_GA...,SET,23,0.097,0.0034294,0.16202,0.27469,GOBP_CELLULAR_RESPONSE_TO_GAMMA_RADIATION,0.945651297415074
GSE14415_INDUCED_TREG_VS_FOX...1,SET,160,0.041195,0.003827,0.068808,0.27469,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN,0.945651297415074
REN_ALVEOLAR_RHABDOMYOSARCOM...1,SET,369,0.027475,0.0038538,0.045892,0.2747,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,0.945651297415074
GSE17721_PAM3CSK4_VS_GADIQUI...3,SET,194,0.037037,0.0037852,0.061872,0.27472,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN,0.945651297415074
GOBP_NEGATIVE_REGULATION_OF_...192,SET,22,0.10634,0.0036771,0.17766,0.27473,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.945651297415074
NAKAYA_PLASMACYTOID_DENDRITI...2,SET,186,0.037093,0.0037127,0.061969,0.27473,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.945651297415074
HP_MYOPATHY,SET,280,0.030385,0.0037218,0.05079,0.27484,HP_MYOPATHY,0.945652260406583
HP_INCREASED_FEMALE_LIBIDO,SET,18,0.13088,0.004094,0.21879,0.27485,HP_INCREASED_FEMALE_LIBIDO,0.945652260406583
GOBP_POSITIVE_REGULATION_OF_...389,SET,89,0.05629,0.0039077,0.094102,0.27486,GOBP_POSITIVE_REGULATION_OF_JNK_CASCADE,0.945652260406583
GOMF_SIALYLTRANSFERASE_ACTIV...,SET,21,0.11704,0.0039542,0.19574,0.27494,GOMF_SIALYLTRANSFERASE_ACTIVITY,0.945652260406583
MIR493_5P,SET,431,0.025823,0.0039079,0.043191,0.27497,MIR493_5P,0.945652260406583
GOBP_RESPONSE_TO_DSRNA,SET,49,0.079355,0.0040921,0.13277,0.27503,GOBP_RESPONSE_TO_DSRNA,0.945652260406583
RGTTAMWNATT_HNF1_01,SET,64,0.068384,0.0040285,0.11442,0.27504,RGTTAMWNATT_HNF1_01,0.945652260406583
GOBP_CENTRAL_NERVOUS_SYSTEM_...8,SET,27,0.10604,0.0040615,0.1775,0.27513,GOBP_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS,0.945652260406583
GSE17721_LPS_VS_CPG_1H_BMDC_...1,SET,192,0.037069,0.003769,0.062078,0.27521,GSE17721_LPS_VS_CPG_1H_BMDC_DN,0.945652260406583
REACTOME_FRS_MEDIATED_FGFR4_...,SET,21,0.10981,0.0037098,0.18394,0.27526,REACTOME_FRS_MEDIATED_FGFR4_SIGNALING,0.945652260406583
PID_IL5_PATHWAY,SET,14,0.14757,0.0040714,0.24721,0.27528,PID_IL5_PATHWAY,0.945652260406583
MODULE_68,SET,26,0.10867,0.0040846,0.18209,0.27532,MODULE_68,0.945652260406583
TRAVAGLINI_LUNG_SIGNALING_AL...,SET,67,0.068002,0.0040984,0.11394,0.27532,TRAVAGLINI_LUNG_SIGNALING_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,0.945652260406583
MIR466,SET,372,0.026349,0.0037107,0.044152,0.27533,MIR466,0.945652260406583
REACTOME_MRNA_DECAY_BY_5_TO_...,SET,15,0.1294,0.0036954,0.21687,0.27537,REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE,0.945652260406583
KEGG_MEDICUS_VARIANT_MUTATIO...69,SET,6,0.18952,0.0034238,0.31771,0.27541,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATXN3_TO_AUTOPHAGY_VESICLE_NUCLEATION,0.945652260406583
GOCC_MITOCHONDRIAL_INTERMEMB...,SET,5,0.20509,0.0033823,0.34378,0.27541,GOCC_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX,0.945652260406583
GOBP_NEGATIVE_REGULATION_OF_...76,SET,6,0.22629,0.0040881,0.37943,0.27546,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.945652260406583
MIR4524A_3P,SET,200,0.036335,0.0037698,0.06094,0.27551,MIR4524A_3P,0.945652260406583
BIOCARTA_NPP1_PATHWAY,SET,8,0.20367,0.0042484,0.34165,0.27555,BIOCARTA_NPP1_PATHWAY,0.945652260406583
GSE26928_EFF_MEMORY_VS_CXCR5...1,SET,164,0.039563,0.0037206,0.066372,0.27556,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,0.945652260406583
HP_RAYNAUD_PHENOMENON,SET,41,0.08314,0.0039225,0.13949,0.27559,HP_RAYNAUD_PHENOMENON,0.945652260406583
HP_ABNORMALITY_OF_CIRCULATIN...1,SET,41,0.086313,0.0040722,0.14487,0.27566,HP_ABNORMALITY_OF_CIRCULATING_FIBRINOGEN,0.945652260406583
HP_PANHYPOGAMMAGLOBULINEMIA,SET,16,0.1217,0.0035894,0.20428,0.27567,HP_PANHYPOGAMMAGLOBULINEMIA,0.945652260406583
WEST_ADRENOCORTICAL_TUMOR_DN,SET,480,0.02387,0.0038069,0.040068,0.27568,WEST_ADRENOCORTICAL_TUMOR_DN,0.945652260406583
REACTOME_NEURONAL_SYSTEM,SET,384,0.028348,0.0040546,0.047584,0.27568,REACTOME_NEURONAL_SYSTEM,0.945652260406583
HP_TRICUSPID_ATRESIA,SET,11,0.18514,0.0045281,0.31077,0.27568,HP_TRICUSPID_ATRESIA,0.945652260406583
GSE36888_UNTREATED_VS_IL2_TR...9,SET,164,0.04127,0.0038811,0.069277,0.27568,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN,0.945652260406583
GSE19888_ADENOSINE_A3R_INH_V...2,SET,173,0.038373,0.0037055,0.064415,0.27569,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP,0.945652260406583
HP_HYPERPLASTIC_CALLUS_FORMA...,SET,5,0.24805,0.0040909,0.41643,0.2757,HP_HYPERPLASTIC_CALLUS_FORMATION,0.945652260406583
GOBP_ATP_TRANSPORT,SET,19,0.1297,0.0041681,0.21775,0.27572,GOBP_ATP_TRANSPORT,0.945652260406583
GOBP_FC_GAMMA_RECEPTOR_SIGNA...,SET,31,0.10082,0.0041371,0.16934,0.27581,GOBP_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY,0.945652260406583
GOBP_GLAND_MORPHOGENESIS,SET,121,0.050238,0.004063,0.084396,0.27584,GOBP_GLAND_MORPHOGENESIS,0.945652260406583
GOBP_NEGATIVE_REGULATION_OF_...118,SET,28,0.10143,0.0039563,0.17043,0.27587,GOBP_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.945652260406583
MIR323A_5P,SET,40,0.074646,0.0034787,0.12544,0.2759,MIR323A_5P,0.945652260406583
GOBP_POSITIVE_REGULATION_OF_...493,SET,29,0.085134,0.0033792,0.14307,0.27591,GOBP_POSITIVE_REGULATION_OF_MRNA_PROCESSING,0.945652260406583
GOBP_REGULATION_OF_LYMPHANGI...,SET,6,0.23805,0.0043005,0.40014,0.27595,GOBP_REGULATION_OF_LYMPHANGIOGENESIS,0.945652260406583
HP_PROGRESSIVE_VISUAL_LOSS,SET,93,0.053325,0.0037837,0.089632,0.27595,HP_PROGRESSIVE_VISUAL_LOSS,0.945652260406583
MODULE_171,SET,122,0.047358,0.0038457,0.079607,0.27596,MODULE_171,0.945652260406583
REACTOME_RELEASE_OF_HH_NP_FR...,SET,8,0.16883,0.0035218,0.28401,0.2761,REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL,0.945652260406583
GSE41867_DAY6_VS_DAY8_LCMV_A...1,SET,187,0.034892,0.0035016,0.058693,0.2761,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.945652260406583
REACTOME_NUCLEAR_ENVELOPE_NE...,SET,71,0.058702,0.0036416,0.098784,0.27618,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,0.945652260406583
BIOCARTA_PRC2_PATHWAY,SET,11,0.16838,0.0041182,0.28343,0.27623,BIOCARTA_PRC2_PATHWAY,0.945652260406583
GOBP_ER_OVERLOAD_RESPONSE,SET,10,0.19513,0.0045505,0.3285,0.27626,GOBP_ER_OVERLOAD_RESPONSE,0.945652260406583
GOBP_GLYCOSPHINGOLIPID_METAB...,SET,62,0.068456,0.0039694,0.11526,0.27628,GOBP_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,0.945652260406583
SCHAEFFER_PROSTATE_DEVELOPME...1,SET,52,0.074219,0.0039424,0.12497,0.27629,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,0.945652260406583
GOBP_REGULATION_OF_GLUCOCORT...2,SET,11,0.1488,0.0036394,0.25057,0.27631,GOBP_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.945652260406583
HP_DECREASED_SIZE_OF_NERVE_T...,SET,15,0.11845,0.0033827,0.19951,0.27636,HP_DECREASED_SIZE_OF_NERVE_TERMINALS,0.945652260406583
GSE15624_CTRL_VS_3H_HALOFUGI...1,SET,144,0.040006,0.0035274,0.067386,0.27636,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.945652260406583
NABA_MATRISOME_ASSOCIATED,SET,698,0.022249,0.0042528,0.037476,0.27637,NABA_MATRISOME_ASSOCIATED,0.945652260406583
GOBP_MYOBLAST_FUSION_INVOLVE...,SET,3,0.33801,0.0043182,0.56933,0.27637,GOBP_MYOBLAST_FUSION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.945652260406583
GSE40666_UNTREATED_VS_IFNA_S...3,SET,177,0.036734,0.0035876,0.061892,0.27642,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN,0.945652260406583
BCAT.100_UP.V1_DN,SET,24,0.10738,0.003878,0.18097,0.27646,BCAT.100_UP.V1_DN,0.945652260406583
WP_TRANSCRIPTIONAL_CASCADE_R...,SET,12,0.17067,0.0043597,0.28763,0.27648,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,0.945652260406583
MIR5195_3P,SET,290,0.030535,0.0038053,0.051466,0.27649,MIR5195_3P,0.945652260406583
GCM_PSME1,SET,75,0.056858,0.0036248,0.09583,0.27649,GCM_PSME1,0.945652260406583
REACTOME_GENERATION_OF_SECON...,SET,27,0.10296,0.0039437,0.17359,0.27654,REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,0.945652260406583
GOMF_SINGLE_STRANDED_DNA_EXO...,SET,10,0.13955,0.0032543,0.23527,0.27655,GOMF_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,0.945652260406583
BILD_CTNNB1_ONCOGENIC_SIGNAT...,SET,72,0.058317,0.003643,0.098358,0.27663,BILD_CTNNB1_ONCOGENIC_SIGNATURE,0.945652260406583
GOBP_MONOATOMIC_ANION_HOMEOS...,SET,20,0.11483,0.003786,0.19373,0.27669,GOBP_MONOATOMIC_ANION_HOMEOSTASIS,0.945652260406583
GOBP_PROTOPORPHYRINOGEN_IX_B...,SET,8,0.1746,0.003642,0.2946,0.2767,GOBP_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS,0.945652260406583
GOBP_POSITIVE_REGULATION_OF_...15,SET,10,0.15755,0.003674,0.2659,0.27676,GOBP_POSITIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.945652260406583
WP_HFE_EFFECT_ON_HEPCIDIN_PR...,SET,6,0.20337,0.003674,0.34336,0.27683,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,0.945652260406583
GOBP_SIRNA_MEDIATED_RETROTRA...,SET,10,0.14263,0.0033262,0.24088,0.27689,GOBP_SIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.945652260406583
GOBP_ESTABLISHMENT_OF_BLOOD_...1,SET,14,0.15532,0.0042853,0.26237,0.27693,GOBP_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER,0.945652260406583
GSE6681_DELETED_FOXP3_VS_WT_...2,SET,175,0.039705,0.003856,0.067068,0.27693,GSE6681_DELETED_FOXP3_VS_WT_TREG_UP,0.945652260406583
GOBP_FOREBRAIN_NEUROBLAST_DI...,SET,6,0.22006,0.0039755,0.37174,0.27694,GOBP_FOREBRAIN_NEUROBLAST_DIVISION,0.945652260406583
GOBP_POSITIVE_REGULATION_OF_...761,SET,13,0.13661,0.003632,0.23079,0.27696,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.945652260406583
GSE19888_ADENOSINE_A3R_ACT_V...2,SET,166,0.03667,0.0034693,0.061962,0.27699,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP,0.945652260406583
GOMF_GLUTAMATE_GATED_RECEPTO...,SET,15,0.1405,0.0040123,0.23742,0.27701,GOMF_GLUTAMATE_GATED_RECEPTOR_ACTIVITY,0.945652260406583
NABA_MATRISOME_METASTATIC_CO...,SET,26,0.11602,0.0043607,0.19607,0.27702,NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS,0.945652260406583
KEGG_MEDICUS_VARIANT_MUTATIO...62,SET,6,0.22655,0.0040928,0.38299,0.27709,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.945652260406583
GOMF_VOLTAGE_GATED_POTASSIUM...1,SET,96,0.058588,0.0042233,0.099075,0.27715,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.945652260406583
HP_THROMBOPHLEBITIS,SET,10,0.15909,0.0037101,0.26907,0.27717,HP_THROMBOPHLEBITIS,0.945652260406583
GSE14415_NATURAL_TREG_VS_TCO...2,SET,146,0.042977,0.0038153,0.072696,0.2772,GSE14415_NATURAL_TREG_VS_TCONV_UP,0.945652260406583
GSE33425_CD8_ALPHAALPHA_VS_A...1,SET,183,0.036797,0.0036535,0.06224,0.2772,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,0.945652260406583
FRANCO_BLOOD_SANOFI_PASTEUR_...4,SET,20,0.11036,0.0036388,0.18669,0.27721,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_POSITIVE,0.945652260406583
GOBP_CELL_PROLIFERATION_INVO...3,SET,9,0.20679,0.004575,0.34982,0.27722,GOBP_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.945652260406583
HP_AUDITORY_HYPERSENSITIVITY,SET,30,0.11073,0.0044701,0.18734,0.27724,HP_AUDITORY_HYPERSENSITIVITY,0.945652260406583
MODULE_226,SET,27,0.097474,0.0037334,0.16492,0.27725,MODULE_226,0.945652260406583
GSE4811_CLASSSICALY_ACTIVATE...2,SET,174,0.037233,0.0036057,0.063018,0.27732,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP,0.945652260406583
JU_AGING_TERC_TARGETS_UP,SET,6,0.20824,0.003762,0.35265,0.27743,JU_AGING_TERC_TARGETS_UP,0.945652260406583
GOBP_POSTSYNAPSE_ORGANIZATION,SET,181,0.03823,0.0037752,0.064746,0.27745,GOBP_POSTSYNAPSE_ORGANIZATION,0.945652260406583
WP_LUNG_PATHOLOGY_OF_COVID19,SET,15,0.13239,0.0037808,0.22423,0.27746,WP_LUNG_PATHOLOGY_OF_COVID19,0.945652260406583
HP_PENETRATING_FOOT_ULCERS,SET,6,0.19713,0.0035614,0.33393,0.27748,HP_PENETRATING_FOOT_ULCERS,0.945652260406583
MIR4749_3P,SET,49,0.070598,0.0036405,0.1196,0.2775,MIR4749_3P,0.945652260406583
GSE26488_CTRL_VS_PEPTIDE_INJ...2,SET,188,0.038982,0.0039225,0.066042,0.27751,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP,0.945652260406583
MIR525_5P,SET,143,0.041748,0.0036683,0.070732,0.27752,MIR525_5P,0.945652260406583
HP_AMENORRHEA,SET,171,0.038691,0.0037147,0.065553,0.27753,HP_AMENORRHEA,0.945652260406583
WORSCHECH_TUMOR_REJECTION_DN,SET,8,0.17699,0.0036919,0.2999,0.27754,WORSCHECH_TUMOR_REJECTION_DN,0.945652260406583
GOBP_NEGATIVE_REGULATION_OF_...341,SET,12,0.14858,0.0037954,0.25175,0.27754,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.945652260406583
HP_ABNORMAL_CONSUMPTION_BEHA...,SET,253,0.033537,0.0039077,0.056839,0.27759,HP_ABNORMAL_CONSUMPTION_BEHAVIOR,0.945652260406583
HP_ABNORMAL_CEREBRAL_VASCULA...,SET,307,0.029423,0.003771,0.04987,0.2776,HP_ABNORMAL_CEREBRAL_VASCULAR_MORPHOLOGY,0.945652260406583
HP_DECREASED_SPECIFIC_ANTIBO...2,SET,3,0.35904,0.0045869,0.60874,0.27766,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_CONJUGATED_POLYSACCHARIDE_VACCINE,0.945652260406583
GOBP_RESPONSE_TO_GRAVITY,SET,8,0.17117,0.0035705,0.29025,0.27768,GOBP_RESPONSE_TO_GRAVITY,0.945652260406583
HP_ABNORMALITY_OF_EXOCRINE_P...,SET,66,0.061932,0.0037047,0.10501,0.27768,HP_ABNORMALITY_OF_EXOCRINE_PANCREAS_PHYSIOLOGY,0.945652260406583
GSE36888_STAT5_AB_KNOCKIN_VS...2,SET,182,0.036757,0.0036397,0.062331,0.2777,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP,0.945652260406583
GOMF_PROTEIN_PHOSPHORYLATED_...,SET,58,0.068851,0.0038618,0.11676,0.27772,GOMF_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING,0.945652260406583
GSE7568_CTRL_VS_24H_TGFB_TRE...1,SET,180,0.039204,0.0038609,0.066489,0.27772,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,0.945652260406583
HP_LARGE_POSTERIOR_FONTANELLE,SET,17,0.12576,0.003823,0.21332,0.27776,HP_LARGE_POSTERIOR_FONTANELLE,0.945652260406583
MIR1468_5P,SET,14,0.12701,0.0035041,0.21545,0.27777,MIR1468_5P,0.945652260406583
GSE15735_CTRL_VS_HDAC_INHIBI...4,SET,178,0.039192,0.0038383,0.066489,0.27779,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP,0.945652260406583
KEGG_MEDICUS_REFERENCE_NOTCH...4,SET,13,0.1457,0.0038737,0.24722,0.27782,KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY,0.945652260406583
PSMB5_TARGET_GENES,SET,196,0.036823,0.0037824,0.062482,0.27782,PSMB5_TARGET_GENES,0.945652260406583
GOBP_POSITIVE_REGULATION_OF_...146,SET,4,0.28003,0.0041309,0.47516,0.27782,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_ELONGATION,0.945652260406583
GOBP_REGULATION_OF_JNK_CASCA...,SET,131,0.044581,0.0037504,0.075668,0.27788,GOBP_REGULATION_OF_JNK_CASCADE,0.945652260406583
MIR4270,SET,164,0.040114,0.0037725,0.068096,0.27791,MIR4270,0.945652260406583
GOBP_NEGATIVE_REGULATION_BY_...1,SET,8,0.17919,0.0037379,0.30421,0.27791,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.945652260406583
MIR3138,SET,65,0.066664,0.0039576,0.11319,0.27794,MIR3138,0.945652260406583
GSE11961_PLASMA_CELL_DAY7_VS...3,SET,177,0.037367,0.0036494,0.063465,0.27801,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.945652260406583
MULLIGHAN_NPM1_MUTATED_SIGNA...3,SET,65,0.056439,0.0033506,0.095863,0.27802,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,0.945652260406583
GOBP_FC_RECEPTOR_SIGNALING_P...,SET,53,0.074739,0.0040078,0.12696,0.27803,GOBP_FC_RECEPTOR_SIGNALING_PATHWAY,0.945652260406583
REACTOME_REGULATION_OF_KIT_S...,SET,15,0.13468,0.0038461,0.22878,0.27804,REACTOME_REGULATION_OF_KIT_SIGNALING,0.945652260406583
REACTOME_DAP12_SIGNALING,SET,27,0.093772,0.0035916,0.1593,0.27805,REACTOME_DAP12_SIGNALING,0.945652260406583
HP_ABNORMAL_CONNECTION_OF_TH...,SET,234,0.033484,0.0037542,0.056893,0.27809,HP_ABNORMAL_CONNECTION_OF_THE_CARDIAC_SEGMENTS,0.945652260406583
LIU_CMYB_TARGETS_UP,SET,147,0.043078,0.0038373,0.073218,0.27815,LIU_CMYB_TARGETS_UP,0.945652260406583
GOBP_INTEGRATED_STRESS_RESPO...,SET,44,0.079201,0.0038707,0.13465,0.2782,GOBP_INTEGRATED_STRESS_RESPONSE_SIGNALING,0.945652260406583
GOBP_PROTEIN_DEGLYCOSYLATION,SET,14,0.13908,0.0038373,0.23646,0.2782,GOBP_PROTEIN_DEGLYCOSYLATION,0.945652260406583
HP_SPHEROCYTOSIS,SET,8,0.18512,0.0038615,0.31477,0.27823,HP_SPHEROCYTOSIS,0.945652260406583
MIR142_5P,SET,314,0.028485,0.0036914,0.048459,0.27833,MIR142_5P,0.945652260406583
HP_DECREASED_CIRCULATING_ALD...,SET,18,0.12726,0.0039806,0.2165,0.27834,HP_DECREASED_CIRCULATING_ALDOSTERONE_LEVEL,0.945652260406583
HP_POOR_SUCK,SET,126,0.047501,0.0039196,0.080813,0.27834,HP_POOR_SUCK,0.945652260406583
HP_ABNORMAL_CIRCULATING_VITA...2,SET,24,0.11103,0.0040098,0.18893,0.27837,HP_ABNORMAL_CIRCULATING_VITAMIN_B12_CONCENTRATION,0.945652260406583
GOMF_ACYL_COA_BINDING,SET,18,0.11836,0.0037025,0.20144,0.27841,GOMF_ACYL_COA_BINDING,0.945652260406583
GSE14308_TH2_VS_NATURAL_TREG...1,SET,181,0.037706,0.0037235,0.064191,0.27847,GSE14308_TH2_VS_NATURAL_TREG_DN,0.945652260406583
DESCARTES_FETAL_STOMACH_PARI...,SET,36,0.091487,0.0040451,0.15574,0.27847,DESCARTES_FETAL_STOMACH_PARIETAL_AND_CHIEF_CELLS,0.945652260406583
GSE43863_TH1_VS_LY6C_INT_CXC...4,SET,187,0.036414,0.0036545,0.061996,0.27848,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,0.945652260406583
MIR4633_5P,SET,38,0.084486,0.0038378,0.14385,0.27849,MIR4633_5P,0.945652260406583
KEGG_MEDICUS_PATHOGEN_YERSIN...1,SET,5,0.2314,0.0038162,0.3941,0.27856,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY,0.945652260406583
HP_VENOUS_INSUFFICIENCY,SET,35,0.08938,0.0038968,0.15223,0.27856,HP_VENOUS_INSUFFICIENCY,0.945652260406583
MULLIGHAN_MLL_SIGNATURE_1_DN,SET,216,0.035448,0.0038204,0.060388,0.2786,MULLIGHAN_MLL_SIGNATURE_1_DN,0.945652260406583
MIR6504_3P,SET,342,0.028081,0.0037949,0.047843,0.27862,MIR6504_3P,0.945652260406583
MIR1468_3P,SET,589,0.021512,0.0037889,0.036658,0.27866,MIR1468_3P,0.945652260406583
GOBP_NEGATIVE_REGULATION_OF_...611,SET,6,0.23793,0.0042984,0.40546,0.27866,GOBP_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.945652260406583
GSE43863_NAIVE_VS_MEMORY_LY6...1,SET,184,0.035464,0.0035307,0.060438,0.27868,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN,0.945652260406583
GOBP_ACTIN_FILAMENT_BASED_PR...,SET,755,0.019135,0.0037979,0.032619,0.27874,GOBP_ACTIN_FILAMENT_BASED_PROCESS,0.945652260406583
GOMF_DNA_DNA_ANNEALING_ACTIV...,SET,7,0.19997,0.0039019,0.34091,0.27875,GOMF_DNA_DNA_ANNEALING_ACTIVITY,0.945652260406583
AP4_Q6_01,SET,233,0.033242,0.0037192,0.056684,0.27879,AP4_Q6_01,0.945652260406583
GSE22601_CD4_SINGLE_POSITIVE...1,SET,180,0.035193,0.0034658,0.060011,0.27879,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.945652260406583
GSE43955_TH0_VS_TGFB_IL6_TH1...4,SET,188,0.037926,0.0038162,0.064678,0.27881,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP,0.945652260406583
GOBP_GLIAL_CELL_PROLIFERATION,SET,52,0.072692,0.0038612,0.124,0.27886,GOBP_GLIAL_CELL_PROLIFERATION,0.945652260406583
MATZUK_SPERMATOZOA,SET,105,0.049451,0.0037271,0.084363,0.27888,MATZUK_SPERMATOZOA,0.945652260406583
GOCC_LSM1_7_PAT1_COMPLEX,SET,5,0.19136,0.0031559,0.32647,0.2789,GOCC_LSM1_7_PAT1_COMPLEX,0.945652260406583
KEGG_MEDICUS_REFERENCE_GHRHR...,SET,28,0.093055,0.0036294,0.15881,0.27896,KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY,0.945652260406583
WP_OSTEOCLAST_SIGNALING,SET,16,0.13024,0.0038412,0.22228,0.27896,WP_OSTEOCLAST_SIGNALING,0.945652260406583
GOBP_IMMATURE_B_CELL_DIFFERE...,SET,12,0.14957,0.0038207,0.25528,0.27898,GOBP_IMMATURE_B_CELL_DIFFERENTIATION,0.945652260406583
KEGG_MEDICUS_REFERENCE_AUTOP...6,SET,16,0.11716,0.0034555,0.20001,0.27901,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1,0.945652260406583
LANDIS_ERBB2_BREAST_PRENEOPL...1,SET,56,0.069212,0.0038147,0.11815,0.27902,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,0.945652260406583
GOBP_NEGATIVE_REGULATION_OF_...397,SET,6,0.19224,0.003473,0.32828,0.27907,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,0.945652260406583
MIR4735_5P,SET,170,0.037781,0.0036169,0.064531,0.27912,MIR4735_5P,0.945652260406583
MIR6747_3P,SET,105,0.049453,0.0037273,0.084466,0.27912,MIR6747_3P,0.945652260406583
GOBP_VAGINA_DEVELOPMENT,SET,10,0.18392,0.0042891,0.31417,0.27913,GOBP_VAGINA_DEVELOPMENT,0.945652260406583
HP_RETROCOLLIS,SET,8,0.15976,0.0033326,0.27289,0.27913,HP_RETROCOLLIS,0.945652260406583
MIR7156_5P,SET,126,0.047396,0.0039109,0.08096,0.27914,MIR7156_5P,0.945652260406583
GSE40274_CTRL_VS_HELIOS_TRAN...2,SET,146,0.04204,0.0037321,0.071814,0.27914,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.945652260406583
MIR6825_5P,SET,380,0.026875,0.0038243,0.04591,0.27915,MIR6825_5P,0.945652260406583
GOBP_NEGATIVE_REGULATION_OF_...579,SET,9,0.19057,0.0042162,0.32558,0.27917,GOBP_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.945652260406583
GSE16450_CTRL_VS_IFNA_12H_ST...2,SET,172,0.038793,0.0037353,0.066278,0.27917,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.945652260406583
GIAROLA_SILVA_BLOOD_PANDEMRI...2,SET,4,0.21448,0.0031638,0.36644,0.27918,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_3DY_UP,0.945652260406583
ALONSO_METASTASIS_UP,SET,175,0.037252,0.0036178,0.063652,0.27919,ALONSO_METASTASIS_UP,0.945652260406583
MIR4510,SET,166,0.039479,0.0037351,0.067454,0.27919,MIR4510,0.945652260406583
CGTSACG_PAX3_B,SET,141,0.043995,0.0038388,0.07517,0.27919,CGTSACG_PAX3_B,0.945652260406583
HOLLEMAN_DAUNORUBICIN_B_ALL_...1,SET,12,0.1351,0.0034512,0.23093,0.27926,HOLLEMAN_DAUNORUBICIN_B_ALL_DN,0.945652260406583
GOCC_DYNACTIN_COMPLEX,SET,8,0.1584,0.0033041,0.27076,0.27927,GOCC_DYNACTIN_COMPLEX,0.945652260406583
GOMF_TBP_CLASS_PROTEIN_BINDI...,SET,23,0.10818,0.0038248,0.18499,0.27934,GOMF_TBP_CLASS_PROTEIN_BINDING,0.945652260406583
GSE21546_UNSTIM_VS_ANTI_CD3_...4,SET,160,0.040376,0.0037509,0.069057,0.27939,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP,0.945652260406583
CHANG_POU5F1_TARGETS_UP,SET,13,0.15421,0.0040999,0.26377,0.2794,CHANG_POU5F1_TARGETS_UP,0.945652260406583
MODULE_178,SET,15,0.14531,0.0041496,0.2486,0.27945,MODULE_178,0.945652260406583
GOBP_SUBTELOMERIC_HETEROCHRO...,SET,6,0.17898,0.0032334,0.30623,0.27946,GOBP_SUBTELOMERIC_HETEROCHROMATIN_FORMATION,0.945652260406583
HP_AGAMMAGLOBULINEMIA,SET,19,0.12208,0.0039233,0.2089,0.27948,HP_AGAMMAGLOBULINEMIA,0.945652260406583
HP_ALBINISM,SET,18,0.12793,0.0040016,0.21895,0.27952,HP_ALBINISM,0.945652260406583
GSE17721_LPS_VS_GARDIQUIMOD_...10,SET,182,0.038425,0.0038049,0.065764,0.27952,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP,0.945652260406583
GOBP_PROTEIN_LOCALIZATION_TO...11,SET,36,0.078119,0.0034541,0.13372,0.27954,GOBP_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.945652260406583
GOBP_POSITIVE_REGULATION_OF_...180,SET,35,0.094034,0.0040997,0.161,0.27959,GOBP_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY,0.945652260406583
KEGG_MEDICUS_REFERENCE_COPI_...,SET,23,0.089007,0.0031468,0.15241,0.27961,KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION,0.945652260406583
MIR6782_3P,SET,79,0.057593,0.0037679,0.098621,0.27962,MIR6782_3P,0.945652260406583
HP_PARTIAL_AGENESIS_OF_THE_C...,SET,46,0.067918,0.0033937,0.11631,0.27964,HP_PARTIAL_AGENESIS_OF_THE_CORPUS_CALLOSUM,0.945652260406583
MIR7106_5P,SET,325,0.027791,0.0036628,0.047601,0.27968,MIR7106_5P,0.945652260406583
GOMF_INTERLEUKIN_12_RECEPTOR...,SET,5,0.2811,0.004636,0.4816,0.27972,GOMF_INTERLEUKIN_12_RECEPTOR_BINDING,0.945652260406583
GOMF_PEPTIDE_ANTIGEN_BINDING,SET,32,0.099958,0.0041674,0.17128,0.27975,GOMF_PEPTIDE_ANTIGEN_BINDING,0.945652260406583
HP_MULTIPLE_IMPACTED_TEETH,SET,4,0.2854,0.00421,0.48905,0.27976,HP_MULTIPLE_IMPACTED_TEETH,0.945652260406583
GSE3982_MAST_CELL_VS_MAC_DN,SET,172,0.038489,0.003706,0.065959,0.27977,GSE3982_MAST_CELL_VS_MAC_DN,0.945652260406583
GSE5589_LPS_VS_LPS_AND_IL10_...6,SET,184,0.035489,0.0035332,0.060826,0.2798,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP,0.945652260406583
WP_RALA_DOWNSTREAM_REGULATED...,SET,12,0.13863,0.0035412,0.23762,0.27982,WP_RALA_DOWNSTREAM_REGULATED_GENES,0.945652260406583
AMIT_EGF_RESPONSE_40_MCF10A,SET,15,0.13681,0.003907,0.23454,0.27984,AMIT_EGF_RESPONSE_40_MCF10A,0.945652260406583
GOBP_REGULATION_OF_SMOOTH_MU...2,SET,34,0.083018,0.0035675,0.14234,0.27987,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.945652260406583
MIR378E,SET,37,0.077118,0.0034567,0.13227,0.27994,MIR378E,0.945652260406583
WARTERS_RESPONSE_TO_IR_SKIN,SET,70,0.059013,0.0036351,0.10123,0.27996,WARTERS_RESPONSE_TO_IR_SKIN,0.945652260406583
GOBP_MARGINAL_ZONE_B_CELL_DI...,SET,8,0.1769,0.00369,0.30346,0.27997,GOBP_MARGINAL_ZONE_B_CELL_DIFFERENTIATION,0.945652260406583
GOBP_ADULT_FEEDING_BEHAVIOR,SET,9,0.19138,0.0042341,0.32838,0.28002,GOBP_ADULT_FEEDING_BEHAVIOR,0.945652260406583
REACTOME_ROLE_OF_SECOND_MESS...,SET,9,0.17432,0.0038568,0.29915,0.28004,REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING,0.945652260406583
HP_APLASIA_HYPOPLASIA_OF_THE...60,SET,20,0.11334,0.0037368,0.19451,0.28006,HP_APLASIA_HYPOPLASIA_OF_THE_PUBIC_BONE,0.945652260406583
BENPORATH_ES_WITH_H3K27ME3,SET,1000,0.018233,0.0041358,0.031296,0.28009,BENPORATH_ES_WITH_H3K27ME3,0.945652260406583
HP_ABSENT_THUMBNAIL,SET,16,0.12855,0.0037915,0.22069,0.28011,HP_ABSENT_THUMBNAIL,0.945652260406583
MIR876_3P,SET,80,0.057561,0.0037895,0.098845,0.28017,MIR876_3P,0.945652260406583
BIOCARTA_P53_PATHWAY,SET,16,0.11875,0.0035023,0.20396,0.28021,BIOCARTA_P53_PATHWAY,0.945652260406583
REACTOME_ACTIVATED_NTRK2_SIG...4,SET,7,0.20453,0.003991,0.35132,0.28023,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K,0.945652260406583
GOBP_NEGATIVE_REGULATION_OF_...619,SET,137,0.04138,0.0035594,0.071085,0.28025,GOBP_NEGATIVE_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.945652260406583
LIU_TARGETS_OF_VMYB_VS_CMYB_...2,SET,15,0.13645,0.0038966,0.23444,0.28028,LIU_TARGETS_OF_VMYB_VS_CMYB_UP,0.945652260406583
GOBP_REGULATION_OF_INTRACELL...1,SET,29,0.088439,0.0035104,0.15196,0.28028,GOBP_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.945652260406583
HUANG_FOXA2_TARGETS_UP,SET,46,0.080786,0.0040366,0.13883,0.28032,HUANG_FOXA2_TARGETS_UP,0.945652260406583
GOMF_ARMADILLO_REPEAT_DOMAIN...,SET,8,0.1555,0.0032437,0.26724,0.28032,GOMF_ARMADILLO_REPEAT_DOMAIN_BINDING,0.945652260406583
GOBP_REGULATION_OF_TRANSPORT,SET,1450,0.013984,0.0037698,0.024036,0.28036,GOBP_REGULATION_OF_TRANSPORT,0.945652260406583
GSE37301_MULTIPOTENT_PROGENI...6,SET,181,0.036911,0.003645,0.063448,0.28037,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,0.945652260406583
KEGG_GLUTATHIONE_METABOLISM,SET,45,0.080743,0.0039905,0.13881,0.28039,KEGG_GLUTATHIONE_METABOLISM,0.945652260406583
GSE5455_HEALTHY_VS_TUMOR_BEA...1,SET,179,0.038048,0.0037366,0.065417,0.28041,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN,0.945652260406583
GOBP_NATURAL_KILLER_CELL_ACT...1,SET,89,0.057443,0.0039877,0.098764,0.28042,GOBP_NATURAL_KILLER_CELL_ACTIVATION,0.945652260406583
REACTOME_NR1H2_NR1H3_REGULAT...3,SET,5,0.18052,0.0029772,0.31043,0.28045,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE,0.945652260406583
WP_UDPDERIVED_SUGARS_SYNTHES...,SET,11,0.15313,0.0037452,0.26345,0.28054,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,0.945652260406583
MIR2909,SET,47,0.069154,0.0034927,0.11898,0.28054,MIR2909,0.945652260406583
GOBP_CATECHOL_CONTAINING_COM...1,SET,20,0.1213,0.0039994,0.20871,0.28055,GOBP_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.945652260406583
GOBP_INTRINSIC_APOPTOTIC_SIG...8,SET,10,0.15645,0.0036485,0.26923,0.28059,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.945652260406583
GOBP_VESICLE_CARGO_LOADING,SET,31,0.082028,0.0033661,0.14116,0.28059,GOBP_VESICLE_CARGO_LOADING,0.945652260406583
MODULE_537,SET,17,0.12267,0.0037291,0.21113,0.28062,MODULE_537,0.945652260406583
MODULE_202,SET,26,0.10247,0.0038516,0.1764,0.28065,MODULE_202,0.945652260406583
MODULE_307,SET,21,0.10133,0.0034234,0.17451,0.28073,MODULE_307,0.945652260406583
GSE29618_PRE_VS_DAY7_POST_LA...3,SET,172,0.03754,0.0036147,0.064652,0.28074,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN,0.945652260406583
GOBP_TRANSCRIPTION_PREINITIA...,SET,64,0.057791,0.0034044,0.099545,0.28078,GOBP_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,0.945652260406583
GOCC_PI_BODY,SET,9,0.16439,0.0036369,0.28321,0.28081,GOCC_PI_BODY,0.945652260406583
GSE2405_0H_VS_24H_A_PHAGOCYT...2,SET,188,0.035441,0.0035662,0.061061,0.28082,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.945652260406583
WP_FATTY_ACID_BETAOXIDATION,SET,31,0.091739,0.0037646,0.15809,0.28086,WP_FATTY_ACID_BETAOXIDATION,0.945652260406583
WP_ESTROGEN_SIGNALING,SET,21,0.11058,0.0037358,0.19057,0.28087,WP_ESTROGEN_SIGNALING,0.945652260406583
GSE21670_UNTREATED_VS_TGFB_T...4,SET,181,0.035539,0.0035095,0.061259,0.28091,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP,0.945652260406583
HP_GENETIC_ANTICIPATION,SET,8,0.15975,0.0033323,0.27539,0.28093,HP_GENETIC_ANTICIPATION,0.945652260406583
HP_WEAKNESS_OF_THE_INTRINSIC...,SET,24,0.089636,0.0032371,0.15452,0.28093,HP_WEAKNESS_OF_THE_INTRINSIC_HAND_MUSCLES,0.945652260406583
GOBP_REGULATION_OF_ATP_BIOSY...,SET,11,0.14315,0.0035011,0.24679,0.28095,GOBP_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.945652260406583
MIR7855_5P,SET,70,0.062767,0.0038663,0.10822,0.28096,MIR7855_5P,0.945652260406583
HOLLERN_SOLID_NODULAR_BREAST...1,SET,29,0.10511,0.0041721,0.18126,0.281,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,0.945652260406583
REACTOME_BACTERIAL_INFECTION...,SET,67,0.061011,0.0036771,0.10521,0.281,REACTOME_BACTERIAL_INFECTION_PATHWAYS,0.945652260406583
GSE9037_CTRL_VS_LPS_4H_STIM_...4,SET,174,0.037799,0.0036605,0.065183,0.281,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP,0.945652260406583
GOMF_I_SMAD_BINDING,SET,16,0.13966,0.004119,0.24092,0.28106,GOMF_I_SMAD_BINDING,0.945652260406583
HP_PHTHISIS_BULBI,SET,13,0.14827,0.003942,0.25576,0.28106,HP_PHTHISIS_BULBI,0.945652260406583
GSE7460_CD8_TCELL_VS_CD4_TCE...2,SET,173,0.038531,0.0037207,0.06647,0.28107,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP,0.945652260406583
GOBP_NEGATIVE_REGULATION_OF_...287,SET,4,0.24615,0.003631,0.42472,0.28111,GOBP_NEGATIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,0.945695290872133
GOBP_CELL_FATE_COMMITMENT_IN...2,SET,11,0.15885,0.0038851,0.27415,0.28116,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION,0.945747691861028
GSE7460_CTRL_VS_FOXP3_OVEREX...1,SET,184,0.037445,0.003728,0.064632,0.28118,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN,0.945747691861028
HP_GRANULOCYTIC_HYPERPLASIA,SET,6,0.2356,0.0042564,0.4068,0.28124,HP_GRANULOCYTIC_HYPERPLASIA,0.945857964002322
PID_FANCONI_PATHWAY,SET,40,0.069332,0.003231,0.11976,0.28132,PID_FANCONI_PATHWAY,0.945890633130963
KEGG_MEDICUS_REFERENCE_NON_H...,SET,13,0.10754,0.0028592,0.18579,0.28135,KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING,0.945890633130963
MIR4526,SET,94,0.05239,0.0037373,0.090511,0.28136,MIR4526,0.945890633130963
WP_HIJACK_OF_UBIQUITINATION_...,SET,6,0.18683,0.0033752,0.32279,0.28137,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,0.945890633130963
HP_LARGE_HANDS,SET,29,0.083813,0.0033267,0.14487,0.28145,HP_LARGE_HANDS,0.945890633130963
WP_TOLLLIKE_RECEPTOR_SIGNALI...1,SET,95,0.055273,0.0039637,0.095552,0.28148,WP_TOLLLIKE_RECEPTOR_SIGNALING,0.945890633130963
GOBP_SPLEEN_DEVELOPMENT,SET,38,0.081703,0.0037113,0.14125,0.28149,GOBP_SPLEEN_DEVELOPMENT,0.945890633130963
REACTOME_DEACTIVATION_OF_THE...,SET,38,0.081748,0.0037134,0.14134,0.2815,REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,0.945890633130963
GOBP_PHOSPHATIDYLINOSITOL_3_...2,SET,21,0.096787,0.0032699,0.16746,0.28165,GOBP_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.945890633130963
GSE12845_IGD_NEG_BLOOD_VS_DA...1,SET,182,0.033826,0.0033495,0.058527,0.28165,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.945890633130963
GSE19888_CTRL_VS_TCELL_MEMBR...2,SET,171,0.037532,0.0036035,0.064939,0.28165,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP,0.945890633130963
GSE12963_UNINF_VS_ENV_AND_NE...2,SET,119,0.044984,0.003608,0.07785,0.28169,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.945890633130963
GOCC_LATERAL_PART_OF_CELL,SET,5,0.23737,0.0039147,0.41081,0.2817,GOCC_LATERAL_PART_OF_CELL,0.945890633130963
BRACHAT_RESPONSE_TO_CAMPTOTH...1,SET,39,0.077975,0.0035882,0.13496,0.28171,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,0.945890633130963
GOCC_DENDRITIC_GROWTH_CONE,SET,7,0.1777,0.0034674,0.30756,0.28171,GOCC_DENDRITIC_GROWTH_CONE,0.945890633130963
GOBP_CELLULAR_RESPONSE_TO_L_...1,SET,6,0.19829,0.0035822,0.34322,0.28173,GOBP_CELLULAR_RESPONSE_TO_L_GLUTAMATE,0.945890633130963
GOBP_NEGATIVE_REGULATION_OF_...150,SET,52,0.073035,0.0038794,0.12643,0.28174,GOBP_NEGATIVE_REGULATION_OF_COAGULATION,0.945890633130963
GOBP_POSITIVE_REGULATION_OF_...730,SET,20,0.10187,0.0033587,0.17636,0.28177,GOBP_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.945890633130963
GOBP_NEGATIVE_REGULATION_OF_...592,SET,2,0.34523,0.0036012,0.59791,0.28184,GOBP_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,0.945890633130963
NF1_Q6_01,SET,249,0.032271,0.0037308,0.055905,0.28189,NF1_Q6_01,0.945890633130963
GSE32986_GMCSF_VS_GMCSF_AND_...3,SET,161,0.039229,0.0036556,0.067969,0.28192,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.945890633130963
GAUTAM_EYE_IRIS_CILIARY_BODY...10,SET,77,0.061744,0.0039882,0.107,0.28196,GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS,0.945890633130963
GSE17974_0.5H_VS_72H_IL4_AND...1,SET,175,0.034768,0.0033765,0.060262,0.28199,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.945890633130963
GSE9316_IL6_KO_VS_IFNG_KO_IN...2,SET,184,0.036983,0.003682,0.064104,0.282,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP,0.945890633130963
chr5p14,SET,5,0.32443,0.0053505,0.56237,0.28201,chr5p14,0.945890633130963
HP_ABNORMAL_SYNAPTIC_TRANSMI...,SET,111,0.047285,0.0036637,0.081969,0.28202,HP_ABNORMAL_SYNAPTIC_TRANSMISSION_AT_THE_NEUROMUSCULAR_JUNCTION,0.945890633130963
ZNF510_TARGET_GENES,SET,36,0.081054,0.0035838,0.14051,0.28203,ZNF510_TARGET_GENES,0.945890633130963
HP_PROXIMAL_FEMORAL_EPIPHYSI...,SET,7,0.14966,0.0029203,0.25951,0.28207,HP_PROXIMAL_FEMORAL_EPIPHYSIOLYSIS,0.945890633130963
GOBP_POSITIVE_REGULATION_OF_...365,SET,14,0.13069,0.0036056,0.22662,0.28209,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,0.945890633130963
GOBP_ARACHIDONIC_ACID_METABO...,SET,55,0.069927,0.0038196,0.12128,0.28211,GOBP_ARACHIDONIC_ACID_METABOLIC_PROCESS,0.945890633130963
GOBP_ESTABLISHMENT_OF_TISSUE...,SET,35,0.087629,0.0038205,0.15201,0.28216,GOBP_ESTABLISHMENT_OF_TISSUE_POLARITY,0.945890633130963
GOBP_NEGATIVE_REGULATION_OF_...319,SET,511,0.022012,0.0036191,0.038186,0.28216,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,0.945890633130963
GOBP_RESPONSE_TO_IONIZING_RA...,SET,129,0.041394,0.0034558,0.071826,0.28221,GOBP_RESPONSE_TO_IONIZING_RADIATION,0.945890633130963
WP_P38_MAPK_SIGNALING,SET,33,0.086114,0.0036458,0.14943,0.28222,WP_P38_MAPK_SIGNALING,0.945890633130963
GSE9988_ANTI_TREM1_VS_ANTI_T...2,SET,181,0.034926,0.003449,0.060608,0.28222,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.945890633130963
MORF_EIF4E,SET,79,0.053026,0.0034691,0.092024,0.28224,MORF_EIF4E,0.945890633130963
MODULE_70,SET,39,0.081691,0.0037592,0.14182,0.28231,MODULE_70,0.945890633130963
HP_RHIZOMELIC_ARM_SHORTENING,SET,9,0.17089,0.0037809,0.29668,0.28231,HP_RHIZOMELIC_ARM_SHORTENING,0.945890633130963
MISIAK_ANAPLASTIC_THYROID_CA...2,SET,44,0.078272,0.0038253,0.13592,0.28236,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_UP,0.945890633130963
GOBP_REGULATION_OF_RNA_EXPOR...,SET,14,0.12323,0.0033999,0.214,0.28236,GOBP_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,0.945890633130963
HP_ABSENT_SPERM_FLAGELLA,SET,23,0.098474,0.0034815,0.17101,0.28237,HP_ABSENT_SPERM_FLAGELLA,0.945890633130963
MORF_PPP1CC,SET,146,0.039167,0.0034771,0.068029,0.2824,MORF_PPP1CC,0.945890633130963
GOBP_RNA_LOCALIZATION,SET,180,0.033679,0.0033167,0.058503,0.28242,GOBP_RNA_LOCALIZATION,0.945890633130963
GOCC_AGGRESOME,SET,30,0.088478,0.0035718,0.15379,0.28255,GOCC_AGGRESOME,0.946087893369262
WP_HIPPOMERLIN_SIGNALING_DYS...,SET,113,0.05028,0.0039305,0.087403,0.28256,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,0.946087893369262
GNF2_TTK,SET,39,0.075575,0.0034778,0.13141,0.28261,GNF2_TTK,0.946087893369262
GOBP_NEGATIVE_REGULATION_OF_...366,SET,31,0.086826,0.003563,0.15099,0.28264,GOBP_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY,0.946087893369262
HP_SCHIZOPHRENIA,SET,61,0.072495,0.0041697,0.12608,0.28265,HP_SCHIZOPHRENIA,0.946087893369262
HP_CONSPICUOUSLY_HAPPY_DISPO...,SET,5,0.28623,0.0047205,0.49789,0.28269,HP_CONSPICUOUSLY_HAPPY_DISPOSITION,0.946087893369262
HP_EPIDERMOID_CYST,SET,15,0.1158,0.0033069,0.20143,0.28269,HP_EPIDERMOID_CYST,0.946087893369262
GOBP_MUSCLE_ORGAN_DEVELOPMENT,SET,328,0.028454,0.0037673,0.049516,0.28277,GOBP_MUSCLE_ORGAN_DEVELOPMENT,0.946087893369262
GSE7764_NKCELL_VS_SPLENOCYTE...2,SET,184,0.037957,0.0037789,0.066059,0.28279,GSE7764_NKCELL_VS_SPLENOCYTE_UP,0.946087893369262
SHEDDEN_LUNG_CANCER_GOOD_SUR...3,SET,64,0.061869,0.0036447,0.10768,0.2828,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,0.946087893369262
REACTOME_CELLULAR_SENESCENCE,SET,122,0.044824,0.00364,0.078027,0.28283,REACTOME_CELLULAR_SENESCENCE,0.946087893369262
FOXD3_01,SET,179,0.038676,0.0037983,0.067323,0.28283,FOXD3_01,0.946087893369262
JIANG_AGING_CEREBRAL_CORTEX_...2,SET,31,0.09241,0.0037922,0.16088,0.28285,JIANG_AGING_CEREBRAL_CORTEX_UP,0.946087893369262
HP_POLYCYSTIC_KIDNEY_DYSPLAS...,SET,48,0.07154,0.0036514,0.12455,0.28286,HP_POLYCYSTIC_KIDNEY_DYSPLASIA,0.946087893369262
GOBP_NEGATIVE_REGULATION_OF_...62,SET,7,0.20437,0.0039878,0.35593,0.28292,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.946104620192308
REACTOME_TRAFFICKING_OF_GLUR...,SET,15,0.13412,0.0038301,0.23359,0.28293,REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS,0.946104620192308
GOBP_CARBON_CATABOLITE_REGUL...,SET,7,0.16284,0.0031774,0.28368,0.28298,GOBP_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION,0.946104620192308
GSE15767_MED_VS_SCS_MAC_LN_UP,SET,176,0.039127,0.0038106,0.06818,0.28303,GSE15767_MED_VS_SCS_MAC_LN_UP,0.946104620192308
REACTOME_COENZYME_A_BIOSYNTH...,SET,7,0.17033,0.0033235,0.29682,0.28304,REACTOME_COENZYME_A_BIOSYNTHESIS,0.946104620192308
HP_ABNORMAL_FEMORAL_HEAD_MOR...,SET,87,0.052526,0.0036054,0.091531,0.28304,HP_ABNORMAL_FEMORAL_HEAD_MORPHOLOGY,0.946104620192308
MIR4715_5P,SET,39,0.081135,0.0037336,0.14142,0.28309,MIR4715_5P,0.946104620192308
GOBP_TRANSFERRIN_TRANSPORT,SET,10,0.15369,0.003584,0.26788,0.28309,GOBP_TRANSFERRIN_TRANSPORT,0.946104620192308
HP_NEOPLASM_OF_THE_ADRENAL_C...,SET,26,0.10619,0.0039913,0.18511,0.28311,HP_NEOPLASM_OF_THE_ADRENAL_CORTEX,0.946104620192308
HP_ABSENT_TOENAIL,SET,17,0.11506,0.0034979,0.20078,0.2833,HP_ABSENT_TOENAIL,0.946136115107914
HP_DIAPHRAGMATIC_PARALYSIS,SET,6,0.20952,0.0037852,0.36562,0.28331,HP_DIAPHRAGMATIC_PARALYSIS,0.946136115107914
HP_MULTIPLE_JOINT_DISLOCATION,SET,7,0.15606,0.0030452,0.27234,0.28331,HP_MULTIPLE_JOINT_DISLOCATION,0.946136115107914
GOBP_HYDROGEN_SULFIDE_METABO...,SET,4,0.23642,0.0034876,0.41263,0.28334,GOBP_HYDROGEN_SULFIDE_METABOLIC_PROCESS,0.946136115107914
GOBP_REGULATED_EXOCYTOSIS,SET,210,0.033704,0.0035821,0.058828,0.28335,GOBP_REGULATED_EXOCYTOSIS,0.946136115107914
HP_ANIRIDIA,SET,41,0.076775,0.0036222,0.134,0.28335,HP_ANIRIDIA,0.946136115107914
GOCC_PLATELET_ALPHA_GRANULE,SET,81,0.058226,0.003857,0.10166,0.28341,GOCC_PLATELET_ALPHA_GRANULE,0.946136115107914
GOBP_REGULATION_OF_GOLGI_TO_...,SET,8,0.16454,0.0034323,0.28732,0.28343,GOBP_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.946136115107914
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,SET,55,0.067305,0.0036765,0.11754,0.28346,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,0.946136115107914
GOBP_VENTRICULAR_CARDIAC_MUS...2,SET,10,0.18239,0.0042534,0.31864,0.28353,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.946136115107914
HP_MACRODONTIA_OF_PERMANENT_...,SET,12,0.1564,0.0039953,0.27326,0.28354,HP_MACRODONTIA_OF_PERMANENT_MAXILLARY_CENTRAL_INCISOR,0.946136115107914
KEGG_CELL_ADHESION_MOLECULES...,SET,119,0.050046,0.0040141,0.087449,0.28357,KEGG_CELL_ADHESION_MOLECULES_CAMS,0.946136115107914
VANGURP_PANCREATIC_ALPHA_CELL,SET,38,0.086589,0.0039333,0.15131,0.28358,VANGURP_PANCREATIC_ALPHA_CELL,0.946136115107914
GOBP_DETECTION_OF_VISIBLE_LI...,SET,43,0.075481,0.0036468,0.13194,0.28363,GOBP_DETECTION_OF_VISIBLE_LIGHT,0.946136115107914
HP_FEW_CAFE_AU_LAIT_SPOTS,SET,6,0.20184,0.0036463,0.35281,0.28364,HP_FEW_CAFE_AU_LAIT_SPOTS,0.946136115107914
GOBP_INNERVATION,SET,26,0.10847,0.0040769,0.18963,0.28366,GOBP_INNERVATION,0.946136115107914
GSE19401_PAM2CSK4_VS_RETINOI...4,SET,179,0.035787,0.0035146,0.062564,0.28366,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.946136115107914
GSE2770_UNTREATED_VS_ACT_CD4...6,SET,180,0.036689,0.0036132,0.064143,0.28367,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP,0.946136115107914
MODULE_395,SET,12,0.13754,0.0035133,0.24047,0.28369,MODULE_395,0.946136115107914
LIANG_SILENCED_BY_METHYLATIO...1,SET,45,0.077037,0.0038073,0.13473,0.28374,LIANG_SILENCED_BY_METHYLATION_2,0.946136115107914
GOMF_COMPLEMENT_RECEPTOR_ACT...,SET,10,0.19924,0.0046463,0.34846,0.28374,GOMF_COMPLEMENT_RECEPTOR_ACTIVITY,0.946136115107914
HELLER_HDAC_TARGETS_SILENCED...2,SET,371,0.026414,0.0037149,0.0462,0.28376,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,0.946136115107914
HP_ABLEPHARON,SET,5,0.22944,0.0037839,0.40135,0.28378,HP_ABLEPHARON,0.946136115107914
HENDRICKS_SMARCA4_TARGETS_DN,SET,41,0.082067,0.0038719,0.14357,0.2838,HENDRICKS_SMARCA4_TARGETS_DN,0.946136115107914
GSE17721_CTRL_VS_POLYIC_2H_B...1,SET,189,0.035523,0.0035839,0.062146,0.2838,GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN,0.946136115107914
GOBP_DEVELOPMENTAL_GROWTH,SET,587,0.021401,0.0037632,0.037451,0.28385,GOBP_DEVELOPMENTAL_GROWTH,0.946212042010359
GOBP_REGULATION_OF_SNRNA_TRA...,SET,5,0.18233,0.003007,0.31923,0.28395,GOBP_REGULATION_OF_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.946373084667753
GSE17721_PAM3CSK4_VS_CPG_8H_...1,SET,183,0.035339,0.0035087,0.061879,0.28397,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN,0.946373084667753
GSE28726_ACT_CD4_TCELL_VS_AC...3,SET,185,0.036443,0.0036379,0.063816,0.28398,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN,0.946373084667753
GOBP_RESPONSE_TO_GAMMA_RADIA...,SET,47,0.068156,0.0034423,0.1194,0.28407,GOBP_RESPONSE_TO_GAMMA_RADIATION,0.946404874558809
REACTOME_VLDLR_INTERNALISATI...,SET,15,0.12182,0.003479,0.21344,0.28408,REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,0.946404874558809
GOBP_CYTOKINE_MEDIATED_SIGNA...,SET,472,0.024484,0.0038731,0.042907,0.28413,GOBP_CYTOKINE_MEDIATED_SIGNALING_PATHWAY,0.946404874558809
GSE15330_HSC_VS_GRANULOCYTE_...4,SET,185,0.033531,0.0033473,0.058769,0.28415,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.946404874558809
GOBP_REGULATION_OF_INFLAMMAT...3,SET,10,0.15956,0.0037209,0.27972,0.2842,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.946404874558809
DODD_NASOPHARYNGEAL_CARCINOM...2,SET,1247,0.014175,0.0035648,0.024854,0.28423,DODD_NASOPHARYNGEAL_CARCINOMA_UP,0.946404874558809
GSE17721_LPS_VS_PAM3CSK4_8H_...2,SET,182,0.035867,0.0035515,0.062889,0.28423,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP,0.946404874558809
HP_OROMANDIBULAR_DYSTONIA,SET,18,0.10573,0.0033074,0.1854,0.28424,HP_OROMANDIBULAR_DYSTONIA,0.946404874558809
HAN_SATB1_TARGETS_UP,SET,388,0.026141,0.0037579,0.045841,0.28426,HAN_SATB1_TARGETS_UP,0.946404874558809
MORF_CD8A,SET,111,0.049829,0.0038608,0.087385,0.28427,MORF_CD8A,0.946404874558809
GOBP_LEUKOTRIENE_TRANSPORT,SET,7,0.19849,0.003873,0.34822,0.28434,GOBP_LEUKOTRIENE_TRANSPORT,0.946404874558809
GOBP_REGULATION_OF_MEIOTIC_C...1,SET,63,0.061028,0.003567,0.10707,0.28435,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.946404874558809
HP_APNEA,SET,213,0.032992,0.0035311,0.057889,0.28437,HP_APNEA,0.946404874558809
HP_NARROW_JAW,SET,13,0.13205,0.0035108,0.23177,0.28443,HP_NARROW_JAW,0.946404874558809
GGTGTGT_MIR329,SET,103,0.052665,0.0039316,0.092473,0.28451,GGTGTGT_MIR329,0.946404874558809
KEGG_VIRAL_MYOCARDITIS,SET,64,0.065815,0.0038771,0.1156,0.28456,KEGG_VIRAL_MYOCARDITIS,0.946404874558809
MYLLYKANGAS_AMPLIFICATION_HO...15,SET,6,0.20326,0.003672,0.35709,0.28461,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5,0.946404874558809
HP_PERIVENTRICULAR_HETEROTOP...,SET,37,0.073889,0.003312,0.12982,0.28462,HP_PERIVENTRICULAR_HETEROTOPIA,0.946404874558809
GOBP_DICARBOXYLIC_ACID_CATAB...,SET,17,0.11331,0.0034445,0.19908,0.28463,GOBP_DICARBOXYLIC_ACID_CATABOLIC_PROCESS,0.946404874558809
GOBP_NEGATIVE_REGULATION_OF_...321,SET,46,0.067121,0.0033539,0.11794,0.28464,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.946404874558809
AGUIRRE_PANCREATIC_CANCER_CO...2,SET,271,0.031483,0.0037948,0.055337,0.2847,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,0.946404874558809
REACTOME_DOPAMINE_CLEARANCE_...,SET,3,0.36031,0.0046032,0.63333,0.28471,REACTOME_DOPAMINE_CLEARANCE_FROM_THE_SYNAPTIC_CLEFT,0.946404874558809
GOBP_GLUTATHIONE_TRANSPORT,SET,9,0.17357,0.0038402,0.30512,0.28473,GOBP_GLUTATHIONE_TRANSPORT,0.946404874558809
GOBP_T_HELPER_1_CELL_DIFFERE...,SET,23,0.11181,0.003953,0.19655,0.28473,GOBP_T_HELPER_1_CELL_DIFFERENTIATION,0.946404874558809
GSE2706_UNSTIM_VS_2H_LPS_DC_...2,SET,155,0.03631,0.0033205,0.063829,0.28473,GSE2706_UNSTIM_VS_2H_LPS_DC_UP,0.946404874558809
HINATA_NFKB_TARGETS_FIBROBLA...,SET,80,0.056746,0.0037358,0.099783,0.28478,HINATA_NFKB_TARGETS_FIBROBLAST_UP,0.946404874558809
GSE19888_CTRL_VS_A3R_INHIBIT...2,SET,179,0.034113,0.0033503,0.05999,0.2848,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP,0.946404874558809
GOBP_NUCLEAR_MEMBRANE_ORGANI...,SET,44,0.071278,0.0034835,0.12535,0.28481,GOBP_NUCLEAR_MEMBRANE_ORGANIZATION,0.946404874558809
RORIE_TARGETS_OF_EWSR1_FLI1_...1,SET,25,0.10923,0.0040259,0.19211,0.28482,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.946404874558809
COLINA_TARGETS_OF_4EBP1_AND_...,SET,319,0.027955,0.0036509,0.049178,0.28487,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,0.946404874558809
GOBP_REGULATION_OF_POTASSIUM...4,SET,87,0.056549,0.0038815,0.099503,0.28491,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.946404874558809
MAFG_TARGET_GENES,SET,1315,0.013673,0.0035242,0.024063,0.28494,MAFG_TARGET_GENES,0.946404874558809
GSE14386_UNTREATED_VS_IFNA_T...1,SET,149,0.041016,0.0036782,0.072184,0.28495,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN,0.946404874558809
GSE17974_CTRL_VS_ACT_IL4_AND...18,SET,172,0.037597,0.0036202,0.066174,0.28497,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP,0.946404874558809
HP_ABNORMALITY_OF_MASSETER_M...,SET,5,0.22764,0.0037543,0.40073,0.285,HP_ABNORMALITY_OF_MASSETER_MUSCLE,0.946404874558809
GOBP_POSITIVE_REGULATION_OF_...387,SET,11,0.13912,0.0034025,0.24496,0.28505,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.946404874558809
GOBP_SEQUESTERING_OF_TRIGLYC...,SET,18,0.12321,0.003854,0.217,0.2851,GOBP_SEQUESTERING_OF_TRIGLYCERIDE,0.946404874558809
PEPPER_CHRONIC_LYMPHOCYTIC_L...2,SET,29,0.096699,0.0038382,0.17034,0.28513,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.946404874558809
GOBP_POSITIVE_REGULATION_OF_...280,SET,9,0.17537,0.0038799,0.30895,0.28514,GOBP_POSITIVE_REGULATION_OF_FEEDING_BEHAVIOR,0.946404874558809
MIR5193,SET,158,0.038827,0.0035846,0.068413,0.28518,MIR5193,0.946404874558809
MIR7160_5P,SET,171,0.037662,0.0036159,0.066366,0.2852,MIR7160_5P,0.946404874558809
GSE13522_CTRL_VS_T_CRUZI_G_S...1,SET,121,0.044958,0.0036359,0.079228,0.28521,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN,0.946404874558809
GOMF_LIPOPEPTIDE_BINDING,SET,10,0.21848,0.0050949,0.38507,0.28524,GOMF_LIPOPEPTIDE_BINDING,0.946404874558809
GSE15659_NAIVE_CD4_TCELL_VS_...5,SET,171,0.036207,0.0034763,0.063825,0.28526,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN,0.946404874558809
WP_AEROBIC_GLYCOLYSIS,SET,10,0.12351,0.0028802,0.21773,0.28528,WP_AEROBIC_GLYCOLYSIS,0.946404874558809
GOBP_REGULATION_OF_CELLULAR_...13,SET,70,0.05693,0.0035068,0.10037,0.28528,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.946404874558809
HP_CRUMPLED_LONG_BONES,SET,6,0.1879,0.0033946,0.33127,0.28529,HP_CRUMPLED_LONG_BONES,0.946404874558809
GSE3982_EOSINOPHIL_VS_NKCELL...2,SET,179,0.036769,0.0036111,0.064832,0.28531,GSE3982_EOSINOPHIL_VS_NKCELL_UP,0.946404874558809
HP_HYPOCALCEMIC_SEIZURES,SET,12,0.14666,0.0037464,0.25863,0.28533,HP_HYPOCALCEMIC_SEIZURES,0.946404874558809
BIOCARTA_STRESS_PATHWAY,SET,23,0.10256,0.003626,0.18091,0.28539,BIOCARTA_STRESS_PATHWAY,0.946404874558809
LI_ESTROGENE_EARLY_E2_RESPON...2,SET,82,0.05681,0.0037863,0.10022,0.28542,LI_ESTROGENE_EARLY_E2_RESPONSE_UP,0.946404874558809
GOBP_NEGATIVE_REGULATION_OF_...104,SET,11,0.13083,0.0031997,0.23082,0.28543,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.946404874558809
GOBP_STRIATED_MUSCLE_CELL_PR...,SET,67,0.062719,0.00378,0.11067,0.28545,GOBP_STRIATED_MUSCLE_CELL_PROLIFERATION,0.946404874558809
GSE37532_TREG_VS_TCONV_PPARG...4,SET,187,0.035275,0.0035401,0.062246,0.28546,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,0.946404874558809
MODULE_96,SET,36,0.08937,0.0039516,0.15774,0.28551,MODULE_96,0.94643240987984
GSE2706_2H_VS_8H_R848_AND_LP...1,SET,177,0.037075,0.0036209,0.065449,0.28554,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN,0.94643240987984
GOBP_NEGATIVE_REGULATION_OF_...175,SET,6,0.22375,0.0040422,0.39502,0.28555,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.94643240987984
HP_ABNORMAL_U_WAVE,SET,5,0.24832,0.0040954,0.43869,0.28568,HP_ABNORMAL_U_WAVE,0.946748998855835
BIOCARTA_TSP1_PATHWAY,SET,7,0.20366,0.003974,0.35983,0.2857,BIOCARTA_TSP1_PATHWAY,0.946748998855835
MIR4485_5P,SET,7,0.18675,0.0036441,0.33017,0.28583,MIR4485_5P,0.946928165460777
GSE24574_BCL6_HIGH_VS_LOW_TF...1,SET,182,0.034802,0.0034461,0.061549,0.28589,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN,0.946928165460777
GOBP_POSITIVE_REGULATION_OF_...764,SET,6,0.2029,0.0036655,0.35886,0.28591,GOBP_POSITIVE_REGULATION_OF_TOOTH_MINERALIZATION,0.946928165460777
DESCARTES_FETAL_INTESTINE_LY...1,SET,26,0.10166,0.003821,0.17984,0.28594,DESCARTES_FETAL_INTESTINE_LYMPHATIC_ENDOTHELIAL_CELLS,0.946928165460777
HP_ABNORMAL_LYMPHATIC_VESSEL...,SET,16,0.12493,0.0036847,0.22106,0.28598,HP_ABNORMAL_LYMPHATIC_VESSEL_MORPHOLOGY,0.946928165460777
RYTTCCTG_ETS2_B,SET,1009,0.016087,0.0036645,0.028472,0.28603,RYTTCCTG_ETS2_B,0.946928165460777
GSE45365_NK_CELL_VS_BCELL_DN,SET,126,0.04492,0.0037066,0.079511,0.28606,GSE45365_NK_CELL_VS_BCELL_DN,0.946928165460777
MNX1_TARGET_GENES,SET,8,0.16887,0.0035226,0.29894,0.28607,MNX1_TARGET_GENES,0.946928165460777
BIOCARTA_RARRXR_PATHWAY,SET,7,0.16678,0.0032544,0.29527,0.28609,BIOCARTA_RARRXR_PATHWAY,0.946928165460777
ACACTGG_MIR199A_MIR199B,SET,140,0.041314,0.0035921,0.073142,0.28609,ACACTGG_MIR199A_MIR199B,0.946928165460777
GOMF_CHEMOREPELLENT_ACTIVITY,SET,28,0.097068,0.0037859,0.17185,0.28609,GOMF_CHEMOREPELLENT_ACTIVITY,0.946928165460777
HP_CONGENITAL_MUSCULAR_TORTI...,SET,6,0.20455,0.0036954,0.36215,0.2861,HP_CONGENITAL_MUSCULAR_TORTICOLLIS,0.946928165460777
BIOCARTA_ATRBRCA_PATHWAY,SET,21,0.092607,0.0031286,0.16399,0.28614,BIOCARTA_ATRBRCA_PATHWAY,0.946928165460777
GOCC_INTERCELLULAR_BRIDGE,SET,83,0.050982,0.0034184,0.090286,0.28615,GOCC_INTERCELLULAR_BRIDGE,0.946928165460777
GOBP_REGULATION_OF_TELOMERAS...,SET,43,0.071976,0.0034775,0.12748,0.28618,GOBP_REGULATION_OF_TELOMERASE_ACTIVITY,0.946928165460777
GOBP_SMOOTH_MUSCLE_CELL_PROL...,SET,131,0.04419,0.0037175,0.078273,0.28619,GOBP_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.946928165460777
MIR652_5P,SET,34,0.08226,0.0035349,0.14583,0.28635,MIR652_5P,0.947066331467603
REACTOME_TELOMERE_EXTENSION_...,SET,22,0.097098,0.0033575,0.1722,0.28643,REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE,0.947066331467603
GOCC_INTERMEDIATE_FILAMENT_C...,SET,208,0.041664,0.0044073,0.0739,0.28645,GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON,0.947066331467603
GOMF_PROTEIN_KINASE_ACTIVITY,SET,534,0.021331,0.0035829,0.03784,0.28648,GOMF_PROTEIN_KINASE_ACTIVITY,0.947066331467603
HP_MYOFIBER_DISARRAY,SET,10,0.14432,0.0033655,0.25604,0.2865,HP_MYOFIBER_DISARRAY,0.947066331467603
HP_ABNORMAL_ENDOMETRIUM_MORP...,SET,28,0.082213,0.0032066,0.14589,0.28653,HP_ABNORMAL_ENDOMETRIUM_MORPHOLOGY,0.947066331467603
MIR3609,SET,324,0.027424,0.0036091,0.048681,0.2866,MIR3609,0.947066331467603
GOBP_PROTEIN_RETENTION_IN_GO...,SET,5,0.23328,0.0038473,0.41411,0.28661,GOBP_PROTEIN_RETENTION_IN_GOLGI_APPARATUS,0.947066331467603
KEGG_MEDICUS_VARIANT_PAX8_PP...,SET,5,0.21267,0.0035073,0.37754,0.28662,KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION,0.947066331467603
HP_LIMITED_PRONATION_SUPINAT...,SET,11,0.16818,0.0041133,0.29859,0.28663,HP_LIMITED_PRONATION_SUPINATION_OF_FOREARM,0.947066331467603
GOBP_NEGATIVE_REGULATION_OF_...84,SET,387,0.025535,0.0036663,0.045342,0.28666,GOBP_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.947066331467603
HP_PERIVENTRICULAR_CYSTS,SET,12,0.1423,0.0036349,0.25278,0.28675,HP_PERIVENTRICULAR_CYSTS,0.947066331467603
GSE31082_DP_VS_CD8_SP_THYMOC...2,SET,180,0.033627,0.0033116,0.059745,0.28677,GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP,0.947066331467603
HNF1_01,SET,219,0.035704,0.0038743,0.063445,0.2868,HNF1_01,0.947066331467603
HP_NEOPLASM_OF_THE_PARATHYRO...,SET,18,0.12267,0.0038371,0.21797,0.2868,HP_NEOPLASM_OF_THE_PARATHYROID_GLAND,0.947066331467603
REACTOME_ORGANIC_ANION_TRANS...2,SET,12,0.1486,0.0037959,0.26412,0.28685,REACTOME_ORGANIC_ANION_TRANSPORTERS,0.947066331467603
MIR1257,SET,88,0.052132,0.0035988,0.092661,0.28685,MIR1257,0.947066331467603
RUBENSTEIN_SKELETAL_MUSCLE_N...,SET,198,0.034525,0.0035642,0.06137,0.28687,RUBENSTEIN_SKELETAL_MUSCLE_NK_CELLS,0.947066331467603
GSE21546_WT_VS_ELK1_KO_ANTI_...2,SET,183,0.035222,0.0034972,0.062613,0.28688,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.947066331467603
GOMF_GUANYL_RIBONUCLEOTIDE_B...,SET,342,0.026236,0.0035455,0.046642,0.28689,GOMF_GUANYL_RIBONUCLEOTIDE_BINDING,0.947066331467603
GOBP_RESPONSE_TO_DIETARY_EXC...,SET,33,0.090336,0.0038245,0.16065,0.28695,GOBP_RESPONSE_TO_DIETARY_EXCESS,0.947066331467603
DUTERTRE_ESTRADIOL_RESPONSE_...4,SET,209,0.033584,0.003561,0.059727,0.28696,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,0.947066331467603
BIOCARTA_STAT3_PATHWAY,SET,8,0.20074,0.0041874,0.35706,0.28699,BIOCARTA_STAT3_PATHWAY,0.947066331467603
GOCC_ORGANELLE_SUBCOMPARTMENT,SET,1359,0.013599,0.0035587,0.024189,0.287,GOCC_ORGANELLE_SUBCOMPARTMENT,0.947066331467603
MIR520A_5P,SET,146,0.039507,0.0035073,0.070289,0.28704,MIR520A_5P,0.947066331467603
GOBP_POSITIVE_REGULATION_OF_...65,SET,32,0.091866,0.00383,0.16344,0.28704,GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.947066331467603
GSE2706_LPS_VS_R848_AND_LPS_...1,SET,128,0.044642,0.0037127,0.07945,0.2871,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN,0.947066331467603
GSE15659_CD45RA_NEG_CD4_TCEL...6,SET,159,0.039074,0.0036187,0.069551,0.28713,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP,0.947066331467603
HP_GENERALIZED_CLONIC_SEIZURE,SET,28,0.095425,0.0037219,0.16987,0.28714,HP_GENERALIZED_CLONIC_SEIZURE,0.947066331467603
WP_PTF1A_RELATED_REGULATORY_...,SET,11,0.16497,0.0040348,0.2937,0.28716,WP_PTF1A_RELATED_REGULATORY_PATHWAY,0.947066331467603
MIR15B_3P,SET,73,0.057991,0.0036476,0.10327,0.28721,MIR15B_3P,0.947066331467603
GOBP_POSITIVE_REGULATION_OF_...10,SET,26,0.099077,0.0037239,0.17643,0.28721,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.947066331467603
GOBP_REGULATION_OF_COPII_VES...,SET,5,0.17525,0.0028902,0.31208,0.28722,GOBP_REGULATION_OF_COPII_VESICLE_COATING,0.947066331467603
GOCC_FANCONI_ANAEMIA_NUCLEAR...,SET,7,0.15526,0.0030296,0.2765,0.28722,GOCC_FANCONI_ANAEMIA_NUCLEAR_COMPLEX,0.947066331467603
WP_MET_IN_TYPE_1_PAPILLARY_R...,SET,53,0.067465,0.0036177,0.12015,0.28724,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,0.947066331467603
GOMF_ISOCITRATE_DEHYDROGENAS...,SET,4,0.24747,0.0036505,0.44075,0.28724,GOMF_ISOCITRATE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.947066331467603
HP_ELEVATED_CIRCULATING_CREA...,SET,265,0.028981,0.0034549,0.051615,0.28724,HP_ELEVATED_CIRCULATING_CREATINE_KINASE_CONCENTRATION,0.947066331467603
MAGRANGEAS_MULTIPLE_MYELOMA_...3,SET,22,0.10412,0.0036003,0.18553,0.28733,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,0.947249288627525
GOBP_REGULATION_OF_MAST_CELL...4,SET,25,0.10397,0.0038321,0.18528,0.28735,GOBP_REGULATION_OF_MAST_CELL_DEGRANULATION,0.947249288627525
GOBP_TRICARBOXYLIC_ACID_CYCLE,SET,28,0.083982,0.0032755,0.1497,0.2874,GOBP_TRICARBOXYLIC_ACID_CYCLE,0.947267382645804
KEGG_MEDICUS_VARIANT_MUTATIO...36,SET,6,0.19077,0.0034464,0.34006,0.28741,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION,0.947267382645804
HP_APLASIA_HYPOPLASIA_OF_THE...2,SET,15,0.12409,0.0035437,0.2213,0.28749,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_FINGER,0.947273822609684
chr20p13,SET,78,0.11378,0.007397,0.20293,0.28751,chr20p13,0.947273822609684
KEGG_CHEMOKINE_SIGNALING_PAT...,SET,176,0.038563,0.0037557,0.068789,0.28754,KEGG_CHEMOKINE_SIGNALING_PATHWAY,0.947273822609684
GOBP_CELLULAR_RESPONSE_TO_GO...,SET,17,0.13337,0.0040545,0.23791,0.28754,GOBP_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS,0.947273822609684
GSE16755_CTRL_VS_IFNA_TREATE...2,SET,179,0.033654,0.0033051,0.060048,0.28759,GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP,0.947273822609684
REACTOME_GPCR_LIGAND_BINDING,SET,426,0.026458,0.0039812,0.047217,0.28762,REACTOME_GPCR_LIGAND_BINDING,0.947273822609684
DESCARTES_FETAL_KIDNEY_METAN...,SET,110,0.050952,0.0039301,0.090929,0.28762,DESCARTES_FETAL_KIDNEY_METANEPHRIC_CELLS,0.947273822609684
MIR4644,SET,274,0.029681,0.003597,0.052969,0.28763,MIR4644,0.947273822609684
GOBP_SPINAL_CORD_OLIGODENDRO...,SET,5,0.26005,0.0042887,0.46421,0.28768,GOBP_SPINAL_CORD_OLIGODENDROCYTE_CELL_DIFFERENTIATION,0.947324822359072
GOBP_GLYCEROPHOSPHOLIPID_BIO...,SET,190,0.034073,0.0034466,0.060833,0.2877,GOBP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.947324822359072
HP_IMPACTED_TOOTH,SET,6,0.21498,0.0038837,0.38395,0.28778,HP_IMPACTED_TOOTH,0.947344023118128
GCM_BECN1,SET,62,0.056755,0.0032909,0.10143,0.2879,GCM_BECN1,0.947344023118128
MIR4524B_3P,SET,65,0.063321,0.0037591,0.11319,0.28793,MIR4524B_3P,0.947344023118128
GOMF_BMP_BINDING,SET,18,0.11864,0.0037111,0.21206,0.28793,GOMF_BMP_BINDING,0.947344023118128
MODULE_257,SET,153,0.036237,0.0032926,0.064792,0.28799,MODULE_257,0.947344023118128
BEGUM_TARGETS_OF_PAX3_FOXO1_...1,SET,7,0.2156,0.0042069,0.38556,0.28802,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3,0.947344023118128
GSE23321_CD8_STEM_CELL_MEMOR...5,SET,178,0.034915,0.0034195,0.062443,0.28803,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.947344023118128
GSE12963_UNINF_VS_ENV_AND_NE...3,SET,129,0.042901,0.0035817,0.076769,0.28814,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.947344023118128
SOBOLEV_PBMC_PANDEMRIX_AGE_1...2,SET,32,0.096378,0.0040182,0.17249,0.28817,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN,0.947344023118128
REACTOME_CHYLOMICRON_ASSEMBLY,SET,10,0.15179,0.0035399,0.27168,0.28818,REACTOME_CHYLOMICRON_ASSEMBLY,0.947344023118128
REACTOME_SPECIFICATION_OF_TH...,SET,16,0.13606,0.0040128,0.24353,0.28819,REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER,0.947344023118128
NOJIMA_SFRP2_TARGETS_DN,SET,23,0.112,0.0039597,0.20049,0.28821,NOJIMA_SFRP2_TARGETS_DN,0.947344023118128
TCF11_01,SET,225,0.033051,0.0036346,0.059166,0.28821,TCF11_01,0.947344023118128
MIR548AJ_3P_MIR548X_3P,SET,835,0.016986,0.0035375,0.030414,0.28826,MIR548AJ_3P_MIR548X_3P,0.947344023118128
GSE17186_NAIVE_VS_CD21LOW_TR...1,SET,187,0.034985,0.003511,0.062652,0.28829,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.947344023118128
MIR7151_3P,SET,250,0.030014,0.0034767,0.053754,0.2883,MIR7151_3P,0.947344023118128
GAUSSMANN_MLL_AF4_FUSION_TAR...10,SET,90,0.052942,0.0036958,0.09485,0.28837,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,0.947344023118128
WP_OSTEOBLAST_DIFFERENTIATIO...,SET,116,0.048825,0.0038667,0.087472,0.28837,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,0.947344023118128
RORA1_01,SET,219,0.032703,0.0035486,0.058593,0.28838,RORA1_01,0.947344023118128
HP_ABNORMALITY_OF_THROMBOCYT...,SET,426,0.023493,0.003535,0.042098,0.28841,HP_ABNORMALITY_OF_THROMBOCYTES,0.947344023118128
MORF_BCL2,SET,208,0.0337,0.0035648,0.060396,0.28843,MORF_BCL2,0.947344023118128
GSE37532_TREG_VS_TCONV_CD4_T...2,SET,181,0.034345,0.0033916,0.061572,0.28849,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP,0.947344023118128
GAUSSMANN_MLL_AF4_FUSION_TAR...6,SET,157,0.036963,0.0034018,0.066267,0.2885,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,0.947344023118128
GOBP_MACROMOLECULE_CATABOLIC...,SET,1247,0.013615,0.003424,0.024412,0.28853,GOBP_MACROMOLECULE_CATABOLIC_PROCESS,0.947344023118128
MIR4646_5P,SET,133,0.040863,0.0034636,0.073298,0.2886,MIR4646_5P,0.947344023118128
MIR5689,SET,137,0.042373,0.0036448,0.076007,0.2886,MIR5689,0.947344023118128
GOBP_ORGANELLE_ASSEMBLY,SET,914,0.015653,0.0034028,0.02808,0.28862,GOBP_ORGANELLE_ASSEMBLY,0.947344023118128
REACTOME_RHOA_GTPASE_CYCLE,SET,138,0.041915,0.0036185,0.075213,0.28867,REACTOME_RHOA_GTPASE_CYCLE,0.947344023118128
REACTOME_DUAL_INCISION_IN_TC...,SET,60,0.054026,0.0030819,0.09695,0.28868,REACTOME_DUAL_INCISION_IN_TC_NER,0.947344023118128
GOBP_ORGANIC_ANION_TRANSPORT,SET,425,0.024424,0.0036709,0.043834,0.2887,GOBP_ORGANIC_ANION_TRANSPORT,0.947344023118128
PRC1_BMI_UP.V1_UP,SET,162,0.039115,0.0036562,0.070212,0.28873,PRC1_BMI_UP.V1_UP,0.947344023118128
BAKER_HEMATOPOESIS_STAT5_TAR...,SET,7,0.21232,0.0041428,0.38113,0.28874,BAKER_HEMATOPOESIS_STAT5_TARGETS,0.947344023118128
KEGG_CARDIAC_MUSCLE_CONTRACT...,SET,68,0.058245,0.0035364,0.10459,0.2888,KEGG_CARDIAC_MUSCLE_CONTRACTION,0.947344023118128
WP_KYNURENINE_PATHWAY_AND_LI...,SET,24,0.10454,0.0037752,0.18774,0.28883,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,0.947344023118128
GOBP_PRIMARY_MIRNA_PROCESSING,SET,18,0.10238,0.0032026,0.18387,0.28883,GOBP_PRIMARY_MIRNA_PROCESSING,0.947344023118128
HP_ABNORMAL_GLOBUS_PALLIDUS_...,SET,21,0.10349,0.0034962,0.18585,0.28883,HP_ABNORMAL_GLOBUS_PALLIDUS_MORPHOLOGY,0.947344023118128
WATANABE_ULCERATIVE_COLITIS_...2,SET,17,0.114,0.0034657,0.20478,0.28887,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,0.947344023118128
GSE15750_WT_VS_TRAF6KO_DAY6_...2,SET,176,0.034439,0.003354,0.061881,0.28893,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP,0.947344023118128
GOBP_AZOLE_TRANSMEMBRANE_TRA...,SET,13,0.14001,0.0037225,0.25169,0.28901,GOBP_AZOLE_TRANSMEMBRANE_TRANSPORT,0.947344023118128
REACTOME_DEFECTIVE_CHST3_CAU...,SET,7,0.16394,0.0031989,0.29477,0.28905,REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD,0.947344023118128
REACTOME_HIV_LIFE_CYCLE,SET,138,0.03606,0.003113,0.064845,0.28908,REACTOME_HIV_LIFE_CYCLE,0.947344023118128
GAVISH_3CA_MALIGNANT_METAPRO...3,SET,42,0.081895,0.0039106,0.14727,0.28908,GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1,0.947344023118128
CHASSOT_SKIN_WOUND,SET,9,0.18292,0.004047,0.329,0.28911,CHASSOT_SKIN_WOUND,0.947344023118128
YAO_TEMPORAL_RESPONSE_TO_PRO...15,SET,71,0.062218,0.0038597,0.11192,0.28914,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,0.947344023118128
GOBP_CELLULAR_CATABOLIC_PROC...,SET,1035,0.015187,0.0035012,0.027322,0.28915,GOBP_CELLULAR_CATABOLIC_PROCESS,0.947344023118128
GOBP_LATE_ENDOSOME_TO_LYSOSO...,SET,21,0.10189,0.0034424,0.1833,0.28915,GOBP_LATE_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.947344023118128
GOMF_TRANSMEMBRANE_RECEPTOR_...3,SET,18,0.12112,0.0037885,0.21789,0.28915,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.947344023118128
CREL_01,SET,242,0.031186,0.003555,0.056107,0.28917,CREL_01,0.947344023118128
GOBP_RESPONSE_TO_L_ASCORBIC_...,SET,5,0.24325,0.0040117,0.43772,0.28921,GOBP_RESPONSE_TO_L_ASCORBIC_ACID,0.947344023118128
XIE_LT_HSC_S1PR3_OE_UP,SET,26,0.10022,0.0037669,0.18037,0.28924,XIE_LT_HSC_S1PR3_OE_UP,0.947344023118128
GOBP_DNA_METHYLATION_DEPENDE...,SET,30,0.087608,0.0035367,0.15769,0.28925,GOBP_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.947344023118128
GOBP_REGULATION_OF_MIRNA_MET...,SET,81,0.052433,0.0034733,0.094396,0.2893,GOBP_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.947344023118128
GOBP_UTERUS_MORPHOGENESIS,SET,6,0.19324,0.0034909,0.34792,0.28931,GOBP_UTERUS_MORPHOGENESIS,0.947344023118128
HP_NEUROFIBROMA,SET,19,0.10594,0.0034047,0.19076,0.28933,HP_NEUROFIBROMA,0.947344023118128
MIR656_3P,SET,358,0.025614,0.0035399,0.046146,0.28943,MIR656_3P,0.947344023118128
HP_ESOPHAGITIS,SET,33,0.08903,0.0037693,0.1604,0.28943,HP_ESOPHAGITIS,0.947344023118128
GROSS_HYPOXIA_VIA_HIF1A_ONLY,SET,8,0.18666,0.0038937,0.33636,0.28947,GROSS_HYPOXIA_VIA_HIF1A_ONLY,0.947344023118128
WP_MITOCHONDRIAL_BETAOXIDATI...,SET,8,0.17398,0.003629,0.31353,0.28949,WP_MITOCHONDRIAL_BETAOXIDATION,0.947344023118128
REACTOME_HISTIDINE_CATABOLISM,SET,7,0.1902,0.0037114,0.3428,0.2895,REACTOME_HISTIDINE_CATABOLISM,0.947344023118128
REACTOME_PRESYNAPTIC_NICOTIN...,SET,12,0.15175,0.0038764,0.2735,0.2895,REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.947344023118128
REACTOME_SIGNALING_BY_INTERL...,SET,430,0.023626,0.0035714,0.04258,0.2895,REACTOME_SIGNALING_BY_INTERLEUKINS,0.947344023118128
MIR16_2_3P,SET,205,0.033701,0.0035394,0.060743,0.28952,MIR16_2_3P,0.947344023118128
GSE29614_DAY3_VS_DAY7_TIV_FL...2,SET,144,0.042211,0.0037218,0.076083,0.28952,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.947344023118128
RECHTIEN_PBMC_RVSV_ZEBOV_AGE...,SET,10,0.16224,0.0037834,0.29243,0.28953,RECHTIEN_PBMC_RVSV_ZEBOV_AGE_18_55YO_1DY_UP,0.947344023118128
DESCARTES_FETAL_STOMACH_VASC...,SET,28,0.10103,0.0039405,0.18219,0.28961,DESCARTES_FETAL_STOMACH_VASCULAR_ENDOTHELIAL_CELLS,0.947344023118128
GOMF_DIPHOSPHOTRANSFERASE_AC...,SET,4,0.2255,0.0033264,0.40668,0.28963,GOMF_DIPHOSPHOTRANSFERASE_ACTIVITY,0.947344023118128
CROMER_TUMORIGENESIS_UP,SET,53,0.076666,0.0041112,0.13831,0.28968,CROMER_TUMORIGENESIS_UP,0.947344023118128
YANG_BREAST_CANCER_ESR1_LASE...2,SET,27,0.088765,0.0033998,0.16015,0.2897,YANG_BREAST_CANCER_ESR1_LASER_UP,0.947344023118128
HP_DYSPAREUNIA,SET,34,0.087533,0.0037615,0.15795,0.28973,HP_DYSPAREUNIA,0.947344023118128
GOBP_PROTEIN_TO_MEMBRANE_DOC...,SET,5,0.21361,0.0035228,0.38549,0.28975,GOBP_PROTEIN_TO_MEMBRANE_DOCKING,0.947344023118128
GOCC_GLYCOSYLPHOSPHATIDYLINO...,SET,6,0.19538,0.0035297,0.35259,0.28975,GOCC_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX,0.947344023118128
MORF_ERCC2,SET,98,0.045956,0.0033469,0.08294,0.28976,MORF_ERCC2,0.947344023118128
GOMF_DOPAMINE_RECEPTOR_BINDI...,SET,13,0.12455,0.0033114,0.22485,0.28982,GOMF_DOPAMINE_RECEPTOR_BINDING,0.947344023118128
HP_TONGUE_NODULES,SET,12,0.11414,0.0029156,0.20606,0.28982,HP_TONGUE_NODULES,0.947344023118128
GOBP_POSITIVE_REGULATION_OF_...588,SET,15,0.12767,0.0036458,0.23049,0.28983,GOBP_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.947344023118128
GOBP_PROTEIN_AUTOUBIQUITINAT...,SET,67,0.056815,0.0034242,0.10257,0.28983,GOBP_PROTEIN_AUTOUBIQUITINATION,0.947344023118128
HP_FETAL_POLYURIA,SET,11,0.15576,0.0038097,0.28121,0.28983,HP_FETAL_POLYURIA,0.947344023118128
AMIT_DELAYED_EARLY_GENES,SET,18,0.11846,0.0037055,0.21399,0.28994,AMIT_DELAYED_EARLY_GENES,0.947344023118128
GOBP_NEGATIVE_REGULATION_OF_...307,SET,2,0.40573,0.0042323,0.73291,0.28994,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,0.947344023118128
GSE15930_STIM_VS_STIM_AND_TR...6,SET,180,0.033515,0.0033006,0.060544,0.28994,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP,0.947344023118128
MIR10399_5P,SET,332,0.027095,0.0036088,0.048951,0.28996,MIR10399_5P,0.947344023118128
HP_REDUCED_BRAIN_N_ACETYL_AS...,SET,16,0.10955,0.003231,0.19792,0.28996,HP_REDUCED_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.947344023118128
WP_UROTENSINIIMEDIATED_SIGNA...,SET,66,0.059621,0.0035665,0.10773,0.28998,WP_UROTENSINIIMEDIATED_SIGNALING,0.947344023118128
GOBP_REGULATION_OF_PHOSPHATI...2,SET,10,0.16422,0.0038297,0.29679,0.29002,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,0.947344023118128
HP_SMALL_ANTERIOR_FONTANELLE,SET,6,0.19101,0.0034508,0.34523,0.29004,HP_SMALL_ANTERIOR_FONTANELLE,0.947344023118128
GOBP_RESPONSE_TO_TRANSFORMIN...,SET,255,0.030668,0.0035873,0.055433,0.29005,GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA,0.947344023118128
GOBP_REGULATION_OF_MITOTIC_R...,SET,6,0.16824,0.0030393,0.3042,0.29012,GOBP_REGULATION_OF_MITOTIC_RECOMBINATION,0.947415621185088
FAN_EMBRYONIC_CTX_BRAIN_EFFE...,SET,116,0.045743,0.0036227,0.082716,0.29013,FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL,0.947415621185088
BHAT_ESR1_TARGETS_NOT_VIA_AK...2,SET,201,0.035007,0.003641,0.063314,0.29016,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,0.947415621185088
REACTOME_SMAC_XIAP_REGULATED...,SET,6,0.16776,0.0030307,0.30346,0.29019,REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE,0.947415621185088
GOBP_POSITIVE_REGULATION_OF_...339,SET,17,0.12542,0.0038128,0.2269,0.29022,GOBP_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.947415621185088
MIR1304_3P,SET,100,0.048562,0.0035724,0.087871,0.29026,MIR1304_3P,0.947415621185088
REACTOME_ACYL_CHAIN_REMODELL...4,SET,16,0.12792,0.0037726,0.23148,0.29027,REACTOME_ACYL_CHAIN_REMODELLING_OF_PI,0.947415621185088
ARID3B_TARGET_GENES,SET,114,0.045214,0.00355,0.081828,0.29029,ARID3B_TARGET_GENES,0.947415621185088
GSE8621_UNSTIM_VS_LPS_PRIMED...2,SET,180,0.034773,0.0034245,0.062944,0.29032,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.947424563380282
GSE16451_CTRL_VS_WEST_EQUINE...4,SET,181,0.034335,0.0033907,0.062179,0.29041,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.947629288329734
ZHAN_MULTIPLE_MYELOMA_MF_UP,SET,40,0.076113,0.0035471,0.13788,0.29047,ZHAN_MULTIPLE_MYELOMA_MF_UP,0.947632341623651
GOBP_NEGATIVE_REGULATION_OF_...393,SET,13,0.13297,0.0035352,0.24087,0.29047,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.947632341623651
GOBP_BONE_MATURATION,SET,24,0.099352,0.003588,0.18002,0.29052,GOBP_BONE_MATURATION,0.947632341623651
GOBP_PIGMENT_CATABOLIC_PROCE...,SET,11,0.14968,0.0036609,0.27123,0.29052,GOBP_PIGMENT_CATABOLIC_PROCESS,0.947632341623651
MIR3654,SET,43,0.069464,0.0033561,0.126,0.29072,MIR3654,0.947825388769904
GOBP_REGULATION_OF_RECEPTOR_...3,SET,14,0.1253,0.0034569,0.22738,0.2908,GOBP_REGULATION_OF_RECEPTOR_CLUSTERING,0.947825388769904
GOBP_LYMPHOCYTE_APOPTOTIC_PR...,SET,78,0.055185,0.0035876,0.10016,0.29084,GOBP_LYMPHOCYTE_APOPTOTIC_PROCESS,0.947825388769904
GOMF_DICARBOXYLIC_ACID_TRANS...,SET,30,0.084746,0.0034212,0.15383,0.29085,GOMF_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.947825388769904
GOBP_RESPONSE_TO_PHEROMONE,SET,6,0.18647,0.0033688,0.33853,0.29088,GOBP_RESPONSE_TO_PHEROMONE,0.947825388769904
GOMF_INOSITOL_1_3_4_5_TETRAK...,SET,5,0.22052,0.0036368,0.40035,0.29088,GOMF_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_BINDING,0.947825388769904
MIR4726_5P,SET,89,0.046997,0.0032626,0.085384,0.29102,MIR4726_5P,0.947825388769904
HP_ABNORMAL_GLYCOSYLATION,SET,44,0.065816,0.0032166,0.11959,0.29105,HP_ABNORMAL_GLYCOSYLATION,0.947825388769904
REACTOME_FORMATION_OF_INCISI...,SET,38,0.066636,0.0030269,0.12109,0.29106,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,0.947825388769904
GSE23321_CENTRAL_VS_EFFECTOR...1,SET,179,0.034554,0.0033935,0.06279,0.29106,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.947825388769904
HP_PROLONGED_NEONATAL_JAUNDI...,SET,63,0.056768,0.003318,0.10317,0.29108,HP_PROLONGED_NEONATAL_JAUNDICE,0.947825388769904
GOBP_POSITIVE_REGULATION_OF_...555,SET,12,0.14201,0.0036277,0.2581,0.29109,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.947825388769904
MARIADASON_RESPONSE_TO_BUTYR...4,SET,16,0.11483,0.0033868,0.20872,0.2911,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4,0.947825388769904
GAGCCAG_MIR149,SET,130,0.039977,0.0033504,0.072675,0.29113,GAGCCAG_MIR149,0.947825388769904
HP_GENERALIZED_LIPODYSTROPHY,SET,8,0.20312,0.004237,0.36925,0.29113,HP_GENERALIZED_LIPODYSTROPHY,0.947825388769904
BOYAULT_LIVER_CANCER_SUBCLAS...7,SET,27,0.10232,0.0039191,0.18604,0.29116,BOYAULT_LIVER_CANCER_SUBCLASS_G2,0.947825388769904
DAIRKEE_CANCER_PRONE_RESPONS...3,SET,27,0.096489,0.0036957,0.1755,0.29124,DAIRKEE_CANCER_PRONE_RESPONSE_E2,0.947825388769904
GOMF_VITAMIN_D_BINDING,SET,6,0.2216,0.0040033,0.40313,0.29127,GOMF_VITAMIN_D_BINDING,0.947825388769904
VALK_AML_CLUSTER_8,SET,23,0.10189,0.0036021,0.18539,0.29131,VALK_AML_CLUSTER_8,0.947825388769904
GOBP_POSITIVE_REGULATION_OF_...752,SET,17,0.11118,0.0033797,0.20234,0.29135,GOBP_POSITIVE_REGULATION_OF_TELOMERE_CAPPING,0.947825388769904
SAKAI_CHRONIC_HEPATITIS_VS_L...1,SET,33,0.08516,0.0036054,0.155,0.29136,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,0.947825388769904
HP_ABNORMAL_JOINT_MORPHOLOGY,SET,1068,0.014672,0.0034326,0.026707,0.29138,HP_ABNORMAL_JOINT_MORPHOLOGY,0.947825388769904
CADWELL_ATG16L1_TARGETS_DN,SET,61,0.056212,0.0032331,0.10233,0.29139,CADWELL_ATG16L1_TARGETS_DN,0.947825388769904
GOCC_PWP2P_CONTAINING_SUBCOM...,SET,4,0.20915,0.0030853,0.38079,0.29142,GOCC_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME,0.947825388769904
HERNANDEZ_MITOTIC_ARREST_BY_...3,SET,14,0.11819,0.0032608,0.2152,0.29144,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,0.947825388769904
MILI_PSEUDOPODIA_CHEMOTAXIS_...2,SET,72,0.052182,0.0032598,0.095053,0.29151,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,0.947825388769904
GOBP_PROTON_TRANSPORTING_TWO...,SET,11,0.14365,0.0035133,0.26173,0.29156,GOBP_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY,0.947825388769904
LOPEZ_EPITHELIOID_MESOTHELIO...,SET,15,0.11813,0.0033736,0.21526,0.29158,LOPEZ_EPITHELIOID_MESOTHELIOMA,0.947825388769904
MIR6764_3P,SET,98,0.046368,0.0033769,0.084499,0.29159,MIR6764_3P,0.947825388769904
GSE12366_GC_VS_MEMORY_BCELL_...2,SET,174,0.034975,0.003387,0.063739,0.2916,GSE12366_GC_VS_MEMORY_BCELL_UP,0.947825388769904
GSE25123_CTRL_VS_ROSIGLITAZO...2,SET,184,0.033892,0.0033742,0.061781,0.29165,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.947825388769904
GOBP_MUSCLE_CELL_DIFFERENTIA...,SET,376,0.024774,0.0035071,0.045162,0.29166,GOBP_MUSCLE_CELL_DIFFERENTIATION,0.947825388769904
HP_ABNORMALITY_OF_IMMUNE_SYS...,SET,1562,0.012527,0.0034933,0.022836,0.29166,HP_ABNORMALITY_OF_IMMUNE_SYSTEM_PHYSIOLOGY,0.947825388769904
HALLMARK_HEME_METABOLISM,SET,179,0.034948,0.0034322,0.063727,0.29171,HALLMARK_HEME_METABOLISM,0.947825388769904
MIR29A_5P,SET,183,0.035226,0.0034976,0.064247,0.29175,MIR29A_5P,0.947825388769904
HP_UNDETECTABLE_LIGHT_ADAPTE...,SET,6,0.22273,0.0040238,0.40624,0.29175,HP_UNDETECTABLE_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.947825388769904
REACTOME_NEUREXINS_AND_NEURO...,SET,51,0.067761,0.0035646,0.12362,0.29179,REACTOME_NEUREXINS_AND_NEUROLIGINS,0.947825388769904
GOCC_CELL_CELL_CONTACT_ZONE,SET,68,0.059637,0.0036209,0.10881,0.29182,GOCC_CELL_CELL_CONTACT_ZONE,0.947825388769904
GOBP_NITRIC_OXIDE_SYNTHASE_B...,SET,18,0.13017,0.0040717,0.23751,0.29183,GOBP_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.947825388769904
HE_LIM_SUN_FETAL_LUNG_C1_EAR...3,SET,124,0.04051,0.0033163,0.073915,0.29183,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL,0.947825388769904
GOBP_RIBONUCLEOSIDE_MONOPHOS...1,SET,29,0.087779,0.0034842,0.16019,0.29186,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.947825388769904
GSE4748_CTRL_VS_CYANOBACTERI...3,SET,178,0.033661,0.0032966,0.061427,0.29186,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.947825388769904
LI_WILMS_TUMOR_VS_FETAL_KIDN...2,SET,170,0.037346,0.0035752,0.068161,0.29188,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,0.947825388769904
GOBP_PROTEIN_LOCALIZATION_TO...8,SET,4,0.23089,0.0034059,0.42148,0.29192,GOBP_PROTEIN_LOCALIZATION_TO_CELL_LEADING_EDGE,0.947825388769904
GOBP_MICROTUBULE_NUCLEATION,SET,41,0.065491,0.0030899,0.11958,0.29196,GOBP_MICROTUBULE_NUCLEATION,0.947825388769904
HOWARD_DENDRITIC_CELL_INACT_...2,SET,140,0.042754,0.0037173,0.078071,0.29198,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.947825388769904
GOBP_TRANSFORMING_GROWTH_FAC...4,SET,196,0.034462,0.0035399,0.062943,0.29201,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.947825388769904
GSE26912_TUMORICIDAL_VS_CTRL...2,SET,187,0.035801,0.0035929,0.065387,0.29201,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP,0.947825388769904
GSE3982_MAST_CELL_VS_TH1_DN,SET,173,0.035338,0.0034124,0.064548,0.29203,GSE3982_MAST_CELL_VS_TH1_DN,0.947825388769904
GOBP_TERTIARY_ALCOHOL_METABO...,SET,22,0.11713,0.0040503,0.21396,0.29204,GOBP_TERTIARY_ALCOHOL_METABOLIC_PROCESS,0.947825388769904
GOBP_PIGMENT_CELL_DIFFERENTI...,SET,34,0.087304,0.0037517,0.15953,0.29211,GOBP_PIGMENT_CELL_DIFFERENTIATION,0.947825388769904
MIR5088_5P,SET,33,0.081311,0.0034424,0.14859,0.29212,MIR5088_5P,0.947825388769904
GSE2770_TGFB_AND_IL4_ACT_VS_...3,SET,179,0.035161,0.0034531,0.064276,0.29218,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,0.947825388769904
GOBP_MAMMARY_GLAND_DUCT_MORP...,SET,30,0.094044,0.0037965,0.17197,0.29224,GOBP_MAMMARY_GLAND_DUCT_MORPHOGENESIS,0.947825388769904
GSE24142_EARLY_THYMIC_PROGEN...6,SET,188,0.037041,0.0037271,0.067731,0.29224,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP,0.947825388769904
GOMF_ESTROGEN_RESPONSE_ELEME...,SET,10,0.16859,0.0039316,0.30831,0.29225,GOMF_ESTROGEN_RESPONSE_ELEMENT_BINDING,0.947825388769904
MIR6797_3P,SET,58,0.063895,0.0035838,0.11687,0.2923,MIR6797_3P,0.947825388769904
GOMF_ORGANIC_ANION_TRANSMEMB...,SET,253,0.030708,0.0035782,0.056188,0.29235,GOMF_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.947825388769904
HP_METATARSUS_ADDUCTUS,SET,44,0.069791,0.0034108,0.1277,0.29236,HP_METATARSUS_ADDUCTUS,0.947825388769904
HP_EXPRESSIVE_LANGUAGE_DELAY,SET,50,0.064927,0.0033819,0.11881,0.29237,HP_EXPRESSIVE_LANGUAGE_DELAY,0.947825388769904
DAZARD_RESPONSE_TO_UV_NHEK_DN,SET,283,0.028234,0.0034765,0.051671,0.29239,DAZARD_RESPONSE_TO_UV_NHEK_DN,0.947825388769904
GOBP_FC_RECEPTOR_MEDIATED_ST...,SET,30,0.090411,0.0036499,0.16549,0.29242,GOBP_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.947825388769904
HP_MOTOR_REGRESSION,SET,19,0.10961,0.0035225,0.20062,0.29242,HP_MOTOR_REGRESSION,0.947825388769904
MIR6753_3P,SET,50,0.068996,0.0035939,0.1263,0.29244,MIR6753_3P,0.947825388769904
GOMF_CALCIUM_DEPENDENT_CYSTE...,SET,15,0.13421,0.0038328,0.24568,0.29244,GOMF_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.947825388769904
GOBP_SUCCINATE_TRANSMEMBRANE...,SET,6,0.19704,0.0035596,0.36072,0.29246,GOBP_SUCCINATE_TRANSMEMBRANE_TRANSPORT,0.947825388769904
GOMF_SUCCINATE_TRANSMEMBRANE...,SET,6,0.19704,0.0035596,0.36072,0.29246,GOMF_SUCCINATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.947825388769904
GOMF_ALPHA_1_4_GLUCOSIDASE_A...,SET,5,0.21324,0.0035168,0.39043,0.29248,GOMF_ALPHA_1_4_GLUCOSIDASE_ACTIVITY,0.947825388769904
GOBP_REGULATION_OF_ADIPOSE_T...,SET,14,0.12535,0.0034585,0.22952,0.29249,GOBP_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.947825388769904
GOBP_POSITIVE_REGULATION_OF_...332,SET,6,0.19907,0.0035963,0.36454,0.29251,GOBP_POSITIVE_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.947825388769904
MIR493_3P,SET,61,0.057291,0.0032952,0.10495,0.29257,MIR493_3P,0.947825388769904
GSE33425_CD8_ALPHAALPHA_VS_A...2,SET,187,0.033781,0.0033902,0.061889,0.29259,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,0.947825388769904
WP_METAPATHWAY_BIOTRANSFORMA...,SET,173,0.039916,0.0038545,0.073139,0.29262,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,0.947825388769904
GOCC_GAP_JUNCTION,SET,27,0.10466,0.0040087,0.1918,0.29264,GOCC_GAP_JUNCTION,0.947825388769904
GOBP_ALDITOL_CATABOLIC_PROCE...,SET,5,0.22796,0.0037595,0.41775,0.29265,GOBP_ALDITOL_CATABOLIC_PROCESS,0.947825388769904
HP_FEMALE_SEXUAL_DYSFUNCTION,SET,61,0.061815,0.0035554,0.11331,0.29269,HP_FEMALE_SEXUAL_DYSFUNCTION,0.947825388769904
GSE22886_UNSTIM_VS_STIM_MEMO...2,SET,178,0.035769,0.0035031,0.065573,0.29271,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP,0.947825388769904
GSE24210_TCONV_VS_TREG_UP,SET,184,0.034899,0.0034745,0.063987,0.29274,GSE24210_TCONV_VS_TREG_UP,0.947825388769904
HP_ABNORMAL_URINARY_COLOR,SET,18,0.10486,0.0032802,0.19229,0.29276,HP_ABNORMAL_URINARY_COLOR,0.947825388769904
PSIP1_TARGET_GENES,SET,547,0.01982,0.003368,0.036349,0.29279,PSIP1_TARGET_GENES,0.947825388769904
GOBP_EXOCYTIC_PROCESS,SET,75,0.050958,0.0032487,0.093458,0.29279,GOBP_EXOCYTIC_PROCESS,0.947825388769904
WHITFIELD_CELL_CYCLE_S,SET,127,0.041152,0.0034091,0.075486,0.29282,WHITFIELD_CELL_CYCLE_S,0.947825388769904
GOBP_DRINKING_BEHAVIOR,SET,8,0.19458,0.0040589,0.357,0.29286,GOBP_DRINKING_BEHAVIOR,0.947825388769904
KEGG_MEDICUS_VARIANT_MUTATIO...25,SET,16,0.1177,0.0034713,0.21595,0.29287,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY,0.947825388769904
MORF_RAB11A,SET,51,0.057115,0.0030046,0.10486,0.293,MORF_RAB11A,0.948069546597151
GOBP_CARDIAC_CELL_FATE_COMMI...,SET,12,0.15884,0.0040576,0.29164,0.293,GOBP_CARDIAC_CELL_FATE_COMMITMENT,0.948069546597151
GOBP_NEGATIVE_REGULATION_OF_...102,SET,197,0.035893,0.0036962,0.065918,0.29305,GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION,0.948143059951592
GOMF_ORGANOPHOSPHATE_PHOSPHA...,SET,7,0.17574,0.0034292,0.32291,0.29314,GOMF_ORGANOPHOSPHATE_PHOSPHATE_ANTIPORTER_ACTIVITY,0.948257697319434
GSE3039_NKT_CELL_VS_B2_BCELL...1,SET,185,0.035016,0.0034954,0.064337,0.29314,GSE3039_NKT_CELL_VS_B2_BCELL_DN,0.948257697319434
MODULE_291,SET,61,0.064493,0.0037094,0.11853,0.29319,MODULE_291,0.948331172638437
MIR4717_5P,SET,94,0.04675,0.0033349,0.085952,0.29326,MIR4717_5P,0.948386555090656
GOBP_NEGATIVE_REGULATION_OF_...80,SET,18,0.11588,0.0036249,0.21309,0.29329,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH,0.948386555090656
GOBP_CELLULAR_RESPONSE_TO_LI...2,SET,557,0.020839,0.0035725,0.038329,0.29333,GOBP_CELLULAR_RESPONSE_TO_LIPID,0.948386555090656
PARK_HSC_AND_MULTIPOTENT_PRO...,SET,42,0.068073,0.0032505,0.12522,0.29336,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,0.948386555090656
GSE31082_DP_VS_CD8_SP_THYMOC...1,SET,179,0.034975,0.0034349,0.064345,0.29338,GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN,0.948386555090656
chr4q13,SET,70,0.11384,0.0070123,0.2095,0.29344,chr4q13,0.948386555090656
HP_BLEPHARITIS,SET,43,0.066722,0.0032236,0.12279,0.29344,HP_BLEPHARITIS,0.948386555090656
GOBP_SKELETAL_MUSCLE_THIN_FI...,SET,7,0.18678,0.0036446,0.34377,0.29345,GOBP_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY,0.948386555090656
PID_CD8_TCR_DOWNSTREAM_PATHW...,SET,61,0.064821,0.0037283,0.11931,0.29346,PID_CD8_TCR_DOWNSTREAM_PATHWAY,0.948386555090656
GSE20366_TREG_VS_NAIVE_CD4_T...3,SET,179,0.035887,0.0035244,0.066058,0.29348,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN,0.948386555090656
GOBP_REGULATION_OF_CELL_CYCL...5,SET,665,0.018069,0.0033743,0.033267,0.29352,GOBP_REGULATION_OF_CELL_CYCLE_PROCESS,0.948427631089624
GOBP_WNT_SIGNALING_PATHWAY,SET,416,0.024068,0.0035799,0.044324,0.29356,GOBP_WNT_SIGNALING_PATHWAY,0.948447867496748
KOINUMA_COLON_CANCER_MSI_UP,SET,16,0.11136,0.0032845,0.20515,0.29362,KOINUMA_COLON_CANCER_MSI_UP,0.948447867496748
HP_MOTOR_SEIZURE,SET,367,0.024421,0.0034164,0.044995,0.29366,HP_MOTOR_SEIZURE,0.948447867496748
HP_AXIAL_HYPOTONIA,SET,288,0.027139,0.0033707,0.050011,0.29368,HP_AXIAL_HYPOTONIA,0.948447867496748
FARDIN_HYPOXIA_9,SET,7,0.16677,0.0032542,0.30734,0.29369,FARDIN_HYPOXIA_9,0.948447867496748
GOBP_CELLULAR_RESPONSE_TO_ES...2,SET,18,0.11037,0.0034523,0.20338,0.29369,GOBP_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS,0.948447867496748
NABA_SECRETED_FACTORS,SET,318,0.030332,0.0039552,0.055914,0.29375,NABA_SECRETED_FACTORS,0.948526580633182
MIR3117_3P,SET,30,0.090969,0.0036724,0.16773,0.29379,MIR3117_3P,0.948526580633182
chr6q27,SET,25,0.14195,0.005232,0.2619,0.29391,chr6q27,0.948526580633182
MIR6823_3P,SET,56,0.061651,0.003398,0.11375,0.29391,MIR6823_3P,0.948526580633182
GOMF_OPIOID_RECEPTOR_BINDING,SET,7,0.20445,0.0039893,0.37723,0.29392,GOMF_OPIOID_RECEPTOR_BINDING,0.948526580633182
GOBP_DIACYLGLYCEROL_BIOSYNTH...,SET,9,0.16406,0.0036296,0.30273,0.29394,GOBP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.948526580633182
MIR5009_3P,SET,155,0.039507,0.0036128,0.072906,0.29395,MIR5009_3P,0.948526580633182
ERWIN_COHEN_BLOOD_VACCINE_TC...3,SET,5,0.20426,0.0033687,0.37694,0.29395,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_DN,0.948526580633182
HP_PERCUSSION_MYOTONIA,SET,9,0.15607,0.0034529,0.28802,0.29396,HP_PERCUSSION_MYOTONIA,0.948526580633182
GSE16385_UNTREATED_VS_12H_RO...2,SET,183,0.034635,0.0034389,0.063954,0.29406,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.948761167842555
DORSAM_HOXA9_TARGETS_UP,SET,35,0.080489,0.0035092,0.14875,0.29422,DORSAM_HOXA9_TARGETS_UP,0.948926846630304
GNF2_INPP5D,SET,39,0.078086,0.0035933,0.14433,0.29425,GNF2_INPP5D,0.948926846630304
GOBP_HYDROGEN_PEROXIDE_CATAB...,SET,26,0.10189,0.0038296,0.18839,0.29431,GOBP_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS,0.948926846630304
GOBP_RESPONSE_TO_AMINO_ACID_...,SET,50,0.065126,0.0033924,0.12042,0.29431,GOBP_RESPONSE_TO_AMINO_ACID_STARVATION,0.948926846630304
GOBP_CELLULAR_RESPONSE_TO_AM...1,SET,5,0.23976,0.0039541,0.44345,0.29437,GOBP_CELLULAR_RESPONSE_TO_AMMONIUM_ION,0.948926846630304
GOBP_RESPONSE_TO_AMMONIUM_ION,SET,5,0.23976,0.0039541,0.44345,0.29437,GOBP_RESPONSE_TO_AMMONIUM_ION,0.948926846630304
GNATENKO_PLATELET_SIGNATURE,SET,34,0.081229,0.0034906,0.15025,0.29438,GNATENKO_PLATELET_SIGNATURE,0.948926846630304
WENG_POR_TARGETS_GLOBAL_DN,SET,23,0.09965,0.0035231,0.18436,0.29442,WENG_POR_TARGETS_GLOBAL_DN,0.948926846630304
BUSSLINGER_GASTRIC_G_CELLS,SET,88,0.055408,0.0038249,0.10252,0.29445,BUSSLINGER_GASTRIC_G_CELLS,0.948926846630304
GOBP_PYRAMIDAL_NEURON_DIFFER...,SET,12,0.13212,0.003375,0.24453,0.29449,GOBP_PYRAMIDAL_NEURON_DIFFERENTIATION,0.948926846630304
GAUTAM_EYE_IRIS_CILIARY_BODY...4,SET,83,0.052275,0.0035051,0.096764,0.29452,GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS,0.948926846630304
HP_SHORTENING_OF_ALL_MIDDLE_...,SET,6,0.20499,0.0037034,0.37953,0.29456,HP_SHORTENING_OF_ALL_MIDDLE_PHALANGES_OF_THE_FINGERS,0.948926846630304
GSE360_L_MAJOR_VS_M_TUBERCUL...2,SET,169,0.036029,0.0034391,0.066716,0.29459,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP,0.948926846630304
AP1_01,SET,235,0.030747,0.0034545,0.056942,0.29461,AP1_01,0.948926846630304
GOBP_NEGATIVE_REGULATION_OF_...607,SET,12,0.143,0.0036529,0.26487,0.29464,GOBP_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.948926846630304
GOBP_REGULATION_OF_ASTROCYTE...1,SET,5,0.23294,0.0038418,0.4315,0.29465,GOBP_REGULATION_OF_ASTROCYTE_ACTIVATION,0.948926846630304
GOBP_POSITIVE_REGULATION_OF_...57,SET,98,0.047557,0.0034635,0.088096,0.29466,GOBP_POSITIVE_REGULATION_OF_BINDING,0.948926846630304
GOBP_MYELOID_LEUKOCYTE_DIFFE...,SET,219,0.033771,0.0036645,0.062563,0.29467,GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.948926846630304
GOCC_AMINOACYL_TRNA_SYNTHETA...,SET,3,0.21585,0.0027576,0.39988,0.29468,GOCC_AMINOACYL_TRNA_SYNTHETASE_MULTIENZYME_COMPLEX,0.948926846630304
GOCC_PROTEIN_COMPLEX_INVOLVE...2,SET,5,0.19718,0.0032519,0.36537,0.29471,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_CELL_ADHESION,0.948926846630304
GOBP_POSITIVE_REGULATION_OF_...206,SET,9,0.17373,0.0038436,0.322,0.29476,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION,0.948926846630304
FEVR_CTNNB1_TARGETS_UP,SET,636,0.019168,0.0035035,0.035535,0.29481,FEVR_CTNNB1_TARGETS_UP,0.948926846630304
GSE3982_BASOPHIL_VS_CENT_MEM...2,SET,176,0.035029,0.0034115,0.064948,0.29483,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.948926846630304
LEIN_ASTROCYTE_MARKERS,SET,41,0.074302,0.0035056,0.1378,0.29488,LEIN_ASTROCYTE_MARKERS,0.948926846630304
MIR153_3P,SET,308,0.027665,0.0035513,0.05131,0.29489,MIR153_3P,0.948926846630304
REACTOME_SNRNP_ASSEMBLY,SET,49,0.060954,0.0031432,0.11309,0.29495,REACTOME_SNRNP_ASSEMBLY,0.948926846630304
SAUL_SEN_MAYO,SET,123,0.047845,0.003901,0.088779,0.29497,SAUL_SEN_MAYO,0.948926846630304
HP_EXCESSIVE_SHYNESS,SET,8,0.13914,0.0029024,0.25822,0.295,HP_EXCESSIVE_SHYNESS,0.948926846630304
REACTOME_SIGNALING_BY_MEMBRA...,SET,5,0.21272,0.0035083,0.39479,0.29501,REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB,0.948926846630304
GOBP_PARTURITION,SET,14,0.12274,0.0033865,0.22782,0.29503,GOBP_PARTURITION,0.948926846630304
REACTOME_DNA_DAMAGE_REVERSAL,SET,8,0.163,0.0034001,0.3026,0.29506,REACTOME_DNA_DAMAGE_REVERSAL,0.948926846630304
GSE28783_ANTI_MIR33_VS_CTRL_...1,SET,166,0.037368,0.0035354,0.06937,0.29506,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN,0.948926846630304
BLANCO_MELO_COVID19_SARS_COV...11,SET,159,0.034407,0.0031865,0.063877,0.29507,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,0.948926846630304
GOBP_AMYLOID_BETA_CLEARANCE_...2,SET,7,0.15632,0.0030502,0.29025,0.29509,GOBP_AMYLOID_BETA_CLEARANCE_BY_TRANSCYTOSIS,0.948926846630304
GOBP_GLIAL_CELL_FATE_COMMITM...,SET,13,0.14969,0.0039798,0.27795,0.2951,GOBP_GLIAL_CELL_FATE_COMMITMENT,0.948926846630304
GOBP_LYMPHOCYTE_ANERGY,SET,7,0.17268,0.0033694,0.32071,0.29514,GOBP_LYMPHOCYTE_ANERGY,0.948926846630304
WP_EPITHELIAL_TO_MESENCHYMAL...,SET,153,0.040397,0.0036706,0.075029,0.29515,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,0.948926846630304
GSE37605_C57BL6_VS_NOD_FOXP3...6,SET,123,0.042774,0.0034876,0.079471,0.29521,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP,0.948926846630304
SOGA_COLORECTAL_CANCER_MYC_UP,SET,76,0.0511,0.0032793,0.094943,0.29522,SOGA_COLORECTAL_CANCER_MYC_UP,0.948926846630304
JECHLINGER_EPITHELIAL_TO_MES...2,SET,66,0.060439,0.0036154,0.11231,0.29524,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.948926846630304
HP_TELECANTHUS,SET,148,0.038468,0.0034381,0.071494,0.29527,HP_TELECANTHUS,0.948926846630304
HP_HYPOKALEMIC_METABOLIC_ALK...,SET,9,0.16713,0.0036977,0.31064,0.29528,HP_HYPOKALEMIC_METABOLIC_ALKALOSIS,0.948926846630304
REACTOME_REPRODUCTION,SET,93,0.045982,0.0032627,0.085468,0.29529,REACTOME_REPRODUCTION,0.948926846630304
MIR3680_5P,SET,31,0.076254,0.0031291,0.14176,0.29533,MIR3680_5P,0.948926846630304
GOBP_LAMELLIPODIUM_ASSEMBLY,SET,61,0.062513,0.0035955,0.11623,0.29534,GOBP_LAMELLIPODIUM_ASSEMBLY,0.948926846630304
SCHMAHL_PDGF_SIGNALING,SET,9,0.17717,0.0039198,0.32945,0.29537,SCHMAHL_PDGF_SIGNALING,0.948935510260677
WP_REGULATORY_CIRCUITS_OF_ST...,SET,72,0.060894,0.003804,0.11326,0.29541,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,0.94897629633053
GSE29617_CTRL_VS_DAY3_TIV_FL...1,SET,178,0.033339,0.0032652,0.062033,0.29548,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN,0.948989961211673
MIR558,SET,106,0.045331,0.0034328,0.084357,0.29551,MIR558,0.948989961211673
LI_PBMC_MENACTRA_AGE_18_45YO...1,SET,8,0.17295,0.0036075,0.32191,0.29555,LI_PBMC_MENACTRA_AGE_18_45YO_7DY_UP,0.948989961211673
GSE360_L_DONOVANI_VS_L_MAJOR...3,SET,177,0.034573,0.0033766,0.064359,0.29557,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN,0.948989961211673
MIR138_2_3P,SET,154,0.039224,0.0035755,0.073033,0.29561,MIR138_2_3P,0.948989961211673
GOMF_PEROXISOME_PROLIFERATOR...,SET,10,0.17346,0.0040451,0.32301,0.29563,GOMF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING,0.948989961211673
HP_ABNORMAL_PAROTID_GLAND_MO...,SET,8,0.16402,0.0034214,0.30545,0.29564,HP_ABNORMAL_PAROTID_GLAND_MORPHOLOGY,0.948989961211673
GOCC_MITOTIC_SPINDLE_ASTRAL_...,SET,7,0.1614,0.0031493,0.30058,0.29565,GOCC_MITOTIC_SPINDLE_ASTRAL_MICROTUBULE,0.948989961211673
REACTOME_IRAK1_RECRUITS_IKK_...,SET,11,0.14343,0.0035081,0.26713,0.29566,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,0.948989961211673
REACTOME_NETRIN_1_SIGNALING,SET,42,0.072055,0.0034407,0.13431,0.29581,REACTOME_NETRIN_1_SIGNALING,0.949234951724138
HP_DUPLICATION_OF_THUMB_PHAL...,SET,53,0.060884,0.0032649,0.11352,0.29586,HP_DUPLICATION_OF_THUMB_PHALANX,0.949234951724138
REACTOME_THROMBIN_SIGNALLING...,SET,32,0.085417,0.0035611,0.15933,0.29595,REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS,0.949234951724138
TAKADA_GASTRIC_CANCER_COPY_N...2,SET,7,0.17228,0.0033617,0.32149,0.29602,TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP,0.949234951724138
DESCARTES_FETAL_KIDNEY_URETE...,SET,236,0.032683,0.0036797,0.060989,0.29603,DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS,0.949234951724138
BENPORATH_MYC_TARGETS_WITH_E...,SET,201,0.032109,0.0033396,0.059928,0.29605,BENPORATH_MYC_TARGETS_WITH_EBOX,0.949234951724138
GAVISH_3CA_METAPROGRAM_ENDOT...13,SET,49,0.071498,0.0036869,0.13345,0.29607,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NF_KB,0.949234951724138
GOBP_REGULATION_OF_ERYTHROCY...,SET,42,0.071623,0.00342,0.1337,0.29609,GOBP_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.949234951724138
MIR18B_3P,SET,46,0.066515,0.0033236,0.12421,0.29615,MIR18B_3P,0.949234951724138
GOBP_EMBRYONIC_ORGAN_MORPHOG...,SET,280,0.029482,0.0036113,0.055059,0.29617,GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS,0.949234951724138
HP_PAROXYSMAL_BURSTS_OF_LAUG...,SET,9,0.14653,0.0032419,0.27365,0.29617,HP_PAROXYSMAL_BURSTS_OF_LAUGHTER,0.949234951724138
HP_DECREASED_SPECIFIC_ANTIBO...4,SET,29,0.091712,0.0036403,0.17129,0.29618,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_VACCINATION,0.949234951724138
HP_PTERYGIUM,SET,45,0.067396,0.0033309,0.12588,0.29618,HP_PTERYGIUM,0.949234951724138
GOBP_REGULATION_OF_PHOSPHOLI...7,SET,29,0.084965,0.0033725,0.1587,0.29619,GOBP_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.949234951724138
ACEVEDO_LIVER_CANCER_WITH_H3...1,SET,141,0.041807,0.0036479,0.078089,0.2962,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,0.949234951724138
GOBP_REGULATION_OF_EOSINOPHI...,SET,5,0.22284,0.0036751,0.41623,0.2962,GOBP_REGULATION_OF_EOSINOPHIL_MIGRATION,0.949234951724138
GOBP_CEREBELLAR_GRANULAR_LAY...1,SET,12,0.14833,0.0037891,0.27708,0.29621,GOBP_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT,0.949234951724138
GSE13762_CTRL_VS_125_VITAMIN...2,SET,131,0.040191,0.0033811,0.075121,0.29632,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP,0.949234951724138
KEGG_MEDICUS_REFERENCE_DNA_R...2,SET,17,0.10142,0.003083,0.18963,0.29639,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION,0.949234951724138
GOCC_EARLY_PHAGOSOME,SET,12,0.12982,0.0033163,0.24274,0.29639,GOCC_EARLY_PHAGOSOME,0.949234951724138
HP_VISUALLY_INDUCED_SEIZURE,SET,15,0.12889,0.0036808,0.24104,0.29642,HP_VISUALLY_INDUCED_SEIZURE,0.949234951724138
REACTOME_LISTERIA_MONOCYTOGE...,SET,18,0.10582,0.0033102,0.19793,0.29645,REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,0.949234951724138
MIR5587_5P,SET,101,0.044441,0.0032855,0.083148,0.29651,MIR5587_5P,0.949234951724138
GOCC_FASCIA_ADHERENS,SET,9,0.17732,0.0039231,0.33178,0.29651,GOCC_FASCIA_ADHERENS,0.949234951724138
HP_PURE_RED_CELL_APLASIA,SET,25,0.087051,0.0032085,0.16288,0.29652,HP_PURE_RED_CELL_APLASIA,0.949234951724138
HP_SEPTO_OPTIC_DYSPLASIA,SET,18,0.11618,0.0036343,0.21747,0.29659,HP_SEPTO_OPTIC_DYSPLASIA,0.949234951724138
GOBP_REGULATION_OF_CYCLIN_DE...,SET,73,0.052509,0.0033028,0.09829,0.2966,GOBP_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.949234951724138
GOBP_NEUROTRANSMITTER_TRANSP...,SET,194,0.033271,0.0034003,0.062292,0.29663,GOBP_NEUROTRANSMITTER_TRANSPORT,0.949234951724138
GSE43863_DAY6_EFF_VS_DAY150_...2,SET,177,0.035587,0.0034756,0.066642,0.29667,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP,0.949234951724138
REACTOME_NEGATIVE_REGULATION...2,SET,31,0.087403,0.0035867,0.16369,0.29669,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,0.949234951724138
GOBP_CYTOCHROME_COMPLEX_ASSE...,SET,32,0.072179,0.0030093,0.13518,0.29669,GOBP_CYTOCHROME_COMPLEX_ASSEMBLY,0.949234951724138
HP_RESTLESSNESS,SET,128,0.041593,0.003459,0.077896,0.29669,HP_RESTLESSNESS,0.949234951724138
HP_HIGH_MYOPIA,SET,76,0.052661,0.0033795,0.098658,0.29675,HP_HIGH_MYOPIA,0.949234951724138
WP_G_PROTEIN_SIGNALING,SET,90,0.048913,0.0034145,0.091639,0.29676,WP_G_PROTEIN_SIGNALING,0.949234951724138
GOBP_PHOSPHATIDYLETHANOLAMIN...1,SET,7,0.19107,0.0037284,0.35802,0.29678,GOBP_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING,0.949234951724138
HP_MALNUTRITION,SET,41,0.074214,0.0035014,0.13911,0.29685,HP_MALNUTRITION,0.949234951724138
GSE15659_NONSUPPRESSIVE_TCEL...1,SET,170,0.034434,0.0032964,0.064548,0.29686,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN,0.949234951724138
FOURNIER_ACINAR_DEVELOPMENT_...5,SET,11,0.14023,0.0034298,0.26289,0.29687,FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,0.949234951724138
GOMF_DOUBLE_STRANDED_METHYLA...,SET,4,0.22218,0.0032774,0.41654,0.29689,GOMF_DOUBLE_STRANDED_METHYLATED_DNA_BINDING,0.949234951724138
GOBP_SYNAPTIC_TRANSMISSION_C...,SET,32,0.085513,0.0035652,0.16034,0.29691,GOBP_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.949234951724138
MODULE_184,SET,28,0.084087,0.0032796,0.15768,0.29693,MODULE_184,0.949234951724138
GSE24574_NAIVE_VS_TCONV_CD4_...1,SET,185,0.03242,0.0032363,0.060802,0.29695,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN,0.949234951724138
GSE17721_4H_VS_24H_POLYIC_BM...2,SET,179,0.034443,0.0033827,0.064601,0.29696,GSE17721_4H_VS_24H_POLYIC_BMDC_UP,0.949234951724138
MIR6891_3P,SET,62,0.058166,0.0033727,0.1091,0.29698,MIR6891_3P,0.949234951724138
MIR519D_5P,SET,220,0.030035,0.0032665,0.056342,0.29699,MIR519D_5P,0.949234951724138
GOBP_POSITIVE_REGULATION_OF_...799,SET,14,0.12844,0.0035435,0.24095,0.297,GOBP_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.949234951724138
HAY_BONE_MARROW_FOLLICULAR_B...,SET,125,0.043272,0.0035566,0.081186,0.29702,HAY_BONE_MARROW_FOLLICULAR_B_CELL,0.949234951724138
LAMB_CCND1_TARGETS,SET,18,0.11458,0.0035842,0.21507,0.2971,LAMB_CCND1_TARGETS,0.949324613899614
SABATES_COLORECTAL_ADENOMA_S...2,SET,15,0.11208,0.0032008,0.21039,0.29711,SABATES_COLORECTAL_ADENOMA_SIZE_UP,0.949324613899614
WP_NRXN1_DELETION_SYNDROME,SET,14,0.13073,0.0036067,0.24541,0.29713,WP_NRXN1_DELETION_SYNDROME,0.949324613899614
HP_ODONTOGENIC_NEOPLASM,SET,6,0.16628,0.003004,0.31231,0.29722,HP_ODONTOGENIC_NEOPLASM,0.949524873609707
REACTOME_SIGNALING_BY_ERBB2_...1,SET,15,0.10656,0.0030431,0.20025,0.29731,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,0.949631518743109
GOBP_POSITIVE_REGULATION_OF_...51,SET,68,0.057282,0.0034779,0.10767,0.29736,GOBP_POSITIVE_REGULATION_OF_AXONOGENESIS,0.949631518743109
GOBP_NUCLEAR_MIGRATION_ALONG...,SET,5,0.19888,0.0032799,0.37384,0.29737,GOBP_NUCLEAR_MIGRATION_ALONG_MICROTUBULE,0.949631518743109
GOBP_PEPTIDYL_CYSTEINE_MODIF...,SET,39,0.074596,0.0034327,0.14023,0.29738,GOBP_PEPTIDYL_CYSTEINE_MODIFICATION,0.949631518743109
GOBP_TRACHEA_FORMATION,SET,7,0.20625,0.0040244,0.38772,0.29739,GOBP_TRACHEA_FORMATION,0.949631518743109
PID_GMCSF_PATHWAY,SET,35,0.079034,0.0034457,0.14863,0.29745,PID_GMCSF_PATHWAY,0.949680534631637
GOBP_REGULATION_OF_FIBROBLAS...4,SET,86,0.050581,0.003452,0.095127,0.29746,GOBP_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.949680534631637
MIR30C_2_3P,SET,117,0.044054,0.0035038,0.082916,0.29761,MIR30C_2_3P,0.949857524271845
HP_SPONDYLOEPIMETAPHYSEAL_DY...,SET,15,0.1145,0.0032698,0.21552,0.29762,HP_SPONDYLOEPIMETAPHYSEAL_DYSPLASIA,0.949857524271845
HP_ABNORMALITY_OF_OCULAR_ABD...,SET,11,0.14208,0.003475,0.26745,0.29763,HP_ABNORMALITY_OF_OCULAR_ABDUCTION,0.949857524271845
GOBP_RNA_GUANINE_N7_METHYLAT...,SET,4,0.18194,0.0026839,0.34251,0.29764,GOBP_RNA_GUANINE_N7_METHYLATION,0.949857524271845
VERHAAK_GLIOBLASTOMA_MESENCH...,SET,204,0.033688,0.0035295,0.063426,0.29767,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,0.949857524271845
KEGG_MEDICUS_REFERENCE_TRANS...4,SET,5,0.20808,0.0034318,0.39181,0.29768,KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM,0.949857524271845
GSE41978_WT_VS_ID2_KO_KLRG1_...1,SET,190,0.034543,0.0034941,0.065055,0.29772,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.949857524271845
GSE12003_4D_VS_8D_CULTURE_MI...2,SET,134,0.041482,0.0035292,0.078172,0.29783,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP,0.949857524271845
HP_MUSCULAR_VENTRICULAR_SEPT...,SET,22,0.098913,0.0034202,0.18644,0.29787,HP_MUSCULAR_VENTRICULAR_SEPTAL_DEFECT,0.949857524271845
GATA1_05,SET,260,0.030028,0.0035462,0.056603,0.29789,GATA1_05,0.949857524271845
HALLMARK_ADIPOGENESIS,SET,187,0.032217,0.0032333,0.060743,0.29793,HALLMARK_ADIPOGENESIS,0.949857524271845
KEGG_DILATED_CARDIOMYOPATHY,SET,85,0.051589,0.0035003,0.097277,0.29795,KEGG_DILATED_CARDIOMYOPATHY,0.949857524271845
GOBP_REGULATION_OF_CALCIUM_I...4,SET,40,0.07325,0.0034136,0.13816,0.29799,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT,0.949857524271845
GOBP_ECTODERMAL_CELL_DIFFERE...,SET,5,0.23084,0.0038071,0.43546,0.29802,GOBP_ECTODERMAL_CELL_DIFFERENTIATION,0.949857524271845
GOBP_NEGATIVE_REGULATION_OF_...22,SET,9,0.14055,0.0031096,0.26526,0.29811,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.949857524271845
HAHTOLA_SEZARY_SYNDROM_DN,SET,38,0.075763,0.0034415,0.143,0.29812,HAHTOLA_SEZARY_SYNDROM_DN,0.949857524271845
GOMF_WW_DOMAIN_BINDING,SET,21,0.096803,0.0032704,0.18271,0.29813,GOMF_WW_DOMAIN_BINDING,0.949857524271845
REACTOME_DISPLACEMENT_OF_DNA...,SET,9,0.14385,0.0031825,0.27154,0.29815,REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1,0.949857524271845
HP_ABSENT_FINGERNAIL,SET,35,0.076217,0.0033229,0.14389,0.29816,HP_ABSENT_FINGERNAIL,0.949857524271845
LASTOWSKA_COAMPLIFIED_WITH_M...,SET,35,0.096893,0.0042244,0.18294,0.29818,LASTOWSKA_COAMPLIFIED_WITH_MYCN,0.949857524271845
GOMF_OXIDOREDUCTASE_ACTIVITY...28,SET,23,0.10517,0.0037184,0.19859,0.29819,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN,0.949857524271845
GOMF_G_PROTEIN_BETA_GAMMA_SU...,SET,21,0.10061,0.0033992,0.19,0.29821,GOMF_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING,0.949857524271845
GOBP_MAINTENANCE_OF_CELL_NUM...,SET,170,0.034554,0.003308,0.065253,0.29822,GOBP_MAINTENANCE_OF_CELL_NUMBER,0.949857524271845
GOCC_CYTOCHROME_COMPLEX,SET,34,0.072577,0.0031188,0.13706,0.29822,GOCC_CYTOCHROME_COMPLEX,0.949857524271845
BROWNE_HCMV_INFECTION_30MIN_...2,SET,47,0.068621,0.0034658,0.12961,0.29825,BROWNE_HCMV_INFECTION_30MIN_UP,0.949857524271845
MIR613,SET,289,0.02677,0.0033305,0.05057,0.29828,MIR613,0.949857524271845
HALLMARK_APICAL_SURFACE,SET,39,0.075027,0.0034526,0.14173,0.29828,HALLMARK_APICAL_SURFACE,0.949857524271845
VART_KSHV_INFECTION_ANGIOGEN...1,SET,124,0.043934,0.0035966,0.082999,0.29829,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,0.949857524271845
GSE12845_IGD_POS_BLOOD_VS_NA...1,SET,187,0.032173,0.0032288,0.060788,0.29832,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,0.949857524271845
HP_OSTEOMYELITIS,SET,58,0.063368,0.0035542,0.11975,0.29835,HP_OSTEOMYELITIS,0.949857524271845
GOBP_SMOOTHENED_SIGNALING_PA...1,SET,129,0.038802,0.0032394,0.073335,0.29837,GOBP_SMOOTHENED_SIGNALING_PATHWAY,0.949857524271845
GOBP_POSITIVE_REGULATION_OF_...360,SET,11,0.13436,0.0032862,0.25397,0.29839,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.949857524271845
GOBP_TERPENOID_CATABOLIC_PRO...,SET,7,0.18444,0.0035989,0.34875,0.29845,GOBP_TERPENOID_CATABOLIC_PROCESS,0.949874519230769
GOMF_CILIARY_NEUROTROPHIC_FA...,SET,6,0.1815,0.003279,0.3432,0.29845,GOMF_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING,0.949874519230769
GOBP_REGULATION_OF_B_CELL_RE...,SET,21,0.10003,0.0033795,0.18921,0.29851,GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.949906433470508
WP_PHASE_I_BIOTRANSFORMATION...,SET,8,0.19098,0.0039838,0.36145,0.29862,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,0.949906433470508
KEGG_MEDICUS_REFERENCE_ITGA_...5,SET,27,0.087865,0.0033653,0.1663,0.29863,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.949906433470508
GSE2405_S_AUREUS_VS_A_PHAGOC...1,SET,189,0.031302,0.003158,0.059249,0.29865,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN,0.949906433470508
GOCC_MYOFILAMENT,SET,25,0.090944,0.0033519,0.17215,0.29866,GOCC_MYOFILAMENT,0.949906433470508
HP_METHYLMALONIC_ACIDURIA,SET,18,0.10652,0.0033321,0.20164,0.29866,HP_METHYLMALONIC_ACIDURIA,0.949906433470508
HP_EXTRA_AXIAL_CEREBROSPINAL...,SET,14,0.11689,0.0032249,0.22132,0.29871,HP_EXTRA_AXIAL_CEREBROSPINAL_FLUID_ACCUMULATION,0.949906433470508
QI_PBMC_ZOSTAVAX_AGE_50_75YO...1,SET,6,0.1733,0.0031308,0.32817,0.29873,QI_PBMC_ZOSTAVAX_AGE_50_75YO_1DY_UP,0.949906433470508
GSE22601_IMMATURE_CD4_SINGLE...1,SET,180,0.033464,0.0032955,0.063376,0.29875,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.949906433470508
E47_01,SET,233,0.02956,0.0033072,0.055988,0.29876,E47_01,0.949906433470508
GOCC_OXOGLUTARATE_DEHYDROGEN...,SET,11,0.11784,0.0028821,0.22326,0.29881,GOCC_OXOGLUTARATE_DEHYDROGENASE_COMPLEX,0.949906433470508
GOMF_LONG_CHAIN_FATTY_ACID_B...,SET,16,0.10782,0.0031798,0.20427,0.29882,GOMF_LONG_CHAIN_FATTY_ACID_BINDING,0.949906433470508
HP_SUDDEN_LOSS_OF_VISUAL_ACU...,SET,5,0.1861,0.0030691,0.35263,0.29884,HP_SUDDEN_LOSS_OF_VISUAL_ACUITY,0.949906433470508
HP_PROGRESSIVE_VISUAL_FIELD_...,SET,13,0.1267,0.0033685,0.24009,0.29885,HP_PROGRESSIVE_VISUAL_FIELD_DEFECTS,0.949906433470508
HP_CARDIOMEGALY,SET,114,0.043099,0.0033839,0.08168,0.29887,HP_CARDIOMEGALY,0.949906433470508
INAMURA_LUNG_CANCER_SCC_DN,SET,13,0.13014,0.0034601,0.24673,0.29893,INAMURA_LUNG_CANCER_SCC_DN,0.950010255120702
MZF1_TARGET_GENES,SET,1376,0.012762,0.0033589,0.024213,0.29907,MZF1_TARGET_GENES,0.950344939659901
KEGG_AUTOIMMUNE_THYROID_DISE...,SET,44,0.081573,0.0039866,0.15478,0.29909,KEGG_AUTOIMMUNE_THYROID_DISEASE,0.950344939659901
MIR429,SET,457,0.022457,0.003497,0.04262,0.29913,MIR429,0.950385149465216
REACTOME_FCGR3A_MEDIATED_IL1...,SET,37,0.077444,0.0034714,0.14703,0.2992,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,0.950520658135283
LANDIS_ERBB2_BREAST_TUMORS_6...1,SET,36,0.082499,0.0036478,0.15682,0.29942,LANDIS_ERBB2_BREAST_TUMORS_65_DN,0.950770060290491
chr17q21,SET,271,0.062309,0.0075104,0.11845,0.29943,chr17q21,0.950770060290491
PETRETTO_LEFT_VENTRICLE_MASS...1,SET,9,0.13683,0.0030272,0.2601,0.29943,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN,0.950770060290491
GSE29164_UNTREATED_VS_CD8_TC...8,SET,188,0.033478,0.0033686,0.063642,0.29944,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP,0.950770060290491
KEGG_MEDICUS_REFERENCE_CONDE...,SET,19,0.10026,0.0032221,0.19061,0.29945,KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING,0.950770060290491
MIR555,SET,39,0.074153,0.0034123,0.14098,0.29945,MIR555,0.950770060290491
chr1q25,SET,73,0.11367,0.0071496,0.21612,0.29947,chr1q25,0.950770060290491
GSE14350_IL2RB_KO_VS_WT_TREG...2,SET,183,0.033253,0.0033017,0.063245,0.29953,GSE14350_IL2RB_KO_VS_WT_TREG_UP,0.950786843547356
GSE15930_NAIVE_VS_72H_IN_VIT...5,SET,182,0.03316,0.0032835,0.063072,0.29953,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.950786843547356
GGCCAGT_MIR193A_MIR193B,SET,84,0.04661,0.0031439,0.08867,0.29957,GGCCAGT_MIR193A_MIR193B,0.95082697260274
REACTOME_NEGATIVE_REGULATION...4,SET,27,0.090898,0.0034815,0.173,0.29965,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,0.950994041640033
AIGNER_ZEB1_TARGETS,SET,33,0.086083,0.0036445,0.16386,0.29968,AIGNER_ZEB1_TARGETS,0.951002410518627
HP_NARROW_PALM,SET,13,0.13997,0.0037214,0.26668,0.29984,HP_NARROW_PALM,0.951147741376164
GOCC_SAGA_COMPLEX,SET,21,0.08527,0.0028808,0.16247,0.29985,GOCC_SAGA_COMPLEX,0.951147741376164
MIR513A_3P_MIR513C_3P,SET,409,0.02262,0.0033368,0.043101,0.29986,MIR513A_3P_MIR513C_3P,0.951147741376164
GSE6269_E_COLI_VS_STREP_PNEU...1,SET,153,0.03692,0.0033546,0.070347,0.29986,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN,0.951147741376164
GSE34156_NOD2_LIGAND_VS_NOD2...4,SET,161,0.032728,0.0030498,0.06237,0.29988,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.951147741376164
CONRAD_STEM_CELL,SET,35,0.083254,0.0036297,0.15867,0.29989,CONRAD_STEM_CELL,0.951147741376164
GEISS_RESPONSE_TO_DSRNA_UP,SET,37,0.072012,0.0032279,0.13726,0.29993,GEISS_RESPONSE_TO_DSRNA_UP,0.95118780454421
HP_ABNORMAL_PONS_MORPHOLOGY,SET,105,0.041678,0.0031413,0.079477,0.3,HP_ABNORMAL_PONS_MORPHOLOGY,0.95132299270073
HP_DECREASED_DISTAL_SENSORY_...,SET,9,0.16154,0.0035739,0.30817,0.30008,HP_DECREASED_DISTAL_SENSORY_NERVE_ACTION_POTENTIAL,0.951489864063498
REACTOME_COOPERATION_OF_PDCL...,SET,38,0.072365,0.0032872,0.13816,0.30022,REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING,0.951660379332302
GOCC_EUCHROMATIN,SET,49,0.063072,0.0032524,0.12047,0.3003,GOCC_EUCHROMATIN,0.951660379332302
HP_ANONYCHIA,SET,60,0.058883,0.0033589,0.1125,0.30034,HP_ANONYCHIA,0.951660379332302
WP_IL1_SIGNALING,SET,52,0.063653,0.0033811,0.12163,0.30037,WP_IL1_SIGNALING,0.951660379332302
WP_NICOTINE_METABOLISM_IN_LI...,SET,6,0.23715,0.0042844,0.45314,0.30037,WP_NICOTINE_METABOLISM_IN_LIVER_CELLS,0.951660379332302
REACTOME_P75NTR_SIGNALS_VIA_...,SET,14,0.12842,0.0035432,0.24544,0.30041,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,0.951660379332302
GSE1460_DP_THYMOCYTE_VS_THYM...1,SET,174,0.032662,0.003163,0.062431,0.30043,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.951660379332302
HP_INCREASED_LDL_CHOLESTEROL...,SET,31,0.086719,0.0035586,0.16579,0.30047,HP_INCREASED_LDL_CHOLESTEROL_CONCENTRATION,0.951660379332302
VALK_AML_CLUSTER_4,SET,25,0.095757,0.0035294,0.18309,0.30049,VALK_AML_CLUSTER_4,0.951660379332302
KEGG_MEDICUS_VARIANT_MUTATIO...50,SET,6,0.19094,0.0034494,0.36513,0.30051,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM,0.951660379332302
MODULE_311,SET,16,0.11678,0.0034441,0.22332,0.30052,MODULE_311,0.951660379332302
GSE17974_IL4_AND_ANTI_IL12_V...17,SET,173,0.034921,0.0033721,0.066792,0.30055,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN,0.951660379332302
RACCACAR_AML_Q6,SET,240,0.029599,0.0033603,0.056618,0.30057,RACCACAR_AML_Q6,0.951660379332302
GOBP_NON_MOTILE_CILIUM_ASSEM...,SET,60,0.055125,0.0031446,0.10547,0.3006,GOBP_NON_MOTILE_CILIUM_ASSEMBLY,0.951660379332302
GOBP_NEGATIVE_REGULATION_OF_...455,SET,61,0.053392,0.0030709,0.10216,0.30063,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION,0.951660379332302
GSE6674_ANTI_IGM_VS_PL2_3_ST...1,SET,176,0.032932,0.0032073,0.06303,0.30067,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN,0.951660379332302
ZHAN_MULTIPLE_MYELOMA_DN,SET,37,0.080233,0.0035964,0.1536,0.30072,ZHAN_MULTIPLE_MYELOMA_DN,0.951660379332302
GOMF_PHOSPHATIDYLCHOLINE_FLO...,SET,8,0.1692,0.0035293,0.32396,0.30074,GOMF_PHOSPHATIDYLCHOLINE_FLOPPASE_ACTIVITY,0.951660379332302
GOBP_MALE_MATING_BEHAVIOR,SET,7,0.19809,0.0038653,0.37933,0.30077,GOBP_MALE_MATING_BEHAVIOR,0.951660379332302
GOBP_REGULATION_OF_NEUROGENE...,SET,346,0.024968,0.0033935,0.047824,0.30081,GOBP_REGULATION_OF_NEUROGENESIS,0.951660379332302
MIR376A_5P,SET,56,0.060736,0.0033476,0.11634,0.30082,MIR376A_5P,0.951660379332302
MORF_RFC5,SET,72,0.049662,0.0031023,0.09514,0.30084,MORF_RFC5,0.951660379332302
SETD7_TARGET_GENES,SET,718,0.016264,0.0031513,0.031159,0.30085,SETD7_TARGET_GENES,0.951660379332302
MODULE_164,SET,58,0.063181,0.0035438,0.12105,0.30086,MODULE_164,0.951660379332302
GOMF_LARGE_RIBOSOMAL_SUBUNIT...,SET,5,0.19589,0.0032307,0.37532,0.30086,GOMF_LARGE_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.951660379332302
TURJANSKI_MAPK7_TARGETS,SET,7,0.1894,0.0036958,0.36291,0.30087,TURJANSKI_MAPK7_TARGETS,0.951660379332302
KAUFFMANN_DNA_REPAIR_GENES,SET,208,0.028157,0.0029785,0.053964,0.30092,KAUFFMANN_DNA_REPAIR_GENES,0.951660379332302
MIR610,SET,77,0.052928,0.0034188,0.10146,0.30096,MIR610,0.951660379332302
MIR5691_MIR6805_3P,SET,144,0.038791,0.0034203,0.074366,0.30097,MIR5691_MIR6805_3P,0.951660379332302
HP_PERSONALITY_CHANGES,SET,33,0.076986,0.0032593,0.14759,0.30097,HP_PERSONALITY_CHANGES,0.951660379332302
WP_H19_RBE2F1_AND_CDKBETACAT...,SET,13,0.12047,0.0032029,0.231,0.30101,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,0.951660379332302
GSE16385_ROSIGLITAZONE_IL4_V...3,SET,188,0.031818,0.0032016,0.061011,0.30101,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN,0.951660379332302
GOBP_REGULATION_OF_MITOCHOND...12,SET,18,0.10491,0.0032817,0.20121,0.30104,GOBP_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.951668655630344
HP_RESPIRATORY_PARALYSIS,SET,7,0.19089,0.0037249,0.36631,0.30114,HP_RESPIRATORY_PARALYSIS,0.951874845398327
GOMF_PROTEIN_DISULFIDE_REDUC...,SET,7,0.15035,0.0029338,0.28854,0.30116,GOMF_PROTEIN_DISULFIDE_REDUCTASE_NAD_P_H_ACTIVITY,0.951874845398327
WP_TCELL_ANTIGEN_RECEPTOR_TC...,SET,59,0.058566,0.003313,0.11245,0.30125,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,0.952072724379376
KEGG_MEDICUS_REFERENCE_LHCGR...,SET,16,0.11653,0.0034369,0.22379,0.30129,KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY,0.952082298672968
GYORFFY_DOXORUBICIN_RESISTAN...,SET,34,0.076292,0.0032784,0.14653,0.30131,GYORFFY_DOXORUBICIN_RESISTANCE,0.952082298672968
GSE7460_TCONV_VS_TREG_THYMUS...1,SET,185,0.034733,0.0034673,0.066726,0.30135,GSE7460_TCONV_VS_TREG_THYMUS_DN,0.952082298672968
GOBP_REGULATION_OF_SISTER_CH...1,SET,11,0.14896,0.0036432,0.2862,0.30137,GOBP_REGULATION_OF_SISTER_CHROMATID_COHESION,0.952082298672968
GOERING_BLOOD_HDL_CHOLESTERO...2,SET,12,0.1377,0.0035175,0.26459,0.30139,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS,0.952082298672968
MODULE_438,SET,64,0.057849,0.0034079,0.11119,0.30144,MODULE_438,0.952153703535399
MIR3605_5P,SET,76,0.053683,0.0034451,0.10323,0.30153,MIR3605_5P,0.952186590351594
HP_HYPERLORDOSIS,SET,184,0.033674,0.0033525,0.064757,0.30153,HP_HYPERLORDOSIS,0.952186590351594
GOBERT_CORE_OLIGODENDROCYTE_...,SET,40,0.073349,0.0034182,0.14108,0.30156,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,0.952186590351594
MANNE_COVID19_NONICU_VS_HEAL...2,SET,131,0.038367,0.0032277,0.073795,0.30156,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,0.952186590351594
MIR4650_5P,SET,64,0.053751,0.0031664,0.10342,0.30164,MIR4650_5P,0.952287
MIR659_5P,SET,25,0.097445,0.0035916,0.18752,0.30166,MIR659_5P,0.952287
GOBP_REGULATION_OF_APOPTOTIC...4,SET,4,0.2473,0.003648,0.47619,0.30177,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,0.952287
HP_WHITE_FORELOCK,SET,14,0.13165,0.0036323,0.25351,0.30177,HP_WHITE_FORELOCK,0.952287
HP_DUPLICATION_OF_PHALANX_OF...,SET,12,0.10994,0.0028083,0.21174,0.30181,HP_DUPLICATION_OF_PHALANX_OF_TOE,0.952287
GTCTTCC_MIR7,SET,155,0.0359,0.003283,0.069165,0.30187,GTCTTCC_MIR7,0.952287
GOBP_NEGATIVE_REGULATION_OF_...485,SET,19,0.10603,0.0034076,0.20431,0.30189,GOBP_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS,0.952287
HP_ANGLE_CLOSURE_GLAUCOMA,SET,5,0.22821,0.0037637,0.43977,0.30191,HP_ANGLE_CLOSURE_GLAUCOMA,0.952287
GOBP_PHOTOTRANSDUCTION_VISIB...,SET,16,0.11198,0.0033028,0.21589,0.30199,GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT,0.952287
GSE1432_1H_VS_24H_IFNG_MICRO...2,SET,188,0.034089,0.0034301,0.065737,0.30203,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.952287
GOMF_OUTWARD_RECTIFIER_POTAS...,SET,26,0.092575,0.0034796,0.17853,0.30204,GOMF_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.952287
GOBP_CGMP_BIOSYNTHETIC_PROCE...,SET,7,0.17792,0.0034717,0.34314,0.30206,GOBP_CGMP_BIOSYNTHETIC_PROCESS,0.952287
GOBP_TELOMERE_MAINTENANCE_VI...2,SET,9,0.14107,0.0031211,0.2721,0.30207,GOBP_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION,0.952287
GOMF_DNA_EXONUCLEASE_ACTIVITY,SET,23,0.087254,0.0030848,0.16831,0.30209,GOMF_DNA_EXONUCLEASE_ACTIVITY,0.952287
GOBP_NEGATIVE_REGULATION_OF_...201,SET,33,0.086346,0.0036556,0.16664,0.30218,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.952287
HP_APLASIA_HYPOPLASIA_INVOLV...5,SET,90,0.045754,0.003194,0.088304,0.30218,HP_APLASIA_HYPOPLASIA_INVOLVING_FOREARM_BONES,0.952287
WP_AMINO_ACID_METABOLISM_IN_...,SET,7,0.16997,0.0033166,0.32806,0.3022,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.952287
GSE24142_EARLY_THYMIC_PROGEN...7,SET,180,0.032406,0.0031913,0.062563,0.30224,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN,0.952287
GOCC_SPINDLE_POLE_CENTROSOME,SET,11,0.12463,0.0030482,0.24064,0.30227,GOCC_SPINDLE_POLE_CENTROSOME,0.952287
HP_SENSORY_ATAXIA,SET,14,0.11081,0.0030571,0.21398,0.30229,HP_SENSORY_ATAXIA,0.952287
GSE13229_IMM_VS_MATURE_NKCEL...2,SET,181,0.032759,0.003235,0.063269,0.30231,GSE13229_IMM_VS_MATURE_NKCELL_UP,0.952287
HOEK_MONOCYTE_2011_2012_TIV_...4,SET,2,0.38496,0.0040156,0.74353,0.30232,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_UP,0.952287
HP_MEGACYSTIS,SET,9,0.15912,0.0035204,0.30735,0.30234,HP_MEGACYSTIS,0.952287
MIR124_5P,SET,102,0.043522,0.0032333,0.084081,0.30237,MIR124_5P,0.952287
MIR378F,SET,36,0.069125,0.0030564,0.13356,0.30238,MIR378F,0.952287
HP_UPPER_AIRWAY_OBSTRUCTION,SET,15,0.12415,0.0035453,0.23986,0.30238,HP_UPPER_AIRWAY_OBSTRUCTION,0.952287
HALLMARK_PI3K_AKT_MTOR_SIGNA...,SET,102,0.042389,0.0031492,0.081938,0.30246,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.952287
KEGG_MEDICUS_ENV_FACTOR_NNK_...5,SET,5,0.23025,0.0037973,0.44523,0.30253,KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS,0.952287
GSE3982_EOSINOPHIL_VS_CENT_M...2,SET,180,0.033147,0.0032643,0.064101,0.30254,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.952287
HP_ABNORMALITY_OF_THE_SPINOC...,SET,10,0.14296,0.0033339,0.27648,0.30256,HP_ABNORMALITY_OF_THE_SPINOCEREBELLAR_TRACTS,0.952287
GOBP_BILE_ACID_SECRETION,SET,10,0.13859,0.0032319,0.26804,0.30257,GOBP_BILE_ACID_SECRETION,0.952287
GSE46242_CTRL_VS_EGR2_DELETE...3,SET,162,0.035452,0.0033138,0.068569,0.30257,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN,0.952287
FOURNIER_ACINAR_DEVELOPMENT_...1,SET,6,0.20075,0.0036267,0.38829,0.30258,FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN,0.952287
MIR612,SET,97,0.043418,0.003146,0.083992,0.3026,MIR612,0.952287
CCCAGAG_MIR326,SET,137,0.038339,0.0032978,0.074177,0.30263,CCCAGAG_MIR326,0.952287
GOBP_DNA_CYTOSINE_DEAMINATION,SET,8,0.23043,0.0048066,0.44587,0.30265,GOBP_DNA_CYTOSINE_DEAMINATION,0.952287
HP_NARROW_PALPEBRAL_FISSURE,SET,59,0.055039,0.0031135,0.1065,0.30266,HP_NARROW_PALPEBRAL_FISSURE,0.952287
AMIT_EGF_RESPONSE_40_HELA,SET,41,0.074511,0.0035154,0.14419,0.30267,AMIT_EGF_RESPONSE_40_HELA,0.952287
HP_ENLARGED_CISTERNA_MAGNA,SET,52,0.056407,0.0029962,0.10916,0.30267,HP_ENLARGED_CISTERNA_MAGNA,0.952287
REACTOME_CLEC7A_DECTIN_1_IND...,SET,11,0.1191,0.0029128,0.2305,0.30269,REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION,0.952287
HP_PHOTOSENSITIVE_MYOCLONIC_...,SET,7,0.18004,0.0035131,0.34851,0.30272,HP_PHOTOSENSITIVE_MYOCLONIC_SEIZURE,0.952287
HSIAO_HOUSEKEEPING_GENES,SET,344,0.02328,0.0031551,0.045076,0.30277,HSIAO_HOUSEKEEPING_GENES,0.952287
GOBP_UNSATURATED_FATTY_ACID_...2,SET,104,0.045412,0.0034065,0.087927,0.30277,GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS,0.952287
HP_PERINEAL_HYPOSPADIAS,SET,4,0.20901,0.0030832,0.40514,0.30297,HP_PERINEAL_HYPOSPADIAS,0.952384100008898
GOBP_VENTRICULAR_TRABECULA_M...,SET,14,0.13639,0.003763,0.26447,0.30303,GOBP_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS,0.952384100008898
GOBP_SEQUESTERING_OF_IRON_ION,SET,5,0.2147,0.0035409,0.41641,0.30307,GOBP_SEQUESTERING_OF_IRON_ION,0.952384100008898
GOBP_DE_NOVO_NAD_BIOSYNTHETI...,SET,8,0.16879,0.0035208,0.3274,0.30309,GOBP_DE_NOVO_NAD_BIOSYNTHETIC_PROCESS,0.952384100008898
GOCC_CENTROSOME,SET,667,0.01679,0.0031401,0.032568,0.30309,GOCC_CENTROSOME,0.952384100008898
GOMF_TASTE_RECEPTOR_ACTIVITY,SET,28,0.10127,0.0039497,0.19648,0.30313,GOMF_TASTE_RECEPTOR_ACTIVITY,0.952384100008898
HP_ULCERATIVE_COLITIS,SET,13,0.12954,0.0034442,0.25138,0.30316,HP_ULCERATIVE_COLITIS,0.952384100008898
HP_APLASIA_HYPOPLASIA_OF_THE...77,SET,70,0.053819,0.0033152,0.10444,0.30317,HP_APLASIA_HYPOPLASIA_OF_THE_UTERUS,0.952384100008898
HP_GASTROINTESTINAL_OBSTRUCT...,SET,85,0.049307,0.0033455,0.095682,0.30317,HP_GASTROINTESTINAL_OBSTRUCTION,0.952384100008898
HP_BURKITT_LYMPHOMA,SET,8,0.17298,0.0036082,0.3357,0.30318,HP_BURKITT_LYMPHOMA,0.952384100008898
MIR6511B_5P,SET,66,0.056609,0.0033863,0.10988,0.30322,MIR6511B_5P,0.952384100008898
HP_ACRAL_OVERGROWTH,SET,3,0.21064,0.002691,0.40895,0.30325,HP_ACRAL_OVERGROWTH,0.952384100008898
MIR195_3P,SET,206,0.031231,0.0032879,0.06065,0.3033,MIR195_3P,0.952384100008898
GOBP_NEGATIVE_REGULATION_OF_...231,SET,33,0.075093,0.0031792,0.14586,0.30334,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.952384100008898
HP_DERMATAN_SULFATE_EXCRETIO...,SET,4,0.20792,0.0030671,0.40387,0.30334,HP_DERMATAN_SULFATE_EXCRETION_IN_URINE,0.952384100008898
GOBP_CELL_CELL_ADHESION,SET,897,0.016674,0.0035926,0.032394,0.30338,GOBP_CELL_CELL_ADHESION,0.952384100008898
MIR548AB,SET,443,0.021064,0.0032307,0.040927,0.3034,MIR548AB,0.952384100008898
GSE13484_12H_VS_3H_YF17D_VAC...2,SET,174,0.033225,0.0032175,0.064592,0.3035,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.952384100008898
BUSSLINGER_DUODENAL_K_CELLS,SET,17,0.11281,0.0034296,0.21934,0.30351,BUSSLINGER_DUODENAL_K_CELLS,0.952384100008898
GOBP_NEGATIVE_REGULATION_OF_...412,SET,20,0.089565,0.002953,0.17414,0.30352,GOBP_NEGATIVE_REGULATION_OF_MRNA_PROCESSING,0.952384100008898
GSE3982_DC_VS_NEUTROPHIL_DN,SET,172,0.033623,0.0032375,0.06538,0.30353,GSE3982_DC_VS_NEUTROPHIL_DN,0.952384100008898
CUI_DEVELOPING_HEART_VALVAR_...,SET,126,0.042426,0.0035009,0.082525,0.30359,CUI_DEVELOPING_HEART_VALVAR_ENDOTHELIAL_CELL,0.952384100008898
GOMF_CARBOHYDRATE_BINDING,SET,248,0.029806,0.003439,0.057992,0.30364,GOMF_CARBOHYDRATE_BINDING,0.952384100008898
GOBP_NEGATIVE_REGULATION_OF_...534,SET,68,0.05261,0.0031943,0.10237,0.30365,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,0.952384100008898
chr18p11,SET,63,0.11133,0.0065071,0.21668,0.3037,chr18p11,0.952384100008898
HP_SYMPHALANGISM_OF_MIDDLE_P...1,SET,4,0.25127,0.0037066,0.48909,0.30372,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_5TH_FINGER,0.952384100008898
GSE17721_LPS_VS_PAM3CSK4_0.5...2,SET,181,0.031851,0.0031453,0.062018,0.30378,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP,0.952384100008898
ZNF354A_TARGET_GENES,SET,15,0.10577,0.0030206,0.20599,0.30381,ZNF354A_TARGET_GENES,0.952384100008898
GOBP_REGULATION_OF_STORE_OPE...2,SET,14,0.12363,0.0034109,0.24081,0.30384,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY,0.952384100008898
PEART_HDAC_PROLIFERATION_CLU...1,SET,68,0.051511,0.0031275,0.10035,0.30386,PEART_HDAC_PROLIFERATION_CLUSTER_DN,0.952384100008898
HP_RADIAL_DEVIATION_OF_THE_2...,SET,6,0.19755,0.0035689,0.38484,0.30386,HP_RADIAL_DEVIATION_OF_THE_2ND_FINGER,0.952384100008898
STARK_BRAIN_22Q11_DELETION,SET,10,0.14845,0.003462,0.28922,0.30388,STARK_BRAIN_22Q11_DELETION,0.952384100008898
MIR1178_5P,SET,32,0.082032,0.00342,0.15985,0.30391,MIR1178_5P,0.952384100008898
HP_ABNORMALITY_OF_IRON_HOMEO...,SET,23,0.089669,0.0031702,0.17478,0.30396,HP_ABNORMALITY_OF_IRON_HOMEOSTASIS,0.952384100008898
GOCC_MLL1_2_COMPLEX,SET,29,0.071765,0.0028485,0.1399,0.30399,GOCC_MLL1_2_COMPLEX,0.952384100008898
JIANG_HYPOXIA_NORMAL,SET,189,0.030998,0.0031273,0.060441,0.30403,JIANG_HYPOXIA_NORMAL,0.952384100008898
BIOCARTA_NTHI_PATHWAY,SET,23,0.097787,0.0034572,0.19071,0.30406,BIOCARTA_NTHI_PATHWAY,0.952384100008898
GOBP_REGULATION_OF_STEROID_B...,SET,69,0.057214,0.0034992,0.11158,0.30407,GOBP_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS,0.952384100008898
BIOCARTA_CELL2CELL_PATHWAY,SET,12,0.13175,0.0033655,0.25699,0.3041,BIOCARTA_CELL2CELL_PATHWAY,0.952384100008898
GSE13522_CTRL_VS_T_CRUZI_BRA...2,SET,131,0.039855,0.0033529,0.077746,0.30411,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP,0.952384100008898
HP_OSTEOARTHRITIS,SET,57,0.061453,0.0034171,0.11993,0.30418,HP_OSTEOARTHRITIS,0.952384100008898
GOMF_PHOSPHATIDYLINOSITOL_3_...8,SET,11,0.10767,0.0026333,0.21014,0.3042,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.952384100008898
GOBP_REGULATION_OF_ODONTOGEN...2,SET,12,0.14631,0.0037374,0.28557,0.30421,GOBP_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.952384100008898
GSE10239_KLRG1INT_VS_KLRG1HI...1,SET,179,0.033435,0.0032836,0.065274,0.30425,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.952384100008898
MAHAJAN_RESPONSE_TO_IL1A_UP,SET,73,0.055004,0.0034597,0.10739,0.30426,MAHAJAN_RESPONSE_TO_IL1A_UP,0.952384100008898
GOBP_REGULATION_OF_TRANSLATI...5,SET,12,0.12179,0.003111,0.23777,0.30426,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_BY_EIF2_ALPHA_PHOSPHORYLATION,0.952384100008898
GOBP_NEGATIVE_REGULATION_OF_...312,SET,6,0.22226,0.0040153,0.43396,0.30427,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.952384100008898
GSE14000_UNSTIM_VS_4H_LPS_DC...2,SET,178,0.034841,0.0034122,0.068031,0.30428,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN,0.952384100008898
BIOCARTA_BCELLSURVIVAL_PATHW...,SET,14,0.13062,0.0036039,0.25506,0.30429,BIOCARTA_BCELLSURVIVAL_PATHWAY,0.952384100008898
WP_8P231_COPY_NUMBER_VARIATI...,SET,51,0.079012,0.0041565,0.15431,0.30431,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,0.952384100008898
GOBP_REGULATION_OF_MITOPHAGY,SET,33,0.075287,0.0031874,0.14703,0.30432,GOBP_REGULATION_OF_MITOPHAGY,0.952384100008898
HP_FOOT_DORSIFLEXOR_WEAKNESS,SET,128,0.038321,0.003187,0.074855,0.30435,HP_FOOT_DORSIFLEXOR_WEAKNESS,0.952384100008898
GOBP_T_CELL_ACTIVATION_VIA_T...,SET,10,0.14331,0.003342,0.28,0.30439,GOBP_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,0.952384100008898
HP_PERIPHERAL_AXONAL_NEUROPA...,SET,152,0.035007,0.0031705,0.068413,0.30443,HP_PERIPHERAL_AXONAL_NEUROPATHY,0.952384100008898
REACTOME_LOSS_OF_MECP2_BINDI...,SET,5,0.16117,0.002658,0.31506,0.30449,REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX,0.952384100008898
GOBP_POSITIVE_REGULATION_OF_...767,SET,6,0.15419,0.0027856,0.3015,0.30453,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.952384100008898
GOBP_SNRNA_PROCESSING,SET,22,0.086534,0.0029922,0.16921,0.30454,GOBP_SNRNA_PROCESSING,0.952384100008898
GSE3982_MAC_VS_TH2_UP,SET,181,0.033583,0.0033163,0.065678,0.30457,GSE3982_MAC_VS_TH2_UP,0.952384100008898
GOBP_NEGATIVE_REGULATION_OF_...223,SET,30,0.08503,0.0034326,0.16631,0.30458,GOBP_NEGATIVE_REGULATION_OF_EXOCYTOSIS,0.952384100008898
GTATGAT_MIR154_MIR487,SET,63,0.055897,0.0032671,0.10933,0.30459,GTATGAT_MIR154_MIR487,0.952384100008898
HP_ENLARGED_THORAX,SET,57,0.056231,0.0031267,0.10999,0.3046,HP_ENLARGED_THORAX,0.952384100008898
GOMF_SNORNA_BINDING,SET,28,0.076117,0.0029688,0.14892,0.30463,GOMF_SNORNA_BINDING,0.952384100008898
RHEIN_ALL_GLUCOCORTICOID_THE...2,SET,67,0.053026,0.0031958,0.10376,0.30466,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,0.952384100008898
GOBP_T_HELPER_17_CELL_DIFFER...,SET,33,0.082443,0.0034904,0.16133,0.30467,GOBP_T_HELPER_17_CELL_DIFFERENTIATION,0.952384100008898
HP_HYPOPLASTIC_VERTEBRAL_BOD...,SET,17,0.10532,0.0032017,0.20615,0.30472,HP_HYPOPLASTIC_VERTEBRAL_BODIES,0.952384100008898
KEGG_MEDICUS_VARIANT_MUTATIO...8,SET,24,0.088131,0.0031827,0.17252,0.30474,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.952384100008898
MIR138_5P,SET,189,0.032197,0.0032483,0.063061,0.30483,MIR138_5P,0.952384100008898
GOBP_CHROMOSOME_SEGREGATION,SET,383,0.021382,0.0030544,0.04188,0.30483,GOBP_CHROMOSOME_SEGREGATION,0.952384100008898
HP_DISTAL_SENSORY_IMPAIRMENT,SET,117,0.038388,0.0030532,0.075196,0.30485,HP_DISTAL_SENSORY_IMPAIRMENT,0.952384100008898
GOBP_CELLULAR_RESPONSE_TO_IN...6,SET,7,0.16476,0.003215,0.3228,0.30488,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA,0.952384100008898
HP_DECREASED_METHYLMALONYL_C...,SET,5,0.21469,0.0035407,0.42079,0.30496,HP_DECREASED_METHYLMALONYL_COA_MUTASE_ACTIVITY,0.952384100008898
GSE37605_C57BL6_VS_NOD_FOXP3...2,SET,148,0.037274,0.0033315,0.073068,0.30498,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP,0.952384100008898
GOBP_CELLULAR_RESPONSE_TO_EX...1,SET,13,0.11887,0.0031603,0.23309,0.30504,GOBP_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA,0.952384100008898
REACTOME_CASPASE_ACTIVATION_...1,SET,16,0.11391,0.0033597,0.22344,0.30509,REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND,0.952384100008898
GOBP_GLUTAMINE_FAMILY_AMINO_...2,SET,24,0.096531,0.0034861,0.1894,0.30514,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.952384100008898
SCHERER_PBMC_APSV_WETVAX_AGE...8,SET,23,0.094257,0.0033324,0.18496,0.30517,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_UP,0.952384100008898
STN1_TARGET_GENES,SET,8,0.16164,0.0033717,0.31723,0.30519,STN1_TARGET_GENES,0.952384100008898
GOBP_FUCOSE_CATABOLIC_PROCESS,SET,9,0.16811,0.0037193,0.32996,0.3052,GOBP_FUCOSE_CATABOLIC_PROCESS,0.952384100008898
GOBP_LIPOSACCHARIDE_METABOLI...,SET,103,0.042415,0.0031664,0.083267,0.30524,GOBP_LIPOSACCHARIDE_METABOLIC_PROCESS,0.952384100008898
REACTOME_TAK1_DEPENDENT_IKK_...,SET,40,0.066868,0.0031162,0.13129,0.30527,REACTOME_TAK1_DEPENDENT_IKK_AND_NF_KAPPA_B_ACTIVATION,0.952384100008898
HP_VIRAL_ENCEPHALITIS,SET,11,0.13151,0.0032164,0.25824,0.30529,HP_VIRAL_ENCEPHALITIS,0.952384100008898
LEE_LIVER_CANCER_ACOX1_UP,SET,62,0.062144,0.0036034,0.12206,0.30533,LEE_LIVER_CANCER_ACOX1_UP,0.952384100008898
HP_MIXED_HEARING_IMPAIRMENT,SET,32,0.080998,0.0033769,0.15915,0.3054,HP_MIXED_HEARING_IMPAIRMENT,0.952384100008898
GSE17721_0.5H_VS_24H_GARDIQU...2,SET,172,0.031882,0.0030699,0.062646,0.3054,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP,0.952384100008898
GSE7548_NAIVE_VS_DAY7_PCC_IM...1,SET,184,0.03288,0.0032735,0.06462,0.30544,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN,0.952384100008898
GOBP_NEGATIVE_REGULATION_OF_...361,SET,151,0.038166,0.0034453,0.075041,0.30552,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION,0.952384100008898
F10_TARGET_GENES,SET,211,0.031588,0.0033651,0.062113,0.30554,F10_TARGET_GENES,0.952384100008898
KEGG_MEDICUS_VARIANT_AMPLIFI...2,SET,6,0.17187,0.003105,0.33802,0.30557,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S,0.952384100008898
MIR6728_3P,SET,134,0.037338,0.0031767,0.073439,0.30558,MIR6728_3P,0.952384100008898
GOBP_VENOUS_BLOOD_VESSEL_DEV...,SET,16,0.11538,0.0034029,0.22693,0.30558,GOBP_VENOUS_BLOOD_VESSEL_DEVELOPMENT,0.952384100008898
ALPHACP1_01,SET,224,0.030212,0.0033151,0.05943,0.3056,ALPHACP1_01,0.952384100008898
GSE36078_UNTREATED_VS_AD5_IN...1,SET,183,0.031495,0.0031272,0.061975,0.30566,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN,0.952384100008898
GSE32034_LY6C_HIGH_VS_LOW_MO...2,SET,181,0.033149,0.0032735,0.065235,0.30568,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP,0.952384100008898
HP_HYPOCALCEMIC_TETANY,SET,7,0.17534,0.0034213,0.34523,0.30577,HP_HYPOCALCEMIC_TETANY,0.952384100008898
GOBP_ENDONUCLEOLYTIC_CLEAVAG...2,SET,9,0.14364,0.003178,0.28289,0.30581,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_ITS1_TO_SEPARATE_SSU_RRNA_FROM_5_8S_RRNA_AND_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.952384100008898
GOMF_TYPE_I_INTERFERON_RECEP...,SET,13,0.18488,0.0049155,0.36414,0.30583,GOMF_TYPE_I_INTERFERON_RECEPTOR_BINDING,0.952384100008898
GOCC_DEATH_INDUCING_SIGNALIN...,SET,9,0.15918,0.0035217,0.31354,0.30584,GOCC_DEATH_INDUCING_SIGNALING_COMPLEX,0.952384100008898
HP_HYPERCOAGULABILITY,SET,15,0.11432,0.0032647,0.22518,0.30584,HP_HYPERCOAGULABILITY,0.952384100008898
GSE18893_CTRL_VS_TNF_TREATED...4,SET,182,0.031273,0.0030966,0.061609,0.30587,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP,0.952384100008898
GOBP_PHOSPHATIDYLETHANOLAMIN...3,SET,23,0.091453,0.0032333,0.18018,0.30588,GOBP_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,0.952384100008898
AACTGAC_MIR223,SET,90,0.046217,0.0032263,0.091063,0.3059,AACTGAC_MIR223,0.952384100008898
HP_CRANIAL_HYPEROSTOSIS,SET,40,0.062835,0.0029283,0.12381,0.3059,HP_CRANIAL_HYPEROSTOSIS,0.952384100008898
HP_INCREASED_CIRCULATING_IGM...,SET,32,0.080835,0.0033701,0.15928,0.3059,HP_INCREASED_CIRCULATING_IGM_LEVEL,0.952384100008898
HP_KINETIC_TREMOR,SET,90,0.043652,0.0030473,0.086034,0.30595,HP_KINETIC_TREMOR,0.952384100008898
KEGG_MEDICUS_REFERENCE_FAS_J...,SET,7,0.1723,0.0033619,0.33961,0.30597,KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY,0.952384100008898
GOMF_INTEGRIN_BINDING_INVOLV...,SET,5,0.20966,0.0034577,0.4134,0.30603,GOMF_INTEGRIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,0.952384100008898
HP_KELOIDS,SET,9,0.14291,0.0031618,0.2818,0.30603,HP_KELOIDS,0.952384100008898
INGRAM_SHH_TARGETS_UP,SET,113,0.044155,0.0034517,0.087073,0.30605,INGRAM_SHH_TARGETS_UP,0.952384100008898
GOBP_PIGMENT_BIOSYNTHETIC_PR...,SET,49,0.061925,0.0031933,0.12215,0.3061,GOBP_PIGMENT_BIOSYNTHETIC_PROCESS,0.952384100008898
GOBP_NEGATIVE_REGULATION_OF_...123,SET,641,0.018289,0.0033556,0.036081,0.30612,GOBP_NEGATIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.952384100008898
HP_ELEVATED_CIRCULATING_PARA...,SET,18,0.11317,0.0035401,0.22328,0.30612,HP_ELEVATED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.952384100008898
GOBP_ANTIGEN_PROCESSING_AND_...9,SET,7,0.23404,0.0045668,0.46178,0.30614,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.952384100008898
GOBP_OLIGODENDROCYTE_DIFFERE...,SET,104,0.045412,0.0034065,0.089602,0.30614,GOBP_OLIGODENDROCYTE_DIFFERENTIATION,0.952384100008898
MIR6838_3P,SET,58,0.055636,0.0031206,0.10981,0.3062,MIR6838_3P,0.952384100008898
KEGG_MEDICUS_REFERENCE_TGFA_...2,SET,7,0.17412,0.0033976,0.34368,0.30621,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY,0.952384100008898
REACTOME_NOTCH4_ACTIVATION_A...,SET,10,0.13891,0.0032395,0.27423,0.30624,REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.952384100008898
GOBP_GALACTOLIPID_METABOLIC_...,SET,9,0.1548,0.0034248,0.30561,0.30625,GOBP_GALACTOLIPID_METABOLIC_PROCESS,0.952384100008898
GOBP_METANEPHROS_DEVELOPMENT,SET,86,0.052707,0.0035971,0.10408,0.3063,GOBP_METANEPHROS_DEVELOPMENT,0.952384100008898
HP_POLYCLONAL_ELEVATION_OF_I...,SET,6,0.16504,0.0029816,0.32591,0.3063,HP_POLYCLONAL_ELEVATION_OF_IGM,0.952384100008898
HP_ABNORMAL_CAPILLARY_PHYSIO...,SET,8,0.15996,0.0033368,0.31591,0.30631,HP_ABNORMAL_CAPILLARY_PHYSIOLOGY,0.952384100008898
GOBP_DIRECT_OSSIFICATION,SET,7,0.15445,0.0030138,0.30515,0.30638,GOBP_DIRECT_OSSIFICATION,0.952384100008898
GSE5589_LPS_VS_LPS_AND_IL10_...5,SET,180,0.031977,0.0031491,0.063182,0.30639,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN,0.952384100008898
TORCHIA_TARGETS_OF_EWSR1_FLI...4,SET,241,0.028723,0.0032676,0.056758,0.30641,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.952384100008898
MATHEW_FANCONI_ANEMIA_GENES,SET,10,0.11483,0.0026778,0.22697,0.30646,MATHEW_FANCONI_ANEMIA_GENES,0.952384100008898
GSE12001_MIR223_KO_VS_WT_NEU...1,SET,179,0.031862,0.0031292,0.062985,0.30648,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN,0.952384100008898
GOBP_GLUTAMINE_FAMILY_AMINO_...1,SET,14,0.10954,0.0030221,0.21656,0.3065,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.952384100008898
GSE40274_CTRL_VS_XBP1_TRANSD...1,SET,148,0.033918,0.0030315,0.06706,0.30651,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.952384100008898
GSE21033_3H_VS_24H_POLYIC_ST...1,SET,108,0.039905,0.0030501,0.078904,0.30652,GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN,0.952384100008898
PID_UPA_UPAR_PATHWAY,SET,42,0.076311,0.0036439,0.1509,0.30653,PID_UPA_UPAR_PATHWAY,0.952384100008898
chr3q21,SET,62,0.096441,0.0055921,0.19072,0.30654,chr3q21,0.952384100008898
REACTOME_NUCLEOTIDE_EXCISION...,SET,103,0.03793,0.0028316,0.075007,0.30654,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,0.952384100008898
GOBP_VESICLE_MEDIATED_TRANSP...2,SET,44,0.064231,0.0031391,0.12705,0.30658,GOBP_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS,0.952384100008898
GSE37301_COMMON_LYMPHOID_PRO...1,SET,181,0.031663,0.0031267,0.062635,0.3066,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN,0.952384100008898
SCHERER_PBMC_APSV_WETVAX_AGE...5,SET,171,0.032505,0.0031208,0.064305,0.30662,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN,0.952384100008898
HP_REFLEX_SEIZURE,SET,19,0.10181,0.003272,0.20149,0.30667,HP_REFLEX_SEIZURE,0.952384100008898
HP_FINGER_SYNDACTYLY,SET,177,0.032236,0.0031483,0.063797,0.30668,HP_FINGER_SYNDACTYLY,0.952384100008898
GSE19888_ADENOSINE_A3R_ACT_V...5,SET,160,0.032435,0.0030132,0.064189,0.30668,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN,0.952384100008898
HP_LARYNGEAL_STRIDOR,SET,4,0.2101,0.0030992,0.41585,0.3067,HP_LARYNGEAL_STRIDOR,0.952384100008898
GOCC_BOX_H_ACA_RNP_COMPLEX,SET,3,0.20334,0.0025978,0.4025,0.30671,GOCC_BOX_H_ACA_RNP_COMPLEX,0.952384100008898
GOCC_BOX_H_ACA_TELOMERASE_RN...,SET,3,0.20334,0.0025978,0.4025,0.30671,GOCC_BOX_H_ACA_TELOMERASE_RNP_COMPLEX,0.952384100008898
BONCI_TARGETS_OF_MIR15A_AND_...,SET,90,0.0454,0.0031693,0.089877,0.30673,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,0.952384100008898
GOMF_INOSITOL_1_4_5_TRISPHOS...1,SET,6,0.15233,0.002752,0.30156,0.30673,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.952384100008898
HP_ATROPHY_DEGENERATION_INVO...3,SET,19,0.099624,0.0032016,0.19723,0.30674,HP_ATROPHY_DEGENERATION_INVOLVING_THE_SPINAL_CORD,0.952384100008898
REACTOME_THE_ROLE_OF_NEF_IN_...,SET,27,0.081246,0.0031118,0.16088,0.30678,REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS,0.952384100008898
GOBP_INTRACELLULAR_STEROL_TR...,SET,32,0.075494,0.0031474,0.14951,0.30681,GOBP_INTRACELLULAR_STEROL_TRANSPORT,0.952384100008898
GOBP_MICROGLIAL_CELL_MIGRATI...,SET,8,0.16879,0.0035208,0.3343,0.30682,GOBP_MICROGLIAL_CELL_MIGRATION,0.952384100008898
MIR92A_1_5P,SET,41,0.069805,0.0032934,0.13828,0.30685,MIR92A_1_5P,0.952384100008898
GOBP_SRP_DEPENDENT_COTRANSLA...2,SET,3,0.20156,0.002575,0.39931,0.30686,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_SIGNAL_SEQUENCE_RECOGNITION,0.952384100008898
GAVISH_3CA_MALIGNANT_METAPRO...40,SET,45,0.064452,0.0031854,0.12773,0.30692,GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA,0.952384100008898
REACTOME_RHOQ_GTPASE_CYCLE,SET,57,0.056702,0.0031529,0.11237,0.30693,REACTOME_RHOQ_GTPASE_CYCLE,0.952384100008898
THAKAR_PBMC_INACTIVATED_INFL...9,SET,15,0.1026,0.0029301,0.20349,0.30705,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP,0.952384100008898
GOBP_AIM2_INFLAMMASOME_COMPL...,SET,5,0.15795,0.002605,0.31336,0.30711,GOBP_AIM2_INFLAMMASOME_COMPLEX_ASSEMBLY,0.952384100008898
GOBP_MICROTUBULE_POLYMERIZAT...1,SET,87,0.043876,0.0030117,0.087055,0.30713,GOBP_MICROTUBULE_POLYMERIZATION,0.952384100008898
GOCC_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.21515,0.0027487,0.42693,0.30715,GOCC_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_COMPLEX,0.952384100008898
GOMF_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.21515,0.0027487,0.42693,0.30715,GOMF_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY,0.952384100008898
MODULE_229,SET,27,0.080323,0.0030765,0.15942,0.30719,MODULE_229,0.952384100008898
GOMF_RNA_POLYMERASE_III_TRAN...,SET,8,0.13176,0.0027484,0.26155,0.30722,GOMF_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.952384100008898
MIR671_5P,SET,117,0.040164,0.0031945,0.07974,0.30724,MIR671_5P,0.952384100008898
MORF_KDR,SET,82,0.050474,0.003364,0.10023,0.30728,MORF_KDR,0.952384100008898
GOBP_PROTEIN_DNA_COVALENT_CR...,SET,8,0.12744,0.0026583,0.25311,0.30731,GOBP_PROTEIN_DNA_COVALENT_CROSS_LINKING_REPAIR,0.952384100008898
GSE22886_NAIVE_CD4_TCELL_VS_...14,SET,172,0.033689,0.0032439,0.06691,0.30731,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP,0.952384100008898
DESCARTES_FETAL_PANCREAS_VAS...,SET,54,0.064297,0.0034802,0.1277,0.30731,DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS,0.952384100008898
GSE17721_POLYIC_VS_CPG_24H_B...1,SET,182,0.032074,0.003176,0.06371,0.30733,GSE17721_POLYIC_VS_CPG_24H_BMDC_DN,0.952384100008898
COREBINDINGFACTOR_Q6,SET,247,0.028619,0.0032955,0.056865,0.30738,COREBINDINGFACTOR_Q6,0.952384100008898
GOBP_RIBONUCLEOPROTEIN_COMPL...2,SET,10,0.11691,0.0027263,0.23233,0.30742,GOBP_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION,0.952384100008898
GSE16385_ROSIGLITAZONE_IL4_V...6,SET,177,0.034321,0.0033519,0.068212,0.30743,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP,0.952384100008898
TNCATNTCCYR_UNKNOWN,SET,119,0.038839,0.0031151,0.077193,0.30744,TNCATNTCCYR_UNKNOWN,0.952384100008898
REACTOME_DOWNSTREAM_SIGNALIN...2,SET,31,0.077527,0.0031814,0.15411,0.30746,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,0.952384100008898
REACTOME_RHOBTB1_GTPASE_CYCLE,SET,22,0.082598,0.0028561,0.1642,0.30748,REACTOME_RHOBTB1_GTPASE_CYCLE,0.952384100008898
GOBP_REGULATION_OF_MITOCHOND...6,SET,12,0.11362,0.0029023,0.22591,0.30751,GOBP_REGULATION_OF_MITOCHONDRIAL_FUSION,0.952384100008898
GOBP_POSITIVE_REGULATION_OF_...163,SET,12,0.11167,0.0028525,0.22213,0.30759,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,0.952384100008898
GOBP_REGULATION_OF_G_PROTEIN...,SET,133,0.038525,0.0032654,0.076638,0.30759,GOBP_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.952384100008898
HP_ABNORMAL_PERIFOLLICULAR_M...,SET,5,0.26509,0.0043718,0.52738,0.30761,HP_ABNORMAL_PERIFOLLICULAR_MORPHOLOGY,0.952384100008898
MIR6510_5P,SET,78,0.047762,0.003105,0.09507,0.3077,MIR6510_5P,0.952384100008898
GSE17721_POLYIC_VS_CPG_12H_B...1,SET,184,0.031068,0.0030931,0.061852,0.30773,GSE17721_POLYIC_VS_CPG_12H_BMDC_DN,0.952384100008898
GOBP_PREPULSE_INHIBITION,SET,13,0.125,0.0033234,0.24889,0.30775,GOBP_PREPULSE_INHIBITION,0.952384100008898
GOBP_NEGATIVE_REGULATION_OF_...79,SET,6,0.18335,0.0033124,0.3651,0.30777,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.952384100008898
GOBP_REGULATION_OF_ESTABLISH...4,SET,43,0.062657,0.0030272,0.12476,0.30777,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.952384100008898
MIR6779_3P,SET,64,0.055879,0.0032918,0.11131,0.30783,MIR6779_3P,0.952384100008898
WP_BENZOAPYRENE_METABOLISM,SET,9,0.16318,0.0036101,0.32515,0.30789,WP_BENZOAPYRENE_METABOLISM,0.952384100008898
GOCC_PROTEASOME_CORE_COMPLEX...2,SET,11,0.11911,0.0029132,0.23737,0.30791,GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX,0.952384100008898
SIG_CD40PATHWAYMAP,SET,33,0.076607,0.0032433,0.15268,0.30793,SIG_CD40PATHWAYMAP,0.952384100008898
MODULE_208,SET,108,0.043083,0.003293,0.085871,0.30794,MODULE_208,0.952384100008898
GOBP_HYDROGEN_PEROXIDE_METAB...,SET,46,0.068708,0.0034332,0.13695,0.30795,GOBP_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.952384100008898
GOBP_REGULATION_OF_INNER_EAR...,SET,8,0.15712,0.0032775,0.3132,0.30795,GOBP_REGULATION_OF_INNER_EAR_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION,0.952384100008898
HP_ABNORMAL_MAGNESIUM_CONCEN...,SET,31,0.084501,0.0034676,0.16844,0.30795,HP_ABNORMAL_MAGNESIUM_CONCENTRATION,0.952384100008898
OLSSON_E2F3_TARGETS_DN,SET,33,0.082533,0.0034942,0.16453,0.30797,OLSSON_E2F3_TARGETS_DN,0.952384100008898
GOBP_SKELETAL_MUSCLE_CONTRAC...,SET,43,0.065311,0.0031555,0.1302,0.30797,GOBP_SKELETAL_MUSCLE_CONTRACTION,0.952384100008898
GOMF_VOLTAGE_GATED_MONOATOMI...2,SET,139,0.040518,0.0035104,0.08078,0.30798,GOMF_VOLTAGE_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.952384100008898
GSE4984_LPS_VS_VEHICLE_CTRL_...2,SET,168,0.033008,0.0031415,0.06582,0.30801,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP,0.952392130782918
MIR221_5P,SET,74,0.050432,0.0031937,0.10064,0.30815,MIR221_5P,0.952457500888731
GOBP_RESPONSE_TO_PEPTIDE_HOR...,SET,405,0.021915,0.0032172,0.043734,0.30816,GOBP_RESPONSE_TO_PEPTIDE_HORMONE,0.952457500888731
REACTOME_RRNA_PROCESSING,SET,177,0.030403,0.0029693,0.060678,0.30817,REACTOME_RRNA_PROCESSING,0.952457500888731
BIOCARTA_AMI_PATHWAY,SET,18,0.10944,0.0034233,0.21847,0.30821,BIOCARTA_AMI_PATHWAY,0.952457500888731
KEGG_MEDICUS_PATHOGEN_HCMV_U...1,SET,26,0.083188,0.0031267,0.16606,0.30821,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY,0.952457500888731
GOMF_FMN_BINDING,SET,15,0.11013,0.003145,0.21988,0.30824,GOMF_FMN_BINDING,0.952457500888731
HP_ABNORMAL_SOFT_PALATE_MORP...,SET,224,0.028267,0.0031017,0.056437,0.30824,HP_ABNORMAL_SOFT_PALATE_MORPHOLOGY,0.952457500888731
KINSEY_TARGETS_OF_EWSR1_FLII...1,SET,299,0.025749,0.0032575,0.051419,0.30827,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,0.952457500888731
WP_INTERFERONMEDIATED_SIGNAL...,SET,33,0.090815,0.0038448,0.18137,0.30829,WP_INTERFERONMEDIATED_SIGNALING,0.952457500888731
GSE37533_PPARG2_FOXP3_VS_FOX...4,SET,175,0.032601,0.003166,0.065118,0.30832,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.952457500888731
MORF_SS18,SET,56,0.053831,0.002967,0.10755,0.30835,MORF_SS18,0.952457500888731
GOMF_TRANSKETOLASE_OR_TRANSA...,SET,3,0.24218,0.0030939,0.48386,0.30836,GOMF_TRANSKETOLASE_OR_TRANSALDOLASE_ACTIVITY,0.952457500888731
GOBP_REGULATION_OF_VERY_LOW_...1,SET,4,0.19327,0.002851,0.3862,0.30839,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.952465515862437
HP_RENAL_HYPOPLASIA,SET,116,0.040702,0.0032234,0.081361,0.30845,HP_RENAL_HYPOPLASIA,0.952481541537095
HP_STOMATOCYTOSIS,SET,12,0.13341,0.003408,0.26669,0.30845,HP_STOMATOCYTOSIS,0.952481541537095
GOBP_MITOCHONDRION_ENDOPLASM...,SET,7,0.15456,0.003016,0.30903,0.30848,GOBP_MITOCHONDRION_ENDOPLASMIC_RETICULUM_MEMBRANE_TETHERING,0.952489552238806
GSE17974_IL4_AND_ANTI_IL12_V...3,SET,168,0.034986,0.0033297,0.069969,0.30853,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN,0.952559309762814
WP_IMMUNE_RESPONSE_TO_TUBERC...,SET,22,0.089683,0.0031011,0.17941,0.30858,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.952629054894298
GATA1_01,SET,216,0.02969,0.0031997,0.059408,0.30862,GATA1_01,0.952653037030459
RHEIN_ALL_GLUCOCORTICOID_THE...1,SET,324,0.02377,0.0031281,0.047572,0.30866,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,0.952653037030459
ZNF488_TARGET_GENES,SET,25,0.082333,0.0030346,0.16479,0.30867,ZNF488_TARGET_GENES,0.952653037030459
GSE3982_MAST_CELL_VS_BCELL_DN,SET,161,0.033238,0.0030973,0.066546,0.30873,GSE3982_MAST_CELL_VS_BCELL_DN,0.952753609483218
HP_NON_HODGKIN_LYMPHOMA,SET,38,0.072019,0.0032714,0.14432,0.30889,HP_NON_HODGKIN_LYMPHOMA,0.953041243013042
MIR3657,SET,49,0.06326,0.0032621,0.12678,0.3089,MIR3657,0.953041243013042
BURTON_ADIPOGENESIS_1,SET,28,0.087069,0.003396,0.17454,0.30894,BURTON_ADIPOGENESIS_1,0.953041243013042
HP_HEMIHYPERTROPHY,SET,14,0.10993,0.0030329,0.22035,0.30894,HP_HEMIHYPERTROPHY,0.953041243013042
GOBP_MALE_GENITALIA_DEVELOPM...,SET,23,0.09748,0.0034464,0.1955,0.30903,GOBP_MALE_GENITALIA_DEVELOPMENT,0.953041243013042
GOBP_ZINC_ION_IMPORT_ACROSS_...,SET,10,0.13327,0.0031079,0.2673,0.30904,GOBP_ZINC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.953041243013042
GSE23321_CD8_STEM_CELL_MEMOR...3,SET,180,0.0311,0.0030627,0.062385,0.30906,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.953041243013042
GOBP_NEGATIVE_REGULATION_OF_...535,SET,6,0.18432,0.0033299,0.36976,0.30907,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.953041243013042
HP_ABNORMAL_BASAL_GANGLIA_MR...,SET,35,0.069245,0.003019,0.1389,0.30907,HP_ABNORMAL_BASAL_GANGLIA_MRI_SIGNAL_INTENSITY,0.953041243013042
LI_PBMC_MENACTRA_AGE_18_45YO...7,SET,34,0.084694,0.0036395,0.16993,0.3091,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE,0.953049192689851
GOUYER_TATI_TARGETS_UP,SET,10,0.15479,0.0036098,0.3107,0.30917,GOUYER_TATI_TARGETS_UP,0.953134682926829
GOCC_FICOLIN_1_RICH_GRANULE,SET,172,0.032761,0.0031545,0.065769,0.3092,GOCC_FICOLIN_1_RICH_GRANULE,0.953134682926829
GSE25123_CTRL_VS_ROSIGLITAZO...4,SET,176,0.033756,0.0032875,0.067769,0.30921,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,0.953134682926829
GSE27786_CD4_VS_CD8_TCELL_DN,SET,176,0.031836,0.0031005,0.063967,0.30935,GSE27786_CD4_VS_CD8_TCELL_DN,0.953275600354453
GSE5455_HEALTHY_VS_TUMOR_BEA...2,SET,176,0.032335,0.0031491,0.064967,0.30935,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP,0.953275600354453
WP_IL6_SIGNALING,SET,42,0.071703,0.0034239,0.14408,0.30936,WP_IL6_SIGNALING,0.953275600354453
GOMF_MYOSIN_LIGHT_CHAIN_BIND...,SET,8,0.14639,0.0030537,0.29421,0.3094,GOMF_MYOSIN_LIGHT_CHAIN_BINDING,0.953275600354453
ACAACTT_MIR382,SET,62,0.052666,0.0030538,0.10588,0.30946,ACAACTT_MIR382,0.953275600354453
GOBP_REGULATION_OF_ACUTE_INF...2,SET,13,0.12018,0.0031952,0.24163,0.30947,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.953275600354453
JIANG_AGING_HYPOTHALAMUS_UP,SET,39,0.065923,0.0030336,0.13258,0.30952,JIANG_AGING_HYPOTHALAMUS_UP,0.953275600354453
ZNF843_TARGET_GENES,SET,677,0.016944,0.0031916,0.034077,0.30952,ZNF843_TARGET_GENES,0.953275600354453
CARRILLOREIXACH_14Q32OVEREXP...,SET,2,0.38127,0.0039772,0.76684,0.30953,CARRILLOREIXACH_14Q32OVEREXPRESSION_IN_HEPATOBLASTOMA,0.953275600354453
MUELLER_PLURINET,SET,278,0.02515,0.0030698,0.050583,0.30953,MUELLER_PLURINET,0.953275600354453
MIR889_3P,SET,214,0.029644,0.0031802,0.059643,0.30959,MIR889_3P,0.953285275367452
GOBP_HYPEROSMOTIC_RESPONSE,SET,25,0.087535,0.0032263,0.17622,0.30969,GOBP_HYPEROSMOTIC_RESPONSE,0.953285275367452
GOBP_REGULATION_OF_MRNA_SPLI...,SET,97,0.039605,0.0028697,0.079738,0.3097,GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME,0.953285275367452
GOBP_DENDRITE_MORPHOGENESIS,SET,131,0.037428,0.0031487,0.07536,0.30972,GOBP_DENDRITE_MORPHOGENESIS,0.953285275367452
HP_INCREASED_B_CELL_COUNT,SET,11,0.14286,0.003494,0.2877,0.30975,HP_INCREASED_B_CELL_COUNT,0.953285275367452
GSE37416_12H_VS_24H_F_TULARE...1,SET,166,0.032244,0.0030506,0.064934,0.30975,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.953285275367452
GOBP_REGULATION_OF_PHOSPHOLI...9,SET,15,0.10664,0.0030454,0.21477,0.30976,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSPORT,0.953285275367452
REACTOME_RECEPTOR_MEDIATED_M...,SET,10,0.13248,0.0030895,0.26684,0.30978,REACTOME_RECEPTOR_MEDIATED_MITOPHAGY,0.953285275367452
GOBP_NEGATIVE_REGULATION_OF_...238,SET,7,0.15515,0.0030273,0.31249,0.30978,GOBP_NEGATIVE_REGULATION_OF_FERTILIZATION,0.953285275367452
HP_HYPERCONVEX_FINGERNAILS,SET,6,0.18913,0.0034168,0.38105,0.30983,HP_HYPERCONVEX_FINGERNAILS,0.953354727755644
GOBP_PEPTIDYL_L_CYSTEINE_S_P...,SET,21,0.093443,0.0031569,0.18832,0.30988,GOBP_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION,0.953424167847025
OCT1_Q5_01,SET,224,0.030242,0.0033184,0.060979,0.30997,OCT1_Q5_01,0.953459827738516
BIOCARTA_TCRA_PATHWAY,SET,10,0.13695,0.0031937,0.27625,0.31004,BIOCARTA_TCRA_PATHWAY,0.953459827738516
GSE7460_WT_VS_FOXP3_HET_ACT_...4,SET,183,0.031345,0.0031122,0.063243,0.31008,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP,0.953459827738516
GOBP_POSITIVE_REGULATION_OF_...270,SET,9,0.14629,0.0032365,0.29529,0.31016,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,0.953459827738516
LHX3_TARGET_GENES,SET,18,0.10527,0.0032928,0.21251,0.31018,LHX3_TARGET_GENES,0.953459827738516
GSE17721_POLYIC_VS_GARDIQUIM...5,SET,177,0.030076,0.0029373,0.060723,0.3102,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN,0.953459827738516
WP_LUNG_FIBROSIS,SET,59,0.06088,0.0034439,0.12295,0.31024,WP_LUNG_FIBROSIS,0.953459827738516
WP_NOTCH1_REGULATION_OF_ENDO...,SET,16,0.1178,0.0034744,0.23794,0.31027,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,0.953459827738516
HP_RENAL_DUPLICATION,SET,31,0.089561,0.0036752,0.18097,0.31034,HP_RENAL_DUPLICATION,0.953459827738516
GSE21546_SAP1A_KO_VS_SAP1A_K...3,SET,185,0.03022,0.0030167,0.06107,0.31036,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.953459827738516
REACTOME_BILE_ACID_AND_BILE_...,SET,44,0.068394,0.0033425,0.13822,0.31037,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,0.953459827738516
MIR3192_3P,SET,75,0.04799,0.0030594,0.096997,0.31039,MIR3192_3P,0.953459827738516
REACTOME_ENDOSOMAL_VACUOLAR_...,SET,11,0.14177,0.0034674,0.28656,0.3104,REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,0.953459827738516
GOBP_NEGATIVE_REGULATION_OF_...398,SET,11,0.13673,0.0033441,0.27641,0.31042,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.953459827738516
PGF_UP.V1_UP,SET,167,0.033313,0.0031612,0.067346,0.31042,PGF_UP.V1_UP,0.953459827738516
MIR4777_3P,SET,61,0.05288,0.0030415,0.1069,0.31043,MIR4777_3P,0.953459827738516
GOBP_NEURONAL_SIGNAL_TRANSDU...,SET,6,0.20723,0.0037437,0.41897,0.31044,GOBP_NEURONAL_SIGNAL_TRANSDUCTION,0.953459827738516
GOCC_LUMENAL_SIDE_OF_ENDOPLA...,SET,29,0.077665,0.0030827,0.15704,0.31046,GOCC_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.953459827738516
MIR3651,SET,18,0.10302,0.0032224,0.20836,0.31051,MIR3651,0.953459827738516
HP_ABNORMAL_FACIAL_SKELETON_...,SET,1162,0.012759,0.0031051,0.025805,0.31051,HP_ABNORMAL_FACIAL_SKELETON_MORPHOLOGY,0.953459827738516
KEGG_OTHER_GLYCAN_DEGRADATION,SET,15,0.11645,0.0033256,0.23555,0.31052,KEGG_OTHER_GLYCAN_DEGRADATION,0.953459827738516
HP_ELONGATED_SUPERIOR_CEREBE...,SET,10,0.11752,0.0027406,0.23771,0.31052,HP_ELONGATED_SUPERIOR_CEREBELLAR_PEDUNCLE,0.953459827738516
REACTOME_RESPONSE_OF_EIF2AK4...,SET,91,0.043819,0.0030758,0.088647,0.31055,REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,0.953459827738516
GOBP_REGULATION_OF_CENTRIOLE...,SET,22,0.084553,0.0029237,0.17106,0.31055,GOBP_REGULATION_OF_CENTRIOLE_REPLICATION,0.953459827738516
HP_HYPERSOMNIA,SET,15,0.11389,0.0032524,0.23052,0.31064,HP_HYPERSOMNIA,0.953583406923349
GSE46606_UNSTIM_VS_CD40L_IL2...8,SET,184,0.02962,0.0029489,0.05996,0.31066,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,0.953583406923349
GOBP_REGULATION_OF_STORE_OPE...1,SET,5,0.17719,0.0029223,0.35876,0.31069,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.953583406923349
GOBP_NEUROTRANSMITTER_RECEPT...4,SET,9,0.14952,0.0033079,0.30275,0.3107,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_ENDOSOME_TO_POSTSYNAPTIC_MEMBRANE,0.953583406923349
GOMF_OXIDOREDUCTASE_ACTIVITY...31,SET,59,0.051236,0.0028983,0.10379,0.31077,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS,0.953714026490066
MURAKAMI_UV_RESPONSE_1HR_UP,SET,14,0.11149,0.0030761,0.22589,0.31081,MURAKAMI_UV_RESPONSE_1HR_UP,0.953729729849033
POMEROY_MEDULLOBLASTOMA_PROG...1,SET,40,0.065605,0.0030573,0.13293,0.31083,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,0.953729729849033
HP_ABNORMAL_METABOLISM,SET,146,0.034312,0.003046,0.069565,0.31093,HP_ABNORMAL_METABOLISM,0.953900132310135
GOCC_TRAPPIII_PROTEIN_COMPLEX,SET,10,0.12269,0.0028611,0.24882,0.31098,GOCC_TRAPPIII_PROTEIN_COMPLEX,0.953900132310135
HP_SPOKEN_WORD_RECOGNITION_D...,SET,8,0.14084,0.0029378,0.28564,0.31099,HP_SPOKEN_WORD_RECOGNITION_DEFICIT,0.953900132310135
MIR5681B,SET,48,0.060073,0.0030661,0.12188,0.31105,MIR5681B,0.953900132310135
GSE17721_CTRL_VS_LPS_6H_BMDC...2,SET,179,0.031297,0.0030736,0.063499,0.31106,GSE17721_CTRL_VS_LPS_6H_BMDC_UP,0.953900132310135
GOBP_PHOSPHATIDYLINOSITOL_ME...1,SET,23,0.090997,0.0032172,0.18464,0.31107,GOBP_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING,0.953900132310135
GSE37532_VISCERAL_ADIPOSE_TI...7,SET,139,0.034819,0.0030167,0.070664,0.3111,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN,0.953900132310135
GSE11961_MEMORY_BCELL_DAY7_V...7,SET,185,0.032086,0.003203,0.065122,0.31112,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,0.953900132310135
GOBP_NEGATIVE_REGULATION_OF_...322,SET,96,0.042006,0.003028,0.085267,0.31114,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.953900132310135
BUSSLINGER_DUODENAL_EARLY_IM...,SET,99,0.04355,0.0031877,0.088415,0.31116,BUSSLINGER_DUODENAL_EARLY_IMMATURE_ENTEROCYTES,0.953900132310135
CAO_BLOOD_FLUMIST_AGE_05_14Y...7,SET,9,0.14189,0.0031391,0.28814,0.31121,CAO_BLOOD_FLUMIST_AGE_05_14YO_CORRELATED_WITH_H3N2_VN_TITER_7DY_POSITIVE,0.953969267066502
REACTOME_HDL_CLEARANCE,SET,5,0.20139,0.0033214,0.40906,0.31125,REACTOME_HDL_CLEARANCE,0.954001784140969
GOBP_REGULATION_OF_SKELETAL_...2,SET,11,0.12687,0.003103,0.25781,0.31133,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION,0.954001784140969
GOBP_REGULATION_OF_SENSORY_P...,SET,13,0.12215,0.0032477,0.24832,0.31139,GOBP_REGULATION_OF_SENSORY_PERCEPTION,0.954001784140969
BRUECKNER_TARGETS_OF_MIRLET7...2,SET,104,0.043344,0.0032513,0.088114,0.3114,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,0.954001784140969
GOCC_FEMALE_GERM_CELL_NUCLEUS,SET,14,0.11515,0.0031771,0.23412,0.31141,GOCC_FEMALE_GERM_CELL_NUCLEUS,0.954001784140969
GOBP_REGULATION_OF_MEIOTIC_N...,SET,32,0.074868,0.0031214,0.15231,0.31152,GOBP_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.954001784140969
HP_DECREASED_SPECIFIC_ANTIBO...1,SET,12,0.1219,0.0031139,0.24801,0.31153,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_POLYSACCHARIDE_VACCINE,0.954001784140969
WP_WHITE_FAT_CELL_DIFFERENTI...,SET,31,0.084611,0.0034721,0.17215,0.31154,WP_WHITE_FAT_CELL_DIFFERENTIATION,0.954001784140969
MIR1298_5P,SET,40,0.063207,0.0029456,0.1286,0.31154,MIR1298_5P,0.954001784140969
GSE8921_UNSTIM_VS_TLR1_2_STI...2,SET,183,0.031625,0.00314,0.064342,0.31154,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP,0.954001784140969
MIR3671,SET,571,0.018276,0.0031711,0.037187,0.31155,MIR3671,0.954001784140969
LEF1_UP.V1_UP,SET,173,0.034295,0.0033117,0.06978,0.31155,LEF1_UP.V1_UP,0.954001784140969
GOBP_REGULATION_OF_VACUOLE_O...,SET,54,0.057452,0.0031096,0.11693,0.3116,GOBP_REGULATION_OF_VACUOLE_ORGANIZATION,0.954025209195807
GSE29949_DC_BRAIN_VS_MONOCYT...1,SET,179,0.032583,0.0031999,0.066322,0.31162,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.954025209195807
GCM_MAP4K4,SET,161,0.031782,0.0029616,0.064699,0.31164,GCM_MAP4K4,0.954025209195807
GSE2770_TGFB_AND_IL4_VS_IL4_...5,SET,171,0.031563,0.0030304,0.064297,0.31175,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.954201646706587
MIR561_3P,SET,437,0.020968,0.0031947,0.04272,0.31177,MIR561_3P,0.954201646706587
GSE26488_WT_VS_HDAC7_KO_DOUB...2,SET,159,0.033688,0.0031199,0.068634,0.31178,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.954201646706587
HP_EMG_CHRONIC_DENERVATION_S...,SET,25,0.080964,0.0029841,0.16506,0.31189,HP_EMG_CHRONIC_DENERVATION_SIGNS,0.954454252883684
BIERIE_INFLAMMATORY_RESPONSE...,SET,5,0.23525,0.0038798,0.4798,0.31196,BIERIE_INFLAMMATORY_RESPONSE_TGFB1,0.954477544014084
GSE21927_SPLENIC_VS_TUMOR_MO...1,SET,178,0.029358,0.0028752,0.059876,0.31196,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN,0.954477544014084
CAO_BLOOD_FLUZONE_AGE_05_14Y...6,SET,5,0.17645,0.0029101,0.35992,0.31198,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_UP,0.954477544014084
GAUSSMANN_MLL_AF4_FUSION_TAR...8,SET,36,0.07095,0.0031371,0.14474,0.31201,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,0.954485304990758
KEGG_MEDICUS_REFERENCE_BASE_...3,SET,9,0.12514,0.0027686,0.25537,0.31206,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE,0.954500822846079
GOCC_POLE_PLASM,SET,23,0.085155,0.0030106,0.17378,0.31207,GOCC_POLE_PLASM,0.954500822846079
MODULE_4,SET,19,0.085084,0.0027343,0.17374,0.31217,MODULE_4,0.954707557628013
MODULE_127,SET,11,0.12003,0.0029357,0.24516,0.31221,MODULE_127,0.954707557628013
REACTOME_N_GLYCAN_ANTENNAE_E...2,SET,26,0.089377,0.0033594,0.18256,0.31222,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,0.954707557628013
ELVIDGE_HYPOXIA_DN,SET,137,0.034328,0.0029528,0.070153,0.31231,ELVIDGE_HYPOXIA_DN,0.954898746371074
MYLLYKANGAS_AMPLIFICATION_HO...1,SET,11,0.12011,0.0029376,0.24555,0.31237,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,0.954990743997889
GCM_ERCC4,SET,25,0.080746,0.0029761,0.16511,0.3124,GCM_ERCC4,0.954990743997889
WP_HEART_DEVELOPMENT,SET,42,0.072264,0.0034507,0.14779,0.31243,WP_HEART_DEVELOPMENT,0.954990743997889
GOBP_GLUTATHIONE_TRANSMEMBRA...,SET,8,0.15548,0.0032433,0.318,0.31245,GOBP_GLUTATHIONE_TRANSMEMBRANE_TRANSPORT,0.954990743997889
REACTOME_GLYCEROPHOSPHOLIPID...1,SET,113,0.041293,0.0032279,0.084469,0.31248,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,0.954998452339078
MIR12120,SET,164,0.032571,0.003063,0.066645,0.31252,MIR12120,0.95503671854392
HP_PRIMARY_AMENORRHEA,SET,108,0.040676,0.003109,0.08325,0.31257,HP_PRIMARY_AMENORRHEA,0.955105534552488
MIR520G_3P_MIR520H,SET,182,0.030708,0.0030408,0.062877,0.31264,MIR520G_3P_MIR520H,0.955235446153846
GOMF_MYOSIN_PHOSPHATASE_ACTI...,SET,69,0.048041,0.0029381,0.098403,0.3127,GOMF_MYOSIN_PHOSPHATASE_ACTIVITY,0.955334783755274
GOMF_ALDOSE_REDUCTASE_NADPH_...,SET,12,0.15639,0.0039948,0.32048,0.31279,GOMF_ALDOSE_REDUCTASE_NADPH_ACTIVITY,0.955525749318801
GSE27786_CD4_TCELL_VS_NKCELL...2,SET,183,0.029985,0.0029772,0.061477,0.31287,GSE27786_CD4_TCELL_VS_NKCELL_UP,0.955686135524697
HP_ABNORMAL_CILIARY_BODY_MOR...,SET,6,0.15985,0.0028879,0.32806,0.31304,HP_ABNORMAL_CILIARY_BODY_MORPHOLOGY,0.95580811023622
GOBP_NEUROMUSCULAR_JUNCTION_...,SET,47,0.060709,0.0030662,0.1246,0.31305,GOBP_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.95580811023622
GOBP_DORSAL_VENTRAL_AXIS_SPE...,SET,14,0.12452,0.0034354,0.25557,0.31306,GOBP_DORSAL_VENTRAL_AXIS_SPECIFICATION,0.95580811023622
GOBP_VITAMIN_BIOSYNTHETIC_PR...,SET,24,0.08795,0.0031762,0.18052,0.31306,GOBP_VITAMIN_BIOSYNTHETIC_PROCESS,0.95580811023622
NIKOLSKY_BREAST_CANCER_12Q24...,SET,14,0.21229,0.0058571,0.43586,0.31311,NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON,0.95580811023622
GOBP_ANTIGEN_PROCESSING_AND_...3,SET,30,0.08817,0.0035594,0.18104,0.31312,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN,0.95580811023622
HP_CARDIORESPIRATORY_ARREST,SET,10,0.14399,0.003358,0.29567,0.31313,HP_CARDIORESPIRATORY_ARREST,0.95580811023622
HP_BONE_MARROW_HYPOCELLULARI...,SET,64,0.04993,0.0029414,0.10253,0.31314,HP_BONE_MARROW_HYPOCELLULARITY,0.95580811023622
PID_WNT_CANONICAL_PATHWAY,SET,20,0.088346,0.0029128,0.1815,0.31322,PID_WNT_CANONICAL_PATHWAY,0.95580811023622
GOBP_NEURON_CELL_CELL_ADHESI...,SET,13,0.12746,0.0033889,0.26188,0.31323,GOBP_NEURON_CELL_CELL_ADHESION,0.95580811023622
FULLER_PBMC_F_TULARENSIS_VAC...11,SET,57,0.061173,0.0034015,0.12571,0.31327,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP,0.95580811023622
MIR1285_5P,SET,60,0.054129,0.0030878,0.11129,0.31335,MIR1285_5P,0.95580811023622
MIR145_5P,SET,285,0.025213,0.0031154,0.051854,0.3134,MIR145_5P,0.95580811023622
BENPORATH_ES_2,SET,32,0.071534,0.0029824,0.14714,0.31343,BENPORATH_ES_2,0.95580811023622
WP_IL17_SIGNALING,SET,30,0.079751,0.0032195,0.16404,0.31343,WP_IL17_SIGNALING,0.95580811023622
GSE7400_CTRL_VS_CSF3_IN_VIVO...1,SET,175,0.031542,0.0030632,0.064884,0.31344,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN,0.95580811023622
HP_DECREASED_SPECIFIC_PNEUMO...,SET,7,0.16969,0.003311,0.34907,0.31345,HP_DECREASED_SPECIFIC_PNEUMOCOCCAL_ANTIBODY_LEVEL,0.95580811023622
PAF1_TARGET_GENES,SET,55,0.057723,0.0031531,0.11879,0.31351,PAF1_TARGET_GENES,0.95580811023622
KEGG_MEDICUS_REFERENCE_LOADI...,SET,7,0.16968,0.0033109,0.34927,0.31355,KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX,0.95580811023622
GOBP_PHOTORECEPTOR_CELL_OUTE...,SET,12,0.11266,0.0028778,0.2319,0.31356,GOBP_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION,0.95580811023622
HP_DECREASED_LYMPHOCYTE_PROL...1,SET,9,0.15868,0.0035107,0.32664,0.31356,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_ANTI_CD3,0.95580811023622
BIOCARTA_FEEDER_PATHWAY,SET,8,0.11884,0.0024789,0.24466,0.31358,BIOCARTA_FEEDER_PATHWAY,0.95580811023622
GOMF_JUN_KINASE_KINASE_KINAS...,SET,9,0.14482,0.003204,0.29818,0.3136,GOMF_JUN_KINASE_KINASE_KINASE_ACTIVITY,0.95580811023622
GOBP_NEGATIVE_REGULATION_OF_...257,SET,12,0.12236,0.0031256,0.25196,0.31362,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT,0.95580811023622
LI_WILMS_TUMOR,SET,23,0.099217,0.0035078,0.20438,0.31368,LI_WILMS_TUMOR,0.95580811023622
GOBP_POSITIVE_REGULATION_OF_...95,SET,770,0.015778,0.0031613,0.032503,0.31369,GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.95580811023622
GOBP_CHROMOSOME_ATTACHMENT_T...,SET,4,0.17679,0.0026079,0.36427,0.31373,GOBP_CHROMOSOME_ATTACHMENT_TO_THE_NUCLEAR_ENVELOPE,0.95580811023622
HP_NEURONAL_LOSS_IN_CENTRAL_...,SET,34,0.067596,0.0029047,0.1393,0.31376,HP_NEURONAL_LOSS_IN_CENTRAL_NERVOUS_SYSTEM,0.95580811023622
HP_DIFFUSE_ALVEOLAR_HEMORRHA...,SET,16,0.10763,0.0031745,0.22185,0.31378,HP_DIFFUSE_ALVEOLAR_HEMORRHAGE,0.95580811023622
TCCAGAG_MIR518C,SET,137,0.039505,0.0033981,0.081428,0.31379,TCCAGAG_MIR518C,0.95580811023622
NRF2_Q4,SET,227,0.027588,0.003047,0.056864,0.31379,NRF2_Q4,0.95580811023622
GSE32255_WT_UNSTIM_VS_JMJD2D...2,SET,160,0.033109,0.0030758,0.068249,0.3138,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.95580811023622
HP_ABNORMAL_FRONTALIS_MUSCLE...,SET,10,0.13874,0.0032354,0.28619,0.31392,HP_ABNORMAL_FRONTALIS_MUSCLE_PHYSIOLOGY,0.95580811023622
HP_EPISODIC_RESPIRATORY_DIST...,SET,10,0.13874,0.0032354,0.28619,0.31392,HP_EPISODIC_RESPIRATORY_DISTRESS,0.95580811023622
GOBP_NEGATIVE_REGULATION_OF_...442,SET,115,0.038806,0.0030601,0.080074,0.31398,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.95580811023622
LXR_Q3,SET,74,0.047668,0.0030187,0.098399,0.31404,LXR_Q3,0.95580811023622
GSE22886_DAY0_VS_DAY1_MONOCY...2,SET,183,0.031623,0.0031399,0.065276,0.31404,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP,0.95580811023622
HP_JUVENILE_MYELOMONOCYTIC_L...,SET,18,0.091331,0.0028569,0.18854,0.31405,HP_JUVENILE_MYELOMONOCYTIC_LEUKEMIA,0.95580811023622
GOBP_BIOMINERAL_TISSUE_DEVEL...,SET,161,0.034957,0.0032575,0.072177,0.31408,GOBP_BIOMINERAL_TISSUE_DEVELOPMENT,0.95580811023622
MIR221_3P,SET,161,0.033865,0.0031557,0.06993,0.3141,MIR221_3P,0.95580811023622
MIR571,SET,61,0.053834,0.0030963,0.11116,0.3141,MIR571,0.95580811023622
GOBP_POSITIVE_REGULATION_OF_...780,SET,4,0.18079,0.0026669,0.37346,0.31417,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.95580811023622
GSE12845_IGD_POS_BLOOD_VS_DA...1,SET,174,0.02946,0.002853,0.060866,0.31419,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.95580811023622
GSE8685_IL2_ACT_IL2_STARVED_...4,SET,161,0.033811,0.0031508,0.069863,0.31421,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.95580811023622
GOBP_POSITIVE_REGULATION_OF_...581,SET,24,0.087592,0.0031633,0.18106,0.31427,GOBP_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.95580811023622
MIR1203,SET,4,0.19523,0.0028799,0.40355,0.31428,MIR1203,0.95580811023622
GOBP_PROTEIN_LINEAR_POLYUBIQ...,SET,3,0.21606,0.0027602,0.44663,0.31428,GOBP_PROTEIN_LINEAR_POLYUBIQUITINATION,0.95580811023622
GSE42021_CD24HI_TREG_VS_CD24...2,SET,179,0.029718,0.0029185,0.061435,0.31429,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP,0.95580811023622
ZHANG_TARGETS_OF_EWSR1_FLI1_...,SET,83,0.050307,0.0033732,0.104,0.3143,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,0.95580811023622
GOBP_SKELETAL_MUSCLE_CELL_PR...,SET,23,0.082979,0.0029337,0.17158,0.31433,GOBP_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.95580811023622
AGGCACT_MIR5153P,SET,80,0.046583,0.0030668,0.096325,0.31434,AGGCACT_MIR5153P,0.95580811023622
GOBP_STEROID_CATABOLIC_PROCE...,SET,24,0.089145,0.0032194,0.18433,0.31434,GOBP_STEROID_CATABOLIC_PROCESS,0.95580811023622
HP_IRREGULARLY_SHAPED_SPERM_...,SET,11,0.12044,0.0029457,0.24928,0.31449,HP_IRREGULARLY_SHAPED_SPERM_TAIL,0.956104487011283
MEINHOLD_OVARIAN_CANCER_LOW_...1,SET,19,0.097012,0.0031177,0.20079,0.3145,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,0.956104487011283
HP_INCREASED_TOTAL_BILIRUBIN,SET,14,0.10672,0.0029443,0.22091,0.31452,HP_INCREASED_TOTAL_BILIRUBIN,0.956104487011283
HP_UNILATERAL_CLEFT_LIP,SET,8,0.121,0.0025239,0.25064,0.31464,HP_UNILATERAL_CLEFT_LIP,0.956324632802938
GSE17721_CTRL_VS_POLYIC_8H_B...2,SET,178,0.029599,0.0028988,0.06132,0.31466,GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP,0.956324632802938
GOBP_PROTEIN_LOCALIZATION_TO...48,SET,11,0.12392,0.0030309,0.25682,0.31471,GOBP_PROTEIN_LOCALIZATION_TO_SITE_OF_DOUBLE_STRAND_BREAK,0.956324632802938
CYCLIN_D1_KE_.V1_DN,SET,179,0.031026,0.003047,0.064297,0.31472,CYCLIN_D1_KE_.V1_DN,0.956324632802938
HP_COOMBS_POSITIVE_HEMOLYTIC...,SET,9,0.14368,0.0031789,0.29779,0.31473,HP_COOMBS_POSITIVE_HEMOLYTIC_ANEMIA,0.956324632802938
GOBP_ANDROGEN_CATABOLIC_PROC...,SET,5,0.18773,0.0030961,0.38915,0.31476,GOBP_ANDROGEN_CATABOLIC_PROCESS,0.95633217938631
GOBP_REGULATION_OF_RELEASE_O...2,SET,77,0.05064,0.003271,0.10501,0.31482,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.956377646184774
TRAVAGLINI_LUNG_CAPILLARY_AE...,SET,41,0.06868,0.0032403,0.14243,0.31483,TRAVAGLINI_LUNG_CAPILLARY_AEROCYTE_CELL,0.956377646184774
GOMF_MUTSALPHA_COMPLEX_BINDI...,SET,7,0.15421,0.0030091,0.31986,0.31486,GOMF_MUTSALPHA_COMPLEX_BINDING,0.956385186156266
GOBP_REGULATION_OF_PROTEIN_O...,SET,5,0.19086,0.0031477,0.39605,0.31493,GOBP_REGULATION_OF_PROTEIN_OLIGOMERIZATION,0.956514213929913
REACTOME_ATF6_ATF6_ALPHA_ACT...1,SET,11,0.11282,0.0027592,0.23417,0.31499,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,0.956612849528137
HE_LIM_SUN_FETAL_LUNG_C4_ACT...,SET,46,0.063402,0.003168,0.13165,0.31505,HE_LIM_SUN_FETAL_LUNG_C4_ACTIVATED_NK_CELL,0.956619468447238
HP_DISTURBANCE_OF_FACIAL_EXP...,SET,40,0.06548,0.0030515,0.13605,0.31515,HP_DISTURBANCE_OF_FACIAL_EXPRESSION,0.956619468447238
YTCCCRNNAGGY_UNKNOWN,SET,59,0.052397,0.0029641,0.10889,0.31519,YTCCCRNNAGGY_UNKNOWN,0.956619468447238
REACTOME_PP2A_MEDIATED_DEPHO...,SET,6,0.16637,0.0030056,0.34576,0.3152,REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.956619468447238
MIR6750_5P,SET,63,0.048606,0.0028409,0.10103,0.31522,MIR6750_5P,0.956619468447238
GSE43955_TGFB_IL6_VS_TGFB_IL...2,SET,185,0.029302,0.0029251,0.060903,0.31522,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,0.956619468447238
GSE40274_CTRL_VS_FOXP3_AND_I...2,SET,146,0.034791,0.0030886,0.072322,0.31524,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.956619468447238
GOBP_POSITIVE_REGULATION_OF_...528,SET,62,0.055145,0.0031976,0.11465,0.31527,GOBP_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.956619468447238
HP_ABNORMAL_OSSIFICATION_INV...,SET,23,0.082368,0.0029121,0.17125,0.31527,HP_ABNORMAL_OSSIFICATION_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,0.956619468447238
MIR1301_3P_MIR5047,SET,105,0.041292,0.0031122,0.085859,0.31529,MIR1301_3P_MIR5047,0.956619468447238
KIM_WT1_TARGETS_12HR_UP,SET,154,0.034369,0.0031329,0.071472,0.31531,KIM_WT1_TARGETS_12HR_UP,0.956619468447238
GOBP_NEGATIVE_REGULATION_OF_...215,SET,7,0.18261,0.0035633,0.3798,0.31533,GOBP_NEGATIVE_REGULATION_OF_ERAD_PATHWAY,0.956619468447238
GOBP_3_UTR_MEDIATED_MRNA_DES...,SET,19,0.097375,0.0031293,0.20255,0.31535,GOBP_3_UTR_MEDIATED_MRNA_DESTABILIZATION,0.956619468447238
GSE21546_UNSTIM_VS_ANTI_CD3_...1,SET,170,0.029683,0.0028416,0.061753,0.31538,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.956626976784779
chr14q21,SET,33,0.12014,0.0050863,0.25014,0.31551,chr14q21,0.956884607329843
GOMF_COENZYME_A_DIPHOSPHATAS...,SET,5,0.1752,0.0028893,0.36479,0.31552,GOMF_COENZYME_A_DIPHOSPHATASE_ACTIVITY,0.956884607329843
ZFP91_TARGET_GENES,SET,1121,0.012569,0.003008,0.026176,0.31556,ZFP91_TARGET_GENES,0.95692241514702
MIR556_5P,SET,39,0.065082,0.0029949,0.13571,0.31577,MIR556_5P,0.95745221069155
CHAF1B_TARGET_GENES,SET,719,0.015858,0.0030746,0.033071,0.31579,CHAF1B_TARGET_GENES,0.95745221069155
GOBP_POSITIVE_REGULATION_OF_...463,SET,58,0.055176,0.0030948,0.11513,0.31589,GOBP_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.95745221069155
GOBP_POSITIVE_REGULATION_OF_...704,SET,18,0.10608,0.0033182,0.22135,0.31589,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,0.95745221069155
GOBP_REGULATION_OF_MITOCHOND...16,SET,136,0.035071,0.0030057,0.073184,0.3159,GOBP_REGULATION_OF_MITOCHONDRION_ORGANIZATION,0.95745221069155
HP_ABNORMAL_CIRCULATING_SEX_...,SET,108,0.039458,0.0030159,0.08234,0.3159,HP_ABNORMAL_CIRCULATING_SEX_HORMONE_CONCENTRATION,0.95745221069155
WP_NIPBL_ROLE_IN_DNA_DAMAGE_...,SET,7,0.14544,0.0028378,0.3037,0.31601,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.957617937766931
HP_SECONDARY_AMENORRHEA,SET,62,0.049694,0.0028815,0.10377,0.31601,HP_SECONDARY_AMENORRHEA,0.957617937766931
HP_ABNORMAL_MITOCHONDRIAL_MO...,SET,23,0.076684,0.0027111,0.16017,0.31605,HP_ABNORMAL_MITOCHONDRIAL_MORPHOLOGY,0.957617937766931
MIR6753_5P,SET,20,0.093754,0.0030911,0.19585,0.31608,MIR6753_5P,0.957617937766931
GOBP_GLUTAMATE_SECRETION_NEU...,SET,8,0.15908,0.0033184,0.33236,0.3161,GOBP_GLUTAMATE_SECRETION_NEUROTRANSMISSION,0.957617937766931
MATZUK_PREOVULATORY_FOLLICLE,SET,9,0.16179,0.0035794,0.33805,0.31612,MATZUK_PREOVULATORY_FOLLICLE,0.957617937766931
MIR6780A_3P,SET,138,0.035165,0.0030358,0.073542,0.31627,MIR6780A_3P,0.957759913793103
WP_MICROGLIA_PATHOGEN_PHAGOC...,SET,37,0.071861,0.0032211,0.15031,0.3163,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.957759913793103
GOBP_POSITIVE_REGULATION_OF_...784,SET,5,0.20972,0.0034588,0.43874,0.31632,GOBP_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.957759913793103
GSE13547_WT_VS_ZFX_KO_BCELL_...2,SET,125,0.039379,0.0032366,0.08238,0.31632,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP,0.957759913793103
CCAGGGG_MIR331,SET,83,0.043373,0.0029082,0.090746,0.31634,CCAGGGG_MIR331,0.957759913793103
HP_ACROMESOMELIA,SET,5,0.16713,0.0027563,0.34974,0.31638,HP_ACROMESOMELIA,0.957759913793103
HP_ABNORMAL_PULMONARY_ALVEOL...,SET,5,0.21944,0.0036191,0.45929,0.3164,HP_ABNORMAL_PULMONARY_ALVEOLAR_SYSTEM_MORPHOLOGY,0.957759913793103
BOQUEST_STEM_CELL_CULTURED_V...2,SET,385,0.022863,0.0032743,0.047861,0.31644,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,0.957759913793103
GOBP_NEGATIVE_REGULATION_OF_...93,SET,8,0.15865,0.0033094,0.33214,0.31644,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,0.957759913793103
HP_ORAL_MUCOSAL_BLISTERS,SET,13,0.11774,0.0031305,0.2465,0.31645,HP_ORAL_MUCOSAL_BLISTERS,0.957759913793103
HP_UNILATERAL_PRIMARY_PULMON...,SET,3,0.2123,0.0027122,0.44451,0.31647,HP_UNILATERAL_PRIMARY_PULMONARY_DYSGENESIS,0.957759913793103
MIR3974,SET,86,0.046958,0.0032047,0.098341,0.31651,MIR3974,0.957774695281212
BIDUS_METASTASIS_DN,SET,131,0.036078,0.0030351,0.075567,0.31653,BIDUS_METASTASIS_DN,0.957774695281212
chr1q43,SET,21,0.15158,0.0051211,0.31778,0.31668,chr1q43,0.958072454387489
HP_SPOTTY_HYPOPIGMENTATION,SET,7,0.15795,0.0030821,0.33117,0.3167,HP_SPOTTY_HYPOPIGMENTATION,0.958072454387489
GOBP_NUCLEOLAR_LARGE_RRNA_TR...,SET,19,0.092502,0.0029727,0.19402,0.31677,GOBP_NUCLEOLAR_LARGE_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.958072454387489
GSE43955_1H_VS_10H_ACT_CD4_T...1,SET,186,0.029606,0.0029634,0.062111,0.3168,GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN,0.958072454387489
KARLSSON_TGFB1_TARGETS_DN,SET,175,0.03061,0.0029727,0.064236,0.31686,KARLSSON_TGFB1_TARGETS_DN,0.958072454387489
HP_ALACRIMA,SET,17,0.097704,0.0029702,0.20514,0.31694,HP_ALACRIMA,0.958072454387489
MIR4793_5P,SET,58,0.053987,0.0030281,0.11341,0.31702,MIR4793_5P,0.958072454387489
GOMF_HSP70_PROTEIN_BINDING,SET,48,0.058183,0.0029696,0.12222,0.31702,GOMF_HSP70_PROTEIN_BINDING,0.958072454387489
GSE26495_NAIVE_VS_PD1LOW_CD8...2,SET,153,0.033647,0.0030572,0.070688,0.31704,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP,0.958072454387489
DESCARTES_MAIN_FETAL_VASCULA...,SET,40,0.067762,0.0031579,0.14236,0.31704,DESCARTES_MAIN_FETAL_VASCULAR_ENDOTHELIAL_CELLS,0.958072454387489
GSE15139_GMCSF_TREATED_VS_UN...1,SET,187,0.028414,0.0028516,0.059705,0.31707,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN,0.958072454387489
GOBP_NEGATIVE_REGULATION_OF_...396,SET,8,0.15145,0.0031591,0.31826,0.31709,GOBP_NEGATIVE_REGULATION_OF_MIRNA_PROCESSING,0.958072454387489
GOCC_CHROMOSOME_TELOMERIC_RE...1,SET,134,0.033439,0.0028449,0.070279,0.31711,GOCC_CHROMOSOME_TELOMERIC_REGION,0.958072454387489
GOMF_RETINYL_PALMITATE_ESTER...,SET,6,0.19131,0.0034561,0.40207,0.31711,GOMF_RETINYL_PALMITATE_ESTERASE_ACTIVITY,0.958072454387489
GOBP_REGULATION_OF_ACTIVATIO...,SET,8,0.15445,0.0032217,0.32462,0.31712,GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.958072454387489
GOBP_REGULATION_OF_POTASSIUM...2,SET,4,0.23174,0.0034185,0.48709,0.31712,GOBP_REGULATION_OF_POTASSIUM_ION_IMPORT,0.958072454387489
HP_PULMONARY_EDEMA,SET,25,0.086576,0.003191,0.182,0.31715,HP_PULMONARY_EDEMA,0.958072454387489
GSE43863_LY6C_INT_CXCR5POS_V...2,SET,181,0.032453,0.0032048,0.068236,0.31718,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.958072454387489
GOBP_CANONICAL_WNT_SIGNALING...,SET,288,0.025373,0.0031513,0.053354,0.31719,GOBP_CANONICAL_WNT_SIGNALING_PATHWAY,0.958072454387489
GOBP_REGULATION_OF_DNA_CATAB...,SET,10,0.12943,0.0030183,0.27216,0.31719,GOBP_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.958072454387489
PID_BCR_5PATHWAY,SET,59,0.054337,0.0030738,0.11429,0.31725,PID_BCR_5PATHWAY,0.958072454387489
GSE21670_TGFB_VS_IL6_TREATED...3,SET,185,0.031052,0.0030998,0.065323,0.31727,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.958072454387489
GSE3982_DC_VS_EFF_MEMORY_CD4...2,SET,187,0.030282,0.0030391,0.063706,0.31727,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP,0.958072454387489
SA_REG_CASCADE_OF_CYCLIN_EXPR,SET,13,0.11263,0.0029944,0.23696,0.31729,SA_REG_CASCADE_OF_CYCLIN_EXPR,0.958072454387489
GSE42724_NAIVE_VS_B1_BCELL_UP,SET,182,0.029593,0.0029303,0.062295,0.31738,GSE42724_NAIVE_VS_B1_BCELL_UP,0.958254896438166
REACTOME_SARS_COV_1_INFECTION,SET,129,0.034553,0.0028847,0.07276,0.31744,REACTOME_SARS_COV_1_INFECTION,0.958254896438166
MIR7162_3P,SET,201,0.029611,0.0030797,0.062393,0.31754,MIR7162_3P,0.958254896438166
KRAS.AMP.LUNG_UP.V1_UP,SET,117,0.039675,0.0031555,0.083605,0.31756,KRAS.AMP.LUNG_UP.V1_UP,0.958254896438166
HP_TYPIFIED_BY_INCOMPLETE_PE...,SET,132,0.036634,0.0030936,0.077222,0.31761,HP_TYPIFIED_BY_INCOMPLETE_PENETRANCE,0.958254896438166
GOBP_DETECTION_OF_STIMULUS_I...1,SET,418,0.026897,0.00401,0.056709,0.31765,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.958254896438166
GSE6875_WT_VS_FOXP3_KO_TREG_...1,SET,179,0.030845,0.0030292,0.065038,0.31766,GSE6875_WT_VS_FOXP3_KO_TREG_DN,0.958254896438166
GSE14415_INDUCED_TREG_VS_FAI...1,SET,168,0.032431,0.0030865,0.068401,0.31771,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN,0.958254896438166
GOBP_POSITIVE_REGULATION_OF_...831,SET,7,0.17161,0.0033486,0.36209,0.31777,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.958254896438166
HP_MALE_PSEUDOHERMAPHRODITISM,SET,36,0.064708,0.0028611,0.13654,0.31778,HP_MALE_PSEUDOHERMAPHRODITISM,0.958254896438166
GOBP_DENDRITIC_SPINE_DEVELOP...,SET,88,0.043262,0.0029864,0.091314,0.31784,GOBP_DENDRITIC_SPINE_DEVELOPMENT,0.958254896438166
GOBP_RETINAL_CONE_CELL_DIFFE...,SET,13,0.12348,0.0032829,0.26064,0.31785,GOBP_RETINAL_CONE_CELL_DIFFERENTIATION,0.958254896438166
GSE39556_CD8A_DC_VS_NK_CELL_...2,SET,181,0.031192,0.0030803,0.065848,0.31786,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN,0.958254896438166
GSE17721_CPG_VS_GARDIQUIMOD_...9,SET,178,0.030423,0.0029795,0.06423,0.31787,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN,0.958254896438166
GOBP_POLYOL_CATABOLIC_PROCESS,SET,8,0.16146,0.003368,0.34089,0.31788,GOBP_POLYOL_CATABOLIC_PROCESS,0.958254896438166
FRASOR_RESPONSE_TO_SERM_OR_F...1,SET,48,0.05677,0.0028975,0.11987,0.31789,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,0.958254896438166
GSE13411_IGM_VS_SWITCHED_MEM...1,SET,176,0.030386,0.0029593,0.064161,0.3179,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN,0.958254896438166
MIR1288_3P,SET,36,0.069256,0.0030622,0.14631,0.31798,MIR1288_3P,0.958254896438166
GSE37416_CTRL_VS_24H_F_TULAR...2,SET,166,0.032247,0.0030509,0.068127,0.31799,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.958254896438166
MIR34C_3P,SET,58,0.050073,0.0028086,0.10582,0.31803,MIR34C_3P,0.958254896438166
REACTOME_STRIATED_MUSCLE_CON...,SET,35,0.06609,0.0028814,0.13967,0.31804,REACTOME_STRIATED_MUSCLE_CONTRACTION,0.958254896438166
YTAATTAA_LHX3_01,SET,179,0.03356,0.0032959,0.070924,0.31805,YTAATTAA_LHX3_01,0.958254896438166
GOBP_ISOPRENOID_CATABOLIC_PR...,SET,9,0.14768,0.0032673,0.31211,0.31805,GOBP_ISOPRENOID_CATABOLIC_PROCESS,0.958254896438166
REACTOME_FCERI_MEDIATED_CA_2...,SET,30,0.071726,0.0028956,0.1516,0.31807,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,0.958254896438166
GSE37416_0H_VS_12H_F_TULAREN...2,SET,169,0.031851,0.0030403,0.067335,0.3181,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.958254896438166
REACTOME_NFE2L2_REGULATING_M...,SET,8,0.1524,0.0031789,0.32221,0.31812,REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES,0.958254896438166
GOBP_CENTRIOLE_ASSEMBLY,SET,45,0.056945,0.0028144,0.1204,0.31812,GOBP_CENTRIOLE_ASSEMBLY,0.958254896438166
GOBP_REGULATION_OF_MITOTIC_S...2,SET,22,0.075478,0.0026099,0.15961,0.31815,GOBP_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY,0.958254896438166
GOBP_REGULATION_OF_RAS_PROTE...,SET,46,0.061222,0.0030591,0.12946,0.31815,GOBP_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.958254896438166
HP_DECREASED_CIRCULATING_VIT...1,SET,8,0.17015,0.0035492,0.35992,0.3182,HP_DECREASED_CIRCULATING_VITAMIN_B12_CONCENTRATION,0.958269521705225
GOBP_MIRNA_CATABOLIC_PROCESS,SET,8,0.1318,0.0027492,0.27881,0.31821,GOBP_MIRNA_CATABOLIC_PROCESS,0.958269521705225
MOSERLE_IFNA_RESPONSE,SET,30,0.087015,0.0035128,0.18413,0.31826,MOSERLE_IFNA_RESPONSE,0.958337055969503
HP_SMALL_INTESTINAL_POLYPOSIS,SET,5,0.16446,0.0027123,0.34809,0.3183,HP_SMALL_INTESTINAL_POLYPOSIS,0.958374469375379
MMEF2_Q6,SET,245,0.027042,0.0031014,0.057247,0.31833,MMEF2_Q6,0.95838176975052
GNF2_HLA_C,SET,40,0.063672,0.0029673,0.13491,0.31848,GNF2_HLA_C,0.958478439691748
GOCC_TERTIARY_GRANULE,SET,147,0.033908,0.0030204,0.071849,0.31849,GOCC_TERTIARY_GRANULE,0.958478439691748
GSE36392_EOSINOPHIL_VS_MAC_I...1,SET,177,0.029076,0.0028397,0.061611,0.31849,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN,0.958478439691748
AMIT_SERUM_RESPONSE_120_MCF1...,SET,63,0.052455,0.0030659,0.11116,0.3185,AMIT_SERUM_RESPONSE_120_MCF10A,0.958478439691748
GCNP_SHH_UP_LATE.V1_UP,SET,163,0.030859,0.0028933,0.065392,0.3185,GCNP_SHH_UP_LATE.V1_UP,0.958478439691748
GOBP_RESPONSE_TO_NUTRIENT_LE...,SET,455,0.01994,0.0030984,0.042292,0.31865,GOBP_RESPONSE_TO_NUTRIENT_LEVELS,0.958593758060356
NAKAMURA_TUMOR_ZONE_PERIPHER...1,SET,550,0.017547,0.0029898,0.037221,0.31867,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN,0.958593758060356
MIR4256,SET,68,0.047976,0.0029129,0.10177,0.31868,MIR4256,0.958593758060356
GOMF_BRANCHED_CHAIN_AMINO_AC...,SET,9,0.14134,0.003127,0.29987,0.31871,GOMF_BRANCHED_CHAIN_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.958593758060356
LEE_LIVER_CANCER_DENA_UP,SET,56,0.057603,0.0031749,0.12228,0.31879,LEE_LIVER_CANCER_DENA_UP,0.958593758060356
GSE11924_TFH_VS_TH2_CD4_TCEL...2,SET,183,0.028117,0.0027917,0.059715,0.31888,GSE11924_TFH_VS_TH2_CD4_TCELL_UP,0.958593758060356
GSE18893_TCONV_VS_TREG_2H_CU...2,SET,175,0.029725,0.0028868,0.063144,0.31891,GSE18893_TCONV_VS_TREG_2H_CULTURE_UP,0.958593758060356
YAATNANRNNNCAG_UNKNOWN,SET,61,0.052211,0.003003,0.11093,0.31894,YAATNANRNNNCAG_UNKNOWN,0.958593758060356
chr2p23,SET,84,0.086831,0.0058569,0.18451,0.31897,chr2p23,0.958593758060356
PID_RETINOIC_ACID_PATHWAY,SET,30,0.072814,0.0029395,0.15473,0.31897,PID_RETINOIC_ACID_PATHWAY,0.958593758060356
MODULE_153,SET,31,0.075695,0.0031062,0.16085,0.31897,MODULE_153,0.958593758060356
AGARWAL_AKT_PATHWAY_TARGETS,SET,10,0.14493,0.0033798,0.30809,0.31903,AGARWAL_AKT_PATHWAY_TARGETS,0.958593758060356
HP_PANCYTOPENIA,SET,116,0.03659,0.0028978,0.077784,0.31903,HP_PANCYTOPENIA,0.958593758060356
HP_EXUDATIVE_VITREORETINOPAT...,SET,7,0.13153,0.0025665,0.27961,0.31904,HP_EXUDATIVE_VITREORETINOPATHY,0.958593758060356
GOBP_DESMOSOME_ORGANIZATION,SET,9,0.16154,0.0035739,0.3435,0.31908,GOBP_DESMOSOME_ORGANIZATION,0.958593758060356
GOBP_POSITIVE_REGULATION_OF_...848,SET,5,0.18266,0.0030125,0.3885,0.31912,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.958593758060356
GOBP_HIGH_DENSITY_LIPOPROTEI...2,SET,11,0.12224,0.0029897,0.26,0.31913,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.958593758060356
GOCC_PRESYNAPTIC_CYTOSOL,SET,12,0.1178,0.0030091,0.25056,0.31913,GOCC_PRESYNAPTIC_CYTOSOL,0.958593758060356
HP_APLASIA_HYPOPLASIA_OF_THE...10,SET,13,0.11305,0.0030056,0.24057,0.31921,HP_APLASIA_HYPOPLASIA_OF_THE_BLADDER,0.958593758060356
GOBP_POSITIVE_REGULATION_OF_...495,SET,1505,0.011225,0.0030778,0.023894,0.31926,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.958593758060356
MIR548I,SET,441,0.019216,0.0029408,0.040908,0.31927,MIR548I,0.958593758060356
GSE17721_POLYIC_VS_GARDIQUIM...10,SET,185,0.030114,0.0030062,0.064149,0.31938,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP,0.958593758060356
GSE18893_TCONV_VS_TREG_2H_TN...2,SET,185,0.029017,0.0028966,0.061827,0.31942,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP,0.958593758060356
GOBP_POSITIVE_REGULATION_OF_...456,SET,5,0.21605,0.0035631,0.46038,0.31944,GOBP_POSITIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.958593758060356
DEBIASI_APOPTOSIS_BY_REOVIRU...2,SET,272,0.025017,0.0030209,0.053323,0.31948,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,0.958593758060356
GSE16385_IFNG_TNF_VS_ROSIGLI...2,SET,160,0.031582,0.002934,0.067328,0.31951,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.958593758060356
PID_ANTHRAX_PATHWAY,SET,17,0.098421,0.002992,0.20985,0.31953,PID_ANTHRAX_PATHWAY,0.958593758060356
MODULE_54,SET,237,0.025535,0.002881,0.054445,0.31954,MODULE_54,0.958593758060356
GSE24634_IL4_VS_CTRL_TREATED...8,SET,177,0.02882,0.0028147,0.061452,0.31954,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP,0.958593758060356
NAKAYAMA_SOFT_TISSUE_TUMORS_...2,SET,69,0.052094,0.003186,0.11109,0.31956,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,0.958593758060356
GSE5542_IFNG_VS_IFNA_TREATED...3,SET,172,0.030981,0.0029831,0.066066,0.31956,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,0.958593758060356
chr10p11,SET,23,0.14495,0.0051247,0.30912,0.31957,chr10p11,0.958593758060356
GOBP_REGULATION_OF_ENDOTHELI...1,SET,19,0.10216,0.0032832,0.21792,0.31961,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.958593758060356
GSE21927_SPLEEN_VS_TUMOR_MON...2,SET,142,0.032838,0.0028753,0.070061,0.31964,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP,0.958593758060356
BIOCARTA_EEA1_PATHWAY,SET,7,0.13953,0.0027227,0.29772,0.31965,BIOCARTA_EEA1_PATHWAY,0.958593758060356
PID_LPA4_PATHWAY,SET,14,0.11375,0.0031382,0.24271,0.31966,PID_LPA4_PATHWAY,0.958593758060356
HP_EEG_WITH_GENERALIZED_POLY...,SET,6,0.16821,0.0030387,0.35892,0.31966,HP_EEG_WITH_GENERALIZED_POLYSPIKES,0.958593758060356
chr18q23,SET,15,0.15699,0.0044833,0.33505,0.31969,chr18q23,0.958593758060356
WP_FAMILIAL_HYPERLIPIDEMIA_T...2,SET,16,0.10246,0.0030218,0.21866,0.31969,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,0.958593758060356
HP_CONGENITAL_ONSET,SET,951,0.013319,0.0029503,0.028439,0.31978,HP_CONGENITAL_ONSET,0.958593758060356
FUJIWARA_PARK2_IN_LIVER_CANC...1,SET,5,0.19123,0.0031537,0.40835,0.31979,FUJIWARA_PARK2_IN_LIVER_CANCER_DN,0.958593758060356
BIOCARTA_TUBBY_PATHWAY,SET,4,0.22783,0.0033609,0.48662,0.31983,BIOCARTA_TUBBY_PATHWAY,0.958593758060356
CAGTGTT_MIR141_MIR200A,SET,288,0.023872,0.0029648,0.05099,0.31984,CAGTGTT_MIR141_MIR200A,0.958593758060356
GOBP_PROTEIN_INSERTION_INTO_...5,SET,10,0.12394,0.0028903,0.26478,0.31986,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_INNER_MEMBRANE,0.958593758060356
HP_SHORT_PROXIMAL_PHALANX_OF...,SET,7,0.15573,0.0030387,0.33273,0.31988,HP_SHORT_PROXIMAL_PHALANX_OF_FINGER,0.958593758060356
FRANCO_BLOOD_SANOFI_PASTEUR_...7,SET,17,0.10105,0.0030719,0.21591,0.31989,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_3DY_POSITIVE,0.958593758060356
chr20q11,SET,118,0.095163,0.0076008,0.20334,0.3199,chr20q11,0.958593758060356
GOBP_REGULATION_OF_PRESYNAPT...1,SET,12,0.13174,0.0033654,0.28159,0.31995,GOBP_REGULATION_OF_PRESYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.958593758060356
MIR222_3P,SET,158,0.033006,0.0030472,0.070552,0.31996,MIR222_3P,0.958593758060356
KEGG_MEDICUS_REFERENCE_EARLY...,SET,8,0.12458,0.0025987,0.26639,0.32001,KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION,0.958593758060356
GOBP_PROTEIN_LOCALIZATION_TO...16,SET,8,0.12356,0.0025774,0.2642,0.32001,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_TRANSITION_ZONE,0.958593758060356
MODULE_377,SET,10,0.13547,0.0031593,0.28973,0.32004,MODULE_377,0.958593758060356
WP_OVARIAN_INFERTILITY,SET,38,0.065131,0.0029586,0.13931,0.32006,WP_OVARIAN_INFERTILITY,0.958593758060356
GOBP_REGULATION_OF_ATTACHMEN...2,SET,22,0.081455,0.0028166,0.17423,0.32007,GOBP_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.958593758060356
HP_PERIPHERAL_VISUAL_FIELD_L...,SET,92,0.042227,0.0029802,0.09032,0.32007,HP_PERIPHERAL_VISUAL_FIELD_LOSS,0.958593758060356
HP_PENOSCROTAL_HYPOSPADIAS,SET,8,0.15148,0.0031598,0.32407,0.3201,HP_PENOSCROTAL_HYPOSPADIAS,0.958593758060356
MIR548AH_5P,SET,321,0.022794,0.0029861,0.048784,0.32016,MIR548AH_5P,0.958593758060356
GOBP_CELLULAR_PIGMENTATION,SET,60,0.052948,0.0030204,0.11332,0.32017,GOBP_CELLULAR_PIGMENTATION,0.958593758060356
chr12p13,SET,133,0.080488,0.0068223,0.17234,0.32024,chr12p13,0.958593758060356
GOMF_CYSTEINE_TYPE_ENDOPEPTI...4,SET,6,0.17425,0.003148,0.37309,0.32024,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.958593758060356
GOBP_REGULATION_OF_MODIFICAT...3,SET,12,0.1072,0.0027383,0.22964,0.32032,GOBP_REGULATION_OF_MODIFICATION_OF_SYNAPTIC_STRUCTURE,0.958593758060356
MIR5694,SET,49,0.058024,0.0029921,0.12434,0.32038,MIR5694,0.958593758060356
GOBP_MITOCHONDRIAL_OUTER_MEM...,SET,26,0.07474,0.0028092,0.16018,0.3204,GOBP_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION,0.958593758060356
HP_ERYSIPELAS,SET,11,0.12672,0.0030992,0.27158,0.3204,HP_ERYSIPELAS,0.958593758060356
REACTOME_METABOLISM_OF_PORPH...,SET,26,0.07828,0.0029423,0.16779,0.32042,REACTOME_METABOLISM_OF_PORPHYRINS,0.958593758060356
REACTOME_MAP2K_AND_MAPK_ACTI...,SET,38,0.064337,0.0029225,0.13795,0.32047,REACTOME_MAP2K_AND_MAPK_ACTIVATION,0.958593758060356
MIR7112_3P,SET,87,0.042588,0.0029233,0.091324,0.32049,MIR7112_3P,0.958593758060356
MIR591,SET,44,0.062217,0.0030406,0.13346,0.32055,MIR591,0.958593758060356
REACTOME_MICRORNA_MIRNA_BIOG...,SET,24,0.075985,0.0027441,0.16301,0.32056,REACTOME_MICRORNA_MIRNA_BIOGENESIS,0.958593758060356
GOMF_1_PHOSPHATIDYLINOSITOL_...4,SET,7,0.15505,0.0030254,0.33262,0.32056,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY,0.958593758060356
GOBP_REGULATION_OF_SPINDLE_A...,SET,32,0.063196,0.0026347,0.13558,0.32058,GOBP_REGULATION_OF_SPINDLE_ASSEMBLY,0.958593758060356
CEBP_01,SET,238,0.027596,0.00312,0.059216,0.3206,CEBP_01,0.958593758060356
ZNF322_TARGET_GENES,SET,715,0.014791,0.0028602,0.031741,0.32061,ZNF322_TARGET_GENES,0.958593758060356
TONKS_TARGETS_OF_RUNX1_RUNX1...5,SET,177,0.03225,0.0031497,0.069234,0.32068,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,0.958593758060356
MIR503_3P,SET,36,0.070742,0.0031279,0.15187,0.32068,MIR503_3P,0.958593758060356
GSE45365_NK_CELL_VS_CD8A_DC_...2,SET,161,0.030472,0.0028396,0.065422,0.32069,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN,0.958593758060356
LEIN_LOCALIZED_TO_DISTAL_AND...,SET,16,0.10573,0.0031183,0.22701,0.3207,LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,0.958593758060356
TRAVAGLINI_LUNG_LYMPHATIC_CE...,SET,191,0.031273,0.0031716,0.067163,0.32074,TRAVAGLINI_LUNG_LYMPHATIC_CELL,0.958593758060356
SCHAEFFER_PROSTATE_DEVELOPME...12,SET,33,0.063336,0.0026814,0.13605,0.32078,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,0.958593758060356
HP_ASCENDING_TUBULAR_AORTA_A...,SET,26,0.077048,0.002896,0.16552,0.32079,HP_ASCENDING_TUBULAR_AORTA_ANEURYSM,0.958593758060356
GSE27786_BCELL_VS_NKCELL_DN,SET,183,0.028998,0.0028792,0.062295,0.32079,GSE27786_BCELL_VS_NKCELL_DN,0.958593758060356
PID_IFNG_PATHWAY,SET,40,0.064721,0.0030161,0.13904,0.3208,PID_IFNG_PATHWAY,0.958593758060356
CAO_BLOOD_FLUZONE_AGE_05_14Y...7,SET,6,0.1562,0.0028218,0.33567,0.32085,CAO_BLOOD_FLUZONE_AGE_05_14YO_CORRELATED_WITH_H3N1_HI_TITER_1DY_POSITIVE,0.958660741918845
ZNF407_TARGET_GENES,SET,1554,0.010602,0.0029496,0.022794,0.32093,ZNF407_TARGET_GENES,0.958741116075264
HP_INCREASED_CIRCULATING_ACT...,SET,14,0.10666,0.0029428,0.22937,0.32096,HP_INCREASED_CIRCULATING_ACTH_LEVEL,0.958741116075264
GOMF_BIOTIN_BINDING,SET,5,0.19194,0.0031655,0.41288,0.32101,GOMF_BIOTIN_BINDING,0.958741116075264
MIR874_3P,SET,49,0.053643,0.0027662,0.1154,0.32102,MIR874_3P,0.958741116075264
GOBP_POSITIVE_REGULATION_OF_...14,SET,28,0.083506,0.003257,0.17965,0.32103,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.958741116075264
WENDT_COHESIN_TARGETS_UP,SET,31,0.078599,0.0032254,0.16913,0.32106,WENDT_COHESIN_TARGETS_UP,0.958741116075264
MIR296_3P,SET,28,0.074201,0.0028941,0.15967,0.32107,MIR296_3P,0.958741116075264
HP_SPHEROPHAKIA,SET,5,0.19286,0.0031807,0.41523,0.32116,HP_SPHEROPHAKIA,0.958927474226804
chr2p14,SET,17,0.12183,0.0037036,0.26236,0.3212,chr2p14,0.958964521948286
HP_BROAD_HALLUX_PHALANX,SET,19,0.097982,0.0031488,0.21107,0.32125,HP_BROAD_HALLUX_PHALANX,0.959008747745426
GOMF_SMALL_RIBOSOMAL_SUBUNIT...,SET,7,0.14772,0.0028825,0.31825,0.32127,GOMF_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.959008747745426
GSE16385_UNTREATED_VS_12H_RO...3,SET,176,0.03051,0.0029714,0.065765,0.32136,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,0.959118669527897
HP_PSYCHOSIS,SET,94,0.042608,0.0030394,0.091875,0.32141,HP_PSYCHOSIS,0.959118669527897
GOBP_ACTIN_POLYMERIZATION_OR...,SET,171,0.031136,0.0029894,0.067139,0.32142,GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION,0.959118669527897
HP_ELEVATED_HEMOGLOBIN_A1C,SET,26,0.083765,0.0031484,0.18063,0.32142,HP_ELEVATED_HEMOGLOBIN_A1C,0.959118669527897
GSE43863_TFH_VS_LY6C_LOW_CXC...1,SET,175,0.031471,0.0030564,0.067874,0.32145,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.959118669527897
GOBP_NEGATIVE_REGULATION_OF_...688,SET,3,0.26615,0.0034002,0.57419,0.3215,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.959118669527897
GSE25087_TREG_VS_TCONV_FETUS...1,SET,162,0.030571,0.0028576,0.065955,0.3215,GSE25087_TREG_VS_TCONV_FETUS_DN,0.959118669527897
REACTOME_CARDIAC_CONDUCTION,SET,125,0.037345,0.0030695,0.080631,0.32163,REACTOME_CARDIAC_CONDUCTION,0.959235635312128
GOMF_EPIDERMAL_GROWTH_FACTOR...,SET,34,0.070137,0.0030139,0.15144,0.32164,GOMF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING,0.959235635312128
KEGG_MEDICUS_REFERENCE_ANXA2...,SET,5,0.19626,0.0032367,0.4239,0.32169,KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON,0.959235635312128
TRAVAGLINI_LUNG_BASAL_CELL,SET,174,0.031889,0.0030882,0.068878,0.32169,TRAVAGLINI_LUNG_BASAL_CELL,0.959235635312128
GSE17721_POLYIC_VS_GARDIQUIM...6,SET,186,0.028896,0.0028923,0.062421,0.32171,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP,0.959235635312128
GSE2770_UNTREATED_VS_IL12_TR...5,SET,178,0.029077,0.0028477,0.062826,0.32175,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.959235635312128
GSE17721_PAM3CSK4_VS_CPG_1H_...2,SET,180,0.028144,0.0027716,0.060813,0.32176,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP,0.959235635312128
GOCC_EARLY_ENDOSOME,SET,401,0.019726,0.0028819,0.04264,0.32182,GOCC_EARLY_ENDOSOME,0.959235635312128
GOBP_REGULATION_OF_EPITHELIA...1,SET,97,0.042619,0.0030881,0.09213,0.32183,GOBP_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.959235635312128
GOMF_NADPLUS_PROTEIN_ARGININ...,SET,6,0.16723,0.0030211,0.36168,0.32191,GOMF_NADPLUS_PROTEIN_ARGININE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.959235635312128
HP_INTERMITTENT_THROMBOCYTOP...,SET,4,0.21303,0.0031425,0.46082,0.32194,HP_INTERMITTENT_THROMBOCYTOPENIA,0.959235635312128
GOBP_MATURATION_OF_5_8S_RRNA,SET,33,0.063487,0.0026878,0.13734,0.32195,GOBP_MATURATION_OF_5_8S_RRNA,0.959235635312128
HP_PERIANAL_ABSCESS,SET,8,0.15074,0.0031443,0.32608,0.32195,HP_PERIANAL_ABSCESS,0.959235635312128
GOBP_SEROTONIN_RECEPTOR_SIGN...,SET,8,0.14956,0.0031197,0.32363,0.32199,GOBP_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.959235635312128
GOMF_HISTONE_H4_ACETYLTRANSF...,SET,21,0.075426,0.0025482,0.16322,0.322,GOMF_HISTONE_H4_ACETYLTRANSFERASE_ACTIVITY,0.959235635312128
GOBP_CENTROSOME_SEPARATION,SET,16,0.091772,0.0027066,0.19864,0.32204,GOBP_CENTROSOME_SEPARATION,0.959235635312128
HP_POLYPHAGIA,SET,67,0.053008,0.0031948,0.11474,0.32204,HP_POLYPHAGIA,0.959235635312128
GOBP_REGULATION_OF_INTRINSIC...6,SET,8,0.14008,0.0029221,0.30323,0.32205,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.959235635312128
DESCARTES_FETAL_HEART_CARDIO...,SET,6,0.17818,0.0032189,0.38575,0.32208,DESCARTES_FETAL_HEART_CARDIOMYOCYTES,0.959235635312128
GOBP_LUNG_GROWTH,SET,5,0.21753,0.0035876,0.47102,0.32211,GOBP_LUNG_GROWTH,0.959235635312128
GOBP_PEPTIDYL_LYSINE_ACETYLA...,SET,22,0.073526,0.0025424,0.15926,0.32217,GOBP_PEPTIDYL_LYSINE_ACETYLATION,0.959235635312128
WHITEHURST_PACLITAXEL_SENSIT...,SET,31,0.066611,0.0027334,0.1443,0.32219,WHITEHURST_PACLITAXEL_SENSITIVITY,0.959235635312128
GOMF_HISTONE_H4_DEMETHYLASE_...,SET,4,0.19644,0.0028977,0.42571,0.32225,GOMF_HISTONE_H4_DEMETHYLASE_ACTIVITY,0.959235635312128
REACTOME_NRCAM_INTERACTIONS,SET,6,0.16814,0.0030376,0.36469,0.32238,REACTOME_NRCAM_INTERACTIONS,0.959235635312128
HP_AXIAL_MUSCLE_WEAKNESS,SET,39,0.061322,0.0028219,0.13302,0.32241,HP_AXIAL_MUSCLE_WEAKNESS,0.959235635312128
GOBP_MYELOID_CELL_DEVELOPMENT,SET,80,0.046556,0.0030649,0.10105,0.32251,GOBP_MYELOID_CELL_DEVELOPMENT,0.959235635312128
OVSYANNIKOVA_PBMC_FLUARIX_AG...2,SET,6,0.15843,0.0028621,0.34393,0.32253,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,0.959235635312128
MIR3159,SET,84,0.044548,0.0030049,0.096727,0.32256,MIR3159,0.959235635312128
GOBP_RESPONSE_TO_GONADOTROPI...,SET,5,0.16874,0.0027829,0.36637,0.32256,GOBP_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE,0.959235635312128
GOBP_UBIQUITIN_DEPENDENT_PRO...1,SET,12,0.10679,0.0027278,0.23187,0.32257,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY,0.959235635312128
GOCC_PHOSPHATIDYLINOSITOL_3_...1,SET,29,0.07743,0.0030734,0.16814,0.32258,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX,0.959235635312128
GOMF_LYSINE_N_ACETYLTRANSFER...,SET,6,0.16184,0.0029238,0.35149,0.3226,GOMF_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR,0.959235635312128
MIR518A_5P_MIR527,SET,237,0.026171,0.0029528,0.056845,0.32262,MIR518A_5P_MIR527,0.959235635312128
MIR23C,SET,538,0.017672,0.002979,0.038388,0.32264,MIR23C,0.959235635312128
GOBP_CELLULAR_DEFENSE_RESPON...,SET,47,0.060368,0.0030489,0.1312,0.32272,GOBP_CELLULAR_DEFENSE_RESPONSE,0.959235635312128
GSE6269_HEALTHY_VS_STAPH_AUR...2,SET,154,0.031043,0.0028297,0.067468,0.32272,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP,0.959235635312128
HP_ARTHROGRYPOSIS_MULTIPLEX_...,SET,122,0.035312,0.0028675,0.076749,0.32273,HP_ARTHROGRYPOSIS_MULTIPLEX_CONGENITA,0.959235635312128
HOEBEKE_LYMPHOID_STEM_CELL_UP,SET,86,0.042849,0.0029243,0.093137,0.32274,HOEBEKE_LYMPHOID_STEM_CELL_UP,0.959235635312128
HP_ABNORMAL_SPERM_TAIL_MORPH...,SET,36,0.063469,0.0028063,0.13796,0.32274,HP_ABNORMAL_SPERM_TAIL_MORPHOLOGY,0.959235635312128
KEGG_MEDICUS_REFERENCE_WNT_S...3,SET,17,0.10249,0.0031157,0.22286,0.3228,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION,0.959235635312128
GINESTIER_BREAST_CANCER_20Q1...2,SET,95,0.040053,0.0028722,0.087105,0.32283,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,0.959235635312128
GOBP_NEGATIVE_REGULATION_OF_...472,SET,31,0.078878,0.0032368,0.17157,0.32285,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.959235635312128
GSE22611_NOD2_TRANSDUCED_VS_...2,SET,166,0.031477,0.002978,0.068464,0.32285,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP,0.959235635312128
GSE3982_CTRL_VS_LPS_4H_MAC_UP,SET,177,0.02782,0.002717,0.060511,0.32285,GSE3982_CTRL_VS_LPS_4H_MAC_UP,0.959235635312128
GAZIN_EPIGENETIC_SILENCING_B...,SET,24,0.083468,0.0030143,0.18158,0.32287,GAZIN_EPIGENETIC_SILENCING_BY_KRAS,0.959235635312128
REACTOME_RHO_GTPASES_ACTIVAT...3,SET,29,0.078378,0.003111,0.17051,0.32288,REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS,0.959235635312128
HP_MULTIPLE_MITOCHONDRIAL_DN...,SET,9,0.11271,0.0024937,0.2452,0.32288,HP_MULTIPLE_MITOCHONDRIAL_DNA_DELETIONS,0.959235635312128
GOMF_INTEGRIN_BINDING,SET,145,0.03436,0.0030399,0.074755,0.32289,GOMF_INTEGRIN_BINDING,0.959235635312128
REACTOME_NA_CL_DEPENDENT_NEU...,SET,18,0.11111,0.0034756,0.24175,0.3229,REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS,0.959235635312128
GSE46468_LUNG_INNATE_LYMPHOI...1,SET,178,0.028157,0.0027577,0.061284,0.32296,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN,0.959235635312128
MIR4519,SET,73,0.045369,0.0028537,0.098769,0.323,MIR4519,0.959235635312128
WP_PRIMARY_FOCAL_SEGMENTAL_G...,SET,70,0.048357,0.0029787,0.1053,0.32304,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,0.959235635312128
GOBP_PURKINJE_MYOCYTE_TO_VEN...,SET,6,0.178,0.0032158,0.38768,0.32306,GOBP_PURKINJE_MYOCYTE_TO_VENTRICULAR_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.959235635312128
GOBP_ANTIBACTERIAL_PEPTIDE_P...,SET,10,0.13886,0.0032382,0.30243,0.32307,GOBP_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.959235635312128
OLSSON_E2F3_TARGETS_UP,SET,22,0.094663,0.0032733,0.2062,0.32309,OLSSON_E2F3_TARGETS_UP,0.959235635312128
MA_MYELOID_DIFFERENTIATION_DN,SET,40,0.061142,0.0028494,0.13329,0.32322,MA_MYELOID_DIFFERENTIATION_DN,0.959235635312128
GOBP_APOPTOTIC_SIGNALING_PAT...,SET,558,0.016859,0.0028927,0.036752,0.32322,GOBP_APOPTOTIC_SIGNALING_PATHWAY,0.959235635312128
GSE21033_CTRL_VS_POLYIC_STIM...10,SET,183,0.029339,0.0029131,0.063972,0.32326,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP,0.959235635312128
HP_BRUSHFIELD_SPOTS,SET,12,0.10487,0.002679,0.22875,0.32331,HP_BRUSHFIELD_SPOTS,0.959235635312128
GOBP_TRANSCYTOSIS,SET,21,0.085605,0.0028921,0.18682,0.3234,GOBP_TRANSCYTOSIS,0.959235635312128
REACTOME_SUMOYLATION_OF_DNA_...3,SET,43,0.056247,0.0027176,0.12282,0.32349,REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,0.959235635312128
GOBP_POSITIVE_REGULATION_OF_...727,SET,24,0.084913,0.0030665,0.18548,0.32355,GOBP_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.959235635312128
GOBP_REGULATION_OF_PIGMENTAT...,SET,17,0.098745,0.0030019,0.21572,0.32357,GOBP_REGULATION_OF_PIGMENTATION,0.959235635312128
GOCC_F_ACTIN_CAPPING_PROTEIN...,SET,8,0.12795,0.002669,0.27952,0.32357,GOCC_F_ACTIN_CAPPING_PROTEIN_COMPLEX,0.959235635312128
RNTCANNRNNYNATTW_UNKNOWN,SET,58,0.053055,0.0029758,0.11595,0.32363,RNTCANNRNNYNATTW_UNKNOWN,0.959235635312128
GOBP_SKELETAL_MUSCLE_ATROPHY,SET,5,0.17815,0.0029381,0.38934,0.32363,GOBP_SKELETAL_MUSCLE_ATROPHY,0.959235635312128
GSE3982_BCELL_VS_NKCELL_DN,SET,171,0.031216,0.0029971,0.068238,0.32367,GSE3982_BCELL_VS_NKCELL_DN,0.959235635312128
GOBP_T_CELL_PROLIFERATION,SET,194,0.029899,0.0030557,0.06536,0.32368,GOBP_T_CELL_PROLIFERATION,0.959235635312128
WP_4P163_COPY_NUMBER_VARIATI...,SET,27,0.072188,0.0027649,0.15782,0.32369,WP_4P163_COPY_NUMBER_VARIATION,0.959235635312128
HP_RECURRENT_ASPERGILLUS_INF...,SET,22,0.087872,0.0030385,0.19212,0.3237,HP_RECURRENT_ASPERGILLUS_INFECTIONS,0.959235635312128
REACTOME_P75NTR_REGULATES_AX...,SET,9,0.14449,0.0031968,0.31593,0.32371,REACTOME_P75NTR_REGULATES_AXONOGENESIS,0.959235635312128
HP_DECREASED_THYROID_STIMULA...,SET,11,0.12277,0.0030027,0.26854,0.32378,HP_DECREASED_THYROID_STIMULATING_HORMONE_LEVEL,0.959235635312128
UDAYAKUMAR_MED1_TARGETS_DN,SET,212,0.026869,0.0028692,0.05879,0.32382,UDAYAKUMAR_MED1_TARGETS_DN,0.959235635312128
HP_FULMINANT_HEPATIC_FAILURE,SET,5,0.15009,0.0024753,0.3284,0.32383,HP_FULMINANT_HEPATIC_FAILURE,0.959235635312128
MIR589_5P,SET,77,0.04415,0.0028518,0.09661,0.32384,MIR589_5P,0.959235635312128
GSE13485_DAY1_VS_DAY7_YF17D_...2,SET,140,0.034124,0.002967,0.074677,0.32385,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.959235635312128
GSE14769_UNSTIM_VS_40MIN_LPS...1,SET,190,0.029607,0.0029948,0.06479,0.32385,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN,0.959235635312128
HP_APLASIA_HYPOPLASIA_OF_THE...67,SET,83,0.041063,0.0027533,0.089864,0.32386,HP_APLASIA_HYPOPLASIA_OF_THE_SPLEEN,0.959235635312128
GOBP_PYRIMIDINE_NUCLEOSIDE_T...2,SET,22,0.086811,0.0030018,0.18999,0.32387,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.959235635312128
GOMF_CCR_CHEMOKINE_RECEPTOR_...,SET,38,0.077693,0.0035292,0.17008,0.32391,GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING,0.959235635312128
GSE18791_CTRL_VS_NEWCASTLE_V...3,SET,169,0.030937,0.002953,0.06773,0.32392,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN,0.959235635312128
GOBP_OLIGOSACCHARIDE_BIOSYNT...,SET,29,0.077729,0.0030852,0.17022,0.32396,GOBP_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS,0.959235635312128
HP_RETINAL_FOLD,SET,10,0.12846,0.0029957,0.28129,0.32396,HP_RETINAL_FOLD,0.959235635312128
GOBP_REGULATION_OF_T_CELL_AC...2,SET,6,0.15439,0.0027891,0.33816,0.324,GOBP_REGULATION_OF_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,0.959235635312128
GOBP_THERMOCEPTION,SET,8,0.15324,0.0031964,0.33564,0.324,GOBP_THERMOCEPTION,0.959235635312128
HP_FUNCTIONAL_ABNORMALITY_OF...4,SET,330,0.021379,0.0028389,0.046838,0.32404,HP_FUNCTIONAL_ABNORMALITY_OF_THE_MIDDLE_EAR,0.959235635312128
GSE22935_24H_VS_48H_MBOVIS_B...3,SET,179,0.029898,0.0029363,0.065504,0.32404,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.959235635312128
GOBP_NUCLEAR_PORE_ORGANIZATI...,SET,15,0.093202,0.0026616,0.20424,0.32408,GOBP_NUCLEAR_PORE_ORGANIZATION,0.959235635312128
REACTOME_N_GLYCAN_ANTENNAE_E...1,SET,15,0.11123,0.0031765,0.24377,0.32409,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,0.959235635312128
GOBP_REGULATION_OF_SALIVA_SE...,SET,7,0.19416,0.0037885,0.42564,0.32414,GOBP_REGULATION_OF_SALIVA_SECRETION,0.959235635312128
HP_ABNORMAL_RESPIRATORY_SYST...,SET,1273,0.01142,0.0028998,0.025045,0.3242,HP_ABNORMAL_RESPIRATORY_SYSTEM_MORPHOLOGY,0.959235635312128
SAMOLS_TARGETS_OF_KHSV_MIRNA...2,SET,8,0.1559,0.0032521,0.34192,0.32421,SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP,0.959235635312128
GOMF_MOLECULAR_TRANSDUCER_AC...,SET,1299,0.012979,0.0033264,0.028464,0.32421,GOMF_MOLECULAR_TRANSDUCER_ACTIVITY,0.959235635312128
GSE14415_INDUCED_VS_NATURAL_...2,SET,130,0.033379,0.0027974,0.073216,0.32423,GSE14415_INDUCED_VS_NATURAL_TREG_UP,0.959235635312128
HP_LIPOATROPHY,SET,71,0.047536,0.0029489,0.10433,0.32433,HP_LIPOATROPHY,0.959235635312128
GSE21063_CTRL_VS_ANTI_IGM_ST...3,SET,149,0.030487,0.0027339,0.066911,0.32433,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN,0.959235635312128
HP_ABNORMAL_CEREBRAL_ARTERY_...,SET,74,0.04618,0.0029244,0.10137,0.32435,HP_ABNORMAL_CEREBRAL_ARTERY_MORPHOLOGY,0.959235635312128
GSE40274_CTRL_VS_IRF4_TRANSD...2,SET,150,0.031813,0.0028624,0.069845,0.32438,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.959235635312128
SOBOLEV_PBMC_PANDEMRIX_AGE_1...9,SET,18,0.096783,0.0030274,0.21252,0.32442,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_RESPONDERS_VS_NONRESPONDERS_7DY_UP,0.959235635312128
HP_SPONDYLOLISTHESIS,SET,19,0.089561,0.0028782,0.19668,0.32443,HP_SPONDYLOLISTHESIS,0.959235635312128
GOBP_REGULATION_OF_T_CELL_AP...,SET,39,0.064491,0.0029677,0.14165,0.32446,GOBP_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.959235635312128
GSE9988_ANTI_TREM1_VS_CTRL_T...1,SET,188,0.02804,0.0028214,0.061592,0.32447,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN,0.959235635312128
GOBP_EAR_MORPHOGENESIS,SET,117,0.038663,0.003075,0.084933,0.32448,GOBP_EAR_MORPHOGENESIS,0.959235635312128
GOBP_REGULATION_OF_EXOSOMAL_...,SET,18,0.087151,0.0027261,0.19147,0.32449,GOBP_REGULATION_OF_EXOSOMAL_SECRETION,0.959235635312128
GOMF_TRANSCRIPTION_COREGULAT...2,SET,105,0.039325,0.002964,0.086393,0.32449,GOMF_TRANSCRIPTION_COREGULATOR_BINDING,0.959235635312128
HP_LETHARGY,SET,191,0.028,0.0028396,0.061521,0.32451,HP_LETHARGY,0.959235635312128
GOBP_HEMOGLOBIN_BIOSYNTHETIC...,SET,13,0.11178,0.002972,0.24562,0.32452,GOBP_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.959235635312128
GOMF_KINESIN_BINDING,SET,39,0.059074,0.0027184,0.1298,0.32452,GOMF_KINESIN_BINDING,0.959235635312128
GSE45365_NK_CELL_VS_BCELL_MC...2,SET,181,0.029207,0.0028842,0.064213,0.32461,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP,0.959420065481759
GOBP_EMBRYONIC_CAMERA_TYPE_E...3,SET,26,0.082962,0.0031182,0.18247,0.32468,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS,0.959545357142857
GOCC_RPAP3_R2TP_PREFOLDIN_LI...,SET,9,0.12039,0.0026634,0.26489,0.32475,GOCC_RPAP3_R2TP_PREFOLDIN_LIKE_COMPLEX,0.959618585274613
GSE30083_SP3_VS_SP4_THYMOCYT...2,SET,180,0.03037,0.0029908,0.06683,0.32476,GSE30083_SP3_VS_SP4_THYMOCYTE_UP,0.959618585274613
WORSCHECH_TUMOR_EVASION_AND_...2,SET,29,0.080994,0.0032149,0.17829,0.32481,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,0.959684736036725
GSE22886_NEUTROPHIL_VS_DC_UP,SET,164,0.032342,0.0030415,0.071209,0.32485,GSE22886_NEUTROPHIL_VS_DC_UP,0.959721332029922
GSE37301_LYMPHOID_PRIMED_MPP...2,SET,167,0.030126,0.0028587,0.066346,0.32489,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP,0.959727032882998
LMTK3_TARGET_GENES,SET,426,0.019279,0.002901,0.042472,0.32495,LMTK3_TARGET_GENES,0.959727032882998
GOBP_REGULATION_OF_MATRIX_ME...,SET,5,0.20674,0.0034096,0.45553,0.32497,GOBP_REGULATION_OF_MATRIX_METALLOPEPTIDASE_SECRETION,0.959727032882998
CAHOY_OLIGODENDROCUTIC,SET,88,0.042332,0.0029223,0.093275,0.32498,CAHOY_OLIGODENDROCUTIC,0.959727032882998
RUAN_RESPONSE_TO_TROGLITAZON...2,SET,24,0.089326,0.0032259,0.19683,0.32499,RUAN_RESPONSE_TO_TROGLITAZONE_UP,0.959727032882998
GSE12845_PRE_GC_VS_DARKZONE_...2,SET,174,0.029208,0.0028285,0.06444,0.32518,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.960161493374108
GOBP_INTERLEUKIN_5_MEDIATED_...,SET,6,0.17318,0.0031287,0.38215,0.32521,GOBP_INTERLEUKIN_5_MEDIATED_SIGNALING_PATHWAY,0.960161493374108
GOBP_MAINTENANCE_OF_ANIMAL_O...,SET,5,0.18393,0.0030334,0.4059,0.32522,GOBP_MAINTENANCE_OF_ANIMAL_ORGAN_IDENTITY,0.960161493374108
HP_PANCREATIC_PSEUDOCYST,SET,4,0.21799,0.0032156,0.48123,0.32528,HP_PANCREATIC_PSEUDOCYST,0.960203515028018
MIR6862_5P,SET,44,0.061545,0.0030078,0.13589,0.32531,MIR6862_5P,0.960203515028018
GOBP_PROXIMAL_DISTAL_PATTERN...2,SET,5,0.21528,0.0035504,0.47536,0.32533,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT,0.960203515028018
GSE17721_PAM3CSK4_VS_CPG_16H...1,SET,176,0.029252,0.0028489,0.064609,0.32536,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN,0.960203515028018
HP_DYSCALCULIA,SET,22,0.075983,0.0026274,0.16784,0.32539,HP_DYSCALCULIA,0.960203515028018
MODULE_14,SET,13,0.11937,0.0031736,0.26371,0.3254,MODULE_14,0.960203515028018
GOCC_CONE_PHOTORECEPTOR_OUTE...,SET,7,0.16355,0.0031914,0.36143,0.32545,GOCC_CONE_PHOTORECEPTOR_OUTER_SEGMENT,0.960269526275575
HP_ABNORMALITY_OF_THE_MUSCUL...4,SET,12,0.11612,0.0029662,0.25671,0.32552,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_ARM,0.960342513368984
KEGG_LEISHMANIA_INFECTION,SET,63,0.055513,0.0032447,0.12274,0.32553,KEGG_LEISHMANIA_INFECTION,0.960342513368984
GSE37416_CTRL_VS_12H_F_TULAR...2,SET,170,0.030313,0.0029019,0.067036,0.32557,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.960370449724226
BIOCARTA_CDK5_PATHWAY,SET,13,0.11367,0.0030222,0.25144,0.32561,BIOCARTA_CDK5_PATHWAY,0.960370449724226
KEGG_MEDICUS_REFERENCE_MICRO...1,SET,22,0.084359,0.002917,0.18662,0.32563,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION,0.960370449724226
HP_ABNORMALITY_OF_THE_POSTER...,SET,99,0.037722,0.0027612,0.083463,0.32565,HP_ABNORMALITY_OF_THE_POSTERIOR_HAIRLINE,0.960370449724226
HP_MICROGRAPHIA,SET,13,0.11075,0.0029446,0.24511,0.32569,HP_MICROGRAPHIA,0.960406919226201
KEGG_MEDICUS_REFERENCE_MDA5_...,SET,21,0.093689,0.0031652,0.20742,0.32575,KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY,0.960420872921615
GOCC_OUTER_MITOCHONDRIAL_MEM...,SET,18,0.083859,0.0026231,0.18566,0.32575,GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,0.960420872921615
GOBP_METANEPHRIC_COLLECTING_...,SET,10,0.14159,0.003302,0.31358,0.3258,GOBP_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT,0.960486809737891
REACTOME_NEUROTOXICITY_OF_CL...,SET,10,0.11688,0.0027257,0.25899,0.32589,REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS,0.960551110734272
GOCC_NUCLEOTIDE_ACTIVATED_PR...,SET,10,0.11552,0.002694,0.25599,0.32589,GOCC_NUCLEOTIDE_ACTIVATED_PROTEIN_KINASE_COMPLEX,0.960551110734272
GSE43955_10H_VS_60H_ACT_CD4_...3,SET,184,0.029736,0.0029604,0.065898,0.32591,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.960551110734272
KEGG_MEDICUS_VARIANT_LOSS_OF...1,SET,8,0.12866,0.0026838,0.28518,0.32594,KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S,0.960551110734272
REACTOME_CELL_CYCLE_CHECKPOI...,SET,241,0.023658,0.0026913,0.052446,0.32596,REACTOME_CELL_CYCLE_CHECKPOINTS,0.960551110734272
HP_BROAD_FIRST_METATARSAL,SET,5,0.18045,0.002976,0.40018,0.32603,HP_BROAD_FIRST_METATARSAL,0.960675934718101
GOBP_NEGATIVE_REGULATION_OF_...330,SET,8,0.15584,0.0032507,0.34584,0.32614,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.960840674955595
GOBP_LYMPH_VESSEL_MORPHOGENE...,SET,21,0.087225,0.0029468,0.19361,0.32617,GOBP_LYMPH_VESSEL_MORPHOGENESIS,0.960840674955595
GOBP_REGULATION_OF_GLUCOCORT...1,SET,9,0.14442,0.0031951,0.3207,0.32624,GOBP_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.960840674955595
MIR4273,SET,94,0.041687,0.0029737,0.09259,0.32628,MIR4273,0.960840674955595
BUSSLINGER_GASTRIC_X_CELLS,SET,172,0.030927,0.0029779,0.068704,0.3263,BUSSLINGER_GASTRIC_X_CELLS,0.960840674955595
GOCC_RNA_POLYMERASE_II_TRANS...1,SET,233,0.024213,0.002709,0.053803,0.32634,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX,0.960840674955595
MIR3912_5P,SET,77,0.044887,0.0028994,0.099765,0.32638,MIR3912_5P,0.960840674955595
GSE44732_UNSTIM_VS_IL27_STIM...2,SET,175,0.029332,0.0028487,0.065191,0.32638,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP,0.960840674955595
GSE43955_TH0_VS_TGFB_IL6_TH1...16,SET,184,0.029162,0.0029033,0.064832,0.32643,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP,0.960840674955595
CYCLIN_D1_UP.V1_UP,SET,170,0.030593,0.0029288,0.068022,0.32644,CYCLIN_D1_UP.V1_UP,0.960840674955595
REACTOME_TELOMERE_MAINTENANCE,SET,61,0.045424,0.0026127,0.101,0.32646,REACTOME_TELOMERE_MAINTENANCE,0.960840674955595
GOMF_DNA_SECONDARY_STRUCTURE...,SET,34,0.066576,0.0028609,0.1481,0.32652,GOMF_DNA_SECONDARY_STRUCTURE_BINDING,0.960840674955595
YAO_HOXA10_TARGETS_VIA_PROGE...1,SET,18,0.10791,0.0033754,0.24004,0.32653,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,0.960840674955595
GSE360_L_DONOVANI_VS_T_GONDI...1,SET,169,0.02966,0.0028311,0.065981,0.32653,GSE360_L_DONOVANI_VS_T_GONDII_DC_DN,0.960840674955595
KRAS.600.LUNG.BREAST_UP.V1_DN,SET,254,0.025288,0.0029523,0.056276,0.32659,KRAS.600.LUNG.BREAST_UP.V1_DN,0.960840674955595
GOBP_CARDIAC_PACEMAKER_CELL_...2,SET,11,0.12824,0.0031365,0.28545,0.32662,GOBP_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION,0.960840674955595
HP_FRAGILE_SKIN,SET,34,0.068176,0.0029297,0.15175,0.32662,HP_FRAGILE_SKIN,0.960840674955595
GOBP_NEGATIVE_REGULATION_OF_...14,SET,14,0.11211,0.0030932,0.24956,0.32663,GOBP_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.960840674955595
SCIAN_CELL_CYCLE_TARGETS_OF_...1,SET,22,0.081932,0.002833,0.18242,0.32667,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,0.960840674955595
GOCC_MITOTIC_SPINDLE_MIDZONE,SET,13,0.10291,0.0027361,0.22914,0.32668,GOCC_MITOTIC_SPINDLE_MIDZONE,0.960840674955595
GOMF_UBIQUITIN_LIKE_PROTEIN_...1,SET,112,0.035409,0.0027558,0.078844,0.32668,GOMF_UBIQUITIN_LIKE_PROTEIN_BINDING,0.960840674955595
GATA1_04,SET,222,0.027359,0.0029887,0.060937,0.32673,GATA1_04,0.960840674955595
GSE3982_EOSINOPHIL_VS_MAST_C...2,SET,178,0.029438,0.0028831,0.065568,0.32673,GSE3982_EOSINOPHIL_VS_MAST_CELL_UP,0.960840674955595
HP_ECTOPIA_LENTIS,SET,39,0.067507,0.0031065,0.15041,0.32678,HP_ECTOPIA_LENTIS,0.960840674955595
HP_APLASTIC_ANEMIA,SET,24,0.077127,0.0027854,0.17189,0.32683,HP_APLASTIC_ANEMIA,0.960840674955595
HP_EPIDURAL_HEMORRHAGE,SET,5,0.21463,0.0035397,0.47834,0.32683,HP_EPIDURAL_HEMORRHAGE,0.960840674955595
GOBP_REGULATION_OF_SMALL_MOL...,SET,289,0.023012,0.002863,0.051293,0.32685,GOBP_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.960840674955595
GSE12001_MIR223_KO_VS_WT_NEU...2,SET,150,0.031824,0.0028633,0.07094,0.32686,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP,0.960840674955595
GSE3920_IFNA_VS_IFNB_TREATED...1,SET,151,0.03166,0.002858,0.070596,0.32691,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.960845913887716
WP_METHYLATION_PATHWAYS,SET,9,0.1416,0.0031328,0.31576,0.32692,WP_METHYLATION_PATHWAYS,0.960845913887716
HP_ABNORMAL_REPRODUCTIVE_SYS...,SET,1236,0.011148,0.0027923,0.024889,0.3271,HP_ABNORMAL_REPRODUCTIVE_SYSTEM_MORPHOLOGY,0.960845913887716
KOHOUTEK_CCNT1_TARGETS,SET,47,0.055894,0.002823,0.1248,0.32713,KOHOUTEK_CCNT1_TARGETS,0.960845913887716
GSE1925_CTRL_VS_24H_IFNG_STI...1,SET,186,0.028061,0.0028086,0.062657,0.32713,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.960845913887716
HP_HISTIOCYTOSIS,SET,6,0.16672,0.0030118,0.37229,0.32715,HP_HISTIOCYTOSIS,0.960845913887716
REACTOME_PYROPTOSIS,SET,26,0.081771,0.0030735,0.18269,0.32722,REACTOME_PYROPTOSIS,0.960845913887716
GOBP_PLASMA_MEMBRANE_TO_ENDO...,SET,8,0.13858,0.0028908,0.30963,0.32723,GOBP_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT,0.960845913887716
ALFANO_MYC_TARGETS,SET,224,0.025298,0.0027759,0.056525,0.32724,ALFANO_MYC_TARGETS,0.960845913887716
GOBP_HEART_DEVELOPMENT,SET,557,0.017037,0.0029208,0.038068,0.32724,GOBP_HEART_DEVELOPMENT,0.960845913887716
REACTOME_BETA_OXIDATION_OF_L...,SET,5,0.17672,0.0029145,0.39489,0.32725,REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA,0.960845913887716
GSE4142_NAIVE_BCELL_VS_PLASM...2,SET,175,0.028309,0.0027493,0.063259,0.32725,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.960845913887716
DESCARTES_MAIN_FETAL_GANGLIO...,SET,19,0.098774,0.0031743,0.22073,0.32726,DESCARTES_MAIN_FETAL_GANGLION_CELLS,0.960845913887716
HP_AVASCULAR_NECROSIS_OF_THE...,SET,29,0.071786,0.0028493,0.16046,0.32731,HP_AVASCULAR_NECROSIS_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,0.960845913887716
GOBP_SMOOTH_MUSCLE_CELL_DIFF...,SET,59,0.050689,0.0028674,0.11332,0.32732,GOBP_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.960845913887716
GOBP_KINETOCHORE_ASSEMBLY,SET,16,0.092114,0.0027167,0.20595,0.32734,GOBP_KINETOCHORE_ASSEMBLY,0.960845913887716
GOBP_LATERAL_MESODERM_DEVELO...,SET,18,0.10217,0.0031961,0.22852,0.3274,GOBP_LATERAL_MESODERM_DEVELOPMENT,0.960845913887716
REACTOME_MRNA_SPLICING_MINOR...,SET,48,0.048292,0.0024648,0.10802,0.32742,REACTOME_MRNA_SPLICING_MINOR_PATHWAY,0.960845913887716
GOMF_CALCIUM_CHANNEL_REGULAT...,SET,47,0.05974,0.0030172,0.13364,0.32743,GOMF_CALCIUM_CHANNEL_REGULATOR_ACTIVITY,0.960845913887716
HP_DECREASED_NUMBER_OF_LARGE...,SET,18,0.084463,0.0026421,0.18898,0.32746,HP_DECREASED_NUMBER_OF_LARGE_PERIPHERAL_MYELINATED_NERVE_FIBERS,0.960845913887716
GOCC_RNA_POLYMERASE_I_TRANSC...,SET,5,0.15829,0.0026105,0.35418,0.32747,GOCC_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATOR_COMPLEX,0.960845913887716
GOCC_RNA_POLYMERASE_TRANSCRI...,SET,5,0.15829,0.0026105,0.35418,0.32747,GOCC_RNA_POLYMERASE_TRANSCRIPTION_FACTOR_SL1_COMPLEX,0.960845913887716
GOBP_RESPONSE_TO_IRON_ION,SET,27,0.078027,0.0029885,0.17465,0.32752,GOBP_RESPONSE_TO_IRON_ION,0.960911497551916
HOFT_CD4_POSITIVE_ALPHA_BETA...5,SET,36,0.062413,0.0027596,0.13972,0.32755,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,0.960913179863395
HP_PUNCTATE_PALMOPLANTAR_HYP...,SET,6,0.14934,0.002698,0.33438,0.32758,HP_PUNCTATE_PALMOPLANTAR_HYPERKERATOSIS,0.960913179863395
KAECH_NAIVE_VS_DAY8_EFF_CD8_...1,SET,184,0.028612,0.0028486,0.064095,0.32766,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN,0.960913179863395
HP_ASCITES,SET,125,0.035732,0.0029368,0.080049,0.32767,HP_ASCITES,0.960913179863395
HP_COGWHEEL_RIGIDITY,SET,25,0.081675,0.0030103,0.18298,0.32767,HP_COGWHEEL_RIGIDITY,0.960913179863395
ZFP28_TARGET_GENES,SET,69,0.045628,0.0027905,0.10227,0.32774,ZFP28_TARGET_GENES,0.960913179863395
MODULE_567,SET,90,0.038977,0.0027209,0.087367,0.32775,MODULE_567,0.960913179863395
GSE23321_CD8_STEM_CELL_MEMOR...1,SET,159,0.027389,0.0025366,0.061409,0.32779,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN,0.960913179863395
GSE7348_LPS_VS_TOLERIZED_AND...1,SET,157,0.029828,0.0027452,0.06689,0.32783,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.960913179863395
GSE360_CTRL_VS_L_MAJOR_MAC_DN,SET,171,0.028698,0.0027553,0.064371,0.32787,GSE360_CTRL_VS_L_MAJOR_MAC_DN,0.960913179863395
GOBP_PROTEIN_IMPORT_INTO_PER...4,SET,5,0.15602,0.0025731,0.34999,0.32788,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE,0.960913179863395
GSE15215_CD2_POS_VS_NEG_PDC_...1,SET,179,0.026804,0.0026324,0.060128,0.32788,GSE15215_CD2_POS_VS_NEG_PDC_DN,0.960913179863395
GSE40666_WT_VS_STAT4_KO_CD8_...4,SET,174,0.028693,0.0027786,0.064366,0.32788,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.960913179863395
HALLMARK_P53_PATHWAY,SET,187,0.027585,0.0027684,0.061892,0.32791,HALLMARK_P53_PATHWAY,0.960920071669477
HAN_JNK_SINGALING_UP,SET,34,0.069725,0.0029962,0.15655,0.32802,HAN_JNK_SINGALING_UP,0.961109648457258
MIR548AR_5P,SET,449,0.018164,0.0028042,0.040785,0.32803,MIR548AR_5P,0.961109648457258
BAKKER_FOXO3_TARGETS_UP,SET,51,0.054479,0.0028659,0.12243,0.32817,BAKKER_FOXO3_TARGETS_UP,0.961336305546275
AEBP2_TARGET_GENES,SET,990,0.01228,0.0027723,0.02761,0.32825,AEBP2_TARGET_GENES,0.961336305546275
GOBP_CELLULAR_RESPONSE_TO_NU...2,SET,223,0.026373,0.0028874,0.059308,0.32828,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS,0.961336305546275
GOBP_SKELETAL_MUSCLE_SATELLI...1,SET,9,0.11968,0.0026478,0.2692,0.32831,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_ACTIVATION,0.961336305546275
HP_ABSENT_FOVEAL_REFLEX,SET,14,0.10627,0.002932,0.23913,0.32838,HP_ABSENT_FOVEAL_REFLEX,0.961336305546275
HP_LACRIMATION_ABNORMALITY,SET,76,0.047102,0.0030227,0.106,0.3284,HP_LACRIMATION_ABNORMALITY,0.961336305546275
GOBP_PROTEIN_INSERTION_INTO_...4,SET,4,0.16114,0.0023771,0.36271,0.32843,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE_FROM_INNER_SIDE,0.961336305546275
HP_HYPERNASAL_SPEECH,SET,88,0.041435,0.0028604,0.093287,0.32846,HP_HYPERNASAL_SPEECH,0.961336305546275
HP_FRONTAL_HIRSUTISM,SET,8,0.11516,0.0024022,0.25932,0.3285,HP_FRONTAL_HIRSUTISM,0.961336305546275
GOBP_DISACCHARIDE_METABOLIC_...,SET,11,0.11728,0.0028685,0.26418,0.32854,GOBP_DISACCHARIDE_METABOLIC_PROCESS,0.961336305546275
HP_DIARRHEA,SET,362,0.020639,0.0028679,0.046491,0.32855,HP_DIARRHEA,0.961336305546275
HP_CAMPTODACTYLY_OF_TOE,SET,11,0.11762,0.0028766,0.26501,0.32859,HP_CAMPTODACTYLY_OF_TOE,0.961336305546275
HP_ABNORMALITY_OF_THE_MENSTR...,SET,290,0.022421,0.0027942,0.050524,0.32861,HP_ABNORMALITY_OF_THE_MENSTRUAL_CYCLE,0.961336305546275
GOBP_TRANSCRIPTION_INITIATIO...2,SET,142,0.030162,0.002641,0.067984,0.32865,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_II_PROMOTER,0.961336305546275
SEMENZA_HIF1_TARGETS,SET,32,0.071281,0.0029718,0.16069,0.32868,SEMENZA_HIF1_TARGETS,0.961336305546275
KEGG_MEDICUS_VARIANT_EML4_AL...1,SET,5,0.22496,0.00371,0.50714,0.32868,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY,0.961336305546275
GSE22886_UNSTIM_VS_IL2_STIM_...1,SET,185,0.025998,0.0025953,0.058616,0.32869,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN,0.961336305546275
GOBP_MAINTENANCE_OF_APICAL_B...,SET,9,0.15048,0.0033293,0.33935,0.32872,GOBP_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY,0.961336305546275
GSE3203_INFLUENZA_INF_VS_IFN...2,SET,185,0.02855,0.00285,0.064384,0.32873,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP,0.961336305546275
GNF2_PCAF,SET,31,0.069026,0.0028326,0.15576,0.32883,GNF2_PCAF,0.961336305546275
BIOCARTA_PROTEASOME_PATHWAY,SET,17,0.087043,0.0026461,0.19644,0.32885,BIOCARTA_PROTEASOME_PATHWAY,0.961336305546275
GOBP_POSITIVE_REGULATION_OF_...554,SET,7,0.15873,0.0030972,0.35824,0.32885,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.961336305546275
GSE13484_12H_UNSTIM_VS_YF17D...1,SET,177,0.029467,0.0028779,0.066504,0.32885,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.961336305546275
HP_JOINT_SWELLING,SET,46,0.05978,0.0029871,0.13494,0.32888,HP_JOINT_SWELLING,0.961336305546275
HP_RETROGNATHIA,SET,308,0.021161,0.0027164,0.047781,0.32893,HP_RETROGNATHIA,0.961336305546275
GSE9988_ANTI_TREM1_AND_LPS_V...3,SET,187,0.02759,0.0027689,0.062301,0.32894,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN,0.961336305546275
HP_SKULL_ASYMMETRY,SET,7,0.14605,0.0028499,0.32982,0.32895,HP_SKULL_ASYMMETRY,0.961336305546275
MIR1279,SET,167,0.030712,0.0029143,0.069361,0.32896,MIR1279,0.961336305546275
GOBP_RESPONSE_TO_NICOTINE,SET,51,0.060335,0.0031739,0.13628,0.32898,GOBP_RESPONSE_TO_NICOTINE,0.961336305546275
BREDEMEYER_RAG_SIGNALING_VIA...1,SET,38,0.062883,0.0028564,0.14205,0.329,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,0.961336305546275
HP_PERIPHERAL_AXONAL_DEGENER...,SET,179,0.027684,0.0027188,0.06255,0.32903,HP_PERIPHERAL_AXONAL_DEGENERATION,0.961336305546275
REACTOME_DOWNSTREAM_SIGNAL_T...,SET,29,0.070737,0.0028077,0.15988,0.32909,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,0.961336305546275
HP_HYPERURICOSURIA,SET,8,0.12231,0.0025514,0.27651,0.32912,HP_HYPERURICOSURIA,0.961336305546275
HP_TYPE_II_DIABETES_MELLITUS,SET,191,0.028626,0.0029031,0.064715,0.32912,HP_TYPE_II_DIABETES_MELLITUS,0.961336305546275
WP_COVID19_THROMBOSIS_AND_AN...,SET,7,0.17153,0.003347,0.38781,0.32914,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,0.961336305546275
GOCC_COHESIN_COMPLEX,SET,8,0.12306,0.002567,0.27835,0.3292,GOCC_COHESIN_COMPLEX,0.961336305546275
GOBP_REGULATION_OF_MUSCLE_TI...,SET,42,0.063987,0.0030554,0.14476,0.32923,GOBP_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.961336305546275
GOBP_LEUKOCYTE_APOPTOTIC_PRO...,SET,112,0.036597,0.0028482,0.082793,0.32924,GOBP_LEUKOCYTE_APOPTOTIC_PROCESS,0.961336305546275
GSE22443_NAIVE_VS_ACT_AND_IL...4,SET,188,0.029159,0.0029341,0.065974,0.32925,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP,0.961336305546275
CHYLA_CBFA2T3_TARGETS_DN,SET,213,0.026186,0.0028027,0.059262,0.32929,CHYLA_CBFA2T3_TARGETS_DN,0.961336305546275
GOBP_REGULATION_OF_MOLECULAR...,SET,1745,0.0097182,0.0028489,0.021997,0.32932,GOBP_REGULATION_OF_MOLECULAR_FUNCTION,0.961336305546275
GOBP_RESPONSE_TO_PARATHYROID...,SET,10,0.12293,0.0028668,0.27827,0.32933,GOBP_RESPONSE_TO_PARATHYROID_HORMONE,0.961336305546275
HP_DISTAL_UPPER_LIMB_AMYOTRO...,SET,58,0.049507,0.0027768,0.11207,0.32933,HP_DISTAL_UPPER_LIMB_AMYOTROPHY,0.961336305546275
KEGG_GALACTOSE_METABOLISM,SET,24,0.073748,0.0026633,0.16698,0.32937,KEGG_GALACTOSE_METABOLISM,0.961336305546275
HP_INCREASED_OVERBITE,SET,8,0.13943,0.0029085,0.31569,0.32937,HP_INCREASED_OVERBITE,0.961336305546275
KEGG_MEDICUS_REFERENCE_II_BL...,SET,7,0.16124,0.0031462,0.36518,0.32941,KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS,0.961336305546275
GOCC_TRANSCRIPTION_FACTOR_AP...,SET,5,0.19595,0.0032316,0.4438,0.32942,GOCC_TRANSCRIPTION_FACTOR_AP_1_COMPLEX,0.961336305546275
GSE45739_NRAS_KO_VS_WT_ACD3_...1,SET,166,0.028699,0.0027152,0.065026,0.32948,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN,0.961336305546275
KATSANOU_ELAVL1_TARGETS_UP,SET,155,0.03271,0.0029913,0.074124,0.3295,KATSANOU_ELAVL1_TARGETS_UP,0.961336305546275
GOBP_POSITIVE_REGULATION_OF_...721,SET,12,0.098821,0.0025244,0.22405,0.32959,GOBP_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT,0.961336305546275
KEGG_MELANOGENESIS,SET,98,0.040168,0.0029254,0.09108,0.3296,KEGG_MELANOGENESIS,0.961336305546275
GSE17721_LPS_VS_CPG_1H_BMDC_...2,SET,180,0.026723,0.0026317,0.060599,0.32962,GSE17721_LPS_VS_CPG_1H_BMDC_UP,0.961336305546275
GOMF_D_LOOP_DNA_BINDING,SET,5,0.20489,0.0033791,0.46472,0.32965,GOMF_D_LOOP_DNA_BINDING,0.961336305546275
GSE25088_CTRL_VS_ROSIGLITAZO...3,SET,183,0.026851,0.002666,0.060919,0.32969,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,0.961336305546275
BIOCARTA_GATA3_PATHWAY,SET,14,0.10964,0.003025,0.24887,0.32977,BIOCARTA_GATA3_PATHWAY,0.961336305546275
GOBP_INORGANIC_ANION_TRANSPO...,SET,159,0.032136,0.0029762,0.072949,0.32978,GOBP_INORGANIC_ANION_TRANSPORT,0.961336305546275
GSE9988_ANTI_TREM1_VS_VEHICL...1,SET,184,0.027765,0.0027642,0.063031,0.32979,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN,0.961336305546275
HP_PARTIAL_ABSENCE_OF_SPECIF...1,SET,6,0.16206,0.0029278,0.36795,0.32981,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.961336305546275
REACTOME_MET_ACTIVATES_RAP1_...,SET,11,0.12859,0.0031451,0.29209,0.32988,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,0.961336305546275
chr8p21,SET,79,0.085761,0.0056107,0.19487,0.32994,chr8p21,0.961336305546275
GSE21546_ELK1_KO_VS_SAP1A_KO...3,SET,180,0.026484,0.0026081,0.060199,0.33,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.961336305546275
HP_IRON_ACCUMULATION_IN_BRAIN,SET,14,0.095137,0.0026248,0.21629,0.33002,HP_IRON_ACCUMULATION_IN_BRAIN,0.961336305546275
HP_ABNORMAL_SPEECH_DISCRIMIN...,SET,4,0.18061,0.0026642,0.41062,0.33003,HP_ABNORMAL_SPEECH_DISCRIMINATION,0.961336305546275
HP_BROAD_COLUMELLA,SET,12,0.10525,0.0026885,0.23942,0.33012,HP_BROAD_COLUMELLA,0.961336305546275
GOBP_POSITIVE_REGULATION_OF_...521,SET,270,0.024167,0.0029077,0.054979,0.33013,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.961336305546275
GOBP_HEART_GROWTH,SET,76,0.0474,0.0030418,0.10784,0.33014,GOBP_HEART_GROWTH,0.961336305546275
HP_RENAL_AGENESIS,SET,178,0.027973,0.0027396,0.063651,0.33016,HP_RENAL_AGENESIS,0.961336305546275
POU1F1_Q6,SET,218,0.027533,0.0029808,0.062655,0.33018,POU1F1_Q6,0.961336305546275
GOBP_AMINO_ACID_BIOSYNTHETIC...,SET,71,0.045797,0.0028411,0.10423,0.33019,GOBP_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.961336305546275
GSE39110_DAY3_VS_DAY6_POST_I...1,SET,181,0.027807,0.0027459,0.063292,0.33021,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN,0.961336305546275
HP_AUTOIMMUNE_ANTIBODY_POSIT...,SET,148,0.032179,0.0028761,0.073248,0.33022,HP_AUTOIMMUNE_ANTIBODY_POSITIVITY,0.961336305546275
HP_ANTERIOR_RIB_CUPPING,SET,15,0.094871,0.0027093,0.21605,0.33029,HP_ANTERIOR_RIB_CUPPING,0.961336305546275
GAVISH_3CA_METAPROGRAM_B_CEL...12,SET,44,0.062639,0.0030613,0.14269,0.33033,GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS,0.961336305546275
GOMF_LACTATE_TRANSMEMBRANE_T...,SET,6,0.17672,0.0031925,0.40259,0.33035,GOMF_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.961336305546275
GSE27092_WT_VS_HDAC7_PHOSPHO...2,SET,185,0.028155,0.0028106,0.064145,0.33036,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP,0.961336305546275
GOMF_NUCLEOSIDE_MONOPHOSPHAT...,SET,19,0.085568,0.0027499,0.19496,0.33037,GOMF_NUCLEOSIDE_MONOPHOSPHATE_KINASE_ACTIVITY,0.961336305546275
WP_CODEINE_AND_MORPHINE_META...,SET,14,0.10292,0.0028397,0.23473,0.33052,WP_CODEINE_AND_MORPHINE_METABOLISM,0.961336305546275
GOMF_HISTONE_H3K9_MONOMETHYL...,SET,6,0.15818,0.0028577,0.36078,0.33053,GOMF_HISTONE_H3K9_MONOMETHYLTRANSFERASE_ACTIVITY,0.961336305546275
MIR6760_3P,SET,96,0.03962,0.0028561,0.090366,0.33054,MIR6760_3P,0.961336305546275
GOBP_POSITIVE_REGULATION_OF_...641,SET,1111,0.01177,0.0028051,0.026849,0.33056,GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,0.961336305546275
PUIFFE_INVASION_INHIBITED_BY...1,SET,134,0.031763,0.0027023,0.072471,0.33059,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,0.961336305546275
RUTELLA_RESPONSE_TO_HGF_VS_C...2,SET,373,0.020455,0.0028843,0.046668,0.33059,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,0.961336305546275
REACTOME_INTERLEUKIN_6_FAMIL...,SET,24,0.078031,0.002818,0.17804,0.3306,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,0.961336305546275
JONES_OVARY_OOCYTE,SET,64,0.046849,0.0027598,0.10691,0.33062,JONES_OVARY_OOCYTE,0.961336305546275
MIR4255,SET,155,0.031089,0.0028431,0.070975,0.33068,MIR4255,0.961336305546275
GOBP_POSITIVE_REGULATION_OF_...608,SET,69,0.044083,0.0026961,0.10064,0.33069,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.961336305546275
GOBP_IMP_SALVAGE,SET,4,0.19808,0.0029219,0.4523,0.33072,GOBP_IMP_SALVAGE,0.961336305546275
HP_SYNOSTOSIS_OF_CARPALS_TAR...,SET,42,0.063355,0.0030253,0.14467,0.33073,HP_SYNOSTOSIS_OF_CARPALS_TARSALS,0.961336305546275
HP_ADRENOCORTICAL_ADENOMA,SET,9,0.14091,0.0031175,0.32184,0.33076,HP_ADRENOCORTICAL_ADENOMA,0.961336305546275
GOBP_NEURON_CELLULAR_HOMEOST...,SET,58,0.048,0.0026923,0.10964,0.33077,GOBP_NEURON_CELLULAR_HOMEOSTASIS,0.961336305546275
chr16q21,SET,37,0.11479,0.0051452,0.26223,0.33079,chr16q21,0.961336305546275
GOBP_L_SERINE_BIOSYNTHETIC_P...,SET,6,0.13593,0.0024556,0.31053,0.3308,GOBP_L_SERINE_BIOSYNTHETIC_PROCESS,0.961336305546275
GOBP_POSITIVE_REGULATION_OF_...384,SET,6,0.1513,0.0027334,0.34569,0.33081,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.961336305546275
MIR12114,SET,37,0.06003,0.0026908,0.13717,0.33084,MIR12114,0.961336305546275
GOBP_METHIONINE_METABOLIC_PR...,SET,15,0.10745,0.0030684,0.24555,0.33085,GOBP_METHIONINE_METABOLIC_PROCESS,0.961336305546275
GSE360_L_MAJOR_VS_M_TUBERCUL...1,SET,168,0.029535,0.0028109,0.067509,0.33088,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN,0.961336305546275
MIR4274,SET,51,0.053937,0.0028374,0.1233,0.33089,MIR4274,0.961336305546275
GNF2_APEX1,SET,77,0.03973,0.0025663,0.090822,0.3309,GNF2_APEX1,0.961336305546275
MODULE_23,SET,521,0.017392,0.0028865,0.039758,0.3309,MODULE_23,0.961336305546275
HP_MYOCARDIAL_FIBROSIS,SET,17,0.095917,0.0029159,0.21927,0.3309,HP_MYOCARDIAL_FIBROSIS,0.961336305546275
GOBP_B_CELL_PROLIFERATION,SET,95,0.041531,0.0029783,0.094963,0.33093,GOBP_B_CELL_PROLIFERATION,0.961336305546275
HP_IMMUNE_DYSREGULATION,SET,10,0.11577,0.0026998,0.26481,0.33099,HP_IMMUNE_DYSREGULATION,0.961336305546275
GAURNIER_PSMD4_TARGETS,SET,64,0.052599,0.0030986,0.12032,0.331,GAURNIER_PSMD4_TARGETS,0.961336305546275
WP_MONOAMINE_TRANSPORT,SET,30,0.070296,0.0028378,0.16084,0.33104,WP_MONOAMINE_TRANSPORT,0.961336305546275
GOCC_ACROSOMAL_VESICLE,SET,132,0.03372,0.0028475,0.077153,0.33104,GOCC_ACROSOMAL_VESICLE,0.961336305546275
MIR6759_3P,SET,93,0.039919,0.0028325,0.091349,0.33106,MIR6759_3P,0.961336305546275
GOBP_SNO_S_RNA_PROCESSING,SET,9,0.12041,0.0026639,0.27557,0.33108,GOBP_SNO_S_RNA_PROCESSING,0.961336305546275
PCGF6_TARGET_GENES,SET,64,0.043107,0.0025394,0.098674,0.33111,PCGF6_TARGET_GENES,0.961336305546275
KEGG_MEDICUS_REFERENCE_DRD1_...,SET,16,0.089831,0.0026494,0.20565,0.33113,KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY,0.961336305546275
GOMF_AMINO_ACID_BINDING,SET,43,0.06058,0.0029269,0.1387,0.33115,GOMF_AMINO_ACID_BINDING,0.961336305546275
REACTOME_TNF_RECEPTOR_SUPERF...,SET,16,0.10275,0.0030303,0.23538,0.33123,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,0.961465988809086
HOFFMANN_IMMATURE_TO_MATURE_...2,SET,36,0.067982,0.0030059,0.15576,0.33125,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,0.961465988809086
TASOR_TARGET_GENES,SET,209,0.026245,0.0027828,0.060144,0.33129,TASOR_TARGET_GENES,0.961501791231733
GOCC_ANKYRIN_1_COMPLEX,SET,8,0.14539,0.0030328,0.3334,0.33139,GOCC_ANKYRIN_1_COMPLEX,0.961542429680327
chr7p12,SET,18,0.15135,0.0047345,0.34715,0.33142,chr7p12,0.961542429680327
HP_PERIPHERAL_OPACIFICATION_...,SET,16,0.094597,0.00279,0.21698,0.33143,HP_PERIPHERAL_OPACIFICATION_OF_THE_CORNEA,0.961542429680327
HP_MISCARRIAGE,SET,32,0.071708,0.0029896,0.16449,0.33144,HP_MISCARRIAGE,0.961542429680327
GOBP_BONE_MINERALIZATION_INV...,SET,11,0.11983,0.0029307,0.27488,0.33145,GOBP_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,0.961542429680327
KAAB_FAILED_HEART_ATRIUM_DN,SET,133,0.031745,0.0026908,0.072833,0.33147,KAAB_FAILED_HEART_ATRIUM_DN,0.961542429680327
KEGG_MEDICUS_PATHOGEN_KSHV_K...,SET,7,0.12939,0.0025247,0.29696,0.33153,KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY,0.961636216825238
GSE43955_TH0_VS_TGFB_IL6_TH1...6,SET,173,0.028653,0.0027669,0.065776,0.33156,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP,0.961642977551531
HP_THORACIC_DYSPLASIA,SET,4,0.16195,0.0023889,0.37186,0.3316,HP_THORACIC_DYSPLASIA,0.961656495619525
HP_BILATERAL_SENSORINEURAL_H...,SET,60,0.048512,0.0027673,0.1114,0.33162,HP_BILATERAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.961656495619525
MIR300,SET,406,0.018965,0.0027875,0.043563,0.33166,MIR300,0.961681543400317
HP_SHORT_LINGUAL_FRENULUM,SET,11,0.10559,0.0025824,0.24267,0.33175,HP_SHORT_LINGUAL_FRENULUM,0.961681543400317
COUP_01,SET,235,0.024505,0.0027533,0.056331,0.33177,COUP_01,0.961681543400317
GSE22886_DC_VS_MONOCYTE_UP,SET,186,0.027732,0.0027757,0.06376,0.33181,GSE22886_DC_VS_MONOCYTE_UP,0.961681543400317
GOBP_CD4_POSITIVE_ALPHA_BETA...1,SET,112,0.038089,0.0029643,0.087583,0.33182,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.961681543400317
HP_BONE_MARROW_HYPERCELLULAR...,SET,28,0.075876,0.0029594,0.17448,0.33183,HP_BONE_MARROW_HYPERCELLULARITY,0.961681543400317
GOBP_IRIS_MORPHOGENESIS,SET,9,0.14418,0.0031899,0.33159,0.33185,GOBP_IRIS_MORPHOGENESIS,0.961681543400317
GOBP_SYNAPSE_ORGANIZATION,SET,449,0.018688,0.0028852,0.04298,0.33185,GOBP_SYNAPSE_ORGANIZATION,0.961681543400317
GOBP_REGULATION_OF_CRISTAE_F...,SET,5,0.17693,0.0029179,0.40714,0.33194,GOBP_REGULATION_OF_CRISTAE_FORMATION,0.961750995916326
MIR217_3P,SET,83,0.040586,0.0027214,0.093403,0.33195,MIR217_3P,0.961750995916326
KEGG_MEDICUS_REFERENCE_GLYCO...1,SET,5,0.14978,0.0024702,0.34471,0.33196,KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS,0.961750995916326
MIR548N,SET,553,0.016143,0.0027579,0.037162,0.332,MIR548N,0.961750995916326
GSE5142_CTRL_VS_HTERT_TRANSD...2,SET,188,0.027109,0.0027278,0.062415,0.33203,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP,0.961750995916326
GOBP_PROSTATE_GLAND_DEVELOPM...,SET,47,0.06219,0.003141,0.14319,0.33204,GOBP_PROSTATE_GLAND_DEVELOPMENT,0.961750995916326
GSE40274_FOXP3_VS_FOXP3_AND_...8,SET,176,0.028825,0.0028073,0.066422,0.33216,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.961784692602466
GOBP_GLYCOSYLCERAMIDE_CATABO...,SET,6,0.14853,0.0026834,0.34229,0.33217,GOBP_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS,0.961784692602466
MIR500B_3P,SET,76,0.043558,0.0027953,0.10038,0.33218,MIR500B_3P,0.961784692602466
HP_APLASIA_HYPOPLASIA_AFFECT...2,SET,127,0.032763,0.0027142,0.075509,0.33218,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_ANTERIOR_SEGMENT_OF_THE_EYE,0.961784692602466
MIR548AP_5P_MIR548J_5P,SET,441,0.017802,0.0027243,0.041029,0.33219,MIR548AP_5P_MIR548J_5P,0.961784692602466
MIR6770_3P,SET,4,0.1686,0.0024871,0.3889,0.33231,MIR6770_3P,0.962051982507289
GSE29618_PRE_VS_DAY7_FLU_VAC...3,SET,178,0.026595,0.0026046,0.061375,0.3324,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN,0.962136709967524
WP_METABOLIC_PATHWAY_OF_LDL_...,SET,17,0.094594,0.0028757,0.21836,0.33244,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,0.962136709967524
TGACCTTG_SF1_Q6,SET,215,0.025963,0.0027918,0.059935,0.33244,TGACCTTG_SF1_Q6,0.962136709967524
HP_ABNORMAL_ACETABULUM_MORPH...,SET,84,0.039591,0.0026705,0.091402,0.33245,HP_ABNORMAL_ACETABULUM_MORPHOLOGY,0.962136709967524
chr9p24,SET,33,0.10627,0.0044992,0.24558,0.3326,chr9p24,0.962410540338024
GOBP_EXTRACELLULAR_MATRIX_CE...,SET,4,0.2135,0.0031494,0.49336,0.3326,GOBP_EXTRACELLULAR_MATRIX_CELL_SIGNALING,0.962410540338024
HP_ABNORMALITY_OF_COAGULATION,SET,201,0.025833,0.0026868,0.059707,0.33263,HP_ABNORMALITY_OF_COAGULATION,0.96241722027972
GOBP_C21_STEROID_HORMONE_BIO...,SET,19,0.092625,0.0029767,0.21419,0.33271,GOBP_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.962528448419301
WHITFIELD_CELL_CYCLE_G2,SET,152,0.029458,0.0026679,0.068137,0.33275,WHITFIELD_CELL_CYCLE_G2,0.962528448419301
HP_ATROPHY_DEGENERATION_INVO...1,SET,14,0.10976,0.0030284,0.25389,0.33276,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CAUDATE_NUCLEUS,0.962528448419301
BROWNE_HCMV_INFECTION_4HR_DN,SET,227,0.024527,0.002709,0.056742,0.33278,BROWNE_HCMV_INFECTION_4HR_DN,0.962528448419301
GOBP_REGULATION_OF_CIRCADIAN...2,SET,5,0.18782,0.0030976,0.43473,0.33286,GOBP_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,0.962528448419301
GOMF_TRAIL_BINDING,SET,5,0.20062,0.0033087,0.46436,0.33286,GOMF_TRAIL_BINDING,0.962528448419301
HP_HYPERCHOLESTEROLEMIA,SET,71,0.047499,0.0029466,0.10996,0.33288,HP_HYPERCHOLESTEROLEMIA,0.962528448419301
GAO_STOMACH_24W_C2_TFF2POS_M...,SET,6,0.17497,0.003161,0.40508,0.33289,GAO_STOMACH_24W_C2_TFF2POS_MULTIPOTENT_PROGENITOR,0.962528448419301
HP_ABNORMALITY_OF_URINARY_UR...,SET,11,0.10788,0.0026386,0.24986,0.33296,HP_ABNORMALITY_OF_URINARY_URIC_ACID_LEVEL,0.962555102295409
GOMF_PROTEIN_TYROSINE_KINASE...2,SET,140,0.034293,0.0029817,0.079446,0.333,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.962555102295409
HP_MALE_REPRODUCTIVE_SYSTEM_...,SET,59,0.050988,0.0028843,0.11813,0.33301,HP_MALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.962555102295409
GSE2706_2H_VS_8H_R848_STIM_D...2,SET,172,0.028992,0.0027916,0.06717,0.33301,GSE2706_2H_VS_8H_R848_STIM_DC_UP,0.962555102295409
GSE29618_PRE_VS_DAY7_POST_LA...2,SET,182,0.026909,0.0026645,0.062391,0.33313,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP,0.962821883575883
chr9p21,SET,42,0.098662,0.0047112,0.22888,0.33321,chr9p21,0.962836666943315
MIR5008_5P,SET,78,0.039386,0.0025605,0.091379,0.33323,MIR5008_5P,0.962836666943315
MIR6805_5P,SET,40,0.055037,0.0025649,0.12773,0.33328,MIR6805_5P,0.962836666943315
HP_MECKEL_DIVERTICULUM,SET,25,0.06659,0.0024543,0.15455,0.33328,HP_MECKEL_DIVERTICULUM,0.962836666943315
REACTOME_SLBP_DEPENDENT_PROC...,SET,11,0.10348,0.0025309,0.24017,0.33329,REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,0.962836666943315
GSE19888_CTRL_VS_A3R_ACT_TRE...1,SET,178,0.027144,0.0026584,0.063031,0.33336,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN,0.962836666943315
GOCC_EUKARYOTIC_TRANSLATION_...1,SET,5,0.14236,0.0023478,0.3306,0.33338,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX,0.962836666943315
GOBP_LEUKOCYTE_TETHERING_OR_...,SET,34,0.06862,0.0029488,0.15936,0.33339,GOBP_LEUKOCYTE_TETHERING_OR_ROLLING,0.962836666943315
GOBP_REGULATION_OF_DNA_DAMAG...1,SET,18,0.079782,0.0024956,0.18532,0.33341,GOBP_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.962836666943315
GOCC_RDNA_HETEROCHROMATIN,SET,3,0.19174,0.0024495,0.44547,0.33345,GOCC_RDNA_HETEROCHROMATIN,0.962836666943315
MIR3681_3P,SET,356,0.019979,0.0027536,0.046427,0.33348,MIR3681_3P,0.962836666943315
GOBP_THYMOCYTE_MIGRATION,SET,7,0.15497,0.0030238,0.36026,0.33355,GOBP_THYMOCYTE_MIGRATION,0.962836666943315
GOMF_CALCIUM_DEPENDENT_PROTE...1,SET,74,0.049094,0.003109,0.11414,0.33356,GOMF_CALCIUM_DEPENDENT_PROTEIN_BINDING,0.962836666943315
GSE33292_WT_VS_TCF1_KO_DN3_T...2,SET,176,0.028604,0.0027858,0.066528,0.33361,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP,0.962836666943315
GOBP_T_FOLLICULAR_HELPER_CEL...,SET,7,0.122,0.0023806,0.28378,0.33363,GOBP_T_FOLLICULAR_HELPER_CELL_DIFFERENTIATION,0.962836666943315
GOMF_PYRUVATE_DEHYDROGENASE_...2,SET,5,0.15886,0.00262,0.36954,0.33364,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_PHOSPHATASE_ACTIVITY,0.962836666943315
GSE12484_HEALTHY_VS_PERIDONT...1,SET,138,0.031114,0.002686,0.072377,0.33364,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN,0.962836666943315
GSE37605_FOXP3_FUSION_GFP_VS...2,SET,174,0.029773,0.0028833,0.069277,0.33369,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP,0.962836666943315
GSE42021_CD24HI_VS_CD24LOW_T...2,SET,178,0.027901,0.0027326,0.064945,0.33374,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP,0.962836666943315
GOMF_MALATE_DEHYDROGENASE_AC...,SET,8,0.1314,0.002741,0.3059,0.33376,GOMF_MALATE_DEHYDROGENASE_ACTIVITY,0.962836666943315
GSE1460_DP_THYMOCYTE_VS_NAIV...1,SET,176,0.028229,0.0027493,0.065715,0.33376,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.962836666943315
MATZUK_LUTEAL_GENES,SET,8,0.13077,0.0027279,0.30449,0.33379,MATZUK_LUTEAL_GENES,0.962836666943315
DESCARTES_FETAL_LIVER_STELLA...,SET,122,0.038397,0.003118,0.089403,0.33379,DESCARTES_FETAL_LIVER_STELLATE_CELLS,0.962836666943315
GSE20366_TREG_VS_NAIVE_CD4_T...1,SET,182,0.02812,0.0027845,0.06548,0.3338,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN,0.962836666943315
GSE7852_THYMUS_VS_FAT_TCONV_...1,SET,178,0.029072,0.0028472,0.067747,0.33392,GSE7852_THYMUS_VS_FAT_TCONV_DN,0.96291844986315
REACTOME_PHOSPHOLIPASE_C_MED...1,SET,16,0.10072,0.0029705,0.23473,0.33394,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1,0.96291844986315
HP_ABNORMAL_METAPHYSEAL_TRAB...,SET,21,0.077439,0.0026162,0.18048,0.33394,HP_ABNORMAL_METAPHYSEAL_TRABECULATION,0.96291844986315
GOBP_REGULATION_OF_VASCULOGE...,SET,15,0.098358,0.0028089,0.22925,0.33395,GOBP_REGULATION_OF_VASCULOGENESIS,0.96291844986315
GSE9006_HEALTHY_VS_TYPE_1_DI...3,SET,176,0.025302,0.0024642,0.059003,0.33403,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN,0.96291844986315
GOBP_PHOSPHORYLATION,SET,1257,0.010937,0.0027609,0.025507,0.33404,GOBP_PHOSPHORYLATION,0.96291844986315
MIR1282,SET,10,0.12014,0.0028017,0.2802,0.33405,MIR1282,0.96291844986315
GOBP_REGULATION_OF_MITOCHOND...11,SET,7,0.14332,0.0027966,0.33426,0.33405,GOBP_REGULATION_OF_MITOCHONDRIAL_MRNA_STABILITY,0.96291844986315
GSE14308_TH1_VS_TH17_DN,SET,176,0.026277,0.0025592,0.061297,0.33408,GSE14308_TH1_VS_TH17_DN,0.96292506219937
GOBP_RESOLUTION_OF_DNA_RECOM...,SET,6,0.12926,0.0023352,0.30167,0.33415,GOBP_RESOLUTION_OF_DNA_RECOMBINATION_INTERMEDIATES,0.963046956629903
GOBP_SKELETAL_MUSCLE_SATELLI...3,SET,4,0.20519,0.0030268,0.47909,0.33422,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_MAINTENANCE_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.963095568728237
WP_LET7_INHIBITION_OF_ES_CEL...,SET,6,0.18359,0.0033167,0.42868,0.33423,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,0.963095568728237
HP_INCREASED_INFLAMMATORY_RE...,SET,1104,0.011499,0.0027324,0.026854,0.33425,HP_INCREASED_INFLAMMATORY_RESPONSE,0.963095568728237
HP_ABNORMALITY_OF_CORNEAL_TH...,SET,115,0.034549,0.0027244,0.08074,0.33436,HP_ABNORMALITY_OF_CORNEAL_THICKNESS,0.963332653568764
chr3q11,SET,20,0.14103,0.0046498,0.32964,0.33439,chr3q11,0.963339228282493
MIR8054,SET,268,0.022326,0.0026764,0.052202,0.33444,MIR8054,0.963403414836303
MIR6808_3P,SET,37,0.059621,0.0026725,0.13949,0.33454,MIR6808_3P,0.963611611138737
GOBP_NEGATIVE_REGULATION_OF_...408,SET,7,0.14483,0.0028259,0.33892,0.33458,GOBP_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.963646962791083
HP_HYPERCONVEX_NAIL,SET,16,0.096053,0.0028329,0.22487,0.33464,HP_HYPERCONVEX_NAIL,0.963686225461774
HP_RECURRENT_LOWER_RESPIRATO...,SET,213,0.025888,0.0027708,0.060627,0.33469,HP_RECURRENT_LOWER_RESPIRATORY_TRACT_INFECTIONS,0.963686225461774
MIR6835_3P,SET,414,0.018987,0.0028175,0.044469,0.3347,MIR6835_3P,0.963686225461774
GOMF_IMMUNOGLOBULIN_RECEPTOR...1,SET,12,0.12833,0.0032783,0.30067,0.33475,GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY,0.963686225461774
ATGAAGG_MIR205,SET,139,0.030627,0.0026534,0.071756,0.33476,ATGAAGG_MIR205,0.963686225461774
GSE37416_CTRL_VS_6H_F_TULARE...1,SET,169,0.027844,0.0026578,0.065235,0.33476,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.963686225461774
GOBP_HIPPO_SIGNALING,SET,53,0.054779,0.0029375,0.12838,0.33481,GOBP_HIPPO_SIGNALING,0.963699304347826
HP_MIGRAINE,SET,120,0.034349,0.0027665,0.08051,0.33482,HP_MIGRAINE,0.963699304347826
GOBP_REGULATION_OF_FATTY_ACI...3,SET,82,0.039788,0.0026518,0.093275,0.33485,GOBP_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.96370584216628
GOBP_GAP_JUNCTION_ASSEMBLY,SET,16,0.10973,0.0032363,0.25731,0.33489,GOBP_GAP_JUNCTION_ASSEMBLY,0.963741156744225
GROSS_HYPOXIA_VIA_ELK3_AND_H...2,SET,125,0.033982,0.002793,0.079727,0.33497,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,0.963811768358308
GSE45365_NK_CELL_VS_BCELL_UP,SET,186,0.026783,0.0026807,0.062837,0.33497,GSE45365_NK_CELL_VS_BCELL_UP,0.963811768358308
HP_ABNORMAL_CIRCULATING_CREA...2,SET,49,0.051453,0.0026533,0.12081,0.33509,HP_ABNORMAL_CIRCULATING_CREATININE_CONCENTRATION,0.964039212116196
HP_PROGRESSIVE_PSYCHOMOTOR_D...,SET,12,0.10492,0.0026801,0.24637,0.33511,HP_PROGRESSIVE_PSYCHOMOTOR_DETERIORATION,0.964039212116196
HARALAMBIEVA_PBMC_FLUARIX_AG...6,SET,14,0.11571,0.0031925,0.2718,0.33515,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_POSITIVE,0.964039212116196
REACTOME_OPIOID_SIGNALLING,SET,88,0.040333,0.0027843,0.09474,0.33516,REACTOME_OPIOID_SIGNALLING,0.964039212116196
GOBP_ECTODERMAL_PLACODE_DEVE...,SET,12,0.10767,0.0027504,0.25297,0.33519,GOBP_ECTODERMAL_PLACODE_DEVELOPMENT,0.964045717477656
GOBP_NEGATIVE_REGULATION_OF_...581,SET,8,0.12632,0.002635,0.29699,0.3353,GOBP_NEGATIVE_REGULATION_OF_SCHWANN_CELL_PROLIFERATION,0.964100479814692
GSE339_EX_VIVO_VS_IN_CULTURE...6,SET,183,0.025826,0.0025643,0.060719,0.3353,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP,0.964100479814692
KEGG_MEDICUS_REFERENCE_AGE_R...,SET,15,0.093754,0.0026774,0.22045,0.33532,KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY,0.964100479814692
GOMF_DIACYLGLYCEROL_O_ACYLTR...,SET,5,0.17633,0.002908,0.41461,0.33532,GOMF_DIACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.964100479814692
GOBP_REGULATION_OF_JUN_KINAS...,SET,39,0.057588,0.00265,0.1355,0.33541,GOBP_REGULATION_OF_JUN_KINASE_ACTIVITY,0.964107951727558
RYAN_MANTLE_CELL_LYMPHOMA_NO...,SET,143,0.033588,0.0029513,0.079029,0.33542,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,0.964107951727558
GSE5679_PPARG_LIGAND_ROSIGLI...3,SET,181,0.026842,0.0026507,0.063172,0.33545,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.964107951727558
GAVISH_3CA_METAPROGRAM_EPITH...2,SET,42,0.059751,0.0028532,0.14069,0.33553,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ANDROGEN_PROSTATE,0.964107951727558
HP_DILATATION_OF_THE_CEREBRA...,SET,49,0.052559,0.0027103,0.12376,0.33553,HP_DILATATION_OF_THE_CEREBRAL_ARTERY,0.964107951727558
HP_STRIAE_DISTENSAE,SET,33,0.064913,0.0027482,0.15284,0.33553,HP_STRIAE_DISTENSAE,0.964107951727558
chr7p14,SET,54,0.073987,0.0040047,0.17422,0.33554,chr7p14,0.964107951727558
GOBP_MAPK_CASCADE,SET,686,0.014682,0.0027831,0.034576,0.33556,GOBP_MAPK_CASCADE,0.964107951727558
GOBP_POSITIVE_REGULATION_OF_...781,SET,5,0.14787,0.0024387,0.34829,0.33558,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,0.964107951727558
HP_CONGENITAL_PTOSIS,SET,4,0.19044,0.0028093,0.44864,0.3356,HP_CONGENITAL_PTOSIS,0.964107951727558
SWEET_KRAS_TARGETS_DN,SET,56,0.052451,0.0028909,0.1236,0.33565,SWEET_KRAS_TARGETS_DN,0.964171894371436
GOBP_NEGATIVE_REGULATION_OF_...348,SET,43,0.055313,0.0026724,0.13044,0.33577,GOBP_NEGATIVE_REGULATION_OF_LIPID_LOCALIZATION,0.964195044189312
KERLEY_RESPONSE_TO_CISPLATIN...1,SET,5,0.16278,0.0026846,0.38393,0.33579,KERLEY_RESPONSE_TO_CISPLATIN_DN,0.964195044189312
HP_THYROID_ADENOMA,SET,13,0.10574,0.0028114,0.24946,0.33582,HP_THYROID_ADENOMA,0.964195044189312
HP_CHRONIC_HEPATIC_FAILURE,SET,14,0.09204,0.0025394,0.21716,0.33584,HP_CHRONIC_HEPATIC_FAILURE,0.964195044189312
HP_RECURRENT_INTRAPULMONARY_...,SET,7,0.17778,0.0034689,0.41942,0.33584,HP_RECURRENT_INTRAPULMONARY_HEMORRHAGE,0.964195044189312
GOBP_REGULATION_OF_FEEDING_B...,SET,25,0.083096,0.0030627,0.19609,0.33587,GOBP_REGULATION_OF_FEEDING_BEHAVIOR,0.964195044189312
MODULE_261,SET,89,0.038631,0.0026818,0.091167,0.33588,MODULE_261,0.964195044189312
HP_HEPATIC_CALCIFICATION,SET,5,0.17653,0.0029113,0.41661,0.33588,HP_HEPATIC_CALCIFICATION,0.964195044189312
HP_PLETHORA,SET,12,0.11201,0.0028612,0.2645,0.33598,HP_PLETHORA,0.964351511272607
GSE3982_BASOPHIL_VS_TH1_UP,SET,179,0.026743,0.0026264,0.063155,0.33599,GSE3982_BASOPHIL_VS_TH1_UP,0.964351511272607
GSE19888_NO_PRETREAT_VS_ADEN...1,SET,179,0.025777,0.0025315,0.060903,0.33606,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN,0.964403206239168
GOBP_PROTEIN_O_LINKED_GLYCOS...1,SET,87,0.039644,0.0027212,0.093683,0.33609,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION,0.964403206239168
GSE17301_ACD3_ACD28_VS_ACD3_...1,SET,183,0.026201,0.0026015,0.061923,0.33611,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN,0.964403206239168
GNF2_MLH1,SET,36,0.056147,0.0024826,0.13271,0.33612,GNF2_MLH1,0.964403206239168
HP_ELEVATED_SERUM_11_DEOXYCO...,SET,9,0.13402,0.0029651,0.31689,0.33618,HP_ELEVATED_SERUM_11_DEOXYCORTISOL,0.964403206239168
WP_SMITHMAGENIS_AND_POTOCKIL...,SET,144,0.033176,0.0029252,0.078463,0.33621,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,0.964403206239168
HP_CARDIOGENIC_SHOCK,SET,6,0.14283,0.0025804,0.33782,0.33622,HP_CARDIOGENIC_SHOCK,0.964403206239168
GSE19941_UNSTIM_VS_LPS_STIM_...3,SET,174,0.027729,0.0026853,0.065585,0.33623,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.964403206239168
HP_ABNORMAL_CARDIAC_BIOMARKE...,SET,6,0.17237,0.003114,0.40813,0.33639,HP_ABNORMAL_CARDIAC_BIOMARKER_TEST,0.964611024985569
HP_CORNEAL_DYSTROPHY,SET,29,0.073276,0.0029085,0.17353,0.33642,HP_CORNEAL_DYSTROPHY,0.964611024985569
WWTAAGGC_UNKNOWN,SET,130,0.033363,0.0027961,0.079017,0.33643,WWTAAGGC_UNKNOWN,0.964611024985569
FAN_EMBRYONIC_CTX_IN_4_INTER...,SET,8,0.14175,0.0029567,0.33574,0.33645,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.964611024985569
REACTOME_FASL_CD95L_SIGNALING,SET,5,0.17893,0.002951,0.42386,0.33646,REACTOME_FASL_CD95L_SIGNALING,0.964611024985569
KEGG_MEDICUS_VARIANT_MUTATIO...41,SET,13,0.093678,0.0024906,0.22198,0.33651,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION,0.964611024985569
GOBP_SHORT_CHAIN_FATTY_ACID_...1,SET,7,0.15151,0.0029564,0.35901,0.33651,GOBP_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.964611024985569
HP_APLASIA_HYPOPLASIA_OF_THE...55,SET,6,0.13585,0.0024542,0.32199,0.33655,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HALLUX,0.964611024985569
GOMF_PALMITOYLTRANSFERASE_AC...,SET,35,0.060022,0.0026169,0.14228,0.33657,GOMF_PALMITOYLTRANSFERASE_ACTIVITY,0.964611024985569
GSE5099_UNSTIM_VS_MCSF_TREAT...2,SET,177,0.026245,0.0025632,0.062218,0.33658,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP,0.964611024985569
REACTOME_FASTK_FAMILY_PROTEI...,SET,4,0.19492,0.0028754,0.46226,0.33663,REACTOME_FASTK_FAMILY_PROTEINS_REGULATE_PROCESSING_AND_STABILITY_OF_MITOCHONDRIAL_RNAS,0.964665406809002
RFX1_01,SET,224,0.024016,0.0026352,0.05697,0.33667,RFX1_01,0.964665406809002
CCTGCTG_MIR214,SET,218,0.023014,0.0024916,0.054601,0.3367,CCTGCTG_MIR214,0.964665406809002
GOMF_PROTEIN_ARGININE_N_METH...,SET,12,0.096858,0.0024742,0.22982,0.33671,GOMF_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY,0.964665406809002
WP_IL9_SIGNALING,SET,15,0.10841,0.0030958,0.25749,0.33688,WP_IL9_SIGNALING,0.964942471567496
GOMF_POTASSIUM_CHANNEL_ACTIV...2,SET,122,0.036409,0.0029566,0.086483,0.33688,GOMF_POTASSIUM_CHANNEL_ACTIVITY,0.964942471567496
HP_DEPRESSED_NASAL_RIDGE,SET,112,0.034343,0.0026728,0.081577,0.33689,HP_DEPRESSED_NASAL_RIDGE,0.964942471567496
GOBP_CALCIUM_ION_IMPORT_INTO...,SET,5,0.12859,0.0021207,0.30556,0.33694,GOBP_CALCIUM_ION_IMPORT_INTO_SARCOPLASMIC_RETICULUM,0.96498391562294
MIR7114_5P,SET,136,0.031641,0.0027118,0.075196,0.33696,MIR7114_5P,0.96498391562294
HP_BIFID_RIBS,SET,16,0.088637,0.0026142,0.21069,0.33699,HP_BIFID_RIBS,0.964990314740051
GSE13411_SWITCHED_MEMORY_BCE...2,SET,178,0.027086,0.0026527,0.064413,0.33706,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.965111245674741
HP_MACROORCHIDISM,SET,10,0.12035,0.0028067,0.28636,0.33714,HP_MACROORCHIDISM,0.965181276771005
HP_WIDELY_SPACED_MAXILLARY_C...,SET,9,0.10871,0.0024051,0.25865,0.33714,HP_WIDELY_SPACED_MAXILLARY_CENTRAL_INCISORS,0.965181276771005
GOBP_EPITHELIAL_TUBE_MORPHOG...,SET,315,0.020835,0.0027042,0.049588,0.33719,GOBP_EPITHELIAL_TUBE_MORPHOGENESIS,0.965241786743516
GOMF_PRIMARY_MIRNA_BINDING,SET,9,0.11247,0.0024883,0.26778,0.33724,GOMF_PRIMARY_MIRNA_BINDING,0.965241786743516
GSE2770_TGFB_AND_IL4_VS_TGFB...2,SET,139,0.03134,0.0027153,0.074625,0.33725,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.965241786743516
HP_ABNORMALLY_OSSIFIED_VERTE...,SET,19,0.083844,0.0026945,0.19968,0.33729,HP_ABNORMALLY_OSSIFIED_VERTEBRAE,0.965241786743516
HP_SUBRETINAL_FLUID,SET,9,0.13245,0.0029303,0.31545,0.3373,HP_SUBRETINAL_FLUID,0.965241786743516
AIZARANI_LIVER_C22_RESIDENT_...,SET,26,0.070112,0.0026352,0.1671,0.3374,AIZARANI_LIVER_C22_RESIDENT_B_CELLS_2,0.965426204000988
HP_ABNORMALITY_THIGH_MUSCULA...,SET,15,0.09936,0.0028375,0.23684,0.33742,HP_ABNORMALITY_THIGH_MUSCULATURE_MORPHOLOGY,0.965426204000988
HP_PATCHY_CHANGES_OF_BONE_MI...,SET,5,0.16759,0.002764,0.39974,0.33752,HP_PATCHY_CHANGES_OF_BONE_MINERAL_DENSITY,0.965495838117107
HP_DERMAL_ATROPHY,SET,90,0.037842,0.0026417,0.090308,0.3376,HP_DERMAL_ATROPHY,0.965495838117107
GOBP_CYCLIC_NUCLEOTIDE_METAB...,SET,37,0.06201,0.0027796,0.14805,0.33767,GOBP_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,0.965495838117107
CHEN_HOXA5_TARGETS_6HR_DN,SET,4,0.17974,0.0026514,0.42916,0.33768,CHEN_HOXA5_TARGETS_6HR_DN,0.965495838117107
GOBP_SUPRAMOLECULAR_FIBER_OR...,SET,776,0.013492,0.0027134,0.032223,0.33771,GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.965495838117107
FOROUTAN_TGFB_EMT_DN,SET,102,0.039553,0.0029385,0.094505,0.33778,FOROUTAN_TGFB_EMT_DN,0.965495838117107
GSE6269_HEALTHY_VS_STAPH_AUR...1,SET,145,0.029732,0.0026305,0.071052,0.33781,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN,0.965495838117107
GOBP_DERMATAN_SULFATE_METABO...,SET,8,0.13369,0.0027887,0.3195,0.33782,GOBP_DERMATAN_SULFATE_METABOLIC_PROCESS,0.965495838117107
HP_ABSCESS,SET,61,0.046488,0.0026739,0.11112,0.33784,HP_ABSCESS,0.965495838117107
HP_T_CELL_LYMPHOMA,SET,14,0.0946,0.00261,0.22612,0.33784,HP_T_CELL_LYMPHOMA,0.965495838117107
MODULE_457,SET,10,0.10948,0.0025531,0.26171,0.33786,MODULE_457,0.965495838117107
WU_CELL_MIGRATION,SET,167,0.029994,0.0028461,0.071705,0.33787,WU_CELL_MIGRATION,0.965495838117107
HP_DUPLICATION_OF_THE_DISTAL...1,SET,12,0.10431,0.0026646,0.24941,0.33789,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_HAND,0.965495838117107
GOMF_N_FORMYL_PEPTIDE_RECEPT...,SET,4,0.23199,0.0034222,0.5548,0.33792,GOMF_N_FORMYL_PEPTIDE_RECEPTOR_ACTIVITY,0.965495838117107
REACTOME_ADENYLATE_CYCLASE_I...,SET,14,0.10069,0.0027781,0.24081,0.33793,REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,0.965495838117107
GOBP_REGULATION_OF_VOLTAGE_G...2,SET,6,0.15851,0.0028637,0.37924,0.33798,GOBP_REGULATION_OF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.965495838117107
HP_IMPAIRED_MASTICATION,SET,41,0.058294,0.0027503,0.13946,0.33798,HP_IMPAIRED_MASTICATION,0.965495838117107
HP_THYROTOXICOSIS_WITH_DIFFU...,SET,4,0.19551,0.002884,0.46775,0.33799,HP_THYROTOXICOSIS_WITH_DIFFUSE_GOITER,0.965495838117107
GSE29618_BCELL_VS_PDC_DAY7_F...2,SET,165,0.029401,0.0027733,0.07035,0.33801,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP,0.965495838117107
PRDM4_TARGET_GENES,SET,467,0.017032,0.0026804,0.040776,0.33808,PRDM4_TARGET_GENES,0.965495838117107
GSE34156_UNTREATED_VS_6H_NOD...1,SET,146,0.029388,0.002609,0.070362,0.3381,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.965495838117107
MIR582_3P,SET,83,0.039216,0.0026295,0.093898,0.33811,MIR582_3P,0.965495838117107
GSE20152_SPHK1_KO_VS_WT_HTNF...1,SET,180,0.02518,0.0024797,0.060306,0.33815,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN,0.965495838117107
KEGG_MEDICUS_REFERENCE_TBK1_...,SET,10,0.11508,0.0026836,0.27565,0.33817,KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION,0.965495838117107
MIR8089,SET,155,0.030967,0.0028319,0.074184,0.33818,MIR8089,0.965495838117107
GOBP_NEGATIVE_REGULATION_OF_...528,SET,32,0.060295,0.0025138,0.1445,0.33825,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.965495838117107
WP_TP53_NETWORK,SET,19,0.089383,0.0028725,0.21424,0.33826,WP_TP53_NETWORK,0.965495838117107
GOBP_RESPONSE_TO_VITAMIN_E,SET,9,0.12207,0.0027006,0.29262,0.33829,GOBP_RESPONSE_TO_VITAMIN_E,0.965495838117107
GOMF_ICOSANOID_RECEPTOR_ACTI...,SET,14,0.098461,0.0027165,0.23613,0.33835,GOMF_ICOSANOID_RECEPTOR_ACTIVITY,0.965495838117107
HP_FASTING_HYPERINSULINEMIA,SET,9,0.12458,0.0027563,0.29879,0.33835,HP_FASTING_HYPERINSULINEMIA,0.965495838117107
MODULE_63,SET,197,0.028039,0.0028874,0.067246,0.33836,MODULE_63,0.965495838117107
GOBP_FOLATE_TRANSMEMBRANE_TR...,SET,5,0.18529,0.0030558,0.44446,0.33839,GOBP_FOLATE_TRANSMEMBRANE_TRANSPORT,0.965495838117107
GSE12366_GC_VS_NAIVE_BCELL_UP,SET,178,0.025644,0.0025115,0.061546,0.33846,GSE12366_GC_VS_NAIVE_BCELL_UP,0.965495838117107
DASU_IL6_SIGNALING_UP,SET,56,0.049893,0.00275,0.11975,0.33847,DASU_IL6_SIGNALING_UP,0.965495838117107
HP_HYPOKALEMIC_ALKALOSIS,SET,12,0.1099,0.0028075,0.26379,0.33848,HP_HYPOKALEMIC_ALKALOSIS,0.965495838117107
ACOSTA_PROLIFERATION_INDEPEN...2,SET,77,0.038947,0.0025157,0.093512,0.33853,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,0.965495838117107
MIR6867_5P,SET,773,0.013612,0.0027323,0.032689,0.33855,MIR6867_5P,0.965495838117107
HP_DIAPHRAGMATIC_WEAKNESS,SET,16,0.09569,0.0028222,0.22986,0.3386,HP_DIAPHRAGMATIC_WEAKNESS,0.965495838117107
HP_ULNAR_DEVIATION_OF_THE_2N...,SET,7,0.12521,0.0024431,0.30077,0.3386,HP_ULNAR_DEVIATION_OF_THE_2ND_FINGER,0.965495838117107
REACTOME_EUKARYOTIC_TRANSLAT...1,SET,85,0.037399,0.0025375,0.089874,0.33866,REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION,0.965495838117107
GOBP_HOMOLOGOUS_RECOMBINATION,SET,58,0.043601,0.0024455,0.1048,0.33869,GOBP_HOMOLOGOUS_RECOMBINATION,0.965495838117107
GOCC_PRE_SNORNP_COMPLEX,SET,7,0.12509,0.0024409,0.30067,0.33869,GOCC_PRE_SNORNP_COMPLEX,0.965495838117107
GOBP_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.13705,0.0022602,0.32943,0.3387,GOBP_CERAMIDE_1_PHOSPHATE_TRANSPORT,0.965495838117107
GOMF_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.13705,0.0022602,0.32943,0.3387,GOMF_CERAMIDE_1_PHOSPHATE_TRANSFER_ACTIVITY,0.965495838117107
GSE43955_TH0_VS_TGFB_IL6_TH1...12,SET,177,0.026835,0.0026208,0.064512,0.33872,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP,0.965495838117107
MODULE_48,SET,293,0.020976,0.0026273,0.050438,0.33875,MODULE_48,0.965495838117107
GOBP_EPITHELIAL_FLUID_TRANSP...,SET,12,0.1077,0.0027513,0.25897,0.33875,GOBP_EPITHELIAL_FLUID_TRANSPORT,0.965495838117107
GOCC_SMN_COMPLEX,SET,7,0.1186,0.0023143,0.28531,0.33882,GOCC_SMN_COMPLEX,0.965616162361624
GOBP_FOREGUT_MORPHOGENESIS,SET,10,0.11606,0.0027064,0.27941,0.33894,GOBP_FOREGUT_MORPHOGENESIS,0.965799762236616
GOMF_POTASSIUM_CHLORIDE_SYMP...,SET,9,0.11119,0.0024599,0.26769,0.33894,GOMF_POTASSIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.965799762236616
MIR4639_3P,SET,66,0.044875,0.0026844,0.10808,0.339,MIR4639_3P,0.965812361668989
JONES_OVARY_STROMAL,SET,135,0.032857,0.0028058,0.079134,0.339,JONES_OVARY_STROMAL,0.965812361668989
GOBP_REGULATION_OF_LYMPHOCYT...1,SET,467,0.017404,0.0027388,0.041934,0.33906,GOBP_REGULATION_OF_LYMPHOCYTE_ACTIVATION,0.96590412295082
KAUFFMANN_DNA_REPLICATION_GE...,SET,135,0.029597,0.0025273,0.071333,0.33911,KAUFFMANN_DNA_REPLICATION_GENES,0.965951470949766
GOBP_PLASMA_MEMBRANE_TUBULAT...,SET,18,0.077686,0.0024301,0.18728,0.33914,GOBP_PLASMA_MEMBRANE_TUBULATION,0.965951470949766
GOBP_REGULATION_OF_PROTEIN_K...5,SET,18,0.089361,0.0027953,0.21546,0.33916,GOBP_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.965951470949766
GSE40666_NAIVE_VS_EFFECTOR_C...3,SET,179,0.025822,0.0025359,0.062332,0.33934,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.966030181803292
GOBP_PROGRAMMED_CELL_DEATH_I...1,SET,24,0.072747,0.0026272,0.17562,0.33936,GOBP_PROGRAMMED_CELL_DEATH_INVOLVED_IN_CELL_DEVELOPMENT,0.966030181803292
HP_ATELECTASIS,SET,67,0.044563,0.0026857,0.10758,0.33936,HP_ATELECTASIS,0.966030181803292
HP_CHIARI_TYPE_I_MALFORMATION,SET,41,0.055942,0.0026393,0.13506,0.33936,HP_CHIARI_TYPE_I_MALFORMATION,0.966030181803292
GOMF_RNA_POLYMERASE_II_SPECI...,SET,318,0.019729,0.0025727,0.047641,0.33939,GOMF_RNA_POLYMERASE_II_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,0.966030181803292
HE_LIM_SUN_FETAL_LUNG_C3_SCG...,SET,523,0.016127,0.0026816,0.038942,0.33939,HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL,0.966030181803292
REACTOME_DOWNREGULATION_OF_S...,SET,28,0.064933,0.0025326,0.15681,0.33941,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,0.966030181803292
GSE17322_CD103_POS_VS_CD11B_...1,SET,173,0.026382,0.0025476,0.063713,0.33941,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN,0.966030181803292
GOBP_PROTEIN_LOCALIZATION_TO...28,SET,53,0.046539,0.0024956,0.11244,0.33948,GOBP_PROTEIN_LOCALIZATION_TO_LYSOSOME,0.966100510037539
REACTOME_SYNAPTIC_ADHESION_L...,SET,19,0.081462,0.0026179,0.19689,0.33953,REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES,0.966100510037539
GOBP_NEURAL_CREST_CELL_DIFFE...,SET,87,0.041337,0.0028374,0.099918,0.33955,GOBP_NEURAL_CREST_CELL_DIFFERENTIATION,0.966100510037539
GOBP_CYTOKINE_PRODUCTION_INV...2,SET,57,0.046319,0.0025756,0.11201,0.33961,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.966100510037539
GSE22919_RESTING_VS_IL2_IL12...2,SET,181,0.024589,0.0024282,0.059465,0.33962,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP,0.966100510037539
KEGG_MEDICUS_REFERENCE_NALP1...,SET,4,0.1473,0.0021729,0.35632,0.33966,KEGG_MEDICUS_REFERENCE_NALP12_INFLAMMASOME_SIGNALING_PATHWAY,0.966100510037539
GSE27786_LSK_VS_CD8_TCELL_DN,SET,182,0.025863,0.0025609,0.062624,0.33981,GSE27786_LSK_VS_CD8_TCELL_DN,0.966100510037539
KEGG_MEDICUS_VARIANT_MUTATIO...54,SET,14,0.092558,0.0025537,0.22425,0.3399,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.966100510037539
WP_GPR40_PATHWAY,SET,15,0.086563,0.002472,0.2098,0.33995,WP_GPR40_PATHWAY,0.966100510037539
GOBP_ENDOPLASMIC_RETICULUM_U...,SET,70,0.041709,0.0025692,0.10112,0.33999,GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.966100510037539
GOBP_NEGATIVE_REGULATION_OF_...29,SET,29,0.064796,0.0025719,0.15709,0.33999,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.966100510037539
HP_ABSENT_OUTER_DYNEIN_ARMS,SET,9,0.11468,0.0025372,0.27803,0.34,HP_ABSENT_OUTER_DYNEIN_ARMS,0.966100510037539
REACTOME_G_PROTEIN_ACTIVATION,SET,24,0.078334,0.0028289,0.18995,0.34003,REACTOME_G_PROTEIN_ACTIVATION,0.966100510037539
HP_RED_HAIR,SET,8,0.1337,0.0027889,0.3242,0.34003,HP_RED_HAIR,0.966100510037539
GSE29618_PDC_VS_MDC_UP,SET,173,0.027531,0.0026586,0.066776,0.34006,GSE29618_PDC_VS_MDC_UP,0.966100510037539
REACTOME_ACTIVATION_OF_NIMA_...,SET,7,0.1149,0.002242,0.27877,0.34011,REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7,0.966100510037539
REACTOME_NEUROFASCIN_INTERAC...,SET,6,0.14829,0.0026789,0.35989,0.34016,REACTOME_NEUROFASCIN_INTERACTIONS,0.966100510037539
MIR2467_5P,SET,102,0.034548,0.0025666,0.083866,0.34019,MIR2467_5P,0.966100510037539
GOBP_MEIOTIC_CELL_CYCLE_PROC...2,SET,6,0.14997,0.0027092,0.36403,0.34019,GOBP_MEIOTIC_CELL_CYCLE_PROCESS_INVOLVED_IN_OOCYTE_MATURATION,0.966100510037539
DACOSTA_UV_RESPONSE_VIA_ERCC...1,SET,436,0.017185,0.0026153,0.041725,0.34023,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,0.966100510037539
GOCC_ER_TO_GOLGI_TRANSPORT_V...,SET,56,0.048051,0.0026484,0.11668,0.34024,GOCC_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE,0.966100510037539
MODULE_64,SET,491,0.01748,0.0028188,0.042449,0.34025,MODULE_64,0.966100510037539
DESCARTES_MAIN_FETAL_SQUAMOU...,SET,94,0.039404,0.0028109,0.095692,0.34025,DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS,0.966100510037539
WP_AFFECTED_PATHWAYS_IN_DUCH...,SET,67,0.045669,0.0027524,0.11095,0.34031,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,0.966100510037539
KEGG_MEDICUS_VARIANT_MUTATIO...34,SET,11,0.11369,0.0027807,0.2763,0.34036,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004,0.966100510037539
HP_ABNORMAL_ERYTHROCYTE_ENZY...,SET,37,0.053421,0.0023945,0.12982,0.34036,HP_ABNORMAL_ERYTHROCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.966100510037539
KEGG_MEDICUS_VARIANT_CDX2_OV...,SET,5,0.18566,0.0030619,0.45132,0.3404,KEGG_MEDICUS_VARIANT_CDX2_OVEREXPRESSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.966100510037539
GOMF_CORTICOTROPIN_RELEASING...,SET,5,0.16743,0.0027613,0.407,0.3404,GOMF_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING,0.966100510037539
GOMF_DNA_DNA_TETHERING_ACTIV...,SET,5,0.14701,0.0024246,0.35736,0.3404,GOMF_DNA_DNA_TETHERING_ACTIVITY,0.966100510037539
GSE6681_DELETED_FOXP3_VS_WT_...1,SET,176,0.026376,0.0025688,0.064117,0.3404,GSE6681_DELETED_FOXP3_VS_WT_TREG_DN,0.966100510037539
GOMF_CALMODULIN_DEPENDENT_PR...2,SET,5,0.13097,0.0021599,0.31841,0.34042,GOMF_CALMODULIN_DEPENDENT_PROTEIN_PHOSPHATASE_ACTIVITY,0.966100510037539
GOMF_PROSTAGLANDIN_E_RECEPTO...,SET,5,0.18677,0.0030802,0.45411,0.34043,GOMF_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY,0.966100510037539
GOBP_REGULATION_OF_ANTIBACTE...,SET,7,0.14465,0.0028224,0.35171,0.34044,GOBP_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.966100510037539
GOMF_PHOSPHATIDYLINOSITOL_MO...,SET,11,0.098004,0.002397,0.23831,0.34045,GOMF_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY,0.966100510037539
GOBP_RESPONSE_TO_AXON_INJURY,SET,79,0.041019,0.0026836,0.099768,0.34049,GOBP_RESPONSE_TO_AXON_INJURY,0.966100510037539
FOXC1_TARGET_GENES,SET,59,0.046563,0.002634,0.11327,0.3405,FOXC1_TARGET_GENES,0.966100510037539
MIR6800_5P,SET,42,0.050068,0.0023908,0.1218,0.34051,MIR6800_5P,0.966100510037539
BRUINS_UVC_RESPONSE_LATE,SET,1032,0.010963,0.0025239,0.026676,0.34055,BRUINS_UVC_RESPONSE_LATE,0.966100510037539
KEGG_MEDICUS_PATHOGEN_SHIGEL...8,SET,6,0.16595,0.002998,0.40388,0.34058,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.966100510037539
AAGWWRNYGGC_UNKNOWN,SET,111,0.03282,0.0025429,0.079876,0.34058,AAGWWRNYGGC_UNKNOWN,0.966100510037539
GOBP_SYMPATHETIC_NERVOUS_SYS...,SET,21,0.087936,0.0029708,0.21402,0.34059,GOBP_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,0.966100510037539
NAKAYA_PLASMACYTOID_DENDRITI...4,SET,1082,0.010462,0.0024627,0.025469,0.34062,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.966100510037539
GSE3982_NEUTROPHIL_VS_BCELL_...1,SET,182,0.024542,0.0024302,0.059751,0.34063,GSE3982_NEUTROPHIL_VS_BCELL_DN,0.966100510037539
HP_LEFT_ANTERIOR_FASCICULAR_...,SET,7,0.14661,0.0028608,0.3571,0.3407,HP_LEFT_ANTERIOR_FASCICULAR_BLOCK,0.966198074412533
JIANG_MELANOMA_TRM5_CD8,SET,180,0.026759,0.0026353,0.065185,0.34072,JIANG_MELANOMA_TRM5_CD8,0.966198074412533
GOMF_OLIGOPEPTIDE_TRANSMEMBR...,SET,14,0.09852,0.0027182,0.24008,0.34077,GOMF_OLIGOPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.966229251284561
WP_SULFATASE_AND_AROMATASE_P...,SET,14,0.099854,0.002755,0.24335,0.34079,WP_SULFATASE_AND_AROMATASE_PATHWAY,0.966229251284561
MIR5690,SET,110,0.035478,0.0027366,0.08648,0.34082,MIR5690,0.966229251284561
GOMF_G_QUADRUPLEX_DNA_BINDING,SET,11,0.10586,0.0025892,0.25812,0.34086,GOMF_G_QUADRUPLEX_DNA_BINDING,0.966229251284561
GOBP_HYPERSENSITIVITY,SET,15,0.10197,0.002912,0.24864,0.34087,GOBP_HYPERSENSITIVITY,0.966229251284561
GOBP_SEROTONIN_SECRETION,SET,9,0.12196,0.0026982,0.2976,0.34098,GOBP_SEROTONIN_SECRETION,0.966462232914696
GOBP_STEROL_METABOLIC_PROCESS,SET,140,0.030145,0.002621,0.073592,0.34105,GOBP_STEROL_METABOLIC_PROCESS,0.966581811139199
GSE22886_NEUTROPHIL_VS_MONOC...1,SET,176,0.025929,0.0025252,0.063332,0.34112,GSE22886_NEUTROPHIL_VS_MONOCYTE_DN,0.966622551977171
GSE33424_CD161_HIGH_VS_NEG_C...1,SET,183,0.026136,0.0025951,0.063837,0.34112,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.966622551977171
GSE1432_CTRL_VS_IFNG_1H_MICR...1,SET,185,0.025427,0.0025383,0.062125,0.34117,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.966634947419907
LAKE_ADULT_KIDNEY_C23_ENDOTH...,SET,115,0.033779,0.0026637,0.082537,0.34118,LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR,0.966634947419907
REACTOME_CONSTITUTIVE_SIGNAL...5,SET,10,0.094314,0.0021994,0.23055,0.34124,REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,0.96664733882142
GSE2770_TGFB_AND_IL4_VS_IL12...1,SET,182,0.026449,0.002619,0.064655,0.34124,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.96664733882142
MIR548AS_5P,SET,441,0.016769,0.0025663,0.041021,0.34135,MIR548AS_5P,0.966870337325837
GOBP_RETINAL_GANGLION_CELL_A...,SET,22,0.082905,0.0028667,0.20288,0.3414,GOBP_RETINAL_GANGLION_CELL_AXON_GUIDANCE,0.966870337325837
GOBP_REGULATION_OF_EPITHELIA...8,SET,6,0.16294,0.0029436,0.39879,0.34142,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,0.966870337325837
GOBP_LYSOSOMAL_TRANSPORT,SET,126,0.030441,0.0025119,0.074503,0.34143,GOBP_LYSOSOMAL_TRANSPORT,0.966870337325837
GOMF_ALKANE_1_MONOOXYGENASE_...,SET,5,0.17146,0.0028277,0.41988,0.34151,GOMF_ALKANE_1_MONOOXYGENASE_ACTIVITY,0.966893241597662
HP_ERYTHROID_HYPOPLASIA,SET,26,0.064814,0.0024361,0.1588,0.34159,HP_ERYTHROID_HYPOPLASIA,0.966893241597662
GOBP_RESPONSE_TO_HORMONE,SET,816,0.012923,0.002662,0.031678,0.34166,GOBP_RESPONSE_TO_HORMONE,0.966893241597662
HP_APLASIA_CUTIS_CONGENITA_O...2,SET,6,0.15029,0.0027151,0.36842,0.34167,HP_APLASIA_CUTIS_CONGENITA_ON_TRUNK_OR_LIMBS,0.966893241597662
GSE24634_TREG_VS_TCONV_POST_...8,SET,177,0.024998,0.0024414,0.06129,0.34169,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP,0.966893241597662
MIR891A_3P,SET,119,0.033614,0.0026961,0.082418,0.3417,MIR891A_3P,0.966893241597662
MOHANKUMAR_HOXA1_TARGETS_UP,SET,366,0.017814,0.0024888,0.043684,0.34172,MOHANKUMAR_HOXA1_TARGETS_UP,0.966893241597662
HP_REDUCED_NATURAL_KILLER_CE...2,SET,24,0.070964,0.0025628,0.1741,0.34178,HP_REDUCED_NATURAL_KILLER_CELL_COUNT,0.966893241597662
REACTOME_TRAIL_SIGNALING,SET,8,0.14719,0.0030703,0.36116,0.34181,REACTOME_TRAIL_SIGNALING,0.966893241597662
MORF_IL4,SET,162,0.028348,0.0026498,0.069572,0.34184,MORF_IL4,0.966893241597662
HP_MACULAR_PURPURA,SET,79,0.040759,0.0026666,0.10007,0.3419,HP_MACULAR_PURPURA,0.966893241597662
MIR2276_3P,SET,109,0.034342,0.0026369,0.084342,0.34194,MIR2276_3P,0.966893241597662
REACTOME_SIGNALING_BY_NTRK2_...,SET,25,0.066565,0.0024534,0.16353,0.34198,REACTOME_SIGNALING_BY_NTRK2_TRKB,0.966893241597662
MIR9902,SET,259,0.022009,0.0025942,0.054101,0.34208,MIR9902,0.966893241597662
MIR298,SET,170,0.026626,0.002549,0.065459,0.34209,MIR298,0.966893241597662
WP_DISORDERS_OF_BILE_ACID_SY...,SET,29,0.068937,0.0027363,0.16949,0.34211,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,0.966893241597662
WP_RETINOL_METABOLISM,SET,15,0.095391,0.0027241,0.23455,0.34212,WP_RETINOL_METABOLISM,0.966893241597662
GSE21360_PRIMARY_VS_TERTIARY...1,SET,180,0.026858,0.002645,0.066099,0.34225,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.966893241597662
GSE37534_UNTREATED_VS_PIOGLI...2,SET,176,0.025482,0.0024817,0.062709,0.34225,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.966893241597662
GOBP_STARTLE_RESPONSE,SET,25,0.072503,0.0026723,0.17845,0.34226,GOBP_STARTLE_RESPONSE,0.966893241597662
ESC_J1_UP_LATE.V1_UP,SET,163,0.028406,0.0026633,0.069918,0.34227,ESC_J1_UP_LATE.V1_UP,0.966893241597662
GSE1448_CTRL_VS_ANTI_VALPHA2...1,SET,182,0.025516,0.0025266,0.062801,0.34227,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN,0.966893241597662
HP_AIRWAY_HYPERRESPONSIVENESS,SET,8,0.13203,0.002754,0.32507,0.34232,HP_AIRWAY_HYPERRESPONSIVENESS,0.966893241597662
GSE46606_IRF4HIGH_VS_IRF4MID...3,SET,181,0.026591,0.0026259,0.06548,0.34234,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.966893241597662
GOBP_CEREBELLAR_GRANULAR_LAY...2,SET,6,0.18048,0.0032605,0.44447,0.34235,GOBP_CEREBELLAR_GRANULAR_LAYER_FORMATION,0.966893241597662
LEE_LIVER_CANCER_CIPROFIBRAT...2,SET,57,0.049519,0.0027535,0.12196,0.34236,LEE_LIVER_CANCER_CIPROFIBRATE_UP,0.966893241597662
HP_HAIR_PULLING,SET,7,0.15325,0.0029904,0.37744,0.34236,HP_HAIR_PULLING,0.966893241597662
GSE9006_HEALTHY_VS_TYPE_1_DI...5,SET,178,0.027751,0.0027179,0.068347,0.34236,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN,0.966893241597662
GOBP_NEGATIVE_REGULATION_OF_...432,SET,10,0.10847,0.0025296,0.26718,0.34238,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,0.966893241597662
GOCC_CHROMOSOME_CENTROMERIC_...1,SET,2,0.26361,0.0027498,0.64931,0.34238,GOCC_CHROMOSOME_CENTROMERIC_CORE_DOMAIN,0.966893241597662
MIR2681_3P,SET,33,0.0588,0.0024894,0.14485,0.3424,MIR2681_3P,0.966893241597662
GOBP_PHOSPHOLIPID_DEPHOSPHOR...,SET,27,0.059128,0.0022647,0.14568,0.34242,GOBP_PHOSPHOLIPID_DEPHOSPHORYLATION,0.966893241597662
GOLUB_ALL_VS_AML_DN,SET,22,0.079943,0.0027643,0.197,0.34245,GOLUB_ALL_VS_AML_DN,0.966893241597662
MIR921,SET,57,0.04939,0.0027463,0.12174,0.34249,MIR921,0.966893241597662
GSE17721_12H_VS_24H_POLYIC_B...1,SET,180,0.025514,0.0025126,0.062898,0.34251,GSE17721_12H_VS_24H_POLYIC_BMDC_DN,0.966893241597662
GSE20727_CTRL_VS_ROS_INH_AND...1,SET,170,0.02623,0.002511,0.06467,0.34252,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.966893241597662
GAVISH_3CA_METAPROGRAM_CD4_T...2,SET,44,0.059473,0.0029066,0.14667,0.34256,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CYTOTOXIC,0.966893241597662
GOMF_NUCLEAR_EXPORT_SIGNAL_R...,SET,11,0.098414,0.002407,0.24274,0.34259,GOMF_NUCLEAR_EXPORT_SIGNAL_RECEPTOR_ACTIVITY,0.966893241597662
FUNG_IL2_SIGNALING_1,SET,9,0.11498,0.0025439,0.28365,0.3426,FUNG_IL2_SIGNALING_1,0.966893241597662
GOBP_MODULATION_OF_INHIBITOR...,SET,7,0.14924,0.002912,0.36814,0.3426,GOBP_MODULATION_OF_INHIBITORY_POSTSYNAPTIC_POTENTIAL,0.966893241597662
HP_SPINOCEREBELLAR_TRACT_DEG...,SET,8,0.12209,0.0025466,0.30117,0.3426,HP_SPINOCEREBELLAR_TRACT_DEGENERATION,0.966893241597662
GOMF_ACTIVE_TRANSMEMBRANE_TR...,SET,421,0.017264,0.0025829,0.042593,0.34262,GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.966893241597662
GOBP_EMBRYONIC_HEART_TUBE_MO...,SET,70,0.041209,0.0025384,0.10168,0.34264,GOBP_EMBRYONIC_HEART_TUBE_MORPHOGENESIS,0.966893241597662
GSE39022_LN_VS_SPLEEN_DC_UP,SET,181,0.025194,0.0024879,0.062178,0.34267,GSE39022_LN_VS_SPLEEN_DC_UP,0.966893241597662
GOBP_LUTEINIZATION,SET,11,0.11588,0.0028341,0.28601,0.34269,GOBP_LUTEINIZATION,0.966893241597662
GSE17721_LPS_VS_PAM3CSK4_6H_...1,SET,182,0.024393,0.0024154,0.06024,0.34277,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN,0.967023345498783
NAKAYA_PBMC_FLUMIST_AGE_18_5...4,SET,765,0.012643,0.0025252,0.03123,0.3428,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN,0.967023345498783
HP_ANTI_ACETYLCHOLINE_RECEPT...,SET,21,0.073997,0.0024999,0.1829,0.3429,HP_ANTI_ACETYLCHOLINE_RECEPTOR_ANTIBODY_POSITIVITY,0.967023345498783
GOBP_SULFUR_AMINO_ACID_BIOSY...,SET,15,0.097372,0.0027807,0.2407,0.34291,GOBP_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.967023345498783
GOBP_GLUCOSE_IMPORT_ACROSS_P...,SET,4,0.19637,0.0028968,0.48548,0.34293,GOBP_GLUCOSE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.967023345498783
MIR548BB_5P,SET,446,0.016511,0.0025407,0.040823,0.34294,MIR548BB_5P,0.967023345498783
MIR7112_5P,SET,7,0.12548,0.0024484,0.31026,0.34295,MIR7112_5P,0.967023345498783
HP_INCREASED_URINARY_PORPHOB...,SET,5,0.16342,0.0026952,0.40415,0.34298,HP_INCREASED_URINARY_PORPHOBILINOGEN,0.967023345498783
GNF2_CBFB,SET,28,0.064206,0.0025042,0.15883,0.34302,GNF2_CBFB,0.967023345498783
HP_ABNORMAL_BASOPHIL_COUNT,SET,5,0.17946,0.0029598,0.444,0.34303,HP_ABNORMAL_BASOPHIL_COUNT,0.967023345498783
REACTOME_SYNTHESIS_OF_SUBSTR...,SET,58,0.044073,0.002472,0.10905,0.34305,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,0.967023345498783
GOBP_NEGATIVE_REGULATION_OF_...324,SET,28,0.064003,0.0024963,0.15838,0.34307,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.967023345498783
GSE339_CD8POS_VS_CD4CD8DN_DC...4,SET,184,0.024907,0.0024797,0.06166,0.34313,GSE339_CD8POS_VS_CD4CD8DN_DC_UP,0.967114033736112
GOBP_UTP_BIOSYNTHETIC_PROCESS,SET,9,0.11715,0.0025919,0.29017,0.34321,GOBP_UTP_BIOSYNTHETIC_PROCESS,0.967160584562997
GOMF_TETRAPYRROLE_BINDING,SET,135,0.032301,0.0027582,0.080012,0.34322,GOMF_TETRAPYRROLE_BINDING,0.967160584562997
HP_MEGAKARYOCYTE_DYSPLASIA,SET,4,0.179,0.0026405,0.44344,0.34323,HP_MEGAKARYOCYTE_DYSPLASIA,0.967160584562997
HP_EPILEPTIC_ENCEPHALOPATHY,SET,105,0.033524,0.0025267,0.083092,0.34331,HP_EPILEPTIC_ENCEPHALOPATHY,0.967214961327747
GOBP_MITOTIC_CELL_CYCLE_PROC...,SET,701,0.012979,0.002486,0.032172,0.34332,GOBP_MITOTIC_CELL_CYCLE_PROCESS,0.967214961327747
HP_RENAL_FANCONI_SYNDROME,SET,10,0.11247,0.0026228,0.27882,0.34334,HP_RENAL_FANCONI_SYNDROME,0.967214961327747
REACTOME_NUCLEOTIDE_BINDING_...,SET,50,0.048237,0.0025126,0.11965,0.34342,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,0.967214961327747
GOBP_MRNA_MODIFICATION,SET,17,0.072858,0.0022149,0.18073,0.34343,GOBP_MRNA_MODIFICATION,0.967214961327747
GSE39110_DAY3_VS_DAY6_POST_I...4,SET,183,0.024761,0.0024585,0.061432,0.34346,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP,0.967214961327747
GSE46606_IRF4HIGH_VS_WT_CD40...4,SET,180,0.026219,0.0025821,0.065052,0.34346,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.967214961327747
MIR4515,SET,38,0.057903,0.0026302,0.14378,0.34358,MIR4515,0.967214961327747
HP_ELLIPTOCYTOSIS,SET,8,0.11424,0.0023831,0.28375,0.34362,HP_ELLIPTOCYTOSIS,0.967214961327747
SASSON_FSH_RESPONSE,SET,7,0.14621,0.0028529,0.36318,0.34363,SASSON_FSH_RESPONSE,0.967214961327747
chr8q11,SET,19,0.12581,0.0040432,0.31255,0.34365,chr8q11,0.967214961327747
WHITFIELD_CELL_CYCLE_G2_M,SET,183,0.024928,0.0024751,0.061938,0.34367,WHITFIELD_CELL_CYCLE_G2_M,0.967214961327747
GSE18791_UNSTIM_VS_NEWCATSLE...1,SET,171,0.027219,0.0026133,0.067653,0.34372,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN,0.967214961327747
LINSLEY_MIR16_TARGETS,SET,193,0.023469,0.0023924,0.058361,0.34379,LINSLEY_MIR16_TARGETS,0.967214961327747
GRAESSMANN_APOPTOSIS_BY_SERU...2,SET,509,0.01522,0.0024976,0.03785,0.3438,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,0.967214961327747
HP_PARADOXICAL_INCREASED_COR...,SET,14,0.095065,0.0026228,0.23656,0.34389,HP_PARADOXICAL_INCREASED_CORTISOL_SECRETION_ON_DEXAMETHASONE_SUPPRESSION_TEST,0.967214961327747
KEGG_GLYCOLYSIS_GLUCONEOGENE...,SET,54,0.049023,0.0026535,0.122,0.34391,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,0.967214961327747
REACTOME_N_GLYCAN_TRIMMING_A...,SET,5,0.19178,0.0031628,0.47733,0.34393,REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI,0.967214961327747
GSE22886_NAIVE_TCELL_VS_NEUT...1,SET,173,0.028117,0.0027151,0.069982,0.34393,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN,0.967214961327747
TORCHIA_TARGETS_OF_EWSR1_FLI...3,SET,18,0.087327,0.0027316,0.21742,0.34397,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,0.967214961327747
chr14q31,SET,15,0.14837,0.0042371,0.36967,0.34408,chr14q31,0.967214961327747
HP_DENTAL_MALOCCLUSION,SET,127,0.03185,0.0026385,0.079354,0.34408,HP_DENTAL_MALOCCLUSION,0.967214961327747
FUJIWARA_PARK2_HEPATOCYTE_PR...1,SET,7,0.14382,0.0028064,0.35843,0.34412,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN,0.967214961327747
REACTOME_SIGNALING_BY_FGFR1,SET,50,0.050241,0.002617,0.12522,0.34413,REACTOME_SIGNALING_BY_FGFR1,0.967214961327747
GSE43955_TH0_VS_TGFB_IL6_TH1...11,SET,190,0.02525,0.002554,0.062938,0.34415,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN,0.967214961327747
GOBP_DECIDUALIZATION,SET,24,0.0738,0.0026652,0.18398,0.34417,GOBP_DECIDUALIZATION,0.967214961327747
GOBP_POSITIVE_REGULATION_OF_...496,SET,30,0.067657,0.0027313,0.16868,0.34417,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.967214961327747
chr20q13,SET,207,0.05422,0.0057218,0.1352,0.3442,chr20q13,0.967214961327747
GOBP_MITOTIC_NUCLEAR_MEMBRAN...2,SET,10,0.095832,0.0022348,0.23896,0.3442,GOBP_MITOTIC_NUCLEAR_MEMBRANE_ORGANIZATION,0.967214961327747
WP_JAKSTAT_SIGNALING_IN_THE_...,SET,34,0.062046,0.0026663,0.15473,0.34422,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,0.967214961327747
HP_CHRONIC_PULMONARY_OBSTRUC...,SET,30,0.069024,0.0027865,0.17218,0.34426,HP_CHRONIC_PULMONARY_OBSTRUCTION,0.967214961327747
HP_UROGENITAL_SINUS_ANOMALY,SET,15,0.095456,0.002726,0.23813,0.34427,HP_UROGENITAL_SINUS_ANOMALY,0.967214961327747
MIR6776_3P,SET,57,0.047033,0.0026153,0.11737,0.34431,MIR6776_3P,0.967214961327747
GSE1112_HY_CD8AB_VS_HY_CD8AA...2,SET,160,0.027606,0.0025645,0.068919,0.34438,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,0.967214961327747
GOBP_VESICLE_MEDIATED_TRANSP...3,SET,209,0.023716,0.0025147,0.059227,0.34442,GOBP_VESICLE_MEDIATED_TRANSPORT_IN_SYNAPSE,0.967214961327747
MIR8077,SET,62,0.045666,0.0026479,0.11405,0.34443,MIR8077,0.967214961327747
HP_CEREBRAL_WHITE_MATTER_ATR...,SET,56,0.044483,0.0024517,0.1111,0.34444,HP_CEREBRAL_WHITE_MATTER_ATROPHY,0.967214961327747
GSE16385_MONOCYTE_VS_12H_IL4...1,SET,188,0.023188,0.0023333,0.05795,0.34453,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN,0.967214961327747
GOBP_POSITIVE_REGULATION_BY_...2,SET,20,0.076902,0.0025355,0.19221,0.34455,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.967214961327747
CCANNAGRKGGC_UNKNOWN,SET,106,0.03398,0.0025732,0.084943,0.34457,CCANNAGRKGGC_UNKNOWN,0.967214961327747
GOBP_SMOOTHENED_SIGNALING_PA...2,SET,5,0.15559,0.002566,0.38896,0.34458,GOBP_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.967214961327747
HP_WIDE_NOSE,SET,108,0.033301,0.0025453,0.083275,0.34462,HP_WIDE_NOSE,0.967214961327747
chr5q11,SET,34,0.10149,0.0043612,0.25386,0.34466,chr5q11,0.967214961327747
HP_ABNORMAL_GLYCOSPHINGOLIPI...,SET,6,0.15548,0.0028088,0.3889,0.34466,HP_ABNORMAL_GLYCOSPHINGOLIPID_METABOLISM,0.967214961327747
GSE19941_UNSTIM_VS_LPS_AND_I...3,SET,175,0.025629,0.002489,0.064149,0.34476,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.967214961327747
HP_GRAVES_DISEASE,SET,3,0.21155,0.0027026,0.52954,0.34477,HP_GRAVES_DISEASE,0.967214961327747
GOCC_GOLGI_APPARATUS_SUBCOMP...,SET,330,0.018469,0.0024525,0.046245,0.34481,GOCC_GOLGI_APPARATUS_SUBCOMPARTMENT,0.967214961327747
MIR635,SET,40,0.057059,0.0026591,0.14291,0.34485,MIR635,0.967214961327747
GOBP_N_TERMINAL_PROTEIN_AMIN...1,SET,13,0.088372,0.0023496,0.22136,0.34487,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION,0.967214961327747
HP_SHORT_5TH_TOE,SET,5,0.16793,0.0027695,0.42063,0.34487,HP_SHORT_5TH_TOE,0.967214961327747
GOBP_POSITIVE_REGULATION_OF_...380,SET,9,0.11326,0.0025058,0.28372,0.34488,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.967214961327747
GOBP_SPHINGOID_METABOLIC_PRO...,SET,18,0.085399,0.0026713,0.21393,0.34488,GOBP_SPHINGOID_METABOLIC_PROCESS,0.967214961327747
WELCSH_BRCA1_TARGETS_DN,SET,125,0.028829,0.0023694,0.072242,0.34493,WELCSH_BRCA1_TARGETS_DN,0.967214961327747
GOMF_AMINO_ACID_SODIUM_SYMPO...,SET,21,0.087519,0.0029567,0.21938,0.34497,GOMF_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.967214961327747
HP_ABNORMAL_MITOCHONDRIAL_NU...,SET,6,0.11659,0.0021062,0.29225,0.34498,HP_ABNORMAL_MITOCHONDRIAL_NUMBER,0.967214961327747
REACTOME_MUSCARINIC_ACETYLCH...,SET,5,0.16996,0.0028029,0.42606,0.34499,REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS,0.967214961327747
MIR6890_5P,SET,18,0.080037,0.0025036,0.20069,0.34502,MIR6890_5P,0.967214961327747
GOBP_METANEPHRIC_DISTAL_TUBU...,SET,6,0.15729,0.0028416,0.39442,0.34502,GOBP_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT,0.967214961327747
GSE40274_FOXP3_VS_FOXP3_AND_...4,SET,183,0.026281,0.0026094,0.065928,0.34508,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.967214961327747
GOBP_RESPONSE_TO_ACTIVITY,SET,72,0.042035,0.0026259,0.10548,0.34513,GOBP_RESPONSE_TO_ACTIVITY,0.967214961327747
GSE22611_UNSTIM_VS_2H_MDP_ST...4,SET,170,0.026179,0.0025062,0.065691,0.34513,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.967214961327747
GSE41867_NAIVE_VS_DAY6_LCMV_...4,SET,185,0.024136,0.0024094,0.060565,0.34513,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP,0.967214961327747
GOBP_CORONARY_VASCULATURE_MO...,SET,17,0.08887,0.0027016,0.22305,0.34516,GOBP_CORONARY_VASCULATURE_MORPHOGENESIS,0.967214961327747
HP_ABNORMAL_PULMONARY_VALVE_...2,SET,52,0.047419,0.0025188,0.11904,0.34519,HP_ABNORMAL_PULMONARY_VALVE_MORPHOLOGY,0.967214961327747
HP_ABSENT_BRAINSTEM_AUDITORY...,SET,9,0.11522,0.0025491,0.28934,0.34524,HP_ABSENT_BRAINSTEM_AUDITORY_RESPONSES,0.967214961327747
CEBP_Q3,SET,218,0.024732,0.0026776,0.062116,0.34526,CEBP_Q3,0.967214961327747
GSE22935_24H_VS_48H_MBOVIS_B...1,SET,182,0.024571,0.002433,0.061712,0.34526,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.967214961327747
REACTOME_GLYCOGEN_STORAGE_DI...,SET,13,0.095342,0.0025349,0.23949,0.34528,REACTOME_GLYCOGEN_STORAGE_DISEASES,0.967214961327747
REACTOME_TRNA_AMINOACYLATION,SET,24,0.06398,0.0023106,0.16072,0.34528,REACTOME_TRNA_AMINOACYLATION,0.967214961327747
GOBP_LATE_ENDOSOME_TO_GOLGI_...,SET,3,0.15992,0.002043,0.40173,0.34529,GOBP_LATE_ENDOSOME_TO_GOLGI_TRANSPORT,0.967214961327747
GSE21927_BALBC_VS_C57BL6_MON...2,SET,153,0.027903,0.0025353,0.070107,0.34531,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP,0.967214961327747
HP_ABSENCE_OF_PUBERTAL_DEVEL...,SET,30,0.067255,0.0027151,0.16898,0.34532,HP_ABSENCE_OF_PUBERTAL_DEVELOPMENT,0.967214961327747
SAGIV_CD24_TARGETS_UP,SET,21,0.077438,0.0026162,0.1946,0.34534,SAGIV_CD24_TARGETS_UP,0.967214961327747
REACTOME_NFE2L2_REGULATING_E...,SET,5,0.15082,0.0024873,0.37905,0.34536,REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES,0.967214961327747
PID_INTEGRIN5_PATHWAY,SET,16,0.090082,0.0026568,0.22645,0.34539,PID_INTEGRIN5_PATHWAY,0.967214961327747
GSE7460_TREG_VS_TCONV_ACT_UP,SET,175,0.026819,0.0026046,0.067423,0.3454,GSE7460_TREG_VS_TCONV_ACT_UP,0.967214961327747
GENTILE_UV_RESPONSE_CLUSTER_...5,SET,33,0.058762,0.0024878,0.14775,0.34542,GENTILE_UV_RESPONSE_CLUSTER_D6,0.967214961327747
GOCC_NUCLEAR_INNER_MEMBRANE,SET,48,0.04761,0.00243,0.11971,0.34542,GOCC_NUCLEAR_INNER_MEMBRANE,0.967214961327747
HP_DIABETES_INSIPIDUS,SET,53,0.0487,0.0026115,0.12248,0.34546,HP_DIABETES_INSIPIDUS,0.967249037299605
WP_MODULATORS_OF_TCR_SIGNALI...,SET,57,0.044791,0.0024906,0.11268,0.3455,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,0.967283107781537
HP_ABNORMAL_ANTERIOR_EYE_SEG...,SET,1153,0.010329,0.0025046,0.026044,0.34584,HP_ABNORMAL_ANTERIOR_EYE_SEGMENT_MORPHOLOGY,0.968091037204059
IBRAHIM_NRF3_UP,SET,5,0.16246,0.0026793,0.40967,0.34585,IBRAHIM_NRF3_UP,0.968091037204059
E2F_Q3,SET,196,0.023398,0.0024034,0.059024,0.3459,E2F_Q3,0.968091037204059
GOBP_REGULATION_OF_DENDRITIC...5,SET,12,0.10613,0.002711,0.26772,0.3459,GOBP_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.968091037204059
GSE12366_PLASMA_CELL_VS_MEMO...1,SET,175,0.024955,0.0024235,0.062971,0.34595,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.968153011514615
NEMETH_INFLAMMATORY_RESPONSE...1,SET,28,0.066425,0.0025908,0.16771,0.34603,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,0.968198981645468
HP_ABNORMALITY_OF_THE_MIDDLE...4,SET,12,0.10074,0.0025733,0.25436,0.34604,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANX_OF_THE_2ND_FINGER,0.968198981645468
GOMF_ANKYRIN_BINDING,SET,19,0.083858,0.0026949,0.21175,0.34605,GOMF_ANKYRIN_BINDING,0.968198981645468
HP_ABNORMALITY_OF_THE_PERIOR...,SET,229,0.023377,0.0025932,0.059051,0.3461,HP_ABNORMALITY_OF_THE_PERIORBITAL_REGION,0.968260927312243
VALK_AML_WITH_T_8_21_TRANSLO...,SET,4,0.19025,0.0028064,0.48066,0.34613,VALK_AML_WITH_T_8_21_TRANSLOCATION,0.968266914842241
GOMF_PRE_MRNA_BINDING,SET,36,0.051568,0.0022801,0.13034,0.34619,GOMF_PRE_MRNA_BINDING,0.968282795915085
HP_ABNORMALITY_OF_FIBRINOLYS...,SET,4,0.13221,0.0019503,0.33432,0.34625,HP_ABNORMALITY_OF_FIBRINOLYSIS,0.968282795915085
GAVISH_3CA_MALIGNANT_METAPRO...25,SET,44,0.052783,0.0025796,0.1335,0.34628,GAVISH_3CA_MALIGNANT_METAPROGRAM_33_RBCS,0.968282795915085
GOMF_DELAYED_RECTIFIER_POTAS...,SET,27,0.076586,0.0029333,0.19378,0.34634,GOMF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.968282795915085
GOBP_DNA_CONFORMATION_CHANGE,SET,83,0.035667,0.0023915,0.090249,0.34635,GOBP_DNA_CONFORMATION_CHANGE,0.968282795915085
GOCC_PTW_PP1_PHOSPHATASE_COM...,SET,7,0.11297,0.0022043,0.28586,0.34636,GOCC_PTW_PP1_PHOSPHATASE_COMPLEX,0.968282795915085
GSE22611_UNSTIM_VS_6H_MDP_ST...3,SET,180,0.024912,0.0024534,0.063057,0.3464,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.968282795915085
GSE33425_CD161_HIGH_VS_INT_C...1,SET,178,0.025739,0.0025208,0.065152,0.3464,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN,0.968282795915085
MIR6775_5P,SET,4,0.18181,0.002682,0.46026,0.34642,MIR6775_5P,0.968282795915085
GSE3982_NKCELL_VS_TH2_UP,SET,171,0.026248,0.0025201,0.066461,0.34644,GSE3982_NKCELL_VS_TH2_UP,0.968282795915085
GOBP_POSITIVE_REGULATION_OF_...399,SET,23,0.071341,0.0025222,0.18065,0.34645,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.968282795915085
GOBP_RESPONSE_TO_INSULIN,SET,251,0.021259,0.0024674,0.053838,0.34647,GOBP_RESPONSE_TO_INSULIN,0.968282795915085
MIR889_5P,SET,110,0.032087,0.002475,0.081321,0.34658,MIR889_5P,0.968512334164187
AAAYRNCTG_UNKNOWN,SET,324,0.019532,0.0025704,0.049523,0.34664,AAAYRNCTG_UNKNOWN,0.96852015189263
GOBP_REGULATION_OF_NON_MOTIL...,SET,9,0.10202,0.0022571,0.25872,0.34667,GOBP_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.96852015189263
SCHLOSSER_SERUM_RESPONSE_DN,SET,635,0.013371,0.0024422,0.03392,0.34672,SCHLOSSER_SERUM_RESPONSE_DN,0.96852015189263
GOBP_LOW_DENSITY_LIPOPROTEIN...2,SET,16,0.093811,0.0027668,0.23799,0.34673,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.96852015189263
KEGG_MEDICUS_REFERENCE_CXCR4...3,SET,21,0.071115,0.0024026,0.18042,0.34674,KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.96852015189263
REACTOME_METALLOTHIONEINS_BI...,SET,11,0.15983,0.003909,0.40554,0.34675,REACTOME_METALLOTHIONEINS_BIND_METALS,0.96852015189263
GOBP_SINOATRIAL_NODE_CELL_DE...,SET,5,0.17152,0.0028287,0.4356,0.34689,GOBP_SINOATRIAL_NODE_CELL_DEVELOPMENT,0.968811333869024
GOBP_MATERNAL_PROCESS_INVOLV...2,SET,5,0.13149,0.0021685,0.334,0.34691,GOBP_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION,0.968811333869024
GOBP_PEPTIDYL_ARGININE_METHY...1,SET,10,0.097996,0.0022853,0.24908,0.347,GOBP_PEPTIDYL_ARGININE_METHYLATION,0.968912889620823
MAPK3_TARGET_GENES,SET,69,0.04017,0.0024567,0.10211,0.34702,MAPK3_TARGET_GENES,0.968912889620823
GSE22886_NAIVE_CD4_TCELL_VS_...11,SET,179,0.024559,0.0024119,0.062432,0.34703,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN,0.968912889620823
GSE41867_DAY8_EFFECTOR_VS_DA...4,SET,186,0.023368,0.0023389,0.059427,0.34708,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.96897464856615
GOBP_REGULATION_OF_CARDIAC_M...11,SET,5,0.18771,0.0030957,0.47761,0.34716,GOBP_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.969120144578313
GSE12845_IGD_POS_VS_NEG_BLOO...2,SET,170,0.024933,0.0023869,0.063472,0.34723,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP,0.969237703798892
GOCC_BETA_CATENIN_TCF_COMPLEX,SET,13,0.098599,0.0026214,0.25105,0.34726,GOCC_BETA_CATENIN_TCF_COMPLEX,0.96924359942178
GOBP_SCHWANN_CELL_PROLIFERAT...,SET,9,0.10475,0.0023176,0.26682,0.34731,GOBP_SCHWANN_CELL_PROLIFERATION,0.969305311973019
GOCC_VCP_NPL4_UFD1_AAA_ATPAS...,SET,7,0.13117,0.0025594,0.33429,0.34739,GOCC_VCP_NPL4_UFD1_AAA_ATPASE_COMPLEX,0.969327802241793
WP_MITOCHONDRIAL_IMMUNE_RESP...,SET,23,0.068334,0.0024159,0.17419,0.34742,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.969327802241793
HP_ECTOPIC_ANTERIOR_PITUITAR...,SET,8,0.11796,0.0024605,0.30099,0.34757,HP_ECTOPIC_ANTERIOR_PITUITARY_GLAND,0.969327802241793
KASLER_HDAC7_TARGETS_1_UP,SET,181,0.02501,0.0024697,0.063828,0.34759,KASLER_HDAC7_TARGETS_1_UP,0.969327802241793
REACTOME_OTHER_INTERLEUKIN_S...,SET,24,0.070613,0.0025501,0.18023,0.34761,REACTOME_OTHER_INTERLEUKIN_SIGNALING,0.969327802241793
HP_FLUCTUATIONS_IN_CONSCIOUS...,SET,6,0.15272,0.002759,0.38982,0.34761,HP_FLUCTUATIONS_IN_CONSCIOUSNESS,0.969327802241793
REACTOME_MELANIN_BIOSYNTHESIS,SET,5,0.18177,0.0029978,0.46411,0.34766,REACTOME_MELANIN_BIOSYNTHESIS,0.969327802241793
GOBP_MEMBRANE_DEPOLARIZATION...3,SET,21,0.082989,0.0028037,0.21193,0.34769,GOBP_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.969327802241793
GOBP_MAMMARY_GLAND_BRANCHING...,SET,6,0.15512,0.0028023,0.39619,0.34771,GOBP_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY,0.969327802241793
WP_SARSCOV2_INNATE_IMMUNITY_...,SET,62,0.043954,0.0025486,0.11231,0.34777,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.969327802241793
GSE7768_OVA_WITH_LPS_VS_OVA_...1,SET,154,0.026882,0.0024504,0.068703,0.3478,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.969327802241793
GSE40068_BCL6_POS_VS_NEG_CXC...2,SET,186,0.024362,0.0024384,0.062272,0.34782,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP,0.969327802241793
PID_S1P_META_PATHWAY,SET,21,0.073184,0.0024724,0.18708,0.34783,PID_S1P_META_PATHWAY,0.969327802241793
WP_METASTATIC_BRAIN_TUMOR,SET,6,0.15545,0.0028083,0.39736,0.34783,WP_METASTATIC_BRAIN_TUMOR,0.969327802241793
MIR198,SET,76,0.042012,0.0026961,0.10739,0.34783,MIR198,0.969327802241793
GOBP_FOREBRAIN_NEURON_FATE_C...,SET,7,0.15121,0.0029504,0.3867,0.34789,GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT,0.969327802241793
GOBP_ISOLEUCINE_METABOLIC_PR...,SET,6,0.14274,0.0025786,0.36514,0.34794,GOBP_ISOLEUCINE_METABOLIC_PROCESS,0.969327802241793
GOMF_3_CHLOROALLYL_ALDEHYDE_...,SET,5,0.18282,0.0030151,0.46768,0.34794,GOMF_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY,0.969327802241793
KASLER_HDAC7_TARGETS_2_UP,SET,5,0.19356,0.0031922,0.49543,0.34802,KASLER_HDAC7_TARGETS_2_UP,0.969327802241793
GOMF_INWARD_RECTIFIER_POTASS...,SET,26,0.075251,0.0028284,0.19264,0.34804,GOMF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.969327802241793
GSE17721_CTRL_VS_GARDIQUIMOD...13,SET,184,0.024471,0.0024363,0.062658,0.34806,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN,0.969327802241793
GOMF_COA_TRANSFERASE_ACTIVITY,SET,5,0.16482,0.0027182,0.42202,0.34807,GOMF_COA_TRANSFERASE_ACTIVITY,0.969327802241793
GOBP_POSITIVE_REGULATION_OF_...293,SET,6,0.16149,0.0029175,0.4137,0.34814,GOBP_POSITIVE_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,0.969327802241793
GOMF_CIS_REGULATORY_REGION_S...,SET,1112,0.011186,0.002667,0.028664,0.34818,GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.969327802241793
GSE18791_CTRL_VS_NEWCASTLE_V...5,SET,166,0.026701,0.0025261,0.068421,0.34818,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN,0.969327802241793
WP_CHEMOKINE_SIGNALING,SET,157,0.027945,0.0025719,0.071613,0.34819,WP_CHEMOKINE_SIGNALING,0.969327802241793
GCNP_SHH_UP_LATE.V1_DN,SET,159,0.027354,0.0025332,0.070105,0.3482,GCNP_SHH_UP_LATE.V1_DN,0.969327802241793
GOBP_NEGATIVE_REGULATION_OF_...439,SET,147,0.029109,0.002593,0.074607,0.34821,GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.969327802241793
GOBP_REGULATION_OF_MRNA_PROC...,SET,117,0.028478,0.002265,0.07299,0.34821,GOBP_REGULATION_OF_MRNA_PROCESSING,0.969327802241793
GSE17580_TREG_VS_TEFF_S_MANS...2,SET,180,0.025246,0.0024862,0.064713,0.34823,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP,0.969327802241793
MORF_RPA1,SET,59,0.03985,0.0022543,0.10216,0.34824,MORF_RPA1,0.969327802241793
GOBP_RESPONSE_TO_TOXIC_SUBST...,SET,226,0.023423,0.0025815,0.060062,0.34827,GOBP_RESPONSE_TO_TOXIC_SUBSTANCE,0.969327802241793
GOMF_SOLUTE_INORGANIC_ANION_...,SET,31,0.060444,0.0024804,0.15498,0.34827,GOMF_SOLUTE_INORGANIC_ANION_ANTIPORTER_ACTIVITY,0.969327802241793
PID_TCR_CALCIUM_PATHWAY,SET,27,0.062576,0.0023967,0.16051,0.34832,PID_TCR_CALCIUM_PATHWAY,0.969327802241793
HP_SYNOSTOSIS_INVOLVING_BONE...2,SET,43,0.054256,0.0026213,0.13918,0.34834,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_HAND,0.969327802241793
HP_ABNORMAL_JEJUNUM_MORPHOLO...,SET,9,0.11204,0.0024788,0.28745,0.34835,HP_ABNORMAL_JEJUNUM_MORPHOLOGY,0.969327802241793
HP_HYPEROSTOSIS,SET,47,0.045876,0.002317,0.1177,0.34835,HP_HYPEROSTOSIS,0.969327802241793
GSE17721_LPS_VS_GARDIQUIMOD_...9,SET,176,0.024418,0.0023781,0.062694,0.34846,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN,0.969412773109244
REACTOME_PKA_MEDIATED_PHOSPH...2,SET,4,0.14984,0.0022103,0.38482,0.3485,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.969412773109244
GSE28737_WT_VS_BCL6_KO_FOLLI...1,SET,183,0.024954,0.0024777,0.064089,0.34851,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.969412773109244
GOBP_MACROPHAGE_MIGRATION,SET,57,0.044936,0.0024987,0.11542,0.34852,GOBP_MACROPHAGE_MIGRATION,0.969412773109244
GOBP_NEGATIVE_REGULATION_OF_...2,SET,40,0.049007,0.0022838,0.12588,0.34852,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.969412773109244
GOBP_NEGATIVE_REGULATION_OF_...314,SET,43,0.053472,0.0025835,0.13742,0.3486,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,0.969557698463508
GOBP_TISSUE_MORPHOGENESIS,SET,576,0.014628,0.0025487,0.037605,0.34865,GOBP_TISSUE_MORPHOGENESIS,0.969619168600464
GOBP_B_CELL_RECEPTOR_SIGNALI...,SET,58,0.046365,0.0026006,0.1193,0.34877,GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.969804363621846
GOBP_GRANZYME_MEDIATED_PROGR...,SET,8,0.12529,0.0026134,0.32254,0.34885,GOBP_GRANZYME_MEDIATED_PROGRAMMED_CELL_DEATH_SIGNALING_PATHWAY,0.969804363621846
MODULE_521,SET,35,0.063158,0.0027536,0.16264,0.34889,MODULE_521,0.969804363621846
BECKER_TAMOXIFEN_RESISTANCE_...2,SET,51,0.048682,0.0025609,0.12537,0.3489,BECKER_TAMOXIFEN_RESISTANCE_UP,0.969804363621846
MATSUMIYA_PBMC_MODIFIED_VACC...7,SET,9,0.10801,0.0023897,0.27819,0.34891,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_28DY_UP,0.969804363621846
GOMF_HISTONE_H3K4_METHYLTRAN...,SET,18,0.077536,0.0024254,0.19973,0.34893,GOMF_HISTONE_H3K4_METHYLTRANSFERASE_ACTIVITY,0.969804363621846
GOBP_MDA_5_SIGNALING_PATHWAY,SET,10,0.085925,0.0020038,0.22135,0.34894,GOBP_MDA_5_SIGNALING_PATHWAY,0.969804363621846
GOBP_ANGIOGENESIS_INVOLVED_I...1,SET,5,0.16276,0.0026843,0.41984,0.34913,GOBP_ANGIOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.969804363621846
HP_ADRENOCORTICAL_CARCINOMA,SET,17,0.084583,0.0025713,0.2182,0.34914,HP_ADRENOCORTICAL_CARCINOMA,0.969804363621846
MIR711,SET,36,0.05407,0.0023907,0.13949,0.34915,MIR711,0.969804363621846
GSE15930_STIM_VS_STIM_AND_TR...2,SET,177,0.024772,0.0024194,0.063909,0.34915,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP,0.969804363621846
GOBP_HOMEOSTASIS_OF_NUMBER_O...1,SET,295,0.019758,0.0024831,0.050978,0.34917,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS,0.969804363621846
GSE41176_WT_VS_TAK1_KO_UNSTI...1,SET,175,0.025376,0.0024644,0.065472,0.34917,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN,0.969804363621846
GOBP_PROTOPORPHYRINOGEN_IX_M...,SET,10,0.10097,0.0023547,0.26057,0.34919,GOBP_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS,0.969804363621846
SWEET_KRAS_TARGETS_UP,SET,74,0.04217,0.0026705,0.10884,0.34921,SWEET_KRAS_TARGETS_UP,0.969804363621846
REACTOME_LDL_CLEARANCE,SET,19,0.077541,0.0024919,0.20021,0.34927,REACTOME_LDL_CLEARANCE,0.969804363621846
GOBP_GLOMERULAR_ENDOTHELIUM_...,SET,4,0.2028,0.0029915,0.52367,0.34928,GOBP_GLOMERULAR_ENDOTHELIUM_DEVELOPMENT,0.969804363621846
HP_SPONTANEOUS_RECURRENT_EPI...,SET,13,0.10092,0.0026832,0.2606,0.34929,HP_SPONTANEOUS_RECURRENT_EPISTAXIS,0.969804363621846
GSE28726_NAIVE_CD4_TCELL_VS_...3,SET,173,0.025414,0.0024541,0.065626,0.34929,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN,0.969804363621846
KENNY_CTNNB1_TARGETS_DN,SET,49,0.046557,0.0024008,0.12026,0.34933,KENNY_CTNNB1_TARGETS_DN,0.969804363621846
GOBP_POSITIVE_REGULATION_OF_...835,SET,11,0.099709,0.0024387,0.25765,0.34938,GOBP_POSITIVE_REGULATION_OF_VASCULOGENESIS,0.969804363621846
AMIT_SERUM_RESPONSE_40_MCF10A,SET,29,0.069065,0.0027413,0.17847,0.34939,AMIT_SERUM_RESPONSE_40_MCF10A,0.969804363621846
LANDEMAINE_LUNG_METASTASIS,SET,20,0.0783,0.0025816,0.20235,0.3494,LANDEMAINE_LUNG_METASTASIS,0.969804363621846
WP_PATHOGENESIS_OF_SARSCOV2_...,SET,18,0.087996,0.0027526,0.22744,0.34942,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,0.969804363621846
REACTOME_HUR_ELAVL1_BINDS_AN...,SET,8,0.13182,0.0027496,0.34076,0.34945,REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA,0.969804363621846
MIR548AV_3P,SET,162,0.02594,0.0024247,0.067063,0.34945,MIR548AV_3P,0.969804363621846
GOBP_FOLIC_ACID_TRANSPORT,SET,10,0.12318,0.0028727,0.31851,0.34947,GOBP_FOLIC_ACID_TRANSPORT,0.969804363621846
COLDREN_GEFITINIB_RESISTANCE...1,SET,205,0.024281,0.0025501,0.062793,0.3495,COLDREN_GEFITINIB_RESISTANCE_DN,0.969810179640718
GSE17301_CTRL_VS_48H_ACD3_AC...6,SET,177,0.02445,0.0023879,0.063247,0.34954,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP,0.969843741018681
HP_ABNORMAL_VISUAL_ELECTROPH...,SET,233,0.02218,0.0024816,0.057403,0.3496,HP_ABNORMAL_VISUAL_ELECTROPHYSIOLOGY,0.969855363984674
GSE21927_SPLEEN_VS_4T1_TUMOR...1,SET,173,0.024711,0.0023863,0.06395,0.3496,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,0.969855363984674
SCHRAETS_MLL_TARGETS_UP,SET,29,0.068749,0.0027288,0.17803,0.34969,SCHRAETS_MLL_TARGETS_UP,0.969905054309046
CSHL1_TARGET_GENES,SET,178,0.024635,0.0024127,0.063814,0.34973,CSHL1_TARGET_GENES,0.969905054309046
KIM_WT1_TARGETS_8HR_UP,SET,159,0.026508,0.002455,0.068685,0.34977,KIM_WT1_TARGETS_8HR_UP,0.969905054309046
GOMF_POTASSIUM_ION_TRANSMEMB...,SET,156,0.029116,0.0026711,0.075512,0.34991,GOMF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.969905054309046
HP_SLOPING_FOREHEAD,SET,165,0.024285,0.0022907,0.062996,0.34994,HP_SLOPING_FOREHEAD,0.969905054309046
LI_ESTROGENE_META_E2_RESPONS...2,SET,61,0.044981,0.0025872,0.11671,0.34997,LI_ESTROGENE_META_E2_RESPONSE_UP,0.969905054309046
REACTOME_PI_3K_CASCADE_FGFR1,SET,21,0.076372,0.0025802,0.19821,0.35,REACTOME_PI_3K_CASCADE_FGFR1,0.969905054309046
REACTOME_ACETYLCHOLINE_BINDI...,SET,14,0.097296,0.0026844,0.25259,0.35005,REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,0.969905054309046
HP_ABNORMAL_MALE_REPRODUCTIV...,SET,283,0.019648,0.0024193,0.05101,0.35006,HP_ABNORMAL_MALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.969905054309046
GOBP_POSITIVE_REGULATION_OF_...798,SET,61,0.044066,0.0025345,0.11448,0.35016,GOBP_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.969905054309046
MARTINEZ_RB1_AND_TP53_TARGET...1,SET,550,0.014243,0.0024268,0.037017,0.35021,MARTINEZ_RB1_AND_TP53_TARGETS_DN,0.969905054309046
GSE19941_IL10_KO_VS_IL10_KO_...3,SET,179,0.024187,0.0023753,0.062871,0.35023,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN,0.969905054309046
MIR23A_3P_MIR23B_3P,SET,536,0.014789,0.0024885,0.038453,0.35027,MIR23A_3P_MIR23B_3P,0.969905054309046
REACTOME_ANCHORING_OF_THE_BA...,SET,91,0.030949,0.0021724,0.080507,0.35033,REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,0.969905054309046
REACTOME_SARS_COV_2_MODULATE...2,SET,43,0.047947,0.0023166,0.12473,0.35034,REACTOME_SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,0.969905054309046
HP_SYSTEMIC_LUPUS_ERYTHEMATO...,SET,29,0.06579,0.0026113,0.17117,0.35036,HP_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.969905054309046
GOBP_POSITIVE_REGULATION_OF_...612,SET,179,0.024658,0.0024217,0.064183,0.35042,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.969905054309046
SEMBA_FHIT_TARGETS_DN,SET,9,0.099879,0.0022097,0.26001,0.35044,SEMBA_FHIT_TARGETS_DN,0.969905054309046
HOSHIDA_LIVER_CANCER_SURVIVA...1,SET,99,0.032808,0.0024014,0.085422,0.35047,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,0.969905054309046
DESCARTES_FETAL_INTESTINE_ST...,SET,33,0.064055,0.0027119,0.16678,0.35047,DESCARTES_FETAL_INTESTINE_STROMAL_CELLS,0.969905054309046
ZHAN_MULTIPLE_MYELOMA_PR_UP,SET,41,0.05196,0.0024515,0.13532,0.3505,ZHAN_MULTIPLE_MYELOMA_PR_UP,0.969905054309046
GSE43955_TH0_VS_TGFB_IL6_TH1...15,SET,190,0.024494,0.0024776,0.06381,0.35054,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN,0.969905054309046
GSE6259_FLT3L_INDUCED_DEC205...5,SET,161,0.026206,0.0024421,0.068315,0.35063,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN,0.969905054309046
GOCC_ORGANELLE_ENVELOPE,SET,1110,0.0099042,0.0023594,0.02582,0.35065,GOCC_ORGANELLE_ENVELOPE,0.969905054309046
GOCC_LAMIN_FILAMENT,SET,5,0.13754,0.0022684,0.35861,0.35066,GOCC_LAMIN_FILAMENT,0.969905054309046
GOBP_L_ALANINE_TRANSPORT,SET,10,0.11045,0.0025757,0.28801,0.35068,GOBP_L_ALANINE_TRANSPORT,0.969905054309046
WP_SEBALEIC_ACID_FORMATION_A...,SET,5,0.15506,0.0025573,0.40452,0.35074,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,0.969905054309046
HP_PALMAR_TELANGIECTASIA,SET,7,0.1326,0.0025873,0.3459,0.35074,HP_PALMAR_TELANGIECTASIA,0.969905054309046
GSE3691_IFN_PRODUCING_KILLER...2,SET,173,0.024373,0.0023535,0.06358,0.35074,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP,0.969905054309046
GOCC_AXONEMAL_A_TUBULE_INNER...,SET,9,0.12256,0.0027114,0.31973,0.35075,GOCC_AXONEMAL_A_TUBULE_INNER_SHEATH,0.969905054309046
MIR3184_5P,SET,120,0.028134,0.0022659,0.07347,0.35089,MIR3184_5P,0.969905054309046
GOMF_METALLOPEPTIDASE_ACTIVI...,SET,173,0.026767,0.0025847,0.069904,0.3509,GOMF_METALLOPEPTIDASE_ACTIVITY,0.969905054309046
JOHANSSON_GLIOMAGENESIS_BY_P...2,SET,55,0.044913,0.0024533,0.1173,0.35091,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,0.969905054309046
GSE3039_ALPHABETA_CD8_TCELL_...4,SET,180,0.023797,0.0023435,0.062156,0.35092,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP,0.969905054309046
GSE20500_CTRL_VS_RETINOIC_AC...1,SET,174,0.025435,0.0024631,0.066446,0.35094,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN,0.969905054309046
MIR4290,SET,62,0.038673,0.0022424,0.10105,0.35097,MIR4290,0.969905054309046
MIR6861_5P,SET,62,0.041299,0.0023947,0.10794,0.35101,MIR6861_5P,0.969905054309046
GOBP_REGULATION_OF_URINE_VOL...,SET,19,0.083119,0.0026712,0.21728,0.35103,GOBP_REGULATION_OF_URINE_VOLUME,0.969905054309046
CHUNG_BLISTER_CYTOTOXICITY_UP,SET,120,0.029645,0.0023876,0.077512,0.35106,CHUNG_BLISTER_CYTOTOXICITY_UP,0.969905054309046
HP_AGENESIS_OF_CENTRAL_INCIS...,SET,13,0.097328,0.0025877,0.25457,0.35111,HP_AGENESIS_OF_CENTRAL_INCISOR,0.969905054309046
chr16q24,SET,72,0.076972,0.0048084,0.20134,0.35112,chr16q24,0.969905054309046
GCM_CBFB,SET,63,0.038872,0.002272,0.10168,0.35112,GCM_CBFB,0.969905054309046
GOBP_TRIGLYCERIDE_RICH_LIPOP...2,SET,12,0.10405,0.002658,0.27218,0.35113,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING,0.969905054309046
GSE33162_HDAC3_KO_VS_HDAC3_K...4,SET,182,0.023258,0.002303,0.06084,0.35113,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP,0.969905054309046
MIR6754_5P,SET,111,0.031998,0.0024792,0.083717,0.35115,MIR6754_5P,0.969905054309046
WILLIAMS_ESR2_TARGETS_DN,SET,10,0.10797,0.0025178,0.28249,0.35116,WILLIAMS_ESR2_TARGETS_DN,0.969905054309046
GSE29164_CD8_TCELL_VS_CD8_TC...2,SET,175,0.023617,0.0022936,0.061792,0.35116,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.969905054309046
GOMF_GLUCOSE_SODIUM_SYMPORTE...,SET,7,0.13076,0.0025514,0.34215,0.35117,GOMF_GLUCOSE_SODIUM_SYMPORTER_ACTIVITY,0.969905054309046
MODULE_410,SET,35,0.06104,0.0026613,0.15974,0.35119,MODULE_410,0.969905054309046
LEE_LIVER_CANCER_E2F1_DN,SET,59,0.046001,0.0026022,0.12046,0.35128,LEE_LIVER_CANCER_E2F1_DN,0.969905054309046
GSE360_L_DONOVANI_VS_B_MALAY...5,SET,181,0.024198,0.0023895,0.063381,0.35131,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN,0.969905054309046
GOBP_POSITIVE_REGULATION_OF_...123,SET,31,0.058497,0.0024005,0.15325,0.35134,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.969905054309046
GOBP_PRIMITIVE_HEMOPOIESIS,SET,8,0.12595,0.0026272,0.33016,0.35142,GOBP_PRIMITIVE_HEMOPOIESIS,0.969905054309046
FIRESTEIN_CTNNB1_PATHWAY_AND...,SET,6,0.13805,0.0024939,0.36187,0.35143,FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION,0.969905054309046
WP_CYTOKINES_AND_INFLAMMATOR...,SET,25,0.071667,0.0026414,0.18787,0.35143,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.969905054309046
HP_REDUCED_FACTOR_XII_ACTIVI...,SET,6,0.13122,0.0023706,0.34399,0.35143,HP_REDUCED_FACTOR_XII_ACTIVITY,0.969905054309046
GOCC_NUCLEAR_PORE_NUCLEAR_BA...,SET,11,0.090289,0.0022083,0.23674,0.35146,GOCC_NUCLEAR_PORE_NUCLEAR_BASKET,0.969905054309046
HP_MULTIPLE_BLADDER_DIVERTIC...,SET,4,0.17698,0.0026107,0.46411,0.35148,HP_MULTIPLE_BLADDER_DIVERTICULA,0.969905054309046
WORSCHECH_TUMOR_EVASION_AND_...1,SET,14,0.091272,0.0025182,0.23937,0.35149,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,0.969905054309046
HP_PREAXIAL_HAND_POLYDACTYLY,SET,53,0.040996,0.0021984,0.10753,0.35151,HP_PREAXIAL_HAND_POLYDACTYLY,0.969905054309046
GSE46606_UNSTIM_VS_CD40L_IL2...3,SET,171,0.024666,0.0023682,0.064699,0.35151,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.969905054309046
GOBP_NEGATIVE_REGULATION_OF_...318,SET,32,0.054502,0.0022723,0.14298,0.35154,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,0.969905054309046
GSE3982_EOSINOPHIL_VS_TH1_UP,SET,178,0.024225,0.0023725,0.063552,0.35154,GSE3982_EOSINOPHIL_VS_TH1_UP,0.969905054309046
EGR3_01,SET,72,0.038946,0.0024329,0.10221,0.35158,EGR3_01,0.969905054309046
GSE3982_MEMORY_CD4_TCELL_VS_...5,SET,186,0.023197,0.0023218,0.060883,0.3516,GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN,0.969905054309046
GNF2_CDH11,SET,24,0.079749,0.00288,0.20939,0.35165,GNF2_CDH11,0.969905054309046
GSE13738_TCR_VS_BYSTANDER_AC...1,SET,169,0.025056,0.0023917,0.065794,0.35167,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,0.969905054309046
KEGG_MEDICUS_PATHOGEN_HIV_TA...2,SET,14,0.11833,0.0032648,0.31075,0.35168,KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY,0.969905054309046
GOBP_CELLULAR_RESPONSE_TO_LE...1,SET,4,0.19605,0.0028919,0.515,0.35172,GOBP_CELLULAR_RESPONSE_TO_LEAD_ION,0.969905054309046
GSE21546_ELK1_KO_VS_SAP1A_KO...1,SET,187,0.023664,0.0023748,0.062161,0.35172,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.969905054309046
HP_REDUCED_PROTEIN_C_ACTIVITY,SET,10,0.089504,0.0020872,0.23516,0.35175,HP_REDUCED_PROTEIN_C_ACTIVITY,0.969905054309046
chr3q27,SET,60,0.089984,0.0051331,0.2365,0.35179,chr3q27,0.969905054309046
GOBP_NEGATIVE_REGULATION_OF_...540,SET,5,0.15166,0.0025012,0.39858,0.35179,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION,0.969905054309046
GOBP_REGULATION_OF_PEPTIDYL_...6,SET,200,0.024045,0.0024946,0.063191,0.35179,GOBP_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.969905054309046
NAKAYA_B_CELL_FLUARIX_FLUVIR...2,SET,321,0.017376,0.0022763,0.045681,0.35184,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.969905054309046
MIR520F_5P,SET,182,0.02464,0.0024398,0.064799,0.35188,MIR520F_5P,0.969905054309046
HP_ABNORMAL_URINE_SODIUM_CON...,SET,16,0.085505,0.0025218,0.22485,0.35188,HP_ABNORMAL_URINE_SODIUM_CONCENTRATION,0.969905054309046
GSE1925_CTRL_VS_3H_IFNG_STIM...4,SET,186,0.023308,0.002333,0.061301,0.35189,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP,0.969905054309046
MIR200B_3P,SET,448,0.016431,0.002534,0.043228,0.35194,MIR200B_3P,0.969905054309046
MIR200C_3P,SET,448,0.016431,0.002534,0.043228,0.35194,MIR200C_3P,0.969905054309046
BALDWIN_PRKCI_TARGETS_UP,SET,32,0.064344,0.0026826,0.16929,0.35195,BALDWIN_PRKCI_TARGETS_UP,0.969905054309046
BYSTRYKH_HEMATOPOIESIS_STEM_...5,SET,8,0.12093,0.0025226,0.31819,0.35195,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA,0.969905054309046
HP_NEONATAL_SEIZURE,SET,8,0.11641,0.0024283,0.30632,0.35196,HP_NEONATAL_SEIZURE,0.969905054309046
KEGG_MEDICUS_REFERENCE_MISMA...,SET,26,0.056853,0.0021369,0.14962,0.35198,KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR,0.969905054309046
chr13q31,SET,9,0.15086,0.0033376,0.39703,0.35199,chr13q31,0.969905054309046
HP_ARTERIOVENOUS_MALFORMATION,SET,53,0.043735,0.0023453,0.11514,0.35203,HP_ARTERIOVENOUS_MALFORMATION,0.969938374028857
GOBP_MIRNA_MEDIATED_GENE_SIL...2,SET,8,0.11236,0.0023437,0.29598,0.35212,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_MRNA_DESTABILIZATION,0.970032545973367
HP_FASTING_HYPOGLYCEMIA,SET,20,0.077588,0.0025581,0.20438,0.35212,HP_FASTING_HYPOGLYCEMIA,0.970032545973367
GSE22432_CDC_VS_COMMON_DC_PR...1,SET,184,0.023533,0.0023429,0.062025,0.35219,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN,0.970052256710745
KEGG_MEDICUS_REFERENCE_BMP_S...2,SET,14,0.094667,0.0026119,0.24962,0.35225,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST,0.970052256710745
MIR4679,SET,141,0.027928,0.0024368,0.073645,0.35226,MIR4679,0.970052256710745
GOBP_FC_EPSILON_RECEPTOR_SIG...,SET,24,0.069757,0.0025192,0.18399,0.3523,GOBP_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY,0.970052256710745
GSE2770_IL12_AND_TGFB_VS_IL4...2,SET,179,0.023622,0.0023199,0.062308,0.3523,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.970052256710745
BARRIER_CANCER_RELAPSE_NORMA...2,SET,29,0.061675,0.002448,0.16269,0.35231,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,0.970052256710745
THAKAR_PBMC_INACTIVATED_INFL...5,SET,787,0.011533,0.0023349,0.03043,0.35235,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN,0.970052256710745
P53_DN.V1_UP,SET,178,0.026212,0.0025671,0.069176,0.35238,P53_DN.V1_UP,0.970052256710745
HP_ABNORMAL_CIRCULATING_MONO...,SET,66,0.04019,0.0024041,0.10608,0.3524,HP_ABNORMAL_CIRCULATING_MONOCARBOXYLIC_ACID_CONCENTRATION,0.970052256710745
MIR3691_3P,SET,59,0.039894,0.0022568,0.10534,0.35245,MIR3691_3P,0.970052256710745
GSE36078_UNTREATED_VS_AD5_IN...3,SET,175,0.024362,0.0023659,0.064326,0.35245,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN,0.970052256710745
GOBP_REGULATION_OF_CARBOHYDR...2,SET,58,0.039541,0.0022178,0.10443,0.35248,GOBP_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS,0.970052256710745
REACTOME_SYNTHESIS_OF_BILE_A...2,SET,13,0.10738,0.0028549,0.28362,0.35249,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL,0.970052256710745
MURAKAMI_UV_RESPONSE_24HR,SET,20,0.072001,0.0023739,0.19038,0.35265,MURAKAMI_UV_RESPONSE_24HR,0.970174988129155
FAN_EMBRYONIC_CTX_NSC_2,SET,215,0.021359,0.0022966,0.056476,0.35265,FAN_EMBRYONIC_CTX_NSC_2,0.970174988129155
KEGG_CELL_CYCLE,SET,120,0.028864,0.0023248,0.076335,0.35267,KEGG_CELL_CYCLE,0.970174988129155
HP_HEMIANOPIA,SET,37,0.053832,0.002413,0.14237,0.35268,HP_HEMIANOPIA,0.970174988129155
GCM_CASP2,SET,26,0.05751,0.0021616,0.15212,0.3527,GCM_CASP2,0.970174988129155
GOBP_CELLULAR_RESPONSE_TO_NI...2,SET,587,0.013807,0.0024279,0.036525,0.35271,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND,0.970174988129155
REACTOME_REGULATION_OF_ENDOG...1,SET,80,0.035141,0.0023134,0.092972,0.35273,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS,0.970174988129155
GOMF_STRUCTURAL_CONSTITUENT_...7,SET,18,0.078384,0.0024519,0.20747,0.35279,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPSE,0.970186457509099
GSE16450_CTRL_VS_IFNA_6H_STI...2,SET,180,0.024517,0.0024145,0.064892,0.35279,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.970186457509099
WP_HEPATITIS_B_INFECTION,SET,141,0.0281,0.0024518,0.074429,0.35289,WP_HEPATITIS_B_INFECTION,0.970187625563553
WANG_METHYLATED_IN_BREAST_CA...,SET,34,0.059033,0.0025368,0.15639,0.35292,WANG_METHYLATED_IN_BREAST_CANCER,0.970187625563553
GOCC_CILIARY_TIP,SET,40,0.050669,0.0023613,0.13424,0.35292,GOCC_CILIARY_TIP,0.970187625563553
GOBP_PLASMA_MEMBRANE_PHOSPHO...,SET,24,0.068148,0.0024611,0.18056,0.35293,GOBP_PLASMA_MEMBRANE_PHOSPHOLIPID_SCRAMBLING,0.970187625563553
GOCC_SPHERICAL_HIGH_DENSITY_...,SET,8,0.11454,0.0023891,0.30346,0.35293,GOCC_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.970187625563553
MURARO_PANCREAS_MESENCHYMAL_...,SET,620,0.013921,0.0025134,0.036893,0.35296,MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL,0.970193356532743
HP_INCISOR_MACRODONTIA,SET,15,0.093781,0.0026781,0.2486,0.353,HP_INCISOR_MACRODONTIA,0.970200249011858
GSE13484_3H_UNSTIM_VS_YF17D_...2,SET,185,0.022851,0.0022811,0.060609,0.35308,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.970200249011858
MIR216A_3P,SET,408,0.016446,0.0024231,0.043631,0.35311,MIR216A_3P,0.970200249011858
MIR4280,SET,43,0.050495,0.0024397,0.13397,0.35312,MIR4280,0.970200249011858
GSE40274_EOS_VS_FOXP3_AND_EO...1,SET,108,0.03256,0.0024886,0.086385,0.35312,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.970200249011858
MYOD_Q6,SET,227,0.021526,0.0023775,0.057117,0.35313,MYOD_Q6,0.970200249011858
MIR4685_3P,SET,117,0.029995,0.0023856,0.079617,0.35319,MIR4685_3P,0.970288392221959
WP_CANNABINOID_RECEPTOR_SIGN...,SET,29,0.061913,0.0024575,0.16448,0.3533,WP_CANNABINOID_RECEPTOR_SIGNALING,0.970454286504425
E2F_Q3_01,SET,209,0.022106,0.0023439,0.058729,0.35331,E2F_Q3_01,0.970454286504425
YANG_BREAST_CANCER_ESR1_BULK...1,SET,22,0.071827,0.0024836,0.19091,0.35337,YANG_BREAST_CANCER_ESR1_BULK_DN,0.970454286504425
chr17p13,SET,218,0.051826,0.005611,0.13776,0.35339,chr17p13,0.970454286504425
GOMF_S100_PROTEIN_BINDING,SET,14,0.08829,0.0024359,0.23469,0.35339,GOMF_S100_PROTEIN_BINDING,0.970454286504425
MIR3064_5P,SET,133,0.028043,0.002377,0.074568,0.35343,MIR3064_5P,0.970465693632485
MIR4534,SET,146,0.026965,0.0023938,0.071709,0.35345,MIR4534,0.970465693632485
GOBP_NEGATIVE_REGULATION_OF_...689,SET,8,0.11066,0.0023083,0.2944,0.3535,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.970526305395371
FISCHER_G2_M_CELL_CYCLE,SET,221,0.021277,0.0023192,0.056618,0.35353,FISCHER_G2_M_CELL_CYCLE,0.970532002369668
GSE5542_UNTREATED_VS_IFNA_AN...4,SET,163,0.025083,0.0023518,0.066771,0.35359,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.970620049759103
MORF_NOS2A,SET,263,0.020306,0.0024117,0.054075,0.35364,MORF_NOS2A,0.970632416324597
CORONEL_RFX7_DIRECT_TARGETS_...,SET,39,0.049675,0.0022859,0.13236,0.35372,CORONEL_RFX7_DIRECT_TARGETS_UP,0.970632416324597
GSE27786_BCELL_VS_CD8_TCELL_...2,SET,185,0.022732,0.0022692,0.06057,0.35372,GSE27786_BCELL_VS_CD8_TCELL_UP,0.970632416324597
GOBP_REGULATION_OF_TELOMERE_...4,SET,57,0.039619,0.002203,0.10558,0.35374,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.970632416324597
REACTOME_AKT_PHOSPHORYLATES_...1,SET,14,0.078081,0.0021542,0.2081,0.35376,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,0.970632416324597
ONO_AML1_TARGETS_UP,SET,23,0.075019,0.0026523,0.19996,0.35377,ONO_AML1_TARGETS_UP,0.970632416324597
FOXO4_02,SET,239,0.021795,0.0024693,0.058103,0.35379,FOXO4_02,0.970632416324597
GSE7460_CTRL_VS_TGFB_TREATED...9,SET,185,0.023402,0.0023361,0.06242,0.35386,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN,0.970726077348066
GSE6269_STAPH_AUREUS_VS_STRE...2,SET,146,0.026252,0.0023306,0.070031,0.35388,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP,0.970726077348066
CAIRO_HEPATOBLASTOMA_CLASSES...1,SET,195,0.024026,0.0024617,0.064108,0.35392,CAIRO_HEPATOBLASTOMA_CLASSES_DN,0.970759182384974
GOBP_REGULATION_OF_PROTEIN_L...5,SET,12,0.10105,0.0025814,0.26971,0.35395,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,0.970764855587121
BIOCARTA_EPO_PATHWAY,SET,17,0.080067,0.002434,0.21378,0.354,BIOCARTA_EPO_PATHWAY,0.970825376785291
REACTOME_REGULATION_OF_ENDOG...4,SET,9,0.088867,0.0019661,0.23736,0.35406,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX,0.970865924320063
PID_ALK1_PATHWAY,SET,24,0.065405,0.002362,0.17473,0.35408,PID_ALK1_PATHWAY,0.970865924320063
PRC2_EZH2_UP.V1_DN,SET,169,0.024197,0.0023096,0.064681,0.35417,PRC2_EZH2_UP.V1_DN,0.970865924320063
GOBP_NEGATIVE_REGULATION_OF_...639,SET,43,0.048322,0.0023346,0.12919,0.35419,GOBP_NEGATIVE_REGULATION_OF_TORC1_SIGNALING,0.970865924320063
WP_NUCLEOTIDE_EXCISION_REPAI...,SET,55,0.036926,0.002017,0.098741,0.35422,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,0.970865924320063
BAE_BRCA1_TARGETS_DN,SET,29,0.062421,0.0024776,0.16694,0.35424,BAE_BRCA1_TARGETS_DN,0.970865924320063
MIR578,SET,168,0.02501,0.0023803,0.066908,0.35428,MIR578,0.970865924320063
WP_CELL_DIFFERENTIATION_EXPA...,SET,18,0.084926,0.0026565,0.22722,0.35429,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,0.970865924320063
HP_IMPAIRED_OCULAR_ADDUCTION,SET,9,0.11085,0.0024525,0.2966,0.3543,HP_IMPAIRED_OCULAR_ADDUCTION,0.970865924320063
GOBP_NEGATIVE_REGULATION_OF_...283,SET,6,0.12843,0.0023202,0.34365,0.35431,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,0.970865924320063
KEGG_MEDICUS_REFERENCE_GLOBA...,SET,16,0.06568,0.0019371,0.17578,0.35434,KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER,0.970865924320063
GOBP_REGULATION_OF_CEREBELLA...,SET,9,0.10977,0.0024286,0.29383,0.35435,GOBP_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,0.970865924320063
HP_POSTERIOR_PHARYNGEAL_CLEFT,SET,12,0.10495,0.0026808,0.28103,0.35441,HP_POSTERIOR_PHARYNGEAL_CLEFT,0.970904634665406
WP_CATABOLISM_OF_SKELETAL_MU...,SET,39,0.053631,0.002468,0.14362,0.35442,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,0.970904634665406
GOMF_SECONDARY_ACTIVE_MONOCA...,SET,17,0.08034,0.0024423,0.2153,0.35452,GOMF_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.971080282134132
GSE2770_IL4_ACT_VS_ACT_CD4_T...5,SET,173,0.023128,0.0022334,0.061991,0.35454,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.971080282134132
SMID_BREAST_CANCER_RELAPSE_I...1,SET,275,0.020485,0.002487,0.05492,0.35458,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,0.971113309692671
REACTOME_INACTIVATION_OF_CSF...,SET,22,0.080766,0.0027928,0.21665,0.35465,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,0.971173094661143
GSE6269_HEALTHY_VS_FLU_INF_P...1,SET,143,0.026361,0.0023163,0.070749,0.35472,GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN,0.971173094661143
GOBP_ENDOCRINE_SYSTEM_DEVELO...,SET,130,0.030655,0.0025691,0.082308,0.35478,GOBP_ENDOCRINE_SYSTEM_DEVELOPMENT,0.971173094661143
VISALA_AGING_LYMPHOCYTE_DN,SET,16,0.075621,0.0022303,0.20306,0.3548,VISALA_AGING_LYMPHOCYTE_DN,0.971173094661143
KEGG_MEDICUS_REFERENCE_AUTOP...2,SET,5,0.13271,0.0021886,0.35645,0.35483,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55,0.971173094661143
YAO_HOXA10_TARGETS_VIA_PROGE...2,SET,76,0.038736,0.0024859,0.10411,0.35492,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,0.971173094661143
GAVISH_3CA_METAPROGRAM_EPITH...7,SET,47,0.050748,0.0025631,0.13645,0.35497,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_2,0.971173094661143
GOBP_SYNAPTIC_VESICLE_CLUSTE...,SET,15,0.08923,0.0025482,0.23994,0.35499,GOBP_SYNAPTIC_VESICLE_CLUSTERING,0.971173094661143
GOBP_POSITIVE_REGULATION_OF_...323,SET,29,0.059401,0.0023578,0.15974,0.355,GOBP_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.971173094661143
GOBP_DEFENSE_RESPONSE_TO_TUM...,SET,12,0.0933,0.0023833,0.25095,0.35503,GOBP_DEFENSE_RESPONSE_TO_TUMOR_CELL,0.971173094661143
GSE5542_IFNG_VS_IFNA_AND_IFN...2,SET,179,0.022646,0.0022241,0.060911,0.35503,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.971173094661143
DESCARTES_FETAL_CEREBRUM_AST...,SET,141,0.028422,0.0024799,0.07645,0.35504,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.971173094661143
YANG_BCL3_TARGETS_DN,SET,8,0.12065,0.0025167,0.32472,0.35511,YANG_BCL3_TARGETS_DN,0.971173094661143
GSE34392_ST2_KO_VS_WT_DAY8_L...1,SET,189,0.024707,0.0024927,0.066518,0.35516,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,0.971173094661143
INGA_TP53_TARGETS,SET,16,0.079212,0.0023362,0.21328,0.35517,INGA_TP53_TARGETS,0.971173094661143
GSE15659_CD45RA_NEG_CD4_TCEL...4,SET,155,0.02626,0.0024014,0.07071,0.35518,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,0.971173094661143
GOCC_MCRD_MEDIATED_MRNA_STAB...,SET,5,0.14154,0.0023342,0.38113,0.35519,GOCC_MCRD_MEDIATED_MRNA_STABILITY_COMPLEX,0.971173094661143
HP_PARANOIA,SET,20,0.06823,0.0022496,0.18376,0.35521,HP_PARANOIA,0.971173094661143
QUEREC_PBMC_YF_17D_VACCINE_A...1,SET,42,0.052843,0.0025233,0.14232,0.35521,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP,0.971173094661143
QUEREC_PBMC_YF_17D_VACCINE_A...2,SET,42,0.052843,0.0025233,0.14232,0.35521,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP,0.971173094661143
HP_ABNORMAL_HYPNAGOGIA,SET,8,0.12081,0.00252,0.32543,0.35524,HP_ABNORMAL_HYPNAGOGIA,0.971173094661143
GOMF_L_GLUTAMATE_TRANSMEMBRA...,SET,14,0.08886,0.0024516,0.23941,0.35526,GOMF_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.971173094661143
KEGG_MEDICUS_REFERENCE_CLASS...,SET,4,0.18119,0.0026728,0.48827,0.35529,KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,0.971173094661143
ELVIDGE_HIF1A_TARGETS_DN,SET,81,0.036062,0.0023888,0.097214,0.35534,ELVIDGE_HIF1A_TARGETS_DN,0.971173094661143
KEGG_MEDICUS_PATHOGEN_HTLV_1...2,SET,6,0.155,0.0028002,0.41804,0.3554,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY,0.971173094661143
WP_CARDIOMYOCYTE_SIGNALING_C...,SET,31,0.057911,0.0023765,0.15618,0.3554,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,0.971173094661143
GSE10239_MEMORY_VS_KLRG1HIGH...2,SET,180,0.023538,0.0023181,0.063511,0.35546,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.971173094661143
MODULE_328,SET,13,0.087097,0.0023157,0.23504,0.35548,MODULE_328,0.971173094661143
GOMF_SPHINGOMYELIN_PHOSPHODI...,SET,7,0.12238,0.0023879,0.33037,0.35553,GOMF_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY,0.971173094661143
REACTOME_PI_3K_CASCADE_FGFR3,SET,17,0.079782,0.0024254,0.21543,0.35557,REACTOME_PI_3K_CASCADE_FGFR3,0.971173094661143
OSMAN_BLOOD_CHAD63_KH_AGE_18...1,SET,1468,0.0086848,0.0023545,0.02346,0.35562,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN,0.971173094661143
TGANNYRGCA_TCF11MAFG_01,SET,271,0.019558,0.0023574,0.052838,0.35564,TGANNYRGCA_TCF11MAFG_01,0.971173094661143
GOBP_ICOSANOID_METABOLIC_PRO...,SET,110,0.031227,0.0024087,0.084385,0.35567,GOBP_ICOSANOID_METABOLIC_PROCESS,0.971173094661143
MODULE_50,SET,13,0.076947,0.0020458,0.20794,0.35568,MODULE_50,0.971173094661143
GOBP_NEGATIVE_REGULATION_OF_...568,SET,1522,0.0085218,0.0023486,0.023037,0.35572,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_STIMULUS,0.971173094661143
GSE13485_DAY3_VS_DAY7_YF17D_...1,SET,175,0.024728,0.0024015,0.066869,0.35577,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.971173094661143
GOBP_DNA_REPLICATION_SYNTHES...,SET,6,0.11806,0.0021328,0.31926,0.35578,GOBP_DNA_REPLICATION_SYNTHESIS_OF_PRIMER,0.971173094661143
DESCARTES_FETAL_EYE_BIPOLAR_...,SET,19,0.084278,0.0027084,0.22798,0.35581,DESCARTES_FETAL_EYE_BIPOLAR_CELLS,0.971173094661143
PID_HNF3A_PATHWAY,SET,42,0.050546,0.0024136,0.13673,0.35582,PID_HNF3A_PATHWAY,0.971173094661143
METHYLCYTOSINE_DIOXYGENASE_T...,SET,117,0.027704,0.0022035,0.074946,0.35582,METHYLCYTOSINE_DIOXYGENASE_TET_UNIPROT_A0A023HHK9_UNREVIEWED_TARGET_GENES,0.971173094661143
MODULE_159,SET,69,0.034954,0.0021378,0.094586,0.35586,MODULE_159,0.971173094661143
MIR181C_3P,SET,10,0.084021,0.0019594,0.22738,0.35587,MIR181C_3P,0.971173094661143
LE_EGR2_TARGETS_UP,SET,103,0.031128,0.0023238,0.084259,0.35591,LE_EGR2_TARGETS_UP,0.971173094661143
GOBP_PROTEIN_MODIFICATION_BY...2,SET,91,0.031119,0.0021844,0.084246,0.35592,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL,0.971173094661143
KRAS.AMP.LUNG_UP.V1_DN,SET,121,0.029539,0.002389,0.07999,0.35596,KRAS.AMP.LUNG_UP.V1_DN,0.971173094661143
HUANG_AML_LSC47,SET,41,0.056105,0.002647,0.15204,0.35606,HUANG_AML_LSC47,0.971173094661143
GOBP_NEGATIVE_REGULATION_OF_...240,SET,7,0.10297,0.0020092,0.27904,0.35606,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.971173094661143
GOBP_REGULATION_OF_TRANSCRIP...1,SET,8,0.097368,0.002031,0.26401,0.35614,GOBP_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.971173094661143
GSE18281_SUBCAPSULAR_CORTICA...3,SET,172,0.024275,0.0023374,0.065828,0.35616,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,0.971173094661143
MIR93_5P,SET,570,0.01365,0.0023663,0.037019,0.35617,MIR93_5P,0.971173094661143
BOUDOUKHA_BOUND_BY_IGF2BP2,SET,92,0.032141,0.0022684,0.087174,0.35618,BOUDOUKHA_BOUND_BY_IGF2BP2,0.971173094661143
GOMF_CARBON_SULFUR_LYASE_ACT...,SET,10,0.10727,0.0025016,0.291,0.3562,GOMF_CARBON_SULFUR_LYASE_ACTIVITY,0.971173094661143
ZNF669_TARGET_GENES,SET,95,0.031892,0.002287,0.086539,0.35624,ZNF669_TARGET_GENES,0.971173094661143
HP_NARROW_FORAMEN_OBTURATORI...,SET,4,0.15183,0.0022397,0.41206,0.35626,HP_NARROW_FORAMEN_OBTURATORIUM,0.971173094661143
HP_ACIDEMIA,SET,22,0.066489,0.0022991,0.18046,0.35627,HP_ACIDEMIA,0.971173094661143
GOMF_RNA_POLYMERASE_II_GENER...1,SET,35,0.046541,0.0020291,0.12634,0.35629,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.971173094661143
GSE15330_HSC_VS_MEGAKARYOCYT...4,SET,149,0.025593,0.0022951,0.069478,0.3563,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.971173094661143
ZHENG_CORD_BLOOD_C5_SIMILAR_...,SET,53,0.048975,0.0026262,0.13297,0.35632,ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE,0.971173094661143
HARALAMBIEVA_PBMC_FLUARIX_AG...9,SET,318,0.017607,0.0022959,0.047824,0.35638,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE,0.971173094661143
KEGG_MEDICUS_VARIANT_SCRAPIE...3,SET,6,0.15059,0.0027206,0.40915,0.35642,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY,0.971173094661143
WP_MYD88_DISTINCT_INPUTOUTPU...,SET,15,0.092628,0.0026452,0.2517,0.35643,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,0.971173094661143
GOBP_POSITIVE_REGULATION_OF_...685,SET,9,0.10179,0.0022521,0.2766,0.35643,GOBP_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.971173094661143
GOBP_OSTEOCLAST_PROLIFERATION,SET,11,0.098227,0.0024024,0.26698,0.35647,GOBP_OSTEOCLAST_PROLIFERATION,0.971173094661143
GOBP_REGULATION_OF_RYANODINE...,SET,20,0.082359,0.0027154,0.22394,0.35652,GOBP_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.971173094661143
GOBP_REGULATION_OF_POTASSIUM...3,SET,45,0.049554,0.0024491,0.13475,0.35653,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.971173094661143
WP_INTEGRINMEDIATED_CELL_ADH...,SET,95,0.034019,0.0024396,0.092511,0.35654,WP_INTEGRINMEDIATED_CELL_ADHESION,0.971173094661143
GOBP_REGULATION_OF_NUCLEAR_T...2,SET,11,0.091043,0.0022267,0.24763,0.35657,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.971173094661143
REACTOME_CYTOPROTECTION_BY_H...,SET,51,0.041962,0.0022075,0.11416,0.35659,REACTOME_CYTOPROTECTION_BY_HMOX1,0.971173094661143
HP_VERTEBRAL_WEDGING,SET,16,0.076769,0.0022642,0.2089,0.35662,HP_VERTEBRAL_WEDGING,0.971173094661143
GOBP_MODULATION_OF_MICROTUBU...,SET,4,0.15629,0.0023055,0.42528,0.35663,GOBP_MODULATION_OF_MICROTUBULE_CYTOSKELETON_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,0.971173094661143
EHRLICH_ICF_SYNDROM_DN,SET,12,0.09716,0.0024819,0.26441,0.35664,EHRLICH_ICF_SYNDROM_DN,0.971173094661143
KANG_CISPLATIN_RESISTANCE_DN,SET,8,0.10856,0.0022645,0.29545,0.35665,KANG_CISPLATIN_RESISTANCE_DN,0.971173094661143
HP_EPILEPTIC_SPASM,SET,167,0.024574,0.0023319,0.066902,0.3567,HP_EPILEPTIC_SPASM,0.971173094661143
HP_BILATERAL_TONIC_CLONIC_SE...3,SET,41,0.053452,0.0025218,0.14553,0.35671,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_GENERALIZED_ONSET,0.971173094661143
GOBP_FOREBRAIN_DORSAL_VENTRA...,SET,7,0.13856,0.0027037,0.37732,0.35673,GOBP_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION,0.971173094661143
SA_TRKA_RECEPTOR,SET,16,0.074306,0.0021915,0.20239,0.35676,SA_TRKA_RECEPTOR,0.971173094661143
REACTOME_CILIUM_ASSEMBLY,SET,182,0.021735,0.0021523,0.059227,0.35682,REACTOME_CILIUM_ASSEMBLY,0.971173094661143
GOBP_PROSTANOID_METABOLIC_PR...,SET,45,0.04819,0.0023817,0.13133,0.35683,GOBP_PROSTANOID_METABOLIC_PROCESS,0.971173094661143
HP_SUPERNUMERARY_TOOTH,SET,44,0.049872,0.0024373,0.13594,0.35686,HP_SUPERNUMERARY_TOOTH,0.971173094661143
GSE10463_CD40L_AND_VA347_VS_...1,SET,147,0.025576,0.0022782,0.069756,0.35694,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN,0.971173094661143
HP_FINGER_APLASIA,SET,77,0.034735,0.0022436,0.094785,0.35701,HP_FINGER_APLASIA,0.971173094661143
GSE26488_WT_VS_VP16_TRANSGEN...2,SET,181,0.023914,0.0023615,0.065262,0.35702,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.971173094661143
MODULE_209,SET,83,0.035996,0.0024136,0.098254,0.35705,MODULE_209,0.971173094661143
GOMF_GUANYLATE_CYCLASE_ACTIV...,SET,5,0.14414,0.0023771,0.39363,0.35712,GOMF_GUANYLATE_CYCLASE_ACTIVITY,0.971173094661143
STAT6_02,SET,239,0.021266,0.0024094,0.058083,0.35713,STAT6_02,0.971173094661143
GOCC_PROTON_TRANSPORTING_TWO...1,SET,26,0.061685,0.0023185,0.16847,0.35713,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX,0.971173094661143
GSE2197_CPG_DNA_VS_UNTREATED...1,SET,175,0.023112,0.0022445,0.063131,0.35715,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN,0.971173094661143
LEE_NEURAL_CREST_STEM_CELL_UP,SET,139,0.029235,0.0025329,0.079861,0.35716,LEE_NEURAL_CREST_STEM_CELL_UP,0.971173094661143
MIR4441,SET,271,0.019464,0.002346,0.053191,0.35721,MIR4441,0.971173094661143
GSE17721_0.5H_VS_24H_CPG_BMD...1,SET,188,0.024112,0.0024262,0.065892,0.35721,GSE17721_0.5H_VS_24H_CPG_BMDC_DN,0.971173094661143
GCM_FCGR2B,SET,35,0.051086,0.0022273,0.13961,0.35722,GCM_FCGR2B,0.971173094661143
MIR141_3P,SET,369,0.017175,0.0024091,0.046946,0.35724,MIR141_3P,0.971173094661143
REACTOME_FORMATION_OF_THE_PO...,SET,9,0.11582,0.0025623,0.31664,0.35727,REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE,0.971173094661143
RELA_DN.V1_UP,SET,136,0.027384,0.0023469,0.074878,0.35729,RELA_DN.V1_UP,0.971173094661143
REACTOME_INFECTIOUS_DISEASE,SET,889,0.010212,0.0021911,0.027933,0.35733,REACTOME_INFECTIOUS_DISEASE,0.971173094661143
WP_PEPTIDE_GPCRS,SET,66,0.043999,0.002632,0.12036,0.35734,WP_PEPTIDE_GPCRS,0.971173094661143
HP_PROMINENT_EAR_HELIX,SET,6,0.14811,0.0026756,0.40546,0.35745,HP_PROMINENT_EAR_HELIX,0.971173094661143
GOBP_POSITIVE_REGULATION_OF_...99,SET,41,0.053435,0.002521,0.1463,0.35747,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.971173094661143
GSE34156_NOD2_LIGAND_VS_TLR1...1,SET,155,0.022925,0.0020964,0.062769,0.35747,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.971173094661143
REACTOME_HYDROLYSIS_OF_LPC,SET,9,0.11132,0.0024628,0.3048,0.35748,REACTOME_HYDROLYSIS_OF_LPC,0.971173094661143
GOBP_RESPONSE_TO_PROSTAGLAND...2,SET,5,0.1762,0.0029059,0.48246,0.35748,GOBP_RESPONSE_TO_PROSTAGLANDIN_D,0.971173094661143
HP_APLASIA_HYPOPLASIA_OF_THE...9,SET,32,0.0557,0.0023222,0.15251,0.35748,HP_APLASIA_HYPOPLASIA_OF_THE_ABDOMINAL_WALL_MUSCULATURE,0.971173094661143
GSE24210_CTRL_VS_IL35_TREATE...1,SET,180,0.022138,0.0021801,0.060618,0.35748,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN,0.971173094661143
REACTOME_N_GLYCAN_TRIMMING_I...,SET,33,0.053705,0.0022737,0.14714,0.35756,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,0.971175398188632
GOBP_AUTOPHAGOSOME_MATURATION,SET,60,0.037012,0.0021114,0.1014,0.35756,GOBP_AUTOPHAGOSOME_MATURATION,0.971175398188632
BIOCARTA_MTA3_PATHWAY,SET,17,0.073756,0.0022422,0.20218,0.35763,BIOCARTA_MTA3_PATHWAY,0.971175398188632
BIOCARTA_BOTULIN_PATHWAY,SET,5,0.15037,0.0024799,0.41239,0.3577,BIOCARTA_BOTULIN_PATHWAY,0.971175398188632
NR5A1_TARGET_GENES,SET,11,0.096931,0.0023707,0.26593,0.35774,NR5A1_TARGET_GENES,0.971175398188632
GTCAACC_MIR3805P,SET,20,0.077642,0.0025599,0.21309,0.35779,GTCAACC_MIR3805P,0.971175398188632
GOBP_EATING_BEHAVIOR,SET,37,0.056385,0.0025274,0.1548,0.35784,GOBP_EATING_BEHAVIOR,0.971175398188632
HP_RECURRENT_URINARY_TRACT_I...,SET,144,0.026571,0.0023428,0.072952,0.35784,HP_RECURRENT_URINARY_TRACT_INFECTIONS,0.971175398188632
GSE20366_TREG_VS_NAIVE_CD4_T...4,SET,184,0.02397,0.0023864,0.065807,0.35784,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN,0.971175398188632
MZF1_01,SET,222,0.021,0.002294,0.057657,0.35785,MZF1_01,0.971175398188632
GOMF_VOLTAGE_GATED_POTASSIUM...2,SET,14,0.093305,0.0025743,0.25617,0.35785,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,0.971175398188632
SPIELMAN_LYMPHOBLAST_EUROPEA...2,SET,12,0.086863,0.0022189,0.23853,0.35787,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,0.971175398188632
GSE17974_2.5H_VS_72H_IL4_AND...2,SET,178,0.022371,0.002191,0.061438,0.35788,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.971175398188632
XU_HGF_SIGNALING_NOT_VIA_AKT...2,SET,32,0.057073,0.0023795,0.15674,0.35789,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,0.971175398188632
HP_APLASIA_OF_THE_MUSCULATURE,SET,9,0.11613,0.0025693,0.31896,0.3579,HP_APLASIA_OF_THE_MUSCULATURE,0.971175398188632
REACTOME_INLB_MEDIATED_ENTRY...,SET,13,0.086366,0.0022962,0.23732,0.35796,REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,0.971262378015458
REACTOME_REGULATED_NECROSIS,SET,54,0.043376,0.0023478,0.11923,0.35801,REACTOME_REGULATED_NECROSIS,0.971322213114754
GSE16386_IL4_VS_IL4_AND_ROSI...2,SET,181,0.021355,0.0021089,0.058722,0.35806,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP,0.971360474555105
MIR5192,SET,45,0.043069,0.0021286,0.11845,0.35808,MIR5192,0.971360474555105
WP_15Q25_COPY_NUMBER_VARIATI...,SET,42,0.053131,0.0025371,0.14616,0.35811,WP_15Q25_COPY_NUMBER_VARIATION,0.971366038398501
WP_HAIR_FOLLICLE_DEVELOPMENT...1,SET,86,0.037579,0.0025646,0.10343,0.35819,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,0.971507214765101
KEGG_MEDICUS_REFERENCE_P15_C...,SET,13,0.079874,0.0021236,0.22002,0.35829,KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S,0.971643995633188
GAVISH_3CA_METAPROGRAM_ENDOT...4,SET,48,0.049867,0.0025452,0.13744,0.35836,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_2,0.971643995633188
WP_DEGRADATION_PATHWAY_OF_SP...,SET,15,0.090346,0.0025801,0.24902,0.35838,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,0.971643995633188
HP_NODULAR_CHANGES_AFFECTING...,SET,27,0.067355,0.0025798,0.18567,0.35839,HP_NODULAR_CHANGES_AFFECTING_THE_EYELIDS,0.971643995633188
GOBP_LATERAL_VENTRICLE_DEVEL...,SET,12,0.08514,0.0021749,0.23471,0.3584,GOBP_LATERAL_VENTRICLE_DEVELOPMENT,0.971643995633188
HP_BIFID_NASAL_TIP,SET,13,0.082903,0.0022041,0.22861,0.35844,HP_BIFID_NASAL_TIP,0.971643995633188
HUMMERICH_BENIGN_SKIN_TUMOR_...1,SET,19,0.076652,0.0024633,0.21139,0.35845,HUMMERICH_BENIGN_SKIN_TUMOR_DN,0.971643995633188
HP_TERATOMA,SET,12,0.085803,0.0021918,0.23673,0.35851,HP_TERATOMA,0.971643995633188
MARKS_HDAC_TARGETS_UP,SET,20,0.074907,0.0024697,0.20669,0.35852,MARKS_HDAC_TARGETS_UP,0.971643995633188
MIR4484,SET,31,0.05572,0.0022865,0.15375,0.35852,MIR4484,0.971643995633188
GOMF_CARBOXYLESTERASE_ACTIVI...,SET,6,0.13123,0.0023708,0.36221,0.35857,GOMF_CARBOXYLESTERASE_ACTIVITY,0.971703730994152
GOBP_MITOCHONDRIAL_DNA_REPAIR,SET,6,0.114,0.0020595,0.31479,0.35862,GOBP_MITOCHONDRIAL_DNA_REPAIR,0.971720322731525
GOBP_DENDRITIC_SPINE_MORPHOG...,SET,54,0.04237,0.0022933,0.11702,0.35865,GOBP_DENDRITIC_SPINE_MORPHOGENESIS,0.971720322731525
HP_SPONTANEOUS_PNEUMOTHORAX,SET,14,0.092352,0.002548,0.25508,0.35866,HP_SPONTANEOUS_PNEUMOTHORAX,0.971720322731525
MIR548A_5P,SET,443,0.014814,0.0022721,0.040951,0.35877,MIR548A_5P,0.971899427168576
NOUSHMEHR_GBM_GERMLINE_MUTAT...,SET,7,0.12592,0.0024571,0.34815,0.35879,NOUSHMEHR_GBM_GERMLINE_MUTATED,0.971899427168576
LI_ESTROGENE_MCF7_E2_RESPONS...1,SET,35,0.059047,0.0025744,0.16327,0.35881,LI_ESTROGENE_MCF7_E2_RESPONSE_DN,0.971899427168576
GOBP_RESPONSE_TO_FORSKOLIN,SET,13,0.098567,0.0026206,0.27276,0.35891,GOBP_RESPONSE_TO_FORSKOLIN,0.972046292257361
MIR30C_1_3P,SET,119,0.029814,0.0023913,0.082542,0.35898,MIR30C_1_3P,0.972046292257361
GOBP_UBIQUINONE_METABOLIC_PR...,SET,16,0.067118,0.0019795,0.18582,0.35898,GOBP_UBIQUINONE_METABOLIC_PROCESS,0.972046292257361
GOBP_SECRETION_OF_LYSOSOMAL_...,SET,6,0.10948,0.0019779,0.30314,0.35899,GOBP_SECRETION_OF_LYSOSOMAL_ENZYMES,0.972046292257361
REACTOME_SEMAPHORIN_INTERACT...,SET,61,0.04101,0.0023587,0.11358,0.35903,REACTOME_SEMAPHORIN_INTERACTIONS,0.972046292257361
GSE2770_UNTREATED_VS_IL4_TRE...5,SET,185,0.021821,0.0021783,0.060444,0.35905,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.972046292257361
GOBP_TETRAPYRROLE_CATABOLIC_...,SET,13,0.086536,0.0023007,0.23973,0.35906,GOBP_TETRAPYRROLE_CATABOLIC_PROCESS,0.972046292257361
REACTOME_TRANSPORT_OF_INORGA...,SET,103,0.032409,0.0024194,0.089844,0.35916,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,0.972073202540259
CUI_DEVELOPING_HEART_RIGHT_V...,SET,20,0.063812,0.0021039,0.17698,0.35922,CUI_DEVELOPING_HEART_RIGHT_VENTRICULAR_CARDIOMYOCYTE,0.972073202540259
ZHONG_PFC_C1_MICROGLIA,SET,233,0.019129,0.0021402,0.053075,0.35927,ZHONG_PFC_C1_MICROGLIA,0.972073202540259
GOBP_RESPONSE_TO_NEMATODE,SET,7,0.12693,0.0024768,0.35222,0.35928,GOBP_RESPONSE_TO_NEMATODE,0.972073202540259
GOBP_POTASSIUM_ION_EXPORT_AC...,SET,18,0.081589,0.0025521,0.22652,0.35936,GOBP_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.972073202540259
HP_GASTROINTESTINAL_HEMORRHA...,SET,154,0.025494,0.0023239,0.070805,0.3594,HP_GASTROINTESTINAL_HEMORRHAGE,0.972073202540259
HP_VASCULITIS,SET,65,0.039711,0.0023575,0.11039,0.35953,HP_VASCULITIS,0.972073202540259
HP_ABNORMAL_INTRAHEPATIC_BIL...,SET,28,0.060424,0.0023567,0.16805,0.35959,HP_ABNORMAL_INTRAHEPATIC_BILE_DUCT_MORPHOLOGY,0.972073202540259
GOMF_ERBB_3_CLASS_RECEPTOR_B...,SET,5,0.13848,0.0022838,0.38523,0.35963,GOMF_ERBB_3_CLASS_RECEPTOR_BINDING,0.972073202540259
GOBP_SOFT_PALATE_DEVELOPMENT,SET,5,0.1653,0.0027262,0.45998,0.35966,GOBP_SOFT_PALATE_DEVELOPMENT,0.972073202540259
GSE27786_NKCELL_VS_NKTCELL_DN,SET,182,0.022572,0.0022351,0.062839,0.35972,GSE27786_NKCELL_VS_NKTCELL_DN,0.972073202540259
HP_CALCIFICATION_OF_FALX_CER...,SET,7,0.10788,0.0021051,0.30039,0.35974,HP_CALCIFICATION_OF_FALX_CEREBRI,0.972073202540259
HP_DECREASED_ADIPOSE_TISSUE,SET,43,0.046837,0.0022629,0.13041,0.35974,HP_DECREASED_ADIPOSE_TISSUE,0.972073202540259
HP_HYPOPARATHYROIDISM,SET,28,0.061844,0.0024121,0.17221,0.35976,HP_HYPOPARATHYROIDISM,0.972073202540259
MIR6895_5P,SET,38,0.050172,0.0022791,0.13975,0.3598,MIR6895_5P,0.972073202540259
GOBP_RESPONSE_TO_ACTINOMYCIN...,SET,5,0.13306,0.0021944,0.37064,0.3598,GOBP_RESPONSE_TO_ACTINOMYCIN_D,0.972073202540259
MIR20A_3P,SET,173,0.023308,0.0022507,0.064934,0.35982,MIR20A_3P,0.972073202540259
HADDAD_T_LYMPHOCYTE_AND_NK_P...1,SET,59,0.042068,0.0023797,0.11724,0.35987,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,0.972073202540259
ATM_DN.V1_UP,SET,138,0.027316,0.0023581,0.07613,0.35987,ATM_DN.V1_UP,0.972073202540259
GSE14000_TRANSLATED_RNA_VS_M...3,SET,152,0.024526,0.0022213,0.068364,0.35989,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN,0.972073202540259
GSE7460_CTRL_VS_TGFB_TREATED...10,SET,183,0.021223,0.0021072,0.059161,0.3599,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...169,SET,13,0.096046,0.0025536,0.26775,0.35991,GOBP_POSITIVE_REGULATION_OF_CILIUM_MOVEMENT,0.972073202540259
ZHAN_MULTIPLE_MYELOMA_LB_DN,SET,35,0.051587,0.0022491,0.14385,0.35995,ZHAN_MULTIPLE_MYELOMA_LB_DN,0.972073202540259
HP_NORMOCHROMIC_ANEMIA,SET,33,0.049418,0.0020922,0.13784,0.35998,HP_NORMOCHROMIC_ANEMIA,0.972073202540259
GSE19888_ADENOSINE_A3R_ACT_V...6,SET,178,0.023519,0.0023033,0.065604,0.35999,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...506,SET,32,0.05628,0.0023464,0.15701,0.36001,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.972073202540259
GOMF_TELOMERASE_INHIBITOR_AC...,SET,5,0.13558,0.002236,0.37832,0.36003,GOMF_TELOMERASE_INHIBITOR_ACTIVITY,0.972073202540259
GOBP_REGULATION_OF_ATTACHMEN...1,SET,9,0.099822,0.0022085,0.27859,0.36006,GOBP_REGULATION_OF_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.972073202540259
MIR6766_5P,SET,225,0.020845,0.0022923,0.058236,0.36019,MIR6766_5P,0.972073202540259
GNF2_CENPF,SET,57,0.04068,0.002262,0.11365,0.3602,GNF2_CENPF,0.972073202540259
GOBP_CELL_CYCLE_PROCESS,SET,1143,0.0091286,0.0022046,0.025514,0.36025,GOBP_CELL_CYCLE_PROCESS,0.972073202540259
HP_ABNORMALITY_OF_THE_PHARYNX,SET,198,0.022155,0.0022872,0.061937,0.36028,HP_ABNORMALITY_OF_THE_PHARYNX,0.972073202540259
GOBP_NEGATIVE_REGULATION_OF_...637,SET,4,0.16442,0.0024255,0.45989,0.36035,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.972073202540259
GOBP_RNA_POLYMERASE_II_PREIN...,SET,52,0.038725,0.002057,0.10833,0.36036,GOBP_RNA_POLYMERASE_II_PREINITIATION_COMPLEX_ASSEMBLY,0.972073202540259
GOBP_INSEMINATION,SET,13,0.094668,0.0025169,0.26482,0.36037,GOBP_INSEMINATION,0.972073202540259
GOBP_REGULATORY_T_CELL_DIFFE...,SET,35,0.052714,0.0022982,0.14746,0.36037,GOBP_REGULATORY_T_CELL_DIFFERENTIATION,0.972073202540259
GOCC_CHROMOCENTER,SET,13,0.084568,0.0022484,0.23671,0.36045,GOCC_CHROMOCENTER,0.972073202540259
HP_MESOMELIA,SET,32,0.052796,0.0022011,0.1478,0.36047,HP_MESOMELIA,0.972073202540259
BIOCARTA_HSWI_SNF_PATHWAY,SET,12,0.088256,0.0022545,0.24713,0.3605,BIOCARTA_HSWI_SNF_PATHWAY,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...603,SET,121,0.028118,0.002274,0.078734,0.3605,GOBP_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.972073202540259
REACTOME_GAP_JUNCTION_ASSEMB...,SET,33,0.061294,0.002595,0.17166,0.36052,REACTOME_GAP_JUNCTION_ASSEMBLY,0.972073202540259
HP_ABNORMAL_ORAL_FRENULUM_MO...,SET,58,0.038427,0.0021554,0.10762,0.36052,HP_ABNORMAL_ORAL_FRENULUM_MORPHOLOGY,0.972073202540259
REACTOME_AUTOPHAGY,SET,145,0.024682,0.0021837,0.069127,0.36053,REACTOME_AUTOPHAGY,0.972073202540259
GOBP_NEUTROPHIL_MEDIATED_KIL...1,SET,7,0.14293,0.0027889,0.4004,0.36057,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_GRAM_NEGATIVE_BACTERIUM,0.972073202540259
REACTOME_RHOH_GTPASE_CYCLE,SET,35,0.052736,0.0022992,0.14779,0.36061,REACTOME_RHOH_GTPASE_CYCLE,0.972073202540259
HP_LEUKOPENIA,SET,129,0.026232,0.00219,0.073538,0.36065,HP_LEUKOPENIA,0.972073202540259
ELLWOOD_MYC_TARGETS_UP,SET,13,0.085761,0.0022801,0.24064,0.36078,ELLWOOD_MYC_TARGETS_UP,0.972073202540259
GOBP_RESPONSE_TO_CALCIUM_ION,SET,124,0.028592,0.0023407,0.080253,0.36082,GOBP_RESPONSE_TO_CALCIUM_ION,0.972073202540259
HP_BILATERAL_RENAL_AGENESIS,SET,10,0.1105,0.0025768,0.31022,0.36085,HP_BILATERAL_RENAL_AGENESIS,0.972073202540259
GSE36826_NORMAL_VS_STAPH_AUR...2,SET,187,0.022595,0.0022676,0.063449,0.36088,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP,0.972073202540259
GSE22140_GERMFREE_VS_SPF_ART...1,SET,175,0.022838,0.002218,0.064144,0.3609,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.972073202540259
GOBP_PHOSPHATIDYLETHANOLAMIN...2,SET,9,0.10069,0.0022277,0.28281,0.36091,GOBP_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS,0.972073202540259
MIR194_3P,SET,81,0.035727,0.0023666,0.10035,0.36092,MIR194_3P,0.972073202540259
HARALAMBIEVA_PBMC_FLUARIX_AG...5,SET,11,0.08923,0.0021824,0.25064,0.36092,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_NEGATIVE,0.972073202540259
REACTOME_METABOLIC_DISORDERS...,SET,32,0.05708,0.0023797,0.16038,0.36096,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...147,SET,8,0.09874,0.0020596,0.27748,0.36098,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.972073202540259
REACTOME_MITOCHONDRIAL_FATTY...2,SET,11,0.086903,0.0021255,0.24423,0.36099,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS,0.972073202540259
REACTOME_NEGATIVE_REGULATION...11,SET,5,0.13262,0.0021871,0.37277,0.36101,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS,0.972073202540259
WP_FOCAL_ADHESION,SET,190,0.023334,0.0023602,0.065594,0.36102,WP_FOCAL_ADHESION,0.972073202540259
HP_POSTERIOR_POLAR_CATARACT,SET,8,0.10314,0.0021514,0.28993,0.36102,HP_POSTERIOR_POLAR_CATARACT,0.972073202540259
GSE17721_CPG_VS_GARDIQUIMOD_...17,SET,183,0.021968,0.0021811,0.061792,0.36111,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN,0.972073202540259
REACTOME_VEGFR2_MEDIATED_VAS...,SET,26,0.063625,0.0023914,0.17899,0.36112,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,0.972073202540259
HP_ABNORMAL_FINGER_FLEXION_C...,SET,19,0.075121,0.0024141,0.21135,0.36113,HP_ABNORMAL_FINGER_FLEXION_CREASE,0.972073202540259
GSE12845_IGD_POS_BLOOD_VS_PR...1,SET,186,0.021639,0.0021659,0.060889,0.36115,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,0.972073202540259
GOBP_ASTROCYTE_CELL_MIGRATION,SET,9,0.099398,0.0021991,0.27972,0.36117,GOBP_ASTROCYTE_CELL_MIGRATION,0.972073202540259
GOBP_REGULATION_OF_PRODUCTIO...,SET,171,0.023805,0.0022855,0.067019,0.36122,GOBP_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.972073202540259
REACTOME_TP53_REGULATES_META...,SET,77,0.033756,0.0021804,0.095051,0.36124,REACTOME_TP53_REGULATES_METABOLIC_GENES,0.972073202540259
WP_PATHOPHYSIOLOGICAL_ROLES_...,SET,15,0.082528,0.0023568,0.23243,0.36127,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,0.972073202540259
GSE17974_IL4_AND_ANTI_IL12_V...13,SET,153,0.025784,0.0023428,0.072625,0.36128,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN,0.972073202540259
GOBP_NUCLEOSIDE_MONOPHOSPHAT...3,SET,69,0.036988,0.0022621,0.10419,0.36129,GOBP_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.972073202540259
REACTOME_MITOCHONDRIAL_RNA_D...,SET,10,0.088854,0.0020721,0.2503,0.3613,REACTOME_MITOCHONDRIAL_RNA_DEGRADATION,0.972073202540259
HP_ABNORMAL_SPERM_AXONEME_MO...,SET,6,0.1311,0.0023684,0.36942,0.36134,HP_ABNORMAL_SPERM_AXONEME_MORPHOLOGY,0.972073202540259
HP_APLASIA_OF_THE_ULNA,SET,5,0.17257,0.0028461,0.48652,0.3614,HP_APLASIA_OF_THE_ULNA,0.972073202540259
HP_SMALL_FORAMEN_MAGNUM,SET,11,0.080753,0.001975,0.22764,0.3614,HP_SMALL_FORAMEN_MAGNUM,0.972073202540259
GOBP_POSTSYNAPTIC_MODULATION...,SET,26,0.059774,0.0022467,0.16857,0.36145,GOBP_POSTSYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,0.972073202540259
GOCC_MICROTUBULE_CYTOSKELETON,SET,1224,0.0086908,0.0021669,0.024513,0.36147,GOCC_MICROTUBULE_CYTOSKELETON,0.972073202540259
GSE22886_NAIVE_VS_MEMORY_TCE...1,SET,183,0.022498,0.0022338,0.063474,0.3615,GSE22886_NAIVE_VS_MEMORY_TCELL_DN,0.972073202540259
HOEK_NK_CELL_2011_2012_TIV_1...,SET,42,0.049001,0.0023398,0.13824,0.3615,HOEK_NK_CELL_2011_2012_TIV_1D_VS_0DY_ADULT_1D_DN,0.972073202540259
THAKAR_PBMC_INACTIVATED_INFL...7,SET,547,0.012695,0.0021574,0.035819,0.36151,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN,0.972073202540259
GOMF_CHLORIDE_CHANNEL_INHIBI...,SET,7,0.1042,0.0020331,0.29407,0.36155,GOMF_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY,0.972073202540259
HP_DACRYOCYSTITIS,SET,7,0.11542,0.0022522,0.32582,0.36158,HP_DACRYOCYSTITIS,0.972073202540259
SCHERER_PBMC_APSV_WETVAX_AGE...4,SET,156,0.025198,0.0023117,0.071136,0.36159,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP,0.972073202540259
GOBP_LEUKOTRIENE_CATABOLIC_P...,SET,6,0.1243,0.0022455,0.35093,0.3616,GOBP_LEUKOTRIENE_CATABOLIC_PROCESS,0.972073202540259
REACTOME_COHESIN_LOADING_ONT...,SET,7,0.12361,0.0024119,0.34904,0.36162,REACTOME_COHESIN_LOADING_ONTO_CHROMATIN,0.972073202540259
THAKAR_PBMC_INACTIVATED_INFL...10,SET,127,0.02697,0.0022342,0.076153,0.36162,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN,0.972073202540259
HP_ABNORMAL_PROPORTION_OF_ME...,SET,5,0.1439,0.0023733,0.40637,0.36163,HP_ABNORMAL_PROPORTION_OF_MEMORY_T_CELLS,0.972073202540259
WP_PREIMPLANTATION_EMBRYO,SET,54,0.043372,0.0023476,0.1225,0.36165,WP_PREIMPLANTATION_EMBRYO,0.972073202540259
MIR20B_5P,SET,571,0.013079,0.0022692,0.036946,0.36167,MIR20B_5P,0.972073202540259
ODONNELL_TARGETS_OF_MYC_AND_...1,SET,42,0.043848,0.0020938,0.12388,0.36169,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,0.972073202540259
GSE22342_CD11C_HIGH_VS_LOW_D...1,SET,154,0.025097,0.0022877,0.070966,0.3618,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN,0.972073202540259
CRX_NRL_DN.V1_UP,SET,131,0.026769,0.002252,0.075697,0.36181,CRX_NRL_DN.V1_UP,0.972073202540259
GOCC_SPINDLE_MICROTUBULE,SET,76,0.032407,0.0020797,0.091714,0.36192,GOCC_SPINDLE_MICROTUBULE,0.972073202540259
GOBP_REGULATION_OF_MEMBRANE_...4,SET,15,0.091392,0.0026099,0.25877,0.36198,GOBP_REGULATION_OF_MEMBRANE_INVAGINATION,0.972073202540259
KCCGNSWTTT_UNKNOWN,SET,96,0.029717,0.0021422,0.084152,0.36199,KCCGNSWTTT_UNKNOWN,0.972073202540259
GOCC_ELASTIC_FIBER,SET,4,0.16376,0.0024157,0.46377,0.36201,GOCC_ELASTIC_FIBER,0.972073202540259
PICCALUGA_ANGIOIMMUNOBLASTIC...2,SET,191,0.024407,0.0024752,0.069127,0.36202,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,0.972073202540259
GOBP_REGULATION_OF_CARDIAC_M...4,SET,16,0.072815,0.0021475,0.20623,0.36202,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.972073202540259
HP_CORNEAL_SCARRING,SET,19,0.067292,0.0021625,0.19063,0.36205,HP_CORNEAL_SCARRING,0.972073202540259
GOMF_SERINE_HYDROLASE_ACTIVI...,SET,182,0.024364,0.0024126,0.069124,0.36224,GOMF_SERINE_HYDROLASE_ACTIVITY,0.972073202540259
RIEGE_DELTANP63_DIRECT_TARGE...,SET,130,0.026789,0.0022451,0.076006,0.36225,RIEGE_DELTANP63_DIRECT_TARGETS_UP,0.972073202540259
GOBP_REGULATION_OF_CELLULAR_...10,SET,285,0.01879,0.0023217,0.053319,0.36227,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,0.972073202540259
YANG_BREAST_CANCER_ESR1_UP,SET,35,0.052215,0.0022765,0.14819,0.36229,YANG_BREAST_CANCER_ESR1_UP,0.972073202540259
MIR544B,SET,191,0.021579,0.0021884,0.061242,0.36229,MIR544B,0.972073202540259
GOBP_REGULATION_OF_PHOSPHATI...4,SET,5,0.11218,0.00185,0.31849,0.36234,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.972073202540259
WANG_RESPONSE_TO_GSK3_INHIBI...2,SET,310,0.017045,0.002195,0.048405,0.36237,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,0.972073202540259
SUH_COEXPRESSED_WITH_ID1_AND...,SET,18,0.073686,0.0023049,0.20927,0.36238,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,0.972073202540259
GOCC_MKS_COMPLEX,SET,13,0.072648,0.0019315,0.20638,0.36241,GOCC_MKS_COMPLEX,0.972073202540259
GOBP_HYPEROSMOTIC_SALINITY_R...,SET,10,0.096664,0.0022542,0.27472,0.36247,GOBP_HYPEROSMOTIC_SALINITY_RESPONSE,0.972073202540259
GSE3982_CTRL_VS_IGE_STIM_MAS...1,SET,180,0.021982,0.0021648,0.062483,0.36249,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN,0.972073202540259
GOBP_TRANS_SYNAPTIC_SIGNALIN...2,SET,7,0.12913,0.0025197,0.3671,0.36251,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.972073202540259
MIR6502_5P,SET,51,0.042647,0.0022435,0.1213,0.36258,MIR6502_5P,0.972073202540259
GOBP_CARDIOBLAST_PROLIFERATI...,SET,9,0.11158,0.0024686,0.31737,0.36258,GOBP_CARDIOBLAST_PROLIFERATION,0.972073202540259
GSE12839_CTRL_VS_IL12_TREATE...1,SET,111,0.028539,0.0022112,0.081174,0.36258,GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN,0.972073202540259
GARGALOVIC_RESPONSE_TO_OXIDI...23,SET,22,0.065792,0.002275,0.18715,0.36259,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,0.972073202540259
REACTOME_ADENYLATE_CYCLASE_A...,SET,10,0.10186,0.0023754,0.28975,0.36259,REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY,0.972073202540259
BANDRES_RESPONSE_TO_CARMUSTI...5,SET,9,0.10811,0.0023918,0.30755,0.3626,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN,0.972073202540259
GOBP_REGULATION_OF_CELL_GROW...2,SET,14,0.08358,0.002306,0.23778,0.36261,GOBP_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.972073202540259
GOMF_STRUCTURAL_CONSTITUENT_...1,SET,3,0.18353,0.0023447,0.52227,0.36264,GOMF_STRUCTURAL_CONSTITUENT_OF_CHROMATIN,0.972073202540259
DURANTE_ADULT_OLFACTORY_NEUR...19,SET,119,0.027073,0.0021714,0.077058,0.36267,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_CILIATED_CELLS,0.972073202540259
AHR_Q5,SET,195,0.021958,0.0022499,0.062505,0.36268,AHR_Q5,0.972073202540259
MIR3684,SET,30,0.056861,0.0022955,0.16192,0.36273,MIR3684,0.972073202540259
DURAND_STROMA_NS_UP,SET,161,0.0244,0.0022737,0.069491,0.36275,DURAND_STROMA_NS_UP,0.972073202540259
GOBP_INTERLEUKIN_1_MEDIATED_...,SET,29,0.05557,0.0022057,0.15827,0.36275,GOBP_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.972073202540259
NRF1_Q6,SET,231,0.019211,0.0021402,0.054719,0.36276,NRF1_Q6,0.972073202540259
HP_ACUTE_ENCEPHALOPATHY,SET,10,0.098465,0.0022962,0.28048,0.36277,HP_ACUTE_ENCEPHALOPATHY,0.972073202540259
DESCARTES_FETAL_STOMACH_CILI...,SET,225,0.019379,0.0021311,0.055211,0.36279,DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS,0.972073202540259
MONNIER_POSTRADIATION_TUMOR_...1,SET,335,0.016464,0.0022025,0.04692,0.36284,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,0.972073202540259
WP_FOLATEALCOHOL_AND_CANCER_...,SET,8,0.13629,0.0028429,0.38851,0.36287,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,0.972073202540259
HP_TIBIALIS_MUSCLE_WEAKNESS,SET,6,0.13094,0.0023654,0.37328,0.36288,HP_TIBIALIS_MUSCLE_WEAKNESS,0.972073202540259
GSE39022_LN_VS_SPLEEN_DC_DN,SET,175,0.022528,0.0021879,0.064224,0.36288,GSE39022_LN_VS_SPLEEN_DC_DN,0.972073202540259
GOBP_REGULATION_OF_ADENYLATE...1,SET,19,0.069372,0.0022294,0.19781,0.36291,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.972073202540259
GOBP_NEGATIVE_REGULATION_OF_...126,SET,8,0.10931,0.0022802,0.31175,0.36293,GOBP_NEGATIVE_REGULATION_OF_CELL_SIZE,0.972073202540259
KEGG_MEDICUS_REFERENCE_FSHR_...,SET,16,0.079024,0.0023307,0.22551,0.36301,KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY,0.972073202540259
REACTOME_INTERLEUKIN_17_SIGN...,SET,65,0.038788,0.0023027,0.11073,0.36306,REACTOME_INTERLEUKIN_17_SIGNALING,0.972073202540259
GOBP_JNK_CASCADE,SET,159,0.02413,0.0022347,0.068884,0.36306,GOBP_JNK_CASCADE,0.972073202540259
HP_DOUBLE_AORTIC_ARCH,SET,5,0.1318,0.0021737,0.37638,0.3631,HP_DOUBLE_AORTIC_ARCH,0.972073202540259
GOBP_REGULATION_OF_ESTABLISH...2,SET,489,0.013669,0.0021998,0.039039,0.36312,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.972073202540259
HP_ABNORMAL_HEART_VALVE_MORP...,SET,307,0.017742,0.0022739,0.050693,0.36318,HP_ABNORMAL_HEART_VALVE_MORPHOLOGY,0.972073202540259
MIR3659,SET,73,0.035309,0.0022209,0.10091,0.36321,MIR3659,0.972073202540259
HP_TRUNCUS_ARTERIOSUS,SET,24,0.068962,0.0024905,0.19713,0.36323,HP_TRUNCUS_ARTERIOSUS,0.972073202540259
REACTOME_MEIOTIC_SYNAPSIS,SET,31,0.049954,0.0020499,0.14284,0.36327,REACTOME_MEIOTIC_SYNAPSIS,0.972073202540259
HP_LIMB_UNDERGROWTH,SET,220,0.019952,0.0021699,0.057057,0.36329,HP_LIMB_UNDERGROWTH,0.972073202540259
chr4p13,SET,12,0.12852,0.0032829,0.36754,0.3633,chr4p13,0.972073202540259
HP_CUTANEOUS_ANERGY,SET,6,0.13032,0.0023543,0.3727,0.3633,HP_CUTANEOUS_ANERGY,0.972073202540259
HP_RENOVASCULAR_HYPERTENSION,SET,25,0.06741,0.0024845,0.19285,0.36334,HP_RENOVASCULAR_HYPERTENSION,0.972073202540259
GOBP_REGULATION_OF_CELLULAR_...3,SET,898,0.010178,0.0021942,0.029131,0.3634,GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.972073202540259
MIR381_3P,SET,407,0.015163,0.0022313,0.043413,0.36345,MIR381_3P,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...738,SET,56,0.044399,0.0024471,0.12721,0.36354,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.972073202540259
TSAI_RESPONSE_TO_IONIZING_RA...,SET,142,0.024895,0.0021798,0.071337,0.36356,TSAI_RESPONSE_TO_IONIZING_RADIATION,0.972073202540259
WONG_EMBRYONIC_STEM_CELL_CORE,SET,309,0.016123,0.002073,0.046212,0.36359,WONG_EMBRYONIC_STEM_CELL_CORE,0.972073202540259
REACTOME_ENDOSOMAL_SORTING_C...,SET,30,0.051568,0.0020818,0.14785,0.36363,REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,0.972073202540259
MIR10396A_5P,SET,8,0.093065,0.0019413,0.2669,0.36366,MIR10396A_5P,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...600,SET,32,0.055384,0.0023091,0.15884,0.36367,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,0.972073202540259
GOMF_POLY_ADP_D_RIBOSE_MODIF...,SET,2,0.22592,0.0023567,0.64806,0.36369,GOMF_POLY_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.972073202540259
WP_ANGIOPOIETINLIKE_PROTEIN_...,SET,126,0.027737,0.0022888,0.079571,0.3637,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,0.972073202540259
ESC_V6.5_UP_LATE.V1_DN,SET,162,0.023327,0.0021804,0.066924,0.36371,ESC_V6.5_UP_LATE.V1_DN,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...226,SET,6,0.1402,0.0025328,0.40234,0.36375,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION,0.972073202540259
MCGARVEY_SILENCED_BY_METHYLA...,SET,41,0.050521,0.0023836,0.14499,0.36376,MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,0.972073202540259
GOMF_LIGAND_ACTIVATED_TRANSC...,SET,52,0.04254,0.0022596,0.12212,0.36379,GOMF_LIGAND_ACTIVATED_TRANSCRIPTION_FACTOR_ACTIVITY,0.972073202540259
GAVISH_3CA_MALIGNANT_METAPRO...18,SET,45,0.047371,0.0023412,0.13599,0.3638,GAVISH_3CA_MALIGNANT_METAPROGRAM_27_OLIGO_PROGENITOR,0.972073202540259
GOBP_PROTEIN_SIDE_CHAIN_DEGL...,SET,5,0.15985,0.0026363,0.45891,0.3638,GOBP_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION,0.972073202540259
PID_ERBB1_RECEPTOR_PROXIMAL_...,SET,34,0.048884,0.0021007,0.14036,0.36382,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,0.972073202540259
KEGG_MEDICUS_REFERENCE_FLCN_...,SET,13,0.078144,0.0020776,0.22449,0.36389,KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY,0.972073202540259
GOBP_NEGATIVE_REGULATION_OF_...613,SET,11,0.08996,0.0022002,0.25844,0.36389,GOBP_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT,0.972073202540259
GOMF_TRANSPORTER_REGULATOR_A...,SET,141,0.026459,0.0023086,0.076024,0.36391,GOMF_TRANSPORTER_REGULATOR_ACTIVITY,0.972073202540259
REACTOME_NF_KB_IS_ACTIVATED_...,SET,11,0.093551,0.0022881,0.26882,0.36392,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,0.972073202540259
GSE22589_HEALTHY_VS_HIV_AND_...1,SET,171,0.021836,0.0020965,0.062745,0.36392,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN,0.972073202540259
chr2q14,SET,65,0.062922,0.0037354,0.18088,0.36397,chr2q14,0.972073202540259
GOBP_REGULATION_OF_VASCULAR_...1,SET,2,0.22997,0.002399,0.66131,0.36401,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEDIFFERENTIATION,0.972073202540259
HP_ASTIGMATISM,SET,196,0.021031,0.0021603,0.060473,0.36401,HP_ASTIGMATISM,0.972073202540259
GROSS_HYPOXIA_VIA_ELK3_DN,SET,137,0.027526,0.0023678,0.079176,0.36405,GROSS_HYPOXIA_VIA_ELK3_DN,0.972073202540259
MODULE_516,SET,15,0.084161,0.0024034,0.24217,0.3641,MODULE_516,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...254,SET,15,0.066968,0.0019124,0.19273,0.36412,GOBP_POSITIVE_REGULATION_OF_ERAD_PATHWAY,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...626,SET,10,0.11062,0.0025798,0.3184,0.36413,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,0.972073202540259
GOMF_CHLORIDE_CHANNEL_REGULA...,SET,13,0.077711,0.0020661,0.22378,0.3642,GOMF_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY,0.972073202540259
HP_DOWN_SLOPING_SHOULDERS,SET,34,0.057335,0.0024638,0.16511,0.3642,HP_DOWN_SLOPING_SHOULDERS,0.972073202540259
PID_ERBB2_ERBB3_PATHWAY,SET,44,0.044491,0.0021744,0.12814,0.36422,PID_ERBB2_ERBB3_PATHWAY,0.972073202540259
GOBP_TELOMERE_TETHERING_AT_N...,SET,3,0.14105,0.001802,0.40635,0.36425,GOBP_TELOMERE_TETHERING_AT_NUCLEAR_PERIPHERY,0.972073202540259
MIR1272,SET,80,0.032512,0.0021404,0.093722,0.36434,MIR1272,0.972073202540259
GOBP_ABSCISSION,SET,5,0.11317,0.0018664,0.32668,0.36452,GOBP_ABSCISSION,0.972073202540259
GOBP_MITOCHONDRIAL_ATP_TRANS...,SET,6,0.1338,0.0024172,0.38631,0.36454,GOBP_MITOCHONDRIAL_ATP_TRANSMEMBRANE_TRANSPORT,0.972073202540259
BANDRES_RESPONSE_TO_CARMUSTI...8,SET,18,0.069131,0.0021625,0.19969,0.3646,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,0.972073202540259
MIR6132,SET,119,0.026839,0.0021526,0.077538,0.36462,MIR6132,0.972073202540259
HP_RIMMED_VACUOLES,SET,38,0.045697,0.0020758,0.13203,0.36463,HP_RIMMED_VACUOLES,0.972073202540259
HP_BULBAR_PALSY,SET,39,0.045124,0.0020765,0.13039,0.36465,HP_BULBAR_PALSY,0.972073202540259
GROSS_HIF1A_TARGETS_DN,SET,21,0.06391,0.0021591,0.18469,0.36466,GROSS_HIF1A_TARGETS_DN,0.972073202540259
HP_PERIPHERAL_RETINAL_AVASCU...,SET,7,0.12404,0.0024204,0.35852,0.36468,HP_PERIPHERAL_RETINAL_AVASCULARIZATION,0.972073202540259
MARSON_FOXP3_CORE_DIRECT_TAR...,SET,17,0.083741,0.0025457,0.2421,0.36471,MARSON_FOXP3_CORE_DIRECT_TARGETS,0.972073202540259
NABA_BASEMENT_MEMBRANES,SET,37,0.053218,0.0023855,0.15385,0.36471,NABA_BASEMENT_MEMBRANES,0.972073202540259
HP_ABNORMAL_GLIAL_CELL_MORPH...,SET,143,0.024078,0.0021156,0.069615,0.36472,HP_ABNORMAL_GLIAL_CELL_MORPHOLOGY,0.972073202540259
HE_LIM_SUN_FETAL_LUNG_C2_MYE...,SET,15,0.087033,0.0024854,0.2517,0.36476,HE_LIM_SUN_FETAL_LUNG_C2_MYELOCYTE_LIKE_CELL,0.972073202540259
BIOCARTA_COMP_PATHWAY,SET,15,0.08388,0.0023954,0.2426,0.36477,BIOCARTA_COMP_PATHWAY,0.972073202540259
GSE3982_MAC_VS_TH2_DN,SET,187,0.020624,0.0020698,0.059669,0.36481,GSE3982_MAC_VS_TH2_DN,0.972073202540259
MIR4704_5P,SET,55,0.039634,0.002165,0.11468,0.36482,MIR4704_5P,0.972073202540259
HP_RENAL_SALT_WASTING,SET,20,0.073588,0.0024262,0.21298,0.36485,HP_RENAL_SALT_WASTING,0.972073202540259
REACTOME_CREATION_OF_C4_AND_...,SET,12,0.1041,0.0026592,0.30132,0.36487,REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS,0.972073202540259
NKX62_Q2,SET,220,0.021543,0.0023429,0.062358,0.36487,NKX62_Q2,0.972073202540259
REACTOME_GLUCOSE_METABOLISM,SET,77,0.031617,0.0020422,0.091524,0.36488,REACTOME_GLUCOSE_METABOLISM,0.972073202540259
HE_PTEN_TARGETS_DN,SET,7,0.12828,0.002503,0.37137,0.36489,HE_PTEN_TARGETS_DN,0.972073202540259
STAMBOLSKY_RESPONSE_TO_VITAM...1,SET,22,0.063549,0.0021974,0.18397,0.36489,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,0.972073202540259
REACTOME_DOWNSTREAM_SIGNALIN...3,SET,29,0.054573,0.0021661,0.15802,0.36492,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,0.972073202540259
MYLLYKANGAS_AMPLIFICATION_HO...18,SET,12,0.090423,0.0023098,0.2619,0.36495,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8,0.972073202540259
GOBP_PROTEIN_ACTIVATION_CASC...,SET,18,0.081488,0.002549,0.23604,0.36497,GOBP_PROTEIN_ACTIVATION_CASCADE,0.972073202540259
MIR4493,SET,88,0.031059,0.0021441,0.090023,0.36504,MIR4493,0.972073202540259
GSE23398_WT_VS_IL2_KO_CD4_TC...1,SET,180,0.021508,0.0021181,0.06234,0.36505,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN,0.972073202540259
HP_TORTUOUS_CEREBRAL_ARTERIES,SET,5,0.11899,0.0019624,0.345,0.36509,HP_TORTUOUS_CEREBRAL_ARTERIES,0.972073202540259
GSE1740_UNSTIM_VS_IFNA_STIMU...1,SET,159,0.023924,0.0022156,0.069363,0.36509,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN,0.972073202540259
GOCC_ENZYME_ACTIVATOR_COMPLEX,SET,13,0.072053,0.0019157,0.20893,0.3651,GOCC_ENZYME_ACTIVATOR_COMPLEX,0.972073202540259
GOCC_BRISC_COMPLEX,SET,3,0.16736,0.0021381,0.48538,0.36512,GOCC_BRISC_COMPLEX,0.972073202540259
BORLAK_LIVER_CANCER_EGF_UP,SET,49,0.044446,0.0022919,0.12893,0.36515,BORLAK_LIVER_CANCER_EGF_UP,0.972073202540259
REACTOME_2_LTR_CIRCLE_FORMAT...,SET,7,0.09817,0.0019156,0.2848,0.36516,REACTOME_2_LTR_CIRCLE_FORMATION,0.972073202540259
GAZDA_DIAMOND_BLACKFAN_ANEMI...1,SET,404,0.014108,0.0020687,0.040939,0.36519,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,0.972073202540259
DESCARTES_FETAL_LUNG_SQUAMOU...,SET,176,0.024249,0.0023616,0.070403,0.36526,DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS,0.972073202540259
GSE13485_DAY7_VS_DAY21_YF17D...2,SET,183,0.02256,0.0022399,0.065527,0.36532,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.972073202540259
FAN_EMBRYONIC_CTX_BIG_GROUPS...6,SET,8,0.12753,0.0026601,0.37068,0.36541,FAN_EMBRYONIC_CTX_BIG_GROUPS_INHIBITORY,0.972073202540259
HP_ANAPHYLACTIC_SHOCK,SET,8,0.10825,0.0022581,0.31469,0.36543,HP_ANAPHYLACTIC_SHOCK,0.972073202540259
GOBP_REGULATION_OF_B_CELL_AP...,SET,18,0.071906,0.0022493,0.20909,0.36547,GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.972073202540259
GOBP_CGAS_STING_SIGNALING_PA...,SET,15,0.066028,0.0018856,0.19205,0.3655,GOBP_CGAS_STING_SIGNALING_PATHWAY,0.972073202540259
REACTOME_REMOVAL_OF_AMINOTER...,SET,8,0.10309,0.0021503,0.29993,0.36554,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,0.972073202540259
GOBP_CELL_MOTILITY_INVOLVED_...,SET,5,0.13281,0.0021902,0.3865,0.36557,GOBP_CELL_MOTILITY_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,0.972073202540259
GOBP_CARDIAC_SEPTUM_DEVELOPM...,SET,104,0.031107,0.0023334,0.090559,0.36561,GOBP_CARDIAC_SEPTUM_DEVELOPMENT,0.972073202540259
ROSS_AML_WITH_PML_RARA_FUSION,SET,69,0.03445,0.0021069,0.1003,0.36562,ROSS_AML_WITH_PML_RARA_FUSION,0.972073202540259
HP_ABNORMAL_METATARSAL_MORPH...,SET,139,0.025551,0.0022137,0.074406,0.36565,HP_ABNORMAL_METATARSAL_MORPHOLOGY,0.972073202540259
WU_HBX_TARGETS_3_DN,SET,13,0.088189,0.0023447,0.25684,0.36566,WU_HBX_TARGETS_3_DN,0.972073202540259
GOBP_BRANCHING_INVOLVED_IN_M...,SET,21,0.069948,0.0023631,0.20373,0.36568,GOBP_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS,0.972073202540259
GOBP_PROLINE_TRANSMEMBRANE_T...,SET,9,0.11162,0.0024696,0.32515,0.36569,GOBP_PROLINE_TRANSMEMBRANE_TRANSPORT,0.972073202540259
HP_RECURRENT_CANDIDA_INFECTI...,SET,17,0.076136,0.0023145,0.22195,0.36579,HP_RECURRENT_CANDIDA_INFECTIONS,0.972073202540259
GOBP_VENTRICULAR_CARDIAC_MUS...3,SET,14,0.090356,0.0024929,0.26344,0.3658,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.972073202540259
KEGG_MEDICUS_REFERENCE_IRE1A...,SET,7,0.11474,0.002239,0.33458,0.36582,KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY,0.972073202540259
GSE26156_DOUBLE_POSITIVE_VS_...2,SET,178,0.022488,0.0022024,0.065602,0.36588,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.972073202540259
GSE3982_CTRL_VS_LPS_4H_MAC_DN,SET,187,0.0224,0.002248,0.065344,0.36588,GSE3982_CTRL_VS_LPS_4H_MAC_DN,0.972073202540259
REACTOME_EICOSANOID_LIGAND_B...,SET,14,0.081139,0.0022386,0.23677,0.36592,REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,0.972073202540259
HP_ABNORMAL_PELVIC_GIRDLE_BO...,SET,548,0.012668,0.0021547,0.03697,0.36593,HP_ABNORMAL_PELVIC_GIRDLE_BONE_MORPHOLOGY,0.972073202540259
GSE17721_LPS_VS_PAM3CSK4_16H...1,SET,182,0.021992,0.0021776,0.064179,0.36593,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN,0.972073202540259
MODULE_389,SET,196,0.020802,0.0021368,0.060718,0.36595,MODULE_389,0.972073202540259
GSE3982_BCELL_VS_CENT_MEMORY...2,SET,177,0.021702,0.0021195,0.063364,0.36599,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.972073202540259
AGCGCAG_MIR191,SET,12,0.076664,0.0019583,0.22385,0.366,AGCGCAG_MIR191,0.972073202540259
GOBP_CHEMOKINE_C_X_C_MOTIF_L...1,SET,6,0.12804,0.0023131,0.37396,0.36603,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_12_SIGNALING_PATHWAY,0.972073202540259
chr17q25,SET,176,0.043177,0.0042051,0.12612,0.36604,chr17q25,0.972073202540259
MYLLYKANGAS_AMPLIFICATION_HO...2,SET,9,0.1085,0.0024005,0.31703,0.36608,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,0.972073202540259
GOBP_INTERLEUKIN_23_PRODUCTI...,SET,10,0.10294,0.0024007,0.3008,0.36609,GOBP_INTERLEUKIN_23_PRODUCTION,0.972073202540259
GAVISH_3CA_METAPROGRAM_EPITH...6,SET,45,0.045799,0.0022635,0.13384,0.36611,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1,0.972073202540259
GSE42021_CD24INT_VS_CD24LOW_...3,SET,179,0.021969,0.0021576,0.064229,0.36616,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN,0.972073202540259
GSE12366_NAIVE_VS_MEMORY_BCE...2,SET,162,0.023143,0.0021632,0.067691,0.36622,GSE12366_NAIVE_VS_MEMORY_BCELL_UP,0.972073202540259
GAVISH_3CA_METAPROGRAM_FIBRO...17,SET,44,0.049625,0.0024253,0.14521,0.36627,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II,0.972073202540259
GOCC_MEIOTIC_SPINDLE,SET,12,0.088287,0.0022553,0.25858,0.36639,GOCC_MEIOTIC_SPINDLE,0.972073202540259
GSE3982_EOSINOPHIL_VS_DC_DN,SET,184,0.021554,0.0021458,0.063128,0.36639,GSE3982_EOSINOPHIL_VS_DC_DN,0.972073202540259
REACTOME_SARS_COV_2_MODULATE...1,SET,11,0.078903,0.0019298,0.23119,0.36644,REACTOME_SARS_COV_2_MODULATES_AUTOPHAGY,0.972073202540259
GOBP_REGULATION_OF_CELLULAR_...1,SET,12,0.08307,0.002122,0.24343,0.36646,GOBP_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS,0.972073202540259
HP_TENDON_RUPTURE,SET,5,0.1338,0.0022067,0.3921,0.36646,HP_TENDON_RUPTURE,0.972073202540259
WP_BIOSYNTHESIS_AND_TURNOVER...,SET,8,0.1032,0.0021526,0.30258,0.36653,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,0.972073202540259
GOBP_STEM_CELL_DIFFERENTIATI...,SET,229,0.019842,0.0022011,0.058182,0.36654,GOBP_STEM_CELL_DIFFERENTIATION,0.972073202540259
GSE32986_CURDLAN_LOWDOSE_VS_...4,SET,179,0.021219,0.0020839,0.062223,0.36655,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.972073202540259
KEGG_MEDICUS_REFERENCE_TCR_P...,SET,19,0.066058,0.0021229,0.19383,0.36663,KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY,0.972073202540259
HP_OVERGROWTH,SET,37,0.046081,0.0020656,0.13526,0.36667,HP_OVERGROWTH,0.972073202540259
HP_ANTERIOR_OPEN_BITE_MALOCC...,SET,14,0.081898,0.0022596,0.24052,0.36674,HP_ANTERIOR_OPEN_BITE_MALOCCLUSION,0.972073202540259
HP_ABNORMALITY_OF_THE_PHALAN...1,SET,16,0.073991,0.0021822,0.21732,0.36675,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_2ND_FINGER,0.972073202540259
GOMF_LIGAND_GATED_CHANNEL_AC...,SET,177,0.023645,0.0023093,0.06945,0.36676,GOMF_LIGAND_GATED_CHANNEL_ACTIVITY,0.972073202540259
CHARAFE_BREAST_CANCER_LUMINA...4,SET,402,0.014885,0.0021773,0.04374,0.36681,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,0.972073202540259
HP_ABNORMALITY_OF_THYROID_PH...,SET,347,0.016207,0.0022059,0.047682,0.36697,HP_ABNORMALITY_OF_THYROID_PHYSIOLOGY,0.972073202540259
GOBP_OLIGODENDROCYTE_DEVELOP...,SET,44,0.04549,0.0022232,0.13385,0.36698,GOBP_OLIGODENDROCYTE_DEVELOPMENT,0.972073202540259
GOBP_REGULATION_OF_CD4_POSIT...3,SET,4,0.15863,0.00234,0.46673,0.36698,GOBP_REGULATION_OF_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,0.972073202540259
MIR548AD_5P_MIR548AE_5P_MIR5...,SET,444,0.013895,0.0021335,0.040892,0.36701,MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P,0.972073202540259
GOBP_DIGESTION,SET,127,0.027947,0.0023152,0.082251,0.36701,GOBP_DIGESTION,0.972073202540259
BLANCO_MELO_RESPIRATORY_SYNC...2,SET,272,0.019264,0.0023262,0.056703,0.36703,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...267,SET,6,0.11435,0.0020659,0.33675,0.36709,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.972073202540259
GOBP_RESPONSE_TO_METHIONINE,SET,5,0.14856,0.0024501,0.43748,0.36709,GOBP_RESPONSE_TO_METHIONINE,0.972073202540259
HOLLEMAN_VINCRISTINE_RESISTA...2,SET,25,0.057035,0.0021022,0.168,0.36712,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,0.972073202540259
XU_GH1_EXOGENOUS_TARGETS_UP,SET,48,0.042653,0.002177,0.12566,0.36714,XU_GH1_EXOGENOUS_TARGETS_UP,0.972073202540259
HP_ABNORMAL_FEMALE_EXTERNAL_...,SET,137,0.025624,0.0022041,0.075514,0.36718,HP_ABNORMAL_FEMALE_EXTERNAL_GENITALIA_MORPHOLOGY,0.972073202540259
GOBP_PROTEIN_UFMYLATION,SET,6,0.11245,0.0020314,0.33172,0.36731,GOBP_PROTEIN_UFMYLATION,0.972073202540259
GOMF_SUPEROXIDE_GENERATING_N...2,SET,7,0.11232,0.0021916,0.33132,0.36731,GOMF_SUPEROXIDE_GENERATING_NAD_P_H_OXIDASE_ACTIVITY,0.972073202540259
WP_CYTOPLASMIC_RIBOSOMAL_PRO...,SET,78,0.032225,0.0020949,0.095092,0.36735,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,0.972073202540259
GOBP_INTRINSIC_APOPTOTIC_SIG...3,SET,98,0.028501,0.0020757,0.084102,0.36735,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.972073202540259
GOCC_DNA_REPLICATION_FACTOR_...2,SET,5,0.12893,0.0021264,0.38045,0.36735,GOCC_DNA_REPLICATION_FACTOR_C_COMPLEX,0.972073202540259
MODULE_11,SET,496,0.013897,0.002252,0.041014,0.36737,MODULE_11,0.972073202540259
GSE13946_CTRL_VS_DSS_COLITIS...2,SET,163,0.02405,0.0022549,0.070977,0.36737,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP,0.972073202540259
SP1_Q6,SET,235,0.018685,0.0020993,0.055152,0.36739,SP1_Q6,0.972073202540259
SCHLESINGER_H3K27ME3_IN_NORM...,SET,26,0.070227,0.0026396,0.20733,0.36741,SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,0.972073202540259
MIR4260,SET,64,0.036742,0.0021644,0.10852,0.36747,MIR4260,0.972073202540259
PAX8_TARGET_GENES,SET,65,0.033466,0.0019868,0.098874,0.3675,PAX8_TARGET_GENES,0.972073202540259
CROONQUIST_IL6_DEPRIVATION_UP,SET,17,0.077997,0.0023711,0.23045,0.36751,CROONQUIST_IL6_DEPRIVATION_UP,0.972073202540259
GOBP_NEGATIVE_REGULATION_OF_...65,SET,5,0.10646,0.0017557,0.31458,0.36753,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.972073202540259
GOBP_CELLULAR_RESPONSE_TO_TO...2,SET,116,0.027969,0.002215,0.082661,0.36755,GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE,0.972073202540259
GOBP_CEREBELLAR_GRANULAR_LAY...3,SET,8,0.12813,0.0026727,0.37868,0.36755,GOBP_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS,0.972073202540259
GSE13306_TREG_VS_TCONV_UP,SET,187,0.021312,0.0021388,0.062996,0.36757,GSE13306_TREG_VS_TCONV_UP,0.972073202540259
WEIGEL_OXIDATIVE_STRESS_RESP...,SET,32,0.04964,0.0020696,0.14675,0.36758,WEIGEL_OXIDATIVE_STRESS_RESPONSE,0.972073202540259
GOLDRATH_NAIVE_VS_MEMORY_CD8...1,SET,183,0.022209,0.0022052,0.065673,0.36761,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.972073202540259
GSE28737_FOLLICULAR_VS_MARGI...4,SET,185,0.019616,0.0019582,0.058004,0.36761,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP,0.972073202540259
chr11q22,SET,51,0.076533,0.0040261,0.22635,0.36764,chr11q22,0.972073202540259
GOBP_REGULATION_OF_T_HELPER_...3,SET,31,0.054231,0.0022254,0.16041,0.36765,GOBP_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.972073202540259
HP_FETAL_NECK_ANOMALY,SET,92,0.030896,0.0021805,0.091382,0.36765,HP_FETAL_NECK_ANOMALY,0.972073202540259
GSE36476_CTRL_VS_TSST_ACT_16...1,SET,181,0.020243,0.001999,0.059885,0.36767,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN,0.972073202540259
REACTOME_REACTIONS_SPECIFIC_...,SET,10,0.098195,0.0022899,0.29053,0.36769,REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY,0.972073202540259
GOBP_REGULATION_OF_PROTEIN_C...5,SET,110,0.026726,0.0020615,0.079078,0.36769,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.972073202540259
chr3p11,SET,7,0.16267,0.0031741,0.48141,0.36772,chr3p11,0.972073202540259
REACTOME_TRANSPORT_OF_ORGANI...,SET,10,0.107,0.0024953,0.31671,0.36774,REACTOME_TRANSPORT_OF_ORGANIC_ANIONS,0.972073202540259
TAKEDA_TARGETS_OF_NUP98_HOXA...10,SET,145,0.026534,0.0023476,0.078546,0.36775,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,0.972073202540259
GSE38304_MYC_NEG_VS_POS_GC_B...1,SET,182,0.021914,0.0021699,0.064897,0.36781,GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN,0.972073202540259
GOBP_PIGMENT_METABOLIC_PROCE...,SET,72,0.034775,0.0021724,0.103,0.36782,GOBP_PIGMENT_METABOLIC_PROCESS,0.972073202540259
GNF2_PTX3,SET,34,0.056635,0.0024337,0.16778,0.36785,GNF2_PTX3,0.972073202540259
MIR1292_5P,SET,15,0.073198,0.0020903,0.21688,0.36787,MIR1292_5P,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...687,SET,5,0.14516,0.002394,0.43026,0.36792,GOBP_POSITIVE_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,0.972073202540259
GSE39110_DAY3_VS_DAY6_POST_I...3,SET,178,0.021182,0.0020745,0.062792,0.36794,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN,0.972073202540259
HP_PAIN_INSENSITIVITY,SET,26,0.057267,0.0021525,0.16985,0.368,HP_PAIN_INSENSITIVITY,0.972073202540259
REACTOME_MTORC1_MEDIATED_SIG...,SET,23,0.059276,0.0020957,0.17583,0.36801,REACTOME_MTORC1_MEDIATED_SIGNALLING,0.972073202540259
HP_HYPERCAPNIA,SET,12,0.088535,0.0022616,0.26267,0.36804,HP_HYPERCAPNIA,0.972073202540259
MEK_UP.V1_UP,SET,177,0.022916,0.0022381,0.067989,0.36804,MEK_UP.V1_UP,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...711,SET,15,0.069642,0.0019888,0.20664,0.36805,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.972073202540259
KEGG_MEDICUS_PATHOGEN_HCMV_U...6,SET,19,0.064334,0.0020675,0.19093,0.36808,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.972073202540259
MIR944,SET,381,0.015122,0.0021547,0.044906,0.36815,MIR944,0.972073202540259
GOBP_CELLULAR_RESPONSE_TO_PU...,SET,13,0.080242,0.0021334,0.23827,0.36815,GOBP_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,0.972073202540259
GOBP_CYCLIC_NUCLEOTIDE_BIOSY...,SET,17,0.074645,0.0022692,0.22172,0.36819,GOBP_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.972073202540259
KEGG_MEDICUS_REFERENCE_TLR7_...2,SET,15,0.089311,0.0025505,0.26533,0.36821,KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY,0.972073202540259
GOBP_MEMBRANE_PROTEIN_ECTODO...,SET,46,0.041278,0.0020625,0.12263,0.36821,GOBP_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.972073202540259
HP_PREMATURE_LOSS_OF_TEETH,SET,53,0.039203,0.0021022,0.11649,0.36823,HP_PREMATURE_LOSS_OF_TEETH,0.972073202540259
GSE37534_GW1929_VS_PIOGLITAZ...1,SET,180,0.021358,0.0021034,0.063474,0.36825,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.972073202540259
MARTENS_TRETINOIN_RESPONSE_DN,SET,683,0.010935,0.0020685,0.032503,0.36828,MARTENS_TRETINOIN_RESPONSE_DN,0.972073202540259
HP_SPARSE_SCALP_HAIR,SET,127,0.025028,0.0020734,0.074406,0.36829,HP_SPARSE_SCALP_HAIR,0.972073202540259
GOMF_HORMONE_BINDING,SET,88,0.032543,0.0022465,0.096766,0.36832,GOMF_HORMONE_BINDING,0.972073202540259
GOMF_TITIN_BINDING,SET,13,0.075533,0.0020082,0.22462,0.36833,GOMF_TITIN_BINDING,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...561,SET,83,0.030649,0.0020551,0.091151,0.36834,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,0.972073202540259
GOBP_L_LEUCINE_TRANSPORT,SET,10,0.0976,0.0022761,0.29033,0.36837,GOBP_L_LEUCINE_TRANSPORT,0.972073202540259
GSE3982_MAST_CELL_VS_NEUTROP...1,SET,176,0.021886,0.0021315,0.065102,0.36837,GSE3982_MAST_CELL_VS_NEUTROPHIL_DN,0.972073202540259
HP_NEONATAL_HYPERBILIRUBINEM...,SET,22,0.062743,0.0021695,0.18668,0.3684,HP_NEONATAL_HYPERBILIRUBINEMIA,0.972073202540259
MIR548AK_MIR548AM_5P_MIR548C...,SET,443,0.013761,0.0021105,0.040966,0.36847,MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P,0.972073202540259
MIR548O_5P_MIR548W,SET,443,0.013761,0.0021105,0.040966,0.36847,MIR548O_5P_MIR548W,0.972073202540259
GOBP_REGULATORY_NCRNA_MEDIAT...2,SET,16,0.069959,0.0020633,0.20828,0.36848,GOBP_REGULATORY_NCRNA_MEDIATED_HETEROCHROMATIN_FORMATION,0.972073202540259
REACTOME_NOSTRIN_MEDIATED_EN...,SET,5,0.12111,0.0019974,0.36063,0.3685,REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING,0.972073202540259
MIR12135,SET,185,0.021123,0.0021086,0.062894,0.3685,MIR12135,0.972073202540259
GOBP_POSITIVE_REGULATION_OF_...659,SET,10,0.084608,0.0019731,0.25197,0.36852,GOBP_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.972073202540259
KUMAMOTO_RESPONSE_TO_NUTLIN_...1,SET,9,0.083011,0.0018365,0.24731,0.36857,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN,0.972073202540259
GTF2A2_TARGET_GENES,SET,385,0.015011,0.0021498,0.044722,0.36857,GTF2A2_TARGET_GENES,0.972073202540259
GSE15930_STIM_VS_STIM_AND_IF...3,SET,190,0.020888,0.0021129,0.062252,0.36861,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN,0.972073202540259
GNF2_TYK2,SET,28,0.049297,0.0019227,0.14692,0.36862,GNF2_TYK2,0.972073202540259
HP_PALPITATIONS,SET,102,0.029563,0.0021963,0.088154,0.36868,HP_PALPITATIONS,0.972073202540259
MIR4694_3P,SET,281,0.017742,0.002177,0.052915,0.36871,MIR4694_3P,0.972073202540259
GOBP_PROTEIN_LOCALIZATION_TO...38,SET,12,0.066472,0.001698,0.19831,0.36874,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOPLASM,0.972073202540259
WGGAATGY_TEF1_Q6,SET,331,0.01658,0.002205,0.049494,0.36882,WGGAATGY_TEF1_Q6,0.972073202540259
GOCC_BLOC_COMPLEX,SET,19,0.06536,0.0021005,0.19513,0.36883,GOCC_BLOC_COMPLEX,0.972073202540259
MORF_HEAB,SET,79,0.030608,0.0020024,0.091387,0.36884,MORF_HEAB,0.972073202540259
GSE29949_CD8_NEG_DC_SPLEEN_V...3,SET,179,0.021919,0.0021527,0.065441,0.36884,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN,0.972073202540259
GOMF_SERINE_TYPE_ENDOPEPTIDA...,SET,92,0.035577,0.0025109,0.10623,0.36885,GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.972073202540259
GOCC_NSL_COMPLEX,SET,9,0.083398,0.0018451,0.24904,0.36886,GOCC_NSL_COMPLEX,0.972073202540259
MODULE_162,SET,17,0.078044,0.0023725,0.23321,0.36894,MODULE_162,0.972073202540259
MIR34B_3P,SET,98,0.026906,0.0019595,0.080433,0.369,MIR34B_3P,0.972073202540259
GOCC_COLLAGEN_TRIMER,SET,83,0.035804,0.0024007,0.10705,0.36901,GOCC_COLLAGEN_TRIMER,0.972073202540259
GSE32034_UNTREATED_VS_ROSIGL...3,SET,166,0.023161,0.0021913,0.069258,0.36903,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN,0.972073202540259
GOCC_NUCLEAR_SPECK,SET,374,0.014131,0.0019953,0.042273,0.36908,GOCC_NUCLEAR_SPECK,0.972073202540259
GOBP_LYMPHOCYTE_ACTIVATION_I...,SET,194,0.021486,0.0021959,0.064282,0.3691,GOBP_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.972073202540259
GOBP_REGULATION_OF_BRANCHING...1,SET,6,0.13251,0.002394,0.39656,0.36913,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,0.972073202540259
GOBP_PROTEIN_GERANYLGERANYLA...,SET,6,0.10415,0.0018816,0.31184,0.3692,GOBP_PROTEIN_GERANYLGERANYLATION,0.972073202540259
JACKSON_DNMT1_TARGETS_DN,SET,20,0.071882,0.00237,0.21525,0.36921,JACKSON_DNMT1_TARGETS_DN,0.972073202540259
GOBP_MISMATCH_REPAIR,SET,31,0.046583,0.0019116,0.1395,0.36921,GOBP_MISMATCH_REPAIR,0.972073202540259
GOBP_INTERMEDIATE_FILAMENT_B...2,SET,7,0.12251,0.0023906,0.36691,0.36923,GOBP_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY,0.972073202540259
GOBP_ANAGEN,SET,5,0.14127,0.0023299,0.42326,0.36928,GOBP_ANAGEN,0.972073202540259
JINESH_BLEBBISHIELD_TO_IMMUN...2,SET,341,0.016651,0.0022469,0.049895,0.3693,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,0.972073202540259
GOMF_JUN_KINASE_BINDING,SET,11,0.087061,0.0021293,0.26088,0.3693,GOMF_JUN_KINASE_BINDING,0.972073202540259
GOBP_ENUCLEATE_ERYTHROCYTE_M...,SET,3,0.20465,0.0026144,0.61332,0.36932,GOBP_ENUCLEATE_ERYTHROCYTE_MATURATION,0.972073202540259
HP_MYELOID_LEUKEMIA,SET,30,0.05218,0.0021065,0.15641,0.36933,HP_MYELOID_LEUKEMIA,0.972073202540259
GSE13762_CTRL_VS_125_VITAMIN...4,SET,122,0.027594,0.0022407,0.082708,0.36933,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP,0.972073202540259
KEGG_MEDICUS_REFERENCE_IL1_I...2,SET,15,0.080352,0.0022947,0.2409,0.36936,KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY,0.972073202540259
SA_FAS_SIGNALING,SET,9,0.097733,0.0021623,0.29305,0.36938,SA_FAS_SIGNALING,0.972073202540259
GOBP_BLOOD_COAGULATION_FIBRI...,SET,14,0.091314,0.0025193,0.27381,0.36938,GOBP_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION,0.972073202540259
GOBP_INTESTINAL_EPITHELIAL_C...2,SET,26,0.058814,0.0022106,0.17636,0.36938,GOBP_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION,0.972073202540259
chr19p12,SET,29,0.086405,0.0034296,0.2593,0.36948,chr19p12,0.972073202540259
GOCC_PARANODAL_JUNCTION,SET,8,0.092138,0.0019219,0.27651,0.36949,GOCC_PARANODAL_JUNCTION,0.972073202540259
GOBP_REGULATION_OF_PROTEIN_L...12,SET,9,0.084437,0.0018681,0.2535,0.36954,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.972073202540259
ZNF423_TARGET_GENES,SET,844,0.010052,0.0021041,0.030184,0.36956,ZNF423_TARGET_GENES,0.972073202540259
HP_HYPOPLASTIC_ILIA,SET,47,0.041233,0.0020825,0.12385,0.3696,HP_HYPOPLASTIC_ILIA,0.972073202540259
GOBP_REGULATION_OF_CELL_ACTI...,SET,579,0.012649,0.0022094,0.038001,0.36963,GOBP_REGULATION_OF_CELL_ACTIVATION,0.972073202540259
DAZARD_UV_RESPONSE_CLUSTER_G6,SET,135,0.025295,0.00216,0.076028,0.36968,DAZARD_UV_RESPONSE_CLUSTER_G6,0.972073202540259
WP_DIFFERENTIATION_OF_WHITE_...,SET,25,0.064655,0.002383,0.19437,0.36971,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,0.972073202540259
MIR4275,SET,139,0.024705,0.0021404,0.074268,0.36971,MIR4275,0.972073202540259
GOMF_AZOLE_TRANSMEMBRANE_TRA...,SET,12,0.086477,0.002209,0.26,0.36972,GOMF_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.972073202540259
GSE16451_IMMATURE_VS_MATURE_...2,SET,181,0.021151,0.0020887,0.063593,0.36972,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.972073202540259
GSE15624_3H_VS_6H_HALOFUGINO...2,SET,159,0.022785,0.0021102,0.068518,0.36974,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.972073202540259
GSE7831_CPG_VS_INFLUENZA_STI...1,SET,186,0.021408,0.0021428,0.06438,0.36975,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN,0.972073202540259
TSENG_ADIPOGENIC_POTENTIAL_UP,SET,25,0.058013,0.0021382,0.1745,0.36977,TSENG_ADIPOGENIC_POTENTIAL_UP,0.972073202540259
REACTOME_TRANSMISSION_ACROSS...,SET,252,0.019366,0.0022521,0.058247,0.36977,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,0.972073202540259
GSE18791_UNSTIM_VS_NEWCATSLE...8,SET,135,0.025451,0.0021733,0.076552,0.36977,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP,0.972073202540259
MARTENS_TRETINOIN_RESPONSE_UP,SET,754,0.01166,0.0023128,0.035081,0.36981,MARTENS_TRETINOIN_RESPONSE_UP,0.972073202540259
HP_ACUTE_PANCREATITIS,SET,7,0.115,0.0022439,0.34602,0.36982,HP_ACUTE_PANCREATITIS,0.972073202540259
HP_INGUINAL_FRECKLING,SET,6,0.098332,0.0017764,0.29594,0.36985,HP_INGUINAL_FRECKLING,0.972073202540259
PROVENZANI_METASTASIS_UP,SET,169,0.023217,0.0022161,0.06988,0.36986,PROVENZANI_METASTASIS_UP,0.972073202540259
GOBP_PANCREATIC_JUICE_SECRET...,SET,11,0.084072,0.0020562,0.2531,0.36988,GOBP_PANCREATIC_JUICE_SECRETION,0.972073202540259
GAUTAM_EYE_CORNEA_TGFBI_HIGH...,SET,102,0.029081,0.0021605,0.087562,0.3699,GAUTAM_EYE_CORNEA_TGFBI_HIGH_EPITHELIAL_CELLS,0.972073202540259
MIR4802_5P,SET,57,0.038726,0.0021534,0.11663,0.36993,MIR4802_5P,0.972073202540259
GOCC_DEUTEROSOME,SET,5,0.094667,0.0015613,0.28515,0.36995,GOCC_DEUTEROSOME,0.972073202540259
HP_NOCTURIA,SET,14,0.078677,0.0021707,0.23714,0.37003,HP_NOCTURIA,0.972209907015422
GOBP_KERATINOCYTE_DIFFERENTI...,SET,161,0.026202,0.0024417,0.079003,0.37008,GOBP_KERATINOCYTE_DIFFERENTIATION,0.972267775342052
GOMF_IMMUNOGLOBULIN_RECEPTOR...2,SET,9,0.10633,0.0023525,0.32075,0.37013,GOMF_IMMUNOGLOBULIN_RECEPTOR_BINDING,0.972325634920635
GOBP_NEUTROPHIL_MEDIATED_KIL...2,SET,13,0.092395,0.0024565,0.27888,0.37021,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL,0.972462289320535
HP_HYPERGLYCEMIA,SET,77,0.03257,0.0021038,0.098354,0.37027,HP_HYPERGLYCEMIA,0.972546391324063
PID_EPHB_FWD_PATHWAY,SET,39,0.04426,0.0020367,0.13372,0.37033,PID_EPHB_FWD_PATHWAY,0.972593834995467
BYSTROEM_CORRELATED_WITH_IL5...1,SET,55,0.03868,0.0021128,0.11689,0.37035,BYSTROEM_CORRELATED_WITH_IL5_DN,0.972593834995467
REACTOME_SIGNALING_BY_HIPPO,SET,19,0.072454,0.0023284,0.219,0.37038,REACTOME_SIGNALING_BY_HIPPO,0.972593834995467
chr7p13,SET,30,0.097632,0.0039414,0.29513,0.3704,chr7p13,0.972593834995467
HP_PULMONARY_ARTERIOVENOUS_M...,SET,4,0.14928,0.0022021,0.45141,0.37044,HP_PULMONARY_ARTERIOVENOUS_MALFORMATION,0.972625383395029
BURTON_ADIPOGENESIS_PEAK_AT_...5,SET,38,0.049338,0.0022412,0.14925,0.37049,BURTON_ADIPOGENESIS_PEAK_AT_8HR,0.972683180994108
MIR548V,SET,124,0.025705,0.0021043,0.077792,0.37054,MIR548V,0.972703157264701
MIR524_3P_MIR525_3P,SET,11,0.087334,0.002136,0.26471,0.37073,MIR524_3P_MIR525_3P,0.972703157264701
HP_POLYCYTHEMIA,SET,22,0.063286,0.0021883,0.19191,0.37079,HP_POLYCYTHEMIA,0.972703157264701
HP_GONADOBLASTOMA,SET,14,0.083137,0.0022937,0.25212,0.3708,HP_GONADOBLASTOMA,0.972703157264701
GOMF_BETA_TUBULIN_BINDING,SET,35,0.046184,0.0020135,0.14011,0.37085,GOMF_BETA_TUBULIN_BINDING,0.972703157264701
REACTOME_RND3_GTPASE_CYCLE,SET,41,0.045541,0.0021486,0.13822,0.3709,REACTOME_RND3_GTPASE_CYCLE,0.972703157264701
MIR6756_5P,SET,242,0.018616,0.0021221,0.056517,0.37093,MIR6756_5P,0.972703157264701
GOBP_REGULATION_OF_PROTEIN_L...13,SET,137,0.02343,0.0020154,0.07114,0.37095,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.972703157264701
GOMF_THIOREDOXIN_DISULFIDE_R...,SET,6,0.10994,0.0019862,0.33393,0.37099,GOMF_THIOREDOXIN_DISULFIDE_REDUCTASE_NADPH_ACTIVITY,0.972703157264701
GSE21546_ELK1_KO_VS_SAP1A_KO...2,SET,176,0.020202,0.0019675,0.061385,0.37104,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.972703157264701
GSE26890_CXCR1_NEG_VS_POS_EF...1,SET,177,0.020457,0.0019979,0.062176,0.37107,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN,0.972703157264701
GOBP_REGULATION_OF_FERTILIZA...,SET,16,0.071986,0.0021231,0.21883,0.3711,GOBP_REGULATION_OF_FERTILIZATION,0.972703157264701
HP_SMALL_PITUITARY_GLAND,SET,12,0.083537,0.0021339,0.25405,0.37115,HP_SMALL_PITUITARY_GLAND,0.972703157264701
TGTGTGA_MIR377,SET,182,0.020759,0.0020556,0.063147,0.37117,TGTGTGA_MIR377,0.972703157264701
GOBP_NEGATIVE_REGULATION_OF_...278,SET,10,0.096631,0.0022535,0.29399,0.3712,GOBP_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,0.972703157264701
GOMF_ATPASE_COUPLED_ION_TRAN...,SET,22,0.060609,0.0020957,0.1844,0.3712,GOMF_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.972703157264701
GOCC_PROTEIN_PHOSPHATASE_TYP...1,SET,18,0.062891,0.0019673,0.19137,0.37121,GOCC_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX,0.972703157264701
MIR1200,SET,301,0.016577,0.002104,0.050447,0.37123,MIR1200,0.972703157264701
HP_ABDOMINAL_WALL_MUSCLE_WEA...,SET,14,0.072117,0.0019897,0.21947,0.37123,HP_ABDOMINAL_WALL_MUSCLE_WEAKNESS,0.972703157264701
EWSR1_TARGET_GENES,SET,771,0.010219,0.0020487,0.0311,0.37124,EWSR1_TARGET_GENES,0.972703157264701
NATSUME_RESPONSE_TO_INTERFER...2,SET,69,0.035559,0.0021747,0.10825,0.37127,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.972703157264701
GOBP_MORPHOGENESIS_OF_A_POLA...,SET,58,0.038539,0.0021616,0.11738,0.37134,GOBP_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM,0.972703157264701
MIR6822_3P,SET,49,0.038893,0.0020056,0.11853,0.37141,MIR6822_3P,0.972703157264701
CROONQUIST_STROMAL_STIMULATI...2,SET,49,0.044399,0.0022895,0.13532,0.37142,CROONQUIST_STROMAL_STIMULATION_UP,0.972703157264701
HP_UNDETECTABLE_ELECTRORETIN...,SET,33,0.053414,0.0022614,0.16281,0.37143,HP_UNDETECTABLE_ELECTRORETINOGRAM,0.972703157264701
HP_AXIAL_DYSTONIA,SET,15,0.069564,0.0019866,0.21219,0.37152,HP_AXIAL_DYSTONIA,0.972703157264701
GOBP_MITOTIC_METAPHASE_CHROM...,SET,62,0.033532,0.0019444,0.10232,0.37156,GOBP_MITOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,0.972703157264701
HP_SCLEROTIC_VERTEBRAL_ENDPL...,SET,5,0.1406,0.0023188,0.42908,0.37158,HP_SCLEROTIC_VERTEBRAL_ENDPLATES,0.972703157264701
AIZARANI_LIVER_C3_NK_NKT_CEL...,SET,139,0.02458,0.0021296,0.075045,0.37163,AIZARANI_LIVER_C3_NK_NKT_CELLS_2,0.972703157264701
GOMF_PENTOSYLTRANSFERASE_ACT...,SET,47,0.040536,0.0020473,0.1238,0.37167,GOMF_PENTOSYLTRANSFERASE_ACTIVITY,0.972703157264701
HP_ABNORMAL_ENERGY_EXPENDITU...,SET,12,0.088132,0.0022513,0.26916,0.37167,HP_ABNORMAL_ENERGY_EXPENDITURE,0.972703157264701
GOBP_CELL_CELL_RECOGNITION,SET,71,0.03362,0.0020856,0.10272,0.37173,GOBP_CELL_CELL_RECOGNITION,0.972703157264701
CHICAS_RB1_TARGETS_SENESCENT,SET,506,0.012828,0.002099,0.039199,0.37174,CHICAS_RB1_TARGETS_SENESCENT,0.972703157264701
MODULE_552,SET,7,0.10912,0.0021292,0.3335,0.37176,MODULE_552,0.972703157264701
BIOCARTA_SET_PATHWAY,SET,10,0.10304,0.002403,0.31496,0.37177,BIOCARTA_SET_PATHWAY,0.972703157264701
GOBP_GALACTOSYLCERAMIDE_BIOS...,SET,6,0.12084,0.0021831,0.36953,0.37183,GOBP_GALACTOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.972703157264701
GSE14000_UNSTIM_VS_16H_LPS_D...2,SET,176,0.022234,0.0021654,0.067991,0.37183,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN,0.972703157264701
GOMF_ALDEHYDE_LYASE_ACTIVITY,SET,9,0.083955,0.0018574,0.25676,0.37184,GOMF_ALDEHYDE_LYASE_ACTIVITY,0.972703157264701
SCHWAB_TARGETS_OF_BMYB_POLYM...2,SET,12,0.073705,0.0018828,0.22547,0.37188,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,0.972703157264701
HP_ABNORMAL_MIDDLE_PHALANX_M...,SET,58,0.037079,0.0020797,0.11343,0.37188,HP_ABNORMAL_MIDDLE_PHALANX_MORPHOLOGY_OF_THE_HAND,0.972703157264701
GOBP_REGULATION_OF_LIPID_MET...,SET,282,0.017119,0.0021043,0.052391,0.37193,GOBP_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.972703157264701
GOCC_PLASMA_MEMBRANE_REGION,SET,1187,0.0086804,0.0021336,0.026565,0.37193,GOCC_PLASMA_MEMBRANE_REGION,0.972703157264701
WP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,6,0.12542,0.0022658,0.38394,0.37196,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,0.972703157264701
STK33_DN,SET,237,0.018529,0.0020905,0.056722,0.37196,STK33_DN,0.972703157264701
MODULE_560,SET,10,0.092587,0.0021591,0.28353,0.372,MODULE_560,0.972703157264701
HP_ABNORMAL_CAROTID_ARTERY_M...,SET,83,0.031878,0.0021374,0.097665,0.37206,HP_ABNORMAL_CAROTID_ARTERY_MORPHOLOGY,0.972703157264701
MODULE_87,SET,41,0.042257,0.0019937,0.12947,0.37207,MODULE_87,0.972703157264701
MATSUMIYA_PBMC_MODIFIED_VACC...5,SET,26,0.056604,0.0021275,0.17345,0.37208,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_WILD_TYPE_MVA_6HR_UP,0.972703157264701
GSE12392_WT_VS_IFNAR_KO_CD8A...1,SET,168,0.020744,0.0019743,0.06357,0.37209,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN,0.972703157264701
DESCARTES_MAIN_FETAL_MYELOID...,SET,78,0.033179,0.002157,0.10168,0.3721,DESCARTES_MAIN_FETAL_MYELOID_CELLS,0.972703157264701
GOBP_SPHINGOID_BIOSYNTHETIC_...,SET,13,0.08125,0.0021602,0.24907,0.37213,GOBP_SPHINGOID_BIOSYNTHETIC_PROCESS,0.972703157264701
PRC2_EED_DN.V1_UP,SET,172,0.02212,0.0021299,0.067818,0.37215,PRC2_EED_DN.V1_UP,0.972703157264701
GOMF_STORE_OPERATED_CALCIUM_...,SET,9,0.10116,0.0022381,0.31023,0.37218,GOMF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.972703157264701
HP_CHOANAL_ATRESIA,SET,107,0.026079,0.0019841,0.079985,0.3722,HP_CHOANAL_ATRESIA,0.972703157264701
HP_TRIPHALANGEAL_THUMB,SET,64,0.032684,0.0019254,0.10025,0.3722,HP_TRIPHALANGEAL_THUMB,0.972703157264701
GOBP_CELLULAR_OXIDANT_DETOXI...,SET,84,0.031003,0.0020912,0.095108,0.37222,GOBP_CELLULAR_OXIDANT_DETOXIFICATION,0.972703157264701
DAVICIONI_MOLECULAR_ARMS_VS_...2,SET,301,0.016177,0.0020532,0.049642,0.37226,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,0.972703157264701
HP_NARROW_PELVIS_BONE,SET,7,0.089369,0.0017438,0.2743,0.37229,HP_NARROW_PELVIS_BONE,0.972703157264701
REACTOME_MITOTIC_PROMETAPHASE,SET,185,0.019656,0.0019622,0.060371,0.37237,REACTOME_MITOTIC_PROMETAPHASE,0.972703157264701
REACTOME_DIFFERENTIATION_OF_...,SET,37,0.049517,0.0022196,0.15216,0.37243,REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN,0.972703157264701
HP_MILD_SHORT_STATURE,SET,18,0.070508,0.0022055,0.21674,0.37247,HP_MILD_SHORT_STATURE,0.972703157264701
HP_REMNANTS_OF_THE_HYALOID_V...,SET,9,0.10422,0.0023057,0.32043,0.3725,HP_REMNANTS_OF_THE_HYALOID_VASCULAR_SYSTEM,0.972703157264701
GSE25088_CTRL_VS_IL4_STIM_MA...1,SET,174,0.020704,0.002005,0.063663,0.37251,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.972703157264701
GOBP_REGULATION_OF_EMBRYONIC...,SET,81,0.029479,0.0019528,0.090649,0.37252,GOBP_REGULATION_OF_EMBRYONIC_DEVELOPMENT,0.972703157264701
HP_CUTANEOUS_MELANOMA,SET,19,0.054781,0.0017605,0.16852,0.37257,HP_CUTANEOUS_MELANOMA,0.972703157264701
GOCC_CATSPER_COMPLEX,SET,11,0.078049,0.0019089,0.24015,0.37259,GOCC_CATSPER_COMPLEX,0.972703157264701
GAJATE_RESPONSE_TO_TRABECTED...1,SET,16,0.076754,0.0022637,0.23623,0.37262,GAJATE_RESPONSE_TO_TRABECTEDIN_DN,0.972703157264701
GOMF_MRNA_3_UTR_BINDING,SET,98,0.027032,0.0019687,0.083206,0.37264,GOMF_MRNA_3_UTR_BINDING,0.972703157264701
GOCC_SPINDLE,SET,386,0.013598,0.0019499,0.041878,0.3727,GOCC_SPINDLE,0.972703157264701
REACTOME_SYNDECAN_INTERACTIO...,SET,26,0.057296,0.0021535,0.17648,0.37272,REACTOME_SYNDECAN_INTERACTIONS,0.972703157264701
GOBP_SMOOTH_MUSCLE_CELL_MATR...,SET,6,0.10557,0.0019072,0.32516,0.37272,GOBP_SMOOTH_MUSCLE_CELL_MATRIX_ADHESION,0.972703157264701
chr5q22,SET,26,0.10605,0.003986,0.32669,0.37274,chr5q22,0.972703157264701
KEGG_ALLOGRAFT_REJECTION,SET,32,0.056747,0.0023659,0.17485,0.37276,KEGG_ALLOGRAFT_REJECTION,0.972703157264701
GOBP_MYELOID_LEUKOCYTE_MIGRA...,SET,217,0.020864,0.0022538,0.0643,0.37279,GOBP_MYELOID_LEUKOCYTE_MIGRATION,0.972703157264701
GSE39556_UNTREATED_VS_3H_POL...4,SET,178,0.02062,0.0020195,0.063562,0.37281,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP,0.972703157264701
MIR216B_5P,SET,85,0.030457,0.0020666,0.09389,0.37282,MIR216B_5P,0.972703157264701
GSE26343_WT_VS_NFAT5_KO_MACR...4,SET,181,0.019658,0.0019413,0.060607,0.37284,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP,0.972703157264701
REACTOME_TRANSPORT_OF_MATURE...2,SET,74,0.028731,0.0018195,0.088631,0.37291,REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,0.972703157264701
KEGG_MEDICUS_ENV_FACTOR_PARA...,SET,5,0.14178,0.0023383,0.43763,0.37298,KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY,0.972703157264701
GOBP_BUNDLE_OF_HIS_CELL_TO_P...1,SET,15,0.086028,0.0024567,0.26558,0.373,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION,0.972703157264701
GSE17974_1.5H_VS_72H_IL4_AND...2,SET,173,0.021497,0.0020759,0.066365,0.373,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.972703157264701
GSE3982_MAC_VS_BCELL_UP,SET,178,0.020939,0.0020507,0.064713,0.37313,GSE3982_MAC_VS_BCELL_UP,0.972703157264701
GOMF_CALMODULIN_BINDING,SET,197,0.020015,0.0020611,0.06187,0.37316,GOMF_CALMODULIN_BINDING,0.972703157264701
LBP1_Q6,SET,211,0.019737,0.0021026,0.061015,0.37317,LBP1_Q6,0.972703157264701
HP_ENAMEL_HYPOPLASIA,SET,90,0.029144,0.0020345,0.09011,0.37319,HP_ENAMEL_HYPOPLASIA,0.972703157264701
GGATTA_PITX2_Q2,SET,522,0.013097,0.0021757,0.04051,0.37324,GGATTA_PITX2_Q2,0.972703157264701
HE_LIM_SUN_FETAL_LUNG_C2_SPP...,SET,44,0.043575,0.0021296,0.1348,0.37325,HE_LIM_SUN_FETAL_LUNG_C2_SPP1_POS_MACROPHAGE_CELL,0.972703157264701
GOMF_PROTEIN_SERINE_THREONIN...1,SET,63,0.035273,0.0020617,0.10913,0.37327,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.972703157264701
HP_ABNORMALITY_OF_CHROMOSOME...1,SET,13,0.085066,0.0022616,0.26319,0.37327,HP_ABNORMALITY_OF_CHROMOSOME_SEGREGATION,0.972703157264701
REACTOME_BINDING_OF_TCF_LEF_...,SET,8,0.10085,0.0021037,0.31209,0.3733,REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS,0.972703157264701
GOBP_EMBRYONIC_HEART_TUBE_DE...,SET,82,0.030703,0.0020463,0.095051,0.37334,GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT,0.972703157264701
GOBP_DETECTION_OF_MECHANICAL...2,SET,33,0.051804,0.0021932,0.16039,0.37336,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.972703157264701
GOBP_REGULATION_OF_GLUTAMINE...,SET,6,0.12038,0.0021748,0.37278,0.37337,GOBP_REGULATION_OF_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.972703157264701
HP_CIRRHOSIS,SET,147,0.023175,0.0020644,0.071761,0.37337,HP_CIRRHOSIS,0.972703157264701
HP_ABNORMAL_SMALL_INTESTINE_...,SET,244,0.017827,0.0020404,0.055217,0.37341,HP_ABNORMAL_SMALL_INTESTINE_MORPHOLOGY,0.972703157264701
REACTOME_ACTIVATION_OF_C3_AN...,SET,4,0.13941,0.0020566,0.43191,0.37343,REACTOME_ACTIVATION_OF_C3_AND_C5,0.972703157264701
GOBP_RETROGRADE_TRANSPORT_EN...,SET,88,0.02685,0.0018535,0.083179,0.37343,GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,0.972703157264701
MIR1183,SET,112,0.026513,0.0020634,0.082143,0.37344,MIR1183,0.972703157264701
HP_DYSTONIA,SET,462,0.012704,0.0019888,0.039361,0.37344,HP_DYSTONIA,0.972703157264701
GOCC_COATED_VESICLE_MEMBRANE,SET,185,0.020535,0.0020499,0.063631,0.37346,GOCC_COATED_VESICLE_MEMBRANE,0.972703157264701
GOMF_ESTROGEN_2_HYDROXYLASE_...,SET,5,0.1407,0.0023204,0.43601,0.37346,GOMF_ESTROGEN_2_HYDROXYLASE_ACTIVITY,0.972703157264701
MATZUK_CENTRAL_FOR_FEMALE_FE...,SET,29,0.05194,0.0020616,0.16099,0.37349,MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,0.972703157264701
HP_INCREASED_CIRCULATING_INT...2,SET,5,0.13153,0.0021692,0.40775,0.37351,HP_INCREASED_CIRCULATING_INTERLEUKIN_18_CONCENTRATION,0.972703157264701
REACTOME_SIGNALING_BY_ROBO_R...,SET,198,0.01905,0.0019667,0.059062,0.37352,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,0.972703157264701
HP_FOCAL_MYOCLONIC_SEIZURE,SET,18,0.064515,0.0020181,0.20019,0.37363,HP_FOCAL_MYOCLONIC_SEIZURE,0.972703157264701
HP_IRREGULAR_HYPERPIGMENTATI...,SET,211,0.018312,0.0019509,0.056831,0.37364,HP_IRREGULAR_HYPERPIGMENTATION,0.972703157264701
HP_METHYLMALONIC_ACIDEMIA,SET,13,0.073511,0.0019544,0.22813,0.37364,HP_METHYLMALONIC_ACIDEMIA,0.972703157264701
HP_PROPTOSIS,SET,257,0.017096,0.0020075,0.053061,0.37365,HP_PROPTOSIS,0.972703157264701
GOBP_FACE_MORPHOGENESIS,SET,30,0.053684,0.0021672,0.16663,0.37366,GOBP_FACE_MORPHOGENESIS,0.972703157264701
REACTOME_TERMINATION_OF_TRAN...,SET,30,0.044465,0.001795,0.13802,0.37367,REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,0.972703157264701
GOBP_BASE_EXCISION_REPAIR_AP...,SET,12,0.076384,0.0019512,0.23724,0.37374,GOBP_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.972703157264701
MIR4662A_5P,SET,81,0.030642,0.0020298,0.095221,0.3738,MIR4662A_5P,0.972703157264701
GSE360_L_MAJOR_VS_M_TUBERCUL...4,SET,172,0.021646,0.0020843,0.067263,0.3738,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP,0.972703157264701
GOBP_REGULATION_OF_ARACHIDON...,SET,7,0.10204,0.001991,0.31709,0.37381,GOBP_REGULATION_OF_ARACHIDONIC_ACID_SECRETION,0.972703157264701
GOBP_RETINA_VASCULATURE_DEVE...,SET,18,0.064928,0.002031,0.2018,0.37383,GOBP_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.972703157264701
PID_HDAC_CLASSII_PATHWAY,SET,30,0.052533,0.0021207,0.16336,0.37389,PID_HDAC_CLASSII_PATHWAY,0.972703157264701
GOBP_REGULATION_OF_LIPASE_AC...,SET,61,0.037112,0.0021345,0.11543,0.37392,GOBP_REGULATION_OF_LIPASE_ACTIVITY,0.972703157264701
ZBED4_TARGET_GENES,SET,248,0.017274,0.0019931,0.053733,0.37393,ZBED4_TARGET_GENES,0.972703157264701
GOBP_LIPOXYGENASE_PATHWAY,SET,11,0.094234,0.0023048,0.2932,0.37395,GOBP_LIPOXYGENASE_PATHWAY,0.972703157264701
GOBP_REGULATION_OF_ENAMEL_MI...,SET,7,0.10767,0.002101,0.33504,0.37396,GOBP_REGULATION_OF_ENAMEL_MINERALIZATION,0.972703157264701
GOBP_RENAL_SODIUM_ION_ABSORP...,SET,12,0.08731,0.0022303,0.27166,0.37396,GOBP_RENAL_SODIUM_ION_ABSORPTION,0.972703157264701
GOBP_REGULATION_OF_PROTEIN_P...1,SET,179,0.02043,0.0020064,0.063574,0.37397,GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION,0.972703157264701
WP_TCA_CYCLE_IN_SENESCENCE,SET,9,0.10041,0.0022214,0.31247,0.37398,WP_TCA_CYCLE_IN_SENESCENCE,0.972703157264701
GOBP_POSITIVE_REGULATION_OF_...61,SET,30,0.054286,0.0021915,0.16894,0.37398,GOBP_POSITIVE_REGULATION_OF_BLOOD_PRESSURE,0.972703157264701
HP_CONE_SHAPED_EPIPHYSIS,SET,72,0.031101,0.0019428,0.096803,0.374,HP_CONE_SHAPED_EPIPHYSIS,0.972703157264701
MIR1281,SET,9,0.095792,0.0021193,0.29826,0.37404,MIR1281,0.972703157264701
GOBP_COLLECTING_DUCT_DEVELOP...,SET,15,0.08356,0.0023863,0.26023,0.37407,GOBP_COLLECTING_DUCT_DEVELOPMENT,0.972703157264701
GOMF_OXIDOREDUCTASE_ACTIVITY...25,SET,7,0.11111,0.0021681,0.34605,0.37408,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.972703157264701
GOBP_EXCITATORY_CHEMICAL_SYN...,SET,10,0.0935,0.0021804,0.29137,0.37415,GOBP_EXCITATORY_CHEMICAL_SYNAPTIC_TRANSMISSION,0.972812392459041
GOBP_MIRNA_METABOLIC_PROCESS,SET,92,0.028254,0.001994,0.088112,0.37424,GOBP_MIRNA_METABOLIC_PROCESS,0.972885365580144
MIR3168,SET,122,0.024429,0.0019837,0.076205,0.37427,MIR3168,0.972885365580144
HP_LYMPHANGIOMA,SET,11,0.093002,0.0022746,0.29012,0.37427,HP_LYMPHANGIOMA,0.972885365580144
GOBP_CHROMATIN_REMODELING,SET,515,0.011682,0.0019279,0.036451,0.3743,GOBP_CHROMATIN_REMODELING,0.972885365580144
GOBP_POSITIVE_REGULATION_OF_...36,SET,5,0.14548,0.0023993,0.45425,0.37438,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.972885365580144
GOBP_POSITIVE_REGULATION_OF_...37,SET,5,0.14548,0.0023993,0.45425,0.37438,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,0.972885365580144
GSE22432_MULTIPOTENT_VS_COMM...3,SET,174,0.019441,0.0018827,0.060715,0.37441,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP,0.972885365580144
MIR5007_5P,SET,53,0.038181,0.0020474,0.11926,0.37443,MIR5007_5P,0.972885365580144
GOBP_MACROPHAGE_APOPTOTIC_PR...,SET,12,0.071215,0.0018192,0.22244,0.37443,GOBP_MACROPHAGE_APOPTOTIC_PROCESS,0.972885365580144
MIR128_3P,SET,408,0.013944,0.0020544,0.043566,0.37446,MIR128_3P,0.972890580847724
chr7q35,SET,17,0.10929,0.0033224,0.34153,0.37449,chr7q35,0.972895795335626
HP_GLOMERULAR_SCLEROSIS,SET,78,0.030177,0.0019618,0.094373,0.37458,HP_GLOMERULAR_SCLEROSIS,0.97292193755602
ACOSTA_PROLIFERATION_INDEPEN...1,SET,106,0.027477,0.0020808,0.085966,0.37463,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,0.97292193755602
GOBP_RESPONSE_TO_MAGNESIUM_I...,SET,20,0.06712,0.002213,0.20999,0.37463,GOBP_RESPONSE_TO_MAGNESIUM_ION,0.97292193755602
REACTOME_NTRK2_ACTIVATES_RAC1,SET,5,0.12882,0.0021246,0.40313,0.37465,REACTOME_NTRK2_ACTIVATES_RAC1,0.97292193755602
GOCC_NADPH_OXIDASE_COMPLEX,SET,13,0.077721,0.0020664,0.24326,0.37468,GOCC_NADPH_OXIDASE_COMPLEX,0.97292193755602
GSE46606_IRF4HIGH_VS_IRF4MID...4,SET,178,0.018898,0.0018508,0.059171,0.37472,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.97292193755602
MIKKELSEN_MCV6_HCP_WITH_H3K2...,SET,412,0.015017,0.0022231,0.04704,0.37477,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,0.97292193755602
MIR4528,SET,203,0.020013,0.0020917,0.062689,0.37477,MIR4528,0.97292193755602
GOBP_GEPHYRIN_CLUSTERING_INV...,SET,5,0.12489,0.0020597,0.39121,0.37477,GOBP_GEPHYRIN_CLUSTERING_INVOLVED_IN_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.97292193755602
WP_APOPTOSIS_MODULATION_AND_...,SET,84,0.03068,0.0020695,0.096109,0.37478,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.97292193755602
HP_RECURRENT_BACTERIAL_INFEC...,SET,184,0.020634,0.0020543,0.064657,0.37481,HP_RECURRENT_BACTERIAL_INFECTIONS,0.97292714541788
REACTOME_CHYLOMICRON_CLEARAN...,SET,5,0.14024,0.0023129,0.43982,0.37492,REACTOME_CHYLOMICRON_CLEARANCE,0.973036215005599
MARKEY_RB1_CHRONIC_LOF_DN,SET,108,0.027854,0.002129,0.087373,0.37494,MARKEY_RB1_CHRONIC_LOF_DN,0.973036215005599
KEGG_MEDICUS_REFERENCE_DISAS...,SET,16,0.066386,0.0019579,0.20826,0.37495,KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC,0.973036215005599
HP_ABNORMAL_CORNEAL_STROMA_M...,SET,96,0.028698,0.0020687,0.090056,0.37499,HP_ABNORMAL_CORNEAL_STROMA_MORPHOLOGY,0.973036215005599
chr3p23,SET,3,0.19255,0.0024599,0.60439,0.37502,chr3p23,0.973036215005599
HP_FLARED_LOWER_LIMB_METAPHY...,SET,5,0.11494,0.0018957,0.36078,0.37502,HP_FLARED_LOWER_LIMB_METAPHYSIS,0.973036215005599
JINESH_BLEBBISHIELD_VS_LIVE_...1,SET,241,0.01862,0.0021182,0.058492,0.37512,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,0.973223021797552
MORF_PRKAG1,SET,203,0.018013,0.0018827,0.056622,0.3752,MORF_PRKAG1,0.973228171168482
MIR6508_3P,SET,46,0.041969,0.0020971,0.13196,0.37522,MIR6508_3P,0.973228171168482
GSE9601_UNTREATED_VS_NFKB_IN...2,SET,145,0.023446,0.0020744,0.07374,0.37526,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.973228171168482
HP_BLINDNESS,SET,266,0.016588,0.0019812,0.052175,0.37527,HP_BLINDNESS,0.973228171168482
GOBP_REGULATION_OF_TRANSLATI...6,SET,15,0.069735,0.0019915,0.21936,0.37528,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS,0.973228171168482
HP_DEMENTIA,SET,188,0.020136,0.0020262,0.063344,0.37529,HP_DEMENTIA,0.973228171168482
GOBP_REGULATION_OF_PLATELET_...2,SET,29,0.055882,0.0022181,0.17599,0.37542,GOBP_REGULATION_OF_PLATELET_AGGREGATION,0.973492658360069
MIR4530,SET,133,0.024444,0.002072,0.077065,0.37555,MIR4530,0.973757106087735
GSE5589_IL6_KO_VS_IL10_KO_LP...4,SET,182,0.020514,0.0020314,0.064741,0.37567,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.973995587467363
GSE17974_IL4_AND_ANTI_IL12_V...15,SET,173,0.020798,0.0020083,0.065671,0.37574,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN,0.974057675095099
HP_LARGE_ILIAC_WING,SET,3,0.1529,0.0019533,0.48284,0.37575,HP_LARGE_ILIAC_WING,0.974057675095099
GOMF_MELANOCORTIN_RECEPTOR_B...,SET,5,0.12506,0.0020625,0.39553,0.37593,GOMF_MELANOCORTIN_RECEPTOR_BINDING,0.974404854948169
GSE26156_DOUBLE_POSITIVE_VS_...1,SET,185,0.019261,0.0019228,0.06092,0.37594,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.974404854948169
KANNAN_BLOOD_2012_2013_TIV_A...1,SET,297,0.015138,0.0019088,0.0479,0.37599,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN,0.974440947729476
MIR4496,SET,268,0.017265,0.0020697,0.05464,0.37601,MIR4496,0.974440947729476
GOBP_NUCLEAR_PORE_COMPLEX_AS...,SET,11,0.074258,0.0018162,0.23512,0.37607,GOBP_NUCLEAR_PORE_COMPLEX_ASSEMBLY,0.97445111831805
HP_ABNORMAL_CERVICAL_SPINE_M...,SET,19,0.062689,0.0020146,0.1985,0.37607,HP_ABNORMAL_CERVICAL_SPINE_MORPHOLOGY,0.97445111831805
MCAATNNNNNGCG_UNKNOWN,SET,74,0.032955,0.002087,0.10438,0.3761,MCAATNNNNNGCG_UNKNOWN,0.974456202475026
HP_HEPATIC_VEIN_THROMBOSIS,SET,9,0.089369,0.0019772,0.28334,0.37623,HP_HEPATIC_VEIN_THROMBOSIS,0.974720361535595
GOCC_MYOSIN_COMPLEX,SET,55,0.03908,0.0021347,0.124,0.37632,GOCC_MYOSIN_COMPLEX,0.974880858676207
REACTOME_DOPAMINE_NEUROTRANS...,SET,20,0.063603,0.002097,0.20192,0.37639,REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.974989524483864
GOBP_REGULATION_OF_UBIQUITIN...3,SET,34,0.044387,0.0019074,0.14097,0.37643,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.97502046877329
HP_SNORING,SET,6,0.11467,0.0020716,0.36468,0.37659,HP_SNORING,0.975027032354035
MIR370_3P,SET,88,0.028438,0.0019631,0.090473,0.37664,MIR370_3P,0.975027032354035
GOBP_CELL_JUNCTION_ORGANIZAT...,SET,705,0.01084,0.002082,0.034491,0.37665,GOBP_CELL_JUNCTION_ORGANIZATION,0.975027032354035
FIGUEROA_AML_METHYLATION_CLU...2,SET,105,0.026654,0.002009,0.084826,0.37668,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,0.975027032354035
GOBP_GLYCINE_IMPORT_ACROSS_P...,SET,5,0.14257,0.0023512,0.45384,0.37671,GOBP_GLYCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.975027032354035
GOBP_VESICLE_TARGETING_ROUGH...,SET,24,0.050413,0.0018206,0.1605,0.37672,GOBP_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI,0.975027032354035
KEGG_MEDICUS_VARIANT_CDH1_RE...,SET,8,0.091903,0.001917,0.29263,0.37674,KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.975027032354035
GOBP_NEURON_INTRINSIC_APOPTO...,SET,18,0.06733,0.0021061,0.21455,0.37683,GOBP_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,0.975027032354035
FAN_OVARY_CL16_LYMPHATIC_END...,SET,206,0.019674,0.0020712,0.062693,0.37684,FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL,0.975027032354035
GOBP_REGULATION_OF_PROTEIN_T...2,SET,31,0.047425,0.0019461,0.15121,0.3769,GOBP_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.975027032354035
GOBP_SARCOMERE_ORGANIZATION,SET,50,0.038299,0.001995,0.12212,0.3769,GOBP_SARCOMERE_ORGANIZATION,0.975027032354035
KEGG_MEDICUS_REFERENCE_REGUL...8,SET,19,0.0688,0.002211,0.21937,0.37691,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP,0.975027032354035
HP_CHEST_PAIN,SET,127,0.024999,0.002071,0.079733,0.37694,HP_CHEST_PAIN,0.975027032354035
HP_ABNORMAL_ELECTRORETINOGRAM,SET,188,0.020175,0.0020301,0.064359,0.37696,HP_ABNORMAL_ELECTRORETINOGRAM,0.975027032354035
MODULE_573,SET,24,0.056635,0.0020453,0.18073,0.377,MODULE_573,0.975027032354035
GSE40666_UNTREATED_VS_IFNA_S...2,SET,147,0.022863,0.0020365,0.072968,0.37702,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP,0.975027032354035
MORF_XRCC5,SET,210,0.017088,0.0018161,0.054543,0.37703,MORF_XRCC5,0.975027032354035
GOBP_PHOSPHOLIPID_TRANSPORT,SET,95,0.027685,0.0019853,0.088372,0.37704,GOBP_PHOSPHOLIPID_TRANSPORT,0.975027032354035
PID_LYMPH_ANGIOGENESIS_PATHW...,SET,24,0.059048,0.0021325,0.18852,0.37706,PID_LYMPH_ANGIOGENESIS_PATHWAY,0.975027032354035
NFY_C,SET,212,0.018875,0.0020155,0.06026,0.37706,NFY_C,0.975027032354035
GOMF_MEMBRANE_POTENTIAL_DRIV...,SET,5,0.14194,0.0023409,0.45317,0.37706,GOMF_MEMBRANE_POTENTIAL_DRIVEN_UNIPORTER_ACTIVITY,0.975027032354035
GOBP_INTERNAL_PEPTIDYL_LYSIN...,SET,8,0.078843,0.0016446,0.25179,0.37709,GOBP_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION,0.975027032354035
GOBP_REGULATION_OF_NOTCH_SIG...,SET,86,0.029584,0.002019,0.094491,0.37711,GOBP_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.975027032354035
KAAB_HEART_ATRIUM_VS_VENTRIC...2,SET,233,0.01831,0.0020485,0.058499,0.37715,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,0.975027032354035
GOBP_ECTOPIC_GERM_CELL_PROGR...,SET,17,0.064524,0.0019615,0.2062,0.37717,GOBP_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH,0.975027032354035
REACTOME_SIGNALING_BY_ACTIVIN,SET,16,0.072707,0.0021443,0.23235,0.37718,REACTOME_SIGNALING_BY_ACTIVIN,0.975027032354035
GSE33162_UNTREATED_VS_4H_LPS...2,SET,183,0.019707,0.0019567,0.06299,0.37719,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP,0.975027032354035
BOYLAN_MULTIPLE_MYELOMA_PCA3...2,SET,75,0.034677,0.0022108,0.1109,0.37726,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,0.975067961778703
GSE9988_LOW_LPS_VS_ANTI_TREM...2,SET,176,0.020625,0.0020086,0.065966,0.37727,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.975067961778703
ARID5B_TARGET_GENES,SET,725,0.010052,0.0019567,0.032155,0.37729,ARID5B_TARGET_GENES,0.975067961778703
WP_BIOGENIC_AMINE_SYNTHESIS,SET,13,0.077423,0.0020585,0.24783,0.37737,WP_BIOGENIC_AMINE_SYNTHESIS,0.975202197189382
GOBP_POSITIVE_REGULATION_OF_...317,SET,8,0.095056,0.0019828,0.3044,0.37742,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.975258892193308
MIR4482_5P,SET,32,0.047175,0.0019668,0.15121,0.37753,MIR4482_5P,0.975388079519323
TONKS_TARGETS_OF_RUNX1_RUNX1...10,SET,7,0.10961,0.0021389,0.35156,0.3776,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN,0.975388079519323
HP_LEUKONYCHIA,SET,14,0.073779,0.0020356,0.23668,0.37763,HP_LEUKONYCHIA,0.975388079519323
HP_MARCUS_GUNN_JAW_WINKING_S...,SET,10,0.091368,0.0021307,0.29317,0.37765,HP_MARCUS_GUNN_JAW_WINKING_SYNKINESIS,0.975388079519323
GSE19198_6H_VS_24H_IL21_TREA...2,SET,179,0.020653,0.0020283,0.066291,0.37769,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP,0.975388079519323
GOBP_AMINOGLYCAN_CATABOLIC_P...,SET,32,0.048465,0.0020206,0.15558,0.37771,GOBP_AMINOGLYCAN_CATABOLIC_PROCESS,0.975388079519323
GOBP_REGULATION_OF_INSULIN_S...1,SET,157,0.022279,0.0020504,0.071537,0.37774,GOBP_REGULATION_OF_INSULIN_SECRETION,0.975388079519323
GOCC_PERICHROMATIN_FIBRILS,SET,6,0.11148,0.002014,0.35799,0.37774,GOCC_PERICHROMATIN_FIBRILS,0.975388079519323
MIR3943,SET,39,0.043682,0.0020101,0.14031,0.37778,MIR3943,0.975388079519323
WP_MIRNAS_INVOLVED_IN_DNA_DA...,SET,14,0.072442,0.0019987,0.23271,0.37779,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,0.975388079519323
GOBP_CELLULAR_COMPONENT_DISA...2,SET,31,0.047613,0.0019539,0.15296,0.3778,GOBP_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.975388079519323
GSE22886_NAIVE_CD4_TCELL_VS_...9,SET,188,0.019639,0.0019761,0.063114,0.37784,GSE22886_NAIVE_CD4_TCELL_VS_DC_DN,0.975388079519323
KEGG_MEDICUS_PATHOGEN_SALMON...1,SET,6,0.10771,0.0019459,0.3464,0.37792,KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.975388079519323
HP_SPEECH_ARTICULATION_DIFFI...,SET,29,0.054593,0.0021669,0.17559,0.37793,HP_SPEECH_ARTICULATION_DIFFICULTIES,0.975388079519323
GOBP_GTP_BIOSYNTHETIC_PROCESS,SET,10,0.085021,0.0019827,0.27361,0.378,GOBP_GTP_BIOSYNTHETIC_PROCESS,0.975388079519323
GOBP_C21_STEROID_HORMONE_MET...,SET,35,0.050032,0.0021813,0.16102,0.37801,GOBP_C21_STEROID_HORMONE_METABOLIC_PROCESS,0.975388079519323
REACTOME_TRISTETRAPROLIN_TTP...,SET,16,0.064634,0.0019063,0.20805,0.37803,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,0.975388079519323
GSE36891_POLYIC_TLR3_VS_PAM_...2,SET,140,0.024232,0.0021069,0.078032,0.37808,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.975388079519323
MIR4435,SET,79,0.029491,0.0019294,0.094984,0.3781,MIR4435,0.975388079519323
HP_ABNORMAL_GREATER_SCIATIC_...,SET,19,0.061268,0.001969,0.19737,0.37812,HP_ABNORMAL_GREATER_SCIATIC_NOTCH_MORPHOLOGY,0.975388079519323
GSE24210_IL35_TREATED_VS_UNT...1,SET,183,0.020187,0.0020043,0.065031,0.37812,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN,0.975388079519323
HP_ABNORMAL_CIRCULATING_LONG...,SET,16,0.06324,0.0018652,0.20377,0.37815,HP_ABNORMAL_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.975388079519323
HE_LIM_SUN_FETAL_LUNG_C2_PLA...,SET,316,0.015175,0.0019727,0.04891,0.37818,HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL,0.975388079519323
HP_CNS_HYPOMYELINATION,SET,79,0.02811,0.001839,0.090605,0.37819,HP_CNS_HYPOMYELINATION,0.975388079519323
GSE23321_CD8_STEM_CELL_MEMOR...6,SET,168,0.020396,0.0019411,0.06575,0.3782,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.975388079519323
REACTOME_MEIOSIS,SET,56,0.033227,0.0018314,0.10713,0.37823,REACTOME_MEIOSIS,0.975388079519323
HP_ABNORMAL_PULMONARY_VEIN_M...,SET,66,0.031772,0.0019006,0.10246,0.37824,HP_ABNORMAL_PULMONARY_VEIN_MORPHOLOGY,0.975388079519323
MCMURRAY_TP53_HRAS_COOPERATI...1,SET,64,0.0361,0.0021266,0.11644,0.37827,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,0.975388079519323
MIR200A_3P,SET,366,0.014602,0.0020401,0.047107,0.37829,MIR200A_3P,0.975388079519323
MODULE_362,SET,19,0.06822,0.0021924,0.22018,0.37834,MODULE_362,0.975388079519323
GSE41867_NAIVE_VS_DAY30_LCMV...1,SET,175,0.019264,0.0018709,0.062171,0.37834,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN,0.975388079519323
GAUTAM_EYE_IRIS_CILIARY_BODY...9,SET,202,0.018171,0.0018946,0.058717,0.37848,GAUTAM_EYE_IRIS_CILIARY_BODY_MELANOCYTES,0.975442064903312
GOBP_MALE_GAMETE_GENERATION,SET,530,0.011366,0.0019021,0.036735,0.37851,GOBP_MALE_GAMETE_GENERATION,0.975442064903312
HP_INCREASED_SERUM_ESTRADIOL,SET,8,0.095345,0.0019888,0.30821,0.37853,HP_INCREASED_SERUM_ESTRADIOL,0.975442064903312
VALK_AML_WITH_EVI1,SET,22,0.06291,0.0021753,0.20341,0.37856,VALK_AML_WITH_EVI1,0.975442064903312
GOBP_NEGATIVE_REGULATION_OF_...311,SET,26,0.055619,0.0020905,0.17988,0.37859,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.975442064903312
GOCC_FIBRILLAR_CENTER,SET,134,0.022096,0.0018799,0.071472,0.3786,GOCC_FIBRILLAR_CENTER,0.975442064903312
REACTOME_COPII_MEDIATED_VESI...,SET,66,0.030922,0.0018497,0.10004,0.37863,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,0.975442064903312
GOBP_REGULATION_OF_PRE_MIRNA...,SET,5,0.11653,0.0019219,0.3771,0.37866,GOBP_REGULATION_OF_PRE_MIRNA_PROCESSING,0.975442064903312
REACTOME_ATF6_ATF6_ALPHA_ACT...2,SET,10,0.075056,0.0017503,0.24291,0.37867,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,0.975442064903312
GSE3982_EFF_MEMORY_VS_CENT_M...1,SET,172,0.019862,0.0019125,0.064296,0.3787,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN,0.975442064903312
HP_ABNORMAL_BLOOD_MONOVALENT...,SET,140,0.023469,0.0020405,0.075991,0.37873,HP_ABNORMAL_BLOOD_MONOVALENT_INORGANIC_CATION_CONCENTRATION,0.975442064903312
HP_PERSISTENT_OPEN_ANTERIOR_...,SET,7,0.087363,0.0017047,0.28302,0.37878,HP_PERSISTENT_OPEN_ANTERIOR_FONTANELLE,0.975442064903312
GOBP_GLYCOSYL_COMPOUND_BIOSY...,SET,21,0.055818,0.0018858,0.18086,0.3788,GOBP_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS,0.975442064903312
VILLANUEVA_LIVER_CANCER_KRT1...1,SET,55,0.034794,0.0019006,0.11274,0.37881,VILLANUEVA_LIVER_CANCER_KRT19_DN,0.975442064903312
MIR6812_5P,SET,62,0.032987,0.0019127,0.10688,0.37881,MIR6812_5P,0.975442064903312
HP_EXTERNAL_OPHTHALMOPLEGIA,SET,51,0.035685,0.0018773,0.11563,0.37881,HP_EXTERNAL_OPHTHALMOPLEGIA,0.975442064903312
GOBP_HEAT_ACCLIMATION,SET,5,0.12799,0.0021109,0.41495,0.37887,GOBP_HEAT_ACCLIMATION,0.975466953043994
WOOD_EBV_EBNA1_TARGETS_UP,SET,103,0.027287,0.0020371,0.088512,0.37893,WOOD_EBV_EBNA1_TARGETS_UP,0.975466953043994
HP_ANTEVERTED_EARS,SET,10,0.088856,0.0020721,0.28823,0.37894,HP_ANTEVERTED_EARS,0.975466953043994
GSE29618_BCELL_VS_MDC_DAY7_F...1,SET,183,0.02024,0.0020096,0.065654,0.37894,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN,0.975466953043994
HP_ABNORMAL_LIVER_METABOLITE...,SET,182,0.019178,0.001899,0.062218,0.37896,HP_ABNORMAL_LIVER_METABOLITE_CONCENTRATION,0.975466953043994
GOMF_HISTONE_ACETYLTRANSFERA...,SET,23,0.055445,0.0019602,0.17996,0.379,GOMF_HISTONE_ACETYLTRANSFERASE_BINDING,0.975476903139811
GOMF_RETINOIC_ACID_BINDING,SET,26,0.067309,0.0025299,0.21849,0.37902,GOMF_RETINOIC_ACID_BINDING,0.975476903139811
MIR8075,SET,90,0.029281,0.0020441,0.095103,0.37909,MIR8075,0.975584816734543
HUANG_GATA2_TARGETS_DN,SET,66,0.032587,0.0019493,0.10588,0.37913,HUANG_GATA2_TARGETS_DN,0.975615515326522
RAMJAUN_APOPTOSIS_BY_TGFB1_V...1,SET,8,0.10331,0.002155,0.33608,0.37927,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN,0.975903520396831
CAIRO_HEPATOBLASTOMA_UP,SET,190,0.019467,0.0019692,0.06339,0.37938,CAIRO_HEPATOBLASTOMA_UP,0.9760183244916
GOBP_RESPONSE_TO_RETINOIC_AC...,SET,101,0.028641,0.0021174,0.093286,0.37942,GOBP_RESPONSE_TO_RETINOIC_ACID,0.9760183244916
GSE37534_UNTREATED_VS_ROSIGL...2,SET,178,0.019529,0.0019126,0.063677,0.37954,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.9760183244916
GATA2_01,SET,99,0.02721,0.0019917,0.088726,0.37955,GATA2_01,0.9760183244916
PODAR_RESPONSE_TO_ADAPHOSTIN...2,SET,127,0.025297,0.0020956,0.082511,0.37958,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,0.9760183244916
GSE13229_IMM_VS_INTMATURE_NK...1,SET,177,0.018711,0.0018274,0.061028,0.37958,GSE13229_IMM_VS_INTMATURE_NKCELL_DN,0.9760183244916
ACEVEDO_LIVER_CANCER_UP,SET,860,0.0089709,0.0018946,0.029262,0.37959,ACEVEDO_LIVER_CANCER_UP,0.9760183244916
MIR3619_3P,SET,49,0.044549,0.0022973,0.14535,0.37961,MIR3619_3P,0.9760183244916
BIOCARTA_HER2_PATHWAY,SET,23,0.054683,0.0019333,0.17843,0.37962,BIOCARTA_HER2_PATHWAY,0.9760183244916
GOBP_NEUTROPHIL_DIFFERENTIAT...,SET,11,0.083011,0.0020303,0.27091,0.37964,GOBP_NEUTROPHIL_DIFFERENTIATION,0.9760183244916
MIR942_3P,SET,104,0.025507,0.0019133,0.083244,0.37965,MIR942_3P,0.9760183244916
GSE14769_UNSTIM_VS_360MIN_LP...1,SET,192,0.018686,0.0018999,0.061004,0.37969,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN,0.9760183244916
WP_PHOTODYNAMIC_THERAPYINDUC...4,SET,34,0.047683,0.0020491,0.15574,0.37974,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,0.9760183244916
MIR3179,SET,117,0.023012,0.0018302,0.075159,0.37974,MIR3179,0.9760183244916
GSE37532_WT_VS_PPARG_KO_LN_T...1,SET,166,0.020005,0.0018927,0.065346,0.37975,GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN,0.9760183244916
GOBP_GERM_CELL_MIGRATION,SET,9,0.10125,0.00224,0.33095,0.37983,GOBP_GERM_CELL_MIGRATION,0.9760183244916
HP_FUNCTIONAL_ABNORMALITY_OF...2,SET,1080,0.0082875,0.0019491,0.027099,0.37987,HP_FUNCTIONAL_ABNORMALITY_OF_THE_GASTROINTESTINAL_TRACT,0.9760183244916
GSE17301_CTRL_VS_48H_ACD3_AC...2,SET,178,0.01926,0.0018862,0.062986,0.37989,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP,0.9760183244916
GOBP_POSITIVE_REGULATION_OF_...751,SET,14,0.061506,0.0016969,0.20118,0.37991,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_RNA_LOCALIZATION_TO_CAJAL_BODY,0.9760183244916
GSE40274_CTRL_VS_GATA1_TRANS...1,SET,148,0.02154,0.0019252,0.070522,0.38002,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.9760183244916
GOBP_REGULATION_OF_NON_CANON...2,SET,26,0.054981,0.0020665,0.18006,0.38005,GOBP_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.9760183244916
CEBP_Q2,SET,205,0.018674,0.0019612,0.061158,0.38006,CEBP_Q2,0.9760183244916
HP_ABNORMAL_RENAL_VASCULAR_M...,SET,24,0.049732,0.001796,0.1629,0.38007,HP_ABNORMAL_RENAL_VASCULAR_MORPHOLOGY,0.9760183244916
GSE3039_NKT_CELL_VS_ALPHAALP...2,SET,185,0.019864,0.001983,0.06508,0.3801,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP,0.9760183244916
DESCARTES_FETAL_INTESTINE_EN...2,SET,131,0.024904,0.0020951,0.081611,0.38012,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.9760183244916
GSE30971_2H_VS_4H_LPS_STIM_M...1,SET,152,0.022259,0.0020159,0.072952,0.38014,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN,0.9760183244916
MIR628_5P,SET,75,0.031697,0.0020207,0.10389,0.38015,MIR628_5P,0.9760183244916
HP_PALMOPLANTAR_ERYTHEMA,SET,5,0.14363,0.0023688,0.47093,0.38019,HP_PALMOPLANTAR_ERYTHEMA,0.9760183244916
GSE40685_TREG_VS_FOXP3_KO_TR...1,SET,182,0.019532,0.0019341,0.064053,0.38021,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.9760183244916
HP_PROLONGED_QTC_INTERVAL,SET,28,0.053614,0.0020911,0.17594,0.38029,HP_PROLONGED_QTC_INTERVAL,0.9760183244916
BUSSLINGER_ESOPHAGEAL_LATE_S...,SET,130,0.025182,0.0021104,0.082639,0.38029,BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS,0.9760183244916
HU_GENOTOXIC_DAMAGE_4HR,SET,34,0.043704,0.001878,0.14343,0.3803,HU_GENOTOXIC_DAMAGE_4HR,0.9760183244916
MIR581,SET,73,0.029665,0.0018659,0.097401,0.38035,MIR581,0.9760183244916
CUI_DEVELOPING_HEART_COMPACT...2,SET,58,0.036597,0.0020527,0.12016,0.38035,CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE,0.9760183244916
HP_CONGENITAL_POSTERIOR_URET...,SET,8,0.087463,0.0018244,0.2873,0.3804,HP_CONGENITAL_POSTERIOR_URETHRAL_VALVE,0.9760183244916
HP_RETINAL_HOLE,SET,5,0.11933,0.0019679,0.39198,0.38041,HP_RETINAL_HOLE,0.9760183244916
HP_DIFFUSE_DEMYELINATION_OF_...,SET,8,0.096885,0.002021,0.31848,0.38049,HP_DIFFUSE_DEMYELINATION_OF_THE_CEREBRAL_WHITE_MATTER,0.9760183244916
MIR5695,SET,87,0.028317,0.0019437,0.093107,0.38052,MIR5695,0.9760183244916
GOBP_GLUCOCORTICOID_METABOLI...,SET,24,0.054397,0.0019645,0.17887,0.38052,GOBP_GLUCOCORTICOID_METABOLIC_PROCESS,0.9760183244916
chr11p11,SET,62,0.069139,0.004009,0.22737,0.38054,chr11p11,0.9760183244916
MIR12129,SET,131,0.023828,0.0020045,0.078381,0.38057,MIR12129,0.9760183244916
GSE19512_NAUTRAL_VS_INDUCED_...2,SET,179,0.02018,0.0019819,0.066382,0.38057,GSE19512_NAUTRAL_VS_INDUCED_TREG_UP,0.9760183244916
GOBP_CARDIAC_MUSCLE_TISSUE_M...,SET,58,0.037802,0.0021203,0.12444,0.38065,GOBP_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.9760183244916
MIR6755_5P,SET,32,0.044468,0.0018539,0.14642,0.38068,MIR6755_5P,0.9760183244916
WILLERT_WNT_SIGNALING,SET,21,0.053939,0.0018223,0.17769,0.38073,WILLERT_WNT_SIGNALING,0.9760183244916
GOBP_NEGATIVE_REGULATION_OF_...112,SET,242,0.017578,0.0020038,0.05794,0.3808,GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT,0.9760183244916
GOMF_L_ORNITHINE_TRANSMEMBRA...,SET,4,0.15742,0.0023222,0.5189,0.3808,GOMF_L_ORNITHINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.9760183244916
MIR6826_3P,SET,93,0.025902,0.0018379,0.085398,0.38083,MIR6826_3P,0.9760183244916
MIR6831_5P,SET,106,0.025681,0.0019447,0.084679,0.38084,MIR6831_5P,0.9760183244916
GOCC_ESCRT_COMPLEX,SET,29,0.047267,0.0018761,0.15585,0.38084,GOCC_ESCRT_COMPLEX,0.9760183244916
HP_HAND_MUSCLE_WEAKNESS,SET,43,0.036995,0.0017874,0.12202,0.38088,HP_HAND_MUSCLE_WEAKNESS,0.9760183244916
PID_TCR_PATHWAY,SET,59,0.032299,0.0018271,0.10662,0.38097,PID_TCR_PATHWAY,0.9760183244916
GOBP_U4_SNRNA_3_END_PROCESSI...,SET,7,0.092453,0.001804,0.30527,0.381,GOBP_U4_SNRNA_3_END_PROCESSING,0.9760183244916
HP_LOW_SERUM_CALCITRIOL,SET,7,0.10344,0.0020185,0.34157,0.381,HP_LOW_SERUM_CALCITRIOL,0.9760183244916
MIR3935,SET,70,0.030284,0.0018655,0.10001,0.38102,MIR3935,0.9760183244916
GSE45365_HEALTHY_VS_MCMV_INF...12,SET,153,0.020642,0.0018756,0.068175,0.38103,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP,0.9760183244916
KEGG_MEDICUS_REFERENCE_PURIN...1,SET,11,0.080227,0.0019622,0.26499,0.38104,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP,0.9760183244916
GOBP_REGULATION_OF_ALPHA_BET...1,SET,107,0.027181,0.0020679,0.08978,0.38104,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.9760183244916
GOMF_DIPEPTIDE_TRANSMEMBRANE...,SET,5,0.12245,0.0020195,0.40447,0.38104,GOMF_DIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.9760183244916
GSE28737_FOLLICULAR_VS_MARGI...1,SET,184,0.01945,0.0019364,0.064257,0.38107,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN,0.9760183244916
GOBP_CELLULAR_RESPONSE_TO_OX...2,SET,11,0.080271,0.0019633,0.26527,0.3811,GOBP_CELLULAR_RESPONSE_TO_OXIDISED_LOW_DENSITY_LIPOPROTEIN_PARTICLE_STIMULUS,0.9760183244916
LEIN_PONS_MARKERS,SET,79,0.029958,0.0019599,0.099011,0.38111,LEIN_PONS_MARKERS,0.9760183244916
HP_HYPERINSULINEMIC_HYPOGLYC...,SET,25,0.053117,0.0019578,0.17556,0.38111,HP_HYPERINSULINEMIC_HYPOGLYCEMIA,0.9760183244916
MODULE_471,SET,9,0.090604,0.0020045,0.29951,0.38113,MODULE_471,0.9760183244916
GSE22601_IMMATURE_CD4_SINGLE...3,SET,184,0.019738,0.001965,0.06525,0.38114,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.9760183244916
GSE36476_CTRL_VS_TSST_ACT_16...2,SET,170,0.020321,0.0019453,0.067229,0.38123,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP,0.976042862929955
GOBP_PYRIDINE_CONTAINING_COM...2,SET,91,0.025498,0.0017898,0.084367,0.38124,GOBP_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.976042862929955
HP_ABNORMAL_RESPONSE_TO_INSU...,SET,8,0.096108,0.0020048,0.31798,0.38124,HP_ABNORMAL_RESPONSE_TO_INSULIN_TOLERANCE_TEST,0.976042862929955
chr9p22,SET,20,0.11674,0.003849,0.38638,0.38128,chr9p22,0.976042862929955
MIR10392_3P,SET,5,0.10932,0.0018029,0.36185,0.38129,MIR10392_3P,0.976042862929955
GOBP_GLYCOLIPID_CATABOLIC_PR...,SET,20,0.059622,0.0019658,0.19746,0.38135,GOBP_GLYCOLIPID_CATABOLIC_PROCESS,0.976079922765723
HP_COMPULSIVE_BEHAVIORS,SET,137,0.022681,0.0019509,0.07513,0.38137,HP_COMPULSIVE_BEHAVIORS,0.976079922765723
MIR4695_3P,SET,70,0.031642,0.0019491,0.10489,0.38145,MIR4695_3P,0.976079922765723
CHEOK_RESPONSE_TO_MERCAPTOPU...4,SET,8,0.10434,0.0021764,0.34589,0.38146,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,0.976079922765723
KRIEG_HYPOXIA_VIA_KDM3A,SET,46,0.040689,0.0020331,0.13491,0.38148,KRIEG_HYPOXIA_VIA_KDM3A,0.976079922765723
MIR17_5P,SET,580,0.011043,0.0019305,0.036631,0.38154,MIR17_5P,0.976079922765723
REACTOME_CELLULAR_RESPONSES_...,SET,699,0.0097421,0.0018635,0.03232,0.38155,REACTOME_CELLULAR_RESPONSES_TO_STIMULI,0.976079922765723
GOBP_INTESTINAL_ABSORPTION,SET,40,0.041935,0.0019543,0.13914,0.38156,GOBP_INTESTINAL_ABSORPTION,0.976079922765723
HP_PALMOPLANTAR_BLISTERING,SET,11,0.078512,0.0019202,0.26062,0.38161,HP_PALMOPLANTAR_BLISTERING,0.976079922765723
MODULE_297,SET,72,0.031951,0.0019959,0.10607,0.38162,MODULE_297,0.976079922765723
GOBP_REGULATION_OF_POSTSYNAP...6,SET,83,0.02862,0.001919,0.095076,0.3817,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_NEUROTRANSMITTER_RECEPTOR_LEVELS,0.976079922765723
LOPEZ_TRANSLATION_VIA_FN1_SI...,SET,34,0.04671,0.0020072,0.15521,0.38173,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,0.976079922765723
COLE_BLOOD_FLUZONE_FLUARIX_A...,SET,7,0.11729,0.0022887,0.3898,0.38174,COLE_BLOOD_FLUZONE_FLUARIX_AGE_03_17YO_7DY_DN,0.976079922765723
GOMF_ATP_TRANSMEMBRANE_TRANS...,SET,12,0.07934,0.0020267,0.26371,0.38176,GOMF_ATP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976079922765723
GOMF_LIGAND_GATED_MONOATOMIC...3,SET,15,0.071927,0.002054,0.23913,0.38179,GOMF_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.976079922765723
GOCC_PROTON_TRANSPORTING_V_T...1,SET,24,0.052294,0.0018885,0.17387,0.3818,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX,0.976079922765723
BEGUM_TARGETS_OF_PAX3_FOXO1_...3,SET,54,0.038197,0.0020675,0.12701,0.38181,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.976079922765723
GOBP_POSITIVE_REGULATION_OF_...210,SET,199,0.018717,0.0019371,0.062238,0.38181,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.976079922765723
REACTOME_GLUCONEOGENESIS,SET,21,0.051892,0.0017531,0.17263,0.38186,REACTOME_GLUCONEOGENESIS,0.97613594439541
HP_VARICOSE_VEINS,SET,29,0.051023,0.0020252,0.16977,0.38189,HP_VARICOSE_VEINS,0.976140836213871
REACTOME_ACTIVATED_NTRK2_SIG...3,SET,7,0.10546,0.0020579,0.35114,0.38196,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN,0.976247962935726
HUMMERICH_SKIN_CANCER_PROGRE...1,SET,90,0.027323,0.0019074,0.09101,0.38201,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,0.976303959849989
HP_ABNORMAL_GALLBLADDER_PHYS...,SET,18,0.059575,0.0018635,0.19856,0.38208,HP_ABNORMAL_GALLBLADDER_PHYSIOLOGY,0.976364822439526
WANG_MLL_TARGETS,SET,273,0.016797,0.002032,0.055988,0.38209,WANG_MLL_TARGETS,0.976364822439526
MODULE_392,SET,14,0.070602,0.0019479,0.23551,0.38217,MODULE_392,0.976481630402823
WILLIAMS_ESR1_TARGETS_DN,SET,6,0.10199,0.0018425,0.34031,0.38221,WILLIAMS_ESR1_TARGETS_DN,0.976481630402823
GSE1925_CTRL_VS_IFNG_PRIMED_...1,SET,184,0.0194,0.0019315,0.064739,0.38222,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN,0.976481630402823
GSE360_HIGH_VS_LOW_DOSE_B_MA...4,SET,177,0.018188,0.0017763,0.060724,0.38227,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP,0.97652413349978
GSE14769_UNSTIM_VS_40MIN_LPS...2,SET,178,0.01969,0.0019284,0.065778,0.38234,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP,0.97652413349978
GOBP_REGULATION_OF_NEURONAL_...1,SET,3,0.17496,0.0022352,0.58455,0.38236,GOBP_REGULATION_OF_NEURONAL_ACTION_POTENTIAL,0.97652413349978
HP_ABNORMALITY_OF_THE_ENDOCR...,SET,1249,0.007479,0.0018823,0.024991,0.38237,HP_ABNORMALITY_OF_THE_ENDOCRINE_SYSTEM,0.97652413349978
GOBP_MITOCHONDRIAL_ELECTRON_...3,SET,5,0.092581,0.0015269,0.30948,0.38241,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_SUCCINATE_TO_UBIQUINONE,0.97652413349978
WP_DNA_DAMAGE_RESPONSE_ONLY_...,SET,108,0.02557,0.0019544,0.085527,0.38248,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,0.97652413349978
GOMF_RETINOIC_ACID_RESPONSIV...,SET,6,0.10212,0.0018448,0.34155,0.38248,GOMF_RETINOIC_ACID_RESPONSIVE_ELEMENT_BINDING,0.97652413349978
GOBP_REGULATION_OF_BLOOD_PRE...,SET,170,0.021135,0.0020233,0.070697,0.38249,GOBP_REGULATION_OF_BLOOD_PRESSURE,0.97652413349978
GOBP_PROTEIN_CONTAINING_COMP...1,SET,1375,0.006926,0.0018222,0.023179,0.38255,GOBP_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.97652413349978
HP_BONE_FRACTURE,SET,21,0.051253,0.0017315,0.17153,0.38255,HP_BONE_FRACTURE,0.97652413349978
GSE17721_CTRL_VS_CPG_24H_BMD...2,SET,180,0.01862,0.0018337,0.06234,0.38259,GSE17721_CTRL_VS_CPG_24H_BMDC_UP,0.97652413349978
ROY_WOUND_BLOOD_VESSEL_DN,SET,19,0.061044,0.0019618,0.20442,0.38261,ROY_WOUND_BLOOD_VESSEL_DN,0.97652413349978
WP_LEUKOTRIENE_METABOLIC_PAT...,SET,13,0.072135,0.0019179,0.2416,0.38263,WP_LEUKOTRIENE_METABOLIC_PATHWAY,0.97652413349978
GSE17186_BLOOD_VS_CORD_BLOOD...3,SET,182,0.0187,0.0018517,0.062629,0.38263,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN,0.97652413349978
GSE9037_CTRL_VS_LPS_4H_STIM_...3,SET,183,0.019339,0.0019202,0.064812,0.38271,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN,0.976605307917889
MODULE_525,SET,58,0.03284,0.0018419,0.11011,0.38276,MODULE_525,0.976605307917889
GSE411_WT_VS_SOCS3_KO_MACROP...3,SET,187,0.017648,0.0017711,0.059209,0.38283,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP,0.976605307917889
CAR_MYST2,SET,25,0.049885,0.0018386,0.16738,0.38284,CAR_MYST2,0.976605307917889
TTCYRGAA_UNKNOWN,SET,300,0.014989,0.0018994,0.050335,0.38294,TTCYRGAA_UNKNOWN,0.976605307917889
HP_SEVERE_LACTIC_ACIDOSIS,SET,11,0.077779,0.0019023,0.26121,0.38294,HP_SEVERE_LACTIC_ACIDOSIS,0.976605307917889
HP_DYSCHROMATOPSIA,SET,29,0.04946,0.0019632,0.16617,0.38299,HP_DYSCHROMATOPSIA,0.976605307917889
GAVISH_3CA_METAPROGRAM_B_CEL...2,SET,40,0.041281,0.0019238,0.13873,0.38302,GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE,0.976605307917889
GOBP_7_METHYLGUANOSINE_CAP_H...,SET,8,0.088468,0.0018454,0.2973,0.38302,GOBP_7_METHYLGUANOSINE_CAP_HYPERMETHYLATION,0.976605307917889
WP_SARSCOV2_MITOCHONDRIAL_CH...,SET,22,0.055331,0.0019133,0.18596,0.38303,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.976605307917889
MYB_Q5_01,SET,247,0.016333,0.0018808,0.054922,0.38308,MYB_Q5_01,0.976605307917889
GOBP_PROTEIN_TRANSPORT_TO_VA...,SET,15,0.061111,0.0017452,0.20548,0.38308,GOBP_PROTEIN_TRANSPORT_TO_VACUOLE_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.976605307917889
GOBP_REGULATION_OF_VENTRICUL...3,SET,22,0.058408,0.0020197,0.19639,0.38308,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.976605307917889
MIR27A_5P,SET,34,0.046683,0.0020061,0.15705,0.38314,MIR27A_5P,0.976605307917889
HP_APLASIA_HYPOPLASIA_OF_THE...40,SET,142,0.021555,0.0018874,0.072524,0.38315,HP_APLASIA_HYPOPLASIA_OF_THE_LUNGS,0.976605307917889
GARCIA_PINERES_PBMC_HPV_16_L...7,SET,125,0.023652,0.001944,0.079594,0.38317,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN,0.976605307917889
GOBP_REGULATION_OF_HEMOGLOBI...,SET,8,0.090706,0.0018921,0.30526,0.38318,GOBP_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.976605307917889
RIZ_ERYTHROID_DIFFERENTIATIO...4,SET,38,0.041544,0.0018871,0.13983,0.3832,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,0.976605307917889
HP_SPRENGEL_ANOMALY,SET,43,0.037649,0.001819,0.12672,0.3832,HP_SPRENGEL_ANOMALY,0.976605307917889
REACTOME_ROS_AND_RNS_PRODUCT...,SET,33,0.045885,0.0019426,0.15454,0.38327,REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,0.976605307917889
GOBP_REGULATION_OF_OXIDATIVE...1,SET,19,0.054648,0.0017562,0.18406,0.38327,GOBP_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION,0.976605307917889
REACTOME_NONSENSE_MEDIATED_D...,SET,103,0.024335,0.0018167,0.081969,0.38328,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,0.976605307917889
REACTOME_CREB1_PHOSPHORYLATI...3,SET,8,0.10147,0.0021166,0.34189,0.38331,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE,0.976610149549153
BIOCARTA_IL6_PATHWAY,SET,20,0.058831,0.0019397,0.1983,0.38336,BIOCARTA_IL6_PATHWAY,0.976665943410057
HP_ABSENT_HAIR,SET,56,0.035641,0.0019644,0.12018,0.38341,HP_ABSENT_HAIR,0.976705921582997
KEGG_ARRHYTHMOGENIC_RIGHT_VE...,SET,70,0.032038,0.0019735,0.10809,0.38346,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,0.976705921582997
WP_ARRHYTHMOGENIC_RIGHT_VENT...,SET,70,0.032038,0.0019735,0.10809,0.38346,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,0.976705921582997
HP_ABNORMAL_HEMOGLOBIN,SET,65,0.031177,0.0018509,0.10523,0.38351,HP_ABNORMAL_HEMOGLOBIN,0.976761692070937
CERVERA_SDHB_TARGETS_1_DN,SET,34,0.046657,0.002005,0.15754,0.38356,CERVERA_SDHB_TARGETS_1_DN,0.97681341677646
ZHENG_FOXP3_TARGETS_IN_T_LYM...2,SET,12,0.072023,0.0018398,0.24335,0.38363,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP,0.97681341677646
chr6q14,SET,36,0.066813,0.0029542,0.22588,0.3837,chr6q14,0.97681341677646
GAVISH_3CA_METAPROGRAM_FIBRO...12,SET,42,0.042072,0.002009,0.14229,0.38374,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_COMPLEMENT,0.97681341677646
GSE22282_HYPOXIA_VS_NORMOXIA...1,SET,178,0.019715,0.0019308,0.066676,0.38374,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN,0.97681341677646
GSE46606_IRF4HIGH_VS_WT_CD40...2,SET,177,0.018386,0.0017956,0.062217,0.3838,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.97681341677646
HP_APLASTIC_HYPOPLASTIC_TOEN...,SET,105,0.02493,0.001879,0.084394,0.38384,HP_APLASTIC_HYPOPLASTIC_TOENAIL,0.97681341677646
GOBP_NEURON_REMODELING,SET,15,0.076356,0.0021805,0.25848,0.38385,GOBP_NEURON_REMODELING,0.97681341677646
GOBP_REGULATION_OF_P38MAPK_C...,SET,41,0.043078,0.0020324,0.14588,0.38388,GOBP_REGULATION_OF_P38MAPK_CASCADE,0.97681341677646
GOBP_SPERM_CAPACITATION,SET,29,0.048045,0.001907,0.16274,0.38391,GOBP_SPERM_CAPACITATION,0.97681341677646
KOKKINAKIS_METHIONINE_DEPRIV...4,SET,113,0.025133,0.0019647,0.085149,0.38394,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,0.97681341677646
REACTOME_ATF4_ACTIVATES_GENE...,SET,26,0.049814,0.0018723,0.16879,0.38395,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.97681341677646
GOBP_HIPPOCAMPAL_NEURON_APOP...,SET,6,0.11603,0.0020962,0.39316,0.38395,GOBP_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,0.97681341677646
REACTOME_ONCOGENE_INDUCED_SE...,SET,32,0.045789,0.001909,0.15516,0.38396,REACTOME_ONCOGENE_INDUCED_SENESCENCE,0.97681341677646
GOBP_ENDOPLASMIC_RETICULUM_T...2,SET,126,0.0214,0.0017659,0.072524,0.38397,GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.97681341677646
DARWICHE_PAPILLOMA_PROGRESSI...,SET,72,0.030207,0.001887,0.10238,0.38398,DARWICHE_PAPILLOMA_PROGRESSION_RISK,0.97681341677646
ZBTB5_TARGET_GENES,SET,396,0.013066,0.0018972,0.044349,0.38414,ZBTB5_TARGET_GENES,0.97714892044207
HP_ABNORMALITY_OF_ENDOCRINE_...,SET,28,0.052399,0.0020437,0.17796,0.38421,HP_ABNORMALITY_OF_ENDOCRINE_PANCREAS_PHYSIOLOGY,0.977255455942623
SIMBULAN_UV_RESPONSE_NORMAL_...1,SET,33,0.04767,0.0020182,0.16194,0.38424,SIMBULAN_UV_RESPONSE_NORMAL_DN,0.977260241492865
REACTOME_PROTEIN_UBIQUITINAT...,SET,57,0.031709,0.0017632,0.10774,0.38427,REACTOME_PROTEIN_UBIQUITINATION,0.977265026342748
GSE34156_TLR1_TLR2_LIGAND_VS...4,SET,185,0.019577,0.0019543,0.066594,0.38439,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.977338249488154
BIOCARTA_ERAD_PATHWAY,SET,19,0.05513,0.0017717,0.18762,0.38444,BIOCARTA_ERAD_PATHWAY,0.977338249488154
FREAC7_01,SET,173,0.020506,0.0019801,0.069784,0.38444,FREAC7_01,0.977338249488154
KEGG_MEDICUS_REFERENCE_WEE1_...,SET,6,0.085454,0.0015438,0.29084,0.38445,KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M,0.977338249488154
KEGG_MEDICUS_REFERENCE_N_GLY...4,SET,7,0.072654,0.0014177,0.2473,0.38446,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL,0.977338249488154
GSE25088_WT_VS_STAT6_KO_MACR...2,SET,178,0.018369,0.001799,0.06254,0.38449,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN,0.977338249488154
GOBP_MUSCLE_CELL_CELLULAR_HO...,SET,21,0.052004,0.0017569,0.17709,0.38451,GOBP_MUSCLE_CELL_CELLULAR_HOMEOSTASIS,0.977338249488154
GOBP_GLYCEROLIPID_METABOLIC_...,SET,357,0.01348,0.0018605,0.045928,0.38457,GOBP_GLYCEROLIPID_METABOLIC_PROCESS,0.977338249488154
GOMF_RIBOSOMAL_SMALL_SUBUNIT...,SET,15,0.060571,0.0017297,0.20638,0.38458,GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING,0.977338249488154
HP_HYPOPLASTIC_LABIA_MINORA,SET,28,0.052445,0.0020455,0.1787,0.38458,HP_HYPOPLASTIC_LABIA_MINORA,0.977338249488154
WIERENGA_STAT5A_TARGETS_UP,SET,186,0.01947,0.0019488,0.066448,0.38476,WIERENGA_STAT5A_TARGETS_UP,0.977652712384852
KEGG_MEDICUS_REFERENCE_KINET...2,SET,19,0.063548,0.0020422,0.21689,0.38476,KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT,0.977652712384852
HP_ELEVATED_TISSUE_NON_SPECI...,SET,17,0.062848,0.0019106,0.21465,0.38484,HP_ELEVATED_TISSUE_NON_SPECIFIC_ALKALINE_PHOSPHATASE,0.977784501791067
HP_ANOTIA,SET,12,0.069675,0.0017798,0.23816,0.38493,HP_ANOTIA,0.977843073213503
MIR576_5P,SET,313,0.01461,0.0018904,0.049946,0.38494,MIR576_5P,0.977843073213503
LIEN_BREAST_CARCINOMA_METAPL...1,SET,32,0.050104,0.0020889,0.17132,0.38497,LIEN_BREAST_CARCINOMA_METAPLASTIC,0.977843073213503
WINNEPENNINCKX_MELANOMA_META...1,SET,38,0.044977,0.0020431,0.15381,0.38498,WINNEPENNINCKX_MELANOMA_METASTASIS_DN,0.977843073213503
HE_LIM_SUN_FETAL_LUNG_C3_DEF...1,SET,23,0.050675,0.0017916,0.17337,0.38503,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROBLAST,0.977843073213503
MOOTHA_FFA_OXYDATION,SET,22,0.052976,0.0018318,0.18128,0.38506,MOOTHA_FFA_OXYDATION,0.977843073213503
GSE17974_CTRL_VS_ACT_IL4_AND...17,SET,169,0.018612,0.0017765,0.063691,0.38506,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN,0.977843073213503
HOLLERN_EMT_BREAST_TUMOR_UP,SET,128,0.022893,0.0019039,0.078403,0.38515,HOLLERN_EMT_BREAST_TUMOR_UP,0.977850821587673
GOBP_THREONINE_METABOLIC_PRO...,SET,4,0.13229,0.0019515,0.45317,0.38517,GOBP_THREONINE_METABOLIC_PROCESS,0.977850821587673
HP_ANGULAR_CHEILITIS,SET,11,0.083888,0.0020517,0.28738,0.38518,HP_ANGULAR_CHEILITIS,0.977850821587673
GSE4590_PRE_BCELL_VS_VPREB_P...1,SET,147,0.019337,0.0017224,0.066258,0.38521,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.977850821587673
HP_DECREASED_NASAL_NITRIC_OX...,SET,24,0.050286,0.001816,0.17233,0.38522,HP_DECREASED_NASAL_NITRIC_OXIDE,0.977850821587673
GAVISH_3CA_METAPROGRAM_FIBRO...2,SET,49,0.040839,0.0021059,0.14001,0.38526,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_10,0.977850821587673
HP_WIDENED_CEREBRAL_SUBARACH...,SET,3,0.18313,0.0023396,0.62778,0.38526,HP_WIDENED_CEREBRAL_SUBARACHNOID_SPACE,0.977850821587673
LET_7I_3P,SET,5,0.11224,0.001851,0.38493,0.38531,LET_7I_3P,0.977883930656934
GOMF_NON_MEMBRANE_SPANNING_P...1,SET,43,0.041902,0.0020245,0.14377,0.38536,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.977883930656934
KANG_AR_TARGETS_DN,SET,18,0.062854,0.0019661,0.21573,0.38539,KANG_AR_TARGETS_DN,0.977883930656934
HP_DEXTROTRANSPOSITION_OF_TH...,SET,5,0.09766,0.0016106,0.33521,0.3854,HP_DEXTROTRANSPOSITION_OF_THE_GREAT_ARTERIES,0.977883930656934
WP_NAD_BIOSYNTHETIC_PATHWAYS,SET,22,0.054903,0.0018984,0.18848,0.38542,WP_NAD_BIOSYNTHETIC_PATHWAYS,0.977883930656934
HP_ELEVATED_CIRCULATING_ALDO...,SET,6,0.090539,0.0016357,0.31092,0.38545,HP_ELEVATED_CIRCULATING_ALDOLASE_CONCENTRATION,0.977883930656934
GSE3039_ALPHAALPHA_CD8_TCELL...3,SET,182,0.018867,0.0018682,0.064803,0.38547,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN,0.977883930656934
RBM15_TARGET_GENES,SET,141,0.021363,0.001864,0.073433,0.38556,RBM15_TARGET_GENES,0.977999562139677
EHRLICH_ICF_SYNDROM_UP,SET,9,0.080228,0.001775,0.27584,0.38559,EHRLICH_ICF_SYNDROM_UP,0.977999562139677
WP_TYPE_I_INTERFERON_INDUCTI...,SET,28,0.046332,0.0018071,0.15933,0.3856,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,0.977999562139677
YAUCH_HEDGEHOG_SIGNALING_PAR...2,SET,132,0.022954,0.0019384,0.078951,0.38563,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,0.978004279772329
GSE14026_TH1_VS_TH17_UP,SET,178,0.018907,0.0018517,0.06506,0.38568,GSE14026_TH1_VS_TH17_UP,0.978059715432324
REACTOME_SIGNALING_BY_ERYTHR...,SET,25,0.051099,0.0018834,0.17601,0.38578,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,0.978241930541369
KEGG_MEDICUS_REFERENCE_TIGHT...,SET,34,0.04615,0.0019832,0.15911,0.38589,KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY,0.978304845413446
MIR519D_3P,SET,567,0.010762,0.0018609,0.037102,0.38589,MIR519D_3P,0.978304845413446
GSE37301_COMMON_LYMPHOID_PRO...6,SET,177,0.018885,0.0018444,0.065109,0.38589,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP,0.978304845413446
REACTOME_MISCELLANEOUS_TRANS...,SET,21,0.056244,0.0019002,0.19397,0.38592,REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS,0.978304845413446
REACTOME_SELECTIVE_AUTOPHAGY,SET,81,0.026953,0.0017854,0.093001,0.38598,REACTOME_SELECTIVE_AUTOPHAGY,0.978304845413446
HP_ABNORMAL_PULMONARY_VALVE_...1,SET,3,0.15001,0.0019164,0.51768,0.386,HP_ABNORMAL_PULMONARY_VALVE_CUSP_MORPHOLOGY,0.978304845413446
GOBP_OOCYTE_DIFFERENTIATION,SET,60,0.032509,0.0018545,0.1122,0.38601,GOBP_OOCYTE_DIFFERENTIATION,0.978304845413446
BOGNI_TREATMENT_RELATED_MYEL...1,SET,31,0.042154,0.0017299,0.14552,0.38603,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,0.978304845413446
KEGG_MEDICUS_REFERENCE_REGUL...1,SET,4,0.1864,0.0027496,0.64359,0.38606,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR,0.978309537003281
GSE8835_CD4_VS_CD8_TCELL_DN,SET,178,0.019248,0.0018851,0.066497,0.38612,GSE8835_CD4_VS_CD8_TCELL_DN,0.978390244969379
MASSARWEH_TAMOXIFEN_RESISTAN...1,SET,212,0.018077,0.0019303,0.062529,0.38626,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,0.97855432454095
GOBP_NUCLEAR_PORE_LOCALIZATI...,SET,5,0.11536,0.0019025,0.39917,0.3863,GOBP_NUCLEAR_PORE_LOCALIZATION,0.97855432454095
WP_TRANSCRIPTIONAL_ACTIVATIO...,SET,15,0.065874,0.0018812,0.22801,0.38633,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,0.97855432454095
HP_DIMINISHED_MOVEMENT,SET,72,0.02792,0.0017441,0.096655,0.38635,HP_DIMINISHED_MOVEMENT,0.97855432454095
HE_LIM_SUN_FETAL_LUNG_C5_LAT...,SET,25,0.053406,0.0019684,0.18488,0.38635,HE_LIM_SUN_FETAL_LUNG_C5_LATE_PRO_B_CELL,0.97855432454095
WP_PLURIPOTENT_STEM_CELL_DIF...,SET,46,0.03968,0.0019827,0.13742,0.38639,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,0.97855432454095
QUEREC_MODEL_PBMC_YF_17D_VAC...1,SET,46,0.034908,0.0017442,0.12089,0.38639,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_PREDICTIVE,0.97855432454095
chr4p11,SET,8,0.13489,0.0028138,0.46723,0.38641,chr4p11,0.97855432454095
GOBP_REGULATION_OF_IRE1_MEDI...,SET,14,0.070387,0.001942,0.24393,0.38646,GOBP_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.978609639344262
BURTON_ADIPOGENESIS_4,SET,42,0.037626,0.0017967,0.13044,0.3865,BURTON_ADIPOGENESIS_4,0.978639625528195
TFCP2_TARGET_GENES,SET,77,0.027415,0.0017708,0.095107,0.38658,TFCP2_TARGET_GENES,0.978656265016381
GOMF_ACETYLGLUCOSAMINYLTRANS...,SET,40,0.044021,0.0020515,0.15273,0.38659,GOMF_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.978656265016381
KORKOLA_EMBRYONAL_CARCINOMA,SET,8,0.093654,0.0019536,0.32498,0.3866,KORKOLA_EMBRYONAL_CARCINOMA,0.978656265016381
GSE36888_STAT5_AB_KNOCKIN_VS...4,SET,170,0.019406,0.0018578,0.06736,0.38664,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP,0.978656265016381
GOBP_POSITIVE_REGULATION_OF_...828,SET,17,0.059382,0.0018052,0.20618,0.38667,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.978656265016381
GSE10147_IL3_VS_IL3_AND_CPG_...2,SET,132,0.021674,0.0018302,0.075301,0.38674,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP,0.978656265016381
GSE5589_LPS_AND_IL10_VS_LPS_...5,SET,184,0.018267,0.0018187,0.063475,0.38675,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.978656265016381
MIR6818_5P,SET,100,0.024744,0.0018203,0.085981,0.38676,MIR6818_5P,0.978656265016381
GSE3982_BCELL_VS_TH2_UP,SET,173,0.018421,0.0017788,0.064009,0.38676,GSE3982_BCELL_VS_TH2_UP,0.978656265016381
GOBP_RESPONSE_TO_NUTRIENT,SET,156,0.021078,0.0019337,0.073344,0.38691,GOBP_RESPONSE_TO_NUTRIENT,0.978902565688915
HP_FOLLICULAR_HYPERKERATOSIS,SET,26,0.048467,0.0018217,0.16869,0.38694,HP_FOLLICULAR_HYPERKERATOSIS,0.978902565688915
GOBP_POSITIVE_REGULATION_OF_...344,SET,7,0.10166,0.0019837,0.35392,0.38696,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.978902565688915
HP_PULMONARY_HYPOPLASIA,SET,121,0.0224,0.0018116,0.077987,0.38697,HP_PULMONARY_HYPOPLASIA,0.978902565688915
XU_HGF_TARGETS_INDUCED_BY_AK...3,SET,15,0.063192,0.0018046,0.22024,0.38709,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,0.978929558151346
GOMF_ARYL_SULFOTRANSFERASE_A...,SET,7,0.11755,0.0022936,0.40984,0.38713,GOMF_ARYL_SULFOTRANSFERASE_ACTIVITY,0.978929558151346
HP_FACIAL_ASYMMETRY,SET,128,0.021496,0.0017877,0.074979,0.38717,HP_FACIAL_ASYMMETRY,0.978929558151346
AREB6_03,SET,242,0.01626,0.0018536,0.056752,0.38724,AREB6_03,0.978929558151346
HP_PELVIC_GIRDLE_AMYOTROPHY,SET,3,0.10554,0.0013483,0.3684,0.38725,HP_PELVIC_GIRDLE_AMYOTROPHY,0.978929558151346
GOBP_POSITIVE_REGULATION_OF_...498,SET,26,0.04551,0.0017105,0.15894,0.38731,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,0.978929558151346
MIR501_5P,SET,125,0.022582,0.001856,0.078882,0.38733,MIR501_5P,0.978929558151346
GSE21063_CTRL_VS_ANTI_IGM_ST...12,SET,173,0.018887,0.0018239,0.066009,0.38739,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP,0.978929558151346
REACTOME_SIRT1_NEGATIVELY_RE...,SET,7,0.085044,0.0016594,0.29725,0.3874,REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION,0.978929558151346
GOBP_NEGATIVE_REGULATION_OF_...334,SET,3,0.15547,0.0019862,0.54354,0.38743,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.978929558151346
GOBP_MAINTENANCE_OF_GASTROIN...,SET,21,0.06041,0.0020409,0.21124,0.38745,GOBP_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM,0.978929558151346
HP_DEGENERATION_OF_THE_LATER...,SET,19,0.050712,0.0016297,0.17737,0.38747,HP_DEGENERATION_OF_THE_LATERAL_CORTICOSPINAL_TRACTS,0.978929558151346
GOBP_CARNITINE_TRANSPORT,SET,7,0.12127,0.0023664,0.42424,0.38749,GOBP_CARNITINE_TRANSPORT,0.978929558151346
MIR539_5P,SET,341,0.013751,0.0018556,0.048107,0.3875,MIR539_5P,0.978929558151346
GOBP_IMMATURE_T_CELL_PROLIFE...,SET,10,0.084862,0.001979,0.29697,0.38753,GOBP_IMMATURE_T_CELL_PROLIFERATION,0.978929558151346
GOBP_NEGATIVE_REGULATION_OF_...254,SET,39,0.041701,0.0019189,0.14593,0.38754,GOBP_NEGATIVE_REGULATION_OF_GLIOGENESIS,0.978929558151346
MORF_LMO1,SET,48,0.036161,0.0018456,0.1266,0.38758,MORF_LMO1,0.978929558151346
GOMF_BICARBONATE_MONOATOMIC_...,SET,12,0.069022,0.0017631,0.24166,0.38759,GOMF_BICARBONATE_MONOATOMIC_ANION_ANTIPORTER_ACTIVITY,0.978929558151346
GOBP_BRADYKININ_CATABOLIC_PR...,SET,7,0.10118,0.0019743,0.35456,0.38768,GOBP_BRADYKININ_CATABOLIC_PROCESS,0.978929558151346
HP_DELAYED_EPIPHYSEAL_OSSIFI...,SET,37,0.040641,0.0018217,0.14242,0.38768,HP_DELAYED_EPIPHYSEAL_OSSIFICATION,0.978929558151346
GOBP_GOLGI_ORGANIZATION,SET,136,0.019937,0.0017087,0.069873,0.38769,GOBP_GOLGI_ORGANIZATION,0.978929558151346
GOBP_REGULATION_OF_VENTRICUL...2,SET,7,0.11376,0.0022197,0.39872,0.3877,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,0.978929558151346
GOCC_MICROVILLUS_MEMBRANE,SET,29,0.046979,0.0018647,0.16467,0.38771,GOCC_MICROVILLUS_MEMBRANE,0.978929558151346
TAL1BETAITF2_01,SET,237,0.016483,0.0018597,0.057783,0.38772,TAL1BETAITF2_01,0.978929558151346
SHARMA_ASTROCYTOMA_WITH_NF1_...,SET,4,0.12664,0.0018682,0.44417,0.38778,SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM,0.978929558151346
MIR423_5P,SET,124,0.020712,0.0016956,0.072646,0.38778,MIR423_5P,0.978929558151346
GOBP_REGULATION_OF_TRANSLATI...2,SET,10,0.06953,0.0016215,0.24395,0.38782,GOBP_REGULATION_OF_TRANSLATIONAL_ELONGATION,0.978929558151346
GOMF_N_ACETYLLACTOSAMINIDE_B...,SET,6,0.12237,0.0022106,0.42933,0.38782,GOMF_N_ACETYLLACTOSAMINIDE_BETA_1_3_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.978929558151346
MORF_BUB3,SET,242,0.014723,0.0016784,0.051667,0.38783,MORF_BUB3,0.978929558151346
GSE2770_TGFB_AND_IL4_VS_IL4_...4,SET,177,0.017927,0.0017508,0.062905,0.38783,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.978929558151346
GOBP_CHROMOSOME_ORGANIZATION,SET,543,0.0099928,0.0016921,0.035086,0.3879,GOBP_CHROMOSOME_ORGANIZATION,0.978929558151346
HP_SUBCAPSULAR_CATARACT,SET,104,0.023833,0.0017877,0.083715,0.38794,HP_SUBCAPSULAR_CATARACT,0.978929558151346
GOBP_MEIOTIC_ATTACHMENT_OF_T...,SET,2,0.13127,0.0013693,0.46122,0.38797,GOBP_MEIOTIC_ATTACHMENT_OF_TELOMERE_TO_NUCLEAR_ENVELOPE,0.978929558151346
GOBP_POSITIVE_REGULATION_OF_...777,SET,16,0.065986,0.0019461,0.23188,0.38799,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.978929558151346
FOXJ2_02,SET,213,0.017294,0.0018509,0.060785,0.38801,FOXJ2_02,0.978929558151346
GOBP_CELLULAR_RESPONSE_TO_PE...1,SET,13,0.073491,0.0019539,0.25843,0.38806,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE,0.978929558151346
FU_INTERACT_WITH_ALKBH8,SET,13,0.056396,0.0014994,0.19839,0.3881,FU_INTERACT_WITH_ALKBH8,0.978929558151346
REACTOME_FGFR2C_LIGAND_BINDI...,SET,12,0.079323,0.0020263,0.27908,0.38812,REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,0.978929558151346
GOCC_DENSE_BODY,SET,5,0.1141,0.0018817,0.40147,0.38813,GOCC_DENSE_BODY,0.978929558151346
MIR302F,SET,167,0.019226,0.0018244,0.06767,0.38816,MIR302F,0.978929558151346
GOBP_SMALL_GTPASE_MEDIATED_S...,SET,462,0.011531,0.0018051,0.040589,0.38817,GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.978929558151346
HP_ABNORMAL_MORPHOLOGY_OF_TH...10,SET,28,0.043687,0.0017039,0.1538,0.38819,HP_ABNORMAL_MORPHOLOGY_OF_THE_VESTIBULE_OF_THE_INNER_EAR,0.978929558151346
DORN_ADENOVIRUS_INFECTION_24...2,SET,11,0.071887,0.0017582,0.25313,0.38821,DORN_ADENOVIRUS_INFECTION_24HR_UP,0.978929558151346
HP_PSEUDOEPIPHYSES_OF_THE_ME...,SET,8,0.076784,0.0016017,0.27039,0.38822,HP_PSEUDOEPIPHYSES_OF_THE_METACARPALS,0.978929558151346
GOBP_GLIAL_CELL_ACTIVATION,SET,53,0.036516,0.0019582,0.12863,0.38825,GOBP_GLIAL_CELL_ACTIVATION,0.978934180934417
GSE13522_WT_VS_IFNG_KO_SKING...2,SET,107,0.02406,0.0018305,0.084812,0.38833,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,0.978973253789802
KEGG_PATHWAYS_IN_CANCER,SET,311,0.014408,0.0018584,0.050797,0.38834,KEGG_PATHWAYS_IN_CANCER,0.978973253789802
HOXA4_Q2,SET,244,0.016617,0.0019019,0.058586,0.38835,HOXA4_Q2,0.978973253789802
KANG_CISPLATIN_RESISTANCE_UP,SET,18,0.056572,0.0017696,0.19962,0.38844,KANG_CISPLATIN_RESISTANCE_UP,0.978996707237557
HP_MYELOFIBROSIS,SET,11,0.068481,0.0016749,0.2418,0.38851,HP_MYELOFIBROSIS,0.978996707237557
GOBP_PROTEIN_MONOUBIQUITINAT...,SET,42,0.034448,0.0016449,0.12166,0.38853,GOBP_PROTEIN_MONOUBIQUITINATION,0.978996707237557
REACTOME_BUDDING_AND_MATURAT...,SET,27,0.045019,0.0017243,0.15903,0.38856,REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION,0.978996707237557
MODULE_419,SET,30,0.045194,0.0018245,0.15968,0.38858,MODULE_419,0.978996707237557
HP_SCLEROCORNEA,SET,43,0.035313,0.0017061,0.12484,0.38864,HP_SCLEROCORNEA,0.978996707237557
PID_AVB3_OPN_PATHWAY,SET,31,0.047561,0.0019517,0.16819,0.38867,PID_AVB3_OPN_PATHWAY,0.978996707237557
MSX2_TARGET_GENES,SET,15,0.059205,0.0016907,0.20938,0.38868,MSX2_TARGET_GENES,0.978996707237557
GENTILE_UV_RESPONSE_CLUSTER_...3,SET,52,0.033182,0.0017626,0.11739,0.38871,GENTILE_UV_RESPONSE_CLUSTER_D4,0.978996707237557
HP_DYSTROPHIC_FINGERNAILS,SET,25,0.046313,0.001707,0.16383,0.38871,HP_DYSTROPHIC_FINGERNAILS,0.978996707237557
WP_RAS_SIGNALING,SET,174,0.018853,0.0018257,0.066698,0.38872,WP_RAS_SIGNALING,0.978996707237557
GOCC_DNA_REPLICATION_FACTOR_...1,SET,12,0.066753,0.0017052,0.23618,0.38873,GOCC_DNA_REPLICATION_FACTOR_A_COMPLEX,0.978996707237557
GOBP_PHAGOSOME_ACIDIFICATION,SET,7,0.10364,0.0020223,0.36676,0.38875,GOBP_PHAGOSOME_ACIDIFICATION,0.978996707237557
GOBP_REGULATION_OF_TRANSCRIP...4,SET,11,0.067587,0.001653,0.23926,0.38879,GOBP_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.978996707237557
GSE3203_UNTREATED_VS_IFNB_TR...2,SET,169,0.018129,0.0017305,0.064178,0.38879,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP,0.978996707237557
GOBP_REGULATION_OF_BRANCHING...4,SET,17,0.064473,0.00196,0.22829,0.38881,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS,0.978996707237557
KEGG_PROXIMAL_TUBULE_BICARBO...,SET,21,0.054085,0.0018272,0.19159,0.38886,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,0.979051673427992
GOBP_MOTILE_CILIUM_ASSEMBLY,SET,64,0.028765,0.0016945,0.10195,0.38891,GOBP_MOTILE_CILIUM_ASSEMBLY,0.979060886571056
GOBP_NEGATIVE_REGULATION_OF_...7,SET,16,0.069946,0.0020629,0.24791,0.38892,GOBP_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.979060886571056
GOBP_OLIGODENDROCYTE_PROGENI...,SET,8,0.096356,0.0020099,0.3416,0.38895,GOBP_OLIGODENDROCYTE_PROGENITOR_PROLIFERATION,0.979065492141667
GOMF_PROTEIN_SERINE_THREONIN...2,SET,392,0.012095,0.0017475,0.042898,0.38899,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.979095267236385
MARSON_FOXP3_TARGETS_STIMULA...2,SET,29,0.049131,0.0019501,0.1743,0.38902,MARSON_FOXP3_TARGETS_STIMULATED_UP,0.979099869650228
HP_CHYLOTHORAX,SET,16,0.05985,0.0017652,0.21248,0.3891,HP_CHYLOTHORAX,0.979138835794961
GSE41867_DAY8_VS_DAY15_LCMV_...3,SET,179,0.016718,0.0016419,0.059353,0.3891,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.979138835794961
WP_DISORDERS_OF_FRUCTOSE_MET...,SET,12,0.060686,0.0015502,0.2155,0.38912,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.979138835794961
HP_LOW_APGAR_SCORE,SET,9,0.088787,0.0019643,0.31558,0.38922,HP_LOW_APGAR_SCORE,0.97931956128285
GSE22140_GERMFREE_VS_SPF_MOU...2,SET,185,0.01801,0.0017978,0.064055,0.3893,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP,0.979449942087737
GOCC_PCG_PROTEIN_COMPLEX,SET,43,0.035256,0.0017034,0.1256,0.38947,GOCC_PCG_PROTEIN_COMPLEX,0.979645911450822
GSE360_L_DONOVANI_VS_L_MAJOR...1,SET,178,0.017886,0.0017517,0.063744,0.38952,GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN,0.979645911450822
GOCC_SEX_CHROMOSOME,SET,26,0.044014,0.0016543,0.15688,0.38953,GOCC_SEX_CHROMOSOME,0.979645911450822
MIR4744,SET,155,0.019031,0.0017404,0.067847,0.38955,MIR4744,0.979645911450822
GOBP_CYTOSOLIC_TRANSPORT,SET,123,0.020129,0.0016412,0.071808,0.38962,GOBP_CYTOSOLIC_TRANSPORT,0.979645911450822
GSE8921_UNSTIM_VS_TLR1_2_STI...1,SET,181,0.018016,0.001779,0.064293,0.38966,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN,0.979645911450822
RADMACHER_AML_PROGNOSIS,SET,73,0.029502,0.0018557,0.1053,0.38967,RADMACHER_AML_PROGNOSIS,0.979645911450822
GOBP_ANTIGEN_PROCESSING_AND_...4,SET,23,0.054846,0.001939,0.19581,0.3897,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN,0.979645911450822
GOBP_PROTEIN_ACETYLATION,SET,49,0.031478,0.0016232,0.11241,0.38973,GOBP_PROTEIN_ACETYLATION,0.979645911450822
HP_INFANTILE_SPASMS,SET,119,0.022236,0.0017835,0.079466,0.38981,HP_INFANTILE_SPASMS,0.979645911450822
MIR5787,SET,230,0.016035,0.0017826,0.057327,0.38985,MIR5787,0.979645911450822
STAT1_01,SET,62,0.030322,0.0017582,0.10845,0.38989,STAT1_01,0.979645911450822
HP_UNDERDEVELOPED_SUPRAORBIT...,SET,55,0.033368,0.0018227,0.11937,0.38992,HP_UNDERDEVELOPED_SUPRAORBITAL_RIDGES,0.979645911450822
GAUSSMANN_MLL_AF4_FUSION_TAR...11,SET,31,0.046777,0.0019196,0.16742,0.38997,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,0.979645911450822
BIOCARTA_D4GDI_PATHWAY,SET,12,0.066975,0.0017109,0.23976,0.38999,BIOCARTA_D4GDI_PATHWAY,0.979645911450822
HEB_Q6,SET,239,0.01548,0.0017538,0.055416,0.39,HEB_Q6,0.979645911450822
GOBP_POSITIVE_REGULATION_OF_...48,SET,7,0.084441,0.0016477,0.30235,0.39002,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.979645911450822
HOFFMANN_PRE_BI_TO_LARGE_PRE...1,SET,73,0.028903,0.001818,0.10352,0.39005,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,0.979645911450822
HP_RECURRENT_ACUTE_RESPIRATO...,SET,11,0.067632,0.0016541,0.24228,0.39007,HP_RECURRENT_ACUTE_RESPIRATORY_TRACT_INFECTION,0.979645911450822
GSE21360_TERTIARY_VS_QUATERN...1,SET,162,0.01986,0.0018564,0.07117,0.3901,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.979645911450822
HP_NAIL_DYSPLASIA,SET,140,0.020526,0.0017847,0.073594,0.39016,HP_NAIL_DYSPLASIA,0.979645911450822
COBLL1_TARGET_GENES,SET,115,0.021137,0.0016668,0.075841,0.39024,COBLL1_TARGET_GENES,0.979645911450822
GOBP_MEMBRANE_REPOLARIZATION,SET,48,0.037793,0.0019289,0.1356,0.39024,GOBP_MEMBRANE_REPOLARIZATION,0.979645911450822
GOBP_AXON_EXTENSION,SET,94,0.024922,0.0017778,0.089427,0.39025,GOBP_AXON_EXTENSION,0.979645911450822
HP_ABNORMAL_ATRIOVENTRICULAR...4,SET,183,0.018012,0.0017884,0.064649,0.39027,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_PHYSIOLOGY,0.979645911450822
HP_ABNORMAL_DISTAL_FEMORAL_M...,SET,5,0.11532,0.0019019,0.414,0.39029,HP_ABNORMAL_DISTAL_FEMORAL_METAPHYSIS_MORPHOLOGY,0.979645911450822
GOBP_GOLGI_LUMEN_ACIDIFICATI...,SET,9,0.074899,0.0016571,0.26891,0.3903,GOBP_GOLGI_LUMEN_ACIDIFICATION,0.979645911450822
HP_SMALL_FACE,SET,112,0.023229,0.0018079,0.083434,0.39035,HP_SMALL_FACE,0.979645911450822
GOBP_MUSCLE_SYSTEM_PROCESS,SET,411,0.012337,0.0018242,0.044319,0.39037,GOBP_MUSCLE_SYSTEM_PROCESS,0.979645911450822
HP_HIGH_ANTERIOR_HAIRLINE,SET,59,0.029735,0.0016821,0.10684,0.39039,HP_HIGH_ANTERIOR_HAIRLINE,0.979645911450822
GSE2585_THYMIC_DC_VS_MTEC_UP,SET,172,0.017972,0.0017305,0.064586,0.39041,GSE2585_THYMIC_DC_VS_MTEC_UP,0.979645911450822
GSE18804_BRAIN_VS_COLON_TUMO...2,SET,144,0.021101,0.0018605,0.075856,0.39044,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP,0.979645911450822
MIR4639_5P,SET,86,0.027361,0.0018673,0.09837,0.39045,MIR4639_5P,0.979645911450822
CASTELLANO_HRAS_AND_NRAS_TAR...1,SET,7,0.093549,0.0018254,0.33642,0.39048,CASTELLANO_HRAS_AND_NRAS_TARGETS_DN,0.979645911450822
GOCC_MITOTIC_COHESIN_COMPLEX,SET,4,0.14824,0.0021867,0.53334,0.39053,GOCC_MITOTIC_COHESIN_COMPLEX,0.979645911450822
GSE43955_1H_VS_10H_ACT_CD4_T...4,SET,173,0.018509,0.0017874,0.066624,0.39058,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.979645911450822
GSE43863_DAY6_EFF_VS_DAY150_...3,SET,181,0.018682,0.0018449,0.067272,0.39062,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN,0.979645911450822
HP_ABNORMALITY_OF_FACIAL_ADI...,SET,10,0.079104,0.0018447,0.28487,0.39063,HP_ABNORMALITY_OF_FACIAL_ADIPOSE_TISSUE,0.979645911450822
MIR4743_3P,SET,185,0.017532,0.0017502,0.063146,0.39064,MIR4743_3P,0.979645911450822
GOMF_ADENYLATE_CYCLASE_ACTIV...,SET,14,0.066597,0.0018374,0.23987,0.39065,GOMF_ADENYLATE_CYCLASE_ACTIVITY,0.979645911450822
GOBP_POSITIVE_REGULATION_OF_...511,SET,11,0.070641,0.0017277,0.25448,0.39066,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,0.979645911450822
SASSON_RESPONSE_TO_GONADOTRO...2,SET,76,0.02652,0.0017019,0.095543,0.39067,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,0.979645911450822
GOBP_CARDIOLIPIN_METABOLIC_P...,SET,13,0.073304,0.0019489,0.26409,0.39067,GOBP_CARDIOLIPIN_METABOLIC_PROCESS,0.979645911450822
GOBP_PROTEIN_LOCALIZATION_TO...36,SET,12,0.066079,0.001688,0.23809,0.39068,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_ENVELOPE,0.979645911450822
TORCHIA_TARGETS_OF_EWSR1_FLI...1,SET,291,0.014711,0.0018365,0.05301,0.39069,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.979645911450822
GOBP_GLIAL_CELL_MIGRATION,SET,57,0.034358,0.0019105,0.12388,0.39076,GOBP_GLIAL_CELL_MIGRATION,0.979645911450822
HP_MUSCLE_FIBRILLATION,SET,58,0.031205,0.0017502,0.11255,0.3908,HP_MUSCLE_FIBRILLATION,0.979645911450822
WP_MITOCHONDRIAL_COMPLEX_II_...,SET,8,0.072887,0.0015204,0.26296,0.39082,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,0.979645911450822
MENSE_HYPOXIA_UP,SET,89,0.025044,0.0017386,0.090361,0.39083,MENSE_HYPOXIA_UP,0.979645911450822
GSE30971_WBP7_HET_VS_KO_MACR...4,SET,178,0.017713,0.0017348,0.06392,0.39085,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP,0.979645911450822
GSE17721_POLYIC_VS_CPG_2H_BM...2,SET,182,0.017226,0.0017058,0.06218,0.39088,GSE17721_POLYIC_VS_CPG_2H_BMDC_UP,0.979645911450822
GOCC_INSULIN_RESPONSIVE_COMP...,SET,7,0.081191,0.0015843,0.2931,0.39089,GOCC_INSULIN_RESPONSIVE_COMPARTMENT,0.979645911450822
KEGG_MEDICUS_REFERENCE_CX3CR...,SET,17,0.060005,0.0018242,0.21664,0.3909,KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY,0.979645911450822
GOBP_POSITIVE_REGULATION_OF_...690,SET,9,0.083156,0.0018398,0.30022,0.3909,GOBP_POSITIVE_REGULATION_OF_RRNA_PROCESSING,0.979645911450822
GSE34156_UNTREATED_VS_24H_NO...4,SET,151,0.018879,0.0017042,0.068181,0.39093,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.979650454250487
GOBP_MRNA_METABOLIC_PROCESS,SET,643,0.0089105,0.0016373,0.032226,0.39108,GOBP_MRNA_METABOLIC_PROCESS,0.979857563418853
DIRMEIER_LMP1_RESPONSE_LATE_...1,SET,26,0.047626,0.0017901,0.1723,0.39112,DIRMEIER_LMP1_RESPONSE_LATE_DN,0.979857563418853
GOCC_INTRACELLULAR_PROTEIN_C...,SET,806,0.0080831,0.0016552,0.029244,0.39112,GOCC_INTRACELLULAR_PROTEIN_CONTAINING_COMPLEX,0.979857563418853
HP_DEVIATION_OF_THE_3RD_FING...,SET,10,0.076346,0.0017804,0.27625,0.39113,HP_DEVIATION_OF_THE_3RD_FINGER,0.979857563418853
MIR567,SET,95,0.024112,0.0017291,0.087274,0.39117,MIR567,0.979857563418853
MIR935,SET,106,0.02334,0.0017674,0.084507,0.3912,MIR935,0.979857563418853
HP_ABNORMAL_TARSAL_OSSIFICAT...,SET,8,0.082102,0.0017126,0.29729,0.39121,HP_ABNORMAL_TARSAL_OSSIFICATION,0.979857563418853
GOMF_ALCOHOL_DEHYDROGENASE_N...1,SET,7,0.147,0.0028683,0.53287,0.39133,GOMF_ALCOHOL_DEHYDROGENASE_NADPLUS_ACTIVITY_ZINC_DEPENDENT,0.979950505303899
GOBP_NATURAL_KILLER_CELL_ACT...2,SET,29,0.051555,0.0020463,0.18705,0.39142,GOBP_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.979950505303899
GOCC_CORTICAL_CYTOSKELETON,SET,103,0.022944,0.0017128,0.083239,0.39142,GOCC_CORTICAL_CYTOSKELETON,0.979950505303899
HERNANDEZ_MITOTIC_ARREST_BY_...4,SET,53,0.032147,0.0017239,0.11668,0.39146,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,0.979950505303899
WANG_TARGETS_OF_MLL_CBP_FUSI...1,SET,38,0.039023,0.0017726,0.14169,0.3915,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,0.979950505303899
GOBP_POSITIVE_REGULATION_OF_...361,SET,20,0.047802,0.0015761,0.17356,0.3915,GOBP_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.979950505303899
KEGG_PANTOTHENATE_AND_COA_BI...,SET,16,0.060196,0.0017754,0.21858,0.39151,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,0.979950505303899
GSE13484_UNSTIM_VS_3H_YF17D_...1,SET,180,0.017518,0.0017252,0.063615,0.39152,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,0.979950505303899
HP_BLEPHAROPHIMOSIS,SET,111,0.023568,0.0018261,0.085602,0.39153,HP_BLEPHAROPHIMOSIS,0.979950505303899
GSE37301_MULTIPOTENT_PROGENI...11,SET,184,0.01683,0.0016755,0.061143,0.39156,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.979950505303899
MIR6874_5P,SET,35,0.042308,0.0018446,0.1538,0.39163,MIR6874_5P,0.979950505303899
DORN_ADENOVIRUS_INFECTION_12...1,SET,30,0.041731,0.0016847,0.15177,0.39167,DORN_ADENOVIRUS_INFECTION_12HR_DN,0.979950505303899
GOBP_CARBOHYDRATE_IMPORT_ACR...,SET,5,0.12117,0.0019984,0.4407,0.39168,GOBP_CARBOHYDRATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.979950505303899
HP_SHORT_NASAL_BRIDGE,SET,5,0.12636,0.0020839,0.4597,0.39171,HP_SHORT_NASAL_BRIDGE,0.979950505303899
REACTOME_GLI_PROTEINS_BIND_P...,SET,7,0.093514,0.0018247,0.34042,0.39177,REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION,0.979950505303899
YANG_BREAST_CANCER_ESR1_BULK...2,SET,25,0.041868,0.0015432,0.15243,0.39178,YANG_BREAST_CANCER_ESR1_BULK_UP,0.979950505303899
GOBP_REGULATION_OF_ASTROCYTE...2,SET,27,0.050201,0.0019228,0.1828,0.39181,GOBP_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.979950505303899
HP_ABNORMAL_TRANSFERRIN_SATU...,SET,12,0.068674,0.0017542,0.25007,0.39181,HP_ABNORMAL_TRANSFERRIN_SATURATION,0.979950505303899
FULCHER_INFLAMMATORY_RESPONS...2,SET,525,0.010785,0.0017966,0.039295,0.39187,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,0.979950505303899
GSE26351_UNSTIM_VS_WNT_PATHW...2,SET,178,0.016944,0.0016595,0.061758,0.3919,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.979950505303899
HE_LIM_SUN_FETAL_LUNG_C0_MYO...2,SET,78,0.029634,0.0019265,0.10802,0.39191,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL,0.979950505303899
MORF_PSMC2,SET,101,0.020877,0.0015434,0.076148,0.39198,MORF_PSMC2,0.979950505303899
SIMBULAN_UV_RESPONSE_NORMAL_...2,SET,9,0.084135,0.0018614,0.30694,0.392,SIMBULAN_UV_RESPONSE_NORMAL_UP,0.979950505303899
HP_STARING_GAZE,SET,20,0.050521,0.0016657,0.18433,0.39201,HP_STARING_GAZE,0.979950505303899
MENON_FETAL_KIDNEY_3_STROMAL...,SET,68,0.030754,0.0018672,0.11231,0.39211,MENON_FETAL_KIDNEY_3_STROMAL_CELLS,0.979950505303899
GSE17721_0.5H_VS_8H_POLYIC_B...2,SET,183,0.016237,0.0016121,0.059327,0.39217,GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP,0.979950505303899
MARTIN_INTERACT_WITH_HDAC,SET,37,0.036624,0.0016417,0.13392,0.39224,MARTIN_INTERACT_WITH_HDAC,0.979950505303899
MA_RAT_AGING_UP,SET,96,0.025062,0.0018066,0.091657,0.39226,MA_RAT_AGING_UP,0.979950505303899
FAN_OVARY_CL2_PUTATIVE_EARLY...,SET,83,0.026732,0.0017924,0.097781,0.39228,FAN_OVARY_CL2_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_1,0.979950505303899
HP_CHONDROCALCINOSIS,SET,21,0.058508,0.0019766,0.21403,0.39229,HP_CHONDROCALCINOSIS,0.979950505303899
NABA_MATRISOME_POORLY_METAST...3,SET,35,0.039654,0.0017288,0.14507,0.3923,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA,0.979950505303899
MIR6857_5P,SET,73,0.026103,0.0016419,0.095514,0.39232,MIR6857_5P,0.979950505303899
HP_ASYMMETRIC_GROWTH,SET,58,0.03194,0.0017915,0.1169,0.39235,HP_ASYMMETRIC_GROWTH,0.979950505303899
GOBP_CELLULAR_RESPONSE_TO_TE...2,SET,8,0.075183,0.0015683,0.27526,0.39238,GOBP_CELLULAR_RESPONSE_TO_TESTOSTERONE_STIMULUS,0.979950505303899
GOBP_POSITIVE_REGULATION_OF_...699,SET,21,0.052248,0.0017652,0.19152,0.3925,GOBP_POSITIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.979950505303899
GSE2770_IL12_VS_TGFB_AND_IL1...4,SET,180,0.018011,0.0017737,0.066062,0.39257,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.979950505303899
GOBP_IMMUNE_SYSTEM_DEVELOPME...,SET,182,0.01729,0.0017121,0.063445,0.39261,GOBP_IMMUNE_SYSTEM_DEVELOPMENT,0.979950505303899
JIANG_CORE_DUPLICON_GENES,SET,4,0.10236,0.00151,0.37565,0.39262,JIANG_CORE_DUPLICON_GENES,0.979950505303899
GOBP_MORPHOGENESIS_OF_EMBRYO...,SET,144,0.020039,0.0017668,0.073545,0.39263,GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM,0.979950505303899
GOBP_RIBONUCLEOPROTEIN_COMPL...1,SET,398,0.01087,0.0015822,0.039896,0.39264,GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS,0.979950505303899
BPTF_TARGET_GENES,SET,885,0.0081275,0.0017401,0.029837,0.39266,BPTF_TARGET_GENES,0.979950505303899
HP_NARROW_ILIAC_WING,SET,8,0.074834,0.001561,0.27479,0.39269,HP_NARROW_ILIAC_WING,0.979950505303899
HP_LOW_MOLECULAR_WEIGHT_PROT...,SET,5,0.10477,0.0017279,0.38477,0.3927,HP_LOW_MOLECULAR_WEIGHT_PROTEINURIA,0.979950505303899
MIR3176,SET,67,0.027293,0.0016449,0.10024,0.39271,MIR3176,0.979950505303899
GOMF_LIPASE_INHIBITOR_ACTIVI...,SET,16,0.062837,0.0018533,0.23078,0.39271,GOMF_LIPASE_INHIBITOR_ACTIVITY,0.979950505303899
KEGG_MEDICUS_REFERENCE_TLR5_...,SET,15,0.060401,0.0017249,0.222,0.39278,KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY,0.979950505303899
WP_MAJOR_RECEPTORS_TARGETED_...,SET,16,0.063958,0.0018863,0.23506,0.39278,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,0.979950505303899
GOBP_NEGATIVE_REGULATION_OF_...69,SET,56,0.031704,0.0017474,0.11653,0.39279,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.979950505303899
MIR372_5P,SET,226,0.015265,0.0016823,0.05612,0.39281,MIR372_5P,0.979950505303899
LHX4_TARGET_GENES,SET,5,0.090318,0.0014895,0.33204,0.39281,LHX4_TARGET_GENES,0.979950505303899
BIOCARTA_CXCR4_PATHWAY,SET,19,0.05597,0.0017987,0.20581,0.39283,BIOCARTA_CXCR4_PATHWAY,0.979950505303899
GSE18791_UNSTIM_VS_NEWCATSLE...6,SET,143,0.020654,0.0018148,0.075944,0.39283,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP,0.979950505303899
WESTON_VEGFA_TARGETS_12HR,SET,21,0.057221,0.0019332,0.21043,0.39284,WESTON_VEGFA_TARGETS_12HR,0.979950505303899
MIR506_5P,SET,118,0.021711,0.0017341,0.079845,0.39285,MIR506_5P,0.979950505303899
HNF6_Q6,SET,217,0.017007,0.0018371,0.062582,0.39291,HNF6_Q6,0.979950505303899
GOBP_NEGATIVE_REGULATION_OF_...500,SET,11,0.073399,0.0017952,0.27012,0.39292,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.979950505303899
GSE11818_WT_VS_DICER_KO_TREG...2,SET,129,0.0223,0.0018617,0.082066,0.39292,GSE11818_WT_VS_DICER_KO_TREG_UP,0.979950505303899
GSE7348_UNSTIM_VS_TOLERIZED_...2,SET,147,0.017969,0.0016006,0.066189,0.39302,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,0.979950505303899
REACTOME_PROCESSING_OF_CAPPE...1,SET,28,0.039824,0.0015532,0.14671,0.39303,REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,0.979950505303899
GSE29949_CD8_NEG_DC_SPLEEN_V...2,SET,176,0.018245,0.0017769,0.067216,0.39303,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP,0.979950505303899
HP_RIGHT_VENTRICULAR_CARDIOM...,SET,7,0.10387,0.0020268,0.38274,0.39305,HP_RIGHT_VENTRICULAR_CARDIOMYOPATHY,0.979950505303899
RAMJAUN_APOPTOSIS_BY_TGFB1_V...3,SET,10,0.078626,0.0018336,0.28976,0.39306,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,0.979950505303899
HOFFMANN_LARGE_TO_SMALL_PRE_...2,SET,142,0.019207,0.0016817,0.070842,0.39315,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,0.979950505303899
HP_PORENCEPHALIC_CYST,SET,30,0.041493,0.0016751,0.15311,0.3932,HP_PORENCEPHALIC_CYST,0.979950505303899
PASQUALUCCI_LYMPHOMA_BY_GC_S...2,SET,262,0.0148,0.0017544,0.054621,0.39322,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,0.979950505303899
MIR373_5P,SET,852,0.0081573,0.0017152,0.030108,0.39322,MIR373_5P,0.979950505303899
GSE17812_WT_VS_THPOK_KO_MEMO...2,SET,182,0.016926,0.0016761,0.062491,0.39325,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP,0.979950505303899
GOBP_RESPONSE_TO_INTERLEUKIN...1,SET,100,0.024858,0.0018287,0.091782,0.39326,GOBP_RESPONSE_TO_INTERLEUKIN_1,0.979950505303899
GOBP_POSITIVE_REGULATION_OF_...229,SET,10,0.06194,0.0014444,0.22884,0.39332,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.979950505303899
HP_DEPLETION_OF_MITOCHONDRIA...,SET,16,0.052742,0.0015555,0.19486,0.39333,HP_DEPLETION_OF_MITOCHONDRIAL_DNA_IN_MUSCLE_TISSUE,0.979950505303899
GSE31082_DN_VS_CD4_SP_THYMOC...1,SET,181,0.01688,0.0016669,0.062373,0.39334,GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN,0.979950505303899
GOCC_AUTOLYSOSOME,SET,12,0.066939,0.0017099,0.24738,0.39335,GOCC_AUTOLYSOSOME,0.979950505303899
GOBP_REGULATION_OF_CELLULAR_...11,SET,16,0.059794,0.0017635,0.221,0.39337,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT,0.979950505303899
HP_DUPLICATION_OF_THE_DISTAL...2,SET,6,0.09108,0.0016454,0.33666,0.39337,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.979950505303899
WP_FATTY_ACID_OMEGAOXIDATION,SET,15,0.066902,0.0019106,0.2473,0.39338,WP_FATTY_ACID_OMEGAOXIDATION,0.979950505303899
GOBP_HINDBRAIN_TANGENTIAL_CE...,SET,5,0.10528,0.0017364,0.38921,0.39339,GOBP_HINDBRAIN_TANGENTIAL_CELL_MIGRATION,0.979950505303899
GOBP_NEGATIVE_REGULATION_OF_...681,SET,8,0.095092,0.0019836,0.35193,0.3935,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.980154267899377
GOBP_PROTEIN_TRANSPORT_WITHI...,SET,6,0.093681,0.0016924,0.3468,0.39353,GOBP_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER,0.980158746595958
GOBP_ARTERIAL_ENDOTHELIAL_CE...,SET,6,0.10538,0.0019038,0.39031,0.39359,GOBP_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.980228387281581
GSE360_CTRL_VS_B_MALAYI_LOW_...4,SET,181,0.017139,0.0016925,0.063501,0.39362,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.980228387281581
GSE33292_DN3_THYMOCYTE_VS_TC...3,SET,137,0.020801,0.0017892,0.077126,0.3937,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN,0.980228387281581
GOBP_NOTOCHORD_DEVELOPMENT,SET,16,0.062998,0.001858,0.23362,0.39371,GOBP_NOTOCHORD_DEVELOPMENT,0.980228387281581
GOBP_NEGATIVE_REGULATION_OF_...212,SET,121,0.022645,0.0018314,0.083989,0.39373,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.980228387281581
SIMBULAN_UV_RESPONSE_IMMORTA...,SET,31,0.042575,0.0017471,0.15792,0.39374,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,0.980228387281581
GOBP_INTERFERON_ALPHA_PRODUC...,SET,26,0.041895,0.0015747,0.15543,0.39376,GOBP_INTERFERON_ALPHA_PRODUCTION,0.980228387281581
MIKKELSEN_MCV6_LCP_WITH_H3K2...,SET,24,0.048876,0.0017651,0.18141,0.3938,MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,0.980228387281581
KEGG_MEDICUS_REFERENCE_TLR2_...,SET,25,0.050112,0.001847,0.18604,0.39382,KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY,0.980228387281581
REACTOME_DEFECTIVE_B4GALT7_C...,SET,17,0.057219,0.0017394,0.21244,0.39384,REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,0.980228387281581
GSE42021_CD24HI_VS_CD24LOW_T...3,SET,183,0.017668,0.0017543,0.06564,0.3939,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN,0.980307518796992
GSE20152_SPHK1_KO_VS_WT_HTNF...2,SET,179,0.017306,0.0016996,0.064365,0.39402,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP,0.980413376753507
GSE29618_PRE_VS_DAY7_POST_LA...5,SET,185,0.016819,0.0016789,0.062582,0.39406,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN,0.980413376753507
BARRIER_COLON_CANCER_RECURRE...2,SET,37,0.038956,0.0017462,0.14498,0.39408,BARRIER_COLON_CANCER_RECURRENCE_UP,0.980413376753507
HP_FUNDUS_ATROPHY,SET,3,0.18186,0.0023233,0.67684,0.39409,HP_FUNDUS_ATROPHY,0.980413376753507
GOBP_REGULATION_OF_EXTENT_OF...,SET,84,0.025452,0.0017168,0.094744,0.39411,GOBP_REGULATION_OF_EXTENT_OF_CELL_GROWTH,0.980413376753507
HP_SUBMUCOUS_CLEFT_PALATE,SET,70,0.027033,0.0016652,0.10065,0.39413,HP_SUBMUCOUS_CLEFT_PALATE,0.980413376753507
GOBP_GLYCEROL_3_PHOSPHATE_ME...,SET,7,0.099623,0.0019439,0.37096,0.39414,GOBP_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS,0.980413376753507
MIR3149,SET,130,0.019948,0.0016718,0.074316,0.39419,MIR3149,0.980422284242164
ZWANG_CLASS_2_TRANSIENTLY_IN...,SET,47,0.034302,0.0017325,0.12781,0.3942,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,0.980422284242164
GOBP_GLYCOLIPID_TRANSPORT,SET,8,0.079258,0.0016533,0.29568,0.39433,GOBP_GLYCOLIPID_TRANSPORT,0.98055731654985
WP_PHYSIOLOGICAL_AND_PATHOLO...,SET,24,0.050637,0.0018287,0.18901,0.39439,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,0.98055731654985
ESC_J1_UP_LATE.V1_DN,SET,151,0.018928,0.0017087,0.070688,0.39444,ESC_J1_UP_LATE.V1_DN,0.98055731654985
HOLLEMAN_PREDNISOLONE_RESIST...1,SET,11,0.066352,0.0016228,0.24782,0.39445,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,0.98055731654985
GSE17721_PAM3CSK4_VS_CPG_16H...2,SET,177,0.016844,0.001645,0.062911,0.39445,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP,0.98055731654985
HP_IMPAIRMENT_OF_ACTIVITIES_...,SET,170,0.017741,0.0016984,0.066267,0.39446,HP_IMPAIRMENT_OF_ACTIVITIES_OF_DAILY_LIVING,0.98055731654985
GSE22443_NAIVE_VS_ACT_AND_IL...2,SET,187,0.01677,0.001683,0.062655,0.39448,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP,0.98055731654985
DESCARTES_FETAL_LIVER_HEPATO...,SET,382,0.012922,0.0018435,0.048275,0.39448,DESCARTES_FETAL_LIVER_HEPATOBLASTS,0.98055731654985
MIR1250_3P,SET,457,0.010988,0.001711,0.041081,0.39456,MIR1250_3P,0.98068603304012
GOMF_DNA_BINDING_TRANSCRIPTI...1,SET,442,0.011446,0.0017536,0.042818,0.39461,GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY,0.980720472075418
GSE17721_POLYIC_VS_PAM3CSK4_...18,SET,185,0.017082,0.0017052,0.063933,0.39467,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP,0.980720472075418
HP_ADVANCED_ERUPTION_OF_TEETH,SET,37,0.036707,0.0016453,0.13742,0.39469,HP_ADVANCED_ERUPTION_OF_TEETH,0.980720472075418
GOBP_NEGATIVE_REGULATION_OF_...519,SET,10,0.061839,0.0014421,0.23167,0.39476,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.980720472075418
HP_ABNORMAL_MIDBRAIN_MORPHOL...,SET,72,0.024443,0.001527,0.091639,0.39484,HP_ABNORMAL_MIDBRAIN_MORPHOLOGY,0.980720472075418
PBX1_02,SET,113,0.023164,0.0018108,0.086858,0.39486,PBX1_02,0.980720472075418
GOBP_CARDIAC_CHAMBER_DEVELOP...,SET,162,0.019528,0.0018254,0.073241,0.39488,GOBP_CARDIAC_CHAMBER_DEVELOPMENT,0.980720472075418
GOCC_ENDOSOME_LUMEN,SET,37,0.039337,0.0017633,0.14759,0.39492,GOCC_ENDOSOME_LUMEN,0.980720472075418
GOCC_TROPONIN_COMPLEX,SET,8,0.089463,0.0018661,0.33569,0.39493,GOCC_TROPONIN_COMPLEX,0.980720472075418
GOBP_PERICENTRIC_HETEROCHROM...,SET,3,0.1591,0.0020326,0.59714,0.39495,GOBP_PERICENTRIC_HETEROCHROMATIN_FORMATION,0.980720472075418
GSE14308_TH17_VS_NATURAL_TRE...1,SET,180,0.016233,0.0015987,0.060941,0.39498,GSE14308_TH17_VS_NATURAL_TREG_DN,0.980720472075418
HOXA10_TARGET_GENES,SET,205,0.015314,0.0016083,0.057502,0.395,HOXA10_TARGET_GENES,0.980720472075418
GOCC_SCF_UBIQUITIN_LIGASE_CO...,SET,59,0.030597,0.0017308,0.11494,0.39504,GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX,0.980720472075418
GOCC_H4_HISTONE_ACETYLTRANSF...,SET,37,0.035668,0.0015988,0.13399,0.39505,GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.980720472075418
GOBP_METANEPHRIC_LOOP_OF_HEN...,SET,5,0.11362,0.0018739,0.4269,0.39506,GOBP_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT,0.980720472075418
ADDYA_ERYTHROID_DIFFERENTIAT...,SET,69,0.030627,0.0018731,0.11509,0.39508,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,0.980720472075418
HP_SPASTIC_HYPERACTIVE_BLADD...,SET,9,0.078193,0.00173,0.29385,0.39508,HP_SPASTIC_HYPERACTIVE_BLADDER,0.980720472075418
REACTOME_ACTIVATION_OF_THE_T...,SET,11,0.072445,0.0017718,0.27229,0.3951,REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS,0.980720472075418
REACTOME_NEUROTRANSMITTER_CL...,SET,9,0.077419,0.0017128,0.29103,0.39511,REACTOME_NEUROTRANSMITTER_CLEARANCE,0.980720472075418
TAKAYAMA_BOUND_BY_AR,SET,10,0.073152,0.0017059,0.27531,0.39523,TAKAYAMA_BOUND_BY_AR,0.980732737585616
MORF_MTA1,SET,93,0.022284,0.0015812,0.08386,0.39523,MORF_MTA1,0.980732737585616
GOBP_VITAMIN_A_METABOLIC_PRO...,SET,8,0.089236,0.0018614,0.33601,0.39528,GOBP_VITAMIN_A_METABOLIC_PROCESS,0.980732737585616
WP_ACUTE_VIRAL_MYOCARDITIS,SET,82,0.025985,0.0017318,0.097848,0.39529,WP_ACUTE_VIRAL_MYOCARDITIS,0.980732737585616
GOBP_MITOPHAGY,SET,57,0.028649,0.001593,0.10793,0.39534,GOBP_MITOPHAGY,0.980732737585616
GOBP_REGULATION_OF_EPIDERMIS...,SET,58,0.032143,0.0018029,0.12111,0.39535,GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.980732737585616
GSE45365_WT_VS_IFNAR_KO_BCEL...4,SET,161,0.017059,0.0015896,0.064275,0.39535,GSE45365_WT_VS_IFNAR_KO_BCELL_UP,0.980732737585616
REACTOME_SERINE_BIOSYNTHESIS,SET,9,0.070432,0.0015583,0.2655,0.3954,REACTOME_SERINE_BIOSYNTHESIS,0.980732737585616
HP_PROLINURIA,SET,7,0.10007,0.0019527,0.37728,0.39541,HP_PROLINURIA,0.980732737585616
BOWIE_RESPONSE_TO_EXTRACELLU...,SET,17,0.052795,0.001605,0.19911,0.39544,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,0.980732737585616
HP_TURRICEPHALY,SET,42,0.035031,0.0016727,0.1321,0.39544,HP_TURRICEPHALY,0.980732737585616
MIR6758_3P,SET,99,0.023182,0.0016969,0.087453,0.39548,MIR6758_3P,0.980732737585616
MIR4999_3P,SET,35,0.036503,0.0015915,0.13773,0.39549,MIR4999_3P,0.980732737585616
GCM_PTK2,SET,135,0.018886,0.0016127,0.071267,0.39551,GCM_PTK2,0.980732737585616
GSE23502_WT_VS_HDC_KO_MYELOI...4,SET,185,0.016915,0.0016886,0.063882,0.39559,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP,0.980861129342941
BYSTRYKH_HEMATOPOIESIS_STEM_...6,SET,121,0.019721,0.0015949,0.074562,0.3957,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,0.980947551849476
CHARAFE_BREAST_CANCER_LUMINA...1,SET,414,0.011986,0.0017786,0.045326,0.39572,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,0.980947551849476
REACTOME_APOBEC3G_MEDIATED_R...,SET,5,0.096476,0.0015911,0.36524,0.39584,REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION,0.980947551849476
GOBP_NEGATIVE_REGULATION_OF_...699,SET,51,0.034442,0.0018119,0.13047,0.39589,GOBP_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.980947551849476
GOMF_THIAMINE_TRANSMEMBRANE_...,SET,7,0.091745,0.0017902,0.34752,0.39589,GOMF_THIAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.980947551849476
GOBP_VESICLE_DOCKING,SET,57,0.029774,0.0016556,0.1128,0.39591,GOBP_VESICLE_DOCKING,0.980947551849476
GOCC_COLLAGEN_TYPE_IV_TRIMER,SET,4,0.12312,0.0018162,0.46652,0.39592,GOCC_COLLAGEN_TYPE_IV_TRIMER,0.980947551849476
GOBP_PROTEIN_RETENTION_IN_ER...,SET,8,0.073482,0.0015328,0.27846,0.39593,GOBP_PROTEIN_RETENTION_IN_ER_LUMEN,0.980947551849476
BIOCARTA_TH1TH2_PATHWAY,SET,18,0.055311,0.0017301,0.20963,0.39595,BIOCARTA_TH1TH2_PATHWAY,0.980947551849476
REACTOME_UPTAKE_AND_ACTIONS_...,SET,28,0.043886,0.0017117,0.16634,0.39596,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,0.980947551849476
HP_INCREASED_CUP_TO_DISC_RAT...,SET,8,0.092426,0.001928,0.35041,0.39598,HP_INCREASED_CUP_TO_DISC_RATIO,0.980947551849476
DEBOSSCHER_NFKB_TARGETS_REPR...,SET,21,0.052644,0.0017785,0.19961,0.39599,DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,0.980947551849476
MEISSNER_NPC_HCP_WITH_H3K4ME...2,SET,140,0.020315,0.0017663,0.077038,0.39601,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.980947551849476
GSE40274_FOXP3_VS_FOXP3_AND_...6,SET,138,0.019853,0.0017139,0.075301,0.39602,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.980947551849476
GOBP_HOMOTYPIC_CELL_CELL_ADH...,SET,94,0.024859,0.0017733,0.094358,0.3961,GOBP_HOMOTYPIC_CELL_CELL_ADHESION,0.980960741769987
GOMF_PROTEIN_CARRIER_CHAPERO...,SET,31,0.039184,0.001608,0.14873,0.3961,GOMF_PROTEIN_CARRIER_CHAPERONE,0.980960741769987
JAK2_DN.V1_DN,SET,116,0.019755,0.0015645,0.07499,0.39611,JAK2_DN.V1_DN,0.980960741769987
DESCARTES_MAIN_FETAL_SLC26A4...,SET,197,0.014944,0.0015389,0.056749,0.39615,DESCARTES_MAIN_FETAL_SLC26A4_PAEP_POSITIVE_CELLS,0.980989900249377
MIR3135B,SET,97,0.022786,0.0016511,0.086558,0.39618,MIR3135B,0.980994293245939
GSE41978_WT_VS_BIM_KO_KLRG1_...1,SET,178,0.017098,0.0016746,0.064971,0.39621,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.980998685616585
GSE35685_CD34POS_CD10NEG_CD6...1,SET,191,0.016674,0.001691,0.063385,0.39625,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN,0.981027835161704
GOCC_NEURONAL_DENSE_CORE_VES...1,SET,25,0.050974,0.0018788,0.19392,0.39633,GOCC_NEURONAL_DENSE_CORE_VESICLE,0.98115600470119
GOMF_NUCLEOTIDYLTRANSFERASE_...,SET,120,0.018811,0.0015151,0.071619,0.39641,GOMF_NUCLEOTIDYLTRANSFERASE_ACTIVITY,0.981284155982906
GSE24210_IL35_TREATED_VS_RES...2,SET,178,0.017455,0.0017095,0.066475,0.39644,GSE24210_IL35_TREATED_VS_RESTING_TREG_UP,0.98128852645823
WP_PYRIMIDINE_METABOLISM_AND...,SET,19,0.052233,0.0016786,0.19909,0.39653,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.981441400797607
GOBP_NEGATIVE_REGULATION_OF_...610,SET,23,0.05187,0.0018338,0.19782,0.39658,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,0.981450117487895
HP_CRANIAL_ASYMMETRY,SET,15,0.058107,0.0016594,0.22162,0.39659,HP_CRANIAL_ASYMMETRY,0.981450117487895
REACTOME_HEME_SIGNALING,SET,45,0.033979,0.0016793,0.12984,0.39678,REACTOME_HEME_SIGNALING,0.981850402278391
GOMF_EXTRACELLULAR_MATRIX_ST...2,SET,19,0.050396,0.0016196,0.19276,0.39688,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE,0.981958026624902
HP_NREM_PARASOMNIA,SET,16,0.059605,0.0017579,0.228,0.39688,HP_NREM_PARASOMNIA,0.981958026624902
GOBP_NITROGEN_CYCLE_METABOLI...,SET,12,0.060686,0.0015502,0.23228,0.39694,GOBP_NITROGEN_CYCLE_METABOLIC_PROCESS,0.981991405082212
HP_4_5_FINGER_SYNDACTYLY,SET,5,0.11286,0.0018613,0.43196,0.39695,HP_4_5_FINGER_SYNDACTYLY,0.981991405082212
REACTOME_ALPHA_LINOLENIC_OME...,SET,12,0.066053,0.0016873,0.25291,0.39698,REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,0.981995722419929
chr9q34,SET,183,0.031499,0.0031276,0.12074,0.39709,chr9q34,0.982183029467882
MIR3160_3P,SET,66,0.028164,0.0016848,0.10799,0.39713,MIR3160_3P,0.982183029467882
GOBP_NEGATIVE_REGULATION_OF_...207,SET,12,0.072239,0.0018453,0.27716,0.39719,GOBP_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.982183029467882
GSE37301_HEMATOPOIETIC_STEM_...5,SET,162,0.017912,0.0016743,0.068731,0.3972,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN,0.982183029467882
GOCC_PLATELET_DENSE_TUBULAR_...2,SET,8,0.071682,0.0014953,0.27511,0.39722,GOCC_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE,0.982183029467882
HP_LIMB_GIRDLE_MUSCLE_WEAKNE...,SET,86,0.022932,0.001565,0.08806,0.39728,HP_LIMB_GIRDLE_MUSCLE_WEAKNESS,0.982183029467882
GOBP_CELLULAR_RESPONSE_TO_DS...,SET,19,0.052815,0.0016973,0.20299,0.39736,GOBP_CELLULAR_RESPONSE_TO_DSRNA,0.982183029467882
GOMF_CHROMO_SHADOW_DOMAIN_BI...,SET,5,0.088382,0.0014576,0.33972,0.39737,GOMF_CHROMO_SHADOW_DOMAIN_BINDING,0.982183029467882
GOBP_REGULATION_OF_MUSCLE_OR...,SET,23,0.054038,0.0019105,0.20773,0.39738,GOBP_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,0.982183029467882
GSE360_LOW_DOSE_B_MALAYI_VS_...1,SET,184,0.016717,0.0016643,0.064273,0.3974,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,0.982183029467882
GOBP_OLFACTORY_BULB_INTERNEU...2,SET,12,0.076174,0.0019458,0.29293,0.39742,GOBP_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION,0.982183029467882
TONKS_TARGETS_OF_RUNX1_RUNX1...9,SET,42,0.034827,0.001663,0.13396,0.39744,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,0.982183029467882
WP_LIVER_X_RECEPTOR_PATHWAY,SET,10,0.07353,0.0017147,0.28284,0.39745,WP_LIVER_X_RECEPTOR_PATHWAY,0.982183029467882
GOMF_TPR_DOMAIN_BINDING,SET,7,0.066409,0.0012958,0.25568,0.39754,GOMF_TPR_DOMAIN_BINDING,0.982183029467882
GOBP_POSITIVE_REGULATION_OF_...367,SET,8,0.068721,0.0014335,0.26466,0.39757,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,0.982183029467882
HP_LATE_FIRST_TRIMESTER_ONSET,SET,7,0.079529,0.0015518,0.30662,0.39768,HP_LATE_FIRST_TRIMESTER_ONSET,0.982183029467882
VANASSE_BCL2_TARGETS_DN,SET,53,0.029255,0.0015688,0.11284,0.39771,VANASSE_BCL2_TARGETS_DN,0.982183029467882
GOBP_RESPONSE_TO_ENDOGENOUS_...,SET,1524,0.006134,0.0016916,0.023659,0.39772,GOBP_RESPONSE_TO_ENDOGENOUS_STIMULUS,0.982183029467882
GSE40273_EOS_KO_VS_WT_TREG_DN,SET,189,0.016089,0.0016232,0.062095,0.39778,GSE40273_EOS_KO_VS_WT_TREG_DN,0.982183029467882
GOCC_REPLICATION_FORK,SET,69,0.025035,0.0015311,0.096639,0.3978,GOCC_REPLICATION_FORK,0.982183029467882
GOMF_PHOSPHORUS_OXYGEN_LYASE...,SET,20,0.053275,0.0017565,0.2057,0.39782,GOMF_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY,0.982183029467882
HP_PAROXYSMAL_SUPRAVENTRICUL...,SET,5,0.10884,0.001795,0.42048,0.39788,HP_PAROXYSMAL_SUPRAVENTRICULAR_TACHYCARDIA,0.982183029467882
KYNG_NORMAL_AGING_DN,SET,16,0.056541,0.0016676,0.21859,0.39795,KYNG_NORMAL_AGING_DN,0.982183029467882
GSE41867_LCMV_ARMSTRONG_VS_C...6,SET,174,0.016598,0.0016074,0.06421,0.39801,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP,0.982183029467882
HE_LIM_SUN_FETAL_LUNG_C3_MID...,SET,50,0.03439,0.0017914,0.13305,0.39802,HE_LIM_SUN_FETAL_LUNG_C3_MID_CAP_CELL,0.982183029467882
GOBP_POSITIVE_REGULATION_OF_...759,SET,6,0.08817,0.0015928,0.34122,0.39805,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.982183029467882
GOBP_NEGATIVE_REGULATION_OF_...426,SET,10,0.074274,0.0017321,0.28763,0.39812,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.982183029467882
GSE339_CD4POS_VS_CD4CD8DN_DC...2,SET,189,0.01608,0.0016223,0.062275,0.39812,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,0.982183029467882
GSE5589_LPS_VS_LPS_AND_IL6_S...3,SET,188,0.015985,0.0016084,0.061907,0.39813,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.982183029467882
HASLINGER_B_CLL_WITH_MUTATED...,SET,16,0.058721,0.0017319,0.22751,0.39817,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,0.982183029467882
GOBP_FATTY_ACYL_COA_CATABOLI...,SET,5,0.090268,0.0014887,0.34975,0.39817,GOBP_FATTY_ACYL_COA_CATABOLIC_PROCESS,0.982183029467882
GOBP_ANTIBACTERIAL_INNATE_IM...,SET,8,0.080366,0.0016764,0.31142,0.39818,GOBP_ANTIBACTERIAL_INNATE_IMMUNE_RESPONSE,0.982183029467882
GOBP_TRABECULA_MORPHOGENESIS,SET,46,0.035271,0.0017624,0.13678,0.39826,GOBP_TRABECULA_MORPHOGENESIS,0.982183029467882
GSE26727_WT_VS_KLF2_KO_LPS_S...1,SET,189,0.015993,0.0016135,0.062023,0.39826,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN,0.982183029467882
GOBP_REGULATION_OF_RETROGRAD...1,SET,12,0.055721,0.0014234,0.21613,0.39828,GOBP_REGULATION_OF_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL,0.982183029467882
GOBP_EYELID_DEVELOPMENT_IN_C...,SET,13,0.069784,0.0018553,0.27088,0.39835,GOBP_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.982183029467882
HP_HYPNOPOMPIC_HALLUCINATION,SET,6,0.097907,0.0017688,0.38005,0.39835,HP_HYPNOPOMPIC_HALLUCINATION,0.982183029467882
REACTOME_FORMATION_OF_LATERA...,SET,5,0.10426,0.0017195,0.40474,0.39836,REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM,0.982183029467882
GOBP_DEVELOPMENTAL_GROWTH_IN...,SET,212,0.015834,0.0016908,0.061482,0.39839,GOBP_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS,0.982183029467882
GOMF_PHOSPHORIC_DIESTER_HYDR...,SET,86,0.023936,0.0016336,0.092953,0.39839,GOMF_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY,0.982183029467882
GOBP_HISTIDINE_METABOLIC_PRO...,SET,8,0.082534,0.0017216,0.32052,0.3984,GOBP_HISTIDINE_METABOLIC_PROCESS,0.982183029467882
HP_ABNORMALITY_OF_RADIAL_EPI...,SET,5,0.10303,0.0016992,0.40102,0.39862,HP_ABNORMALITY_OF_RADIAL_EPIPHYSES,0.982183029467882
GOCC_U5_SNRNP,SET,19,0.048526,0.0015595,0.18891,0.39864,GOCC_U5_SNRNP,0.982183029467882
GOBP_PEPTIDE_MODIFICATION,SET,5,0.10224,0.0016862,0.39827,0.3987,GOBP_PEPTIDE_MODIFICATION,0.982183029467882
GSE6092_IFNG_VS_IFNG_AND_B_B...1,SET,160,0.018205,0.0016912,0.070947,0.39874,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,0.982183029467882
GOBP_INTRACELLULAR_GLUCOSE_H...,SET,142,0.019103,0.0016727,0.074455,0.39876,GOBP_INTRACELLULAR_GLUCOSE_HOMEOSTASIS,0.982183029467882
KEGG_MEDICUS_REFERENCE_HYDRO...,SET,8,0.080125,0.0016714,0.31238,0.39878,KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN,0.982183029467882
GAVISH_3CA_MALIGNANT_METAPRO...38,SET,46,0.028504,0.0014243,0.11114,0.3988,GAVISH_3CA_MALIGNANT_METAPROGRAM_8_PROTEASOMAL_DEGRADATION,0.982183029467882
GSE18893_CTRL_VS_TNF_TREATED...3,SET,178,0.015688,0.0015364,0.061234,0.3989,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN,0.982183029467882
GOMF_PRE_MRNA_3_SPLICE_SITE_...,SET,3,0.12247,0.0015646,0.47808,0.39891,GOMF_PRE_MRNA_3_SPLICE_SITE_BINDING,0.982183029467882
WP_PHOSPHOINOSITIDES_METABOL...,SET,43,0.032683,0.0015791,0.12759,0.39892,WP_PHOSPHOINOSITIDES_METABOLISM,0.982183029467882
MODULE_318,SET,27,0.03964,0.0015183,0.15484,0.39898,MODULE_318,0.982183029467882
GOBP_REGULATION_OF_LAMELLIPO...1,SET,32,0.041146,0.0017154,0.16073,0.39898,GOBP_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.982183029467882
MIR4430,SET,128,0.019358,0.0016099,0.075627,0.39899,MIR4430,0.982183029467882
GOMF_CLATHRIN_LIGHT_CHAIN_BI...,SET,6,0.079696,0.0014398,0.31142,0.39901,GOMF_CLATHRIN_LIGHT_CHAIN_BINDING,0.982183029467882
GSE3982_EFF_MEMORY_CD4_TCELL...5,SET,184,0.015757,0.0015687,0.061571,0.39901,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN,0.982183029467882
WP_EICOSANOID_METABOLISM_VIA...1,SET,30,0.041254,0.0016654,0.16126,0.39905,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.982183029467882
GOMF_SIGNALING_ADAPTOR_ACTIV...,SET,109,0.021077,0.0016184,0.08239,0.39905,GOMF_SIGNALING_ADAPTOR_ACTIVITY,0.982183029467882
GOMF_IRON_ION_BINDING,SET,139,0.019684,0.0017054,0.076996,0.39911,GOMF_IRON_ION_BINDING,0.982183029467882
MODULE_501,SET,15,0.05788,0.0016529,0.22642,0.39912,MODULE_501,0.982183029467882
HP_OROFACIAL_DYSKINESIA,SET,24,0.043542,0.0015725,0.17035,0.39913,HP_OROFACIAL_DYSKINESIA,0.982183029467882
HP_PERSISTENT_BLEEDING_AFTER...,SET,12,0.066971,0.0017108,0.26205,0.39915,HP_PERSISTENT_BLEEDING_AFTER_TRAUMA,0.982183029467882
NABA_MATRISOME_HIGHLY_METAST...1,SET,37,0.034665,0.0015538,0.13566,0.39916,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER,0.982183029467882
HP_ABNORMAL_CIRCULATING_ARGI...,SET,8,0.067787,0.001414,0.26528,0.39916,HP_ABNORMAL_CIRCULATING_ARGININE_CONCENTRATION,0.982183029467882
GOBP_INTESTINAL_EPITHELIAL_C...3,SET,6,0.087439,0.0015797,0.34233,0.3992,GOBP_INTESTINAL_EPITHELIAL_CELL_MATURATION,0.982183029467882
MIR503_5P,SET,95,0.023144,0.0016597,0.090638,0.39923,MIR503_5P,0.982183029467882
ZHANG_BREAST_CANCER_PROGENIT...2,SET,396,0.01082,0.0015711,0.042379,0.39924,ZHANG_BREAST_CANCER_PROGENITORS_UP,0.982183029467882
GNF2_CKS1B,SET,36,0.033012,0.0014597,0.1293,0.39924,GNF2_CKS1B,0.982183029467882
HP_AORTIC_ARCH_ANEURYSM,SET,37,0.042984,0.0019267,0.16835,0.39924,HP_AORTIC_ARCH_ANEURYSM,0.982183029467882
REACTOME_INLA_MEDIATED_ENTRY...,SET,8,0.080345,0.0016759,0.31482,0.39928,REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS,0.982183029467882
MIR122B_3P,SET,124,0.020341,0.0016652,0.0797,0.39928,MIR122B_3P,0.982183029467882
ZNF112_TARGET_GENES,SET,3,0.13225,0.0016895,0.51817,0.39928,ZNF112_TARGET_GENES,0.982183029467882
HP_SUPRANUCLEAR_OPHTHALMOPLE...,SET,4,0.095112,0.001403,0.37281,0.39931,HP_SUPRANUCLEAR_OPHTHALMOPLEGIA,0.982183029467882
GSE28726_NAIVE_VS_ACTIVATED_...6,SET,181,0.015768,0.0015571,0.061822,0.39934,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP,0.982183029467882
WANG_LSD1_TARGETS_DN,SET,34,0.040224,0.0017285,0.15795,0.3995,WANG_LSD1_TARGETS_DN,0.982183029467882
KEGG_STEROID_HORMONE_BIOSYNT...,SET,52,0.036776,0.0019535,0.14443,0.3995,KEGG_STEROID_HORMONE_BIOSYNTHESIS,0.982183029467882
GOCC_DENDRITIC_TREE,SET,571,0.0095039,0.001649,0.037326,0.39951,GOCC_DENDRITIC_TREE,0.982183029467882
GSE22601_DOUBLE_POSITIVE_VS_...1,SET,183,0.015386,0.0015276,0.06043,0.39952,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.982183029467882
LUND_SILENCED_BY_METHYLATION,SET,14,0.054434,0.0015018,0.21385,0.39954,LUND_SILENCED_BY_METHYLATION,0.982183029467882
SP1_01,SET,216,0.014867,0.0016023,0.058418,0.39956,SP1_01,0.982183029467882
MIR548AE_3P_MIR548AQ_3P,SET,720,0.0082699,0.0016045,0.0325,0.39957,MIR548AE_3P_MIR548AQ_3P,0.982183029467882
HP_BRACHYTURRICEPHALY,SET,8,0.082284,0.0017164,0.32341,0.39958,HP_BRACHYTURRICEPHALY,0.982183029467882
MIR4649_3P,SET,186,0.016541,0.0016557,0.065016,0.39959,MIR4649_3P,0.982183029467882
GSE360_CTRL_VS_B_MALAYI_LOW_...3,SET,179,0.016044,0.0015757,0.06307,0.3996,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.982183029467882
GOBP_VENTRICULAR_CARDIAC_MUS...5,SET,60,0.031873,0.0018182,0.12538,0.39967,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.982183029467882
GOMF_MRNA_METHYLTRANSFERASE_...,SET,12,0.054216,0.0013849,0.2133,0.39968,GOMF_MRNA_METHYLTRANSFERASE_ACTIVITY,0.982183029467882
HP_ABNORMAL_BRAIN_N_ACETYL_A...,SET,19,0.046621,0.0014982,0.18342,0.39968,HP_ABNORMAL_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.982183029467882
GOBP_ATRIOVENTRICULAR_NODE_D...,SET,9,0.075227,0.0016643,0.29599,0.39969,GOBP_ATRIOVENTRICULAR_NODE_DEVELOPMENT,0.982183029467882
GAVISH_3CA_METAPROGRAM_B_CEL...1,SET,41,0.032565,0.0015364,0.12814,0.3997,GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1,0.982183029467882
GOMF_TELOMERASE_RNA_BINDING,SET,20,0.049572,0.0016344,0.19506,0.3997,GOMF_TELOMERASE_RNA_BINDING,0.982183029467882
GSE3982_CTRL_VS_LPS_48H_DC_UP,SET,183,0.016158,0.0016044,0.063582,0.3997,GSE3982_CTRL_VS_LPS_48H_DC_UP,0.982183029467882
WP_SREBF_AND_MIR33_IN_CHOLES...,SET,16,0.052193,0.0015393,0.20544,0.39973,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,0.982183029467882
GSE41867_NAIVE_VS_DAY30_LCMV...4,SET,170,0.017501,0.0016754,0.068925,0.39978,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP,0.982183029467882
GSE19198_1H_VS_24H_IL21_TREA...2,SET,179,0.016899,0.0016596,0.066561,0.39979,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP,0.982183029467882
GOBP_POSITIVE_REGULATION_OF_...504,SET,9,0.078759,0.0017425,0.31024,0.3998,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.982183029467882
GOBP_CELLULAR_RESPONSE_TO_CO...2,SET,13,0.057659,0.001533,0.22716,0.39982,GOBP_CELLULAR_RESPONSE_TO_COLD,0.982183029467882
GOBP_MODULATION_BY_HOST_OF_V...2,SET,43,0.03363,0.0016248,0.13253,0.39984,GOBP_MODULATION_BY_HOST_OF_VIRAL_PROCESS,0.982183029467882
chr17q11,SET,76,0.054975,0.0035279,0.21674,0.39988,chr17q11,0.982183029467882
HP_APLASIA_HYPOPLASIA_INVOLV...7,SET,4,0.10619,0.0015664,0.4186,0.39988,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.982183029467882
MIR616_5P,SET,856,0.007609,0.0016035,0.03,0.39989,MIR616_5P,0.982183029467882
GOBP_CELL_MORPHOGENESIS_INVO...,SET,535,0.0099615,0.0016747,0.039282,0.39991,GOBP_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION,0.982183029467882
SENESE_HDAC2_TARGETS_UP,SET,106,0.020393,0.0015443,0.080494,0.4,SENESE_HDAC2_TARGETS_UP,0.982334652345958
REACTOME_ASPARAGINE_N_LINKED...,SET,291,0.012391,0.0015468,0.048928,0.40004,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,0.982363470642267
FAN_EMBRYONIC_CTX_IN_3_INTER...,SET,5,0.10415,0.0017176,0.41135,0.40007,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.982367729970326
HP_UPPER_EYELID_COLOBOMA,SET,9,0.074348,0.0016449,0.29385,0.40013,HP_UPPER_EYELID_COLOBOMA,0.98242534967505
HP_JAW_HYPERREFLEXIA,SET,39,0.033303,0.0015325,0.13165,0.40015,HP_JAW_HYPERREFLEXIA,0.98242534967505
GSE15324_NAIVE_VS_ACTIVATED_...1,SET,184,0.015439,0.0015371,0.061103,0.40026,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.982528733319212
LEE_LIVER_CANCER_E2F1_UP,SET,60,0.032313,0.0018433,0.12805,0.40039,LEE_LIVER_CANCER_E2F1_UP,0.982528733319212
KEGG_MEDICUS_VARIANT_AMPLIFI...11,SET,6,0.076218,0.0013769,0.30204,0.40039,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_REPRESSION,0.982528733319212
GOBP_NEGATIVE_REGULATION_OF_...445,SET,7,0.07395,0.001443,0.29305,0.40039,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.982528733319212
GOBP_PROTEIN_TARGETING,SET,296,0.012347,0.0015543,0.048932,0.40039,GOBP_PROTEIN_TARGETING,0.982528733319212
GSE13522_CTRL_VS_T_CRUZI_Y_S...4,SET,122,0.018171,0.0014756,0.072007,0.40039,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP,0.982528733319212
GSE25123_WT_VS_PPARG_KO_MACR...3,SET,162,0.016795,0.0015698,0.066554,0.40039,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP,0.982528733319212
GOBP_PURINE_CONTAINING_COMPO...1,SET,138,0.017912,0.0015463,0.071038,0.40046,GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.982541465480729
GSE17721_CTRL_VS_LPS_24H_BMD...1,SET,185,0.015814,0.0015786,0.06272,0.40047,GSE17721_CTRL_VS_LPS_24H_BMDC_DN,0.982541465480729
MIR514B_5P,SET,167,0.016885,0.0016022,0.066974,0.40048,MIR514B_5P,0.982541465480729
HP_SKELETAL_MUSCLE_HYPERTROP...,SET,184,0.016271,0.0016199,0.064591,0.40056,HP_SKELETAL_MUSCLE_HYPERTROPHY,0.982541682459465
WEINMANN_ADAPTATION_TO_HYPOX...2,SET,25,0.047749,0.0017599,0.18967,0.40062,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,0.982541682459465
GOMF_UBIQUITIN_LIKE_PROTEIN_...6,SET,93,0.020523,0.0014563,0.081534,0.40063,GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY,0.982541682459465
GSE26669_CTRL_VS_COSTIM_BLOC...1,SET,174,0.016318,0.0015803,0.064899,0.40074,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN,0.982541682459465
GOMF_LIGASE_ACTIVITY_FORMING...4,SET,38,0.03325,0.0015104,0.13229,0.40077,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS,0.982541682459465
GNF2_SNRK,SET,26,0.042269,0.0015887,0.16817,0.40078,GNF2_SNRK,0.982541682459465
GOBP_GDP_MANNOSE_METABOLIC_P...,SET,6,0.070934,0.0012815,0.28227,0.40079,GOBP_GDP_MANNOSE_METABOLIC_PROCESS,0.982541682459465
MIR4704_3P,SET,124,0.019768,0.0016183,0.078737,0.40088,MIR4704_3P,0.982541682459465
HEBERT_MATRISOME_TNBC_LIVER_...,SET,13,0.06388,0.0016984,0.25449,0.4009,HEBERT_MATRISOME_TNBC_LIVER_METASTASIS,0.982541682459465
KEGG_MEDICUS_VARIANT_MUTATIO...86,SET,27,0.040919,0.0015672,0.16308,0.40094,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.982541682459465
GSE42021_CD24LO_TREG_VS_CD24...1,SET,184,0.015049,0.0014982,0.059985,0.40096,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN,0.982541682459465
GSE3039_B2_VS_B1_BCELL_DN,SET,180,0.014948,0.0014721,0.05961,0.401,GSE3039_B2_VS_B1_BCELL_DN,0.982541682459465
ZNF101_TARGET_GENES,SET,360,0.011268,0.0015616,0.044947,0.40102,ZNF101_TARGET_GENES,0.982541682459465
HU_GENOTOXIN_ACTION_DIRECT_V...2,SET,37,0.036241,0.0016245,0.14461,0.40106,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,0.982541682459465
GSE24634_NAIVE_CD4_TCELL_VS_...7,SET,178,0.015519,0.0015199,0.061931,0.40107,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN,0.982541682459465
HP_CELLULITIS,SET,44,0.032667,0.0015965,0.1305,0.40117,HP_CELLULITIS,0.982541682459465
MIR4782_3P,SET,140,0.0178,0.0015476,0.071121,0.40119,MIR4782_3P,0.982541682459465
HP_OSTEOPENIA,SET,288,0.012705,0.0015779,0.050767,0.40119,HP_OSTEOPENIA,0.982541682459465
GOBP_BONE_TRABECULA_FORMATION,SET,11,0.064862,0.0015864,0.25929,0.40124,GOBP_BONE_TRABECULA_FORMATION,0.982541682459465
HP_MESOAXIAL_FOOT_POLYDACTYLY,SET,4,0.12718,0.0018761,0.50851,0.40125,HP_MESOAXIAL_FOOT_POLYDACTYLY,0.982541682459465
LI_PBMC_MENACTRA_AGE_18_45YO...2,SET,15,0.059421,0.0016969,0.23759,0.40126,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.982541682459465
GOBP_BODY_MORPHOGENESIS,SET,45,0.031892,0.0015762,0.12759,0.40131,GOBP_BODY_MORPHOGENESIS,0.982541682459465
GOBP_CELL_VOLUME_HOMEOSTASIS,SET,34,0.038514,0.001655,0.1541,0.40132,GOBP_CELL_VOLUME_HOMEOSTASIS,0.982541682459465
GOMF_D1_DOPAMINE_RECEPTOR_BI...,SET,6,0.07808,0.0014106,0.31242,0.40133,GOMF_D1_DOPAMINE_RECEPTOR_BINDING,0.982541682459465
HP_ALVEOLAR_RIDGE_OVERGROWTH,SET,11,0.062698,0.0015335,0.25087,0.40133,HP_ALVEOLAR_RIDGE_OVERGROWTH,0.982541682459465
HP_EMG_SLOW_MOTOR_CONDUCTION,SET,5,0.08848,0.0014592,0.35414,0.40136,HP_EMG_SLOW_MOTOR_CONDUCTION,0.982541682459465
REACTOME_TGFBR3_PTM_REGULATI...,SET,9,0.071056,0.001572,0.28449,0.40139,REACTOME_TGFBR3_PTM_REGULATION,0.982541682459465
GOBP_DENSE_CORE_GRANULE_TRAN...,SET,10,0.068328,0.0015934,0.27381,0.40147,GOBP_DENSE_CORE_GRANULE_TRANSPORT,0.982541682459465
GOBP_L_AMINO_ACID_BIOSYNTHET...,SET,55,0.029111,0.0015902,0.11669,0.4015,GOBP_L_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.982541682459465
GSE17721_LPS_VS_POLYIC_16H_B...1,SET,190,0.0158,0.0015982,0.063353,0.40153,GSE17721_LPS_VS_POLYIC_16H_BMDC_DN,0.982541682459465
GOBP_REGULATION_OF_MRNA_3_EN...,SET,9,0.06507,0.0014396,0.26109,0.4016,GOBP_REGULATION_OF_MRNA_3_END_PROCESSING,0.982541682459465
GSE17721_LPS_VS_CPG_8H_BMDC_...2,SET,186,0.015954,0.0015969,0.064071,0.40168,GSE17721_LPS_VS_CPG_8H_BMDC_UP,0.982541682459465
MIR6767_3P,SET,24,0.04335,0.0015655,0.17413,0.4017,MIR6767_3P,0.982541682459465
GOBP_RESPONSE_TO_EPIDERMAL_G...,SET,42,0.032309,0.0015428,0.1298,0.40172,GOBP_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR,0.982541682459465
GOBP_NEGATIVE_REGULATION_OF_...549,SET,9,0.067979,0.001504,0.2732,0.40175,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING,0.982541682459465
GSE4535_BM_DERIVED_DC_VS_FOL...1,SET,177,0.01563,0.0015265,0.06282,0.40176,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN,0.982541682459465
GAVISH_3CA_METAPROGRAM_EPITH...16,SET,48,0.029598,0.0015107,0.11899,0.40178,GAVISH_3CA_METAPROGRAM_EPITHELIAL_MYC,0.982541682459465
GOBP_EMBRYONIC_PLACENTA_MORP...,SET,24,0.046164,0.0016671,0.18559,0.40178,GOBP_EMBRYONIC_PLACENTA_MORPHOGENESIS,0.982541682459465
HP_ABNORMAL_DENTAL_ROOT_MORP...,SET,47,0.030878,0.0015595,0.12416,0.4018,HP_ABNORMAL_DENTAL_ROOT_MORPHOLOGY,0.982541682459465
REACTOME_KERATAN_SULFATE_DEG...,SET,15,0.057322,0.001637,0.23051,0.40181,REACTOME_KERATAN_SULFATE_DEGRADATION,0.982541682459465
REACTOME_CREB3_FACTORS_ACTIV...,SET,8,0.066655,0.0013904,0.26813,0.40184,REACTOME_CREB3_FACTORS_ACTIVATE_GENES,0.982541682459465
WP_NUCLEAR_RECEPTORS_IN_LIPI...,SET,33,0.038325,0.0016226,0.15416,0.40184,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.982541682459465
GSE40277_EOS_AND_LEF1_TRANSD...3,SET,181,0.01598,0.001578,0.064309,0.40188,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN,0.982541682459465
WP_IL4_SIGNALING,SET,50,0.032025,0.0016682,0.12896,0.40194,WP_IL4_SIGNALING,0.982541682459465
HP_SLOW_SACCADIC_EYE_MOVEMEN...,SET,34,0.035431,0.0015225,0.14269,0.40195,HP_SLOW_SACCADIC_EYE_MOVEMENTS,0.982541682459465
HP_NEONATAL_HYPOGLYCEMIA,SET,42,0.033044,0.0015779,0.13311,0.40198,HP_NEONATAL_HYPOGLYCEMIA,0.982541682459465
GOBP_NEGATIVE_REGULATION_OF_...598,SET,31,0.034131,0.0014006,0.13752,0.40199,GOBP_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.982541682459465
BROWNE_HCMV_INFECTION_8HR_UP,SET,92,0.022403,0.0015811,0.090294,0.40202,BROWNE_HCMV_INFECTION_8HR_UP,0.982541682459465
SCHLOSSER_SERUM_RESPONSE_AUG...,SET,100,0.019467,0.0014321,0.078472,0.40204,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,0.982541682459465
AZARE_STAT3_TARGETS,SET,23,0.045359,0.0016036,0.18292,0.40208,AZARE_STAT3_TARGETS,0.982541682459465
GOBP_NEGATIVE_REGULATION_OF_...367,SET,14,0.060811,0.0016778,0.24523,0.40208,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,0.982541682459465
HE_LIM_SUN_FETAL_LUNG_C1_SMG...1,SET,347,0.012344,0.0016801,0.049789,0.4021,HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL,0.982541682459465
GSE20500_CTRL_VS_RARA_ANTAGO...1,SET,180,0.014946,0.0014719,0.060289,0.40211,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,0.982541682459465
MIR5003_3P,SET,293,0.012707,0.0015917,0.051281,0.40215,MIR5003_3P,0.982541682459465
GSE1432_1H_VS_6H_IFNG_MICROG...1,SET,180,0.015863,0.0015622,0.06407,0.40223,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.982541682459465
GOBP_RESPONSE_TO_VIRUS,SET,369,0.011654,0.0016347,0.047076,0.40224,GOBP_RESPONSE_TO_VIRUS,0.982541682459465
HP_ABNORMALITY_OF_RENIN_ANGI...,SET,35,0.038656,0.0016853,0.1562,0.40227,HP_ABNORMALITY_OF_RENIN_ANGIOTENSIN_SYSTEM,0.982541682459465
BIOCARTA_VOBESITY_PATHWAY,SET,8,0.084992,0.0017729,0.34347,0.40228,BIOCARTA_VOBESITY_PATHWAY,0.982541682459465
QI_HYPOXIA,SET,128,0.018709,0.0015559,0.075623,0.4023,QI_HYPOXIA,0.982541682459465
HAY_BONE_MARROW_CD34_POS_LYM...,SET,7,0.094011,0.0018344,0.38013,0.40233,HAY_BONE_MARROW_CD34_POS_LYMPHOID_UNK,0.982541682459465
CUI_TCF21_TARGETS_DN,SET,30,0.04514,0.0018223,0.18255,0.40235,CUI_TCF21_TARGETS_DN,0.982541682459465
NUYTTEN_EZH2_TARGETS_DN,SET,909,0.0068724,0.0014901,0.027792,0.40235,NUYTTEN_EZH2_TARGETS_DN,0.982541682459465
WP_ENVELOPE_PROTEINS_AND_THE...,SET,43,0.033445,0.0016159,0.13525,0.40235,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,0.982541682459465
HP_ABSENCE_OF_SECONDARY_SEX_...,SET,40,0.03551,0.0016549,0.14361,0.40235,HP_ABSENCE_OF_SECONDARY_SEX_CHARACTERISTICS,0.982541682459465
GOBP_ENDOSOME_TO_LYSOSOME_TR...2,SET,17,0.047894,0.001456,0.19385,0.40243,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.982541682459465
GSE17721_PAM3CSK4_VS_CPG_2H_...2,SET,181,0.016139,0.0015937,0.065338,0.40245,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP,0.982541682459465
GSE37301_HEMATOPOIETIC_STEM_...7,SET,154,0.016434,0.001498,0.066576,0.40252,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN,0.982541682459465
GSE29617_CTRL_VS_DAY7_TIV_FL...2,SET,171,0.017558,0.0016857,0.07116,0.40256,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,0.982541682459465
REACTOME_RHO_GTPASES_ACTIVAT...2,SET,129,0.018186,0.0015183,0.073728,0.40259,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,0.982541682459465
GOBP_CELL_ADHESION_INVOLVED_...,SET,7,0.097073,0.0018942,0.39372,0.40263,GOBP_CELL_ADHESION_INVOLVED_IN_HEART_MORPHOGENESIS,0.982541682459465
GOBP_PIGMENT_GRANULE_ORGANIZ...,SET,37,0.035814,0.0016054,0.14527,0.40263,GOBP_PIGMENT_GRANULE_ORGANIZATION,0.982541682459465
GSE41978_WT_VS_ID2_KO_KLRG1_...2,SET,187,0.015767,0.0015824,0.063952,0.40263,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.982541682459465
MIR4787_5P,SET,6,0.095619,0.0017274,0.38787,0.40264,MIR4787_5P,0.982541682459465
GOCC_AUTOPHAGOSOME,SET,105,0.020096,0.0015147,0.081518,0.40264,GOCC_AUTOPHAGOSOME,0.982541682459465
GOBP_TUMOR_NECROSIS_FACTOR_S...,SET,162,0.017594,0.0016446,0.071384,0.40266,GOBP_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.982541682459465
DESCARTES_FETAL_HEART_EPICAR...,SET,90,0.023755,0.0016583,0.096384,0.40267,DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS,0.982541682459465
GOMF_PROTEIN_ARGININE_OMEGA_...1,SET,7,0.081639,0.001593,0.33142,0.40272,GOMF_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY,0.982541682459465
GOBP_PEPTIDYL_ARGININE_METHY...2,SET,8,0.066916,0.0013958,0.27173,0.40274,GOBP_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE,0.982541682459465
LIU_VAV3_PROSTATE_CARCINOGEN...1,SET,14,0.061552,0.0016982,0.24998,0.40275,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,0.982541682459465
GSE29618_LAIV_VS_TIV_FLU_VAC...5,SET,173,0.015722,0.0015182,0.063847,0.40275,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN,0.982541682459465
GOBP_DEADENYLATION_DEPENDENT...,SET,10,0.061596,0.0014364,0.25019,0.40277,GOBP_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA,0.982541682459465
HATADA_METHYLATED_IN_LUNG_CA...2,SET,350,0.011634,0.0015902,0.047321,0.4029,HATADA_METHYLATED_IN_LUNG_CANCER_UP,0.982572107293128
HP_ABNORMAL_DENTAL_PULP_MORP...,SET,50,0.02986,0.0015554,0.12147,0.40291,HP_ABNORMAL_DENTAL_PULP_MORPHOLOGY,0.982572107293128
REACTOME_LEISHMANIA_INFECTION,SET,152,0.017061,0.0015452,0.069432,0.40295,REACTOME_LEISHMANIA_INFECTION,0.982572107293128
HP_TRACHEOESOPHAGEAL_FISTULA,SET,82,0.023824,0.0015879,0.096968,0.40296,HP_TRACHEOESOPHAGEAL_FISTULA,0.982572107293128
HP_ABNORMAL_PORTAL_VENOUS_SY...,SET,13,0.063713,0.0016939,0.25933,0.40297,HP_ABNORMAL_PORTAL_VENOUS_SYSTEM_MORPHOLOGY,0.982572107293128
HP_SYNKINESIS,SET,28,0.044109,0.0017204,0.17958,0.40299,HP_SYNKINESIS,0.982572107293128
BIOCARTA_CB1R_PATHWAY,SET,7,0.081352,0.0015874,0.33125,0.403,BIOCARTA_CB1R_PATHWAY,0.982572107293128
HE_LIM_SUN_FETAL_LUNG_C3_INT...,SET,354,0.012148,0.0016697,0.049495,0.40306,HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL,0.982572107293128
WP_ENTEROHEPATIC_CIRCULATION...,SET,12,0.064118,0.0016379,0.26133,0.40309,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,0.982572107293128
MACLACHLAN_BRCA1_TARGETS_UP,SET,19,0.048183,0.0015484,0.19642,0.40311,MACLACHLAN_BRCA1_TARGETS_UP,0.982572107293128
GOMF_RRNA_CYTOSINE_METHYLTRA...,SET,4,0.098408,0.0014517,0.40117,0.40311,GOMF_RRNA_CYTOSINE_METHYLTRANSFERASE_ACTIVITY,0.982572107293128
GOMF_PEPTIDASE_ACTIVATOR_ACT...2,SET,21,0.044596,0.0015066,0.18186,0.40314,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.982572107293128
HP_ABNORMAL_CIRCULATING_C_RE...,SET,59,0.028538,0.0016143,0.11638,0.40315,HP_ABNORMAL_CIRCULATING_C_REACTIVE_PROTEIN_CONCENTRATION,0.982572107293128
GOBP_NEGATIVE_REGULATION_OF_...687,SET,4,0.11704,0.0017265,0.47776,0.40324,GOBP_NEGATIVE_REGULATION_OF_URINE_VOLUME,0.982722544001122
WP_CELL_CYCLE,SET,116,0.018899,0.0014967,0.077206,0.40331,WP_CELL_CYCLE,0.982755314449975
GOMF_ACIDIC_AMINO_ACID_TRANS...,SET,18,0.052112,0.0016301,0.21288,0.40331,GOMF_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.982755314449975
KEGG_AMINOACYL_TRNA_BIOSYNTH...,SET,22,0.041508,0.0014353,0.16966,0.40336,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,0.982758435369417
chr10p15,SET,30,0.060688,0.00245,0.24822,0.40342,chr10p15,0.982758435369417
GSE2405_HEAT_KILLED_VS_LIVE_...3,SET,183,0.015661,0.001555,0.064066,0.40344,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,0.982758435369417
GOBP_NEUROPEPTIDE_SIGNALING_...,SET,92,0.023897,0.0016865,0.097846,0.40353,GOBP_NEUROPEPTIDE_SIGNALING_PATHWAY,0.982758435369417
GSE360_T_GONDII_VS_B_MALAYI_...3,SET,180,0.015328,0.0015095,0.062775,0.40355,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.982758435369417
HP_PROLONGED_BLEEDING_FOLLOW...2,SET,29,0.041434,0.0016446,0.16972,0.40357,HP_PROLONGED_BLEEDING_FOLLOWING_PROCEDURE,0.982758435369417
HP_CAROTID_ARTERY_TORTUOSITY,SET,4,0.11037,0.001628,0.45234,0.40362,HP_CAROTID_ARTERY_TORTUOSITY,0.982758435369417
KEGG_MEDICUS_REFERENCE_MLK_J...,SET,10,0.06956,0.0016221,0.28539,0.40372,KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY,0.982758435369417
GSE23321_EFFECTOR_MEMORY_VS_...2,SET,172,0.016389,0.001578,0.067285,0.40378,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.982758435369417
GSE40274_FOXP3_VS_FOXP3_AND_...12,SET,176,0.016135,0.0015714,0.06626,0.4038,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.982758435369417
GOMF_ALANINE_TRANSMEMBRANE_T...,SET,14,0.062054,0.0017121,0.25492,0.40384,GOMF_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.982758435369417
REACTOME_FGFR1_LIGAND_BINDIN...,SET,17,0.057932,0.0017611,0.23809,0.40388,REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,0.982758435369417
GOBP_REGULATION_OF_EXTRINSIC...3,SET,45,0.030009,0.0014831,0.12333,0.40388,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.982758435369417
MORF_PML,SET,133,0.018133,0.001537,0.07456,0.40392,MORF_PML,0.982758435369417
MORF_ETV3,SET,60,0.027002,0.0015403,0.1111,0.40399,MORF_ETV3,0.982758435369417
GSE411_UNSTIM_VS_400MIN_IL6_...1,SET,180,0.015112,0.0014882,0.06219,0.404,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN,0.982758435369417
GOBP_POSITIVE_REGULATION_OF_...145,SET,31,0.037406,0.001535,0.15395,0.40401,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.982758435369417
MODULE_29,SET,24,0.038978,0.0014076,0.16049,0.40405,MODULE_29,0.982758435369417
GSE17721_LPS_VS_PAM3CSK4_8H_...1,SET,181,0.014867,0.0014681,0.061222,0.40407,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN,0.982758435369417
GOBP_RESPONSE_TO_METAL_ION,SET,322,0.012115,0.0015895,0.049898,0.40409,GOBP_RESPONSE_TO_METAL_ION,0.982758435369417
KEGG_MEDICUS_REFERENCE_PRL_J...,SET,5,0.12819,0.0021141,0.52829,0.40414,KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY,0.982758435369417
GOMF_PROTEIN_TYROSINE_KINASE...4,SET,5,0.10228,0.0016868,0.42152,0.40414,GOMF_PROTEIN_TYROSINE_KINASE_INHIBITOR_ACTIVITY,0.982758435369417
MIR526B_5P,SET,94,0.021886,0.0015612,0.09021,0.40416,MIR526B_5P,0.982758435369417
HP_ABNORMAL_INTRAOCULAR_PRES...,SET,36,0.037037,0.0016376,0.15269,0.40417,HP_ABNORMAL_INTRAOCULAR_PRESSURE,0.982758435369417
MIR1843,SET,58,0.028072,0.0015745,0.11576,0.4042,MIR1843,0.982758435369417
GOBP_DENDRITE_SELF_AVOIDANCE,SET,14,0.067997,0.001876,0.28053,0.40424,GOBP_DENDRITE_SELF_AVOIDANCE,0.982758435369417
HP_RENAL_ARTERY_STENOSIS,SET,21,0.043453,0.001468,0.17936,0.40429,HP_RENAL_ARTERY_STENOSIS,0.982758435369417
HP_BLISTERING_BY_HISTOLOGICA...,SET,13,0.054794,0.0014568,0.22623,0.40431,HP_BLISTERING_BY_HISTOLOGICAL_LOCATION,0.982758435369417
HP_ROUND_EAR,SET,7,0.088638,0.0017296,0.3662,0.40437,HP_ROUND_EAR,0.982758435369417
GSE18791_CTRL_VS_NEWCASTLE_V...12,SET,138,0.018053,0.0015585,0.074586,0.40437,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP,0.982758435369417
GOBP_OSSIFICATION,SET,382,0.011219,0.0016006,0.046366,0.4044,GOBP_OSSIFICATION,0.982758435369417
HP_MANDIBULAR_APLASIA,SET,10,0.068882,0.0016063,0.2848,0.40445,HP_MANDIBULAR_APLASIA,0.982758435369417
FIRESTEIN_PROLIFERATION,SET,150,0.016659,0.0014989,0.068918,0.4045,FIRESTEIN_PROLIFERATION,0.982758435369417
HP_PULMONARY_CARCINOID_TUMOR,SET,8,0.065081,0.0013575,0.26925,0.4045,HP_PULMONARY_CARCINOID_TUMOR,0.982758435369417
GSE22589_HIV_VS_HIV_AND_SIV_...1,SET,182,0.014882,0.0014736,0.061564,0.4045,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN,0.982758435369417
GOBP_FATTY_ACID_CATABOLIC_PR...,SET,101,0.019517,0.0014428,0.080756,0.40452,GOBP_FATTY_ACID_CATABOLIC_PROCESS,0.982758435369417
HP_ERYTHROCYTE_INCLUSION_BOD...,SET,6,0.076381,0.0013799,0.3161,0.40453,HP_ERYTHROCYTE_INCLUSION_BODIES,0.982758435369417
WP_PAFAH1B1_COPY_NUMBER_VARI...,SET,10,0.058314,0.0013599,0.24148,0.40459,WP_PAFAH1B1_COPY_NUMBER_VARIATION,0.982758435369417
WIERENGA_STAT5A_TARGETS_GROU...1,SET,117,0.019488,0.00155,0.080725,0.40462,WIERENGA_STAT5A_TARGETS_GROUP1,0.982758435369417
SIX1_TARGET_GENES,SET,292,0.012455,0.0015574,0.051613,0.40466,SIX1_TARGET_GENES,0.982758435369417
MIR553,SET,10,0.061758,0.0014402,0.25598,0.40468,MIR553,0.982758435369417
HP_DELAYED_PROXIMAL_FEMORAL_...,SET,16,0.051131,0.001508,0.21198,0.4047,HP_DELAYED_PROXIMAL_FEMORAL_EPIPHYSEAL_OSSIFICATION,0.982758435369417
GOBP_NEGATIVE_REGULATION_OF_...673,SET,9,0.069467,0.0015369,0.28813,0.40474,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.982758435369417
MIR483_5P,SET,7,0.085684,0.0016719,0.35547,0.40476,MIR483_5P,0.982758435369417
GOMF_GROWTH_FACTOR_RECEPTOR_...,SET,133,0.01881,0.0015944,0.078047,0.40477,GOMF_GROWTH_FACTOR_RECEPTOR_BINDING,0.982758435369417
GOBP_AMINOGLYCOSIDE_ANTIBIOT...,SET,10,0.083005,0.0019357,0.34461,0.40483,GOBP_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS,0.982758435369417
TBPL1_TARGET_GENES,SET,136,0.017995,0.0015423,0.074719,0.40484,TBPL1_TARGET_GENES,0.982758435369417
GOCC_ZONULA_ADHERENS,SET,7,0.080428,0.0015694,0.33395,0.40484,GOCC_ZONULA_ADHERENS,0.982758435369417
GOBP_POSITIVE_REGULATION_OF_...474,SET,12,0.058553,0.0014957,0.24318,0.40486,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY,0.982758435369417
GOMF_MRNA_BINDING,SET,304,0.011059,0.0014105,0.045928,0.40486,GOMF_MRNA_BINDING,0.982758435369417
HP_CARDIAC_ARREST,SET,146,0.018739,0.0016636,0.077843,0.40488,HP_CARDIAC_ARREST,0.982758435369417
HP_GENERALIZED_HYPOPIGMENTAT...2,SET,45,0.031121,0.0015381,0.12931,0.40491,HP_GENERALIZED_HYPOPIGMENTATION_OF_HAIR,0.982758435369417
GSE46606_IRF4_KO_VS_WT_CD40L...4,SET,176,0.016448,0.0016019,0.068383,0.40496,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP,0.982758435369417
MULLIGHAN_NPM1_MUTATED_SIGNA...2,SET,234,0.013476,0.0015109,0.056029,0.40497,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,0.982758435369417
HP_ABNORMALITY_OF_THE_THORAC...,SET,47,0.031525,0.0015922,0.13118,0.40504,HP_ABNORMALITY_OF_THE_THORACIC_CAVITY,0.982758435369417
GSE1460_INTRATHYMIC_T_PROGEN...4,SET,171,0.015971,0.0015333,0.066468,0.40506,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP,0.982758435369417
GSE19941_UNSTIM_VS_LPS_STIM_...4,SET,182,0.014999,0.0014852,0.062442,0.40509,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.982758435369417
HP_DECREASED_URINARY_POTASSI...,SET,4,0.112,0.0016522,0.46645,0.40512,HP_DECREASED_URINARY_POTASSIUM,0.982758435369417
REACTOME_BIOSYNTHESIS_OF_SPE...,SET,19,0.049637,0.0015952,0.20684,0.40517,REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS,0.982758435369417
GOBP_NEGATIVE_REGULATION_OF_...100,SET,14,0.058419,0.0016118,0.24341,0.40517,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.982758435369417
MIR9903,SET,44,0.031413,0.0015352,0.13092,0.40519,MIR9903,0.982758435369417
REACTOME_TRAF6_MEDIATED_INDU...,SET,14,0.059364,0.0016378,0.24745,0.4052,REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX,0.982758435369417
GOBP_POSITIVE_REGULATION_OF_...288,SET,26,0.039879,0.0014989,0.16624,0.40521,GOBP_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY,0.982758435369417
WP_DISRUPTION_OF_POSTSYNAPTI...,SET,29,0.039332,0.0015612,0.16407,0.40527,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,0.982758435369417
GOBP_REGULATION_OF_CHROMATIN...1,SET,10,0.059813,0.0013948,0.24951,0.40528,GOBP_REGULATION_OF_CHROMATIN_BINDING,0.982758435369417
WP_CANCER_PATHWAYS,SET,483,0.0099301,0.0015885,0.041439,0.40531,WP_CANCER_PATHWAYS,0.982758435369417
GSE37301_HEMATOPOIETIC_STEM_...13,SET,159,0.016871,0.0015624,0.070451,0.40537,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN,0.982758435369417
GOBP_NEGATIVE_REGULATION_OF_...97,SET,41,0.030812,0.0014537,0.12869,0.40538,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.982758435369417
MIR1288_5P,SET,46,0.033528,0.0016753,0.14013,0.40545,MIR1288_5P,0.982758435369417
GOBP_REGULATION_OF_PHOSPHATA...,SET,50,0.028707,0.0014953,0.12006,0.40552,GOBP_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.982758435369417
HP_HYPERGONADOTROPIC_HYPOGON...,SET,54,0.026109,0.0014132,0.10921,0.40553,HP_HYPERGONADOTROPIC_HYPOGONADISM,0.982758435369417
GOBP_PROTEIN_IMPORT_INTO_MIT...,SET,18,0.044506,0.0013922,0.18621,0.40555,GOBP_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX,0.982758435369417
GSE26495_PD1HIGH_VS_PD1LOW_C...2,SET,166,0.015757,0.0014908,0.065968,0.40561,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP,0.982758435369417
MODULE_71,SET,19,0.05217,0.0016766,0.21844,0.40562,MODULE_71,0.982758435369417
GSE34006_WT_VS_A2AR_KO_TREG_...2,SET,183,0.015635,0.0015524,0.065473,0.40563,GSE34006_WT_VS_A2AR_KO_TREG_UP,0.982758435369417
MIR6870_5P,SET,199,0.014308,0.0014808,0.059944,0.40567,MIR6870_5P,0.982758435369417
REACTOME_RHO_GTPASES_ACTIVAT...4,SET,11,0.055588,0.0013595,0.23289,0.40568,REACTOME_RHO_GTPASES_ACTIVATE_KTN1,0.982758435369417
JEPSEN_SMRT_TARGETS,SET,30,0.038236,0.0015436,0.16022,0.40569,JEPSEN_SMRT_TARGETS,0.982758435369417
GARCIA_PINERES_PBMC_HPV_16_L...8,SET,238,0.014348,0.0016222,0.060125,0.4057,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP,0.982758435369417
HP_INCREASED_LAXITY_OF_FINGE...,SET,5,0.10646,0.0017557,0.44638,0.40575,HP_INCREASED_LAXITY_OF_FINGERS,0.982758435369417
HP_ABNORMAL_LUNG_MORPHOLOGY,SET,1069,0.0065016,0.0015218,0.027285,0.40583,HP_ABNORMAL_LUNG_MORPHOLOGY,0.982758435369417
GOCC_NUCLEAR_OUTER_MEMBRANE_...,SET,1100,0.0063676,0.0015105,0.026724,0.40584,GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK,0.982758435369417
GOBP_NEGATIVE_REGULATION_OF_...198,SET,6,0.084381,0.0015244,0.3543,0.40588,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION,0.982758435369417
GOCC_TRICARBOXYLIC_ACID_CYCL...,SET,18,0.041805,0.0013077,0.17556,0.40589,GOCC_TRICARBOXYLIC_ACID_CYCLE_HETEROMERIC_ENZYME_COMPLEX,0.982758435369417
GOBP_OLIGODENDROCYTE_APOPTOT...,SET,5,0.10095,0.0016649,0.42428,0.40597,GOBP_OLIGODENDROCYTE_APOPTOTIC_PROCESS,0.982758435369417
GSE42021_CD24HI_VS_CD24LOW_T...4,SET,171,0.01559,0.0014968,0.065525,0.40597,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP,0.982758435369417
KYNG_DNA_DAMAGE_UP,SET,188,0.014816,0.0014909,0.06228,0.40598,KYNG_DNA_DAMAGE_UP,0.982758435369417
REACTOME_GLYCOSPHINGOLIPID_C...,SET,31,0.037323,0.0015316,0.15689,0.40598,REACTOME_GLYCOSPHINGOLIPID_CATABOLISM,0.982758435369417
WP_TUMOR_SUPPRESSOR_ACTIVITY...,SET,29,0.03791,0.0015048,0.15935,0.40598,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,0.982758435369417
HP_IRREGULAR_ACETABULAR_ROOF,SET,6,0.075014,0.0013552,0.31539,0.406,HP_IRREGULAR_ACETABULAR_ROOF,0.982758435369417
YU_MYC_TARGETS_DN,SET,50,0.030481,0.0015877,0.12818,0.40602,YU_MYC_TARGETS_DN,0.982758435369417
HP_MILD_PROTEINURIA,SET,4,0.091342,0.0013474,0.38417,0.40603,HP_MILD_PROTEINURIA,0.982758435369417
GOBP_BONE_CELL_DEVELOPMENT,SET,18,0.0531,0.001661,0.22355,0.40612,GOBP_BONE_CELL_DEVELOPMENT,0.982758435369417
HP_ABNORMAL_NEUTROPHIL_MORPH...,SET,18,0.053857,0.0016847,0.22673,0.40612,HP_ABNORMAL_NEUTROPHIL_MORPHOLOGY,0.982758435369417
GSE40685_NAIVE_CD4_TCELL_VS_...4,SET,164,0.015511,0.0014587,0.065312,0.40614,GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP,0.982758435369417
HP_GONADAL_DYSGENESIS,SET,28,0.035185,0.0013723,0.14819,0.40616,HP_GONADAL_DYSGENESIS,0.982758435369417
WP_NICOTINE_EFFECT_ON_DOPAMI...,SET,21,0.045986,0.0015536,0.19372,0.40618,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.982758435369417
GOBP_NEGATIVE_REGULATION_OF_...1,SET,27,0.039657,0.0015189,0.16709,0.40619,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.982758435369417
REACTOME_BLOOD_GROUP_SYSTEMS...,SET,21,0.046841,0.0015825,0.19738,0.40621,REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS,0.982758435369417
BOYERINAS_ONCOFETAL_TARGETS_...,SET,10,0.068518,0.0015979,0.28879,0.40623,BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,0.982758435369417
HP_ABNORMAL_EXPERIENCE_OF_RE...,SET,534,0.0090473,0.0015196,0.038157,0.40629,HP_ABNORMAL_EXPERIENCE_OF_REALITY,0.982758435369417
REACTOME_BETA_OXIDATION_OF_V...,SET,10,0.065168,0.0015197,0.27487,0.4063,REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS,0.982758435369417
GOBP_POSITIVE_REGULATION_OF_...31,SET,5,0.10107,0.0016668,0.4263,0.4063,GOBP_POSITIVE_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.982758435369417
GOBP_PERICYTE_CELL_DIFFERENT...,SET,10,0.067618,0.0015769,0.28529,0.40632,GOBP_PERICYTE_CELL_DIFFERENTIATION,0.982758435369417
KEGG_MEDICUS_VARIANT_MUTATIO...66,SET,12,0.059319,0.0015153,0.25045,0.40639,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY,0.982758435369417
MIR1301_5P,SET,50,0.028863,0.0015035,0.12187,0.40639,MIR1301_5P,0.982758435369417
HP_GENERALIZED_LYMPHADENOPAT...,SET,9,0.074593,0.0016503,0.31494,0.40639,HP_GENERALIZED_LYMPHADENOPATHY,0.982758435369417
GSE14908_RESTING_VS_HDM_STIM...4,SET,186,0.014842,0.0014856,0.06268,0.40641,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP,0.982758435369417
CREBP1_Q2,SET,231,0.013377,0.0014903,0.056498,0.40642,CREBP1_Q2,0.982758435369417
MIR599,SET,81,0.022883,0.0015158,0.09666,0.40643,MIR599,0.982758435369417
GOMF_MONOCARBOXYLATE_SODIUM_...,SET,13,0.056464,0.0015012,0.23855,0.40645,GOMF_MONOCARBOXYLATE_SODIUM_SYMPORTER_ACTIVITY,0.982758435369417
REACTOME_GROWTH_HORMONE_RECE...,SET,22,0.048934,0.0016921,0.20692,0.40653,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,0.982839294657763
GSE37534_GW1929_VS_PIOGLITAZ...2,SET,180,0.014917,0.001469,0.063087,0.40654,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.982839294657763
HE_LIM_SUN_FETAL_LUNG_C0_MID...2,SET,168,0.017007,0.0016186,0.071968,0.40659,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL,0.982871786757546
GOMF_SIGNALING_RECEPTOR_INHI...,SET,27,0.040002,0.0015321,0.1693,0.40661,GOMF_SIGNALING_RECEPTOR_INHIBITOR_ACTIVITY,0.982871786757546
GOCC_TERMINAL_BOUTON,SET,43,0.032256,0.0015584,0.13659,0.40666,GOCC_TERMINAL_BOUTON,0.982880100834492
GSE28130_ACTIVATED_VS_INDUCE...1,SET,171,0.01597,0.0015332,0.067633,0.40667,GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN,0.982880100834492
MIR6832_5P,SET,74,0.02397,0.0015179,0.10157,0.40672,MIR6832_5P,0.982912578222778
GSE27786_CD8_TCELL_VS_ERYTHR...1,SET,183,0.015276,0.0015168,0.064743,0.40674,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN,0.982912578222778
GOBP_CDP_DIACYLGLYCEROL_BIOS...,SET,11,0.06644,0.001625,0.28175,0.40679,GOBP_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.982965059445178
GOCC_ALPHA_KETOACID_DEHYDROG...,SET,15,0.04787,0.0013671,0.20319,0.40687,GOCC_ALPHA_KETOACID_DEHYDROGENASE_COMPLEX,0.983007395732299
CAO_BLOOD_FLUMIST_AGE_05_14Y...4,SET,3,0.11529,0.0014729,0.48961,0.40692,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_UP,0.983007395732299
GSE25677_MPL_VS_MPL_AND_R848...2,SET,141,0.016568,0.0014456,0.070392,0.40697,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP,0.983007395732299
HEIDENBLAD_AMPLICON_8Q24_UP,SET,35,0.030012,0.0013085,0.12756,0.407,HEIDENBLAD_AMPLICON_8Q24_UP,0.983007395732299
HP_GINGIVAL_FIBROMATOSIS,SET,22,0.044708,0.0015459,0.19011,0.40704,HP_GINGIVAL_FIBROMATOSIS,0.983007395732299
HP_PSEUDOEPIPHYSES_OF_THE_PH...,SET,5,0.10139,0.0016721,0.43118,0.40705,HP_PSEUDOEPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.983007395732299
GSE29618_MONOCYTE_VS_PDC_DAY...1,SET,174,0.015095,0.0014618,0.06419,0.40705,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN,0.983007395732299
DELACROIX_RAR_BOUND_ES,SET,411,0.010211,0.0015098,0.043426,0.40706,DELACROIX_RAR_BOUND_ES,0.983007395732299
GSE12845_IGD_NEG_BLOOD_VS_PR...2,SET,169,0.014988,0.0014307,0.063783,0.40711,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.983007395732299
GOBP_CELLULAR_RESPONSE_TO_EL...,SET,10,0.063569,0.0014824,0.27062,0.40714,GOBP_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS,0.983007395732299
GSE360_CTRL_VS_M_TUBERCULOSI...4,SET,179,0.014629,0.0014367,0.062271,0.40714,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP,0.983007395732299
VEGF_A_UP.V1_UP,SET,177,0.015209,0.0014854,0.064764,0.40717,VEGF_A_UP.V1_UP,0.983007395732299
chr11q14,SET,48,0.056293,0.0028732,0.23976,0.40719,chr11q14,0.983007395732299
GOBP_HEMATOPOIETIC_OR_LYMPHO...,SET,97,0.020917,0.0015156,0.089158,0.40726,GOBP_HEMATOPOIETIC_OR_LYMPHOID_ORGAN_DEVELOPMENT,0.983007395732299
GOBP_MEMBRANE_REPOLARIZATION...1,SET,26,0.044324,0.001666,0.18896,0.40727,GOBP_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,0.983007395732299
GOCC_SOMATODENDRITIC_COMPART...,SET,771,0.007628,0.0015293,0.032517,0.40727,GOCC_SOMATODENDRITIC_COMPARTMENT,0.983007395732299
REACTOME_HIGHLY_CALCIUM_PERM...1,SET,9,0.084649,0.0018728,0.36125,0.40737,REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.983007395732299
GOBP_POSITIVE_REGULATION_OF_...568,SET,28,0.043284,0.0016882,0.18474,0.40738,GOBP_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.983007395732299
HP_CENTRAL_Y_SHAPED_METACARP...,SET,8,0.05717,0.0011925,0.244,0.40738,HP_CENTRAL_Y_SHAPED_METACARPAL,0.983007395732299
MIR1185_5P,SET,54,0.02692,0.0014571,0.11492,0.4074,MIR1185_5P,0.983007395732299
GOBP_REGULATION_OF_SYNAPTIC_...7,SET,6,0.094586,0.0017088,0.40398,0.40744,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CLUSTERING,0.983007395732299
chr1q24,SET,54,0.048988,0.0026516,0.20929,0.40747,chr1q24,0.983007395732299
GOBP_PLATELET_AGGREGATION,SET,73,0.02523,0.0015869,0.10785,0.40752,GOBP_PLATELET_AGGREGATION,0.983007395732299
AGUIRRE_PANCREATIC_CANCER_CO...1,SET,221,0.014507,0.0015812,0.062069,0.4076,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,0.983007395732299
GOBP_PROTEIN_PALMITOYLATION,SET,28,0.036814,0.0014358,0.15752,0.40761,GOBP_PROTEIN_PALMITOYLATION,0.983007395732299
GOBP_POSITIVE_REGULATION_OF_...94,SET,485,0.009219,0.0014777,0.039458,0.40763,GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS,0.983007395732299
GOBP_ESTABLISHMENT_OF_MITOCH...2,SET,22,0.044045,0.001523,0.18853,0.40764,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED,0.983007395732299
GSE28737_BCL6_HET_VS_BCL6_KO...1,SET,186,0.014764,0.0014777,0.063223,0.40768,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.983007395732299
GOBP_GLUTAMATE_METABOLIC_PRO...,SET,32,0.03577,0.0014913,0.1532,0.40769,GOBP_GLUTAMATE_METABOLIC_PROCESS,0.983007395732299
GOMF_DEMETHYLASE_ACTIVITY,SET,33,0.030858,0.0013064,0.13219,0.40771,GOMF_DEMETHYLASE_ACTIVITY,0.983007395732299
HP_BIFID_TONGUE,SET,22,0.040734,0.0014085,0.17452,0.40773,HP_BIFID_TONGUE,0.983007395732299
FIGUEROA_AML_METHYLATION_CLU...9,SET,42,0.035361,0.0016885,0.15158,0.40777,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,0.983007395732299
GOBP_PRENYLATION,SET,10,0.059747,0.0013933,0.25614,0.40778,GOBP_PRENYLATION,0.983007395732299
HP_ABNORMAL_LYMPHOCYTE_APOPT...,SET,8,0.069982,0.0014598,0.30001,0.40778,HP_ABNORMAL_LYMPHOCYTE_APOPTOSIS,0.983007395732299
GSE44649_NAIVE_VS_ACTIVATED_...3,SET,176,0.014675,0.0014292,0.062982,0.40788,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP,0.983007395732299
DESCARTES_FETAL_HEART_SCHWAN...,SET,47,0.030605,0.0015458,0.13135,0.40788,DESCARTES_FETAL_HEART_SCHWANN_CELLS,0.983007395732299
HP_ACRAL_BLISTERING,SET,9,0.065365,0.0014461,0.28057,0.40789,HP_ACRAL_BLISTERING,0.983007395732299
HP_KERATOSIS_PILARIS,SET,34,0.036091,0.0015509,0.15493,0.4079,HP_KERATOSIS_PILARIS,0.983007395732299
MIR548AV_5P_MIR548K,SET,267,0.012215,0.0014615,0.052485,0.40799,MIR548AV_5P_MIR548K,0.983007395732299
ARHGAP35_TARGET_GENES,SET,87,0.021219,0.0014565,0.09118,0.40799,ARHGAP35_TARGET_GENES,0.983007395732299
GSE45365_NK_CELL_VS_CD11B_DC...3,SET,186,0.014785,0.0014799,0.06353,0.40799,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP,0.983007395732299
MIR548AD_3P,SET,23,0.04152,0.0014679,0.1786,0.40809,MIR548AD_3P,0.983007395732299
HP_FACIAL_GRIMACING,SET,10,0.057659,0.0013446,0.24807,0.4081,HP_FACIAL_GRIMACING,0.983007395732299
HP_PRENATAL_MOVEMENT_ABNORMA...,SET,211,0.014051,0.0014969,0.060458,0.40811,HP_PRENATAL_MOVEMENT_ABNORMALITY,0.983007395732299
GOBP_POSITIVE_REGULATION_OF_...579,SET,9,0.078525,0.0017373,0.338,0.40815,GOBP_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.983007395732299
GOCC_CAVEOLA,SET,75,0.024147,0.0015394,0.10394,0.40815,GOCC_CAVEOLA,0.983007395732299
WP_WNT_SIGNALING_AND_PLURIPO...,SET,95,0.021575,0.0015472,0.092891,0.40817,WP_WNT_SIGNALING_AND_PLURIPOTENCY,0.983007395732299
HP_ABNORMAL_CORTICAL_GYRATION,SET,347,0.01052,0.0014319,0.045308,0.40819,HP_ABNORMAL_CORTICAL_GYRATION,0.983007395732299
GOCC_COPII_VESICLE_COAT,SET,16,0.048528,0.0014313,0.20911,0.40824,GOCC_COPII_VESICLE_COAT,0.983007395732299
HP_URETHRAL_DIVERTICULUM,SET,4,0.11027,0.0016267,0.47514,0.40824,HP_URETHRAL_DIVERTICULUM,0.983007395732299
GOBP_NEGATIVE_REGULATION_OF_...242,SET,16,0.054909,0.0016194,0.23662,0.40825,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.983007395732299
GSE13493_DP_VS_CD8POS_THYMOC...1,SET,181,0.014292,0.0014113,0.061627,0.40831,GSE13493_DP_VS_CD8POS_THYMOCYTE_DN,0.983023919517939
MIR892A,SET,117,0.019363,0.00154,0.083515,0.40833,MIR892A,0.983023919517939
GSE26351_UNSTIM_VS_BMP_PATHW...1,SET,176,0.014708,0.0014324,0.063455,0.40835,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.983023919517939
GOBP_REGULATION_OF_RESPONSE_...8,SET,16,0.051863,0.0015296,0.2238,0.40837,GOBP_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS,0.983023919517939
GOBP_POSITIVE_REGULATION_OF_...488,SET,87,0.022128,0.0015189,0.095519,0.4084,GOBP_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.983028049033867
GOBP_PYRUVATE_TRANSPORT,SET,7,0.08198,0.0015997,0.35406,0.40845,GOBP_PYRUVATE_TRANSPORT,0.983028753894081
GOBP_PEPTIDE_TRANSPORT,SET,244,0.013274,0.0015193,0.057341,0.40847,GOBP_PEPTIDE_TRANSPORT,0.983028753894081
HP_PROMINENT_ANTIHELIX,SET,13,0.053661,0.0014267,0.23187,0.40849,HP_PROMINENT_ANTIHELIX,0.983028753894081
GOBP_POSITIVE_REGULATION_OF_...446,SET,17,0.049585,0.0015074,0.21431,0.40852,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.983028753894081
GSE19374_UNINF_VS_LISTERIA_I...2,SET,177,0.014926,0.0014577,0.064544,0.40856,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP,0.983028753894081
GOBP_PLATELET_DENSE_GRANULE_...,SET,24,0.040763,0.0014721,0.1763,0.40857,GOBP_PLATELET_DENSE_GRANULE_ORGANIZATION,0.983028753894081
LIN_NPAS4_TARGETS_DN,SET,65,0.025938,0.0015398,0.11235,0.40871,LIN_NPAS4_TARGETS_DN,0.983098838334947
MIR6799_5P,SET,131,0.016552,0.0013925,0.071711,0.40873,MIR6799_5P,0.983098838334947
HP_ABNORMAL_CIRCULATING_SERI...2,SET,30,0.036749,0.0014836,0.15931,0.40878,HP_ABNORMAL_CIRCULATING_SERINE_FAMILY_AMINO_ACID_CONCENTRATION,0.983098838334947
GOBP_TOLL_LIKE_RECEPTOR_9_SI...,SET,18,0.047433,0.0014837,0.20567,0.4088,GOBP_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.983098838334947
GOMF_RACEMASE_AND_EPIMERASE_...2,SET,9,0.063613,0.0014074,0.27588,0.40882,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES,0.983098838334947
MIR5197_3P,SET,178,0.014868,0.0014561,0.064517,0.40887,MIR5197_3P,0.983098838334947
HP_ARTHROPATHY,SET,41,0.032006,0.00151,0.1389,0.40888,HP_ARTHROPATHY,0.983098838334947
WP_COMMON_PATHWAYS_UNDERLYIN...,SET,38,0.034607,0.001572,0.15019,0.40889,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.983098838334947
KEGG_MEDICUS_REFERENCE_ISOLE...,SET,9,0.067153,0.0014857,0.2915,0.4089,KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION,0.983098838334947
REACTOME_NEGATIVE_REGULATION...6,SET,14,0.049576,0.0013678,0.21519,0.4089,REACTOME_NEGATIVE_REGULATION_OF_FLT3,0.983098838334947
AGCGCTT_MIR518F_MIR518E_MIR5...,SET,16,0.048138,0.0014198,0.20899,0.40892,AGCGCTT_MIR518F_MIR518E_MIR518A,0.983098838334947
HANN_RESISTANCE_TO_BCL2_INHI...2,SET,30,0.039705,0.0016029,0.17249,0.40897,HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,0.983098838334947
GOCC_LUMENAL_SIDE_OF_MEMBRANE,SET,38,0.031565,0.0014338,0.13712,0.40897,GOCC_LUMENAL_SIDE_OF_MEMBRANE,0.983098838334947
HP_PROLONGED_BLEEDING_AFTER_...1,SET,21,0.048245,0.0016299,0.20975,0.40904,HP_PROLONGED_BLEEDING_AFTER_DENTAL_EXTRACTION,0.983098838334947
GSE36527_CD62L_HIGH_CD69_NEG...1,SET,180,0.015223,0.0014992,0.066195,0.40906,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN,0.983098838334947
GOBP_NEGATIVE_REGULATION_OF_...695,SET,4,0.10918,0.0016105,0.47479,0.40907,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.983098838334947
HP_ABNORMAL_OLFACTORY_LOBE_M...,SET,6,0.074687,0.0013493,0.32483,0.40908,HP_ABNORMAL_OLFACTORY_LOBE_MORPHOLOGY,0.983098838334947
HP_PATCHY_ALOPECIA,SET,19,0.051025,0.0016398,0.222,0.40911,HP_PATCHY_ALOPECIA,0.983102955818295
GSE22025_PROGESTERONE_VS_TGF...2,SET,177,0.014734,0.001439,0.064148,0.40917,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.983179158600664
LOPES_METHYLATED_IN_COLON_CA...2,SET,27,0.043285,0.0016579,0.18852,0.4092,LOPES_METHYLATED_IN_COLON_CANCER_UP,0.983183269961977
GOBP_EXTRACELLULAR_MATRIX_CO...,SET,13,0.063209,0.0016805,0.27549,0.40926,GOBP_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,0.983259456656989
GOBP_VESICLE_FUSION_TO_PLASM...,SET,23,0.040085,0.0014172,0.17498,0.4094,GOBP_VESICLE_FUSION_TO_PLASMA_MEMBRANE,0.983448625405816
MIR26B_3P,SET,95,0.019395,0.0013908,0.084683,0.40942,MIR26B_3P,0.983448625405816
GOBP_RESPONSE_TO_STARVATION,SET,191,0.014501,0.0014706,0.063358,0.40948,GOBP_RESPONSE_TO_STARVATION,0.983448625405816
GSE27786_LIN_NEG_VS_BCELL_UP,SET,185,0.014485,0.001446,0.063293,0.40949,GSE27786_LIN_NEG_VS_BCELL_UP,0.983448625405816
GSE5589_IL6_KO_VS_IL10_KO_LP...9,SET,180,0.014525,0.0014305,0.063483,0.40951,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.983448625405816
SCHLOSSER_MYC_TARGETS_REPRES...,SET,140,0.015825,0.001376,0.069185,0.40954,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,0.983448625405816
GOMF_PHOSPHATASE_BINDING,SET,176,0.014475,0.0014097,0.06329,0.40955,GOMF_PHOSPHATASE_BINDING,0.983448625405816
MODULE_408,SET,18,0.048648,0.0015217,0.21277,0.40958,MODULE_408,0.983448625405816
GSE42021_TCONV_PLN_VS_TREG_P...1,SET,183,0.01512,0.0015013,0.066148,0.4096,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN,0.983448625405816
TAFAZZIN_TARGET_GENES,SET,368,0.010253,0.0014362,0.044867,0.40963,TAFAZZIN_TARGET_GENES,0.983448625405816
GNF2_MLF1,SET,77,0.022556,0.001457,0.098738,0.40965,GNF2_MLF1,0.983448625405816
MODULE_163,SET,489,0.0091341,0.00147,0.040089,0.40988,MODULE_163,0.983925041430742
MIR4533,SET,303,0.011018,0.001403,0.048388,0.40994,MIR4533,0.983925041430742
GSE360_DC_VS_MAC_T_GONDII_UP,SET,182,0.015436,0.0015285,0.067812,0.40997,GSE360_DC_VS_MAC_T_GONDII_UP,0.983925041430742
BIOCARTA_P35ALZHEIMERS_PATHW...,SET,8,0.075447,0.0015738,0.3315,0.40998,BIOCARTA_P35ALZHEIMERS_PATHWAY,0.983925041430742
BANG_VERTEPORFIN_ENDOMETRIAL...2,SET,16,0.048479,0.0014298,0.21303,0.40999,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP,0.983925041430742
GOBP_MONOCARBOXYLIC_ACID_BIO...,SET,204,0.014155,0.0014831,0.062236,0.41004,GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.983977090381827
HP_VENTRICULAR_SEPTAL_HYPERT...,SET,12,0.053654,0.0013706,0.23611,0.41012,HP_VENTRICULAR_SEPTAL_HYPERTROPHY,0.984055623194387
GOBP_PROTEIN_TARGETING_TO_VA...1,SET,44,0.027882,0.0013626,0.12274,0.41015,GOBP_PROTEIN_TARGETING_TO_VACUOLE,0.984055623194387
GOBP_DETECTION_OF_MECHANICAL...3,SET,14,0.055277,0.0015251,0.24336,0.41016,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.984055623194387
BIOCARTA_PELP1_PATHWAY,SET,6,0.077033,0.0013917,0.33926,0.41019,BIOCARTA_PELP1_PATHWAY,0.984055623194387
HP_IMPAIRED_ANTIGEN_SPECIFIC...,SET,47,0.030324,0.0015315,0.13363,0.41024,HP_IMPAIRED_ANTIGEN_SPECIFIC_RESPONSE,0.984055623194387
HP_GLOSSITIS,SET,10,0.072304,0.0016861,0.31881,0.41029,HP_GLOSSITIS,0.984055623194387
GROSS_HYPOXIA_VIA_HIF1A_UP,SET,75,0.021944,0.0013989,0.09676,0.4103,GROSS_HYPOXIA_VIA_HIF1A_UP,0.984055623194387
GOMF_NEUREXIN_FAMILY_PROTEIN...,SET,8,0.072488,0.0015121,0.31975,0.41033,GOMF_NEUREXIN_FAMILY_PROTEIN_BINDING,0.984055623194387
GOBP_NEURAL_CREST_CELL_FATE_...,SET,6,0.094358,0.0017046,0.41642,0.41037,GOBP_NEURAL_CREST_CELL_FATE_COMMITMENT,0.984055623194387
KRAS.50_UP.V1_UP,SET,44,0.03273,0.0015996,0.14445,0.41038,KRAS.50_UP.V1_UP,0.984055623194387
HP_SCAPULAR_WINGING,SET,88,0.020012,0.0013815,0.088367,0.41042,HP_SCAPULAR_WINGING,0.984055623194387
GAVISH_3CA_METAPROGRAM_MACRO...2,SET,47,0.029984,0.0015144,0.13245,0.41045,GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON,0.984055623194387
HP_REDUCED_FACTOR_XIII_ACTIV...,SET,6,0.075736,0.0013682,0.3346,0.41047,HP_REDUCED_FACTOR_XIII_ACTIVITY,0.984055623194387
GOBP_ALANINE_TRANSPORT,SET,16,0.054067,0.0015946,0.23895,0.4105,GOBP_ALANINE_TRANSPORT,0.984055623194387
GOBP_NADP_METABOLIC_PROCESS,SET,40,0.031737,0.001479,0.1403,0.41052,GOBP_NADP_METABOLIC_PROCESS,0.984055623194387
HP_REDUCED_CONSCIOUSNESS,SET,206,0.013522,0.0014236,0.0598,0.41055,HP_REDUCED_CONSCIOUSNESS,0.984055623194387
KEGG_MEDICUS_REFERENCE_CXCR4...1,SET,9,0.062797,0.0013893,0.2778,0.41058,KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY,0.984055623194387
MIR4251,SET,353,0.01074,0.0014742,0.047534,0.41062,MIR4251,0.984055623194387
HP_ALKALOSIS,SET,29,0.036555,0.0014509,0.16193,0.4107,HP_ALKALOSIS,0.984055623194387
GOBP_BEHAVIORAL_RESPONSE_TO_...3,SET,8,0.077561,0.0016179,0.34393,0.41079,GOBP_BEHAVIORAL_RESPONSE_TO_NICOTINE,0.984055623194387
WP_INTERLEUKIN1_IL1_STRUCTUR...,SET,46,0.028975,0.0014478,0.12852,0.41081,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,0.984055623194387
GOMF_TAU_PROTEIN_KINASE_ACTI...,SET,22,0.037188,0.0012859,0.16509,0.41089,GOMF_TAU_PROTEIN_KINASE_ACTIVITY,0.984055623194387
PIAS4_TARGET_GENES,SET,49,0.027894,0.0014384,0.12394,0.41097,PIAS4_TARGET_GENES,0.984055623194387
EVI1_01,SET,14,0.051031,0.0014079,0.22675,0.41097,EVI1_01,0.984055623194387
HP_ARTERIAL_DISSECTION,SET,12,0.064932,0.0016587,0.28861,0.411,HP_ARTERIAL_DISSECTION,0.984055623194387
HP_ABNORMALITY_OF_HAIR_GROWTH,SET,29,0.034435,0.0013668,0.1531,0.41102,HP_ABNORMALITY_OF_HAIR_GROWTH,0.984055623194387
ZHONG_PFC_MAJOR_TYPES_MICROG...,SET,391,0.010231,0.0014763,0.045487,0.41102,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.984055623194387
MIR6074,SET,249,0.012839,0.0014842,0.057097,0.41105,MIR6074,0.984055623194387
HP_TYPE_II_TRANSFERRIN_ISOFO...,SET,13,0.055827,0.0014843,0.24852,0.41113,HP_TYPE_II_TRANSFERRIN_ISOFORM_PROFILE,0.984055623194387
GENTLES_LEUKEMIC_STEM_CELL_DN,SET,16,0.049574,0.0014621,0.22074,0.41115,GENTLES_LEUKEMIC_STEM_CELL_DN,0.984055623194387
GSE15659_NAIVE_CD4_TCELL_VS_...2,SET,160,0.015226,0.0014145,0.067795,0.41115,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.984055623194387
GSE36826_NORMAL_VS_STAPH_AUR...1,SET,183,0.013882,0.0013783,0.061839,0.41119,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN,0.984055623194387
MIR1297,SET,579,0.0082582,0.0014425,0.036792,0.4112,MIR1297,0.984055623194387
GSE11057_CD4_EFF_MEM_VS_PBMC...2,SET,176,0.014175,0.0013805,0.063182,0.41124,GSE11057_CD4_EFF_MEM_VS_PBMC_UP,0.984055623194387
HP_LIMITED_NECK_RANGE_OF_MOT...,SET,8,0.07672,0.0016003,0.34198,0.41125,HP_LIMITED_NECK_RANGE_OF_MOTION,0.984055623194387
CARRILLOREIXACH_HEPATOBLASTO...3,SET,157,0.016269,0.0014973,0.072531,0.41126,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP,0.984055623194387
KEGG_MEDICUS_VARIANT_MUTATIO...59,SET,11,0.057455,0.0014052,0.25615,0.41126,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.984055623194387
GOBP_NEGATIVE_REGULATION_OF_...229,SET,5,0.095451,0.0015742,0.42554,0.41126,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.984055623194387
REACTOME_FOXO_MEDIATED_TRANS...4,SET,28,0.03858,0.0015048,0.17219,0.41136,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,0.984055623194387
PR_02,SET,123,0.017595,0.0014346,0.078603,0.41144,PR_02,0.984055623194387
REACTOME_DEFECTIVE_FACTOR_VI...,SET,5,0.090202,0.0014876,0.40304,0.41146,REACTOME_DEFECTIVE_FACTOR_VIII_CAUSES_HEMOPHILIA_A,0.984055623194387
MIR409_5P,SET,35,0.029766,0.0012977,0.13304,0.41148,MIR409_5P,0.984055623194387
GOBP_MESODERMAL_CELL_DIFFERE...,SET,31,0.036017,0.001478,0.16099,0.41149,GOBP_MESODERMAL_CELL_DIFFERENTIATION,0.984055623194387
GOBP_REGULATION_OF_CALCIUM_I...1,SET,5,0.08764,0.0014454,0.39175,0.41149,GOBP_REGULATION_OF_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.984055623194387
MIR374C_3P,SET,47,0.029962,0.0015133,0.13396,0.41151,MIR374C_3P,0.984055623194387
GSE8515_CTRL_VS_IL6_4H_STIM_...2,SET,179,0.014091,0.0013839,0.063,0.41151,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP,0.984055623194387
GSE7509_UNSTIM_VS_IFNA_STIM_...1,SET,163,0.015647,0.001467,0.070004,0.41157,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN,0.984055623194387
MIR6885_5P,SET,46,0.027812,0.0013897,0.12444,0.41158,MIR6885_5P,0.984055623194387
GOMF_PIRNA_BINDING,SET,5,0.092656,0.0015281,0.41468,0.4116,GOMF_PIRNA_BINDING,0.984055623194387
AAAGGAT_MIR501,SET,111,0.018658,0.0014456,0.083514,0.41161,AAAGGAT_MIR501,0.984055623194387
GOBP_ESTABLISHMENT_OF_SKIN_B...,SET,33,0.036185,0.0015319,0.16197,0.41161,GOBP_ESTABLISHMENT_OF_SKIN_BARRIER,0.984055623194387
GOBP_INTERLEUKIN_3_MEDIATED_...,SET,6,0.090681,0.0016382,0.40591,0.41161,GOBP_INTERLEUKIN_3_MEDIATED_SIGNALING_PATHWAY,0.984055623194387
REACTOME_PKR_MEDIATED_SIGNAL...,SET,65,0.0236,0.0014011,0.10565,0.41162,REACTOME_PKR_MEDIATED_SIGNALING,0.984055623194387
KEGG_PRIMARY_BILE_ACID_BIOSY...,SET,16,0.052202,0.0015396,0.23371,0.41163,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,0.984055623194387
GSE22935_WT_VS_MYD88_KO_MACR...5,SET,175,0.014572,0.0014152,0.065239,0.41163,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN,0.984055623194387
HP_PREMATURE_ARTERIOSCLEROSIS,SET,8,0.078413,0.0016356,0.35197,0.41185,HP_PREMATURE_ARTERIOSCLEROSIS,0.984470034387895
GSE40274_CTRL_VS_FOXP3_AND_L...2,SET,153,0.016587,0.0015072,0.074461,0.41186,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.984470034387895
WP_PHOTODYNAMIC_THERAPYINDUC...3,SET,23,0.045475,0.0016078,0.20438,0.41196,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,0.98457363498831
GNF2_LCAT,SET,121,0.017911,0.0014485,0.080495,0.41196,GNF2_LCAT,0.98457363498831
MIR548S,SET,119,0.016862,0.0013524,0.075834,0.41202,MIR548S,0.984645759233926
HP_ABNORMAL_PLATELET_FUNCTION,SET,58,0.024351,0.0013658,0.10957,0.41206,HP_ABNORMAL_PLATELET_FUNCTION,0.984645759233926
GSE7852_LN_VS_FAT_TREG_DN,SET,181,0.014782,0.0014597,0.066546,0.41211,GSE7852_LN_VS_FAT_TREG_DN,0.984645759233926
GSE37534_UNTREATED_VS_ROSIGL...1,SET,182,0.01448,0.0014338,0.06526,0.4122,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.984645759233926
MODULE_539,SET,15,0.05259,0.0015018,0.23716,0.41226,MODULE_539,0.984645759233926
GOBP_REGULATION_OF_CELLULAR_...15,SET,13,0.054721,0.0014549,0.24683,0.41228,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,0.984645759233926
GOBP_REGULATION_OF_SKELETAL_...8,SET,10,0.071699,0.001672,0.32378,0.41238,GOBP_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,0.984645759233926
GOCC_FHF_COMPLEX,SET,4,0.070004,0.0010327,0.31622,0.4124,GOCC_FHF_COMPLEX,0.984645759233926
GOMF_NUCLEAR_RECEPTOR_COACTI...,SET,51,0.025061,0.0013183,0.1132,0.4124,GOMF_NUCLEAR_RECEPTOR_COACTIVATOR_ACTIVITY,0.984645759233926
GOCC_TORC1_COMPLEX,SET,6,0.064559,0.0011663,0.29169,0.41242,GOCC_TORC1_COMPLEX,0.984645759233926
NAKAYA_PBMC_FLUARIX_FLUVIRIN...4,SET,491,0.0081913,0.0013209,0.037008,0.41242,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.984645759233926
LINDGREN_BLADDER_CANCER_CLUS...7,SET,288,0.011038,0.0013709,0.049898,0.41246,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,0.984645759233926
AAGTCCA_MIR422B_MIR422A,SET,63,0.023298,0.0013618,0.10539,0.41252,AAGTCCA_MIR422B_MIR422A,0.984645759233926
GOMF_DNA_DAMAGE_SENSOR_ACTIV...,SET,20,0.03592,0.0011843,0.16253,0.41255,GOMF_DNA_DAMAGE_SENSOR_ACTIVITY,0.984645759233926
WANG_LMO4_TARGETS_UP,SET,311,0.010588,0.0013657,0.047942,0.4126,WANG_LMO4_TARGETS_UP,0.984645759233926
MIR4329,SET,70,0.023045,0.0014195,0.10437,0.41263,MIR4329,0.984645759233926
DEMAGALHAES_AGING_UP,SET,48,0.026693,0.0013624,0.12091,0.41264,DEMAGALHAES_AGING_UP,0.984645759233926
GOBP_REPRODUCTIVE_BEHAVIOR,SET,44,0.032034,0.0015655,0.14518,0.41268,GOBP_REPRODUCTIVE_BEHAVIOR,0.984645759233926
GOMF_L_ARGININE_TRANSMEMBRAN...,SET,11,0.066603,0.001629,0.30188,0.41269,GOMF_L_ARGININE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984645759233926
GSE45365_NK_CELL_VS_BCELL_MC...1,SET,172,0.015072,0.0014512,0.068314,0.41269,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN,0.984645759233926
WP_RIBOFLAVIN_AND_COQ_DISORD...,SET,13,0.047226,0.0012556,0.21427,0.41278,WP_RIBOFLAVIN_AND_COQ_DISORDERS,0.984645759233926
GOBP_PURINE_CONTAINING_COMPO...3,SET,14,0.055896,0.0015422,0.25368,0.41281,GOBP_PURINE_CONTAINING_COMPOUND_SALVAGE,0.984645759233926
GSE8621_LPS_PRIMED_UNSTIM_VS...1,SET,177,0.013425,0.0013111,0.060936,0.41282,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.984645759233926
MIR4725_5P,SET,52,0.025796,0.0013702,0.1171,0.41283,MIR4725_5P,0.984645759233926
GOBP_SEMAPHORIN_PLEXIN_SIGNA...,SET,42,0.0305,0.0014564,0.13854,0.41288,GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY,0.984645759233926
MIKKELSEN_DEDIFFERENTIATED_S...2,SET,6,0.08079,0.0014595,0.36704,0.41289,MIKKELSEN_DEDIFFERENTIATED_STATE_UP,0.984645759233926
GSE17974_0H_VS_24H_IN_VITRO_...2,SET,162,0.015097,0.0014112,0.06859,0.4129,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP,0.984645759233926
REACTOME_RESPONSE_TO_ELEVATE...,SET,120,0.017984,0.0014484,0.081749,0.41294,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,0.984645759233926
HP_UTERINE_RUPTURE,SET,8,0.077786,0.0016226,0.35403,0.41305,HP_UTERINE_RUPTURE,0.984645759233926
HP_TONGUE_THRUSTING,SET,13,0.047988,0.0012759,0.21847,0.41307,HP_TONGUE_THRUSTING,0.984645759233926
HP_URETERAL_DUPLICATION,SET,41,0.027337,0.0012898,0.12447,0.41308,HP_URETERAL_DUPLICATION,0.984645759233926
HP_RECURRENT_RESPIRATORY_INF...,SET,545,0.0083686,0.0014196,0.038122,0.41312,HP_RECURRENT_RESPIRATORY_INFECTIONS,0.984645759233926
HP_BONE_MARROW_FOAM_CELLS,SET,5,0.10742,0.0017715,0.48944,0.41314,HP_BONE_MARROW_FOAM_CELLS,0.984645759233926
KAECH_DAY15_EFF_VS_MEMORY_CD...2,SET,186,0.013878,0.0013891,0.063242,0.41315,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP,0.984645759233926
WP_PI3KAKT_SIGNALING,SET,322,0.011171,0.0014657,0.050936,0.4132,WP_PI3KAKT_SIGNALING,0.984645759233926
GOBP_NEGATIVE_REGULATION_OF_...299,SET,9,0.068841,0.001523,0.31407,0.41325,GOBP_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.984645759233926
GOMF_PROTEIN_LYSINE_DEACETYL...,SET,21,0.039695,0.0013411,0.1811,0.41325,GOMF_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.984645759233926
HP_TRACTIONAL_RETINAL_DETACH...,SET,7,0.065426,0.0012766,0.2985,0.41325,HP_TRACTIONAL_RETINAL_DETACHMENT,0.984645759233926
HP_STEROID_RESISTANT_NEPHROT...,SET,14,0.046804,0.0012913,0.21355,0.41326,HP_STEROID_RESISTANT_NEPHROTIC_SYNDROME,0.984645759233926
BRUINS_UVC_RESPONSE_VIA_TP53...4,SET,245,0.01232,0.001413,0.056266,0.41334,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,0.984645759233926
GSE21063_CTRL_VS_ANTI_IGM_ST...7,SET,175,0.013679,0.0013285,0.062472,0.41334,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN,0.984645759233926
AMUNDSON_DNA_DAMAGE_RESPONSE...,SET,16,0.048843,0.0014405,0.22312,0.41336,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,0.984645759233926
GSE2128_C57BL6_VS_NOD_THYMOC...4,SET,179,0.01366,0.0013415,0.062412,0.41338,GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP,0.984645759233926
GOMF_CARD_DOMAIN_BINDING,SET,15,0.046462,0.0013268,0.21234,0.4134,GOMF_CARD_DOMAIN_BINDING,0.984645759233926
GOBP_NEGATIVE_REGULATION_OF_...3,SET,54,0.024918,0.0013487,0.1139,0.41342,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,0.984645759233926
LEE_AGING_NEOCORTEX_DN,SET,62,0.023104,0.0013397,0.10562,0.41343,LEE_AGING_NEOCORTEX_DN,0.984645759233926
GSE13306_RA_VS_UNTREATED_TCO...2,SET,183,0.013533,0.0013437,0.061872,0.41343,GSE13306_RA_VS_UNTREATED_TCONV_UP,0.984645759233926
GOBP_POSITIVE_REGULATION_OF_...526,SET,226,0.012954,0.0014276,0.059265,0.41349,GOBP_POSITIVE_REGULATION_OF_NEUROGENESIS,0.984645759233926
GOBP_ESTABLISHMENT_OF_RNA_LO...,SET,143,0.014346,0.0012605,0.065673,0.41354,GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION,0.984645759233926
GSE22025_UNTREATED_VS_TGFB1_...3,SET,184,0.014268,0.0014205,0.065333,0.41357,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN,0.984645759233926
MIR629_3P,SET,165,0.014903,0.0014058,0.068301,0.41364,MIR629_3P,0.984645759233926
HP_IMPAIRED_CORTISOL_RESPONS...,SET,5,0.093895,0.0015485,0.43031,0.41364,HP_IMPAIRED_CORTISOL_RESPONSE_TO_INSULIN_STIMULATION_TEST,0.984645759233926
GOCC_GRANULAR_COMPONENT,SET,7,0.066465,0.0012969,0.30474,0.41368,GOCC_GRANULAR_COMPONENT,0.984645759233926
MIR1202,SET,67,0.021734,0.0013099,0.099689,0.41371,MIR1202,0.984645759233926
GOMF_L_HISTIDINE_TRANSMEMBRA...,SET,3,0.11609,0.0014831,0.5325,0.41371,GOMF_L_HISTIDINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984645759233926
REACTOME_REGULATION_OF_TBK1_...1,SET,13,0.058224,0.001548,0.26717,0.41374,REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7,0.984645759233926
GOBP_REGULATION_OF_OSTEOCLAS...2,SET,65,0.026246,0.0015581,0.12045,0.41375,GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.984645759233926
HP_C1_C2_VERTEBRAL_ABNORMALI...,SET,7,0.069392,0.001354,0.31854,0.41378,HP_C1_C2_VERTEBRAL_ABNORMALITY,0.984645759233926
MODULE_39,SET,9,0.061321,0.0013567,0.28163,0.41382,MODULE_39,0.984645759233926
GSE24972_WT_VS_IRF8_KO_MARGI...1,SET,181,0.014241,0.0014063,0.065422,0.41384,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN,0.984645759233926
chr11q12,SET,178,0.031904,0.0031246,0.14658,0.41385,chr11q12,0.984645759233926
BUSSLINGER_DUODENAL_IMMUNE_C...,SET,822,0.0066376,0.001372,0.030497,0.41385,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.984645759233926
GOBP_REGULATION_OF_LIPID_TRA...2,SET,4,0.10834,0.0015982,0.49783,0.41386,GOBP_REGULATION_OF_LIPID_TRANSPORTER_ACTIVITY,0.984645759233926
HP_CHOLANGIOCARCINOMA,SET,8,0.068632,0.0014316,0.31553,0.4139,HP_CHOLANGIOCARCINOMA,0.984645759233926
RICKMAN_HEAD_AND_NECK_CANCER...2,SET,33,0.034645,0.0014667,0.15929,0.41391,RICKMAN_HEAD_AND_NECK_CANCER_B,0.984645759233926
DESCARTES_FETAL_STOMACH_GOBL...,SET,16,0.052751,0.0015558,0.24258,0.41393,DESCARTES_FETAL_STOMACH_GOBLET_CELLS,0.984645759233926
REACTOME_SYNTHESIS_OF_PIPS_A...1,SET,15,0.039627,0.0011317,0.18235,0.41398,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE,0.984645759233926
GOBP_CIRCADIAN_REGULATION_OF...,SET,62,0.024525,0.0014221,0.11286,0.41398,GOBP_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION,0.984645759233926
GOBP_INTERLEUKIN_17_MEDIATED...,SET,11,0.061325,0.0014999,0.28244,0.41406,GOBP_INTERLEUKIN_17_MEDIATED_SIGNALING_PATHWAY,0.984645759233926
GSE26030_TH1_VS_TH17_RESTIMU...3,SET,180,0.013546,0.001334,0.062421,0.4141,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN,0.984645759233926
HOFMANN_MYELODYSPLASTIC_SYND...1,SET,20,0.039614,0.0013061,0.18255,0.41411,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,0.984645759233926
RUAN_RESPONSE_TO_TROGLITAZON...1,SET,16,0.051218,0.0015106,0.23606,0.41412,RUAN_RESPONSE_TO_TROGLITAZONE_DN,0.984645759233926
KEGG_MEDICUS_REFERENCE_CROSS...,SET,15,0.049871,0.0014242,0.22985,0.41412,KEGG_MEDICUS_REFERENCE_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.984645759233926
HP_ABNORMALITY_OF_LOWER_EYEL...,SET,5,0.084367,0.0013914,0.38899,0.41415,HP_ABNORMALITY_OF_LOWER_EYELASHES,0.984645759233926
GOCC_CHECKPOINT_CLAMP_COMPLEX,SET,5,0.085708,0.0014135,0.39529,0.41417,GOCC_CHECKPOINT_CLAMP_COMPLEX,0.984645759233926
HP_ABNORMALITY_OF_THE_CALCAN...,SET,31,0.037024,0.0015193,0.17076,0.41418,HP_ABNORMALITY_OF_THE_CALCANEUS,0.984645759233926
GOBP_ORGANELLE_FISSION,SET,450,0.0084514,0.0013062,0.038986,0.41419,GOBP_ORGANELLE_FISSION,0.984645759233926
REACTOME_DNA_STRAND_ELONGATI...,SET,31,0.030933,0.0012693,0.1427,0.4142,REACTOME_DNA_STRAND_ELONGATION,0.984645759233926
NABA_MATRISOME,SET,950,0.0069401,0.0015366,0.032044,0.41427,NABA_MATRISOME,0.984705193872666
GGARNTKYCCA_UNKNOWN,SET,70,0.023771,0.0014643,0.10979,0.41429,GGARNTKYCCA_UNKNOWN,0.984705193872666
MORF_PHB,SET,115,0.016157,0.0012741,0.074634,0.41431,MORF_PHB,0.984705193872666
MARIADASON_RESPONSE_TO_CURCU...2,SET,12,0.049983,0.0012768,0.23106,0.41437,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,0.984748759228876
MEF2_Q6_01,SET,221,0.013044,0.0014218,0.060327,0.41441,MEF2_Q6_01,0.984748759228876
GOCC_PRESYNAPTIC_CYTOSKELETON,SET,10,0.066444,0.0015495,0.30745,0.41445,GOCC_PRESYNAPTIC_CYTOSKELETON,0.984748759228876
GSE24210_TCONV_VS_TREG_DN,SET,176,0.013438,0.0013087,0.062187,0.41446,GSE24210_TCONV_VS_TREG_DN,0.984748759228876
GSE29618_BCELL_VS_PDC_DN,SET,177,0.014443,0.0014106,0.066845,0.41447,GSE29618_BCELL_VS_PDC_DN,0.984748759228876
HP_ABNORMAL_UMBILICAL_STUMP_...,SET,8,0.071378,0.0014889,0.33047,0.4145,HP_ABNORMAL_UMBILICAL_STUMP_BLEEDING,0.984752084029123
HP_EEG_WITH_FOCAL_SPIKES,SET,30,0.03555,0.0014351,0.16479,0.4146,HP_EEG_WITH_FOCAL_SPIKES,0.984752084029123
GSE2770_TGFB_AND_IL4_VS_TGFB...3,SET,170,0.014089,0.0013488,0.06534,0.41464,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.984752084029123
MIR1225_5P,SET,25,0.0372,0.0013711,0.17263,0.41469,MIR1225_5P,0.984752084029123
RIZ_ERYTHROID_DIFFERENTIATIO...6,SET,25,0.041107,0.0015151,0.19083,0.41472,RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,0.984752084029123
GOBP_POSITIVE_REGULATION_OF_...121,SET,17,0.040484,0.0012307,0.18817,0.41483,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT,0.984752084029123
GOBP_POSITIVE_REGULATION_OF_...148,SET,6,0.070496,0.0012736,0.32778,0.41486,GOBP_POSITIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,0.984752084029123
GOCC_CYTOPLASMIC_SIDE_OF_ROU...,SET,4,0.077734,0.0011467,0.36144,0.41486,GOCC_CYTOPLASMIC_SIDE_OF_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.984752084029123
GOMF_CALCITONIN_FAMILY_RECEP...,SET,6,0.078564,0.0014193,0.36587,0.41499,GOMF_CALCITONIN_FAMILY_RECEPTOR_ACTIVITY,0.984752084029123
GSE2706_UNSTIM_VS_8H_LPS_AND...2,SET,176,0.013541,0.0013187,0.063166,0.41513,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP,0.984752084029123
MIR592,SET,70,0.022311,0.0013743,0.10411,0.41516,MIR592,0.984752084029123
GOBP_NEGATIVE_REGULATION_OF_...296,SET,8,0.065604,0.0013685,0.30628,0.4152,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.984752084029123
TBK1.DN.48HRS_DN,SET,46,0.027166,0.0013574,0.12698,0.4153,TBK1.DN.48HRS_DN,0.984752084029123
GOMF_THYROID_HORMONE_TRANSME...,SET,7,0.071516,0.0013955,0.33447,0.41534,GOMF_THYROID_HORMONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984752084029123
REACTOME_ACTIVATED_TAK1_MEDI...,SET,19,0.044533,0.0014311,0.20829,0.41535,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,0.984752084029123
GSE39820_TGFBETA3_IL6_VS_TGF...2,SET,181,0.013418,0.001325,0.062791,0.4154,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP,0.984752084029123
GOMF_N_ACYLSPHINGOSINE_AMIDO...,SET,7,0.07887,0.001539,0.36944,0.41548,GOMF_N_ACYLSPHINGOSINE_AMIDOHYDROLASE_ACTIVITY,0.984752084029123
HP_CEREBRAL_HYPOPLASIA,SET,53,0.024511,0.0013144,0.11491,0.41554,HP_CEREBRAL_HYPOPLASIA,0.984752084029123
GSE25088_ROSIGLITAZONE_VS_IL...1,SET,181,0.013221,0.0013056,0.061978,0.41554,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.984752084029123
GAUCHER_PBMC_YF_VAX_STAMARIL...1,SET,96,0.018719,0.0013494,0.087747,0.41554,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_DN,0.984752084029123
GARGALOVIC_RESPONSE_TO_OXIDI...18,SET,16,0.045773,0.00135,0.21459,0.41555,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,0.984752084029123
GOMF_VITAMIN_TRANSMEMBRANE_T...,SET,33,0.032538,0.0013776,0.15259,0.41557,GOMF_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984752084029123
KOINUMA_COLON_CANCER_MSI_DN,SET,8,0.073241,0.0015278,0.3435,0.41558,KOINUMA_COLON_CANCER_MSI_DN,0.984752084029123
HP_PILOMATRIXOMA,SET,7,0.074864,0.0014608,0.35112,0.41558,HP_PILOMATRIXOMA,0.984752084029123
GOMF_ANGIOTENSIN_RECEPTOR_AC...,SET,4,0.1064,0.0015695,0.49934,0.41563,GOMF_ANGIOTENSIN_RECEPTOR_ACTIVITY,0.984752084029123
MYLLYKANGAS_AMPLIFICATION_HO...8,SET,9,0.064416,0.0014251,0.30233,0.41564,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,0.984752084029123
HP_ABNORMAL_LUNG_DEVELOPMENT,SET,208,0.012662,0.0013395,0.05945,0.41567,HP_ABNORMAL_LUNG_DEVELOPMENT,0.984752084029123
MODULE_215,SET,14,0.057523,0.0015871,0.27018,0.4157,MODULE_215,0.984752084029123
HP_PROLONGED_QRS_COMPLEX,SET,6,0.086437,0.0015615,0.40609,0.41572,HP_PROLONGED_QRS_COMPLEX,0.984752084029123
GCM_GSPT1,SET,154,0.013334,0.0012155,0.062649,0.41573,GCM_GSPT1,0.984752084029123
GOCC_ENDOLYSOSOME_MEMBRANE,SET,17,0.044197,0.0013436,0.20772,0.41575,GOCC_ENDOLYSOSOME_MEMBRANE,0.984752084029123
GSE17974_1H_VS_72H_UNTREATED...2,SET,179,0.013248,0.0013011,0.062306,0.41581,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.984752084029123
GOBP_POSITIVE_REGULATION_OF_...534,SET,17,0.046699,0.0014196,0.21975,0.41586,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.984752084029123
MIR147B_3P,SET,5,0.089485,0.0014758,0.42127,0.41589,MIR147B_3P,0.984752084029123
STEGER_ADIPOGENESIS_UP,SET,21,0.04324,0.0014608,0.20357,0.4159,STEGER_ADIPOGENESIS_UP,0.984752084029123
GOBP_STRIATED_MUSCLE_CELL_DE...,SET,77,0.020613,0.0013315,0.097107,0.41595,GOBP_STRIATED_MUSCLE_CELL_DEVELOPMENT,0.984752084029123
GOBP_PLASMA_MEMBRANE_ORGANIZ...,SET,149,0.015121,0.001356,0.071251,0.41597,GOBP_PLASMA_MEMBRANE_ORGANIZATION,0.984752084029123
GSE22886_NEUTROPHIL_VS_MONOC...2,SET,169,0.01451,0.001385,0.068382,0.41598,GSE22886_NEUTROPHIL_VS_MONOCYTE_UP,0.984752084029123
GSE3982_BCELL_VS_EFF_MEMORY_...1,SET,177,0.014002,0.0013675,0.066,0.41599,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN,0.984752084029123
HAY_BONE_MARROW_CD34_POS_MEP,SET,8,0.067739,0.001413,0.31945,0.41604,HAY_BONE_MARROW_CD34_POS_MEP,0.984752084029123
HP_DECREASED_FERTILITY_IN_FE...,SET,87,0.01878,0.0012891,0.088622,0.41609,HP_DECREASED_FERTILITY_IN_FEMALES,0.984752084029123
MIR4795_5P,SET,62,0.023506,0.001363,0.11098,0.41614,MIR4795_5P,0.984752084029123
HP_PROGRESSIVE_EXTERNAL_OPHT...,SET,20,0.037196,0.0012264,0.17565,0.41614,HP_PROGRESSIVE_EXTERNAL_OPHTHALMOPLEGIA,0.984752084029123
MORF_PDPK1,SET,66,0.02179,0.0013035,0.103,0.41623,MORF_PDPK1,0.984752084029123
ZNF563_TARGET_GENES,SET,473,0.0084595,0.0013396,0.039996,0.41625,ZNF563_TARGET_GENES,0.984752084029123
REACTOME_G_ALPHA_I_SIGNALLIN...,SET,296,0.011612,0.0014618,0.05491,0.41626,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,0.984752084029123
BIOCARTA_CD40_PATHWAY,SET,12,0.053594,0.001369,0.25372,0.41636,BIOCARTA_CD40_PATHWAY,0.984752084029123
GSE38304_MYC_NEG_VS_POS_GC_B...2,SET,184,0.013823,0.0013762,0.065453,0.41637,GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP,0.984752084029123
REACTOME_CLEC7A_INFLAMMASOME...,SET,5,0.082242,0.0013563,0.38998,0.41649,REACTOME_CLEC7A_INFLAMMASOME_PATHWAY,0.984752084029123
HP_INFANTILE_SENSORINEURAL_H...,SET,5,0.075345,0.0012426,0.3573,0.41649,HP_INFANTILE_SENSORINEURAL_HEARING_IMPAIRMENT,0.984752084029123
HP_ABNORMALITY_OF_PERIPHERAL...,SET,129,0.015526,0.0012962,0.073653,0.41652,HP_ABNORMALITY_OF_PERIPHERAL_NERVE_CONDUCTION,0.984752084029123
WP_ACETYLCHOLINE_SYNTHESIS,SET,5,0.078506,0.0012947,0.37247,0.41653,WP_ACETYLCHOLINE_SYNTHESIS,0.984752084029123
GOBP_CELLULAR_RESPONSE_TO_PE...2,SET,293,0.010788,0.0013513,0.051188,0.41654,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS,0.984752084029123
REACTOME_GLUTAMATE_NEUROTRAN...,SET,23,0.041638,0.0014721,0.1976,0.41655,REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE,0.984752084029123
BAKER_HEMATOPOIESIS_STAT3_TA...,SET,14,0.05176,0.001428,0.24566,0.41656,BAKER_HEMATOPOIESIS_STAT3_TARGETS,0.984752084029123
LY_AGING_PREMATURE_DN,SET,29,0.033328,0.0013229,0.15819,0.41657,LY_AGING_PREMATURE_DN,0.984752084029123
GOBP_POSITIVE_REGULATION_OF_...740,SET,10,0.054836,0.0012788,0.26036,0.41659,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY,0.984752084029123
GOBP_POSITIVE_REGULATION_OF_...125,SET,239,0.011734,0.0013294,0.055724,0.41661,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.984752084029123
KEGG_MEDICUS_REFERENCE_TYPE_...3,SET,20,0.049156,0.0016207,0.23351,0.41663,KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,0.984752084029123
PID_RAC1_REG_PATHWAY,SET,36,0.031062,0.0013734,0.14758,0.41665,PID_RAC1_REG_PATHWAY,0.984752084029123
WP_CYTOSINE_METHYLATION,SET,7,0.073322,0.0014307,0.34848,0.41668,WP_CYTOSINE_METHYLATION,0.984752084029123
HP_IMPULSIVITY,SET,128,0.016253,0.0013517,0.077291,0.41672,HP_IMPULSIVITY,0.984752084029123
GOBP_REGULATION_OF_CELL_SHAPE,SET,125,0.016446,0.0013517,0.078212,0.41673,GOBP_REGULATION_OF_CELL_SHAPE,0.984752084029123
HP_AORTIC_VALVE_STENOSIS,SET,51,0.025887,0.0013618,0.12313,0.41674,HP_AORTIC_VALVE_STENOSIS,0.984752084029123
VERHAAK_AML_WITH_NPM1_MUTATE...2,SET,168,0.015343,0.0014602,0.072981,0.41675,VERHAAK_AML_WITH_NPM1_MUTATED_UP,0.984752084029123
GGATCCG_MIR127,SET,9,0.068155,0.0015079,0.32423,0.41676,GGATCCG_MIR127,0.984752084029123
HP_HYPOESTHESIA,SET,16,0.044949,0.0013257,0.21385,0.41676,HP_HYPOESTHESIA,0.984752084029123
WP_CYSTEINE_AND_METHIONINE_C...,SET,13,0.054154,0.0014398,0.25774,0.41679,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,0.984752084029123
GOBP_NEGATIVE_REGULATION_OF_...94,SET,8,0.062311,0.0012998,0.29659,0.4168,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPIRATION,0.984752084029123
GOBP_POST_EMBRYONIC_EYE_MORP...,SET,7,0.07552,0.0014736,0.35946,0.4168,GOBP_POST_EMBRYONIC_EYE_MORPHOGENESIS,0.984752084029123
HP_ABNORMAL_PROPORTION_OF_NA...,SET,4,0.10333,0.0015243,0.49185,0.4168,HP_ABNORMAL_PROPORTION_OF_NAIVE_T_CELLS,0.984752084029123
GSE2706_UNSTIM_VS_8H_LPS_DC_...2,SET,178,0.013243,0.0012969,0.063059,0.41683,GSE2706_UNSTIM_VS_8H_LPS_DC_UP,0.984752084029123
HP_ELEVATED_CIRCULATING_CALC...,SET,22,0.034023,0.0011764,0.16202,0.41684,HP_ELEVATED_CIRCULATING_CALCITONIN_CONCENTRATION,0.984752084029123
OSMAN_BLOOD_CHAD63_KH_AGE_18...2,SET,1577,0.0049256,0.0013796,0.023461,0.41686,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP,0.984752084029123
REACTOME_ROBO_RECEPTORS_BIND...,SET,9,0.057001,0.0012611,0.27154,0.41687,REACTOME_ROBO_RECEPTORS_BIND_AKAP5,0.984752084029123
REACTOME_INTERACTIONS_OF_VPR...,SET,33,0.028625,0.0012119,0.13645,0.41692,REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,0.984752084029123
GOBP_GLYCOSYLCERAMIDE_BIOSYN...,SET,8,0.063947,0.0013339,0.30483,0.41692,GOBP_GLYCOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.984752084029123
GSE13484_12H_UNSTIM_VS_YF17D...2,SET,177,0.01322,0.0012911,0.063031,0.41694,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.984752084029123
TRAVAGLINI_LUNG_DIFFERENTIAT...,SET,148,0.015613,0.0013955,0.074443,0.41694,TRAVAGLINI_LUNG_DIFFERENTIATING_BASAL_CELL,0.984752084029123
RODRIGUES_DCC_TARGETS_UP,SET,5,0.079604,0.0013128,0.37959,0.41695,RODRIGUES_DCC_TARGETS_UP,0.984752084029123
GSE7460_CTRL_VS_TGFB_TREATED...4,SET,192,0.012409,0.0012617,0.059219,0.41701,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP,0.984752084029123
MIR3177_3P,SET,8,0.071519,0.0014918,0.34135,0.41702,MIR3177_3P,0.984752084029123
NAGY_STAGA_COMPONENTS_HUMAN,SET,13,0.045668,0.0012142,0.21816,0.4171,NAGY_STAGA_COMPONENTS_HUMAN,0.984752084029123
GOBP_AMIDE_TRANSPORT,SET,295,0.01098,0.0013799,0.052455,0.4171,GOBP_AMIDE_TRANSPORT,0.984752084029123
GOBP_SENSORY_PERCEPTION_OF_P...,SET,73,0.022297,0.0014025,0.10654,0.41711,GOBP_SENSORY_PERCEPTION_OF_PAIN,0.984752084029123
GOBP_EMBRYONIC_EYE_MORPHOGEN...,SET,34,0.033741,0.0014499,0.16144,0.41723,GOBP_EMBRYONIC_EYE_MORPHOGENESIS,0.984752084029123
TSUNODA_CISPLATIN_RESISTANCE...1,SET,43,0.028846,0.0013937,0.13807,0.41725,TSUNODA_CISPLATIN_RESISTANCE_DN,0.984752084029123
RUBENSTEIN_SKELETAL_MUSCLE_F...1,SET,154,0.015381,0.0014021,0.073623,0.41726,RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS,0.984752084029123
GOBP_REGULATION_OF_AMINE_MET...,SET,27,0.03518,0.0013474,0.16846,0.41729,GOBP_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.984752084029123
GOMF_TRANSCRIPTION_FACTOR_BI...,SET,554,0.007737,0.0013229,0.03705,0.41729,GOMF_TRANSCRIPTION_FACTOR_BINDING,0.984752084029123
GSE22103_UNSTIM_VS_LPS_STIM_...1,SET,178,0.013643,0.0013362,0.065328,0.41729,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN,0.984752084029123
BOWIE_RESPONSE_TO_TAMOXIFEN,SET,18,0.040605,0.0012701,0.19453,0.41733,BOWIE_RESPONSE_TO_TAMOXIFEN,0.984752084029123
GOMF_LIPID_TRANSPORTER_ACTIV...,SET,158,0.014944,0.0013797,0.071604,0.41734,GOMF_LIPID_TRANSPORTER_ACTIVITY,0.984752084029123
RB_P107_DN.V1_UP,SET,121,0.015817,0.0012792,0.075811,0.41737,RB_P107_DN.V1_UP,0.984752084029123
HP_ABNORMAL_LABIA_MINORA_MOR...,SET,34,0.034184,0.001469,0.16394,0.41741,HP_ABNORMAL_LABIA_MINORA_MORPHOLOGY,0.984752084029123
GSE3982_EOSINOPHIL_VS_MAC_DN,SET,178,0.013495,0.0013217,0.064762,0.41747,GSE3982_EOSINOPHIL_VS_MAC_DN,0.984752084029123
HP_CLASS_III_OBESITY,SET,5,0.10702,0.001765,0.51369,0.41749,HP_CLASS_III_OBESITY,0.984752084029123
MODULE_267,SET,14,0.046188,0.0012743,0.22185,0.41754,MODULE_267,0.984752084029123
GOBP_REGULATION_OF_BLOOD_BRA...,SET,9,0.070477,0.0015592,0.33878,0.4176,GOBP_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.984752084029123
RGAGGAARY_PU1_Q6,SET,462,0.0086433,0.0013531,0.041554,0.41761,RGAGGAARY_PU1_Q6,0.984752084029123
REACTOME_TP53_REGULATES_TRAN...9,SET,18,0.039021,0.0012206,0.18766,0.41764,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,0.984752084029123
PID_KIT_PATHWAY,SET,51,0.027014,0.0014211,0.12993,0.41765,PID_KIT_PATHWAY,0.984752084029123
GOBP_PROTEIN_ACYLATION,SET,83,0.018431,0.0012358,0.088699,0.4177,GOBP_PROTEIN_ACYLATION,0.984752084029123
KYNG_WERNER_SYNDROM_DN,SET,18,0.043105,0.0013484,0.20746,0.41771,KYNG_WERNER_SYNDROM_DN,0.984752084029123
GOMF_G_PROTEIN_COUPLED_RECEP...2,SET,254,0.012037,0.0014053,0.057955,0.41773,GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING,0.984752084029123
GOBP_POSITIVE_REGULATION_OF_...70,SET,15,0.043151,0.0012323,0.20784,0.41776,GOBP_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.984752084029123
HP_SHORT_PHILTRUM,SET,213,0.012253,0.0013114,0.059012,0.41776,HP_SHORT_PHILTRUM,0.984752084029123
REACTOME_SIGNALING_BY_FLT3_I...,SET,16,0.043544,0.0012843,0.20985,0.41781,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,0.984752084029123
GOMF_CIS_TRANS_ISOMERASE_ACT...,SET,37,0.026104,0.0011701,0.12588,0.41786,GOMF_CIS_TRANS_ISOMERASE_ACTIVITY,0.984752084029123
GOBP_REGULATION_OF_UNSATURAT...,SET,10,0.053659,0.0012513,0.25879,0.41787,GOBP_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.984752084029123
GOMF_ALPHA_N_ACETYLNEURAMINA...,SET,6,0.089124,0.0016101,0.42983,0.41787,GOMF_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY,0.984752084029123
HP_PULMONIC_STENOSIS,SET,115,0.017736,0.0013986,0.085582,0.41791,HP_PULMONIC_STENOSIS,0.984752084029123
MIR6766_3P,SET,139,0.014749,0.0012778,0.07118,0.41793,MIR6766_3P,0.984752084029123
XU_RESPONSE_TO_TRETINOIN_DN,SET,10,0.059682,0.0013918,0.28812,0.41795,XU_RESPONSE_TO_TRETINOIN_DN,0.984752084029123
GOBP_NEGATIVE_REGULATION_OF_...464,SET,42,0.025707,0.0012275,0.12411,0.41796,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,0.984752084029123
HP_PROXIMAL_MUSCLE_WEAKNESS,SET,219,0.011952,0.0012969,0.057708,0.41796,HP_PROXIMAL_MUSCLE_WEAKNESS,0.984752084029123
HP_UPPER_LIMB_JOINT_CONTRACT...,SET,300,0.010625,0.0013464,0.051302,0.41796,HP_UPPER_LIMB_JOINT_CONTRACTURE,0.984752084029123
GSE21927_SPLEEN_VS_C26GM_TUM...1,SET,162,0.013805,0.0012904,0.066663,0.41797,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN,0.984752084029123
WP_SPINAL_CORD_INJURY,SET,116,0.017744,0.0014053,0.085692,0.41798,WP_SPINAL_CORD_INJURY,0.984752084029123
MIR4691_5P,SET,119,0.016498,0.0013233,0.079746,0.41805,MIR4691_5P,0.984752084029123
MIR4745_5P,SET,79,0.020515,0.0013421,0.099206,0.41809,MIR4745_5P,0.984752084029123
GNF2_MYL3,SET,31,0.034201,0.0014035,0.16573,0.41825,GNF2_MYL3,0.984752084029123
HP_ABNORMAL_URINARY_PURINE_L...,SET,7,0.081552,0.0015913,0.39541,0.4183,HP_ABNORMAL_URINARY_PURINE_LEVEL,0.984752084029123
chr2p13,SET,81,0.044606,0.0029548,0.21633,0.41832,chr2p13,0.984752084029123
HP_VITILIGO,SET,22,0.040718,0.001408,0.19752,0.41834,HP_VITILIGO,0.984752084029123
GOBP_REGULATION_OF_LIPOPHAGY,SET,5,0.083115,0.0013707,0.4034,0.41838,GOBP_REGULATION_OF_LIPOPHAGY,0.984752084029123
MIR492,SET,23,0.035629,0.0012596,0.17295,0.41839,MIR492,0.984752084029123
GOCC_CYTOPLASMIC_EXOSOME_RNA...,SET,15,0.040011,0.0011426,0.19423,0.4184,GOCC_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX,0.984752084029123
MODULE_424,SET,17,0.044598,0.0013558,0.21654,0.41841,MODULE_424,0.984752084029123
HP_TRICUSPID_STENOSIS,SET,6,0.081176,0.0014665,0.39418,0.41842,HP_TRICUSPID_STENOSIS,0.984752084029123
BLANCO_MELO_COVID19_SARS_COV...3,SET,373,0.0093109,0.0013129,0.045219,0.41843,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,0.984752084029123
HP_BIPOLAR_AFFECTIVE_DISORDER,SET,24,0.036261,0.0013095,0.17629,0.41852,HP_BIPOLAR_AFFECTIVE_DISORDER,0.984752084029123
GSE26488_WT_VS_HDAC7_DELTAP_...1,SET,184,0.013414,0.0013354,0.065287,0.41861,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN,0.984752084029123
TCANNTGAY_SREBP1_01,SET,421,0.0085401,0.0012777,0.04157,0.41862,TCANNTGAY_SREBP1_01,0.984752084029123
GSE339_EX_VIVO_VS_IN_CULTURE...2,SET,180,0.012794,0.00126,0.06228,0.41862,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP,0.984752084029123
GSE12198_LOW_IL2_STIM_NK_CEL...2,SET,184,0.012283,0.0012228,0.059813,0.41865,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.984752084029123
BANP_TARGET_GENES,SET,613,0.0071413,0.0012823,0.034783,0.41867,BANP_TARGET_GENES,0.984752084029123
GOBP_REGULATION_OF_DNA_DAMAG...2,SET,33,0.031609,0.0013382,0.15402,0.4187,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.984752084029123
HP_ABNORMALITY_OF_THE_BREAST,SET,393,0.0086393,0.0012498,0.042146,0.41879,HP_ABNORMALITY_OF_THE_BREAST,0.984752084029123
GOMF_NEUROTRANSMITTER_TRANSM...,SET,20,0.041371,0.001364,0.20189,0.41882,GOMF_NEUROTRANSMITTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984752084029123
GSE2770_UNTREATED_VS_ACT_CD4...5,SET,178,0.012757,0.0012494,0.062256,0.41882,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN,0.984752084029123
GOBP_REGULATION_OF_SEROTONIN...,SET,6,0.074257,0.0013415,0.36246,0.41884,GOBP_REGULATION_OF_SEROTONIN_SECRETION,0.984752084029123
GSE15930_NAIVE_VS_48H_IN_VIT...5,SET,179,0.012561,0.0012336,0.061316,0.41884,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.984752084029123
GARGALOVIC_RESPONSE_TO_OXIDI...13,SET,10,0.060697,0.0014155,0.29645,0.41889,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN,0.984752084029123
MIR3944_5P,SET,103,0.016872,0.0012595,0.082405,0.41889,MIR3944_5P,0.984752084029123
GSE18148_CBFB_KO_VS_WT_TREG_...1,SET,174,0.013884,0.0013445,0.067847,0.41893,GSE18148_CBFB_KO_VS_WT_TREG_DN,0.984752084029123
MODULE_340,SET,24,0.034727,0.0012541,0.16976,0.41896,MODULE_340,0.984752084029123
HP_ABNORMAL_MENINGEAL_MORPHO...,SET,177,0.013035,0.0012731,0.063724,0.41896,HP_ABNORMAL_MENINGEAL_MORPHOLOGY,0.984752084029123
GSE43955_TH0_VS_TGFB_IL6_TH1...5,SET,180,0.013059,0.0012861,0.063905,0.41904,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN,0.984752084029123
GSE5542_UNTREATED_VS_IFNA_AN...3,SET,177,0.01319,0.0012882,0.064578,0.41908,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.984752084029123
REACTOME_APOPTOSIS_INDUCED_D...,SET,7,0.063379,0.0012367,0.31034,0.41909,REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION,0.984752084029123
GOBP_MESENCHYME_MORPHOGENESIS,SET,58,0.026552,0.0014893,0.13001,0.41909,GOBP_MESENCHYME_MORPHOGENESIS,0.984752084029123
HP_VEGETATIVE_STATE,SET,9,0.057244,0.0012665,0.28034,0.4191,HP_VEGETATIVE_STATE,0.984752084029123
REACTOME_CARDIOGENESIS,SET,24,0.038925,0.0014057,0.19068,0.41912,REACTOME_CARDIOGENESIS,0.984752084029123
GOBP_T_HELPER_17_CELL_LINEAG...,SET,19,0.045039,0.0014474,0.22061,0.41912,GOBP_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.984752084029123
GSE11924_TH1_VS_TH17_CD4_TCE...1,SET,186,0.01239,0.0012401,0.06069,0.41912,GSE11924_TH1_VS_TH17_CD4_TCELL_DN,0.984752084029123
GOBP_SPHINGOMYELIN_CATABOLIC...,SET,8,0.064204,0.0013392,0.31457,0.41914,GOBP_SPHINGOMYELIN_CATABOLIC_PROCESS,0.984752084029123
HP_DECREASED_ACTIVITY_OF_MIT...5,SET,60,0.019813,0.0011302,0.097076,0.41914,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_IV,0.984752084029123
MIR1_5P,SET,82,0.019997,0.0013327,0.098009,0.41917,MIR1_5P,0.984752084029123
GOMF_TRNA_URIDINE_METHYLTRAN...,SET,3,0.078182,0.00099881,0.3832,0.41917,GOMF_TRNA_URIDINE_METHYLTRANSFERASE_ACTIVITY,0.984752084029123
GSE24634_TEFF_VS_TCONV_DAY5_...1,SET,174,0.013038,0.0012626,0.063906,0.41917,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN,0.984752084029123
HP_BARREL_SHAPED_CHEST,SET,20,0.0397,0.001309,0.19466,0.4192,HP_BARREL_SHAPED_CHEST,0.984752084029123
GRABARCZYK_BCL11B_TARGETS_UP,SET,68,0.020799,0.0012628,0.10207,0.41927,GRABARCZYK_BCL11B_TARGETS_UP,0.984752084029123
GSE6674_UNSTIM_VS_ANTI_IGM_A...1,SET,178,0.012331,0.0012077,0.060531,0.41929,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,0.984752084029123
HP_SPINAL_RIGIDITY,SET,54,0.023492,0.0012716,0.11533,0.4193,HP_SPINAL_RIGIDITY,0.984752084029123
LOPEZ_MESOTHELIOMA_SURVIVAL_...2,SET,11,0.059254,0.0014492,0.29094,0.41931,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,0.984752084029123
GOBP_REGULATION_OF_NUCLEAR_C...,SET,12,0.046635,0.0011913,0.22913,0.41936,GOBP_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.984752084029123
GOMF_MHC_CLASS_II_PROTEIN_BI...,SET,7,0.068972,0.0013458,0.33891,0.41937,GOMF_MHC_CLASS_II_PROTEIN_BINDING,0.984752084029123
GOBP_CLEAVAGE_FURROW_FORMATI...,SET,7,0.070919,0.0013838,0.34862,0.4194,GOBP_CLEAVAGE_FURROW_FORMATION,0.984752084029123
SOBOLEV_PBMC_PANDEMRIX_AGE_1...6,SET,5,0.090015,0.0014845,0.44256,0.41941,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_LOW_VS_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_0DY_DN,0.984752084029123
MORF_ARL3,SET,280,0.010641,0.0013034,0.052326,0.41943,MORF_ARL3,0.984752084029123
GOMF_PROTEIN_GLUTAMINE_GAMMA...,SET,9,0.062071,0.0013733,0.30522,0.41943,GOMF_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY,0.984752084029123
REACTOME_DEFECTS_OF_CONTACT_...,SET,14,0.05137,0.0014173,0.25271,0.41946,REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS,0.984752084029123
GOBP_REGULATION_OF_DENDRITE_...3,SET,57,0.022641,0.001259,0.11137,0.41946,GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.984752084029123
GSE18893_CTRL_VS_TNF_TREATED...1,SET,178,0.013202,0.001293,0.064966,0.41948,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN,0.984752084029123
GOMF_G_PROTEIN_COUPLED_RECEP...3,SET,4,0.078679,0.0011606,0.38752,0.41956,GOMF_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY,0.984752084029123
NIKOLSKY_BREAST_CANCER_21Q22...,SET,15,0.072209,0.0020621,0.35606,0.41965,NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,0.984752084029123
GSE3982_EOSINOPHIL_VS_MAST_C...1,SET,174,0.013158,0.0012742,0.064924,0.4197,GSE3982_EOSINOPHIL_VS_MAST_CELL_DN,0.984752084029123
GOBP_NEGATIVE_REGULATION_OF_...72,SET,9,0.057383,0.0012695,0.28319,0.41971,GOBP_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.984752084029123
MODULE_323,SET,52,0.021995,0.0011683,0.10856,0.41972,MODULE_323,0.984752084029123
HP_EPIPHORA,SET,22,0.036963,0.0012781,0.18242,0.41972,HP_EPIPHORA,0.984752084029123
GSE25085_FETAL_LIVER_VS_ADUL...1,SET,167,0.01253,0.001189,0.061847,0.41973,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,0.984752084029123
GOBP_DIENCEPHALON_DEVELOPMENT,SET,71,0.022842,0.001417,0.11277,0.41974,GOBP_DIENCEPHALON_DEVELOPMENT,0.984752084029123
HALLMARK_ALLOGRAFT_REJECTION,SET,184,0.013543,0.0013483,0.066896,0.41979,HALLMARK_ALLOGRAFT_REJECTION,0.984752084029123
WP_CLASSICAL_PATHWAY_OF_STER...,SET,16,0.047265,0.001394,0.23389,0.41993,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,0.984752084029123
GOBP_VENTRICULAR_COMPACT_MYO...,SET,7,0.075203,0.0014674,0.37228,0.41996,GOBP_VENTRICULAR_COMPACT_MYOCARDIUM_MORPHOGENESIS,0.984752084029123
MIR548AH_3P_MIR548AM_3P,SET,715,0.0065952,0.0012753,0.032652,0.41997,MIR548AH_3P_MIR548AM_3P,0.984752084029123
ZHAN_MULTIPLE_MYELOMA_LB_UP,SET,45,0.028128,0.0013902,0.13932,0.42,ZHAN_MULTIPLE_MYELOMA_LB_UP,0.984752084029123
GSE18281_CORTICAL_VS_MEDULLA...1,SET,170,0.013606,0.0013025,0.067408,0.42002,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN,0.984752084029123
CCAWWNAAGG_SRF_Q4,SET,77,0.020936,0.0013523,0.10391,0.42016,CCAWWNAAGG_SRF_Q4,0.984752084029123
RUIZ_TNC_TARGETS_UP,SET,138,0.016092,0.0013892,0.079884,0.42018,RUIZ_TNC_TARGETS_UP,0.984752084029123
HP_ELEVATED_URINARY_3_HYDROX...,SET,5,0.079381,0.0013092,0.39425,0.42022,HP_ELEVATED_URINARY_3_HYDROXYBUTYRIC_ACID,0.984752084029123
GSE19401_UNSTIM_VS_RETINOIC_...3,SET,169,0.013156,0.0012558,0.065357,0.42023,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,0.984752084029123
BIOCARTA_ECM_PATHWAY,SET,19,0.039204,0.0012599,0.19477,0.42024,BIOCARTA_ECM_PATHWAY,0.984752084029123
CAR_MLANA,SET,40,0.026517,0.0012358,0.13184,0.4203,CAR_MLANA,0.984752084029123
GOBP_STEM_CELL_DIVISION,SET,29,0.03312,0.0013146,0.16467,0.4203,GOBP_STEM_CELL_DIVISION,0.984752084029123
GOMF_POLY_PURINE_TRACT_BINDI...,SET,26,0.03374,0.0012682,0.16779,0.42032,GOMF_POLY_PURINE_TRACT_BINDING,0.984752084029123
GOMF_CYTOCHROME_B5_REDUCTASE...,SET,6,0.065364,0.0011808,0.32541,0.4204,GOMF_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,0.984752084029123
GOMF_L_ALANINE_TRANSMEMBRANE...,SET,9,0.060425,0.0013369,0.30084,0.42041,GOMF_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984752084029123
NKX25_02,SET,232,0.012008,0.0013407,0.059832,0.42047,NKX25_02,0.984752084029123
GOBP_REGULATION_OF_SUPRAMOLE...,SET,336,0.009322,0.0012489,0.046463,0.42049,GOBP_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.984752084029123
GOMF_METAL_DEPENDENT_DEUBIQU...,SET,11,0.053197,0.0013011,0.26514,0.42049,GOMF_METAL_DEPENDENT_DEUBIQUITINASE_ACTIVITY,0.984752084029123
HP_CORNEAL_ULCERATION,SET,18,0.040455,0.0012655,0.20166,0.4205,HP_CORNEAL_ULCERATION,0.984752084029123
GOBP_REGULATION_OF_CORE_PROM...,SET,5,0.075653,0.0012477,0.37718,0.42052,GOBP_REGULATION_OF_CORE_PROMOTER_BINDING,0.984752084029123
MIR6715B_3P,SET,116,0.015405,0.00122,0.076902,0.42062,MIR6715B_3P,0.984752084029123
HP_ASTERIXIS,SET,5,0.085425,0.0014088,0.42645,0.42062,HP_ASTERIXIS,0.984752084029123
MIR6731_3P,SET,68,0.020662,0.0012545,0.10321,0.42067,MIR6731_3P,0.984752084029123
NAKAYA_PBMC_FLUARIX_FLUVIRIN...6,SET,379,0.0088674,0.0012602,0.044295,0.42067,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE,0.984752084029123
GSE19401_RETINOIC_ACID_VS_RE...1,SET,187,0.011803,0.0011846,0.058969,0.42068,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.984752084029123
WP_MARKERS_OF_KIDNEY_CELL_LI...,SET,57,0.025266,0.0014049,0.12624,0.42069,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,0.984752084029123
HP_DYSDIADOCHOKINESIS,SET,49,0.023203,0.0011965,0.11603,0.42075,HP_DYSDIADOCHOKINESIS,0.984752084029123
GOBP_REGULATION_OF_AMYLOID_F...,SET,15,0.03906,0.0011154,0.19538,0.42077,GOBP_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.984752084029123
REACTOME_REGULATION_OF_PTEN_...1,SET,56,0.022161,0.0012215,0.11087,0.42078,REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,0.984752084029123
HP_HIATUS_HERNIA,SET,32,0.028966,0.0012076,0.14498,0.42082,HP_HIATUS_HERNIA,0.984752084029123
REACTOME_MITOTIC_G1_PHASE_AN...,SET,143,0.013336,0.0011718,0.066758,0.42083,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,0.984752084029123
HP_ABNORMAL_CIRCULATING_CITR...,SET,10,0.054687,0.0012753,0.27378,0.42084,HP_ABNORMAL_CIRCULATING_CITRULLINE_CONCENTRATION,0.984752084029123
GOBP_MITOCHONDRIAL_RESPIRASO...,SET,7,0.054828,0.0010698,0.27452,0.42085,GOBP_MITOCHONDRIAL_RESPIRASOME_ASSEMBLY,0.984752084029123
GOCC_TRANSCRIPTION_FACTOR_TF...5,SET,17,0.036015,0.0010949,0.18042,0.42089,GOCC_TRANSCRIPTION_FACTOR_TFTC_COMPLEX,0.984752084029123
GSE22589_SIV_VS_HIV_AND_SIV_...2,SET,179,0.012772,0.0012543,0.064022,0.42094,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP,0.984752084029123
GOBP_PROTEIN_LOCALIZATION_TO...37,SET,15,0.040279,0.0011503,0.20193,0.42095,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.984752084029123
MCBRYAN_PUBERTAL_BREAST_3_4W...2,SET,193,0.013201,0.0013456,0.066277,0.42106,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,0.984752084029123
GOBP_SEPTUM_PRIMUM_DEVELOPME...,SET,4,0.092954,0.0013712,0.46699,0.42111,GOBP_SEPTUM_PRIMUM_DEVELOPMENT,0.984752084029123
GSE17974_IL4_AND_ANTI_IL12_V...11,SET,164,0.0137,0.0012884,0.068834,0.42112,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN,0.984752084029123
GSE40274_FOXP3_VS_FOXP3_AND_...16,SET,134,0.014859,0.0012642,0.074665,0.42113,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.984752084029123
WP_IRON_METABOLISM_IN_PLACEN...,SET,12,0.053157,0.0013579,0.26722,0.42116,WP_IRON_METABOLISM_IN_PLACENTA,0.984752084029123
REACTOME_NEF_MEDIATES_DOWN_M...,SET,20,0.036203,0.0011937,0.18204,0.42118,REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,0.984752084029123
GOBP_DOPAMINE_TRANSPORT,SET,43,0.027515,0.0013294,0.13837,0.42119,GOBP_DOPAMINE_TRANSPORT,0.984752084029123
GOBP_HETEROCHROMATIN_FORMATI...,SET,95,0.016969,0.0012169,0.085346,0.4212,GOBP_HETEROCHROMATIN_FORMATION,0.984752084029123
KEGG_MEDICUS_VARIANT_MUTATIO...33,SET,13,0.049845,0.0013252,0.25095,0.42128,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM,0.984752084029123
MIR4765,SET,44,0.026271,0.0012839,0.13231,0.4213,MIR4765,0.984752084029123
GSE11864_CSF1_VS_CSF1_IFNG_P...1,SET,173,0.012658,0.0012224,0.063751,0.4213,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.984752084029123
GOBP_REGULATION_OF_LEUKOCYTE...10,SET,18,0.041804,0.0013077,0.21066,0.42135,GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.984752084029123
GSE17974_IL4_AND_ANTI_IL12_V...16,SET,151,0.014384,0.0012985,0.072513,0.42138,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP,0.984752084029123
GOBP_REGULATION_OF_FIBROBLAS...2,SET,29,0.034246,0.0013593,0.17278,0.42144,GOBP_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.984752084029123
MIR6844,SET,306,0.0098446,0.0012597,0.049683,0.42147,MIR6844,0.984752084029123
GSE28737_WT_VS_BCL6_HET_FOLL...1,SET,178,0.012603,0.0012343,0.063619,0.42148,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN,0.984752084029123
GOBP_RAB_PROTEIN_SIGNAL_TRAN...,SET,17,0.039916,0.0012134,0.20166,0.42155,GOBP_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.984752084029123
GOMF_SELENIUM_BINDING,SET,6,0.07983,0.0014422,0.40346,0.42158,GOMF_SELENIUM_BINDING,0.984752084029123
HP_DECREASED_CIRCULATING_GON...,SET,37,0.029044,0.0013019,0.14692,0.42165,HP_DECREASED_CIRCULATING_GONADOTROPIN_CONCENTRATION,0.984752084029123
WINTER_HYPOXIA_METAGENE,SET,216,0.012089,0.0013029,0.061206,0.42171,WINTER_HYPOXIA_METAGENE,0.984752084029123
GOBP_DOUBLE_STRAND_BREAK_REP...2,SET,7,0.056582,0.0011041,0.28649,0.42172,GOBP_DOUBLE_STRAND_BREAK_REPAIR_INVOLVED_IN_MEIOTIC_RECOMBINATION,0.984752084029123
HP_IVORY_EPIPHYSES_OF_THE_PH...,SET,6,0.078007,0.0014093,0.39503,0.42173,HP_IVORY_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.984752084029123
GOBP_EXPLORATION_BEHAVIOR,SET,29,0.033163,0.0013163,0.16797,0.42174,GOBP_EXPLORATION_BEHAVIOR,0.984752084029123
HP_MULTIPLE_PULMONARY_CYSTS,SET,18,0.041798,0.0013075,0.2117,0.42174,HP_MULTIPLE_PULMONARY_CYSTS,0.984752084029123
MIR6734_3P,SET,134,0.014661,0.0012473,0.074323,0.42181,MIR6734_3P,0.984752084029123
GOMF_BETA_2_MICROGLOBULIN_BI...,SET,8,0.061618,0.0012853,0.31234,0.42181,GOMF_BETA_2_MICROGLOBULIN_BINDING,0.984752084029123
GSE13485_DAY7_VS_DAY21_YF17D...1,SET,141,0.015002,0.001309,0.076072,0.42183,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.984752084029123
GAVISH_3CA_METAPROGRAM_B_CEL...9,SET,36,0.027204,0.0012028,0.13801,0.42187,GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA,0.984752084029123
GOBP_GROWTH,SET,819,0.0062293,0.0012854,0.031605,0.42188,GOBP_GROWTH,0.984752084029123
GOBP_NAD_BIOSYNTHESIS_VIA_NI...,SET,9,0.059282,0.0013116,0.301,0.42193,GOBP_NAD_BIOSYNTHESIS_VIA_NICOTINAMIDE_RIBOSIDE_SALVAGE_PATHWAY,0.984752084029123
HP_APLASIA_HYPOPLASIA_OF_THE...16,SET,9,0.058088,0.0012851,0.29514,0.42199,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBRAL_WHITE_MATTER,0.984752084029123
HP_CEREBRAL_WHITE_MATTER_HYP...,SET,9,0.058088,0.0012851,0.29514,0.42199,HP_CEREBRAL_WHITE_MATTER_HYPOPLASIA,0.984752084029123
HP_RHEGMATOGENOUS_RETINAL_DE...,SET,11,0.053718,0.0013138,0.27299,0.422,HP_RHEGMATOGENOUS_RETINAL_DETACHMENT,0.984752084029123
MORF_CASP2,SET,89,0.017179,0.0011926,0.087322,0.42202,MORF_CASP2,0.984752084029123
GOMF_PEPTIDE_BINDING,SET,234,0.011819,0.0013252,0.060076,0.42202,GOMF_PEPTIDE_BINDING,0.984752084029123
GAZDA_DIAMOND_BLACKFAN_ANEMI...4,SET,27,0.031526,0.0012075,0.16027,0.42203,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,0.984752084029123
REACTOME_ONCOGENIC_MAPK_SIGN...,SET,77,0.019766,0.0012767,0.10061,0.42212,REACTOME_ONCOGENIC_MAPK_SIGNALING,0.984752084029123
GSE40274_GATA1_VS_FOXP3_AND_...2,SET,180,0.01259,0.0012398,0.064083,0.42213,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.984752084029123
HP_OVAL_FACE,SET,15,0.043146,0.0012321,0.21964,0.42214,HP_OVAL_FACE,0.984752084029123
CAMPS_COLON_CANCER_COPY_NUMB...1,SET,35,0.032066,0.001398,0.16327,0.42215,CAMPS_COLON_CANCER_COPY_NUMBER_DN,0.984752084029123
GOBP_NEGATIVE_REGULATION_OF_...527,SET,6,0.064532,0.0011658,0.32858,0.42215,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.984752084029123
OLF1_01,SET,242,0.010859,0.0012378,0.055351,0.42224,OLF1_01,0.984752084029123
GOBP_REGULATION_OF_RAC_PROTE...,SET,23,0.034888,0.0012334,0.17786,0.42225,GOBP_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.984752084029123
GSE22611_NOD2_TRANSDUCED_VS_...1,SET,173,0.012146,0.0011729,0.061923,0.42225,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN,0.984752084029123
MIR6793_3P,SET,70,0.018864,0.001162,0.096192,0.42226,MIR6793_3P,0.984752084029123
GOMF_EXTRACELLULAR_LIGAND_GA...,SET,67,0.022712,0.0013688,0.11581,0.42226,GOMF_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.984752084029123
GAVISH_3CA_METAPROGRAM_CD4_T...10,SET,46,0.025337,0.001266,0.12921,0.42227,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_UNASSIGNED,0.984752084029123
PAX3_TARGET_GENES,SET,1195,0.005152,0.0012703,0.026276,0.42228,PAX3_TARGET_GENES,0.984752084029123
GOMF_FLAP_ENDONUCLEASE_ACTIV...,SET,6,0.061322,0.0011078,0.31278,0.42228,GOMF_FLAP_ENDONUCLEASE_ACTIVITY,0.984752084029123
GSE43955_10H_VS_60H_ACT_CD4_...1,SET,182,0.012835,0.0012709,0.065463,0.42228,GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN,0.984752084029123
HP_DEPRESSED_NASAL_TIP,SET,22,0.036752,0.0012708,0.18749,0.4223,HP_DEPRESSED_NASAL_TIP,0.984752084029123
GSE17721_POLYIC_VS_GARDIQUIM...16,SET,186,0.01267,0.0012682,0.064648,0.42231,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP,0.984752084029123
GSE1460_CORD_VS_ADULT_BLOOD_...2,SET,165,0.013019,0.0012281,0.066465,0.42235,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP,0.984752084029123
HP_HYPERSEGMENTATION_OF_NEUT...,SET,6,0.077852,0.0014064,0.39754,0.42237,HP_HYPERSEGMENTATION_OF_NEUTROPHIL_NUCLEI,0.984752084029123
HP_TALIPES_VALGUS,SET,17,0.042953,0.0013058,0.21944,0.42241,HP_TALIPES_VALGUS,0.984752084029123
WP_CHRONIC_HYPERGLYCEMIA_IMP...,SET,43,0.02858,0.0013808,0.14608,0.42244,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.984752084029123
P53_DN.V2_DN,SET,134,0.015055,0.0012809,0.076946,0.42244,P53_DN.V2_DN,0.984752084029123
HP_ABNORMAL_PATTERN_ELECTROR...,SET,7,0.066661,0.0013007,0.34091,0.42249,HP_ABNORMAL_PATTERN_ELECTRORETINOGRAM,0.984752084029123
IRX3_TARGET_GENES,SET,45,0.024762,0.0012238,0.12669,0.42252,IRX3_TARGET_GENES,0.984752084029123
GOBP_NEGATIVE_CHEMOTAXIS,SET,46,0.026858,0.001342,0.13742,0.42252,GOBP_NEGATIVE_CHEMOTAXIS,0.984752084029123
HU_FETAL_RETINA_FIBROBLAST,SET,337,0.0099416,0.0013338,0.05088,0.42254,HU_FETAL_RETINA_FIBROBLAST,0.984752084029123
GAVISH_3CA_METAPROGRAM_ENDOT...12,SET,47,0.026087,0.0013175,0.13353,0.42256,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_INTERFERON,0.984752084029123
KAT2A_TARGET_GENES,SET,902,0.005674,0.0012258,0.029049,0.42257,KAT2A_TARGET_GENES,0.984752084029123
HOEK_NK_CELL_2011_2012_TIV_A...1,SET,7,0.058269,0.001137,0.29851,0.42262,HOEK_NK_CELL_2011_2012_TIV_ADULT_1DY_UP,0.984752084029123
HP_EXANTHEM,SET,20,0.037777,0.0012456,0.19365,0.42266,HP_EXANTHEM,0.984752084029123
REACTOME_REGULATION_OF_NF_KA...,SET,16,0.038393,0.0011323,0.19686,0.42269,REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING,0.984752084029123
GOMF_FERROUS_IRON_BINDING,SET,23,0.033117,0.0011708,0.16997,0.42276,GOMF_FERROUS_IRON_BINDING,0.984752084029123
GOBP_PROTEIN_LOCALIZATION_TO...41,SET,6,0.054931,0.00099236,0.28211,0.42281,GOBP_PROTEIN_LOCALIZATION_TO_PERINUCLEAR_REGION_OF_CYTOPLASM,0.984752084029123
LMNB2_TARGET_GENES,SET,31,0.028376,0.0011644,0.14586,0.42287,LMNB2_TARGET_GENES,0.984752084029123
GOBP_ALPHA_LINOLENIC_ACID_ME...,SET,9,0.055294,0.0012233,0.28424,0.42288,GOBP_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS,0.984752084029123
GOBP_CELLULAR_RESPONSE_TO_IN...8,SET,78,0.019845,0.0012901,0.10207,0.42292,GOBP_CELLULAR_RESPONSE_TO_INTERLEUKIN_1,0.984752084029123
MCCABE_HOXC6_TARGETS_DN,SET,18,0.040608,0.0012702,0.20893,0.42295,MCCABE_HOXC6_TARGETS_DN,0.984752084029123
GSE43863_NAIVE_VS_TFH_CD4_EF...1,SET,149,0.014279,0.0012805,0.073564,0.42305,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN,0.984752084029123
GSE10325_BCELL_VS_LUPUS_BCEL...1,SET,186,0.012229,0.001224,0.063053,0.42311,GSE10325_BCELL_VS_LUPUS_BCELL_DN,0.984752084029123
GAVISH_3CA_METAPROGRAM_CD4_T...9,SET,43,0.027424,0.001325,0.14148,0.42315,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_T_REG,0.984752084029123
GOBP_L_GLUTAMATE_TRANSMEMBRA...,SET,29,0.031034,0.0012318,0.1602,0.4232,GOBP_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT,0.984752084029123
MISHRA_CARCINOMA_ASSOCIATED_...2,SET,22,0.038034,0.0013151,0.19638,0.42322,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,0.984752084029123
DACOSTA_UV_RESPONSE_VIA_ERCC...3,SET,808,0.0059441,0.0012187,0.030715,0.42327,DACOSTA_UV_RESPONSE_VIA_ERCC3_DN,0.984752084029123
GOMF_EPHRIN_RECEPTOR_ACTIVITY,SET,18,0.043582,0.0013633,0.22519,0.42327,GOMF_EPHRIN_RECEPTOR_ACTIVITY,0.984752084029123
GOBP_L_GLUTAMATE_IMPORT_ACRO...,SET,17,0.041385,0.0012581,0.21429,0.42343,GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.984752084029123
BIOCARTA_BBCELL_PATHWAY,SET,6,0.078137,0.0014116,0.4047,0.42345,BIOCARTA_BBCELL_PATHWAY,0.984752084029123
MIR744_5P,SET,10,0.045935,0.0010712,0.23798,0.42347,MIR744_5P,0.984752084029123
REACTOME_NUCLEOTIDE_SALVAGE,SET,21,0.037239,0.0012581,0.19301,0.42351,REACTOME_NUCLEOTIDE_SALVAGE,0.984752084029123
GOBP_NEGATIVE_REGULATION_OF_...526,SET,11,0.057442,0.0014049,0.29791,0.42355,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.984752084029123
NAKAYA_B_CELL_FLUMIST_AGE_18...1,SET,347,0.0088517,0.0012048,0.045904,0.42355,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.984752084029123
GOMF_HEXOSE_TRANSMEMBRANE_TR...,SET,21,0.039334,0.0013289,0.20407,0.42358,GOMF_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984752084029123
HP_ABNORMAL_LARYNX_PHYSIOLOGY,SET,43,0.024911,0.0012035,0.12925,0.42359,HP_ABNORMAL_LARYNX_PHYSIOLOGY,0.984752084029123
GOBP_REGULATION_OF_CELL_GROW...1,SET,354,0.0089871,0.0012352,0.046641,0.4236,GOBP_REGULATION_OF_CELL_GROWTH,0.984752084029123
GSE9037_WT_VS_IRAK4_KO_LPS_4...1,SET,187,0.012293,0.0012337,0.06382,0.42363,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN,0.984752084029123
FRASOR_TAMOXIFEN_RESPONSE_UP,SET,44,0.026014,0.0012714,0.13509,0.42365,FRASOR_TAMOXIFEN_RESPONSE_UP,0.984752084029123
GOBP_PEPTIDYL_THREONINE_DEPH...,SET,17,0.043193,0.0013131,0.22429,0.42365,GOBP_PEPTIDYL_THREONINE_DEPHOSPHORYLATION,0.984752084029123
GSE17721_LPS_VS_POLYIC_24H_B...1,SET,178,0.012383,0.0012127,0.0643,0.42365,GSE17721_LPS_VS_POLYIC_24H_BMDC_DN,0.984752084029123
GOBP_B_CELL_PROLIFERATION_IN...,SET,6,0.07734,0.0013972,0.40173,0.42367,GOBP_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,0.984752084029123
KEGG_MEDICUS_PATHOGEN_SHIGEL...9,SET,7,0.057322,0.0011185,0.29804,0.42374,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPG_TO_TNF_NFKB_SIGNALING_PATHWAY,0.984752084029123
GOBP_REGULATION_OF_METALLOPE...,SET,9,0.06329,0.0014002,0.32911,0.42375,GOBP_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.984752084029123
FOURATI_BLOOD_TWINRIX_AGE_25...1,SET,598,0.0069074,0.0012256,0.035924,0.42376,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN,0.984752084029123
ZNF816_TARGET_GENES,SET,419,0.008144,0.0012156,0.042363,0.42378,ZNF816_TARGET_GENES,0.984752084029123
GSE37532_WT_VS_PPARG_KO_VISC...2,SET,173,0.012473,0.0012045,0.064903,0.4238,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP,0.984752084029123
HP_ABNORMALITY_OF_THE_TONSILS,SET,29,0.032052,0.0012722,0.16681,0.42382,HP_ABNORMALITY_OF_THE_TONSILS,0.984752084029123
GOBP_ESTABLISHMENT_OF_PROTEI...6,SET,31,0.028451,0.0011675,0.1481,0.42383,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE,0.984752084029123
GOBP_POSITIVE_REGULATION_OF_...823,SET,23,0.034336,0.0012139,0.17874,0.42383,GOBP_POSITIVE_REGULATION_OF_VACUOLE_ORGANIZATION,0.984752084029123
MIR6842_3P,SET,112,0.016342,0.0012719,0.085087,0.42385,MIR6842_3P,0.984752084029123
HP_METAPHYSEAL_IRREGULARITY,SET,44,0.024687,0.0012065,0.12854,0.42385,HP_METAPHYSEAL_IRREGULARITY,0.984752084029123
GOBP_CELLULAR_RESPONSE_TO_RE...3,SET,63,0.022666,0.0013248,0.11803,0.42386,GOBP_CELLULAR_RESPONSE_TO_RETINOIC_ACID,0.984752084029123
GOBP_CONDITIONED_PLACE_PREFE...,SET,5,0.075149,0.0012394,0.39132,0.42386,GOBP_CONDITIONED_PLACE_PREFERENCE,0.984752084029123
GOBP_CALCIUM_ION_TRANSMEMBRA...3,SET,17,0.043807,0.0013317,0.22832,0.42392,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.984752084029123
RBM17_TARGET_GENES,SET,5,0.068841,0.0011353,0.35889,0.42394,RBM17_TARGET_GENES,0.984752084029123
GSE29949_MICROGLIA_VS_DC_BRA...2,SET,185,0.01217,0.0012149,0.063439,0.42394,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.984752084029123
CIITA_TARGET_GENES,SET,973,0.0053359,0.0011948,0.027829,0.42397,CIITA_TARGET_GENES,0.984752084029123
GOCC_MICROTUBULE,SET,416,0.0078446,0.0011668,0.040913,0.42397,GOCC_MICROTUBULE,0.984752084029123
MODULE_111,SET,140,0.013842,0.0012035,0.072191,0.42398,MODULE_111,0.984752084029123
GOBP_TOLL_LIKE_RECEPTOR_8_SI...,SET,2,0.14108,0.0014717,0.73587,0.42398,GOBP_TOLL_LIKE_RECEPTOR_8_SIGNALING_PATHWAY,0.984752084029123
GOBP_QUINOLINATE_METABOLIC_P...,SET,5,0.078484,0.0012944,0.40962,0.42403,GOBP_QUINOLINATE_METABOLIC_PROCESS,0.984752084029123
GOBP_MUSCLE_TISSUE_DEVELOPME...,SET,398,0.0085977,0.0012515,0.0449,0.42407,GOBP_MUSCLE_TISSUE_DEVELOPMENT,0.984752084029123
GOBP_STRIATED_MUSCLE_CELL_DI...,SET,281,0.010099,0.0012391,0.052748,0.42409,GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.984752084029123
MIR644A,SET,56,0.02272,0.0012523,0.11869,0.4241,MIR644A,0.984752084029123
MIR4712_3P,SET,57,0.022323,0.0012413,0.11663,0.42411,MIR4712_3P,0.984752084029123
HP_VISUAL_LOSS,SET,207,0.011558,0.0012197,0.060401,0.42412,HP_VISUAL_LOSS,0.984752084029123
GSE15659_NONSUPPRESSIVE_TCEL...2,SET,162,0.01301,0.0012161,0.067981,0.42412,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP,0.984752084029123
MIR181C_5P,SET,556,0.0071594,0.0012263,0.037427,0.42415,MIR181C_5P,0.984752084029123
GSE10273_LOW_IL7_VS_HIGH_IL7...1,SET,178,0.011956,0.001171,0.062504,0.42415,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.984752084029123
HP_LIMB_DYSTONIA,SET,74,0.018378,0.0011638,0.096096,0.42417,HP_LIMB_DYSTONIA,0.984752084029123
GOBP_DEFINITIVE_HEMOPOIESIS,SET,18,0.044319,0.0013863,0.23179,0.42419,GOBP_DEFINITIVE_HEMOPOIESIS,0.984752084029123
GSE11961_MEMORY_BCELL_DAY40_...1,SET,178,0.012246,0.0011993,0.06412,0.42427,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.984813966611018
GSE21546_UNSTIM_VS_ANTI_CD3_...6,SET,147,0.01401,0.001248,0.073371,0.42428,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.984813966611018
YU_BAP1_TARGETS,SET,29,0.0289,0.0011471,0.1514,0.42431,YU_BAP1_TARGETS,0.984813966611018
HP_ABNORMALITY_OF_DERMAL_MEL...,SET,5,0.078574,0.0012958,0.41177,0.42433,HP_ABNORMALITY_OF_DERMAL_MELANOSOMES,0.984813966611018
REACTOME_MOLYBDENUM_COFACTOR...,SET,6,0.074351,0.0013432,0.39055,0.42451,REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS,0.985100156907258
GOBP_PROSTHETIC_GROUP_METABO...,SET,6,0.074351,0.0013432,0.39055,0.42451,GOBP_PROSTHETIC_GROUP_METABOLIC_PROCESS,0.985100156907258
GSE10273_HIGH_IL7_VS_HIGH_IL...1,SET,175,0.012242,0.0011889,0.06435,0.42456,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.985131043460845
GSE32423_IL7_VS_IL7_IL4_MEMO...1,SET,180,0.011534,0.0011359,0.060644,0.42458,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.985131043460845
GOBP_RESPONSE_TO_ETHANOL,SET,118,0.01577,0.0012596,0.083047,0.4247,GOBP_RESPONSE_TO_ETHANOL,0.985327902321858
HMGB2_TARGET_GENES,SET,412,0.0082069,0.0012149,0.043263,0.42477,HMGB2_TARGET_GENES,0.985327902321858
chr4q23,SET,18,0.062789,0.0019641,0.3311,0.4248,chr4q23,0.985327902321858
HP_BRONCHIECTASIS,SET,154,0.013274,0.00121,0.070005,0.42481,HP_BRONCHIECTASIS,0.985327902321858
GSE7852_TREG_VS_TCONV_THYMUS...1,SET,178,0.012289,0.0012035,0.064851,0.42485,GSE7852_TREG_VS_TCONV_THYMUS_DN,0.985327902321858
HOEK_NEUTROPHIL_2011_2012_TI...5,SET,37,0.02943,0.0013192,0.15533,0.42486,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_DN,0.985327902321858
SANSOM_WNT_PATHWAY_REQUIRE_M...,SET,60,0.023639,0.0013485,0.12481,0.42489,SANSOM_WNT_PATHWAY_REQUIRE_MYC,0.985327902321858
GSE360_CTRL_VS_B_MALAYI_HIGH...1,SET,177,0.012202,0.0011917,0.064442,0.42491,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.985327902321858
WP_GLYCOSPHINGOLIPID_METABOL...,SET,19,0.038812,0.0012473,0.205,0.42492,WP_GLYCOSPHINGOLIPID_METABOLISM,0.985327902321858
GOCC_EXTERNAL_SIDE_OF_APICAL...,SET,6,0.067998,0.0012284,0.35936,0.42496,GOCC_EXTERNAL_SIDE_OF_APICAL_PLASMA_MEMBRANE,0.985354913603309
VISALA_AGING_LYMPHOCYTE_UP,SET,6,0.081165,0.0014663,0.42913,0.42499,VISALA_AGING_LYMPHOCYTE_UP,0.985358735823883
GSE41867_DAY6_EFFECTOR_VS_DA...4,SET,183,0.012034,0.0011949,0.063674,0.42505,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.985432109265559
GOBP_REGULATION_OF_TETRAPYRR...,SET,7,0.066653,0.0013006,0.35304,0.42513,GOBP_REGULATION_OF_TETRAPYRROLE_METABOLIC_PROCESS,0.985502209944751
GOCC_EXTRINSIC_COMPONENT_OF_...3,SET,6,0.059755,0.0010795,0.31665,0.42516,GOCC_EXTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE,0.985502209944751
GOBP_METANEPHRIC_GLOMERULUS_...2,SET,9,0.066279,0.0014664,0.35135,0.42519,GOBP_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT,0.985502209944751
HP_PORTAL_VEIN_THROMBOSIS,SET,11,0.051882,0.0012689,0.27527,0.42525,HP_PORTAL_VEIN_THROMBOSIS,0.985502209944751
REACTOME_COLLAGEN_FORMATION,SET,88,0.018738,0.0012935,0.099471,0.42529,REACTOME_COLLAGEN_FORMATION,0.985502209944751
ELVIDGE_HIF1A_AND_HIF2A_TARG...1,SET,94,0.017116,0.0012209,0.090901,0.42533,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,0.985502209944751
MIR548Y,SET,450,0.0076721,0.0011857,0.040776,0.42538,MIR548Y,0.985502209944751
GOBP_POSITIVE_REGULATION_OF_...297,SET,49,0.022544,0.0011625,0.1199,0.42543,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.985502209944751
GOMF_MDM2_MDM4_FAMILY_PROTEI...,SET,10,0.054144,0.0012626,0.28796,0.42543,GOMF_MDM2_MDM4_FAMILY_PROTEIN_BINDING,0.985502209944751
HP_INTESTINAL_PSEUDO_OBSTRUC...,SET,18,0.032899,0.0010291,0.17499,0.42544,HP_INTESTINAL_PSEUDO_OBSTRUCTION,0.985502209944751
GNF2_SMC1L1,SET,23,0.032469,0.0011479,0.17273,0.42545,GNF2_SMC1L1,0.985502209944751
GNF2_CCNA1,SET,56,0.022127,0.0012196,0.1178,0.4255,GNF2_CCNA1,0.985502209944751
HU_GENOTOXIN_ACTION_DIRECT_V...1,SET,45,0.024475,0.0012096,0.13035,0.42553,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,0.985502209944751
GOBP_RESPONSE_TO_SALT_STRESS,SET,24,0.032547,0.0011754,0.1734,0.42556,GOBP_RESPONSE_TO_SALT_STRESS,0.985502209944751
GOCC_INO80_COMPLEX,SET,16,0.037373,0.0011023,0.19921,0.42559,GOCC_INO80_COMPLEX,0.985502209944751
GSE14413_UNSTIM_VS_IFNB_STIM...4,SET,129,0.013899,0.0011604,0.074128,0.42563,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP,0.985502209944751
HE_LIM_SUN_FETAL_LUNG_C0_MES...1,SET,264,0.010613,0.0012628,0.056617,0.42565,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL,0.985502209944751
KEGG_MEDICUS_REFERENCE_REGUL...15,SET,5,0.070378,0.0011607,0.37575,0.42571,KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION,0.985502209944751
MIR3140_3P,SET,207,0.01152,0.0012157,0.061515,0.42573,MIR3140_3P,0.985502209944751
HALMOS_CEBPA_TARGETS_UP,SET,47,0.026323,0.0013295,0.1406,0.42574,HALMOS_CEBPA_TARGETS_UP,0.985502209944751
GSE17186_CD21LOW_VS_CD21HIGH...2,SET,184,0.011328,0.0011278,0.060529,0.42577,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.985502209944751
BIOCARTA_IL2RB_PATHWAY,SET,35,0.028866,0.0012585,0.15453,0.42591,BIOCARTA_IL2RB_PATHWAY,0.985502209944751
GOMF_CALCIUM_DEPENDENT_PROTE...3,SET,7,0.047611,0.00092902,0.25501,0.42595,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.985502209944751
GOCC_U2_TYPE_CATALYTIC_STEP_...,SET,30,0.026154,0.0010558,0.14017,0.42599,GOCC_U2_TYPE_CATALYTIC_STEP_2_SPLICEOSOME,0.985502209944751
KLF7_TARGET_GENES,SET,737,0.0059476,0.0011669,0.031891,0.42603,KLF7_TARGET_GENES,0.985502209944751
GSE9006_TYPE_1_DIABETES_AT_D...1,SET,163,0.011969,0.0011222,0.064191,0.42605,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN,0.985502209944751
KEGG_MEDICUS_VARIANT_MUTATIO...70,SET,10,0.04982,0.0011618,0.26732,0.42608,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY,0.985502209944751
GSE7460_TREG_VS_TCONV_ACT_DN,SET,173,0.012646,0.0012211,0.067878,0.42611,GSE7460_TREG_VS_TCONV_ACT_DN,0.985502209944751
GOBP_CELLULAR_RESPONSE_TO_CO...4,SET,62,0.021956,0.0012731,0.11791,0.42614,GOBP_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS,0.985502209944751
HP_EEG_WITH_FOCAL_SPIKE_WAVES,SET,13,0.045671,0.0012143,0.24548,0.4262,HP_EEG_WITH_FOCAL_SPIKE_WAVES,0.985502209944751
GOBP_NEGATIVE_REGULATION_OF_...373,SET,12,0.044333,0.0011325,0.23835,0.42622,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_MIGRATION,0.985502209944751
GOCC_MICOS_COMPLEX,SET,5,0.066397,0.001095,0.357,0.42623,GOCC_MICOS_COMPLEX,0.985502209944751
SANA_RESPONSE_TO_IFNG_DN,SET,79,0.018564,0.0012145,0.099821,0.42624,SANA_RESPONSE_TO_IFNG_DN,0.985502209944751
BRCA1_DN.V1_UP,SET,112,0.015972,0.0012431,0.08595,0.42629,BRCA1_DN.V1_UP,0.985502209944751
MIR6747_5P,SET,40,0.024451,0.0011395,0.13167,0.42634,MIR6747_5P,0.985502209944751
GSE19888_CTRL_VS_T_CELL_MEMB...2,SET,185,0.011118,0.0011098,0.059886,0.42636,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP,0.985502209944751
GOBP_NEGATIVE_REGULATION_OF_...603,SET,11,0.052395,0.0012815,0.28229,0.42638,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,0.985502209944751
GSE21546_WT_VS_ELK1_KO_ANTI_...1,SET,177,0.011456,0.0011189,0.061726,0.42638,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.985502209944751
GOMF_VOLTAGE_GATED_SODIUM_CH...1,SET,23,0.036668,0.0012964,0.19758,0.42639,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.985502209944751
ZHONG_PFC_C1_NEUROD1_POS_EXC...,SET,25,0.035925,0.0013241,0.19358,0.42639,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.985502209944751
GSE3982_BASOPHIL_VS_NKCELL_DN,SET,182,0.01194,0.0011823,0.064382,0.42644,GSE3982_BASOPHIL_VS_NKCELL_DN,0.985502209944751
GOMF_ALCOHOL_BINDING,SET,85,0.017972,0.0012194,0.096942,0.42646,GOMF_ALCOHOL_BINDING,0.985502209944751
GOBP_CELLULAR_RESPONSE_TO_ST...1,SET,157,0.012936,0.0011905,0.069783,0.42647,GOBP_CELLULAR_RESPONSE_TO_STARVATION,0.985502209944751
MIR6739_5P,SET,243,0.010238,0.0011695,0.055259,0.4265,MIR6739_5P,0.985502209944751
GSE5589_LPS_VS_LPS_AND_IL10_...2,SET,181,0.011886,0.0011738,0.064145,0.4265,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP,0.985502209944751
HP_APLASTIC_HYPOPLASTIC_LACR...,SET,8,0.060478,0.0012615,0.32644,0.42651,HP_APLASTIC_HYPOPLASTIC_LACRIMAL_GLANDS,0.985502209944751
GOBP_RESPONSE_TO_EPINEPHRINE,SET,14,0.043924,0.0012119,0.23726,0.42656,GOBP_RESPONSE_TO_EPINEPHRINE,0.985502209944751
HP_APLASIA_HYPOPLASIA_OF_THE...62,SET,44,0.026318,0.0012862,0.14219,0.42658,HP_APLASIA_HYPOPLASIA_OF_THE_RETINA,0.985502209944751
GOBP_RESPONSE_TO_TYPE_III_IN...,SET,11,0.05494,0.0013437,0.29701,0.42662,GOBP_RESPONSE_TO_TYPE_III_INTERFERON,0.985502209944751
GOBP_DETECTION_OF_OTHER_ORGA...,SET,17,0.040152,0.0012206,0.21719,0.42667,GOBP_DETECTION_OF_OTHER_ORGANISM,0.985502209944751
DEURIG_T_CELL_PROLYMPHOCYTIC...2,SET,310,0.0089826,0.0011568,0.048608,0.42669,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,0.985502209944751
HP_ECTOPIC_KIDNEY,SET,72,0.01969,0.00123,0.10665,0.42676,HP_ECTOPIC_KIDNEY,0.985502209944751
MIR181A_5P_MIR181B_5P,SET,555,0.0069105,0.0011826,0.037455,0.42681,MIR181A_5P_MIR181B_5P,0.985502209944751
MIR3193,SET,7,0.049077,0.00095763,0.26604,0.42682,MIR3193,0.985502209944751
GOMF_CYCLASE_ACTIVATOR_ACTIV...,SET,11,0.052056,0.0012732,0.28229,0.42685,GOMF_CYCLASE_ACTIVATOR_ACTIVITY,0.985502209944751
HP_SUBEPIDERMAL_BLISTERING,SET,11,0.048232,0.0011796,0.26155,0.42685,HP_SUBEPIDERMAL_BLISTERING,0.985502209944751
PID_TNF_PATHWAY,SET,43,0.022411,0.0010828,0.12155,0.42686,PID_TNF_PATHWAY,0.985502209944751
GSE14000_UNSTIM_VS_4H_LPS_DC...1,SET,179,0.012414,0.0012191,0.067354,0.42689,GSE14000_UNSTIM_VS_4H_LPS_DC_DN,0.985502209944751
HP_SHORTENED_PR_INTERVAL,SET,6,0.066364,0.0011989,0.3603,0.42693,HP_SHORTENED_PR_INTERVAL,0.985502209944751
GOBP_ADULT_HEART_DEVELOPMENT,SET,13,0.047311,0.0012579,0.25689,0.42694,GOBP_ADULT_HEART_DEVELOPMENT,0.985502209944751
GOCC_AXON,SET,601,0.0068316,0.001215,0.037117,0.42699,GOCC_AXON,0.985502209944751
REACTOME_CYTOSOLIC_IRON_SULF...,SET,10,0.044252,0.001032,0.24048,0.427,REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY,0.985502209944751
HP_ATTENTION_DEFICIT_HYPERAC...,SET,349,0.0085615,0.0011686,0.046549,0.42704,HP_ATTENTION_DEFICIT_HYPERACTIVITY_DISORDER,0.985502209944751
HP_ABNORMAL_RAPID_EYE_MOVEME...,SET,13,0.047314,0.0012579,0.25733,0.42706,HP_ABNORMAL_RAPID_EYE_MOVEMENT_SLEEP,0.985502209944751
HP_CORTICAL_THICKENING_OF_LO...,SET,5,0.069004,0.001138,0.37531,0.42706,HP_CORTICAL_THICKENING_OF_LONG_BONE_DIAPHYSES,0.985502209944751
GOBP_MAST_CELL_MIGRATION,SET,14,0.043698,0.0012056,0.23779,0.4271,GOBP_MAST_CELL_MIGRATION,0.985502209944751
GOBP_POSITIVE_REGULATION_OF_...215,SET,5,0.070245,0.0011585,0.38237,0.42712,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.985502209944751
HP_CALCIFICATION_OF_THE_AORTA,SET,21,0.036786,0.0012428,0.20041,0.42718,HP_CALCIFICATION_OF_THE_AORTA,0.985502209944751
GOBP_REGULATION_OF_MRNA_EXPO...,SET,8,0.045467,0.00094841,0.24781,0.42722,GOBP_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS,0.985502209944751
GNF2_BNIP3L,SET,61,0.019741,0.0011354,0.10767,0.42727,GNF2_BNIP3L,0.985502209944751
GSE20366_CD103_POS_VS_NEG_TR...1,SET,177,0.011787,0.0011512,0.064298,0.42727,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN,0.985502209944751
HP_VERY_LONG_CHAIN_FATTY_ACI...,SET,15,0.038856,0.0011096,0.21205,0.42731,HP_VERY_LONG_CHAIN_FATTY_ACID_ACCUMULATION,0.985502209944751
GOBP_MICROGLIA_DIFFERENTIATI...,SET,11,0.049813,0.0012183,0.27193,0.42733,GOBP_MICROGLIA_DIFFERENTIATION,0.985502209944751
SILIGAN_TARGETS_OF_EWS_FLI1_...1,SET,17,0.037907,0.0011524,0.20703,0.42736,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,0.985502209944751
GOBP_CORTISOL_METABOLIC_PROC...,SET,12,0.05028,0.0012844,0.27462,0.42736,GOBP_CORTISOL_METABOLIC_PROCESS,0.985502209944751
GSE3720_UNSTIM_VS_PMA_STIM_V...3,SET,173,0.011581,0.0011184,0.063264,0.42738,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.985502209944751
HP_STOMATITIS,SET,66,0.019892,0.0011899,0.10874,0.42743,HP_STOMATITIS,0.985502209944751
GOBP_REGULATION_OF_HISTAMINE...,SET,6,0.063791,0.0011524,0.34914,0.42751,GOBP_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL,0.985502209944751
GOBP_TRNA_TRANSPORT,SET,6,0.048223,0.00087118,0.26401,0.42753,GOBP_TRNA_TRANSPORT,0.985502209944751
BUSSLINGER_GASTRIC_IMMUNE_CE...,SET,1342,0.004431,0.0011528,0.024258,0.42753,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.985502209944751
GOMF_SERINE_TYPE_EXOPEPTIDAS...,SET,12,0.044082,0.001126,0.24141,0.42756,GOMF_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY,0.985502209944751
GOBP_MITOCHONDRIAL_ADP_TRANS...,SET,3,0.08179,0.0010449,0.44812,0.42759,GOBP_MITOCHONDRIAL_ADP_TRANSMEMBRANE_TRANSPORT,0.985502209944751
HP_ABNORMALITY_OF_VISUAL_EVO...,SET,63,0.019856,0.0011606,0.1088,0.4276,HP_ABNORMALITY_OF_VISUAL_EVOKED_POTENTIALS,0.985502209944751
HP_MYOCLONUS,SET,323,0.0087085,0.0011443,0.047732,0.42762,HP_MYOCLONUS,0.985502209944751
HP_ABNORMAL_URINE_CHLORIDE_C...,SET,5,0.082343,0.001358,0.45142,0.42763,HP_ABNORMAL_URINE_CHLORIDE_CONCENTRATION,0.985502209944751
MIR598_3P,SET,10,0.053336,0.0012438,0.29246,0.42765,MIR598_3P,0.985502209944751
GOBP_PHOSPHATIDYLGLYCEROL_ME...,SET,32,0.030054,0.001253,0.16491,0.4277,GOBP_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS,0.985502209944751
GOBP_BIOLOGICAL_PROCESS_INVO...3,SET,1528,0.004341,0.0011985,0.023826,0.42772,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS,0.985502209944751
GOBP_REGULATION_OF_ICOSANOID...,SET,21,0.037854,0.0012788,0.20787,0.42775,GOBP_REGULATION_OF_ICOSANOID_SECRETION,0.985502209944751
SVIL_TARGET_GENES,SET,10,0.055856,0.0013026,0.30683,0.42778,SVIL_TARGET_GENES,0.985502209944751
GSE11057_NAIVE_VS_CENT_MEMOR...2,SET,153,0.01277,0.0011603,0.07017,0.4278,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,0.985502209944751
MIR106A_5P,SET,596,0.0065741,0.0011645,0.036162,0.42787,MIR106A_5P,0.985502209944751
GOBP_IMMUNE_RESPONSE_REGULAT...2,SET,21,0.036046,0.0012178,0.19831,0.42789,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS,0.985502209944751
HP_FIBROADENOMA_OF_THE_BREAST,SET,11,0.048013,0.0011743,0.26447,0.42797,HP_FIBROADENOMA_OF_THE_BREAST,0.985502209944751
HP_ABNORMAL_FACTOR_IX_ACTIVI...,SET,5,0.060581,0.00099911,0.33379,0.42799,HP_ABNORMAL_FACTOR_IX_ACTIVITY,0.985502209944751
WP_ETHANOL_EFFECTS_ON_HISTON...,SET,29,0.028993,0.0011508,0.15979,0.42801,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,0.985502209944751
LHX2_TARGET_GENES,SET,1130,0.0047644,0.0011445,0.026265,0.42803,LHX2_TARGET_GENES,0.985502209944751
BENNETT_SYSTEMIC_LUPUS_ERYTH...,SET,25,0.033877,0.0012486,0.18681,0.42805,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.985502209944751
REACTOME_M_PHASE,SET,329,0.0081903,0.001086,0.045183,0.42808,REACTOME_M_PHASE,0.985502209944751
MIR6875_3P,SET,361,0.0083268,0.0011555,0.045939,0.42808,MIR6875_3P,0.985502209944751
GOMF_SIGNALING_RECEPTOR_COMP...,SET,51,0.021459,0.0011289,0.11843,0.42811,GOMF_SIGNALING_RECEPTOR_COMPLEX_ADAPTOR_ACTIVITY,0.985502209944751
GOBP_SYNAPTIC_VESICLE_EXOCYT...,SET,90,0.015877,0.0011083,0.087634,0.42812,GOBP_SYNAPTIC_VESICLE_EXOCYTOSIS,0.985502209944751
NIKOLSKY_BREAST_CANCER_19Q13...2,SET,7,0.086757,0.0016929,0.47894,0.42813,NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON,0.985502209944751
HP_INCREASED_HEPATIC_GLYCOGE...,SET,11,0.04944,0.0012092,0.27313,0.42818,HP_INCREASED_HEPATIC_GLYCOGEN_CONTENT,0.985502209944751
WP_HUNGER_AND_SATIETY,SET,8,0.056662,0.0011819,0.31327,0.42823,WP_HUNGER_AND_SATIETY,0.985502209944751
GSE24726_WT_VS_E2_22_KO_PDC_...,SET,178,0.011461,0.0011225,0.063367,0.42824,GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN,0.985502209944751
HP_METAPHYSEAL_CHONDRODYSPLA...,SET,10,0.053137,0.0012392,0.29384,0.42825,HP_METAPHYSEAL_CHONDRODYSPLASIA,0.985502209944751
MORI_LARGE_PRE_BII_LYMPHOCYT...1,SET,53,0.022205,0.0011907,0.12292,0.42832,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,0.985502209944751
chr2p12,SET,13,0.0639,0.0016989,0.35376,0.42833,chr2p12,0.985502209944751
BIOCARTA_NUCLEARRS_PATHWAY,SET,34,0.027514,0.0011824,0.15232,0.42833,BIOCARTA_NUCLEARRS_PATHWAY,0.985502209944751
MIR4714_3P,SET,53,0.022411,0.0012018,0.12407,0.42833,MIR4714_3P,0.985502209944751
GOBP_REGULATION_OF_MDA_5_SIG...,SET,6,0.054307,0.00098109,0.30065,0.42833,GOBP_REGULATION_OF_MDA_5_SIGNALING_PATHWAY,0.985502209944751
MIR4505,SET,237,0.010113,0.0011409,0.056002,0.42835,MIR4505,0.985502209944751
REACTOME_ORGANELLE_BIOGENESI...,SET,250,0.0092979,0.001077,0.0515,0.42836,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,0.985502209944751
GOBP_POST_EMBRYONIC_ANIMAL_M...,SET,4,0.071811,0.0010593,0.39794,0.4284,GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS,0.985502209944751
GOCC_VOLTAGE_GATED_CALCIUM_C...,SET,41,0.025129,0.0011856,0.13925,0.4284,GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.985502209944751
GOMF_L_LEUCINE_TRANSMEMBRANE...,SET,6,0.066811,0.001207,0.37049,0.42845,GOMF_L_LEUCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.985502209944751
HP_BREAST_HYPOPLASIA,SET,42,0.025452,0.0012153,0.14117,0.42846,HP_BREAST_HYPOPLASIA,0.985502209944751
BURTON_ADIPOGENESIS_8,SET,70,0.019109,0.0011771,0.106,0.42847,BURTON_ADIPOGENESIS_8,0.985502209944751
GOCC_TERTIARY_GRANULE_MEMBRA...,SET,63,0.01945,0.0011368,0.10806,0.42858,GOCC_TERTIARY_GRANULE_MEMBRANE,0.985502209944751
GOBP_REGULATION_OF_POSTSYNAP...2,SET,100,0.015833,0.0011648,0.088016,0.42862,GOBP_REGULATION_OF_POSTSYNAPSE_ORGANIZATION,0.985502209944751
MORF_HDAC1,SET,225,0.0095477,0.0010499,0.053083,0.42863,MORF_HDAC1,0.985502209944751
GOBP_CHROMOSOME_ORGANIZATION...,SET,55,0.018755,0.0010245,0.10428,0.42864,GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE,0.985502209944751
GOBP_VASOCONSTRICTION,SET,83,0.018492,0.0012399,0.10287,0.42867,GOBP_VASOCONSTRICTION,0.985502209944751
HP_MUSCLE_FIBER_ATROPHY,SET,61,0.018764,0.0010792,0.10451,0.42875,HP_MUSCLE_FIBER_ATROPHY,0.985502209944751
BIOCARTA_KERATINOCYTE_PATHWAY,SET,46,0.023618,0.0011801,0.13155,0.42876,BIOCARTA_KERATINOCYTE_PATHWAY,0.985502209944751
HP_METAPHYSEAL_SCLEROSIS,SET,12,0.048934,0.00125,0.27272,0.4288,HP_METAPHYSEAL_SCLEROSIS,0.985502209944751
HP_SEPTIC_ARTHRITIS,SET,7,0.052724,0.0010288,0.29391,0.42882,HP_SEPTIC_ARTHRITIS,0.985502209944751
WP_NOVEL_INTRACELLULAR_COMPO...,SET,54,0.020807,0.0011262,0.11616,0.42892,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,0.985502209944751
GCM_HDAC1,SET,35,0.025432,0.0011088,0.14202,0.42894,GCM_HDAC1,0.985502209944751
GSE29615_CTRL_VS_LAIV_FLU_VA...1,SET,136,0.01294,0.0011091,0.072346,0.42902,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN,0.985502209944751
WP_OSTEOPONTIN_SIGNALING,SET,13,0.043214,0.0011489,0.24167,0.42904,WP_OSTEOPONTIN_SIGNALING,0.985502209944751
GOMF_THYROID_HORMONE_BINDING,SET,6,0.069472,0.0012551,0.3885,0.42904,GOMF_THYROID_HORMONE_BINDING,0.985502209944751
HP_SECOND_DEGREE_ATRIOVENTRI...,SET,12,0.043132,0.0011018,0.24122,0.42905,HP_SECOND_DEGREE_ATRIOVENTRICULAR_BLOCK,0.985502209944751
GOBP_POSITIVE_REGULATION_OF_...765,SET,47,0.021853,0.0011037,0.12227,0.42908,GOBP_POSITIVE_REGULATION_OF_TORC1_SIGNALING,0.985502209944751
GSE43863_TH1_VS_LY6C_INT_CXC...3,SET,177,0.011724,0.001145,0.06568,0.42916,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.985502209944751
REACTOME_TNFR1_MEDIATED_CERA...,SET,5,0.065251,0.0010761,0.36577,0.42921,REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION,0.985502209944751
GOMF_CYCLASE_ACTIVITY,SET,17,0.038582,0.0011729,0.21635,0.42923,GOMF_CYCLASE_ACTIVITY,0.985502209944751
GOBP_LUNG_EPITHELIUM_DEVELOP...,SET,45,0.024275,0.0011997,0.13622,0.42928,GOBP_LUNG_EPITHELIUM_DEVELOPMENT,0.985502209944751
GOBP_CELL_FATE_COMMITMENT_IN...1,SET,31,0.029516,0.0012112,0.16564,0.42929,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER,0.985502209944751
FAN_EMBRYONIC_CTX_IN_6_INTER...,SET,4,0.086483,0.0012757,0.48589,0.42937,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.985502209944751
GOBP_REGULATION_OF_INSULIN_S...2,SET,51,0.021385,0.001125,0.12024,0.42942,GOBP_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.985502209944751
HP_ABNORMAL_FOOT_BONE_OSSIFI...,SET,9,0.049417,0.0010933,0.27811,0.42948,HP_ABNORMAL_FOOT_BONE_OSSIFICATION,0.985502209944751
HP_GAIT_IMBALANCE,SET,63,0.020297,0.0011864,0.11432,0.42954,HP_GAIT_IMBALANCE,0.985502209944751
MIR548J_3P,SET,717,0.0057916,0.0011214,0.032623,0.42955,MIR548J_3P,0.985502209944751
PRAMOONJAGO_SOX4_TARGETS_DN,SET,46,0.021569,0.0010777,0.12151,0.42956,PRAMOONJAGO_SOX4_TARGETS_DN,0.985502209944751
HP_MYOCARDITIS,SET,6,0.072391,0.0013078,0.40783,0.42956,HP_MYOCARDITIS,0.985502209944751
GSE360_T_GONDII_VS_B_MALAYI_...7,SET,184,0.010978,0.001093,0.061846,0.42956,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.985502209944751
PTPRA_TARGET_GENES,SET,94,0.0156,0.0011128,0.08793,0.42959,PTPRA_TARGET_GENES,0.985502209944751
GOBP_POSITIVE_REGULATION_OF_...846,SET,8,0.061688,0.0012868,0.34797,0.42965,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.985502209944751
MODULE_489,SET,26,0.029375,0.0011041,0.16581,0.42969,MODULE_489,0.985502209944751
GUTIERREZ_MULTIPLE_MYELOMA_UP,SET,30,0.028203,0.0011386,0.15922,0.4297,GUTIERREZ_MULTIPLE_MYELOMA_UP,0.985502209944751
GOBP_RIBOFLAVIN_TRANSPORT,SET,6,0.067972,0.001228,0.3838,0.42972,GOBP_RIBOFLAVIN_TRANSPORT,0.985502209944751
GOMF_RIBOFLAVIN_TRANSMEMBRAN...,SET,6,0.067972,0.001228,0.3838,0.42972,GOMF_RIBOFLAVIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.985502209944751
HP_ABNORMAL_HAIRSHAFT_MORPHO...,SET,25,0.029498,0.0010872,0.16677,0.4298,HP_ABNORMAL_HAIRSHAFT_MORPHOLOGY,0.985502209944751
GSE36888_UNTREATED_VS_IL2_TR...11,SET,174,0.010994,0.0010647,0.062158,0.4298,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN,0.985502209944751
GSE40274_CTRL_VS_FOXP3_AND_X...2,SET,148,0.011759,0.001051,0.066481,0.42981,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.985502209944751
MORF_MYL3,SET,63,0.02005,0.0011719,0.11338,0.42982,MORF_MYL3,0.985502209944751
GSE360_L_MAJOR_VS_T_GONDII_D...1,SET,176,0.01129,0.0010995,0.063866,0.42985,GSE360_L_MAJOR_VS_T_GONDII_DC_DN,0.985502209944751
GNF2_BNIP2,SET,32,0.024425,0.0010183,0.13825,0.42989,GNF2_BNIP2,0.985502209944751
GOBP_TRANSFORMING_GROWTH_FAC...2,SET,8,0.056014,0.0011684,0.31708,0.42989,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION,0.985502209944751
GOCC_MITOCHONDRIAL_CRISTA,SET,6,0.071071,0.0012839,0.40229,0.42989,GOCC_MITOCHONDRIAL_CRISTA,0.985502209944751
ZNF302_TARGET_GENES,SET,4,0.061979,0.00091428,0.35093,0.42991,ZNF302_TARGET_GENES,0.985502209944751
GOBP_CARBOHYDRATE_DERIVATIVE...2,SET,249,0.0097577,0.0011281,0.055399,0.43009,GOBP_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS,0.985502209944751
HP_GANGLIONEUROBLASTOMA,SET,7,0.070996,0.0013853,0.40319,0.43011,HP_GANGLIONEUROBLASTOMA,0.985502209944751
HP_PERONEAL_MUSCLE_ATROPHY,SET,10,0.05278,0.0012308,0.30004,0.43018,HP_PERONEAL_MUSCLE_ATROPHY,0.985502209944751
WONG_PROTEASOME_GENE_MODULE,SET,47,0.020283,0.0010244,0.11533,0.4302,WONG_PROTEASOME_GENE_MODULE,0.985502209944751
GOBP_NEGATIVE_REGULATION_OF_...121,SET,8,0.054267,0.001132,0.3087,0.43023,GOBP_NEGATIVE_REGULATION_OF_CELL_MATURATION,0.985502209944751
GOBP_NEGATIVE_REGULATION_OF_...595,SET,20,0.037737,0.0012442,0.21471,0.43024,GOBP_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.985502209944751
HP_AUTOIMMUNITY,SET,264,0.0097037,0.0011546,0.055209,0.43024,HP_AUTOIMMUNITY,0.985502209944751
MIR498_3P,SET,196,0.010856,0.0011151,0.061822,0.4303,MIR498_3P,0.985502209944751
HP_PREMATURELY_AGED_APPEARAN...,SET,156,0.01183,0.0010853,0.067395,0.43033,HP_PREMATURELY_AGED_APPEARANCE,0.985502209944751
MIR1278,SET,56,0.020084,0.001107,0.11443,0.43034,MIR1278,0.985502209944751
GOBP_POSITIVE_REGULATION_OF_...695,SET,297,0.0091519,0.001154,0.052141,0.43034,GOBP_POSITIVE_REGULATION_OF_SECRETION,0.985502209944751
GSE7460_CTRL_VS_FOXP3_OVEREX...3,SET,174,0.011287,0.001093,0.064333,0.43037,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN,0.985502209944751
REACTOME_CHYLOMICRON_REMODEL...,SET,10,0.05699,0.001329,0.32505,0.43041,REACTOME_CHYLOMICRON_REMODELING,0.985502209944751
REACTOME_DEGRADATION_OF_THE_...,SET,132,0.014415,0.0012172,0.08224,0.43043,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,0.985502209944751
GSE20727_CTRL_VS_H2O2_TREATE...2,SET,179,0.010954,0.0010758,0.062496,0.43043,GSE20727_CTRL_VS_H2O2_TREATED_DC_UP,0.985502209944751
GOBP_MORPHOGENESIS_OF_A_BRAN...,SET,189,0.011669,0.0011772,0.066588,0.43045,GOBP_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,0.985502209944751
REACTOME_TRAFFICKING_OF_AMPA...,SET,29,0.029064,0.0011536,0.16605,0.43053,REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS,0.985502209944751
GOBP_REGULATION_OF_EXTRACELL...3,SET,13,0.039925,0.0010615,0.22825,0.43057,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.985502209944751
HOEK_PBMC_INACTIVATED_INFLUE...4,SET,6,0.061911,0.0011185,0.35402,0.43059,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_UP,0.985502209944751
REACTOME_RESPIRATORY_SYNCYTI...1,SET,106,0.014241,0.0010784,0.08144,0.4306,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,0.985502209944751
REACTOME_CELL_JUNCTION_ORGAN...,SET,105,0.015998,0.0012058,0.091551,0.43064,REACTOME_CELL_JUNCTION_ORGANIZATION,0.985502209944751
GSE22886_NAIVE_VS_IGM_MEMORY...2,SET,173,0.01145,0.0011057,0.065565,0.43068,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP,0.985502209944751
GOBP_REGULATION_OF_PHAGOCYTO...,SET,90,0.017126,0.0011955,0.098102,0.43071,GOBP_REGULATION_OF_PHAGOCYTOSIS,0.985502209944751
GOBP_RESPONSE_TO_SALT,SET,22,0.034139,0.0011805,0.19558,0.43072,GOBP_RESPONSE_TO_SALT,0.985502209944751
REACTOME_SPRY_REGULATION_OF_...,SET,15,0.039672,0.0011329,0.22743,0.43076,REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,0.985502209944751
GOBP_IMPORT_INTO_CELL,SET,847,0.0053857,0.0011293,0.030887,0.43079,GOBP_IMPORT_INTO_CELL,0.985502209944751
HP_THROMBOEMBOLIC_STROKE,SET,69,0.01923,0.0011761,0.1103,0.4308,HP_THROMBOEMBOLIC_STROKE,0.985502209944751
GSE7219_WT_VS_NIK_NFKB2_KO_L...2,SET,181,0.011823,0.0011675,0.067816,0.4308,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP,0.985502209944751
FOURATI_BLOOD_TWINRIX_AGE_65...3,SET,4,0.071304,0.0010518,0.40903,0.43081,FOURATI_BLOOD_TWINRIX_AGE_65_83YO_POOR_RESPONDERS_VS_RESPONDERS_0DY_NETWORK_INFERENCE_UP,0.985502209944751
HP_ABNORMAL_LEUKOCYTE_ENZYME...,SET,6,0.063342,0.0011443,0.36359,0.43085,HP_ABNORMAL_LEUKOCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.985502209944751
HP_EXCESSIVE_BLEEDING_FROM_S...,SET,5,0.071075,0.0011722,0.40797,0.43085,HP_EXCESSIVE_BLEEDING_FROM_SUPERFICIAL_CUTS,0.985502209944751
WP_LEPTIN_SIGNALING,SET,74,0.017965,0.0011377,0.10318,0.43089,WP_LEPTIN_SIGNALING,0.985502209944751
GOBP_MYELOID_LEUKOCYTE_CYTOK...,SET,47,0.022671,0.001145,0.13021,0.43089,GOBP_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION,0.985502209944751
GOBP_NEGATIVE_REGULATION_OF_...217,SET,59,0.019908,0.0011262,0.11437,0.43091,GOBP_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,0.985502209944751
GOBP_POSITIVE_REGULATION_OF_...826,SET,14,0.047872,0.0013208,0.27504,0.43091,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.985502209944751
GSE1925_3H_VS_24H_IFNG_STIM_...2,SET,187,0.010922,0.0010961,0.062751,0.43091,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.985502209944751
REACTOME_ERCC6_CSB_AND_EHMT2...,SET,15,0.035535,0.0010148,0.20422,0.43093,REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,0.985502209944751
GOBP_NEGATIVE_REGULATION_OF_...120,SET,32,0.028419,0.0011848,0.16333,0.43094,GOBP_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.985502209944751
WORSCHECH_TUMOR_REJECTION_UP,SET,58,0.020308,0.001139,0.11676,0.43096,WORSCHECH_TUMOR_REJECTION_UP,0.985502209944751
HP_ABNORMAL_CIRCULATING_FATT...2,SET,68,0.017461,0.0010602,0.10039,0.43096,HP_ABNORMAL_CIRCULATING_FATTY_ACID_CONCENTRATION,0.985502209944751
HP_CONGENITAL_ADRENAL_HYPERP...,SET,5,0.069033,0.0011385,0.39698,0.43097,HP_CONGENITAL_ADRENAL_HYPERPLASIA,0.985502209944751
HP_U_SHAPED_UPPER_LIP_VERMIL...,SET,6,0.050813,0.00091798,0.29229,0.43099,HP_U_SHAPED_UPPER_LIP_VERMILION,0.985502209944751
MARCHINI_TRABECTEDIN_RESISTA...2,SET,16,0.037693,0.0011117,0.21682,0.431,MARCHINI_TRABECTEDIN_RESISTANCE_UP,0.985502209944751
GOMF_PHOSPHATE_ION_BINDING,SET,8,0.057275,0.0011947,0.32952,0.43101,GOMF_PHOSPHATE_ION_BINDING,0.985502209944751
TOMLINS_METASTASIS_UP,SET,14,0.037444,0.0010331,0.21548,0.43103,TOMLINS_METASTASIS_UP,0.985502209944751
GOBP_POSITIVE_REGULATION_OF_...642,SET,681,0.0059178,0.0011179,0.034062,0.43104,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.985502209944751
HP_ABNORMAL_SERUM_ESTRADIOL,SET,59,0.018944,0.0010716,0.10909,0.43107,HP_ABNORMAL_SERUM_ESTRADIOL,0.985502209944751
GSE21063_CTRL_VS_ANTI_IGM_ST...6,SET,140,0.013327,0.0011587,0.076758,0.43108,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP,0.985502209944751
GSE14308_TH2_VS_INDUCED_TREG...2,SET,181,0.011193,0.0011054,0.064499,0.43111,GSE14308_TH2_VS_INDUCED_TREG_UP,0.985502209944751
MIR4664_5P,SET,76,0.01666,0.0010691,0.096013,0.43112,MIR4664_5P,0.985502209944751
GSE14000_TRANSLATED_RNA_VS_M...1,SET,162,0.011282,0.0010546,0.065115,0.43122,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN,0.985539451379763
HP_INCREASED_CIRCULATING_REN...,SET,18,0.039851,0.0012466,0.23011,0.43125,HP_INCREASED_CIRCULATING_RENIN_LEVEL,0.985539451379763
GOBP_HETEROCHROMATIN_ORGANIZ...,SET,13,0.042355,0.0011261,0.24489,0.43134,GOBP_HETEROCHROMATIN_ORGANIZATION,0.985539451379763
GOBP_INSULIN_RECEPTOR_SIGNAL...,SET,119,0.013341,0.00107,0.07713,0.43134,GOBP_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.985539451379763
GSE14413_UNSTIM_VS_IFNB_STIM...3,SET,124,0.012888,0.001055,0.074555,0.43138,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN,0.985539451379763
GSE37301_RAG2_KO_VS_RAG2_AND...2,SET,181,0.01086,0.0010725,0.062867,0.43142,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP,0.985539451379763
GAVISH_3CA_MALIGNANT_METAPRO...11,SET,47,0.019488,0.00098426,0.11284,0.43145,GAVISH_3CA_MALIGNANT_METAPROGRAM_20_MYC,0.985539451379763
HP_ABNORMAL_NUMBER_OF_ERYTHR...,SET,42,0.021724,0.0010374,0.12582,0.43146,HP_ABNORMAL_NUMBER_OF_ERYTHROID_PRECURSORS,0.985539451379763
BIOCARTA_P53HYPOXIA_PATHWAY,SET,20,0.033606,0.001108,0.19485,0.43153,BIOCARTA_P53HYPOXIA_PATHWAY,0.985539451379763
WP_TRANSSULFURATION_PATHWAY,SET,9,0.058781,0.0013005,0.34077,0.43153,WP_TRANSSULFURATION_PATHWAY,0.985539451379763
PID_RAC1_PATHWAY,SET,51,0.021146,0.0011124,0.12261,0.43154,PID_RAC1_PATHWAY,0.985539451379763
MODULE_146,SET,96,0.016058,0.0011575,0.093107,0.43154,MODULE_146,0.985539451379763
MIR4733_3P,SET,66,0.017673,0.0010572,0.1025,0.43155,MIR4733_3P,0.985539451379763
GNF2_RAD23A,SET,60,0.018763,0.0010704,0.10884,0.43157,GNF2_RAD23A,0.985539451379763
GOMF_SODIUM_CHANNEL_REGULATO...,SET,38,0.026058,0.0011837,0.15119,0.43158,GOMF_SODIUM_CHANNEL_REGULATOR_ACTIVITY,0.985539451379763
MODULE_33,SET,346,0.0083667,0.0011371,0.04855,0.43159,MODULE_33,0.985539451379763
VERNOCHET_ADIPOGENESIS,SET,18,0.040527,0.0012677,0.23531,0.43163,VERNOCHET_ADIPOGENESIS,0.985540631344554
NADLER_OBESITY_UP,SET,58,0.020167,0.0011312,0.11721,0.4317,NADLER_OBESITY_UP,0.985540631344554
GOBP_POSITIVE_REGULATION_OF_...47,SET,18,0.035105,0.0010981,0.20448,0.43185,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.985540631344554
GSE5542_IFNG_VS_IFNA_AND_IFN...3,SET,174,0.010916,0.0010571,0.063592,0.43185,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.985540631344554
GOBP_HETEROTYPIC_CELL_CELL_A...,SET,62,0.020562,0.0011923,0.1199,0.43192,GOBP_HETEROTYPIC_CELL_CELL_ADHESION,0.985540631344554
GOBP_LEUKOCYTE_ADHESION_TO_A...,SET,5,0.074737,0.0012326,0.43579,0.43192,GOBP_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.985540631344554
HP_PERIPHERAL_NEUROPATHY,SET,407,0.0071782,0.0010563,0.041884,0.43196,HP_PERIPHERAL_NEUROPATHY,0.985540631344554
GOMF_GUANYLATE_CYCLASE_REGUL...,SET,7,0.058846,0.0011482,0.34397,0.43208,GOMF_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY,0.985540631344554
GOBP_REGULATION_OF_PEPTIDYL_...4,SET,106,0.01475,0.001117,0.08627,0.43212,GOBP_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.985540631344554
HP_EPISODIC_VOMITING,SET,37,0.021514,0.00096436,0.12589,0.43215,HP_EPISODIC_VOMITING,0.985540631344554
MODULE_188,SET,118,0.013708,0.0010948,0.080236,0.43218,MODULE_188,0.985540631344554
DESCARTES_MAIN_FETAL_NEUROEN...,SET,27,0.03046,0.0011667,0.17832,0.43218,DESCARTES_MAIN_FETAL_NEUROENDOCRINE_CELLS,0.985540631344554
SRC_UP.V1_UP,SET,149,0.012276,0.0011009,0.071869,0.43219,SRC_UP.V1_UP,0.985540631344554
GSE19888_ADENOSINE_A3R_INH_V...1,SET,179,0.011145,0.0010945,0.06525,0.43219,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN,0.985540631344554
SCHAEFFER_PROSTATE_DEVELOPME...16,SET,5,0.072982,0.0012036,0.42742,0.43221,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN,0.985540631344554
ACTGAAA_MIR30A3P_MIR30E3P,SET,180,0.010765,0.0010602,0.063047,0.43221,ACTGAAA_MIR30A3P_MIR30E3P,0.985540631344554
GOBP_NEGATIVE_REGULATION_OF_...297,SET,83,0.015878,0.0010646,0.09299,0.43221,GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE,0.985540631344554
MIR4728_3P,SET,99,0.015349,0.0011235,0.089904,0.43222,MIR4728_3P,0.985540631344554
GOCC_TIM22_MITOCHONDRIAL_IMP...,SET,6,0.060694,0.0010965,0.35574,0.43227,GOCC_TIM22_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_INSERTION_COMPLEX,0.985540631344554
GSE28237_FOLLICULAR_VS_LATE_...1,SET,177,0.01089,0.0010635,0.063854,0.43229,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN,0.985540631344554
REACTOME_CHK1_CHK2_CDS1_MEDI...,SET,13,0.039443,0.0010487,0.23146,0.43235,REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,0.985540631344554
LI_PBMC_MENOMUNE_A_C_Y_W_135...3,SET,19,0.03651,0.0011733,0.21441,0.43239,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE,0.985540631344554
GSE9650_EFFECTOR_VS_EXHAUSTE...2,SET,183,0.010308,0.0010235,0.060542,0.4324,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP,0.985540631344554
GSE37301_CD4_TCELL_VS_GRANUL...1,SET,170,0.011526,0.0011034,0.067703,0.43241,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.985540631344554
COLDREN_GEFITINIB_RESISTANCE...2,SET,72,0.016865,0.0010535,0.099124,0.43245,COLDREN_GEFITINIB_RESISTANCE_UP,0.985540631344554
GOBP_CILIUM_OR_FLAGELLUM_DEP...,SET,149,0.011748,0.0010535,0.069048,0.43245,GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY,0.985540631344554
HP_RAGGED_RED_MUSCLE_FIBERS,SET,40,0.021759,0.001014,0.12802,0.43252,HP_RAGGED_RED_MUSCLE_FIBERS,0.985540631344554
GOBP_INTEGRIN_BIOSYNTHETIC_P...,SET,4,0.084601,0.001248,0.49802,0.43255,GOBP_INTEGRIN_BIOSYNTHETIC_PROCESS,0.985540631344554
GFI1_01,SET,241,0.0097774,0.0011123,0.057591,0.4326,GFI1_01,0.985540631344554
NAGASHIMA_NRG1_SIGNALING_UP,SET,166,0.012027,0.0011378,0.070853,0.43261,NAGASHIMA_NRG1_SIGNALING_UP,0.985540631344554
DESCARTES_FETAL_LUNG_LYMPHOI...,SET,118,0.014422,0.0011519,0.084977,0.43262,DESCARTES_FETAL_LUNG_LYMPHOID_CELLS,0.985540631344554
GOBP_HINDBRAIN_MORPHOGENESIS,SET,40,0.023802,0.0011092,0.14027,0.43263,GOBP_HINDBRAIN_MORPHOGENESIS,0.985540631344554
HP_GENERALIZED_NON_CONVULSIV...,SET,16,0.035856,0.0010575,0.21138,0.43265,HP_GENERALIZED_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,0.985540631344554
MIR3919,SET,278,0.0088334,0.0010782,0.05208,0.43266,MIR3919,0.985540631344554
ZIC1_01,SET,234,0.0092567,0.0010378,0.054577,0.43266,ZIC1_01,0.985540631344554
MIR12132,SET,134,0.012239,0.0010412,0.072216,0.43271,MIR12132,0.985540631344554
HP_T_WAVE_INVERSION,SET,5,0.063271,0.0010435,0.37346,0.43274,HP_T_WAVE_INVERSION,0.985540631344554
HP_DICARBOXYLIC_ACIDURIA,SET,64,0.018107,0.0010667,0.1069,0.43275,HP_DICARBOXYLIC_ACIDURIA,0.985540631344554
GSE17301_CTRL_VS_48H_ACD3_AC...3,SET,186,0.010646,0.0010656,0.062853,0.43275,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN,0.985540631344554
HP_ABNORMALITY_OF_BODY_MASS_...,SET,25,0.031323,0.0011545,0.18499,0.43277,HP_ABNORMALITY_OF_BODY_MASS_INDEX,0.985540631344554
HP_RIGHT_ATRIAL_ENLARGEMENT,SET,23,0.032537,0.0011503,0.19222,0.43279,HP_RIGHT_ATRIAL_ENLARGEMENT,0.985540631344554
KEGG_MEDICUS_VARIANT_MUTATIO...27,SET,11,0.043737,0.0010697,0.25848,0.43282,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.985540631344554
GOMF_OXIDOREDUCTASE_ACTIVITY...19,SET,164,0.011543,0.0010855,0.068291,0.43289,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN,0.985540631344554
GOBP_MUCOPOLYSACCHARIDE_META...,SET,86,0.016085,0.0010977,0.095226,0.43293,GOBP_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS,0.985540631344554
GOBP_RENAL_TUBULAR_SECRETION,SET,18,0.03684,0.0011524,0.2181,0.43293,GOBP_RENAL_TUBULAR_SECRETION,0.985540631344554
MORF_MDM2,SET,248,0.0093811,0.0010824,0.055552,0.43295,MORF_MDM2,0.985540631344554
GSE411_100MIN_VS_400MIN_IL6_...4,SET,187,0.0102,0.0010236,0.06041,0.43296,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.985540631344554
GOBP_OXIDATIVE_DEMETHYLATION,SET,10,0.045776,0.0010675,0.27115,0.43297,GOBP_OXIDATIVE_DEMETHYLATION,0.985540631344554
GSE27786_NKCELL_VS_MONO_MAC_...1,SET,177,0.011082,0.0010824,0.065654,0.43298,GSE27786_NKCELL_VS_MONO_MAC_DN,0.985540631344554
GOBP_TELENCEPHALON_DEVELOPME...,SET,257,0.0094236,0.0011066,0.055854,0.43301,GOBP_TELENCEPHALON_DEVELOPMENT,0.985544371316307
MARTINEZ_RB1_AND_TP53_TARGET...2,SET,569,0.0061346,0.0010626,0.036417,0.43311,MARTINEZ_RB1_AND_TP53_TARGETS_UP,0.985665636458879
PID_PDGFRA_PATHWAY,SET,21,0.032185,0.0010873,0.19108,0.43312,PID_PDGFRA_PATHWAY,0.985665636458879
GOBP_INTRINSIC_APOPTOTIC_SIG...6,SET,6,0.054846,0.00099083,0.32617,0.43323,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,0.985767839607201
GOBP_BONE_TRABECULA_MORPHOGE...,SET,14,0.038884,0.0010728,0.23129,0.43324,GOBP_BONE_TRABECULA_MORPHOGENESIS,0.985767839607201
GSE18804_SPLEEN_MACROPHAGE_V...1,SET,170,0.010923,0.0010456,0.064969,0.43325,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN,0.985767839607201
GOBP_ROUNDABOUT_SIGNALING_PA...,SET,5,0.069875,0.0011524,0.41652,0.43339,GOBP_ROUNDABOUT_SIGNALING_PATHWAY,0.985978558352403
GOBP_REGULATION_OF_PEPTIDYL_...2,SET,10,0.041658,0.00097147,0.24877,0.43351,GOBP_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,0.985978558352403
HP_OROPHARYNGEAL_SQUAMOUS_CE...,SET,6,0.056773,0.0010256,0.33907,0.43351,HP_OROPHARYNGEAL_SQUAMOUS_CELL_CARCINOMA,0.985978558352403
GSE15330_HSC_VS_PRO_BCELL_DN,SET,177,0.010074,0.00098391,0.060188,0.43354,GSE15330_HSC_VS_PRO_BCELL_DN,0.985978558352403
GOCC_EXTRINSIC_COMPONENT_OF_...4,SET,22,0.029291,0.0010128,0.17512,0.43358,GOCC_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE,0.985978558352403
GOBP_POSITIVE_REGULATION_OF_...59,SET,5,0.074995,0.0012368,0.44868,0.43363,GOBP_POSITIVE_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.985978558352403
MIR4666A_5P,SET,226,0.0096894,0.0010679,0.057994,0.43366,MIR4666A_5P,0.985978558352403
CHIBA_RESPONSE_TO_TSA,SET,37,0.024813,0.0011122,0.14855,0.43367,CHIBA_RESPONSE_TO_TSA,0.985978558352403
GOBP_NOTOCHORD_MORPHOGENESIS,SET,6,0.063201,0.0011418,0.37851,0.4337,GOBP_NOTOCHORD_MORPHOGENESIS,0.985978558352403
YAN_ESCAPE_FROM_ANOIKIS,SET,23,0.029912,0.0010575,0.17921,0.43372,YAN_ESCAPE_FROM_ANOIKIS,0.985978558352403
MIR424_3P,SET,34,0.023361,0.0010039,0.13996,0.43372,MIR424_3P,0.985978558352403
GOBP_SURFACTANT_HOMEOSTASIS,SET,20,0.03263,0.0010758,0.19549,0.43372,GOBP_SURFACTANT_HOMEOSTASIS,0.985978558352403
GSE9650_EFFECTOR_VS_MEMORY_C...2,SET,183,0.010314,0.0010241,0.061804,0.43373,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP,0.985978558352403
GSE21546_WT_VS_SAP1A_KO_ANTI...1,SET,183,0.010403,0.0010329,0.062367,0.43376,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.985978558352403
MIR3171,SET,73,0.015784,0.00099279,0.094673,0.4338,MIR3171,0.985978558352403
HP_CONGENITAL_THROMBOCYTOPEN...,SET,4,0.060549,0.00089318,0.36356,0.43387,HP_CONGENITAL_THROMBOCYTOPENIA,0.985978558352403
HP_ACUTE_INFECTIOUS_PNEUMONIA,SET,5,0.069217,0.0011415,0.41573,0.43388,HP_ACUTE_INFECTIOUS_PNEUMONIA,0.985978558352403
GOBP_MONOSACCHARIDE_TRANSMEM...,SET,110,0.013985,0.0010787,0.084002,0.43389,GOBP_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORT,0.985978558352403
HP_EPISODIC_HYPERHIDROSIS,SET,25,0.026173,0.00096468,0.15724,0.4339,HP_EPISODIC_HYPERHIDROSIS,0.985978558352403
GSE18791_CTRL_VS_NEWCASTLE_V...7,SET,168,0.011285,0.001074,0.067804,0.43391,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN,0.985978558352403
HP_ABNORMAL_GRANULOCYTOPOIET...,SET,14,0.037857,0.0010445,0.22756,0.43394,HP_ABNORMAL_GRANULOCYTOPOIETIC_CELL_MORPHOLOGY,0.98598226333682
GOLUB_ALL_VS_AML_UP,SET,24,0.030868,0.0011148,0.186,0.4341,GOLUB_ALL_VS_AML_UP,0.986068923599765
MIR4446_3P,SET,56,0.018922,0.0010429,0.11405,0.43411,MIR4446_3P,0.986068923599765
GOBP_VIRAL_GENOME_REPLICATION,SET,117,0.013753,0.0010938,0.082889,0.43411,GOBP_VIRAL_GENOME_REPLICATION,0.986068923599765
KEGG_PATHOGENIC_ESCHERICHIA_...,SET,53,0.019549,0.0010483,0.11784,0.43412,KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.986068923599765
WP_PATHOGENIC_ESCHERICHIA_CO...,SET,53,0.019549,0.0010483,0.11784,0.43412,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.986068923599765
GOBP_POSITIVE_REGULATION_OF_...618,SET,15,0.038549,0.0011009,0.23271,0.43422,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,0.986148144276006
KIM_WT1_TARGETS_DN,SET,426,0.0067636,0.0010178,0.040841,0.43423,KIM_WT1_TARGETS_DN,0.986148144276006
KEGG_MEDICUS_VARIANT_SCRAPIE...4,SET,16,0.035708,0.0010531,0.21565,0.43424,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM,0.986148144276006
MIR1537_5P,SET,109,0.013789,0.0010587,0.083423,0.43436,MIR1537_5P,0.986314474715798
REACTOME_INTERCONVERSION_OF_...,SET,28,0.028141,0.0010976,0.17029,0.43437,REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES,0.986314474715798
REACTOME_RSV_HOST_INTERACTIO...,SET,84,0.015455,0.0010425,0.093579,0.43441,REACTOME_RSV_HOST_INTERACTIONS,0.986340860390671
GSE23308_WT_VS_MINERALCORTIC...2,SET,175,0.010541,0.0010237,0.063878,0.43446,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP,0.986389946433238
ZNF708_TARGET_GENES,SET,72,0.01622,0.0010132,0.098421,0.43455,ZNF708_TARGET_GENES,0.986488099281515
GARCIA_TARGETS_OF_FLI1_AND_D...1,SET,148,0.011021,0.00098502,0.066888,0.43456,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,0.986488099281515
MIR6889_3P,SET,100,0.014815,0.0010899,0.089983,0.43461,MIR6889_3P,0.986495434952978
HP_NEGATIVISM,SET,10,0.051027,0.00119,0.30996,0.43462,HP_NEGATIVISM,0.986495434952978
MIR3200_3P,SET,24,0.029627,0.00107,0.18039,0.43477,MIR3200_3P,0.986771458891138
HP_AXILLARY_PTERYGIUM,SET,9,0.048675,0.0010769,0.29686,0.43488,HP_AXILLARY_PTERYGIUM,0.986906782427051
GOMF_CYCLIN_DEPENDENT_PROTEI...3,SET,12,0.043086,0.0011006,0.26302,0.43494,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,0.986906782427051
KEGG_MEDICUS_PATHOGEN_SARS_C...1,SET,6,0.069921,0.0012632,0.42716,0.43499,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE,0.986906782427051
GAVISH_3CA_METAPROGRAM_B_CEL...6,SET,43,0.021252,0.0010268,0.12984,0.43499,GAVISH_3CA_METAPROGRAM_B_CELLS_MEMORY,0.986906782427051
HE_LIM_SUN_FETAL_LUNG_C1_EAR...1,SET,32,0.029133,0.0012146,0.17799,0.43499,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL,0.986906782427051
GOBP_REGULATION_OF_CYTOPLASM...2,SET,101,0.01365,0.0010091,0.083402,0.435,GOBP_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.986906782427051
GSE2706_LPS_VS_R848_AND_LPS_...2,SET,146,0.011463,0.0010177,0.070108,0.43506,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP,0.98695159358702
GOBP_POSTSYNAPTIC_CYTOSKELET...,SET,17,0.037297,0.0011338,0.22832,0.43512,GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION,0.98695159358702
REACTOME_CYCLIN_D_ASSOCIATED...,SET,45,0.020235,0.0010001,0.12411,0.43524,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,0.98695159358702
HP_GLUTARIC_ACIDURIA,SET,7,0.051859,0.0010119,0.31842,0.43531,HP_GLUTARIC_ACIDURIA,0.98695159358702
GOBP_ENERGY_HOMEOSTASIS,SET,76,0.017073,0.0010956,0.10485,0.43533,GOBP_ENERGY_HOMEOSTASIS,0.98695159358702
DE_YY1_TARGETS_UP,SET,17,0.037664,0.001145,0.23134,0.43534,DE_YY1_TARGETS_UP,0.98695159358702
KEGG_MEDICUS_VARIANT_MUTATIO...67,SET,25,0.028153,0.0010377,0.17293,0.43534,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.98695159358702
ZHONG_SECRETOME_OF_LUNG_CANC...3,SET,69,0.016723,0.0010228,0.10278,0.43537,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,0.98695159358702
GOBP_RESPONSE_TO_ANTIBIOTIC,SET,36,0.023369,0.0010333,0.14371,0.43541,GOBP_RESPONSE_TO_ANTIBIOTIC,0.98695159358702
GOMF_ORGANIC_ACID_SODIUM_SYM...,SET,32,0.02603,0.0010852,0.16017,0.43545,GOMF_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY,0.98695159358702
GOBP_POSITIVE_REGULATION_OF_...720,SET,8,0.04542,0.00094743,0.2795,0.43546,GOBP_POSITIVE_REGULATION_OF_SPINDLE_ASSEMBLY,0.98695159358702
HE_LIM_SUN_FETAL_LUNG_C7_KCN...,SET,95,0.016038,0.0011501,0.09889,0.43558,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.98695159358702
TCGA_GLIOBLASTOMA_MUTATED,SET,8,0.046302,0.00096582,0.28575,0.43564,TCGA_GLIOBLASTOMA_MUTATED,0.98695159358702
HP_ST_SEGMENT_DEPRESSION,SET,13,0.043337,0.0011522,0.26751,0.43565,HP_ST_SEGMENT_DEPRESSION,0.98695159358702
GOBP_DORSAL_ROOT_GANGLION_DE...,SET,7,0.061427,0.0011986,0.37923,0.43566,GOBP_DORSAL_ROOT_GANGLION_DEVELOPMENT,0.98695159358702
RREB1_01,SET,191,0.010112,0.0010255,0.062436,0.43567,RREB1_01,0.98695159358702
GOBP_POSITIVE_REGULATION_OF_...512,SET,13,0.042228,0.0011227,0.26072,0.43567,GOBP_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.98695159358702
GSE26912_TUMORICIDAL_VS_CTRL...1,SET,184,0.0099817,0.00099376,0.061627,0.43567,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN,0.98695159358702
GOBP_REVERSIBLE_DIFFERENTIAT...,SET,5,0.070479,0.0011624,0.43561,0.43574,GOBP_REVERSIBLE_DIFFERENTIATION,0.98695159358702
GOBP_PROTEIN_INSERTION_INTO_...3,SET,40,0.022081,0.001029,0.13651,0.43575,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE,0.98695159358702
GCAAAAA_MIR129,SET,171,0.01051,0.0010091,0.064984,0.43576,GCAAAAA_MIR129,0.98695159358702
HP_CHRONIC_ORAL_CANDIDIASIS,SET,26,0.026999,0.0010148,0.16697,0.43577,HP_CHRONIC_ORAL_CANDIDIASIS,0.98695159358702
YNTTTNNNANGCARM_UNKNOWN,SET,63,0.019203,0.0011224,0.11882,0.4358,YNTTTNNNANGCARM_UNKNOWN,0.98695159358702
chr18q12,SET,43,0.038498,0.00186,0.23827,0.43582,chr18q12,0.98695159358702
MIR498_5P,SET,215,0.0099474,0.0010696,0.061578,0.43583,MIR498_5P,0.98695159358702
WP_TRANSLATION_INHIBITORS_IN...,SET,45,0.021202,0.0010479,0.13142,0.43592,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,0.98695159358702
GSE3982_MAC_VS_BCELL_DN,SET,163,0.010409,0.00097596,0.064565,0.43596,GSE3982_MAC_VS_BCELL_DN,0.98695159358702
SMAD3_Q6,SET,214,0.0097767,0.0010488,0.060646,0.43597,SMAD3_Q6,0.98695159358702
HP_ABNORMAL_ESOPHAGUS_PHYSIO...,SET,774,0.0050765,0.0010196,0.031491,0.43597,HP_ABNORMAL_ESOPHAGUS_PHYSIOLOGY,0.98695159358702
GOBP_REGULATION_OF_REPRODUCT...,SET,187,0.010239,0.0010275,0.063526,0.43598,GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS,0.98695159358702
MIR3622B_5P,SET,47,0.019866,0.0010033,0.1233,0.436,MIR3622B_5P,0.98695159358702
HP_INCREASED_CIRCULATING_IGE...,SET,39,0.022259,0.0010243,0.13817,0.43601,HP_INCREASED_CIRCULATING_IGE_LEVEL,0.98695159358702
GOBP_POSITIVE_REGULATION_OF_...224,SET,66,0.015664,0.00093699,0.097294,0.43605,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.98695159358702
ZNF513_TARGET_GENES,SET,613,0.0058017,0.0010418,0.036056,0.43608,ZNF513_TARGET_GENES,0.98695159358702
GSE360_CTRL_VS_L_DONOVANI_DC...2,SET,179,0.010224,0.0010041,0.063548,0.43609,GSE360_CTRL_VS_L_DONOVANI_DC_UP,0.98695159358702
GSE41176_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.010506,0.0010261,0.065297,0.43609,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN,0.98695159358702
PETRETTO_BLOOD_PRESSURE_DN,SET,7,0.056746,0.0011073,0.35331,0.4362,PETRETTO_BLOOD_PRESSURE_DN,0.98695159358702
GOBP_SIGNALING_RECEPTOR_LIGA...,SET,36,0.02374,0.0010497,0.14785,0.43622,GOBP_SIGNALING_RECEPTOR_LIGAND_PRECURSOR_PROCESSING,0.98695159358702
HP_INCREASED_BONE_MINERAL_DE...,SET,95,0.014911,0.0010693,0.092938,0.43627,HP_INCREASED_BONE_MINERAL_DENSITY,0.98695159358702
HP_BICORNUATE_UTERUS,SET,48,0.019085,0.00097407,0.11902,0.43631,HP_BICORNUATE_UTERUS,0.98695159358702
GSE3982_MAC_VS_NKCELL_DN,SET,177,0.010615,0.0010367,0.066215,0.43632,GSE3982_MAC_VS_NKCELL_DN,0.98695159358702
REACTOME_METAL_SEQUESTRATION...,SET,6,0.064024,0.0011566,0.39982,0.43639,REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS,0.98695159358702
GNF2_MAP2K3,SET,66,0.016877,0.0010096,0.10539,0.43639,GNF2_MAP2K3,0.98695159358702
GOBP_SPERMATID_DIFFERENTIATI...,SET,190,0.0097381,0.00098502,0.060864,0.43644,GOBP_SPERMATID_DIFFERENTIATION,0.98695159358702
GOBP_CELLULAR_RESPONSE_TO_VI...2,SET,27,0.028654,0.0010975,0.17927,0.4365,GOBP_CELLULAR_RESPONSE_TO_VITAMIN,0.98695159358702
GOBP_POSITIVE_REGULATION_OF_...516,SET,25,0.030197,0.001113,0.18891,0.4365,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.98695159358702
GSE22886_CTRL_VS_LPS_24H_DC_...1,SET,176,0.010663,0.0010385,0.066729,0.43652,GSE22886_CTRL_VS_LPS_24H_DC_DN,0.98695159358702
REACTOME_EXTRINSIC_PATHWAY_O...,SET,4,0.080878,0.0011931,0.50625,0.43654,REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.98695159358702
GSE9316_CD4_TCELL_BALBC_VS_T...1,SET,180,0.010568,0.0010408,0.066243,0.43662,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN,0.98695159358702
GOBP_THYROID_GLAND_DEVELOPME...,SET,30,0.025879,0.0010447,0.16243,0.43671,GOBP_THYROID_GLAND_DEVELOPMENT,0.98695159358702
GOBP_GLUCOCORTICOID_BIOSYNTH...,SET,16,0.038456,0.0011342,0.24146,0.43673,GOBP_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.98695159358702
GOBP_REGULATION_OF_PEROXISOM...,SET,14,0.041438,0.0011433,0.26046,0.4368,GOBP_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.98695159358702
GOBP_AMP_SALVAGE,SET,4,0.073689,0.001087,0.46324,0.43681,GOBP_AMP_SALVAGE,0.98695159358702
BIOCARTA_RANKL_PATHWAY,SET,14,0.040319,0.0011124,0.25353,0.43682,BIOCARTA_RANKL_PATHWAY,0.98695159358702
GSE17721_CPG_VS_GARDIQUIMOD_...18,SET,179,0.0099879,0.0009809,0.062827,0.43685,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP,0.98695159358702
HP_ABNORMAL_TRICUSPID_VALVE_...1,SET,35,0.025637,0.0011177,0.16129,0.43686,HP_ABNORMAL_TRICUSPID_VALVE_MORPHOLOGY,0.98695159358702
GOMF_U1_SNRNA_BINDING,SET,8,0.041419,0.00086397,0.26069,0.43688,GOMF_U1_SNRNA_BINDING,0.98695159358702
GOMF_CALCIUM_ACTIVATED_POTAS...,SET,13,0.042659,0.0011342,0.26859,0.4369,GOMF_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY,0.98695159358702
GOBP_SPERM_EGG_RECOGNITION,SET,49,0.018885,0.00097381,0.11892,0.43691,GOBP_SPERM_EGG_RECOGNITION,0.98695159358702
GOBP_INNER_MITOCHONDRIAL_MEM...,SET,35,0.022407,0.00097689,0.14122,0.43697,GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.98695159358702
GSE21033_1H_VS_24H_POLYIC_ST...2,SET,154,0.010964,0.00099944,0.069176,0.43703,GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP,0.98695159358702
GSE37533_UNTREATED_VS_PIOGLI...3,SET,180,0.010088,0.00099345,0.063704,0.43709,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.98695159358702
GOBP_DETECTION_OF_LIGHT_STIM...2,SET,19,0.031126,0.0010003,0.19667,0.43712,GOBP_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.98695159358702
GOBP_RESPONSE_TO_ESTROGEN,SET,64,0.017241,0.0010157,0.10904,0.43718,GOBP_RESPONSE_TO_ESTROGEN,0.98695159358702
CDPCR3HD_01,SET,213,0.0097671,0.0010454,0.061795,0.43721,CDPCR3HD_01,0.98695159358702
REACTOME_DIGESTION_OF_DIETAR...2,SET,6,0.07457,0.0013472,0.47228,0.43727,REACTOME_DIGESTION_OF_DIETARY_LIPID,0.98695159358702
TUOMISTO_TUMOR_SUPPRESSION_B...1,SET,19,0.032486,0.001044,0.2058,0.43729,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,0.98695159358702
REACTOME_TRNA_MODIFICATION_I...2,SET,38,0.019494,0.00088549,0.12357,0.43733,REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.98695159358702
HALLMARK_IL6_JAK_STAT3_SIGNA...,SET,80,0.016411,0.0010804,0.10404,0.43733,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.98695159358702
GNF2_MKI67,SET,27,0.026304,0.0010075,0.1669,0.43738,GNF2_MKI67,0.98695159358702
GOBP_REGULATION_OF_MESONEPHR...,SET,4,0.068608,0.0010121,0.43546,0.43741,GOBP_REGULATION_OF_MESONEPHROS_DEVELOPMENT,0.98695159358702
GSE18804_SPLEEN_MACROPHAGE_V...4,SET,183,0.010064,0.00099928,0.06389,0.43742,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP,0.98695159358702
ZNF26_TARGET_GENES,SET,20,0.029639,0.00097722,0.18821,0.43744,ZNF26_TARGET_GENES,0.98695159358702
GOBP_PHOTORECEPTOR_CELL_DEVE...,SET,49,0.020261,0.0010448,0.12868,0.43745,GOBP_PHOTORECEPTOR_CELL_DEVELOPMENT,0.98695159358702
GOCC_MITOCHONDRIAL_CRISTA_JU...,SET,4,0.068159,0.0010054,0.43301,0.43746,GOCC_MITOCHONDRIAL_CRISTA_JUNCTION,0.98695159358702
GOBP_REGULATION_OF_T_HELPER_...1,SET,22,0.029944,0.0010354,0.19024,0.43747,GOBP_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.98695159358702
GOCC_SPECTRIN_ASSOCIATED_CYT...,SET,9,0.043439,0.00096105,0.27626,0.43753,GOCC_SPECTRIN_ASSOCIATED_CYTOSKELETON,0.98695159358702
HP_DERMATOLOGICAL_MANIFESTAT...,SET,301,0.0077863,0.00098828,0.049516,0.43753,HP_DERMATOLOGICAL_MANIFESTATIONS_OF_SYSTEMIC_DISORDERS,0.98695159358702
GRAESSMANN_APOPTOSIS_BY_SERU...1,SET,215,0.009264,0.00099613,0.058979,0.43759,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,0.98695159358702
OCT1_01,SET,227,0.0096116,0.0010616,0.061183,0.43759,OCT1_01,0.98695159358702
GSE21927_SPLEEN_MONOCYTE_VS_...1,SET,166,0.010377,0.00098175,0.066084,0.43761,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN,0.98695159358702
WP_SARS_CORONAVIRUS_AND_INNA...,SET,26,0.029267,0.0011,0.18645,0.43764,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,0.98695159358702
HP_ABSENT_SKIN_PIGMENTATION,SET,5,0.069015,0.0011382,0.43986,0.43766,HP_ABSENT_SKIN_PIGMENTATION,0.98695159358702
ZNF136_TARGET_GENES,SET,5,0.059667,0.00098404,0.3804,0.43768,ZNF136_TARGET_GENES,0.98695159358702
GOMF_NADPLUS_PROTEIN_LYSINE_...,SET,5,0.062366,0.0010285,0.39811,0.43776,GOMF_NADPLUS_PROTEIN_LYSINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.98695159358702
DESCARTES_MAIN_FETAL_SMOOTH_...,SET,37,0.023278,0.0010434,0.14862,0.43777,DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS,0.98695159358702
SU_PLACENTA,SET,23,0.029037,0.0010266,0.18548,0.4378,SU_PLACENTA,0.98695159358702
DESCARTES_FETAL_PANCREAS_ENS...2,SET,125,0.012928,0.0010625,0.082571,0.4378,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.98695159358702
SOX3_TARGET_GENES,SET,414,0.0067399,0.0010001,0.043103,0.43787,SOX3_TARGET_GENES,0.98695159358702
GOBP_POSITIVE_REGULATION_OF_...632,SET,7,0.054707,0.0010675,0.3499,0.43788,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,0.98695159358702
GOBP_REGULATION_OF_CANONICAL...,SET,234,0.0091955,0.001031,0.058811,0.43788,GOBP_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.98695159358702
GOCC_COMPACT_MYELIN,SET,13,0.040312,0.0010718,0.25784,0.43788,GOCC_COMPACT_MYELIN,0.98695159358702
HP_OSTEOCHONDROMA,SET,7,0.055529,0.0010835,0.35514,0.43788,HP_OSTEOCHONDROMA,0.98695159358702
chr10q23,SET,81,0.028524,0.0018895,0.18253,0.43791,chr10q23,0.98695159358702
GSE31622_WT_VS_KLF3_KO_BCELL...2,SET,178,0.0098607,0.00096573,0.063107,0.43792,GSE31622_WT_VS_KLF3_KO_BCELL_UP,0.98695159358702
GOBP_SIGNAL_RELEASE,SET,456,0.0065172,0.0010138,0.041768,0.438,GOBP_SIGNAL_RELEASE,0.98695159358702
TERF1_TARGET_GENES,SET,214,0.0093688,0.0010051,0.060058,0.43802,TERF1_TARGET_GENES,0.98695159358702
GOMF_ACTIN_FILAMENT_BINDING,SET,197,0.0097548,0.0010045,0.062538,0.43802,GOMF_ACTIN_FILAMENT_BINDING,0.98695159358702
GOMF_MICROFILAMENT_MOTOR_ACT...,SET,37,0.02365,0.0010601,0.1516,0.43802,GOMF_MICROFILAMENT_MOTOR_ACTIVITY,0.98695159358702
HP_RESPIRATORY_FAILURE_REQUI...,SET,29,0.023632,0.00093803,0.15159,0.43806,HP_RESPIRATORY_FAILURE_REQUIRING_ASSISTED_VENTILATION,0.98695159358702
GOBP_CHROMOSOME_LOCALIZATION,SET,112,0.012161,0.00094647,0.078037,0.43808,GOBP_CHROMOSOME_LOCALIZATION,0.98695159358702
MIR4696,SET,91,0.013908,0.00097626,0.089265,0.43809,MIR4696,0.98695159358702
DESCARTES_MAIN_FETAL_BRONCHI...,SET,34,0.025864,0.0011115,0.166,0.43809,DESCARTES_MAIN_FETAL_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,0.98695159358702
REACTOME_SIGNALING_BY_ERBB2_...2,SET,25,0.025103,0.00092522,0.16122,0.43814,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,0.98695159358702
GOBP_CARDIAC_CHAMBER_FORMATI...,SET,11,0.047789,0.0011688,0.30705,0.43816,GOBP_CARDIAC_CHAMBER_FORMATION,0.98695159358702
TERAMOTO_OPN_TARGETS_CLUSTER...3,SET,13,0.034554,0.0009187,0.22207,0.43818,TERAMOTO_OPN_TARGETS_CLUSTER_4,0.98695159358702
GOCC_ENDOCYTIC_VESICLE_LUMEN,SET,21,0.02988,0.0010095,0.19204,0.43818,GOCC_ENDOCYTIC_VESICLE_LUMEN,0.98695159358702
MARTORIATI_MDM4_TARGETS_NEUR...2,SET,150,0.011021,0.00099161,0.070869,0.43821,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,0.98695159358702
MIR3074_3P,SET,79,0.015414,0.0010084,0.099124,0.43821,MIR3074_3P,0.98695159358702
NRSF_01,SET,93,0.014443,0.0010249,0.092959,0.43826,NRSF_01,0.98695159358702
HP_ABNORMALITY_OF_DNA_REPAIR,SET,14,0.027899,0.00076973,0.17953,0.43826,HP_ABNORMALITY_OF_DNA_REPAIR,0.98695159358702
GOCC_MICROTUBULE_ORGANIZING_...1,SET,780,0.0046963,0.00094676,0.030231,0.43828,GOCC_MICROTUBULE_ORGANIZING_CENTER,0.98695159358702
GOBP_NEGATIVE_REGULATION_OF_...153,SET,9,0.050558,0.0011185,0.326,0.43838,GOBP_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.98695159358702
ALX4_01,SET,15,0.036902,0.0010538,0.23805,0.43841,ALX4_01,0.98695159358702
GSE42724_B1_BCELL_VS_PLASMAB...1,SET,181,0.0094101,0.00092925,0.060775,0.43848,GSE42724_B1_BCELL_VS_PLASMABLAST_DN,0.98695159358702
ZBTB12_TARGET_GENES,SET,1036,0.0041746,0.00096283,0.026977,0.43851,ZBTB12_TARGET_GENES,0.98695159358702
REACTOME_CA2_ACTIVATED_K_CHA...,SET,9,0.048339,0.0010694,0.31251,0.43854,REACTOME_CA2_ACTIVATED_K_CHANNELS,0.98695159358702
WP_NEUROINFLAMMATION_AND_GLU...,SET,135,0.012287,0.0010492,0.079458,0.43855,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.98695159358702
GSE42021_TCONV_PLN_VS_CD24LO...1,SET,180,0.0099534,0.00098022,0.064397,0.43858,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN,0.98695159358702
GOBP_REGULATION_OF_ERAD_PATH...,SET,22,0.026227,0.00090689,0.16976,0.43861,GOBP_REGULATION_OF_ERAD_PATHWAY,0.98695159358702
HP_GIANT_SOMATOSENSORY_EVOKE...,SET,5,0.060027,0.00098997,0.38852,0.43861,HP_GIANT_SOMATOSENSORY_EVOKED_POTENTIALS,0.98695159358702
HP_RIGHT_VENTRICULAR_DILATAT...,SET,17,0.034336,0.0010438,0.22228,0.43862,HP_RIGHT_VENTRICULAR_DILATATION,0.98695159358702
MIR4763_3P,SET,228,0.0088338,0.00097781,0.057246,0.43868,MIR4763_3P,0.98695159358702
GSE2585_CTEC_VS_MTEC_THYMUS_...1,SET,188,0.0098068,0.00098679,0.063558,0.43869,GSE2585_CTEC_VS_MTEC_THYMUS_DN,0.98695159358702
HP_HYPEREXTENSIBILITY_OF_THE...1,SET,21,0.030673,0.0010362,0.19895,0.43874,HP_HYPEREXTENSIBILITY_OF_THE_FINGER_JOINTS,0.98695159358702
GREB1_TARGET_GENES,SET,683,0.0051497,0.00097414,0.033462,0.43885,GREB1_TARGET_GENES,0.98695159358702
SEIDEN_ONCOGENESIS_BY_MET,SET,79,0.01488,0.0009735,0.096756,0.43889,SEIDEN_ONCOGENESIS_BY_MET,0.98695159358702
ESC_V6.5_UP_EARLY.V1_UP,SET,154,0.010907,0.00099422,0.070922,0.43889,ESC_V6.5_UP_EARLY.V1_UP,0.98695159358702
GOBP_REGULATION_OF_ATP_DEPEN...,SET,58,0.017127,0.00096062,0.11138,0.4389,GOBP_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.98695159358702
KEGG_MEDICUS_VARIANT_MUTATIO...1,SET,5,0.063068,0.0010401,0.41031,0.43892,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY,0.98695159358702
GOBP_DETOXIFICATION_OF_COPPE...,SET,13,0.049915,0.0013271,0.32487,0.43895,GOBP_DETOXIFICATION_OF_COPPER_ION,0.98695159358702
GOMF_DOUBLE_STRANDED_RNA_ADE...,SET,6,0.059829,0.0010809,0.38942,0.43895,GOMF_DOUBLE_STRANDED_RNA_ADENOSINE_DEAMINASE_ACTIVITY,0.98695159358702
HP_PIERRE_ROBIN_SEQUENCE,SET,25,0.026869,0.00099031,0.17497,0.43898,HP_PIERRE_ROBIN_SEQUENCE,0.98695159358702
chr2q22,SET,11,0.059758,0.0014616,0.3892,0.43899,chr2q22,0.98695159358702
YAO_TEMPORAL_RESPONSE_TO_PRO...16,SET,69,0.015432,0.00094383,0.10051,0.43899,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,0.98695159358702
HP_PROGRESSIVE_PTOSIS,SET,4,0.057798,0.0008526,0.3767,0.43903,HP_PROGRESSIVE_PTOSIS,0.98695159358702
MIR6076,SET,49,0.019716,0.0010167,0.1286,0.43908,MIR6076,0.98695159358702
CREBP1CJUN_01,SET,238,0.0087364,0.00098773,0.056998,0.43909,CREBP1CJUN_01,0.98695159358702
HP_ABNORMAL_UVEA_MORPHOLOGY,SET,523,0.0059382,0.00098739,0.038752,0.43911,HP_ABNORMAL_UVEA_MORPHOLOGY,0.98695159358702
SALVADOR_MARTIN_PEDIATRIC_TB...1,SET,21,0.02811,0.00094968,0.18362,0.43916,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,0.98695159358702
GSE18281_PERIMEDULLARY_CORTI...4,SET,187,0.0095748,0.0009609,0.062566,0.43919,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.98695159358702
NOTCH3_TARGET_GENES,SET,1079,0.0041939,0.00098592,0.027419,0.43922,NOTCH3_TARGET_GENES,0.98695159358702
GOBP_POSITIVE_REGULATION_OF_...255,SET,29,0.024394,0.00096824,0.15957,0.43925,GOBP_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.98695159358702
GOBP_RESPONSE_TO_FLUID_SHEAR...,SET,33,0.025012,0.0010589,0.16371,0.43929,GOBP_RESPONSE_TO_FLUID_SHEAR_STRESS,0.98695159358702
GSE29164_UNTREATED_VS_CD8_TC...3,SET,181,0.0098591,0.00097359,0.064533,0.43929,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,0.98695159358702
WP_GLP1_IN_PANCREATIC_ISLET_...,SET,7,0.057563,0.0011232,0.37709,0.43934,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,0.98695159358702
HP_HYPEREXTENSIBILITY_AT_ELB...,SET,6,0.054669,0.00098763,0.35821,0.43935,HP_HYPEREXTENSIBILITY_AT_ELBOW,0.98695159358702
ZNF146_TARGET_GENES,SET,889,0.0044831,0.00096187,0.029379,0.43936,ZNF146_TARGET_GENES,0.98695159358702
HALLMARK_MYC_TARGETS_V1,SET,182,0.0089955,0.00089074,0.058949,0.43936,HALLMARK_MYC_TARGETS_V1,0.98695159358702
HP_PYELONEPHRITIS,SET,20,0.028279,0.00093238,0.18538,0.43938,HP_PYELONEPHRITIS,0.98695159358702
GNF2_ICAM3,SET,34,0.022183,0.00095325,0.14552,0.43942,GNF2_ICAM3,0.98695159358702
GOBP_L_ARGININE_TRANSMEMBRAN...,SET,13,0.041971,0.0011159,0.27534,0.43942,GOBP_L_ARGININE_TRANSMEMBRANE_TRANSPORT,0.98695159358702
HP_MEDIASTINAL_LYMPHADENOPAT...,SET,24,0.028794,0.0010399,0.18906,0.43948,HP_MEDIASTINAL_LYMPHADENOPATHY,0.98695159358702
WP_HOMOLOGOUS_RECOMBINATION,SET,12,0.035512,0.00090713,0.23321,0.43949,WP_HOMOLOGOUS_RECOMBINATION,0.98695159358702
HP_ANGIOFIBROMAS,SET,31,0.02154,0.0008839,0.14151,0.43951,HP_ANGIOFIBROMAS,0.98695159358702
MODULE_97,SET,88,0.013555,0.00093571,0.089126,0.43956,MODULE_97,0.98695159358702
GAUTAM_EYE_IRIS_CILIARY_BODY...8,SET,99,0.013942,0.0010206,0.091744,0.43961,GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS,0.98695159358702
HP_LEFT_VENTRICULAR_DIASTOLI...,SET,7,0.050202,0.00097957,0.33046,0.43963,HP_LEFT_VENTRICULAR_DIASTOLIC_DYSFUNCTION,0.98695159358702
IRF_Q6,SET,219,0.0090483,0.00098183,0.059625,0.43969,IRF_Q6,0.98695159358702
GOBP_NEURAL_TUBE_DEVELOPMENT,SET,150,0.010762,0.00096829,0.070932,0.4397,GOBP_NEURAL_TUBE_DEVELOPMENT,0.98695159358702
SCIAN_INVERSED_TARGETS_OF_TP...2,SET,9,0.045797,0.0010132,0.30236,0.43981,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP,0.98695159358702
KEGG_MEDICUS_VARIANT_BCL2_OV...,SET,7,0.047465,0.00092617,0.31401,0.43993,KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.98695159358702
HP_ABNORMAL_JAW_MORPHOLOGY,SET,987,0.0041894,0.00094444,0.027736,0.43997,HP_ABNORMAL_JAW_MORPHOLOGY,0.98695159358702
KIM_LRRC3B_TARGETS,SET,29,0.023709,0.00094106,0.15698,0.43998,KIM_LRRC3B_TARGETS,0.98695159358702
HP_CAVERNOUS_HEMANGIOMA,SET,33,0.021548,0.00091226,0.14268,0.43998,HP_CAVERNOUS_HEMANGIOMA,0.98695159358702
GOBP_POTASSIUM_ION_TRANSPORT,SET,227,0.0094039,0.0010387,0.062276,0.43999,GOBP_POTASSIUM_ION_TRANSPORT,0.98695159358702
WP_GABA_RECEPTOR_SIGNALING,SET,28,0.027826,0.0010853,0.18431,0.44,WP_GABA_RECEPTOR_SIGNALING,0.98695159358702
GOBP_AMYLOID_BETA_CLEARANCE_...1,SET,8,0.045361,0.00094621,0.30093,0.44009,GOBP_AMYLOID_BETA_CLEARANCE_BY_CELLULAR_CATABOLIC_PROCESS,0.98695159358702
WHITFIELD_CELL_CYCLE_G1_S,SET,117,0.011158,0.00088748,0.074048,0.44011,WHITFIELD_CELL_CYCLE_G1_S,0.98695159358702
GOBP_CYCLIC_NUCLEOTIDE_CATAB...,SET,14,0.034642,0.00095577,0.22998,0.44013,GOBP_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS,0.98695159358702
WANG_NEOPLASTIC_TRANSFORMATI...,SET,17,0.038004,0.0011553,0.25247,0.44017,WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,0.98695159358702
HALLMARK_MYC_TARGETS_V2,SET,56,0.015899,0.00087631,0.10562,0.44017,HALLMARK_MYC_TARGETS_V2,0.98695159358702
GOBP_CELL_GROWTH,SET,428,0.0064198,0.00096823,0.042658,0.44019,GOBP_CELL_GROWTH,0.98695159358702
MIR6721_5P,SET,316,0.0073832,0.00095978,0.049089,0.44022,MIR6721_5P,0.98695159358702
GSE22527_ANTI_CD3_INVIVO_VS_...2,SET,176,0.009947,0.00096875,0.066138,0.44023,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP,0.98695159358702
GSE9037_CTRL_VS_LPS_1H_STIM_...3,SET,175,0.0098449,0.0009561,0.065489,0.44025,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN,0.98695159358702
HP_ABNORMAL_OCCIPITAL_BONE_M...,SET,103,0.011839,0.0008838,0.078802,0.44029,HP_ABNORMAL_OCCIPITAL_BONE_MORPHOLOGY,0.98695159358702
chr8p22,SET,20,0.051953,0.0017129,0.34593,0.44031,chr8p22,0.98695159358702
GSE42021_TCONV_PLN_VS_TREG_P...2,SET,180,0.0097165,0.00095688,0.064697,0.44031,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP,0.98695159358702
WP_MITOCHONDRIAL_COMPLEX_III...,SET,15,0.029508,0.00084268,0.19651,0.44032,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,0.98695159358702
HOEK_T_CELL_2011_2012_TIV_AD...5,SET,2,0.072694,0.0007583,0.48423,0.44034,HOEK_T_CELL_2011_2012_TIV_ADULT_7DY_UP,0.98695159358702
HP_ABNORMALITY_OF_THE_VASCUL...,SET,337,0.0070715,0.00094876,0.047126,0.44036,HP_ABNORMALITY_OF_THE_VASCULATURE_OF_THE_EYE,0.98695159358702
BUSSLINGER_DUODENAL_LATE_IMM...,SET,164,0.010372,0.00097544,0.069119,0.44036,BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES,0.98695159358702
GOBP_SYNAPSE_MATURATION,SET,33,0.023375,0.00098961,0.15589,0.44041,GOBP_SYNAPSE_MATURATION,0.98695159358702
GOBP_DETECTION_OF_MECHANICAL...4,SET,13,0.039086,0.0010392,0.26074,0.44042,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND,0.98695159358702
GOMF_CALCIUM_POTASSIUM_SODIU...,SET,5,0.069863,0.0011522,0.46635,0.44046,GOMF_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY,0.98695159358702
HP_ABNORMAL_CIRCULATING_HAPT...,SET,11,0.036999,0.00090492,0.24728,0.44053,HP_ABNORMAL_CIRCULATING_HAPTOGLOBIN_CONCENTRATION,0.98695159358702
REACTOME_RUNX3_REGULATES_WNT...,SET,8,0.045918,0.00095781,0.3072,0.44059,REACTOME_RUNX3_REGULATES_WNT_SIGNALING,0.98695159358702
MIR4701_5P,SET,107,0.012966,0.00098647,0.086779,0.44061,MIR4701_5P,0.98695159358702
GSE16697_CD4_TCELL_VS_TFH_CD...1,SET,183,0.0096347,0.00095662,0.064514,0.44064,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN,0.98695159358702
GOBP_REGULATION_OF_APPETITE,SET,20,0.030896,0.0010187,0.20694,0.44066,GOBP_REGULATION_OF_APPETITE,0.98695159358702
NAKAYA_PBMC_IMUVAC_MALE_AGE_...,SET,38,0.021119,0.00095933,0.14148,0.44067,NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP,0.98695159358702
GOMF_TYPE_II_TRANSFORMING_GR...,SET,11,0.043309,0.0010593,0.29018,0.44068,GOMF_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.98695159358702
HP_CARDIAC_VALVE_CALCIFICATI...,SET,11,0.043591,0.0010661,0.29222,0.44071,HP_CARDIAC_VALVE_CALCIFICATION,0.98695159358702
HP_COLOR_VISION_TEST_ABNORMA...,SET,9,0.049946,0.001105,0.33491,0.44072,HP_COLOR_VISION_TEST_ABNORMALITY,0.98695159358702
KIM_PTEN_TARGETS_UP,SET,17,0.031009,0.00094266,0.20796,0.44074,KIM_PTEN_TARGETS_UP,0.98695159358702
GOBP_REGULATION_OF_SYSTEMIC_...2,SET,15,0.03816,0.0010897,0.25608,0.44077,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN,0.98695159358702
HP_ACUTE_LYMPHOBLASTIC_LEUKE...,SET,40,0.020494,0.00095509,0.13756,0.44078,HP_ACUTE_LYMPHOBLASTIC_LEUKEMIA,0.98695159358702
GOBP_CELLULAR_RESPONSE_TO_AL...4,SET,36,0.021943,0.00097024,0.14729,0.44079,GOBP_CELLULAR_RESPONSE_TO_ALKALOID,0.98695159358702
MIR6793_5P,SET,56,0.017945,0.00098907,0.12049,0.4408,MIR6793_5P,0.98695159358702
GOBP_THYROID_HORMONE_METABOL...,SET,28,0.025812,0.0010068,0.17329,0.4408,GOBP_THYROID_HORMONE_METABOLIC_PROCESS,0.98695159358702
GOBP_REGULATION_OF_PHOSPHOLI...5,SET,14,0.034222,0.00094419,0.22982,0.44081,GOBP_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.98695159358702
GOBP_HORMONE_MEDIATED_APOPTO...,SET,5,0.063289,0.0010438,0.42519,0.44084,GOBP_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY,0.98695159358702
REACTOME_CIPROFLOXACIN_ADME,SET,5,0.059065,0.00097411,0.39714,0.44089,REACTOME_CIPROFLOXACIN_ADME,0.98695159358702
REACTOME_FCERI_MEDIATED_MAPK...,SET,32,0.022548,0.00094005,0.15165,0.4409,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,0.98695159358702
REACTOME_METABOLISM_OF_CARBO...,SET,267,0.0077398,0.0009261,0.052082,0.44093,REACTOME_METABOLISM_OF_CARBOHYDRATES,0.98695159358702
WP_CANCER_IMMUNOTHERAPY_BY_P...,SET,22,0.028176,0.00097429,0.18966,0.44095,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,0.98695159358702
GOBP_NEGATIVE_REGULATION_OF_...30,SET,5,0.067678,0.0011162,0.45572,0.44097,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.98695159358702
GOBP_CILIARY_NEUROTROPHIC_FA...,SET,5,0.06348,0.0010469,0.42749,0.44098,GOBP_CILIARY_NEUROTROPHIC_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.98695159358702
HP_PLACENTAL_ABRUPTION,SET,4,0.074535,0.0010995,0.50217,0.441,HP_PLACENTAL_ABRUPTION,0.98695159358702
IWANAGA_E2F1_TARGETS_INDUCED...,SET,22,0.026962,0.00093229,0.18175,0.44103,IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM,0.98695159358702
GOBP_REGULATION_OF_ADENYLATE...2,SET,42,0.021265,0.0010154,0.14335,0.44104,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.98695159358702
HP_TACHYCARDIA,SET,134,0.011306,0.00096188,0.076288,0.44109,HP_TACHYCARDIA,0.986958765209554
GOCC_SPERM_HEAD,SET,17,0.028262,0.00085916,0.19071,0.4411,GOCC_SPERM_HEAD,0.986958765209554
HP_OPEN_ANGLE_GLAUCOMA,SET,12,0.04121,0.0010527,0.27831,0.44114,HP_OPEN_ANGLE_GLAUCOMA,0.986984723831595
HP_RESPIRATORY_TRACT_INFECTI...,SET,681,0.0050472,0.00095341,0.034099,0.44117,HP_RESPIRATORY_TRACT_INFECTION,0.9869883070486
REACTOME_SHC_MEDIATED_CASCAD...1,SET,21,0.028172,0.00095178,0.1906,0.44125,REACTOME_SHC_MEDIATED_CASCADE_FGFR1,0.987102824604298
LEE_NAIVE_T_LYMPHOCYTE,SET,16,0.034259,0.0010104,0.23197,0.4413,LEE_NAIVE_T_LYMPHOCYTE,0.987102824604298
REACTOME_HCMV_EARLY_EVENTS,SET,68,0.01524,0.00092531,0.10329,0.44135,REACTOME_HCMV_EARLY_EVENTS,0.987102824604298
GSE5542_UNTREATED_VS_IFNA_AN...1,SET,179,0.0091282,0.00089647,0.061914,0.4414,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.987102824604298
KUMAR_PATHOGEN_LOAD_BY_MACRO...,SET,228,0.0084873,0.00093946,0.05758,0.44141,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,0.987102824604298
MODULE_265,SET,25,0.027901,0.0010284,0.18933,0.44142,MODULE_265,0.987102824604298
HP_SYNOSTOSIS_INVOLVING_THE_...,SET,10,0.043313,0.0010101,0.29392,0.44142,HP_SYNOSTOSIS_INVOLVING_THE_ELBOW,0.987102824604298
HP_ABNORMAL_LACRIMAL_GLAND_M...,SET,9,0.044785,0.00099083,0.30414,0.44147,HP_ABNORMAL_LACRIMAL_GLAND_MORPHOLOGY,0.987151119475005
HP_GINGIVAL_BLEEDING,SET,52,0.018799,0.00099856,0.12789,0.44157,HP_GINGIVAL_BLEEDING,0.987218595624559
HP_INCREASED_LEVEL_OF_L_FUCO...,SET,16,0.031172,0.00091936,0.21211,0.44158,HP_INCREASED_LEVEL_OF_L_FUCOSE_IN_URINE,0.987218595624559
GOBP_REGULATION_OF_BROWN_FAT...,SET,22,0.027323,0.00094476,0.18609,0.44164,GOBP_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.987218595624559
GOBP_PULMONARY_VALVE_MORPHOG...,SET,20,0.033356,0.0010998,0.22732,0.44167,GOBP_PULMONARY_VALVE_MORPHOGENESIS,0.987218595624559
MIR6867_3P,SET,105,0.012026,0.00090643,0.081984,0.44169,MIR6867_3P,0.987218595624559
GOMF_TRANSCRIPTION_COREPRESS...1,SET,174,0.0092168,0.00089257,0.062926,0.44178,GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY,0.987218595624559
GOBP_RESPONSE_TO_MANGANESE_I...,SET,16,0.032799,0.00096734,0.22404,0.4418,GOBP_RESPONSE_TO_MANGANESE_ION,0.987218595624559
MIR4652_3P,SET,290,0.0076651,0.00095524,0.052403,0.44185,MIR4652_3P,0.987218595624559
MIR4292,SET,143,0.010488,0.00092153,0.071748,0.44189,MIR4292,0.987218595624559
GCM_DFFA,SET,116,0.010656,0.00084395,0.072904,0.44189,GCM_DFFA,0.987218595624559
GNF2_HPN,SET,130,0.011361,0.00095212,0.077764,0.44192,GNF2_HPN,0.987218595624559
GOBP_METHYLGLYOXAL_METABOLIC...,SET,4,0.051045,0.00075299,0.34956,0.44195,GOBP_METHYLGLYOXAL_METABOLIC_PROCESS,0.987218595624559
SA_B_CELL_RECEPTOR_COMPLEXES,SET,22,0.026972,0.00093263,0.18474,0.44196,SA_B_CELL_RECEPTOR_COMPLEXES,0.987218595624559
VALK_AML_CLUSTER_15,SET,28,0.024407,0.00095196,0.16725,0.44199,VALK_AML_CLUSTER_15,0.987218595624559
BIOCARTA_IL7_PATHWAY,SET,16,0.032156,0.00094838,0.22049,0.44203,BIOCARTA_IL7_PATHWAY,0.987218595624559
HP_BRAIN_IMAGING_ABNORMALITY,SET,138,0.01066,0.00092026,0.07314,0.44206,HP_BRAIN_IMAGING_ABNORMALITY,0.987218595624559
GOBP_ECTODERM_DEVELOPMENT,SET,19,0.030196,0.00097039,0.20734,0.44211,GOBP_ECTODERM_DEVELOPMENT,0.987218595624559
HP_ABNORMAL_THYROID_MORPHOLO...,SET,166,0.0098511,0.00093201,0.067673,0.44213,HP_ABNORMAL_THYROID_MORPHOLOGY,0.987218595624559
NAKAMURA_CANCER_MICROENVIRON...1,SET,40,0.017981,0.00083797,0.12362,0.44218,NAKAMURA_CANCER_MICROENVIRONMENT_DN,0.987218595624559
MIR548AQ_5P,SET,444,0.0059627,0.00091553,0.040994,0.44218,MIR548AQ_5P,0.987218595624559
HP_ABNORMAL_THIRD_VENTRICLE_...,SET,14,0.035288,0.0009736,0.24281,0.44222,HP_ABNORMAL_THIRD_VENTRICLE_MORPHOLOGY,0.987218595624559
GSE43955_1H_VS_42H_ACT_CD4_T...4,SET,181,0.0091921,0.00090773,0.063265,0.44224,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.987218595624559
HP_HYPOPIGMENTATION_OF_HAIR,SET,88,0.013923,0.00096112,0.095835,0.44225,HP_HYPOPIGMENTATION_OF_HAIR,0.987218595624559
BIOCARTA_LYM_PATHWAY,SET,13,0.037899,0.0010076,0.26094,0.44226,BIOCARTA_LYM_PATHWAY,0.987218595624559
GSE27241_CTRL_VS_DIGOXIN_TRE...4,SET,175,0.0091961,0.00089309,0.063382,0.44232,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.987218595624559
WP_7Q1123_COPY_NUMBER_VARIAT...,SET,86,0.01401,0.00095611,0.096584,0.44234,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,0.987218595624559
GOMF_TRNA_PSEUDOURIDINE_SYNT...,SET,8,0.038713,0.00080752,0.26691,0.44234,GOMF_TRNA_PSEUDOURIDINE_SYNTHASE_ACTIVITY,0.987218595624559
HP_UNICORONAL_SYNOSTOSIS,SET,7,0.053855,0.0010508,0.37151,0.44237,HP_UNICORONAL_SYNOSTOSIS,0.987218595624559
GOMF_MAP_KINASE_KINASE_KINAS...2,SET,6,0.049812,0.00089988,0.34368,0.44238,GOMF_MAP_KINASE_KINASE_KINASE_KINASE_ACTIVITY,0.987218595624559
JAZAG_TGFB1_SIGNALING_VIA_SM...2,SET,98,0.012452,0.00090683,0.085934,0.4424,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,0.987218595624559
GOBP_PRESYNAPTIC_MODULATION_...,SET,33,0.022699,0.00096101,0.15665,0.4424,GOBP_PRESYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,0.987218595624559
GOBP_POSITIVE_REGULATION_OF_...112,SET,11,0.037189,0.00090956,0.25686,0.44244,GOBP_POSITIVE_REGULATION_OF_CELLULAR_SENESCENCE,0.987218595624559
GOBP_RENAL_SODIUM_EXCRETION,SET,11,0.040479,0.00099002,0.27999,0.44252,GOBP_RENAL_SODIUM_EXCRETION,0.987218595624559
GSE28726_NAIVE_VS_ACTIVATED_...4,SET,177,0.009363,0.00091443,0.064765,0.44253,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP,0.987218595624559
HP_HYPOMELANOTIC_MACULE,SET,8,0.042408,0.00088461,0.29342,0.44254,HP_HYPOMELANOTIC_MACULE,0.987218595624559
GOMF_INHIBITORY_MHC_CLASS_I_...,SET,8,0.061556,0.001284,0.42596,0.44255,GOMF_INHIBITORY_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.987218595624559
MIR4763_5P,SET,54,0.016003,0.00086618,0.11076,0.44256,MIR4763_5P,0.987218595624559
GSE43260_BTLA_POS_VS_NEG_INT...2,SET,182,0.0092296,0.00091392,0.06392,0.4426,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP,0.987218595624559
KEGG_GRAFT_VERSUS_HOST_DISEA...,SET,33,0.025037,0.00106,0.17347,0.44262,KEGG_GRAFT_VERSUS_HOST_DISEASE,0.987218595624559
HP_DECREASED_BODY_MASS_INDEX,SET,20,0.02964,0.00097725,0.20565,0.4427,HP_DECREASED_BODY_MASS_INDEX,0.987218595624559
HP_HYPOARGININEMIA,SET,6,0.042312,0.00076439,0.29369,0.44272,HP_HYPOARGININEMIA,0.987218595624559
LAKE_ADULT_KIDNEY_C21_COLLEC...,SET,98,0.013516,0.00098435,0.093822,0.44273,LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B,0.987218595624559
GSE40273_XBP1_KO_VS_WT_TREG_...2,SET,185,0.0091247,0.00091087,0.063353,0.44274,GSE40273_XBP1_KO_VS_WT_TREG_UP,0.987218595624559
MIR219A_5P,SET,141,0.010205,0.00089044,0.070871,0.44275,MIR219A_5P,0.987218595624559
GOBP_EXOCRINE_PANCREAS_DEVEL...,SET,7,0.054264,0.0010588,0.37767,0.44288,GOBP_EXOCRINE_PANCREAS_DEVELOPMENT,0.987221863190931
PAX8_B,SET,91,0.013387,0.00093971,0.093247,0.44292,PAX8_B,0.987221863190931
GCM_FANCC,SET,111,0.011219,0.00086925,0.078136,0.44292,GCM_FANCC,0.987221863190931
GSE7831_UNSTIM_VS_CPG_STIM_P...4,SET,185,0.0089948,0.0008979,0.062718,0.44298,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP,0.987221863190931
HOSHIDA_LIVER_CANCER_LATE_RE...1,SET,63,0.01578,0.00092231,0.11007,0.443,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,0.987221863190931
GOBP_RRNA_METABOLIC_PROCESS,SET,228,0.0075782,0.00083883,0.052881,0.44302,GOBP_RRNA_METABOLIC_PROCESS,0.987221863190931
HP_WIDE_PUBIC_SYMPHYSIS,SET,7,0.053116,0.0010364,0.37061,0.44302,HP_WIDE_PUBIC_SYMPHYSIS,0.987221863190931
SAKAI_CHRONIC_HEPATITIS_VS_L...2,SET,79,0.012648,0.00082747,0.08833,0.44307,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,0.987221863190931
KEGG_MEDICUS_REFERENCE_ITGA_...4,SET,22,0.027514,0.00095137,0.19216,0.44307,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,0.987221863190931
TGASTMAGC_NFE2_01,SET,172,0.0092946,0.00089496,0.064911,0.44307,TGASTMAGC_NFE2_01,0.987221863190931
GOMF_PHOSPHATIDYLINOSITOL_PH...2,SET,12,0.029217,0.00074635,0.20406,0.44308,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.987221863190931
WP_NUCLEAR_RECEPTORS,SET,36,0.020564,0.00090925,0.14374,0.44312,WP_NUCLEAR_RECEPTORS,0.987221863190931
KIM_RESPONSE_TO_TSA_AND_DECI...1,SET,8,0.040062,0.00083567,0.28025,0.44317,KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,0.987221863190931
WP_HOSTPATHOGEN_INTERACTION_...2,SET,18,0.029904,0.00093542,0.20922,0.44317,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,0.987221863190931
KEGG_MEDICUS_PATHOGEN_HCMV_U...5,SET,13,0.033646,0.00089455,0.23547,0.44319,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY,0.987221863190931
MIR302C_5P,SET,524,0.0055689,0.00092685,0.03901,0.44324,MIR302C_5P,0.987221863190931
HP_SPONDYLOLYSIS,SET,5,0.051257,0.00084533,0.35953,0.44332,HP_SPONDYLOLYSIS,0.987221863190931
WP_EICOSANOID_METABOLISM_VIA...3,SET,28,0.02266,0.00088383,0.15899,0.44333,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.987221863190931
GSE22443_NAIVE_VS_ACT_AND_IL...3,SET,185,0.0092854,0.00092691,0.065143,0.44333,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN,0.987221863190931
GOBP_MYD88_INDEPENDENT_TOLL_...,SET,16,0.028734,0.00084744,0.20162,0.44334,GOBP_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.987221863190931
WP_HIPPOYAP_SIGNALING,SET,22,0.025954,0.00089744,0.18214,0.44335,WP_HIPPOYAP_SIGNALING,0.987221863190931
HP_TRICEPS_WEAKNESS,SET,17,0.026866,0.00081672,0.18881,0.44343,HP_TRICEPS_WEAKNESS,0.987221863190931
GOBP_IMMUNOLOGICAL_SYNAPSE_F...,SET,16,0.032712,0.00096479,0.23,0.44345,GOBP_IMMUNOLOGICAL_SYNAPSE_FORMATION,0.987221863190931
GOBP_SODIUM_ION_HOMEOSTASIS,SET,46,0.020301,0.0010144,0.14277,0.44346,GOBP_SODIUM_ION_HOMEOSTASIS,0.987221863190931
WP_INFLAMMATORY_RESPONSE_PAT...,SET,28,0.024405,0.00095188,0.17167,0.44348,WP_INFLAMMATORY_RESPONSE_PATHWAY,0.987221863190931
WP_METABOLISM_OF_ALPHALINOLE...,SET,6,0.053713,0.00097037,0.3779,0.44349,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.987221863190931
GOBP_MEIOSIS_I_CELL_CYCLE_PR...,SET,120,0.010215,0.00082273,0.071911,0.44352,GOBP_MEIOSIS_I_CELL_CYCLE_PROCESS,0.987225413090816
GSE11864_CSF1_VS_CSF1_IFNG_P...2,SET,167,0.0088918,0.00084376,0.062675,0.44359,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.987302823845809
GSE14769_UNSTIM_VS_120MIN_LP...2,SET,184,0.0086808,0.00086424,0.061235,0.44363,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP,0.987302823845809
SA_MMP_CYTOKINE_CONNECTION,SET,15,0.034987,0.00099913,0.24681,0.44364,SA_MMP_CYTOKINE_CONNECTION,0.987302823845809
PID_ECADHERIN_STABILIZATION_...,SET,39,0.019045,0.0008764,0.13454,0.44372,PID_ECADHERIN_STABILIZATION_PATHWAY,0.987379185332139
GOBP_CELLULAR_RESPONSE_TO_IR...,SET,7,0.045725,0.00089222,0.32329,0.44376,GOBP_CELLULAR_RESPONSE_TO_IRON_ION,0.987379185332139
HP_ASTHENIA,SET,8,0.040713,0.00084924,0.28795,0.44378,HP_ASTHENIA,0.987379185332139
GOBP_RECEPTOR_CATABOLIC_PROC...,SET,27,0.023416,0.00089685,0.16578,0.44384,GOBP_RECEPTOR_CATABOLIC_PROCESS,0.987379185332139
HP_ABNORMALITY_OF_THE_PLANTA...,SET,159,0.0099923,0.00092539,0.070767,0.44386,HP_ABNORMALITY_OF_THE_PLANTAR_SKIN_OF_FOOT,0.987379185332139
HP_RENAL_CORTICAL_CYSTS,SET,16,0.028509,0.00084081,0.20197,0.44388,HP_RENAL_CORTICAL_CYSTS,0.987379185332139
GOBP_RECOMBINATIONAL_REPAIR,SET,165,0.0089163,0.00084104,0.063199,0.4439,GOBP_RECOMBINATIONAL_REPAIR,0.987379185332139
BIOCARTA_CBL_PATHWAY,SET,11,0.03784,0.00092548,0.26825,0.44391,BIOCARTA_CBL_PATHWAY,0.987379185332139
WP_OVERVIEW_OF_PROINFLAMMATO...,SET,121,0.01332,0.0010773,0.094465,0.44393,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,0.987379185332139
GOBP_MRNA_TRANSPORT,SET,112,0.010621,0.00082663,0.075613,0.44415,GOBP_MRNA_TRANSPORT,0.987805288923018
MIR1323,SET,285,0.0073047,0.00090258,0.052081,0.44423,MIR1323,0.987821642793196
SMID_BREAST_CANCER_RELAPSE_I...4,SET,34,0.022849,0.00098185,0.16317,0.44432,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,0.987821642793196
REACTOME_ORGANIC_ANION_TRANS...1,SET,5,0.050008,0.00082473,0.35748,0.44438,REACTOME_ORGANIC_ANION_TRANSPORT,0.987821642793196
MODULE_358,SET,71,0.014221,0.00088219,0.10171,0.4444,MODULE_358,0.987821642793196
GOBP_REGULATION_OF_CELL_POPU...,SET,1515,0.0033075,0.00090966,0.023655,0.4444,GOBP_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.987821642793196
PID_SYNDECAN_3_PATHWAY,SET,15,0.031545,0.00090083,0.2257,0.44442,PID_SYNDECAN_3_PATHWAY,0.987821642793196
GOMF_ATP_DEPENDENT_DNA_DAMAG...,SET,16,0.025119,0.00074085,0.17973,0.44442,GOMF_ATP_DEPENDENT_DNA_DAMAGE_SENSOR_ACTIVITY,0.987821642793196
GOMF_ADENINE_TRANSMEMBRANE_T...,SET,4,0.063947,0.00094332,0.45757,0.44443,GOMF_ADENINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.987821642793196
GOBP_REGULATION_OF_CORTISOL_...,SET,7,0.050031,0.00097624,0.35814,0.44445,GOBP_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS,0.987821642793196
HP_IMPAIRED_DISTAL_TACTILE_S...,SET,18,0.025913,0.00081057,0.18552,0.44446,HP_IMPAIRED_DISTAL_TACTILE_SENSATION,0.987821642793196
GOBP_POSITIVE_REGULATION_OF_...713,SET,36,0.0224,0.00099041,0.16041,0.44447,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,0.987821642793196
GOCC_PHOSPHATASE_COMPLEX,SET,49,0.016127,0.00083163,0.1157,0.44457,GOCC_PHOSPHATASE_COMPLEX,0.987908501175424
DALESSIO_TSA_RESPONSE,SET,19,0.031974,0.0010275,0.22975,0.44466,DALESSIO_TSA_RESPONSE,0.987908501175424
GOBP_DNA_LIGATION_INVOLVED_I...,SET,5,0.041775,0.00068896,0.30042,0.4447,GOBP_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR,0.987908501175424
GOBP_CYTOSOLIC_RIBOSOME_ASSE...,SET,7,0.039595,0.0007726,0.28491,0.44474,GOBP_CYTOSOLIC_RIBOSOME_ASSEMBLY,0.987908501175424
HP_LOBULATED_TONGUE,SET,15,0.02724,0.00077791,0.19618,0.44478,HP_LOBULATED_TONGUE,0.987908501175424
MODULE_445,SET,11,0.037213,0.00091015,0.26813,0.44481,MODULE_445,0.987908501175424
GSE23984_CTRL_VS_HYPOCALEMIC...1,SET,168,0.0091321,0.00086913,0.065851,0.44485,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN,0.987908501175424
GOMF_SIGNALING_RECEPTOR_REGU...,SET,489,0.0059711,0.00096095,0.043116,0.44493,GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY,0.987908501175424
SHETH_LIVER_CANCER_VS_TXNIP_...5,SET,96,0.012819,0.00092404,0.092587,0.44494,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,0.987908501175424
GSE43955_1H_VS_20H_ACT_CD4_T...3,SET,189,0.0092207,0.00093025,0.066639,0.44498,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.987908501175424
GOBP_NEGATIVE_REGULATION_OF_...593,SET,6,0.049944,0.00090227,0.36116,0.44501,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.987908501175424
GOBP_POSITIVE_REGULATION_OF_...778,SET,112,0.010632,0.00082748,0.076887,0.44501,GOBP_POSITIVE_REGULATION_OF_TRANSLATION,0.987908501175424
KEGG_MEDICUS_REFERENCE_RORA_...,SET,5,0.050209,0.00082805,0.36352,0.44507,KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION,0.987908501175424
HP_EPIPHYSEAL_DYSPLASIA,SET,28,0.022479,0.00087674,0.16277,0.44508,HP_EPIPHYSEAL_DYSPLASIA,0.987908501175424
BILD_HRAS_ONCOGENIC_SIGNATURE,SET,229,0.0083351,0.00092461,0.060459,0.44517,BILD_HRAS_ONCOGENIC_SIGNATURE,0.987908501175424
HP_BUDD_CHIARI_SYNDROME,SET,7,0.048596,0.00094824,0.35254,0.44518,HP_BUDD_CHIARI_SYNDROME,0.987908501175424
chr1p12,SET,16,0.04935,0.0014555,0.35864,0.44528,chr1p12,0.987908501175424
GSE25088_CTRL_VS_IL4_STIM_ST...1,SET,155,0.0096353,0.00088113,0.070028,0.44528,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN,0.987908501175424
GSE5679_PPARG_LIGAND_ROSIGLI...1,SET,185,0.0084382,0.00084234,0.061342,0.44529,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN,0.987908501175424
GOMF_OXIDOREDUCTASE_ACTIVITY...12,SET,4,0.068595,0.0010119,0.4989,0.44532,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_OXYGEN_AS_ACCEPTOR,0.987908501175424
GOBP_POSITIVE_REGULATION_OF_...46,SET,11,0.032599,0.00079731,0.23721,0.44535,GOBP_POSITIVE_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.987908501175424
GOBP_VACUOLE_ORGANIZATION,SET,212,0.0078354,0.00083668,0.057047,0.44538,GOBP_VACUOLE_ORGANIZATION,0.987908501175424
POMEROY_MEDULLOBLASTOMA_DESM...1,SET,52,0.016835,0.00089422,0.12259,0.44539,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,0.987908501175424
GOBP_REGULATION_OF_INTRINSIC...1,SET,160,0.0090486,0.00084061,0.065926,0.44542,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.987908501175424
WP_HEMATOPOIETIC_STEM_CELL_G...,SET,19,0.028745,0.00092377,0.20948,0.44543,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,0.987908501175424
HP_BROAD_JAW,SET,5,0.048111,0.00079346,0.35104,0.4455,HP_BROAD_JAW,0.987908501175424
GSE19923_WT_VS_E2A_KO_DP_THY...1,SET,176,0.0086538,0.0008428,0.063207,0.44555,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN,0.987908501175424
MIR1537_3P,SET,9,0.04711,0.0010423,0.34419,0.44557,MIR1537_3P,0.987908501175424
BUSSLINGER_ESOPHAGEAL_DENDRI...,SET,194,0.0088713,0.00090664,0.064823,0.44557,BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS,0.987908501175424
GOBP_CYTOSKELETON_ORGANIZATI...,SET,1361,0.0033086,0.0008664,0.024228,0.44569,GOBP_CYTOSKELETON_ORGANIZATION,0.987908501175424
GOBP_NEGATIVE_REGULATION_OF_...336,SET,6,0.055677,0.0010058,0.40768,0.44569,GOBP_NEGATIVE_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.987908501175424
ER_Q6_02,SET,235,0.0078197,0.00087858,0.057271,0.4457,ER_Q6_02,0.987908501175424
MARKEY_RB1_ACUTE_LOF_UP,SET,215,0.007844,0.00084343,0.057457,0.44571,MARKEY_RB1_ACUTE_LOF_UP,0.987908501175424
TERAMOTO_OPN_TARGETS_CLUSTER...2,SET,7,0.036818,0.00071843,0.26979,0.44572,TERAMOTO_OPN_TARGETS_CLUSTER_3,0.987908501175424
MIR3198,SET,43,0.016956,0.0008192,0.12426,0.44573,MIR3198,0.987908501175424
HP_GENERALIZED_TONIC_SEIZURE,SET,50,0.016923,0.0008815,0.12402,0.44573,HP_GENERALIZED_TONIC_SEIZURE,0.987908501175424
HP_VASCULAR_CALCIFICATION,SET,31,0.022387,0.00091867,0.16407,0.44573,HP_VASCULAR_CALCIFICATION,0.987908501175424
GARY_CD5_TARGETS_DN,SET,396,0.0055955,0.00081247,0.041046,0.44578,GARY_CD5_TARGETS_DN,0.987908501175424
HP_ABNORMAL_PREPUTIUM_MORPHO...,SET,30,0.019196,0.00077492,0.14089,0.44581,HP_ABNORMAL_PREPUTIUM_MORPHOLOGY,0.987908501175424
GOBP_CARDIAC_ATRIUM_MORPHOGE...,SET,26,0.025851,0.00097163,0.18994,0.44587,GOBP_CARDIAC_ATRIUM_MORPHOGENESIS,0.987908501175424
ROY_WOUND_BLOOD_VESSEL_UP,SET,45,0.017676,0.0008736,0.12991,0.44589,ROY_WOUND_BLOOD_VESSEL_UP,0.987908501175424
GOCC_SPERM_HEAD_PLASMA_MEMBR...,SET,6,0.047771,0.00086302,0.35111,0.44589,GOCC_SPERM_HEAD_PLASMA_MEMBRANE,0.987908501175424
GSE16522_ANTI_CD3CD28_STIM_V...4,SET,174,0.0086725,0.00083986,0.063743,0.44589,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP,0.987908501175424
NAM_FXYD5_TARGETS_DN,SET,17,0.027039,0.00082198,0.1988,0.44591,NAM_FXYD5_TARGETS_DN,0.987908501175424
WP_ANDROGEN_RECEPTOR_NETWORK...,SET,106,0.011437,0.00086607,0.084099,0.44591,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,0.987908501175424
HP_APLASIA_HYPOPLASIA_OF_THE...7,SET,58,0.015818,0.00088722,0.1163,0.44591,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_FINGER,0.987908501175424
OSADA_ASCL1_TARGETS_UP,SET,43,0.019099,0.00092274,0.14047,0.44593,OSADA_ASCL1_TARGETS_UP,0.987908501175424
MIR1306_5P,SET,45,0.016809,0.00083076,0.1237,0.44595,MIR1306_5P,0.987908501175424
HP_KETONURIA,SET,32,0.020483,0.00085397,0.15076,0.44596,HP_KETONURIA,0.987908501175424
GSE18804_BRAIN_VS_COLON_TUMO...1,SET,174,0.0091935,0.00089031,0.067719,0.44601,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN,0.987908501175424
REACTOME_P75NTR_RECRUITS_SIG...,SET,11,0.037683,0.00092165,0.27768,0.44603,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,0.987908501175424
GOBP_ORGANOPHOSPHATE_ESTER_T...,SET,144,0.0099905,0.00088087,0.073635,0.44604,GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT,0.987908501175424
REACTOME_TRNA_PROCESSING_IN_...2,SET,53,0.01529,0.00081989,0.11276,0.44607,REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS,0.987908501175424
GSE18791_UNSTIM_VS_NEWCATSLE...4,SET,176,0.0082666,0.00080509,0.060969,0.44607,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP,0.987908501175424
HP_STAGE_5_CHRONIC_KIDNEY_DI...,SET,124,0.010187,0.00083394,0.075206,0.44613,HP_STAGE_5_CHRONIC_KIDNEY_DISEASE,0.987908501175424
MIR617,SET,57,0.01484,0.00082516,0.10967,0.44618,MIR617,0.987908501175424
HP_COMMON_ATRIUM,SET,8,0.040825,0.00085159,0.30211,0.44625,HP_COMMON_ATRIUM,0.987908501175424
PID_ATR_PATHWAY,SET,38,0.01728,0.00078493,0.12789,0.44626,PID_ATR_PATHWAY,0.987908501175424
GOBP_NEGATIVE_REGULATION_OF_...117,SET,9,0.038436,0.00085036,0.28455,0.44628,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.987908501175424
ZHENG_CORD_BLOOD_C4_PUTATIVE...,SET,86,0.013081,0.00089271,0.096854,0.44628,ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT,0.987908501175424
GCM_UBE2N,SET,141,0.0095073,0.00082955,0.070413,0.4463,GCM_UBE2N,0.987908501175424
GSE41978_ID2_KO_AND_BIM_KO_V...1,SET,177,0.0088881,0.00086805,0.065842,0.44631,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.987908501175424
HP_ABNORMAL_MALE_GERM_CELL_M...,SET,57,0.015115,0.00084049,0.11205,0.44635,HP_ABNORMAL_MALE_GERM_CELL_MORPHOLOGY,0.987908501175424
WP_EXTRACELLULAR_VESICLEMEDI...,SET,29,0.022124,0.00087816,0.16412,0.44638,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,0.987908501175424
GOBP_POSITIVE_REGULATION_OF_...693,SET,5,0.05298,0.00087375,0.39345,0.44644,GOBP_POSITIVE_REGULATION_OF_SARCOMERE_ORGANIZATION,0.987908501175424
GOBP_L_SERINE_METABOLIC_PROC...,SET,11,0.032481,0.00079442,0.24154,0.44651,GOBP_L_SERINE_METABOLIC_PROCESS,0.987908501175424
GOCC_TIGHT_JUNCTION,SET,116,0.011312,0.00089589,0.084113,0.44651,GOCC_TIGHT_JUNCTION,0.987908501175424
HP_ACANTHOCYTOSIS,SET,10,0.036145,0.0008429,0.26903,0.44656,HP_ACANTHOCYTOSIS,0.987908501175424
GOBP_EXTRACELLULAR_MATRIX_DI...,SET,58,0.015984,0.00089653,0.11906,0.4466,GOBP_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.987908501175424
GSE3982_NEUTROPHIL_VS_TH2_DN,SET,182,0.0079365,0.00078588,0.059148,0.44663,GSE3982_NEUTROPHIL_VS_TH2_DN,0.987908501175424
REACTOME_NEGATIVE_REGULATION...3,SET,32,0.021788,0.00090836,0.16239,0.44664,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,0.987908501175424
DESCARTES_FETAL_STOMACH_ENS_...2,SET,64,0.015305,0.0009016,0.11408,0.44664,DESCARTES_FETAL_STOMACH_ENS_NEURONS,0.987908501175424
GOMF_URIDYLYLTRANSFERASE_ACT...,SET,5,0.042301,0.00069764,0.31565,0.4467,GOMF_URIDYLYLTRANSFERASE_ACTIVITY,0.987908501175424
GSE21670_UNTREATED_VS_IL6_TR...3,SET,180,0.0083558,0.00082289,0.06237,0.44671,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.987908501175424
GOBP_DEFENSE_RESPONSE_TO_BAC...,SET,274,0.0077605,0.00094049,0.057977,0.44676,GOBP_DEFENSE_RESPONSE_TO_BACTERIUM,0.987908501175424
GSE17721_PAM3CSK4_VS_GADIQUI...1,SET,180,0.0085496,0.00084197,0.063888,0.44677,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN,0.987908501175424
MIR4739,SET,127,0.010598,0.00087798,0.079255,0.44681,MIR4739,0.987908501175424
GOMF_NUCLEAR_RETINOID_X_RECE...,SET,17,0.027691,0.00084181,0.20705,0.44681,GOMF_NUCLEAR_RETINOID_X_RECEPTOR_BINDING,0.987908501175424
GSE360_CTRL_VS_L_DONOVANI_MA...1,SET,175,0.0086207,0.00083721,0.064489,0.44683,GSE360_CTRL_VS_L_DONOVANI_MAC_DN,0.987908501175424
MIR6887_3P,SET,178,0.0088233,0.00086413,0.066054,0.44687,MIR6887_3P,0.987908501175424
GOCC_CYTOPLASMIC_UBIQUITIN_L...,SET,6,0.048506,0.0008763,0.36323,0.44688,GOCC_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX,0.987908501175424
HP_EMBRYONAL_NEOPLASM,SET,73,0.01417,0.00089129,0.10614,0.4469,HP_EMBRYONAL_NEOPLASM,0.987908501175424
REACTOME_ACTIVATION_OF_PUMA_...,SET,9,0.041184,0.00091116,0.30863,0.44692,REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.987908501175424
HP_DISTAL_MUSCLE_WEAKNESS,SET,205,0.0077962,0.0008188,0.058426,0.44692,HP_DISTAL_MUSCLE_WEAKNESS,0.987908501175424
HP_RECURRENT_PANCREATITIS,SET,11,0.043308,0.0010592,0.32476,0.44696,HP_RECURRENT_PANCREATITIS,0.987908501175424
REACTOME_NGF_STIMULATED_TRAN...,SET,38,0.019288,0.00087614,0.1448,0.44702,REACTOME_NGF_STIMULATED_TRANSCRIPTION,0.987908501175424
ZNF184_TARGET_GENES,SET,1078,0.0035244,0.00082818,0.026461,0.44702,ZNF184_TARGET_GENES,0.987908501175424
GOBP_POSITIVE_REGULATION_OF_...162,SET,9,0.035417,0.00078357,0.26619,0.44708,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_BINDING,0.987908501175424
GOBP_HIPPOCAMPUS_DEVELOPMENT,SET,90,0.012505,0.00087296,0.094048,0.44711,GOBP_HIPPOCAMPUS_DEVELOPMENT,0.987908501175424
BROWNE_HCMV_INFECTION_18HR_UP,SET,156,0.0090475,0.00083003,0.068052,0.44712,BROWNE_HCMV_INFECTION_18HR_UP,0.987908501175424
REACTOME_ANTIGEN_ACTIVATES_B...,SET,27,0.021686,0.00083061,0.16331,0.44718,REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,0.987908501175424
chr3q22,SET,54,0.031959,0.0017299,0.24076,0.4472,chr3q22,0.987908501175424
WP_TCELL_ACTIVATION_SARSCOV2,SET,86,0.012868,0.00087823,0.09699,0.44722,WP_TCELL_ACTIVATION_SARSCOV2,0.987908501175424
REACTOME_CD22_MEDIATED_BCR_R...,SET,4,0.065418,0.000965,0.49309,0.44723,REACTOME_CD22_MEDIATED_BCR_REGULATION,0.987908501175424
REACTOME_NETRIN_MEDIATED_REP...,SET,8,0.042294,0.00088224,0.31899,0.44726,REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS,0.987908501175424
REACTOME_PROPIONYL_COA_CATAB...,SET,4,0.06522,0.00096209,0.49192,0.44726,REACTOME_PROPIONYL_COA_CATABOLISM,0.987908501175424
MIR561_5P,SET,131,0.0099061,0.00083337,0.074759,0.44729,MIR561_5P,0.987908501175424
PID_INTEGRIN_A9B1_PATHWAY,SET,22,0.026779,0.00092595,0.20223,0.44733,PID_INTEGRIN_A9B1_PATHWAY,0.987908501175424
TTTGTAG_MIR520D,SET,310,0.0067115,0.00086428,0.050701,0.44735,TTTGTAG_MIR520D,0.987908501175424
ACCAAAG_MIR9,SET,467,0.0053045,0.00083476,0.040081,0.44736,ACCAAAG_MIR9,0.987908501175424
GOCC_MICROVILLUS,SET,94,0.01162,0.00082893,0.087835,0.44738,GOCC_MICROVILLUS,0.987908501175424
GCM_SMARCD1,SET,90,0.011578,0.00080827,0.08766,0.44746,GCM_SMARCD1,0.988003773584906
MIR760,SET,116,0.010057,0.00079647,0.076173,0.44748,MIR760,0.988003773584906
GR_Q6_01,SET,247,0.0074464,0.00085745,0.056517,0.44759,GR_Q6_01,0.988080041870202
HP_GLOBAL_BRAIN_ATROPHY,SET,58,0.014686,0.0008237,0.11164,0.44767,HP_GLOBAL_BRAIN_ATROPHY,0.988080041870202
GOBP_NEGATIVE_REGULATION_OF_...108,SET,351,0.0059721,0.00081742,0.045407,0.44768,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE,0.988080041870202
MARIADASON_RESPONSE_TO_BUTYR...2,SET,7,0.044968,0.00087745,0.34206,0.44771,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2,0.988080041870202
REACTOME_PEROXISOMAL_PROTEIN...,SET,60,0.014446,0.00082408,0.10996,0.44774,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,0.988080041870202
GSE15750_DAY6_VS_DAY10_EFF_C...1,SET,180,0.0082214,0.00080965,0.06261,0.44777,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN,0.988080041870202
GOBP_SNO_S_RNA_METABOLIC_PRO...,SET,11,0.033836,0.00082756,0.25803,0.44784,GOBP_SNO_S_RNA_METABOLIC_PROCESS,0.988080041870202
GOBP_PROTEIN_LOCALIZATION_TO...35,SET,11,0.026605,0.00065069,0.203,0.44787,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_BODY,0.988080041870202
GOBP_REGULATION_OF_DENDRITE_...2,SET,24,0.025495,0.00092072,0.1947,0.44791,GOBP_REGULATION_OF_DENDRITE_EXTENSION,0.988080041870202
GOBP_VASCULAR_ASSOCIATED_SMO...1,SET,11,0.034505,0.00084393,0.2635,0.44791,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.988080041870202
WP_ESTRADIOL_REGULATION_IN_P...,SET,5,0.053353,0.00087991,0.40767,0.44794,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.988080041870202
MIKKELSEN_PARTIALLY_REPROGRA...,SET,9,0.038983,0.00086247,0.2981,0.44798,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,0.988080041870202
HP_INCREASED_T_CELL_COUNT,SET,4,0.062339,0.00091959,0.47671,0.44798,HP_INCREASED_T_CELL_COUNT,0.988080041870202
KEGG_MEDICUS_VARIANT_ESR1_PO...,SET,5,0.056705,0.00093519,0.43372,0.44799,KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.988080041870202
GOBP_LOCOMOTOR_RHYTHM,SET,16,0.028827,0.00085019,0.22062,0.44802,GOBP_LOCOMOTOR_RHYTHM,0.988080041870202
GOBP_REGULATION_OF_RIBOSOME_...,SET,6,0.043968,0.00079431,0.3365,0.44802,GOBP_REGULATION_OF_RIBOSOME_BIOGENESIS,0.988080041870202
MIR6868_5P,SET,111,0.010435,0.00080853,0.079934,0.44807,MIR6868_5P,0.988080041870202
GOBP_REGULATION_OF_LYASE_ACT...,SET,53,0.016121,0.00086445,0.12351,0.44808,GOBP_REGULATION_OF_LYASE_ACTIVITY,0.988080041870202
GSE3982_EFF_MEMORY_CD4_TCELL...1,SET,172,0.0084309,0.00081179,0.064652,0.44812,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN,0.988080041870202
GOBP_CELL_CELL_SIGNALING,SET,1198,0.0035114,0.00086682,0.026932,0.44813,GOBP_CELL_CELL_SIGNALING,0.988080041870202
MARKS_ACETYLATED_NON_HISTONE...,SET,11,0.033079,0.00080905,0.25375,0.44814,MARKS_ACETYLATED_NON_HISTONE_PROTEINS,0.988080041870202
GOBP_POSITIVE_REGULATION_OF_...4,SET,9,0.039568,0.00087541,0.30351,0.44814,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.988080041870202
MANNO_MIDBRAIN_NEUROTYPES_HN...5,SET,197,0.0083611,0.00086101,0.064348,0.44831,MANNO_MIDBRAIN_NEUROTYPES_HNPROG,0.988102979208925
GOBP_TRANSFORMING_GROWTH_FAC...1,SET,11,0.038675,0.00094591,0.29783,0.44834,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.988102979208925
GOBP_REGULATION_OF_THYROID_H...,SET,7,0.044399,0.00086634,0.34195,0.44835,GOBP_REGULATION_OF_THYROID_HORMONE_GENERATION,0.988102979208925
LET_7D_3P,SET,8,0.043793,0.0009135,0.33756,0.44839,LET_7D_3P,0.988102979208925
GOBP_REGULATION_OF_FAT_CELL_...1,SET,121,0.010883,0.00088014,0.083921,0.44841,GOBP_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.988102979208925
GNF2_SMC4L1,SET,80,0.011863,0.00078098,0.091531,0.44844,GNF2_SMC4L1,0.988102979208925
GOBP_AUTOPHAGIC_CELL_DEATH,SET,9,0.036105,0.00079879,0.27866,0.44845,GOBP_AUTOPHAGIC_CELL_DEATH,0.988102979208925
WP_GENES_RELATED_TO_PRIMARY_...,SET,88,0.010831,0.00074771,0.08361,0.44846,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,0.988102979208925
GOBP_ACUTE_INFLAMMATORY_RESP...1,SET,99,0.012267,0.0008979,0.094713,0.44848,GOBP_ACUTE_INFLAMMATORY_RESPONSE,0.988102979208925
GSE17721_LPS_VS_CPG_8H_BMDC_...1,SET,167,0.0084841,0.00080507,0.065513,0.44848,GSE17721_LPS_VS_CPG_8H_BMDC_DN,0.988102979208925
GSE37605_C57BL6_VS_NOD_FOXP3...7,SET,177,0.0083096,0.00081155,0.06417,0.44848,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN,0.988102979208925
ATAACCT_MIR154,SET,59,0.01364,0.00077158,0.10539,0.44851,ATAACCT_MIR154,0.988102979208925
GSE10240_CTRL_VS_IL22_STIM_P...2,SET,182,0.0083513,0.00082695,0.064542,0.44852,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.988102979208925
GOBP_THYROID_HORMONE_GENERAT...,SET,22,0.024633,0.00085176,0.19051,0.44856,GOBP_THYROID_HORMONE_GENERATION,0.988128465487735
GSE2706_LPS_VS_R848_AND_LPS_...4,SET,166,0.0085933,0.00081301,0.066599,0.44867,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP,0.988298533696478
MIR134_5P,SET,68,0.013719,0.00083298,0.10643,0.44872,MIR134_5P,0.988298533696478
TAGHAVI_NEOPLASTIC_TRANSFORM...,SET,11,0.029924,0.00073186,0.23231,0.44875,TAGHAVI_NEOPLASTIC_TRANSFORMATION,0.988298533696478
GROSS_HIF1A_TARGETS_UP,SET,7,0.049383,0.0009636,0.38382,0.44881,GROSS_HIF1A_TARGETS_UP,0.988298533696478
GOBP_COLLAGEN_BIOSYNTHETIC_P...,SET,39,0.019475,0.00089618,0.15137,0.44881,GOBP_COLLAGEN_BIOSYNTHETIC_PROCESS,0.988298533696478
GOMF_ARACHIDONIC_ACID_MONOOX...,SET,18,0.030483,0.00095353,0.23699,0.44883,GOMF_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY,0.988298533696478
HP_BILATERAL_CAMPTODACTYLY,SET,5,0.046419,0.00076554,0.36127,0.44888,HP_BILATERAL_CAMPTODACTYLY,0.988298533696478
HP_FALCIFORM_RETINAL_FOLD,SET,5,0.052088,0.00085903,0.40557,0.4489,HP_FALCIFORM_RETINAL_FOLD,0.988298533696478
chr4q21,SET,60,0.026761,0.0015266,0.20848,0.44893,chr4q21,0.988298533696478
ZNF549_TARGET_GENES,SET,1015,0.0035049,0.00080061,0.02731,0.44894,ZNF549_TARGET_GENES,0.988298533696478
GGCNKCCATNK_UNKNOWN,SET,111,0.010028,0.000777,0.078151,0.44895,GGCNKCCATNK_UNKNOWN,0.988298533696478
GOCC_CONDENSED_NUCLEAR_CHROM...,SET,70,0.012239,0.00075388,0.095478,0.449,GOCC_CONDENSED_NUCLEAR_CHROMOSOME,0.988332937713635
ZNF169_TARGET_GENES,SET,35,0.016722,0.00072904,0.13057,0.44905,ZNF169_TARGET_GENES,0.988332937713635
GSE35435_RESTING_VS_IL4_TREA...1,SET,170,0.0083375,0.00079816,0.065165,0.4491,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN,0.988332937713635
GSE6259_DEC205_POS_DC_VS_BCE...2,SET,139,0.0099918,0.00086567,0.078093,0.4491,GSE6259_DEC205_POS_DC_VS_BCELL_UP,0.988332937713635
PASTURAL_RIZ1_TARGETS_DN,SET,5,0.055854,0.00092115,0.43663,0.44911,PASTURAL_RIZ1_TARGETS_DN,0.988332937713635
HOFMANN_MYELODYSPLASTIC_SYND...2,SET,8,0.04123,0.00086004,0.32286,0.44919,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP,0.988332937713635
REACTOME_RESPONSE_OF_MTB_TO_...,SET,21,0.023205,0.00078396,0.18176,0.44921,REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,0.988332937713635
GOBP_DOUBLE_STRAND_BREAK_REP...4,SET,12,0.030863,0.00078839,0.24178,0.44921,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_BREAK_INDUCED_REPLICATION,0.988332937713635
BOYAULT_LIVER_CANCER_SUBCLAS...10,SET,51,0.016848,0.00088628,0.13202,0.44923,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,0.988332937713635
HP_ABNORMAL_LOWER_LIMB_MOTOR...,SET,5,0.047603,0.00078508,0.37317,0.44925,HP_ABNORMAL_LOWER_LIMB_MOTOR_EVOKED_POTENTIALS,0.988332937713635
GOBP_RESPONSE_TO_INACTIVITY,SET,12,0.034598,0.00088379,0.2716,0.44932,GOBP_RESPONSE_TO_INACTIVITY,0.988424368630926
SMID_BREAST_CANCER_RELAPSE_I...9,SET,22,0.023611,0.00081643,0.1856,0.44939,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,0.988515787974684
GSE37301_HEMATOPOIETIC_STEM_...1,SET,118,0.010598,0.00084651,0.083418,0.44945,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN,0.988585200303778
FULLER_PBMC_F_TULARENSIS_VAC...10,SET,16,0.027844,0.0008212,0.2197,0.44958,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_DN,0.988634543614397
PELLICCIOTTA_HDAC_IN_ANTIGEN...2,SET,60,0.012732,0.00072628,0.10049,0.44959,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,0.988634543614397
GOBP_REGULATION_OF_CILIUM_BE...2,SET,9,0.035312,0.00078126,0.2787,0.44959,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY,0.988634543614397
JIANG_TIP30_TARGETS_UP,SET,42,0.017445,0.00083302,0.13772,0.4496,JIANG_TIP30_TARGETS_UP,0.988634543614397
MIR4666A_3P,SET,502,0.0050553,0.00082402,0.039972,0.44968,MIR4666A_3P,0.988634543614397
GOBP_PROSTATIC_BUD_FORMATION,SET,7,0.050074,0.00097709,0.3959,0.44968,GOBP_PROSTATIC_BUD_FORMATION,0.988634543614397
RAMJAUN_APOPTOSIS_BY_TGFB1_V...2,SET,6,0.045302,0.00081842,0.35835,0.4497,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP,0.988634543614397
GOBP_DNA_TEMPLATED_TRANSCRIP...2,SET,175,0.0077629,0.00075391,0.061402,0.4497,GOBP_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.988634543614397
HP_ABNORMAL_BRONCHOALVEOLAR_...,SET,14,0.033536,0.00092524,0.26584,0.44981,HP_ABNORMAL_BRONCHOALVEOLAR_LAVAGE_FLUID_MORPHOLOGY,0.988692164674635
HP_PERIPORTAL_FIBROSIS,SET,10,0.033267,0.0007758,0.26371,0.44981,HP_PERIPORTAL_FIBROSIS,0.988692164674635
HP_CHRONIC_SINUSITIS,SET,57,0.013773,0.00076582,0.1092,0.44982,HP_CHRONIC_SINUSITIS,0.988692164674635
HP_SEA_BLUE_HISTIOCYTOSIS,SET,5,0.06039,0.00099597,0.479,0.44984,HP_SEA_BLUE_HISTIOCYTOSIS,0.988692164674635
GOBP_EMBRYONIC_CAMERA_TYPE_E...1,SET,37,0.019157,0.0008587,0.15209,0.44988,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.988717554066018
GOBP_REGULATION_OF_DNA_STRAN...,SET,17,0.024615,0.00074829,0.19567,0.44995,GOBP_REGULATION_OF_DNA_STRAND_ELONGATION,0.988803915929203
GSE33424_CD161_HIGH_VS_NEG_C...2,SET,189,0.0081036,0.00081755,0.064473,0.44999,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP,0.988803915929203
GOBP_NERVOUS_SYSTEM_PROCESS,SET,1294,0.0034461,0.00088164,0.027435,0.45002,GOBP_NERVOUS_SYSTEM_PROCESS,0.988803915929203
GOBP_CELLULAR_LIPID_CATABOLI...,SET,222,0.0071816,0.00078453,0.057193,0.45004,GOBP_CELLULAR_LIPID_CATABOLIC_PROCESS,0.988803915929203
IGARASHI_ATF4_TARGETS_UP,SET,4,0.07154,0.0010553,0.57005,0.45007,IGARASHI_ATF4_TARGETS_UP,0.988803915929203
HP_PROMINENT_INTERPHALANGEAL...,SET,6,0.04316,0.00077972,0.34409,0.45009,HP_PROMINENT_INTERPHALANGEAL_JOINTS,0.988803915929203
REACTOME_ECM_PROTEOGLYCANS,SET,73,0.013372,0.0008411,0.10694,0.45025,REACTOME_ECM_PROTEOGLYCANS,0.98900001579679
JINESH_BLEBBISHIELD_TRANSFOR...1,SET,248,0.0067925,0.00078371,0.054353,0.45027,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,0.98900001579679
HP_ABNORMAL_PERIPHERAL_NERVO...2,SET,151,0.0085409,0.000771,0.068338,0.45027,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_PHYSIOLOGY,0.98900001579679
BIOCARTA_CHEMICAL_PATHWAY,SET,18,0.02557,0.00079984,0.20481,0.45032,BIOCARTA_CHEMICAL_PATHWAY,0.98900001579679
GOBP_MATING_BEHAVIOR,SET,36,0.019773,0.00087429,0.15843,0.45034,GOBP_MATING_BEHAVIOR,0.98900001579679
GOBP_AGGRESSIVE_BEHAVIOR,SET,8,0.045323,0.00094542,0.36324,0.45035,GOBP_AGGRESSIVE_BEHAVIOR,0.98900001579679
GSE9509_10MIN_VS_30MIN_LPS_A...1,SET,142,0.0091373,0.00080007,0.073297,0.4504,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.989028752843063
REACTOME_G2_M_DNA_REPLICATIO...,SET,5,0.044583,0.00073527,0.35784,0.45042,REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT,0.989028752843063
MIR3160_5P,SET,188,0.0081513,0.0008202,0.065608,0.45056,MIR3160_5P,0.989195967028802
GOBP_ESTABLISHMENT_OF_SERTOL...,SET,4,0.041906,0.00061818,0.33755,0.4506,GOBP_ESTABLISHMENT_OF_SERTOLI_CELL_BARRIER,0.989195967028802
MIR6754_3P,SET,88,0.011586,0.00079983,0.093351,0.45061,MIR6754_3P,0.989195967028802
MIR6892_5P,SET,84,0.011226,0.00075724,0.090445,0.45061,MIR6892_5P,0.989195967028802
HP_RHABDOMYOMA,SET,5,0.053557,0.00088327,0.43205,0.45067,HP_RHABDOMYOMA,0.989265196109392
MORF_ACP1,SET,198,0.0069998,0.00072264,0.056549,0.45074,MORF_ACP1,0.989356366047745
GSE12003_4D_VS_8D_CULTURE_BM...2,SET,153,0.0084995,0.00077228,0.068704,0.45077,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP,0.989359731607199
GOBP_REGULATION_OF_STRIATED_...3,SET,18,0.028898,0.00090395,0.23373,0.4508,GOBP_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,0.989363096741601
SHIN_B_CELL_LYMPHOMA_CLUSTER...4,SET,18,0.025921,0.00081084,0.20994,0.45087,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,0.989454243227884
REACTOME_BETA_OXIDATION_OF_O...,SET,5,0.048821,0.00080516,0.39608,0.45095,REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA,0.989567322262912
GSE360_L_DONOVANI_VS_B_MALAY...7,SET,179,0.0077694,0.00076303,0.06311,0.45101,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.9896127074787
HP_NECK_MUSCLE_WEAKNESS,SET,84,0.010993,0.00074152,0.089368,0.45105,HP_NECK_MUSCLE_WEAKNESS,0.9896127074787
REACTOME_CELL_SURFACE_INTERA...,SET,131,0.010189,0.00085716,0.082962,0.45113,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,0.9896127074787
HP_GLUCOCORTOCOID_INSENSITIV...,SET,5,0.051692,0.00085252,0.42089,0.45113,HP_GLUCOCORTOCOID_INSENSITIVE_PRIMARY_HYPERALDOSTERONISM,0.9896127074787
PEREZ_TP53_TARGETS,SET,1026,0.0034179,0.00078471,0.027842,0.45115,PEREZ_TP53_TARGETS,0.9896127074787
GCM_SIRT2,SET,40,0.016163,0.00075323,0.13166,0.45115,GCM_SIRT2,0.9896127074787
GOMF_NADPLUS_PROTEIN_ADP_RIB...,SET,28,0.019603,0.00076459,0.15976,0.45117,GOMF_NADPLUS_PROTEIN_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.9896127074787
HP_ORTHOKERATOSIS,SET,18,0.025759,0.00080576,0.21013,0.45122,HP_ORTHOKERATOSIS,0.989619096676927
HP_INCREASED_CIRCULATING_AND...,SET,17,0.024547,0.00074622,0.20048,0.45127,HP_INCREASED_CIRCULATING_ANDROGEN_CONCENTRATION,0.989619096676927
GOBP_GPI_ANCHOR_METABOLIC_PR...,SET,30,0.017308,0.00069874,0.14159,0.45136,GOBP_GPI_ANCHOR_METABOLIC_PROCESS,0.989619096676927
GOBP_POSITIVE_REGULATION_OF_...276,SET,23,0.023768,0.00084032,0.19467,0.45141,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,0.989619096676927
GOBP_SMOOTH_MUSCLE_CELL_APOP...,SET,29,0.019116,0.00075877,0.15666,0.45144,GOBP_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.989619096676927
KAPOSI_LIVER_CANCER_MET_DN,SET,5,0.04954,0.00081702,0.40654,0.45151,KAPOSI_LIVER_CANCER_MET_DN,0.989619096676927
MIR2861,SET,83,0.013375,0.00089678,0.10979,0.45152,MIR2861,0.989619096676927
MODULE_82,SET,22,0.019659,0.00067976,0.16138,0.45152,MODULE_82,0.989619096676927
GOBP_POSITIVE_REGULATION_OF_...628,SET,451,0.00488,0.00075502,0.040113,0.45159,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION,0.989619096676927
GOBP_TRNA_THIO_MODIFICATION,SET,5,0.045551,0.00075123,0.37446,0.45159,GOBP_TRNA_THIO_MODIFICATION,0.989619096676927
GOBP_ACROSOME_REACTION,SET,39,0.017336,0.00079775,0.14265,0.45164,GOBP_ACROSOME_REACTION,0.989619096676927
GOBP_DITERPENOID_BIOSYNTHETI...,SET,10,0.035692,0.00083235,0.29373,0.45164,GOBP_DITERPENOID_BIOSYNTHETIC_PROCESS,0.989619096676927
GOBP_POSITIVE_REGULATION_OF_...391,SET,4,0.053338,0.00078682,0.43905,0.45165,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_APOPTOTIC_PROCESS,0.989619096676927
GSE37605_FOXP3_FUSION_GFP_VS...3,SET,151,0.0087611,0.00079087,0.072118,0.45166,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN,0.989619096676927
GSE10094_LCMV_VS_LISTERIA_IN...1,SET,178,0.007832,0.00076705,0.06454,0.45171,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN,0.989619096676927
GOBP_PROTEIN_PEPTIDYL_PROLYL...,SET,17,0.022723,0.00069079,0.18739,0.45174,GOBP_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION,0.989619096676927
chr16q13,SET,25,0.032255,0.0011888,0.26622,0.45178,chr16q13,0.989619096676927
REACTOME_SIGNALING_BY_EGFR_I...,SET,24,0.021066,0.00076078,0.174,0.45182,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,0.989619096676927
GSE5099_UNSTIM_VS_MCSF_TREAT...3,SET,174,0.0077317,0.00074875,0.063977,0.45191,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN,0.989619096676927
ZSCAN26_TARGET_GENES,SET,4,0.0553,0.00081575,0.45786,0.45193,ZSCAN26_TARGET_GENES,0.989619096676927
REACTOME_ACTIVATION_OF_NOXA_...,SET,5,0.052146,0.00086,0.43196,0.45196,REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.989619096676927
HP_BONE_CYST,SET,27,0.019547,0.00074868,0.16235,0.45208,HP_BONE_CYST,0.989619096676927
GOBP_NUCLEOBASE_CONTAINING_C...,SET,207,0.0068811,0.00072616,0.057208,0.45213,GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.989619096676927
HP_ABNORMAL_CIRCULATING_PORP...,SET,8,0.036081,0.00075262,0.30006,0.45215,HP_ABNORMAL_CIRCULATING_PORPHYRIN_CONCENTRATION,0.989619096676927
CARD_MIR302A_TARGETS,SET,74,0.012587,0.00079708,0.1047,0.45216,CARD_MIR302A_TARGETS,0.989619096676927
GOBP_ADP_BIOSYNTHETIC_PROCESS,SET,5,0.05193,0.00085644,0.43216,0.45218,GOBP_ADP_BIOSYNTHETIC_PROCESS,0.989619096676927
GSE17721_CPG_VS_GARDIQUIMOD_...13,SET,177,0.0076525,0.00074737,0.063754,0.45223,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN,0.989619096676927
GSE15330_MEGAKARYOCYTE_ERYTH...4,SET,175,0.007618,0.00073983,0.063508,0.45226,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.989619096676927
FARMER_BREAST_CANCER_APOCRIN...1,SET,297,0.0061995,0.00078172,0.051715,0.45229,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,0.989619096676927
GSE46606_IRF4MID_VS_WT_CD40L...2,SET,171,0.0075663,0.00072644,0.063118,0.45229,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.989619096676927
GOBP_CHOLINE_TRANSPORT,SET,9,0.035662,0.00078898,0.29791,0.45236,GOBP_CHOLINE_TRANSPORT,0.989619096676927
ATM_DN.V1_DN,SET,124,0.0098175,0.0008037,0.082039,0.45237,ATM_DN.V1_DN,0.989619096676927
GOBP_INTRINSIC_APOPTOTIC_SIG...4,SET,41,0.014696,0.00069335,0.12288,0.4524,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,0.989619096676927
ERWIN_COHEN_BLOOD_LIVE_VACCI...,SET,617,0.0042275,0.00076149,0.035353,0.45241,ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP,0.989619096676927
GOBP_SULFUR_AMINO_ACID_METAB...,SET,30,0.020761,0.00083814,0.17369,0.45243,GOBP_SULFUR_AMINO_ACID_METABOLIC_PROCESS,0.989619096676927
GSE17974_CTRL_VS_ACT_IL4_AND...16,SET,161,0.0082738,0.00077101,0.069286,0.45247,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP,0.989619096676927
GOBP_REGULATION_OF_INTERLEUK...2,SET,4,0.055686,0.00082145,0.46639,0.45248,GOBP_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,0.989619096676927
HP_ADVANCED_OSSIFICATION_OF_...,SET,10,0.031169,0.00072688,0.26123,0.45251,HP_ADVANCED_OSSIFICATION_OF_CARPAL_BONES,0.989619096676927
HP_CLEFT_PALATE,SET,510,0.0045635,0.00074959,0.038241,0.45251,HP_CLEFT_PALATE,0.989619096676927
GSE29618_PRE_VS_DAY7_POST_TI...1,SET,172,0.0072523,0.00069832,0.060849,0.45256,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN,0.989619096676927
GOBP_REGULATION_OF_DNA_DAMAG...3,SET,6,0.041234,0.00074493,0.34613,0.45259,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.989619096676927
GSE17721_CTRL_VS_CPG_2H_BMDC...1,SET,189,0.0076582,0.00077262,0.064298,0.4526,GSE17721_CTRL_VS_CPG_2H_BMDC_DN,0.989619096676927
MIR5008_3P,SET,151,0.0086573,0.0007815,0.072785,0.45266,MIR5008_3P,0.989619096676927
REACTOME_EARLY_SARS_COV_2_IN...,SET,34,0.017317,0.00074413,0.14566,0.45269,REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS,0.989619096676927
WP_GLUTATHIONE_METABOLISM,SET,16,0.025814,0.00076134,0.21729,0.45272,WP_GLUTATHIONE_METABOLISM,0.989619096676927
MIR371B_5P,SET,856,0.0035666,0.0007516,0.030039,0.45274,MIR371B_5P,0.989619096676927
BMI1_DN.V1_UP,SET,137,0.0094498,0.00081285,0.079576,0.45274,BMI1_DN.V1_UP,0.989619096676927
SMID_BREAST_CANCER_BASAL_UP,SET,588,0.0044809,0.00078858,0.037772,0.45278,SMID_BREAST_CANCER_BASAL_UP,0.989619096676927
BIOCARTA_RAN_PATHWAY,SET,5,0.038787,0.00063969,0.32701,0.45279,BIOCARTA_RAN_PATHWAY,0.989619096676927
REACTOME_REGULATION_OF_GLYCO...,SET,11,0.028688,0.00070163,0.24188,0.4528,REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,0.989619096676927
GOBP_NEGATIVE_REGULATION_OF_...289,SET,181,0.0078389,0.0007741,0.066107,0.45281,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE,0.989619096676927
GSE37605_TREG_VS_TCONV_NOD_F...2,SET,133,0.0092941,0.00078778,0.078453,0.45285,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP,0.989619096676927
GOBP_REGULATION_OF_ENDODEOXY...,SET,8,0.037592,0.00078415,0.31793,0.45294,GOBP_REGULATION_OF_ENDODEOXYRIBONUCLEASE_ACTIVITY,0.989619096676927
GOMF_NAD_DEPENDENT_HISTONE_D...,SET,5,0.042403,0.00069932,0.35882,0.45297,GOMF_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY,0.989619096676927
GOMF_U4_SNRNA_BINDING,SET,5,0.031895,0.00052602,0.2699,0.45297,GOMF_U4_SNRNA_BINDING,0.989619096676927
GOBP_NEGATIVE_REGULATION_OF_...449,SET,3,0.063084,0.00080593,0.53415,0.45299,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.989619096676927
GCAAGGA_MIR502,SET,65,0.012189,0.00072363,0.10324,0.45301,GCAAGGA_MIR502,0.989619096676927
GSE22886_NAIVE_BCELL_VS_NEUT...1,SET,179,0.0079817,0.00078387,0.067621,0.45302,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN,0.989619096676927
HP_FOCAL_CORTICAL_DYSPLASIA,SET,15,0.026377,0.00075325,0.2235,0.45303,HP_FOCAL_CORTICAL_DYSPLASIA,0.989619096676927
GOCC_AP_2_ADAPTOR_COMPLEX,SET,11,0.031128,0.00076132,0.26395,0.45306,GOCC_AP_2_ADAPTOR_COMPLEX,0.989619096676927
HP_FIBER_TYPE_GROUPING,SET,10,0.027531,0.00064203,0.23354,0.45308,HP_FIBER_TYPE_GROUPING,0.989619096676927
HP_HYPOMETRIC_SACCADES,SET,13,0.028938,0.00076938,0.24547,0.45308,HP_HYPOMETRIC_SACCADES,0.989619096676927
MIR21_5P,SET,133,0.0089627,0.0007597,0.0761,0.45312,MIR21_5P,0.989619096676927
GSE26351_WNT_VS_BMP_PATHWAY_...1,SET,176,0.0073705,0.00071782,0.06263,0.45316,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.989619096676927
BIOCARTA_DSP_PATHWAY,SET,8,0.041828,0.00087251,0.35565,0.45319,BIOCARTA_DSP_PATHWAY,0.989619096676927
GOBP_MAINTENANCE_OF_DNA_REPE...,SET,7,0.03639,0.00071007,0.3094,0.45319,GOBP_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS,0.989619096676927
KRAS.600_UP.V1_UP,SET,249,0.0070875,0.00081937,0.060279,0.4532,KRAS.600_UP.V1_UP,0.989619096676927
GOBP_RESPONSE_TO_SYMBIONT,SET,6,0.037327,0.00067434,0.31754,0.45321,GOBP_RESPONSE_TO_SYMBIONT,0.989619096676927
WANG_ADIPOGENIC_GENES_REPRES...,SET,24,0.020679,0.0007468,0.176,0.45323,WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,0.989619096676927
MIR4764_5P,SET,68,0.012077,0.00073324,0.10279,0.45324,MIR4764_5P,0.989619096676927
REACTOME_CYTOCHROME_P450_ARR...,SET,63,0.014265,0.00083376,0.12144,0.45325,REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,0.989619096676927
GOBP_NATURAL_KILLER_CELL_DEG...,SET,10,0.031336,0.00073077,0.26677,0.45325,GOBP_NATURAL_KILLER_CELL_DEGRANULATION,0.989619096676927
GOBP_REGULATION_OF_ACTIN_FIL...4,SET,135,0.0087371,0.00074608,0.074434,0.45328,GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH,0.989619096676927
HP_INTERMEDIATE_YOUNG_ADULT_...,SET,19,0.022091,0.00070994,0.18819,0.45328,HP_INTERMEDIATE_YOUNG_ADULT_ONSET,0.989619096676927
GOBP_POSITIVE_REGULATION_OF_...710,SET,33,0.017736,0.0007509,0.15128,0.45334,GOBP_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.989669417750141
REACTOME_DISEASES_OF_HEMOSTA...,SET,17,0.02642,0.00080318,0.22549,0.45336,REACTOME_DISEASES_OF_HEMOSTASIS,0.989669417750141
GOBP_NEGATIVE_REGULATION_OF_...440,SET,68,0.013287,0.00080674,0.11346,0.45339,GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION,0.989672745258134
HP_CONVEX_NASAL_RIDGE,SET,82,0.010151,0.00067651,0.086822,0.45347,HP_CONVEX_NASAL_RIDGE,0.989785206933367
GOBP_MESONEPHRIC_TUBULE_FORM...,SET,8,0.040802,0.0008511,0.34935,0.45351,GOBP_MESONEPHRIC_TUBULE_FORMATION,0.98979747696358
GRAHAM_CML_DIVIDING_VS_NORMA...1,SET,9,0.040394,0.00089368,0.34624,0.45356,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN,0.98979747696358
GOBP_POSITIVE_REGULATION_OF_...191,SET,167,0.0077815,0.0007384,0.066847,0.45367,GOBP_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.98979747696358
HP_KERATOACANTHOMA,SET,4,0.038567,0.00056892,0.33136,0.45367,HP_KERATOACANTHOMA,0.98979747696358
SARTIPY_BLUNTED_BY_INSULIN_R...1,SET,17,0.027286,0.0008295,0.23457,0.4537,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,0.98979747696358
BIOCARTA_CARM1_PATHWAY,SET,12,0.030101,0.00076891,0.25928,0.45379,BIOCARTA_CARM1_PATHWAY,0.98979747696358
GSE36392_TYPE_2_MYELOID_VS_N...1,SET,181,0.0072385,0.00071481,0.062399,0.45383,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.98979747696358
FAN_EMBRYONIC_CTX_BIG_GROUPS...7,SET,335,0.0057395,0.0007678,0.049518,0.45386,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.98979747696358
HP_ABNORMAL_RENAL_INSTERSTIT...,SET,52,0.014112,0.00074959,0.12177,0.45387,HP_ABNORMAL_RENAL_INSTERSTITIAL_MORPHOLOGY,0.98979747696358
BIOCARTA_AGPCR_PATHWAY,SET,11,0.032455,0.00079378,0.28017,0.45389,BIOCARTA_AGPCR_PATHWAY,0.98979747696358
MIR6733_5P,SET,240,0.0064269,0.00072963,0.05551,0.45391,MIR6733_5P,0.98979747696358
GOBP_INTRINSIC_APOPTOTIC_SIG...2,SET,75,0.011116,0.00070868,0.096043,0.45393,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.98979747696358
HP_METAPHYSEAL_CUPPING,SET,14,0.027432,0.00075684,0.23732,0.45399,HP_METAPHYSEAL_CUPPING,0.98979747696358
GSE3982_MEMORY_CD4_TCELL_VS_...4,SET,168,0.0075854,0.00072193,0.065653,0.45401,GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP,0.98979747696358
GNF2_ITGAL,SET,51,0.014268,0.00075058,0.12359,0.45404,GNF2_ITGAL,0.98979747696358
GSE15271_CXCR4_POS_VS_NEG_GC...2,SET,158,0.0075096,0.0006933,0.065036,0.45404,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP,0.98979747696358
MIR4450,SET,67,0.011612,0.00069987,0.10064,0.45407,MIR4450,0.98979747696358
GSE16755_CTRL_VS_IFNA_TREATE...1,SET,174,0.0078696,0.0007621,0.068271,0.45412,GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN,0.98979747696358
HP_REDUCED_ANTIGEN_SPECIFIC_...,SET,8,0.033358,0.00069583,0.28956,0.45414,HP_REDUCED_ANTIGEN_SPECIFIC_T_CELL_PROLIFERATION,0.98979747696358
GOBP_POSITIVE_REGULATION_OF_...350,SET,666,0.0039796,0.00074372,0.034556,0.45416,GOBP_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE,0.98979747696358
GSE29164_CD8_TCELL_VS_CD8_TC...3,SET,162,0.0078446,0.00073326,0.068159,0.45419,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,0.98979747696358
HP_FACIAL_TELANGIECTASIA,SET,15,0.022671,0.00064742,0.19713,0.45422,HP_FACIAL_TELANGIECTASIA,0.98979747696358
GSE21927_SPLEEN_VS_BONE_MARR...1,SET,164,0.0078754,0.00074062,0.068492,0.45423,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN,0.98979747696358
BRUINS_UVC_RESPONSE_VIA_TP53...3,SET,85,0.010881,0.00073826,0.094742,0.45428,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,0.98979747696358
REACTOME_WNT5A_DEPENDENT_INT...2,SET,15,0.024255,0.00069266,0.21119,0.45428,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,0.98979747696358
GOBP_EARLY_ENDOSOME_TO_RECYC...,SET,7,0.040183,0.00078408,0.34985,0.45428,GOBP_EARLY_ENDOSOME_TO_RECYCLING_ENDOSOME_TRANSPORT,0.98979747696358
HP_UTERUS_DIDELPHYS,SET,10,0.031082,0.00072484,0.27066,0.45429,HP_UTERUS_DIDELPHYS,0.98979747696358
GOBP_PROTEIN_K63_LINKED_DEUB...,SET,21,0.021006,0.00070967,0.18298,0.4543,GOBP_PROTEIN_K63_LINKED_DEUBIQUITINATION,0.98979747696358
GOBP_POSITIVE_REGULATION_OF_...472,SET,7,0.034142,0.0006662,0.29744,0.45431,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.98979747696358
GOBP_CORONARY_ARTERY_MORPHOG...,SET,8,0.038664,0.00080651,0.33701,0.45433,GOBP_CORONARY_ARTERY_MORPHOGENESIS,0.98979747696358
GOBP_NEGATIVE_REGULATION_OF_...372,SET,7,0.043808,0.00085481,0.38235,0.45439,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.98986614328695
MIKKELSEN_NPC_HCP_WITH_H3K4M...,SET,202,0.0075672,0.00078897,0.066111,0.45444,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.989876066929874
GAUSSMANN_MLL_AF4_FUSION_TAR...9,SET,17,0.025421,0.0007728,0.22231,0.45448,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,0.989876066929874
HP_CROHN_S_DISEASE,SET,13,0.03324,0.00088376,0.29069,0.45448,HP_CROHN_S_DISEASE,0.989876066929874
WP_FAMILIAL_PARTIAL_LIPODYST...,SET,30,0.018424,0.00074376,0.1614,0.45456,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,0.989948013660004
KEGG_MEDICUS_REFERENCE_IL6_F...,SET,25,0.020356,0.00075026,0.17837,0.45457,KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.989948013660004
GOBP_MULTIVESICULAR_BODY_ORG...,SET,32,0.016133,0.00067261,0.14147,0.4546,GOBP_MULTIVESICULAR_BODY_ORGANIZATION,0.989951315789474
MIR6792_5P,SET,113,0.0096912,0.00075758,0.085115,0.45468,MIR6792_5P,0.990004764142078
GOBP_MHC_CLASS_I_BIOSYNTHETI...,SET,8,0.04053,0.00084543,0.35627,0.45471,GOBP_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.990004764142078
GOMF_SINGLE_STRANDED_DNA_HEL...,SET,23,0.020427,0.0007222,0.17955,0.45471,GOMF_SINGLE_STRANDED_DNA_HELICASE_ACTIVITY,0.990004764142078
GOCC_I_BAND,SET,137,0.0084996,0.00073111,0.074886,0.45482,GOCC_I_BAND,0.990133364643998
GSE32986_UNSTIM_VS_GMCSF_AND...3,SET,174,0.0072351,0.00070065,0.063778,0.45484,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.990133364643998
REACTOME_SHC_MEDIATED_CASCAD...2,SET,17,0.023307,0.00070853,0.20574,0.4549,REACTOME_SHC_MEDIATED_CASCADE_FGFR3,0.990133364643998
GOBP_REGULATION_OF_STEM_CELL...3,SET,67,0.011464,0.00069095,0.10119,0.4549,GOBP_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.990133364643998
GSE360_DC_VS_MAC_L_MAJOR_DN,SET,177,0.0071439,0.00069771,0.063097,0.45493,GSE360_DC_VS_MAC_L_MAJOR_DN,0.990133364643998
GOBP_LIPOPHAGY,SET,7,0.038143,0.00074428,0.33696,0.45494,GOBP_LIPOPHAGY,0.990133364643998
GSE29618_BCELL_VS_MDC_DAY7_F...2,SET,169,0.0078132,0.0007458,0.069121,0.455,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP,0.990201941139637
KEGG_MEDICUS_REFERENCE_PKR_E...,SET,7,0.033356,0.00065086,0.29525,0.45503,KEGG_MEDICUS_REFERENCE_PKR_EIF2ALPHA_SIGNALING_PATHWAY,0.990205225095486
MIR4288,SET,144,0.0084941,0.00074893,0.075428,0.45517,MIR4288,0.990340676696423
GSE1925_CTRL_VS_3H_IFNG_STIM...3,SET,177,0.007727,0.00075466,0.068623,0.45517,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN,0.990340676696423
GOBP_NEGATIVE_REGULATION_OF_...503,SET,17,0.026492,0.00080534,0.23553,0.45522,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.990340676696423
GOBP_POSITIVE_REGULATION_OF_...747,SET,8,0.033647,0.00070187,0.29921,0.45523,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,0.990340676696423
GOBP_REGULATION_OF_SMALL_GTP...,SET,280,0.0059028,0.00072303,0.052527,0.45526,GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.990340676696423
GSE17721_LPS_VS_GARDIQUIMOD_...13,SET,176,0.0069451,0.00067639,0.061819,0.45528,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN,0.990340676696423
REACTOME_VITAMINS,SET,6,0.044144,0.00079749,0.39363,0.45535,REACTOME_VITAMINS,0.990340676696423
HP_SHORT_UPPER_LIP,SET,9,0.030853,0.0006826,0.27523,0.45537,HP_SHORT_UPPER_LIP,0.990340676696423
MIR3606_3P,SET,331,0.0053302,0.00070887,0.047557,0.45538,MIR3606_3P,0.990340676696423
PID_S1P_S1P4_PATHWAY,SET,14,0.0237,0.00065389,0.21148,0.45539,PID_S1P_S1P4_PATHWAY,0.990340676696423
GOBP_REGULATION_OF_DOPAMINE_...2,SET,24,0.021634,0.00078129,0.19345,0.45548,GOBP_REGULATION_OF_DOPAMINE_SECRETION,0.990340676696423
GNF2_RRM1,SET,85,0.0098629,0.0006692,0.088245,0.4555,GNF2_RRM1,0.990340676696423
MIR186_5P,SET,507,0.0043138,0.00070654,0.038614,0.45553,MIR186_5P,0.990340676696423
GOBP_BRANCHING_INVOLVED_IN_L...,SET,12,0.02985,0.00076252,0.26749,0.45557,GOBP_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS,0.990340676696423
GOMF_GLUCOSE_BINDING,SET,9,0.033383,0.00073857,0.2991,0.45557,GOMF_GLUCOSE_BINDING,0.990340676696423
HP_ABNORMAL_CARDIOMYOCYTE_MO...,SET,15,0.023357,0.00066701,0.20938,0.45559,HP_ABNORMAL_CARDIOMYOCYTE_MORPHOLOGY,0.990340676696423
GOMF_GROWTH_FACTOR_ACTIVITY,SET,145,0.008341,0.00073796,0.074793,0.4556,GOMF_GROWTH_FACTOR_ACTIVITY,0.990340676696423
GOMF_PYRUVATE_TRANSMEMBRANE_...,SET,5,0.045231,0.00074596,0.40592,0.45564,GOMF_PYRUVATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.990340676696423
BRACHAT_RESPONSE_TO_METHOTRE...1,SET,23,0.018698,0.00066105,0.16784,0.45565,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,0.990340676696423
GSE9037_CTRL_VS_LPS_4H_STIM_...1,SET,183,0.006717,0.00066693,0.060333,0.45568,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN,0.990340676696423
GSE17721_PAM3CSK4_VS_GADIQUI...5,SET,180,0.0069383,0.00068329,0.062429,0.45575,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN,0.990340676696423
REACTOME_INTEGRATION_OF_PROV...,SET,9,0.027146,0.00060059,0.24441,0.45578,REACTOME_INTEGRATION_OF_PROVIRUS,0.990340676696423
GOBP_CELL_SURFACE_RECEPTOR_P...3,SET,6,0.036773,0.00066433,0.33173,0.45587,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY,0.990340676696423
WP_CIRCADIAN_RHYTHM_GENES,SET,191,0.0072356,0.00073379,0.065357,0.45592,WP_CIRCADIAN_RHYTHM_GENES,0.990340676696423
CDC5_01,SET,228,0.0066357,0.00073451,0.060018,0.45598,CDC5_01,0.990340676696423
GOBP_MITOCHONDRIAL_RNA_CATAB...,SET,6,0.034092,0.0006159,0.30833,0.45598,GOBP_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,0.990340676696423
HP_ABSENT_VAS_DEFERENS,SET,19,0.023284,0.00074829,0.21083,0.45603,HP_ABSENT_VAS_DEFERENS,0.990340676696423
HP_RETICULATED_SKIN_PIGMENTA...,SET,5,0.040343,0.00066535,0.36546,0.45605,HP_RETICULATED_SKIN_PIGMENTATION,0.990340676696423
CAMP_UP.V1_DN,SET,178,0.0071931,0.00070447,0.065198,0.45608,CAMP_UP.V1_DN,0.990340676696423
GSE29618_MONOCYTE_VS_MDC_DAY...2,SET,189,0.0074746,0.0007541,0.067758,0.45608,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP,0.990340676696423
GOBP_RESPONSE_TO_HEPARIN,SET,6,0.046698,0.00084364,0.42353,0.4561,GOBP_RESPONSE_TO_HEPARIN,0.990340676696423
CREIGHTON_ENDOCRINE_THERAPY_...2,SET,366,0.004758,0.00066473,0.04316,0.45611,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,0.990340676696423
REACTOME_SUPPRESSION_OF_APOP...,SET,7,0.035059,0.0006841,0.31803,0.45611,REACTOME_SUPPRESSION_OF_APOPTOSIS,0.990340676696423
GOBP_GOLGI_VESICLE_TRANSPORT,SET,281,0.0054182,0.00066483,0.049162,0.45612,GOBP_GOLGI_VESICLE_TRANSPORT,0.990340676696423
HP_CAPILLARY_MALFORMATION,SET,58,0.01417,0.00079477,0.12872,0.45617,HP_CAPILLARY_MALFORMATION,0.990340676696423
MIR1914_3P,SET,23,0.020567,0.00072712,0.18688,0.45618,MIR1914_3P,0.990340676696423
GSE1460_CORD_VS_ADULT_BLOOD_...1,SET,176,0.0069377,0.00067567,0.063065,0.4562,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN,0.990340676696423
GOBP_POSITIVE_REGULATION_OF_...763,SET,6,0.041026,0.00074116,0.37346,0.45626,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.990340676696423
HP_BROAD_PHALANX_OF_THE_TOES,SET,38,0.01599,0.00072633,0.14553,0.45626,HP_BROAD_PHALANX_OF_THE_TOES,0.990340676696423
HP_ABNORMAL_MOTOR_EVOKED_POT...,SET,10,0.027114,0.0006323,0.2469,0.45628,HP_ABNORMAL_MOTOR_EVOKED_POTENTIALS,0.990340676696423
GOCC_AP_1_ADAPTOR_COMPLEX,SET,10,0.028902,0.000674,0.26345,0.45632,GOCC_AP_1_ADAPTOR_COMPLEX,0.990340676696423
GSE16385_UNTREATED_VS_12H_RO...5,SET,165,0.0073285,0.00069127,0.066812,0.45633,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,0.990340676696423
GOBP_STEROID_METABOLIC_PROCE...,SET,301,0.0057256,0.00072673,0.052233,0.45636,GOBP_STEROID_METABOLIC_PROCESS,0.990340676696423
GSE2770_UNTREATED_VS_IL12_TR...4,SET,179,0.0068904,0.0006767,0.062926,0.4564,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.990340676696423
WP_2Q112_COPY_NUMBER_VARIATI...,SET,32,0.021196,0.00088369,0.19365,0.45642,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,0.990340676696423
GOBP_POSITIVE_REGULATION_OF_...443,SET,12,0.029018,0.00074125,0.26519,0.45643,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,0.990340676696423
MIR3672,SET,41,0.014087,0.00066461,0.12875,0.45644,MIR3672,0.990340676696423
GSE26343_WT_VS_NFAT5_KO_MACR...2,SET,176,0.0070686,0.00068842,0.064632,0.45646,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN,0.990340676696423
HP_ABNORMAL_CIRCULATING_BETA...,SET,8,0.033362,0.0006959,0.30568,0.45655,HP_ABNORMAL_CIRCULATING_BETA_GLOBULIN_LEVEL,0.990415547372363
REACTOME_VIRAL_INFECTION_PAT...,SET,708,0.0033662,0.00064785,0.030861,0.45657,REACTOME_VIRAL_INFECTION_PATHWAYS,0.990415547372363
DESCARTES_FETAL_PANCREAS_ISL...,SET,117,0.009759,0.00077618,0.089481,0.45658,DESCARTES_FETAL_PANCREAS_ISLET_ENDOCRINE_CELLS,0.990415547372363
GOBP_REGULATION_OF_DELAYED_R...,SET,15,0.026556,0.00075836,0.24373,0.45662,GOBP_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.990440498034076
GSE7219_WT_VS_NIK_NFKB2_KO_D...1,SET,158,0.0074693,0.00068958,0.068678,0.4567,GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN,0.99049151819088
FOXO3_01,SET,227,0.0065141,0.00071949,0.059918,0.45671,FOXO3_01,0.99049151819088
HP_ABNORMAL_POSTERIOR_PITUIT...,SET,33,0.016393,0.00069404,0.15088,0.45674,HP_ABNORMAL_POSTERIOR_PITUITARY_MORPHOGENESIS,0.99049151819088
TORCHIA_TARGETS_OF_EWSR1_FLI...2,SET,19,0.022987,0.00073873,0.21183,0.45679,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,0.99049151819088
RYTAAWNNNTGAY_UNKNOWN,SET,55,0.013174,0.0007196,0.12144,0.45681,RYTAAWNNNTGAY_UNKNOWN,0.99049151819088
HP_ILEUS,SET,29,0.018276,0.00072542,0.16866,0.45686,HP_ILEUS,0.99049151819088
GOCC_ER_UBIQUITIN_LIGASE_COM...,SET,4,0.047827,0.00070552,0.44204,0.45692,GOCC_ER_UBIQUITIN_LIGASE_COMPLEX,0.99049151819088
PHONG_TNF_TARGETS_DN,SET,8,0.034824,0.00072641,0.32204,0.45694,PHONG_TNF_TARGETS_DN,0.99049151819088
GOBP_REGULATION_OF_SPINDLE_O...,SET,46,0.012593,0.00062922,0.11663,0.45701,GOBP_REGULATION_OF_SPINDLE_ORGANIZATION,0.99049151819088
MIR181D_5P,SET,554,0.0040468,0.00069195,0.037491,0.45702,MIR181D_5P,0.99049151819088
PID_VEGFR1_2_PATHWAY,SET,68,0.011117,0.00067497,0.10306,0.45705,PID_VEGFR1_2_PATHWAY,0.99049151819088
GOBP_POSITIVE_REGULATION_OF_...12,SET,116,0.0089598,0.00070959,0.083141,0.45709,GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.99049151819088
GSE22935_UNSTIM_VS_48H_MBOVI...3,SET,177,0.007012,0.00068482,0.065105,0.45712,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.99049151819088
GSE18791_CTRL_VS_NEWCASTLE_V...8,SET,181,0.006573,0.00064909,0.06105,0.45713,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP,0.99049151819088
DESCARTES_FETAL_LUNG_CILIATE...,SET,360,0.0048166,0.0006675,0.044754,0.45715,DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS,0.99049151819088
MIR5088_3P,SET,121,0.0082876,0.00067025,0.077045,0.45717,MIR5088_3P,0.99049151819088
HP_HYPERINTENSITY_OF_CEREBRA...,SET,72,0.011341,0.00070846,0.10556,0.45722,HP_HYPERINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,0.99049151819088
GOBP_POSITIVE_REGULATION_OF_...422,SET,35,0.016793,0.00073215,0.15636,0.45724,GOBP_POSITIVE_REGULATION_OF_LYASE_ACTIVITY,0.99049151819088
PID_S1P_S1P1_PATHWAY,SET,21,0.020183,0.00068186,0.18811,0.45728,PID_S1P_S1P1_PATHWAY,0.99049151819088
HP_OPTIC_ATROPHY,SET,512,0.0039806,0.00065509,0.037098,0.45728,HP_OPTIC_ATROPHY,0.99049151819088
GSE16385_IFNG_TNF_VS_IL4_STI...4,SET,184,0.0067872,0.00067571,0.063376,0.45736,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.99049151819088
KEGG_MEDICUS_REFERENCE_SKELE...,SET,21,0.022112,0.00074705,0.20654,0.45737,KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING,0.99049151819088
REACTOME_MAPK_FAMILY_SIGNALI...,SET,308,0.0052726,0.00067683,0.049264,0.45738,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,0.99049151819088
KORKOLA_EMBRYONIC_CARCINOMA_...1,SET,19,0.021552,0.00069262,0.20147,0.45741,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,0.99049151819088
LEI_HOXC8_TARGETS_UP,SET,11,0.028174,0.00068908,0.26344,0.45742,LEI_HOXC8_TARGETS_UP,0.99049151819088
WU_ALZHEIMER_DISEASE_DN,SET,17,0.022934,0.00069721,0.21445,0.45742,WU_ALZHEIMER_DISEASE_DN,0.99049151819088
REACTOME_THE_CANONICAL_RETIN...,SET,22,0.019847,0.00068628,0.18564,0.45743,REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION,0.99049151819088
HP_APLASIA_HYPOPLASIA_OF_THE...8,SET,11,0.028635,0.00070035,0.26801,0.45746,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_METACARPAL,0.99049151819088
GAVISH_3CA_METAPROGRAM_CD4_T...6,SET,44,0.014699,0.00071836,0.13763,0.45747,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_1,0.99049151819088
MIR8073,SET,76,0.010532,0.00067585,0.098736,0.45753,MIR8073,0.990519664881027
HP_PROXIMAL_AMYOTROPHY,SET,48,0.012909,0.00065888,0.12107,0.45754,HP_PROXIMAL_AMYOTROPHY,0.990519664881027
MIR649,SET,62,0.011291,0.0006547,0.10599,0.45758,MIR649,0.990544559327312
GOBP_REGULATION_OF_MYOBLAST_...2,SET,19,0.022411,0.00072021,0.21059,0.45763,GOBP_REGULATION_OF_MYOBLAST_FUSION,0.990591096786248
GSE36527_CD69_NEG_VS_POS_TRE...2,SET,188,0.0070181,0.00070618,0.066011,0.45767,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP,0.990597580645161
MIR378A_5P,SET,120,0.0086073,0.00069325,0.081003,0.45769,MIR378A_5P,0.990597580645161
GAVISH_3CA_METAPROGRAM_FIBRO...1,SET,47,0.01446,0.0007303,0.13631,0.45776,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1,0.990647344333748
VERRECCHIA_EARLY_RESPONSE_TO...,SET,52,0.013191,0.00070066,0.12437,0.45777,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,0.990647344333748
HP_GOWERS_SIGN,SET,68,0.01133,0.00068792,0.10721,0.45792,HP_GOWERS_SIGN,0.990855011205179
HP_HYPOVOLEMIA,SET,30,0.018385,0.00074221,0.174,0.45793,HP_HYPOVOLEMIA,0.990855011205179
KEGG_MEDICUS_REFERENCE_BETA_...1,SET,11,0.026934,0.00065874,0.25521,0.45798,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION,0.990855011205179
REACTOME_ASPIRIN_ADME,SET,41,0.01706,0.00080489,0.16165,0.45798,REACTOME_ASPIRIN_ADME,0.990855011205179
CHEN_PDGF_TARGETS,SET,18,0.024616,0.00076999,0.23395,0.4581,CHEN_PDGF_TARGETS,0.990990665796345
REACTOME_ACTIVATION_OF_CASPA...,SET,5,0.03704,0.00061087,0.35251,0.45816,REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE,0.990990665796345
MIR490_3P,SET,40,0.014236,0.00066344,0.13573,0.45823,MIR490_3P,0.990990665796345
GOBP_POSITIVE_REGULATION_OF_...134,SET,55,0.012435,0.00067925,0.11857,0.45824,GOBP_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.990990665796345
REACTOME_GRB7_EVENTS_IN_ERBB...,SET,5,0.044135,0.00072788,0.42144,0.4583,REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING,0.990990665796345
GOBP_PROSTANOID_BIOSYNTHETIC...,SET,27,0.017536,0.00067164,0.16761,0.45834,GOBP_PROSTANOID_BIOSYNTHETIC_PROCESS,0.990990665796345
GSE2770_IL12_AND_TGFB_VS_IL4...4,SET,182,0.0066469,0.00065818,0.063559,0.45836,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.990990665796345
WP_PROXIMAL_TUBULE_TRANSPORT,SET,55,0.012503,0.00068296,0.11976,0.45843,WP_PROXIMAL_TUBULE_TRANSPORT,0.990990665796345
GOBP_T_CELL_ACTIVATION_INVOL...,SET,117,0.009049,0.00071971,0.086703,0.45844,GOBP_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.990990665796345
ACTGTAG_MIR139,SET,109,0.0089336,0.00068596,0.085654,0.45847,ACTGTAG_MIR139,0.990990665796345
GOMF_CLASS_I_DNA_APURINIC_OR...,SET,8,0.029786,0.00062132,0.28578,0.45849,GOMF_CLASS_I_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,0.990990665796345
HP_CEREBRAL_DYSMYELINATION,SET,12,0.022493,0.00057458,0.21579,0.45849,HP_CEREBRAL_DYSMYELINATION,0.990990665796345
GOBP_POSITIVE_REGULATION_OF_...563,SET,44,0.01429,0.0006984,0.13717,0.45851,GOBP_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.990990665796345
REACTOME_CYCLIN_A_B1_B2_ASSO...,SET,24,0.016715,0.00060365,0.16083,0.45861,REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,0.990990665796345
GOBP_POSITIVE_REGULATION_OF_...190,SET,4,0.037229,0.00054918,0.35823,0.45861,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.990990665796345
HP_GENERALIZED_LIMB_MUSCLE_A...,SET,18,0.019171,0.00059968,0.18446,0.45861,HP_GENERALIZED_LIMB_MUSCLE_ATROPHY,0.990990665796345
NUFIP1_TARGET_GENES,SET,39,0.014294,0.00065777,0.13755,0.45862,NUFIP1_TARGET_GENES,0.990990665796345
KEGG_AMINO_SUGAR_AND_NUCLEOT...,SET,40,0.013316,0.00062055,0.1282,0.45864,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,0.990990665796345
GSE360_CTRL_VS_M_TUBERCULOSI...2,SET,185,0.0066878,0.00066761,0.064395,0.45864,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP,0.990990665796345
TCCAGAT_MIR5165P,SET,96,0.0092542,0.0006671,0.089126,0.45865,TCCAGAT_MIR5165P,0.990990665796345
GSE21033_CTRL_VS_POLYIC_STIM...1,SET,177,0.0067466,0.0006589,0.064977,0.45865,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN,0.990990665796345
GOBP_PEPTIDYL_TYROSINE_DEPHO...1,SET,27,0.017696,0.00067778,0.17049,0.45867,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION,0.990990665796345
GSE8621_UNSTIM_VS_LPS_PRIMED...1,SET,188,0.0064327,0.00064728,0.062131,0.45877,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.991038792621576
SILIGAN_TARGETS_OF_EWS_FLI1_...2,SET,15,0.023045,0.00065811,0.22267,0.45879,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP,0.991038792621576
GSE12392_WT_VS_IFNB_KO_CD8A_...2,SET,185,0.0063368,0.00063257,0.061282,0.45882,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP,0.991038792621576
HP_FOCAL_DYSTONIA,SET,122,0.0077107,0.00062615,0.074698,0.45889,HP_FOCAL_DYSTONIA,0.991038792621576
GOBP_POSITIVE_REGULATION_OF_...501,SET,25,0.01947,0.0007176,0.18868,0.45891,GOBP_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,0.991038792621576
E2F_01,SET,59,0.011087,0.00062717,0.10758,0.45896,E2F_01,0.991038792621576
GSE17721_CTRL_VS_PAM3CSK4_4H...1,SET,187,0.0063749,0.00063977,0.061869,0.45897,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN,0.991038792621576
KEGG_MEDICUS_VARIANT_NOTCH_O...,SET,16,0.023348,0.00068861,0.22669,0.45898,KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY,0.991038792621576
REACTOME_SIGNALING_BY_WNT,SET,260,0.0055432,0.00065465,0.053817,0.45898,REACTOME_SIGNALING_BY_WNT,0.991038792621576
HP_DISINHIBITION,SET,540,0.0038987,0.0006584,0.037926,0.45906,HP_DISINHIBITION,0.991038792621576
WP_FATTY_ACID_TRANSPORTERS,SET,17,0.021729,0.00066055,0.21151,0.45909,WP_FATTY_ACID_TRANSPORTERS,0.991038792621576
GSE21927_SPLEEN_C57BL6_VS_4T...2,SET,182,0.0062456,0.00061844,0.060803,0.45909,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP,0.991038792621576
DESCARTES_FETAL_HEART_ELF3_A...,SET,34,0.015233,0.0006546,0.14837,0.45911,DESCARTES_FETAL_HEART_ELF3_AGBL2_POSITIVE_CELLS,0.991038792621576
MODULE_241,SET,69,0.011395,0.00069692,0.11101,0.45912,MODULE_241,0.991038792621576
GOBP_METAPHASE_CHROMOSOME_AL...,SET,96,0.0086939,0.0006267,0.084685,0.45912,GOBP_METAPHASE_CHROMOSOME_ALIGNMENT,0.991038792621576
HP_ABNORMAL_VENOUS_MORPHOLOGY,SET,136,0.0074884,0.0006418,0.073107,0.45921,HP_ABNORMAL_VENOUS_MORPHOLOGY,0.991045323763169
REACTOME_THE_RETINOID_CYCLE_...,SET,3,0.065305,0.0008343,0.63768,0.45922,REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION,0.991045323763169
chr5q34,SET,12,0.038764,0.00099022,0.37878,0.45924,chr5q34,0.991045323763169
GOBP_EXTERNAL_ENCAPSULATING_...,SET,307,0.0053499,0.00068566,0.052293,0.45926,GOBP_EXTERNAL_ENCAPSULATING_STRUCTURE_ORGANIZATION,0.991045323763169
GOBP_P38MAPK_CASCADE,SET,53,0.013017,0.00069801,0.12731,0.45928,GOBP_P38MAPK_CASCADE,0.991045323763169
REACTOME_CITRIC_ACID_CYCLE_T...,SET,32,0.013975,0.00058265,0.13674,0.4593,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,0.991045323763169
GOBP_RECEPTOR_MEDIATED_ENDOC...1,SET,242,0.0056861,0.00064818,0.055682,0.45933,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.991045323763169
GSE16385_IFNG_TNF_VS_UNSTIM_...1,SET,179,0.0065401,0.00064229,0.064179,0.45942,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,0.991045323763169
GOBP_NEGATIVE_REGULATION_OF_...425,SET,49,0.013797,0.00071148,0.1355,0.45945,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.991045323763169
GSE17721_CTRL_VS_LPS_2H_BMDC...2,SET,184,0.0060625,0.00060357,0.059657,0.45953,GSE17721_CTRL_VS_LPS_2H_BMDC_UP,0.991045323763169
HP_PRODUCTIVE_COUGH,SET,56,0.011254,0.00062027,0.11082,0.45956,HP_PRODUCTIVE_COUGH,0.991045323763169
HP_2_4_TOE_CUTANEOUS_SYNDACT...,SET,4,0.052631,0.00077638,0.51875,0.45959,HP_2_4_TOE_CUTANEOUS_SYNDACTYLY,0.991045323763169
GSE40277_EOS_AND_LEF1_TRANSD...1,SET,188,0.0063424,0.00063819,0.062562,0.45963,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.991045323763169
LIU_IL13_PRIMING_MODEL,SET,15,0.023565,0.00067294,0.23251,0.45964,LIU_IL13_PRIMING_MODEL,0.991045323763169
MIR449B_3P,SET,110,0.0086199,0.00066488,0.085444,0.45982,MIR449B_3P,0.991045323763169
HP_ABSENT_CIRCULATING_B_CELLS,SET,6,0.038822,0.00070135,0.38489,0.45983,HP_ABSENT_CIRCULATING_B_CELLS,0.991045323763169
GSE17721_0.5H_VS_24H_LPS_BMD...2,SET,183,0.0064414,0.00063956,0.063869,0.45983,GSE17721_0.5H_VS_24H_LPS_BMDC_UP,0.991045323763169
MIR8071,SET,31,0.014813,0.00060785,0.14689,0.45984,MIR8071,0.991045323763169
GTGCCAT_MIR183,SET,159,0.0071653,0.00066358,0.07108,0.45985,GTGCCAT_MIR183,0.991045323763169
GOBP_REGULATION_OF_TELOMERE_...1,SET,26,0.015765,0.00059256,0.15643,0.45986,GOBP_REGULATION_OF_TELOMERE_CAPPING,0.991045323763169
GOMF_TRANSCRIPTION_COREGULAT...1,SET,452,0.0039036,0.00060461,0.038795,0.45993,GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY,0.991045323763169
GOMF_GLUTATHIONE_PEROXIDASE_...,SET,21,0.019864,0.0006711,0.19747,0.45994,GOMF_GLUTATHIONE_PEROXIDASE_ACTIVITY,0.991045323763169
GOBP_POSITIVE_REGULATION_OF_...697,SET,9,0.031572,0.00069849,0.3146,0.46003,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.991045323763169
SMID_BREAST_CANCER_LUMINAL_A...1,SET,16,0.022303,0.00065778,0.22239,0.46006,SMID_BREAST_CANCER_LUMINAL_A_DN,0.991045323763169
HP_HIP_PAIN,SET,11,0.025501,0.0006237,0.25433,0.46007,HP_HIP_PAIN,0.991045323763169
GOBP_REGULATION_OF_NADP_META...,SET,8,0.031931,0.00066607,0.31866,0.46009,GOBP_REGULATION_OF_NADP_METABOLIC_PROCESS,0.991045323763169
GOBP_COPULATION,SET,19,0.022287,0.00071623,0.22247,0.4601,GOBP_COPULATION,0.991045323763169
GOBP_POSITIVE_REGULATION_OF_...483,SET,184,0.0067506,0.00067207,0.067432,0.46013,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.991045323763169
SHETH_LIVER_CANCER_VS_TXNIP_...1,SET,236,0.0057031,0.00064211,0.057133,0.46024,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,0.991045323763169
BIOCARTA_IL2_PATHWAY,SET,20,0.020291,0.000669,0.20329,0.46025,BIOCARTA_IL2_PATHWAY,0.991045323763169
HP_ABNORMALITY_OF_HAIR_PIGME...,SET,109,0.0084629,0.00064982,0.084831,0.46027,HP_ABNORMALITY_OF_HAIR_PIGMENTATION,0.991045323763169
MODULE_528,SET,10,0.028713,0.00066959,0.28789,0.46028,MODULE_528,0.991045323763169
HP_NEPHROLITHIASIS,SET,131,0.0080619,0.00067822,0.080839,0.46028,HP_NEPHROLITHIASIS,0.991045323763169
GSE11057_EFF_MEM_VS_CENT_MEM...1,SET,158,0.0067855,0.00062645,0.068092,0.46031,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN,0.991045323763169
CGTCTTA_MIR208,SET,8,0.031073,0.00064816,0.31187,0.46032,CGTCTTA_MIR208,0.991045323763169
FOXD3_TARGET_GENES,SET,29,0.016341,0.00064862,0.16408,0.46033,FOXD3_TARGET_GENES,0.991045323763169
GOBP_REGULATION_OF_SYNAPTIC_...8,SET,12,0.023691,0.00060518,0.23788,0.46034,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CYCLE,0.991045323763169
WP_TAMOXIFEN_METABOLISM,SET,21,0.020073,0.00067815,0.20173,0.46037,WP_TAMOXIFEN_METABOLISM,0.991045323763169
ZHAN_MULTIPLE_MYELOMA_SPIKED,SET,20,0.020202,0.00066607,0.20307,0.46038,ZHAN_MULTIPLE_MYELOMA_SPIKED,0.991045323763169
GOMF_G_PROTEIN_BETA_SUBUNIT_...,SET,21,0.02023,0.00068346,0.20341,0.46039,GOMF_G_PROTEIN_BETA_SUBUNIT_BINDING,0.991045323763169
GSE3982_BCELL_VS_EFF_MEMORY_...2,SET,171,0.0063951,0.000614,0.064304,0.46039,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP,0.991045323763169
HP_HAND_TREMOR,SET,37,0.014158,0.0006346,0.14237,0.4604,HP_HAND_TREMOR,0.991045323763169
GOBP_NUCLEAR_BODY_ORGANIZATI...,SET,15,0.020069,0.00057312,0.20199,0.46043,GOBP_NUCLEAR_BODY_ORGANIZATION,0.991045323763169
ZEILSTRA_CD44_TARGETS_DN,SET,9,0.026894,0.00059501,0.27086,0.46045,ZEILSTRA_CD44_TARGETS_DN,0.991045323763169
HP_ABDUCENS_PALSY,SET,9,0.030123,0.00066645,0.30337,0.46045,HP_ABDUCENS_PALSY,0.991045323763169
TGACGTCA_ATF3_Q6,SET,211,0.0060442,0.0006439,0.0609,0.46047,TGACGTCA_ATF3_Q6,0.991045323763169
MIR1914_5P,SET,55,0.012132,0.00066272,0.12246,0.46054,MIR1914_5P,0.991045323763169
GOBP_REGULATION_OF_XENOPHAGY,SET,9,0.025429,0.00056259,0.25664,0.46054,GOBP_REGULATION_OF_XENOPHAGY,0.991045323763169
GOMF_KERATIN_FILAMENT_BINDING,SET,6,0.032543,0.00058791,0.32872,0.46057,GOMF_KERATIN_FILAMENT_BINDING,0.991045323763169
WP_OXYSTEROLS_DERIVED_FROM_C...,SET,49,0.012808,0.00066049,0.12945,0.46059,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,0.991045323763169
GOBP_POSITIVE_REGULATION_OF_...417,SET,547,0.0039322,0.00066823,0.039743,0.46059,GOBP_POSITIVE_REGULATION_OF_LOCOMOTION,0.991045323763169
HP_HYPOPLASIA_OF_TEETH,SET,109,0.0080094,0.000615,0.081019,0.46063,HP_HYPOPLASIA_OF_TEETH,0.991045323763169
MIR206,SET,340,0.0046118,0.00062145,0.046733,0.4607,MIR206,0.991045323763169
PID_CONE_PATHWAY,SET,20,0.019443,0.00064105,0.19711,0.46071,PID_CONE_PATHWAY,0.991045323763169
GOBP_EXCRETION,SET,28,0.017123,0.00066784,0.17359,0.46071,GOBP_EXCRETION,0.991045323763169
GOBP_RESPONSE_TO_KETONE,SET,201,0.0063719,0.00066272,0.064661,0.46075,GOBP_RESPONSE_TO_KETONE,0.991045323763169
GOMF_PROLINE_RICH_REGION_BIN...,SET,16,0.022743,0.00067076,0.23192,0.46094,GOMF_PROLINE_RICH_REGION_BINDING,0.991045323763169
GOBP_NEGATIVE_REGULATION_OF_...90,SET,7,0.033325,0.00065026,0.33993,0.46095,GOBP_NEGATIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.991045323763169
FOROUTAN_INTEGRATED_TGFB_EMT...1,SET,70,0.011378,0.00070084,0.11615,0.46098,FOROUTAN_INTEGRATED_TGFB_EMT_DN,0.991045323763169
GSE43863_NAIVE_VS_MEMORY_TFH...1,SET,183,0.0061857,0.00061417,0.063207,0.46102,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN,0.991045323763169
HP_REDUCED_FACTOR_XI_ACTIVITY,SET,13,0.020443,0.00054353,0.20898,0.46104,HP_REDUCED_FACTOR_XI_ACTIVITY,0.991045323763169
GOBP_REGULATION_OF_MACROPHAG...1,SET,54,0.012356,0.00066878,0.12636,0.46105,GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION,0.991045323763169
MIR604,SET,13,0.023003,0.00061157,0.2354,0.46108,MIR604,0.991045323763169
GOBP_REGULATION_OF_EXTRACELL...2,SET,9,0.032682,0.00072307,0.33457,0.46109,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,0.991045323763169
MIR6504_5P,SET,128,0.0073814,0.00061387,0.075635,0.46113,MIR6504_5P,0.991045323763169
GOBP_POSITIVE_REGULATION_OF_...481,SET,1056,0.002706,0.00062973,0.027729,0.46113,GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.991045323763169
WANG_CLIM2_TARGETS_DN,SET,162,0.0061659,0.00057634,0.063254,0.46117,WANG_CLIM2_TARGETS_DN,0.991045323763169
GOBP_NEGATIVE_REGULATION_OF_...140,SET,5,0.037045,0.00061096,0.38025,0.4612,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.991045323763169
LIM_MAMMARY_STEM_CELL_UP,SET,430,0.0042681,0.00064517,0.043952,0.46132,LIM_MAMMARY_STEM_CELL_UP,0.991045323763169
BUSSLINGER_GASTRIC_PREZYMOGE...,SET,57,0.011818,0.00065714,0.12181,0.46136,BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS,0.991045323763169
MIR1207_5P,SET,305,0.0048573,0.00062053,0.050128,0.4614,MIR1207_5P,0.991045323763169
HP_URINARY_BLADDER_SPHINCTER...,SET,28,0.014415,0.00056222,0.14881,0.46142,HP_URINARY_BLADDER_SPHINCTER_DYSFUNCTION,0.991045323763169
MORF_PSMC1,SET,170,0.0057189,0.00054749,0.059096,0.46145,MORF_PSMC1,0.991045323763169
GSE17721_POLYIC_VS_PAM3CSK4_...4,SET,189,0.0060672,0.0006121,0.062779,0.46151,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP,0.991045323763169
REACTOME_TP53_REGULATES_TRAN...1,SET,20,0.018258,0.00060197,0.18899,0.46152,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN,0.991045323763169
GOBP_CELL_FATE_COMMITMENT,SET,268,0.0055342,0.00066341,0.057281,0.46152,GOBP_CELL_FATE_COMMITMENT,0.991045323763169
HP_ABNORMAL_CAUDATE_NUCLEUS_...,SET,19,0.019718,0.00063367,0.20422,0.46154,HP_ABNORMAL_CAUDATE_NUCLEUS_MORPHOLOGY,0.991045323763169
GOBP_ENDOTHELIUM_DEVELOPMENT,SET,129,0.007773,0.00064894,0.080616,0.46159,GOBP_ENDOTHELIUM_DEVELOPMENT,0.991045323763169
TSENG_IRS1_TARGETS_DN,SET,112,0.0083855,0.00065263,0.087082,0.46164,TSENG_IRS1_TARGETS_DN,0.991045323763169
GRADE_COLON_VS_RECTAL_CANCER...2,SET,34,0.014109,0.00060631,0.1466,0.46166,GRADE_COLON_VS_RECTAL_CANCER_UP,0.991045323763169
REACTOME_TRANSLATION_OF_SARS...1,SET,28,0.014971,0.00058393,0.15554,0.46166,REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,0.991045323763169
GOCC_LEWY_BODY,SET,7,0.030038,0.00058613,0.31208,0.46166,GOCC_LEWY_BODY,0.991045323763169
HP_COXA_VARA,SET,58,0.010613,0.0005953,0.11044,0.46172,HP_COXA_VARA,0.991045323763169
MIR6886_5P,SET,8,0.031615,0.00065947,0.32907,0.46173,MIR6886_5P,0.991045323763169
HP_PORPHYRINURIA,SET,7,0.029184,0.00056946,0.30424,0.46179,HP_PORPHYRINURIA,0.991045323763169
HP_ABNORMAL_RENAL_TUBULAR_RE...,SET,19,0.019884,0.00063899,0.20748,0.46183,HP_ABNORMAL_RENAL_TUBULAR_RESORPTION,0.991045323763169
GAVISH_3CA_MALIGNANT_METAPRO...35,SET,41,0.012017,0.00056696,0.12546,0.46185,GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN,0.991045323763169
GSE22282_HYPOXIA_VS_NORMOXIA...2,SET,174,0.0062459,0.00060486,0.065269,0.46188,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP,0.991045323763169
HP_SUBCORTICAL_HETEROTOPIA,SET,11,0.022481,0.00054984,0.23544,0.46196,HP_SUBCORTICAL_HETEROTOPIA,0.991045323763169
GSE35543_IN_VIVO_NTREG_VS_CO...2,SET,157,0.0063551,0.00058487,0.066551,0.46196,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP,0.991045323763169
GOBP_PHOSPHATIDYLCHOLINE_MET...,SET,68,0.010187,0.00061851,0.10669,0.46197,GOBP_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,0.991045323763169
GOBP_TUBULIN_DEACETYLATION,SET,18,0.017565,0.00054943,0.18417,0.46201,GOBP_TUBULIN_DEACETYLATION,0.991045323763169
GSE17721_LPS_VS_CPG_16H_BMDC...1,SET,184,0.0055976,0.00055729,0.058714,0.46202,GSE17721_LPS_VS_CPG_16H_BMDC_DN,0.991045323763169
MIR6886_3P,SET,84,0.0085564,0.00057715,0.089771,0.46203,MIR6886_3P,0.991045323763169
MIR548AW,SET,539,0.0035881,0.00060541,0.037658,0.46205,MIR548AW,0.991045323763169
GSE339_CD8POS_VS_CD4CD8DN_DC...3,SET,185,0.0059474,0.0005937,0.06242,0.46205,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,0.991045323763169
GSE23505_IL6_IL1_VS_IL6_IL1_...2,SET,178,0.0059868,0.00058633,0.06289,0.46208,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.991045323763169
MIR6768_3P,SET,127,0.0073446,0.00060844,0.077254,0.46213,MIR6768_3P,0.991045323763169
GOMF_FATTY_ACID_BINDING,SET,45,0.012206,0.00060325,0.12858,0.46219,GOMF_FATTY_ACID_BINDING,0.991045323763169
CHEN_HOXA5_TARGETS_6HR_UP,SET,9,0.029345,0.00064923,0.30931,0.46221,CHEN_HOXA5_TARGETS_6HR_UP,0.991045323763169
GOCC_APICAL_JUNCTION_COMPLEX,SET,130,0.0074684,0.0006259,0.078747,0.46222,GOCC_APICAL_JUNCTION_COMPLEX,0.991045323763169
HP_ABNORMALITY_OF_THE_INTRIN...,SET,35,0.0124,0.00054062,0.131,0.46229,HP_ABNORMALITY_OF_THE_INTRINSIC_PATHWAY,0.991045323763169
GOCC_GOLGI_CIS_CISTERNA,SET,15,0.019819,0.00056599,0.20957,0.46233,GOCC_GOLGI_CIS_CISTERNA,0.991045323763169
REACTOME_RIPK1_MEDIATED_REGU...,SET,28,0.014876,0.0005802,0.15733,0.46234,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,0.991045323763169
chr11p12,SET,6,0.041515,0.00074999,0.43939,0.46236,chr11p12,0.991045323763169
AR_Q6,SET,234,0.0053246,0.00059698,0.056345,0.46236,AR_Q6,0.991045323763169
GSE37301_HEMATOPOIETIC_STEM_...6,SET,149,0.0065884,0.00059082,0.069721,0.46236,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP,0.991045323763169
GOBP_NEGATIVE_REGULATION_OF_...428,SET,2,0.06662,0.00069493,0.70513,0.46237,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,0.991045323763169
FAELT_B_CLL_WITH_VH_REARRANG...2,SET,44,0.012095,0.00059111,0.12812,0.4624,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,0.991045323763169
HP_ABNORMAL_ERYTHROCYTE_ADEN...,SET,22,0.016142,0.00055817,0.171,0.4624,HP_ABNORMAL_ERYTHROCYTE_ADENOSINE_DEAMINASE_ACTIVITY,0.991045323763169
HP_CHRONIC_FURUNCULOSIS,SET,4,0.040454,0.00059676,0.42879,0.46242,HP_CHRONIC_FURUNCULOSIS,0.991045323763169
HP_HYPERPROSTAGLANDINURIA,SET,6,0.039067,0.00070578,0.41412,0.46242,HP_HYPERPROSTAGLANDINURIA,0.991045323763169
GSE13738_TCR_VS_BYSTANDER_AC...2,SET,178,0.0060561,0.00059312,0.064205,0.46243,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.991045323763169
WP_SEROTONIN_TRANSPORTER_ACT...,SET,10,0.025537,0.00059553,0.27104,0.46247,WP_SEROTONIN_TRANSPORTER_ACTIVITY,0.991045323763169
HP_DECREASED_CIRCULATING_COM...3,SET,3,0.048086,0.00061432,0.51059,0.46248,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_B_CONCENTRATION,0.991045323763169
CREB_Q2,SET,238,0.0053113,0.00060049,0.056522,0.46257,CREB_Q2,0.991045323763169
GSE17721_0.5H_VS_24H_LPS_BMD...1,SET,183,0.0058215,0.00057801,0.061955,0.46257,GSE17721_0.5H_VS_24H_LPS_BMDC_DN,0.991045323763169
GOBP_DETECTION_OF_TEMPERATUR...3,SET,5,0.039853,0.00065727,0.42485,0.46263,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_THERMOCEPTION,0.991045323763169
HP_OCCIPITAL_ENCEPHALOCELE,SET,36,0.012502,0.0005528,0.13328,0.46263,HP_OCCIPITAL_ENCEPHALOCELE,0.991045323763169
BILD_SRC_ONCOGENIC_SIGNATURE,SET,55,0.010277,0.00056136,0.10963,0.46266,BILD_SRC_ONCOGENIC_SIGNATURE,0.991045323763169
SA_G1_AND_S_PHASES,SET,15,0.020858,0.00059566,0.22251,0.46266,SA_G1_AND_S_PHASES,0.991045323763169
GOBP_C_TERMINAL_PROTEIN_AMIN...,SET,16,0.020827,0.00061426,0.22226,0.46267,GOBP_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,0.991045323763169
GOBP_MATURATION_OF_5_8S_RRNA...,SET,24,0.014733,0.00053208,0.15729,0.46269,GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.991045323763169
WP_APOPTOSISRELATED_NETWORK_...,SET,52,0.011861,0.00063002,0.12669,0.4627,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.991045323763169
GOBP_CELL_PROLIFERATION_INVO...2,SET,21,0.020083,0.00067848,0.21451,0.46271,GOBP_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.991045323763169
REACTOME_GAP_JUNCTION_TRAFFI...,SET,46,0.013248,0.00066196,0.14177,0.46277,REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,0.991045323763169
REACTOME_EXTRACELLULAR_MATRI...,SET,285,0.0050877,0.00062864,0.054452,0.46278,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,0.991045323763169
GSE3039_NKT_CELL_VS_B1_BCELL...2,SET,176,0.00588,0.00057266,0.062982,0.46281,GSE3039_NKT_CELL_VS_B1_BCELL_UP,0.991045323763169
MODULE_379,SET,178,0.0060828,0.00059573,0.065173,0.46282,MODULE_379,0.991045323763169
HP_EEG_WITH_IRREGULAR_GENERA...,SET,11,0.025084,0.00061349,0.26879,0.46283,HP_EEG_WITH_IRREGULAR_GENERALIZED_SPIKE_AND_WAVE_COMPLEXES,0.991045323763169
GOBP_RESPONSE_TO_POTASSIUM_I...,SET,18,0.020155,0.00063046,0.21654,0.46292,GOBP_RESPONSE_TO_POTASSIUM_ION,0.99108262195122
NABA_MATRISOME_HIGHLY_METAST...4,SET,12,0.024398,0.00062324,0.26219,0.46293,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,0.99108262195122
UNTERMAN_PROGRESSIVE_VS_STAB...3,SET,5,0.039342,0.00064883,0.42302,0.46295,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_UP,0.99108262195122
PETRETTO_LEFT_VENTRICLE_MASS...2,SET,5,0.03395,0.00055991,0.3653,0.46298,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP,0.99108262195122
BASAKI_YBX1_TARGETS_UP,SET,261,0.0048826,0.00057772,0.052555,0.46299,BASAKI_YBX1_TARGETS_UP,0.99108262195122
GOBP_REGULATION_OF_POSTSYNAP...10,SET,15,0.019911,0.00056861,0.21472,0.46306,GOBP_REGULATION_OF_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,0.991171417133707
HP_ABNORMAL_FRONTAL_BONE_MOR...,SET,365,0.0040528,0.00056546,0.043819,0.46315,HP_ABNORMAL_FRONTAL_BONE_MORPHOLOGY,0.991303008375416
KEGG_MEDICUS_REFERENCE_GPI_A...,SET,23,0.015193,0.00053712,0.16453,0.46321,KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS,0.991329013105273
REACTOME_FORMATION_OF_APOPTO...,SET,10,0.024731,0.00057673,0.26795,0.46323,REACTOME_FORMATION_OF_APOPTOSOME,0.991329013105273
DESCARTES_FETAL_THYMUS_STROM...,SET,116,0.0077883,0.00061681,0.08446,0.46326,DESCARTES_FETAL_THYMUS_STROMAL_CELLS,0.991329013105273
GOBP_AMPA_GLUTAMATE_RECEPTOR...,SET,10,0.026655,0.0006216,0.28925,0.46329,GOBP_AMPA_GLUTAMATE_RECEPTOR_CLUSTERING,0.991329013105273
GOBP_METANEPHRIC_GLOMERULAR_...,SET,5,0.042818,0.00070616,0.46523,0.46334,GOBP_METANEPHRIC_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.991329013105273
GOBP_REGULATION_OF_APOPTOTIC...2,SET,9,0.026685,0.00059038,0.29042,0.4634,GOBP_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION,0.991329013105273
BIOCARTA_CTL_PATHWAY,SET,13,0.022909,0.00060908,0.24959,0.46343,BIOCARTA_CTL_PATHWAY,0.991329013105273
HP_APLASIA_HYPOPLASIA_OF_FIN...,SET,314,0.0044454,0.00057608,0.048475,0.46347,HP_APLASIA_HYPOPLASIA_OF_FINGERS,0.991329013105273
HP_ABNORMAL_THYMUS_MORPHOLOGY,SET,51,0.011764,0.00061886,0.12833,0.46348,HP_ABNORMAL_THYMUS_MORPHOLOGY,0.991329013105273
CHUANG_OXIDATIVE_STRESS_RESP...2,SET,26,0.016082,0.00060447,0.1755,0.46349,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,0.991329013105273
FIGUEROA_AML_METHYLATION_CLU...6,SET,151,0.0066621,0.0006014,0.072775,0.46353,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,0.991329013105273
HP_HYPERREFLEXIA,SET,707,0.0029164,0.0005609,0.031863,0.46354,HP_HYPERREFLEXIA,0.991329013105273
GSE22432_MULTIPOTENT_PROGENI...2,SET,183,0.0058566,0.0005815,0.06399,0.46354,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP,0.991329013105273
GOBP_REGULATION_OF_ENDODERMA...,SET,6,0.038949,0.00070364,0.42606,0.46358,GOBP_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION,0.991329013105273
HP_BICARBONATE_WASTING_RENAL...,SET,5,0.035329,0.00058265,0.38653,0.46359,HP_BICARBONATE_WASTING_RENAL_TUBULAR_ACIDOSIS,0.991329013105273
GOBP_RNA_EXPORT_FROM_NUCLEUS,SET,80,0.0081144,0.0005342,0.088905,0.46364,GOBP_RNA_EXPORT_FROM_NUCLEUS,0.991338484251969
HP_EEG_WITH_POLYSPIKE_WAVE_C...,SET,46,0.01209,0.00060412,0.13256,0.46367,HP_EEG_WITH_POLYSPIKE_WAVE_COMPLEXES,0.991338484251969
GSE3920_UNTREATED_VS_IFNG_TR...1,SET,174,0.0057871,0.00056043,0.06347,0.46368,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.991338484251969
MIR6817_5P,SET,98,0.007839,0.0005709,0.086452,0.46388,MIR6817_5P,0.991650350553505
AMIT_EGF_RESPONSE_240_MCF10A,SET,21,0.018825,0.00063599,0.20769,0.46389,AMIT_EGF_RESPONSE_240_MCF10A,0.991650350553505
HP_CHORIORETINAL_ATROPHY,SET,40,0.012656,0.00058981,0.13974,0.46392,HP_CHORIORETINAL_ATROPHY,0.991650350553505
NIKOLSKY_BREAST_CANCER_22Q13...,SET,16,0.030055,0.00088641,0.33202,0.46394,NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,0.991650350553505
HP_ABNORMAL_TOENAIL_MORPHOLO...,SET,152,0.0063567,0.0005757,0.070387,0.46402,HP_ABNORMAL_TOENAIL_MORPHOLOGY,0.991662893507132
GOBP_CELLULAR_RESPONSE_TO_NI...4,SET,6,0.028058,0.00050688,0.31072,0.46403,GOBP_CELLULAR_RESPONSE_TO_NITROSATIVE_STRESS,0.991662893507132
HP_UVEAL_MELANOMA,SET,8,0.023799,0.00049644,0.26373,0.46405,HP_UVEAL_MELANOMA,0.991662893507132
GOBP_RESPONSE_TO_ARSENIC_CON...,SET,30,0.013796,0.00055693,0.15292,0.46406,GOBP_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,0.991662893507132
GOBP_MESENDODERM_DEVELOPMENT,SET,9,0.026243,0.0005806,0.29141,0.46412,GOBP_MESENDODERM_DEVELOPMENT,0.991687960914454
GSE37534_PIOGLITAZONE_VS_ROS...2,SET,174,0.0054449,0.00052729,0.060476,0.46413,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.991687960914454
REACTOME_METABOLISM_OF_FAT_S...,SET,45,0.012443,0.00061497,0.13842,0.46419,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,0.991687960914454
GOBP_POSITIVE_REGULATION_OF_...277,SET,61,0.010424,0.00059955,0.11612,0.46424,GOBP_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.991687960914454
HP_JOINT_DISLOCATION,SET,330,0.0042579,0.00056541,0.04744,0.46424,HP_JOINT_DISLOCATION,0.991687960914454
GSE40274_CTRL_VS_IRF4_TRANSD...1,SET,151,0.0063075,0.00056938,0.070286,0.46425,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.991687960914454
GOMF_NEUROTROPHIN_RECEPTOR_A...,SET,5,0.03801,0.00062687,0.42418,0.4643,GOMF_NEUROTROPHIN_RECEPTOR_ACTIVITY,0.991687960914454
HP_TONGUE_ATROPHY,SET,49,0.010875,0.0005608,0.12138,0.4643,HP_TONGUE_ATROPHY,0.991687960914454
LEE_LIVER_CANCER_MYC_DN,SET,56,0.011805,0.00065064,0.13215,0.46441,LEE_LIVER_CANCER_MYC_DN,0.991746858879882
MOOTHA_TCA,SET,14,0.017909,0.00049411,0.20048,0.46441,MOOTHA_TCA,0.991746858879882
GOBP_PROTEIN_NITROSYLATION,SET,13,0.024121,0.00064131,0.27022,0.46444,GOBP_PROTEIN_NITROSYLATION,0.991746858879882
GOBP_POSITIVE_REGULATION_OF_...745,SET,6,0.030253,0.00054654,0.33911,0.46446,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.991746858879882
GOMF_BETA_2_ADRENERGIC_RECEP...,SET,5,0.034658,0.00057158,0.38885,0.46449,GOMF_BETA_2_ADRENERGIC_RECEPTOR_BINDING,0.991746858879882
GOBP_MUSCLE_ORGAN_MORPHOGENE...,SET,76,0.0097707,0.00062702,0.10968,0.46451,GOBP_MUSCLE_ORGAN_MORPHOGENESIS,0.991746858879882
GOBP_CELL_ADHESION,SET,1401,0.002285,0.00060636,0.025681,0.46455,GOBP_CELL_ADHESION,0.991746858879882
GSE32986_UNSTIM_VS_CURDLAN_H...1,SET,174,0.0057402,0.00055589,0.064535,0.46456,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,0.991746858879882
GSE45837_WT_VS_GFI1_KO_PDC_DN,SET,175,0.005454,0.00052968,0.061405,0.46461,GSE45837_WT_VS_GFI1_KO_PDC_DN,0.991746858879882
CDPCR1_01,SET,117,0.0075299,0.00059889,0.084809,0.46463,CDPCR1_01,0.991746858879882
GOCC_GUANYL_NUCLEOTIDE_EXCHA...,SET,22,0.01602,0.00055393,0.18057,0.46465,GOCC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX,0.991746858879882
GSE14415_ACT_VS_CTRL_NATURAL...2,SET,157,0.0058306,0.0005366,0.06576,0.46467,GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP,0.991746858879882
ACEVEDO_LIVER_CANCER_DN,SET,490,0.0034891,0.00056207,0.039392,0.46471,ACEVEDO_LIVER_CANCER_DN,0.991771326373964
GOBP_POSITIVE_REGULATION_OF_...661,SET,17,0.019851,0.00060348,0.22433,0.46474,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.991774450448238
AMIT_SERUM_RESPONSE_240_MCF1...,SET,53,0.011327,0.00060739,0.1282,0.4648,AMIT_SERUM_RESPONSE_240_MCF10A,0.991780697445973
GOBP_CELL_CELL_JUNCTION_ASSE...,SET,146,0.0067844,0.00060229,0.076801,0.4648,GOBP_CELL_CELL_JUNCTION_ASSEMBLY,0.991780697445973
RUBENSTEIN_SKELETAL_MUSCLE_S...1,SET,266,0.0046276,0.00055269,0.052423,0.46483,RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS,0.991783820369575
GAVISH_3CA_METAPROGRAM_EPITH...9,SET,50,0.011117,0.00057906,0.12604,0.46486,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI4,0.991786942909761
GOBP_REGULATION_OF_STEROID_M...,SET,91,0.008352,0.00058625,0.095092,0.46501,GOBP_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.991911997306727
HP_ABNORMAL_SYSTEMIC_ARTERIA...,SET,471,0.0035121,0.00055499,0.040033,0.46505,HP_ABNORMAL_SYSTEMIC_ARTERIAL_MORPHOLOGY,0.991911997306727
HE_LIM_SUN_FETAL_LUNG_C4_TH1...,SET,15,0.021309,0.00060853,0.24301,0.46506,HE_LIM_SUN_FETAL_LUNG_C4_TH17_CELL,0.991911997306727
GOBP_THORAX_AND_ANTERIOR_ABD...,SET,5,0.046572,0.00076807,0.53162,0.4651,GOBP_THORAX_AND_ANTERIOR_ABDOMEN_DETERMINATION,0.991911997306727
BIOCARTA_AKT_PATHWAY,SET,20,0.016857,0.00055579,0.1927,0.46515,BIOCARTA_AKT_PATHWAY,0.991911997306727
SOGA_COLORECTAL_CANCER_MYC_DN,SET,69,0.0093138,0.00056962,0.10654,0.46517,SOGA_COLORECTAL_CANCER_MYC_DN,0.991911997306727
GSE10239_NAIVE_VS_MEMORY_CD8...1,SET,181,0.0055213,0.00054523,0.063188,0.46519,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.991911997306727
MURARO_PANCREAS_DELTA_CELL,SET,222,0.0056015,0.00061191,0.064237,0.46526,MURARO_PANCREAS_DELTA_CELL,0.991911997306727
HP_ATLANTOAXIAL_INSTABILITY,SET,5,0.032249,0.00053186,0.37068,0.46534,HP_ATLANTOAXIAL_INSTABILITY,0.991911997306727
HP_ABNORMAL_BLOOD_PHOSPHATE_...,SET,58,0.010331,0.00057946,0.11879,0.46535,HP_ABNORMAL_BLOOD_PHOSPHATE_CONCENTRATION,0.991911997306727
GSE3720_UNSTIM_VS_PMA_STIM_V...2,SET,158,0.0056849,0.00052484,0.06542,0.46538,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,0.991911997306727
GOBP_REGULATION_OF_LIPOPROTE...2,SET,15,0.018988,0.00054226,0.21868,0.4654,GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,0.991911997306727
GOBP_PROTEIN_CONTAINING_COMP...3,SET,177,0.0056364,0.00055047,0.06494,0.46542,GOBP_PROTEIN_CONTAINING_COMPLEX_LOCALIZATION,0.991911997306727
GOCC_CILIARY_PLASM,SET,135,0.0060467,0.00051634,0.069715,0.46544,GOCC_CILIARY_PLASM,0.991911997306727
GOCC_AP_TYPE_MEMBRANE_COAT_A...,SET,39,0.0113,0.00051998,0.13039,0.46547,GOCC_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX,0.991911997306727
BERENJENO_TRANSFORMED_BY_RHO...4,SET,25,0.016266,0.00059953,0.18801,0.46553,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,0.991911997306727
GSE22611_MUTANT_NOD2_TRANSDU...2,SET,172,0.0055249,0.00053198,0.06395,0.46558,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP,0.991911997306727
GTACAGG_MIR486,SET,53,0.010082,0.00054066,0.1168,0.46561,GTACAGG_MIR486,0.991911997306727
GOCC_CBM_COMPLEX,SET,5,0.031916,0.00052636,0.3698,0.46561,GOCC_CBM_COMPLEX,0.991911997306727
WP_MECHANOREGULATION_AND_PAT...,SET,44,0.011723,0.00057294,0.13612,0.46568,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,0.991911997306727
HP_COMA,SET,91,0.0076977,0.00054033,0.089409,0.4657,HP_COMA,0.991911997306727
GOCC_BASAL_PART_OF_CELL,SET,297,0.0045512,0.00057387,0.0529,0.46572,GOCC_BASAL_PART_OF_CELL,0.991911997306727
RORA2_01,SET,134,0.0065228,0.00055494,0.07595,0.46578,RORA2_01,0.991911997306727
GOBP_LIPOPROTEIN_LOCALIZATION,SET,19,0.01512,0.00048591,0.17611,0.46579,GOBP_LIPOPROTEIN_LOCALIZATION,0.991911997306727
NUYTTEN_NIPP1_TARGETS_UP,SET,665,0.0028665,0.00053531,0.033426,0.46583,NUYTTEN_NIPP1_TARGETS_UP,0.991911997306727
MIR4667_5P,SET,157,0.0063502,0.00058442,0.074077,0.46584,MIR4667_5P,0.991911997306727
MIR6809_3P,SET,504,0.0034565,0.00056449,0.04032,0.46584,MIR6809_3P,0.991911997306727
GOBP_EMBRYONIC_DIGESTIVE_TRA...1,SET,33,0.014644,0.00061999,0.17087,0.46585,GOBP_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT,0.991911997306727
GOMF_O_ACYLTRANSFERASE_ACTIV...,SET,47,0.011002,0.00055568,0.12837,0.46585,GOMF_O_ACYLTRANSFERASE_ACTIVITY,0.991911997306727
GSE9946_IMMATURE_VS_PROSTAGL...2,SET,139,0.0061593,0.00053363,0.071943,0.46589,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.991911997306727
REACTOME_REGULATION_OF_TLR_B...,SET,20,0.019513,0.00064335,0.22807,0.46591,REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND,0.991911997306727
GOMF_SUGAR_TRANSMEMBRANE_TRA...,SET,25,0.015198,0.00056017,0.17767,0.46592,GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.991911997306727
HP_FOCAL_MOTOR_SEIZURE,SET,100,0.0074214,0.00054595,0.086918,0.46598,HP_FOCAL_MOTOR_SEIZURE,0.991911997306727
AP3_Q6,SET,228,0.0052583,0.00058204,0.061598,0.46599,AP3_Q6,0.991911997306727
GSE2770_UNTREATED_VS_IL4_TRE...2,SET,188,0.0053114,0.00053445,0.062256,0.46601,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.991911997306727
MIR7703,SET,101,0.0074329,0.00054951,0.087243,0.46605,MIR7703,0.991911997306727
WP_SARSCOV2_AND_ACE2_RECEPTO...,SET,6,0.036168,0.00065341,0.42468,0.46606,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,0.991911997306727
MIR2115_5P,SET,123,0.0064756,0.00052799,0.07602,0.46606,MIR2115_5P,0.991911997306727
REACTOME_INFECTION_WITH_MYCO...,SET,25,0.014406,0.00053097,0.16925,0.46608,REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,0.991911997306727
WP_POLYCYSTIC_KIDNEY_DISEASE...,SET,82,0.0085001,0.00056651,0.099851,0.46608,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,0.991911997306727
KEGG_MEDICUS_VARIANT_TRK_FUS...,SET,10,0.02184,0.00050931,0.25667,0.4661,KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.991911997306727
GAO_LARGE_INTESTINE_ADULT_CA...,SET,260,0.0048205,0.00056929,0.056704,0.46613,GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS,0.991911997306727
KEGG_MEDICUS_REFERENCE_CXCR_...2,SET,26,0.015346,0.00057679,0.18069,0.46616,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,0.991911997306727
ZHAN_V2_LATE_DIFFERENTIATION...,SET,36,0.012518,0.00055347,0.14755,0.4662,ZHAN_V2_LATE_DIFFERENTIATION_GENES,0.991911997306727
GOMF_PHOSPHATIDYLINOSITOL_3_...3,SET,35,0.012377,0.0005396,0.14612,0.46625,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING,0.991911997306727
HP_ABNORMAL_SACROILIAC_JOINT...,SET,6,0.035491,0.00064117,0.41899,0.46625,HP_ABNORMAL_SACROILIAC_JOINT_MORPHOLOGY,0.991911997306727
MORF_RAF1,SET,108,0.0063024,0.00048171,0.074429,0.46626,MORF_RAF1,0.991911997306727
NIKOLSKY_BREAST_CANCER_19P13...,SET,5,0.048132,0.0007938,0.57004,0.46636,NIKOLSKY_BREAST_CANCER_19P13_AMPLICON,0.992052434548569
MIR4769_3P,SET,97,0.0073148,0.00053002,0.086854,0.46644,MIR4769_3P,0.992052434548569
MIR6888_5P,SET,45,0.011762,0.00058131,0.13983,0.46648,MIR6888_5P,0.992052434548569
RUIZ_TNC_TARGETS_DN,SET,136,0.0062999,0.00053994,0.074904,0.46649,RUIZ_TNC_TARGETS_DN,0.992052434548569
SANSOM_APC_TARGETS_REQUIRE_M...,SET,210,0.004701,0.00049964,0.055894,0.46649,SANSOM_APC_TARGETS_REQUIRE_MYC,0.992052434548569
GOBP_RESPONSE_TO_CORTICOSTER...1,SET,146,0.0063758,0.00056602,0.075992,0.46657,GOBP_RESPONSE_TO_CORTICOSTEROID,0.992052434548569
GSE21063_CTRL_VS_ANTI_IGM_ST...8,SET,181,0.0055864,0.00055166,0.066605,0.46658,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP,0.992052434548569
VISALA_RESPONSE_TO_HEAT_SHOC...2,SET,14,0.018034,0.00049755,0.21512,0.4666,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,0.992052434548569
LOCKWOOD_AMPLIFIED_IN_LUNG_C...,SET,203,0.0055821,0.00058342,0.066641,0.46662,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,0.992052434548569
HP_SYNOSTOSIS_OF_JOINTS,SET,171,0.0056864,0.00054596,0.067891,0.46662,HP_SYNOSTOSIS_OF_JOINTS,0.992052434548569
GSE17974_CTRL_VS_ACT_IL4_AND...13,SET,178,0.0050189,0.00049154,0.059945,0.46664,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN,0.992052434548569
CHEMNITZ_RESPONSE_TO_PROSTAG...2,SET,126,0.0060875,0.00050232,0.07294,0.46674,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,0.992092637980563
GSE22432_MULTIPOTENT_PROGENI...3,SET,177,0.0050535,0.00049355,0.060549,0.46674,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN,0.992092637980563
GOBP_TRANSCRIPTION_ELONGATIO...1,SET,6,0.031116,0.00056214,0.37312,0.46677,GOBP_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_I,0.992092637980563
REPIN1_TARGET_GENES,SET,5,0.035106,0.00057897,0.42172,0.46683,REPIN1_TARGET_GENES,0.992092637980563
HP_INCREASED_NUMBER_OF_SKIN_...,SET,6,0.02587,0.00046736,0.3109,0.46684,HP_INCREASED_NUMBER_OF_SKIN_FOLDS,0.992092637980563
GSE40685_NAIVE_CD4_TCELL_VS_...1,SET,171,0.0056265,0.0005402,0.067604,0.46684,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.992092637980563
REACTOME_ACTIVATED_NTRK2_SIG...1,SET,6,0.031537,0.00056973,0.37929,0.46687,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5,0.992092637980563
WANG_METASTASIS_OF_BREAST_CA...3,SET,19,0.014589,0.00046884,0.17555,0.46689,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,0.992092637980563
MIKI_COEXPRESSED_WITH_CYP19A1,SET,7,0.02562,0.00049991,0.30873,0.46693,MIKI_COEXPRESSED_WITH_CYP19A1,0.992092637980563
GOMF_AMP_ACTIVATED_PROTEIN_K...,SET,8,0.024261,0.00050606,0.2929,0.46699,GOMF_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY,0.992092637980563
GOBP_CIRCULATORY_SYSTEM_PROC...,SET,566,0.0032564,0.0005626,0.039319,0.467,GOBP_CIRCULATORY_SYSTEM_PROCESS,0.992092637980563
DELASERNA_MYOD_TARGETS_UP,SET,81,0.0079995,0.0005299,0.096688,0.46703,DELASERNA_MYOD_TARGETS_UP,0.992092637980563
GOBP_REGULATION_OF_MODIFICAT...2,SET,9,0.02138,0.00047301,0.25839,0.46703,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,0.992092637980563
MIR3130_5P,SET,49,0.010045,0.00051798,0.12167,0.4671,MIR3130_5P,0.992093413740458
HP_MOTOR_POLYNEUROPATHY,SET,33,0.011995,0.00050784,0.14535,0.46711,HP_MOTOR_POLYNEUROPATHY,0.992093413740458
GOBP_TOLL_LIKE_RECEPTOR_2_SI...,SET,16,0.018402,0.00054273,0.22305,0.46712,GOBP_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.992093413740458
HP_ABNORMAL_MORPHOLOGY_OF_TH...1,SET,52,0.0097896,0.00052,0.11888,0.46719,HP_ABNORMAL_MORPHOLOGY_OF_THE_ABDOMINAL_MUSCULATURE,0.992093413740458
GSE13306_RA_VS_UNTREATED_MEM...1,SET,170,0.0055417,0.00053052,0.067318,0.4672,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN,0.992093413740458
GOCC_MEIOTIC_COHESIN_COMPLEX,SET,6,0.024401,0.00044082,0.29707,0.46727,GOCC_MEIOTIC_COHESIN_COMPLEX,0.992093413740458
HP_ALOPECIA,SET,218,0.0049188,0.00053253,0.059889,0.46727,HP_ALOPECIA,0.992093413740458
GOBP_NEGATIVE_REGULATION_OF_...558,SET,18,0.016548,0.00051764,0.20151,0.46728,GOBP_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.992093413740458
GOBP_POSITIVE_REGULATION_OF_...120,SET,300,0.004141,0.00052474,0.050456,0.4673,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE,0.992093413740458
GOMF_RACEMASE_AND_EPIMERASE_...1,SET,15,0.017444,0.00049814,0.21296,0.46736,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY,0.992093413740458
HP_DIMPLE_CHIN,SET,14,0.021001,0.00057941,0.25654,0.46738,HP_DIMPLE_CHIN,0.992093413740458
GOBP_REGULATION_OF_FATTY_ACI...1,SET,17,0.016687,0.0005073,0.20393,0.46739,GOBP_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.992093413740458
GSE13411_NAIVE_VS_IGM_MEMORY...2,SET,171,0.0054114,0.00051955,0.066195,0.46742,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP,0.992093413740458
GOBP_LONG_CHAIN_FATTY_ACID_M...,SET,102,0.0071317,0.00052983,0.087262,0.46743,GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.992093413740458
GSE46606_IRF4_KO_VS_WT_CD40L...2,SET,170,0.0055753,0.00053373,0.068352,0.4675,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP,0.992122310271259
HP_ABNORMAL_TEMPORAL_LOBE_MO...,SET,125,0.0063708,0.00052362,0.078154,0.46752,HP_ABNORMAL_TEMPORAL_LOBE_MORPHOLOGY,0.992122310271259
HP_ABNORMALITY_OF_VITAMIN_ME...,SET,94,0.007287,0.00051982,0.08948,0.46755,HP_ABNORMALITY_OF_VITAMIN_METABOLISM,0.992122310271259
REACTOME_FOXO_MEDIATED_TRANS...2,SET,16,0.018185,0.00053634,0.22384,0.46762,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,0.992122310271259
HP_NEPHROGENIC_DIABETES_INSI...,SET,7,0.027569,0.00053794,0.33956,0.46765,HP_NEPHROGENIC_DIABETES_INSIPIDUS,0.992122310271259
GOBP_REGULATION_OF_CELL_CYCL...1,SET,41,0.0098756,0.00046593,0.12185,0.4677,GOBP_REGULATION_OF_CELL_CYCLE_CHECKPOINT,0.992122310271259
REACTOME_POST_TRANSLATIONAL_...2,SET,1289,0.0019801,0.00050568,0.024443,0.46772,REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.992122310271259
ZHAN_EARLY_DIFFERENTIATION_G...1,SET,41,0.011717,0.00055279,0.14476,0.46775,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,0.992122310271259
GOCC_P_BODY,SET,93,0.0070553,0.00050062,0.087188,0.46775,GOCC_P_BODY,0.992122310271259
GOBP_GLYCOLIPID_BIOSYNTHETIC...,SET,74,0.0078654,0.00049809,0.097239,0.46777,GOBP_GLYCOLIPID_BIOSYNTHETIC_PROCESS,0.992122310271259
BERGER_MBD2_TARGETS,SET,4,0.041409,0.00061084,0.51301,0.46783,BERGER_MBD2_TARGETS,0.992122310271259
AGGAAGC_MIR5163P,SET,113,0.0067247,0.00052569,0.08335,0.46785,AGGAAGC_MIR5163P,0.992122310271259
KEGG_MEDICUS_REFERENCE_CITRA...2,SET,10,0.019269,0.00044935,0.23936,0.46792,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2,0.992122310271259
HP_ENLARGED_KIDNEY,SET,41,0.010483,0.0004946,0.1304,0.46796,HP_ENLARGED_KIDNEY,0.992122310271259
GOBP_ACUTE_INFLAMMATORY_RESP...2,SET,23,0.015797,0.00055851,0.19684,0.46802,GOBP_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.992122310271259
GSE37301_PRO_BCELL_VS_CD4_TC...1,SET,150,0.0057285,0.00051542,0.071379,0.46802,GSE37301_PRO_BCELL_VS_CD4_TCELL_DN,0.992122310271259
GOBP_CARBOHYDRATE_TRANSPORT,SET,126,0.0063305,0.00052237,0.078913,0.46803,GOBP_CARBOHYDRATE_TRANSPORT,0.992122310271259
GOBP_POSITIVE_REGULATION_OF_...156,SET,8,0.023347,0.000487,0.29172,0.46811,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.992122310271259
GCTTGAA_MIR498,SET,98,0.007048,0.00051329,0.088107,0.46812,GCTTGAA_MIR498,0.992122310271259
REACTOME_SIGNALING_BY_NTRKS,SET,132,0.0060577,0.00051154,0.075762,0.46814,REACTOME_SIGNALING_BY_NTRKS,0.992122310271259
MIR501_3P_MIR502_3P,SET,65,0.008935,0.00053044,0.11176,0.46814,MIR501_3P_MIR502_3P,0.992122310271259
TRAVAGLINI_LUNG_OLR1_CLASSIC...,SET,654,0.0028255,0.00052345,0.035339,0.46814,TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL,0.992122310271259
HP_OPPORTUNISTIC_FUNGAL_INFE...,SET,13,0.018681,0.00049666,0.23409,0.4682,HP_OPPORTUNISTIC_FUNGAL_INFECTION,0.992122310271259
GSE32986_CURDLAN_LOWDOSE_VS_...3,SET,181,0.004962,0.00049001,0.062207,0.46821,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.992122310271259
GSE18281_MEDULLARY_THYMOCYTE...1,SET,167,0.0051706,0.00049065,0.064831,0.46822,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN,0.992122310271259
SEF1_C,SET,5,0.031868,0.00052557,0.39975,0.46823,SEF1_C,0.992122310271259
KEGG_MEDICUS_REFERENCE_TYPE_...2,SET,20,0.017312,0.00057078,0.21725,0.46824,KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY,0.992122310271259
GOBP_GLOMERULAR_MESANGIAL_CE...1,SET,4,0.035818,0.00052836,0.44985,0.46827,GOBP_GLOMERULAR_MESANGIAL_CELL_DEVELOPMENT,0.992122310271259
GOBP_EOSINOPHIL_DIFFERENTIAT...,SET,6,0.029044,0.00052471,0.36518,0.4683,GOBP_EOSINOPHIL_DIFFERENTIATION,0.992122310271259
GOBP_SNRNA_CATABOLIC_PROCESS,SET,4,0.028348,0.00041818,0.3564,0.4683,GOBP_SNRNA_CATABOLIC_PROCESS,0.992122310271259
PID_TGFBR_PATHWAY,SET,52,0.0096841,0.00051439,0.12211,0.46839,PID_TGFBR_PATHWAY,0.992154173764906
ZNF680_TARGET_GENES,SET,614,0.0027413,0.00049263,0.034568,0.4684,ZNF680_TARGET_GENES,0.992154173764906
GOBP_PYRIDINE_CONTAINING_COM...3,SET,158,0.0052674,0.0004863,0.066455,0.46841,GOBP_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.992154173764906
HP_APLASIA_HYPOPLASIA_OF_THE...24,SET,4,0.030071,0.00044358,0.37975,0.46844,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.992154173764906
GOBP_VIRAL_PROCESS,SET,397,0.0035114,0.00051049,0.04453,0.46857,GOBP_VIRAL_PROCESS,0.992154173764906
MIR590_5P,SET,118,0.0062937,0.00050269,0.079887,0.4686,MIR590_5P,0.992154173764906
GSE39864_WT_VS_GATA3_KO_TREG...1,SET,180,0.0048387,0.00047652,0.061418,0.4686,GSE39864_WT_VS_GATA3_KO_TREG_DN,0.992154173764906
MDM2_TARGET_GENES,SET,9,0.019696,0.00043575,0.25033,0.46864,MDM2_TARGET_GENES,0.992154173764906
WP_HEPATITIS_C_AND_HEPATOCEL...,SET,49,0.010095,0.00052057,0.12831,0.46865,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,0.992154173764906
MIR129_5P,SET,336,0.0037993,0.000509,0.048313,0.46866,MIR129_5P,0.992154173764906
HP_CARCINOID_TUMOR,SET,12,0.018079,0.00046183,0.2299,0.46866,HP_CARCINOID_TUMOR,0.992154173764906
GOBP_GONADOTROPIN_SECRETION,SET,17,0.018128,0.00055108,0.23134,0.46877,GOBP_GONADOTROPIN_SECRETION,0.992154173764906
GOBP_POSTSYNAPTIC_NEUROTRANS...,SET,26,0.012907,0.00048513,0.16483,0.46879,GOBP_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.992154173764906
GSE17721_POLYIC_VS_GARDIQUIM...2,SET,184,0.0050446,0.00050223,0.064411,0.46879,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.992154173764906
GSE13887_RESTING_VS_NO_TREAT...1,SET,93,0.0068306,0.00048467,0.087269,0.46881,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN,0.992154173764906
HP_HEMOPTYSIS,SET,81,0.0081507,0.00053992,0.10418,0.46882,HP_HEMOPTYSIS,0.992154173764906
REACTOME_ADRENOCEPTORS,SET,9,0.026038,0.00057608,0.33289,0.46883,REACTOME_ADRENOCEPTORS,0.992154173764906
MIR3945,SET,34,0.011155,0.00047936,0.14352,0.46902,MIR3945,0.992154173764906
YAUCH_HEDGEHOG_SIGNALING_PAR...1,SET,237,0.0044321,0.00050005,0.057036,0.46903,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,0.992154173764906
MIR4803,SET,411,0.0033972,0.00050232,0.043719,0.46903,MIR4803,0.992154173764906
GOCC_ACETYLCHOLINE_GATED_CHA...,SET,16,0.018089,0.00053351,0.23275,0.46903,GOCC_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX,0.992154173764906
HP_ABNORMAL_MITRAL_VALVE_PHY...,SET,151,0.0055337,0.00049953,0.071236,0.46904,HP_ABNORMAL_MITRAL_VALVE_PHYSIOLOGY,0.992154173764906
GOBP_MORPHOGENESIS_OF_AN_EPI...4,SET,472,0.0031859,0.00050396,0.04102,0.46905,GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM,0.992154173764906
HP_TYPE_2_MUSCLE_FIBER_ATROP...,SET,16,0.015552,0.00045868,0.20035,0.46906,HP_TYPE_2_MUSCLE_FIBER_ATROPHY,0.992154173764906
REACTOME_ERYTHROPOIETIN_ACTI...3,SET,14,0.01747,0.00048199,0.22539,0.46911,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,0.992154173764906
GOMF_PEPTIDE_HORMONE_BINDING,SET,48,0.010683,0.00054526,0.13784,0.46911,GOMF_PEPTIDE_HORMONE_BINDING,0.992154173764906
GOCC_CHROMOSOME_TELOMERIC_RE...2,SET,12,0.016712,0.00042691,0.21604,0.46917,GOCC_CHROMOSOME_TELOMERIC_REPEAT_REGION,0.992154173764906
MIR30B_5P_MIR30C_5P,SET,713,0.002606,0.00050324,0.033696,0.46918,MIR30B_5P_MIR30C_5P,0.992154173764906
HP_ENLARGED_INTERPHALANGEAL_...,SET,5,0.029217,0.00048185,0.37794,0.46919,HP_ENLARGED_INTERPHALANGEAL_JOINTS,0.992154173764906
HP_BRUISING_SUSCEPTIBILITY,SET,162,0.0052853,0.00049404,0.0684,0.4692,HP_BRUISING_SUSCEPTIBILITY,0.992154173764906
GSE369_IFNG_KO_VS_WT_LIVER_UP,SET,179,0.0049953,0.00049058,0.064633,0.4692,GSE369_IFNG_KO_VS_WT_LIVER_UP,0.992154173764906
GRABARCZYK_BCL11B_TARGETS_DN,SET,56,0.0088786,0.00048936,0.11522,0.46929,GRABARCZYK_BCL11B_TARGETS_DN,0.99219680715198
GSE30971_CTRL_VS_LPS_STIM_MA...7,SET,169,0.005257,0.00050179,0.068246,0.4693,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN,0.99219680715198
GOBP_NONASSOCIATIVE_LEARNING,SET,6,0.026945,0.00048678,0.34993,0.46931,GOBP_NONASSOCIATIVE_LEARNING,0.99219680715198
WP_OVERLAP_BETWEEN_SIGNAL_TR...,SET,51,0.0092071,0.00048435,0.11976,0.46936,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,0.99219680715198
HOQUE_METHYLATED_IN_CANCER,SET,56,0.0091287,0.00050314,0.1188,0.46937,HOQUE_METHYLATED_IN_CANCER,0.99219680715198
GOBP_PURINE_NUCLEOSIDE_DIPHO...,SET,6,0.02829,0.00051108,0.36865,0.46942,GOBP_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99219680715198
GOCC_TRAPP_COMPLEX,SET,14,0.017493,0.00048264,0.22799,0.46942,GOCC_TRAPP_COMPLEX,0.99219680715198
HP_POOR_GROSS_MOTOR_COORDINA...,SET,12,0.020766,0.00053046,0.27139,0.4695,HP_POOR_GROSS_MOTOR_COORDINATION,0.992230209156685
GSE25123_IL4_VS_IL4_AND_ROSI...1,SET,177,0.0047997,0.00046876,0.06275,0.46952,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.992230209156685
REACTOME_HDL_ASSEMBLY,SET,7,0.022685,0.00044265,0.29669,0.46953,REACTOME_HDL_ASSEMBLY,0.992230209156685
REACTOME_DEFECTIVE_CHST14_CA...,SET,7,0.022411,0.0004373,0.29335,0.46955,REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE,0.992230209156685
GOBP_POSITIVE_REGULATION_OF_...116,SET,2,0.054854,0.00057221,0.71969,0.46962,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,0.992299726427138
HP_FLEXION_CONTRACTURE_OF_TH...,SET,4,0.039102,0.0005768,0.51337,0.46964,HP_FLEXION_CONTRACTURE_OF_THE_2ND_FINGER,0.992299726427138
REACTOME_ION_CHANNEL_TRANSPO...,SET,170,0.0051765,0.00049556,0.068134,0.46972,REACTOME_ION_CHANNEL_TRANSPORT,0.992396462651188
MCCABE_BOUND_BY_HOXC6,SET,356,0.0035386,0.00048771,0.046615,0.46975,MCCABE_BOUND_BY_HOXC6,0.992396462651188
WP_GLIOBLASTOMA_SIGNALING,SET,80,0.0073383,0.00048311,0.096793,0.46978,WP_GLIOBLASTOMA_SIGNALING,0.992396462651188
CUI_DEVELOPING_HEART_5TH_WEE...1,SET,36,0.011196,0.00049506,0.14778,0.4698,CUI_DEVELOPING_HEART_5TH_WEEK_ATRIAL_CARDIOMYOCYTE,0.992396462651188
HP_ABNORMAL_CIRCULATING_NON_...,SET,21,0.013632,0.00046056,0.1808,0.46995,HP_ABNORMAL_CIRCULATING_NON_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,0.992652987115595
GSE37533_PPARG1_FOXP3_VS_PPA...2,SET,190,0.0048847,0.00049409,0.064879,0.46999,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.992677146763902
HP_CALCIFIC_STIPPLING,SET,3,0.046136,0.00058941,0.61415,0.47006,HP_CALCIFIC_STIPPLING,0.992764663344677
HP_DECREASED_CIRCULATING_IRO...,SET,5,0.024743,0.00040806,0.32993,0.47011,HP_DECREASED_CIRCULATING_IRON_CONCENTRATION,0.992809931943854
GOBP_N_GLYCAN_PROCESSING,SET,17,0.015884,0.00048287,0.21206,0.47015,GOBP_N_GLYCAN_PROCESSING,0.992834077652206
CHEOK_RESPONSE_TO_HD_MTX_DN,SET,19,0.012955,0.00041634,0.17337,0.47022,CHEOK_RESPONSE_TO_HD_MTX_DN,0.992921568746583
OCT1_02,SET,187,0.0050461,0.00050641,0.067706,0.4703,OCT1_02,0.992960815322972
GSE14308_TH1_VS_NATURAL_TREG...1,SET,181,0.004568,0.0004511,0.061345,0.47032,GSE14308_TH1_VS_NATURAL_TREG_DN,0.992960815322972
GOBP_POLARIZED_EPITHELIAL_CE...,SET,24,0.013344,0.0004819,0.1793,0.47034,GOBP_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION,0.992960815322972
GOBP_POSITIVE_REGULATION_OF_...336,SET,14,0.018915,0.00052186,0.2551,0.47045,GOBP_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.992960815322972
MIR497_3P,SET,217,0.0043137,0.00046597,0.05824,0.47048,MIR497_3P,0.992960815322972
GOMF_RNA_DNA_HYBRID_RIBONUCL...,SET,6,0.026711,0.00048255,0.36072,0.47049,GOMF_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY,0.992960815322972
GOCC_PAM_COMPLEX_TIM23_ASSOC...,SET,5,0.027151,0.00044777,0.36704,0.47052,GOCC_PAM_COMPLEX_TIM23_ASSOCIATED_IMPORT_MOTOR,0.992960815322972
GOMF_CADHERIN_BINDING,SET,302,0.0036125,0.00045926,0.048848,0.47052,GOMF_CADHERIN_BINDING,0.992960815322972
GSE7831_1H_VS_4H_INFLUENZA_S...2,SET,182,0.0047362,0.00046898,0.064045,0.47053,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP,0.992960815322972
HP_POSTAXIAL_FOOT_POLYDACTYLY,SET,63,0.0077177,0.00045109,0.1044,0.47054,HP_POSTAXIAL_FOOT_POLYDACTYLY,0.992960815322972
JIANG_MELANOMA_TRM7_CD8,SET,78,0.0070735,0.00045984,0.095776,0.47056,JIANG_MELANOMA_TRM7_CD8,0.992960815322972
KEGG_MEDICUS_ENV_FACTOR_PHIP...,SET,3,0.040377,0.00051584,0.5473,0.4706,KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS,0.992960815322972
SCHUHMACHER_MYC_TARGETS_DN,SET,7,0.023962,0.00046757,0.32499,0.47061,SCHUHMACHER_MYC_TARGETS_DN,0.992960815322972
GSE17721_LPS_VS_CPG_16H_BMDC...2,SET,182,0.0046945,0.00046485,0.063816,0.47068,GSE17721_LPS_VS_CPG_16H_BMDC_UP,0.993048224367146
GOBP_XENOPHAGY,SET,14,0.016433,0.00045338,0.22367,0.47072,GOBP_XENOPHAGY,0.993072332159767
MIR588,SET,108,0.0063381,0.00048444,0.086493,0.47079,MIR588,0.993159723823976
SPIRA_SMOKERS_LUNG_CANCER_DN,SET,14,0.015821,0.00043651,0.21667,0.4709,SPIRA_SMOKERS_LUNG_CANCER_DN,0.993316376380629
MIR490_5P,SET,39,0.0098803,0.00045467,0.13553,0.47094,MIR490_5P,0.993316376380629
GSE5589_UNSTIM_VS_45MIN_LPS_...5,SET,182,0.0043678,0.00043251,0.059926,0.47095,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN,0.993316376380629
HOXD1_TARGET_GENES,SET,56,0.0080051,0.00044122,0.1101,0.47102,HOXD1_TARGET_GENES,0.993403732022574
MIR34C_5P,SET,240,0.0039386,0.00044714,0.054308,0.47109,MIR34C_5P,0.993457853546078
GOBP_NEURAL_FOLD_FORMATION,SET,7,0.023576,0.00046004,0.32528,0.47111,GOBP_NEURAL_FOLD_FORMATION,0.993457853546078
GSE17721_CTRL_VS_LPS_4H_BMDC...1,SET,181,0.0046144,0.00045568,0.063752,0.47115,GSE17721_CTRL_VS_LPS_4H_BMDC_DN,0.993457853546078
GOBP_BRANCHING_MORPHOGENESIS...1,SET,144,0.0055329,0.00048784,0.07648,0.47116,GOBP_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE,0.993457853546078
REACTOME_GRB2_SOS_PROVIDES_L...,SET,15,0.017014,0.00048587,0.23598,0.47126,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.993544480460467
GOBP_TELOMERIC_D_LOOP_DISASS...,SET,7,0.024756,0.00048306,0.34332,0.47126,GOBP_TELOMERIC_D_LOOP_DISASSEMBLY,0.993544480460467
WP_INVOLVEMENT_OF_SECRETASE_...,SET,16,0.01614,0.00047603,0.22404,0.47129,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,0.993544480460467
MILI_PSEUDOPODIA_HAPTOTAXIS_...2,SET,451,0.0028232,0.0004368,0.03926,0.47134,MILI_PSEUDOPODIA_HAPTOTAXIS_UP,0.993544480460467
HP_APLASIA_HYPOPLASIA_OF_THE...35,SET,7,0.020974,0.00040927,0.29195,0.47136,HP_APLASIA_HYPOPLASIA_OF_THE_GALLBLADDER,0.993544480460467
GOBP_POSITIVE_REGULATION_OF_...354,SET,137,0.0057452,0.00049419,0.080136,0.47142,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,0.993544480460467
CATTGTYY_SOX9_B1,SET,330,0.0034635,0.00045992,0.048353,0.47145,CATTGTYY_SOX9_B1,0.993544480460467
GOCC_PROTEIN_KINASE_COMPLEX,SET,135,0.0048996,0.00041838,0.068492,0.47149,GOCC_PROTEIN_KINASE_COMPLEX,0.993544480460467
chr7q22,SET,121,0.012293,0.00099419,0.17208,0.47153,chr7q22,0.993544480460467
MIR5092,SET,6,0.022978,0.00041511,0.32202,0.47156,MIR5092,0.993544480460467
GOBP_POSITIVE_REGULATION_OF_...282,SET,7,0.026384,0.00051482,0.37003,0.47158,GOBP_POSITIVE_REGULATION_OF_FEVER_GENERATION,0.993544480460467
GSE411_UNSTIM_VS_400MIN_IL6_...4,SET,188,0.0042612,0.00042877,0.059933,0.47166,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.993544480460467
RIZ_ERYTHROID_DIFFERENTIATIO...3,SET,24,0.01331,0.00048069,0.18729,0.47167,RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,0.993544480460467
GSE22935_WT_VS_MYD88_KO_MACR...4,SET,180,0.0043441,0.00042781,0.061122,0.47167,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP,0.993544480460467
MIR1303,SET,189,0.004398,0.0004437,0.061972,0.47171,MIR1303,0.993544480460467
BILANGES_SERUM_SENSITIVE_VIA...2,SET,24,0.013062,0.00047172,0.1841,0.47172,BILANGES_SERUM_SENSITIVE_VIA_TSC2,0.993544480460467
HP_ECTRODACTYLY,SET,66,0.0080217,0.00047985,0.11311,0.47173,HP_ECTRODACTYLY,0.993544480460467
GSE21360_PRIMARY_VS_QUATERNA...2,SET,157,0.005143,0.00047332,0.072692,0.4718,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.993544480460467
GSE24634_TREG_VS_TCONV_POST_...4,SET,181,0.0042889,0.00042353,0.060622,0.4718,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP,0.993544480460467
GOBP_POSITIVE_REGULATION_OF_...735,SET,11,0.017709,0.00043313,0.25037,0.47181,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.993544480460467
GSE16450_IMMATURE_VS_MATURE_...6,SET,164,0.0047555,0.00044722,0.067298,0.47183,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.993544480460467
GSE4984_GALECTIN1_VS_VEHICLE...1,SET,177,0.0043897,0.00042872,0.062113,0.47183,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN,0.993544480460467
WP_MATRIX_METALLOPROTEINASES,SET,28,0.012765,0.00049787,0.18097,0.47188,WP_MATRIX_METALLOPROTEINASES,0.993546528365792
MIR124_3P,SET,691,0.0023536,0.00044771,0.033405,0.47192,MIR124_3P,0.993546528365792
GOBP_GLANDULAR_EPITHELIAL_CE...1,SET,33,0.011445,0.00048456,0.16248,0.47192,GOBP_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT,0.993546528365792
GSE40666_WT_VS_STAT4_KO_CD8_...1,SET,175,0.0043585,0.00042328,0.061985,0.47197,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN,0.993546528365792
HP_HYPOPLASIA_OF_THE_VENTRAL...,SET,6,0.026904,0.00048604,0.38388,0.47206,HP_HYPOPLASIA_OF_THE_VENTRAL_PONS,0.993546528365792
WP_QUERCETIN_AND_NFKB_AP1_IN...,SET,15,0.016691,0.00047665,0.23825,0.47208,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.993546528365792
GOBP_REGULATION_OF_COLLAGEN_...2,SET,32,0.01162,0.00048446,0.16616,0.47212,GOBP_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.993546528365792
MIR6854_3P,SET,10,0.021874,0.00051011,0.31283,0.47213,MIR6854_3P,0.993546528365792
GOBP_ENDOSOME_TO_LYSOSOME_TR...1,SET,68,0.0071724,0.00043547,0.10257,0.47213,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.993546528365792
HP_ABNORMAL_PARANASAL_SINUS_...,SET,158,0.0049237,0.00045457,0.070425,0.47213,HP_ABNORMAL_PARANASAL_SINUS_MORPHOLOGY,0.993546528365792
GOCC_LOW_DENSITY_LIPOPROTEIN...,SET,13,0.016743,0.00044515,0.23975,0.47216,GOCC_LOW_DENSITY_LIPOPROTEIN_PARTICLE,0.993546528365792
KEGG_SULFUR_METABOLISM,SET,11,0.018041,0.00044125,0.25895,0.47223,KEGG_SULFUR_METABOLISM,0.993546528365792
GOLDRATH_IMMUNE_MEMORY,SET,61,0.0080592,0.00046354,0.11606,0.47232,GOLDRATH_IMMUNE_MEMORY,0.993546528365792
GSE17974_CTRL_VS_ACT_IL4_AND...15,SET,178,0.0043875,0.0004297,0.063238,0.47234,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN,0.993546528365792
GOCC_TRNA_SPLICING_LIGASE_CO...,SET,7,0.023553,0.00045958,0.34019,0.4724,GOCC_TRNA_SPLICING_LIGASE_COMPLEX,0.993546528365792
GSE369_SOCS3_KO_VS_WT_LIVER_...4,SET,178,0.0042379,0.00041505,0.0612,0.4724,GSE369_SOCS3_KO_VS_WT_LIVER_UP,0.993546528365792
MODULE_95,SET,485,0.0027777,0.00044525,0.04022,0.47247,MODULE_95,0.993546528365792
GSE8835_HEALTHY_VS_CLL_CD8_T...2,SET,183,0.0043142,0.00042835,0.06248,0.47248,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP,0.993546528365792
HP_DUPLICATION_INVOLVING_BON...,SET,122,0.0051632,0.00041928,0.074898,0.47252,HP_DUPLICATION_INVOLVING_BONES_OF_THE_FEET,0.993546528365792
chr12q13,SET,248,0.0090223,0.001041,0.1309,0.47253,chr12q13,0.993546528365792
GOBP_LIMB_BUD_FORMATION,SET,9,0.021276,0.00047071,0.30879,0.47253,GOBP_LIMB_BUD_FORMATION,0.993546528365792
GOBP_SYNAPTIC_VESICLE_MEMBRA...,SET,27,0.01107,0.000424,0.16069,0.47254,GOBP_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.993546528365792
HP_ABNORMAL_5TH_METACARPAL_M...,SET,17,0.014393,0.00043754,0.20902,0.47255,HP_ABNORMAL_5TH_METACARPAL_MORPHOLOGY,0.993546528365792
GOBP_NEGATIVE_REGULATION_OF_...13,SET,4,0.031236,0.00046078,0.45458,0.47261,GOBP_NEGATIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.993546528365792
REACTOME_HIV_INFECTION,SET,215,0.0036365,0.00039102,0.052941,0.47262,REACTOME_HIV_INFECTION,0.993546528365792
LIM_MAMMARY_STEM_CELL_DN,SET,387,0.0029666,0.00042594,0.043223,0.47264,LIM_MAMMARY_STEM_CELL_DN,0.993546528365792
TRAVAGLINI_LUNG_CD8_MEMORY_E...,SET,26,0.011721,0.00044056,0.17082,0.47265,TRAVAGLINI_LUNG_CD8_MEMORY_EFFECTOR_T_CELL,0.993546528365792
YANAGIHARA_ESX1_TARGETS,SET,26,0.011991,0.00045069,0.1748,0.47266,YANAGIHARA_ESX1_TARGETS,0.993546528365792
MIR6792_3P,SET,117,0.0054983,0.00043731,0.080169,0.47266,MIR6792_3P,0.993546528365792
HP_XEROSTOMIA,SET,52,0.0083393,0.00044296,0.12171,0.47269,HP_XEROSTOMIA,0.993549498034472
GOBP_NON_CANONICAL_WNT_SIGNA...,SET,68,0.0075956,0.00046117,0.11108,0.47274,GOBP_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.99355543629437
GOBP_RESPONSE_TO_LIGHT_STIMU...,SET,289,0.0034399,0.00042797,0.050327,0.47275,GOBP_RESPONSE_TO_LIGHT_STIMULUS,0.99355543629437
BIOCARTA_EPONFKB_PATHWAY,SET,11,0.017725,0.00043352,0.25978,0.4728,BIOCARTA_EPONFKB_PATHWAY,0.993588319932289
LU_TUMOR_ENDOTHELIAL_MARKERS...1,SET,4,0.021541,0.00031775,0.31628,0.47285,LU_TUMOR_ENDOTHELIAL_MARKERS_DN,0.993588319932289
HP_FLATTENED_FEMORAL_HEAD,SET,6,0.020592,0.000372,0.30242,0.47286,HP_FLATTENED_FEMORAL_HEAD,0.993588319932289
LI_CYTIDINE_ANALOG_PATHWAY,SET,17,0.01505,0.00045754,0.22119,0.47288,LI_CYTIDINE_ANALOG_PATHWAY,0.993588319932289
HECKER_IFNB1_TARGETS,SET,88,0.0069413,0.00047917,0.10233,0.47296,HECKER_IFNB1_TARGETS,0.993648117483532
GSE557_CIITA_KO_VS_I_AB_KO_D...1,SET,183,0.0041121,0.00040829,0.060695,0.47299,GSE557_CIITA_KO_VS_I_AB_KO_DC_DN,0.993648117483532
GERY_CEBP_TARGETS,SET,118,0.0058196,0.00046482,0.085913,0.473,GERY_CEBP_TARGETS,0.993648117483532
GOBP_NEGATIVE_REGULATION_OF_...369,SET,7,0.019904,0.00038839,0.29443,0.47305,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.993648117483532
GOBP_TELOMERE_LOCALIZATION,SET,8,0.018478,0.00038545,0.27346,0.47306,GOBP_TELOMERE_LOCALIZATION,0.993648117483532
HP_ATOPIC_DERMATITIS,SET,35,0.010001,0.00043601,0.14809,0.47308,HP_ATOPIC_DERMATITIS,0.993648117483532
PID_P53_REGULATION_PATHWAY,SET,55,0.0077149,0.00042142,0.11478,0.47321,PID_P53_REGULATION_PATHWAY,0.993650736487705
GOBP_INTERLEUKIN_2_PRODUCTION,SET,60,0.0080846,0.00046119,0.12079,0.47332,GOBP_INTERLEUKIN_2_PRODUCTION,0.993650736487705
REACTOME_INTERFERON_ALPHA_BE...,SET,72,0.0073042,0.00045629,0.10923,0.47334,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.993650736487705
HP_CHRONIC_PANCREATITIS,SET,4,0.027988,0.00041286,0.41872,0.47335,HP_CHRONIC_PANCREATITIS,0.993650736487705
MIR3194_5P,SET,71,0.0064112,0.00039772,0.096036,0.47339,MIR3194_5P,0.993650736487705
MIR505_3P,SET,98,0.0057905,0.00042171,0.086732,0.47339,MIR505_3P,0.993650736487705
HP_ABNORMAL_CELLULAR_PHENOTY...,SET,573,0.0023312,0.00040516,0.035055,0.47349,HP_ABNORMAL_CELLULAR_PHENOTYPE,0.993650736487705
HP_PERICARDIAL_EFFUSION,SET,39,0.0091513,0.00042112,0.13763,0.47349,HP_PERICARDIAL_EFFUSION,0.993650736487705
GOBP_EPITHELIAL_CELL_PROLIFE...2,SET,10,0.021176,0.00049384,0.3189,0.47353,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,0.993650736487705
GOBP_INSULIN_SECRETION_INVOL...,SET,59,0.0073206,0.00041412,0.11028,0.47354,GOBP_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.993650736487705
HP_HYPERTROPHIC_NERVE_CHANGES,SET,6,0.02703,0.00048832,0.40791,0.47358,HP_HYPERTROPHIC_NERVE_CHANGES,0.993650736487705
MIR21_3P,SET,122,0.005392,0.00043786,0.081427,0.4736,MIR21_3P,0.993650736487705
TAL1ALPHAE47_01,SET,228,0.0039486,0.00043707,0.059629,0.4736,TAL1ALPHAE47_01,0.993650736487705
ANDERSON_BLOOD_CN54GP140_ADJ...5,SET,53,0.0074441,0.00039918,0.11281,0.47369,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN,0.993650736487705
HP_NECK_PAIN,SET,5,0.028218,0.00046538,0.4277,0.4737,HP_NECK_PAIN,0.993650736487705
HP_SLOWED_SLURRED_SPEECH,SET,6,0.021889,0.00039544,0.33206,0.47372,HP_SLOWED_SLURRED_SPEECH,0.993650736487705
GOBP_REGULATION_OF_POSITIVE_...,SET,25,0.01252,0.00046144,0.19052,0.4738,GOBP_REGULATION_OF_POSITIVE_CHEMOTAXIS,0.993650736487705
MIR6751_5P,SET,66,0.0070988,0.00042465,0.1081,0.47382,MIR6751_5P,0.993650736487705
MIR1321,SET,124,0.0052635,0.00043089,0.080247,0.47385,MIR1321,0.993650736487705
GSE43955_TH0_VS_TGFB_IL6_IL2...2,SET,182,0.0042684,0.00042266,0.065058,0.47385,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,0.993650736487705
GOBP_CELLULAR_RESPONSE_TO_PA...,SET,8,0.020143,0.00042017,0.30715,0.47386,GOBP_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS,0.993650736487705
MIR4443,SET,155,0.0046757,0.00042758,0.071335,0.47387,MIR4443,0.993650736487705
GOBP_REGULATION_OF_INTRACELL...6,SET,242,0.0034835,0.0003971,0.053156,0.47387,GOBP_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.993650736487705
HP_FETAL_DISTRESS,SET,52,0.0074662,0.00039659,0.11431,0.47396,HP_FETAL_DISTRESS,0.993650736487705
MODULE_112,SET,237,0.0040371,0.00045548,0.061823,0.47397,MODULE_112,0.993650736487705
REACTOME_SLC15A4_TASL_DEPEND...,SET,4,0.024367,0.00035945,0.37387,0.47402,REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION,0.993650736487705
GSE26928_EFF_MEM_VS_CENTR_ME...1,SET,146,0.004606,0.0004089,0.071031,0.47415,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN,0.993650736487705
SMID_BREAST_CANCER_NORMAL_LI...1,SET,6,0.024763,0.00044736,0.38208,0.47416,SMID_BREAST_CANCER_NORMAL_LIKE_DN,0.993650736487705
MORF_RAD51L3,SET,343,0.0030861,0.00041766,0.047633,0.47417,MORF_RAD51L3,0.993650736487705
GOBP_STRESS_GRANULE_DISASSEM...,SET,7,0.017944,0.00035013,0.27714,0.47419,GOBP_STRESS_GRANULE_DISASSEMBLY,0.993650736487705
GRADE_COLON_AND_RECTAL_CANCE...2,SET,256,0.0033779,0.00039589,0.052197,0.4742,GRADE_COLON_AND_RECTAL_CANCER_UP,0.993650736487705
BACOLOD_RESISTANCE_TO_ALKYLA...1,SET,44,0.0085532,0.00041801,0.1323,0.47423,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,0.993650736487705
HP_DECREASED_CIRCULATING_BET...,SET,5,0.025477,0.00042016,0.3949,0.47428,HP_DECREASED_CIRCULATING_BETA_2_MICROGLOBULIN_LEVEL,0.993650736487705
HP_AREFLEXIA_OF_LOWER_LIMBS,SET,76,0.0060522,0.00038839,0.093892,0.4743,HP_AREFLEXIA_OF_LOWER_LIMBS,0.993650736487705
GOBP_POSITIVE_REGULATION_OF_...639,SET,5,0.027677,0.00045646,0.42998,0.47434,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.993650736487705
GOBP_RESPONSE_TO_FOOD,SET,35,0.0099934,0.0004357,0.1554,0.47436,GOBP_RESPONSE_TO_FOOD,0.993650736487705
MIR3059_3P,SET,47,0.0074411,0.00037582,0.1159,0.4744,MIR3059_3P,0.993650736487705
GSE17974_0H_VS_0.5H_IN_VITRO...2,SET,162,0.0042068,0.00039322,0.065535,0.47441,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP,0.993650736487705
REACTOME_POU5F1_OCT4_SOX2_NA...1,SET,10,0.01868,0.00043563,0.29151,0.47445,REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION,0.993650736487705
GSE5679_CTRL_VS_PPARG_LIGAND...2,SET,179,0.0043727,0.00042944,0.068273,0.47447,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,0.993650736487705
GOBP_N_TERMINAL_PEPTIDYL_MET...,SET,5,0.022225,0.00036654,0.34741,0.4745,GOBP_N_TERMINAL_PEPTIDYL_METHIONINE_ACETYLATION,0.993650736487705
HP_VENTRICULAR_FIBRILLATION,SET,52,0.0079305,0.00042125,0.12441,0.47459,HP_VENTRICULAR_FIBRILLATION,0.993650736487705
HP_ERYTHROMELALGIA,SET,7,0.020786,0.00040559,0.32692,0.47465,HP_ERYTHROMELALGIA,0.993650736487705
GOBP_REGULATION_OF_MICROGLIA...,SET,17,0.014083,0.00042812,0.22209,0.47472,GOBP_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.993650736487705
GAVISH_3CA_MALIGNANT_METAPRO...17,SET,38,0.0098804,0.00044882,0.15586,0.47473,GAVISH_3CA_MALIGNANT_METAPROGRAM_26_NPC_GLIOMA,0.993650736487705
HP_RENAL_MAGNESIUM_WASTING,SET,7,0.020011,0.00039047,0.31633,0.47478,HP_RENAL_MAGNESIUM_WASTING,0.993650736487705
GSE17721_LPS_VS_GARDIQUIMOD_...17,SET,182,0.0039379,0.00038993,0.062382,0.47483,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN,0.993650736487705
HP_ARACHNOID_HEMANGIOMATOSIS,SET,16,0.011779,0.00034739,0.18673,0.47485,HP_ARACHNOID_HEMANGIOMATOSIS,0.993650736487705
GSE2770_TGFB_AND_IL4_ACT_VS_...6,SET,177,0.0039904,0.00038972,0.063358,0.47489,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,0.993650736487705
YAGI_AML_WITH_INV_16_TRANSLO...,SET,372,0.0027793,0.0003914,0.044142,0.4749,YAGI_AML_WITH_INV_16_TRANSLOCATION,0.993650736487705
MIR6514_5P,SET,47,0.0083259,0.00042051,0.13236,0.47492,MIR6514_5P,0.993650736487705
MIR5087,SET,85,0.006003,0.00040731,0.095498,0.47494,MIR5087,0.993650736487705
KIM_ALL_DISORDERS_CALB1_CORR...1,SET,35,0.0094301,0.00041114,0.15015,0.47496,KIM_ALL_DISORDERS_CALB1_CORR_DN,0.993650736487705
KEGG_MEDICUS_REFERENCE_CA2_E...1,SET,12,0.016,0.00040871,0.25483,0.47497,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL,0.993650736487705
MIR3652,SET,135,0.004559,0.0003893,0.072628,0.47497,MIR3652,0.993650736487705
HP_HYPOPLASTIC_AORTIC_ARCH,SET,11,0.016411,0.00040138,0.26149,0.47498,HP_HYPOPLASTIC_AORTIC_ARCH,0.993650736487705
REACTOME_RESPIRATORY_SYNCYTI...3,SET,16,0.012287,0.00036237,0.19603,0.47501,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION,0.993650736487705
GOBP_NEGATIVE_REGULATION_OF_...50,SET,7,0.021842,0.00042619,0.34849,0.47501,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.993650736487705
LI_ESTROGENE_T47D_E2_RESPONS...1,SET,33,0.010532,0.00044591,0.16823,0.47504,LI_ESTROGENE_T47D_E2_RESPONSE_DN,0.993650736487705
GOBP_POSITIVE_REGULATION_OF_...629,SET,6,0.022497,0.00040643,0.3595,0.47505,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,0.993650736487705
HP_SPLIT_NAIL,SET,4,0.02008,0.00029621,0.32092,0.47505,HP_SPLIT_NAIL,0.993650736487705
HP_TIGER_TAIL_BANDING,SET,4,0.02008,0.00029621,0.32092,0.47505,HP_TIGER_TAIL_BANDING,0.993650736487705
GSE45365_HEALTHY_VS_MCMV_INF...11,SET,157,0.0043112,0.00039676,0.068898,0.47505,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN,0.993650736487705
HP_COCHLEAR_MALFORMATION,SET,8,0.017696,0.00036913,0.28322,0.47509,HP_COCHLEAR_MALFORMATION,0.993650736487705
HP_LEWY_BODIES,SET,25,0.010639,0.00039214,0.17034,0.4751,HP_LEWY_BODIES,0.993650736487705
GOBP_NEGATIVE_REGULATION_OF_...382,SET,9,0.018646,0.00041253,0.29889,0.47513,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.993650736487705
MODULE_182,SET,89,0.0055414,0.00038469,0.088861,0.47514,MODULE_182,0.993650736487705
GSE7568_IL4_TGFB_DEXAMETHASO...1,SET,160,0.0040729,0.00037837,0.065429,0.47518,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN,0.993650736487705
chr6p12,SET,59,0.012583,0.00071178,0.20241,0.47522,chr6p12,0.993650736487705
HP_HYPOCHOLESTEROLEMIA,SET,17,0.012714,0.00038652,0.20453,0.47522,HP_HYPOCHOLESTEROLEMIA,0.993650736487705
KEGG_MEDICUS_REFERENCE_DYNEI...,SET,29,0.0096934,0.00038475,0.156,0.47523,KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE,0.993650736487705
REACTOME_G_PROTEIN_MEDIATED_...,SET,52,0.0078981,0.00041953,0.12711,0.47523,REACTOME_G_PROTEIN_MEDIATED_EVENTS,0.993650736487705
DING_LUNG_CANCER_MUTATED_SIG...,SET,25,0.010605,0.00039088,0.17133,0.47532,DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,0.993650736487705
chr2p25,SET,45,0.013985,0.00069119,0.2261,0.47534,chr2p25,0.993650736487705
RAPA_EARLY_UP.V1_DN,SET,168,0.0039913,0.00037986,0.06455,0.47535,RAPA_EARLY_UP.V1_DN,0.993650736487705
GSE9960_HEALTHY_VS_SEPSIS_PB...1,SET,139,0.0046219,0.00040043,0.074791,0.47536,GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN,0.993650736487705
GOBP_EPITHELIAL_CILIUM_MOVEM...,SET,9,0.016559,0.00036636,0.26843,0.4754,GOBP_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY,0.993650736487705
HP_PITUITARY_DWARFISM,SET,9,0.018404,0.00040718,0.29853,0.47542,HP_PITUITARY_DWARFISM,0.993650736487705
AIZARANI_LIVER_C33_STELLATE_...,SET,117,0.0052707,0.00041921,0.085617,0.47546,AIZARANI_LIVER_C33_STELLATE_CELLS_2,0.993650736487705
MIR6513_5P,SET,88,0.0056437,0.0003896,0.091727,0.47547,MIR6513_5P,0.993650736487705
GOMF_DNA_RNA_HYBRID_BINDING,SET,5,0.021193,0.00034952,0.34442,0.47547,GOMF_DNA_RNA_HYBRID_BINDING,0.993650736487705
GSE1460_DP_THYMOCYTE_VS_NAIV...2,SET,170,0.0039039,0.00037372,0.063453,0.47547,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.993650736487705
HP_MACULE,SET,209,0.0034978,0.00037088,0.056915,0.4755,HP_MACULE,0.993650736487705
PHONG_TNF_RESPONSE_NOT_VIA_P...,SET,325,0.0031612,0.00041665,0.051465,0.47551,PHONG_TNF_RESPONSE_NOT_VIA_P38,0.993650736487705
INAMURA_LUNG_CANCER_SCC_UP,SET,11,0.016506,0.0004037,0.26909,0.47554,INAMURA_LUNG_CANCER_SCC_UP,0.993650736487705
GSE13493_CD4INTCD8POS_VS_CD8...2,SET,168,0.0038619,0.00036754,0.062942,0.47554,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP,0.993650736487705
HP_ABNORMALITY_OF_THE_COAGUL...,SET,136,0.0044821,0.00038414,0.073524,0.4757,HP_ABNORMALITY_OF_THE_COAGULATION_CASCADE,0.993886447249775
BACH1_01,SET,238,0.0035319,0.00039932,0.057968,0.47571,BACH1_01,0.993886447249775
GOBP_NEGATIVE_REGULATION_OF_...664,SET,15,0.014548,0.00041544,0.23979,0.47581,GOBP_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.993936623610694
MIR4281,SET,19,0.012602,0.00040499,0.20786,0.47583,MIR4281,0.993936623610694
GOMF_ATP_GATED_ION_CHANNEL_A...,SET,9,0.017839,0.00039468,0.29488,0.47588,GOMF_ATP_GATED_ION_CHANNEL_ACTIVITY,0.993936623610694
MIR122_5P,SET,82,0.0055739,0.00037149,0.092183,0.47589,MIR122_5P,0.993936623610694
HP_EXOPHORIA,SET,6,0.020111,0.00036333,0.33253,0.47589,HP_EXOPHORIA,0.993936623610694
PID_IL8_CXCR2_PATHWAY,SET,34,0.0091841,0.00039466,0.15205,0.47592,PID_IL8_CXCR2_PATHWAY,0.993936623610694
GCM_AIP,SET,34,0.0084245,0.00036202,0.13962,0.47594,GCM_AIP,0.993936623610694
GOBP_RETROTRANSPOSON_SILENCI...,SET,15,0.012387,0.00035374,0.20568,0.47599,GOBP_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.993936623610694
HP_YELLOW_WHITE_LESIONS_OF_T...1,SET,17,0.014508,0.00044104,0.24111,0.47601,HP_YELLOW_WHITE_LESIONS_OF_THE_MACULA,0.993936623610694
ZHENG_GLIOBLASTOMA_PLASTICIT...2,SET,227,0.0035635,0.00039359,0.059239,0.47602,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,0.993936623610694
GOBP_REGULATION_OF_MICROTUBU...6,SET,16,0.010938,0.00032261,0.18274,0.47614,GOBP_REGULATION_OF_MICROTUBULE_NUCLEATION,0.994034252225519
HP_ATONIC_SEIZURE,SET,87,0.0055656,0.00038202,0.093006,0.47614,HP_ATONIC_SEIZURE,0.994034252225519
MORF_CASP10,SET,109,0.0048278,0.0003707,0.080813,0.47618,MORF_CASP10,0.994034252225519
HP_WHITE_HAIR,SET,21,0.011106,0.00037519,0.18601,0.4762,HP_WHITE_HAIR,0.994034252225519
HP_ERLENMEYER_FLASK_DEFORMIT...,SET,8,0.018295,0.00038162,0.30726,0.47626,HP_ERLENMEYER_FLASK_DEFORMITY_OF_THE_FEMURS,0.994034252225519
MIR3175,SET,158,0.0039509,0.00036476,0.066448,0.47629,MIR3175,0.994034252225519
MIR548O_3P,SET,250,0.003296,0.00038179,0.055432,0.47629,MIR548O_3P,0.994034252225519
CREB_01,SET,242,0.003329,0.00037948,0.056037,0.47631,CREB_01,0.994034252225519
chr8p11,SET,50,0.013262,0.00069081,0.22431,0.47643,chr8p11,0.994034252225519
HP_SHORT_THUMB,SET,104,0.004917,0.00036884,0.083426,0.4765,HP_SHORT_THUMB,0.994034252225519
HP_JERKY_HEAD_MOVEMENTS,SET,11,0.017003,0.00041585,0.28878,0.47652,HP_JERKY_HEAD_MOVEMENTS,0.994034252225519
GSE23321_CENTRAL_MEMORY_VS_N...2,SET,182,0.0037309,0.00036944,0.063418,0.47654,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.994034252225519
GSE18281_SUBCAPSULAR_VS_PERI...2,SET,182,0.0036476,0.00036119,0.062034,0.47656,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP,0.994034252225519
HP_NEUTROPENIA_IN_PRESENCE_O...,SET,21,0.01124,0.00037972,0.19152,0.4766,HP_NEUTROPENIA_IN_PRESENCE_OF_ANTI_NEUTROPIL_ANTIBODIES,0.994034252225519
GOCC_MHC_PROTEIN_COMPLEX,SET,21,0.013189,0.00044558,0.22494,0.47662,GOCC_MHC_PROTEIN_COMPLEX,0.994034252225519
GSE31622_WT_VS_KLF3_KO_BCELL...1,SET,178,0.0038932,0.00038128,0.066388,0.47662,GSE31622_WT_VS_KLF3_KO_BCELL_DN,0.994034252225519
HP_ABNORMAL_ERYTHROCYTE_SEDI...,SET,57,0.0071753,0.00039898,0.12276,0.47669,HP_ABNORMAL_ERYTHROCYTE_SEDIMENTATION_RATE,0.994034252225519
GOBP_CELLULAR_RESPONSE_TO_FL...,SET,19,0.012463,0.00040052,0.21339,0.47671,GOBP_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS,0.994034252225519
HP_LOSS_OF_VOICE,SET,6,0.017722,0.00032016,0.30437,0.47679,HP_LOSS_OF_VOICE,0.994034252225519
GOBP_ADRENERGIC_RECEPTOR_SIG...,SET,30,0.0098112,0.00039608,0.16859,0.4768,GOBP_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,0.994034252225519
HP_PHOTOSENSITIVE_TONIC_CLON...,SET,12,0.015837,0.00040455,0.27324,0.47689,HP_PHOTOSENSITIVE_TONIC_CLONIC_SEIZURE,0.994034252225519
KEGG_MEDICUS_REFERENCE_MICRO...4,SET,20,0.011472,0.00037826,0.19829,0.47693,KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.994034252225519
GOBP_EXTRACELLULAR_VESICLE_B...,SET,24,0.009635,0.00034796,0.16655,0.47693,GOBP_EXTRACELLULAR_VESICLE_BIOGENESIS,0.994034252225519
MIR3085_5P,SET,33,0.008537,0.00036143,0.14845,0.47707,MIR3085_5P,0.994034252225519
GOMF_C_PALMITOYLTRANSFERASE_...,SET,5,0.02394,0.00039482,0.41631,0.47707,GOMF_C_PALMITOYLTRANSFERASE_ACTIVITY,0.994034252225519
WEST_ADRENOCORTICAL_TUMOR_UP,SET,280,0.002927,0.00035852,0.050929,0.47709,WEST_ADRENOCORTICAL_TUMOR_UP,0.994034252225519
MENON_FETAL_KIDNEY_10_IMMUNE...,SET,71,0.0059873,0.00037143,0.10422,0.47709,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.994034252225519
EVI1_04,SET,198,0.0037646,0.00038864,0.065624,0.47713,EVI1_04,0.994034252225519
HP_DORSOCERVICAL_FAT_PAD,SET,14,0.012164,0.0003356,0.21212,0.47714,HP_DORSOCERVICAL_FAT_PAD,0.994034252225519
KINNEY_DNMT1_METHYLATION_TAR...,SET,14,0.014095,0.00038888,0.24592,0.47715,KINNEY_DNMT1_METHYLATION_TARGETS,0.994034252225519
GOBP_REGULATION_OF_ORGANELLE...1,SET,231,0.0030938,0.00034467,0.054068,0.47719,GOBP_REGULATION_OF_ORGANELLE_ASSEMBLY,0.994034252225519
GOBP_POSTSYNAPTIC_DENSITY_PR...,SET,10,0.016077,0.00037492,0.28138,0.47722,GOBP_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING,0.994034252225519
BRUECKNER_TARGETS_OF_MIRLET7...1,SET,72,0.0062825,0.00039246,0.11026,0.47728,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,0.994034252225519
WP_AIRWAY_SMOOTH_MUSCLE_CELL...,SET,15,0.013155,0.00037567,0.23112,0.47731,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,0.994034252225519
GNF2_TST,SET,102,0.0049258,0.00036595,0.086552,0.47731,GNF2_TST,0.994034252225519
GOCC_TUBULAR_ENDOSOME,SET,5,0.021617,0.00035651,0.38017,0.47733,GOCC_TUBULAR_ENDOSOME,0.994034252225519
GSE360_DC_VS_MAC_UP,SET,178,0.0036477,0.00035724,0.064321,0.47739,GSE360_DC_VS_MAC_UP,0.994034252225519
MIR5702,SET,68,0.0059958,0.00036404,0.10583,0.47741,MIR5702,0.994034252225519
STANHILL_HRAS_TRANSFROMATION...,SET,5,0.021115,0.00034823,0.3729,0.47742,STANHILL_HRAS_TRANSFROMATION_UP,0.994034252225519
GOCC_NEURON_SPINE,SET,167,0.0038844,0.00036859,0.068652,0.47744,GOCC_NEURON_SPINE,0.994034252225519
FUNG_IL2_SIGNALING_2,SET,12,0.014235,0.00036362,0.25194,0.47747,FUNG_IL2_SIGNALING_2,0.994034252225519
BIOCARTA_MYOSIN_PATHWAY,SET,11,0.015285,0.00037384,0.27079,0.47749,BIOCARTA_MYOSIN_PATHWAY,0.994034252225519
REACTOME_PLATELET_AGGREGATIO...,SET,39,0.0079429,0.00036551,0.14163,0.47764,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,0.994034252225519
HP_ATRIAL_STANDSTILL,SET,6,0.021935,0.00039626,0.39165,0.47767,HP_ATRIAL_STANDSTILL,0.994034252225519
BOYAULT_LIVER_CANCER_SUBCLAS...9,SET,46,0.0066946,0.00033451,0.11987,0.47773,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,0.994034252225519
GSE13522_CTRL_VS_T_CRUZI_G_S...2,SET,186,0.0035145,0.00035178,0.063028,0.47777,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP,0.994034252225519
GOBP_INNATE_IMMUNE_RESPONSE,SET,847,0.0017358,0.00036395,0.031168,0.47779,GOBP_INNATE_IMMUNE_RESPONSE,0.994034252225519
GSE37533_PPARG2_FOXP3_VS_FOX...2,SET,172,0.0034771,0.0003348,0.062497,0.47782,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.994034252225519
GOBP_REGULATION_OF_CELL_PROJ...1,SET,202,0.0034499,0.0003597,0.062034,0.47783,GOBP_REGULATION_OF_CELL_PROJECTION_ASSEMBLY,0.994034252225519
GOBP_SATELLITE_CELL_ACTIVATI...,SET,6,0.017729,0.00032028,0.31895,0.47784,GOBP_SATELLITE_CELL_ACTIVATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.994034252225519
MIR652_3P,SET,4,0.026809,0.00039547,0.48307,0.47787,MIR652_3P,0.994034252225519
GNF2_MYL2,SET,32,0.0088839,0.00037038,0.1603,0.4779,GNF2_MYL2,0.994034252225519
HP_ABNORMAL_LEUKOCYTE_PHYSIO...,SET,263,0.0029429,0.00034952,0.053395,0.47802,HP_ABNORMAL_LEUKOCYTE_PHYSIOLOGY,0.994034252225519
GOBP_SYNAPTIC_TRANSMISSION_G...3,SET,5,0.022618,0.00037302,0.41053,0.47803,GOBP_SYNAPTIC_TRANSMISSION_GLYCINERGIC,0.994034252225519
SMITH_TERT_TARGETS_DN,SET,83,0.0056246,0.00037713,0.10212,0.47804,SMITH_TERT_TARGETS_DN,0.994034252225519
GSE17721_CTRL_VS_PAM3CSK4_2H...1,SET,183,0.0036838,0.00036577,0.066901,0.47804,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN,0.994034252225519
MIR1_3P,SET,337,0.0025763,0.00034566,0.046791,0.47805,MIR1_3P,0.994034252225519
MIR4724_5P,SET,116,0.0045134,0.00035744,0.081994,0.47805,MIR4724_5P,0.994034252225519
HP_ABNORMAL_BRAINSTEM_WHITE_...,SET,15,0.010892,0.00031106,0.19787,0.47805,HP_ABNORMAL_BRAINSTEM_WHITE_MATTER_MORPHOLOGY,0.994034252225519
MIR4675,SET,38,0.0072848,0.00033091,0.13245,0.47807,MIR4675,0.994034252225519
GOBP_POSITIVE_REGULATION_OF_...374,SET,10,0.014975,0.00034921,0.27222,0.47807,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,0.994034252225519
HP_ABNORMAL_GASTROINTESTINAL...1,SET,87,0.0050206,0.00034461,0.09128,0.47807,HP_ABNORMAL_GASTROINTESTINAL_MOTILITY,0.994034252225519
GSE3982_EOSINOPHIL_VS_BCELL_...2,SET,182,0.0037037,0.00036674,0.06739,0.47809,GSE3982_EOSINOPHIL_VS_BCELL_UP,0.994034252225519
GOCC_SEROTONIN_RECEPTOR_COMP...,SET,5,0.026436,0.00043598,0.48371,0.47821,GOCC_SEROTONIN_RECEPTOR_COMPLEX,0.994034252225519
GOMF_SEROTONIN_GATED_MONOATO...,SET,5,0.026436,0.00043598,0.48371,0.47821,GOMF_SEROTONIN_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.994034252225519
NR1H4_TARGET_GENES,SET,328,0.0026602,0.0003522,0.048696,0.47822,NR1H4_TARGET_GENES,0.994034252225519
MYCMAX_B,SET,245,0.0030538,0.00035023,0.056011,0.47826,MYCMAX_B,0.994034252225519
GSE39820_TGFBETA3_IL6_VS_TGF...1,SET,179,0.0033731,0.00033127,0.061884,0.47827,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN,0.994034252225519
ISSAEVA_MLL2_TARGETS,SET,52,0.0071513,0.00037986,0.13153,0.47832,ISSAEVA_MLL2_TARGETS,0.994034252225519
AP1_Q6,SET,233,0.0031002,0.00034686,0.057013,0.47832,AP1_Q6,0.994034252225519
GOBP_PHOSPHATE_ION_HOMEOSTAS...,SET,19,0.012596,0.00040478,0.23192,0.47834,GOBP_PHOSPHATE_ION_HOMEOSTASIS,0.994034252225519
GOCC_VARICOSITY,SET,8,0.019929,0.0004157,0.36727,0.47836,GOCC_VARICOSITY,0.994034252225519
GOBP_INDUCTION_OF_POSITIVE_C...,SET,13,0.01468,0.00039031,0.27087,0.47839,GOBP_INDUCTION_OF_POSITIVE_CHEMOTAXIS,0.994034252225519
REACTOME_DOWNREGULATION_OF_T...,SET,25,0.0086529,0.00031892,0.15982,0.47841,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,0.994034252225519
LY_AGING_OLD_UP,SET,7,0.017513,0.00034173,0.32432,0.47847,LY_AGING_OLD_UP,0.994034252225519
GOMF_GUANINE_NUCLEOTIDE_TRAN...,SET,5,0.025229,0.00041608,0.46866,0.47853,GOMF_GUANINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.994034252225519
SANA_TNF_SIGNALING_DN,SET,74,0.005564,0.00035235,0.10347,0.47856,SANA_TNF_SIGNALING_DN,0.994034252225519
BOYLAN_MULTIPLE_MYELOMA_C_CL...1,SET,27,0.010362,0.00039688,0.19278,0.47857,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,0.994034252225519
GSE32901_TH1_VS_TH17_ENRICHE...2,SET,160,0.0036029,0.00033471,0.06704,0.47857,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP,0.994034252225519
GSE15930_NAIVE_VS_48H_IN_VIT...4,SET,184,0.0034082,0.00033931,0.063501,0.4786,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,0.994034252225519
GOMF_OXIDOREDUCTASE_ACTIVITY...14,SET,10,0.013281,0.00030971,0.24833,0.47867,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR,0.994034252225519
GSE25677_MPL_VS_R848_STIM_BC...1,SET,166,0.0036165,0.00034215,0.067663,0.47869,GSE25677_MPL_VS_R848_STIM_BCELL_DN,0.994034252225519
BIOCARTA_SM_PATHWAY,SET,13,0.012963,0.00034464,0.24272,0.4787,BIOCARTA_SM_PATHWAY,0.994034252225519
GOMF_INOSITOL_POLYPHOSPHATE_...,SET,6,0.017166,0.00031012,0.32221,0.47876,GOMF_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.994034252225519
HP_EXAGGERATED_STARTLE_RESPO...,SET,29,0.0088046,0.00034948,0.16608,0.47886,HP_EXAGGERATED_STARTLE_RESPONSE,0.994034252225519
GSE25677_R848_VS_MPL_AND_R84...1,SET,146,0.0037497,0.00033288,0.07082,0.47889,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN,0.994034252225519
HP_MELENA,SET,21,0.010189,0.00034422,0.19266,0.47891,HP_MELENA,0.994034252225519
HP_PHONIC_TICS,SET,5,0.023053,0.00038019,0.43578,0.47891,HP_PHONIC_TICS,0.994034252225519
GOBP_REGULATION_OF_TRANSLATI...12,SET,11,0.012981,0.00031749,0.24605,0.47896,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.994034252225519
GSE21670_STAT3_KO_VS_WT_CD4_...4,SET,175,0.0036163,0.00035121,0.068571,0.47897,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN,0.994034252225519
HP_NEOPLASM_OF_THE_ADRENAL_G...,SET,45,0.0067158,0.00033191,0.12797,0.47907,HP_NEOPLASM_OF_THE_ADRENAL_GLAND,0.994034252225519
KEGG_MEDICUS_REFERENCE_RTK_P...,SET,53,0.006709,0.00035977,0.12803,0.4791,KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY,0.994034252225519
HE_LIM_SUN_FETAL_LUNG_C1_LAT...1,SET,22,0.011169,0.00038621,0.21331,0.47912,HE_LIM_SUN_FETAL_LUNG_C1_LATE_AIRWAY_PROGENITOR_CELL,0.994034252225519
GOCC_SPINDLE_POLE,SET,162,0.0034195,0.00031963,0.065514,0.47919,GOCC_SPINDLE_POLE,0.994034252225519
WP_AMINO_ACID_METABOLISM,SET,80,0.0050802,0.00033445,0.097414,0.4792,WP_AMINO_ACID_METABOLISM,0.994034252225519
WP_GLP1_FROM_INTESTINE_AND_P...,SET,6,0.021487,0.00038818,0.41203,0.47921,WP_GLP1_FROM_INTESTINE_AND_PANCREAS_AND_ROLE_IN_GLUCOSE_HOMEOSTASIS,0.994034252225519
GSE2706_UNSTIM_VS_8H_R848_DC...2,SET,172,0.0034081,0.00032816,0.065555,0.47927,GSE2706_UNSTIM_VS_8H_R848_DC_UP,0.994034252225519
GOCC_PLATELET_DENSE_TUBULAR_...1,SET,10,0.013327,0.00031079,0.257,0.47932,GOCC_PLATELET_DENSE_TUBULAR_NETWORK,0.994034252225519
GSE12366_PLASMA_CELL_VS_NAIV...1,SET,170,0.0033124,0.0003171,0.063869,0.47932,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN,0.994034252225519
MIR3680_3P,SET,491,0.0021453,0.00034593,0.041382,0.47933,MIR3680_3P,0.994034252225519
WIEDERSCHAIN_TARGETS_OF_BMI1...,SET,55,0.0065149,0.00035587,0.12592,0.47937,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,0.994034252225519
GOBP_LIPOPOLYSACCHARIDE_MEDI...,SET,54,0.0062171,0.00033651,0.1203,0.47939,GOBP_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.994034252225519
REACTOME_NOREPINEPHRINE_NEUR...,SET,16,0.011784,0.00034754,0.22825,0.47941,REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.994034252225519
REACTOME_POSTMITOTIC_NUCLEAR...,SET,26,0.0081987,0.00030816,0.15877,0.47941,REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION,0.994034252225519
GOBP_NEGATIVE_REGULATION_OF_...300,SET,6,0.017976,0.00032476,0.34946,0.47949,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.994034252225519
HP_SHAGREEN_PATCH,SET,5,0.021857,0.00036047,0.42584,0.47953,HP_SHAGREEN_PATCH,0.994034252225519
GUCY1B1_TARGET_GENES,SET,518,0.0019534,0.00032329,0.038114,0.47956,GUCY1B1_TARGET_GENES,0.994034252225519
MORF_ITGA2,SET,47,0.006614,0.00033405,0.12908,0.47957,MORF_ITGA2,0.994034252225519
MIR454_5P,SET,21,0.0098894,0.00033411,0.19321,0.47959,MIR454_5P,0.994034252225519
GOBP_BLOOD_COAGULATION_INTRI...,SET,6,0.021383,0.0003863,0.41785,0.47959,GOBP_BLOOD_COAGULATION_INTRINSIC_PATHWAY,0.994034252225519
GSE2770_UNTREATED_VS_ACT_CD4...3,SET,164,0.0034927,0.00032847,0.068243,0.47959,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN,0.994034252225519
GOBP_GLOMERULAR_BASEMENT_MEM...,SET,11,0.013832,0.00033831,0.27035,0.4796,GOBP_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT,0.994034252225519
HP_NEOPLASM_OF_THE_RESPIRATO...,SET,74,0.0050707,0.00032112,0.099138,0.4796,HP_NEOPLASM_OF_THE_RESPIRATORY_SYSTEM,0.994034252225519
HP_PRENATAL_DEATH,SET,61,0.0058769,0.00033802,0.11486,0.4796,HP_PRENATAL_DEATH,0.994034252225519
GOMF_PHOSPHATIDYLINOSITOL_KI...,SET,25,0.0091249,0.00033632,0.17848,0.47961,GOMF_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY,0.994034252225519
HP_JOINT_HYPERMOBILITY,SET,476,0.0020138,0.00031987,0.039391,0.47961,HP_JOINT_HYPERMOBILITY,0.994034252225519
MOREIRA_RESPONSE_TO_TSA_DN,SET,18,0.010585,0.0003311,0.20725,0.47963,MOREIRA_RESPONSE_TO_TSA_DN,0.994034252225519
GOCC_DENSE_CORE_GRANULE,SET,38,0.0077635,0.00035266,0.15201,0.47963,GOCC_DENSE_CORE_GRANULE,0.994034252225519
BHAT_ESR1_TARGETS_NOT_VIA_AK...1,SET,84,0.0051628,0.00034824,0.10117,0.47965,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,0.994034252225519
GSE29618_PDC_VS_MDC_DAY7_FLU...1,SET,179,0.0033847,0.00033241,0.066541,0.47972,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN,0.994034252225519
GOBP_REGULATION_OF_RNA_BINDI...,SET,6,0.016901,0.00030533,0.33292,0.47976,GOBP_REGULATION_OF_RNA_BINDING,0.994034252225519
GOBP_POSITIVE_REGULATION_OF_...573,SET,152,0.0036252,0.00032832,0.07176,0.47985,GOBP_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,0.994034252225519
GOBP_REGULATION_OF_VASCULAR_...3,SET,8,0.015466,0.00032262,0.30634,0.47987,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,0.994034252225519
HARALAMBIEVA_PBMC_FLUARIX_AG...4,SET,15,0.012315,0.0003517,0.24393,0.47987,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_POSITIVE,0.994034252225519
GOBP_CANNABINOID_SIGNALING_P...,SET,7,0.018108,0.00035333,0.35984,0.47993,GOBP_CANNABINOID_SIGNALING_PATHWAY,0.994034252225519
GSE5589_LPS_VS_LPS_AND_IL6_S...4,SET,172,0.0033627,0.00032378,0.066863,0.47995,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.994034252225519
HP_ABNORMALITY_OF_ALKALINE_P...,SET,120,0.0039521,0.0003183,0.078675,0.47997,HP_ABNORMALITY_OF_ALKALINE_PHOSPHATASE_LEVEL,0.994034252225519
GOMF_DEAMINASE_ACTIVITY,SET,29,0.0092272,0.00036625,0.18377,0.47998,GOMF_DEAMINASE_ACTIVITY,0.994034252225519
GOBP_HYDROGEN_PEROXIDE_BIOSY...,SET,14,0.012429,0.00034291,0.24835,0.48004,GOBP_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.994034252225519
HP_ABNORMALITY_OF_THE_PREMAX...,SET,11,0.01292,0.000316,0.25842,0.48006,HP_ABNORMALITY_OF_THE_PREMAXILLA,0.994034252225519
MIR6836_5P,SET,115,0.0039291,0.00030984,0.078802,0.48012,MIR6836_5P,0.994034252225519
GOBP_CELL_COMMUNICATION_BY_E...2,SET,26,0.0092563,0.00034791,0.18598,0.48015,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,0.994034252225519
HP_ABNORMAL_TONGUE_PHYSIOLOGY,SET,57,0.0056511,0.00031423,0.11356,0.48016,HP_ABNORMAL_TONGUE_PHYSIOLOGY,0.994034252225519
GOMF_HYDROLASE_ACTIVITY_ACTI...8,SET,10,0.015353,0.00035803,0.30887,0.48018,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS,0.994034252225519
GSE7568_IL4_TGFB_DEXAMETHASO...2,SET,154,0.0031543,0.00028753,0.063787,0.48028,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP,0.994034252225519
KINSEY_TARGETS_OF_EWSR1_FLII...2,SET,1155,0.0012447,0.00030208,0.02531,0.48039,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP,0.994034252225519
HP_LONG_HALLUX,SET,20,0.0095403,0.00031455,0.1942,0.48041,HP_LONG_HALLUX,0.994034252225519
UNTERMAN_IPF_VS_CTRL_MONOCYT...2,SET,11,0.012974,0.00031732,0.26436,0.48043,UNTERMAN_IPF_VS_CTRL_MONOCYTE_UP,0.994034252225519
GOBP_LOOP_OF_HENLE_DEVELOPME...,SET,11,0.014131,0.00034562,0.28894,0.4805,GOBP_LOOP_OF_HENLE_DEVELOPMENT,0.994034252225519
GSE15750_DAY6_VS_DAY10_TRAF6...1,SET,183,0.0029766,0.00029554,0.060931,0.48052,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN,0.994034252225519
GSE46606_UNSTIM_VS_CD40L_IL2...13,SET,180,0.0029905,0.00029451,0.061493,0.48061,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.994034252225519
PECE_MAMMARY_STEM_CELL_DN,SET,122,0.0037894,0.00030772,0.077985,0.48062,PECE_MAMMARY_STEM_CELL_DN,0.994034252225519
GOBP_RESPONSE_TO_NITROSATIVE...,SET,10,0.01266,0.00029524,0.26071,0.48064,GOBP_RESPONSE_TO_NITROSATIVE_STRESS,0.994034252225519
PID_RXR_VDR_PATHWAY,SET,26,0.0079793,0.00029991,0.16451,0.48066,PID_RXR_VDR_PATHWAY,0.994034252225519
MIR6741_3P,SET,5,0.018197,0.00030011,0.37534,0.48067,MIR6741_3P,0.994034252225519
GRAHAM_CML_QUIESCENT_VS_NORM...1,SET,9,0.01613,0.00035687,0.33326,0.4807,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.994034252225519
HP_ABNORMAL_BRONCHUS_PHYSIOL...,SET,20,0.0087767,0.00028937,0.18138,0.4807,HP_ABNORMAL_BRONCHUS_PHYSIOLOGY,0.994034252225519
GOBP_POSITIVE_REGULATION_OF_...185,SET,455,0.0020296,0.00031537,0.04205,0.48075,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION,0.994034252225519
KEGG_MEDICUS_VARIANT_MUTATIO...82,SET,4,0.018227,0.00026888,0.37847,0.48079,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY,0.994034252225519
HP_WHITE_EYEBROW,SET,11,0.013423,0.00032829,0.27862,0.48079,HP_WHITE_EYEBROW,0.994034252225519
GOMF_PHOTORECEPTOR_ACTIVITY,SET,13,0.011613,0.00030876,0.24142,0.48082,GOMF_PHOTORECEPTOR_ACTIVITY,0.994034252225519
GSE15330_LYMPHOID_MULTIPOTEN...7,SET,149,0.0034557,0.0003099,0.071863,0.48082,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.994034252225519
GOBP_POSITIVE_REGULATION_OF_...357,SET,81,0.004679,0.00030995,0.097404,0.48084,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION,0.994034252225519
chr9q31,SET,55,0.0097465,0.00053239,0.20309,0.48086,chr9q31,0.994034252225519
GOBP_GLYCOSYLCERAMIDE_METABO...,SET,16,0.010365,0.00030571,0.2162,0.48088,GOBP_GLYCOSYLCERAMIDE_METABOLIC_PROCESS,0.994034252225519
MACLACHLAN_BRCA1_TARGETS_DN,SET,16,0.0099435,0.00029326,0.20745,0.48089,MACLACHLAN_BRCA1_TARGETS_DN,0.994034252225519
GSE17721_PAM3CSK4_VS_GADIQUI...13,SET,181,0.0030241,0.00029863,0.06313,0.4809,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN,0.994034252225519
GSE46606_IRF4_KO_VS_WT_UNSTI...1,SET,182,0.0032251,0.00031935,0.067671,0.48099,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN,0.994034252225519
SUZUKI_CTCFL_TARGETS_UP,SET,11,0.01211,0.00029619,0.25463,0.48103,SUZUKI_CTCFL_TARGETS_UP,0.994034252225519
GSE3982_MAST_CELL_VS_TH2_UP,SET,181,0.0030849,0.00030464,0.064838,0.48103,GSE3982_MAST_CELL_VS_TH2_UP,0.994034252225519
HP_ABNORMAL_PERIPHERAL_NERVO...1,SET,360,0.0021326,0.00029555,0.044847,0.48104,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_MORPHOLOGY,0.994034252225519
GSE15930_NAIVE_VS_48H_IN_VIT...1,SET,183,0.0027968,0.00027769,0.058816,0.48104,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN,0.994034252225519
GOBP_LIPID_CATABOLIC_PROCESS,SET,325,0.0023003,0.00030318,0.048408,0.48105,GOBP_LIPID_CATABOLIC_PROCESS,0.994034252225519
KEGG_GLYCOSYLPHOSPHATIDYLINO...,SET,24,0.0075381,0.00027223,0.15895,0.48109,KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,0.994034252225519
WP_VALPROIC_ACID_PATHWAY,SET,11,0.012343,0.00030188,0.2604,0.4811,WP_VALPROIC_ACID_PATHWAY,0.994034252225519
HP_HEPATIC_FAILURE,SET,133,0.0034692,0.00029406,0.073321,0.48113,HP_HEPATIC_FAILURE,0.994034252225519
GOBP_POSITIVE_REGULATION_OF_...792,SET,12,0.010653,0.00027214,0.2254,0.48115,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.994034252225519
HP_REFRACTORY_ANEMIA,SET,6,0.017931,0.00032394,0.3795,0.48116,HP_REFRACTORY_ANEMIA,0.994034252225519
GOBP_REGULATION_OF_VASOCONST...,SET,63,0.0056963,0.00033294,0.12099,0.48123,GOBP_REGULATION_OF_VASOCONSTRICTION,0.994034252225519
GSE23308_WT_VS_MINERALCORTIC...1,SET,174,0.0030882,0.00029907,0.065664,0.48124,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN,0.994034252225519
GSE24142_EARLY_THYMIC_PROGEN...1,SET,183,0.0029784,0.00029572,0.06341,0.48127,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN,0.994034252225519
GOBP_ANIMAL_ORGAN_MATURATION,SET,28,0.0078768,0.00030722,0.16815,0.48132,GOBP_ANIMAL_ORGAN_MATURATION,0.994034252225519
GTCTACC_MIR379,SET,22,0.009299,0.00032154,0.19875,0.48134,GTCTACC_MIR379,0.994034252225519
GOBP_REGULATION_OF_NEURON_PR...3,SET,30,0.0077413,0.00031251,0.16567,0.48137,GOBP_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.994034252225519
MAGRANGEAS_MULTIPLE_MYELOMA_...4,SET,38,0.0069227,0.00031446,0.14828,0.48138,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,0.994034252225519
GOBP_ESTABLISHMENT_OF_ENDOTH...1,SET,50,0.0060863,0.00031703,0.1304,0.48139,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER,0.994034252225519
ZNF257_TARGET_GENES,SET,447,0.0018795,0.00028953,0.040389,0.48144,ZNF257_TARGET_GENES,0.994034252225519
WP_AUTOPHAGY_IN_PANCREATIC_D...,SET,18,0.0094043,0.00029417,0.20269,0.4815,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,0.994034252225519
GOBP_OVULATION_CYCLE,SET,71,0.0050423,0.0003128,0.10868,0.4815,GOBP_OVULATION_CYCLE,0.994034252225519
GOMF_OXIDOREDUCTASE_ACTIVITY...21,SET,38,0.0066593,0.0003025,0.14352,0.4815,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.994034252225519
GOCC_ANNULATE_LAMELLAE,SET,5,0.016254,0.00026806,0.35074,0.48152,GOCC_ANNULATE_LAMELLAE,0.994034252225519
HP_MACROCEPHALY,SET,375,0.0020483,0.00028959,0.044356,0.48158,HP_MACROCEPHALY,0.994034252225519
GOMF_INTRACILIARY_TRANSPORT_...,SET,2,0.026121,0.00027248,0.56683,0.48162,GOMF_INTRACILIARY_TRANSPORT_PARTICLE_B_BINDING,0.994034252225519
REACTOME_SEALING_OF_THE_NUCL...,SET,29,0.0072038,0.00028594,0.15648,0.48164,REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III,0.994034252225519
MIR4668_3P,SET,277,0.0024143,0.00029417,0.052433,0.48164,MIR4668_3P,0.994034252225519
MIKKELSEN_ES_LCP_WITH_H3K27M...,SET,12,0.011943,0.00030508,0.25951,0.48165,MIKKELSEN_ES_LCP_WITH_H3K27ME3,0.994034252225519
GOBP_PHOSPHATIDYLGLYCEROL_BI...,SET,9,0.014184,0.00031381,0.30838,0.48166,GOBP_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.994034252225519
HP_CERVICAL_KYPHOSIS,SET,8,0.01238,0.00025823,0.26924,0.48166,HP_CERVICAL_KYPHOSIS,0.994034252225519
MIR1252_5P,SET,294,0.0022974,0.00028825,0.049972,0.48167,MIR1252_5P,0.994034252225519
REACTOME_HIGHLY_CALCIUM_PERM...2,SET,11,0.014542,0.00035566,0.31674,0.48169,REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.994034252225519
HP_ABNORMAL_LENGTH_OF_CORPUS...,SET,6,0.017473,0.00031565,0.38051,0.48169,HP_ABNORMAL_LENGTH_OF_CORPUS_CALLOSUM,0.994034252225519
GSE360_HIGH_VS_LOW_DOSE_B_MA...3,SET,179,0.0028911,0.00028393,0.062973,0.48169,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN,0.994034252225519
GOMF_EXCITATORY_EXTRACELLULA...,SET,34,0.007428,0.0003192,0.16193,0.48171,GOMF_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.994034252225519
GOMF_ALCOHOL_DEHYDROGENASE_N...2,SET,23,0.0091276,0.0003227,0.19937,0.48174,GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.994034252225519
WP_PARKINSONS_DISEASE_PATHWAY,SET,33,0.0065907,0.00027903,0.14413,0.48176,WP_PARKINSONS_DISEASE_PATHWAY,0.994034252225519
HP_ABNORMAL_MEAN_CORPUSCULAR...1,SET,16,0.0092217,0.00027198,0.20172,0.48177,HP_ABNORMAL_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.994034252225519
GOCC_APICAL_DENDRITE,SET,16,0.0099352,0.00029302,0.21762,0.48179,GOCC_APICAL_DENDRITE,0.994034252225519
GOMF_HISTONE_METHYLTRANSFERA...2,SET,13,0.0094448,0.00025111,0.20682,0.48179,GOMF_HISTONE_METHYLTRANSFERASE_BINDING,0.994034252225519
GSE17721_POLYIC_VS_PAM3CSK4_...14,SET,180,0.0028792,0.00028355,0.063063,0.48179,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP,0.994034252225519
GOBP_PROTEIN_POLY_ADP_RIBOSY...,SET,10,0.011753,0.00027407,0.25829,0.48185,GOBP_PROTEIN_POLY_ADP_RIBOSYLATION,0.994034252225519
REACTOME_RHOV_GTPASE_CYCLE,SET,36,0.0061349,0.00027126,0.13488,0.48186,REACTOME_RHOV_GTPASE_CYCLE,0.994034252225519
GOBP_POSITIVE_REGULATION_OF_...694,SET,9,0.013185,0.00029171,0.29029,0.48189,GOBP_POSITIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.994034252225519
HP_BARRETT_ESOPHAGUS,SET,6,0.016009,0.00028921,0.35303,0.48192,HP_BARRETT_ESOPHAGUS,0.994034252225519
JIANG_AGING_CEREBRAL_CORTEX_...1,SET,44,0.0058528,0.00028604,0.12919,0.48193,JIANG_AGING_CEREBRAL_CORTEX_DN,0.994034252225519
HP_DISTURBANCE_DURING_TRANSI...,SET,17,0.010213,0.00031048,0.22536,0.48193,HP_DISTURBANCE_DURING_TRANSITIONS_BETWEEN_SLEEP_AND_WAKE_STATES,0.994034252225519
HP_CONGENITAL_BILATERAL_HIP_...,SET,6,0.0191,0.00034506,0.42283,0.48199,HP_CONGENITAL_BILATERAL_HIP_DISLOCATION,0.994099011928075
GOBP_REGULATION_OF_PATTERN_R...,SET,149,0.0030726,0.00027554,0.068405,0.48209,GOBP_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.99424625860432
GOMF_CYCLIC_NUCLEOTIDE_ACTIV...,SET,10,0.012435,0.00028999,0.2797,0.48227,GOMF_CYCLIC_NUCLEOTIDE_ACTIVATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.994447684528034
PID_HES_HEY_PATHWAY,SET,45,0.0057163,0.00028252,0.12913,0.48235,PID_HES_HEY_PATHWAY,0.994447684528034
VDR_Q6,SET,237,0.0025152,0.00028377,0.057155,0.48245,VDR_Q6,0.994447684528034
BURTON_ADIPOGENESIS_PEAK_AT_...2,SET,39,0.0056794,0.00026135,0.1295,0.48251,BURTON_ADIPOGENESIS_PEAK_AT_16HR,0.994447684528034
HP_HYPOPLASIA_OF_THE_BLADDER,SET,5,0.01544,0.00025464,0.35226,0.48252,HP_HYPOPLASIA_OF_THE_BLADDER,0.994447684528034
GSE41978_WT_VS_ID2_KO_AND_BI...1,SET,179,0.0027377,0.00026887,0.062492,0.48253,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.994447684528034
GOBP_NEGATIVE_REGULATION_OF_...530,SET,35,0.0063064,0.00027495,0.14426,0.48257,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.994447684528034
HP_AXILLARY_FRECKLING,SET,5,0.017414,0.0002872,0.39856,0.48257,HP_AXILLARY_FRECKLING,0.994447684528034
GOBP_NEGATIVE_REGULATION_OF_...156,SET,20,0.0084948,0.00028008,0.19452,0.48258,GOBP_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.994447684528034
GSE5503_LIVER_DC_VS_SPLEEN_D...2,SET,182,0.0028344,0.00028066,0.064915,0.48259,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.994447684528034
REACTOME_PEPTIDE_HORMONE_MET...,SET,81,0.0043789,0.00029006,0.10039,0.48261,REACTOME_PEPTIDE_HORMONE_METABOLISM,0.994447684528034
GSE21360_NAIVE_VS_PRIMARY_ME...1,SET,170,0.0029551,0.0002829,0.068009,0.48267,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN,0.994447684528034
GOMF_PROMOTER_SPECIFIC_CHROM...,SET,61,0.0046244,0.00026598,0.10655,0.48269,GOMF_PROMOTER_SPECIFIC_CHROMATIN_BINDING,0.994447684528034
MIR526B_3P,SET,565,0.0016125,0.00027835,0.037223,0.48272,MIR526B_3P,0.994447684528034
HP_INFECTION_FOLLOWING_LIVE_...,SET,20,0.0086683,0.0002858,0.20018,0.48273,HP_INFECTION_FOLLOWING_LIVE_VACCINATION,0.994447684528034
GSE46143_CTRL_VS_LMP2A_TRANS...1,SET,181,0.0027189,0.0002685,0.062953,0.48278,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN,0.994447684528034
MORI_EMU_MYC_LYMPHOMA_BY_ONS...2,SET,104,0.0035837,0.00026882,0.083267,0.48284,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,0.994447684528034
KEGG_HEMATOPOIETIC_CELL_LINE...,SET,80,0.0045317,0.00029834,0.10532,0.48284,KEGG_HEMATOPOIETIC_CELL_LINEAGE,0.994447684528034
GOBP_L_GLUTAMATE_IMPORT,SET,39,0.0059695,0.0002747,0.13879,0.48285,GOBP_L_GLUTAMATE_IMPORT,0.994447684528034
KENNY_CTNNB1_TARGETS_UP,SET,47,0.0053364,0.00026952,0.12445,0.4829,KENNY_CTNNB1_TARGETS_UP,0.994447684528034
KEGG_MEDICUS_ENV_FACTOR_NICO...2,SET,5,0.019863,0.00032758,0.46382,0.48292,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.994447684528034
GOBP_RESPONSE_TO_IMMOBILIZAT...,SET,25,0.0072071,0.00026563,0.16851,0.48294,GOBP_RESPONSE_TO_IMMOBILIZATION_STRESS,0.994447684528034
GOBP_RESPONSE_TO_HISTAMINE,SET,10,0.012208,0.00028469,0.28564,0.48296,GOBP_RESPONSE_TO_HISTAMINE,0.994447684528034
GOBP_NEGATIVE_REGULATION_OF_...525,SET,29,0.0063991,0.000254,0.14983,0.48297,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.994447684528034
GSE5589_LPS_VS_LPS_AND_IL10_...4,SET,177,0.0027252,0.00026616,0.063838,0.48297,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.994447684528034
BIOCARTA_EXTRINSIC_PATHWAY,SET,13,0.010937,0.00029079,0.25633,0.48298,BIOCARTA_EXTRINSIC_PATHWAY,0.994447684528034
GOBP_ENDOPLASMIC_RETICULUM_P...,SET,5,0.016855,0.00027798,0.39552,0.483,GOBP_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_TETHERING,0.994447684528034
JONES_OVARY_MACROPHAGE,SET,215,0.0026896,0.0002892,0.063549,0.48312,JONES_OVARY_MACROPHAGE,0.994447684528034
BRUNEAU_SEPTATION_ATRIAL,SET,5,0.017799,0.00029354,0.42115,0.48314,BRUNEAU_SEPTATION_ATRIAL,0.994447684528034
MODULE_108,SET,52,0.0061939,0.000329,0.1467,0.48316,MODULE_108,0.994447684528034
HP_RADIAL_DEVIATION_OF_THE_H...2,SET,51,0.0050239,0.00026428,0.11953,0.48324,HP_RADIAL_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,0.994447684528034
DESCARTES_FETAL_LIVER_LYMPHO...,SET,90,0.0041494,0.00028966,0.098745,0.48324,DESCARTES_FETAL_LIVER_LYMPHOID_CELLS,0.994447684528034
HP_THORACIC_PLATYSPONDYLY,SET,6,0.012966,0.00023424,0.30905,0.48327,HP_THORACIC_PLATYSPONDYLY,0.994447684528034
GSE24634_NAIVE_CD4_TCELL_VS_...2,SET,168,0.0027968,0.00026618,0.066663,0.48327,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP,0.994447684528034
MIR10A_3P,SET,20,0.0080937,0.00026686,0.19339,0.48331,MIR10A_3P,0.994447684528034
HP_ABNORMAL_PULMONARY_INTERS...,SET,135,0.003083,0.00026327,0.073651,0.48331,HP_ABNORMAL_PULMONARY_INTERSTITIAL_MORPHOLOGY,0.994447684528034
MIR3118,SET,70,0.0043918,0.00027053,0.10529,0.48336,MIR3118,0.994447684528034
ZHAN_MULTIPLE_MYELOMA_CD1_UP,SET,40,0.0060101,0.00028009,0.14418,0.48337,ZHAN_MULTIPLE_MYELOMA_CD1_UP,0.994447684528034
GOERING_BLOOD_HDL_CHOLESTERO...1,SET,8,0.014855,0.00030986,0.35647,0.48338,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS,0.994447684528034
BIOCARTA_IFNA_PATHWAY,SET,9,0.011777,0.00026056,0.28342,0.48343,BIOCARTA_IFNA_PATHWAY,0.994447684528034
HP_ABNORMAL_AORTIC_VALVE_CUS...,SET,101,0.0037903,0.00028022,0.091205,0.48343,HP_ABNORMAL_AORTIC_VALVE_CUSP_MORPHOLOGY,0.994447684528034
GSE30153_LUPUS_VS_HEALTHY_DO...1,SET,180,0.0027791,0.00027369,0.067041,0.48347,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN,0.994447684528034
GSE40274_CTRL_VS_SATB1_TRANS...1,SET,151,0.0028076,0.00025345,0.067815,0.48349,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.994447684528034
GSE24671_BAKIMULC_VS_SENDAI_...1,SET,173,0.0024893,0.00024038,0.060275,0.48353,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.994447684528034
KOKKINAKIS_METHIONINE_DEPRIV...2,SET,125,0.0032938,0.00027072,0.079844,0.48355,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,0.994447684528034
GOBP_NEGATIVE_REGULATION_OF_...609,SET,22,0.0074919,0.00025906,0.18169,0.48355,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.994447684528034
MODULE_249,SET,21,0.0071728,0.00024233,0.17403,0.48356,MODULE_249,0.994447684528034
DESCARTES_FETAL_EYE_PHOTOREC...,SET,29,0.0074462,0.00029556,0.18088,0.48358,DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS,0.994447684528034
HP_ASYMMETRIC_SEPTAL_HYPERTR...,SET,13,0.010728,0.00028523,0.26112,0.48361,HP_ASYMMETRIC_SEPTAL_HYPERTROPHY,0.994447684528034
GSE40274_CTRL_VS_FOXP3_TRANS...2,SET,182,0.002544,0.00025191,0.062027,0.48364,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.994447684528034
BURTON_ADIPOGENESIS_PEAK_AT_...1,SET,59,0.0046122,0.00026091,0.11257,0.48366,BURTON_ADIPOGENESIS_PEAK_AT_0HR,0.994447684528034
GSE33162_UNTREATED_VS_4H_LPS...1,SET,182,0.0025731,0.00025479,0.062923,0.48369,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN,0.994447684528034
GOCC_MOTILE_CILIUM,SET,229,0.0022742,0.00025227,0.055797,0.48374,GOCC_MOTILE_CILIUM,0.994447684528034
GOMF_HISTONE_H3K9_METHYLTRAN...,SET,12,0.010414,0.00026603,0.25571,0.48376,GOMF_HISTONE_H3K9_METHYLTRANSFERASE_ACTIVITY,0.994447684528034
GOCC_SIGNAL_PEPTIDASE_COMPLEX,SET,5,0.014228,0.00023465,0.34968,0.48377,GOCC_SIGNAL_PEPTIDASE_COMPLEX,0.994447684528034
REACTOME_CYTOCHROME_C_MEDIAT...,SET,12,0.010115,0.00025838,0.24894,0.48379,REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE,0.994447684528034
JONES_OVARY_THECA,SET,44,0.0059567,0.00029111,0.147,0.48384,JONES_OVARY_THECA,0.99449164350346
GSE19941_LPS_VS_LPS_AND_IL10...1,SET,137,0.0031249,0.0002688,0.077271,0.48387,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.994494491425192
GOBP_ERROR_PRONE_TRANSLESION...,SET,12,0.0083337,0.00021288,0.20778,0.484,GOBP_ERROR_PRONE_TRANSLESION_SYNTHESIS,0.994612469055759
HP_ABNORMAL_URINE_ALPHA_KETO...,SET,14,0.0097145,0.00026802,0.24279,0.48404,HP_ABNORMAL_URINE_ALPHA_KETOGLUTARATE_CONCENTRATION,0.994612469055759
HP_UNILATERAL_PTOSIS,SET,8,0.011867,0.00024754,0.29809,0.48412,HP_UNILATERAL_PTOSIS,0.994612469055759
GSE13411_NAIVE_BCELL_VS_PLAS...2,SET,169,0.0026543,0.00025336,0.066856,0.48417,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.994612469055759
REACTOME_THE_NLRP3_INFLAMMAS...,SET,14,0.0087255,0.00024074,0.21994,0.48418,REACTOME_THE_NLRP3_INFLAMMASOME,0.994612469055759
GSE22432_MULTIPOTENT_VS_COMM...2,SET,174,0.0024964,0.00024176,0.062983,0.48419,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN,0.994612469055759
GOBP_NEGATIVE_REGULATION_OF_...134,SET,5,0.017123,0.00028239,0.43381,0.48426,GOBP_NEGATIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.994612469055759
GOBP_POSITIVE_REGULATION_OF_...470,SET,34,0.0055667,0.00023921,0.14122,0.48428,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,0.994612469055759
GOMF_DYNEIN_HEAVY_CHAIN_BIND...,SET,12,0.008606,0.00021984,0.21848,0.48429,GOMF_DYNEIN_HEAVY_CHAIN_BINDING,0.994612469055759
GOBP_MACROPHAGE_CHEMOTAXIS,SET,39,0.0053489,0.00024614,0.13585,0.4843,GOBP_MACROPHAGE_CHEMOTAXIS,0.994612469055759
GSE7460_FOXP3_MUT_VS_HET_ACT...1,SET,182,0.0024873,0.00024629,0.063176,0.4843,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN,0.994612469055759
HP_FEMALE_INFERTILITY,SET,69,0.003862,0.00023619,0.098505,0.48436,HP_FEMALE_INFERTILITY,0.994612469055759
HOWLIN_CITED1_TARGETS_1_UP,SET,31,0.006359,0.00026095,0.16235,0.48438,HOWLIN_CITED1_TARGETS_1_UP,0.994612469055759
GOMF_5_N_7_METHYLGUANOSINE_5...,SET,9,0.012678,0.0002805,0.32441,0.48441,GOMF_5_N_7_METHYLGUANOSINE_5_TRIPHOSPHO_MRNA_HYDROLASE_ACTIVITY,0.994612469055759
GOMF_ACETYLCHOLINE_RECEPTOR_...1,SET,22,0.0076496,0.00026451,0.19568,0.48441,GOMF_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.994612469055759
GSE22611_NOD2_TRANSD_VS_CTRL...4,SET,173,0.0024633,0.00023787,0.063139,0.48444,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP,0.994612469055759
GOMF_ASPARTIC_ENDOPEPTIDASE_...,SET,8,0.009919,0.0002069,0.25502,0.48449,GOMF_ASPARTIC_ENDOPEPTIDASE_ACTIVITY_INTRAMEMBRANE_CLEAVING,0.994612469055759
HP_ABNORMAL_FORAMEN_MAGNUM_M...,SET,16,0.0075819,0.00022361,0.19492,0.48449,HP_ABNORMAL_FORAMEN_MAGNUM_MORPHOLOGY,0.994612469055759
GOMF_RNA_POLYMERASE_II_CTD_H...3,SET,7,0.011458,0.00022357,0.29531,0.48453,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_PHOSPHATASE_ACTIVITY,0.994612469055759
GSE17721_0.5H_VS_4H_PAM3CSK4...2,SET,181,0.002449,0.00024184,0.063236,0.48455,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP,0.994612469055759
KEGG_MEDICUS_VARIANT_MUTATIO...71,SET,6,0.013024,0.00023528,0.33636,0.48456,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY,0.994612469055759
GSE22033_UNTREATED_VS_MRL24_...2,SET,178,0.0023583,0.00023097,0.060949,0.48457,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP,0.994612469055759
REACTOME_TRYPTOPHAN_CATABOLI...,SET,12,0.010099,0.00025797,0.26195,0.48462,REACTOME_TRYPTOPHAN_CATABOLISM,0.994612469055759
GOBP_REGULATION_OF_MEMBRANE_...9,SET,25,0.0067693,0.0002495,0.17623,0.48468,GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.994612469055759
HP_ADRENOCORTICOTROPIC_HORMO...1,SET,14,0.0088722,0.00024478,0.23181,0.48474,HP_ADRENOCORTICOTROPIC_HORMONE_DEFICIENCY,0.994612469055759
GOMF_LAMININ_BINDING,SET,28,0.0062868,0.0002452,0.16493,0.4848,GOMF_LAMININ_BINDING,0.994612469055759
GOBP_NEGATIVE_REGULATION_OF_...9,SET,4,0.019382,0.00028592,0.50953,0.48483,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.994612469055759
WP_NRP1TRIGGERED_SIGNALING_I...,SET,52,0.0049538,0.00026313,0.13045,0.48485,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,0.994612469055759
WP_PROTEASOME_DEGRADATION,SET,56,0.0040839,0.00022509,0.10752,0.48485,WP_PROTEASOME_DEGRADATION,0.994612469055759
GOBP_CELLULAR_RESPONSE_TO_NI...3,SET,11,0.0099577,0.00024354,0.2652,0.48502,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS,0.994612469055759
GSE12392_IFNAR_KO_VS_IFNB_KO...2,SET,177,0.0023629,0.00023078,0.063048,0.48505,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP,0.994612469055759
REACTOME_REGULATION_OF_IFNA_...,SET,22,0.0080958,0.00027994,0.21611,0.48506,REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING,0.994612469055759
REACTOME_DIGESTION,SET,17,0.0090622,0.00027549,0.24208,0.48507,REACTOME_DIGESTION,0.994612469055759
GOMF_POLY_ADP_D_RIBOSE_BINDI...,SET,4,0.013555,0.00019996,0.36203,0.48507,GOMF_POLY_ADP_D_RIBOSE_BINDING,0.994612469055759
SHIN_B_CELL_LYMPHOMA_CLUSTER...8,SET,17,0.008826,0.00026831,0.23615,0.48509,SHIN_B_CELL_LYMPHOMA_CLUSTER_9,0.994612469055759
MIR6892_3P,SET,92,0.003411,0.00024073,0.091299,0.4851,MIR6892_3P,0.994612469055759
GSE33425_CD161_INT_VS_NEG_CD...1,SET,190,0.0023518,0.00023789,0.063019,0.48512,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN,0.994612469055759
GSE17974_0H_VS_72H_IN_VITRO_...2,SET,163,0.0025932,0.00024313,0.069663,0.48515,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP,0.994612469055759
HP_EARLY_SATIETY,SET,6,0.012023,0.00021721,0.3246,0.48523,HP_EARLY_SATIETY,0.994612469055759
GSE7596_AKT_TRANSD_VS_CTRL_C...2,SET,147,0.0025475,0.00022692,0.068839,0.48524,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP,0.994612469055759
SUNG_METASTASIS_STROMA_DN,SET,51,0.0044696,0.00023513,0.12083,0.48525,SUNG_METASTASIS_STROMA_DN,0.994612469055759
HEBERT_MATRISOME_TNBC_BONE_M...2,SET,4,0.017369,0.00025622,0.4714,0.4853,HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED,0.994612469055759
HP_FOOT_OLIGODACTYLY,SET,10,0.0091075,0.00021239,0.24748,0.48532,HP_FOOT_OLIGODACTYLY,0.994612469055759
GOMF_OXIDOREDUCTASE_ACTIVITY...1,SET,11,0.0083218,0.00020353,0.22645,0.48534,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS,0.994612469055759
GSE22935_UNSTIM_VS_12H_MBOVI...1,SET,184,0.002282,0.00022719,0.06228,0.48539,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.994612469055759
GOBP_PEROXISOME_PROLIFERATOR...,SET,22,0.0073856,0.00025538,0.20178,0.4854,GOBP_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.994612469055759
GSE17974_CTRL_VS_ACT_IL4_AND...9,SET,173,0.0022936,0.00022148,0.062678,0.4854,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN,0.994612469055759
GSE20366_TREG_VS_TCONV_UP,SET,179,0.0024255,0.00023821,0.066287,0.48541,GSE20366_TREG_VS_TCONV_UP,0.994612469055759
HP_DECREASED_CIRCULATING_ADE...,SET,7,0.012813,0.00025001,0.3505,0.48542,HP_DECREASED_CIRCULATING_ADENOSYLCOBALAMIN_CONCENTRATION,0.994612469055759
GSE36078_UNTREATED_VS_AD5_IN...2,SET,182,0.002278,0.00022557,0.062361,0.48543,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP,0.994612469055759
GSE22886_NAIVE_CD4_TCELL_VS_...15,SET,174,0.0025638,0.00024828,0.070225,0.48544,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN,0.994612469055759
GSE14308_TH2_VS_NATURAL_TREG...2,SET,168,0.0022604,0.00021513,0.062113,0.48548,GSE14308_TH2_VS_NATURAL_TREG_UP,0.994612469055759
CHEOK_RESPONSE_TO_MERCAPTOPU...1,SET,23,0.0062771,0.00022192,0.17265,0.4855,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,0.994612469055759
GOBP_CELL_REDOX_HOMEOSTASIS,SET,34,0.0053375,0.00022936,0.14678,0.4855,GOBP_CELL_REDOX_HOMEOSTASIS,0.994612469055759
MIR4306,SET,429,0.0015326,0.00023141,0.042257,0.48553,MIR4306,0.994612469055759
HP_UPGAZE_PALSY,SET,11,0.0095338,0.00023318,0.26281,0.48553,HP_UPGAZE_PALSY,0.994612469055759
GOMF_LIGAND_GATED_SODIUM_CHA...,SET,16,0.007811,0.00023037,0.21579,0.48556,GOMF_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY,0.994615300288796
GOMF_CAMP_DEPENDENT_PROTEIN_...1,SET,5,0.011101,0.00018307,0.30906,0.48567,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.994731840678765
GSE28408_LY6G_POS_VS_NEG_DC_...2,SET,175,0.0022834,0.00022176,0.063626,0.48569,GSE28408_LY6G_POS_VS_NEG_DC_UP,0.994731840678765
GOBP_METANEPHRIC_PROXIMAL_TU...,SET,5,0.015094,0.00024893,0.42211,0.48574,GOBP_METANEPHRIC_PROXIMAL_TUBULE_DEVELOPMENT,0.994731840678765
PYEON_HPV_POSITIVE_TUMORS_UP,SET,81,0.0032462,0.00021503,0.09083,0.48575,PYEON_HPV_POSITIVE_TUMORS_UP,0.994731840678765
REACTOME_RHOJ_GTPASE_CYCLE,SET,50,0.0042997,0.00022397,0.1204,0.48576,REACTOME_RHOJ_GTPASE_CYCLE,0.994731840678765
GOBP_RESPONSE_TO_AUDITORY_ST...,SET,32,0.0052947,0.00022074,0.14901,0.48583,GOBP_RESPONSE_TO_AUDITORY_STIMULUS,0.994735973248856
GOCC_ATP_BINDING_CASSETTE_AB...,SET,6,0.012873,0.00023256,0.36374,0.48588,GOCC_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX,0.994735973248856
GSE21546_SAP1A_KO_VS_SAP1A_K...1,SET,190,0.0022621,0.00022881,0.063897,0.48588,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.994735973248856
GSE9650_EFFECTOR_VS_MEMORY_C...1,SET,184,0.0022234,0.00022136,0.062809,0.48588,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN,0.994735973248856
GOCC_ACROSOMAL_MEMBRANE,SET,30,0.0060364,0.00024369,0.17264,0.48605,GOCC_ACROSOMAL_MEMBRANE,0.994735973248856
GOBP_RESPONSE_TO_OZONE,SET,5,0.015506,0.00025573,0.44362,0.48606,GOBP_RESPONSE_TO_OZONE,0.994735973248856
GSE42021_TCONV_PLN_VS_CD24IN...2,SET,177,0.0022687,0.00022158,0.064925,0.48606,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP,0.994735973248856
HP_NEOPLASM_OF_THE_EYE,SET,47,0.0038681,0.00019536,0.11098,0.4861,HP_NEOPLASM_OF_THE_EYE,0.994735973248856
REACTOME_MITOTIC_TELOPHASE_C...,SET,10,0.0092286,0.00021521,0.265,0.48611,REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS,0.994735973248856
NAKAYA_B_CELL_FLUARIX_FLUVIR...1,SET,261,0.0017214,0.00020368,0.049647,0.48617,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.994735973248856
GOBP_REGULATION_OF_TRANSMEMB...2,SET,420,0.0015451,0.0002309,0.044677,0.48621,GOBP_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.994735973248856
MIR18A_3P,SET,82,0.0031669,0.00021107,0.091677,0.48622,MIR18A_3P,0.994735973248856
BIOCARTA_S1P_PATHWAY,SET,7,0.010314,0.00020125,0.29916,0.48625,BIOCARTA_S1P_PATHWAY,0.994735973248856
GOBP_MITOTIC_SISTER_CHROMATI...4,SET,60,0.0036178,0.00020638,0.10497,0.48625,GOBP_MITOTIC_SISTER_CHROMATID_SEPARATION,0.994735973248856
ZHANG_ANTIVIRAL_RESPONSE_TO_...2,SET,24,0.0062531,0.00022582,0.18242,0.48633,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,0.994735973248856
HP_RACHITIC_ROSARY,SET,6,0.0129,0.00023305,0.37715,0.48636,HP_RACHITIC_ROSARY,0.994735973248856
BARRIER_CANCER_RELAPSE_TUMOR...2,SET,15,0.0074522,0.00021282,0.21863,0.4864,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP,0.994735973248856
HP_HYPERAMMONEMIA,SET,66,0.00345,0.00020638,0.10142,0.48643,HP_HYPERAMMONEMIA,0.994735973248856
MANNO_MIDBRAIN_NEUROTYPES_HD...2,SET,450,0.0014845,0.00022943,0.04376,0.48647,MANNO_MIDBRAIN_NEUROTYPES_HDA2,0.994735973248856
MIR1204,SET,6,0.01241,0.0002242,0.36601,0.48648,MIR1204,0.994735973248856
OSAWA_TNF_TARGETS,SET,10,0.0090098,0.00021011,0.26628,0.4865,OSAWA_TNF_TARGETS,0.994735973248856
GOBP_SEQUESTERING_OF_EXTRACE...,SET,10,0.010399,0.00024251,0.30812,0.48654,GOBP_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR,0.994735973248856
GOBP_ATRIAL_CARDIAC_MUSCLE_T...2,SET,5,0.014686,0.0002422,0.43759,0.48661,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.994735973248856
GOBP_REGULATION_OF_SECONDARY...1,SET,8,0.011148,0.00023255,0.33258,0.48663,GOBP_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION,0.994735973248856
HP_MACROCEPHALY_AT_BIRTH,SET,8,0.010819,0.00022567,0.32368,0.48667,HP_MACROCEPHALY_AT_BIRTH,0.994735973248856
HP_ENLARGEMENT_OF_THE_ANKLES,SET,5,0.013702,0.00022598,0.41095,0.4867,HP_ENLARGEMENT_OF_THE_ANKLES,0.994735973248856
GOBP_RESPIRATORY_CHAIN_COMPL...2,SET,23,0.0051573,0.00018233,0.15487,0.48672,GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY,0.994735973248856
GOCC_NLRP1_INFLAMMASOME_COMP...,SET,5,0.015352,0.00025319,0.46267,0.48676,GOCC_NLRP1_INFLAMMASOME_COMPLEX,0.994735973248856
WP_IL7_SIGNALING,SET,24,0.0064139,0.00023163,0.19332,0.48677,WP_IL7_SIGNALING,0.994735973248856
REACTOME_OTHER_SEMAPHORIN_IN...,SET,18,0.0074974,0.00023452,0.22659,0.4868,REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,0.994735973248856
GOMF_FATTY_ACYL_COA_SYNTHASE...,SET,6,0.016014,0.00028931,0.48575,0.48685,GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY,0.994735973248856
GOBP_ELASTIC_FIBER_ASSEMBLY,SET,8,0.0097077,0.0002025,0.29503,0.48688,GOBP_ELASTIC_FIBER_ASSEMBLY,0.994735973248856
GOBP_PROTEIN_POLYUBIQUITINAT...,SET,251,0.001718,0.0001994,0.052265,0.48689,GOBP_PROTEIN_POLYUBIQUITINATION,0.994735973248856
GOMF_K48_LINKED_DEUBIQUITINA...,SET,10,0.0084362,0.00019674,0.25687,0.4869,GOMF_K48_LINKED_DEUBIQUITINASE_ACTIVITY,0.994735973248856
REACTOME_NEGATIVE_REGULATION...9,SET,20,0.0064997,0.0002143,0.1983,0.48693,REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION,0.994735973248856
GOBP_NORADRENERGIC_NEURON_DE...,SET,4,0.016659,0.00024574,0.51014,0.48697,GOBP_NORADRENERGIC_NEURON_DEVELOPMENT,0.994735973248856
WP_ARYLAMINE_METABOLISM,SET,6,0.014982,0.00027066,0.46033,0.48702,WP_ARYLAMINE_METABOLISM,0.994735973248856
POS_RESPONSE_TO_HISTAMINE_UP,SET,11,0.0079262,0.00019386,0.24393,0.48704,POS_RESPONSE_TO_HISTAMINE_UP,0.994735973248856
GSE22527_ANTI_CD3_INVIVO_VS_...1,SET,178,0.0019158,0.00018763,0.059112,0.48707,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN,0.994735973248856
GOBP_NEUTROPHIL_APOPTOTIC_PR...,SET,7,0.012281,0.00023963,0.37944,0.48709,GOBP_NEUTROPHIL_APOPTOTIC_PROCESS,0.994735973248856
GSE17721_0.5H_VS_24H_CPG_BMD...2,SET,182,0.0020507,0.00020306,0.063354,0.48709,GSE17721_0.5H_VS_24H_CPG_BMDC_UP,0.994735973248856
HP_ALOPECIA_OF_SCALP,SET,37,0.0044301,0.00019858,0.13714,0.48711,HP_ALOPECIA_OF_SCALP,0.994735973248856
HP_ABNORMAL_PROXIMAL_FEMORAL...,SET,8,0.0089145,0.00018595,0.27605,0.48712,HP_ABNORMAL_PROXIMAL_FEMORAL_METAPHYSIS_MORPHOLOGY,0.994735973248856
STAT_01,SET,233,0.0018595,0.00020804,0.057612,0.48713,STAT_01,0.994735973248856
MODULE_66,SET,503,0.0013167,0.00021483,0.04083,0.48714,MODULE_66,0.994735973248856
GOBP_CELLULAR_RESPONSE_TO_AN...2,SET,11,0.0088214,0.00021575,0.27576,0.48724,GOBP_CELLULAR_RESPONSE_TO_ANTIBIOTIC,0.994735973248856
GSE7460_WT_VS_FOXP3_HET_ACT_...2,SET,186,0.0020249,0.00020268,0.063551,0.48729,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP,0.994735973248856
GSE24574_BCL6_HIGH_TFH_VS_TC...2,SET,175,0.0021138,0.00020529,0.066377,0.4873,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP,0.994735973248856
GSE17721_CTRL_VS_PAM3CSK4_1H...2,SET,178,0.0019095,0.00018701,0.060007,0.48731,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP,0.994735973248856
MIR513B_3P,SET,144,0.0023791,0.00020977,0.075029,0.48735,MIR513B_3P,0.994735973248856
GOBP_CATECHOLAMINE_SECRETION,SET,46,0.004282,0.00021396,0.13497,0.48735,GOBP_CATECHOLAMINE_SECRETION,0.994735973248856
MIR6072,SET,72,0.0031341,0.00019578,0.099568,0.48744,MIR6072,0.994735973248856
HAEGERSTRAND_RESPONSE_TO_IMA...,SET,9,0.01097,0.00024271,0.34961,0.48748,HAEGERSTRAND_RESPONSE_TO_IMATINIB,0.994735973248856
HP_NUMEROUS_PIGMENTED_FRECKL...,SET,7,0.0088366,0.00017243,0.28203,0.4875,HP_NUMEROUS_PIGMENTED_FRECKLES,0.994735973248856
USF_C,SET,262,0.0016545,0.00019613,0.05283,0.48751,USF_C,0.994735973248856
GOMF_2_ACYLGLYCEROL_3_PHOSPH...,SET,8,0.010376,0.00021645,0.33244,0.48755,GOMF_2_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,0.994735973248856
GOBP_REGULATION_OF_GLIAL_CEL...4,SET,36,0.0045426,0.00020086,0.14582,0.48757,GOBP_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.994735973248856
YGCANTGCR_UNKNOWN,SET,109,0.002592,0.00019903,0.083602,0.48763,YGCANTGCR_UNKNOWN,0.994735973248856
FARMER_BREAST_CANCER_CLUSTER...6,SET,14,0.0072487,0.00019999,0.23392,0.48764,FARMER_BREAST_CANCER_CLUSTER_6,0.994735973248856
REACTOME_RESPIRATORY_ELECTRO...,SET,135,0.0020172,0.00017225,0.065095,0.48764,REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,0.994735973248856
HALLMARK_TNFA_SIGNALING_VIA_...,SET,190,0.0020975,0.00021216,0.067681,0.48764,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.994735973248856
GOBP_DEVELOPMENTAL_CELL_GROW...,SET,199,0.0019491,0.00020172,0.062957,0.48765,GOBP_DEVELOPMENTAL_CELL_GROWTH,0.994735973248856
GSE42021_TCONV_PLN_VS_CD24HI...1,SET,181,0.0020012,0.00019762,0.06466,0.48765,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN,0.994735973248856
BUCASAS_PBMC_FLUARIX_FLUVIRI...1,SET,6,0.010984,0.00019844,0.35468,0.48765,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_3DY_POSITIVE_PREDICTIVE_OF_TITER,0.994735973248856
HP_ANTINEUTROPHIL_ANTIBODY_P...,SET,42,0.004064,0.00019406,0.13223,0.48774,HP_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,0.994735973248856
GOBP_NEGATIVE_REGULATION_OF_...694,SET,16,0.0070839,0.00020893,0.23078,0.48776,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.994735973248856
GOCC_PHOTORECEPTOR_INNER_SEG...,SET,65,0.0033725,0.00020021,0.10991,0.48776,GOCC_PHOTORECEPTOR_INNER_SEGMENT,0.994735973248856
MIR6851_5P,SET,95,0.0026275,0.00018842,0.086027,0.48782,MIR6851_5P,0.994735973248856
GOBP_FORMATE_METABOLIC_PROCE...,SET,6,0.011725,0.00021182,0.38385,0.48782,GOBP_FORMATE_METABOLIC_PROCESS,0.994735973248856
GOBP_GABAERGIC_NEURON_DIFFER...,SET,18,0.007267,0.00022732,0.23847,0.48784,GOBP_GABAERGIC_NEURON_DIFFERENTIATION,0.994735973248856
GSE17721_CTRL_VS_POLYIC_6H_B...1,SET,189,0.0019446,0.00019619,0.0638,0.48784,GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN,0.994735973248856
GOBP_NEGATIVE_REGULATION_OF_...81,SET,11,0.0080911,0.00019789,0.26571,0.48785,GOBP_NEGATIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.994735973248856
GSE19923_HEB_KO_VS_HEB_AND_E...2,SET,177,0.0019174,0.00018726,0.063007,0.48786,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.994735973248856
GOBP_CELL_JUNCTION_ASSEMBLY,SET,421,0.001358,0.00020317,0.044706,0.48788,GOBP_CELL_JUNCTION_ASSEMBLY,0.994735973248856
GOCC_GLIAL_CELL_PROJECTION,SET,38,0.0045365,0.00020607,0.15,0.48794,GOCC_GLIAL_CELL_PROJECTION,0.994793596059113
HP_LIMITATION_OF_KNEE_MOBILI...,SET,30,0.0049788,0.00020099,0.16511,0.48797,HP_LIMITATION_OF_KNEE_MOBILITY,0.994793596059113
GOBP_PROTEIN_LOCALIZATION_TO...33,SET,4,0.01141,0.00016831,0.38082,0.48805,GOBP_PROTEIN_LOCALIZATION_TO_MOTILE_CILIUM,0.994793596059113
GSE27786_CD4_VS_CD8_TCELL_UP,SET,188,0.0018364,0.00018478,0.061295,0.48805,GSE27786_CD4_VS_CD8_TCELL_UP,0.994793596059113
GSE22886_NAIVE_TCELL_VS_MONO...2,SET,177,0.0019072,0.00018626,0.063791,0.48807,GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP,0.994793596059113
GOBP_POSTSYNAPTIC_SPECIALIZA...2,SET,45,0.003945,0.00019497,0.13198,0.48808,GOBP_POSTSYNAPTIC_SPECIALIZATION_ORGANIZATION,0.994793596059113
MODULE_181,SET,270,0.0015748,0.00018947,0.053013,0.48815,MODULE_181,0.99487792470533
GSE2770_UNTREATED_VS_ACT_CD4...1,SET,181,0.0017911,0.00017687,0.060641,0.48822,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN,0.99488632739212
GSE11961_MEMORY_BCELL_DAY7_V...3,SET,179,0.0018939,0.000186,0.064175,0.48823,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.99488632739212
GATGKMRGCG_UNKNOWN,SET,60,0.0032509,0.00018545,0.11027,0.48824,GATGKMRGCG_UNKNOWN,0.99488632739212
GSE23505_IL6_IL1_VS_IL6_IL1_...4,SET,186,0.001831,0.00018326,0.062464,0.48831,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.994970630826054
GOBP_BLASTOCYST_GROWTH,SET,21,0.0052105,0.00017603,0.17859,0.48836,GOBP_BLASTOCYST_GROWTH,0.994976220763233
LIU_SOX4_TARGETS_UP,SET,126,0.002284,0.00018847,0.078331,0.48837,LIU_SOX4_TARGETS_UP,0.994976220763233
REACTOME_SIGNALLING_TO_RAS,SET,20,0.0055691,0.00018362,0.19238,0.48845,REACTOME_SIGNALLING_TO_RAS,0.995080876318875
MIR7111_5P,SET,189,0.0017445,0.000176,0.060639,0.48852,MIR7111_5P,0.995165148584491
DURANTE_ADULT_OLFACTORY_NEUR...16,SET,47,0.0039434,0.00019917,0.13733,0.48855,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_MICROVILLAR_CELLS,0.995167931661001
GSE3982_EOSINOPHIL_VS_CENT_M...1,SET,178,0.0017538,0.00017176,0.061506,0.48863,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.995254966596343
HP_ECTOPIC_CALCIFICATION,SET,209,0.0017545,0.00018604,0.061663,0.48865,HP_ECTOPIC_CALCIFICATION,0.995254966596343
GOBP_MAINTENANCE_OF_PROTEIN_...5,SET,7,0.010332,0.00020161,0.36402,0.48868,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION,0.995257743920305
ERWIN_COHEN_BLOOD_VACCINE_TC...1,SET,6,0.0096052,0.00017352,0.33972,0.48872,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_DN,0.995280885972108
REACTOME_RET_SIGNALING,SET,40,0.0037993,0.00017706,0.13533,0.4888,REACTOME_RET_SIGNALING,0.995385480752329
GSE12366_GC_VS_MEMORY_BCELL_...1,SET,179,0.0017698,0.00017381,0.063555,0.48889,GSE12366_GC_VS_MEMORY_BCELL_DN,0.99543727373909
HP_SPINAL_CORD_LESION,SET,41,0.0035565,0.0001678,0.12813,0.48893,HP_SPINAL_CORD_LESION,0.99543727373909
GSE17721_POLYIC_VS_CPG_16H_B...1,SET,180,0.0017376,0.00017112,0.062601,0.48893,GSE17721_POLYIC_VS_CPG_16H_BMDC_DN,0.99543727373909
REACTOME_ADHERENS_JUNCTIONS_...,SET,51,0.0037205,0.00019572,0.13423,0.48894,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,0.99543727373909
ONDER_CDH1_TARGETS_2_UP,SET,225,0.0017164,0.00018875,0.062046,0.48897,ONDER_CDH1_TARGETS_2_UP,0.995440039245548
HP_INSOMNIA,SET,62,0.0031746,0.00018408,0.11576,0.48906,HP_INSOMNIA,0.995564944649447
GSE34179_THPOK_KO_VS_WT_VA14...2,SET,187,0.0016394,0.00016453,0.060174,0.48913,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP,0.995649124399672
GOBP_TAURINE_METABOLIC_PROCE...,SET,9,0.0089486,0.00019798,0.33166,0.48924,GOBP_TAURINE_METABOLIC_PROCESS,0.995814711566618
GOMF_TRNA_SPECIFIC_ADENOSINE...,SET,8,0.0082627,0.00017236,0.30772,0.48929,GOMF_TRNA_SPECIFIC_ADENOSINE_DEAMINASE_ACTIVITY,0.995858160576247
HP_LOCALIZED_HIRSUTISM,SET,17,0.0051587,0.00015682,0.1946,0.48943,HP_LOCALIZED_HIRSUTISM,0.995906115548301
HP_ABNORMAL_PROXIMAL_PHALANX...,SET,27,0.0043606,0.00016702,0.16482,0.48945,HP_ABNORMAL_PROXIMAL_PHALANX_MORPHOLOGY_OF_THE_HAND,0.995906115548301
GOBP_NEGATIVE_REGULATION_OF_...146,SET,83,0.0023499,0.00015756,0.08908,0.48948,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,0.995906115548301
GOBP_REGULATION_OF_T_CELL_CH...,SET,15,0.0057528,0.00016428,0.21843,0.48949,GOBP_REGULATION_OF_T_CELL_CHEMOTAXIS,0.995906115548301
FULLER_PBMC_F_TULARENSIS_VAC...7,SET,42,0.0036505,0.00017431,0.1393,0.48955,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP,0.995906115548301
GOBP_NEGATIVE_REGULATION_OF_...453,SET,6,0.010232,0.00018484,0.39239,0.4896,GOBP_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION,0.995906115548301
RAO_BOUND_BY_SALL4,SET,205,0.0015906,0.00016705,0.061468,0.48968,RAO_BOUND_BY_SALL4,0.995906115548301
GOBP_CORTISOL_BIOSYNTHETIC_P...,SET,10,0.0081896,0.00019098,0.31657,0.48968,GOBP_CORTISOL_BIOSYNTHETIC_PROCESS,0.995906115548301
chr11p13,SET,36,0.0077837,0.00034416,0.30206,0.48972,chr11p13,0.995906115548301
GOCC_NUCLEAR_RNA_EXPORT_FACT...,SET,2,0.012748,0.00013298,0.49596,0.48975,GOCC_NUCLEAR_RNA_EXPORT_FACTOR_COMPLEX,0.995906115548301
GSE37534_UNTREATED_VS_GW1929...2,SET,183,0.0016567,0.0001645,0.064603,0.48977,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.995906115548301
GOBP_ASTROCYTE_DEVELOPMENT,SET,40,0.0036478,0.00016999,0.14239,0.48978,GOBP_ASTROCYTE_DEVELOPMENT,0.995906115548301
GOCC_CYTOSKELETON_OF_PRESYNA...,SET,8,0.0086636,0.00018072,0.3381,0.48978,GOCC_CYTOSKELETON_OF_PRESYNAPTIC_ACTIVE_ZONE,0.995906115548301
GSE35685_CD34POS_CD10NEG_CD6...2,SET,184,0.0015906,0.00015836,0.06207,0.48978,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP,0.995906115548301
GOMF_ICOSANOID_TRANSMEMBRANE...,SET,13,0.006557,0.00017433,0.25739,0.48984,GOMF_ICOSANOID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.995906115548301
GOBP_SECRETION_BY_TISSUE,SET,46,0.0034546,0.00017262,0.13625,0.48989,GOBP_SECRETION_BY_TISSUE,0.995906115548301
GOBP_MEMBRANOUS_SEPTUM_MORPH...,SET,6,0.010785,0.00019484,0.42679,0.48992,GOBP_MEMBRANOUS_SEPTUM_MORPHOGENESIS,0.995906115548301
GSE21380_TFH_VS_GERMINAL_CEN...1,SET,179,0.0015402,0.00015126,0.060993,0.48993,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,0.995906115548301
GSE34156_UNTREATED_VS_6H_NOD...4,SET,160,0.0017033,0.00015823,0.067594,0.48995,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.995906115548301
chr4q25,SET,28,0.0070936,0.00027667,0.28277,0.48999,chr4q25,0.995906115548301
GSE14308_TH1_VS_TH17_UP,SET,177,0.001596,0.00015587,0.063693,0.49,GSE14308_TH1_VS_TH17_UP,0.995906115548301
GOCC_MICROTUBULE_MINUS_END,SET,6,0.010177,0.00018385,0.40638,0.49001,GOCC_MICROTUBULE_MINUS_END,0.995906115548301
GSE39820_CTRL_VS_IL1B_IL6_IL...2,SET,180,0.0016025,0.00015782,0.064379,0.49007,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP,0.995906115548301
REACTOME_DEFECTIVE_EXT2_CAUS...,SET,12,0.0070741,0.0001807,0.28513,0.4901,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,0.995906115548301
GOBP_PROTEIN_HETEROOLIGOMERI...,SET,29,0.003788,0.00015036,0.15295,0.49012,GOBP_PROTEIN_HETEROOLIGOMERIZATION,0.995906115548301
HP_OPTIC_DISC_PALLOR,SET,216,0.001395,0.00015034,0.056658,0.49018,HP_OPTIC_DISC_PALLOR,0.995906115548301
ZEILSTRA_CD44_TARGETS_UP,SET,8,0.0079582,0.000166,0.32522,0.49024,ZEILSTRA_CD44_TARGETS_UP,0.995906115548301
REACTOME_RUNX1_REGULATES_TRA...3,SET,8,0.0069757,0.00014551,0.28581,0.49026,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES,0.995906115548301
GOMF_ACETYLCHOLINE_GATED_MON...,SET,16,0.0056286,0.000166,0.23091,0.49028,GOMF_ACETYLCHOLINE_GATED_MONOATOMIC_CATION_SELECTIVE_CHANNEL_ACTIVITY,0.995906115548301
MIR7849_3P,SET,105,0.002088,0.00015738,0.085864,0.4903,MIR7849_3P,0.995906115548301
GSE16451_CTRL_VS_WEST_EQUINE...2,SET,178,0.0015968,0.00015638,0.065704,0.49031,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.995906115548301
GOMF_TRANSMEMBRANE_RECEPTOR_...7,SET,17,0.0052071,0.0001583,0.21493,0.49034,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY,0.995906115548301
MORF_AATF,SET,197,0.0013451,0.00013852,0.055775,0.49038,MORF_AATF,0.995906115548301
GOBP_DNA_REPAIR,SET,530,0.00084053,0.00014067,0.034961,0.49041,GOBP_DNA_REPAIR,0.995906115548301
GOBP_NEGATIVE_REGULATION_OF_...338,SET,52,0.002897,0.00015388,0.12074,0.49043,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.995906115548301
GOMF_SPHINGOSINE_1_PHOSPHATE...2,SET,8,0.0077377,0.0001614,0.32374,0.49047,GOMF_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY,0.995906115548301
GOCC_GOLGI_ASSOCIATED_VESICLE,SET,85,0.0021196,0.00014382,0.089142,0.49051,GOCC_GOLGI_ASSOCIATED_VESICLE,0.995906115548301
GOCC_SECRETORY_VESICLE,SET,986,0.00067876,0.00015294,0.028648,0.49055,GOCC_SECRETORY_VESICLE,0.995906115548301
GOBP_GLAND_DEVELOPMENT,SET,427,0.0010563,0.00015913,0.044709,0.49058,GOBP_GLAND_DEVELOPMENT,0.995906115548301
GSE20198_IL12_VS_IL12_IL18_T...2,SET,175,0.0014869,0.0001444,0.063113,0.4906,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,0.995906115548301
GOBP_VACUOLE_FUSION,SET,12,0.0056466,0.00014424,0.23985,0.49061,GOBP_VACUOLE_FUSION,0.995906115548301
chr5q12,SET,26,0.0064412,0.0002421,0.27545,0.49067,chr5q12,0.995906115548301
HP_ABNORMAL_PROPORTION_OF_DO...,SET,6,0.0089125,0.00016101,0.3813,0.49068,HP_ABNORMAL_PROPORTION_OF_DOUBLE_NEGATIVE_ALPHA_BETA_REGULATORY_T_CELL,0.995906115548301
DESCARTES_FETAL_PANCREAS_LYM...2,SET,112,0.0020538,0.00015984,0.087978,0.49069,DESCARTES_FETAL_PANCREAS_LYMPHOID_CELLS,0.995906115548301
DUTERTRE_ESTRADIOL_RESPONSE_...1,SET,475,0.00098677,0.00015658,0.042379,0.49071,DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,0.995906115548301
OHGUCHI_LIVER_HNF4A_TARGETS_...2,SET,45,0.0031309,0.00015474,0.13441,0.49071,OHGUCHI_LIVER_HNF4A_TARGETS_UP,0.995906115548301
GOCC_COMPLEX_OF_COLLAGEN_TRI...,SET,19,0.0048286,0.00015518,0.20784,0.49073,GOCC_COMPLEX_OF_COLLAGEN_TRIMERS,0.995906115548301
GSE2405_0H_VS_1.5H_A_PHAGOCY...1,SET,181,0.0013719,0.00013548,0.05949,0.4908,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.995906115548301
YEGNASUBRAMANIAN_PROSTATE_CA...,SET,100,0.0020603,0.00015156,0.089741,0.49084,YEGNASUBRAMANIAN_PROSTATE_CANCER,0.995906115548301
REACTOME_REGULATION_OF_IFNG_...,SET,13,0.0056394,0.00014993,0.24615,0.49086,REACTOME_REGULATION_OF_IFNG_SIGNALING,0.995906115548301
REN_BOUND_BY_E2F,SET,53,0.0025285,0.00013559,0.11049,0.49087,REN_BOUND_BY_E2F,0.995906115548301
GSE22886_NAIVE_VS_IGG_IGA_ME...2,SET,169,0.001504,0.00014356,0.065745,0.49087,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP,0.995906115548301
KEGG_PRION_DISEASES,SET,33,0.0036798,0.00015579,0.16116,0.49089,KEGG_PRION_DISEASES,0.995906115548301
ACCGAGC_MIR423,SET,5,0.0095678,0.00015779,0.41968,0.49091,ACCGAGC_MIR423,0.995906115548301
GOBP_POSITIVE_REGULATION_OF_...75,SET,13,0.0053358,0.00014186,0.23498,0.49094,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.995906115548301
KEGG_MEDICUS_REFERENCE_ITGA_...6,SET,29,0.0038179,0.00015154,0.16855,0.49096,KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.995906115548301
GOBP_T_CELL_DIFFERENTIATION_...1,SET,81,0.0023181,0.00015356,0.10247,0.49098,GOBP_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.995906115548301
HP_ABNORMAL_BRONCHUS_MORPHOL...,SET,186,0.0014313,0.00014326,0.063348,0.49099,HP_ABNORMAL_BRONCHUS_MORPHOLOGY,0.995906115548301
GOBP_NEGATIVE_REGULATION_OF_...337,SET,5,0.0098898,0.0001631,0.43872,0.49101,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.995906115548301
REACTOME_CIRCADIAN_CLOCK,SET,64,0.002424,0.0001428,0.10841,0.49108,REACTOME_CIRCADIAN_CLOCK,0.995906115548301
WP_BIOMARKERS_FOR_PYRIMIDINE...,SET,15,0.0049224,0.00014057,0.22047,0.49109,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.995906115548301
GSE1791_CTRL_VS_NEUROMEDINU_...4,SET,173,0.0014069,0.00013586,0.063417,0.49115,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP,0.995906115548301
PID_GLYPICAN_1PATHWAY,SET,26,0.0039307,0.00014774,0.17757,0.49117,PID_GLYPICAN_1PATHWAY,0.995906115548301
GOBP_OLFACTORY_NERVE_DEVELOP...,SET,6,0.0082037,0.00014821,0.37069,0.49117,GOBP_OLFACTORY_NERVE_DEVELOPMENT,0.995906115548301
MODULE_262,SET,19,0.0052979,0.00017026,0.23989,0.49119,MODULE_262,0.995906115548301
TAVOR_CEBPA_TARGETS_DN,SET,29,0.0037265,0.00014791,0.17023,0.49127,TAVOR_CEBPA_TARGETS_DN,0.995906115548301
GOMF_GENERAL_TRANSCRIPTION_I...2,SET,50,0.0025853,0.00013467,0.11843,0.49129,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,0.995906115548301
HP_MALIGNANT_HYPERTHERMIA,SET,25,0.0037653,0.00013878,0.17325,0.49133,HP_MALIGNANT_HYPERTHERMIA,0.995906115548301
TSANG_PBMC_FLUVIRIN_PANDEMRI...,SET,65,0.0023689,0.00014063,0.10978,0.49139,TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE,0.995906115548301
GOMF_SULFOTRANSFERASE_ACTIVI...,SET,49,0.0028733,0.00014817,0.13354,0.49142,GOMF_SULFOTRANSFERASE_ACTIVITY,0.995906115548301
GSE22886_TCELL_VS_BCELL_NAIV...2,SET,182,0.0013297,0.00013167,0.061807,0.49142,GSE22886_TCELL_VS_BCELL_NAIVE_UP,0.995906115548301
WP_ARSENIC_METABOLISM_AND_RE...,SET,9,0.0065548,0.00014502,0.30636,0.49147,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,0.995906115548301
GOBP_NEGATIVE_REGULATION_OF_...115,SET,10,0.0073031,0.00017031,0.34144,0.49147,GOBP_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.995906115548301
GSE14350_TREG_VS_TEFF_IN_IL2...2,SET,183,0.0013089,0.00012996,0.061387,0.49149,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP,0.995906115548301
GOMF_CELL_ADHESIVE_PROTEIN_B...,SET,5,0.0099716,0.00016445,0.46796,0.4915,GOMF_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION,0.995906115548301
HP_ABNORMAL_CIRCULATING_ANDR...2,SET,11,0.0058195,0.00014233,0.27307,0.4915,HP_ABNORMAL_CIRCULATING_ANDROSTENEDIONE_CONCENTRATION,0.995906115548301
KEGG_MEDICUS_VARIANT_MUTATIO...47,SET,44,0.002696,0.00013176,0.12688,0.49152,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT,0.995906115548301
GOBP_CELL_SURFACE_RECEPTOR_S...1,SET,7,0.0076716,0.00014969,0.36206,0.49155,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT,0.995908840503673
MIR4799_3P,SET,78,0.0020404,0.00013265,0.097059,0.49161,MIR4799_3P,0.995934547680112
GOBP_DNA_TEMPLATED_TRANSCRIP...1,SET,123,0.0014979,0.00012213,0.071339,0.49162,GOBP_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.995934547680112
KEGG_MEDICUS_REFERENCE_COHES...1,SET,4,0.0077119,0.00011376,0.37131,0.49171,KEGG_MEDICUS_REFERENCE_COHESIN_ACETYLATION,0.99602250087382
BIOCARTA_SRCRPTP_PATHWAY,SET,11,0.004951,0.00012109,0.2397,0.49176,BIOCARTA_SRCRPTP_PATHWAY,0.99602250087382
GOBP_RESPONSE_TO_MUSCLE_ACTI...,SET,24,0.0039719,0.00014344,0.19267,0.49178,GOBP_RESPONSE_TO_MUSCLE_ACTIVITY,0.99602250087382
HP_LIMITED_KNEE_FLEXION,SET,4,0.0088681,0.00013082,0.4323,0.49182,HP_LIMITED_KNEE_FLEXION,0.99602250087382
GOBP_ANDROGEN_METABOLIC_PROC...,SET,28,0.0035179,0.00013721,0.17221,0.49185,GOBP_ANDROGEN_METABOLIC_PROCESS,0.99602250087382
MENON_FETAL_KIDNEY_2_NEPHRON...,SET,35,0.0030436,0.0001327,0.14918,0.49186,MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS,0.99602250087382
GOCC_ENDOSOME,SET,963,0.0005779,0.00012878,0.028445,0.4919,GOCC_ENDOSOME,0.99602250087382
REACTOME_PHOSPHOLIPID_METABO...,SET,189,0.0012852,0.00012966,0.063455,0.49192,REACTOME_PHOSPHOLIPID_METABOLISM,0.99602250087382
GOBP_REGULATION_OF_HETEROTYP...,SET,24,0.0038058,0.00013744,0.18811,0.49193,GOBP_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.99602250087382
MIR4278,SET,31,0.0030954,0.00012702,0.15343,0.49195,MIR4278,0.99602250087382
HP_ALOPECIA_TOTALIS,SET,13,0.0054769,0.00014561,0.27239,0.49198,HP_ALOPECIA_TOTALIS,0.996025216986078
GOBP_NEGATIVE_REGULATION_OF_...258,SET,17,0.0043056,0.00013089,0.21669,0.49207,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.996148113537118
GOBP_NEGATIVE_REGULATION_OF_...471,SET,5,0.0085217,0.00014054,0.43529,0.49219,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,0.996148113537118
HP_ELEVATED_URINARY_NOREPINE...,SET,18,0.0035376,0.00011066,0.18067,0.49219,HP_ELEVATED_URINARY_NOREPINEPHRINE_LEVEL,0.996148113537118
GOBP_CELLULAR_GLUCURONIDATION,SET,19,0.0064334,0.00020675,0.32886,0.4922,GOBP_CELLULAR_GLUCURONIDATION,0.996148113537118
TGTTTAC_MIR30A5P_MIR30C_MIR3...,SET,530,0.00074663,0.00012495,0.038247,0.49221,TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P,0.996148113537118
GOBP_REGULATION_OF_HIPPOCAMP...,SET,5,0.0086233,0.00014222,0.44266,0.49223,GOBP_REGULATION_OF_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,0.996148113537118
MIR3174,SET,38,0.002805,0.00012742,0.14456,0.49226,MIR3174,0.996148113537118
GOBP_NEGATIVE_REGULATION_OF_...646,SET,6,0.0077057,0.00013921,0.39741,0.49227,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.996148113537118
GOMF_NUCLEOSIDE_TRIPHOSPHATE...,SET,9,0.0060207,0.0001332,0.31799,0.49245,GOMF_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY,0.99625611627907
MEBARKI_HCC_PROGENITOR_FZD8C...1,SET,373,0.00086711,0.00012227,0.046233,0.49252,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,0.99625611627907
REACTOME_SIGNALING_BY_CSF3_G...,SET,27,0.0033567,0.00012857,0.17893,0.49252,REACTOME_SIGNALING_BY_CSF3_G_CSF,0.99625611627907
GOBP_PROTEIN_LOCALIZATION_TO...42,SET,15,0.0040668,0.00011614,0.21691,0.49252,GOBP_PROTEIN_LOCALIZATION_TO_PHAGOPHORE_ASSEMBLY_SITE,0.99625611627907
HP_ORTHOPNEA,SET,68,0.0019547,0.00011868,0.10463,0.49255,HP_ORTHOPNEA,0.99625611627907
REACTOME_DIGESTION_AND_ABSOR...,SET,22,0.0038942,0.00013466,0.20868,0.49256,REACTOME_DIGESTION_AND_ABSORPTION,0.99625611627907
HP_POSTERIOR_UVEITIS,SET,5,0.0076019,0.00012537,0.40794,0.49257,HP_POSTERIOR_UVEITIS,0.99625611627907
HP_ABNORMALITY_OF_THE_VESTIB...,SET,9,0.0058392,0.00012919,0.31567,0.49262,HP_ABNORMALITY_OF_THE_VESTIBULOCOCHLEAR_NERVE,0.99625611627907
TRAVAGLINI_LUNG_NEUTROPHIL_C...,SET,294,0.00094019,0.00011796,0.050947,0.49264,TRAVAGLINI_LUNG_NEUTROPHIL_CELL,0.99625611627907
HP_URETHRAL_VALVE,SET,11,0.0047404,0.00011594,0.25794,0.49267,HP_URETHRAL_VALVE,0.99625611627907
GOBP_EMBRYONIC_NEUROCRANIUM_...,SET,8,0.0061013,0.00012727,0.33577,0.49275,GOBP_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS,0.99625611627907
KUWANO_RNA_STABILIZED_BY_NO,SET,7,0.0071098,0.00013873,0.39264,0.49278,KUWANO_RNA_STABILIZED_BY_NO,0.99625611627907
GOBP_DIAPHRAGM_DEVELOPMENT,SET,9,0.0056673,0.00012538,0.31333,0.49278,GOBP_DIAPHRAGM_DEVELOPMENT,0.99625611627907
HP_ABNORMAL_TRABECULAR_BONE_...,SET,28,0.0029287,0.00011423,0.16181,0.49278,HP_ABNORMAL_TRABECULAR_BONE_MORPHOLOGY,0.99625611627907
GOBP_MEDIUM_CHAIN_FATTY_ACYL...,SET,6,0.0062427,0.00011278,0.34592,0.4928,GOBP_MEDIUM_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,0.99625611627907
GSE3982_DC_VS_TH1_DN,SET,177,0.0011296,0.00011033,0.062699,0.49281,GSE3982_DC_VS_TH1_DN,0.99625611627907
REACTOME_SIGNALING_BY_PTK6,SET,53,0.0021975,0.00011784,0.12204,0.49282,REACTOME_SIGNALING_BY_PTK6,0.99625611627907
GOBP_NEGATIVE_REGULATION_OF_...522,SET,4,0.0078671,0.00011605,0.44432,0.49294,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.99625611627907
HP_PANCREATIC_ISLET_CELL_HYP...,SET,10,0.0057679,0.00013451,0.32666,0.49296,HP_PANCREATIC_ISLET_CELL_HYPERPLASIA,0.99625611627907
CREB_Q4,SET,237,0.00099579,0.00011235,0.056597,0.49298,CREB_Q4,0.99625611627907
HAY_BONE_MARROW_CD8_T_CELL,SET,61,0.0019964,0.00011483,0.11347,0.49298,HAY_BONE_MARROW_CD8_T_CELL,0.99625611627907
MATSUMIYA_BLOOD_MODIFIED_VAC...2,SET,13,0.003898,0.00010364,0.22187,0.49299,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_UP,0.99625611627907
GOCC_INTRACILIARY_TRANSPORT_...2,SET,8,0.0046097,9.6155e-05,0.26327,0.49302,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_A,0.99625611627907
GSE26488_CTRL_VS_PEPTIDE_INJ...3,SET,172,0.001199,0.00011545,0.068645,0.49303,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN,0.99625611627907
REACTOME_FLT3_SIGNALING_IN_D...,SET,27,0.0027864,0.00010672,0.15961,0.49304,REACTOME_FLT3_SIGNALING_IN_DISEASE,0.99625611627907
HP_NONPROGRESSIVE_CEREBELLAR...,SET,8,0.0056032,0.00011688,0.32254,0.49307,HP_NONPROGRESSIVE_CEREBELLAR_ATAXIA,0.996258813441079
GOBP_NEGATIVE_REGULATION_OF_...643,SET,809,0.00053842,0.00011045,0.031199,0.49312,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.996301918381584
GSE40274_FOXP3_VS_FOXP3_AND_...7,SET,174,0.0011265,0.00010909,0.065697,0.49316,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.996303297656928
GOBP_REGULATION_OF_HYDROLASE...,SET,643,0.00060573,0.0001113,0.036249,0.49333,GOBP_REGULATION_OF_HYDROLASE_ACTIVITY,0.996303297656928
GOBP_SUBSTRATE_DEPENDENT_CEL...2,SET,7,0.0052586,0.00010261,0.31503,0.49334,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION,0.996303297656928
BLANCO_MELO_COVID19_SARS_COV...4,SET,428,0.00070012,0.00010559,0.042376,0.49341,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.996303297656928
WP_OSX_AND_MIRNAS_IN_TOOTH_D...,SET,15,0.0039697,0.00011336,0.24091,0.49343,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,0.996303297656928
GSE36888_UNTREATED_VS_IL2_TR...2,SET,168,0.0011297,0.00010751,0.068703,0.49344,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP,0.996303297656928
HP_CHRONIC_HEPATITIS_DUE_TO_...,SET,5,0.0068559,0.00011307,0.41778,0.49345,HP_CHRONIC_HEPATITIS_DUE_TO_CRYPTOSPORIDIUM_INFECTION,0.996303297656928
GAUTAM_EYE_IRIS_CILIARY_BODY...6,SET,68,0.0015785,9.5837e-05,0.096657,0.49349,GAUTAM_EYE_IRIS_CILIARY_BODY_CYTOTOXIC_T_CELLS,0.996303297656928
HP_TRIANGULAR_MOUTH,SET,19,0.0028452,9.1434e-05,0.17551,0.49353,HP_TRIANGULAR_MOUTH,0.996303297656928
HP_HAMARTOMA_OF_TONGUE,SET,21,0.002785,9.409e-05,0.17293,0.49358,HP_HAMARTOMA_OF_TONGUE,0.996303297656928
SCHAEFFER_PROSTATE_DEVELOPME...8,SET,14,0.0031542,8.7025e-05,0.19819,0.49365,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,0.996303297656928
GRYDER_PAX3FOXO1_TOP_ENHANCE...,SET,415,0.00070172,0.00010425,0.044211,0.49367,GRYDER_PAX3FOXO1_TOP_ENHANCERS,0.996303297656928
OUYANG_PROSTATE_CANCER_PROGR...2,SET,18,0.0032461,0.00010154,0.20489,0.49368,OUYANG_PROSTATE_CANCER_PROGRESSION_UP,0.996303297656928
REACTOME_TICAM1_DEPENDENT_AC...,SET,12,0.0039574,0.00010109,0.25023,0.49369,REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,0.996303297656928
ZHOU_CELL_CYCLE_GENES_IN_IR_...1,SET,116,0.0012224,9.6807e-05,0.077529,0.49371,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,0.996303297656928
HP_CAPILLARY_FRAGILITY,SET,6,0.005614,0.00010142,0.35737,0.49373,HP_CAPILLARY_FRAGILITY,0.996303297656928
GOBP_RESPONSE_TO_CYTOKINE,SET,858,0.00049557,0.00010455,0.031597,0.49374,GOBP_RESPONSE_TO_CYTOKINE,0.996303297656928
GSE22025_UNTREATED_VS_TGFB1_...1,SET,174,0.0010218,9.8953e-05,0.065265,0.49375,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.996303297656928
GOMF_TUMOR_NECROSIS_FACTOR_B...,SET,6,0.0049092,8.8689e-05,0.31634,0.49381,GOMF_TUMOR_NECROSIS_FACTOR_BINDING,0.996303297656928
GSE360_DC_VS_MAC_B_MALAYI_LO...2,SET,177,0.00096777,9.4517e-05,0.062332,0.49381,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP,0.996303297656928
TAKEDA_TARGETS_OF_NUP98_HOXA...6,SET,168,0.0011349,0.00010801,0.07326,0.49382,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,0.996303297656928
chr2q35,SET,64,0.0032503,0.00019148,0.21037,0.49384,chr2q35,0.996303297656928
NAGY_PCAF_COMPONENTS_HUMAN,SET,9,0.0041853,9.2596e-05,0.27227,0.49387,NAGY_PCAF_COMPONENTS_HUMAN,0.996303297656928
GOBP_MITOCHONDRIAL_TRANSLATI...2,SET,5,0.004891,8.0663e-05,0.32205,0.49394,GOBP_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION,0.996303297656928
CHEN_LVAD_SUPPORT_OF_FAILING...2,SET,88,0.0014501,0.0001001,0.096065,0.49398,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,0.996303297656928
GOBP_NEGATIVE_REGULATION_OF_...169,SET,4,0.0056708,8.3652e-05,0.37807,0.49402,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.996303297656928
HP_KNEE_DISLOCATION,SET,13,0.0034739,9.2361e-05,0.23172,0.49402,HP_KNEE_DISLOCATION,0.996303297656928
GOMF_CUPROUS_ION_BINDING,SET,8,0.0043452,9.0639e-05,0.29036,0.49403,GOMF_CUPROUS_ION_BINDING,0.996303297656928
GSE17721_CTRL_VS_PAM3CSK4_2H...2,SET,184,0.000909,9.0498e-05,0.061061,0.49406,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP,0.996303297656928
KEGG_MEDICUS_REFERENCE_WNT_S...1,SET,18,0.0033283,0.00010411,0.22613,0.49413,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO,0.996303297656928
GOBP_DISTAL_CONVOLUTED_TUBUL...,SET,4,0.007524,0.00011099,0.51137,0.49413,GOBP_DISTAL_CONVOLUTED_TUBULE_DEVELOPMENT,0.996303297656928
GOMF_DNA_BINDING_TRANSCRIPTI...4,SET,263,0.00079948,9.4953e-05,0.054301,0.49413,GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY,0.996303297656928
REACTOME_PENTOSE_PHOSPHATE_P...,SET,12,0.0039025,9.9687e-05,0.26572,0.49414,REACTOME_PENTOSE_PHOSPHATE_PATHWAY,0.996303297656928
DESCARTES_FETAL_LIVER_HEMATO...,SET,23,0.0028667,0.00010135,0.19609,0.49417,DESCARTES_FETAL_LIVER_HEMATOPOIETIC_STEM_CELLS,0.996303297656928
MTF1_Q4,SET,222,0.00087143,9.5196e-05,0.059694,0.49418,MTF1_Q4,0.996303297656928
ZHAN_MULTIPLE_MYELOMA_UP,SET,47,0.0016268,8.2165e-05,0.11237,0.49422,ZHAN_MULTIPLE_MYELOMA_UP,0.996303297656928
GOBP_PHENYLPROPANOID_METABOL...,SET,7,0.0048916,9.5448e-05,0.3409,0.49428,GOBP_PHENYLPROPANOID_METABOLIC_PROCESS,0.996303297656928
HP_SKELETAL_MUSCLE_ATROPHY,SET,497,0.00054367,8.8188e-05,0.038306,0.49434,HP_SKELETAL_MUSCLE_ATROPHY,0.996303297656928
REACTOME_COMMON_PATHWAY_OF_F...,SET,21,0.0029625,0.00010009,0.20899,0.49435,REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.996303297656928
HP_ABNORMAL_RETICULOCYTE_MOR...,SET,73,0.0013752,8.6498e-05,0.097527,0.49437,HP_ABNORMAL_RETICULOCYTE_MORPHOLOGY,0.996303297656928
GOMF_ALDO_KETO_REDUCTASE_NAD...,SET,29,0.0024394,9.6826e-05,0.17453,0.49442,GOMF_ALDO_KETO_REDUCTASE_NADPH_ACTIVITY,0.996303297656928
GSE29618_PRE_VS_DAY7_POST_TI...8,SET,176,0.0008938,8.7048e-05,0.064208,0.49445,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP,0.996303297656928
GOMF_COMPLEMENT_BINDING,SET,20,0.00285,9.3968e-05,0.20577,0.49447,GOMF_COMPLEMENT_BINDING,0.996303297656928
SHEN_SMARCA2_TARGETS_DN,SET,265,0.00075808,9.0372e-05,0.054931,0.49449,SHEN_SMARCA2_TARGETS_DN,0.996303297656928
HP_COMMUNICATING_HYDROCEPHAL...,SET,21,0.0025342,8.5617e-05,0.18399,0.49451,HP_COMMUNICATING_HYDROCEPHALUS,0.996303297656928
HARALAMBIEVA_PBMC_FLUARIX_AG...2,SET,405,0.00056921,8.3562e-05,0.041375,0.49451,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE,0.996303297656928
GSE21063_CTRL_VS_ANTI_IGM_ST...4,SET,162,0.00094928,8.8732e-05,0.069095,0.49452,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP,0.996303297656928
GOMF_GLUTAMATE_GATED_CALCIUM...,SET,7,0.0046228,9.0204e-05,0.33997,0.49458,GOMF_GLUTAMATE_GATED_CALCIUM_ION_CHANNEL_ACTIVITY,0.996303297656928
HP_ABNORMAL_LIBIDO,SET,37,0.0019519,8.7493e-05,0.1445,0.49461,HP_ABNORMAL_LIBIDO,0.996303297656928
HP_SHORT_1ST_METACARPAL,SET,21,0.0025373,8.5719e-05,0.18859,0.49463,HP_SHORT_1ST_METACARPAL,0.996303297656928
REACTOME_IRON_UPTAKE_AND_TRA...,SET,53,0.0016279,8.7297e-05,0.12143,0.49465,REACTOME_IRON_UPTAKE_AND_TRANSPORT,0.996303297656928
HP_VESTIBULAR_SCHWANNOMA,SET,6,0.0049259,8.899e-05,0.36822,0.49466,HP_VESTIBULAR_SCHWANNOMA,0.996303297656928
GOBP_ERBB3_SIGNALING_PATHWAY,SET,10,0.0037615,8.7719e-05,0.28352,0.49471,GOBP_ERBB3_SIGNALING_PATHWAY,0.996303297656928
GOBP_AROMATIC_AMINO_ACID_TRA...,SET,9,0.0039055,8.6406e-05,0.29604,0.49474,GOBP_AROMATIC_AMINO_ACID_TRANSPORT,0.996303297656928
GAVISH_3CA_METAPROGRAM_B_CEL...5,SET,50,0.0016845,8.7745e-05,0.12818,0.49476,GAVISH_3CA_METAPROGRAM_B_CELLS_INTERFERON,0.996303297656928
HUPER_BREAST_BASAL_VS_LUMINA...1,SET,54,0.00175,9.4723e-05,0.13388,0.49479,HUPER_BREAST_BASAL_VS_LUMINAL_DN,0.996303297656928
GOBP_PROTEIN_AUTO_ADP_RIBOSY...,SET,11,0.0035786,8.7525e-05,0.27473,0.4948,GOBP_PROTEIN_AUTO_ADP_RIBOSYLATION,0.996303297656928
GSE11924_TH1_VS_TH17_CD4_TCE...2,SET,182,0.00083662,8.2843e-05,0.064174,0.4948,GSE11924_TH1_VS_TH17_CD4_TCELL_UP,0.996303297656928
HE_LIM_SUN_FETAL_LUNG_C1_PUL...2,SET,270,0.00071318,8.5806e-05,0.055704,0.49489,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL,0.996303297656928
GAVISH_3CA_METAPROGRAM_FIBRO...21,SET,45,0.0017656,8.7259e-05,0.13823,0.4949,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS,0.996303297656928
MIR371A_5P,SET,159,0.00085679,7.9348e-05,0.067993,0.49497,MIR371A_5P,0.996303297656928
LIANG_HEMATOPOIESIS_STEM_CEL...5,SET,36,0.0018217,8.0548e-05,0.14549,0.495,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,0.996303297656928
GOBP_LYTIC_VACUOLE_ORGANIZAT...,SET,98,0.0010725,7.8112e-05,0.086471,0.49505,GOBP_LYTIC_VACUOLE_ORGANIZATION,0.996303297656928
GOMF_CCR2_CHEMOKINE_RECEPTOR...,SET,5,0.0054759,9.0309e-05,0.44298,0.49507,GOMF_CCR2_CHEMOKINE_RECEPTOR_BINDING,0.996303297656928
WP_GPCRS_CLASS_A_RHODOPSINLI...,SET,230,0.00080029,8.8967e-05,0.064909,0.49508,WP_GPCRS_CLASS_A_RHODOPSINLIKE,0.996303297656928
MIR6791_5P,SET,152,0.00085736,7.7648e-05,0.069935,0.49511,MIR6791_5P,0.996303297656928
MIR155_5P,SET,215,0.00073525,7.9059e-05,0.060624,0.49516,MIR155_5P,0.996303297656928
GOBP_REGULATION_OF_MYOBLAST_...1,SET,70,0.0012783,7.8743e-05,0.10577,0.49518,GOBP_REGULATION_OF_MYOBLAST_DIFFERENTIATION,0.996303297656928
IBRAHIM_NRF2_DOWN,SET,129,0.00091502,7.6392e-05,0.076435,0.49522,IBRAHIM_NRF2_DOWN,0.996303297656928
GOBP_STRIATED_MUSCLE_ADAPTAT...,SET,45,0.0015949,7.8822e-05,0.13308,0.49522,GOBP_STRIATED_MUSCLE_ADAPTATION,0.996303297656928
GSE40068_CXCR5POS_BCL6POS_TF...1,SET,184,0.00079856,7.9503e-05,0.066807,0.49523,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN,0.996303297656928
GOBP_REGULATION_OF_PLASMA_ME...2,SET,6,0.0044531,8.0449e-05,0.3739,0.49525,GOBP_REGULATION_OF_PLASMA_MEMBRANE_REPAIR,0.996303297656928
HP_LIMB_FASCICULATIONS,SET,6,0.0038514,6.9579e-05,0.32784,0.49531,HP_LIMB_FASCICULATIONS,0.996303297656928
GOBP_POSITIVE_REGULATION_OF_...149,SET,6,0.004509,8.1459e-05,0.38629,0.49534,GOBP_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,0.996303297656928
GSE14699_NAIVE_VS_ACT_CD8_TC...1,SET,158,0.00080151,7.3997e-05,0.068546,0.49534,GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN,0.996303297656928
GOBP_PEPTIDE_CROSS_LINKING,SET,26,0.0019662,7.3902e-05,0.16887,0.49536,GOBP_PEPTIDE_CROSS_LINKING,0.996303297656928
HP_BIRTH_LENGTH_LESS_THAN_3R...,SET,13,0.0025793,6.8576e-05,0.22198,0.49536,HP_BIRTH_LENGTH_LESS_THAN_3RD_PERCENTILE,0.996303297656928
GSE19825_NAIVE_VS_DAY3_EFF_C...1,SET,181,0.00069845,6.8973e-05,0.060433,0.49539,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN,0.996303297656928
HP_ABNORMAL_HELIX_MORPHOLOGY,SET,151,0.00081491,7.3563e-05,0.071002,0.49542,HP_ABNORMAL_HELIX_MORPHOLOGY,0.996303297656928
GOBP_FEMALE_MEIOSIS_CHROMOSO...,SET,6,0.0038189,6.8991e-05,0.33312,0.49543,GOBP_FEMALE_MEIOSIS_CHROMOSOME_SEGREGATION,0.996303297656928
GSE7460_FOXP3_MUT_VS_WT_ACT_...3,SET,184,0.00072869,7.2546e-05,0.064034,0.49546,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN,0.996303297656928
GOBP_DEOXYRIBONUCLEOSIDE_MON...2,SET,14,0.0028059,7.7414e-05,0.24876,0.4955,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.996303297656928
GOBP_NEGATIVE_REGULATION_OF_...63,SET,4,0.0057413,8.4692e-05,0.50908,0.4955,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.996303297656928
chr12q24,SET,200,0.0015086,0.00015651,0.1363,0.49558,chr12q24,0.99633948007634
MODULE_533,SET,41,0.0015185,7.1641e-05,0.13962,0.49566,MODULE_533,0.99633948007634
GOBP_POSITIVE_REGULATION_OF_...301,SET,19,0.0021759,6.9927e-05,0.19988,0.49566,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.99633948007634
MIR4687_3P,SET,76,0.0011015,7.0688e-05,0.10178,0.49568,MIR4687_3P,0.99633948007634
MORF_RAB1A,SET,173,0.00064856,6.2628e-05,0.060056,0.49569,MORF_RAB1A,0.99633948007634
GSE2770_IL12_ACT_VS_ACT_CD4_...6,SET,170,0.00069904,6.6921e-05,0.064633,0.49569,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP,0.99633948007634
HP_NON_MENDELIAN_INHERITANCE,SET,86,0.0010734,7.3258e-05,0.10026,0.49573,HP_NON_MENDELIAN_INHERITANCE,0.996362257113116
GOBP_NEGATIVE_REGULATION_OF_...606,SET,4,0.0052861,7.7977e-05,0.5004,0.49579,GOBP_NEGATIVE_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.996372961956522
FAN_EMBRYONIC_CTX_BRAIN_B_CE...,SET,84,0.0010528,7.1015e-05,0.10043,0.49582,FAN_EMBRYONIC_CTX_BRAIN_B_CELL,0.996372961956522
GSE3982_NEUTROPHIL_VS_NKCELL...1,SET,176,0.00063297,6.1645e-05,0.06074,0.49584,GSE3982_NEUTROPHIL_VS_NKCELL_DN,0.996372961956522
HP_INCREASED_LAXITY_OF_ANKLES,SET,5,0.0045062,7.4317e-05,0.43352,0.49585,HP_INCREASED_LAXITY_OF_ANKLES,0.996372961956522
GOMF_CERAMIDE_BINDING,SET,17,0.0022251,6.7644e-05,0.2156,0.49588,GOMF_CERAMIDE_BINDING,0.996375637393768
GSE15930_NAIVE_VS_24H_IN_VIT...4,SET,188,0.00063995,6.4394e-05,0.06291,0.49594,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,0.996438588276101
ZHENG_RESPONSE_TO_ARSENITE_UP,SET,14,0.0027386,7.5559e-05,0.27283,0.496,ZHENG_RESPONSE_TO_ARSENITE_UP,0.996501531880455
REACTOME_SYNTHESIS_OF_EPOXY_...,SET,8,0.0029519,6.1574e-05,0.29787,0.49605,REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET,0.996506866655107
GOCC_CYTOPLASMIC_STRESS_GRAN...,SET,83,0.00086844,5.823e-05,0.087988,0.49606,GOCC_CYTOPLASMIC_STRESS_GRANULE,0.996506866655107
HP_NONSPHEROCYTIC_HEMOLYTIC_...,SET,7,0.0027268,5.3207e-05,0.2799,0.49611,HP_NONSPHEROCYTIC_HEMOLYTIC_ANEMIA,0.996532286308733
TTTTGAG_MIR373,SET,213,0.00056453,6.0422e-05,0.05814,0.49613,TTTTGAG_MIR373,0.996532286308733
GOBP_REGULATION_OF_CATION_CH...,SET,86,0.00096941,6.6159e-05,0.10117,0.49618,GOBP_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.99655770008668
MIR3202,SET,229,0.00052087,5.7779e-05,0.054647,0.4962,MIR3202,0.99655770008668
KEGG_SPHINGOLIPID_METABOLISM,SET,34,0.0014499,6.2307e-05,0.15703,0.49632,KEGG_SPHINGOLIPID_METABOLISM,0.996741107130475
GOBP_REGULATION_OF_INTRINSIC...5,SET,3,0.0038947,4.9756e-05,0.42786,0.49637,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,0.996783922690241
GOBP_REGULATION_OF_CELL_DEVE...,SET,765,0.00028742,5.7407e-05,0.032435,0.49646,GOBP_REGULATION_OF_CELL_DEVELOPMENT,0.996834674484432
GOBP_REGULATION_OF_MEMBRANE_...5,SET,58,0.0010223,5.7338e-05,0.11573,0.49648,GOBP_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION,0.996834674484432
GOBP_TERMINAL_BUTTON_ORGANIZ...,SET,6,0.0032918,5.9469e-05,0.37421,0.49649,GOBP_TERMINAL_BUTTON_ORGANIZATION,0.996834674484432
GAUTAM_EYE_IRIS_CILIARY_BODY...16,SET,229,0.00047616,5.2821e-05,0.054392,0.49651,GAUTAM_EYE_IRIS_CILIARY_BODY_SMOOTH_MUSCLE_CELLS,0.996834674484432
HP_JUVENILE_ASEPTIC_NECROSIS,SET,41,0.0011742,5.5399e-05,0.13703,0.49658,HP_JUVENILE_ASEPTIC_NECROSIS,0.996917623613678
MIR6827_3P,SET,72,0.00083705,5.229e-05,0.099857,0.49666,MIR6827_3P,0.996983126371722
GSE39152_CD103_NEG_VS_POS_ME...2,SET,185,0.00053359,5.3265e-05,0.063983,0.49667,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP,0.996983126371722
WANG_ESOPHAGUS_CANCER_PROGRE...,SET,9,0.0024866,5.5013e-05,0.31373,0.49684,WANG_ESOPHAGUS_CANCER_PROGRESSION_UP,0.997066718506998
MIR101_3P,SET,418,0.00034627,5.1624e-05,0.04401,0.49686,MIR101_3P,0.997066718506998
GSE14769_UNSTIM_VS_60MIN_LPS...1,SET,189,0.00051678,5.2137e-05,0.066623,0.49691,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN,0.997066718506998
MIR3927_3P,SET,94,0.00068848,4.9113e-05,0.089762,0.49694,MIR3927_3P,0.997066718506998
FOX_Q2,SET,191,0.00049736,5.044e-05,0.064983,0.49695,FOX_Q2,0.997066718506998
GSE339_CD4POS_VS_CD8POS_DC_I...1,SET,181,0.00046029,4.5454e-05,0.061319,0.49701,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN,0.997066718506998
GOBP_NEGATIVE_REGULATION_OF_...355,SET,11,0.0019274,4.714e-05,0.25907,0.49703,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.997066718506998
GOBP_SINOATRIAL_NODE_CELL_DI...,SET,6,0.0029592,5.3461e-05,0.39801,0.49703,GOBP_SINOATRIAL_NODE_CELL_DIFFERENTIATION,0.997066718506998
FUJII_YBX1_TARGETS_DN,SET,183,0.00045871,4.5545e-05,0.062555,0.49707,FUJII_YBX1_TARGETS_DN,0.997066718506998
GOMF_IGG_BINDING,SET,10,0.0022258,5.1906e-05,0.3089,0.49713,GOMF_IGG_BINDING,0.997066718506998
HP_THICKENED_RIBS,SET,7,0.0024022,4.6874e-05,0.33922,0.49717,HP_THICKENED_RIBS,0.997066718506998
chr14q11,SET,91,0.0012714,8.9244e-05,0.1811,0.4972,chr14q11,0.997066718506998
chr6q12,SET,5,0.0041991,6.9252e-05,0.59918,0.4972,chr6q12,0.997066718506998
REACTOME_SIGNALING_BY_MODERA...,SET,42,0.00095139,4.5429e-05,0.13592,0.49721,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,0.997066718506998
HP_EPISODIC_METABOLIC_ACIDOS...,SET,4,0.0034168,5.0403e-05,0.49462,0.49724,HP_EPISODIC_METABOLIC_ACIDOSIS,0.997066718506998
HP_ANTALGIC_GAIT,SET,9,0.0022815,5.0476e-05,0.33311,0.49727,HP_ANTALGIC_GAIT,0.997066718506998
MIR6733_3P,SET,128,0.00055021,4.5758e-05,0.080598,0.49728,MIR6733_3P,0.997066718506998
GOBP_POSITIVE_REGULATION_OF_...726,SET,11,0.0019643,4.8041e-05,0.28886,0.49729,GOBP_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION,0.997066718506998
GOBP_COCHLEA_DEVELOPMENT,SET,48,0.00089974,4.5922e-05,0.13454,0.49733,GOBP_COCHLEA_DEVELOPMENT,0.997066718506998
HP_FATIGABLE_WEAKNESS_OF_RES...,SET,57,0.0007477,4.1576e-05,0.11167,0.49733,HP_FATIGABLE_WEAKNESS_OF_RESPIRATORY_MUSCLES,0.997066718506998
HP_APLASIA_HYPOPLASIA_OF_THE...26,SET,186,0.00040047,4.0084e-05,0.060136,0.49734,HP_APLASIA_HYPOPLASIA_OF_THE_EAR,0.997066718506998
GOBP_NEGATIVE_REGULATION_OF_...4,SET,8,0.0018282,3.8135e-05,0.27526,0.49735,GOBP_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION,0.997066718506998
MIR506_3P,SET,693,0.00021601,4.1147e-05,0.033342,0.49742,MIR506_3P,0.997066718506998
GOCC_PRC1_COMPLEX,SET,16,0.0013599,4.0107e-05,0.21322,0.49746,GOCC_PRC1_COMPLEX,0.997066718506998
GOBP_NEGATIVE_REGULATION_OF_...561,SET,5,0.0025144,4.1468e-05,0.4044,0.49752,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.997066718506998
HP_METHEMOGLOBINEMIA,SET,5,0.0024634,4.0626e-05,0.39916,0.49754,HP_METHEMOGLOBINEMIA,0.997066718506998
GOBP_POSITIVE_REGULATION_OF_...601,SET,18,0.0011889,3.7188e-05,0.20097,0.49764,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.997066718506998
GSE17974_CTRL_VS_ACT_IL4_AND...3,SET,178,0.00035882,3.5141e-05,0.061742,0.49768,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN,0.997066718506998
HP_COR_PULMONALE,SET,10,0.0015866,3.7001e-05,0.2765,0.49771,HP_COR_PULMONALE,0.997066718506998
GOMF_GLUTAMATE_BINDING,SET,8,0.0019397,4.0461e-05,0.34908,0.49778,GOMF_GLUTAMATE_BINDING,0.997066718506998
FAN_OVARY_CL13_MONOCYTE_MACR...,SET,411,0.00023951,3.5414e-05,0.042979,0.49778,FAN_OVARY_CL13_MONOCYTE_MACROPHAGE,0.997066718506998
GOTTWEIN_TARGETS_OF_KSHV_MIR...,SET,58,0.00063244,3.5473e-05,0.11411,0.49779,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,0.997066718506998
WP_TNFRELATED_WEAK_INDUCER_O...,SET,42,0.00073086,3.4899e-05,0.13227,0.4978,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.997066718506998
GOBP_CARDIAC_MUSCLE_CELL_CON...,SET,78,0.0005758,3.7432e-05,0.10506,0.49781,GOBP_CARDIAC_MUSCLE_CELL_CONTRACTION,0.997066718506998
GSE5589_IL6_KO_VS_IL10_KO_LP...3,SET,179,0.00034993,3.4367e-05,0.064075,0.49782,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.997066718506998
GSE5589_LPS_VS_LPS_AND_IL10_...7,SET,185,0.00033734,3.3675e-05,0.063558,0.49788,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.997066718506998
GOMF_MYOSIN_II_BINDING,SET,11,0.0013591,3.3241e-05,0.25983,0.49791,GOMF_MYOSIN_II_BINDING,0.997066718506998
GSE360_L_MAJOR_VS_B_MALAYI_H...1,SET,180,0.00032493,3.1999e-05,0.063094,0.49795,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.997066718506998
GSE45365_HEALTHY_VS_MCMV_INF...4,SET,160,0.00034743,3.2276e-05,0.067917,0.49796,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN,0.997066718506998
GOBP_GLOMERULUS_MORPHOGENESIS,SET,9,0.0016776,3.7116e-05,0.32893,0.49797,GOBP_GLOMERULUS_MORPHOGENESIS,0.997066718506998
GSE19772_CTRL_VS_HCMV_INF_MO...4,SET,182,0.0003232,3.2003e-05,0.063596,0.49797,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP,0.997066718506998
GSE25088_CTRL_VS_IL4_STIM_MA...2,SET,171,0.00034643,3.3261e-05,0.068173,0.49797,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP,0.997066718506998
GOMF_LYSINE_N_METHYLTRANSFER...,SET,49,0.00060687,3.1294e-05,0.12135,0.498,GOMF_LYSINE_N_METHYLTRANSFERASE_ACTIVITY,0.997066718506998
MIR10525_3P,SET,55,0.00061098,3.3374e-05,0.12248,0.49801,MIR10525_3P,0.997066718506998
DAVICIONI_PAX_FOXO1_SIGNATUR...2,SET,52,0.00064299,3.4154e-05,0.13053,0.49803,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,0.997066718506998
KEGG_MEDICUS_REFERENCE_ASSEM...,SET,17,0.00090723,2.758e-05,0.18458,0.49804,KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE,0.997066718506998
BIOCARTA_LYMPHOCYTE_PATHWAY,SET,9,0.001671,3.697e-05,0.34284,0.49806,BIOCARTA_LYMPHOCYTE_PATHWAY,0.997066718506998
GOMF_GLUTATHIONE_DISULFIDE_O...,SET,5,0.001925,3.1747e-05,0.43252,0.49822,GOMF_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.997329576085704
MOOTHA_GLYCOLYSIS,SET,17,0.00078539,2.3876e-05,0.1793,0.49825,MOOTHA_GLYCOLYSIS,0.997332186258135
MCBRYAN_PUBERTAL_BREAST_5_6W...2,SET,115,0.00034132,2.6915e-05,0.084044,0.49838,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,0.997440081193136
CREB3_TARGET_GENES,SET,389,0.00017581,2.5306e-05,0.043415,0.49838,CREB3_TARGET_GENES,0.997440081193136
GSE27859_MACROPHAGE_VS_DC_DN,SET,171,0.0002647,2.5414e-05,0.065669,0.49839,GSE27859_MACROPHAGE_VS_DC_DN,0.997440081193136
LIU_OVARIAN_CANCER_TUMORS_AN...2,SET,1383,0.00010556,2.7847e-05,0.026663,0.49842,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN,0.997442684401451
MIR146B_3P,SET,62,0.00043159,2.5025e-05,0.11089,0.49845,MIR146B_3P,0.997445287309995
YCATTAA_UNKNOWN,SET,499,0.00014962,2.4317e-05,0.040752,0.49854,YCATTAA_UNKNOWN,0.99748689312011
GROSS_HYPOXIA_VIA_HIF1A_DN,SET,99,0.0003121,2.2845e-05,0.087102,0.49857,GROSS_HYPOXIA_VIA_HIF1A_DN,0.99748689312011
WP_NEOVASCULARIZATION_PROCES...,SET,37,0.00054194,2.4292e-05,0.15996,0.49865,WP_NEOVASCULARIZATION_PROCESSES,0.99748689312011
GSE4590_SMALL_VS_VPREB_POS_L...2,SET,150,0.00022937,2.0637e-05,0.068859,0.49867,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.99748689312011
GSE8515_CTRL_VS_IL6_4H_STIM_...1,SET,170,0.00022781,2.1809e-05,0.068213,0.49867,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN,0.99748689312011
TERF2_TARGET_GENES,SET,97,0.00027049,1.9599e-05,0.087136,0.49876,TERF2_TARGET_GENES,0.99748689312011
GOMF_OXIDOREDUCTASE_ACTIVITY...23,SET,42,0.00047306,2.2589e-05,0.15258,0.49876,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.99748689312011
MIR152_5P,SET,74,0.00031647,2.0041e-05,0.1033,0.49878,MIR152_5P,0.99748689312011
GSE20366_EX_VIVO_VS_HOMEOSTA...3,SET,179,0.00019877,1.9521e-05,0.064755,0.49878,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN,0.99748689312011
WEIGEL_OXIDATIVE_STRESS_BY_T...,SET,35,0.00042877,1.8694e-05,0.14444,0.49882,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,0.99748689312011
HP_ABNORMAL_JUDGMENT,SET,438,0.00012101,1.8458e-05,0.04188,0.49885,HP_ABNORMAL_JUDGMENT,0.99748689312011
GOBP_IRES_DEPENDENT_VIRAL_TR...,SET,10,0.00074131,1.7287e-05,0.26683,0.49889,GOBP_IRES_DEPENDENT_VIRAL_TRANSLATIONAL_INITIATION,0.99748689312011
GSE11057_NAIVE_VS_MEMORY_CD4...2,SET,158,0.00020155,1.8608e-05,0.072401,0.49889,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP,0.99748689312011
KEGG_MEDICUS_REFERENCE_WNT5A...,SET,15,0.00065173,1.8612e-05,0.24187,0.49893,KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY,0.99748689312011
GOBP_NEGATIVE_REGULATION_OF_...679,SET,22,0.00047743,1.6509e-05,0.17773,0.49893,GOBP_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99748689312011
GSE11961_FOLLICULAR_BCELL_VS...2,SET,186,0.00015971,1.5986e-05,0.059821,0.49893,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99748689312011
E2F1_Q4_01,SET,202,0.00014063,1.4662e-05,0.060335,0.49907,E2F1_Q4_01,0.997535432595573
GOBP_WALKING_BEHAVIOR,SET,34,0.00033175,1.4256e-05,0.14729,0.4991,GOBP_WALKING_BEHAVIOR,0.997535432595573
HP_GLANDULAR_HYPOSPADIAS,SET,4,0.00095274,1.4054e-05,0.4243,0.4991,HP_GLANDULAR_HYPOSPADIAS,0.997535432595573
GOBP_CAMP_BIOSYNTHETIC_PROCE...,SET,10,0.00062594,1.4597e-05,0.29056,0.49914,GOBP_CAMP_BIOSYNTHETIC_PROCESS,0.997535432595573
HP_ABNORMAL_ANATOMIC_LOCATIO...,SET,127,0.00014206,1.1769e-05,0.070629,0.4992,HP_ABNORMAL_ANATOMIC_LOCATION_OF_THE_HEART,0.997535432595573
HP_PARAGANGLIOMA,SET,19,0.0003499,1.1245e-05,0.17424,0.4992,HP_PARAGANGLIOMA,0.997535432595573
GSE25147_UNSTIM_VS_HELIOBACT...2,SET,151,0.00013205,1.1921e-05,0.068145,0.49923,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP,0.997535432595573
NGUYEN_NOTCH1_TARGETS_DN,SET,78,0.0001881,1.2228e-05,0.099917,0.49925,NGUYEN_NOTCH1_TARGETS_DN,0.997535432595573
GSE11864_UNTREATED_VS_CSF1_I...4,SET,169,0.00011942,1.1399e-05,0.063807,0.49925,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.997535432595573
GSE45365_WT_VS_IFNAR_KO_BCEL...3,SET,150,0.00012497,1.1244e-05,0.067473,0.49926,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP,0.997535432595573
NUTT_GBM_VS_AO_GLIOMA_UP,SET,41,0.00025786,1.2166e-05,0.14119,0.49927,NUTT_GBM_VS_AO_GLIOMA_UP,0.997535432595573
GOCC_CUL3_RING_UBIQUITIN_LIG...,SET,37,0.00024458,1.0963e-05,0.14212,0.49931,GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX,0.997558004713727
REACTOME_COMPLEX_III_ASSEMBLY,SET,22,0.00024776,8.567e-06,0.16531,0.4994,REACTOME_COMPLEX_III_ASSEMBLY,0.997608318965517
MIR3085_3P,SET,132,0.00010672,9.0122e-06,0.074394,0.49943,MIR3085_3P,0.997608318965517
GOBP_VESICLE_FUSION_WITH_GOL...,SET,8,0.00039043,8.1441e-06,0.27973,0.49944,GOBP_VESICLE_FUSION_WITH_GOLGI_APPARATUS,0.997608318965517
GOBP_POSITIVE_REGULATION_OF_...351,SET,974,3.9887e-05,8.936e-06,0.029178,0.49945,GOBP_POSITIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.997608318965517
ZHOU_INFLAMMATORY_RESPONSE_L...1,SET,323,6.1123e-05,8.0317e-06,0.046728,0.49948,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,0.997610907419114
GOBP_THROMBOPOIETIN_MEDIATED...,SET,5,0.00039027,6.4364e-06,0.36175,0.49957,GOBP_THROMBOPOIETIN_MEDIATED_SIGNALING_PATHWAY,0.997658610089635
GOBP_DNA_DAMAGE_RESPONSE_SIG...3,SET,15,0.00022661,6.4714e-06,0.21725,0.49958,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION,0.997658610089635
GSE36476_CTRL_VS_TSST_ACT_16...4,SET,173,6.7678e-05,6.5353e-06,0.066467,0.49959,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP,0.997658610089635
GSE37605_FOXP3_FUSION_GFP_VS...1,SET,157,6.0782e-05,5.5939e-06,0.069662,0.49965,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN,0.997668948184743
GOBP_APOLIPOPROTEIN_A_I_MEDI...,SET,5,0.00031069,5.124e-06,0.39088,0.49968,GOBP_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY,0.997668948184743
GOBP_POSITIVE_REGULATION_OF_...732,SET,7,0.00017759,3.4653e-06,0.2429,0.49971,GOBP_POSITIVE_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,0.997668948184743
KRAS.LUNG.BREAST_UP.V1_UP,SET,126,6.1334e-05,5.061e-06,0.084104,0.49971,KRAS.LUNG.BREAST_UP.V1_UP,0.997668948184743
GOBP_NON_LYTIC_VIRAL_RELEASE,SET,14,0.00010828,2.9875e-06,0.21982,0.4998,GOBP_NON_LYTIC_VIRAL_RELEASE,0.997712832137733
HP_POLAR_CATARACT,SET,15,5.3826e-05,1.5371e-06,0.22958,0.49991,HP_POLAR_CATARACT,0.997712832137733
MIR4731_5P,SET,238,1.0324e-05,1.1673e-06,0.055421,0.49993,MIR4731_5P,0.997712832137733
JIANG_HYPOXIA_VIA_VHL,SET,17,2.5267e-05,7.6811e-07,0.20838,0.49995,JIANG_HYPOXIA_VIA_VHL,0.997712832137733
GOBP_HYALOID_VASCULAR_PLEXUS...,SET,7,2.4212e-05,4.7244e-07,0.36814,0.49997,GOBP_HYALOID_VASCULAR_PLEXUS_REGRESSION,0.997712832137733
GOMF_NUCLEAR_THYROID_HORMONE...,SET,27,-5.2986e-07,-2.0294e-08,0.15312,0.5,GOMF_NUCLEAR_THYROID_HORMONE_RECEPTOR_BINDING,0.997712832137733
GOMF_CARBONATE_DEHYDRATASE_A...,SET,14,-1.4021e-05,-3.8685e-07,0.24623,0.50002,GOMF_CARBONATE_DEHYDRATASE_ACTIVITY,0.997712832137733
HP_ROTARY_NYSTAGMUS,SET,21,-4.2345e-05,-1.4306e-06,0.19232,0.50009,HP_ROTARY_NYSTAGMUS,0.997712832137733
GOBP_POSITIVE_REGULATION_OF_...104,SET,207,-1.5002e-05,-1.5831e-06,0.060177,0.5001,GOBP_POSITIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.997712832137733
GSE27786_LIN_NEG_VS_CD4_TCEL...1,SET,181,-1.8022e-05,-1.7797e-06,0.061987,0.50012,GSE27786_LIN_NEG_VS_CD4_TCELL_DN,0.997712832137733
GOMF_NADH_DEHYDROGENASE_ACTI...,SET,8,-9.2754e-05,-1.9348e-06,0.27364,0.50014,GOMF_NADH_DEHYDROGENASE_ACTIVITY,0.997712832137733
HE_LIM_SUN_FETAL_LUNG_C3_GRI...,SET,113,-3.1765e-05,-2.4832e-06,0.089983,0.50014,HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL,0.997712832137733
GOBP_GANGLIOSIDE_BIOSYNTHETI...1,SET,17,-8.5785e-05,-2.6079e-06,0.22142,0.50015,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS,0.997712832137733
HP_ANURIA,SET,11,-0.00011108,-2.7167e-06,0.28903,0.50015,HP_ANURIA,0.997712832137733
GOCC_RNA_N6_METHYLADENOSINE_...,SET,8,-0.00012944,-2.7001e-06,0.29532,0.50017,GOCC_RNA_N6_METHYLADENOSINE_METHYLTRANSFERASE_COMPLEX,0.997712832137733
GOBP_MICROTUBULE_BASED_PROCE...,SET,831,-1.6494e-05,-3.4271e-06,0.029544,0.50022,GOBP_MICROTUBULE_BASED_PROCESS,0.997712832137733
HP_GIANT_CELL_HEPATITIS,SET,5,-0.00022335,-3.6835e-06,0.40394,0.50022,HP_GIANT_CELL_HEPATITIS,0.997712832137733
GOBP_CELL_CYCLE_PHASE_TRANSI...,SET,495,-2.6787e-05,-4.3365e-06,0.03827,0.50028,GOBP_CELL_CYCLE_PHASE_TRANSITION,0.997757875710105
GSE13484_12H_VS_3H_YF17D_VAC...1,SET,178,-4.8438e-05,-4.7439e-06,0.063748,0.5003,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,0.997757875710105
MIR181B_2_3P_MIR181B_3P,SET,188,-5.3317e-05,-5.3649e-06,0.063195,0.50034,MIR181B_2_3P_MIR181B_3P,0.997780393619463
GOMF_INOSITOL_1_4_5_TRISPHOS...2,SET,11,-0.00027887,-6.8206e-06,0.279,0.5004,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING,0.997808696026148
WP_PROGERIAASSOCIATED_LIPODY...,SET,21,-0.00021916,-7.4042e-06,0.18386,0.50048,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,0.997808696026148
SCHEIDEREIT_IKK_INTERACTING_...,SET,52,-0.00015699,-8.3388e-06,0.1206,0.50052,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,0.997808696026148
DOANE_RESPONSE_TO_ANDROGEN_UP,SET,163,-8.8513e-05,-8.2988e-06,0.066061,0.50053,DOANE_RESPONSE_TO_ANDROGEN_UP,0.997808696026148
REACTOME_REDUCTION_OF_CYTOSO...,SET,11,-0.00036656,-8.9651e-06,0.24986,0.50059,REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS,0.997808696026148
GSE24210_CTRL_VS_IL35_TREATE...2,SET,187,-9.6559e-05,-9.6904e-06,0.063465,0.50061,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP,0.997808696026148
GSE35825_IFNA_VS_IFNG_STIM_M...1,SET,178,-9.6143e-05,-9.4159e-06,0.062062,0.50062,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN,0.997808696026148
REACTOME_EUKARYOTIC_TRANSLAT...2,SET,108,-0.00012858,-9.8277e-06,0.079843,0.50064,REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,0.997808696026148
REACTOME_TERMINATION_OF_O_GL...,SET,21,-0.00030883,-1.0433e-05,0.19279,0.50064,REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,0.997808696026148
GOMF_NUCLEAR_ESTROGEN_RECEPT...,SET,35,-0.00023608,-1.0293e-05,0.14272,0.50066,GOMF_NUCLEAR_ESTROGEN_RECEPTOR_BINDING,0.997808696026148
MIR449B_5P,SET,237,-9.1165e-05,-1.0286e-05,0.054643,0.50067,MIR449B_5P,0.997808696026148
WP_COVID19_STRUCTURAL_COVERA...,SET,19,-0.0003796,-1.2199e-05,0.19533,0.50078,WP_COVID19_STRUCTURAL_COVERAGE_MAP,0.997846609538003
GOBP_REGULATION_OF_RESPIRATO...3,SET,22,-0.00038183,-1.3203e-05,0.19175,0.50079,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE,0.997846609538003
GOBP_CRISTAE_FORMATION,SET,15,-0.00045705,-1.3052e-05,0.22751,0.5008,GOBP_CRISTAE_FORMATION,0.997846609538003
POS_RESPONSE_TO_HISTAMINE_DN,SET,11,-0.00043927,-1.0744e-05,0.21194,0.50083,POS_RESPONSE_TO_HISTAMINE_DN,0.997846609538003
HP_ABNORMAL_MACROPHAGE_MORPH...,SET,42,-0.0003154,-1.506e-05,0.14952,0.50084,HP_ABNORMAL_MACROPHAGE_MORPHOLOGY,0.997846609538003
TAKEDA_TARGETS_OF_NUP98_HOXA...7,SET,42,-0.00031586,-1.5082e-05,0.14131,0.50089,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,0.997846609538003
HP_ABNORMAL_CIRCULATING_BRAN...,SET,8,-0.00067808,-1.4144e-05,0.30241,0.50089,HP_ABNORMAL_CIRCULATING_BRANCHED_CHAIN_AMINO_ACID_CONCENTRATION,0.997846609538003
HP_PAROXYSMAL_ATRIAL_FIBRILL...,SET,23,-0.00045063,-1.5932e-05,0.18951,0.50095,HP_PAROXYSMAL_ATRIAL_FIBRILLATION,0.997908938499456
GSE3982_NKCELL_VS_TH1_DN,SET,180,-0.00016881,-1.6624e-05,0.064132,0.50105,GSE3982_NKCELL_VS_TH1_DN,0.998050937070151
HP_HYPODONTIA,SET,206,-0.00016276,-1.7135e-05,0.05893,0.5011,HP_HYPODONTIA,0.998093329130609
BIOCARTA_ALK_PATHWAY,SET,34,-0.00045791,-1.9677e-05,0.15814,0.50116,BIOCARTA_ALK_PATHWAY,0.998146167532761
HP_ABNORMAL_AORTIC_MORPHOLOGY,SET,351,-0.00014051,-1.9233e-05,0.046154,0.50121,HP_ABNORMAL_AORTIC_MORPHOLOGY,0.998146167532761
SRF_Q6,SET,228,-0.00018274,-2.0227e-05,0.059473,0.50123,SRF_Q6,0.998146167532761
GOBP_POSITIVE_REGULATION_OF_...505,SET,97,-0.00030155,-2.185e-05,0.091838,0.50131,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.998146167532761
GOBP_REGULATION_OF_ODONTOGEN...1,SET,19,-0.00073659,-2.3672e-05,0.22509,0.50131,GOBP_REGULATION_OF_ODONTOGENESIS,0.998146167532761
HP_ABNORMAL_CERVICAL_CURVATU...,SET,11,-0.00079777,-1.9512e-05,0.24157,0.50132,HP_ABNORMAL_CERVICAL_CURVATURE,0.998146167532761
KEGG_MEDICUS_REFERENCE_BCR_P...2,SET,7,-0.0011461,-2.2363e-05,0.33766,0.50135,KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY,0.998146167532761
GSE37416_12H_VS_48H_F_TULARE...1,SET,148,-0.00026025,-2.326e-05,0.070897,0.50146,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.998146167532761
PID_SMAD2_3PATHWAY,SET,16,-0.00082119,-2.422e-05,0.22284,0.50147,PID_SMAD2_3PATHWAY,0.998146167532761
MIR6773_3P,SET,96,-0.00034069,-2.4559e-05,0.090643,0.5015,MIR6773_3P,0.998146167532761
MORF_ATF2,SET,288,-0.0001959,-2.4331e-05,0.051745,0.50151,MORF_ATF2,0.998146167532761
GSE45365_NK_CELL_VS_CD11B_DC...1,SET,184,-0.00024935,-2.4824e-05,0.065757,0.50151,GSE45365_NK_CELL_VS_CD11B_DC_DN,0.998146167532761
GSE24972_MARGINAL_ZONE_BCELL...1,SET,179,-0.00024996,-2.4548e-05,0.064715,0.50154,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN,0.998146167532761
REACTOME_SIGNALING_BY_HEDGEH...,SET,144,-0.00026992,-2.3799e-05,0.067876,0.50159,REACTOME_SIGNALING_BY_HEDGEHOG,0.998146167532761
GOBP_PHOSPHATIDYLINOSITOL_DE...,SET,24,-0.00061171,-2.2091e-05,0.15118,0.50161,GOBP_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.998146167532761
KEGG_MEDICUS_VARIANT_MUTATIO...2,SET,24,-0.00073121,-2.6407e-05,0.17569,0.50166,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.998146167532761
BIOCARTA_IL3_PATHWAY,SET,13,-0.0010801,-2.8715e-05,0.24593,0.50175,BIOCARTA_IL3_PATHWAY,0.998146167532761
GOCC_HFE_TRANSFERRIN_RECEPTO...,SET,7,-0.0014629,-2.8546e-05,0.32844,0.50178,GOCC_HFE_TRANSFERRIN_RECEPTOR_COMPLEX,0.998146167532761
GOBP_DNA_SYNTHESIS_INVOLVED_...,SET,38,-0.00056863,-2.583e-05,0.11887,0.50191,GOBP_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR,0.998146167532761
GOBP_NEURAL_TUBE_PATTERNING,SET,28,-0.00078076,-3.0452e-05,0.16138,0.50193,GOBP_NEURAL_TUBE_PATTERNING,0.998146167532761
MIR660_5P,SET,68,-0.00052268,-3.1735e-05,0.10713,0.50195,MIR660_5P,0.998146167532761
BOSCO_ALLERGEN_INDUCED_TH2_A...,SET,133,-0.00039633,-3.3594e-05,0.080782,0.50196,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,0.998146167532761
REACTOME_SLC_MEDIATED_TRANSM...,SET,235,-0.00029349,-3.2975e-05,0.058828,0.50199,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,0.998146167532761
GSE369_SOCS3_KO_VS_WT_LIVER_...2,SET,182,-0.0003183,-3.1519e-05,0.063841,0.50199,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN,0.998146167532761
AIZARANI_LIVER_C21_STELLATE_...,SET,176,-0.00036119,-3.5176e-05,0.071981,0.502,AIZARANI_LIVER_C21_STELLATE_CELLS_1,0.998146167532761
MIR425_5P,SET,78,-0.00049914,-3.2448e-05,0.096924,0.50205,MIR425_5P,0.998146167532761
GOBP_NEGATIVE_REGULATION_OF_...328,SET,34,-0.00072505,-3.1157e-05,0.13797,0.5021,GOBP_NEGATIVE_REGULATION_OF_JNK_CASCADE,0.998146167532761
GSE25123_CTRL_VS_IL4_AND_ROS...4,SET,177,-0.00034986,-3.4169e-05,0.066437,0.5021,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,0.998146167532761
MIR486_5P,SET,85,-0.0004884,-3.3138e-05,0.091496,0.50213,MIR486_5P,0.998146167532761
KIM_GASTRIC_CANCER_CHEMOSENS...,SET,86,-0.00051238,-3.4968e-05,0.092152,0.50222,KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,0.998146167532761
WP_TYPE_III_INTERFERON_SIGNA...,SET,10,-0.0014472,-3.375e-05,0.25849,0.50223,WP_TYPE_III_INTERFERON_SIGNALING,0.998146167532761
HP_ABNORMALITY_OF_THE_DISTAL...5,SET,9,-0.0016099,-3.5618e-05,0.28357,0.50226,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.998146167532761
NRL_DN.V1_UP,SET,131,-0.00043816,-3.6861e-05,0.076259,0.50229,NRL_DN.V1_UP,0.998146167532761
GOMF_TRANSPORTER_INHIBITOR_A...,SET,38,-0.0008482,-3.8529e-05,0.1458,0.50232,GOMF_TRANSPORTER_INHIBITOR_ACTIVITY,0.998146167532761
GSE29614_CTRL_VS_DAY7_TIV_FL...2,SET,145,-0.00045183,-3.9975e-05,0.075658,0.50238,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.998146167532761
MIR1251_5P,SET,23,-0.0010078,-3.5631e-05,0.16594,0.50242,MIR1251_5P,0.998146167532761
PDGF_ERK_DN.V1_UP,SET,126,-0.00044233,-3.6499e-05,0.073041,0.50242,PDGF_ERK_DN.V1_UP,0.998146167532761
GOBP_PROTEASOME_MEDIATED_UBI...,SET,369,-0.00026818,-3.7618e-05,0.043694,0.50245,GOBP_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.998146167532761
HP_WIDELY_PATENT_FONTANELLES...,SET,15,-0.0014604,-4.1706e-05,0.23379,0.50249,HP_WIDELY_PATENT_FONTANELLES_AND_SUTURES,0.998146167532761
GSE19888_ADENOSINE_A3R_INH_V...5,SET,177,-0.00043451,-4.2437e-05,0.068459,0.50253,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN,0.998146167532761
GSE1112_OT1_CD8AB_VS_HY_CD8A...2,SET,132,-0.00048766,-4.118e-05,0.076326,0.50255,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,0.998146167532761
GOBP_MATURATION_OF_SSU_RRNA_...,SET,30,-0.00098238,-3.9659e-05,0.15307,0.50256,GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.998146167532761
FUJIWARA_PARK2_HEPATOCYTE_PR...2,SET,12,-0.0018589,-4.7485e-05,0.28348,0.50262,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,0.998146167532761
GSE2770_UNTREATED_VS_ACT_CD4...4,SET,171,-0.00041828,-4.016e-05,0.063064,0.50265,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP,0.998146167532761
GOTZMANN_EPITHELIAL_TO_MESEN...1,SET,192,-0.00041737,-4.2437e-05,0.062428,0.50267,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.998146167532761
REACTOME_EXTRA_NUCLEAR_ESTRO...,SET,74,-0.00071813,-4.5477e-05,0.10721,0.50267,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,0.998146167532761
GOCC_PHAGOCYTIC_VESICLE_LUMEN,SET,5,-0.0026048,-4.2959e-05,0.378,0.50275,GOCC_PHAGOCYTIC_VESICLE_LUMEN,0.998146167532761
GOCC_SECONDARY_LYSOSOME,SET,19,-0.0013574,-4.3623e-05,0.19185,0.50282,GOCC_SECONDARY_LYSOSOME,0.998146167532761
GAO_SMALL_INTESTINE_24W_C3_E...,SET,41,-0.0008956,-4.2254e-05,0.12569,0.50284,GAO_SMALL_INTESTINE_24W_C3_ENTEROCYTE_PROGENITOR_SUBTYPE_1,0.998146167532761
GOBP_POSITIVE_REGULATION_OF_...228,SET,38,-0.0010111,-4.5928e-05,0.13974,0.50289,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.998146167532761
HP_HYPERTONIC_DEHYDRATION,SET,4,-0.0035355,-5.2153e-05,0.48593,0.5029,HP_HYPERTONIC_DEHYDRATION,0.998146167532761
HP_FOOD_INTOLERANCE,SET,9,-0.0018917,-4.1852e-05,0.25977,0.50291,HP_FOOD_INTOLERANCE,0.998146167532761
HP_ABNORMAL_BLOOD_ZINC_CONCE...,SET,6,-0.0024035,-4.3421e-05,0.32793,0.50292,HP_ABNORMAL_BLOOD_ZINC_CONCENTRATION,0.998146167532761
GSE37416_0H_VS_3H_F_TULARENS...1,SET,182,-0.00045497,-4.5051e-05,0.062179,0.50292,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.998146167532761
GSE32533_MIR17_KO_VS_MIR17_O...1,SET,176,-0.00047734,-4.6489e-05,0.064784,0.50294,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,0.998146167532761
REACTOME_AMINO_ACID_TRANSPOR...,SET,30,-0.0013073,-5.2774e-05,0.17072,0.50305,REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,0.998146167532761
MIR132_3P,SET,173,-0.0004943,-4.7733e-05,0.064281,0.50307,MIR132_3P,0.998146167532761
ZNF391_TARGET_GENES,SET,752,-0.00024489,-4.8513e-05,0.031819,0.50307,ZNF391_TARGET_GENES,0.998146167532761
WEBER_METHYLATED_LCP_IN_FIBR...2,SET,11,-0.0019232,-4.7037e-05,0.24892,0.50308,WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP,0.998146167532761
GSE3039_ALPHAALPHA_CD8_TCELL...2,SET,189,-0.00047691,-4.8114e-05,0.060399,0.50315,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP,0.998146167532761
HP_BROAD_EYEBROW,SET,23,-0.0014123,-4.9931e-05,0.17759,0.50317,HP_BROAD_EYEBROW,0.998146167532761
HP_JAUNDICE,SET,200,-0.00047905,-4.9701e-05,0.059441,0.50322,HP_JAUNDICE,0.998146167532761
HP_FIBROSARCOMA,SET,9,-0.0026142,-5.7837e-05,0.32236,0.50324,HP_FIBROSARCOMA,0.998146167532761
GOBP_POSITIVE_REGULATION_OF_...585,SET,9,-0.0021844,-4.8327e-05,0.26847,0.50325,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.998146167532761
GOMF_NUCLEOTIDASE_ACTIVITY,SET,13,-0.0018696,-4.9708e-05,0.22896,0.50326,GOMF_NUCLEOTIDASE_ACTIVITY,0.998146167532761
MIR92B_5P,SET,8,-0.0021995,-4.588e-05,0.26864,0.50327,MIR92B_5P,0.998146167532761
KATSANOU_ELAVL1_TARGETS_DN,SET,133,-0.0006481,-5.4934e-05,0.077493,0.50334,KATSANOU_ELAVL1_TARGETS_DN,0.998146167532761
LAKE_ADULT_KIDNEY_C4_PROXIMA...,SET,159,-0.00063533,-5.8838e-05,0.075408,0.50336,LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2,0.998146167532761
GSE41867_MEMORY_VS_EXHAUSTED...2,SET,186,-0.00054409,-5.4459e-05,0.06327,0.50343,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP,0.998146167532761
PHONG_TNF_TARGETS_UP,SET,61,-0.0010953,-6.2999e-05,0.12625,0.50346,PHONG_TNF_TARGETS_UP,0.998146167532761
GSE43955_TH0_VS_TGFB_IL6_TH1...1,SET,180,-0.00056044,-5.5192e-05,0.064522,0.50347,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN,0.998146167532761
HP_ABNORMAL_RETINAL_NERVE_FI...,SET,5,-0.0033802,-5.5747e-05,0.3872,0.50348,HP_ABNORMAL_RETINAL_NERVE_FIBER_LAYER_MORPHOLOGY,0.998146167532761
GOBP_PHOSPHATIDYLCHOLINE_BIO...,SET,26,-0.0014843,-5.579e-05,0.1652,0.50358,GOBP_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,0.998146167532761
GOBP_CELLULAR_RESPONSE_TO_GL...2,SET,53,-0.0011482,-6.1571e-05,0.12685,0.50361,GOBP_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS,0.998146167532761
MIR4736,SET,100,-0.0007882,-5.7983e-05,0.08603,0.50365,MIR4736,0.998146167532761
GOBP_GLUTAMATE_RECEPTOR_SIGN...,SET,48,-0.0012368,-6.3125e-05,0.1352,0.50365,GOBP_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.998146167532761
MOLENAAR_TARGETS_OF_CCND1_AN...2,SET,58,-0.0010015,-5.6172e-05,0.10799,0.5037,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,0.998146167532761
VECCHI_GASTRIC_CANCER_EARLY_...2,SET,386,-0.00040403,-5.7937e-05,0.043424,0.50371,VECCHI_GASTRIC_CANCER_EARLY_UP,0.998146167532761
MIR4722_3P,SET,79,-0.00089902,-5.8816e-05,0.095978,0.50374,MIR4722_3P,0.998146167532761
GOBP_RESPONSE_TO_WATER,SET,13,-0.0022055,-5.8638e-05,0.23541,0.50374,GOBP_RESPONSE_TO_WATER,0.998146167532761
NAKAMURA_TUMOR_ZONE_PERIPHER...2,SET,249,-0.00050514,-5.8398e-05,0.053697,0.50375,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,0.998146167532761
MIR6515_3P,SET,199,-0.00056994,-5.8985e-05,0.060687,0.50375,MIR6515_3P,0.998146167532761
HP_ABNORMAL_TEMPER_TANTRUMS,SET,29,-0.0015404,-6.1143e-05,0.15989,0.50384,HP_ABNORMAL_TEMPER_TANTRUMS,0.998146167532761
GOBP_NEGATIVE_REGULATION_OF_...654,SET,5,-0.0041805,-6.8945e-05,0.43182,0.50386,GOBP_NEGATIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.998146167532761
GSE6259_FLT3L_INDUCED_DEC205...6,SET,134,-0.000727,-6.1851e-05,0.073764,0.50393,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP,0.998146167532761
HP_ABNORMAL_URINE_MAGNESIUM_...,SET,9,-0.0028648,-6.3382e-05,0.29027,0.50394,HP_ABNORMAL_URINE_MAGNESIUM_CONCENTRATION,0.998146167532761
MORI_PRE_BI_LYMPHOCYTE_UP,SET,73,-0.001054,-6.6298e-05,0.10453,0.50402,MORI_PRE_BI_LYMPHOCYTE_UP,0.998146167532761
GSE2706_R848_VS_LPS_2H_STIM_...2,SET,142,-0.0007631,-6.6818e-05,0.073842,0.50412,GSE2706_R848_VS_LPS_2H_STIM_DC_UP,0.998146167532761
GOBP_POSTSYNAPSE_TO_NUCLEUS_...,SET,6,-0.003018,-5.4521e-05,0.2894,0.50416,GOBP_POSTSYNAPSE_TO_NUCLEUS_SIGNALING_PATHWAY,0.998146167532761
HERNANDEZ_ABERRANT_MITOSIS_B...4,SET,18,-0.0022141,-6.9259e-05,0.21005,0.50421,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,0.998146167532761
GOBP_POSITIVE_REGULATION_OF_...734,SET,41,-0.0015195,-7.1688e-05,0.14377,0.50422,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.998146167532761
GSE4590_SMALL_VS_LARGE_PRE_B...1,SET,139,-0.0008014,-6.9432e-05,0.075474,0.50424,GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN,0.998146167532761
REACTOME_TRANSCRIPTION_COUPL...,SET,73,-0.00093783,-5.8989e-05,0.08761,0.50427,REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,0.998146167532761
GOBP_REGULATION_OF_RNA_SPLIC...,SET,161,-0.00068045,-6.3409e-05,0.06341,0.50428,GOBP_REGULATION_OF_RNA_SPLICING,0.998146167532761
GSE13306_LAMINA_PROPRIA_VS_S...1,SET,186,-0.00069124,-6.9187e-05,0.064397,0.50428,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN,0.998146167532761
GOBP_CENTRAL_NERVOUS_SYSTEM_...1,SET,930,-0.00032005,-7.0151e-05,0.029657,0.50431,GOBP_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT,0.998146167532761
FOURATI_BLOOD_TWINRIX_AGE_25...2,SET,406,-0.00047062,-6.9173e-05,0.043131,0.50435,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP,0.998146167532761
MODULE_145,SET,95,-0.00096231,-6.9009e-05,0.087932,0.50437,MODULE_145,0.998146167532761
GOBP_IN_UTERO_EMBRYONIC_DEVE...,SET,377,-0.00048383,-6.8582e-05,0.043775,0.50441,GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT,0.998146167532761
MIR4756_5P,SET,123,-0.000898,-7.3219e-05,0.080582,0.50445,MIR4756_5P,0.998146167532761
MIR3918,SET,83,-0.0010165,-6.8157e-05,0.090848,0.50446,MIR3918,0.998146167532761
GSE18791_CTRL_VS_NEWCASTLE_V...14,SET,165,-0.00073172,-6.9021e-05,0.065392,0.50446,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP,0.998146167532761
JIANG_MELANOMA_TRM_HIGH_SURV...,SET,19,-0.0022662,-7.283e-05,0.20223,0.50447,JIANG_MELANOMA_TRM_HIGH_SURVIVAL_22_GENE_SIGNATURE,0.998146167532761
KIM_MYCN_AMPLIFICATION_TARGE...2,SET,79,-0.0011045,-7.2259e-05,0.097656,0.50451,KIM_MYCN_AMPLIFICATION_TARGETS_UP,0.998146167532761
NR1I2_TARGET_GENES,SET,270,-0.00057483,-6.9161e-05,0.050806,0.50451,NR1I2_TARGET_GENES,0.998146167532761
GOBP_REGULATION_OF_GAMMA_DEL...1,SET,11,-0.0029603,-7.2402e-05,0.26161,0.50451,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,0.998146167532761
REACTOME_DNA_DAMAGE_RECOGNIT...,SET,35,-0.0015757,-6.8696e-05,0.13897,0.50452,REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER,0.998146167532761
HP_ABNORMAL_INTESTINE_MORPHO...,SET,675,-0.00038675,-7.2746e-05,0.033735,0.50457,HP_ABNORMAL_INTESTINE_MORPHOLOGY,0.998146167532761
GOBP_GENERAL_ADAPTATION_SYND...2,SET,5,-0.004613,-7.6078e-05,0.3992,0.50461,GOBP_GENERAL_ADAPTATION_SYNDROME_BEHAVIORAL_PROCESS,0.998146167532761
CHEN_LIVER_METABOLISM_QTL_CIS,SET,88,-0.0011782,-8.1335e-05,0.10166,0.50462,CHEN_LIVER_METABOLISM_QTL_CIS,0.998146167532761
REACTOME_INTERLEUKIN_1_FAMIL...,SET,143,-0.00081146,-7.13e-05,0.069642,0.50465,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,0.998146167532761
ESC_J1_UP_EARLY.V1_DN,SET,155,-0.00082205,-7.5176e-05,0.070273,0.50467,ESC_J1_UP_EARLY.V1_DN,0.998146167532761
HP_ELEVATED_CIRCULATING_ASPA...,SET,68,-0.0012122,-7.3599e-05,0.10286,0.5047,HP_ELEVATED_CIRCULATING_ASPARTATE_AMINOTRANSFERASE_CONCENTRATION,0.998146167532761
GOBP_ALPHA_BETA_T_CELL_ACTIV...,SET,168,-0.00084978,-8.0876e-05,0.071014,0.50477,GOBP_ALPHA_BETA_T_CELL_ACTIVATION,0.998146167532761
STEIN_ESRRA_TARGETS_RESPONSI...2,SET,26,-0.0021123,-7.9395e-05,0.17365,0.50485,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,0.998146167532761
KEGG_MEDICUS_REFERENCE_CRHR_...,SET,27,-0.0020135,-7.712e-05,0.16492,0.50487,KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.998146167532761
GENTILE_UV_LOW_DOSE_DN,SET,59,-0.001495,-8.4571e-05,0.12189,0.50489,GENTILE_UV_LOW_DOSE_DN,0.998146167532761
KEGG_MEDICUS_REFERENCE_UCHL1...,SET,4,-0.0068882,-0.00010161,0.56223,0.50489,KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS,0.998146167532761
HP_DISTAL_PERIPHERAL_SENSORY...,SET,6,-0.0042502,-7.6782e-05,0.34703,0.50489,HP_DISTAL_PERIPHERAL_SENSORY_NEUROPATHY,0.998146167532761
REACTOME_CELLULAR_RESPONSE_T...4,SET,6,-0.0037518,-6.7779e-05,0.30399,0.50492,REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS,0.998146167532761
HP_ABSENT_DISTAL_PHALANGES,SET,6,-0.0046281,-8.361e-05,0.37527,0.50492,HP_ABSENT_DISTAL_PHALANGES,0.998146167532761
GSE17721_LPS_VS_PAM3CSK4_4H_...1,SET,188,-0.00071097,-7.1539e-05,0.057649,0.50492,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN,0.998146167532761
KEGG_MEDICUS_REFERENCE_MICRO...3,SET,26,-0.0022303,-8.3827e-05,0.18,0.50494,KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION,0.998146167532761
KEGG_MEDICUS_REFERENCE_TESTO...,SET,11,-0.0030874,-7.5512e-05,0.24904,0.50495,KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS,0.998146167532761
GOMF_NEUROPEPTIDE_BINDING,SET,28,-0.0022837,-8.9071e-05,0.1832,0.50497,GOMF_NEUROPEPTIDE_BINDING,0.998146167532761
REACTOME_RUNX1_AND_FOXP3_CON...,SET,9,-0.0039367,-8.7096e-05,0.31449,0.50499,REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,0.998146167532761
GOBP_BIOLOGICAL_PROCESS_INVO...4,SET,47,-0.0015757,-7.9585e-05,0.12556,0.50501,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS,0.998146167532761
HP_HYPOKALEMIA,SET,74,-0.0013264,-8.3997e-05,0.10534,0.50502,HP_HYPOKALEMIA,0.998146167532761
TURASHVILI_BREAST_CARCINOMA_...2,SET,21,-0.0025693,-8.6801e-05,0.20361,0.50503,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.998146167532761
REACTOME_FGFR3_LIGAND_BINDIN...,SET,12,-0.0035524,-9.0745e-05,0.28145,0.50504,REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,0.998146167532761
GAVISH_3CA_METAPROGRAM_EPITH...21,SET,34,-0.0018246,-7.8409e-05,0.14453,0.50504,GAVISH_3CA_METAPROGRAM_EPITHELIAL_RESPIRATION,0.998146167532761
PID_VEGFR1_PATHWAY,SET,26,-0.0020421,-7.6756e-05,0.16138,0.50505,PID_VEGFR1_PATHWAY,0.998146167532761
BIOCARTA_VEGF_PATHWAY,SET,24,-0.0021447,-7.7454e-05,0.16777,0.5051,BIOCARTA_VEGF_PATHWAY,0.998146167532761
GOBP_NEGATIVE_REGULATION_OF_...448,SET,11,-0.0039834,-9.7425e-05,0.30271,0.50525,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.998146167532761
MIR7156_3P,SET,89,-0.0011865,-8.2369e-05,0.089561,0.50529,MIR7156_3P,0.998146167532761
MIR1911_3P,SET,42,-0.0018593,-8.8782e-05,0.13692,0.50542,MIR1911_3P,0.998146167532761
LOPEZ_MESOTHELIOMA_SURVIVAL_...6,SET,12,-0.0036426,-9.3048e-05,0.26416,0.5055,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,0.998146167532761
REACTOME_MITOCHONDRIAL_TRNA_...,SET,18,-0.0026892,-8.4119e-05,0.19499,0.5055,REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,0.998146167532761
GOMF_WNT_PROTEIN_BINDING,SET,30,-0.0024748,-9.9906e-05,0.1793,0.50551,GOMF_WNT_PROTEIN_BINDING,0.998146167532761
PKCA_DN.V1_UP,SET,143,-0.0010113,-8.8855e-05,0.071838,0.50562,PKCA_DN.V1_UP,0.998146167532761
PRAMOONJAGO_SOX4_TARGETS_UP,SET,48,-0.0018421,-9.4019e-05,0.1306,0.50563,PRAMOONJAGO_SOX4_TARGETS_UP,0.998146167532761
MEF2_01,SET,137,-0.0010705,-9.2084e-05,0.075774,0.50564,MEF2_01,0.998146167532761
GOBP_RESPONSE_TO_VITAMIN,SET,85,-0.0014638,-9.9318e-05,0.10353,0.50564,GOBP_RESPONSE_TO_VITAMIN,0.998146167532761
HP_AZOOSPERMIA,SET,105,-0.0011582,-8.7295e-05,0.081545,0.50567,HP_AZOOSPERMIA,0.998146167532761
HP_ABNORMAL_CARDIAC_TEST,SET,24,-0.0027182,-9.8165e-05,0.1903,0.5057,HP_ABNORMAL_CARDIAC_TEST,0.998146167532761
ERCC8_TARGET_GENES,SET,7,-0.0047828,-9.3326e-05,0.33401,0.50571,ERCC8_TARGET_GENES,0.998146167532761
GOMF_POU_DOMAIN_BINDING,SET,2,-0.010696,-0.00011157,0.74646,0.50572,GOMF_POU_DOMAIN_BINDING,0.998146167532761
HP_RECURRENT_BRONCHOPULMONAR...,SET,10,-0.0032341,-7.5419e-05,0.22515,0.50573,HP_RECURRENT_BRONCHOPULMONARY_INFECTIONS,0.998146167532761
ZHONG_PFC_C6_DLX5_GAD1_GAD2_...,SET,13,-0.0037187,-9.8868e-05,0.25711,0.50577,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.998146167532761
JIANG_TIP30_TARGETS_DN,SET,22,-0.0030261,-0.00010464,0.20879,0.50578,JIANG_TIP30_TARGETS_DN,0.998146167532761
GOBP_CELL_CELL_JUNCTION_MAIN...,SET,15,-0.0036745,-0.00010494,0.24976,0.50587,GOBP_CELL_CELL_JUNCTION_MAINTENANCE,0.998146167532761
GSE360_CTRL_VS_L_DONOVANI_MA...2,SET,183,-0.00091865,-9.1213e-05,0.062341,0.50588,GSE360_CTRL_VS_L_DONOVANI_MAC_UP,0.998146167532761
GSE29615_CTRL_VS_DAY7_LAIV_F...1,SET,131,-0.0010877,-9.1504e-05,0.073638,0.50589,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,0.998146167532761
GOBP_4_HYDROXYPROLINE_METABO...,SET,12,-0.0032305,-8.2522e-05,0.21831,0.5059,GOBP_4_HYDROXYPROLINE_METABOLIC_PROCESS,0.998146167532761
GOBP_ADAPTIVE_IMMUNE_RESPONS...,SET,283,-0.00081237,-0.00010003,0.054896,0.5059,GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS,0.998146167532761
MIR412_3P,SET,67,-0.0016109,-9.7085e-05,0.10832,0.50593,MIR412_3P,0.998146167532761
MODULE_157,SET,100,-0.0012592,-9.2631e-05,0.084673,0.50593,MODULE_157,0.998146167532761
WP_CARDIAC_HYPERTROPHIC_RESP...,SET,53,-0.0018331,-9.8296e-05,0.12269,0.50596,WP_CARDIAC_HYPERTROPHIC_RESPONSE,0.998146167532761
REACTOME_ACTIVATED_NTRK2_SIG...5,SET,9,-0.0038967,-8.6211e-05,0.25976,0.50598,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS,0.998146167532761
GSE3691_IFN_PRODUCING_KILLER...3,SET,176,-0.00094474,-9.2009e-05,0.062816,0.506,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN,0.998146167532761
RIZ_ERYTHROID_DIFFERENTIATIO...1,SET,32,-0.0025432,-0.00010603,0.16737,0.50606,RIZ_ERYTHROID_DIFFERENTIATION_12HR,0.998146167532761
GOBP_CELLULAR_RESPONSE_TO_WA...,SET,6,-0.0057229,-0.00010339,0.376,0.50607,GOBP_CELLULAR_RESPONSE_TO_WATER_STIMULUS,0.998146167532761
GOBP_NITRIC_OXIDE_MEDIATED_S...,SET,19,-0.0033678,-0.00010823,0.22033,0.5061,GOBP_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,0.998146167532761
GSE1925_CTRL_VS_IFNG_PRIMED_...2,SET,180,-0.00097429,-9.5948e-05,0.063523,0.50612,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP,0.998146167532761
GOBP_POSITIVE_REGULATION_OF_...664,SET,7,-0.0048695,-9.5017e-05,0.3147,0.50617,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,0.998146167532761
KAECH_NAIVE_VS_DAY15_EFF_CD8...1,SET,183,-0.0010101,-0.0001003,0.06465,0.50623,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN,0.998146167532761
GOBP_MIDBODY_ABSCISSION,SET,17,-0.003229,-9.816e-05,0.20589,0.50626,GOBP_MIDBODY_ABSCISSION,0.998146167532761
EVI1_06,SET,19,-0.0030496,-9.8005e-05,0.19337,0.50629,EVI1_06,0.998146167532761
GOBP_VALINE_METABOLIC_PROCESS,SET,7,-0.0049962,-9.749e-05,0.31622,0.5063,GOBP_VALINE_METABOLIC_PROCESS,0.998146167532761
MODULE_123,SET,233,-0.00092502,-0.00010349,0.058448,0.50631,MODULE_123,0.998146167532761
GOBP_PROTEIN_AUTOPHOSPHORYLA...,SET,175,-0.0010727,-0.00010417,0.067322,0.50636,GOBP_PROTEIN_AUTOPHOSPHORYLATION,0.998146167532761
GOBP_REGULATION_OF_RIG_I_SIG...,SET,17,-0.0031627,-9.6146e-05,0.19749,0.50639,GOBP_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.998146167532761
GOCC_STEREOCILIUM_TIP,SET,18,-0.0034592,-0.0001082,0.21569,0.5064,GOCC_STEREOCILIUM_TIP,0.998146167532761
SPZ1_01,SET,216,-0.00094587,-0.00010194,0.058857,0.50641,SPZ1_01,0.998146167532761
MORF_TFDP2,SET,211,-0.00094254,-0.00010041,0.058654,0.50641,MORF_TFDP2,0.998146167532761
GOMF_PHOSPHOLIPASE_D_ACTIVITY,SET,6,-0.0053282,-9.6258e-05,0.32804,0.50648,GOMF_PHOSPHOLIPASE_D_ACTIVITY,0.998146167532761
HP_CHRONIC_DIARRHEA,SET,93,-0.0014413,-0.00010227,0.088469,0.5065,HP_CHRONIC_DIARRHEA,0.998146167532761
CASTELLANO_NRAS_TARGETS_DN,SET,13,-0.004172,-0.00011092,0.2521,0.5066,CASTELLANO_NRAS_TARGETS_DN,0.998146167532761
HP_ABNORMALITY_OF_THE_SUPRAO...,SET,87,-0.0015712,-0.00010785,0.094989,0.5066,HP_ABNORMALITY_OF_THE_SUPRAORBITAL_RIDGES,0.998146167532761
HP_UNCONTROLLED_EYE_MOVEMENTS,SET,8,-0.0060363,-0.00012591,0.36381,0.50662,HP_UNCONTROLLED_EYE_MOVEMENTS,0.998146167532761
GSE1448_CTRL_VS_ANTI_VBETA5_...2,SET,187,-0.0010584,-0.00010622,0.063663,0.50663,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP,0.998146167532761
GOBP_IRON_ION_TRANSPORT,SET,48,-0.0020782,-0.00010607,0.12491,0.50664,GOBP_IRON_ION_TRANSPORT,0.998146167532761
GSE34217_MIR17_92_OVEREXPRES...2,SET,122,-0.0012983,-0.00010543,0.078053,0.50664,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP,0.998146167532761
GOCC_CLATHRIN_VESICLE_COAT,SET,32,-0.0025686,-0.00010709,0.15417,0.50665,GOCC_CLATHRIN_VESICLE_COAT,0.998146167532761
WP_PRADERWILLI_AND_ANGELMAN_...,SET,93,-0.0015919,-0.00011295,0.095037,0.50668,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,0.998146167532761
RUAN_RESPONSE_TO_TNF_TROGLIT...2,SET,17,-0.0037312,-0.00011343,0.22205,0.5067,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,0.998146167532761
GOMF_CHROMATIN_DNA_BINDING,SET,95,-0.0014592,-0.00010464,0.08687,0.5067,GOMF_CHROMATIN_DNA_BINDING,0.998146167532761
GOMF_C_METHYLTRANSFERASE_ACT...,SET,6,-0.0054823,-9.9042e-05,0.32063,0.50682,GOMF_C_METHYLTRANSFERASE_ACTIVITY,0.998146167532761
GOBP_GLYCOPHAGY,SET,11,-0.0046851,-0.00011459,0.27345,0.50683,GOBP_GLYCOPHAGY,0.998146167532761
REACTOME_DISEASES_OF_SIGNAL_...,SET,439,-0.00069989,-0.00010687,0.040783,0.50685,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,0.998146167532761
GOBP_REGULATION_OF_INTEGRIN_...2,SET,3,-0.010012,-0.00012791,0.58288,0.50685,GOBP_REGULATION_OF_INTEGRIN_BIOSYNTHETIC_PROCESS,0.998146167532761
PID_IL2_1PATHWAY,SET,54,-0.0021538,-0.00011658,0.12515,0.50687,PID_IL2_1PATHWAY,0.998146167532761
DESCARTES_FETAL_ADRENAL_CSH1...,SET,146,-0.0013166,-0.00011689,0.076178,0.50689,DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS,0.998146167532761
DELASERNA_MYOD_TARGETS_DN,SET,49,-0.0022876,-0.00011796,0.13218,0.5069,DELASERNA_MYOD_TARGETS_DN,0.998146167532761
GSE39916_B_CELL_SPLEEN_VS_PL...1,SET,179,-0.001162,-0.00011412,0.067022,0.50692,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN,0.998146167532761
chr4q24,SET,24,-0.0057972,-0.00020936,0.33354,0.50693,chr4q24,0.998146167532761
HP_ABNORMAL_PSYCHOTIC_PATTERN,SET,171,-0.0012061,-0.0001158,0.069433,0.50693,HP_ABNORMAL_PSYCHOTIC_PATTERN,0.998146167532761
GSE10500_ARTHRITIC_SYNOVIAL_...1,SET,125,-0.0013596,-0.00011175,0.078037,0.50695,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN,0.998146167532761
GSE17974_IL4_AND_ANTI_IL12_V...4,SET,167,-0.0011866,-0.0001126,0.067904,0.50697,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP,0.998146167532761
HP_PARTIAL_DUPLICATION_OF_TH...2,SET,38,-0.0022925,-0.00010414,0.13013,0.50703,HP_PARTIAL_DUPLICATION_OF_THE_PHALANX_OF_HAND,0.998146167532761
MIR766_5P,SET,196,-0.0010992,-0.00011291,0.062073,0.50706,MIR766_5P,0.998146167532761
GOBP_NEGATIVE_REGULATION_OF_...647,SET,9,-0.0056586,-0.00012519,0.31788,0.5071,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.998146167532761
GOBP_VASCULAR_ENDOTHELIAL_CE...,SET,25,-0.0030762,-0.00011338,0.17177,0.50714,GOBP_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.998146167532761
GNF2_MMP1,SET,32,-0.0031576,-0.00013165,0.1756,0.50717,GNF2_MMP1,0.998146167532761
HP_ABNORMAL_DRINKING_BEHAVIOR,SET,50,-0.0023393,-0.00012185,0.12991,0.50718,HP_ABNORMAL_DRINKING_BEHAVIOR,0.998146167532761
REACTOME_INTERLEUKIN_15_SIGN...,SET,13,-0.0047699,-0.00012682,0.26388,0.50721,REACTOME_INTERLEUKIN_15_SIGNALING,0.998146167532761
MIR181A_3P,SET,7,-0.006387,-0.00012463,0.35202,0.50724,MIR181A_3P,0.998146167532761
GOBP_REGULATION_OF_NEURON_MI...,SET,43,-0.0025825,-0.00012477,0.14232,0.50724,GOBP_REGULATION_OF_NEURON_MIGRATION,0.998146167532761
GOBP_REGULATION_OF_TISSUE_RE...,SET,72,-0.0019767,-0.00012348,0.1085,0.50727,GOBP_REGULATION_OF_TISSUE_REMODELING,0.998146167532761
KEGG_FATTY_ACID_METABOLISM,SET,41,-0.0025015,-0.00011802,0.13683,0.50729,KEGG_FATTY_ACID_METABOLISM,0.998146167532761
HP_CHILBLAINS,SET,10,-0.004664,-0.00010877,0.25475,0.5073,HP_CHILBLAINS,0.998146167532761
MODULE_263,SET,44,-0.0030086,-0.00014704,0.16315,0.50736,MODULE_263,0.998146167532761
HP_METATARSAL_SYNOSTOSIS,SET,7,-0.0066109,-0.000129,0.35667,0.50739,HP_METATARSAL_SYNOSTOSIS,0.998146167532761
GOBP_MITOTIC_G1_S_TRANSITION...,SET,30,-0.0027943,-0.0001128,0.15007,0.50743,GOBP_MITOTIC_G1_S_TRANSITION_CHECKPOINT_SIGNALING,0.998146167532761
HP_ABNORMAL_FETAL_MORPHOLOGY,SET,265,-0.00098769,-0.00011775,0.05298,0.50744,HP_ABNORMAL_FETAL_MORPHOLOGY,0.998146167532761
HP_CEPHALOHEMATOMA,SET,9,-0.005817,-0.0001287,0.31107,0.50746,HP_CEPHALOHEMATOMA,0.998146167532761
GOBP_RESPONSE_TO_STEROL_DEPL...,SET,15,-0.0042147,-0.00012036,0.22318,0.50753,GOBP_RESPONSE_TO_STEROL_DEPLETION,0.998146167532761
WP_EMBRYONIC_STEM_CELL_PLURI...,SET,108,-0.0016901,-0.00012918,0.088933,0.50758,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,0.998146167532761
GOBP_AUTOPHAGY_OF_MITOCHONDR...,SET,91,-0.0016502,-0.00011583,0.086378,0.50762,GOBP_AUTOPHAGY_OF_MITOCHONDRION,0.998146167532761
HALLMARK_KRAS_SIGNALING_DN,SET,175,-0.0012909,-0.00012537,0.067577,0.50762,HALLMARK_KRAS_SIGNALING_DN,0.998146167532761
GOMF_DNA_ENDONUCLEASE_ACTIVI...2,SET,9,-0.0047419,-0.00010491,0.24758,0.50764,GOMF_DNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,0.998146167532761
GSE19772_HCMV_INFL_VS_HCMV_I...1,SET,181,-0.0011972,-0.00011822,0.061887,0.50772,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,0.998146167532761
GOBP_NUCLEUS_ORGANIZATION,SET,132,-0.0013835,-0.00011683,0.071411,0.50773,GOBP_NUCLEUS_ORGANIZATION,0.998146167532761
HP_ABNORMALITY_OF_UPPER_LIMB...,SET,489,-0.00077848,-0.00012528,0.040106,0.50774,HP_ABNORMALITY_OF_UPPER_LIMB_JOINT,0.998146167532761
HP_SECUNDUM_ATRIAL_SEPTAL_DE...,SET,38,-0.0027987,-0.00012713,0.14397,0.50775,HP_SECUNDUM_ATRIAL_SEPTAL_DEFECT,0.998146167532761
MIR5698,SET,187,-0.0011918,-0.00011961,0.06116,0.50777,MIR5698,0.998146167532761
GOBP_MYOBLAST_DIFFERENTIATION,SET,108,-0.0016291,-0.00012452,0.083648,0.50777,GOBP_MYOBLAST_DIFFERENTIATION,0.998146167532761
GOBP_CELLULAR_RESPONSE_TO_PR...1,SET,6,-0.0061225,-0.00011061,0.31382,0.50778,GOBP_CELLULAR_RESPONSE_TO_PROGESTERONE_STIMULUS,0.998146167532761
GOBP_MEMBRANE_REPOLARIZATION...3,SET,14,-0.005135,-0.00014167,0.26255,0.5078,GOBP_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.998146167532761
GOBP_POSITIVE_REGULATION_OF_...258,SET,307,-0.00094762,-0.00012145,0.048164,0.50785,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.998146167532761
TCF11MAFG_01,SET,182,-0.0012955,-0.00012828,0.065322,0.50791,TCF11MAFG_01,0.998146167532761
UNTERMAN_IPF_VS_CTRL_DC_UP,SET,4,-0.0078622,-0.00011598,0.3934,0.50797,UNTERMAN_IPF_VS_CTRL_DC_UP,0.998146167532761
HP_IMPAIRED_HORIZONTAL_SMOOT...,SET,7,-0.0062443,-0.00012184,0.31162,0.50799,HP_IMPAIRED_HORIZONTAL_SMOOTH_PURSUIT,0.998146167532761
MIR6822_5P,SET,64,-0.0020163,-0.00011878,0.10051,0.508,MIR6822_5P,0.998146167532761
GSE7459_UNTREATED_VS_IL6_TRE...2,SET,117,-0.0016021,-0.00012742,0.079663,0.50802,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP,0.998146167532761
KEGG_MEDICUS_REFERENCE_TNF_P...,SET,24,-0.0034523,-0.00012468,0.17056,0.50807,KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY,0.998146167532761
REACTOME_RIP_MEDIATED_NFKB_A...,SET,16,-0.004425,-0.00013051,0.21876,0.50807,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,0.998146167532761
IRF7_01,SET,224,-0.0012176,-0.00013361,0.060141,0.50808,IRF7_01,0.998146167532761
GOBP_MICROTUBULE_ORGANIZING_...2,SET,143,-0.0013561,-0.00011916,0.066976,0.50808,GOBP_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION,0.998146167532761
GOMF_S_METHYLTRANSFERASE_ACT...,SET,8,-0.0073828,-0.000154,0.36348,0.5081,GOMF_S_METHYLTRANSFERASE_ACTIVITY,0.998146167532761
GOCC_FILAMENTOUS_ACTIN,SET,30,-0.0031246,-0.00012614,0.15334,0.50813,GOCC_FILAMENTOUS_ACTIN,0.998146167532761
MIR3151_3P,SET,39,-0.0025747,-0.00011848,0.12605,0.50815,MIR3151_3P,0.998146167532761
GOBP_RESPONSE_TO_INTERLEUKIN...5,SET,17,-0.004812,-0.00014629,0.23518,0.50816,GOBP_RESPONSE_TO_INTERLEUKIN_17,0.998146167532761
GOBP_MECHANOSENSORY_BEHAVIOR,SET,14,-0.005109,-0.00014096,0.24939,0.50817,GOBP_MECHANOSENSORY_BEHAVIOR,0.998146167532761
GSE17974_0H_VS_4H_IN_VITRO_A...1,SET,179,-0.0012248,-0.00012028,0.059745,0.50818,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN,0.998146167532761
WP_HIF1A_AND_PPARG_REGULATIO...,SET,6,-0.0078928,-0.00014259,0.38286,0.50822,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,0.998146167532761
GOBP_SERTOLI_CELL_PROLIFERAT...,SET,5,-0.0080139,-0.00013217,0.38766,0.50825,GOBP_SERTOLI_CELL_PROLIFERATION,0.998146167532761
HP_OPPORTUNISTIC_INFECTION,SET,43,-0.0028148,-0.00013599,0.13534,0.5083,HP_OPPORTUNISTIC_INFECTION,0.998146167532761
GOBP_EXPORT_ACROSS_PLASMA_ME...,SET,65,-0.0024384,-0.00014476,0.1168,0.50833,GOBP_EXPORT_ACROSS_PLASMA_MEMBRANE,0.998146167532761
DARWICHE_SQUAMOUS_CELL_CARCI...2,SET,136,-0.0015738,-0.00013488,0.075311,0.50834,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,0.998146167532761
GOBP_INFLAMMATORY_CELL_APOPT...,SET,21,-0.0038948,-0.00013158,0.18505,0.5084,GOBP_INFLAMMATORY_CELL_APOPTOTIC_PROCESS,0.998146167532761
HP_BELL_SHAPED_THORAX,SET,32,-0.0033317,-0.00013891,0.15758,0.50843,HP_BELL_SHAPED_THORAX,0.998146167532761
GOMF_FLOPPASE_ACTIVITY,SET,15,-0.0049868,-0.00014241,0.23575,0.50844,GOMF_FLOPPASE_ACTIVITY,0.998146167532761
GOBP_AMP_BIOSYNTHETIC_PROCESS,SET,10,-0.0055251,-0.00012885,0.26075,0.50845,GOBP_AMP_BIOSYNTHETIC_PROCESS,0.998146167532761
HP_HYPOPLASIA_OF_THE_UTERUS,SET,47,-0.0027534,-0.00013907,0.12995,0.50845,HP_HYPOPLASIA_OF_THE_UTERUS,0.998146167532761
GOMF_RNA_POLYMERASE_III_TYPE...,SET,6,-0.0064524,-0.00011657,0.30253,0.50851,GOMF_RNA_POLYMERASE_III_TYPE_3_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.998146646341463
WATANABE_COLON_CANCER_MSI_VS...1,SET,53,-0.0026846,-0.00014396,0.12498,0.50857,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,0.998146646341463
GOBP_NEGATIVE_REGULATION_OF_...370,SET,12,-0.0056587,-0.00014455,0.26244,0.5086,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,0.998146646341463
GSE45365_WT_VS_IFNAR_KO_BCEL...2,SET,153,-0.0015001,-0.0001363,0.069486,0.50861,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN,0.998146646341463
HP_POLYARTICULAR_ARTHROPATHY,SET,18,-0.0045634,-0.00014275,0.21115,0.50862,HP_POLYARTICULAR_ARTHROPATHY,0.998146646341463
TAAYNRNNTCC_UNKNOWN,SET,159,-0.0014943,-0.00013839,0.068829,0.50866,TAAYNRNNTCC_UNKNOWN,0.998146646341463
PID_S1P_S1P2_PATHWAY,SET,23,-0.0039481,-0.00013958,0.18167,0.50867,PID_S1P_S1P2_PATHWAY,0.998146646341463
GOBP_V_D_J_RECOMBINATION,SET,17,-0.0042156,-0.00012815,0.19373,0.50868,GOBP_V_D_J_RECOMBINATION,0.998146646341463
REACTOME_MITOTIC_G2_G2_M_PHA...,SET,187,-0.0012859,-0.00012905,0.058813,0.50872,REACTOME_MITOTIC_G2_G2_M_PHASES,0.998151670994693
ABDELMOHSEN_ELAVL4_TARGETS,SET,15,-0.0051745,-0.00014777,0.23605,0.50874,ABDELMOHSEN_ELAVL4_TARGETS,0.998151670994693
HP_ADENOMA_SEBACEUM,SET,26,-0.0034476,-0.00012958,0.15663,0.50878,HP_ADENOMA_SEBACEUM,0.998173801862828
KEGG_MEDICUS_REFERENCE_MODIF...1,SET,6,-0.0067253,-0.0001215,0.30274,0.50886,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_II_SUBUNITS,0.998274401670806
GOBP_TELOMERE_MAINTENANCE_VI...3,SET,74,-0.0020478,-0.00012968,0.091785,0.5089,GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.99827941076871
GSE3720_VD1_VS_VD2_GAMMADELT...1,SET,184,-0.0014213,-0.0001415,0.063565,0.50892,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN,0.99827941076871
GOBP_POSITIVE_REGULATION_OF_...650,SET,27,-0.0035552,-0.00013617,0.15826,0.50896,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.99829693370945
GSE19198_6H_VS_24H_IL21_TREA...1,SET,177,-0.0014566,-0.00014226,0.064661,0.50899,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN,0.99829693370945
HP_MATERNAL_AUTOIMMUNE_DISEA...,SET,14,-0.0052131,-0.00014383,0.22921,0.50907,HP_MATERNAL_AUTOIMMUNE_DISEASE,0.99829693370945
MORF_USP5,SET,46,-0.0025831,-0.00012907,0.11346,0.50908,MORF_USP5,0.99829693370945
GOMF_S_ACYLTRANSFERASE_ACTIV...,SET,28,-0.0034513,-0.00013461,0.15122,0.5091,GOMF_S_ACYLTRANSFERASE_ACTIVITY,0.99829693370945
WP_SPHINGOLIPID_METABOLISM_O...,SET,23,-0.0044961,-0.00015896,0.19665,0.50912,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.99829693370945
HP_PSYCHOTIC_EPISODES,SET,15,-0.0050938,-0.00014547,0.22256,0.50913,HP_PSYCHOTIC_EPISODES,0.99829693370945
GSE21546_WT_VS_SAP1A_KO_ANTI...2,SET,183,-0.0014822,-0.00014717,0.06422,0.50921,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.998326544080321
HP_DECREASED_LACRIMATION,SET,26,-0.0040576,-0.00015251,0.1755,0.50922,HP_DECREASED_LACRIMATION,0.998326544080321
GNF2_MCM5,SET,54,-0.0026969,-0.00014597,0.11648,0.50924,GNF2_MCM5,0.998326544080321
HP_OBSTRUCTIVE_SLEEP_APNEA,SET,72,-0.0024281,-0.00015168,0.10462,0.50926,HP_OBSTRUCTIVE_SLEEP_APNEA,0.998326544080321
GOMF_PURINE_RIBONUCLEOTIDE_T...,SET,20,-0.0048945,-0.00016138,0.21013,0.50929,GOMF_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.998329043993232
REACTOME_NOTCH1_INTRACELLULA...,SET,43,-0.0030003,-0.00014496,0.12807,0.50935,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.998336542040264
HP_HYPOTHALAMIC_GONADOTROPIN...,SET,20,-0.0049401,-0.00016288,0.21055,0.50936,HP_HYPOTHALAMIC_GONADOTROPIN_RELEASING_HORMONE_DEFICIENCY,0.998336542040264
GOBP_POSITIVE_REGULATION_OF_...142,SET,5,-0.007959,-0.00013126,0.33833,0.50938,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,0.998336542040264
MIR5589_5P,SET,67,-0.0025264,-0.00015227,0.10658,0.50946,MIR5589_5P,0.998380733013814
GOCC_CYTOSOLIC_RIBOSOME,SET,102,-0.001918,-0.00014249,0.080859,0.50946,GOCC_CYTOSOLIC_RIBOSOME,0.998380733013814
GSE3982_CTRL_VS_PMA_STIM_EOS...2,SET,174,-0.0015235,-0.00014754,0.063953,0.5095,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP,0.998402824763193
ABRAHAM_ALPC_VS_MULTIPLE_MYE...2,SET,25,-0.0044265,-0.00016315,0.18376,0.50961,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,0.998562076450358
ZHONG_PFC_C1_DLX5_POS_INTERN...,SET,6,-0.01008,-0.0001821,0.41527,0.50968,ZHONG_PFC_C1_DLX5_POS_INTERNEURON,0.998608714768884
GOMF_DISULFIDE_OXIDOREDUCTAS...,SET,37,-0.0032808,-0.00014706,0.13491,0.5097,GOMF_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.998608714768884
GOMF_CO_RECEPTOR_BINDING,SET,13,-0.0057931,-0.00015402,0.23776,0.50972,GOMF_CO_RECEPTOR_BINDING,0.998608714768884
MIR1911_5P,SET,24,-0.0040171,-0.00014507,0.16395,0.50977,MIR1911_5P,0.998650377656276
GOBP_TRICARBOXYLIC_ACID_META...,SET,15,-0.0053283,-0.00015216,0.21639,0.50982,GOBP_TRICARBOXYLIC_ACID_METABOLIC_PROCESS,0.998692035847143
HP_ABNORMAL_URINE_PH,SET,129,-0.0018879,-0.00015761,0.076238,0.50988,HP_ABNORMAL_URINE_PH,0.998692150689393
ZNF766_TARGET_GENES,SET,933,-0.00070403,-0.00015455,0.028376,0.5099,ZNF766_TARGET_GENES,0.998692150689393
TGCCTTA_MIR124A,SET,511,-0.00096125,-0.00015804,0.038592,0.50994,TGCCTTA_MIR124A,0.998692150689393
REACTOME_HEDGEHOG_ON_STATE,SET,82,-0.0022061,-0.00014704,0.088256,0.50997,REACTOME_HEDGEHOG_ON_STATE,0.998692150689393
RUBENSTEIN_SKELETAL_MUSCLE_E...,SET,123,-0.0021277,-0.00017348,0.08381,0.51013,RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS,0.998692150689393
GOMF_FATZ_BINDING,SET,5,-0.0098407,-0.00016229,0.38506,0.51019,GOMF_FATZ_BINDING,0.998692150689393
MIR4721,SET,64,-0.0026378,-0.00015539,0.10231,0.51028,MIR4721,0.998692150689393
MIR6769B_5P,SET,71,-0.0026509,-0.00016445,0.10272,0.51029,MIR6769B_5P,0.998692150689393
GAVISH_3CA_METAPROGRAM_ENDOT...2,SET,47,-0.0035061,-0.00017708,0.13595,0.51029,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_COAGULATION,0.998692150689393
BIOCARTA_ERK_PATHWAY,SET,26,-0.0045572,-0.00017129,0.17649,0.5103,BIOCARTA_ERK_PATHWAY,0.998692150689393
MARTINEZ_TP53_TARGETS_UP,SET,570,-0.00094195,-0.0001633,0.036328,0.51034,MARTINEZ_TP53_TARGETS_UP,0.998692150689393
GOMF_SALT_TRANSMEMBRANE_TRAN...,SET,9,-0.0065363,-0.00014461,0.25188,0.51035,GOMF_SALT_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.998692150689393
MIR6739_3P,SET,174,-0.0017493,-0.00016941,0.067054,0.51041,MIR6739_3P,0.998692150689393
FXR_IR1_Q6,SET,104,-0.0022628,-0.00016974,0.086486,0.51044,FXR_IR1_Q6,0.998692150689393
VECCHI_GASTRIC_CANCER_ADVANC...2,SET,155,-0.0019858,-0.0001816,0.075572,0.51048,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,0.998692150689393
MODULE_191,SET,19,-0.0062088,-0.00019953,0.23642,0.51048,MODULE_191,0.998692150689393
MIR3661,SET,62,-0.0029563,-0.00017142,0.11196,0.51053,MIR3661,0.998692150689393
GOCC_SMC5_SMC6_COMPLEX,SET,6,-0.009931,-0.00017941,0.37635,0.51053,GOCC_SMC5_SMC6_COMPLEX,0.998692150689393
REACTOME_CELLULAR_HEXOSE_TRA...,SET,18,-0.0054923,-0.0001718,0.20781,0.51054,REACTOME_CELLULAR_HEXOSE_TRANSPORT,0.998692150689393
GSE30971_CTRL_VS_LPS_STIM_MA...5,SET,173,-0.0017196,-0.00016605,0.065082,0.51054,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN,0.998692150689393
GSE15659_CD45RA_NEG_CD4_TCEL...2,SET,164,-0.0017633,-0.00016583,0.066703,0.51055,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.998692150689393
GOBP_INTERNAL_PROTEIN_AMINO_...,SET,10,-0.0062078,-0.00014477,0.23456,0.51056,GOBP_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION,0.998692150689393
GOBP_LEUKOTRIENE_METABOLIC_P...,SET,29,-0.0044907,-0.00017825,0.16892,0.5106,GOBP_LEUKOTRIENE_METABOLIC_PROCESS,0.998692150689393
LU_AGING_BRAIN_UP,SET,235,-0.0015667,-0.00017603,0.058506,0.51068,LU_AGING_BRAIN_UP,0.998692150689393
REACTOME_INTESTINAL_ABSORPTI...,SET,5,-0.011081,-0.00018275,0.41222,0.51072,REACTOME_INTESTINAL_ABSORPTION,0.998692150689393
REACTOME_NR1H2_NR1H3_REGULAT...1,SET,5,-0.0094209,-0.00015537,0.34946,0.51075,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS,0.998692150689393
HE_LIM_SUN_FETAL_LUNG_C1_PUL...1,SET,202,-0.0017607,-0.00018358,0.06522,0.51077,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL,0.998692150689393
HP_PSEUDOEPIPHYSES_OF_HAND_B...,SET,14,-0.0059265,-0.00016351,0.21887,0.5108,HP_PSEUDOEPIPHYSES_OF_HAND_BONES,0.998692150689393
GOBP_REGULATION_OF_VASCULAR_...5,SET,45,-0.0037911,-0.00018737,0.13934,0.51085,GOBP_REGULATION_OF_VASCULAR_PERMEABILITY,0.998692150689393
REACTOME_SIGNALING_BY_GPCR,SET,652,-0.001016,-0.00018794,0.036994,0.51095,REACTOME_SIGNALING_BY_GPCR,0.998692150689393
GOBP_CHEMOKINE_C_X_C_MOTIF_L...2,SET,6,-0.0097522,-0.00017618,0.35467,0.51097,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,0.998692150689393
SCHERER_PBMC_YF_VAX_AGE_18_4...2,SET,317,-0.0013412,-0.00017462,0.048546,0.51102,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP,0.998692150689393
REACTOME_REGULATION_OF_GENE_...5,SET,15,-0.0060361,-0.00017237,0.21737,0.51108,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS,0.998692150689393
GOMF_RNA_2_O_METHYLTRANSFERA...,SET,6,-0.0085515,-0.00015449,0.30566,0.51116,GOMF_RNA_2_O_METHYLTRANSFERASE_ACTIVITY,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...424,SET,76,-0.0029766,-0.00019102,0.10616,0.51118,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.998692150689393
PID_PI3K_PLC_TRK_PATHWAY,SET,36,-0.0041568,-0.0001838,0.14792,0.51121,PID_PI3K_PLC_TRK_PATHWAY,0.998692150689393
GSE3982_BASOPHIL_VS_NKCELL_UP,SET,177,-0.001787,-0.00017453,0.063456,0.51123,GSE3982_BASOPHIL_VS_NKCELL_UP,0.998692150689393
MIR5680,SET,425,-0.0012229,-0.00018381,0.043379,0.51125,MIR5680,0.998692150689393
HP_METAMORPHOPSIA,SET,17,-0.0060567,-0.00018412,0.21369,0.51131,HP_METAMORPHOPSIA,0.998692150689393
HP_CONGENITAL_SENSORINEURAL_...,SET,54,-0.0035066,-0.0001898,0.12323,0.51135,HP_CONGENITAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.998692150689393
RUTELLA_RESPONSE_TO_HGF_VS_C...1,SET,223,-0.0016833,-0.00018429,0.059001,0.51138,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,0.998692150689393
PETRETTO_BLOOD_PRESSURE_UP,SET,11,-0.0070196,-0.00017168,0.24591,0.51139,PETRETTO_BLOOD_PRESSURE_UP,0.998692150689393
NKX22_01,SET,169,-0.0020497,-0.00019565,0.071673,0.51141,NKX22_01,0.998692150689393
HP_UNCONJUGATED_HYPERBILIRUB...,SET,11,-0.006877,-0.0001682,0.24017,0.51142,HP_UNCONJUGATED_HYPERBILIRUBINEMIA,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...213,SET,4,-0.010629,-0.0001568,0.37006,0.51146,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.998692150689393
RAY_TUMORIGENESIS_BY_ERBB2_C...1,SET,243,-0.0016261,-0.00018574,0.056483,0.51148,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,0.998692150689393
MODULE_326,SET,13,-0.0075976,-0.000202,0.26284,0.51153,MODULE_326,0.998692150689393
HP_OVARIAN_GONADOBLASTOMA,SET,9,-0.0087267,-0.00019307,0.30199,0.51153,HP_OVARIAN_GONADOBLASTOMA,0.998692150689393
WEBER_METHYLATED_HCP_IN_FIBR...2,SET,6,-0.010469,-0.00018913,0.3618,0.51154,WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP,0.998692150689393
GOMF_CCR5_CHEMOKINE_RECEPTOR...,SET,7,-0.010481,-0.00020451,0.36222,0.51154,GOMF_CCR5_CHEMOKINE_RECEPTOR_BINDING,0.998692150689393
HP_FUNCTIONAL_ABNORMALITY_OF...3,SET,920,-0.00083261,-0.00018157,0.028565,0.51163,HP_FUNCTIONAL_ABNORMALITY_OF_THE_INNER_EAR,0.998692150689393
RUAN_RESPONSE_TO_TNF_UP,SET,13,-0.0073418,-0.0001952,0.25146,0.51165,RUAN_RESPONSE_TO_TNF_UP,0.998692150689393
WP_IMATINIB_AND_CHRONIC_MYEL...,SET,19,-0.0062885,-0.00020209,0.21504,0.51166,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,0.998692150689393
GOMF_LYSOPHOSPHOLIPID_ACYLTR...,SET,18,-0.0063854,-0.00019974,0.21841,0.51166,GOMF_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY,0.998692150689393
GOBP_TRYPTOPHAN_METABOLIC_PR...,SET,10,-0.0092059,-0.00021468,0.31427,0.51168,GOBP_TRYPTOPHAN_METABOLIC_PROCESS,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...306,SET,3,-0.016102,-0.00020571,0.54954,0.51169,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...527,SET,14,-0.007259,-0.00020028,0.24779,0.51169,GOBP_POSITIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.998692150689393
MIR4685_5P,SET,113,-0.0023264,-0.00018186,0.079095,0.51173,MIR4685_5P,0.998692150689393
GOBP_BONE_MARROW_DEVELOPMENT,SET,9,-0.0086568,-0.00019152,0.2918,0.51183,GOBP_BONE_MARROW_DEVELOPMENT,0.998692150689393
GOBP_REGULATION_OF_MICROTUBU...7,SET,56,-0.0032374,-0.00017843,0.10892,0.51186,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.998692150689393
GSE10239_NAIVE_VS_KLRG1INT_E...2,SET,181,-0.0018685,-0.00018451,0.062197,0.51198,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP,0.998692150689393
GAVISH_3CA_MALIGNANT_METAPRO...13,SET,48,-0.0038979,-0.00019895,0.12962,0.51199,GAVISH_3CA_MALIGNANT_METAPROGRAM_22_SECRETED_1,0.998692150689393
GSE1432_CTRL_VS_IFNG_24H_MIC...1,SET,182,-0.0020207,-0.00020009,0.067008,0.51203,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.998692150689393
DESCARTES_FETAL_LUNG_VASCULA...,SET,43,-0.0042643,-0.00020603,0.14082,0.51208,DESCARTES_FETAL_LUNG_VASCULAR_ENDOTHELIAL_CELLS,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...197,SET,65,-0.0030704,-0.00018228,0.10103,0.51212,GOBP_NEGATIVE_REGULATION_OF_ENDOCYTOSIS,0.998692150689393
GOBP_OOCYTE_ANTERIOR_POSTERI...,SET,6,-0.010942,-0.00019767,0.35818,0.51218,GOBP_OOCYTE_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,0.998692150689393
GOBP_EMBRYONIC_DIGESTIVE_TRA...2,SET,17,-0.0073304,-0.00022284,0.23996,0.51219,GOBP_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS,0.998692150689393
GOBP_RESPONSE_TO_INSECTICIDE,SET,6,-0.012246,-0.00022123,0.4006,0.51219,GOBP_RESPONSE_TO_INSECTICIDE,0.998692150689393
GSE9960_HEALTHY_VS_GRAM_NEG_...3,SET,176,-0.0020389,-0.00019857,0.066614,0.51221,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...198,SET,11,-0.0081269,-0.00019877,0.26518,0.51222,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.998692150689393
VANTVEER_BREAST_CANCER_METAS...2,SET,41,-0.0041722,-0.00019684,0.13519,0.51231,VANTVEER_BREAST_CANCER_METASTASIS_UP,0.998692150689393
KEGG_MEDICUS_REFERENCE_NUCLE...3,SET,5,-0.013653,-0.00022516,0.44117,0.51234,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,0.998692150689393
GSE15930_NAIVE_VS_72H_IN_VIT...8,SET,185,-0.0018722,-0.00018689,0.060346,0.51237,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP,0.998692150689393
MIR5591_5P,SET,59,-0.0033768,-0.00019102,0.10878,0.51238,MIR5591_5P,0.998692150689393
GSE25085_FETAL_LIVER_VS_ADUL...2,SET,166,-0.0019381,-0.00018336,0.062405,0.51239,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,0.998692150689393
GOBP_NORADRENERGIC_NEURON_DI...,SET,9,-0.011321,-0.00025046,0.3628,0.51245,GOBP_NORADRENERGIC_NEURON_DIFFERENTIATION,0.998692150689393
REACTOME_MYOCLONIC_EPILEPSY_...,SET,8,-0.0096264,-0.0002008,0.30757,0.51248,REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA,0.998692150689393
MORF_ZNF10,SET,46,-0.0042983,-0.00021477,0.13691,0.51252,MORF_ZNF10,0.998692150689393
KYNG_WERNER_SYNDROM_AND_NORM...1,SET,163,-0.0020204,-0.00018943,0.064209,0.51255,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,0.998692150689393
GOBP_L_ASPARTATE_IMPORT_ACRO...,SET,6,-0.012402,-0.00022405,0.39326,0.51258,GOBP_L_ASPARTATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.998692150689393
HP_ABNORMALITY_OF_THE_WRIST,SET,147,-0.0023088,-0.00020566,0.073174,0.51259,HP_ABNORMALITY_OF_THE_WRIST,0.998692150689393
GOBP_REGULATION_OF_T_HELPER_...2,SET,10,-0.0093259,-0.00021748,0.29524,0.5126,GOBP_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.998692150689393
GOBP_NEGATIVE_T_CELL_SELECTI...,SET,13,-0.0086592,-0.00023022,0.27367,0.51262,GOBP_NEGATIVE_T_CELL_SELECTION,0.998692150689393
GOBP_REGULATION_OF_CARDIAC_M...8,SET,68,-0.0033696,-0.00020459,0.10637,0.51263,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.998692150689393
GOMF_CAMP_RESPONSE_ELEMENT_B...1,SET,12,-0.0080331,-0.0002052,0.25348,0.51264,GOMF_CAMP_RESPONSE_ELEMENT_BINDING,0.998692150689393
GOBP_NEUROINFLAMMATORY_RESPO...,SET,75,-0.0034708,-0.00022127,0.10913,0.51269,GOBP_NEUROINFLAMMATORY_RESPONSE,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...546,SET,6,-0.010971,-0.0001982,0.34486,0.51269,GOBP_POSITIVE_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.998692150689393
GSE32164_RESTING_DIFFERENTIA...4,SET,181,-0.002096,-0.00020698,0.065737,0.51272,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.998692150689393
KESHELAVA_MULTIPLE_DRUG_RESI...,SET,66,-0.0031603,-0.00018905,0.09904,0.51273,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,0.998692150689393
REACTOME_REVERSIBLE_HYDRATIO...,SET,11,-0.0086715,-0.00021209,0.27175,0.51273,REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,0.998692150689393
PID_RAS_PATHWAY,SET,29,-0.0048558,-0.00019274,0.152,0.51274,PID_RAS_PATHWAY,0.998692150689393
HP_ABNORMAL_CIRCULATING_CARB...1,SET,55,-0.0034851,-0.00019037,0.10887,0.51277,HP_ABNORMAL_CIRCULATING_CARBOHYDRATE_CONCENTRATION,0.998692150689393
HP_PANCREATIC_ISLET_CELL_ADE...,SET,9,-0.0098553,-0.00021804,0.30754,0.51278,HP_PANCREATIC_ISLET_CELL_ADENOMA,0.998692150689393
GSE13493_DP_VS_CD4INTCD8POS_...1,SET,183,-0.00203,-0.00020156,0.063374,0.51278,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN,0.998692150689393
GOMF_ASPARTIC_TYPE_PEPTIDASE...,SET,25,-0.0052359,-0.00019298,0.16322,0.5128,GOMF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.998692150689393
HP_NORMOCYTIC_ANEMIA,SET,15,-0.0066536,-0.00019001,0.20402,0.51301,HP_NORMOCYTIC_ANEMIA,0.998692150689393
REACTOME_DEFECTIVE_CSF2RB_CA...,SET,7,-0.01312,-0.000256,0.40142,0.51304,REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5,0.998692150689393
GSE37563_WT_VS_CTLA4_KO_CD4_...2,SET,149,-0.0023405,-0.00020989,0.071039,0.51314,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP,0.998692150689393
GOMF_PLATELET_DERIVED_GROWTH...2,SET,13,-0.0091636,-0.00024363,0.27777,0.51316,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING,0.998692150689393
NADERI_BREAST_CANCER_PROGNOS...2,SET,47,-0.0042548,-0.0002149,0.12867,0.51319,NADERI_BREAST_CANCER_PROGNOSIS_UP,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...106,SET,1025,-0.00091515,-0.00021001,0.027662,0.5132,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,0.998692150689393
DAZARD_RESPONSE_TO_UV_SCC_DN,SET,110,-0.0027704,-0.00021369,0.083371,0.51325,DAZARD_RESPONSE_TO_UV_SCC_DN,0.998692150689393
GOBP_ESCRT_COMPLEX_DISASSEMB...,SET,10,-0.0077299,-0.00018026,0.23268,0.51325,GOBP_ESCRT_COMPLEX_DISASSEMBLY,0.998692150689393
HFH8_01,SET,191,-0.002206,-0.00022372,0.06622,0.51329,HFH8_01,0.998692150689393
GOBP_DIAPEDESIS,SET,6,-0.01281,-0.00023142,0.38446,0.51329,GOBP_DIAPEDESIS,0.998692150689393
GOBP_GASTRIC_ACID_SECRETION,SET,13,-0.0080848,-0.00021495,0.24199,0.51333,GOBP_GASTRIC_ACID_SECRETION,0.998692150689393
MIR7108_5P,SET,43,-0.0043161,-0.00020853,0.12909,0.51334,MIR7108_5P,0.998692150689393
TMTCGCGANR_UNKNOWN,SET,148,-0.0022994,-0.00020551,0.068755,0.51334,TMTCGCGANR_UNKNOWN,0.998692150689393
GOBP_RESPONSE_TO_COPPER_ION,SET,31,-0.0058509,-0.0002401,0.1747,0.51336,GOBP_RESPONSE_TO_COPPER_ION,0.998692150689393
GOMF_NEUTRAL_L_AMINO_ACID_TR...,SET,40,-0.004803,-0.00022383,0.14334,0.51337,GOMF_NEUTRAL_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.998692150689393
GOBP_RESPONSE_TO_GRANULOCYTE...,SET,9,-0.01023,-0.00022634,0.30441,0.5134,GOBP_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR,0.998692150689393
HP_BILIARY_TRACT_ABNORMALITY,SET,93,-0.0030617,-0.00021725,0.090631,0.51347,HP_BILIARY_TRACT_ABNORMALITY,0.998692150689393
GSE40274_FOXP3_VS_FOXP3_AND_...2,SET,184,-0.0021417,-0.00021322,0.063121,0.51353,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.998692150689393
HU_ANGIOGENESIS_UP,SET,20,-0.0064815,-0.0002137,0.19062,0.51356,HU_ANGIOGENESIS_UP,0.998692150689393
GOBP_CHOLINE_METABOLIC_PROCE...,SET,6,-0.013654,-0.00024666,0.40065,0.51359,GOBP_CHOLINE_METABOLIC_PROCESS,0.998692150689393
chr14q13,SET,22,-0.009077,-0.00031387,0.26598,0.51361,chr14q13,0.998692150689393
GALIE_TUMOR_ANGIOGENESIS,SET,7,-0.012081,-0.00023572,0.35417,0.51361,GALIE_TUMOR_ANGIOGENESIS,0.998692150689393
HP_ABNORMAL_VISUAL_FIXATION,SET,24,-0.0058387,-0.00021086,0.17081,0.51363,HP_ABNORMAL_VISUAL_FIXATION,0.998692150689393
GTGCCTT_MIR506,SET,664,-0.0011524,-0.00021506,0.033704,0.51364,GTGCCTT_MIR506,0.998692150689393
HP_DECREASED_FERTILITY_IN_MA...,SET,183,-0.002103,-0.00020881,0.061485,0.51364,HP_DECREASED_FERTILITY_IN_MALES,0.998692150689393
GOCC_AMPHISOME,SET,13,-0.0079426,-0.00021117,0.23202,0.51365,GOCC_AMPHISOME,0.998692150689393
GSE7348_LPS_VS_TOLERIZED_AND...2,SET,170,-0.0021813,-0.00020882,0.063735,0.51365,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...64,SET,14,-0.0075444,-0.00020815,0.21995,0.51368,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT,0.998692150689393
GSE37605_TREG_VS_TCONV_C57BL...4,SET,114,-0.0028272,-0.00022198,0.082368,0.51369,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP,0.998692150689393
KEGG_MEDICUS_REFERENCE_IFN_R...,SET,28,-0.0065164,-0.00025416,0.18953,0.51371,KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY,0.998692150689393
GOBP_GLUTAMINE_TRANSPORT,SET,9,-0.010886,-0.00024085,0.31637,0.51372,GOBP_GLUTAMINE_TRANSPORT,0.998692150689393
GTTRYCATRR_UNKNOWN,SET,156,-0.0023556,-0.00021611,0.06844,0.51373,GTTRYCATRR_UNKNOWN,0.998692150689393
CUI_DEVELOPING_HEART_C6_EPIC...,SET,178,-0.0023811,-0.0002332,0.069145,0.51374,CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL,0.998692150689393
MODULE_275,SET,15,-0.0081052,-0.00023146,0.23505,0.51375,MODULE_275,0.998692150689393
HP_ABNORMAL_T_CELL_MORPHOLOGY,SET,105,-0.0029162,-0.00021979,0.084536,0.51376,HP_ABNORMAL_T_CELL_MORPHOLOGY,0.998692150689393
MORI_IMMATURE_B_LYMPHOCYTE_DN,SET,86,-0.003142,-0.00021443,0.090864,0.51379,MORI_IMMATURE_B_LYMPHOCYTE_DN,0.998692150689393
GOMF_ATP_ACTIVATED_INWARD_RE...,SET,6,-0.01556,-0.0002811,0.44887,0.51383,GOMF_ATP_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.998692150689393
GOBP_REGULATION_OF_HOMOTYPIC...,SET,36,-0.0054369,-0.0002404,0.15651,0.51386,GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.998692150689393
REACTOME_REGULATION_OF_NPAS4...2,SET,5,-0.014119,-0.00023286,0.40579,0.51388,REACTOME_REGULATION_OF_NPAS4_GENE_TRANSCRIPTION,0.998692150689393
GSE40441_NRP1_POS_INDUCED_TR...2,SET,184,-0.0023197,-0.00023095,0.066663,0.51388,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP,0.998692150689393
GOBP_PROGRAMMED_CELL_DEATH_I...2,SET,12,-0.0088438,-0.00022591,0.25304,0.51394,GOBP_PROGRAMMED_CELL_DEATH_IN_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.998692150689393
GOBP_MULTICELLULAR_ORGANISM_...,SET,136,-0.0027324,-0.00023418,0.077897,0.51399,GOBP_MULTICELLULAR_ORGANISM_GROWTH,0.998692150689393
MATTIOLI_MULTIPLE_MYELOMA_WI...,SET,31,-0.0057529,-0.00023608,0.16347,0.51404,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,0.998692150689393
GSE23925_DARK_ZONE_VS_NAIVE_...2,SET,182,-0.0021864,-0.00021649,0.062053,0.51405,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP,0.998692150689393
ZWANG_TRANSIENTLY_UP_BY_2ND_...,SET,1329,-0.00089364,-0.00023146,0.025301,0.51409,ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY,0.998692150689393
TANAKA_METHYLATED_IN_ESOPHAG...,SET,97,-0.0037627,-0.00027264,0.10632,0.51412,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,0.998692150689393
REACTOME_CD28_DEPENDENT_VAV1...,SET,11,-0.0093026,-0.00022752,0.26233,0.51414,REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,0.998692150689393
GOBP_PYRIMIDINE_CONTAINING_C...3,SET,80,-0.0035756,-0.00023539,0.1007,0.51416,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.998692150689393
GSE9988_LPS_VS_VEHICLE_TREAT...1,SET,184,-0.002205,-0.00021953,0.062118,0.51416,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,0.998692150689393
DEURIG_T_CELL_PROLYMPHOCYTIC...1,SET,282,-0.0018375,-0.00022586,0.051674,0.51418,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,0.998692150689393
HP_CALCINOSIS,SET,11,-0.010257,-0.00025087,0.28771,0.51422,HP_CALCINOSIS,0.998692150689393
FAN_EMBRYONIC_CTX_BRAIN_ENDO...1,SET,402,-0.0016595,-0.00024273,0.046327,0.51429,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1,0.998692150689393
WP_SERINE_METABOLISM,SET,8,-0.009267,-0.0001933,0.25794,0.51433,WP_SERINE_METABOLISM,0.998692150689393
MCM2_TARGET_GENES,SET,75,-0.0035143,-0.00022404,0.097564,0.51437,MCM2_TARGET_GENES,0.998692150689393
HP_CARDIOVASCULAR_CALCIFICAT...,SET,36,-0.005486,-0.00024257,0.15226,0.51437,HP_CARDIOVASCULAR_CALCIFICATION,0.998692150689393
GOBP_SPINAL_CORD_ASSOCIATION...,SET,11,-0.010965,-0.00026817,0.30344,0.51441,GOBP_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION,0.998692150689393
ZAMORA_NOS2_TARGETS_UP,SET,51,-0.00428,-0.00022515,0.11835,0.51442,ZAMORA_NOS2_TARGETS_UP,0.998692150689393
HP_ABNORMAL_DENTATE_NUCLEUS_...,SET,12,-0.0084682,-0.00021632,0.23255,0.51452,HP_ABNORMAL_DENTATE_NUCLEUS_MORPHOLOGY,0.998692150689393
FINETTI_BREAST_CANCER_KINOME...1,SET,14,-0.009005,-0.00024845,0.24554,0.51463,FINETTI_BREAST_CANCER_KINOME_GREEN,0.998692150689393
GAVISH_3CA_METAPROGRAM_FIBRO...14,SET,47,-0.00498,-0.00025152,0.1357,0.51464,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_INTERFERON,0.998692150689393
GOMF_MAP_KINASE_ACTIVITY,SET,16,-0.0088896,-0.00026218,0.24176,0.51467,GOMF_MAP_KINASE_ACTIVITY,0.998692150689393
GOBP_MITOCHONDRIAL_DEPOLARIZ...,SET,21,-0.0073584,-0.0002486,0.19934,0.51472,GOBP_MITOCHONDRIAL_DEPOLARIZATION,0.998692150689393
MIR6787_3P,SET,90,-0.00338,-0.00023595,0.091537,0.51473,MIR6787_3P,0.998692150689393
HP_CUTANEOUS_ABSCESS,SET,23,-0.0066808,-0.0002362,0.1793,0.51486,HP_CUTANEOUS_ABSCESS,0.998692150689393
HP_RECURRENT_MYCOBACTERIAL_I...,SET,48,-0.0045547,-0.00023247,0.12176,0.51492,HP_RECURRENT_MYCOBACTERIAL_INFECTIONS,0.998692150689393
GOMF_PHOSPHOTYROSINE_RESIDUE...,SET,46,-0.0049104,-0.00024536,0.13113,0.51494,GOMF_PHOSPHOTYROSINE_RESIDUE_BINDING,0.998692150689393
HP_ABNORMAL_AUTONOMIC_NERVOU...,SET,121,-0.0030434,-0.00024613,0.081141,0.51496,HP_ABNORMAL_AUTONOMIC_NERVOUS_SYSTEM_PHYSIOLOGY,0.998692150689393
REACTOME_ACTIVATED_NTRK3_SIG...1,SET,6,-0.01506,-0.00027207,0.40114,0.51497,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K,0.998692150689393
HOEK_PBMC_INACTIVATED_INFLUE...3,SET,10,-0.011119,-0.00025929,0.29458,0.51505,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_DN,0.998692150689393
MIR6796_3P,SET,55,-0.0044019,-0.00024045,0.11626,0.5151,MIR6796_3P,0.998692150689393
GOBP_AMYLOID_FIBRIL_FORMATION,SET,35,-0.0053269,-0.00023225,0.14056,0.51511,GOBP_AMYLOID_FIBRIL_FORMATION,0.998692150689393
HP_ABNORMALITY_OF_THE_UPPER_...3,SET,443,-0.0015801,-0.00024234,0.041442,0.51521,HP_ABNORMALITY_OF_THE_UPPER_RESPIRATORY_TRACT,0.998692150689393
GSE1460_INTRATHYMIC_T_PROGEN...1,SET,186,-0.0025258,-0.00025281,0.066035,0.51526,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN,0.998692150689393
GSE9006_TYPE_1_DIABETES_AT_D...3,SET,172,-0.0023785,-0.00022902,0.062175,0.51526,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN,0.998692150689393
GSE27786_CD8_TCELL_VS_NEUTRO...2,SET,176,-0.0023373,-0.00022763,0.061032,0.51527,GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP,0.998692150689393
RAMALHO_STEMNESS_DN,SET,65,-0.0042876,-0.00025454,0.11186,0.51529,RAMALHO_STEMNESS_DN,0.998692150689393
HP_BOWEL_DIVERTICULOSIS,SET,32,-0.0062176,-0.00025922,0.16178,0.51533,HP_BOWEL_DIVERTICULOSIS,0.998692150689393
GOBP_MACROPHAGE_DIFFERENTIAT...,SET,57,-0.0046996,-0.00026132,0.1219,0.51538,GOBP_MACROPHAGE_DIFFERENTIATION,0.998692150689393
GSE14769_UNSTIM_VS_360MIN_LP...2,SET,176,-0.0023689,-0.00023071,0.061129,0.51546,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP,0.998692150689393
SHIN_B_CELL_LYMPHOMA_CLUSTER...6,SET,27,-0.006329,-0.00024241,0.16255,0.51553,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,0.998692150689393
HP_BROAD_NAIL,SET,8,-0.012865,-0.00026836,0.33034,0.51553,HP_BROAD_NAIL,0.998692150689393
GOBP_MICROGLIAL_CELL_ACTIVAT...,SET,5,-0.016583,-0.00027348,0.42312,0.51563,GOBP_MICROGLIAL_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.998692150689393
REACTOME_REGULATION_OF_EXPRE...,SET,154,-0.0026194,-0.00023877,0.06646,0.51572,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,0.998692150689393
GNF2_SPTA1,SET,69,-0.0040932,-0.00025034,0.10326,0.51581,GNF2_SPTA1,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...789,SET,8,-0.011385,-0.00023749,0.28706,0.51582,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY,0.998692150689393
HP_ABNORMAL_TUBULAR_BASEMENT...,SET,5,-0.013849,-0.00022839,0.34892,0.51583,HP_ABNORMAL_TUBULAR_BASEMENT_MEMBRANE_MORPHOLOGY,0.998692150689393
GSE7768_OVA_ALONE_VS_OVA_WIT...3,SET,148,-0.0027772,-0.00024822,0.069964,0.51583,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.998692150689393
HP_METAPHYSEAL_DYSPLASIA,SET,31,-0.0061237,-0.00025129,0.15374,0.51589,HP_METAPHYSEAL_DYSPLASIA,0.998692150689393
ENGELMANN_CANCER_PROGENITORS...2,SET,46,-0.0053201,-0.00026583,0.1333,0.51592,ENGELMANN_CANCER_PROGENITORS_UP,0.998692150689393
GSE3982_MAC_VS_NEUTROPHIL_LP...2,SET,173,-0.0025183,-0.00024318,0.063072,0.51592,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP,0.998692150689393
GOBP_REGULATION_OF_LYMPHOCYT...4,SET,206,-0.0024554,-0.0002585,0.061475,0.51593,GOBP_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...347,SET,26,-0.0072199,-0.00027137,0.18061,0.51594,GOBP_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,0.998692150689393
MIR504_5P,SET,53,-0.0046363,-0.00024862,0.11593,0.51595,MIR504_5P,0.998692150689393
GOBP_PLASMA_LIPOPROTEIN_PART...,SET,40,-0.0057856,-0.00026962,0.14391,0.51603,GOBP_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE,0.998692150689393
REACTOME_NUCLEAR_EVENTS_KINA...,SET,59,-0.0046672,-0.00026402,0.11605,0.51604,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,0.998692150689393
REACTOME_TRANSCRIPTIONAL_REG...15,SET,79,-0.0036419,-0.00023826,0.090425,0.51606,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,0.998692150689393
HP_SERTOLI_CELL_NEOPLASM,SET,5,-0.015841,-0.00026126,0.39287,0.51608,HP_SERTOLI_CELL_NEOPLASM,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...219,SET,118,-0.003172,-0.00025336,0.078555,0.5161,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.998692150689393
GSE17721_CTRL_VS_POLYIC_1H_B...2,SET,176,-0.0024637,-0.00023994,0.061042,0.5161,GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP,0.998692150689393
UNTERMAN_IPF_VS_CTRL_TREG_CE...2,SET,13,-0.010989,-0.00029216,0.2715,0.51614,UNTERMAN_IPF_VS_CTRL_TREG_CELL_UP,0.998692150689393
GOMF_NATURAL_KILLER_CELL_LEC...,SET,8,-0.015353,-0.00032026,0.3789,0.51616,GOMF_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING,0.998692150689393
HP_PERISYLVIAN_POLYMICROGYRIA,SET,32,-0.0065857,-0.00027457,0.16219,0.51619,HP_PERISYLVIAN_POLYMICROGYRIA,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...110,SET,24,-0.0073131,-0.0002641,0.17952,0.51625,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.998692150689393
GOMF_PROTEIN_DEMETHYLASE_ACT...,SET,24,-0.0062865,-0.00022703,0.15431,0.51625,GOMF_PROTEIN_DEMETHYLASE_ACTIVITY,0.998692150689393
KORKOLA_SEMINOMA_UP,SET,29,-0.0076878,-0.00030515,0.18831,0.51628,KORKOLA_SEMINOMA_UP,0.998692150689393
HP_SMALL_BOWEL_DIVERTICULA,SET,5,-0.014246,-0.00023495,0.34904,0.51628,HP_SMALL_BOWEL_DIVERTICULA,0.998692150689393
HP_HYPOCHROMIC_ANEMIA,SET,51,-0.0049172,-0.00025867,0.12042,0.51629,HP_HYPOCHROMIC_ANEMIA,0.998692150689393
GSE20152_HTNFA_OVERXPRESS_AN...2,SET,174,-0.0027291,-0.00026429,0.066639,0.51633,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP,0.998692150689393
GSE2770_IL12_AND_TGFB_VS_IL4...5,SET,175,-0.0028592,-0.00027768,0.069744,0.51635,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.998692150689393
GSE5589_WT_VS_IL6_KO_LPS_AND...5,SET,178,-0.0026356,-0.00025813,0.064031,0.51642,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.998692150689393
WP_OCTADECANOID_FORMATION_FR...,SET,12,-0.011023,-0.00028159,0.26706,0.51646,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,0.998692150689393
GOBP_RESPONSE_TO_CARBOHYDRATE,SET,212,-0.0024605,-0.00026273,0.059628,0.51646,GOBP_RESPONSE_TO_CARBOHYDRATE,0.998692150689393
GOBP_DEFENSE_RESPONSE,SET,1632,-0.00096694,-0.00027505,0.023405,0.51648,GOBP_DEFENSE_RESPONSE,0.998692150689393
GOBP_GANGLION_DEVELOPMENT,SET,16,-0.0098666,-0.000291,0.23805,0.51653,GOBP_GANGLION_DEVELOPMENT,0.998692150689393
HP_INCREASED_RED_BLOOD_CELL_...,SET,5,-0.015748,-0.00025973,0.37818,0.51661,HP_INCREASED_RED_BLOOD_CELL_MASS,0.998692150689393
GOBP_PROTON_TRANSMEMBRANE_TR...,SET,118,-0.0032895,-0.00026273,0.078929,0.51662,GOBP_PROTON_TRANSMEMBRANE_TRANSPORT,0.998692150689393
chr3p26,SET,14,-0.017444,-0.00048128,0.41569,0.51674,chr3p26,0.998692150689393
HP_ABNORMALITY_OF_THE_PERIUN...,SET,20,-0.0084318,-0.000278,0.20053,0.51677,HP_ABNORMALITY_OF_THE_PERIUNGUAL_REGION,0.998692150689393
HP_ABNORMAL_FETAL_PHYSIOLOGY,SET,261,-0.0022578,-0.00026714,0.053702,0.51677,HP_ABNORMAL_FETAL_PHYSIOLOGY,0.998692150689393
KEGG_MEDICUS_VARIANT_MUTATIO...87,SET,5,-0.017915,-0.00029546,0.42509,0.51681,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RUNX1_TO_TRANSCRIPTION,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...226,SET,13,-0.010825,-0.00028781,0.25661,0.51682,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.998692150689393
JIANG_MELANOMA_TRM3_CD8,SET,363,-0.0019223,-0.00026748,0.045385,0.51689,JIANG_MELANOMA_TRM3_CD8,0.998692150689393
GSE32986_GMCSF_VS_GMCSF_AND_...1,SET,167,-0.0028941,-0.00027463,0.0681,0.51695,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.998692150689393
AIZARANI_LIVER_C10_MVECS_1,SET,245,-0.0026153,-0.00029994,0.061485,0.51696,AIZARANI_LIVER_C10_MVECS_1,0.998692150689393
CCCNNNNNNAAGWT_UNKNOWN,SET,93,-0.003771,-0.00026758,0.088406,0.51701,CCCNNNNNNAAGWT_UNKNOWN,0.998692150689393
GOBP_REGULATION_OF_MORPHOGEN...2,SET,46,-0.005861,-0.00029286,0.13689,0.51707,GOBP_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,0.998692150689393
HP_DELAYED_ABILITY_TO_CRAWL,SET,8,-0.010475,-0.0002185,0.24476,0.51707,HP_DELAYED_ABILITY_TO_CRAWL,0.998692150689393
GSE29617_CTRL_VS_DAY7_TIV_FL...1,SET,160,-0.0028328,-0.00026316,0.066172,0.51707,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,0.998692150689393
IRF1_Q6,SET,248,-0.0023721,-0.00027369,0.055298,0.51711,IRF1_Q6,0.998692150689393
GSE19198_CTRL_VS_IL21_TREATE...4,SET,183,-0.0028808,-0.00028604,0.067142,0.51711,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP,0.998692150689393
GOMF_NAD_BINDING,SET,55,-0.0049522,-0.00027051,0.11511,0.51716,GOMF_NAD_BINDING,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...532,SET,145,-0.003123,-0.00027631,0.072358,0.51721,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.998692150689393
GOMF_DELTA_CATENIN_BINDING,SET,9,-0.013509,-0.00029888,0.31278,0.51723,GOMF_DELTA_CATENIN_BINDING,0.998692150689393
BCAT_GDS748_UP,SET,45,-0.005898,-0.0002915,0.13628,0.51726,BCAT_GDS748_UP,0.998692150689393
JIANG_MELANOMA_TRM10_LAMINA_...,SET,79,-0.0047344,-0.00030974,0.10929,0.51728,JIANG_MELANOMA_TRM10_LAMINA_PROPRIA,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...423,SET,17,-0.0087246,-0.00026523,0.20124,0.51729,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.998692150689393
GOBP_REGULATION_OF_OSTEOCLAS...3,SET,6,-0.014582,-0.00026343,0.33644,0.51729,GOBP_REGULATION_OF_OSTEOCLAST_PROLIFERATION,0.998692150689393
GSE22601_DOUBLE_POSITIVE_VS_...3,SET,183,-0.0026631,-0.00026442,0.061179,0.51736,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.998692150689393
REACTOME_HEMOSTASIS,SET,570,-0.0016719,-0.00028984,0.038377,0.51737,REACTOME_HEMOSTASIS,0.998692150689393
GSE14308_TH2_VS_TH1_DN,SET,181,-0.0027163,-0.00026824,0.062316,0.51738,GSE14308_TH2_VS_TH1_DN,0.998692150689393
MIR3144_5P,SET,46,-0.0056496,-0.00028229,0.12944,0.51741,MIR3144_5P,0.998692150689393
ZNF558_TARGET_GENES,SET,225,-0.0024436,-0.00026872,0.055963,0.51741,ZNF558_TARGET_GENES,0.998692150689393
SCHERER_PBMC_APSV_WETVAX_AGE...2,SET,57,-0.0051399,-0.0002858,0.11755,0.51744,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_UP,0.998692150689393
GSE27786_CD8_TCELL_VS_NKTCEL...2,SET,176,-0.0027135,-0.00026427,0.062003,0.51745,GSE27786_CD8_TCELL_VS_NKTCELL_UP,0.998692150689393
GSE35825_UNTREATED_VS_IFNA_S...2,SET,161,-0.0028736,-0.00026778,0.065403,0.51752,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP,0.998692150689393
KEGG_INTESTINAL_IMMUNE_NETWO...,SET,40,-0.0065563,-0.00030554,0.1482,0.51764,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,0.998692150689393
MIR136_5P,SET,102,-0.0037668,-0.00027985,0.085147,0.51764,MIR136_5P,0.998692150689393
GOCC_COPII_COATED_ER_TO_GOLG...,SET,84,-0.0041038,-0.00027681,0.092772,0.51764,GOCC_COPII_COATED_ER_TO_GOLGI_TRANSPORT_VESICLE,0.998692150689393
HP_HAPPY_DEMEANOR,SET,23,-0.0095102,-0.00033623,0.21455,0.51768,HP_HAPPY_DEMEANOR,0.998692150689393
MIR7152_5P,SET,223,-0.002631,-0.00028805,0.059312,0.51769,MIR7152_5P,0.998692150689393
MIR4283,SET,186,-0.0027596,-0.00027622,0.062058,0.51773,MIR4283,0.998692150689393
VANDESLUIS_COMMD1_TARGETS_GR...1,SET,15,-0.010132,-0.00028935,0.22775,0.51774,VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...384,SET,18,-0.0084006,-0.00026278,0.18874,0.51775,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,0.998692150689393
GOBP_HEART_MORPHOGENESIS,SET,251,-0.0025913,-0.00030076,0.058136,0.51778,GOBP_HEART_MORPHOGENESIS,0.998692150689393
KEGG_B_CELL_RECEPTOR_SIGNALI...,SET,72,-0.0045787,-0.00028603,0.10249,0.51782,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.998692150689393
HP_THICKENED_NUCHAL_SKIN_FOLD,SET,49,-0.0051203,-0.00026404,0.11459,0.51782,HP_THICKENED_NUCHAL_SKIN_FOLD,0.998692150689393
MAML1_TARGET_GENES,SET,212,-0.0027006,-0.00028837,0.060399,0.51783,MAML1_TARGET_GENES,0.998692150689393
GOMF_ALL_TRANS_RETINOL_DEHYD...,SET,13,-0.011031,-0.00029327,0.24655,0.51784,GOMF_ALL_TRANS_RETINOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.998692150689393
NAGY_TFTC_COMPONENTS_HUMAN,SET,17,-0.0080494,-0.0002447,0.17957,0.51788,NAGY_TFTC_COMPONENTS_HUMAN,0.998692150689393
GOBP_REGULATION_OF_PANCREATI...,SET,7,-0.013267,-0.00025887,0.29598,0.51788,GOBP_REGULATION_OF_PANCREATIC_JUICE_SECRETION,0.998692150689393
MIR627_3P,SET,423,-0.0019433,-0.00029141,0.043254,0.51792,MIR627_3P,0.998692150689393
GSE5542_IFNA_VS_IFNA_AND_IFN...2,SET,183,-0.0028519,-0.00028316,0.063446,0.51793,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.998692150689393
GOBP_REGULATION_OF_GONAD_DEV...,SET,12,-0.012487,-0.00031896,0.27721,0.51796,GOBP_REGULATION_OF_GONAD_DEVELOPMENT,0.998692150689393
FLECHNER_BIOPSY_KIDNEY_TRANS...4,SET,81,-0.0043284,-0.00028672,0.096085,0.51797,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.998692150689393
GOBP_CELLULAR_RESPONSE_TO_CA...5,SET,137,-0.0033926,-0.00029182,0.07522,0.51799,GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS,0.998692150689393
HP_VILLOUS_ATROPHY,SET,24,-0.0071047,-0.00025658,0.15714,0.51803,HP_VILLOUS_ATROPHY,0.998692150689393
P300_01,SET,223,-0.0026799,-0.00029341,0.059029,0.51811,P300_01,0.998692150689393
GSE21033_CTRL_VS_POLYIC_STIM...6,SET,142,-0.0033846,-0.00029636,0.074287,0.51817,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP,0.998692150689393
MIR5687,SET,16,-0.0093732,-0.00027645,0.20503,0.51823,MIR5687,0.998692150689393
HP_BROAD_METACARPALS,SET,17,-0.010481,-0.00031864,0.22928,0.51823,HP_BROAD_METACARPALS,0.998692150689393
REACTOME_DISEASES_ASSOCIATED...5,SET,9,-0.016005,-0.00035409,0.34994,0.51824,REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM,0.998692150689393
REACTOME_SIGNALING_BY_NOTCH2,SET,30,-0.007593,-0.00030653,0.16591,0.51825,REACTOME_SIGNALING_BY_NOTCH2,0.998692150689393
MIR3689D,SET,88,-0.0041008,-0.00028309,0.089013,0.51837,MIR3689D,0.998692150689393
GOBP_ALCOHOL_METABOLIC_PROCE...,SET,334,-0.0022245,-0.00029715,0.048248,0.51839,GOBP_ALCOHOL_METABOLIC_PROCESS,0.998692150689393
HP_ABNORMAL_EPIPHYSEAL_OSSIF...,SET,70,-0.0047493,-0.00029255,0.10287,0.51841,HP_ABNORMAL_EPIPHYSEAL_OSSIFICATION,0.998692150689393
GOBP_EPITHELIAL_CELL_FATE_CO...,SET,14,-0.011876,-0.00032765,0.25715,0.51842,GOBP_EPITHELIAL_CELL_FATE_COMMITMENT,0.998692150689393
GSE30083_SP1_VS_SP2_THYMOCYT...2,SET,178,-0.0030263,-0.00029638,0.065361,0.51846,GSE30083_SP1_VS_SP2_THYMOCYTE_UP,0.998692150689393
GOBP_PRIMITIVE_ERYTHROCYTE_D...,SET,4,-0.023393,-0.00034508,0.50455,0.51849,GOBP_PRIMITIVE_ERYTHROCYTE_DIFFERENTIATION,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...827,SET,35,-0.0075455,-0.00032897,0.16255,0.51851,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...371,SET,7,-0.017401,-0.00033954,0.3746,0.51852,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION,0.998692150689393
HP_UPPER_MOTOR_NEURON_DYSFUN...,SET,1035,-0.0012526,-0.00028877,0.026965,0.51853,HP_UPPER_MOTOR_NEURON_DYSFUNCTION,0.998692150689393
BILANGES_SERUM_SENSITIVE_VIA...1,SET,20,-0.0091997,-0.00030332,0.19712,0.51861,BILANGES_SERUM_SENSITIVE_VIA_TSC1,0.998692150689393
MIR517_5P,SET,78,-0.0045327,-0.00029467,0.097037,0.51863,MIR517_5P,0.998692150689393
GSE6092_IFNG_VS_IFNG_AND_B_B...2,SET,166,-0.0031585,-0.00029882,0.067586,0.51864,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.998692150689393
HP_REDUCED_NUMBER_OF_CORNEAL...,SET,8,-0.01562,-0.00032582,0.33356,0.51867,HP_REDUCED_NUMBER_OF_CORNEAL_ENDOTHELIAL_CELLS,0.998692150689393
KEGG_MEDICUS_PATHOGEN_ESCHER...3,SET,16,-0.010977,-0.00032375,0.23421,0.51869,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.998692150689393
GOBP_SECRETORY_GRANULE_ORGAN...,SET,61,-0.0052219,-0.00030035,0.11126,0.51872,GOBP_SECRETORY_GRANULE_ORGANIZATION,0.998692150689393
GOBP_NERVE_GROWTH_FACTOR_SIG...,SET,14,-0.011945,-0.00032957,0.25407,0.51875,GOBP_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY,0.998692150689393
GSE46606_UNSTIM_VS_CD40L_IL2...16,SET,168,-0.003236,-0.00030797,0.068634,0.5188,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.998692150689393
REACTOME_VEGF_LIGAND_RECEPTO...,SET,7,-0.017098,-0.00033362,0.36204,0.51883,REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS,0.998692150689393
GNF2_TAL1,SET,61,-0.0051147,-0.00029418,0.10811,0.51887,GNF2_TAL1,0.998692150689393
WP_GLP1_SECRETION_FROM_INTES...,SET,5,-0.021534,-0.00035514,0.45348,0.51894,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,0.998692150689393
GOBP_HOMOLOGOUS_CHROMOSOME_S...,SET,56,-0.004953,-0.00027299,0.1042,0.51896,GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION,0.998692150689393
REACTOME_ACTIVATION_OF_RAS_I...,SET,5,-0.01652,-0.00027245,0.34704,0.51898,REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS,0.998692150689393
ZNF2_TARGET_GENES,SET,941,-0.001354,-0.00029845,0.028457,0.51898,ZNF2_TARGET_GENES,0.998692150689393
HEIDENBLAD_AMPLIFIED_IN_SOFT...,SET,13,-0.011179,-0.00029722,0.23476,0.51899,HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER,0.998692150689393
MIR892C_5P,SET,252,-0.0026469,-0.00030782,0.055592,0.51899,MIR892C_5P,0.998692150689393
HP_PARONYCHIA,SET,16,-0.010673,-0.00031478,0.22346,0.51905,HP_PARONYCHIA,0.998692150689393
KEGG_NATURAL_KILLER_CELL_MED...,SET,121,-0.00404,-0.00032673,0.0843,0.51911,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.998692150689393
HP_MIXED_DEMYELINATING_AND_A...,SET,3,-0.025722,-0.00032861,0.53684,0.51911,HP_MIXED_DEMYELINATING_AND_AXONAL_POLYNEUROPATHY,0.998692150689393
MIR1295B_3P,SET,18,-0.01089,-0.00034063,0.22716,0.51912,MIR1295B_3P,0.998692150689393
NAKAYA_PBMC_FLUMIST_AGE_18_5...7,SET,1367,-0.0011059,-0.00029017,0.023062,0.51912,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP,0.998692150689393
HP_ABNORMAL_ULNAR_METAPHYSIS...,SET,10,-0.016029,-0.0003738,0.33271,0.51921,HP_ABNORMAL_ULNAR_METAPHYSIS_MORPHOLOGY,0.998692150689393
GSE2770_IL12_VS_TGFB_AND_IL1...5,SET,184,-0.002931,-0.0002918,0.060856,0.51921,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.998692150689393
GOCC_OUTER_MEMBRANE,SET,208,-0.0028389,-0.00030031,0.058765,0.51927,GOCC_OUTER_MEMBRANE,0.998692150689393
GSE9988_LPS_VS_VEHICLE_TREAT...2,SET,162,-0.0035203,-0.00032905,0.072853,0.51927,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.998692150689393
MEISSNER_NPC_ICP_WITH_H3K4ME3,SET,17,-0.0089751,-0.00027284,0.18556,0.51929,MEISSNER_NPC_ICP_WITH_H3K4ME3,0.998692150689393
MIR653_5P,SET,116,-0.0038452,-0.00030452,0.079217,0.51936,MIR653_5P,0.998692150689393
GSE26669_CD4_VS_CD8_TCELL_IN...3,SET,179,-0.0030667,-0.00030118,0.063117,0.51938,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN,0.998692150689393
GOBP_SKELETAL_MUSCLE_SATELLI...4,SET,16,-0.009355,-0.00027591,0.19242,0.51939,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.998692150689393
GSE2197_CPG_DNA_VS_UNTREATED...2,SET,177,-0.003165,-0.00030911,0.065069,0.5194,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP,0.998692150689393
GOBP_GLUCOSYLCERAMIDE_METABO...,SET,7,-0.016375,-0.00031951,0.33643,0.51941,GOBP_GLUCOSYLCERAMIDE_METABOLIC_PROCESS,0.998692150689393
GOCC_MULTIVESICULAR_BODY_MEM...,SET,27,-0.007922,-0.00030342,0.16259,0.51943,GOCC_MULTIVESICULAR_BODY_MEMBRANE,0.998692150689393
GOBP_SERTOLI_CELL_DIFFERENTI...,SET,17,-0.0096915,-0.00029462,0.1987,0.51945,GOBP_SERTOLI_CELL_DIFFERENTIATION,0.998692150689393
HP_OSTEOPOROSIS,SET,281,-0.0025692,-0.00031525,0.052647,0.51946,HP_OSTEOPOROSIS,0.998692150689393
REACTOME_MAP3K8_TPL2_DEPENDE...,SET,14,-0.01079,-0.0002977,0.22096,0.51947,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,0.998692150689393
DESCARTES_MAIN_FETAL_OLIGODE...,SET,40,-0.0072549,-0.0003381,0.14854,0.51948,DESCARTES_MAIN_FETAL_OLIGODENDROCYTES,0.998692150689393
GOBP_REGULATION_OF_ACTIN_FIL...2,SET,341,-0.0023197,-0.00031303,0.047444,0.5195,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...628,SET,9,-0.014977,-0.00033136,0.3061,0.51951,GOBP_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY,0.998692150689393
MIR7110_5P,SET,154,-0.0034941,-0.00031851,0.07123,0.51956,MIR7110_5P,0.998692150689393
GOBP_THYROID_HORMONE_TRANSPO...,SET,10,-0.013774,-0.00032121,0.28019,0.5196,GOBP_THYROID_HORMONE_TRANSPORT,0.998692150689393
GOCC_TRANSCRIPTION_ELONGATIO...,SET,45,-0.0057614,-0.00028474,0.11724,0.5196,GOCC_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,0.998692150689393
GOBP_PURINE_DEOXYRIBONUCLEOT...1,SET,5,-0.018264,-0.00030121,0.3712,0.51962,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.998692150689393
GOMF_DEOXYNUCLEOSIDE_KINASE_...,SET,5,-0.018237,-0.00030077,0.37075,0.51962,GOMF_DEOXYNUCLEOSIDE_KINASE_ACTIVITY,0.998692150689393
GSE20366_CD103_POS_VS_NEG_TR...2,SET,179,-0.0032843,-0.00032255,0.06651,0.51969,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP,0.998692150689393
WP_MIRNA_REGULATION_OF_PROST...,SET,29,-0.0079639,-0.00031611,0.1612,0.5197,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,0.998692150689393
GOBP_MEIOTIC_CELL_CYCLE,SET,249,-0.0025756,-0.00029776,0.051979,0.51976,GOBP_MEIOTIC_CELL_CYCLE,0.998692150689393
REACTOME_RNA_POLYMERASE_II_T...3,SET,60,-0.0049485,-0.00028229,0.099718,0.51979,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,0.998692150689393
GOBP_HOMOLOGOUS_CHROMOSOME_P...,SET,44,-0.0057721,-0.00028209,0.11626,0.5198,GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS,0.998692150689393
MODULE_458,SET,31,-0.007983,-0.00032759,0.1606,0.51982,MODULE_458,0.998692150689393
GOBP_CELLULAR_RESPONSE_TO_LI...3,SET,33,-0.0077541,-0.00032828,0.15553,0.51988,GOBP_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS,0.998692150689393
GSE20715_0H_VS_6H_OZONE_TLR4...2,SET,179,-0.0031818,-0.00031248,0.063818,0.51988,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP,0.998692150689393
GOBP_REGULATION_OF_NUCLEOBAS...,SET,17,-0.0099103,-0.00030127,0.19812,0.51995,GOBP_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.998692150689393
GOBP_REGULATION_OF_MODIFICAT...1,SET,4,-0.022396,-0.00033037,0.44716,0.51997,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.998692150689393
HAN_JNK_SINGALING_DN,SET,36,-0.0075969,-0.0003359,0.15134,0.52002,HAN_JNK_SINGALING_DN,0.998692150689393
SESTO_RESPONSE_TO_UV_C7,SET,64,-0.0057383,-0.00033804,0.11406,0.52006,SESTO_RESPONSE_TO_UV_C7,0.998692150689393
chr4q12,SET,33,-0.01424,-0.00060286,0.28264,0.52009,chr4q12,0.998692150689393
HP_DYSPLASIA_OF_THE_FEMORAL_...,SET,5,-0.018564,-0.00030616,0.36852,0.52009,HP_DYSPLASIA_OF_THE_FEMORAL_HEAD,0.998692150689393
LIM_MAMMARY_LUMINAL_MATURE_UP,SET,97,-0.0046291,-0.00033542,0.091682,0.52013,LIM_MAMMARY_LUMINAL_MATURE_UP,0.998692150689393
GOBP_SUBPALLIUM_DEVELOPMENT,SET,26,-0.009341,-0.00035109,0.18442,0.5202,GOBP_SUBPALLIUM_DEVELOPMENT,0.998692150689393
MIR139_5P,SET,145,-0.0037023,-0.00032756,0.073064,0.52021,MIR139_5P,0.998692150689393
GOBP_HOMEOSTATIC_PROCESS,SET,1569,-0.0011902,-0.00033259,0.023473,0.52022,GOBP_HOMEOSTATIC_PROCESS,0.998692150689393
GOMF_INTERLEUKIN_1_BINDING,SET,8,-0.016317,-0.00034037,0.32086,0.52028,GOMF_INTERLEUKIN_1_BINDING,0.998692150689393
VERHAAK_GLIOBLASTOMA_NEURAL,SET,112,-0.0041353,-0.00032184,0.081257,0.52029,VERHAAK_GLIOBLASTOMA_NEURAL,0.998692150689393
GOMF_LIPOPOLYSACCHARIDE_BIND...,SET,36,-0.0078087,-0.00034527,0.15329,0.52031,GOMF_LIPOPOLYSACCHARIDE_BINDING,0.998692150689393
KEGG_MEDICUS_REFERENCE_ORGAN...1,SET,14,-0.011169,-0.00030815,0.21907,0.52033,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_INNER_KINETOCHORE,0.998692150689393
GOCC_ACTIN_CYTOSKELETON,SET,481,-0.0020499,-0.00032727,0.040177,0.52035,GOCC_ACTIN_CYTOSKELETON,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...319,SET,220,-0.0030635,-0.00033317,0.060011,0.52036,GOBP_POSITIVE_REGULATION_OF_GROWTH,0.998692150689393
HP_VERTICAL_NYSTAGMUS,SET,21,-0.0093381,-0.00031548,0.18285,0.52036,HP_VERTICAL_NYSTAGMUS,0.998692150689393
GSE17721_0.5H_VS_12H_CPG_BMD...1,SET,186,-0.0031192,-0.00031221,0.061048,0.52037,GSE17721_0.5H_VS_12H_CPG_BMDC_DN,0.998692150689393
GSE19198_1H_VS_6H_IL21_TREAT...1,SET,186,-0.0032943,-0.00032973,0.064326,0.52042,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN,0.998692150689393
REACTOME_LECTIN_PATHWAY_OF_C...,SET,8,-0.017673,-0.00036864,0.34496,0.52043,REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION,0.998692150689393
GSE27241_CTRL_VS_DIGOXIN_TRE...1,SET,176,-0.0032959,-0.00032099,0.064319,0.52043,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.998692150689393
GOBP_RIBONUCLEOSIDE_MONOPHOS...3,SET,52,-0.0062453,-0.00033173,0.12174,0.52046,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.998692150689393
GOCC_RADIAL_SPOKE_HEAD,SET,5,-0.019085,-0.00031475,0.37185,0.52047,GOCC_RADIAL_SPOKE_HEAD,0.998692150689393
chr17q24,SET,32,-0.012949,-0.00053985,0.25154,0.52053,chr17q24,0.998692150689393
BYSTRYKH_HEMATOPOIESIS_STEM_...9,SET,26,-0.0091445,-0.00034371,0.17765,0.52053,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...177,SET,6,-0.019264,-0.00034801,0.37392,0.52054,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.998692150689393
GOBP_PLASMA_MEMBRANE_REPAIR,SET,27,-0.008341,-0.00031947,0.16192,0.52054,GOBP_PLASMA_MEMBRANE_REPAIR,0.998692150689393
HP_BRANCHIAL_CYST,SET,4,-0.017017,-0.00025102,0.32883,0.52064,HP_BRANCHIAL_CYST,0.998692150689393
HP_HEMIPARESIS,SET,79,-0.0052781,-0.00034531,0.10194,0.52065,HP_HEMIPARESIS,0.998692150689393
GRAHAM_CML_DIVIDING_VS_NORMA...3,SET,77,-0.0053746,-0.00034716,0.10371,0.52066,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,0.998692150689393
HP_SELF_MUTILATION,SET,39,-0.0071258,-0.00032791,0.13697,0.52074,HP_SELF_MUTILATION,0.998692150689393
GSE10147_IL3_VS_IL3_AND_HIVP...2,SET,151,-0.0034419,-0.0003107,0.066147,0.52075,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP,0.998692150689393
MIR6848_3P,SET,81,-0.0052123,-0.00034527,0.10013,0.52076,MIR6848_3P,0.998692150689393
GOBP_MONOACYLGLYCEROL_METABO...,SET,14,-0.011232,-0.00030989,0.21557,0.52078,GOBP_MONOACYLGLYCEROL_METABOLIC_PROCESS,0.998692150689393
HP_ORTHOSTATIC_HYPOTENSION_D...,SET,15,-0.012954,-0.00036993,0.24817,0.52081,HP_ORTHOSTATIC_HYPOTENSION_DUE_TO_AUTONOMIC_DYSFUNCTION,0.998692150689393
REACTOME_TRAF6_MEDIATED_IRF7...2,SET,10,-0.014259,-0.00033253,0.2728,0.52084,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,0.998692150689393
HP_LUMBAR_KYPHOSIS,SET,6,-0.017811,-0.00032177,0.34084,0.52084,HP_LUMBAR_KYPHOSIS,0.998692150689393
GOBP_REGULATION_OF_LEUKOCYTE...3,SET,84,-0.0050087,-0.00033785,0.095663,0.52088,GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.998692150689393
GOBP_FIBROBLAST_ACTIVATION,SET,15,-0.013406,-0.00038283,0.25522,0.52094,GOBP_FIBROBLAST_ACTIVATION,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...239,SET,6,-0.017928,-0.00032388,0.34143,0.52094,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,0.998692150689393
GNF2_SERPINI2,SET,21,-0.011359,-0.00038374,0.21596,0.52097,GNF2_SERPINI2,0.998692150689393
GAVISH_3CA_METAPROGRAM_EPITH...17,SET,38,-0.008495,-0.00038588,0.16139,0.52099,GAVISH_3CA_METAPROGRAM_EPITHELIAL_NEUROENDOCRINE,0.998692150689393
REACTOME_BASE_EXCISION_REPAI...,SET,17,-0.010316,-0.00031361,0.19565,0.52102,REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.998692150689393
GSE36888_UNTREATED_VS_IL2_TR...3,SET,173,-0.0034387,-0.00033206,0.065161,0.52104,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN,0.998692150689393
GOBP_RNA_DECAPPING,SET,17,-0.010634,-0.00032329,0.2008,0.52112,GOBP_RNA_DECAPPING,0.998692150689393
MODULE_478,SET,18,-0.010791,-0.00033755,0.20344,0.52115,MODULE_478,0.998692150689393
GSE17974_2H_VS_72H_UNTREATED...2,SET,174,-0.0032728,-0.00031695,0.061713,0.52115,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.998692150689393
MIR2114_3P,SET,40,-0.0071868,-0.00033492,0.1354,0.52116,MIR2114_3P,0.998692150689393
GSE6259_33D1_POS_DC_VS_BCELL...1,SET,133,-0.0038455,-0.00032595,0.072464,0.52116,GSE6259_33D1_POS_DC_VS_BCELL_DN,0.998692150689393
GOBP_ESTABLISHMENT_OF_GOLGI_...,SET,6,-0.019235,-0.00034749,0.36211,0.52118,GOBP_ESTABLISHMENT_OF_GOLGI_LOCALIZATION,0.998692150689393
GOBP_RESOLUTION_OF_MEIOTIC_R...,SET,13,-0.012517,-0.00033279,0.23527,0.52121,GOBP_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES,0.998692150689393
HP_ABSENT_FACIAL_HAIR,SET,33,-0.0085308,-0.00036117,0.15979,0.52129,HP_ABSENT_FACIAL_HAIR,0.998692150689393
GSE7852_TREG_VS_TCONV_THYMUS...2,SET,182,-0.0035249,-0.00034903,0.065694,0.5214,GSE7852_TREG_VS_TCONV_THYMUS_UP,0.998692150689393
MIR202_5P,SET,103,-0.0045125,-0.00033688,0.083957,0.52143,MIR202_5P,0.998692150689393
GAVISH_3CA_METAPROGRAM_EPITH...13,SET,43,-0.0079953,-0.00038629,0.14867,0.52144,GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC,0.998692150689393
HP_CERVICAL_SPINE_INSTABILITY,SET,8,-0.018821,-0.00039259,0.3482,0.52155,HP_CERVICAL_SPINE_INSTABILITY,0.998692150689393
GOBP_CEREBROSPINAL_FLUID_CIR...,SET,9,-0.016845,-0.00037268,0.31128,0.52158,GOBP_CEREBROSPINAL_FLUID_CIRCULATION,0.998692150689393
CAIRO_LIVER_DEVELOPMENT_DN,SET,204,-0.0034115,-0.00035743,0.062921,0.52162,CAIRO_LIVER_DEVELOPMENT_DN,0.998692150689393
HP_RETINAL_ARTERIAL_TORTUOSI...,SET,3,-0.02323,-0.00029677,0.42838,0.52162,HP_RETINAL_ARTERIAL_TORTUOSITY,0.998692150689393
HHEX_TARGET_GENES,SET,825,-0.0016185,-0.00033513,0.029811,0.52165,HHEX_TARGET_GENES,0.998692150689393
WP_LNCRNAMEDIATED_MECHANISMS...,SET,6,-0.019074,-0.00034459,0.35121,0.52166,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,0.998692150689393
RHODES_UNDIFFERENTIATED_CANC...,SET,64,-0.0055243,-0.00032543,0.10159,0.52168,RHODES_UNDIFFERENTIATED_CANCER,0.998692150689393
TTF1_Q6,SET,238,-0.0031064,-0.00035121,0.05697,0.52174,TTF1_Q6,0.998692150689393
MIR933,SET,6,-0.021874,-0.00039517,0.40073,0.52177,MIR933,0.998692150689393
GCM_ACTG1,SET,109,-0.004407,-0.00033839,0.080656,0.52179,GCM_ACTG1,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...407,SET,13,-0.013137,-0.00034927,0.24027,0.5218,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.998692150689393
GOBP_REGULATION_OF_ATRIAL_CA...1,SET,9,-0.018744,-0.00041469,0.34276,0.52181,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,0.998692150689393
HP_RENAL_POTASSIUM_WASTING,SET,6,-0.021522,-0.00038882,0.39266,0.52186,HP_RENAL_POTASSIUM_WASTING,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...399,SET,214,-0.0031333,-0.00033614,0.057136,0.52187,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,0.998692150689393
GAUSSMANN_MLL_AF4_FUSION_TAR...5,SET,20,-0.011648,-0.00038403,0.21195,0.52191,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,0.998692150689393
TING_SILENCED_BY_DICER,SET,26,-0.010046,-0.00037761,0.1827,0.52193,TING_SILENCED_BY_DICER,0.998692150689393
GOMF_ADRENERGIC_RECEPTOR_ACT...,SET,10,-0.017477,-0.00040757,0.31771,0.52193,GOMF_ADRENERGIC_RECEPTOR_ACTIVITY,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...362,SET,33,-0.0079961,-0.00033853,0.14522,0.52195,GOBP_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,0.998692150689393
MIR487A_5P,SET,94,-0.004655,-0.00033206,0.084466,0.52197,MIR487A_5P,0.998692150689393
MIR487B_5P,SET,94,-0.004655,-0.00033206,0.084466,0.52197,MIR487B_5P,0.998692150689393
MIR6513_3P,SET,133,-0.0041389,-0.00035082,0.075058,0.52199,MIR6513_3P,0.998692150689393
chr6q16,SET,24,-0.018295,-0.0006607,0.3316,0.522,chr6q16,0.998692150689393
GOBP_LENS_FIBER_CELL_MORPHOG...,SET,6,-0.020895,-0.00037748,0.37877,0.522,GOBP_LENS_FIBER_CELL_MORPHOGENESIS,0.998692150689393
GOBP_CELL_MIGRATION_IN_HINDB...,SET,16,-0.011353,-0.00033485,0.20569,0.52201,GOBP_CELL_MIGRATION_IN_HINDBRAIN,0.998692150689393
GOBP_MALE_SEX_DIFFERENTIATION,SET,158,-0.0039569,-0.00036531,0.071501,0.52207,GOBP_MALE_SEX_DIFFERENTIATION,0.998692150689393
HP_APLASIA_HYPOPLASIA_INVOLV...13,SET,3,-0.032898,-0.00042028,0.59398,0.52208,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SHOULDER_MUSCULATURE,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...35,SET,6,-0.018521,-0.0003346,0.33421,0.5221,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,0.998692150689393
GOBP_PARENTAL_BEHAVIOR,SET,13,-0.015706,-0.00041756,0.28287,0.52214,GOBP_PARENTAL_BEHAVIOR,0.998692150689393
BIOCARTA_ACE2_PATHWAY,SET,9,-0.018336,-0.00040567,0.32997,0.52216,BIOCARTA_ACE2_PATHWAY,0.998692150689393
WP_NITRIC_OXIDE_METABOLISM_I...,SET,13,-0.013758,-0.00036577,0.24756,0.52216,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.998692150689393
GOBP_ARGININE_CATABOLIC_PROC...,SET,9,-0.017622,-0.00038988,0.31707,0.52216,GOBP_ARGININE_CATABOLIC_PROCESS,0.998692150689393
GOMF_INTRACELLULARLY_LIGAND_...,SET,30,-0.0087039,-0.00035137,0.15639,0.52219,GOMF_INTRACELLULARLY_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.998692150689393
GSE29618_BCELL_VS_PDC_DAY7_F...1,SET,181,-0.0036491,-0.00036035,0.065534,0.5222,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN,0.998692150689393
chr5q23,SET,35,-0.012715,-0.00055435,0.22829,0.52221,chr5q23,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...126,SET,428,-0.0024113,-0.00036367,0.043273,0.52222,GOBP_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT,0.998692150689393
HP_CEREBELLAR_DENTATE_NUCLEU...,SET,5,-0.025319,-0.00041756,0.45405,0.52223,HP_CEREBELLAR_DENTATE_NUCLEUS_CALCIFICATION,0.998692150689393
GAGCTGG_MIR337,SET,144,-0.0038375,-0.00033836,0.068683,0.52228,GAGCTGG_MIR337,0.998692150689393
HP_NARROW_NOSE,SET,21,-0.010649,-0.00035975,0.19053,0.52228,HP_NARROW_NOSE,0.998692150689393
HP_ABNORMAL_RENAL_TUBULAR_LU...,SET,5,-0.023306,-0.00038436,0.41648,0.52231,HP_ABNORMAL_RENAL_TUBULAR_LUMEN_MORPHOLOGY,0.998692150689393
WP_FATTY_ACIDS_AND_LIPOPROTE...,SET,359,-0.0025702,-0.0003557,0.045754,0.5224,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,0.998692150689393
FAN_EMBRYONIC_CTX_EX_4_EXCIT...,SET,133,-0.004238,-0.00035922,0.075373,0.52242,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.998692150689393
ZNF394_TARGET_GENES,SET,829,-0.0017086,-0.0003546,0.030336,0.52246,ZNF394_TARGET_GENES,0.998692150689393
GNF2_HPX,SET,131,-0.0043861,-0.00036899,0.07774,0.5225,GNF2_HPX,0.998692150689393
ONDER_CDH1_TARGETS_2_DN,SET,445,-0.0024952,-0.00038355,0.044114,0.52255,ONDER_CDH1_TARGETS_2_DN,0.998692150689393
GOBP_EPIGENETIC_PROGRAMMING_...1,SET,12,-0.01454,-0.00037142,0.257,0.52256,GOBP_EPIGENETIC_PROGRAMMING_IN_THE_ZYGOTIC_PRONUCLEI,0.998692150689393
MORF_CDH4,SET,115,-0.0047128,-0.00037163,0.082902,0.52267,MORF_CDH4,0.998692150689393
HP_ABNORMAL_RELATIONSHIP,SET,11,-0.015682,-0.00038354,0.27544,0.5227,HP_ABNORMAL_RELATIONSHIP,0.998692150689393
KEGG_MEDICUS_PATHOGEN_KSHV_L...,SET,7,-0.018117,-0.00035351,0.31805,0.52271,KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY,0.998692150689393
GOCC_CYTOPLASMIC_SIDE_OF_LYS...,SET,9,-0.015026,-0.00033243,0.26385,0.52271,GOCC_CYTOPLASMIC_SIDE_OF_LYSOSOMAL_MEMBRANE,0.998692150689393
GCANCTGNY_MYOD_Q6,SET,845,-0.0017502,-0.00036656,0.03068,0.52275,GCANCTGNY_MYOD_Q6,0.998692150689393
MIR3613_5P,SET,64,-0.0064362,-0.00037915,0.1125,0.52281,MIR3613_5P,0.998692150689393
BECKER_TAMOXIFEN_RESISTANCE_...1,SET,49,-0.0073467,-0.00037884,0.12826,0.52284,BECKER_TAMOXIFEN_RESISTANCE_DN,0.998692150689393
LIN_SILENCED_BY_TUMOR_MICROE...,SET,96,-0.0054175,-0.00039052,0.094491,0.52286,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,0.998692150689393
HP_ABNORMALITY_OF_THE_DISTAL...3,SET,4,-0.026812,-0.00039551,0.46755,0.52286,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_3RD_FINGER,0.998692150689393
GOBP_CELLULAR_RESPONSE_TO_L_...2,SET,11,-0.014417,-0.0003526,0.25135,0.52287,GOBP_CELLULAR_RESPONSE_TO_L_LEUCINE,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...582,SET,5,-0.022025,-0.00036323,0.38272,0.52295,GOBP_NEGATIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.998692150689393
HP_BRADYPHRENIA,SET,5,-0.020349,-0.00033559,0.35312,0.52298,HP_BRADYPHRENIA,0.998692150689393
REACTOME_FRUCTOSE_CATABOLISM,SET,5,-0.016113,-0.00026574,0.27933,0.523,REACTOME_FRUCTOSE_CATABOLISM,0.998692150689393
GOBP_REGULATION_OF_CATECHOLA...1,SET,15,-0.012981,-0.00037071,0.22507,0.523,GOBP_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,0.998692150689393
GOBP_LIMB_JOINT_MORPHOGENESIS,SET,7,-0.020236,-0.00039486,0.35011,0.52305,GOBP_LIMB_JOINT_MORPHOGENESIS,0.998692150689393
GOCC_GLYCINERGIC_SYNAPSE,SET,7,-0.020158,-0.00039334,0.34816,0.52309,GOCC_GLYCINERGIC_SYNAPSE,0.998692150689393
BIOCARTA_RAC1_PATHWAY,SET,21,-0.011432,-0.00038623,0.19717,0.52312,BIOCARTA_RAC1_PATHWAY,0.998692150689393
GOBP_MUSCLE_ADAPTATION,SET,98,-0.0053581,-0.00039022,0.092312,0.52314,GOBP_MUSCLE_ADAPTATION,0.998692150689393
HP_ARRHINENCEPHALY,SET,30,-0.0085607,-0.00034559,0.14665,0.52327,HP_ARRHINENCEPHALY,0.998692150689393
GOBP_MACROPHAGE_CYTOKINE_PRO...,SET,35,-0.0088373,-0.00038529,0.15128,0.52329,GOBP_MACROPHAGE_CYTOKINE_PRODUCTION,0.998692150689393
GSE36009_UNSTIM_VS_LPS_STIM_...1,SET,181,-0.0035721,-0.00035274,0.060984,0.52335,GSE36009_UNSTIM_VS_LPS_STIM_DC_DN,0.998692150689393
HP_LONG_NOSE,SET,32,-0.0087185,-0.00036349,0.14848,0.52341,HP_LONG_NOSE,0.998692150689393
GSE15930_STIM_VS_STIM_AND_IL...3,SET,190,-0.0039504,-0.00039958,0.067275,0.52341,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN,0.998692150689393
NOUZOVA_METHYLATED_IN_APL,SET,57,-0.0074303,-0.00041316,0.12649,0.52342,NOUZOVA_METHYLATED_IN_APL,0.998692150689393
GOBP_PYRUVATE_METABOLIC_PROC...,SET,109,-0.0046853,-0.00035976,0.079676,0.52345,GOBP_PYRUVATE_METABOLIC_PROCESS,0.998692150689393
GOBP_STRIATED_MUSCLE_TISSUE_...,SET,239,-0.0034439,-0.00039018,0.058537,0.52346,GOBP_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,0.998692150689393
KEGG_MEDICUS_PATHOGEN_HPV_E7...1,SET,6,-0.017503,-0.00031621,0.29666,0.52352,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_CELL_CYCLE_G1_S,0.998692150689393
GSE5589_IL6_KO_VS_IL10_KO_LP...2,SET,179,-0.0036779,-0.0003612,0.062205,0.52357,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.998692150689393
MODULE_154,SET,67,-0.0065512,-0.00039483,0.11075,0.52358,MODULE_154,0.998692150689393
REACTOME_REGULATION_OF_HSF1_...,SET,77,-0.0055097,-0.00035589,0.092818,0.52367,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,0.998692150689393
GSE360_L_DONOVANI_VS_B_MALAY...6,SET,177,-0.0040054,-0.00039119,0.067464,0.52367,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP,0.998692150689393
GOBP_ACTIVATION_OF_IMMUNE_RE...,SET,485,-0.0023771,-0.00038103,0.039978,0.52371,GOBP_ACTIVATION_OF_IMMUNE_RESPONSE,0.998692150689393
HP_LICHENIFICATION,SET,15,-0.013067,-0.00037315,0.21957,0.52373,HP_LICHENIFICATION,0.998692150689393
WP_SPHINGOLIPID_METABOLISM_I...2,SET,27,-0.010363,-0.00039691,0.17382,0.52377,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.998692150689393
GSE17721_LPS_VS_CPG_12H_BMDC...2,SET,177,-0.0039305,-0.00038387,0.065914,0.52378,GSE17721_LPS_VS_CPG_12H_BMDC_UP,0.998692150689393
GOMF_MICROFIBRIL_BINDING,SET,6,-0.025103,-0.00045351,0.42072,0.52379,GOMF_MICROFIBRIL_BINDING,0.998692150689393
GSE42724_MEMORY_BCELL_VS_PLA...1,SET,175,-0.0037007,-0.00035939,0.062024,0.52379,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN,0.998692150689393
FUNG_IL2_TARGETS_WITH_STAT5_...1,SET,6,-0.022548,-0.00040735,0.37733,0.52382,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES,0.998692150689393
HP_ABNORMAL_SCAPULA_MORPHOLO...,SET,159,-0.0039529,-0.00036608,0.066102,0.52384,HP_ABNORMAL_SCAPULA_MORPHOLOGY,0.998692150689393
GOBP_REGULATION_OF_SECONDARY...2,SET,15,-0.013944,-0.00039819,0.23292,0.52387,GOBP_REGULATION_OF_SECONDARY_METABOLIC_PROCESS,0.998692150689393
GOBP_DORSAL_AORTA_MORPHOGENE...,SET,8,-0.020399,-0.0004255,0.34061,0.52388,GOBP_DORSAL_AORTA_MORPHOGENESIS,0.998692150689393
GSE39820_CTRL_VS_TGFBETA3_IL...1,SET,182,-0.0037974,-0.00037602,0.06339,0.52388,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN,0.998692150689393
GOBP_MODIFICATION_OF_SYNAPTI...,SET,26,-0.0097679,-0.00036714,0.163,0.52389,GOBP_MODIFICATION_OF_SYNAPTIC_STRUCTURE,0.998692150689393
HP_PRIMITIVE_NEUROECTODERMAL...,SET,68,-0.0063186,-0.00038364,0.10533,0.52392,HP_PRIMITIVE_NEUROECTODERMAL_TUMOR,0.998692150689393
HP_RELATIVE_MACROCEPHALY,SET,52,-0.0070298,-0.0003734,0.11697,0.52396,HP_RELATIVE_MACROCEPHALY,0.998692150689393
GOCC_PIP_BODY,SET,5,-0.018543,-0.00030581,0.30836,0.52398,GOCC_PIP_BODY,0.998692150689393
GSE2585_CD80_HIGH_VS_LOW_AIR...1,SET,183,-0.0039316,-0.00039036,0.065372,0.52398,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN,0.998692150689393
MIR3679_3P,SET,145,-0.0042949,-0.00037998,0.071361,0.524,MIR3679_3P,0.998692150689393
MIR7_1_3P,SET,593,-0.0022431,-0.00039638,0.037241,0.52401,MIR7_1_3P,0.998692150689393
GRADE_COLON_VS_RECTAL_CANCER...1,SET,46,-0.007466,-0.00037305,0.12393,0.52402,GRADE_COLON_VS_RECTAL_CANCER_DN,0.998692150689393
MIR193A_3P_MIR193B_3P,SET,79,-0.0059863,-0.00039164,0.099282,0.52404,MIR193A_3P_MIR193B_3P,0.998692150689393
GOBP_RESPONSE_TO_RAPAMYCIN,SET,4,-0.026376,-0.00038908,0.43706,0.52406,GOBP_RESPONSE_TO_RAPAMYCIN,0.998692150689393
GSE25890_CTRL_VS_IL33_IL7_TR...1,SET,185,-0.0037724,-0.00037658,0.062333,0.52413,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN,0.998692150689393
GAUTAM_EYE_CORNEA_ELF3_HIGH_...,SET,134,-0.0045408,-0.00038632,0.075023,0.52413,GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS,0.998692150689393
chr14q24,SET,107,-0.010712,-0.00081496,0.17683,0.52415,chr14q24,0.998692150689393
WP_PENTOSE_PHOSPHATE_METABOL...,SET,6,-0.022569,-0.00040773,0.37259,0.52415,WP_PENTOSE_PHOSPHATE_METABOLISM,0.998692150689393
MATZUK_FERTILIZATION,SET,7,-0.019192,-0.00037449,0.31613,0.5242,MATZUK_FERTILIZATION,0.998692150689393
GSE11864_CSF1_IFNG_VS_CSF1_I...2,SET,174,-0.0039719,-0.00038464,0.065437,0.5242,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.998692150689393
HP_TETRAPARESIS,SET,101,-0.005199,-0.00038436,0.085606,0.52421,HP_TETRAPARESIS,0.998692150689393
GOBP_NADPH_REGENERATION,SET,21,-0.011777,-0.00039788,0.19387,0.52422,GOBP_NADPH_REGENERATION,0.998692150689393
MIR4499,SET,103,-0.0052673,-0.00039322,0.086543,0.52427,MIR4499,0.998692150689393
GOBP_CYTOPLASMIC_PATTERN_REC...,SET,148,-0.0042043,-0.00037577,0.06888,0.52434,GOBP_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.998692150689393
GSE21774_CD62L_POS_CD56_DIM_...2,SET,183,-0.0039989,-0.00039705,0.065447,0.52436,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,0.998692150689393
GOBP_REGULATION_OF_PROTEIN_D...1,SET,25,-0.0096117,-0.00035426,0.15709,0.52439,GOBP_REGULATION_OF_PROTEIN_DEACETYLATION,0.998692150689393
MANNO_MIDBRAIN_NEUROTYPES_HN...2,SET,262,-0.0034129,-0.00040459,0.055742,0.52441,MANNO_MIDBRAIN_NEUROTYPES_HNBM,0.998692150689393
AGTGCGT_MIR521,SET,6,-0.019882,-0.00035918,0.3245,0.52443,AGTGCGT_MIR521,0.998692150689393
SCHRAETS_MLL_TARGETS_DN,SET,32,-0.010418,-0.00043434,0.16997,0.52444,SCHRAETS_MLL_TARGETS_DN,0.998692150689393
HP_ABNORMALITY_OF_MUSCLE_SIZE,SET,635,-0.0021118,-0.00038571,0.034417,0.52446,HP_ABNORMALITY_OF_MUSCLE_SIZE,0.998692150689393
HP_APPENDICULAR_HYPOTONIA,SET,16,-0.011269,-0.00033236,0.18338,0.5245,HP_APPENDICULAR_HYPOTONIA,0.998692150689393
SOBOLEV_PBMC_PANDEMRIX_AGE_1...7,SET,4,-0.024546,-0.00036209,0.39939,0.5245,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN,0.998692150689393
GOBP_REGULATION_OF_APOPTOTIC...1,SET,8,-0.018843,-0.00039306,0.30631,0.52453,GOBP_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,0.998692150689393
HP_ABNORMAL_MUSCLE_FIBER_MOR...,SET,234,-0.0033032,-0.00037035,0.053654,0.52455,HP_ABNORMAL_MUSCLE_FIBER_MORPHOLOGY,0.998692150689393
BIOCARTA_TPO_PATHWAY,SET,24,-0.011231,-0.00040559,0.18204,0.5246,BIOCARTA_TPO_PATHWAY,0.998692150689393
ATF2_S_UP.V1_UP,SET,174,-0.004272,-0.00041371,0.069149,0.52463,ATF2_S_UP.V1_UP,0.998692150689393
GOBP_TRANSEPITHELIAL_TRANSPO...,SET,35,-0.0097679,-0.00042587,0.15785,0.52467,GOBP_TRANSEPITHELIAL_TRANSPORT,0.998692150689393
KEGG_MEDICUS_VARIANT_AMPLIFI...13,SET,15,-0.012394,-0.00035395,0.19953,0.52477,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S,0.998692150689393
MIR4778_3P,SET,230,-0.0036309,-0.00040364,0.058425,0.52478,MIR4778_3P,0.998692150689393
MIR596,SET,29,-0.0099236,-0.00039389,0.15942,0.52482,MIR596,0.998692150689393
GOBP_CARDIAC_VASCULAR_SMOOTH...,SET,8,-0.02154,-0.0004493,0.34531,0.52487,GOBP_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.998692150689393
MIR570_3P,SET,686,-0.0020964,-0.00039739,0.033588,0.52488,MIR570_3P,0.998692150689393
HP_WIDE_ANTERIOR_FONTANEL,SET,80,-0.0060234,-0.00039655,0.096385,0.52491,HP_WIDE_ANTERIOR_FONTANEL,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...459,SET,1307,-0.0015327,-0.00039393,0.024516,0.52492,GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...550,SET,12,-0.014818,-0.00037853,0.2368,0.52495,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.998692150689393
GSE17721_LPS_VS_CPG_4H_BMDC_...1,SET,173,-0.0039626,-0.00038265,0.063301,0.52496,GSE17721_LPS_VS_CPG_4H_BMDC_DN,0.998692150689393
MIR4741,SET,41,-0.0080281,-0.00037877,0.12818,0.52497,MIR4741,0.998692150689393
GOMF_TRNA_CYTIDINE_METHYLTRA...,SET,9,-0.016069,-0.0003555,0.25616,0.52501,GOMF_TRNA_CYTIDINE_METHYLTRANSFERASE_ACTIVITY,0.998692150689393
MANNO_MIDBRAIN_NEUROTYPES_HN...1,SET,619,-0.002347,-0.00042342,0.037403,0.52502,MANNO_MIDBRAIN_NEUROTYPES_HNBGABA,0.998692150689393
GOBP_REGULATION_OF_CILIUM_DE...,SET,27,-0.010558,-0.00040438,0.16785,0.52508,GOBP_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY,0.998692150689393
HP_ABNORMAL_UVULA_MORPHOLOGY,SET,168,-0.00409,-0.00038925,0.064982,0.52509,HP_ABNORMAL_UVULA_MORPHOLOGY,0.998692150689393
GOBP_BLASTOCYST_FORMATION,SET,45,-0.007902,-0.00039054,0.12553,0.5251,GOBP_BLASTOCYST_FORMATION,0.998692150689393
GOBP_REGULATION_OF_NITRIC_OX...2,SET,55,-0.0078655,-0.00042964,0.1249,0.52511,GOBP_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.998692150689393
MIR6833_5P,SET,119,-0.0051227,-0.00041088,0.081279,0.52513,MIR6833_5P,0.998692150689393
HP_VOLVULUS,SET,13,-0.014502,-0.00038557,0.23011,0.52513,HP_VOLVULUS,0.998692150689393
PID_REELIN_PATHWAY,SET,28,-0.010766,-0.00041992,0.16993,0.52526,PID_REELIN_PATHWAY,0.998692150689393
MIR6777_5P,SET,5,-0.026387,-0.00043517,0.41641,0.52526,MIR6777_5P,0.998692150689393
HP_SCAPHOCEPHALY,SET,38,-0.0086805,-0.00039431,0.13686,0.52529,HP_SCAPHOCEPHALY,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...480,SET,5,-0.02737,-0.00045139,0.43133,0.5253,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.998692150689393
GOBP_PENILE_ERECTION,SET,7,-0.025313,-0.00049392,0.39869,0.52531,GOBP_PENILE_ERECTION,0.998692150689393
GOMF_PEPTIDE_LYSINE_N_ACETYL...,SET,43,-0.0075121,-0.00036294,0.11822,0.52533,GOMF_PEPTIDE_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY,0.998692150689393
GOBP_MYOBLAST_FUSION,SET,44,-0.0087488,-0.00042757,0.13762,0.52534,GOBP_MYOBLAST_FUSION,0.998692150689393
REACTOME_HDR_THROUGH_MMEJ_AL...,SET,11,-0.015399,-0.00037662,0.24202,0.52537,REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ,0.998692150689393
GSE17721_LPS_VS_GARDIQUIMOD_...7,SET,181,-0.0039931,-0.00039432,0.062629,0.52542,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN,0.998692150689393
MIR6871_3P,SET,116,-0.0053355,-0.00042255,0.08364,0.52543,MIR6871_3P,0.998692150689393
MODULE_333,SET,27,-0.0099084,-0.00037951,0.15495,0.52549,MODULE_333,0.998692150689393
GOBP_NON_PROTEINOGENIC_AMINO...2,SET,14,-0.015987,-0.00044109,0.24961,0.52553,GOBP_NON_PROTEINOGENIC_AMINO_ACID_CATABOLIC_PROCESS,0.998692150689393
GOBP_REGULATION_OF_RNA_POLYM...2,SET,6,-0.022318,-0.00040319,0.34824,0.52555,GOBP_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,0.998692150689393
BUSSLINGER_DUODENAL_TUFT_CEL...,SET,71,-0.0073954,-0.00045878,0.11494,0.52565,BUSSLINGER_DUODENAL_TUFT_CELLS,0.998692150689393
GOCC_UBIQUITIN_LIGASE_COMPLEX,SET,281,-0.0032268,-0.00039594,0.050078,0.52569,GOCC_UBIQUITIN_LIGASE_COMPLEX,0.998692150689393
GSE17186_NAIVE_VS_CD21HIGH_T...3,SET,179,-0.0041315,-0.00040575,0.064126,0.52569,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.998692150689393
HP_OLIGOSACCHARIDURIA,SET,9,-0.017779,-0.00039336,0.27582,0.5257,HP_OLIGOSACCHARIDURIA,0.998692150689393
MIR7_2_3P,SET,591,-0.0024087,-0.00042494,0.03729,0.52575,MIR7_2_3P,0.998692150689393
GOBP_POST_EMBRYONIC_CAMERA_T...,SET,8,-0.022336,-0.0004659,0.3453,0.52579,GOBP_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.998692150689393
GOBP_PROTEIN_POLYUFMYLATION,SET,5,-0.022781,-0.0003757,0.35195,0.5258,GOBP_PROTEIN_POLYUFMYLATION,0.998692150689393
GOMF_C_ACYLTRANSFERASE_ACTIV...,SET,19,-0.013263,-0.00042623,0.20415,0.5259,GOMF_C_ACYLTRANSFERASE_ACTIVITY,0.998692150689393
GSE43955_TH0_VS_TGFB_IL6_TH1...2,SET,184,-0.0041957,-0.00041771,0.064559,0.52591,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP,0.998692150689393
BIOCARTA_PYK2_PATHWAY,SET,27,-0.010892,-0.00041717,0.16754,0.52592,BIOCARTA_PYK2_PATHWAY,0.998692150689393
GNF2_DAP3,SET,105,-0.0050138,-0.0003779,0.077069,0.52594,GNF2_DAP3,0.998692150689393
GOBP_NEGATIVE_REGULATION_OF_...253,SET,16,-0.01414,-0.00041703,0.21727,0.52594,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.998692150689393
GOBP_RNA_TEMPLATED_DNA_BIOSY...,SET,66,-0.0063608,-0.0003805,0.097515,0.526,GOBP_RNA_TEMPLATED_DNA_BIOSYNTHETIC_PROCESS,0.998692150689393
REACTOME_DEPOLYMERIZATION_OF...,SET,14,-0.014783,-0.00040787,0.22568,0.52611,REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA,0.998692150689393
chr2q37,SET,107,-0.010264,-0.00078088,0.15644,0.52616,chr2q37,0.998692150689393
GOBP_PROTEIN_LOCALIZATION_TO...31,SET,37,-0.0086737,-0.00038879,0.13185,0.52622,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE_ORGANIZING_CENTER,0.998692150689393
HP_LAGOPHTHALMOS,SET,12,-0.014864,-0.00037969,0.22599,0.52622,HP_LAGOPHTHALMOS,0.998692150689393
LEE_LIVER_CANCER_MYC_TGFA_UP,SET,58,-0.0081244,-0.00045569,0.12327,0.52627,LEE_LIVER_CANCER_MYC_TGFA_UP,0.998692150689393
GOBP_HEPATOCYTE_GROWTH_FACTO...,SET,11,-0.018557,-0.00045386,0.28152,0.52628,GOBP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.998692150689393
HP_ABNORMALITY_OF_SOMATOSENS...,SET,14,-0.0159,-0.00043867,0.24105,0.5263,HP_ABNORMALITY_OF_SOMATOSENSORY_EVOKED_POTENTIALS,0.998692150689393
HP_NEUROENDOCRINE_NEOPLASM,SET,37,-0.0088222,-0.00039545,0.13369,0.52631,HP_NEUROENDOCRINE_NEOPLASM,0.998692150689393
MIR4676_5P,SET,51,-0.0075942,-0.0003995,0.115,0.52632,MIR4676_5P,0.998692150689393
HP_METRORRHAGIA,SET,15,-0.015347,-0.00043828,0.23181,0.52639,HP_METRORRHAGIA,0.998692150689393
GOBP_PURINE_NUCLEOTIDE_SALVA...,SET,10,-0.019092,-0.00044522,0.28829,0.5264,GOBP_PURINE_NUCLEOTIDE_SALVAGE,0.998692150689393
HP_SPARSE_MEDIAL_EYEBROW,SET,5,-0.023022,-0.00037967,0.34769,0.5264,HP_SPARSE_MEDIAL_EYEBROW,0.998692150689393
GSE42021_TREG_PLN_VS_CD24INT...1,SET,184,-0.0043359,-0.00043168,0.065459,0.52641,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN,0.998692150689393
GOBP_REGULATION_OF_MYELOID_C...1,SET,29,-0.010384,-0.00041215,0.15669,0.52642,GOBP_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.998692150689393
SWEET_KRAS_ONCOGENIC_SIGNATU...,SET,82,-0.0063091,-0.00042049,0.095153,0.52643,SWEET_KRAS_ONCOGENIC_SIGNATURE,0.998692150689393
WP_LEUKOCYTEINTRINSIC_HIPPO_...,SET,30,-0.010606,-0.00042816,0.15988,0.52644,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,0.998692150689393
GSE15330_LYMPHOID_MULTIPOTEN...2,SET,187,-0.0041263,-0.0004141,0.062092,0.52649,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...644,SET,5,-0.023011,-0.00037951,0.34619,0.5265,GOBP_POSITIVE_REGULATION_OF_PROTEIN_NEDDYLATION,0.998692150689393
GOBP_L_LEUCINE_IMPORT_ACROSS...,SET,5,-0.026382,-0.0004351,0.39653,0.52652,GOBP_L_LEUCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.998692150689393
HP_DESMOID_TUMORS,SET,6,-0.025287,-0.00045684,0.3801,0.52652,HP_DESMOID_TUMORS,0.998692150689393
KEGG_MEDICUS_PATHOGEN_SALMON...3,SET,8,-0.018072,-0.00037697,0.27152,0.52653,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,0.998692150689393
HP_ABNORMAL_ARTERIAL_PHYSIOL...,SET,154,-0.0048479,-0.00044191,0.072854,0.52653,HP_ABNORMAL_ARTERIAL_PHYSIOLOGY,0.998692150689393
REACTOME_INTERLEUKIN_10_SIGN...,SET,43,-0.0097587,-0.00047149,0.1465,0.52656,REACTOME_INTERLEUKIN_10_SIGNALING,0.998692150689393
HP_TOENAIL_DYSPLASIA,SET,15,-0.016433,-0.00046929,0.24665,0.52656,HP_TOENAIL_DYSPLASIA,0.998692150689393
HOOI_ST7_TARGETS_DN,SET,95,-0.0063667,-0.00045657,0.095534,0.52657,HOOI_ST7_TARGETS_DN,0.998692150689393
MIR7844_5P,SET,139,-0.0048767,-0.00042251,0.073076,0.5266,MIR7844_5P,0.998692150689393
REACTOME_REGULATION_OF_MITF_...2,SET,17,-0.013186,-0.00040084,0.19746,0.52662,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION,0.998692150689393
GOBP_KERATINIZATION,SET,72,-0.008384,-0.00052374,0.12542,0.52665,GOBP_KERATINIZATION,0.998692150689393
GSE17974_0H_VS_2H_IN_VITRO_A...1,SET,177,-0.0041802,-0.00040826,0.062517,0.52665,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN,0.998692150689393
KEGG_MEDICUS_REFERENCE_E2_ER...,SET,22,-0.011749,-0.00040627,0.17498,0.52677,KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY,0.998692150689393
MIR1343_3P,SET,144,-0.0048291,-0.00042578,0.071905,0.52677,MIR1343_3P,0.998692150689393
GOBP_REGULATION_OF_PHOSPHOPR...,SET,38,-0.0091232,-0.00041442,0.13588,0.52677,GOBP_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.998692150689393
GOBP_NATURAL_KILLER_CELL_MED...1,SET,9,-0.020157,-0.00044595,0.29995,0.52679,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.998692150689393
KAPOSI_LIVER_CANCER_MET_UP,SET,18,-0.012531,-0.00039198,0.18614,0.52684,KAPOSI_LIVER_CANCER_MET_UP,0.998692150689393
GOBP_REGULATION_OF_POSTSYNAP...1,SET,6,-0.029633,-0.00053534,0.44019,0.52684,GOBP_REGULATION_OF_POSTSYNAPSE_ASSEMBLY,0.998692150689393
HP_ATRIAL_FIBRILLATION,SET,79,-0.0072572,-0.00047479,0.10752,0.52691,HP_ATRIAL_FIBRILLATION,0.998692150689393
SPIRA_SMOKERS_LUNG_CANCER_UP,SET,36,-0.0099555,-0.00044019,0.14736,0.52693,SPIRA_SMOKERS_LUNG_CANCER_UP,0.998692150689393
GOBP_MUSCLE_CONTRACTION,SET,328,-0.003324,-0.00044009,0.049172,0.52695,GOBP_MUSCLE_CONTRACTION,0.998692150689393
GOBP_PEPTIDYL_AMINO_ACID_MOD...,SET,763,-0.0021433,-0.00042755,0.031673,0.52697,GOBP_PEPTIDYL_AMINO_ACID_MODIFICATION,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...615,SET,32,-0.010274,-0.00042832,0.15151,0.52703,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.998692150689393
LAKE_ADULT_KIDNEY_C25_ENDOTH...,SET,37,-0.010812,-0.00048462,0.15942,0.52703,LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED,0.998692150689393
VERRECCHIA_RESPONSE_TO_TGFB1...3,SET,14,-0.01617,-0.00044612,0.23826,0.52705,VERRECCHIA_RESPONSE_TO_TGFB1_C3,0.998692150689393
GOBP_PURINE_NUCLEOSIDE_TRIPH...,SET,5,-0.025758,-0.0004248,0.37964,0.52705,GOBP_PURINE_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,0.998692150689393
MIR6770_5P,SET,170,-0.004471,-0.00042802,0.065835,0.52707,MIR6770_5P,0.998692150689393
WNT_UP.V1_DN,SET,160,-0.0049552,-0.00046034,0.072932,0.52708,WNT_UP.V1_DN,0.998692150689393
HP_INTERVERTEBRAL_SPACE_NARR...,SET,6,-0.024445,-0.00044162,0.35977,0.52709,HP_INTERVERTEBRAL_SPACE_NARROWING,0.998692150689393
REACTOME_O_GLYCOSYLATION_OF_...,SET,36,-0.010877,-0.00048092,0.16002,0.5271,REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS,0.998692150689393
BIOCARTA_GCR_PATHWAY,SET,17,-0.015279,-0.00046448,0.22457,0.52712,BIOCARTA_GCR_PATHWAY,0.998692150689393
GOCC_MICROBODY_LUMEN,SET,50,-0.0082823,-0.00043141,0.12176,0.52712,GOCC_MICROBODY_LUMEN,0.998692150689393
GSE36078_WT_VS_IL1R_KO_LUNG_...6,SET,183,-0.0043245,-0.00042938,0.063573,0.52712,GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP,0.998692150689393
GSE9946_LISTERIA_INF_MATURE_...2,SET,123,-0.0050742,-0.00041372,0.074581,0.52712,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.998692150689393
GSE16450_IMMATURE_VS_MATURE_...1,SET,180,-0.0043023,-0.00042369,0.063192,0.52714,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.998692150689393
HOLLEMAN_ASPARAGINASE_RESIST...3,SET,12,-0.015108,-0.00038592,0.22148,0.52719,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,0.998692150689393
BUSSLINGER_GASTRIC_ANTRAL_ECS,SET,10,-0.021412,-0.00049932,0.31368,0.52721,BUSSLINGER_GASTRIC_ANTRAL_ECS,0.998692150689393
GSE13887_RESTING_VS_ACT_CD4_...2,SET,94,-0.0060027,-0.0004282,0.087814,0.52725,GSE13887_RESTING_VS_ACT_CD4_TCELL_UP,0.998692150689393
JIANG_MELANOMA_TRM1_CD8,SET,152,-0.0050498,-0.00045735,0.073819,0.52727,JIANG_MELANOMA_TRM1_CD8,0.998692150689393
GOMF_PROLINE_SODIUM_SYMPORTE...,SET,5,-0.032951,-0.00054344,0.48116,0.5273,GOMF_PROLINE_SODIUM_SYMPORTER_ACTIVITY,0.998692150689393
GSE360_DC_VS_MAC_B_MALAYI_LO...1,SET,176,-0.0043577,-0.0004244,0.063628,0.5273,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN,0.998692150689393
WP_CANCER_IMMUNOTHERAPY_BY_C...,SET,12,-0.018472,-0.00047187,0.26931,0.52734,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,0.998692150689393
NFXL1_TARGET_GENES,SET,341,-0.0032458,-0.00043801,0.04731,0.52735,NFXL1_TARGET_GENES,0.998692150689393
GSE17721_LPS_VS_POLYIC_16H_B...2,SET,176,-0.0042534,-0.00041424,0.061756,0.52745,GSE17721_LPS_VS_POLYIC_16H_BMDC_UP,0.998692150689393
GSE29617_CTRL_VS_TIV_FLU_VAC...1,SET,171,-0.0043844,-0.00042094,0.0636,0.52748,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN,0.998692150689393
PPARA_TARGET_GENES,SET,55,-0.0074466,-0.00040676,0.10796,0.5275,PPARA_TARGET_GENES,0.998692150689393
GSE25123_IL4_VS_IL4_AND_ROSI...4,SET,125,-0.0051684,-0.0004248,0.074893,0.52751,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.998692150689393
HP_ABNORMALITY_OF_THE_GLENOI...,SET,6,-0.026643,-0.00048133,0.38533,0.52756,HP_ABNORMALITY_OF_THE_GLENOID_FOSSA,0.998692150689393
REACTOME_POTENTIAL_THERAPEUT...,SET,92,-0.0060021,-0.00042361,0.086705,0.52759,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,0.998692150689393
GOCC_CYTOPLASMIC_SIDE_OF_END...2,SET,6,-0.019084,-0.00034476,0.27518,0.52764,GOCC_CYTOPLASMIC_SIDE_OF_ENDOSOME_MEMBRANE,0.998692150689393
GOBP_ARGININE_BIOSYNTHETIC_P...,SET,4,-0.026372,-0.00038903,0.37918,0.52772,GOBP_ARGININE_BIOSYNTHETIC_PROCESS,0.998692150689393
GOBP_EYE_PHOTORECEPTOR_CELL_...1,SET,36,-0.010587,-0.00046812,0.15222,0.52772,GOBP_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT,0.998692150689393
BROWNE_HCMV_INFECTION_10HR_UP,SET,90,-0.0060965,-0.00042559,0.087616,0.52774,BROWNE_HCMV_INFECTION_10HR_UP,0.998692150689393
KEGG_MEDICUS_REFERENCE_LECTI...2,SET,8,-0.023685,-0.00049406,0.33983,0.52778,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...524,SET,37,-0.010333,-0.00046317,0.14826,0.52778,GOBP_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.998692150689393
JIANG_AGING_HYPOTHALAMUS_DN,SET,31,-0.010428,-0.00042792,0.14914,0.52787,JIANG_AGING_HYPOTHALAMUS_DN,0.998692150689393
PID_CXCR3_PATHWAY,SET,42,-0.0098715,-0.00047137,0.14111,0.52788,PID_CXCR3_PATHWAY,0.998692150689393
WIERENGA_PML_INTERACTOME,SET,38,-0.0092594,-0.00042061,0.1323,0.5279,WIERENGA_PML_INTERACTOME,0.998692150689393
FULLER_PBMC_F_TULARENSIS_VAC...8,SET,30,-0.012293,-0.00049626,0.17521,0.52797,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_DN,0.998692150689393
WP_GASTRIC_ACID_PRODUCTION,SET,8,-0.023409,-0.00048829,0.33339,0.52799,WP_GASTRIC_ACID_PRODUCTION,0.998692150689393
GOBP_POSTSYNAPSE_ASSEMBLY,SET,41,-0.0098986,-0.00046702,0.14082,0.52802,GOBP_POSTSYNAPSE_ASSEMBLY,0.998692150689393
WP_ANGIOGENESIS,SET,24,-0.012884,-0.00046529,0.18272,0.52811,WP_ANGIOGENESIS,0.998692150689393
GOMF_3_5_EXONUCLEASE_ACTIVITY,SET,56,-0.0075275,-0.00041489,0.10672,0.52812,GOMF_3_5_EXONUCLEASE_ACTIVITY,0.998692150689393
ATCATGA_MIR433,SET,107,-0.0058001,-0.00044127,0.082184,0.52813,ATCATGA_MIR433,0.998692150689393
HP_FACIAL_SHAPE_DEFORMATION,SET,14,-0.018138,-0.00050042,0.25699,0.52813,HP_FACIAL_SHAPE_DEFORMATION,0.998692150689393
GOBP_INTRACELLULAR_MONOATOMI...,SET,10,-0.020644,-0.00048143,0.29232,0.52815,GOBP_INTRACELLULAR_MONOATOMIC_ANION_HOMEOSTASIS,0.998692150689393
TOMLINS_METASTASIS_DN,SET,18,-0.014106,-0.00044125,0.1996,0.52817,TOMLINS_METASTASIS_DN,0.998692150689393
HP_PNEUMOCYSTIS_JIROVECII_PN...,SET,3,-0.031198,-0.00039856,0.44148,0.52817,HP_PNEUMOCYSTIS_JIROVECII_PNEUMONIA,0.998692150689393
REACTOME_SARS_COV_1_HOST_INT...,SET,85,-0.0064388,-0.00043687,0.090997,0.5282,REACTOME_SARS_COV_1_HOST_INTERACTIONS,0.998692150689393
WP_MFAP5_EFFECT_ON_PERMEABIL...,SET,17,-0.015358,-0.00046689,0.21701,0.52821,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,0.998692150689393
AKT_UP_MTOR_DN.V1_UP,SET,166,-0.0048823,-0.00046191,0.068932,0.52823,AKT_UP_MTOR_DN.V1_UP,0.998692150689393
GOMF_SODIUM_CHANNEL_INHIBITO...,SET,8,-0.024762,-0.00051653,0.34921,0.52826,GOMF_SODIUM_CHANNEL_INHIBITOR_ACTIVITY,0.998692150689393
PID_FAS_PATHWAY,SET,36,-0.01083,-0.00047885,0.15256,0.5283,PID_FAS_PATHWAY,0.998692150689393
GOBP_T_CELL_DIFFERENTIATION,SET,297,-0.0036758,-0.00046349,0.051763,0.52831,GOBP_T_CELL_DIFFERENTIATION,0.998692150689393
KEGG_MEDICUS_VARIANT_MUTATIO...26,SET,23,-0.013885,-0.0004909,0.1951,0.52837,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.998692150689393
VERHAAK_GLIOBLASTOMA_CLASSIC...,SET,152,-0.0052127,-0.0004721,0.07321,0.52838,VERHAAK_GLIOBLASTOMA_CLASSICAL,0.998692150689393
HP_BILATERAL_COXA_VALGA,SET,13,-0.019895,-0.00052894,0.2789,0.52843,HP_BILATERAL_COXA_VALGA,0.998692150689393
HP_TRUE_HERMAPHRODITISM,SET,20,-0.012224,-0.00040304,0.17131,0.52844,HP_TRUE_HERMAPHRODITISM,0.998692150689393
HP_ABNORMAL_HYPOTHALAMUS_MOR...,SET,19,-0.01276,-0.00041007,0.17852,0.52849,HP_ABNORMAL_HYPOTHALAMUS_MORPHOLOGY,0.998692150689393
GOBP_MAMMARY_GLAND_MORPHOGEN...,SET,44,-0.010143,-0.00049569,0.14171,0.52853,GOBP_MAMMARY_GLAND_MORPHOGENESIS,0.998692150689393
GSE12845_IGD_NEG_BLOOD_VS_NA...2,SET,173,-0.0044489,-0.0004296,0.062131,0.52854,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,0.998692150689393
GOMF_KINASE_REGULATOR_ACTIVI...,SET,253,-0.0038923,-0.00045354,0.054343,0.52855,GOMF_KINASE_REGULATOR_ACTIVITY,0.998692150689393
BIOCARTA_MTOR_PATHWAY,SET,21,-0.014116,-0.0004769,0.19656,0.52862,BIOCARTA_MTOR_PATHWAY,0.998692150689393
SCHAEFFER_PROSTATE_DEVELOPME...9,SET,7,-0.023945,-0.00046723,0.33299,0.52866,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN,0.998692150689393
GSE46606_DAY1_VS_DAY3_CD40L_...4,SET,186,-0.0043116,-0.00043155,0.05972,0.52878,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP,0.998692150689393
REACTOME_INFLAMMASOMES,SET,19,-0.013677,-0.00043953,0.18923,0.52881,REACTOME_INFLAMMASOMES,0.998692150689393
GSE11057_NAIVE_CD4_VS_PBMC_C...1,SET,186,-0.004584,-0.00045882,0.063422,0.52881,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN,0.998692150689393
HP_ABNORMAL_ANTERIOR_CHAMBER...,SET,54,-0.0090285,-0.00048868,0.12488,0.52882,HP_ABNORMAL_ANTERIOR_CHAMBER_MORPHOLOGY,0.998692150689393
GOMF_ACETYLTRANSFERASE_ACTIV...,SET,88,-0.006051,-0.00041771,0.083648,0.52883,GOMF_ACETYLTRANSFERASE_ACTIVITY,0.998692150689393
GOMF_ALKALINE_PHOSPHATASE_AC...,SET,5,-0.035032,-0.00057776,0.48418,0.52884,GOMF_ALKALINE_PHOSPHATASE_ACTIVITY,0.998692150689393
GSE8685_IL2_STARVED_VS_IL2_A...1,SET,177,-0.0045819,-0.00044749,0.063324,0.52884,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN,0.998692150689393
JINESH_BLEBBISHIELD_TO_IMMUN...1,SET,343,-0.0035955,-0.00048659,0.049659,0.52886,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,0.998692150689393
GSE3982_BASOPHIL_VS_TH2_DN,SET,180,-0.0045817,-0.0004512,0.06328,0.52886,GSE3982_BASOPHIL_VS_TH2_DN,0.998692150689393
GSE18791_UNSTIM_VS_NEWCATSLE...7,SET,140,-0.0052067,-0.0004527,0.07187,0.52888,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN,0.998692150689393
HP_DISTAL_LOWER_LIMB_MUSCLE_...,SET,84,-0.0069074,-0.00046592,0.09526,0.5289,HP_DISTAL_LOWER_LIMB_MUSCLE_WEAKNESS,0.998692150689393
OVOL3_TARGET_GENES,SET,392,-0.0031068,-0.00044888,0.042837,0.52891,OVOL3_TARGET_GENES,0.998692150689393
GSE42021_TREG_PLN_VS_TREG_PR...2,SET,175,-0.0047501,-0.00046131,0.065433,0.52894,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP,0.998692150689393
HP_ACETABULAR_SPURS,SET,5,-0.028577,-0.00047129,0.39276,0.529,HP_ACETABULAR_SPURS,0.998692150689393
RTAAACA_FREAC2_01,SET,845,-0.0023048,-0.00048273,0.031668,0.52901,RTAAACA_FREAC2_01,0.998692150689393
REACTOME_TICAM1_RIP1_MEDIATE...,SET,17,-0.016296,-0.0004954,0.22381,0.52902,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,0.998692150689393
GSE7348_UNSTIM_VS_LPS_STIM_M...2,SET,141,-0.0050046,-0.00043668,0.068711,0.52903,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.998692150689393
GOBP_CELL_MIGRATION_INVOLVED...4,SET,5,-0.03488,-0.00057524,0.47871,0.52904,GOBP_CELL_MIGRATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.998692150689393
GOBP_CELLULAR_RESPONSE_TO_MO...,SET,209,-0.0046097,-0.00048878,0.063216,0.52906,GOBP_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.998692150689393
MIR10523_5P,SET,216,-0.0043736,-0.00047135,0.059963,0.52907,MIR10523_5P,0.998692150689393
WP_ACTIVATION_OF_NLRP3_INFLA...,SET,6,-0.023148,-0.00041819,0.31615,0.52918,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,0.998692150689393
HP_PALMOPLANTAR_HYPERKERATOS...,SET,120,-0.0060324,-0.00048586,0.082387,0.52918,HP_PALMOPLANTAR_HYPERKERATOSIS,0.998692150689393
GNF2_CDC27,SET,56,-0.0084318,-0.00046473,0.11515,0.52919,GNF2_CDC27,0.998692150689393
GOBP_REGULATION_OF_RESPONSE_...7,SET,29,-0.012014,-0.00047688,0.16399,0.5292,GOBP_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,0.998692150689393
GSE17721_LPS_VS_GARDIQUIMOD_...8,SET,187,-0.0045851,-0.00046015,0.062477,0.52925,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP,0.998692150689393
KYNG_ENVIRONMENTAL_STRESS_RE...3,SET,33,-0.010419,-0.00044111,0.14191,0.52926,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,0.998692150689393
GOBP_NITRIC_OXIDE_CGMP_MEDIA...,SET,7,-0.027428,-0.00053518,0.37346,0.52927,GOBP_NITRIC_OXIDE_CGMP_MEDIATED_SIGNALING,0.998692150689393
GSE26669_CD4_VS_CD8_TCELL_IN...1,SET,189,-0.0047344,-0.00047764,0.064394,0.5293,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN,0.998692150689393
GOBP_POSITIVE_REGULATION_OF_...80,SET,107,-0.0064034,-0.00048718,0.087037,0.52932,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.998692150689393
HP_ABNORMAL_BLOOD_CHLORIDE_C...,SET,10,-0.022459,-0.00052375,0.30507,0.52934,HP_ABNORMAL_BLOOD_CHLORIDE_CONCENTRATION,0.998692150689393
GSE2770_UNTREATED_VS_TGFB_AN...7,SET,181,-0.0046538,-0.00045956,0.063214,0.52934,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.998692150689393
REACTOME_RAB_REGULATION_OF_T...,SET,111,-0.0057483,-0.00044539,0.078073,0.52935,REACTOME_RAB_REGULATION_OF_TRAFFICKING,0.998692150689393
HP_DECREASED_SERUM_LEPTIN,SET,11,-0.019635,-0.00048024,0.26656,0.52936,HP_DECREASED_SERUM_LEPTIN,0.998692150689393
MANNO_MIDBRAIN_NEUROTYPES_HR...1,SET,316,-0.0038553,-0.00050118,0.051818,0.52965,MANNO_MIDBRAIN_NEUROTYPES_HRGL1,0.999144988610478
GOBP_POSTREPLICATION_REPAIR,SET,32,-0.0094663,-0.00039466,0.12691,0.52973,GOBP_POSTREPLICATION_REPAIR,0.999144988610478
GSE7460_CTRL_VS_TGFB_TREATED...1,SET,185,-0.0047547,-0.00047464,0.063632,0.52978,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN,0.999144988610478
NIKOLSKY_BREAST_CANCER_8P12_...,SET,50,-0.016962,-0.00088352,0.22687,0.5298,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,0.999144988610478
KAECH_DAY8_EFF_VS_MEMORY_CD8...1,SET,184,-0.0047161,-0.00046953,0.062974,0.52985,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN,0.999144988610478
PID_DNA_PK_PATHWAY,SET,16,-0.013016,-0.00038389,0.17355,0.52989,PID_DNA_PK_PATHWAY,0.999144988610478
GOBP_EPITHELIAL_TUBE_BRANCHI...,SET,30,-0.0125,-0.00050461,0.1666,0.5299,GOBP_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,0.999144988610478
HP_REDUNDANT_NECK_SKIN,SET,28,-0.010847,-0.00042305,0.14458,0.5299,HP_REDUNDANT_NECK_SKIN,0.999144988610478
GOBP_POSITIVE_REGULATION_OF_...135,SET,9,-0.022602,-0.00050004,0.3012,0.52991,GOBP_POSITIVE_REGULATION_OF_CELL_MATURATION,0.999144988610478
HP_ABNORMAL_CIRCULATING_DEHY...,SET,15,-0.017243,-0.0004924,0.22958,0.52993,HP_ABNORMAL_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.999144988610478
MIR3614_3P,SET,58,-0.0082687,-0.00046378,0.10992,0.52998,MIR3614_3P,0.999144988610478
GOBP_MITOCHONDRIAL_RESPIRATO...,SET,82,-0.0064136,-0.00042745,0.08527,0.52998,GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY,0.999144988610478
GOBP_REGULATION_OF_MONONUCLE...,SET,130,-0.0058581,-0.00049095,0.07789,0.52998,GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.999144988610478
GOBP_CELLULAR_RESPONSE_TO_VI...1,SET,70,-0.0085158,-0.00052456,0.11297,0.53004,GOBP_CELLULAR_RESPONSE_TO_VIRUS,0.999144988610478
GOBP_MAINTENANCE_OF_ORGANELL...,SET,11,-0.017063,-0.00041733,0.22627,0.53005,GOBP_MAINTENANCE_OF_ORGANELLE_LOCATION,0.999144988610478
HP_ABNORMAL_SEX_DETERMINATION,SET,18,-0.016154,-0.0005053,0.21417,0.53006,HP_ABNORMAL_SEX_DETERMINATION,0.999144988610478
GOBP_REGULATION_OF_SYNAPTIC_...11,SET,12,-0.019417,-0.000496,0.25693,0.53012,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.999187402386117
GOBP_REGULATION_OF_EXECUTION...,SET,22,-0.015072,-0.00052117,0.1993,0.53014,GOBP_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.999187402386117
GOBP_FATTY_ACID_BETA_OXIDATI...1,SET,70,-0.0073747,-0.00045427,0.096981,0.53031,GOBP_FATTY_ACID_BETA_OXIDATION,0.999321585306388
HOOI_ST7_TARGETS_UP,SET,84,-0.0073923,-0.00049863,0.097136,0.53033,HOOI_ST7_TARGETS_UP,0.999321585306388
HP_HYPOPLASTIC_DERMOEPIDERMA...,SET,7,-0.027315,-0.00053299,0.35864,0.53035,HP_HYPOPLASTIC_DERMOEPIDERMAL_HEMIDESMOSOMES,0.999321585306388
GOBP_PROTEIN_OXIDATION,SET,12,-0.020737,-0.00052973,0.27182,0.53041,GOBP_PROTEIN_OXIDATION,0.999321585306388
GOBP_REGULATION_OF_FIBROBLAS...3,SET,35,-0.010915,-0.00047587,0.14295,0.53043,GOBP_REGULATION_OF_FIBROBLAST_MIGRATION,0.999321585306388
WP_PERTURBATIONS_TO_HOSTCELL...,SET,42,-0.010008,-0.0004779,0.13087,0.53048,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,0.999321585306388
RICHERT_PBMC_HIV_LIPO_5_AGE_...2,SET,5,-0.030049,-0.00049557,0.39258,0.53051,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_INTERFERON_SUBSET_UP,0.999321585306388
GSE43863_TH1_VS_LY6C_INT_CXC...1,SET,189,-0.0047733,-0.00048157,0.062275,0.53055,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.999321585306388
DI_MARTINO_MATRISOME_HIGHLY_...1,SET,26,-0.01316,-0.00049462,0.1715,0.53058,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC,0.999321585306388
HP_YOUNG_ADULT_ONSET,SET,512,-0.0029151,-0.00047974,0.037987,0.53058,HP_YOUNG_ADULT_ONSET,0.999321585306388
GOCC_PML_BODY,SET,99,-0.0064686,-0.00047349,0.084264,0.53059,GOCC_PML_BODY,0.999321585306388
HP_EPIDERMAL_ACANTHOSIS,SET,49,-0.0095833,-0.00049418,0.12482,0.5306,HP_EPIDERMAL_ACANTHOSIS,0.999321585306388
KRASNOSELSKAYA_ILF3_TARGETS_...1,SET,43,-0.0099656,-0.00048148,0.12969,0.53063,KRASNOSELSKAYA_ILF3_TARGETS_DN,0.999321585306388
GOBP_NEGATIVE_REGULATION_OF_...574,SET,7,-0.021824,-0.00042584,0.28374,0.53065,GOBP_NEGATIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.999321585306388
VALK_AML_CLUSTER_7,SET,25,-0.013647,-0.000503,0.17731,0.53068,VALK_AML_CLUSTER_7,0.999321585306388
HP_SYNDACTYLY,SET,346,-0.0035689,-0.00048507,0.046327,0.5307,HP_SYNDACTYLY,0.999321585306388
DESCARTES_FETAL_STOMACH_ENS_...1,SET,42,-0.010797,-0.00051559,0.14016,0.5307,DESCARTES_FETAL_STOMACH_ENS_GLIA,0.999321585306388
HP_ELEVATED_URINARY_HOMOVANI...,SET,9,-0.026295,-0.00058176,0.34012,0.53081,HP_ELEVATED_URINARY_HOMOVANILLIC_ACID,0.999474566583595
GOMF_SODIUM_PHOSPHATE_SYMPOR...,SET,13,-0.021977,-0.00058429,0.28391,0.53085,GOMF_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY,0.999495733788396
GSE18281_PERIMEDULLARY_CORTI...1,SET,170,-0.0051628,-0.00049424,0.066549,0.53092,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,0.99957338028169
GARGALOVIC_RESPONSE_TO_OXIDI...16,SET,9,-0.024478,-0.00054156,0.31408,0.53106,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN,0.99959653371577
GOMF_MONOATOMIC_ANION_SODIUM...,SET,17,-0.018254,-0.00055493,0.23388,0.5311,GOMF_MONOATOMIC_ANION_SODIUM_SYMPORTER_ACTIVITY,0.99959653371577
REACTOME_TRANSLESION_SYNTHES...3,SET,36,-0.0096994,-0.00042886,0.12419,0.53112,REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,0.99959653371577
MODULE_204,SET,79,-0.007353,-0.00048105,0.093891,0.53121,MODULE_204,0.99959653371577
MIR8086,SET,21,-0.015842,-0.00053521,0.20216,0.53123,MIR8086,0.99959653371577
GOBP_CHROMOSOME_CONDENSATION,SET,31,-0.011632,-0.00047731,0.14844,0.53123,GOBP_CHROMOSOME_CONDENSATION,0.99959653371577
HP_ABNORMAL_LIGHT_ADAPTED_EL...,SET,9,-0.025994,-0.00057509,0.33165,0.53124,HP_ABNORMAL_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.99959653371577
GOBP_SENSORY_PERCEPTION_OF_T...1,SET,65,-0.0094674,-0.00056204,0.12069,0.53126,GOBP_SENSORY_PERCEPTION_OF_TASTE,0.99959653371577
GOCC_GAMMA_DELTA_T_CELL_RECE...,SET,3,-0.037898,-0.00048416,0.4828,0.53128,GOCC_GAMMA_DELTA_T_CELL_RECEPTOR_COMPLEX,0.99959653371577
GSE26023_PHD3_KO_VS_WT_NEUTR...2,SET,171,-0.0051135,-0.00049095,0.065126,0.53129,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP,0.99959653371577
HP_GENERALIZED_ICHTHYOSIS,SET,4,-0.028153,-0.00041529,0.35815,0.53133,HP_GENERALIZED_ICHTHYOSIS,0.99959653371577
HP_FACIAL_ERYTHEMA,SET,11,-0.02161,-0.00052854,0.27478,0.53134,HP_FACIAL_ERYTHEMA,0.99959653371577
GOBP_CATECHOL_CONTAINING_COM...3,SET,46,-0.011014,-0.00055031,0.14002,0.53135,GOBP_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99959653371577
GOBP_NUCLEOSIDE_BISPHOSPHATE...1,SET,51,-0.0096361,-0.00050692,0.12247,0.53136,GOBP_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99959653371577
GOMF_LYSOPHOSPHATIDIC_ACID_P...,SET,2,-0.0583,-0.00060815,0.73983,0.5314,GOMF_LYSOPHOSPHATIDIC_ACID_PHOSPHATASE_ACTIVITY,0.99959653371577
GSE27859_MACROPHAGE_VS_CD11C...1,SET,169,-0.0050532,-0.00048234,0.064132,0.5314,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,0.99959653371577
MYB_Q3,SET,233,-0.0044355,-0.00049625,0.056203,0.53145,MYB_Q3,0.99959653371577
ZHONG_PFC_C7_SST_LHX6_POS_PU...,SET,13,-0.019781,-0.00052591,0.25062,0.53145,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.99959653371577
KEGG_MEDICUS_REFERENCE_ACH_C...2,SET,20,-0.014244,-0.00046965,0.1801,0.53152,KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY,0.999662068685776
MIR1238_5P_MIR4758_5P,SET,43,-0.010777,-0.0005207,0.13601,0.53158,MIR1238_5P_MIR4758_5P,0.999662068685776
HAY_BONE_MARROW_CD34_POS_ERP...,SET,10,-0.020306,-0.00047354,0.25617,0.53159,HAY_BONE_MARROW_CD34_POS_ERP_EARLY,0.999662068685776
GOBP_GENERAL_ADAPTATION_SYND...1,SET,6,-0.029716,-0.00053684,0.37475,0.5316,GOBP_GENERAL_ADAPTATION_SYNDROME,0.999662068685776
GOMF_KINASE_ACTIVATOR_ACTIVI...,SET,130,-0.0059829,-0.00050141,0.075339,0.53165,GOMF_KINASE_ACTIVATOR_ACTIVITY,0.999662068685776
GOBP_INTERCELLULAR_TRANSPORT,SET,10,-0.024676,-0.00057546,0.30999,0.53172,GOBP_INTERCELLULAR_TRANSPORT,0.999662068685776
HP_PROTRUDING_EAR,SET,168,-0.0052294,-0.0004977,0.065634,0.53175,HP_PROTRUDING_EAR,0.999662068685776
GOBP_NEURAL_CREST_FORMATION,SET,15,-0.019074,-0.0005447,0.23935,0.53176,GOBP_NEURAL_CREST_FORMATION,0.999662068685776
GOBP_LIPID_DROPLET_DISASSEMB...,SET,6,-0.02618,-0.00047296,0.32842,0.53177,GOBP_LIPID_DROPLET_DISASSEMBLY,0.999662068685776
GOMF_METHYL_CPG_BINDING,SET,25,-0.013392,-0.0004936,0.16781,0.5318,GOMF_METHYL_CPG_BINDING,0.999662068685776
HP_HORNER_SYNDROME,SET,9,-0.027625,-0.00061118,0.34595,0.53182,HP_HORNER_SYNDROME,0.999662068685776
ZMYM2_TARGET_GENES,SET,109,-0.0066733,-0.00051241,0.083546,0.53183,ZMYM2_TARGET_GENES,0.999662068685776
GSE339_CD4POS_VS_CD8POS_DC_DN,SET,185,-0.0049537,-0.00049451,0.061918,0.53188,GSE339_CD4POS_VS_CD8POS_DC_DN,0.999701984749337
GOCC_INTERCELLULAR_CANALICUL...,SET,6,-0.031902,-0.00057633,0.39761,0.53197,GOCC_INTERCELLULAR_CANALICULUS,0.999788253565255
GSE2405_0H_VS_6H_A_PHAGOCYTO...2,SET,171,-0.0049824,-0.00047836,0.062037,0.53201,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.999788253565255
HP_UNUSUAL_INFECTION,SET,918,-0.0023578,-0.00051362,0.029302,0.53207,HP_UNUSUAL_INFECTION,0.999788253565255
HP_PARAKERATOSIS,SET,30,-0.012994,-0.00052457,0.16138,0.53209,HP_PARAKERATOSIS,0.999788253565255
GOBP_RELAXATION_OF_VASCULAR_...,SET,4,-0.036285,-0.00053526,0.44979,0.53215,GOBP_RELAXATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE,0.999788253565255
ISHIDA_E2F_TARGETS,SET,50,-0.0092755,-0.00048315,0.11476,0.53221,ISHIDA_E2F_TARGETS,0.999788253565255
MIR5002_3P,SET,41,-0.010386,-0.00049001,0.12845,0.53222,MIR5002_3P,0.999788253565255
GOBP_CHORION_DEVELOPMENT,SET,10,-0.025014,-0.00058332,0.30887,0.53227,GOBP_CHORION_DEVELOPMENT,0.999788253565255
GSE1448_ANTI_VALPHA2_VS_VBET...2,SET,184,-0.0051119,-0.00050893,0.063116,0.53228,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP,0.999788253565255
MIR10401_3P,SET,6,-0.027285,-0.00049292,0.33656,0.53231,MIR10401_3P,0.999788253565255
KEGG_MEDICUS_VARIANT_MUTATIO...9,SET,25,-0.014002,-0.00051608,0.17266,0.53232,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.999788253565255
GOMF_PROTEIN_ARGININE_DEIMIN...,SET,5,-0.037825,-0.00062382,0.4661,0.53234,GOMF_PROTEIN_ARGININE_DEIMINASE_ACTIVITY,0.999788253565255
HP_ADRENOCORTICOTROPIC_HORMO...2,SET,4,-0.031981,-0.00047177,0.39397,0.53235,HP_ADRENOCORTICOTROPIC_HORMONE_EXCESS,0.999788253565255
HP_JOINT_CONTRACTURE_OF_THE_...3,SET,237,-0.0046697,-0.00052686,0.057531,0.53235,HP_JOINT_CONTRACTURE_OF_THE_HAND,0.999788253565255
REACTOME_RAS_ACTIVATION_UPON...,SET,19,-0.016648,-0.00053502,0.2049,0.53238,REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR,0.999788253565255
WP_EICOSANOID_SYNTHESIS,SET,22,-0.016456,-0.00056903,0.20207,0.53245,WP_EICOSANOID_SYNTHESIS,0.999788253565255
WP_GENETIC_CAUSES_OF_PORTOSI...,SET,30,-0.013148,-0.00053077,0.16143,0.53245,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.999788253565255
WAKABAYASHI_ADIPOGENESIS_PPA...1,SET,28,-0.013258,-0.00051712,0.16275,0.53246,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,0.999788253565255
WARTERS_IR_RESPONSE_5GY,SET,44,-0.010015,-0.00048947,0.12276,0.53251,WARTERS_IR_RESPONSE_5GY,0.999788253565255
GOBP_RESPONSE_TO_CAFFEINE,SET,14,-0.017897,-0.00049377,0.21927,0.53252,GOBP_RESPONSE_TO_CAFFEINE,0.999788253565255
GOBP_POSITIVE_REGULATION_OF_...17,SET,24,-0.01485,-0.00053628,0.18194,0.53253,GOBP_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.999788253565255
SOBOLEV_PBMC_PANDEMRIX_AGE_1...4,SET,18,-0.01894,-0.00059244,0.23169,0.53257,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP,0.999790316397603
GSE10325_LUPUS_CD4_TCELL_VS_...3,SET,183,-0.0055021,-0.0005463,0.067192,0.53263,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN,0.999790316397603
PID_TRKR_PATHWAY,SET,60,-0.0091462,-0.00052174,0.11166,0.53264,PID_TRKR_PATHWAY,0.999790316397603
GSE22611_NOD2_VS_MUTANT_NOD2...1,SET,159,-0.0054348,-0.00050332,0.06632,0.53266,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.999790316397603
MCCABE_HOXC6_TARGETS_UP,SET,7,-0.025237,-0.00049244,0.30717,0.53274,MCCABE_HOXC6_TARGETS_UP,0.999790316397603
TONKS_TARGETS_OF_RUNX1_RUNX1...6,SET,167,-0.0056733,-0.00053834,0.069053,0.53274,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,0.999790316397603
GSE23114_WT_VS_SLE2C1_MOUSE_...3,SET,181,-0.0052131,-0.0005148,0.06341,0.53276,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN,0.999790316397603
GOMF_CARBOHYDRATE_TRANSMEMBR...,SET,36,-0.012719,-0.00056238,0.15467,0.53277,GOMF_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.999790316397603
GSE17974_1.5H_VS_72H_IL4_AND...1,SET,165,-0.0050572,-0.00047703,0.061451,0.53279,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.999790316397603
REACTOME_PROLACTIN_RECEPTOR_...,SET,14,-0.019174,-0.000529,0.23224,0.5329,REACTOME_PROLACTIN_RECEPTOR_SIGNALING,0.999872306197365
MIR4799_5P,SET,364,-0.0037893,-0.00052798,0.045889,0.53291,MIR4799_5P,0.999872306197365
GOBP_BEHAVIOR,SET,612,-0.0030231,-0.00054241,0.036595,0.53292,GOBP_BEHAVIOR,0.999872306197365
HP_ELEVATED_ALKALINE_PHOSPHA...,SET,13,-0.020518,-0.00054551,0.24812,0.53295,HP_ELEVATED_ALKALINE_PHOSPHATASE_OF_BONE_ORIGIN,0.999874615384615
ELVIDGE_HYPOXIA_BY_DMOG_UP,SET,122,-0.0069288,-0.00056266,0.083542,0.53305,ELVIDGE_HYPOXIA_BY_DMOG_UP,0.999927969255664
GOBP_REGULATION_OF_MITOCHOND...13,SET,5,-0.025987,-0.00042858,0.31316,0.53307,GOBP_REGULATION_OF_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,0.999927969255664
GOBP_TRABECULA_FORMATION,SET,27,-0.014576,-0.00055826,0.17545,0.5331,GOBP_TRABECULA_FORMATION,0.999927969255664
HP_APLASIA_OF_THE_OLFACTORY_...,SET,13,-0.020584,-0.00054725,0.24769,0.53311,HP_APLASIA_OF_THE_OLFACTORY_BULB,0.999927969255664
HP_CUTIS_LAXA,SET,110,-0.0068218,-0.00052619,0.082003,0.53315,HP_CUTIS_LAXA,0.999927969255664
GSE22886_NAIVE_CD8_TCELL_VS_...3,SET,181,-0.0051784,-0.00051137,0.062234,0.53316,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN,0.999927969255664
GOBP_REGULATION_OF_CYTOSOLIC...,SET,52,-0.010631,-0.00056468,0.12768,0.53318,GOBP_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.999927969255664
KEGG_MEDICUS_REFERENCE_NLRC4...,SET,4,-0.026885,-0.00039659,0.32243,0.53323,KEGG_MEDICUS_REFERENCE_NLRC4_INFLAMMASOME_SIGNALING_PATHWAY,0.999927969255664
GSE33292_DN3_THYMOCYTE_VS_TC...2,SET,154,-0.0053397,-0.00048674,0.063961,0.53327,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP,0.999927969255664
GOBP_GRANULOCYTE_MACROPHAGE_...,SET,17,-0.018527,-0.00056323,0.2217,0.5333,GOBP_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.999927969255664
GCM_TINF2,SET,38,-0.010375,-0.00047128,0.12398,0.53335,GCM_TINF2,0.999927969255664
MIR541_3P,SET,94,-0.0074673,-0.00053268,0.089106,0.53339,MIR541_3P,0.999927969255664
GOMF_SPHINGOLIPID_BINDING,SET,25,-0.014386,-0.00053022,0.17168,0.53339,GOMF_SPHINGOLIPID_BINDING,0.999927969255664
GSE28737_BCL6_HET_VS_BCL6_KO...3,SET,186,-0.0050985,-0.00051032,0.060828,0.5334,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,0.999927969255664
GOBP_POSITIVE_REGULATION_OF_...177,SET,3,-0.043388,-0.0005543,0.5175,0.53341,GOBP_POSITIVE_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,0.999927969255664
CUI_DEVELOPING_HEART_C3_FIBR...,SET,103,-0.0078393,-0.00058523,0.093026,0.53358,CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL,0.999995029901406
HP_SPORADIC,SET,86,-0.0080545,-0.00054969,0.095539,0.53359,HP_SPORADIC,0.999995029901406
MODULE_329,SET,50,-0.010089,-0.00052553,0.11963,0.5336,MODULE_329,0.999995029901406
RUBENSTEIN_SKELETAL_MUSCLE_M...,SET,306,-0.0041197,-0.00052714,0.048832,0.53362,RUBENSTEIN_SKELETAL_MUSCLE_MYELOID_CELLS,0.999995029901406
GAUTAM_EYE_IRIS_CILIARY_BODY...2,SET,93,-0.0079146,-0.00056159,0.093715,0.53365,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_CELLS,0.999995029901406
HP_ANHYDRAMNIOS,SET,6,-0.028757,-0.00051951,0.3392,0.53378,HP_ANHYDRAMNIOS,0.999995029901406
LI_ESTROGENE_EARLY_E2_RESPON...1,SET,73,-0.0093741,-0.00058962,0.11046,0.53381,LI_ESTROGENE_EARLY_E2_RESPONSE_DN,0.999995029901406
PHONG_TNF_RESPONSE_VIA_P38_C...,SET,214,-0.0050161,-0.00053812,0.059121,0.53381,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,0.999995029901406
HP_DYSLEXIA,SET,29,-0.01354,-0.00053744,0.15954,0.53382,HP_DYSLEXIA,0.999995029901406
GOBP_POSITIVE_REGULATION_OF_...793,SET,104,-0.0075302,-0.00056486,0.088532,0.53389,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.999995029901406
GSE24972_WT_VS_IRF8_KO_MARGI...2,SET,174,-0.0055506,-0.00053753,0.065259,0.53389,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP,0.999995029901406
DAZARD_UV_RESPONSE_CLUSTER_G1,SET,53,-0.010035,-0.00053814,0.11791,0.53391,DAZARD_UV_RESPONSE_CLUSTER_G1,0.999995029901406
REACTOME_PHASE_I_FUNCTIONALI...,SET,99,-0.0081474,-0.00059637,0.095729,0.53391,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,0.999995029901406
OCT1_05,SET,222,-0.005247,-0.00057319,0.061633,0.53392,OCT1_05,0.999995029901406
GOBP_DTMP_METABOLIC_PROCESS,SET,6,-0.027452,-0.00049594,0.32245,0.53392,GOBP_DTMP_METABOLIC_PROCESS,0.999995029901406
MODULE_126,SET,166,-0.005788,-0.0005476,0.06797,0.53393,MODULE_126,0.999995029901406
HE_LIM_SUN_FETAL_LUNG_C0_MID...1,SET,58,-0.010482,-0.00058791,0.12291,0.53398,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL,0.999995029901406
HP_INTERNALLY_NUCLEATED_SKEL...,SET,6,-0.032937,-0.00059503,0.38603,0.534,HP_INTERNALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,0.999995029901406
GSE3982_DC_VS_EFF_MEMORY_CD4...1,SET,163,-0.0053823,-0.00050464,0.063057,0.53401,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN,0.999995029901406
LEE_TARGETS_OF_PTCH1_AND_SUF...1,SET,80,-0.0082656,-0.00054416,0.096716,0.53405,LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,0.999995029901406
GSE10325_MYELOID_VS_LUPUS_MY...1,SET,185,-0.0054561,-0.00054465,0.063845,0.53405,GSE10325_MYELOID_VS_LUPUS_MYELOID_DN,0.999995029901406
HP_HIP_FLEXOR_WEAKNESS,SET,15,-0.016884,-0.00048215,0.19705,0.53414,HP_HIP_FLEXOR_WEAKNESS,1
GOBP_SOMITE_ROSTRAL_CAUDAL_A...,SET,9,-0.023983,-0.00053061,0.27966,0.53417,GOBP_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...52,SET,11,-0.021764,-0.00053231,0.25329,0.53424,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GOBP_HINDBRAIN_DEVELOPMENT,SET,142,-0.0063646,-0.00055729,0.074055,0.53424,GOBP_HINDBRAIN_DEVELOPMENT,1
RSRFC4_Q2,SET,195,-0.0054094,-0.00055424,0.062932,0.53425,RSRFC4_Q2,1
GSE16385_MONOCYTE_VS_12H_ROS...4,SET,173,-0.0053511,-0.00051673,0.062181,0.53429,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,1
HOEK_MONOCYTE_2011_2012_TIV_...2,SET,7,-0.034828,-0.00067958,0.40418,0.53433,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_UP,1
HP_PULMONARY_ARTERY_STENOSIS,SET,66,-0.0096555,-0.00057758,0.11204,0.53434,HP_PULMONARY_ARTERY_STENOSIS,1
GSE19923_WT_VS_HEB_KO_DP_THY...1,SET,180,-0.0053503,-0.0005269,0.061921,0.53443,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN,1
HOWARD_T_CELL_INACT_MONOV_IN...,SET,41,-0.012139,-0.00057272,0.14043,0.53444,HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
GSE17721_0.5H_VS_8H_LPS_BMDC...1,SET,180,-0.0055191,-0.00054353,0.063798,0.53447,GSE17721_0.5H_VS_8H_LPS_BMDC_DN,1
MIR4738_3P,SET,163,-0.005949,-0.00055777,0.068516,0.53459,MIR4738_3P,1
XU_HGF_TARGETS_REPRESSED_BY_...2,SET,9,-0.025268,-0.00055903,0.29089,0.53461,XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,1
MIR154_3P,SET,91,-0.0079656,-0.00055913,0.091359,0.53474,MIR154_3P,1
TIMOFEEVA_GROWTH_STRESS_VIA_...,SET,16,-0.019059,-0.00056211,0.21855,0.53475,TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN,1
HP_APLASIA_HYPOPLASIA_INVOLV...10,SET,4,-0.044085,-0.00065032,0.50351,0.53488,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_MUSCULATURE_OF_THE_EXTREMITIES,1
BIOCARTA_NDKDYNAMIN_PATHWAY,SET,17,-0.018677,-0.00056778,0.21297,0.53494,BIOCARTA_NDKDYNAMIN_PATHWAY,1
KEGG_MEDICUS_REFERENCE_BLOCK...,SET,12,-0.021141,-0.00054003,0.24107,0.53494,KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2,1
PARK_TRETINOIN_RESPONSE,SET,11,-0.025439,-0.00062219,0.29,0.53495,PARK_TRETINOIN_RESPONSE,1
GSE17186_CD21LOW_VS_CD21HIGH...3,SET,185,-0.0057129,-0.00057029,0.064927,0.53506,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,1
HP_HEMOPHAGOCYTOSIS,SET,19,-0.019039,-0.00061186,0.21598,0.53512,HP_HEMOPHAGOCYTOSIS,1
PID_DELTA_NP63_PATHWAY,SET,43,-0.012027,-0.00058107,0.1364,0.53513,PID_DELTA_NP63_PATHWAY,1
DESCARTES_MAIN_FETAL_EPICARD...,SET,38,-0.013575,-0.00061664,0.15389,0.53515,DESCARTES_MAIN_FETAL_EPICARDIAL_FAT_CELLS,1
GOBP_FLAVIN_CONTAINING_COMPO...,SET,6,-0.029991,-0.00054181,0.3397,0.53518,GOBP_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_ENDOSOME_...2,SET,9,-0.024739,-0.00054732,0.27986,0.53522,GOBP_REGULATION_OF_ENDOSOME_SIZE,1
WP_P53_TRANSCRIPTIONAL_GENE_...,SET,89,-0.0078841,-0.00054732,0.089046,0.53528,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1
GSE10239_MEMORY_VS_KLRG1INT_...2,SET,179,-0.0057753,-0.00056719,0.06515,0.53532,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...693,SET,10,-0.02227,-0.00051933,0.25098,0.53535,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
MIR873_5P,SET,101,-0.0077418,-0.00057235,0.087226,0.53536,MIR873_5P,1
GOBP_OOGENESIS,SET,100,-0.007657,-0.00056328,0.086195,0.53539,GOBP_OOGENESIS,1
SARTIPY_NORMAL_AT_INSULIN_RE...1,SET,17,-0.018545,-0.00056376,0.20869,0.5354,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,1
GSE26488_HDAC7_KO_VS_VP16_TR...2,SET,157,-0.0061522,-0.0005662,0.069157,0.53544,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,1
MCCABE_HOXC6_TARGETS_CANCER_...2,SET,23,-0.01654,-0.00058478,0.18584,0.53546,MCCABE_HOXC6_TARGETS_CANCER_UP,1
GOCC_PHOTORECEPTOR_OUTER_SEG...2,SET,16,-0.017049,-0.00050282,0.19148,0.53547,GOCC_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE,1
GOBP_REGULATION_OF_SYNAPTIC_...4,SET,8,-0.022744,-0.00047443,0.25543,0.53548,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,1
HP_DELAYED_ERUPTION_OF_PERMA...,SET,32,-0.013845,-0.0005772,0.15529,0.53552,HP_DELAYED_ERUPTION_OF_PERMANENT_TEETH,1
GSE17721_12H_VS_24H_CPG_BMDC...2,SET,186,-0.0056034,-0.00056086,0.062798,0.53555,GSE17721_12H_VS_24H_CPG_BMDC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...631,SET,18,-0.016836,-0.00052663,0.1885,0.53558,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE,1
GOBP_RESPONSE_TO_UV_A,SET,13,-0.024167,-0.00064253,0.27053,0.53559,GOBP_RESPONSE_TO_UV_A,1
GOBP_CELL_DIFFERENTIATION_IN...4,SET,3,-0.051743,-0.00066104,0.57883,0.53561,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_PHENOTYPIC_SWITCHING,1
BLANCO_MELO_COVID19_SARS_COV...10,SET,133,-0.0070352,-0.00059632,0.07863,0.53565,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,1
BIOCARTA_MEF2D_PATHWAY,SET,18,-0.019087,-0.00059705,0.21332,0.53565,BIOCARTA_MEF2D_PATHWAY,1
KRISHNAN_FURIN_TARGETS_UP,SET,8,-0.02902,-0.00060533,0.3241,0.53567,KRISHNAN_FURIN_TARGETS_UP,1
GSE28726_NAIVE_CD4_TCELL_VS_...4,SET,184,-0.0054706,-0.00054464,0.061083,0.53568,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP,1
GOBP_DNA_REPLICATION_DEPENDE...,SET,6,-0.026449,-0.00047783,0.29527,0.53569,GOBP_DNA_REPLICATION_DEPENDENT_CHROMATIN_ASSEMBLY,1
MIR8057,SET,79,-0.0082242,-0.00053805,0.091687,0.53574,MIR8057,1
GSE25088_WT_VS_STAT6_KO_MACR...1,SET,181,-0.0057835,-0.00057113,0.064353,0.5358,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN,1
GSE7852_TREG_VS_TCONV_UP,SET,183,-0.0058932,-0.00058513,0.065567,0.53581,GSE7852_TREG_VS_TCONV_UP,1
ARNT2_TARGET_GENES,SET,552,-0.00326,-0.00055644,0.036238,0.53584,ARNT2_TARGET_GENES,1
HP_MYOKYMIA,SET,18,-0.016216,-0.00050724,0.18027,0.53584,HP_MYOKYMIA,1
GOBP_REGULATION_OF_PIGMENT_C...,SET,8,-0.03241,-0.00067606,0.3602,0.53585,GOBP_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION,1
HP_UPPER_LIMB_AMYOTROPHY,SET,70,-0.0093779,-0.00057767,0.104,0.53592,HP_UPPER_LIMB_AMYOTROPHY,1
REACTOME_G_BETA_GAMMA_SIGNAL...2,SET,25,-0.016363,-0.00060312,0.18091,0.53603,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA,1
GOBP_EPITHELIAL_CELL_PROLIFE...1,SET,408,-0.0040667,-0.00059917,0.044968,0.53603,GOBP_EPITHELIAL_CELL_PROLIFERATION,1
GOBP_NEGATIVE_REGULATION_OF_...176,SET,11,-0.025899,-0.00063344,0.28603,0.53607,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
MIR5194,SET,33,-0.014302,-0.0006055,0.15784,0.5361,MIR5194,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...3,SET,27,-0.01652,-0.00063274,0.18207,0.53615,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,1
GOBP_MAST_CELL_ACTIVATION_IN...,SET,52,-0.011323,-0.00060147,0.1248,0.53615,GOBP_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
TRAVAGLINI_LUNG_CD8_NAIVE_T_...,SET,131,-0.0072559,-0.00061042,0.079824,0.53621,TRAVAGLINI_LUNG_CD8_NAIVE_T_CELL,1
HP_GENU_VARUM,SET,54,-0.010829,-0.00058611,0.11891,0.53628,HP_GENU_VARUM,1
MIR10393_5P,SET,135,-0.0067258,-0.00057433,0.073837,0.53629,MIR10393_5P,1
NKX2_8_TARGET_GENES,SET,31,-0.015471,-0.00063485,0.16983,0.53629,NKX2_8_TARGET_GENES,1
GOBP_SUBSTRATE_DEPENDENT_CEL...1,SET,23,-0.017242,-0.00060956,0.18907,0.53633,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION,1
BIOCARTA_CELLCYCLE_PATHWAY,SET,23,-0.015637,-0.00055285,0.17138,0.53635,BIOCARTA_CELLCYCLE_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...56,SET,8,-0.031768,-0.00066266,0.34807,0.53636,GOBP_POSITIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
GOMF_INTERMEDIATE_FILAMENT_B...,SET,10,-0.024118,-0.00056244,0.26375,0.53643,GOMF_INTERMEDIATE_FILAMENT_BINDING,1
HP_PARTIAL_DUPLICATION_OF_TH...1,SET,6,-0.030824,-0.00055685,0.3365,0.53649,HP_PARTIAL_DUPLICATION_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,1
GOBP_UBIQUITIN_DEPENDENT_PRO...2,SET,34,-0.012629,-0.00054271,0.13746,0.5366,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,1
GOMF_GLIAL_CELL_DERIVED_NEUR...,SET,5,-0.038247,-0.00063078,0.41596,0.53663,GOMF_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...824,SET,8,-0.027291,-0.00056926,0.29657,0.53666,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOBP_OLIGOPEPTIDE_IMPORT_ACR...,SET,5,-0.037862,-0.00062442,0.41083,0.53671,GOBP_OLIGOPEPTIDE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GSE2585_THYMIC_DC_VS_THYMIC_...2,SET,158,-0.0064976,-0.00059987,0.070515,0.53671,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP,1
HP_RECURRENT_CUTANEOUS_FUNGA...,SET,53,-0.011058,-0.000593,0.11982,0.53677,HP_RECURRENT_CUTANEOUS_FUNGAL_INFECTIONS,1
GOBP_CARDIAC_VENTRICLE_FORMA...,SET,7,-0.035557,-0.00069381,0.38508,0.53678,GOBP_CARDIAC_VENTRICLE_FORMATION,1
KEGG_MEDICUS_REFERENCE_REGUL...14,SET,8,-0.023451,-0.00048918,0.25397,0.53679,KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA,1
HP_REDUCED_CIRCULATING_GROWT...,SET,10,-0.027469,-0.00064059,0.29737,0.5368,HP_REDUCED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,1
CASORELLI_APL_SECONDARY_VS_D...,SET,34,-0.014153,-0.00060819,0.15316,0.53681,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,1
GOMF_PYRIMIDINE_NUCLEOTIDE_B...,SET,5,-0.032108,-0.00052953,0.34738,0.53682,GOMF_PYRIMIDINE_NUCLEOTIDE_BINDING,1
GSE17721_0.5H_VS_12H_POLYIC_...1,SET,186,-0.0056166,-0.00056218,0.060771,0.53682,GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN,1
GOCC_CELL_BODY,SET,508,-0.0036803,-0.00060336,0.039789,0.53685,GOCC_CELL_BODY,1
GOBP_REGULATION_OF_PROTEIN_T...3,SET,401,-0.0040187,-0.00058711,0.043393,0.53689,GOBP_REGULATION_OF_PROTEIN_TRANSPORT,1
GSE32255_WT_VS_JMJD2D_KNOCKD...1,SET,129,-0.0068253,-0.00056982,0.073659,0.53691,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,1
GSE20715_0H_VS_24H_OZONE_LUN...2,SET,183,-0.0058649,-0.00058233,0.063285,0.53692,GSE20715_0H_VS_24H_OZONE_LUNG_UP,1
GOBP_NEGATIVE_REGULATION_OF_...625,SET,4,-0.042839,-0.00063193,0.46189,0.53695,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,1
HP_SLOWLY_PROGRESSIVE,SET,141,-0.0066141,-0.00057711,0.071311,0.53695,HP_SLOWLY_PROGRESSIVE,1
GOBP_MITOTIC_CELL_CYCLE_PHAS...,SET,403,-0.0039199,-0.00057407,0.042244,0.53697,GOBP_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
GOBP_POSITIVE_REGULATION_OF_...152,SET,5,-0.035216,-0.00058078,0.37921,0.53699,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,1
DURANTE_ADULT_OLFACTORY_NEUR...8,SET,128,-0.007497,-0.00062348,0.080591,0.53706,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,1
HP_SUBRETINAL_DEPOSITS,SET,6,-0.033432,-0.00060397,0.35916,0.53708,HP_SUBRETINAL_DEPOSITS,1
HP_INCREASED_URINARY_POTASSI...,SET,9,-0.028647,-0.00063378,0.30764,0.53709,HP_INCREASED_URINARY_POTASSIUM,1
JIANG_MELANOMA_TRM8_CD4,SET,364,-0.0042664,-0.00059446,0.045813,0.5371,JIANG_MELANOMA_TRM8_CD4,1
HP_ABNORMAL_MONOCYTE_COUNT,SET,20,-0.016877,-0.00055644,0.18121,0.5371,HP_ABNORMAL_MONOCYTE_COUNT,1
HP_DECREASED_ACTIVITY_OF_NAD...,SET,3,-0.050051,-0.00063942,0.53745,0.5371,HP_DECREASED_ACTIVITY_OF_NADPH_OXIDASE,1
GSE41867_DAY6_EFFECTOR_VS_DA...3,SET,186,-0.0057196,-0.00057248,0.061378,0.53712,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,1
GOCC_PROTEIN_DNA_COMPLEX,SET,1227,-0.0023692,-0.0005914,0.025411,0.53714,GOCC_PROTEIN_DNA_COMPLEX,1
GOCC_RIBBON_SYNAPSE,SET,15,-0.022051,-0.00062971,0.2363,0.53717,GOCC_RIBBON_SYNAPSE,1
GOBP_REGULATION_OF_MACROPHAG...2,SET,9,-0.024519,-0.00054246,0.26263,0.53719,GOBP_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,1
HP_ASYMMETRY_OF_THE_EARS,SET,4,-0.035965,-0.00053053,0.38528,0.53719,HP_ASYMMETRY_OF_THE_EARS,1
GSE25677_R848_VS_MPL_AND_R84...2,SET,134,-0.0068431,-0.0005822,0.0733,0.53719,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP,1
GOBP_REGULATION_OF_FILOPODIU...,SET,41,-0.013683,-0.00064554,0.14637,0.53724,GOBP_REGULATION_OF_FILOPODIUM_ASSEMBLY,1
HP_ABNORMAL_BLOOD_SODIUM_CON...,SET,63,-0.011022,-0.00064421,0.11779,0.53727,HP_ABNORMAL_BLOOD_SODIUM_CONCENTRATION,1
GOMF_MHC_CLASS_IB_PROTEIN_BI...,SET,6,-0.034481,-0.00062293,0.3683,0.53729,GOMF_MHC_CLASS_IB_PROTEIN_BINDING,1
WP_HAIR_FOLLICLE_DEVELOPMENT...2,SET,31,-0.016408,-0.00067334,0.17506,0.53734,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,1
MIR3622A_3P_MIR3622B_3P,SET,90,-0.0088474,-0.00061762,0.094363,0.53735,MIR3622A_3P_MIR3622B_3P,1
GOMF_O_PALMITOYLTRANSFERASE_...,SET,5,-0.035241,-0.00058121,0.37566,0.53737,GOMF_O_PALMITOYLTRANSFERASE_ACTIVITY,1
WP_PURINE_METABOLISM,SET,10,-0.028812,-0.00067191,0.30695,0.53739,WP_PURINE_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...179,SET,13,-0.023257,-0.00061832,0.24761,0.53741,GOBP_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY,1
MORF_MAGEA9,SET,376,-0.004293,-0.00060774,0.045663,0.53745,MORF_MAGEA9,1
GSE43863_TH1_VS_TFH_EFFECTOR...2,SET,187,-0.0060641,-0.00060858,0.064426,0.53749,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP,1
GSE36891_UNSTIM_VS_POLYIC_TL...1,SET,178,-0.0060627,-0.00059376,0.064348,0.53753,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN,1
MARTORIATI_MDM4_TARGETS_NEUR...1,SET,147,-0.0070992,-0.00063238,0.075241,0.53758,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,1
MIR4802_3P,SET,153,-0.0072313,-0.00065705,0.076543,0.53763,MIR4802_3P,1
MODULE_519,SET,15,-0.02198,-0.00062768,0.23244,0.53767,MODULE_519,1
HP_CHOROIDEREMIA,SET,6,-0.035641,-0.00064388,0.37599,0.53776,HP_CHOROIDEREMIA,1
HAY_BONE_MARROW_CD34_POS_EO_...,SET,15,-0.023225,-0.00066326,0.24504,0.53776,HAY_BONE_MARROW_CD34_POS_EO_B_MAST,1
HP_FETAL_ULTRASOUND_SOFT_MAR...,SET,104,-0.0075857,-0.00056902,0.079997,0.53777,HP_FETAL_ULTRASOUND_SOFT_MARKER,1
GSE4984_UNTREATED_VS_LPS_TRE...1,SET,156,-0.0064468,-0.00059143,0.067938,0.5378,GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN,1
GOMF_ALPHA_ADRENERGIC_RECEPT...,SET,6,-0.037029,-0.00066895,0.38991,0.53783,GOMF_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY,1
MIR4535,SET,26,-0.01577,-0.00059274,0.16598,0.53785,MIR4535,1
GGAMTNNNNNTCCY_UNKNOWN,SET,107,-0.0075261,-0.00057259,0.079151,0.53788,GGAMTNNNNNTCCY_UNKNOWN,1
MIR548AT_5P,SET,313,-0.0047099,-0.0006094,0.049503,0.5379,MIR548AT_5P,1
HP_APLASIA_HYPOPLASIA_OF_THE...74,SET,37,-0.012576,-0.00056369,0.13209,0.53792,HP_APLASIA_HYPOPLASIA_OF_THE_TONGUE,1
HP_DECREASED_PROPORTION_OF_N...,SET,3,-0.055522,-0.00070932,0.58325,0.53792,HP_DECREASED_PROPORTION_OF_NAIVE_T_CELLS,1
HP_OSTEOPETROSIS,SET,17,-0.020476,-0.00062249,0.21502,0.53793,HP_OSTEOPETROSIS,1
GAVIN_FOXP3_TARGETS_CLUSTER_...3,SET,92,-0.0091273,-0.00064416,0.095827,0.53794,GAVIN_FOXP3_TARGETS_CLUSTER_P4,1
IRX2_TARGET_GENES,SET,187,-0.0058589,-0.00058798,0.061489,0.53795,IRX2_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...234,SET,143,-0.0071606,-0.00062917,0.075082,0.53799,GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS,1
HP_EPIDERMAL_HYPERKERATOSIS,SET,11,-0.026436,-0.00064658,0.27697,0.53802,HP_EPIDERMAL_HYPERKERATOSIS,1
GOBP_B_CELL_APOPTOTIC_PROCESS,SET,24,-0.017655,-0.00063758,0.18491,0.53803,GOBP_B_CELL_APOPTOTIC_PROCESS,1
HP_SEVERE_SHORT_LIMB_DWARFISM,SET,5,-0.041097,-0.00067777,0.43044,0.53803,HP_SEVERE_SHORT_LIMB_DWARFISM,1
GSE17721_PAM3CSK4_VS_GADIQUI...9,SET,186,-0.0058508,-0.00058562,0.061247,0.53805,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN,1
MIR151A_5P_MIR151B,SET,10,-0.024438,-0.00056991,0.25563,0.53808,MIR151A_5P_MIR151B,1
AKL_HTLV1_INFECTION_UP,SET,24,-0.015436,-0.00055744,0.16122,0.53814,AKL_HTLV1_INFECTION_UP,1
MAZR_01,SET,204,-0.0055047,-0.00057673,0.057418,0.53819,MAZR_01,1
GOBP_REGULATION_OF_DENDRITIC...4,SET,53,-0.011231,-0.00060224,0.11712,0.5382,GOBP_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
MARCINIAK_ER_STRESS_RESPONSE...,SET,20,-0.018694,-0.00061636,0.19486,0.53821,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,1
MIR4311,SET,325,-0.0045355,-0.00059778,0.047202,0.53827,MIR4311,1
SOX9_B1,SET,213,-0.005877,-0.00062903,0.061163,0.53827,SOX9_B1,1
HP_ELBOW_ANKYLOSIS,SET,7,-0.034314,-0.00066955,0.3571,0.53828,HP_ELBOW_ANKYLOSIS,1
HALLMARK_ESTROGEN_RESPONSE_L...,SET,185,-0.0064249,-0.00064137,0.06682,0.5383,HALLMARK_ESTROGEN_RESPONSE_LATE,1
TRAVAGLINI_LUNG_BRONCHIAL_VE...1,SET,207,-0.0058384,-0.00061613,0.060689,0.53832,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_1_CELL,1
CEBPDELTA_Q6,SET,217,-0.005729,-0.00061884,0.059531,0.53833,CEBPDELTA_Q6,1
GOBP_BUNDLE_OF_HIS_CELL_TO_P...2,SET,7,-0.036894,-0.00071991,0.38312,0.53836,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_SIGNALING,1
REACTOME_PI_3K_CASCADE_FGFR2,SET,22,-0.018877,-0.00065272,0.19592,0.53838,REACTOME_PI_3K_CASCADE_FGFR2,1
HP_PRECOCIOUS_ATHEROSCLEROSIS,SET,12,-0.026326,-0.00067249,0.27325,0.53838,HP_PRECOCIOUS_ATHEROSCLEROSIS,1
MIR3186_5P,SET,2,-0.055035,-0.00057409,0.57097,0.53839,MIR3186_5P,1
GOBP_POSITIVE_REGULATION_OF_...821,SET,12,-0.026324,-0.00067244,0.27288,0.53843,GOBP_POSITIVE_REGULATION_OF_URINE_VOLUME,1
GCGSCMNTTT_UNKNOWN,SET,62,-0.010061,-0.00058337,0.10411,0.53849,GCGSCMNTTT_UNKNOWN,1
KIM_ALL_DISORDERS_DURATION_C...1,SET,131,-0.0067154,-0.00056494,0.069464,0.53851,KIM_ALL_DISORDERS_DURATION_CORR_DN,1
GOMF_TRANSPORTER_ACTIVITY,SET,1110,-0.0026685,-0.0006357,0.027576,0.53855,GOMF_TRANSPORTER_ACTIVITY,1
GSE42724_B1_BCELL_VS_PLASMAB...2,SET,184,-0.0059047,-0.00058786,0.061004,0.53855,GSE42724_B1_BCELL_VS_PLASMABLAST_UP,1
GSE22886_NAIVE_CD8_TCELL_VS_...10,SET,175,-0.0062002,-0.00060214,0.064017,0.53858,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP,1
HP_ABNORMAL_PITUITARY_GLAND_...,SET,304,-0.0048309,-0.00061616,0.049842,0.53861,HP_ABNORMAL_PITUITARY_GLAND_MORPHOLOGY,1
GOMF_CYTOKINE_RECEPTOR_BINDI...,SET,247,-0.0057756,-0.00066506,0.05947,0.53868,GOMF_CYTOKINE_RECEPTOR_BINDING,1
MIR6887_5P,SET,120,-0.0076788,-0.00061846,0.079056,0.53869,MIR6887_5P,1
HP_GRANULAR_MACULAR_APPEARAN...,SET,8,-0.032712,-0.00068236,0.33678,0.53869,HP_GRANULAR_MACULAR_APPEARANCE,1
GOBP_FACE_DEVELOPMENT,SET,49,-0.012504,-0.00064477,0.12865,0.53871,GOBP_FACE_DEVELOPMENT,1
MIR6882_5P,SET,154,-0.0066935,-0.00061015,0.068843,0.53873,MIR6882_5P,1
USF_Q6_01,SET,221,-0.0054782,-0.00059711,0.056258,0.53879,USF_Q6_01,1
MIR514A_5P,SET,61,-0.011259,-0.0006476,0.11539,0.53886,MIR514A_5P,1
GSE41867_DAY6_EFFECTOR_VS_DA...1,SET,181,-0.0059432,-0.00058689,0.060912,0.53886,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,1
GOBP_ERYTHROSE_4_PHOSPHATE_P...,SET,17,-0.022155,-0.00067351,0.22701,0.53887,GOBP_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
HP_RETINAL_NEOVASCULARIZATION,SET,9,-0.031081,-0.00068764,0.31813,0.53891,HP_RETINAL_NEOVASCULARIZATION,1
ROZANOV_MMP14_TARGETS_SUBSET,SET,32,-0.017247,-0.00071904,0.1765,0.53892,ROZANOV_MMP14_TARGETS_SUBSET,1
YAMAZAKI_TCEB3_TARGETS_UP,SET,155,-0.0069125,-0.00063214,0.07074,0.53892,YAMAZAKI_TCEB3_TARGETS_UP,1
PARK_OSTEOBLAST_DIFFERENTIAT...2,SET,12,-0.026492,-0.00067674,0.27108,0.53893,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP,1
GOCC_AUTOPHAGOSOME_MEMBRANE,SET,49,-0.0117,-0.00060332,0.11972,0.53893,GOCC_AUTOPHAGOSOME_MEMBRANE,1
REACTOME_INCRETIN_SYNTHESIS_...,SET,23,-0.018413,-0.00065099,0.18824,0.53896,REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION,1
FINETTI_BREAST_CANCERS_KINOM...2,SET,15,-0.020977,-0.00059905,0.21422,0.539,FINETTI_BREAST_CANCERS_KINOME_GRAY,1
HP_GENERALIZED_AMINOACIDURIA,SET,14,-0.023548,-0.00064968,0.24031,0.53903,HP_GENERALIZED_AMINOACIDURIA,1
GSE33424_CD161_HIGH_VS_INT_C...2,SET,183,-0.0064967,-0.00064505,0.066295,0.53903,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...464,SET,5,-0.03642,-0.00060064,0.37109,0.53909,GOBP_POSITIVE_REGULATION_OF_MIRNA_PROCESSING,1
GSE30083_SP1_VS_SP4_THYMOCYT...1,SET,189,-0.006221,-0.00062762,0.063332,0.53912,GSE30083_SP1_VS_SP4_THYMOCYTE_DN,1
HP_PREMATURE_THELARCHE,SET,10,-0.026569,-0.00061959,0.26973,0.53923,HP_PREMATURE_THELARCHE,1
MIR6843_3P,SET,82,-0.009819,-0.00065442,0.099581,0.53927,MIR6843_3P,1
GGCACAT_MIR455,SET,54,-0.011293,-0.00061127,0.11455,0.53927,GGCACAT_MIR455,1
GSE14350_IL2RB_KO_VS_WT_TREG...1,SET,181,-0.006322,-0.0006243,0.064107,0.53928,GSE14350_IL2RB_KO_VS_WT_TREG_DN,1
NAGASHIMA_NRG1_SIGNALING_DN,SET,50,-0.01207,-0.00062872,0.12235,0.53929,NAGASHIMA_NRG1_SIGNALING_DN,1
GSE17721_LPS_VS_GARDIQUIMOD_...15,SET,180,-0.0061092,-0.00060164,0.061853,0.53934,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN,1
GOBP_PRIMARY_AMINO_COMPOUND_...2,SET,13,-0.022134,-0.00058849,0.22394,0.53937,GOBP_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS,1
REACTOME_TRANSCRIPTIONAL_REG...12,SET,30,-0.01657,-0.00066895,0.16761,0.53938,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,1
GSE5542_IFNG_VS_IFNA_TREATED...2,SET,178,-0.0060246,-0.00059003,0.060937,0.53938,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,1
GOMF_EPOXIDE_HYDROLASE_ACTIV...,SET,8,-0.033788,-0.00070481,0.34166,0.53939,GOMF_EPOXIDE_HYDROLASE_ACTIVITY,1
CUI_TCF21_TARGETS_UP,SET,35,-0.015631,-0.00068149,0.15788,0.53943,CUI_TCF21_TARGETS_UP,1
chr20p11,SET,52,-0.02225,-0.0011819,0.22454,0.53947,chr20p11,1
LIN_APC_TARGETS,SET,63,-0.010646,-0.00062226,0.10742,0.53947,LIN_APC_TARGETS,1
GOBP_LATERAL_SPROUTING_FROM_...,SET,9,-0.032643,-0.00072219,0.32882,0.53954,GOBP_LATERAL_SPROUTING_FROM_AN_EPITHELIUM,1
SREBP1_Q6,SET,234,-0.0055668,-0.00062414,0.056013,0.53958,SREBP1_Q6,1
GSE2826_WT_VS_XID_BCELL_DN,SET,183,-0.0065892,-0.00065424,0.066298,0.53958,GSE2826_WT_VS_XID_BCELL_DN,1
KEGG_MEDICUS_VARIANT_LOSS_OF...3,SET,6,-0.030156,-0.00054479,0.30227,0.53973,KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY,1
GSE14769_UNSTIM_VS_120MIN_LP...1,SET,194,-0.006354,-0.00064937,0.063654,0.53976,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN,1
GOBP_MITOTIC_INTRA_S_DNA_DAM...,SET,16,-0.018476,-0.00054492,0.18497,0.53978,GOBP_MITOTIC_INTRA_S_DNA_DAMAGE_CHECKPOINT_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...358,SET,28,-0.015864,-0.00061876,0.15867,0.53982,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
MODULE_242,SET,187,-0.006353,-0.00063757,0.063509,0.53984,MODULE_242,1
MIR4740_5P,SET,61,-0.012345,-0.00071004,0.12337,0.53985,MIR4740_5P,1
HP_MACROVESICULAR_HEPATIC_ST...,SET,15,-0.01928,-0.00055058,0.19262,0.53986,HP_MACROVESICULAR_HEPATIC_STEATOSIS,1
GOBP_EPHRIN_RECEPTOR_SIGNALI...,SET,48,-0.013056,-0.00066639,0.13041,0.53987,GOBP_EPHRIN_RECEPTOR_SIGNALING_PATHWAY,1
SANCHEZ_MDM2_TARGETS,SET,9,-0.028609,-0.00063294,0.28571,0.53988,SANCHEZ_MDM2_TARGETS,1
GAVISH_3CA_MALIGNANT_METAPRO...21,SET,48,-0.011633,-0.00059373,0.11607,0.53992,GAVISH_3CA_MALIGNANT_METAPROGRAM_2_CELL_CYCLE_G1_S,1
HP_SHORT_NAIL,SET,13,-0.023019,-0.00061201,0.22932,0.53998,HP_SHORT_NAIL,1
NICK_RESPONSE_TO_PROC_TREATM...1,SET,23,-0.016089,-0.00056882,0.15998,0.54005,NICK_RESPONSE_TO_PROC_TREATMENT_DN,1
KMCATNNWGGA_UNKNOWN,SET,87,-0.0089309,-0.00061302,0.088814,0.54005,KMCATNNWGGA_UNKNOWN,1
GOBP_NEGATIVE_REGULATION_OF_...181,SET,14,-0.025265,-0.00069706,0.25051,0.54017,GOBP_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...566,SET,11,-0.027745,-0.00067859,0.27487,0.5402,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,1
GAVISH_3CA_METAPROGRAM_ENDOT...1,SET,45,-0.013387,-0.0006616,0.13253,0.54023,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE,1
GNF2_CASP4,SET,21,-0.019238,-0.00064994,0.19047,0.54023,GNF2_CASP4,1
GOBP_POSITIVE_REGULATION_OF_...580,SET,64,-0.012067,-0.00071088,0.11942,0.54024,GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS,1
GSE24574_BCL6_HIGH_TFH_VS_NA...1,SET,187,-0.0062926,-0.00063152,0.062282,0.54024,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN,1
GOBP_PROTEIN_C_LINKED_GLYCOS...,SET,4,-0.048851,-0.00072061,0.48304,0.54028,GOBP_PROTEIN_C_LINKED_GLYCOSYLATION,1
GOBP_REGULATION_OF_HETEROCHR...,SET,18,-0.018669,-0.00058399,0.18445,0.54031,GOBP_REGULATION_OF_HETEROCHROMATIN_FORMATION,1
WP_GLYCOGEN_SYNTHESIS_AND_DE...,SET,35,-0.013526,-0.0005897,0.13355,0.54034,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1
HDGF_TARGET_GENES,SET,718,-0.0032549,-0.00063066,0.032123,0.54035,HDGF_TARGET_GENES,1
MODULE_100,SET,495,-0.0041863,-0.00067773,0.041314,0.54035,MODULE_100,1
BIOCARTA_CHREBP_PATHWAY,SET,19,-0.019638,-0.00063109,0.19359,0.5404,BIOCARTA_CHREBP_PATHWAY,1
HP_CONNECTIVE_TISSUE_NEVI,SET,6,-0.039258,-0.00070923,0.38611,0.54049,HP_CONNECTIVE_TISSUE_NEVI,1
HP_STEREOTYPICAL_BODY_ROCKING,SET,6,-0.032534,-0.00058776,0.31985,0.54051,HP_STEREOTYPICAL_BODY_ROCKING,1
KEGG_MEDICUS_PATHOGEN_HBV_LH...,SET,11,-0.028619,-0.00069996,0.28131,0.54052,KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY,1
REACTOME_UPTAKE_OF_DIETARY_C...,SET,9,-0.032667,-0.00072273,0.32071,0.54056,REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES,1
HP_DECREASED_SERUM_ZINC,SET,4,-0.03748,-0.00055288,0.36799,0.54056,HP_DECREASED_SERUM_ZINC,1
GOCC_NMDA_SELECTIVE_GLUTAMAT...,SET,9,-0.030223,-0.00066866,0.29664,0.54058,GOCC_NMDA_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,1
GSE15330_HSC_VS_MEGAKARYOCYT...3,SET,188,-0.0064027,-0.00064426,0.062732,0.54065,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,1
REACTOME_REGULATION_OF_BETA_...,SET,41,-0.014403,-0.00067954,0.14083,0.54073,REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT,1
GOMF_PROTEIN_MEMBRANE_ADAPTO...,SET,32,-0.014772,-0.00061585,0.14442,0.54073,GOMF_PROTEIN_MEMBRANE_ADAPTOR_ACTIVITY,1
DESCARTES_MAIN_FETAL_PDE1C_A...,SET,238,-0.0054387,-0.0006149,0.053175,0.54073,DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS,1
MIR4277,SET,116,-0.0080372,-0.00063652,0.078534,0.54076,MIR4277,1
GSE360_CTRL_VS_B_MALAYI_LOW_...1,SET,177,-0.0066845,-0.00065283,0.065312,0.54076,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN,1
GOBP_REGULATION_OF_CELL_COMM...2,SET,12,-0.029734,-0.00075954,0.29001,0.54083,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,1
CTCCAAG_MIR432,SET,74,-0.0098386,-0.00062305,0.095817,0.54089,CTCCAAG_MIR432,1
LI_ESTROGENE_MCF7_E2_RESPONS...2,SET,46,-0.013868,-0.00069295,0.13498,0.54092,LI_ESTROGENE_MCF7_E2_RESPONSE_UP,1
GOBP_EXECUTION_PHASE_OF_APOP...,SET,77,-0.010158,-0.00065614,0.098744,0.54097,GOBP_EXECUTION_PHASE_OF_APOPTOSIS,1
HP_ERUPTION_FAILURE,SET,16,-0.022388,-0.00066029,0.21759,0.54097,HP_ERUPTION_FAILURE,1
DACOSTA_UV_RESPONSE_VIA_ERCC...2,SET,65,-0.010639,-0.00063162,0.10334,0.541,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1
GSE19772_CTRL_VS_HCMV_INF_MO...1,SET,184,-0.006596,-0.00065669,0.064033,0.54102,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,1
VIETOR_IFRD1_TARGETS,SET,20,-0.020211,-0.00066636,0.19614,0.54103,VIETOR_IFRD1_TARGETS,1
MISIAK_ANAPLASTIC_THYROID_CA...1,SET,17,-0.022437,-0.00068207,0.21757,0.54107,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN,1
GOCC_H3_HISTONE_ACETYLTRANSF...,SET,8,-0.032111,-0.00066982,0.31122,0.54109,GOCC_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX,1
GSE41176_UNSTIM_VS_ANTI_IGM_...8,SET,184,-0.0066413,-0.00066119,0.064358,0.54109,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP,1
GSE9650_NAIVE_VS_MEMORY_CD8_...1,SET,181,-0.0068021,-0.00067171,0.065874,0.54112,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
BRAUNE_GEIST_20_GENE_NOTCH_S...,SET,20,-0.022256,-0.00073378,0.21543,0.54114,BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER,1
GOBP_CYTOPLASMIC_MICROTUBULE...,SET,58,-0.011344,-0.00063627,0.10969,0.54118,GOBP_CYTOPLASMIC_MICROTUBULE_ORGANIZATION,1
GOBP_SMOOTH_MUSCLE_CELL_CHEM...,SET,8,-0.032529,-0.00067853,0.31457,0.54118,GOBP_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,1
chr14q12,SET,52,-0.024128,-0.0012816,0.23317,0.54121,chr14q12,1
HP_CONSTRICTION_OF_PERIPHERA...,SET,126,-0.0080019,-0.00066029,0.077324,0.54121,HP_CONSTRICTION_OF_PERIPHERAL_VISUAL_FIELD,1
REACTOME_MET_ACTIVATES_RAS_S...,SET,10,-0.025589,-0.00059674,0.24711,0.54124,REACTOME_MET_ACTIVATES_RAS_SIGNALING,1
GOMF_LYSOPHOSPHOLIPASE_ACTIV...,SET,26,-0.016759,-0.0006299,0.16154,0.54131,GOMF_LYSOPHOSPHOLIPASE_ACTIVITY,1
DESCARTES_MAIN_FETAL_ACINAR_...,SET,50,-0.013987,-0.00072855,0.13473,0.54134,DESCARTES_MAIN_FETAL_ACINAR_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...139,SET,42,-0.014246,-0.00068024,0.13718,0.54135,GOBP_NEGATIVE_REGULATION_OF_CHEMOTAXIS,1
GSE5589_UNSTIM_VS_180MIN_LPS...4,SET,180,-0.0065894,-0.00064892,0.063455,0.54135,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP,1
GOBP_CELLULAR_RESPONSE_TO_AC...2,SET,79,-0.010186,-0.00066641,0.097951,0.54141,GOBP_CELLULAR_RESPONSE_TO_ACID_CHEMICAL,1
HP_SKIN_PIT,SET,62,-0.01138,-0.00065984,0.10933,0.54145,HP_SKIN_PIT,1
WP_RAC1PAK1P38MMP2_PATHWAY,SET,66,-0.011185,-0.00066907,0.10721,0.54154,WP_RAC1PAK1P38MMP2_PATHWAY,1
GSE17721_PAM3CSK4_VS_GADIQUI...15,SET,182,-0.0067107,-0.0006645,0.064323,0.54155,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN,1
SUMO1_TARGET_GENES,SET,804,-0.0032038,-0.00065528,0.030696,0.54156,SUMO1_TARGET_GENES,1
MODULE_18,SET,415,-0.0044253,-0.00065744,0.042403,0.54156,MODULE_18,1
GAVISH_3CA_METAPROGRAM_CD8_T...6,SET,47,-0.012783,-0.00064563,0.12232,0.54162,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK,1
GOBP_MAINTENANCE_OF_PROTEIN_...4,SET,62,-0.011169,-0.00064761,0.10683,0.54163,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL,1
REACTOME_ERKS_ARE_INACTIVATED,SET,13,-0.024357,-0.00064758,0.23266,0.54169,REACTOME_ERKS_ARE_INACTIVATED,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...5,SET,291,-0.0051451,-0.00064228,0.049129,0.5417,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING,1
GSE40274_FOXP3_VS_FOXP3_AND_...1,SET,180,-0.0064444,-0.00063465,0.06149,0.54173,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_ORGANIC_ACIDURIA,SET,112,-0.0086735,-0.00067504,0.082716,0.54176,HP_ORGANIC_ACIDURIA,1
HP_AORTIC_DISSECTION,SET,37,-0.016107,-0.00072198,0.15354,0.54177,HP_AORTIC_DISSECTION,1
WEINMANN_ADAPTATION_TO_HYPOX...1,SET,37,-0.016527,-0.00074079,0.15732,0.54183,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,1
HP_INCREASED_CIRCULATING_LAC...2,SET,73,-0.010789,-0.00067865,0.10253,0.5419,HP_INCREASED_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,1
MIR6826_5P,SET,34,-0.014905,-0.00064049,0.1415,0.54194,MIR6826_5P,1
SUBTIL_PROGESTIN_TARGETS,SET,31,-0.016124,-0.00066166,0.15299,0.54197,SUBTIL_PROGESTIN_TARGETS,1
HP_ABSENCE_OF_STOMACH_BUBBLE...,SET,5,-0.041464,-0.00068383,0.39339,0.54197,HP_ABSENCE_OF_STOMACH_BUBBLE_ON_FETAL_SONOGRAPHY,1
GOBP_LOCALIZATION_OF_CELL,SET,5,-0.039252,-0.00064735,0.37213,0.542,GOBP_LOCALIZATION_OF_CELL,1
COULOUARN_TEMPORAL_TGFB1_SIG...1,SET,125,-0.0082186,-0.0006755,0.077897,0.54201,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,1
ELVIDGE_HYPOXIA_UP,SET,155,-0.0075851,-0.00069365,0.071882,0.54202,ELVIDGE_HYPOXIA_UP,1
REACTOME_M_DECAY_DEGRADATION...,SET,31,-0.015944,-0.00065428,0.15106,0.54203,REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS,1
GOMF_N_ACYLTRANSFERASE_ACTIV...,SET,79,-0.0096215,-0.00062946,0.09103,0.54209,GOMF_N_ACYLTRANSFERASE_ACTIVITY,1
GOBP_PEPTIDYL_LYSINE_DEACETY...,SET,5,-0.039339,-0.00064878,0.37181,0.54213,GOBP_PEPTIDYL_LYSINE_DEACETYLATION,1
HP_ABNORMALITY_OF_FOVEAL_PIG...,SET,6,-0.044827,-0.00080983,0.42316,0.54218,HP_ABNORMALITY_OF_FOVEAL_PIGMENTATION,1
GSE41867_NAIVE_VS_DAY8_LCMV_...3,SET,159,-0.0069886,-0.00064722,0.065918,0.54222,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...810,SET,8,-0.033113,-0.00069071,0.31183,0.54228,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,1
GOMF_ACTIVE_MONOATOMIC_ION_T...,SET,261,-0.0056093,-0.00066371,0.052784,0.54231,GOMF_ACTIVE_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,SET,168,-0.0076446,-0.00072756,0.071852,0.54236,WP_VITAMIN_D_RECEPTOR_PATHWAY,1
GSE21033_1H_VS_12H_POLYIC_ST...2,SET,166,-0.0071343,-0.00067497,0.06702,0.54239,GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP,1
GSE8835_CD4_VS_CD8_TCELL_CLL...1,SET,186,-0.0068436,-0.00068498,0.064223,0.54243,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN,1
GOMF_PHOSPHATIDYLINOSITOL_4_...1,SET,9,-0.024042,-0.00053191,0.22547,0.54246,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,1
GOMF_PHOSPHATIDYLINOSITOL_4_...3,SET,9,-0.024042,-0.00053191,0.22547,0.54246,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,1
GOMF_HISTONE_H4K16_ACETYLTRA...,SET,8,-0.030163,-0.00062917,0.2828,0.54247,GOMF_HISTONE_H4K16_ACETYLTRANSFERASE_ACTIVITY,1
GSE18791_CTRL_VS_NEWCASTLE_V...16,SET,182,-0.0064919,-0.00064283,0.06084,0.54249,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP,1
GOCC_BRUSH_BORDER_MEMBRANE,SET,55,-0.01168,-0.00063802,0.10943,0.5425,GOCC_BRUSH_BORDER_MEMBRANE,1
KEGG_MEDICUS_VARIANT_MUTATIO...63,SET,27,-0.016311,-0.00062472,0.15273,0.54252,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT,1
HP_MILIA,SET,16,-0.024161,-0.00071258,0.22623,0.54253,HP_MILIA,1
GSE2124_CTRL_VS_LYMPHOTOXIN_...1,SET,178,-0.0068167,-0.00066761,0.063774,0.54256,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN,1
GSE26030_UNSTIM_VS_RESTIM_TH...8,SET,180,-0.006943,-0.00068375,0.06494,0.54257,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP,1
GOBP_POSITIVE_REGULATION_OF_...762,SET,3,-0.065408,-0.00083561,0.61169,0.54258,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,1
HP_HIP_DISLOCATION,SET,226,-0.0059582,-0.00065665,0.055692,0.5426,HP_HIP_DISLOCATION,1
GSE6259_33D1_POS_DC_VS_CD8_T...2,SET,122,-0.0084536,-0.00068648,0.078961,0.54263,GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...325,SET,5,-0.0394,-0.0006498,0.36763,0.54267,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,1
GOMF_DNA_DIRECTED_DNA_POLYME...,SET,22,-0.015286,-0.00052856,0.14243,0.54273,GOMF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,1
PITX2_Q2,SET,235,-0.0063938,-0.00071838,0.059418,0.54285,PITX2_Q2,1
MIR149_5P,SET,133,-0.0078783,-0.00066778,0.073173,0.54287,MIR149_5P,1
GSE25123_CTRL_VS_ROSIGLITAZO...1,SET,178,-0.0070243,-0.00068794,0.06519,0.5429,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
ROSS_AML_WITH_CBFB_MYH11_FUS...,SET,45,-0.014769,-0.00072994,0.13674,0.54301,ROSS_AML_WITH_CBFB_MYH11_FUSION,1
HP_PROTRUDING_TONGUE,SET,38,-0.015181,-0.0006896,0.14036,0.54307,HP_PROTRUDING_TONGUE,1
HP_RENAL_ATROPHY,SET,7,-0.033971,-0.00066286,0.31404,0.54307,HP_RENAL_ATROPHY,1
WP_INFLAMMATORY_BOWEL_DISEAS...,SET,41,-0.015905,-0.00075038,0.14692,0.5431,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,1
OSMAN_BLADDER_CANCER_DN,SET,353,-0.0046633,-0.00064007,0.043064,0.54312,OSMAN_BLADDER_CANCER_DN,1
GOBP_PROTEIN_DEUBIQUITINATIO...,SET,5,-0.041363,-0.00068216,0.38181,0.54313,GOBP_PROTEIN_DEUBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GOMF_APOLIPOPROTEIN_RECEPTOR...,SET,7,-0.034704,-0.00067717,0.3203,0.54314,GOMF_APOLIPOPROTEIN_RECEPTOR_BINDING,1
GOBP_REGULATION_OF_CALCIUM_I...8,SET,223,-0.0065622,-0.00071846,0.060506,0.54318,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT,1
CLAUS_PGR_POSITIVE_MENINGIOM...2,SET,8,-0.035284,-0.00073601,0.32527,0.54319,CLAUS_PGR_POSITIVE_MENINGIOMA_UP,1
MIR3614_5P,SET,64,-0.01198,-0.00070573,0.11026,0.54326,MIR3614_5P,1
GOBP_REGULATION_OF_EARLY_END...,SET,16,-0.025492,-0.00075183,0.23457,0.54327,GOBP_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,1
MODULE_375,SET,85,-0.01091,-0.00074023,0.10036,0.54328,MODULE_375,1
REACTOME_FATTY_ACID_METABOLI...,SET,167,-0.0074237,-0.00070444,0.068269,0.5433,REACTOME_FATTY_ACID_METABOLISM,1
GOBP_VENTRICULAR_CARDIAC_MUS...4,SET,27,-0.019581,-0.00074997,0.17968,0.54339,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,1
HP_MYELIN_OUTFOLDINGS,SET,7,-0.034644,-0.000676,0.31788,0.54339,HP_MYELIN_OUTFOLDINGS,1
HP_SCAPULOPERONEAL_AMYOTROPHY,SET,5,-0.041626,-0.0006865,0.38187,0.5434,HP_SCAPULOPERONEAL_AMYOTROPHY,1
HP_LOW_BACK_PAIN,SET,13,-0.025061,-0.0006663,0.2298,0.54342,HP_LOW_BACK_PAIN,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...7,SET,10,-0.029239,-0.00068185,0.26802,0.54343,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION,1
SCHUHMACHER_MYC_TARGETS_UP,SET,74,-0.010534,-0.00066708,0.096503,0.54346,SCHUHMACHER_MYC_TARGETS_UP,1
NUNODA_RESPONSE_TO_DASATINIB...1,SET,13,-0.024761,-0.00065832,0.2266,0.5435,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,1
MIR4266,SET,74,-0.010733,-0.00067968,0.098187,0.54352,MIR4266,1
GAVISH_3CA_MALIGNANT_METAPRO...34,SET,36,-0.014286,-0.00063165,0.13071,0.54352,GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED,1
GOMF_PRIMARY_ACTIVE_TRANSMEM...,SET,143,-0.007522,-0.00066093,0.068791,0.54354,GOMF_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_MEMBRANE_...14,SET,5,-0.038353,-0.00063253,0.34985,0.54365,GOBP_REGULATION_OF_MEMBRANE_TUBULATION,1
TERAMOTO_OPN_TARGETS_CLUSTER...5,SET,25,-0.019071,-0.00070291,0.17344,0.54378,TERAMOTO_OPN_TARGETS_CLUSTER_6,1
GOCC_SMN_SM_PROTEIN_COMPLEX,SET,14,-0.024402,-0.00067326,0.22193,0.54378,GOCC_SMN_SM_PROTEIN_COMPLEX,1
HP_IMPAIRED_EXECUTIVE_FUNCTI...,SET,9,-0.033989,-0.00075197,0.30877,0.54383,HP_IMPAIRED_EXECUTIVE_FUNCTIONING,1
GSE6674_UNSTIM_VS_ANTI_IGM_A...2,SET,185,-0.0067945,-0.00067826,0.0617,0.54384,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,1
GOBP_REGULATION_OF_MESODERMA...1,SET,8,-0.036901,-0.00076973,0.33493,0.54386,GOBP_REGULATION_OF_MESODERMAL_CELL_DIFFERENTIATION,1
GSE36888_STAT5_AB_KNOCKIN_VS...1,SET,177,-0.0073061,-0.00071354,0.066319,0.54386,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN,1
WP_PHOTODYNAMIC_THERAPYINDUC...1,SET,49,-0.01424,-0.00073433,0.12923,0.54387,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,1
GOMF_GLYCINE_TRANSMEMBRANE_T...,SET,9,-0.032812,-0.00072594,0.29669,0.54403,GOMF_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE39556_CD8A_DC_VS_NK_CELL_...1,SET,178,-0.0074411,-0.00072876,0.067237,0.54406,GSE39556_CD8A_DC_VS_NK_CELL_DN,1
GOBP_HINDGUT_DEVELOPMENT,SET,8,-0.041489,-0.00086543,0.37411,0.54415,GOBP_HINDGUT_DEVELOPMENT,1
GOMF_ARP2_3_COMPLEX_BINDING,SET,13,-0.025527,-0.00067868,0.2302,0.54415,GOMF_ARP2_3_COMPLEX_BINDING,1
MODULE_26,SET,187,-0.0070901,-0.00071155,0.063904,0.54417,MODULE_26,1
HP_NAIL_DYSTROPHY,SET,125,-0.0087602,-0.00072001,0.078906,0.5442,HP_NAIL_DYSTROPHY,1
KEGG_MEDICUS_REFERENCE_IL2_F...,SET,20,-0.02406,-0.00079327,0.21665,0.54421,KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,1
GOMF_L_GLUTAMINE_TRANSMEMBRA...,SET,8,-0.036793,-0.00076748,0.33128,0.54422,GOMF_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_EXONUCLEASE_ACTIVITY,SET,82,-0.0097636,-0.00065072,0.087887,0.54423,GOMF_EXONUCLEASE_ACTIVITY,1
GOMF_STRUCTURAL_CONSTITUENT_...8,SET,7,-0.03915,-0.00076391,0.3523,0.54424,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,1
GOBP_REGULATION_OF_MEMBRANE_...12,SET,4,-0.052848,-0.00077958,0.47548,0.54425,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GOBP_REGULATION_OF_MEMBRANE_...13,SET,4,-0.052848,-0.00077958,0.47548,0.54425,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GOMF_NAD_DEPENDENT_PROTEIN_L...,SET,7,-0.033629,-0.00065619,0.30236,0.54428,GOMF_NAD_DEPENDENT_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,1
MIYAGAWA_TARGETS_OF_EWSR1_ET...1,SET,204,-0.0074223,-0.00077765,0.066623,0.54435,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,1
GOBP_REGULATION_OF_MEMBRANE_...8,SET,420,-0.005069,-0.0007575,0.045408,0.54444,GOBP_REGULATION_OF_MEMBRANE_POTENTIAL,1
BIOCARTA_KREB_PATHWAY,SET,8,-0.034615,-0.00072204,0.31002,0.54445,BIOCARTA_KREB_PATHWAY,1
HP_ABNORMAL_SERUM_INSULIN_LI...,SET,26,-0.018292,-0.00068753,0.16374,0.54447,HP_ABNORMAL_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1_LEVEL,1
DURANTE_ADULT_OLFACTORY_NEUR...25,SET,25,-0.019888,-0.00073303,0.17774,0.54455,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_UNSPECIFIED,1
GCM_SMARCC1,SET,32,-0.015614,-0.00065096,0.13934,0.54461,GCM_SMARCC1,1
GOMF_NERVE_GROWTH_FACTOR_REC...,SET,4,-0.057949,-0.00085483,0.51679,0.54464,GOMF_NERVE_GROWTH_FACTOR_RECEPTOR_BINDING,1
HP_RECURRENT_SINUSITIS,SET,58,-0.012576,-0.00070536,0.11212,0.54465,HP_RECURRENT_SINUSITIS,1
GSE46606_UNSTIM_VS_CD40L_IL2...15,SET,168,-0.0070296,-0.00066902,0.062644,0.54467,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,1
NAKAYA_PLASMACYTOID_DENDRITI...3,SET,806,-0.0034734,-0.00071128,0.030957,0.54467,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,1
MIR548AU_3P,SET,157,-0.0075903,-0.00069855,0.067565,0.54472,MIR548AU_3P,1
MORF_BRCA1,SET,242,-0.0059809,-0.00068178,0.05324,0.54472,MORF_BRCA1,1
GAUCHER_PBMC_YF_VAX_STAMARIL...7,SET,91,-0.0098651,-0.00069246,0.087806,0.54473,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN,1
ABE_INNER_EAR,SET,39,-0.016205,-0.00074571,0.14414,0.54476,ABE_INNER_EAR,1
MANALO_HYPOXIA_UP,SET,184,-0.0076686,-0.00076347,0.068198,0.54476,MANALO_HYPOXIA_UP,1
REACTOME_NR1H2_NR1H3_REGULAT...5,SET,5,-0.03561,-0.00058728,0.31635,0.54481,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE,1
GAVISH_3CA_METAPROGRAM_B_CEL...4,SET,45,-0.013994,-0.00069164,0.12428,0.54483,GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS,1
KEGG_GLYCOSPHINGOLIPID_BIOSY...1,SET,15,-0.02798,-0.00079904,0.24834,0.54485,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,1
HOLLEMAN_VINCRISTINE_RESISTA...4,SET,36,-0.015718,-0.00069498,0.13948,0.54486,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,1
ROETH_TERT_TARGETS_DN,SET,9,-0.034454,-0.00076227,0.30554,0.54489,ROETH_TERT_TARGETS_DN,1
HP_NASOGASTRIC_TUBE_FEEDING_...,SET,34,-0.016894,-0.00072596,0.14956,0.54497,HP_NASOGASTRIC_TUBE_FEEDING_IN_INFANCY,1
GOBP_REGULATION_OF_ISOTYPE_S...2,SET,6,-0.039105,-0.00070647,0.34606,0.54498,GOBP_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES,1
KEGG_MEDICUS_VARIANT_MUTATIO...61,SET,8,-0.033077,-0.00068996,0.29258,0.545,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
GSE32164_RESTING_DIFFERENTIA...1,SET,183,-0.0073553,-0.0007303,0.06499,0.54505,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN,1
MIR624_5P,SET,97,-0.0098618,-0.00071457,0.087046,0.5451,MIR624_5P,1
HP_PECTUS_EXCAVATUM,SET,263,-0.0059584,-0.00070767,0.052598,0.5451,HP_PECTUS_EXCAVATUM,1
MIR4471,SET,68,-0.01157,-0.00070249,0.1021,0.54511,MIR4471,1
GOBP_REGULATION_OF_VITAMIN_M...,SET,12,-0.027703,-0.00070766,0.24435,0.54513,GOBP_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,1
WP_EFFECTS_OF_MFN2_MUTATION,SET,22,-0.022088,-0.00076376,0.19461,0.54518,WP_EFFECTS_OF_MFN2_MUTATION,1
WP_NUCLEOTIDEBINDING_OLIGOME...,SET,37,-0.01545,-0.00069253,0.13606,0.5452,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,1
MIR5003_5P,SET,177,-0.0074725,-0.0007298,0.065787,0.54522,MIR5003_5P,1
GOBP_POSITIVE_REGULATION_OF_...613,SET,5,-0.051341,-0.00084672,0.45107,0.54531,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
FAN_EMBRYONIC_CTX_IN_1_INTER...,SET,10,-0.035251,-0.00082206,0.30965,0.54532,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,1
GAO_LARGE_INTESTINE_24W_C11_...,SET,293,-0.0061953,-0.00077599,0.054401,0.54533,GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL,1
HP_SLOW_DECREASE_IN_VISUAL_A...,SET,24,-0.020096,-0.00072573,0.17639,0.54535,HP_SLOW_DECREASE_IN_VISUAL_ACUITY,1
GOBP_POSITIVE_REGULATION_OF_...557,SET,34,-0.017531,-0.00075335,0.15355,0.54545,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,1
GOBP_RETINAL_ROD_CELL_DIFFER...,SET,16,-0.024963,-0.00073625,0.21866,0.54545,GOBP_RETINAL_ROD_CELL_DIFFERENTIATION,1
GOCC_ENDOCYTIC_VESICLE_MEMBR...,SET,178,-0.0077667,-0.00076065,0.067996,0.54547,GOCC_ENDOCYTIC_VESICLE_MEMBRANE,1
GSE21927_SPLENIC_C26GM_TUMOR...1,SET,162,-0.0074615,-0.00069745,0.065314,0.54548,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN,1
HP_ABNORMAL_SACCADIC_EYE_MOV...,SET,84,-0.01062,-0.00071634,0.092886,0.54551,HP_ABNORMAL_SACCADIC_EYE_MOVEMENTS,1
GSE3982_DC_VS_BCELL_UP,SET,183,-0.0074971,-0.00074439,0.065559,0.54552,GSE3982_DC_VS_BCELL_UP,1
GOBP_ADHESION_OF_SYMBIONT_TO...2,SET,8,-0.039559,-0.00082518,0.34579,0.54554,GOBP_ADHESION_OF_SYMBIONT_TO_HOST_CELL,1
GOBP_RESPONSE_TO_CHEMOKINE,SET,91,-0.012177,-0.00085477,0.10635,0.54558,GOBP_RESPONSE_TO_CHEMOKINE,1
HP_GASTROINTESTINAL_INFLAMMA...,SET,150,-0.0084346,-0.0007589,0.073657,0.54558,HP_GASTROINTESTINAL_INFLAMMATION,1
GSE12003_MIR223_KO_VS_WT_BM_...1,SET,187,-0.0073571,-0.00073834,0.064238,0.54559,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN,1
MIR30A_5P,SET,709,-0.0038728,-0.00074586,0.033804,0.54561,MIR30A_5P,1
MIR30D_5P,SET,709,-0.0038728,-0.00074586,0.033804,0.54561,MIR30D_5P,1
MIR30E_5P,SET,709,-0.0038728,-0.00074586,0.033804,0.54561,MIR30E_5P,1
GOMF_PHOSPHATIDYLINOSITOL_3_...11,SET,4,-0.038245,-0.00056416,0.33364,0.54563,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_INHIBITOR_ACTIVITY,1
GOMF_PHOSPHATIDYLSERINE_BIND...,SET,65,-0.013168,-0.00078172,0.11483,0.54565,GOMF_PHOSPHATIDYLSERINE_BINDING,1
GOBP_REGULATION_OF_ENDOCYTIC...,SET,18,-0.023753,-0.00074302,0.207,0.54568,GOBP_REGULATION_OF_ENDOCYTIC_RECYCLING,1
GOBP_REGULATION_OF_GLUTAMATE...4,SET,5,-0.046384,-0.00076498,0.40424,0.54568,GOBP_REGULATION_OF_GLUTAMATE_SECRETION_NEUROTRANSMISSION,1
HP_FIBULAR_APLASIA,SET,6,-0.0454,-0.00082018,0.39555,0.54569,HP_FIBULAR_APLASIA,1
HP_NUMEROUS_NEVI,SET,11,-0.029534,-0.00072233,0.2573,0.54569,HP_NUMEROUS_NEVI,1
HP_MICROCYTIC_ANEMIA,SET,37,-0.016695,-0.00074836,0.1454,0.54571,HP_MICROCYTIC_ANEMIA,1
GOBP_POSITIVE_REGULATION_OF_...648,SET,114,-0.0095155,-0.00074711,0.082854,0.54572,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_ST...5,SET,1637,-0.0024799,-0.00070641,0.021558,0.54579,GOBP_CELLULAR_RESPONSE_TO_STRESS,1
KEGG_MEDICUS_REFERENCE_PLASM...,SET,8,-0.037765,-0.00078776,0.32806,0.54582,KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA,1
GOBP_2_OXOGLUTARATE_METABOLI...,SET,16,-0.024424,-0.00072034,0.21207,0.54584,GOBP_2_OXOGLUTARATE_METABOLIC_PROCESS,1
GOBP_SULFATION,SET,20,-0.02513,-0.00082855,0.218,0.54589,GOBP_SULFATION,1
HP_VENTRICULAR_ARRHYTHMIA,SET,188,-0.0073298,-0.00073754,0.06357,0.5459,HP_VENTRICULAR_ARRHYTHMIA,1
GOBP_NEGATIVE_REGULATION_OF_...632,SET,23,-0.019788,-0.00069959,0.17157,0.54591,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,1
DESCARTES_FETAL_PLACENTA_STR...,SET,56,-0.015211,-0.00083837,0.1319,0.54591,DESCARTES_FETAL_PLACENTA_STROMAL_CELLS,1
MODULE_387,SET,48,-0.014134,-0.00072141,0.12239,0.54597,MODULE_387,1
GOBP_REGULATION_OF_WNT_SIGNA...2,SET,15,-0.02801,-0.0007999,0.24222,0.54603,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,1
HP_PARESIS_OF_EXTENSOR_MUSCL...,SET,6,-0.046286,-0.00083619,0.39981,0.54608,HP_PARESIS_OF_EXTENSOR_MUSCLES_OF_THE_BIG_TOE,1
GOBP_CARBOHYDRATE_HOMEOSTASIS,SET,229,-0.006747,-0.00074844,0.058193,0.54615,GOBP_CARBOHYDRATE_HOMEOSTASIS,1
GOMF_PROTEIN_SERINE_KINASE_A...,SET,334,-0.0054076,-0.00072235,0.046633,0.54616,GOMF_PROTEIN_SERINE_KINASE_ACTIVITY,1
REACTOME_ANTIGEN_PROCESSING_...2,SET,287,-0.0056725,-0.00070331,0.048891,0.54618,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1
ZNF581_TARGET_GENES,SET,266,-0.0060594,-0.00072369,0.052186,0.54622,ZNF581_TARGET_GENES,1
GOMF_RECEPTOR_SIGNALING_PROT...,SET,3,-0.04999,-0.00063865,0.42989,0.54629,GOMF_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
HAY_BONE_MARROW_NAIVE_T_CELL,SET,324,-0.0057672,-0.00075897,0.04958,0.5463,HAY_BONE_MARROW_NAIVE_T_CELL,1
GOBP_POSITIVE_REGULATION_OF_...115,SET,20,-0.023773,-0.00078383,0.204,0.54638,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,1
GOBP_SPLICEOSOMAL_COMPLEX_AS...,SET,68,-0.010756,-0.00065307,0.092302,0.54638,GOBP_SPLICEOSOMAL_COMPLEX_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...109,SET,13,-0.026179,-0.00069601,0.22451,0.54641,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPIRATION,1
GSE14000_4H_VS_16H_LPS_DC_TR...1,SET,172,-0.007423,-0.00071475,0.063648,0.54642,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN,1
MIR10524_5P,SET,79,-0.011627,-0.00076068,0.099668,0.54643,MIR10524_5P,1
KIM_BIPOLAR_DISORDER_OLIGODE...1,SET,81,-0.011384,-0.00075409,0.097551,0.54645,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,1
GSE41867_NAIVE_VS_DAY15_LCMV...1,SET,180,-0.0072732,-0.00071627,0.062312,0.54646,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
HP_ABNORMAL_BRANCHING_PATTER...,SET,26,-0.019586,-0.00073617,0.16777,0.54647,HP_ABNORMAL_BRANCHING_PATTERN_OF_THE_AORTIC_ARCH,1
PID_ALPHA_SYNUCLEIN_PATHWAY,SET,30,-0.018496,-0.0007467,0.15801,0.54659,PID_ALPHA_SYNUCLEIN_PATHWAY,1
PID_NFAT_3PATHWAY,SET,53,-0.013946,-0.00074785,0.11914,0.54659,PID_NFAT_3PATHWAY,1
GOMF_PROTEIN_TYROSINE_KINASE...3,SET,118,-0.0091729,-0.00073266,0.07832,0.54662,GOMF_PROTEIN_TYROSINE_KINASE_BINDING,1
HP_TESSIER_CLEFT,SET,17,-0.024287,-0.00073832,0.20723,0.54665,HP_TESSIER_CLEFT,1
NABA_MATRISOME_POORLY_METAST...4,SET,23,-0.021461,-0.00075873,0.18289,0.54671,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,1
GSE41176_WT_VS_TAK1_KO_ANTI_...2,SET,183,-0.0074202,-0.00073674,0.06317,0.54675,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP,1
TBK1.DF_DN,SET,264,-0.0060804,-0.00072351,0.051713,0.5468,TBK1.DF_DN,1
GOCC_SIGNAL_RECOGNITION_PART...,SET,6,-0.031483,-0.00056876,0.26756,0.54683,GOCC_SIGNAL_RECOGNITION_PARTICLE,1
HP_LACUNAR_STROKE,SET,6,-0.038076,-0.00068787,0.32351,0.54685,HP_LACUNAR_STROKE,1
VANGURP_PANCREATIC_GAMMA_CELL,SET,41,-0.018239,-0.00086051,0.1547,0.54693,VANGURP_PANCREATIC_GAMMA_CELL,1
GSE25088_CTRL_VS_ROSIGLITAZO...2,SET,183,-0.007536,-0.00074825,0.063869,0.54696,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
GSE21927_BALBC_VS_C57BL6_MON...1,SET,148,-0.0080775,-0.00072194,0.068378,0.54702,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN,1
MIR6730_5P,SET,120,-0.0090893,-0.00073207,0.076814,0.5471,MIR6730_5P,1
WP_NOTCH_SIGNALING_WP61,SET,58,-0.012901,-0.00072363,0.109,0.54711,WP_NOTCH_SIGNALING_WP61,1
TONKS_TARGETS_OF_RUNX1_RUNX1...7,SET,53,-0.015297,-0.00082029,0.12915,0.54714,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,1
GOBP_CELLULAR_RESPONSE_TO_DE...,SET,27,-0.021933,-0.00084007,0.18517,0.54714,GOBP_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS,1
MIR597_3P,SET,100,-0.010022,-0.00073725,0.084395,0.54726,MIR597_3P,1
GOBP_NEGATIVE_REGULATION_OF_...395,SET,27,-0.019367,-0.00074178,0.16277,0.54736,GOBP_NEGATIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,1
NAKAYA_MONOCYTE_FLUARIX_FLUV...2,SET,75,-0.011891,-0.00075805,0.099863,0.54739,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,1
GOBP_REGULATION_OF_TRANSLATI...4,SET,76,-0.01095,-0.00070269,0.091917,0.54741,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION,1
GOMF_RIBOSOMAL_LARGE_SUBUNIT...,SET,12,-0.028039,-0.00071625,0.23514,0.54746,GOMF_RIBOSOMAL_LARGE_SUBUNIT_BINDING,1
HP_SHORT_FOURTH_METATARSAL,SET,15,-0.025071,-0.00071597,0.20984,0.54755,HP_SHORT_FOURTH_METATARSAL,1
GOCC_MHC_CLASS_I_PEPTIDE_LOA...,SET,8,-0.033891,-0.00070694,0.28359,0.54756,GOCC_MHC_CLASS_I_PEPTIDE_LOADING_COMPLEX,1
CAHOY_ASTROGLIAL,SET,89,-0.011474,-0.00079651,0.09583,0.54765,CAHOY_ASTROGLIAL,1
HP_ABNORMALLY_FOLDED_HELIX,SET,71,-0.012587,-0.00078084,0.10508,0.54767,HP_ABNORMALLY_FOLDED_HELIX,1
WP_CAMKK2_PATHWAY,SET,32,-0.018868,-0.00078664,0.15718,0.54777,WP_CAMKK2_PATHWAY,1
GOBP_DENDRITE_ARBORIZATION,SET,11,-0.031776,-0.00077718,0.26447,0.54782,GOBP_DENDRITE_ARBORIZATION,1
GSE29618_PRE_VS_DAY7_POST_TI...3,SET,177,-0.0073811,-0.00072088,0.061424,0.54782,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...12,SET,14,-0.027902,-0.00076982,0.23214,0.54784,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_ANTEROGRADE_AXONAL_TRAN...2,SET,6,-0.042692,-0.00077127,0.35493,0.54787,GOBP_ANTEROGRADE_AXONAL_TRANSPORT_OF_MITOCHONDRION,1
GOBP_CARNITINE_TRANSMEMBRANE...,SET,6,-0.05635,-0.001018,0.46813,0.5479,GOBP_CARNITINE_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...173,SET,98,-0.01111,-0.00080909,0.092262,0.54792,GOBP_POSITIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,1
HP_MYOPATHIC_FACIES,SET,46,-0.015408,-0.0007699,0.12798,0.54792,HP_MYOPATHIC_FACIES,1
MIR6802_3P,SET,36,-0.017004,-0.00075185,0.14087,0.54804,MIR6802_3P,1
HP_LOW_ALKALINE_PHOSPHATASE,SET,10,-0.0344,-0.00080222,0.28499,0.54804,HP_LOW_ALKALINE_PHOSPHATASE,1
GSE5589_LPS_AND_IL10_VS_LPS_...3,SET,179,-0.0077542,-0.00076154,0.06424,0.54804,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,1
GSE17974_0H_VS_24H_IN_VITRO_...1,SET,178,-0.0073605,-0.00072086,0.060947,0.54806,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN,1
ACEVEDO_LIVER_TUMOR_VS_NORMA...1,SET,241,-0.0067928,-0.00077276,0.056198,0.5481,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,1
GOBP_ACTIN_MODIFICATION,SET,4,-0.049734,-0.00073364,0.41134,0.54812,GOBP_ACTIN_MODIFICATION,1
GOBP_FAT_CELL_DIFFERENTIATION,SET,218,-0.0074736,-0.00080913,0.061786,0.54814,GOBP_FAT_CELL_DIFFERENTIATION,1
HP_CHRONIC_GASTRITIS,SET,2,-0.072649,-0.00075784,0.60056,0.54814,HP_CHRONIC_GASTRITIS,1
GOBP_S_SHAPED_BODY_MORPHOGEN...,SET,7,-0.048608,-0.00094848,0.40176,0.54815,GOBP_S_SHAPED_BODY_MORPHOGENESIS,1
GGGNNTTTCC_NFKB_Q6_01,SET,126,-0.0093989,-0.00077557,0.077673,0.54816,GGGNNTTTCC_NFKB_Q6_01,1
TTTNNANAGCYR_UNKNOWN,SET,79,-0.012117,-0.00079275,0.10004,0.5482,TTTNNANAGCYR_UNKNOWN,1
NIKOLSKY_BREAST_CANCER_12Q13...,SET,42,-0.027688,-0.0013221,0.22833,0.54826,NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,1
GOBP_REGULATION_OF_KIDNEY_SI...,SET,5,-0.050118,-0.00082655,0.4133,0.54826,GOBP_REGULATION_OF_KIDNEY_SIZE,1
HP_SCLEROSIS_OF_HAND_BONE,SET,11,-0.03517,-0.00086018,0.29004,0.54826,HP_SCLEROSIS_OF_HAND_BONE,1
REACTOME_FRS_MEDIATED_FGFR1_...,SET,23,-0.021722,-0.00076798,0.17907,0.54827,REACTOME_FRS_MEDIATED_FGFR1_SIGNALING,1
HP_BROAD_FACE,SET,15,-0.027872,-0.00079596,0.22981,0.54827,HP_BROAD_FACE,1
GOBP_NEGATIVE_REGULATION_OF_...404,SET,5,-0.055116,-0.00090898,0.4543,0.54828,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
HP_CYANOSIS,SET,100,-0.01058,-0.00077828,0.087098,0.54834,HP_CYANOSIS,1
GOBP_EOSINOPHIL_MIGRATION,SET,28,-0.023434,-0.00091399,0.19289,0.54835,GOBP_EOSINOPHIL_MIGRATION,1
GOMF_AROMATIC_AMINO_ACID_TRA...,SET,8,-0.037892,-0.0007904,0.31138,0.54843,GOMF_AROMATIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_CERVICAL_CORD_COMPRESSION,SET,6,-0.043858,-0.00079232,0.36022,0.54845,HP_CERVICAL_CORD_COMPRESSION,1
HP_SEVERE_FAILURE_TO_THRIVE,SET,16,-0.026642,-0.00078577,0.21871,0.54848,HP_SEVERE_FAILURE_TO_THRIVE,1
IGARASHI_ATF4_TARGETS_DN,SET,88,-0.011442,-0.00078989,0.093856,0.54852,IGARASHI_ATF4_TARGETS_DN,1
GSE11961_MEMORY_BCELL_DAY40_...2,SET,182,-0.0076034,-0.00075289,0.062319,0.54855,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GSE3565_DUSP1_VS_WT_SPLENOCY...2,SET,146,-0.0090638,-0.00080464,0.074232,0.54859,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN,1
MIR4680_3P,SET,228,-0.0069677,-0.00077125,0.057048,0.5486,MIR4680_3P,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...6,SET,34,-0.021572,-0.00092701,0.17645,0.54865,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
GOBP_CGMP_METABOLIC_PROCESS,SET,13,-0.030442,-0.00080937,0.24841,0.54877,GOBP_CGMP_METABOLIC_PROCESS,1
GOBP_SENSORY_SYSTEM_DEVELOPM...,SET,383,-0.0057609,-0.00082294,0.047003,0.54877,GOBP_SENSORY_SYSTEM_DEVELOPMENT,1
GOBP_MAINTENANCE_OF_PROTEIN_...7,SET,24,-0.020249,-0.00073128,0.16503,0.54883,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS,1
GSE42021_CD24HI_VS_CD24INT_T...3,SET,182,-0.0080991,-0.00080198,0.066001,0.54883,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...357,SET,13,-0.031754,-0.00084423,0.25834,0.54891,GOBP_NEGATIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
MIR4662A_3P,SET,63,-0.013919,-0.00081354,0.1131,0.54897,MIR4662A_3P,1
GSE21927_SPLEEN_C57BL6_VS_4T...1,SET,185,-0.0076256,-0.00076122,0.061938,0.54899,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN,1
GOBP_RESPONSE_TO_MITOCHONDRI...,SET,16,-0.024763,-0.00073033,0.20107,0.54901,GOBP_RESPONSE_TO_MITOCHONDRIAL_DEPOLARISATION,1
GOBP_RESPONSE_TO_CYCLOHEXIMI...,SET,5,-0.054144,-0.00089295,0.43894,0.54908,GOBP_RESPONSE_TO_CYCLOHEXIMIDE,1
chr10p12,SET,45,-0.02804,-0.0013858,0.22726,0.5491,chr10p12,1
GOBP_CELLULAR_RESPONSE_TO_MA...3,SET,9,-0.034737,-0.00076852,0.28133,0.54913,GOBP_CELLULAR_RESPONSE_TO_MANGANESE_ION,1
HP_VERY_LOW_VISUAL_ACUITY,SET,5,-0.051355,-0.00084695,0.41561,0.54917,HP_VERY_LOW_VISUAL_ACUITY,1
GOBP_SUPPRESSION_OF_VIRAL_RE...,SET,14,-0.030385,-0.00083832,0.24561,0.54923,GOBP_SUPPRESSION_OF_VIRAL_RELEASE_BY_HOST,1
FAN_OVARY_CL8_MATURE_CUMULUS...,SET,541,-0.0045326,-0.00076615,0.036626,0.54924,FAN_OVARY_CL8_MATURE_CUMULUS_GRANULOSA_CELL_2,1
WP_IL3_SIGNALING,SET,46,-0.016521,-0.0008255,0.13349,0.54925,WP_IL3_SIGNALING,1
GSE13547_2H_VS_12_H_ANTI_IGM...4,SET,154,-0.0084982,-0.00077466,0.068618,0.54928,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP,1
GOMF_P_TYPE_POTASSIUM_TRANSM...,SET,8,-0.042621,-0.00088905,0.34381,0.54933,GOMF_P_TYPE_POTASSIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE23505_UNTREATED_VS_4DAY_I...5,SET,184,-0.0079431,-0.00079079,0.064071,0.54933,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN,1
MIR155_3P,SET,85,-0.011352,-0.00077025,0.091412,0.54942,MIR155_3P,1
GSE19401_UNSTIM_VS_RETINOIC_...4,SET,183,-0.0078163,-0.00077608,0.062926,0.54943,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,1
GOBP_REGULATION_OF_FOCAL_ADH...,SET,6,-0.046812,-0.00084569,0.37667,0.54945,GOBP_REGULATION_OF_FOCAL_ADHESION_DISASSEMBLY,1
GSE15330_WT_VS_IKAROS_KO_HSC...2,SET,178,-0.0078544,-0.00076924,0.063209,0.54945,GSE15330_WT_VS_IKAROS_KO_HSC_UP,1
GOCC_EARP_COMPLEX,SET,3,-0.052485,-0.00067052,0.42197,0.54949,GOCC_EARP_COMPLEX,1
GOMF_HISTONE_H3_METHYLTRANSF...,SET,40,-0.016649,-0.00077586,0.13382,0.5495,GOMF_HISTONE_H3_METHYLTRANSFERASE_ACTIVITY,1
GOBP_RESPONSE_TO_MUSCLE_INAC...,SET,9,-0.038916,-0.00086098,0.3127,0.54952,GOBP_RESPONSE_TO_MUSCLE_INACTIVITY,1
GGAANCGGAANY_UNKNOWN,SET,103,-0.0099547,-0.00074315,0.079857,0.5496,GGAANCGGAANY_UNKNOWN,1
GOBP_LEUKOCYTE_AGGREGATION,SET,12,-0.034408,-0.00087895,0.27594,0.54962,GOBP_LEUKOCYTE_AGGREGATION,1
GOBP_ACTIVATION_INDUCED_CELL...,SET,8,-0.04013,-0.00083708,0.32171,0.54963,GOBP_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS,1
GOBP_GLYCEROPHOSPHOLIPID_MET...,SET,277,-0.0063903,-0.0007786,0.051222,0.54964,GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS,1
MIR6861_3P,SET,45,-0.0155,-0.00076605,0.12421,0.54966,MIR6861_3P,1
REACTOME_LIPID_PARTICLE_ORGA...,SET,6,-0.047735,-0.00086238,0.38205,0.54972,REACTOME_LIPID_PARTICLE_ORGANIZATION,1
DESCARTES_MAIN_FETAL_CCL19_C...,SET,159,-0.0086125,-0.00079761,0.068904,0.54973,DESCARTES_MAIN_FETAL_CCL19_CCL21_POSITIVE_CELLS,1
HP_SCHISTOCYTOSIS,SET,10,-0.033419,-0.00077934,0.26716,0.54977,HP_SCHISTOCYTOSIS,1
GSE15930_STIM_VS_STIM_AND_IF...2,SET,176,-0.0075984,-0.00074001,0.060739,0.54978,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP,1
REACTOME_DEFECTS_IN_VITAMIN_...,SET,20,-0.024084,-0.00079406,0.19235,0.54982,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,1
MODULE_505,SET,16,-0.028683,-0.00084595,0.22902,0.54983,MODULE_505,1
GOBP_REGULATION_OF_RESPIRATO...5,SET,14,-0.031404,-0.00086643,0.25063,0.54986,GOBP_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS,1
CUI_DEVELOPING_HEART_LEFT_VE...,SET,37,-0.019939,-0.00089376,0.1591,0.54986,CUI_DEVELOPING_HEART_LEFT_VENTRICULAR_CARDIOMYOCYTE,1
GSE29618_MONOCYTE_VS_PDC_DN,SET,170,-0.0083199,-0.00079648,0.066356,0.54989,GSE29618_MONOCYTE_VS_PDC_DN,1
YUAN_ZNF143_PARTNERS,SET,20,-0.023617,-0.00077867,0.18832,0.5499,YUAN_ZNF143_PARTNERS,1
GSE37319_WT_VS_RC3H1_KO_CD44...2,SET,130,-0.0097966,-0.00082102,0.077981,0.54999,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP,1
HP_MOTOR_AXONAL_NEUROPATHY,SET,34,-0.016717,-0.00071839,0.13296,0.55003,HP_MOTOR_AXONAL_NEUROPATHY,1
HP_SCLEROSIS_OF_FINGER_PHALA...,SET,8,-0.043322,-0.00090366,0.34433,0.55006,HP_SCLEROSIS_OF_FINGER_PHALANX,1
TURASHVILI_BREAST_LOBULAR_CA...3,SET,67,-0.013964,-0.00084162,0.11092,0.55009,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,1
HP_CERVICAL_C2_C3_VERTEBRAL_...,SET,11,-0.032828,-0.00080289,0.26064,0.55011,HP_CERVICAL_C2_C3_VERTEBRAL_FUSION,1
MYLLYKANGAS_AMPLIFICATION_HO...6,SET,5,-0.049871,-0.00082248,0.39593,0.55012,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2,1
GOBP_POSITIVE_REGULATION_OF_...576,SET,79,-0.013292,-0.0008696,0.10549,0.55013,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
GSE3982_MAST_CELL_VS_TH1_UP,SET,180,-0.0082147,-0.00080899,0.065146,0.55017,GSE3982_MAST_CELL_VS_TH1_UP,1
chr13q13,SET,31,-0.034794,-0.0014278,0.27534,0.55028,chr13q13,1
GOMF_CATECHOLAMINE_BINDING,SET,12,-0.035772,-0.00091379,0.28301,0.55029,GOMF_CATECHOLAMINE_BINDING,1
GOBP_DORSAL_AORTA_DEVELOPMENT,SET,10,-0.039241,-0.00091511,0.31033,0.55031,GOBP_DORSAL_AORTA_DEVELOPMENT,1
GSE43863_NAIVE_VS_TH1_EFF_CD...1,SET,147,-0.0092555,-0.00082445,0.073178,0.55032,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN,1
MYLLYKANGAS_AMPLIFICATION_HO...4,SET,18,-0.023302,-0.00072891,0.1837,0.55047,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,1
WAGNER_APO2_SENSITIVITY,SET,25,-0.024161,-0.0008905,0.19048,0.55047,WAGNER_APO2_SENSITIVITY,1
HOLLEMAN_VINCRISTINE_RESISTA...1,SET,19,-0.025338,-0.00081429,0.19954,0.55052,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,1
WIERENGA_STAT5A_TARGETS_GROU...2,SET,50,-0.017013,-0.00088618,0.13363,0.55065,WIERENGA_STAT5A_TARGETS_GROUP2,1
HP_MUSCLE_FIBER_NECROSIS,SET,10,-0.035092,-0.00081836,0.27547,0.55068,HP_MUSCLE_FIBER_NECROSIS,1
GSE2405_0H_VS_1.5H_A_PHAGOCY...2,SET,189,-0.0082159,-0.00082888,0.064453,0.55072,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
GOBP_CELLULAR_RESPONSE_TO_HE...,SET,59,-0.014119,-0.00079871,0.11071,0.55074,GOBP_CELLULAR_RESPONSE_TO_HEAT,1
GOBP_CELLULAR_RESPONSE_TO_ST...4,SET,14,-0.029241,-0.00080675,0.22914,0.55077,GOBP_CELLULAR_RESPONSE_TO_STEROL_DEPLETION,1
FIRESTEIN_CTNNB1_PATHWAY,SET,26,-0.02201,-0.00082727,0.17232,0.55082,FIRESTEIN_CTNNB1_PATHWAY,1
HUANG_FOXA2_TARGETS_DN,SET,35,-0.018967,-0.00082695,0.14848,0.55082,HUANG_FOXA2_TARGETS_DN,1
GOBP_PEPTIDYL_TYROSINE_DEPHO...2,SET,7,-0.043468,-0.00084818,0.34004,0.55086,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION_INVOLVED_IN_INACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,1
GOBP_LOBAR_BRONCHUS_EPITHELI...,SET,5,-0.056274,-0.00092808,0.43995,0.55089,GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT,1
HP_REDUCED_PROGRESSIVE_SPERM...,SET,15,-0.026435,-0.00075491,0.20661,0.5509,HP_REDUCED_PROGRESSIVE_SPERM_MOTILITY,1
HP_MONOCHROMACY,SET,8,-0.040686,-0.00084869,0.31789,0.55092,HP_MONOCHROMACY,1
MOHANKUMAR_HOXA1_TARGETS_DN,SET,151,-0.0096446,-0.00087063,0.075308,0.55095,MOHANKUMAR_HOXA1_TARGETS_DN,1
MIR4789_5P,SET,350,-0.0059413,-0.00081207,0.046398,0.55095,MIR4789_5P,1
MIR3180_5P,SET,289,-0.0066063,-0.0008219,0.051571,0.55097,MIR3180_5P,1
GOBP_RELAXATION_OF_MUSCLE,SET,31,-0.020852,-0.00085567,0.16259,0.55102,GOBP_RELAXATION_OF_MUSCLE,1
GOBP_UDP_N_ACETYLGLUCOSAMINE...2,SET,14,-0.030743,-0.00084819,0.23969,0.55103,GOBP_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,1
HAMAI_APOPTOSIS_VIA_TRAIL_DN,SET,178,-0.0081939,-0.00080249,0.063797,0.5511,HAMAI_APOPTOSIS_VIA_TRAIL_DN,1
HEIDENBLAD_AMPLICON_12P11_12...1,SET,20,-0.02517,-0.00082988,0.19598,0.5511,HEIDENBLAD_AMPLICON_12P11_12_DN,1
REACTOME_APOPTOTIC_CLEAVAGE_...2,SET,11,-0.03746,-0.00091618,0.2915,0.55112,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS,1
HP_SUBCORTICAL_BAND_HETEROTO...,SET,10,-0.031135,-0.00072607,0.24214,0.55116,HP_SUBCORTICAL_BAND_HETEROTOPIA,1
GOBP_G_PROTEIN_COUPLED_GLUTA...,SET,15,-0.029948,-0.00085525,0.2327,0.5512,GOBP_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
HP_AGENESIS_OF_PERMANENT_TEE...,SET,19,-0.024982,-0.00080284,0.1941,0.5512,HP_AGENESIS_OF_PERMANENT_TEETH,1
GOBP_POSITIVE_REGULATION_OF_...748,SET,22,-0.023814,-0.00082344,0.185,0.55121,GOBP_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
KEGG_MEDICUS_REFERENCE_AUTOP...9,SET,13,-0.03356,-0.00089226,0.26035,0.55128,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR,1
GOBP_DNA_STRAND_ELONGATION,SET,35,-0.016781,-0.00073161,0.1302,0.55128,GOBP_DNA_STRAND_ELONGATION,1
GOBP_NEGATIVE_REGULATION_OF_...497,SET,18,-0.028944,-0.00090539,0.22451,0.55129,GOBP_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION,1
GOBP_RESPONSE_TO_ZINC_ION,SET,44,-0.01737,-0.00084892,0.1347,0.5513,GOBP_RESPONSE_TO_ZINC_ION,1
GSE11961_FOLLICULAR_BCELL_VS...6,SET,180,-0.0083571,-0.00082301,0.06481,0.5513,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP,1
GOBP_MEMBRANE_PROTEIN_PROTEO...,SET,57,-0.014221,-0.00079076,0.11019,0.55134,GOBP_MEMBRANE_PROTEIN_PROTEOLYSIS,1
NAGASHIMA_EGF_SIGNALING_UP,SET,53,-0.016629,-0.00089173,0.12866,0.55142,NAGASHIMA_EGF_SIGNALING_UP,1
GSE12845_IGD_NEG_BLOOD_VS_NA...1,SET,182,-0.0079995,-0.00079212,0.061879,0.55143,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,1
HP_CAFE_AU_LAIT_SPOT,SET,120,-0.0094665,-0.00076244,0.073211,0.55144,HP_CAFE_AU_LAIT_SPOT,1
HP_SUPRAVENTRICULAR_ARRHYTHM...,SET,111,-0.01146,-0.00088793,0.088617,0.55145,HP_SUPRAVENTRICULAR_ARRHYTHMIA,1
GOBP_POSITIVE_REGULATION_OF_...714,SET,79,-0.013298,-0.00086998,0.10275,0.55149,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
LEIN_MEDULLA_MARKERS,SET,76,-0.013087,-0.00083983,0.101,0.55154,LEIN_MEDULLA_MARKERS,1
PID_PTP1B_PATHWAY,SET,52,-0.016491,-0.00087598,0.12721,0.55157,PID_PTP1B_PATHWAY,1
HP_DISTAL_AMYOTROPHY,SET,199,-0.0076651,-0.00079328,0.059136,0.55157,HP_DISTAL_AMYOTROPHY,1
GSE2706_R848_VS_R848_AND_LPS...1,SET,164,-0.0091944,-0.00086467,0.070925,0.55157,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...113,SET,342,-0.006349,-0.00085801,0.048965,0.55158,GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION,1
GSE42021_TREG_PLN_VS_CD24LO_...1,SET,181,-0.0084096,-0.00083046,0.064746,0.55167,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN,1
MIR3907,SET,49,-0.015949,-0.00082243,0.12276,0.55168,MIR3907,1
GOBP_POSITIVE_REGULATION_OF_...616,SET,6,-0.04228,-0.00076382,0.3254,0.55169,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION,1
HP_ABNORMAL_THORAX_MORPHOLOGY,SET,783,-0.0040366,-0.00081526,0.031067,0.55169,HP_ABNORMAL_THORAX_MORPHOLOGY,1
GOBP_WHITE_FAT_CELL_DIFFEREN...,SET,16,-0.028623,-0.00084419,0.22009,0.55174,GOBP_WHITE_FAT_CELL_DIFFERENTIATION,1
KAECH_NAIVE_VS_MEMORY_CD8_TC...1,SET,184,-0.0084612,-0.00084238,0.065054,0.55174,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
GSE22886_NAIVE_VS_IGG_IGA_ME...1,SET,173,-0.0088238,-0.00085207,0.067806,0.55177,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN,1
BIOCARTA_RACCYCD_PATHWAY,SET,25,-0.021052,-0.00077593,0.16173,0.55178,BIOCARTA_RACCYCD_PATHWAY,1
GOBP_RESPONSE_TO_PHENYLPROPA...,SET,4,-0.064092,-0.00094545,0.49217,0.5518,GOBP_RESPONSE_TO_PHENYLPROPANOID,1
GOBP_REGULATION_OF_DIGESTIVE...,SET,38,-0.018385,-0.00083514,0.14115,0.55182,GOBP_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
HP_SKIN_PLAQUE,SET,41,-0.017475,-0.00082447,0.13413,0.55183,HP_SKIN_PLAQUE,1
HP_REDUCED_CEREBRAL_WHITE_MA...,SET,31,-0.020269,-0.00083176,0.15549,0.55186,HP_REDUCED_CEREBRAL_WHITE_MATTER_VOLUME,1
MIR4713_5P,SET,140,-0.0094293,-0.00081985,0.072304,0.55188,MIR4713_5P,1
GOBP_PROTEIN_DEACETYLATION,SET,37,-0.017208,-0.00077132,0.13196,0.55188,GOBP_PROTEIN_DEACETYLATION,1
KEGG_MEDICUS_REFERENCE_TSH_D...,SET,12,-0.031908,-0.00081508,0.24458,0.5519,KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY,1
SHETH_LIVER_CANCER_VS_TXNIP_...2,SET,152,-0.0094135,-0.00085255,0.072141,0.55191,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1
HP_SMALL_PLACENTA,SET,9,-0.041631,-0.00092105,0.31904,0.55191,HP_SMALL_PLACENTA,1
GOBP_RNA_PROCESSING,SET,833,-0.0036949,-0.00076861,0.028308,0.55192,GOBP_RNA_PROCESSING,1
GSE29618_PDC_VS_MDC_DAY7_FLU...2,SET,173,-0.0088941,-0.00085886,0.068089,0.55196,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP,1
FAN_EMBRYONIC_CTX_BRAIN_MYEL...,SET,121,-0.010852,-0.00087767,0.083001,0.55201,FAN_EMBRYONIC_CTX_BRAIN_MYELOID,1
SENGUPTA_NASOPHARYNGEAL_CARC...4,SET,362,-0.0061409,-0.00085333,0.046884,0.5521,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,1
HP_PROFOUND_GLOBAL_DEVELOPME...,SET,59,-0.014243,-0.0008057,0.10876,0.5521,HP_PROFOUND_GLOBAL_DEVELOPMENTAL_DELAY,1
GNF2_ZAP70,SET,23,-0.023347,-0.0008254,0.17823,0.55211,GNF2_ZAP70,1
GSE22611_NOD2_VS_MUTANT_NOD2...2,SET,170,-0.008434,-0.0008074,0.064376,0.55212,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,1
HP_ACHROMATOPSIA,SET,5,-0.058125,-0.0009586,0.44352,0.55213,HP_ACHROMATOPSIA,1
BIOCARTA_INTRINSIC_PATHWAY,SET,19,-0.028477,-0.00091517,0.21716,0.55217,BIOCARTA_INTRINSIC_PATHWAY,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,SET,43,-0.018833,-0.0009099,0.14355,0.55219,MCDOWELL_ACUTE_LUNG_INJURY_UP,1
GOCC_OMEGASOME,SET,4,-0.04227,-0.00062354,0.32218,0.55219,GOCC_OMEGASOME,1
MODULE_288,SET,34,-0.022951,-0.00098627,0.1748,0.55223,MODULE_288,1
GOBP_NEGATIVE_REGULATION_OF_...28,SET,9,-0.038889,-0.00086037,0.29604,0.55226,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_ABNORMALITY_OF_THE_GLABEL...,SET,22,-0.024898,-0.00086091,0.18952,0.55226,HP_ABNORMALITY_OF_THE_GLABELLA,1
GOBP_ENDOSOMAL_LUMEN_ACIDIFI...,SET,11,-0.0329,-0.00080466,0.2502,0.55231,GOBP_ENDOSOMAL_LUMEN_ACIDIFICATION,1
MIR519A_2_5P_MIR520B_5P,SET,190,-0.008135,-0.00082287,0.061813,0.55235,MIR519A_2_5P_MIR520B_5P,1
GOBP_COCHLEA_MORPHOGENESIS,SET,22,-0.026054,-0.0009009,0.19788,0.55238,GOBP_COCHLEA_MORPHOGENESIS,1
chr15q22,SET,65,-0.026999,-0.0016028,0.20471,0.55246,chr15q22,1
WP_SPHINGOLIPID_PATHWAY,SET,27,-0.022689,-0.00086903,0.17195,0.55249,WP_SPHINGOLIPID_PATHWAY,1
GOMF_SH2_DOMAIN_BINDING,SET,39,-0.019689,-0.00090605,0.14914,0.55251,GOMF_SH2_DOMAIN_BINDING,1
HP_FACIAL_HYPOTONIA,SET,41,-0.017289,-0.00081569,0.13097,0.55251,HP_FACIAL_HYPOTONIA,1
GOBP_EPIDIDYMIS_DEVELOPMENT,SET,3,-0.07875,-0.0010061,0.59593,0.55256,GOBP_EPIDIDYMIS_DEVELOPMENT,1
GSE20727_CTRL_VS_DNFB_ALLERG...1,SET,165,-0.0088645,-0.00083615,0.067,0.55263,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN,1
DESCARTES_MAIN_FETAL_CLC_IL5...,SET,151,-0.0088734,-0.00080101,0.067053,0.55264,DESCARTES_MAIN_FETAL_CLC_IL5RA_POSITIVE_CELLS,1
GOBP_DNA_DAMAGE_RESPONSE_SIG...1,SET,67,-0.014049,-0.00084673,0.10613,0.55265,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
chr1p32,SET,63,-0.025453,-0.0014877,0.19218,0.55268,chr1p32,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...5,SET,35,-0.020253,-0.00088299,0.15292,0.55268,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS,1
GSE43863_DAY6_EFF_VS_DAY150_...4,SET,184,-0.0085259,-0.00084882,0.064351,0.5527,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP,1
MIR6769A_5P,SET,43,-0.017409,-0.0008411,0.13135,0.55272,MIR6769A_5P,1
GSE17974_IL4_AND_ANTI_IL12_V...1,SET,135,-0.010113,-0.00086358,0.076292,0.55273,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN,1
GSE40068_CXCR5POS_BCL6POS_TF...2,SET,177,-0.0082544,-0.00080616,0.062252,0.55274,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP,1
GSE46606_UNSTIM_VS_CD40L_IL2...7,SET,180,-0.0086216,-0.00084906,0.065008,0.55275,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,1
PANAPASA_BLOOD_FLUENZ_AGE_03...2,SET,9,-0.042618,-0.00094289,0.32099,0.55281,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_6DY_7DY_UP,1
HIPC_SIGNATURES_PROJECT_PBMC...1,SET,6,-0.043876,-0.00079266,0.33043,0.55282,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_DOWN,1
KEGG_MEDICUS_REFERENCE_SPIND...,SET,20,-0.026023,-0.00085802,0.19591,0.55284,KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,1
PID_FRA_PATHWAY,SET,35,-0.019957,-0.00087011,0.15022,0.55284,PID_FRA_PATHWAY,1
WP_ESTROGEN_METABOLISM_WP697,SET,14,-0.034563,-0.00095359,0.26018,0.55284,WP_ESTROGEN_METABOLISM_WP697,1
GSE42724_NAIVE_BCELL_VS_PLAS...2,SET,181,-0.0086869,-0.00085784,0.065375,0.55285,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP,1
HP_PATELLAR_APLASIA,SET,20,-0.02743,-0.00090439,0.20639,0.55286,HP_PATELLAR_APLASIA,1
GSE21380_NON_TFH_VS_TFH_CD4_...1,SET,180,-0.008578,-0.00084477,0.064519,0.55288,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...70,SET,127,-0.010089,-0.00083582,0.075842,0.55291,HP_APLASIA_HYPOPLASIA_OF_THE_THUMB,1
GOMF_MEDIUM_CHAIN_FATTY_ACID...,SET,9,-0.045773,-0.0010127,0.34387,0.55295,GOMF_MEDIUM_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
HP_INTRAALVEOLAR_PHOSPHOLIPI...,SET,7,-0.050405,-0.00098355,0.37858,0.55296,HP_INTRAALVEOLAR_PHOSPHOLIPID_ACCUMULATION,1
GSE45365_WT_VS_IFNAR_KO_CD11...1,SET,154,-0.0089395,-0.00081488,0.067139,0.55296,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN,1
HP_APLASIA_HYPOPLASIA_INVOLV...12,SET,64,-0.01476,-0.00086948,0.11076,0.553,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_PELVIS,1
PID_ECADHERIN_KERATINOCYTE_P...,SET,21,-0.024533,-0.00082882,0.18397,0.55304,PID_ECADHERIN_KERATINOCYTE_PATHWAY,1
GSE17721_CTRL_VS_PAM3CSK4_8H...2,SET,178,-0.0083716,-0.00081989,0.062738,0.55307,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP,1
TRAVAGLINI_LUNG_FIBROMYOCYTE...,SET,21,-0.028266,-0.00095495,0.21184,0.55307,TRAVAGLINI_LUNG_FIBROMYOCYTE_CELL,1
GOBP_SKELETAL_MUSCLE_ADAPTAT...,SET,22,-0.02552,-0.00088243,0.19124,0.55308,GOBP_SKELETAL_MUSCLE_ADAPTATION,1
GSE6259_33D1_POS_DC_VS_CD4_T...2,SET,161,-0.0089418,-0.00083325,0.067002,0.55308,GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP,1
HP_LEFT_VENTRICULAR_OUTFLOW_...,SET,8,-0.047008,-0.00098056,0.35199,0.55312,HP_LEFT_VENTRICULAR_OUTFLOW_TRACT_OBSTRUCTION,1
GOBP_TELOMERE_CAPPING,SET,37,-0.017207,-0.0007713,0.1288,0.55314,GOBP_TELOMERE_CAPPING,1
GSE18281_SUBCAPSULAR_CORTICA...1,SET,167,-0.0088097,-0.00083596,0.065946,0.55314,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,1
WP_APOPTOSIS_MODULATION_BY_H...,SET,18,-0.027162,-0.00084964,0.20326,0.55315,WP_APOPTOSIS_MODULATION_BY_HSP70,1
PAPASPYRIDONOS_UNSTABLE_ATER...1,SET,39,-0.018454,-0.00084922,0.13779,0.55327,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1
REACTOME_GLYCOSPHINGOLIPID_M...,SET,50,-0.016952,-0.00088302,0.12647,0.55331,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,1
HOEK_MYELOID_DENDRITIC_CELL_...4,SET,3,-0.079338,-0.0010136,0.59167,0.55333,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_UP,1
GSE7460_FOXP3_MUT_VS_WT_ACT_...1,SET,184,-0.0084301,-0.00083928,0.062844,0.55335,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN,1
GOMF_GTPASE_ACTIVITY,SET,287,-0.0068851,-0.00085367,0.051246,0.55344,GOMF_GTPASE_ACTIVITY,1
GSE28237_EARLY_VS_LATE_GC_BC...2,SET,183,-0.0089224,-0.0008859,0.066389,0.55345,GSE28237_EARLY_VS_LATE_GC_BCELL_UP,1
HP_TETRAPLEGIA_TETRAPARESIS,SET,125,-0.010184,-0.00083701,0.075738,0.55348,HP_TETRAPLEGIA_TETRAPARESIS,1
HP_LONG_EAR,SET,6,-0.040513,-0.0007319,0.30123,0.55349,HP_LONG_EAR,1
WP_TH17_CELL_DIFFERENTIATION...,SET,67,-0.015298,-0.00092201,0.11371,0.55351,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,1
GOBP_AORTA_MORPHOGENESIS,SET,33,-0.022182,-0.00093911,0.16485,0.55352,GOBP_AORTA_MORPHOGENESIS,1
HONMA_DOCETAXEL_RESISTANCE,SET,32,-0.022114,-0.00092196,0.16427,0.55354,HONMA_DOCETAXEL_RESISTANCE,1
GOBP_EARLY_ENDOSOME_TO_GOLGI...,SET,16,-0.02627,-0.00077478,0.19506,0.55356,GOBP_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT,1
HP_PERIPHERAL_ARTERIAL_STENO...,SET,31,-0.022767,-0.00093426,0.16894,0.5536,HP_PERIPHERAL_ARTERIAL_STENOSIS,1
GERHOLD_RESPONSE_TO_TZD_UP,SET,6,-0.052665,-0.00095142,0.39061,0.55362,GERHOLD_RESPONSE_TO_TZD_UP,1
KEGG_MEDICUS_REFERENCE_RETRO...,SET,42,-0.017497,-0.0008355,0.12978,0.55362,KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT,1
HP_RETINAL_PERFORATION,SET,10,-0.037378,-0.00087165,0.27723,0.55362,HP_RETINAL_PERFORATION,1
GSE33513_TCF7_KO_VS_HET_EARL...1,SET,181,-0.0083968,-0.0008292,0.062258,0.55364,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN,1
GSE7768_OVA_ALONE_VS_OVA_WIT...1,SET,158,-0.0094738,-0.00087463,0.070251,0.55364,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,1
GSE22025_PROGESTERONE_VS_TGF...1,SET,181,-0.0089014,-0.00087902,0.065993,0.55365,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,1
GSE13484_UNSTIM_VS_YF17D_VAC...2,SET,179,-0.0081874,-0.00080408,0.060678,0.55367,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,1
ZNF274_TARGET_GENES,SET,743,-0.0042788,-0.00084277,0.031664,0.55375,ZNF274_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...460,SET,7,-0.047642,-0.00092962,0.35253,0.55375,GOBP_POSITIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,1
GSE27786_BCELL_VS_CD8_TCELL_...1,SET,180,-0.0085899,-0.00084593,0.063441,0.55385,GSE27786_BCELL_VS_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...143,SET,10,-0.037314,-0.00087017,0.27547,0.55387,GOBP_POSITIVE_REGULATION_OF_CELL_SIZE,1
GOBP_MESENCHYMAL_CELL_PROLIF...2,SET,6,-0.054111,-0.00097755,0.39942,0.55388,GOBP_MESENCHYMAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_DEVELOPMENT,1
HP_AMYLOIDOSIS,SET,35,-0.020864,-0.00090965,0.15385,0.55393,HP_AMYLOIDOSIS,1
DICER1_TARGET_GENES,SET,52,-0.016142,-0.00085742,0.119,0.55395,DICER1_TARGET_GENES,1
MIR5093,SET,221,-0.0079374,-0.00086516,0.058502,0.55396,MIR5093,1
MIR549A_5P,SET,43,-0.018968,-0.00091642,0.13979,0.55396,MIR549A_5P,1
GOBP_REGULATION_OF_NODAL_SIG...,SET,7,-0.053042,-0.001035,0.39093,0.55396,GOBP_REGULATION_OF_NODAL_SIGNALING_PATHWAY,1
GSE16385_IFNG_TNF_VS_IL4_STI...3,SET,161,-0.0092756,-0.00086436,0.068342,0.55398,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,1
MIR548E_5P,SET,659,-0.0046924,-0.00087249,0.034561,0.554,MIR548E_5P,1
GSE27786_LSK_VS_BCELL_DN,SET,182,-0.0085411,-0.00084575,0.062845,0.55405,GSE27786_LSK_VS_BCELL_DN,1
GOCC_KAINATE_SELECTIVE_GLUTA...,SET,5,-0.055026,-0.00090749,0.40441,0.55411,GOCC_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,1
GOMF_KAINATE_SELECTIVE_GLUTA...,SET,5,-0.055026,-0.00090749,0.40441,0.55411,GOMF_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY,1
GSE27786_CD8_TCELL_VS_NKCELL...1,SET,182,-0.008589,-0.00085049,0.063123,0.55412,GSE27786_CD8_TCELL_VS_NKCELL_DN,1
GSE27786_LSK_VS_NKCELL_DN,SET,182,-0.0087293,-0.00086438,0.064144,0.55412,GSE27786_LSK_VS_NKCELL_DN,1
GOBP_NEURON_PROJECTION_GUIDA...,SET,217,-0.0087234,-0.0009423,0.064001,0.55421,GOBP_NEURON_PROJECTION_GUIDANCE,1
GOBP_POSITIVE_REGULATION_OF_...582,SET,172,-0.0096068,-0.00092502,0.070485,0.55421,GOBP_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
FERREIRA_EWINGS_SARCOMA_UNST...1,SET,86,-0.012566,-0.00085759,0.09204,0.5543,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1
HP_ABNORMAL_VENA_CAVA_MORPHO...,SET,68,-0.013958,-0.00084749,0.10224,0.5543,HP_ABNORMAL_VENA_CAVA_MORPHOLOGY,1
GOBP_MONOCYTE_ACTIVATION,SET,12,-0.036095,-0.00092203,0.26395,0.55438,GOBP_MONOCYTE_ACTIVATION,1
GOBP_AUTOPHAGOSOME_MEMBRANE_...,SET,7,-0.038989,-0.00076079,0.28506,0.55439,GOBP_AUTOPHAGOSOME_MEMBRANE_DOCKING,1
DESCARTES_MAIN_FETAL_DUCTAL_...,SET,50,-0.018162,-0.00094602,0.13278,0.5544,DESCARTES_MAIN_FETAL_DUCTAL_CELLS,1
GOBP_NEPHRON_TUBULE_FORMATION,SET,18,-0.031978,-0.0010003,0.2337,0.55442,GOBP_NEPHRON_TUBULE_FORMATION,1
WP_MRNA_PROTEIN_AND_METABOLI...,SET,7,-0.045246,-0.00088287,0.33049,0.55445,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,1
GOBP_POSITIVE_REGULATION_OF_...193,SET,450,-0.0057098,-0.00088247,0.041675,0.55449,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE,1
GOBP_REGULATION_OF_T_CELL_DI...,SET,25,-0.024175,-0.00089103,0.17644,0.55449,GOBP_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,1
GNF2_PTPN6,SET,41,-0.018335,-0.00086505,0.1338,0.5545,GNF2_PTPN6,1
GOBP_GLIAL_CELL_FATE_SPECIFI...,SET,7,-0.052242,-0.0010194,0.38122,0.5545,GOBP_GLIAL_CELL_FATE_SPECIFICATION,1
HP_ABNORMALITY_OF_THE_PYLORUS,SET,92,-0.012772,-0.00090139,0.093164,0.55452,HP_ABNORMALITY_OF_THE_PYLORUS,1
GSE39382_IL3_VS_IL3_IL33_TRE...2,SET,182,-0.0084337,-0.00083511,0.06151,0.55453,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD...1,SET,101,-0.011187,-0.00082707,0.081524,0.55457,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,1
REACTOME_PREDNISONE_ADME,SET,9,-0.040059,-0.00088627,0.29133,0.55468,REACTOME_PREDNISONE_ADME,1
GSE9988_LPS_VS_LPS_AND_ANTI_...2,SET,177,-0.0089868,-0.00087769,0.065359,0.55468,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP,1
GOMF_MAGNESIUM_ION_BINDING,SET,209,-0.0081178,-0.00086075,0.059023,0.5547,GOMF_MAGNESIUM_ION_BINDING,1
WUNDER_INFLAMMATORY_RESPONSE...2,SET,59,-0.016196,-0.00091619,0.11772,0.55471,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,1
chr2p21,SET,35,-0.035304,-0.0015392,0.25653,0.55473,chr2p21,1
WP_SMALL_LIGAND_GPCRS,SET,18,-0.031166,-0.00097489,0.2264,0.55474,WP_SMALL_LIGAND_GPCRS,1
GOBP_RESPONSE_TO_ISCHEMIA,SET,62,-0.015493,-0.00089834,0.11256,0.55474,GOBP_RESPONSE_TO_ISCHEMIA,1
GOBP_PROTEIN_IMPORT_INTO_PER...2,SET,5,-0.04945,-0.00081554,0.35908,0.55477,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_RECEPTOR_RECYCLING,1
HP_ABNORMAL_SIZE_OF_THE_DENT...,SET,14,-0.034951,-0.00096428,0.25331,0.55487,HP_ABNORMAL_SIZE_OF_THE_DENTAL_ROOT,1
DESCARTES_MAIN_FETAL_HEPATOB...,SET,88,-0.012959,-0.00089457,0.093726,0.55498,DESCARTES_MAIN_FETAL_HEPATOBLASTS,1
GOBP_NEGATIVE_REGULATION_OF_...32,SET,6,-0.045259,-0.00081764,0.3273,0.55499,GOBP_NEGATIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
GOCC_PHOSPHATIDYLINOSITOL_3_...2,SET,9,-0.046089,-0.0010197,0.33323,0.555,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I,1
THAKAR_PBMC_INACTIVATED_INFL...6,SET,376,-0.0060137,-0.00085133,0.04345,0.55504,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP,1
GOBP_MEIOTIC_CHROMOSOME_SEGR...,SET,79,-0.012645,-0.00082726,0.091298,0.55508,GOBP_MEIOTIC_CHROMOSOME_SEGREGATION,1
REACTOME_SIGNALING_BY_MST1,SET,5,-0.046306,-0.00076368,0.33401,0.55513,REACTOME_SIGNALING_BY_MST1,1
KEGG_MEDICUS_PATHOGEN_EBV_LM...2,SET,5,-0.054826,-0.0009042,0.39533,0.55515,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY,1
MIR6866_5P,SET,67,-0.014774,-0.00089042,0.10649,0.55517,MIR6866_5P,1
HEDENFALK_BREAST_CANCER_BRAC...2,SET,15,-0.03155,-0.00090099,0.22724,0.55521,HEDENFALK_BREAST_CANCER_BRACX_UP,1
GOCC_ENDOPLASMIC_RETICULUM_T...2,SET,4,-0.053989,-0.00079642,0.38883,0.55521,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_MEMBRANE,1
GOBP_DEOXYRIBONUCLEOSIDE_TRI...,SET,9,-0.0384,-0.00084956,0.27644,0.55524,GOBP_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_SKELETAL_...10,SET,24,-0.025491,-0.00092059,0.18337,0.55528,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...609,SET,11,-0.03317,-0.00081127,0.23856,0.55529,GOBP_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION,1
GOBP_POSITIVE_REGULATION_OF_...610,SET,21,-0.026597,-0.00089857,0.19127,0.5553,GOBP_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,1
MIR328_5P,SET,53,-0.015994,-0.00085765,0.11498,0.55531,MIR328_5P,1
WP_1Q211_COPY_NUMBER_VARIATI...,SET,23,-0.028465,-0.0010064,0.20459,0.55533,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_HOST_MEDIATED_REGULATIO...,SET,9,-0.040971,-0.00090645,0.2943,0.55536,GOBP_HOST_MEDIATED_REGULATION_OF_INTESTINAL_MICROBIOTA_COMPOSITION,1
GAVISH_3CA_METAPROGRAM_MACRO...8,SET,46,-0.019503,-0.00097449,0.14006,0.55537,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MONOCYTE_SECRETED,1
GOCC_RIBONUCLEOPROTEIN_COMPL...,SET,620,-0.0045417,-0.00082,0.032508,0.55555,GOCC_RIBONUCLEOPROTEIN_COMPLEX,1
EGUCHI_CELL_CYCLE_RB1_TARGETS,SET,22,-0.025313,-0.00087526,0.181,0.55561,EGUCHI_CELL_CYCLE_RB1_TARGETS,1
BIOCARTA_NEUTROPHIL_PATHWAY,SET,8,-0.051637,-0.0010771,0.36914,0.55562,BIOCARTA_NEUTROPHIL_PATHWAY,1
WP_STING_PATHWAY_IN_KAWASAKI...,SET,18,-0.027553,-0.00086187,0.19673,0.55569,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...3,SET,4,-0.054246,-0.0008002,0.38726,0.5557,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M,1
HP_DUPLICATION_OF_BONES_INVO...,SET,193,-0.0084554,-0.00086193,0.060349,0.55571,HP_DUPLICATION_OF_BONES_INVOLVING_THE_UPPER_EXTREMITIES,1
GSE22033_UNTREATED_VS_ROSIGL...2,SET,182,-0.0084143,-0.00083319,0.060026,0.55574,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP,1
HP_PROMINENT_UMBILICUS,SET,5,-0.064062,-0.0010565,0.45689,0.55575,HP_PROMINENT_UMBILICUS,1
GOBP_NEGATIVE_REGULATION_OF_...263,SET,4,-0.071498,-0.0010547,0.50933,0.55582,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,1
REACTOME_PHOSPHOLIPASE_C_MED...2,SET,17,-0.032425,-0.00098571,0.23095,0.55583,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2,1
ADNP_TARGET_GENES,SET,511,-0.0053383,-0.00087769,0.038013,0.55584,ADNP_TARGET_GENES,1
REACTOME_TELOMERE_C_STRAND_S...,SET,11,-0.032149,-0.00078628,0.22889,0.55585,REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION,1
GOBP_ADENYLATE_CYCLASE_MODUL...,SET,249,-0.0083546,-0.00096586,0.05948,0.55585,GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_RETINAL_PIGMENT_EPITHEL...,SET,6,-0.055301,-0.00099906,0.39363,0.55586,GOBP_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT,1
GOBP_RETROGRADE_TRANS_SYNAPT...2,SET,5,-0.05934,-0.00097864,0.4218,0.55594,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,1
WP_INTERACTIONS_BETWEEN_LOXL...,SET,17,-0.027832,-0.00084608,0.19767,0.55599,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,1
GOBP_4FE_4S_CLUSTER_ASSEMBLY,SET,4,-0.058876,-0.0008685,0.41772,0.55604,GOBP_4FE_4S_CLUSTER_ASSEMBLY,1
GSE5589_WT_VS_IL10_KO_LPS_ST...1,SET,134,-0.011197,-0.00095261,0.079444,0.55604,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,1
GSE26343_WT_VS_NFAT5_KO_MACR...3,SET,189,-0.0088941,-0.00089731,0.063098,0.55605,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP,1
GOMF_FATTY_ACID_DERIVATIVE_B...,SET,18,-0.028569,-0.00089367,0.20264,0.55606,GOMF_FATTY_ACID_DERIVATIVE_BINDING,1
HP_ABNORMAL_GALLBLADDER_MORP...,SET,84,-0.013844,-0.00093383,0.09812,0.5561,HP_ABNORMAL_GALLBLADDER_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C2_PRO...1,SET,258,-0.0073592,-0.0008658,0.052162,0.5561,HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL,1
CRX_NRL_DN.V1_DN,SET,112,-0.012003,-0.00093417,0.085043,0.55612,CRX_NRL_DN.V1_DN,1
GCM_CSNK2B,SET,85,-0.012002,-0.00081437,0.085012,0.55614,GCM_CSNK2B,1
GOBP_REGULATION_OF_MICROTUBU...3,SET,7,-0.041391,-0.00080765,0.29309,0.55615,GOBP_REGULATION_OF_MICROTUBULE_BINDING,1
GOBP_SMALL_MOLECULE_CATABOLI...,SET,350,-0.0065418,-0.00089415,0.046208,0.55629,GOBP_SMALL_MOLECULE_CATABOLIC_PROCESS,1
GOMF_ORGANOPHOSPHATE_ESTER_T...,SET,35,-0.022164,-0.00096631,0.15643,0.55634,GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
PID_IL2_STAT5_PATHWAY,SET,28,-0.023851,-0.00093026,0.16828,0.55635,PID_IL2_STAT5_PATHWAY,1
GSE43955_1H_VS_60H_ACT_CD4_T...1,SET,182,-0.0093288,-0.00092375,0.065715,0.55644,GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN,1
HP_HYPOPLASTIC_HELICES,SET,10,-0.042577,-0.00099291,0.29988,0.55645,HP_HYPOPLASTIC_HELICES,1
GSE26488_HDAC7_KO_VS_VP16_TR...1,SET,187,-0.0088706,-0.00089023,0.062416,0.55651,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,1
HP_OLIVOPONTOCEREBELLAR_ATRO...,SET,6,-0.044438,-0.00080281,0.3125,0.55654,HP_OLIVOPONTOCEREBELLAR_ATROPHY,1
GOBP_DORSAL_SPINAL_CORD_DEVE...,SET,19,-0.033,-0.0010605,0.23195,0.55657,GOBP_DORSAL_SPINAL_CORD_DEVELOPMENT,1
REACTOME_HIGHLY_SODIUM_PERME...,SET,7,-0.043266,-0.00084423,0.30404,0.55658,REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS,1
GOBP_REGULATION_OF_SYSTEMIC_...3,SET,6,-0.055332,-0.00099962,0.38867,0.5566,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN,1
MIR1180_3P,SET,6,-0.05111,-0.00092334,0.35843,0.55669,MIR1180_3P,1
MIR4730,SET,6,-0.058446,-0.0010559,0.40943,0.55675,MIR4730,1
MORF_PTEN,SET,77,-0.013049,-0.00084288,0.091409,0.55676,MORF_PTEN,1
GSE17721_POLYIC_VS_CPG_2H_BM...1,SET,182,-0.0091545,-0.00090649,0.064084,0.5568,GSE17721_POLYIC_VS_CPG_2H_BMDC_DN,1
GOBP_PROTEIN_KINASE_A_SIGNAL...,SET,37,-0.021467,-0.00096223,0.15024,0.55681,GOBP_PROTEIN_KINASE_A_SIGNALING,1
HP_ABNORMALITY_OF_THE_UPPER_...4,SET,1281,-0.0035609,-0.00090676,0.024909,0.55684,HP_ABNORMALITY_OF_THE_UPPER_URINARY_TRACT,1
GOBP_RETINAL_CONE_CELL_DEVEL...,SET,11,-0.041797,-0.0010223,0.29233,0.55685,GOBP_RETINAL_CONE_CELL_DEVELOPMENT,1
PID_TRAIL_PATHWAY,SET,27,-0.024252,-0.00092888,0.16954,0.55687,PID_TRAIL_PATHWAY,1
MIR1912_5P,SET,73,-0.014648,-0.00092135,0.10233,0.55691,MIR1912_5P,1
BUSSLINGER_DUODENAL_I_CELLS,SET,14,-0.033866,-0.00093437,0.23649,0.55693,BUSSLINGER_DUODENAL_I_CELLS,1
REACTOME_REGULATION_OF_GENE_...2,SET,21,-0.029656,-0.0010019,0.20677,0.55702,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS,1
DESCARTES_FETAL_INTESTINE_LY...2,SET,129,-0.011728,-0.0009791,0.081763,0.55703,DESCARTES_FETAL_INTESTINE_LYMPHOID_CELLS,1
GOMF_HISTONE_H3K36_TRIMETHYL...,SET,4,-0.054971,-0.0008109,0.38313,0.55704,GOMF_HISTONE_H3K36_TRIMETHYLTRANSFERASE_ACTIVITY,1
TACGGGT_MIR99A_MIR100_MIR99B,SET,23,-0.027911,-0.00098678,0.1942,0.55714,TACGGGT_MIR99A_MIR100_MIR99B,1
GSE19512_NAUTRAL_VS_INDUCED_...1,SET,173,-0.0094993,-0.0009173,0.066079,0.55715,GSE19512_NAUTRAL_VS_INDUCED_TREG_DN,1
GOBP_FRUCTOSE_METABOLIC_PROC...,SET,13,-0.027615,-0.00073419,0.19208,0.55716,GOBP_FRUCTOSE_METABOLIC_PROCESS,1
GOBP_ORGANISM_EMERGENCE_FROM...,SET,22,-0.025214,-0.00087184,0.17535,0.55717,GOBP_ORGANISM_EMERGENCE_FROM_PROTECTIVE_STRUCTURE,1
GOBP_AMINO_ACID_IMPORT_ACROS...,SET,45,-0.019028,-0.0009404,0.13231,0.55718,GOBP_AMINO_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_ANGINA_PECTORIS,SET,37,-0.022027,-0.00098736,0.15315,0.55718,HP_ANGINA_PECTORIS,1
GOBP_REGULATION_OF_TOOTH_MIN...,SET,10,-0.041767,-0.00097402,0.29035,0.55719,GOBP_REGULATION_OF_TOOTH_MINERALIZATION,1
GOBP_TYPE_2_IMMUNE_RESPONSE,SET,42,-0.020524,-0.00098003,0.14255,0.55724,GOBP_TYPE_2_IMMUNE_RESPONSE,1
KEGG_MEDICUS_REFERENCE_REGUL...9,SET,7,-0.042372,-0.00082678,0.29426,0.55725,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP,1
GOBP_GERM_CELL_PROLIFERATION,SET,10,-0.034784,-0.00081118,0.24141,0.55728,GOBP_GERM_CELL_PROLIFERATION,1
GOBP_ORGANIC_HYDROXY_COMPOUN...3,SET,513,-0.0057232,-0.00094276,0.039718,0.55729,GOBP_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_EPITH...19,SET,46,-0.019483,-0.00097353,0.13518,0.5573,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_2,1
MIR620,SET,69,-0.015236,-0.00093183,0.1057,0.55731,MIR620,1
GOMF_PEPTIDE_N_ACETYLTRANSFE...,SET,46,-0.016629,-0.00083093,0.11534,0.55732,GOMF_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY,1
HP_SQUARE_FACE,SET,11,-0.041441,-0.0010135,0.28724,0.55736,HP_SQUARE_FACE,1
NMYC_01,SET,258,-0.0076778,-0.00090329,0.053209,0.55737,NMYC_01,1
HP_RECTAL_PROLAPSE,SET,49,-0.020026,-0.0010327,0.1387,0.5574,HP_RECTAL_PROLAPSE,1
GOBP_DNA_MODIFICATION,SET,38,-0.021887,-0.00099419,0.1515,0.55743,GOBP_DNA_MODIFICATION,1
PID_AMB2_NEUTROPHILS_PATHWAY,SET,40,-0.020104,-0.00093688,0.13912,0.55745,PID_AMB2_NEUTROPHILS_PATHWAY,1
GOBP_CELL_PROLIFERATION_IN_H...,SET,13,-0.034152,-0.00090801,0.23624,0.55747,GOBP_CELL_PROLIFERATION_IN_HINDBRAIN,1
REACTOME_ERK_MAPK_TARGETS,SET,20,-0.028572,-0.00094206,0.19754,0.5575,REACTOME_ERK_MAPK_TARGETS,1
GOBP_POSITIVE_REGULATION_OF_...408,SET,48,-0.018588,-0.00094872,0.12849,0.55751,GOBP_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY,1
REACTOME_BUTYRATE_RESPONSE_F...,SET,16,-0.029794,-0.00087871,0.2058,0.55755,REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,1
REACTOME_SUMO_IS_PROTEOLYTIC...,SET,6,-0.044104,-0.00079676,0.3046,0.55756,REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED,1
WP_SEROTONIN_HTR1_GROUP_AND_...,SET,36,-0.022977,-0.0010159,0.15858,0.5576,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,1
HP_LOWER_LIMB_AMYOTROPHY,SET,69,-0.015647,-0.00095692,0.10798,0.5576,HP_LOWER_LIMB_AMYOTROPHY,1
GSE41176_WT_VS_TAK1_KO_UNSTI...2,SET,178,-0.0094141,-0.00092199,0.064775,0.55778,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP,1
REACTOME_APEX1_INDEPENDENT_R...,SET,7,-0.039334,-0.00076751,0.27051,0.5578,REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY,1
HP_WEAKNESS_OF_LONG_FINGER_E...,SET,20,-0.02462,-0.00081173,0.16914,0.55786,HP_WEAKNESS_OF_LONG_FINGER_EXTENSOR_MUSCLES,1
GSE13547_WT_VS_ZFX_KO_BCELL_...4,SET,158,-0.0097025,-0.00089575,0.066647,0.55787,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP,1
GOBP_ENDOSOME_ORGANIZATION,SET,86,-0.012636,-0.00086238,0.086774,0.55789,GOBP_ENDOSOME_ORGANIZATION,1
HP_ACROMICRIA,SET,8,-0.054048,-0.0011274,0.37104,0.55791,HP_ACROMICRIA,1
GSE24142_EARLY_THYMIC_PROGEN...5,SET,186,-0.009741,-0.00097499,0.066868,0.55791,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP,1
GSE43863_TH1_VS_TFH_MEMORY_C...1,SET,181,-0.009424,-0.00093063,0.064487,0.55809,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN,1
GOBP_HEPARAN_SULFATE_PROTEOG...4,SET,8,-0.045505,-0.00094921,0.31126,0.55812,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_CATABOLIC_PROCESS,1
MIR7843_3P,SET,80,-0.014419,-0.00094924,0.098447,0.55822,MIR7843_3P,1
GSE11924_TH1_VS_TH2_CD4_TCEL...1,SET,178,-0.0095193,-0.0009323,0.064986,0.55823,GSE11924_TH1_VS_TH2_CD4_TCELL_DN,1
GOBP_RELEASE_OF_CYTOCHROME_C...,SET,52,-0.018106,-0.00096173,0.12348,0.55829,GOBP_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,1
GOBP_NEGATIVE_REGULATION_OF_...638,SET,18,-0.027428,-0.00085796,0.18702,0.5583,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
GSE5679_PPARG_LIGAND_ROSIGLI...4,SET,178,-0.0094853,-0.00092896,0.064672,0.5583,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,1
GSE7852_LN_VS_THYMUS_TCONV_UP,SET,177,-0.0097659,-0.00095378,0.066567,0.55832,GSE7852_LN_VS_THYMUS_TCONV_UP,1
HP_OLIGOHYDRAMNIOS,SET,166,-0.009521,-0.00090078,0.064876,0.55834,HP_OLIGOHYDRAMNIOS,1
KRAS.LUNG_UP.V1_UP,SET,122,-0.012308,-0.0009995,0.083783,0.5584,KRAS.LUNG_UP.V1_UP,1
WP_AEROBIC_GLYCOLYSIS_AUGMEN...,SET,11,-0.030677,-0.0007503,0.20855,0.55847,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,1
FORTSCHEGGER_PHF8_TARGETS_UP,SET,230,-0.0084912,-0.00094395,0.057693,0.5585,FORTSCHEGGER_PHF8_TARGETS_UP,1
HP_AUTISTIC_BEHAVIOR,SET,499,-0.005756,-0.0009355,0.039105,0.55851,HP_AUTISTIC_BEHAVIOR,1
HE_LIM_SUN_FETAL_LUNG_C4_CD1...,SET,16,-0.037636,-0.00111,0.25565,0.55852,HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL,1
GOBP_REGULATION_OF_SPINDLE_C...,SET,22,-0.023828,-0.00082393,0.16179,0.55854,GOBP_REGULATION_OF_SPINDLE_CHECKPOINT,1
REACTOME_TRIF_MEDIATED_PROGR...,SET,9,-0.045109,-0.00099799,0.30614,0.55857,REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH,1
GOBP_UDP_N_ACETYLGLUCOSAMINE...1,SET,9,-0.045135,-0.00099857,0.30626,0.55858,GOBP_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...50,SET,15,-0.030781,-0.00087902,0.20854,0.55867,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,1
GSE20198_UNTREATED_VS_IFNA_T...2,SET,186,-0.0090475,-0.00090558,0.061289,0.55868,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,1
GAUTAM_EYE_CHOROID_SCLERA_MO...,SET,120,-0.011571,-0.00093197,0.078359,0.5587,GAUTAM_EYE_CHOROID_SCLERA_MONOCYTES,1
HE_LIM_SUN_FETAL_LUNG_C2_HSC...2,SET,350,-0.006843,-0.00093532,0.046313,0.55873,HE_LIM_SUN_FETAL_LUNG_C2_HSC_ELP_CELL,1
MIR487A_3P,SET,92,-0.013445,-0.00094891,0.090968,0.55875,MIR487A_3P,1
GOBP_POSITIVE_REGULATION_OF_...523,SET,61,-0.017438,-0.001003,0.11792,0.55878,GOBP_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
GOBP_ISOTYPE_SWITCHING_TO_IG...1,SET,6,-0.04616,-0.00083392,0.31195,0.55882,GOBP_ISOTYPE_SWITCHING_TO_IGA_ISOTYPES,1
YAMAZAKI_TCEB3_TARGETS_DN,SET,180,-0.0095103,-0.00093658,0.064241,0.55884,YAMAZAKI_TCEB3_TARGETS_DN,1
REACTOME_PROCESSING_OF_INTRO...,SET,19,-0.025258,-0.00081172,0.17058,0.55885,REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,1
GOBP_RETROGRADE_TRANS_SYNAPT...1,SET,9,-0.047764,-0.0010567,0.32246,0.55888,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING,1
REACTOME_INTERFERON_SIGNALING,SET,246,-0.0083445,-0.00095895,0.056314,0.5589,REACTOME_INTERFERON_SIGNALING,1
GSE6259_BCELL_VS_CD4_TCELL_DN,SET,167,-0.0098029,-0.00093021,0.066145,0.55891,GSE6259_BCELL_VS_CD4_TCELL_DN,1
PID_THROMBIN_PAR1_PATHWAY,SET,42,-0.019856,-0.00094815,0.13373,0.55902,PID_THROMBIN_PAR1_PATHWAY,1
GOBP_POLY_N_ACETYLLACTOSAMIN...,SET,9,-0.045131,-0.00099848,0.30396,0.55902,GOBP_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS,1
REACTOME_TRANSCRIPTIONAL_REG...4,SET,170,-0.0097673,-0.00093505,0.065715,0.55908,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1
GOBP_NEURAL_TUBE_FORMATION,SET,99,-0.01278,-0.00093549,0.085873,0.55915,GOBP_NEURAL_TUBE_FORMATION,1
GOMF_AMINOACYLASE_ACTIVITY,SET,4,-0.066166,-0.00097604,0.44458,0.55915,GOMF_AMINOACYLASE_ACTIVITY,1
GOBP_TAXIS,SET,423,-0.0067609,-0.0010138,0.045398,0.55919,GOBP_TAXIS,1
GOBP_PANTOTHENATE_METABOLIC_...,SET,7,-0.048799,-0.00095219,0.32754,0.55922,GOBP_PANTOTHENATE_METABOLIC_PROCESS,1
GOCC_SMALL_RIBOSOMAL_SUBUNIT,SET,66,-0.01476,-0.00088294,0.099031,0.55924,GOCC_SMALL_RIBOSOMAL_SUBUNIT,1
HP_PARATHYROID_CARCINOMA,SET,7,-0.052174,-0.0010181,0.35007,0.55924,HP_PARATHYROID_CARCINOMA,1
GOBP_REGULATION_OF_LEUKOCYTE...6,SET,309,-0.0076085,-0.00097824,0.05098,0.55932,GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,1
GOBP_SPERM_EJACULATION,SET,6,-0.05623,-0.0010158,0.37667,0.55933,GOBP_SPERM_EJACULATION,1
GOBP_NEURON_DEVELOPMENT,SET,1054,-0.0041793,-0.00097175,0.02797,0.55939,GOBP_NEURON_DEVELOPMENT,1
HP_TREMOR,SET,540,-0.0055033,-0.00092939,0.036803,0.55943,HP_TREMOR,1
GOBP_INTRACILIARY_ANTEROGRAD...,SET,15,-0.033356,-0.00095257,0.22295,0.55946,GOBP_INTRACILIARY_ANTEROGRADE_TRANSPORT,1
HP_SCLERODERMA,SET,11,-0.036489,-0.00089243,0.24364,0.55952,HP_SCLERODERMA,1
GSE33424_CD161_HIGH_VS_INT_C...1,SET,185,-0.0095481,-0.00095314,0.063715,0.55956,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN,1
GSE17721_POLYIC_VS_PAM3CSK4_...11,SET,186,-0.0095592,-0.0009568,0.063772,0.55958,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN,1
HP_ABNORMAL_LIGHT_AND_DARK_A...,SET,35,-0.023296,-0.0010157,0.15535,0.5596,HP_ABNORMAL_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,1
GOCC_SARCOPLASMIC_RETICULUM_...1,SET,9,-0.045595,-0.0010087,0.30391,0.55963,GOCC_SARCOPLASMIC_RETICULUM_LUMEN,1
MIR1270,SET,72,-0.015542,-0.0009709,0.1034,0.55974,MIR1270,1
REACTOME_SENSORY_PROCESSING_...1,SET,69,-0.016293,-0.00099643,0.10837,0.55975,REACTOME_SENSORY_PROCESSING_OF_SOUND,1
GOBP_MEIOTIC_CELL_CYCLE_PROC...1,SET,189,-0.0088781,-0.00089568,0.05903,0.55977,GOBP_MEIOTIC_CELL_CYCLE_PROCESS,1
HP_RECURRENT_JOINT_DISLOCATI...,SET,10,-0.043762,-0.0010205,0.29082,0.55981,HP_RECURRENT_JOINT_DISLOCATION,1
TGGTGCT_MIR29A_MIR29B_MIR29C,SET,470,-0.0060551,-0.00095587,0.040222,0.55983,TGGTGCT_MIR29A_MIR29B_MIR29C,1
GSE19888_ADENOSINE_A3R_INH_V...3,SET,179,-0.0097807,-0.00096055,0.064969,0.55983,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN,1
HP_SINUS_BRADYCARDIA,SET,30,-0.02516,-0.0010157,0.16702,0.55987,HP_SINUS_BRADYCARDIA,1
HARALAMBIEVA_PBMC_M_M_R_II_A...4,SET,11,-0.044535,-0.0010892,0.29548,0.5599,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,1
AAACCAC_MIR140,SET,98,-0.013212,-0.00096222,0.087648,0.55991,AAACCAC_MIR140,1
HP_ABNORMAL_DENTAL_MORPHOLOGY,SET,255,-0.0082958,-0.00097039,0.055027,0.55992,HP_ABNORMAL_DENTAL_MORPHOLOGY,1
HP_DYSGENESIS_OF_THE_BASAL_G...,SET,5,-0.055577,-0.00091658,0.36863,0.55992,HP_DYSGENESIS_OF_THE_BASAL_GANGLIA,1
HP_ALVEOLAR_RHABDOMYOSARCOMA,SET,5,-0.065804,-0.0010852,0.43634,0.55994,HP_ALVEOLAR_RHABDOMYOSARCOMA,1
GSE20715_0H_VS_24H_OZONE_LUN...1,SET,189,-0.009611,-0.00096963,0.063699,0.55996,GSE20715_0H_VS_24H_OZONE_LUNG_DN,1
MIR4423_3P,SET,116,-0.01227,-0.00097176,0.081301,0.55998,MIR4423_3P,1
MIR3692_3P,SET,261,-0.0081864,-0.00096863,0.054233,0.55999,MIR3692_3P,1
SALVADOR_MARTIN_PEDIATRIC_TB...2,SET,19,-0.032349,-0.0010396,0.21393,0.56009,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP,1
HP_ABNORMAL_FEMALE_REPRODUCT...,SET,354,-0.0069528,-0.00095562,0.045975,0.5601,HP_ABNORMAL_FEMALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...29,SET,47,-0.01965,-0.00099245,0.12989,0.56012,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS,1
MIR4300,SET,57,-0.016643,-0.00092544,0.11001,0.56013,MIR4300,1
HP_LARYNGEAL_HYPOPLASIA,SET,8,-0.039735,-0.00082885,0.26236,0.56019,HP_LARYNGEAL_HYPOPLASIA,1
GSE17974_IL4_AND_ANTI_IL12_V...6,SET,151,-0.01073,-0.00096861,0.070819,0.56021,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP,1
PID_ER_NONGENOMIC_PATHWAY,SET,39,-0.020569,-0.00094654,0.13573,0.56023,PID_ER_NONGENOMIC_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...264,SET,72,-0.015079,-0.00094198,0.099429,0.56027,GOBP_POSITIVE_REGULATION_OF_EXOCYTOSIS,1
GOBP_INSULIN_PROCESSING,SET,7,-0.051018,-0.00099549,0.3363,0.56029,GOBP_INSULIN_PROCESSING,1
WEBER_METHYLATED_HCP_IN_FIBR...1,SET,38,-0.020625,-0.00093688,0.13594,0.5603,WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,1
GOBP_REGULATION_OF_INOSITOL_...1,SET,4,-0.07034,-0.0010376,0.46351,0.56031,GOBP_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
BIOCARTA_TNFR2_PATHWAY,SET,15,-0.032629,-0.00093181,0.21496,0.56032,BIOCARTA_TNFR2_PATHWAY,1
BIOCARTA_TNFR1_PATHWAY,SET,29,-0.023394,-0.00092855,0.15407,0.56034,BIOCARTA_TNFR1_PATHWAY,1
BIOCARTA_RHODOPSIN_PATHWAY,SET,8,-0.043795,-0.00091353,0.28835,0.56036,BIOCARTA_RHODOPSIN_PATHWAY,1
GOCC_SPERM_PRINCIPAL_PIECE,SET,29,-0.02504,-0.0009939,0.16475,0.5604,GOCC_SPERM_PRINCIPAL_PIECE,1
HP_INTERMITTENT_HYPERVENTILA...,SET,3,-0.082782,-0.0010576,0.54467,0.5604,HP_INTERMITTENT_HYPERVENTILATION,1
HP_ABNORMAL_BRAIN_EVOKED_POT...,SET,91,-0.013691,-0.00096101,0.09004,0.56043,HP_ABNORMAL_BRAIN_EVOKED_POTENTIALS,1
HP_ABNORMAL_TISSUE_METABOLIT...,SET,238,-0.0082635,-0.00093427,0.054321,0.56045,HP_ABNORMAL_TISSUE_METABOLITE_CONCENTRATION,1
GOBP_HYDROCARBON_METABOLIC_P...,SET,7,-0.051239,-0.0009998,0.33645,0.56052,GOBP_HYDROCARBON_METABOLIC_PROCESS,1
KRAS.300_UP.V1_UP,SET,127,-0.013077,-0.0010833,0.085828,0.56055,KRAS.300_UP.V1_UP,1
BUSSLINGER_GASTRIC_REG3A_POS...,SET,40,-0.023356,-0.0010885,0.15325,0.56057,BUSSLINGER_GASTRIC_REG3A_POSITIVE_CELLS,1
HP_POOR_APPETITE,SET,47,-0.018248,-0.00092166,0.11969,0.56059,HP_POOR_APPETITE,1
CHANG_IMMORTALIZED_BY_HPV31_...1,SET,58,-0.017171,-0.00096312,0.11259,0.56061,CHANG_IMMORTALIZED_BY_HPV31_DN,1
GSE7764_NKCELL_VS_SPLENOCYTE...1,SET,189,-0.0095207,-0.00096052,0.062411,0.56062,GSE7764_NKCELL_VS_SPLENOCYTE_DN,1
GOBP_DISRUPTION_OF_ANATOMICA...,SET,81,-0.016288,-0.0010789,0.10671,0.56066,GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,1
TAKEDA_TARGETS_OF_NUP98_HOXA...4,SET,160,-0.01131,-0.0010507,0.074051,0.56069,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1
GSE15659_CD45RA_NEG_CD4_TCEL...3,SET,172,-0.0098338,-0.00094688,0.064352,0.56073,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,1
GOBP_VITAMIN_D_METABOLIC_PRO...,SET,21,-0.029484,-0.00099609,0.19288,0.56074,GOBP_VITAMIN_D_METABOLIC_PROCESS,1
KEGG_NITROGEN_METABOLISM,SET,21,-0.029028,-0.00098069,0.18989,0.56075,KEGG_NITROGEN_METABOLISM,1
PID_AP1_PATHWAY,SET,68,-0.016834,-0.0010221,0.11012,0.56075,PID_AP1_PATHWAY,1
GSE17721_CPG_VS_GARDIQUIMOD_...8,SET,190,-0.0093198,-0.00094271,0.060885,0.56083,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP,1
MIR1237_3P,SET,120,-0.012404,-0.00099903,0.081023,0.56084,MIR1237_3P,1
GSE3982_NEUTROPHIL_VS_CENT_M...1,SET,183,-0.0090178,-0.00089538,0.05882,0.56092,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,1
HP_STOOPED_POSTURE,SET,8,-0.040973,-0.00085467,0.26717,0.56094,HP_STOOPED_POSTURE,1
GSE17721_PAM3CSK4_VS_CPG_12H...2,SET,175,-0.0096248,-0.00093473,0.062691,0.56101,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP,1
HP_CONJUNCTIVAL_HYPEREMIA,SET,5,-0.062213,-0.001026,0.40516,0.56102,HP_CONJUNCTIVAL_HYPEREMIA,1
GOBP_POSITIVE_REGULATION_OF_...840,SET,22,-0.027169,-0.00093947,0.1769,0.56103,GOBP_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...2,SET,51,-0.018231,-0.00095907,0.11859,0.56109,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS,1
GSE29949_MICROGLIA_BRAIN_VS_...4,SET,180,-0.0099623,-0.00098109,0.064803,0.56109,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,1
HP_CAESARIAN_SECTION,SET,13,-0.040252,-0.0010702,0.26168,0.56112,HP_CAESARIAN_SECTION,1
REACTOME_CYP2E1_REACTIONS,SET,11,-0.042866,-0.0010484,0.27816,0.56124,REACTOME_CYP2E1_REACTIONS,1
GOBP_CITRULLINE_BIOSYNTHETIC...,SET,4,-0.057403,-0.00084677,0.37215,0.56129,GOBP_CITRULLINE_BIOSYNTHETIC_PROCESS,1
GSE14769_UNSTIM_VS_20MIN_LPS...2,SET,174,-0.009995,-0.00096793,0.064798,0.56129,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP,1
GSE35435_RESTING_VS_IL4_TREA...2,SET,175,-0.0095822,-0.00093059,0.062126,0.56129,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...5,SET,108,-0.012034,-0.0009198,0.078011,0.5613,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE,1
MEBARKI_HCC_PROGENITOR_WNT_U...2,SET,72,-0.017232,-0.0010765,0.11169,0.56131,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1
HP_NEOPLASM_OF_THE_INNER_EAR,SET,8,-0.049877,-0.0010404,0.32295,0.56137,HP_NEOPLASM_OF_THE_INNER_EAR,1
GSE10325_CD4_TCELL_VS_MYELOI...2,SET,179,-0.0099727,-0.00097941,0.064513,0.56142,GSE10325_CD4_TCELL_VS_MYELOID_UP,1
DESCARTES_FETAL_ADRENAL_SCHW...,SET,108,-0.014227,-0.0010874,0.092023,0.56143,DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS,1
MIR575,SET,49,-0.01803,-0.00092977,0.11657,0.56146,MIR575,1
WP_PROSTAGLANDIN_AND_LEUKOTR...1,SET,29,-0.025519,-0.0010129,0.16496,0.56147,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,1
HE_LIM_SUN_FETAL_LUNG_C2_S10...,SET,32,-0.024167,-0.0010076,0.15604,0.56154,HE_LIM_SUN_FETAL_LUNG_C2_S100A12_HI_CLASSICAL_MONOCYTE,1
DARWICHE_PAPILLOMA_RISK_LOW_...1,SET,153,-0.010418,-0.00094657,0.06722,0.56158,DARWICHE_PAPILLOMA_RISK_LOW_DN,1
CEBPE_TARGET_GENES,SET,25,-0.031372,-0.0011563,0.20235,0.5616,CEBPE_TARGET_GENES,1
PAX3_01,SET,19,-0.027638,-0.00088819,0.17807,0.56167,PAX3_01,1
GSE6259_33D1_POS_DC_VS_CD8_T...1,SET,112,-0.012551,-0.00097683,0.080874,0.56167,GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN,1
GOBP_URATE_METABOLIC_PROCESS,SET,10,-0.044623,-0.0010406,0.28742,0.56169,GOBP_URATE_METABOLIC_PROCESS,1
GOMF_DYSTROGLYCAN_BINDING,SET,10,-0.040839,-0.00095238,0.26233,0.56186,GOMF_DYSTROGLYCAN_BINDING,1
HP_OMPHALOCELE,SET,67,-0.016714,-0.0010074,0.10734,0.56187,HP_OMPHALOCELE,1
MIR299_3P,SET,50,-0.017611,-0.00091732,0.11304,0.5619,MIR299_3P,1
GOBP_SPLICEOSOMAL_CONFORMATI...,SET,4,-0.062875,-0.00092749,0.40344,0.56192,GOBP_SPLICEOSOMAL_CONFORMATIONAL_CHANGES_TO_GENERATE_CATALYTIC_CONFORMATION,1
SMIRNOV_CIRCULATING_ENDOTHEL...1,SET,5,-0.060744,-0.0010018,0.38956,0.56195,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN,1
HP_FATIGABLE_WEAKNESS_OF_BUL...,SET,52,-0.018029,-0.00095767,0.11542,0.56206,HP_FATIGABLE_WEAKNESS_OF_BULBAR_MUSCLES,1
WAMUNYOKOLI_OVARIAN_CANCER_L...2,SET,256,-0.0085567,-0.0010028,0.054737,0.56211,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,1
GOBP_NUCLEOSIDE_METABOLIC_PR...,SET,50,-0.020484,-0.001067,0.13092,0.56216,GOBP_NUCLEOSIDE_METABOLIC_PROCESS,1
REACTOME_TRANSCRIPTIONAL_REG...14,SET,12,-0.041294,-0.0010548,0.26362,0.56224,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_TESTIS_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...658,SET,5,-0.060242,-0.00099352,0.38427,0.56229,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,1
GSE28737_WT_VS_BCL6_HET_FOLL...2,SET,183,-0.009871,-0.00098009,0.062927,0.56232,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP,1
HOEK_NEUTROPHIL_2011_2012_TI...4,SET,7,-0.05931,-0.0011573,0.37801,0.56234,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_UP,1
GINESTIER_BREAST_CANCER_20Q1...1,SET,158,-0.0099349,-0.00091721,0.063296,0.56236,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,1
HP_TAPERED_FINGER,SET,111,-0.012171,-0.00094306,0.07751,0.56239,HP_TAPERED_FINGER,1
DR4_Q2,SET,227,-0.0089247,-0.00098573,0.056805,0.56242,DR4_Q2,1
GOCC_PRESYNAPTIC_ACTIVE_ZONE...1,SET,16,-0.035568,-0.001049,0.22641,0.56242,GOCC_PRESYNAPTIC_ACTIVE_ZONE_CYTOPLASMIC_COMPONENT,1
chr5q15,SET,19,-0.046202,-0.0014848,0.29382,0.56247,chr5q15,1
GSE17721_12H_VS_24H_CPG_BMDC...1,SET,178,-0.0097147,-0.00095143,0.06177,0.56248,GSE17721_12H_VS_24H_CPG_BMDC_DN,1
HAY_BONE_MARROW_CD34_POS_PRE...1,SET,80,-0.016105,-0.0010603,0.1024,0.56249,HAY_BONE_MARROW_CD34_POS_PRE_B,1
KEGG_MEDICUS_REFERENCE_REGUL...11,SET,6,-0.051115,-0.00092344,0.32459,0.56256,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1,1
HP_PERSISTENT_HEAD_LAG,SET,25,-0.025486,-0.00093937,0.16166,0.56263,HP_PERSISTENT_HEAD_LAG,1
MOREAUX_B_LYMPHOCYTE_MATURAT...1,SET,69,-0.014906,-0.00091163,0.094466,0.56269,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,1
WP_MRNA_PROCESSING,SET,117,-0.011414,-0.0009078,0.072333,0.56269,WP_MRNA_PROCESSING,1
GOBP_NEGATIVE_REGULATION_OF_...444,SET,5,-0.050978,-0.00084073,0.32304,0.56269,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,1
GSE16385_MONOCYTE_VS_12H_ROS...6,SET,171,-0.010589,-0.0010166,0.067101,0.56269,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,1
HP_HYPERNATREMIA,SET,8,-0.053336,-0.0011126,0.33763,0.56276,HP_HYPERNATREMIA,1
MODULE_115,SET,25,-0.025555,-0.00094191,0.16171,0.56278,MODULE_115,1
GOMF_ACYLTRANSFERASE_ACTIVIT...2,SET,199,-0.0093282,-0.00096541,0.059018,0.56279,GOMF_ACYLTRANSFERASE_ACTIVITY_TRANSFERRING_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS,1
HP_MOVEMENT_ABNORMALITY_OF_T...,SET,15,-0.035983,-0.0010276,0.2274,0.56287,HP_MOVEMENT_ABNORMALITY_OF_THE_TONGUE,1
NEBEN_AML_WITH_FLT3_OR_NRAS_...1,SET,12,-0.040028,-0.0010225,0.25269,0.56293,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,1
GSE28726_NAIVE_CD4_TCELL_VS_...2,SET,188,-0.0096828,-0.00097431,0.061078,0.56298,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP,1
PACHER_TARGETS_OF_IGF1_AND_I...,SET,35,-0.025534,-0.0011132,0.16099,0.56301,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1
WP_MACROPHAGE_MARKERS,SET,8,-0.051122,-0.0010664,0.32225,0.56302,WP_MACROPHAGE_MARKERS,1
HP_ABNORMAL_SIZE_OF_THE_PALP...,SET,259,-0.0084148,-0.00099189,0.053041,0.56303,HP_ABNORMAL_SIZE_OF_THE_PALPEBRAL_FISSURES,1
PID_BETA_CATENIN_NUC_PATHWAY,SET,70,-0.017345,-0.0010684,0.1093,0.56304,PID_BETA_CATENIN_NUC_PATHWAY,1
GSE1925_CTRL_VS_24H_IFNG_STI...2,SET,184,-0.010179,-0.0010134,0.064129,0.56306,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,1
HP_NEURONAL_LOSS_IN_THE_CERE...,SET,12,-0.038012,-0.00097101,0.23924,0.56312,HP_NEURONAL_LOSS_IN_THE_CEREBRAL_CORTEX,1
GSE36009_WT_VS_NLRP10_KO_DC_...3,SET,186,-0.0096203,-0.00096291,0.060463,0.56321,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP,1
GSE41867_LCMV_ARMSTRONG_VS_C...3,SET,187,-0.0093738,-0.00094074,0.058886,0.56324,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN,1
WP_SYNAPTIC_VESICLE_PATHWAY,SET,49,-0.019735,-0.0010176,0.12383,0.56331,WP_SYNAPTIC_VESICLE_PATHWAY,1
HP_HYPOREFLEXIA_OF_UPPER_LIM...,SET,7,-0.059038,-0.001152,0.37038,0.56332,HP_HYPOREFLEXIA_OF_UPPER_LIMBS,1
CTCTATG_MIR368,SET,38,-0.022743,-0.0010331,0.14259,0.56336,CTCTATG_MIR368,1
GSE11057_NAIVE_VS_EFF_MEMORY...1,SET,173,-0.010447,-0.0010088,0.065442,0.56342,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,1
GAVISH_3CA_METAPROGRAM_EPITH...23,SET,46,-0.022365,-0.0011175,0.13992,0.5635,GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS,1
GSE7831_UNSTIM_VS_INFLUENZA_...1,SET,182,-0.010543,-0.001044,0.065901,0.56355,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN,1
GOMF_FIBROBLAST_GROWTH_FACTO...2,SET,5,-0.06847,-0.0011292,0.42747,0.56363,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_ACTIVITY,1
PXR_Q2,SET,240,-0.009058,-0.0010283,0.056522,0.56366,PXR_Q2,1
HP_MACULAR_HYPERPIGMENTATION,SET,6,-0.064823,-0.0011711,0.4044,0.56367,HP_MACULAR_HYPERPIGMENTATION,1
CHANGOLKAR_H2AFY_TARGETS_DN,SET,35,-0.021999,-0.00095913,0.13711,0.56374,CHANGOLKAR_H2AFY_TARGETS_DN,1
GOCC_COLLAGEN_CONTAINING_EXT...,SET,393,-0.0074594,-0.0010791,0.046457,0.56378,GOCC_COLLAGEN_CONTAINING_EXTRACELLULAR_MATRIX,1
GOBP_R_LOOP_PROCESSING,SET,8,-0.041187,-0.00085914,0.25639,0.56381,GOBP_R_LOOP_PROCESSING,1
WP_MICROTUBULE_CYTOSKELETON_...,SET,48,-0.019333,-0.00098675,0.12031,0.56383,WP_MICROTUBULE_CYTOSKELETON_REGULATION,1
KEGG_MEDICUS_REFERENCE_TRAIP...,SET,14,-0.034675,-0.00095669,0.21577,0.56384,KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY,1
GOBP_REGULATION_OF_ANTIGEN_P...2,SET,5,-0.060331,-0.00099498,0.37535,0.56385,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,1
MIR656_5P,SET,32,-0.023474,-0.00097867,0.146,0.56387,MIR656_5P,1
GSE26559_TCF1_KO_VS_WT_LIN_N...2,SET,183,-0.010294,-0.0010221,0.064021,0.56387,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP,1
GSE15767_MED_VS_SCS_MAC_LN_DN,SET,180,-0.010045,-0.00098928,0.062436,0.56391,GSE15767_MED_VS_SCS_MAC_LN_DN,1
GOBP_POSITIVE_REGULATION_OF_...88,SET,2,-0.11023,-0.0011498,0.68495,0.56392,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,1
HE_LIM_SUN_FETAL_LUNG_C7_MFN...,SET,17,-0.034397,-0.0010457,0.21376,0.56392,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,1
MORF_UNG,SET,65,-0.0155,-0.00092019,0.096266,0.56396,MORF_UNG,1
GOMF_MONOATOMIC_ANION_MONOAT...,SET,24,-0.029071,-0.0010499,0.18055,0.56396,GOMF_MONOATOMIC_ANION_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...4,SET,266,-0.0087021,-0.0010393,0.054035,0.56397,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE,1
GOMF_1_PHOSPHATIDYLINOSITOL_...2,SET,15,-0.04054,-0.0011577,0.25147,0.56404,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_POSTSYNAP...8,SET,5,-0.070759,-0.001167,0.43857,0.56409,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
GOBP_MEMBRANE_DEPOLARIZATION...1,SET,27,-0.030133,-0.0011541,0.18672,0.5641,GOBP_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,1
GSE16522_MEMORY_VS_NAIVE_CD8...1,SET,181,-0.010298,-0.0010169,0.06373,0.56418,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
GSE46606_DAY1_VS_DAY3_CD40L_...8,SET,183,-0.010209,-0.0010137,0.063171,0.56419,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP,1
BENPORATH_SUZ12_TARGETS,SET,873,-0.0053848,-0.0011454,0.033287,0.56426,BENPORATH_SUZ12_TARGETS,1
GOBP_MICROTUBULE_POLYMERIZAT...2,SET,124,-0.011638,-0.00095272,0.071857,0.56433,GOBP_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
GOBP_NEURAL_CREST_CELL_MIGRA...,SET,6,-0.061447,-0.0011101,0.37932,0.56434,GOBP_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,1
GOBP_REGULATION_OF_MAST_CELL...2,SET,4,-0.072507,-0.0010696,0.44759,0.56434,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GSE25087_FETAL_VS_ADULT_TREG...1,SET,157,-0.011247,-0.001035,0.069336,0.56443,GSE25087_FETAL_VS_ADULT_TREG_DN,1
GSE13411_IGM_VS_SWITCHED_MEM...2,SET,174,-0.010843,-0.0010501,0.066831,0.56445,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP,1
HP_ABNORMAL_B_CELL_MORPHOLOGY,SET,90,-0.014878,-0.0010386,0.091598,0.56452,HP_ABNORMAL_B_CELL_MORPHOLOGY,1
DESCARTES_MAIN_FETAL_SCHWANN...,SET,37,-0.023478,-0.0010524,0.14454,0.56452,DESCARTES_MAIN_FETAL_SCHWANN_CELLS,1
GOCC_CYTOSOLIC_LARGE_RIBOSOM...,SET,50,-0.018805,-0.00097952,0.11571,0.56455,GOCC_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT,1
HP_PERIVENTRICULAR_NODULAR_H...,SET,14,-0.035945,-0.00099171,0.22108,0.56458,HP_PERIVENTRICULAR_NODULAR_HETEROTOPIA,1
ELF2_TARGET_GENES,SET,1233,-0.0040892,-0.001023,0.025145,0.56459,ELF2_TARGET_GENES,1
HP_SOMATIC_SENSORY_DYSFUNCTI...,SET,379,-0.0072056,-0.001024,0.044255,0.56467,HP_SOMATIC_SENSORY_DYSFUNCTION,1
GSE21927_GMCSF_IL6_VS_GMCSF_...1,SET,181,-0.0096826,-0.00095616,0.059434,0.56471,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,1
GOBP_EPIDERMAL_CELL_FATE_SPE...,SET,5,-0.069016,-0.0011382,0.42327,0.56476,GOBP_EPIDERMAL_CELL_FATE_SPECIFICATION,1
GOBP_GLOMERULUS_DEVELOPMENT,SET,68,-0.019019,-0.0011548,0.1166,0.56479,GOBP_GLOMERULUS_DEVELOPMENT,1
GSE411_UNSTIM_VS_100MIN_IL6_...1,SET,186,-0.0098194,-0.00098284,0.06013,0.56486,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN,1
HP_ANKLE_PAIN,SET,5,-0.065363,-0.001078,0.40015,0.56488,HP_ANKLE_PAIN,1
DNMT1_TARGET_GENES,SET,173,-0.010536,-0.0010174,0.064464,0.56491,DNMT1_TARGET_GENES,1
HP_ABNORMAL_PLEURA_MORPHOLOGY,SET,168,-0.011379,-0.001083,0.06962,0.56492,HP_ABNORMAL_PLEURA_MORPHOLOGY,1
GOBP_MANNOSE_METABOLIC_PROCE...,SET,9,-0.043777,-0.00096852,0.26776,0.56493,GOBP_MANNOSE_METABOLIC_PROCESS,1
GATA_C,SET,237,-0.0093733,-0.0010575,0.057301,0.56497,GATA_C,1
GOCC_TRANSCRIPTION_FACTOR_TF...3,SET,11,-0.033744,-0.00082531,0.20624,0.56498,GOCC_TRANSCRIPTION_FACTOR_TFIIH_HOLO_COMPLEX,1
GOCC_INTRACILIARY_TRANSPORT_...3,SET,15,-0.042003,-0.0011995,0.25667,0.56499,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_B,1
BRCA2_TARGET_GENES,SET,1258,-0.0040788,-0.00103,0.024895,0.56507,BRCA2_TARGET_GENES,1
CAGTATT_MIR200B_MIR200C_MIR4...,SET,422,-0.0070311,-0.0010531,0.042909,0.56508,CAGTATT_MIR200B_MIR200C_MIR429,1
WP_CEREBRAL_ORGANIC_ACIDURIA...,SET,8,-0.048449,-0.0010106,0.29561,0.56509,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,1
E2F1_UP.V1_DN,SET,176,-0.01062,-0.0010343,0.064767,0.56512,E2F1_UP.V1_DN,1
HP_ABNORMAL_URINE_HORMONE_LE...,SET,16,-0.035881,-0.0010582,0.21868,0.56516,HP_ABNORMAL_URINE_HORMONE_LEVEL,1
GSE8685_IL2_ACT_IL2_STARVED_...3,SET,127,-0.012384,-0.0010259,0.075473,0.56517,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...443,SET,16,-0.037008,-0.0010915,0.22546,0.56519,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,1
IKEDA_MIR30_TARGETS_DN,SET,22,-0.030746,-0.0010631,0.18729,0.5652,IKEDA_MIR30_TARGETS_DN,1
HP_CONGENITAL_BLINDNESS,SET,8,-0.050032,-0.0010436,0.30445,0.56526,HP_CONGENITAL_BLINDNESS,1
POOLA_INVASIVE_BREAST_CANCER...2,SET,257,-0.0094062,-0.0011045,0.057195,0.56531,POOLA_INVASIVE_BREAST_CANCER_UP,1
WP_11P112_COPY_NUMBER_VARIAT...,SET,52,-0.022198,-0.0011791,0.13497,0.56532,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,1
GOCC_TRANS_GOLGI_NETWORK_TRA...2,SET,18,-0.032312,-0.0010107,0.19646,0.56532,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE,1
GSE5099_MONOCYTE_VS_ALTERNAT...1,SET,166,-0.010142,-0.00095949,0.061646,0.56534,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN,1
BIOCARTA_CARDIACEGF_PATHWAY,SET,17,-0.037407,-0.0011372,0.22732,0.56535,BIOCARTA_CARDIACEGF_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...309,SET,6,-0.054189,-0.00097896,0.32914,0.56538,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,1
HP_PORTAL_FIBROSIS,SET,15,-0.035263,-0.001007,0.21417,0.56539,HP_PORTAL_FIBROSIS,1
GSE15624_CTRL_VS_6H_HALOFUGI...2,SET,123,-0.013265,-0.0010816,0.080551,0.5654,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,1
GSE27786_LSK_VS_LIN_NEG_CELL...1,SET,179,-0.010336,-0.0010151,0.062767,0.5654,GSE27786_LSK_VS_LIN_NEG_CELL_DN,1
HP_BILATERAL_TONIC_CLONIC_SE...2,SET,47,-0.018971,-0.00095813,0.11514,0.56543,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_FOCAL_ONSET,1
GOBP_FUSED_ANTRUM_STAGE,SET,6,-0.064416,-0.0011637,0.39083,0.56546,GOBP_FUSED_ANTRUM_STAGE,1
GSE5099_UNSTIM_VS_MCSF_TREAT...4,SET,175,-0.010148,-0.0009855,0.061524,0.5655,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP,1
MIR6071,SET,155,-0.01117,-0.0010215,0.067695,0.56553,MIR6071,1
GSE42021_TREG_PLN_VS_CD24INT...2,SET,183,-0.010889,-0.0010812,0.065992,0.56553,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP,1
HP_ABNORMAL_CELLULAR_COMPOSI...,SET,8,-0.057891,-0.0012076,0.35031,0.56563,HP_ABNORMAL_CELLULAR_COMPOSITION_OF_BRONCHOALVEOLAR_FLUID,1
HP_EXUDATIVE_RETINAL_DETACHM...,SET,5,-0.075539,-0.0012458,0.45665,0.56569,HP_EXUDATIVE_RETINAL_DETACHMENT,1
GSE15930_STIM_VS_STIM_AND_IL...2,SET,179,-0.0099888,-0.00098099,0.060374,0.5657,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP,1
HP_ABNORMAL_TENDON_MORPHOLOGY,SET,752,-0.0052965,-0.0010493,0.032005,0.56572,HP_ABNORMAL_TENDON_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...427,SET,23,-0.031114,-0.0011,0.18798,0.56573,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
GOBP_RHO_PROTEIN_SIGNAL_TRAN...,SET,132,-0.012597,-0.0010637,0.076108,0.56573,GOBP_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
HP_ABNORMAL_ISOHEMAGGLUTININ...,SET,7,-0.060981,-0.0011899,0.36828,0.56576,HP_ABNORMAL_ISOHEMAGGLUTININ_LEVEL,1
REACTOME_TRANSLESION_SYNTHES...1,SET,17,-0.03025,-0.00091959,0.18256,0.5658,REACTOME_TRANSLESION_SYNTHESIS_BY_POLH,1
GOBP_SODIUM_ION_TRANSMEMBRAN...,SET,177,-0.011634,-0.0011363,0.070203,0.56581,GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_MACROPHAGE_COLONY_STIMU...1,SET,6,-0.060767,-0.0010978,0.36646,0.56585,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...329,SET,12,-0.03726,-0.0009518,0.22471,0.56585,GOBP_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...11,SET,5,-0.070655,-0.0011652,0.42575,0.5659,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
ID1_TARGET_GENES,SET,1009,-0.0045785,-0.0010429,0.027587,0.56591,ID1_TARGET_GENES,1
MODULE_243,SET,71,-0.016982,-0.0010535,0.10232,0.56591,MODULE_243,1
HP_SPASTIC_TETRAPARESIS,SET,60,-0.018428,-0.0010512,0.11101,0.56592,HP_SPASTIC_TETRAPARESIS,1
HP_MYOCLONIC_STATUS_EPILEPTI...,SET,5,-0.070736,-0.0011666,0.42573,0.56598,HP_MYOCLONIC_STATUS_EPILEPTICUS,1
GSE557_WT_VS_I_AB_KO_DC_DN,SET,181,-0.010349,-0.001022,0.062264,0.566,GSE557_WT_VS_I_AB_KO_DC_DN,1
MIR5588_5P,SET,80,-0.016007,-0.0010538,0.096282,0.56602,MIR5588_5P,1
P53_02,SET,229,-0.0097002,-0.001076,0.058328,0.56604,P53_02,1
HP_REDUNDANT_SKIN,SET,79,-0.01645,-0.0010762,0.09891,0.56604,HP_REDUNDANT_SKIN,1
HOEK_MONOCYTE_2011_2012_TIV_...6,SET,5,-0.063031,-0.0010395,0.37899,0.56604,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_UP,1
KEGG_MEDICUS_PATHOGEN_EBV_BA...,SET,7,-0.0526,-0.0010264,0.31625,0.56605,KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_HY...1,SET,63,-0.018109,-0.0010584,0.10885,0.56606,GOBP_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE,1
HP_SHOULDER_GIRDLE_MUSCLE_WE...,SET,50,-0.018994,-0.00098939,0.11406,0.56613,HP_SHOULDER_GIRDLE_MUSCLE_WEAKNESS,1
ANASTASSIOU_MULTICANCER_INVA...,SET,61,-0.019906,-0.0011449,0.11951,0.56614,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,1
MEF2_04,SET,23,-0.03022,-0.0010684,0.1814,0.56615,MEF2_04,1
GOMF_MANGANESE_ION_TRANSMEMB...,SET,9,-0.04578,-0.0010128,0.27481,0.56615,GOMF_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE20366_EX_VIVO_VS_DEC205_C...4,SET,182,-0.010398,-0.0010297,0.062401,0.56617,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP,1
GOCC_RADIAL_SPOKE,SET,12,-0.033432,-0.000854,0.20059,0.56618,GOCC_RADIAL_SPOKE,1
MORF_PPP2CA,SET,117,-0.012084,-0.00096109,0.07248,0.5662,MORF_PPP2CA,1
HP_ELEVATED_SERUM_ACID_PHOSP...,SET,5,-0.06421,-0.001059,0.38511,0.56621,HP_ELEVATED_SERUM_ACID_PHOSPHATASE,1
HP_ABNORMALITY_OF_THE_GALLBL...,SET,99,-0.015101,-0.0011053,0.090491,0.56627,HP_ABNORMALITY_OF_THE_GALLBLADDER,1
GOMF_N_ACETYLLACTOSAMINE_SYN...,SET,5,-0.068843,-0.0011354,0.41213,0.56633,GOMF_N_ACETYLLACTOSAMINE_SYNTHASE_ACTIVITY,1
GOBP_POINTED_END_ACTIN_FILAM...,SET,7,-0.047228,-0.00092154,0.28268,0.56634,GOBP_POINTED_END_ACTIN_FILAMENT_CAPPING,1
GOBP_CELLULAR_RESPONSE_TO_LE...2,SET,17,-0.036162,-0.0010993,0.21631,0.56638,GOBP_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS,1
HP_ABNORMAL_PLATELET_GRANULES,SET,12,-0.038066,-0.00097238,0.22763,0.5664,HP_ABNORMAL_PLATELET_GRANULES,1
ZNF544_TARGET_GENES,SET,3,-0.071648,-0.00091533,0.42788,0.56649,ZNF544_TARGET_GENES,1
MODULE_186,SET,19,-0.035786,-0.0011501,0.21342,0.56658,MODULE_186,1
GSE24142_DN2_VS_DN3_THYMOCYT...2,SET,173,-0.010964,-0.0010587,0.065347,0.56662,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP,1
GOMF_TRANSMEMBRANE_RECEPTOR_...1,SET,80,-0.017703,-0.0011655,0.1055,0.56663,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY,1
chr22q13,SET,177,-0.021252,-0.0020756,0.12648,0.56672,chr22q13,1
GOBP_MELANOCYTE_DIFFERENTIAT...,SET,23,-0.033118,-0.0011709,0.19698,0.56676,GOBP_MELANOCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_CARDIAC_C...,SET,23,-0.030551,-0.0010801,0.18172,0.56676,GOBP_REGULATION_OF_CARDIAC_CONDUCTION,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...2,SET,33,-0.025981,-0.0010999,0.15454,0.56676,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_DN,1
GSE4748_CTRL_VS_CYANOBACTERI...1,SET,176,-0.010944,-0.0010659,0.06501,0.56684,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN,1
MIR6124,SET,410,-0.0071842,-0.001061,0.042674,0.56685,MIR6124,1
GOBP_REGULATION_OF_INTEGRIN_...1,SET,17,-0.036703,-0.0011158,0.21794,0.56687,GOBP_REGULATION_OF_INTEGRIN_ACTIVATION,1
GOBP_DETECTION_OF_LIGHT_STIM...1,SET,58,-0.019555,-0.0010968,0.11609,0.56688,GOBP_DETECTION_OF_LIGHT_STIMULUS,1
LI_ESTROGENE_META_E2_RESPONS...1,SET,22,-0.032813,-0.0011346,0.1947,0.56691,LI_ESTROGENE_META_E2_RESPONSE_DN,1
GOBP_RECEPTOR_LOCALIZATION_T...1,SET,4,-0.051467,-0.00075921,0.30543,0.56691,GOBP_RECEPTOR_LOCALIZATION_TO_NON_MOTILE_CILIUM,1
GOMF_ACID_PHOSPHATASE_ACTIVI...,SET,6,-0.059947,-0.001083,0.35512,0.56703,GOMF_ACID_PHOSPHATASE_ACTIVITY,1
HP_ABNORMALLY_SHAPED_CARPAL_...,SET,7,-0.058529,-0.0011421,0.34664,0.56704,HP_ABNORMALLY_SHAPED_CARPAL_BONES,1
HP_LATE_ONSET,SET,123,-0.013242,-0.0010797,0.078415,0.56705,HP_LATE_ONSET,1
MIR339_5P,SET,65,-0.017818,-0.0010578,0.10548,0.56707,MIR339_5P,1
GOBP_NEGATIVE_REGULATION_OF_...559,SET,68,-0.017749,-0.0010776,0.10505,0.56709,GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,1
WP_ALTERNATIVE_PATHWAY_OF_FE...,SET,11,-0.044188,-0.0010807,0.26145,0.5671,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,1
GOCC_CALCIUM_CHANNEL_COMPLEX,SET,63,-0.018799,-0.0010988,0.11114,0.56716,GOCC_CALCIUM_CHANNEL_COMPLEX,1
GSE21360_PRIMARY_VS_TERTIARY...2,SET,186,-0.010181,-0.0010191,0.06019,0.56716,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
GOMF_PROTEIN_GERANYLGERANYLT...,SET,4,-0.063802,-0.00094117,0.37694,0.5672,GOMF_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY,1
MIR4718,SET,97,-0.016324,-0.0011828,0.096387,0.56724,MIR4718,1
ROSTY_CERVICAL_CANCER_PROLIF...,SET,130,-0.011963,-0.0010026,0.070602,0.56728,ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,1
SHI_SPARC_TARGETS_DN,SET,12,-0.046557,-0.0011893,0.27476,0.56728,SHI_SPARC_TARGETS_DN,1
HP_CHRONIC_LYMPHOCYTIC_MENIN...,SET,5,-0.069911,-0.001153,0.41257,0.56728,HP_CHRONIC_LYMPHOCYTIC_MENINGITIS,1
GOBP_NEUROBLAST_DIVISION,SET,14,-0.040282,-0.0011114,0.23766,0.5673,GOBP_NEUROBLAST_DIVISION,1
GOBP_LENS_FIBER_CELL_DEVELOP...,SET,14,-0.041005,-0.0011313,0.24175,0.56734,GOBP_LENS_FIBER_CELL_DEVELOPMENT,1
REACTOME_NOTCH2_ACTIVATION_A...,SET,20,-0.033552,-0.0011062,0.19778,0.56735,REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1
GOBP_KETONE_BIOSYNTHETIC_PRO...,SET,42,-0.021878,-0.0010447,0.12897,0.56735,GOBP_KETONE_BIOSYNTHETIC_PROCESS,1
GSE17721_POLYIC_VS_GARDIQUIM...11,SET,184,-0.010443,-0.0010397,0.061557,0.56736,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN,1
HP_RECURRENT_PROTOZOAN_INFEC...,SET,5,-0.071433,-0.0011781,0.42059,0.56743,HP_RECURRENT_PROTOZOAN_INFECTIONS,1
GSE360_HIGH_DOSE_B_MALAYI_VS...2,SET,176,-0.010858,-0.0010575,0.06389,0.56747,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,1
MODULE_462,SET,15,-0.042257,-0.0012068,0.24864,0.56748,MODULE_462,1
REACTOME_RAS_SIGNALING_DOWNS...,SET,7,-0.053282,-0.0010397,0.31333,0.56751,REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS,1
MURARO_PANCREAS_ENDOTHELIAL_...,SET,337,-0.0086418,-0.0011594,0.050811,0.56752,MURARO_PANCREAS_ENDOTHELIAL_CELL,1
GOBP_PEPTIDYL_LYSINE_DIMETHY...,SET,4,-0.075787,-0.001118,0.44539,0.56756,GOBP_PEPTIDYL_LYSINE_DIMETHYLATION,1
HP_CONTRACTURE_OF_THE_DISTAL...,SET,6,-0.066989,-0.0012102,0.39368,0.56756,HP_CONTRACTURE_OF_THE_DISTAL_INTERPHALANGEAL_JOINT_OF_THE_FINGERS,1
GSE40666_WT_VS_STAT4_KO_CD8_...3,SET,187,-0.010621,-0.0010659,0.062415,0.56756,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,1
MORF_CTSB,SET,156,-0.012178,-0.0011172,0.071523,0.5676,MORF_CTSB,1
GOBP_FORMATION_OF_ANATOMICAL...,SET,6,-0.059728,-0.001079,0.35048,0.56766,GOBP_FORMATION_OF_ANATOMICAL_BOUNDARY,1
HP_LYMPHADENITIS,SET,13,-0.038249,-0.0010169,0.2244,0.56767,HP_LYMPHADENITIS,1
HP_GALACTORRHEA,SET,9,-0.047822,-0.001058,0.2804,0.56771,HP_GALACTORRHEA,1
REACTOME_RECEPTOR_TYPE_TYROS...,SET,16,-0.039537,-0.0011661,0.23173,0.56773,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,1
GOCC_CUL4A_RING_E3_UBIQUITIN...,SET,12,-0.043923,-0.001122,0.25738,0.56775,GOCC_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX,1
GOBP_MRNA_METHYLGUANOSINE_CA...,SET,14,-0.036288,-0.0010012,0.21262,0.56776,GOBP_MRNA_METHYLGUANOSINE_CAP_DECAPPING,1
MIR12124,SET,289,-0.0085178,-0.0010597,0.049899,0.56777,MIR12124,1
HE_LIM_SUN_FETAL_LUNG_C0_AIR...,SET,20,-0.037019,-0.0012205,0.2166,0.56785,HE_LIM_SUN_FETAL_LUNG_C0_AIRWAY_FIBROBLAST,1
HP_DISTAL_UPPER_LIMB_MUSCLE_...,SET,37,-0.025859,-0.0011591,0.15122,0.56789,HP_DISTAL_UPPER_LIMB_MUSCLE_WEAKNESS,1
STEIN_ESTROGEN_RESPONSE_NOT_...,SET,17,-0.040702,-0.0012373,0.23769,0.56798,STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,1
REACTOME_PHASE_3_RAPID_REPOL...,SET,8,-0.051187,-0.0010677,0.29872,0.56803,REACTOME_PHASE_3_RAPID_REPOLARISATION,1
REACTOME_TRANSPORT_OF_SMALL_...,SET,688,-0.0058803,-0.0011163,0.034307,0.56805,REACTOME_TRANSPORT_OF_SMALL_MOLECULES,1
REACTOME_CELLULAR_RESPONSE_T...1,SET,191,-0.010314,-0.001046,0.060111,0.56811,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1
GOBP_REGULATION_OF_CHROMATIN...2,SET,28,-0.026043,-0.0010158,0.15178,0.56812,GOBP_REGULATION_OF_CHROMATIN_ORGANIZATION,1
HP_HYPOPLASTIC_TOENAILS,SET,75,-0.017602,-0.0011222,0.10255,0.56814,HP_HYPOPLASTIC_TOENAILS,1
HP_DECREASED_ACTIVITY_OF_MIT...1,SET,8,-0.043365,-0.00090457,0.25241,0.5682,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_ATP_SYNTHASE_COMPLEX,1
HP_ABNORMAL_PERIOSTEUM_MORPH...,SET,8,-0.059692,-0.0012451,0.34737,0.56822,HP_ABNORMAL_PERIOSTEUM_MORPHOLOGY,1
HALLMARK_EPITHELIAL_MESENCHY...,SET,187,-0.011882,-0.0011925,0.06911,0.56825,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,1
WP_3Q29_COPY_NUMBER_VARIATIO...,SET,57,-0.022503,-0.0012513,0.13084,0.56827,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_RESPONSE_TO_LUTEINIZING...,SET,7,-0.057543,-0.0011228,0.33459,0.56827,GOBP_RESPONSE_TO_LUTEINIZING_HORMONE,1
GOBP_NEGATIVE_REGULATION_OF_...470,SET,12,-0.046378,-0.0011847,0.26961,0.56829,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,1
GSE6259_33D1_POS_VS_DEC205_P...2,SET,159,-0.011932,-0.0011051,0.069366,0.56829,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP,1
MIR4640_3P,SET,14,-0.038488,-0.0010619,0.22364,0.56832,MIR4640_3P,1
GSE22611_MUTANT_NOD2_VS_CTRL...2,SET,176,-0.010926,-0.0010641,0.063478,0.56833,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...52,SET,30,-0.028586,-0.001154,0.166,0.56836,HP_APLASIA_HYPOPLASIA_OF_THE_PATELLA,1
GSE1925_3H_VS_24H_IFNG_STIM_...4,SET,170,-0.011275,-0.0010794,0.06548,0.56836,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP,1
GOMF_CAMP_BINDING,SET,23,-0.03222,-0.0011391,0.18703,0.56838,GOMF_CAMP_BINDING,1
MIR190B_5P,SET,104,-0.015189,-0.0011394,0.088157,0.5684,MIR190B_5P,1
HP_PROMINENT_DIGIT_PAD,SET,35,-0.025811,-0.0011253,0.14965,0.56847,HP_PROMINENT_DIGIT_PAD,1
GOBP_NEGATIVE_REGULATION_OF_...267,SET,55,-0.020867,-0.0011398,0.12082,0.56856,GOBP_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GSE3039_CD4_TCELL_VS_ALPHAAL...2,SET,182,-0.011222,-0.0011113,0.064978,0.56856,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP,1
REACTOME_FRS_MEDIATED_FGFR3_...,SET,19,-0.033075,-0.0010629,0.19146,0.56858,REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,1
GSE27670_CTRL_VS_BLIMP1_TRAN...1,SET,180,-0.01135,-0.0011178,0.065687,0.56859,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN,1
TATCTGG_MIR488,SET,58,-0.019707,-0.0011054,0.11386,0.5687,TATCTGG_MIR488,1
GOBP_NEGATIVE_REGULATION_OF_...352,SET,13,-0.039368,-0.0010467,0.22716,0.56879,GOBP_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
WAKABAYASHI_ADIPOGENESIS_PPA...4,SET,781,-0.005462,-0.0011018,0.031505,0.56882,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D,1
GOMF_ALCOHOL_TRANSMEMBRANE_T...,SET,6,-0.059594,-0.0010766,0.34357,0.56885,GOMF_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_PERICARDIUM_MORPHOGENES...,SET,8,-0.059839,-0.0012482,0.34485,0.56888,GOBP_PERICARDIUM_MORPHOGENESIS,1
REACTOME_TRANSPORT_OF_CONNEX...,SET,18,-0.039068,-0.0012221,0.22511,0.56889,REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE,1
GOBP_EPIDERMIS_MORPHOGENESIS,SET,36,-0.029146,-0.0012887,0.16792,0.5689,GOBP_EPIDERMIS_MORPHOGENESIS,1
HP_NEUTROPHILIA,SET,22,-0.034788,-0.0012029,0.20043,0.5689,HP_NEUTROPHILIA,1
chr1p31,SET,77,-0.032618,-0.0021069,0.18781,0.56894,chr1p31,1
HNF1_Q6,SET,232,-0.010685,-0.0011929,0.06152,0.56894,HNF1_Q6,1
GOBP_MESENCHYME_DEVELOPMENT,SET,293,-0.0092799,-0.0011624,0.053413,0.56896,GOBP_MESENCHYME_DEVELOPMENT,1
GOMF_DENEDDYLASE_ACTIVITY,SET,6,-0.049729,-0.00089839,0.28622,0.56897,GOMF_DENEDDYLASE_ACTIVITY,1
GSE1740_MCSF_VS_MCSF_AND_IFN...2,SET,161,-0.011917,-0.0011105,0.068587,0.56897,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP,1
MIR3942_5P,SET,197,-0.011348,-0.0011685,0.06529,0.56899,MIR3942_5P,1
MIR920,SET,47,-0.020509,-0.0010359,0.11799,0.569,MIR920,1
chr12q22,SET,18,-0.061145,-0.0019126,0.35164,0.56902,chr12q22,1
HP_SPLIT_FOOT,SET,6,-0.06333,-0.0011441,0.36421,0.56902,HP_SPLIT_FOOT,1
GOBP_REGULATION_OF_ACTIN_FIL...1,SET,39,-0.023724,-0.0010917,0.13642,0.56903,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT,1
GOCC_PROTEIN_PHOSPHATASE_4_C...,SET,3,-0.070679,-0.00090295,0.40644,0.56903,GOCC_PROTEIN_PHOSPHATASE_4_COMPLEX,1
MIR4771,SET,48,-0.021275,-0.0010859,0.12227,0.56907,MIR4771,1
GSE360_T_GONDII_VS_M_TUBERCU...4,SET,181,-0.011028,-0.001089,0.063373,0.56907,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP,1
GSE5542_IFNG_VS_IFNA_TREATED...1,SET,175,-0.011369,-0.0011041,0.065327,0.56908,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,1
GOBP_REGULATION_OF_FLAGELLAT...,SET,18,-0.036588,-0.0011445,0.21004,0.56914,GOBP_REGULATION_OF_FLAGELLATED_SPERM_MOTILITY,1
HP_CONCAVE_NAIL,SET,11,-0.041133,-0.001006,0.23604,0.56917,HP_CONCAVE_NAIL,1
MIR4258,SET,5,-0.058014,-0.00095678,0.3327,0.56921,MIR4258,1
GSE17974_0.5H_VS_72H_UNTREAT...2,SET,160,-0.011787,-0.001095,0.067577,0.56923,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,1
GOMF_VOLTAGE_GATED_POTASSIUM...3,SET,11,-0.052553,-0.0012853,0.30119,0.56926,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...418,SET,19,-0.03728,-0.0011981,0.2136,0.56927,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION,1
GOBP_CELL_CHEMOTAXIS,SET,290,-0.0096483,-0.0012024,0.055271,0.56929,GOBP_CELL_CHEMOTAXIS,1
GOBP_REGULATION_OF_BIOMINERA...,SET,89,-0.016873,-0.0011713,0.096613,0.56932,GOBP_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,1
MATSUMIYA_PBMC_MODIFIED_VACC...3,SET,10,-0.051665,-0.0012048,0.29574,0.56934,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_LOW_VS_HIGH_RESPONDERS_2DY_GO_T_CELL_ACTIV_AND_CO_STIM_UP,1
BILBAN_B_CLL_LPL_DN,SET,37,-0.025602,-0.0011476,0.14643,0.5694,BILBAN_B_CLL_LPL_DN,1
HP_ABNORMAL_CARPAL_MORPHOLOGY,SET,79,-0.01702,-0.0011135,0.097338,0.5694,HP_ABNORMAL_CARPAL_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...502,SET,21,-0.037265,-0.001259,0.21309,0.56941,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,1
KEGG_MEDICUS_REFERENCE_LECTI...1,SET,10,-0.060513,-0.0014112,0.34582,0.56945,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN,1
REACTOME_EPHRIN_SIGNALING,SET,17,-0.037713,-0.0011465,0.21504,0.56961,REACTOME_EPHRIN_SIGNALING,1
GOMF_GTPASE_ACTIVATING_PROTE...,SET,11,-0.044747,-0.0010944,0.25511,0.56962,GOMF_GTPASE_ACTIVATING_PROTEIN_BINDING,1
GSE11961_MARGINAL_ZONE_BCELL...2,SET,179,-0.010539,-0.001035,0.060052,0.56965,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GOMF_DISORDERED_DOMAIN_SPECI...,SET,27,-0.028635,-0.0010968,0.16315,0.56966,GOMF_DISORDERED_DOMAIN_SPECIFIC_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...560,SET,6,-0.065032,-0.0011748,0.3703,0.5697,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST,1
MIR574_3P,SET,5,-0.074049,-0.0012212,0.42153,0.56972,MIR574_3P,1
HP_INSULINOMA,SET,6,-0.062403,-0.0011274,0.35522,0.56972,HP_INSULINOMA,1
GSE4984_UNTREATED_VS_GALECTI...1,SET,154,-0.012461,-0.0011359,0.07089,0.56976,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...359,SET,11,-0.04927,-0.001205,0.28025,0.56978,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...402,SET,89,-0.016968,-0.0011779,0.096502,0.56978,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,1
GOCC_CATION_CHANNEL_COMPLEX,SET,195,-0.011804,-0.0012095,0.067144,0.56978,GOCC_CATION_CHANNEL_COMPLEX,1
GOBP_REGULATION_OF_LOCOMOTION,SET,961,-0.0052653,-0.0011721,0.02992,0.56984,GOBP_REGULATION_OF_LOCOMOTION,1
HELLER_HDAC_TARGETS_DN,SET,266,-0.0096834,-0.0011565,0.054985,0.56989,HELLER_HDAC_TARGETS_DN,1
GOBP_ANTIFUNGAL_HUMORAL_RESP...,SET,4,-0.084213,-0.0012423,0.47794,0.56993,GOBP_ANTIFUNGAL_HUMORAL_RESPONSE,1
BANDRES_RESPONSE_TO_CARMUSTI...7,SET,28,-0.029838,-0.0011638,0.16918,0.57,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,1
GOBP_REGULATION_OF_DNA_TEMPL...3,SET,94,-0.014341,-0.001023,0.081293,0.57001,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
HP_LOWER_EXTREMITY_JOINT_DIS...,SET,271,-0.0092101,-0.0011101,0.052158,0.57008,HP_LOWER_EXTREMITY_JOINT_DISLOCATION,1
GOBP_CELL_CELL_ADHESION_INVO...,SET,11,-0.046211,-0.0011302,0.26165,0.57009,GOBP_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION,1
HP_POSTERIOR_SYNECHIAE_OF_TH...,SET,10,-0.05213,-0.0012157,0.29503,0.57012,HP_POSTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,1
GOBP_LOCOMOTORY_EXPLORATION_...,SET,15,-0.041697,-0.0011908,0.2356,0.57024,GOBP_LOCOMOTORY_EXPLORATION_BEHAVIOR,1
chr3p21,SET,185,-0.025943,-0.0025898,0.14654,0.57026,chr3p21,1
WENG_POR_DOSAGE,SET,22,-0.035181,-0.0012165,0.19865,0.57028,WENG_POR_DOSAGE,1
GOBP_NEGATIVE_REGULATION_OF_...489,SET,4,-0.087841,-0.0012958,0.49598,0.57029,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_REFLEX,SET,1089,-0.004624,-0.0010917,0.026104,0.5703,HP_ABNORMAL_REFLEX,1
HP_BILATERAL_CRYPTORCHIDISM,SET,43,-0.020995,-0.0010143,0.11848,0.57032,HP_BILATERAL_CRYPTORCHIDISM,1
GSE21033_CTRL_VS_POLYIC_STIM...9,SET,147,-0.011849,-0.0010554,0.066806,0.57038,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN,1
BEIER_GLIOMA_STEM_CELL_DN,SET,60,-0.019487,-0.0011117,0.10985,0.5704,BEIER_GLIOMA_STEM_CELL_DN,1
BANDRES_RESPONSE_TO_CARMUSTI...6,SET,12,-0.038951,-0.00099498,0.21952,0.57042,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,1
WP_MAP3K1_ROLE_IN_PROMOTING_...,SET,16,-0.041332,-0.001219,0.23277,0.57047,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,1
FOXR2_TARGET_GENES,SET,168,-0.011693,-0.0011129,0.065824,0.5705,FOXR2_TARGET_GENES,1
MORF_PAX7,SET,242,-0.010077,-0.0011488,0.056665,0.57058,MORF_PAX7,1
ROSS_AML_WITH_MLL_FUSIONS,SET,69,-0.018703,-0.0011439,0.10511,0.57061,ROSS_AML_WITH_MLL_FUSIONS,1
HATADA_METHYLATED_IN_LUNG_CA...1,SET,31,-0.031089,-0.0012758,0.17466,0.57063,HATADA_METHYLATED_IN_LUNG_CANCER_DN,1
WP_MELATONIN_METABOLISM_AND_...,SET,31,-0.028165,-0.0011558,0.15813,0.57068,WP_MELATONIN_METABOLISM_AND_EFFECTS,1
GOBP_ENZYME_LINKED_RECEPTOR_...,SET,891,-0.0054669,-0.0011742,0.030689,0.57069,GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,1
GSE21360_SECONDARY_VS_TERTIA...1,SET,149,-0.012291,-0.0011022,0.068973,0.57072,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,1
BONOME_OVARIAN_CANCER_SURVIV...1,SET,215,-0.010655,-0.0011457,0.059783,0.57073,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1
HP_ABNORMAL_IRIS_PIGMENTATION,SET,131,-0.014478,-0.001218,0.081228,0.57073,HP_ABNORMAL_IRIS_PIGMENTATION,1
PID_THROMBIN_PAR4_PATHWAY,SET,15,-0.04356,-0.001244,0.24427,0.57077,PID_THROMBIN_PAR4_PATHWAY,1
MIR342_5P,SET,57,-0.019681,-0.0010944,0.11028,0.57082,MIR342_5P,1
CTCNANGTGNY_UNKNOWN,SET,74,-0.017053,-0.0010799,0.095557,0.57082,CTCNANGTGNY_UNKNOWN,1
GOMF_ANGIOTENSIN_RECEPTOR_BI...,SET,9,-0.054762,-0.0012116,0.30686,0.57082,GOMF_ANGIOTENSIN_RECEPTOR_BINDING,1
KANNAN_TP53_TARGETS_UP,SET,56,-0.020004,-0.0011025,0.11204,0.57085,KANNAN_TP53_TARGETS_UP,1
ZNF10_TARGET_GENES,SET,643,-0.0060711,-0.0011156,0.034001,0.57086,ZNF10_TARGET_GENES,1
GOBP_TOLL_LIKE_RECEPTOR_7_SI...,SET,8,-0.060005,-0.0012517,0.33587,0.57089,GOBP_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,1
HEBERT_MATRISOME_TNBC_BONE_B...1,SET,13,-0.046309,-0.0012312,0.25912,0.57092,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES,1
HP_ABNORMAL_SPUTUM,SET,119,-0.014693,-0.0011785,0.082197,0.57093,HP_ABNORMAL_SPUTUM,1
GOCC_POSTSYNAPSE,SET,608,-0.0065088,-0.0011641,0.036384,0.57099,GOCC_POSTSYNAPSE,1
HP_APLASIA_CUTIS_CONGENITA_O...3,SET,7,-0.061036,-0.001191,0.34112,0.571,HP_APLASIA_CUTIS_CONGENITA_OVER_THE_SCALP_VERTEX,1
AP2GAMMA_01,SET,234,-0.0098775,-0.0011075,0.055194,0.57101,AP2GAMMA_01,1
GOBP_COENZYME_A_BIOSYNTHETIC...,SET,10,-0.046193,-0.0010772,0.25814,0.57101,GOBP_COENZYME_A_BIOSYNTHETIC_PROCESS,1
HP_C1_C2_SUBLUXATION,SET,5,-0.064654,-0.0010663,0.36126,0.57102,HP_C1_C2_SUBLUXATION,1
HP_ABNORMALITY_OF_SKELETAL_M...2,SET,106,-0.014383,-0.0010892,0.080349,0.57103,HP_ABNORMALITY_OF_SKELETAL_MUSCLE_FIBER_SIZE,1
GLI3_TARGET_GENES,SET,588,-0.0062964,-0.0011081,0.03517,0.57104,GLI3_TARGET_GENES,1
GOBP_PYRIMIDINE_NUCLEOTIDE_C...,SET,21,-0.034059,-0.0011507,0.1901,0.57109,GOBP_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS,1
HP_STROKE_LIKE_EPISODE,SET,12,-0.045405,-0.0011598,0.2534,0.5711,HP_STROKE_LIKE_EPISODE,1
HP_ABNORMAL_CIRCULATING_ORNI...,SET,5,-0.065105,-0.0010737,0.36328,0.57111,HP_ABNORMAL_CIRCULATING_ORNITHINE_CONCENTRATION,1
GOCC_HOPS_COMPLEX,SET,14,-0.035611,-0.0009825,0.19868,0.57112,GOCC_HOPS_COMPLEX,1
GOBP_NUCLEOSOME_ORGANIZATION,SET,64,-0.017934,-0.0010565,0.10003,0.57115,GOBP_NUCLEOSOME_ORGANIZATION,1
GOBP_KERATINOCYTE_MIGRATION,SET,20,-0.038386,-0.0012656,0.21381,0.57124,GOBP_KERATINOCYTE_MIGRATION,1
HP_RESPIRATORY_ALKALOSIS,SET,5,-0.067101,-0.0011066,0.37339,0.57131,HP_RESPIRATORY_ALKALOSIS,1
GSE17721_CTRL_VS_CPG_0.5H_BM...1,SET,181,-0.011649,-0.0011504,0.064768,0.57137,GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN,1
GOMF_QUINONE_BINDING,SET,14,-0.036543,-0.0010082,0.20311,0.57139,GOMF_QUINONE_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...141,SET,9,-0.058301,-0.0012899,0.32383,0.57144,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOBP_MITOTIC_NUCLEAR_MEMBRAN...1,SET,8,-0.053708,-0.0011203,0.29768,0.57159,GOBP_MITOTIC_NUCLEAR_MEMBRANE_DISASSEMBLY,1
HP_BRONCHIAL_WALL_THICKENING,SET,6,-0.076977,-0.0013907,0.42663,0.57159,HP_BRONCHIAL_WALL_THICKENING,1
GOCC_CUL4B_RING_E3_UBIQUITIN...,SET,5,-0.067122,-0.001107,0.37194,0.57161,GOCC_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX,1
MIR190A_5P,SET,105,-0.015808,-0.0011914,0.087573,0.57162,MIR190A_5P,1
GOBP_NEGATIVE_REGULATION_OF_...358,SET,8,-0.058517,-0.0012206,0.32421,0.57162,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GSE24142_DN2_VS_DN3_THYMOCYT...1,SET,180,-0.011675,-0.0011497,0.064663,0.57164,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN,1
GSE11367_CTRL_VS_IL17_TREATE...1,SET,101,-0.01644,-0.0012154,0.091031,0.57166,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN,1
KEGG_SMALL_CELL_LUNG_CANCER,SET,80,-0.017246,-0.0011354,0.095475,0.57167,KEGG_SMALL_CELL_LUNG_CANCER,1
MODULE_150,SET,12,-0.037227,-0.00095095,0.20599,0.57171,MODULE_150,1
LUI_THYROID_CANCER_CLUSTER_4,SET,10,-0.057837,-0.0013488,0.31992,0.57173,LUI_THYROID_CANCER_CLUSTER_4,1
GOBP_POSITIVE_REGULATION_OF_...419,SET,6,-0.074177,-0.0013401,0.41028,0.57173,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,1
GOBP_CARDIAC_CONDUCTION,SET,91,-0.017637,-0.001238,0.097551,0.57174,GOBP_CARDIAC_CONDUCTION,1
GOCC_REPLISOME,SET,22,-0.030529,-0.0010556,0.16883,0.57175,GOCC_REPLISOME,1
MIR4642,SET,90,-0.017011,-0.0011875,0.094063,0.57176,MIR4642,1
GSE9239_CTRL_VS_TNF_INHIBITO...2,SET,175,-0.01175,-0.0011411,0.064972,0.57176,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP,1
GSE22886_TH1_VS_TH2_12H_ACT_...2,SET,180,-0.011303,-0.0011131,0.062439,0.57183,GSE22886_TH1_VS_TH2_12H_ACT_UP,1
HP_HYPERVENTILATION,SET,26,-0.031303,-0.0011766,0.1727,0.57192,HP_HYPERVENTILATION,1
GSE27859_MACROPHAGE_VS_CD11C...4,SET,153,-0.012727,-0.0011564,0.070219,0.57192,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP,1
KEGG_LYSINE_DEGRADATION,SET,37,-0.025028,-0.0011218,0.13802,0.57194,KEGG_LYSINE_DEGRADATION,1
WP_THERMOGENESIS,SET,105,-0.015332,-0.0011555,0.084525,0.57197,WP_THERMOGENESIS,1
GCNP_SHH_UP_EARLY.V1_DN,SET,150,-0.012806,-0.0011522,0.070448,0.57212,GCNP_SHH_UP_EARLY.V1_DN,1
SCHLINGEMANN_SKIN_CARCINOGEN...1,SET,24,-0.031112,-0.0011236,0.17111,0.57214,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,1
REACTOME_PEPTIDE_LIGAND_BIND...,SET,180,-0.013446,-0.0013242,0.07394,0.57215,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,1
MIR631,SET,48,-0.023233,-0.0011858,0.12773,0.57216,MIR631,1
GOBP_MIRNA_MEDIATED_GENE_SIL...1,SET,18,-0.036309,-0.0011358,0.19924,0.5723,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_INHIBITION_OF_TRANSLATION,1
GOBP_SEQUESTERING_OF_ACTIN_M...,SET,6,-0.064848,-0.0011715,0.35583,0.5723,GOBP_SEQUESTERING_OF_ACTIN_MONOMERS,1
HP_CLITORAL_HYPERTROPHY,SET,60,-0.020421,-0.0011649,0.112,0.57233,HP_CLITORAL_HYPERTROPHY,1
GOBP_REGULATION_OF_ADHERENS_...,SET,5,-0.071193,-0.0011741,0.39037,0.57235,GOBP_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,1
GAO_STOMACH_24W_C5_PUTATIVE_...,SET,51,-0.022262,-0.0011711,0.12209,0.57235,GAO_STOMACH_24W_C5_PUTATIVE_PIT_CELL_PROGENITOR,1
GOBP_POSITIVE_REGULATION_OF_...393,SET,15,-0.04366,-0.0012468,0.239,0.57247,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
MIR374B_5P,SET,343,-0.0088216,-0.0011939,0.048272,0.5725,MIR374B_5P,1
HP_PERIFOVEAL_RING_OF_HYPERA...,SET,15,-0.042859,-0.0012239,0.23446,0.57252,HP_PERIFOVEAL_RING_OF_HYPERAUTOFLUORESCENCE,1
GOMF_3_5_RNA_HELICASE_ACTIVI...,SET,5,-0.096416,-0.0015901,0.52738,0.57253,GOMF_3_5_RNA_HELICASE_ACTIVITY,1
MODULE_357,SET,72,-0.019718,-0.0012317,0.10775,0.5726,MODULE_357,1
GOCC_TOR_COMPLEX,SET,12,-0.04308,-0.0011005,0.23537,0.57261,GOCC_TOR_COMPLEX,1
GAVISH_3CA_METAPROGRAM_CD8_T...8,SET,44,-0.02561,-0.0012516,0.13977,0.57269,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_MEMORY_NAIVE_1,1
GSE45881_CXCR6HI_VS_CXCR1LO_...1,SET,185,-0.011488,-0.0011468,0.062699,0.57269,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN,1
EHLERS_ANEUPLOIDY_UP,SET,35,-0.025678,-0.0011195,0.14012,0.5727,EHLERS_ANEUPLOIDY_UP,1
HP_ABNORMAL_PYRAMIDAL_SIGN,SET,383,-0.00785,-0.0011214,0.042828,0.57271,HP_ABNORMAL_PYRAMIDAL_SIGN,1
GOBP_LIVER_REGENERATION,SET,30,-0.029731,-0.0012002,0.16217,0.57273,GOBP_LIVER_REGENERATION,1
MIR410_5P,SET,38,-0.024017,-0.001091,0.13098,0.57274,MIR410_5P,1
GOBP_ORGANIC_ACID_BIOSYNTHET...,SET,303,-0.0093616,-0.0011921,0.051038,0.57277,GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_AXON_EXTE...1,SET,69,-0.018861,-0.0011535,0.1028,0.57279,GOBP_REGULATION_OF_AXON_EXTENSION,1
MIR5583_3P,SET,76,-0.019186,-0.0012313,0.10453,0.57282,MIR5583_3P,1
MIR6885_3P,SET,364,-0.0084445,-0.0011766,0.045993,0.57284,MIR6885_3P,1
HP_TENTED_UPPER_LIP_VERMILION,SET,101,-0.015467,-0.0011435,0.084228,0.57285,HP_TENTED_UPPER_LIP_VERMILION,1
MIR623,SET,107,-0.015155,-0.001153,0.082508,0.57287,MIR623,1
GSE16450_IMMATURE_VS_MATURE_...3,SET,177,-0.011742,-0.0011468,0.06393,0.57287,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,1
HP_HEMANGIOBLASTOMA,SET,18,-0.032695,-0.0010227,0.17793,0.57289,HP_HEMANGIOBLASTOMA,1
GSE3982_MAC_VS_BASOPHIL_UP,SET,182,-0.011592,-0.0011479,0.063085,0.5729,GSE3982_MAC_VS_BASOPHIL_UP,1
GOBP_TUMOR_NECROSIS_FACTOR_M...,SET,104,-0.015723,-0.0011794,0.085544,0.57291,GOBP_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
HP_ACUTE_PHASE_RESPONSE,SET,168,-0.012727,-0.0012113,0.069137,0.57302,HP_ACUTE_PHASE_RESPONSE,1
MIR6828_3P,SET,107,-0.015405,-0.001172,0.083587,0.57311,MIR6828_3P,1
SNF5_DN.V1_UP,SET,148,-0.013367,-0.0011947,0.072459,0.57318,SNF5_DN.V1_UP,1
GOBP_CELLULAR_RESPONSE_TO_CA...3,SET,69,-0.019882,-0.001216,0.10772,0.57322,GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION,1
HP_CHORIOCARCINOMA,SET,8,-0.060513,-0.0012623,0.32784,0.57322,HP_CHORIOCARCINOMA,1
BACOLOD_RESISTANCE_TO_ALKYLA...2,SET,22,-0.036995,-0.0012792,0.20011,0.57333,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,1
HP_GASTROINTESTINAL_ULCER,SET,46,-0.026555,-0.0013269,0.14357,0.57337,HP_GASTROINTESTINAL_ULCER,1
GOBP_REGULATION_OF_HYDROGEN_...2,SET,9,-0.054137,-0.0011977,0.29259,0.5734,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,1
HP_INTERCOSTAL_MUSCLE_WEAKNE...,SET,9,-0.058448,-0.0012931,0.31588,0.5734,HP_INTERCOSTAL_MUSCLE_WEAKNESS,1
HP_HALITOSIS,SET,6,-0.069381,-0.0012534,0.37492,0.57341,HP_HALITOSIS,1
GSE32164_RESTING_DIFFERENTIA...2,SET,186,-0.011696,-0.0011707,0.063178,0.57343,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP,1
GOBP_EXTRACELLULAR_MATRIX_AS...,SET,43,-0.024557,-0.0011864,0.13265,0.57344,GOBP_EXTRACELLULAR_MATRIX_ASSEMBLY,1
HP_HYPOPLASIA_OF_OLFACTORY_T...,SET,8,-0.045502,-0.00094914,0.24565,0.57347,HP_HYPOPLASIA_OF_OLFACTORY_TRACT,1
GOBP_LOCOMOTORY_BEHAVIOR,SET,194,-0.011754,-0.0012013,0.063413,0.57353,GOBP_LOCOMOTORY_BEHAVIOR,1
HP_BROAD_TOE,SET,72,-0.018301,-0.0011433,0.098713,0.57354,HP_BROAD_TOE,1
HP_ELEVATED_URINARY_CATECHOL...,SET,27,-0.029568,-0.0011325,0.15942,0.57357,HP_ELEVATED_URINARY_CATECHOLAMINE_LEVEL,1
GOCC_CHAPERONIN_CONTAINING_T...,SET,10,-0.042498,-0.00099107,0.22902,0.57361,GOCC_CHAPERONIN_CONTAINING_T_COMPLEX,1
MIKKELSEN_MEF_LCP_WITH_H3K4M...,SET,112,-0.015139,-0.0011782,0.081556,0.57363,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,1
HP_LACK_OF_T_CELL_FUNCTION,SET,7,-0.065882,-0.0012855,0.35487,0.57364,HP_LACK_OF_T_CELL_FUNCTION,1
GOMF_ADP_D_RIBOSE_MODIFICATI...,SET,4,-0.073165,-0.0010793,0.39405,0.57365,GOMF_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
HP_ACNE_INVERSA,SET,11,-0.040135,-0.00098161,0.21611,0.57366,HP_ACNE_INVERSA,1
GSE17974_0H_VS_2H_IN_VITRO_A...2,SET,166,-0.012293,-0.0011631,0.066204,0.57366,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP,1
HP_LIMITED_ELBOW_EXTENSION,SET,45,-0.023106,-0.0011419,0.12423,0.57378,HP_LIMITED_ELBOW_EXTENSION,1
HP_OCULOMOTOR_NERVE_PALSY,SET,27,-0.030886,-0.001183,0.16597,0.57381,HP_OCULOMOTOR_NERVE_PALSY,1
BIOCARTA_EIF4_PATHWAY,SET,24,-0.035108,-0.0012679,0.18855,0.57385,BIOCARTA_EIF4_PATHWAY,1
GOBP_MAMMARY_GLAND_DEVELOPME...,SET,128,-0.015399,-0.0012807,0.082658,0.57389,GOBP_MAMMARY_GLAND_DEVELOPMENT,1
GOCC_CUL4_RING_E3_UBIQUITIN_...,SET,31,-0.02737,-0.0011232,0.14686,0.57392,GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX,1
KEGG_MEDICUS_VARIANT_MUTATIO...37,SET,17,-0.041702,-0.0012677,0.22373,0.57393,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...66,SET,40,-0.024947,-0.0011626,0.13375,0.57398,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
MORF_AP2M1,SET,194,-0.010613,-0.0010847,0.05688,0.57401,MORF_AP2M1,1
GOBP_INHIBITORY_POSTSYNAPTIC...,SET,13,-0.049286,-0.0013104,0.26413,0.57401,GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL,1
GRANDVAUX_IRF3_TARGETS_DN,SET,17,-0.04266,-0.0012969,0.2286,0.57402,GRANDVAUX_IRF3_TARGETS_DN,1
HP_ABNORMALITY_OF_THE_ELBOW,SET,246,-0.010304,-0.0011841,0.055192,0.57405,HP_ABNORMALITY_OF_THE_ELBOW,1
HP_ABNORMAL_PALATE_MORPHOLOGY,SET,991,-0.0051567,-0.0011647,0.02762,0.57405,HP_ABNORMAL_PALATE_MORPHOLOGY,1
FAN_EMBRYONIC_CTX_OPC,SET,48,-0.025947,-0.0013243,0.13883,0.57413,FAN_EMBRYONIC_CTX_OPC,1
GOBP_RESPONSE_TO_2_3_7_8_TET...,SET,5,-0.087395,-0.0014413,0.46757,0.57414,GOBP_RESPONSE_TO_2_3_7_8_TETRACHLORODIBENZODIOXINE,1
GOBP_ESTABLISHMENT_OF_PROTEI...3,SET,23,-0.029062,-0.0010275,0.15536,0.57419,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
LEIN_CHOROID_PLEXUS_MARKERS,SET,98,-0.016788,-0.0012227,0.089729,0.57421,LEIN_CHOROID_PLEXUS_MARKERS,1
GSE5503_PLN_DC_VS_SPLEEN_DC_...1,SET,181,-0.011699,-0.0011553,0.062459,0.57429,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
WP_VITAMIN_D_METABOLISM,SET,10,-0.050291,-0.0011728,0.26839,0.57432,WP_VITAMIN_D_METABOLISM,1
GOBP_NUCLEAR_MRNA_SURVEILLAN...,SET,10,-0.046279,-0.0010792,0.24679,0.57437,GOBP_NUCLEAR_MRNA_SURVEILLANCE,1
GOBP_NEGATIVE_REGULATION_OF_...692,SET,5,-0.082165,-0.0013551,0.43809,0.57438,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,1
GOCC_GBAF_COMPLEX,SET,12,-0.045676,-0.0011668,0.24348,0.5744,GOCC_GBAF_COMPLEX,1
REACTOME_METABOLISM_OF_STERO...2,SET,33,-0.02933,-0.0012417,0.15631,0.57442,REACTOME_METABOLISM_OF_STEROID_HORMONES,1
TOOKER_GEMCITABINE_RESISTANC...2,SET,73,-0.019858,-0.001249,0.1058,0.57444,TOOKER_GEMCITABINE_RESISTANCE_UP,1
HP_OCCIPITAL_MENINGOCELE,SET,7,-0.063072,-0.0012307,0.33593,0.57446,HP_OCCIPITAL_MENINGOCELE,1
ZNF596_TARGET_GENES,SET,486,-0.0075677,-0.0012143,0.04029,0.57449,ZNF596_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_DEUBI...,SET,20,-0.038547,-0.0012709,0.20512,0.57453,KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119,1
MIR1827,SET,359,-0.0084098,-0.0011639,0.044752,0.57453,MIR1827,1
HP_HEPARAN_SULFATE_EXCRETION...,SET,8,-0.053543,-0.0011169,0.28468,0.57459,HP_HEPARAN_SULFATE_EXCRETION_IN_URINE,1
LIM_MAMMARY_LUMINAL_MATURE_DN,SET,90,-0.018513,-0.0012923,0.098404,0.57461,LIM_MAMMARY_LUMINAL_MATURE_DN,1
GOCC_CYTOSOLIC_PROTEASOME_CO...,SET,5,-0.057993,-0.00095643,0.30819,0.57463,GOCC_CYTOSOLIC_PROTEASOME_COMPLEX,1
GOBP_LOCOMOTION,SET,1125,-0.0052435,-0.001257,0.027853,0.57466,GOBP_LOCOMOTION,1
GOBP_PROTEIN_HOMOOLIGOMERIZA...,SET,190,-0.011996,-0.0012134,0.06372,0.57466,GOBP_PROTEIN_HOMOOLIGOMERIZATION,1
GOMF_TRANSFORMING_GROWTH_FAC...2,SET,13,-0.048969,-0.0013019,0.25999,0.5747,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY,1
GSE12505_WT_VS_E2_2_HET_PDC_...2,SET,119,-0.015009,-0.0012038,0.079585,0.57479,GSE12505_WT_VS_E2_2_HET_PDC_UP,1
REACTOME_NFE2L2_REGULATING_I...,SET,5,-0.076678,-0.0012646,0.40635,0.57484,REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES,1
GSE360_L_DONOVANI_VS_T_GONDI...4,SET,175,-0.012237,-0.0011884,0.064843,0.57484,GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP,1
GSE17186_NAIVE_VS_CD21LOW_TR...2,SET,175,-0.011719,-0.0011381,0.062048,0.5749,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP,1
HP_DECREASED_CERVICAL_SPINE_...2,SET,11,-0.046257,-0.0011313,0.24488,0.57491,HP_DECREASED_CERVICAL_SPINE_MOBILITY,1
ACTACCT_MIR196A_MIR196B,SET,133,-0.014659,-0.0012425,0.077571,0.57494,ACTACCT_MIR196A_MIR196B,1
ZFP37_TARGET_GENES,SET,4,-0.097709,-0.0014413,0.51682,0.57497,ZFP37_TARGET_GENES,1
HP_CALVARIAL_SKULL_DEFECT,SET,27,-0.033212,-0.0012721,0.17569,0.57497,HP_CALVARIAL_SKULL_DEFECT,1
HP_DELAYED_CRANIAL_SUTURE_CL...,SET,87,-0.017053,-0.0011706,0.090187,0.57499,HP_DELAYED_CRANIAL_SUTURE_CLOSURE,1
CHAUHAN_RESPONSE_TO_METHOXYE...2,SET,41,-0.023675,-0.001117,0.12506,0.57507,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,1
GOBP_POSITIVE_REGULATION_OF_...192,SET,155,-0.014636,-0.0013384,0.077302,0.57508,GOBP_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
WP_ECTODERM_DIFFERENTIATION,SET,121,-0.016119,-0.0013036,0.085001,0.5752,WP_ECTODERM_DIFFERENTIATION,1
TURJANSKI_MAPK8_AND_MAPK9_TA...,SET,7,-0.054846,-0.0010702,0.2892,0.57521,TURJANSKI_MAPK8_AND_MAPK9_TARGETS,1
BANG_VERTEPORFIN_ENDOMETRIAL...1,SET,13,-0.045331,-0.0012052,0.23889,0.57525,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_DN,1
GSE30971_CTRL_VS_LPS_STIM_MA...3,SET,170,-0.011661,-0.0011163,0.061427,0.57528,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN,1
HP_DEEP_VENOUS_THROMBOSIS,SET,17,-0.037997,-0.0011551,0.20013,0.57529,HP_DEEP_VENOUS_THROMBOSIS,1
GSE22611_NOD2_TRANSD_VS_CTRL...2,SET,165,-0.012357,-0.0011656,0.065076,0.5753,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP,1
HP_ABNORMAL_CIRCULATING_FREE...1,SET,9,-0.049748,-0.0011006,0.26177,0.57536,HP_ABNORMAL_CIRCULATING_FREE_FATTY_ACID_CONCENTRATION,1
GOMF_INTRAMOLECULAR_OXIDORED...2,SET,5,-0.057245,-0.00094409,0.30117,0.57537,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES,1
REACTOME_STAT5_ACTIVATION_DO...,SET,10,-0.053419,-0.0012457,0.28076,0.57545,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,1
SAENZ_DETOX_PATHWAY_AND_CARC...,SET,14,-0.042943,-0.0011848,0.22566,0.57546,SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN,1
HP_INCREASED_THETA_FREQUENCY...,SET,10,-0.056019,-0.0013064,0.29422,0.5755,HP_INCREASED_THETA_FREQUENCY_ACTIVITY_IN_EEG,1
HP_FOCAL_HEAD_NODDING_AUTOMA...,SET,5,-0.073216,-0.0012075,0.38438,0.57553,HP_FOCAL_HEAD_NODDING_AUTOMATISM_SEIZURE,1
GAUTAM_EYE_IRIS_CILIARY_BODY...5,SET,76,-0.018636,-0.0011959,0.097822,0.57554,GAUTAM_EYE_IRIS_CILIARY_BODY_CRYAA_HIGH_CILIARY_BODY_CELLS,1
HP_ABSENT_THUMB,SET,51,-0.021459,-0.0011289,0.11259,0.57558,HP_ABSENT_THUMB,1
NERF_Q2,SET,228,-0.010964,-0.0012136,0.057516,0.57559,NERF_Q2,1
MIR4742_3P,SET,201,-0.011727,-0.0012197,0.061504,0.57561,MIR4742_3P,1
MOOTHA_VOXPHOS,SET,68,-0.017523,-0.0010639,0.091852,0.57565,MOOTHA_VOXPHOS,1
GOBP_UREA_CYCLE,SET,10,-0.048219,-0.0011245,0.25267,0.57567,GOBP_UREA_CYCLE,1
GOMF_CO_SMAD_BINDING,SET,9,-0.059809,-0.0013232,0.31337,0.57568,GOMF_CO_SMAD_BINDING,1
MIR6833_3P,SET,375,-0.0086803,-0.0012272,0.045456,0.57572,MIR6833_3P,1
HP_POLYSPLENIA,SET,49,-0.0219,-0.0011293,0.11467,0.57573,HP_POLYSPLENIA,1
GAVISH_3CA_MALIGNANT_METAPRO...12,SET,38,-0.024389,-0.0011079,0.12764,0.57577,GAVISH_3CA_MALIGNANT_METAPROGRAM_21_RESPIRATION,1
MIR4669,SET,10,-0.051104,-0.0011918,0.26731,0.57581,MIR4669,1
GOBP_KERATINOCYTE_APOPTOTIC_...,SET,7,-0.064056,-0.0012499,0.33496,0.57583,GOBP_KERATINOCYTE_APOPTOTIC_PROCESS,1
LEE_CALORIE_RESTRICTION_MUSC...2,SET,36,-0.027551,-0.0012182,0.14402,0.57585,LEE_CALORIE_RESTRICTION_MUSCLE_UP,1
GOMF_NEUROTRANSMITTER_RECEPT...2,SET,52,-0.025618,-0.0013607,0.1339,0.57586,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY_INVOLVED_IN_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,1
HP_HAND_MUSCLE_ATROPHY,SET,48,-0.023612,-0.0012052,0.1233,0.57593,HP_HAND_MUSCLE_ATROPHY,1
HP_DEGENERATION_OF_THE_STRIA...,SET,11,-0.046754,-0.0011435,0.24411,0.57594,HP_DEGENERATION_OF_THE_STRIATUM,1
HP_NEOPLASM_OF_THE_LUNG,SET,60,-0.0213,-0.0012151,0.11119,0.57596,HP_NEOPLASM_OF_THE_LUNG,1
GSE22919_RESTING_VS_IL2_IL12...1,SET,181,-0.01172,-0.0011574,0.061181,0.57596,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN,1
NIKOLSKY_BREAST_CANCER_7P15_...,SET,11,-0.080302,-0.001964,0.41903,0.57599,NIKOLSKY_BREAST_CANCER_7P15_AMPLICON,1
HP_ABNORMAL_SERUM_BICARBONAT...,SET,5,-0.075149,-0.0012394,0.39195,0.57602,HP_ABNORMAL_SERUM_BICARBONATE_CONCENTRATION,1
REACTOME_KERATINIZATION,SET,183,-0.017199,-0.0017077,0.089696,0.57603,REACTOME_KERATINIZATION,1
GSE12963_UNINF_VS_ENV_AND_NE...4,SET,127,-0.014695,-0.0012173,0.076601,0.57606,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP,1
GOBP_FEMALE_MEIOSIS_I,SET,9,-0.059662,-0.00132,0.31092,0.57608,GOBP_FEMALE_MEIOSIS_I,1
GSE45365_NK_CELL_VS_CD8_TCEL...3,SET,183,-0.012183,-0.0012096,0.063408,0.57618,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP,1
DORN_ADENOVIRUS_INFECTION_48...1,SET,37,-0.025804,-0.0011567,0.13428,0.57619,DORN_ADENOVIRUS_INFECTION_48HR_DN,1
GSE17974_CTRL_VS_ACT_IL4_AND...1,SET,167,-0.012163,-0.0011542,0.063268,0.57623,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN,1
GOBP_REGULATION_OF_RELAXATIO...2,SET,13,-0.050672,-0.0013472,0.26331,0.5763,GOBP_REGULATION_OF_RELAXATION_OF_MUSCLE,1
GAVISH_3CA_METAPROGRAM_CD8_T...10,SET,47,-0.026956,-0.0013614,0.14004,0.57632,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_3,1
MEISSNER_BRAIN_HCP_WITH_H3K4...1,SET,16,-0.041562,-0.0012258,0.21575,0.57638,MEISSNER_BRAIN_HCP_WITH_H3K4ME2,1
YAGUE_PRETUMOR_DRUG_RESISTAN...2,SET,7,-0.071077,-0.0013869,0.36852,0.57647,YAGUE_PRETUMOR_DRUG_RESISTANCE_UP,1
GOMF_INORGANIC_MOLECULAR_ENT...,SET,659,-0.0067806,-0.0012608,0.035156,0.57647,GOMF_INORGANIC_MOLECULAR_ENTITY_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
WP_NETWORK_MAP_OF_SARSCOV2_S...,SET,204,-0.012098,-0.0012675,0.062719,0.57648,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,1
GOBP_LUNG_SECRETORY_CELL_DIF...,SET,11,-0.05286,-0.0012928,0.27403,0.57648,GOBP_LUNG_SECRETORY_CELL_DIFFERENTIATION,1
GOCC_INTERCHROMATIN_GRANULE,SET,5,-0.073427,-0.001211,0.3803,0.57655,GOCC_INTERCHROMATIN_GRANULE,1
HP_ABNORMAL_UMBILICUS_MORPHO...,SET,265,-0.010362,-0.0012353,0.053651,0.57657,HP_ABNORMAL_UMBILICUS_MORPHOLOGY,1
GARGALOVIC_RESPONSE_TO_OXIDI...4,SET,126,-0.015013,-0.0012388,0.077721,0.57658,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1
REACTOME_SIGNALING_BY_MET,SET,76,-0.019586,-0.0012569,0.10131,0.57665,REACTOME_SIGNALING_BY_MET,1
ERWIN_COHEN_PBMC_TC_83_AGE_1...1,SET,36,-0.033112,-0.0014641,0.17126,0.57665,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,1
MIR4276,SET,243,-0.010701,-0.0012224,0.055348,0.57666,MIR4276,1
MIR7109_5P,SET,71,-0.01868,-0.0011588,0.096587,0.57668,MIR7109_5P,1
GOBP_INORGANIC_ION_IMPORT_AC...,SET,113,-0.01658,-0.0012961,0.085713,0.57669,GOBP_INORGANIC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
MIR4651,SET,189,-0.012635,-0.0012747,0.065306,0.5767,MIR4651,1
GOMF_TRANSLATION_INITIATION_...2,SET,28,-0.028518,-0.0011123,0.14742,0.5767,GOMF_TRANSLATION_INITIATION_FACTOR_BINDING,1
MIR8081,SET,50,-0.023602,-0.0012294,0.12186,0.57678,MIR8081,1
MODULE_75,SET,369,-0.0097238,-0.0013639,0.050201,0.57679,MODULE_75,1
GSE7460_TCONV_VS_TREG_THYMUS...2,SET,182,-0.01241,-0.0012288,0.064062,0.5768,GSE7460_TCONV_VS_TREG_THYMUS_UP,1
GOBP_POSITIVE_REGULATION_OF_...223,SET,57,-0.019847,-0.0011036,0.10242,0.57682,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
BUSSLINGER_DUODENAL_TRANSIT_...,SET,162,-0.012735,-0.0011904,0.065727,0.57682,BUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS,1
MIR4320,SET,48,-0.025523,-0.0013027,0.13164,0.57687,MIR4320,1
GOBP_VACUOLAR_LOCALIZATION,SET,75,-0.019573,-0.0012478,0.1009,0.5769,GOBP_VACUOLAR_LOCALIZATION,1
HP_INCREASED_ARM_SPAN,SET,7,-0.05655,-0.0011034,0.29143,0.57693,HP_INCREASED_ARM_SPAN,1
GSE5589_IL6_KO_VS_IL10_KO_LP...5,SET,179,-0.012807,-0.0012578,0.066004,0.57693,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
GSE40274_CTRL_VS_FOXP3_TRANS...1,SET,182,-0.012472,-0.001235,0.064266,0.57694,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GSE14769_40MIN_VS_360MIN_LPS...1,SET,189,-0.01161,-0.0011713,0.059808,0.57696,GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN,1
GOMF_AMINE_BINDING,SET,12,-0.045963,-0.0011741,0.23671,0.57698,GOMF_AMINE_BINDING,1
HP_ATRIOVENTRICULAR_CANAL_DE...,SET,52,-0.021799,-0.0011579,0.11225,0.57699,HP_ATRIOVENTRICULAR_CANAL_DEFECT,1
HAY_BONE_MARROW_PRO_B,SET,255,-0.010176,-0.0011903,0.052402,0.57699,HAY_BONE_MARROW_PRO_B,1
GOBP_REGULATION_OF_CELL_SIZE,SET,157,-0.013775,-0.0012677,0.070912,0.57701,GOBP_REGULATION_OF_CELL_SIZE,1
DACH1_TARGET_GENES,SET,741,-0.006105,-0.0012009,0.03142,0.57703,DACH1_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_LECTI...3,SET,9,-0.059068,-0.0013068,0.30365,0.57712,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,1
GSE360_L_DONOVANI_VS_M_TUBER...2,SET,177,-0.012531,-0.0012238,0.064412,0.57712,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP,1
GOBP_REGULATION_OF_NATURAL_K...4,SET,8,-0.061101,-0.0012745,0.31403,0.57713,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
HP_APLASIA_CUTIS_CONGENITA_O...1,SET,19,-0.038373,-0.0012332,0.19708,0.57719,HP_APLASIA_CUTIS_CONGENITA_OF_SCALP,1
HP_ABNORMAL_4TH_METACARPAL_M...,SET,14,-0.048701,-0.0013436,0.24998,0.57723,HP_ABNORMAL_4TH_METACARPAL_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...575,SET,1111,-0.0051899,-0.0012369,0.02662,0.57729,GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS,1
HP_DECREASED_THALAMIC_VOLUME,SET,9,-0.052771,-0.0011675,0.27066,0.57729,HP_DECREASED_THALAMIC_VOLUME,1
GSE41176_WT_VS_TAK1_KO_ANTI_...4,SET,183,-0.012564,-0.0012475,0.064413,0.57733,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP,1
SCHLESINGER_METHYLATED_DE_NO...,SET,80,-0.020449,-0.0013462,0.1048,0.57735,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,1
GOMF_GLYCEROPHOSPHOLIPID_FLI...,SET,12,-0.052518,-0.0013416,0.26912,0.57736,GOMF_GLYCEROPHOSPHOLIPID_FLIPPASE_ACTIVITY,1
KYNG_ENVIRONMENTAL_STRESS_RE...1,SET,16,-0.039908,-0.001177,0.20446,0.57738,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,1
NAKAYA_B_CELL_FLUMIST_AGE_18...2,SET,416,-0.0080186,-0.0011927,0.041046,0.57744,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP,1
OCT_Q6,SET,217,-0.012065,-0.0013033,0.061755,0.57745,OCT_Q6,1
GSE16385_UNTREATED_VS_12H_IL...1,SET,171,-0.012528,-0.0012028,0.064119,0.57745,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN,1
MANNO_MIDBRAIN_NEUROTYPES_HR...5,SET,502,-0.008027,-0.0013084,0.041073,0.57747,MANNO_MIDBRAIN_NEUROTYPES_HRGL3,1
GOMF_PHOSPHOLIPID_SCRAMBLASE...,SET,15,-0.047867,-0.001367,0.24489,0.57748,GOMF_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY,1
GSE19888_ADENOSINE_A3R_INH_P...2,SET,170,-0.013022,-0.0012466,0.066598,0.57751,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP,1
SMID_BREAST_CANCER_RELAPSE_I...10,SET,6,-0.07203,-0.0013013,0.36832,0.57752,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP,1
FOROUTAN_INTEGRATED_TGFB_EMT...2,SET,116,-0.016547,-0.0013105,0.084603,0.57753,FOROUTAN_INTEGRATED_TGFB_EMT_UP,1
GOBP_B_CELL_LINEAGE_COMMITME...,SET,6,-0.061032,-0.0011026,0.31203,0.57754,GOBP_B_CELL_LINEAGE_COMMITMENT,1
IVANOVA_HEMATOPOIESIS_STEM_C...4,SET,18,-0.036958,-0.0011561,0.18892,0.57755,IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM,1
GSE22140_HEALTHY_VS_ARTHRITI...4,SET,178,-0.012502,-0.0012244,0.063845,0.57762,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP,1
GSE36009_UNSTIM_VS_LPS_STIM_...2,SET,174,-0.013047,-0.0012635,0.066635,0.57762,GSE36009_UNSTIM_VS_LPS_STIM_DC_UP,1
GOBP_THROMBIN_ACTIVATED_RECE...,SET,13,-0.051378,-0.001366,0.26226,0.57766,GOBP_THROMBIN_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,1
TSAI_DNAJB4_TARGETS_DN,SET,6,-0.069211,-0.0012503,0.35256,0.57782,TSAI_DNAJB4_TARGETS_DN,1
GCM_RAN,SET,178,-0.012131,-0.0011881,0.061793,0.57782,GCM_RAN,1
BIOCARTA_MELANOCYTE_PATHWAY,SET,7,-0.074977,-0.001463,0.38178,0.57785,BIOCARTA_MELANOCYTE_PATHWAY,1
VALK_AML_CLUSTER_11,SET,37,-0.02916,-0.0013071,0.14843,0.57787,VALK_AML_CLUSTER_11,1
BIOCARTA_PDGF_PATHWAY,SET,27,-0.033229,-0.0012727,0.16914,0.57787,BIOCARTA_PDGF_PATHWAY,1
MIR892C_3P,SET,189,-0.01225,-0.0012359,0.06236,0.57787,MIR892C_3P,1
GRAHAM_CML_QUIESCENT_VS_NORM...2,SET,52,-0.02611,-0.0013869,0.13278,0.57794,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,1
HP_HYPEREOSINOPHILIA,SET,5,-0.074979,-0.0012366,0.38126,0.57795,HP_HYPEREOSINOPHILIA,1
GOMF_INSULIN_LIKE_GROWTH_FAC...2,SET,8,-0.073046,-0.0015237,0.37121,0.578,GOMF_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING,1
GOBP_ORGANIC_ACID_CATABOLIC_...,SET,234,-0.010945,-0.0012271,0.055571,0.57807,GOBP_ORGANIC_ACID_CATABOLIC_PROCESS,1
REACTOME_RUNX1_INTERACTS_WIT...,SET,35,-0.029915,-0.0013043,0.15186,0.57808,REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN,1
REACTOME_TRANSPORT_OF_FATTY_...,SET,8,-0.055815,-0.0011643,0.28307,0.57815,REACTOME_TRANSPORT_OF_FATTY_ACIDS,1
REACTOME_TP53_REGULATES_TRAN...8,SET,14,-0.04607,-0.0012711,0.23355,0.57819,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,1
GOBP_CELL_PROJECTION_MORPHOG...,SET,614,-0.0071733,-0.0012891,0.036353,0.57821,GOBP_CELL_PROJECTION_MORPHOGENESIS,1
HOEK_B_CELL_2011_2012_TIV_AD...1,SET,5,-0.079085,-0.0013043,0.40076,0.57822,HOEK_B_CELL_2011_2012_TIV_ADULT_1DY_UP,1
GOMF_GATED_CHANNEL_ACTIVITY,SET,301,-0.010657,-0.0013526,0.053995,0.57823,GOMF_GATED_CHANNEL_ACTIVITY,1
GOBP_MEDIUM_CHAIN_FATTY_ACID...2,SET,5,-0.065486,-0.00108,0.33145,0.57831,GOBP_MEDIUM_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,1
MODULE_493,SET,58,-0.022514,-0.0012628,0.11377,0.57843,MODULE_493,1
HP_ABNORMAL_SCALP_MORPHOLOGY,SET,385,-0.0084943,-0.0012165,0.042904,0.57847,HP_ABNORMAL_SCALP_MORPHOLOGY,1
GOBP_PRODUCTION_OF_MOLECULAR...1,SET,84,-0.018529,-0.0012498,0.093525,0.57852,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
HP_ARTERIA_LUSORIA,SET,6,-0.080339,-0.0014514,0.40552,0.57852,HP_ARTERIA_LUSORIA,1
GOBP_GLYCOPROTEIN_CATABOLIC_...,SET,31,-0.034327,-0.0014086,0.17314,0.57858,GOBP_GLYCOPROTEIN_CATABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...4,SET,13,-0.048749,-0.0012961,0.24585,0.57859,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY,1
HP_BRITTLE_HAIR,SET,41,-0.025086,-0.0011835,0.12647,0.57861,HP_BRITTLE_HAIR,1
REACTOME_PHENYLALANINE_AND_T...,SET,10,-0.058239,-0.0013581,0.2936,0.57862,REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM,1
WP_NONSMALL_CELL_LUNG_CANCER,SET,71,-0.020129,-0.0012487,0.10147,0.57863,WP_NONSMALL_CELL_LUNG_CANCER,1
GSE22935_UNSTIM_VS_12H_MBOVI...2,SET,182,-0.012039,-0.0011921,0.060676,0.57864,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
GSE18893_TCONV_VS_TREG_24H_T...2,SET,176,-0.012155,-0.0011837,0.061247,0.57865,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP,1
GOMF_PHOSPHOTRANSFERASE_ACTI...3,SET,34,-0.02814,-0.0012092,0.14175,0.57868,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR,1
EGR_Q6,SET,250,-0.010947,-0.0012681,0.055138,0.57869,EGR_Q6,1
GOBP_NEGATIVE_REGULATION_OF_...420,SET,9,-0.060075,-0.0013291,0.30234,0.57875,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,1
MODULE_330,SET,27,-0.033321,-0.0012762,0.16768,0.57876,MODULE_330,1
GOBP_REGULATION_OF_CELL_MATU...,SET,22,-0.038279,-0.0013236,0.19256,0.57878,GOBP_REGULATION_OF_CELL_MATURATION,1
GSE16385_ROSIGLITAZONE_VS_UN...1,SET,188,-0.011654,-0.0011727,0.058603,0.57881,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN,1
GSE37533_PPARG1_FOXP3_VS_FOX...3,SET,189,-0.012617,-0.0012729,0.063421,0.57884,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,1
HP_LOBAR_HOLOPROSENCEPHALY,SET,23,-0.031305,-0.0011068,0.15724,0.5789,HP_LOBAR_HOLOPROSENCEPHALY,1
GSE11924_TFH_VS_TH1_CD4_TCEL...1,SET,174,-0.012799,-0.0012394,0.064265,0.57893,GSE11924_TFH_VS_TH1_CD4_TCELL_DN,1
GOBP_COMPLEMENT_ACTIVATION_A...,SET,14,-0.049491,-0.0013654,0.24836,0.57897,GOBP_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,1
REACTOME_O_LINKED_GLYCOSYLAT...2,SET,56,-0.025117,-0.0013844,0.126,0.579,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,1
REACTOME_DEVELOPMENTAL_BIOLO...,SET,1245,-0.0053123,-0.001335,0.026639,0.57903,REACTOME_DEVELOPMENTAL_BIOLOGY,1
GOBP_SNRNA_TRANSPORT,SET,5,-0.068787,-0.0011344,0.34453,0.57912,GOBP_SNRNA_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...469,SET,4,-0.075181,-0.001109,0.37651,0.57913,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,1
GSE19825_NAIVE_VS_IL2RAHIGH_...1,SET,180,-0.012127,-0.0011943,0.060705,0.57917,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,1
GSE17974_0H_VS_1H_IN_VITRO_A...1,SET,183,-0.012153,-0.0012066,0.060819,0.57919,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN,1
GSE23568_ID3_TRANSDUCED_VS_I...1,SET,182,-0.012861,-0.0012735,0.064318,0.57924,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN,1
HP_TEMPORAL_PATTERN,SET,18,-0.03897,-0.001219,0.19484,0.57926,HP_TEMPORAL_PATTERN,1
HE_LIM_SUN_FETAL_LUNG_C4_TRE...,SET,36,-0.032924,-0.0014558,0.1646,0.57927,HE_LIM_SUN_FETAL_LUNG_C4_TREG_CELL,1
REACTOME_EPH_EPHRIN_MEDIATED...,SET,49,-0.025906,-0.0013359,0.12947,0.57929,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,1
AAGCACT_MIR520F,SET,219,-0.011555,-0.0012538,0.057747,0.5793,AAGCACT_MIR520F,1
THILLAINADESAN_ZNF217_TARGET...1,SET,6,-0.079093,-0.0014289,0.3951,0.57933,THILLAINADESAN_ZNF217_TARGETS_DN,1
GAVISH_3CA_METAPROGRAM_B_CEL...7,SET,48,-0.023712,-0.0012103,0.11845,0.57933,GAVISH_3CA_METAPROGRAM_B_CELLS_METABOLISM_MYC,1
HP_RECURRENT_MENINGITIS,SET,3,-0.1124,-0.001436,0.56117,0.57937,HP_RECURRENT_MENINGITIS,1
BROWNE_INTERFERON_RESPONSIVE...,SET,65,-0.022492,-0.0013352,0.11229,0.57938,BROWNE_INTERFERON_RESPONSIVE_GENES,1
KORKOLA_YOLK_SAC_TUMOR,SET,53,-0.025906,-0.0013892,0.12928,0.57941,KORKOLA_YOLK_SAC_TUMOR,1
MIR4709_5P,SET,94,-0.018482,-0.0013184,0.092234,0.57941,MIR4709_5P,1
GOBP_NEGATIVE_REGULATION_OF_...680,SET,10,-0.054943,-0.0012813,0.2742,0.57941,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,1
GOBP_REGULATION_OF_LEUKOCYTE...5,SET,41,-0.027054,-0.0012764,0.13496,0.57944,GOBP_REGULATION_OF_LEUKOCYTE_DEGRANULATION,1
GOMF_GAP_JUNCTION_CHANNEL_AC...1,SET,21,-0.045245,-0.0015285,0.22571,0.57944,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY,1
HP_CEREBRAL_HYPOMYELINATION,SET,25,-0.031039,-0.001144,0.15479,0.57946,HP_CEREBRAL_HYPOMYELINATION,1
HP_PNEUMONIA,SET,275,-0.010506,-0.0012755,0.052383,0.57948,HP_PNEUMONIA,1
TONKS_TARGETS_OF_RUNX1_RUNX1...12,SET,9,-0.062681,-0.0013868,0.31234,0.57953,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,1
HP_SCLERAL_STAPHYLOMA,SET,9,-0.059812,-0.0013233,0.29776,0.5796,HP_SCLERAL_STAPHYLOMA,1
MIR3972,SET,62,-0.021225,-0.0012307,0.10565,0.57961,MIR3972,1
chr7p11,SET,14,-0.067274,-0.0018561,0.33429,0.57974,chr7p11,1
GOBP_FOREBRAIN_GENERATION_OF...,SET,50,-0.027045,-0.0014088,0.13439,0.57974,GOBP_FOREBRAIN_GENERATION_OF_NEURONS,1
GOLDRATH_NAIVE_VS_EFF_CD8_TC...2,SET,181,-0.012385,-0.0012231,0.061459,0.57985,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP,1
GSE38681_WT_VS_LYL1_KO_LYMPH...2,SET,179,-0.012554,-0.001233,0.062245,0.57992,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,1
HP_LEFT_VENTRICULAR_NONCOMPA...,SET,9,-0.065364,-0.0014461,0.32403,0.57993,HP_LEFT_VENTRICULAR_NONCOMPACTION_CARDIOMYOPATHY,1
GOBP_POSITIVE_REGULATION_OF_...240,SET,10,-0.061983,-0.0014455,0.30718,0.57995,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GSE21063_WT_VS_NFATC1_KO_3H_...1,SET,190,-0.012826,-0.0012974,0.063571,0.57995,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN,1
GOMF_GDP_DISSOCIATION_INHIBI...,SET,15,-0.042282,-0.0012075,0.2095,0.57997,GOMF_GDP_DISSOCIATION_INHIBITOR_ACTIVITY,1
GSE3039_NKT_CELL_VS_ALPHABET...2,SET,183,-0.012343,-0.0012256,0.06109,0.58006,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP,1
GSE13306_TREG_RA_VS_TCONV_RA...1,SET,177,-0.013276,-0.0012966,0.065687,0.58008,GSE13306_TREG_RA_VS_TCONV_RA_DN,1
GOBP_SYNAPTIC_VESICLE_LUMEN_...,SET,15,-0.044389,-0.0012676,0.21962,0.58009,GOBP_SYNAPTIC_VESICLE_LUMEN_ACIDIFICATION,1
GSE10325_CD4_TCELL_VS_LUPUS_...1,SET,178,-0.013558,-0.0013278,0.067059,0.58011,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN,1
TET1_TARGET_GENES,SET,1072,-0.0054291,-0.0012724,0.026851,0.58012,TET1_TARGET_GENES,1
GOCC_PERIKARYON,SET,131,-0.015928,-0.0013399,0.078737,0.58015,GOCC_PERIKARYON,1
HP_B_LYMPHOCYTOPENIA,SET,53,-0.024404,-0.0013087,0.12063,0.58016,HP_B_LYMPHOCYTOPENIA,1
ZNF677_TARGET_GENES,SET,128,-0.015543,-0.0012926,0.076807,0.58018,ZNF677_TARGET_GENES,1
RICKMAN_HEAD_AND_NECK_CANCER...1,SET,88,-0.020365,-0.0014058,0.10063,0.58019,RICKMAN_HEAD_AND_NECK_CANCER_A,1
HAHTOLA_CTCL_PATHOGENESIS,SET,15,-0.048644,-0.0013892,0.24034,0.5802,HAHTOLA_CTCL_PATHOGENESIS,1
HP_PARATHYROID_HYPERPLASIA,SET,10,-0.056952,-0.0013281,0.28118,0.58025,HP_PARATHYROID_HYPERPLASIA,1
GSE3039_ALPHAALPHA_VS_ALPHAB...2,SET,180,-0.012727,-0.0012533,0.062831,0.58026,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP,1
GOBP_RESPONSE_TO_ALCOHOL,SET,244,-0.011832,-0.0013543,0.058381,0.5803,GOBP_RESPONSE_TO_ALCOHOL,1
GSE24634_TEFF_VS_TCONV_DAY7_...1,SET,183,-0.013746,-0.0013649,0.067794,0.58034,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN,1
ONO_FOXP3_TARGETS_DN,SET,40,-0.028093,-0.0013092,0.13852,0.58036,ONO_FOXP3_TARGETS_DN,1
HP_PROGRESSIVE_DISTAL_MUSCUL...,SET,37,-0.027655,-0.0012396,0.13636,0.58036,HP_PROGRESSIVE_DISTAL_MUSCULAR_ATROPHY,1
REACTOME_CATION_COUPLED_CHLO...,SET,7,-0.06345,-0.0012381,0.31281,0.58037,REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS,1
GSE21546_WT_VS_SAP1A_KO_DP_T...2,SET,176,-0.013793,-0.0013433,0.067979,0.58039,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP,1
GOBP_EXTRINSIC_APOPTOTIC_SIG...2,SET,79,-0.019138,-0.0012521,0.094292,0.58042,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
MODULE_237,SET,54,-0.023093,-0.0012499,0.11359,0.58055,MODULE_237,1
GSE2770_TGFB_AND_IL4_ACT_VS_...2,SET,163,-0.013332,-0.00125,0.065577,0.58055,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,1
PYEON_CANCER_HEAD_AND_NECK_V...2,SET,157,-0.01395,-0.0012839,0.068593,0.58058,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,1
GOMF_COMPLEMENT_COMPONENT_C1...,SET,7,-0.067148,-0.0013102,0.33012,0.58059,GOMF_COMPLEMENT_COMPONENT_C1Q_COMPLEX_BINDING,1
GOMF_SULFUR_COMPOUND_TRANSME...,SET,59,-0.022969,-0.0012993,0.11293,0.58059,GOMF_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_HORIZONTAL_RIBS,SET,15,-0.041592,-0.0011878,0.20434,0.58064,HP_HORIZONTAL_RIBS,1
GSE24634_IL4_VS_CTRL_TREATED...6,SET,180,-0.01359,-0.0013384,0.06675,0.58066,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP,1
CHESLER_BRAIN_QTL_CIS,SET,68,-0.021138,-0.0012834,0.10381,0.58067,CHESLER_BRAIN_QTL_CIS,1
GOBP_HARD_PALATE_DEVELOPMENT,SET,8,-0.077159,-0.0016095,0.37891,0.58068,GOBP_HARD_PALATE_DEVELOPMENT,1
HP_TRUNCAL_TITUBATION,SET,7,-0.067755,-0.0013221,0.33266,0.5807,HP_TRUNCAL_TITUBATION,1
GOBP_REGULATION_OF_TOLL_LIKE...6,SET,29,-0.030012,-0.0011912,0.14727,0.58074,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMAL_STOOL_COMPOSITION,SET,18,-0.041446,-0.0012964,0.20337,0.58074,HP_ABNORMAL_STOOL_COMPOSITION,1
GOCC_HETEROCHROMATIN,SET,68,-0.020848,-0.0012658,0.10228,0.58076,GOCC_HETEROCHROMATIN,1
KEGG_PROPANOATE_METABOLISM,SET,31,-0.032529,-0.0013349,0.15952,0.58079,KEGG_PROPANOATE_METABOLISM,1
GOBP_TRIF_DEPENDENT_TOLL_LIK...,SET,11,-0.049769,-0.0012172,0.24406,0.58079,GOBP_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
MIR4676_3P,SET,189,-0.012748,-0.0012861,0.062499,0.58081,MIR4676_3P,1
REACTOME_RECYCLING_PATHWAY_O...,SET,40,-0.029106,-0.0013564,0.14268,0.58082,REACTOME_RECYCLING_PATHWAY_OF_L1,1
HP_ABNORMAL_HALLUX_MORPHOLOGY,SET,177,-0.013561,-0.0013245,0.066477,0.58082,HP_ABNORMAL_HALLUX_MORPHOLOGY,1
GOMF_ACETYLESTERASE_ACTIVITY,SET,5,-0.071651,-0.0011817,0.3511,0.58085,GOMF_ACETYLESTERASE_ACTIVITY,1
GSE35825_IFNA_VS_IFNG_STIM_M...2,SET,154,-0.014242,-0.0012982,0.069787,0.58085,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP,1
HP_PERMANENT_ATRIAL_FIBRILLA...,SET,9,-0.062328,-0.001379,0.30533,0.58087,HP_PERMANENT_ATRIAL_FIBRILLATION,1
MIR4299,SET,67,-0.021194,-0.0012774,0.10377,0.58091,MIR4299,1
HP_CRACKLES,SET,21,-0.041272,-0.0013943,0.20205,0.58093,HP_CRACKLES,1
HP_MOLAR_TOOTH_SIGN_ON_MRI,SET,37,-0.024431,-0.0010951,0.1196,0.58093,HP_MOLAR_TOOTH_SIGN_ON_MRI,1
FAN_OVARY_CL12_T_LYMPHOCYTE_...,SET,138,-0.015013,-0.0012961,0.07348,0.58095,FAN_OVARY_CL12_T_LYMPHOCYTE_NK_CELL_2,1
DER_IFN_BETA_RESPONSE_UP,SET,98,-0.017757,-0.0012932,0.08686,0.58099,DER_IFN_BETA_RESPONSE_UP,1
HP_POSTERIOR_EMBRYOTOXON,SET,46,-0.02936,-0.001467,0.14352,0.58104,HP_POSTERIOR_EMBRYOTOXON,1
GSE18893_TCONV_VS_TREG_24H_T...1,SET,169,-0.013063,-0.0012469,0.063841,0.58106,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN,1
GOBP_NEGATIVE_REGULATION_OF_...390,SET,4,-0.096353,-0.0014213,0.47064,0.58111,GOBP_NEGATIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,1
MIR3616_3P,SET,54,-0.022719,-0.0012297,0.11095,0.58112,MIR3616_3P,1
GOBP_GLUCOSE_IMPORT,SET,68,-0.021758,-0.0013211,0.10621,0.58116,GOBP_GLUCOSE_IMPORT,1
GOMF_BMP_RECEPTOR_BINDING,SET,10,-0.058554,-0.0013655,0.28578,0.58117,GOMF_BMP_RECEPTOR_BINDING,1
LIU_SMARCA4_TARGETS,SET,44,-0.028419,-0.0013889,0.13869,0.58118,LIU_SMARCA4_TARGETS,1
GOMF_AROMATASE_ACTIVITY,SET,25,-0.043351,-0.0015978,0.21154,0.58118,GOMF_AROMATASE_ACTIVITY,1
GSE17721_LPS_VS_PAM3CSK4_6H_...2,SET,185,-0.012678,-0.0012656,0.061847,0.58121,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP,1
HP_ABNORMALITY_OF_HEPATOBILI...,SET,181,-0.012754,-0.0012595,0.062212,0.58122,HP_ABNORMALITY_OF_HEPATOBILIARY_SYSTEM_PHYSIOLOGY,1
MATSUMIYA_BLOOD_MODIFIED_VAC...1,SET,9,-0.058245,-0.0012886,0.28409,0.58122,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_DN,1
GSE29617_DAY3_VS_DAY7_TIV_FL...1,SET,151,-0.013403,-0.0012099,0.065316,0.58129,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,1
GOBP_REGULATION_OF_VESICLE_S...,SET,15,-0.046041,-0.0013148,0.22434,0.5813,GOBP_REGULATION_OF_VESICLE_SIZE,1
GSE30083_SP1_VS_SP3_THYMOCYT...2,SET,178,-0.013787,-0.0013503,0.067181,0.5813,GSE30083_SP1_VS_SP3_THYMOCYTE_UP,1
GSE17721_LPS_VS_GARDIQUIMOD_...12,SET,184,-0.013866,-0.0013805,0.067547,0.58132,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP,1
WP_MAMMARY_GLAND_DEVELOPMENT...4,SET,12,-0.055494,-0.0014176,0.27028,0.58134,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,1
WP_PANCREATIC_CANCER_SUBTYPES,SET,46,-0.028827,-0.0014404,0.14037,0.58136,WP_PANCREATIC_CANCER_SUBTYPES,1
GSE23505_IL6_IL1_VS_IL6_IL1_...1,SET,185,-0.0132,-0.0013177,0.064236,0.5814,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,1
IGF1R_TARGET_GENES,SET,2,-0.14924,-0.0015568,0.72584,0.58145,IGF1R_TARGET_GENES,1
REACTOME_SIGNALING_BY_NOTCH1,SET,68,-0.020548,-0.0012476,0.099897,0.58148,REACTOME_SIGNALING_BY_NOTCH1,1
GOBP_MAST_CELL_DIFFERENTIATI...,SET,6,-0.081844,-0.0014786,0.39784,0.58149,GOBP_MAST_CELL_DIFFERENTIATION,1
HP_DECREASED_LIGHT_AND_DARK_...,SET,14,-0.048699,-0.0013436,0.23675,0.58149,HP_DECREASED_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM_AMPLITUDE,1
HP_ENLARGED_METAPHYSES,SET,5,-0.075405,-0.0012436,0.36655,0.58149,HP_ENLARGED_METAPHYSES,1
GOBP_OPTIC_NERVE_DEVELOPMENT,SET,20,-0.041329,-0.0013627,0.20082,0.58152,GOBP_OPTIC_NERVE_DEVELOPMENT,1
IIZUKA_LIVER_CANCER_PROGRESS...8,SET,19,-0.044124,-0.001418,0.21437,0.58154,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,1
HP_PULMONARY_CYST,SET,26,-0.037439,-0.0014072,0.18189,0.58154,HP_PULMONARY_CYST,1
HP_ABNORMAL_PIGMENTATION_OF_...,SET,35,-0.031389,-0.0013685,0.15242,0.58158,HP_ABNORMAL_PIGMENTATION_OF_THE_ORAL_MUCOSA,1
REACTOME_TGF_BETA_RECEPTOR_S...1,SET,46,-0.025529,-0.0012756,0.12395,0.58159,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1
GREENBAUM_E2A_TARGETS_DN,SET,17,-0.042803,-0.0013012,0.20779,0.5816,GREENBAUM_E2A_TARGETS_DN,1
GOBP_CENP_A_CONTAINING_CHROM...,SET,9,-0.05601,-0.0012392,0.27173,0.58165,GOBP_CENP_A_CONTAINING_CHROMATIN_ASSEMBLY,1
TCTGATC_MIR383,SET,46,-0.02607,-0.0013026,0.12642,0.58168,TCTGATC_MIR383,1
HP_RECURRENT_MALADAPTIVE_BEH...,SET,961,-0.00592,-0.0013179,0.028707,0.58169,HP_RECURRENT_MALADAPTIVE_BEHAVIOR,1
HOWARD_NK_CELL_INACT_MONOV_I...1,SET,19,-0.04243,-0.0013636,0.20567,0.58172,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
SYED_ESTRADIOL_RESPONSE,SET,15,-0.045083,-0.0012875,0.21851,0.58173,SYED_ESTRADIOL_RESPONSE,1
WP_7OXOC_AND_7BETAHC_PATHWAYS,SET,25,-0.037692,-0.0013892,0.18269,0.58173,WP_7OXOC_AND_7BETAHC_PATHWAYS,1
GOBP_WOUND_HEALING_SPREADING...,SET,26,-0.032989,-0.0012399,0.15989,0.58173,GOBP_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
GOMF_NUCLEOBASE_CONTAINING_C...2,SET,52,-0.0254,-0.0013492,0.12311,0.58173,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
LIANG_HEMATOPOIESIS_STEM_CEL...4,SET,33,-0.030083,-0.0012736,0.14578,0.58174,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,1
MANNO_MIDBRAIN_NEUROTYPES_HP...1,SET,703,-0.0071577,-0.0013729,0.034689,0.58174,MANNO_MIDBRAIN_NEUROTYPES_HPERIC,1
OSF2_Q6,SET,245,-0.011803,-0.0013536,0.057194,0.58175,OSF2_Q6,1
HP_ABNORMAL_TRICUSPID_VALVE_...2,SET,72,-0.021005,-0.0013122,0.10178,0.58175,HP_ABNORMAL_TRICUSPID_VALVE_PHYSIOLOGY,1
GOBP_REGULATION_OF_MYELOID_L...2,SET,52,-0.024961,-0.0013258,0.12094,0.58176,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,1
GOBP_EPOXYGENASE_P450_PATHWAY,SET,18,-0.049172,-0.0015381,0.23801,0.58183,GOBP_EPOXYGENASE_P450_PATHWAY,1
GOBP_GRANULOCYTE_COLONY_STIM...1,SET,5,-0.082404,-0.001359,0.39889,0.58183,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
WP_MIR5093P_ALTERATION_OF_YA...,SET,17,-0.049759,-0.0015127,0.24081,0.58185,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,1
GOBP_RIBOSE_PHOSPHATE_BIOSYN...,SET,176,-0.012896,-0.0012559,0.062412,0.58185,GOBP_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GTCAGGA_MIR378,SET,50,-0.025278,-0.0013167,0.12232,0.58186,GTCAGGA_MIR378,1
GOBP_REGULATION_OF_GENERATIO...,SET,121,-0.015276,-0.0012354,0.07391,0.58187,GOBP_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,1
MIR5699_3P,SET,60,-0.023151,-0.0013206,0.11197,0.5819,MIR5699_3P,1
GOMF_ORGANIC_CATION_TRANSMEM...,SET,75,-0.022203,-0.0014155,0.10724,0.58201,GOMF_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GNF2_CD48,SET,30,-0.031792,-0.0012834,0.15348,0.58205,GNF2_CD48,1
GOBP_BRANCH_ELONGATION_OF_AN...,SET,19,-0.045915,-0.0014756,0.22165,0.58205,GOBP_BRANCH_ELONGATION_OF_AN_EPITHELIUM,1
GSE16385_ROSIGLITAZONE_IL4_V...1,SET,169,-0.014208,-0.0013562,0.06852,0.58214,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN,1
GOBP_POSITIVE_REGULATION_OF_...140,SET,5,-0.090788,-0.0014973,0.43752,0.58219,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,1
HP_RING_SCOTOMA,SET,5,-0.076192,-0.0012566,0.36705,0.58222,HP_RING_SCOTOMA,1
GSE19401_PLN_VS_PEYERS_PATCH...1,SET,186,-0.012643,-0.0012655,0.060855,0.58229,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN,1
PARK_HSC_MARKERS,SET,40,-0.027833,-0.0012971,0.13392,0.58232,PARK_HSC_MARKERS,1
GSE28783_CTRL_ANTI_MIR_VS_UN...1,SET,182,-0.013616,-0.0013482,0.065501,0.58233,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,1
GOBP_C_TERMINAL_PROTEIN_LIPI...,SET,8,-0.061116,-0.0012748,0.2939,0.58237,GOBP_C_TERMINAL_PROTEIN_LIPIDATION,1
MIR134_3P,SET,81,-0.019982,-0.0013237,0.096014,0.58243,MIR134_3P,1
HP_ABNORMAL_LOWER_LIMB_METAP...,SET,20,-0.037106,-0.0012234,0.17806,0.58254,HP_ABNORMAL_LOWER_LIMB_METAPHYSIS_MORPHOLOGY,1
KEGG_MEDICUS_VARIANT_MUTATIO...43,SET,11,-0.047203,-0.0011545,0.22647,0.58255,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III,1
GOBP_ACTIVATION_OF_ADENYLATE...,SET,23,-0.042301,-0.0014955,0.20284,0.5826,GOBP_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY,1
GOBP_FOREBRAIN_NEURON_DIFFER...,SET,40,-0.032089,-0.0014954,0.15387,0.5826,GOBP_FOREBRAIN_NEURON_DIFFERENTIATION,1
HP_POSTAXIAL_HAND_POLYDACTYLY,SET,78,-0.019256,-0.0012518,0.092335,0.5826,HP_POSTAXIAL_HAND_POLYDACTYLY,1
GOBP_REACTIVE_NITROGEN_SPECI...,SET,74,-0.022329,-0.0014141,0.10705,0.58261,GOBP_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS,1
GOBP_FEVER_GENERATION,SET,11,-0.062758,-0.0015349,0.30085,0.58262,GOBP_FEVER_GENERATION,1
HP_ONYCHOLYSIS,SET,20,-0.039909,-0.0013158,0.19119,0.58267,HP_ONYCHOLYSIS,1
MIR3910,SET,365,-0.0097155,-0.0013555,0.046525,0.58271,MIR3910,1
ANDERSON_BLOOD_CN54GP140_ADJ...4,SET,25,-0.035066,-0.0012924,0.16789,0.58272,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_UP,1
GOBP_ASPARTATE_FAMILY_AMINO_...1,SET,21,-0.044012,-0.0014869,0.21066,0.58275,GOBP_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_VAGINA_MORPHOLOGY,SET,111,-0.017468,-0.0013535,0.083565,0.58279,HP_ABNORMAL_VAGINA_MORPHOLOGY,1
GSE23502_BM_VS_COLON_TUMOR_H...1,SET,187,-0.013098,-0.0013145,0.062661,0.58279,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...30,SET,6,-0.0823,-0.0014868,0.39359,0.58281,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_THE_HYPOTH...1,SET,360,-0.0093594,-0.001297,0.044759,0.58282,HP_ABNORMALITY_OF_THE_HYPOTHALAMUS_PITUITARY_AXIS,1
TRAVAGLINI_LUNG_PLATELET_MEG...,SET,513,-0.0080352,-0.0013236,0.038395,0.58288,TRAVAGLINI_LUNG_PLATELET_MEGAKARYOCYTE_CELL,1
HP_HYPOCHLOREMIA,SET,6,-0.08703,-0.0015723,0.41583,0.58289,HP_HYPOCHLOREMIA,1
GRADE_COLON_AND_RECTAL_CANCE...1,SET,94,-0.019145,-0.0013657,0.0914,0.58295,GRADE_COLON_AND_RECTAL_CANCER_DN,1
HP_FRONTAL_LOBE_DEMENTIA,SET,18,-0.039779,-0.0012443,0.18983,0.58299,HP_FRONTAL_LOBE_DEMENTIA,1
HP_DECREASED_CIRCULATING_PRE...,SET,4,-0.10216,-0.001507,0.48732,0.58302,HP_DECREASED_CIRCULATING_PREALBUMIN_CONCENTRATION,1
HP_MICROPHTHALMIA,SET,239,-0.011573,-0.0013111,0.055169,0.58307,HP_MICROPHTHALMIA,1
MIR605_3P,SET,233,-0.011829,-0.0013235,0.05639,0.58308,MIR605_3P,1
GOBP_RANDOM_INACTIVATION_OF_...,SET,6,-0.069967,-0.001264,0.33327,0.58314,GOBP_RANDOM_INACTIVATION_OF_X_CHROMOSOME,1
MIR488_5P,SET,71,-0.020951,-0.0012997,0.099784,0.58315,MIR488_5P,1
CHIANG_LIVER_CANCER_SUBCLASS...6,SET,67,-0.022473,-0.0013544,0.107,0.58318,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,1
JEON_SMAD6_TARGETS_DN,SET,19,-0.040674,-0.0013071,0.19365,0.58318,JEON_SMAD6_TARGETS_DN,1
IRF5_TARGET_GENES,SET,654,-0.0070339,-0.0013031,0.033486,0.58319,IRF5_TARGET_GENES,1
GCM_RAB10,SET,162,-0.01344,-0.0012563,0.063976,0.5832,GCM_RAB10,1
BENPORATH_NANOG_TARGETS,SET,877,-0.0062722,-0.0013371,0.029839,0.58324,BENPORATH_NANOG_TARGETS,1
GAVISH_3CA_METAPROGRAM_EPITH...3,SET,44,-0.027719,-0.0013547,0.13188,0.58324,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE,1
STARK_HYPPOCAMPUS_22Q11_DELE...1,SET,19,-0.056686,-0.0018217,0.26963,0.58326,STARK_HYPPOCAMPUS_22Q11_DELETION_DN,1
REACTOME_SIGNALING_BY_BRAF_A...,SET,62,-0.02371,-0.0013748,0.11276,0.58327,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,1
GSE14350_IL2RB_KO_VS_WT_TEFF...1,SET,184,-0.012906,-0.0012849,0.061359,0.5833,GSE14350_IL2RB_KO_VS_WT_TEFF_DN,1
GOBP_MESENCHYMAL_CELL_DIFFER...1,SET,237,-0.012444,-0.001404,0.059105,0.58337,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION,1
HP_ABNORMALITY_OF_THE_COSTOC...,SET,17,-0.047318,-0.0014385,0.22475,0.58337,HP_ABNORMALITY_OF_THE_COSTOCHONDRAL_JUNCTION,1
GOMF_SOLUTE_POTASSIUM_ANTIPO...,SET,17,-0.046567,-0.0014156,0.22106,0.58342,GOMF_SOLUTE_POTASSIUM_ANTIPORTER_ACTIVITY,1
GSE7831_1H_VS_4H_CPG_STIM_PD...2,SET,179,-0.012941,-0.0012709,0.061422,0.58343,GSE7831_1H_VS_4H_CPG_STIM_PDC_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...29,SET,9,-0.063017,-0.0013942,0.29901,0.58346,GOBP_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT,1
GNF2_ESPL1,SET,35,-0.028252,-0.0012317,0.13397,0.58351,GNF2_ESPL1,1
TOMLINS_PROSTATE_CANCER_UP,SET,36,-0.030002,-0.0013266,0.14224,0.58353,TOMLINS_PROSTATE_CANCER_UP,1
HP_GENERALIZED_MUSCLE_WEAKNE...,SET,120,-0.016362,-0.0013178,0.077571,0.58353,HP_GENERALIZED_MUSCLE_WEAKNESS,1
HP_IMPAIRED_OCULAR_ABDUCTION,SET,4,-0.1066,-0.0015725,0.50487,0.58361,HP_IMPAIRED_OCULAR_ABDUCTION,1
HU_FETAL_RETINA_RPC,SET,97,-0.019895,-0.0014415,0.094189,0.58364,HU_FETAL_RETINA_RPC,1
GOBP_MEMBRANE_DEPOLARIZATION,SET,85,-0.021565,-0.0014632,0.10205,0.58368,GOBP_MEMBRANE_DEPOLARIZATION,1
KEGG_MEDICUS_REFERENCE_INACT...,SET,6,-0.070629,-0.001276,0.33402,0.58373,KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I,1
RBM34_TARGET_GENES,SET,811,-0.0064545,-0.0013256,0.03052,0.58374,RBM34_TARGET_GENES,1
HP_DUPLICATION_OF_RENAL_PELV...,SET,3,-0.12546,-0.0016028,0.59322,0.58375,HP_DUPLICATION_OF_RENAL_PELVIS,1
GSE20366_CD103_POS_VS_CD103_...1,SET,179,-0.01355,-0.0013307,0.06407,0.58375,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN,1
GSE22886_IL2_VS_IL15_STIM_NK...2,SET,177,-0.014739,-0.0014395,0.069685,0.58375,GSE22886_IL2_VS_IL15_STIM_NKCELL_UP,1
MIR4318,SET,100,-0.018197,-0.0013386,0.086019,0.58377,MIR4318,1
GSE19888_CTRL_VS_A3R_ACTIVAT...1,SET,171,-0.014026,-0.0013467,0.066305,0.58377,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN,1
GSE13306_TREG_VS_TCONV_SPLEE...1,SET,177,-0.014127,-0.0013797,0.066685,0.58388,GSE13306_TREG_VS_TCONV_SPLEEN_DN,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...2,SET,131,-0.016462,-0.0013849,0.077712,0.58388,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,1
REACTOME_DEFECTIVE_INTRINSIC...,SET,25,-0.038001,-0.0014006,0.17935,0.5839,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1
GSE32901_TH1_VS_TH17_NEG_CD4...2,SET,114,-0.017103,-0.0013428,0.080691,0.58393,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_...2,SET,30,-0.036372,-0.0014683,0.1714,0.58402,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,1
GOBP_GLUCOSE_METABOLIC_PROCE...,SET,168,-0.01411,-0.0013429,0.066478,0.58404,GOBP_GLUCOSE_METABOLIC_PROCESS,1
HP_CARPAL_BONE_HYPOPLASIA,SET,11,-0.048182,-0.0011784,0.22694,0.58406,HP_CARPAL_BONE_HYPOPLASIA,1
MIR4262,SET,704,-0.0071052,-0.0013637,0.033464,0.58407,MIR4262,1
WP_REGULATION_OF_ACTIN_CYTOS...,SET,140,-0.016291,-0.0014165,0.076724,0.58408,WP_REGULATION_OF_ACTIN_CYTOSKELETON,1
GOMF_HISTONE_UBIQUITIN_LIGAS...,SET,10,-0.056723,-0.0013228,0.26709,0.58409,GOMF_HISTONE_UBIQUITIN_LIGASE_ACTIVITY,1
HP_FOCAL_AWARE_SEIZURE,SET,26,-0.036878,-0.0013861,0.17364,0.5841,HP_FOCAL_AWARE_SEIZURE,1
MIKKELSEN_DEDIFFERENTIATED_S...1,SET,7,-0.079795,-0.001557,0.37556,0.58413,MIKKELSEN_DEDIFFERENTIATED_STATE_DN,1
GOBP_VASCULAR_PROCESS_IN_CIR...,SET,254,-0.012562,-0.0014666,0.059106,0.58415,GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM,1
REACTOME_ACTIVATED_NOTCH1_TR...,SET,29,-0.032411,-0.0012865,0.15243,0.58419,REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,1
WP_FATTY_ACID_BIOSYNTHESIS,SET,21,-0.03755,-0.0012686,0.17657,0.58421,WP_FATTY_ACID_BIOSYNTHESIS,1
GOBP_PERIPHERAL_NERVOUS_SYST...5,SET,14,-0.052363,-0.0014447,0.24616,0.58423,GOBP_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,1
REACTOME_FACTORS_INVOLVED_IN...,SET,144,-0.015734,-0.0013873,0.073935,0.58426,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1
GOBP_METANEPHRIC_GLOMERULUS_...1,SET,16,-0.052864,-0.0015591,0.24841,0.58426,GOBP_METANEPHRIC_GLOMERULUS_DEVELOPMENT,1
GSE17721_PAM3CSK4_VS_GADIQUI...11,SET,182,-0.012933,-0.0012807,0.060772,0.58426,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN,1
GSE22886_NEUTROPHIL_VS_DC_DN,SET,177,-0.013083,-0.0012778,0.061458,0.58429,GSE22886_NEUTROPHIL_VS_DC_DN,1
chr6q15,SET,23,-0.070036,-0.0024761,0.32896,0.5843,chr6q15,1
WP_VITAMIN_A_AND_CAROTENOID_...,SET,42,-0.029451,-0.0014063,0.1383,0.58432,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,1
GSE39820_TGFBETA1_VS_TGFBETA...1,SET,184,-0.01307,-0.0013012,0.061349,0.58435,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN,1
GSE2770_TGFB_AND_IL4_VS_TGFB...5,SET,174,-0.014176,-0.0013728,0.066511,0.58439,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
HSD17B8_TARGET_GENES,SET,518,-0.0084052,-0.0013911,0.039402,0.58446,HSD17B8_TARGET_GENES,1
GOBP_VASCULAR_TRANSPORT,SET,82,-0.022057,-0.00147,0.10329,0.58454,GOBP_VASCULAR_TRANSPORT,1
HP_ABNORMAL_CIRCULATING_PROT...3,SET,607,-0.0075592,-0.0013509,0.035403,0.58454,HP_ABNORMAL_CIRCULATING_PROTEIN_CONCENTRATION,1
DESCARTES_FETAL_LIVER_MESOTH...,SET,266,-0.012172,-0.0014538,0.056985,0.58457,DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS,1
REACTOME_TCR_SIGNALING,SET,108,-0.017341,-0.0013254,0.081151,0.5846,REACTOME_TCR_SIGNALING,1
NFY_Q6,SET,223,-0.012385,-0.001356,0.057948,0.58462,NFY_Q6,1
YAMASHITA_SILENCED_BY_METHYL...,SET,7,-0.076294,-0.0014887,0.35679,0.58466,YAMASHITA_SILENCED_BY_METHYLATION,1
ZNF560_TARGET_GENES,SET,42,-0.027689,-0.0013222,0.12942,0.58471,ZNF560_TARGET_GENES,1
MODULE_104,SET,314,-0.010452,-0.0013545,0.04885,0.58471,MODULE_104,1
HP_PROGRESSIVE_DISTAL_MUSCLE...,SET,14,-0.044569,-0.0012296,0.20826,0.58473,HP_PROGRESSIVE_DISTAL_MUSCLE_WEAKNESS,1
WP_ACETAMINOPHEN_IN_ANALGESI...,SET,9,-0.06923,-0.0015317,0.32328,0.58478,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,1
DAVICIONI_MOLECULAR_ARMS_VS_...1,SET,166,-0.015429,-0.0014597,0.072032,0.5848,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1
MANNO_MIDBRAIN_NEUROTYPES_HM...,SET,525,-0.0083751,-0.0013952,0.039097,0.58481,MANNO_MIDBRAIN_NEUROTYPES_HMGL,1
MORF_TNFRSF6,SET,146,-0.015754,-0.0013986,0.073533,0.58482,MORF_TNFRSF6,1
GOMF_HYDROLASE_ACTIVITY_ACTI...6,SET,11,-0.058419,-0.0014288,0.27268,0.58482,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES,1
GOMF_MONOATOMIC_ION_GATED_CH...,SET,30,-0.036195,-0.0014612,0.16894,0.58482,GOMF_MONOATOMIC_ION_GATED_CHANNEL_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_DICA...,SET,139,-0.015874,-0.0013753,0.074039,0.58488,HP_ABNORMAL_CIRCULATING_DICARBOXYLIC_ACID_CONCENTRATION,1
GOBP_PHOSPHOLIPID_BIOSYNTHET...,SET,230,-0.011823,-0.0013144,0.05514,0.58489,GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
BURTON_ADIPOGENESIS_11,SET,47,-0.027203,-0.0013739,0.12681,0.58493,BURTON_ADIPOGENESIS_11,1
GOBP_NEUROTRANSMITTER_GATED_...,SET,16,-0.051126,-0.0015079,0.23824,0.58496,GOBP_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING,1
GOBP_REGULATION_OF_ORGANELLE...2,SET,1094,-0.0056418,-0.0013349,0.026283,0.58498,GOBP_REGULATION_OF_ORGANELLE_ORGANIZATION,1
GSE22886_NAIVE_CD4_TCELL_VS_...16,SET,176,-0.013697,-0.001334,0.063812,0.58498,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP,1
YAO_TEMPORAL_RESPONSE_TO_PRO...12,SET,13,-0.055705,-0.001481,0.25927,0.58506,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,1
GSE21360_NAIVE_VS_QUATERNARY...1,SET,181,-0.013468,-0.00133,0.062685,0.58506,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_PO...,SET,12,-0.059105,-0.0015098,0.27502,0.58508,GOBP_CELLULAR_RESPONSE_TO_POTASSIUM_ION,1
HP_FOCAL_MOTOR_STATUS_EPILEP...,SET,13,-0.049268,-0.0013099,0.22904,0.58516,HP_FOCAL_MOTOR_STATUS_EPILEPTICUS,1
GOBP_REGULATION_OF_LEUKOCYTE...1,SET,4,-0.10315,-0.0015216,0.47937,0.58518,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,1
chr9q33,SET,74,-0.046161,-0.0029232,0.21451,0.58519,chr9q33,1
MIR212_3P,SET,170,-0.013894,-0.0013301,0.064561,0.5852,MIR212_3P,1
SPIELMAN_LYMPHOBLAST_EUROPEA...4,SET,430,-0.0085364,-0.0012904,0.039655,0.58522,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,1
GOMF_GUANYL_NUCLEOTIDE_EXCHA...,SET,215,-0.012553,-0.0013498,0.058271,0.58528,GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
KAYO_CALORIE_RESTRICTION_MUS...1,SET,77,-0.019529,-0.0012615,0.090605,0.58533,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,1
PID_NEPHRIN_NEPH1_PATHWAY,SET,30,-0.033484,-0.0013518,0.15534,0.58533,PID_NEPHRIN_NEPH1_PATHWAY,1
GOBP_PHOSPHATIDYLINOSITOL_PH...,SET,59,-0.022848,-0.0012925,0.10596,0.58536,GOBP_PHOSPHATIDYLINOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOCC_ACTIN_FILAMENT,SET,105,-0.018311,-0.0013801,0.08482,0.58546,GOCC_ACTIN_FILAMENT,1
DESCARTES_FETAL_CEREBELLUM_M...,SET,490,-0.0090554,-0.0014588,0.041926,0.5855,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,1
MIR25_5P,SET,6,-0.080544,-0.0014551,0.37267,0.58555,MIR25_5P,1
GSE21670_STAT3_KO_VS_WT_CD4_...8,SET,174,-0.01432,-0.0013868,0.066253,0.58556,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP,1
GSE21774_CD62L_POS_CD56_BRIG...2,SET,173,-0.014961,-0.0014447,0.069003,0.58582,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,1
HP_ABNORMAL_SEPTUM_PELLUCIDU...,SET,92,-0.018879,-0.0013324,0.087038,0.58586,HP_ABNORMAL_SEPTUM_PELLUCIDUM_MORPHOLOGY,1
PEREZ_TP63_TARGETS,SET,309,-0.01127,-0.001449,0.051913,0.58593,PEREZ_TP63_TARGETS,1
GOBP_GLUCOSE_6_PHOSPHATE_MET...,SET,26,-0.037491,-0.0014091,0.17259,0.58598,GOBP_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS,1
HP_INCREASED_CIRCULATING_VER...,SET,8,-0.070699,-0.0014747,0.32536,0.58601,HP_INCREASED_CIRCULATING_VERY_LONG_CHAIN_FATTY_ACID_CONCENTRATION,1
PID_CXCR4_PATHWAY,SET,95,-0.019422,-0.0013928,0.089316,0.58607,PID_CXCR4_PATHWAY,1
GOBP_ACTIN_CROSSLINK_FORMATI...,SET,13,-0.057663,-0.0015331,0.26489,0.58616,GOBP_ACTIN_CROSSLINK_FORMATION,1
GOMF_PHOSPHATIDYLSERINE_FLOP...,SET,8,-0.070363,-0.0014677,0.32301,0.58622,GOMF_PHOSPHATIDYLSERINE_FLOPPASE_ACTIVITY,1
BLANCO_MELO_BRONCHIAL_EPITHE...4,SET,124,-0.017193,-0.0014075,0.078892,0.58626,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1
WEINBERGER_BLOOD_TWINRIX_AGE...1,SET,32,-0.034905,-0.0014552,0.16016,0.58626,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_ANTI_HBS_CONC_PRIMARY_VACC_1DY_SIGNIFICANT,1
HP_MECONIUM_STAINED_AMNIOTIC...,SET,8,-0.071592,-0.0014934,0.32811,0.58636,HP_MECONIUM_STAINED_AMNIOTIC_FLUID,1
GSE21670_TGFB_VS_TGFB_AND_IL...2,SET,181,-0.013854,-0.0013681,0.06345,0.58642,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,1
HE_LIM_SUN_FETAL_LUNG_C7_SCH...,SET,214,-0.012477,-0.0013385,0.057141,0.58642,HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL,1
REACTOME_SEMA4D_MEDIATED_INH...,SET,8,-0.069512,-0.00145,0.31828,0.58644,REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION,1
GOBP_SYNAPTIC_VESICLE_COATING,SET,5,-0.080206,-0.0013228,0.36724,0.58644,GOBP_SYNAPTIC_VESICLE_COATING,1
GAO_ESOPHAGUS_25W_C4_FGFR1HI...,SET,178,-0.013839,-0.0013554,0.063365,0.58644,GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS,1
MIR4723_5P,SET,194,-0.013128,-0.0013416,0.060087,0.58647,MIR4723_5P,1
GOBP_N_TERMINAL_PROTEIN_LIPI...,SET,6,-0.079444,-0.0014352,0.36363,0.58647,GOBP_N_TERMINAL_PROTEIN_LIPIDATION,1
GSE31082_DN_VS_CD4_SP_THYMOC...2,SET,172,-0.013219,-0.0012729,0.060505,0.58647,GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP,1
MIR3934_5P,SET,55,-0.02517,-0.0013749,0.11518,0.58649,MIR3934_5P,1
HP_RHABDOMYOLYSIS,SET,37,-0.029194,-0.0013086,0.13359,0.58649,HP_RHABDOMYOLYSIS,1
GOBP_POSITIVE_REGULATION_OF_...787,SET,12,-0.049459,-0.0012634,0.22618,0.58654,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,1
GOMF_TROPOMYOSIN_BINDING,SET,14,-0.046928,-0.0012947,0.21463,0.58654,GOMF_TROPOMYOSIN_BINDING,1
GSE23502_WT_VS_HDC_KO_MYELOI...1,SET,186,-0.014079,-0.0014092,0.064375,0.58656,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN,1
LET_7C_3P,SET,536,-0.008337,-0.0014029,0.038094,0.58662,LET_7C_3P,1
GOBP_NEGATIVE_REGULATION_OF_...158,SET,42,-0.028162,-0.0013447,0.12867,0.58662,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...450,SET,11,-0.060451,-0.0014785,0.27593,0.58671,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL,1
HP_HYPERKERATOSIS,SET,212,-0.013078,-0.0013965,0.059691,0.58671,HP_HYPERKERATOSIS,1
GOBP_TOLERANCE_INDUCTION_TO_...,SET,5,-0.093925,-0.001549,0.42849,0.58675,GOBP_TOLERANCE_INDUCTION_TO_SELF_ANTIGEN,1
GSE3982_DC_VS_NEUTROPHIL_LPS...2,SET,176,-0.013843,-0.0013482,0.063158,0.58675,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP,1
GOBP_POSITIVE_REGULATION_OF_...552,SET,6,-0.084954,-0.0015348,0.38733,0.5868,GOBP_POSITIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,1
GOMF_ACTIN_MONOMER_BINDING,SET,21,-0.040542,-0.0013697,0.18474,0.58685,GOMF_ACTIN_MONOMER_BINDING,1
GOBP_DEOXYRIBONUCLEOSIDE_MON...3,SET,24,-0.039381,-0.0014222,0.17922,0.58696,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GOBP_MICROTUBULE_CYTOSKELETO...1,SET,577,-0.0076146,-0.0013279,0.03465,0.58697,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION,1
MIR4326,SET,78,-0.022612,-0.00147,0.10288,0.58698,MIR4326,1
GAO_STOMACH_24W_C4_PARIETAL_...,SET,8,-0.071434,-0.0014901,0.32497,0.58699,GAO_STOMACH_24W_C4_PARIETAL_PROGENITOR,1
HUMMERICH_MALIGNANT_SKIN_TUM...2,SET,16,-0.045578,-0.0013442,0.20721,0.58705,HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,1
HP_EYE_OF_THE_TIGER_ANOMALY_...,SET,9,-0.062024,-0.0013722,0.28198,0.58705,HP_EYE_OF_THE_TIGER_ANOMALY_OF_GLOBUS_PALLIDUS,1
GOBP_POSITIVE_REGULATION_OF_...45,SET,29,-0.035847,-0.0014228,0.16292,0.58707,GOBP_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_AXON_EXTE...2,SET,15,-0.049971,-0.001427,0.22713,0.58707,GOBP_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,1
GOBP_COBALT_ION_TRANSPORT,SET,6,-0.079248,-0.0014317,0.36013,0.58708,GOBP_COBALT_ION_TRANSPORT,1
GSE8921_UNSTIM_VS_TLR1_2_STI...5,SET,183,-0.013805,-0.0013707,0.062711,0.58712,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN,1
GOMF_PHOSPHATIDYLETHANOLAMIN...2,SET,5,-0.092913,-0.0015323,0.42201,0.58713,GOMF_PHOSPHATIDYLETHANOLAMINE_FLIPPASE_ACTIVITY,1
REACTOME_TNFR1_INDUCED_PROAP...,SET,23,-0.039413,-0.0013934,0.17893,0.58717,REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING,1
HE_LIM_SUN_FETAL_LUNG_C5_CD5...3,SET,588,-0.0078916,-0.0013888,0.035824,0.58718,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL,1
JONES_OVARY_MAST_CELL,SET,40,-0.03222,-0.0015015,0.14622,0.5872,JONES_OVARY_MAST_CELL,1
HP_FOCAL_T2_HYPERINTENSE_BRA...,SET,26,-0.032814,-0.0012334,0.14886,0.58723,HP_FOCAL_T2_HYPERINTENSE_BRAINSTEM_LESION,1
MIR6801_5P,SET,97,-0.020234,-0.0014661,0.09177,0.58725,MIR6801_5P,1
HP_INCREASED_URINE_PROTEINOG...,SET,10,-0.058916,-0.0013739,0.2672,0.58725,HP_INCREASED_URINE_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_LEVEL,1
CAIRO_PML_TARGETS_BOUND_BY_M...1,SET,12,-0.058082,-0.0014837,0.26295,0.58741,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,1
MIR942_5P,SET,194,-0.013639,-0.0013939,0.061714,0.58745,MIR942_5P,1
HP_PELVIC_GIRDLE_MUSCLE_WEAK...,SET,42,-0.026721,-0.001276,0.12085,0.58749,HP_PELVIC_GIRDLE_MUSCLE_WEAKNESS,1
GOBP_POSITIVE_REGULATION_OF_...22,SET,6,-0.081778,-0.0014774,0.36979,0.58751,GOBP_POSITIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...8,SET,146,-0.015425,-0.0013694,0.069731,0.58753,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP,1
GOBP_POSITIVE_REGULATION_OF_...166,SET,27,-0.033678,-0.0012899,0.15222,0.58754,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...5,SET,24,-0.041319,-0.0014922,0.18661,0.58761,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,1
HP_ABSENT_NIPPLE,SET,9,-0.057064,-0.0012625,0.25751,0.58769,HP_ABSENT_NIPPLE,1
HP_STEREOTYPIC_WHOLE_BODY_MO...,SET,8,-0.061251,-0.0012777,0.27638,0.58769,HP_STEREOTYPIC_WHOLE_BODY_MOVEMENTS,1
REACTOME_SIGNALING_BY_VEGF,SET,101,-0.01945,-0.0014379,0.087752,0.5877,REACTOME_SIGNALING_BY_VEGF,1
HP_SPINAL_MUSCULAR_ATROPHY,SET,51,-0.025494,-0.0013411,0.11502,0.5877,HP_SPINAL_MUSCULAR_ATROPHY,1
CHAF1A_TARGET_GENES,SET,79,-0.021816,-0.0014273,0.098406,0.58772,CHAF1A_TARGET_GENES,1
BREDEMEYER_RAG_SIGNALING_VIA...2,SET,46,-0.03018,-0.001508,0.13609,0.58775,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,1
GOBP_POSITIVE_REGULATION_OF_...459,SET,6,-0.089037,-0.0016085,0.40114,0.58783,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,1
ASTON_MAJOR_DEPRESSIVE_DISOR...2,SET,42,-0.03096,-0.0014784,0.13936,0.58791,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,1
GOBP_POSITIVE_REGULATION_OF_...265,SET,15,-0.044869,-0.0012813,0.20194,0.58791,GOBP_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION,1
HP_VOCAL_CORD_PARESIS,SET,14,-0.052644,-0.0014524,0.23693,0.58792,HP_VOCAL_CORD_PARESIS,1
GSE17721_POLYIC_VS_CPG_0.5H_...2,SET,184,-0.014009,-0.0013947,0.06299,0.58799,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP,1
GOBP_DEFENSE_RESPONSE_TO_OTH...,SET,1094,-0.0062368,-0.0014757,0.028042,0.588,GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM,1
HP_LIMITED_HIP_MOVEMENT,SET,22,-0.042865,-0.0014822,0.19271,0.58801,HP_LIMITED_HIP_MOVEMENT,1
RFX7_TARGET_GENES,SET,403,-0.0093528,-0.0013697,0.042045,0.58802,RFX7_TARGET_GENES,1
REACTOME_ENOS_ACTIVATION,SET,10,-0.063628,-0.0014838,0.28598,0.58803,REACTOME_ENOS_ACTIVATION,1
GOBP_RETINA_VASCULATURE_MORP...,SET,9,-0.067462,-0.0014925,0.3032,0.58803,GOBP_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
MARTINEZ_RESPONSE_TO_TRABECT...1,SET,45,-0.028587,-0.0014128,0.12847,0.58805,MARTINEZ_RESPONSE_TO_TRABECTEDIN,1
GCM_NF2,SET,266,-0.010867,-0.0012978,0.048834,0.58805,GCM_NF2,1
GSE6875_TCONV_VS_TREG_DN,SET,186,-0.014472,-0.0014485,0.065025,0.58806,GSE6875_TCONV_VS_TREG_DN,1
GOBP_REGULATION_OF_POSTSYNAP...9,SET,18,-0.044297,-0.0013856,0.19897,0.58809,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,1
HP_RENAL_INSUFFICIENCY,SET,365,-0.0099835,-0.0013929,0.044822,0.58813,HP_RENAL_INSUFFICIENCY,1
MIR6857_3P,SET,68,-0.024665,-0.0014975,0.11072,0.58814,MIR6857_3P,1
CAFFAREL_RESPONSE_TO_THC_24H...3,SET,44,-0.027036,-0.0013213,0.12132,0.58818,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,1
HP_PILI_CANALICULI,SET,5,-0.10088,-0.0016637,0.45251,0.5882,HP_PILI_CANALICULI,1
REACTOME_TBC_RABGAPS,SET,40,-0.026984,-0.0012575,0.12104,0.58821,REACTOME_TBC_RABGAPS,1
HOLLEMAN_DAUNORUBICIN_ALL_UP,SET,6,-0.078711,-0.001422,0.35267,0.5883,HOLLEMAN_DAUNORUBICIN_ALL_UP,1
GSE21546_WT_VS_ELK1_KO_DP_TH...1,SET,179,-0.014185,-0.0013931,0.063507,0.58837,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN,1
KIM_MYC_AMPLIFICATION_TARGET...2,SET,170,-0.014739,-0.001411,0.065949,0.58842,KIM_MYC_AMPLIFICATION_TARGETS_UP,1
DESCARTES_FETAL_EYE_RETINAL_...2,SET,10,-0.068117,-0.0015885,0.30442,0.58853,DESCARTES_FETAL_EYE_RETINAL_PROGENITORS_AND_MULLER_GLIA,1
CORRE_MULTIPLE_MYELOMA_DN,SET,52,-0.028979,-0.0015393,0.12948,0.58854,CORRE_MULTIPLE_MYELOMA_DN,1
REACTOME_UBIQUINOL_BIOSYNTHE...,SET,10,-0.05461,-0.0012735,0.24396,0.58856,REACTOME_UBIQUINOL_BIOSYNTHESIS,1
GSE5589_LPS_AND_IL10_VS_LPS_...2,SET,178,-0.014742,-0.0014438,0.06584,0.58858,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
GOBP_REGULATION_OF_PENTOSE_P...,SET,6,-0.079178,-0.0014304,0.35297,0.58874,GOBP_REGULATION_OF_PENTOSE_PHOSPHATE_SHUNT,1
chr10q22,SET,85,-0.041823,-0.0028377,0.18639,0.58877,chr10q22,1
GOBP_ARTICULAR_CARTILAGE_DEV...,SET,5,-0.071619,-0.0011811,0.31913,0.58878,GOBP_ARTICULAR_CARTILAGE_DEVELOPMENT,1
GSE17721_PAM3CSK4_VS_CPG_4H_...2,SET,177,-0.013909,-0.0013584,0.061955,0.58881,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP,1
KAUFFMANN_MELANOMA_RELAPSE_UP,SET,59,-0.024103,-0.0013635,0.10735,0.58883,KAUFFMANN_MELANOMA_RELAPSE_UP,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...2,SET,39,-0.029234,-0.0013453,0.13018,0.58884,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1
POU3F2_01,SET,96,-0.020839,-0.0015022,0.092754,0.58888,POU3F2_01,1
HP_ABNORMAL_NUMBER_OF_TEETH,SET,356,-0.01024,-0.0014113,0.045566,0.5889,HP_ABNORMAL_NUMBER_OF_TEETH,1
MIR659_3P,SET,204,-0.013923,-0.0014587,0.061909,0.58897,MIR659_3P,1
STEARMAN_LUNG_CANCER_EARLY_V...2,SET,118,-0.016818,-0.0013433,0.074735,0.58902,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1
WP_CELL_INTERACTIONS_OF_THE_...,SET,23,-0.045752,-0.0016175,0.20327,0.58904,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,1
MIR4761_3P,SET,46,-0.028585,-0.0014283,0.127,0.58904,MIR4761_3P,1
HP_RECURRENT_MYOGLOBINURIA,SET,5,-0.070439,-0.0011617,0.31293,0.58905,HP_RECURRENT_MYOGLOBINURIA,1
HP_BULL_S_EYE_MACULOPATHY,SET,9,-0.070466,-0.001559,0.3129,0.58909,HP_BULL_S_EYE_MACULOPATHY,1
HP_GASTROINTESTINAL_STROMA_T...,SET,19,-0.045967,-0.0014772,0.20407,0.5891,HP_GASTROINTESTINAL_STROMA_TUMOR,1
REACTOME_VISUAL_PHOTOTRANSDU...,SET,90,-0.021064,-0.0014704,0.093498,0.58912,REACTOME_VISUAL_PHOTOTRANSDUCTION,1
WP_RIOK1_AND_RIOK2_IN_EGFR_A...,SET,15,-0.052386,-0.001496,0.23243,0.58916,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,1
GOBP_RESPONSE_TO_LEAD_ION,SET,19,-0.048114,-0.0015462,0.21348,0.58916,GOBP_RESPONSE_TO_LEAD_ION,1
GSE5589_IL6_KO_VS_IL10_KO_LP...10,SET,175,-0.014007,-0.0013603,0.062126,0.58919,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
BRCA1_DN.V1_DN,SET,115,-0.018554,-0.0014631,0.082216,0.58927,BRCA1_DN.V1_DN,1
GSE37301_LYMPHOID_PRIMED_MPP...10,SET,185,-0.013758,-0.0013734,0.060915,0.58934,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP,1
ERBB2_UP.V1_DN,SET,180,-0.014325,-0.0014108,0.063408,0.58937,ERBB2_UP.V1_DN,1
INSM2_TARGET_GENES,SET,748,-0.0071774,-0.0014182,0.031765,0.58938,INSM2_TARGET_GENES,1
REACTOME_ACTIVATION_OF_MATRI...,SET,30,-0.040908,-0.0016514,0.18087,0.58946,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,1
MORF_PPP2R5B,SET,156,-0.015603,-0.0014314,0.068956,0.5895,MORF_PPP2R5B,1
HP_CAVUM_SEPTUM_PELLUCIDUM,SET,30,-0.03431,-0.0013851,0.15161,0.58952,HP_CAVUM_SEPTUM_PELLUCIDUM,1
GOBP_AXONEMAL_CENTRAL_APPARA...,SET,5,-0.085307,-0.0014069,0.37663,0.58959,GOBP_AXONEMAL_CENTRAL_APPARATUS_ASSEMBLY,1
GOCC_CLEAVAGE_FURROW,SET,50,-0.027305,-0.0014223,0.12056,0.58959,GOCC_CLEAVAGE_FURROW,1
WP_LIPID_METABOLISM_IN_SENES...,SET,20,-0.04509,-0.0014867,0.19892,0.58966,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,1
PR_01,SET,134,-0.017264,-0.0014688,0.076159,0.58966,PR_01,1
GSE14308_TH1_VS_NAIVE_CD4_TC...2,SET,178,-0.013961,-0.0013673,0.061594,0.58966,GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP,1
MODULE_575,SET,12,-0.064611,-0.0016505,0.28498,0.58968,MODULE_575,1
GOBP_DEOXYRIBONUCLEOSIDE_MON...1,SET,8,-0.065152,-0.001359,0.2873,0.5897,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GSE34156_UNTREATED_VS_24H_NO...2,SET,154,-0.016042,-0.0014623,0.070726,0.58972,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
GOBP_HRI_MEDIATED_SIGNALING,SET,5,-0.084404,-0.001392,0.37188,0.58977,GOBP_HRI_MEDIATED_SIGNALING,1
KEGG_MEDICUS_REFERENCE_LYSOS...,SET,10,-0.058595,-0.0013664,0.25793,0.58985,KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE,1
GCM_DLG1,SET,69,-0.021976,-0.001344,0.096703,0.58988,GCM_DLG1,1
HP_HYPOAUTOFLUORESCENT_RETIN...,SET,5,-0.10382,-0.0017122,0.45688,0.58988,HP_HYPOAUTOFLUORESCENT_RETINAL_LESION,1
LAKE_ADULT_KIDNEY_C7_PROXIMA...,SET,129,-0.018055,-0.0015073,0.07945,0.58988,LAKE_ADULT_KIDNEY_C7_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S3,1
KEGG_O_GLYCAN_BIOSYNTHESIS,SET,27,-0.043202,-0.0016547,0.19004,0.58991,KEGG_O_GLYCAN_BIOSYNTHESIS,1
GOBP_REGULATION_OF_NEURAL_PR...,SET,96,-0.021207,-0.0015287,0.093282,0.58992,GOBP_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
MODULE_3,SET,362,-0.010261,-0.0014259,0.045119,0.58995,MODULE_3,1
GOBP_MITOCHONDRIAL_GENOME_MA...,SET,29,-0.033465,-0.0013283,0.14716,0.58995,GOBP_MITOCHONDRIAL_GENOME_MAINTENANCE,1
TURASHVILI_BREAST_LOBULAR_CA...1,SET,81,-0.022977,-0.0015221,0.10096,0.59002,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,1
GOBP_DETECTION_OF_BACTERIUM,SET,15,-0.051752,-0.0014779,0.22737,0.59002,GOBP_DETECTION_OF_BACTERIUM,1
ATGCACG_MIR517B,SET,18,-0.049356,-0.0015439,0.21683,0.59003,ATGCACG_MIR517B,1
MORF_PPP6C,SET,95,-0.017738,-0.001272,0.077868,0.5901,MORF_PPP6C,1
chr2q23,SET,21,-0.084596,-0.002858,0.37127,0.59012,chr2q23,1
SCHAEFFER_PROSTATE_DEVELOPME...10,SET,6,-0.085962,-0.001553,0.37726,0.59012,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP,1
HP_PERSISTENCE_OF_HEMOGLOBIN...,SET,32,-0.033065,-0.0013785,0.14511,0.59012,HP_PERSISTENCE_OF_HEMOGLOBIN_F,1
GOMF_CLATHRIN_HEAVY_CHAIN_BI...,SET,11,-0.060657,-0.0014835,0.26607,0.59016,GOMF_CLATHRIN_HEAVY_CHAIN_BINDING,1
HP_APLASIA_HYPOPLASIA_OF_THE...5,SET,3,-0.13208,-0.0016873,0.57868,0.59027,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_METACARPAL,1
MANN_RESPONSE_TO_AMIFOSTINE_...2,SET,19,-0.042895,-0.0013785,0.18786,0.59031,MANN_RESPONSE_TO_AMIFOSTINE_UP,1
HBZ_TARGET_GENES,SET,837,-0.0068764,-0.0014337,0.030112,0.59032,HBZ_TARGET_GENES,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...4,SET,795,-0.0070431,-0.0014328,0.030834,0.59034,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,1
HP_HYPOLIPIDEMIA,SET,10,-0.063552,-0.0014821,0.27823,0.59034,HP_HYPOLIPIDEMIA,1
HP_HYPERORALITY,SET,15,-0.050701,-0.0014479,0.22193,0.59035,HP_HYPERORALITY,1
HP_SLENDER_LONG_BONES_WITH_N...,SET,5,-0.07591,-0.0012519,0.33223,0.59037,HP_SLENDER_LONG_BONES_WITH_NARROW_DIAPHYSES,1
GOBP_REGULATION_OF_PHOSPHOLI...6,SET,7,-0.07841,-0.00153,0.34301,0.59041,GOBP_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS,1
GOMF_IGG_RECEPTOR_ACTIVITY,SET,6,-0.10249,-0.0018515,0.44834,0.59041,GOMF_IGG_RECEPTOR_ACTIVITY,1
MORF_BNIP1,SET,174,-0.014394,-0.0013939,0.062933,0.59045,MORF_BNIP1,1
GSE24574_BCL6_LOW_TFH_VS_TCO...1,SET,180,-0.014321,-0.0014104,0.06259,0.59049,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN,1
GOBP_MEMBRANE_DOCKING,SET,83,-0.021092,-0.0014143,0.092159,0.59051,GOBP_MEMBRANE_DOCKING,1
GOBP_PHENOL_CONTAINING_COMPO...1,SET,44,-0.031847,-0.0015564,0.13915,0.59051,GOBP_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
WP_CILIARY_LANDSCAPE,SET,197,-0.013615,-0.001402,0.059454,0.59056,WP_CILIARY_LANDSCAPE,1
KEGG_MEDICUS_REFERENCE_UREA_...,SET,5,-0.07742,-0.0012768,0.33804,0.59057,KEGG_MEDICUS_REFERENCE_UREA_CYCLE,1
MIR380_3P,SET,210,-0.013706,-0.0014567,0.059848,0.59057,MIR380_3P,1
HP_HIGHLY_ELEVATED_CREATINE_...,SET,6,-0.072539,-0.0013105,0.3167,0.59058,HP_HIGHLY_ELEVATED_CREATINE_KINASE,1
GOMF_NADPLUS_PROTEIN_ASPARTA...,SET,5,-0.087016,-0.0014351,0.37983,0.5906,GOMF_NADPLUS_PROTEIN_ASPARTATE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
WP_TCA_CYCLE_AKA_KREBS_OR_CI...,SET,17,-0.041197,-0.0012524,0.17975,0.59064,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,1
HARALAMBIEVA_PBMC_TIV_AGE_50...2,SET,13,-0.045009,-0.0011967,0.19636,0.59065,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_NEGATIVE,1
GOMF_GLUTAMATE_SODIUM_SYMPOR...,SET,5,-0.10346,-0.0017063,0.45124,0.59068,GOMF_GLUTAMATE_SODIUM_SYMPORTER_ACTIVITY,1
GSE3920_UNTREATED_VS_IFNA_TR...4,SET,159,-0.015768,-0.0014603,0.068757,0.59069,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP,1
AACGGTT_MIR451,SET,9,-0.072192,-0.0015972,0.31471,0.59072,AACGGTT_MIR451,1
SMID_BREAST_CANCER_ERBB2_DN,SET,5,-0.089674,-0.0014789,0.39084,0.59073,SMID_BREAST_CANCER_ERBB2_DN,1
HP_TRANSPOSITION_OF_THE_GREA...,SET,68,-0.023158,-0.0014061,0.10094,0.59073,HP_TRANSPOSITION_OF_THE_GREAT_ARTERIES,1
MIR4524A_5P,SET,221,-0.013607,-0.0014831,0.059273,0.59078,MIR4524A_5P,1
MIR4524B_5P,SET,221,-0.013607,-0.0014831,0.059273,0.59078,MIR4524B_5P,1
GSE25088_WT_VS_STAT6_KO_MACR...4,SET,167,-0.015454,-0.0014665,0.067312,0.59079,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN,1
HP_EXERCISE_INDUCED_MUSCLE_C...,SET,14,-0.047557,-0.0013121,0.20698,0.59086,HP_EXERCISE_INDUCED_MUSCLE_CRAMPS,1
GSE39110_UNTREATED_VS_IL2_TR...4,SET,182,-0.014945,-0.0014799,0.065005,0.59092,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP,1
HP_REDUCED_CIRCULATING_CH50_...,SET,4,-0.10382,-0.0015315,0.45146,0.59094,HP_REDUCED_CIRCULATING_CH50_ACTIVITY,1
HP_ABNORMAL_AORTIC_VALVE_MOR...,SET,151,-0.016502,-0.0014897,0.071756,0.59095,HP_ABNORMAL_AORTIC_VALVE_MORPHOLOGY,1
GSE26030_TH1_VS_TH17_DAY5_PO...1,SET,183,-0.014619,-0.0014515,0.063539,0.59098,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN,1
HP_ABNORMAL_METACARPAL_MORPH...,SET,196,-0.014333,-0.0014723,0.062254,0.59104,HP_ABNORMAL_METACARPAL_MORPHOLOGY,1
MULLIGHAN_MLL_SIGNATURE_2_DN,SET,255,-0.012927,-0.0015121,0.056142,0.59105,MULLIGHAN_MLL_SIGNATURE_2_DN,1
GOBP_ENDOTHELIAL_CELL_PROLIF...,SET,147,-0.017259,-0.0015374,0.074909,0.59111,GOBP_ENDOTHELIAL_CELL_PROLIFERATION,1
GOBP_NEGATIVE_REGULATION_OF_...617,SET,7,-0.07876,-0.0015368,0.34179,0.59112,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,1
GOMF_STRUCTURAL_CONSTITUENT_...5,SET,9,-0.073578,-0.0016278,0.31915,0.59116,GOMF_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH,1
MIR887_5P,SET,92,-0.021096,-0.0014888,0.091488,0.59118,MIR887_5P,1
GOBP_CYTOKINE_PRODUCTION_INV...1,SET,115,-0.019603,-0.0015458,0.084996,0.5912,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
BILANGES_RAPAMYCIN_SENSITIVE...2,SET,59,-0.02416,-0.0013667,0.10471,0.59124,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,1
REACTOME_P38MAPK_EVENTS,SET,13,-0.057274,-0.0015227,0.2482,0.59124,REACTOME_P38MAPK_EVENTS,1
MANNO_MIDBRAIN_NEUROTYPES_HR...4,SET,296,-0.012383,-0.0015588,0.053665,0.59124,MANNO_MIDBRAIN_NEUROTYPES_HRGL2C,1
GOBP_RNA_CAPPING,SET,13,-0.049345,-0.0013119,0.21378,0.59127,GOBP_RNA_CAPPING,1
MODULE_448,SET,40,-0.029405,-0.0013704,0.12738,0.59128,MODULE_448,1
GOBP_NEGATIVE_REGULATION_OF_...141,SET,6,-0.086832,-0.0015687,0.37583,0.59136,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,1
WP_DEVELOPMENT_OF_PULMONARY_...,SET,13,-0.055957,-0.0014877,0.24217,0.59137,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,1
TEL2_Q6,SET,221,-0.013021,-0.0014193,0.056323,0.59141,TEL2_Q6,1
HP_PERIPHERAL_HYPERMYELINATI...,SET,9,-0.066557,-0.0014725,0.28768,0.59148,HP_PERIPHERAL_HYPERMYELINATION,1
GOBP_REGULATION_OF_DNA_BINDI...1,SET,67,-0.024981,-0.0015056,0.10791,0.59153,GOBP_REGULATION_OF_DNA_BINDING,1
CHICAS_RB1_TARGETS_CONFLUENT,SET,500,-0.0095058,-0.0015464,0.041058,0.59154,CHICAS_RB1_TARGETS_CONFLUENT,1
HOWARD_NK_CELL_INACT_MONOV_I...2,SET,56,-0.028304,-0.00156,0.12223,0.59156,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN,1
GSE3720_VD1_VS_VD2_GAMMADELT...4,SET,172,-0.015002,-0.0014445,0.06477,0.59158,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP,1
PID_RHODOPSIN_PATHWAY,SET,21,-0.04111,-0.0013889,0.17745,0.5916,PID_RHODOPSIN_PATHWAY,1
GOCC_DYSTROGLYCAN_COMPLEX,SET,7,-0.066078,-0.0012894,0.28522,0.5916,GOCC_DYSTROGLYCAN_COMPLEX,1
GOMF_CATALYTIC_ACTIVITY_ACTI...1,SET,22,-0.049399,-0.0017081,0.21319,0.59162,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_GLYCOPROTEIN,1
chr7q33,SET,24,-0.057081,-0.0020614,0.24628,0.59164,chr7q33,1
GOBP_BASOLATERAL_PROTEIN_SEC...,SET,5,-0.081776,-0.0013487,0.35264,0.59169,GOBP_BASOLATERAL_PROTEIN_SECRETION,1
MIR2467_3P,SET,139,-0.016422,-0.0014228,0.070755,0.59177,MIR2467_3P,1
HP_POSTURAL_TREMOR,SET,53,-0.026834,-0.001439,0.11561,0.59177,HP_POSTURAL_TREMOR,1
GOBP_POSITIVE_REGULATION_OF_...194,SET,13,-0.059764,-0.0015889,0.25739,0.5918,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
CHOI_ATL_ACUTE_STAGE,SET,4,-0.10656,-0.001572,0.45869,0.59185,CHOI_ATL_ACUTE_STAGE,1
HP_POSTERIOR_FOSSA_CYST,SET,15,-0.050654,-0.0014465,0.21798,0.59188,HP_POSTERIOR_FOSSA_CYST,1
HP_HYDRANENCEPHALY,SET,8,-0.071256,-0.0014864,0.30651,0.59191,HP_HYDRANENCEPHALY,1
GSE7831_CPG_VS_INFLUENZA_STI...2,SET,181,-0.014039,-0.0013864,0.060296,0.59205,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP,1
GOBP_CELL_JUNCTION_MAINTENAN...,SET,41,-0.033435,-0.0015775,0.14355,0.59209,GOBP_CELL_JUNCTION_MAINTENANCE,1
GOBP_NUCLEOLAR_CHROMATIN_ORG...,SET,8,-0.069219,-0.0014439,0.29711,0.59211,GOBP_NUCLEOLAR_CHROMATIN_ORGANIZATION,1
GSE41176_UNSTIM_VS_ANTI_IGM_...7,SET,175,-0.014772,-0.0014346,0.063402,0.59211,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...6,SET,76,-0.024901,-0.001598,0.10686,0.59213,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT,1
GOBP_VENTRICULAR_CARDIAC_MUS...6,SET,45,-0.033529,-0.0016571,0.14388,0.59213,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,1
HP_HOLOPROSENCEPHALY,SET,69,-0.023075,-0.0014112,0.099017,0.59213,HP_HOLOPROSENCEPHALY,1
GSE36888_UNTREATED_VS_IL2_TR...5,SET,178,-0.014528,-0.0014228,0.062333,0.59214,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN,1
GSE19198_CTRL_VS_IL21_TREATE...2,SET,149,-0.016565,-0.0014855,0.071071,0.59215,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP,1
GOBP_SYNAPTIC_SIGNALING,SET,717,-0.0079098,-0.0015316,0.033918,0.5922,GOBP_SYNAPTIC_SIGNALING,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...3,SET,12,-0.060416,-0.0015433,0.25903,0.59221,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350,1
GAVISH_3CA_MALIGNANT_METAPRO...22,SET,47,-0.03299,-0.0016662,0.14142,0.59223,GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL,1
HP_METAPHYSEAL_SPURS,SET,7,-0.076229,-0.0014874,0.32669,0.59225,HP_METAPHYSEAL_SPURS,1
GOBP_MONOATOMIC_ION_TRANSPORT,SET,1105,-0.0065238,-0.0015509,0.027952,0.59227,GOBP_MONOATOMIC_ION_TRANSPORT,1
HP_THENAR_MUSCLE_ATROPHY,SET,13,-0.047742,-0.0012693,0.20456,0.59227,HP_THENAR_MUSCLE_ATROPHY,1
REACTOME_DUAL_INCISION_IN_GG...,SET,38,-0.028809,-0.0013087,0.12339,0.59231,REACTOME_DUAL_INCISION_IN_GG_NER,1
GOCC_PERICILIARY_MEMBRANE_CO...,SET,4,-0.097096,-0.0014323,0.41555,0.59237,GOCC_PERICILIARY_MEMBRANE_COMPARTMENT,1
VARELA_ZMPSTE24_TARGETS_DN,SET,35,-0.036151,-0.0015761,0.15439,0.59256,VARELA_ZMPSTE24_TARGETS_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_CYC...,SET,1243,-0.005604,-0.0014073,0.023929,0.59258,HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL,1
REACTOME_AMPK_INHIBITS_CHREB...,SET,8,-0.07321,-0.0015271,0.31256,0.5926,REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY,1
MIR375_3P,SET,36,-0.035278,-0.0015599,0.15038,0.59274,MIR375_3P,1
GOBP_LUNG_MORPHOGENESIS,SET,54,-0.029235,-0.0015824,0.12461,0.59274,GOBP_LUNG_MORPHOGENESIS,1
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SET,51,-0.029325,-0.0015426,0.12489,0.59282,SMIRNOV_RESPONSE_TO_IR_2HR_DN,1
GSE29618_BCELL_VS_MDC_UP,SET,160,-0.016678,-0.0015494,0.071031,0.59282,GSE29618_BCELL_VS_MDC_UP,1
GSE24142_EARLY_THYMIC_PROGEN...3,SET,183,-0.014902,-0.0014796,0.063461,0.59283,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN,1
GOBP_KILLING_BY_HOST_OF_SYMB...,SET,23,-0.048153,-0.0017024,0.2049,0.5929,GOBP_KILLING_BY_HOST_OF_SYMBIONT_CELLS,1
GSE23568_CTRL_VS_ID3_TRANSDU...2,SET,183,-0.014463,-0.001436,0.061521,0.59293,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP,1
SNRNP70_TARGET_GENES,SET,685,-0.0076727,-0.0014534,0.032628,0.59295,SNRNP70_TARGET_GENES,1
GSE18804_SPLEEN_MACROPHAGE_V...3,SET,174,-0.015986,-0.0015481,0.067949,0.593,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN,1
GSE2770_UNTREATED_VS_TGFB_AN...4,SET,175,-0.014601,-0.001418,0.062048,0.59302,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
REACTOME_SIGNALING_BY_TGFB_F...,SET,149,-0.016368,-0.0014678,0.069527,0.59306,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,1
WP_STEROID_HORMONE_PRECURSOR...,SET,9,-0.070811,-0.0015666,0.30079,0.59306,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1
GSE13306_RA_VS_UNTREATED_TCO...1,SET,179,-0.015641,-0.001536,0.066432,0.59306,GSE13306_RA_VS_UNTREATED_TCONV_DN,1
GSE9037_WT_VS_IRAK4_KO_BMDM_...2,SET,179,-0.015155,-0.0014884,0.064362,0.59308,GSE9037_WT_VS_IRAK4_KO_BMDM_UP,1
GOBP_POSITIVE_REGULATION_OF_...596,SET,5,-0.09286,-0.0015315,0.39431,0.59309,GOBP_POSITIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_OPSONIN_BINDING,SET,16,-0.055026,-0.0016229,0.23344,0.59317,GOMF_OPSONIN_BINDING,1
HP_ABNORMAL_CIRCULATING_LEPT...,SET,12,-0.05951,-0.0015202,0.25239,0.5932,HP_ABNORMAL_CIRCULATING_LEPTIN_CONCENTRATION,1
GOMF_PHOSPHODIESTERASE_I_ACT...,SET,5,-0.091754,-0.0015132,0.38905,0.59322,GOMF_PHOSPHODIESTERASE_I_ACTIVITY,1
HP_ABNORMALITY_OF_TASTE_SENS...,SET,5,-0.09273,-0.0015293,0.39315,0.59323,HP_ABNORMALITY_OF_TASTE_SENSATION,1
HP_LATE_ONSET_PROXIMAL_MUSCL...,SET,6,-0.078098,-0.0014109,0.33096,0.59327,HP_LATE_ONSET_PROXIMAL_MUSCLE_WEAKNESS,1
GSE22886_IGG_IGA_MEMORY_BCEL...2,SET,180,-0.015529,-0.0015293,0.065803,0.59328,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
MEISSNER_ES_ICP_WITH_H3K4ME3,SET,29,-0.035592,-0.0014127,0.15081,0.59329,MEISSNER_ES_ICP_WITH_H3K4ME3,1
MIR4325,SET,245,-0.013194,-0.0015132,0.055866,0.59335,MIR4325,1
GSE45365_WT_VS_IFNAR_KO_CD8A...1,SET,183,-0.014944,-0.0014838,0.063276,0.59335,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN,1
GSE7348_UNSTIM_VS_TOLERIZED_...1,SET,145,-0.016861,-0.0014917,0.071384,0.59336,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,1
ENK_UV_RESPONSE_KERATINOCYTE...1,SET,437,-0.0095578,-0.0014562,0.040444,0.59341,ENK_UV_RESPONSE_KERATINOCYTE_DN,1
GSE5503_LIVER_DC_VS_PLN_DC_A...1,SET,176,-0.014477,-0.0014099,0.061259,0.59341,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GOBP_REGULATION_OF_ESTABLISH...6,SET,22,-0.043462,-0.0015029,0.18388,0.59342,GOBP_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,1
AGTCTTA_MIR499,SET,68,-0.024312,-0.0014761,0.10284,0.59344,AGTCTTA_MIR499,1
DESERT_PERIPORTAL_HEPATOCELL...,SET,147,-0.017202,-0.0015323,0.072746,0.59346,DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1
REACTOME_TRANSPORT_OF_NUCLEO...1,SET,10,-0.066892,-0.0015599,0.28283,0.59348,REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE,1
GOBP_REGULATION_OF_PROTON_TR...,SET,12,-0.061293,-0.0015657,0.25898,0.59354,GOBP_REGULATION_OF_PROTON_TRANSPORT,1
GSE3982_CENT_MEMORY_CD4_TCEL...1,SET,175,-0.015753,-0.0015299,0.066482,0.59365,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN,1
GSE3982_MAST_CELL_VS_BCELL_UP,SET,180,-0.015631,-0.0015394,0.065968,0.59365,GSE3982_MAST_CELL_VS_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...231,SET,17,-0.051234,-0.0015575,0.21612,0.5937,GOBP_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT,1
WP_COMPLEMENT_ACTIVATION,SET,17,-0.054823,-0.0016666,0.23122,0.59371,WP_COMPLEMENT_ACTIVATION,1
SUNG_METASTASIS_STROMA_UP,SET,102,-0.020606,-0.0015309,0.08684,0.59378,SUNG_METASTASIS_STROMA_UP,1
GOMF_PRIMARY_AMINE_OXIDASE_A...,SET,7,-0.099326,-0.0019381,0.41848,0.59381,GOMF_PRIMARY_AMINE_OXIDASE_ACTIVITY,1
GOBP_AMINE_METABOLIC_PROCESS,SET,102,-0.021372,-0.0015878,0.090024,0.59383,GOBP_AMINE_METABOLIC_PROCESS,1
GOMF_UNMETHYLATED_CPG_BINDING,SET,9,-0.059957,-0.0013265,0.25253,0.59384,GOMF_UNMETHYLATED_CPG_BINDING,1
MIR4756_3P,SET,106,-0.019858,-0.0015038,0.083608,0.59387,MIR4756_3P,1
REACTOME_TRANSFERRIN_ENDOCYT...,SET,29,-0.038745,-0.0015379,0.16301,0.59393,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,1
KEGG_PENTOSE_PHOSPHATE_PATHW...,SET,22,-0.041398,-0.0014315,0.17417,0.59394,KEGG_PENTOSE_PHOSPHATE_PATHWAY,1
GATA1_03,SET,218,-0.014174,-0.0015345,0.059622,0.59395,GATA1_03,1
ATF2_UP.V1_UP,SET,171,-0.015826,-0.0015195,0.066564,0.59396,ATF2_UP.V1_UP,1
HP_ANTERIOR_SYNECHIAE_OF_THE...,SET,13,-0.064842,-0.001724,0.27271,0.59397,HP_ANTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,1
MATZUK_EARLY_ANTRAL_FOLLICLE,SET,12,-0.064681,-0.0016522,0.27198,0.59398,MATZUK_EARLY_ANTRAL_FOLLICLE,1
HP_INCREASED_CIRCULATING_IGG...,SET,23,-0.044973,-0.00159,0.18898,0.59405,HP_INCREASED_CIRCULATING_IGG_LEVEL,1
MIR4456,SET,119,-0.017909,-0.0014364,0.07523,0.59408,MIR4456,1
MODULE_465,SET,13,-0.057938,-0.0015404,0.24335,0.59409,MODULE_465,1
GOBP_MALE_MEIOSIS_I,SET,25,-0.038111,-0.0014047,0.16001,0.59413,GOBP_MALE_MEIOSIS_I,1
GSE16385_MONOCYTE_VS_MACROPH...2,SET,178,-0.01534,-0.0015023,0.064392,0.59414,GSE16385_MONOCYTE_VS_MACROPHAGE_UP,1
GSE8921_UNSTIM_VS_TLR1_2_STI...7,SET,178,-0.014853,-0.0014547,0.062331,0.59417,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN,1
GOMF_UBIQUITIN_LIGASE_INHIBI...,SET,9,-0.074874,-0.0016565,0.31418,0.59418,GOMF_UBIQUITIN_LIGASE_INHIBITOR_ACTIVITY,1
REACTOME_HDMS_DEMETHYLATE_HI...,SET,17,-0.041087,-0.001249,0.17233,0.59422,REACTOME_HDMS_DEMETHYLATE_HISTONES,1
CUI_DEVELOPING_HEART_ENDOCAR...,SET,50,-0.031653,-0.0016488,0.13276,0.59423,CUI_DEVELOPING_HEART_ENDOCARDIAL_CELL,1
DESCARTES_FETAL_PLACENTA_TRO...,SET,66,-0.028226,-0.0016884,0.11831,0.59428,DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS,1
WP_BRAINDERIVED_NEUROTROPHIC...,SET,135,-0.018883,-0.0016125,0.079147,0.59429,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,1
HP_ELEVATED_BRONCHOALVEOLAR_...,SET,6,-0.10152,-0.001834,0.42544,0.5943,HP_ELEVATED_BRONCHOALVEOLAR_LAVAGE_FLUID_NEUTROPHIL_PROPORTION,1
GSE33513_TCF7_KO_VS_HET_EARL...2,SET,178,-0.016106,-0.0015774,0.067492,0.5943,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP,1
GOBP_REGULATION_OF_PEPTIDE_T...,SET,187,-0.015775,-0.0015832,0.066093,0.59432,GOBP_REGULATION_OF_PEPTIDE_TRANSPORT,1
KIM_MYCN_AMPLIFICATION_TARGE...1,SET,97,-0.0209,-0.0015144,0.08749,0.5944,KIM_MYCN_AMPLIFICATION_TARGETS_DN,1
MIR4473,SET,79,-0.022762,-0.0014892,0.095267,0.59442,MIR4473,1
HP_ABNORMAL_NASOPHARYNX_MORP...,SET,160,-0.01657,-0.0015393,0.069334,0.59444,HP_ABNORMAL_NASOPHARYNX_MORPHOLOGY,1
HP_COGNITIVE_IMPAIRMENT,SET,878,-0.007066,-0.0015071,0.029558,0.59447,HP_COGNITIVE_IMPAIRMENT,1
HP_RETINAL_HAMARTOMA,SET,22,-0.039759,-0.0013748,0.16618,0.59454,HP_RETINAL_HAMARTOMA,1
REACTOME_INTERACTION_WITH_CU...,SET,11,-0.058853,-0.0014394,0.24597,0.59455,REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA,1
MIR4658,SET,44,-0.03344,-0.0016343,0.13972,0.59458,MIR4658,1
RAFFEL_VEGFA_TARGETS_UP,SET,9,-0.073561,-0.0016275,0.30732,0.59459,RAFFEL_VEGFA_TARGETS_UP,1
REACTOME_RA_BIOSYNTHESIS_PAT...,SET,22,-0.047527,-0.0016434,0.19852,0.5946,REACTOME_RA_BIOSYNTHESIS_PATHWAY,1
BOYLAN_MULTIPLE_MYELOMA_C_DN,SET,53,-0.030809,-0.0016521,0.1286,0.59467,BOYLAN_MULTIPLE_MYELOMA_C_DN,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...4,SET,5,-0.084939,-0.0014008,0.35441,0.5947,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00484,1
GOBP_CELL_MOTILITY,SET,1578,-0.0056172,-0.0015737,0.023436,0.59471,GOBP_CELL_MOTILITY,1
GOMF_LBD_DOMAIN_BINDING,SET,6,-0.096682,-0.0017466,0.40327,0.59473,GOMF_LBD_DOMAIN_BINDING,1
PTEN_DN.V1_UP,SET,163,-0.017012,-0.001595,0.070964,0.59473,PTEN_DN.V1_UP,1
GOBP_INTERLEUKIN_13_PRODUCTI...,SET,21,-0.045878,-0.00155,0.19103,0.59489,GOBP_INTERLEUKIN_13_PRODUCTION,1
GSE30083_SP3_VS_SP4_THYMOCYT...1,SET,181,-0.01623,-0.0016027,0.067566,0.59492,GSE30083_SP3_VS_SP4_THYMOCYTE_DN,1
GOCC_AP_3_ADAPTOR_COMPLEX,SET,11,-0.058545,-0.0014319,0.24365,0.59494,GOCC_AP_3_ADAPTOR_COMPLEX,1
HP_BROAD_NECK,SET,21,-0.041215,-0.0013924,0.17153,0.59494,HP_BROAD_NECK,1
GOBP_PHYSIOLOGICAL_CARDIAC_M...,SET,21,-0.04731,-0.0015983,0.19686,0.59496,GOBP_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY,1
HP_GENERALIZED_ABNORMALITY_O...,SET,945,-0.0068404,-0.0015107,0.028461,0.59497,HP_GENERALIZED_ABNORMALITY_OF_SKIN,1
RB_P107_DN.V1_DN,SET,110,-0.018569,-0.0014323,0.07726,0.59497,RB_P107_DN.V1_DN,1
GSE2770_UNTREATED_VS_TGFB_AN...8,SET,177,-0.015205,-0.001485,0.0632,0.59506,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
MIR2682_5P,SET,106,-0.020314,-0.0015383,0.084415,0.59508,MIR2682_5P,1
GOBP_REGULATION_OF_ORGANIC_A...,SET,73,-0.025778,-0.0016214,0.10706,0.59514,GOBP_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
HP_RETINAL_PIGMENT_EPITHELIA...1,SET,36,-0.034281,-0.0015158,0.14237,0.59514,HP_RETINAL_PIGMENT_EPITHELIAL_ATROPHY,1
GOMF_CHOLINE_TRANSMEMBRANE_T...,SET,7,-0.087435,-0.0017061,0.36303,0.59516,GOMF_CHOLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE24671_BAKIMULC_VS_SENDAI_...2,SET,182,-0.014624,-0.0014481,0.060722,0.59516,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,1
HP_CONCENTRIC_HYPERTROPHIC_C...,SET,7,-0.08902,-0.001737,0.36952,0.59519,HP_CONCENTRIC_HYPERTROPHIC_CARDIOMYOPATHY,1
HP_PROPORTIONATE_TALL_STATURE,SET,14,-0.055287,-0.0015254,0.22924,0.59529,HP_PROPORTIONATE_TALL_STATURE,1
GSE2826_WT_VS_BTK_KO_BCELL_DN,SET,193,-0.015205,-0.00155,0.063034,0.59531,GSE2826_WT_VS_BTK_KO_BCELL_DN,1
OCT1_07,SET,143,-0.018619,-0.001636,0.077174,0.59532,OCT1_07,1
RICHERT_PBMC_HIV_LIPO_5_AGE_...1,SET,8,-0.11474,-0.0023935,0.47533,0.59538,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP,1
MIR4420,SET,176,-0.015808,-0.0015396,0.065442,0.59544,MIR4420,1
WEBER_METHYLATED_LCP_IN_SPER...2,SET,14,-0.055624,-0.0015347,0.23007,0.59552,WEBER_METHYLATED_LCP_IN_SPERM_UP,1
REACTOME_DEFECTIVE_CHSY1_CAU...,SET,7,-0.071003,-0.0013855,0.29362,0.59554,REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS,1
ZHAN_V1_LATE_DIFFERENTIATION...2,SET,31,-0.036481,-0.0014971,0.15085,0.59555,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1
WP_NODLIKE_RECEPTOR_NLR_SIGN...,SET,7,-0.075675,-0.0014766,0.31291,0.59555,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,1
GOBP_SNRNA_3_END_PROCESSING,SET,18,-0.044013,-0.0013767,0.18199,0.59555,GOBP_SNRNA_3_END_PROCESSING,1
GOBP_NON_PROTEINOGENIC_AMINO...1,SET,16,-0.052478,-0.0015478,0.21697,0.59556,GOBP_NON_PROTEINOGENIC_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
REACTOME_RECRUITMENT_OF_NUMA...,SET,87,-0.020811,-0.0014285,0.086011,0.59559,REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1
GOBP_L_ALANINE_TRANSMEMBRANE...,SET,4,-0.10992,-0.0016215,0.45431,0.59559,GOBP_L_ALANINE_TRANSMEMBRANE_TRANSPORT,1
HARRIS_HYPOXIA,SET,74,-0.025967,-0.0016444,0.10731,0.5956,HARRIS_HYPOXIA,1
GOBP_REGULATION_OF_TYPE_I_IN...,SET,40,-0.032818,-0.0015294,0.13558,0.59563,GOBP_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOBP_SIGNAL_TRANSDUCTION_BY_...,SET,159,-0.016241,-0.0015041,0.067086,0.59564,GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
GOCC_INTRACILIARY_TRANSPORT_...1,SET,22,-0.045871,-0.0015861,0.18939,0.59569,GOCC_INTRACILIARY_TRANSPORT_PARTICLE,1
GOMF_HISTONE_H4_METHYLTRANSF...,SET,13,-0.057522,-0.0015293,0.23749,0.59569,GOMF_HISTONE_H4_METHYLTRANSFERASE_ACTIVITY,1
GOBP_HEART_TRABECULA_MORPHOG...,SET,31,-0.041608,-0.0017074,0.17176,0.5957,GOBP_HEART_TRABECULA_MORPHOGENESIS,1
SOX15_TARGET_GENES,SET,3,-0.11743,-0.0015002,0.48461,0.59573,SOX15_TARGET_GENES,1
GOBP_PROTEIN_TRANSPORT_INTO_...,SET,4,-0.1047,-0.0015444,0.43184,0.59578,GOBP_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT,1
HP_EYE_MOVEMENT_INDUCED_PAIN,SET,5,-0.098726,-0.0016282,0.40712,0.5958,HP_EYE_MOVEMENT_INDUCED_PAIN,1
E2F3_UP.V1_DN,SET,132,-0.017578,-0.0014844,0.072477,0.59582,E2F3_UP.V1_DN,1
BIOCARTA_AKAPCENTROSOME_PATH...,SET,14,-0.050901,-0.0014044,0.20983,0.59583,BIOCARTA_AKAPCENTROSOME_PATHWAY,1
EFC_Q6,SET,242,-0.013585,-0.0015486,0.055978,0.59587,EFC_Q6,1
GSE13485_DAY3_VS_DAY7_YF17D_...2,SET,151,-0.016617,-0.0015,0.068469,0.59588,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP,1
MIR3074_5P,SET,136,-0.018327,-0.0015708,0.075489,0.59591,MIR3074_5P,1
GNF2_IGF1,SET,26,-0.042716,-0.0016055,0.17595,0.59591,GNF2_IGF1,1
GOBP_MITOCHONDRIAL_DNA_REPLI...,SET,13,-0.049742,-0.0013225,0.2047,0.59599,GOBP_MITOCHONDRIAL_DNA_REPLICATION,1
GOBP_PULMONARY_VALVE_DEVELOP...,SET,24,-0.050333,-0.0018177,0.20704,0.59604,GOBP_PULMONARY_VALVE_DEVELOPMENT,1
HP_MECHANICAL_ILEUS,SET,21,-0.049264,-0.0016643,0.20259,0.59606,HP_MECHANICAL_ILEUS,1
HP_EPISODIC_PAIN,SET,38,-0.032941,-0.0014963,0.13546,0.59607,HP_EPISODIC_PAIN,1
GOBP_LEUKOCYTE_ACTIVATION_IN...,SET,48,-0.033173,-0.0016931,0.1364,0.59608,GOBP_LEUKOCYTE_ACTIVATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GOBP_INDOLE_CONTAINING_COMPO...2,SET,9,-0.08127,-0.001798,0.33404,0.59611,GOBP_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
HP_MICROLISSENCEPHALY,SET,5,-0.097933,-0.0016151,0.40241,0.59614,HP_MICROLISSENCEPHALY,1
HOXA9_DN.V1_DN,SET,165,-0.016275,-0.0015352,0.066874,0.59614,HOXA9_DN.V1_DN,1
GOBP_REGULATION_OF_CORTICOTR...,SET,4,-0.10969,-0.0016181,0.45068,0.59615,GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION,1
GOMF_VOLTAGE_GATED_CALCIUM_C...1,SET,41,-0.035258,-0.0016635,0.14479,0.59619,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
HP_INVERTED_NIPPLES,SET,44,-0.029213,-0.0014277,0.11997,0.59619,HP_INVERTED_NIPPLES,1
HAHTOLA_MYCOSIS_FUNGOIDES_SK...2,SET,163,-0.016144,-0.0015137,0.066291,0.5962,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,1
GOBP_SCF_DEPENDENT_PROTEASOM...,SET,43,-0.032506,-0.0015705,0.13347,0.59621,GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
WP_CONTROL_OF_IMMUNE_TOLERAN...,SET,13,-0.063245,-0.0016815,0.25959,0.59624,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,1
DESCARTES_FETAL_MUSCLE_STROM...,SET,65,-0.028459,-0.0016895,0.1168,0.59625,DESCARTES_FETAL_MUSCLE_STROMAL_CELLS,1
MODULE_124,SET,92,-0.020209,-0.0014263,0.082906,0.59629,MODULE_124,1
HP_THENAR_MUSCLE_WEAKNESS,SET,4,-0.12287,-0.0018125,0.50396,0.59631,HP_THENAR_MUSCLE_WEAKNESS,1
GOBP_REGULATION_OF_MONOATOMI...4,SET,410,-0.011084,-0.0016369,0.045456,0.59632,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,1
HP_APLASIA_OF_THE_MIDDLE_PHA...,SET,7,-0.071932,-0.0014036,0.29478,0.59639,HP_APLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_HAND,1
GAVISH_3CA_METAPROGRAM_CD8_T...11,SET,40,-0.032397,-0.0015098,0.13268,0.59645,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1,1
GOBP_REGULATION_OF_MYELINATI...,SET,44,-0.032151,-0.0015713,0.13167,0.59645,GOBP_REGULATION_OF_MYELINATION,1
GOCC_SPECIFIC_GRANULE_LUMEN,SET,57,-0.029444,-0.0016373,0.12057,0.59647,GOCC_SPECIFIC_GRANULE_LUMEN,1
HP_ABNORMAL_BRAINSTEM_MRI_SI...,SET,31,-0.033171,-0.0013612,0.13581,0.59648,HP_ABNORMAL_BRAINSTEM_MRI_SIGNAL_INTENSITY,1
chr13q22,SET,14,-0.09541,-0.0026323,0.39047,0.59652,chr13q22,1
HP_ABNORMAL_5TH_FINGER_PHALA...,SET,54,-0.029419,-0.0015923,0.12039,0.59652,HP_ABNORMAL_5TH_FINGER_PHALANX_MORPHOLOGY,1
HP_PERONEAL_MUSCLE_WEAKNESS,SET,8,-0.079175,-0.0016515,0.32401,0.59652,HP_PERONEAL_MUSCLE_WEAKNESS,1
HP_ABNORMALITY_OF_LOWER_LIMB...,SET,639,-0.0083611,-0.0015317,0.03421,0.59654,HP_ABNORMALITY_OF_LOWER_LIMB_JOINT,1
GOCC_CATALYTIC_STEP_1_SPLICE...,SET,10,-0.059608,-0.0013901,0.24387,0.59655,GOCC_CATALYTIC_STEP_1_SPLICEOSOME,1
GOBP_FOREBRAIN_NEURON_DEVELO...,SET,21,-0.049092,-0.0016585,0.20083,0.59656,GOBP_FOREBRAIN_NEURON_DEVELOPMENT,1
SCHUETZ_BREAST_CANCER_DUCTAL...1,SET,78,-0.025846,-0.0016802,0.10569,0.59659,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1
GOBP_INTRACILIARY_TRANSPORT,SET,40,-0.033595,-0.0015656,0.13733,0.59663,GOBP_INTRACILIARY_TRANSPORT,1
GGGGCCC_MIR296,SET,66,-0.024617,-0.0014726,0.10062,0.59664,GGGGCCC_MIR296,1
HP_ABNORMAL_PHALANGEAL_JOINT...,SET,194,-0.015372,-0.001571,0.062831,0.59664,HP_ABNORMAL_PHALANGEAL_JOINT_MORPHOLOGY_OF_THE_HAND,1
GSE7460_TCONV_VS_TREG_LN_DN,SET,181,-0.016219,-0.0016016,0.066261,0.59668,GSE7460_TCONV_VS_TREG_LN_DN,1
GSE24026_PD1_LIGATION_VS_CTR...2,SET,180,-0.015835,-0.0015594,0.06468,0.5967,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP,1
REACTOME_BASIGIN_INTERACTIONS,SET,24,-0.04586,-0.0016562,0.18727,0.59673,REACTOME_BASIGIN_INTERACTIONS,1
FONTAINE_FOLLICULAR_THYROID_...2,SET,71,-0.02435,-0.0015105,0.09941,0.59675,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,1
GOBP_MAST_CELL_PROLIFERATION,SET,7,-0.091562,-0.0017866,0.37355,0.59681,GOBP_MAST_CELL_PROLIFERATION,1
GOBP_PROTEIN_STABILIZATION,SET,187,-0.014741,-0.0014794,0.06014,0.59682,GOBP_PROTEIN_STABILIZATION,1
HP_ABNORMALITY_OF_SKELETAL_M...1,SET,358,-0.011105,-0.0015348,0.045279,0.59687,HP_ABNORMALITY_OF_SKELETAL_MATURATION,1
HP_PRIMITIVE_REFLEX,SET,24,-0.041368,-0.001494,0.16864,0.59689,HP_PRIMITIVE_REFLEX,1
STAT_Q6,SET,234,-0.014121,-0.0015833,0.057548,0.59692,STAT_Q6,1
MIR6738_5P,SET,25,-0.043998,-0.0016217,0.1792,0.59698,MIR6738_5P,1
MIR3615,SET,8,-0.079703,-0.0016626,0.32456,0.59699,MIR3615,1
HP_ELEVATED_CIRCULATING_GROW...,SET,15,-0.054659,-0.0015609,0.22257,0.59699,HP_ELEVATED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,1
HP_HYPERGRANULOSIS,SET,20,-0.046936,-0.0015475,0.19114,0.59699,HP_HYPERGRANULOSIS,1
HP_PERSISTENT_CMV_VIREMIA,SET,5,-0.097838,-0.0016136,0.3982,0.59704,HP_PERSISTENT_CMV_VIREMIA,1
GOMF_CYCLIN_DEPENDENT_PROTEI...4,SET,45,-0.029264,-0.0014463,0.11908,0.59706,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_HOMOPHILI...,SET,5,-0.097592,-0.0016095,0.39705,0.59708,GOBP_REGULATION_OF_HOMOPHILIC_CELL_ADHESION,1
KEGG_MEDICUS_VARIANT_MUTATIO...48,SET,6,-0.090903,-0.0016422,0.36973,0.5971,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY,1
KEGG_BLADDER_CANCER,SET,40,-0.033062,-0.0015408,0.13445,0.59712,KEGG_BLADDER_CANCER,1
GSE18893_TCONV_VS_TREG_2H_CU...1,SET,187,-0.015469,-0.0015524,0.062893,0.59714,GSE18893_TCONV_VS_TREG_2H_CULTURE_DN,1
GSE27786_LSK_VS_NKTCELL_DN,SET,173,-0.015363,-0.0014835,0.062438,0.59718,GSE27786_LSK_VS_NKTCELL_DN,1
GOBP_REGULATION_OF_NEUROTRAN...1,SET,40,-0.035298,-0.001645,0.14344,0.59719,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_VI...3,SET,19,-0.050501,-0.0016229,0.20517,0.59721,GOBP_CELLULAR_RESPONSE_TO_VITAMIN_D,1
GSE32423_CTRL_VS_IL4_MEMORY_...2,SET,176,-0.016123,-0.0015702,0.065496,0.59722,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP,1
HP_IMMUNOLOGIC_HYPERSENSITIV...,SET,210,-0.014887,-0.0015822,0.060431,0.59729,HP_IMMUNOLOGIC_HYPERSENSITIVITY,1
KEGG_CHRONIC_MYELOID_LEUKEMIA,SET,71,-0.02544,-0.0015782,0.10325,0.59731,KEGG_CHRONIC_MYELOID_LEUKEMIA,1
REACTOME_CASPASE_MEDIATED_CL...,SET,12,-0.057937,-0.00148,0.23507,0.59734,REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,1
REACTOME_TOXICITY_OF_BOTULIN...,SET,5,-0.087194,-0.001438,0.35372,0.59735,REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD,1
GSE39820_CTRL_VS_TGFBETA3_IL...2,SET,177,-0.015597,-0.0015233,0.063132,0.59757,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP,1
REACTOME_SYNTHESIS_OF_PIPS_A...3,SET,16,-0.047177,-0.0013914,0.19093,0.59758,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,1
GSE24634_TREG_VS_TCONV_POST_...6,SET,179,-0.015291,-0.0015017,0.061877,0.59759,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP,1
MIR4474_5P,SET,44,-0.03355,-0.0016397,0.13571,0.59763,MIR4474_5P,1
GSE360_L_MAJOR_VS_T_GONDII_M...1,SET,178,-0.015142,-0.001483,0.061247,0.59763,GSE360_L_MAJOR_VS_T_GONDII_MAC_DN,1
GSE39820_TGFBETA1_VS_TGFBETA...2,SET,185,-0.015108,-0.0015081,0.061043,0.59773,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP,1
GOBP_HEPATOCYTE_DIFFERENTIAT...,SET,13,-0.067736,-0.0018009,0.27358,0.59777,GOBP_HEPATOCYTE_DIFFERENTIATION,1
TRAVAGLINI_LUNG_NEUROENDOCRI...,SET,114,-0.021384,-0.001679,0.086371,0.59777,TRAVAGLINI_LUNG_NEUROENDOCRINE_CELL,1
GOCC_ENDOPLASMIC_RETICULUM_Q...,SET,15,-0.053099,-0.0015164,0.21444,0.59778,GOCC_ENDOPLASMIC_RETICULUM_QUALITY_CONTROL_COMPARTMENT,1
GOBP_BONE_MINERALIZATION,SET,113,-0.02129,-0.0016643,0.085911,0.59786,GOBP_BONE_MINERALIZATION,1
PAX8_01,SET,33,-0.038457,-0.0016282,0.15515,0.59788,PAX8_01,1
GOBP_LYSINE_METABOLIC_PROCESS,SET,8,-0.068287,-0.0014244,0.2754,0.59791,GOBP_LYSINE_METABOLIC_PROCESS,1
HP_HYPOPLASIA_OF_THE_FRONTAL...,SET,33,-0.034737,-0.0014706,0.14003,0.59796,HP_HYPOPLASIA_OF_THE_FRONTAL_LOBES,1
GOBP_NEGATIVE_REGULATION_OF_...122,SET,15,-0.056217,-0.0016054,0.22642,0.59804,GOBP_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...785,SET,773,-0.0080028,-0.0016064,0.032223,0.59807,GOBP_POSITIVE_REGULATION_OF_TRANSPORT,1
GOBP_REGULATION_OF_MICROTUBU...8,SET,85,-0.021933,-0.0014881,0.088272,0.59811,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...4,SET,22,-0.045866,-0.001586,0.18449,0.59817,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,1
GSE19888_ADENOSINE_A3R_INH_V...6,SET,176,-0.015959,-0.0015543,0.064175,0.5982,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP,1
HP_ABNORMAL_INTERNAL_CAROTID...,SET,10,-0.07642,-0.0017821,0.30689,0.59832,HP_ABNORMAL_INTERNAL_CAROTID_ARTERY_MORPHOLOGY,1
GOBP_REGULATION_OF_TERMINATI...,SET,5,-0.098477,-0.0016241,0.3954,0.59834,GOBP_REGULATION_OF_TERMINATION_OF_DNA_TEMPLATED_TRANSCRIPTION,1
HOFT_CD4_POSITIVE_ALPHA_BETA...2,SET,17,-0.050075,-0.0015223,0.20094,0.59839,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,1
REACTOME_ESTABLISHMENT_OF_SI...,SET,8,-0.074549,-0.0015551,0.29912,0.59841,REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,1
GOCC_OLIGOSACCHARYLTRANSFERA...,SET,13,-0.059777,-0.0015893,0.23974,0.59845,GOCC_OLIGOSACCHARYLTRANSFERASE_COMPLEX,1
GOBP_CYTOPLASM_ORGANIZATION,SET,15,-0.056156,-0.0016037,0.2252,0.59846,GOBP_CYTOPLASM_ORGANIZATION,1
HP_ABNORMAL_NASOLABIAL_REGIO...,SET,17,-0.049288,-0.0014984,0.19765,0.59846,HP_ABNORMAL_NASOLABIAL_REGION_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...24,SET,6,-0.088251,-0.0015943,0.35386,0.59847,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,1
HP_HETEROPHORIA,SET,11,-0.061438,-0.0015026,0.24629,0.59849,HP_HETEROPHORIA,1
HP_ABNORMALITY_OF_THE_TARSAL...,SET,113,-0.020911,-0.0016346,0.083815,0.59851,HP_ABNORMALITY_OF_THE_TARSAL_BONES,1
GOBP_LIPID_TRANSPORT_ACROSS_...,SET,6,-0.081757,-0.001477,0.32753,0.59856,GOBP_LIPID_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,1
WP_HEPATOCYTE_GROWTH_FACTOR_...,SET,33,-0.038984,-0.0016505,0.15607,0.59862,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,1
GSE25087_FETAL_VS_ADULT_TCON...2,SET,174,-0.016313,-0.0015798,0.065314,0.59862,GSE25087_FETAL_VS_ADULT_TCONV_UP,1
WANG_BARRETTS_ESOPHAGUS_UP,SET,50,-0.032945,-0.0017161,0.13184,0.59866,WANG_BARRETTS_ESOPHAGUS_UP,1
REACTOME_REGULATION_BY_C_FLIP,SET,11,-0.066608,-0.0016291,0.26615,0.59881,REACTOME_REGULATION_BY_C_FLIP,1
WP_FLUOROPYRIMIDINE_ACTIVITY,SET,33,-0.037167,-0.0015735,0.14845,0.59885,WP_FLUOROPYRIMIDINE_ACTIVITY,1
HP_ALLERGIC_RHINITIS,SET,10,-0.06092,-0.0014207,0.24331,0.59885,HP_ALLERGIC_RHINITIS,1
GSE11864_CSF1_PAM3CYS_VS_CSF...2,SET,166,-0.016789,-0.0015884,0.066985,0.59895,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,1
GOBP_CALCIUM_DEPENDENT_CELL_...,SET,47,-0.035687,-0.0018024,0.14236,0.59896,GOBP_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,1
MIR4760_3P,SET,249,-0.014052,-0.0016245,0.056057,0.59897,MIR4760_3P,1
MEISSNER_ES_ICP_WITH_H3K4ME3...,SET,11,-0.066991,-0.0016384,0.26719,0.59898,MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
GOBP_CENTROMERE_COMPLEX_ASSE...,SET,26,-0.03868,-0.0014538,0.1542,0.59903,GOBP_CENTROMERE_COMPLEX_ASSEMBLY,1
KEGG_MEDICUS_REFERENCE_STERO...,SET,5,-0.10147,-0.0016735,0.40448,0.59904,KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...1,SET,13,-0.056586,-0.0015045,0.22543,0.5991,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION,1
GSE10325_CD4_TCELL_VS_BCELL_...1,SET,166,-0.017817,-0.0016857,0.070972,0.59911,GSE10325_CD4_TCELL_VS_BCELL_DN,1
GSE12392_CD8A_POS_VS_NEG_SPL...2,SET,189,-0.015628,-0.0015766,0.062236,0.59913,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP,1
GSE43863_TFH_VS_LY6C_LOW_CXC...2,SET,185,-0.016421,-0.0016393,0.065383,0.59915,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,1
HP_GASTROINTESTINAL_ARTERIOV...,SET,4,-0.12621,-0.0018617,0.50202,0.59924,HP_GASTROINTESTINAL_ARTERIOVENOUS_MALFORMATION,1
WEST_ADRENOCORTICAL_CARCINOM...2,SET,16,-0.055595,-0.0016397,0.22098,0.59932,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,1
ZNF502_TARGET_GENES,SET,25,-0.040662,-0.0014987,0.16158,0.59935,ZNF502_TARGET_GENES,1
HP_ABNORMAL_GROWTH_HORMONE_L...,SET,25,-0.044802,-0.0016513,0.178,0.59936,HP_ABNORMAL_GROWTH_HORMONE_LEVEL,1
GOMF_TAURINE_TRANSMEMBRANE_T...,SET,5,-0.11018,-0.0018171,0.4373,0.59946,GOMF_TAURINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KUUSELO_PANCREATIC_CANCER_19...,SET,31,-0.058872,-0.0024159,0.23354,0.59951,KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,1
GOBP_POSITIVE_REGULATION_OF_...471,SET,6,-0.086317,-0.0015594,0.34236,0.59953,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,1
GOMF_STEROID_HORMONE_BINDING,SET,6,-0.097336,-0.0017584,0.38602,0.59954,GOMF_STEROID_HORMONE_BINDING,1
GOBP_GLYCOSPHINGOLIPID_BIOSY...,SET,38,-0.037262,-0.0016926,0.14774,0.59956,GOBP_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_DNA_REPAIR,SET,194,-0.01451,-0.0014829,0.057498,0.59962,GOBP_REGULATION_OF_DNA_REPAIR,1
AACTTT_UNKNOWN,SET,1693,-0.0058114,-0.0016806,0.023022,0.59964,AACTTT_UNKNOWN,1
GOBP_VIRAL_TRANSLATION,SET,18,-0.050033,-0.0015651,0.19818,0.59966,GOBP_VIRAL_TRANSLATION,1
HP_ABNORMAL_CIRCULATING_GLUT...2,SET,30,-0.035914,-0.0014499,0.14213,0.59974,HP_ABNORMAL_CIRCULATING_GLUTAMINE_FAMILY_AMINO_ACID_CONCENTRATION,1
GSE25088_WT_VS_STAT6_KO_MACR...3,SET,176,-0.015982,-0.0015565,0.063254,0.59974,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP,1
GOBP_REGULATION_OF_VESICLE_F...,SET,22,-0.049237,-0.0017025,0.19476,0.59979,GOBP_REGULATION_OF_VESICLE_FUSION,1
HP_ABNORMALITY_OF_THE_MIDDLE...2,SET,19,-0.05356,-0.0017212,0.21186,0.59979,HP_ABNORMALITY_OF_THE_MIDDLE_EAR_OSSICLES,1
REACTOME_GLOBAL_GENOME_NUCLE...,SET,79,-0.021607,-0.0014136,0.085459,0.5998,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1
GOCC_GOLGI_MEMBRANE,SET,624,-0.0088646,-0.0016055,0.035057,0.59981,GOCC_GOLGI_MEMBRANE,1
GOBP_REPLICATION_BORN_DOUBLE...,SET,6,-0.09223,-0.0016662,0.36462,0.59984,GOBP_REPLICATION_BORN_DOUBLE_STRAND_BREAK_REPAIR_VIA_SISTER_CHROMATID_EXCHANGE,1
GOBP_COMMA_SHAPED_BODY_MORPH...,SET,5,-0.12174,-0.0020078,0.48119,0.59986,GOBP_COMMA_SHAPED_BODY_MORPHOGENESIS,1
GOMF_LYASE_ACTIVITY,SET,179,-0.016546,-0.001625,0.065388,0.59988,GOMF_LYASE_ACTIVITY,1
BIOCARTA_BTG2_PATHWAY,SET,11,-0.058479,-0.0014303,0.23091,0.59996,BIOCARTA_BTG2_PATHWAY,1
REACTOME_PI3K_EVENTS_IN_ERBB...2,SET,10,-0.07011,-0.001635,0.27683,0.59996,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,1
HP_ECTROPION,SET,58,-0.02561,-0.0014365,0.10113,0.59996,HP_ECTROPION,1
GOBP_POSITIVE_REGULATION_OF_...91,SET,6,-0.090866,-0.0016416,0.35873,0.59998,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,1
GOBP_POSITIVE_REGULATION_OF_...396,SET,23,-0.047424,-0.0016766,0.18719,0.6,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...5,SET,9,-0.077286,-0.0017099,0.30499,0.60002,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_TRANSIENT_UP,1
ERWIN_COHEN_BLOOD_VACCINE_TC...4,SET,71,-0.027004,-0.0016752,0.10656,0.60003,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP,1
GOBP_CELLULAR_RESPONSE_TO_TO...1,SET,95,-0.0219,-0.0015705,0.086399,0.60005,GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,1
HP_PROXIMAL_PLACEMENT_OF_THU...,SET,34,-0.036229,-0.0015568,0.14288,0.60008,HP_PROXIMAL_PLACEMENT_OF_THUMB,1
ZHONG_PFC_C2_THY1_POS_OPC,SET,22,-0.050017,-0.0017295,0.19719,0.60011,ZHONG_PFC_C2_THY1_POS_OPC,1
GSE16385_ROSIGLITAZONE_IL4_V...4,SET,178,-0.016181,-0.0015847,0.06377,0.60015,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP,1
GSE26495_NAIVE_VS_PD1HIGH_CD...1,SET,181,-0.016686,-0.0016478,0.065759,0.60015,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN,1
MORF_CTBP1,SET,155,-0.015929,-0.0014567,0.062734,0.60022,MORF_CTBP1,1
GOBP_URINARY_TRACT_SMOOTH_MU...,SET,9,-0.07716,-0.0017071,0.30371,0.60027,GOBP_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION,1
BIOCARTA_GH_PATHWAY,SET,26,-0.044223,-0.0016622,0.17401,0.6003,BIOCARTA_GH_PATHWAY,1
HP_APLASIA_HYPOPLASIA_OF_THE...54,SET,3,-0.13163,-0.0016816,0.51793,0.60031,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_TOE,1
HP_ABNORMAL_RIGHT_VENTRICULA...,SET,19,-0.05268,-0.001693,0.20717,0.60036,HP_ABNORMAL_RIGHT_VENTRICULAR_FUNCTION,1
HOLLMANN_APOPTOSIS_VIA_CD40_...1,SET,234,-0.014592,-0.001636,0.057365,0.60039,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1
GOBP_POSITIVE_REGULATION_OF_...589,SET,634,-0.0091035,-0.0016614,0.035784,0.6004,GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_BCR_ABL...1,SET,11,-0.064552,-0.0015788,0.25374,0.60041,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,1
ZHENG_CORD_BLOOD_C9_GRANULOC...,SET,90,-0.022849,-0.001595,0.089771,0.60045,ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR,1
SIG_REGULATION_OF_THE_ACTIN_...,SET,30,-0.038839,-0.0015679,0.15257,0.60047,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,1
SREBP1_02,SET,79,-0.023206,-0.0015182,0.091127,0.60051,SREBP1_02,1
WP_IL11_SIGNALING,SET,41,-0.035122,-0.0016571,0.13788,0.60053,WP_IL11_SIGNALING,1
RACTNNRTTTNC_UNKNOWN,SET,111,-0.020823,-0.0016134,0.081716,0.60057,RACTNNRTTTNC_UNKNOWN,1
LEE_BMP2_TARGETS_UP,SET,699,-0.0088483,-0.0016925,0.034717,0.60059,LEE_BMP2_TARGETS_UP,1
HP_MILDLY_ELEVATED_CREATINE_...,SET,53,-0.028689,-0.0015384,0.11252,0.60063,HP_MILDLY_ELEVATED_CREATINE_KINASE,1
MIR4720_5P,SET,79,-0.024601,-0.0016095,0.096424,0.60069,MIR4720_5P,1
GOBP_DERMATAN_SULFATE_PROTEO...2,SET,11,-0.065095,-0.0015921,0.25508,0.60071,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,1
BUSSLINGER_GASTRIC_METALLOTH...,SET,91,-0.024237,-0.0017013,0.094968,0.60072,BUSSLINGER_GASTRIC_METALLOTHIONEIN_CELLS,1
TEF_Q6,SET,235,-0.01515,-0.0017022,0.059335,0.60077,TEF_Q6,1
HP_EPILEPSIA_PARTIALIS_CONTI...,SET,8,-0.071491,-0.0014913,0.27993,0.60079,HP_EPILEPSIA_PARTIALIS_CONTINUA,1
HP_SEVERE_VARICELLA_ZOSTER_I...,SET,13,-0.064851,-0.0017242,0.25369,0.60088,HP_SEVERE_VARICELLA_ZOSTER_INFECTION,1
HP_ABSENT_AXILLARY_HAIR,SET,12,-0.066496,-0.0016986,0.26002,0.60092,HP_ABSENT_AXILLARY_HAIR,1
SIMBULAN_PARP1_TARGETS_DN,SET,16,-0.051397,-0.0015159,0.20085,0.60099,SIMBULAN_PARP1_TARGETS_DN,1
GATTGGY_NFY_Q6_01,SET,1023,-0.0071044,-0.0016288,0.027759,0.601,GATTGGY_NFY_Q6_01,1
GOMF_UNIPORTER_ACTIVITY,SET,9,-0.085829,-0.0018989,0.33526,0.60103,GOMF_UNIPORTER_ACTIVITY,1
GSE28726_NAIVE_VS_ACTIVATED_...5,SET,177,-0.016911,-0.0016516,0.066056,0.60103,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...8,SET,135,-0.018954,-0.0016186,0.074029,0.60104,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE,1
GOBP_POSITIVE_REGULATION_OF_...660,SET,18,-0.053668,-0.0016788,0.20945,0.60111,GOBP_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
REACTOME_TP53_REGULATES_TRAN...3,SET,48,-0.030788,-0.0015714,0.12013,0.60114,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...1,SET,177,-0.016395,-0.0016012,0.063963,0.60115,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,1
MEBARKI_HCC_PROGENITOR_WNT_D...1,SET,54,-0.030366,-0.0016436,0.11844,0.60117,MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD,1
HP_ROD_CONE_DYSTROPHY,SET,197,-0.015261,-0.0015715,0.059523,0.60117,HP_ROD_CONE_DYSTROPHY,1
GOBP_NEGATIVE_REGULATION_OF_...405,SET,5,-0.10481,-0.0017285,0.40857,0.60122,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,1
HP_SHORT_FIRST_METATARSAL,SET,4,-0.11317,-0.0016694,0.44117,0.60123,HP_SHORT_FIRST_METATARSAL,1
GOBP_AV_NODE_CELL_TO_BUNDLE_...1,SET,13,-0.069254,-0.0018413,0.26987,0.60126,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION,1
MULLIGAN_NTF3_SIGNALING_VIA_...1,SET,7,-0.097927,-0.0019108,0.38153,0.60128,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,1
HP_OPTIC_NERVE_GLIOMA,SET,5,-0.10937,-0.0018038,0.42578,0.60136,HP_OPTIC_NERVE_GLIOMA,1
MIR8070,SET,116,-0.021477,-0.0017009,0.08358,0.60139,MIR8070,1
GOBP_PEPTIDYL_GLUTAMIC_ACID_...,SET,25,-0.04653,-0.001715,0.18109,0.60139,GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION,1
SETLUR_PROSTATE_CANCER_TMPRS...1,SET,16,-0.056809,-0.0016755,0.22106,0.6014,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,1
MIR1909_3P,SET,120,-0.020114,-0.00162,0.078271,0.6014,MIR1909_3P,1
HELLER_SILENCED_BY_METHYLATI...1,SET,100,-0.024019,-0.0017669,0.093457,0.60141,HELLER_SILENCED_BY_METHYLATION_DN,1
GSE46468_LUNG_INNATE_LYMPHOI...2,SET,164,-0.016173,-0.001521,0.062919,0.60143,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP,1
GOBP_ENDOTHELIAL_CELL_ACTIVA...,SET,9,-0.084041,-0.0018593,0.32688,0.60145,GOBP_ENDOTHELIAL_CELL_ACTIVATION,1
HP_JERKY_OCULAR_PURSUIT_MOVE...,SET,8,-0.068585,-0.0014306,0.26651,0.60154,HP_JERKY_OCULAR_PURSUIT_MOVEMENTS,1
MIR4709_3P,SET,148,-0.018157,-0.0016228,0.070544,0.60156,MIR4709_3P,1
HP_UPPER_LIMB_PAIN,SET,8,-0.082389,-0.0017186,0.32007,0.60157,HP_UPPER_LIMB_PAIN,1
HP_ABNORMAL_EXTEROCEPTIVE_SE...,SET,219,-0.015111,-0.0016397,0.058649,0.60166,HP_ABNORMAL_EXTEROCEPTIVE_SENSATION,1
HP_CAROTID_ARTERY_DILATATION,SET,23,-0.047866,-0.0016923,0.18577,0.60166,HP_CAROTID_ARTERY_DILATATION,1
GOBP_REGULATION_OF_CELLULAR_...4,SET,311,-0.012759,-0.0016456,0.049453,0.60179,GOBP_REGULATION_OF_CELLULAR_COMPONENT_SIZE,1
FAN_EMBRYONIC_CTX_IN_2_INTER...,SET,7,-0.082205,-0.001604,0.31855,0.60182,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,1
GOMF_PEPTIDOGLYCAN_BINDING,SET,18,-0.057608,-0.001802,0.22308,0.60189,GOMF_PEPTIDOGLYCAN_BINDING,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...9,SET,6,-0.077815,-0.0014058,0.30128,0.6019,HP_ABNORMAL_MORPHOLOGY_OF_THE_PROXIMAL_PHALANX_OF_THE_HALLUX,1
HP_RECURRENT_NEISSERIAL_INFE...,SET,7,-0.087714,-0.0017115,0.33959,0.60191,HP_RECURRENT_NEISSERIAL_INFECTIONS,1
HP_FATIGABLE_WEAKNESS_OF_SKE...,SET,42,-0.032049,-0.0015303,0.12401,0.60197,HP_FATIGABLE_WEAKNESS_OF_SKELETAL_MUSCLES,1
PID_INTEGRIN1_PATHWAY,SET,63,-0.030563,-0.0017864,0.11824,0.60198,PID_INTEGRIN1_PATHWAY,1
GSE29618_PRE_VS_DAY7_FLU_VAC...2,SET,177,-0.016921,-0.0016525,0.065444,0.60201,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP,1
FAN_EMBRYONIC_CTX_MICROGLIA_3,SET,19,-0.05787,-0.0018598,0.22376,0.60204,FAN_EMBRYONIC_CTX_MICROGLIA_3,1
MODULE_83,SET,281,-0.01274,-0.0015632,0.049252,0.60205,MODULE_83,1
GSE6090_UNSTIM_VS_DC_SIGN_ST...1,SET,129,-0.020631,-0.0017224,0.079736,0.60208,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN,1
HP_ABNORMALITY_OF_CYTOKINE_S...,SET,6,-0.102,-0.0018427,0.39396,0.60215,HP_ABNORMALITY_OF_CYTOKINE_SECRETION,1
HP_METOPIC_SYNOSTOSIS,SET,23,-0.041043,-0.001451,0.15852,0.60215,HP_METOPIC_SYNOSTOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...143,SET,21,-0.054168,-0.00183,0.20903,0.60223,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
LU_TUMOR_ANGIOGENESIS_UP,SET,25,-0.04718,-0.0017389,0.18195,0.6023,LU_TUMOR_ANGIOGENESIS_UP,1
FUKUSHIMA_TNFSF11_TARGETS,SET,16,-0.061305,-0.0018081,0.23632,0.60234,FUKUSHIMA_TNFSF11_TARGETS,1
GOMF_HYALURONIC_ACID_BINDING,SET,24,-0.045488,-0.0016427,0.17521,0.60242,GOMF_HYALURONIC_ACID_BINDING,1
GOBP_REGULATION_OF_IMMUNE_SY...,SET,1405,-0.006373,-0.0016934,0.024545,0.60243,GOBP_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,1
HOFFMAN_CLOCK_TARGETS_DN,SET,10,-0.070943,-0.0016544,0.27317,0.60245,HOFFMAN_CLOCK_TARGETS_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...42,SET,5,-0.082743,-0.0013646,0.31859,0.60246,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,1
JAIN_NFKB_SIGNALING,SET,68,-0.026171,-0.001589,0.10075,0.60247,JAIN_NFKB_SIGNALING,1
SONG_TARGETS_OF_IE86_CMV_PRO...,SET,51,-0.031523,-0.0016583,0.12111,0.60268,SONG_TARGETS_OF_IE86_CMV_PROTEIN,1
HP_RECTAL_POLYPOSIS,SET,5,-0.10375,-0.0017111,0.3986,0.60268,HP_RECTAL_POLYPOSIS,1
GSE21546_WT_VS_SAP1A_KO_AND_...1,SET,182,-0.016703,-0.001654,0.064131,0.60274,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
GSE3720_LPS_VS_PMA_STIM_VD1_...2,SET,124,-0.019877,-0.0016272,0.076298,0.60277,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,1
GOBP_DNA_DAMAGE_RESPONSE,SET,794,-0.007636,-0.0015525,0.029308,0.60278,GOBP_DNA_DAMAGE_RESPONSE,1
chr4p14,SET,29,-0.077436,-0.0030736,0.29689,0.60288,chr4p14,1
GSE22935_24H_VS_48H_MBOVIS_B...2,SET,178,-0.016712,-0.0016367,0.064078,0.60288,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
GSE4748_LPS_VS_LPS_AND_CYANO...1,SET,143,-0.018151,-0.0015948,0.069587,0.60289,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
GOBP_REGULATION_OF_NUCLEAR_D...,SET,142,-0.01859,-0.0016278,0.071242,0.60293,GOBP_REGULATION_OF_NUCLEAR_DIVISION,1
GSE24972_MARGINAL_ZONE_BCELL...2,SET,181,-0.016809,-0.0016599,0.064415,0.60293,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN,1
AR_Q2,SET,115,-0.021577,-0.0017015,0.08268,0.60294,AR_Q2,1
GOBP_CYTOPLASMIC_TRANSLATION...1,SET,4,-0.091524,-0.0013501,0.35061,0.60297,GOBP_CYTOPLASMIC_TRANSLATIONAL_ELONGATION,1
MIR676_3P,SET,47,-0.032035,-0.001618,0.12267,0.60301,MIR676_3P,1
KLEIN_PRIMARY_EFFUSION_LYMPH...1,SET,50,-0.033986,-0.0017703,0.13011,0.60304,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,1
MIR6871_5P,SET,51,-0.035107,-0.0018468,0.13439,0.60304,MIR6871_5P,1
GSE16451_CTRL_VS_WEST_EQUINE...3,SET,182,-0.016408,-0.0016248,0.062799,0.60306,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,1
GSE27786_NKCELL_VS_NKTCELL_UP,SET,187,-0.016095,-0.0016153,0.061599,0.60306,GSE27786_NKCELL_VS_NKTCELL_UP,1
GOBP_RESPIRATORY_SYSTEM_PROC...,SET,40,-0.038304,-0.001785,0.14655,0.60309,GOBP_RESPIRATORY_SYSTEM_PROCESS,1
FOXE1_TARGET_GENES,SET,567,-0.0098062,-0.0016957,0.037513,0.60311,FOXE1_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...348,SET,4,-0.14439,-0.0021299,0.55226,0.60313,GOBP_POSITIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,1
HP_LYMPHOPROLIFERATIVE_DISOR...,SET,13,-0.062235,-0.0016546,0.23803,0.60313,HP_LYMPHOPROLIFERATIVE_DISORDER,1
HP_AXONAL_REGENERATION,SET,6,-0.10321,-0.0018645,0.39427,0.60325,HP_AXONAL_REGENERATION,1
MIR12136,SET,903,-0.0077649,-0.0016784,0.029643,0.60332,MIR12136,1
HP_FUNCTIONAL_ABNORMALITY_OF...1,SET,228,-0.014819,-0.0016403,0.056558,0.60335,HP_FUNCTIONAL_ABNORMALITY_OF_MALE_INTERNAL_GENITALIA,1
TERAMOTO_OPN_TARGETS_CLUSTER...6,SET,17,-0.058942,-0.0017919,0.22492,0.60336,TERAMOTO_OPN_TARGETS_CLUSTER_7,1
HP_HYPOTHERMIA,SET,40,-0.03523,-0.0016418,0.13444,0.60336,HP_HYPOTHERMIA,1
HP_RENAL_PHOSPHATE_WASTING,SET,11,-0.072356,-0.0017697,0.27599,0.6034,HP_RENAL_PHOSPHATE_WASTING,1
MIR127_5P,SET,80,-0.025702,-0.001692,0.098018,0.60342,MIR127_5P,1
MIR382_5P,SET,52,-0.030518,-0.001621,0.11634,0.60346,MIR382_5P,1
GSE9988_LPS_VS_CTRL_TREATED_...1,SET,189,-0.015633,-0.0015771,0.059595,0.60346,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN,1
REACTOME_LYSINE_CATABOLISM,SET,12,-0.061787,-0.0015783,0.23553,0.60347,REACTOME_LYSINE_CATABOLISM,1
ONKEN_UVEAL_MELANOMA_DN,SET,474,-0.010667,-0.0016908,0.040621,0.60357,ONKEN_UVEAL_MELANOMA_DN,1
GSE24574_BCL6_HIGH_TFH_VS_TF...2,SET,176,-0.017403,-0.0016949,0.066269,0.60357,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP,1
MUNSHI_MULTIPLE_MYELOMA_DN,SET,9,-0.08225,-0.0018197,0.31317,0.60358,MUNSHI_MULTIPLE_MYELOMA_DN,1
GOBP_STRIATUM_DEVELOPMENT,SET,20,-0.053613,-0.0017677,0.20415,0.60358,GOBP_STRIATUM_DEVELOPMENT,1
BERENJENO_ROCK_SIGNALING_NOT...2,SET,28,-0.042302,-0.0016499,0.16104,0.6036,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,1
WHITFIELD_CELL_CYCLE_LITERAT...,SET,44,-0.030423,-0.0014868,0.11579,0.60362,WHITFIELD_CELL_CYCLE_LITERATURE,1
MODULE_431,SET,15,-0.064082,-0.00183,0.24392,0.60362,MODULE_431,1
GSE27291_6H_VS_7D_STIM_GAMMA...2,SET,176,-0.015802,-0.0015389,0.060146,0.60362,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP,1
MIR20A_5P,SET,623,-0.0092781,-0.0016791,0.035309,0.60364,MIR20A_5P,1
CASORELLI_ACUTE_PROMYELOCYTI...1,SET,591,-0.0091202,-0.001609,0.034689,0.60369,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN,1
HP_SPECIFIC_LEARNING_DISABIL...,SET,267,-0.013987,-0.0016735,0.053178,0.60373,HP_SPECIFIC_LEARNING_DISABILITY,1
PETROVA_ENDOTHELIUM_LYMPHATI...2,SET,125,-0.021015,-0.0017273,0.079895,0.60374,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1
CP2_01,SET,238,-0.014588,-0.0016494,0.055458,0.60374,CP2_01,1
GOBP_SERINE_FAMILY_AMINO_ACI...1,SET,15,-0.056116,-0.0016025,0.21332,0.60375,GOBP_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
HP_SEBORRHEIC_DERMATITIS,SET,22,-0.049467,-0.0017105,0.18804,0.60375,HP_SEBORRHEIC_DERMATITIS,1
DELACROIX_RAR_TARGETS_UP,SET,44,-0.038857,-0.001899,0.14768,0.60377,DELACROIX_RAR_TARGETS_UP,1
BIOCARTA_TID_PATHWAY,SET,19,-0.051352,-0.0016503,0.19512,0.60379,BIOCARTA_TID_PATHWAY,1
GRAHAM_CML_QUIESCENT_VS_CML_...2,SET,23,-0.05706,-0.0020173,0.21679,0.6038,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,1
GOCC_TRAPPII_PROTEIN_COMPLEX,SET,9,-0.068835,-0.0015229,0.26151,0.60381,GOCC_TRAPPII_PROTEIN_COMPLEX,1
HP_EPISODIC_HYPOKALEMIA,SET,4,-0.12652,-0.0018663,0.48038,0.60387,HP_EPISODIC_HYPOKALEMIA,1
CTACTAG_MIR325,SET,13,-0.059392,-0.0015791,0.22545,0.60389,CTACTAG_MIR325,1
HP_ABNORMAL_TESTIS_MORPHOLOGY,SET,832,-0.0079244,-0.0016475,0.03008,0.60389,HP_ABNORMAL_TESTIS_MORPHOLOGY,1
GSE1791_CTRL_VS_NEUROMEDINU_...8,SET,176,-0.016847,-0.0016407,0.063914,0.60395,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP,1
GSE22589_HEALTHY_VS_HIV_INFE...2,SET,188,-0.015376,-0.0015472,0.058334,0.60395,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP,1
GSE25123_WT_VS_PPARG_KO_MACR...6,SET,149,-0.018762,-0.0016825,0.071174,0.60396,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,1
GOBP_PYRIMIDINE_CONTAINING_C...5,SET,16,-0.060101,-0.0017726,0.22794,0.60398,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,1
GSE40274_IRF4_VS_FOXP3_AND_I...1,SET,102,-0.022918,-0.0017027,0.086917,0.60399,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_ADENOSINE_TO_INOSINE_ED...,SET,6,-0.10202,-0.001843,0.38665,0.60405,GOBP_ADENOSINE_TO_INOSINE_EDITING,1
GOMF_FIBRONECTIN_BINDING,SET,30,-0.047,-0.0018974,0.17806,0.60409,GOMF_FIBRONECTIN_BINDING,1
REACTOME_FICOLINS_BIND_TO_RE...,SET,5,-0.1125,-0.0018554,0.42587,0.60417,REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE,1
GOBP_NEGATIVE_REGULATION_OF_...151,SET,44,-0.032323,-0.0015797,0.12235,0.60418,GOBP_NEGATIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,1
GOBP_REGULATION_OF_GRANULOCY...2,SET,15,-0.058113,-0.0016596,0.21991,0.60421,GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,1
WP_VITAMIN_DSENSITIVE_CALCIU...,SET,34,-0.039909,-0.001715,0.15101,0.60422,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,1
ROZANOV_MMP14_CORRELATED,SET,10,-0.078244,-0.0018247,0.29603,0.60423,ROZANOV_MMP14_CORRELATED,1
HP_NIGHT_SWEATS,SET,10,-0.075958,-0.0017714,0.28737,0.60423,HP_NIGHT_SWEATS,1
GOMF_CALCIUM_SODIUM_ANTIPORT...,SET,10,-0.081268,-0.0018952,0.30734,0.60427,GOMF_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY,1
GSE36392_EOSINOPHIL_VS_NEUTR...1,SET,179,-0.016373,-0.001608,0.061901,0.6043,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,1
GOBP_REGULATION_OF_STRIATED_...2,SET,87,-0.024975,-0.0017143,0.094415,0.60431,GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,1
MODULE_176,SET,209,-0.017435,-0.0018487,0.065896,0.60434,MODULE_176,1
GOBP_REGULATION_OF_CGMP_MEDI...,SET,10,-0.076996,-0.0017956,0.29085,0.60439,GOBP_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
chr6q25,SET,67,-0.060329,-0.003636,0.22784,0.60441,chr6q25,1
GSE11961_FOLLICULAR_BCELL_VS...4,SET,177,-0.016575,-0.0016187,0.062596,0.60441,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,1
STEIN_ESRRA_TARGETS_DN,SET,94,-0.023023,-0.0016423,0.086944,0.60442,STEIN_ESRRA_TARGETS_DN,1
REACTOME_ASPARTATE_AND_ASPAR...,SET,11,-0.068009,-0.0016634,0.25679,0.60443,REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM,1
HP_PROMINENT_SUPRAORBITAL_RI...,SET,33,-0.041133,-0.0017414,0.15527,0.60446,HP_PROMINENT_SUPRAORBITAL_RIDGES,1
GOBP_POSITIVE_REGULATION_OF_...771,SET,48,-0.029115,-0.001486,0.10983,0.60453,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_II,1
GOBP_REGULATION_OF_MUSCLE_AD...,SET,73,-0.028518,-0.0017938,0.10756,0.60455,GOBP_REGULATION_OF_MUSCLE_ADAPTATION,1
REACTOME_LONG_TERM_POTENTIAT...,SET,22,-0.05305,-0.0018344,0.20004,0.60457,REACTOME_LONG_TERM_POTENTIATION,1
REACTOME_RECRUITMENT_OF_MITO...,SET,74,-0.023989,-0.0015191,0.090459,0.60457,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1
IGLESIAS_E2F_TARGETS_DN,SET,11,-0.072802,-0.0017806,0.27445,0.6046,IGLESIAS_E2F_TARGETS_DN,1
UNTERMAN_IPF_VS_CTRL_CD8T_UP,SET,2,-0.17117,-0.0017856,0.64529,0.6046,UNTERMAN_IPF_VS_CTRL_CD8T_UP,1
REACTOME_VITAMIN_B1_THIAMIN_...,SET,5,-0.09613,-0.0015854,0.36238,0.6046,REACTOME_VITAMIN_B1_THIAMIN_METABOLISM,1
GOBP_THIAMINE_CONTAINING_COM...,SET,5,-0.09613,-0.0015854,0.36238,0.6046,GOBP_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_THIAMINE_DIPHOSPHATE_ME...,SET,5,-0.09613,-0.0015854,0.36238,0.6046,GOBP_THIAMINE_DIPHOSPHATE_METABOLIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_IN...5,SET,196,-0.015998,-0.0016433,0.060292,0.60462,GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,1
GSE22611_UNSTIM_VS_2H_MDP_ST...2,SET,177,-0.016626,-0.0016237,0.06265,0.60464,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,1
MIR654_5P,SET,95,-0.023558,-0.0016894,0.088715,0.60471,MIR654_5P,1
MIR183_3P,SET,186,-0.016797,-0.0016812,0.063244,0.60472,MIR183_3P,1
ELVIDGE_HIF1A_AND_HIF2A_TARG...2,SET,37,-0.035702,-0.0016003,0.1344,0.60474,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,1
GOBP_DNA_REPAIR_DEPENDENT_CH...,SET,18,-0.04855,-0.0015187,0.18277,0.60474,GOBP_DNA_REPAIR_DEPENDENT_CHROMATIN_REMODELING,1
TERAO_AOX4_TARGETS_HG_UP,SET,27,-0.042376,-0.0016231,0.1595,0.60475,TERAO_AOX4_TARGETS_HG_UP,1
HP_UNUSUAL_FUNGAL_INFECTION,SET,103,-0.023329,-0.0017416,0.087795,0.60477,HP_UNUSUAL_FUNGAL_INFECTION,1
GSE17721_POLYIC_VS_PAM3CSK4_...5,SET,172,-0.016568,-0.0015953,0.062349,0.60477,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN,1
GNF2_AF1Q,SET,25,-0.048724,-0.0017958,0.18333,0.60479,GNF2_AF1Q,1
GSE24726_WT_VS_E2_2_KO_PDC_UP,SET,177,-0.016977,-0.0016581,0.063877,0.60479,GSE24726_WT_VS_E2_2_KO_PDC_UP,1
GOBP_POSITIVE_REGULATION_OF_...151,SET,5,-0.10554,-0.0017406,0.39676,0.60488,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
HP_RECURRENT_SINOPULMONARY_I...,SET,58,-0.029179,-0.0016366,0.10969,0.60488,HP_RECURRENT_SINOPULMONARY_INFECTIONS,1
RYTGCNWTGGNR_UNKNOWN,SET,100,-0.022894,-0.0016842,0.086047,0.6049,RYTGCNWTGGNR_UNKNOWN,1
WP_SMALL_CELL_LUNG_CANCER,SET,93,-0.023315,-0.0016543,0.087603,0.60493,WP_SMALL_CELL_LUNG_CANCER,1
FULLER_PBMC_F_TULARENSIS_VAC...2,SET,7,-0.085042,-0.0016594,0.31949,0.60495,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_336HR_SUSTAINED_UP,1
GOBP_REGULATION_OF_MYELOID_L...1,SET,116,-0.023001,-0.0018216,0.086304,0.60507,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,1
AMIT_EGF_RESPONSE_120_MCF10A,SET,38,-0.039873,-0.0018112,0.1496,0.60508,AMIT_EGF_RESPONSE_120_MCF10A,1
REACTOME_SIGNALING_BY_NOTCH1...2,SET,52,-0.030199,-0.0016041,0.11329,0.6051,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,1
MIR495_5P,SET,62,-0.029126,-0.0016888,0.10926,0.6051,MIR495_5P,1
DORN_ADENOVIRUS_INFECTION_48...2,SET,12,-0.069008,-0.0017628,0.25879,0.60513,DORN_ADENOVIRUS_INFECTION_48HR_UP,1
TRAVAGLINI_LUNG_BASOPHIL_MAS...2,SET,425,-0.011542,-0.0017347,0.043276,0.60515,TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL,1
GOBP_ATRIAL_SEPTUM_MORPHOGEN...,SET,13,-0.071522,-0.0019016,0.26809,0.60518,GOBP_ATRIAL_SEPTUM_MORPHOGENESIS,1
WANG_BARRETTS_ESOPHAGUS_AND_...2,SET,24,-0.050662,-0.0018296,0.18985,0.60521,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,1
GOBP_REGULATION_OF_SYNAPTIC_...13,SET,22,-0.047291,-0.0016352,0.1772,0.60522,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,1
HP_ATROPHY_DEGENERATION_AFFE...3,SET,593,-0.0092456,-0.0016338,0.034613,0.60531,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CEREBRUM,1
REACTOME_CHROMOSOME_MAINTENA...,SET,83,-0.023442,-0.0015718,0.087753,0.60532,REACTOME_CHROMOSOME_MAINTENANCE,1
GOBP_VESICLE_MEDIATED_CHOLES...,SET,9,-0.073288,-0.0016214,0.27389,0.60549,GOBP_VESICLE_MEDIATED_CHOLESTEROL_TRANSPORT,1
GOBP_TERMINATION_OF_RNA_POLY...,SET,10,-0.077506,-0.0018075,0.28957,0.60552,GOBP_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION,1
HP_HYPOPIGMENTATION_OF_THE_F...,SET,22,-0.048463,-0.0016758,0.18093,0.60559,HP_HYPOPIGMENTATION_OF_THE_FUNDUS,1
GSE1925_CTRL_VS_IFNG_PRIMED_...4,SET,156,-0.017305,-0.0015875,0.064608,0.60559,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP,1
GOBP_L_ARGININE_IMPORT_ACROS...,SET,4,-0.14085,-0.0020778,0.52578,0.60561,GOBP_L_ARGININE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
MIR4778_5P,SET,161,-0.017898,-0.0016678,0.066725,0.60574,MIR4778_5P,1
WINTER_HYPOXIA_UP,SET,87,-0.023274,-0.0015976,0.086621,0.60591,WINTER_HYPOXIA_UP,1
MIR608,SET,196,-0.01704,-0.0017504,0.063418,0.60592,MIR608,1
MORF_MSH3,SET,225,-0.014884,-0.0016367,0.055391,0.60592,MORF_MSH3,1
MEISSNER_BRAIN_HCP_WITH_H3K4...3,SET,1022,-0.0081242,-0.0018618,0.03023,0.60593,MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3,1
GOBP_POSITIVE_REGULATION_OF_...703,SET,8,-0.096385,-0.0020105,0.35853,0.60597,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,1
TRAVAGLINI_LUNG_PROLIFERATIN...1,SET,800,-0.0080602,-0.0016447,0.029944,0.6061,TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL,1
GOBP_REGULATION_OF_BLOOD_VOL...,SET,5,-0.12339,-0.0020349,0.45836,0.60611,GOBP_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN,1
CACTTTG_MIR520G_MIR520H,SET,215,-0.016407,-0.0017642,0.060943,0.60612,CACTTTG_MIR520G_MIR520H,1
GOBP_NEGATIVE_REGULATION_OF_...563,SET,79,-0.025597,-0.0016746,0.09507,0.60613,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
MODULE_399,SET,49,-0.034101,-0.0017585,0.12662,0.60616,MODULE_399,1
CAIRO_HEPATOBLASTOMA_POOR_SU...,SET,13,-0.059101,-0.0015713,0.21935,0.6062,CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL,1
GOBP_POSITIVE_REGULATION_OF_...250,SET,5,-0.11861,-0.0019561,0.43985,0.60629,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
EPPERT_CE_HSC_LSC,SET,36,-0.042151,-0.0018638,0.15628,0.60631,EPPERT_CE_HSC_LSC,1
REACTOME_SUMOYLATION_OF_DNA_...2,SET,14,-0.064051,-0.0017672,0.23741,0.60634,REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS,1
GOBP_POSITIVE_REGULATION_OF_...322,SET,4,-0.13588,-0.0020044,0.50304,0.60646,GOBP_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,1
GSE37301_MULTIPOTENT_PROGENI...10,SET,178,-0.017663,-0.0017299,0.06536,0.60651,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP,1
GOBP_VITAMIN_CATABOLIC_PROCE...,SET,15,-0.061314,-0.001751,0.22685,0.60653,GOBP_VITAMIN_CATABOLIC_PROCESS,1
MIR544A,SET,202,-0.0164,-0.0017099,0.060661,0.60655,MIR544A,1
MAHADEVAN_IMATINIB_RESISTANC...2,SET,17,-0.066491,-0.0020213,0.24594,0.60656,MAHADEVAN_IMATINIB_RESISTANCE_UP,1
HP_ABNORMAL_SELLA_TURCICA_MO...,SET,37,-0.035001,-0.0015689,0.12944,0.60657,HP_ABNORMAL_SELLA_TURCICA_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_DNA_D...,SET,6,-0.098738,-0.0017838,0.36507,0.6066,KEGG_MEDICUS_REFERENCE_DNA_DEGRADATION_BY_EXTRACELLULAR_ENDOLYSOSOMAL_DNASE,1
GSE40277_EOS_AND_LEF1_TRANSD...2,SET,177,-0.017453,-0.0017046,0.06451,0.60663,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,1
HP_ABNORMAL_CIRCULATING_AMYL...,SET,6,-0.08652,-0.001563,0.31976,0.60664,HP_ABNORMAL_CIRCULATING_AMYLASE_CONCENTRATION,1
GOBP_ACTIVATED_T_CELL_PROLIF...,SET,42,-0.038976,-0.0018611,0.14403,0.60665,GOBP_ACTIVATED_T_CELL_PROLIFERATION,1
GOBP_RESPONSE_TO_VITAMIN_D,SET,35,-0.04309,-0.0018787,0.15919,0.60668,GOBP_RESPONSE_TO_VITAMIN_D,1
KEGG_MEDICUS_REFERENCE_MYOST...,SET,8,-0.082262,-0.0017159,0.30381,0.60671,KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY,1
MIR3923,SET,45,-0.034565,-0.0017083,0.12755,0.6068,MIR3923,1
HP_RETINAL_FLECKS,SET,8,-0.089156,-0.0018597,0.32899,0.6068,HP_RETINAL_FLECKS,1
GSE20366_EX_VIVO_VS_DEC205_C...1,SET,182,-0.017296,-0.0017127,0.063816,0.60681,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN,1
GSE3720_UNSTIM_VS_LPS_STIM_V...2,SET,176,-0.017334,-0.0016882,0.06396,0.60681,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP,1
MIR4512,SET,17,-0.056924,-0.0017305,0.21001,0.60683,MIR4512,1
GSE46606_IRF4_KO_VS_WT_CD40L...1,SET,168,-0.017539,-0.0016693,0.064685,0.60686,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN,1
JONES_OVARY_ENDOTHELIAL,SET,145,-0.021272,-0.001882,0.078377,0.60696,JONES_OVARY_ENDOTHELIAL,1
MIR499B_5P,SET,86,-0.025384,-0.0017324,0.093509,0.60698,MIR499B_5P,1
ATTCTTT_MIR186,SET,241,-0.015523,-0.0017659,0.057186,0.60698,ATTCTTT_MIR186,1
MIR1324,SET,107,-0.022986,-0.0017488,0.084658,0.607,MIR1324,1
HP_LENTICONUS,SET,8,-0.075295,-0.0015706,0.27729,0.60701,HP_LENTICONUS,1
GTCGATC_MIR3695P,SET,4,-0.10821,-0.0015963,0.39834,0.60706,GTCGATC_MIR3695P,1
MIR3127_5P,SET,49,-0.033655,-0.0017355,0.12388,0.60707,MIR3127_5P,1
HP_GUSTATORY_LACRIMATION,SET,4,-0.1343,-0.0019811,0.4943,0.60707,HP_GUSTATORY_LACRIMATION,1
RAMPON_ENRICHED_LEARNING_ENV...2,SET,14,-0.058468,-0.0016131,0.21509,0.60712,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,1
GOBP_DOUBLE_STRAND_BREAK_REP...7,SET,6,-0.091225,-0.001648,0.33559,0.60712,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SINGLE_STRAND_ANNEALING,1
GOBP_MESENCHYMAL_TO_EPITHELI...1,SET,18,-0.064871,-0.0020292,0.23864,0.60712,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION,1
HP_HEINZ_BODIES,SET,2,-0.16509,-0.0017221,0.6072,0.60714,HP_HEINZ_BODIES,1
HP_SHOULDER_DISLOCATION,SET,16,-0.056271,-0.0016596,0.20684,0.60721,HP_SHOULDER_DISLOCATION,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...7,SET,15,-0.059496,-0.0016991,0.21854,0.60728,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,1
KEGG_MEDICUS_PATHOGEN_ESCHER...2,SET,17,-0.052112,-0.0015842,0.19134,0.60732,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY,1
REACTOME_PROSTANOID_LIGAND_R...,SET,9,-0.089353,-0.0019769,0.32801,0.60734,REACTOME_PROSTANOID_LIGAND_RECEPTORS,1
HP_INFRA_ORBITAL_CREASE,SET,7,-0.090828,-0.0017723,0.33336,0.60736,HP_INFRA_ORBITAL_CREASE,1
HP_CHORIORETINAL_DEGENERATION,SET,48,-0.035192,-0.0017961,0.12915,0.60737,HP_CHORIORETINAL_DEGENERATION,1
HP_ABNORMAL_SYSTEMIC_BLOOD_P...,SET,487,-0.011032,-0.0017719,0.040447,0.60748,HP_ABNORMAL_SYSTEMIC_BLOOD_PRESSURE,1
HP_ABNORMAL_ATRIAL_ARRANGEME...,SET,41,-0.03499,-0.0016508,0.12824,0.60752,HP_ABNORMAL_ATRIAL_ARRANGEMENT,1
GOCC_RECEPTOR_COMPLEX,SET,382,-0.012874,-0.0018368,0.047168,0.60755,GOCC_RECEPTOR_COMPLEX,1
GOBP_ACETYLCHOLINE_SECRETION,SET,5,-0.10277,-0.0016949,0.37642,0.60758,GOBP_ACETYLCHOLINE_SECRETION,1
GOBP_REGULATION_OF_CENTROMER...1,SET,4,-0.10394,-0.0015333,0.38072,0.60758,GOBP_REGULATION_OF_CENTROMERE_COMPLEX_ASSEMBLY,1
REACTOME_BETA_OXIDATION_OF_H...,SET,5,-0.10666,-0.001759,0.39053,0.60761,REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA,1
GOBP_PROTEIN_DNA_COMPLEX_DIS...,SET,21,-0.054316,-0.001835,0.19868,0.60772,GOBP_PROTEIN_DNA_COMPLEX_DISASSEMBLY,1
LIU_VAV3_PROSTATE_CARCINOGEN...2,SET,82,-0.027343,-0.0018224,0.09998,0.60776,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,1
REACTOME_NEPHRON_DEVELOPMENT,SET,12,-0.076266,-0.0019482,0.27885,0.60776,REACTOME_NEPHRON_DEVELOPMENT,1
GOCC_ATG1_ULK1_KINASE_COMPLEX,SET,9,-0.084415,-0.0018676,0.30866,0.60776,GOCC_ATG1_ULK1_KINASE_COMPLEX,1
AP1_Q6_01,SET,239,-0.015524,-0.0017588,0.056758,0.60777,AP1_Q6_01,1
REACTOME_GLYCOGEN_METABOLISM,SET,21,-0.046492,-0.0015707,0.16979,0.60789,REACTOME_GLYCOGEN_METABOLISM,1
GOBP_LOBAR_BRONCHUS_DEVELOPM...,SET,6,-0.10978,-0.0019833,0.40082,0.60792,GOBP_LOBAR_BRONCHUS_DEVELOPMENT,1
MIR421,SET,160,-0.018722,-0.0017393,0.068344,0.60793,MIR421,1
REACTOME_ACTIVATION_OF_RAC1_...,SET,7,-0.084432,-0.0016475,0.30819,0.60794,REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS,1
GOBP_O_GLYCAN_PROCESSING,SET,41,-0.039848,-0.00188,0.14543,0.60795,GOBP_O_GLYCAN_PROCESSING,1
GSE339_EX_VIVO_VS_IN_CULTURE...1,SET,180,-0.01745,-0.0017185,0.063691,0.60795,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN,1
GOBP_PARATHYROID_GLAND_DEVEL...,SET,7,-0.085588,-0.0016701,0.31222,0.60801,GOBP_PARATHYROID_GLAND_DEVELOPMENT,1
VILLANUEVA_LIVER_CANCER_KRT1...2,SET,152,-0.018346,-0.0016616,0.066903,0.60804,VILLANUEVA_LIVER_CANCER_KRT19_UP,1
MANNO_MIDBRAIN_NEUROTYPES_HR...2,SET,513,-0.011216,-0.0018476,0.040855,0.60816,MANNO_MIDBRAIN_NEUROTYPES_HRGL2A,1
GSE43955_1H_VS_42H_ACT_CD4_T...2,SET,180,-0.017007,-0.0016749,0.061943,0.60817,GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP,1
GAUSSMANN_MLL_AF4_FUSION_TAR...14,SET,219,-0.016474,-0.0017876,0.059961,0.60824,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1
ACEVEDO_NORMAL_TISSUE_ADJACE...1,SET,321,-0.012982,-0.0017007,0.047235,0.60828,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,1
HP_SYMPHALANGISM_AFFECTING_T...,SET,16,-0.057567,-0.0016978,0.20942,0.6083,HP_SYMPHALANGISM_AFFECTING_THE_PHALANGES_OF_THE_HAND,1
GSE25087_TREG_VS_TCONV_FETUS...2,SET,175,-0.017896,-0.001738,0.065092,0.60831,GSE25087_TREG_VS_TCONV_FETUS_UP,1
PID_REG_GR_PATHWAY,SET,80,-0.026729,-0.0017597,0.097152,0.60839,PID_REG_GR_PATHWAY,1
GOMF_RNA_POLYMERASE_II_INTRO...,SET,8,-0.088387,-0.0018437,0.32126,0.60839,GOMF_RNA_POLYMERASE_II_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...17,SET,13,-0.068022,-0.0018085,0.24701,0.60849,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,1
HP_CUTANEOUS_FINGER_SYNDACTY...,SET,30,-0.04461,-0.0018009,0.16198,0.6085,HP_CUTANEOUS_FINGER_SYNDACTYLY,1
GOMF_ORGANIC_HYDROXY_COMPOUN...,SET,52,-0.035914,-0.0019077,0.13031,0.60857,GOMF_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR5195_5P,SET,18,-0.059289,-0.0018546,0.21509,0.60859,MIR5195_5P,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,SET,82,-0.027209,-0.0018134,0.098695,0.6086,HOEBEKE_LYMPHOID_STEM_CELL_DN,1
GOBP_REGULATION_OF_SYSTEMIC_...6,SET,20,-0.058549,-0.0019304,0.21238,0.6086,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN,1
GOCC_PROTON_TRANSPORTING_TWO...2,SET,13,-0.069263,-0.0018415,0.2511,0.60866,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN,1
GOMF_LIPASE_BINDING,SET,6,-0.10522,-0.0019009,0.38144,0.60867,GOMF_LIPASE_BINDING,1
NAKAYA_PBMC_FLUAD_MALE_AGE_1...1,SET,36,-0.041048,-0.001815,0.14879,0.60868,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP,1
BLANCO_MELO_MERS_COV_INFECTI...1,SET,31,-0.045603,-0.0018714,0.16529,0.60869,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_DN,1
GOBP_FEMALE_GAMETE_GENERATION,SET,145,-0.019812,-0.0017528,0.071763,0.60875,GOBP_FEMALE_GAMETE_GENERATION,1
GOBP_MEIOTIC_SPINDLE_ASSEMBLY,SET,10,-0.079023,-0.0018428,0.28614,0.60879,GOBP_MEIOTIC_SPINDLE_ASSEMBLY,1
HP_VAGINAL_FISTULA,SET,25,-0.046742,-0.0017228,0.16922,0.60881,HP_VAGINAL_FISTULA,1
NEWMAN_ERCC6_TARGETS_UP,SET,23,-0.060772,-0.0021486,0.21973,0.60894,NEWMAN_ERCC6_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_IGG_F...,SET,9,-0.085805,-0.0018984,0.30998,0.60904,KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY,1
MIR3145_5P,SET,93,-0.023761,-0.001686,0.085793,0.60909,MIR3145_5P,1
GOBP_PARASYMPATHETIC_NERVOUS...,SET,17,-0.062972,-0.0019143,0.22726,0.60914,GOBP_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,1
GSE557_WT_VS_CIITA_KO_DC_UP,SET,182,-0.01629,-0.0016131,0.05878,0.60916,GSE557_WT_VS_CIITA_KO_DC_UP,1
HP_SIMPLE_EAR,SET,19,-0.055206,-0.0017741,0.19912,0.6092,HP_SIMPLE_EAR,1
GSE17721_CTRL_VS_CPG_2H_BMDC...2,SET,176,-0.017584,-0.0017125,0.063412,0.60922,GSE17721_CTRL_VS_CPG_2H_BMDC_UP,1
GOMF_GLUTAMATE_RECEPTOR_BIND...,SET,42,-0.036801,-0.0017573,0.13265,0.60927,GOMF_GLUTAMATE_RECEPTOR_BINDING,1
GOBP_MICROTUBULE_ORGANIZING_...1,SET,30,-0.041111,-0.0016596,0.14814,0.6093,GOBP_MICROTUBULE_ORGANIZING_CENTER_LOCALIZATION,1
HP_HYPEROXALURIA,SET,6,-0.092639,-0.0016736,0.33377,0.60932,HP_HYPEROXALURIA,1
WP_KIT_RECEPTOR_SIGNALING,SET,56,-0.035022,-0.0019303,0.12613,0.60936,WP_KIT_RECEPTOR_SIGNALING,1
REACTOME_MITOCHONDRIAL_BIOGE...,SET,68,-0.02866,-0.0017401,0.10321,0.60937,REACTOME_MITOCHONDRIAL_BIOGENESIS,1
WANG_TNF_TARGETS,SET,24,-0.051545,-0.0018615,0.18559,0.60939,WANG_TNF_TARGETS,1
GSE17580_UNINFECTED_VS_S_MAN...1,SET,175,-0.017935,-0.0017417,0.064571,0.6094,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN,1
MIR1299,SET,300,-0.014068,-0.0017826,0.050605,0.60949,MIR1299,1
HP_HYPOPLASIA_OF_THE_MUSCULA...,SET,20,-0.058072,-0.0019147,0.20889,0.60949,HP_HYPOPLASIA_OF_THE_MUSCULATURE,1
GOBP_SYNAPTIC_VESICLE_MATURA...,SET,21,-0.051884,-0.0017528,0.18662,0.6095,GOBP_SYNAPTIC_VESICLE_MATURATION,1
DESCARTES_FETAL_EYE_STROMAL_...,SET,81,-0.029439,-0.0019501,0.10589,0.6095,DESCARTES_FETAL_EYE_STROMAL_CELLS,1
GSE17721_0.5H_VS_4H_CPG_BMDC...2,SET,185,-0.016785,-0.0016756,0.060345,0.60955,GSE17721_0.5H_VS_4H_CPG_BMDC_UP,1
KEGG_MEDICUS_REFERENCE_ITGA_...1,SET,25,-0.050726,-0.0018696,0.18232,0.60958,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY,1
GSE2405_HEAT_KILLED_LYSATE_V...3,SET,182,-0.016676,-0.0016513,0.059885,0.60967,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,1
MODULE_421,SET,15,-0.061837,-0.0017659,0.22205,0.60968,MODULE_421,1
HP_HYPOPHOSPHATEMIA,SET,41,-0.039697,-0.0018729,0.14255,0.60968,HP_HYPOPHOSPHATEMIA,1
HP_HYPOTELORISM,SET,114,-0.021103,-0.0016569,0.075778,0.60968,HP_HYPOTELORISM,1
HP_DYSKINESIA,SET,172,-0.01774,-0.0017081,0.063643,0.60977,HP_DYSKINESIA,1
PALOMERO_GSI_SENSITIVITY_DN,SET,3,-0.14659,-0.0018727,0.52582,0.60979,PALOMERO_GSI_SENSITIVITY_DN,1
GOCC_TETRASPANIN_ENRICHED_MI...,SET,10,-0.079203,-0.001847,0.28394,0.60985,GOCC_TETRASPANIN_ENRICHED_MICRODOMAIN,1
GSE18281_CORTICAL_THYMOCYTE_...1,SET,177,-0.016892,-0.0016497,0.060561,0.60985,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN,1
BIOCARTA_ALTERNATIVE_PATHWAY,SET,8,-0.087083,-0.0018165,0.31213,0.60987,BIOCARTA_ALTERNATIVE_PATHWAY,1
GOBP_SUCKLING_BEHAVIOR,SET,11,-0.072909,-0.0017832,0.26126,0.6099,GOBP_SUCKLING_BEHAVIOR,1
HP_CLOVERLEAF_SKULL,SET,8,-0.076429,-0.0015943,0.27382,0.60992,HP_CLOVERLEAF_SKULL,1
GSE4142_NAIVE_VS_GC_BCELL_DN,SET,179,-0.01693,-0.0016627,0.060654,0.60992,GSE4142_NAIVE_VS_GC_BCELL_DN,1
GSE7568_IL4_VS_IL4_AND_TGFB_...1,SET,176,-0.017211,-0.0016762,0.061638,0.60997,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN,1
GOCC_PHOTORECEPTOR_RIBBON_SY...,SET,9,-0.088581,-0.0019598,0.31715,0.60999,GOCC_PHOTORECEPTOR_RIBBON_SYNAPSE,1
DESCARTES_MAIN_FETAL_SLC24A4...,SET,16,-0.069215,-0.0020414,0.24782,0.60999,DESCARTES_MAIN_FETAL_SLC24A4_PEX5L_POSITIVE_CELLS,1
HP_INAPPROPRIATE_BEHAVIOR,SET,14,-0.061682,-0.0017018,0.22078,0.61002,HP_INAPPROPRIATE_BEHAVIOR,1
GSE3720_VD1_VS_VD2_GAMMADELT...2,SET,171,-0.018127,-0.0017404,0.064852,0.61007,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP,1
MIR3617_3P,SET,79,-0.027217,-0.0017806,0.097366,0.61008,MIR3617_3P,1
YTTCCNNNGGAMR_UNKNOWN,SET,46,-0.036897,-0.0018436,0.13199,0.61008,YTTCCNNNGGAMR_UNKNOWN,1
HP_ABNORMAL_FOVEAL_MORPHOLOG...,SET,6,-0.1018,-0.0018391,0.36414,0.61009,HP_ABNORMAL_FOVEAL_MORPHOLOGY_ON_MACULAR_OCT,1
GOCC_SNARE_COMPLEX,SET,48,-0.032676,-0.0016678,0.11687,0.6101,GOCC_SNARE_COMPLEX,1
HP_UNEXPLAINED_FEVERS,SET,18,-0.056708,-0.0017739,0.20264,0.6102,HP_UNEXPLAINED_FEVERS,1
IK3_01,SET,201,-0.017677,-0.0018386,0.063157,0.61022,IK3_01,1
GOBP_CONSTITUTIVE_SECRETORY_...,SET,7,-0.092136,-0.0017978,0.32918,0.61022,GOBP_CONSTITUTIVE_SECRETORY_PATHWAY,1
KEGG_MEDICUS_REFERENCE_TYPE_...1,SET,18,-0.072828,-0.0022781,0.26015,0.61024,KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,1
HP_VASCULAR_TORTUOSITY,SET,21,-0.052471,-0.0017727,0.18725,0.61034,HP_VASCULAR_TORTUOSITY,1
MORF_TPT1,SET,90,-0.024528,-0.0017123,0.087521,0.61036,MORF_TPT1,1
HP_INCREASED_PULMONARY_VASCU...,SET,13,-0.075502,-0.0020074,0.26937,0.61037,HP_INCREASED_PULMONARY_VASCULAR_RESISTANCE,1
GOBP_POSITIVE_REGULATION_OF_...746,SET,6,-0.10547,-0.0019053,0.37621,0.61039,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,1
BIOCARTA_RAS_PATHWAY,SET,20,-0.055105,-0.0018168,0.19654,0.6104,BIOCARTA_RAS_PATHWAY,1
REACTOME_ARACHIDONIC_ACID_ME...,SET,56,-0.034002,-0.0018741,0.12117,0.6105,REACTOME_ARACHIDONIC_ACID_METABOLISM,1
REACTOME_SIGNALING_BY_EGFR,SET,51,-0.033167,-0.0017448,0.11816,0.61052,REACTOME_SIGNALING_BY_EGFR,1
GSE14413_UNSTIM_VS_IFNB_STIM...6,SET,123,-0.021932,-0.0017882,0.078136,0.61052,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP,1
GSE24634_TEFF_VS_TCONV_DAY5_...2,SET,188,-0.016819,-0.0016923,0.059893,0.61057,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP,1
BOCHKIS_FOXA2_TARGETS,SET,393,-0.012241,-0.0017708,0.043589,0.61058,BOCHKIS_FOXA2_TARGETS,1
MIR4703_3P,SET,37,-0.04044,-0.0018127,0.14393,0.61064,MIR4703_3P,1
GOBP_KINETOCHORE_ORGANIZATION,SET,20,-0.054066,-0.0017826,0.19241,0.61064,GOBP_KINETOCHORE_ORGANIZATION,1
TERAMOTO_OPN_TARGETS_CLUSTER...4,SET,6,-0.085869,-0.0015513,0.30557,0.61065,TERAMOTO_OPN_TARGETS_CLUSTER_5,1
HP_DIFFUSE_PALMOPLANTAR_HYPE...,SET,10,-0.088783,-0.0020704,0.31587,0.61067,HP_DIFFUSE_PALMOPLANTAR_HYPERKERATOSIS,1
HP_REDUCED_FORCED_VITAL_CAPA...,SET,34,-0.039128,-0.0016814,0.13914,0.61072,HP_REDUCED_FORCED_VITAL_CAPACITY,1
GOBP_SYNCYTIUM_FORMATION,SET,60,-0.032339,-0.0018448,0.11498,0.61074,GOBP_SYNCYTIUM_FORMATION,1
REACTOME_FOLDING_OF_ACTIN_BY...,SET,10,-0.064344,-0.0015005,0.22865,0.6108,REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,1
GOBP_MONOCYTE_AGGREGATION,SET,5,-0.13245,-0.0021845,0.47067,0.6108,GOBP_MONOCYTE_AGGREGATION,1
REACTOME_REGULATION_OF_CDH11...3,SET,9,-0.084778,-0.0018756,0.30121,0.61082,REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS,1
REICHERT_G1S_REGULATORS_AS_P...,SET,8,-0.073811,-0.0015397,0.26207,0.61089,REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS,1
ANDERSEN_LIVER_CANCER_KRT19_...2,SET,33,-0.041626,-0.0017623,0.14774,0.61093,ANDERSEN_LIVER_CANCER_KRT19_UP,1
REACTOME_ABC_TRANSPORTERS_IN...,SET,17,-0.06128,-0.0018629,0.21746,0.61095,REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS,1
ZHONG_PFC_C7_ORG_UNDERGOING_...,SET,61,-0.033337,-0.0019174,0.11829,0.61096,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,1
HP_ELEVATED_URINARY_VANILLYL...,SET,9,-0.098739,-0.0021845,0.35026,0.61099,HP_ELEVATED_URINARY_VANILLYLMANDELIC_ACID,1
HP_VASCULAR_SKIN_ABNORMALITY,SET,514,-0.010794,-0.0017797,0.038284,0.611,HP_VASCULAR_SKIN_ABNORMALITY,1
CAIRO_LIVER_DEVELOPMENT_UP,SET,145,-0.020556,-0.0018186,0.072897,0.61102,CAIRO_LIVER_DEVELOPMENT_UP,1
GOBP_REGULATION_OF_MICROTUBU...5,SET,25,-0.044262,-0.0016314,0.15697,0.61102,GOBP_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...482,SET,16,-0.06361,-0.0018761,0.22524,0.61118,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
HP_ABNORMAL_EATING_BEHAVIOR,SET,114,-0.024021,-0.001886,0.085018,0.61124,HP_ABNORMAL_EATING_BEHAVIOR,1
HP_PHEOCHROMOCYTOMA,SET,28,-0.04207,-0.0016409,0.14883,0.61128,HP_PHEOCHROMOCYTOMA,1
MODULE_137,SET,495,-0.011665,-0.0018884,0.041264,0.61129,MODULE_137,1
HP_INFLAMMATION_OF_THE_LARGE...,SET,104,-0.024667,-0.0018503,0.087248,0.6113,HP_INFLAMMATION_OF_THE_LARGE_INTESTINE,1
GNF2_KPNB1,SET,65,-0.028383,-0.001685,0.10036,0.61134,GNF2_KPNB1,1
WILCOX_RESPONSE_TO_PROGESTER...2,SET,136,-0.021202,-0.0018171,0.074947,0.61137,WILCOX_RESPONSE_TO_PROGESTERONE_UP,1
GOBP_GENERATION_OF_NEURONS,SET,1372,-0.0070677,-0.0018576,0.024983,0.61137,GOBP_GENERATION_OF_NEURONS,1
DELYS_THYROID_CANCER_UP,SET,415,-0.012589,-0.0018703,0.044487,0.61141,DELYS_THYROID_CANCER_UP,1
GOBP_POST_ANAL_TAIL_MORPHOGE...,SET,18,-0.057565,-0.0018007,0.20339,0.61142,GOBP_POST_ANAL_TAIL_MORPHOGENESIS,1
TGTYNNNNNRGCARM_UNKNOWN,SET,79,-0.027991,-0.0018312,0.098887,0.61143,TGTYNNNNNRGCARM_UNKNOWN,1
MIR4724_3P,SET,78,-0.025983,-0.0016891,0.091725,0.61151,MIR4724_3P,1
GOBP_EMBRYONIC_VISCEROCRANIU...,SET,9,-0.085702,-0.0018961,0.3025,0.61153,GOBP_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS,1
GOBP_REGULATION_OF_SARCOMERE...,SET,8,-0.086143,-0.0017969,0.30405,0.61153,GOBP_REGULATION_OF_SARCOMERE_ORGANIZATION,1
BLANCO_MELO_BETA_INTERFERON_...2,SET,338,-0.0143,-0.0019214,0.050471,0.61154,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,1
LOPEZ_MBD_TARGETS,SET,862,-0.0080895,-0.0017104,0.028549,0.61154,LOPEZ_MBD_TARGETS,1
NKX2_2_TARGET_GENES,SET,1061,-0.0074628,-0.0017406,0.026333,0.61156,NKX2_2_TARGET_GENES,1
MCM3_TARGET_GENES,SET,184,-0.017986,-0.0017906,0.063451,0.61159,MCM3_TARGET_GENES,1
GOBP_PHOSPHATIDYLCHOLINE_CAT...,SET,16,-0.063427,-0.0018707,0.22374,0.61159,GOBP_PHOSPHATIDYLCHOLINE_CATABOLIC_PROCESS,1
REACTOME_RAB_GERANYLGERANYLA...,SET,57,-0.031932,-0.0017756,0.11262,0.61161,REACTOME_RAB_GERANYLGERANYLATION,1
GSE22601_DOUBLE_NEGATIVE_VS_...4,SET,163,-0.020049,-0.0018797,0.070603,0.61178,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
GSE36009_WT_VS_NLRP10_KO_DC_...4,SET,184,-0.017762,-0.0017683,0.062533,0.61181,GSE36009_WT_VS_NLRP10_KO_DC_UP,1
KEGG_MEDICUS_PATHOGEN_SARS_C...2,SET,12,-0.0801,-0.0020461,0.28191,0.61184,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_NEUROINFL...,SET,33,-0.046946,-0.0019875,0.16522,0.61184,GOBP_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,1
GAVISH_3CA_METAPROGRAM_ENDOT...3,SET,47,-0.040456,-0.0020433,0.14233,0.61189,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1,1
GOBP_POSITIVE_REGULATION_OF_...783,SET,185,-0.018837,-0.0018804,0.066254,0.61192,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
GSE13738_RESTING_VS_TCR_ACTI...1,SET,178,-0.017912,-0.0017542,0.062995,0.61192,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN,1
MIR6864_3P,SET,39,-0.037261,-0.0017146,0.13102,0.61194,MIR6864_3P,1
GOBERT_OLIGODENDROCYTE_DIFFE...1,SET,979,-0.0080594,-0.0018099,0.028338,0.61195,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN,1
HP_HETEROTROPIA,SET,234,-0.015954,-0.0017887,0.056081,0.61198,HP_HETEROTROPIA,1
HP_MOTOR_STEREOTYPY,SET,224,-0.016085,-0.001765,0.056536,0.61199,HP_MOTOR_STEREOTYPY,1
HP_URETERAL_STENOSIS,SET,29,-0.043655,-0.0017328,0.15343,0.612,HP_URETERAL_STENOSIS,1
HP_ELEVATED_URINARY_CARBOXYL...,SET,94,-0.025792,-0.0018398,0.090573,0.61208,HP_ELEVATED_URINARY_CARBOXYLIC_ACID,1
GOBP_SPINDLE_ASSEMBLY_INVOLV...,SET,8,-0.089644,-0.0018699,0.3146,0.61215,GOBP_SPINDLE_ASSEMBLY_INVOLVED_IN_FEMALE_MEIOSIS,1
GOBP_MYELOID_LEUKOCYTE_MEDIA...,SET,107,-0.024199,-0.0018411,0.084915,0.61217,GOBP_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,1
GSE14413_UNSTIM_VS_IFNB_STIM...1,SET,104,-0.02471,-0.0018536,0.086707,0.61217,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN,1
BUSSLINGER_GASTRIC_OXYNTIC_E...,SET,74,-0.031193,-0.0019754,0.10942,0.6122,BUSSLINGER_GASTRIC_OXYNTIC_ENTEROCHROMAFFIN_LIKE_CELLS,1
GOBP_CELLULAR_RESPONSE_TO_ES...1,SET,36,-0.04302,-0.0019022,0.15081,0.61227,GOBP_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS,1
REACTOME_RND1_GTPASE_CYCLE,SET,41,-0.040569,-0.0019141,0.14215,0.61233,REACTOME_RND1_GTPASE_CYCLE,1
GOZGIT_ESR1_TARGETS_DN,SET,656,-0.010432,-0.0019354,0.036543,0.61236,GOZGIT_ESR1_TARGETS_DN,1
GOBP_REGULATION_OF_CHROMOSOM...1,SET,11,-0.068213,-0.0016683,0.23895,0.61236,GOBP_REGULATION_OF_CHROMOSOME_CONDENSATION,1
MIR4699_3P,SET,440,-0.012259,-0.0018741,0.042937,0.61238,MIR4699_3P,1
LIEN_BREAST_CARCINOMA_METAPL...2,SET,104,-0.023629,-0.0017725,0.082734,0.61241,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,1
GOBP_SENSORY_PERCEPTION,SET,813,-0.01038,-0.0021344,0.036339,0.61242,GOBP_SENSORY_PERCEPTION,1
VALK_AML_CLUSTER_16,SET,22,-0.053739,-0.0018582,0.18799,0.61251,VALK_AML_CLUSTER_16,1
HP_ABNORMAL_OPTICAL_COHERENC...,SET,18,-0.061969,-0.0019384,0.21665,0.61257,HP_ABNORMAL_OPTICAL_COHERENCE_TOMOGRAPHY,1
WP_FGFR3_SIGNALING_IN_CHONDR...,SET,27,-0.050103,-0.001919,0.17512,0.6126,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...67,SET,21,-0.055049,-0.0018598,0.19239,0.61261,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GRAESSMANN_RESPONSE_TO_MC_AN...4,SET,200,-0.017789,-0.0018457,0.062146,0.61266,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1
HP_VOCAL_CORD_PARALYSIS,SET,53,-0.033009,-0.0017701,0.11527,0.6127,HP_VOCAL_CORD_PARALYSIS,1
GOCC_IGG_IMMUNOGLOBULIN_COMP...,SET,2,-0.20707,-0.00216,0.72272,0.61276,GOCC_IGG_IMMUNOGLOBULIN_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...587,SET,5,-0.10806,-0.0017822,0.37696,0.61281,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,1
GOBP_MICTURITION,SET,8,-0.091807,-0.001915,0.32017,0.61284,GOBP_MICTURITION,1
KEGG_MEDICUS_REFERENCE_PP2A_...,SET,18,-0.054044,-0.0016905,0.18842,0.61287,KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY,1
GOCC_ATAC_COMPLEX,SET,12,-0.063444,-0.0016207,0.2212,0.61287,GOCC_ATAC_COMPLEX,1
GOBP_REGULATION_OF_DNA_METHY...,SET,14,-0.062241,-0.0017172,0.21699,0.61288,GOBP_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
GSE45365_HEALTHY_VS_MCMV_INF...2,SET,184,-0.017347,-0.001727,0.060458,0.61291,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP,1
HP_ABNORMAL_CLAVICLE_MORPHOL...,SET,94,-0.024676,-0.0017603,0.085991,0.61293,HP_ABNORMAL_CLAVICLE_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...667,SET,50,-0.036137,-0.0018823,0.12591,0.61294,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
GSE17721_0.5H_VS_12H_GARDIQU...1,SET,189,-0.017627,-0.0017783,0.061419,0.61294,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN,1
HP_SYRINGOMYELIA,SET,30,-0.043019,-0.0017367,0.14988,0.61295,HP_SYRINGOMYELIA,1
GOMF_DNA_BINDING_TRANSCRIPTI...3,SET,441,-0.011817,-0.0018085,0.041152,0.613,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,1
GOBP_TRANSCRIPTION_COUPLED_N...,SET,10,-0.073306,-0.0017095,0.25526,0.61301,GOBP_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR,1
HP_NON_CONVULSIVE_STATUS_EPI...,SET,18,-0.058315,-0.0018241,0.20288,0.61311,HP_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,1
HP_NECK_FLEXOR_WEAKNESS,SET,43,-0.0349,-0.0016861,0.12141,0.61312,HP_NECK_FLEXOR_WEAKNESS,1
MIR12113,SET,83,-0.027347,-0.0018336,0.095073,0.61319,MIR12113,1
GOCC_PICLN_SM_PROTEIN_COMPLEX,SET,6,-0.10393,-0.0018776,0.36126,0.61321,GOCC_PICLN_SM_PROTEIN_COMPLEX,1
NR2E3_TARGET_GENES,SET,8,-0.098868,-0.0020623,0.34362,0.61322,NR2E3_TARGET_GENES,1
POU3F2_02,SET,227,-0.016794,-0.0018549,0.058367,0.61322,POU3F2_02,1
GOBP_NEGATIVE_REGULATION_OF_...641,SET,11,-0.076758,-0.0018773,0.26673,0.61324,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING,1
KEGG_MEDICUS_VARIANT_MUTATIO...14,SET,5,-0.10127,-0.0016701,0.35185,0.61325,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_LRRK2_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
MIR6863,SET,8,-0.087251,-0.00182,0.30293,0.61334,MIR6863,1
REACTOME_RESPONSE_TO_METAL_I...,SET,14,-0.08264,-0.00228,0.28687,0.61335,REACTOME_RESPONSE_TO_METAL_IONS,1
GOBP_TAIL_ANCHORED_MEMBRANE_...,SET,12,-0.064553,-0.001649,0.22404,0.61337,GOBP_TAIL_ANCHORED_MEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
DESCARTES_FETAL_EYE_SKELETAL...,SET,132,-0.021967,-0.001855,0.076243,0.61337,DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS,1
GOBP_TENDON_DEVELOPMENT,SET,5,-0.13191,-0.0021755,0.45778,0.61338,GOBP_TENDON_DEVELOPMENT,1
GSE32423_CTRL_VS_IL7_MEMORY_...1,SET,174,-0.01924,-0.0018632,0.066772,0.61338,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN,1
MIR296_5P,SET,50,-0.032859,-0.0017116,0.114,0.61341,MIR296_5P,1
REACTOME_FORMATION_OF_TUBULI...,SET,24,-0.048563,-0.0017538,0.16848,0.61342,REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,1
MIR6737_3P,SET,173,-0.019402,-0.0018736,0.067283,0.61346,MIR6737_3P,1
GOBP_POSITIVE_REGULATION_OF_...514,SET,5,-0.11967,-0.0019736,0.41481,0.61352,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,1
GOMF_FERROUS_IRON_TRANSMEMBR...,SET,5,-0.098437,-0.0016234,0.34114,0.61354,GOMF_FERROUS_IRON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_ANTEROGRADE_AXONAL_TRAN...1,SET,48,-0.035575,-0.0018157,0.12327,0.61355,GOBP_ANTEROGRADE_AXONAL_TRANSPORT,1
HP_RECURRENT_OPPORTUNISTIC_I...,SET,9,-0.084449,-0.0018683,0.29257,0.61357,HP_RECURRENT_OPPORTUNISTIC_INFECTIONS,1
GOBP_TELENCEPHALON_REGIONALI...,SET,13,-0.086195,-0.0022917,0.2985,0.61362,GOBP_TELENCEPHALON_REGIONALIZATION,1
GOBP_SYNAPTIC_VESICLE_BUDDING,SET,12,-0.069073,-0.0017645,0.23905,0.61369,GOBP_SYNAPTIC_VESICLE_BUDDING,1
GOBP_INTERSTRAND_CROSS_LINK_...,SET,34,-0.037194,-0.0015983,0.1287,0.6137,GOBP_INTERSTRAND_CROSS_LINK_REPAIR,1
GSE37416_0H_VS_3H_F_TULARENS...2,SET,179,-0.018119,-0.0017795,0.062703,0.6137,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOMF_GABA_A_RECEPTOR_ACTIVITY,SET,16,-0.078266,-0.0023083,0.27065,0.61378,GOMF_GABA_A_RECEPTOR_ACTIVITY,1
CROMER_METASTASIS_DN,SET,74,-0.029325,-0.001857,0.10134,0.61385,CROMER_METASTASIS_DN,1
REACTOME_BH3_ONLY_PROTEINS_A...,SET,9,-0.096723,-0.0021399,0.33415,0.61388,REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS,1
GOBP_REGULATION_OF_CELL_MATR...,SET,115,-0.023605,-0.0018614,0.081535,0.6139,GOBP_REGULATION_OF_CELL_MATRIX_ADHESION,1
GSE23505_UNTREATED_VS_4DAY_I...6,SET,171,-0.017669,-0.0016964,0.060994,0.61397,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP,1
GOBP_LABYRINTHINE_LAYER_MORP...,SET,20,-0.06078,-0.0020039,0.20978,0.61399,GOBP_LABYRINTHINE_LAYER_MORPHOGENESIS,1
MODULE_485,SET,49,-0.033716,-0.0017386,0.11636,0.614,MODULE_485,1
WP_GANGLIO_SPHINGOLIPID_META...,SET,13,-0.075256,-0.0020008,0.25963,0.61404,WP_GANGLIO_SPHINGOLIPID_METABOLISM,1
GOBP_MAINTENANCE_OF_LOCATION...,SET,210,-0.017492,-0.0018591,0.060329,0.61407,GOBP_MAINTENANCE_OF_LOCATION_IN_CELL,1
HP_PHOTOPHOBIA,SET,246,-0.016225,-0.0018645,0.055948,0.61409,HP_PHOTOPHOBIA,1
MIR7157_3P,SET,174,-0.019475,-0.001886,0.067111,0.61416,MIR7157_3P,1
BLANCO_MELO_COVID19_BRONCHIA...2,SET,137,-0.023295,-0.0020038,0.080238,0.61421,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,1
MIR6726_5P,SET,45,-0.034739,-0.0017169,0.11949,0.61437,MIR6726_5P,1
ZHOU_INFLAMMATORY_RESPONSE_L...2,SET,389,-0.013434,-0.0019337,0.04618,0.61444,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1
KEGG_MEDICUS_REFERENCE_HGF_M...1,SET,10,-0.081886,-0.0019096,0.28145,0.61445,KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY,1
GOMF_O_METHYLTRANSFERASE_ACT...,SET,17,-0.053023,-0.0016119,0.18218,0.61449,GOMF_O_METHYLTRANSFERASE_ACTIVITY,1
GSE11386_NAIVE_VS_MEMORY_BCE...1,SET,144,-0.021079,-0.0018586,0.072406,0.61452,GSE11386_NAIVE_VS_MEMORY_BCELL_DN,1
GOBP_ANTEROGRADE_DENDRITIC_T...2,SET,5,-0.12794,-0.0021101,0.43937,0.61455,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT_OF_NEUROTRANSMITTER_RECEPTOR_COMPLEX,1
REACTOME_RAB_GEFS_EXCHANGE_G...,SET,82,-0.02709,-0.0018055,0.093,0.61458,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,1
SARRIO_EPITHELIAL_MESENCHYMA...1,SET,133,-0.022647,-0.0019196,0.077687,0.61467,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1
HP_ABSENT_EPIPHYSES,SET,20,-0.061498,-0.0020276,0.2109,0.6147,HP_ABSENT_EPIPHYSES,1
GSE15330_LYMPHOID_MULTIPOTEN...6,SET,164,-0.020457,-0.0019238,0.07011,0.61477,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,1
GOMF_SULFUR_AMINO_ACID_TRANS...,SET,11,-0.072739,-0.001779,0.2492,0.61481,GOMF_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
BIOCARTA_IL4_PATHWAY,SET,10,-0.082579,-0.0019258,0.2828,0.61486,BIOCARTA_IL4_PATHWAY,1
GSE27786_BCELL_VS_NKCELL_UP,SET,180,-0.017808,-0.0017537,0.060986,0.61486,GSE27786_BCELL_VS_NKCELL_UP,1
GINESTIER_BREAST_CANCER_ZNF2...1,SET,304,-0.013563,-0.00173,0.046435,0.61489,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,1
RAPA_EARLY_UP.V1_UP,SET,142,-0.022022,-0.0019283,0.075375,0.61492,RAPA_EARLY_UP.V1_UP,1
GOBP_VOLUNTARY_SKELETAL_MUSC...,SET,5,-0.097763,-0.0016123,0.33439,0.61499,GOBP_VOLUNTARY_SKELETAL_MUSCLE_CONTRACTION,1
MIR4800_5P,SET,23,-0.050381,-0.0017812,0.17226,0.61504,MIR4800_5P,1
KIM_WT1_TARGETS_8HR_DN,SET,113,-0.023041,-0.0018011,0.078751,0.61507,KIM_WT1_TARGETS_8HR_DN,1
MIR6514_3P,SET,67,-0.03078,-0.0018551,0.10521,0.61507,MIR6514_3P,1
HP_GENERALIZED_ONSET_SEIZURE,SET,277,-0.015338,-0.0018688,0.052388,0.61515,HP_GENERALIZED_ONSET_SEIZURE,1
HP_INCREASED_FECAL_PORPHYRIN,SET,4,-0.11421,-0.0016847,0.3901,0.61515,HP_INCREASED_FECAL_PORPHYRIN,1
GOMF_5ALPHA_ANDROSTANE_3BETA...,SET,6,-0.11713,-0.0021161,0.39997,0.61518,GOMF_5ALPHA_ANDROSTANE_3BETA_17BETA_DIOL_DEHYDROGENASE_ACTIVITY,1
HP_BROAD_DISTAL_PHALANX_OF_T...,SET,5,-0.12423,-0.0020489,0.4242,0.61519,HP_BROAD_DISTAL_PHALANX_OF_THE_TOES,1
GOBP_TYPE_II_PNEUMOCYTE_DIFF...,SET,6,-0.10187,-0.0018403,0.34777,0.6152,GOBP_TYPE_II_PNEUMOCYTE_DIFFERENTIATION,1
GOBP_ERBB2_ERBB4_SIGNALING_P...,SET,5,-0.1202,-0.0019823,0.4103,0.61522,GOBP_ERBB2_ERBB4_SIGNALING_PATHWAY,1
RANKIN_ANGIOGENIC_TARGETS_OF...2,SET,5,-0.13098,-0.0021602,0.44662,0.61534,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP,1
MIR361_3P,SET,81,-0.02828,-0.0018733,0.096434,0.61534,MIR361_3P,1
REACTOME_GLUTAMATE_AND_GLUTA...,SET,10,-0.076249,-0.0017781,0.25995,0.61536,REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...403,SET,103,-0.026385,-0.0019697,0.089943,0.61537,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,1
HP_CONFUSIONAL_AROUSAL,SET,9,-0.091669,-0.0020281,0.31234,0.61542,HP_CONFUSIONAL_AROUSAL,1
GSE14908_RESTING_VS_HDM_STIM...1,SET,185,-0.018027,-0.0017996,0.061424,0.61542,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN,1
CHEMNITZ_RESPONSE_TO_PROSTAG...1,SET,348,-0.01379,-0.0018796,0.046945,0.61552,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,1
HP_ABNORMAL_ANTERIOR_HORN_CE...,SET,18,-0.059938,-0.0018749,0.20405,0.61552,HP_ABNORMAL_ANTERIOR_HORN_CELL_MORPHOLOGY,1
GOBP_REGULATION_OF_TESTOSTER...,SET,6,-0.11484,-0.0020746,0.39087,0.61554,GOBP_REGULATION_OF_TESTOSTERONE_BIOSYNTHETIC_PROCESS,1
REACTOME_INTERLEUKIN_1_SIGNA...,SET,108,-0.022742,-0.0017383,0.077394,0.61556,REACTOME_INTERLEUKIN_1_SIGNALING,1
HP_PSEUDOHYPOALDOSTERONISM,SET,6,-0.11016,-0.0019901,0.37475,0.6156,HP_PSEUDOHYPOALDOSTERONISM,1
HERNANDEZ_MITOTIC_ARREST_BY_...1,SET,35,-0.046516,-0.002028,0.15822,0.61562,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,1
KUROZUMI_RESPONSE_TO_ONCOCYT...1,SET,41,-0.043427,-0.0020489,0.14765,0.61566,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1
GOBP_MITOCHONDRION_DISTRIBUT...,SET,18,-0.062506,-0.0019552,0.21253,0.61566,GOBP_MITOCHONDRION_DISTRIBUTION,1
KEGG_MEDICUS_REFERENCE_VALIN...,SET,8,-0.090413,-0.001886,0.30739,0.61567,KEGG_MEDICUS_REFERENCE_VALINE_DEGRADATION,1
REACTOME_INTRINSIC_PATHWAY_O...,SET,20,-0.05901,-0.0019456,0.20054,0.61572,REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,1
PLASARI_TGFB1_TARGETS_1HR_UP,SET,33,-0.049394,-0.0020912,0.16772,0.61581,PLASARI_TGFB1_TARGETS_1HR_UP,1
DER_IFN_GAMMA_RESPONSE_UP,SET,67,-0.031256,-0.0018838,0.1061,0.61585,DER_IFN_GAMMA_RESPONSE_UP,1
HP_ABNORMAL_HEART_VALVE_PHYS...,SET,336,-0.014155,-0.0018963,0.048031,0.61589,HP_ABNORMAL_HEART_VALVE_PHYSIOLOGY,1
HP_ABNORMAL_ATRIOVENTRICULAR...3,SET,150,-0.021982,-0.0019778,0.074564,0.61593,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_MORPHOLOGY,1
GSE14769_UNSTIM_VS_80MIN_LPS...1,SET,188,-0.019872,-0.0019996,0.067398,0.61594,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN,1
GOBP_SODIUM_ION_IMPORT_ACROS...,SET,22,-0.054299,-0.0018775,0.18412,0.61597,GOBP_SODIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
CAGGGTC_MIR504,SET,69,-0.030529,-0.0018671,0.1035,0.61599,CAGGGTC_MIR504,1
REACTOME_IRS_MEDIATED_SIGNAL...,SET,47,-0.03816,-0.0019273,0.12935,0.616,REACTOME_IRS_MEDIATED_SIGNALLING,1
DAVICIONI_TARGETS_OF_PAX_FOX...1,SET,62,-0.034996,-0.0020292,0.11859,0.61604,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,1
GOBP_CELLULAR_SENESCENCE,SET,93,-0.026162,-0.0018564,0.088637,0.61606,GOBP_CELLULAR_SENESCENCE,1
GOBP_REGULATION_OF_MYOBLAST_...3,SET,15,-0.064775,-0.0018498,0.21942,0.61608,GOBP_REGULATION_OF_MYOBLAST_PROLIFERATION,1
PID_RHOA_REG_PATHWAY,SET,42,-0.040118,-0.0019157,0.13587,0.6161,PID_RHOA_REG_PATHWAY,1
LI_WILMS_TUMOR_VS_FETAL_KIDN...3,SET,46,-0.04245,-0.0021211,0.14373,0.61613,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,1
GSE17721_0.5H_VS_12H_LPS_BMD...1,SET,185,-0.018216,-0.0018184,0.061624,0.61623,GSE17721_0.5H_VS_12H_LPS_BMDC_DN,1
GOBP_DICARBOXYLIC_ACID_BIOSY...,SET,12,-0.079383,-0.0020278,0.26851,0.61625,GOBP_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,1
GOCC_LAMELLIPODIUM_MEMBRANE,SET,22,-0.056073,-0.0019389,0.18953,0.61633,GOCC_LAMELLIPODIUM_MEMBRANE,1
HP_GEOGRAPHIC_ATROPHY,SET,5,-0.11439,-0.0018866,0.3864,0.6164,HP_GEOGRAPHIC_ATROPHY,1
GOCC_INTERPHOTORECEPTOR_MATR...,SET,5,-0.1014,-0.0016723,0.34228,0.61648,GOCC_INTERPHOTORECEPTOR_MATRIX,1
GOBP_GONADAL_MESODERM_DEVELO...,SET,2,-0.19166,-0.0019992,0.64664,0.61653,GOBP_GONADAL_MESODERM_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...477,SET,4,-0.11699,-0.0017258,0.39471,0.61654,GOBP_NEGATIVE_REGULATION_OF_PANCREATIC_JUICE_SECRETION,1
GOBP_REGULATION_OF_CENTROSOM...,SET,52,-0.03324,-0.0017656,0.11214,0.61655,GOBP_REGULATION_OF_CENTROSOME_CYCLE,1
HP_ANKLE_CLONUS,SET,44,-0.036487,-0.0017832,0.12309,0.61655,HP_ANKLE_CLONUS,1
SRF_C,SET,198,-0.018207,-0.0018796,0.061409,0.61657,SRF_C,1
MODULE_563,SET,13,-0.069869,-0.0018576,0.23561,0.61659,MODULE_563,1
GOBP_URINARY_BLADDER_SMOOTH_...,SET,7,-0.10018,-0.0019547,0.3378,0.61659,GOBP_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION,1
GSE369_IFNG_KO_VS_WT_LIVER_DN,SET,171,-0.018558,-0.0017818,0.062582,0.61659,GSE369_IFNG_KO_VS_WT_LIVER_DN,1
SCHERER_PBMC_YF_VAX_AGE_18_4...4,SET,10,-0.081926,-0.0019105,0.27608,0.61667,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_UP,1
GSE7460_TREG_VS_TCONV_ACT_WI...2,SET,175,-0.019712,-0.0019144,0.066414,0.61669,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP,1
LOPEZ_MESOTELIOMA_SURVIVAL_T...2,SET,10,-0.084053,-0.0019601,0.28315,0.61671,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP,1
HP_PERSISTENT_EBV_VIREMIA,SET,12,-0.068437,-0.0017482,0.23054,0.61671,HP_PERSISTENT_EBV_VIREMIA,1
HP_SUBVALVULAR_AORTIC_STENOS...,SET,21,-0.05777,-0.0019517,0.19455,0.61674,HP_SUBVALVULAR_AORTIC_STENOSIS,1
STAT4_01,SET,250,-0.016673,-0.0019314,0.056143,0.61676,STAT4_01,1
MIR758_5P,SET,31,-0.04465,-0.0018323,0.15026,0.61682,MIR758_5P,1
BIOCARTA_NFAT_PATHWAY,SET,50,-0.03776,-0.0019669,0.12706,0.61684,BIOCARTA_NFAT_PATHWAY,1
GNF2_KISS1,SET,43,-0.044115,-0.0021314,0.14831,0.61694,GNF2_KISS1,1
GOBP_POSITIVE_REGULATION_OF_...97,SET,11,-0.086563,-0.0021171,0.29094,0.61697,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,1
FRASOR_RESPONSE_TO_ESTRADIOL...1,SET,69,-0.032259,-0.0019729,0.10841,0.61698,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1
GOBP_CEREBRAL_CORTEX_GABAERG...2,SET,9,-0.099007,-0.0021904,0.33269,0.61699,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...432,SET,22,-0.055845,-0.001931,0.18762,0.61701,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...6,SET,9,-0.07932,-0.0017549,0.26641,0.61705,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482,1
HE_LIM_SUN_FETAL_LUNG_C4_CD4...,SET,30,-0.049452,-0.0019964,0.16609,0.61705,HE_LIM_SUN_FETAL_LUNG_C4_CD4_T_CELL,1
HP_PORTAL_INFLAMMATION,SET,4,-0.15082,-0.0022249,0.5065,0.61706,HP_PORTAL_INFLAMMATION,1
BIOCARTA_BARRESTIN_PATHWAY,SET,11,-0.085227,-0.0020845,0.28616,0.61708,BIOCARTA_BARRESTIN_PATHWAY,1
MIR10401_5P,SET,73,-0.030847,-0.0019403,0.10357,0.61709,MIR10401_5P,1
HP_MULTIFOCAL_CEREBRAL_WHITE...,SET,15,-0.063504,-0.0018135,0.21308,0.61716,HP_MULTIFOCAL_CEREBRAL_WHITE_MATTER_ABNORMALITIES,1
WP_THYROID_HORMONES_PRODUCTI...,SET,90,-0.027482,-0.0019185,0.092172,0.61721,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1
WP_OVERVIEW_OF_NANOPARTICLE_...,SET,19,-0.065105,-0.0020923,0.21822,0.61728,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,1
GOMF_GLYCEROL_3_PHOSPHATE_O_...,SET,3,-0.16855,-0.0021533,0.56436,0.6174,GOMF_GLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,1
GOCC_TRANSCRIPTION_EXPORT_CO...2,SET,4,-0.11646,-0.001718,0.38986,0.61743,GOCC_TRANSCRIPTION_EXPORT_COMPLEX_2,1
HP_TORSADE_DE_POINTES,SET,24,-0.055452,-0.0020026,0.18552,0.61749,HP_TORSADE_DE_POINTES,1
GOMF_ENDOPEPTIDASE_REGULATOR...,SET,168,-0.0224,-0.0021318,0.074906,0.61754,GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY,1
GOBP_CD4_POSITIVE_ALPHA_BETA...3,SET,90,-0.029108,-0.002032,0.097311,0.61757,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOCC_FLEMMING_BODY,SET,34,-0.043452,-0.0018672,0.1452,0.61763,GOCC_FLEMMING_BODY,1
GOBP_NATURAL_KILLER_CELL_MED...2,SET,75,-0.032197,-0.0020526,0.10754,0.61768,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
BUYTAERT_PHOTODYNAMIC_THERAP...2,SET,759,-0.0094698,-0.0018843,0.031624,0.6177,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP,1
REACTOME_SIGNALING_BY_LTK_IN...,SET,7,-0.10014,-0.0019539,0.33424,0.61776,REACTOME_SIGNALING_BY_LTK_IN_CANCER,1
GOBP_SULFUR_AMINO_ACID_CATAB...,SET,9,-0.090609,-0.0020046,0.30225,0.61783,GOBP_SULFUR_AMINO_ACID_CATABOLIC_PROCESS,1
GOBP_RECEPTOR_MEDIATED_ENDOC...2,SET,5,-0.12428,-0.0020497,0.41431,0.6179,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_INVOLVED_IN_CHOLESTEROL_TRANSPORT,1
GSE20754_WT_VS_TCF1_KO_MEMOR...2,SET,188,-0.017866,-0.0017977,0.059474,0.61806,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP,1
HP_NASAL_CONGESTION,SET,47,-0.036529,-0.0018449,0.12159,0.61807,HP_NASAL_CONGESTION,1
HP_THICK_CORPUS_CALLOSUM,SET,15,-0.057698,-0.0016477,0.19205,0.61807,HP_THICK_CORPUS_CALLOSUM,1
HP_ABNORMAL_MACULAR_MORPHOLO...,SET,189,-0.019388,-0.001956,0.064512,0.61811,HP_ABNORMAL_MACULAR_MORPHOLOGY,1
GOBP_PLACENTA_DEVELOPMENT,SET,142,-0.022491,-0.0019693,0.07482,0.61814,GOBP_PLACENTA_DEVELOPMENT,1
GOBP_BASEMENT_MEMBRANE_ASSEM...,SET,9,-0.080208,-0.0017745,0.26677,0.61816,GOBP_BASEMENT_MEMBRANE_ASSEMBLY,1
GOBP_EMBRYONIC_CLEAVAGE,SET,8,-0.088749,-0.0018512,0.29516,0.61817,GOBP_EMBRYONIC_CLEAVAGE,1
GOMF_MHC_CLASS_I_RECEPTOR_AC...,SET,10,-0.10678,-0.00249,0.35503,0.61819,GOMF_MHC_CLASS_I_RECEPTOR_ACTIVITY,1
GSE38697_LIGHT_ZONE_VS_DARK_...2,SET,154,-0.020062,-0.0018287,0.066708,0.61819,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,1
MIR7154_3P,SET,57,-0.034607,-0.0019243,0.11507,0.6182,MIR7154_3P,1
GOBP_MALE_MEIOTIC_NUCLEAR_DI...,SET,49,-0.033676,-0.0017366,0.11194,0.61823,GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION,1
GOBP_NEGATIVE_REGULATION_OF_...155,SET,15,-0.069283,-0.0019785,0.2303,0.61823,GOBP_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY,1
GSE25088_WT_VS_STAT6_KO_MACR...7,SET,167,-0.018579,-0.001763,0.061689,0.61836,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,1
EGFR_UP.V1_UP,SET,170,-0.021675,-0.002075,0.071936,0.61841,EGFR_UP.V1_UP,1
KUNINGER_IGF1_VS_PDGFB_TARGE...2,SET,75,-0.02985,-0.001903,0.099043,0.61844,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,1
ALONSO_METASTASIS_DN,SET,23,-0.057132,-0.0020199,0.18951,0.61847,ALONSO_METASTASIS_DN,1
AR_03,SET,54,-0.034788,-0.0018829,0.11536,0.6185,AR_03,1
GAVISH_3CA_MALIGNANT_METAPRO...14,SET,49,-0.04117,-0.002123,0.13651,0.61852,GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2,1
KEGG_MEDICUS_VARIANT_RET_FUS...,SET,10,-0.078574,-0.0018324,0.26046,0.61855,KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_IMMOTILE_SPERM,SET,14,-0.069519,-0.001918,0.2303,0.61862,HP_IMMOTILE_SPERM,1
GOBP_NEUROTROPHIN_SIGNALING_...,SET,38,-0.042608,-0.0019355,0.14104,0.61871,GOBP_NEUROTROPHIN_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...56,SET,14,-0.068229,-0.0018824,0.22578,0.61875,GOBP_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,1
GOMF_LRR_DOMAIN_BINDING,SET,15,-0.069382,-0.0019814,0.22956,0.61876,GOMF_LRR_DOMAIN_BINDING,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...5,SET,123,-0.024657,-0.0020104,0.081555,0.6188,FAN_EMBRYONIC_CTX_BIG_GROUPS_GLIAL,1
CREIGHTON_AKT1_SIGNALING_VIA...2,SET,32,-0.04395,-0.0018323,0.14535,0.61881,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,1
GOBP_REGULATION_OF_GLUCOSE_I...,SET,52,-0.038365,-0.0020378,0.12686,0.61884,GOBP_REGULATION_OF_GLUCOSE_IMPORT,1
GOMF_TRNA_METHYLTRANSFERASE_...,SET,30,-0.041613,-0.0016799,0.13756,0.61886,GOMF_TRNA_METHYLTRANSFERASE_ACTIVITY,1
VANDESLUIS_COMMD1_TARGETS_GR...2,SET,32,-0.052484,-0.0021881,0.17349,0.61887,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,1
GSE30971_WBP7_HET_VS_KO_MACR...3,SET,174,-0.019682,-0.0019061,0.065064,0.61887,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN,1
GOBP_POSITIVE_REGULATION_OF_...651,SET,236,-0.016771,-0.0018883,0.055426,0.61889,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT,1
HP_INCREASED_BODY_MASS_INDEX,SET,4,-0.13271,-0.0019577,0.43843,0.61894,HP_INCREASED_BODY_MASS_INDEX,1
HP_ABNORMALITY_OF_THE_PULMON...2,SET,185,-0.019671,-0.0019637,0.064916,0.61906,HP_ABNORMALITY_OF_THE_PULMONARY_VASCULATURE,1
GSE32034_LY6C_HIGH_VS_LOW_RO...2,SET,183,-0.018605,-0.0018473,0.061397,0.61906,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP,1
GOBP_REGULATION_OF_FEMALE_GO...,SET,7,-0.11,-0.0021464,0.36292,0.61909,GOBP_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT,1
DUTERTRE_ESTRADIOL_RESPONSE_...3,SET,86,-0.030523,-0.0020831,0.10069,0.6191,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,1
WP_UREA_CYCLE_AND_RELATED_DI...,SET,8,-0.089062,-0.0018578,0.29382,0.6191,WP_UREA_CYCLE_AND_RELATED_DISEASES,1
MIR3152_5P,SET,55,-0.033628,-0.0018369,0.11094,0.6191,MIR3152_5P,1
GSE3982_MEMORY_CD4_TCELL_VS_...6,SET,172,-0.019989,-0.0019247,0.065924,0.61913,GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP,1
GOBP_CILIUM_MOVEMENT,SET,172,-0.019463,-0.0018741,0.064167,0.61918,GOBP_CILIUM_MOVEMENT,1
MIR4653_5P,SET,137,-0.022595,-0.0019435,0.074483,0.61919,MIR4653_5P,1
HP_EPIBLEPHARON,SET,6,-0.10261,-0.0018538,0.33822,0.6192,HP_EPIBLEPHARON,1
GSE17721_POLYIC_VS_GARDIQUIM...15,SET,184,-0.018523,-0.0018441,0.061055,0.6192,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN,1
CHEOK_RESPONSE_TO_MERCAPTOPU...2,SET,4,-0.14284,-0.0021072,0.47077,0.61922,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP,1
KEGG_TYPE_I_DIABETES_MELLITUS,SET,39,-0.047955,-0.0022068,0.15801,0.61924,KEGG_TYPE_I_DIABETES_MELLITUS,1
REACTOME_PARACETAMOL_ADME,SET,25,-0.058284,-0.0021482,0.19203,0.61925,REACTOME_PARACETAMOL_ADME,1
HP_ABNORMAL_CIRCULATING_INTE...2,SET,8,-0.10155,-0.0021183,0.33432,0.61934,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_10_CONCENTRATION,1
KEGG_MEDICUS_REFERENCE_GLYCO...2,SET,8,-0.079817,-0.0016649,0.26271,0.61936,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION,1
GSE12198_CTRL_VS_LOW_IL2_STI...2,SET,181,-0.018639,-0.0018406,0.061355,0.61936,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP,1
HDAC8_TARGET_GENES,SET,126,-0.023551,-0.0019434,0.077493,0.6194,HDAC8_TARGET_GENES,1
ETS1_B,SET,242,-0.016857,-0.0019216,0.05546,0.61942,ETS1_B,1
GSE43955_10H_VS_60H_ACT_CD4_...4,SET,181,-0.018995,-0.0018757,0.062486,0.61943,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
KEGG_MEDICUS_REFERENCE_TLR7_...1,SET,16,-0.080878,-0.0023853,0.26603,0.61944,KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY,1
MIR1302,SET,63,-0.031018,-0.001813,0.10202,0.61945,MIR1302,1
MIR6772_5P,SET,31,-0.045962,-0.0018861,0.15108,0.61952,MIR6772_5P,1
WHITESIDE_CISPLATIN_RESISTAN...2,SET,11,-0.079874,-0.0019535,0.26246,0.61956,WHITESIDE_CISPLATIN_RESISTANCE_UP,1
GOBP_BIOGENIC_AMINE_METABOLI...,SET,83,-0.030068,-0.0020161,0.098774,0.61959,GOBP_BIOGENIC_AMINE_METABOLIC_PROCESS,1
GOMF_GUANYLYLTRANSFERASE_ACT...,SET,4,-0.11921,-0.0017585,0.39148,0.61963,GOMF_GUANYLYLTRANSFERASE_ACTIVITY,1
GOBP_ACTIVATION_OF_PROTEIN_K...2,SET,21,-0.06253,-0.0021125,0.20532,0.61965,GOBP_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY,1
GOBP_NADH_OXIDATION,SET,6,-0.10187,-0.0018404,0.33448,0.61965,GOBP_NADH_OXIDATION,1
GSE1925_CTRL_VS_24H_IFNG_STI...4,SET,177,-0.019784,-0.0019321,0.064958,0.61965,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP,1
HP_ABNORMAL_BLOOD_INORGANIC_...,SET,160,-0.021751,-0.0020207,0.071387,0.6197,HP_ABNORMAL_BLOOD_INORGANIC_CATION_CONCENTRATION,1
GOBP_REGULATION_OF_BONE_MINE...1,SET,70,-0.033122,-0.0020403,0.10863,0.61978,GOBP_REGULATION_OF_BONE_MINERALIZATION,1
GOBP_ORGANOPHOSPHATE_BIOSYNT...,SET,508,-0.011555,-0.0018943,0.037883,0.61982,GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_RECURRENT_PAROXYSMAL_HEAD...,SET,18,-0.055216,-0.0017272,0.18103,0.61982,HP_RECURRENT_PAROXYSMAL_HEADACHE,1
GOCC_VACUOLAR_LUMEN,SET,160,-0.02111,-0.0019611,0.069204,0.61983,GOCC_VACUOLAR_LUMEN,1
GOBP_CELLULAR_RESPONSE_TO_TY...,SET,91,-0.028232,-0.0019817,0.092523,0.61987,GOBP_CELLULAR_RESPONSE_TO_TYPE_II_INTERFERON,1
HP_AUTOPHAGIC_VACUOLES,SET,8,-0.084771,-0.0017683,0.27775,0.61989,HP_AUTOPHAGIC_VACUOLES,1
GOBP_ADRENAL_GLAND_DEVELOPME...,SET,26,-0.057685,-0.0021682,0.18896,0.61992,GOBP_ADRENAL_GLAND_DEVELOPMENT,1
GOBP_REGULATION_OF_EXIT_FROM...,SET,16,-0.065814,-0.0019411,0.2156,0.61992,GOBP_REGULATION_OF_EXIT_FROM_MITOSIS,1
GSE11864_UNTREATED_VS_CSF1_I...1,SET,172,-0.019113,-0.0018403,0.062549,0.62003,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN,1
GOCC_VACUOLAR_MEMBRANE,SET,438,-0.012451,-0.0018992,0.040719,0.62011,GOCC_VACUOLAR_MEMBRANE,1
REACTOME_SYNTHESIS_OF_PIPS_A...5,SET,48,-0.037106,-0.0018939,0.12134,0.62012,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,1
HP_ABNORMAL_ALPHA_GRANULES,SET,4,-0.10733,-0.0015833,0.3509,0.62015,HP_ABNORMAL_ALPHA_GRANULES,1
PID_IL4_2PATHWAY,SET,55,-0.037361,-0.0020408,0.12207,0.62022,PID_IL4_2PATHWAY,1
GOBP_MANCHETTE_ASSEMBLY,SET,8,-0.083445,-0.0017406,0.2726,0.62024,GOBP_MANCHETTE_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...562,SET,472,-0.011977,-0.0018945,0.039111,0.62028,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,1
MIR6862_3P,SET,26,-0.046844,-0.0017607,0.1529,0.62034,MIR6862_3P,1
REACTOME_TP53_REGULATES_TRAN...5,SET,12,-0.080341,-0.0020523,0.26218,0.62036,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS,1
GOBP_POSITIVE_REGULATION_OF_...698,SET,1622,-0.0070216,-0.0019918,0.022905,0.62041,GOBP_POSITIVE_REGULATION_OF_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...178,SET,7,-0.10699,-0.0020876,0.34895,0.62042,GOBP_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,1
MURARO_PANCREAS_ACINAR_CELL,SET,660,-0.010867,-0.0020221,0.035428,0.62048,MURARO_PANCREAS_ACINAR_CELL,1
GOBP_ELASTIN_CATABOLIC_PROCE...,SET,4,-0.15613,-0.0023031,0.50894,0.62049,GOBP_ELASTIN_CATABOLIC_PROCESS,1
GSE6259_FLT3L_INDUCED_VS_WT_...1,SET,145,-0.023328,-0.0020639,0.07604,0.62049,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN,1
HP_AUTOAMPUTATION_OF_DIGITS,SET,13,-0.070846,-0.0018836,0.2309,0.62051,HP_AUTOAMPUTATION_OF_DIGITS,1
HP_FRECKLING,SET,46,-0.036048,-0.0018012,0.11749,0.62051,HP_FRECKLING,1
GOBP_AV_NODE_CELL_TO_BUNDLE_...2,SET,10,-0.09542,-0.0022252,0.31085,0.62056,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_SIGNALING,1
GSE411_100MIN_VS_400MIN_IL6_...1,SET,182,-0.018019,-0.0017842,0.058649,0.62066,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN,1
MIR4305,SET,50,-0.037177,-0.0019365,0.12094,0.62073,MIR4305,1
GOMF_HYDROLASE_ACTIVITY_ACTI...1,SET,716,-0.010018,-0.0019384,0.032589,0.62073,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES,1
GOBP_KERATINOCYTE_PROLIFERAT...,SET,56,-0.038409,-0.002117,0.12494,0.62074,GOBP_KERATINOCYTE_PROLIFERATION,1
NIKOLSKY_BREAST_CANCER_20P13...,SET,7,-0.13292,-0.0025936,0.43229,0.62076,NIKOLSKY_BREAST_CANCER_20P13_AMPLICON,1
WP_13Q1212_COPY_NUMBER_VARIA...,SET,31,-0.048013,-0.0019702,0.15604,0.62084,WP_13Q1212_COPY_NUMBER_VARIATION,1
KEGG_MEDICUS_REFERENCE_TLR3_...2,SET,16,-0.081904,-0.0024156,0.26612,0.62087,KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY,1
GOBP_CAP_DEPENDENT_TRANSLATI...,SET,7,-0.07944,-0.0015501,0.25811,0.62087,GOBP_CAP_DEPENDENT_TRANSLATIONAL_INITIATION,1
GOBP_MEMBRANE_HYPERPOLARIZAT...,SET,11,-0.079635,-0.0019477,0.25872,0.62088,GOBP_MEMBRANE_HYPERPOLARIZATION,1
GOBP_MUSCLE_STRUCTURE_DEVELO...,SET,639,-0.010887,-0.0019944,0.035364,0.6209,GOBP_MUSCLE_STRUCTURE_DEVELOPMENT,1
PID_TAP63_PATHWAY,SET,53,-0.035853,-0.0019226,0.11645,0.62091,PID_TAP63_PATHWAY,1
GSE2128_C57BL6_VS_NOD_THYMOC...2,SET,181,-0.019944,-0.0019695,0.064762,0.62094,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN,1
GOBP_POSITIVE_REGULATION_OF_...625,SET,230,-0.017934,-0.0019937,0.058233,0.62095,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY,1
RASHI_RESPONSE_TO_IONIZING_R...6,SET,73,-0.030114,-0.0018942,0.097719,0.62102,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,1
GAO_ESOPHAGUS_25W_C2_KRT6BPO...,SET,66,-0.035156,-0.002103,0.11406,0.62104,GAO_ESOPHAGUS_25W_C2_KRT6BPOS_SECRETORY_PROGENITOR_CELLS,1
MIR6868_3P,SET,241,-0.017703,-0.0020139,0.057433,0.62105,MIR6868_3P,1
ATGCTGG_MIR338,SET,108,-0.024739,-0.0018909,0.08026,0.62105,ATGCTGG_MIR338,1
GAVIN_FOXP3_TARGETS_CLUSTER_...6,SET,82,-0.029895,-0.0019925,0.096916,0.62113,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1
FIGUEROA_AML_METHYLATION_CLU...5,SET,35,-0.047823,-0.002085,0.15494,0.62121,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,1
GSE17974_0H_VS_48H_IN_VITRO_...1,SET,173,-0.019251,-0.001859,0.062356,0.62123,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN,1
MODULE_557,SET,9,-0.105,-0.0023231,0.34011,0.62124,MODULE_557,1
BIOCARTA_EOSINOPHILS_PATHWAY,SET,7,-0.095228,-0.0018582,0.30834,0.62128,BIOCARTA_EOSINOPHILS_PATHWAY,1
GOBP_DELAMINATION,SET,7,-0.092125,-0.0017976,0.29813,0.62134,GOBP_DELAMINATION,1
HP_ABNORMAL_CSF_GLUCOSE_CONC...,SET,6,-0.1171,-0.0021156,0.37876,0.6214,HP_ABNORMAL_CSF_GLUCOSE_CONCENTRATION,1
FAN_EMBRYONIC_CTX_BRAIN_NAIV...,SET,139,-0.023591,-0.0020439,0.076294,0.62142,FAN_EMBRYONIC_CTX_BRAIN_NAIVE_LIKE_T_CELL,1
REACTOME_SUPPRESSION_OF_PHAG...,SET,12,-0.072079,-0.0018412,0.23305,0.62145,REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,1
GSE38681_WT_VS_LYL1_KO_LYMPH...1,SET,191,-0.019641,-0.0019919,0.063479,0.62149,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,1
GSE5679_CTRL_VS_RARA_AGONIST...1,SET,180,-0.019135,-0.0018845,0.061844,0.62149,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN,1
WP_OXIDATION_BY_CYTOCHROME_P...,SET,61,-0.038029,-0.0021873,0.12288,0.62152,WP_OXIDATION_BY_CYTOCHROME_P450,1
GOBP_NEGATIVE_REGULATION_OF_...486,SET,19,-0.05578,-0.0017926,0.18021,0.62154,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,1
GOBP_REGULATION_OF_SMOOTHENE...,SET,79,-0.028514,-0.0018655,0.092093,0.62157,GOBP_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,1
HALLMARK_COMPLEMENT,SET,192,-0.020039,-0.0020375,0.064696,0.62162,HALLMARK_COMPLEMENT,1
GCM_DDX5,SET,59,-0.032533,-0.0018404,0.10501,0.62165,GCM_DDX5,1
DESCARTES_FETAL_CEREBRUM_MIC...,SET,364,-0.014936,-0.0020811,0.04821,0.62165,DESCARTES_FETAL_CEREBRUM_MICROGLIA,1
WP_PDGF_PATHWAY,SET,38,-0.04287,-0.0019473,0.13835,0.62167,WP_PDGF_PATHWAY,1
GOBP_C4_DICARBOXYLATE_TRANSP...,SET,28,-0.051288,-0.0020004,0.16551,0.62167,GOBP_C4_DICARBOXYLATE_TRANSPORT,1
GOCC_MITOCHONDRIAL_RESPIRATO...,SET,12,-0.069856,-0.0017844,0.22533,0.62173,GOCC_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III,1
HP_ABNORMAL_FACIAL_EXPRESSION,SET,165,-0.020852,-0.0019669,0.067251,0.62174,HP_ABNORMAL_FACIAL_EXPRESSION,1
GOCC_MRE11_COMPLEX,SET,3,-0.13916,-0.0017778,0.44872,0.62176,GOCC_MRE11_COMPLEX,1
REACTOME_POLYMERASE_SWITCHING,SET,13,-0.067553,-0.001796,0.21782,0.62177,REACTOME_POLYMERASE_SWITCHING,1
GOBP_BRANCHED_CHAIN_AMINO_AC...3,SET,27,-0.050766,-0.0019444,0.16357,0.62186,GOBP_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS,1
WP_MALE_STEROID_HORMONES_IN_...,SET,13,-0.075153,-0.0019981,0.24207,0.62189,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,1
BIOCARTA_DC_PATHWAY,SET,16,-0.075789,-0.0022353,0.244,0.62195,BIOCARTA_DC_PATHWAY,1
GCM_PTPRD,SET,53,-0.036316,-0.0019474,0.1169,0.62196,GCM_PTPRD,1
NIKOLSKY_BREAST_CANCER_20Q12...,SET,136,-0.043358,-0.003716,0.13954,0.62199,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1
VANLOO_SP3_TARGETS_DN,SET,83,-0.027375,-0.0018355,0.088031,0.62209,VANLOO_SP3_TARGETS_DN,1
HP_ANKYLOSIS,SET,16,-0.073921,-0.0021802,0.2377,0.62209,HP_ANKYLOSIS,1
GSE15659_NAIVE_CD4_TCELL_VS_...4,SET,160,-0.020308,-0.0018866,0.065283,0.62213,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...313,SET,4,-0.13604,-0.0020069,0.4372,0.62216,GOBP_POSITIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
MURARO_PANCREAS_EPSILON_CELL,SET,42,-0.044402,-0.0021202,0.14256,0.62227,MURARO_PANCREAS_EPSILON_CELL,1
REACTOME_MODULATION_BY_MTB_O...,SET,6,-0.12727,-0.0022993,0.40862,0.62228,REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM,1
HP_LOCALIZED_OSTEOPOROSIS,SET,19,-0.056344,-0.0018107,0.18081,0.62234,HP_LOCALIZED_OSTEOPOROSIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...89,SET,9,-0.086324,-0.0019099,0.27673,0.62245,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION,1
HP_DOWNSLANTED_PALPEBRAL_FIS...,SET,428,-0.012984,-0.0019583,0.041613,0.62249,HP_DOWNSLANTED_PALPEBRAL_FISSURES,1
MIR758_3P,SET,112,-0.02476,-0.001927,0.079343,0.6225,MIR758_3P,1
HP_BILATERAL_SUPERIOR_VENA_C...,SET,8,-0.096187,-0.0020064,0.30819,0.62252,HP_BILATERAL_SUPERIOR_VENA_CAVA,1
GOBP_MEIOTIC_CYTOKINESIS,SET,7,-0.11203,-0.0021861,0.35877,0.62258,GOBP_MEIOTIC_CYTOKINESIS,1
HP_LATE_YOUNG_ADULT_ONSET,SET,42,-0.040657,-0.0019414,0.1302,0.62258,HP_LATE_YOUNG_ADULT_ONSET,1
GSE24634_TEFF_VS_TCONV_DAY3_...1,SET,169,-0.02142,-0.0020446,0.068557,0.62265,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN,1
KEGG_MEDICUS_ENV_FACTOR_META...1,SET,8,-0.10653,-0.002222,0.34076,0.62271,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY,1
GSE15139_GMCSF_TREATED_VS_UN...2,SET,180,-0.019432,-0.0019137,0.062151,0.62273,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP,1
KEGG_MEDICUS_REFERENCE_TELOM...2,SET,16,-0.06248,-0.0018427,0.19982,0.62274,KEGG_MEDICUS_REFERENCE_TELOMERE_ELONGATION,1
HP_SHORT_PALM,SET,93,-0.027761,-0.0019698,0.088779,0.62274,HP_SHORT_PALM,1
HP_CUTANEOUS_PHOTOSENSITIVITY,SET,94,-0.026906,-0.0019193,0.086037,0.62275,HP_CUTANEOUS_PHOTOSENSITIVITY,1
KEGG_TYROSINE_METABOLISM,SET,38,-0.049717,-0.0022584,0.15888,0.62283,KEGG_TYROSINE_METABOLISM,1
MIR937_5P,SET,50,-0.039616,-0.0020635,0.1266,0.62283,MIR937_5P,1
GSE4590_PRE_BCELL_VS_LARGE_P...2,SET,142,-0.024296,-0.0021274,0.077613,0.62287,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP,1
GSE22935_WT_VS_MYD88_KO_MACR...1,SET,187,-0.019956,-0.0020027,0.06374,0.62289,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN,1
HP_ABNORMAL_CORNEAL_ENDOTHEL...,SET,18,-0.070711,-0.0022119,0.22577,0.62293,HP_ABNORMAL_CORNEAL_ENDOTHELIUM_MORPHOLOGY,1
GSE5503_LIVER_DC_VS_PLN_DC_A...2,SET,184,-0.019442,-0.0019356,0.062,0.62308,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...314,SET,7,-0.11533,-0.0022503,0.3677,0.6231,GOBP_POSITIVE_REGULATION_OF_GONADOTROPIN_SECRETION,1
TURASHVILI_BREAST_LOBULAR_CA...4,SET,90,-0.029374,-0.0020506,0.093626,0.62314,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,1
GOBP_REGULATION_OF_CELL_DIFF...,SET,1406,-0.0076585,-0.0020357,0.024409,0.62315,GOBP_REGULATION_OF_CELL_DIFFERENTIATION,1
GOBP_MULTICELLULAR_ORGANISMA...5,SET,58,-0.035402,-0.0019857,0.11282,0.62316,GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT,1
GOCC_U7_SNRNP,SET,7,-0.1234,-0.0024078,0.39311,0.6232,GOCC_U7_SNRNP,1
GOBP_EMBRYONIC_ORGAN_DEVELOP...,SET,429,-0.013822,-0.002087,0.044022,0.62323,GOBP_EMBRYONIC_ORGAN_DEVELOPMENT,1
MIR513C_5P,SET,164,-0.021095,-0.0019839,0.067132,0.62333,MIR513C_5P,1
FLOTHO_PEDIATRIC_ALL_THERAPY...2,SET,50,-0.036378,-0.0018949,0.11575,0.62334,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,1
GOCC_SECRETORY_GRANULE,SET,826,-0.0097831,-0.0020269,0.031126,0.62335,GOCC_SECRETORY_GRANULE,1
HP_DISPROPORTIONATE_TALL_STA...,SET,32,-0.047812,-0.0019933,0.1521,0.62336,HP_DISPROPORTIONATE_TALL_STATURE,1
REACTOME_HCMV_LATE_EVENTS,SET,51,-0.034645,-0.0018225,0.1102,0.62338,REACTOME_HCMV_LATE_EVENTS,1
GOMF_CERAMIDE_1_PHOSPHATE_BI...,SET,5,-0.11088,-0.0018286,0.35255,0.62343,GOMF_CERAMIDE_1_PHOSPHATE_BINDING,1
GOCC_CILIARY_TRANSITION_ZONE,SET,65,-0.031301,-0.0018582,0.099512,0.62344,GOCC_CILIARY_TRANSITION_ZONE,1
GOMF_CYCLIC_NUCLEOTIDE_BINDI...,SET,36,-0.045878,-0.0020285,0.14585,0.62345,GOMF_CYCLIC_NUCLEOTIDE_BINDING,1
WP_ID_SIGNALING,SET,15,-0.065365,-0.0018667,0.20769,0.62351,WP_ID_SIGNALING,1
MIR5572,SET,70,-0.033632,-0.0020717,0.10684,0.62353,MIR5572,1
GOBP_REGULATION_OF_DEFENSE_R...2,SET,18,-0.063259,-0.0019788,0.20096,0.62354,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
HP_ABNORMAL_PLATELET_AGGREGA...,SET,39,-0.042882,-0.0019733,0.13618,0.62358,HP_ABNORMAL_PLATELET_AGGREGATION,1
GSE2585_AIRE_KO_VS_WT_CD80_L...1,SET,193,-0.019239,-0.0019612,0.061087,0.6236,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN,1
GAO_SMALL_INTESTINE_24W_C6_G...,SET,40,-0.040779,-0.0019004,0.12946,0.62361,GAO_SMALL_INTESTINE_24W_C6_GOBLET_CELLS,1
GSE29949_MICROGLIA_BRAIN_VS_...6,SET,182,-0.020447,-0.0020247,0.064903,0.62363,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,1
GSE14308_TH1_VS_NAIVE_CD4_TC...1,SET,176,-0.020114,-0.001959,0.063833,0.62366,GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN,1
HP_ABNORMAL_DIGESTIVE_SYSTEM...,SET,923,-0.0091862,-0.0020063,0.029143,0.6237,HP_ABNORMAL_DIGESTIVE_SYSTEM_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_BETA_...2,SET,10,-0.085084,-0.0019842,0.2699,0.62371,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS,1
GOBP_RESPONSE_TO_VASOPRESSIN,SET,8,-0.10141,-0.0021154,0.32169,0.62371,GOBP_RESPONSE_TO_VASOPRESSIN,1
GSE22432_CDC_VS_COMMON_DC_PR...2,SET,175,-0.020522,-0.001993,0.065092,0.62372,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP,1
WP_SUDDEN_INFANT_DEATH_SYNDR...,SET,148,-0.024489,-0.0021888,0.077668,0.62373,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1
GSE22601_DOUBLE_POSITIVE_VS_...2,SET,167,-0.021196,-0.0020113,0.067222,0.62373,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,1
GSE21670_UNTREATED_VS_IL6_TR...4,SET,167,-0.021613,-0.0020508,0.068482,0.62384,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
HP_CENTRAL_APNEA,SET,37,-0.044204,-0.0019814,0.14003,0.62387,HP_CENTRAL_APNEA,1
HP_ABNORMALITY_OF_THE_PERIPH...,SET,405,-0.013379,-0.0019641,0.042343,0.62399,HP_ABNORMALITY_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,1
GOBP_REGULATION_OF_INOSITOL_...2,SET,15,-0.076652,-0.002189,0.2424,0.62408,GOBP_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_CELL_PROLIFERATION_INVO...1,SET,17,-0.073693,-0.0022403,0.23301,0.6241,GOBP_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,1
GOBP_VESICLE_CYTOSKELETAL_TR...,SET,55,-0.036007,-0.0019668,0.11384,0.62411,GOBP_VESICLE_CYTOSKELETAL_TRAFFICKING,1
MIR4777_5P,SET,101,-0.027896,-0.0020623,0.088163,0.62415,MIR4777_5P,1
GOCC_EXCITATORY_SYNAPSE,SET,57,-0.037445,-0.0020821,0.11833,0.62417,GOCC_EXCITATORY_SYNAPSE,1
GOCC_LIPID_DROPLET,SET,91,-0.029229,-0.0020516,0.092354,0.62418,GOCC_LIPID_DROPLET,1
GOMF_STRUCTURAL_MOLECULE_ACT...2,SET,12,-0.083125,-0.0021234,0.26256,0.62422,GOMF_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY,1
GSE21379_TFH_VS_NON_TFH_CD4_...2,SET,178,-0.020636,-0.002021,0.065145,0.62429,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP,1
HP_FLAT_FACE,SET,94,-0.027563,-0.0019662,0.087005,0.6243,HP_FLAT_FACE,1
GOCC_PROTEASOME_CORE_COMPLEX,SET,20,-0.055724,-0.0018373,0.17587,0.62432,GOCC_PROTEASOME_CORE_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...261,SET,31,-0.050301,-0.0020642,0.15869,0.62437,GOBP_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
KLEIN_TARGETS_OF_BCR_ABL1_FU...,SET,40,-0.0464,-0.0021623,0.14636,0.62439,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,1
PID_TCR_RAS_PATHWAY,SET,13,-0.076086,-0.0020229,0.23999,0.62439,PID_TCR_RAS_PATHWAY,1
GSE17721_0.5H_VS_8H_GARDIQUI...1,SET,184,-0.020016,-0.0019928,0.063133,0.62439,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN,1
MIR378H,SET,39,-0.04059,-0.0018679,0.128,0.62442,MIR378H,1
GOBP_REGULATION_OF_PROTEIN_L...2,SET,9,-0.086158,-0.0019062,0.27167,0.62443,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
GOBP_CALCIUM_ION_REGULATED_E...2,SET,21,-0.059424,-0.0020076,0.18724,0.62452,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER,1
GNF2_CD7,SET,34,-0.04927,-0.0021173,0.15516,0.62458,GNF2_CD7,1
LAKE_ADULT_KIDNEY_C9_THIN_AS...,SET,246,-0.017609,-0.0020237,0.055426,0.62465,LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB,1
MURARO_PANCREAS_DUCTAL_CELL,SET,1167,-0.0087064,-0.0021231,0.027383,0.62474,MURARO_PANCREAS_DUCTAL_CELL,1
GOCC_PROTEIN_COMPLEX_INVOLVE...1,SET,55,-0.038382,-0.0020965,0.1207,0.62475,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION,1
HP_POSTNATAL_MACROCEPHALY,SET,5,-0.11437,-0.0018862,0.35964,0.62476,HP_POSTNATAL_MACROCEPHALY,1
GOBP_REGULATION_OF_ANATOMICA...2,SET,445,-0.013515,-0.0020774,0.042494,0.62477,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE,1
PURBEY_TARGETS_OF_CTBP1_AND_...2,SET,65,-0.032377,-0.0019221,0.10179,0.62479,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,1
HP_COARSE_HAIR,SET,48,-0.03673,-0.0018747,0.11541,0.62486,HP_COARSE_HAIR,1
HP_INERTIA,SET,4,-0.1494,-0.0022039,0.46943,0.62486,HP_INERTIA,1
HP_SEMILOBAR_HOLOPROSENCEPHA...,SET,7,-0.10078,-0.0019665,0.31662,0.62487,HP_SEMILOBAR_HOLOPROSENCEPHALY,1
DESCARTES_FETAL_HEART_ENDOCA...,SET,29,-0.056899,-0.0022584,0.17875,0.62488,DESCARTES_FETAL_HEART_ENDOCARDIAL_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...1,SET,3,-0.17924,-0.0022899,0.56298,0.6249,GOBP_POSITIVE_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,1
GOBP_RESPONSE_TO_PAIN,SET,35,-0.048683,-0.0021225,0.1529,0.6249,GOBP_RESPONSE_TO_PAIN,1
GOCC_MRNA_CLEAVAGE_FACTOR_CO...,SET,22,-0.054507,-0.0018848,0.17113,0.62495,GOCC_MRNA_CLEAVAGE_FACTOR_COMPLEX,1
HP_ABNORMAL_PR_INTERVAL,SET,17,-0.071722,-0.0021804,0.22518,0.62495,HP_ABNORMAL_PR_INTERVAL,1
DESCARTES_MAIN_FETAL_ELF3_AG...,SET,127,-0.022063,-0.0018277,0.069268,0.62495,DESCARTES_MAIN_FETAL_ELF3_AGBL2_POSITIVE_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...504,SET,26,-0.060374,-0.0022692,0.1895,0.62498,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
REACTOME_RMTS_METHYLATE_HIST...,SET,29,-0.052212,-0.0020724,0.16386,0.62499,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,1
GOBP_REGULATION_OF_SNARE_COM...,SET,13,-0.072695,-0.0019327,0.22813,0.625,GOBP_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY,1
GOBP_REGULATION_OF_MYELOID_C...2,SET,186,-0.021085,-0.0021104,0.066143,0.62505,GOBP_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,1
GSE37301_HEMATOPOIETIC_STEM_...12,SET,176,-0.020659,-0.002012,0.064778,0.6251,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP,1
CHEOK_RESPONSE_TO_MERCAPTOPU...5,SET,19,-0.06416,-0.0020619,0.20113,0.62514,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,1
GSE2405_S_AUREUS_VS_UNTREATE...2,SET,173,-0.019334,-0.001867,0.06059,0.62517,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP,1
GOBP_REGULATION_OF_FEVER_GEN...,SET,9,-0.1056,-0.0023362,0.33088,0.62519,GOBP_REGULATION_OF_FEVER_GENERATION,1
HP_ECLAMPSIA,SET,7,-0.11073,-0.0021606,0.34694,0.62519,HP_ECLAMPSIA,1
HP_LEFT_SUPERIOR_VENA_CAVA_D...,SET,3,-0.16637,-0.0021254,0.52116,0.62522,HP_LEFT_SUPERIOR_VENA_CAVA_DRAINING_TO_CORONARY_SINUS,1
GGTGAAG_MIR412,SET,55,-0.038157,-0.0020843,0.11951,0.62524,GGTGAAG_MIR412,1
GOBP_SEQUESTERING_OF_BMP_IN_...,SET,4,-0.14676,-0.0021649,0.45964,0.62524,GOBP_SEQUESTERING_OF_BMP_IN_EXTRACELLULAR_MATRIX,1
MORF_CDC16,SET,63,-0.0335,-0.001958,0.10489,0.62528,MORF_CDC16,1
BARRIER_COLON_CANCER_RECURRE...1,SET,16,-0.066738,-0.0019683,0.20892,0.6253,BARRIER_COLON_CANCER_RECURRENCE_DN,1
GOBP_DEVELOPMENT_OF_SECONDAR...2,SET,9,-0.10479,-0.0023185,0.32794,0.62534,GOBP_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS,1
HP_NEURODEGENERATION,SET,76,-0.030549,-0.0019604,0.095534,0.62543,HP_NEURODEGENERATION,1
GOMF_POTASSIUM_PROTON_ANTIPO...,SET,12,-0.080309,-0.0020515,0.25106,0.62547,GOMF_POTASSIUM_PROTON_ANTIPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...292,SET,7,-0.11688,-0.0022807,0.36532,0.62549,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
KAZMIN_PBMC_P_FALCIPARUM_RTS...3,SET,9,-0.10106,-0.0022358,0.31582,0.62551,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_UNKN_AGE_IMM_WITH_ARR_VS_IMM_BY_RRR_PRIMARY_IMMUNIZ_WITH_RECOMB_ADENOVIRUS_35_1DY_UP,1
GOMF_SEROTONIN_RECEPTOR_ACTI...,SET,6,-0.13992,-0.0025278,0.43714,0.62555,GOMF_SEROTONIN_RECEPTOR_ACTIVITY,1
DESCARTES_FETAL_LUNG_MEGAKAR...,SET,133,-0.02505,-0.0021232,0.078245,0.62557,DESCARTES_FETAL_LUNG_MEGAKARYOCYTES,1
GOMF_VASCULAR_ENDOTHELIAL_GR...4,SET,12,-0.084788,-0.0021659,0.26478,0.6256,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING,1
RAX2_TARGET_GENES,SET,62,-0.036701,-0.0021281,0.11459,0.62562,RAX2_TARGET_GENES,1
HP_ABNORMAL_FOREARM_MORPHOLO...,SET,211,-0.019381,-0.0020647,0.06051,0.62563,HP_ABNORMAL_FOREARM_MORPHOLOGY,1
GSE29618_PRE_VS_DAY7_POST_LA...6,SET,182,-0.020384,-0.0020184,0.063639,0.62563,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP,1
ZHAN_MULTIPLE_MYELOMA_PR_DN,SET,45,-0.044371,-0.0021929,0.13852,0.62564,ZHAN_MULTIPLE_MYELOMA_PR_DN,1
GOCC_PHOTORECEPTOR_DISC_MEMB...,SET,18,-0.062296,-0.0019486,0.19447,0.62564,GOCC_PHOTORECEPTOR_DISC_MEMBRANE,1
HP_BICARBONATURIA,SET,5,-0.11205,-0.0018479,0.34958,0.62571,HP_BICARBONATURIA,1
GSE6674_PL2_3_VS_ANTI_IGM_AN...1,SET,179,-0.02142,-0.0021037,0.066793,0.62578,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
GSE339_EX_VIVO_VS_IN_CULTURE...4,SET,187,-0.019834,-0.0019905,0.061792,0.62589,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP,1
GSE37416_CTRL_VS_12H_F_TULAR...1,SET,175,-0.020025,-0.0019447,0.062378,0.6259,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOBP_EXOCYST_LOCALIZATION,SET,5,-0.12258,-0.0020217,0.3818,0.62592,GOBP_EXOCYST_LOCALIZATION,1
GOBP_CELLULAR_RESPONSE_TO_ET...2,SET,6,-0.10029,-0.0018119,0.31232,0.62594,GOBP_CELLULAR_RESPONSE_TO_ETHER,1
HE_LIM_SUN_FETAL_LUNG_C1_GHR...1,SET,140,-0.025196,-0.0021907,0.078417,0.62601,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL,1
WP_COMPLEMENT_SYSTEM_IN_NEUR...,SET,95,-0.02994,-0.002147,0.093147,0.62605,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1
GOBP_RESPONSE_TO_TUMOR_NECRO...,SET,213,-0.019451,-0.0020819,0.060519,0.62605,GOBP_RESPONSE_TO_TUMOR_NECROSIS_FACTOR,1
REACTOME_ACTIVATED_NTRK3_SIG...2,SET,8,-0.086323,-0.0018006,0.26845,0.6261,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS,1
GOBP_SPROUTING_ANGIOGENESIS,SET,126,-0.025987,-0.0021443,0.080818,0.6261,GOBP_SPROUTING_ANGIOGENESIS,1
GSE360_DC_VS_MAC_B_MALAYI_HI...2,SET,181,-0.020459,-0.0020204,0.063616,0.62612,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP,1
HP_OSTEOARTHRITIS_OF_THE_SMA...,SET,4,-0.14627,-0.0021577,0.45478,0.62613,HP_OSTEOARTHRITIS_OF_THE_SMALL_JOINTS_OF_THE_HAND,1
MIR335_3P,SET,786,-0.010349,-0.002094,0.03216,0.6262,MIR335_3P,1
GOMF_INSULIN_RECEPTOR_SUBSTR...,SET,13,-0.076669,-0.0020384,0.23824,0.6262,GOMF_INSULIN_RECEPTOR_SUBSTRATE_BINDING,1
GSE6259_BCELL_VS_CD4_TCELL_UP,SET,154,-0.021876,-0.0019941,0.067956,0.62624,GSE6259_BCELL_VS_CD4_TCELL_UP,1
HP_MULTIPLE_SUTURE_CRANIOSYN...,SET,11,-0.091286,-0.0022326,0.28349,0.62627,HP_MULTIPLE_SUTURE_CRANIOSYNOSTOSIS,1
GOBP_LUNG_LOBE_DEVELOPMENT,SET,7,-0.12456,-0.0024304,0.38676,0.62629,GOBP_LUNG_LOBE_DEVELOPMENT,1
GSE14000_UNSTIM_VS_16H_LPS_D...3,SET,180,-0.020331,-0.0020022,0.063126,0.6263,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP,1
MIR11400,SET,8,-0.085753,-0.0017888,0.26614,0.62635,MIR11400,1
GOBP_NEGATIVE_REGULATION_OF_...47,SET,20,-0.060305,-0.0019883,0.18716,0.62635,GOBP_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION,1
GOBP_REGULATION_OF_NEUROTROP...,SET,9,-0.089279,-0.0019752,0.27704,0.62637,GOBP_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
HP_CACHEXIA,SET,89,-0.027416,-0.0019033,0.085073,0.62637,HP_CACHEXIA,1
GSE17721_CTRL_VS_GARDIQUIMOD...16,SET,179,-0.020598,-0.0020229,0.063907,0.62639,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP,1
REACTOME_G2_PHASE,SET,5,-0.13068,-0.0021551,0.40531,0.62643,REACTOME_G2_PHASE,1
TSAI_RESPONSE_TO_RADIATION_T...,SET,28,-0.059313,-0.0023134,0.18395,0.62644,TSAI_RESPONSE_TO_RADIATION_THERAPY,1
GOMF_CCR6_CHEMOKINE_RECEPTOR...,SET,5,-0.1469,-0.0024226,0.45548,0.62646,GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING,1
WONG_ENDOMETRIAL_CANCER_LATE,SET,7,-0.11852,-0.0023127,0.36735,0.62651,WONG_ENDOMETRIAL_CANCER_LATE,1
chr10q11,SET,45,-0.073178,-0.0036167,0.22681,0.62652,chr10q11,1
BOYAULT_LIVER_CANCER_SUBCLAS...4,SET,38,-0.042731,-0.001941,0.1324,0.62655,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,1
GOBP_ATRIOVENTRICULAR_CANAL_...,SET,13,-0.083555,-0.0022215,0.25886,0.62657,GOBP_ATRIOVENTRICULAR_CANAL_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...449,SET,38,-0.043183,-0.0019616,0.13376,0.62658,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,1
KEGG_GLYCEROPHOSPHOLIPID_MET...,SET,69,-0.034034,-0.0020815,0.10541,0.6266,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,1
WP_EXERCISEINDUCED_CIRCADIAN...,SET,46,-0.041661,-0.0020817,0.12901,0.62663,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1
DOANE_BREAST_CANCER_CLASSES_...1,SET,32,-0.051582,-0.0021505,0.15967,0.62667,DOANE_BREAST_CANCER_CLASSES_DN,1
GOBP_PURINE_NUCLEOSIDE_TRANS...,SET,5,-0.12581,-0.0020749,0.38943,0.62667,GOBP_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,1
GOCC_EMC_COMPLEX,SET,8,-0.093988,-0.0019605,0.29095,0.62667,GOCC_EMC_COMPLEX,1
MIR4705,SET,111,-0.027432,-0.0021254,0.084906,0.62668,MIR4705,1
GOBP_COP9_SIGNALOSOME_ASSEMB...,SET,5,-0.13029,-0.0021487,0.40326,0.62668,GOBP_COP9_SIGNALOSOME_ASSEMBLY,1
KRAS.KIDNEY_UP.V1_UP,SET,127,-0.027075,-0.002243,0.083769,0.62673,KRAS.KIDNEY_UP.V1_UP,1
WP_PDGFRBETA_PATHWAY,SET,28,-0.054636,-0.002131,0.169,0.62676,WP_PDGFRBETA_PATHWAY,1
GOBP_CELL_ADHESION_MEDIATED_...,SET,82,-0.031451,-0.0020962,0.097256,0.6268,GOBP_CELL_ADHESION_MEDIATED_BY_INTEGRIN,1
DESCARTES_FETAL_PANCREAS_ENS...1,SET,58,-0.038754,-0.0021737,0.11982,0.62682,DESCARTES_FETAL_PANCREAS_ENS_GLIA,1
DESCARTES_MAIN_FETAL_AMACRIN...,SET,16,-0.076353,-0.0022519,0.23604,0.62683,DESCARTES_MAIN_FETAL_AMACRINE_CELLS,1
GSE21927_C26GM_VS_4T1_TUMOR_...1,SET,176,-0.019998,-0.0019477,0.06175,0.62698,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,1
HP_SENSORY_AXONAL_NEUROPATHY,SET,36,-0.045132,-0.0019956,0.13921,0.6271,HP_SENSORY_AXONAL_NEUROPATHY,1
HP_ABNORMALITY_OF_AMINO_ACID...,SET,7,-0.10322,-0.0020141,0.31838,0.62711,HP_ABNORMALITY_OF_AMINO_ACID_METABOLISM,1
CHEN_HOXA5_TARGETS_9HR_DN,SET,37,-0.047027,-0.0021079,0.14503,0.62712,CHEN_HOXA5_TARGETS_9HR_DN,1
GOCC_SUMO_LIGASE_COMPLEX,SET,10,-0.090683,-0.0021148,0.27961,0.62715,GOCC_SUMO_LIGASE_COMPLEX,1
GOBP_BROWN_FAT_CELL_DIFFEREN...,SET,50,-0.040285,-0.0020984,0.12421,0.62716,GOBP_BROWN_FAT_CELL_DIFFERENTIATION,1
HP_SYMPHALANGISM_OF_MIDDLE_P...2,SET,5,-0.12739,-0.0021009,0.3926,0.62721,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_FINGER,1
MIR661,SET,146,-0.023024,-0.0020439,0.070928,0.62726,MIR661,1
POS_HISTAMINE_RESPONSE_NETWO...,SET,27,-0.054688,-0.0020946,0.16837,0.62734,POS_HISTAMINE_RESPONSE_NETWORK,1
GOMF_CALCIUM_MONOATOMIC_CATI...,SET,13,-0.088752,-0.0023596,0.2732,0.62735,GOMF_CALCIUM_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,1
CTTTGCA_MIR527,SET,215,-0.019012,-0.0020443,0.058497,0.62741,CTTTGCA_MIR527,1
MODULE_152,SET,102,-0.025257,-0.0018764,0.077709,0.62741,MODULE_152,1
REACTOME_BINDING_AND_UPTAKE_...,SET,39,-0.048249,-0.0022203,0.14843,0.62743,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,1
GOBP_GLOMERULAR_EPITHELIUM_D...,SET,25,-0.063637,-0.0023455,0.19577,0.62743,GOBP_GLOMERULAR_EPITHELIUM_DEVELOPMENT,1
HP_INVOLUNTARY_VOCALIZATION,SET,42,-0.042564,-0.0020324,0.13092,0.62745,HP_INVOLUNTARY_VOCALIZATION,1
REACTOME_SHC_RELATED_EVENTS_...,SET,9,-0.085906,-0.0019006,0.26419,0.62747,REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R,1
DESCARTES_FETAL_EYE_HORIZONT...,SET,13,-0.08059,-0.0021426,0.24781,0.62749,DESCARTES_FETAL_EYE_HORIZONTAL_CELLS,1
LINDGREN_BLADDER_CANCER_CLUS...6,SET,205,-0.019245,-0.0020212,0.059173,0.6275,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,1
MIR1255A_MIR1255B_5P,SET,65,-0.034108,-0.0020248,0.10485,0.62753,MIR1255A_MIR1255B_5P,1
FINETTI_BREAST_CANCERS_KINOM...1,SET,20,-0.060563,-0.0019968,0.18614,0.62754,FINETTI_BREAST_CANCERS_KINOME_BLUE,1
REACTOME_FORMATION_OF_FIBRIN...,SET,36,-0.051454,-0.0022751,0.1581,0.62758,REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,1
GOMF_ROUNDABOUT_BINDING,SET,8,-0.10856,-0.0022644,0.33347,0.62761,GOMF_ROUNDABOUT_BINDING,1
DOANE_BREAST_CANCER_ESR1_UP,SET,102,-0.029424,-0.0021859,0.090365,0.62764,DOANE_BREAST_CANCER_ESR1_UP,1
GOCC_CD40_RECEPTOR_COMPLEX,SET,11,-0.077136,-0.0018866,0.2369,0.62764,GOCC_CD40_RECEPTOR_COMPLEX,1
GOBP_PROTEIN_HOMOTETRAMERIZA...,SET,60,-0.03607,-0.0020576,0.11077,0.62765,GOBP_PROTEIN_HOMOTETRAMERIZATION,1
REACTOME_SIGNAL_REGULATORY_P...,SET,14,-0.081939,-0.0022607,0.25156,0.62768,REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS,1
WP_FOLATE_METABOLISM,SET,66,-0.037036,-0.0022154,0.11369,0.6277,WP_FOLATE_METABOLISM,1
GGGACCA_MIR133A_MIR133B,SET,184,-0.021845,-0.0021748,0.067056,0.6277,GGGACCA_MIR133A_MIR133B,1
YAGUE_PRETUMOR_DRUG_RESISTAN...1,SET,12,-0.07701,-0.0019672,0.23637,0.62771,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,1
GSE29615_CTRL_VS_DAY3_LAIV_I...1,SET,153,-0.021607,-0.0019632,0.066314,0.62772,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN,1
GSE25123_WT_VS_PPARG_KO_MACR...7,SET,181,-0.020801,-0.0020542,0.06383,0.62774,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,1
BIOCARTA_HBX_PATHWAY,SET,7,-0.098561,-0.0019232,0.30243,0.62775,BIOCARTA_HBX_PATHWAY,1
GOBP_SIGNAL_PEPTIDE_PROCESSI...,SET,13,-0.075826,-0.002016,0.23246,0.62785,GOBP_SIGNAL_PEPTIDE_PROCESSING,1
GSE45365_BCELL_VS_CD8_TCELL_...1,SET,137,-0.024087,-0.0020719,0.073829,0.62788,GSE45365_BCELL_VS_CD8_TCELL_DN,1
WP_MAPK_CASCADE,SET,31,-0.048165,-0.0019765,0.14762,0.62789,WP_MAPK_CASCADE,1
HP_ABNORMALITY_OF_VISION,SET,1187,-0.0083704,-0.0020574,0.025652,0.6279,HP_ABNORMALITY_OF_VISION,1
GOBP_PERIPHERAL_NERVOUS_SYST...3,SET,83,-0.032257,-0.0021628,0.098828,0.62793,GOBP_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT,1
PEDERSEN_METASTASIS_BY_ERBB2...2,SET,17,-0.076874,-0.002337,0.23549,0.62795,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,1
NABA_MATRISOME_PRIMARY_METAS...,SET,54,-0.042362,-0.0022929,0.12976,0.62796,NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR,1
GOBP_ESTABLISHMENT_OR_MAINTE...5,SET,11,-0.097195,-0.0023772,0.29765,0.62799,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_TRANSMEMBRANE_ELECTROCHEMICAL_GRADIENT,1
WP_PI3KAKTMTOR_VITAMIN_D3_SI...,SET,20,-0.066534,-0.0021937,0.20374,0.628,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,1
HP_APLASIA_HYPOPLASIA_OF_THE...11,SET,80,-0.030813,-0.0020285,0.094316,0.62805,HP_APLASIA_HYPOPLASIA_OF_THE_BRAINSTEM,1
GOBP_REGULATION_OF_FATTY_ACI...5,SET,31,-0.053682,-0.0022029,0.16429,0.62807,GOBP_REGULATION_OF_FATTY_ACID_TRANSPORT,1
BLANCO_MELO_HUMAN_PARAINFLUE...2,SET,188,-0.022189,-0.0022327,0.0679,0.62808,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,1
HP_ABNORMALITY_OF_SKIN_PHYSI...,SET,505,-0.012737,-0.0020821,0.038978,0.62808,HP_ABNORMALITY_OF_SKIN_PHYSIOLOGY,1
FOURATI_BLOOD_TWINRIX_AGE_65...1,SET,4,-0.15803,-0.0023312,0.48352,0.6281,FOURATI_BLOOD_TWINRIX_AGE_65_81Y0_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_UP,1
HP_SEVERE_VIRAL_INFECTION,SET,29,-0.051131,-0.0020295,0.15644,0.62811,HP_SEVERE_VIRAL_INFECTION,1
MIR4732_3P,SET,81,-0.031941,-0.0021158,0.0977,0.62814,MIR4732_3P,1
GOBP_VIRAL_BUDDING,SET,25,-0.053871,-0.0019855,0.16477,0.62814,GOBP_VIRAL_BUDDING,1
HP_POSTPRANDIAL_HYPERGLYCEMIA,SET,7,-0.115,-0.002244,0.35154,0.62822,HP_POSTPRANDIAL_HYPERGLYCEMIA,1
GOBP_NEGATIVE_REGULATION_OF_...251,SET,24,-0.064513,-0.0023298,0.19713,0.62827,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,1
GSE34515_CD16_POS_MONOCYTE_V...2,SET,188,-0.020693,-0.0020822,0.063226,0.62827,GSE34515_CD16_POS_MONOCYTE_VS_DC_UP,1
HP_ANISOCYTOSIS,SET,17,-0.073987,-0.0022492,0.226,0.62831,HP_ANISOCYTOSIS,1
GOMF_RETINOIC_ACID_4_HYDROXY...,SET,10,-0.09909,-0.0023108,0.3026,0.62834,GOMF_RETINOIC_ACID_4_HYDROXYLASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...318,SET,14,-0.078841,-0.0021752,0.24075,0.62835,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
GOMF_EXONUCLEASE_ACTIVITY_AC...,SET,58,-0.034383,-0.0019285,0.10499,0.62835,GOMF_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,1
GSE14908_RESTING_VS_HDM_STIM...2,SET,177,-0.019886,-0.0019422,0.060704,0.62839,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP,1
HP_ABNORMAL_SHAPE_OF_THE_PAL...,SET,51,-0.038201,-0.0020096,0.1166,0.6284,HP_ABNORMAL_SHAPE_OF_THE_PALPEBRAL_FISSURE,1
GOBP_AMINE_CATABOLIC_PROCESS,SET,14,-0.085968,-0.0023718,0.26215,0.62852,GOBP_AMINE_CATABOLIC_PROCESS,1
GOBP_NEUROFILAMENT_CYTOSKELE...,SET,10,-0.084281,-0.0019655,0.25693,0.62855,GOBP_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION,1
GOMF_NF_KAPPAB_BINDING,SET,28,-0.049291,-0.0019225,0.15023,0.62858,GOMF_NF_KAPPAB_BINDING,1
GLI1_UP.V1_DN,SET,16,-0.067642,-0.001995,0.20616,0.62858,GLI1_UP.V1_DN,1
GOBP_RESPONSE_TO_LEPTIN,SET,21,-0.064655,-0.0021843,0.19705,0.62859,GOBP_RESPONSE_TO_LEPTIN,1
HP_SUICIDAL_IDEATION,SET,21,-0.058848,-0.0019881,0.17929,0.62863,HP_SUICIDAL_IDEATION,1
MORF_SUPT3H,SET,288,-0.017098,-0.0021235,0.052087,0.62864,MORF_SUPT3H,1
HP_PREAXIAL_POLYDACTYLY,SET,73,-0.030676,-0.0019295,0.093441,0.62865,HP_PREAXIAL_POLYDACTYLY,1
FAN_OVARY_CL14_MATURE_SMOOTH...,SET,268,-0.01759,-0.0021087,0.053579,0.62866,FAN_OVARY_CL14_MATURE_SMOOTH_MUSCLE_CELL,1
GSE22935_WT_VS_MYD88_KO_MACR...2,SET,188,-0.020421,-0.0020548,0.062189,0.62868,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP,1
GOBP_CARBOHYDRATE_CATABOLIC_...,SET,157,-0.021523,-0.0019808,0.065507,0.62875,GOBP_CARBOHYDRATE_CATABOLIC_PROCESS,1
GOBP_EXCITATORY_SYNAPSE_ASSE...,SET,34,-0.05187,-0.002229,0.15776,0.62884,GOBP_EXCITATORY_SYNAPSE_ASSEMBLY,1
HP_ABNORMAL_CORONARY_ARTERY_...1,SET,68,-0.036753,-0.0022315,0.11177,0.62885,HP_ABNORMAL_CORONARY_ARTERY_MORPHOLOGY,1
KIM_GERMINAL_CENTER_T_HELPER...2,SET,57,-0.039175,-0.0021783,0.11909,0.6289,KIM_GERMINAL_CENTER_T_HELPER_UP,1
KEGG_MEDICUS_VARIANT_EML4_AL...3,SET,13,-0.080523,-0.0021409,0.2447,0.62895,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY,1
HP_SCHIZENCEPHALY,SET,9,-0.11165,-0.0024702,0.33926,0.62896,HP_SCHIZENCEPHALY,1
GOMF_KINASE_INHIBITOR_ACTIVI...,SET,73,-0.033801,-0.0021261,0.1027,0.62897,GOMF_KINASE_INHIBITOR_ACTIVITY,1
MIR593_3P,SET,127,-0.02611,-0.002163,0.079324,0.62898,MIR593_3P,1
REACTOME_LIPOPHAGY,SET,9,-0.094817,-0.0020977,0.28802,0.62899,REACTOME_LIPOPHAGY,1
GOMF_PASSIVE_TRANSMEMBRANE_T...,SET,454,-0.014561,-0.0022601,0.044225,0.62901,GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
PICCALUGA_ANGIOIMMUNOBLASTIC...1,SET,117,-0.027789,-0.0022102,0.084288,0.62918,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,1
MIR2110,SET,160,-0.021827,-0.0020277,0.066196,0.6292,MIR2110,1
HP_TRACHEOMALACIA,SET,43,-0.042293,-0.0020434,0.1282,0.62925,HP_TRACHEOMALACIA,1
HP_TESTICULAR_DYSGENESIS,SET,10,-0.096827,-0.002258,0.29341,0.6293,HP_TESTICULAR_DYSGENESIS,1
GOBP_DEOXYRIBONUCLEOSIDE_DIP...,SET,5,-0.12233,-0.0020175,0.37062,0.62932,GOBP_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
DARWICHE_SKIN_TUMOR_PROMOTER...1,SET,175,-0.02095,-0.0020346,0.063453,0.62936,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1
GSE5503_MLN_DC_VS_SPLEEN_DC_...2,SET,178,-0.021524,-0.002108,0.065148,0.62944,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
CREIGHTON_ENDOCRINE_THERAPY_...5,SET,430,-0.014091,-0.00213,0.042641,0.62947,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1
MODULE_401,SET,16,-0.078437,-0.0023134,0.23734,0.62948,MODULE_401,1
LINDSTEDT_DENDRITIC_CELL_MAT...4,SET,60,-0.037467,-0.0021373,0.11326,0.6296,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,1
GOCC_SPERM_MITOCHONDRIAL_SHE...,SET,6,-0.11843,-0.0021395,0.35791,0.62963,GOCC_SPERM_MITOCHONDRIAL_SHEATH,1
GNF2_ST13,SET,57,-0.035599,-0.0019795,0.10758,0.62964,GNF2_ST13,1
BUSSLINGER_GASTRIC_D_CELLS,SET,24,-0.065952,-0.0023818,0.19925,0.62967,BUSSLINGER_GASTRIC_D_CELLS,1
GSE7768_OVA_ALONE_VS_OVA_WIT...2,SET,155,-0.022111,-0.002022,0.066778,0.62972,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
GOCC_CONDENSED_CHROMOSOME,SET,250,-0.017107,-0.0019816,0.05166,0.62973,GOCC_CONDENSED_CHROMOSOME,1
GOBP_FOLLICLE_STIMULATING_HO...,SET,8,-0.11577,-0.002415,0.34938,0.62981,GOBP_FOLLICLE_STIMULATING_HORMONE_SECRETION,1
GOBP_RESPONSE_TO_BACTERIAL_L...,SET,8,-0.10335,-0.0021558,0.31189,0.62981,GOBP_RESPONSE_TO_BACTERIAL_LIPOPROTEIN,1
MIR6848_5P,SET,70,-0.034622,-0.0021326,0.10446,0.62984,MIR6848_5P,1
GOBP_ACTIVATION_OF_PHOSPHOLI...,SET,21,-0.06681,-0.0022571,0.20154,0.62986,GOBP_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY,1
HP_WRITER_S_CRAMP,SET,18,-0.064642,-0.002022,0.195,0.62986,HP_WRITER_S_CRAMP,1
GOBP_PROTEIN_UNFOLDING,SET,5,-0.11667,-0.0019242,0.35187,0.62989,GOBP_PROTEIN_UNFOLDING,1
KEGG_MEDICUS_REFERENCE_PURIN...2,SET,10,-0.091142,-0.0021254,0.27487,0.6299,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP,1
MARTORIATI_MDM4_TARGETS_FETA...2,SET,211,-0.019641,-0.0020924,0.059228,0.62991,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1
ERR1_Q2,SET,231,-0.018909,-0.0021066,0.057013,0.62993,ERR1_Q2,1
GOBP_METANEPHROS_MORPHOGENES...,SET,30,-0.059811,-0.0024146,0.18029,0.62996,GOBP_METANEPHROS_MORPHOGENESIS,1
GSE10500_ARTHRITIC_SYNOVIAL_...2,SET,136,-0.024169,-0.0020715,0.072837,0.62999,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP,1
GOBP_MITOCHONDRION_LOCALIZAT...,SET,45,-0.04302,-0.0021261,0.12964,0.63,GOBP_MITOCHONDRION_LOCALIZATION,1
REACTOME_MHC_CLASS_II_ANTIGE...,SET,117,-0.026449,-0.0021036,0.079688,0.63002,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1
GSE22103_UNSTIM_VS_GMCSF_AND...1,SET,188,-0.019649,-0.0019772,0.059193,0.63004,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,1
GOBP_ENDOCARDIUM_DEVELOPMENT,SET,12,-0.093566,-0.0023901,0.2817,0.63011,GOBP_ENDOCARDIUM_DEVELOPMENT,1
DESCARTES_FETAL_HEART_STROMA...,SET,25,-0.062073,-0.0022879,0.18665,0.63027,DESCARTES_FETAL_HEART_STROMAL_CELLS,1
GOCC_GOLGI_APPARATUS,SET,1466,-0.007795,-0.002112,0.023429,0.63032,GOCC_GOLGI_APPARATUS,1
AIZARANI_LIVER_C31_KUPFFER_C...,SET,107,-0.028095,-0.0021375,0.084438,0.63033,AIZARANI_LIVER_C31_KUPFFER_CELLS_5,1
MIR6728_5P,SET,66,-0.03381,-0.0020225,0.10159,0.63035,MIR6728_5P,1
MIR106B_5P,SET,632,-0.011681,-0.0021285,0.035094,0.63037,MIR106B_5P,1
GOBP_NEGATIVE_REGULATION_OF_...247,SET,953,-0.0093514,-0.0020735,0.02809,0.6304,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION,1
HP_APLASIA_HYPOPLASIA_OF_THE...72,SET,23,-0.059591,-0.0021068,0.179,0.6304,HP_APLASIA_HYPOPLASIA_OF_THE_THYROID_GLAND,1
BOYLAN_MULTIPLE_MYELOMA_C_UP,SET,44,-0.045054,-0.0022018,0.13529,0.63043,BOYLAN_MULTIPLE_MYELOMA_C_UP,1
GOBP_POSITIVE_REGULATION_OF_...592,SET,97,-0.029959,-0.0021708,0.089966,0.63043,GOBP_POSITIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,1
LEE_LIVER_CANCER_SURVIVAL_DN,SET,165,-0.022447,-0.0021174,0.067398,0.63045,LEE_LIVER_CANCER_SURVIVAL_DN,1
HP_OLIGODONTIA,SET,52,-0.038936,-0.0020682,0.11689,0.63047,HP_OLIGODONTIA,1
GOMF_SODIUM_ION_TRANSMEMBRAN...,SET,156,-0.024531,-0.0022505,0.073637,0.63048,GOMF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HOLLEMAN_VINCRISTINE_RESISTA...3,SET,16,-0.069753,-0.0020572,0.20938,0.63049,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...2,SET,120,-0.025606,-0.0020623,0.076861,0.63049,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP,1
GOBP_CELLULAR_RESPONSE_TO_BI...,SET,232,-0.020052,-0.0022387,0.060183,0.6305,GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS,1
GOBP_INTRACELLULAR_TRANSPORT...,SET,10,-0.09247,-0.0021564,0.27754,0.6305,GOBP_INTRACELLULAR_TRANSPORT_OF_VIRUS,1
HP_ABNORMAL_POSTERIOR_SEGMEN...,SET,41,-0.048876,-0.0023059,0.14664,0.63054,HP_ABNORMAL_POSTERIOR_SEGMENT_IMAGING,1
CUI_DEVELOPING_HEART_TRABECU...2,SET,99,-0.028307,-0.002072,0.084869,0.63063,CUI_DEVELOPING_HEART_TRABECULAR_VENTRICULAR_CARDIOMYOCYTE,1
GOBP_ASPARTATE_FAMILY_AMINO_...2,SET,12,-0.082411,-0.0021051,0.24706,0.63064,GOBP_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_CD8_T...7,SET,48,-0.042987,-0.002194,0.12885,0.63066,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_INTERFERON,1
GCM_MYCL1,SET,23,-0.054676,-0.001933,0.1638,0.63073,GCM_MYCL1,1
GOCC_BLOOD_MICROPARTICLE,SET,98,-0.031463,-0.0022914,0.094249,0.63074,GOCC_BLOOD_MICROPARTICLE,1
MIR4421,SET,49,-0.040743,-0.002101,0.12205,0.63075,MIR4421,1
STAT5A_02,SET,124,-0.026463,-0.0021664,0.079267,0.63075,STAT5A_02,1
KEGG_MEDICUS_REFERENCE_TETHE...,SET,9,-0.087504,-0.001936,0.26208,0.63076,KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,1
GSE40274_SATB1_VS_FOXP3_AND_...2,SET,155,-0.022423,-0.0020506,0.067116,0.63084,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
MIR514A_3P_MIR514B_3P,SET,101,-0.028521,-0.0021085,0.085365,0.63085,MIR514A_3P_MIR514B_3P,1
HP_APLASIA_OF_THE_PHALANGES_...,SET,8,-0.095673,-0.0019957,0.28616,0.63093,HP_APLASIA_OF_THE_PHALANGES_OF_THE_TOES,1
GAUCHER_PBMC_YF_VAX_STAMARIL...8,SET,206,-0.020708,-0.0021801,0.061924,0.63096,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP,1
HP_ABNORMAL_LYMPHOCYTE_PROLI...,SET,39,-0.046057,-0.0021194,0.1377,0.63099,HP_ABNORMAL_LYMPHOCYTE_PROLIFERATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...58,SET,26,-0.05687,-0.0021375,0.16993,0.63106,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,1
GOBP_CELLULAR_COMPONENT_MAIN...,SET,65,-0.03781,-0.0022446,0.11292,0.63113,GOBP_CELLULAR_COMPONENT_MAINTENANCE,1
RICKMAN_HEAD_AND_NECK_CANCER...5,SET,75,-0.035527,-0.0022649,0.10609,0.63114,RICKMAN_HEAD_AND_NECK_CANCER_E,1
BRUINS_UVC_RESPONSE_EARLY_LA...,SET,286,-0.016527,-0.0020456,0.049339,0.63117,BRUINS_UVC_RESPONSE_EARLY_LATE,1
REACTOME_UREA_CYCLE,SET,9,-0.092243,-0.0020408,0.27539,0.63117,REACTOME_UREA_CYCLE,1
MODULE_294,SET,18,-0.062076,-0.0019418,0.18526,0.63122,MODULE_294,1
DESCARTES_FETAL_HEART_VASCUL...,SET,16,-0.078021,-0.0023011,0.23279,0.63124,DESCARTES_FETAL_HEART_VASCULAR_ENDOTHELIAL_CELLS,1
GOBP_QUINONE_METABOLIC_PROCE...,SET,21,-0.056184,-0.0018981,0.16763,0.63125,GOBP_QUINONE_METABOLIC_PROCESS,1
GSE2770_IL12_AND_TGFB_ACT_VS...6,SET,171,-0.022284,-0.0021395,0.066477,0.63126,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP,1
MORF_FEN1,SET,56,-0.035469,-0.0019549,0.10575,0.63134,MORF_FEN1,1
GOBP_PML_BODY_ORGANIZATION,SET,6,-0.11679,-0.0021099,0.34789,0.63145,GOBP_PML_BODY_ORGANIZATION,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...5,SET,186,-0.021165,-0.0021185,0.063006,0.63153,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN,1
KEGG_MEDICUS_REFERENCE_RAB7_...,SET,40,-0.046564,-0.00217,0.13854,0.63161,KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT,1
GSE17974_CTRL_VS_ACT_IL4_AND...8,SET,167,-0.023156,-0.0021973,0.068888,0.63161,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP,1
GOBP_T_CELL_LINEAGE_COMMITME...,SET,35,-0.050779,-0.0022139,0.15105,0.63163,GOBP_T_CELL_LINEAGE_COMMITMENT,1
GOMF_K63_LINKED_POLYUBIQUITI...,SET,22,-0.054096,-0.0018705,0.16088,0.63166,GOMF_K63_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
MIR8080,SET,127,-0.025627,-0.0021229,0.076202,0.63167,MIR8080,1
GOBP_ENDOPLASMIC_RETICULUM_L...,SET,9,-0.1072,-0.0023717,0.31877,0.63167,GOBP_ENDOPLASMIC_RETICULUM_LOCALIZATION,1
REACTOME_ZINC_TRANSPORTERS,SET,15,-0.069584,-0.0019871,0.2069,0.63168,REACTOME_ZINC_TRANSPORTERS,1
GSE17721_CPG_VS_GARDIQUIMOD_...4,SET,184,-0.021823,-0.0021727,0.064889,0.63168,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP,1
GOCC_SARCOPLASM,SET,92,-0.029714,-0.0020971,0.088344,0.63169,GOCC_SARCOPLASM,1
GOBP_NUCLEOTIDE_SUGAR_BIOSYN...,SET,16,-0.071991,-0.0021232,0.21403,0.6317,GOBP_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS,1
GARGALOVIC_RESPONSE_TO_OXIDI...3,SET,59,-0.036284,-0.0020526,0.10787,0.63171,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,1
GNF2_TIMP2,SET,39,-0.052551,-0.0024182,0.15618,0.63175,GNF2_TIMP2,1
GOBP_RESPONSE_TO_PEPTIDE,SET,20,-0.068721,-0.0022658,0.20419,0.63177,GOBP_RESPONSE_TO_PEPTIDE,1
GSE1460_CD4_THYMOCYTE_VS_THY...2,SET,177,-0.021362,-0.0020863,0.06344,0.63183,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,1
GOMF_SINGLE_STRANDED_DNA_BIN...,SET,107,-0.026613,-0.0020248,0.079008,0.63188,GOMF_SINGLE_STRANDED_DNA_BINDING,1
GSE17721_ALL_VS_24H_PAM3CSK4...1,SET,174,-0.021428,-0.0020751,0.063613,0.63188,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...739,SET,8,-0.10308,-0.0021501,0.30599,0.63189,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION,1
GSE43863_TH1_VS_TFH_MEMORY_C...2,SET,179,-0.021037,-0.0020661,0.06245,0.63189,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP,1
MIR759,SET,65,-0.039597,-0.0023507,0.11753,0.6319,MIR759,1
GRANDVAUX_IRF3_TARGETS_UP,SET,13,-0.081319,-0.002162,0.24129,0.63195,GRANDVAUX_IRF3_TARGETS_UP,1
WP_SPHINGOLIPID_METABOLISM_I...1,SET,23,-0.064365,-0.0022756,0.19075,0.6321,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,1
GOBP_REGULATION_OF_AUTOPHAGY...1,SET,39,-0.045059,-0.0020735,0.13353,0.63211,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,1
REACTOME_VITAMIN_C_ASCORBATE...,SET,7,-0.10496,-0.002048,0.31095,0.63214,REACTOME_VITAMIN_C_ASCORBATE_METABOLISM,1
GCM_PRKCG,SET,55,-0.036128,-0.0019735,0.10702,0.63216,GCM_PRKCG,1
CHIANG_LIVER_CANCER_SUBCLASS...10,SET,80,-0.033609,-0.0022126,0.099543,0.63218,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,1
chr13q32,SET,29,-0.10113,-0.0040143,0.29941,0.63223,chr13q32,1
GOBP_CARDIAC_MYOFIBRIL_ASSEM...,SET,19,-0.064808,-0.0020827,0.19184,0.63225,GOBP_CARDIAC_MYOFIBRIL_ASSEMBLY,1
GOBP_NEUTROPHIL_MEDIATED_CYT...,SET,15,-0.08471,-0.0024191,0.25075,0.63225,GOBP_NEUTROPHIL_MEDIATED_CYTOTOXICITY,1
HP_EOSINOPHILIC_INFILTRATION...,SET,10,-0.10454,-0.0024378,0.30941,0.63226,HP_EOSINOPHILIC_INFILTRATION_OF_THE_ESOPHAGUS,1
GSE26488_WT_VS_HDAC7_DELTAP_...2,SET,184,-0.022574,-0.0022475,0.066818,0.63226,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP,1
GOBP_ADAPTIVE_THERMOGENESIS,SET,160,-0.023526,-0.0021856,0.069622,0.63228,GOBP_ADAPTIVE_THERMOGENESIS,1
WP_2Q37_COPY_NUMBER_VARIATIO...,SET,124,-0.034239,-0.002803,0.10132,0.63229,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,1
ZNF354C_TARGET_GENES,SET,10,-0.086574,-0.0020189,0.2562,0.63229,ZNF354C_TARGET_GENES,1
GSE39110_UNTREATED_VS_IL2_TR...2,SET,182,-0.021964,-0.0021749,0.064994,0.63229,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP,1
HP_4_5_TOE_SYNDACTYLY,SET,8,-0.11383,-0.0023743,0.3368,0.6323,HP_4_5_TOE_SYNDACTYLY,1
KEGG_FRUCTOSE_AND_MANNOSE_ME...,SET,28,-0.048282,-0.0018831,0.14286,0.63231,KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,1
GSE7852_LN_VS_THYMUS_TREG_UP,SET,182,-0.021653,-0.0021441,0.064041,0.63236,GSE7852_LN_VS_THYMUS_TREG_UP,1
GAVISH_3CA_METAPROGRAM_EPITH...8,SET,49,-0.042676,-0.0022007,0.12621,0.63237,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3,1
GOBP_NOREPINEPHRINE_UPTAKE,SET,8,-0.12441,-0.0025951,0.3678,0.63241,GOBP_NOREPINEPHRINE_UPTAKE,1
GAVISH_3CA_MALIGNANT_METAPRO...33,SET,50,-0.04565,-0.0023778,0.13493,0.63244,GAVISH_3CA_MALIGNANT_METAPROGRAM_40_PDAC_RELATED,1
HP_AMEGAKARYOCYTIC_THROMBOCY...,SET,6,-0.11399,-0.0020594,0.33682,0.63248,HP_AMEGAKARYOCYTIC_THROMBOCYTOPENIA,1
REACTOME_CAMK_IV_MEDIATED_PH...,SET,10,-0.10447,-0.0024362,0.30846,0.63257,REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB,1
HP_RECURRENT_BRONCHITIS,SET,33,-0.052225,-0.002211,0.15415,0.63261,HP_RECURRENT_BRONCHITIS,1
MIR10397_3P,SET,42,-0.046613,-0.0022258,0.13753,0.63266,MIR10397_3P,1
GOMF_ANDROSTAN_3_ALPHA_17_BE...,SET,8,-0.11861,-0.0024741,0.34979,0.63273,GOMF_ANDROSTAN_3_ALPHA_17_BETA_DIOL_DEHYDROGENASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...55,SET,22,-0.071415,-0.0024694,0.21058,0.63274,GOBP_POSITIVE_REGULATION_OF_BEHAVIOR,1
HP_NUCHAL_RIGIDITY,SET,10,-0.088997,-0.0020754,0.2624,0.63275,HP_NUCHAL_RIGIDITY,1
FAN_EMBRYONIC_CTX_NSC_1,SET,16,-0.080899,-0.002386,0.23829,0.63288,FAN_EMBRYONIC_CTX_NSC_1,1
GOBP_NEURON_RECOGNITION,SET,46,-0.050479,-0.0025223,0.14867,0.6329,GOBP_NEURON_RECOGNITION,1
MYOD_01,SET,232,-0.019714,-0.002201,0.058052,0.63292,MYOD_01,1
GOBP_REGULATION_OF_DNA_TOPOI...,SET,5,-0.14604,-0.0024085,0.43004,0.63292,GOBP_REGULATION_OF_DNA_TOPOISOMERASE_ATP_HYDROLYZING_ACTIVITY,1
ZHOU_INFLAMMATORY_RESPONSE_F...2,SET,427,-0.01473,-0.002219,0.043366,0.63294,ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,1
GOBP_NEGATIVE_REGULATION_OF_...359,SET,6,-0.1146,-0.0020703,0.33737,0.63295,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...70,SET,21,-0.063372,-0.002141,0.18648,0.63301,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
GOMF_CGMP_BINDING,SET,15,-0.075225,-0.0021482,0.22135,0.63301,GOMF_CGMP_BINDING,1
GSE5455_EX_VIVO_VS_POST_24H_...1,SET,181,-0.021093,-0.002083,0.062048,0.63305,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN,1
HP_CEREBELLAR_ATROPHY,SET,393,-0.014008,-0.0020264,0.041191,0.6331,HP_CEREBELLAR_ATROPHY,1
GOCC_ESCRT_I_COMPLEX,SET,12,-0.085335,-0.0021798,0.25089,0.63312,GOCC_ESCRT_I_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...814,SET,9,-0.10521,-0.0023278,0.3093,0.63313,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,1
GOBP_TROPHOBLAST_CELL_MIGRAT...,SET,15,-0.076652,-0.002189,0.22528,0.63317,GOBP_TROPHOBLAST_CELL_MIGRATION,1
HANSON_HRAS_SIGNALING_VIA_NF...,SET,21,-0.065497,-0.0022128,0.19237,0.63325,HANSON_HRAS_SIGNALING_VIA_NFKB,1
REACTOME_INSERTION_OF_TAIL_A...,SET,18,-0.071759,-0.0022446,0.21075,0.63326,REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,1
LI_ESTROGENE_MID_E2_RESPONSE...2,SET,14,-0.084777,-0.002339,0.24894,0.63328,LI_ESTROGENE_MID_E2_RESPONSE_UP,1
GOMF_ACETYLCHOLINE_RECEPTOR_...2,SET,11,-0.09655,-0.0023614,0.2835,0.63328,GOMF_ACETYLCHOLINE_RECEPTOR_BINDING,1
GSE8868_SPLEEN_VS_INTESTINE_...1,SET,178,-0.021792,-0.0021343,0.063982,0.63329,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN,1
HOEK_MONOCYTE_2011_2012_TIV_...3,SET,4,-0.12451,-0.0018367,0.36553,0.6333,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_DN,1
GILDEA_METASTASIS,SET,28,-0.05735,-0.0022368,0.16828,0.63337,GILDEA_METASTASIS,1
GSE2770_TGFB_AND_IL4_VS_TGFB...6,SET,177,-0.022097,-0.0021581,0.064839,0.63337,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
HP_RECURRENT_ENTEROVIRAL_INF...,SET,3,-0.1704,-0.0021769,0.49998,0.63338,HP_RECURRENT_ENTEROVIRAL_INFECTIONS,1
REACTOME_ALPHA_OXIDATION_OF_...,SET,6,-0.14367,-0.0025954,0.42144,0.63341,REACTOME_ALPHA_OXIDATION_OF_PHYTANATE,1
MIR10393_3P,SET,96,-0.031345,-0.0022595,0.091929,0.63344,MIR10393_3P,1
WP_TGFB_SMAD_SIGNALING,SET,11,-0.10287,-0.002516,0.30168,0.63345,WP_TGFB_SMAD_SIGNALING,1
KIM_WT1_TARGETS_12HR_DN,SET,202,-0.020354,-0.0021222,0.059678,0.63347,KIM_WT1_TARGETS_12HR_DN,1
GSE360_DC_VS_MAC_L_MAJOR_UP,SET,172,-0.022296,-0.0021468,0.065362,0.63349,GSE360_DC_VS_MAC_L_MAJOR_UP,1
GOMF_TRANSCRIPTION_COACTIVAT...2,SET,40,-0.048921,-0.0022798,0.1434,0.6335,GOMF_TRANSCRIPTION_COACTIVATOR_BINDING,1
HP_JUVENILE_ONSET,SET,598,-0.011975,-0.0021246,0.035074,0.6336,HP_JUVENILE_ONSET,1
HP_HOFFMANN_SIGN,SET,9,-0.088619,-0.0019606,0.25954,0.63361,HP_HOFFMANN_SIGN,1
GSE15330_WT_VS_IKAROS_KO_HSC...1,SET,184,-0.021535,-0.002144,0.063068,0.63362,GSE15330_WT_VS_IKAROS_KO_HSC_DN,1
MIR5000_5P,SET,91,-0.030792,-0.0021614,0.090161,0.63364,MIR5000_5P,1
HP_STAPES_ANKYLOSIS,SET,6,-0.1319,-0.0023828,0.38618,0.63365,HP_STAPES_ANKYLOSIS,1
KANG_FLUOROURACIL_RESISTANCE...1,SET,16,-0.075681,-0.0022321,0.22156,0.63366,KANG_FLUOROURACIL_RESISTANCE_DN,1
BILD_MYC_ONCOGENIC_SIGNATURE,SET,181,-0.020666,-0.0020408,0.060484,0.6337,BILD_MYC_ONCOGENIC_SIGNATURE,1
MIR323B_5P,SET,38,-0.046085,-0.0020934,0.13488,0.6337,MIR323B_5P,1
MODULE_37,SET,428,-0.013839,-0.0020872,0.040484,0.63377,MODULE_37,1
GSE22886_UNSTIM_VS_IL15_STIM...1,SET,183,-0.020839,-0.0020691,0.060915,0.63386,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN,1
HP_DECREASED_CIRCULATING_FRE...2,SET,4,-0.12897,-0.0019025,0.37697,0.63387,HP_DECREASED_CIRCULATING_FREE_T4_CONCENTRATION,1
HP_DILATATION_OF_THE_VENTRIC...,SET,9,-0.09362,-0.0020713,0.27358,0.6339,HP_DILATATION_OF_THE_VENTRICULAR_CAVITY,1
GOBP_ADAPTIVE_IMMUNE_RESPONSE,SET,427,-0.015519,-0.0023378,0.045346,0.63391,GOBP_ADAPTIVE_IMMUNE_RESPONSE,1
HP_HIGH_PITCHED_VOICE,SET,41,-0.046792,-0.0022076,0.13665,0.63398,HP_HIGH_PITCHED_VOICE,1
WANG_ESOPHAGUS_CANCER_VS_NOR...2,SET,114,-0.02921,-0.0022935,0.0853,0.63399,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...227,SET,92,-0.031,-0.0021878,0.090527,0.63399,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
PAX3_B,SET,82,-0.035043,-0.0023355,0.10233,0.634,PAX3_B,1
GOBP_ALDITOL_PHOSPHATE_METAB...,SET,9,-0.10815,-0.0023927,0.31579,0.634,GOBP_ALDITOL_PHOSPHATE_METABOLIC_PROCESS,1
GOBP_RETINOIC_ACID_METABOLIC...,SET,33,-0.0597,-0.0025275,0.17431,0.63401,GOBP_RETINOIC_ACID_METABOLIC_PROCESS,1
AP1_Q2_01,SET,247,-0.019212,-0.0022123,0.056084,0.63403,AP1_Q2_01,1
GALI_TP53_TARGETS_APOPTOTIC_...1,SET,6,-0.10091,-0.0018229,0.29454,0.63404,GALI_TP53_TARGETS_APOPTOTIC_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...20,SET,10,-0.10196,-0.0023778,0.29759,0.63406,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,1
HP_ABNORMAL_RETINAL_VASCULAR...,SET,227,-0.01983,-0.0021902,0.057876,0.63406,HP_ABNORMAL_RETINAL_VASCULAR_MORPHOLOGY,1
GOBP_FATTY_ACID_BIOSYNTHETIC...,SET,147,-0.024575,-0.0021891,0.071688,0.63413,GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
REACTOME_ENDOGENOUS_STEROLS,SET,24,-0.062619,-0.0022614,0.18259,0.63418,REACTOME_ENDOGENOUS_STEROLS,1
GOCC_CHROMOSOME_PASSENGER_CO...,SET,6,-0.12318,-0.0022253,0.35919,0.63418,GOCC_CHROMOSOME_PASSENGER_COMPLEX,1
GOBP_MODULATION_BY_HOST_OF_S...,SET,79,-0.032426,-0.0021214,0.094516,0.63423,GOBP_MODULATION_BY_HOST_OF_SYMBIONT_PROCESS,1
GOBP_DNA_STRAND_ELONGATION_I...,SET,14,-0.066515,-0.0018351,0.19385,0.63424,GOBP_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION,1
REACTOME_CLASS_I_MHC_MEDIATE...,SET,353,-0.015377,-0.0021105,0.044803,0.63428,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1
GSE1925_CTRL_VS_IFNG_PRIMED_...3,SET,115,-0.028179,-0.0022221,0.082088,0.6343,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN,1
HP_ENLARGED_NARIS,SET,5,-0.13085,-0.002158,0.38116,0.63431,HP_ENLARGED_NARIS,1
GOBP_DITERPENOID_METABOLIC_P...,SET,86,-0.035854,-0.0024469,0.10443,0.63432,GOBP_DITERPENOID_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...723,SET,21,-0.063708,-0.0021523,0.18557,0.63432,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...733,SET,12,-0.082251,-0.0021011,0.23956,0.63433,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOMF_L_LEUCINE_BINDING,SET,6,-0.10567,-0.001909,0.30764,0.63438,GOMF_L_LEUCINE_BINDING,1
ZHAN_LATE_DIFFERENTIATION_GE...2,SET,28,-0.058186,-0.0022694,0.16936,0.63441,ZHAN_LATE_DIFFERENTIATION_GENES_UP,1
GOBP_REGULATION_OF_DENDRITIC...6,SET,41,-0.047056,-0.0022201,0.13697,0.63441,GOBP_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,1
HP_CHRONIC_AXONAL_NEUROPATHY,SET,7,-0.13331,-0.0026011,0.38794,0.63443,HP_CHRONIC_AXONAL_NEUROPATHY,1
REACTOME_PROTEIN_FOLDING,SET,92,-0.02942,-0.0020764,0.085598,0.63446,REACTOME_PROTEIN_FOLDING,1
HP_NON_SMALL_CELL_LUNG_CARCI...,SET,22,-0.059874,-0.0020703,0.1741,0.63454,HP_NON_SMALL_CELL_LUNG_CARCINOMA,1
MIR1246,SET,47,-0.043466,-0.0021953,0.12638,0.63455,MIR1246,1
GOBP_MEDIUM_CHAIN_FATTY_ACID...1,SET,6,-0.11024,-0.0019917,0.3205,0.63456,GOBP_MEDIUM_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_OSSIFICAT...,SET,111,-0.029596,-0.0022932,0.086038,0.63457,GOBP_REGULATION_OF_OSSIFICATION,1
GSE360_L_DONOVANI_VS_M_TUBER...1,SET,183,-0.021677,-0.0021523,0.063003,0.6346,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN,1
HP_ABNORMAL_DESCEMET_MEMBRAN...,SET,14,-0.08978,-0.002477,0.26078,0.63468,HP_ABNORMAL_DESCEMET_MEMBRANE_MORPHOLOGY,1
MIR3618,SET,88,-0.03227,-0.0022277,0.093722,0.63469,MIR3618,1
GOMF_HEPARAN_SULFATE_BINDING,SET,7,-0.11858,-0.0023139,0.34425,0.63475,GOMF_HEPARAN_SULFATE_BINDING,1
MIR4438,SET,61,-0.038402,-0.0022087,0.11142,0.63482,MIR4438,1
MORF_DAP3,SET,175,-0.020396,-0.0019808,0.059163,0.63486,MORF_DAP3,1
GOBP_CALMODULIN_DEPENDENT_KI...,SET,12,-0.087717,-0.0022407,0.25437,0.63489,GOBP_CALMODULIN_DEPENDENT_KINASE_SIGNALING_PATHWAY,1
MIR8062,SET,97,-0.029229,-0.0021179,0.084748,0.63491,MIR8062,1
MIR29B_1_5P,SET,155,-0.023651,-0.0021628,0.06857,0.63492,MIR29B_1_5P,1
HP_WHEEZING,SET,52,-0.040077,-0.0021288,0.11618,0.63494,HP_WHEEZING,1
ZNF404_TARGET_GENES,SET,17,-0.063174,-0.0019205,0.18311,0.63495,ZNF404_TARGET_GENES,1
GSE32986_UNSTIM_VS_CURDLAN_L...2,SET,190,-0.020666,-0.0020904,0.059902,0.63495,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP,1
KEGG_RIBOFLAVIN_METABOLISM,SET,13,-0.082506,-0.0021936,0.23912,0.63497,KEGG_RIBOFLAVIN_METABOLISM,1
QI_PLASMACYTOMA_DN,SET,92,-0.030019,-0.0021186,0.086991,0.63498,QI_PLASMACYTOMA_DN,1
HP_NONTUBERCULOUS_MYCOBACTER...,SET,19,-0.070083,-0.0022523,0.203,0.63504,HP_NONTUBERCULOUS_MYCOBACTERIAL_PULMONARY_INFECTION,1
HP_PROLONGED_PARTIAL_THROMBO...,SET,30,-0.058255,-0.0023517,0.16873,0.63505,HP_PROLONGED_PARTIAL_THROMBOPLASTIN_TIME,1
GOBP_REGULATION_OF_GLOMERULU...,SET,4,-0.1698,-0.0025047,0.49175,0.63506,GOBP_REGULATION_OF_GLOMERULUS_DEVELOPMENT,1
HP_ABNORMALLY_LOW_PITCHED_VO...,SET,10,-0.094146,-0.0021955,0.27263,0.63507,HP_ABNORMALLY_LOW_PITCHED_VOICE,1
MEIS1AHOXA9_01,SET,107,-0.031728,-0.0024139,0.091833,0.63514,MEIS1AHOXA9_01,1
GAVISH_3CA_METAPROGRAM_CD4_T...1,SET,45,-0.046503,-0.0022983,0.13454,0.63519,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE,1
HP_ABNORMAL_THYROID_STIMULAT...,SET,39,-0.049044,-0.0022569,0.14187,0.63521,HP_ABNORMAL_THYROID_STIMULATING_HORMONE_LEVEL,1
WP_THYROXINE_THYROID_HORMONE...,SET,23,-0.06407,-0.0022652,0.18533,0.63522,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,1
MIR6748_5P,SET,59,-0.039919,-0.0022582,0.11545,0.63524,MIR6748_5P,1
HEBERT_MATRISOME_TNBC_BONE_M...1,SET,10,-0.10493,-0.0024471,0.30331,0.63531,HEBERT_MATRISOME_TNBC_BONE_METASTASIS,1
GSE28737_BCL6_HET_VS_BCL6_KO...2,SET,179,-0.021189,-0.002081,0.061222,0.63537,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP,1
HP_ABNORMAL_ASCENDING_AORTA_...,SET,26,-0.063443,-0.0023846,0.18327,0.63539,HP_ABNORMAL_ASCENDING_AORTA_MORPHOLOGY,1
HP_ANTECUBITAL_PTERYGIUM,SET,7,-0.12576,-0.0024539,0.36327,0.6354,HP_ANTECUBITAL_PTERYGIUM,1
MIR6796_5P,SET,67,-0.035076,-0.002114,0.10126,0.63548,MIR6796_5P,1
GSE20198_IL12_VS_IL12_IL18_T...1,SET,191,-0.021299,-0.00216,0.061483,0.63549,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,1
GOBP_NUCLEAR_RNA_SURVEILLANCE,SET,14,-0.074994,-0.0020691,0.21644,0.63551,GOBP_NUCLEAR_RNA_SURVEILLANCE,1
GOBP_RENAL_VESICLE_FORMATION,SET,8,-0.11265,-0.0023499,0.32502,0.63555,GOBP_RENAL_VESICLE_FORMATION,1
GOBP_SPERM_FLAGELLUM_ASSEMBLY,SET,42,-0.043494,-0.0020768,0.12544,0.6356,GOBP_SPERM_FLAGELLUM_ASSEMBLY,1
HP_ABNORMAL_TEMPORAL_BONE_MO...,SET,4,-0.18797,-0.0027728,0.54212,0.6356,HP_ABNORMAL_TEMPORAL_BONE_MORPHOLOGY,1
GOBP_ANTIGEN_RECEPTOR_MEDIAT...,SET,171,-0.023323,-0.0022393,0.067259,0.63561,GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_NUCLEOBASE_BIOSYNTHETIC...,SET,15,-0.073419,-0.0020967,0.21172,0.63561,GOBP_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
GOBP_SODIUM_ION_EXPORT_ACROS...,SET,15,-0.087761,-0.0025062,0.25309,0.63561,GOBP_SODIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
HP_SHUFFLING_GAIT,SET,30,-0.054554,-0.0022023,0.15733,0.63561,HP_SHUFFLING_GAIT,1
VANTVEER_BREAST_CANCER_ESR1_...1,SET,207,-0.021318,-0.0022497,0.061471,0.63563,VANTVEER_BREAST_CANCER_ESR1_DN,1
GOMF_1_ACYLGLYCEROPHOSPHOCHO...,SET,6,-0.13941,-0.0025185,0.40199,0.63563,GOMF_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY,1
MIR4291,SET,351,-0.015838,-0.0021679,0.045665,0.63564,MIR4291,1
DARWICHE_PAPILLOMA_RISK_HIGH...1,SET,164,-0.022445,-0.0021108,0.064688,0.6357,DARWICHE_PAPILLOMA_RISK_HIGH_DN,1
WP_TARGET_OF_RAPAMYCIN_SIGNA...,SET,35,-0.052461,-0.0022872,0.15117,0.63572,WP_TARGET_OF_RAPAMYCIN_SIGNALING,1
HP_ABNORMAL_ERYTHROID_LINEAG...,SET,6,-0.12706,-0.0022955,0.36578,0.63584,HP_ABNORMAL_ERYTHROID_LINEAGE_CELL_MORPHOLOGY,1
HP_ABNORMAL_AORTIC_ARCH_MORP...,SET,58,-0.040134,-0.0022511,0.1155,0.63588,HP_ABNORMAL_AORTIC_ARCH_MORPHOLOGY,1
GSE21670_UNTREATED_VS_TGFB_I...3,SET,177,-0.021708,-0.0021201,0.062461,0.6359,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
GOMF_PHOSPHATE_TRANSMEMBRANE...,SET,16,-0.077944,-0.0022988,0.2242,0.63595,GOMF_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE46606_IRF4HIGH_VS_WT_CD40...3,SET,183,-0.021565,-0.0021412,0.062021,0.63597,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,1
REACTOME_THYROXINE_BIOSYNTHE...,SET,10,-0.10591,-0.0024698,0.30454,0.63599,REACTOME_THYROXINE_BIOSYNTHESIS,1
GSE32901_NAIVE_VS_TH17_ENRIC...1,SET,154,-0.023772,-0.0021669,0.068355,0.63599,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...170,SET,16,-0.078605,-0.0023183,0.226,0.63601,GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM,1
GEISS_RESPONSE_TO_DSRNA_DN,SET,15,-0.07425,-0.0021204,0.21346,0.63602,GEISS_RESPONSE_TO_DSRNA_DN,1
GOMF_SEQUENCE_SPECIFIC_MRNA_...,SET,11,-0.079613,-0.0019472,0.22879,0.63607,GOMF_SEQUENCE_SPECIFIC_MRNA_BINDING,1
GSE28408_LY6G_POS_VS_NEG_DC_...1,SET,176,-0.020962,-0.0020415,0.060209,0.63613,GSE28408_LY6G_POS_VS_NEG_DC_DN,1
GOBP_RESPONSE_TO_ODORANT,SET,5,-0.14178,-0.0023382,0.40722,0.63614,GOBP_RESPONSE_TO_ODORANT,1
MIR3921,SET,135,-0.026109,-0.0022295,0.074951,0.63621,MIR3921,1
GOMF_MONOOXYGENASE_ACTIVITY,SET,100,-0.033355,-0.0024538,0.095742,0.63622,GOMF_MONOOXYGENASE_ACTIVITY,1
GSE31082_DP_VS_CD4_SP_THYMOC...2,SET,171,-0.021744,-0.0020876,0.062407,0.63623,GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP,1
GOBP_REGULATION_OF_CELL_SUBS...1,SET,202,-0.021917,-0.0022851,0.062887,0.63627,GOBP_REGULATION_OF_CELL_SUBSTRATE_ADHESION,1
GSE3982_MAST_CELL_VS_BASOPHI...2,SET,174,-0.02305,-0.0022322,0.06614,0.63627,GSE3982_MAST_CELL_VS_BASOPHIL_UP,1
GAVISH_3CA_METAPROGRAM_FIBRO...18,SET,43,-0.049615,-0.0023971,0.14236,0.63628,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II_CYTOKINE,1
GOMF_POLYSACCHARIDE_BINDING,SET,21,-0.068971,-0.0023301,0.19787,0.63629,GOMF_POLYSACCHARIDE_BINDING,1
GOBP_REGULATION_OF_DNA_TEMPL...4,SET,79,-0.031482,-0.0020597,0.09028,0.63635,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
WP_FTO_OBESITY_VARIANT_MECHA...,SET,8,-0.11376,-0.0023729,0.32619,0.63636,WP_FTO_OBESITY_VARIANT_MECHANISM,1
GOBP_MUCOSA_ASSOCIATED_LYMPH...,SET,8,-0.11548,-0.0024089,0.33109,0.63637,GOBP_MUCOSA_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT,1
GSE12366_GC_BCELL_VS_PLASMA_...1,SET,162,-0.023087,-0.002158,0.066179,0.6364,GSE12366_GC_BCELL_VS_PLASMA_CELL_DN,1
GSE11864_CSF1_VS_CSF1_IFNG_I...2,SET,161,-0.023208,-0.0021627,0.066514,0.63642,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP,1
KEGG_CYSTEINE_AND_METHIONINE...,SET,32,-0.058572,-0.002442,0.1678,0.63647,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,1
HP_VERTEBRAL_FUSION,SET,63,-0.037525,-0.0021933,0.10751,0.63647,HP_VERTEBRAL_FUSION,1
MODULE_170,SET,89,-0.033274,-0.0023099,0.095319,0.63648,MODULE_170,1
RRAGTTGT_UNKNOWN,SET,228,-0.020617,-0.0022821,0.059058,0.63649,RRAGTTGT_UNKNOWN,1
KEGG_OOCYTE_MEIOSIS,SET,105,-0.02837,-0.0021383,0.081247,0.63652,KEGG_OOCYTE_MEIOSIS,1
GOBP_GOLGI_LOCALIZATION,SET,12,-0.078174,-0.0019969,0.22385,0.63654,GOBP_GOLGI_LOCALIZATION,1
HP_RIGHT_AORTIC_ARCH,SET,20,-0.065755,-0.002168,0.18826,0.63656,HP_RIGHT_AORTIC_ARCH,1
GOBP_POSITIVE_REGULATION_OF_...702,SET,6,-0.12382,-0.002237,0.35446,0.63658,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
GOBP_PHARYNGEAL_SYSTEM_DEVEL...,SET,29,-0.064107,-0.0025445,0.1835,0.63659,GOBP_PHARYNGEAL_SYSTEM_DEVELOPMENT,1
DUNNE_TARGETS_OF_AML1_MTG8_F...1,SET,17,-0.07431,-0.002259,0.21267,0.63661,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,1
HP_DELAYED_MENARCHE,SET,23,-0.056707,-0.0020048,0.16227,0.63663,HP_DELAYED_MENARCHE,1
GOBP_HYALURONAN_BIOSYNTHETIC...,SET,14,-0.081669,-0.0022532,0.23366,0.63665,GOBP_HYALURONAN_BIOSYNTHETIC_PROCESS,1
HP_PLATYSPONDYLY,SET,108,-0.029098,-0.0022241,0.083225,0.63669,HP_PLATYSPONDYLY,1
GSE27291_6H_VS_7D_STIM_GAMMA...1,SET,156,-0.025033,-0.0022965,0.071583,0.63672,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN,1
HP_ABSENT_PATELLAR_REFLEXES,SET,11,-0.095122,-0.0023265,0.27186,0.63679,HP_ABSENT_PATELLAR_REFLEXES,1
GOBP_ACTIVATION_OF_INNATE_IM...,SET,266,-0.018243,-0.0021788,0.052118,0.63684,GOBP_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE,1
GOMF_FIBROBLAST_GROWTH_FACTO...3,SET,24,-0.068144,-0.002461,0.19463,0.63687,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,1
GOBP_RESPONSE_TO_DEXAMETHASO...,SET,42,-0.050423,-0.0024077,0.14397,0.63691,GOBP_RESPONSE_TO_DEXAMETHASONE,1
GSE37534_GW1929_VS_ROSIGLITA...1,SET,147,-0.02333,-0.0020782,0.066616,0.63691,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
YANG_BCL3_TARGETS_UP,SET,308,-0.01746,-0.0022413,0.049791,0.63708,YANG_BCL3_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...382,SET,52,-0.04093,-0.0021741,0.1167,0.6371,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
HP_MUSCLE_WEAKNESS,SET,912,-0.010031,-0.0021784,0.028591,0.63715,HP_MUSCLE_WEAKNESS,1
MARIADASON_RESPONSE_TO_CURCU...1,SET,22,-0.060285,-0.0020845,0.1718,0.63717,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,1
HP_TOOTH_ABSCESS,SET,6,-0.13874,-0.0025064,0.39526,0.6372,HP_TOOTH_ABSCESS,1
GSE15930_NAIVE_VS_48H_IN_VIT...2,SET,182,-0.022831,-0.0022607,0.065005,0.63728,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP,1
GSE17721_CTRL_VS_LPS_8H_BMDC...2,SET,180,-0.022452,-0.0022111,0.063922,0.63729,GSE17721_CTRL_VS_LPS_8H_BMDC_UP,1
MORF_MAP2K7,SET,157,-0.02494,-0.0022953,0.071003,0.6373,MORF_MAP2K7,1
HERNANDEZ_ABERRANT_MITOSIS_B...3,SET,5,-0.16274,-0.0026839,0.46307,0.63737,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN,1
REACTOME_ACTIVATED_NTRK2_SIG...2,SET,11,-0.081762,-0.0019997,0.23264,0.63737,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3,1
GOMF_PHOSPHATIDYLINOSITOL_3_...2,SET,6,-0.099372,-0.0017952,0.28268,0.6374,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,1
GOBP_REGULATION_OF_T_HELPER_...4,SET,11,-0.10285,-0.0025154,0.29245,0.63745,GOBP_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,1
HP_STILLBIRTH,SET,28,-0.057747,-0.0022523,0.16422,0.63745,HP_STILLBIRTH,1
GSE37301_MULTIPOTENT_PROGENI...7,SET,169,-0.024286,-0.0023181,0.069055,0.63746,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN,1
REACTOME_ACYL_CHAIN_REMODELL...2,SET,23,-0.069413,-0.002454,0.19729,0.63752,REACTOME_ACYL_CHAIN_REMODELLING_OF_PE,1
GNF2_FEN1,SET,54,-0.038656,-0.0020923,0.10987,0.63752,GNF2_FEN1,1
HP_LONG_TOE,SET,38,-0.049325,-0.0022406,0.14015,0.63756,HP_LONG_TOE,1
HP_DEVELOPMENTAL_REGRESSION,SET,360,-0.015825,-0.0021931,0.044948,0.63761,HP_DEVELOPMENTAL_REGRESSION,1
GOBP_POSITIVE_REGULATION_OF_...676,SET,350,-0.016253,-0.0022214,0.046141,0.63767,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,1
BLANCO_MELO_COVID19_SARS_COV...7,SET,16,-0.073467,-0.0021668,0.20846,0.63774,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN,1
GOCC_PHAGOLYSOSOME,SET,7,-0.10766,-0.0021007,0.30542,0.63776,GOCC_PHAGOLYSOSOME,1
KYNG_ENVIRONMENTAL_STRESS_RE...4,SET,29,-0.053384,-0.0021189,0.15139,0.63781,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1
GSE3982_NEUTROPHIL_VS_NKCELL...2,SET,179,-0.022596,-0.0022192,0.06407,0.63783,GSE3982_NEUTROPHIL_VS_NKCELL_UP,1
REACTOME_NEUROTRANSMITTER_RE...2,SET,47,-0.049021,-0.0024759,0.13894,0.63789,REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,1
ERBB2_UP.V1_UP,SET,170,-0.024367,-0.0023327,0.069065,0.63789,ERBB2_UP.V1_UP,1
GOBP_CATECHOLAMINE_UPTAKE_IN...,SET,11,-0.093301,-0.0022819,0.26439,0.63791,GOBP_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,1
GSE3337_CTRL_VS_16H_IFNG_IN_...2,SET,181,-0.023186,-0.0022896,0.065621,0.63808,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP,1
HP_ELEVATED_CIRCULATING_ALAN...,SET,70,-0.034204,-0.0021069,0.096734,0.63817,HP_ELEVATED_CIRCULATING_ALANINE_AMINOTRANSFERASE_CONCENTRATION,1
KEGG_INOSITOL_PHOSPHATE_META...,SET,52,-0.041029,-0.0021793,0.11602,0.63819,KEGG_INOSITOL_PHOSPHATE_METABOLISM,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...4,SET,177,-0.022743,-0.0022212,0.064294,0.63823,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,1
HP_ABNORMALITY_OF_FACIAL_SOF...,SET,458,-0.014476,-0.0022566,0.040896,0.63832,HP_ABNORMALITY_OF_FACIAL_SOFT_TISSUE,1
REACTOME_RESOLUTION_OF_ABASI...,SET,37,-0.044514,-0.0019953,0.1257,0.63837,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,1
MIR136_3P,SET,8,-0.10064,-0.0020994,0.28407,0.63844,MIR136_3P,1
chr15q13,SET,18,-0.095528,-0.0029882,0.2695,0.6385,chr15q13,1
GSE20500_RETINOIC_ACID_VS_RA...2,SET,182,-0.022914,-0.002269,0.064631,0.63853,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,1
DACOSTA_UV_RESPONSE_VIA_ERCC...5,SET,49,-0.044796,-0.00231,0.12633,0.63855,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,1
GSE37563_WT_VS_CTLA4_KO_CD4_...1,SET,168,-0.022389,-0.0021309,0.063132,0.63857,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN,1
HP_TONIC_SEIZURE,SET,121,-0.027492,-0.0022234,0.077495,0.63861,HP_TONIC_SEIZURE,1
GOBP_PURINE_RIBONUCLEOTIDE_S...,SET,7,-0.12142,-0.0023693,0.34214,0.63866,GOBP_PURINE_RIBONUCLEOTIDE_SALVAGE,1
GOMF_DNA_NUCLEASE_ACTIVITY,SET,59,-0.037348,-0.0021128,0.10523,0.63868,GOMF_DNA_NUCLEASE_ACTIVITY,1
GSE40666_NAIVE_VS_EFFECTOR_C...1,SET,185,-0.023279,-0.0023238,0.065565,0.63872,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,1
REACTOME_ADAPTIVE_IMMUNE_SYS...,SET,707,-0.011729,-0.0022558,0.033013,0.63881,REACTOME_ADAPTIVE_IMMUNE_SYSTEM,1
HP_GASTROINTESTINAL_EOSINOPH...,SET,14,-0.085529,-0.0023597,0.24062,0.63887,HP_GASTROINTESTINAL_EOSINOPHILIA,1
GOMF_RNA_METHYLTRANSFERASE_A...,SET,53,-0.03635,-0.0019493,0.10226,0.63888,GOMF_RNA_METHYLTRANSFERASE_ACTIVITY,1
GOBP_CYSTEINE_CATABOLIC_PROC...,SET,3,-0.19495,-0.0024906,0.54834,0.6389,GOBP_CYSTEINE_CATABOLIC_PROCESS,1
WP_NEPHROGENESIS,SET,18,-0.078432,-0.0024534,0.22056,0.63893,WP_NEPHROGENESIS,1
CAGCTG_AP4_Q5,SET,1354,-0.0087787,-0.0022934,0.024684,0.63894,CAGCTG_AP4_Q5,1
GOBP_PLATELET_MORPHOGENESIS,SET,23,-0.05732,-0.0020265,0.16117,0.63895,GOBP_PLATELET_MORPHOGENESIS,1
GSE10273_LOW_IL7_VS_HIGH_IL7...2,SET,176,-0.022608,-0.0022018,0.063566,0.63895,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,1
YANAGISAWA_LUNG_CANCER_RECUR...,SET,6,-0.12875,-0.002326,0.36199,0.63896,YANAGISAWA_LUNG_CANCER_RECURRENCE,1
GSE10273_HIGH_VS_LOW_IL7_TRE...1,SET,175,-0.023046,-0.0022382,0.064764,0.63902,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN,1
HP_ABSENT_HYPOPLASTIC_PARANA...,SET,5,-0.15263,-0.0025172,0.42889,0.63903,HP_ABSENT_HYPOPLASTIC_PARANASAL_SINUSES,1
KEGG_MEDICUS_REFERENCE_CASR_...,SET,7,-0.11815,-0.0023054,0.33181,0.6391,KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY,1
GSE3982_EFF_MEMORY_CD4_TCELL...6,SET,174,-0.022962,-0.0022237,0.064452,0.63918,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP,1
GOCC_EXORIBONUCLEASE_COMPLEX,SET,22,-0.060126,-0.002079,0.16874,0.6392,GOCC_EXORIBONUCLEASE_COMPLEX,1
GOBP_FATTY_ACID_ALPHA_OXIDAT...,SET,8,-0.11695,-0.0024395,0.3282,0.63921,GOBP_FATTY_ACID_ALPHA_OXIDATION,1
GOBP_REGULATION_OF_AXON_GUID...,SET,11,-0.10666,-0.0026088,0.29919,0.63927,GOBP_REGULATION_OF_AXON_GUIDANCE,1
GOMF_RNA_CAP_BINDING,SET,17,-0.066449,-0.0020201,0.18636,0.63929,GOMF_RNA_CAP_BINDING,1
GSE42088_UNINF_VS_LEISHMANIA...3,SET,178,-0.023731,-0.0023242,0.066499,0.6394,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN,1
GSE9960_HEALTHY_VS_GRAM_NEG_...4,SET,186,-0.022077,-0.0022097,0.061866,0.6394,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP,1
SHEDDEN_LUNG_CANCER_GOOD_SUR...2,SET,182,-0.02376,-0.0023527,0.066571,0.63942,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,1
GOBP_NEGATIVE_REGULATION_OF_...45,SET,97,-0.030631,-0.0022195,0.085821,0.63942,GOBP_NEGATIVE_REGULATION_OF_BINDING,1
HP_CONGENITAL_HYPOTHYROIDISM,SET,30,-0.05836,-0.002356,0.16352,0.63942,HP_CONGENITAL_HYPOTHYROIDISM,1
GSE37301_LYMPHOID_PRIMED_MPP...1,SET,176,-0.022101,-0.0021525,0.061921,0.63942,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN,1
HP_ABNORMAL_CALCIFICATION_OF...,SET,5,-0.15596,-0.0025721,0.4369,0.63944,HP_ABNORMAL_CALCIFICATION_OF_THE_CARPAL_BONES,1
MANNE_COVID19_ICU_VS_HEALTHY...2,SET,117,-0.027815,-0.0022122,0.077914,0.63945,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1
GOBP_VIRAL_RNA_GENOME_REPLIC...,SET,24,-0.071458,-0.0025806,0.20016,0.63945,GOBP_VIRAL_RNA_GENOME_REPLICATION,1
DURANTE_ADULT_OLFACTORY_NEUR...12,SET,35,-0.058444,-0.0025481,0.16365,0.6395,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES,1
MODULE_480,SET,83,-0.032768,-0.0021971,0.091731,0.63953,MODULE_480,1
JAATINEN_HEMATOPOIETIC_STEM_...1,SET,208,-0.023066,-0.00244,0.06454,0.6396,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1
GOBP_DIPHOSPHOINOSITOL_POLYP...,SET,2,-0.28442,-0.0029669,0.79571,0.63962,GOBP_DIPHOSPHOINOSITOL_POLYPHOSPHATE_METABOLIC_PROCESS,1
GOMF_ENDOPOLYPHOSPHATASE_ACT...,SET,2,-0.28442,-0.0029669,0.79571,0.63962,GOMF_ENDOPOLYPHOSPHATASE_ACTIVITY,1
REACTOME_IL_6_TYPE_CYTOKINE_...,SET,17,-0.075885,-0.0023069,0.21222,0.63967,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,1
MIR450A_1_3P,SET,168,-0.023624,-0.0022483,0.066061,0.63968,MIR450A_1_3P,1
HP_OPEN_BITE,SET,54,-0.045,-0.0024357,0.12582,0.63969,HP_OPEN_BITE,1
GOMF_LIGAND_GATED_CALCIUM_CH...,SET,30,-0.05674,-0.0022906,0.15864,0.6397,GOMF_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY,1
REACTOME_DISEASES_OF_IMMUNE_...,SET,29,-0.059825,-0.0023746,0.16722,0.63974,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,1
GOMF_TRANSPORTER_ACTIVATOR_A...,SET,7,-0.11528,-0.0022494,0.32221,0.63974,GOMF_TRANSPORTER_ACTIVATOR_ACTIVITY,1
NABA_PROTEOGLYCANS,SET,33,-0.058965,-0.0024964,0.16466,0.63986,NABA_PROTEOGLYCANS,1
GOBP_POSITIVE_REGULATION_OF_...766,SET,65,-0.038476,-0.0022841,0.10741,0.6399,GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING,1
MORF_IL16,SET,214,-0.021174,-0.0022715,0.059103,0.63992,MORF_IL16,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...6,SET,184,-0.023305,-0.0023202,0.065036,0.63995,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP,1
MIR6893_3P,SET,86,-0.033536,-0.0022887,0.093585,0.63996,MIR6893_3P,1
GSE30971_CTRL_VS_LPS_STIM_MA...4,SET,178,-0.023112,-0.0022635,0.064491,0.63996,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP,1
MIR2355_5P,SET,118,-0.027143,-0.002168,0.075737,0.63997,MIR2355_5P,1
GSE23925_LIGHT_ZONE_VS_DARK_...2,SET,180,-0.023067,-0.0022717,0.064353,0.64,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,1
GAVISH_3CA_METAPROGRAM_ENDOT...6,SET,42,-0.053813,-0.0025696,0.15009,0.64002,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_4,1
GOMF_P_TYPE_CALCIUM_TRANSPOR...,SET,8,-0.096393,-0.0020107,0.2688,0.64005,GOMF_P_TYPE_CALCIUM_TRANSPORTER_ACTIVITY,1
HP_POOR_WOUND_HEALING,SET,40,-0.049804,-0.002321,0.13888,0.64005,HP_POOR_WOUND_HEALING,1
GOBP_NON_PROTEINOGENIC_AMINO...3,SET,68,-0.037638,-0.0022852,0.10492,0.64011,GOBP_NON_PROTEINOGENIC_AMINO_ACID_METABOLIC_PROCESS,1
HP_CEREBELLAR_CALCIFICATIONS,SET,8,-0.1269,-0.0026471,0.35371,0.64011,HP_CEREBELLAR_CALCIFICATIONS,1
MIR4694_5P,SET,34,-0.053451,-0.0022969,0.14892,0.64017,MIR4694_5P,1
BIOCARTA_IGF1MTOR_PATHWAY,SET,18,-0.080125,-0.0025064,0.22308,0.64027,BIOCARTA_IGF1MTOR_PATHWAY,1
GOBP_ENDONUCLEOLYTIC_CLEAVAG...3,SET,16,-0.076149,-0.0022459,0.21188,0.64035,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
GSE14308_NAIVE_CD4_TCELL_VS_...4,SET,177,-0.022576,-0.0022049,0.062803,0.64038,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP,1
GSE3203_HEALTHY_VS_INFLUENZA...2,SET,178,-0.023474,-0.002299,0.065266,0.64045,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP,1
HP_NEOPLASIA_OF_THE_NASOPHAR...,SET,5,-0.13169,-0.0021719,0.36587,0.64055,HP_NEOPLASIA_OF_THE_NASOPHARYNX,1
GOBP_ISOCITRATE_METABOLIC_PR...,SET,5,-0.1332,-0.0021968,0.36995,0.6406,GOBP_ISOCITRATE_METABOLIC_PROCESS,1
LIN_MELANOMA_COPY_NUMBER_UP,SET,65,-0.040249,-0.0023894,0.11174,0.64065,LIN_MELANOMA_COPY_NUMBER_UP,1
BOSCO_INTERFERON_INDUCED_ANT...,SET,72,-0.035587,-0.0022231,0.098766,0.64069,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1
HP_ABNORMAL_SUBSTANTIA_NIGRA...,SET,18,-0.070305,-0.0021992,0.19507,0.64072,HP_ABNORMAL_SUBSTANTIA_NIGRA_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...349,SET,233,-0.021456,-0.0024006,0.059492,0.64082,GOBP_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
GOMF_ANTIGEN_BINDING,SET,63,-0.045162,-0.0026397,0.12519,0.64085,GOMF_ANTIGEN_BINDING,1
GOBP_VIRAL_LIFE_CYCLE,SET,298,-0.018823,-0.0023774,0.052176,0.64086,GOBP_VIRAL_LIFE_CYCLE,1
GSE6259_DEC205_POS_DC_VS_CD8...2,SET,168,-0.022959,-0.0021851,0.063642,0.64086,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP,1
GSE12707_AT16L1_HYPOMORPH_VS...2,SET,111,-0.030653,-0.002375,0.084918,0.64094,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP,1
GOBP_T_CELL_ACTIVATION,SET,527,-0.01439,-0.0024015,0.039852,0.64098,GOBP_T_CELL_ACTIVATION,1
REACTOME_COSTIMULATION_BY_TH...,SET,62,-0.042456,-0.0024618,0.11757,0.64099,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,1
REACTOME_REGULATION_OF_NPAS4...1,SET,13,-0.089784,-0.0023871,0.24864,0.64099,REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION,1
GOBP_POSITIVE_REGULATION_OF_...98,SET,41,-0.053769,-0.0025368,0.1489,0.64099,GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_FANCO...,SET,12,-0.07235,-0.0018482,0.20028,0.64104,KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY,1
MIR5089_5P,SET,103,-0.0297,-0.0022172,0.082201,0.64106,MIR5089_5P,1
GSE41176_UNSTIM_VS_ANTI_IGM_...4,SET,183,-0.023858,-0.0023689,0.066036,0.64106,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP,1
GOBP_IMP_BIOSYNTHETIC_PROCESS,SET,10,-0.097589,-0.0022758,0.27008,0.64107,GOBP_IMP_BIOSYNTHETIC_PROCESS,1
HP_HYPOCALCEMIA,SET,74,-0.037524,-0.0023763,0.10384,0.64108,HP_HYPOCALCEMIA,1
GSE7548_NAIVE_VS_DAY28_PCC_I...1,SET,173,-0.024413,-0.0023574,0.067558,0.64108,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,1
BIOCARTA_SAM68_PATHWAY,SET,6,-0.13057,-0.0023589,0.36132,0.64109,BIOCARTA_SAM68_PATHWAY,1
GOBP_RESPONSE_TO_STEROL,SET,32,-0.057563,-0.0023999,0.15929,0.64109,GOBP_RESPONSE_TO_STEROL,1
GSE17721_0.5H_VS_8H_CPG_BMDC...2,SET,188,-0.022165,-0.0022303,0.061292,0.64118,GSE17721_0.5H_VS_8H_CPG_BMDC_UP,1
HP_RESPIRATORY_ARREST,SET,27,-0.062482,-0.0023932,0.17277,0.64119,HP_RESPIRATORY_ARREST,1
HELLER_HDAC_TARGETS_SILENCED...1,SET,258,-0.020158,-0.0023716,0.05573,0.64122,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,1
KEGG_ECM_RECEPTOR_INTERACTION,SET,82,-0.036225,-0.0024143,0.10003,0.64137,KEGG_ECM_RECEPTOR_INTERACTION,1
GOMF_POTASSIUM_CHANNEL_REGUL...,SET,46,-0.047622,-0.0023795,0.13146,0.64141,GOMF_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY,1
MIR877_3P,SET,174,-0.023714,-0.0022965,0.065455,0.64143,MIR877_3P,1
GOMF_LEUCINE_ZIPPER_DOMAIN_B...,SET,10,-0.10605,-0.002473,0.29266,0.64145,GOMF_LEUCINE_ZIPPER_DOMAIN_BINDING,1
GSE29618_PRE_VS_DAY7_FLU_VAC...4,SET,174,-0.024196,-0.0023432,0.066737,0.64153,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP,1
HP_INCREASED_CIRCULATING_INT...3,SET,11,-0.099261,-0.0024277,0.27373,0.64156,HP_INCREASED_CIRCULATING_INTERLEUKIN_6_CONCENTRATION,1
REACTOME_BIOTIN_TRANSPORT_AN...,SET,10,-0.091578,-0.0021356,0.25247,0.64159,REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM,1
HP_ABNORMAL_SENSORY_NERVE_CO...,SET,24,-0.060987,-0.0022025,0.16813,0.6416,HP_ABNORMAL_SENSORY_NERVE_CONDUCTION_VELOCITY,1
GOMF_BILE_ACID_SODIUM_SYMPOR...,SET,5,-0.13477,-0.0022226,0.3714,0.64164,GOMF_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY,1
GSE1460_INTRATHYMIC_T_PROGEN...7,SET,178,-0.023625,-0.0023138,0.065093,0.64167,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,1
GOBP_MONOCARBOXYLIC_ACID_TRA...,SET,173,-0.025225,-0.0024359,0.069478,0.64172,GOBP_MONOCARBOXYLIC_ACID_TRANSPORT,1
AP2ALPHA_01,SET,223,-0.020468,-0.002241,0.056373,0.64173,AP2ALPHA_01,1
GOBP_FOREBRAIN_REGIONALIZATI...,SET,23,-0.077038,-0.0027236,0.21206,0.6418,GOBP_FOREBRAIN_REGIONALIZATION,1
GOBP_ICOSANOID_TRANSPORT,SET,64,-0.04272,-0.0025166,0.11759,0.64181,GOBP_ICOSANOID_TRANSPORT,1
HP_SOCIAL_AND_OCCUPATIONAL_D...,SET,14,-0.095826,-0.0026438,0.26376,0.64181,HP_SOCIAL_AND_OCCUPATIONAL_DETERIORATION,1
GOBP_CILIUM_ORGANIZATION,SET,369,-0.015715,-0.0022044,0.043246,0.64184,GOBP_CILIUM_ORGANIZATION,1
MIR4506,SET,42,-0.045864,-0.0021901,0.12616,0.6419,MIR4506,1
HP_ERYTHEMA,SET,106,-0.031389,-0.002377,0.08633,0.64192,HP_ERYTHEMA,1
DAZARD_UV_RESPONSE_CLUSTER_G...2,SET,17,-0.087629,-0.0026639,0.24095,0.64195,DAZARD_UV_RESPONSE_CLUSTER_G28,1
KEGG_MEDICUS_VARIANT_MUTATIO...12,SET,9,-0.10067,-0.0022273,0.27678,0.64196,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY,1
GSE43863_NAIVE_VS_LY6C_INT_C...2,SET,160,-0.025266,-0.0023472,0.069469,0.64196,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP,1
HP_IRIS_HYPOPIGMENTATION,SET,58,-0.044098,-0.0024734,0.12123,0.64197,HP_IRIS_HYPOPIGMENTATION,1
MIR4682,SET,117,-0.028564,-0.0022718,0.078515,0.64199,MIR4682,1
WP_DRAVET_SYNDROME,SET,26,-0.068956,-0.0025918,0.18949,0.64203,WP_DRAVET_SYNDROME,1
REACTOME_METABOLISM_OF_INGES...,SET,7,-0.13569,-0.0026477,0.37286,0.64204,REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE,1
GOCC_AZUROPHIL_GRANULE,SET,139,-0.026113,-0.0022624,0.071745,0.64206,GOCC_AZUROPHIL_GRANULE,1
BENPORATH_ES_1,SET,337,-0.016828,-0.0022578,0.04623,0.64207,BENPORATH_ES_1,1
GSE32533_MIR17_KO_VS_MIR17_O...2,SET,180,-0.02315,-0.0022798,0.063594,0.64208,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...729,SET,4,-0.17137,-0.002528,0.47073,0.64209,GOBP_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...437,SET,6,-0.13876,-0.0025069,0.38114,0.6421,GOBP_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
chr9p23,SET,4,-0.20367,-0.0030045,0.55927,0.64214,chr9p23,1
HP_LIMB_GIRDLE_MUSCLE_ATROPHY,SET,31,-0.053177,-0.0021822,0.14601,0.64214,HP_LIMB_GIRDLE_MUSCLE_ATROPHY,1
HP_ABNORMAL_SPINAL_MENINGEAL...,SET,22,-0.071613,-0.0024762,0.19661,0.64215,HP_ABNORMAL_SPINAL_MENINGEAL_MORPHOLOGY,1
GOBP_MONOSACCHARIDE_METABOLI...,SET,226,-0.020461,-0.002255,0.056168,0.64217,GOBP_MONOSACCHARIDE_METABOLIC_PROCESS,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...2,SET,11,-0.094565,-0.0023129,0.25955,0.6422,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339,1
HP_CYTOCHROME_C_OXIDASE_NEGA...,SET,26,-0.056959,-0.0021409,0.15633,0.6422,HP_CYTOCHROME_C_OXIDASE_NEGATIVE_MUSCLE_FIBERS,1
GOMF_UBIQUITIN_LIGASE_ACTIVA...,SET,9,-0.10084,-0.002231,0.27673,0.64222,GOMF_UBIQUITIN_LIGASE_ACTIVATOR_ACTIVITY,1
GOBP_MOTOR_NEURON_APOPTOTIC_...,SET,21,-0.066389,-0.0022429,0.18213,0.64226,GOBP_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GSE24574_BCL6_HIGH_TFH_VS_NA...2,SET,179,-0.023401,-0.0022982,0.064172,0.64232,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP,1
ZWANG_EGF_PERSISTENTLY_DN,SET,56,-0.038479,-0.0021209,0.1055,0.64234,ZWANG_EGF_PERSISTENTLY_DN,1
GOMF_KINASE_ACTIVITY,SET,682,-0.012084,-0.0022842,0.033129,0.64234,GOMF_KINASE_ACTIVITY,1
ESC_J1_UP_EARLY.V1_UP,SET,155,-0.02513,-0.0022981,0.068886,0.64237,ESC_J1_UP_EARLY.V1_UP,1
GSE22935_WT_VS_MYD88_KO_MACR...6,SET,184,-0.022747,-0.0022646,0.06234,0.6424,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP,1
HP_POIKILOCYTOSIS,SET,49,-0.044993,-0.0023201,0.12327,0.64244,HP_POIKILOCYTOSIS,1
REACTOME_SENSORY_PROCESSING_...2,SET,49,-0.047839,-0.0024669,0.13106,0.64245,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,1
MIR5189_3P,SET,51,-0.042344,-0.0022275,0.11601,0.64245,MIR5189_3P,1
HP_PUNCTATE_KERATITIS,SET,5,-0.16597,-0.0027372,0.45469,0.64245,HP_PUNCTATE_KERATITIS,1
PID_ARF6_PATHWAY,SET,35,-0.054104,-0.0023588,0.14821,0.64246,PID_ARF6_PATHWAY,1
GSE13887_HEALTHY_VS_LUPUS_RE...2,SET,104,-0.031743,-0.0023811,0.08695,0.64247,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP,1
GOBP_CELLULAR_RESPONSE_TO_EX...2,SET,72,-0.040174,-0.0025097,0.10999,0.64254,GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS,1
GOBP_REGULATION_OF_PROTEIN_D...3,SET,77,-0.033969,-0.0021941,0.092998,0.64254,GOBP_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,1
NABA_MATRISOME_HIGHLY_METAST...2,SET,26,-0.05885,-0.0022119,0.16108,0.64257,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,1
GSE32423_MEMORY_VS_NAIVE_CD8...6,SET,184,-0.023592,-0.0023488,0.064567,0.64259,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_TGF_B...,SET,8,-0.12509,-0.0026093,0.34222,0.64264,KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY,1
GOBP_PROXIMAL_TUBULE_DEVELOP...,SET,10,-0.10372,-0.0024188,0.28372,0.64266,GOBP_PROXIMAL_TUBULE_DEVELOPMENT,1
HP_RENAL_SODIUM_WASTING,SET,7,-0.11386,-0.0022218,0.31146,0.64266,HP_RENAL_SODIUM_WASTING,1
WP_BILE_ACID_SYNTHESIS_AND_E...,SET,12,-0.10241,-0.0026161,0.28013,0.64267,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,1
GOBP_IMMUNOGLOBULIN_PRODUCTI...2,SET,47,-0.043547,-0.0021994,0.11907,0.64272,GOBP_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE,1
WP_MAPK_AND_NFKB_SIGNALING_I...,SET,11,-0.095561,-0.0023372,0.26105,0.64284,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,1
GSE11961_GERMINAL_CENTER_BCE...2,SET,179,-0.02349,-0.002307,0.064171,0.64284,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GOBP_FATTY_ACID_TRANSPORT,SET,115,-0.031024,-0.0024464,0.084726,0.64288,GOBP_FATTY_ACID_TRANSPORT,1
GOBP_LYMPHANGIOGENESIS,SET,17,-0.07883,-0.0023964,0.21528,0.64288,GOBP_LYMPHANGIOGENESIS,1
HP_SQUAMOUS_CELL_CARCINOMA,SET,62,-0.037534,-0.0021764,0.1025,0.64288,HP_SQUAMOUS_CELL_CARCINOMA,1
HP_CANDIDA_ESOPHAGITIS,SET,5,-0.14413,-0.002377,0.39357,0.64289,HP_CANDIDA_ESOPHAGITIS,1
MIR5196_5P,SET,267,-0.019301,-0.0023095,0.052653,0.64303,MIR5196_5P,1
GOMF_DYNEIN_LIGHT_CHAIN_BIND...,SET,5,-0.12318,-0.0020315,0.33588,0.64309,GOMF_DYNEIN_LIGHT_CHAIN_BINDING,1
GOBP_REGULATION_OF_HORMONE_B...,SET,23,-0.070846,-0.0025047,0.19313,0.64312,GOBP_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
NAKAYAMA_FRA2_TARGETS,SET,43,-0.052618,-0.0025422,0.14343,0.64313,NAKAYAMA_FRA2_TARGETS,1
MIR7515,SET,142,-0.026034,-0.0022795,0.070965,0.64313,MIR7515,1
GOMF_RECEPTOR_TYROSINE_KINAS...,SET,76,-0.034636,-0.0022227,0.094405,0.64315,GOMF_RECEPTOR_TYROSINE_KINASE_BINDING,1
HP_INCREASED_CIRCULATING_IGA...,SET,26,-0.066133,-0.0024857,0.18023,0.64316,HP_INCREASED_CIRCULATING_IGA_LEVEL,1
GSE15330_WT_VS_IKAROS_KO_MEG...2,SET,180,-0.022912,-0.0022564,0.062411,0.64323,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,1
GSE7509_DC_VS_MONOCYTE_UP,SET,182,-0.023685,-0.0023454,0.064508,0.64325,GSE7509_DC_VS_MONOCYTE_UP,1
GOBP_CATECHOLAMINE_TRANSPORT,SET,61,-0.042909,-0.002468,0.11678,0.64335,GOBP_CATECHOLAMINE_TRANSPORT,1
VALK_AML_CLUSTER_6,SET,32,-0.05662,-0.0023606,0.15406,0.64339,VALK_AML_CLUSTER_6,1
KEGG_MEDICUS_REFERENCE_INTRI...,SET,13,-0.092501,-0.0024593,0.25153,0.64347,KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY,1
HP_HEMATOCHEZIA,SET,20,-0.074578,-0.0024589,0.20279,0.64347,HP_HEMATOCHEZIA,1
DORSEY_GAB2_TARGETS,SET,27,-0.064538,-0.0024719,0.17545,0.64351,DORSEY_GAB2_TARGETS,1
HP_ABNORMAL_3RD_FINGER_PHALA...,SET,6,-0.14289,-0.0025815,0.38834,0.64354,HP_ABNORMAL_3RD_FINGER_PHALANX_MORPHOLOGY,1
GSE14415_INDUCED_TREG_VS_FAI...2,SET,169,-0.022104,-0.0021099,0.060076,0.64354,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP,1
BONOME_OVARIAN_CANCER_POOR_S...1,SET,19,-0.064706,-0.0020794,0.17582,0.64357,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN,1
HP_AXONAL_LOSS,SET,17,-0.070581,-0.0021457,0.19177,0.64358,HP_AXONAL_LOSS,1
GOBP_REGULATION_OF_AMACRINE_...,SET,6,-0.13144,-0.0023746,0.35692,0.64366,GOBP_REGULATION_OF_AMACRINE_CELL_DIFFERENTIATION,1
FONTAINE_THYROID_TUMOR_UNCER...1,SET,26,-0.065314,-0.0024549,0.17733,0.64368,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,1
HAY_BONE_MARROW_EOSINOPHIL,SET,41,-0.052917,-0.0024966,0.14367,0.64368,HAY_BONE_MARROW_EOSINOPHIL,1
GSE22033_WT_VS_PPARG_KO_MEF_...1,SET,181,-0.023855,-0.0023557,0.064726,0.64377,GSE22033_WT_VS_PPARG_KO_MEF_DN,1
SUMI_HNF4A_TARGETS,SET,28,-0.06439,-0.0025114,0.17465,0.64381,SUMI_HNF4A_TARGETS,1
GOBP_PHOSPHOLIPID_HOMEOSTASIS,SET,17,-0.078238,-0.0023784,0.21221,0.64382,GOBP_PHOSPHOLIPID_HOMEOSTASIS,1
HP_ABNORMAL_CLITORIS_MORPHOL...,SET,81,-0.036335,-0.0024069,0.098511,0.64388,HP_ABNORMAL_CLITORIS_MORPHOLOGY,1
DESCARTES_FETAL_EYE_MICROGLIA,SET,127,-0.028827,-0.0023881,0.078153,0.64388,DESCARTES_FETAL_EYE_MICROGLIA,1
GSE30083_SP2_VS_SP4_THYMOCYT...2,SET,183,-0.024329,-0.0024156,0.065944,0.64391,GSE30083_SP2_VS_SP4_THYMOCYTE_UP,1
HP_MULTIFOCAL_SEIZURES,SET,16,-0.076879,-0.0022674,0.20827,0.64398,HP_MULTIFOCAL_SEIZURES,1
DESCARTES_FETAL_SPLEEN_STC2_...,SET,10,-0.10747,-0.0025062,0.29108,0.64401,DESCARTES_FETAL_SPLEEN_STC2_TLX1_POSITIVE_CELLS,1
WHITFIELD_CELL_CYCLE_M_G1,SET,115,-0.029055,-0.0022911,0.078673,0.64405,WHITFIELD_CELL_CYCLE_M_G1,1
REACTOME_TRNA_PROCESSING,SET,96,-0.029585,-0.0021326,0.080084,0.64409,REACTOME_TRNA_PROCESSING,1
GOBP_FIBROBLAST_MIGRATION,SET,49,-0.045828,-0.0023632,0.12404,0.6441,GOBP_FIBROBLAST_MIGRATION,1
ZNF41_TARGET_GENES,SET,171,-0.023984,-0.0023027,0.06491,0.64412,ZNF41_TARGET_GENES,1
HP_HYDROCELE_TESTIS,SET,35,-0.052346,-0.0022822,0.14164,0.64414,HP_HYDROCELE_TESTIS,1
GOBP_GDP_METABOLIC_PROCESS,SET,9,-0.10916,-0.0024151,0.29534,0.64416,GOBP_GDP_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...795,SET,71,-0.040553,-0.0025157,0.10972,0.64416,GOBP_POSITIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,1
HP_ABNORMAL_FINGERNAIL_MORPH...,SET,173,-0.024543,-0.00237,0.066391,0.64419,HP_ABNORMAL_FINGERNAIL_MORPHOLOGY,1
GSE7852_THYMUS_VS_FAT_TREG_DN,SET,178,-0.023658,-0.002317,0.063982,0.64422,GSE7852_THYMUS_VS_FAT_TREG_DN,1
REACTOME_DNA_REPLICATION_PRE...,SET,94,-0.030112,-0.0021481,0.081417,0.64425,REACTOME_DNA_REPLICATION_PRE_INITIATION,1
HP_CLUBBING_OF_TOES,SET,28,-0.054465,-0.0021243,0.14716,0.64435,HP_CLUBBING_OF_TOES,1
GOBP_POSITIVE_REGULATION_OF_...161,SET,8,-0.11882,-0.0024785,0.32101,0.64436,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,1
GOBP_POSITIVE_REGULATION_OF_...507,SET,58,-0.044973,-0.0025225,0.12149,0.64438,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,1
MARTINEZ_RB1_TARGETS_UP,SET,644,-0.012705,-0.0023362,0.03431,0.64442,MARTINEZ_RB1_TARGETS_UP,1
HP_PRECOCIOUS_PUBERTY_IN_FEM...,SET,9,-0.11009,-0.0024357,0.29723,0.64445,HP_PRECOCIOUS_PUBERTY_IN_FEMALES,1
HP_PREMATURE_SKIN_WRINKLING,SET,61,-0.039877,-0.0022936,0.10757,0.64457,HP_PREMATURE_SKIN_WRINKLING,1
HP_ABNORMAL_MUSCLE_FIBER_PRO...,SET,25,-0.063537,-0.0023418,0.17127,0.64467,HP_ABNORMAL_MUSCLE_FIBER_PROTEIN_EXPRESSION,1
GOMF_GLYCOSPHINGOLIPID_BINDI...,SET,10,-0.10308,-0.0024038,0.27784,0.64468,GOMF_GLYCOSPHINGOLIPID_BINDING,1
GOMF_GAMMA_CATENIN_BINDING,SET,12,-0.0987,-0.0025213,0.26598,0.64471,GOMF_GAMMA_CATENIN_BINDING,1
GSE17721_POLYIC_VS_GARDIQUIM...9,SET,176,-0.023365,-0.0022755,0.062959,0.64472,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN,1
GOCC_SHELTERIN_COMPLEX,SET,6,-0.12067,-0.00218,0.32513,0.64473,GOCC_SHELTERIN_COMPLEX,1
REACTOME_NERVOUS_SYSTEM_DEVE...,SET,533,-0.014178,-0.0023792,0.038195,0.64475,REACTOME_NERVOUS_SYSTEM_DEVELOPMENT,1
TURJANSKI_MAPK11_TARGETS,SET,4,-0.16662,-0.0024579,0.44886,0.64476,TURJANSKI_MAPK11_TARGETS,1
GSE9006_1MONTH_VS_4MONTH_POS...1,SET,169,-0.025209,-0.0024062,0.067902,0.64477,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN,1
REACTOME_THE_PHOTOTRANSDUCTI...,SET,31,-0.054537,-0.002238,0.14689,0.64478,REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,1
HP_MESOAXIAL_POLYDACTYLY,SET,18,-0.071115,-0.0022245,0.19149,0.64482,HP_MESOAXIAL_POLYDACTYLY,1
REACTOME_SEMA3A_PAK_DEPENDEN...,SET,14,-0.08677,-0.002394,0.23355,0.64487,REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,1
GOBP_POSITIVE_REGULATION_OF_...77,SET,9,-0.092577,-0.0020482,0.24913,0.6449,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
MODULE_327,SET,21,-0.071249,-0.0024071,0.1916,0.645,MODULE_327,1
GAVISH_3CA_MALIGNANT_METAPRO...36,SET,48,-0.050277,-0.0025661,0.13514,0.64506,GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS,1
GOBP_FACULTATIVE_HETEROCHROM...,SET,37,-0.052363,-0.0023471,0.14075,0.64506,GOBP_FACULTATIVE_HETEROCHROMATIN_FORMATION,1
GOMF_CD4_RECEPTOR_BINDING,SET,7,-0.13104,-0.0025569,0.35203,0.64514,GOMF_CD4_RECEPTOR_BINDING,1
MULLIGHAN_MLL_SIGNATURE_2_UP,SET,388,-0.016081,-0.0023118,0.0432,0.64515,MULLIGHAN_MLL_SIGNATURE_2_UP,1
HP_TRANSIENT_NEUTROPENIA,SET,7,-0.10234,-0.001997,0.27475,0.64524,HP_TRANSIENT_NEUTROPENIA,1
REACTOME_SENSORY_PERCEPTION,SET,515,-0.017897,-0.0029536,0.048028,0.64528,REACTOME_SENSORY_PERCEPTION,1
MIR4259,SET,23,-0.063439,-0.0022428,0.17025,0.64528,MIR4259,1
HP_PROLONGED_BLEEDING_TIME,SET,46,-0.048679,-0.0024323,0.1306,0.64532,HP_PROLONGED_BLEEDING_TIME,1
GOBP_VACUOLAR_TRANSMEMBRANE_...,SET,8,-0.11036,-0.002302,0.296,0.64536,GOBP_VACUOLAR_TRANSMEMBRANE_TRANSPORT,1
MIR4776_3P,SET,152,-0.027635,-0.0025028,0.074115,0.64537,MIR4776_3P,1
GOBP_REGULATION_OF_LIPOPOLYS...,SET,27,-0.062065,-0.0023772,0.16644,0.64538,GOBP_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...68,SET,22,-0.068437,-0.0023664,0.18346,0.64543,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
AAAGGGA_MIR204_MIR211,SET,211,-0.022262,-0.0023717,0.059683,0.64543,AAAGGGA_MIR204_MIR211,1
GOBP_XENOBIOTIC_GLUCURONIDAT...,SET,6,-0.15345,-0.0027721,0.41103,0.64555,GOBP_XENOBIOTIC_GLUCURONIDATION,1
GOCC_SITE_OF_DOUBLE_STRAND_B...,SET,85,-0.032307,-0.002192,0.086504,0.6456,GOCC_SITE_OF_DOUBLE_STRAND_BREAK,1
BIOCARTA_AGR_PATHWAY,SET,29,-0.063849,-0.0025343,0.17092,0.64563,BIOCARTA_AGR_PATHWAY,1
GOBP_REGULATION_OF_RESPONSE_...13,SET,14,-0.079224,-0.0021858,0.21208,0.64563,GOBP_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
GOMF_OXIDOREDUCTASE_ACTIVITY...32,SET,31,-0.054388,-0.0022319,0.14554,0.64568,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,1
REACTOME_ENERGY_DEPENDENT_RE...,SET,28,-0.059008,-0.0023015,0.15785,0.64573,REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,1
GSE33162_HDAC3_KO_VS_HDAC3_K...2,SET,180,-0.023024,-0.0022674,0.061579,0.64576,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP,1
WATANABE_RECTAL_CANCER_RADIO...2,SET,96,-0.030237,-0.0021797,0.08085,0.64579,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...8,SET,5,-0.15309,-0.0025247,0.40934,0.64579,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SRF_MEDIATED_TRANSCRIPTION,1
ZNF223_TARGET_GENES,SET,257,-0.019735,-0.0023174,0.052768,0.64579,ZNF223_TARGET_GENES,1
HP_HEPATIC_ENCEPHALOPATHY,SET,19,-0.083534,-0.0026845,0.22335,0.6458,HP_HEPATIC_ENCEPHALOPATHY,1
MIR3976,SET,104,-0.031347,-0.0023514,0.083795,0.64583,MIR3976,1
GOBP_REGULATION_OF_NEUROBLAS...,SET,51,-0.047761,-0.0025125,0.12765,0.64586,GOBP_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
HP_THORACIC_KYPHOSCOLIOSIS,SET,24,-0.058846,-0.0021252,0.15723,0.64589,HP_THORACIC_KYPHOSCOLIOSIS,1
GOBP_DIACYLGLYCEROL_METABOLI...,SET,25,-0.065363,-0.0024091,0.17458,0.64595,GOBP_DIACYLGLYCEROL_METABOLIC_PROCESS,1
HP_PANIC_ATTACK,SET,49,-0.043542,-0.0022453,0.11628,0.64596,HP_PANIC_ATTACK,1
CADWELL_ATG16L1_TARGETS_UP,SET,94,-0.034263,-0.0024441,0.091492,0.64598,CADWELL_ATG16L1_TARGETS_UP,1
HP_ABNORMAL_PATELLA_MORPHOLO...,SET,91,-0.037293,-0.0026177,0.099573,0.64599,HP_ABNORMAL_PATELLA_MORPHOLOGY,1
REACTOME_TRANSPORT_AND_SYNTH...,SET,6,-0.13635,-0.0024632,0.36392,0.64604,REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS,1
CTGYNNCTYTAA_UNKNOWN,SET,81,-0.036618,-0.0024256,0.097693,0.6461,CTGYNNCTYTAA_UNKNOWN,1
HP_T_LYMPHOCYTOPENIA,SET,60,-0.040963,-0.0023367,0.10929,0.6461,HP_T_LYMPHOCYTOPENIA,1
HINATA_NFKB_MATRIX,SET,10,-0.11265,-0.002627,0.30048,0.64613,HINATA_NFKB_MATRIX,1
GAUCHER_PBMC_YF_VAX_STAMARIL...9,SET,31,-0.055899,-0.0022939,0.14901,0.64621,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_DN,1
GSE2706_R848_VS_R848_AND_LPS...3,SET,158,-0.026907,-0.0024841,0.071725,0.64622,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN,1
GSE7831_UNSTIM_VS_INFLUENZA_...2,SET,179,-0.023103,-0.0022689,0.061575,0.64624,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...5,SET,28,-0.068978,-0.0026904,0.18379,0.64628,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP,1
GOBP_POSITIVE_REGULATION_OF_...244,SET,26,-0.067493,-0.0025368,0.17975,0.64635,GOBP_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
GOCC_CLATHRIN_COAT,SET,48,-0.045621,-0.0023284,0.12148,0.64637,GOCC_CLATHRIN_COAT,1
MIR193B_5P,SET,55,-0.042685,-0.0023316,0.11366,0.64638,MIR193B_5P,1
VERHAAK_GLIOBLASTOMA_PRONEUR...,SET,149,-0.027522,-0.0024681,0.073254,0.64643,VERHAAK_GLIOBLASTOMA_PRONEURAL,1
GSE3982_MAST_CELL_VS_NEUTROP...2,SET,180,-0.021855,-0.0021523,0.058149,0.64648,GSE3982_MAST_CELL_VS_NEUTROPHIL_UP,1
HP_ABNORMAL_RESPONSE_TO_ACTH...,SET,6,-0.13863,-0.0025044,0.36883,0.64649,HP_ABNORMAL_RESPONSE_TO_ACTH_STIMULATION_TEST,1
chr8q22,SET,62,-0.073427,-0.0042576,0.1953,0.64653,chr8q22,1
GSE29164_CD8_TCELL_VS_CD8_TC...4,SET,174,-0.024368,-0.0023598,0.064804,0.64655,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,1
GOMF_TESTOSTERONE_DEHYDROGEN...1,SET,7,-0.11429,-0.0022302,0.30393,0.64656,GOMF_TESTOSTERONE_DEHYDROGENASE_NADPLUS_ACTIVITY,1
GOMF_LIGAND_GATED_MONOATOMIC...2,SET,132,-0.029902,-0.002525,0.079505,0.64658,GOMF_LIGAND_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
HP_REDUCED_FEV1_FVC_RATIO,SET,7,-0.12524,-0.0024437,0.33287,0.64663,HP_REDUCED_FEV1_FVC_RATIO,1
GOMF_ICOSANOID_BINDING,SET,7,-0.12758,-0.0024895,0.33907,0.64664,GOMF_ICOSANOID_BINDING,1
HP_SOMNAMBULISM,SET,7,-0.12851,-0.0025076,0.34145,0.64667,HP_SOMNAMBULISM,1
KEGG_MEDICUS_VARIANT_SCRAPIE...2,SET,17,-0.078059,-0.002373,0.20732,0.64673,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
BIOCARTA_LEPTIN_PATHWAY,SET,11,-0.093837,-0.002295,0.24916,0.64677,BIOCARTA_LEPTIN_PATHWAY,1
GOBP_OUTFLOW_TRACT_SEPTUM_MO...,SET,26,-0.073247,-0.0027531,0.19448,0.64677,GOBP_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...537,SET,4,-0.14356,-0.0021177,0.38112,0.64679,GOBP_POSITIVE_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
HP_SMALL_HAND,SET,94,-0.035002,-0.0024969,0.092909,0.64681,HP_SMALL_HAND,1
GSE27786_BCELL_VS_MONO_MAC_UP,SET,170,-0.024327,-0.0023288,0.064551,0.64686,GSE27786_BCELL_VS_MONO_MAC_UP,1
GNF2_ANK1,SET,61,-0.041513,-0.0023877,0.11014,0.64688,GNF2_ANK1,1
GNF2_SPTB,SET,61,-0.041513,-0.0023877,0.11014,0.64688,GNF2_SPTB,1
GSE39556_UNTREATED_VS_3H_POL...3,SET,178,-0.024938,-0.0024423,0.066164,0.64688,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN,1
GSE46606_IRF4_KO_VS_WT_UNSTI...2,SET,186,-0.023306,-0.0023327,0.061827,0.64689,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP,1
REACTOME_DNA_DAMAGE_BYPASS,SET,44,-0.042899,-0.0020966,0.1138,0.6469,REACTOME_DNA_DAMAGE_BYPASS,1
GSE21678_WT_VS_FOXO1_FOXO3_K...1,SET,163,-0.023855,-0.0022366,0.063278,0.64691,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN,1
GNF2_STAT6,SET,73,-0.037105,-0.0023339,0.098416,0.64692,GNF2_STAT6,1
HP_INCREASED_ERYTHROCYTE_PRO...,SET,4,-0.1589,-0.002344,0.42147,0.64692,HP_INCREASED_ERYTHROCYTE_PROTOPORPHYRIN_CONCENTRATION,1
HP_RIB_FUSION,SET,45,-0.049413,-0.0024421,0.13104,0.64694,HP_RIB_FUSION,1
GOBP_MAINTENANCE_OF_SYNAPSE_...,SET,24,-0.068518,-0.0024744,0.18164,0.647,GOBP_MAINTENANCE_OF_SYNAPSE_STRUCTURE,1
GCM_RAP2A,SET,33,-0.056417,-0.0023885,0.14948,0.64706,GCM_RAP2A,1
GOBP_POSITIVE_REGULATION_OF_...24,SET,22,-0.071314,-0.0024659,0.18887,0.64713,GOBP_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,1
GSE2405_HEAT_KILLED_VS_LIVE_...1,SET,173,-0.024335,-0.0023499,0.064428,0.64718,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,1
HP_REDUCED_FORCED_EXPIRATORY...,SET,27,-0.062317,-0.0023868,0.16497,0.64719,HP_REDUCED_FORCED_EXPIRATORY_VOLUME_IN_ONE_SECOND,1
GOBP_POSITIVE_REGULATION_OF_...719,SET,5,-0.14957,-0.0024668,0.39588,0.64722,GOBP_POSITIVE_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,1
HP_LARGE_CAFE_AU_LAIT_MACULE...,SET,6,-0.13205,-0.0023856,0.34935,0.64728,HP_LARGE_CAFE_AU_LAIT_MACULES_WITH_IRREGULAR_MARGINS,1
GSE7768_OVA_ALONE_VS_OVA_WIT...4,SET,164,-0.024253,-0.0022809,0.064162,0.64728,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
CLIMENT_BREAST_CANCER_COPY_N...1,SET,8,-0.11661,-0.0024324,0.30842,0.64732,CLIMENT_BREAST_CANCER_COPY_NUMBER_DN,1
NEMETH_INFLAMMATORY_RESPONSE...2,SET,76,-0.040212,-0.0025806,0.10635,0.64733,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,1
GOBP_PROTEIN_DENEDDYLATION,SET,11,-0.08703,-0.0021286,0.23014,0.64734,GOBP_PROTEIN_DENEDDYLATION,1
GOMF_SULFUR_COMPOUND_BINDING,SET,246,-0.022261,-0.0025582,0.058861,0.64735,GOMF_SULFUR_COMPOUND_BINDING,1
GSE13306_TREG_VS_TCONV_LAMIN...1,SET,181,-0.023701,-0.0023405,0.062672,0.64735,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN,1
REACTOME_AKT_PHOSPHORYLATES_...2,SET,9,-0.1024,-0.0022655,0.27075,0.64736,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS,1
GOMF_SHORT_CHAIN_CARBOXYLEST...,SET,6,-0.12489,-0.0022562,0.33021,0.64736,GOMF_SHORT_CHAIN_CARBOXYLESTERASE_ACTIVITY,1
GSE29618_PRE_VS_DAY7_POST_LA...7,SET,177,-0.022578,-0.002205,0.059696,0.64736,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN,1
GOBP_CARDIAC_CELL_DEVELOPMENT,SET,82,-0.036733,-0.0024482,0.097092,0.6474,GOBP_CARDIAC_CELL_DEVELOPMENT,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...1,SET,10,-0.099915,-0.0023301,0.26406,0.64742,KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION,1
MODULE_289,SET,117,-0.032727,-0.0026029,0.086482,0.64744,MODULE_289,1
GOBP_NEURAL_PLATE_PATTERN_SP...,SET,7,-0.12929,-0.0025228,0.34151,0.6475,GOBP_NEURAL_PLATE_PATTERN_SPECIFICATION,1
WP_PROSTAGLANDIN_SIGNALING,SET,32,-0.062722,-0.002615,0.16565,0.64752,WP_PROSTAGLANDIN_SIGNALING,1
REACTOME_FGFR1B_LIGAND_BINDI...,SET,8,-0.12389,-0.0025842,0.32712,0.64755,REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION,1
GOBP_INTRINSIC_APOPTOTIC_SIG...9,SET,54,-0.042793,-0.0023162,0.11298,0.64756,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,1
HP_MIXED_HYPO_AND_HYPERPIGME...,SET,10,-0.082932,-0.001934,0.21897,0.64756,HP_MIXED_HYPO_AND_HYPERPIGMENTATION_OF_THE_SKIN,1
GSE17721_CTRL_VS_GARDIQUIMOD...3,SET,184,-0.023651,-0.0023547,0.062445,0.64756,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN,1
WU_HBX_TARGETS_1_DN,SET,22,-0.074319,-0.0025698,0.19613,0.64763,WU_HBX_TARGETS_1_DN,1
ZNF410_TARGET_GENES,SET,488,-0.014656,-0.0023562,0.038659,0.64769,ZNF410_TARGET_GENES,1
MIR12126,SET,34,-0.057105,-0.0024539,0.15062,0.6477,MIR12126,1
GOBP_GRANULOCYTE_DIFFERENTIA...,SET,38,-0.054383,-0.0024703,0.14344,0.6477,GOBP_GRANULOCYTE_DIFFERENTIATION,1
KEGG_MEDICUS_ENV_FACTOR_META...3,SET,14,-0.080656,-0.0022253,0.21273,0.64771,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_BEHAVIOR,SET,71,-0.042603,-0.0026429,0.11237,0.64771,GOBP_REGULATION_OF_BEHAVIOR,1
GOBP_PROTEIN_RNA_COMPLEX_DIS...,SET,10,-0.090483,-0.0021101,0.23859,0.64774,GOBP_PROTEIN_RNA_COMPLEX_DISASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...583,SET,5,-0.16318,-0.0026912,0.43027,0.64775,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,1
HP_AUTOIMMUNE_THROMBOCYTOPEN...,SET,43,-0.051984,-0.0025116,0.13705,0.64777,HP_AUTOIMMUNE_THROMBOCYTOPENIA,1
HP_BLEPHAROCHALASIS,SET,6,-0.14563,-0.0026309,0.38384,0.6478,HP_BLEPHAROCHALASIS,1
STEIN_ESRRA_TARGETS_RESPONSI...1,SET,39,-0.053695,-0.0024709,0.14148,0.64785,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,1
chr7p21,SET,35,-0.087413,-0.0038111,0.23031,0.64786,chr7p21,1
REACTOME_RUNX1_REGULATES_EST...,SET,6,-0.13902,-0.0025116,0.36615,0.64791,REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION,1
GOBP_POSITIVE_REGULATION_OF_...44,SET,37,-0.051739,-0.0023192,0.13626,0.64791,GOBP_POSITIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,1
BIOCARTA_ARF_PATHWAY,SET,17,-0.077695,-0.0023619,0.20462,0.64792,BIOCARTA_ARF_PATHWAY,1
GOCC_NEURON_PROJECTION,SET,1215,-0.0099584,-0.0024744,0.026215,0.64798,GOCC_NEURON_PROJECTION,1
GOBP_REGULATION_OF_ADAPTIVE_...,SET,191,-0.025014,-0.0025368,0.065841,0.64799,GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,1
KEGG_MEDICUS_REFERENCE_NLRP1...,SET,4,-0.13394,-0.0019758,0.35253,0.648,KEGG_MEDICUS_REFERENCE_NLRP1_INFLAMMASOME_SIGNALING_PATHWAY,1
REACTOME_ACYL_CHAIN_REMODELL...3,SET,18,-0.083116,-0.0025999,0.21873,0.64802,REACTOME_ACYL_CHAIN_REMODELLING_OF_PG,1
REACTOME_REGULATION_OF_PTEN_...2,SET,7,-0.1476,-0.0028801,0.38845,0.64802,REACTOME_REGULATION_OF_PTEN_LOCALIZATION,1
GOBP_POSITIVE_REGULATION_OF_...111,SET,29,-0.061777,-0.0024521,0.16254,0.64805,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,1
GOCC_ENDOPLASMIC_RETICULUM_T...1,SET,24,-0.059581,-0.0021517,0.15677,0.64805,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK,1
GSE26030_TH1_VS_TH17_RESTIMU...2,SET,175,-0.025194,-0.0024467,0.066288,0.64805,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP,1
WP_NEUROGENESIS_REGULATION_I...,SET,55,-0.047058,-0.0025705,0.12379,0.64808,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,1
HP_LOW_HANGING_COLUMELLA,SET,43,-0.048241,-0.0023307,0.1269,0.64808,HP_LOW_HANGING_COLUMELLA,1
GSE21670_TGFB_VS_IL6_TREATED...1,SET,177,-0.023292,-0.0022748,0.061259,0.64811,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN,1
GOBP_URIDINE_TRANSMEMBRANE_T...,SET,6,-0.13938,-0.002518,0.36642,0.64817,GOBP_URIDINE_TRANSMEMBRANE_TRANSPORT,1
MIR2681_5P,SET,146,-0.027621,-0.002452,0.072599,0.64819,MIR2681_5P,1
GOBP_KIDNEY_MESENCHYME_DEVEL...,SET,15,-0.096516,-0.0027563,0.25369,0.64819,GOBP_KIDNEY_MESENCHYME_DEVELOPMENT,1
GSE27241_WT_CTRL_VS_DIGOXIN_...1,SET,162,-0.024485,-0.0022887,0.064342,0.64823,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,1
LINDGREN_BLADDER_CANCER_CLUS...5,SET,343,-0.019043,-0.0025772,0.050026,0.64827,LINDGREN_BLADDER_CANCER_CLUSTER_2B,1
GOBP_POSITIVE_REGULATION_OF_...372,SET,33,-0.063749,-0.0026989,0.16747,0.64827,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,1
GAVISH_3CA_METAPROGRAM_CD4_T...5,SET,47,-0.04855,-0.0024521,0.1275,0.64832,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_INTERFERON,1
GOBP_POSITIVE_REGULATION_OF_...294,SET,5,-0.13658,-0.0022524,0.35858,0.64835,GOBP_POSITIVE_REGULATION_OF_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,1
GOBP_POSITIVE_REGULATION_OF_...144,SET,119,-0.031687,-0.0025416,0.083185,0.64837,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,1
LIAO_HAVE_SOX4_BINDING_SITES,SET,40,-0.047524,-0.0022147,0.12475,0.64838,LIAO_HAVE_SOX4_BINDING_SITES,1
GOBP_OUTFLOW_TRACT_MORPHOGEN...,SET,75,-0.043785,-0.0027914,0.1149,0.64842,GOBP_OUTFLOW_TRACT_MORPHOGENESIS,1
GOBP_INNER_DYNEIN_ARM_ASSEMB...,SET,11,-0.088472,-0.0021638,0.23215,0.64843,GOBP_INNER_DYNEIN_ARM_ASSEMBLY,1
GOBP_REGULATION_OF_PROTEIN_C...3,SET,13,-0.081108,-0.0021564,0.21282,0.64844,GOBP_REGULATION_OF_PROTEIN_COMPLEX_STABILITY,1
HP_SENSORY_BEHAVIORAL_ABNORM...,SET,295,-0.019745,-0.0024815,0.051796,0.64847,HP_SENSORY_BEHAVIORAL_ABNORMALITY,1
GSE8515_IL1_VS_IL6_4H_STIM_M...2,SET,177,-0.024934,-0.0024352,0.065408,0.64847,GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP,1
ZHAN_MULTIPLE_MYELOMA_MF_DN,SET,40,-0.05424,-0.0025277,0.14223,0.64853,ZHAN_MULTIPLE_MYELOMA_MF_DN,1
WP_HDAC6_INTERACTIONS_IN_THE...,SET,106,-0.030923,-0.0023417,0.081074,0.64855,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,1
GOBP_ASPARTATE_TRANSMEMBRANE...,SET,20,-0.074144,-0.0024446,0.19436,0.64857,GOBP_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
GOBP_SKELETAL_MUSCLE_FIBER_D...,SET,11,-0.10529,-0.0025751,0.27579,0.64868,GOBP_SKELETAL_MUSCLE_FIBER_DIFFERENTIATION,1
HP_LONG_CLAVICLES,SET,13,-0.086137,-0.0022901,0.22559,0.6487,HP_LONG_CLAVICLES,1
GOBP_NEGATIVE_REGULATION_OF_...163,SET,23,-0.064643,-0.0022854,0.16928,0.64872,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
MIR3914,SET,50,-0.048309,-0.0025164,0.12646,0.64877,MIR3914,1
DER_IFN_ALPHA_RESPONSE_DN,SET,4,-0.17516,-0.0025839,0.45824,0.64886,DER_IFN_ALPHA_RESPONSE_DN,1
MIR6790_5P,SET,46,-0.052482,-0.0026224,0.1373,0.64886,MIR6790_5P,1
GOCC_MON1_CCZ1_COMPLEX,SET,4,-0.16997,-0.0025073,0.44464,0.64887,GOCC_MON1_CCZ1_COMPLEX,1
GSE5589_WT_VS_IL10_KO_LPS_AN...3,SET,183,-0.02403,-0.0023859,0.06285,0.64889,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
GSE3982_DC_VS_NEUTROPHIL_UP,SET,181,-0.023807,-0.002351,0.062223,0.64899,GSE3982_DC_VS_NEUTROPHIL_UP,1
MIR3184_3P,SET,66,-0.038053,-0.0022763,0.099449,0.649,MIR3184_3P,1
GOBP_CELLULAR_RESPONSE_TO_RE...1,SET,14,-0.092368,-0.0025484,0.24137,0.64902,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES,1
OUELLET_OVARIAN_CANCER_INVAS...1,SET,11,-0.11311,-0.0027665,0.29536,0.64913,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1
HP_ABNORMAL_CIRCULATING_GLUT...1,SET,11,-0.086432,-0.0021139,0.22561,0.64918,HP_ABNORMAL_CIRCULATING_GLUTAMINE_CONCENTRATION,1
WP_WNT_SIGNALING_WP363,SET,51,-0.047551,-0.0025015,0.12407,0.64924,WP_WNT_SIGNALING_WP363,1
BENPORATH_PROLIFERATION,SET,135,-0.028448,-0.0024292,0.074196,0.64929,BENPORATH_PROLIFERATION,1
MONTERO_THYROID_CANCER_POOR_...1,SET,9,-0.095853,-0.0021207,0.24995,0.64932,MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,1
MIR6851_3P,SET,53,-0.044615,-0.0023925,0.11634,0.64932,MIR6851_3P,1
GOBP_CELL_COMMUNICATION_BY_E...1,SET,33,-0.062845,-0.0026607,0.16383,0.64936,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,1
GSE2826_WT_VS_BTK_KO_BCELL_UP,SET,182,-0.023652,-0.0023421,0.061648,0.64938,GSE2826_WT_VS_BTK_KO_BCELL_UP,1
GSE2935_UV_INACTIVATED_VS_LI...1,SET,162,-0.027553,-0.0025754,0.071791,0.64943,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN,1
chr7p22,SET,67,-0.083285,-0.0050195,0.21698,0.64945,chr7p22,1
GOBP_NEGATIVE_REGULATION_OF_...133,SET,11,-0.086795,-0.0021228,0.22611,0.64946,GOBP_NEGATIVE_REGULATION_OF_CGAS_STING_SIGNALING_PATHWAY,1
chr1q42,SET,83,-0.074663,-0.0050063,0.19448,0.64947,chr1q42,1
GOMF_HISTONE_H2A_UBIQUITIN_L...,SET,6,-0.12779,-0.0023087,0.33287,0.64948,GOMF_HISTONE_H2A_UBIQUITIN_LIGASE_ACTIVITY,1
GOMF_ACTIN_BINDING,SET,400,-0.016828,-0.0024555,0.043829,0.64949,GOMF_ACTIN_BINDING,1
JISON_SICKLE_CELL_DISEASE_UP,SET,165,-0.026254,-0.0024764,0.068367,0.64951,JISON_SICKLE_CELL_DISEASE_UP,1
REACTOME_ANCHORING_FIBRIL_FO...,SET,13,-0.097098,-0.0025816,0.25285,0.64951,REACTOME_ANCHORING_FIBRIL_FORMATION,1
GOBP_REGULATION_OF_INTERLEUK...1,SET,9,-0.10869,-0.0024048,0.28305,0.64951,GOBP_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,1
HP_BONE_SPICULE_PIGMENTATION...,SET,101,-0.032861,-0.0024294,0.085563,0.64953,HP_BONE_SPICULE_PIGMENTATION_OF_THE_RETINA,1
GOBP_REGULATION_OF_MESODERMA...2,SET,6,-0.14288,-0.0025812,0.37191,0.64958,GOBP_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION,1
HOFFMANN_SMALL_PRE_BII_TO_IM...2,SET,62,-0.0449,-0.0026035,0.11685,0.64961,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1
GOBP_CERAMIDE_METABOLIC_PROC...,SET,99,-0.034204,-0.0025037,0.088974,0.64967,GOBP_CERAMIDE_METABOLIC_PROCESS,1
MODULE_388,SET,16,-0.078236,-0.0023074,0.2035,0.64968,MODULE_388,1
MIR218_1_3P,SET,84,-0.037546,-0.0025325,0.097654,0.64969,MIR218_1_3P,1
HP_CEREBRAL_EDEMA,SET,28,-0.061075,-0.0023821,0.15884,0.64969,HP_CEREBRAL_EDEMA,1
GOBP_BEHAVIORAL_RESPONSE_TO_...4,SET,19,-0.077282,-0.0024836,0.20099,0.6497,GOBP_BEHAVIORAL_RESPONSE_TO_PAIN,1
HP_THICK_EYEBROW,SET,134,-0.029261,-0.0024895,0.076102,0.6497,HP_THICK_EYEBROW,1
HP_PARASOMNIA,SET,37,-0.055228,-0.0024756,0.14361,0.64972,HP_PARASOMNIA,1
SQSTM1_TARGET_GENES,SET,30,-0.058346,-0.0023554,0.15159,0.64984,SQSTM1_TARGET_GENES,1
MIR802,SET,121,-0.030875,-0.002497,0.080205,0.64986,MIR802,1
SAFB2_TARGET_GENES,SET,614,-0.013474,-0.0024214,0.035001,0.64987,SAFB2_TARGET_GENES,1
GAVISH_3CA_METAPROGRAM_CD4_T...4,SET,47,-0.04418,-0.0022314,0.11473,0.64991,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_GLYCOLYSIS_MYC,1
HP_INCREASED_HEPATOCELLULAR_...,SET,3,-0.16399,-0.002095,0.42586,0.64991,HP_INCREASED_HEPATOCELLULAR_LIPID_DROPLETS,1
GNF2_PRDX2,SET,27,-0.064658,-0.0024765,0.16789,0.64992,GNF2_PRDX2,1
HP_HYPOREFLEXIA,SET,349,-0.017251,-0.0023546,0.044794,0.64992,HP_HYPOREFLEXIA,1
GOCC_ANCHORING_JUNCTION,SET,837,-0.012019,-0.002506,0.031206,0.64994,GOCC_ANCHORING_JUNCTION,1
GNF2_MMP11,SET,36,-0.062296,-0.0027544,0.16173,0.64995,GNF2_MMP11,1
GOBP_CORTISOL_SECRETION,SET,5,-0.14237,-0.002348,0.36959,0.64996,GOBP_CORTISOL_SECRETION,1
GOBP_REGULATION_OF_SUBSTRATE...,SET,58,-0.043849,-0.0024595,0.11383,0.64996,GOBP_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
GOBP_CELLULAR_RESPONSE_TO_LE...3,SET,10,-0.097737,-0.0022793,0.25366,0.64999,GOBP_CELLULAR_RESPONSE_TO_LEUCINE_STARVATION,1
GOCC_MITOCHONDRIAL_ENVELOPE,SET,687,-0.012324,-0.0023377,0.031985,0.64999,GOCC_MITOCHONDRIAL_ENVELOPE,1
ZNF528_TARGET_GENES,SET,597,-0.013647,-0.0024194,0.035417,0.65,ZNF528_TARGET_GENES,1
GOMF_RNA_POLYMERASE_II_GENER...2,SET,21,-0.066411,-0.0022436,0.1723,0.65004,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,1
HP_DIPLOPIA,SET,85,-0.034636,-0.00235,0.089857,0.65005,HP_DIPLOPIA,1
GOBP_REGULATION_OF_RAB_PROTE...,SET,7,-0.12479,-0.002435,0.32352,0.65015,GOBP_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE15330_LYMPHOID_MULTIPOTEN...9,SET,177,-0.025241,-0.0024652,0.065423,0.65018,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN,1
MARSON_BOUND_BY_FOXP3_STIMUL...,SET,879,-0.01157,-0.0024691,0.02998,0.65022,MARSON_BOUND_BY_FOXP3_STIMULATED,1
GOCC_AXOLEMMA,SET,15,-0.098692,-0.0028184,0.25571,0.65023,GOCC_AXOLEMMA,1
GSE25087_TREG_VS_TCONV_ADULT...1,SET,164,-0.02592,-0.0024376,0.067155,0.65024,GSE25087_TREG_VS_TCONV_ADULT_DN,1
HP_ABNORMALITY_OF_DENTAL_STR...,SET,315,-0.01861,-0.0024154,0.048197,0.65029,HP_ABNORMALITY_OF_DENTAL_STRUCTURE,1
GOBP_POSITIVE_REGULATION_OF_...64,SET,2,-0.17862,-0.0018632,0.46247,0.65033,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_REMODELING,1
HP_OSTEOPATHIA_STRIATA,SET,3,-0.27203,-0.0034753,0.70431,0.65034,HP_OSTEOPATHIA_STRIATA,1
HE_LIM_SUN_FETAL_LUNG_C7_COL...,SET,65,-0.045102,-0.0026775,0.11677,0.65035,HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL,1
ZHENG_BOUND_BY_FOXP3,SET,456,-0.016657,-0.0025911,0.04312,0.65036,ZHENG_BOUND_BY_FOXP3,1
GOBP_CELLULAR_RESPONSE_TO_IN...3,SET,196,-0.025018,-0.0025698,0.064758,0.65037,GOBP_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE,1
GOBP_MRNA_TRANSCRIPTION,SET,46,-0.045168,-0.0022569,0.1169,0.65039,GOBP_MRNA_TRANSCRIPTION,1
MODULE_17,SET,319,-0.017976,-0.0023477,0.046517,0.65041,MODULE_17,1
GSE13522_WT_VS_IFNG_KO_SKIN_...1,SET,109,-0.033196,-0.0025489,0.085885,0.65044,GSE13522_WT_VS_IFNG_KO_SKIN_DN,1
GSE37532_TREG_VS_TCONV_PPARG...3,SET,172,-0.024594,-0.0023681,0.063607,0.65049,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,1
HALLMARK_FATTY_ACID_METABOLI...,SET,145,-0.027134,-0.0024006,0.070175,0.65049,HALLMARK_FATTY_ACID_METABOLISM,1
WP_IDO_METABOLIC_PATHWAY,SET,9,-0.12616,-0.0027912,0.32619,0.65054,WP_IDO_METABOLIC_PATHWAY,1
GOBP_RNA_3_END_PROCESSING,SET,76,-0.034398,-0.0022075,0.088902,0.65059,GOBP_RNA_3_END_PROCESSING,1
WATANABE_ULCERATIVE_COLITIS_...1,SET,14,-0.093286,-0.0025737,0.24108,0.6506,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,1
ZNF331_TARGET_GENES,SET,270,-0.020392,-0.0024534,0.052697,0.65061,ZNF331_TARGET_GENES,1
AIZARANI_LIVER_C25_KUPFFER_C...,SET,158,-0.028437,-0.0026254,0.073483,0.65061,AIZARANI_LIVER_C25_KUPFFER_CELLS_4,1
GOBP_NUCLEOTIDE_EXCISION_REP...1,SET,80,-0.033413,-0.0021997,0.08634,0.65062,GOBP_NUCLEOTIDE_EXCISION_REPAIR,1
GOBP_REGULATION_OF_GRANULOCY...1,SET,47,-0.051438,-0.0025979,0.1329,0.65064,GOBP_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,1
GOMF_ALCOHOL_DEHYDROGENASE_N...3,SET,24,-0.079373,-0.0028665,0.20494,0.65073,GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,1
GOBP_SNORNA_LOCALIZATION,SET,6,-0.1234,-0.0022293,0.31858,0.65074,GOBP_SNORNA_LOCALIZATION,1
GOMF_NAADP_SENSITIVE_CALCIUM...,SET,5,-0.15132,-0.0024957,0.39068,0.65074,GOMF_NAADP_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
ZHOU_TNF_SIGNALING_30MIN,SET,42,-0.051096,-0.0024399,0.1319,0.65076,ZHOU_TNF_SIGNALING_30MIN,1
MIR5696,SET,621,-0.013628,-0.0024624,0.035175,0.65078,MIR5696,1
GOBP_REGULATION_OF_ACTION_PO...,SET,52,-0.050359,-0.002675,0.12995,0.65082,GOBP_REGULATION_OF_ACTION_POTENTIAL,1
GSE23308_CTRL_VS_CORTICOSTER...3,SET,185,-0.023679,-0.0023637,0.061097,0.65083,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP,1
GSE41867_DAY15_EFFECTOR_VS_D...1,SET,182,-0.023265,-0.0023038,0.060015,0.65086,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,1
GAUTAM_EYE_CORNEA_FIBROBLASTS,SET,147,-0.027778,-0.0024744,0.071658,0.65086,GAUTAM_EYE_CORNEA_FIBROBLASTS,1
WP_EFFECT_OF_OMEGA3_PUFA_ON_...,SET,115,-0.032458,-0.0025595,0.083716,0.65088,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,1
GOBP_POSTSYNAPTIC_SPECIALIZA...1,SET,29,-0.063352,-0.0025146,0.16339,0.6509,GOBP_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,1
WP_HIPPO_SIGNALING_REGULATION,SET,98,-0.03601,-0.0026226,0.092857,0.65092,WP_HIPPO_SIGNALING_REGULATION,1
AAAYWAACM_HFH4_01,SET,224,-0.023464,-0.0025746,0.060502,0.65092,AAAYWAACM_HFH4_01,1
WP_GDNFRET_SIGNALING_AXIS,SET,20,-0.088027,-0.0029023,0.22696,0.65094,WP_GDNFRET_SIGNALING_AXIS,1
HP_NARROW_VERTEBRAL_INTERPED...,SET,13,-0.087368,-0.0023229,0.22526,0.65094,HP_NARROW_VERTEBRAL_INTERPEDICULAR_DISTANCE,1
KEGG_RENIN_ANGIOTENSIN_SYSTEM,SET,15,-0.095213,-0.0027191,0.24538,0.651,KEGG_RENIN_ANGIOTENSIN_SYSTEM,1
GOMF_PROTEIN_KINASE_B_BINDING,SET,10,-0.095537,-0.0022279,0.24617,0.65102,GOMF_PROTEIN_KINASE_B_BINDING,1
GSE3982_NEUTROPHIL_VS_CENT_M...2,SET,188,-0.024433,-0.0024586,0.062956,0.65103,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,1
JONES_OVARY_GRANULOSA,SET,69,-0.041975,-0.0025671,0.10814,0.65104,JONES_OVARY_GRANULOSA,1
GOBP_NEGATIVE_REGULATION_OF_...682,SET,5,-0.172,-0.0028367,0.44309,0.65106,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
GOMF_WATER_TRANSMEMBRANE_TRA...,SET,17,-0.097242,-0.0029562,0.25047,0.65108,GOMF_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_INTERLEUKIN_1_PROCE...,SET,9,-0.10431,-0.0023079,0.26867,0.65109,REACTOME_INTERLEUKIN_1_PROCESSING,1
ATATGCA_MIR448,SET,191,-0.02689,-0.0027271,0.069257,0.65109,ATATGCA_MIR448,1
GOBP_REGULATION_OF_EPITHELIA...2,SET,144,-0.030408,-0.0026811,0.078297,0.65113,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,1
STAEGE_EWING_FAMILY_TUMOR,SET,24,-0.077294,-0.0027914,0.19897,0.65116,STAEGE_EWING_FAMILY_TUMOR,1
VANTVEER_BREAST_CANCER_BRCA1...2,SET,31,-0.057533,-0.0023609,0.14806,0.6512,VANTVEER_BREAST_CANCER_BRCA1_UP,1
GOBP_NEGATIVE_REGULATION_OF_...103,SET,272,-0.021185,-0.0025581,0.054519,0.6512,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION,1
REACTOME_IRAK4_DEFICIENCY_TL...,SET,17,-0.084486,-0.0025684,0.21725,0.65132,REACTOME_IRAK4_DEFICIENCY_TLR2_4,1
GAVISH_3CA_METAPROGRAM_CD8_T...12,SET,47,-0.048345,-0.0024417,0.12432,0.65132,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_2,1
HP_ORTHOKERATOTIC_HYPERKERAT...,SET,7,-0.12589,-0.0024565,0.32365,0.65135,HP_ORTHOKERATOTIC_HYPERKERATOSIS,1
GOBP_T_HELPER_CELL_LINEAGE_C...,SET,23,-0.078604,-0.002779,0.20201,0.6514,GOBP_T_HELPER_CELL_LINEAGE_COMMITMENT,1
MIR6516_5P,SET,172,-0.025166,-0.0024232,0.06467,0.65141,MIR6516_5P,1
JONES_TCOF1_TARGETS,SET,5,-0.15126,-0.0024947,0.38868,0.65142,JONES_TCOF1_TARGETS,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...4,SET,35,-0.053123,-0.0023161,0.1365,0.65143,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
HP_DEVIATION_OF_THE_THUMB,SET,41,-0.04857,-0.0022915,0.1248,0.65143,HP_DEVIATION_OF_THE_THUMB,1
GSE29618_LAIV_VS_TIV_FLU_VAC...2,SET,166,-0.02566,-0.0024277,0.065907,0.65148,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP,1
GSE15330_MEGAKARYOCYTE_ERYTH...1,SET,174,-0.024412,-0.0023641,0.062672,0.65155,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...2,SET,564,-0.013827,-0.0023848,0.035498,0.65155,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP,1
HP_NEONATAL_SHORT_LIMB_SHORT...,SET,13,-0.095562,-0.0025407,0.2452,0.65163,HP_NEONATAL_SHORT_LIMB_SHORT_STATURE,1
GOBP_REGULATION_OF_PROTEIN_N...,SET,18,-0.075436,-0.0023597,0.19351,0.65167,GOBP_REGULATION_OF_PROTEIN_NEDDYLATION,1
GOMF_OXYSTEROL_BINDING,SET,16,-0.088043,-0.0025967,0.22582,0.65168,GOMF_OXYSTEROL_BINDING,1
MIR6501_3P,SET,132,-0.029461,-0.0024878,0.075534,0.65174,MIR6501_3P,1
HP_ERYTHRODERMA,SET,56,-0.043768,-0.0024123,0.11218,0.65178,HP_ERYTHRODERMA,1
GSE3982_MAST_CELL_VS_BASOPHI...1,SET,172,-0.026135,-0.0025165,0.066983,0.65179,GSE3982_MAST_CELL_VS_BASOPHIL_DN,1
GOBP_NOTCH_SIGNALING_PATHWAY,SET,164,-0.026973,-0.0025367,0.069078,0.6519,GOBP_NOTCH_SIGNALING_PATHWAY,1
GOMF_PHOSPHATIDYL_PHOSPHOLIP...,SET,11,-0.10461,-0.0025584,0.26786,0.65192,GOMF_PHOSPHATIDYL_PHOSPHOLIPASE_B_ACTIVITY,1
GOBP_GLOMERULAR_MESANGIUM_DE...,SET,16,-0.094849,-0.0027974,0.24285,0.65194,GOBP_GLOMERULAR_MESANGIUM_DEVELOPMENT,1
GOBP_PROTEIN_TARGETING_TO_LY...,SET,29,-0.058826,-0.0023349,0.15062,0.65194,GOBP_PROTEIN_TARGETING_TO_LYSOSOME,1
HP_ABNORMAL_AUDITORY_CANAL_M...,SET,76,-0.038182,-0.0024503,0.097703,0.65202,HP_ABNORMAL_AUDITORY_CANAL_MORPHOLOGY,1
REACTOME_SARS_COV_1_ACTIVATE...,SET,34,-0.054506,-0.0023422,0.13942,0.65208,REACTOME_SARS_COV_1_ACTIVATES_MODULATES_INNATE_IMMUNE_RESPONSES,1
BOHN_PRIMARY_IMMUNODEFICIENC...1,SET,36,-0.05708,-0.0025238,0.14599,0.65209,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,1
GRAHAM_CML_QUIESCENT_VS_NORM...3,SET,37,-0.060549,-0.0027141,0.1548,0.65215,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,1
DAVICIONI_TARGETS_OF_PAX_FOX...2,SET,233,-0.024385,-0.0027282,0.062341,0.65216,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,1
BURTON_ADIPOGENESIS_12,SET,28,-0.061469,-0.0023975,0.15706,0.65224,BURTON_ADIPOGENESIS_12,1
MCBRYAN_PUBERTAL_BREAST_4_5W...2,SET,242,-0.023383,-0.0026655,0.059744,0.65224,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,1
MOOTHA_GLUCONEOGENESIS,SET,27,-0.060965,-0.002335,0.15574,0.65227,MOOTHA_GLUCONEOGENESIS,1
HP_MITOCHONDRIAL_INHERITANCE,SET,4,-0.14491,-0.0021376,0.37018,0.65227,HP_MITOCHONDRIAL_INHERITANCE,1
DLX4_TARGET_GENES,SET,689,-0.012941,-0.0024582,0.033053,0.65229,DLX4_TARGET_GENES,1
GOBP_PHENOL_CONTAINING_COMPO...2,SET,7,-0.14864,-0.0029004,0.37964,0.65229,GOBP_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
HP_HYPERTROPHIC_CARDIOMYOPAT...,SET,243,-0.021197,-0.0024212,0.05409,0.65242,HP_HYPERTROPHIC_CARDIOMYOPATHY,1
GSE411_WT_VS_SOCS3_KO_MACROP...4,SET,182,-0.024138,-0.0023902,0.061579,0.65246,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...2,SET,726,-0.012804,-0.0024941,0.032653,0.65252,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN,1
MIR3682_3P,SET,72,-0.040198,-0.0025111,0.10249,0.65255,MIR3682_3P,1
GOMF_5_3_DNA_EXONUCLEASE_ACT...,SET,9,-0.098434,-0.0021778,0.25096,0.65256,GOMF_5_3_DNA_EXONUCLEASE_ACTIVITY,1
GSE4590_PRE_BCELL_VS_SMALL_P...1,SET,109,-0.031275,-0.0024014,0.079716,0.65259,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...150,SET,5,-0.15382,-0.0025368,0.39197,0.65263,GOBP_POSITIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
MIR7153_3P,SET,43,-0.049811,-0.0024066,0.12689,0.65268,MIR7153_3P,1
HP_PULMONARY_ARTERY_ANEURYSM,SET,7,-0.12723,-0.0024825,0.32408,0.65268,HP_PULMONARY_ARTERY_ANEURYSM,1
KEGG_REGULATION_OF_ACTIN_CYT...,SET,196,-0.024987,-0.0025667,0.063626,0.65274,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1
GSE24210_RESTING_TREG_VS_TCO...2,SET,179,-0.025076,-0.0024627,0.063844,0.65275,GSE24210_RESTING_TREG_VS_TCONV_UP,1
HP_FOCAL_AUTONOMIC_SEIZURE,SET,11,-0.099368,-0.0024303,0.25299,0.65276,HP_FOCAL_AUTONOMIC_SEIZURE,1
GOBP_POSITIVE_REGULATION_OF_...89,SET,8,-0.11248,-0.0023464,0.28629,0.6528,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
HP_PITUITARY_CORTICOTROPIC_C...,SET,11,-0.102,-0.0024947,0.25959,0.65281,HP_PITUITARY_CORTICOTROPIC_CELL_ADENOMA,1
GSE43955_TH0_VS_TGFB_IL6_TH1...8,SET,191,-0.02586,-0.0026226,0.065798,0.65285,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP,1
GOMF_SULFATE_BINDING,SET,4,-0.1752,-0.0025844,0.44562,0.6529,GOMF_SULFATE_BINDING,1
RNGTGGGC_UNKNOWN,SET,708,-0.013202,-0.0025408,0.033573,0.65292,RNGTGGGC_UNKNOWN,1
HP_SHOULDER_CONTRACTURE,SET,8,-0.12168,-0.0025382,0.3094,0.65294,HP_SHOULDER_CONTRACTURE,1
GSE6092_CTRL_VS_BORRELIA_BIR...1,SET,140,-0.028654,-0.0024914,0.072851,0.65296,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...23,SET,11,-0.08887,-0.0021736,0.22588,0.653,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,1
GOCC_3M_COMPLEX,SET,5,-0.1337,-0.0022049,0.33982,0.653,GOCC_3M_COMPLEX,1
GSE11961_MARGINAL_ZONE_BCELL...6,SET,181,-0.024906,-0.0024595,0.063305,0.653,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP,1
GOBP_OLFACTORY_LOBE_DEVELOPM...,SET,36,-0.064075,-0.0028331,0.1628,0.65305,GOBP_OLFACTORY_LOBE_DEVELOPMENT,1
GOBP_SODIUM_ION_TRANSPORT,SET,232,-0.024211,-0.002703,0.061503,0.65308,GOBP_SODIUM_ION_TRANSPORT,1
GOBP_MITOTIC_CHROMOSOME_COND...,SET,17,-0.072738,-0.0022112,0.18477,0.65309,GOBP_MITOTIC_CHROMOSOME_CONDENSATION,1
HP_ABNORMAL_CIRCULATING_FOLL...,SET,77,-0.037963,-0.0024521,0.096429,0.65309,HP_ABNORMAL_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,1
GOCC_T_CELL_RECEPTOR_COMPLEX,SET,15,-0.092571,-0.0026436,0.23513,0.6531,GOCC_T_CELL_RECEPTOR_COMPLEX,1
BIOCARTA_PAR1_PATHWAY,SET,19,-0.082109,-0.0026387,0.20848,0.65315,BIOCARTA_PAR1_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...326,SET,50,-0.051903,-0.0027036,0.13178,0.65316,GOBP_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_DEGRADATION_OF_BETA...,SET,80,-0.036911,-0.00243,0.093703,0.65317,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1
HP_INTRA_ORAL_HYPERPIGMENTAT...,SET,7,-0.13391,-0.0026129,0.33986,0.65321,HP_INTRA_ORAL_HYPERPIGMENTATION,1
GOBP_POSITIVE_REGULATION_OF_...315,SET,8,-0.14012,-0.0029228,0.35555,0.65324,GOBP_POSITIVE_REGULATION_OF_GONAD_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_BY_...3,SET,14,-0.088557,-0.0024433,0.22464,0.65329,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,1
KEGG_MEDICUS_ENV_FACTOR_META...4,SET,11,-0.10134,-0.0024786,0.25703,0.65331,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY,1
REACTOME_TRANSPORT_TO_THE_GO...,SET,181,-0.024551,-0.0024244,0.062266,0.65332,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1
GOBP_PIRNA_MEDIATED_RETROTRA...,SET,5,-0.13365,-0.0022042,0.33884,0.65337,GOBP_PIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,1
MIR4503,SET,248,-0.0218,-0.0025152,0.055254,0.6534,MIR4503,1
CCTGAGT_MIR510,SET,35,-0.055477,-0.0024187,0.14062,0.6534,CCTGAGT_MIR510,1
GOBP_MANGANESE_ION_TRANSPORT,SET,11,-0.10002,-0.0024463,0.2535,0.65341,GOBP_MANGANESE_ION_TRANSPORT,1
GOBP_ADHERENS_JUNCTION_MAINT...,SET,6,-0.15113,-0.0027303,0.38297,0.65344,GOBP_ADHERENS_JUNCTION_MAINTENANCE,1
GOBP_TRANSITION_METAL_ION_TR...,SET,89,-0.034571,-0.0024,0.087605,0.65344,GOBP_TRANSITION_METAL_ION_TRANSPORT,1
GOBP_REGULATION_OF_MONOATOMI...3,SET,302,-0.020939,-0.002662,0.053056,0.65345,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
GSE6269_STAPH_AUREUS_VS_STRE...1,SET,158,-0.026267,-0.002425,0.066546,0.65347,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN,1
GOMF_RNA_7_METHYLGUANOSINE_C...,SET,11,-0.091541,-0.0022389,0.23189,0.65349,GOMF_RNA_7_METHYLGUANOSINE_CAP_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...349,SET,94,-0.035738,-0.0025493,0.090509,0.65352,GOBP_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,1
GSE360_CTRL_VS_L_DONOVANI_DC...1,SET,181,-0.02622,-0.0025893,0.066405,0.65352,GSE360_CTRL_VS_L_DONOVANI_DC_DN,1
E2A_Q2,SET,220,-0.022291,-0.0024242,0.056435,0.65357,E2A_Q2,1
GOBP_FLAVONE_METABOLIC_PROCE...,SET,6,-0.12066,-0.0021798,0.30547,0.65357,GOBP_FLAVONE_METABOLIC_PROCESS,1
REACTOME_TNF_SIGNALING,SET,51,-0.044614,-0.0023469,0.1129,0.65363,REACTOME_TNF_SIGNALING,1
MIR3166,SET,103,-0.035128,-0.0026224,0.088889,0.65364,MIR3166,1
GOMF_SODIUM_CHANNEL_ACTIVITY,SET,47,-0.053532,-0.0027037,0.13547,0.65364,GOMF_SODIUM_CHANNEL_ACTIVITY,1
GOMF_ENOYL_COA_HYDRATASE_ACT...,SET,11,-0.11824,-0.0028919,0.29872,0.65388,GOMF_ENOYL_COA_HYDRATASE_ACTIVITY,1
HP_FAILURE_TO_THRIVE_IN_INFA...,SET,108,-0.033396,-0.0025525,0.084367,0.65388,HP_FAILURE_TO_THRIVE_IN_INFANCY,1
MIR4520_2_3P,SET,111,-0.032542,-0.0025214,0.082192,0.65392,MIR4520_2_3P,1
GOBP_REGULATION_OF_INFLAMMAS...,SET,35,-0.057685,-0.002515,0.14566,0.65395,GOBP_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
PID_SMAD2_3NUCLEAR_PATHWAY,SET,75,-0.039708,-0.0025315,0.10026,0.65396,PID_SMAD2_3NUCLEAR_PATHWAY,1
HP_CHRONIC_HEPATITIS,SET,9,-0.11678,-0.0025837,0.29481,0.65399,HP_CHRONIC_HEPATITIS,1
GSE44649_WT_VS_MIR155_KO_NAI...1,SET,188,-0.026132,-0.0026295,0.065972,0.65399,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_IN...1,SET,10,-0.097059,-0.0022634,0.24501,0.654,GOBP_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,1
SHETH_LIVER_CANCER_VS_TXNIP_...6,SET,51,-0.049346,-0.0025959,0.12455,0.65401,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,1
MODULE_79,SET,89,-0.038119,-0.0026462,0.096187,0.65405,MODULE_79,1
HP_ABNORMAL_1ST_METACARPAL_M...,SET,31,-0.058717,-0.0024095,0.14816,0.65406,HP_ABNORMAL_1ST_METACARPAL_MORPHOLOGY,1
HP_ABNORMAL_CIRCULATING_PROL...,SET,19,-0.069991,-0.0022493,0.1766,0.65406,HP_ABNORMAL_CIRCULATING_PROLINE_CONCENTRATION,1
GSE15735_CTRL_VS_HDAC_INHIBI...2,SET,179,-0.025057,-0.0024608,0.0632,0.65412,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP,1
MODULE_277,SET,47,-0.046705,-0.0023589,0.11779,0.65413,MODULE_277,1
GOBP_REGULATION_OF_PROTEIN_L...7,SET,11,-0.081391,-0.0019907,0.20522,0.65417,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,1
HP_ABNORMAL_HEMOGLOBIN_CONCE...,SET,17,-0.084332,-0.0025637,0.21261,0.65419,HP_ABNORMAL_HEMOGLOBIN_CONCENTRATION,1
HP_EXERTIONAL_DYSPNEA,SET,134,-0.029602,-0.0025185,0.074622,0.6542,HP_EXERTIONAL_DYSPNEA,1
GOBP_INOSITOL_METABOLIC_PROC...,SET,8,-0.10544,-0.0021993,0.26576,0.65422,GOBP_INOSITOL_METABOLIC_PROCESS,1
WCAANNNYCAG_UNKNOWN,SET,228,-0.022968,-0.0025423,0.057886,0.65423,WCAANNNYCAG_UNKNOWN,1
GSE7460_WT_VS_FOXP3_HET_ACT_...3,SET,176,-0.025288,-0.0024628,0.063737,0.65423,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN,1
STK33_NOMO_UP,SET,263,-0.022227,-0.0026399,0.056008,0.65426,STK33_NOMO_UP,1
REACTOME_BASE_EXCISION_REPAIR,SET,44,-0.046274,-0.0022615,0.11659,0.65427,REACTOME_BASE_EXCISION_REPAIR,1
ONDER_CDH1_SIGNALING_VIA_CTN...,SET,79,-0.042978,-0.0028117,0.10824,0.65434,ONDER_CDH1_SIGNALING_VIA_CTNNB1,1
HP_MINICORE_MYOPATHY,SET,8,-0.11755,-0.0024521,0.29581,0.65446,HP_MINICORE_MYOPATHY,1
BLANCO_MELO_INFLUENZA_A_INFE...1,SET,101,-0.031587,-0.0023352,0.079482,0.65447,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN,1
MIR4652_5P,SET,32,-0.058974,-0.0024587,0.14832,0.65454,MIR4652_5P,1
HP_LIMB_PAIN,SET,52,-0.049756,-0.0026429,0.1251,0.65458,HP_LIMB_PAIN,1
HP_HYPERTYROSINEMIA,SET,6,-0.15213,-0.0027484,0.3824,0.65462,HP_HYPERTYROSINEMIA,1
GOBP_CELLULAR_RESPONSE_TO_MA...2,SET,7,-0.1376,-0.0026849,0.34585,0.65463,GOBP_CELLULAR_RESPONSE_TO_MAGNESIUM_ION,1
RAY_TARGETS_OF_P210_BCR_ABL_...2,SET,12,-0.11231,-0.0028689,0.28211,0.65472,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,1
HP_BILATERAL_SINGLE_TRANSVER...,SET,55,-0.046984,-0.0025664,0.11801,0.65474,HP_BILATERAL_SINGLE_TRANSVERSE_PALMAR_CREASES,1
YORDY_RECIPROCAL_REGULATION_...2,SET,20,-0.0784,-0.0025849,0.1969,0.65475,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,1
GSE40666_STAT1_KO_VS_STAT4_K...3,SET,145,-0.030036,-0.0026574,0.075407,0.6548,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,1
MIR7976,SET,91,-0.03493,-0.0024518,0.087682,0.65482,MIR7976,1
GSE2128_CTRL_VS_MIMETOPE_NEG...4,SET,181,-0.026325,-0.0025996,0.066082,0.65482,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP,1
WP_BONE_MORPHOGENIC_PROTEIN_...,SET,11,-0.10719,-0.0026215,0.26897,0.65487,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,1
GOBP_CELL_KILLING,SET,204,-0.026737,-0.0028013,0.067067,0.65493,GOBP_CELL_KILLING,1
MIR143_5P,SET,120,-0.031922,-0.002571,0.080063,0.65494,MIR143_5P,1
MIR6742_3P,SET,94,-0.034761,-0.0024796,0.087159,0.65498,MIR6742_3P,1
GNF2_TPT1,SET,34,-0.058197,-0.0025009,0.14591,0.655,GNF2_TPT1,1
GSE26351_UNSTIM_VS_WNT_PATHW...1,SET,176,-0.025141,-0.0024485,0.063009,0.65505,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,1
GSE34156_NOD2_LIGAND_VS_TLR1...2,SET,152,-0.027417,-0.0024831,0.068673,0.65514,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,1
HP_INCOMPLETE_PARTITION_OF_T...,SET,7,-0.12728,-0.0024835,0.31875,0.65516,HP_INCOMPLETE_PARTITION_OF_THE_COCHLEA_TYPE_II,1
GOMF_STAT_FAMILY_PROTEIN_BIN...,SET,10,-0.10611,-0.0024745,0.26571,0.65517,GOMF_STAT_FAMILY_PROTEIN_BINDING,1
HP_LOCALIZED_SKIN_LESION,SET,792,-0.012638,-0.0025664,0.031647,0.65517,HP_LOCALIZED_SKIN_LESION,1
KORKOLA_CHORIOCARCINOMA,SET,5,-0.16634,-0.0027433,0.4165,0.65519,KORKOLA_CHORIOCARCINOMA,1
GOBP_REGULATION_OF_ADIPONECT...,SET,7,-0.13628,-0.0026592,0.34122,0.65519,GOBP_REGULATION_OF_ADIPONECTIN_SECRETION,1
HP_FLARED_NOSTRILS,SET,6,-0.14341,-0.0025909,0.35909,0.65519,HP_FLARED_NOSTRILS,1
GSE34006_UNTREATED_VS_A2AR_A...2,SET,176,-0.025175,-0.0024518,0.06302,0.65523,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP,1
GOBP_RESPONSE_TO_HUMAN_CHORI...,SET,5,-0.18122,-0.0029887,0.45355,0.65525,GOBP_RESPONSE_TO_HUMAN_CHORIONIC_GONADOTROPIN,1
GOBP_PROSTAGLANDIN_TRANSPORT,SET,29,-0.073205,-0.0029057,0.18321,0.65526,GOBP_PROSTAGLANDIN_TRANSPORT,1
KEGG_BIOSYNTHESIS_OF_UNSATUR...,SET,22,-0.078679,-0.0027206,0.19689,0.65528,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,1
GOBP_CELL_MATRIX_ADHESION,SET,225,-0.02371,-0.0026073,0.059313,0.65532,GOBP_CELL_MATRIX_ADHESION,1
GOBP_REGULATION_OF_MITOTIC_N...,SET,116,-0.031125,-0.002465,0.077864,0.65532,GOBP_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,1
GOBP_NEGATIVE_REGULATION_OF_...339,SET,129,-0.032367,-0.0027022,0.080965,0.65534,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,1
HP_TUBULOINTERSTITIAL_NEPHRI...,SET,19,-0.067898,-0.002182,0.16983,0.65534,HP_TUBULOINTERSTITIAL_NEPHRITIS,1
GOMF_INTRONIC_TRANSCRIPTION_...,SET,11,-0.11061,-0.0027053,0.27658,0.65539,GOMF_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
HP_INCREASED_CIRCULATING_HEM...,SET,12,-0.10368,-0.0026486,0.25922,0.65541,HP_INCREASED_CIRCULATING_HEMOGLOBIN_CONCENTRATION,1
PID_WNT_NONCANONICAL_PATHWAY,SET,31,-0.06367,-0.0026128,0.15918,0.65542,PID_WNT_NONCANONICAL_PATHWAY,1
REACTOME_NOTCH2_INTRACELLULA...,SET,11,-0.11331,-0.0027712,0.28317,0.65547,REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
HP_ABNORMAL_CIRCULATING_GLYC...,SET,27,-0.067965,-0.0026032,0.16975,0.65556,HP_ABNORMAL_CIRCULATING_GLYCINE_CONCENTRATION,1
GSE13493_CD4INTCD8POS_VS_CD8...1,SET,182,-0.024722,-0.002448,0.06172,0.65562,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...317,SET,2,-0.24129,-0.0025169,0.60218,0.65567,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,1
IWANAGA_CARCINOGENESIS_BY_KR...3,SET,169,-0.026602,-0.0025392,0.066377,0.6557,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1
GSE13887_RESTING_VS_NO_TREAT...2,SET,113,-0.034027,-0.00266,0.084898,0.65571,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP,1
REACTOME_PECAM1_INTERACTIONS,SET,11,-0.10298,-0.0025188,0.25689,0.65575,REACTOME_PECAM1_INTERACTIONS,1
GSE27786_CD8_TCELL_VS_NEUTRO...1,SET,179,-0.02493,-0.0024484,0.06218,0.65576,GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN,1
HP_CERVICAL_LYMPHADENOPATHY,SET,9,-0.10327,-0.0022847,0.25745,0.65583,HP_CERVICAL_LYMPHADENOPATHY,1
WP_DEVELOPMENT_AND_HETEROGEN...,SET,32,-0.065832,-0.0027446,0.16411,0.65584,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,1
OHASHI_AURKB_TARGETS,SET,7,-0.12958,-0.0025285,0.32301,0.65585,OHASHI_AURKB_TARGETS,1
LET_7F_1_3P,SET,663,-0.013744,-0.0025631,0.034257,0.65587,LET_7F_1_3P,1
GAVISH_3CA_METAPROGRAM_FIBRO...7,SET,48,-0.0547,-0.0027919,0.13633,0.65588,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_6,1
HP_CHRONIC_KIDNEY_DISEASE,SET,178,-0.025061,-0.0024544,0.062458,0.65588,HP_CHRONIC_KIDNEY_DISEASE,1
GAUSSMANN_MLL_AF4_FUSION_TAR...13,SET,26,-0.063784,-0.0023974,0.1589,0.65594,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,1
SENGUPTA_EBNA1_ANTICORRELATED,SET,126,-0.030374,-0.0025063,0.07566,0.65595,SENGUPTA_EBNA1_ANTICORRELATED,1
GSE17721_PAM3CSK4_VS_CPG_24H...1,SET,182,-0.02475,-0.0024508,0.06163,0.656,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...425,SET,19,-0.080267,-0.0025795,0.19987,0.65601,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,1
BROWNE_HCMV_INFECTION_24HR_DN,SET,131,-0.030265,-0.0025461,0.075356,0.65602,BROWNE_HCMV_INFECTION_24HR_DN,1
GOMF_HISTONE_H2A_DEUBIQUITIN...,SET,5,-0.12388,-0.0020431,0.30832,0.65608,GOMF_HISTONE_H2A_DEUBIQUITINASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_AMH_S...,SET,9,-0.11666,-0.0025809,0.29028,0.65611,KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY,1
GOBP_IMMUNE_EFFECTOR_PROCESS,SET,582,-0.015312,-0.0026813,0.038096,0.65613,GOBP_IMMUNE_EFFECTOR_PROCESS,1
GOBP_REGULATION_OF_ENDOSOME_...1,SET,4,-0.14404,-0.0021248,0.35829,0.65616,GOBP_REGULATION_OF_ENDOSOME_ORGANIZATION,1
GOCC_NUCLEAR_UBIQUITIN_LIGAS...,SET,41,-0.051606,-0.0024348,0.12835,0.65618,GOCC_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX,1
HUMMERICH_BENIGN_SKIN_TUMOR_...2,SET,15,-0.094675,-0.0027037,0.23538,0.65624,HUMMERICH_BENIGN_SKIN_TUMOR_UP,1
GOBP_ENDOPLASMIC_RETICULUM_M...,SET,11,-0.081543,-0.0019944,0.20273,0.65624,GOBP_ENDOPLASMIC_RETICULUM_MEMBRANE_ORGANIZATION,1
GOCC_DENDRITE_CYTOPLASM,SET,26,-0.062992,-0.0023676,0.15661,0.65624,GOCC_DENDRITE_CYTOPLASM,1
KEGG_MEDICUS_ENV_FACTOR_ZN_T...,SET,18,-0.090287,-0.0028242,0.22445,0.65625,KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
GOBP_RESPONSE_TO_CORTICOTROP...,SET,5,-0.17672,-0.0029145,0.43928,0.65627,GOBP_RESPONSE_TO_CORTICOTROPIN_RELEASING_HORMONE,1
HP_TRICUSPID_VALVE_PROLAPSE,SET,10,-0.11563,-0.0026964,0.28726,0.65635,HP_TRICUSPID_VALVE_PROLAPSE,1
BIOCARTA_LONGEVITY_PATHWAY,SET,15,-0.093649,-0.0026744,0.23262,0.65637,BIOCARTA_LONGEVITY_PATHWAY,1
BIOCARTA_BAD_PATHWAY,SET,24,-0.0789,-0.0028494,0.19596,0.65639,BIOCARTA_BAD_PATHWAY,1
HP_CONGENITAL_CONTRACTURE,SET,156,-0.027642,-0.0025359,0.068632,0.65643,HP_CONGENITAL_CONTRACTURE,1
HOEK_NK_CELL_2011_2012_TIV_A...3,SET,13,-0.10281,-0.0027334,0.25528,0.65643,HOEK_NK_CELL_2011_2012_TIV_ADULT_7DY_UP,1
GOBP_LIGAND_GATED_ION_CHANNE...,SET,30,-0.069225,-0.0027946,0.17179,0.65651,GOBP_LIGAND_GATED_ION_CHANNEL_SIGNALING_PATHWAY,1
WP_SELECTIVE_EXPRESSION_OF_C...,SET,27,-0.074199,-0.0028419,0.1841,0.65654,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,1
GSE22601_IMMATURE_CD4_SINGLE...5,SET,181,-0.02624,-0.0025913,0.065098,0.65656,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,1
GOBP_REGULATION_OF_BRANCHING...3,SET,9,-0.11273,-0.002494,0.27963,0.65657,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
HP_CUTANEOUS_SYNDACTYLY_OF_T...,SET,25,-0.071136,-0.0026219,0.17645,0.65658,HP_CUTANEOUS_SYNDACTYLY_OF_TOES,1
HP_DIFFICULTY_RUNNING,SET,47,-0.051223,-0.0025871,0.12705,0.65659,HP_DIFFICULTY_RUNNING,1
GOBP_REGULATION_OF_TUBE_SIZE,SET,140,-0.032193,-0.0027991,0.079845,0.6566,GOBP_REGULATION_OF_TUBE_SIZE,1
GSE27786_BCELL_VS_NKTCELL_DN,SET,178,-0.026151,-0.0025612,0.064853,0.65661,GSE27786_BCELL_VS_NKTCELL_DN,1
GOBP_PSEUDOURIDINE_SYNTHESIS,SET,17,-0.075308,-0.0022894,0.18671,0.65665,GOBP_PSEUDOURIDINE_SYNTHESIS,1
GOMF_RNA_POLYMERASE_I_GENERA...,SET,3,-0.20211,-0.0025821,0.501,0.65668,GOMF_RNA_POLYMERASE_I_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
REACTOME_ACYL_CHAIN_REMODELL...1,SET,25,-0.076538,-0.002821,0.18967,0.65672,REACTOME_ACYL_CHAIN_REMODELLING_OF_PC,1
GOBP_POSITIVE_REGULATION_OF_...440,SET,76,-0.041662,-0.0026736,0.10317,0.65683,GOBP_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,1
ELVIDGE_HIF2A_TARGETS_UP,SET,6,-0.14534,-0.0026258,0.35989,0.65684,ELVIDGE_HIF2A_TARGETS_UP,1
REACTOME_TRANSCRIPTIONAL_ACT...1,SET,50,-0.049148,-0.0025601,0.12159,0.65697,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,1
HP_NONCOMPACTION_CARDIOMYOPA...,SET,15,-0.095434,-0.0027253,0.23608,0.65698,HP_NONCOMPACTION_CARDIOMYOPATHY,1
MIR1825,SET,149,-0.028565,-0.0025616,0.070632,0.65705,MIR1825,1
TGTATGA_MIR4853P,SET,145,-0.028905,-0.0025574,0.071473,0.65705,TGTATGA_MIR4853P,1
GOMF_TRANSFERASE_ACTIVITY_TR...4,SET,822,-0.012063,-0.0024935,0.029814,0.65711,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,1
STAT5B_01,SET,223,-0.024034,-0.0026314,0.059393,0.65714,STAT5B_01,1
HP_TEMPORAL_OPTIC_DISC_PALLOR,SET,7,-0.14012,-0.0027341,0.34622,0.65715,HP_TEMPORAL_OPTIC_DISC_PALLOR,1
MIR1277_5P,SET,820,-0.012713,-0.0026249,0.031407,0.65718,MIR1277_5P,1
GSE37416_CTRL_VS_48H_F_TULAR...2,SET,167,-0.027288,-0.0025894,0.067397,0.65721,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
HP_ENCHONDROMA,SET,21,-0.073135,-0.0024708,0.18062,0.65723,HP_ENCHONDROMA,1
HORIUCHI_WTAP_TARGETS_DN,SET,284,-0.019992,-0.002466,0.04936,0.65727,HORIUCHI_WTAP_TARGETS_DN,1
OSADA_ASCL1_TARGETS_DN,SET,23,-0.081468,-0.0028802,0.20114,0.65727,OSADA_ASCL1_TARGETS_DN,1
HAY_BONE_MARROW_CD34_POS_LMPP,SET,6,-0.1584,-0.0028617,0.39107,0.65728,HAY_BONE_MARROW_CD34_POS_LMPP,1
GSE35685_CD34POS_CD38NEG_VS_...3,SET,188,-0.025134,-0.0025291,0.062006,0.65739,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN,1
GOBP_REGULATION_OF_ACTIN_NUC...,SET,27,-0.061126,-0.0023412,0.15075,0.65743,GOBP_REGULATION_OF_ACTIN_NUCLEATION,1
GSE15624_CTRL_VS_3H_HALOFUGI...2,SET,147,-0.027699,-0.0024674,0.068317,0.65743,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP,1
GOBP_SYNAPTIC_VESICLE_RECYCL...1,SET,74,-0.039527,-0.0025031,0.097467,0.65746,GOBP_SYNAPTIC_VESICLE_RECYCLING,1
GOCC_SYNAPTONEMAL_STRUCTURE,SET,34,-0.053952,-0.0023184,0.13303,0.65746,GOCC_SYNAPTONEMAL_STRUCTURE,1
HP_SHORT_MIDDLE_PHALANX_OF_T...2,SET,5,-0.17557,-0.0028956,0.43292,0.65746,HP_SHORT_MIDDLE_PHALANX_OF_TOE,1
GSE3982_NEUTROPHIL_VS_EFF_ME...2,SET,183,-0.025727,-0.0025544,0.063422,0.65749,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
SENESE_HDAC2_TARGETS_DN,SET,111,-0.035348,-0.0027388,0.08713,0.65751,SENESE_HDAC2_TARGETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...5,SET,45,-0.053268,-0.0026326,0.13129,0.65752,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,1
PID_AURORA_B_PATHWAY,SET,36,-0.057892,-0.0025598,0.14267,0.65754,PID_AURORA_B_PATHWAY,1
REACTOME_SYNTHESIS_OF_LEUKOT...,SET,21,-0.085905,-0.0029022,0.21169,0.65755,REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX,1
DROSHA_TARGET_GENES,SET,36,-0.055464,-0.0024524,0.13668,0.65755,DROSHA_TARGET_GENES,1
RUAN_RESPONSE_TO_TNF_DN,SET,76,-0.041589,-0.0026689,0.10247,0.65758,RUAN_RESPONSE_TO_TNF_DN,1
GOBP_MESENCHYMAL_TO_EPITHELI...2,SET,11,-0.12643,-0.0030922,0.31149,0.65759,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,1
THAKAR_PBMC_INACTIVATED_INFL...4,SET,115,-0.03203,-0.0025258,0.078909,0.65759,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP,1
GOBP_PROTEIN_INSERTION_INTO_...1,SET,25,-0.069631,-0.0025664,0.17149,0.65764,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
RASHI_RESPONSE_TO_IONIZING_R...4,SET,45,-0.050641,-0.0025028,0.12467,0.6577,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,1
GOBP_POSITIVE_REGULATION_OF_...217,SET,271,-0.020505,-0.0024715,0.050479,0.6577,GOBP_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,1
HP_ABNORMAL_URINE_PHOSPHATE_...,SET,26,-0.068324,-0.0025681,0.16817,0.65773,HP_ABNORMAL_URINE_PHOSPHATE_CONCENTRATION,1
GOBP_ACTIN_FILAMENT_DEPOLYME...,SET,54,-0.045502,-0.0024629,0.11198,0.65776,GOBP_ACTIN_FILAMENT_DEPOLYMERIZATION,1
GOBP_LIPID_BIOSYNTHETIC_PROC...,SET,671,-0.013813,-0.0025907,0.033981,0.6578,GOBP_LIPID_BIOSYNTHETIC_PROCESS,1
GOBP_MEIOTIC_SISTER_CHROMATI...,SET,12,-0.10368,-0.0026486,0.25503,0.65783,GOBP_MEIOTIC_SISTER_CHROMATID_COHESION,1
LET_7A_3P,SET,665,-0.01391,-0.0025977,0.034212,0.65784,LET_7A_3P,1
GSE37301_LYMPHOID_PRIMED_MPP...8,SET,176,-0.025177,-0.002452,0.061911,0.65787,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP,1
GOCC_BBAF_COMPLEX,SET,10,-0.12391,-0.0028896,0.30464,0.6579,GOCC_BBAF_COMPLEX,1
GSE17721_0.5H_VS_24H_POLYIC_...1,SET,183,-0.024849,-0.0024672,0.061084,0.65792,GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN,1
GSE29949_MICROGLIA_VS_DC_BRA...1,SET,176,-0.026974,-0.0026271,0.066293,0.65796,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,1
ZHENG_IL22_SIGNALING_UP,SET,53,-0.051589,-0.0027664,0.12676,0.65798,ZHENG_IL22_SIGNALING_UP,1
REACTOME_OREXIN_AND_NEUROPEP...,SET,6,-0.1788,-0.0032301,0.4392,0.65803,REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS,1
HP_PERIODONTITIS,SET,33,-0.060051,-0.0025424,0.14749,0.65805,HP_PERIODONTITIS,1
HP_SHORT_PALPEBRAL_FISSURE,SET,107,-0.033149,-0.002522,0.081367,0.65814,HP_SHORT_PALPEBRAL_FISSURE,1
GOBP_RNA_IMPORT_INTO_MITOCHO...,SET,5,-0.1136,-0.0018735,0.27879,0.65817,GOBP_RNA_IMPORT_INTO_MITOCHONDRION,1
HP_LATERAL_CLAVICLE_HOOK,SET,11,-0.10163,-0.0024856,0.24935,0.6582,HP_LATERAL_CLAVICLE_HOOK,1
REACTOME_LAMININ_INTERACTIONS,SET,28,-0.068889,-0.0026869,0.16901,0.65822,REACTOME_LAMININ_INTERACTIONS,1
GSE360_CTRL_VS_T_GONDII_MAC_...1,SET,179,-0.025859,-0.0025396,0.063432,0.65824,GSE360_CTRL_VS_T_GONDII_MAC_DN,1
GSE22886_NAIVE_TCELL_VS_NKCE...2,SET,173,-0.026622,-0.0025708,0.065293,0.65826,GSE22886_NAIVE_TCELL_VS_NKCELL_UP,1
GOCC_X_CHROMOSOME,SET,6,-0.15607,-0.0028196,0.38276,0.65827,GOCC_X_CHROMOSOME,1
VART_KSHV_INFECTION_ANGIOGEN...2,SET,152,-0.031254,-0.0028305,0.076625,0.65832,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,1
GOBP_COMPLEMENT_ACTIVATION_L...,SET,10,-0.12191,-0.0028431,0.29881,0.65836,GOBP_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY,1
GOMF_PROSTANOID_RECEPTOR_ACT...,SET,11,-0.12062,-0.0029501,0.29555,0.6584,GOMF_PROSTANOID_RECEPTOR_ACTIVITY,1
GOBP_RECEPTOR_MEDIATED_VIRIO...,SET,5,-0.18191,-0.003,0.44569,0.65841,GOBP_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL,1
PID_P38_MK2_PATHWAY,SET,21,-0.085037,-0.0028729,0.20834,0.65842,PID_P38_MK2_PATHWAY,1
GOBP_TRNA_PSEUDOURIDINE_SYNT...,SET,6,-0.12563,-0.0022695,0.30771,0.65846,GOBP_TRNA_PSEUDOURIDINE_SYNTHESIS,1
JOHANSSON_BRAIN_CANCER_EARLY...2,SET,6,-0.13442,-0.0024283,0.32902,0.65856,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP,1
HP_THROMBOCYTOSIS,SET,55,-0.04599,-0.0025121,0.11257,0.65856,HP_THROMBOCYTOSIS,1
HP_ABNORMAL_3RD_FINGER_MORPH...,SET,24,-0.076185,-0.0027513,0.18637,0.65865,HP_ABNORMAL_3RD_FINGER_MORPHOLOGY,1
GOBP_CELL_DIFFERENTIATION_IN...3,SET,21,-0.088951,-0.0030051,0.21759,0.65866,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,1
HP_ABNORMAL_RESPIRATORY_MOTI...,SET,29,-0.062108,-0.0024652,0.15192,0.65866,HP_ABNORMAL_RESPIRATORY_MOTILE_CILIUM_PHYSIOLOGY,1
HP_OVOID_VERTEBRAL_BODIES,SET,34,-0.061413,-0.002639,0.15022,0.65866,HP_OVOID_VERTEBRAL_BODIES,1
GOBP_2FE_2S_CLUSTER_ASSEMBLY,SET,8,-0.12703,-0.0026497,0.31071,0.65867,GOBP_2FE_2S_CLUSTER_ASSEMBLY,1
GOBP_REGULATION_OF_GLUCOSE_T...,SET,70,-0.04454,-0.0027436,0.10893,0.65869,GOBP_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_GLIAL_CEL...1,SET,12,-0.10191,-0.0026031,0.24919,0.65871,GOBP_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,1
GOBP_FAS_SIGNALING_PATHWAY,SET,6,-0.12984,-0.0023456,0.31748,0.65872,GOBP_FAS_SIGNALING_PATHWAY,1
GSE9988_LPS_VS_LOW_LPS_MONOC...2,SET,137,-0.03037,-0.0026123,0.074225,0.65878,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...4,SET,4,-0.19738,-0.0029117,0.48241,0.65879,GOBP_PROTEIN_LOCALIZATION_TO_BICELLULAR_TIGHT_JUNCTION,1
GOMF_WNT_RECEPTOR_ACTIVITY,SET,16,-0.10092,-0.0029765,0.24663,0.6588,GOMF_WNT_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_LENS_MORPHOLOGY,SET,720,-0.013314,-0.0025832,0.032516,0.6589,HP_ABNORMAL_LENS_MORPHOLOGY,1
BIOCARTA_GABA_PATHWAY,SET,9,-0.12114,-0.0026801,0.29582,0.65891,BIOCARTA_GABA_PATHWAY,1
WP_LEPTIN_AND_ADIPONECTIN,SET,10,-0.10681,-0.0024909,0.26082,0.65892,WP_LEPTIN_AND_ADIPONECTIN,1
MIR6852_5P,SET,175,-0.026737,-0.0025966,0.065291,0.65892,MIR6852_5P,1
GSE7768_OVA_WITH_LPS_VS_OVA_...2,SET,156,-0.026817,-0.0024602,0.065459,0.65897,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
GOBP_POSITIVE_REGULATION_OF_...200,SET,36,-0.05597,-0.0024748,0.13661,0.65899,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
HP_ABNORMALITY_OF_NEURONAL_M...,SET,424,-0.01675,-0.0025147,0.040883,0.65899,HP_ABNORMALITY_OF_NEURONAL_MIGRATION,1
HE_LIM_SUN_FETAL_LUNG_C4_CD8...,SET,46,-0.053172,-0.0026569,0.12978,0.65899,HE_LIM_SUN_FETAL_LUNG_C4_CD8_T_CELL,1
GNF2_RBBP6,SET,65,-0.03931,-0.0023337,0.095856,0.65913,GNF2_RBBP6,1
HP_ABNORMAL_CD4_CD8_RATIO,SET,17,-0.085959,-0.0026132,0.2096,0.65913,HP_ABNORMAL_CD4_CD8_RATIO,1
KEGG_LYSOSOME,SET,113,-0.033158,-0.002592,0.080848,0.65914,KEGG_LYSOSOME,1
MIR4796_3P,SET,224,-0.02399,-0.0026323,0.05849,0.65915,MIR4796_3P,1
HP_SEVERE_INFECTION,SET,61,-0.045141,-0.0025963,0.11006,0.65915,HP_SEVERE_INFECTION,1
GSE30971_2H_VS_4H_LPS_STIM_M...4,SET,184,-0.025296,-0.0025184,0.061667,0.65917,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP,1
SESTO_RESPONSE_TO_UV_C4,SET,20,-0.079128,-0.0026089,0.19285,0.6592,SESTO_RESPONSE_TO_UV_C4,1
HP_VOMITING,SET,301,-0.020221,-0.0025666,0.049277,0.65923,HP_VOMITING,1
GSE20715_0H_VS_6H_OZONE_TLR4...1,SET,189,-0.025919,-0.0026149,0.06315,0.65925,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN,1
HP_CSF_PLEOCYTOSIS,SET,23,-0.07184,-0.0025399,0.17503,0.65926,HP_CSF_PLEOCYTOSIS,1
WP_CHOLESTASIS,SET,19,-0.089458,-0.0028749,0.21792,0.65928,WP_CHOLESTASIS,1
ZNF454_TARGET_GENES,SET,11,-0.10602,-0.002593,0.25821,0.65931,ZNF454_TARGET_GENES,1
chr22q12,SET,107,-0.074115,-0.0056387,0.18048,0.65933,chr22q12,1
GOBP_RESPONSE_TO_GRAM_POSITI...,SET,6,-0.14436,-0.0026079,0.35154,0.65933,GOBP_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,1
GOBP_ADULT_BEHAVIOR,SET,141,-0.030832,-0.0026902,0.074998,0.6595,GOBP_ADULT_BEHAVIOR,1
MIR4781_5P,SET,5,-0.17093,-0.002819,0.41571,0.65953,MIR4781_5P,1
HP_EXCESSIVE_DAYTIME_SOMNOLE...,SET,64,-0.04423,-0.0026056,0.10747,0.65966,HP_EXCESSIVE_DAYTIME_SOMNOLENCE,1
GOBP_RRNA_PROCESSING,SET,194,-0.023375,-0.002389,0.056785,0.6597,GOBP_RRNA_PROCESSING,1
MIR4711_5P,SET,94,-0.035518,-0.0025337,0.086274,0.65972,MIR4711_5P,1
GOCC_EXTRINSIC_COMPONENT_OF_...9,SET,13,-0.090932,-0.0024176,0.22077,0.65978,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_MEMBRANE,1
MCLACHLAN_DENTAL_CARIES_DN,SET,70,-0.04447,-0.0027393,0.10794,0.65982,MCLACHLAN_DENTAL_CARIES_DN,1
REACTOME_ACTIVATION_OF_THE_M...,SET,52,-0.046521,-0.0024711,0.1129,0.65984,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1
MIR12122,SET,193,-0.025702,-0.00262,0.062375,0.65985,MIR12122,1
GOCC_RIBONUCLEOPROTEIN_GRANU...,SET,246,-0.021876,-0.002514,0.053087,0.65986,GOCC_RIBONUCLEOPROTEIN_GRANULE,1
MIR4683,SET,47,-0.054586,-0.0027569,0.13244,0.65989,MIR4683,1
MASSARWEH_TAMOXIFEN_RESISTAN...2,SET,510,-0.016141,-0.0026513,0.039154,0.65992,MASSARWEH_TAMOXIFEN_RESISTANCE_UP,1
DESCARTES_FETAL_PLACENTA_PAE...,SET,132,-0.03204,-0.0027056,0.077705,0.65995,DESCARTES_FETAL_PLACENTA_PAEP_MECOM_POSITIVE_CELLS,1
VANHARANTA_UTERINE_FIBROID_DN,SET,59,-0.051152,-0.0028936,0.12403,0.65998,VANHARANTA_UTERINE_FIBROID_DN,1
HP_ADDUCTED_THUMB,SET,97,-0.03698,-0.0026795,0.089626,0.66005,HP_ADDUCTED_THUMB,1
SATO_SILENCED_BY_METHYLATION...2,SET,41,-0.057633,-0.0027191,0.13963,0.6601,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1
MIR369_3P,SET,276,-0.021717,-0.0026413,0.052609,0.66012,MIR369_3P,1
REACTOME_PI3K_EVENTS_IN_ERBB...1,SET,16,-0.090199,-0.0026603,0.21849,0.66013,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,1
MODULE_417,SET,21,-0.083061,-0.0028061,0.20117,0.66015,MODULE_417,1
GSE26343_UNSTIM_VS_LPS_STIM_...4,SET,185,-0.025945,-0.0025899,0.062839,0.66015,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP,1
MORI_LARGE_PRE_BII_LYMPHOCYT...2,SET,81,-0.039865,-0.0026407,0.096543,0.66017,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...377,SET,5,-0.17259,-0.0028464,0.41787,0.6602,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,1
GOBP_POSITIVE_REGULATION_OF_...286,SET,52,-0.052881,-0.0028089,0.12803,0.66021,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,1
MIKKELSEN_MEF_HCP_WITH_H3K27...,SET,558,-0.016807,-0.0028837,0.040677,0.66026,MIKKELSEN_MEF_HCP_WITH_H3K27ME3,1
MIR4801,SET,242,-0.024058,-0.0027425,0.058229,0.66026,MIR4801,1
HP_ACTION_TREMOR,SET,167,-0.026598,-0.0025239,0.064374,0.66026,HP_ACTION_TREMOR,1
GERHOLD_ADIPOGENESIS_DN,SET,58,-0.046693,-0.002619,0.11298,0.6603,GERHOLD_ADIPOGENESIS_DN,1
TRAVAGLINI_LUNG_NATURAL_KILL...1,SET,121,-0.034719,-0.0028078,0.083986,0.66034,TRAVAGLINI_LUNG_NATURAL_KILLER_CELL,1
MIR345_5P,SET,40,-0.05791,-0.0026987,0.14004,0.66039,MIR345_5P,1
GOBP_VASCULAR_ASSOCIATED_SMO...2,SET,11,-0.10281,-0.0025144,0.24842,0.66051,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEVELOPMENT,1
GSE2770_IL12_VS_IL4_TREATED_...2,SET,129,-0.029559,-0.0024678,0.071391,0.66058,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
GOCC_ASYMMETRIC_GLUTAMATERGI...,SET,13,-0.10502,-0.0027922,0.25359,0.66061,GOCC_ASYMMETRIC_GLUTAMATERGIC_EXCITATORY_SYNAPSE,1
HUANG_DASATINIB_SENSITIVITY_...,SET,75,-0.045603,-0.0029073,0.1101,0.66063,HUANG_DASATINIB_SENSITIVITY_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...6,SET,11,-0.10444,-0.0025543,0.25209,0.66067,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
REACTOME_GERM_LAYER_FORMATIO...,SET,15,-0.096045,-0.0027428,0.23182,0.66068,REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION,1
MIR627_5P,SET,36,-0.057079,-0.0025238,0.13775,0.6607,MIR627_5P,1
GOBP_AMYGDALA_DEVELOPMENT,SET,5,-0.16249,-0.0026797,0.39209,0.66071,GOBP_AMYGDALA_DEVELOPMENT,1
STEIN_ESRRA_TARGETS,SET,473,-0.016435,-0.0026024,0.039652,0.66073,STEIN_ESRRA_TARGETS,1
GOBP_POSITIVE_REGULATION_OF_...117,SET,304,-0.022011,-0.0028074,0.053099,0.66075,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION,1
TRAVAGLINI_LUNG_PROLIFERATIN...3,SET,121,-0.031642,-0.002559,0.076335,0.66075,TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL,1
chr17q22,SET,42,-0.093077,-0.0044445,0.22452,0.66077,chr17q22,1
GOMF_SHORT_CHAIN_FATTY_ACYL_...,SET,5,-0.14868,-0.002452,0.35858,0.66079,GOMF_SHORT_CHAIN_FATTY_ACYL_COA_DEHYDROGENASE_ACTIVITY,1
YAP1_UP,SET,40,-0.055378,-0.0025807,0.13353,0.66082,YAP1_UP,1
GOBP_MITOCHONDRION_ORGANIZAT...,SET,442,-0.016221,-0.0024852,0.039098,0.66089,GOBP_MITOCHONDRION_ORGANIZATION,1
GSE21360_SECONDARY_VS_QUATER...1,SET,147,-0.030595,-0.0027253,0.073726,0.66092,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
HP_DECREASED_COMPOUND_MUSCLE...,SET,13,-0.097228,-0.002585,0.23427,0.66094,HP_DECREASED_COMPOUND_MUSCLE_ACTION_POTENTIAL_AMPLITUDE,1
GOMF_CHOLESTEROL_BINDING,SET,51,-0.051012,-0.0026835,0.1229,0.66095,GOMF_CHOLESTEROL_BINDING,1
GOBP_RRNA_3_END_PROCESSING,SET,10,-0.10266,-0.002394,0.24728,0.66098,GOBP_RRNA_3_END_PROCESSING,1
HP_SHOCK,SET,12,-0.1075,-0.0027462,0.25884,0.66104,HP_SHOCK,1
MIR767_3P,SET,115,-0.036102,-0.0028468,0.086922,0.66105,MIR767_3P,1
HES2_TARGET_GENES,SET,1002,-0.011802,-0.0026795,0.028404,0.66111,HES2_TARGET_GENES,1
GOMF_PSEUDOURIDINE_SYNTHASE_...,SET,12,-0.091388,-0.0023345,0.21993,0.66112,GOMF_PSEUDOURIDINE_SYNTHASE_ACTIVITY,1
HP_LIPODYSTROPHY,SET,114,-0.033868,-0.0026592,0.081494,0.66114,HP_LIPODYSTROPHY,1
HP_HYPOPLASIA_OF_THE_PHALANG...,SET,6,-0.13145,-0.0023747,0.31628,0.66115,HP_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,1
SMAD_Q6,SET,232,-0.024121,-0.002693,0.058002,0.66124,SMAD_Q6,1
GSE33162_HDAC3_KO_VS_HDAC3_K...3,SET,176,-0.026919,-0.0026216,0.064716,0.66127,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN,1
HP_ABNORMAL_CIRCULATING_LIPI...,SET,290,-0.021616,-0.0026938,0.051964,0.66128,HP_ABNORMAL_CIRCULATING_LIPID_CONCENTRATION,1
GSE33292_DN3_THYMOCYTE_VS_TC...1,SET,183,-0.026964,-0.0026772,0.064816,0.66129,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN,1
GSE14308_TH1_VS_NATURAL_TREG...2,SET,176,-0.025769,-0.0025097,0.061942,0.6613,GSE14308_TH1_VS_NATURAL_TREG_UP,1
GOBP_REGULATION_OF_TRANSPORT...,SET,194,-0.027371,-0.0027973,0.065772,0.66135,GOBP_REGULATION_OF_TRANSPORTER_ACTIVITY,1
GSE17721_LPS_VS_CPG_0.5H_BMD...2,SET,177,-0.025841,-0.0025237,0.06206,0.66143,GSE17721_LPS_VS_CPG_0.5H_BMDC_UP,1
MIR98_3P,SET,667,-0.014227,-0.0026608,0.034162,0.66146,MIR98_3P,1
TUOMISTO_TUMOR_SUPPRESSION_B...2,SET,17,-0.097406,-0.0029611,0.23387,0.66147,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP,1
MODULE_210,SET,26,-0.076354,-0.0028699,0.18333,0.66147,MODULE_210,1
BHATI_G2M_ARREST_BY_2METHOXY...1,SET,107,-0.034612,-0.0026333,0.083098,0.66148,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,1
GOBP_POSITIVE_REGULATION_OF_...522,SET,28,-0.074089,-0.0028897,0.17788,0.66148,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
GOBP_TRACHEA_DEVELOPMENT,SET,18,-0.094488,-0.0029556,0.22683,0.6615,GOBP_TRACHEA_DEVELOPMENT,1
GOBP_SYNAPTIC_TRANSMISSION_G...2,SET,98,-0.03786,-0.0027573,0.090873,0.66152,GOBP_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
GSE17974_CTRL_VS_ACT_IL4_AND...7,SET,176,-0.024859,-0.002421,0.059659,0.66154,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN,1
AMIT_SERUM_RESPONSE_20_MCF10A,SET,15,-0.099646,-0.0028456,0.23909,0.66157,AMIT_SERUM_RESPONSE_20_MCF10A,1
GOBP_REGULATION_OF_MAMMARY_G...,SET,14,-0.10228,-0.0028219,0.24541,0.66158,GOBP_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
HP_ABNORMAL_CIRCULATING_CARB...2,SET,305,-0.020599,-0.0026316,0.049422,0.66159,HP_ABNORMAL_CIRCULATING_CARBOXYLIC_ACID_CONCENTRATION,1
REACTOME_MUCOPOLYSACCHARIDOS...,SET,10,-0.11737,-0.0027372,0.28159,0.6616,REACTOME_MUCOPOLYSACCHARIDOSES,1
GOCC_SODIUM_POTASSIUM_EXCHAN...,SET,11,-0.12192,-0.0029818,0.29235,0.66167,GOCC_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...606,SET,6,-0.1749,-0.0031597,0.41932,0.6617,GOBP_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...637,SET,91,-0.036201,-0.002541,0.086786,0.6617,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,1
HP_QUADRICEPS_MUSCLE_WEAKNESS,SET,19,-0.083552,-0.0026851,0.20025,0.66175,HP_QUADRICEPS_MUSCLE_WEAKNESS,1
GOBP_POSITIVE_REGULATION_OF_...475,SET,7,-0.14455,-0.0028205,0.34641,0.66176,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
REACTOME_ROLE_OF_PHOSPHOLIPI...,SET,23,-0.074949,-0.0026498,0.17959,0.66178,REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,1
GOMF_UBIQUITIN_PROTEIN_TRANS...1,SET,14,-0.095502,-0.0026349,0.22884,0.66178,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVATOR_ACTIVITY,1
HP_DIAPHYSEAL_DYSPLASIA,SET,5,-0.17112,-0.0028221,0.40994,0.66181,HP_DIAPHYSEAL_DYSPLASIA,1
BIOCARTA_CK1_PATHWAY,SET,16,-0.09645,-0.0028446,0.23104,0.66183,BIOCARTA_CK1_PATHWAY,1
MIR6853_5P,SET,6,-0.14454,-0.0026113,0.34595,0.66196,MIR6853_5P,1
GOMF_PROMOTER_ENHANCER_LOOP_...,SET,4,-0.17643,-0.0026027,0.42215,0.662,GOMF_PROMOTER_ENHANCER_LOOP_ANCHORING_ACTIVITY,1
DESCARTES_MAIN_FETAL_ENDOCAR...,SET,66,-0.044553,-0.0026651,0.10661,0.662,DESCARTES_MAIN_FETAL_ENDOCARDIAL_CELLS,1
HP_FEMORAL_BOWING,SET,41,-0.059199,-0.002793,0.14157,0.66209,HP_FEMORAL_BOWING,1
GOMF_PEPTIDE_HORMONE_RECEPTO...,SET,19,-0.090325,-0.0029028,0.21598,0.6621,GOMF_PEPTIDE_HORMONE_RECEPTOR_BINDING,1
HP_LARGE_JOINT_HYPERMOBILTY,SET,6,-0.14924,-0.0026962,0.3568,0.66213,HP_LARGE_JOINT_HYPERMOBILTY,1
GOBP_EMBRYONIC_SKELETAL_SYST...2,SET,88,-0.042837,-0.0029571,0.1024,0.66214,GOBP_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS,1
GSE37301_MULTIPOTENT_PROGENI...9,SET,163,-0.029389,-0.0027555,0.070252,0.66215,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN,1
TURJANSKI_MAPK1_AND_MAPK2_TA...,SET,11,-0.12038,-0.0029443,0.28774,0.66216,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,1
MIR4747_5P,SET,256,-0.022466,-0.002633,0.053688,0.66219,MIR4747_5P,1
GOMF_MRNA_5_UTR_BINDING,SET,22,-0.069962,-0.0024192,0.16714,0.66224,GOMF_MRNA_5_UTR_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...755,SET,5,-0.17885,-0.0029496,0.42724,0.66225,GOBP_POSITIVE_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,1
GARGALOVIC_RESPONSE_TO_OXIDI...1,SET,10,-0.10747,-0.0025061,0.25666,0.66228,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,1
GOBP_REGULATION_OF_DEOXYRIBO...,SET,10,-0.11608,-0.0027069,0.27722,0.66228,GOBP_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_C...2,SET,11,-0.11805,-0.0028872,0.28188,0.66231,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
HP_CHILLS,SET,18,-0.083528,-0.0026128,0.19942,0.66234,HP_CHILLS,1
GOBP_T_CELL_MEDIATED_CYTOTOX...,SET,56,-0.054973,-0.0030299,0.13121,0.66237,GOBP_T_CELL_MEDIATED_CYTOTOXICITY,1
MIR6507_5P,SET,306,-0.02134,-0.0027307,0.050934,0.66238,MIR6507_5P,1
JAERVINEN_AMPLIFIED_IN_LARYN...,SET,39,-0.058486,-0.0026914,0.13958,0.66239,JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,1
MIR636,SET,204,-0.026676,-0.0027949,0.063635,0.66246,MIR636,1
HP_CYSTIC_RENAL_DYSPLASIA,SET,8,-0.1202,-0.0025072,0.28674,0.66246,HP_CYSTIC_RENAL_DYSPLASIA,1
HP_ABNORMAL_HEMATOCRIT,SET,11,-0.11155,-0.0027282,0.26605,0.66249,HP_ABNORMAL_HEMATOCRIT,1
LET_7B_3P,SET,662,-0.014372,-0.0026781,0.034275,0.6625,LET_7B_3P,1
HNF4_DR1_Q3,SET,243,-0.023175,-0.0026472,0.055233,0.6626,HNF4_DR1_Q3,1
GOCC_BRAHMA_COMPLEX,SET,14,-0.10616,-0.0029289,0.25301,0.6626,GOCC_BRAHMA_COMPLEX,1
GSE3039_ALPHABETA_CD8_TCELL_...1,SET,179,-0.026541,-0.0026066,0.063254,0.66261,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN,1
GOBP_REGULATION_OF_HORMONE_M...,SET,38,-0.060461,-0.0027464,0.14407,0.66263,GOBP_REGULATION_OF_HORMONE_METABOLIC_PROCESS,1
HP_PHARYNGITIS,SET,15,-0.094653,-0.002703,0.22553,0.66264,HP_PHARYNGITIS,1
GSE32533_WT_VS_MIR17_OVEREXP...2,SET,171,-0.027757,-0.0026649,0.066125,0.66267,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,1
DESCARTES_FETAL_ADRENAL_STRO...,SET,122,-0.036129,-0.0029339,0.086065,0.66268,DESCARTES_FETAL_ADRENAL_STROMAL_CELLS,1
WP_FERROPTOSIS,SET,56,-0.051284,-0.0028266,0.12213,0.66272,WP_FERROPTOSIS,1
MIR5579_5P,SET,71,-0.042995,-0.0026672,0.10238,0.66274,MIR5579_5P,1
GOBP_REGULATION_PROTEIN_CATA...,SET,4,-0.15032,-0.0022174,0.35794,0.66274,GOBP_REGULATION_PROTEIN_CATABOLIC_PROCESS_AT_SYNAPSE,1
ZHAN_MULTIPLE_MYELOMA_CD1_AN...1,SET,51,-0.052456,-0.0027595,0.12487,0.66279,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,1
KEGG_MEDICUS_PATHOGEN_HIV_TA...1,SET,8,-0.12234,-0.0025519,0.29116,0.66282,KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
MIR6515_5P,SET,79,-0.039167,-0.0025624,0.093207,0.66283,MIR6515_5P,1
CCAGGTT_MIR490,SET,58,-0.044702,-0.0025073,0.10636,0.66286,CCAGGTT_MIR490,1
GOMF_DNA_METHYLTRANSFERASE_A...,SET,7,-0.15459,-0.0030164,0.3678,0.66287,GOMF_DNA_METHYLTRANSFERASE_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C3_LYM...,SET,345,-0.020987,-0.0028484,0.049931,0.66287,HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL,1
WAKABAYASHI_ADIPOGENESIS_PPA...3,SET,143,-0.031146,-0.0027367,0.074098,0.66288,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,1
HP_CLITORAL_HYPOPLASIA,SET,26,-0.075159,-0.002825,0.17871,0.66296,HP_CLITORAL_HYPOPLASIA,1
GOCC_CENTRIOLAR_SUBDISTAL_AP...,SET,9,-0.13443,-0.0029741,0.31958,0.66299,GOCC_CENTRIOLAR_SUBDISTAL_APPENDAGE,1
GSE45365_NK_CELL_VS_CD8_TCEL...2,SET,171,-0.028321,-0.0027191,0.067326,0.66299,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN,1
MIR3121_5P,SET,95,-0.038805,-0.0027828,0.092248,0.663,MIR3121_5P,1
GSE22886_NAIVE_BCELL_VS_BM_P...2,SET,178,-0.026109,-0.0025571,0.062066,0.663,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP,1
HP_CONGENITAL_LOCALIZED_ABSE...,SET,9,-0.12346,-0.0027315,0.29332,0.66309,HP_CONGENITAL_LOCALIZED_ABSENCE_OF_SKIN,1
HP_FACIAL_MYOKYMIA,SET,7,-0.1179,-0.0023006,0.2801,0.66309,HP_FACIAL_MYOKYMIA,1
HP_CORNEAL_GUTTATA,SET,6,-0.16017,-0.0028935,0.38046,0.66311,HP_CORNEAL_GUTTATA,1
GSE12845_NAIVE_VS_PRE_GC_TON...1,SET,175,-0.026627,-0.0025859,0.063243,0.66313,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN,1
MIR27B_5P,SET,43,-0.052903,-0.002556,0.12563,0.66315,MIR27B_5P,1
AP2REP_01,SET,157,-0.029903,-0.002752,0.07099,0.6632,AP2REP_01,1
GOBP_ENDOCARDIUM_MORPHOGENES...,SET,6,-0.176,-0.0031796,0.41784,0.6632,GOBP_ENDOCARDIUM_MORPHOGENESIS,1
GOCC_ATPASE_DEPENDENT_TRANSM...,SET,24,-0.080303,-0.0029,0.19065,0.6632,GOCC_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX,1
GOMF_NEDD8_TRANSFERASE_ACTIV...,SET,7,-0.11927,-0.0023273,0.28312,0.66322,GOMF_NEDD8_TRANSFERASE_ACTIVITY,1
KUROKAWA_LIVER_CANCER_EARLY_...2,SET,12,-0.092704,-0.0023681,0.21998,0.66328,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,1
GOBP_NUCLEOSIDE_PHOSPHATE_BI...,SET,232,-0.023328,-0.0026044,0.055342,0.66331,GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOMF_HISTONE_H3K9_DEMETHYLAS...,SET,12,-0.089733,-0.0022922,0.21286,0.66333,GOMF_HISTONE_H3K9_DEMETHYLASE_ACTIVITY,1
GOMF_ACID_THIOL_LIGASE_ACTIV...,SET,29,-0.066074,-0.0026226,0.15672,0.66334,GOMF_ACID_THIOL_LIGASE_ACTIVITY,1
GOCC_GARP_COMPLEX,SET,4,-0.14644,-0.0021603,0.34732,0.66335,GOCC_GARP_COMPLEX,1
HP_COILED_SPERM_FLAGELLA,SET,26,-0.070093,-0.0026345,0.16618,0.66341,HP_COILED_SPERM_FLAGELLA,1
HP_ABNORMAL_PLACENTAL_SIZE,SET,14,-0.10787,-0.0029762,0.25566,0.66346,HP_ABNORMAL_PLACENTAL_SIZE,1
REACTOME_IMMUNOREGULATORY_IN...,SET,114,-0.03769,-0.0029592,0.089313,0.66348,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1
MODULE_46,SET,368,-0.021223,-0.002973,0.050293,0.66348,MODULE_46,1
GOBP_GALACTOSE_TRANSMEMBRANE...,SET,4,-0.21373,-0.0031528,0.50644,0.66349,GOBP_GALACTOSE_TRANSMEMBRANE_TRANSPORT,1
HP_BIFID_EPIGLOTTIS,SET,5,-0.14767,-0.0024354,0.34987,0.66351,HP_BIFID_EPIGLOTTIS,1
HEBERT_MATRISOME_TNBC_LUNG_M...2,SET,6,-0.12847,-0.0023209,0.30434,0.66353,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED,1
HP_HYPOPHOSPHATEMIC_RICKETS,SET,18,-0.090151,-0.00282,0.21354,0.66355,HP_HYPOPHOSPHATEMIC_RICKETS,1
ER_Q6,SET,246,-0.023456,-0.0026956,0.05555,0.66358,ER_Q6,1
HP_ABNORMALITY_OF_THE_LARYNX,SET,192,-0.026128,-0.0026566,0.061867,0.6636,HP_ABNORMALITY_OF_THE_LARYNX,1
GOBP_POSITIVE_REGULATION_OF_...679,SET,576,-0.015676,-0.0027313,0.037116,0.66361,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
GOBP_REGULATION_OF_ISOMERASE...,SET,7,-0.15258,-0.0029772,0.36124,0.66362,GOBP_REGULATION_OF_ISOMERASE_ACTIVITY,1
HP_GENERALIZED_HYPERKERATOSIS,SET,13,-0.090878,-0.0024162,0.21516,0.66362,HP_GENERALIZED_HYPERKERATOSIS,1
MIR6807_5P,SET,53,-0.047467,-0.0025454,0.11236,0.66365,MIR6807_5P,1
MORF_DEK,SET,237,-0.02176,-0.0024551,0.051495,0.66369,MORF_DEK,1
GSE17186_NAIVE_VS_CD21LOW_TR...4,SET,184,-0.027505,-0.0027383,0.065075,0.66373,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP,1
MYOCD_TARGET_GENES,SET,1134,-0.011198,-0.0026945,0.026486,0.66377,MYOCD_TARGET_GENES,1
ALONSO_METASTASIS_EMT_DN,SET,5,-0.19778,-0.0032619,0.46753,0.66386,ALONSO_METASTASIS_EMT_DN,1
HP_EQUINOVARUS_DEFORMITY,SET,13,-0.11413,-0.0030344,0.26976,0.66388,HP_EQUINOVARUS_DEFORMITY,1
HE_LIM_SUN_FETAL_LUNG_C4_CD5...,SET,5,-0.1606,-0.0026487,0.37961,0.66388,HE_LIM_SUN_FETAL_LUNG_C4_CD56BRIGHT_NK_CELL,1
REACTOME_NON_INTEGRIN_MEMBRA...,SET,55,-0.051698,-0.0028239,0.12218,0.6639,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1
WP_KETOGENESIS_AND_KETOLYSIS,SET,8,-0.14361,-0.0029955,0.33914,0.66401,WP_KETOGENESIS_AND_KETOLYSIS,1
HP_BROAD_DISTAL_PHALANX_OF_F...,SET,20,-0.080407,-0.0026511,0.18985,0.66404,HP_BROAD_DISTAL_PHALANX_OF_FINGER,1
SCIAN_CELL_CYCLE_TARGETS_OF_...2,SET,8,-0.1218,-0.0025407,0.28752,0.66408,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP,1
GSE29949_DC_BRAIN_VS_MONOCYT...2,SET,176,-0.026513,-0.0025822,0.062581,0.66409,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,1
WP_EGFEGFR_SIGNALING,SET,155,-0.030232,-0.0027646,0.071355,0.6641,WP_EGFEGFR_SIGNALING,1
GOMF_LNCRNA_BINDING,SET,17,-0.079932,-0.0024299,0.18865,0.6641,GOMF_LNCRNA_BINDING,1
GOBP_EXTRINSIC_APOPTOTIC_SIG...1,SET,216,-0.025531,-0.0027516,0.060255,0.66411,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GSE24102_GRANULOCYSTIC_MDSC_...2,SET,183,-0.02647,-0.0026282,0.062459,0.66414,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP,1
GOCC_CLATHRIN_ADAPTOR_COMPLEX,SET,25,-0.07001,-0.0025804,0.16517,0.66416,GOCC_CLATHRIN_ADAPTOR_COMPLEX,1
WP_VITAMIN_A1_AND_A5X_PATHWA...,SET,6,-0.14509,-0.0026211,0.34223,0.6642,WP_VITAMIN_A1_AND_A5X_PATHWAYS,1
KEGG_MEDICUS_REFERENCE_IGF_I...3,SET,13,-0.096961,-0.0025779,0.22869,0.66421,KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY,1
REACTOME_PLATELET_CALCIUM_HO...,SET,27,-0.069539,-0.0026634,0.16398,0.66424,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,1
GOMF_FATTY_ACID_OMEGA_HYDROX...,SET,7,-0.16366,-0.0031934,0.38588,0.66426,GOMF_FATTY_ACID_OMEGA_HYDROXYLASE_ACTIVITY,1
GSE17974_0.5H_VS_72H_IL4_AND...2,SET,178,-0.027083,-0.0026524,0.063852,0.66427,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,1
MIR4474_3P,SET,79,-0.042825,-0.0028017,0.10094,0.6643,MIR4474_3P,1
GOBP_POSITIVE_REGULATION_OF_...395,SET,273,-0.022904,-0.0027707,0.053979,0.66433,GOBP_POSITIVE_REGULATION_OF_KINASE_ACTIVITY,1
GSE20366_EX_VIVO_VS_HOMEOSTA...1,SET,182,-0.027361,-0.0027093,0.06447,0.66436,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN,1
HAND1E47_01,SET,245,-0.024202,-0.0027757,0.057011,0.6644,HAND1E47_01,1
SIRNA_EIF4GI_UP,SET,84,-0.037582,-0.002535,0.088534,0.6644,SIRNA_EIF4GI_UP,1
GSE40184_HEALTHY_VS_HCV_INFE...2,SET,178,-0.026845,-0.0026291,0.063228,0.66442,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP,1
HP_ENLARGEMENT_OF_THE_COSTOC...,SET,8,-0.13527,-0.0028216,0.31858,0.66443,HP_ENLARGEMENT_OF_THE_COSTOCHONDRAL_JUNCTION,1
GSE17721_LPS_VS_CPG_2H_BMDC_...2,SET,183,-0.027531,-0.0027335,0.064832,0.66445,GSE17721_LPS_VS_CPG_2H_BMDC_UP,1
GNF2_IGFBP1,SET,30,-0.074935,-0.0030251,0.17645,0.66446,GNF2_IGFBP1,1
GAVISH_3CA_METAPROGRAM_CD8_T...1,SET,44,-0.057852,-0.0028273,0.13618,0.66452,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE,1
GOBP_POSITIVE_REGULATION_OF_...303,SET,7,-0.15597,-0.0030433,0.3668,0.66466,GOBP_POSITIVE_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,1
GSE16386_IL4_VS_IL4_AND_ROSI...1,SET,173,-0.027938,-0.0026978,0.065683,0.6647,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN,1
WP_EGFR_TYROSINE_KINASE_INHI...,SET,83,-0.043247,-0.0028998,0.10166,0.66472,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,1
GOBP_REGULATION_OF_CAVEOLIN_...,SET,6,-0.16121,-0.0029123,0.37884,0.66477,GOBP_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS,1
GSE13485_DAY1_VS_DAY7_YF17D_...1,SET,180,-0.026815,-0.0026407,0.063013,0.66478,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN,1
PID_LIS1_PATHWAY,SET,27,-0.068107,-0.0026086,0.15996,0.66486,PID_LIS1_PATHWAY,1
DESCARTES_FETAL_MUSCLE_MYELO...,SET,106,-0.037788,-0.0028616,0.088752,0.66486,DESCARTES_FETAL_MUSCLE_MYELOID_CELLS,1
WP_TRANSSULFURATION_ONECARBO...,SET,63,-0.048288,-0.0028224,0.1134,0.66488,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,1
GSE20715_0H_VS_24H_OZONE_TLR...1,SET,193,-0.0273,-0.0027829,0.064095,0.66492,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN,1
HP_FOOT_JOINT_CONTRACTURE,SET,123,-0.032341,-0.0026369,0.075845,0.66509,HP_FOOT_JOINT_CONTRACTURE,1
GOCC_PRONUCLEUS,SET,12,-0.097857,-0.0024997,0.22945,0.66512,GOCC_PRONUCLEUS,1
MIR532_3P,SET,74,-0.040927,-0.0025918,0.09596,0.66513,MIR532_3P,1
GOBP_FIBROBLAST_PROLIFERATION,SET,104,-0.0369,-0.002768,0.086518,0.66513,GOBP_FIBROBLAST_PROLIFERATION,1
GOMF_ACTININ_BINDING,SET,36,-0.064781,-0.0028643,0.15188,0.66514,GOMF_ACTININ_BINDING,1
NABA_MATRISOME_HIGHLY_METAST...3,SET,18,-0.092047,-0.0028793,0.21578,0.66515,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA,1
GOBP_CYTOPLASMIC_TRANSLATION,SET,142,-0.028858,-0.0025268,0.067647,0.66516,GOBP_CYTOPLASMIC_TRANSLATION,1
ONKEN_UVEAL_MELANOMA_UP,SET,718,-0.014107,-0.0027334,0.033062,0.66519,ONKEN_UVEAL_MELANOMA_UP,1
MIR192_5P,SET,32,-0.066227,-0.0027611,0.1552,0.66521,MIR192_5P,1
GSE41087_WT_VS_FOXP3_MUT_ANT...2,SET,168,-0.028392,-0.0027021,0.066503,0.66528,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,1
REACTOME_NFE2L2_REGULATING_T...,SET,11,-0.11982,-0.0029304,0.28062,0.66529,REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES,1
GOBP_POSITIVE_REGULATION_OF_...535,SET,22,-0.082872,-0.0028656,0.19409,0.6653,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,1
GSE12963_UNINF_VS_ENV_AND_NE...1,SET,122,-0.032946,-0.0026754,0.077127,0.66537,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,1
GOBP_UV_PROTECTION,SET,11,-0.095554,-0.002337,0.22367,0.66538,GOBP_UV_PROTECTION,1
GSE37416_0H_VS_24H_F_TULAREN...2,SET,166,-0.028427,-0.0026894,0.066533,0.6654,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
WP_MITOCHONDRIAL_FATTY_ACID_...2,SET,12,-0.11212,-0.0028641,0.26231,0.66547,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,1
HP_BIFID_UVULA,SET,139,-0.031048,-0.0026899,0.072631,0.66548,HP_BIFID_UVULA,1
GSE360_CTRL_VS_M_TUBERCULOSI...1,SET,184,-0.027364,-0.0027243,0.064013,0.66548,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...220,SET,7,-0.13553,-0.0026446,0.31704,0.66549,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
MIR3650,SET,49,-0.051259,-0.0026433,0.11988,0.66552,MIR3650,1
TRAVAGLINI_LUNG_CLUB_CELL,SET,102,-0.038854,-0.0028866,0.090858,0.66554,TRAVAGLINI_LUNG_CLUB_CELL,1
REACTOME_RECOGNITION_OF_DNA_...,SET,28,-0.065039,-0.0025367,0.15207,0.66556,REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,1
HP_ABNORMAL_RENAL_TUBULE_MOR...,SET,74,-0.043421,-0.0027498,0.1015,0.66559,HP_ABNORMAL_RENAL_TUBULE_MORPHOLOGY,1
WP_MAPK_PATHWAY_IN_CONGENITA...,SET,14,-0.098401,-0.0027149,0.23002,0.6656,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,1
DAVICIONI_RHABDOMYOSARCOMA_P...1,SET,13,-0.12449,-0.0033099,0.29095,0.66563,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,1
REACTOME_CARBOXYTERMINAL_POS...,SET,41,-0.061458,-0.0028996,0.14364,0.66563,REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN,1
GOBP_REGULATION_OF_DENDRITE_...1,SET,90,-0.039084,-0.0027284,0.091339,0.66563,GOBP_REGULATION_OF_DENDRITE_DEVELOPMENT,1
GSE43863_NAIVE_VS_LY6C_LOW_C...1,SET,173,-0.027321,-0.0026383,0.063853,0.66563,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN,1
GOCC_CORTICAL_ACTIN_CYTOSKEL...,SET,72,-0.042756,-0.0026709,0.099898,0.66567,GOCC_CORTICAL_ACTIN_CYTOSKELETON,1
GOCC_G_PROTEIN_COUPLED_RECEP...2,SET,7,-0.14951,-0.0029173,0.34928,0.66569,GOCC_G_PROTEIN_COUPLED_RECEPTOR_DIMERIC_COMPLEX,1
HP_ABNORMAL_GASTRIC_MUCOSA_M...,SET,39,-0.066167,-0.0030448,0.15456,0.66571,HP_ABNORMAL_GASTRIC_MUCOSA_MORPHOLOGY,1
ZNF532_TARGET_GENES,SET,53,-0.052222,-0.0028004,0.12196,0.66574,ZNF532_TARGET_GENES,1
MIR8056,SET,40,-0.057572,-0.002683,0.13445,0.66575,MIR8056,1
GOMF_BMP_RECEPTOR_ACTIVITY,SET,7,-0.16237,-0.0031683,0.37916,0.66576,GOMF_BMP_RECEPTOR_ACTIVITY,1
WP_ADHD_AND_AUTISM_ASD_PATHW...,SET,342,-0.021219,-0.0028676,0.049544,0.66578,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,1
GSE2770_TGFB_AND_IL4_ACT_VS_...1,SET,176,-0.027541,-0.0026822,0.064298,0.66579,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,1
HP_DECREASED_EOSINOPHIL_COUNT,SET,8,-0.13591,-0.0028349,0.31717,0.66586,HP_DECREASED_EOSINOPHIL_COUNT,1
GOBP_RESPONSE_TO_FATTY_ACID,SET,54,-0.055642,-0.0030117,0.12978,0.66594,GOBP_RESPONSE_TO_FATTY_ACID,1
HP_PATELLAR_DISLOCATION,SET,56,-0.055598,-0.0030644,0.12962,0.66601,HP_PATELLAR_DISLOCATION,1
GOBP_REGULATION_OF_GASTRIC_A...,SET,6,-0.14261,-0.0025763,0.33245,0.66602,GOBP_REGULATION_OF_GASTRIC_ACID_SECRETION,1
GOBP_RESPONSE_TO_AMINE,SET,50,-0.055983,-0.0029161,0.1305,0.66604,GOBP_RESPONSE_TO_AMINE,1
GOBP_GOLGI_DISASSEMBLY,SET,6,-0.14952,-0.0027011,0.34843,0.66608,GOBP_GOLGI_DISASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...478,SET,112,-0.038357,-0.0029852,0.089383,0.66608,GOBP_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,1
GOBP_REGULATION_OF_CONNECTIV...,SET,5,-0.1665,-0.0027459,0.38796,0.6661,GOBP_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,1
GSE26928_NAIVE_VS_CENT_MEMOR...2,SET,163,-0.028035,-0.0026285,0.065322,0.6661,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,1
REACTOME_REGULATION_OF_INSUL...2,SET,77,-0.044971,-0.0029048,0.10477,0.66613,REACTOME_REGULATION_OF_INSULIN_SECRETION,1
HU_FETAL_RETINA_MICROGLIA,SET,338,-0.020843,-0.0028006,0.048544,0.66617,HU_FETAL_RETINA_MICROGLIA,1
HP_SPARSE_BONE_TRABECULAE,SET,4,-0.19331,-0.0028516,0.4501,0.66621,HP_SPARSE_BONE_TRABECULAE,1
BIOCARTA_EGF_PATHWAY,SET,26,-0.073419,-0.0027595,0.17091,0.66624,BIOCARTA_EGF_PATHWAY,1
HP_ABNORMAL_ILIAC_WING_MORPH...,SET,53,-0.049573,-0.0026583,0.11541,0.66624,HP_ABNORMAL_ILIAC_WING_MORPHOLOGY,1
HP_ATTACHED_EARLOBE,SET,6,-0.15481,-0.0027968,0.36032,0.66627,HP_ATTACHED_EARLOBE,1
MODULE_43,SET,92,-0.037028,-0.0026133,0.086175,0.66628,MODULE_43,1
GSE3982_EOSINOPHIL_VS_TH1_DN,SET,179,-0.026567,-0.0026091,0.061818,0.66631,GSE3982_EOSINOPHIL_VS_TH1_DN,1
WP_HOSTPATHOGEN_INTERACTION_...3,SET,30,-0.068463,-0.0027638,0.1593,0.66632,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,1
GSE14000_4H_VS_16H_LPS_DC_UP,SET,165,-0.028919,-0.0027279,0.067275,0.66635,GSE14000_4H_VS_16H_LPS_DC_UP,1
HP_ABNORMALITY_OF_THE_AUTONO...,SET,269,-0.022237,-0.0026706,0.051715,0.6664,HP_ABNORMALITY_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,1
GSE18791_CTRL_VS_NEWCASTLE_V...11,SET,150,-0.030447,-0.0027395,0.070808,0.6664,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN,1
GOBP_REGULATION_OF_CELL_CYCL...4,SET,398,-0.018187,-0.0026473,0.042294,0.66641,GOBP_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,1
HP_ELEVATED_TRANSFERRIN_SATU...,SET,9,-0.11978,-0.0026501,0.27853,0.66642,HP_ELEVATED_TRANSFERRIN_SATURATION,1
GOBP_POSITIVE_REGULATION_OF_...451,SET,15,-0.095994,-0.0027413,0.22319,0.66643,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,1
GOBP_INTESTINE_SMOOTH_MUSCLE...,SET,8,-0.12681,-0.0026452,0.29483,0.66644,GOBP_INTESTINE_SMOOTH_MUSCLE_CONTRACTION,1
SCHAEFFER_PROSTATE_DEVELOPME...17,SET,7,-0.165,-0.0032196,0.38357,0.66646,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP,1
REACTOME_RESOLUTION_OF_AP_SI...,SET,24,-0.068267,-0.0024654,0.15867,0.66649,REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,1
GOBP_LEFT_RIGHT_AXIS_SPECIFI...,SET,12,-0.10247,-0.0026176,0.23815,0.6665,GOBP_LEFT_RIGHT_AXIS_SPECIFICATION,1
GSE17721_POLYIC_VS_CPG_8H_BM...2,SET,180,-0.026608,-0.0026204,0.061832,0.66652,GSE17721_POLYIC_VS_CPG_8H_BMDC_UP,1
MCCLUNG_COCAINE_REWARD_5D,SET,68,-0.045436,-0.0027587,0.10558,0.66653,MCCLUNG_COCAINE_REWARD_5D,1
GOBP_NEGATIVE_REGULATION_OF_...161,SET,265,-0.023668,-0.0028215,0.054982,0.66657,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION,1
MODULE_247,SET,35,-0.068887,-0.0030034,0.16001,0.66659,MODULE_247,1
HP_ABNORMALITY_OF_SECONDARY_...,SET,71,-0.044315,-0.0027491,0.10292,0.66661,HP_ABNORMALITY_OF_SECONDARY_SEXUAL_HAIR,1
HP_CHORIOCAPILLARIS_ATROPHY,SET,8,-0.13258,-0.0027656,0.30791,0.66661,HP_CHORIOCAPILLARIS_ATROPHY,1
RAMJAUN_APOPTOSIS_BY_TGFB1_V...4,SET,10,-0.12285,-0.0028648,0.28526,0.66664,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,1
WP_OSTEOARTHRITIC_CHONDROCYT...,SET,48,-0.055877,-0.0028519,0.12974,0.66665,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,1
GOMF_NUCLEAR_VITAMIN_D_RECEP...,SET,13,-0.092002,-0.0024461,0.21361,0.66665,GOMF_NUCLEAR_VITAMIN_D_RECEPTOR_BINDING,1
E4F1_Q6,SET,255,-0.023332,-0.0027292,0.054164,0.66668,E4F1_Q6,1
SRF_Q5_01,SET,203,-0.026934,-0.0028151,0.062521,0.66669,SRF_Q5_01,1
GSE2770_TGFB_AND_IL4_VS_TGFB...1,SET,166,-0.027316,-0.0025844,0.063388,0.66674,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
HP_ATROPHY_DEGENERATION_AFFE...2,SET,752,-0.013301,-0.0026349,0.030861,0.66676,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CENTRAL_NERVOUS_SYSTEM,1
GOMF_TRANSFORMING_GROWTH_FAC...3,SET,5,-0.19076,-0.0031461,0.44259,0.66677,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY_TYPE_I,1
HP_ABNORMALITY_OF_THE_URINAR...,SET,990,-0.011968,-0.0027019,0.027765,0.66678,HP_ABNORMALITY_OF_THE_URINARY_SYSTEM_PHYSIOLOGY,1
WP_NANOPARTICLE_TRIGGERED_AU...,SET,22,-0.076971,-0.0026615,0.17853,0.66681,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,1
GSE40274_CTRL_VS_GATA1_TRANS...2,SET,128,-0.032384,-0.0026932,0.075089,0.66686,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
SA_PTEN_PATHWAY,SET,17,-0.082711,-0.0025144,0.19178,0.66687,SA_PTEN_PATHWAY,1
GOBP_REGULATION_OF_MITOCHOND...1,SET,6,-0.13956,-0.0025212,0.32352,0.6669,GOBP_REGULATION_OF_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,1
REACTOME_HEME_DEGRADATION,SET,15,-0.098121,-0.0028021,0.22744,0.66691,REACTOME_HEME_DEGRADATION,1
GOBP_LEUKOCYTE_CELL_CELL_ADH...,SET,383,-0.020565,-0.0029377,0.04764,0.66701,GOBP_LEUKOCYTE_CELL_CELL_ADHESION,1
MIR8061,SET,150,-0.030793,-0.0027705,0.071322,0.66703,MIR8061,1
REACTOME_TRANSCRIPTIONAL_REG...11,SET,30,-0.06702,-0.0027056,0.15517,0.6671,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION,1
GOBP_MYOBLAST_PROLIFERATION,SET,24,-0.077465,-0.0027976,0.17933,0.66711,GOBP_MYOBLAST_PROLIFERATION,1
GOMF_HYDRO_LYASE_ACTIVITY,SET,52,-0.053788,-0.0028571,0.12451,0.66713,GOMF_HYDRO_LYASE_ACTIVITY,1
GOBP_REGULATION_OF_NEURON_DI...,SET,176,-0.03051,-0.0029714,0.070612,0.66715,GOBP_REGULATION_OF_NEURON_DIFFERENTIATION,1
WP_PI3KAKTMTOR_SIGNALING_AND...,SET,31,-0.07229,-0.0029665,0.16729,0.66717,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,1
GOBP_DENDRITE_DEVELOPMENT,SET,220,-0.025202,-0.0027409,0.058318,0.66718,GOBP_DENDRITE_DEVELOPMENT,1
HP_NEOPLASM_OF_THE_MALE_EXTE...,SET,32,-0.071502,-0.002981,0.1654,0.66723,HP_NEOPLASM_OF_THE_MALE_EXTERNAL_GENITALIA,1
HP_SPINAL_DYSRAPHISM,SET,129,-0.034188,-0.0028542,0.079078,0.66725,HP_SPINAL_DYSRAPHISM,1
WP_BDNFTRKB_SIGNALING,SET,33,-0.067202,-0.0028451,0.15542,0.66727,WP_BDNFTRKB_SIGNALING,1
MIR6847_3P,SET,55,-0.048662,-0.0026581,0.11254,0.66728,MIR6847_3P,1
HP_SHOULDER_PAIN,SET,6,-0.17585,-0.0031768,0.40664,0.66728,HP_SHOULDER_PAIN,1
GOBP_POSITIVE_REGULATION_OF_...757,SET,11,-0.11439,-0.0027978,0.26449,0.66731,GOBP_POSITIVE_REGULATION_OF_TISSUE_REMODELING,1
GOBP_CARDIOLIPIN_ACYL_CHAIN_...,SET,5,-0.20498,-0.0033806,0.47388,0.66733,GOBP_CARDIOLIPIN_ACYL_CHAIN_REMODELING,1
GOBP_IP_10_PRODUCTION,SET,4,-0.21183,-0.0031248,0.48972,0.66733,GOBP_IP_10_PRODUCTION,1
HOEK_MYELOID_DENDRITIC_CELL_...5,SET,6,-0.15215,-0.0027487,0.35175,0.66733,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_DN,1
GSE43955_1H_VS_20H_ACT_CD4_T...2,SET,184,-0.027745,-0.0027623,0.064134,0.66735,GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...8,SET,72,-0.045703,-0.002855,0.10564,0.66736,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE,1
GOBP_POSITIVE_REGULATION_OF_...40,SET,6,-0.15747,-0.0028448,0.36387,0.6674,GOBP_POSITIVE_REGULATION_OF_ARTERY_MORPHOGENESIS,1
GOBP_REGULATION_OF_ARTERY_MO...,SET,6,-0.15747,-0.0028448,0.36387,0.6674,GOBP_REGULATION_OF_ARTERY_MORPHOGENESIS,1
GOBP_REGULATION_OF_SKELETAL_...3,SET,18,-0.081979,-0.0025643,0.18944,0.6674,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_REFERENCE_EGF_J...,SET,7,-0.17954,-0.0035033,0.41485,0.66741,KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CALCIDIOL...,SET,7,-0.14657,-0.00286,0.33859,0.66745,GOBP_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY,1
REACTOME_MET_ACTIVATES_PTPN11,SET,5,-0.16454,-0.0027136,0.37994,0.66752,REACTOME_MET_ACTIVATES_PTPN11,1
GOMF_ATPASE_COUPLED_MONOATOM...,SET,49,-0.053906,-0.0027798,0.12445,0.66755,GOMF_ATPASE_COUPLED_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
BARRIER_CANCER_RELAPSE_TUMOR...1,SET,10,-0.1067,-0.0024884,0.24615,0.66767,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,1
GSE360_L_DONOVANI_VS_B_MALAY...1,SET,178,-0.028226,-0.0027644,0.06503,0.66787,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...590,SET,564,-0.016536,-0.002852,0.03808,0.66794,GOBP_POSITIVE_REGULATION_OF_PHOSPHORYLATION,1
GCM_BAG5,SET,34,-0.059736,-0.002567,0.13748,0.66804,GCM_BAG5,1
EPPERT_HSC_R,SET,107,-0.037331,-0.0028401,0.085909,0.66805,EPPERT_HSC_R,1
REACTOME_BIOSYNTHESIS_OF_MAR...1,SET,8,-0.1303,-0.0027179,0.29983,0.66806,REACTOME_BIOSYNTHESIS_OF_MARESINS,1
GSE21546_SAP1A_KO_VS_SAP1A_K...4,SET,175,-0.027189,-0.0026405,0.062566,0.66806,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
REACTOME_MEMBRANE_TRAFFICKING,SET,596,-0.015116,-0.0026776,0.034777,0.66809,REACTOME_MEMBRANE_TRAFFICKING,1
GOBP_THIOESTER_BIOSYNTHETIC_...,SET,41,-0.059949,-0.0028284,0.1379,0.66812,GOBP_THIOESTER_BIOSYNTHETIC_PROCESS,1
GOBP_LUNG_ALVEOLUS_DEVELOPME...,SET,51,-0.055804,-0.0029356,0.12835,0.66813,GOBP_LUNG_ALVEOLUS_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...845,SET,129,-0.035351,-0.0029514,0.081306,0.66814,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,1
HP_ABNORMAL_SERUM_BILE_ACID_...,SET,25,-0.079707,-0.0029378,0.18325,0.6682,HP_ABNORMAL_SERUM_BILE_ACID_CONCENTRATION,1
GOBP_REGULATION_OF_VERY_LOW_...2,SET,6,-0.16832,-0.0030409,0.38696,0.66821,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,1
GOBP_DNA_CATABOLIC_PROCESS,SET,27,-0.070616,-0.0027047,0.16233,0.66822,GOBP_DNA_CATABOLIC_PROCESS,1
chr6q23,SET,45,-0.10182,-0.005032,0.23401,0.66825,chr6q23,1
FIGUEROA_AML_METHYLATION_CLU...13,SET,4,-0.22037,-0.0032508,0.50642,0.66827,FIGUEROA_AML_METHYLATION_CLUSTER_7_DN,1
TGACCTY_ERR1_Q2,SET,936,-0.012652,-0.0027817,0.029072,0.66829,TGACCTY_ERR1_Q2,1
REACTOME_SCAVENGING_BY_CLASS...1,SET,19,-0.095335,-0.0030638,0.21902,0.66832,REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,1
REACTOME_CELL_EXTRACELLULAR_...,SET,16,-0.095683,-0.002822,0.21978,0.66834,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,1
GOBP_POSITIVE_REGULATION_OF_...614,SET,178,-0.027733,-0.0027161,0.063687,0.66838,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,1
GOMF_ACYLGLYCEROL_LIPASE_ACT...,SET,15,-0.087591,-0.0025014,0.20112,0.6684,GOMF_ACYLGLYCEROL_LIPASE_ACTIVITY,1
MIR6832_3P,SET,233,-0.025119,-0.0028103,0.05766,0.66845,MIR6832_3P,1
WP_SELENIUM_MICRONUTRIENT_NE...,SET,70,-0.048919,-0.0030133,0.11228,0.66847,WP_SELENIUM_MICRONUTRIENT_NETWORK,1
MIR217_5P,SET,170,-0.028592,-0.0027372,0.065613,0.66849,MIR217_5P,1
MIR485_5P,SET,127,-0.031917,-0.002644,0.07316,0.66867,MIR485_5P,1
GOBP_REGULATION_OF_PHOSPHOLI...8,SET,6,-0.15447,-0.0027906,0.35397,0.66872,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,1
HP_GENERALIZED_HYPERREFLEXIA,SET,10,-0.097702,-0.0022784,0.22374,0.66883,HP_GENERALIZED_HYPERREFLEXIA,1
GOBP_PYRIMIDINE_NUCLEOSIDE_B...,SET,4,-0.16827,-0.0024822,0.38514,0.6689,GOBP_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,1
HP_ALVEOLAR_CELL_CARCINOMA,SET,17,-0.09071,-0.0027576,0.20762,0.66891,HP_ALVEOLAR_CELL_CARCINOMA,1
HP_CHROMOSOMAL_BREAKAGE_INDU...1,SET,16,-0.083177,-0.0024532,0.19038,0.66891,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_CROSSLINKING_AGENTS,1
HP_ENDOCARDIAL_FIBROELASTOSIS,SET,7,-0.14435,-0.0028167,0.33038,0.66892,HP_ENDOCARDIAL_FIBROELASTOSIS,1
GSE24081_CONTROLLER_VS_PROGR...2,SET,178,-0.029204,-0.0028601,0.066831,0.66893,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP,1
BERENJENO_TRANSFORMED_BY_RHO...6,SET,497,-0.016501,-0.0026767,0.03776,0.66894,BERENJENO_TRANSFORMED_BY_RHOA_UP,1
GOMF_ACETYLCHOLINE_BINDING,SET,10,-0.11635,-0.0027134,0.26627,0.66894,GOMF_ACETYLCHOLINE_BINDING,1
GSE27859_MACROPHAGE_VS_CD11C...2,SET,159,-0.028853,-0.0026721,0.065975,0.66906,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,1
GOBP_ENDOCARDIAL_CELL_DIFFER...,SET,6,-0.17342,-0.003133,0.39653,0.66907,GOBP_ENDOCARDIAL_CELL_DIFFERENTIATION,1
HP_ESOPHORIA,SET,5,-0.16054,-0.0026476,0.36657,0.66928,HP_ESOPHORIA,1
MIR3682_5P,SET,88,-0.039593,-0.0027332,0.090405,0.66929,MIR3682_5P,1
BIOCARTA_TFF_PATHWAY,SET,24,-0.078007,-0.0028171,0.17805,0.66935,BIOCARTA_TFF_PATHWAY,1
GOBP_MICROTUBULE_ANCHORING,SET,21,-0.076628,-0.0025888,0.17487,0.66938,GOBP_MICROTUBULE_ANCHORING,1
GOBP_NEGATIVE_REGULATION_OF_...556,SET,5,-0.182,-0.0030015,0.41531,0.66938,GOBP_NEGATIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,1
CCATCCA_MIR432,SET,50,-0.053697,-0.002797,0.12249,0.66945,CCATCCA_MIR432,1
MIR605_5P,SET,125,-0.03525,-0.0028972,0.080399,0.66946,MIR605_5P,1
GOBP_REGULATION_OF_TRANSLATI...8,SET,5,-0.18084,-0.0029824,0.41244,0.66947,GOBP_REGULATION_OF_TRANSLATION_AT_POSTSYNAPSE,1
WP_TCELL_RECEPTOR_SIGNALING,SET,87,-0.041262,-0.0028322,0.094093,0.66949,WP_TCELL_RECEPTOR_SIGNALING,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...3,SET,119,-0.032802,-0.0026309,0.074799,0.6695,GOBP_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
GOBP_FLAVONOID_METABOLIC_PRO...,SET,11,-0.12506,-0.0030586,0.28512,0.66953,GOBP_FLAVONOID_METABOLIC_PROCESS,1
BIOCARTA_SPRY_PATHWAY,SET,16,-0.093296,-0.0027516,0.21269,0.66954,BIOCARTA_SPRY_PATHWAY,1
GOCC_COATED_VESICLE,SET,292,-0.022293,-0.0027876,0.050774,0.66969,GOCC_COATED_VESICLE,1
GOBP_REGULATION_OF_LYSOSOME_...2,SET,4,-0.18878,-0.0027848,0.42986,0.66973,GOBP_REGULATION_OF_LYSOSOME_SIZE,1
GOCC_BORC_COMPLEX,SET,4,-0.18878,-0.0027848,0.42986,0.66973,GOCC_BORC_COMPLEX,1
REACTOME_SYNTHESIS_OF_IP3_AN...,SET,25,-0.072099,-0.0026574,0.16414,0.66976,REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL,1
GOBP_NEGATIVE_REGULATION_OF_...516,SET,129,-0.032765,-0.0027355,0.074581,0.66979,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,1
GOBP_RIBOSOME_ASSOCIATED_UBI...,SET,7,-0.1096,-0.0021385,0.24939,0.66983,GOBP_RIBOSOME_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GOBP_RENAL_VESICLE_DEVELOPME...,SET,18,-0.10197,-0.0031898,0.23203,0.66984,GOBP_RENAL_VESICLE_DEVELOPMENT,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SET,85,-0.042132,-0.0028587,0.095813,0.66993,SAFFORD_T_LYMPHOCYTE_ANERGY,1
HP_ABNORMALITY_OF_THE_FIRST_...,SET,11,-0.11052,-0.0027031,0.25116,0.67004,HP_ABNORMALITY_OF_THE_FIRST_METATARSAL_BONE,1
MEF2C_TARGET_GENES,SET,1333,-0.010682,-0.0027706,0.024267,0.6701,MEF2C_TARGET_GENES,1
GSE15750_WT_VS_TRAF6KO_DAY10...1,SET,180,-0.02965,-0.0029199,0.067311,0.67021,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN,1
GOBP_POSTSYNAPTIC_DENSITY_AS...,SET,24,-0.080842,-0.0029195,0.1835,0.67023,GOBP_POSTSYNAPTIC_DENSITY_ASSEMBLY,1
KEGG_NON_HOMOLOGOUS_END_JOIN...,SET,12,-0.086853,-0.0022186,0.19707,0.67029,KEGG_NON_HOMOLOGOUS_END_JOINING,1
HP_BROAD_FINGER,SET,113,-0.035678,-0.002789,0.080944,0.67031,HP_BROAD_FINGER,1
KEGG_MEDICUS_REFERENCE_EGF_E...6,SET,14,-0.1055,-0.0029108,0.23931,0.67034,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY,1
HP_OPTIC_DISC_COLOBOMA,SET,24,-0.074291,-0.0026829,0.16849,0.67036,HP_OPTIC_DISC_COLOBOMA,1
MIR619_3P,SET,53,-0.051345,-0.0027533,0.11638,0.67046,MIR619_3P,1
GOBP_PROTEIN_PROCESSING_INVO...,SET,7,-0.14732,-0.0028746,0.33383,0.6705,GOBP_PROTEIN_PROCESSING_INVOLVED_IN_PROTEIN_TARGETING_TO_MITOCHONDRION,1
GSE2770_TGFB_AND_IL4_VS_IL12...5,SET,180,-0.026622,-0.0026217,0.060298,0.67057,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
GSE41867_DAY8_VS_DAY15_LCMV_...1,SET,133,-0.035067,-0.0029724,0.079426,0.67058,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...696,SET,13,-0.11198,-0.0029771,0.25357,0.67061,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION,1
HP_HYPERMAGNESEMIA,SET,7,-0.1501,-0.0029289,0.33987,0.67062,HP_HYPERMAGNESEMIA,1
KONG_E2F1_TARGETS,SET,8,-0.12434,-0.0025936,0.28153,0.67063,KONG_E2F1_TARGETS,1
GOMF_NUCLEASE_ACTIVITY,SET,197,-0.026047,-0.0026823,0.058965,0.67066,GOMF_NUCLEASE_ACTIVITY,1
GOBP_CARDIAC_MUSCLE_MYOBLAST...,SET,3,-0.21587,-0.0027578,0.48829,0.67078,GOBP_CARDIAC_MUSCLE_MYOBLAST_PROLIFERATION,1
GOBP_NEGATIVE_REGULATION_OF_...675,SET,5,-0.20857,-0.0034398,0.47163,0.67084,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
CHICAS_RB1_TARGETS_LOW_SERUM,SET,74,-0.04385,-0.0027769,0.09915,0.67085,CHICAS_RB1_TARGETS_LOW_SERUM,1
GSE9650_NAIVE_VS_EFF_CD8_TCE...1,SET,188,-0.028559,-0.0028737,0.064565,0.67087,GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_DC1...,SET,292,-0.022742,-0.0028437,0.051413,0.67087,HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL,1
chr18q21,SET,76,-0.080824,-0.0051868,0.1827,0.67089,chr18q21,1
DESCARTES_MAIN_FETAL_TROPHOB...,SET,125,-0.035209,-0.0028939,0.079585,0.6709,DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS,1
GSE3982_BASOPHIL_VS_TH1_DN,SET,175,-0.027865,-0.0027062,0.062966,0.67095,GSE3982_BASOPHIL_VS_TH1_DN,1
HP_NEOPLASM_OF_THE_TRACHEOBR...,SET,19,-0.088343,-0.0028391,0.19956,0.671,HP_NEOPLASM_OF_THE_TRACHEOBRONCHIAL_SYSTEM,1
HP_ANGIOEDEMA,SET,12,-0.12506,-0.0031946,0.28244,0.67104,HP_ANGIOEDEMA,1
MIR4495,SET,435,-0.019151,-0.0029114,0.043239,0.67109,MIR4495,1
KEGG_MEDICUS_REFERENCE_AUTOP...1,SET,15,-0.090835,-0.002594,0.20507,0.6711,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR,1
GSE3039_ALPHAALPHA_VS_ALPHAB...1,SET,189,-0.028501,-0.0028754,0.064313,0.67117,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN,1
HP_CHRONIC_CSF_LYMPHOCYTOSIS,SET,8,-0.12421,-0.002591,0.28027,0.67118,HP_CHRONIC_CSF_LYMPHOCYTOSIS,1
GOBP_POSITIVE_REGULATION_OF_...68,SET,14,-0.10213,-0.0028177,0.2304,0.67121,GOBP_POSITIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,1
GOCC_PROTEIN_COMPLEX_INVOLVE...3,SET,17,-0.0939,-0.0028546,0.21176,0.67127,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_MATRIX_ADHESION,1
MIR4681,SET,5,-0.14743,-0.0024315,0.33247,0.67128,MIR4681,1
HP_ABNORMAL_FUNDUS_AUTOFLUOR...,SET,26,-0.082399,-0.0030971,0.1858,0.67129,HP_ABNORMAL_FUNDUS_AUTOFLUORESCENCE_IMAGING,1
ZNF746_TARGET_GENES,SET,55,-0.051684,-0.0028232,0.11651,0.67133,ZNF746_TARGET_GENES,1
GOCC_SARCOPLASMIC_RETICULUM_...2,SET,42,-0.056079,-0.0026778,0.12635,0.67141,GOCC_SARCOPLASMIC_RETICULUM_MEMBRANE,1
GOMF_PHOSPHOLIPASE_A2_ACTIVI...,SET,28,-0.073072,-0.00285,0.16458,0.67147,GOMF_PHOSPHOLIPASE_A2_ACTIVITY,1
HP_LINGUAL_DYSTONIA,SET,5,-0.17122,-0.0028238,0.38561,0.67148,HP_LINGUAL_DYSTONIA,1
WOTTON_RUNX_TARGETS_DN,SET,26,-0.082871,-0.0031148,0.18654,0.67156,WOTTON_RUNX_TARGETS_DN,1
GOBP_EPITHELIAL_TUBE_FORMATI...,SET,131,-0.033527,-0.0028205,0.075468,0.67157,GOBP_EPITHELIAL_TUBE_FORMATION,1
GSE13484_UNSTIM_VS_12H_YF17D...2,SET,185,-0.028007,-0.0027958,0.063025,0.67161,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP,1
GOBP_REGULATION_OF_MITOCHOND...15,SET,23,-0.074539,-0.0026353,0.16769,0.67166,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,1
GOCC_LATE_ENDOSOME_LUMEN,SET,7,-0.14961,-0.0029194,0.33649,0.6717,GOCC_LATE_ENDOSOME_LUMEN,1
HP_ABSENT_PALMAR_CREASE,SET,13,-0.10466,-0.0027827,0.2354,0.6717,HP_ABSENT_PALMAR_CREASE,1
chr1p34,SET,154,-0.063187,-0.0057599,0.1421,0.67172,chr1p34,1
WANG_TUMOR_INVASIVENESS_UP,SET,362,-0.019469,-0.0027054,0.043763,0.67179,WANG_TUMOR_INVASIVENESS_UP,1
REACTOME_GLYCOSPHINGOLIPID_T...,SET,8,-0.1207,-0.0025177,0.27132,0.67179,REACTOME_GLYCOSPHINGOLIPID_TRANSPORT,1
HP_MORNING_MYOCLONIC_JERKS,SET,10,-0.13528,-0.0031549,0.3039,0.6719,HP_MORNING_MYOCLONIC_JERKS,1
HP_LOSS_OF_EYELASHES,SET,4,-0.16283,-0.002402,0.36564,0.67196,HP_LOSS_OF_EYELASHES,1
HP_NASAL_REGURGITATION,SET,13,-0.10811,-0.0028742,0.24266,0.67202,HP_NASAL_REGURGITATION,1
GOBP_STRIATED_MUSCLE_ATROPHY,SET,7,-0.15088,-0.002944,0.33857,0.67207,GOBP_STRIATED_MUSCLE_ATROPHY,1
HOFMANN_CELL_LYMPHOMA_DN,SET,37,-0.060845,-0.0027273,0.13651,0.6721,HOFMANN_CELL_LYMPHOMA_DN,1
GSE13411_NAIVE_BCELL_VS_PLAS...1,SET,166,-0.029869,-0.0028259,0.067005,0.67212,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN,1
WP_METABOLIC_REPROGRAMMING_I...1,SET,39,-0.057273,-0.0026355,0.12847,0.67213,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,1
WEI_MYCN_TARGETS_WITH_E_BOX,SET,724,-0.014029,-0.0027292,0.031467,0.67214,WEI_MYCN_TARGETS_WITH_E_BOX,1
GSE22935_UNSTIM_VS_24H_MBOVI...3,SET,182,-0.028224,-0.0027948,0.063304,0.67215,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
REACTOME_PI_METABOLISM,SET,77,-0.042305,-0.0027326,0.094824,0.67225,REACTOME_PI_METABOLISM,1
GOBP_RESPONSE_TO_ELECTRICAL_...,SET,41,-0.061479,-0.0029006,0.13775,0.67231,GOBP_RESPONSE_TO_ELECTRICAL_STIMULUS,1
MIR6884_5P,SET,132,-0.032243,-0.0027227,0.072231,0.67234,MIR6884_5P,1
HP_TOE_SYNDACTYLY,SET,199,-0.027144,-0.0028093,0.060806,0.67235,HP_TOE_SYNDACTYLY,1
STARK_PREFRONTAL_CORTEX_22Q1...2,SET,180,-0.02921,-0.0028766,0.065404,0.67242,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1
REACTOME_FBXW7_MUTANTS_AND_N...,SET,5,-0.15041,-0.0024805,0.33677,0.67242,REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER,1
GSE17721_POLYIC_VS_CPG_16H_B...2,SET,184,-0.028157,-0.0028032,0.063041,0.67243,GSE17721_POLYIC_VS_CPG_16H_BMDC_UP,1
BIOCARTA_ARAP_PATHWAY,SET,17,-0.086511,-0.0026299,0.19353,0.67256,BIOCARTA_ARAP_PATHWAY,1
NIKOLSKY_BREAST_CANCER_20Q11...,SET,31,-0.12034,-0.0049382,0.2692,0.67257,NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON,1
MIR4298,SET,50,-0.051284,-0.0026713,0.11471,0.67259,MIR4298,1
KEGG_ARACHIDONIC_ACID_METABO...,SET,58,-0.056197,-0.003152,0.12569,0.6726,KEGG_ARACHIDONIC_ACID_METABOLISM,1
MYLLYKANGAS_AMPLIFICATION_HO...16,SET,6,-0.14255,-0.0025752,0.31881,0.67261,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6,1
MIR603,SET,150,-0.031471,-0.0028316,0.070371,0.67264,MIR603,1
HAHTOLA_MYCOSIS_FUNGOIDES_SK...1,SET,26,-0.080012,-0.0030074,0.17888,0.67266,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,1
CAGCCTC_MIR4855P,SET,135,-0.032381,-0.0027651,0.072383,0.67269,CAGCCTC_MIR4855P,1
GAVISH_3CA_METAPROGRAM_ENDOT...5,SET,47,-0.062432,-0.0031532,0.13955,0.67269,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3,1
HP_ACCELERATED_SKELETAL_MATU...,SET,63,-0.050201,-0.0029342,0.11221,0.6727,HP_ACCELERATED_SKELETAL_MATURATION,1
GOBP_REACTIVE_GLIOSIS,SET,5,-0.20109,-0.0033164,0.44942,0.67272,GOBP_REACTIVE_GLIOSIS,1
GSE33162_UNTREATED_VS_4H_LPS...3,SET,186,-0.02873,-0.0028757,0.064211,0.67272,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN,1
UZONYI_RESPONSE_TO_LEUKOTRIE...,SET,34,-0.078641,-0.0033794,0.17569,0.67278,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,1
GOBP_NEGATIVE_REGULATION_OF_...513,SET,62,-0.047631,-0.0027619,0.10637,0.67284,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_BINDING,1
GSE19888_CTRL_VS_A3R_INHIBIT...1,SET,168,-0.03034,-0.0028875,0.067759,0.67284,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN,1
BIOCARTA_RELA_PATHWAY,SET,14,-0.10283,-0.002837,0.22962,0.67285,BIOCARTA_RELA_PATHWAY,1
REACTOME_SIGNALING_BY_TGFBR3,SET,44,-0.060859,-0.0029743,0.1359,0.67286,REACTOME_SIGNALING_BY_TGFBR3,1
GOBP_CELLULAR_RESPONSE_TO_XE...,SET,187,-0.030343,-0.0030451,0.067749,0.67288,GOBP_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS,1
GAUTAM_EYE_IRIS_CILIARY_BODY...7,SET,89,-0.045241,-0.0031407,0.101,0.67289,GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS,1
REACTOME_ERBB2_REGULATES_CEL...,SET,15,-0.095037,-0.002714,0.21216,0.6729,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,1
HP_APLASIA_HYPOPLASIA_INVOLV...8,SET,40,-0.061544,-0.0028681,0.13738,0.67292,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,1
MIR6516_3P,SET,126,-0.033928,-0.0027996,0.075717,0.67295,MIR6516_3P,1
GOBP_AROMATIC_AMINO_ACID_FAM...,SET,16,-0.10707,-0.0031579,0.23894,0.67296,GOBP_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS,1
WONG_ENDMETRIUM_CANCER_UP,SET,24,-0.078259,-0.0028262,0.17462,0.67298,WONG_ENDMETRIUM_CANCER_UP,1
HP_ABNORMAL_NERVOUS_SYSTEM_E...,SET,610,-0.01567,-0.0028071,0.034951,0.67304,HP_ABNORMAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,1
MODULE_53,SET,361,-0.020462,-0.0028396,0.045622,0.67311,MODULE_53,1
GOBP_POSITIVE_REGULATION_OF_...62,SET,50,-0.056524,-0.0029443,0.12598,0.67316,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,1
MIR550A_3P,SET,70,-0.046708,-0.0028772,0.1041,0.67317,MIR550A_3P,1
WP_NONCLASSICAL_ROLE_OF_VITA...,SET,6,-0.17704,-0.0031984,0.39446,0.67322,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,1
GOMF_INTRACELLULARLY_CAMP_AC...,SET,8,-0.13556,-0.0028276,0.30181,0.67333,GOMF_INTRACELLULARLY_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,1
SRPK2_TARGET_GENES,SET,47,-0.056133,-0.002835,0.12497,0.67335,SRPK2_TARGET_GENES,1
GOBP_CELL_MORPHOGENESIS,SET,896,-0.013543,-0.0029165,0.030141,0.67339,GOBP_CELL_MORPHOGENESIS,1
HP_ABNORMALITY_OF_THE_URETHRA,SET,375,-0.019657,-0.0027791,0.043748,0.67339,HP_ABNORMALITY_OF_THE_URETHRA,1
HP_ABNORMAL_DENSE_GRANULES,SET,9,-0.12583,-0.0027838,0.28005,0.67339,HP_ABNORMAL_DENSE_GRANULES,1
MIR4429,SET,275,-0.024517,-0.0029765,0.054559,0.67341,MIR4429,1
GSE27786_BCELL_VS_NEUTROPHIL...1,SET,184,-0.028446,-0.002832,0.063281,0.67347,GSE27786_BCELL_VS_NEUTROPHIL_DN,1
HP_ABNORMALITY_OF_THE_MIDDLE...3,SET,10,-0.11536,-0.0026902,0.2566,0.67348,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,1
BYSTRYKH_HEMATOPOIESIS_STEM_...2,SET,142,-0.032015,-0.0028032,0.071208,0.67349,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1
GOBP_BASIC_AMINO_ACID_TRANSP...,SET,20,-0.092462,-0.0030485,0.20562,0.67352,GOBP_BASIC_AMINO_ACID_TRANSPORT,1
MIR3925_5P,SET,141,-0.032787,-0.0028608,0.072902,0.67355,MIR3925_5P,1
GSE37532_VISCERAL_ADIPOSE_TI...2,SET,148,-0.030384,-0.0027156,0.067526,0.67363,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP,1
MIR4671_3P,SET,191,-0.028123,-0.0028521,0.06249,0.67366,MIR4671_3P,1
WP_HEMATOPOIETIC_STEM_CELL_D...,SET,52,-0.056166,-0.0029834,0.12478,0.67369,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
GSE11961_MEMORY_BCELL_DAY7_V...2,SET,180,-0.028524,-0.0028091,0.063366,0.6737,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
HP_DELAYED_PUBERTY,SET,177,-0.029008,-0.002833,0.064436,0.67371,HP_DELAYED_PUBERTY,1
GOBP_PROTEIN_LOCALIZATION_TO...7,SET,98,-0.039994,-0.0029127,0.088825,0.67374,GOBP_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION,1
MIR5197_5P,SET,164,-0.030378,-0.0028568,0.067438,0.67381,MIR5197_5P,1
KEGG_MEDICUS_REFERENCE_PDGF_...2,SET,17,-0.10209,-0.0031035,0.22661,0.67383,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_UBIQUITIN...2,SET,18,-0.086059,-0.002692,0.19097,0.67387,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...598,SET,11,-0.12301,-0.0030085,0.27287,0.67393,GOBP_POSITIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,1
HP_ENCEPHALOPATHY,SET,276,-0.022856,-0.0027798,0.0507,0.67393,HP_ENCEPHALOPATHY,1
REACTOME_FC_EPSILON_RECEPTOR...,SET,125,-0.033158,-0.0027253,0.073551,0.67394,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...540,SET,37,-0.067279,-0.0030157,0.14923,0.67394,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,1
NUYTTEN_EZH2_TARGETS_UP,SET,942,-0.013252,-0.0029223,0.029391,0.67396,NUYTTEN_EZH2_TARGETS_UP,1
WP_T_CELL_RECEPTOR_AND_COSTI...,SET,27,-0.078643,-0.0030121,0.17442,0.67396,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,1
MIR3142,SET,49,-0.053717,-0.00277,0.11912,0.67398,MIR3142,1
GOBP_LACTONE_METABOLIC_PROCE...,SET,12,-0.12126,-0.0030977,0.2689,0.67399,GOBP_LACTONE_METABOLIC_PROCESS,1
CHESLER_BRAIN_HIGHEST_EXPRES...,SET,34,-0.067573,-0.0029038,0.1498,0.67403,CHESLER_BRAIN_HIGHEST_EXPRESSION,1
HP_ABNORMAL_CIRCULATING_BILI...,SET,114,-0.037073,-0.0029108,0.082175,0.67405,HP_ABNORMAL_CIRCULATING_BILIRUBIN_CONCENTRATION,1
GSE17721_POLYIC_VS_CPG_24H_B...2,SET,188,-0.028034,-0.0028209,0.062133,0.67407,GSE17721_POLYIC_VS_CPG_24H_BMDC_UP,1
FARMER_BREAST_CANCER_CLUSTER...3,SET,13,-0.12457,-0.0033119,0.27607,0.67408,FARMER_BREAST_CANCER_CLUSTER_3,1
GOMF_CATALYTIC_ACTIVITY_ACTI...5,SET,225,-0.023952,-0.0026339,0.053075,0.6741,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_DNA,1
HP_ABNORMALITY_OF_THE_MIDDLE...1,SET,544,-0.017095,-0.0028974,0.03788,0.67411,HP_ABNORMALITY_OF_THE_MIDDLE_EAR,1
GSE7460_CD8_TCELL_VS_TREG_AC...1,SET,178,-0.027745,-0.0027173,0.061448,0.67419,GSE7460_CD8_TCELL_VS_TREG_ACT_DN,1
KEGG_MEDICUS_ENV_FACTOR_E2_T...2,SET,15,-0.10288,-0.002938,0.22781,0.67422,KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE9037_WT_VS_IRAK4_KO_LPS_4...2,SET,184,-0.028102,-0.0027978,0.062226,0.67422,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP,1
HP_OXYCEPHALY,SET,7,-0.14138,-0.0027586,0.31303,0.67423,HP_OXYCEPHALY,1
KOBAYASHI_EGFR_SIGNALING_6HR...2,SET,6,-0.15064,-0.0027215,0.33354,0.67424,KOBAYASHI_EGFR_SIGNALING_6HR_UP,1
HOFT_CD4_POSITIVE_ALPHA_BETA...6,SET,39,-0.059689,-0.0027467,0.13215,0.67425,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,1
HP_ABNORMALITY_OF_THE_LEYDIG...,SET,12,-0.11061,-0.0028255,0.24486,0.67426,HP_ABNORMALITY_OF_THE_LEYDIG_CELLS,1
HP_OVARIAN_CYST,SET,106,-0.039188,-0.0029676,0.086746,0.67427,HP_OVARIAN_CYST,1
GSE1460_DP_THYMOCYTE_VS_THYM...2,SET,169,-0.028887,-0.0027574,0.063948,0.67427,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,1
GOMF_MOLECULAR_SEQUESTERING_...,SET,41,-0.061031,-0.0028795,0.13508,0.67429,GOMF_MOLECULAR_SEQUESTERING_ACTIVITY,1
GOMF_MELANOCORTIN_RECEPTOR_A...,SET,6,-0.178,-0.0032156,0.39388,0.67433,GOMF_MELANOCORTIN_RECEPTOR_ACTIVITY,1
MIR144_5P,SET,47,-0.056078,-0.0028323,0.12406,0.67438,MIR144_5P,1
HP_LARGE_EARLOBE,SET,28,-0.071371,-0.0027837,0.15789,0.67438,HP_LARGE_EARLOBE,1
HP_STATUS_EPILEPTICUS_WITHOU...,SET,24,-0.078551,-0.0028368,0.17372,0.67443,HP_STATUS_EPILEPTICUS_WITHOUT_PROMINENT_MOTOR_SYMPTOMS,1
ZNF589_TARGET_GENES,SET,509,-0.017384,-0.0028527,0.038432,0.67448,ZNF589_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...642,SET,7,-0.11336,-0.002212,0.25061,0.67448,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,1
GOBP_REGULATION_OF_GERMINAL_...,SET,8,-0.15255,-0.0031821,0.33721,0.6745,GOBP_REGULATION_OF_GERMINAL_CENTER_FORMATION,1
WP_SYNTHESIS_OF_CERAMIDES_AN...,SET,22,-0.089037,-0.0030787,0.1968,0.67451,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,1
GOBP_HYPOXIA_INDUCIBLE_FACTO...,SET,3,-0.24281,-0.003102,0.53668,0.67452,GOBP_HYPOXIA_INDUCIBLE_FACTOR_1ALPHA_SIGNALING_PATHWAY,1
GOBP_CELL_PROLIFERATION_IN_B...,SET,8,-0.13269,-0.0027679,0.29326,0.67453,GOBP_CELL_PROLIFERATION_IN_BONE_MARROW,1
HP_NONCOMMUNICATING_HYDROCEP...,SET,6,-0.17141,-0.0030967,0.37871,0.67458,HP_NONCOMMUNICATING_HYDROCEPHALUS,1
MIR4752,SET,74,-0.044864,-0.0028411,0.099107,0.67461,MIR4752,1
HP_STEPPAGE_GAIT,SET,49,-0.05388,-0.0027784,0.119,0.67464,HP_STEPPAGE_GAIT,1
GSE37605_NOD_VS_C57BL6_IRES_...1,SET,143,-0.033008,-0.0029003,0.072886,0.67468,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN,1
GOBP_PROTEIN_K48_LINKED_DEUB...,SET,22,-0.075019,-0.002594,0.16562,0.6747,GOBP_PROTEIN_K48_LINKED_DEUBIQUITINATION,1
GSE22886_NAIVE_TCELL_VS_MONO...1,SET,189,-0.029749,-0.0030013,0.065676,0.67471,GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN,1
HOELZEL_NF1_TARGETS_DN,SET,99,-0.044623,-0.0032663,0.098497,0.67474,HOELZEL_NF1_TARGETS_DN,1
GOMF_SEQUENCE_SPECIFIC_SINGL...,SET,12,-0.10239,-0.0026154,0.22599,0.67474,GOMF_SEQUENCE_SPECIFIC_SINGLE_STRANDED_DNA_BINDING,1
GOMF_PROTEIN_SEQUESTERING_AC...,SET,25,-0.078659,-0.0028992,0.17359,0.67477,GOMF_PROTEIN_SEQUESTERING_ACTIVITY,1
GSE3982_MAST_CELL_VS_DC_DN,SET,179,-0.030854,-0.0030302,0.068092,0.67477,GSE3982_MAST_CELL_VS_DC_DN,1
TUBG1_TARGET_GENES,SET,2,-0.20497,-0.0021381,0.45225,0.6748,TUBG1_TARGET_GENES,1
MIR3678_5P,SET,13,-0.10298,-0.0027378,0.22717,0.67483,MIR3678_5P,1
GOBP_REGULATION_OF_PEPTIDASE...,SET,268,-0.025411,-0.0030461,0.056057,0.67483,GOBP_REGULATION_OF_PEPTIDASE_ACTIVITY,1
GOBP_REGULATION_OF_INNATE_IM...,SET,396,-0.019622,-0.0028491,0.043285,0.67484,GOBP_REGULATION_OF_INNATE_IMMUNE_RESPONSE,1
REACTOME_TRANSCRIPTIONAL_REG...10,SET,38,-0.062992,-0.0028614,0.13895,0.67485,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,1
GOBP_WATER_SOLUBLE_VITAMIN_M...,SET,58,-0.049725,-0.0027891,0.10967,0.67488,GOBP_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS,1
HP_GOITER,SET,54,-0.053477,-0.0028945,0.11791,0.67491,HP_GOITER,1
MIR6778_3P,SET,204,-0.026083,-0.0027328,0.057508,0.67492,MIR6778_3P,1
GOBP_ANOIKIS,SET,31,-0.073889,-0.0030321,0.16284,0.67499,GOBP_ANOIKIS,1
NOTCH_DN.V1_UP,SET,157,-0.031648,-0.0029126,0.069748,0.67499,NOTCH_DN.V1_UP,1
KEGG_MEDICUS_REFERENCE_MEMBR...,SET,9,-0.12539,-0.0027742,0.27633,0.675,KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,1
GOBP_HEPARAN_SULFATE_PROTEOG...2,SET,11,-0.13344,-0.0032635,0.29407,0.675,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION,1
LE_SKI_TARGETS_UP,SET,17,-0.098879,-0.0030059,0.21785,0.67504,LE_SKI_TARGETS_UP,1
REACTOME_AURKA_ACTIVATION_BY...,SET,67,-0.042362,-0.0025531,0.093315,0.67507,REACTOME_AURKA_ACTIVATION_BY_TPX2,1
REACTOME_HEDGEHOG_OFF_STATE,SET,108,-0.035764,-0.0027335,0.078769,0.67509,REACTOME_HEDGEHOG_OFF_STATE,1
GOBP_CARBOHYDRATE_METABOLIC_...,SET,516,-0.017127,-0.0028293,0.037724,0.67509,GOBP_CARBOHYDRATE_METABOLIC_PROCESS,1
MIR5187_3P,SET,91,-0.0393,-0.0027586,0.08655,0.67511,MIR5187_3P,1
MATZUK_MEIOTIC_AND_DNA_REPAIR,SET,35,-0.05539,-0.0024149,0.12197,0.67512,MATZUK_MEIOTIC_AND_DNA_REPAIR,1
GOBP_ENDOTHELIAL_CELL_FATE_C...,SET,8,-0.15554,-0.0032444,0.34247,0.67514,GOBP_ENDOTHELIAL_CELL_FATE_COMMITMENT,1
MIR191_5P,SET,19,-0.087714,-0.0028188,0.19311,0.67516,MIR191_5P,1
GAO_SMALL_INTESTINE_24W_C9_E...,SET,42,-0.063047,-0.0030105,0.13874,0.67523,GAO_SMALL_INTESTINE_24W_C9_ENTEROENDOCRINE_CELL,1
GOCC_NUCLEAR_CHROMOSOME,SET,211,-0.025498,-0.0027164,0.056099,0.67527,GOCC_NUCLEAR_CHROMOSOME,1
GOBP_RESPONSE_TO_BLUE_LIGHT,SET,6,-0.15316,-0.002767,0.33693,0.67529,GOBP_RESPONSE_TO_BLUE_LIGHT,1
GSE14769_20MIN_VS_360MIN_LPS...1,SET,178,-0.028861,-0.0028265,0.06349,0.67529,GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN,1
KRIGE_AMINO_ACID_DEPRIVATION,SET,24,-0.090929,-0.0032838,0.19996,0.67535,KRIGE_AMINO_ACID_DEPRIVATION,1
GOBP_MITOCHONDRIAL_MEMBRANE_...,SET,99,-0.037948,-0.0027777,0.083441,0.67537,GOBP_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,1
GOCC_CYCLIN_DEPENDENT_PROTEI...,SET,51,-0.048683,-0.002561,0.10704,0.67537,GOCC_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,1
MORF_PTPN11,SET,93,-0.038261,-0.0027149,0.084125,0.67538,MORF_PTPN11,1
GOBP_MESODERMAL_CELL_FATE_SP...,SET,13,-0.11024,-0.0029311,0.24229,0.67545,GOBP_MESODERMAL_CELL_FATE_SPECIFICATION,1
GSE369_PRE_VS_POST_IL6_INJEC...2,SET,176,-0.029631,-0.0028857,0.065118,0.67545,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP,1
GOBP_NEGATIVE_REGULATION_OF_...450,SET,5,-0.21057,-0.0034728,0.46263,0.6755,GOBP_NEGATIVE_REGULATION_OF_NODAL_SIGNALING_PATHWAY,1
HP_ACQUIRED_ABNORMAL_HAIR_PA...,SET,34,-0.070319,-0.0030218,0.15449,0.6755,HP_ACQUIRED_ABNORMAL_HAIR_PATTERN,1
GSE6259_FLT3L_INDUCED_33D1_P...2,SET,177,-0.028053,-0.0027397,0.061617,0.67554,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP,1
GOBP_CYCLOOXYGENASE_PATHWAY,SET,9,-0.12614,-0.0027908,0.27704,0.67556,GOBP_CYCLOOXYGENASE_PATHWAY,1
PPARA_01,SET,31,-0.070409,-0.0028893,0.15456,0.67563,PPARA_01,1
GSE2770_TGFB_AND_IL4_VS_IL12...4,SET,173,-0.029103,-0.0028103,0.063891,0.67563,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
HP_PEPTIC_ULCER,SET,34,-0.081127,-0.0034862,0.17807,0.67565,HP_PEPTIC_ULCER,1
GSE37336_LY6C_POS_VS_NEG_NAI...1,SET,141,-0.033786,-0.002948,0.074158,0.67566,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN,1
HP_USUAL_INTERSTITIAL_PNEUMO...,SET,13,-0.11457,-0.003046,0.25142,0.67569,HP_USUAL_INTERSTITIAL_PNEUMONIA,1
FLETCHER_PBMC_BCG_10W_INFANT...1,SET,235,-0.026517,-0.0029793,0.058179,0.67573,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN,1
KEGG_MEDICUS_PATHOGEN_HCMV_G...2,SET,7,-0.15128,-0.0029518,0.33184,0.67576,KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY,1
AGCTCCT_MIR28,SET,80,-0.04271,-0.0028118,0.093666,0.6758,AGCTCCT_MIR28,1
GOBP_POSITIVE_REGULATION_OF_...753,SET,66,-0.043672,-0.0026124,0.095658,0.676,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE,1
GSE40685_NAIVE_CD4_TCELL_VS_...2,SET,186,-0.028326,-0.0028352,0.06202,0.67606,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP,1
RYBP_TARGET_GENES,SET,1410,-0.011171,-0.0029732,0.024459,0.67607,RYBP_TARGET_GENES,1
GOBP_CITRULLINE_METABOLIC_PR...,SET,7,-0.14175,-0.0027658,0.31029,0.6761,GOBP_CITRULLINE_METABOLIC_PROCESS,1
MIKKELSEN_IPS_HCP_WITH_H3_UN...,SET,77,-0.04832,-0.0031211,0.10577,0.67611,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,1
GOBP_PIRNA_PROCESSING,SET,21,-0.078483,-0.0026515,0.17178,0.67612,GOBP_PIRNA_PROCESSING,1
GOBP_NEGATIVE_ADAPTATION_OF_...,SET,12,-0.11057,-0.0028244,0.2419,0.67619,GOBP_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY,1
REACTOME_TIE2_SIGNALING,SET,18,-0.088057,-0.0027545,0.19261,0.67623,REACTOME_TIE2_SIGNALING,1
GOMF_BILE_ACID_TRANSMEMBRANE...,SET,20,-0.095574,-0.0031512,0.209,0.67627,GOMF_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...278,SET,5,-0.19883,-0.0032792,0.43475,0.67629,GOBP_POSITIVE_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_TORC2_SIG...,SET,4,-0.19278,-0.0028437,0.42137,0.67634,GOBP_REGULATION_OF_TORC2_SIGNALING,1
GSE17721_CTRL_VS_POLYIC_12H_...2,SET,178,-0.028122,-0.0027542,0.061455,0.67638,GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP,1
HOLLEMAN_DAUNORUBICIN_ALL_DN,SET,8,-0.13413,-0.002798,0.29305,0.67642,HOLLEMAN_DAUNORUBICIN_ALL_DN,1
MIR7851_3P,SET,52,-0.055432,-0.0029444,0.1211,0.67642,MIR7851_3P,1
GSE8921_UNSTIM_VS_TLR1_2_STI...3,SET,187,-0.028606,-0.0028708,0.062472,0.67648,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...1,SET,68,-0.04763,-0.0028919,0.10402,0.67649,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1
DURANTE_ADULT_OLFACTORY_NEUR...3,SET,21,-0.088189,-0.0029794,0.19253,0.67654,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD4_T_CELLS,1
GNF2_XRCC5,SET,65,-0.04519,-0.0026828,0.098629,0.67659,GNF2_XRCC5,1
GOMF_HISTONE_H3K9_TRIMETHYLT...,SET,4,-0.21982,-0.0032427,0.47955,0.67666,GOMF_HISTONE_H3K9_TRIMETHYLTRANSFERASE_ACTIVITY,1
GAVIN_FOXP3_TARGETS_CLUSTER_...5,SET,82,-0.044525,-0.0029675,0.097108,0.6767,GAVIN_FOXP3_TARGETS_CLUSTER_P7,1
MIR1258,SET,57,-0.052714,-0.0029312,0.11496,0.67672,MIR1258,1
SHEDDEN_LUNG_CANCER_GOOD_SUR...1,SET,252,-0.025876,-0.0030092,0.056405,0.67679,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,1
GOBP_MONOSACCHARIDE_BIOSYNTH...,SET,79,-0.043889,-0.0028714,0.095674,0.67679,GOBP_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...629,SET,8,-0.11922,-0.0024868,0.25986,0.6768,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_CAPPING,1
GOBP_NEGATIVE_REGULATION_OF_...195,SET,17,-0.085941,-0.0026126,0.18729,0.67683,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,1
GOCC_NBAF_COMPLEX,SET,16,-0.10402,-0.0030677,0.22663,0.67687,GOCC_NBAF_COMPLEX,1
HP_INTERICTAL_EEG_ABNORMALITY,SET,289,-0.023454,-0.0029179,0.051097,0.67688,HP_INTERICTAL_EEG_ABNORMALITY,1
GOBP_REGULATION_OF_MITOCHOND...9,SET,36,-0.062264,-0.002753,0.13563,0.67691,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
HP_REDUCED_TENDON_REFLEXES,SET,521,-0.01693,-0.0028099,0.036876,0.67692,HP_REDUCED_TENDON_REFLEXES,1
MIR8059,SET,55,-0.053433,-0.0029187,0.11636,0.67696,MIR8059,1
GLI4_TARGET_GENES,SET,664,-0.015354,-0.0028652,0.033429,0.67699,GLI4_TARGET_GENES,1
HP_ARTERIAL_RUPTURE,SET,8,-0.15009,-0.0031308,0.32678,0.67699,HP_ARTERIAL_RUPTURE,1
HP_INTELLECTUAL_DISABILITY_M...1,SET,289,-0.023469,-0.0029198,0.051092,0.67701,HP_INTELLECTUAL_DISABILITY_MILD,1
MODULE_301,SET,136,-0.034034,-0.0029169,0.07407,0.67705,MODULE_301,1
GOCC_STRIATED_MUSCLE_THIN_FI...,SET,21,-0.087056,-0.0029411,0.18947,0.67705,GOCC_STRIATED_MUSCLE_THIN_FILAMENT,1
SASAI_TARGETS_OF_CXCR6_AND_P...2,SET,12,-0.12317,-0.0031463,0.26801,0.67708,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP,1
GOBP_OSMOSENSORY_SIGNALING_P...,SET,6,-0.14921,-0.0026956,0.32456,0.67714,GOBP_OSMOSENSORY_SIGNALING_PATHWAY,1
HP_EPISODIC_HYPERTENSION,SET,5,-0.16832,-0.0027759,0.36584,0.67727,HP_EPISODIC_HYPERTENSION,1
GOBP_PROTEIN_NEDDYLATION,SET,27,-0.069575,-0.0026648,0.1512,0.67729,GOBP_PROTEIN_NEDDYLATION,1
GOBP_ACTIVATION_OF_PROTEIN_K...1,SET,75,-0.046833,-0.0029857,0.10174,0.67735,GOBP_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,1
CCCNNGGGAR_OLF1_01,SET,293,-0.023719,-0.002971,0.051527,0.67736,CCCNNGGGAR_OLF1_01,1
DAIRKEE_CANCER_PRONE_RESPONS...1,SET,50,-0.052097,-0.0027136,0.11314,0.6774,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,1
HOEK_NK_CELL_2011_2012_TIV_3...,SET,208,-0.029189,-0.0030876,0.063391,0.6774,HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN,1
GOMF_FOLIC_ACID_TRANSMEMBRAN...,SET,5,-0.20179,-0.0033279,0.43821,0.67741,GOMF_FOLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_FIFTH_TOE_MORPHO...,SET,83,-0.042453,-0.0028465,0.092194,0.67741,HP_ABNORMAL_FIFTH_TOE_MORPHOLOGY,1
GSE6269_E_COLI_VS_STREP_PNEU...2,SET,145,-0.034439,-0.003047,0.074777,0.67744,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP,1
GOBP_SISTER_CHROMATID_COHESI...,SET,42,-0.058388,-0.0027881,0.12674,0.67749,GOBP_SISTER_CHROMATID_COHESION,1
DESCARTES_FETAL_KIDNEY_MYELO...,SET,151,-0.034364,-0.0031021,0.07458,0.67752,DESCARTES_FETAL_KIDNEY_MYELOID_CELLS,1
BROWNE_HCMV_INFECTION_10HR_DN,SET,52,-0.057485,-0.0030534,0.12474,0.67754,BROWNE_HCMV_INFECTION_10HR_DN,1
JAEGER_METASTASIS_UP,SET,38,-0.066186,-0.0030065,0.1436,0.67756,JAEGER_METASTASIS_UP,1
HP_ANTERIOR_POLAR_CATARACT,SET,7,-0.17326,-0.0033808,0.37593,0.67756,HP_ANTERIOR_POLAR_CATARACT,1
GSE35825_UNTREATED_VS_IFNG_S...1,SET,167,-0.029608,-0.0028095,0.06424,0.67756,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN,1
SMN1_SMN2_TARGET_GENES,SET,628,-0.01559,-0.0028322,0.033818,0.6776,SMN1_SMN2_TARGET_GENES,1
HP_PROGRESSIVE_SPASTIC_PARAP...1,SET,5,-0.16726,-0.0027585,0.36266,0.67767,HP_PROGRESSIVE_SPASTIC_PARAPARESIS,1
NKX25_01,SET,109,-0.039835,-0.0030587,0.086357,0.6777,NKX25_01,1
GOBP_REGULATION_OF_ACUTE_INF...1,SET,44,-0.063673,-0.0031118,0.13802,0.67772,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,1
REACTOME_ACTIVATION_OF_NMDA_...,SET,85,-0.044879,-0.0030451,0.097266,0.67774,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,1
KEGG_NEUROACTIVE_LIGAND_RECE...,SET,252,-0.027894,-0.0032439,0.060447,0.67776,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,1
GOBP_PHARYNGEAL_ARCH_ARTERY_...,SET,9,-0.15232,-0.0033699,0.33009,0.67776,GOBP_PHARYNGEAL_ARCH_ARTERY_MORPHOGENESIS,1
HP_DECREASED_ACHILLES_REFLEX,SET,8,-0.13015,-0.0027148,0.28204,0.67776,HP_DECREASED_ACHILLES_REFLEX,1
GNF2_SPI1,SET,34,-0.070868,-0.0030453,0.15352,0.67782,GNF2_SPI1,1
GSE22601_IMMATURE_CD4_SINGLE...6,SET,163,-0.032676,-0.0030637,0.070787,0.67782,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,1
GSE9006_TYPE_1_DIABETES_AT_D...2,SET,182,-0.028175,-0.0027899,0.061035,0.67782,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP,1
GOBP_MULTICELLULAR_ORGANISMA...3,SET,24,-0.078736,-0.0028435,0.17041,0.67797,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_IRON_ION_HOMEOSTASIS,1
HP_ABNORMALITY_OF_LENS_SHAPE,SET,15,-0.10259,-0.0029296,0.22202,0.67798,HP_ABNORMALITY_OF_LENS_SHAPE,1
GOBP_NEGATIVE_REGULATION_OF_...605,SET,14,-0.12308,-0.0033959,0.26623,0.67807,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...447,SET,5,-0.21246,-0.0035039,0.45939,0.67813,GOBP_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,1
MIR517A_3P_MIR517B_3P_MIR517...,SET,19,-0.0896,-0.0028795,0.19371,0.67815,MIR517A_3P_MIR517B_3P_MIR517C_3P,1
LAKE_ADULT_KIDNEY_C28_INTERS...,SET,79,-0.049504,-0.0032387,0.10697,0.67824,LAKE_ADULT_KIDNEY_C28_INTERSTITIUM,1
GSE7568_CTRL_VS_3H_TGFB_TREA...1,SET,150,-0.031384,-0.0028238,0.06781,0.67825,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,1
GOBP_KETONE_CATABOLIC_PROCESS,SET,12,-0.11,-0.00281,0.23761,0.6783,GOBP_KETONE_CATABOLIC_PROCESS,1
MIR494_5P,SET,38,-0.061971,-0.002815,0.13382,0.67834,MIR494_5P,1
GSE17721_CTRL_VS_GARDIQUIMOD...8,SET,177,-0.030457,-0.0029745,0.065738,0.67842,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP,1
GGCAGCT_MIR22,SET,209,-0.027746,-0.002942,0.059874,0.67846,GGCAGCT_MIR22,1
REACTOME_METABOLISM_OF_NITRI...,SET,14,-0.10508,-0.0028991,0.22673,0.67848,REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,1
GAVISH_3CA_METAPROGRAM_EPITH...10,SET,48,-0.064807,-0.0033077,0.13983,0.67848,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN,1
GOBP_MATURATION_OF_SSU_RRNA,SET,47,-0.056109,-0.0028339,0.12104,0.67851,GOBP_MATURATION_OF_SSU_RRNA,1
GOCC_EXTERNAL_ENCAPSULATING_...,SET,520,-0.018968,-0.0031452,0.04092,0.67851,GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE,1
GSE17721_POLYIC_VS_PAM3CSK4_...9,SET,179,-0.02796,-0.0027459,0.060315,0.67852,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN,1
REACTOME_HS_GAG_DEGRADATION,SET,21,-0.094069,-0.003178,0.20274,0.67867,REACTOME_HS_GAG_DEGRADATION,1
GOCC_INTEGRIN_COMPLEX,SET,29,-0.079707,-0.0031638,0.17179,0.67867,GOCC_INTEGRIN_COMPLEX,1
GOCC_CALCITONIN_FAMILY_RECEP...,SET,5,-0.19511,-0.0032178,0.42045,0.67869,GOCC_CALCITONIN_FAMILY_RECEPTOR_COMPLEX,1
HP_REDUCED_C_PEPTIDE_LEVEL,SET,7,-0.15949,-0.0031121,0.3436,0.67873,HP_REDUCED_C_PEPTIDE_LEVEL,1
KEGG_REGULATION_OF_AUTOPHAGY,SET,31,-0.081157,-0.0033303,0.17483,0.67875,KEGG_REGULATION_OF_AUTOPHAGY,1
LEE_NEURAL_CREST_STEM_CELL_DN,SET,103,-0.04276,-0.0031922,0.092074,0.67882,LEE_NEURAL_CREST_STEM_CELL_DN,1
SMID_BREAST_CANCER_ERBB2_UP,SET,127,-0.036077,-0.0029886,0.077684,0.67882,SMID_BREAST_CANCER_ERBB2_UP,1
GOMF_CHITIN_BINDING,SET,8,-0.14841,-0.0030958,0.31946,0.67888,GOMF_CHITIN_BINDING,1
KEGG_MEDICUS_ENV_FACTOR_DCE_...,SET,15,-0.13881,-0.0039642,0.29874,0.67891,KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS,1
GOBP_UBIQUITIN_INDEPENDENT_P...,SET,5,-0.17988,-0.0029667,0.38701,0.67896,GOBP_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,1
GSE25085_FETAL_BM_VS_ADULT_B...1,SET,180,-0.030569,-0.0030105,0.065749,0.67901,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,1
HP_HIP_CONTRACTURE,SET,51,-0.057894,-0.0030456,0.12451,0.67902,HP_HIP_CONTRACTURE,1
GOBP_NEURAL_PLATE_REGIONALIZ...,SET,5,-0.19158,-0.0031595,0.41199,0.67903,GOBP_NEURAL_PLATE_REGIONALIZATION,1
MIR3116,SET,87,-0.04234,-0.0029062,0.09105,0.67904,MIR3116,1
HP_THICKENED_HELICES,SET,43,-0.056717,-0.0027402,0.12197,0.67904,HP_THICKENED_HELICES,1
HP_EEG_WITH_GENERALIZED_EPIL...,SET,247,-0.02566,-0.0029547,0.055169,0.67907,HP_EEG_WITH_GENERALIZED_EPILEPTIFORM_DISCHARGES,1
GSE22886_IGA_VS_IGM_MEMORY_B...2,SET,172,-0.031087,-0.0029933,0.066823,0.67911,GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP,1
GSE39820_TGFBETA1_VS_TGFBETA...4,SET,184,-0.027708,-0.0027586,0.059547,0.67915,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP,1
MIR4753_5P,SET,156,-0.032784,-0.0030077,0.070399,0.67928,MIR4753_5P,1
MODULE_545,SET,18,-0.095906,-0.003,0.20594,0.67928,MODULE_545,1
GOBP_RADIAL_GLIA_GUIDED_PYRA...,SET,6,-0.17398,-0.0031431,0.37347,0.67933,GOBP_RADIAL_GLIA_GUIDED_PYRAMIDAL_NEURON_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...249,SET,189,-0.030777,-0.003105,0.066062,0.67934,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,1
HP_UNDETECTABLE_VISUAL_EVOKE...,SET,8,-0.12977,-0.002707,0.27853,0.67936,HP_UNDETECTABLE_VISUAL_EVOKED_POTENTIALS,1
IVANOVA_HEMATOPOIESIS_MATURE...,SET,259,-0.025035,-0.002951,0.053731,0.67937,IVANOVA_HEMATOPOIESIS_MATURE_CELL,1
GSE10094_LCMV_VS_LISTERIA_IN...2,SET,175,-0.028196,-0.0027383,0.060463,0.67951,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP,1
HP_SIRENOMELIA,SET,11,-0.12977,-0.0031738,0.27826,0.67952,HP_SIRENOMELIA,1
GOBP_POSITIVE_REGULATION_OF_...415,SET,10,-0.13549,-0.0031596,0.29051,0.67953,GOBP_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_ABIOTIC_STI...,SET,1026,-0.012939,-0.0029706,0.027743,0.67953,GOBP_RESPONSE_TO_ABIOTIC_STIMULUS,1
NEBEN_AML_WITH_FLT3_OR_NRAS_...2,SET,7,-0.13716,-0.0026763,0.29403,0.67956,NEBEN_AML_WITH_FLT3_OR_NRAS_UP,1
GOBP_RESPONSE_TO_X_RAY,SET,26,-0.070953,-0.0026669,0.15206,0.6796,GOBP_RESPONSE_TO_X_RAY,1
HP_BEAKING_OF_VERTEBRAL_BODI...,SET,25,-0.078464,-0.002892,0.16817,0.6796,HP_BEAKING_OF_VERTEBRAL_BODIES,1
BORCZUK_MALIGNANT_MESOTHELIO...1,SET,86,-0.042312,-0.0028877,0.090674,0.67962,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,1
GOBP_ACTIN_FILAMENT_NETWORK_...,SET,6,-0.17669,-0.0031921,0.37862,0.67963,GOBP_ACTIN_FILAMENT_NETWORK_FORMATION,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...3,SET,25,-0.073153,-0.0026962,0.15675,0.67964,HP_ABNORMAL_MORPHOLOGY_OF_THE_CONJUNCTIVAL_VASCULATURE,1
STTTCRNTTT_IRF_Q6,SET,174,-0.031934,-0.0030926,0.068404,0.67969,STTTCRNTTT_IRF_Q6,1
HP_HYPOURICEMIA,SET,16,-0.10428,-0.0030756,0.22338,0.67969,HP_HYPOURICEMIA,1
REACTOME_ACETYLCHOLINE_INHIB...,SET,5,-0.21344,-0.0035201,0.45702,0.67976,REACTOME_ACETYLCHOLINE_INHIBITS_CONTRACTION_OF_OUTER_HAIR_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...832,SET,16,-0.11434,-0.0033722,0.24477,0.67979,GOBP_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY,1
WNT_UP.V1_UP,SET,167,-0.032024,-0.0030388,0.06855,0.6798,WNT_UP.V1_UP,1
MIR320A_3P_MIR320B_MIR320C_M...,SET,276,-0.025456,-0.0030961,0.054481,0.67983,MIR320A_3P_MIR320B_MIR320C_MIR320D,1
GSE21033_CTRL_VS_POLYIC_STIM...8,SET,179,-0.028093,-0.002759,0.060124,0.67984,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP,1
POMEROY_MEDULLOBLASTOMA_PROG...2,SET,42,-0.058614,-0.0027989,0.1254,0.6799,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,1
PIONTEK_PKD1_TARGETS_UP,SET,39,-0.063764,-0.0029343,0.13637,0.67995,PIONTEK_PKD1_TARGETS_UP,1
GOBP_PSYCHOMOTOR_BEHAVIOR,SET,3,-0.2803,-0.0035809,0.5994,0.67997,GOBP_PSYCHOMOTOR_BEHAVIOR,1
BIOCARTA_CDMAC_PATHWAY,SET,16,-0.1088,-0.0032088,0.23262,0.68,BIOCARTA_CDMAC_PATHWAY,1
GOBP_LACRIMAL_GLAND_DEVELOPM...,SET,7,-0.16136,-0.0031487,0.34497,0.68002,GOBP_LACRIMAL_GLAND_DEVELOPMENT,1
HP_DYSTROPHIC_TOENAIL,SET,19,-0.095877,-0.0030812,0.20498,0.68002,HP_DYSTROPHIC_TOENAIL,1
KEGG_MEDICUS_REFERENCE_CARDI...,SET,21,-0.096459,-0.0032588,0.20615,0.68007,KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING,1
REACTOME_THE_ACTIVATION_OF_A...,SET,8,-0.13707,-0.0028591,0.2929,0.6801,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,1
HP_REDUCED_NUMBER_OF_INTRAHE...,SET,5,-0.1984,-0.003272,0.42393,0.6801,HP_REDUCED_NUMBER_OF_INTRAHEPATIC_BILE_DUCTS,1
GOBP_RESPIRATORY_BURST,SET,30,-0.077903,-0.0031449,0.16644,0.68013,GOBP_RESPIRATORY_BURST,1
GOMF_PROTON_TRANSMEMBRANE_TR...,SET,143,-0.032149,-0.0028248,0.068682,0.68014,GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_CARBONYL_REDUCTASE_NADP...,SET,9,-0.1479,-0.0032722,0.31595,0.68015,GOMF_CARBONYL_REDUCTASE_NADPH_ACTIVITY,1
GARCIA_PINERES_PBMC_HPV_16_L...3,SET,259,-0.025394,-0.0029933,0.054227,0.68021,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN,1
GOMF_CELL_MATRIX_ADHESION_ME...,SET,8,-0.15613,-0.0032568,0.33333,0.68025,GOMF_CELL_MATRIX_ADHESION_MEDIATOR_ACTIVITY,1
MIR744_3P,SET,55,-0.053228,-0.0029075,0.11363,0.68026,MIR744_3P,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...5,SET,4,-0.18752,-0.0027662,0.40027,0.68028,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAH7.8_TO_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,1
GSE30971_CTRL_VS_LPS_STIM_MA...1,SET,173,-0.030669,-0.0029616,0.065439,0.68034,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN,1
REACTOME_DERMATAN_SULFATE_BI...,SET,10,-0.1191,-0.0027774,0.25409,0.68036,REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS,1
GOCC_TRANSCRIPTION_PREINITIA...,SET,13,-0.10629,-0.0028259,0.22676,0.68036,GOCC_TRANSCRIPTION_PREINITIATION_COMPLEX,1
GSE5503_MLN_DC_VS_SPLEEN_DC_...1,SET,179,-0.028925,-0.0028407,0.061711,0.68036,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
HP_PECTUS_EXCAVATUM_OF_INFER...,SET,5,-0.16679,-0.0027506,0.35574,0.68041,HP_PECTUS_EXCAVATUM_OF_INFERIOR_STERNUM,1
GSE32423_MEMORY_VS_NAIVE_CD8...3,SET,178,-0.030088,-0.0029467,0.064173,0.68041,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN,1
MIR6788_3P,SET,3,-0.22682,-0.0028977,0.48374,0.68042,MIR6788_3P,1
GOBP_POSITIVE_REGULATION_OF_...482,SET,132,-0.037359,-0.0031548,0.079652,0.68047,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
GSE45365_HEALTHY_VS_MCMV_INF...6,SET,154,-0.031077,-0.0028329,0.066214,0.68059,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...544,SET,57,-0.052916,-0.0029424,0.11274,0.6806,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
HOEK_B_CELL_2011_2012_TIV_AD...2,SET,3,-0.23358,-0.002984,0.49753,0.68063,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_DN,1
HP_CEREBRAL_HAMARTOMA,SET,18,-0.086547,-0.0027072,0.18433,0.68065,HP_CEREBRAL_HAMARTOMA,1
GOBP_VERY_LONG_CHAIN_FATTY_A...1,SET,13,-0.13205,-0.0035109,0.28117,0.6807,GOBP_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
SU_KIDNEY,SET,12,-0.12542,-0.0032039,0.26699,0.68074,SU_KIDNEY,1
GOBP_POSITIVE_REGULATION_OF_...114,SET,452,-0.020344,-0.0031511,0.043308,0.68074,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION,1
GOBP_REGULATION_OF_SYNAPTIC_...9,SET,17,-0.095181,-0.0028935,0.2026,0.68075,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,1
BIOCARTA_LECTIN_PATHWAY,SET,10,-0.12676,-0.0029561,0.26967,0.68085,BIOCARTA_LECTIN_PATHWAY,1
GOMF_ACYLGLYCEROL_O_ACYLTRAN...,SET,24,-0.085619,-0.003092,0.18213,0.68085,GOMF_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,1
HP_DEFORMED_SELLA_TURCICA,SET,18,-0.084716,-0.00265,0.18012,0.68094,HP_DEFORMED_SELLA_TURCICA,1
HP_LOWER_LIMB_PAIN,SET,37,-0.070108,-0.0031425,0.14905,0.68094,HP_LOWER_LIMB_PAIN,1
GSE36888_UNTREATED_VS_IL2_TR...8,SET,170,-0.030857,-0.002954,0.065603,0.68095,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP,1
MIR6720_5P,SET,123,-0.035955,-0.0029316,0.076427,0.68098,MIR6720_5P,1
chr11p15,SET,274,-0.053393,-0.0064707,0.11349,0.68099,chr11p15,1
GSE13411_IGM_MEMORY_BCELL_VS...1,SET,174,-0.030172,-0.0029219,0.06412,0.68102,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN,1
MODULE_349,SET,17,-0.10635,-0.0032331,0.22596,0.68106,MODULE_349,1
GSE3982_MAC_VS_EFF_MEMORY_CD...1,SET,173,-0.030672,-0.0029618,0.065153,0.68109,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN,1
GALLUZZI_PERMEABILIZE_MITOCH...,SET,39,-0.069655,-0.0032053,0.14794,0.68112,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,1
GAVISH_3CA_MALIGNANT_METAPRO...20,SET,47,-0.061899,-0.0031263,0.1314,0.6812,GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC,1
HP_RECTOVAGINAL_FISTULA,SET,20,-0.090616,-0.0029877,0.19236,0.6812,HP_RECTOVAGINAL_FISTULA,1
NCOA4_TARGET_GENES,SET,845,-0.014059,-0.0029446,0.029838,0.68125,NCOA4_TARGET_GENES,1
GSE41176_UNSTIM_VS_ANTI_IGM_...15,SET,174,-0.031345,-0.0030355,0.066514,0.68127,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN,1
HP_PERIORBITAL_WRINKLES,SET,4,-0.2245,-0.0033117,0.4761,0.68137,HP_PERIORBITAL_WRINKLES,1
HP_ANTI_THYROGLOBULIN_ANTIBO...,SET,6,-0.17987,-0.0032494,0.38141,0.68138,HP_ANTI_THYROGLOBULIN_ANTIBODY_POSITIVITY,1
GOBP_POSITIVE_REGULATION_OF_...218,SET,9,-0.12413,-0.0027462,0.26314,0.68144,GOBP_POSITIVE_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
HP_ASPIRATION,SET,26,-0.079691,-0.0029953,0.16892,0.68145,HP_ASPIRATION,1
GOBP_L_CYSTINE_TRANSPORT,SET,6,-0.16644,-0.0030069,0.35278,0.68146,GOBP_L_CYSTINE_TRANSPORT,1
HALLMARK_ESTROGEN_RESPONSE_E...,SET,187,-0.031924,-0.0032038,0.067653,0.68149,HALLMARK_ESTROGEN_RESPONSE_EARLY,1
GOBP_PROTEOGLYCAN_CATABOLIC_...,SET,9,-0.14067,-0.0031121,0.29808,0.6815,GOBP_PROTEOGLYCAN_CATABOLIC_PROCESS,1
GOBP_CARDIAC_LEFT_VENTRICLE_...,SET,16,-0.11032,-0.0032537,0.23366,0.68159,GOBP_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS,1
GAVISH_3CA_METAPROGRAM_CD4_T...7,SET,38,-0.063867,-0.0029011,0.13525,0.68161,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_2,1
GSE17721_CTRL_VS_LPS_2H_BMDC...1,SET,183,-0.030523,-0.0030306,0.064624,0.68165,GSE17721_CTRL_VS_LPS_2H_BMDC_DN,1
SENESE_HDAC1_AND_HDAC2_TARGE...2,SET,212,-0.028841,-0.0030797,0.061041,0.6817,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1
CHEMELLO_SOLEUS_VS_EDL_MYOFI...2,SET,16,-0.095237,-0.0028089,0.20154,0.68173,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,1
MIR4295,SET,353,-0.02158,-0.002962,0.045666,0.68174,MIR4295,1
HP_CUTANEOUS_SYNDACTYLY,SET,64,-0.04938,-0.0029089,0.10439,0.68191,HP_CUTANEOUS_SYNDACTYLY,1
MYLLYKANGAS_AMPLIFICATION_HO...10,SET,14,-0.099332,-0.0027406,0.20995,0.68194,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,1
GOBP_POSITIVE_REGULATION_OF_...341,SET,14,-0.10884,-0.0030028,0.22997,0.68199,GOBP_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,1
REACTOME_G_PROTEIN_BETA_GAMM...,SET,30,-0.076219,-0.0030769,0.16099,0.68205,REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING,1
MIR130B_5P,SET,175,-0.031343,-0.0030439,0.066156,0.68217,MIR130B_5P,1
GOBP_REGULATION_OF_SYSTEMIC_...1,SET,84,-0.046688,-0.0031492,0.098537,0.68218,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GOBP_NEGATIVE_REGULATION_OF_...106,SET,181,-0.031919,-0.003152,0.06735,0.68222,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION,1
BRACHAT_RESPONSE_TO_METHOTRE...2,SET,18,-0.089286,-0.0027929,0.18836,0.68226,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,1
HP_MONOTONIC_SPEECH,SET,8,-0.16725,-0.0034888,0.35281,0.68227,HP_MONOTONIC_SPEECH,1
GCACCTT_MIR18A_MIR18B,SET,112,-0.038364,-0.0029857,0.080855,0.68242,GCACCTT_MIR18A_MIR18B,1
GOBP_REGULATION_OF_HEART_RAT...2,SET,5,-0.19899,-0.0032817,0.41937,0.68242,GOBP_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL,1
HP_PSYCHOMOTOR_DETERIORATION,SET,19,-0.092965,-0.0029876,0.1959,0.68244,HP_PSYCHOMOTOR_DETERIORATION,1
GOCC_LIPOPOLYSACCHARIDE_RECE...,SET,5,-0.18436,-0.0030405,0.38842,0.68247,GOCC_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX,1
HP_RECURRENT_GRAM_NEGATIVE_B...,SET,32,-0.077587,-0.0032347,0.16345,0.68249,HP_RECURRENT_GRAM_NEGATIVE_BACTERIAL_INFECTIONS,1
HE_LIM_SUN_FETAL_LUNG_C0_MES...2,SET,265,-0.025754,-0.0030701,0.054256,0.68249,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL,1
HP_ABNORMAL_ANKLE_PHYSIOLOGY,SET,54,-0.054256,-0.0029367,0.11425,0.68256,HP_ABNORMAL_ANKLE_PHYSIOLOGY,1
GOCC_PROTON_TRANSPORTING_V_T...3,SET,12,-0.12445,-0.003179,0.26205,0.68257,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN,1
GOMF_ACETYL_COA_C_ACYLTRANSF...,SET,7,-0.13947,-0.0027214,0.29345,0.6827,GOMF_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY,1
GOBP_RNA_SURVEILLANCE,SET,17,-0.096146,-0.0029228,0.20229,0.68271,GOBP_RNA_SURVEILLANCE,1
HP_MEGAKARYOCYTOPENIA,SET,6,-0.15819,-0.0028579,0.33277,0.68274,HP_MEGAKARYOCYTOPENIA,1
REACTOME_CONJUGATION_OF_BENZ...,SET,6,-0.22633,-0.0040889,0.47587,0.68282,REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE,1
GSE26030_UNSTIM_VS_RESTIM_TH...3,SET,174,-0.031868,-0.0030861,0.067001,0.68283,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN,1
MODULE_20,SET,77,-0.044725,-0.0028889,0.094015,0.68286,MODULE_20,1
GTGTCAA_MIR514,SET,55,-0.050414,-0.0027538,0.10595,0.68289,GTGTCAA_MIR514,1
HP_THIN_CLAVICLES,SET,6,-0.14485,-0.0026169,0.30427,0.68298,HP_THIN_CLAVICLES,1
GOBP_REGULATION_OF_PROSTATIC...,SET,5,-0.22277,-0.0036739,0.46785,0.68301,GOBP_REGULATION_OF_PROSTATIC_BUD_FORMATION,1
GOBP_EPIDERMAL_GROWTH_FACTOR...,SET,102,-0.040325,-0.0029958,0.084683,0.68303,GOBP_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_UNBALANCED_ATRIOVENTRICUL...,SET,5,-0.18241,-0.0030083,0.38306,0.68303,HP_UNBALANCED_ATRIOVENTRICULAR_CANAL_DEFECT,1
GSE411_WT_VS_SOCS3_KO_MACROP...2,SET,183,-0.028203,-0.0028003,0.059227,0.68303,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN,1
GSE30962_PRIMARY_VS_SECONDAR...3,SET,176,-0.032308,-0.0031465,0.067844,0.68304,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN,1
GSE23308_WT_VS_MINERALCORTIC...3,SET,189,-0.031254,-0.0031531,0.065595,0.68313,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN,1
GOCC_CALCINEURIN_COMPLEX,SET,6,-0.13859,-0.0025036,0.29083,0.68314,GOCC_CALCINEURIN_COMPLEX,1
MIR1245B_5P,SET,53,-0.054901,-0.002944,0.11521,0.68315,MIR1245B_5P,1
MIR516A_5P,SET,6,-0.1674,-0.0030242,0.35127,0.68316,MIR516A_5P,1
GOMF_OXIDOREDUCTASE_ACTIVITY...22,SET,4,-0.22403,-0.0033047,0.46989,0.68323,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
GOBP_INFLAMMASOME_MEDIATED_S...,SET,39,-0.066698,-0.0030693,0.13989,0.68325,GOBP_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
HAY_BONE_MARROW_PLASMA_CELL,SET,85,-0.046085,-0.0031269,0.096644,0.68326,HAY_BONE_MARROW_PLASMA_CELL,1
KEGG_MEDICUS_VARIANT_ERBB2_O...1,SET,7,-0.16817,-0.0032815,0.35255,0.68332,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY,1
GSE41176_UNSTIM_VS_ANTI_IGM_...2,SET,184,-0.032104,-0.0031962,0.067291,0.68335,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP,1
GOBP_SODIUM_INDEPENDENT_ORGA...,SET,15,-0.12857,-0.0036715,0.26943,0.68338,GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT,1
DESCARTES_FETAL_ADRENAL_ERYT...,SET,84,-0.045269,-0.0030535,0.094859,0.6834,DESCARTES_FETAL_ADRENAL_ERYTHROBLASTS,1
BUSSLINGER_ESOPHAGEAL_EARLY_...,SET,74,-0.046998,-0.0029763,0.098466,0.68342,BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS,1
MODULE_474,SET,13,-0.13114,-0.0034866,0.27472,0.68344,MODULE_474,1
GSE21360_SECONDARY_VS_TERTIA...2,SET,180,-0.028632,-0.0028197,0.059955,0.68352,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_CA2_E...3,SET,24,-0.091342,-0.0032987,0.19118,0.6836,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL,1
GOBP_CELLULAR_RESPONSE_TO_CA...4,SET,49,-0.059485,-0.0030675,0.12443,0.68369,GOBP_CELLULAR_RESPONSE_TO_CAMP,1
HP_INSULIN_RESISTANCE,SET,104,-0.04236,-0.0031776,0.088612,0.68369,HP_INSULIN_RESISTANCE,1
HP_ABNORMAL_CHOROID_PLEXUS_M...,SET,18,-0.10966,-0.0034302,0.22938,0.6837,HP_ABNORMAL_CHOROID_PLEXUS_MORPHOLOGY,1
GOBP_AROMATIC_AMINO_ACID_MET...,SET,29,-0.082459,-0.003273,0.17244,0.68374,GOBP_AROMATIC_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_IMPORT_ACROSS_PLASMA_ME...,SET,184,-0.032069,-0.0031927,0.067064,0.68374,GOBP_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_MAGNESIUM_ION_HOMEOSTAS...,SET,10,-0.13405,-0.003126,0.28029,0.68376,GOBP_MAGNESIUM_ION_HOMEOSTASIS,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...4,SET,18,-0.098436,-0.0030791,0.20581,0.68378,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...107,SET,9,-0.14113,-0.0031224,0.29507,0.68378,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,1
GOBP_PYRIMIDINE_NUCLEOBASE_M...,SET,20,-0.092048,-0.0030349,0.19238,0.68384,GOBP_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS,1
FLECHNER_BIOPSY_KIDNEY_TRANS...1,SET,23,-0.080341,-0.0028404,0.1679,0.68385,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1
HP_HYPOPLASTIC_SACRUM,SET,6,-0.16013,-0.0028928,0.33452,0.68391,HP_HYPOPLASTIC_SACRUM,1
HP_HYPERTENSION,SET,355,-0.02262,-0.0031133,0.047247,0.68394,HP_HYPERTENSION,1
GSE27786_LSK_VS_LIN_NEG_CELL...2,SET,179,-0.030763,-0.0030212,0.064255,0.68394,GSE27786_LSK_VS_LIN_NEG_CELL_UP,1
GSE11924_TH2_VS_TH17_CD4_TCE...1,SET,184,-0.030866,-0.0030729,0.064466,0.68395,GSE11924_TH2_VS_TH17_CD4_TCELL_DN,1
GOBP_MODIFICATION_OF_POSTSYN...2,SET,21,-0.085446,-0.0028867,0.17845,0.68397,GOBP_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,1
MIR34B_5P,SET,120,-0.038112,-0.0030696,0.079585,0.68399,MIR34B_5P,1
GSE9509_10MIN_VS_30MIN_LPS_S...1,SET,171,-0.032608,-0.0031307,0.068069,0.68404,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN,1
HP_BILATERAL_CONDUCTIVE_HEAR...,SET,6,-0.14132,-0.0025531,0.29498,0.68406,HP_BILATERAL_CONDUCTIVE_HEARING_IMPAIRMENT,1
GOBP_REGULATION_OF_SYNAPTIC_...12,SET,8,-0.11571,-0.0024137,0.24149,0.68408,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING,1
GOBP_REGULATION_OF_CELL_SUBS...2,SET,65,-0.051181,-0.0030384,0.10681,0.6841,GOBP_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
GOBP_REGULATION_OF_INTRINSIC...3,SET,35,-0.06637,-0.0028936,0.13847,0.68414,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,1
HP_ANAL_FISSURE,SET,4,-0.16198,-0.0023895,0.33777,0.68423,HP_ANAL_FISSURE,1
GOBP_ORGANELLE_INHERITANCE,SET,15,-0.10166,-0.0029032,0.21198,0.68424,GOBP_ORGANELLE_INHERITANCE,1
GOBP_OXALOACETATE_METABOLIC_...,SET,9,-0.12167,-0.0026918,0.25362,0.68429,GOBP_OXALOACETATE_METABOLIC_PROCESS,1
GOBP_AXON_ENSHEATHMENT_IN_CE...,SET,23,-0.088975,-0.0031456,0.18546,0.6843,GOBP_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM,1
FLECHNER_PBL_KIDNEY_TRANSPLA...3,SET,50,-0.056731,-0.002955,0.11811,0.68449,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1
MIR4750_3P,SET,36,-0.063431,-0.0028047,0.13207,0.68449,MIR4750_3P,1
GOMF_7S_RNA_BINDING,SET,7,-0.12341,-0.002408,0.25689,0.68452,GOMF_7S_RNA_BINDING,1
BIOCARTA_IFNG_PATHWAY,SET,6,-0.19014,-0.003435,0.39575,0.68454,BIOCARTA_IFNG_PATHWAY,1
KEGG_MEDICUS_REFERENCE_VGCC_...,SET,20,-0.094629,-0.00312,0.19693,0.68457,KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY,1
ZHONG_PFC_C2_SOX5_BCL11B_POS...,SET,24,-0.092994,-0.0033584,0.19349,0.6846,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,1
GSE17721_0.5H_VS_24H_PAM3CSK...2,SET,186,-0.029763,-0.002979,0.061924,0.68461,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP,1
MIR374A_3P,SET,128,-0.036884,-0.0030674,0.076733,0.68463,MIR374A_3P,1
KEGG_DRUG_METABOLISM_OTHER_E...,SET,48,-0.073415,-0.0037471,0.15272,0.68464,KEGG_DRUG_METABOLISM_OTHER_ENZYMES,1
HP_URTICARIA,SET,49,-0.058302,-0.0030065,0.12122,0.68472,HP_URTICARIA,1
HP_STREAK_OVARY,SET,31,-0.070621,-0.002898,0.14682,0.68474,HP_STREAK_OVARY,1
GOBP_RESPONSE_TO_CORTICOSTER...2,SET,15,-0.11164,-0.003188,0.23198,0.68482,GOBP_RESPONSE_TO_CORTICOSTERONE,1
GSE13485_PRE_VS_POST_YF17D_V...2,SET,167,-0.031809,-0.0030184,0.066084,0.68486,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP,1
GOBP_ENDOCARDIAL_CUSHION_MOR...,SET,42,-0.074343,-0.0035499,0.15442,0.68489,GOBP_ENDOCARDIAL_CUSHION_MORPHOGENESIS,1
GSE22886_NAIVE_CD8_TCELL_VS_...8,SET,173,-0.030639,-0.0029586,0.063643,0.68489,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP,1
GOCC_SNO_S_RNA_CONTAINING_RI...,SET,19,-0.085637,-0.0027521,0.17786,0.68491,GOCC_SNO_S_RNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...3,SET,8,-0.15734,-0.003282,0.32662,0.68499,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_FORMATION,1
GSE41867_NAIVE_VS_DAY15_LCMV...5,SET,177,-0.029606,-0.0028915,0.06145,0.68502,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN,1
REACTOME_MOLECULES_ASSOCIATE...,SET,35,-0.07306,-0.0031853,0.15163,0.68504,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,1
REACTOME_ATORVASTATIN_ADME,SET,9,-0.15086,-0.0033376,0.31299,0.68509,REACTOME_ATORVASTATIN_ADME,1
GOBP_CELLULAR_RESPONSE_TO_AN...1,SET,32,-0.080959,-0.0033753,0.16796,0.6851,GOBP_CELLULAR_RESPONSE_TO_ANGIOTENSIN,1
GOBP_POSITIVE_REGULATION_OF_...165,SET,99,-0.037911,-0.002775,0.078635,0.68513,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
WP_GASTRIC_CANCER_NETWORK_1,SET,24,-0.087565,-0.0031623,0.18163,0.68514,WP_GASTRIC_CANCER_NETWORK_1,1
GOBP_REGULATION_OF_PROTEIN_S...3,SET,286,-0.023884,-0.0029562,0.049541,0.68514,GOBP_REGULATION_OF_PROTEIN_STABILITY,1
HP_ABNORMAL_VASCULAR_MORPHOL...,SET,1015,-0.013404,-0.0030619,0.027802,0.68514,HP_ABNORMAL_VASCULAR_MORPHOLOGY,1
REACTOME_DISEASES_OF_PROGRAM...,SET,42,-0.064574,-0.0030834,0.13393,0.68515,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,1
GSE43955_1H_VS_10H_ACT_CD4_T...2,SET,185,-0.02975,-0.0029698,0.061695,0.68517,GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP,1
REACTOME_TRANSLATION,SET,257,-0.024166,-0.0028377,0.050108,0.68519,REACTOME_TRANSLATION,1
GOBP_MODULATION_BY_VIRUS_OF_...,SET,3,-0.24016,-0.0030681,0.49796,0.68519,GOBP_MODULATION_BY_VIRUS_OF_HOST_PROCESS,1
MIR6499_3P,SET,111,-0.039419,-0.0030543,0.081733,0.6852,MIR6499_3P,1
HP_PYODERMA,SET,4,-0.24481,-0.0036113,0.50757,0.68521,HP_PYODERMA,1
GOBP_CARDIAC_MUSCLE_CELL_DIF...,SET,112,-0.03978,-0.003096,0.08247,0.68522,GOBP_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
BCAT_BILD_ET_AL_DN,SET,42,-0.06176,-0.0029491,0.12804,0.68522,BCAT_BILD_ET_AL_DN,1
GOCC_PRESYNAPTIC_ENDOCYTIC_Z...,SET,9,-0.14502,-0.0032085,0.30065,0.68523,GOCC_PRESYNAPTIC_ENDOCYTIC_ZONE,1
REACTOME_NEDDYLATION,SET,227,-0.026859,-0.0029666,0.055672,0.68525,REACTOME_NEDDYLATION,1
GOBP_REGULATION_OF_LEUKOCYTE...4,SET,115,-0.04102,-0.0032347,0.085027,0.68525,GOBP_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,1
GOBP_ANTRAL_OVARIAN_FOLLICLE...,SET,12,-0.12013,-0.0030686,0.24896,0.68527,GOBP_ANTRAL_OVARIAN_FOLLICLE_GROWTH,1
HE_LIM_SUN_FETAL_LUNG_C0_MID...3,SET,850,-0.015006,-0.0031518,0.031099,0.68528,HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL,1
REACTOME_SIGNALING_BY_TYPE_1...,SET,52,-0.059538,-0.0031625,0.12338,0.68529,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,1
GOBP_REGULATION_OF_MEMBRANE_...11,SET,7,-0.1742,-0.0033992,0.36102,0.68529,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,1
MIZUSHIMA_AUTOPHAGOSOME_FORM...,SET,12,-0.10692,-0.0027313,0.22143,0.6854,MIZUSHIMA_AUTOPHAGOSOME_FORMATION,1
SKP2_TARGET_GENES,SET,50,-0.05865,-0.003055,0.12145,0.68542,SKP2_TARGET_GENES,1
ZAIDI_OSTEOBLAST_TRANSCRIPTI...,SET,13,-0.13003,-0.0034572,0.26924,0.68543,ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,1
GOBP_REGULATION_OF_DNA_RECOM...,SET,112,-0.036582,-0.0028471,0.075737,0.68545,GOBP_REGULATION_OF_DNA_RECOMBINATION,1
MEBARKI_HCC_PROGENITOR_WNT_U...4,SET,21,-0.091742,-0.0030994,0.18993,0.68546,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,1
GSE22886_NAIVE_VS_MEMORY_TCE...2,SET,175,-0.030144,-0.0029275,0.062402,0.68547,GSE22886_NAIVE_VS_MEMORY_TCELL_UP,1
GOBP_DNA_DAMAGE_RESPONSE_SIG...2,SET,19,-0.087759,-0.0028203,0.18162,0.68552,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST,1
GOBP_REGULATION_OF_HEMOPOIES...,SET,385,-0.022055,-0.0031586,0.045635,0.68555,GOBP_REGULATION_OF_HEMOPOIESIS,1
GSE17721_CTRL_VS_LPS_1H_BMDC...1,SET,181,-0.031851,-0.0031453,0.065894,0.68558,GSE17721_CTRL_VS_LPS_1H_BMDC_DN,1
GSE9509_LPS_VS_LPS_AND_IL10_...6,SET,168,-0.032436,-0.003087,0.067106,0.68558,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP,1
HP_EEG_WITH_CENTROTEMPORAL_E...,SET,3,-0.25565,-0.003266,0.52885,0.68559,HP_EEG_WITH_CENTROTEMPORAL_EPILEPTIFORM_DISCHARGES,1
TAYLOR_METHYLATED_IN_ACUTE_L...,SET,66,-0.054115,-0.0032371,0.11194,0.6856,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1
GSE39152_CD103_NEG_VS_POS_ME...1,SET,186,-0.030067,-0.0030095,0.062192,0.68561,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN,1
GOBP_EPITHELIAL_CELL_PROLIFE...4,SET,5,-0.21084,-0.0034772,0.43609,0.68562,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
KYNG_ENVIRONMENTAL_STRESS_RE...5,SET,28,-0.071239,-0.0027786,0.14728,0.6857,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,1
DHIMAN_PBMC_ATTENUVAX_AGE_15...2,SET,44,-0.061774,-0.003019,0.12769,0.68572,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_UP,1
GOBP_REGULATION_OF_METANEPHR...,SET,5,-0.2199,-0.0036267,0.45455,0.68573,GOBP_REGULATION_OF_METANEPHROS_DEVELOPMENT,1
MIR410_3P,SET,297,-0.024437,-0.0030813,0.050505,0.68575,MIR410_3P,1
HP_PSEUDOBULBAR_PARALYSIS,SET,20,-0.092571,-0.0030521,0.19132,0.68575,HP_PSEUDOBULBAR_PARALYSIS,1
HU_FETAL_RETINA_RGC,SET,393,-0.021467,-0.0031055,0.044365,0.68576,HU_FETAL_RETINA_RGC,1
GSE28737_WT_VS_BCL6_KO_FOLLI...2,SET,180,-0.031464,-0.0030986,0.065019,0.68577,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP,1
HP_ZOLLINGER_ELLISON_SYNDROME,SET,9,-0.14002,-0.0030978,0.2893,0.6858,HP_ZOLLINGER_ELLISON_SYNDROME,1
GOBP_GLIAL_CELL_APOPTOTIC_PR...,SET,17,-0.095491,-0.0029029,0.19727,0.68582,GOBP_GLIAL_CELL_APOPTOTIC_PROCESS,1
HP_CHOKING_EPISODES,SET,16,-0.10699,-0.0031556,0.22091,0.68592,HP_CHOKING_EPISODES,1
WP_PROSURVIVAL_SIGNALING_OF_...,SET,15,-0.10737,-0.0030662,0.22167,0.68594,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,1
HEDENFALK_BREAST_CANCER_BRAC...1,SET,18,-0.09359,-0.0029275,0.19319,0.68596,HEDENFALK_BREAST_CANCER_BRACX_DN,1
TAKEDA_TARGETS_OF_NUP98_HOXA...8,SET,77,-0.049648,-0.0032069,0.10249,0.68596,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,1
GOMF_NADPLUS_BINDING,SET,18,-0.09847,-0.0030802,0.20326,0.68597,GOMF_NADPLUS_BINDING,1
HP_OCULOGYRIC_CRISIS,SET,12,-0.12811,-0.0032724,0.26443,0.68597,HP_OCULOGYRIC_CRISIS,1
GOBP_INFLAMMATORY_RESPONSE,SET,780,-0.016079,-0.0032414,0.033153,0.68616,GOBP_INFLAMMATORY_RESPONSE,1
YAGI_AML_RELAPSE_PROGNOSIS,SET,33,-0.076551,-0.0032409,0.15782,0.68617,YAGI_AML_RELAPSE_PROGNOSIS,1
GSE5589_IL6_KO_VS_IL10_KO_LP...8,SET,176,-0.032221,-0.003138,0.06643,0.68617,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,1
GOMF_PHOSPHATIDYLINOSITOL_3_...7,SET,26,-0.077647,-0.0029185,0.16007,0.68619,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING,1
chr2q33,SET,74,-0.09872,-0.0062516,0.2035,0.6862,chr2q33,1
HP_TONGUE_FASCICULATIONS,SET,36,-0.069577,-0.0030764,0.14338,0.68625,HP_TONGUE_FASCICULATIONS,1
GOBP_WNT_SIGNALING_PATHWAY_P...,SET,48,-0.063115,-0.0032213,0.13005,0.68626,GOBP_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,1
HP_FOCAL_SENSORY_SEIZURE_WIT...,SET,6,-0.15064,-0.0027215,0.31042,0.68626,HP_FOCAL_SENSORY_SEIZURE_WITH_VISUAL_FEATURES,1
BIOCARTA_FREE_PATHWAY,SET,9,-0.13105,-0.0028994,0.27001,0.68629,BIOCARTA_FREE_PATHWAY,1
GOMF_HISTONE_H4K12_ACETYLTRA...,SET,12,-0.11607,-0.002965,0.23915,0.68629,GOMF_HISTONE_H4K12_ACETYLTRANSFERASE_ACTIVITY,1
WP_7Q1123_DISTAL_COPY_NUMBER...,SET,21,-0.10083,-0.0034064,0.20767,0.68634,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,1
GOBP_ALKALOID_METABOLIC_PROC...,SET,7,-0.15365,-0.0029981,0.31639,0.68639,GOBP_ALKALOID_METABOLIC_PROCESS,1
KEGG_OXIDATIVE_PHOSPHORYLATI...,SET,96,-0.038953,-0.002808,0.080196,0.68642,KEGG_OXIDATIVE_PHOSPHORYLATION,1
FOROUTAN_PRODRANK_TGFB_EMT_UP,SET,178,-0.033024,-0.0032343,0.067983,0.68643,FOROUTAN_PRODRANK_TGFB_EMT_UP,1
HP_FATTY_REPLACEMENT_OF_SKEL...,SET,33,-0.065548,-0.0027751,0.13494,0.68643,HP_FATTY_REPLACEMENT_OF_SKELETAL_MUSCLE,1
GOBP_SKELETAL_MUSCLE_SATELLI...2,SET,11,-0.11906,-0.002912,0.24506,0.68646,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_DIFFERENTIATION,1
HP_CONFETTI_LIKE_HYPOPIGMENT...,SET,8,-0.14993,-0.0031275,0.3086,0.68646,HP_CONFETTI_LIKE_HYPOPIGMENTED_MACULES,1
HP_HYPOCALCIURIA,SET,9,-0.15976,-0.0035346,0.3288,0.68648,HP_HYPOCALCIURIA,1
GOBP_GLOMERULAR_MESANGIAL_CE...2,SET,12,-0.14088,-0.0035987,0.28992,0.68649,GOBP_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,1
HP_GASTRITIS,SET,18,-0.099212,-0.0031034,0.20415,0.6865,HP_GASTRITIS,1
GSE21927_BALBC_VS_C57BL6_MON...4,SET,181,-0.029024,-0.0028661,0.05972,0.68651,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP,1
GNF2_GSTM1,SET,105,-0.041508,-0.0031285,0.085393,0.68654,GNF2_GSTM1,1
MODULE_385,SET,28,-0.090713,-0.0035381,0.18662,0.68654,MODULE_385,1
GOBP_NEGATIVE_REGULATION_OF_...562,SET,114,-0.0384,-0.003015,0.079,0.68654,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,1
GOBP_REGULATION_OF_T_CELL_ME...1,SET,47,-0.06988,-0.0035294,0.14372,0.68659,GOBP_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,1
HP_ABNORMALITY_OF_THE_TONGUE,SET,409,-0.020977,-0.0030943,0.043133,0.68663,HP_ABNORMALITY_OF_THE_TONGUE,1
HP_EXERCISE_INDUCED_RHABDOMY...,SET,6,-0.13825,-0.0024976,0.28418,0.68668,HP_EXERCISE_INDUCED_RHABDOMYOLYSIS,1
GOBP_SENSORY_PERCEPTION_OF_C...,SET,403,-0.028614,-0.0041905,0.058813,0.6867,GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS,1
GSE21063_3H_VS_16H_ANTI_IGM_...2,SET,179,-0.032175,-0.0031598,0.066121,0.68673,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP,1
GSE10325_CD4_TCELL_VS_MYELOI...1,SET,179,-0.032951,-0.0032361,0.067712,0.68674,GSE10325_CD4_TCELL_VS_MYELOID_DN,1
GSE17721_0.5H_VS_4H_LPS_BMDC...1,SET,184,-0.031015,-0.0030878,0.063728,0.68675,GSE17721_0.5H_VS_4H_LPS_BMDC_DN,1
YAGI_AML_FAB_MARKERS,SET,179,-0.031691,-0.0031124,0.065113,0.68677,YAGI_AML_FAB_MARKERS,1
HARRIS_BRAIN_CANCER_PROGENIT...,SET,37,-0.071435,-0.003202,0.14675,0.68679,HARRIS_BRAIN_CANCER_PROGENITORS,1
GOMF_PRE_MRNA_INTRONIC_BINDI...,SET,13,-0.10409,-0.0027673,0.21379,0.68682,GOMF_PRE_MRNA_INTRONIC_BINDING,1
REACTOME_ACYL_CHAIN_REMODELI...2,SET,5,-0.1983,-0.0032704,0.40722,0.68686,REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG,1
GOBP_ACID_SECRETION,SET,43,-0.066274,-0.003202,0.13607,0.68688,GOBP_ACID_SECRETION,1
HP_DELAYED_SOMATOSENSORY_CEN...,SET,3,-0.25311,-0.0032335,0.5197,0.68688,HP_DELAYED_SOMATOSENSORY_CENTRAL_CONDUCTION_TIME,1
GOBP_ALPHA_AMINO_ACID_METABO...,SET,194,-0.030282,-0.0030947,0.06217,0.68689,GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS,1
DESCARTES_MAIN_FETAL_URETERI...,SET,27,-0.083932,-0.0032147,0.17233,0.68689,DESCARTES_MAIN_FETAL_URETERIC_BUD_CELLS,1
GOBP_MATURE_CONVENTIONAL_DEN...,SET,5,-0.22031,-0.0036334,0.45208,0.68698,GOBP_MATURE_CONVENTIONAL_DENDRITIC_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_REFERENCE_KEAP1...,SET,20,-0.11705,-0.0038593,0.24017,0.687,KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY,1
REACTOME_ACTIVATION_OF_AMPK_...,SET,26,-0.086002,-0.0032325,0.17644,0.68702,REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS,1
ZAMORA_NOS2_TARGETS_DN,SET,76,-0.048424,-0.0031075,0.099339,0.68703,ZAMORA_NOS2_TARGETS_DN,1
MALIK_REPRESSED_BY_ESTROGEN,SET,13,-0.12474,-0.0033163,0.25585,0.68706,MALIK_REPRESSED_BY_ESTROGEN,1
GOCC_MYELIN_SHEATH_ABAXONAL_...,SET,6,-0.16005,-0.0028915,0.32825,0.68708,GOCC_MYELIN_SHEATH_ABAXONAL_REGION,1
MCBRYAN_TERMINAL_END_BUD_UP,SET,12,-0.12885,-0.0032914,0.26419,0.68712,MCBRYAN_TERMINAL_END_BUD_UP,1
GOBP_ACETYL_COA_BIOSYNTHETIC...1,SET,15,-0.10155,-0.0029,0.20819,0.68715,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS,1
GOMF_CHLORIDE_ION_BINDING,SET,9,-0.15667,-0.0034662,0.32108,0.68721,GOMF_CHLORIDE_ION_BINDING,1
HP_ABNORMALITY_OF_T_CELL_PHY...,SET,50,-0.061198,-0.0031877,0.12542,0.68721,HP_ABNORMALITY_OF_T_CELL_PHYSIOLOGY,1
GOBP_ACROSOME_ASSEMBLY,SET,25,-0.080396,-0.0029632,0.16471,0.68726,GOBP_ACROSOME_ASSEMBLY,1
GOCC_HIPPOCAMPAL_MOSSY_FIBER,SET,6,-0.15468,-0.0027944,0.31676,0.68733,GOCC_HIPPOCAMPAL_MOSSY_FIBER,1
GOBP_STEM_CELL_FATE_COMMITME...,SET,10,-0.15795,-0.0036835,0.32343,0.68735,GOBP_STEM_CELL_FATE_COMMITMENT,1
GOBP_D_ASPARTATE_TRANSMEMBRA...,SET,5,-0.19174,-0.0031622,0.3926,0.68736,GOBP_D_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
MIR6755_3P,SET,72,-0.051337,-0.0032069,0.10508,0.68741,MIR6755_3P,1
AMIT_SERUM_RESPONSE_480_MCF1...,SET,32,-0.071309,-0.002973,0.14593,0.68745,AMIT_SERUM_RESPONSE_480_MCF10A,1
PID_PRL_SIGNALING_EVENTS_PAT...,SET,23,-0.089399,-0.0031606,0.18293,0.68747,PID_PRL_SIGNALING_EVENTS_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...42,SET,5,-0.15455,-0.0025489,0.3162,0.6875,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,1
GOMF_CCR1_CHEMOKINE_RECEPTOR...,SET,5,-0.19934,-0.0032875,0.40769,0.68756,GOMF_CCR1_CHEMOKINE_RECEPTOR_BINDING,1
PRC2_EZH2_UP.V1_UP,SET,171,-0.034579,-0.0033199,0.070707,0.68759,PRC2_EZH2_UP.V1_UP,1
HP_FLUSHING,SET,45,-0.060296,-0.00298,0.12326,0.68764,HP_FLUSHING,1
GSE42021_CD24INT_VS_CD24LOW_...1,SET,175,-0.03281,-0.0031864,0.067064,0.68766,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN,1
GSE411_UNSTIM_VS_100MIN_IL6_...4,SET,177,-0.030183,-0.0029478,0.06169,0.68767,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,1
MORF_FBL,SET,125,-0.034327,-0.0028214,0.070158,0.68768,MORF_FBL,1
TERAMOTO_OPN_TARGETS_CLUSTER...1,SET,13,-0.11359,-0.0030201,0.23215,0.68769,TERAMOTO_OPN_TARGETS_CLUSTER_1,1
REACTOME_SUMO_IS_CONJUGATED_...,SET,5,-0.17431,-0.0028747,0.35621,0.68769,REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1,1
HP_APLASIA_HYPOPLASIA_AFFECT...3,SET,418,-0.020769,-0.0030964,0.042443,0.6877,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_EYE,1
GSE8921_UNSTIM_VS_TLR1_2_STI...4,SET,178,-0.032564,-0.0031892,0.066526,0.68775,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP,1
HP_ENLARGEMENT_OF_THE_WRISTS,SET,6,-0.18663,-0.0033717,0.38124,0.68777,HP_ENLARGEMENT_OF_THE_WRISTS,1
GOBP_NEGATIVE_REGULATION_OF_...488,SET,5,-0.19935,-0.0032878,0.40715,0.6878,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...304,SET,3,-0.26926,-0.0034399,0.54977,0.68785,GOBP_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT,1
HP_PROMINENT_NASAL_BRIDGE,SET,202,-0.027959,-0.0029151,0.057085,0.68785,HP_PROMINENT_NASAL_BRIDGE,1
MODULE_114,SET,290,-0.023735,-0.002958,0.04845,0.68789,MODULE_114,1
HP_ARACHNODACTYLY,SET,109,-0.040216,-0.003088,0.082092,0.68789,HP_ARACHNODACTYLY,1
chr15q26,SET,67,-0.10045,-0.0060542,0.20494,0.68799,chr15q26,1
MIR4711_3P,SET,73,-0.051645,-0.0032485,0.10534,0.68802,MIR4711_3P,1
MEBARKI_HCC_PROGENITOR_WNT_D...4,SET,13,-0.12309,-0.0032727,0.25102,0.68806,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT,1
HP_ERYTHEMATOUS_PLAQUE,SET,13,-0.10532,-0.0028001,0.21476,0.68807,HP_ERYTHEMATOUS_PLAQUE,1
HP_SHORT_COLUMELLA,SET,24,-0.085595,-0.0030912,0.17454,0.68808,HP_SHORT_COLUMELLA,1
GOBP_TRANSMEMBRANE_TRANSPORT,SET,1410,-0.01206,-0.0032097,0.024587,0.6881,GOBP_TRANSMEMBRANE_TRANSPORT,1
HP_DECREASED_CIRCULATING_CAR...,SET,22,-0.082624,-0.002857,0.16844,0.68812,HP_DECREASED_CIRCULATING_CARNITINE_CONCENTRATION,1
GOBP_REGULATION_OF_CYTOPLASM...4,SET,7,-0.13194,-0.0025745,0.26868,0.68831,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
GOCC_PALMITOYLTRANSFERASE_CO...,SET,10,-0.13188,-0.0030754,0.26852,0.68833,GOCC_PALMITOYLTRANSFERASE_COMPLEX,1
GSE29164_UNTREATED_VS_CD8_TC...4,SET,172,-0.030567,-0.0029433,0.06224,0.68833,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,1
MIR602,SET,7,-0.13792,-0.0026912,0.28081,0.68834,MIR602,1
GSE9988_ANTI_TREM1_AND_LPS_V...2,SET,165,-0.035034,-0.0033046,0.07133,0.68834,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP,1
GOMF_POLYPEPTIDE_N_ACETYLGAL...,SET,17,-0.11799,-0.003587,0.24019,0.68837,GOMF_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
WP_HORMONAL_CONTROL_OF_PUBER...,SET,5,-0.21087,-0.0034777,0.42912,0.68842,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1
KEGG_NON_SMALL_CELL_LUNG_CAN...,SET,53,-0.057198,-0.0030672,0.11637,0.68846,KEGG_NON_SMALL_CELL_LUNG_CANCER,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...8,SET,5,-0.17167,-0.0028311,0.34927,0.68846,GOMF_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_ENDOPEPTIDASE_ACTIVITY,1
GOCC_SPERM_MIDPIECE,SET,50,-0.063087,-0.0032861,0.12832,0.68851,GOCC_SPERM_MIDPIECE,1
DESCARTES_FETAL_HEART_ERYTHR...,SET,242,-0.025163,-0.0028685,0.051174,0.68854,DESCARTES_FETAL_HEART_ERYTHROBLASTS,1
GSE1791_CTRL_VS_NEUROMEDINU_...3,SET,141,-0.037652,-0.0032853,0.076568,0.68855,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN,1
GOMF_OLIGOSACCHARIDE_BINDING,SET,17,-0.11557,-0.0035134,0.23495,0.6886,GOMF_OLIGOSACCHARIDE_BINDING,1
MIR4712_5P,SET,92,-0.045471,-0.0032092,0.092437,0.68861,MIR4712_5P,1
GSE25123_CTRL_VS_IL4_STIM_PP...1,SET,175,-0.03303,-0.0032077,0.067144,0.68861,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN,1
GCM_SUFU,SET,70,-0.046453,-0.0028614,0.094419,0.68863,GCM_SUFU,1
GSE41867_MEMORY_VS_EXHAUSTED...1,SET,180,-0.030615,-0.003015,0.062228,0.68863,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN,1
REACTOME_DEFECTS_OF_PLATELET...,SET,8,-0.15554,-0.0032444,0.31611,0.68865,REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,1
GOBP_INTRACELLULAR_PHOSPHATE...,SET,9,-0.16639,-0.0036812,0.33814,0.68866,GOBP_INTRACELLULAR_PHOSPHATE_ION_HOMEOSTASIS,1
WP_15Q11Q13_COPY_NUMBER_VARI...,SET,48,-0.062037,-0.0031663,0.12607,0.68867,WP_15Q11Q13_COPY_NUMBER_VARIATION,1
GOCC_JUXTAPARANODE_REGION_OF...,SET,12,-0.13029,-0.0033283,0.26476,0.68868,GOCC_JUXTAPARANODE_REGION_OF_AXON,1
RIZKI_TUMOR_INVASIVENESS_2D_...2,SET,60,-0.053441,-0.0030486,0.10855,0.68875,RIZKI_TUMOR_INVASIVENESS_2D_UP,1
GOBP_NEGATIVE_REGULATION_OF_...182,SET,28,-0.080916,-0.003156,0.16431,0.6888,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING,1
DESCARTES_FETAL_ADRENAL_LYMP...,SET,131,-0.040244,-0.0033856,0.081713,0.68881,DESCARTES_FETAL_ADRENAL_LYMPHOID_CELLS,1
MODULE_118,SET,368,-0.022806,-0.0031948,0.046289,0.68888,MODULE_118,1
GSE22886_IGG_IGA_MEMORY_BCEL...4,SET,179,-0.031546,-0.0030981,0.063981,0.68901,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,1
WANG_TARGETS_OF_MLL_CBP_FUSI...2,SET,43,-0.063557,-0.0030707,0.1289,0.68902,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,1
HP_IMPAIRED_VIBRATION_SENSAT...2,SET,46,-0.058993,-0.0029477,0.11963,0.68904,HP_IMPAIRED_VIBRATION_SENSATION_IN_THE_LOWER_LIMBS,1
GOBP_REGULATION_OF_CELL_PROL...1,SET,15,-0.12184,-0.0034795,0.24702,0.68908,GOBP_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...52,SET,31,-0.074169,-0.0030436,0.15032,0.68913,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION,1
GOBP_POSITIVE_REGULATION_OF_...430,SET,25,-0.091809,-0.0033838,0.18607,0.68914,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,1
GOBP_RETROGRADE_NEURONAL_DEN...,SET,4,-0.21311,-0.0031437,0.4319,0.68914,GOBP_RETROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,1
HP_APLASIA_HYPOPLASIA_OF_THE...66,SET,178,-0.03171,-0.0031056,0.064264,0.68914,HP_APLASIA_HYPOPLASIA_OF_THE_SKIN,1
GSE27092_WT_VS_HDAC7_PHOSPHO...1,SET,186,-0.029685,-0.0029712,0.060163,0.68914,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN,1
MIR6814_5P,SET,100,-0.041998,-0.0030896,0.085083,0.68921,MIR6814_5P,1
PID_IL8_CXCR1_PATHWAY,SET,27,-0.084011,-0.0032177,0.17018,0.68922,PID_IL8_CXCR1_PATHWAY,1
GOBP_TRYPTOPHAN_TRANSPORT,SET,5,-0.18806,-0.0031015,0.38096,0.68922,GOBP_TRYPTOPHAN_TRANSPORT,1
SINGH_KRAS_DEPENDENCY_SIGNAT...,SET,19,-0.10201,-0.0032782,0.20663,0.68922,SINGH_KRAS_DEPENDENCY_SIGNATURE,1
GOBP_ERBB4_ERBB4_SIGNALING_P...,SET,6,-0.16881,-0.0030497,0.34188,0.68926,GOBP_ERBB4_ERBB4_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_MITOCHOND...14,SET,6,-0.15037,-0.0027166,0.30454,0.68926,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSCRIPTION,1
GOCC_SERINE_TYPE_ENDOPEPTIDA...,SET,11,-0.15264,-0.0037332,0.30907,0.6893,GOCC_SERINE_TYPE_ENDOPEPTIDASE_COMPLEX,1
GOCC_SYMMETRIC_SYNAPSE,SET,7,-0.16466,-0.0032129,0.33335,0.68932,GOCC_SYMMETRIC_SYNAPSE,1
RORIE_TARGETS_OF_EWSR1_FLI1_...2,SET,24,-0.10186,-0.0036785,0.20621,0.68933,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1
GSE14308_TH2_VS_TH1_UP,SET,174,-0.031639,-0.0030639,0.064033,0.68938,GSE14308_TH2_VS_TH1_UP,1
GOBP_NEGATIVE_REGULATION_OF_...262,SET,8,-0.18253,-0.0038074,0.36924,0.68946,GOBP_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION,1
GSE28737_WT_VS_BCL6_KO_MARGI...2,SET,178,-0.031271,-0.0030626,0.063256,0.68947,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,1
HP_ANGULATED_MUSCLE_FIBERS,SET,5,-0.18471,-0.0030463,0.37355,0.68951,HP_ANGULATED_MUSCLE_FIBERS,1
GOBP_LUNG_CELL_DIFFERENTIATI...,SET,29,-0.083352,-0.0033084,0.16852,0.68956,GOBP_LUNG_CELL_DIFFERENTIATION,1
GSE23114_WT_VS_SLE2C1_MOUSE_...2,SET,169,-0.031945,-0.0030493,0.064582,0.68957,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP,1
CHAUHAN_RESPONSE_TO_METHOXYE...1,SET,83,-0.046791,-0.0031374,0.094592,0.68958,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,1
GOMF_PHOSPHOLIPASE_C_ACTIVITY,SET,29,-0.079702,-0.0031636,0.16111,0.6896,GOMF_PHOSPHOLIPASE_C_ACTIVITY,1
HP_FAIR_HAIR,SET,17,-0.10557,-0.0032092,0.21338,0.6896,HP_FAIR_HAIR,1
GOMF_CALCIUM_CHANNEL_INHIBIT...,SET,12,-0.12787,-0.0032663,0.25845,0.68961,GOMF_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY,1
DARWICHE_PAPILLOMA_RISK_HIGH...2,SET,137,-0.037223,-0.0032018,0.075222,0.68964,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1
GOBP_AXONEME_ASSEMBLY,SET,70,-0.048094,-0.0029625,0.097193,0.68964,GOBP_AXONEME_ASSEMBLY,1
GOMF_PROTON_CHANNEL_ACTIVITY,SET,9,-0.12621,-0.0027922,0.25502,0.68965,GOMF_PROTON_CHANNEL_ACTIVITY,1
GOBP_FATTY_ACID_ELONGATION_S...,SET,8,-0.1742,-0.0036338,0.35198,0.68967,GOBP_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID,1
HP_PANCREATIC_ENDOCRINE_TUMOR,SET,13,-0.128,-0.0034031,0.2586,0.68969,HP_PANCREATIC_ENDOCRINE_TUMOR,1
MIR10B_3P,SET,72,-0.049234,-0.0030756,0.09945,0.68972,MIR10B_3P,1
ANDERSEN_CHOLANGIOCARCINOMA_...2,SET,172,-0.034492,-0.0033212,0.069667,0.68973,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,1
GOBP_URETERIC_BUD_ELONGATION,SET,7,-0.14354,-0.0028008,0.28986,0.68976,GOBP_URETERIC_BUD_ELONGATION,1
LHX9_TARGET_GENES,SET,1165,-0.013007,-0.0031694,0.026257,0.68983,LHX9_TARGET_GENES,1
WP_ERBB_SIGNALING,SET,86,-0.04734,-0.0032308,0.095536,0.68988,WP_ERBB_SIGNALING,1
HP_ABNORMAL_ATRIOVENTRICULAR...1,SET,87,-0.047337,-0.0032492,0.095513,0.68991,HP_ABNORMAL_ATRIOVENTRICULAR_CONDUCTION,1
GNF2_MBD4,SET,22,-0.084528,-0.0029228,0.17054,0.68993,GNF2_MBD4,1
GSE27241_WT_CTRL_VS_DIGOXIN_...2,SET,161,-0.034346,-0.0032006,0.069279,0.68997,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...457,SET,7,-0.16223,-0.0031656,0.32717,0.69,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
GOBP_REGULATION_OF_RECEPTOR_...2,SET,11,-0.12796,-0.0031296,0.25804,0.69001,GOBP_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,1
MIR5684,SET,35,-0.07364,-0.0032106,0.14848,0.69004,MIR5684,1
YAMASHITA_LIVER_CANCER_STEM_...1,SET,70,-0.055079,-0.0033928,0.11104,0.69006,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,1
GOBP_METANEPHRIC_NEPHRON_DEV...,SET,40,-0.077525,-0.0036129,0.15625,0.6901,GOBP_METANEPHRIC_NEPHRON_DEVELOPMENT,1
WP_ZINC_HOMEOSTASIS,SET,36,-0.067676,-0.0029923,0.13638,0.69013,WP_ZINC_HOMEOSTASIS,1
HP_ABNORMAL_RIB_CAGE_MORPHOL...,SET,339,-0.023375,-0.0031453,0.047085,0.69021,HP_ABNORMAL_RIB_CAGE_MORPHOLOGY,1
FUJII_YBX1_TARGETS_UP,SET,36,-0.071208,-0.0031485,0.14336,0.6903,FUJII_YBX1_TARGETS_UP,1
HP_FUNCTIONAL_MOTOR_DEFICIT,SET,450,-0.019695,-0.0030439,0.039648,0.69031,HP_FUNCTIONAL_MOTOR_DEFICIT,1
GOBP_LENS_FIBER_CELL_DIFFERE...,SET,34,-0.079305,-0.0034079,0.15962,0.69034,GOBP_LENS_FIBER_CELL_DIFFERENTIATION,1
GSE360_CTRL_VS_B_MALAYI_HIGH...3,SET,189,-0.030215,-0.0030483,0.060808,0.69036,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
REACTOME_INTRAFLAGELLAR_TRAN...,SET,44,-0.066664,-0.003258,0.13416,0.69037,REACTOME_INTRAFLAGELLAR_TRANSPORT,1
HP_SANDAL_GAP,SET,87,-0.046785,-0.0032113,0.094143,0.69039,HP_SANDAL_GAP,1
KEGG_MEDICUS_VARIANT_AML1_ET...,SET,5,-0.16731,-0.0027593,0.33663,0.69041,KEGG_MEDICUS_VARIANT_AML1_ETO_FUSION_TO_PU.1_MEDIATED_TRANSCRIPTION,1
GSE3982_EOSINOPHIL_VS_NEUTRO...1,SET,170,-0.032604,-0.0031212,0.065599,0.69041,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN,1
MIR4477A,SET,329,-0.023444,-0.0031085,0.047155,0.69046,MIR4477A,1
GOCC_PAR_POLARITY_COMPLEX,SET,6,-0.19121,-0.0034543,0.38457,0.69047,GOCC_PAR_POLARITY_COMPLEX,1
GSE5099_DAY3_VS_DAY7_MCSF_TR...2,SET,169,-0.032329,-0.0030859,0.065011,0.6905,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP,1
MENON_FETAL_KIDNEY_4_PODOCYT...,SET,182,-0.032504,-0.0032185,0.065359,0.69051,MENON_FETAL_KIDNEY_4_PODOCYTES,1
GSE39152_SPLEEN_CD103_NEG_VS...2,SET,187,-0.030581,-0.0030691,0.061475,0.69057,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP,1
GOBP_REGULATION_OF_LYMPHOCYT...3,SET,25,-0.090531,-0.0033367,0.18197,0.69058,GOBP_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,1
WP_MITOCHONDRIAL_FATTY_ACID_...3,SET,5,-0.1834,-0.0030247,0.36862,0.69059,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...635,SET,98,-0.042497,-0.003095,0.085404,0.69061,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
GSE41176_WT_VS_TAK1_KO_ANTI_...3,SET,170,-0.032954,-0.0031548,0.066204,0.69067,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN,1
GOBP_APOPTOTIC_DNA_FRAGMENTA...,SET,18,-0.10084,-0.0031543,0.20258,0.69068,GOBP_APOPTOTIC_DNA_FRAGMENTATION,1
GSE21379_WT_VS_SAP_KO_TFH_CD...1,SET,179,-0.032138,-0.0031563,0.064563,0.69068,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN,1
GOMF_TRANSMEMBRANE_RECEPTOR_...6,SET,62,-0.059885,-0.0034724,0.12025,0.69076,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
BLUM_RESPONSE_TO_SALIRASIB_DN,SET,308,-0.023538,-0.0030215,0.047261,0.69077,BLUM_RESPONSE_TO_SALIRASIB_DN,1
ZHONG_PFC_C9_ORG_OTHER,SET,71,-0.056436,-0.003501,0.11331,0.69078,ZHONG_PFC_C9_ORG_OTHER,1
DESCARTES_MAIN_FETAL_MUC13_D...,SET,48,-0.062631,-0.0031966,0.12573,0.6908,DESCARTES_MAIN_FETAL_MUC13_DMBT1_POSITIVE_CELLS,1
GRUETZMANN_PANCREATIC_CANCER...2,SET,331,-0.023948,-0.0031849,0.048075,0.69081,GRUETZMANN_PANCREATIC_CANCER_UP,1
KEGG_MEDICUS_REFERENCE_COHES...2,SET,15,-0.10824,-0.0030909,0.21723,0.69085,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE,1
DING_LUNG_CANCER_MUTATED_FRE...,SET,12,-0.11351,-0.0028995,0.22775,0.69089,DING_LUNG_CANCER_MUTATED_FREQUENTLY,1
DLX2_TARGET_GENES,SET,217,-0.029984,-0.0032389,0.06016,0.6909,DLX2_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...129,SET,5,-0.20739,-0.0034203,0.41599,0.69095,GOBP_NEGATIVE_REGULATION_OF_CELL_VOLUME,1
GOBP_REGULATION_OF_EXTRINSIC...2,SET,43,-0.066974,-0.0032358,0.13432,0.69097,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,1
REACTOME_TNFR1_INDUCED_NF_KA...,SET,27,-0.081098,-0.0031062,0.16259,0.69103,REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...44,SET,4,-0.17911,-0.0026421,0.35901,0.69107,GOBP_NEGATIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
GSE2770_IL12_ACT_VS_ACT_CD4_...1,SET,181,-0.030587,-0.0030205,0.061297,0.69111,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN,1
KEGG_MEDICUS_REFERENCE_CD80_...2,SET,21,-0.089219,-0.0030142,0.17871,0.69119,KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY,1
HP_FETAL_ANOMALY,SET,490,-0.019586,-0.0031551,0.03921,0.69129,HP_FETAL_ANOMALY,1
GOBP_SULFUR_AMINO_ACID_TRANS...,SET,12,-0.12659,-0.0032336,0.2534,0.6913,GOBP_SULFUR_AMINO_ACID_TRANSPORT,1
HP_CYSTIC_HYGROMA,SET,50,-0.058351,-0.0030394,0.11681,0.6913,HP_CYSTIC_HYGROMA,1
GARGALOVIC_RESPONSE_TO_OXIDI...7,SET,21,-0.090459,-0.0030561,0.18107,0.69131,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,1
GSE360_CTRL_VS_M_TUBERCULOSI...3,SET,177,-0.031569,-0.0030831,0.06319,0.69131,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN,1
GSE9988_LOW_LPS_VS_VEHICLE_T...2,SET,164,-0.036527,-0.0034351,0.073102,0.69134,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,1
GOBP_REGULATION_OF_SYSTEMIC_...4,SET,33,-0.081871,-0.0034662,0.16385,0.69135,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE,1
HP_ABNORMAL_MUSCLE_FIBER_MER...,SET,4,-0.20299,-0.0029945,0.4062,0.69137,HP_ABNORMAL_MUSCLE_FIBER_MEROSIN_EXPRESSION,1
GOBP_SEQUESTERING_OF_CALCIUM...,SET,126,-0.039844,-0.0032878,0.079717,0.69139,GOBP_SEQUESTERING_OF_CALCIUM_ION,1
GOBP_DOPAMINE_RECEPTOR_SIGNA...,SET,37,-0.074995,-0.0033616,0.15004,0.6914,GOBP_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
DARWICHE_SKIN_TUMOR_PROMOTER...2,SET,128,-0.03831,-0.003186,0.076632,0.69143,DARWICHE_SKIN_TUMOR_PROMOTER_UP,1
HOLLEMAN_ASPARAGINASE_RESIST...1,SET,22,-0.080644,-0.0027885,0.1613,0.69145,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,1
MIR6858_3P,SET,41,-0.070291,-0.0033163,0.14057,0.69147,MIR6858_3P,1
HP_DECREASED_SERUM_INSULIN_L...,SET,21,-0.092465,-0.0031238,0.18487,0.69151,HP_DECREASED_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1,1
HNF3B_01,SET,196,-0.032607,-0.0033494,0.065182,0.69155,HNF3B_01,1
WP_IL2_SIGNALING,SET,41,-0.071465,-0.0033717,0.14285,0.69156,WP_IL2_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...81,SET,13,-0.13025,-0.0034629,0.26029,0.69159,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
PILON_KLF1_TARGETS_UP,SET,439,-0.021117,-0.0032245,0.0422,0.6916,PILON_KLF1_TARGETS_UP,1
MIF1_01,SET,163,-0.033739,-0.0031634,0.067425,0.6916,MIF1_01,1
KEGG_MEDICUS_REFERENCE_ACH_C...1,SET,7,-0.1556,-0.0030362,0.31092,0.69162,KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY,1
GOBP_L_ASCORBIC_ACID_METABOL...,SET,9,-0.1456,-0.0032212,0.29092,0.69162,GOBP_L_ASCORBIC_ACID_METABOLIC_PROCESS,1
HP_TRANSIENT_ISCHEMIC_ATTACK,SET,53,-0.061294,-0.0032868,0.12247,0.69163,HP_TRANSIENT_ISCHEMIC_ATTACK,1
GOBP_POSITIVE_REGULATION_OF_...490,SET,32,-0.079625,-0.0033197,0.15909,0.69164,GOBP_POSITIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
MIR4633_3P_MIR6500_5P,SET,32,-0.074356,-0.0031,0.14855,0.69166,MIR4633_3P_MIR6500_5P,1
GOBP_NEGATIVE_REGULATION_OF_...683,SET,16,-0.11532,-0.0034011,0.2303,0.69172,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...281,SET,5,-0.20641,-0.0034042,0.41218,0.69173,GOBP_POSITIVE_REGULATION_OF_FERTILIZATION,1
GOMF_EXTRACELLULAR_MATRIX_ST...1,SET,152,-0.037247,-0.0033733,0.074372,0.69175,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT,1
GSE21033_3H_VS_12H_POLYIC_ST...2,SET,149,-0.034553,-0.0030986,0.068986,0.69177,GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP,1
HP_DECREASED_FERTILITY,SET,312,-0.023924,-0.0030906,0.04776,0.69178,HP_DECREASED_FERTILITY,1
HP_LARGE_FLESHY_EARS,SET,13,-0.12712,-0.0033798,0.25378,0.69179,HP_LARGE_FLESHY_EARS,1
SCHLINGEMANN_SKIN_CARCINOGEN...2,SET,36,-0.075764,-0.0033499,0.15123,0.69181,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,1
TTGGGAG_MIR150,SET,82,-0.045961,-0.0030632,0.09174,0.69181,TTGGGAG_MIR150,1
GOMF_HISTONE_H3K4_DEMETHYLAS...,SET,4,-0.20505,-0.0030248,0.40929,0.69181,GOMF_HISTONE_H3K4_DEMETHYLASE_ACTIVITY,1
HP_FETAL_ONSET,SET,170,-0.031963,-0.0030599,0.06379,0.69183,HP_FETAL_ONSET,1
GSE22886_NAIVE_CD4_TCELL_VS_...13,SET,189,-0.033114,-0.0033408,0.066088,0.69183,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN,1
GSE24726_WT_VS_E2_2_KO_PDC_DN,SET,181,-0.031123,-0.0030735,0.062115,0.69183,GSE24726_WT_VS_E2_2_KO_PDC_DN,1
DESCARTES_FETAL_CEREBRUM_INH...,SET,32,-0.090775,-0.0037845,0.18115,0.69185,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,1
GOBP_PROTEIN_DELIPIDATION,SET,4,-0.19007,-0.0028038,0.37905,0.69196,GOBP_PROTEIN_DELIPIDATION,1
MIR542_3P,SET,125,-0.039262,-0.003227,0.078256,0.69206,MIR542_3P,1
HP_PERIORBITAL_ECCHYMOSIS_WI...,SET,7,-0.19616,-0.0038276,0.39096,0.69207,HP_PERIORBITAL_ECCHYMOSIS_WITH_TARSAL_PLATE_SPARING,1
GOBP_MRNA_3_SPLICE_SITE_RECO...,SET,6,-0.17167,-0.0031013,0.34213,0.69208,GOBP_MRNA_3_SPLICE_SITE_RECOGNITION,1
KEGG_CITRATE_CYCLE_TCA_CYCLE,SET,27,-0.075125,-0.0028774,0.1497,0.69211,KEGG_CITRATE_CYCLE_TCA_CYCLE,1
MIR1227_3P,SET,67,-0.052868,-0.0031863,0.10534,0.69212,MIR1227_3P,1
REACTOME_ACETYLCHOLINE_REGUL...,SET,10,-0.14862,-0.0034659,0.29609,0.69215,REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION,1
DEN_INTERACT_WITH_LCA5,SET,24,-0.09646,-0.0034835,0.19214,0.69217,DEN_INTERACT_WITH_LCA5,1
GOBP_STEROID_HORMONE_BIOSYNT...,SET,43,-0.06819,-0.0032946,0.1358,0.69222,GOBP_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,1
TRAVAGLINI_LUNG_PERICYTE_CELL,SET,110,-0.045951,-0.0035444,0.091475,0.69228,TRAVAGLINI_LUNG_PERICYTE_CELL,1
GOBP_ANTERIOR_HEAD_DEVELOPME...,SET,7,-0.17798,-0.0034728,0.35425,0.6923,GOBP_ANTERIOR_HEAD_DEVELOPMENT,1
HP_PARTIAL_ALBINISM,SET,9,-0.15877,-0.0035126,0.31586,0.69239,HP_PARTIAL_ALBINISM,1
GOBP_CHORIONIC_TROPHOBLAST_C...1,SET,7,-0.19738,-0.0038514,0.39256,0.69244,GOBP_CHORIONIC_TROPHOBLAST_CELL_DIFFERENTIATION,1
HP_SKELETAL_MYOPATHY,SET,9,-0.12735,-0.0028175,0.25324,0.69247,HP_SKELETAL_MYOPATHY,1
REACTOME_HOST_INTERACTIONS_O...,SET,121,-0.03622,-0.0029293,0.072009,0.69251,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,1
GOMF_UBIQUINONE_BINDING,SET,5,-0.15405,-0.0025407,0.30621,0.69255,GOMF_UBIQUINONE_BINDING,1
GOBP_INTRACELLULAR_IRON_ION_...,SET,60,-0.055198,-0.0031488,0.10971,0.69256,GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS,1
WP_DDX1_AS_A_REGULATORY_COMP...,SET,6,-0.15777,-0.0028502,0.31356,0.69257,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...9,SET,65,-0.047481,-0.0028188,0.094367,0.69257,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE,1
HP_HAND_POLYDACTYLY,SET,149,-0.034375,-0.0030826,0.068313,0.69259,HP_HAND_POLYDACTYLY,1
DESCARTES_FETAL_PLACENTA_LYM...,SET,114,-0.043425,-0.0034095,0.086271,0.69264,DESCARTES_FETAL_PLACENTA_LYMPHOID_CELLS,1
MIR668_3P,SET,54,-0.057431,-0.0031085,0.11406,0.6927,MIR668_3P,1
GOBP_DNA_METABOLIC_PROCESS,SET,870,-0.014321,-0.0030413,0.028441,0.69271,GOBP_DNA_METABOLIC_PROCESS,1
GOBP_SULFUR_COMPOUND_TRANSPO...,SET,60,-0.057613,-0.0032866,0.1144,0.69272,GOBP_SULFUR_COMPOUND_TRANSPORT,1
HP_MUSCLE_FIBER_SPLITTING,SET,19,-0.087593,-0.002815,0.17393,0.69273,HP_MUSCLE_FIBER_SPLITTING,1
GOBP_RESPONSE_TO_TYPE_I_INTE...,SET,79,-0.052405,-0.0034285,0.10404,0.69276,GOBP_RESPONSE_TO_TYPE_I_INTERFERON,1
HP_ROUND_FACE,SET,95,-0.043111,-0.0030916,0.085584,0.69277,HP_ROUND_FACE,1
TAGCTTT_MIR9,SET,210,-0.029994,-0.0031878,0.05954,0.69278,TAGCTTT_MIR9,1
IBRAHIM_NRF2_UP,SET,476,-0.019449,-0.0030892,0.038604,0.6928,IBRAHIM_NRF2_UP,1
REACTOME_MATURATION_OF_TCA_E...,SET,19,-0.089756,-0.0028845,0.17815,0.69281,REACTOME_MATURATION_OF_TCA_ENZYMES_AND_REGULATION_OF_TCA_CYCLE,1
GOBP_REGULATION_OF_SYSTEMIC_...8,SET,40,-0.076234,-0.0035527,0.15128,0.69284,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL,1
MODULE_136,SET,448,-0.020096,-0.0030992,0.039876,0.69285,MODULE_136,1
GOBP_OLEFINIC_COMPOUND_METAB...,SET,154,-0.03757,-0.0034247,0.074532,0.69289,GOBP_OLEFINIC_COMPOUND_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_CELL_CELL...1,SET,460,-0.021561,-0.0033682,0.042774,0.69289,GOBP_REGULATION_OF_CELL_CELL_ADHESION,1
ATAAGCT_MIR21,SET,111,-0.040748,-0.0031572,0.080833,0.6929,ATAAGCT_MIR21,1
HP_DECREASED_BODY_WEIGHT,SET,1375,-0.012091,-0.0031811,0.023982,0.69293,HP_DECREASED_BODY_WEIGHT,1
GOMF_DNA_POLYMERASE_ACTIVITY,SET,27,-0.066476,-0.0025461,0.13184,0.69294,GOMF_DNA_POLYMERASE_ACTIVITY,1
REACTOME_TRANSCRIPTIONAL_ACT...2,SET,48,-0.057406,-0.00293,0.11381,0.69302,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1
HP_ABNORMALITY_OF_THE_NECK,SET,611,-0.01749,-0.0031356,0.034672,0.69302,HP_ABNORMALITY_OF_THE_NECK,1
HP_ENLARGED_CEREBELLUM,SET,6,-0.17937,-0.0032404,0.35547,0.69307,HP_ENLARGED_CEREBELLUM,1
HP_QUADRICEPS_MUSCLE_ATROPHY,SET,3,-0.27736,-0.0035434,0.54958,0.6931,HP_QUADRICEPS_MUSCLE_ATROPHY,1
GSE17721_CTRL_VS_POLYIC_4H_B...2,SET,183,-0.030777,-0.0030558,0.060963,0.69316,GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP,1
HP_ABNORMAL_LARYNX_MORPHOLOGY,SET,130,-0.037867,-0.0031735,0.075004,0.69317,HP_ABNORMAL_LARYNX_MORPHOLOGY,1
HP_HYPERSPLENISM,SET,20,-0.10244,-0.0033776,0.20283,0.69324,HP_HYPERSPLENISM,1
HP_MACULAR_HYPOPLASIA,SET,13,-0.13076,-0.0034764,0.25884,0.69327,HP_MACULAR_HYPOPLASIA,1
MIR3124_3P,SET,204,-0.030363,-0.0031811,0.060092,0.69331,MIR3124_3P,1
GSE3039_CD4_TCELL_VS_B2_BCEL...2,SET,183,-0.032676,-0.0032444,0.064664,0.69333,GSE3039_CD4_TCELL_VS_B2_BCELL_UP,1
CHNG_MULTIPLE_MYELOMA_HYPERP...2,SET,50,-0.057287,-0.002984,0.11335,0.69336,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,1
HP_MICRORETROGNATHIA,SET,71,-0.050813,-0.0031522,0.10053,0.69338,HP_MICRORETROGNATHIA,1
GSE13887_ACT_CD4_VS_NO_TREAT...2,SET,116,-0.041074,-0.0032529,0.081256,0.69339,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP,1
GSE17721_LPS_VS_GARDIQUIMOD_...1,SET,185,-0.031313,-0.0031258,0.061946,0.69339,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
MIR338_3P,SET,132,-0.039282,-0.0033172,0.077683,0.69345,MIR338_3P,1
GOBP_POSITIVE_REGULATION_OF_...260,SET,9,-0.11731,-0.0025954,0.232,0.69345,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,1
GOBP_AXONAL_TRANSPORT,SET,62,-0.055826,-0.003237,0.11035,0.69353,GOBP_AXONAL_TRANSPORT,1
GOCC_SORTING_ENDOSOME,SET,6,-0.20328,-0.0036724,0.4018,0.69354,GOCC_SORTING_ENDOSOME,1
GSE6269_HEALTHY_VS_FLU_INF_P...2,SET,153,-0.033876,-0.003078,0.066947,0.69357,GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...233,SET,7,-0.15801,-0.0030832,0.31216,0.69363,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,1
HP_WIDE_INTERMAMILLARY_DISTA...,SET,103,-0.04154,-0.0031011,0.082064,0.69363,HP_WIDE_INTERMAMILLARY_DISTANCE,1
ATGTTAA_MIR302C,SET,217,-0.030238,-0.0032663,0.059728,0.69366,ATGTTAA_MIR302C,1
BIOCARTA_GRANULOCYTES_PATHWAY,SET,15,-0.11704,-0.0033422,0.23116,0.69367,BIOCARTA_GRANULOCYTES_PATHWAY,1
REACTOME_SYNTHESIS_OF_UDP_N_...,SET,7,-0.17804,-0.003474,0.35162,0.69369,REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE,1
GOBP_CD4_POSITIVE_CD25_POSIT...,SET,7,-0.19019,-0.0037111,0.3756,0.6937,GOBP_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,1
SERVITJA_ISLET_HNF1A_TARGETS...1,SET,100,-0.046457,-0.0034176,0.091739,0.69371,SERVITJA_ISLET_HNF1A_TARGETS_DN,1
MARSHALL_VIRAL_INFECTION_RES...2,SET,9,-0.17176,-0.0038001,0.3391,0.69375,MARSHALL_VIRAL_INFECTION_RESPONSE_UP,1
GOMF_MYRISTOYLTRANSFERASE_AC...,SET,10,-0.1255,-0.0029266,0.24773,0.69377,GOMF_MYRISTOYLTRANSFERASE_ACTIVITY,1
GOMF_ALPHA_ACTININ_BINDING,SET,28,-0.087833,-0.0034258,0.17336,0.6938,GOMF_ALPHA_ACTININ_BINDING,1
HP_METACARPOPHALANGEAL_JOINT...,SET,3,-0.31944,-0.0040809,0.63049,0.6938,HP_METACARPOPHALANGEAL_JOINT_CONTRACTURE,1
MIR449C_5P,SET,121,-0.04021,-0.0032519,0.079357,0.69381,MIR449C_5P,1
WP_OMEGA3_OMEGA6_FATTY_ACID_...,SET,14,-0.12421,-0.0034269,0.24511,0.69383,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,1
GOBP_POSITIVE_REGULATION_OF_...529,SET,85,-0.052026,-0.00353,0.10266,0.69384,GOBP_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION,1
WP_MECP2_AND_ASSOCIATED_RETT...,SET,68,-0.055679,-0.0033806,0.1098,0.69396,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,1
HP_SLURRED_SPEECH,SET,45,-0.063191,-0.0031231,0.12453,0.69407,HP_SLURRED_SPEECH,1
HP_EPIDIDYMITIS,SET,3,-0.27734,-0.0035432,0.54644,0.69411,HP_EPIDIDYMITIS,1
KEGG_MEDICUS_PATHOGEN_ESCHER...1,SET,14,-0.11264,-0.0031078,0.2219,0.69414,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY,1
HP_ABNORMAL_BASAL_GANGLIA_MO...,SET,158,-0.034051,-0.0031437,0.067076,0.69415,HP_ABNORMAL_BASAL_GANGLIA_MORPHOLOGY,1
SNAPC4_TARGET_GENES,SET,61,-0.054255,-0.0031205,0.10687,0.69416,SNAPC4_TARGET_GENES,1
HOXB6_TARGET_GENES,SET,514,-0.01878,-0.0030965,0.03699,0.69417,HOXB6_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_TAC3_...,SET,10,-0.13999,-0.0032646,0.2757,0.69419,KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY,1
HALLMARK_HEDGEHOG_SIGNALING,SET,33,-0.082947,-0.0035117,0.16335,0.69419,HALLMARK_HEDGEHOG_SIGNALING,1
RYAAAKNNNNNNTTGW_UNKNOWN,SET,74,-0.052694,-0.003337,0.10376,0.69422,RYAAAKNNNNNNTTGW_UNKNOWN,1
MIR6512_3P,SET,122,-0.038945,-0.0031626,0.076647,0.69431,MIR6512_3P,1
GSE7460_CTRL_VS_TGFB_TREATED...7,SET,183,-0.032564,-0.0032333,0.064083,0.69432,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN,1
SMITH_TERT_TARGETS_UP,SET,130,-0.037623,-0.0031531,0.074033,0.69434,SMITH_TERT_TARGETS_UP,1
GSE22611_UNSTIM_VS_2H_MDP_ST...3,SET,176,-0.032856,-0.0031999,0.064631,0.6944,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
PHESSE_TARGETS_OF_APC_AND_MB...1,SET,9,-0.16328,-0.0036125,0.32107,0.69446,PHESSE_TARGETS_OF_APC_AND_MBD2_DN,1
MIR3908,SET,106,-0.045695,-0.0034603,0.089845,0.69448,MIR3908,1
GSE20500_CTRL_VS_RARA_ANTAGO...2,SET,182,-0.031705,-0.0031395,0.06234,0.69448,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,1
HP_INCREASED_HEMATOCRIT,SET,9,-0.15191,-0.0033609,0.29855,0.69456,HP_INCREASED_HEMATOCRIT,1
GOBP_PHOTOTRANSDUCTION,SET,40,-0.071194,-0.0033178,0.13991,0.69457,GOBP_PHOTOTRANSDUCTION,1
GOBP_GLUTAMATERGIC_NEURON_DI...,SET,15,-0.12968,-0.0037032,0.25465,0.6947,GOBP_GLUTAMATERGIC_NEURON_DIFFERENTIATION,1
HP_ABNORMALITY_OF_TUMOR_NECR...,SET,5,-0.21525,-0.0035499,0.42264,0.69472,HP_ABNORMALITY_OF_TUMOR_NECROSIS_FACTOR_SECRETION,1
GSE411_UNSTIM_VS_400MIN_IL6_...3,SET,175,-0.033551,-0.0032584,0.065865,0.69476,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
GOMF_PHOSPHATIDYLCHOLINE_FLI...,SET,5,-0.20675,-0.0034097,0.40566,0.69485,GOMF_PHOSPHATIDYLCHOLINE_FLIPPASE_ACTIVITY,1
ROVERSI_GLIOMA_COPY_NUMBER_DN,SET,51,-0.07454,-0.0039212,0.14621,0.69491,ROVERSI_GLIOMA_COPY_NUMBER_DN,1
E12_Q6,SET,245,-0.028093,-0.0032219,0.055096,0.69493,E12_Q6,1
HP_ABNORMAL_TOE_PHALANX_MORP...,SET,113,-0.040356,-0.0031547,0.079122,0.69499,HP_ABNORMAL_TOE_PHALANX_MORPHOLOGY,1
GOCC_CLATHRIN_COAT_OF_COATED...,SET,18,-0.098859,-0.0030924,0.19373,0.69507,GOCC_CLATHRIN_COAT_OF_COATED_PIT,1
HP_ATROPHY_OF_ALVEOLAR_RIDGES,SET,3,-0.30055,-0.0038396,0.58894,0.69508,HP_ATROPHY_OF_ALVEOLAR_RIDGES,1
HP_CRANIAL_NERVE_PARALYSIS,SET,258,-0.027252,-0.0032062,0.053402,0.69508,HP_CRANIAL_NERVE_PARALYSIS,1
HP_CAUDATE_ATROPHY,SET,11,-0.14235,-0.0034817,0.27894,0.69509,HP_CAUDATE_ATROPHY,1
GOCC_GID_COMPLEX,SET,5,-0.18544,-0.0030582,0.36308,0.69523,GOCC_GID_COMPLEX,1
MURARO_PANCREAS_ALPHA_CELL,SET,471,-0.021115,-0.0033367,0.041342,0.69523,MURARO_PANCREAS_ALPHA_CELL,1
GOBP_INTERLEUKIN_4_MEDIATED_...,SET,9,-0.14032,-0.0031045,0.27471,0.69525,GOBP_INTERLEUKIN_4_MEDIATED_SIGNALING_PATHWAY,1
HP_UNILATERAL_RENAL_HYPOPLAS...,SET,4,-0.21847,-0.0032227,0.42731,0.69542,HP_UNILATERAL_RENAL_HYPOPLASIA,1
GOBP_REGULATION_OF_CELLULAR_...5,SET,37,-0.074571,-0.0033426,0.14583,0.69544,GOBP_REGULATION_OF_CELLULAR_EXTRAVASATION,1
GOMF_TRANSLATION_ELONGATION_...,SET,18,-0.089709,-0.0028061,0.17544,0.69544,GOMF_TRANSLATION_ELONGATION_FACTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...385,SET,7,-0.1968,-0.0038401,0.38467,0.69554,GOBP_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
TRAYNOR_RETT_SYNDROM_DN,SET,14,-0.1251,-0.0034516,0.24451,0.69555,TRAYNOR_RETT_SYNDROM_DN,1
MODULE_484,SET,39,-0.069049,-0.0031774,0.13494,0.69557,MODULE_484,1
GSE29949_MICROGLIA_BRAIN_VS_...2,SET,180,-0.033318,-0.0032812,0.065113,0.69557,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,1
GSE27670_CTRL_VS_LMP1_TRANSD...1,SET,184,-0.033248,-0.0033101,0.064966,0.69559,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN,1
REACTOME_RESPONSE_OF_EIF2AK1...,SET,14,-0.12376,-0.0034145,0.24177,0.69563,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,1
GSE22886_NAIVE_CD4_TCELL_VS_...10,SET,171,-0.032307,-0.0031018,0.063095,0.69568,GSE22886_NAIVE_CD4_TCELL_VS_DC_UP,1
chr13q12,SET,65,-0.10486,-0.006225,0.20477,0.6957,chr13q12,1
REACTOME_FGFR3B_LIGAND_BINDI...,SET,7,-0.19803,-0.003864,0.38666,0.69572,REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION,1
BCAT_BILD_ET_AL_UP,SET,42,-0.069569,-0.0033219,0.13579,0.69579,BCAT_BILD_ET_AL_UP,1
GOCC_BASAL_DENDRITE,SET,6,-0.20449,-0.0036943,0.39909,0.69581,GOCC_BASAL_DENDRITE,1
GSE3720_VD1_VS_VD2_GAMMADELT...5,SET,180,-0.031711,-0.0031229,0.061886,0.69581,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN,1
GOBP_CAMKK_AMPK_SIGNALING_CA...,SET,9,-0.15293,-0.0033835,0.29839,0.69586,GOBP_CAMKK_AMPK_SIGNALING_CASCADE,1
HP_ABNORMALITY_OF_CARDIOVASC...,SET,494,-0.020269,-0.0032782,0.039542,0.69588,HP_ABNORMALITY_OF_CARDIOVASCULAR_SYSTEM_ELECTROPHYSIOLOGY,1
HP_LARGE_FORAMEN_MAGNUM,SET,5,-0.19347,-0.0031907,0.37735,0.69592,HP_LARGE_FORAMEN_MAGNUM,1
HP_ABNORMAL_CARDIAC_EXERCISE...,SET,19,-0.1078,-0.0034642,0.2102,0.69596,HP_ABNORMAL_CARDIAC_EXERCISE_STRESS_TEST,1
HP_ABNORMALITY_OF_VITAMIN_K_...,SET,13,-0.13256,-0.0035244,0.25841,0.69602,HP_ABNORMALITY_OF_VITAMIN_K_METABOLISM,1
MIR4321,SET,4,-0.20579,-0.0030357,0.40111,0.69604,MIR4321,1
GOBP_NEGATIVE_REGULATION_OF_...447,SET,66,-0.052641,-0.003149,0.10259,0.69606,GOBP_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,1
GOBP_EMBRYONIC_SKELETAL_SYST...1,SET,120,-0.04638,-0.0037355,0.090324,0.69619,GOBP_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT,1
NOUSHMEHR_GBM_SILENCED_BY_ME...,SET,45,-0.067817,-0.0033517,0.13206,0.69621,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,1
REACTOME_MATERNAL_TO_ZYGOTIC...,SET,58,-0.056631,-0.0031764,0.11027,0.69622,REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,1
GOBP_PROTEIN_IMPORT_INTO_PER...3,SET,4,-0.20499,-0.0030239,0.39884,0.69636,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_SUBSTRATE_RELEASE,1
GSE37301_HEMATOPOIETIC_STEM_...8,SET,165,-0.03405,-0.0032118,0.066237,0.69639,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP,1
ZNF577_TARGET_GENES,SET,381,-0.022774,-0.003245,0.044294,0.69643,ZNF577_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...749,SET,11,-0.13625,-0.0033324,0.26491,0.69649,GOBP_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GSE11057_NAIVE_VS_CENT_MEMOR...1,SET,183,-0.032717,-0.0032484,0.063604,0.6965,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,1
SMIRNOV_CIRCULATING_ENDOTHEL...2,SET,145,-0.038638,-0.0034184,0.075108,0.69652,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,1
HP_THIN_NAIL,SET,13,-0.11923,-0.0031699,0.23175,0.69653,HP_THIN_NAIL,1
MODULE_128,SET,87,-0.049882,-0.0034239,0.096952,0.69655,MODULE_128,1
GOCC_PROTEIN_FOLDING_CHAPERO...,SET,40,-0.061182,-0.0028512,0.11889,0.69659,GOCC_PROTEIN_FOLDING_CHAPERONE_COMPLEX,1
GSE25088_CTRL_VS_ROSIGLITAZO...4,SET,159,-0.034634,-0.0032075,0.067295,0.6966,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,1
HP_ELBOW_CONTRACTURE,SET,98,-0.046402,-0.0033794,0.090129,0.69667,HP_ELBOW_CONTRACTURE,1
MODULE_403,SET,43,-0.064189,-0.0031013,0.12466,0.6967,MODULE_403,1
GOCC_BBSOME,SET,8,-0.15374,-0.003207,0.29846,0.69677,GOCC_BBSOME,1
RUTELLA_RESPONSE_TO_CSF2RB_A...1,SET,295,-0.026911,-0.0033821,0.052231,0.6968,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,1
HP_BROAD_CHIN,SET,8,-0.17948,-0.0037438,0.34834,0.6968,HP_BROAD_CHIN,1
MIR890,SET,88,-0.04855,-0.0033515,0.094206,0.69685,MIR890,1
HP_ECTODERMAL_DYSPLASIA,SET,23,-0.093014,-0.0032884,0.18046,0.69686,HP_ECTODERMAL_DYSPLASIA,1
HP_ABNORMALITY_OF_THE_TESTIS...,SET,177,-0.032868,-0.00321,0.06376,0.69689,HP_ABNORMALITY_OF_THE_TESTIS_SIZE,1
GAUCHER_PBMC_YF_VAX_STAMARIL...6,SET,26,-0.09281,-0.0034884,0.18003,0.6969,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_UP,1
GSE11961_MARGINAL_ZONE_BCELL...3,SET,182,-0.032015,-0.0031702,0.062091,0.69694,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,1
BROWNE_HCMV_INFECTION_1HR_UP,SET,47,-0.066962,-0.003382,0.12983,0.69699,BROWNE_HCMV_INFECTION_1HR_UP,1
GOBP_LUTEINIZING_HORMONE_SEC...,SET,11,-0.14813,-0.0036228,0.28715,0.69701,GOBP_LUTEINIZING_HORMONE_SECRETION,1
ACTAYRNNNCCCR_UNKNOWN,SET,411,-0.021619,-0.0031966,0.041909,0.69702,ACTAYRNNNCCCR_UNKNOWN,1
TURASHVILI_BREAST_DUCTAL_CAR...1,SET,173,-0.036067,-0.0034829,0.069915,0.69703,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1
GOMF_EXTRACELLULAR_MATRIX_PR...,SET,6,-0.20915,-0.0037785,0.40537,0.69705,GOMF_EXTRACELLULAR_MATRIX_PROTEIN_BINDING,1
GOBP_AMINO_ACID_ACTIVATION,SET,26,-0.077434,-0.0029105,0.15006,0.69708,GOBP_AMINO_ACID_ACTIVATION,1
REACTOME_PLATELET_ACTIVATION...,SET,246,-0.029259,-0.0033625,0.056698,0.69709,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1
HOFT_CD4_POSITIVE_ALPHA_BETA...3,SET,3,-0.22179,-0.0028335,0.42973,0.69711,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_DN,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...2,SET,27,-0.093228,-0.0035707,0.18062,0.69712,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP,1
MIR3144_3P,SET,56,-0.057616,-0.0031756,0.11162,0.69714,MIR3144_3P,1
GOBP_RESPONSE_TO_INTERFERON_...1,SET,17,-0.1137,-0.0034566,0.22026,0.69715,GOBP_RESPONSE_TO_INTERFERON_ALPHA,1
GSE37605_TREG_VS_TCONV_C57BL...2,SET,122,-0.042684,-0.0034661,0.082684,0.69715,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP,1
RIZ_ERYTHROID_DIFFERENTIATIO...5,SET,36,-0.083119,-0.0036752,0.161,0.69716,RIZ_ERYTHROID_DIFFERENTIATION_HBZ,1
GSE3039_NKT_CELL_VS_ALPHAALP...1,SET,188,-0.033196,-0.0033403,0.064301,0.69716,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN,1
GSE27786_LIN_NEG_VS_MONO_MAC...2,SET,181,-0.030955,-0.0030568,0.059951,0.69719,GSE27786_LIN_NEG_VS_MONO_MAC_UP,1
GOCC_CATION_TRANSPORTING_ATP...,SET,18,-0.11559,-0.0036158,0.22386,0.6972,GOCC_CATION_TRANSPORTING_ATPASE_COMPLEX,1
SIG_CHEMOTAXIS,SET,39,-0.068882,-0.0031697,0.13337,0.69723,SIG_CHEMOTAXIS,1
MIR3146,SET,44,-0.069822,-0.0034123,0.13519,0.69724,MIR3146,1
MIR215_5P,SET,34,-0.078383,-0.0033683,0.15171,0.6973,MIR215_5P,1
GSE15659_NAIVE_VS_PTPRC_NEG_...2,SET,156,-0.034287,-0.0031455,0.066365,0.6973,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP,1
HP_ABNORMAL_UPPER_MOTOR_NEUR...,SET,14,-0.1058,-0.0029191,0.20476,0.69732,HP_ABNORMAL_UPPER_MOTOR_NEURON_MORPHOLOGY,1
WP_17P133_YWHAE_COPY_NUMBER_...,SET,21,-0.096825,-0.0032711,0.18736,0.69734,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,1
WP_MAMMARY_GLAND_DEVELOPMENT...1,SET,15,-0.12508,-0.003572,0.24189,0.69745,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,1
MOREAUX_MULTIPLE_MYELOMA_BY_...1,SET,153,-0.032811,-0.0029812,0.06342,0.69754,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,1
GSE27859_MACROPHAGE_VS_CD11C...3,SET,178,-0.033507,-0.0032815,0.064763,0.69755,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN,1
HP_GINGIVITIS,SET,29,-0.083524,-0.0033153,0.16141,0.69758,HP_GINGIVITIS,1
GSE29614_CTRL_VS_DAY3_TIV_FL...2,SET,151,-0.036764,-0.0033187,0.071027,0.69763,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP,1
HP_RENAL_TUBULAR_ATROPHY,SET,18,-0.10031,-0.0031378,0.19378,0.69765,HP_RENAL_TUBULAR_ATROPHY,1
GSE13411_NAIVE_VS_SWITCHED_M...2,SET,175,-0.034279,-0.0033291,0.066211,0.69767,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP,1
JI_CARCINOGENESIS_BY_KRAS_AN...2,SET,12,-0.12865,-0.0032863,0.24848,0.69768,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,1
GOBP_SENSORY_PERCEPTION_OF_S...1,SET,331,-0.034982,-0.0046523,0.067558,0.6977,GOBP_SENSORY_PERCEPTION_OF_SMELL,1
GOBP_GLYCEROPHOSPHOLIPID_CAT...,SET,34,-0.076577,-0.0032907,0.14785,0.69775,GOBP_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS,1
GOMF_G_PROTEIN_COUPLED_RECEP...1,SET,696,-0.021182,-0.0040432,0.040895,0.69775,GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY,1
GOBP_PROTEIN_INSERTION_INTO_...7,SET,14,-0.11364,-0.0031353,0.21937,0.69778,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_OUTER_MEMBRANE,1
BIOCARTA_HES_PATHWAY,SET,11,-0.13615,-0.00333,0.26279,0.6978,BIOCARTA_HES_PATHWAY,1
GOBP_REGULATION_OF_PROTEIN_E...1,SET,24,-0.080519,-0.0029079,0.15541,0.69781,GOBP_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
BILANGES_SERUM_AND_RAPAMYCIN...,SET,60,-0.055486,-0.0031652,0.10707,0.69784,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,1
GOBP_PROTEIN_FOLDING_IN_ENDO...,SET,10,-0.13245,-0.0030889,0.2556,0.69784,GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM,1
KEGG_MEDICUS_ENV_FACTOR_IRON...,SET,18,-0.11483,-0.0035921,0.22157,0.69786,KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
GOMF_CROSSOVER_JUNCTION_DNA_...,SET,7,-0.1387,-0.0027064,0.26755,0.69791,GOMF_CROSSOVER_JUNCTION_DNA_ENDONUCLEASE_ACTIVITY,1
GOBP_PROTEIN_CATABOLIC_PROCE...2,SET,21,-0.10595,-0.0035793,0.20433,0.69795,GOBP_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
GTCNYYATGR_UNKNOWN,SET,103,-0.043331,-0.0032348,0.083561,0.69796,GTCNYYATGR_UNKNOWN,1
GOBP_PROGESTERONE_METABOLIC_...,SET,15,-0.1184,-0.0033811,0.22829,0.69799,GOBP_PROGESTERONE_METABOLIC_PROCESS,1
WIKMAN_ASBESTOS_LUNG_CANCER_...2,SET,15,-0.10981,-0.0031358,0.21172,0.698,WIKMAN_ASBESTOS_LUNG_CANCER_UP,1
HP_THYROID_DEFECT_IN_OXIDATI...,SET,6,-0.1863,-0.0033656,0.35916,0.69801,HP_THYROID_DEFECT_IN_OXIDATION_AND_ORGANIFICATION_OF_IODIDE,1
GSE41867_NAIVE_VS_DAY30_LCMV...2,SET,182,-0.030853,-0.0030551,0.059472,0.69804,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP,1
ZHONG_PFC_C3_MICROGLIA,SET,431,-0.022174,-0.0033556,0.04274,0.69805,ZHONG_PFC_C3_MICROGLIA,1
MIR6811_5P,SET,66,-0.05744,-0.003436,0.11067,0.69813,MIR6811_5P,1
GOBP_NEGATIVE_REGULATION_OF_...667,SET,22,-0.097856,-0.0033837,0.18852,0.69814,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
BANDRES_RESPONSE_TO_CARMUSTI...2,SET,8,-0.14199,-0.0029618,0.27353,0.69815,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP,1
GAUTAM_EYE_CHOROID_SCLERA_CH...,SET,128,-0.038561,-0.0032069,0.074281,0.69816,GAUTAM_EYE_CHOROID_SCLERA_CHOROID_ENDOTHELIAL_CELLS,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...3,SET,259,-0.029287,-0.0034522,0.056396,0.69823,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
chr1p13,SET,106,-0.089382,-0.0067685,0.1721,0.69824,chr1p13,1
GSE13485_DAY3_VS_DAY21_YF17D...1,SET,139,-0.039846,-0.0034522,0.076696,0.6983,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
GRANDVAUX_IFN_RESPONSE_NOT_V...,SET,14,-0.11451,-0.0031592,0.22039,0.69831,GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,1
FAN_OVARY_CL3_MATURE_CUMULUS...,SET,200,-0.03211,-0.0033315,0.061801,0.69832,FAN_OVARY_CL3_MATURE_CUMULUS_GRANULOSA_CELL_1,1
GAL_LEUKEMIC_STEM_CELL_DN,SET,212,-0.03058,-0.0032654,0.058852,0.69833,GAL_LEUKEMIC_STEM_CELL_DN,1
ZHENG_FOXP3_TARGETS_IN_T_LYM...1,SET,34,-0.080194,-0.0034461,0.15431,0.69836,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,1
VARELA_ZMPSTE24_TARGETS_UP,SET,40,-0.070966,-0.0033072,0.13655,0.69837,VARELA_ZMPSTE24_TARGETS_UP,1
GOMF_NEUROTRANSMITTER_RECEPT...1,SET,90,-0.052237,-0.0036465,0.10049,0.69839,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
DING_LUNG_CANCER_BY_MUTATION...,SET,20,-0.10003,-0.0032981,0.19241,0.69842,DING_LUNG_CANCER_BY_MUTATION_RATE,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SET,104,-0.044672,-0.003351,0.085929,0.69842,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1
HP_TELANGIECTASIA,SET,136,-0.035995,-0.0030849,0.069239,0.69842,HP_TELANGIECTASIA,1
GAVISH_3CA_METAPROGRAM_EPITH...22,SET,50,-0.068836,-0.0035856,0.1324,0.69843,GAVISH_3CA_METAPROGRAM_EPITHELIAL_SECRETED,1
HP_SPASTIC_DIPLEGIA,SET,29,-0.087454,-0.0034712,0.16811,0.69854,HP_SPASTIC_DIPLEGIA,1
SMID_BREAST_CANCER_RELAPSE_I...5,SET,10,-0.13304,-0.0031024,0.25569,0.69857,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,1
NIKOLSKY_BREAST_CANCER_14Q22...,SET,12,-0.19301,-0.0049304,0.37087,0.69861,NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON,1
LI_ESTROGENE_BIDIRECTIONAL_E...,SET,85,-0.053177,-0.0036081,0.10217,0.69864,LI_ESTROGENE_BIDIRECTIONAL_E2_RESPONSE,1
GSE5099_CLASSICAL_M1_VS_ALTE...2,SET,178,-0.033967,-0.0033266,0.065249,0.69866,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP,1
MAF_Q6,SET,233,-0.030747,-0.00344,0.059027,0.69878,MAF_Q6,1
GOBP_POSITIVE_REGULATION_OF_...692,SET,9,-0.17264,-0.0038196,0.33144,0.69878,GOBP_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
GSE1566_WT_VS_EZH2_KO_LN_TCE...2,SET,165,-0.03529,-0.0033288,0.067739,0.6988,GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP,1
WP_TNFALPHA_SIGNALING,SET,89,-0.04533,-0.0031468,0.087004,0.69882,WP_TNFALPHA_SIGNALING,1
URS_ADIPOCYTE_DIFFERENTIATIO...2,SET,64,-0.056057,-0.0033023,0.10755,0.69889,URS_ADIPOCYTE_DIFFERENTIATION_UP,1
KEGG_MEDICUS_REFERENCE_ACTIV...1,SET,16,-0.10329,-0.0030463,0.19816,0.69889,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119,1
GAVISH_3CA_METAPROGRAM_MACRO...1,SET,41,-0.072206,-0.0034067,0.13851,0.69892,GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE,1
HP_FOCAL_IMPAIRED_AWARENESS_...,SET,113,-0.043367,-0.0033901,0.083178,0.69895,HP_FOCAL_IMPAIRED_AWARENESS_SEIZURE,1
BASSO_HAIRY_CELL_LEUKEMIA_UP,SET,74,-0.054502,-0.0034515,0.10452,0.69897,BASSO_HAIRY_CELL_LEUKEMIA_UP,1
BIOCARTA_DNAFRAGMENT_PATHWAY,SET,10,-0.16873,-0.0039349,0.32343,0.69905,BIOCARTA_DNAFRAGMENT_PATHWAY,1
GSE21927_HEALTHY_VS_TUMOROUS...1,SET,139,-0.038343,-0.003322,0.073495,0.69906,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN,1
ZHONG_PFC_C4_UNKNOWN_INP,SET,81,-0.049947,-0.0033086,0.095739,0.69906,ZHONG_PFC_C4_UNKNOWN_INP,1
MIR556_3P,SET,129,-0.038824,-0.0032413,0.074413,0.69907,MIR556_3P,1
GOMF_HISTONE_H3K36_DEMETHYLA...,SET,7,-0.14973,-0.0029216,0.28698,0.69907,GOMF_HISTONE_H3K36_DEMETHYLASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_LONG_...,SET,17,-0.096502,-0.0029337,0.18492,0.69911,KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER,1
GOMF_ANNEALING_ACTIVITY,SET,8,-0.16585,-0.0034595,0.31781,0.69911,GOMF_ANNEALING_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C1_MUC...,SET,48,-0.070406,-0.0035934,0.13489,0.69915,HE_LIM_SUN_FETAL_LUNG_C1_MUC5AC_POS_ASCL1_POS_PROGENITOR_CELL,1
MODULE_183,SET,62,-0.053134,-0.003081,0.10176,0.69921,MODULE_183,1
GOMF_VASCULAR_ENDOTHELIAL_GR...2,SET,9,-0.16265,-0.0035985,0.3115,0.69922,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING,1
GOMF_N_ACETYLTRANSFERASE_ACT...,SET,61,-0.052411,-0.0030145,0.10035,0.69925,GOMF_N_ACETYLTRANSFERASE_ACTIVITY,1
HP_AUDITORY_HALLUCINATION,SET,16,-0.1076,-0.0031736,0.20601,0.69927,HP_AUDITORY_HALLUCINATION,1
HE_LIM_SUN_FETAL_LUNG_C4_NKT...2,SET,8,-0.16581,-0.0034586,0.31744,0.69928,HE_LIM_SUN_FETAL_LUNG_C4_NKT2_CELL,1
HP_RECURRENT_HAEMOPHILUS_INF...,SET,22,-0.10329,-0.0035716,0.19773,0.6993,HP_RECURRENT_HAEMOPHILUS_INFLUENZAE_INFECTIONS,1
MODULE_132,SET,13,-0.13634,-0.0036248,0.26096,0.69931,MODULE_132,1
HOXB7_TARGET_GENES,SET,24,-0.091719,-0.0033123,0.1755,0.69937,HOXB7_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...386,SET,7,-0.17279,-0.0033716,0.33056,0.69941,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,1
MAINA_VHL_TARGETS_DN,SET,14,-0.13268,-0.0036607,0.25379,0.69944,MAINA_VHL_TARGETS_DN,1
KEGG_MEDICUS_PATHOGEN_ESCHER...7,SET,4,-0.22823,-0.0033668,0.43657,0.69944,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,1
GSE21670_TGFB_VS_TGFB_AND_IL...4,SET,180,-0.033476,-0.0032968,0.064031,0.69944,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
HP_NORMAL_INTERICTAL_EEG,SET,6,-0.18694,-0.0033771,0.35754,0.69945,HP_NORMAL_INTERICTAL_EEG,1
HP_BONE_MARROW_MATURATION_AR...,SET,6,-0.17713,-0.0032,0.33877,0.69946,HP_BONE_MARROW_MATURATION_ARREST,1
MAEKAWA_ATF2_TARGETS,SET,22,-0.096336,-0.0033311,0.18422,0.69949,MAEKAWA_ATF2_TARGETS,1
GOBP_FOREBRAIN_VENTRICULAR_Z...,SET,5,-0.20019,-0.0033016,0.38274,0.69953,GOBP_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION,1
HP_HYDROPS_FETALIS,SET,115,-0.041411,-0.0032655,0.07916,0.69955,HP_HYDROPS_FETALIS,1
RODRIGUES_THYROID_CARCINOMA_...6,SET,14,-0.13814,-0.0038111,0.26401,0.69959,RODRIGUES_THYROID_CARCINOMA_UP,1
EVI1_02,SET,112,-0.04341,-0.0033785,0.082915,0.6997,EVI1_02,1
GOMF_NEUREGULIN_BINDING,SET,5,-0.21076,-0.0034759,0.40255,0.69971,GOMF_NEUREGULIN_BINDING,1
GOBP_CYTOLYSIS_BY_HOST_OF_SY...,SET,6,-0.19015,-0.0034352,0.36308,0.69976,GOBP_CYTOLYSIS_BY_HOST_OF_SYMBIONT_CELLS,1
HP_HEPATIC_BRIDGING_FIBROSIS,SET,9,-0.14793,-0.0032728,0.28243,0.69978,HP_HEPATIC_BRIDGING_FIBROSIS,1
HP_ABNORMAL_HAND_BONE_OSSIFI...,SET,34,-0.075637,-0.0032503,0.14437,0.69983,HP_ABNORMAL_HAND_BONE_OSSIFICATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...29,SET,607,-0.018593,-0.0033229,0.03549,0.69983,HP_APLASIA_HYPOPLASIA_OF_THE_EXTREMITIES,1
MIR6800_3P,SET,27,-0.091096,-0.0034891,0.17386,0.69984,MIR6800_3P,1
VANGURP_PANCREATIC_BETA_CELL,SET,107,-0.045993,-0.0034992,0.087768,0.69987,VANGURP_PANCREATIC_BETA_CELL,1
GOMF_AMIDE_TRANSMEMBRANE_TRA...,SET,34,-0.081459,-0.0035005,0.1554,0.69992,GOMF_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_RESPONSE_TO_VITAMIN_A,SET,15,-0.12351,-0.003527,0.23558,0.69995,GOBP_RESPONSE_TO_VITAMIN_A,1
HP_DIFFICULTY_IN_TONGUE_MOVE...,SET,12,-0.13838,-0.0035349,0.26393,0.69997,HP_DIFFICULTY_IN_TONGUE_MOVEMENTS,1
HP_ABNORMALITY_IRIS_MORPHOLO...,SET,404,-0.022838,-0.0033486,0.043552,0.69999,HP_ABNORMALITY_IRIS_MORPHOLOGY,1
GOBP_RESPONSE_TO_LIGHT_INTEN...,SET,15,-0.11516,-0.0032886,0.21959,0.7,GOBP_RESPONSE_TO_LIGHT_INTENSITY,1
HP_LOW_SET_NIPPLES,SET,6,-0.14426,-0.0026062,0.27509,0.7,HP_LOW_SET_NIPPLES,1
HAY_BONE_MARROW_NEUTROPHIL,SET,397,-0.023379,-0.0033989,0.044577,0.70002,HAY_BONE_MARROW_NEUTROPHIL,1
FIGUEROA_AML_METHYLATION_CLU...10,SET,12,-0.12631,-0.0032265,0.24081,0.70004,FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,1
REACTOME_ZYGOTIC_GENOME_ACTI...,SET,13,-0.12369,-0.0032885,0.23581,0.70004,REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA,1
MIR708_3P,SET,102,-0.045973,-0.0034154,0.087644,0.70005,MIR708_3P,1
ZSCAN31_TARGET_GENES,SET,746,-0.016917,-0.0033385,0.032248,0.70006,ZSCAN31_TARGET_GENES,1
KEGG_MEDICUS_VARIANT_MUTATIO...45,SET,21,-0.097617,-0.0032979,0.18608,0.70007,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
KEGG_MEDICUS_REFERENCE_NOTCH...1,SET,9,-0.1598,-0.0035354,0.30459,0.70008,KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION,1
GOMF_FIBROBLAST_GROWTH_FACTO...1,SET,23,-0.09475,-0.0033498,0.1806,0.70008,GOMF_FIBROBLAST_GROWTH_FACTOR_BINDING,1
HP_IMPAIRED_PAIN_SENSATION,SET,65,-0.056557,-0.0033576,0.10779,0.7001,HP_IMPAIRED_PAIN_SENSATION,1
HP_IVORY_EPIPHYSES,SET,9,-0.14019,-0.0031017,0.26712,0.70015,HP_IVORY_EPIPHYSES,1
REACTOME_ADIPOGENESIS,SET,104,-0.041753,-0.003132,0.079538,0.70019,REACTOME_ADIPOGENESIS,1
GOBP_ANTIGEN_PROCESSING_AND_...5,SET,45,-0.075229,-0.003718,0.14328,0.70022,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN,1
GOBP_POSITIVE_REGULATION_OF_...742,SET,6,-0.21262,-0.0038411,0.40494,0.70023,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,1
GOBP_NEGATIVE_REGULATION_OF_...474,SET,9,-0.15679,-0.0034688,0.29852,0.70028,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GSE24634_TEFF_VS_TCONV_DAY10...2,SET,182,-0.033227,-0.0032901,0.063221,0.7004,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP,1
GOCC_DENDRITE_MEMBRANE,SET,37,-0.077122,-0.003457,0.14673,0.70041,GOCC_DENDRITE_MEMBRANE,1
VERRECCHIA_RESPONSE_TO_TGFB1...2,SET,19,-0.11656,-0.0037458,0.22175,0.70042,VERRECCHIA_RESPONSE_TO_TGFB1_C2,1
MIR3978,SET,228,-0.030182,-0.0033408,0.057417,0.70043,MIR3978,1
AP1FJ_Q2,SET,248,-0.029852,-0.0034443,0.056775,0.70048,AP1FJ_Q2,1
chr7q32,SET,43,-0.12994,-0.0062778,0.2471,0.7005,chr7q32,1
REACTOME_RELEASE_OF_APOPTOTI...,SET,5,-0.19283,-0.0031802,0.36671,0.7005,REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...3,SET,824,-0.015429,-0.003193,0.029337,0.70053,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN,1
HP_ABNORMAL_SUPERIOR_CEREBEL...,SET,12,-0.11162,-0.0028513,0.21222,0.70054,HP_ABNORMAL_SUPERIOR_CEREBELLAR_PEDUNCLE_MORPHOLOGY,1
FUNG_IL2_TARGETS_WITH_STAT5_...2,SET,9,-0.16951,-0.0037502,0.32216,0.7006,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1,1
GOBP_POSITIVE_REGULATION_OF_...274,SET,34,-0.07843,-0.0033703,0.14905,0.70063,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,1
GOBP_LUNG_VASCULATURE_DEVELO...,SET,9,-0.16431,-0.0036352,0.31222,0.70064,GOBP_LUNG_VASCULATURE_DEVELOPMENT,1
GOBP_L_PHENYLALANINE_METABOL...,SET,8,-0.17508,-0.0036521,0.33256,0.70071,GOBP_L_PHENYLALANINE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_T_CELL_EX...,SET,5,-0.2048,-0.0033776,0.38897,0.70074,GOBP_REGULATION_OF_T_CELL_EXTRAVASATION,1
UDAYAKUMAR_MED1_TARGETS_UP,SET,118,-0.040178,-0.0032091,0.076298,0.70076,UDAYAKUMAR_MED1_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...252,SET,56,-0.067738,-0.0037335,0.12861,0.70079,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GOBP_POSITIVE_REGULATION_OF_...248,SET,140,-0.04031,-0.0035048,0.076533,0.7008,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,1
GSE11884_WT_VS_FURIN_KO_NAIV...1,SET,116,-0.041138,-0.003258,0.0781,0.70081,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN,1
MIR875_3P,SET,283,-0.027313,-0.0033632,0.05184,0.70086,MIR875_3P,1
WP_CELLTYPE_DEPENDENT_SELECT...,SET,13,-0.13987,-0.0037188,0.26544,0.70088,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,1
GOBP_CHEMICAL_HOMEOSTASIS,SET,937,-0.015668,-0.0034463,0.029731,0.70089,GOBP_CHEMICAL_HOMEOSTASIS,1
MODULE_32,SET,210,-0.029628,-0.003149,0.056207,0.70094,MODULE_32,1
TAL1BETAE47_01,SET,225,-0.031476,-0.0034614,0.059704,0.70097,TAL1BETAE47_01,1
GOCC_SPERM_CONNECTING_PIECE,SET,11,-0.1417,-0.0034658,0.26879,0.70097,GOCC_SPERM_CONNECTING_PIECE,1
GOBP_ESTROGEN_METABOLIC_PROC...,SET,37,-0.080993,-0.0036304,0.15359,0.70102,GOBP_ESTROGEN_METABOLIC_PROCESS,1
REACTOME_PHASE_0_RAPID_DEPOL...,SET,31,-0.092552,-0.003798,0.17541,0.70111,REACTOME_PHASE_0_RAPID_DEPOLARISATION,1
WP_ERK_PATHWAY_IN_HUNTINGTON...,SET,16,-0.12634,-0.0037262,0.23946,0.70111,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,1
MODULE_256,SET,54,-0.059226,-0.0032057,0.11225,0.70112,MODULE_256,1
GSE5589_LPS_VS_LPS_AND_IL10_...3,SET,185,-0.035037,-0.0034976,0.066389,0.70116,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
GOMF_CALCIUM_INDUCED_CALCIUM...,SET,6,-0.1703,-0.0030766,0.32252,0.70126,GOMF_CALCIUM_INDUCED_CALCIUM_RELEASE_ACTIVITY,1
ZNF697_TARGET_GENES,SET,121,-0.039274,-0.0031762,0.074347,0.70133,ZNF697_TARGET_GENES,1
MODULE_99,SET,325,-0.027262,-0.0035932,0.051606,0.70134,MODULE_99,1
ERWIN_COHEN_BLOOD_TC_83_AGE_...,SET,108,-0.045768,-0.0034982,0.086608,0.7014,ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP,1
GOMF_CARNITINE_TRANSMEMBRANE...,SET,5,-0.2701,-0.0044546,0.51102,0.70144,GOMF_CARNITINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_OLIGOPEPTIDE_TRANSPORT,SET,18,-0.10831,-0.003388,0.20486,0.70149,GOBP_OLIGOPEPTIDE_TRANSPORT,1
HP_APLASIA_HYPOPLASIA_OF_THE...75,SET,8,-0.14679,-0.0030619,0.27761,0.70151,HP_APLASIA_HYPOPLASIA_OF_THE_TRAGUS,1
GOCC_CELL_POLE,SET,9,-0.15021,-0.0033232,0.28398,0.70157,GOCC_CELL_POLE,1
HP_ANAL_STENOSIS,SET,30,-0.089396,-0.0036089,0.16898,0.7016,HP_ANAL_STENOSIS,1
MODULE_481,SET,81,-0.05017,-0.0033233,0.09483,0.70161,MODULE_481,1
MODULE_544,SET,81,-0.05017,-0.0033233,0.09483,0.70161,MODULE_544,1
GOBP_ORGANELLE_DISASSEMBLY,SET,153,-0.034671,-0.0031503,0.065525,0.70164,GOBP_ORGANELLE_DISASSEMBLY,1
BIOCARTA_PTEN_PATHWAY,SET,18,-0.11015,-0.0034456,0.20814,0.70168,BIOCARTA_PTEN_PATHWAY,1
GOCC_METHYLOSOME,SET,13,-0.12905,-0.0034312,0.24384,0.70168,GOCC_METHYLOSOME,1
DESCARTES_FETAL_HEART_MYELOI...,SET,104,-0.046947,-0.0035216,0.088694,0.7017,DESCARTES_FETAL_HEART_MYELOID_CELLS,1
HP_ACROPARESTHESIA,SET,9,-0.16533,-0.0036579,0.31222,0.70178,HP_ACROPARESTHESIA,1
GOBP_POSITIVE_REGULATION_OF_...345,SET,6,-0.20844,-0.0037657,0.39337,0.7019,GOBP_POSITIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_ERBB_SIGN...,SET,66,-0.056373,-0.0033722,0.10635,0.70197,GOBP_REGULATION_OF_ERBB_SIGNALING_PATHWAY,1
WP_4HYDROXYTAMOXIFEN_DEXAMET...,SET,25,-0.099285,-0.0036594,0.18728,0.70199,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,1
KUMAR_AUTOPHAGY_NETWORK,SET,59,-0.05891,-0.0033325,0.11111,0.702,KUMAR_AUTOPHAGY_NETWORK,1
WP_CILIOPATHIES,SET,162,-0.03403,-0.0031809,0.064174,0.70204,WP_CILIOPATHIES,1
REACTOME_HCMV_INFECTION,SET,91,-0.046149,-0.0032394,0.08702,0.70205,REACTOME_HCMV_INFECTION,1
REACTOME_NUCLEAR_EVENTS_STIM...,SET,32,-0.081133,-0.0033825,0.15297,0.70208,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,1
GOBP_REGULATION_OF_GLUTAMATE...1,SET,6,-0.1994,-0.0036022,0.3759,0.7021,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_CLUSTERING,1
WP_15Q133_COPY_NUMBER_VARIAT...,SET,16,-0.10643,-0.003139,0.20063,0.70211,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_MITOCHONDRIAL_ELECTRON_...4,SET,12,-0.11899,-0.0030395,0.22429,0.70212,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C,1
REACTOME_SIALIC_ACID_METABOL...,SET,33,-0.080725,-0.0034176,0.15215,0.70213,REACTOME_SIALIC_ACID_METABOLISM,1
GOBP_MACROPHAGE_FUSION,SET,6,-0.201,-0.0036313,0.37887,0.70213,GOBP_MACROPHAGE_FUSION,1
TURASHVILI_BREAST_DUCTAL_CAR...2,SET,42,-0.073921,-0.0035298,0.13931,0.70215,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,1
RB_DN.V1_DN,SET,109,-0.045235,-0.0034733,0.085234,0.70219,RB_DN.V1_DN,1
GOBP_LONG_CHAIN_FATTY_ACID_T...,SET,65,-0.057593,-0.0034191,0.10848,0.70225,GOBP_LONG_CHAIN_FATTY_ACID_TRANSPORT,1
PID_IL2_PI3K_PATHWAY,SET,33,-0.082284,-0.0034836,0.15498,0.70226,PID_IL2_PI3K_PATHWAY,1
REACTOME_PHOSPHATE_BOND_HYDR...2,SET,7,-0.17935,-0.0034996,0.33778,0.70228,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS,1
HP_MITRAL_STENOSIS,SET,21,-0.10737,-0.0036273,0.20214,0.70234,HP_MITRAL_STENOSIS,1
GSE4984_UNTREATED_VS_GALECTI...2,SET,170,-0.034906,-0.0033417,0.06571,0.70236,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP,1
KEGG_MEDICUS_REFERENCE_CHOND...,SET,7,-0.17746,-0.0034627,0.33372,0.70255,KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS,1
WANG_CISPLATIN_RESPONSE_AND_...2,SET,159,-0.036975,-0.0034243,0.069526,0.70257,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1
REACTOME_TRAFFICKING_OF_MYRI...,SET,4,-0.21331,-0.0031466,0.4011,0.70257,REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM,1
GSE37533_PPARG1_FOXP3_VS_FOX...1,SET,189,-0.034402,-0.0034707,0.064689,0.70257,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,1
SANDERSON_PPARA_TARGETS,SET,15,-0.12149,-0.0034693,0.22843,0.70258,SANDERSON_PPARA_TARGETS,1
SASSON_RESPONSE_TO_GONADOTRO...1,SET,85,-0.049642,-0.0033682,0.093335,0.70259,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1
GSE36009_WT_VS_NLRP10_KO_DC_...1,SET,188,-0.031944,-0.0032143,0.060051,0.70262,GSE36009_WT_VS_NLRP10_KO_DC_DN,1
WP_KALLMANN_SYNDROME,SET,23,-0.096209,-0.0034014,0.18084,0.70263,WP_KALLMANN_SYNDROME,1
MIR192_3P,SET,95,-0.048045,-0.0034453,0.090304,0.70264,MIR192_3P,1
KEGG_MEDICUS_REFERENCE_BMP_H...2,SET,6,-0.16985,-0.0030684,0.31923,0.70265,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY_AUXILIARY_FACTOR,1
GSE14769_20MIN_VS_360MIN_LPS...2,SET,177,-0.032654,-0.0031892,0.061376,0.70265,GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP,1
GOBP_DNA_LIGATION,SET,16,-0.096101,-0.0028343,0.18059,0.70268,GOBP_DNA_LIGATION,1
HP_ABNORMAL_RENAL_PHYSIOLOGY,SET,625,-0.018403,-0.0033356,0.034584,0.70268,HP_ABNORMAL_RENAL_PHYSIOLOGY,1
REACTOME_CHOLINE_CATABOLISM,SET,6,-0.20885,-0.0037731,0.39245,0.7027,REACTOME_CHOLINE_CATABOLISM,1
MIR377_3P,SET,216,-0.030447,-0.0032814,0.057207,0.70271,MIR377_3P,1
CHANG_POU5F1_TARGETS_DN,SET,7,-0.1956,-0.0038167,0.36732,0.70281,CHANG_POU5F1_TARGETS_DN,1
ACEVEDO_LIVER_CANCER_WITH_H3...2,SET,229,-0.034152,-0.0037885,0.064127,0.70283,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,1
MIR1263,SET,50,-0.06811,-0.0035478,0.12788,0.70284,MIR1263,1
GSE2770_UNTREATED_VS_IL4_TRE...6,SET,187,-0.031921,-0.0032035,0.059931,0.70285,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
GOMF_LIGASE_ACTIVITY_FORMING...3,SET,22,-0.089194,-0.0030842,0.16745,0.70286,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS,1
GOMF_MISMATCH_REPAIR_COMPLEX...,SET,11,-0.13073,-0.0031973,0.24543,0.70286,GOMF_MISMATCH_REPAIR_COMPLEX_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...640,SET,61,-0.056703,-0.0032614,0.10644,0.70288,GOBP_NEGATIVE_REGULATION_OF_TOR_SIGNALING,1
PID_ALK2_PATHWAY,SET,10,-0.14892,-0.0034727,0.2795,0.70291,PID_ALK2_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...410,SET,11,-0.13066,-0.0031956,0.2452,0.70294,GOBP_NEGATIVE_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GOCC_OUTER_DYNEIN_ARM,SET,10,-0.14639,-0.0034138,0.27461,0.70301,GOCC_OUTER_DYNEIN_ARM,1
GSE6259_CD4_TCELL_VS_CD8_TCE...2,SET,173,-0.035707,-0.0034481,0.066965,0.70306,GSE6259_CD4_TCELL_VS_CD8_TCELL_UP,1
HP_MULTIPLE_MYELOMA,SET,7,-0.19205,-0.0037474,0.36012,0.70308,HP_MULTIPLE_MYELOMA,1
MIR769_5P,SET,46,-0.066901,-0.0033429,0.12542,0.70312,MIR769_5P,1
GSE15215_CD2_POS_VS_NEG_PDC_...2,SET,182,-0.033613,-0.0033284,0.063013,0.70313,GSE15215_CD2_POS_VS_NEG_PDC_UP,1
CUI_DEVELOPING_HEART_COMPACT...1,SET,15,-0.10928,-0.0031208,0.20484,0.70316,CUI_DEVELOPING_HEART_COMPACT_ATRIAL_CARDIOMYOCYTE,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...2,SET,96,-0.043615,-0.003144,0.081729,0.70321,GOBP_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS,1
WP_HIPPOCAMPAL_SYNAPTOGENESI...,SET,27,-0.10164,-0.0038929,0.1904,0.70327,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,1
HP_SUPRANUCLEAR_GAZE_PALSY,SET,49,-0.064926,-0.003348,0.12159,0.70332,HP_SUPRANUCLEAR_GAZE_PALSY,1
GSE13522_WT_VS_IFNAR_KO_SKIN...2,SET,187,-0.035291,-0.0035418,0.066083,0.70334,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,1
REACTOME_ERYTHROCYTES_TAKE_U...2,SET,7,-0.17968,-0.003506,0.33642,0.70336,REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE,1
HP_CENTRAL_HYPOVENTILATION,SET,11,-0.15717,-0.0038441,0.29428,0.70336,HP_CENTRAL_HYPOVENTILATION,1
GSE37301_HEMATOPOIETIC_STEM_...3,SET,186,-0.035186,-0.0035218,0.06588,0.70336,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN,1
MIR621,SET,30,-0.086198,-0.0034798,0.16133,0.70343,MIR621,1
HP_SPARSE_BODY_HAIR,SET,57,-0.065594,-0.0036474,0.12276,0.70344,HP_SPARSE_BODY_HAIR,1
HP_THYROIDITIS,SET,45,-0.069057,-0.003413,0.12924,0.70345,HP_THYROIDITIS,1
GOCC_PERICENTRIC_HETEROCHROM...,SET,27,-0.088247,-0.00338,0.16512,0.70348,GOCC_PERICENTRIC_HETEROCHROMATIN,1
SAKAI_TUMOR_INFILTRATING_MON...2,SET,26,-0.088778,-0.0033368,0.16611,0.70349,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,1
HP_SCANNING_SPEECH,SET,14,-0.13339,-0.0036802,0.24956,0.7035,HP_SCANNING_SPEECH,1
GOMF_IMPORTIN_ALPHA_FAMILY_P...,SET,9,-0.14598,-0.0032298,0.2731,0.70351,GOMF_IMPORTIN_ALPHA_FAMILY_PROTEIN_BINDING,1
GOMF_UBIQUITIN_PROTEIN_TRANS...3,SET,29,-0.089879,-0.0035675,0.16808,0.70358,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY,1
HP_BRACHYDACTYLY,SET,337,-0.024734,-0.0033185,0.046255,0.70358,HP_BRACHYDACTYLY,1
HP_PROMINENT_NOSE,SET,86,-0.048894,-0.0033369,0.091431,0.70359,HP_PROMINENT_NOSE,1
MIR4309,SET,40,-0.068307,-0.0031833,0.12768,0.70366,MIR4309,1
GOBP_REGULATORY_NCRNA_PROCES...,SET,65,-0.054214,-0.0032185,0.10133,0.70368,GOBP_REGULATORY_NCRNA_PROCESSING,1
GOBP_ISOPRENOID_METABOLIC_PR...,SET,129,-0.042982,-0.0035884,0.080328,0.7037,GOBP_ISOPRENOID_METABOLIC_PROCESS,1
HOXC13_TARGET_GENES,SET,95,-0.046364,-0.0033248,0.08664,0.70372,HOXC13_TARGET_GENES,1
HP_UPPER_EYELID_EDEMA,SET,6,-0.2088,-0.0037721,0.39015,0.70373,HP_UPPER_EYELID_EDEMA,1
BIOCARTA_CACAM_PATHWAY,SET,9,-0.17812,-0.0039407,0.33276,0.70376,BIOCARTA_CACAM_PATHWAY,1
HP_HYPOPLASIA_OF_THE_VAGINA,SET,13,-0.13299,-0.0035358,0.24845,0.70377,HP_HYPOPLASIA_OF_THE_VAGINA,1
GSE37416_CTRL_VS_3H_F_TULARE...2,SET,169,-0.033722,-0.0032189,0.062996,0.70378,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
chr14q23,SET,53,-0.12421,-0.0066609,0.232,0.70381,chr14q23,1
GOCC_TRANSCRIPTION_EXPORT_CO...1,SET,10,-0.11686,-0.0027253,0.21828,0.70381,GOCC_TRANSCRIPTION_EXPORT_COMPLEX,1
GSE17974_IL4_AND_ANTI_IL12_V...2,SET,149,-0.035882,-0.0032177,0.067005,0.70385,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP,1
GOBP_INDOLALKYLAMINE_METABOL...,SET,11,-0.15426,-0.0037728,0.288,0.70389,GOBP_INDOLALKYLAMINE_METABOLIC_PROCESS,1
MIKKELSEN_IPS_LCP_WITH_H3K27...,SET,10,-0.13697,-0.0031941,0.25567,0.70392,MIKKELSEN_IPS_LCP_WITH_H3K27ME3,1
REACTOME_REGULATION_OF_HOMOT...,SET,30,-0.088993,-0.0035926,0.16607,0.70398,REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
HP_HYPOPLASIA_OF_THE_EPIGLOT...,SET,9,-0.15608,-0.0034531,0.29119,0.70402,HP_HYPOPLASIA_OF_THE_EPIGLOTTIS,1
GALLUZZI_PREVENT_MITOCHONDIA...,SET,14,-0.13288,-0.0036662,0.2479,0.70403,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,1
HP_OPPORTUNISTIC_BACTERIAL_I...,SET,22,-0.10379,-0.0035888,0.19357,0.70407,HP_OPPORTUNISTIC_BACTERIAL_INFECTION,1
KEGG_MEDICUS_VARIANT_MUTATIO...31,SET,19,-0.10987,-0.003531,0.20492,0.70408,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY,1
HP_ANISOMETROPIA,SET,4,-0.18675,-0.0027549,0.34821,0.70413,HP_ANISOMETROPIA,1
HP_BROAD_BASED_GAIT,SET,99,-0.044813,-0.0032802,0.083555,0.70413,HP_BROAD_BASED_GAIT,1
GOBP_NEGATIVE_REGULATION_OF_...580,SET,5,-0.20788,-0.0034284,0.38758,0.70414,GOBP_NEGATIVE_REGULATION_OF_SATELLITE_CELL_DIFFERENTIATION,1
WP_NRF2ARE_REGULATION,SET,23,-0.098114,-0.0034687,0.18291,0.70416,WP_NRF2ARE_REGULATION,1
MORF_CAMK4,SET,253,-0.029716,-0.0034625,0.05536,0.70428,MORF_CAMK4,1
ZNF175_TARGET_GENES,SET,627,-0.018557,-0.0033687,0.034572,0.70429,ZNF175_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...369,SET,56,-0.063894,-0.0035216,0.11901,0.70432,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,1
GOBP_MICROVILLUS_ORGANIZATION,SET,27,-0.089678,-0.0034348,0.16703,0.70433,GOBP_MICROVILLUS_ORGANIZATION,1
HP_HYPOINTENSITY_OF_CEREBRAL...,SET,12,-0.13429,-0.0034304,0.25004,0.70439,HP_HYPOINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,1
REACTOME_HORMONE_LIGAND_BIND...,SET,12,-0.1344,-0.0034333,0.25017,0.70445,REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,1
GSE32901_TH1_VS_TH17_ENRICHE...1,SET,142,-0.038541,-0.0033747,0.071726,0.70448,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN,1
GOCC_90S_PRERIBOSOME,SET,23,-0.089837,-0.0031761,0.16718,0.70449,GOCC_90S_PRERIBOSOME,1
NABA_CORE_MATRISOME,SET,252,-0.031834,-0.0037021,0.059202,0.70461,NABA_CORE_MATRISOME,1
GSE24142_ADULT_VS_FETAL_DN2_...1,SET,170,-0.036222,-0.0034676,0.067357,0.70463,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...423,SET,4,-0.21053,-0.0031056,0.39144,0.70465,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_ANERGY,1
MORF_MLLT10,SET,268,-0.028594,-0.0034277,0.053163,0.70466,MORF_MLLT10,1
GOCC_NUCLEAR_LAMINA,SET,10,-0.13895,-0.0032404,0.25835,0.70466,GOCC_NUCLEAR_LAMINA,1
WP_IL5_SIGNALING,SET,38,-0.079465,-0.0036097,0.14774,0.70467,WP_IL5_SIGNALING,1
BIOCARTA_CCR5_PATHWAY,SET,17,-0.12383,-0.0037643,0.2302,0.70468,BIOCARTA_CCR5_PATHWAY,1
GOBP_INTESTINAL_STEM_CELL_HO...,SET,5,-0.20783,-0.0034275,0.38631,0.7047,GOBP_INTESTINAL_STEM_CELL_HOMEOSTASIS,1
GOCC_APICAL_CORTEX,SET,8,-0.15422,-0.003217,0.28665,0.70472,GOCC_APICAL_CORTEX,1
HP_ABNORMAL_PLATELET_VOLUME,SET,25,-0.094276,-0.0034748,0.17523,0.70472,HP_ABNORMAL_PLATELET_VOLUME,1
GOBP_NEGATIVE_REGULATION_OF_...446,SET,5,-0.23891,-0.0039401,0.44398,0.70474,GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,1
MARKEY_RB1_CHRONIC_LOF_UP,SET,106,-0.044781,-0.0033911,0.08321,0.70477,MARKEY_RB1_CHRONIC_LOF_UP,1
MODULE_280,SET,44,-0.072028,-0.0035201,0.1338,0.70482,MODULE_280,1
HP_BLIND_VAGINA,SET,2,-0.3148,-0.0032838,0.5846,0.70488,HP_BLIND_VAGINA,1
HP_HAMARTOMA_OF_THE_ORBITAL_...,SET,29,-0.079175,-0.0031427,0.14702,0.70489,HP_HAMARTOMA_OF_THE_ORBITAL_REGION,1
HP_HEART_BLOCK,SET,116,-0.04334,-0.0034324,0.08048,0.70489,HP_HEART_BLOCK,1
GOMF_GUANYLATE_KINASE_ACTIVI...,SET,7,-0.17664,-0.0034468,0.328,0.7049,GOMF_GUANYLATE_KINASE_ACTIVITY,1
MIR3182,SET,238,-0.030367,-0.0034333,0.056375,0.70494,MIR3182,1
KEGG_MEDICUS_VARIANT_AMPLIFI...15,SET,14,-0.13105,-0.0036157,0.24326,0.70496,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,1
GOBP_NUCLEOSIDE_MONOPHOSPHAT...2,SET,18,-0.11865,-0.0037113,0.22018,0.705,GOBP_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
GOBP_CALCINEURIN_MEDIATED_SI...,SET,47,-0.066264,-0.0033467,0.12296,0.70502,GOBP_CALCINEURIN_MEDIATED_SIGNALING,1
GOMF_CCR3_CHEMOKINE_RECEPTOR...,SET,4,-0.24803,-0.0036588,0.46025,0.70502,GOMF_CCR3_CHEMOKINE_RECEPTOR_BINDING,1
JI_RESPONSE_TO_FSH_UP,SET,57,-0.058998,-0.0032806,0.10946,0.70505,JI_RESPONSE_TO_FSH_UP,1
ZSCAN4_TARGET_GENES,SET,1097,-0.01459,-0.0034565,0.027067,0.70506,ZSCAN4_TARGET_GENES,1
ZHONG_PFC_MAJOR_TYPES_OPC,SET,86,-0.05465,-0.0037297,0.10138,0.70508,ZHONG_PFC_MAJOR_TYPES_OPC,1
GNF2_RTN1,SET,47,-0.074884,-0.0037821,0.13889,0.70511,GNF2_RTN1,1
GSE15324_NAIVE_VS_ACTIVATED_...3,SET,185,-0.032395,-0.0032338,0.060072,0.70515,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN,1
WP_INHIBITION_OF_EXOSOME_BIO...,SET,17,-0.10103,-0.0030713,0.18733,0.70516,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,1
GOBP_GROWTH_HORMONE_SECRETION,SET,12,-0.14326,-0.0036595,0.26559,0.70519,GOBP_GROWTH_HORMONE_SECRETION,1
GSE37532_TREG_VS_TCONV_CD4_T...1,SET,173,-0.034781,-0.0033587,0.064481,0.70519,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN,1
WP_RESOLVIN_E1_AND_RESOLVIN_...,SET,11,-0.14524,-0.0035522,0.2692,0.70523,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,1
GOBP_POSITIVE_REGULATION_OF_...503,SET,17,-0.12012,-0.0036517,0.22255,0.70531,GOBP_POSITIVE_REGULATION_OF_MYELINATION,1
SWEET_LUNG_CANCER_KRAS_UP,SET,427,-0.02276,-0.0034287,0.042154,0.70537,SWEET_LUNG_CANCER_KRAS_UP,1
GOBP_TYPE_III_INTERFERON_PRO...,SET,3,-0.24633,-0.003147,0.45619,0.70539,GOBP_TYPE_III_INTERFERON_PRODUCTION,1
REACTOME_METABOLISM_OF_NUCLE...,SET,92,-0.049772,-0.0035127,0.092168,0.7054,REACTOME_METABOLISM_OF_NUCLEOTIDES,1
GSE360_L_DONOVANI_VS_B_MALAY...4,SET,176,-0.036032,-0.0035092,0.066721,0.70541,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP,1
REACTOME_P2Y_RECEPTORS,SET,9,-0.16765,-0.0037091,0.31041,0.70543,REACTOME_P2Y_RECEPTORS,1
GOBP_RESPONSE_TO_LEUKEMIA_IN...,SET,92,-0.051286,-0.0036195,0.094942,0.70546,GOBP_RESPONSE_TO_LEUKEMIA_INHIBITORY_FACTOR,1
GNF2_H2AFX,SET,29,-0.089756,-0.0035626,0.16614,0.70548,GNF2_H2AFX,1
GOBP_NEGATIVE_REGULATION_OF_...704,SET,7,-0.19073,-0.0037216,0.35301,0.7055,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,1
HP_LOWER_LIMB_UNDERGROWTH,SET,14,-0.1251,-0.0034514,0.23153,0.70551,HP_LOWER_LIMB_UNDERGROWTH,1
WP_MIR124_PREDICTED_INTERACT...,SET,6,-0.17207,-0.0031086,0.31839,0.70555,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...34,SET,13,-0.11716,-0.0031148,0.21678,0.70555,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_WITH_A_FLAVIN_AS_ACCEPTOR,1
GSE16385_MONOCYTE_VS_12H_IFN...2,SET,183,-0.033649,-0.003341,0.06226,0.70556,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,1
MSX1_TARGET_GENES,SET,167,-0.036245,-0.0034394,0.067035,0.70564,MSX1_TARGET_GENES,1
GOBP_REGULATION_OF_CALCIUM_I...5,SET,11,-0.12548,-0.0030691,0.23206,0.70565,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_SMALL_INTESTINAL_DYSMOTIL...,SET,6,-0.16573,-0.002994,0.30648,0.70565,HP_SMALL_INTESTINAL_DYSMOTILITY,1
GOBP_TORC2_SIGNALING,SET,10,-0.1557,-0.0036309,0.28792,0.70566,GOBP_TORC2_SIGNALING,1
MIR770_5P,SET,93,-0.048993,-0.0034764,0.090598,0.70567,MIR770_5P,1
CHIANG_LIVER_CANCER_SUBCLASS...4,SET,22,-0.10894,-0.003767,0.20144,0.70568,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,1
GSE5589_LPS_VS_LPS_AND_IL6_S...2,SET,180,-0.035032,-0.0034499,0.064774,0.70568,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
MORF_ATOX1,SET,68,-0.052024,-0.0031587,0.096189,0.70569,MORF_ATOX1,1
GSE20727_ROS_INH_VS_ROS_INH_...2,SET,177,-0.034979,-0.0034162,0.064659,0.70574,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,1
GSE21063_WT_VS_NFATC1_KO_16H...1,SET,164,-0.039358,-0.0037013,0.07274,0.70577,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN,1
MIR552_5P,SET,175,-0.035185,-0.0034171,0.06501,0.70582,MIR552_5P,1
KEGG_MEDICUS_REFERENCE_EGF_E...2,SET,13,-0.1244,-0.0033075,0.22982,0.70585,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY,1
KEGG_ADHERENS_JUNCTION,SET,66,-0.05904,-0.0035317,0.10906,0.70587,KEGG_ADHERENS_JUNCTION,1
GOBP_MITOCHONDRIAL_PROTEIN_P...,SET,12,-0.12805,-0.003271,0.23653,0.70587,GOBP_MITOCHONDRIAL_PROTEIN_PROCESSING,1
GSE36392_MAC_VS_NEUTROPHIL_I...1,SET,186,-0.036174,-0.0036207,0.066815,0.70588,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,1
VETTER_TARGETS_OF_PRKCA_AND_...2,SET,16,-0.12376,-0.00365,0.22857,0.7059,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1
GOBP_POSITIVE_REGULATION_OF_...73,SET,8,-0.15848,-0.0033058,0.2927,0.7059,GOBP_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1
HP_PHOCOMELIA,SET,7,-0.18251,-0.0035612,0.33706,0.7059,HP_PHOCOMELIA,1
GOBP_RESPONSE_TO_THYROXINE,SET,4,-0.26573,-0.0039199,0.49056,0.70598,GOBP_RESPONSE_TO_THYROXINE,1
GSE37416_CTRL_VS_3H_F_TULARE...1,SET,176,-0.034585,-0.0033683,0.063812,0.70608,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
HP_ANOMALOUS_TRICHROMACY,SET,9,-0.20508,-0.0045373,0.37835,0.7061,HP_ANOMALOUS_TRICHROMACY,1
HP_TRITANOMALY,SET,9,-0.20508,-0.0045373,0.37835,0.7061,HP_TRITANOMALY,1
TCCCCAC_MIR491,SET,58,-0.058005,-0.0032534,0.107,0.70613,TCCCCAC_MIR491,1
VALK_AML_CLUSTER_12,SET,24,-0.092654,-0.0033461,0.17084,0.70621,VALK_AML_CLUSTER_12,1
MIR1276,SET,163,-0.03621,-0.003395,0.066761,0.70622,MIR1276,1
MIR1470,SET,14,-0.11907,-0.0032852,0.21938,0.70635,MIR1470,1
GOBP_GLUTATHIONE_METABOLIC_P...,SET,46,-0.074014,-0.0036983,0.13636,0.70635,GOBP_GLUTATHIONE_METABOLIC_PROCESS,1
WP_GNAQ_PATHWAYS_IN_PORTWINE...,SET,20,-0.10997,-0.0036256,0.20259,0.70636,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,1
MIR1305,SET,460,-0.022442,-0.0035058,0.041329,0.70643,MIR1305,1
HP_ABNORMALITY_OF_FLUID_REGU...,SET,706,-0.018431,-0.0035424,0.033942,0.70644,HP_ABNORMALITY_OF_FLUID_REGULATION,1
AAGCCAT_MIR135A_MIR135B,SET,306,-0.027304,-0.0034937,0.050274,0.70646,AAGCCAT_MIR135A_MIR135B,1
REACTOME_UNBLOCKING_OF_NMDA_...,SET,19,-0.11629,-0.0037372,0.21409,0.70649,REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION,1
GOBP_REGULATION_OF_MORPHOGEN...1,SET,59,-0.064671,-0.0036584,0.11901,0.70657,GOBP_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
KEGG_MEDICUS_REFERENCE_KITLG...1,SET,11,-0.14425,-0.0035279,0.26542,0.70659,KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY,1
MODULE_321,SET,107,-0.047942,-0.0036475,0.088216,0.70659,MODULE_321,1
GOBP_PROTEIN_PROCESSING,SET,217,-0.031797,-0.0034347,0.058501,0.70661,GOBP_PROTEIN_PROCESSING,1
GAVISH_3CA_METAPROGRAM_ENDOT...9,SET,45,-0.077185,-0.0038147,0.142,0.70662,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7,1
HP_AUTOAMPUTATION,SET,15,-0.11818,-0.0033749,0.21741,0.70663,HP_AUTOAMPUTATION,1
HP_DEMYELINATING_PERIPHERAL_...,SET,49,-0.063136,-0.0032557,0.11613,0.70665,HP_DEMYELINATING_PERIPHERAL_NEUROPATHY,1
HP_HYDROURETER,SET,65,-0.057959,-0.0034408,0.10656,0.70674,HP_HYDROURETER,1
GOBP_REGULATION_OF_PROTEIN_L...15,SET,16,-0.11627,-0.0034293,0.21374,0.70677,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
REACTOME_SIGNALING_BY_MRAS_C...,SET,7,-0.15462,-0.003017,0.28422,0.70678,REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS,1
AKT_UP.V1_DN,SET,178,-0.035839,-0.00351,0.065858,0.70684,AKT_UP.V1_DN,1
HP_FLARING_OF_RIB_CAGE,SET,7,-0.19823,-0.0038681,0.36422,0.70687,HP_FLARING_OF_RIB_CAGE,1
HP_ABNORMAL_T_CELL_SUBSET_DI...,SET,69,-0.057127,-0.0034938,0.10493,0.70692,HP_ABNORMAL_T_CELL_SUBSET_DISTRIBUTION,1
MIR6774_5P,SET,43,-0.070548,-0.0034085,0.12957,0.70694,MIR6774_5P,1
GSE41867_DAY6_VS_DAY15_LCMV_...3,SET,142,-0.039897,-0.0034934,0.073267,0.70696,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
NADELLA_PRKAR1A_TARGETS_UP,SET,9,-0.18187,-0.0040238,0.33397,0.70697,NADELLA_PRKAR1A_TARGETS_UP,1
GOBP_SKELETAL_MUSCLE_CELL_DI...,SET,72,-0.055537,-0.0034693,0.10198,0.70697,GOBP_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
GOMF_TRANSFERASE_ACTIVITY_TR...1,SET,54,-0.066935,-0.0036229,0.12292,0.70697,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS,1
GSE7509_FCGRIIB_VS_TNFA_IL1B...1,SET,131,-0.039958,-0.0033615,0.073375,0.70697,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,1
HP_ABSENT_OR_MINIMALLY_OSSIF...,SET,11,-0.13847,-0.0033867,0.25427,0.70698,HP_ABSENT_OR_MINIMALLY_OSSIFIED_VERTEBRAL_BODIES,1
GOBP_REGULATION_OF_PROSTAGLA...,SET,14,-0.15024,-0.0041452,0.27562,0.70715,GOBP_REGULATION_OF_PROSTAGLANDIN_SECRETION,1
GOMF_GLUTATHIONE_TRANSFERASE...,SET,23,-0.11887,-0.0042026,0.21807,0.70716,GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY,1
GOBP_INTRACELLULAR_LIPID_TRA...,SET,44,-0.067504,-0.0032991,0.12383,0.70717,GOBP_INTRACELLULAR_LIPID_TRANSPORT,1
HP_STATUS_EPILEPTICUS,SET,182,-0.034645,-0.0034306,0.063527,0.70725,HP_STATUS_EPILEPTICUS,1
HP_WEBBED_NECK,SET,104,-0.044528,-0.0033402,0.081644,0.70725,HP_WEBBED_NECK,1
GSE33162_UNTREATED_VS_4H_LPS...4,SET,185,-0.032929,-0.0032871,0.060378,0.70725,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP,1
GOBP_REGULATION_OF_PROTEIN_A...2,SET,5,-0.17119,-0.0028233,0.31379,0.70731,GOBP_REGULATION_OF_PROTEIN_ADP_RIBOSYLATION,1
REACTOME_TFAP2_AP_2_FAMILY_R...1,SET,5,-0.22237,-0.0036673,0.40757,0.70732,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS,1
MODULE_255,SET,406,-0.023261,-0.0034189,0.042635,0.70732,MODULE_255,1
MODULE_116,SET,13,-0.13042,-0.0034675,0.23903,0.70733,MODULE_116,1
GSE339_CD4POS_VS_CD4CD8DN_DC...3,SET,185,-0.034346,-0.0034285,0.062947,0.70734,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,1
MIR3162_3P,SET,20,-0.10842,-0.0035748,0.19856,0.70748,MIR3162_3P,1
GSE34205_RSV_VS_FLU_INF_INFA...1,SET,175,-0.036368,-0.0035319,0.066601,0.70748,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN,1
MIR3909,SET,68,-0.058268,-0.0035378,0.10668,0.70753,MIR3909,1
HE_LIM_SUN_FETAL_LUNG_C0_ALV...,SET,7,-0.20254,-0.003952,0.37077,0.70755,HE_LIM_SUN_FETAL_LUNG_C0_ALVEOLAR_FIBROBLAST,1
GOBP_REGULATION_OF_PROTEIN_L...11,SET,166,-0.035945,-0.0034008,0.065799,0.70756,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
GOCC_HEMOGLOBIN_COMPLEX,SET,8,-0.19532,-0.0040743,0.35755,0.70756,GOCC_HEMOGLOBIN_COMPLEX,1
MIR3681_5P,SET,31,-0.090673,-0.0037209,0.16589,0.70767,MIR3681_5P,1
GOBP_REGULATION_OF_DNA_METAB...,SET,447,-0.021524,-0.0033157,0.039377,0.70767,GOBP_REGULATION_OF_DNA_METABOLIC_PROCESS,1
GSE25677_MPL_VS_MPL_AND_R848...1,SET,118,-0.042522,-0.0033963,0.077786,0.70769,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN,1
GOBP_REGULATION_OF_CELL_CHEM...,SET,5,-0.22116,-0.0036474,0.4045,0.70772,GOBP_REGULATION_OF_CELL_CHEMOTAXIS_TO_FIBROBLAST_GROWTH_FACTOR,1
GOBP_TRANSCRIPTION_DEPENDENT...,SET,7,-0.17402,-0.0033957,0.31823,0.70775,GOBP_TRANSCRIPTION_DEPENDENT_TETHERING_OF_RNA_POLYMERASE_II_GENE_DNA_AT_NUCLEAR_PERIPHERY,1
GOBP_RESPONSE_TO_OXYGEN_CONT...,SET,1510,-0.013008,-0.0035722,0.023785,0.70777,GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,1
GSE22886_NAIVE_BCELL_VS_MONO...1,SET,189,-0.034592,-0.0034899,0.063238,0.70781,GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN,1
HP_ABNORMALITY_OF_TIBIAL_EPI...,SET,4,-0.26932,-0.0039728,0.49232,0.70782,HP_ABNORMALITY_OF_TIBIAL_EPIPHYSES,1
MIR3194_3P,SET,90,-0.048973,-0.0034187,0.089514,0.70784,MIR3194_3P,1
BOQUEST_STEM_CELL_DN,SET,205,-0.036169,-0.0037986,0.066078,0.70793,BOQUEST_STEM_CELL_DN,1
GSE2128_CTRL_VS_MIMETOPE_NEG...3,SET,164,-0.036039,-0.0033892,0.065842,0.70793,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN,1
MIR10398_5P,SET,70,-0.055393,-0.0034121,0.10119,0.70795,MIR10398_5P,1
GOBP_XENOBIOTIC_TRANSPORT_AC...,SET,6,-0.2206,-0.0039854,0.40289,0.708,GOBP_XENOBIOTIC_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,1
CLASPER_LYMPHATIC_VESSELS_DU...1,SET,32,-0.092007,-0.0038359,0.16801,0.70802,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,1
HP_ABNORMAL_OVARIAN_MORPHOLO...,SET,158,-0.03784,-0.0034935,0.069087,0.70805,HP_ABNORMAL_OVARIAN_MORPHOLOGY,1
MIR451A,SET,6,-0.21609,-0.0039038,0.39442,0.7081,MIR451A,1
HP_BILIARY_CIRRHOSIS,SET,19,-0.11637,-0.0037399,0.21239,0.70812,HP_BILIARY_CIRRHOSIS,1
NABA_ECM_AFFILIATED,SET,151,-0.043393,-0.0039171,0.079194,0.70813,NABA_ECM_AFFILIATED,1
MIR7152_3P,SET,87,-0.048581,-0.0033346,0.088654,0.70814,MIR7152_3P,1
HP_HYPOPLASIA_OF_THE_COCHLEA,SET,8,-0.16977,-0.0035414,0.30977,0.70817,HP_HYPOPLASIA_OF_THE_COCHLEA,1
HP_3_4_FINGER_CUTANEOUS_SYND...,SET,6,-0.22174,-0.0040059,0.40458,0.70818,HP_3_4_FINGER_CUTANEOUS_SYNDACTYLY,1
GSE17580_UNINFECTED_VS_S_MAN...2,SET,187,-0.034502,-0.0034625,0.06294,0.70821,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP,1
PEA3_Q6,SET,242,-0.032065,-0.0036552,0.05849,0.70822,PEA3_Q6,1
GOBP_REGULATION_OF_SYNCYTIUM...,SET,27,-0.094368,-0.0036144,0.17212,0.70824,GOBP_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
HP_ABNORMALITY_OF_THE_CRUS_O...,SET,10,-0.15616,-0.0036417,0.28482,0.70824,HP_ABNORMALITY_OF_THE_CRUS_OF_THE_HELIX,1
GSE30971_WBP7_HET_VS_KO_MACR...6,SET,184,-0.035141,-0.0034985,0.064096,0.70824,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP,1
MODULE_281,SET,28,-0.084861,-0.0033098,0.15476,0.70827,MODULE_281,1
GOBP_POSITIVE_REGULATION_OF_...220,SET,118,-0.042355,-0.0033829,0.077231,0.70829,GOBP_POSITIVE_REGULATION_OF_DNA_REPAIR,1
GOCC_POSTSYNAPTIC_CYTOSOL,SET,13,-0.13243,-0.0035209,0.24147,0.7083,GOCC_POSTSYNAPTIC_CYTOSOL,1
SMTTTTGT_UNKNOWN,SET,359,-0.025939,-0.0035898,0.047295,0.70831,SMTTTTGT_UNKNOWN,1
HP_RECURRENT_SKIN_INFECTIONS,SET,122,-0.042483,-0.0034499,0.07745,0.70833,HP_RECURRENT_SKIN_INFECTIONS,1
BENPORATH_EED_TARGETS,SET,902,-0.01807,-0.0039039,0.032916,0.70849,BENPORATH_EED_TARGETS,1
MODULE_571,SET,14,-0.13207,-0.0036438,0.24057,0.70849,MODULE_571,1
REACTOME_GLYCOSPHINGOLIPID_B...,SET,19,-0.11708,-0.0037626,0.21318,0.70856,REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS,1
HP_HYPOMIMIC_FACE,SET,35,-0.079651,-0.0034727,0.14502,0.70857,HP_HYPOMIMIC_FACE,1
GOBP_REGULATION_OF_KERATINOC...1,SET,35,-0.087445,-0.0038125,0.15919,0.7086,GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
HP_HEMOLYTIC_UREMIC_SYNDROME,SET,14,-0.13619,-0.0037574,0.24792,0.7086,HP_HEMOLYTIC_UREMIC_SYNDROME,1
GOBP_REGULATION_OF_TRANSLATI...9,SET,7,-0.17101,-0.003337,0.31131,0.70861,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE,1
GOBP_POSITIVE_REGULATION_OF_...622,SET,7,-0.16768,-0.0032719,0.30508,0.70871,GOBP_POSITIVE_REGULATION_OF_PROTEIN_GLYCOSYLATION,1
GAO_LARGE_INTESTINE_ADULT_CI...,SET,307,-0.028438,-0.0036447,0.051735,0.70873,GAO_LARGE_INTESTINE_ADULT_CI_MESENCHYMAL_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...264,SET,8,-0.16729,-0.0034896,0.3042,0.70882,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,1
GOBP_ANTEROGRADE_NEURONAL_DE...,SET,6,-0.18751,-0.0033875,0.34091,0.70885,GOBP_ANTEROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,1
GSE21670_TGFB_VS_IL6_TREATED...4,SET,188,-0.034657,-0.0034873,0.062996,0.70889,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
GSE9601_UNTREATED_VS_PI3K_IN...2,SET,157,-0.036016,-0.0033146,0.065466,0.70889,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,1
MIR5588_3P,SET,41,-0.072707,-0.0034303,0.13215,0.7089,MIR5588_3P,1
GSE45739_UNSTIM_VS_ACD3_ACD2...1,SET,176,-0.037296,-0.0036323,0.067781,0.70892,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN,1
GOBP_NEUROBLAST_PROLIFERATION,SET,78,-0.055922,-0.0036354,0.10159,0.709,GOBP_NEUROBLAST_PROLIFERATION,1
GSE12198_LOW_IL2_STIM_NK_CEL...1,SET,189,-0.033991,-0.0034293,0.061749,0.709,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN,1
MIR9500,SET,145,-0.038406,-0.003398,0.069757,0.70903,MIR9500,1
GOMF_PHEROMONE_RECEPTOR_ACTI...,SET,3,-0.2976,-0.003802,0.54035,0.7091,GOMF_PHEROMONE_RECEPTOR_ACTIVITY,1
GOBP_ACTIVATION_OF_TRANSMEMB...,SET,6,-0.17782,-0.0032125,0.32261,0.70925,GOBP_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
REACTOME_GAP_JUNCTION_DEGRAD...,SET,12,-0.14275,-0.0036464,0.25895,0.70926,REACTOME_GAP_JUNCTION_DEGRADATION,1
GOBP_NUCLEOSIDE_PHOSPHATE_CA...,SET,165,-0.036023,-0.0033979,0.065342,0.70928,GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS,1
HP_PROGRESSIVE_SPASTIC_PARAP...2,SET,26,-0.090378,-0.003397,0.16393,0.70929,HP_PROGRESSIVE_SPASTIC_PARAPLEGIA,1
RB_P130_DN.V1_UP,SET,117,-0.044463,-0.0035363,0.08063,0.70933,RB_P130_DN.V1_UP,1
chr1q32,SET,139,-0.086945,-0.0075327,0.15764,0.70936,chr1q32,1
GOBP_TISSUE_REMODELING,SET,166,-0.038864,-0.0036769,0.070468,0.70936,GOBP_TISSUE_REMODELING,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...5,SET,23,-0.097903,-0.0034613,0.17748,0.70939,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
GOBP_T_CELL_RECEPTOR_SIGNALI...,SET,127,-0.042898,-0.0035537,0.077736,0.70947,GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
GSE10240_IL17_VS_IL17_AND_IL...1,SET,187,-0.035229,-0.0035355,0.06383,0.70949,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...19,SET,11,-0.14184,-0.0034691,0.25695,0.70952,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
GSE17186_BLOOD_VS_CORD_BLOOD...2,SET,187,-0.034123,-0.0034245,0.061816,0.70953,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP,1
HP_CSF_LYMPHOCYTIC_PLEIOCYTO...,SET,18,-0.10609,-0.0033186,0.19213,0.70958,HP_CSF_LYMPHOCYTIC_PLEIOCYTOSIS,1
REACTOME_FRS_MEDIATED_FGFR2_...,SET,24,-0.097951,-0.0035374,0.17738,0.7096,REACTOME_FRS_MEDIATED_FGFR2_SIGNALING,1
HP_APHTHOUS_ULCER,SET,6,-0.22157,-0.0040029,0.40121,0.70961,HP_APHTHOUS_ULCER,1
WP_INSULIN_SIGNALING_IN_ADIP...1,SET,8,-0.17951,-0.0037445,0.32501,0.70963,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,1
WP_INSULIN_SIGNALING_IN_ADIP...2,SET,8,-0.17951,-0.0037445,0.32501,0.70963,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,1
HP_NASOGASTRIC_TUBE_FEEDING,SET,34,-0.08069,-0.0034674,0.14596,0.7098,HP_NASOGASTRIC_TUBE_FEEDING,1
FOXO1_01,SET,219,-0.033509,-0.003636,0.060613,0.70981,FOXO1_01,1
HP_ABNORMALITY_OF_CONNECTIVE...,SET,1351,-0.013356,-0.0034856,0.024159,0.70981,HP_ABNORMALITY_OF_CONNECTIVE_TISSUE,1
GSE20715_0H_VS_6H_OZONE_LUNG...1,SET,186,-0.034506,-0.0034538,0.062399,0.70986,GSE20715_0H_VS_6H_OZONE_LUNG_DN,1
HP_EXTERNAL_GENITAL_HYPOPLAS...,SET,436,-0.022916,-0.0034875,0.041439,0.70987,HP_EXTERNAL_GENITAL_HYPOPLASIA,1
MODULE_141,SET,14,-0.14508,-0.0040028,0.26224,0.70995,MODULE_141,1
HP_SEX_REVERSAL,SET,11,-0.15864,-0.00388,0.28674,0.70995,HP_SEX_REVERSAL,1
MIR3115,SET,33,-0.075765,-0.0032077,0.13692,0.70998,MIR3115,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...3,SET,6,-0.18754,-0.0033881,0.33882,0.71004,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_INDEPENDENT_DECAY,1
MODULE_27,SET,333,-0.028029,-0.0037386,0.05062,0.71011,MODULE_27,1
GOMF_PEPTIDASE_REGULATOR_ACT...,SET,208,-0.036235,-0.0038331,0.065439,0.71012,GOMF_PEPTIDASE_REGULATOR_ACTIVITY,1
GOBP_RESPONSE_TO_TEMPERATURE...,SET,160,-0.037157,-0.0034519,0.067084,0.71017,GOBP_RESPONSE_TO_TEMPERATURE_STIMULUS,1
HP_FOOD_ALLERGY,SET,15,-0.1244,-0.0035527,0.22455,0.71021,HP_FOOD_ALLERGY,1
HP_APLASIA_HYPOPLASIA_OF_THE...3,SET,5,-0.23813,-0.0039273,0.42978,0.71023,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_METACARPAL,1
HP_HYPERACTIVE_RENIN_ANGIOTE...,SET,8,-0.19812,-0.0041327,0.35756,0.71024,HP_HYPERACTIVE_RENIN_ANGIOTENSIN_SYSTEM,1
GOBP_NEGATIVE_REGULATION_OF_...73,SET,52,-0.065641,-0.0034867,0.11841,0.71033,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GOMF_UBIQUITIN_SPECIFIC_PROT...,SET,14,-0.11134,-0.0030719,0.20077,0.7104,GOMF_UBIQUITIN_SPECIFIC_PROTEASE_BINDING,1
GOMF_LAMININ_1_BINDING,SET,7,-0.21524,-0.0041999,0.38787,0.71053,GOMF_LAMININ_1_BINDING,1
GOBP_REGULATION_OF_HYDROGEN_...1,SET,7,-0.19428,-0.003791,0.34989,0.71064,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,1
MIR5190,SET,121,-0.044771,-0.0036209,0.080585,0.71075,MIR5190,1
HP_ABNORMAL_UPPER_LIMB_METAP...,SET,15,-0.14547,-0.0041542,0.26181,0.71076,HP_ABNORMAL_UPPER_LIMB_METAPHYSIS_MORPHOLOGY,1
GSE22025_UNTREATED_VS_PROGES...2,SET,181,-0.0357,-0.0035254,0.064251,0.71077,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP,1
GSE5542_IFNG_VS_IFNA_AND_IFN...1,SET,182,-0.034997,-0.0034655,0.062986,0.71077,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
GOBP_DENDRITIC_SPINE_MAINTEN...,SET,21,-0.11206,-0.0037857,0.20164,0.71079,GOBP_DENDRITIC_SPINE_MAINTENANCE,1
HP_RED_GREEN_DYSCHROMATOPSIA,SET,8,-0.16707,-0.0034851,0.30063,0.7108,HP_RED_GREEN_DYSCHROMATOPSIA,1
HP_SUBSTANTIA_NIGRA_GLIOSIS,SET,10,-0.15124,-0.0035268,0.27213,0.7108,HP_SUBSTANTIA_NIGRA_GLIOSIS,1
HP_LACK_OF_SKIN_ELASTICITY,SET,56,-0.066076,-0.0036419,0.11888,0.71082,HP_LACK_OF_SKIN_ELASTICITY,1
MODULE_173,SET,16,-0.13071,-0.0038551,0.2351,0.71088,MODULE_173,1
CAFFAREL_RESPONSE_TO_THC_UP,SET,29,-0.086289,-0.003425,0.15518,0.71091,CAFFAREL_RESPONSE_TO_THC_UP,1
SCHAEFFER_PROSTATE_DEVELOPME...3,SET,375,-0.02725,-0.0038526,0.048991,0.71097,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,1
GOBP_CELLULAR_RESPONSE_TO_ATP,SET,16,-0.12466,-0.0036766,0.2241,0.71098,GOBP_CELLULAR_RESPONSE_TO_ATP,1
GOBP_REGULATION_OF_ENDOCYTOS...,SET,269,-0.029432,-0.0035347,0.052912,0.71098,GOBP_REGULATION_OF_ENDOCYTOSIS,1
REACTOME_VOLTAGE_GATED_POTAS...,SET,42,-0.084813,-0.0040499,0.15244,0.71101,REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS,1
REACTOME_NF_KB_ACTIVATION_TH...,SET,11,-0.14713,-0.0035984,0.26442,0.71103,REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,1
GSE15930_NAIVE_VS_72H_IN_VIT...2,SET,188,-0.034182,-0.0034395,0.061433,0.71103,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP,1
MIR6842_5P,SET,143,-0.041109,-0.0036121,0.073875,0.71105,MIR6842_5P,1
HP_HYPERTONIA,SET,977,-0.015343,-0.0034423,0.027569,0.71107,HP_HYPERTONIA,1
HP_APLASIA_HYPOPLASIA_OF_THE...18,SET,10,-0.14778,-0.0034462,0.26544,0.71114,HP_APLASIA_HYPOPLASIA_OF_THE_COLON,1
GOBP_NADPH_OXIDATION,SET,6,-0.19546,-0.0035311,0.351,0.71119,GOBP_NADPH_OXIDATION,1
GOBP_LYMPHOCYTE_COSTIMULATION,SET,44,-0.077253,-0.0037755,0.13872,0.7112,GOBP_LYMPHOCYTE_COSTIMULATION,1
chr4q27,SET,14,-0.19617,-0.0054123,0.35219,0.71123,chr4q27,1
HP_PHYSICAL_URTICARIA,SET,14,-0.1304,-0.0035977,0.2341,0.71124,HP_PHYSICAL_URTICARIA,1
GOBP_REGULATION_OF_EPITHELIA...3,SET,14,-0.15057,-0.0041542,0.27028,0.71126,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOMF_CATALYTIC_ACTIVITY_ACTI...4,SET,109,-0.041709,-0.0032026,0.074858,0.71129,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA,1
MZF1_02,SET,220,-0.032547,-0.0035396,0.058412,0.7113,MZF1_02,1
GOBP_REGULATION_OF_GROWTH_RA...,SET,5,-0.21204,-0.003497,0.38055,0.7113,GOBP_REGULATION_OF_GROWTH_RATE,1
GOBP_ORGANIC_CATION_TRANSPORT,SET,108,-0.04975,-0.0038026,0.089243,0.71139,GOBP_ORGANIC_CATION_TRANSPORT,1
HP_MICROPHALLUS,SET,14,-0.1359,-0.0037495,0.24378,0.71139,HP_MICROPHALLUS,1
GOBP_NUCLEOSIDE_BISPHOSPHATE...3,SET,111,-0.046904,-0.0036342,0.084131,0.71141,GOBP_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS,1
GSE32423_MEMORY_VS_NAIVE_CD8...1,SET,176,-0.036134,-0.0035191,0.06481,0.71142,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
WP_SYNAPTIC_SIGNALING_ASSOCI...,SET,50,-0.070089,-0.0036508,0.12565,0.71151,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,1
GOBP_REGULATION_OF_NATURAL_K...1,SET,38,-0.083015,-0.0037709,0.14882,0.71151,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
KEGG_VEGF_SIGNALING_PATHWAY,SET,76,-0.05599,-0.0035931,0.10034,0.71159,KEGG_VEGF_SIGNALING_PATHWAY,1
GOBP_MITOTIC_DNA_REPLICATION,SET,15,-0.11683,-0.0033365,0.20937,0.71159,GOBP_MITOTIC_DNA_REPLICATION,1
GOBP_LYSOSOMAL_PROTEIN_CATAB...,SET,18,-0.12264,-0.0038364,0.21973,0.71163,GOBP_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,1
GOBP_TELOMERIC_LOOP_DISASSEM...,SET,9,-0.15065,-0.003333,0.2699,0.71164,GOBP_TELOMERIC_LOOP_DISASSEMBLY,1
GOMF_TRANSMEMBRANE_RECEPTOR_...2,SET,16,-0.12593,-0.003714,0.22553,0.7117,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY,1
GSE17721_CTRL_VS_LPS_1H_BMDC...2,SET,177,-0.035217,-0.0034395,0.063058,0.71174,GSE17721_CTRL_VS_LPS_1H_BMDC_UP,1
HP_IMPAIRED_SMOOTH_PURSUIT,SET,38,-0.075002,-0.003407,0.13428,0.71176,HP_IMPAIRED_SMOOTH_PURSUIT,1
WP_GAMMAGLUTAMYL_CYCLE_FOR_T...,SET,6,-0.18529,-0.0033474,0.33167,0.71179,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,1
GOBP_POSITIVE_REGULATION_OF_...428,SET,4,-0.28156,-0.0041535,0.50403,0.71179,GOBP_POSITIVE_REGULATION_OF_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,1
HP_OPEN_NEURAL_TUBE_DEFECT,SET,134,-0.040221,-0.0034219,0.071997,0.71179,HP_OPEN_NEURAL_TUBE_DEFECT,1
IKEDA_MIR133_TARGETS_DN,SET,6,-0.24289,-0.0043881,0.43472,0.71183,IKEDA_MIR133_TARGETS_DN,1
MCCABE_HOXC6_TARGETS_CANCER_...1,SET,19,-0.10651,-0.0034229,0.1906,0.71185,MCCABE_HOXC6_TARGETS_CANCER_DN,1
HP_DISTAL_SYMPHALANGISM,SET,6,-0.1679,-0.0030332,0.30044,0.71187,HP_DISTAL_SYMPHALANGISM,1
GSE16385_IFNG_TNF_VS_IL4_STI...2,SET,174,-0.035392,-0.0034274,0.063318,0.7119,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,1
WP_EFFECT_OF_PROGERIN_ON_GEN...,SET,20,-0.10223,-0.0033706,0.18288,0.71191,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,1
GOBP_ACETYL_COA_BIOSYNTHETIC...2,SET,8,-0.18247,-0.0038062,0.32641,0.71192,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE,1
REACTOME_SIGNALING_BY_NOTCH1...3,SET,7,-0.1618,-0.0031572,0.28942,0.71194,REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT,1
HP_SEVERE_EPSTEIN_BARR_VIRUS...,SET,4,-0.26542,-0.0039153,0.47474,0.71194,HP_SEVERE_EPSTEIN_BARR_VIRUS_INFECTION,1
HP_ABDOMINAL_AORTIC_ANEURYSM,SET,22,-0.11158,-0.0038581,0.19956,0.71196,HP_ABDOMINAL_AORTIC_ANEURYSM,1
HP_DEFORMED_RIB_CAGE,SET,7,-0.18697,-0.0036482,0.33438,0.71196,HP_DEFORMED_RIB_CAGE,1
REACTOME_RHOBTB3_ATPASE_CYCLE,SET,8,-0.16672,-0.0034776,0.29816,0.71197,REACTOME_RHOBTB3_ATPASE_CYCLE,1
HP_ECCHYMOSIS,SET,54,-0.068366,-0.0037004,0.12227,0.71197,HP_ECCHYMOSIS,1
GOBP_REGULATION_OF_SODIUM_DE...,SET,5,-0.22986,-0.0037909,0.41056,0.71221,GOBP_REGULATION_OF_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,1
HP_LARGE_PLACENTA,SET,6,-0.21298,-0.0038477,0.38039,0.71222,HP_LARGE_PLACENTA,1
GOBP_EMBRYO_IMPLANTATION,SET,50,-0.070505,-0.0036725,0.1259,0.71226,GOBP_EMBRYO_IMPLANTATION,1
HP_ABNORMALITY_OF_THE_ACHILL...,SET,50,-0.067316,-0.0035064,0.12018,0.7123,HP_ABNORMALITY_OF_THE_ACHILLES_TENDON,1
GOBP_PURINE_NUCLEOBASE_TRANS...,SET,8,-0.18244,-0.0038057,0.32571,0.71231,GOBP_PURINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORT,1
GOBP_SPHINGOLIPID_MEDIATED_S...,SET,17,-0.12376,-0.0037622,0.2209,0.71233,GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY,1
WEIGEL_OXIDATIVE_STRESS_BY_H...2,SET,59,-0.066223,-0.0037462,0.11819,0.71236,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,1
CDX1_TARGET_GENES,SET,35,-0.082462,-0.0035952,0.14718,0.71236,CDX1_TARGET_GENES,1
UNTERMAN_PROGRESSIVE_VS_STAB...2,SET,12,-0.17008,-0.0043446,0.3034,0.71246,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_DN,1
GSE37301_CD4_TCELL_VS_RAG2_K...1,SET,165,-0.035544,-0.0033527,0.063392,0.71249,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN,1
HP_DILATED_CARDIOMYOPATHY,SET,139,-0.039709,-0.0034403,0.070809,0.71253,HP_DILATED_CARDIOMYOPATHY,1
REACTOME_FORMATION_OF_THE_CO...,SET,120,-0.056261,-0.0045313,0.1003,0.71257,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,1
GOBP_REGULATION_OF_DOUBLE_ST...3,SET,18,-0.10304,-0.0032231,0.18367,0.7126,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
GOCC_CELL_LEADING_EDGE,SET,399,-0.024448,-0.0035629,0.043573,0.71262,GOCC_CELL_LEADING_EDGE,1
HP_WIDOW_S_PEAK,SET,14,-0.12883,-0.0035544,0.2296,0.71264,HP_WIDOW_S_PEAK,1
GAVISH_3CA_METAPROGRAM_FIBRO...22,SET,48,-0.073089,-0.0037304,0.13023,0.71268,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS,1
HP_KNEE_JOINT_HYPERMOBILITY,SET,5,-0.24775,-0.0040859,0.4414,0.71269,HP_KNEE_JOINT_HYPERMOBILITY,1
GOCC_BASAL_CORTEX,SET,5,-0.1768,-0.0029159,0.31498,0.7127,GOCC_BASAL_CORTEX,1
HP_ECZEMATOID_DERMATITIS,SET,145,-0.039485,-0.0034934,0.070316,0.71278,HP_ECZEMATOID_DERMATITIS,1
BIOCARTA_INTEGRIN_PATHWAY,SET,34,-0.083678,-0.0035958,0.14899,0.71282,BIOCARTA_INTEGRIN_PATHWAY,1
GSE6259_FLT3L_INDUCED_DEC205...1,SET,149,-0.038195,-0.0034251,0.068005,0.71282,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...88,SET,11,-0.14302,-0.003498,0.25455,0.71289,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY,1
GSE3720_LPS_VS_PMA_STIM_VD1_...1,SET,157,-0.038104,-0.0035067,0.067817,0.71289,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,1
VANHARANTA_UTERINE_FIBROID_W...2,SET,57,-0.061668,-0.0034291,0.10973,0.71293,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,1
TAAWWATAG_RSRFC4_Q2,SET,148,-0.040446,-0.0036149,0.071962,0.71295,TAAWWATAG_RSRFC4_Q2,1
ZSCAN5DP_TARGET_GENES,SET,1195,-0.014445,-0.0035616,0.025698,0.71297,ZSCAN5DP_TARGET_GENES,1
MIR6508_5P,SET,300,-0.028097,-0.0035604,0.049948,0.71312,MIR6508_5P,1
CATTTCA_MIR203,SET,259,-0.029315,-0.0034555,0.052087,0.71321,CATTTCA_MIR203,1
GOBP_LIMBIC_SYSTEM_DEVELOPME...,SET,118,-0.047231,-0.0037724,0.083862,0.71335,GOBP_LIMBIC_SYSTEM_DEVELOPMENT,1
GOBP_BRANCHING_INVOLVED_IN_B...,SET,31,-0.094844,-0.003892,0.16836,0.71339,GOBP_BRANCHING_INVOLVED_IN_BLOOD_VESSEL_MORPHOGENESIS,1
GOBP_ICOSANOID_BIOSYNTHETIC_...,SET,50,-0.068173,-0.003551,0.12098,0.71345,GOBP_ICOSANOID_BIOSYNTHETIC_PROCESS,1
GSE2706_R848_VS_LPS_2H_STIM_...1,SET,145,-0.04085,-0.0036142,0.07249,0.71346,GSE2706_R848_VS_LPS_2H_STIM_DC_DN,1
GSE3982_CTRL_VS_PMA_STIM_EOS...1,SET,175,-0.03759,-0.0036506,0.066705,0.71346,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN,1
MIR550B_3P,SET,49,-0.068853,-0.0035505,0.12215,0.7135,MIR550B_3P,1
GOMF_RISC_COMPLEX_BINDING,SET,4,-0.2461,-0.0036303,0.43658,0.71351,GOMF_RISC_COMPLEX_BINDING,1
GSE17721_POLYIC_VS_GARDIQUIM...18,SET,185,-0.035754,-0.0035692,0.063425,0.71352,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP,1
HP_ABNORMAL_PROPORTION_OF_CD...3,SET,17,-0.11439,-0.0034774,0.20284,0.7136,HP_ABNORMAL_PROPORTION_OF_CD8_POSITIVE_T_CELLS,1
REACTOME_VESICLE_MEDIATED_TR...,SET,632,-0.019183,-0.0034956,0.034011,0.71363,REACTOME_VESICLE_MEDIATED_TRANSPORT,1
GOBP_EMBRYONIC_PLACENTA_DEVE...,SET,83,-0.055169,-0.0036992,0.097736,0.71378,GOBP_EMBRYONIC_PLACENTA_DEVELOPMENT,1
GSE17301_CTRL_VS_48H_ACD3_AC...1,SET,174,-0.035378,-0.003426,0.062635,0.7139,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...275,SET,13,-0.1373,-0.0036505,0.243,0.71397,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION,1
GSE36078_WT_VS_IL1R_KO_LUNG_...2,SET,182,-0.036108,-0.0035755,0.063885,0.71403,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP,1
ZNF784_TARGET_GENES,SET,433,-0.023325,-0.0035378,0.041266,0.71404,ZNF784_TARGET_GENES,1
GOBP_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,-0.21225,-0.003131,0.37547,0.71406,GOBP_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS,1
GOMF_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,-0.21225,-0.003131,0.37547,0.71406,GOMF_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY,1
GOBP_NOREPINEPHRINE_BIOSYNTH...,SET,6,-0.2272,-0.0041045,0.40166,0.71418,GOBP_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS,1
PID_ERB_GENOMIC_PATHWAY,SET,14,-0.13256,-0.0036574,0.23431,0.71422,PID_ERB_GENOMIC_PATHWAY,1
GSE45365_CD8A_DC_VS_CD11B_DC...4,SET,151,-0.039511,-0.0035667,0.069834,0.71423,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP,1
REACTOME_SYNTHESIS_OF_PYROPH...,SET,8,-0.15105,-0.0031507,0.2669,0.71428,REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL,1
HP_ABNORMAL_SHAPE_OF_THE_RAD...,SET,24,-0.10081,-0.0036405,0.17812,0.71428,HP_ABNORMAL_SHAPE_OF_THE_RADIUS,1
GSE34156_NOD2_LIGAND_VS_TLR1...4,SET,186,-0.036358,-0.0036392,0.064238,0.7143,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,1
JAZAERI_BREAST_CANCER_BRCA1_...1,SET,40,-0.08135,-0.0037911,0.14367,0.71437,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,1
CALVET_IRINOTECAN_SENSITIVE_...3,SET,5,-0.2386,-0.0039349,0.42126,0.71443,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP,1
HP_MITRAL_VALVE_PROLAPSE,SET,103,-0.049822,-0.0037194,0.087939,0.71449,HP_MITRAL_VALVE_PROLAPSE,1
HP_PAPILLARY_THYROID_CARCINO...,SET,24,-0.105,-0.0037919,0.18528,0.71454,HP_PAPILLARY_THYROID_CARCINOMA,1
GAUTAM_EYE_CORNEA_MELANOCYTES,SET,235,-0.030818,-0.0034625,0.054381,0.71454,GAUTAM_EYE_CORNEA_MELANOCYTES,1
GOCC_NUCLEOID,SET,41,-0.070827,-0.0033416,0.12497,0.71456,GOCC_NUCLEOID,1
GOBP_TEMPERATURE_HOMEOSTASIS,SET,177,-0.037896,-0.0037011,0.066856,0.71458,GOBP_TEMPERATURE_HOMEOSTASIS,1
BERENJENO_TRANSFORMED_BY_RHO...2,SET,27,-0.097209,-0.0037232,0.17149,0.71459,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,1
GOBP_REGULATION_OF_LONG_CHAI...1,SET,6,-0.19442,-0.0035123,0.34293,0.71462,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_SNRNA_BINDING,SET,44,-0.062723,-0.0030654,0.1106,0.71467,GOMF_SNRNA_BINDING,1
HP_RADIAL_DEVIATION_OF_FINGER,SET,43,-0.071915,-0.0034745,0.1268,0.71469,HP_RADIAL_DEVIATION_OF_FINGER,1
KEGG_MEDICUS_REFERENCE_CORE_...,SET,27,-0.074321,-0.0028466,0.13104,0.7147,KEGG_MEDICUS_REFERENCE_CORE_NER_REACTION,1
GOBP_NEGATIVE_REGULATION_OF_...600,SET,15,-0.11859,-0.0033866,0.20899,0.71479,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
CHIARADONNA_NEOPLASTIC_TRANS...4,SET,53,-0.070811,-0.0037972,0.12476,0.71483,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1
BOYLAN_MULTIPLE_MYELOMA_D_CL...2,SET,25,-0.10248,-0.0037771,0.18054,0.71485,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,1
GOBP_POSITIVE_REGULATION_OF_...466,SET,9,-0.1617,-0.0035775,0.28487,0.71485,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION,1
MELLMAN_TUT1_TARGETS_DN,SET,46,-0.069099,-0.0034527,0.12171,0.7149,MELLMAN_TUT1_TARGETS_DN,1
MOOTHA_GLYCOGEN_METABOLISM,SET,18,-0.10603,-0.0033168,0.18674,0.71491,MOOTHA_GLYCOGEN_METABOLISM,1
HP_FEMALE_EXTERNAL_GENITALIA...,SET,14,-0.13683,-0.0037751,0.24097,0.71492,HP_FEMALE_EXTERNAL_GENITALIA_IN_INDIVIDUAL_WITH_46_XY_KARYOTYPE,1
DESCARTES_MAIN_FETAL_ISLET_E...,SET,51,-0.072817,-0.0038306,0.12819,0.71499,DESCARTES_MAIN_FETAL_ISLET_ENDOCRINE_CELLS,1
HP_OLIGOMENORRHEA,SET,37,-0.075385,-0.0033791,0.13268,0.71504,HP_OLIGOMENORRHEA,1
GOMF_BHLH_TRANSCRIPTION_FACT...,SET,31,-0.089471,-0.0036715,0.15741,0.71511,GOMF_BHLH_TRANSCRIPTION_FACTOR_BINDING,1
GSE29949_CD8_POS_DC_SPLEEN_V...3,SET,176,-0.037052,-0.0036085,0.065185,0.71512,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,1
DESCARTES_FETAL_INTESTINE_CH...,SET,86,-0.057304,-0.0039108,0.10077,0.7152,DESCARTES_FETAL_INTESTINE_CHROMAFFIN_CELLS,1
WENG_POR_TARGETS_LIVER_DN,SET,22,-0.11995,-0.0041476,0.2109,0.71523,WENG_POR_TARGETS_LIVER_DN,1
GOBP_REGULATION_OF_RETINOIC_...,SET,15,-0.12128,-0.0034635,0.21322,0.71525,GOBP_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...89,SET,9,-0.16923,-0.0037441,0.29741,0.71532,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,1
REACTOME_DNA_METHYLATION,SET,5,-0.24218,-0.0039941,0.42553,0.71536,REACTOME_DNA_METHYLATION,1
GOBP_RESPONSE_TO_INTERLEUKIN...4,SET,11,-0.16884,-0.0041294,0.29667,0.71536,GOBP_RESPONSE_TO_INTERLEUKIN_15,1
GOBP_NEGATIVE_REGULATION_OF_...468,SET,35,-0.087195,-0.0038015,0.15316,0.71542,GOBP_NEGATIVE_REGULATION_OF_OSSIFICATION,1
GTGTTGA_MIR505,SET,89,-0.053119,-0.0036876,0.093287,0.71546,GTGTTGA_MIR505,1
ZHAN_MULTIPLE_MYELOMA_CD2_UP,SET,42,-0.08189,-0.0039103,0.14375,0.71555,ZHAN_MULTIPLE_MYELOMA_CD2_UP,1
REACTOME_ASSEMBLY_AND_CELL_S...,SET,39,-0.085056,-0.0039141,0.14929,0.71556,REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS,1
GOCC_CENTRIOLE,SET,144,-0.038598,-0.0034032,0.067741,0.71559,GOCC_CENTRIOLE,1
GOMF_TRNA_BINDING,SET,62,-0.054701,-0.0031718,0.095961,0.71567,GOMF_TRNA_BINDING,1
HP_INTESTINAL_CARCINOID,SET,6,-0.17836,-0.0032222,0.31281,0.71572,HP_INTESTINAL_CARCINOID,1
GOBP_NEUTROPHIL_MEDIATED_IMM...,SET,37,-0.079613,-0.0035686,0.13961,0.71574,GOBP_NEUTROPHIL_MEDIATED_IMMUNITY,1
GSE40443_INDUCED_VS_TOTAL_TR...1,SET,180,-0.036991,-0.0036429,0.064871,0.71574,GSE40443_INDUCED_VS_TOTAL_TREG_DN,1
REACTOME_ELEVATION_OF_CYTOSO...,SET,16,-0.12606,-0.0037179,0.22103,0.71577,REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,1
MODULE_101,SET,10,-0.17309,-0.0040366,0.30349,0.71578,MODULE_101,1
GOBP_RIBONUCLEOSIDE_CATABOLI...,SET,18,-0.13868,-0.0043379,0.24314,0.71578,GOBP_RIBONUCLEOSIDE_CATABOLIC_PROCESS,1
HP_BILE_DUCT_PROLIFERATION,SET,18,-0.107,-0.003347,0.18759,0.71578,HP_BILE_DUCT_PROLIFERATION,1
GSE13229_IMM_VS_MATURE_NKCEL...1,SET,183,-0.036011,-0.0035755,0.063137,0.71578,GSE13229_IMM_VS_MATURE_NKCELL_DN,1
MIR7975,SET,37,-0.074239,-0.0033277,0.13015,0.7158,MIR7975,1
HP_LAMELLAR_CATARACT,SET,6,-0.19587,-0.0035386,0.34335,0.71582,HP_LAMELLAR_CATARACT,1
KEGG_MEDICUS_REFERENCE_P4_PR...1,SET,8,-0.17381,-0.0036256,0.30465,0.71584,KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY,1
HP_ABSENT_TIBIA,SET,5,-0.24643,-0.0040642,0.43188,0.71586,HP_ABSENT_TIBIA,1
GSE26030_TH1_VS_TH17_RESTIMU...1,SET,181,-0.035631,-0.0035186,0.06244,0.71588,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN,1
HP_ABNORMALITY_OF_VENOUS_PHY...,SET,11,-0.15685,-0.0038363,0.27484,0.7159,HP_ABNORMALITY_OF_VENOUS_PHYSIOLOGY,1
MIR3674,SET,123,-0.04448,-0.0036267,0.077928,0.71592,MIR3674,1
HP_HYPOPLASTIC_IRIS_STROMA,SET,8,-0.20845,-0.0043481,0.36486,0.7161,HP_HYPOPLASTIC_IRIS_STROMA,1
KAECH_NAIVE_VS_DAY8_EFF_CD8_...2,SET,185,-0.035109,-0.0035047,0.061443,0.71613,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP,1
REACTOME_ASSEMBLY_OF_COLLAGE...,SET,59,-0.070945,-0.0040133,0.12414,0.71616,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,1
GSE2770_IL12_AND_TGFB_VS_IL4...3,SET,162,-0.039956,-0.0037348,0.069898,0.71621,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
GOMF_NADPH_OXIDASE_H202_FORM...,SET,5,-0.19449,-0.0032076,0.34018,0.71624,GOMF_NADPH_OXIDASE_H202_FORMING_ACTIVITY,1
GOMF_TOXIN_TRANSMEMBRANE_TRA...,SET,9,-0.18626,-0.0041208,0.32578,0.71625,GOMF_TOXIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_RETINAL_BLOOD_VESSEL_MO...,SET,5,-0.21745,-0.0035862,0.38031,0.71626,GOBP_RETINAL_BLOOD_VESSEL_MORPHOGENESIS,1
GOBP_TUBE_LUMEN_CAVITATION,SET,4,-0.27596,-0.0040708,0.48262,0.71627,GOBP_TUBE_LUMEN_CAVITATION,1
GOBP_CONNECTIVE_TISSUE_REPLA...2,SET,5,-0.2415,-0.0039828,0.42231,0.71628,GOBP_CONNECTIVE_TISSUE_REPLACEMENT_INVOLVED_IN_INFLAMMATORY_RESPONSE_WOUND_HEALING,1
WP_TRANSLATION_FACTORS,SET,44,-0.066247,-0.0032376,0.11575,0.71644,WP_TRANSLATION_FACTORS,1
REACTOME_REGULATION_OF_LIPID...,SET,114,-0.043166,-0.0033892,0.075413,0.71647,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1
GSE11961_PLASMA_CELL_DAY7_VS...1,SET,187,-0.035073,-0.0035198,0.061274,0.71647,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GSE17721_PAM3CSK4_VS_CPG_4H_...1,SET,181,-0.037413,-0.0036946,0.065361,0.71647,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...28,SET,12,-0.14229,-0.0036347,0.24849,0.71654,HP_APLASIA_HYPOPLASIA_OF_THE_EPIGLOTTIS,1
GSE37532_VISCERAL_ADIPOSE_TI...4,SET,156,-0.036794,-0.0033755,0.064245,0.71658,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_PINK_...,SET,15,-0.12892,-0.0036818,0.2251,0.71659,KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
GOBP_MESENCHYMAL_STEM_CELL_M...,SET,6,-0.23915,-0.0043204,0.41754,0.71659,GOBP_MESENCHYMAL_STEM_CELL_MAINTENANCE_INVOLVED_IN_NEPHRON_MORPHOGENESIS,1
HP_DECREASED_HEAD_CIRCUMFERE...,SET,1163,-0.014481,-0.0035256,0.02527,0.71668,HP_DECREASED_HEAD_CIRCUMFERENCE,1
ZNF776_TARGET_GENES,SET,6,-0.20043,-0.0036209,0.34977,0.71669,ZNF776_TARGET_GENES,1
GOCC_PROTEASOME_REGULATORY_P...2,SET,7,-0.16785,-0.0032753,0.2929,0.7167,GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX,1
HP_PHALANGEAL_DISLOCATION,SET,7,-0.20959,-0.0040896,0.36572,0.7167,HP_PHALANGEAL_DISLOCATION,1
GOCC_PERINUCLEAR_REGION_OF_C...,SET,669,-0.019315,-0.0036174,0.033692,0.71677,GOCC_PERINUCLEAR_REGION_OF_CYTOPLASM,1
CCAWNWWNNNGGC_UNKNOWN,SET,75,-0.057603,-0.0036723,0.10047,0.71678,CCAWNWWNNNGGC_UNKNOWN,1
HP_ENCEPHALOMALACIA,SET,12,-0.16338,-0.0041735,0.28498,0.71678,HP_ENCEPHALOMALACIA,1
GOCC_CILIARY_MEMBRANE,SET,72,-0.055379,-0.0034595,0.09656,0.71685,GOCC_CILIARY_MEMBRANE,1
ALK_DN.V1_UP,SET,122,-0.046463,-0.003773,0.081011,0.71686,ALK_DN.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...164,SET,8,-0.16036,-0.0033451,0.27953,0.71691,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_CONDENSATION,1
GOCC_CONDENSIN_COMPLEX,SET,8,-0.16036,-0.0033451,0.27953,0.71691,GOCC_CONDENSIN_COMPLEX,1
GOMF_HISTONE_MODIFYING_ACTIV...,SET,182,-0.034522,-0.0034184,0.060167,0.71693,GOMF_HISTONE_MODIFYING_ACTIVITY,1
VANTVEER_BREAST_CANCER_POOR_...,SET,44,-0.077205,-0.0037731,0.13456,0.71694,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,1
GOBP_ATRIAL_CARDIAC_MUSCLE_C...2,SET,16,-0.1368,-0.0040346,0.2384,0.71695,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION,1
GSE38696_LIGHT_ZONE_VS_DARK_...2,SET,165,-0.03689,-0.0034798,0.064288,0.71696,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,1
GSE39820_IL1B_IL6_VS_IL1B_IL...1,SET,180,-0.037301,-0.0036735,0.064989,0.717,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN,1
REACTOME_PHOSPHORYLATION_OF_...1,SET,6,-0.16746,-0.0030253,0.2917,0.71704,REACTOME_PHOSPHORYLATION_OF_EMI1,1
KEGG_MEDICUS_REFERENCE_TLR3_...3,SET,9,-0.16634,-0.0036801,0.28962,0.71713,KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY,1
GAVISH_3CA_METAPROGRAM_EPITH...15,SET,47,-0.074649,-0.0037702,0.12997,0.71714,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_2,1
MIR3147,SET,35,-0.093029,-0.0040559,0.16196,0.71715,MIR3147,1
GOBP_NEGATIVE_REGULATION_OF_...190,SET,22,-0.10982,-0.0037972,0.19116,0.71717,GOBP_NEGATIVE_REGULATION_OF_DNA_REPLICATION,1
THRAP3_TARGET_GENES,SET,19,-0.11972,-0.0038475,0.20837,0.7172,THRAP3_TARGET_GENES,1
HP_DISPROPORTIONATE_SHORT_TR...,SET,24,-0.098315,-0.0035505,0.17107,0.71725,HP_DISPROPORTIONATE_SHORT_TRUNK_SHORT_STATURE,1
SA_PROGRAMMED_CELL_DEATH,SET,12,-0.14423,-0.0036842,0.25089,0.7173,SA_PROGRAMMED_CELL_DEATH,1
GOMF_OXIDOREDUCTASE_ACTIVITY...10,SET,15,-0.13716,-0.003917,0.2386,0.7173,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS,1
MODULE_156,SET,16,-0.12279,-0.0036215,0.21354,0.71736,MODULE_156,1
HP_CENTRAL_SCOTOMA,SET,36,-0.085675,-0.0037882,0.14899,0.71736,HP_CENTRAL_SCOTOMA,1
HOSHIDA_LIVER_CANCER_SUBCLAS...1,SET,216,-0.03369,-0.0036308,0.058582,0.71738,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,1
GOMF_PHOSPHATIDYLINOSITOL_PH...1,SET,6,-0.18121,-0.0032737,0.3151,0.71738,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_4_PHOSPHATASE_ACTIVITY,1
GOCC_ZYMOGEN_GRANULE,SET,18,-0.10979,-0.0034342,0.19089,0.7174,GOCC_ZYMOGEN_GRANULE,1
HP_APLASIA_CUTIS_CONGENITA,SET,37,-0.081296,-0.003644,0.14124,0.71754,HP_APLASIA_CUTIS_CONGENITA,1
MYLLYKANGAS_AMPLIFICATION_HO...19,SET,7,-0.18771,-0.0036628,0.32607,0.71758,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9,1
MIR6085,SET,35,-0.078894,-0.0034397,0.13703,0.71761,MIR6085,1
MIR6835_5P,SET,30,-0.085292,-0.0034432,0.14806,0.71771,MIR6835_5P,1
ZNF433_TARGET_GENES,SET,46,-0.0695,-0.0034727,0.12063,0.71774,ZNF433_TARGET_GENES,1
WP_PANCREATIC_ADENOCARCINOMA...,SET,83,-0.056026,-0.0037566,0.097235,0.71775,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,1
GOMF_N_METHYLTRANSFERASE_ACT...,SET,82,-0.053435,-0.0035613,0.092717,0.7178,GOMF_N_METHYLTRANSFERASE_ACTIVITY,1
HP_AMELOGENESIS_IMPERFECTA,SET,31,-0.089774,-0.003684,0.15575,0.71783,HP_AMELOGENESIS_IMPERFECTA,1
ZHENG_FOXP3_TARGETS_UP,SET,24,-0.106,-0.0038282,0.18389,0.71784,ZHENG_FOXP3_TARGETS_UP,1
MIR196B_3P,SET,6,-0.22837,-0.0041257,0.3961,0.71787,MIR196B_3P,1
GOBP_MONOACYLGLYCEROL_CATABO...,SET,7,-0.15839,-0.0030907,0.27457,0.71799,GOBP_MONOACYLGLYCEROL_CATABOLIC_PROCESS,1
HP_PROMINENT_OCCIPUT,SET,50,-0.06418,-0.0033431,0.11123,0.71803,HP_PROMINENT_OCCIPUT,1
LAIHO_COLORECTAL_CANCER_SERR...1,SET,67,-0.059241,-0.0035704,0.10265,0.71806,LAIHO_COLORECTAL_CANCER_SERRATED_DN,1
DIDO1_TARGET_GENES,SET,1311,-0.014004,-0.0036045,0.024258,0.71812,DIDO1_TARGET_GENES,1
MODULE_151,SET,274,-0.028857,-0.0034971,0.049975,0.71817,MODULE_151,1
HP_THICK_VERMILION_BORDER,SET,226,-0.032584,-0.003591,0.056423,0.71819,HP_THICK_VERMILION_BORDER,1
GOMF_GLYCOSAMINOGLYCAN_BINDI...,SET,226,-0.036014,-0.0039691,0.062359,0.71821,GOMF_GLYCOSAMINOGLYCAN_BINDING,1
MEISSNER_BRAIN_ICP_WITH_H3K4...,SET,27,-0.0881,-0.0033743,0.15245,0.71832,MEISSNER_BRAIN_ICP_WITH_H3K4ME3,1
KEGG_MEDICUS_REFERENCE_PDGF_...1,SET,13,-0.14539,-0.0038654,0.25149,0.7184,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY,1
ATF_B,SET,174,-0.038785,-0.003756,0.067055,0.7185,ATF_B,1
HP_LACRIMAL_DUCT_APLASIA,SET,9,-0.161,-0.0035619,0.27831,0.71852,HP_LACRIMAL_DUCT_APLASIA,1
MIR3065_3P,SET,234,-0.032732,-0.0036699,0.056567,0.71858,MIR3065_3P,1
HP_THYROID_AGENESIS,SET,7,-0.21433,-0.0041822,0.37038,0.71859,HP_THYROID_AGENESIS,1
PID_CMYB_PATHWAY,SET,78,-0.057635,-0.0037468,0.099594,0.7186,PID_CMYB_PATHWAY,1
GSE17721_4H_VS_24H_POLYIC_BM...1,SET,179,-0.035636,-0.0034998,0.061578,0.7186,GSE17721_4H_VS_24H_POLYIC_BMDC_DN,1
RICKMAN_TUMOR_DIFFERENTIATED...3,SET,101,-0.050411,-0.0037268,0.087089,0.71865,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,1
GOCC_HISTONE_PRE_MRNA_3_END_...,SET,6,-0.16568,-0.0029931,0.28607,0.71875,GOCC_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX,1
HP_LUMBAR_SCOLIOSIS,SET,15,-0.11315,-0.0032313,0.19537,0.71875,HP_LUMBAR_SCOLIOSIS,1
GSE1448_CTRL_VS_ANTI_VBETA5_...1,SET,185,-0.036351,-0.0036287,0.062752,0.71879,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN,1
KEGG_ERBB_SIGNALING_PATHWAY,SET,83,-0.056296,-0.0037747,0.097183,0.7188,KEGG_ERBB_SIGNALING_PATHWAY,1
HP_IMPAIRED_TACTILE_SENSATION,SET,32,-0.082941,-0.0034579,0.14317,0.71881,HP_IMPAIRED_TACTILE_SENSATION,1
REACTOME_DEUBIQUITINATION,SET,217,-0.032297,-0.0034887,0.055734,0.71886,REACTOME_DEUBIQUITINATION,1
HP_IMPAIRED_T_CELL_FUNCTION,SET,28,-0.096894,-0.0037792,0.16721,0.71886,HP_IMPAIRED_T_CELL_FUNCTION,1
REACTOME_POST_TRANSCRIPTIONA...,SET,7,-0.20489,-0.003998,0.3535,0.71891,REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS,1
chr15q11,SET,8,-0.24027,-0.0050119,0.41434,0.719,chr15q11,1
GSE8515_CTRL_VS_IL1_4H_STIM_...2,SET,177,-0.037172,-0.0036304,0.064102,0.719,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP,1
GOBP_SYMPATHETIC_GANGLION_DE...,SET,9,-0.19089,-0.0042232,0.32916,0.71901,GOBP_SYMPATHETIC_GANGLION_DEVELOPMENT,1
GOBP_RESPONSE_TO_ANGIOTENSIN,SET,38,-0.090483,-0.0041102,0.15601,0.71904,GOBP_RESPONSE_TO_ANGIOTENSIN,1
BIOCARTA_AHSP_PATHWAY,SET,9,-0.16393,-0.0036269,0.28262,0.71905,BIOCARTA_AHSP_PATHWAY,1
MODULE_317,SET,397,-0.025067,-0.0036443,0.043212,0.71907,MODULE_317,1
GOBP_INTERLEUKIN_5_PRODUCTION,SET,19,-0.12005,-0.0038579,0.20693,0.71908,GOBP_INTERLEUKIN_5_PRODUCTION,1
BIOCARTA_FBW7_PATHWAY,SET,9,-0.15116,-0.0033444,0.26056,0.71909,BIOCARTA_FBW7_PATHWAY,1
PAX5_01,SET,138,-0.043692,-0.0037719,0.075303,0.71911,PAX5_01,1
HP_ABDOMINAL_MASS,SET,9,-0.20854,-0.0046138,0.35937,0.71914,HP_ABDOMINAL_MASS,1
GOMF_PORIN_ACTIVITY,SET,6,-0.2154,-0.0038913,0.37096,0.71926,GOMF_PORIN_ACTIVITY,1
GOCC_ENDOPLASMIC_RETICULUM_P...1,SET,8,-0.16695,-0.0034825,0.28734,0.71938,GOCC_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX,1
ZHENG_CORD_BLOOD_C10_MULTILY...,SET,81,-0.057784,-0.0038277,0.099424,0.71944,ZHENG_CORD_BLOOD_C10_MULTILYMPHOID_PROGENITOR,1
GSE3982_DC_VS_TH2_UP,SET,181,-0.038487,-0.0038006,0.066187,0.71954,GSE3982_DC_VS_TH2_UP,1
GOBP_REGULATION_OF_ANTIGEN_R...,SET,61,-0.063881,-0.0036742,0.10985,0.71955,GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
REACTOME_PURINE_SALVAGE,SET,12,-0.1506,-0.003847,0.25892,0.7196,REACTOME_PURINE_SALVAGE,1
GOBP_ANTIGEN_PROCESSING_AND_...6,SET,36,-0.089943,-0.0039769,0.15463,0.7196,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN,1
GSE3691_CONVENTIONAL_VS_PLAS...1,SET,182,-0.037206,-0.0036841,0.063958,0.71962,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN,1
GOBP_REGULATION_OF_NATURAL_K...5,SET,49,-0.076953,-0.0039682,0.13217,0.71979,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
GOBP_NEGATIVE_REGULATION_OF_...644,SET,8,-0.18719,-0.0039046,0.32142,0.71984,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
GOCC_CHROMATOID_BODY,SET,12,-0.14852,-0.0037938,0.25502,0.71984,GOCC_CHROMATOID_BODY,1
REACTOME_NEUTROPHIL_DEGRANUL...,SET,439,-0.024348,-0.0037178,0.041796,0.71989,REACTOME_NEUTROPHIL_DEGRANULATION,1
HP_APLASIA_HYPOPLASIA_INVOLV...14,SET,13,-0.13549,-0.0036024,0.23256,0.71992,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SINUSES,1
GOBP_MAINTENANCE_OF_PROTEIN_...1,SET,12,-0.13443,-0.0034341,0.23073,0.71993,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM,1
GSE14415_NATURAL_TREG_VS_FOX...1,SET,144,-0.04041,-0.003563,0.069349,0.71995,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN,1
MIR4296,SET,65,-0.063236,-0.0037541,0.10848,0.72003,MIR4296,1
FAN_OVARY_CL7_ANGEIOGENIC_EN...,SET,224,-0.03564,-0.0039107,0.061115,0.72011,FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL,1
GSE17721_PAM3CSK4_VS_CPG_24H...2,SET,177,-0.036537,-0.0035683,0.062636,0.72016,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP,1
GOBP_EXTRACELLULAR_REGULATIO...,SET,12,-0.15586,-0.0039813,0.26717,0.72018,GOBP_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION,1
GOBP_POSITIVE_REGULATION_OF_...444,SET,10,-0.16068,-0.0037471,0.27542,0.72019,GOBP_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
DURANTE_ADULT_OLFACTORY_NEUR...2,SET,29,-0.09588,-0.0038057,0.16435,0.72019,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_B_CELLS,1
GOBP_CELLULAR_RESPONSE_TO_KE...,SET,97,-0.054142,-0.003923,0.092794,0.72021,GOBP_CELLULAR_RESPONSE_TO_KETONE,1
GOBP_REGULATION_OF_INTESTINA...1,SET,11,-0.14914,-0.0036476,0.25558,0.72022,GOBP_REGULATION_OF_INTESTINAL_ABSORPTION,1
AREB6_04,SET,226,-0.035196,-0.0038789,0.060303,0.72027,AREB6_04,1
GOMF_NUCLEOTIDE_TRANSMEMBRAN...,SET,29,-0.10085,-0.004003,0.17279,0.72027,GOMF_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...188,SET,31,-0.081315,-0.0033369,0.13931,0.72028,GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION,1
GOBP_POSITIVE_REGULATION_OF_...174,SET,22,-0.11617,-0.0040168,0.19897,0.72033,GOBP_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,1
GRAHAM_NORMAL_QUIESCENT_VS_N...1,SET,84,-0.052063,-0.0035118,0.089168,0.72034,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,1
HOFFMANN_PRE_BI_TO_LARGE_PRE...2,SET,26,-0.095562,-0.0035918,0.16366,0.72035,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,1
GOMF_ADRENERGIC_RECEPTOR_BIN...,SET,16,-0.132,-0.003893,0.22607,0.72035,GOMF_ADRENERGIC_RECEPTOR_BINDING,1
MORF_FOSL1,SET,371,-0.026518,-0.0037295,0.04541,0.72038,MORF_FOSL1,1
HP_LOP_EAR,SET,3,-0.32778,-0.0041876,0.5613,0.72038,HP_LOP_EAR,1
DESCARTES_FETAL_EYE_CORNEAL_...,SET,222,-0.036295,-0.0039649,0.062135,0.72043,DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,1
GAVISH_3CA_MALIGNANT_METAPRO...31,SET,42,-0.078703,-0.0037581,0.13468,0.72052,GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE,1
GOMF_TYPE_2_FIBROBLAST_GROWT...,SET,5,-0.27485,-0.0045328,0.47001,0.72064,GOMF_TYPE_2_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,1
GSE12366_PLASMA_CELL_VS_NAIV...2,SET,166,-0.039437,-0.0037311,0.067429,0.72068,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP,1
GOBP_INTERLEUKIN_12_PRODUCTI...,SET,61,-0.068127,-0.0039184,0.11647,0.72069,GOBP_INTERLEUKIN_12_PRODUCTION,1
REACTOME_DISEASES_OF_MITOTIC...,SET,36,-0.079432,-0.0035121,0.13578,0.72072,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1
GOBP_REGULATION_OF_GONADOTRO...,SET,12,-0.16898,-0.0043166,0.28884,0.72073,GOBP_REGULATION_OF_GONADOTROPIN_SECRETION,1
ZHANG_BREAST_CANCER_PROGENIT...1,SET,131,-0.043327,-0.003645,0.074053,0.72075,ZHANG_BREAST_CANCER_PROGENITORS_DN,1
FXR_Q3,SET,102,-0.052511,-0.0039012,0.089742,0.72077,FXR_Q3,1
GSE22025_UNTREATED_VS_PROGES...1,SET,184,-0.038376,-0.0038206,0.065579,0.72078,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN,1
GSE10325_BCELL_VS_MYELOID_DN,SET,182,-0.038389,-0.0038013,0.065538,0.72097,GSE10325_BCELL_VS_MYELOID_DN,1
GOBP_POSITIVE_REGULATION_OF_...640,SET,24,-0.10503,-0.003793,0.17931,0.72098,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MATURATION,1
HP_PARTIAL_ABSENCE_OF_CEREBE...,SET,4,-0.213,-0.0031421,0.36357,0.72101,HP_PARTIAL_ABSENCE_OF_CEREBELLAR_VERMIS,1
GOBP_POSITIVE_REGULATION_OF_...812,SET,6,-0.24035,-0.0043422,0.41021,0.72103,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,1
HP_POSITIVE_BLOOD_INFECTIOUS...,SET,17,-0.1177,-0.0035782,0.20089,0.72103,HP_POSITIVE_BLOOD_INFECTIOUS_AGENT_TEST,1
GSE2405_HEAT_KILLED_VS_LIVE_...2,SET,174,-0.037858,-0.0036662,0.064599,0.72107,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,1
DESCARTES_MAIN_FETAL_CILIATE...,SET,450,-0.023064,-0.0035646,0.039351,0.72109,DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS,1
WDHD1_TARGET_GENES,SET,148,-0.041409,-0.003701,0.070645,0.72111,WDHD1_TARGET_GENES,1
DESCARTES_MAIN_FETAL_LIMBIC_...,SET,6,-0.21004,-0.0037946,0.35827,0.72115,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,1
HU_FETAL_RETINA_BIPOLAR,SET,79,-0.060726,-0.0039728,0.10357,0.72116,HU_FETAL_RETINA_BIPOLAR,1
GSE17721_CTRL_VS_GARDIQUIMOD...7,SET,181,-0.034705,-0.0034272,0.059183,0.72119,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN,1
HP_LIMB_TREMOR,SET,20,-0.11753,-0.0038749,0.20031,0.7213,HP_LIMB_TREMOR,1
HP_AMBIGUOUS_GENITALIA_FEMALE,SET,8,-0.188,-0.0039216,0.32041,0.72131,HP_AMBIGUOUS_GENITALIA_FEMALE,1
HE_LIM_SUN_FETAL_LUNG_C2_ADC...2,SET,95,-0.055926,-0.0040105,0.095301,0.72134,HE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL,1
MIR6730_3P,SET,74,-0.058003,-0.0036732,0.098835,0.72135,MIR6730_3P,1
GOBP_CELL_SUBSTRATE_JUNCTION...1,SET,8,-0.19763,-0.0041224,0.33669,0.72138,GOBP_CELL_SUBSTRATE_JUNCTION_DISASSEMBLY,1
MIR3936,SET,30,-0.089036,-0.0035944,0.15167,0.7214,MIR3936,1
CASP8AP2_TARGET_GENES,SET,262,-0.030904,-0.0036635,0.052648,0.7214,CASP8AP2_TARGET_GENES,1
ZNF592_TARGET_GENES,SET,1472,-0.013572,-0.003684,0.023121,0.7214,ZNF592_TARGET_GENES,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...2,SET,5,-0.26909,-0.0044378,0.45832,0.72143,GOBP_GAMMA_AMINOBUTYRIC_ACID_IMPORT,1
GOBP_PEPTIDYL_LYSINE_HYDROXY...,SET,8,-0.18241,-0.0038051,0.31069,0.72144,GOBP_PEPTIDYL_LYSINE_HYDROXYLATION,1
GSE1740_MCSF_VS_MCSF_AND_IFN...4,SET,183,-0.036193,-0.0035936,0.061623,0.7215,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP,1
GOBP_ESTABLISHMENT_OF_PROTEI...10,SET,17,-0.10676,-0.0032454,0.18177,0.72151,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,1
GSE3982_BCELL_VS_TH1_DN,SET,176,-0.038429,-0.0037426,0.065416,0.72155,GSE3982_BCELL_VS_TH1_DN,1
HP_DELAYED_BRAINSTEM_AUDITOR...,SET,3,-0.31597,-0.0040366,0.53772,0.7216,HP_DELAYED_BRAINSTEM_AUDITORY_EVOKED_RESPONSE_CONDUCTION_TIME,1
GSE42021_TREG_VS_TCONV_PLN_UP,SET,186,-0.03856,-0.0038595,0.065608,0.72164,GSE42021_TREG_VS_TCONV_PLN_UP,1
GOCC_CORE_MEDIATOR_COMPLEX,SET,25,-0.090314,-0.0033287,0.15366,0.72165,GOCC_CORE_MEDIATOR_COMPLEX,1
GSE17974_CTRL_VS_ACT_IL4_AND...14,SET,172,-0.039947,-0.0038464,0.067961,0.72166,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP,1
PCGF1_TARGET_GENES,SET,455,-0.024694,-0.0038371,0.042009,0.72167,PCGF1_TARGET_GENES,1
GOBP_REGULATION_OF_CYTOSKELE...,SET,463,-0.023503,-0.0036832,0.039983,0.72167,GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION,1
GCM_NUMA1,SET,51,-0.063129,-0.003321,0.10737,0.72171,GCM_NUMA1,1
GOBP_KETONE_BODY_BIOSYNTHETI...,SET,6,-0.2073,-0.003745,0.35256,0.72172,GOBP_KETONE_BODY_BIOSYNTHETIC_PROCESS,1
SMITH_LIVER_CANCER,SET,44,-0.076982,-0.0037623,0.13089,0.72178,SMITH_LIVER_CANCER,1
HP_LISSENCEPHALY,SET,166,-0.038676,-0.0036591,0.065754,0.72179,HP_LISSENCEPHALY,1
KEGG_VASCULAR_SMOOTH_MUSCLE_...,SET,109,-0.049682,-0.0038148,0.084465,0.7218,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,1
REACTOME_LATE_ENDOSOMAL_MICR...,SET,32,-0.084671,-0.0035301,0.14394,0.72181,REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,1
HP_THYMOMA,SET,5,-0.22218,-0.0036643,0.37769,0.72182,HP_THYMOMA,1
GSE20366_CD103_POS_VS_CD103_...2,SET,181,-0.037954,-0.003748,0.064519,0.72182,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP,1
HP_DIASTASIS_RECTI,SET,21,-0.11,-0.0037161,0.18695,0.72186,HP_DIASTASIS_RECTI,1
GSE9988_LOW_LPS_VS_CTRL_TREA...1,SET,187,-0.036066,-0.0036195,0.061297,0.72186,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN,1
GSE3720_UNSTIM_VS_LPS_STIM_V...4,SET,143,-0.042635,-0.0037461,0.072449,0.72189,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP,1
GOBP_DOPAMINE_METABOLIC_PROC...,SET,33,-0.094179,-0.0039872,0.16,0.72194,GOBP_DOPAMINE_METABOLIC_PROCESS,1
MODULE_407,SET,13,-0.15331,-0.0040761,0.26045,0.72195,MODULE_407,1
GSE6875_TCONV_VS_TREG_UP,SET,180,-0.037209,-0.0036643,0.063204,0.72197,GSE6875_TCONV_VS_TREG_UP,1
HE_LIM_SUN_FETAL_LUNG_C2_PDC...,SET,133,-0.045475,-0.0038545,0.077216,0.72204,HE_LIM_SUN_FETAL_LUNG_C2_PDC_CELL,1
H1_6_TARGET_GENES,SET,406,-0.02552,-0.003751,0.043332,0.72205,H1_6_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...584,SET,38,-0.086148,-0.0039133,0.14623,0.72211,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...59,SET,15,-0.1221,-0.003487,0.20726,0.72211,HP_APLASIA_HYPOPLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
DACOSTA_ERCC3_ALLELE_XPCS_VS...1,SET,31,-0.09039,-0.0037092,0.15342,0.72212,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,1
GSE25147_UNSTIM_VS_HELIOBACT...1,SET,148,-0.044204,-0.0039508,0.074999,0.7222,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN,1
HP_NEONATAL_ALLOIMMUNE_THROM...,SET,14,-0.13528,-0.0037323,0.22945,0.72226,HP_NEONATAL_ALLOIMMUNE_THROMBOCYTOPENIA,1
YOSHIMURA_MAPK8_TARGETS_UP,SET,1186,-0.015969,-0.0039235,0.027081,0.72229,YOSHIMURA_MAPK8_TARGETS_UP,1
GSE43863_DAY6_EFF_VS_DAY150_...1,SET,175,-0.038337,-0.0037231,0.065014,0.72229,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN,1
GSE26495_NAIVE_VS_PD1LOW_CD8...1,SET,185,-0.038491,-0.0038424,0.065255,0.72236,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN,1
RRCCGTTA_UNKNOWN,SET,79,-0.057678,-0.0037734,0.097755,0.72241,RRCCGTTA_UNKNOWN,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...1,SET,615,-0.020401,-0.003669,0.034564,0.72248,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN,1
HP_ABNORMAL_MAXILLA_MORPHOLO...,SET,133,-0.044538,-0.0037751,0.075443,0.72252,HP_ABNORMAL_MAXILLA_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C0_VAS...1,SET,117,-0.051605,-0.0041044,0.087409,0.72253,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...577,SET,23,-0.096075,-0.0033967,0.16271,0.72255,GOBP_NEGATIVE_REGULATION_OF_RNA_SPLICING,1
LAKE_ADULT_KIDNEY_C29_UNKNOW...,SET,77,-0.064222,-0.0041483,0.10875,0.72259,LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2,1
HP_ABNORMAL_CIRCULATING_META...,SET,1251,-0.014841,-0.003738,0.025116,0.7227,HP_ABNORMAL_CIRCULATING_METABOLITE_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...360,SET,17,-0.12513,-0.0038038,0.21175,0.72271,GOBP_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY,1
GOCC_SPERM_ANNULUS,SET,2,-0.40008,-0.0041734,0.677,0.72272,GOCC_SPERM_ANNULUS,1
REACTOME_VASOPRESSIN_LIKE_RE...,SET,5,-0.27215,-0.0044883,0.46045,0.72275,REACTOME_VASOPRESSIN_LIKE_RECEPTORS,1
HP_ABNORMAL_INTONATION,SET,59,-0.068282,-0.0038627,0.11553,0.72275,HP_ABNORMAL_INTONATION,1
HP_CONGENITAL_HIP_DISLOCATION,SET,68,-0.060513,-0.0036741,0.10238,0.72275,HP_CONGENITAL_HIP_DISLOCATION,1
XU_GH1_AUTOCRINE_TARGETS_DN,SET,117,-0.048424,-0.0038514,0.081919,0.72278,XU_GH1_AUTOCRINE_TARGETS_DN,1
MODULE_335,SET,14,-0.15096,-0.0041648,0.25536,0.72278,MODULE_335,1
GOMF_MONOATOMIC_CATION_CHANN...,SET,302,-0.031389,-0.0039905,0.0531,0.72278,GOMF_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
GOBP_CADMIUM_ION_TRANSMEMBRA...,SET,6,-0.21734,-0.0039264,0.36764,0.7228,GOBP_CADMIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOMF_OLFACTORY_RECEPTOR_ACTI...,SET,305,-0.042943,-0.005486,0.072604,0.72289,GOMF_OLFACTORY_RECEPTOR_ACTIVITY,1
HP_SCLEROSING_CHOLANGITIS,SET,10,-0.17918,-0.0041785,0.30274,0.72302,HP_SCLEROSING_CHOLANGITIS,1
GOBP_CHIASMA_ASSEMBLY,SET,6,-0.17545,-0.0031697,0.29643,0.72303,GOBP_CHIASMA_ASSEMBLY,1
GOBP_CHOLESTEROL_IMPORT,SET,9,-0.19411,-0.0042944,0.32791,0.72305,GOBP_CHOLESTEROL_IMPORT,1
GSE13411_NAIVE_VS_MEMORY_BCE...1,SET,181,-0.037311,-0.0036845,0.06302,0.72309,GSE13411_NAIVE_VS_MEMORY_BCELL_DN,1
GSE9960_HEALTHY_VS_GRAM_POS_...1,SET,166,-0.039974,-0.0037819,0.06751,0.72311,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN,1
ZHU_CMV_24_HR_DN,SET,78,-0.061218,-0.0039797,0.10337,0.72314,ZHU_CMV_24_HR_DN,1
MIR3183,SET,75,-0.058601,-0.0037359,0.098952,0.72314,MIR3183,1
MIR3670,SET,50,-0.070162,-0.0036546,0.11843,0.72322,MIR3670,1
WP_EV_RELEASE_FROM_CARDIAC_C...,SET,7,-0.22395,-0.0043699,0.37775,0.72336,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,1
LIANG_HEMATOPOIESIS_STEM_CEL...2,SET,39,-0.082397,-0.0037917,0.13892,0.72344,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,1
DESCARTES_FETAL_STOMACH_MESO...,SET,29,-0.1052,-0.0041757,0.17737,0.72345,DESCARTES_FETAL_STOMACH_MESOTHELIAL_CELLS,1
HP_FOCAL_WHITE_MATTER_LESIONS,SET,13,-0.14112,-0.003752,0.23784,0.72352,HP_FOCAL_WHITE_MATTER_LESIONS,1
AAGCAAT_MIR137,SET,198,-0.03851,-0.0039756,0.064882,0.72358,AAGCAAT_MIR137,1
SENGUPTA_NASOPHARYNGEAL_CARC...3,SET,146,-0.045145,-0.0040078,0.076047,0.72362,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,1
GCM_MYST2,SET,159,-0.037996,-0.0035188,0.064006,0.72362,GCM_MYST2,1
GSE22886_NAIVE_CD4_TCELL_VS_...4,SET,176,-0.03639,-0.003544,0.061279,0.72368,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP,1
HP_ABNORMAL_BLOOD_TRANSITION...,SET,37,-0.082997,-0.0037203,0.13976,0.72369,HP_ABNORMAL_BLOOD_TRANSITION_ELEMENT_CATION_CONCENTRATION,1
HP_APLASIA_INVOLVING_BONES_O...2,SET,13,-0.14167,-0.0037665,0.23855,0.7237,HP_APLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,1
HP_ESOPHAGEAL_VARIX,SET,39,-0.090217,-0.0041515,0.15191,0.7237,HP_ESOPHAGEAL_VARIX,1
HP_ABNORMAL_INFERIOR_VENA_CA...,SET,42,-0.073609,-0.0035149,0.12393,0.72372,HP_ABNORMAL_INFERIOR_VENA_CAVA_MORPHOLOGY,1
TRAVAGLINI_LUNG_VEIN_CELL,SET,37,-0.089685,-0.0040201,0.151,0.72372,TRAVAGLINI_LUNG_VEIN_CELL,1
GSE3400_UNTREATED_VS_IFNB_TR...1,SET,154,-0.041594,-0.0037915,0.070027,0.72373,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN,1
GOMF_CARBOHYDRATE_PHOSPHATAS...,SET,8,-0.17959,-0.0037461,0.30233,0.72374,GOMF_CARBOHYDRATE_PHOSPHATASE_ACTIVITY,1
MIR584_3P,SET,96,-0.052371,-0.0037752,0.088117,0.72385,MIR584_3P,1
GOMF_FRUCTOSE_BINDING,SET,6,-0.16451,-0.0029721,0.27678,0.72387,GOMF_FRUCTOSE_BINDING,1
GOBP_PURINE_DEOXYRIBONUCLEOS...4,SET,7,-0.18148,-0.0035411,0.3052,0.72395,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GRUETZMANN_PANCREATIC_CANCER...1,SET,182,-0.037274,-0.0036909,0.062677,0.72397,GRUETZMANN_PANCREATIC_CANCER_DN,1
GOBP_ENDOTHELIAL_CELL_MORPHO...,SET,9,-0.19827,-0.0043866,0.33339,0.72398,GOBP_ENDOTHELIAL_CELL_MORPHOGENESIS,1
HUI_MAPK14_TARGETS_UP,SET,18,-0.1249,-0.0039071,0.20999,0.72401,HUI_MAPK14_TARGETS_UP,1
GOBP_NECROPTOTIC_SIGNALING_P...,SET,8,-0.19588,-0.0040859,0.3292,0.72408,GOBP_NECROPTOTIC_SIGNALING_PATHWAY,1
GOMF_DEACETYLASE_ACTIVITY,SET,35,-0.084591,-0.0036881,0.14214,0.72411,GOMF_DEACETYLASE_ACTIVITY,1
GOMF_HORMONE_ACTIVITY,SET,111,-0.052963,-0.0041036,0.088988,0.72413,GOMF_HORMONE_ACTIVITY,1
HP_UPPER_LIMB_POSTURAL_TREMOR,SET,10,-0.17983,-0.0041936,0.30212,0.72414,HP_UPPER_LIMB_POSTURAL_TREMOR,1
MIR664B_3P,SET,442,-0.025172,-0.0038565,0.042285,0.72418,MIR664B_3P,1
HE_LIM_SUN_FETAL_LUNG_C0_MYO...3,SET,22,-0.12377,-0.0042797,0.2079,0.72418,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_3_CELL,1
MIR3137,SET,47,-0.079581,-0.0040193,0.13366,0.72421,MIR3137,1
OCT1_Q6,SET,229,-0.035419,-0.003929,0.059486,0.72421,OCT1_Q6,1
GOMF_MOLECULAR_TAG_ACTIVITY,SET,11,-0.162,-0.0039622,0.27206,0.72423,GOMF_MOLECULAR_TAG_ACTIVITY,1
GOBP_SENSORY_PERCEPTION_OF_S...2,SET,9,-0.17605,-0.0038949,0.29561,0.72425,GOBP_SENSORY_PERCEPTION_OF_SOUR_TASTE,1
GSE28237_FOLLICULAR_VS_EARLY...2,SET,167,-0.037347,-0.0035439,0.062706,0.72427,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP,1
GOBP_INTERNEURON_MIGRATION,SET,13,-0.17001,-0.00452,0.28538,0.72432,GOBP_INTERNEURON_MIGRATION,1
GSE41176_UNSTIM_VS_ANTI_IGM_...13,SET,182,-0.039003,-0.0038621,0.065463,0.72434,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN,1
GOCC_CEREBELLAR_CLIMBING_FIB...,SET,7,-0.22536,-0.0043973,0.37821,0.72436,GOCC_CEREBELLAR_CLIMBING_FIBER_TO_PURKINJE_CELL_SYNAPSE,1
GAVISH_3CA_MALIGNANT_METAPRO...30,SET,45,-0.075448,-0.0037288,0.12662,0.72437,GAVISH_3CA_MALIGNANT_METAPROGRAM_38_GLUTATHIONE,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...1,SET,4,-0.24337,-0.0035901,0.40833,0.72441,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
DIRMEIER_LMP1_RESPONSE_LATE_...2,SET,53,-0.071713,-0.0038455,0.12031,0.72443,DIRMEIER_LMP1_RESPONSE_LATE_UP,1
GSE411_WT_VS_SOCS3_KO_MACROP...1,SET,185,-0.036955,-0.003689,0.061995,0.72444,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN,1
HP_LOWER_LIMB_ASYMMETRY,SET,41,-0.084824,-0.004002,0.14229,0.72446,HP_LOWER_LIMB_ASYMMETRY,1
GOBP_OLEFINIC_COMPOUND_BIOSY...,SET,26,-0.10564,-0.0039705,0.17714,0.72453,GOBP_OLEFINIC_COMPOUND_BIOSYNTHETIC_PROCESS,1
HP_RENAL_CORTICOMEDULLARY_CY...,SET,8,-0.17431,-0.003636,0.29229,0.72453,HP_RENAL_CORTICOMEDULLARY_CYSTS,1
OSMAN_BLADDER_CANCER_UP,SET,363,-0.026242,-0.0036515,0.043992,0.72458,OSMAN_BLADDER_CANCER_UP,1
GOMF_PROTEIN_HETERODIMERIZAT...,SET,232,-0.034855,-0.0038914,0.058433,0.72458,GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY,1
GOBP_ESTABLISHMENT_OF_CELL_P...,SET,145,-0.043063,-0.0038099,0.072178,0.72462,GOBP_ESTABLISHMENT_OF_CELL_POLARITY,1
GOMF_ENDOPEPTIDASE_ACTIVATOR...,SET,17,-0.13215,-0.0040172,0.22148,0.72463,GOMF_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,1
HP_REDUCED_BLOOD_FOLATE_CONC...,SET,4,-0.27423,-0.0040453,0.45922,0.7248,HP_REDUCED_BLOOD_FOLATE_CONCENTRATION,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...5,SET,315,-0.028012,-0.0036357,0.0469,0.72483,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE,1
WP_FEMALE_STEROID_HORMONES_I...,SET,14,-0.12715,-0.0035081,0.21284,0.72487,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,1
HALLMARK_PEROXISOME,SET,98,-0.051694,-0.0037648,0.086534,0.72487,HALLMARK_PEROXISOME,1
GOMF_EXTRACELLULAR_MATRIX_CO...,SET,10,-0.17432,-0.0040652,0.29178,0.72489,GOMF_EXTRACELLULAR_MATRIX_CONSTITUENT_CONFERRING_ELASTICITY,1
HP_ABNORMALITY_OF_CHORIORETI...,SET,12,-0.16174,-0.0041315,0.2707,0.7249,HP_ABNORMALITY_OF_CHORIORETINAL_PIGMENTATION,1
CREB3L4_TARGET_GENES,SET,1160,-0.015248,-0.003708,0.02551,0.72499,CREB3L4_TARGET_GENES,1
MIR518C_5P,SET,175,-0.039286,-0.0038154,0.065694,0.72508,MIR518C_5P,1
HP_INSIDIOUS_ONSET,SET,15,-0.12576,-0.0035913,0.21025,0.72512,HP_INSIDIOUS_ONSET,1
GOBP_POSITIVE_REGULATION_OF_...137,SET,32,-0.082406,-0.0034356,0.13773,0.72519,GOBP_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS,1
HP_ORAL_PHARYNGEAL_DYSPHAGIA,SET,39,-0.084452,-0.0038862,0.14109,0.72527,HP_ORAL_PHARYNGEAL_DYSPHAGIA,1
GOMF_TYPE_1_ANGIOTENSIN_RECE...,SET,6,-0.25118,-0.0045378,0.41961,0.72528,GOMF_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...8,SET,22,-0.1242,-0.0042947,0.20743,0.72533,GOBP_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_CELL_PROL...2,SET,6,-0.19142,-0.0034582,0.31963,0.72537,GOBP_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,1
BIOCARTA_CLASSIC_PATHWAY,SET,10,-0.17498,-0.0040807,0.29215,0.72539,BIOCARTA_CLASSIC_PATHWAY,1
chr15q25,SET,58,-0.11207,-0.006286,0.1871,0.7254,chr15q25,1
HP_ABNORMAL_FEMORAL_TORSION,SET,9,-0.16029,-0.0035463,0.26756,0.72544,HP_ABNORMAL_FEMORAL_TORSION,1
CETS1P54_01,SET,250,-0.031451,-0.0036432,0.052455,0.7256,CETS1P54_01,1
MIR6795_5P,SET,120,-0.047278,-0.0038079,0.078849,0.72561,MIR6795_5P,1
MODULE_149,SET,34,-0.080898,-0.0034764,0.1349,0.72564,MODULE_149,1
LE_NEURONAL_DIFFERENTIATION_...2,SET,17,-0.12003,-0.0036488,0.20014,0.72565,LE_NEURONAL_DIFFERENTIATION_UP,1
GOBP_NEGATIVE_REGULATION_OF_...626,SET,4,-0.25406,-0.0037477,0.42352,0.7257,GOBP_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
HP_ABNORMALITY_OF_THE_DENTIT...,SET,875,-0.017855,-0.003802,0.029761,0.72572,HP_ABNORMALITY_OF_THE_DENTITION,1
MIR665,SET,122,-0.045532,-0.0036974,0.075885,0.72575,MIR665,1
BUSSLINGER_DUODENAL_GOBLET_C...,SET,15,-0.154,-0.0043978,0.25663,0.72577,BUSSLINGER_DUODENAL_GOBLET_CELLS,1
GOBP_TYPE_B_PANCREATIC_CELL_...1,SET,10,-0.19109,-0.0044563,0.31841,0.72579,GOBP_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,1
GSE17974_0.5H_VS_72H_UNTREAT...1,SET,172,-0.036751,-0.0035387,0.061239,0.72579,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
GOBP_DETOXIFICATION_OF_NITRO...,SET,2,-0.42435,-0.0044266,0.70705,0.7258,GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND,1
MIR6823_5P,SET,64,-0.064532,-0.0038016,0.10751,0.72583,MIR6823_5P,1
MIR1248,SET,120,-0.049168,-0.0039601,0.081871,0.72593,MIR1248,1
HP_INCREASED_CIRCULATING_ANT...,SET,93,-0.054858,-0.0038925,0.091344,0.72593,HP_INCREASED_CIRCULATING_ANTIBODY_LEVEL,1
GOBP_REGULATION_OF_CHROMOSOM...3,SET,125,-0.044757,-0.0036786,0.074511,0.72597,GOBP_REGULATION_OF_CHROMOSOME_SEGREGATION,1
GOCC_CENTRAL_ELEMENT,SET,7,-0.17881,-0.003489,0.29758,0.72604,GOCC_CENTRAL_ELEMENT,1
WP_DISORDERS_IN_KETONE_BODY_...,SET,5,-0.23571,-0.0038873,0.39211,0.72612,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,1
GOMF_GABA_RECEPTOR_ACTIVITY,SET,19,-0.14747,-0.0047392,0.24532,0.72612,GOMF_GABA_RECEPTOR_ACTIVITY,1
GSE369_SOCS3_KO_VS_WT_LIVER_...1,SET,184,-0.037139,-0.0036975,0.06178,0.72613,GSE369_SOCS3_KO_VS_WT_LIVER_DN,1
HP_INCREASED_SKULL_OSSIFICAT...,SET,8,-0.17287,-0.003606,0.28752,0.72616,HP_INCREASED_SKULL_OSSIFICATION,1
GAO_ESOPHAGUS_25W_C3_FGFR1LO...,SET,43,-0.07669,-0.0037052,0.12746,0.72631,GAO_ESOPHAGUS_25W_C3_FGFR1LOW_EPITHELIAL_CELLS,1
HP_PHIMOSIS,SET,9,-0.16544,-0.0036602,0.27491,0.72634,HP_PHIMOSIS,1
CARM1_TARGET_GENES,SET,8,-0.18902,-0.0039429,0.31407,0.72636,CARM1_TARGET_GENES,1
HP_EEG_WITH_MULTIFOCAL_SLOW_...,SET,49,-0.071191,-0.0036711,0.11827,0.72639,HP_EEG_WITH_MULTIFOCAL_SLOW_ACTIVITY,1
ZNF37A_TARGET_GENES,SET,116,-0.047213,-0.0037391,0.078428,0.72641,ZNF37A_TARGET_GENES,1
DESCARTES_FETAL_MUSCLE_MEGAK...,SET,195,-0.036879,-0.0037786,0.061238,0.72649,DESCARTES_FETAL_MUSCLE_MEGAKARYOCYTES,1
REACTOME_JOSEPHIN_DOMAIN_DUBS,SET,9,-0.16508,-0.0036523,0.27409,0.72651,REACTOME_JOSEPHIN_DOMAIN_DUBS,1
MORF_CNTN1,SET,91,-0.052889,-0.0037124,0.087802,0.72653,MORF_CNTN1,1
GOBP_REGULATION_OF_LIPOPROTE...3,SET,21,-0.11248,-0.0038,0.18673,0.72653,GOBP_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,1
HE_LIM_SUN_FETAL_LUNG_C0_LAT...1,SET,103,-0.055758,-0.0041625,0.092567,0.72653,HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL,1
HP_RENAL_NECROSIS,SET,5,-0.22769,-0.0037552,0.37783,0.72662,HP_RENAL_NECROSIS,1
GSE27786_LIN_NEG_VS_NKTCELL_...2,SET,179,-0.036602,-0.0035946,0.060726,0.72665,GSE27786_LIN_NEG_VS_NKTCELL_UP,1
GOBP_FATTY_ACID_BETA_OXIDATI...2,SET,11,-0.13938,-0.003409,0.23125,0.72666,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE,1
HP_RENAL_CYST,SET,245,-0.033736,-0.0038692,0.055957,0.72671,HP_RENAL_CYST,1
REACTOME_CELLULAR_RESPONSE_T...2,SET,95,-0.04982,-0.0035727,0.082629,0.72672,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1
REACTOME_SUMOYLATION_OF_RNA_...,SET,43,-0.074581,-0.0036034,0.1237,0.72672,REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS,1
GALE_APL_WITH_FLT3_MUTATED_DN,SET,13,-0.14183,-0.0037709,0.23518,0.72677,GALE_APL_WITH_FLT3_MUTATED_DN,1
PLASARI_TGFB1_TARGETS_10HR_UP,SET,186,-0.041281,-0.0041319,0.068449,0.72677,PLASARI_TGFB1_TARGETS_10HR_UP,1
GOMF_LAMIN_BINDING,SET,16,-0.13291,-0.0039199,0.22038,0.72677,GOMF_LAMIN_BINDING,1
chr2q32,SET,41,-0.15726,-0.0074197,0.26072,0.7268,chr2q32,1
HP_POLYGENIC_INHERITANCE,SET,32,-0.09915,-0.0041337,0.16435,0.72683,HP_POLYGENIC_INHERITANCE,1
VETTER_TARGETS_OF_PRKCA_AND_...1,SET,16,-0.1395,-0.0041144,0.23119,0.72688,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,1
GSE41978_ID2_KO_VS_BIM_KO_KL...2,SET,186,-0.039615,-0.0039651,0.06565,0.72688,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
HP_TEMPOROMANDIBULAR_JOINT_A...,SET,4,-0.23475,-0.0034628,0.38898,0.72691,HP_TEMPOROMANDIBULAR_JOINT_ANKYLOSIS,1
MURARO_PANCREAS_PANCREATIC_P...,SET,134,-0.049796,-0.0042366,0.082507,0.72692,MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL,1
WP_TRANSCRIPTION_COFACTORS_S...,SET,17,-0.14384,-0.0043726,0.23829,0.72694,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,1
GOBP_DENDRITIC_TRANSPORT_OF_...,SET,5,-0.22878,-0.0037731,0.37895,0.72699,GOBP_DENDRITIC_TRANSPORT_OF_RIBONUCLEOPROTEIN_COMPLEX,1
HP_ABNORMAL_CIRCULATING_ORGA...,SET,657,-0.020605,-0.0038256,0.034128,0.72699,HP_ABNORMAL_CIRCULATING_ORGANIC_COMPOUND_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...333,SET,184,-0.039957,-0.003978,0.066169,0.72703,GOBP_POSITIVE_REGULATION_OF_HEMOPOIESIS,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...2,SET,167,-0.039638,-0.0037613,0.06564,0.72703,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP,1
GSE37416_0H_VS_24H_F_TULAREN...1,SET,177,-0.038299,-0.0037404,0.063407,0.72708,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GSE20715_WT_VS_TLR4_KO_LUNG_...2,SET,179,-0.038941,-0.0038244,0.064469,0.72709,GSE20715_WT_VS_TLR4_KO_LUNG_UP,1
GSE17721_POLYIC_VS_GARDIQUIM...3,SET,183,-0.036771,-0.0036509,0.060861,0.72713,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN,1
GSE27786_CD4_TCELL_VS_MONO_M...2,SET,176,-0.036582,-0.0035627,0.060542,0.72715,GSE27786_CD4_TCELL_VS_MONO_MAC_UP,1
GOBP_ANTIBACTERIAL_HUMORAL_R...,SET,48,-0.092197,-0.0047057,0.15257,0.72717,GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE,1
GOBP_ASYMMETRIC_NEUROBLAST_D...,SET,5,-0.23112,-0.0038117,0.38245,0.72718,GOBP_ASYMMETRIC_NEUROBLAST_DIVISION,1
MODULE_372,SET,20,-0.11409,-0.0037617,0.18874,0.72724,MODULE_372,1
GSE2770_IL12_VS_IL4_TREATED_...3,SET,177,-0.038858,-0.0037951,0.064254,0.72733,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
WP_SEROTONIN_RECEPTOR_467_AN...,SET,18,-0.13594,-0.0042522,0.22473,0.72737,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,1
GSE22601_DOUBLE_NEGATIVE_VS_...6,SET,167,-0.039052,-0.0037057,0.064555,0.72739,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,1
GOMF_5_3_EXONUCLEASE_ACTIVITY,SET,17,-0.11259,-0.0034226,0.1861,0.7274,GOMF_5_3_EXONUCLEASE_ACTIVITY,1
PID_INTEGRIN2_PATHWAY,SET,26,-0.11593,-0.0043573,0.1916,0.72742,PID_INTEGRIN2_PATHWAY,1
GSE3982_CENT_MEMORY_CD4_TCEL...3,SET,182,-0.036421,-0.0036065,0.060181,0.72747,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN,1
GSE14000_TRANSLATED_RNA_VS_M...6,SET,178,-0.037583,-0.0036808,0.062091,0.7275,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP,1
GOCC_MULTIVESICULAR_BODY,SET,61,-0.068671,-0.0039497,0.11343,0.72755,GOCC_MULTIVESICULAR_BODY,1
NRF2_01,SET,250,-0.030653,-0.0035508,0.050622,0.72758,NRF2_01,1
TTCNRGNNNNTTC_HSF_Q6,SET,137,-0.044259,-0.0038071,0.073075,0.72763,TTCNRGNNNNTTC_HSF_Q6,1
HP_ATYPICAL_ABSENCE_SEIZURE,SET,31,-0.093166,-0.0038232,0.15381,0.72765,HP_ATYPICAL_ABSENCE_SEIZURE,1
REACTOME_GLUCOCORTICOID_BIOS...,SET,10,-0.18099,-0.0042208,0.29878,0.72766,REACTOME_GLUCOCORTICOID_BIOSYNTHESIS,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD...2,SET,57,-0.076185,-0.0042363,0.12576,0.72767,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1
HP_MOYAMOYA_PHENOMENON,SET,12,-0.13022,-0.0033264,0.21496,0.72767,HP_MOYAMOYA_PHENOMENON,1
WP_RESISTIN_AS_A_REGULATOR_O...,SET,32,-0.09117,-0.003801,0.15046,0.72772,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,1
GOCC_FILOPODIUM_TIP,SET,16,-0.13645,-0.0040242,0.22517,0.72773,GOCC_FILOPODIUM_TIP,1
HP_VERTEBRAL_SEGMENTATION_DE...,SET,131,-0.046298,-0.0038949,0.0764,0.72773,HP_VERTEBRAL_SEGMENTATION_DEFECT,1
HALLMARK_UV_RESPONSE_UP,SET,149,-0.041989,-0.0037654,0.069291,0.72773,HALLMARK_UV_RESPONSE_UP,1
ACEVEDO_LIVER_CANCER_WITH_H3...3,SET,82,-0.056471,-0.0037637,0.093181,0.72775,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1
MIR3139,SET,55,-0.071289,-0.0038941,0.11763,0.72776,MIR3139,1
GOBP_REGULATION_OF_T_CELL_AC...1,SET,357,-0.029574,-0.0040816,0.048788,0.72779,GOBP_REGULATION_OF_T_CELL_ACTIVATION,1
GSE6259_FLT3L_INDUCED_33D1_P...4,SET,159,-0.041167,-0.0038125,0.067915,0.72779,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP,1
GSE13522_WT_VS_IFNAR_KO_SKIN...3,SET,152,-0.044202,-0.0040033,0.072915,0.72781,GSE13522_WT_VS_IFNAR_KO_SKIN_DN,1
GOBP_POSITIVE_REGULATION_OF_...381,SET,127,-0.044178,-0.0036598,0.072867,0.72783,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
GOMF_TRANSLATION_REGULATOR_A...2,SET,91,-0.049287,-0.0034596,0.081287,0.72785,GOMF_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING,1
KEGG_MEDICUS_VARIANT_MUTATIO...15,SET,9,-0.17661,-0.0039073,0.29125,0.72787,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY,1
REACTOME_FGFR2_LIGAND_BINDIN...,SET,19,-0.14049,-0.0045148,0.23161,0.72793,REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION,1
SHAFFER_IRF4_MULTIPLE_MYELOM...,SET,33,-0.095737,-0.0040532,0.15782,0.72795,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1
DORN_ADENOVIRUS_INFECTION_12...2,SET,23,-0.1037,-0.0036663,0.17091,0.72799,DORN_ADENOVIRUS_INFECTION_12HR_UP,1
GENTILE_UV_RESPONSE_CLUSTER_...1,SET,17,-0.12831,-0.0039005,0.21133,0.72811,GENTILE_UV_RESPONSE_CLUSTER_D1,1
GOBP_PRODUCTION_OF_MOLECULAR...2,SET,205,-0.036833,-0.0038684,0.060663,0.72813,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,1
GOBP_OMEGA_HYDROXYLASE_P450_...,SET,11,-0.17194,-0.0042053,0.28317,0.72814,GOBP_OMEGA_HYDROXYLASE_P450_PATHWAY,1
HP_CARIOUS_TEETH,SET,147,-0.044195,-0.0039368,0.072776,0.72816,HP_CARIOUS_TEETH,1
HP_PRIMARY_HYPERPARATHYROIDI...,SET,13,-0.15979,-0.0042483,0.26309,0.72819,HP_PRIMARY_HYPERPARATHYROIDISM,1
REACTOME_ORGANIC_CATION_ANIO...,SET,15,-0.14322,-0.00409,0.2358,0.7282,REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...435,SET,14,-0.13923,-0.0038414,0.22924,0.7282,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
HP_THINNING_OF_DESCEMET_MEMB...,SET,6,-0.25115,-0.0045371,0.41349,0.7282,HP_THINNING_OF_DESCEMET_MEMBRANE,1
GOMF_HEPARIN_BINDING,SET,160,-0.04538,-0.0042158,0.074679,0.72829,GOMF_HEPARIN_BINDING,1
WP_NONGENOMIC_ACTIONS_OF_125...,SET,70,-0.064291,-0.0039603,0.10578,0.72833,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,1
GCM_CSNK1D,SET,29,-0.093613,-0.0037157,0.154,0.72836,GCM_CSNK1D,1
GOBP_CALCIUM_ION_IMPORT,SET,73,-0.064319,-0.0040456,0.1058,0.72838,GOBP_CALCIUM_ION_IMPORT,1
GOMF_METALLOEXOPEPTIDASE_ACT...,SET,63,-0.074059,-0.0043286,0.12181,0.7284,GOMF_METALLOEXOPEPTIDASE_ACTIVITY,1
GSE22886_IGG_IGA_MEMORY_BCEL...3,SET,177,-0.039296,-0.0038378,0.064629,0.72841,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,1
GOMF_RNA_EXONUCLEASE_ACTIVITY,SET,43,-0.074929,-0.0036201,0.12323,0.72842,GOMF_RNA_EXONUCLEASE_ACTIVITY,1
GSE16522_MEMORY_VS_NAIVE_ANT...2,SET,172,-0.040553,-0.0039047,0.06669,0.72843,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP,1
HP_WIDE_FEMORAL_METAPHYSIS,SET,6,-0.19573,-0.003536,0.32185,0.72845,HP_WIDE_FEMORAL_METAPHYSIS,1
MILICIC_FAMILIAL_ADENOMATOUS...2,SET,9,-0.18223,-0.0040317,0.29964,0.72846,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,1
GSE20500_CTRL_VS_RETINOIC_AC...2,SET,174,-0.03772,-0.0036528,0.062017,0.72848,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP,1
GOBP_REGULATION_OF_PROTEIN_K...4,SET,3,-0.3389,-0.0043296,0.55707,0.72852,GOBP_REGULATION_OF_PROTEIN_KINASE_C_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...243,SET,87,-0.05866,-0.0040264,0.096414,0.72854,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,1
GSE6269_HEALTHY_VS_E_COLI_IN...2,SET,157,-0.040436,-0.0037214,0.06646,0.72854,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP,1
GOBP_MAST_CELL_ACTIVATION,SET,64,-0.068953,-0.004062,0.1133,0.72859,GOBP_MAST_CELL_ACTIVATION,1
DESCARTES_FETAL_PANCREAS_SMO...,SET,30,-0.10419,-0.0042063,0.17116,0.72865,DESCARTES_FETAL_PANCREAS_SMOOTH_MUSCLE_CELLS,1
TGCCAAR_NF1_Q6,SET,640,-0.021563,-0.0039532,0.035417,0.72867,TGCCAAR_NF1_Q6,1
GOBP_CD4_POSITIVE_OR_CD8_POS...,SET,29,-0.10891,-0.0043231,0.17887,0.7287,GOBP_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT,1
GOBP_RECEPTOR_LOCALIZATION_T...2,SET,56,-0.072564,-0.0039995,0.11915,0.72873,GOBP_RECEPTOR_LOCALIZATION_TO_SYNAPSE,1
LANG_MYB_FAMILY_TARGETS,SET,28,-0.10073,-0.0039288,0.16539,0.72875,LANG_MYB_FAMILY_TARGETS,1
POOLA_INVASIVE_BREAST_CANCER...1,SET,123,-0.04839,-0.0039455,0.079431,0.7288,POOLA_INVASIVE_BREAST_CANCER_DN,1
GSE22103_LPS_VS_GMCSF_AND_IF...2,SET,173,-0.037427,-0.0036141,0.061437,0.7288,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,1
HP_ABNORMALITY_OF_THE_TONGUE...,SET,3,-0.24466,-0.0031256,0.40153,0.72884,HP_ABNORMALITY_OF_THE_TONGUE_MUSCLE,1
KEGG_HISTIDINE_METABOLISM,SET,26,-0.11118,-0.0041789,0.18243,0.72888,KEGG_HISTIDINE_METABOLISM,1
HEIDENBLAD_AMPLICON_8Q24_DN,SET,38,-0.08799,-0.0039969,0.14437,0.72889,HEIDENBLAD_AMPLICON_8Q24_DN,1
GSE37533_PPARG2_FOXP3_VS_FOX...1,SET,182,-0.039572,-0.0039184,0.064929,0.72889,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,1
GSE22886_NAIVE_BCELL_VS_BLOO...1,SET,175,-0.03864,-0.0037526,0.063389,0.72892,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
NKX61_01,SET,215,-0.038277,-0.0041157,0.062785,0.72895,NKX61_01,1
GSE34515_CD16_NEG_MONOCYTE_V...1,SET,176,-0.037235,-0.0036264,0.061073,0.72896,GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN,1
KYNG_NORMAL_AGING_UP,SET,13,-0.14297,-0.0038011,0.23439,0.72905,KYNG_NORMAL_AGING_UP,1
KYNG_WERNER_SYNDROM_UP,SET,11,-0.15387,-0.0037632,0.25213,0.72916,KYNG_WERNER_SYNDROM_UP,1
GOBP_PALLIUM_DEVELOPMENT,SET,174,-0.041513,-0.0040201,0.06802,0.72916,GOBP_PALLIUM_DEVELOPMENT,1
NAKAYA_MONOCYTE_FLUMIST_AGE_...1,SET,237,-0.033565,-0.0037869,0.054989,0.72919,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN,1
GOBP_ADENYLATE_CYCLASE_INHIB...5,SET,7,-0.23429,-0.0045716,0.38383,0.7292,GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
BIOCARTA_PKC_PATHWAY,SET,7,-0.22316,-0.0043545,0.36555,0.72922,BIOCARTA_PKC_PATHWAY,1
REACTOME_EGFR_DOWNREGULATION,SET,29,-0.10215,-0.0040545,0.16732,0.72923,REACTOME_EGFR_DOWNREGULATION,1
GOBP_RESPONSE_TO_L_PHENYLALA...,SET,5,-0.26791,-0.0044184,0.43881,0.72924,GOBP_RESPONSE_TO_L_PHENYLALANINE_DERIVATIVE,1
GSE17721_12H_VS_24H_LPS_BMDC...1,SET,181,-0.036537,-0.003608,0.059841,0.72925,GSE17721_12H_VS_24H_LPS_BMDC_DN,1
GOMF_SUPEROXIDE_GENERATING_N...1,SET,7,-0.21608,-0.0042163,0.35381,0.72931,GOMF_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY,1
GOBP_EXIT_FROM_MITOSIS,SET,29,-0.091636,-0.0036372,0.15003,0.72933,GOBP_EXIT_FROM_MITOSIS,1
HE_LIM_SUN_FETAL_LUNG_C7_LAT...,SET,90,-0.059318,-0.0041409,0.097115,0.72933,HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL,1
HP_NEOPLASM_OF_STRIATED_MUSC...,SET,29,-0.10402,-0.0041287,0.17027,0.72936,HP_NEOPLASM_OF_STRIATED_MUSCLE,1
WANG_ESOPHAGUS_CANCER_VS_NOR...1,SET,95,-0.052197,-0.0037431,0.08542,0.72942,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1
GOMF_EUKARYOTIC_TRANSLATION_...,SET,6,-0.21696,-0.0039196,0.35494,0.72948,GOMF_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2ALPHA_KINASE_ACTIVITY,1
GSE17721_LPS_VS_GARDIQUIMOD_...4,SET,185,-0.038934,-0.0038866,0.063672,0.72956,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP,1
WP_ALLOGRAFT_REJECTION,SET,82,-0.065081,-0.0043375,0.10641,0.72959,WP_ALLOGRAFT_REJECTION,1
GAUTAM_EYE_IRIS_CILIARY_BODY...17,SET,104,-0.054017,-0.004052,0.088315,0.72961,GAUTAM_EYE_IRIS_CILIARY_BODY_WIF1_HIGH_FIBROBLASTS,1
GSE360_L_DONOVANI_VS_T_GONDI...2,SET,184,-0.039277,-0.0039103,0.064205,0.72964,GSE360_L_DONOVANI_VS_T_GONDII_DC_UP,1
GOBP_GLOMERULUS_VASCULATURE_...,SET,6,-0.24576,-0.0044399,0.4016,0.72971,GOBP_GLOMERULUS_VASCULATURE_MORPHOGENESIS,1
GOCC_GABA_RECEPTOR_COMPLEX,SET,18,-0.15498,-0.0048479,0.25323,0.72973,GOCC_GABA_RECEPTOR_COMPLEX,1
MIR340_3P,SET,44,-0.076231,-0.0037255,0.12455,0.72974,MIR340_3P,1
MEF2D_TARGET_GENES,SET,475,-0.024273,-0.0038516,0.039656,0.72976,MEF2D_TARGET_GENES,1
ZHONG_PFC_C3_UNKNOWN_INP,SET,36,-0.085798,-0.0037936,0.14012,0.72983,ZHONG_PFC_C3_UNKNOWN_INP,1
GSE46025_WT_VS_FOXO1_KO_KLRG...2,SET,166,-0.040073,-0.0037912,0.065441,0.72984,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP,1
AGGAGTG_MIR483,SET,54,-0.070491,-0.0038154,0.1151,0.72987,AGGAGTG_MIR483,1
HP_HEMIATROPHY,SET,4,-0.24204,-0.0035705,0.3952,0.72988,HP_HEMIATROPHY,1
GOBP_NEGATIVE_REGULATION_OF_...157,SET,55,-0.071119,-0.0038848,0.1161,0.72991,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GOMF_NUCLEAR_GLUCOCORTICOID_...,SET,12,-0.16941,-0.0043274,0.27655,0.72992,GOMF_NUCLEAR_GLUCOCORTICOID_RECEPTOR_BINDING,1
HP_THIN_RIBS,SET,46,-0.07803,-0.003899,0.12737,0.72993,HP_THIN_RIBS,1
FLECHNER_PBL_KIDNEY_TRANSPLA...1,SET,37,-0.086422,-0.0038738,0.14104,0.72997,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1
GOBP_REGULATION_OF_IMMUNE_RE...,SET,834,-0.019172,-0.0039905,0.03129,0.72997,GOBP_REGULATION_OF_IMMUNE_RESPONSE,1
GSE15750_WT_VS_TRAF6KO_DAY10...2,SET,175,-0.038484,-0.0037374,0.06279,0.73002,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP,1
GOBP_REGULATION_OF_DOPAMINE_...1,SET,11,-0.19118,-0.0046758,0.31191,0.73003,GOBP_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_SPHINGOLIPID_METABO...,SET,95,-0.056359,-0.0040416,0.091938,0.73006,REACTOME_SPHINGOLIPID_METABOLISM,1
WP_PURINERGIC_SIGNALING,SET,29,-0.10115,-0.004015,0.16499,0.73009,WP_PURINERGIC_SIGNALING,1
MENON_FETAL_KIDNEY_0_CAP_MES...,SET,73,-0.060441,-0.0038017,0.098558,0.73014,MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS,1
REACTOME_METABOLISM_OF_AMINE...,SET,17,-0.13806,-0.004197,0.22508,0.73019,REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES,1
MIR6719_3P,SET,110,-0.052462,-0.0040466,0.085525,0.73019,MIR6719_3P,1
REACTOME_TRANSLOCATION_OF_SL...,SET,69,-0.062893,-0.0038464,0.10252,0.7302,REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,1
REACTOME_NUCLEOTIDE_CATABOLI...,SET,35,-0.092816,-0.0040467,0.15129,0.73022,REACTOME_NUCLEOTIDE_CATABOLISM,1
GOMF_CXCR3_CHEMOKINE_RECEPTO...,SET,5,-0.28686,-0.0047309,0.46758,0.73022,GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING,1
FOROUTAN_TGFB_EMT_UP,SET,185,-0.041099,-0.0041027,0.066976,0.73027,FOROUTAN_TGFB_EMT_UP,1
NUP214_TARGET_GENES,SET,7,-0.23475,-0.0045806,0.38248,0.73031,NUP214_TARGET_GENES,1
GOMF_STEROID_BINDING,SET,102,-0.054295,-0.0040337,0.088455,0.73033,GOMF_STEROID_BINDING,1
GSE12198_CTRL_VS_HIGH_IL2_ST...1,SET,186,-0.037144,-0.0037178,0.060512,0.73033,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN,1
HP_EXERCISE_INTOLERANCE,SET,119,-0.048675,-0.0039041,0.079296,0.73034,HP_EXERCISE_INTOLERANCE,1
GSE3982_CENT_MEMORY_CD4_TCEL...6,SET,175,-0.039804,-0.0038656,0.064842,0.73034,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP,1
KIM_GERMINAL_CENTER_T_HELPER...1,SET,12,-0.18,-0.0045981,0.29318,0.73038,KIM_GERMINAL_CENTER_T_HELPER_DN,1
HARALAMBIEVA_PBMC_TIV_AGE_50...1,SET,19,-0.12335,-0.0039641,0.20091,0.73038,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_28DY_NEGATIVE,1
MIR6722_3P,SET,161,-0.041431,-0.0038608,0.067453,0.73046,MIR6722_3P,1
GOBP_COPPER_ION_HOMEOSTASIS,SET,18,-0.1259,-0.0039383,0.20495,0.73049,GOBP_COPPER_ION_HOMEOSTASIS,1
GOMF_TRANSMEMBRANE_TRANSPORT...,SET,125,-0.050057,-0.0041142,0.081485,0.73049,GOMF_TRANSMEMBRANE_TRANSPORTER_BINDING,1
GOBP_PYRIMIDINE_CONTAINING_C...2,SET,41,-0.09308,-0.0043915,0.15151,0.7305,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
SIGMAR1_TARGET_GENES,SET,9,-0.1698,-0.0037567,0.27634,0.73054,SIGMAR1_TARGET_GENES,1
LOPES_METHYLATED_IN_COLON_CA...1,SET,28,-0.10665,-0.0041595,0.17354,0.73056,LOPES_METHYLATED_IN_COLON_CANCER_DN,1
BROWNE_HCMV_INFECTION_2HR_UP,SET,34,-0.10546,-0.0045318,0.17159,0.73058,BROWNE_HCMV_INFECTION_2HR_UP,1
GOBP_NEGATIVE_REGULATION_OF_...430,SET,5,-0.2066,-0.0034073,0.33616,0.73058,GOBP_NEGATIVE_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,1
GOBP_GLYCINE_BIOSYNTHETIC_PR...,SET,5,-0.23705,-0.0039094,0.38566,0.7306,GOBP_GLYCINE_BIOSYNTHETIC_PROCESS,1
GOMF_VITAMIN_B6_BINDING,SET,48,-0.077986,-0.0039803,0.12687,0.73061,GOMF_VITAMIN_B6_BINDING,1
GSE40274_CTRL_VS_FOXP3_AND_G...1,SET,135,-0.044902,-0.0038343,0.073038,0.73065,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
CHIANG_LIVER_CANCER_SUBCLASS...9,SET,163,-0.039396,-0.0036937,0.064075,0.73067,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,1
AIZARANI_LIVER_C34_MHC_II_PO...,SET,118,-0.05193,-0.0041477,0.084456,0.73068,AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS,1
GSE39110_DAY3_VS_DAY6_POST_I...2,SET,180,-0.040097,-0.0039487,0.065203,0.7307,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_ELECT...2,SET,10,-0.14436,-0.0033665,0.2347,0.73075,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III,1
GSE4142_NAIVE_BCELL_VS_PLASM...1,SET,187,-0.038631,-0.0038769,0.062794,0.73078,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN,1
GOBP_SOMATIC_DIVERSIFICATION...3,SET,55,-0.065631,-0.003585,0.10665,0.73085,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS,1
GSE3982_DC_VS_CENT_MEMORY_CD...1,SET,165,-0.041188,-0.0038851,0.06689,0.73097,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN,1
GOCC_CUL5_RING_UBIQUITIN_LIG...,SET,8,-0.19963,-0.0041641,0.32414,0.731,GOCC_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX,1
GOBP_AXON_DEVELOPMENT,SET,470,-0.025996,-0.0041037,0.042205,0.73103,GOBP_AXON_DEVELOPMENT,1
GSE3565_CTRL_VS_LPS_INJECTED...2,SET,166,-0.044326,-0.0041937,0.071965,0.73103,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP,1
GSE4142_NAIVE_VS_GC_BCELL_UP,SET,181,-0.038777,-0.0038292,0.062956,0.73103,GSE4142_NAIVE_VS_GC_BCELL_UP,1
REACTOME_PLASMA_LIPOPROTEIN_...4,SET,32,-0.097674,-0.0040722,0.15857,0.73104,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1
HP_ABNORMAL_NUMBER_OF_DENSE_...,SET,7,-0.195,-0.0038049,0.31654,0.73105,HP_ABNORMAL_NUMBER_OF_DENSE_GRANULES,1
GOBP_REGULATION_OF_RESPIRATO...1,SET,16,-0.1424,-0.0041998,0.23115,0.73106,GOBP_REGULATION_OF_RESPIRATORY_BURST,1
MIR432_5P,SET,87,-0.057497,-0.0039466,0.093332,0.73107,MIR432_5P,1
GOMF_SEROTONIN_BINDING,SET,10,-0.17086,-0.0039845,0.27725,0.73113,GOMF_SEROTONIN_BINDING,1
HP_APRAXIA,SET,192,-0.035803,-0.0036404,0.058072,0.73122,HP_APRAXIA,1
MIR140_5P,SET,82,-0.057261,-0.0038163,0.092873,0.73123,MIR140_5P,1
GNF2_MSH6,SET,29,-0.083149,-0.0033004,0.13476,0.73139,GNF2_MSH6,1
WP_AUTOSOMAL_RECESSIVE_OSTEO...,SET,11,-0.15398,-0.0037659,0.2495,0.73142,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,1
GSE17721_LPS_VS_GARDIQUIMOD_...11,SET,190,-0.036894,-0.0037319,0.059779,0.73144,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN,1
HP_HYPEROPIC_ASTIGMATISM,SET,5,-0.20329,-0.0033527,0.32935,0.73146,HP_HYPEROPIC_ASTIGMATISM,1
HP_B_CELL_LYMPHOMA,SET,21,-0.12299,-0.0041552,0.19925,0.73147,HP_B_CELL_LYMPHOMA,1
KEGG_MEDICUS_REFERENCE_ITGA_...3,SET,22,-0.11988,-0.0041451,0.19408,0.73159,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY,1
GOBP_ADENYLATE_CYCLASE_ACTIV...2,SET,9,-0.20027,-0.0044308,0.32426,0.73159,GOBP_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
ANDERSEN_CHOLANGIOCARCINOMA_...1,SET,58,-0.072137,-0.0040461,0.11677,0.73164,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,1
GOBP_REGULATION_OF_PHOSPHOLI...2,SET,46,-0.082201,-0.0041074,0.13306,0.73164,GOBP_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...131,SET,4,-0.29716,-0.0043836,0.48094,0.73167,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
BERENJENO_ROCK_SIGNALING_NOT...1,SET,48,-0.081389,-0.004154,0.13167,0.73175,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,1
LU_TUMOR_ENDOTHELIAL_MARKERS...2,SET,20,-0.1246,-0.0041082,0.20155,0.73178,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,1
GSE45365_CTRL_VS_MCMV_INFECT...1,SET,172,-0.039233,-0.0037777,0.063454,0.7318,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN,1
ZHAN_MULTIPLE_MYELOMA_MS_DN,SET,38,-0.082898,-0.0037656,0.13407,0.73181,ZHAN_MULTIPLE_MYELOMA_MS_DN,1
PBX1_01,SET,234,-0.036485,-0.0040906,0.059001,0.73183,PBX1_01,1
GOBP_NEGATIVE_REGULATION_OF_...572,SET,8,-0.18243,-0.0038054,0.29502,0.73183,GOBP_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_PURINE_NUCLEOSIDE_MONOP...1,SET,18,-0.12529,-0.0039193,0.20262,0.73183,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
NABA_MATRISOME_POORLY_METAST...1,SET,25,-0.10614,-0.0039122,0.17162,0.73187,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER,1
GOBP_CEREBRAL_CORTEX_GABAERG...1,SET,5,-0.25908,-0.0042727,0.41887,0.73187,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DEVELOPMENT,1
PID_MTOR_4PATHWAY,SET,67,-0.065884,-0.0039708,0.10651,0.73189,PID_MTOR_4PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_ET...1,SET,12,-0.15225,-0.0038893,0.24614,0.7319,GOBP_CELLULAR_RESPONSE_TO_ETHANOL,1
MIR5693,SET,78,-0.061087,-0.0039712,0.098739,0.73193,MIR5693,1
GOBP_MAINTENANCE_OF_SISTER_C...,SET,8,-0.18171,-0.0037904,0.29371,0.73193,GOBP_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
REACTOME_ERYTHROCYTES_TAKE_U...1,SET,11,-0.16436,-0.00402,0.26556,0.73201,REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN,1
MIR520D_5P,SET,852,-0.018837,-0.0039608,0.030434,0.73202,MIR520D_5P,1
GSE17721_POLYIC_VS_GARDIQUIM...8,SET,181,-0.038168,-0.0037691,0.061656,0.73205,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP,1
TRAVAGLINI_LUNG_MYELOID_DEND...,SET,17,-0.1329,-0.0040402,0.2147,0.73205,TRAVAGLINI_LUNG_MYELOID_DENDRITIC_TYPE_1_CELL,1
GOBP_MAINTENANCE_OF_CELL_POL...,SET,15,-0.16108,-0.0045999,0.26018,0.73207,GOBP_MAINTENANCE_OF_CELL_POLARITY,1
WIERENGA_STAT5A_TARGETS_DN,SET,175,-0.042089,-0.0040875,0.067971,0.73211,WIERENGA_STAT5A_TARGETS_DN,1
GCM_MSN,SET,23,-0.10959,-0.0038744,0.17694,0.73215,GCM_MSN,1
HP_ANTERIOR_BEAKING_OF_LUMBA...,SET,5,-0.24942,-0.0041134,0.40272,0.73215,HP_ANTERIOR_BEAKING_OF_LUMBAR_VERTEBRAE,1
GOBP_SEROTONIN_TRANSPORT,SET,20,-0.13227,-0.0043611,0.21354,0.73218,GOBP_SEROTONIN_TRANSPORT,1
GOBP_AXONAL_TRANSPORT_OF_MIT...,SET,16,-0.13799,-0.0040698,0.22268,0.73226,GOBP_AXONAL_TRANSPORT_OF_MITOCHONDRION,1
GGCKCATGS_UNKNOWN,SET,68,-0.06516,-0.0039562,0.10509,0.73238,GGCKCATGS_UNKNOWN,1
GOBP_L_SERINE_CATABOLIC_PROC...,SET,3,-0.30772,-0.0039313,0.4963,0.73238,GOBP_L_SERINE_CATABOLIC_PROCESS,1
HP_MALROTATION_OF_SMALL_BOWEL,SET,8,-0.19304,-0.0040268,0.31124,0.73244,HP_MALROTATION_OF_SMALL_BOWEL,1
MARCHINI_TRABECTEDIN_RESISTA...1,SET,43,-0.083614,-0.0040398,0.13481,0.73245,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1
GOBP_DEOXYRIBONUCLEOTIDE_CAT...,SET,28,-0.10362,-0.0040415,0.16706,0.73246,GOBP_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,1
HP_WOOLLY_HAIR,SET,22,-0.12154,-0.0042025,0.19592,0.73248,HP_WOOLLY_HAIR,1
MIR4795_3P,SET,629,-0.021969,-0.0039941,0.035408,0.73251,MIR4795_3P,1
KEGG_MEDICUS_VARIANT_MUTATIO...32,SET,20,-0.11886,-0.0039188,0.19149,0.73259,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GSE2405_HEAT_KILLED_LYSATE_V...1,SET,182,-0.040127,-0.0039734,0.064639,0.73263,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,1
GOBP_CYTOPLASMIC_TRANSLATION...2,SET,37,-0.075135,-0.0033679,0.12095,0.73276,GOBP_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
GSE29949_CD8_NEG_DC_SPLEEN_V...6,SET,184,-0.039061,-0.0038888,0.062878,0.73277,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,1
MODULE_55,SET,763,-0.020673,-0.0041239,0.033276,0.73278,MODULE_55,1
chr4q26,SET,15,-0.26062,-0.0074425,0.41947,0.73279,chr4q26,1
GOBP_REGULATION_OF_VESICLE_M...,SET,467,-0.02511,-0.0039515,0.040416,0.73279,GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...183,SET,122,-0.048058,-0.0039026,0.077346,0.73281,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,1
GOBP_GLYCERALDEHYDE_3_PHOSPH...,SET,11,-0.14052,-0.0034368,0.22608,0.73287,GOBP_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS,1
GOMF_SIALIC_ACID_BINDING,SET,20,-0.14353,-0.0047323,0.23092,0.73288,GOMF_SIALIC_ACID_BINDING,1
GOBP_CARDIOLIPIN_BIOSYNTHETI...,SET,7,-0.21014,-0.0041005,0.33807,0.73289,GOBP_CARDIOLIPIN_BIOSYNTHETIC_PROCESS,1
HP_AMNIOTIC_CONSTRICTION_RING,SET,10,-0.19383,-0.0045201,0.31178,0.73292,HP_AMNIOTIC_CONSTRICTION_RING,1
HP_ABNORMAL_CIRCULATING_NITR...,SET,154,-0.04204,-0.0038322,0.067617,0.73294,HP_ABNORMAL_CIRCULATING_NITROGEN_COMPOUND_CONCENTRATION,1
DESCARTES_MAIN_FETAL_HORIZON...,SET,26,-0.1106,-0.0041571,0.17782,0.73302,DESCARTES_MAIN_FETAL_HORIZONTAL_CELLS,1
GOBP_PROTEIN_INSERTION_INTO_...2,SET,9,-0.16972,-0.0037549,0.27285,0.73303,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE_BY_STOP_TRANSFER_MEMBRANE_ANCHOR_SEQUENCE,1
PID_AR_NONGENOMIC_PATHWAY,SET,30,-0.094069,-0.0037976,0.15123,0.73304,PID_AR_NONGENOMIC_PATHWAY,1
REACTOME_DEFECTIVE_FACTOR_IX...,SET,7,-0.22505,-0.0043912,0.36175,0.73306,REACTOME_DEFECTIVE_FACTOR_IX_CAUSES_HEMOPHILIA_B,1
GAVIN_PDE3B_TARGETS,SET,20,-0.12189,-0.0040187,0.19588,0.7331,GAVIN_PDE3B_TARGETS,1
GSE7831_CPG_VS_INFLUENZA_STI...4,SET,176,-0.039882,-0.0038841,0.06409,0.73312,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP,1
MIR4761_5P,SET,62,-0.067631,-0.0039216,0.10866,0.73316,MIR4761_5P,1
MIR1236_3P,SET,170,-0.04143,-0.0039662,0.066552,0.7332,MIR1236_3P,1
GOBP_S_ADENOSYLMETHIONINE_ME...,SET,16,-0.14825,-0.0043724,0.23814,0.7332,GOBP_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS,1
GSE43260_BTLA_POS_VS_NEG_INT...1,SET,173,-0.04087,-0.0039467,0.065646,0.73322,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN,1
MIR4436A,SET,77,-0.064201,-0.0041469,0.10311,0.73324,MIR4436A,1
MATTIOLI_MULTIPLE_MYELOMA_SU...,SET,10,-0.19371,-0.0045173,0.31104,0.73328,MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,1
MIR7113_5P,SET,136,-0.04552,-0.0039013,0.073094,0.73328,MIR7113_5P,1
MIR12119,SET,173,-0.040022,-0.0038647,0.064258,0.7333,MIR12119,1
GSE37301_HEMATOPOIETIC_STEM_...11,SET,149,-0.041226,-0.003697,0.066188,0.73331,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN,1
MIR4641,SET,60,-0.066862,-0.0038141,0.10734,0.73332,MIR4641,1
GOBP_MICROTUBULE_BASED_MOVEM...,SET,367,-0.027564,-0.0038561,0.044242,0.73336,GOBP_MICROTUBULE_BASED_MOVEMENT,1
MIR9851_3P,SET,161,-0.043063,-0.0040129,0.069114,0.73338,MIR9851_3P,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...1,SET,6,-0.25086,-0.004532,0.40254,0.73342,KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
GOMF_STRUCTURAL_CONSTITUENT_...9,SET,148,-0.041599,-0.003718,0.066751,0.73342,GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME,1
GSE34156_UNTREATED_VS_6H_TLR...2,SET,172,-0.042874,-0.0041283,0.068792,0.73343,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
GOBP_PROSTAGLANDIN_SECRETION,SET,18,-0.15216,-0.0047598,0.24408,0.7335,GOBP_PROSTAGLANDIN_SECRETION,1
WP_TCA_CYCLE_AND_DEFICIENCY_...,SET,15,-0.13272,-0.00379,0.21285,0.73352,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,1
HP_PROMINENT_NASAL_TIP,SET,25,-0.11132,-0.0041029,0.17848,0.73358,HP_PROMINENT_NASAL_TIP,1
GAVISH_3CA_METAPROGRAM_FIBRO...6,SET,47,-0.083234,-0.0042038,0.13344,0.7336,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5,1
GSE3982_DC_VS_TH2_DN,SET,178,-0.038632,-0.0037835,0.061931,0.73361,GSE3982_DC_VS_TH2_DN,1
TIEN_INTESTINE_PROBIOTICS_24...2,SET,513,-0.023021,-0.0037921,0.036896,0.73366,TIEN_INTESTINE_PROBIOTICS_24HR_UP,1
GOBP_EXOCRINE_SYSTEM_DEVELOP...,SET,48,-0.080718,-0.0041198,0.12935,0.73369,GOBP_EXOCRINE_SYSTEM_DEVELOPMENT,1
GOMF_ZINC_ION_TRANSMEMBRANE_...,SET,24,-0.094354,-0.0034075,0.15119,0.7337,GOMF_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_CXCL1...,SET,18,-0.1302,-0.0040727,0.2086,0.73373,KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY,1
HP_SEVERELY_REDUCED_LEFT_VEN...,SET,13,-0.12569,-0.0033418,0.20135,0.73376,HP_SEVERELY_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,1
REACTOME_SHC1_EVENTS_IN_ERBB...2,SET,14,-0.13127,-0.0036218,0.21026,0.73379,REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,1
GOBP_NEURON_MATURATION,SET,46,-0.081974,-0.004096,0.13127,0.73384,GOBP_NEURON_MATURATION,1
GOBP_REGULATION_OF_CD8_POSIT...1,SET,19,-0.13219,-0.0042482,0.21168,0.73384,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
CSR_EARLY_UP.V1_DN,SET,113,-0.048643,-0.0038025,0.077874,0.73389,CSR_EARLY_UP.V1_DN,1
MODULE_306,SET,22,-0.1061,-0.0036687,0.16984,0.73391,MODULE_306,1
GOBP_REGULATION_OF_CYCLIC_NU...,SET,6,-0.2021,-0.0036511,0.32348,0.73393,GOBP_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,1
GOBP_PENTOSE_PHOSPHATE_SHUNT...,SET,6,-0.21626,-0.0039069,0.34614,0.73394,GOBP_PENTOSE_PHOSPHATE_SHUNT_NON_OXIDATIVE_BRANCH,1
HP_RENAL_HAMARTOMA,SET,7,-0.20893,-0.0040767,0.33437,0.73396,HP_RENAL_HAMARTOMA,1
KANG_GLIS3_TARGETS,SET,34,-0.1026,-0.0044088,0.16417,0.73399,KANG_GLIS3_TARGETS,1
HP_HYPERPITUITARISM,SET,110,-0.050274,-0.0038778,0.080426,0.73404,HP_HYPERPITUITARISM,1
PID_E2F_PATHWAY,SET,70,-0.060978,-0.0037562,0.097549,0.73405,PID_E2F_PATHWAY,1
GOMF_SINGLE_STRANDED_DNA_END...,SET,10,-0.15799,-0.0036843,0.2526,0.73415,GOMF_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY,1
GOBP_SECONDARY_METABOLIC_PRO...,SET,55,-0.078376,-0.0042812,0.12527,0.73423,GOBP_SECONDARY_METABOLIC_PROCESS,1
MODULE_382,SET,25,-0.12003,-0.0044241,0.19182,0.73426,MODULE_382,1
GCM_CRKL,SET,59,-0.067074,-0.0037943,0.10713,0.73436,GCM_CRKL,1
ZHOU_CELL_CYCLE_GENES_IN_IR_...3,SET,79,-0.059244,-0.0038759,0.094621,0.73438,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,1
MORF_ORC1L,SET,62,-0.064736,-0.0037537,0.10338,0.7344,MORF_ORC1L,1
GSE13229_MATURE_VS_INTMATURE...2,SET,174,-0.041843,-0.0040521,0.066822,0.7344,GSE13229_MATURE_VS_INTMATURE_NKCELL_UP,1
GOBP_ARACHIDONIC_ACID_SECRET...,SET,31,-0.10144,-0.0041629,0.16197,0.73444,GOBP_ARACHIDONIC_ACID_SECRETION,1
DESCARTES_FETAL_INTESTINE_ME...,SET,67,-0.067649,-0.0040772,0.108,0.73446,DESCARTES_FETAL_INTESTINE_MESOTHELIAL_CELLS,1
BIOCARTA_MONOCYTE_PATHWAY,SET,11,-0.18989,-0.0046444,0.30302,0.73455,BIOCARTA_MONOCYTE_PATHWAY,1
GOBP_SEX_CHROMOSOME_DOSAGE_C...,SET,13,-0.14716,-0.0039126,0.23479,0.73459,GOBP_SEX_CHROMOSOME_DOSAGE_COMPENSATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...36,SET,32,-0.098601,-0.0041108,0.15728,0.73463,HP_APLASIA_HYPOPLASIA_OF_THE_HALLUX,1
GOBP_MAMMALIAN_OOGENESIS_STA...,SET,12,-0.16975,-0.0043362,0.27075,0.73465,GOBP_MAMMALIAN_OOGENESIS_STAGE,1
MIR4645_3P,SET,102,-0.05312,-0.0039464,0.084717,0.73468,MIR4645_3P,1
GOBP_SECRETORY_GRANULE_LOCAL...,SET,22,-0.11922,-0.0041225,0.19009,0.73473,GOBP_SECRETORY_GRANULE_LOCALIZATION,1
SASAI_RESISTANCE_TO_NEOPLAST...,SET,45,-0.087117,-0.0043055,0.13887,0.73478,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,1
GOBP_REGULATION_OF_MITOCHOND...7,SET,29,-0.092184,-0.003659,0.14689,0.73485,GOBP_REGULATION_OF_MITOCHONDRIAL_GENE_EXPRESSION,1
CAGCTTT_MIR320,SET,220,-0.037294,-0.0040559,0.059409,0.73491,CAGCTTT_MIR320,1
GOBP_SKELETAL_MUSCLE_ORGAN_D...,SET,169,-0.042942,-0.0040989,0.06839,0.73496,GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT,1
FERRANDO_T_ALL_WITH_MLL_ENL_...1,SET,78,-0.060637,-0.003942,0.096566,0.73497,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,1
GOBP_NEGATIVE_REGULATION_OF_...650,SET,4,-0.26921,-0.0039712,0.42871,0.73498,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_ELONGATION,1
KEGG_MEDICUS_REFERENCE_AUTOP...3,SET,5,-0.29251,-0.0048241,0.46566,0.73505,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TRANS_SNARE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...8,SET,5,-0.23007,-0.0037943,0.36599,0.73519,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS_DISULFIDE_AS_ACCEPTOR,1
GARCIA_PINERES_PBMC_HPV_16_L...6,SET,20,-0.12987,-0.004282,0.20661,0.73519,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,1
GOBP_TRAIL_ACTIVATED_APOPTOT...,SET,9,-0.17426,-0.0038554,0.27722,0.7352,GOBP_TRAIL_ACTIVATED_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_RELAXATION_OF_CARDIAC_M...,SET,17,-0.13738,-0.0041764,0.2185,0.73524,GOBP_RELAXATION_OF_CARDIAC_MUSCLE,1
CHIBA_RESPONSE_TO_TSA_UP,SET,48,-0.083724,-0.0042732,0.13315,0.73525,CHIBA_RESPONSE_TO_TSA_UP,1
MIR4439,SET,66,-0.071484,-0.0042761,0.11367,0.73527,MIR4439,1
REACTOME_METABOLISM_OF_AMINO...,SET,330,-0.029475,-0.003914,0.046864,0.7353,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1
GOBP_RESPONSE_TO_ACID_CHEMIC...,SET,119,-0.051144,-0.0041021,0.081278,0.7354,GOBP_RESPONSE_TO_ACID_CHEMICAL,1
ELK1_01,SET,253,-0.033907,-0.0039508,0.053871,0.73545,ELK1_01,1
GSE20366_TREG_VS_TCONV_DN,SET,179,-0.040908,-0.0040175,0.064991,0.73546,GSE20366_TREG_VS_TCONV_DN,1
GOBP_MACROPINOCYTOSIS,SET,8,-0.19279,-0.0040214,0.30624,0.7355,GOBP_MACROPINOCYTOSIS,1
MIR4723_3P,SET,76,-0.061995,-0.0039785,0.098456,0.73554,MIR4723_3P,1
LASTOWSKA_NEUROBLASTOMA_COPY...1,SET,731,-0.023459,-0.0045846,0.037252,0.73556,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN,1
HOLLEMAN_ASPARAGINASE_RESIST...2,SET,21,-0.12702,-0.0042913,0.20166,0.73561,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,1
GOBP_TELOMERE_MAINTENANCE_VI...1,SET,14,-0.13437,-0.0037072,0.21332,0.73562,GOBP_TELOMERE_MAINTENANCE_VIA_RECOMBINATION,1
GSE36888_STAT5_AB_KNOCKIN_VS...6,SET,175,-0.039448,-0.0038311,0.062626,0.73562,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP,1
GSE24634_IL4_VS_CTRL_TREATED...1,SET,180,-0.040709,-0.004009,0.064611,0.73567,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN,1
REACTOME_INTRA_GOLGI_AND_RET...,SET,194,-0.036393,-0.0037193,0.057757,0.73568,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1
OHM_EMBRYONIC_CARCINOMA_DN,SET,8,-0.21813,-0.0045501,0.34616,0.7357,OHM_EMBRYONIC_CARCINOMA_DN,1
REACTOME_DISORDERS_OF_TRANSM...,SET,166,-0.041211,-0.0038989,0.065393,0.73571,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1
HP_TACTILE_HYPERSENSITIVITY,SET,5,-0.26885,-0.004434,0.42661,0.73572,HP_TACTILE_HYPERSENSITIVITY,1
GOBP_REGULATION_OF_PHOSPHATI...1,SET,5,-0.25864,-0.0042656,0.41018,0.73583,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_WNT_PROTE...,SET,5,-0.2578,-0.0042517,0.4088,0.73585,GOBP_REGULATION_OF_WNT_PROTEIN_SECRETION,1
GOBP_WNT_PROTEIN_SECRETION,SET,5,-0.2578,-0.0042517,0.4088,0.73585,GOBP_WNT_PROTEIN_SECRETION,1
GSE9946_LISTERIA_INF_MATURE_...1,SET,100,-0.055522,-0.0040844,0.088039,0.73586,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,1
ZNF595_TARGET_GENES,SET,99,-0.054152,-0.0039638,0.085843,0.73592,ZNF595_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...405,SET,141,-0.047804,-0.0041711,0.075778,0.73592,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,1
KEGG_MEDICUS_REFERENCE_IL1_I...1,SET,17,-0.14261,-0.0043352,0.22605,0.73593,KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY,1
GOBP_HORMONE_TRANSPORT,SET,304,-0.032637,-0.0041628,0.051736,0.73593,GOBP_HORMONE_TRANSPORT,1
GOBP_LIPID_METABOLIC_PROCESS,SET,1267,-0.016129,-0.0040864,0.025564,0.73596,GOBP_LIPID_METABOLIC_PROCESS,1
BIOCARTA_CREB_PATHWAY,SET,22,-0.12284,-0.0042475,0.19468,0.73597,BIOCARTA_CREB_PATHWAY,1
HP_LACTOSE_INTOLERANCE,SET,5,-0.25382,-0.0041861,0.40222,0.736,HP_LACTOSE_INTOLERANCE,1
GOBP_NEGATIVE_REGULATION_OF_...599,SET,12,-0.1529,-0.0039057,0.24219,0.73607,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
HP_MIDFACE_RETRUSION,SET,253,-0.033423,-0.0038945,0.052944,0.73607,HP_MIDFACE_RETRUSION,1
HP_OVERLAPPING_FINGERS,SET,29,-0.1009,-0.0040049,0.15975,0.73617,HP_OVERLAPPING_FINGERS,1
HP_HYPERLIPOPROTEINEMIA,SET,38,-0.093173,-0.0042323,0.14751,0.73619,HP_HYPERLIPOPROTEINEMIA,1
HP_EEG_WITH_FRONTAL_EPILEPTI...,SET,5,-0.27376,-0.0045149,0.43337,0.73621,HP_EEG_WITH_FRONTAL_EPILEPTIFORM_DISCHARGES,1
GOMF_CYCLIC_NUCLEOTIDE_DEPEN...,SET,7,-0.17884,-0.0034897,0.28295,0.73632,GOMF_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
HP_ABNORMAL_LACRIMAL_DUCT_MO...,SET,41,-0.082829,-0.0039079,0.13104,0.73633,HP_ABNORMAL_LACRIMAL_DUCT_MORPHOLOGY,1
MIR452_5P,SET,197,-0.038591,-0.003974,0.06105,0.73634,MIR452_5P,1
GOMF_PH_DOMAIN_BINDING,SET,8,-0.18757,-0.0039127,0.29668,0.73638,GOMF_PH_DOMAIN_BINDING,1
HP_SHIELD_CHEST,SET,14,-0.13854,-0.0038223,0.21908,0.73643,HP_SHIELD_CHEST,1
HP_UNILATERAL_CRYPTORCHIDISM,SET,11,-0.17864,-0.004369,0.28244,0.73646,HP_UNILATERAL_CRYPTORCHIDISM,1
HP_CEREBRAL_ARTERIOVENOUS_MA...,SET,7,-0.19447,-0.0037947,0.30742,0.7365,HP_CEREBRAL_ARTERIOVENOUS_MALFORMATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...72,SET,5,-0.22755,-0.0037529,0.35961,0.73656,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ERBB4_TO_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,1
GRAHAM_CML_QUIESCENT_VS_NORM...4,SET,82,-0.06027,-0.0040169,0.095197,0.73666,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1
HP_SHORT_CLAVICLES,SET,29,-0.09855,-0.0039117,0.15565,0.73668,HP_SHORT_CLAVICLES,1
KEGG_MEDICUS_REFERENCE_FGF_F...1,SET,30,-0.10849,-0.0043799,0.1713,0.73675,KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY,1
SEKI_INFLAMMATORY_RESPONSE_L...1,SET,20,-0.13812,-0.0045538,0.21804,0.73677,SEKI_INFLAMMATORY_RESPONSE_LPS_DN,1
HP_AGENESIS_OF_MAXILLARY_INC...,SET,15,-0.14999,-0.0042834,0.23679,0.73677,HP_AGENESIS_OF_MAXILLARY_INCISOR,1
REACTOME_TNFR2_NON_CANONICAL...,SET,95,-0.055542,-0.003983,0.087681,0.73678,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1
HP_ABNORMAL_PELVIS_BONE_MORP...,SET,18,-0.11917,-0.0037277,0.18811,0.73679,HP_ABNORMAL_PELVIS_BONE_MORPHOLOGY,1
SASAI_TARGETS_OF_CXCR6_AND_P...1,SET,8,-0.22226,-0.0046361,0.3508,0.73681,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN,1
MIR20B_3P,SET,65,-0.064316,-0.0038182,0.10151,0.73682,MIR20B_3P,1
MIR5580_5P,SET,109,-0.052788,-0.0040533,0.08328,0.73691,MIR5580_5P,1
SIMBULAN_PARP1_TARGETS_UP,SET,27,-0.1156,-0.0044276,0.18235,0.73693,SIMBULAN_PARP1_TARGETS_UP,1
MIR606,SET,87,-0.060264,-0.0041365,0.095045,0.73697,MIR606,1
GSE6092_UNSTIM_VS_IFNG_STIM_...3,SET,173,-0.040001,-0.0038627,0.063086,0.73698,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN,1
GUO_TARGETS_OF_IRS1_AND_IRS2,SET,91,-0.05496,-0.0038578,0.086672,0.73699,GUO_TARGETS_OF_IRS1_AND_IRS2,1
GOMF_SODIUM_INDEPENDENT_ORGA...,SET,16,-0.16086,-0.0047443,0.25368,0.73699,GOMF_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
BIOCARTA_MET_PATHWAY,SET,32,-0.10138,-0.0042267,0.15984,0.73704,BIOCARTA_MET_PATHWAY,1
GSE8835_CD4_VS_CD8_TCELL_UP,SET,179,-0.038445,-0.0037756,0.060614,0.73704,GSE8835_CD4_VS_CD8_TCELL_UP,1
HP_ULNAR_DEVIATION_OF_FINGER,SET,33,-0.098785,-0.0041822,0.15574,0.73705,HP_ULNAR_DEVIATION_OF_FINGER,1
AIZARANI_LIVER_C6_KUPFFER_CE...,SET,203,-0.040702,-0.0042541,0.064164,0.73707,AIZARANI_LIVER_C6_KUPFFER_CELLS_2,1
GOBP_NEUTRAL_AMINO_ACID_TRAN...,SET,54,-0.076657,-0.0041492,0.12081,0.73713,GOBP_NEUTRAL_AMINO_ACID_TRANSPORT,1
IKEDA_MIR30_TARGETS_UP,SET,110,-0.053755,-0.0041464,0.084707,0.73715,IKEDA_MIR30_TARGETS_UP,1
GOMF_HYDROLASE_ACTIVITY_ACTI...4,SET,32,-0.10862,-0.0045286,0.17113,0.7372,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES,1
REACTOME_CREB1_PHOSPHORYLATI...1,SET,25,-0.11655,-0.0042957,0.18359,0.73722,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING,1
MORF_NPM1,SET,147,-0.042836,-0.0038157,0.067479,0.73722,MORF_NPM1,1
GOBP_PROTEIN_DESTABILIZATION,SET,45,-0.083603,-0.0041319,0.1317,0.73722,GOBP_PROTEIN_DESTABILIZATION,1
REACTOME_SYNTHESIS_OF_PIPS_A...2,SET,5,-0.26287,-0.0043352,0.41407,0.73723,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE,1
GSE360_T_GONDII_VS_M_TUBERCU...1,SET,184,-0.041197,-0.0041015,0.064894,0.73723,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN,1
HP_PALPEBRAL_EDEMA,SET,37,-0.091037,-0.0040807,0.1434,0.73724,HP_PALPEBRAL_EDEMA,1
BUSSLINGER_DUODENAL_BCHE_CEL...,SET,39,-0.093502,-0.0043027,0.14726,0.73726,BUSSLINGER_DUODENAL_BCHE_CELLS,1
DELACROIX_RAR_TARGETS_DN,SET,25,-0.11149,-0.0041093,0.17558,0.73728,DELACROIX_RAR_TARGETS_DN,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...2,SET,5,-0.27894,-0.0046003,0.43921,0.73731,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_PROTEIN_M...1,SET,62,-0.067918,-0.0039382,0.10693,0.73734,GOBP_REGULATION_OF_PROTEIN_MATURATION,1
GSE40274_CTRL_VS_XBP1_TRANSD...2,SET,156,-0.044817,-0.0041115,0.070539,0.73739,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
JAATINEN_HEMATOPOIETIC_STEM_...2,SET,274,-0.034926,-0.0042326,0.054966,0.73742,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,1
HP_MYELOPROLIFERATIVE_DISORD...,SET,15,-0.1503,-0.0042921,0.23653,0.73742,HP_MYELOPROLIFERATIVE_DISORDER,1
HP_SUBCUTANEOUS_LIPOMA,SET,7,-0.20753,-0.0040494,0.32651,0.73747,HP_SUBCUTANEOUS_LIPOMA,1
GOCC_SERINE_TYPE_PEPTIDASE_C...,SET,13,-0.17966,-0.0047767,0.28266,0.73748,GOCC_SERINE_TYPE_PEPTIDASE_COMPLEX,1
NAKAMURA_ADIPOGENESIS_LATE_UP,SET,93,-0.055436,-0.0039335,0.087202,0.73751,NAKAMURA_ADIPOGENESIS_LATE_UP,1
DMRT1_TARGET_GENES,SET,329,-0.030467,-0.0040398,0.047922,0.73753,DMRT1_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_ADRB3...,SET,35,-0.094309,-0.0041117,0.14831,0.73757,KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY,1
HP_HYPOTHALAMIC_HAMARTOMA,SET,14,-0.12775,-0.0035247,0.20089,0.73758,HP_HYPOTHALAMIC_HAMARTOMA,1
GOBP_POSITIVE_REGULATION_BY_...4,SET,13,-0.15082,-0.00401,0.23713,0.73762,GOBP_POSITIVE_REGULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,1
STEIN_ESR1_TARGETS,SET,77,-0.066011,-0.0042639,0.10378,0.73763,STEIN_ESR1_TARGETS,1
YIH_RESPONSE_TO_ARSENITE_C2,SET,14,-0.13875,-0.003828,0.21813,0.73763,YIH_RESPONSE_TO_ARSENITE_C2,1
chr17p12,SET,22,-0.17207,-0.0059498,0.27051,0.73764,chr17p12,1
HP_CHRONIC_LYMPHATIC_LEUKEMIA,SET,14,-0.14622,-0.0040341,0.22986,0.73765,HP_CHRONIC_LYMPHATIC_LEUKEMIA,1
GOBP_ATRIOVENTRICULAR_VALVE_...1,SET,29,-0.113,-0.0044853,0.17764,0.73766,GOBP_ATRIOVENTRICULAR_VALVE_DEVELOPMENT,1
GOBP_L_AMINO_ACID_TRANSPORT,SET,88,-0.060803,-0.0041974,0.095563,0.73769,GOBP_L_AMINO_ACID_TRANSPORT,1
GSE20715_0H_VS_48H_OZONE_LUN...1,SET,189,-0.038882,-0.0039228,0.061103,0.73772,GSE20715_0H_VS_48H_OZONE_LUNG_DN,1
GOBP_DGMP_METABOLIC_PROCESS,SET,6,-0.2232,-0.0040323,0.35068,0.73776,GOBP_DGMP_METABOLIC_PROCESS,1
HP_SUNKEN_CHEEKS,SET,5,-0.25208,-0.0041574,0.39601,0.73779,HP_SUNKEN_CHEEKS,1
PASINI_SUZ12_TARGETS_UP,SET,93,-0.060378,-0.0042842,0.094844,0.7378,PASINI_SUZ12_TARGETS_UP,1
GOMF_ENDODEOXYRIBONUCLEASE_A...,SET,11,-0.16021,-0.0039185,0.25158,0.73788,GOMF_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
GSE19888_ADENOSINE_A3R_ACT_V...1,SET,183,-0.039628,-0.0039347,0.062221,0.7379,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN,1
MIR367_5P,SET,67,-0.064391,-0.0038808,0.10109,0.73793,MIR367_5P,1
MIR6807_3P,SET,128,-0.048247,-0.0040125,0.075737,0.73795,MIR6807_3P,1
GSE25123_IL4_VS_IL4_AND_ROSI...2,SET,190,-0.041502,-0.0041979,0.065118,0.73804,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
GSE21033_CTRL_VS_POLYIC_STIM...5,SET,137,-0.047215,-0.0040613,0.074061,0.7381,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN,1
HP_MULTIPLE_EXOSTOSES,SET,7,-0.23231,-0.004533,0.36438,0.73811,HP_MULTIPLE_EXOSTOSES,1
HP_DEVIATION_OF_THE_2ND_TOE,SET,5,-0.28792,-0.0047484,0.45147,0.73817,HP_DEVIATION_OF_THE_2ND_TOE,1
REACTOME_MAPK_TARGETS_NUCLEA...,SET,29,-0.10712,-0.0042517,0.1679,0.73825,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,1
HP_BREATHING_DYSREGULATION,SET,19,-0.13066,-0.0041991,0.2048,0.73826,HP_BREATHING_DYSREGULATION,1
GOMF_PROTEASE_BINDING,SET,126,-0.04907,-0.0040491,0.076908,0.73827,GOMF_PROTEASE_BINDING,1
GOCC_INHIBITORY_SYNAPSE,SET,13,-0.16127,-0.0042876,0.25273,0.73829,GOCC_INHIBITORY_SYNAPSE,1
GSE25088_CTRL_VS_IL4_AND_ROS...4,SET,172,-0.0381,-0.0036686,0.059678,0.73839,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,1
GOCC_COP9_SIGNALOSOME,SET,31,-0.095273,-0.0039096,0.14923,0.7384,GOCC_COP9_SIGNALOSOME,1
MIR4257,SET,120,-0.04748,-0.0038241,0.07436,0.73843,MIR4257,1
HP_ABNORMAL_PROPORTION_OF_CD...2,SET,39,-0.086423,-0.003977,0.13533,0.73846,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_T_CELLS,1
REACTOME_BIOSYNTHESIS_OF_EPA...,SET,6,-0.26531,-0.0047931,0.41537,0.7385,REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS,1
HP_EPILEPTIC_AURA,SET,20,-0.12569,-0.0041439,0.19674,0.73853,HP_EPILEPTIC_AURA,1
HP_SHORT_THORAX,SET,45,-0.078987,-0.0039037,0.12364,0.73853,HP_SHORT_THORAX,1
GSE29615_DAY3_VS_DAY7_LAIV_F...1,SET,162,-0.043197,-0.0040378,0.067614,0.73855,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,1
WP_ROS_IN_COVID19_ENDOTHELIA...,SET,6,-0.25214,-0.0045552,0.3946,0.73858,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,1
GOBP_RETINAL_BIPOLAR_NEURON_...,SET,7,-0.21706,-0.0042354,0.33963,0.73862,GOBP_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...78,SET,77,-0.065664,-0.0042414,0.10272,0.73867,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_T_CELL_DIFFERENTIATION_...2,SET,81,-0.061008,-0.0040413,0.095436,0.73867,GOBP_T_CELL_DIFFERENTIATION_IN_THYMUS,1
GOBP_MITOCHONDRIAL_RIBOSOME_...,SET,11,-0.15724,-0.0038458,0.24594,0.7387,GOBP_MITOCHONDRIAL_RIBOSOME_ASSEMBLY,1
GOBP_REGENERATION,SET,180,-0.042925,-0.0042272,0.067136,0.7387,GOBP_REGENERATION,1
GSE17721_CTRL_VS_LPS_12H_BMD...1,SET,182,-0.040127,-0.0039734,0.06275,0.73874,GSE17721_CTRL_VS_LPS_12H_BMDC_DN,1
HP_2_3_TOE_CUTANEOUS_SYNDACT...,SET,13,-0.16036,-0.0042634,0.25075,0.73875,HP_2_3_TOE_CUTANEOUS_SYNDACTYLY,1
WP_OLIGODENDROCYTE_SPECIFICA...,SET,29,-0.11066,-0.0043923,0.17302,0.73877,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,1
HP_ABNORMAL_PROPORTION_OF_CD...1,SET,26,-0.10825,-0.0040686,0.16925,0.73877,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_HELPER_T_CELLS,1
GSE34156_UNTREATED_VS_24H_NO...1,SET,144,-0.044957,-0.0039639,0.070293,0.73877,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
HP_LOWER_EYELID_COLOBOMA,SET,10,-0.15819,-0.0036891,0.24729,0.73882,HP_LOWER_EYELID_COLOBOMA,1
LINDVALL_IMMORTALIZED_BY_TER...1,SET,64,-0.072206,-0.0042536,0.11286,0.73884,LINDVALL_IMMORTALIZED_BY_TERT_DN,1
HP_BULIMIA,SET,5,-0.30494,-0.0050292,0.47654,0.73888,HP_BULIMIA,1
GAVISH_3CA_MALIGNANT_METAPRO...8,SET,44,-0.08855,-0.0043276,0.13837,0.73889,GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1,1
GOBP_7_METHYLGUANOSINE_RNA_C...,SET,5,-0.19682,-0.003246,0.30756,0.73889,GOBP_7_METHYLGUANOSINE_RNA_CAPPING,1
ZNF618_TARGET_GENES,SET,1050,-0.017748,-0.0041192,0.02772,0.73899,ZNF618_TARGET_GENES,1
GSE16385_MONOCYTE_VS_12H_ROS...1,SET,175,-0.041617,-0.0040417,0.064999,0.739,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,1
GOMF_SODIUM_PROTON_ANTIPORTE...,SET,13,-0.15124,-0.004021,0.2362,0.73901,GOMF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,1
GOBP_REGULATION_OF_TYPE_B_PA...1,SET,8,-0.21011,-0.0043827,0.32809,0.73904,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,1
GOBP_EPITHELIAL_CELL_DIFFERE...2,SET,46,-0.092739,-0.0046339,0.14479,0.73908,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
TEF1_Q6,SET,209,-0.039348,-0.0041722,0.061423,0.73911,TEF1_Q6,1
GOBP_U2_TYPE_PRESPLICEOSOME_...,SET,22,-0.10836,-0.003747,0.16914,0.73913,GOBP_U2_TYPE_PRESPLICEOSOME_ASSEMBLY,1
GSE26890_CXCR1_NEG_VS_POS_EF...2,SET,180,-0.041042,-0.0040418,0.064053,0.73915,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP,1
GOBP_GLUTAMATE_SECRETION,SET,28,-0.11736,-0.0045772,0.18315,0.73916,GOBP_GLUTAMATE_SECRETION,1
REACTOME_GLYCOSAMINOGLYCAN_M...,SET,120,-0.052155,-0.0042006,0.081374,0.73921,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1
VANTVEER_BREAST_CANCER_METAS...1,SET,96,-0.058294,-0.0042022,0.090947,0.73922,VANTVEER_BREAST_CANCER_METASTASIS_DN,1
ZNF20_TARGET_GENES,SET,5,-0.22925,-0.0037809,0.35753,0.7393,ZNF20_TARGET_GENES,1
GOBP_REGULATION_OF_STEM_CELL...1,SET,80,-0.06066,-0.0039935,0.094565,0.73939,GOBP_REGULATION_OF_STEM_CELL_DIFFERENTIATION,1
FLECHNER_PBL_KIDNEY_TRANSPLA...4,SET,57,-0.0701,-0.0038979,0.10926,0.73942,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1
PID_PDGFRB_PATHWAY,SET,124,-0.050598,-0.0041422,0.078867,0.73942,PID_PDGFRB_PATHWAY,1
MIR6080,SET,42,-0.086702,-0.0041401,0.13512,0.73945,MIR6080,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...4,SET,12,-0.15283,-0.003904,0.23817,0.73946,LOPEZ_MESOTHELIOMA_SURVIVAL_UP,1
GSE19825_NAIVE_VS_IL2RALOW_D...2,SET,180,-0.043457,-0.0042797,0.067709,0.7395,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP,1
BRIDEAU_IMPRINTED_GENES,SET,60,-0.083371,-0.0047559,0.12989,0.73951,BRIDEAU_IMPRINTED_GENES,1
AHRARNT_01,SET,129,-0.050706,-0.0042332,0.078998,0.73951,AHRARNT_01,1
STEIN_ESRRA_TARGETS_UP,SET,345,-0.029487,-0.004002,0.045926,0.73958,STEIN_ESRRA_TARGETS_UP,1
MIR10527_5P,SET,530,-0.025267,-0.0042284,0.039349,0.7396,MIR10527_5P,1
REACTOME_PI3K_AKT_SIGNALING_...,SET,108,-0.056147,-0.0042915,0.087421,0.73964,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1
GSE45365_CTRL_VS_MCMV_INFECT...2,SET,180,-0.040627,-0.0040009,0.063254,0.73965,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP,1
BRUINS_UVC_RESPONSE_VIA_TP53...1,SET,815,-0.019945,-0.0041059,0.031047,0.73969,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A,1
HE_LIM_SUN_FETAL_LUNG_C3_HMO...,SET,22,-0.12462,-0.004309,0.1939,0.73978,HE_LIM_SUN_FETAL_LUNG_C3_HMOX1_POS_PRIMITIVE_ERYTHROBLAST,1
GOBP_INNATE_IMMUNE_RESPONSE_...2,SET,12,-0.18638,-0.0047609,0.28996,0.73981,GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA,1
BARIS_THYROID_CANCER_DN,SET,52,-0.074794,-0.0039729,0.11636,0.73982,BARIS_THYROID_CANCER_DN,1
PEDERSEN_METASTASIS_BY_ERBB2...3,SET,99,-0.059842,-0.0043803,0.093068,0.73988,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1
GOBP_POSITIVE_REGULATION_OF_...284,SET,8,-0.20278,-0.0042299,0.31534,0.7399,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
FOXJ2_TARGET_GENES,SET,439,-0.026461,-0.0040406,0.041144,0.73993,FOXJ2_TARGET_GENES,1
MUELLER_COMMON_TARGETS_OF_AM...1,SET,28,-0.11121,-0.0043377,0.17292,0.73994,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,1
MODULE_238,SET,141,-0.046952,-0.0040968,0.073002,0.73994,MODULE_238,1
GSE19941_IL10_KO_VS_IL10_KO_...4,SET,181,-0.041579,-0.004106,0.064646,0.73994,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...3,SET,7,-0.20613,-0.0040222,0.3205,0.73994,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_DN,1
GOBP_BILE_ACID_AND_BILE_SALT...,SET,29,-0.10843,-0.0043037,0.16856,0.73997,GOBP_BILE_ACID_AND_BILE_SALT_TRANSPORT,1
MATZUK_POSTIMPLANTATION_AND_...,SET,13,-0.15811,-0.0042037,0.24569,0.74006,MATZUK_POSTIMPLANTATION_AND_POSTPARTUM,1
THEILGAARD_NEUTROPHIL_AT_SKI...2,SET,73,-0.068121,-0.0042848,0.10585,0.74006,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,1
GOBP_CELLULAR_RESPONSE_TO_MI...,SET,12,-0.17931,-0.0045804,0.27863,0.74006,GOBP_CELLULAR_RESPONSE_TO_MINERALOCORTICOID_STIMULUS,1
GOBP_TRANSEPITHELIAL_CHLORID...,SET,8,-0.2034,-0.0042428,0.31605,0.74007,GOBP_TRANSEPITHELIAL_CHLORIDE_TRANSPORT,1
GSE5455_HEALTHY_VS_TUMOR_BEA...3,SET,183,-0.041764,-0.0041467,0.064892,0.74008,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...368,SET,6,-0.20023,-0.0036173,0.31104,0.74012,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,1
GOBP_REGULATION_OF_CD4_POSIT...1,SET,71,-0.070445,-0.0043701,0.10938,0.74022,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
GOBP_ANTIMICROBIAL_HUMORAL_I...,SET,90,-0.069252,-0.0048343,0.1075,0.74028,GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE,1
HP_ABNORMALITY_OF_FACIAL_MUS...,SET,291,-0.032252,-0.0040261,0.050059,0.7403,HP_ABNORMALITY_OF_FACIAL_MUSCULATURE,1
GOBP_VERY_LONG_CHAIN_FATTY_A...3,SET,33,-0.10075,-0.0042655,0.15637,0.74031,GOBP_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
GOBP_SEX_DETERMINATION,SET,18,-0.1436,-0.0044918,0.22285,0.74033,GOBP_SEX_DETERMINATION,1
GSE13484_3H_UNSTIM_VS_YF17D_...1,SET,184,-0.04252,-0.0042332,0.065974,0.74037,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
GOBP_TUBE_FORMATION,SET,144,-0.046837,-0.0041296,0.072655,0.74042,GOBP_TUBE_FORMATION,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...2,SET,30,-0.10441,-0.004215,0.16196,0.74043,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1
GOBP_REGULATION_OF_NEURON_MA...,SET,8,-0.2046,-0.0042678,0.31736,0.74043,GOBP_REGULATION_OF_NEURON_MATURATION,1
OHGUCHI_LIVER_HNF4A_TARGETS_...1,SET,154,-0.047138,-0.0042969,0.073115,0.74044,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1
WP_DNA_MISMATCH_REPAIR,SET,23,-0.10239,-0.0036198,0.15881,0.74044,WP_DNA_MISMATCH_REPAIR,1
MODULE_9,SET,112,-0.050929,-0.0039637,0.078978,0.74048,MODULE_9,1
GAUCHER_PBMC_YF_VAX_STAMARIL...10,SET,44,-0.084745,-0.0041416,0.13138,0.74055,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP,1
REACTOME_ATTACHMENT_AND_ENTRY,SET,16,-0.1539,-0.0045389,0.23856,0.74057,REACTOME_ATTACHMENT_AND_ENTRY,1
GOMF_COA_LIGASE_ACTIVITY,SET,25,-0.10909,-0.0040208,0.1691,0.74057,GOMF_COA_LIGASE_ACTIVITY,1
HP_EXCESSIVE_WRINKLED_SKIN,SET,36,-0.088795,-0.0039261,0.13762,0.7406,HP_EXCESSIVE_WRINKLED_SKIN,1
CHENG_IMPRINTED_BY_ESTRADIOL,SET,98,-0.057254,-0.0041697,0.08873,0.74062,CHENG_IMPRINTED_BY_ESTRADIOL,1
GOBP_MEIOTIC_CHROMOSOME_COND...,SET,6,-0.21255,-0.0038399,0.32931,0.74067,GOBP_MEIOTIC_CHROMOSOME_CONDENSATION,1
GOBP_POSITIVE_REGULATION_OF_...242,SET,96,-0.059604,-0.0042966,0.092346,0.74067,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,1
GOBP_NEGATIVE_REGULATION_OF_...697,SET,11,-0.18649,-0.004561,0.28893,0.74068,GOBP_NEGATIVE_REGULATION_OF_VASOCONSTRICTION,1
WINZEN_DEGRADED_VIA_KHSRP,SET,96,-0.064358,-0.0046393,0.099705,0.74069,WINZEN_DEGRADED_VIA_KHSRP,1
GOBP_REGULATION_OF_RESPONSE_...1,SET,475,-0.025795,-0.0040931,0.039961,0.7407,GOBP_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,1
MYB_Q6,SET,228,-0.037209,-0.0041186,0.057639,0.74071,MYB_Q6,1
GOBP_RRNA_PSEUDOURIDINE_SYNT...,SET,7,-0.1958,-0.0038205,0.30328,0.74072,GOBP_RRNA_PSEUDOURIDINE_SYNTHESIS,1
HP_DILATATED_INTERNAL_AUDITO...,SET,3,-0.39553,-0.0050531,0.61268,0.74072,HP_DILATATED_INTERNAL_AUDITORY_CANAL,1
KEGG_MEDICUS_REFERENCE_AHR_S...,SET,8,-0.20247,-0.0042234,0.31355,0.74077,KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY,1
WP_CREATINE_PATHWAY,SET,4,-0.31541,-0.0046527,0.48846,0.74077,WP_CREATINE_PATHWAY,1
GSE13738_RESTING_VS_BYSTANDE...1,SET,173,-0.042789,-0.0041319,0.066254,0.7408,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_ORGAN...2,SET,16,-0.14635,-0.0043164,0.22658,0.74083,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE,1
GOCC_CANONICAL_INFLAMMASOME_...,SET,16,-0.15924,-0.0046964,0.24653,0.74083,GOCC_CANONICAL_INFLAMMASOME_COMPLEX,1
GSE9878_CTRL_VS_EBF_TRANSDUC...2,SET,190,-0.040655,-0.0041123,0.062938,0.74084,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP,1
GOBP_MAINTENANCE_OF_PRESYNAP...,SET,5,-0.27666,-0.0045627,0.42827,0.74085,GOBP_MAINTENANCE_OF_PRESYNAPTIC_ACTIVE_ZONE_STRUCTURE,1
MIR3689A_5P_MIR3689B_5P_MIR3...,SET,110,-0.053044,-0.0040915,0.082107,0.74087,MIR3689A_5P_MIR3689B_5P_MIR3689E_MIR3689F,1
GOBP_REGULATION_OF_RNA_POLYM...1,SET,6,-0.22215,-0.0040133,0.34385,0.74088,GOBP_REGULATION_OF_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
GSE22611_UNSTIM_VS_2H_MDP_ST...1,SET,171,-0.039814,-0.0038225,0.061595,0.74098,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
ZNF777_TARGET_GENES,SET,53,-0.078471,-0.004208,0.1214,0.74099,ZNF777_TARGET_GENES,1
GOBP_REGULATION_OF_IRON_ION_...2,SET,6,-0.20908,-0.0037771,0.32335,0.74105,GOBP_REGULATION_OF_IRON_ION_TRANSPORT,1
GOBP_ORGANELLE_TRANSPORT_ALO...,SET,79,-0.061274,-0.0040087,0.094732,0.74112,GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
LINDGREN_BLADDER_CANCER_CLUS...1,SET,348,-0.029959,-0.0040833,0.046314,0.74114,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,1
MIR4717_3P,SET,71,-0.067316,-0.004176,0.10406,0.74114,MIR4717_3P,1
HOEK_T_CELL_2011_2012_TIV_AD...2,SET,8,-0.19252,-0.0040159,0.29756,0.74118,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_UP,1
HP_ABNORMAL_EPIGLOTTIS_MORPH...,SET,20,-0.12295,-0.0040538,0.19001,0.7412,HP_ABNORMAL_EPIGLOTTIS_MORPHOLOGY,1
GSE5142_HTERT_TRANSDUCED_VS_...2,SET,178,-0.039075,-0.0038269,0.06038,0.74123,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP,1
chr6p21,SET,271,-0.076149,-0.0091785,0.11766,0.74124,chr6p21,1
GSE40274_CTRL_VS_FOXP3_AND_E...1,SET,148,-0.045504,-0.004067,0.070296,0.74129,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
MEISSNER_NPC_ICP_WITH_H3_UNM...,SET,20,-0.12708,-0.0041899,0.1963,0.7413,MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,1
HP_LEUKOCORIA,SET,6,-0.20136,-0.0036377,0.31102,0.74131,HP_LEUKOCORIA,1
HP_ABNORMAL_GASTROINTESTINAL...2,SET,6,-0.23513,-0.0042478,0.36314,0.74134,HP_ABNORMAL_GASTROINTESTINAL_VASCULAR_MORPHOLOGY,1
GSE37301_PRO_BCELL_VS_RAG2_K...1,SET,169,-0.043777,-0.0041786,0.067592,0.74139,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN,1
HP_ABNORMAL_COCHLEA_MORPHOLO...,SET,27,-0.1059,-0.0040561,0.1635,0.74141,HP_ABNORMAL_COCHLEA_MORPHOLOGY,1
GOCC_U2AF_COMPLEX,SET,3,-0.30134,-0.0038498,0.46512,0.74146,GOCC_U2AF_COMPLEX,1
HP_ABNORMAL_PERIPHERAL_MYELI...,SET,92,-0.057429,-0.0040531,0.088634,0.74148,HP_ABNORMAL_PERIPHERAL_MYELINATION,1
GOBP_G_PROTEIN_COUPLED_RECEP...2,SET,1096,-0.019982,-0.004732,0.030836,0.74151,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
BIOCARTA_ACTINY_PATHWAY,SET,11,-0.14227,-0.0034796,0.21953,0.74152,BIOCARTA_ACTINY_PATHWAY,1
DESCARTES_FETAL_ADRENAL_CHRO...,SET,75,-0.071723,-0.0045725,0.11066,0.74154,DESCARTES_FETAL_ADRENAL_CHROMAFFIN_CELLS,1
LAKE_ADULT_KIDNEY_C26_MESANG...,SET,164,-0.046121,-0.0043374,0.071156,0.74156,LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS,1
GOBP_AMINO_SUGAR_METABOLIC_P...,SET,38,-0.09315,-0.0042313,0.14369,0.74158,GOBP_AMINO_SUGAR_METABOLIC_PROCESS,1
GOMF_POLYOL_TRANSMEMBRANE_TR...,SET,11,-0.20559,-0.0050283,0.31712,0.7416,GOMF_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_SYSTOLIC_HEART_MURMUR,SET,13,-0.17708,-0.004708,0.27312,0.74162,HP_SYSTOLIC_HEART_MURMUR,1
GOCC_THO_COMPLEX,SET,5,-0.2327,-0.0038377,0.35882,0.74167,GOCC_THO_COMPLEX,1
GNF2_NS,SET,37,-0.086275,-0.0038672,0.13302,0.74169,GNF2_NS,1
GOBP_CERAMIDE_BIOSYNTHETIC_P...,SET,66,-0.0707,-0.0042292,0.10901,0.74169,GOBP_CERAMIDE_BIOSYNTHETIC_PROCESS,1
HP_DEEP_SET_NAILS,SET,6,-0.20205,-0.0036502,0.31147,0.74173,HP_DEEP_SET_NAILS,1
GSE17812_WT_VS_THPOK_KO_MEMO...1,SET,181,-0.043151,-0.0042612,0.06652,0.74173,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...843,SET,6,-0.24714,-0.0044648,0.38089,0.74178,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
KEGG_MEDICUS_VARIANT_MUTATIO...17,SET,7,-0.20539,-0.0040077,0.31642,0.74187,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY,1
GSE17974_IL4_AND_ANTI_IL12_V...18,SET,153,-0.046667,-0.0042403,0.071888,0.74188,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP,1
GOBP_RHOMBOMERE_DEVELOPMENT,SET,7,-0.26697,-0.0052092,0.41111,0.74195,GOBP_RHOMBOMERE_DEVELOPMENT,1
GOMF_DNA_TOPOISOMERASE_ACTIV...,SET,7,-0.18591,-0.0036275,0.28624,0.74198,GOMF_DNA_TOPOISOMERASE_ACTIVITY,1
GOBP_DTTP_METABOLIC_PROCESS,SET,5,-0.25767,-0.0042496,0.39658,0.74206,GOBP_DTTP_METABOLIC_PROCESS,1
AIZARANI_LIVER_C30_HEPATOCYT...,SET,369,-0.028875,-0.0040503,0.044433,0.7421,AIZARANI_LIVER_C30_HEPATOCYTES_4,1
GOBP_TRANSFORMING_GROWTH_FAC...3,SET,31,-0.10895,-0.0044708,0.16762,0.74214,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,1
HP_ABNORMAL_BLOOD_VESSEL_MOR...,SET,855,-0.01965,-0.0041385,0.030232,0.74214,HP_ABNORMAL_BLOOD_VESSEL_MORPHOLOGY,1
chr4q35,SET,36,-0.16589,-0.0073351,0.25518,0.74218,chr4q35,1
GOBP_INTRACILIARY_RETROGRADE...,SET,10,-0.16454,-0.0038372,0.2531,0.74219,GOBP_INTRACILIARY_RETROGRADE_TRANSPORT,1
GOBP_LEUKOCYTE_DEGRANULATION,SET,75,-0.065481,-0.0041746,0.10069,0.74226,GOBP_LEUKOCYTE_DEGRANULATION,1
HP_PREMATURE_PUBARCHE,SET,13,-0.16945,-0.0045052,0.26056,0.74226,HP_PREMATURE_PUBARCHE,1
GOBP_REGULATION_OF_EXTRINSIC...1,SET,145,-0.047251,-0.0041804,0.072633,0.74233,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...521,SET,15,-0.1436,-0.0041009,0.2207,0.74237,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,1
GOMF_HAPTOGLOBIN_BINDING,SET,6,-0.29862,-0.0053947,0.45884,0.74241,GOMF_HAPTOGLOBIN_BINDING,1
GSE36078_UNTREATED_VS_AD5_T4...4,SET,179,-0.041224,-0.0040486,0.063338,0.74243,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP,1
chr12q23,SET,68,-0.12749,-0.0077405,0.19586,0.74245,chr12q23,1
MIR3620_3P,SET,58,-0.074794,-0.0041951,0.1149,0.74246,MIR3620_3P,1
GTGTGAG_MIR342,SET,56,-0.073497,-0.0040509,0.1129,0.74248,GTGTGAG_MIR342,1
MORF_RAD21,SET,158,-0.040588,-0.0037472,0.062337,0.74251,MORF_RAD21,1
SENESE_HDAC1_TARGETS_UP,SET,398,-0.028279,-0.0041163,0.043412,0.74261,SENESE_HDAC1_TARGETS_UP,1
GOBP_REGULATION_OF_TRANSLATI...1,SET,334,-0.0303,-0.0040475,0.046514,0.74261,GOBP_REGULATION_OF_TRANSLATION,1
WP_10Q1121Q1123_COPY_NUMBER_...,SET,55,-0.075341,-0.0041154,0.11565,0.74262,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_NEUROGENESIS,SET,1595,-0.015086,-0.004247,0.023157,0.74262,GOBP_NEUROGENESIS,1
CCCACAT_MIR2993P,SET,48,-0.075171,-0.0038366,0.11534,0.7427,CCCACAT_MIR2993P,1
GOCC_PERINUCLEAR_ENDOPLASMIC...,SET,19,-0.12939,-0.0041582,0.19852,0.74273,GOCC_PERINUCLEAR_ENDOPLASMIC_RETICULUM,1
MODULE_378,SET,394,-0.02828,-0.0040961,0.043382,0.74276,MODULE_378,1
CHOW_RASSF1_TARGETS_DN,SET,29,-0.09953,-0.0039506,0.15265,0.74281,CHOW_RASSF1_TARGETS_DN,1
GOBP_SYMPATHETIC_NEURON_PROJ...,SET,5,-0.26143,-0.0043116,0.40089,0.74284,GOBP_SYMPATHETIC_NEURON_PROJECTION_EXTENSION,1
GSE17721_LPS_VS_POLYIC_2H_BM...1,SET,190,-0.038303,-0.0038744,0.058723,0.74288,GSE17721_LPS_VS_POLYIC_2H_BMDC_DN,1
GSE22886_NAIVE_BCELL_VS_DC_DN,SET,188,-0.040353,-0.0040605,0.061866,0.74288,GSE22886_NAIVE_BCELL_VS_DC_DN,1
REACTOME_ION_HOMEOSTASIS,SET,52,-0.078789,-0.004185,0.12077,0.74292,REACTOME_ION_HOMEOSTASIS,1
HP_ABNORMAL_NERVE_CONDUCTION...,SET,104,-0.053283,-0.0039969,0.081674,0.74292,HP_ABNORMAL_NERVE_CONDUCTION_VELOCITY,1
GSE13173_UNTREATED_VS_IL12_T...2,SET,113,-0.053419,-0.0041759,0.081874,0.74294,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP,1
HP_CLINODACTYLY_OF_THE_5TH_T...,SET,13,-0.15865,-0.004218,0.24314,0.74295,HP_CLINODACTYLY_OF_THE_5TH_TOE,1
GAVISH_3CA_METAPROGRAM_EPITH...11,SET,48,-0.087323,-0.0044569,0.13381,0.74299,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_1,1
CHIBA_RESPONSE_TO_TSA_DN,SET,20,-0.12489,-0.0041178,0.19136,0.74301,CHIBA_RESPONSE_TO_TSA_DN,1
HP_THIN_EYEBROW,SET,22,-0.11588,-0.0040068,0.17753,0.74302,HP_THIN_EYEBROW,1
GOMF_HMG_BOX_DOMAIN_BINDING,SET,12,-0.15691,-0.0040083,0.24034,0.74308,GOMF_HMG_BOX_DOMAIN_BINDING,1
GOBP_BRONCHIOLE_DEVELOPMENT,SET,6,-0.25323,-0.0045748,0.38775,0.74314,GOBP_BRONCHIOLE_DEVELOPMENT,1
GSE7831_UNSTIM_VS_CPG_STIM_P...3,SET,178,-0.041688,-0.0040828,0.063805,0.74324,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN,1
MODULE_49,SET,249,-0.035616,-0.0041175,0.054504,0.74327,MODULE_49,1
GOBP_MAINTENANCE_OF_PROTEIN_...2,SET,42,-0.081629,-0.0038978,0.12489,0.7433,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE,1
REACTOME_NEF_MEDIATED_DOWNRE...,SET,9,-0.16727,-0.0037008,0.25589,0.74334,REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION,1
HP_REDUCED_LEFT_VENTRICULAR_...,SET,55,-0.074415,-0.0040648,0.11384,0.74334,HP_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,1
GOBP_REGULATION_OF_OXIDATIVE...2,SET,37,-0.086554,-0.0038797,0.13238,0.74338,GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOMF_MEMBRANE_INSERTASE_ACTI...,SET,14,-0.14288,-0.003942,0.21853,0.74338,GOMF_MEMBRANE_INSERTASE_ACTIVITY,1
HP_HIGH_FOREHEAD,SET,261,-0.035019,-0.0041435,0.053558,0.74339,HP_HIGH_FOREHEAD,1
REACTOME_YAP1_AND_WWTR1_TAZ_...,SET,14,-0.16202,-0.00447,0.24774,0.74344,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,1
REACTOME_PCNA_DEPENDENT_LONG...,SET,21,-0.11062,-0.0037371,0.16911,0.74348,REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,1
GOBP_MEIOTIC_METAPHASE_CHROM...,SET,3,-0.34807,-0.0044467,0.5321,0.74348,GOBP_MEIOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,1
MODULE_212,SET,302,-0.033255,-0.0042278,0.050837,0.74349,MODULE_212,1
HP_DISTAL_SENSORY_IMPAIRMENT...,SET,10,-0.16186,-0.0037747,0.24736,0.74356,HP_DISTAL_SENSORY_IMPAIRMENT_OF_ALL_MODALITIES,1
GSE24574_BCL6_LOW_TFH_VS_NAI...2,SET,178,-0.041795,-0.0040933,0.063854,0.74361,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP,1
GOBP_CELLULAR_RESPONSE_TO_OX...3,SET,1069,-0.018307,-0.004285,0.027967,0.74363,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,1
GOBP_ORGANIC_ACID_TRANSMEMBR...,SET,139,-0.048897,-0.0042364,0.07468,0.74368,GOBP_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT,1
WP_RUBINSTEINTAYBI_SYNDROME_1,SET,14,-0.1551,-0.0042791,0.23679,0.74376,WP_RUBINSTEINTAYBI_SYNDROME_1,1
GSE15330_LYMPHOID_MULTIPOTEN...10,SET,182,-0.04117,-0.0040766,0.062856,0.74376,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP,1
GATA4_Q3,SET,224,-0.039404,-0.0043237,0.060152,0.74379,GATA4_Q3,1
GSE23695_CD57_POS_VS_NEG_NK_...2,SET,185,-0.040055,-0.0039985,0.06114,0.74381,GSE23695_CD57_POS_VS_NEG_NK_CELL_UP,1
ZNF362_TARGET_GENES,SET,489,-0.02532,-0.0040749,0.038639,0.74386,ZNF362_TARGET_GENES,1
GOBP_ASPARTATE_METABOLIC_PRO...,SET,6,-0.25714,-0.0046454,0.3924,0.74386,GOBP_ASPARTATE_METABOLIC_PROCESS,1
GSE9037_CTRL_VS_LPS_1H_STIM_...2,SET,174,-0.041994,-0.0040668,0.064067,0.74391,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP,1
GOBP_CEREBRAL_CORTEX_TANGENT...,SET,5,-0.28967,-0.0047772,0.44186,0.74395,GOBP_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION,1
GOMF_FIBRINOGEN_BINDING,SET,6,-0.24706,-0.0044633,0.37682,0.74397,GOMF_FIBRINOGEN_BINDING,1
GSE2706_R848_VS_LPS_8H_STIM_...2,SET,141,-0.04822,-0.0042075,0.073548,0.74397,GSE2706_R848_VS_LPS_8H_STIM_DC_UP,1
REACTOME_APOPTOTIC_FACTOR_ME...,SET,17,-0.13843,-0.0042082,0.2111,0.744,REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE,1
HP_ECHOGENIC_FETAL_BOWEL,SET,5,-0.23621,-0.0038956,0.36009,0.74408,HP_ECHOGENIC_FETAL_BOWEL,1
KEGG_MEDICUS_PATHOGEN_HIV_GP...4,SET,13,-0.14982,-0.0039833,0.22838,0.74409,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY,1
GOBP_METANEPHRIC_MESENCHYMAL...,SET,5,-0.29244,-0.0048229,0.44576,0.74409,GOBP_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...285,SET,14,-0.15199,-0.0041934,0.23167,0.7441,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION,1
KEGG_MEDICUS_REFERENCE_NUCLE...1,SET,27,-0.099121,-0.0037965,0.15108,0.74411,KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA,1
GSE37532_WT_VS_PPARG_KO_LN_T...2,SET,180,-0.041852,-0.0041216,0.06379,0.74411,GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP,1
BUSSLINGER_GASTRIC_TUFT_CELLS,SET,11,-0.19494,-0.0047678,0.29708,0.74414,BUSSLINGER_GASTRIC_TUFT_CELLS,1
GSE360_HIGH_DOSE_B_MALAYI_VS...1,SET,186,-0.041892,-0.0041931,0.063817,0.74423,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,1
GOMF_3_HYDROXYACYL_COA_DEHYD...2,SET,5,-0.27316,-0.004505,0.41595,0.74431,GOMF_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY,1
MODULE_451,SET,30,-0.096069,-0.0038783,0.14629,0.74432,MODULE_451,1
GOMF_LIPID_TRANSMEMBRANE_TRA...,SET,54,-0.080243,-0.0043432,0.12218,0.74433,GOMF_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...15,SET,12,-0.15301,-0.0039086,0.23297,0.74434,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR,1
CAMPS_COLON_CANCER_COPY_NUMB...2,SET,81,-0.070647,-0.0046798,0.10754,0.74438,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1
HP_TOE_CLINODACTYLY,SET,24,-0.1154,-0.0041676,0.17565,0.7444,HP_TOE_CLINODACTYLY,1
GSE37301_LYMPHOID_PRIMED_MPP...5,SET,178,-0.040414,-0.0039581,0.061514,0.7444,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN,1
GOBP_NEGATIVE_REGULATION_OF_...402,SET,79,-0.066428,-0.0043459,0.1011,0.74441,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
SCHLOSSER_MYC_AND_SERUM_RESP...,SET,31,-0.10016,-0.0041101,0.15243,0.74443,SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,1
YAO_TEMPORAL_RESPONSE_TO_PRO...7,SET,132,-0.048126,-0.004064,0.073233,0.74446,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,1
chr1p21,SET,29,-0.17567,-0.0069726,0.26729,0.74447,chr1p21,1
GOBP_INTRACELLULAR_SIGNALING...,SET,1731,-0.014611,-0.0042677,0.022232,0.74447,GOBP_INTRACELLULAR_SIGNALING_CASSETTE,1
GOMF_MHC_CLASS_II_RECEPTOR_A...,SET,8,-0.24173,-0.0050423,0.36777,0.74449,GOMF_MHC_CLASS_II_RECEPTOR_ACTIVITY,1
MODULE_25,SET,13,-0.13493,-0.0035875,0.20527,0.74452,MODULE_25,1
MIR208B_3P,SET,39,-0.09027,-0.004154,0.1373,0.74456,MIR208B_3P,1
GSE27786_BCELL_VS_ERYTHROBLA...1,SET,178,-0.043116,-0.0042226,0.065574,0.74457,GSE27786_BCELL_VS_ERYTHROBLAST_DN,1
REACTOME_REGULATION_OF_PTEN_...3,SET,9,-0.19731,-0.0043652,0.29997,0.74465,REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION,1
GOBP_REGULATION_OF_CELLULAR_...17,SET,460,-0.025458,-0.003977,0.038699,0.74468,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS,1
FOXD2_TARGET_GENES,SET,993,-0.017966,-0.0040619,0.027308,0.7447,FOXD2_TARGET_GENES,1
NF1_Q6,SET,240,-0.037837,-0.0042956,0.057506,0.74472,NF1_Q6,1
HP_HEMERALOPIA,SET,8,-0.21446,-0.0044736,0.32582,0.7448,HP_HEMERALOPIA,1
LOPEZ_MBD_TARGETS_IMPRINTED_...,SET,3,-0.27029,-0.003453,0.41053,0.74485,LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,1
KAMIKUBO_MYELOID_CEBPA_NETWO...,SET,27,-0.11912,-0.0045625,0.1809,0.74488,KAMIKUBO_MYELOID_CEBPA_NETWORK,1
MIR4695_5P,SET,80,-0.06199,-0.004081,0.094137,0.74489,MIR4695_5P,1
GOMF_SUPEROXIDE_DISMUTASE_AC...,SET,5,-0.27145,-0.0044767,0.41219,0.7449,GOMF_SUPEROXIDE_DISMUTASE_ACTIVITY,1
WP_TGFBETA_RECEPTOR_SIGNALIN...,SET,55,-0.084793,-0.0046317,0.12875,0.74491,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,1
GOMF_TESTOSTERONE_DEHYDROGEN...2,SET,10,-0.17212,-0.0040139,0.26136,0.74491,GOMF_TESTOSTERONE_DEHYDROGENASE_NAD_P_ACTIVITY,1
UNTERMAN_IPF_VS_CTRL_B_CELL_...,SET,27,-0.12371,-0.0047382,0.18776,0.745,UNTERMAN_IPF_VS_CTRL_B_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...452,SET,7,-0.21051,-0.0041076,0.31951,0.745,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,1
GSE17974_IL4_AND_ANTI_IL12_V...9,SET,144,-0.050339,-0.0044384,0.076397,0.74502,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN,1
GSE17721_POLYIC_VS_CPG_4H_BM...2,SET,180,-0.041237,-0.004061,0.06256,0.7451,GSE17721_POLYIC_VS_CPG_4H_BMDC_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...26,SET,43,-0.089012,-0.0043005,0.13502,0.74513,GAVISH_3CA_MALIGNANT_METAPROGRAM_34_PLATELET_ACTIVATION,1
GSE3920_IFNA_VS_IFNG_TREATED...4,SET,161,-0.044215,-0.0041202,0.067055,0.74517,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP,1
GOBP_REGULATION_OF_T_CELL_RE...,SET,43,-0.086713,-0.0041895,0.13147,0.74523,GOBP_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_ER_TO_GOLGI_ANTEROG...,SET,150,-0.044143,-0.0039717,0.066924,0.74524,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1
MODULE_148,SET,13,-0.17612,-0.0046824,0.26701,0.74524,MODULE_148,1
HP_RESTRICTIVE_VENTILATORY_D...,SET,90,-0.060144,-0.0041986,0.091183,0.74524,HP_RESTRICTIVE_VENTILATORY_DEFECT,1
DESCARTES_FETAL_CEREBELLUM_O...,SET,68,-0.076184,-0.0046256,0.11549,0.74527,DESCARTES_FETAL_CEREBELLUM_OLIGODENDROCYTES,1
HP_ABNORMALITY_OF_THE_CERVIC...,SET,375,-0.029074,-0.0041105,0.044071,0.74528,HP_ABNORMALITY_OF_THE_CERVICAL_SPINE,1
MODULE_76,SET,78,-0.07261,-0.0047203,0.11005,0.7453,MODULE_76,1
SMAD4_Q6,SET,223,-0.039668,-0.004343,0.060116,0.74532,SMAD4_Q6,1
ANDERSON_BLOOD_CN54GP140_ADJ...8,SET,28,-0.10824,-0.0042216,0.16403,0.74532,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_UP,1
LU_TUMOR_VASCULATURE_DN,SET,8,-0.17223,-0.0035926,0.26099,0.74534,LU_TUMOR_VASCULATURE_DN,1
GOBP_BRAIN_MORPHOGENESIS,SET,37,-0.090485,-0.004056,0.13708,0.7454,GOBP_BRAIN_MORPHOGENESIS,1
GSE40274_XBP1_VS_FOXP3_AND_X...1,SET,180,-0.039835,-0.003923,0.060296,0.74558,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GNF2_RAN,SET,78,-0.058153,-0.0037805,0.088011,0.74561,GNF2_RAN,1
GOBP_REGULATION_OF_SODIUM_IO...1,SET,52,-0.088147,-0.0046821,0.13337,0.74566,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
REACTOME_NEGATIVE_FEEDBACK_R...,SET,6,-0.23719,-0.0042849,0.35886,0.74567,REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY,1
GOCC_POSTSYNAPTIC_SPECIALIZA...1,SET,324,-0.032639,-0.0042954,0.049379,0.74569,GOCC_POSTSYNAPTIC_SPECIALIZATION,1
AIZARANI_LIVER_C28_NK_NKT_CE...,SET,85,-0.064448,-0.0043729,0.097488,0.74572,AIZARANI_LIVER_C28_NK_NKT_CELLS_6,1
REACTOME_TRANSLESION_SYNTHES...2,SET,16,-0.12905,-0.003806,0.19519,0.74573,REACTOME_TRANSLESION_SYNTHESIS_BY_POLK,1
ACATATC_MIR190,SET,54,-0.085044,-0.0046031,0.12863,0.74574,ACATATC_MIR190,1
HP_NEVUS_FLAMMEUS_OF_THE_FOR...,SET,6,-0.24099,-0.0043536,0.36437,0.74581,HP_NEVUS_FLAMMEUS_OF_THE_FOREHEAD,1
HP_ATROPHIC_GASTRITIS,SET,7,-0.19996,-0.0039017,0.30229,0.74584,HP_ATROPHIC_GASTRITIS,1
GSE7852_TREG_VS_TCONV_FAT_UP,SET,185,-0.04175,-0.0041677,0.063111,0.74586,GSE7852_TREG_VS_TCONV_FAT_UP,1
GOBP_NEGATIVE_REGULATION_OF_...590,SET,34,-0.10073,-0.0043285,0.15225,0.74588,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,1
REACTOME_MTOR_SIGNALLING,SET,40,-0.087705,-0.0040873,0.13256,0.74589,REACTOME_MTOR_SIGNALLING,1
MIR4254,SET,92,-0.057456,-0.004055,0.086828,0.74592,MIR4254,1
HP_DYSMENORRHEA,SET,12,-0.16195,-0.0041371,0.24475,0.74592,HP_DYSMENORRHEA,1
MIR582_5P,SET,326,-0.032018,-0.0042264,0.048384,0.74593,MIR582_5P,1
HP_IMPAIRED_TEMPERATURE_SENS...,SET,34,-0.10182,-0.0043755,0.15387,0.74593,HP_IMPAIRED_TEMPERATURE_SENSATION,1
GOMF_MONOAMINE_TRANSMEMBRANE...,SET,12,-0.18073,-0.0046167,0.27307,0.74596,GOMF_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_T_CELL_RECEPTOR_BINDING,SET,10,-0.18534,-0.0043221,0.28002,0.74597,GOMF_T_CELL_RECEPTOR_BINDING,1
MIR4693_3P,SET,56,-0.07409,-0.0040836,0.11189,0.74606,MIR4693_3P,1
HP_ABNORMAL_SCROTAL_RUGATION,SET,4,-0.32982,-0.0048653,0.49809,0.74606,HP_ABNORMAL_SCROTAL_RUGATION,1
HP_PSORIASIFORM_DERMATITIS,SET,28,-0.11849,-0.0046216,0.17894,0.74608,HP_PSORIASIFORM_DERMATITIS,1
KONDO_COLON_CANCER_HCP_WITH_...1,SET,22,-0.12637,-0.0043696,0.1908,0.74611,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,1
GSE3400_UNTREATED_VS_IFNB_TR...2,SET,167,-0.042733,-0.004055,0.064521,0.74611,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP,1
MIR331_3P,SET,59,-0.079306,-0.0044863,0.11973,0.74612,MIR331_3P,1
DESCARTES_FETAL_STOMACH_PDE1...,SET,20,-0.13434,-0.0044292,0.20281,0.74613,DESCARTES_FETAL_STOMACH_PDE1C_ACSM3_POSITIVE_CELLS,1
GSE18893_TCONV_VS_TREG_2H_TN...1,SET,174,-0.043041,-0.0041682,0.064971,0.74616,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN,1
SCHAEFFER_PROSTATE_DEVELOPME...6,SET,142,-0.047204,-0.0041333,0.07124,0.74621,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1
GOCC_CENTRIOLAR_SATELLITE,SET,112,-0.051704,-0.004024,0.077998,0.74629,GOCC_CENTRIOLAR_SATELLITE,1
MIR10395_3P,SET,130,-0.048854,-0.0040943,0.073696,0.7463,MIR10395_3P,1
HP_ABNORMAL_PULMONARY_VALVE_...3,SET,137,-0.051719,-0.0044488,0.078015,0.74631,HP_ABNORMAL_PULMONARY_VALVE_PHYSIOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...775,SET,339,-0.031698,-0.0042652,0.04781,0.74633,GOBP_POSITIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,1
HP_DECREASED_HIP_ABDUCTION,SET,7,-0.21629,-0.0042204,0.32621,0.74634,HP_DECREASED_HIP_ABDUCTION,1
chr21q11,SET,4,-0.37579,-0.0055434,0.56663,0.74639,chr21q11,1
PETROVA_PROX1_TARGETS_DN,SET,55,-0.078108,-0.0042666,0.11777,0.7464,PETROVA_PROX1_TARGETS_DN,1
GOMF_PHOSPHATIDYLINOSITOL_3_...1,SET,4,-0.27218,-0.0040151,0.41027,0.74646,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,1
LY_AGING_OLD_DN,SET,53,-0.07162,-0.0038406,0.10795,0.74647,LY_AGING_OLD_DN,1
HP_MACROTHROMBOCYTOPENIA,SET,12,-0.17218,-0.0043984,0.25944,0.74655,HP_MACROTHROMBOCYTOPENIA,1
GOBP_REGULATION_OF_VIRAL_PRO...,SET,154,-0.048644,-0.0044342,0.073271,0.74662,GOBP_REGULATION_OF_VIRAL_PROCESS,1
GOMF_PROTEIN_CONTAINING_COMP...1,SET,1561,-0.015002,-0.0041824,0.022596,0.74663,GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING,1
GSE21379_TFH_VS_NON_TFH_CD4_...1,SET,176,-0.044942,-0.004377,0.067663,0.74672,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN,1
GOBP_CELL_ACTIVATION_INVOLVE...,SET,280,-0.03553,-0.004352,0.053487,0.74674,GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
HP_OPTIC_NEUROPATHY,SET,46,-0.082084,-0.0041015,0.12357,0.74674,HP_OPTIC_NEUROPATHY,1
GOCC_CELL_BODY_MEMBRANE,SET,32,-0.1139,-0.0047488,0.17142,0.7468,GOCC_CELL_BODY_MEMBRANE,1
chr8q21,SET,67,-0.12854,-0.0077469,0.19342,0.74683,chr8q21,1
GOBP_POSITIVE_REGULATION_OF_...677,SET,61,-0.072554,-0.0041731,0.10916,0.74687,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
BLANCO_MELO_COVID19_SARS_COV...9,SET,14,-0.17097,-0.004717,0.2572,0.74688,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,1
GOMF_GROWTH_FACTOR_BINDING,SET,126,-0.055575,-0.0045859,0.083586,0.74694,GOMF_GROWTH_FACTOR_BINDING,1
GOBP_PROTEIN_K48_LINKED_UBIQ...,SET,94,-0.057081,-0.0040718,0.085836,0.74697,GOBP_PROTEIN_K48_LINKED_UBIQUITINATION,1
TTCYNRGAA_STAT5B_01,SET,300,-0.033631,-0.0042617,0.050569,0.74699,TTCYNRGAA_STAT5B_01,1
HP_NEONATAL_RESPIRATORY_DIST...,SET,136,-0.047611,-0.0040805,0.071586,0.747,HP_NEONATAL_RESPIRATORY_DISTRESS,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...3,SET,104,-0.05531,-0.004149,0.083161,0.747,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN,1
REACTOME_CRISTAE_FORMATION,SET,9,-0.1742,-0.0038539,0.26189,0.74702,REACTOME_CRISTAE_FORMATION,1
MIR6816_5P,SET,19,-0.13471,-0.0043291,0.20251,0.74703,MIR6816_5P,1
HP_FIRST_DEGREE_ATRIOVENTRIC...,SET,42,-0.0925,-0.0044169,0.13905,0.74704,HP_FIRST_DEGREE_ATRIOVENTRICULAR_BLOCK,1
MIR6841_5P,SET,32,-0.09971,-0.004157,0.14988,0.74705,MIR6841_5P,1
GOBP_RETINAL_CELL_APOPTOTIC_...,SET,6,-0.23671,-0.0042763,0.35577,0.74708,GOBP_RETINAL_CELL_APOPTOTIC_PROCESS,1
HP_TALIPES_EQUINOVALGUS,SET,13,-0.1496,-0.0039775,0.22484,0.74709,HP_TALIPES_EQUINOVALGUS,1
GOBP_AXONEMAL_DYNEIN_COMPLEX...,SET,26,-0.10263,-0.0038575,0.15424,0.74711,GOBP_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY,1
MIR144_3P,SET,451,-0.028496,-0.0044088,0.042821,0.74712,MIR144_3P,1
GSE22601_CD4_SINGLE_POSITIVE...2,SET,181,-0.039296,-0.0038805,0.05905,0.74712,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
HP_PROGRESSIVE_MUSCLE_WEAKNE...,SET,64,-0.068402,-0.0040295,0.10278,0.74713,HP_PROGRESSIVE_MUSCLE_WEAKNESS,1
MIR6814_3P_MIR6872_5P,SET,7,-0.22238,-0.0043392,0.3341,0.74716,MIR6814_3P_MIR6872_5P,1
HP_CHRONIC_LEUKEMIA,SET,23,-0.11949,-0.0042245,0.1795,0.74719,HP_CHRONIC_LEUKEMIA,1
GSE37532_WT_VS_PPARG_KO_VISC...1,SET,180,-0.04116,-0.0040534,0.061819,0.74723,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN,1
GOBP_NEGATIVE_REGULATION_OF_...236,SET,5,-0.29855,-0.0049237,0.44838,0.74724,GOBP_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...4,SET,204,-0.042138,-0.0044149,0.063283,0.74725,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL,1
LAU_APOPTOSIS_CDKN2A_DN,SET,5,-0.23301,-0.0038429,0.3499,0.74727,LAU_APOPTOSIS_CDKN2A_DN,1
REACTOME_SYNTHESIS_OF_ACTIVE...,SET,26,-0.1088,-0.0040895,0.16337,0.74729,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,1
GOBP_MEMBRANE_FUSION_INVOLVE...,SET,4,-0.32664,-0.0048184,0.49041,0.7473,GOBP_MEMBRANE_FUSION_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,1
GSE30962_ACUTE_VS_CHRONIC_LC...4,SET,180,-0.042257,-0.0041615,0.063433,0.74734,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP,1
HP_ERYTHROID_HYPERPLASIA,SET,14,-0.14333,-0.0039545,0.21515,0.74735,HP_ERYTHROID_HYPERPLASIA,1
REACTOME_OLFACTORY_SIGNALING...,SET,316,-0.046576,-0.0060547,0.069884,0.74744,REACTOME_OLFACTORY_SIGNALING_PATHWAY,1
GSE9960_GRAM_NEG_VS_GRAM_POS...2,SET,175,-0.0429,-0.0041663,0.064366,0.74745,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP,1
GOBP_MAMMARY_GLAND_INVOLUTION,SET,8,-0.22912,-0.0047793,0.34371,0.74748,GOBP_MAMMARY_GLAND_INVOLUTION,1
MIR8058,SET,41,-0.096408,-0.0045485,0.14462,0.74749,MIR8058,1
LAKE_ADULT_KIDNEY_C22_ENDOTH...,SET,135,-0.053764,-0.004591,0.080643,0.74751,LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES,1
GOBP_ZINC_ION_TRANSPORT,SET,29,-0.095678,-0.0037977,0.14351,0.74752,GOBP_ZINC_ION_TRANSPORT,1
GSE21033_CTRL_VS_POLYIC_STIM...3,SET,175,-0.042941,-0.0041703,0.064404,0.74753,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN,1
HP_DECREASED_ACTIVITY_OF_THE...,SET,10,-0.20658,-0.0048174,0.30975,0.74758,HP_DECREASED_ACTIVITY_OF_THE_PYRUVATE_DEHYDROGENASE_COMPLEX,1
TSAI_DNAJB4_TARGETS_UP,SET,12,-0.16575,-0.0042341,0.24848,0.74763,TSAI_DNAJB4_TARGETS_UP,1
GOBP_REGULATION_OF_TRANSLATI...10,SET,4,-0.26349,-0.0038868,0.395,0.74763,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE_MODULATING_SYNAPTIC_TRANSMISSION,1
HP_ABNORMAL_HAIR_WHORL,SET,27,-0.11873,-0.0045474,0.17792,0.74771,HP_ABNORMAL_HAIR_WHORL,1
GSE32034_UNTREATED_VS_ROSIGL...1,SET,178,-0.042302,-0.0041429,0.063392,0.74771,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN,1
GOBP_FAT_SOLUBLE_VITAMIN_BIO...,SET,13,-0.16846,-0.0044787,0.25243,0.74772,GOBP_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,1
HP_HIP_DYSPLASIA,SET,207,-0.039433,-0.0041614,0.059086,0.74773,HP_HIP_DYSPLASIA,1
GSE360_L_DONOVANI_VS_M_TUBER...3,SET,188,-0.042761,-0.0043027,0.06406,0.74777,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN,1
WP_LIPID_METABOLISM_PATHWAY,SET,28,-0.10201,-0.0039787,0.15281,0.74779,WP_LIPID_METABOLISM_PATHWAY,1
WP_LACTATE_SHUTTLE_IN_GLIAL_...,SET,12,-0.17363,-0.0044353,0.25998,0.74788,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,1
HE_LIM_SUN_FETAL_LUNG_C0_INT...1,SET,62,-0.081198,-0.0047083,0.12155,0.74794,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE,1
GSE15330_MEGAKARYOCYTE_ERYTH...6,SET,165,-0.046122,-0.0043505,0.069038,0.74795,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
GOBP_RIBOSE_PHOSPHATE_METABO...,SET,405,-0.028306,-0.0041554,0.04236,0.748,GOBP_RIBOSE_PHOSPHATE_METABOLIC_PROCESS,1
HP_HOARSE_CRY,SET,14,-0.16622,-0.0045861,0.2487,0.74805,HP_HOARSE_CRY,1
REACTOME_INSULIN_RECEPTOR_SI...,SET,53,-0.081277,-0.0043584,0.12155,0.74814,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,1
HP_OSTEOCHONDRITIS_DISSECANS,SET,7,-0.24118,-0.0047061,0.36049,0.74826,HP_OSTEOCHONDRITIS_DISSECANS,1
HP_DISTAL_LOWER_LIMB_AMYOTRO...,SET,46,-0.088482,-0.0044212,0.13224,0.74827,HP_DISTAL_LOWER_LIMB_AMYOTROPHY,1
GOBP_BINDING_OF_SPERM_TO_ZON...,SET,38,-0.089038,-0.0040446,0.13304,0.74833,GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,1
HP_ABNORMALITY_OF_THE_MALE_G...,SET,1026,-0.018166,-0.0041706,0.027132,0.74842,HP_ABNORMALITY_OF_THE_MALE_GENITALIA,1
HP_EPIRETINAL_MEMBRANE,SET,12,-0.178,-0.0045469,0.26583,0.74843,HP_EPIRETINAL_MEMBRANE,1
GOBP_REGULATION_OF_DNA_LIGAT...,SET,6,-0.22534,-0.0040709,0.33649,0.74847,GOBP_REGULATION_OF_DNA_LIGATION,1
MOOTHA_PGC,SET,378,-0.028726,-0.0040772,0.04289,0.74849,MOOTHA_PGC,1
REACTOME_ACTIVATION_OF_THE_P...1,SET,11,-0.16533,-0.0040435,0.24677,0.74856,REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE,1
ZNF610_TARGET_GENES,SET,708,-0.021683,-0.0041732,0.032362,0.74858,ZNF610_TARGET_GENES,1
SABATES_COLORECTAL_ADENOMA_UP,SET,127,-0.057553,-0.0047678,0.085878,0.74862,SABATES_COLORECTAL_ADENOMA_UP,1
GOBP_REGULATION_OF_MACROPHAG...5,SET,23,-0.1258,-0.0044475,0.18768,0.74866,GOBP_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,1
GOBP_REGULATION_OF_MITOTIC_C...2,SET,311,-0.032072,-0.0041367,0.047848,0.74866,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
KEGG_MEDICUS_REFERENCE_MACHR...,SET,18,-0.13996,-0.0043779,0.20876,0.7487,KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY,1
MIR1287_3P,SET,31,-0.093503,-0.003837,0.13946,0.74872,MIR1287_3P,1
GOMF_PEPTIDE_RECEPTOR_ACTIVI...,SET,119,-0.058746,-0.0047118,0.087613,0.74873,GOMF_PEPTIDE_RECEPTOR_ACTIVITY,1
GOBP_MITOCHONDRIAL_DNA_METAB...,SET,21,-0.11142,-0.0037643,0.16614,0.74877,GOBP_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,1
GOBP_GLYOXYLATE_METABOLIC_PR...,SET,8,-0.20772,-0.0043328,0.30969,0.7488,GOBP_GLYOXYLATE_METABOLIC_PROCESS,1
HP_SINUS_TACHYCARDIA,SET,27,-0.10356,-0.0039666,0.15436,0.74887,HP_SINUS_TACHYCARDIA,1
GESERICK_TERT_TARGETS_DN,SET,21,-0.13855,-0.0046808,0.2065,0.74888,GESERICK_TERT_TARGETS_DN,1
GTF3C1_TARGET_GENES,SET,4,-0.29151,-0.0043002,0.43445,0.74888,GTF3C1_TARGET_GENES,1
GOMF_AMYLOID_BETA_BINDING,SET,81,-0.068323,-0.0045259,0.10183,0.74888,GOMF_AMYLOID_BETA_BINDING,1
MIR103B,SET,36,-0.091018,-0.0040244,0.13562,0.74893,MIR103B,1
GSE22886_IGM_MEMORY_BCELL_VS...1,SET,175,-0.042963,-0.0041724,0.064016,0.74893,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
KEGG_MEDICUS_VARIANT_AMPLIFI...9,SET,9,-0.19709,-0.0043604,0.29362,0.74896,KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY,1
WP_TRIACYLGLYCERIDE_SYNTHESIS,SET,20,-0.14049,-0.0046321,0.20931,0.74896,WP_TRIACYLGLYCERIDE_SYNTHESIS,1
GOBP_N_TERMINAL_PROTEIN_AMIN...2,SET,24,-0.11135,-0.0040212,0.16583,0.74904,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,1
GOBP_RECEPTOR_INTERNALIZATION,SET,120,-0.052849,-0.0042565,0.078702,0.74905,GOBP_RECEPTOR_INTERNALIZATION,1
GOBP_ANTEROGRADE_DENDRITIC_T...1,SET,9,-0.1961,-0.0043386,0.29202,0.74906,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT,1
REACTOME_PD_1_SIGNALING,SET,18,-0.15106,-0.0047253,0.22494,0.74907,REACTOME_PD_1_SIGNALING,1
HP_ADULT_ONSET,SET,777,-0.020958,-0.0042172,0.031204,0.74909,HP_ADULT_ONSET,1
HP_ABSENT_TOE,SET,61,-0.074607,-0.0042912,0.11108,0.7491,HP_ABSENT_TOE,1
GOMF_COPPER_ION_BINDING,SET,57,-0.078373,-0.004358,0.11668,0.74911,GOMF_COPPER_ION_BINDING,1
REACTOME_ACYL_CHAIN_REMODELI...1,SET,5,-0.27942,-0.0046083,0.41585,0.74918,REACTOME_ACYL_CHAIN_REMODELING_OF_CL,1
GOMF_GDP_PHOSPHATASE_ACTIVITY,SET,10,-0.17374,-0.0040515,0.25852,0.74921,GOMF_GDP_PHOSPHATASE_ACTIVITY,1
GSE17721_0.5H_VS_8H_LPS_BMDC...2,SET,189,-0.041772,-0.0042143,0.062159,0.74921,GSE17721_0.5H_VS_8H_LPS_BMDC_UP,1
HP_ABNORMAL_SUBCLAVIAN_ARTER...,SET,10,-0.196,-0.0045709,0.29159,0.74926,HP_ABNORMAL_SUBCLAVIAN_ARTERY_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C1_SMG...2,SET,653,-0.023521,-0.0043543,0.034994,0.74926,HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL,1
HP_PREAURICULAR_SKIN_TAG,SET,59,-0.072452,-0.0040985,0.10776,0.74932,HP_PREAURICULAR_SKIN_TAG,1
GNF2_ITGB2,SET,51,-0.080159,-0.0042168,0.11921,0.74934,GNF2_ITGB2,1
KEGG_MEDICUS_REFERENCE_PROMO...,SET,21,-0.1292,-0.004365,0.1921,0.74939,KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH,1
GSE17721_LPS_VS_PAM3CSK4_12H...1,SET,179,-0.042306,-0.0041548,0.062899,0.74939,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN,1
REACTOME_INTEGRATION_OF_ENER...,SET,106,-0.058618,-0.0044389,0.087123,0.74946,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1
KEGG_MEDICUS_PATHOGEN_HIV_NE...,SET,12,-0.15738,-0.0040201,0.23384,0.74953,KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...186,SET,76,-0.069155,-0.0044379,0.10275,0.74953,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOMF_MAP_KINASE_KINASE_KINAS...1,SET,22,-0.12411,-0.0042915,0.18441,0.74953,GOMF_MAP_KINASE_KINASE_KINASE_ACTIVITY,1
MIR2053,SET,159,-0.045928,-0.0042535,0.068226,0.74958,MIR2053,1
GOBP_DEFENSE_RESPONSE_TO_GRA...2,SET,92,-0.064548,-0.0045555,0.095884,0.74958,GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,1
WP_BIOMARKERS_FOR_UREA_CYCLE...,SET,11,-0.17691,-0.0043268,0.26275,0.74961,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,1
HP_BOWED_FOREARM_BONES,SET,31,-0.1086,-0.0044564,0.16127,0.74965,HP_BOWED_FOREARM_BONES,1
HP_MULTIPLE_RIB_FRACTURES,SET,10,-0.20617,-0.0048079,0.30616,0.74965,HP_MULTIPLE_RIB_FRACTURES,1
TRAVAGLINI_LUNG_PLASMACYTOID...,SET,101,-0.060944,-0.0045055,0.090497,0.74966,TRAVAGLINI_LUNG_PLASMACYTOID_DENDRITIC_CELL,1
MATZUK_EMBRYONIC_GERM_CELL,SET,18,-0.15074,-0.0047152,0.2238,0.7497,MATZUK_EMBRYONIC_GERM_CELL,1
SMID_BREAST_CANCER_RELAPSE_I...3,SET,76,-0.069925,-0.0044874,0.10382,0.7497,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,1
GOCC_TIM23_MITOCHONDRIAL_IMP...,SET,14,-0.14387,-0.0039694,0.21359,0.74971,GOCC_TIM23_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_TRANSLOCASE_COMPLEX,1
TENEDINI_MEGAKARYOCYTE_MARKE...,SET,60,-0.077416,-0.0044162,0.11492,0.74973,TENEDINI_MEGAKARYOCYTE_MARKERS,1
MANNO_MIDBRAIN_NEUROTYPES_HP...3,SET,284,-0.034917,-0.0043069,0.051828,0.74975,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL,1
GOMF_DNA_APURINIC_OR_APYRIMI...,SET,12,-0.15558,-0.0039742,0.23091,0.74976,GOMF_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,1
GSE16385_ROSIGLITAZONE_VS_UN...2,SET,178,-0.045081,-0.0044151,0.066905,0.74978,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP,1
BIOCARTA_SPPA_PATHWAY,SET,16,-0.15954,-0.0047054,0.23675,0.7498,BIOCARTA_SPPA_PATHWAY,1
MODULE_174,SET,89,-0.06612,-0.0045901,0.098098,0.74985,MODULE_174,1
GSE17721_POLYIC_VS_PAM3CSK4_...16,SET,185,-0.042661,-0.0042586,0.063287,0.74987,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP,1
GSE10211_UV_INACT_SENDAI_VS_...2,SET,141,-0.048213,-0.0042068,0.071488,0.74997,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP,1
GSE3982_CTRL_VS_LPS_1H_NEUTR...1,SET,174,-0.042575,-0.004123,0.063125,0.74998,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN,1
KEGG_MEDICUS_REFERENCE_RAC_C...,SET,9,-0.19181,-0.0042435,0.28429,0.75005,KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY,1
WANG_RECURRENT_LIVER_CANCER_...2,SET,16,-0.14899,-0.0043942,0.22082,0.75007,WANG_RECURRENT_LIVER_CANCER_UP,1
GOBP_GLYCINE_TRANSPORT,SET,14,-0.16862,-0.0046521,0.24976,0.75019,GOBP_GLYCINE_TRANSPORT,1
MODULE_88,SET,765,-0.022293,-0.0044527,0.033009,0.75027,MODULE_88,1
GOBP_ACTIVATION_OF_CYSTEINE_...1,SET,13,-0.16669,-0.0044317,0.24678,0.7503,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...536,SET,64,-0.075228,-0.0044316,0.11137,0.7503,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION,1
LAIHO_COLORECTAL_CANCER_SERR...2,SET,103,-0.054767,-0.0040886,0.081068,0.75034,LAIHO_COLORECTAL_CANCER_SERRATED_UP,1
GOBP_REGULATION_OF_AMINO_ACI...2,SET,40,-0.098981,-0.0046128,0.14651,0.75034,GOBP_REGULATION_OF_AMINO_ACID_TRANSPORT,1
GOBP_PROTEIN_LOCALIZATION_TO...49,SET,71,-0.070123,-0.0043501,0.10379,0.75035,GOBP_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
GOBP_TRACHEA_CARTILAGE_DEVEL...,SET,7,-0.23047,-0.0044972,0.34108,0.75039,GOBP_TRACHEA_CARTILAGE_DEVELOPMENT,1
GSE21927_SPLEEN_C57BL6_VS_EL...1,SET,184,-0.039393,-0.0039218,0.058286,0.75043,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN,1
HP_CORONARY_ARTERY_ATHEROSCL...,SET,51,-0.089571,-0.0047119,0.13252,0.75045,HP_CORONARY_ARTERY_ATHEROSCLEROSIS,1
MORF_NME2,SET,137,-0.047067,-0.0040485,0.069625,0.75048,MORF_NME2,1
WP_OXIDATIVE_DAMAGE_RESPONSE,SET,36,-0.097171,-0.0042965,0.14373,0.75049,WP_OXIDATIVE_DAMAGE_RESPONSE,1
GOCC_NUCLEAR_PERIPHERY,SET,139,-0.048782,-0.0042264,0.072158,0.75049,GOCC_NUCLEAR_PERIPHERY,1
GSE18791_CTRL_VS_NEWCASTLE_V...13,SET,142,-0.04936,-0.004322,0.073011,0.75049,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN,1
chr5p12,SET,12,-0.26324,-0.0067243,0.38932,0.75052,chr5p12,1
GOMF_DNA_BINDING_BENDING,SET,17,-0.1548,-0.0047059,0.22893,0.75053,GOMF_DNA_BINDING_BENDING,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND...,SET,74,-0.065436,-0.0041439,0.096769,0.75054,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1
GSE25123_CTRL_VS_IL4_STIM_MA...1,SET,175,-0.04384,-0.0042575,0.064829,0.75055,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN,1
GOMF_NUCLEAR_RETINOIC_ACID_R...,SET,24,-0.11311,-0.0040848,0.16726,0.75056,GOMF_NUCLEAR_RETINOIC_ACID_RECEPTOR_BINDING,1
GSE10325_LUPUS_CD4_TCELL_VS_...1,SET,166,-0.048126,-0.0045532,0.071157,0.75058,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN,1
REACTOME_INTRA_GOLGI_TRAFFIC,SET,43,-0.089031,-0.0043015,0.13163,0.75059,REACTOME_INTRA_GOLGI_TRAFFIC,1
GSE19401_UNSTIM_VS_RETINOIC_...2,SET,177,-0.041691,-0.0040717,0.061641,0.75059,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
HP_CRYPTORCHIDISM,SET,636,-0.023218,-0.0042439,0.034324,0.75062,HP_CRYPTORCHIDISM,1
HP_DECREASED_CIRCULATING_REN...,SET,11,-0.17544,-0.0042909,0.25935,0.75062,HP_DECREASED_CIRCULATING_RENIN_LEVEL,1
GOCC_MICROVESICLE,SET,8,-0.21935,-0.0045756,0.32421,0.75066,GOCC_MICROVESICLE,1
GCM_MAX,SET,29,-0.099813,-0.0039618,0.1475,0.7507,GCM_MAX,1
GOCC_CYTOPLASMIC_DYNEIN_COMP...,SET,16,-0.14124,-0.0041656,0.20872,0.7507,GOCC_CYTOPLASMIC_DYNEIN_COMPLEX,1
GOBP_REGULATION_OF_MITOCHOND...8,SET,48,-0.07985,-0.0040755,0.11796,0.75077,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,1
HP_FAILURE_OF_ERUPTION_OF_PE...,SET,5,-0.29524,-0.0048692,0.43616,0.75077,HP_FAILURE_OF_ERUPTION_OF_PERMANENT_TEETH,1
GOBP_T_CELL_HOMEOSTASIS,SET,44,-0.088842,-0.0043419,0.13124,0.75078,GOBP_T_CELL_HOMEOSTASIS,1
GOBP_MEMBRANE_DISASSEMBLY,SET,12,-0.16898,-0.0043165,0.24961,0.75079,GOBP_MEMBRANE_DISASSEMBLY,1
MIR4433B_3P,SET,28,-0.1156,-0.0045088,0.17075,0.7508,MIR4433B_3P,1
GOBP_NUCLEOBASE_CONTAINING_S...4,SET,582,-0.024154,-0.0042298,0.035675,0.75082,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS,1
WP_GROWTH_FACTORS_AND_HORMON...,SET,26,-0.11439,-0.0042996,0.16894,0.75083,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...4,SET,6,-0.22983,-0.0041521,0.33928,0.75092,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOMF_TORC2_COMPLEX_BINDING,SET,4,-0.32085,-0.004733,0.47365,0.75092,GOMF_TORC2_COMPLEX_BINDING,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...1,SET,85,-0.057637,-0.0039107,0.085081,0.75093,GOBP_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
MTOR_UP.V1_DN,SET,171,-0.045026,-0.004323,0.066459,0.75095,MTOR_UP.V1_DN,1
GSE8621_UNSTIM_VS_LPS_STIM_M...2,SET,183,-0.04286,-0.0042555,0.063253,0.75098,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,1
HP_LIVEDO_RETICULARIS,SET,4,-0.26706,-0.0039396,0.39409,0.751,HP_LIVEDO_RETICULARIS,1
OISHI_CHOLANGIOMA_STEM_CELL_...2,SET,324,-0.031051,-0.0040864,0.045808,0.75106,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1
GOBP_REGULATION_OF_MAST_CELL...1,SET,16,-0.15424,-0.004549,0.22745,0.75115,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION,1
MIR4726_3P,SET,65,-0.073483,-0.0043624,0.10835,0.75117,MIR4726_3P,1
KEGG_MEDICUS_PATHOGEN_EBV_LM...1,SET,10,-0.17951,-0.0041862,0.26463,0.75122,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...439,SET,429,-0.029826,-0.0045034,0.043967,0.75122,GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE,1
AKL_HTLV1_INFECTION_DN,SET,61,-0.077268,-0.0044442,0.1139,0.75123,AKL_HTLV1_INFECTION_DN,1
GOBP_FATTY_ACID_OMEGA_OXIDAT...,SET,5,-0.32251,-0.0053188,0.47542,0.75123,GOBP_FATTY_ACID_OMEGA_OXIDATION,1
GOBP_PROTEIN_IMPORT,SET,9,-0.21,-0.004646,0.30953,0.75124,GOBP_PROTEIN_IMPORT,1
HP_CORONARY_ARTERY_ANEURYSM,SET,7,-0.26371,-0.0051458,0.38869,0.75126,HP_CORONARY_ARTERY_ANEURYSM,1
WP_MACROPHAGESTIMULATING_PRO...,SET,104,-0.061808,-0.0046364,0.09109,0.75128,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,1
MIR579_3P,SET,449,-0.028465,-0.0043946,0.041937,0.75135,MIR579_3P,1
GSE17721_PAM3CSK4_VS_GADIQUI...16,SET,179,-0.04091,-0.0040177,0.060273,0.75135,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP,1
GOMF_TRANSFERASE_ACTIVITY_TR...5,SET,67,-0.076394,-0.0046042,0.11253,0.75138,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_SULPHUR_CONTAINING_GROUPS,1
GOBP_POLY_A_PLUS_MRNA_EXPORT...,SET,18,-0.12101,-0.0037854,0.1782,0.75145,GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS,1
GSE7218_IGM_VS_IGG_SIGNAL_TH...2,SET,176,-0.042562,-0.0041452,0.062675,0.75146,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP,1
GOBP_REGULATION_OF_CALCINEUR...,SET,40,-0.089665,-0.0041786,0.13196,0.75158,GOBP_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,1
HP_ABNORMAL_DENTIN_MORPHOLOGY,SET,21,-0.12483,-0.0042171,0.18367,0.75162,HP_ABNORMAL_DENTIN_MORPHOLOGY,1
JOHNSTONE_PARVB_TARGETS_1_DN,SET,56,-0.079614,-0.004388,0.11711,0.75169,JOHNSTONE_PARVB_TARGETS_1_DN,1
BIOCARTA_CCR3_PATHWAY,SET,18,-0.14577,-0.0045599,0.21443,0.75169,BIOCARTA_CCR3_PATHWAY,1
MIR601,SET,34,-0.10176,-0.0043727,0.14964,0.75174,MIR601,1
GOBP_REGULATION_OF_POSTSYNAP...3,SET,9,-0.19509,-0.0043162,0.28688,0.75175,GOBP_REGULATION_OF_POSTSYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
GSE11924_TH2_VS_TH17_CD4_TCE...2,SET,178,-0.044457,-0.004354,0.065375,0.75175,GSE11924_TH2_VS_TH17_CD4_TCELL_UP,1
GSE19772_CTRL_VS_HCMV_INF_MO...2,SET,168,-0.043817,-0.0041702,0.064429,0.75177,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,1
GOMF_U3_SNORNA_BINDING,SET,8,-0.20224,-0.0042185,0.29731,0.75182,GOMF_U3_SNORNA_BINDING,1
REACTOME_NEGATIVE_REGULATION...1,SET,10,-0.19277,-0.0044954,0.28334,0.75185,REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS,1
HP_MOLLUSCOID_PSEUDOTUMORS,SET,6,-0.27505,-0.0049689,0.40427,0.75186,HP_MOLLUSCOID_PSEUDOTUMORS,1
HP_PERSONALITY_DISORDER,SET,16,-0.14609,-0.0043088,0.21469,0.75189,HP_PERSONALITY_DISORDER,1
JIANG_VHL_TARGETS,SET,77,-0.064289,-0.0041526,0.094468,0.75191,JIANG_VHL_TARGETS,1
WP_TGFBETA_RECEPTOR_SIGNALING,SET,51,-0.091573,-0.0048172,0.13456,0.75191,WP_TGFBETA_RECEPTOR_SIGNALING,1
WP_BLADDER_CANCER,SET,39,-0.093636,-0.0043089,0.13759,0.75192,WP_BLADDER_CANCER,1
LINDSTEDT_DENDRITIC_CELL_MAT...2,SET,45,-0.097943,-0.0048406,0.14389,0.75196,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,1
HP_APLASIA_HYPOPLASIA_OF_THE...17,SET,43,-0.085741,-0.0041425,0.12595,0.75199,HP_APLASIA_HYPOPLASIA_OF_THE_CLAVICLES,1
GOBP_REGULATION_OF_SPHINGOLI...,SET,12,-0.14446,-0.0036903,0.21219,0.75201,GOBP_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
HP_NAUSEA,SET,91,-0.060743,-0.0042637,0.089205,0.75204,HP_NAUSEA,1
HP_ELEVATED_CIRCULATING_LUTE...,SET,35,-0.093766,-0.0040881,0.13766,0.7521,HP_ELEVATED_CIRCULATING_LUTEINIZING_HORMONE_LEVEL,1
REACTOME_BIOSYNTHESIS_OF_MAR...2,SET,6,-0.22503,-0.0040653,0.33035,0.75212,REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS,1
GSE7852_TREG_VS_TCONV_FAT_DN,SET,183,-0.04246,-0.0042159,0.062309,0.7522,GSE7852_TREG_VS_TCONV_FAT_DN,1
GOBP_CATECHOL_CONTAINING_COM...2,SET,5,-0.303,-0.0049971,0.44462,0.75221,GOBP_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOBP_STEM_CELL_PROLIFERATION,SET,107,-0.058335,-0.0044382,0.085556,0.75232,GOBP_STEM_CELL_PROLIFERATION,1
HP_ABNORMAL_PUBIC_BONE_MORPH...,SET,39,-0.095532,-0.0043961,0.14011,0.75233,HP_ABNORMAL_PUBIC_BONE_MORPHOLOGY,1
HP_COMPLETE_DUPLICATION_OF_P...,SET,11,-0.16152,-0.0039504,0.23688,0.75233,HP_COMPLETE_DUPLICATION_OF_PHALANX_OF_HAND,1
GOBP_10_FORMYLTETRAHYDROFOLA...,SET,5,-0.26115,-0.0043069,0.38283,0.75243,GOBP_10_FORMYLTETRAHYDROFOLATE_METABOLIC_PROCESS,1
MIR6853_3P,SET,186,-0.043626,-0.0043667,0.063931,0.7525,MIR6853_3P,1
GSE17580_TREG_VS_TEFF_DN,SET,189,-0.042779,-0.0043158,0.062668,0.75257,GSE17580_TREG_VS_TEFF_DN,1
MIR524_5P,SET,853,-0.02078,-0.0043718,0.030439,0.7526,MIR524_5P,1
GSE22886_NAIVE_CD4_TCELL_VS_...2,SET,178,-0.042427,-0.0041552,0.062136,0.75263,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP,1
EINAV_INTERFERON_SIGNATURE_I...,SET,27,-0.11282,-0.0043211,0.16522,0.75265,EINAV_INTERFERON_SIGNATURE_IN_CANCER,1
HONRADO_BREAST_CANCER_BRCA1_...,SET,17,-0.15025,-0.0045676,0.21998,0.75269,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,1
HP_CUTANEOUS_AMYLOIDOSIS,SET,5,-0.2648,-0.0043671,0.38769,0.7527,HP_CUTANEOUS_AMYLOIDOSIS,1
GOBP_MONOCARBOXYLIC_ACID_MET...,SET,589,-0.025224,-0.0044428,0.036924,0.75274,GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS,1
GOCC_MYELIN_SHEATH,SET,41,-0.090862,-0.0042868,0.13298,0.75278,GOCC_MYELIN_SHEATH,1
GOBP_NEGATIVE_REGULATION_OF_...208,SET,5,-0.28302,-0.0046676,0.41413,0.75282,GOBP_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION,1
GSE17721_0.5H_VS_4H_GARDIQUI...1,SET,184,-0.042685,-0.0042497,0.062459,0.75282,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN,1
GSE22886_NAIVE_BCELL_VS_BLOO...2,SET,174,-0.044617,-0.0043208,0.065246,0.75295,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
GOBP_REGULATION_OF_GLUCOCORT...3,SET,5,-0.3003,-0.0049526,0.43913,0.75296,GOBP_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY,1
GSE2770_UNTREATED_VS_IL4_TRE...3,SET,174,-0.041856,-0.0040534,0.061205,0.75297,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...10,SET,5,-0.26983,-0.0044501,0.3945,0.753,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_LOW_IGM_RESPONDERS_6HY_1DY_UP,1
CAFFAREL_RESPONSE_TO_THC_8HR...2,SET,5,-0.2746,-0.0045288,0.40131,0.75309,CAFFAREL_RESPONSE_TO_THC_8HR_3_UP,1
GOBP_NEGATIVE_REGULATION_OF_...524,SET,193,-0.041672,-0.004248,0.060888,0.75314,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION,1
HP_HEPATIC_FIBROSIS,SET,134,-0.049061,-0.004174,0.071654,0.75323,HP_HEPATIC_FIBROSIS,1
THEILGAARD_NEUTROPHIL_AT_SKI...1,SET,213,-0.038661,-0.0041379,0.056453,0.75327,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1
GSE27786_ERYTHROBLAST_VS_NEU...2,SET,178,-0.043702,-0.0042801,0.063811,0.75328,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP,1
MIR502_5P,SET,68,-0.070366,-0.0042723,0.10273,0.75331,MIR502_5P,1
GOBP_TRYPTOPHAN_CATABOLIC_PR...,SET,5,-0.31344,-0.0051692,0.45754,0.75334,GOBP_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE,1
PURWIN_MEWO_SOX10_TARGETS,SET,82,-0.06587,-0.0043901,0.096148,0.75335,PURWIN_MEWO_SOX10_TARGETS,1
GOCC_CYTOSOLIC_REGION,SET,19,-0.13352,-0.0042911,0.19488,0.75338,GOCC_CYTOSOLIC_REGION,1
GSE41867_LCMV_ARMSTRONG_VS_C...1,SET,141,-0.050629,-0.0044176,0.073876,0.75342,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN,1
GOUYER_TUMOR_INVASIVENESS,SET,8,-0.23932,-0.0049921,0.34914,0.75347,GOUYER_TUMOR_INVASIVENESS,1
GOBP_CELLULAR_COMPONENT_ASSE...,SET,130,-0.05076,-0.0042541,0.074042,0.7535,GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS,1
GOBP_SPHINGOSINE_1_PHOSPHATE...,SET,15,-0.16084,-0.0045932,0.23457,0.75354,GOBP_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_SIGNALING_PATHWAY,1
HP_CALVARIAL_HYPEROSTOSIS,SET,10,-0.16917,-0.0039451,0.24664,0.75361,HP_CALVARIAL_HYPEROSTOSIS,1
HJURP_TARGET_GENES,SET,27,-0.10834,-0.0041497,0.15788,0.75371,HJURP_TARGET_GENES,1
DESCARTES_MAIN_FETAL_STELLAT...,SET,44,-0.098765,-0.0048268,0.1439,0.75375,DESCARTES_MAIN_FETAL_STELLATE_CELLS,1
ZHENG_FOXP3_TARGETS_IN_THYMU...2,SET,189,-0.046201,-0.0046611,0.067299,0.7538,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,1
GOBP_HEAD_DEVELOPMENT,SET,701,-0.023369,-0.0044762,0.03403,0.75387,GOBP_HEAD_DEVELOPMENT,1
MIKKELSEN_PLURIPOTENT_STATE_...2,SET,8,-0.19893,-0.0041496,0.28955,0.75397,MIKKELSEN_PLURIPOTENT_STATE_UP,1
WP_FOCAL_ADHESION_PI3KAKTMTO...,SET,288,-0.036655,-0.0045525,0.053351,0.75397,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,1
GOBP_RETINAL_ROD_CELL_DEVELO...,SET,10,-0.19369,-0.004517,0.2819,0.75398,GOBP_RETINAL_ROD_CELL_DEVELOPMENT,1
HP_PREMATURE_BIRTH,SET,151,-0.046493,-0.004197,0.067653,0.75403,HP_PREMATURE_BIRTH,1
HP_EMG_AXONAL_ABNORMALITY,SET,14,-0.16689,-0.0046044,0.2428,0.75406,HP_EMG_AXONAL_ABNORMALITY,1
GSE24142_EARLY_THYMIC_PROGEN...8,SET,186,-0.044454,-0.0044495,0.064675,0.75406,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP,1
WP_EPO_RECEPTOR_SIGNALING,SET,26,-0.12577,-0.0047273,0.18297,0.75407,WP_EPO_RECEPTOR_SIGNALING,1
BORCZUK_MALIGNANT_MESOTHELIO...2,SET,266,-0.034546,-0.0041259,0.050253,0.75409,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1
SHIPP_DLBCL_VS_FOLLICULAR_LY...1,SET,36,-0.099098,-0.0043817,0.14412,0.75414,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,1
DELASERNA_TARGETS_OF_MYOD_AN...,SET,10,-0.20114,-0.0046907,0.29249,0.75417,DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4,1
HP_ABNORMAL_ELECTROPHYSIOLOG...,SET,78,-0.069054,-0.0044891,0.10041,0.75418,HP_ABNORMAL_ELECTROPHYSIOLOGY_OF_SINOATRIAL_NODE_ORIGIN,1
GSE22589_HEALTHY_VS_SIV_INFE...1,SET,186,-0.044808,-0.0044849,0.06515,0.75419,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN,1
chr4p15,SET,46,-0.17059,-0.008524,0.24802,0.75421,chr4p15,1
GOBP_PARANODAL_JUNCTION_ASSE...,SET,6,-0.26642,-0.0048132,0.38728,0.75425,GOBP_PARANODAL_JUNCTION_ASSEMBLY,1
ZNF133_TARGET_GENES,SET,175,-0.044059,-0.0042789,0.064037,0.75428,ZNF133_TARGET_GENES,1
GOMF_PYRIMIDINE_NUCLEOBASE_T...,SET,7,-0.23855,-0.0046547,0.34668,0.7543,GOMF_PYRIMIDINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE23925_LIGHT_ZONE_VS_DARK_...1,SET,187,-0.042628,-0.004278,0.061948,0.75431,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...127,SET,807,-0.022097,-0.0045277,0.032108,0.75434,GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION,1
HALLMARK_XENOBIOTIC_METABOLI...,SET,193,-0.043836,-0.0044686,0.063692,0.75435,HALLMARK_XENOBIOTIC_METABOLISM,1
GOMF_RNA_EXONUCLEASE_ACTIVIT...,SET,39,-0.089446,-0.0041161,0.12994,0.75438,GOMF_RNA_EXONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
LEE_LIVER_CANCER_SURVIVAL_UP,SET,166,-0.046567,-0.0044056,0.067638,0.75442,LEE_LIVER_CANCER_SURVIVAL_UP,1
MIR188_3P,SET,139,-0.049445,-0.0042839,0.071805,0.75446,MIR188_3P,1
MIR6849_5P,SET,28,-0.12297,-0.0047961,0.17857,0.75446,MIR6849_5P,1
GSE42724_NAIVE_VS_B1_BCELL_DN,SET,170,-0.042715,-0.0040892,0.062026,0.75448,GSE42724_NAIVE_VS_B1_BCELL_DN,1
GOBP_REGULATION_OF_CYSTEINE_...2,SET,146,-0.049736,-0.0044154,0.072198,0.75455,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
chr3p12,SET,7,-0.31479,-0.0061424,0.45651,0.75476,chr3p12,1
MODULE_197,SET,168,-0.046365,-0.0044126,0.067234,0.75477,MODULE_197,1
KYNG_DNA_DAMAGE_BY_GAMMA_RAD...,SET,69,-0.072711,-0.0044469,0.10544,0.75478,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1
GOBP_T_CELL_CHEMOTAXIS,SET,24,-0.12215,-0.0044113,0.17713,0.75478,GOBP_T_CELL_CHEMOTAXIS,1
GOBP_L_PROLINE_TRANSMEMBRANE...,SET,3,-0.35065,-0.0044797,0.50842,0.7548,GOBP_L_PROLINE_TRANSMEMBRANE_TRANSPORT,1
GOMF_METALLOENDOPEPTIDASE_IN...,SET,13,-0.16035,-0.0042631,0.23247,0.75482,GOMF_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
KEGG_MEDICUS_VARIANT_AMPLIFI...5,SET,14,-0.16767,-0.004626,0.24302,0.75488,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,1
GOBP_ATTACHMENT_OF_SPINDLE_M...,SET,49,-0.080152,-0.0041332,0.11617,0.75488,GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
GOBP_PROTEIN_K29_LINKED_UBIQ...,SET,10,-0.18246,-0.0042549,0.26445,0.75488,GOBP_PROTEIN_K29_LINKED_UBIQUITINATION,1
WP_CONGENITAL_GENERALIZED_LI...,SET,16,-0.15192,-0.0044806,0.22017,0.7549,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,1
GOBP_NEGATIVE_REGULATION_OF_...261,SET,14,-0.16322,-0.0045031,0.23652,0.75492,GOBP_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
REACTOME_FORMATION_OF_PARAXI...,SET,63,-0.068836,-0.0040234,0.099732,0.75497,REACTOME_FORMATION_OF_PARAXIAL_MESODERM,1
GOBP_TETRAHYDROFOLATE_INTERC...,SET,9,-0.19667,-0.0043511,0.28491,0.75499,GOBP_TETRAHYDROFOLATE_INTERCONVERSION,1
KEGG_COLORECTAL_CANCER,SET,61,-0.077461,-0.0044553,0.11216,0.75509,KEGG_COLORECTAL_CANCER,1
HP_TRICHORRHEXIS_NODOSA,SET,9,-0.1935,-0.0042811,0.28019,0.75509,HP_TRICHORRHEXIS_NODOSA,1
GOBP_INTESTINAL_CHOLESTEROL_...,SET,17,-0.16152,-0.0049102,0.23386,0.7551,GOBP_INTESTINAL_CHOLESTEROL_ABSORPTION,1
GOMF_CADMIUM_ION_BINDING,SET,5,-0.27855,-0.004594,0.40332,0.7551,GOMF_CADMIUM_ION_BINDING,1
REACTOME_METAL_ION_SLC_TRANS...,SET,23,-0.11924,-0.0042155,0.17263,0.75512,REACTOME_METAL_ION_SLC_TRANSPORTERS,1
GOBP_NUCLEOSIDE_TRANSMEMBRAN...,SET,8,-0.22256,-0.0046426,0.32221,0.75513,GOBP_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_REGULATOR...,SET,15,-0.15198,-0.0043402,0.22002,0.75514,GOBP_REGULATION_OF_REGULATORY_NCRNA_PROCESSING,1
GSE5503_LIVER_DC_VS_MLN_DC_A...1,SET,176,-0.04264,-0.0041527,0.061721,0.75516,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
HP_ERRATIC_MYOCLONUS,SET,4,-0.25914,-0.0038227,0.37505,0.7552,HP_ERRATIC_MYOCLONUS,1
MIR203B_5P,SET,64,-0.074108,-0.0043657,0.10723,0.75525,MIR203B_5P,1
GOBP_RESPONSE_TO_YEAST,SET,6,-0.2815,-0.0050856,0.40732,0.75525,GOBP_RESPONSE_TO_YEAST,1
HP_AMINOACIDURIA,SET,123,-0.053584,-0.004369,0.077526,0.75527,HP_AMINOACIDURIA,1
MIR4707_5P,SET,9,-0.18876,-0.0041762,0.27292,0.75541,MIR4707_5P,1
GSE17974_0H_VS_6H_IN_VITRO_A...1,SET,178,-0.042116,-0.0041247,0.060886,0.75544,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN,1
RASHI_RESPONSE_TO_IONIZING_R...1,SET,36,-0.097521,-0.004312,0.14097,0.75545,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...1,SET,9,-0.1788,-0.0039557,0.25847,0.75545,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY,1
GSE27786_LSK_VS_ERYTHROBLAST...2,SET,178,-0.042892,-0.0042007,0.062003,0.75545,GSE27786_LSK_VS_ERYTHROBLAST_UP,1
GOBP_NEGATIVE_REGULATION_OF_...128,SET,14,-0.16705,-0.004609,0.24148,0.75546,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
HP_ELEVATED_BRAIN_CHOLINE_LE...,SET,8,-0.18783,-0.0039179,0.27149,0.75548,HP_ELEVATED_BRAIN_CHOLINE_LEVEL_BY_MRS,1
HP_IMPAIRED_VIBRATORY_SENSAT...,SET,113,-0.0539,-0.0042135,0.077848,0.75564,HP_IMPAIRED_VIBRATORY_SENSATION,1
HP_PTOSIS,SET,652,-0.022927,-0.004241,0.033108,0.75568,HP_PTOSIS,1
GSE24492_LYVE_NEG_VS_POS_MAC...2,SET,168,-0.044576,-0.0042424,0.064361,0.75571,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP,1
GSE3720_VD1_VS_VD2_GAMMADELT...6,SET,178,-0.045124,-0.0044193,0.06514,0.75575,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP,1
DARWICHE_PAPILLOMA_RISK_LOW_...2,SET,148,-0.049798,-0.0044508,0.071885,0.75576,DARWICHE_PAPILLOMA_RISK_LOW_UP,1
MITSIADES_RESPONSE_TO_APLIDI...1,SET,229,-0.038665,-0.0042891,0.055809,0.75578,MITSIADES_RESPONSE_TO_APLIDIN_DN,1
GOBP_CLATHRIN_COAT_ASSEMBLY,SET,18,-0.13843,-0.0043303,0.1998,0.7558,GOBP_CLATHRIN_COAT_ASSEMBLY,1
GSE14308_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.043982,-0.0043551,0.063478,0.7558,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN,1
GSE24634_TREG_VS_TCONV_POST_...7,SET,186,-0.045197,-0.0045239,0.065228,0.75581,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN,1
GSE15659_RESTING_TREG_VS_NON...2,SET,161,-0.047077,-0.004387,0.067935,0.75583,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP,1
GSE25088_ROSIGLITAZONE_VS_IL...2,SET,180,-0.043774,-0.0043108,0.063161,0.75586,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
GOBP_IMMUNE_RESPONSE_REGULAT...3,SET,478,-0.028178,-0.0044848,0.040647,0.75591,GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...351,SET,26,-0.11118,-0.0041788,0.16038,0.75591,GOBP_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT,1
BOYAULT_LIVER_CANCER_SUBCLAS...13,SET,11,-0.20387,-0.0049862,0.29407,0.75592,BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,1
HP_FEMUR_FRACTURE,SET,5,-0.22512,-0.0037128,0.3245,0.75608,HP_FEMUR_FRACTURE,1
BERENJENO_TRANSFORMED_BY_RHO...3,SET,20,-0.13892,-0.0045803,0.20017,0.75616,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,1
TATTATA_MIR374,SET,265,-0.03866,-0.0046087,0.055701,0.75617,TATTATA_MIR374,1
GOBP_NEGATIVE_REGULATION_OF_...191,SET,10,-0.18404,-0.0042919,0.26511,0.75622,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,1
HP_DISPLACEMENT_OF_THE_URETH...,SET,315,-0.032669,-0.0042402,0.047054,0.75624,HP_DISPLACEMENT_OF_THE_URETHRAL_MEATUS,1
MIR4468,SET,107,-0.057419,-0.0043685,0.082679,0.7563,MIR4468,1
GOBP_POSITIVE_REGULATION_OF_...786,SET,75,-0.072347,-0.0046123,0.10417,0.75631,GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,1
GSE39152_BRAIN_VS_SPLEEN_CD1...2,SET,179,-0.044902,-0.0044098,0.064653,0.75631,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP,1
GOMF_BH3_DOMAIN_BINDING,SET,5,-0.29638,-0.004888,0.42668,0.75635,GOMF_BH3_DOMAIN_BINDING,1
HP_NECROTIZING_ENTEROCOLITIS,SET,6,-0.2325,-0.0042002,0.33464,0.75639,HP_NECROTIZING_ENTEROCOLITIS,1
MIR4521,SET,67,-0.075787,-0.0045676,0.10908,0.7564,MIR4521,1
GOBP_GLYCOLYTIC_PROCESS_THRO...1,SET,19,-0.12429,-0.0039942,0.17888,0.75641,GOBP_GLYCOLYTIC_PROCESS_THROUGH_FRUCTOSE_6_PHOSPHATE,1
GOMF_VASCULAR_ENDOTHELIAL_GR...3,SET,7,-0.27404,-0.0053473,0.39437,0.75643,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_ACTIVITY,1
REACTOME_REGULATION_OF_TP53_...2,SET,28,-0.1093,-0.004263,0.15725,0.75648,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,1
KEGG_MEDICUS_PATHOGEN_ESCHER...6,SET,13,-0.15417,-0.004099,0.22178,0.75652,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_ARP2_3_CO...,SET,18,-0.12532,-0.00392,0.18026,0.75653,GOBP_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
GOBP_SEQUESTERING_OF_METAL_I...,SET,9,-0.2077,-0.0045953,0.29871,0.75657,GOBP_SEQUESTERING_OF_METAL_ION,1
GOBP_POSITIVE_REGULATION_OF_...652,SET,19,-0.1386,-0.004454,0.1993,0.75659,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
HP_HYDROCEPHALUS,SET,351,-0.031373,-0.0042941,0.045114,0.7566,HP_HYDROCEPHALUS,1
MALTA_CURATED_STEMNESS_MARKE...,SET,19,-0.15802,-0.0050784,0.22721,0.75662,MALTA_CURATED_STEMNESS_MARKERS,1
GOBP_EPITHELIAL_TO_MESENCHYM...2,SET,18,-0.16108,-0.0050386,0.23159,0.75664,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,1
AIZARANI_LIVER_C32_MVECS_3,SET,121,-0.058797,-0.0047552,0.084528,0.75665,AIZARANI_LIVER_C32_MVECS_3,1
GSE23505_IL6_IL1_IL23_VS_IL6...2,SET,180,-0.043392,-0.0042733,0.062379,0.75666,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
GSE5589_LPS_VS_LPS_AND_IL10_...10,SET,180,-0.044801,-0.0044121,0.064405,0.75666,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,1
GOMF_THIOLESTER_HYDROLASE_AC...,SET,40,-0.089656,-0.0041782,0.12887,0.75669,GOMF_THIOLESTER_HYDROLASE_ACTIVITY,1
GUTIERREZ_WALDENSTROEMS_MACR...3,SET,10,-0.18643,-0.0043475,0.26794,0.75671,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,1
MIR4713_3P,SET,37,-0.098787,-0.0044281,0.14196,0.75674,MIR4713_3P,1
GSE21360_PRIMARY_VS_QUATERNA...1,SET,180,-0.041844,-0.0041208,0.060131,0.75674,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
GOMF_TRIGLYCERIDE_LIPASE_ACT...,SET,24,-0.14756,-0.005329,0.21203,0.75676,GOMF_TRIGLYCERIDE_LIPASE_ACTIVITY,1
HOXC11_TARGET_GENES,SET,48,-0.080787,-0.0041233,0.11608,0.75678,HOXC11_TARGET_GENES,1
HP_RESTLESS_LEGS,SET,22,-0.12413,-0.0042921,0.17832,0.75681,HP_RESTLESS_LEGS,1
GOBP_ACTIVATION_OF_NF_KAPPAB...,SET,10,-0.19867,-0.004633,0.2853,0.75689,GOBP_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY,1
MIR4635,SET,120,-0.0542,-0.0043653,0.077801,0.75698,MIR4635,1
GSE5542_IFNA_VS_IFNA_AND_IFN...3,SET,173,-0.043082,-0.0041602,0.061797,0.75714,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
MIR939_3P,SET,138,-0.048292,-0.0041689,0.069267,0.75715,MIR939_3P,1
HP_SHORTENED_QT_INTERVAL,SET,13,-0.18468,-0.0049102,0.26489,0.75716,HP_SHORTENED_QT_INTERVAL,1
ZNF214_TARGET_GENES,SET,12,-0.18398,-0.0046997,0.26386,0.75718,ZNF214_TARGET_GENES,1
HP_HIGH_PALATE,SET,672,-0.02306,-0.0043281,0.033071,0.75718,HP_HIGH_PALATE,1
TRAYNOR_RETT_SYNDROM_UP,SET,36,-0.12006,-0.0053084,0.17217,0.75719,TRAYNOR_RETT_SYNDROM_UP,1
REACTOME_CTLA4_INHIBITORY_SI...,SET,21,-0.12973,-0.0043827,0.18601,0.75722,REACTOME_CTLA4_INHIBITORY_SIGNALING,1
GSE37532_WT_VS_PPARG_KO_LN_T...3,SET,107,-0.061117,-0.0046498,0.087624,0.75725,GSE37532_WT_VS_PPARG_KO_LN_TREG_DN,1
GOMF_COPPER_CHAPERONE_ACTIVI...,SET,6,-0.19676,-0.0035545,0.28208,0.75726,GOMF_COPPER_CHAPERONE_ACTIVITY,1
BIOCARTA_GLEEVEC_PATHWAY,SET,23,-0.13647,-0.0048249,0.19561,0.7573,BIOCARTA_GLEEVEC_PATHWAY,1
GOMF_HISTONE_DEACETYLASE_REG...,SET,5,-0.30834,-0.0050852,0.44196,0.7573,GOMF_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY,1
GAVISH_3CA_MALIGNANT_METAPRO...37,SET,37,-0.10155,-0.004552,0.14551,0.75737,GAVISH_3CA_MALIGNANT_METAPROGRAM_7_STRESS_IN_VITRO,1
KEGG_MEDICUS_REFERENCE_NON_C...,SET,6,-0.27588,-0.004984,0.3952,0.75743,KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_RRNA_PROC...,SET,15,-0.1574,-0.0044949,0.22544,0.75746,GOBP_REGULATION_OF_RRNA_PROCESSING,1
GOMF_UBIQUITIN_PROTEIN_TRANS...2,SET,12,-0.18855,-0.0048164,0.26997,0.75753,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_INHIBITOR_ACTIVITY,1
LIU_TOPBP1_TARGETS,SET,12,-0.18067,-0.0046151,0.25867,0.75755,LIU_TOPBP1_TARGETS,1
CHEOK_RESPONSE_TO_HD_MTX_UP,SET,19,-0.1473,-0.0047338,0.21089,0.75756,CHEOK_RESPONSE_TO_HD_MTX_UP,1
TCF1P_Q6,SET,239,-0.039925,-0.0045232,0.057159,0.75756,TCF1P_Q6,1
GOBP_NEGATIVE_REGULATION_OF_...298,SET,7,-0.24016,-0.0046863,0.3438,0.75758,GOBP_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_INTERFERON_RECEPTOR_ACT...,SET,5,-0.30105,-0.004965,0.43092,0.7576,GOMF_INTERFERON_RECEPTOR_ACTIVITY,1
CUI_DEVELOPING_HEART_C1_5TH_...,SET,73,-0.071172,-0.0044767,0.10188,0.7576,CUI_DEVELOPING_HEART_C1_5TH_WEEK_CARDIAC_CELLS,1
REACTOME_NFE2L2_REGULATING_A...,SET,19,-0.14779,-0.0047496,0.21154,0.75761,REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES,1
HP_FETAL_ASCITES,SET,8,-0.23558,-0.0049141,0.3372,0.75761,HP_FETAL_ASCITES,1
KEGG_MEDICUS_VARIANT_LOSS_OF...4,SET,12,-0.18543,-0.0047367,0.2654,0.75762,KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY,1
PLASARI_TGFB1_TARGETS_10HR_DN,SET,235,-0.041914,-0.0047092,0.059985,0.75764,PLASARI_TGFB1_TARGETS_10HR_DN,1
MIR6849_3P,SET,68,-0.068929,-0.0041851,0.098638,0.75766,MIR6849_3P,1
GOBP_HEPATOCYTE_APOPTOTIC_PR...,SET,19,-0.1348,-0.004332,0.1929,0.75766,GOBP_HEPATOCYTE_APOPTOTIC_PROCESS,1
GSE35825_UNTREATED_VS_IFNG_S...2,SET,188,-0.047037,-0.004733,0.0673,0.75769,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP,1
GNF2_PAK2,SET,25,-0.11486,-0.0042336,0.16431,0.75775,GNF2_PAK2,1
WP_NONALCOHOLIC_FATTY_LIVER_...,SET,146,-0.047029,-0.004175,0.067268,0.75776,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1
LEE_METASTASIS_AND_ALTERNATI...2,SET,65,-0.075412,-0.0044769,0.10785,0.75779,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1
MIR4520_5P,SET,6,-0.26914,-0.0048623,0.38491,0.75779,MIR4520_5P,1
HP_PERIPHERAL_CYANOSIS,SET,31,-0.10788,-0.0044269,0.15419,0.75792,HP_PERIPHERAL_CYANOSIS,1
GOBP_REGULATION_OF_PHOSPHOLI...3,SET,5,-0.31957,-0.0052703,0.45671,0.75794,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GSE25123_CTRL_VS_IL4_STIM_MA...2,SET,177,-0.044274,-0.004324,0.063268,0.75796,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP,1
GSE15330_HSC_VS_LYMPHOID_PRI...1,SET,164,-0.048198,-0.0045327,0.068863,0.758,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,1
REACTOME_SIGNALING_BY_NOTCH3,SET,46,-0.086234,-0.0043089,0.1232,0.75801,REACTOME_SIGNALING_BY_NOTCH3,1
MIR450B_5P,SET,421,-0.030178,-0.0045149,0.043111,0.75803,MIR450B_5P,1
IVANOVA_HEMATOPOIESIS_STEM_C...3,SET,201,-0.042949,-0.0044669,0.06135,0.75805,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1
DESCARTES_MAIN_FETAL_SYMPATH...,SET,40,-0.10236,-0.0047704,0.14622,0.75805,DESCARTES_MAIN_FETAL_SYMPATHOBLASTS,1
GOMF_AMIDE_BINDING,SET,231,-0.041183,-0.0045881,0.058809,0.75812,GOMF_AMIDE_BINDING,1
PEDERSEN_TARGETS_OF_611CTF_I...,SET,68,-0.080016,-0.0048582,0.11424,0.75816,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1
GOBP_PROTEIN_LOCALIZATION_TO...20,SET,59,-0.071034,-0.0040183,0.10138,0.75824,GOBP_PROTEIN_LOCALIZATION_TO_CYTOSKELETON,1
MODULE_459,SET,390,-0.030566,-0.0044052,0.043614,0.75829,MODULE_459,1
GOCC_U2_SNRNP,SET,22,-0.11747,-0.004062,0.16761,0.7583,GOCC_U2_SNRNP,1
GOBP_ANTIMICROBIAL_HUMORAL_R...,SET,128,-0.063743,-0.0053011,0.090904,0.75841,GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE,1
GOBP_REGULATION_OF_MESENCHYM...3,SET,7,-0.2725,-0.0053173,0.38861,0.75841,GOBP_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,1
PLASARI_TGFB1_SIGNALING_VIA_...3,SET,99,-0.061947,-0.0045344,0.088334,0.75843,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,1
FULLER_PBMC_F_TULARENSIS_VAC...1,SET,19,-0.14657,-0.0047104,0.209,0.75844,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_DN,1
MA_MYELOID_DIFFERENTIATION_UP,SET,37,-0.099975,-0.0044813,0.14251,0.75851,MA_MYELOID_DIFFERENTIATION_UP,1
GOMF_PRE_MIRNA_BINDING,SET,9,-0.2021,-0.0044712,0.28803,0.75855,GOMF_PRE_MIRNA_BINDING,1
GOMF_CHEMOKINE_ACTIVITY,SET,45,-0.11107,-0.0054893,0.15826,0.75859,GOMF_CHEMOKINE_ACTIVITY,1
GOBP_3_UTR_MEDIATED_MRNA_STA...,SET,19,-0.13917,-0.0044726,0.19828,0.75863,GOBP_3_UTR_MEDIATED_MRNA_STABILIZATION,1
BIOCARTA_MALATEX_PATHWAY,SET,7,-0.22939,-0.004476,0.32679,0.75864,BIOCARTA_MALATEX_PATHWAY,1
WANG_SMARCE1_TARGETS_DN,SET,322,-0.034494,-0.0045257,0.04913,0.75869,WANG_SMARCE1_TARGETS_DN,1
MIR6846_3P,SET,23,-0.12062,-0.0042644,0.17177,0.75872,MIR6846_3P,1
HP_REDUCED_ATTENTION_REGULAT...,SET,439,-0.029444,-0.004496,0.04193,0.75872,HP_REDUCED_ATTENTION_REGULATION,1
HP_MATERNAL_HYPERTENSION,SET,7,-0.24276,-0.0047369,0.34569,0.75873,HP_MATERNAL_HYPERTENSION,1
GOMF_GALACTOSYLTRANSFERASE_A...,SET,32,-0.1152,-0.004803,0.16401,0.75878,GOMF_GALACTOSYLTRANSFERASE_ACTIVITY,1
GSE36009_WT_VS_NLRP10_KO_DC_...2,SET,180,-0.042938,-0.0042286,0.061118,0.75883,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN,1
GSE13306_RA_VS_UNTREATED_TRE...2,SET,173,-0.044825,-0.0043286,0.063792,0.75887,GSE13306_RA_VS_UNTREATED_TREG_UP,1
WP_AMINO_ACID_TRANSPORT_DEFE...,SET,8,-0.21436,-0.0044713,0.30499,0.75891,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,1
MIR219A_1_3P,SET,55,-0.078491,-0.0042875,0.11168,0.75891,MIR219A_1_3P,1
HP_GLIOSIS,SET,89,-0.061615,-0.0042774,0.087661,0.75893,HP_GLIOSIS,1
HP_MEGALOCORNEA,SET,42,-0.10633,-0.0050771,0.15124,0.75898,HP_MEGALOCORNEA,1
WP_NEURAL_CREST_CELL_MIGRATI...1,SET,37,-0.10805,-0.0048434,0.15369,0.75899,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1
REACTOME_SHC1_EVENTS_IN_ERBB...1,SET,22,-0.12418,-0.0042939,0.1766,0.75901,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,1
KAECH_DAY15_EFF_VS_MEMORY_CD...1,SET,182,-0.044872,-0.0044433,0.063818,0.75901,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN,1
GSE2770_IL12_AND_TGFB_ACT_VS...5,SET,181,-0.043566,-0.0043021,0.061946,0.75906,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN,1
GOBP_SYMBIONT_ENTRY_INTO_HOST,SET,154,-0.051265,-0.0046731,0.072879,0.7591,GOBP_SYMBIONT_ENTRY_INTO_HOST,1
REACTOME_SYNTHESIS_SECRETION...2,SET,20,-0.14819,-0.0048859,0.21061,0.75916,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1,1
GOBP_RESPONSE_TO_ALKALOID,SET,97,-0.062682,-0.0045418,0.089086,0.75916,GOBP_RESPONSE_TO_ALKALOID,1
KEGG_MEDICUS_REFERENCE_TNFSF...,SET,5,-0.30725,-0.0050672,0.4366,0.75919,KEGG_MEDICUS_REFERENCE_TNFSF10_RIPK1_3_SIGNALING_PATHWAY,1
GSE7852_TREG_VS_TCONV_LN_UP,SET,177,-0.046997,-0.0045899,0.066783,0.7592,GSE7852_TREG_VS_TCONV_LN_UP,1
chr10p13,SET,28,-0.19,-0.0074107,0.26995,0.75923,chr10p13,1
GAVISH_3CA_METAPROGRAM_FIBRO...9,SET,48,-0.094899,-0.0048436,0.13483,0.75923,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8,1
GSE13522_WT_VS_IFNG_KO_SKING...1,SET,110,-0.05628,-0.004341,0.07996,0.75923,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,1
GOBP_NEGATIVE_REGULATION_OF_...301,SET,13,-0.16871,-0.0044855,0.23968,0.75925,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,1
IVANOVA_HEMATOPOIESIS_INTERM...,SET,123,-0.051826,-0.0042256,0.073622,0.75926,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,1
GOBP_POSITIVE_REGULATION_OF_...441,SET,5,-0.26606,-0.0043878,0.37795,0.75926,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION,1
WP_NONHOMOLOGOUS_END_JOINING,SET,10,-0.14978,-0.0034929,0.21275,0.75929,WP_NONHOMOLOGOUS_END_JOINING,1
HP_ABNORMAL_FEMALE_MEIOSIS,SET,6,-0.24857,-0.0044907,0.35297,0.75935,HP_ABNORMAL_FEMALE_MEIOSIS,1
DLX6_TARGET_GENES,SET,451,-0.027687,-0.0042837,0.03931,0.75938,DLX6_TARGET_GENES,1
GOCC_PHAGOCYTIC_VESICLE,SET,126,-0.053537,-0.0044177,0.07601,0.75939,GOCC_PHAGOCYTIC_VESICLE,1
GOMF_HISTONE_H3K14_ACETYLTRA...,SET,9,-0.20456,-0.0045256,0.29028,0.75949,GOMF_HISTONE_H3K14_ACETYLTRANSFERASE_ACTIVITY,1
HP_CONGENITAL_ABNORMAL_HAIR_...,SET,272,-0.035995,-0.0043465,0.051073,0.75952,HP_CONGENITAL_ABNORMAL_HAIR_PATTERN,1
MODULE_360,SET,12,-0.18716,-0.0047809,0.26553,0.75954,MODULE_360,1
HP_HYPOAMYLASEMIA,SET,4,-0.25513,-0.0037635,0.36175,0.75967,HP_HYPOAMYLASEMIA,1
HP_INFANTILE_MUSCULAR_HYPOTO...,SET,177,-0.046517,-0.0045431,0.065958,0.75967,HP_INFANTILE_MUSCULAR_HYPOTONIA,1
MODULE_81,SET,18,-0.1376,-0.0043043,0.19505,0.75974,MODULE_81,1
GNF2_RAB7L1,SET,31,-0.10546,-0.0043276,0.14948,0.75975,GNF2_RAB7L1,1
MARTINELLI_IMMATURE_NEUTROPH...1,SET,13,-0.20101,-0.0053443,0.28482,0.75982,MARTINELLI_IMMATURE_NEUTROPHIL_DN,1
HP_SPARSE_LATERAL_EYEBROW,SET,30,-0.10569,-0.0042666,0.14973,0.75985,HP_SPARSE_LATERAL_EYEBROW,1
BROWNE_HCMV_INFECTION_48HR_DN,SET,425,-0.029539,-0.0044398,0.041842,0.7599,BROWNE_HCMV_INFECTION_48HR_DN,1
HP_ASTHMA,SET,150,-0.049925,-0.004492,0.07071,0.75992,HP_ASTHMA,1
HP_NARROW_FOOT,SET,4,-0.31202,-0.0046028,0.44192,0.75992,HP_NARROW_FOOT,1
MIR2115_3P,SET,215,-0.042121,-0.0045292,0.059643,0.75997,MIR2115_3P,1
GAVISH_3CA_METAPROGRAM_EPITH...1,SET,48,-0.095295,-0.0048638,0.13494,0.75997,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR,1
GOBP_MICROTUBULE_ANCHORING_A...,SET,13,-0.16093,-0.0042788,0.22787,0.75998,GOBP_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER,1
GOBP_NEURON_PROJECTION_EXTEN...1,SET,149,-0.050822,-0.0045575,0.071945,0.76002,GOBP_NEURON_PROJECTION_EXTENSION,1
LANDIS_ERBB2_BREAST_TUMORS_6...2,SET,22,-0.13446,-0.0046493,0.19028,0.7601,LANDIS_ERBB2_BREAST_TUMORS_65_UP,1
GOBP_PHOSPHATIDYLINOSITOL_3_...1,SET,275,-0.038509,-0.0046753,0.054497,0.7601,GOBP_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
GOMF_METALLOCHAPERONE_ACTIVI...,SET,12,-0.16025,-0.0040936,0.22678,0.7601,GOMF_METALLOCHAPERONE_ACTIVITY,1
GOBP_PROTEIN_LOCALIZATION_TO...32,SET,117,-0.054908,-0.0043671,0.077694,0.76013,GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
GOMF_ADENYL_NUCLEOTIDE_EXCHA...,SET,15,-0.13638,-0.0038947,0.19295,0.76016,GOMF_ADENYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
GSE37532_TREG_VS_TCONV_CD4_T...3,SET,149,-0.046713,-0.0041891,0.066065,0.76024,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,1
MIR154_5P,SET,61,-0.081962,-0.0047142,0.1159,0.76027,MIR154_5P,1
GOMF_INSULIN_LIKE_GROWTH_FAC...4,SET,16,-0.17383,-0.0051269,0.24578,0.76029,GOMF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING,1
HP_THIN_SKIN,SET,83,-0.064716,-0.0043393,0.091499,0.7603,HP_THIN_SKIN,1
GOBP_DENDRITIC_CELL_CHEMOTAX...,SET,24,-0.13073,-0.004721,0.18479,0.76035,GOBP_DENDRITIC_CELL_CHEMOTAXIS,1
GOMF_MUSCLE_ALPHA_ACTININ_BI...,SET,15,-0.16995,-0.0048532,0.2402,0.76038,GOMF_MUSCLE_ALPHA_ACTININ_BINDING,1
HP_IRREGULAR_FEMORAL_EPIPHYS...,SET,8,-0.20752,-0.0043288,0.29329,0.76039,HP_IRREGULAR_FEMORAL_EPIPHYSIS,1
GOMF_PROTEIN_PRENYLTRANSFERA...,SET,6,-0.22727,-0.0041058,0.32112,0.76045,GOMF_PROTEIN_PRENYLTRANSFERASE_ACTIVITY,1
GSE339_CD4POS_VS_CD4CD8DN_DC...1,SET,179,-0.045355,-0.0044543,0.064081,0.76045,GSE339_CD4POS_VS_CD4CD8DN_DC_DN,1
GOBP_RNA_MODIFICATION,SET,145,-0.046588,-0.0041218,0.06582,0.76046,GOBP_RNA_MODIFICATION,1
HP_SPARSE_EYEBROW,SET,121,-0.053259,-0.0043073,0.075244,0.76047,HP_SPARSE_EYEBROW,1
HP_CHOLANGITIS,SET,18,-0.1479,-0.0046264,0.20894,0.76048,HP_CHOLANGITIS,1
BENITEZ_GBM_PROTEASOME_INHIB...,SET,45,-0.092544,-0.0045737,0.13072,0.7605,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,1
GOBP_OTIC_VESICLE_DEVELOPMENT,SET,14,-0.15572,-0.0042963,0.21996,0.76051,GOBP_OTIC_VESICLE_DEVELOPMENT,1
GSE7568_CTRL_VS_3H_TGFB_TREA...2,SET,139,-0.054301,-0.0047045,0.076702,0.76051,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,1
GSE7764_IL15_NK_CELL_24H_VS_...1,SET,176,-0.045657,-0.0044466,0.064459,0.76062,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN,1
HP_ABNORMAL_SWEAT_HOMEOSTASIS,SET,28,-0.12521,-0.0048836,0.17676,0.76064,HP_ABNORMAL_SWEAT_HOMEOSTASIS,1
MORI_IMMATURE_B_LYMPHOCYTE_UP,SET,46,-0.095626,-0.0047782,0.13497,0.76068,MORI_IMMATURE_B_LYMPHOCYTE_UP,1
ACCAATC_MIR509,SET,45,-0.10359,-0.0051196,0.14619,0.7607,ACCAATC_MIR509,1
GOBP_POSITIVE_REGULATION_OF_...530,SET,15,-0.15603,-0.0044559,0.22015,0.76076,GOBP_POSITIVE_REGULATION_OF_NEURON_MIGRATION,1
GOBP_NEGATIVE_REGULATION_OF_...422,SET,9,-0.19133,-0.004233,0.26987,0.76083,GOBP_NEGATIVE_REGULATION_OF_MYELINATION,1
GOBP_GMP_SALVAGE,SET,4,-0.29214,-0.0043095,0.4119,0.76092,GOBP_GMP_SALVAGE,1
HP_BILATERAL_PTOSIS,SET,63,-0.077708,-0.0045419,0.10956,0.76092,HP_BILATERAL_PTOSIS,1
VILIMAS_NOTCH1_TARGETS_DN,SET,24,-0.13956,-0.0050402,0.19675,0.76094,VILIMAS_NOTCH1_TARGETS_DN,1
GAVISH_3CA_METAPROGRAM_FIBRO...19,SET,49,-0.093564,-0.0048248,0.13183,0.76106,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MYOFIBROBLASTS,1
MODULE_305,SET,19,-0.14033,-0.0045099,0.19771,0.76108,MODULE_305,1
HP_ABNORMAL_BLOOD_ION_CONCEN...,SET,321,-0.035587,-0.0046619,0.050136,0.76108,HP_ABNORMAL_BLOOD_ION_CONCENTRATION,1
MIKKELSEN_NPC_ICP_WITH_H3K27...,SET,11,-0.21508,-0.0052603,0.30282,0.76122,MIKKELSEN_NPC_ICP_WITH_H3K27ME3,1
HP_EARLY_YOUNG_ADULT_ONSET,SET,57,-0.080885,-0.0044976,0.11387,0.76124,HP_EARLY_YOUNG_ADULT_ONSET,1
MIR6744_3P,SET,56,-0.082879,-0.004568,0.11667,0.76126,MIR6744_3P,1
HP_HYPOPLASTIC_HIPPOCAMPUS,SET,16,-0.14942,-0.0044068,0.21034,0.76126,HP_HYPOPLASTIC_HIPPOCAMPUS,1
SNACANNNYSYAGA_UNKNOWN,SET,79,-0.06605,-0.0043212,0.09297,0.76128,SNACANNNYSYAGA_UNKNOWN,1
HP_PREMATURE_CORONARY_ARTERY...,SET,19,-0.15772,-0.0050685,0.22197,0.76131,HP_PREMATURE_CORONARY_ARTERY_ATHEROSCLEROSIS,1
GSE16385_ROSIGLITAZONE_IFNG_...2,SET,185,-0.04503,-0.0044951,0.063371,0.76132,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,1
HP_ABNORMAL_CIRCULATING_GONA...,SET,110,-0.058344,-0.0045003,0.082103,0.76133,HP_ABNORMAL_CIRCULATING_GONADOTROPIN_CONCENTRATION,1
HP_RESPIRATORY_INSUFFICIENCY...,SET,5,-0.24525,-0.0040448,0.34511,0.76135,HP_RESPIRATORY_INSUFFICIENCY_DUE_TO_DEFECTIVE_CILIARY_CLEARANCE,1
HP_DROWSINESS,SET,52,-0.081164,-0.0043112,0.11415,0.76147,HP_DROWSINESS,1
GOBP_POSITIVE_REGULATION_OF_...320,SET,8,-0.25398,-0.0052978,0.35715,0.76149,GOBP_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION,1
KEGG_MEDICUS_VARIANT_MUTATIO...13,SET,9,-0.1915,-0.0042367,0.26928,0.7615,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY,1
BIOCARTA_CTLA4_PATHWAY,SET,17,-0.15368,-0.004672,0.21605,0.76156,BIOCARTA_CTLA4_PATHWAY,1
YANG_BREAST_CANCER_ESR1_DN,SET,21,-0.14694,-0.0049641,0.20654,0.76158,YANG_BREAST_CANCER_ESR1_DN,1
REACTOME_SYNTHESIS_OF_16_20_...,SET,9,-0.21272,-0.0047062,0.29901,0.76158,REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE,1
GSE9988_LOW_LPS_VS_VEHICLE_T...1,SET,183,-0.044715,-0.0044397,0.062845,0.76161,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,1
HP_ABNORMALITY_OF_THE_METOPI...,SET,80,-0.0675,-0.0044438,0.094856,0.76164,HP_ABNORMALITY_OF_THE_METOPIC_SUTURE,1
HP_KINKED_BRAINSTEM,SET,4,-0.27789,-0.0040993,0.39041,0.7617,HP_KINKED_BRAINSTEM,1
HP_MENINGOENCEPHALOCELE,SET,4,-0.27789,-0.0040993,0.39041,0.7617,HP_MENINGOENCEPHALOCELE,1
GOBP_SULFUR_COMPOUND_CATABOL...,SET,40,-0.098298,-0.0045809,0.13809,0.76172,GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS,1
WP_HYPOTHESIZED_PATHWAYS_IN_...,SET,23,-0.13316,-0.0047079,0.18698,0.76182,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,1
GOBP_MEMBRANE_LIPID_METABOLI...,SET,203,-0.043701,-0.0045675,0.061354,0.76185,GOBP_MEMBRANE_LIPID_METABOLIC_PROCESS,1
HP_PES_VALGUS,SET,48,-0.092246,-0.0047081,0.1295,0.76186,HP_PES_VALGUS,1
GAVISH_3CA_METAPROGRAM_CD8_T...9,SET,40,-0.098915,-0.0046097,0.13886,0.76187,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_2,1
HP_CERVICAL_SUBLUXATION,SET,8,-0.21549,-0.0044951,0.30252,0.76187,HP_CERVICAL_SUBLUXATION,1
GSE14769_UNSTIM_VS_240MIN_LP...2,SET,181,-0.043585,-0.0043041,0.061169,0.76193,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP,1
HP_INCREASED_SERUM_SEROTONIN,SET,9,-0.18722,-0.004142,0.26267,0.76199,HP_INCREASED_SERUM_SEROTONIN,1
TRAVAGLINI_LUNG_B_CELL,SET,142,-0.052458,-0.0045933,0.07359,0.76202,TRAVAGLINI_LUNG_B_CELL,1
BIOCARTA_SODD_PATHWAY,SET,10,-0.18806,-0.0043857,0.26378,0.76206,BIOCARTA_SODD_PATHWAY,1
NAB2_TARGET_GENES,SET,1208,-0.018103,-0.0044862,0.025392,0.76206,NAB2_TARGET_GENES,1
ZNF329_TARGET_GENES,SET,439,-0.028963,-0.0044226,0.040618,0.76209,ZNF329_TARGET_GENES,1
HP_CONGENITAL_HEPATIC_FIBROS...,SET,42,-0.089217,-0.0042602,0.12512,0.76209,HP_CONGENITAL_HEPATIC_FIBROSIS,1
GOBP_REGULATION_OF_MALE_GONA...,SET,8,-0.24716,-0.0051555,0.34656,0.76212,GOBP_REGULATION_OF_MALE_GONAD_DEVELOPMENT,1
HP_DELAYED_ABILITY_TO_ROLL_O...,SET,14,-0.14356,-0.0039608,0.20131,0.76212,HP_DELAYED_ABILITY_TO_ROLL_OVER,1
GAO_LARGE_INTESTINE_24W_C5_L...,SET,50,-0.091339,-0.0047577,0.12808,0.76212,GAO_LARGE_INTESTINE_24W_C5_LGR5POS_STEM_CELL,1
HP_AIRWAY_OBSTRUCTION,SET,115,-0.058345,-0.0046009,0.081808,0.76213,HP_AIRWAY_OBSTRUCTION,1
GOBP_DOUBLE_STRAND_BREAK_REP...1,SET,272,-0.035414,-0.0042763,0.049652,0.76215,GOBP_DOUBLE_STRAND_BREAK_REPAIR,1
GOCC_AXON_CYTOPLASM,SET,61,-0.079517,-0.0045735,0.11148,0.76217,GOCC_AXON_CYTOPLASM,1
GOBP_PROTEIN_HEXAMERIZATION,SET,8,-0.2118,-0.004418,0.29688,0.7622,GOBP_PROTEIN_HEXAMERIZATION,1
GSE3982_BCELL_VS_TH2_DN,SET,173,-0.046066,-0.0044483,0.064564,0.76222,GSE3982_BCELL_VS_TH2_DN,1
DESCARTES_FETAL_HEART_SMOOTH...,SET,36,-0.11137,-0.0049244,0.15606,0.76227,DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS,1
KEGG_NUCLEOTIDE_EXCISION_REP...,SET,40,-0.083605,-0.0038962,0.11714,0.76229,KEGG_NUCLEOTIDE_EXCISION_REPAIR,1
OKUMURA_INFLAMMATORY_RESPONS...,SET,157,-0.049107,-0.0045194,0.068775,0.76239,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1
GSE360_L_MAJOR_VS_B_MALAYI_H...3,SET,183,-0.042898,-0.0042593,0.060075,0.76241,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
GOCC_RESPIRASOME,SET,82,-0.059673,-0.0039771,0.083546,0.76246,GOCC_RESPIRASOME,1
AR_02,SET,34,-0.10452,-0.0044914,0.14632,0.76248,AR_02,1
GOBP_ESTABLISHMENT_OF_EPITHE...2,SET,32,-0.11186,-0.0046636,0.1566,0.76248,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY,1
HP_INTELLECTUAL_DISABILITY_B...,SET,24,-0.1304,-0.0047094,0.18256,0.76248,HP_INTELLECTUAL_DISABILITY_BORDERLINE,1
GOBP_AXONAL_FASCICULATION,SET,20,-0.15133,-0.0049893,0.21184,0.76249,GOBP_AXONAL_FASCICULATION,1
HP_NEURAL_TUBE_DEFECT,SET,271,-0.037343,-0.0045011,0.052273,0.7625,HP_NEURAL_TUBE_DEFECT,1
KYNG_ENVIRONMENTAL_STRESS_RE...6,SET,23,-0.12247,-0.0043298,0.17138,0.76256,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,1
GOBP_REGULATION_OF_CELL_ADHE...1,SET,737,-0.02403,-0.0047147,0.033627,0.76257,GOBP_REGULATION_OF_CELL_ADHESION,1
HP_ABNORMALITY_OF_VITAMIN_B_...,SET,41,-0.096865,-0.0045701,0.13554,0.76259,HP_ABNORMALITY_OF_VITAMIN_B_METABOLISM,1
DESCARTES_FETAL_LUNG_BRONCHI...,SET,48,-0.10052,-0.0051303,0.14059,0.76268,DESCARTES_FETAL_LUNG_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,1
MIR1268A_MIR1268B,SET,7,-0.25034,-0.0048847,0.35011,0.7627,MIR1268A_MIR1268B,1
GOBP_ORGAN_OR_TISSUE_SPECIFI...,SET,26,-0.13672,-0.0051387,0.19118,0.76272,GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE,1
HE_LIM_SUN_FETAL_LUNG_C3_ART...,SET,259,-0.041004,-0.0048333,0.057338,0.76273,HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL,1
GSE39820_CTRL_VS_IL1B_IL6_CD...2,SET,171,-0.047368,-0.0045478,0.066202,0.76284,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...656,SET,57,-0.087604,-0.0048712,0.12239,0.76292,GOBP_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,1
LEE_METASTASIS_AND_RNA_PROCE...,SET,16,-0.13473,-0.0039735,0.18822,0.76294,LEE_METASTASIS_AND_RNA_PROCESSING_UP,1
GOMF_LIPOPROTEIN_LIPASE_ACTI...,SET,9,-0.24913,-0.0055118,0.34803,0.76295,GOMF_LIPOPROTEIN_LIPASE_ACTIVITY,1
HP_OSTEOCHONDROSIS,SET,12,-0.18802,-0.0048028,0.26265,0.76295,HP_OSTEOCHONDROSIS,1
GOBP_REGULATION_OF_MITOCHOND...4,SET,5,-0.24567,-0.0040516,0.34314,0.76298,GOBP_REGULATION_OF_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,1
SETD1A_TARGET_GENES,SET,1214,-0.017966,-0.0044624,0.025091,0.76301,SETD1A_TARGET_GENES,1
HP_MEDULLARY_NEPHROCALCINOSIS,SET,10,-0.2172,-0.0050651,0.30331,0.76303,HP_MEDULLARY_NEPHROCALCINOSIS,1
GSE21670_STAT3_KO_VS_WT_CD4_...3,SET,178,-0.047123,-0.0046151,0.06579,0.76308,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP,1
GSE32164_RESTING_DIFFERENTIA...3,SET,188,-0.044651,-0.0044929,0.062336,0.76309,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN,1
T3R_Q6,SET,230,-0.040758,-0.004531,0.056899,0.7631,T3R_Q6,1
HP_PARALYSIS,SET,146,-0.05119,-0.0045444,0.071448,0.76314,HP_PARALYSIS,1
GOBP_REGULATION_OF_PROTEIN_D...4,SET,9,-0.18682,-0.0041332,0.26074,0.76315,GOBP_REGULATION_OF_PROTEIN_DEUBIQUITINATION,1
PGF_UP.V1_DN,SET,174,-0.046869,-0.0045389,0.065413,0.76316,PGF_UP.V1_DN,1
HP_ABNORMAL_ORAL_MUCOSA_MORP...,SET,336,-0.035426,-0.0047461,0.049434,0.76319,HP_ABNORMAL_ORAL_MUCOSA_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...100,SET,33,-0.11462,-0.0048526,0.15994,0.7632,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOBP_VENTRICULAR_SYSTEM_DEVE...,SET,30,-0.10481,-0.0042313,0.14623,0.76324,GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT,1
GOBP_DICARBOXYLIC_ACID_TRANS...,SET,99,-0.06478,-0.0047418,0.090364,0.76327,GOBP_DICARBOXYLIC_ACID_TRANSPORT,1
BIOCARTA_IGF1R_PATHWAY,SET,23,-0.13247,-0.0046835,0.18475,0.76331,BIOCARTA_IGF1R_PATHWAY,1
GOBP_MONOTERPENOID_METABOLIC...,SET,6,-0.22274,-0.004024,0.31066,0.76331,GOBP_MONOTERPENOID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_ESTABLISH...5,SET,5,-0.28636,-0.0047226,0.39937,0.76331,GOBP_REGULATION_OF_ESTABLISHMENT_OF_T_CELL_POLARITY,1
HP_APLASIA_OF_THE_DISTAL_PHA...,SET,5,-0.24011,-0.0039599,0.33481,0.76335,HP_APLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,1
GSE17721_POLYIC_VS_CPG_6H_BM...2,SET,185,-0.043795,-0.0043719,0.061067,0.76336,GSE17721_POLYIC_VS_CPG_6H_BMDC_UP,1
HP_DEVIATION_OF_THE_HALLUX,SET,75,-0.078479,-0.0050032,0.10942,0.76339,HP_DEVIATION_OF_THE_HALLUX,1
GOBP_METANEPHRIC_TUBULE_DEVE...,SET,23,-0.1451,-0.00513,0.20229,0.7634,GOBP_METANEPHRIC_TUBULE_DEVELOPMENT,1
HP_CEREBRAL_INFARCT,SET,35,-0.10637,-0.0046375,0.14827,0.76342,HP_CEREBRAL_INFARCT,1
HP_ICHTHYOSIS,SET,123,-0.056063,-0.0045711,0.078144,0.76344,HP_ICHTHYOSIS,1
ANDERSEN_LIVER_CANCER_KRT19_...1,SET,70,-0.076537,-0.0047146,0.10661,0.76359,ANDERSEN_LIVER_CANCER_KRT19_DN,1
HP_INTERRUPTED_INFERIOR_VENA...,SET,5,-0.21849,-0.0036033,0.30433,0.76359,HP_INTERRUPTED_INFERIOR_VENA_CAVA_WITH_AZYGOUS_CONTINUATION,1
GOBP_TACHYKININ_RECEPTOR_SIG...,SET,7,-0.23277,-0.004542,0.32404,0.76372,GOBP_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY,1
MORF_TERF1,SET,61,-0.074036,-0.0042583,0.10306,0.76374,MORF_TERF1,1
HP_SPASTIC_DYSARTHRIA,SET,22,-0.12079,-0.0041766,0.16811,0.76377,HP_SPASTIC_DYSARTHRIA,1
HE_LIM_SUN_FETAL_LUNG_C5_CD5...2,SET,142,-0.053945,-0.0047235,0.075065,0.76382,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_NEG_MATURE_B_CELL,1
GSE7852_LN_VS_FAT_TCONV_UP,SET,180,-0.044772,-0.0044092,0.062248,0.76401,GSE7852_LN_VS_FAT_TCONV_UP,1
GOBP_POSITIVE_REGULATION_OF_...328,SET,10,-0.21677,-0.005055,0.30134,0.76403,GOBP_POSITIVE_REGULATION_OF_HEAT_GENERATION,1
GAUTAM_EYE_CORNEA_MONOCYTES,SET,218,-0.040001,-0.0043307,0.055601,0.76406,GAUTAM_EYE_CORNEA_MONOCYTES,1
GSE42021_CD24HI_VS_CD24INT_T...4,SET,180,-0.046225,-0.0045523,0.064222,0.76416,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP,1
WONG_MITOCHONDRIA_GENE_MODULE,SET,191,-0.041471,-0.0042057,0.057614,0.76417,WONG_MITOCHONDRIA_GENE_MODULE,1
GOBP_CENTROSOME_DUPLICATION,SET,71,-0.068705,-0.0042622,0.09545,0.76417,GOBP_CENTROSOME_DUPLICATION,1
SEKI_INFLAMMATORY_RESPONSE_L...2,SET,72,-0.082121,-0.00513,0.11409,0.76418,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1
STAT3_01,SET,21,-0.13306,-0.0044954,0.18479,0.76425,STAT3_01,1
GOMF_EXTRACELLULARLY_ATP_GAT...,SET,7,-0.24926,-0.0048636,0.34611,0.76428,GOMF_EXTRACELLULARLY_ATP_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
GSE15271_CXCR4_POS_VS_NEG_GC...1,SET,164,-0.048571,-0.0045677,0.067422,0.76435,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN,1
KEGG_NOD_LIKE_RECEPTOR_SIGNA...,SET,57,-0.08236,-0.0045796,0.11432,0.76436,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_PHOSPHATIDYLINOSITOL_TR...2,SET,8,-0.18875,-0.0039372,0.26196,0.7644,GOMF_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,1
GOMF_OXO_ACID_LYASE_ACTIVITY,SET,7,-0.23042,-0.0044962,0.31962,0.76452,GOMF_OXO_ACID_LYASE_ACTIVITY,1
HP_NODULAR_GOITER,SET,11,-0.20216,-0.0049445,0.28035,0.76458,HP_NODULAR_GOITER,1
KEGG_MEDICUS_REFERENCE_FE_TF...,SET,7,-0.24197,-0.0047215,0.33553,0.76459,KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...119,SET,29,-0.11767,-0.0046704,0.16315,0.76461,GOBP_NEGATIVE_REGULATION_OF_CELL_KILLING,1
GOCC_PROTEASOME_CORE_COMPLEX...1,SET,8,-0.19612,-0.0040909,0.27189,0.76463,GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX,1
HP_MISSING_RIBS,SET,60,-0.07865,-0.0044866,0.10904,0.76463,HP_MISSING_RIBS,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,SET,132,-0.054116,-0.0045698,0.075022,0.76464,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1
GOBP_DNA_TEMPLATED_TRANSCRIP...3,SET,20,-0.15598,-0.0051429,0.21622,0.76467,GOBP_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION,1
SANA_RESPONSE_TO_IFNG_UP,SET,68,-0.07532,-0.0045731,0.10437,0.76476,SANA_RESPONSE_TO_IFNG_UP,1
GOBP_RESPONSE_TO_CATECHOLAMI...,SET,55,-0.090083,-0.0049207,0.1248,0.76479,GOBP_RESPONSE_TO_CATECHOLAMINE,1
GSE36392_TYPE_2_MYELOID_VS_E...1,SET,176,-0.047253,-0.004602,0.06545,0.76484,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN,1
STEARMAN_TUMOR_FIELD_EFFECT_...,SET,35,-0.10814,-0.0047149,0.14975,0.76489,STEARMAN_TUMOR_FIELD_EFFECT_UP,1
GSE13547_WT_VS_ZFX_KO_BCELL_...1,SET,142,-0.0513,-0.0044919,0.071037,0.7649,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN,1
DESCARTES_FETAL_STOMACH_STRO...,SET,42,-0.10503,-0.0050153,0.14543,0.76491,DESCARTES_FETAL_STOMACH_STROMAL_CELLS,1
GSE17721_CTRL_VS_GARDIQUIMOD...4,SET,180,-0.045763,-0.0045068,0.063356,0.76494,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP,1
GOBP_REGULATION_OF_NEUROTRAN...5,SET,17,-0.14909,-0.0045324,0.2064,0.76495,GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,1
THAKAR_PBMC_INACTIVATED_INFL...3,SET,66,-0.074994,-0.0044861,0.10382,0.76495,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN,1
WANG_RESPONSE_TO_BEXAROTENE_...1,SET,28,-0.12167,-0.0047457,0.16843,0.76497,WANG_RESPONSE_TO_BEXAROTENE_DN,1
GSE9650_GP33_VS_GP276_LCMV_S...2,SET,180,-0.047362,-0.0046642,0.065559,0.76498,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP,1
MIR4330,SET,82,-0.067458,-0.004496,0.093372,0.76499,MIR4330,1
WP_UREA_CYCLE_AND_METABOLISM...,SET,18,-0.13921,-0.0043546,0.1926,0.7651,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,1
GOBP_CLATHRIN_COATED_VESICLE...,SET,7,-0.22688,-0.0044271,0.31374,0.7652,GOBP_CLATHRIN_COATED_VESICLE_CARGO_LOADING,1
SCHERER_PBMC_YF_VAX_AGE_18_4...3,SET,17,-0.1585,-0.0048186,0.21918,0.76521,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_DN,1
REACTOME_COPI_DEPENDENT_GOLG...,SET,95,-0.057382,-0.0041149,0.079336,0.76524,REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1
GOBP_CELLULAR_RESPONSE_TO_AL...3,SET,7,-0.26055,-0.005084,0.36024,0.76524,GOBP_CELLULAR_RESPONSE_TO_ALDOSTERONE,1
HP_GENERALIZED_NEONATAL_HYPO...,SET,18,-0.13653,-0.0042707,0.18876,0.76525,HP_GENERALIZED_NEONATAL_HYPOTONIA,1
GSE17721_CTRL_VS_PAM3CSK4_12...1,SET,185,-0.045478,-0.0045398,0.062862,0.76529,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN,1
GAO_LARGE_INTESTINE_ADULT_CG...,SET,42,-0.10525,-0.0050259,0.14549,0.76529,GAO_LARGE_INTESTINE_ADULT_CG_GOBLET_CELL_SUBTYPE_2,1
HP_CHRONIC_CONSTIPATION,SET,90,-0.067608,-0.0047196,0.09345,0.7653,HP_CHRONIC_CONSTIPATION,1
MIR3188,SET,72,-0.070371,-0.004396,0.097256,0.76533,MIR3188,1
GOBP_BENZENE_CONTAINING_COMP...,SET,23,-0.14107,-0.0049874,0.19495,0.76534,GOBP_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
MIR3153,SET,190,-0.04548,-0.0046004,0.062849,0.76535,MIR3153,1
HP_MULTICYSTIC_KIDNEY_DYSPLA...,SET,82,-0.066441,-0.0044282,0.091814,0.76536,HP_MULTICYSTIC_KIDNEY_DYSPLASIA,1
MEISSNER_BRAIN_HCP_WITH_H3_U...,SET,31,-0.11206,-0.0045985,0.15484,0.76537,MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,1
GSE11057_CD4_CENT_MEM_VS_PBM...1,SET,175,-0.048263,-0.0046872,0.066683,0.76539,GSE11057_CD4_CENT_MEM_VS_PBMC_DN,1
HP_SKIN_PICKING,SET,12,-0.18941,-0.0048384,0.26169,0.7654,HP_SKIN_PICKING,1
GSE43955_TH0_VS_TGFB_IL6_TH1...3,SET,182,-0.04643,-0.0045976,0.064143,0.76542,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN,1
HP_ABNORMAL_ENCHONDRAL_OSSIF...,SET,126,-0.055185,-0.0045537,0.076232,0.76544,HP_ABNORMAL_ENCHONDRAL_OSSIFICATION,1
GOBP_RETINOIC_ACID_RECEPTOR_...,SET,31,-0.11309,-0.0046408,0.15613,0.76557,GOBP_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...182,SET,120,-0.057748,-0.0046511,0.079719,0.76558,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GSE14000_4H_VS_16H_LPS_DC_TR...2,SET,170,-0.049027,-0.0046934,0.067676,0.76559,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP,1
GOMF_TRANSLATION_FACTOR_ACTI...,SET,71,-0.066606,-0.0041319,0.091938,0.7656,GOMF_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...6,SET,224,-0.042703,-0.0046857,0.058942,0.76561,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE,1
APPIERTO_RESPONSE_TO_FENRETI...1,SET,43,-0.086758,-0.0041917,0.11973,0.76565,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,1
HP_DERMATOCHALASIS,SET,8,-0.2421,-0.00505,0.33398,0.76574,HP_DERMATOCHALASIS,1
GSE13411_PLASMA_CELL_VS_MEMO...1,SET,175,-0.047277,-0.0045914,0.065212,0.76576,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN,1
MENON_FETAL_KIDNEY_1_EMBRYON...,SET,83,-0.066273,-0.0044437,0.091402,0.76579,MENON_FETAL_KIDNEY_1_EMBRYONIC_RED_BLOOD_CELLS,1
PID_BMP_PATHWAY,SET,38,-0.11064,-0.005026,0.15258,0.76582,PID_BMP_PATHWAY,1
OSWALD_HEMATOPOIETIC_STEM_CE...1,SET,241,-0.039709,-0.0045173,0.054753,0.76584,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1
GOBP_LOW_DENSITY_LIPOPROTEIN...1,SET,27,-0.12851,-0.0049221,0.1772,0.76584,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
MIR5701,SET,179,-0.046264,-0.0045435,0.06379,0.76585,MIR5701,1
MODULE_366,SET,29,-0.11176,-0.0044359,0.15409,0.76585,MODULE_366,1
MIR3667_3P,SET,136,-0.055677,-0.0047718,0.076764,0.76586,MIR3667_3P,1
GOBP_ANTIGEN_PROCESSING_AND_...10,SET,64,-0.087783,-0.0051712,0.12103,0.76586,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,1
GOBP_IMMUNOGLOBULIN_PRODUCTI...1,SET,91,-0.061719,-0.0043323,0.085095,0.76586,GOBP_IMMUNOGLOBULIN_PRODUCTION,1
GSE45365_WT_VS_IFNAR_KO_CD11...2,SET,151,-0.05276,-0.0047627,0.07272,0.76593,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN,1
HP_ABNORMAL_TRACHEOBRONCHIAL...,SET,330,-0.034766,-0.0046167,0.047916,0.76594,HP_ABNORMAL_TRACHEOBRONCHIAL_MORPHOLOGY,1
HP_SPONTANEOUS_HEMATOMAS,SET,18,-0.1673,-0.0052333,0.23055,0.76597,HP_SPONTANEOUS_HEMATOMAS,1
REACTOME_TRANSPORT_OF_BILE_S...,SET,82,-0.074419,-0.0049598,0.10254,0.76599,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,1
HP_URETERAL_OBSTRUCTION,SET,34,-0.10484,-0.0045051,0.14445,0.766,HP_URETERAL_OBSTRUCTION,1
GOBP_REGULATION_OF_3_UTR_MED...,SET,5,-0.31792,-0.0052432,0.43803,0.76601,GOBP_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,1
HP_DECREASED_FACIAL_EXPRESSI...,SET,126,-0.055628,-0.0045902,0.076629,0.76606,HP_DECREASED_FACIAL_EXPRESSION,1
HP_CONGENITAL_GIANT_MELANOCY...,SET,5,-0.25408,-0.0041904,0.3499,0.76613,HP_CONGENITAL_GIANT_MELANOCYTIC_NEVUS,1
SIG_BCR_SIGNALING_PATHWAY,SET,45,-0.093113,-0.0046019,0.12821,0.76616,SIG_BCR_SIGNALING_PATHWAY,1
GOBP_INTERKINETIC_NUCLEAR_MI...,SET,5,-0.28029,-0.0046226,0.38589,0.76618,GOBP_INTERKINETIC_NUCLEAR_MIGRATION,1
DESCARTES_FETAL_PANCREAS_ACI...,SET,68,-0.083999,-0.0051,0.1156,0.76628,DESCARTES_FETAL_PANCREAS_ACINAR_CELLS,1
DESCARTES_FETAL_CEREBELLUM_S...,SET,33,-0.12426,-0.0052607,0.17099,0.76629,DESCARTES_FETAL_CEREBELLUM_SLC24A4_PEX5L_POSITIVE_CELLS,1
GSE28726_NAIVE_CD4_TCELL_VS_...1,SET,184,-0.046851,-0.0046644,0.064468,0.7663,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN,1
HP_INCREASED_SUSCEPTIBILITY_...,SET,212,-0.042837,-0.0045742,0.058934,0.76634,HP_INCREASED_SUSCEPTIBILITY_TO_FRACTURES,1
BROWNE_HCMV_INFECTION_12HR_DN,SET,88,-0.070677,-0.004879,0.097186,0.76645,BROWNE_HCMV_INFECTION_12HR_DN,1
HP_ABNORMAL_SPERM_HEAD_MORPH...,SET,26,-0.12842,-0.0048268,0.17657,0.76647,HP_ABNORMAL_SPERM_HEAD_MORPHOLOGY,1
GSE17974_2H_VS_72H_UNTREATED...1,SET,164,-0.046792,-0.0044005,0.064335,0.76648,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
GOBP_MRNA_SPLICE_SITE_RECOGN...,SET,30,-0.10688,-0.0043149,0.14695,0.76649,GOBP_MRNA_SPLICE_SITE_RECOGNITION,1
HP_NASOLACRIMAL_DUCT_OBSTRUC...,SET,29,-0.11479,-0.0045563,0.15779,0.76653,HP_NASOLACRIMAL_DUCT_OBSTRUCTION,1
GOBP_REGULATION_OF_GENE_SILE...,SET,25,-0.12779,-0.0047101,0.17563,0.76657,GOBP_REGULATION_OF_GENE_SILENCING_BY_REGULATORY_NCRNA,1
GOCC_MRNA_CLEAVAGE_AND_POLYA...,SET,17,-0.13485,-0.0040996,0.1853,0.76662,GOCC_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX,1
DESCARTES_MAIN_FETAL_STROMAL...,SET,11,-0.21836,-0.0053406,0.29999,0.76665,DESCARTES_MAIN_FETAL_STROMAL_CELLS,1
MUELLER_COMMON_TARGETS_OF_AM...2,SET,12,-0.19673,-0.0050254,0.27025,0.76667,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,1
GOBP_LEUKOCYTE_HOMEOSTASIS,SET,101,-0.063643,-0.004705,0.087411,0.76671,GOBP_LEUKOCYTE_HOMEOSTASIS,1
MODULE_138,SET,80,-0.072132,-0.0047487,0.099063,0.76673,MODULE_138,1
GOBP_SNARE_COMPLEX_ASSEMBLY,SET,21,-0.12807,-0.0043269,0.17587,0.76676,GOBP_SNARE_COMPLEX_ASSEMBLY,1
MIR624_3P,SET,90,-0.066654,-0.004653,0.091519,0.76678,MIR624_3P,1
GOMF_CHEMOKINE_RECEPTOR_BIND...,SET,60,-0.095921,-0.0054718,0.13169,0.7668,GOMF_CHEMOKINE_RECEPTOR_BINDING,1
GOMF_DNA_N_GLYCOSYLASE_ACTIV...,SET,14,-0.15975,-0.0044075,0.21932,0.7668,GOMF_DNA_N_GLYCOSYLASE_ACTIVITY,1
GOBP_PROTEIN_LOCALIZATION_TO...15,SET,11,-0.14455,-0.0035353,0.19841,0.76685,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_MEMBRANE,1
MIR431_5P,SET,49,-0.084704,-0.0043679,0.11624,0.76689,MIR431_5P,1
MORF_BECN1,SET,96,-0.058167,-0.004193,0.079808,0.76694,MORF_BECN1,1
GSE26030_UNSTIM_VS_RESTIM_TH...6,SET,184,-0.047429,-0.0047219,0.065048,0.76703,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP,1
DESCARTES_FETAL_HEART_LYMPHA...,SET,28,-0.13408,-0.0052294,0.18388,0.76703,DESCARTES_FETAL_HEART_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOBP_GLUCOSAMINE_CONTAINING_...1,SET,9,-0.22797,-0.0050437,0.31264,0.76705,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...107,SET,15,-0.15796,-0.004511,0.21663,0.76705,GOBP_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,1
GSE9037_CTRL_VS_LPS_1H_STIM_...4,SET,185,-0.043901,-0.0043825,0.060186,0.76712,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP,1
GSE36476_YOUNG_VS_OLD_DONOR_...3,SET,179,-0.044429,-0.0043633,0.060886,0.76721,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN,1
GSE37301_LYMPHOID_PRIMED_MPP...7,SET,168,-0.047837,-0.0045527,0.065554,0.76722,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN,1
GOBP_OOCYTE_CONSTRUCTION,SET,8,-0.2231,-0.0046538,0.30567,0.76727,GOBP_OOCYTE_CONSTRUCTION,1
BIOCARTA_PTDINS_PATHWAY,SET,22,-0.12227,-0.0042279,0.16742,0.76739,BIOCARTA_PTDINS_PATHWAY,1
MIR4426,SET,133,-0.054452,-0.0046154,0.074563,0.76739,MIR4426,1
GOBP_CELL_MIGRATION_INVOLVED...5,SET,51,-0.091724,-0.0048252,0.12557,0.76745,GOBP_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...136,SET,19,-0.1498,-0.0048141,0.20505,0.76747,GOBP_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
HALLMARK_MYOGENESIS,SET,191,-0.046971,-0.0047635,0.064296,0.76747,HALLMARK_MYOGENESIS,1
GOMF_CAMP_RESPONSE_ELEMENT_B...2,SET,8,-0.23246,-0.0048489,0.31818,0.76748,GOMF_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING,1
HP_HYPOPROTEINEMIA,SET,18,-0.14638,-0.004579,0.20031,0.76754,HP_HYPOPROTEINEMIA,1
GOMF_APOLIPOPROTEIN_BINDING,SET,17,-0.15074,-0.0045825,0.20625,0.76756,GOMF_APOLIPOPROTEIN_BINDING,1
FALVELLA_SMOKERS_WITH_LUNG_C...,SET,72,-0.077196,-0.0048224,0.10562,0.76758,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1
GOBP_SPERM_DNA_CONDENSATION,SET,14,-0.16432,-0.0045336,0.22481,0.76759,GOBP_SPERM_DNA_CONDENSATION,1
GOBP_RESPONSE_TO_ACETYLCHOLI...,SET,44,-0.10253,-0.0050106,0.14025,0.76761,GOBP_RESPONSE_TO_ACETYLCHOLINE,1
GOBP_ERBB_SIGNALING_PATHWAY,SET,122,-0.0565,-0.0045881,0.077287,0.76762,GOBP_ERBB_SIGNALING_PATHWAY,1
DESCARTES_MAIN_FETAL_AFP_ALB...,SET,77,-0.072284,-0.004669,0.09887,0.76764,DESCARTES_MAIN_FETAL_AFP_ALB_POSITIVE_CELLS,1
GOBP_GLYCINE_METABOLIC_PROCE...,SET,12,-0.17092,-0.0043661,0.23372,0.76769,GOBP_GLYCINE_METABOLIC_PROCESS,1
HP_TETRAPLEGIA,SET,31,-0.10749,-0.0044111,0.14697,0.76772,HP_TETRAPLEGIA,1
GOBP_ANTIGEN_PROCESSING_AND_...13,SET,30,-0.13032,-0.0052612,0.17817,0.76775,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,1
GSE40493_BCL6_KO_VS_WT_TREG_...1,SET,95,-0.06533,-0.0046849,0.089308,0.76776,GSE40493_BCL6_KO_VS_WT_TREG_DN,1
GSE5542_UNTREATED_VS_IFNG_TR...3,SET,180,-0.048194,-0.0047462,0.065884,0.76776,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
BRUINS_UVC_RESPONSE_MIDDLE,SET,92,-0.061612,-0.0043483,0.084223,0.76777,BRUINS_UVC_RESPONSE_MIDDLE,1
WP_NUCLEOTIDE_EXCISION_REPAIR,SET,41,-0.085283,-0.0040237,0.11653,0.76786,WP_NUCLEOTIDE_EXCISION_REPAIR,1
GSE18791_UNSTIM_VS_NEWCATSLE...3,SET,154,-0.051841,-0.0047256,0.070817,0.76792,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN,1
HP_NEPHROTIC_SYNDROME,SET,118,-0.057583,-0.0045992,0.078655,0.76794,HP_NEPHROTIC_SYNDROME,1
SS18_SSX1_FUSION_UNIPROT_Q8I...,SET,311,-0.038047,-0.0049073,0.051967,0.76795,SS18_SSX1_FUSION_UNIPROT_Q8IZH1_UNREVIEWED_TARGET_GENES,1
GOBP_RESPONSE_TO_DIACYL_BACT...,SET,4,-0.32623,-0.0048123,0.44559,0.76795,GOBP_RESPONSE_TO_DIACYL_BACTERIAL_LIPOPEPTIDE,1
BRF1_TARGET_GENES,SET,37,-0.10837,-0.0048576,0.14801,0.76796,BRF1_TARGET_GENES,1
MIR302B_5P,SET,187,-0.046328,-0.0046494,0.063247,0.76806,MIR302B_5P,1
MIR499B_3P,SET,153,-0.055032,-0.0050003,0.075121,0.76808,MIR499B_3P,1
GOBP_ADULT_LOCOMOTORY_BEHAVI...,SET,79,-0.072514,-0.0047441,0.098982,0.76809,GOBP_ADULT_LOCOMOTORY_BEHAVIOR,1
REACTOME_METABOLISM_OF_POLYA...,SET,55,-0.075114,-0.004103,0.10252,0.76812,REACTOME_METABOLISM_OF_POLYAMINES,1
GOBP_NEURON_PROJECTION_EXTEN...2,SET,19,-0.15169,-0.0048749,0.207,0.76816,GOBP_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE,1
GOBP_RESPONSE_TO_HYDROGEN_PE...,SET,89,-0.067618,-0.0046941,0.092244,0.76823,GOBP_RESPONSE_TO_HYDROGEN_PEROXIDE,1
GOBP_VISUAL_BEHAVIOR,SET,53,-0.089565,-0.0048029,0.12218,0.76824,GOBP_VISUAL_BEHAVIOR,1
GOCC_MULTIVESICULAR_BODY_LUM...,SET,5,-0.27929,-0.0046061,0.38092,0.76828,GOCC_MULTIVESICULAR_BODY_LUMEN,1
GSE34156_NOD2_LIGAND_VS_TLR1...3,SET,169,-0.050347,-0.0048057,0.068666,0.76828,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
GSE40274_FOXP3_VS_FOXP3_AND_...5,SET,119,-0.057115,-0.004581,0.077896,0.76828,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GARCIA_PINERES_PBMC_HPV_16_L...2,SET,21,-0.14242,-0.0048114,0.19421,0.7683,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,1
REACTOME_GABA_SYNTHESIS_RELE...,SET,19,-0.1569,-0.0050422,0.21394,0.76833,REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,1
GOBP_MIDDLE_EAR_MORPHOGENESIS,SET,19,-0.16215,-0.0052111,0.2211,0.76834,GOBP_MIDDLE_EAR_MORPHOGENESIS,1
GOCC_PRP19_COMPLEX,SET,14,-0.15872,-0.0043791,0.21635,0.7684,GOCC_PRP19_COMPLEX,1
GOBP_CARDIAC_VENTRICLE_MORPH...,SET,68,-0.085553,-0.0051944,0.11658,0.76849,GOBP_CARDIAC_VENTRICLE_MORPHOGENESIS,1
REACTOME_CD28_DEPENDENT_PI3K...,SET,22,-0.1465,-0.0050657,0.1996,0.76851,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,1
GSE2770_TGFB_AND_IL4_VS_IL12...6,SET,184,-0.045447,-0.0045246,0.061899,0.76859,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
HP_SPASTICITY,SET,777,-0.022452,-0.0045178,0.030568,0.76866,HP_SPASTICITY,1
HOEK_B_CELL_2011_2012_TIV_AD...5,SET,33,-0.11668,-0.0049397,0.15885,0.76868,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_UP,1
HP_CONTRACTURE_OF_THE_PROXIM...3,SET,5,-0.27343,-0.0045095,0.37212,0.76876,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_5TH_FINGER,1
HP_HEMOTHORAX,SET,6,-0.26419,-0.0047728,0.35944,0.76883,HP_HEMOTHORAX,1
VANDESLUIS_NORMAL_EMBRYOS_UP,SET,5,-0.28858,-0.0047594,0.39259,0.76885,VANDESLUIS_NORMAL_EMBRYOS_UP,1
HP_SPINAL_CORD_COMPRESSION,SET,34,-0.11529,-0.0049545,0.15683,0.76888,HP_SPINAL_CORD_COMPRESSION,1
HLF_01,SET,228,-0.043005,-0.0047602,0.058488,0.76891,HLF_01,1
MIR4522,SET,52,-0.090297,-0.0047963,0.1228,0.76892,MIR4522,1
GSE36888_UNTREATED_VS_IL2_TR...12,SET,167,-0.051616,-0.0048979,0.070191,0.76894,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP,1
HP_INTERMITTENT_JAUNDICE,SET,9,-0.21686,-0.0047978,0.29486,0.76897,HP_INTERMITTENT_JAUNDICE,1
DESCARTES_FETAL_PLACENTA_SYN...,SET,51,-0.091532,-0.0048151,0.12443,0.76902,DESCARTES_FETAL_PLACENTA_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,1
GOBP_SPERM_AXONEME_ASSEMBLY,SET,26,-0.11757,-0.004419,0.1598,0.76905,GOBP_SPERM_AXONEME_ASSEMBLY,1
REACTOME_PREVENTION_OF_PHAGO...,SET,8,-0.21588,-0.0045031,0.2934,0.76906,REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION,1
GSE39820_CTRL_VS_TGFBETA1_IL...2,SET,181,-0.048391,-0.0047787,0.065766,0.76907,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP,1
GSE17721_CTRL_VS_POLYIC_0.5H...1,SET,187,-0.044729,-0.004489,0.060785,0.76909,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN,1
HP_EMG_NEUROPATHIC_CHANGES,SET,48,-0.087939,-0.0044883,0.11944,0.76921,HP_EMG_NEUROPATHIC_CHANGES,1
WP_TYROBP_CAUSAL_NETWORK_IN_...,SET,56,-0.088386,-0.0048715,0.12003,0.76923,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,1
KEGG_MEDICUS_REFERENCE_NLRP3...,SET,5,-0.2476,-0.0040834,0.33625,0.76924,KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,1
BIOCARTA_RACC_PATHWAY,SET,11,-0.22176,-0.0054238,0.30114,0.76925,BIOCARTA_RACC_PATHWAY,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...5,SET,11,-0.18229,-0.0044584,0.24755,0.76925,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264,1
GOMF_INSULIN_LIKE_GROWTH_FAC...1,SET,18,-0.17388,-0.0054392,0.23611,0.76927,GOMF_INSULIN_LIKE_GROWTH_FACTOR_BINDING,1
HP_DECREASED_ACTIVITY_OF_MIT...3,SET,13,-0.15609,-0.00415,0.21194,0.76928,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_II,1
ZHONG_PFC_C5_BCL11B_CALB2_PO...,SET,22,-0.14323,-0.0049528,0.19446,0.7693,ZHONG_PFC_C5_BCL11B_CALB2_POS_INP,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...1,SET,185,-0.046222,-0.0046141,0.062743,0.76934,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN,1
GARCIA_TARGETS_OF_FLI1_AND_D...2,SET,46,-0.083065,-0.0041505,0.11275,0.76935,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,1
GOBP_POSITIVE_REGULATION_OF_...247,SET,6,-0.31065,-0.005612,0.42165,0.76935,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
MIR1182,SET,28,-0.12656,-0.0049362,0.17178,0.76936,MIR1182,1
ZNF85_TARGET_GENES,SET,252,-0.039027,-0.0045386,0.05296,0.76941,ZNF85_TARGET_GENES,1
GOBP_ANTIGEN_PROCESSING_AND_...11,SET,36,-0.11334,-0.0050113,0.15375,0.76947,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,1
GOMF_EXOPEPTIDASE_ACTIVITY,SET,95,-0.068976,-0.0049463,0.093564,0.7695,GOMF_EXOPEPTIDASE_ACTIVITY,1
GOBP_REGULATION_OF_LONG_TERM...1,SET,23,-0.12744,-0.0045057,0.17286,0.76951,GOBP_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
KEGG_MEDICUS_REFERENCE_TNF_N...,SET,14,-0.16189,-0.0044665,0.21956,0.76954,KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY,1
MCBRYAN_PUBERTAL_BREAST_5_6W...1,SET,119,-0.055748,-0.0044714,0.075598,0.76957,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,1
GSE17721_12H_VS_24H_POLYIC_B...2,SET,179,-0.046808,-0.0045969,0.06347,0.76958,GSE17721_12H_VS_24H_POLYIC_BMDC_UP,1
GOCC_CYTOPLASMIC_REGION,SET,251,-0.038638,-0.0044845,0.052389,0.76959,GOCC_CYTOPLASMIC_REGION,1
GSE18893_TCONV_VS_TREG_24H_C...2,SET,189,-0.047372,-0.0047792,0.064229,0.7696,GSE18893_TCONV_VS_TREG_24H_CULTURE_UP,1
GSE29618_PRE_VS_DAY7_POST_LA...4,SET,169,-0.049999,-0.0047726,0.067776,0.76965,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP,1
GOBP_MITOCHONDRIAL_PROTON_TR...,SET,5,-0.29819,-0.0049179,0.40413,0.7697,GOBP_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_ASSEMBLY,1
HP_ABNORMAL_EAR_MORPHOLOGY,SET,1421,-0.017271,-0.004613,0.023404,0.76971,HP_ABNORMAL_EAR_MORPHOLOGY,1
HP_ABNORMAL_RENAL_MORPHOLOGY,SET,984,-0.020853,-0.0046944,0.028256,0.76975,HP_ABNORMAL_RENAL_MORPHOLOGY,1
GOBP_ADENYLATE_CYCLASE_ACTIV...1,SET,23,-0.14483,-0.0051205,0.19622,0.76977,GOBP_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_ALKANESULFONATE_TRANSME...,SET,8,-0.26372,-0.0055011,0.3573,0.76977,GOBP_ALKANESULFONATE_TRANSMEMBRANE_TRANSPORT,1
HP_DENTAL_ENAMEL_PITS,SET,8,-0.25592,-0.0053383,0.34657,0.76987,HP_DENTAL_ENAMEL_PITS,1
GSE11961_FOLLICULAR_BCELL_VS...12,SET,184,-0.047037,-0.0046829,0.063684,0.76992,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP,1
GOBP_PURINE_DEOXYRIBONUCLEOT...3,SET,16,-0.16026,-0.0047267,0.21697,0.76993,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
MIR5681A,SET,135,-0.053075,-0.0045322,0.071844,0.76997,MIR5681A,1
REACTOME_COPI_INDEPENDENT_GO...,SET,50,-0.090583,-0.0047183,0.12257,0.77005,REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1
PAX2_02,SET,241,-0.043836,-0.0049868,0.059316,0.77005,PAX2_02,1
GOBP_SERINE_FAMILY_AMINO_ACI...3,SET,29,-0.11443,-0.0045418,0.15482,0.77008,GOBP_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_HISTAMINE_SECRETION,SET,12,-0.175,-0.0044703,0.23668,0.77016,GOBP_HISTAMINE_SECRETION,1
GOCC_MICROTUBULE_END,SET,33,-0.10935,-0.0046294,0.14789,0.77016,GOCC_MICROTUBULE_END,1
GOBP_NEGATIVE_REGULATION_OF_...250,SET,10,-0.19867,-0.0046329,0.26862,0.77022,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,1
GOMF_ATPASE_INHIBITOR_ACTIVI...,SET,4,-0.31695,-0.0046754,0.42855,0.77022,GOMF_ATPASE_INHIBITOR_ACTIVITY,1
GOBP_POLYOL_TRANSMEMBRANE_TR...,SET,10,-0.22951,-0.0053523,0.31026,0.77027,GOBP_POLYOL_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...133,SET,70,-0.087981,-0.0054195,0.1189,0.77034,GOBP_POSITIVE_REGULATION_OF_CELL_KILLING,1
GOBP_SYNAPTIC_TRANSMISSION_D...,SET,27,-0.11927,-0.0045681,0.16118,0.77034,GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,1
GOMF_OXIDOREDUCTASE_ACTIVITY...36,SET,14,-0.1984,-0.0054739,0.2681,0.77035,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,1
GSE6674_ANTI_IGM_VS_ANTI_IGM...1,SET,177,-0.046741,-0.004565,0.06316,0.77036,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
MIR4643,SET,197,-0.045873,-0.0047239,0.061981,0.77038,MIR4643,1
GOBP_CARTILAGE_DEVELOPMENT_I...,SET,31,-0.11894,-0.0048809,0.16071,0.77038,GOBP_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_CELL_MIGRATION_INVOLVED...2,SET,19,-0.16806,-0.0054008,0.22703,0.77042,GOBP_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...290,SET,472,-0.030483,-0.004822,0.041165,0.7705,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,1
HP_HIGH_PITCHED_CRY,SET,5,-0.24676,-0.0040695,0.33318,0.77053,HP_HIGH_PITCHED_CRY,1
KUROKAWA_LIVER_CANCER_EARLY_...1,SET,6,-0.26484,-0.0047845,0.35758,0.77054,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN,1
GOMF_OPSIN_BINDING,SET,4,-0.34802,-0.0051337,0.46986,0.77055,GOMF_OPSIN_BINDING,1
HP_MACROSCOPIC_HEMATURIA,SET,8,-0.2552,-0.0053234,0.34453,0.77057,HP_MACROSCOPIC_HEMATURIA,1
HP_FATIGUABLE_WEAKNESS_OF_PR...,SET,21,-0.13569,-0.0045842,0.18315,0.77061,HP_FATIGUABLE_WEAKNESS_OF_PROXIMAL_LIMB_MUSCLES,1
DORN_ADENOVIRUS_INFECTION_24...1,SET,38,-0.10111,-0.0045929,0.13642,0.7707,DORN_ADENOVIRUS_INFECTION_24HR_DN,1
GSE32255_WT_UNSTIM_VS_JMJD2D...1,SET,155,-0.049994,-0.0045719,0.067453,0.7707,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,1
GOMF_BASIC_AMINO_ACID_TRANSM...,SET,16,-0.1719,-0.00507,0.23188,0.77076,GOMF_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_SHORT_PHALANX_OF_THE_THUMB,SET,29,-0.12023,-0.0047721,0.16216,0.77077,HP_SHORT_PHALANX_OF_THE_THUMB,1
GSE5589_LPS_VS_LPS_AND_IL6_S...5,SET,173,-0.047169,-0.0045549,0.063612,0.7708,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
MODULE_94,SET,342,-0.036052,-0.0048721,0.048611,0.77085,MODULE_94,1
MIR4511,SET,139,-0.054413,-0.0047142,0.073345,0.77091,MIR4511,1
HP_DUMBBELL_SHAPED_LONG_BONE,SET,7,-0.23266,-0.0045399,0.3136,0.77092,HP_DUMBBELL_SHAPED_LONG_BONE,1
IBRAHIM_NRF1_UP,SET,390,-0.031444,-0.0045317,0.042369,0.771,IBRAHIM_NRF1_UP,1
MIR4699_5P,SET,95,-0.066001,-0.004733,0.088899,0.77108,MIR4699_5P,1
REACTOME_CLASS_A_1_RHODOPSIN...,SET,299,-0.041523,-0.0052531,0.055926,0.77109,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1
GOBP_POSITIVE_REGULATION_OF_...427,SET,39,-0.10663,-0.0049069,0.14361,0.77111,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
GOBP_NK_T_CELL_DIFFERENTIATI...,SET,11,-0.20731,-0.0050704,0.27919,0.77112,GOBP_NK_T_CELL_DIFFERENTIATION,1
HP_ABNORMALITY_OF_THE_ANUS,SET,197,-0.045441,-0.0046794,0.061186,0.77115,HP_ABNORMALITY_OF_THE_ANUS,1
GAO_LARGE_INTESTINE_ADULT_CF...,SET,22,-0.14159,-0.004896,0.19063,0.77118,GAO_LARGE_INTESTINE_ADULT_CF_GOBLET_CELL_SUBTYPE_1,1
RODRIGUES_THYROID_CARCINOMA_...5,SET,586,-0.025926,-0.0045552,0.034902,0.7712,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP,1
GOCC_ACTIN_FILAMENT_BUNDLE,SET,85,-0.071984,-0.0048841,0.096886,0.77124,GOCC_ACTIN_FILAMENT_BUNDLE,1
HP_PANNICULITIS,SET,25,-0.13294,-0.0049,0.17894,0.77124,HP_PANNICULITIS,1
REACTOME_CARGO_CONCENTRATION...,SET,31,-0.11161,-0.00458,0.15018,0.77131,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,1
GOBP_NEURON_GLIAL_CELL_SIGNA...,SET,5,-0.33788,-0.0055724,0.45461,0.77132,GOBP_NEURON_GLIAL_CELL_SIGNALING,1
CCAATNNSNNNGCG_UNKNOWN,SET,53,-0.092636,-0.0049676,0.12464,0.77133,CCAATNNSNNNGCG_UNKNOWN,1
BLANCO_MELO_BETA_INTERFERON_...1,SET,183,-0.048912,-0.0048565,0.065787,0.7714,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,1
ZIRN_TRETINOIN_RESPONSE_UP,SET,16,-0.17575,-0.0051834,0.23638,0.77141,ZIRN_TRETINOIN_RESPONSE_UP,1
GOBP_PYRIDINE_CONTAINING_COM...1,SET,30,-0.12154,-0.0049064,0.16346,0.77141,GOBP_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOMF_HISTONE_DEACETYLASE_BIN...,SET,103,-0.062573,-0.0046713,0.084157,0.77141,GOMF_HISTONE_DEACETYLASE_BINDING,1
GOMF_OLFACTORY_RECEPTOR_BIND...,SET,6,-0.2865,-0.0051758,0.38532,0.77141,GOMF_OLFACTORY_RECEPTOR_BINDING,1
GSE41176_UNSTIM_VS_ANTI_IGM_...11,SET,174,-0.049605,-0.0048038,0.066715,0.77141,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN,1
GAUCHER_PBMC_YF_VAX_STAMARIL...12,SET,274,-0.040509,-0.0049093,0.054478,0.77143,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP,1
GOBP_SIGNAL_TRANSDUCTION_IN_...1,SET,66,-0.08137,-0.0048675,0.1094,0.77149,GOBP_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,1
MTHFD1_TARGET_GENES,SET,16,-0.15236,-0.0044935,0.20479,0.77155,MTHFD1_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...458,SET,7,-0.22907,-0.0044699,0.30788,0.77157,GOBP_NEGATIVE_REGULATION_OF_NUCLEASE_ACTIVITY,1
MIR1273H_3P,SET,88,-0.070183,-0.0048449,0.094314,0.7716,MIR1273H_3P,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...5,SET,7,-0.23312,-0.0045488,0.31327,0.7716,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_DN,1
GOBP_REGULATION_OF_EPITHELIA...5,SET,335,-0.036845,-0.0049289,0.049503,0.77164,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,1
GOBP_INTERFERON_BETA_PRODUCT...,SET,50,-0.087669,-0.0045666,0.11777,0.77168,GOBP_INTERFERON_BETA_PRODUCTION,1
GOBP_REGULATION_OF_SISTER_CH...2,SET,101,-0.060904,-0.0045026,0.081815,0.77168,GOBP_REGULATION_OF_SISTER_CHROMATID_SEGREGATION,1
PEDRIOLI_MIR31_TARGETS_UP,SET,190,-0.047533,-0.004808,0.063841,0.77172,PEDRIOLI_MIR31_TARGETS_UP,1
GSE3982_MEMORY_CD4_TCELL_VS_...1,SET,174,-0.047592,-0.0046089,0.063912,0.77175,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN,1
MIR3119,SET,341,-0.035321,-0.0047665,0.047431,0.77176,MIR3119,1
HP_ABNORMAL_METENCEPHALON_MO...,SET,887,-0.021378,-0.0045818,0.028706,0.77177,HP_ABNORMAL_METENCEPHALON_MORPHOLOGY,1
GSE21546_ELK1_KO_VS_SAP1A_KO...4,SET,172,-0.048125,-0.0046339,0.064624,0.77177,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
HP_CLONIC_SEIZURE,SET,72,-0.07486,-0.0046764,0.10051,0.77179,HP_CLONIC_SEIZURE,1
GOBP_RESPONSE_TO_ISOQUINOLIN...,SET,13,-0.18759,-0.0049875,0.25184,0.77182,GOBP_RESPONSE_TO_ISOQUINOLINE_ALKALOID,1
HP_OVOTESTIS,SET,3,-0.38179,-0.0048776,0.51246,0.77187,HP_OVOTESTIS,1
HEBERT_MATRISOME_TNBC_BONE_B...2,SET,7,-0.26135,-0.0050996,0.35077,0.77188,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LUNG_LIVER_METASTASTASES_TUMOR_CELL_DERIVED,1
MIR6810_5P,SET,58,-0.081777,-0.0045868,0.10973,0.77195,MIR6810_5P,1
HP_EXERCISE_INDUCED_MYOGLOBI...,SET,7,-0.19134,-0.0037335,0.25672,0.77195,HP_EXERCISE_INDUCED_MYOGLOBINURIA,1
HP_LOW_SET_POSTERIORLY_ROTAT...,SET,216,-0.043903,-0.0047316,0.058863,0.77212,HP_LOW_SET_POSTERIORLY_ROTATED_EARS,1
WP_ENDOMETRIAL_CANCER,SET,61,-0.082734,-0.0047586,0.11087,0.77222,WP_ENDOMETRIAL_CANCER,1
HP_MULTIPLE_JOINT_CONTRACTUR...,SET,57,-0.078723,-0.0043774,0.10547,0.77228,HP_MULTIPLE_JOINT_CONTRACTURES,1
GOBP_PROTEIN_DEMETHYLATION,SET,8,-0.18156,-0.0037872,0.2432,0.77233,GOBP_PROTEIN_DEMETHYLATION,1
GOMF_METAL_CLUSTER_BINDING,SET,69,-0.074944,-0.0045835,0.10033,0.77246,GOMF_METAL_CLUSTER_BINDING,1
MIR9898,SET,52,-0.086502,-0.0045948,0.11579,0.77248,MIR9898,1
MORF_PRKCA,SET,154,-0.052876,-0.00482,0.070775,0.77249,MORF_PRKCA,1
REACTOME_DECTIN_2_FAMILY,SET,19,-0.15654,-0.0050307,0.20951,0.77251,REACTOME_DECTIN_2_FAMILY,1
MIR6783_3P,SET,185,-0.047578,-0.0047495,0.063679,0.77251,MIR6783_3P,1
GSE17721_LPS_VS_POLYIC_6H_BM...1,SET,178,-0.047342,-0.0046365,0.06335,0.77256,GSE17721_LPS_VS_POLYIC_6H_BMDC_DN,1
MODULE_488,SET,29,-0.13401,-0.005319,0.17928,0.7726,MODULE_488,1
ZWANG_EGF_INTERVAL_DN,SET,185,-0.047231,-0.0047148,0.063177,0.77264,ZWANG_EGF_INTERVAL_DN,1
GOBP_POSITIVE_REGULATION_OF_...54,SET,5,-0.23888,-0.0039397,0.31949,0.77267,GOBP_POSITIVE_REGULATION_OF_BASEMENT_MEMBRANE_ASSEMBLY_INVOLVED_IN_EMBRYONIC_BODY_MORPHOGENESIS,1
HP_OTOSCLEROSIS,SET,6,-0.29158,-0.0052676,0.38994,0.77269,HP_OTOSCLEROSIS,1
MIR12115,SET,63,-0.078404,-0.0045826,0.10483,0.77274,MIR12115,1
MENON_FETAL_KIDNEY_7_LOOPOF_...,SET,211,-0.043458,-0.0046297,0.058102,0.77275,MENON_FETAL_KIDNEY_7_LOOPOF_HENLE_CELLS_DISTAL,1
WP_PROSTAGLANDIN_AND_LEUKOTR...2,SET,32,-0.11605,-0.0048384,0.15511,0.77282,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,1
TOX4_TARGET_GENES,SET,164,-0.048613,-0.0045717,0.064963,0.77286,TOX4_TARGET_GENES,1
GSE39864_WT_VS_GATA3_KO_TREG...2,SET,188,-0.048719,-0.0049023,0.065104,0.77286,GSE39864_WT_VS_GATA3_KO_TREG_UP,1
REACTOME_FOXO_MEDIATED_TRANS...1,SET,63,-0.083446,-0.0048773,0.11145,0.77297,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,1
GSE37301_CD4_TCELL_VS_RAG2_K...2,SET,146,-0.054567,-0.0048442,0.072881,0.77298,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP,1
GSE5099_MONOCYTE_VS_ALTERNAT...2,SET,143,-0.05311,-0.0046666,0.070933,0.77299,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP,1
GOBP_DETERMINATION_OF_LIVER_...,SET,5,-0.29378,-0.004845,0.3923,0.77302,GOBP_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY,1
SMID_BREAST_CANCER_RELAPSE_I...6,SET,6,-0.28151,-0.0050858,0.3759,0.77304,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP,1
SUZUKI_RESPONSE_TO_TSA_AND_D...1,SET,20,-0.16063,-0.0052963,0.21448,0.77305,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,1
GSE22935_24H_VS_48H_MBOVIS_B...4,SET,183,-0.047143,-0.0046808,0.062941,0.77307,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
GSE28737_FOLLICULAR_VS_MARGI...3,SET,179,-0.048913,-0.0048037,0.065298,0.77309,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN,1
WEST_ADRENOCORTICAL_TUMOR_MA...2,SET,22,-0.15176,-0.0052475,0.20256,0.77312,WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,1
MIKKELSEN_PLURIPOTENT_STATE_...1,SET,8,-0.27218,-0.0056776,0.36327,0.77315,MIKKELSEN_PLURIPOTENT_STATE_DN,1
MODULE_439,SET,20,-0.1362,-0.0044907,0.18175,0.77319,MODULE_439,1
GOBP_KYNURENINE_METABOLIC_PR...,SET,9,-0.24621,-0.0054472,0.32852,0.7732,GOBP_KYNURENINE_METABOLIC_PROCESS,1
DORN_ADENOVIRUS_INFECTION_32...1,SET,36,-0.10342,-0.004573,0.1379,0.77336,DORN_ADENOVIRUS_INFECTION_32HR_DN,1
GOBP_CHORIO_ALLANTOIC_FUSION,SET,6,-0.2964,-0.0053547,0.39521,0.77336,GOBP_CHORIO_ALLANTOIC_FUSION,1
GOMF_LEUKOTRIENE_C4_SYNTHASE...,SET,5,-0.31532,-0.0052003,0.42039,0.77339,GOMF_LEUKOTRIENE_C4_SYNTHASE_ACTIVITY,1
HP_ABSENT_SEPTUM_PELLUCIDUM,SET,54,-0.084844,-0.0045923,0.1131,0.77342,HP_ABSENT_SEPTUM_PELLUCIDUM,1
GOBP_VESICLE_TARGETING_TO_FR...,SET,31,-0.10359,-0.0042509,0.13807,0.77345,GOBP_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI,1
WAGSCHAL_EHMT2_TARGETS_UP,SET,10,-0.21553,-0.0050261,0.2872,0.7735,WAGSCHAL_EHMT2_TARGETS_UP,1
GOMF_DOPAMINE_BINDING,SET,6,-0.30323,-0.005478,0.40406,0.7735,GOMF_DOPAMINE_BINDING,1
GOBP_REGULATION_OF_SIGNAL_TR...,SET,95,-0.064943,-0.0046571,0.086534,0.77351,GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
GOBP_TOR_SIGNALING,SET,146,-0.052238,-0.0046375,0.069599,0.77353,GOBP_TOR_SIGNALING,1
TIEN_INTESTINE_PROBIOTICS_24...1,SET,192,-0.047449,-0.0048245,0.06321,0.77356,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1
GSE15324_ELF4_KO_VS_WT_ACTIV...2,SET,180,-0.04544,-0.0044749,0.060528,0.77358,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP,1
REACTOME_DNA_DAMAGE_TELOMERE...,SET,27,-0.11253,-0.00431,0.14989,0.77359,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,1
GOMF_INTRACELLULARLY_GATED_C...,SET,18,-0.14834,-0.0046401,0.19759,0.77359,GOMF_INTRACELLULARLY_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GSE20715_WT_VS_TLR4_KO_6H_OZ...1,SET,177,-0.049577,-0.0048419,0.066039,0.77359,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN,1
KORKOLA_EMBRYONAL_CARCINOMA_...1,SET,9,-0.25153,-0.0055648,0.33499,0.77363,KORKOLA_EMBRYONAL_CARCINOMA_DN,1
AIZARANI_LIVER_C2_KUPFFER_CE...,SET,178,-0.051553,-0.0050489,0.068646,0.77367,AIZARANI_LIVER_C2_KUPFFER_CELLS_1,1
GOBP_POSITIVE_REGULATION_OF_...797,SET,63,-0.078984,-0.0046165,0.10515,0.77372,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,1
GOBP_LYSOSOMAL_MEMBRANE_ORGA...,SET,15,-0.16936,-0.0048366,0.22545,0.77374,GOBP_LYSOSOMAL_MEMBRANE_ORGANIZATION,1
HP_CHOLESTASIS,SET,257,-0.04,-0.0046969,0.053229,0.77381,HP_CHOLESTASIS,1
REACTOME_FLT3_SIGNALING_BY_C...,SET,6,-0.24832,-0.0044861,0.33044,0.77382,REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS,1
GOBP_POSITIVE_REGULATION_OF_...822,SET,8,-0.24026,-0.0050117,0.31958,0.77391,GOBP_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION,1
HP_ABNORMALITY_OF_THE_AXILLA...,SET,52,-0.093914,-0.0049885,0.12491,0.77393,HP_ABNORMALITY_OF_THE_AXILLARY_HAIR,1
GOBP_T_CELL_CYTOKINE_PRODUCT...,SET,36,-0.11263,-0.0049799,0.14978,0.77395,GOBP_T_CELL_CYTOKINE_PRODUCTION,1
HP_ABNORMAL_ISCHIUM_MORPHOLO...,SET,24,-0.12989,-0.0046908,0.17273,0.77396,HP_ABNORMAL_ISCHIUM_MORPHOLOGY,1
GOBP_REGULATION_OF_NERVOUS_S...2,SET,107,-0.065969,-0.005019,0.087723,0.77397,GOBP_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
GSE21670_UNTREATED_VS_TGFB_T...1,SET,177,-0.048997,-0.0047852,0.065155,0.77397,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN,1
MIR1225_3P,SET,56,-0.089647,-0.004941,0.11921,0.77398,MIR1225_3P,1
GSE5589_WT_VS_IL10_KO_LPS_AN...4,SET,176,-0.047441,-0.0046203,0.06307,0.77403,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
MIR374B_3P,SET,128,-0.059598,-0.0049564,0.079216,0.77407,MIR374B_3P,1
HOWLIN_CITED1_TARGETS_2_DN,SET,15,-0.18633,-0.0053211,0.24762,0.77412,HOWLIN_CITED1_TARGETS_2_DN,1
REACTOME_DISEASES_ASSOCIATED...4,SET,61,-0.091112,-0.0052405,0.12108,0.77412,REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS,1
GOBP_BODY_FLUID_SECRETION,SET,87,-0.073268,-0.0050291,0.09735,0.77416,GOBP_BODY_FLUID_SECRETION,1
REACTOME_CLATHRIN_MEDIATED_E...,SET,134,-0.056191,-0.0047806,0.074655,0.77417,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1
GOMF_GAMMA_AMINOBUTYRIC_ACID...2,SET,7,-0.29776,-0.00581,0.39559,0.77418,GOMF_GAMMA_AMINOBUTYRIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_FIBRO...15,SET,44,-0.11289,-0.0055171,0.14996,0.77421,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM,1
GSE17721_0.5H_VS_4H_PAM3CSK4...1,SET,191,-0.046892,-0.0047555,0.062274,0.77427,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN,1
GNF2_DDX5,SET,58,-0.078554,-0.004406,0.10431,0.77429,GNF2_DDX5,1
DARWICHE_SQUAMOUS_CELL_CARCI...1,SET,165,-0.048657,-0.0045897,0.064585,0.77439,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,1
GOBP_NERVOUS_SYSTEM_PROCESS_...,SET,10,-0.22119,-0.0051583,0.29349,0.77447,GOBP_NERVOUS_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GSE32986_CURDLAN_HIGHDOSE_VS...1,SET,187,-0.049609,-0.0049787,0.065819,0.77449,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,1
HP_HYPERAUTOFLUORESCENT_RETI...,SET,14,-0.19512,-0.0053833,0.25883,0.77453,HP_HYPERAUTOFLUORESCENT_RETINAL_LESION,1
WP_HOSTPATHOGEN_INTERACTION_...4,SET,35,-0.12334,-0.0053773,0.16358,0.77457,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,1
HP_2_HYDROXYGLUTARATE_ACIDUR...,SET,5,-0.333,-0.0054918,0.44151,0.77464,HP_2_HYDROXYGLUTARATE_ACIDURIA,1
GSE27786_LSK_VS_MONO_MAC_DN,SET,188,-0.048291,-0.0048592,0.064026,0.77464,GSE27786_LSK_VS_MONO_MAC_DN,1
KEGG_ALPHA_LINOLENIC_ACID_ME...,SET,19,-0.15578,-0.0050063,0.20651,0.77467,KEGG_ALPHA_LINOLENIC_ACID_METABOLISM,1
MODULE_274,SET,76,-0.079942,-0.0051302,0.10598,0.77467,MODULE_274,1
GOBP_METANEPHRIC_TUBULE_FORM...,SET,6,-0.28753,-0.0051944,0.38116,0.77467,GOBP_METANEPHRIC_TUBULE_FORMATION,1
HE_LIM_SUN_FETAL_LUNG_C0_VAS...2,SET,156,-0.056285,-0.0051636,0.074614,0.77467,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_2_CELL,1
HP_DYSMETRIC_SACCADES,SET,15,-0.1545,-0.0044121,0.20477,0.77472,HP_DYSMETRIC_SACCADES,1
KEGG_MEDICUS_REFERENCE_CITRA...1,SET,8,-0.21399,-0.0044638,0.28361,0.77473,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION,1
CSR_LATE_UP.V1_DN,SET,130,-0.061461,-0.0051509,0.081452,0.77474,CSR_LATE_UP.V1_DN,1
BROWNE_HCMV_INFECTION_14HR_DN,SET,257,-0.040641,-0.0047723,0.053852,0.77478,BROWNE_HCMV_INFECTION_14HR_DN,1
HP_ANAL_ATRESIA,SET,111,-0.060993,-0.0047258,0.080782,0.77488,HP_ANAL_ATRESIA,1
GSE31082_DN_VS_CD8_SP_THYMOC...1,SET,188,-0.046921,-0.0047213,0.062145,0.77488,GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN,1
FAN_OVARY_CL17_PUTATIVE_APOP...,SET,210,-0.043965,-0.0046727,0.058223,0.7749,FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...651,SET,21,-0.12104,-0.0040891,0.16027,0.77493,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,1
GOCC_GOLGI_TRANSPORT_COMPLEX,SET,10,-0.2082,-0.0048553,0.27565,0.77497,GOCC_GOLGI_TRANSPORT_COMPLEX,1
HP_CHIARI_MALFORMATION,SET,91,-0.071649,-0.0050293,0.094851,0.77499,HP_CHIARI_MALFORMATION,1
MIR4789_3P,SET,305,-0.038323,-0.0048958,0.05073,0.775,MIR4789_3P,1
GOCC_CELL_TIP,SET,7,-0.24457,-0.0047722,0.32373,0.77501,GOCC_CELL_TIP,1
GOCC_LAMELLAR_BODY,SET,18,-0.16592,-0.00519,0.21957,0.77507,GOCC_LAMELLAR_BODY,1
EGR2_01,SET,179,-0.049284,-0.0048401,0.065206,0.77511,EGR2_01,1
HP_CHERRY_RED_SPOT_OF_THE_MA...,SET,13,-0.18046,-0.0047978,0.23874,0.77513,HP_CHERRY_RED_SPOT_OF_THE_MACULA,1
GSE43863_NAIVE_VS_TFH_CD4_EF...2,SET,173,-0.048633,-0.0046962,0.064339,0.77513,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP,1
HP_MICROGLOSSIA,SET,17,-0.16053,-0.00488,0.21234,0.77516,HP_MICROGLOSSIA,1
GSE17974_0H_VS_48H_IN_VITRO_...2,SET,164,-0.05259,-0.0049457,0.069555,0.7752,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP,1
GSE11961_MARGINAL_ZONE_BCELL...8,SET,186,-0.048686,-0.0048731,0.064384,0.77522,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP,1
HP_ABNORMALITY_OF_THE_BLADDER,SET,465,-0.030739,-0.0048273,0.040644,0.77526,HP_ABNORMALITY_OF_THE_BLADDER,1
GOBP_ERBB4_SIGNALING_PATHWAY,SET,9,-0.21252,-0.0047018,0.28096,0.77529,GOBP_ERBB4_SIGNALING_PATHWAY,1
MODULE_92,SET,143,-0.062068,-0.0054537,0.08205,0.77531,MODULE_92,1
GOBP_CHROMOSOME_SEPARATION,SET,78,-0.070473,-0.0045814,0.093151,0.77533,GOBP_CHROMOSOME_SEPARATION,1
HALLMARK_INFLAMMATORY_RESPON...,SET,190,-0.051002,-0.005159,0.067399,0.77539,HALLMARK_INFLAMMATORY_RESPONSE,1
MIR6831_3P,SET,55,-0.083718,-0.004573,0.11062,0.77541,MIR6831_3P,1
HP_ABNORMALITY_OF_THE_UMBILI...,SET,62,-0.081772,-0.0047415,0.10803,0.77546,HP_ABNORMALITY_OF_THE_UMBILICAL_CORD,1
HP_SHORT_DIGIT,SET,523,-0.028273,-0.0047012,0.03735,0.77547,HP_SHORT_DIGIT,1
GOBP_POSITIVE_REGULATION_OF_...39,SET,7,-0.23099,-0.0045072,0.30506,0.77553,GOBP_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
GOBP_HEAT_GENERATION,SET,18,-0.17831,-0.0055778,0.23542,0.7756,GOBP_HEAT_GENERATION,1
HP_GENERALIZED_OSTEOPOROSIS,SET,17,-0.15735,-0.0047835,0.20775,0.7756,HP_GENERALIZED_OSTEOPOROSIS,1
GSE22432_MULTIPOTENT_VS_COMM...4,SET,178,-0.047035,-0.0046065,0.062083,0.77565,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP,1
GSE3920_IFNA_VS_IFNG_TREATED...1,SET,153,-0.05258,-0.0047775,0.069381,0.77572,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,1
MIR5006_3P,SET,334,-0.036964,-0.0049377,0.048775,0.77573,MIR5006_3P,1
KEGG_MEDICUS_REFERENCE_IGF2_...,SET,11,-0.20473,-0.0050072,0.27011,0.77575,KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY,1
HP_MITTEN_DEFORMITY,SET,9,-0.22462,-0.0049696,0.29635,0.77576,HP_MITTEN_DEFORMITY,1
HP_SCARRING_ALOPECIA_OF_SCALP,SET,13,-0.18342,-0.0048766,0.24196,0.77579,HP_SCARRING_ALOPECIA_OF_SCALP,1
TURASHVILI_BREAST_LOBULAR_CA...2,SET,62,-0.089107,-0.0051669,0.11752,0.77583,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1
GOBP_INTRACILIARY_TRANSPORT_...,SET,6,-0.2646,-0.0047802,0.34899,0.77583,GOBP_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_ASSEMBLY,1
HP_DELAYED_GROSS_MOTOR_DEVEL...,SET,410,-0.032207,-0.0047566,0.042475,0.77585,HP_DELAYED_GROSS_MOTOR_DEVELOPMENT,1
GOBP_REGULATION_OF_THE_FORCE...1,SET,24,-0.14105,-0.005094,0.18601,0.77586,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,1
GOBP_TRANSLESION_SYNTHESIS,SET,24,-0.11039,-0.0039865,0.14555,0.77589,GOBP_TRANSLESION_SYNTHESIS,1
GOMF_MICROTUBULE_SEVERING_AT...,SET,9,-0.2196,-0.0048585,0.28952,0.77592,GOMF_MICROTUBULE_SEVERING_ATPASE_ACTIVITY,1
HP_OSTEOMALACIA,SET,22,-0.14867,-0.0051406,0.19599,0.77594,HP_OSTEOMALACIA,1
GOBP_SPERM_MITOCHONDRIAL_SHE...,SET,6,-0.29536,-0.0053359,0.38932,0.77596,GOBP_SPERM_MITOCHONDRIAL_SHEATH_ASSEMBLY,1
BROCKE_APOPTOSIS_REVERSED_BY...,SET,137,-0.056662,-0.0048739,0.074665,0.77603,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1
GSE40666_UNTREATED_VS_IFNA_S...7,SET,176,-0.049495,-0.0048204,0.065215,0.77606,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN,1
GOBP_CARDIOCYTE_DIFFERENTIAT...,SET,142,-0.056691,-0.0049639,0.074691,0.77607,GOBP_CARDIOCYTE_DIFFERENTIATION,1
HP_CARDIOMYOCYTE_HYPERTROPHY,SET,8,-0.23414,-0.0048839,0.30848,0.77607,HP_CARDIOMYOCYTE_HYPERTROPHY,1
GSE17721_CTRL_VS_LPS_8H_BMDC...1,SET,185,-0.04747,-0.0047387,0.062539,0.77608,GSE17721_CTRL_VS_LPS_8H_BMDC_DN,1
STREICHER_LSM1_TARGETS_UP,SET,40,-0.10396,-0.0048448,0.13696,0.77609,STREICHER_LSM1_TARGETS_UP,1
REACTOME_TGFBR3_EXPRESSION,SET,25,-0.14017,-0.0051663,0.18465,0.7761,REACTOME_TGFBR3_EXPRESSION,1
GOBP_NEGATIVE_REGULATION_OF_...125,SET,5,-0.30947,-0.0051038,0.40764,0.77612,GOBP_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOBP_T_HELPER_2_CELL_CYTOKIN...,SET,13,-0.19797,-0.0052633,0.26076,0.77613,GOBP_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,1
GOBP_PITUITARY_GLAND_DEVELOP...,SET,39,-0.11724,-0.0053951,0.15441,0.77615,GOBP_PITUITARY_GLAND_DEVELOPMENT,1
GOBP_TESTOSTERONE_BIOSYNTHET...,SET,10,-0.20598,-0.0048035,0.27126,0.77617,GOBP_TESTOSTERONE_BIOSYNTHETIC_PROCESS,1
GROSS_HYPOXIA_VIA_ELK3_UP,SET,192,-0.046246,-0.0047022,0.060898,0.77619,GROSS_HYPOXIA_VIA_ELK3_UP,1
HP_ABNORMALITY_OF_THE_FONTAN...,SET,407,-0.03207,-0.0047194,0.042226,0.77622,HP_ABNORMALITY_OF_THE_FONTANELLES_OR_CRANIAL_SUTURES,1
GOBP_ESTABLISHMENT_OR_MAINTE...1,SET,51,-0.095097,-0.0050027,0.12516,0.7763,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY,1
HP_PERINUCLEAR_ANTINEUTROPHI...,SET,6,-0.23622,-0.0042675,0.31082,0.77636,HP_PERINUCLEAR_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,1
PETROVA_PROX1_TARGETS_UP,SET,25,-0.13497,-0.0049746,0.17756,0.7764,PETROVA_PROX1_TARGETS_UP,1
AIZARANI_LIVER_C12_NK_NKT_CE...,SET,43,-0.10665,-0.0051525,0.14029,0.77642,AIZARANI_LIVER_C12_NK_NKT_CELLS_4,1
GOBP_NEGATIVE_REGULATION_OF_...668,SET,39,-0.10019,-0.0046107,0.13178,0.77646,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,1
HP_APLASIA_HYPOPLASIA_OF_THE...65,SET,28,-0.118,-0.0046023,0.15519,0.77648,HP_APLASIA_HYPOPLASIA_OF_THE_SCAPULAE,1
GOBP_REGULATION_OF_DOUBLE_ST...2,SET,68,-0.073779,-0.0044795,0.097025,0.77649,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,1
GSE18281_PERIMEDULLARY_CORTI...3,SET,157,-0.051645,-0.004753,0.067892,0.77657,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,1
MIR6769B_3P,SET,76,-0.07483,-0.0048021,0.098366,0.77658,MIR6769B_3P,1
ZC3H11A_TARGET_GENES,SET,747,-0.024215,-0.0047817,0.031826,0.77662,ZC3H11A_TARGET_GENES,1
HP_INTRINSIC_HAND_MUSCLE_ATR...,SET,24,-0.14029,-0.0050665,0.18437,0.77664,HP_INTRINSIC_HAND_MUSCLE_ATROPHY,1
HP_ELEVATED_CIRCULATING_THYR...,SET,27,-0.13102,-0.0050182,0.17215,0.77669,HP_ELEVATED_CIRCULATING_THYROID_STIMULATING_HORMONE_CONCENTRATION,1
GSE8678_IL7R_LOW_VS_HIGH_EFF...1,SET,173,-0.050238,-0.0048512,0.066007,0.7767,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN,1
HOFT_CD4_POSITIVE_ALPHA_BETA...8,SET,25,-0.12725,-0.00469,0.16716,0.77673,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_UP,1
DURANTE_ADULT_OLFACTORY_NEUR...24,SET,46,-0.10855,-0.0054237,0.14259,0.77673,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_SUSTENTACULAR_CELLS,1
GOCC_GOLGI_CISTERNA_MEMBRANE,SET,74,-0.076416,-0.0048392,0.10038,0.77675,GOCC_GOLGI_CISTERNA_MEMBRANE,1
MIR3916,SET,202,-0.044872,-0.0046784,0.058926,0.77681,MIR3916,1
HP_ABSENT_INNER_AND_OUTER_DY...,SET,3,-0.33944,-0.0043365,0.44559,0.7769,HP_ABSENT_INNER_AND_OUTER_DYNEIN_ARMS,1
KEGG_MEDICUS_REFERENCE_PYRIN...,SET,4,-0.26925,-0.0039718,0.35343,0.77691,KEGG_MEDICUS_REFERENCE_PYRIN_INFLAMMASOME_SIGNALING_PATHWAY,1
LIU_VMYB_TARGETS_UP,SET,110,-0.062802,-0.0048441,0.082435,0.77692,LIU_VMYB_TARGETS_UP,1
GOBP_FATTY_ACYL_COA_METABOLI...,SET,37,-0.11429,-0.0051229,0.15001,0.77692,GOBP_FATTY_ACYL_COA_METABOLIC_PROCESS,1
MIR135B_5P,SET,282,-0.039961,-0.004912,0.052449,0.77694,MIR135B_5P,1
HP_FRACTURES_OF_THE_LONG_BON...,SET,12,-0.16885,-0.0043133,0.22161,0.77694,HP_FRACTURES_OF_THE_LONG_BONES,1
HP_ABNORMALITY_OF_THE_PULMON...1,SET,119,-0.062938,-0.0050481,0.082596,0.77696,HP_ABNORMALITY_OF_THE_PULMONARY_ARTERY,1
GSE8685_IL2_STARVED_VS_IL21_...1,SET,186,-0.046014,-0.0046056,0.060368,0.77703,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
chr3q23,SET,27,-0.22109,-0.0084681,0.29004,0.77705,chr3q23,1
REACTOME_GLYCOGEN_BREAKDOWN_...,SET,11,-0.1608,-0.0039327,0.21083,0.77716,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,1
HP_ABNORMAL_VESTIBULO_OCULAR...,SET,7,-0.2327,-0.0045406,0.30513,0.77716,HP_ABNORMAL_VESTIBULO_OCULAR_REFLEX,1
KIM_TIAL1_TARGETS,SET,29,-0.12921,-0.0051288,0.16942,0.77717,KIM_TIAL1_TARGETS,1
SIG_PIP3_SIGNALING_IN_CARDIA...,SET,62,-0.090478,-0.0052463,0.11858,0.77726,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1
GSE29618_PDC_VS_MDC_DN,SET,183,-0.049959,-0.0049604,0.065449,0.77736,GSE29618_PDC_VS_MDC_DN,1
HP_VENTILATOR_DEPENDENCE_WIT...,SET,4,-0.31019,-0.0045757,0.40632,0.77738,HP_VENTILATOR_DEPENDENCE_WITH_INABILITY_TO_WEAN,1
MIR3663_5P,SET,49,-0.09248,-0.0047689,0.12111,0.77745,MIR3663_5P,1
THAKAR_PBMC_INACTIVATED_INFL...11,SET,97,-0.064286,-0.0046581,0.084184,0.77745,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP,1
SLEBOS_HEAD_AND_NECK_CANCER_...,SET,66,-0.074904,-0.0044807,0.098085,0.77746,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,1
GOBP_RETINOL_METABOLIC_PROCE...,SET,50,-0.10229,-0.0053283,0.13392,0.7775,GOBP_RETINOL_METABOLIC_PROCESS,1
GOBP_NEURON_PROJECTION_ORGAN...,SET,86,-0.070327,-0.0047996,0.092057,0.77755,GOBP_NEURON_PROJECTION_ORGANIZATION,1
MIKKELSEN_NPC_ICP_WITH_H3K4M...,SET,381,-0.033469,-0.0047688,0.043805,0.77758,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1
HP_PAROTITIS,SET,4,-0.35615,-0.0052537,0.46611,0.77759,HP_PAROTITIS,1
SIG_PIP3_SIGNALING_IN_B_LYMP...,SET,34,-0.11786,-0.0050647,0.15422,0.77763,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,1
GOBP_POSITIVE_REGULATION_OF_...378,SET,89,-0.064387,-0.0044698,0.084243,0.77765,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...216,SET,5,-0.2839,-0.0046822,0.37132,0.77774,GOBP_POSITIVE_REGULATION_OF_DNA_LIGATION,1
GOBP_REGULATION_OF_CELL_MIGR...,SET,36,-0.11376,-0.0050299,0.14873,0.77782,GOBP_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GOMF_STEROL_BINDING,SET,65,-0.084503,-0.0050166,0.11046,0.77786,GOMF_STEROL_BINDING,1
REACTOME_VEGFR2_MEDIATED_CEL...,SET,19,-0.14732,-0.0047343,0.19253,0.77791,REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,1
GOBP_CELLULAR_RESPONSE_TO_CA...1,SET,33,-0.13426,-0.0056843,0.17546,0.77792,GOBP_CELLULAR_RESPONSE_TO_CADMIUM_ION,1
GSE3982_CENT_MEMORY_CD4_TCEL...2,SET,176,-0.048728,-0.0047456,0.063671,0.77795,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP,1
GOBP_CELLULAR_COMPONENT_DISA...1,SET,481,-0.029598,-0.0047252,0.038664,0.77801,GOBP_CELLULAR_COMPONENT_DISASSEMBLY,1
GOBP_G_PROTEIN_COUPLED_RECEP...3,SET,54,-0.098058,-0.0053075,0.12809,0.77802,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER,1
GSE24814_STAT5_KO_VS_WT_PRE_...2,SET,176,-0.052091,-0.0050732,0.068028,0.77807,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP,1
BAUS_TFF2_TARGETS_DN,SET,11,-0.20581,-0.0050336,0.26875,0.7781,BAUS_TFF2_TARGETS_DN,1
GOBP_TRIGEMINAL_NERVE_DEVELO...,SET,12,-0.22524,-0.0057536,0.29411,0.7781,GOBP_TRIGEMINAL_NERVE_DEVELOPMENT,1
GOBP_REGULATION_OF_ANAPHASE_...,SET,5,-0.24151,-0.003983,0.31533,0.77812,GOBP_REGULATION_OF_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,1
GOBP_TISSUE_REGENERATION,SET,69,-0.082252,-0.0050304,0.10739,0.77813,GOBP_TISSUE_REGENERATION,1
GOBP_REGULATION_OF_THE_FORCE...2,SET,5,-0.35208,-0.0058066,0.45967,0.77814,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL,1
GOBP_AMINOGLYCAN_METABOLIC_P...,SET,116,-0.062526,-0.0049519,0.081617,0.77818,GOBP_AMINOGLYCAN_METABOLIC_PROCESS,1
GOMF_L_AMINO_ACID_TRANSMEMBR...,SET,62,-0.088121,-0.0051097,0.11498,0.77828,GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_RHOU_GTPASE_CYCLE,SET,37,-0.10493,-0.0047035,0.13689,0.77832,REACTOME_RHOU_GTPASE_CYCLE,1
GOBP_REGULATION_OF_FATTY_ACI...4,SET,31,-0.12033,-0.0049379,0.15698,0.77832,GOBP_REGULATION_OF_FATTY_ACID_OXIDATION,1
REACTOME_POU5F1_OCT4_SOX2_NA...2,SET,9,-0.26984,-0.0059701,0.35198,0.77835,REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...31,SET,41,-0.10003,-0.0047195,0.13046,0.77838,HP_APLASIA_HYPOPLASIA_OF_THE_EYELID,1
REACTOME_SOS_MEDIATED_SIGNAL...,SET,7,-0.22901,-0.0044687,0.29859,0.77845,REACTOME_SOS_MEDIATED_SIGNALLING,1
HP_DILATION_OF_VIRCHOW_ROBIN...,SET,13,-0.19026,-0.0050585,0.24806,0.77846,HP_DILATION_OF_VIRCHOW_ROBIN_SPACES,1
HP_ANGIOID_STREAKS_OF_THE_FU...,SET,10,-0.20691,-0.0048253,0.26973,0.77849,HP_ANGIOID_STREAKS_OF_THE_FUNDUS,1
KEGG_MEDICUS_REFERENCE_TRH_T...,SET,12,-0.20231,-0.005168,0.26362,0.77858,KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY,1
KONDO_COLON_CANCER_HCP_WITH_...2,SET,4,-0.37748,-0.0055684,0.49177,0.77863,KONDO_COLON_CANCER_HCP_WITH_H3K27ME3,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...3,SET,8,-0.25757,-0.0053728,0.33556,0.77863,GOBP_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS,1
WP_IRINOTECAN_PATHWAY,SET,12,-0.19921,-0.0050888,0.25952,0.77864,WP_IRINOTECAN_PATHWAY,1
REACTOME_RESOLUTION_OF_SISTE...,SET,113,-0.060476,-0.0047275,0.07876,0.77871,REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,1
GSE411_WT_VS_SOCS3_KO_MACROP...6,SET,178,-0.049013,-0.0048002,0.063828,0.77872,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP,1
REACTOME_RUNX1_REGULATES_TRA...6,SET,5,-0.30658,-0.0050562,0.39914,0.77878,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING,1
GOCC_EARLY_ENDOSOME_LUMEN,SET,5,-0.29276,-0.0048283,0.38115,0.77878,GOCC_EARLY_ENDOSOME_LUMEN,1
HP_ELEVATED_CIRCULATING_PHYT...,SET,14,-0.16948,-0.0046758,0.22055,0.77887,HP_ELEVATED_CIRCULATING_PHYTANIC_ACID_CONCENTRATION,1
DESCARTES_FETAL_PLACENTA_VAS...,SET,85,-0.078946,-0.0053565,0.10273,0.77889,DESCARTES_FETAL_PLACENTA_VASCULAR_ENDOTHELIAL_CELLS,1
REACTOME_SIGNAL_TRANSDUCTION...,SET,20,-0.15908,-0.005245,0.20699,0.77891,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,1
HP_UPPER_LIMB_SPASTICITY,SET,22,-0.13993,-0.0048385,0.18204,0.77895,HP_UPPER_LIMB_SPASTICITY,1
HP_ABSENT_SPEECH,SET,364,-0.033918,-0.0047259,0.044119,0.77898,HP_ABSENT_SPEECH,1
HP_THICK_NASAL_ALAE,SET,34,-0.11381,-0.0048907,0.14804,0.77898,HP_THICK_NASAL_ALAE,1
BANDRES_RESPONSE_TO_CARMUSTI...1,SET,31,-0.12431,-0.005101,0.16169,0.77899,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,1
MIR4279,SET,198,-0.047856,-0.0049405,0.062224,0.77908,MIR4279,1
chr11q13,SET,240,-0.089908,-0.010207,0.11688,0.77911,chr11q13,1
HP_LIMITATION_OF_MOVEMENT_AT...,SET,5,-0.33386,-0.005506,0.43403,0.77911,HP_LIMITATION_OF_MOVEMENT_AT_ANKLES,1
GSE17186_BLOOD_VS_CORD_BLOOD...6,SET,186,-0.048945,-0.004899,0.063629,0.77912,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP,1
GOBP_REGULATION_OF_TAU_PROTE...,SET,4,-0.27343,-0.0040334,0.35544,0.77913,GOBP_REGULATION_OF_TAU_PROTEIN_KINASE_ACTIVITY,1
GOBP_VASCULAR_ENDOTHELIAL_GR...2,SET,6,-0.32943,-0.0059515,0.42823,0.77913,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_SIGNALING_PATHWAY,1
MIR129_1_3P_MIR129_2_3P,SET,120,-0.060483,-0.0048714,0.078618,0.77915,MIR129_1_3P_MIR129_2_3P,1
GOBP_MIRNA_PROCESSING,SET,40,-0.099911,-0.0046561,0.12984,0.7792,GOBP_MIRNA_PROCESSING,1
ZHU_SKIL_TARGETS_DN,SET,9,-0.22251,-0.0049227,0.28906,0.77927,ZHU_SKIL_TARGETS_DN,1
DESCARTES_MAIN_FETAL_INHIBIT...2,SET,4,-0.40212,-0.0059319,0.52241,0.77927,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,1
MODULE_21,SET,9,-0.20294,-0.00449,0.26363,0.77928,MODULE_21,1
MODULE_56,SET,9,-0.20294,-0.00449,0.26363,0.77928,MODULE_56,1
NEWMAN_ERCC6_TARGETS_DN,SET,33,-0.1268,-0.0053682,0.1647,0.7793,NEWMAN_ERCC6_TARGETS_DN,1
HP_TALL_STATURE,SET,147,-0.053042,-0.0047248,0.068877,0.77937,HP_TALL_STATURE,1
GOCC_NLRP3_INFLAMMASOME_COMP...,SET,6,-0.2697,-0.0048723,0.35011,0.77944,GOCC_NLRP3_INFLAMMASOME_COMPLEX,1
GOBP_VITAMIN_D3_METABOLIC_PR...,SET,7,-0.23021,-0.0044921,0.29877,0.7795,GOBP_VITAMIN_D3_METABOLIC_PROCESS,1
HOLLMANN_APOPTOSIS_VIA_CD40_...2,SET,184,-0.0497,-0.004948,0.064484,0.77956,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1
GOMF_METAL_ION_TRANSMEMBRANE...,SET,426,-0.0338,-0.0050861,0.043854,0.77956,GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_SNRNP_BINDING,SET,9,-0.22669,-0.0050154,0.2941,0.77958,GOMF_SNRNP_BINDING,1
GNF2_DEK,SET,51,-0.086981,-0.0045757,0.11283,0.77962,GNF2_DEK,1
GSE3337_4H_VS_16H_IFNG_IN_CD...1,SET,184,-0.049425,-0.0049207,0.064085,0.77971,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN,1
GSE26030_UNSTIM_VS_RESTIM_TH...4,SET,166,-0.051893,-0.0049095,0.06728,0.77973,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP,1
WP_TCA_CYCLE_NUTRIENT_USE_AN...,SET,5,-0.32458,-0.0053531,0.42074,0.77978,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,1
GOBP_CHROMATIN_LOOPING,SET,10,-0.20054,-0.0046767,0.25994,0.77978,GOBP_CHROMATIN_LOOPING,1
GSE22886_CD4_TCELL_VS_BCELL_...2,SET,183,-0.047996,-0.0047655,0.062198,0.77984,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP,1
DOUGLAS_BMI1_TARGETS_UP,SET,513,-0.029797,-0.0049083,0.038598,0.77993,DOUGLAS_BMI1_TARGETS_UP,1
REACTOME_AMINO_ACID_CONJUGAT...,SET,8,-0.34145,-0.0071225,0.44222,0.77998,REACTOME_AMINO_ACID_CONJUGATION,1
MIR7161_3P,SET,77,-0.075052,-0.0048478,0.097194,0.77999,MIR7161_3P,1
HP_INTELLECTUAL_DISABILITY_S...,SET,312,-0.037293,-0.0048177,0.048293,0.78,HP_INTELLECTUAL_DISABILITY_SEVERE,1
GOMF_NADPH_BINDING,SET,16,-0.14302,-0.0042182,0.18519,0.78003,GOMF_NADPH_BINDING,1
REACTOME_REGULATION_OF_ENDOG...3,SET,37,-0.11028,-0.0049431,0.14277,0.78005,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS,1
GOBP_REGULATION_OF_IRON_ION_...1,SET,3,-0.34543,-0.004413,0.44712,0.7801,GOBP_REGULATION_OF_IRON_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_CARBOHYDRATE_DERIVATIVE...3,SET,965,-0.022063,-0.0049212,0.028556,0.78012,GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_AUTOP...5,SET,12,-0.19211,-0.0049074,0.24864,0.78013,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION,1
MIR6077,SET,220,-0.045048,-0.0048992,0.058292,0.78018,MIR6077,1
HP_TYPE_1_MUSCLE_FIBER_PREDO...,SET,60,-0.080155,-0.0045724,0.10371,0.7802,HP_TYPE_1_MUSCLE_FIBER_PREDOMINANCE,1
SNF5_DN.V1_DN,SET,136,-0.061165,-0.0052421,0.079137,0.7802,SNF5_DN.V1_DN,1
RYTGCNNRGNAAC_MIF1_01,SET,78,-0.076951,-0.0050025,0.099519,0.7803,RYTGCNNRGNAAC_MIF1_01,1
BRACHAT_RESPONSE_TO_CAMPTOTH...2,SET,19,-0.14023,-0.0045064,0.18133,0.78033,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,1
NR4A2_TARGET_GENES,SET,4,-0.35051,-0.0051706,0.45324,0.78034,NR4A2_TARGET_GENES,1
HP_INTRACEREBRAL_PERIVENTRIC...,SET,6,-0.26273,-0.0047464,0.33971,0.78035,HP_INTRACEREBRAL_PERIVENTRICULAR_CALCIFICATIONS,1
REACTOME_MET_ACTIVATES_PTK2_...,SET,30,-0.13269,-0.0053566,0.17154,0.78039,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,1
GOBP_G1_TO_G0_TRANSITION,SET,18,-0.1496,-0.0046797,0.1934,0.78039,GOBP_G1_TO_G0_TRANSITION,1
HP_MUSCLE_FIBER_CYTOPLASMATI...,SET,29,-0.12209,-0.004846,0.15784,0.78039,HP_MUSCLE_FIBER_CYTOPLASMATIC_INCLUSION_BODIES,1
REACTOME_DOWNREGULATION_OF_E...1,SET,12,-0.19406,-0.0049572,0.25086,0.78041,REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,1
GOMF_ATP_HYDROLYSIS_ACTIVITY,SET,381,-0.033532,-0.0047778,0.043338,0.78045,GOMF_ATP_HYDROLYSIS_ACTIVITY,1
DASU_IL6_SIGNALING_SCAR_UP,SET,30,-0.1214,-0.0049008,0.15688,0.78047,DASU_IL6_SIGNALING_SCAR_UP,1
HP_DECREASED_MUSCLE_MASS,SET,53,-0.089805,-0.0048157,0.11604,0.7805,HP_DECREASED_MUSCLE_MASS,1
HP_ATTENUATION_OF_RETINAL_BL...,SET,118,-0.061381,-0.0049026,0.079308,0.78051,HP_ATTENUATION_OF_RETINAL_BLOOD_VESSELS,1
BIOCARTA_CIRCADIAN_PATHWAY,SET,5,-0.34073,-0.0056194,0.44023,0.78052,BIOCARTA_CIRCADIAN_PATHWAY,1
GSE26290_WT_VS_PDK1_KO_ANTI_...1,SET,169,-0.048093,-0.0045906,0.062118,0.78059,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,1
TTANTCA_UNKNOWN,SET,838,-0.024659,-0.0051442,0.031844,0.78064,TTANTCA_UNKNOWN,1
GOBP_CHONDROCYTE_HYPERTROPHY,SET,6,-0.33117,-0.0059828,0.42749,0.78073,GOBP_CHONDROCYTE_HYPERTROPHY,1
GOBP_INTERMEDIATE_FILAMENT_B...1,SET,92,-0.083797,-0.005914,0.10815,0.78077,GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS,1
GCM_NCAM1,SET,115,-0.061358,-0.0048385,0.079179,0.7808,GCM_NCAM1,1
GOBP_PROTEIN_LOCALIZATION_TO...46,SET,39,-0.10824,-0.0049811,0.13966,0.78084,GOBP_PROTEIN_LOCALIZATION_TO_POSTSYNAPSE,1
HP_MYOFIBRILLAR_MYOPATHY,SET,10,-0.22404,-0.0052246,0.28905,0.78085,HP_MYOFIBRILLAR_MYOPATHY,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...3,SET,6,-0.28699,-0.0051847,0.37025,0.78086,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
HOFFMAN_CLOCK_TARGETS_UP,SET,9,-0.25601,-0.005664,0.33023,0.7809,HOFFMAN_CLOCK_TARGETS_UP,1
GNF2_RFC4,SET,57,-0.078163,-0.0043463,0.10082,0.7809,GNF2_RFC4,1
GOMF_HISTONE_METHYLTRANSFERA...1,SET,58,-0.084685,-0.0047499,0.10921,0.78096,GOMF_HISTONE_METHYLTRANSFERASE_ACTIVITY,1
JISON_SICKLE_CELL_DISEASE_DN,SET,167,-0.050197,-0.0047632,0.06473,0.78097,JISON_SICKLE_CELL_DISEASE_DN,1
SNAPC2_TARGET_GENES,SET,4,-0.23732,-0.0035008,0.30597,0.78101,SNAPC2_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_FASLG...,SET,5,-0.3328,-0.0054886,0.42906,0.78102,KEGG_MEDICUS_REFERENCE_FASLG_RIPK1_3_SIGNALING_PATHWAY,1
GNF2_TNFSF10,SET,30,-0.1218,-0.004917,0.15702,0.78103,GNF2_TNFSF10,1
DESCARTES_FETAL_PANCREAS_LYM...1,SET,41,-0.11269,-0.0053169,0.14526,0.78107,DESCARTES_FETAL_PANCREAS_LYMPHATIC_ENDOTHELIAL_CELLS,1
HP_ABNORMALITY_OF_CRANIAL_SU...,SET,338,-0.036039,-0.0048422,0.046449,0.78108,HP_ABNORMALITY_OF_CRANIAL_SUTURES,1
HP_DISTAL_ARTHROGRYPOSIS,SET,24,-0.13536,-0.0048883,0.17446,0.78108,HP_DISTAL_ARTHROGRYPOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...407,SET,30,-0.12122,-0.0048935,0.15623,0.78109,GOBP_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,1
REACTOME_GASTRULATION,SET,118,-0.060522,-0.004834,0.078,0.7811,REACTOME_GASTRULATION,1
DESCARTES_FETAL_LUNG_MESOTHE...,SET,83,-0.079856,-0.0053544,0.10291,0.78112,DESCARTES_FETAL_LUNG_MESOTHELIAL_CELLS,1
GOCC_DOPAMINERGIC_SYNAPSE,SET,13,-0.18269,-0.0048571,0.23534,0.7812,GOCC_DOPAMINERGIC_SYNAPSE,1
GOBP_OUTER_EAR_MORPHOGENESIS,SET,8,-0.24515,-0.0051136,0.31576,0.78123,GOBP_OUTER_EAR_MORPHOGENESIS,1
WP_PLATELETMEDIATED_INTERACT...,SET,15,-0.1836,-0.0052433,0.23648,0.78124,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,1
GOBP_DE_NOVO_AMP_BIOSYNTHETI...,SET,6,-0.26142,-0.0047228,0.33669,0.78125,GOBP_DE_NOVO_AMP_BIOSYNTHETIC_PROCESS,1
HP_VASCULITIS_IN_THE_SKIN,SET,7,-0.23508,-0.004587,0.30273,0.78128,HP_VASCULITIS_IN_THE_SKIN,1
WP_MITOCHONDRIAL_COMPLEX_I_A...,SET,45,-0.086657,-0.0042828,0.11158,0.7813,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,1
GSE9988_ANTI_TREM1_VS_LPS_MO...1,SET,176,-0.053021,-0.0051638,0.068266,0.78132,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN,1
CDC5L_TARGET_GENES,SET,225,-0.044,-0.0048386,0.056632,0.7814,CDC5L_TARGET_GENES,1
CERVERA_SDHB_TARGETS_1_UP,SET,111,-0.068206,-0.0052847,0.087782,0.78141,CERVERA_SDHB_TARGETS_1_UP,1
MIR4317,SET,88,-0.070148,-0.0048425,0.090284,0.78141,MIR4317,1
GSE3982_EFF_MEMORY_CD4_TCELL...2,SET,179,-0.048993,-0.0048115,0.063051,0.78142,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP,1
HP_PSEUDOEPIPHYSES,SET,17,-0.15894,-0.0048317,0.20454,0.78143,HP_PSEUDOEPIPHYSES,1
REACTOME_FCERI_MEDIATED_NF_K...,SET,76,-0.072395,-0.0046459,0.093163,0.78144,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1
BIOCARTA_LAIR_PATHWAY,SET,17,-0.17843,-0.0054244,0.22961,0.78145,BIOCARTA_LAIR_PATHWAY,1
WP_CELLS_AND_MOLECULES_INVOL...,SET,17,-0.17843,-0.0054244,0.22961,0.78145,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,1
HP_ABNORMAL_LEFT_VENTRICLE_M...,SET,111,-0.06077,-0.0047085,0.078196,0.78146,HP_ABNORMAL_LEFT_VENTRICLE_MORPHOLOGY,1
WP_SOMATROPH_AXIS_GH_AND_ITS...,SET,6,-0.28022,-0.0050624,0.36055,0.78147,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,1
WP_SULINDAC_METABOLIC_PATHWAY,SET,5,-0.32927,-0.0054303,0.42361,0.7815,WP_SULINDAC_METABOLIC_PATHWAY,1
GOBP_PURINE_NUCLEOSIDE_BIOSY...,SET,9,-0.24541,-0.0054295,0.31571,0.78151,GOBP_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,1
HP_AQUEDUCTAL_STENOSIS,SET,21,-0.12955,-0.0043766,0.16663,0.78154,HP_AQUEDUCTAL_STENOSIS,1
GOBP_MITOTIC_SISTER_CHROMATI...1,SET,21,-0.13771,-0.0046526,0.17713,0.78156,GOBP_MITOTIC_SISTER_CHROMATID_COHESION,1
GOCC_VACUOLE,SET,773,-0.024275,-0.0048728,0.031218,0.7816,GOCC_VACUOLE,1
GOBP_ANDROGEN_BIOSYNTHETIC_P...,SET,10,-0.20726,-0.0048334,0.26652,0.78161,GOBP_ANDROGEN_BIOSYNTHETIC_PROCESS,1
GSE17721_CTRL_VS_PAM3CSK4_8H...1,SET,180,-0.047917,-0.0047188,0.061616,0.78161,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...1,SET,28,-0.1208,-0.0047116,0.15532,0.78163,HP_APLASIA_HYPOPLASIA_OF_THE_1ST_METACARPAL,1
GOBP_TELOMERE_ORGANIZATION,SET,147,-0.050623,-0.0045094,0.065087,0.78164,GOBP_TELOMERE_ORGANIZATION,1
GOMF_DEOXYRIBONUCLEASE_I_ACT...,SET,4,-0.34697,-0.0051183,0.44612,0.78164,GOMF_DEOXYRIBONUCLEASE_I_ACTIVITY,1
HP_ABNORMAL_CARDIOVASCULAR_S...,SET,1283,-0.019368,-0.0049356,0.024901,0.78166,HP_ABNORMAL_CARDIOVASCULAR_SYSTEM_PHYSIOLOGY,1
HP_IMPAIRED_PROPRIOCEPTION,SET,136,-0.055246,-0.0047349,0.071027,0.78166,HP_IMPAIRED_PROPRIOCEPTION,1
GOBP_REGULATION_OF_SYNAPTIC_...3,SET,8,-0.23768,-0.0049578,0.30539,0.78179,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,1
GOMF_POSTSYNAPTIC_NEUROTRANS...,SET,67,-0.091016,-0.0054855,0.11692,0.78185,GOMF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
HP_MASK_LIKE_FACIES,SET,44,-0.095433,-0.004664,0.12257,0.7819,HP_MASK_LIKE_FACIES,1
GOMF_ODORANT_BINDING,SET,95,-0.092782,-0.0066535,0.11914,0.78193,GOMF_ODORANT_BINDING,1
MIR545_3P,SET,349,-0.037671,-0.0051418,0.048373,0.78194,MIR545_3P,1
HP_CYSTINURIA,SET,6,-0.36954,-0.0066759,0.47451,0.78194,HP_CYSTINURIA,1
FREAC4_01,SET,134,-0.063533,-0.0054052,0.081574,0.78196,FREAC4_01,1
HP_PLATYBASIA,SET,16,-0.19318,-0.0056976,0.24804,0.78196,HP_PLATYBASIA,1
WP_WARBURG_EFFECT_MODULATED_...,SET,24,-0.14291,-0.0051611,0.18338,0.7821,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,1
HP_ABNORMAL_LIVER_PARENCHYMA...,SET,10,-0.20455,-0.0047701,0.2624,0.78216,HP_ABNORMAL_LIVER_PARENCHYMA_MORPHOLOGY,1
REACTOME_BETA_OXIDATION_OF_D...,SET,6,-0.25576,-0.0046205,0.32803,0.78221,REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA,1
HP_BROAD_LONG_BONES,SET,128,-0.06033,-0.0050173,0.077375,0.78222,HP_BROAD_LONG_BONES,1
MIR4463,SET,75,-0.074782,-0.0047675,0.095884,0.78227,MIR4463,1
ETS_Q4,SET,228,-0.04436,-0.0049102,0.056872,0.7823,ETS_Q4,1
GOBP_REGULATION_OF_CELLULAR_...9,SET,42,-0.098501,-0.0047035,0.12626,0.78235,GOBP_REGULATION_OF_CELLULAR_RESPIRATION,1
BROWNE_HCMV_INFECTION_12HR_UP,SET,100,-0.066236,-0.0048726,0.08487,0.78243,BROWNE_HCMV_INFECTION_12HR_UP,1
GSE36891_POLYIC_TLR3_VS_PAM_...1,SET,146,-0.053936,-0.0047882,0.069107,0.78244,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,1
HP_ABNORMAL_SUBARACHNOID_SPA...,SET,70,-0.081608,-0.0050269,0.10453,0.78251,HP_ABNORMAL_SUBARACHNOID_SPACE_MORPHOLOGY,1
REACTOME_RUNX1_REGULATES_EXP...,SET,5,-0.31989,-0.0052756,0.40968,0.78254,REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS,1
HP_TUBE_FEEDING,SET,186,-0.049006,-0.0049051,0.062757,0.78256,HP_TUBE_FEEDING,1
HP_ABNORMAL_EYELID_MORPHOLOGY,SET,1180,-0.019895,-0.0048768,0.025472,0.78261,HP_ABNORMAL_EYELID_MORPHOLOGY,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...3,SET,180,-0.050086,-0.0049324,0.064116,0.78264,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,1
HP_ANHIDROSIS,SET,29,-0.13721,-0.0054462,0.17563,0.78267,HP_ANHIDROSIS,1
HP_HASHIMOTO_THYROIDITIS,SET,15,-0.17027,-0.0048625,0.21793,0.78268,HP_HASHIMOTO_THYROIDITIS,1
GSE10325_BCELL_VS_LUPUS_BCEL...2,SET,163,-0.052693,-0.0049404,0.067441,0.78269,GSE10325_BCELL_VS_LUPUS_BCELL_UP,1
WONG_ENDMETRIUM_CANCER_DN,SET,69,-0.088583,-0.0054176,0.11336,0.78273,WONG_ENDMETRIUM_CANCER_DN,1
GOBP_CHOLANGIOCYTE_PROLIFERA...,SET,4,-0.32342,-0.0047709,0.41385,0.78274,GOBP_CHOLANGIOCYTE_PROLIFERATION,1
DACOSTA_ERCC3_ALLELE_XPCS_VS...2,SET,26,-0.14048,-0.0052801,0.1797,0.78281,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,1
GOBP_SKELETAL_MUSCLE_TISSUE_...2,SET,36,-0.11817,-0.0052248,0.15114,0.78284,GOBP_SKELETAL_MUSCLE_TISSUE_REGENERATION,1
GOMF_HISTONE_H4K5_ACETYLTRAN...,SET,11,-0.19574,-0.0047873,0.25034,0.78285,GOMF_HISTONE_H4K5_ACETYLTRANSFERASE_ACTIVITY,1
MCBRYAN_PUBERTAL_BREAST_6_7W...2,SET,177,-0.049452,-0.0048297,0.063246,0.78286,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,1
MORF_IKBKG,SET,121,-0.057702,-0.0046666,0.073796,0.78286,MORF_IKBKG,1
SUPT20H_TARGET_GENES,SET,1113,-0.020336,-0.0048505,0.026004,0.78289,SUPT20H_TARGET_GENES,1
GSE17721_0.5H_VS_12H_LPS_BMD...2,SET,174,-0.048868,-0.0047325,0.062483,0.78292,GSE17721_0.5H_VS_12H_LPS_BMDC_UP,1
HARALAMBIEVA_PBMC_FLUARIX_AG...3,SET,8,-0.24189,-0.0050457,0.30922,0.78297,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE,1
REACTOME_INHIBITION_OF_THE_P...,SET,20,-0.14413,-0.004752,0.18422,0.783,REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,1
WP_HOSTPATHOGEN_INTERACTION_...1,SET,21,-0.15592,-0.0052678,0.19925,0.78305,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,1
MIR211_3P,SET,75,-0.078351,-0.004995,0.10011,0.78307,MIR211_3P,1
CLAUS_PGR_POSITIVE_MENINGIOM...1,SET,12,-0.23025,-0.0058816,0.29417,0.78309,CLAUS_PGR_POSITIVE_MENINGIOMA_DN,1
GCM_ING1,SET,61,-0.073553,-0.0042305,0.093971,0.7831,GCM_ING1,1
MIR4773,SET,171,-0.050614,-0.0048595,0.064649,0.78315,MIR4773,1
MIR92A_2_5P,SET,193,-0.048092,-0.0049024,0.061422,0.78317,MIR92A_2_5P,1
GOBP_ACIDIC_AMINO_ACID_TRANS...,SET,65,-0.088335,-0.0052441,0.11279,0.78323,GOBP_ACIDIC_AMINO_ACID_TRANSPORT,1
GSE28783_CTRL_ANTI_MIR_VS_UN...2,SET,171,-0.050575,-0.0048558,0.064579,0.78323,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,1
HP_BUNDLE_BRANCH_BLOCK,SET,68,-0.08046,-0.0048852,0.10272,0.78326,HP_BUNDLE_BRANCH_BLOCK,1
GOBP_ARP2_3_COMPLEX_MEDIATED...,SET,33,-0.10892,-0.0046113,0.13905,0.78328,GOBP_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
GOBP_INTERLEUKIN_6_PRODUCTION,SET,136,-0.060315,-0.0051693,0.076998,0.78328,GOBP_INTERLEUKIN_6_PRODUCTION,1
GOBP_REGULATION_OF_RETROGRAD...2,SET,5,-0.3,-0.0049477,0.38295,0.7833,GOBP_REGULATION_OF_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,1
GOBP_POSITIVE_REGULATION_OF_...287,SET,25,-0.14857,-0.0054759,0.1896,0.78335,GOBP_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,1
GSE22432_PDC_VS_TGFB1_TREATE...2,SET,168,-0.048636,-0.0046288,0.062068,0.78335,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP,1
MEBARKI_HCC_PROGENITOR_WNT_U...1,SET,107,-0.069948,-0.0053217,0.089258,0.78338,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,1
GOBP_REGULATION_OF_DNA_REPLI...,SET,117,-0.061051,-0.0048557,0.077901,0.78339,GOBP_REGULATION_OF_DNA_REPLICATION,1
REACTOME_SOMITOGENESIS,SET,52,-0.086542,-0.0045969,0.11041,0.78342,REACTOME_SOMITOGENESIS,1
GSE46025_WT_VS_FOXO1_KO_KLRG...1,SET,160,-0.051371,-0.0047723,0.065537,0.78343,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN,1
GNF2_GLTSCR2,SET,30,-0.11716,-0.0047296,0.14944,0.78346,GNF2_GLTSCR2,1
HP_RIEGER_ANOMALY,SET,11,-0.23023,-0.005631,0.29368,0.78346,HP_RIEGER_ANOMALY,1
CAR_WBSCR22,SET,32,-0.10968,-0.0045726,0.1399,0.78347,CAR_WBSCR22,1
CCACACA_MIR147,SET,56,-0.086595,-0.0047728,0.11044,0.78351,CCACACA_MIR147,1
HP_APLASIA_HYPOPLASIA_OF_THE...19,SET,646,-0.026098,-0.0048063,0.033283,0.78351,HP_APLASIA_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,1
GOBP_REGULATION_OF_NEUROTRAN...2,SET,8,-0.23439,-0.0048892,0.29874,0.78365,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
GOBP_POSITIVE_REGULATION_OF_...122,SET,54,-0.089616,-0.0048506,0.11421,0.78366,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GOBP_INTERFERON_MEDIATED_SIG...,SET,98,-0.072621,-0.0052889,0.09255,0.78367,GOBP_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOBP_URETERIC_BUD_FORMATION,SET,5,-0.34089,-0.005622,0.43444,0.78367,GOBP_URETERIC_BUD_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...426,SET,129,-0.061415,-0.0051273,0.078254,0.78371,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_ESTABLISH...3,SET,11,-0.1669,-0.004082,0.21266,0.78371,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
KEGG_LONG_TERM_POTENTIATION,SET,66,-0.081155,-0.0048547,0.1034,0.78374,KEGG_LONG_TERM_POTENTIATION,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...2,SET,177,-0.049518,-0.0048362,0.063068,0.78381,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,1
chr12q12,SET,24,-0.25794,-0.0093152,0.32851,0.78382,chr12q12,1
GOBP_PEPTIDYL_TYROSINE_AUTOP...,SET,16,-0.17071,-0.0050349,0.21741,0.78384,GOBP_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION,1
GNF2_MYD88,SET,54,-0.091788,-0.0049682,0.11688,0.78387,GNF2_MYD88,1
MORF_PDCD1,SET,64,-0.086976,-0.0051237,0.11074,0.78388,MORF_PDCD1,1
GOBP_LEUKOCYTE_CHEMOTAXIS,SET,219,-0.050047,-0.0054306,0.063724,0.78388,GOBP_LEUKOCYTE_CHEMOTAXIS,1
GSE14308_TH1_VS_INDUCED_TREG...1,SET,176,-0.048534,-0.0047267,0.061777,0.78395,GSE14308_TH1_VS_INDUCED_TREG_DN,1
REACTOME_HSF1_DEPENDENT_TRAN...,SET,36,-0.11162,-0.0049356,0.14204,0.78402,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,1
GOBP_ASYMMETRIC_CELL_DIVISION,SET,18,-0.17873,-0.0055907,0.2274,0.78405,GOBP_ASYMMETRIC_CELL_DIVISION,1
BIOCARTA_TGFB_PATHWAY,SET,19,-0.16284,-0.0052333,0.20717,0.78407,BIOCARTA_TGFB_PATHWAY,1
HP_EEG_WITH_BURST_SUPPRESSION,SET,56,-0.090047,-0.0049631,0.11456,0.78407,HP_EEG_WITH_BURST_SUPPRESSION,1
MIR371A_3P,SET,9,-0.24322,-0.0053809,0.3094,0.78408,MIR371A_3P,1
REACTOME_FORMATION_OF_THE_AN...,SET,9,-0.28005,-0.0061959,0.35624,0.7841,REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE,1
REACTOME_MINERALOCORTICOID_B...,SET,6,-0.29677,-0.0053613,0.37743,0.78414,REACTOME_MINERALOCORTICOID_BIOSYNTHESIS,1
GOMF_NEUROPEPTIDE_RECEPTOR_A...,SET,42,-0.11809,-0.0056387,0.15016,0.78417,GOMF_NEUROPEPTIDE_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_CORTICAL_BONE_MO...,SET,77,-0.078254,-0.0050547,0.099483,0.78424,HP_ABNORMAL_CORTICAL_BONE_MORPHOLOGY,1
HP_ABNORMAL_MOTOR_NERVE_COND...,SET,60,-0.084889,-0.0048425,0.10788,0.78433,HP_ABNORMAL_MOTOR_NERVE_CONDUCTION_VELOCITY,1
HP_SMALL_FOR_GESTATIONAL_AGE,SET,226,-0.044807,-0.0049382,0.056933,0.78436,HP_SMALL_FOR_GESTATIONAL_AGE,1
MIR4659B_5P,SET,91,-0.068821,-0.0048308,0.087441,0.78437,MIR4659B_5P,1
GAO_LARGE_INTESTINE_ADULT_CJ...,SET,439,-0.035702,-0.0054516,0.045357,0.78439,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,1
GOBP_IRON_ION_IMPORT_ACROSS_...,SET,4,-0.3149,-0.0046452,0.40003,0.78441,GOBP_IRON_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_REGULATION_OF_HYALURONA...,SET,8,-0.23918,-0.0049891,0.30379,0.78444,GOBP_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS,1
GOBP_TELOMERE_MAINTENANCE,SET,142,-0.052124,-0.004564,0.066203,0.78445,GOBP_TELOMERE_MAINTENANCE,1
GOBP_LYMPHOCYTE_MEDIATED_IMM...,SET,268,-0.044826,-0.0053735,0.056932,0.78446,GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY,1
REACTOME_RIBAVIRIN_ADME,SET,11,-0.23088,-0.0056469,0.2932,0.78449,REACTOME_RIBAVIRIN_ADME,1
TAVOR_CEBPA_TARGETS_UP,SET,47,-0.1075,-0.0054295,0.13651,0.7845,TAVOR_CEBPA_TARGETS_UP,1
GOBP_BRAINSTEM_DEVELOPMENT,SET,7,-0.2482,-0.004843,0.31512,0.78454,GOBP_BRAINSTEM_DEVELOPMENT,1
REACTOME_SENESCENCE_ASSOCIAT...,SET,49,-0.099,-0.0051051,0.12568,0.78456,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1
WP_SENESCENCEASSOCIATED_SECR...,SET,49,-0.099,-0.0051051,0.12568,0.78456,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,1
GSE11961_MEMORY_BCELL_DAY7_V...6,SET,180,-0.050859,-0.0050086,0.064564,0.78457,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,1
PETRETTO_HEART_MASS_QTL_CIS_...2,SET,30,-0.12271,-0.0049539,0.15575,0.78461,PETRETTO_HEART_MASS_QTL_CIS_UP,1
PRDM12_TARGET_GENES,SET,93,-0.067306,-0.0047758,0.085417,0.78464,PRDM12_TARGET_GENES,1
GSE14699_DELETIONAL_TOLERANC...1,SET,167,-0.052168,-0.0049503,0.066195,0.78468,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,1
GOBP_MODULATION_BY_HOST_OF_V...1,SET,21,-0.15146,-0.0051168,0.19214,0.78472,GOBP_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
GOBP_GAMMA_DELTA_T_CELL_DIFF...,SET,13,-0.18128,-0.0048198,0.22993,0.78477,GOBP_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
GOMF_PHOSPHATIDYLINOSITOL_3_...6,SET,5,-0.22491,-0.0037093,0.28527,0.78477,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,1
GSE5542_UNTREATED_VS_IFNG_TR...1,SET,167,-0.051206,-0.004859,0.064936,0.78481,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
GOBP_POSITIVE_REGULATION_OF_...154,SET,67,-0.088287,-0.005321,0.1119,0.78493,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,1
GOBP_REGULATION_OF_HIGH_VOLT...,SET,8,-0.26948,-0.0056212,0.34153,0.78495,GOBP_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_THYR...1,SET,20,-0.15582,-0.0051374,0.19746,0.78497,HP_ABNORMAL_CIRCULATING_THYROGLOBULIN_CONCENTRATION,1
HP_HYPOHIDROSIS_OR_HYPERHIDR...,SET,210,-0.047578,-0.0050568,0.060273,0.78505,HP_HYPOHIDROSIS_OR_HYPERHIDROSIS,1
GOBP_PROTEIN_SULFATION,SET,6,-0.29369,-0.0053057,0.37192,0.78513,GOBP_PROTEIN_SULFATION,1
GSE2770_TGFB_AND_IL4_VS_IL12...2,SET,172,-0.048998,-0.0047179,0.06203,0.7852,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
GSE42724_MEMORY_VS_B1_BCELL_...1,SET,169,-0.053245,-0.0050823,0.067404,0.78521,GSE42724_MEMORY_VS_B1_BCELL_DN,1
GOMF_ATPASE_ACTIVATOR_ACTIVI...,SET,24,-0.13348,-0.0048205,0.16896,0.78523,GOMF_ATPASE_ACTIVATOR_ACTIVITY,1
GOBP_RESPONSE_TO_CORTISOL,SET,6,-0.31126,-0.0056231,0.39394,0.78526,GOBP_RESPONSE_TO_CORTISOL,1
GOMF_OXYGEN_SENSOR_ACTIVITY,SET,5,-0.24064,-0.0039686,0.30452,0.78529,GOMF_OXYGEN_SENSOR_ACTIVITY,1
HP_CHRONIC_MYELOGENOUS_LEUKE...,SET,9,-0.22793,-0.0050427,0.28843,0.7853,HP_CHRONIC_MYELOGENOUS_LEUKEMIA,1
FAN_EMBRYONIC_CTX_OLIG,SET,671,-0.027144,-0.0050911,0.034349,0.78531,FAN_EMBRYONIC_CTX_OLIG,1
MIR370_5P,SET,67,-0.083624,-0.0050399,0.1058,0.78534,MIR370_5P,1
REACTOME_SIGNALING_BY_INSULI...,SET,79,-0.078136,-0.0051119,0.098828,0.78541,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,1
TERT_TARGET_GENES,SET,72,-0.082846,-0.0051753,0.10477,0.78546,TERT_TARGET_GENES,1
GOBP_PURINE_DEOXYRIBONUCLEOT...2,SET,10,-0.21869,-0.0051,0.27655,0.78546,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...675,SET,7,-0.28147,-0.0054923,0.35592,0.78547,GOBP_POSITIVE_REGULATION_OF_RESPIRATORY_BURST,1
HP_ABNORMAL_SCROTUM_MORPHOLO...,SET,110,-0.067577,-0.0052125,0.085445,0.78549,HP_ABNORMAL_SCROTUM_MORPHOLOGY,1
MAGRANGEAS_MULTIPLE_MYELOMA_...1,SET,24,-0.1457,-0.0052618,0.1842,0.78552,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,1
SIX4_TARGET_GENES,SET,33,-0.11115,-0.0047059,0.14051,0.78554,SIX4_TARGET_GENES,1
SESTO_RESPONSE_TO_UV_C8,SET,66,-0.085835,-0.0051346,0.10849,0.78558,SESTO_RESPONSE_TO_UV_C8,1
GOBP_AMINO_ACID_TRANSPORT,SET,147,-0.058994,-0.005255,0.074549,0.78562,GOBP_AMINO_ACID_TRANSPORT,1
GOBP_FIBROBLAST_GROWTH_FACTO...2,SET,74,-0.085848,-0.0054365,0.10848,0.78564,GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_AGGREPHAGY,SET,38,-0.11024,-0.0050078,0.13924,0.78575,REACTOME_AGGREPHAGY,1
MODULE_426,SET,81,-0.076905,-0.0050944,0.097101,0.78582,MODULE_426,1
GOBP_COENZYME_A_METABOLIC_PR...,SET,18,-0.15057,-0.00471,0.19008,0.78586,GOBP_COENZYME_A_METABOLIC_PROCESS,1
GOBP_COLLAGEN_FIBRIL_ORGANIZ...,SET,63,-0.091126,-0.0053262,0.11504,0.78586,GOBP_COLLAGEN_FIBRIL_ORGANIZATION,1
GOBP_BRONCHUS_DEVELOPMENT,SET,11,-0.23532,-0.0057553,0.29705,0.78587,GOBP_BRONCHUS_DEVELOPMENT,1
TCF4_Q5,SET,219,-0.049492,-0.0053703,0.062466,0.7859,TCF4_Q5,1
HP_PROMINENT_SUPERFICIAL_BLO...,SET,33,-0.11155,-0.0047228,0.14079,0.78591,HP_PROMINENT_SUPERFICIAL_BLOOD_VESSELS,1
GOMF_COPPER_ION_TRANSMEMBRAN...,SET,6,-0.26603,-0.004806,0.33573,0.78593,GOMF_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
WP_METABOLIC_EPILEPTIC_DISOR...,SET,80,-0.07503,-0.0049395,0.094683,0.78594,WP_METABOLIC_EPILEPTIC_DISORDERS,1
MIR6780B_3P,SET,56,-0.092272,-0.0050857,0.11643,0.78596,MIR6780B_3P,1
HP_PROTEIN_AVOIDANCE,SET,5,-0.29632,-0.0048869,0.37384,0.78599,HP_PROTEIN_AVOIDANCE,1
GOCC_SEMAPHORIN_RECEPTOR_COM...,SET,11,-0.21726,-0.0053137,0.27406,0.78603,GOCC_SEMAPHORIN_RECEPTOR_COMPLEX,1
REACTOME_O_LINKED_GLYCOSYLAT...1,SET,100,-0.074778,-0.005501,0.0943,0.7861,REACTOME_O_LINKED_GLYCOSYLATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...45,SET,219,-0.045875,-0.0049779,0.057851,0.7861,HP_APLASIA_HYPOPLASIA_OF_THE_NAILS,1
GOMF_NAD_P_H_DEHYDROGENASE_Q...,SET,5,-0.31495,-0.0051943,0.39712,0.78613,GOMF_NAD_P_H_DEHYDROGENASE_QUINONE_ACTIVITY,1
ROYLANCE_BREAST_CANCER_16Q_C...2,SET,59,-0.13359,-0.007557,0.16841,0.78617,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,1
HP_UPPER_EXTREMITY_JOINT_DIS...,SET,81,-0.07584,-0.0050238,0.095607,0.78618,HP_UPPER_EXTREMITY_JOINT_DISLOCATION,1
HP_HYPOPLASIA_OF_PENIS,SET,340,-0.03756,-0.0050612,0.047342,0.78621,HP_HYPOPLASIA_OF_PENIS,1
REACTOME_RUNX2_REGULATES_CHO...,SET,5,-0.31519,-0.0051982,0.39719,0.78627,REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION,1
AHR_01,SET,54,-0.089962,-0.0048693,0.11336,0.78627,AHR_01,1
BIOCARTA_CREM_PATHWAY,SET,6,-0.31868,-0.0057573,0.40153,0.7863,BIOCARTA_CREM_PATHWAY,1
MIR877_5P,SET,75,-0.078123,-0.0049805,0.09841,0.78636,MIR877_5P,1
GOMF_PHOSPHATIDYLINOSITOL_3_...4,SET,25,-0.13427,-0.0049488,0.16907,0.78644,GOMF_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING,1
GSE2770_IL12_AND_TGFB_ACT_VS...3,SET,181,-0.049207,-0.0048592,0.06196,0.78645,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN,1
GOBP_MEMBRANE_DEPOLARIZATION...2,SET,5,-0.35227,-0.0058097,0.44352,0.78647,GOBP_MEMBRANE_DEPOLARIZATION_DURING_AV_NODE_CELL_ACTION_POTENTIAL,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...2,SET,6,-0.25175,-0.0045481,0.31696,0.78647,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_I_PROTEIN_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...36,SET,11,-0.19632,-0.0048014,0.24714,0.7865,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,1
MIR499A_3P,SET,152,-0.059781,-0.0054142,0.075245,0.78654,MIR499A_3P,1
GSE37301_MULTIPOTENT_PROGENI...2,SET,148,-0.058859,-0.0052606,0.074082,0.78654,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP,1
GSE34156_UNTREATED_VS_24H_NO...3,SET,176,-0.05349,-0.0052094,0.067304,0.78661,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN,1
MIR384,SET,109,-0.064622,-0.004962,0.081264,0.78675,MIR384,1
MIR6529_5P,SET,42,-0.1072,-0.0051187,0.13479,0.78676,MIR6529_5P,1
HP_SHORT_STEPPED_SHUFFLING_G...,SET,14,-0.17606,-0.0048573,0.22135,0.78679,HP_SHORT_STEPPED_SHUFFLING_GAIT,1
GOBP_DNA_RECOMBINATION,SET,284,-0.038512,-0.0047503,0.048415,0.78682,GOBP_DNA_RECOMBINATION,1
GSE2770_UNTREATED_VS_TGFB_AN...1,SET,177,-0.051662,-0.0050456,0.06493,0.78688,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
GOBP_REGULATION_OF_RESPIRATO...2,SET,7,-0.28158,-0.0054943,0.35384,0.78691,GOBP_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
MIR411_5P,SET,44,-0.099475,-0.0048615,0.125,0.78692,MIR411_5P,1
GSE17721_LPS_VS_POLYIC_1H_BM...2,SET,177,-0.051408,-0.0050208,0.064598,0.78692,GSE17721_LPS_VS_POLYIC_1H_BMDC_UP,1
HP_APLASIA_OF_THE_OVARY,SET,4,-0.30579,-0.0045108,0.38416,0.78698,HP_APLASIA_OF_THE_OVARY,1
SCHAEFFER_PROSTATE_DEVELOPME...7,SET,9,-0.21033,-0.0046534,0.26422,0.78699,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN,1
GOCC_NEURON_TO_NEURON_SYNAPSE,SET,338,-0.038305,-0.0051468,0.048116,0.78701,GOCC_NEURON_TO_NEURON_SYNAPSE,1
HP_EMPHYSEMA,SET,63,-0.085459,-0.004995,0.10733,0.78704,HP_EMPHYSEMA,1
KAECH_NAIVE_VS_MEMORY_CD8_TC...2,SET,184,-0.051095,-0.0050869,0.064169,0.78706,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
HP_STROKE,SET,148,-0.058911,-0.0052653,0.073977,0.78708,HP_STROKE,1
WP_FOXA2_PATHWAY,SET,21,-0.15781,-0.0053314,0.19809,0.78716,WP_FOXA2_PATHWAY,1
MIR3156_5P,SET,61,-0.09538,-0.0054859,0.11971,0.78719,MIR3156_5P,1
GAL_LEUKEMIC_STEM_CELL_UP,SET,110,-0.066002,-0.005091,0.082833,0.78722,GAL_LEUKEMIC_STEM_CELL_UP,1
MARKS_HDAC_TARGETS_DN,SET,14,-0.19325,-0.0053317,0.2425,0.78723,MARKS_HDAC_TARGETS_DN,1
KEGG_MEDICUS_REFERENCE_BMP9_...,SET,8,-0.27554,-0.0057476,0.34576,0.78724,KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY,1
WP_AXON_GUIDANCE,SET,69,-0.088865,-0.0054349,0.11149,0.78729,WP_AXON_GUIDANCE,1
SHEN_SMARCA2_TARGETS_UP,SET,389,-0.033884,-0.0048773,0.042506,0.78732,SHEN_SMARCA2_TARGETS_UP,1
REACTOME_MATURATION_OF_SARS_...2,SET,15,-0.15844,-0.0045245,0.19868,0.7874,REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,1
HP_LIMB_JOINT_CONTRACTURE,SET,399,-0.035059,-0.0051094,0.043964,0.7874,HP_LIMB_JOINT_CONTRACTURE,1
MIR4440,SET,5,-0.37098,-0.0061183,0.465,0.78751,MIR4440,1
HP_CHRONIC_RHINITIS,SET,49,-0.094897,-0.0048935,0.11894,0.78751,HP_CHRONIC_RHINITIS,1
WP_LIPID_PARTICLES_COMPOSITI...,SET,10,-0.22906,-0.0053418,0.28699,0.7876,WP_LIPID_PARTICLES_COMPOSITION,1
HP_SEVERE_SHORT_STATURE,SET,96,-0.070598,-0.0050891,0.088445,0.78762,HP_SEVERE_SHORT_STATURE,1
GOBP_REGULATION_OF_ELECTRON_...,SET,3,-0.38554,-0.0049254,0.48265,0.78779,GOBP_REGULATION_OF_ELECTRON_TRANSFER_ACTIVITY,1
AACYNNNNTTCCS_UNKNOWN,SET,88,-0.075025,-0.0051791,0.093879,0.7879,AACYNNNNTTCCS_UNKNOWN,1
HP_ABNORMAL_COLUMELLA_MORPHO...,SET,78,-0.075341,-0.0048979,0.094265,0.78792,HP_ABNORMAL_COLUMELLA_MORPHOLOGY,1
MORF_ACTG1,SET,126,-0.059513,-0.0049108,0.074449,0.78796,MORF_ACTG1,1
CONCANNON_APOPTOSIS_BY_EPOXO...2,SET,216,-0.04752,-0.0051214,0.059438,0.78799,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,1
IIZUKA_LIVER_CANCER_PROGRESS...5,SET,15,-0.1724,-0.0049233,0.21564,0.78799,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,1
GOBP_REGULATION_OF_DNA_DEMET...,SET,4,-0.33451,-0.0049346,0.41839,0.788,GOBP_REGULATION_OF_DNA_DEMETHYLATION,1
WP_FOLLICLE_STIMULATING_HORM...,SET,26,-0.13989,-0.0052581,0.17493,0.78805,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,1
HP_ABNORMALITY_OF_THE_ABDOMI...2,SET,467,-0.032287,-0.0050809,0.040368,0.78808,HP_ABNORMALITY_OF_THE_ABDOMINAL_WALL,1
BIOCARTA_FOSB_PATHWAY,SET,5,-0.31135,-0.0051349,0.38924,0.78811,BIOCARTA_FOSB_PATHWAY,1
MIR4327,SET,74,-0.089797,-0.0056866,0.11226,0.78812,MIR4327,1
GSE7852_LN_VS_THYMUS_TCONV_DN,SET,187,-0.048271,-0.0048443,0.060339,0.78814,GSE7852_LN_VS_THYMUS_TCONV_DN,1
GOBP_XENOBIOTIC_CATABOLIC_PR...,SET,23,-0.14028,-0.0049595,0.17534,0.78816,GOBP_XENOBIOTIC_CATABOLIC_PROCESS,1
HP_RIGHT_BUNDLE_BRANCH_BLOCK,SET,50,-0.095657,-0.0049827,0.11956,0.78816,HP_RIGHT_BUNDLE_BRANCH_BLOCK,1
WP_OMEGA6FATTY_ACIDS_IN_SENE...,SET,55,-0.09414,-0.0051423,0.11766,0.78817,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,1
HOX13_01,SET,42,-0.1119,-0.0053433,0.13985,0.78818,HOX13_01,1
HP_LAMBDOIDAL_CRANIOSYNOSTOS...,SET,15,-0.16182,-0.0046211,0.20223,0.78819,HP_LAMBDOIDAL_CRANIOSYNOSTOSIS,1
GOCC_PHOSPHORYLASE_KINASE_CO...,SET,3,-0.31397,-0.0040111,0.39235,0.78821,GOCC_PHOSPHORYLASE_KINASE_COMPLEX,1
PURWIN_A375_MEWO_COMMON_SOX1...,SET,25,-0.13895,-0.0051214,0.17362,0.78823,PURWIN_A375_MEWO_COMMON_SOX10_TARGETS,1
HP_ABNORMALITY_OF_PREMOLAR,SET,12,-0.2192,-0.0055994,0.27389,0.78823,HP_ABNORMALITY_OF_PREMOLAR,1
HP_HYPOPLASTIC_PELVIS,SET,14,-0.19002,-0.0052427,0.23742,0.78824,HP_HYPOPLASTIC_PELVIS,1
KEGG_MEDICUS_VARIANT_ERBB2_O...2,SET,12,-0.19903,-0.0050841,0.24864,0.78828,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
KEGG_TAURINE_AND_HYPOTAURINE...,SET,10,-0.23286,-0.0054303,0.29088,0.78829,KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM,1
KEGG_MEDICUS_VARIANT_MUTATIO...10,SET,8,-0.2457,-0.0051252,0.30685,0.78835,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY,1
HP_SKIN_APPENDAGE_NEOPLASM,SET,16,-0.18175,-0.0053604,0.22692,0.78841,HP_SKIN_APPENDAGE_NEOPLASM,1
GOMF_MONOCARBOXYLIC_ACID_TRA...,SET,67,-0.088188,-0.005315,0.1101,0.78843,GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...20,SET,27,-0.14589,-0.0055877,0.18212,0.78845,GOBP_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT,1
HE_LIM_SUN_FETAL_LUNG_C1_INT...,SET,243,-0.047084,-0.0053782,0.058766,0.78849,HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL,1
HP_SHORT_LOWER_LIMBS,SET,12,-0.19816,-0.0050619,0.24731,0.7885,HP_SHORT_LOWER_LIMBS,1
GOCC_PLATELET_ALPHA_GRANULE_...2,SET,16,-0.19296,-0.005691,0.24082,0.78851,GOCC_PLATELET_ALPHA_GRANULE_MEMBRANE,1
GOMF_GAP_JUNCTION_HEMI_CHANN...,SET,6,-0.33732,-0.0060938,0.42089,0.78855,GOMF_GAP_JUNCTION_HEMI_CHANNEL_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C4_NKT...1,SET,8,-0.26579,-0.0055443,0.33158,0.7886,HE_LIM_SUN_FETAL_LUNG_C4_NKT1_CELL,1
MIR197_5P,SET,57,-0.090454,-0.0050297,0.11282,0.78865,MIR197_5P,1
GOBP_PRIMARY_ALCOHOL_METABOL...,SET,95,-0.077134,-0.0055314,0.096178,0.78872,GOBP_PRIMARY_ALCOHOL_METABOLIC_PROCESS,1
EPPERT_PROGENITOR,SET,124,-0.060314,-0.0049375,0.075192,0.78876,EPPERT_PROGENITOR,1
TIEN_INTESTINE_PROBIOTICS_6H...1,SET,159,-0.053502,-0.0049549,0.066689,0.7888,TIEN_INTESTINE_PROBIOTICS_6HR_DN,1
KEGG_MEDICUS_REFERENCE_HGF_M...2,SET,14,-0.1811,-0.0049964,0.22572,0.7888,KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY,1
ZNF416_TARGET_GENES,SET,4,-0.32018,-0.0047232,0.39904,0.78883,ZNF416_TARGET_GENES,1
GOBP_ERK1_AND_ERK2_CASCADE,SET,281,-0.043012,-0.0052777,0.053589,0.7889,GOBP_ERK1_AND_ERK2_CASCADE,1
DESCARTES_FETAL_CEREBELLUM_I...,SET,24,-0.16364,-0.0059098,0.20388,0.7889,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,1
CHIANG_LIVER_CANCER_SUBCLASS...7,SET,166,-0.056532,-0.0053485,0.070421,0.78894,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,1
GSE14308_INDUCED_VS_NATURAL_...1,SET,182,-0.050637,-0.0050141,0.063077,0.78895,GSE14308_INDUCED_VS_NATURAL_TREG_DN,1
HP_LARGE_FONTANELLES,SET,151,-0.056535,-0.0051035,0.070418,0.78896,HP_LARGE_FONTANELLES,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...1,SET,156,-0.058625,-0.0053783,0.073014,0.78899,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN,1
HP_MONOCYTOSIS,SET,15,-0.15834,-0.0045218,0.19718,0.78901,HP_MONOCYTOSIS,1
chr6q24,SET,32,-0.22466,-0.0093666,0.27967,0.7891,chr6q24,1
REACTOME_NCAM1_INTERACTIONS,SET,41,-0.11623,-0.0054835,0.14464,0.78917,REACTOME_NCAM1_INTERACTIONS,1
GSE17186_BLOOD_VS_CORD_BLOOD...5,SET,175,-0.049947,-0.0048507,0.062151,0.78919,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN,1
CHEN_NEUROBLASTOMA_COPY_NUMB...,SET,48,-0.11563,-0.0059018,0.14384,0.78926,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,1
GOBP_MYOTUBE_DIFFERENTIATION...,SET,7,-0.30173,-0.0058876,0.37524,0.78932,GOBP_MYOTUBE_DIFFERENTIATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
MIR137_3P,SET,482,-0.032784,-0.0052393,0.040767,0.78935,MIR137_3P,1
GOMF_ATP_DEPENDENT_ACTIVITY,SET,533,-0.029715,-0.0049866,0.036945,0.78939,GOMF_ATP_DEPENDENT_ACTIVITY,1
GOBP_L_GLUTAMINE_IMPORT_ACRO...,SET,4,-0.36208,-0.0053412,0.45003,0.78946,GOBP_L_GLUTAMINE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_GENERATION_OF_PRECURSOR...,SET,393,-0.033519,-0.0048489,0.041656,0.78948,GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,1
LI_PROSTATE_CANCER_EPIGENETIC,SET,30,-0.13278,-0.0053605,0.165,0.78951,LI_PROSTATE_CANCER_EPIGENETIC,1
KEGG_MEDICUS_VARIANT_AMPLIFI...17,SET,8,-0.25887,-0.0053999,0.32168,0.78951,KEGG_MEDICUS_VARIANT_AMPLIFIED_REL_TO_TRANSCRIPTION,1
CEBPGAMMA_Q6,SET,233,-0.046859,-0.0052427,0.058222,0.78954,CEBPGAMMA_Q6,1
GOBP_NEPHRON_TUBULE_EPITHELI...,SET,13,-0.22746,-0.0060476,0.28261,0.78955,GOBP_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,1
SHETH_LIVER_CANCER_VS_TXNIP_...4,SET,258,-0.043629,-0.0051329,0.054194,0.7896,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,1
GOBP_NEGATIVE_REGULATION_OF_...209,SET,59,-0.095354,-0.0053941,0.11845,0.7896,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,1
GOCC_NUCLEAR_PORE_OUTER_RING,SET,10,-0.19183,-0.0044736,0.23829,0.7896,GOCC_NUCLEAR_PORE_OUTER_RING,1
GOMF_OXIDOREDUCTASE_ACTIVITY...13,SET,75,-0.073962,-0.0047152,0.091871,0.7896,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,1
GOMF_EFFLUX_TRANSMEMBRANE_TR...,SET,15,-0.17897,-0.005111,0.22228,0.78963,GOMF_EFFLUX_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
FERRARI_RESPONSE_TO_FENRETIN...1,SET,5,-0.36849,-0.0060772,0.45758,0.78967,FERRARI_RESPONSE_TO_FENRETINIDE_DN,1
RUBENSTEIN_SKELETAL_MUSCLE_P...2,SET,116,-0.066981,-0.0053046,0.083174,0.78967,RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES,1
GOBP_CELLULAR_RESPONSE_TO_AR...,SET,16,-0.16854,-0.0049707,0.20927,0.78968,GOBP_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,1
GOBP_N_ACETYLGLUCOSAMINE_MET...,SET,14,-0.19124,-0.0052762,0.23746,0.78968,GOBP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,1
GSE9006_HEALTHY_VS_TYPE_1_DI...1,SET,171,-0.050823,-0.0048795,0.063107,0.78968,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN,1
MARTINEZ_RESPONSE_TO_TRABECT...2,SET,254,-0.041171,-0.0048066,0.05112,0.78969,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1
GCM_ZNF198,SET,111,-0.062402,-0.004835,0.077482,0.78969,GCM_ZNF198,1
KEGG_MEDICUS_VARIANT_MUTATIO...20,SET,8,-0.24463,-0.0051027,0.30368,0.78974,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_SECONDARY_METABOLITE_BI...,SET,24,-0.14904,-0.0053825,0.18503,0.78974,GOBP_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
GOBP_CALCIUM_ION_IMPORT_ACRO...,SET,36,-0.11859,-0.0052434,0.14721,0.78975,GOBP_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
WP_KISSPEPTINKISSPEPTIN_RECE...,SET,38,-0.11321,-0.0051425,0.14051,0.78979,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,1
GAUCHER_PBMC_YF_VAX_STAMARIL...11,SET,171,-0.052976,-0.0050862,0.065721,0.78989,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN,1
HP_GASTROINTESTINAL_INFARCTI...,SET,13,-0.20499,-0.00545,0.25429,0.7899,HP_GASTROINTESTINAL_INFARCTIONS,1
GSE13887_RESTING_VS_ACT_CD4_...1,SET,116,-0.062123,-0.0049199,0.077032,0.79,GSE13887_RESTING_VS_ACT_CD4_TCELL_DN,1
HP_HEMATEMESIS,SET,17,-0.18032,-0.0054818,0.2236,0.79001,HP_HEMATEMESIS,1
GOBP_POLYAMINE_TRANSPORT,SET,16,-0.17597,-0.00519,0.21817,0.79004,GOBP_POLYAMINE_TRANSPORT,1
GOMF_XMP_5_NUCLEOSIDASE_ACTI...,SET,5,-0.37416,-0.0061707,0.46378,0.79009,GOMF_XMP_5_NUCLEOSIDASE_ACTIVITY,1
GOMF_MONOATOMIC_ION_TRANSMEM...,SET,687,-0.027747,-0.0052634,0.034388,0.79012,GOMF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
ZNF350_TARGET_GENES,SET,1153,-0.020985,-0.0050886,0.026004,0.79016,ZNF350_TARGET_GENES,1
GSE36476_YOUNG_VS_OLD_DONOR_...5,SET,173,-0.052305,-0.0050509,0.064815,0.79016,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN,1
MIR6748_3P,SET,79,-0.077694,-0.005083,0.096266,0.79018,MIR6748_3P,1
GSE7596_AKT_TRANSD_VS_CTRL_C...1,SET,109,-0.067424,-0.0051771,0.083537,0.7902,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN,1
GOBP_REGULATION_OF_MITOCHOND...10,SET,62,-0.089289,-0.0051774,0.1106,0.79025,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,1
MIR663B,SET,28,-0.12986,-0.0050648,0.16083,0.79028,MIR663B,1
GOCC_CLATHRIN_COMPLEX,SET,8,-0.2315,-0.004829,0.28668,0.79031,GOCC_CLATHRIN_COMPLEX,1
GSE21927_UNTREATED_VS_GMCSF_...2,SET,166,-0.055123,-0.0052152,0.068262,0.79031,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,1
HP_POLYNEUROPATHY,SET,45,-0.10598,-0.0052379,0.13124,0.79032,HP_POLYNEUROPATHY,1
GOMF_NUCLEOBASE_TRANSMEMBRAN...,SET,10,-0.21513,-0.0050169,0.26635,0.79037,GOMF_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE9960_HEALTHY_VS_GRAM_NEG_...2,SET,148,-0.056852,-0.0050812,0.070379,0.79039,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,1
MIR548AS_3P,SET,241,-0.044634,-0.0050776,0.055243,0.79044,MIR548AS_3P,1
GOBP_REGULATION_OF_EPITHELIA...6,SET,7,-0.29813,-0.0058172,0.36898,0.79044,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
ELF1_Q6,SET,227,-0.044962,-0.0049661,0.055646,0.79045,ELF1_Q6,1
HP_SLENDER_FINGER,SET,130,-0.059935,-0.005023,0.074176,0.79045,HP_SLENDER_FINGER,1
KAECH_DAY8_EFF_VS_DAY15_EFF_...1,SET,183,-0.051778,-0.005141,0.064083,0.79045,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN,1
GSE46606_DAY1_VS_DAY3_CD40L_...2,SET,155,-0.059673,-0.005457,0.073851,0.79046,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP,1
GOCC_CELL_PROJECTION_MEMBRANE,SET,330,-0.037863,-0.0050279,0.046852,0.79049,GOCC_CELL_PROJECTION_MEMBRANE,1
HP_EPISODIC_FLACCID_WEAKNESS,SET,5,-0.35128,-0.0057934,0.4346,0.79053,HP_EPISODIC_FLACCID_WEAKNESS,1
REACTOME_ANDROGEN_BIOSYNTHES...,SET,11,-0.21502,-0.0052588,0.26593,0.79061,REACTOME_ANDROGEN_BIOSYNTHESIS,1
GOBP_ISOTYPE_SWITCHING_TO_IG...2,SET,15,-0.1728,-0.0049347,0.21371,0.79061,GOBP_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,1
GOCC_GEMINI_OF_COILED_BODIES,SET,9,-0.18739,-0.0041459,0.23175,0.79063,GOCC_GEMINI_OF_COILED_BODIES,1
GOBP_MONOAMINE_TRANSPORT,SET,72,-0.087231,-0.0054493,0.10785,0.79068,GOBP_MONOAMINE_TRANSPORT,1
GOBP_MONOATOMIC_ION_TRANSMEM...,SET,904,-0.024788,-0.0053608,0.03063,0.79082,GOBP_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,1
GSE21927_SPLENIC_VS_TUMOR_MO...2,SET,164,-0.05367,-0.0050473,0.066315,0.79083,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP,1
MIR4798_3P,SET,10,-0.18275,-0.0042618,0.2258,0.79084,MIR4798_3P,1
HP_ABNORMALITY_OF_THE_CALF,SET,272,-0.0431,-0.0052044,0.053252,0.79084,HP_ABNORMALITY_OF_THE_CALF,1
HP_ABNORMAL_NIPPLE_MORPHOLOGY,SET,209,-0.046471,-0.0049274,0.057413,0.79086,HP_ABNORMAL_NIPPLE_MORPHOLOGY,1
HERNANDEZ_MITOTIC_ARREST_BY_...2,SET,23,-0.16405,-0.0058,0.20265,0.79089,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,1
MODULE_342,SET,194,-0.052527,-0.0053682,0.064882,0.7909,MODULE_342,1
MODULE_175,SET,52,-0.097199,-0.005163,0.12006,0.79091,MODULE_175,1
GSE2770_UNTREATED_VS_TGFB_AN...11,SET,116,-0.061773,-0.0048922,0.07629,0.79094,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN,1
RAG1_TARGET_GENES,SET,851,-0.024261,-0.0050983,0.029949,0.79104,RAG1_TARGET_GENES,1
KEGG_GAP_JUNCTION,SET,84,-0.080464,-0.0054275,0.099326,0.79105,KEGG_GAP_JUNCTION,1
GSE23568_CTRL_TRANSDUCED_VS_...1,SET,187,-0.049019,-0.0049194,0.060507,0.79106,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN,1
HOEK_T_CELL_2011_2012_TIV_AD...4,SET,9,-0.2385,-0.0052765,0.2944,0.79106,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_UP,1
MIR4768_5P,SET,302,-0.041113,-0.0052268,0.050723,0.79118,MIR4768_5P,1
KEGG_MEDICUS_VARIANT_MUTATIO...78,SET,7,-0.24584,-0.0047969,0.30326,0.79121,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048,1
LANDIS_ERBB2_BREAST_TUMORS_3...1,SET,141,-0.061037,-0.0053257,0.075291,0.79122,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1
GOCC_GOLGI_LUMEN,SET,88,-0.078317,-0.0054064,0.096571,0.7913,GOCC_GOLGI_LUMEN,1
DURANTE_ADULT_OLFACTORY_NEUR...5,SET,103,-0.072969,-0.0054474,0.089976,0.79131,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_DENDRITIC_CELLS,1
REACTOME_PHASE_II_CONJUGATIO...,SET,99,-0.08247,-0.0060366,0.10164,0.79142,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1
HP_PENILE_FRECKLING,SET,5,-0.25392,-0.0041877,0.31295,0.79142,HP_PENILE_FRECKLING,1
WANG_IMMORTALIZED_BY_HOXA9_A...1,SET,24,-0.15718,-0.0056765,0.19371,0.79144,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,1
GOBP_POSITIVE_REGULATION_OF_...155,SET,136,-0.063316,-0.0054265,0.078024,0.79145,GOBP_POSITIVE_REGULATION_OF_CHEMOTAXIS,1
GSE15733_BM_VS_SPLEEN_MEMORY...1,SET,177,-0.05183,-0.0050619,0.063867,0.79146,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN,1
GSE22935_WT_VS_MYD88_KO_MACR...3,SET,182,-0.051165,-0.0050664,0.063043,0.79148,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN,1
GOCC_CILIUM,SET,635,-0.027699,-0.005059,0.034128,0.79149,GOCC_CILIUM,1
GSE24210_IL35_TREATED_VS_UNT...2,SET,174,-0.052537,-0.0050877,0.064724,0.79151,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP,1
MIR4677_3P,SET,120,-0.065293,-0.0052588,0.080426,0.79155,MIR4677_3P,1
GOBP_CRANIAL_SUTURE_MORPHOGE...,SET,9,-0.26019,-0.0057564,0.32047,0.79157,GOBP_CRANIAL_SUTURE_MORPHOGENESIS,1
BIOCARTA_RAB_PATHWAY,SET,12,-0.18279,-0.0046693,0.22512,0.79159,BIOCARTA_RAB_PATHWAY,1
GOBP_RESPONSE_TO_COCAINE,SET,54,-0.1007,-0.0054504,0.12402,0.79159,GOBP_RESPONSE_TO_COCAINE,1
HP_DECREASED_LIBIDO,SET,11,-0.20021,-0.0048967,0.24655,0.79161,HP_DECREASED_LIBIDO,1
GOMF_HISTONE_H3_ACETYLTRANSF...,SET,15,-0.17357,-0.0049566,0.21372,0.79163,GOMF_HISTONE_H3_ACETYLTRANSFERASE_ACTIVITY,1
HOEK_NEUTROPHIL_2011_2012_TI...3,SET,7,-0.2644,-0.0051592,0.32552,0.79167,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_DN,1
GOBP_REGULATION_OF_PROTEIN_G...,SET,11,-0.20795,-0.0050859,0.25601,0.79168,GOBP_REGULATION_OF_PROTEIN_GLYCOSYLATION,1
HP_GENERALIZED_JOINT_HYPERMO...,SET,46,-0.10551,-0.0052721,0.12987,0.79173,HP_GENERALIZED_JOINT_HYPERMOBILITY,1
WP_16P112_PROXIMAL_DELETION_...,SET,68,-0.096128,-0.0058365,0.11826,0.79185,WP_16P112_PROXIMAL_DELETION_SYNDROME,1
GOCC_CHROMOSOMAL_REGION,SET,340,-0.036386,-0.0049031,0.044761,0.79186,GOCC_CHROMOSOMAL_REGION,1
BIOCARTA_FLUMAZENIL_PATHWAY,SET,8,-0.27365,-0.0057081,0.33656,0.7919,BIOCARTA_FLUMAZENIL_PATHWAY,1
HP_ABNORMAL_LARGE_INTESTINE_...2,SET,52,-0.10068,-0.0053477,0.12383,0.7919,HP_ABNORMAL_LARGE_INTESTINE_PHYSIOLOGY,1
GSE20198_UNTREATED_VS_IFNA_T...1,SET,175,-0.048735,-0.004733,0.059934,0.79193,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,1
HP_LUMBAR_HYPERLORDOSIS,SET,82,-0.076893,-0.0051248,0.094552,0.79195,HP_LUMBAR_HYPERLORDOSIS,1
GOCC_RUFFLE_MEMBRANE,SET,95,-0.071177,-0.0051042,0.087509,0.79199,GOCC_RUFFLE_MEMBRANE,1
GOBP_OXYGEN_METABOLIC_PROCESS,SET,6,-0.27037,-0.0048843,0.3324,0.792,GOBP_OXYGEN_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_REACTIVE_...1,SET,35,-0.11558,-0.0050392,0.1421,0.792,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
HP_BULBOUS_NOSE,SET,176,-0.052688,-0.0051313,0.06477,0.79202,HP_BULBOUS_NOSE,1
GOBP_NEGATIVE_REGULATION_OF_...303,SET,17,-0.1679,-0.0051042,0.20638,0.79205,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,1
GOBP_MEMBRANE_TUBULATION,SET,4,-0.38119,-0.0056231,0.46851,0.79207,GOBP_MEMBRANE_TUBULATION,1
GSE9650_NAIVE_VS_EXHAUSTED_C...2,SET,182,-0.049062,-0.0048582,0.060292,0.7921,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP,1
GOBP_TRNA_WOBBLE_BASE_MODIFI...,SET,18,-0.15214,-0.0047592,0.18689,0.7922,GOBP_TRNA_WOBBLE_BASE_MODIFICATION,1
HP_APLASIA_HYPOPLASIA_OF_MET...,SET,59,-0.092536,-0.0052347,0.11366,0.79221,HP_APLASIA_HYPOPLASIA_OF_METATARSAL_BONES,1
KEGG_TRYPTOPHAN_METABOLISM,SET,36,-0.12267,-0.0054241,0.15068,0.79222,KEGG_TRYPTOPHAN_METABOLISM,1
GOBP_REGULATION_OF_BINDING_O...,SET,5,-0.276,-0.0045517,0.33899,0.79222,GOBP_REGULATION_OF_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,1
PARENT_MTOR_SIGNALING_DN,SET,41,-0.11189,-0.0052792,0.13741,0.79225,PARENT_MTOR_SIGNALING_DN,1
GOCC_MIB_COMPLEX,SET,9,-0.21611,-0.0047812,0.26539,0.79226,GOCC_MIB_COMPLEX,1
GOBP_REGULATION_OF_RHO_PROTE...,SET,80,-0.079447,-0.0052303,0.09756,0.79227,GOBP_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
MIR550A_3_5P_MIR550A_5P,SET,67,-0.089587,-0.0053993,0.11,0.79229,MIR550A_3_5P_MIR550A_5P,1
GSE14769_40MIN_VS_360MIN_LPS...2,SET,179,-0.049668,-0.0048779,0.060988,0.79229,GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP,1
WANG_METASTASIS_OF_BREAST_CA...2,SET,29,-0.13397,-0.0053177,0.16449,0.79231,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,1
NABA_MATRISOME_HGSOC_OMENTAL...,SET,57,-0.098104,-0.0054551,0.12043,0.79235,NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS,1
HP_PROPORTIONATE_SHORT_STATU...,SET,130,-0.061683,-0.0051695,0.075721,0.79235,HP_PROPORTIONATE_SHORT_STATURE,1
GOBP_MESENCHYMAL_CELL_DIFFER...2,SET,6,-0.33712,-0.0060903,0.41378,0.79238,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GSE5099_DAY3_VS_DAY7_MCSF_TR...1,SET,144,-0.058236,-0.0051347,0.071478,0.79238,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN,1
KEGG_FC_GAMMA_R_MEDIATED_PHA...,SET,90,-0.077165,-0.0053868,0.094704,0.7924,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,1
REACTOME_PURINE_CATABOLISM,SET,17,-0.18186,-0.0055286,0.2232,0.7924,REACTOME_PURINE_CATABOLISM,1
GSE9960_GRAM_NEG_VS_GRAM_NEG...2,SET,151,-0.056651,-0.0051139,0.069502,0.79249,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,1
YAMANAKA_GLIOBLASTOMA_SURVIV...1,SET,8,-0.22907,-0.0047782,0.281,0.79251,YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN,1
BOYLAN_MULTIPLE_MYELOMA_D_CL...1,SET,35,-0.11867,-0.0051737,0.14555,0.79254,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,1
GSE15930_STIM_VS_STIM_AND_IL...4,SET,186,-0.049653,-0.0049698,0.060899,0.79255,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP,1
GOBP_INTERLEUKIN_17A_MEDIATE...,SET,6,-0.32147,-0.0058075,0.39427,0.79256,GOBP_INTERLEUKIN_17A_MEDIATED_SIGNALING_PATHWAY,1
MIR520A_3P,SET,304,-0.039764,-0.0050717,0.048766,0.79257,MIR520A_3P,1
GOBP_ALANINE_METABOLIC_PROCE...,SET,5,-0.31864,-0.0052551,0.39079,0.79257,GOBP_ALANINE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_TUMOR_NEC...,SET,57,-0.092126,-0.0051227,0.11297,0.7926,GOBP_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
REACTOME_FORMATION_OF_DEFINI...,SET,14,-0.20338,-0.0056112,0.24938,0.79262,REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM,1
WP_DISORDERS_OF_FOLATE_METAB...,SET,19,-0.15631,-0.0050235,0.19165,0.79264,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,1
KONDO_PROSTATE_CANCER_WITH_H...,SET,178,-0.057919,-0.0056725,0.070983,0.79273,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,1
NAKAMURA_CANCER_MICROENVIRON...2,SET,24,-0.1529,-0.0055218,0.18736,0.79277,NAKAMURA_CANCER_MICROENVIRONMENT_UP,1
GSE40273_GATA1_KO_VS_WT_TREG...2,SET,175,-0.051266,-0.0049788,0.062816,0.79278,GSE40273_GATA1_KO_VS_WT_TREG_UP,1
HP_FOAM_CELLS,SET,12,-0.22713,-0.0058019,0.27827,0.79281,HP_FOAM_CELLS,1
GOMF_GAP_JUNCTION_CHANNEL_AC...3,SET,8,-0.29077,-0.0060652,0.35621,0.79282,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,1
HP_STRIDOR,SET,45,-0.10423,-0.0051512,0.12767,0.79286,HP_STRIDOR,1
REACTOME_ENHANCED_BINDING_OF...,SET,7,-0.2922,-0.0057015,0.35786,0.79289,REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN,1
PDGF_UP.V1_UP,SET,134,-0.060647,-0.0051597,0.074256,0.79295,PDGF_UP.V1_UP,1
HP_ABNORMALITY_OF_NAIL_COLOR,SET,17,-0.17481,-0.0053142,0.21398,0.79301,HP_ABNORMALITY_OF_NAIL_COLOR,1
TRAVAGLINI_LUNG_ALVEOLAR_EPI...2,SET,126,-0.067368,-0.005559,0.082433,0.7931,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,1
MORF_PPP1CA,SET,145,-0.052537,-0.0046481,0.064274,0.79314,MORF_PPP1CA,1
GSE26030_UNSTIM_VS_RESTIM_TH...5,SET,192,-0.049102,-0.0049926,0.060069,0.79315,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN,1
BUSSLINGER_DUODENAL_PANETH_C...,SET,15,-0.21291,-0.0060801,0.26046,0.79315,BUSSLINGER_DUODENAL_PANETH_CELLS,1
REACTOME_ASSEMBLY_OF_THE_HIV...,SET,15,-0.17991,-0.0051378,0.22002,0.79323,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,1
MIR3667_5P,SET,53,-0.097501,-0.0052284,0.11923,0.79324,MIR3667_5P,1
GOBP_RNA_CATABOLIC_PROCESS,SET,264,-0.041927,-0.0049889,0.05127,0.79325,GOBP_RNA_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...479,SET,44,-0.11308,-0.0055265,0.13823,0.79334,GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION,1
RICKMAN_TUMOR_DIFFERENTIATED...5,SET,356,-0.038214,-0.0052669,0.046709,0.79336,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,1
GOBP_VASCULAR_ENDOTHELIAL_GR...3,SET,53,-0.10044,-0.0053858,0.12275,0.79337,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...273,SET,107,-0.073699,-0.0056071,0.09007,0.79339,GOBP_NEGATIVE_REGULATION_OF_HEMOPOIESIS,1
KEGG_MEDICUS_REFERENCE_TYROS...,SET,5,-0.316,-0.0052115,0.38617,0.7934,KEGG_MEDICUS_REFERENCE_TYROSINE_DEGRADATION,1
REACTOME_TYROSINE_CATABOLISM,SET,5,-0.316,-0.0052115,0.38617,0.7934,REACTOME_TYROSINE_CATABOLISM,1
WP_TYROSINE_METABOLISM_AND_R...,SET,5,-0.316,-0.0052115,0.38617,0.7934,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,1
REACTOME_NUCLEOTIDE_BIOSYNTH...,SET,12,-0.1998,-0.0051039,0.24413,0.79343,REACTOME_NUCLEOTIDE_BIOSYNTHESIS,1
MIR208A_3P,SET,38,-0.11326,-0.0051448,0.13838,0.79344,MIR208A_3P,1
GOBP_SOMATIC_DIVERSIFICATION...1,SET,66,-0.080251,-0.0048006,0.098049,0.79345,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS,1
GSE9509_LPS_VS_LPS_AND_IL10_...1,SET,178,-0.049925,-0.0048895,0.06098,0.79352,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN,1
GOBP_DEPYRIMIDINATION,SET,8,-0.23458,-0.0048932,0.28651,0.79353,GOBP_DEPYRIMIDINATION,1
GOBP_RESPONSE_TO_VITAMIN_K,SET,4,-0.41623,-0.0061399,0.50828,0.79357,GOBP_RESPONSE_TO_VITAMIN_K,1
FERRARI_RESPONSE_TO_FENRETIN...2,SET,20,-0.18302,-0.0060344,0.22348,0.79359,FERRARI_RESPONSE_TO_FENRETINIDE_UP,1
MIR4302,SET,115,-0.065918,-0.005198,0.080477,0.79362,MIR4302,1
MILI_PSEUDOPODIA,SET,40,-0.10441,-0.0048656,0.12745,0.79365,MILI_PSEUDOPODIA,1
MORF_BAG5,SET,52,-0.087571,-0.0046516,0.10689,0.79368,MORF_BAG5,1
HP_DECREASED_TESTICULAR_SIZE,SET,148,-0.058091,-0.005192,0.070905,0.79368,HP_DECREASED_TESTICULAR_SIZE,1
GOBP_REGULATION_OF_DNA_BINDI...2,SET,320,-0.039704,-0.0051934,0.048459,0.7937,GOBP_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,1
KOHN_EMT_MESENCHYMAL,SET,14,-0.18799,-0.0051865,0.22937,0.79377,KOHN_EMT_MESENCHYMAL,1
PID_FAK_PATHWAY,SET,57,-0.091956,-0.0051132,0.1122,0.79377,PID_FAK_PATHWAY,1
GOBP_NUCLEOBASE_CONTAINING_S...1,SET,15,-0.18806,-0.0053706,0.22941,0.79382,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,1
VALK_AML_WITH_11Q23_REARRANG...,SET,17,-0.17316,-0.0052641,0.21121,0.79384,VALK_AML_WITH_11Q23_REARRANGED,1
YAO_TEMPORAL_RESPONSE_TO_PRO...2,SET,62,-0.098438,-0.0057079,0.12005,0.79387,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,1
GOBP_NEGATIVE_REGULATION_OF_...21,SET,15,-0.20383,-0.0058208,0.24855,0.7939,GOBP_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,1
GOCC_PHOTORECEPTOR_OUTER_SEG...1,SET,82,-0.076206,-0.005079,0.092923,0.79391,GOCC_PHOTORECEPTOR_OUTER_SEGMENT,1
GSE8621_UNSTIM_VS_LPS_STIM_M...1,SET,175,-0.050432,-0.0048977,0.06149,0.79393,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,1
MIR346,SET,61,-0.088857,-0.0051108,0.10831,0.79399,MIR346,1
MCM5_TARGET_GENES,SET,7,-0.26226,-0.0051174,0.3196,0.79405,MCM5_TARGET_GENES,1
GOMF_HYDROLASE_ACTIVITY_ACTI...7,SET,677,-0.02704,-0.0050934,0.032951,0.79406,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS,1
chr2p16,SET,35,-0.18874,-0.0082288,0.22999,0.79407,chr2p16,1
ZNF586_TARGET_GENES,SET,35,-0.11643,-0.0050761,0.14182,0.79415,ZNF586_TARGET_GENES,1
HP_PROXIMAL_RADIO_ULNAR_SYNO...,SET,6,-0.34252,-0.006188,0.41721,0.79417,HP_PROXIMAL_RADIO_ULNAR_SYNOSTOSIS,1
MIR520G_5P,SET,53,-0.097494,-0.0052281,0.1187,0.79427,MIR520G_5P,1
HP_ABNORMAL_FACTOR_VIII_ACTI...,SET,4,-0.32742,-0.0048299,0.39852,0.79434,HP_ABNORMAL_FACTOR_VIII_ACTIVITY,1
GOMF_ACYLTRANSFERASE_ACTIVIT...1,SET,5,-0.29868,-0.0049258,0.36349,0.79437,GOMF_ACYLTRANSFERASE_ACTIVITY_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER,1
MODULE_13,SET,470,-0.032835,-0.0051833,0.039956,0.79439,MODULE_13,1
GOBP_EPIGENETIC_PROGRAMING_O...,SET,4,-0.37659,-0.0055552,0.45827,0.79439,GOBP_EPIGENETIC_PROGRAMING_OF_MALE_PRONUCLEUS,1
GOBP_NEGATIVE_REGULATION_OF_...193,SET,8,-0.27508,-0.005738,0.33475,0.79439,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
GOBP_NEGATIVE_REGULATION_OF_...438,SET,12,-0.22331,-0.0057043,0.27174,0.79439,GOBP_NEGATIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,1
REACTOME_CHROMATIN_MODIFICAT...,SET,7,-0.26448,-0.0051607,0.32182,0.7944,REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,1
NIKOLSKY_BREAST_CANCER_16Q24...,SET,50,-0.18278,-0.0095208,0.22238,0.79443,NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,1
GOBP_REGULATION_OF_INTRACELL...4,SET,1637,-0.018443,-0.0052535,0.022436,0.79446,GOBP_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
GSE43863_NAIVE_VS_LY6C_LOW_C...2,SET,140,-0.059358,-0.005161,0.072185,0.79454,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP,1
GOBP_REGULATION_OF_RESPONSE_...5,SET,984,-0.023623,-0.0053178,0.028727,0.79455,GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
GOBP_CELLULAR_EXTRAVASATION,SET,69,-0.091838,-0.0056167,0.11166,0.79459,GOBP_CELLULAR_EXTRAVASATION,1
GOBP_CHEMOKINE_C_C_MOTIF_LIG...,SET,10,-0.23166,-0.0054024,0.28165,0.79461,GOBP_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
WP_GLUCOCORTICOID_RECEPTOR_P...,SET,68,-0.092429,-0.0056119,0.11236,0.79464,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,1
CTTTGA_LEF1_Q2,SET,1087,-0.023216,-0.0054767,0.02822,0.79465,CTTTGA_LEF1_Q2,1
GSE19401_UNSTIM_VS_PAM2CSK4_...1,SET,183,-0.052217,-0.0051846,0.063471,0.79465,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
HP_ABNORMAL_ANTIHELIX_MORPHO...,SET,36,-0.11633,-0.0051434,0.14137,0.7947,HP_ABNORMAL_ANTIHELIX_MORPHOLOGY,1
GOBP_PHOTORECEPTOR_CELL_MORP...,SET,4,-0.35423,-0.0052254,0.43045,0.79472,GOBP_PHOTORECEPTOR_CELL_MORPHOGENESIS,1
HAY_BONE_MARROW_STROMAL,SET,670,-0.030444,-0.005706,0.036994,0.79473,HAY_BONE_MARROW_STROMAL,1
OUILLETTE_CLL_13Q14_DELETION...1,SET,47,-0.10596,-0.0053517,0.12875,0.79474,OUILLETTE_CLL_13Q14_DELETION_DN,1
ZNF236_TARGET_GENES,SET,212,-0.048102,-0.0051364,0.058447,0.79474,ZNF236_TARGET_GENES,1
HP_LARYNGEAL_EDEMA,SET,4,-0.39377,-0.0058087,0.47845,0.79474,HP_LARYNGEAL_EDEMA,1
WOO_LIVER_CANCER_RECURRENCE_...2,SET,97,-0.072436,-0.0052486,0.087986,0.79482,WOO_LIVER_CANCER_RECURRENCE_UP,1
GSE1112_HY_CD8AB_VS_HY_CD8AA...1,SET,163,-0.057272,-0.0053697,0.06956,0.79484,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,1
REACTOME_TGFBR3_REGULATES_TG...,SET,8,-0.26265,-0.0054787,0.31895,0.79488,REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING,1
HP_GRAY_MATTER_HETEROTOPIA,SET,111,-0.062691,-0.0048574,0.076117,0.79491,HP_GRAY_MATTER_HETEROTOPIA,1
REACTOME_DEFECTIVE_C1GALT1C1...,SET,14,-0.1991,-0.005493,0.24173,0.79492,REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS,1
GOBP_POSITIVE_REGULATION_OF_...2,SET,11,-0.21559,-0.0052727,0.26174,0.79493,GOBP_POSITIVE_REGULATION_OF_ACROSOME_REACTION,1
DACOSTA_UV_RESPONSE_VIA_ERCC...6,SET,287,-0.040195,-0.0049836,0.048772,0.79506,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1
DESCARTES_FETAL_CEREBRUM_OLI...,SET,48,-0.11597,-0.0059188,0.14071,0.79506,DESCARTES_FETAL_CEREBRUM_OLIGODENDROCYTES,1
GSE39820_TGFBETA1_IL6_VS_TGF...2,SET,185,-0.05103,-0.0050941,0.061912,0.79509,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP,1
HP_PROGRESSIVE_GAIT_ATAXIA,SET,26,-0.13403,-0.0050377,0.1626,0.7951,HP_PROGRESSIVE_GAIT_ATAXIA,1
GOBP_PROTEIN_LOCALIZATION_TO...14,SET,27,-0.11984,-0.0045901,0.14538,0.79512,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,1
CDH4_TARGET_GENES,SET,56,-0.097587,-0.0053787,0.11832,0.79524,CDH4_TARGET_GENES,1
GOLDRATH_HOMEOSTATIC_PROLIFE...,SET,134,-0.060615,-0.005157,0.073481,0.79528,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1
GSE17721_POLYIC_VS_PAM3CSK4_...2,SET,180,-0.053785,-0.0052968,0.065188,0.79533,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP,1
DIAZ_CHRONIC_MYELOGENOUS_LEU...1,SET,106,-0.072237,-0.0054703,0.087532,0.79538,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1
IRITANI_MAD1_TARGETS_DN,SET,41,-0.106,-0.005001,0.12842,0.79542,IRITANI_MAD1_TARGETS_DN,1
GOBP_INTRACELLULAR_SODIUM_IO...,SET,22,-0.17521,-0.0060583,0.21227,0.79542,GOBP_INTRACELLULAR_SODIUM_ION_HOMEOSTASIS,1
HP_APLASIA_HYPOPLASIA_OF_THE...48,SET,43,-0.10158,-0.0049078,0.12304,0.79548,HP_APLASIA_HYPOPLASIA_OF_THE_NIPPLES,1
GOBP_EMBRYONIC_HEART_TUBE_LE...,SET,5,-0.27166,-0.0044803,0.32899,0.79552,GOBP_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION,1
HP_LARYNGEAL_STENOSIS,SET,14,-0.21288,-0.0058732,0.25778,0.79554,HP_LARYNGEAL_STENOSIS,1
GOBP_UNSATURATED_FATTY_ACID_...1,SET,45,-0.10978,-0.0054254,0.13292,0.79556,GOBP_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_VESICLE_COATING,SET,37,-0.10515,-0.0047134,0.12728,0.79563,GOBP_VESICLE_COATING,1
HP_LEFT_VENTRICULAR_SYSTOLIC...,SET,81,-0.078758,-0.0052171,0.095316,0.79567,HP_LEFT_VENTRICULAR_SYSTOLIC_DYSFUNCTION,1
GOBP_ENDOCARDIAL_CUSHION_FOR...,SET,30,-0.1501,-0.0060595,0.18159,0.79575,GOBP_ENDOCARDIAL_CUSHION_FORMATION,1
GOBP_REGULATION_OF_CARTILAGE...,SET,62,-0.097815,-0.0056718,0.11833,0.79577,GOBP_REGULATION_OF_CARTILAGE_DEVELOPMENT,1
GOBP_PEPTIDE_CATABOLIC_PROCE...,SET,19,-0.17301,-0.0055601,0.20929,0.79578,GOBP_PEPTIDE_CATABOLIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_INVOLV...6,SET,15,-0.17322,-0.0049467,0.20954,0.79578,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CARPAL_BONES,1
GSE43956_WT_VS_SGK1_KO_TH17_...1,SET,179,-0.055012,-0.0054027,0.066541,0.7958,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN,1
GOBP_CALCITONIN_FAMILY_RECEP...,SET,7,-0.29386,-0.005734,0.35544,0.79581,GOBP_CALCITONIN_FAMILY_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_FATTY_ACID_ELONGASE_ACT...,SET,7,-0.30803,-0.0060105,0.37245,0.79589,GOMF_FATTY_ACID_ELONGASE_ACTIVITY,1
HP_INCREASED_NUCHAL_TRANSLUC...,SET,46,-0.11657,-0.0058247,0.14094,0.7959,HP_INCREASED_NUCHAL_TRANSLUCENCY,1
HP_TARSAL_SYNOSTOSIS,SET,21,-0.17674,-0.0059709,0.21366,0.79593,HP_TARSAL_SYNOSTOSIS,1
GOBP_REGULATION_OF_MICROVILL...1,SET,6,-0.32537,-0.0058781,0.39324,0.796,GOBP_REGULATION_OF_MICROVILLUS_ASSEMBLY,1
REACTOME_PROTEIN_HYDROXYLATI...,SET,17,-0.16325,-0.0049628,0.19722,0.79609,REACTOME_PROTEIN_HYDROXYLATION,1
HALLMARK_KRAS_SIGNALING_UP,SET,186,-0.057272,-0.0057324,0.069187,0.7961,HALLMARK_KRAS_SIGNALING_UP,1
GSE29618_PRE_VS_DAY7_POST_TI...6,SET,166,-0.054055,-0.0051141,0.06529,0.79614,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP,1
HP_AGANGLIONIC_MEGACOLON,SET,132,-0.058202,-0.0049149,0.070282,0.79619,HP_AGANGLIONIC_MEGACOLON,1
GOMF_HYDROXYMETHYL_FORMYL_AN...,SET,8,-0.22363,-0.0046648,0.27004,0.7962,GOMF_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY,1
GOMF_NEUROPEPTIDE_ACTIVITY,SET,25,-0.15356,-0.0056597,0.18543,0.7962,GOMF_NEUROPEPTIDE_ACTIVITY,1
GSE36009_UNSTIM_VS_LPS_STIM_...3,SET,169,-0.051358,-0.0049023,0.062016,0.7962,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN,1
GOBP_METANEPHRIC_NEPHRON_TUB...2,SET,8,-0.27264,-0.0056872,0.32918,0.79623,GOBP_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS,1
SCHAEFFER_PROSTATE_DEVELOPME...11,SET,5,-0.32492,-0.0053586,0.39224,0.79627,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3,1
HP_BILATERAL_MICROPHTHALMOS,SET,19,-0.15008,-0.0048231,0.18115,0.7963,HP_BILATERAL_MICROPHTHALMOS,1
GSE37533_UNTREATED_VS_PIOGLI...6,SET,129,-0.063025,-0.0052618,0.076073,0.7963,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP,1
GOBP_REGULATION_OF_SYNAPTIC_...6,SET,70,-0.090475,-0.0055731,0.10919,0.79633,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
GSE6259_DEC205_POS_DC_VS_BCE...1,SET,165,-0.055696,-0.0052536,0.067209,0.79635,GSE6259_DEC205_POS_DC_VS_BCELL_DN,1
GOBP_ICOSANOID_SECRETION,SET,47,-0.11408,-0.0057615,0.13765,0.79637,GOBP_ICOSANOID_SECRETION,1
KEGG_MEDICUS_VARIANT_EML4_AL...4,SET,11,-0.20909,-0.0051139,0.25229,0.79638,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE27786_BCELL_VS_NEUTROPHIL...2,SET,185,-0.048489,-0.0048404,0.058507,0.79638,GSE27786_BCELL_VS_NEUTROPHIL_UP,1
GSE20715_WT_VS_TLR4_KO_6H_OZ...2,SET,183,-0.051396,-0.0051031,0.062005,0.79642,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP,1
PAPASPYRIDONOS_UNSTABLE_ATER...2,SET,51,-0.10396,-0.005469,0.12541,0.79643,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,1
VANOEVELEN_MYOGENESIS_SIN3A_...,SET,207,-0.046362,-0.0048926,0.055916,0.79648,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,1
HE_LIM_SUN_FETAL_LUNG_C2_HSC...1,SET,1385,-0.019237,-0.0050782,0.023199,0.79651,HE_LIM_SUN_FETAL_LUNG_C2_HSC_CELL,1
WP_1P36_COPY_NUMBER_VARIATIO...,SET,89,-0.091133,-0.0063266,0.10989,0.79654,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,1
GSE37301_GRANULOCYTE_MONOCYT...2,SET,166,-0.054027,-0.0051115,0.065146,0.79654,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,1
GOBP_DEOXYRIBONUCLEOTIDE_BIO...,SET,14,-0.18938,-0.0052249,0.22834,0.79655,GOBP_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_RECEPTOR_...5,SET,16,-0.17198,-0.0050722,0.20733,0.79658,GOBP_REGULATION_OF_RECEPTOR_LOCALIZATION_TO_SYNAPSE,1
SEMBA_FHIT_TARGETS_UP,SET,11,-0.21153,-0.0051735,0.25494,0.79664,SEMBA_FHIT_TARGETS_UP,1
REACTOME_GOLGI_ASSOCIATED_VE...,SET,50,-0.097419,-0.0050744,0.11741,0.79665,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,1
MIR6751_3P,SET,73,-0.082748,-0.0052048,0.099725,0.79666,MIR6751_3P,1
REACTOME_CREB_PHOSPHORYLATION,SET,6,-0.33754,-0.0060978,0.40676,0.79667,REACTOME_CREB_PHOSPHORYLATION,1
GOMF_CALCIUM_DEPENDENT_PROTE...4,SET,5,-0.30499,-0.0050299,0.36753,0.79668,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_REGULATOR_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C2_PRO...2,SET,44,-0.10879,-0.0053169,0.13105,0.79677,HE_LIM_SUN_FETAL_LUNG_C2_PROMYELOCYTE_LIKE_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...225,SET,4,-0.36191,-0.0053386,0.43591,0.79679,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,1
MIR4507,SET,34,-0.11207,-0.0048159,0.13493,0.79689,MIR4507,1
HP_RESTING_TREMOR,SET,45,-0.10243,-0.0050624,0.12332,0.79689,HP_RESTING_TREMOR,1
HP_PROXIMAL_SYMPHALANGISM_OF...,SET,5,-0.35768,-0.0058989,0.43039,0.79702,HP_PROXIMAL_SYMPHALANGISM_OF_HANDS,1
GOMF_ATPASE_BINDING,SET,78,-0.086095,-0.005597,0.10359,0.79703,GOMF_ATPASE_BINDING,1
FARMER_BREAST_CANCER_BASAL_V...,SET,292,-0.04236,-0.0052969,0.050962,0.79707,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,1
HP_INTELLECTUAL_DISABILITY_P...2,SET,31,-0.11853,-0.0048638,0.14258,0.79709,HP_INTELLECTUAL_DISABILITY_PROGRESSIVE,1
GSE14308_TH17_VS_NATURAL_TRE...2,SET,180,-0.051876,-0.0051088,0.062398,0.79711,GSE14308_TH17_VS_NATURAL_TREG_UP,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...3,SET,150,-0.055557,-0.0049987,0.066813,0.79716,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN,1
LI_ESTROGENE_LATE_E2_RESPONS...1,SET,71,-0.091422,-0.0056714,0.10992,0.7972,LI_ESTROGENE_LATE_E2_RESPONSE_DN,1
GOMF_INSULIN_RECEPTOR_BINDING,SET,21,-0.16962,-0.0057304,0.20389,0.79727,GOMF_INSULIN_RECEPTOR_BINDING,1
GSE15330_LYMPHOID_MULTIPOTEN...5,SET,189,-0.052135,-0.0052597,0.06266,0.7973,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,1
GSE34515_CD16_NEG_VS_POS_MON...1,SET,163,-0.055155,-0.0051712,0.06628,0.79733,GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...266,SET,17,-0.17905,-0.0054432,0.21515,0.79735,GOBP_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY,1
GOBP_RENAL_CONTROL_OF_PERIPH...,SET,4,-0.34149,-0.0050375,0.41034,0.79735,GOBP_RENAL_CONTROL_OF_PERIPHERAL_VASCULAR_RESISTANCE_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
HP_DYSURIA,SET,14,-0.18259,-0.0050376,0.21939,0.79736,HP_DYSURIA,1
GOBP_NEGATIVE_REGULATION_OF_...186,SET,12,-0.22149,-0.0056579,0.26613,0.79737,GOBP_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
chr13q34,SET,34,-0.20062,-0.008621,0.24098,0.79743,chr13q34,1
HP_ABNORMAL_PROSODY,SET,61,-0.095223,-0.0054769,0.11438,0.79743,HP_ABNORMAL_PROSODY,1
RAY_TARGETS_OF_P210_BCR_ABL_...1,SET,15,-0.19182,-0.0054778,0.23034,0.7975,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...5,SET,21,-0.17262,-0.0058317,0.20723,0.79757,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CELL_JUNCTION,1
GSE1432_1H_VS_6H_IFNG_MICROG...2,SET,185,-0.053336,-0.0053243,0.064027,0.79758,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,1
MIR9900,SET,40,-0.11546,-0.0053809,0.13858,0.79762,MIR9900,1
GOBP_POSITIVE_REGULATION_OF_...620,SET,12,-0.19623,-0.0050127,0.23545,0.79769,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
HP_FOCAL_EMOTIONAL_SEIZURE,SET,17,-0.17524,-0.0053273,0.21024,0.79772,HP_FOCAL_EMOTIONAL_SEIZURE,1
HP_EYELID_COLOBOMA,SET,34,-0.11771,-0.0050583,0.14118,0.79779,HP_EYELID_COLOBOMA,1
GSE23321_CENTRAL_MEMORY_VS_N...1,SET,180,-0.054633,-0.0053803,0.065524,0.79779,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
GOBP_CARDIAC_MUSCLE_TISSUE_R...,SET,6,-0.27986,-0.0050559,0.33563,0.7978,GOBP_CARDIAC_MUSCLE_TISSUE_REGENERATION,1
BENPORATH_ES_CORE_NINE,SET,8,-0.24608,-0.0051331,0.29508,0.79784,BENPORATH_ES_CORE_NINE,1
WP_CLOCKCONTROLLED_AUTOPHAGY...,SET,77,-0.085585,-0.0055282,0.10262,0.79785,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,1
HP_DEATH_IN_ADOLESCENCE,SET,21,-0.16253,-0.0054909,0.19489,0.79785,HP_DEATH_IN_ADOLESCENCE,1
WP_ESTROGEN_METABOLISM_WP5276,SET,23,-0.15729,-0.005561,0.18858,0.79788,WP_ESTROGEN_METABOLISM_WP5276,1
GOMF_HISTONE_H3K36_METHYLTRA...,SET,11,-0.19954,-0.0048802,0.2392,0.7979,GOMF_HISTONE_H3K36_METHYLTRANSFERASE_ACTIVITY,1
GSE12003_MIR223_KO_VS_WT_BM_...2,SET,178,-0.053616,-0.005251,0.064274,0.7979,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP,1
ZNF768_TARGET_GENES,SET,1015,-0.023015,-0.0052573,0.027578,0.79801,ZNF768_TARGET_GENES,1
HP_ABNORMAL_TRACHEAL_MORPHOL...,SET,150,-0.059371,-0.0053419,0.071142,0.79801,HP_ABNORMAL_TRACHEAL_MORPHOLOGY,1
GOBP_PROTEIN_TETRAMERIZATION,SET,91,-0.073417,-0.0051534,0.087969,0.79802,GOBP_PROTEIN_TETRAMERIZATION,1
HAY_BONE_MARROW_PLATELET,SET,217,-0.049216,-0.0053163,0.058968,0.79803,HAY_BONE_MARROW_PLATELET,1
GSE17721_PAM3CSK4_VS_GADIQUI...7,SET,178,-0.052926,-0.0051834,0.063405,0.79806,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN,1
HP_ABNORMAL_EPIDERMAL_MORPHO...,SET,87,-0.076231,-0.0052326,0.091309,0.7981,HP_ABNORMAL_EPIDERMAL_MORPHOLOGY,1
KEGG_MEDICUS_VARIANT_HRAS_OV...,SET,9,-0.25073,-0.0055472,0.30031,0.79811,KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY,1
WP_NEURAL_CREST_CELL_MIGRATI...2,SET,40,-0.12471,-0.0058116,0.14937,0.79811,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,1
GOBP_DENDRITIC_CELL_APOPTOTI...,SET,12,-0.23163,-0.0059169,0.2774,0.79813,GOBP_DENDRITIC_CELL_APOPTOTIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...686,SET,4,-0.31719,-0.0046791,0.37988,0.79813,GOBP_POSITIVE_REGULATION_OF_RNA_BINDING,1
AIZARANI_LIVER_C5_NK_NKT_CEL...,SET,110,-0.072343,-0.0055801,0.086629,0.79816,AIZARANI_LIVER_C5_NK_NKT_CELLS_3,1
MIR520D_3P,SET,303,-0.040788,-0.0051939,0.048823,0.79825,MIR520D_3P,1
chr1q22,SET,43,-0.18238,-0.0088116,0.21826,0.79831,chr1q22,1
GCM_SUPT4H1,SET,52,-0.093297,-0.0049557,0.11165,0.79831,GCM_SUPT4H1,1
LIAN_NEUTROPHIL_GRANULE_CONS...,SET,23,-0.16944,-0.0059903,0.20276,0.79832,LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,1
MCDOWELL_ACUTE_LUNG_INJURY_DN,SET,41,-0.11366,-0.0053623,0.13601,0.79832,MCDOWELL_ACUTE_LUNG_INJURY_DN,1
HP_CONTRACTURE_OF_THE_PROXIM...2,SET,5,-0.31167,-0.0051401,0.37295,0.79833,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_4TH_FINGER,1
GOBP_RESPONSE_TO_ATP,SET,31,-0.1397,-0.0057327,0.16714,0.79836,GOBP_RESPONSE_TO_ATP,1
GOBP_REGULATION_OF_IMMUNE_EF...,SET,356,-0.040292,-0.0055533,0.048207,0.79837,GOBP_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
GOMF_LIM_DOMAIN_BINDING,SET,5,-0.34546,-0.0056974,0.41331,0.79837,GOMF_LIM_DOMAIN_BINDING,1
GOBP_CRANIAL_NERVE_DEVELOPME...,SET,61,-0.097683,-0.0056184,0.11685,0.79841,GOBP_CRANIAL_NERVE_DEVELOPMENT,1
GOBP_REGULATION_OF_FAS_SIGNA...,SET,4,-0.32395,-0.0047787,0.3875,0.79842,GOBP_REGULATION_OF_FAS_SIGNALING_PATHWAY,1
HP_RETICULOCYTOPENIA,SET,32,-0.11735,-0.0048924,0.14036,0.79843,HP_RETICULOCYTOPENIA,1
GSE27786_LIN_NEG_VS_ERYTHROB...2,SET,183,-0.05053,-0.0050171,0.060439,0.79843,GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP,1
GSE40666_NAIVE_VS_EFFECTOR_C...2,SET,177,-0.05524,-0.005395,0.066059,0.79848,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,1
HP_GASTRIC_ULCER,SET,5,-0.30632,-0.0050519,0.3663,0.79849,HP_GASTRIC_ULCER,1
GOBP_POSITIVE_REGULATION_OF_...736,SET,41,-0.11107,-0.0052402,0.13281,0.7985,GOBP_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
GOMF_ADENOSINE_3_5_BISPHOSPH...,SET,5,-0.3185,-0.0052528,0.38081,0.79852,GOMF_ADENOSINE_3_5_BISPHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
DESCARTES_FETAL_LUNG_MYELOID...,SET,143,-0.065741,-0.0057764,0.078602,0.79852,DESCARTES_FETAL_LUNG_MYELOID_CELLS,1
GOBP_RESPONSE_TO_TOPOLOGICAL...,SET,144,-0.058917,-0.0051947,0.07044,0.79853,GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,1
GOBP_POSITIVE_REGULATION_OF_...462,SET,33,-0.11959,-0.005063,0.14297,0.79854,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
REACTOME_TACHYKININ_RECEPTOR...,SET,5,-0.33941,-0.0055977,0.40576,0.79855,REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS,1
ZHONG_PFC_HES1_POS_C1_NPC,SET,6,-0.31649,-0.0057176,0.37836,0.79855,ZHONG_PFC_HES1_POS_C1_NPC,1
GSE19923_WT_VS_E2A_KO_DP_THY...2,SET,181,-0.053777,-0.0053105,0.064288,0.79856,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP,1
REACTOME_CHAPERONE_MEDIATED_...,SET,19,-0.14936,-0.0048,0.17853,0.79859,REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,1
GOBP_CGMP_CATABOLIC_PROCESS,SET,5,-0.32358,-0.0053365,0.38667,0.79865,GOBP_CGMP_CATABOLIC_PROCESS,1
GSE42021_CD24HI_VS_CD24INT_T...1,SET,188,-0.054611,-0.0054951,0.065251,0.79868,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN,1
GOLDRATH_EFF_VS_MEMORY_CD8_T...1,SET,186,-0.051988,-0.0052035,0.062102,0.79873,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN,1
GSE8835_HEALTHY_VS_CLL_CD4_T...2,SET,177,-0.053995,-0.0052734,0.064501,0.79873,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP,1
HP_ABNORMAL_VENTRICULAR_SEPT...,SET,429,-0.034619,-0.0052271,0.041352,0.79875,HP_ABNORMAL_VENTRICULAR_SEPTUM_MORPHOLOGY,1
REACTOME_DEFECTIVE_GALNT3_CA...,SET,14,-0.20251,-0.0055871,0.24187,0.79877,REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC,1
GOBP_REGULATION_OF_PHOSPHATE...,SET,7,-0.29256,-0.0057087,0.34942,0.79878,GOBP_REGULATION_OF_PHOSPHATE_TRANSPORT,1
GSE16385_IFNG_TNF_VS_ROSIGLI...1,SET,143,-0.061249,-0.0053817,0.073151,0.79878,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
GOBP_POSITIVE_REGULATION_OF_...653,SET,89,-0.074067,-0.0051418,0.088447,0.79882,GOBP_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,1
GOMF_DEAD_H_BOX_RNA_HELICASE...,SET,8,-0.28919,-0.0060323,0.34531,0.79883,GOMF_DEAD_H_BOX_RNA_HELICASE_BINDING,1
DESCARTES_FETAL_STOMACH_NEUR...,SET,40,-0.12177,-0.0056747,0.14538,0.79887,DESCARTES_FETAL_STOMACH_NEUROENDOCRINE_CELLS,1
MIR593_5P,SET,146,-0.060883,-0.005405,0.072683,0.79888,MIR593_5P,1
GOCC_NEURONAL_DENSE_CORE_VES...2,SET,5,-0.3625,-0.0059784,0.43276,0.79888,GOCC_NEURONAL_DENSE_CORE_VESICLE_MEMBRANE,1
MIR1231,SET,48,-0.10737,-0.0054803,0.12814,0.79896,MIR1231,1
GOBP_NEGATIVE_REGULATION_OF_...189,SET,29,-0.12337,-0.0048968,0.14723,0.79897,GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR,1
GOBP_NEGATIVE_REGULATION_OF_...705,SET,8,-0.28031,-0.0058471,0.33448,0.79899,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GOMF_DYNACTIN_BINDING,SET,11,-0.19274,-0.004714,0.22994,0.79904,GOMF_DYNACTIN_BINDING,1
MIR4447,SET,255,-0.044441,-0.0051984,0.053009,0.79908,MIR4447,1
GSE3039_CD4_TCELL_VS_B1_BCEL...2,SET,184,-0.052545,-0.0052313,0.06266,0.79914,GSE3039_CD4_TCELL_VS_B1_BCELL_UP,1
MIR4307,SET,389,-0.03767,-0.0054222,0.044917,0.79916,MIR4307,1
HP_APLASIA_OF_METACARPAL_BON...,SET,12,-0.19893,-0.0050817,0.23719,0.79918,HP_APLASIA_OF_METACARPAL_BONES,1
chr15q23,SET,33,-0.19895,-0.0084228,0.23716,0.79922,chr15q23,1
GOBP_TYPE_II_INTERFERON_MEDI...,SET,26,-0.13968,-0.0052499,0.1665,0.79923,GOBP_TYPE_II_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOCC_NUCLEOTIDE_EXCISION_REP...,SET,11,-0.1755,-0.0042923,0.20914,0.7993,GOCC_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX,1
MEBARKI_HCC_PROGENITOR_FZD8C...2,SET,477,-0.032505,-0.0051683,0.038734,0.79931,MEBARKI_HCC_PROGENITOR_FZD8CRD_UP,1
GSE40274_CTRL_VS_FOXP3_AND_X...1,SET,134,-0.064378,-0.0054771,0.076712,0.79932,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
YNGTTNNNATT_UNKNOWN,SET,339,-0.041935,-0.0056427,0.049966,0.79934,YNGTTNNNATT_UNKNOWN,1
GSE17186_MEMORY_VS_NAIVE_BCE...2,SET,169,-0.055871,-0.005333,0.066562,0.79937,GSE17186_MEMORY_VS_NAIVE_BCELL_UP,1
DESCARTES_FETAL_KIDNEY_LYMPH...,SET,150,-0.06387,-0.0057466,0.076081,0.7994,DESCARTES_FETAL_KIDNEY_LYMPHOID_CELLS,1
FRANCO_BLOOD_SANOFI_PASTEUR_...6,SET,119,-0.068443,-0.0054896,0.081522,0.79942,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE,1
PID_AURORA_A_PATHWAY,SET,31,-0.1186,-0.0048667,0.14117,0.79957,PID_AURORA_A_PATHWAY,1
MIR4999_5P,SET,81,-0.080295,-0.0053189,0.095557,0.79962,MIR4999_5P,1
HP_HYPERGLUTAMINEMIA,SET,8,-0.21979,-0.0045847,0.26152,0.79966,HP_HYPERGLUTAMINEMIA,1
HP_ABNORMAL_BREATH_SOUND,SET,112,-0.068047,-0.0052959,0.080946,0.79972,HP_ABNORMAL_BREATH_SOUND,1
GOBP_NADH_DEHYDROGENASE_COMP...,SET,48,-0.093191,-0.0047564,0.11084,0.79977,GOBP_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY,1
MODULE_179,SET,421,-0.035237,-0.0052718,0.041906,0.79978,MODULE_179,1
GOBP_INOSITOL_PHOSPHATE_BIOS...,SET,26,-0.13919,-0.0052316,0.16551,0.79981,GOBP_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
WP_NANOMATERIAL_INDUCED_APOP...,SET,19,-0.16505,-0.0053041,0.19622,0.79986,WP_NANOMATERIAL_INDUCED_APOPTOSIS,1
DELPUECH_FOXO3_TARGETS_UP,SET,61,-0.099152,-0.0057029,0.11787,0.79988,DELPUECH_FOXO3_TARGETS_UP,1
MIR4537,SET,6,-0.30147,-0.0054464,0.35835,0.7999,MIR4537,1
MIR135A_5P,SET,283,-0.044042,-0.005423,0.052349,0.79991,MIR135A_5P,1
FRASOR_TAMOXIFEN_RESPONSE_DN,SET,10,-0.22727,-0.0053001,0.27007,0.79997,FRASOR_TAMOXIFEN_RESPONSE_DN,1
GSE28726_ACT_CD4_TCELL_VS_AC...2,SET,188,-0.051044,-0.0051362,0.06065,0.79999,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP,1
ADCYAP1_TARGET_GENES,SET,7,-0.22997,-0.0044874,0.27323,0.80001,ADCYAP1_TARGET_GENES,1
MIR4494,SET,52,-0.098585,-0.0052366,0.1171,0.80006,MIR4494,1
GOBP_POSITIVE_REGULATION_OF_...684,SET,33,-0.13213,-0.0055939,0.15695,0.80007,GOBP_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
HP_MACRODACTYLY,SET,4,-0.32558,-0.0048028,0.38671,0.80008,HP_MACRODACTYLY,1
AHRR_TARGET_GENES,SET,1028,-0.023368,-0.00537,0.027751,0.80012,AHRR_TARGET_GENES,1
GOBP_COGNITION,SET,291,-0.043799,-0.0054676,0.052006,0.80016,GOBP_COGNITION,1
GOBP_REGULATION_OF_LONG_CHAI...2,SET,7,-0.26051,-0.0050833,0.30929,0.80019,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_INTO_CELL,1
GSE10239_MEMORY_VS_DAY4.5_EF...2,SET,187,-0.051919,-0.0052104,0.061634,0.8002,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP,1
ZHOU_TNF_SIGNALING_4HR,SET,42,-0.10841,-0.0051768,0.1287,0.80021,ZHOU_TNF_SIGNALING_4HR,1
PANGAS_TUMOR_SUPPRESSION_BY_...2,SET,118,-0.068745,-0.0054908,0.081605,0.80022,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1
GOMF_FATTY_ACID_TRANSMEMBRAN...,SET,18,-0.16707,-0.0052261,0.19829,0.80026,GOMF_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KIM_HYPOXIA,SET,15,-0.18811,-0.0053719,0.22323,0.80028,KIM_HYPOXIA,1
MIR642B_5P,SET,70,-0.086962,-0.0053567,0.1032,0.80028,MIR642B_5P,1
MEBARKI_HCC_PROGENITOR_WNT_UP,SET,168,-0.05965,-0.0056771,0.070785,0.80029,MEBARKI_HCC_PROGENITOR_WNT_UP,1
GSE17974_1H_VS_72H_UNTREATED...1,SET,178,-0.049425,-0.0048406,0.058646,0.80032,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
GSE11961_FOLLICULAR_BCELL_VS...11,SET,185,-0.051864,-0.0051774,0.061533,0.80034,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN,1
GOBP_REGULATION_OF_NITRIC_OX...1,SET,6,-0.31163,-0.0056298,0.3697,0.80036,GOBP_REGULATION_OF_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,1
GSE40274_FOXP3_VS_FOXP3_AND_...9,SET,179,-0.053894,-0.0052929,0.063934,0.80037,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_MGLUR...1,SET,13,-0.20345,-0.0054092,0.24135,0.80038,KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
CTAWWWATA_RSRFC4_Q2,SET,324,-0.041275,-0.0054319,0.048958,0.8004,CTAWWWATA_RSRFC4_Q2,1
HP_ABNORMAL_PALM_MORPHOLOGY,SET,445,-0.034753,-0.0053419,0.041211,0.80046,HP_ABNORMAL_PALM_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...805,SET,32,-0.13033,-0.0054338,0.15454,0.80048,GOBP_POSITIVE_REGULATION_OF_T_CELL_MIGRATION,1
WHITESIDE_CISPLATIN_RESISTAN...1,SET,12,-0.18595,-0.0047501,0.22038,0.80059,WHITESIDE_CISPLATIN_RESISTANCE_DN,1
MIR5683,SET,217,-0.050827,-0.0054903,0.060228,0.80064,MIR5683,1
GOMF_CYTOSKELETAL_ANCHOR_ACT...,SET,23,-0.14833,-0.0052442,0.17574,0.80067,GOMF_CYTOSKELETAL_ANCHOR_ACTIVITY,1
GOBP_HEMATOPOIETIC_STEM_CELL...1,SET,36,-0.11917,-0.0052691,0.14116,0.80071,GOBP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
MIR647,SET,75,-0.0811,-0.0051703,0.096063,0.80073,MIR647,1
GOBP_AMACRINE_CELL_DIFFERENT...,SET,12,-0.2296,-0.0058651,0.27195,0.80074,GOBP_AMACRINE_CELL_DIFFERENTIATION,1
HP_INFERTILITY,SET,248,-0.04557,-0.0052578,0.053962,0.80079,HP_INFERTILITY,1
GOBP_NEGATIVE_REGULATION_OF_...604,SET,12,-0.24516,-0.0062625,0.29029,0.8008,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOCC_ROD_PHOTORECEPTOR_OUTER...,SET,7,-0.27067,-0.0052816,0.32051,0.8008,GOCC_ROD_PHOTORECEPTOR_OUTER_SEGMENT,1
MIR4686,SET,74,-0.081848,-0.0051832,0.096909,0.80082,MIR4686,1
GOBP_POSITIVE_REGULATION_OF_...211,SET,68,-0.084464,-0.0051283,0.10001,0.80082,GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,1
GOMF_ENDONUCLEASE_ACTIVITY_A...1,SET,15,-0.17903,-0.0051127,0.21196,0.80084,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS,1
HP_EXOSTOSES,SET,18,-0.18128,-0.0056707,0.21451,0.80097,HP_EXOSTOSES,1
MIR181A_2_3P,SET,99,-0.073609,-0.005388,0.087094,0.80099,MIR181A_2_3P,1
BOYLAN_MULTIPLE_MYELOMA_C_D_...2,SET,125,-0.062897,-0.0051696,0.074405,0.80103,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,1
GSE6269_HEALTHY_VS_STAPH_PNE...1,SET,152,-0.059692,-0.0054061,0.070611,0.80104,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN,1
REACTOME_INSULIN_RECEPTOR_RE...,SET,28,-0.13939,-0.0054368,0.16488,0.80106,REACTOME_INSULIN_RECEPTOR_RECYCLING,1
GOBP_NUCLEIC_ACID_CATABOLIC_...,SET,606,-0.028183,-0.0050326,0.033334,0.80108,GOBP_NUCLEIC_ACID_CATABOLIC_PROCESS,1
GSE7460_CTRL_VS_TGFB_TREATED...3,SET,182,-0.054287,-0.0053756,0.064181,0.80118,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN,1
GOBP_DNA_DEMETHYLATION,SET,18,-0.20566,-0.0064331,0.24309,0.80122,GOBP_DNA_DEMETHYLATION,1
HP_RECURRENT_VIRAL_INFECTIONS,SET,54,-0.099043,-0.0053608,0.11706,0.80124,HP_RECURRENT_VIRAL_INFECTIONS,1
GOMF_ALPHA_N_ACETYLGALACTOSA...,SET,6,-0.3565,-0.0064404,0.4213,0.80127,GOMF_ALPHA_N_ACETYLGALACTOSAMINIDE_ALPHA_2_6_SIALYLTRANSFERASE_ACTIVITY,1
HAY_BONE_MARROW_ERYTHROBLAST,SET,1136,-0.021095,-0.0050799,0.024929,0.80127,HAY_BONE_MARROW_ERYTHROBLAST,1
BIOCARTA_VITCB_PATHWAY,SET,8,-0.22544,-0.0047026,0.2664,0.80129,BIOCARTA_VITCB_PATHWAY,1
KEGG_MEDICUS_REFERENCE_KISS1...,SET,11,-0.23764,-0.0058123,0.28072,0.80137,KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY,1
GSE36476_CTRL_VS_TSST_ACT_40...4,SET,177,-0.055121,-0.0053833,0.065107,0.80139,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP,1
GOBP_ESTABLISHMENT_OF_LYMPHO...,SET,15,-0.19236,-0.0054934,0.2272,0.8014,GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY,1
GOBP_FACIAL_NERVE_MORPHOGENE...,SET,9,-0.27499,-0.006084,0.32475,0.80144,GOBP_FACIAL_NERVE_MORPHOGENESIS,1
GOBP_REGULATION_OF_MITOTIC_C...1,SET,472,-0.033483,-0.0052966,0.039539,0.80145,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE,1
MIR5584_5P,SET,229,-0.047704,-0.0052918,0.05633,0.80146,MIR5584_5P,1
GSE4748_CTRL_VS_LPS_STIM_DC_...2,SET,183,-0.056331,-0.0055931,0.066515,0.80147,GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP,1
GOCC_CLATHRIN_COATED_ENDOCYT...1,SET,85,-0.086115,-0.0058429,0.10166,0.80152,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE,1
GOBP_PROTEIN_TARGETING_TO_MI...,SET,97,-0.071744,-0.0051984,0.084685,0.80155,GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION,1
CUI_DEVELOPING_HEART_C7_MAST...,SET,135,-0.065658,-0.0056067,0.077493,0.80157,CUI_DEVELOPING_HEART_C7_MAST_CELL,1
GSE36392_TYPE_2_MYELOID_VS_N...2,SET,182,-0.053439,-0.0052915,0.063058,0.80162,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,1
HP_ABNORMAL_PUPIL_MORPHOLOGY,SET,66,-0.095544,-0.0057154,0.11274,0.80163,HP_ABNORMAL_PUPIL_MORPHOLOGY,1
ZNF781_TARGET_GENES,SET,121,-0.062814,-0.00508,0.074099,0.80169,ZNF781_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...172,SET,8,-0.25277,-0.0052727,0.29819,0.80169,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,1
GOMF_INOSITOL_TETRAKISPHOSPH...1,SET,5,-0.34947,-0.0057635,0.41223,0.80171,GOMF_INOSITOL_TETRAKISPHOSPHATE_KINASE_ACTIVITY,1
GOMF_UBIQUINOL_CYTOCHROME_C_...,SET,5,-0.27066,-0.0044637,0.31922,0.80174,GOMF_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY,1
MIR12131,SET,154,-0.059071,-0.0053846,0.069666,0.80175,MIR12131,1
GSE25088_CTRL_VS_IL4_STIM_ST...2,SET,156,-0.059921,-0.0054972,0.070666,0.80176,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP,1
REACTOME_CD28_CO_STIMULATION,SET,32,-0.13798,-0.0057527,0.16271,0.80178,REACTOME_CD28_CO_STIMULATION,1
GOBP_METANEPHRIC_MESENCHYME_...,SET,13,-0.22777,-0.0060556,0.26859,0.80178,GOBP_METANEPHRIC_MESENCHYME_DEVELOPMENT,1
GOMF_G_PROTEIN_COUPLED_ACETY...,SET,7,-0.3102,-0.0060529,0.36573,0.80182,GOMF_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY,1
ZNF30_TARGET_GENES,SET,1186,-0.021392,-0.0052561,0.02522,0.80183,ZNF30_TARGET_GENES,1
GOBP_REGULATION_OF_RESPONSE_...2,SET,158,-0.057826,-0.0053386,0.068166,0.80186,GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
GSE23505_UNTREATED_VS_4DAY_I...4,SET,182,-0.053241,-0.005272,0.062752,0.8019,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
RAHMAN_TP53_TARGETS_PHOSPHOR...,SET,19,-0.16174,-0.0051979,0.19062,0.80191,RAHMAN_TP53_TARGETS_PHOSPHORYLATED,1
WP_EBSTEINBARR_VIRUS_LMP1_SI...,SET,21,-0.14984,-0.0050621,0.17659,0.80192,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,1
GOBP_LEUKOCYTE_MIGRATION,SET,369,-0.041224,-0.0057825,0.048579,0.80194,GOBP_LEUKOCYTE_MIGRATION,1
LUCAS_HNF4A_TARGETS_UP,SET,53,-0.099151,-0.0053169,0.11679,0.80204,LUCAS_HNF4A_TARGETS_UP,1
HP_VENTRICULAR_HYPERTROPHY,SET,138,-0.059328,-0.0051217,0.069883,0.80204,HP_VENTRICULAR_HYPERTROPHY,1
HP_ABNORMALITY_OF_DENTAL_ERU...,SET,209,-0.051394,-0.0054494,0.060524,0.80209,HP_ABNORMALITY_OF_DENTAL_ERUPTION,1
PETROVA_ENDOTHELIUM_LYMPHATI...1,SET,154,-0.062345,-0.0056831,0.073393,0.80218,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1
GOBP_POSITIVE_REGULATION_OF_...338,SET,12,-0.26847,-0.006858,0.31599,0.80222,GOBP_POSITIVE_REGULATION_OF_HIPPO_SIGNALING,1
HP_SKIN_EROSION,SET,26,-0.13301,-0.0049993,0.15656,0.80222,HP_SKIN_EROSION,1
GOBP_INTERMEDIATE_FILAMENT_O...,SET,71,-0.1173,-0.007277,0.13806,0.80224,GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION,1
GOMF_THREONINE_TYPE_ENDOPEPT...,SET,9,-0.23739,-0.0052521,0.27929,0.80233,GOMF_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
HOXA9_DN.V1_UP,SET,172,-0.058024,-0.0055871,0.068263,0.80234,HOXA9_DN.V1_UP,1
WP_NF1_COPY_NUMBER_VARIATION...,SET,74,-0.091453,-0.0057914,0.10758,0.80236,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,1
MIR518A_3P_MIR518B_MIR518C_3...,SET,8,-0.28019,-0.0058446,0.3296,0.80236,MIR518A_3P_MIR518B_MIR518C_3P_MIR518D_3P_MIR518F_3P_MIR526A_3P,1
MODULE_532,SET,367,-0.038015,-0.0053181,0.044703,0.80244,MODULE_532,1
GSE36476_CTRL_VS_TSST_ACT_72...4,SET,175,-0.055662,-0.0054057,0.065449,0.80246,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP,1
BLANCO_MELO_COVID19_SARS_COV...6,SET,70,-0.094932,-0.0058477,0.11159,0.80253,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,1
MIR532_5P,SET,68,-0.087859,-0.0053344,0.10327,0.80254,MIR532_5P,1
HP_PAROXYSMAL_VENTRICULAR_TA...,SET,26,-0.1454,-0.0054651,0.17089,0.80256,HP_PAROXYSMAL_VENTRICULAR_TACHYCARDIA,1
GOBP_NEGATIVE_REGULATION_OF_...385,SET,12,-0.21076,-0.0053839,0.24766,0.80261,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL,1
GSE19772_HCMV_INFL_VS_HCMV_I...2,SET,187,-0.054482,-0.0054677,0.064016,0.80263,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,1
GSE5589_LPS_VS_LPS_AND_IL10_...11,SET,186,-0.052003,-0.0052051,0.061104,0.80263,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
MORF_ERCC4,SET,286,-0.044125,-0.0054615,0.05184,0.80266,MORF_ERCC4,1
REACTOME_TRANSCRIPTIONAL_REG...3,SET,32,-0.13751,-0.005733,0.16153,0.80269,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4,1
GOBP_ELECTRON_TRANSPORT_CHAIN,SET,107,-0.063985,-0.004868,0.075163,0.80269,GOBP_ELECTRON_TRANSPORT_CHAIN,1
WP_METABOLIC_REPROGRAMMING_I...2,SET,41,-0.11291,-0.0053272,0.13263,0.80271,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,1
WUNDER_INFLAMMATORY_RESPONSE...1,SET,11,-0.21498,-0.0052579,0.25247,0.80275,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN,1
HP_THICKENED_SKIN,SET,381,-0.038176,-0.0054395,0.044834,0.80275,HP_THICKENED_SKIN,1
PEDERSEN_METASTASIS_BY_ERBB2...6,SET,346,-0.04005,-0.0054433,0.047033,0.80276,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,1
HP_LONG_FINGERS,SET,246,-0.045374,-0.0052143,0.053285,0.80276,HP_LONG_FINGERS,1
REACTOME_REGULATION_OF_PLK1_...,SET,81,-0.072922,-0.0048305,0.085617,0.80281,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1
GOMF_BH_DOMAIN_BINDING,SET,10,-0.24045,-0.0056075,0.28228,0.80284,GOMF_BH_DOMAIN_BINDING,1
GSE17721_LPS_VS_CPG_4H_BMDC_...2,SET,188,-0.053114,-0.0053445,0.062317,0.80298,GSE17721_LPS_VS_CPG_4H_BMDC_UP,1
PID_RHOA_PATHWAY,SET,42,-0.11664,-0.0055697,0.13684,0.80299,PID_RHOA_PATHWAY,1
SATO_SILENCED_EPIGENETICALLY...,SET,39,-0.11879,-0.0054663,0.13936,0.803,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,1
REACTOME_ALPHA_DEFENSINS,SET,6,-0.35431,-0.0064009,0.41565,0.80301,REACTOME_ALPHA_DEFENSINS,1
CHARAFE_BREAST_CANCER_BASAL_...1,SET,50,-0.11351,-0.0059125,0.13311,0.80309,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,1
HU_FETAL_RETINA_HORIZONTAL,SET,34,-0.13357,-0.0057397,0.15661,0.80312,HU_FETAL_RETINA_HORIZONTAL,1
REACTOME_CA2_PATHWAY,SET,62,-0.095173,-0.0055186,0.11158,0.80316,REACTOME_CA2_PATHWAY,1
MIR4475,SET,58,-0.09475,-0.0053144,0.11106,0.8032,MIR4475,1
GRAESSMANN_APOPTOSIS_BY_DOXO...1,SET,1596,-0.018822,-0.0053005,0.022059,0.80324,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN,1
BIOCARTA_MHC_PATHWAY,SET,10,-0.27829,-0.0064897,0.32614,0.80324,BIOCARTA_MHC_PATHWAY,1
GOMF_PEPTIDASE_ACTIVATOR_ACT...1,SET,52,-0.099708,-0.0052962,0.11684,0.80327,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY,1
HP_ESODEVIATION,SET,200,-0.051054,-0.0052968,0.059819,0.8033,HP_ESODEVIATION,1
GOBP_CHITIN_METABOLIC_PROCESS,SET,6,-0.3158,-0.0057052,0.36997,0.80332,GOBP_CHITIN_METABOLIC_PROCESS,1
GOMF_CHITINASE_ACTIVITY,SET,6,-0.3158,-0.0057052,0.36997,0.80332,GOMF_CHITINASE_ACTIVITY,1
GOBP_NUCLEOTIDE_TRANSPORT,SET,44,-0.12116,-0.0059214,0.14193,0.80335,GOBP_NUCLEOTIDE_TRANSPORT,1
GOBP_REGULATION_OF_PROTEIN_K...1,SET,6,-0.29494,-0.0053283,0.3455,0.80335,GOBP_REGULATION_OF_PROTEIN_K48_LINKED_UBIQUITINATION,1
GSE15330_GRANULOCYTE_MONOCYT...1,SET,184,-0.052738,-0.0052505,0.061764,0.8034,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...285,SET,172,-0.058981,-0.0056792,0.069066,0.80344,GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY,1
HP_ABNORMALITY_OF_CENTRAL_NE...,SET,525,-0.032327,-0.0053853,0.037847,0.80349,HP_ABNORMALITY_OF_CENTRAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,1
PLASARI_TGFB1_TARGETS_1HR_DN,SET,4,-0.42743,-0.0063052,0.50037,0.8035,PLASARI_TGFB1_TARGETS_1HR_DN,1
HP_ELEVATED_CIRCULATING_HEPA...,SET,325,-0.040156,-0.0052925,0.047007,0.80351,HP_ELEVATED_CIRCULATING_HEPATIC_TRANSAMINASE_CONCENTRATION,1
HP_VISUAL_IMPAIRMENT,SET,995,-0.023878,-0.0054036,0.027951,0.80352,HP_VISUAL_IMPAIRMENT,1
GSE42021_CD24HI_VS_CD24LOW_T...1,SET,183,-0.055251,-0.0054859,0.064674,0.80353,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...365,SET,14,-0.1965,-0.0054215,0.22998,0.80356,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
GOBP_REGULATORY_NCRNA_MEDIAT...1,SET,112,-0.066543,-0.0051789,0.077881,0.80356,GOBP_REGULATORY_NCRNA_MEDIATED_GENE_SILENCING,1
HALLMARK_INTERFERON_ALPHA_RE...,SET,93,-0.074861,-0.0053119,0.087596,0.80361,HALLMARK_INTERFERON_ALPHA_RESPONSE,1
REACTOME_CHONDROITIN_SULFATE...1,SET,18,-0.16472,-0.0051525,0.19269,0.80367,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,1
YIH_RESPONSE_TO_ARSENITE_C1,SET,21,-0.15755,-0.0053226,0.18427,0.80371,YIH_RESPONSE_TO_ARSENITE_C1,1
XU_RESPONSE_TO_TRETINOIN_UP,SET,13,-0.22028,-0.0058567,0.25759,0.80376,XU_RESPONSE_TO_TRETINOIN_UP,1
GSE17974_0H_VS_12H_IN_VITRO_...2,SET,167,-0.055983,-0.0053123,0.065464,0.80377,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP,1
WANG_PROSTATE_CANCER_ANDROGE...,SET,58,-0.099497,-0.0055807,0.11634,0.80378,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,1
GOBP_MEMBRANE_RAFT_LOCALIZAT...,SET,6,-0.32432,-0.005859,0.37911,0.80385,GOBP_MEMBRANE_RAFT_LOCALIZATION,1
HP_VERTEBRAL_COMPRESSION_FRA...,SET,32,-0.12738,-0.0053105,0.14887,0.80388,HP_VERTEBRAL_COMPRESSION_FRACTURE,1
BUFFA_HYPOXIA_METAGENE,SET,44,-0.10872,-0.0053135,0.12705,0.80393,BUFFA_HYPOXIA_METAGENE,1
HP_CEREBELLAR_HEMISPHERE_HYP...,SET,8,-0.22843,-0.004765,0.26692,0.80394,HP_CEREBELLAR_HEMISPHERE_HYPOPLASIA,1
GOCC_NEURON_PROJECTION_CYTOP...,SET,83,-0.079734,-0.0053462,0.093155,0.80397,GOCC_NEURON_PROJECTION_CYTOPLASM,1
chr1q44,SET,56,-0.16741,-0.0092268,0.19558,0.80398,chr1q44,1
LINDGREN_BLADDER_CANCER_CLUS...3,SET,118,-0.070014,-0.0055922,0.081796,0.80398,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1
MIR224_5P,SET,164,-0.05638,-0.0053021,0.065865,0.80399,MIR224_5P,1
GSE25123_WT_VS_PPARG_KO_MACR...1,SET,177,-0.055623,-0.0054324,0.064968,0.80404,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN,1
MIR6773_5P,SET,33,-0.123,-0.0052076,0.14364,0.8041,MIR6773_5P,1
GOBP_RESPONSE_TO_ESTRADIOL,SET,113,-0.071788,-0.0056118,0.083821,0.80412,GOBP_RESPONSE_TO_ESTRADIOL,1
GOCC_FICOLIN_1_RICH_GRANULE_...1,SET,120,-0.067132,-0.0054069,0.07838,0.80413,GOCC_FICOLIN_1_RICH_GRANULE_LUMEN,1
HP_FRONTAL_BALDING,SET,13,-0.1995,-0.0053042,0.23292,0.80414,HP_FRONTAL_BALDING,1
GOBP_LYMPHATIC_ENDOTHELIAL_C...,SET,8,-0.26242,-0.0054739,0.3063,0.8042,GOBP_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION,1
HE_LIM_SUN_FETAL_LUNG_C7_TM4...1,SET,51,-0.10999,-0.005786,0.12837,0.80421,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,1
HP_TYPE_2_MUSCLE_FIBER_PREDO...,SET,9,-0.27365,-0.0060544,0.31932,0.80427,HP_TYPE_2_MUSCLE_FIBER_PREDOMINANCE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...16,SET,50,-0.093979,-0.0048952,0.10966,0.80428,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR,1
WP_NOCGMPPKG_MEDIATED_NEUROP...,SET,41,-0.11804,-0.0055693,0.13773,0.80429,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,1
GSE32533_WT_VS_MIR17_KO_ACT_...2,SET,179,-0.054831,-0.0053849,0.063967,0.80432,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP,1
GSE7218_IGM_VS_IGG_SIGNAL_TH...1,SET,161,-0.060024,-0.0055935,0.070022,0.80433,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN,1
HP_RETINAL_DETACHMENT,SET,97,-0.076796,-0.0055645,0.089568,0.80438,HP_RETINAL_DETACHMENT,1
MIR676_5P,SET,141,-0.064535,-0.005631,0.075236,0.80448,MIR676_5P,1
GOBP_FATTY_ACID_ELONGATION,SET,13,-0.24119,-0.0064124,0.28119,0.80448,GOBP_FATTY_ACID_ELONGATION,1
MODULE_234,SET,53,-0.11615,-0.0062287,0.13541,0.80449,MODULE_234,1
GSE20715_0H_VS_24H_OZONE_TLR...2,SET,175,-0.057677,-0.0056014,0.06723,0.80452,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP,1
HP_ECLABION,SET,147,-0.064071,-0.0057072,0.074668,0.80457,HP_ECLABION,1
KAZMIN_PBMC_P_FALCIPARUM_RTS...2,SET,6,-0.27987,-0.0050561,0.32612,0.8046,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_POSITIVE,1
PEREZ_TP53_AND_TP63_TARGETS,SET,178,-0.058471,-0.0057265,0.068124,0.80463,PEREZ_TP53_AND_TP63_TARGETS,1
GOBP_ONCOGENE_INDUCED_CELL_S...,SET,6,-0.26154,-0.004725,0.30471,0.80464,GOBP_ONCOGENE_INDUCED_CELL_SENESCENCE,1
BUSSLINGER_DUODENAL_STEM_CEL...,SET,281,-0.045217,-0.0055483,0.052674,0.80467,BUSSLINGER_DUODENAL_STEM_CELLS,1
GOBP_RESPONSE_TO_NERVE_GROWT...,SET,51,-0.10723,-0.0056406,0.12489,0.8047,GOBP_RESPONSE_TO_NERVE_GROWTH_FACTOR,1
HP_TICS,SET,22,-0.15521,-0.0053668,0.18078,0.8047,HP_TICS,1
GNF2_CDH3,SET,26,-0.15242,-0.005729,0.17753,0.80471,GNF2_CDH3,1
GSE21033_CTRL_VS_POLYIC_STIM...4,SET,174,-0.056245,-0.0054468,0.065491,0.80477,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...9,SET,5,-0.39855,-0.0065729,0.46403,0.80479,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY,1
REACTOME_INTERLEUKIN_18_SIGN...,SET,8,-0.2832,-0.0059073,0.32972,0.80479,REACTOME_INTERLEUKIN_18_SIGNALING,1
MATZUK_MALE_REPRODUCTION_SER...,SET,25,-0.15153,-0.0055851,0.17642,0.8048,MATZUK_MALE_REPRODUCTION_SERTOLI,1
HP_RECTAL_FISTULA,SET,23,-0.15441,-0.0054591,0.17974,0.80485,HP_RECTAL_FISTULA,1
MIR1224_5P,SET,55,-0.097663,-0.0053347,0.11367,0.80487,MIR1224_5P,1
GSE17721_0.5H_VS_12H_PAM3CSK...2,SET,182,-0.05403,-0.00535,0.062885,0.80487,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP,1
GOMF_LONG_CHAIN_FATTY_ACYL_C...,SET,12,-0.20311,-0.0051885,0.23638,0.8049,GOMF_LONG_CHAIN_FATTY_ACYL_COA_HYDROLASE_ACTIVITY,1
KEGG_ACUTE_MYELOID_LEUKEMIA,SET,54,-0.10204,-0.005523,0.11871,0.80499,KEGG_ACUTE_MYELOID_LEUKEMIA,1
HP_ABNORMAL_MIDDLE_EAR_MORPH...,SET,323,-0.043447,-0.005709,0.050532,0.80504,HP_ABNORMAL_MIDDLE_EAR_MORPHOLOGY,1
HP_ABNORMAL_RENAL_CORTICOMED...,SET,21,-0.17201,-0.0058113,0.20006,0.80505,HP_ABNORMAL_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
GOBP_VIRAL_TRANSLATIONAL_TER...,SET,5,-0.29938,-0.0049374,0.348,0.80518,GOBP_VIRAL_TRANSLATIONAL_TERMINATION_REINITIATION,1
GSE17721_CPG_VS_GARDIQUIMOD_...12,SET,183,-0.055266,-0.0054873,0.064236,0.8052,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP,1
GOMF_OXIDOREDUCTION_DRIVEN_A...,SET,52,-0.087952,-0.0046718,0.10221,0.80524,GOMF_OXIDOREDUCTION_DRIVEN_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE17974_CTRL_VS_ACT_IL4_AND...12,SET,156,-0.06204,-0.0056916,0.07209,0.80526,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP,1
HP_ANTERIORLY_PLACED_ANUS,SET,56,-0.10068,-0.0055492,0.11695,0.80534,HP_ANTERIORLY_PLACED_ANUS,1
HP_ABSENT_FOREARM_BONE,SET,24,-0.14952,-0.0053997,0.17367,0.80535,HP_ABSENT_FOREARM_BONE,1
GSE40274_LEF1_VS_FOXP3_AND_L...2,SET,182,-0.056695,-0.005614,0.065842,0.8054,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_FAT_PAD_DEVELOPMENT,SET,8,-0.26065,-0.005437,0.30268,0.80542,GOBP_FAT_PAD_DEVELOPMENT,1
GOBP_NERVE_DEVELOPMENT,SET,92,-0.08351,-0.0058938,0.096968,0.80543,GOBP_NERVE_DEVELOPMENT,1
GOBP_VASODILATION,SET,45,-0.12534,-0.0061948,0.14554,0.80544,GOBP_VASODILATION,1
HP_ABNORMALITY_OF_THE_URETER,SET,328,-0.041231,-0.0054589,0.047874,0.80545,HP_ABNORMALITY_OF_THE_URETER,1
KEGG_MEDICUS_REFERENCE_MGLUR...2,SET,20,-0.16413,-0.0054114,0.19056,0.80546,KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GOBP_PROTEIN_LOCALIZATION_TO...19,SET,7,-0.25894,-0.0050525,0.30057,0.80551,GOBP_PROTEIN_LOCALIZATION_TO_CYTOPLASMIC_STRESS_GRANULE,1
GARGALOVIC_RESPONSE_TO_OXIDI...11,SET,8,-0.31657,-0.0066034,0.36743,0.80553,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN,1
GSE2405_0H_VS_3H_A_PHAGOCYTO...1,SET,163,-0.061446,-0.0057611,0.071312,0.80555,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
MYOGNF1_01,SET,41,-0.11748,-0.0055425,0.13633,0.80557,MYOGNF1_01,1
GARGALOVIC_RESPONSE_TO_OXIDI...22,SET,75,-0.087081,-0.0055516,0.10105,0.80559,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1
chr10p14,SET,15,-0.30219,-0.0086297,0.35061,0.80562,chr10p14,1
ATF3_Q6,SET,229,-0.050428,-0.005594,0.058505,0.80564,ATF3_Q6,1
KEGG_MISMATCH_REPAIR,SET,22,-0.14459,-0.0049996,0.16773,0.80565,KEGG_MISMATCH_REPAIR,1
GSE14000_4H_VS_16H_LPS_DC_DN,SET,161,-0.054618,-0.0050897,0.06336,0.80566,GSE14000_4H_VS_16H_LPS_DC_DN,1
GSE22229_RENAL_TRANSPLANT_IM...2,SET,185,-0.052711,-0.0052619,0.061133,0.80572,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP,1
DESCARTES_MAIN_FETAL_CORNEAL...,SET,218,-0.049929,-0.0054055,0.057898,0.80575,DESCARTES_MAIN_FETAL_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,1
HP_EDEMA_OF_THE_DORSUM_OF_FE...,SET,4,-0.35232,-0.0051972,0.40849,0.80578,HP_EDEMA_OF_THE_DORSUM_OF_FEET,1
GAGACTG_MIR452,SET,88,-0.078342,-0.0054081,0.090831,0.80579,GAGACTG_MIR452,1
HP_RECURRENT_CUTANEOUS_ABSCE...,SET,6,-0.32767,-0.0059196,0.37991,0.80579,HP_RECURRENT_CUTANEOUS_ABSCESS_FORMATION,1
ZNF774_TARGET_GENES,SET,19,-0.16486,-0.005298,0.1911,0.80584,ZNF774_TARGET_GENES,1
CAFFAREL_RESPONSE_TO_THC_8HR...3,SET,11,-0.21547,-0.00527,0.24972,0.80589,CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,1
GOBP_ENDOCARDIAL_CUSHION_DEV...,SET,52,-0.11846,-0.0062922,0.13727,0.80591,GOBP_ENDOCARDIAL_CUSHION_DEVELOPMENT,1
GSE35543_IN_VITRO_ITREG_VS_C...1,SET,178,-0.055716,-0.0054567,0.064557,0.80594,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN,1
GOBP_NEGATIVE_REGULATION_OF_...132,SET,5,-0.26557,-0.0043799,0.30768,0.80597,GOBP_NEGATIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,1
GOBP_RESPONSE_TO_TYPE_II_INT...,SET,112,-0.072971,-0.0056791,0.084523,0.80601,GOBP_RESPONSE_TO_TYPE_II_INTERFERON,1
HP_MUSCLE_FIBER_INCLUSION_BO...,SET,36,-0.11906,-0.0052645,0.13791,0.80603,HP_MUSCLE_FIBER_INCLUSION_BODIES,1
GSE34156_TLR1_TLR2_LIGAND_VS...3,SET,147,-0.060477,-0.0053871,0.07004,0.80605,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...376,SET,9,-0.26811,-0.0059317,0.31047,0.80608,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...574,SET,106,-0.074852,-0.0056683,0.086673,0.80609,GOBP_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION,1
TSUNODA_CISPLATIN_RESISTANCE...2,SET,11,-0.25731,-0.0062933,0.29782,0.80619,TSUNODA_CISPLATIN_RESISTANCE_UP,1
GOCC_CULLIN_RING_UBIQUITIN_L...,SET,164,-0.057747,-0.0054307,0.066829,0.80623,GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...653,SET,108,-0.074053,-0.0056601,0.085679,0.80628,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
GOBP_PHENOL_CONTAINING_COMPO...3,SET,103,-0.079479,-0.0059333,0.091957,0.80628,GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_EEG_WITH_FOCAL_SHARP_SLOW...,SET,12,-0.23281,-0.005947,0.26936,0.80628,HP_EEG_WITH_FOCAL_SHARP_SLOW_WAVES,1
GSE20366_EX_VIVO_VS_HOMEOSTA...4,SET,187,-0.050534,-0.0050715,0.05847,0.80628,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP,1
GNF2_EGFR,SET,29,-0.15482,-0.0061451,0.1791,0.80632,GNF2_EGFR,1
GSE7460_TREG_VS_TCONV_ACT_WI...1,SET,179,-0.053939,-0.0052973,0.062397,0.80632,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN,1
GOBP_HOMOCYSTEINE_METABOLIC_...,SET,11,-0.24105,-0.0058956,0.2788,0.80637,GOBP_HOMOCYSTEINE_METABOLIC_PROCESS,1
HP_ABNORMAL_PLACENTA_MORPHOL...,SET,33,-0.14161,-0.0059954,0.16374,0.80643,HP_ABNORMAL_PLACENTA_MORPHOLOGY,1
KEGG_MEDICUS_VARIANT_EGFR_OV...,SET,10,-0.23751,-0.0055388,0.2746,0.80646,KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMAL_SPINAL_CORD_MORP...,SET,274,-0.046499,-0.0056352,0.053758,0.80647,HP_ABNORMAL_SPINAL_CORD_MORPHOLOGY,1
FONTAINE_FOLLICULAR_THYROID_...1,SET,62,-0.09708,-0.0056292,0.1122,0.80655,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,1
GOBP_CYCLIC_NUCLEOTIDE_TRANS...,SET,11,-0.25265,-0.0061792,0.29193,0.80659,GOBP_CYCLIC_NUCLEOTIDE_TRANSPORT,1
GOBP_REGULATION_OF_KERATINOC...3,SET,44,-0.1239,-0.0060553,0.14315,0.80663,GOBP_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
CHIANG_LIVER_CANCER_SUBCLASS...3,SET,46,-0.10902,-0.0054472,0.12593,0.80666,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,1
REACTOME_SEMA3A_PLEXIN_REPUL...,SET,13,-0.22142,-0.005887,0.25578,0.80666,REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,1
MIR10522_5P,SET,215,-0.050898,-0.0054728,0.058795,0.80666,MIR10522_5P,1
REACTOME_RUNX3_REGULATES_NOT...,SET,13,-0.19543,-0.0051958,0.22574,0.80667,REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING,1
GSE34156_UNTREATED_VS_6H_NOD...3,SET,166,-0.057955,-0.0054831,0.066939,0.80669,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN,1
MIR130B_3P,SET,358,-0.039598,-0.0054726,0.045734,0.8067,MIR130B_3P,1
WP_KCNQ2RELATED_EPILEPSIES,SET,19,-0.17573,-0.0056474,0.20295,0.80671,WP_KCNQ2RELATED_EPILEPSIES,1
SRF_Q4,SET,202,-0.054252,-0.0056564,0.062651,0.80673,SRF_Q4,1
GOBP_SEROTONIN_UPTAKE,SET,12,-0.23266,-0.0059431,0.26868,0.80673,GOBP_SEROTONIN_UPTAKE,1
GSE16450_CTRL_VS_IFNA_12H_ST...1,SET,155,-0.061532,-0.005627,0.071057,0.80673,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,1
GSE2770_IL12_AND_TGFB_ACT_VS...2,SET,174,-0.054554,-0.005283,0.062998,0.80674,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP,1
GOCC_ASTROCYTE_END_FOOT,SET,11,-0.24293,-0.0059414,0.2805,0.80676,GOCC_ASTROCYTE_END_FOOT,1
REACTOME_LAGGING_STRAND_SYNT...,SET,19,-0.15499,-0.0049808,0.17895,0.80677,REACTOME_LAGGING_STRAND_SYNTHESIS,1
RODRIGUES_THYROID_CARCINOMA_...1,SET,469,-0.034954,-0.0055121,0.040353,0.80681,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,1
GSE24574_BCL6_LOW_TFH_VS_TCO...2,SET,168,-0.059278,-0.0056416,0.068424,0.80684,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP,1
MIR200C_5P,SET,58,-0.098804,-0.0055418,0.11404,0.80686,MIR200C_5P,1
HP_ABNORMAL_PYRAMIDAL_TRACT_...,SET,61,-0.10192,-0.0058623,0.11764,0.80686,HP_ABNORMAL_PYRAMIDAL_TRACT_MORPHOLOGY,1
GSE16385_ROSIGLITAZONE_IL4_V...5,SET,181,-0.053771,-0.00531,0.062056,0.80689,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN,1
GOBP_RNA_SPLICING_VIA_ENDONU...,SET,13,-0.21891,-0.0058201,0.25261,0.80691,GOBP_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION,1
HP_SENSORY_NEUROPATHY,SET,88,-0.076832,-0.0053039,0.088661,0.80691,HP_SENSORY_NEUROPATHY,1
CURSONS_NATURAL_KILLER_CELLS,SET,17,-0.19467,-0.0059181,0.22463,0.80692,CURSONS_NATURAL_KILLER_CELLS,1
MIR3611,SET,135,-0.064612,-0.0055174,0.07454,0.80697,MIR3611,1
GOBP_NOREPINEPHRINE_TRANSPORT,SET,23,-0.17731,-0.0062687,0.20455,0.80698,GOBP_NOREPINEPHRINE_TRANSPORT,1
MYLLYKANGAS_AMPLIFICATION_HO...14,SET,5,-0.27569,-0.0045467,0.31801,0.807,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30,1
GSE34205_RSV_VS_FLU_INF_INFA...2,SET,154,-0.061474,-0.0056037,0.0709,0.80704,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP,1
KEGG_MEDICUS_REFERENCE_HIF_1...,SET,9,-0.25929,-0.0057365,0.299,0.80707,KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY,1
GOMF_HISTONE_H3K9ME_H3K9ME2_...,SET,4,-0.31883,-0.0047032,0.36767,0.80707,GOMF_HISTONE_H3K9ME_H3K9ME2_DEMETHYLASE_ACTIVITY,1
GSE37301_HEMATOPOIETIC_STEM_...14,SET,155,-0.061138,-0.005591,0.070503,0.80707,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP,1
REACTOME_MECP2_REGULATES_NEU...,SET,16,-0.20631,-0.0060848,0.23791,0.80708,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,1
HP_OROTICACIDURIA,SET,7,-0.27208,-0.005309,0.31374,0.80708,HP_OROTICACIDURIA,1
HP_ATRIAL_FLUTTER,SET,17,-0.19639,-0.0059704,0.22646,0.80709,HP_ATRIAL_FLUTTER,1
HP_HIGH_SERUM_CALCITRIOL,SET,5,-0.39342,-0.0064883,0.45362,0.8071,HP_HIGH_SERUM_CALCITRIOL,1
WP_ENDOCHONDRAL_OSSIFICATION,SET,63,-0.10281,-0.0060093,0.11849,0.80721,WP_ENDOCHONDRAL_OSSIFICATION,1
WP_ENDOCHONDRAL_OSSIFICATION...,SET,63,-0.10281,-0.0060093,0.11849,0.80721,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1
GSE3982_NKCELL_VS_TH2_DN,SET,179,-0.054337,-0.0053364,0.062619,0.80723,GSE3982_NKCELL_VS_TH2_DN,1
REACTOME_POLB_DEPENDENT_LONG...,SET,7,-0.25615,-0.0049982,0.29517,0.80725,REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,1
HP_APLASIA_HYPOPLASIA_OF_THE...20,SET,5,-0.27825,-0.004589,0.32062,0.80726,HP_APLASIA_HYPOPLASIA_OF_THE_DIAPHRAGM,1
GOMF_FRUCTOSE_6_PHOSPHATE_BI...,SET,4,-0.30782,-0.0045407,0.35467,0.80727,GOMF_FRUCTOSE_6_PHOSPHATE_BINDING,1
MORF_HAT1,SET,153,-0.054635,-0.0049642,0.062932,0.80734,MORF_HAT1,1
REACTOME_FATTY_ACYL_COA_BIOS...,SET,35,-0.13402,-0.0058429,0.15435,0.80738,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,1
GSE360_CTRL_VS_B_MALAYI_HIGH...2,SET,173,-0.05476,-0.0052879,0.063054,0.80742,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
GSE9006_TYPE_1_VS_TYPE_2_DIA...1,SET,180,-0.053706,-0.005289,0.061839,0.80743,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,1
KEGG_PANCREATIC_CANCER,SET,66,-0.094602,-0.005659,0.10892,0.80745,KEGG_PANCREATIC_CANCER,1
chr2q21,SET,33,-0.27463,-0.011627,0.31609,0.80752,chr2q21,1
MODULE_192,SET,100,-0.074346,-0.0054692,0.085561,0.80755,MODULE_192,1
HE_LIM_SUN_FETAL_LUNG_C1_SQU...,SET,230,-0.052128,-0.005795,0.059968,0.80764,HE_LIM_SUN_FETAL_LUNG_C1_SQUAMOUS_CELL,1
GSE17974_IL4_AND_ANTI_IL12_V...5,SET,139,-0.064411,-0.0055804,0.074097,0.80765,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN,1
GOBP_METANEPHRIC_EPITHELIUM_...,SET,27,-0.16139,-0.0061813,0.18564,0.80767,GOBP_METANEPHRIC_EPITHELIUM_DEVELOPMENT,1
HP_EXTRAMEDULLARY_HEMATOPOIE...,SET,19,-0.16921,-0.005438,0.19464,0.80767,HP_EXTRAMEDULLARY_HEMATOPOIESIS,1
REACTOME_NR1H2_NR1H3_REGULAT...2,SET,9,-0.2239,-0.0049536,0.25747,0.80774,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS,1
GOBP_RENAL_SYSTEM_VASCULATUR...1,SET,31,-0.15273,-0.0062676,0.17559,0.80779,GOBP_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT,1
CHUANG_OXIDATIVE_STRESS_RESP...1,SET,10,-0.1961,-0.0045731,0.22543,0.80782,CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,1
WENG_POR_TARGETS_GLOBAL_UP,SET,18,-0.1609,-0.0050331,0.18496,0.80783,WENG_POR_TARGETS_GLOBAL_UP,1
MORF_JUND,SET,57,-0.09405,-0.0052296,0.1081,0.80785,MORF_JUND,1
GOBP_MEMBRANE_LIPID_BIOSYNTH...,SET,143,-0.063295,-0.0055615,0.072746,0.80786,GOBP_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS,1
GSE22601_DOUBLE_POSITIVE_VS_...4,SET,186,-0.056398,-0.0056449,0.06481,0.8079,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
GOBP_PHOSPHATE_ION_TRANSMEMB...,SET,14,-0.20588,-0.0056802,0.23652,0.80797,GOBP_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT,1
GSE5542_UNTREATED_VS_IFNA_TR...3,SET,171,-0.055144,-0.0052944,0.063348,0.80798,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,1
ZIM3_TARGET_GENES,SET,800,-0.026107,-0.005327,0.029989,0.80799,ZIM3_TARGET_GENES,1
HP_ASPIRATION_PNEUMONIA,SET,88,-0.07883,-0.0054418,0.090531,0.80805,HP_ASPIRATION_PNEUMONIA,1
GOBP_NEGATIVE_REGULATION_OF_...259,SET,5,-0.3778,-0.0062308,0.43382,0.80808,GOBP_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION,1
GSE2706_LPS_VS_R848_AND_LPS_...3,SET,159,-0.062348,-0.0057741,0.07159,0.80809,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN,1
WP_TYPE_II_INTERFERON_SIGNAL...,SET,35,-0.13326,-0.00581,0.153,0.80811,WP_TYPE_II_INTERFERON_SIGNALING,1
THAKAR_PBMC_INACTIVATED_INFL...2,SET,158,-0.060143,-0.0055525,0.069047,0.80813,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP,1
HP_VERTICAL_SUPRANUCLEAR_GAZ...,SET,26,-0.14739,-0.0055399,0.16921,0.80814,HP_VERTICAL_SUPRANUCLEAR_GAZE_PALSY,1
JIANG_MELANOMA_TRM11_CD8,SET,43,-0.1217,-0.0058801,0.13971,0.80815,JIANG_MELANOMA_TRM11_CD8,1
GOBP_HEMATOPOIETIC_STEM_CELL...5,SET,31,-0.13358,-0.0054817,0.15332,0.80819,GOBP_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
HP_PROMINENCE_OF_THE_PREMAXI...,SET,7,-0.26197,-0.0051118,0.30065,0.80821,HP_PROMINENCE_OF_THE_PREMAXILLA,1
MORF_ERH,SET,97,-0.071672,-0.0051932,0.08221,0.80834,MORF_ERH,1
MIR4539,SET,67,-0.092229,-0.0055586,0.10576,0.80841,MIR4539,1
MIR642A_5P,SET,82,-0.084755,-0.0056488,0.097185,0.80842,MIR642A_5P,1
TGAATGT_MIR181A_MIR181B_MIR1...,SET,449,-0.036867,-0.0056918,0.042275,0.80842,TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D,1
HP_XANTHOMATOSIS,SET,38,-0.13335,-0.0060572,0.1529,0.80842,HP_XANTHOMATOSIS,1
KEGG_STEROID_BIOSYNTHESIS,SET,15,-0.18418,-0.0052597,0.21116,0.80845,KEGG_STEROID_BIOSYNTHESIS,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...3,SET,41,-0.12578,-0.0059344,0.1442,0.80847,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...14,SET,27,-0.14456,-0.0055367,0.16564,0.80859,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,1
FOSTER_TOLERANT_MACROPHAGE_DN,SET,383,-0.040725,-0.0058176,0.046661,0.8086,FOSTER_TOLERANT_MACROPHAGE_DN,1
TRAVAGLINI_LUNG_BASOPHIL_MAS...1,SET,248,-0.049464,-0.0057071,0.05666,0.80866,TRAVAGLINI_LUNG_BASOPHIL_MAST_1_CELL,1
GOBP_REGULATION_OF_TELOMERE_...3,SET,19,-0.15479,-0.0049745,0.17731,0.80867,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,1
DANG_MYC_TARGETS_UP,SET,118,-0.068203,-0.0054475,0.078089,0.80877,DANG_MYC_TARGETS_UP,1
GOBP_EPITHELIAL_CELL_CELL_AD...,SET,16,-0.19463,-0.0057404,0.22285,0.80877,GOBP_EPITHELIAL_CELL_CELL_ADHESION,1
GSE2405_0H_VS_24H_A_PHAGOCYT...1,SET,183,-0.057091,-0.0056685,0.065357,0.80881,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
GOBP_GOLGI_VESICLE_BUDDING,SET,10,-0.20362,-0.0047485,0.23308,0.80883,GOBP_GOLGI_VESICLE_BUDDING,1
GSE17721_PAM3CSK4_VS_GADIQUI...18,SET,169,-0.055132,-0.0052625,0.063109,0.80883,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP,1
GSE22886_NAIVE_BCELL_VS_DC_UP,SET,153,-0.061494,-0.0055875,0.070387,0.80884,GSE22886_NAIVE_BCELL_VS_DC_UP,1
REACTOME_PROGRAMMED_CELL_DEA...,SET,193,-0.053378,-0.0054413,0.061087,0.80888,REACTOME_PROGRAMMED_CELL_DEATH,1
GSE17721_CTRL_VS_LPS_24H_BMD...2,SET,187,-0.05459,-0.0054785,0.062465,0.80891,GSE17721_CTRL_VS_LPS_24H_BMDC_UP,1
GSE5679_CTRL_VS_PPARG_LIGAND...3,SET,181,-0.054303,-0.0053625,0.06213,0.80894,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN,1
FOXQ1_TARGET_GENES,SET,34,-0.13703,-0.0058884,0.15677,0.80896,FOXQ1_TARGET_GENES,1
HP_BOWING_OF_THE_ARM,SET,38,-0.12406,-0.0056353,0.14191,0.80899,HP_BOWING_OF_THE_ARM,1
MARSON_FOXP3_TARGETS_STIMULA...1,SET,10,-0.23005,-0.0053648,0.26312,0.80902,MARSON_FOXP3_TARGETS_STIMULATED_DN,1
MODULE_416,SET,22,-0.1647,-0.0056951,0.18836,0.80904,MODULE_416,1
GOBP_NOREPINEPHRINE_SECRETION,SET,14,-0.22143,-0.0061093,0.25317,0.80911,GOBP_NOREPINEPHRINE_SECRETION,1
GSE15330_HSC_VS_LYMPHOID_PRI...4,SET,181,-0.056259,-0.0055556,0.064317,0.80913,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,1
GOBP_GLUCOSAMINE_CONTAINING_...2,SET,21,-0.16755,-0.0056606,0.19153,0.80915,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_POSITIVE_T_CELL_SELECTI...,SET,44,-0.12226,-0.0059751,0.13975,0.80916,GOBP_POSITIVE_T_CELL_SELECTION,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...6,SET,174,-0.055991,-0.0054223,0.063986,0.80922,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP,1
GSE10239_MEMORY_VS_KLRG1INT_...1,SET,184,-0.053553,-0.0053316,0.061194,0.80924,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN,1
OCT_C,SET,220,-0.053312,-0.0057979,0.060916,0.80925,OCT_C,1
GOBP_REGULATION_OF_KILLING_O...,SET,9,-0.28737,-0.0063577,0.32836,0.80925,GOBP_REGULATION_OF_KILLING_OF_CELLS_OF_ANOTHER_ORGANISM,1
DESCARTES_FETAL_PANCREAS_MYE...,SET,185,-0.059453,-0.0059349,0.067917,0.80931,DESCARTES_FETAL_PANCREAS_MYELOID_CELLS,1
HP_CHORIORETINAL_HYPOPIGMENT...,SET,10,-0.25628,-0.0059766,0.29272,0.80935,HP_CHORIORETINAL_HYPOPIGMENTATION,1
GOBP_REGULATION_OF_RESPIRATO...4,SET,11,-0.24666,-0.0060327,0.28171,0.80937,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NERVOUS_SYSTEM_PROCESS,1
COLLER_MYC_TARGETS_DN,SET,4,-0.38844,-0.00573,0.44358,0.8094,COLLER_MYC_TARGETS_DN,1
STANELLE_E2F1_TARGETS,SET,26,-0.14932,-0.0056122,0.17047,0.80945,STANELLE_E2F1_TARGETS,1
GSE45365_NK_CELL_VS_CD11B_DC...2,SET,178,-0.056144,-0.0054986,0.0641,0.80945,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN,1
HP_HAMMERTOE,SET,52,-0.10596,-0.0056283,0.12096,0.80947,HP_HAMMERTOE,1
MIR125B_2_3P,SET,121,-0.066769,-0.0053999,0.076215,0.80949,MIR125B_2_3P,1
HP_ABNORMAL_PLACENTAL_MEMBRA...,SET,13,-0.24094,-0.0064058,0.27503,0.80949,HP_ABNORMAL_PLACENTAL_MEMBRANE_MORPHOLOGY,1
GOBP_L_KYNURENINE_METABOLIC_...,SET,5,-0.37733,-0.006223,0.43066,0.80952,GOBP_L_KYNURENINE_METABOLIC_PROCESS,1
MIR6813_5P,SET,36,-0.11884,-0.0052546,0.13562,0.80955,MIR6813_5P,1
MIER1_TARGET_GENES,SET,297,-0.044581,-0.0056214,0.050876,0.80956,MIER1_TARGET_GENES,1
HP_ABNORMAL_BRAIN_LACTATE_LE...,SET,23,-0.1526,-0.005395,0.17414,0.80956,HP_ABNORMAL_BRAIN_LACTATE_LEVEL_BY_MRS,1
NABA_MATRISOME_POORLY_METAST...2,SET,12,-0.20252,-0.0051733,0.2311,0.80957,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,1
WP_OXIDATIVE_STRESS_RESPONSE,SET,29,-0.14889,-0.0059098,0.1699,0.80957,WP_OXIDATIVE_STRESS_RESPONSE,1
REACTOME_S_PHASE,SET,155,-0.055156,-0.005044,0.062929,0.80961,REACTOME_S_PHASE,1
HP_PYODERMA_GANGRENOSUM,SET,11,-0.22249,-0.0054416,0.25383,0.80963,HP_PYODERMA_GANGRENOSUM,1
HP_WEAK_CRY,SET,44,-0.11041,-0.0053958,0.12594,0.80966,HP_WEAK_CRY,1
HOSHIDA_LIVER_CANCER_SUBCLAS...3,SET,243,-0.04918,-0.0056177,0.056098,0.80967,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1
GOBP_CELLULAR_RESPONSE_TO_BR...,SET,10,-0.25112,-0.0058561,0.28642,0.80968,GOBP_CELLULAR_RESPONSE_TO_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_STIMULUS,1
GOBP_NEGATIVE_REGULATION_OF_...378,SET,5,-0.34089,-0.005622,0.38881,0.80968,GOBP_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
GOBP_CELL_CYCLE_G1_S_PHASE_T...,SET,222,-0.051068,-0.0055787,0.058236,0.80973,GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GOCC_CARBOXY_TERMINAL_DOMAIN...,SET,19,-0.13334,-0.0042852,0.15206,0.80973,GOCC_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX,1
GOBP_ARF_PROTEIN_SIGNAL_TRAN...,SET,21,-0.1628,-0.0055002,0.18563,0.80976,GOBP_ARF_PROTEIN_SIGNAL_TRANSDUCTION,1
GOMF_PURINE_NUCLEOTIDE_TRANS...,SET,25,-0.16368,-0.006033,0.18661,0.8098,GOMF_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_CELLULAR_HOMEOSTASIS,SET,747,-0.02886,-0.0056989,0.032898,0.80982,GOBP_CELLULAR_HOMEOSTASIS,1
GOBP_NOREPINEPHRINE_METABOLI...,SET,10,-0.27676,-0.006454,0.31543,0.80986,GOBP_NOREPINEPHRINE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_INFLAMMAT...1,SET,358,-0.042037,-0.0058097,0.047904,0.8099,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...124,SET,103,-0.071525,-0.0053396,0.081493,0.80994,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,1
YRTCANNRCGC_UNKNOWN,SET,61,-0.095015,-0.005465,0.10823,0.80999,YRTCANNRCGC_UNKNOWN,1
HP_ABNORMAL_SEVENTH_CRANIAL_...,SET,167,-0.056977,-0.0054066,0.064903,0.80999,HP_ABNORMAL_SEVENTH_CRANIAL_PHYSIOLOGY,1
HP_ABNORMALITY_OF_THE_HEPATI...,SET,84,-0.083364,-0.0056231,0.094941,0.81004,HP_ABNORMALITY_OF_THE_HEPATIC_VASCULATURE,1
HP_INCREASED_MUSCLE_FATIGUAB...,SET,16,-0.19289,-0.0056891,0.21968,0.81004,HP_INCREASED_MUSCLE_FATIGUABILITY,1
GSE19825_NAIVE_VS_IL2RAHIGH_...2,SET,182,-0.058601,-0.0058027,0.066724,0.81009,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,1
GYORFFY_MITOXANTRONE_RESISTA...,SET,32,-0.14634,-0.0061012,0.16662,0.8101,GYORFFY_MITOXANTRONE_RESISTANCE,1
GOBP_HINDBRAIN_RADIAL_GLIA_G...,SET,8,-0.24529,-0.0051165,0.27909,0.81026,GOBP_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION,1
GOMF_LIPASE_ACTIVITY,SET,127,-0.069016,-0.0057174,0.078528,0.81026,GOMF_LIPASE_ACTIVITY,1
GOBP_DENSE_CORE_GRANULE_EXOC...,SET,10,-0.26263,-0.0061246,0.2988,0.81028,GOBP_DENSE_CORE_GRANULE_EXOCYTOSIS,1
GOBP_RESPONSE_TO_ETHER,SET,15,-0.19989,-0.0057083,0.22742,0.81028,GOBP_RESPONSE_TO_ETHER,1
HP_CAPILLARY_HEMANGIOMA,SET,37,-0.13033,-0.0058418,0.14827,0.81028,HP_CAPILLARY_HEMANGIOMA,1
GOBP_GRANULOCYTE_MIGRATION,SET,140,-0.071948,-0.0062556,0.08185,0.8103,GOBP_GRANULOCYTE_MIGRATION,1
GOBP_RETROGRADE_VESICLE_MEDI...,SET,48,-0.095578,-0.0048782,0.10871,0.81035,GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM,1
GSE17721_CTRL_VS_LPS_6H_BMDC...1,SET,184,-0.056046,-0.0055798,0.063744,0.81035,GSE17721_CTRL_VS_LPS_6H_BMDC_DN,1
KUNINGER_IGF1_VS_PDGFB_TARGE...1,SET,41,-0.12574,-0.0059326,0.143,0.81039,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,1
MODULE_547,SET,11,-0.22243,-0.0054401,0.25295,0.81039,MODULE_547,1
REACTOME_CHREBP_ACTIVATES_ME...,SET,8,-0.22648,-0.0047242,0.25752,0.81042,REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION,1
GOBP_REGULATION_OF_MRNA_META...,SET,271,-0.044137,-0.00532,0.05018,0.81045,GOBP_REGULATION_OF_MRNA_METABOLIC_PROCESS,1
GSE37533_PPARG1_FOXP3_VS_PPA...4,SET,164,-0.056523,-0.0053156,0.064239,0.81053,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...724,SET,43,-0.11246,-0.0054337,0.12781,0.81055,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,1
GOBP_POSITIVE_REGULATION_OF_...298,SET,11,-0.26611,-0.0065084,0.30241,0.81056,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_DEMETHYLATION,1
GSE17721_LPS_VS_POLYIC_12H_B...1,SET,187,-0.0542,-0.0054394,0.061591,0.81057,GSE17721_LPS_VS_POLYIC_12H_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...96,SET,4,-0.38217,-0.0056376,0.43423,0.8106,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,1
HP_MOTOR_DELAY,SET,852,-0.026021,-0.0054713,0.029553,0.8107,HP_MOTOR_DELAY,1
GOBP_POSITIVE_REGULATION_OF_...556,SET,20,-0.17358,-0.0057231,0.19713,0.81071,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,1
MORF_CSNK2B,SET,251,-0.044767,-0.0051959,0.050837,0.81073,MORF_CSNK2B,1
GSE27786_NEUTROPHIL_VS_MONO_...1,SET,179,-0.05371,-0.0052749,0.060992,0.81073,GSE27786_NEUTROPHIL_VS_MONO_MAC_DN,1
GACAATC_MIR219,SET,134,-0.065983,-0.0056137,0.074917,0.81077,GACAATC_MIR219,1
MODULE_396,SET,9,-0.27573,-0.0061002,0.31302,0.8108,MODULE_396,1
GOMF_INTRAMEMBRANE_LIPID_TRA...,SET,41,-0.12517,-0.0059054,0.14208,0.81083,GOMF_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,1
GOBP_PROTEIN_LOCALIZATION_TO...47,SET,11,-0.22671,-0.0055448,0.25733,0.81084,GOBP_PROTEIN_LOCALIZATION_TO_PRESYNAPSE,1
GOBP_MUCOCILIARY_CLEARANCE,SET,7,-0.30397,-0.0059313,0.34502,0.81085,GOBP_MUCOCILIARY_CLEARANCE,1
GOBP_REGULATION_OF_PHOSPHOLI...4,SET,32,-0.14427,-0.0060149,0.16373,0.81088,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY,1
YEMELYANOV_GR_TARGETS_DN,SET,10,-0.24256,-0.0056565,0.27524,0.8109,YEMELYANOV_GR_TARGETS_DN,1
HP_PARAPARESIS,SET,67,-0.089203,-0.0053762,0.10122,0.81092,HP_PARAPARESIS,1
GSE43863_LY6C_INT_CXCR5POS_V...1,SET,181,-0.058049,-0.0057324,0.065864,0.81093,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,1
HP_EPIPHYSEAL_STIPPLING,SET,30,-0.13791,-0.0055674,0.15646,0.81096,HP_EPIPHYSEAL_STIPPLING,1
GSE3565_DUSP1_VS_WT_SPLENOCY...4,SET,148,-0.067463,-0.0060296,0.076513,0.81103,GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP,1
HP_ABNORMAL_CEREBELLAR_CORTE...,SET,4,-0.30456,-0.0044927,0.34532,0.8111,HP_ABNORMAL_CEREBELLAR_CORTEX_MORPHOLOGY,1
GOBP_PROTEIN_COMPLEX_OLIGOME...,SET,250,-0.049045,-0.0056812,0.055601,0.81113,GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION,1
MIR6506_5P,SET,93,-0.078057,-0.0055386,0.088482,0.81115,MIR6506_5P,1
GOBP_GAS_TRANSPORT,SET,18,-0.21158,-0.0066184,0.23983,0.81116,GOBP_GAS_TRANSPORT,1
HP_DECREASED_SKULL_OSSIFICAT...,SET,38,-0.12202,-0.0055428,0.13829,0.81121,HP_DECREASED_SKULL_OSSIFICATION,1
MIR320E,SET,60,-0.099593,-0.0056813,0.11285,0.81124,MIR320E,1
GOBP_CELLULAR_RESPIRATION,SET,189,-0.051441,-0.0051898,0.058289,0.81124,GOBP_CELLULAR_RESPIRATION,1
MIR4448,SET,61,-0.098746,-0.0056795,0.11188,0.81127,MIR4448,1
GOBP_MRNA_PSEUDOURIDINE_SYNT...,SET,8,-0.22311,-0.0046539,0.25268,0.81136,GOBP_MRNA_PSEUDOURIDINE_SYNTHESIS,1
KEGG_MEDICUS_REFERENCE_BMP_H...1,SET,11,-0.22845,-0.0055874,0.25872,0.81137,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...164,SET,48,-0.10212,-0.005212,0.11565,0.81137,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
ODONNELL_TFRC_TARGETS_UP,SET,329,-0.042271,-0.005605,0.047866,0.81141,ODONNELL_TFRC_TARGETS_UP,1
HP_DIFFUSE_WHITE_MATTER_ABNO...,SET,29,-0.13606,-0.0054005,0.15404,0.81144,HP_DIFFUSE_WHITE_MATTER_ABNORMALITIES,1
MODULE_436,SET,118,-0.072648,-0.0058025,0.082238,0.81148,MODULE_436,1
HP_EXODEVIATION,SET,104,-0.07364,-0.005524,0.083337,0.81155,HP_EXODEVIATION,1
HP_DEHYDRATION,SET,99,-0.081096,-0.005936,0.091759,0.81159,HP_DEHYDRATION,1
KONDO_HYPOXIA,SET,6,-0.30271,-0.0054687,0.3425,0.8116,KONDO_HYPOXIA,1
OZANNE_AP1_TARGETS_UP,SET,14,-0.19266,-0.0053154,0.21793,0.81165,OZANNE_AP1_TARGETS_UP,1
BIOCARTA_MSP_PATHWAY,SET,6,-0.30092,-0.0054364,0.34037,0.81167,BIOCARTA_MSP_PATHWAY,1
MODULE_300,SET,33,-0.13228,-0.0056001,0.14959,0.81171,MODULE_300,1
DOUGLAS_BMI1_TARGETS_DN,SET,292,-0.044144,-0.00552,0.049922,0.81172,DOUGLAS_BMI1_TARGETS_DN,1
GAVIN_FOXP3_TARGETS_CLUSTER_...1,SET,72,-0.092087,-0.0057526,0.10414,0.81173,GAVIN_FOXP3_TARGETS_CLUSTER_P2,1
GSE29618_BCELL_VS_MONOCYTE_D...2,SET,169,-0.0617,-0.0058895,0.069768,0.81174,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP,1
MIR6780A_5P,SET,203,-0.051641,-0.0053973,0.058389,0.81176,MIR6780A_5P,1
GOCC_EXTRINSIC_COMPONENT_OF_...7,SET,4,-0.28023,-0.0041338,0.31679,0.81181,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
GOBP_SOMATOTROPIN_SECRETING_...,SET,5,-0.39909,-0.0065818,0.45105,0.81186,GOBP_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION,1
GOBP_GUANINE_NUCLEOTIDE_TRAN...,SET,11,-0.25982,-0.0063547,0.29363,0.81188,GOBP_GUANINE_NUCLEOTIDE_TRANSPORT,1
GOBP_PEPTIDYL_ARGININE_MODIF...,SET,13,-0.18779,-0.0049927,0.21216,0.81195,GOBP_PEPTIDYL_ARGININE_MODIFICATION,1
HP_APLASIA_OF_THE_2ND_FINGER,SET,4,-0.36793,-0.0054275,0.41566,0.81196,HP_APLASIA_OF_THE_2ND_FINGER,1
GOBP_MONOATOMIC_CATION_TRANS...2,SET,917,-0.026779,-0.0058306,0.030248,0.812,GOBP_MONOATOMIC_CATION_TRANSPORT,1
GOBP_SALIVARY_GLAND_DEVELOPM...,SET,36,-0.13044,-0.0057673,0.14728,0.81208,GOBP_SALIVARY_GLAND_DEVELOPMENT,1
GOMF_OXIDOREDUCTASE_ACTIVITY...9,SET,8,-0.23581,-0.0049188,0.26624,0.8121,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS,1
HP_ABNORMAL_MASTOID_MORPHOLO...,SET,10,-0.23325,-0.0054395,0.26336,0.8121,HP_ABNORMAL_MASTOID_MORPHOLOGY,1
REACTOME_PROCESSING_OF_SMDT1,SET,12,-0.22129,-0.0056528,0.24979,0.81216,REACTOME_PROCESSING_OF_SMDT1,1
REACTOME_SIGNALING_BY_ERBB2,SET,48,-0.10507,-0.0053625,0.1186,0.81216,REACTOME_SIGNALING_BY_ERBB2,1
GOBP_POSITIVE_REGULATION_OF_...289,SET,5,-0.35323,-0.0058255,0.3987,0.81217,GOBP_POSITIVE_REGULATION_OF_G0_TO_G1_TRANSITION,1
GSE17721_0.5H_VS_4H_CPG_BMDC...1,SET,188,-0.056722,-0.0057076,0.064024,0.81217,GSE17721_0.5H_VS_4H_CPG_BMDC_DN,1
REACTOME_ABC_FAMILY_PROTEINS...,SET,97,-0.074069,-0.0053669,0.083599,0.81219,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1
PID_VEGF_VEGFR_PATHWAY,SET,9,-0.28694,-0.0063482,0.32378,0.81224,PID_VEGF_VEGFR_PATHWAY,1
MIR340_5P,SET,707,-0.02956,-0.0056852,0.033352,0.81227,MIR340_5P,1
MIR6846_5P,SET,70,-0.09139,-0.0056295,0.10307,0.81236,MIR6846_5P,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMA...,SET,48,-0.12354,-0.0063053,0.13932,0.81238,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1
REACTOME_BIOLOGICAL_OXIDATIO...,SET,204,-0.061632,-0.0064573,0.069506,0.81238,REACTOME_BIOLOGICAL_OXIDATIONS,1
GOBP_NEURON_FATE_DETERMINATI...,SET,8,-0.32408,-0.0067602,0.36547,0.81239,GOBP_NEURON_FATE_DETERMINATION,1
BIOCARTA_G1_PATHWAY,SET,28,-0.13944,-0.0054387,0.15724,0.8124,BIOCARTA_G1_PATHWAY,1
GSE39556_UNTREATED_VS_3H_POL...1,SET,183,-0.058046,-0.0057633,0.065448,0.81243,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN,1
HP_ABDOMINAL_DISTENTION,SET,139,-0.066178,-0.0057336,0.074605,0.81247,HP_ABDOMINAL_DISTENTION,1
MODULE_113,SET,96,-0.080083,-0.0057728,0.090276,0.81248,MODULE_113,1
GOBP_AXO_DENDRITIC_TRANSPORT,SET,74,-0.089681,-0.0056792,0.10108,0.8125,GOBP_AXO_DENDRITIC_TRANSPORT,1
GOBP_INDUCTION_OF_BACTERIAL_...,SET,5,-0.41844,-0.006901,0.47157,0.81254,GOBP_INDUCTION_OF_BACTERIAL_AGGLUTINATION,1
KEGG_NICOTINATE_AND_NICOTINA...,SET,24,-0.16865,-0.0060906,0.19003,0.81258,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,1
GOBP_COPPER_ION_TRANSMEMBRAN...,SET,7,-0.27187,-0.0053048,0.30633,0.81258,GOBP_COPPER_ION_TRANSMEMBRANE_TRANSPORT,1
GSE33424_CD161_INT_VS_NEG_CD...1,SET,181,-0.056738,-0.0056029,0.063926,0.8126,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN,1
HP_SPINA_BIFIDA_OCCULTA,SET,68,-0.09973,-0.0060552,0.11236,0.81262,HP_SPINA_BIFIDA_OCCULTA,1
HP_FALLS,SET,38,-0.12851,-0.0058374,0.14474,0.81268,HP_FALLS,1
GOBP_REGULATION_OF_WOUND_HEA...2,SET,10,-0.21594,-0.0050358,0.2432,0.8127,GOBP_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
GOBP_REGULATION_OF_LOW_DENSI...,SET,15,-0.20261,-0.0057861,0.22818,0.81271,GOBP_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
MIR4760_5P,SET,181,-0.058177,-0.0057451,0.065504,0.81277,MIR4760_5P,1
GOBP_BRANCHED_CHAIN_AMINO_AC...2,SET,21,-0.15839,-0.005351,0.17833,0.81278,GOBP_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...569,SET,8,-0.27763,-0.0057912,0.31257,0.81278,GOBP_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CILIUM_MO...,SET,36,-0.13054,-0.0057719,0.14697,0.81278,GOBP_REGULATION_OF_CILIUM_MOVEMENT,1
REACTOME_A_TETRASACCHARIDE_L...,SET,23,-0.15719,-0.0055572,0.17696,0.81279,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,1
HP_HYPOPLASTIC_ISCHIA,SET,16,-0.19128,-0.0056415,0.21535,0.81279,HP_HYPOPLASTIC_ISCHIA,1
MIR4766_3P,SET,151,-0.068158,-0.0061527,0.076724,0.81282,MIR4766_3P,1
TCCGTCC_MIR184,SET,12,-0.22057,-0.0056344,0.24828,0.81283,TCCGTCC_MIR184,1
KEGG_VASOPRESSIN_REGULATED_W...,SET,42,-0.11486,-0.0054847,0.12926,0.81288,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,1
GOBP_NEGATIVE_REGULATION_OF_...331,SET,21,-0.18539,-0.0062634,0.20864,0.81288,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
BIOCARTA_ERBB4_PATHWAY,SET,7,-0.26262,-0.0051243,0.29541,0.81299,BIOCARTA_ERBB4_PATHWAY,1
GOCC_SARCOPLASMIC_RETICULUM,SET,73,-0.087456,-0.005501,0.098369,0.81301,GOCC_SARCOPLASMIC_RETICULUM,1
CHO_NR4A1_TARGETS,SET,29,-0.15671,-0.0062201,0.17622,0.81306,CHO_NR4A1_TARGETS,1
HP_RECEPTIVE_LANGUAGE_DELAY,SET,13,-0.21459,-0.0057053,0.24124,0.81313,HP_RECEPTIVE_LANGUAGE_DELAY,1
GSE14415_ACT_TCONV_VS_ACT_NA...1,SET,164,-0.060135,-0.0056553,0.067598,0.81315,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN,1
GSE360_DC_VS_MAC_L_DONOVANI_...1,SET,175,-0.056718,-0.0055083,0.063758,0.81315,GSE360_DC_VS_MAC_L_DONOVANI_DN,1
HP_STATUS_EPILEPTICUS_WITH_P...,SET,24,-0.15321,-0.0055329,0.17222,0.81316,HP_STATUS_EPILEPTICUS_WITH_PROMINENT_MOTOR_SYMPTOMS,1
VANGURP_PANCREATIC_DELTA_CELL,SET,73,-0.10072,-0.0063355,0.11322,0.81316,VANGURP_PANCREATIC_DELTA_CELL,1
OCONNOR_PBMC_MENVEO_ACWYVAX_...1,SET,221,-0.050883,-0.0055462,0.057193,0.81317,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN,1
HP_DOLICHOCEPHALY,SET,196,-0.053575,-0.0055032,0.060219,0.81318,HP_DOLICHOCEPHALY,1
CHESLER_BRAIN_HIGHEST_GENETI...,SET,36,-0.13051,-0.0057708,0.14668,0.81321,CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,1
HP_COMPLETE_OR_NEAR_COMPLETE...2,SET,5,-0.3114,-0.0051356,0.34994,0.81322,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,1
HOWLIN_CITED1_TARGETS_1_DN,SET,36,-0.13647,-0.006034,0.15335,0.81323,HOWLIN_CITED1_TARGETS_1_DN,1
REACTOME_RETROGRADE_TRANSPOR...,SET,46,-0.10213,-0.0051031,0.11476,0.81325,REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,1
HP_ABNORMAL_BASOPHIL_MORPHOL...,SET,8,-0.29011,-0.0060514,0.32592,0.81329,HP_ABNORMAL_BASOPHIL_MORPHOLOGY,1
HP_REDUCED_SUBCUTANEOUS_ADIP...,SET,30,-0.14567,-0.0058805,0.16365,0.81329,HP_REDUCED_SUBCUTANEOUS_ADIPOSE_TISSUE,1
REACTOME_ROLE_OF_ABL_IN_ROBO...,SET,8,-0.26015,-0.0054266,0.29209,0.81343,REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING,1
HUNSBERGER_EXERCISE_REGULATE...,SET,28,-0.15488,-0.0060409,0.1739,0.81344,HUNSBERGER_EXERCISE_REGULATED_GENES,1
MIR632,SET,56,-0.1061,-0.005848,0.11907,0.81354,MIR632,1
GOCC_PINOSOME,SET,7,-0.28099,-0.0054829,0.31532,0.81356,GOCC_PINOSOME,1
HP_UNSTEADY_GAIT,SET,169,-0.057615,-0.0054995,0.064654,0.81356,HP_UNSTEADY_GAIT,1
REACTOME_SIGNALING_BY_NTRK3_...,SET,17,-0.16675,-0.0050693,0.18709,0.81361,REACTOME_SIGNALING_BY_NTRK3_TRKC,1
HP_ELEVATED_HEPATIC_IRON_CON...,SET,11,-0.25308,-0.0061897,0.28394,0.81361,HP_ELEVATED_HEPATIC_IRON_CONCENTRATION,1
GOMF_U6_SNRNA_BINDING,SET,14,-0.17246,-0.0047582,0.19348,0.81363,GOMF_U6_SNRNA_BINDING,1
GSE7764_IL15_TREATED_VS_CTRL...2,SET,175,-0.052993,-0.0051465,0.059448,0.81364,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP,1
GOBP_APOPTOTIC_MITOCHONDRIAL...,SET,94,-0.078904,-0.0056286,0.088512,0.81365,GOBP_APOPTOTIC_MITOCHONDRIAL_CHANGES,1
REACTOME_FATTY_ACIDS_BOUND_T...,SET,8,-0.28822,-0.0060121,0.32325,0.8137,REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION,1
GOBP_BIOLOGICAL_PROCESS_INVO...5,SET,287,-0.046512,-0.0057669,0.052149,0.81377,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,1
REACTOME_PTK6_EXPRESSION,SET,5,-0.33881,-0.0055877,0.37986,0.81378,REACTOME_PTK6_EXPRESSION,1
KEGG_MEDICUS_REFERENCE_V_D_J...,SET,12,-0.17749,-0.0045338,0.19898,0.81379,KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION,1
GOBP_REGULATION_OF_HORMONE_S...,SET,243,-0.052441,-0.0059901,0.058783,0.81382,GOBP_REGULATION_OF_HORMONE_SECRETION,1
GOBP_RHYTHMIC_PROCESS,SET,281,-0.047987,-0.0058881,0.053791,0.81382,GOBP_RHYTHMIC_PROCESS,1
GOCC_AZUROPHIL_GRANULE_LUMEN,SET,81,-0.084996,-0.0056303,0.09527,0.81384,GOCC_AZUROPHIL_GRANULE_LUMEN,1
HP_MUSCLE_STIFFNESS,SET,74,-0.083557,-0.0052914,0.093631,0.81391,HP_MUSCLE_STIFFNESS,1
GOBP_BIOLOGICAL_PROCESS_INVO...2,SET,107,-0.074091,-0.0056369,0.083019,0.81392,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_SYMBIONT,1
ATM_TARGET_GENES,SET,11,-0.25272,-0.0061809,0.2831,0.81398,ATM_TARGET_GENES,1
HP_CONGENITAL_MALFORMATION_O...1,SET,454,-0.036182,-0.0056162,0.040533,0.81398,HP_CONGENITAL_MALFORMATION_OF_THE_GREAT_ARTERIES,1
REACTOME_FGFRL1_MODULATION_O...,SET,13,-0.23651,-0.0062881,0.26493,0.81399,REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,1
MARTIN_NFKB_TARGETS_DN,SET,10,-0.23694,-0.0055254,0.26536,0.81404,MARTIN_NFKB_TARGETS_DN,1
HOFMANN_MYELODYSPLASTIC_SYND...3,SET,24,-0.15313,-0.0055301,0.17148,0.81407,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,1
GOBP_XENOBIOTIC_TRANSMEMBRAN...,SET,17,-0.19325,-0.005875,0.21641,0.81407,GOBP_XENOBIOTIC_TRANSMEMBRANE_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...135,SET,5,-0.35451,-0.0058466,0.39694,0.81409,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
GOMF_ADENOSINE_DEAMINASE_ACT...,SET,12,-0.22761,-0.0058142,0.25485,0.81409,GOMF_ADENOSINE_DEAMINASE_ACTIVITY,1
MIR3913_5P,SET,79,-0.083395,-0.0054559,0.093351,0.81416,MIR3913_5P,1
GSE18791_CTRL_VS_NEWCASTLE_V...10,SET,186,-0.052174,-0.0052222,0.058402,0.81416,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP,1
GSE13485_CTRL_VS_DAY3_YF17D_...2,SET,151,-0.06413,-0.005789,0.07178,0.81418,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP,1
GSE6269_FLU_VS_STAPH_AUREUS_...2,SET,172,-0.055874,-0.00538,0.062537,0.81419,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP,1
GOMF_TRANSLATION_INITIATION_...1,SET,43,-0.10854,-0.0052439,0.12145,0.81425,GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY,1
ZHANG_INTERFERON_RESPONSE,SET,23,-0.17887,-0.0063239,0.2001,0.81431,ZHANG_INTERFERON_RESPONSE,1
GSE22229_RENAL_TRANSPLANT_VS...1,SET,179,-0.057861,-0.0056825,0.064724,0.81432,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN,1
REACTOME_REGULATION_OF_MITF_...4,SET,41,-0.12271,-0.0057893,0.13726,0.81433,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,1
GOMF_GLUCURONOSYL_N_ACETYLGA...,SET,6,-0.3155,-0.0056997,0.35287,0.81436,GOMF_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_FRONTA...,SET,184,-0.055244,-0.0055,0.061786,0.81436,HP_ABNORMALITY_OF_THE_FRONTAL_HAIRLINE,1
GOBP_POSITIVE_THYMIC_T_CELL_...,SET,15,-0.2012,-0.0057458,0.22502,0.81438,GOBP_POSITIVE_THYMIC_T_CELL_SELECTION,1
MIR5581_5P,SET,67,-0.093138,-0.0056134,0.10416,0.81439,MIR5581_5P,1
GOCC_NPBAF_COMPLEX,SET,14,-0.20527,-0.0056633,0.22954,0.8144,GOCC_NPBAF_COMPLEX,1
HP_UTERINE_PROLAPSE,SET,6,-0.37144,-0.0067103,0.41534,0.81441,HP_UTERINE_PROLAPSE,1
GOBP_POSITIVE_REGULATION_OF_...273,SET,18,-0.17568,-0.0054953,0.19643,0.81443,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_BICELLULA...,SET,21,-0.16514,-0.0055793,0.18461,0.81448,GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
TURASHVILI_BREAST_CARCINOMA_...1,SET,3,-0.47096,-0.0060167,0.52646,0.81449,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1
REACTOME_RUNX3_REGULATES_CDK...,SET,7,-0.28431,-0.0055476,0.31776,0.81452,REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION,1
VERNELL_RETINOBLASTOMA_PATHW...2,SET,68,-0.090136,-0.0054727,0.10073,0.81456,VERNELL_RETINOBLASTOMA_PATHWAY_UP,1
HP_EPICANTHUS,SET,527,-0.033189,-0.005539,0.037086,0.81458,HP_EPICANTHUS,1
GOMF_PEPTIDOGLYCAN_IMMUNE_RE...,SET,5,-0.39557,-0.0065237,0.44198,0.8146,GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY,1
GSE17721_CTRL_VS_LPS_0.5H_BM...1,SET,182,-0.0582,-0.005763,0.06502,0.81463,GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN,1
GOBP_I_KAPPAB_PHOSPHORYLATION,SET,13,-0.24159,-0.0064231,0.26988,0.81465,GOBP_I_KAPPAB_PHOSPHORYLATION,1
GSE19198_CTRL_VS_IL21_TREATE...3,SET,186,-0.056664,-0.0056716,0.063284,0.81471,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN,1
GOCC_TORC2_COMPLEX,SET,9,-0.26299,-0.0058183,0.29362,0.81478,GOCC_TORC2_COMPLEX,1
MIR4315,SET,3,-0.4231,-0.0054053,0.47222,0.81486,MIR4315,1
HASLINGER_B_CLL_WITH_CHROMOS...,SET,20,-0.16116,-0.0053134,0.17985,0.81488,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,1
GOBP_LONG_TERM_SYNAPTIC_POTE...,SET,89,-0.083754,-0.0058143,0.093466,0.81489,GOBP_LONG_TERM_SYNAPTIC_POTENTIATION,1
GOBP_REGULATION_OF_MYOSIN_LI...,SET,7,-0.27192,-0.005306,0.30344,0.8149,GOBP_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,1
JOHANSSON_BRAIN_CANCER_EARLY...1,SET,41,-0.11259,-0.0053119,0.12559,0.815,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,1
GOBP_POSITIVE_REGULATION_OF_...308,SET,40,-0.12965,-0.0060421,0.14462,0.81501,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...709,SET,128,-0.070162,-0.005835,0.078252,0.81503,GOBP_POSITIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,1
ANDERSON_BLOOD_CN54GP140_ADJ...9,SET,5,-0.40888,-0.0067434,0.45594,0.81508,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_HIGH_IGM_RESPONDERS_3DY_7D_DN,1
GOBP_TRANSLATIONAL_INITIATION,SET,106,-0.068309,-0.0051728,0.076166,0.81509,GOBP_TRANSLATIONAL_INITIATION,1
GSE5589_LPS_AND_IL10_VS_LPS_...6,SET,180,-0.054326,-0.0053501,0.060568,0.81512,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
DORN_ADENOVIRUS_INFECTION_32...2,SET,9,-0.26577,-0.0058799,0.29622,0.81519,DORN_ADENOVIRUS_INFECTION_32HR_UP,1
HP_LYMPH_NODE_HYPOPLASIA,SET,3,-0.48043,-0.0061377,0.53533,0.81525,HP_LYMPH_NODE_HYPOPLASIA,1
GOBP_POSITIVE_REGULATION_OF_...599,SET,110,-0.070435,-0.0054329,0.078468,0.8153,GOBP_POSITIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
HP_ABNORMAL_MORPHOLOGY_OF_MY...,SET,19,-0.18025,-0.0057926,0.20072,0.8154,HP_ABNORMAL_MORPHOLOGY_OF_MYOCARDIAL_TRABECULAE,1
GOBP_RESPONSE_TO_HYDROXYUREA,SET,9,-0.26006,-0.0057537,0.28957,0.81543,GOBP_RESPONSE_TO_HYDROXYUREA,1
GOBP_SYNAPTIC_VESICLE_DOCKING,SET,9,-0.25161,-0.0055667,0.28015,0.81543,GOBP_SYNAPTIC_VESICLE_DOCKING,1
PID_PI3KCI_AKT_PATHWAY,SET,34,-0.12663,-0.0054415,0.14099,0.81544,PID_PI3KCI_AKT_PATHWAY,1
GAVISH_3CA_METAPROGRAM_MACRO...4,SET,46,-0.12295,-0.0061434,0.13688,0.81545,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_1,1
HP_ADULT_ONSET_SENSORINEURAL...,SET,5,-0.44537,-0.0073452,0.49579,0.81548,HP_ADULT_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,1
GOBP_ACTIVATION_OF_PROTEIN_K...3,SET,3,-0.47898,-0.0061192,0.53314,0.81551,GOBP_ACTIVATION_OF_PROTEIN_KINASE_C_ACTIVITY,1
GSE4590_SMALL_VS_LARGE_PRE_B...2,SET,164,-0.060362,-0.0056766,0.067175,0.81555,GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP,1
GOBP_MACROPHAGE_ACTIVATION,SET,103,-0.083097,-0.0062034,0.092455,0.81561,GOBP_MACROPHAGE_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...60,SET,33,-0.14468,-0.0061254,0.16098,0.81561,GOBP_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION,1
GOBP_POSITIVE_REGULATION_OF_...392,SET,15,-0.22562,-0.0064431,0.25102,0.81561,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
GOMF_TRACE_AMINE_RECEPTOR_AC...,SET,6,-0.4776,-0.0086282,0.53138,0.81561,GOMF_TRACE_AMINE_RECEPTOR_ACTIVITY,1
HP_SMALL_FOREHEAD,SET,11,-0.2272,-0.0055569,0.25278,0.81561,HP_SMALL_FOREHEAD,1
BROWNE_HCMV_INFECTION_16HR_UP,SET,199,-0.052918,-0.0054767,0.058876,0.81562,BROWNE_HCMV_INFECTION_16HR_UP,1
NCOA6_TARGET_GENES,SET,275,-0.048443,-0.0058813,0.053893,0.81563,NCOA6_TARGET_GENES,1
ZSCAN21_TARGET_GENES,SET,393,-0.03835,-0.0055478,0.042655,0.81569,ZSCAN21_TARGET_GENES,1
GSE17721_CTRL_VS_GARDIQUIMOD...6,SET,188,-0.054174,-0.0054512,0.060246,0.81573,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP,1
WAMUNYOKOLI_OVARIAN_CANCER_G...1,SET,63,-0.10113,-0.0059107,0.11244,0.81576,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1
HP_HYPOVOLEMIC_SHOCK,SET,5,-0.39551,-0.0065229,0.43976,0.81577,HP_HYPOVOLEMIC_SHOCK,1
MIR3180_MIR3180_3P,SET,20,-0.1769,-0.0058325,0.19668,0.81578,MIR3180_MIR3180_3P,1
GSE22033_UNTREATED_VS_ROSIGL...1,SET,176,-0.058524,-0.0056997,0.065066,0.81579,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN,1
MODULE_454,SET,10,-0.27073,-0.0063136,0.30098,0.8158,MODULE_454,1
MIR5010_5P,SET,33,-0.13007,-0.0055066,0.14459,0.81582,MIR5010_5P,1
WP_ACUTE_MYELOID_LEUKEMIA,SET,65,-0.097628,-0.0057958,0.1085,0.81588,WP_ACUTE_MYELOID_LEUKEMIA,1
GOBP_LIPID_DIGESTION,SET,20,-0.19631,-0.0064725,0.21816,0.81589,GOBP_LIPID_DIGESTION,1
GSE12366_GC_BCELL_VS_PLASMA_...2,SET,171,-0.057281,-0.0054996,0.063643,0.81594,GSE12366_GC_BCELL_VS_PLASMA_CELL_UP,1
GOBP_POSTSYNAPTIC_SIGNAL_TRA...,SET,46,-0.11573,-0.0057826,0.12856,0.81597,GOBP_POSTSYNAPTIC_SIGNAL_TRANSDUCTION,1
REACTOME_GAP_FILLING_DNA_REP...,SET,24,-0.13942,-0.0050352,0.15489,0.81598,REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,1
HP_HYPERAUTOFLUORESCENT_MACU...,SET,11,-0.26256,-0.0064216,0.29163,0.81602,HP_HYPERAUTOFLUORESCENT_MACULAR_LESION,1
GSE13485_CTRL_VS_DAY7_YF17D_...1,SET,187,-0.058665,-0.0058875,0.065157,0.81603,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN,1
GSE37532_TREG_VS_TCONV_CD4_T...4,SET,119,-0.076641,-0.0061472,0.085111,0.81606,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,1
PID_INTEGRIN_CS_PATHWAY,SET,25,-0.16794,-0.0061898,0.18648,0.81609,PID_INTEGRIN_CS_PATHWAY,1
GOBP_BRANCHING_MORPHOGENESIS...2,SET,10,-0.27224,-0.0063486,0.30225,0.81612,GOBP_BRANCHING_MORPHOGENESIS_OF_A_NERVE,1
TCTAGAG_MIR517,SET,41,-0.12229,-0.0057696,0.13573,0.8162,TCTAGAG_MIR517,1
GSE27786_CD4_TCELL_VS_NKTCEL...2,SET,180,-0.055243,-0.0054403,0.061313,0.8162,GSE27786_CD4_TCELL_VS_NKTCELL_UP,1
REACTOME_REGULATION_OF_NPAS4...3,SET,9,-0.26834,-0.0059369,0.29779,0.81623,REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION,1
MIR218_5P,SET,383,-0.041624,-0.005946,0.046186,0.81626,MIR218_5P,1
GOBP_REGULATION_OF_RUFFLE_AS...,SET,29,-0.15104,-0.005995,0.16755,0.81632,GOBP_REGULATION_OF_RUFFLE_ASSEMBLY,1
KEGG_FOCAL_ADHESION,SET,190,-0.059029,-0.0059709,0.065476,0.81634,KEGG_FOCAL_ADHESION,1
GSE29618_MONOCYTE_VS_MDC_UP,SET,186,-0.059913,-0.0059968,0.066456,0.81634,GSE29618_MONOCYTE_VS_MDC_UP,1
HP_ELEVATED_CIRCULATING_CATE...,SET,12,-0.22244,-0.0056822,0.24673,0.81635,HP_ELEVATED_CIRCULATING_CATECHOLAMINE_LEVEL,1
GOBP_INSULIN_METABOLIC_PROCE...,SET,15,-0.21029,-0.0060053,0.23324,0.81636,GOBP_INSULIN_METABOLIC_PROCESS,1
REACTOME_SMAD2_SMAD3_SMAD4_H...,SET,35,-0.12227,-0.0053308,0.1356,0.81638,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,1
GSE2770_TGFB_AND_IL4_VS_IL4_...6,SET,162,-0.05836,-0.0054551,0.064725,0.81638,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
REACTOME_KINESINS,SET,57,-0.098483,-0.0054761,0.10921,0.8164,REACTOME_KINESINS,1
GSE339_CD4POS_VS_CD8POS_DC_I...2,SET,183,-0.056934,-0.005653,0.063131,0.81642,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP,1
GOBP_ORGANIC_ACID_TRANSPORT,SET,331,-0.045139,-0.006003,0.05005,0.81643,GOBP_ORGANIC_ACID_TRANSPORT,1
BMI1_DN_MEL18_DN.V1_UP,SET,135,-0.072976,-0.0062315,0.080916,0.81643,BMI1_DN_MEL18_DN.V1_UP,1
HP_VASCULAR_DILATATION,SET,196,-0.056046,-0.005757,0.062141,0.81644,HP_VASCULAR_DILATATION,1
REACTOME_FGFR2B_LIGAND_BINDI...,SET,10,-0.28077,-0.0065476,0.31126,0.81647,REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION,1
WAESCH_ANAPHASE_PROMOTING_CO...,SET,12,-0.22253,-0.0056844,0.24668,0.81649,WAESCH_ANAPHASE_PROMOTING_COMPLEX,1
NFAT_Q6,SET,217,-0.054901,-0.0059304,0.060851,0.81653,NFAT_Q6,1
LEE_DOUBLE_POLAR_THYMOCYTE,SET,24,-0.18163,-0.0065594,0.20125,0.8166,LEE_DOUBLE_POLAR_THYMOCYTE,1
KEGG_FC_EPSILON_RI_SIGNALING...,SET,78,-0.093665,-0.0060891,0.10378,0.81661,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,1
ZNF213_TARGET_GENES,SET,474,-0.035715,-0.0056613,0.039572,0.81661,ZNF213_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...634,SET,8,-0.303,-0.0063204,0.33555,0.81673,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,1
GOMF_ALPHA_1_3_FUCOSYLTRANSF...,SET,8,-0.32208,-0.0067184,0.35662,0.81677,GOMF_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY,1
GSE30083_SP2_VS_SP3_THYMOCYT...2,SET,185,-0.062114,-0.0062005,0.068775,0.81677,GSE30083_SP2_VS_SP3_THYMOCYTE_UP,1
HP_ABSENT_FRONTAL_SINUSES,SET,6,-0.28045,-0.0050665,0.3105,0.81679,HP_ABSENT_FRONTAL_SINUSES,1
MIR6841_3P,SET,49,-0.1081,-0.0055742,0.11965,0.81685,MIR6841_3P,1
HP_ABNORMALITY_OF_HAND_JOINT...,SET,43,-0.12211,-0.0058998,0.13513,0.8169,HP_ABNORMALITY_OF_HAND_JOINT_MOBILITY,1
GSE35543_IN_VIVO_NTREG_VS_IN...2,SET,170,-0.065346,-0.0062557,0.072296,0.81696,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP,1
GSE2405_S_AUREUS_VS_UNTREATE...1,SET,180,-0.057244,-0.0056374,0.063324,0.81699,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN,1
HP_MALE_HYPOGONADISM,SET,38,-0.1293,-0.0058736,0.14303,0.817,HP_MALE_HYPOGONADISM,1
GSE6259_DEC205_POS_DC_VS_CD4...2,SET,180,-0.056359,-0.0055503,0.062343,0.817,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP,1
BIOCARTA_MCALPAIN_PATHWAY,SET,18,-0.2002,-0.0062623,0.22144,0.81702,BIOCARTA_MCALPAIN_PATHWAY,1
ZHONG_PFC_C3_ASTROCYTE,SET,338,-0.04281,-0.0057521,0.047347,0.81704,ZHONG_PFC_C3_ASTROCYTE,1
GOBP_POSITIVE_REGULATION_OF_...331,SET,8,-0.24987,-0.0052122,0.27633,0.81706,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
HP_PONTOCEREBELLAR_ATROPHY,SET,8,-0.23919,-0.0049894,0.26453,0.81706,HP_PONTOCEREBELLAR_ATROPHY,1
HP_ABNORMAL_ACTIVITY_OF_MITO...,SET,125,-0.062368,-0.0051261,0.068968,0.81708,HP_ABNORMAL_ACTIVITY_OF_MITOCHONDRIAL_RESPIRATORY_CHAIN,1
HEIDENBLAD_AMPLICON_12P11_12...2,SET,33,-0.14281,-0.0060461,0.15791,0.81709,HEIDENBLAD_AMPLICON_12P11_12_UP,1
HP_ABNORMAL_CARDIAC_VENTRICL...,SET,599,-0.031773,-0.0056419,0.035125,0.81714,HP_ABNORMAL_CARDIAC_VENTRICLE_MORPHOLOGY,1
DURCHDEWALD_SKIN_CARCINOGENE...2,SET,74,-0.092527,-0.0058595,0.10229,0.81715,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1
HP_DELAYED_CNS_MYELINATION,SET,171,-0.058046,-0.005573,0.064163,0.81717,HP_DELAYED_CNS_MYELINATION,1
HP_HELICOBACTER_PYLORI_INFEC...,SET,4,-0.40632,-0.0059938,0.44915,0.81717,HP_HELICOBACTER_PYLORI_INFECTION,1
GOBP_REGULATION_OF_FOREBRAIN...,SET,5,-0.39352,-0.00649,0.4349,0.81722,GOBP_REGULATION_OF_FOREBRAIN_NEURON_DIFFERENTIATION,1
GOBP_REGULATION_OF_MELANOCYT...,SET,6,-0.3819,-0.0068994,0.42205,0.81723,GOBP_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,1
MIR628_3P,SET,66,-0.088689,-0.0053053,0.097963,0.81735,MIR628_3P,1
GOBP_RIG_I_SIGNALING_PATHWAY,SET,22,-0.16177,-0.0055938,0.17865,0.8174,GOBP_RIG_I_SIGNALING_PATHWAY,1
HP_NEUROPATHIC_SPINAL_ARTHRO...,SET,20,-0.16829,-0.0055485,0.18585,0.8174,HP_NEUROPATHIC_SPINAL_ARTHROPATHY,1
GSE17974_CTRL_VS_ACT_IL4_AND...10,SET,167,-0.060689,-0.0057588,0.067017,0.81741,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP,1
SUZUKI_AMPLIFIED_IN_ORAL_CAN...,SET,17,-0.2121,-0.0064478,0.23419,0.81744,SUZUKI_AMPLIFIED_IN_ORAL_CANCER,1
GSE1925_3H_VS_24H_IFNG_STIM_...3,SET,181,-0.056216,-0.0055514,0.062067,0.81745,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN,1
HP_ABNORMAL_THUMB_MORPHOLOGY,SET,344,-0.041146,-0.0055765,0.045429,0.81746,HP_ABNORMAL_THUMB_MORPHOLOGY,1
GSE7852_TREG_VS_TCONV_DN,SET,178,-0.060105,-0.0058865,0.066357,0.81747,GSE7852_TREG_VS_TCONV_DN,1
GSE1460_NAIVE_CD4_TCELL_CORD...1,SET,173,-0.058271,-0.0056269,0.064319,0.81752,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN,1
REACTOME_BUTYROPHILIN_BTN_FA...,SET,12,-0.2802,-0.0071575,0.30925,0.81754,REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS,1
WP_22Q112_COPY_NUMBER_VARIAT...,SET,105,-0.085047,-0.0064101,0.09386,0.81755,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1
WANG_LSD1_TARGETS_UP,SET,21,-0.18658,-0.0063034,0.20591,0.81756,WANG_LSD1_TARGETS_UP,1
BOYLAN_MULTIPLE_MYELOMA_C_D_...1,SET,247,-0.052602,-0.0060571,0.05805,0.81757,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,1
GSE34156_TLR1_TLR2_LIGAND_VS...2,SET,174,-0.060265,-0.0058362,0.066502,0.81758,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,1
GOBP_PERISTALSIS,SET,12,-0.25814,-0.006594,0.28485,0.81759,GOBP_PERISTALSIS,1
REACTOME_RUNX3_REGULATES_IMM...,SET,6,-0.35181,-0.0063557,0.38819,0.8176,REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION,1
GOBP_SPERMATID_NUCLEUS_DIFFE...,SET,22,-0.16645,-0.0057554,0.18361,0.81766,GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION,1
GOBP_REGULATION_OF_TELOMERE_...2,SET,94,-0.073671,-0.0052553,0.081266,0.81767,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE,1
GOCC_MMXD_COMPLEX,SET,3,-0.36943,-0.0047197,0.40739,0.81775,GOCC_MMXD_COMPLEX,1
HP_CLINODACTYLY_OF_THE_3RD_F...,SET,6,-0.35202,-0.0063596,0.38808,0.81782,HP_CLINODACTYLY_OF_THE_3RD_FINGER,1
NABA_ECM_GLYCOPROTEINS,SET,177,-0.06335,-0.006187,0.069835,0.81783,NABA_ECM_GLYCOPROTEINS,1
MIR9_3P,SET,308,-0.045595,-0.005853,0.050263,0.81783,MIR9_3P,1
XU_HGF_TARGETS_INDUCED_BY_AK...2,SET,13,-0.23814,-0.0063315,0.26247,0.81788,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,1
HP_WADDLING_GAIT,SET,116,-0.071572,-0.0056683,0.078877,0.81789,HP_WADDLING_GAIT,1
REACTOME_PLATELET_ADHESION_T...,SET,15,-0.21447,-0.0061247,0.23633,0.81792,REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,1
GOBP_REGULATION_OF_DNA_TEMPL...1,SET,47,-0.11086,-0.0055989,0.12214,0.81796,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,1
BLANCO_MELO_SARS_COV_1_INFEC...2,SET,11,-0.25018,-0.006119,0.27563,0.81797,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP,1
TSHZ1_TARGET_GENES,SET,180,-0.055827,-0.0054979,0.061505,0.81797,TSHZ1_TARGET_GENES,1
HU_GENOTOXIC_DAMAGE_24HR,SET,31,-0.13022,-0.0053436,0.14346,0.81798,HU_GENOTOXIC_DAMAGE_24HR,1
HP_ABNORMAL_LEFT_ATRIUM_MORP...,SET,22,-0.17115,-0.0059181,0.18853,0.81801,HP_ABNORMAL_LEFT_ATRIUM_MORPHOLOGY,1
JAZAERI_BREAST_CANCER_BRCA1_...2,SET,45,-0.10616,-0.0052466,0.11692,0.81804,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,1
HALLMARK_UV_RESPONSE_DN,SET,136,-0.074538,-0.0063883,0.082095,0.81804,HALLMARK_UV_RESPONSE_DN,1
HP_GLOMERULAR_DEPOSITS,SET,18,-0.17594,-0.0055035,0.19373,0.81811,HP_GLOMERULAR_DEPOSITS,1
RAO_BOUND_BY_SALL4_ISOFORM_B,SET,463,-0.037213,-0.0058318,0.040969,0.81814,RAO_BOUND_BY_SALL4_ISOFORM_B,1
GSE40274_CTRL_VS_FOXP3_AND_S...1,SET,138,-0.067167,-0.0057985,0.073946,0.81814,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_JOINT_STIFFNESS,SET,177,-0.060708,-0.005929,0.066833,0.81815,HP_JOINT_STIFFNESS,1
ZBTB1_TARGET_GENES,SET,90,-0.081614,-0.0056973,0.089842,0.81816,ZBTB1_TARGET_GENES,1
LAKE_ADULT_KIDNEY_C17_COLLEC...,SET,225,-0.055965,-0.0061544,0.061594,0.81822,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,1
GSE7568_IL4_VS_IL4_AND_DEXAM...1,SET,138,-0.064466,-0.0055653,0.070943,0.81824,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN,1
REACTOME_REGULATION_OF_MITF_...1,SET,18,-0.2038,-0.006375,0.22426,0.81826,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS,1
REACTOME_ELASTIC_FIBRE_FORMA...,SET,42,-0.12709,-0.0060687,0.13983,0.81829,REACTOME_ELASTIC_FIBRE_FORMATION,1
MIR653_3P,SET,121,-0.070909,-0.0057347,0.077998,0.81835,MIR653_3P,1
GSE13493_DP_VS_CD8POS_THYMOC...2,SET,172,-0.058022,-0.0055868,0.063822,0.81835,GSE13493_DP_VS_CD8POS_THYMOCYTE_UP,1
HP_RESPIRATORY_FAILURE,SET,228,-0.05087,-0.0056308,0.055953,0.81836,HP_RESPIRATORY_FAILURE,1
CHIARADONNA_NEOPLASTIC_TRANS...1,SET,135,-0.068704,-0.0058668,0.075561,0.81838,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1
HP_ABNORMALITY_OF_FRONTAL_SI...,SET,13,-0.20979,-0.0055777,0.23073,0.81839,HP_ABNORMALITY_OF_FRONTAL_SINUS,1
AKT_UP.V1_UP,SET,149,-0.065324,-0.005858,0.071838,0.81841,AKT_UP.V1_UP,1
BROWNE_HCMV_INFECTION_30MIN_...1,SET,126,-0.069897,-0.0057677,0.076857,0.81844,BROWNE_HCMV_INFECTION_30MIN_DN,1
GOBP_MAINTENANCE_OF_PROTEIN_...6,SET,5,-0.36702,-0.0060529,0.40354,0.81845,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_MITOCHONDRION,1
GSE15735_2H_VS_12H_HDAC_INHI...2,SET,188,-0.058955,-0.0059322,0.064817,0.81847,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP,1
MIR4755_5P,SET,333,-0.044383,-0.00592,0.048792,0.81849,MIR4755_5P,1
KRISHNAN_FURIN_TARGETS_DN,SET,9,-0.21742,-0.0048102,0.239,0.8185,KRISHNAN_FURIN_TARGETS_DN,1
chr15q15,SET,86,-0.18033,-0.012307,0.19821,0.81852,chr15q15,1
BIOCARTA_PLC_PATHWAY,SET,9,-0.27049,-0.0059844,0.2973,0.81854,BIOCARTA_PLC_PATHWAY,1
GOMF_POLY_A_SPECIFIC_RIBONUC...,SET,12,-0.21786,-0.0055652,0.23941,0.81858,GOMF_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY,1
WP_6Q16_COPY_NUMBER_VARIATION,SET,14,-0.21985,-0.0060655,0.24153,0.81864,WP_6Q16_COPY_NUMBER_VARIATION,1
GOMF_PROTEIN_CYSTEINE_S_STEA...,SET,6,-0.3131,-0.0056564,0.34384,0.81874,GOMF_PROTEIN_CYSTEINE_S_STEAROYLTRANSFERASE_ACTIVITY,1
MIR4491,SET,67,-0.095134,-0.0057336,0.10447,0.81876,MIR4491,1
GOMF_HETEROTRIMERIC_G_PROTEI...,SET,5,-0.39535,-0.0065202,0.43409,0.81878,GOMF_HETEROTRIMERIC_G_PROTEIN_BINDING,1
HP_THICKENED_CALVARIA,SET,32,-0.13632,-0.0056832,0.14967,0.81878,HP_THICKENED_CALVARIA,1
GSE37534_GW1929_VS_ROSIGLITA...2,SET,150,-0.062347,-0.0056096,0.068454,0.81879,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,1
GOCC_MITOCHONDRIAL_SMALL_RIB...,SET,31,-0.12644,-0.0051885,0.13881,0.81881,GOCC_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT,1
DESCARTES_FETAL_CEREBRUM_EXC...,SET,13,-0.24733,-0.0065758,0.27139,0.81894,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,1
GOBP_REGULATION_OF_MONOOXYGE...,SET,32,-0.13823,-0.005763,0.15164,0.81899,GOBP_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
HP_HYPOPLASIA_OF_THE_EAR_CAR...,SET,10,-0.21283,-0.0049633,0.23348,0.81899,HP_HYPOPLASIA_OF_THE_EAR_CARTILAGE,1
BHATTACHARYA_EMBRYONIC_STEM_...,SET,76,-0.087897,-0.0056407,0.09642,0.81901,BHATTACHARYA_EMBRYONIC_STEM_CELL,1
GSE30083_SP1_VS_SP4_THYMOCYT...2,SET,181,-0.05819,-0.0057463,0.063821,0.81905,GSE30083_SP1_VS_SP4_THYMOCYTE_UP,1
MIR4478,SET,162,-0.061762,-0.005773,0.06773,0.81908,MIR4478,1
GOBP_FATTY_ACYL_COA_BIOSYNTH...,SET,25,-0.17144,-0.0063188,0.18797,0.81912,GOBP_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,1
GOMF_HEPARAN_SULFATE_GLUCOSA...,SET,7,-0.35358,-0.0068992,0.38757,0.81919,GOMF_HEPARAN_SULFATE_GLUCOSAMINE_3_SULFOTRANSFERASE_1_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_P4_PR...2,SET,15,-0.19951,-0.0056974,0.21868,0.8192,KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY,1
GOCC_CHROMOSOME_CENTROMERIC_...2,SET,219,-0.050911,-0.0055243,0.055793,0.81924,GOCC_CHROMOSOME_CENTROMERIC_REGION,1
GOBP_BEHAVIORAL_RESPONSE_TO_...1,SET,16,-0.19948,-0.0058832,0.2186,0.81925,GOBP_BEHAVIORAL_RESPONSE_TO_COCAINE,1
GOBP_POSITIVE_REGULATION_OF_...816,SET,25,-0.16566,-0.0061057,0.18154,0.81925,GOBP_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,1
REACTOME_INTRACELLULAR_SIGNA...,SET,299,-0.045332,-0.005735,0.049669,0.81929,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1
HP_UNILATERAL_RENAL_AGENESIS,SET,83,-0.087112,-0.005841,0.095423,0.81935,HP_UNILATERAL_RENAL_AGENESIS,1
GSE13485_CTRL_VS_DAY3_YF17D_...1,SET,179,-0.058448,-0.0057402,0.064002,0.81943,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN,1
MIR4690_5P,SET,68,-0.099626,-0.0060488,0.10907,0.81948,MIR4690_5P,1
HP_PALLOR,SET,140,-0.064982,-0.00565,0.071142,0.81948,HP_PALLOR,1
GSE42021_TREG_PLN_VS_CD24LO_...2,SET,171,-0.059074,-0.0056718,0.064643,0.8196,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP,1
HP_LETHAL_SKELETAL_DYSPLASIA,SET,8,-0.25762,-0.0053738,0.28189,0.81961,HP_LETHAL_SKELETAL_DYSPLASIA,1
chr11q21,SET,28,-0.24153,-0.0094203,0.26426,0.81963,chr11q21,1
GOMF_AMMONIUM_TRANSMEMBRANE_...,SET,12,-0.24048,-0.006143,0.26308,0.81966,GOMF_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_DESCENDING_AORTIC_DISSECT...,SET,20,-0.18741,-0.006179,0.205,0.81968,HP_DESCENDING_AORTIC_DISSECTION,1
GOBP_REGULATION_OF_NEUTROPHI...5,SET,5,-0.35818,-0.0059072,0.3918,0.81969,GOBP_REGULATION_OF_NEUTROPHIL_MEDIATED_CYTOTOXICITY,1
GOBP_REGULATION_OF_POST_TRAN...,SET,210,-0.05289,-0.0056213,0.057848,0.81971,GOBP_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
HP_ABNORMAL_MYOCARDIUM_MORPH...,SET,511,-0.03438,-0.0056526,0.037602,0.81972,HP_ABNORMAL_MYOCARDIUM_MORPHOLOGY,1
GOBP_DETERMINATION_OF_DORSAL...,SET,10,-0.25984,-0.0060596,0.28416,0.81974,GOBP_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY,1
GOBP_PLUS_END_DIRECTED_ORGAN...,SET,7,-0.29517,-0.0057595,0.32273,0.81979,GOBP_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
MIR5579_3P,SET,140,-0.067318,-0.0058531,0.073588,0.81984,MIR5579_3P,1
MORF_RAN,SET,232,-0.048605,-0.0054264,0.053106,0.81996,MORF_RAN,1
HP_ABNORMALITY_OF_THE_DISTAL...6,SET,29,-0.13743,-0.0054548,0.15012,0.82002,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,1
CHIN_BREAST_CANCER_COPY_NUMB...2,SET,27,-0.15838,-0.0060662,0.17291,0.82016,CHIN_BREAST_CANCER_COPY_NUMBER_UP,1
ZFP3_TARGET_GENES,SET,287,-0.046511,-0.0057667,0.050773,0.82017,ZFP3_TARGET_GENES,1
GOBP_CARDIAC_NEURAL_CREST_CE...3,SET,10,-0.29368,-0.0068486,0.32053,0.82022,GOBP_CARDIAC_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,1
HP_PERIMEMBRANOUS_VENTRICULA...,SET,23,-0.17427,-0.006161,0.1902,0.82022,HP_PERIMEMBRANOUS_VENTRICULAR_SEPTAL_DEFECT,1
WEINBERGER_BLOOD_TWINRIX_AGE...2,SET,7,-0.32964,-0.0064322,0.35973,0.82025,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_30_PRIMARY_VACC_1DY_POSITIVE,1
KEGG_MEDICUS_REFERENCE_PDL_P...,SET,8,-0.31325,-0.0065342,0.34184,0.82026,KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMAL_NASOLACRIMAL_SYS...,SET,63,-0.096141,-0.0056193,0.10491,0.82027,HP_ABNORMAL_NASOLACRIMAL_SYSTEM_MORPHOLOGY,1
GOBP_REGULATION_OF_HEART_RATE,SET,96,-0.087483,-0.0063063,0.095452,0.82029,GOBP_REGULATION_OF_HEART_RATE,1
KEGG_PYRUVATE_METABOLISM,SET,38,-0.12525,-0.0056896,0.13664,0.82033,KEGG_PYRUVATE_METABOLISM,1
HP_APLASIA_HYPOPLASIA_OF_THE...22,SET,13,-0.21417,-0.0056941,0.23353,0.82045,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,1
HP_ABNORMAL_FETAL_SKIN_MORPH...,SET,14,-0.19374,-0.0053453,0.21119,0.82053,HP_ABNORMAL_FETAL_SKIN_MORPHOLOGY,1
HP_ABNORMALITY_OF_THUMB_PHAL...,SET,171,-0.058526,-0.0056192,0.063791,0.82055,HP_ABNORMALITY_OF_THUMB_PHALANX,1
HP_SUBGLOTTIC_STENOSIS,SET,14,-0.20811,-0.0057416,0.22681,0.82057,HP_SUBGLOTTIC_STENOSIS,1
GOBP_ACTIN_NUCLEATION,SET,45,-0.10978,-0.0054258,0.11963,0.8206,GOBP_ACTIN_NUCLEATION,1
ZNF318_TARGET_GENES,SET,826,-0.027798,-0.0057593,0.030289,0.82062,ZNF318_TARGET_GENES,1
HP_ABNORMALITY_OF_JOINT_MOBI...,SET,1163,-0.023609,-0.0057482,0.025725,0.82063,HP_ABNORMALITY_OF_JOINT_MOBILITY,1
IKEDA_MIR1_TARGETS_UP,SET,53,-0.10851,-0.005819,0.1182,0.8207,IKEDA_MIR1_TARGETS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...565,SET,364,-0.042576,-0.0059323,0.046368,0.82074,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
chr1p36,SET,326,-0.094055,-0.012415,0.10242,0.82077,chr1p36,1
GOBP_POSITIVE_REGULATION_OF_...497,SET,4,-0.46209,-0.0068164,0.50316,0.82078,GOBP_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION,1
KEGG_MEDICUS_REFERENCE_EGF_E...5,SET,15,-0.21767,-0.0062162,0.23701,0.82079,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY,1
GSE2128_C57BL6_VS_NOD_THYMOC...3,SET,183,-0.059599,-0.0059175,0.064895,0.82079,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP,1
MAHADEVAN_IMATINIB_RESISTANC...1,SET,19,-0.21134,-0.0067919,0.23008,0.82084,MAHADEVAN_IMATINIB_RESISTANCE_DN,1
GOBP_ENSHEATHMENT_OF_NEURONS,SET,148,-0.066356,-0.0059307,0.072236,0.82084,GOBP_ENSHEATHMENT_OF_NEURONS,1
chr2q13,SET,14,-0.30659,-0.0084588,0.33374,0.82085,chr2q13,1
GOBP_REGULATION_OF_CALCIUM_I...6,SET,153,-0.066609,-0.0060522,0.072504,0.82087,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
HP_ABNORMAL_VASCULAR_PHYSIOL...,SET,285,-0.048161,-0.0059508,0.05241,0.82093,HP_ABNORMAL_VASCULAR_PHYSIOLOGY,1
GOMF_RNA_STEM_LOOP_BINDING,SET,13,-0.20458,-0.005439,0.22258,0.82098,GOMF_RNA_STEM_LOOP_BINDING,1
PAX6_01,SET,86,-0.087326,-0.0059597,0.095005,0.82099,PAX6_01,1
HP_LIMITED_ELBOW_MOVEMENT,SET,145,-0.066953,-0.0059236,0.072815,0.82107,HP_LIMITED_ELBOW_MOVEMENT,1
REACTOME_EPHB_MEDIATED_FORWA...,SET,41,-0.1255,-0.0059212,0.13649,0.82108,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,1
GSE6674_UNSTIM_VS_ANTI_IGM_S...2,SET,150,-0.060097,-0.0054071,0.065353,0.82109,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP,1
MIR210_5P,SET,49,-0.10927,-0.0056346,0.11879,0.82116,MIR210_5P,1
GOBP_GLYCOPROTEIN_METABOLIC_...,SET,344,-0.043954,-0.0059569,0.047785,0.82116,GOBP_GLYCOPROTEIN_METABOLIC_PROCESS,1
GOBP_RESPONSE_TO_INORGANIC_S...,SET,469,-0.037979,-0.0059892,0.041278,0.82123,GOBP_RESPONSE_TO_INORGANIC_SUBSTANCE,1
ZNF529_TARGET_GENES,SET,33,-0.12598,-0.0053337,0.13689,0.82128,ZNF529_TARGET_GENES,1
HP_PREMATURE_RUPTURE_OF_MEMB...,SET,15,-0.18632,-0.0053207,0.20244,0.82129,HP_PREMATURE_RUPTURE_OF_MEMBRANES,1
GSE46606_UNSTIM_VS_CD40L_IL2...12,SET,143,-0.06639,-0.0058334,0.072127,0.82133,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP,1
HP_ABNORMAL_NASAL_DORSUM_MOR...,SET,228,-0.050778,-0.0056206,0.05516,0.82135,HP_ABNORMAL_NASAL_DORSUM_MORPHOLOGY,1
BURTON_ADIPOGENESIS_2,SET,70,-0.095575,-0.0058873,0.10381,0.82138,BURTON_ADIPOGENESIS_2,1
MIR6744_5P,SET,42,-0.12527,-0.0059819,0.13605,0.82141,MIR6744_5P,1
GOMF_RNA_NUCLEASE_ACTIVITY,SET,117,-0.072354,-0.0057546,0.07857,0.82144,GOMF_RNA_NUCLEASE_ACTIVITY,1
MIR5009_5P,SET,56,-0.11147,-0.0061437,0.12103,0.82146,MIR5009_5P,1
GSE43863_TFH_VS_LY6C_INT_CXC...4,SET,184,-0.060492,-0.0060224,0.065675,0.82149,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,1
TURASHVILI_BREAST_DUCTAL_CAR...3,SET,60,-0.10892,-0.0062132,0.11823,0.82153,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,1
GSE29618_MONOCYTE_VS_MDC_DAY...1,SET,171,-0.062395,-0.0059906,0.067716,0.82158,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN,1
GOBP_ASPARTATE_FAMILY_AMINO_...3,SET,41,-0.12669,-0.0059774,0.13748,0.82161,GOBP_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GGGATGC_MIR3245P,SET,42,-0.11963,-0.0057122,0.12979,0.82164,GGGATGC_MIR3245P,1
GSE29614_CTRL_VS_TIV_FLU_VAC...2,SET,148,-0.06882,-0.006151,0.074671,0.82164,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP,1
GSE11961_MEMORY_BCELL_DAY7_V...4,SET,179,-0.058792,-0.0057739,0.063784,0.82166,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP,1
MIR3975,SET,46,-0.11894,-0.0059432,0.129,0.82173,MIR3975,1
GOBP_REGULATION_OF_MACROPHAG...6,SET,5,-0.37681,-0.0062144,0.40866,0.82175,GOBP_REGULATION_OF_MACROPHAGE_FUSION,1
SCHLOSSER_SERUM_RESPONSE_UP,SET,116,-0.073558,-0.0058255,0.079768,0.82177,SCHLOSSER_SERUM_RESPONSE_UP,1
MODULE_219,SET,21,-0.17095,-0.0057755,0.18534,0.82183,MODULE_219,1
HP_ENDOCARDIAL_FIBROSIS,SET,6,-0.34972,-0.0063179,0.37915,0.82183,HP_ENDOCARDIAL_FIBROSIS,1
GSE46606_UNSTIM_VS_CD40L_IL2...11,SET,162,-0.061298,-0.0057297,0.066444,0.82187,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN,1
GOBP_FREE_UBIQUITIN_CHAIN_PO...,SET,8,-0.2961,-0.0061764,0.32085,0.82195,GOBP_FREE_UBIQUITIN_CHAIN_POLYMERIZATION,1
FLETCHER_PBMC_BCG_10W_INFANT...3,SET,165,-0.064507,-0.0060848,0.069898,0.82196,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN,1
KOBAYASHI_EGFR_SIGNALING_6HR...1,SET,17,-0.2076,-0.006311,0.22492,0.82199,KOBAYASHI_EGFR_SIGNALING_6HR_DN,1
TARTE_PLASMA_CELL_VS_PLASMAB...1,SET,277,-0.044991,-0.0054818,0.048744,0.82199,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1
GOBP_DIET_INDUCED_THERMOGENE...,SET,13,-0.23315,-0.0061987,0.25256,0.82202,GOBP_DIET_INDUCED_THERMOGENESIS,1
GSE15735_CTRL_VS_HDAC_INHIBI...3,SET,178,-0.060005,-0.0058767,0.064989,0.82207,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN,1
HP_APLASIA_INVOLVING_BONES_O...1,SET,22,-0.16597,-0.0057388,0.17974,0.82208,HP_APLASIA_INVOLVING_BONES_OF_THE_EXTREMITIES,1
HP_WIDE_NASAL_BRIDGE,SET,433,-0.038463,-0.005834,0.041656,0.82208,HP_WIDE_NASAL_BRIDGE,1
GOBP_REGULATION_OF_INTRACELL...3,SET,139,-0.063334,-0.0054871,0.068572,0.82215,GOBP_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
GOBP_REGULATION_OF_HEMATOPOI...3,SET,14,-0.21213,-0.0058527,0.22965,0.82218,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
GOBP_EXTRAEMBRYONIC_MEMBRANE...,SET,13,-0.25348,-0.0067393,0.27441,0.82219,GOBP_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT,1
GOBP_L_PROLINE_BIOSYNTHETIC_...,SET,5,-0.34711,-0.0057247,0.37569,0.82224,GOBP_L_PROLINE_BIOSYNTHETIC_PROCESS,1
MIR1972,SET,88,-0.083499,-0.0057641,0.090369,0.82225,MIR1972,1
MIR374C_5P,SET,381,-0.042216,-0.0060151,0.045669,0.82235,MIR374C_5P,1
HP_PERIVENTRICULAR_WHITE_MAT...,SET,29,-0.15019,-0.0059613,0.16244,0.82239,HP_PERIVENTRICULAR_WHITE_MATTER_HYPERINTENSITIES,1
HP_MULTIPLE_GASTRIC_POLYPS,SET,7,-0.28137,-0.0054903,0.30431,0.82241,HP_MULTIPLE_GASTRIC_POLYPS,1
GSE2585_AIRE_KO_VS_WT_CD80_H...1,SET,181,-0.058251,-0.0057524,0.063001,0.82241,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN,1
HP_ABNORMAL_URINE_OSMOLALITY,SET,6,-0.37851,-0.0068381,0.40935,0.82242,HP_ABNORMAL_URINE_OSMOLALITY,1
KEGG_SNARE_INTERACTIONS_IN_V...,SET,36,-0.12604,-0.0055731,0.13631,0.82243,KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT,1
GOBP_MESENCHYME_MIGRATION,SET,5,-0.38145,-0.006291,0.41252,0.82243,GOBP_MESENCHYME_MIGRATION,1
NGO_MALIGNANT_GLIOMA_1P_LOH,SET,13,-0.18945,-0.0050368,0.20487,0.82244,NGO_MALIGNANT_GLIOMA_1P_LOH,1
HP_ABNORMAL_KNEE_PHYSIOLOGY,SET,78,-0.089755,-0.0058349,0.097047,0.82247,HP_ABNORMAL_KNEE_PHYSIOLOGY,1
GOBP_METANEPHRIC_RENAL_VESIC...,SET,14,-0.25037,-0.0069078,0.27069,0.8225,GOBP_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS,1
HP_ABNORMAL_POSTURING,SET,5,-0.33377,-0.0055046,0.36081,0.82253,HP_ABNORMAL_POSTURING,1
GOBP_EPITHELIAL_TO_MESENCHYM...1,SET,164,-0.06461,-0.0060761,0.069835,0.82256,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GSE3920_UNTREATED_VS_IFNA_TR...1,SET,146,-0.066643,-0.0059163,0.072029,0.82257,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN,1
GOBP_MAMMARY_GLAND_FORMATION,SET,7,-0.34447,-0.0067215,0.37222,0.82262,GOBP_MAMMARY_GLAND_FORMATION,1
HP_MACROGLOSSIA,SET,134,-0.069844,-0.0059421,0.075468,0.82263,HP_MACROGLOSSIA,1
HP_NON_OBSTRUCTIVE_AZOOSPERM...,SET,48,-0.11334,-0.0057849,0.12247,0.82264,HP_NON_OBSTRUCTIVE_AZOOSPERMIA,1
GOBP_RESPIRATORY_GASEOUS_EXC...,SET,72,-0.10117,-0.0063203,0.10929,0.82271,GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM,1
GOBP_REGULATION_OF_PROTEIN_U...,SET,164,-0.061572,-0.0057904,0.066493,0.82277,GOBP_REGULATION_OF_PROTEIN_UBIQUITINATION,1
GOBP_POSITIVE_REGULATION_OF_...509,SET,42,-0.12767,-0.0060962,0.13787,0.82278,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
MIR657,SET,68,-0.09482,-0.0057571,0.10232,0.82296,MIR657,1
GOBP_REGULATION_OF_PROTEIN_K...3,SET,18,-0.20071,-0.0062784,0.21658,0.82297,GOBP_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,1
WP_MIRNA_TARGETS_IN_ECM_AND_...,SET,22,-0.18543,-0.0064117,0.20007,0.82299,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,1
HP_LONG_PALPEBRAL_FISSURE,SET,62,-0.092837,-0.0053831,0.10013,0.82307,HP_LONG_PALPEBRAL_FISSURE,1
MCBRYAN_PUBERTAL_BREAST_6_7W...1,SET,71,-0.09624,-0.0059703,0.10379,0.82309,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1
BIOCARTA_BIOPEPTIDES_PATHWAY,SET,28,-0.15585,-0.0060787,0.16808,0.82309,BIOCARTA_BIOPEPTIDES_PATHWAY,1
SMARCA1_TARGET_GENES,SET,98,-0.079971,-0.0058242,0.086247,0.82309,SMARCA1_TARGET_GENES,1
HP_MICROPENIS,SET,226,-0.052522,-0.0057884,0.056635,0.82313,HP_MICROPENIS,1
GOBP_FATTY_ACID_METABOLIC_PR...,SET,367,-0.042595,-0.0059589,0.045929,0.82314,GOBP_FATTY_ACID_METABOLIC_PROCESS,1
ZNF707_TARGET_GENES,SET,35,-0.12845,-0.0056002,0.13848,0.82318,ZNF707_TARGET_GENES,1
FOXO1_02,SET,233,-0.053824,-0.0060219,0.058017,0.82322,FOXO1_02,1
HP_HYPOSEGMENTATION_OF_NEUTR...,SET,6,-0.33662,-0.0060814,0.36284,0.82322,HP_HYPOSEGMENTATION_OF_NEUTROPHIL_NUCLEI,1
GSE17301_IFNA2_VS_IFNA5_STIM...1,SET,174,-0.06057,-0.0058657,0.065288,0.82322,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN,1
HP_SPERMATOCYTE_MATURATION_A...,SET,3,-0.37086,-0.0047379,0.39972,0.82324,HP_SPERMATOCYTE_MATURATION_ARREST,1
MIR520B_3P_MIR520C_3P_MIR520...,SET,302,-0.045566,-0.0057929,0.049109,0.82325,MIR520B_3P_MIR520C_3P_MIR520E_3P,1
GSE36078_UNTREATED_VS_AD5_T4...3,SET,181,-0.059065,-0.0058327,0.063638,0.82333,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN,1
NKX2_5_TARGET_GENES,SET,1230,-0.023765,-0.0059388,0.025601,0.82336,NKX2_5_TARGET_GENES,1
GOBP_PEPTIDYL_LYSINE_MODIFIC...,SET,127,-0.067635,-0.005603,0.072856,0.82338,GOBP_PEPTIDYL_LYSINE_MODIFICATION,1
MIR3165,SET,33,-0.13198,-0.0055875,0.14215,0.8234,MIR3165,1
GOMF_TYPE_1_FIBROBLAST_GROWT...,SET,5,-0.39923,-0.0065841,0.42997,0.82342,GOMF_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,1
GOBP_GLUCOSE_CATABOLIC_PROCE...,SET,21,-0.16593,-0.0056057,0.17869,0.82344,GOBP_GLUCOSE_CATABOLIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_INVOLV...4,SET,479,-0.036901,-0.0058793,0.039733,0.82348,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,1
YAO_TEMPORAL_RESPONSE_TO_PRO...9,SET,71,-0.095515,-0.0059253,0.1028,0.82359,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,1
GOBP_BASE_EXCISION_REPAIR,SET,41,-0.10878,-0.0051323,0.11702,0.8237,GOBP_BASE_EXCISION_REPAIR,1
GOBP_XENOBIOTIC_METABOLIC_PR...,SET,120,-0.080728,-0.006502,0.086843,0.8237,GOBP_XENOBIOTIC_METABOLIC_PROCESS,1
HP_ABNORMAL_OPTIC_NERVE_MORP...,SET,753,-0.028874,-0.0057237,0.031062,0.8237,HP_ABNORMAL_OPTIC_NERVE_MORPHOLOGY,1
IVANOVA_HEMATOPOIESIS_EARLY_...,SET,404,-0.03931,-0.005764,0.042283,0.82373,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1
DESCARTES_FETAL_SPLEEN_STROM...,SET,31,-0.16275,-0.0066785,0.17505,0.82374,DESCARTES_FETAL_SPLEEN_STROMAL_CELLS,1
GSE17721_PAM3CSK4_VS_GADIQUI...6,SET,180,-0.060139,-0.0059226,0.06468,0.82376,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP,1
GOBP_CELLULAR_RESPONSE_TO_TH...,SET,12,-0.26325,-0.0067247,0.28298,0.82388,GOBP_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS,1
MIR504_3P,SET,130,-0.066588,-0.0055805,0.071576,0.82389,MIR504_3P,1
chr5q31,SET,179,-0.13838,-0.01359,0.14871,0.82395,chr5q31,1
GSE40666_WT_VS_STAT1_KO_CD8_...1,SET,181,-0.058966,-0.005823,0.063368,0.82395,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN,1
REACTOME_ORGANIC_CATION_TRAN...,SET,10,-0.29202,-0.0068099,0.31371,0.82403,REACTOME_ORGANIC_CATION_TRANSPORT,1
GOBP_POST_TRANSCRIPTIONAL_RE...,SET,466,-0.036974,-0.0058126,0.039713,0.82408,GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION,1
WP_OPIOID_RECEPTOR_PATHWAYS,SET,41,-0.12972,-0.0061203,0.13932,0.8241,WP_OPIOID_RECEPTOR_PATHWAYS,1
GOBP_PROTEIN_K63_LINKED_UBIQ...,SET,64,-0.096165,-0.005665,0.10326,0.82414,GOBP_PROTEIN_K63_LINKED_UBIQUITINATION,1
GOBP_REGULATION_OF_SODIUM_IO...3,SET,76,-0.10131,-0.0065016,0.10878,0.82415,GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT,1
GOMF_PRENYLTRANSFERASE_ACTIV...,SET,16,-0.18773,-0.0055366,0.20157,0.82415,GOMF_PRENYLTRANSFERASE_ACTIVITY,1
WP_VASOPRESSINREGULATED_WATE...,SET,43,-0.11943,-0.0057704,0.12823,0.82418,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,1
GSE3982_MAST_CELL_VS_EFF_MEM...2,SET,178,-0.060099,-0.0058859,0.064519,0.82419,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP,1
HP_ABNORMAL_MUSCLE_FIBER_TYP...,SET,76,-0.085771,-0.0055043,0.092071,0.82422,HP_ABNORMAL_MUSCLE_FIBER_TYPE_DISTRIBUTION,1
GSE27786_LSK_VS_CD8_TCELL_UP,SET,168,-0.060911,-0.0057971,0.06537,0.82427,GSE27786_LSK_VS_CD8_TCELL_UP,1
MIR6794_5P,SET,78,-0.090918,-0.0059105,0.097569,0.82428,MIR6794_5P,1
GSE8921_UNSTIM_VS_TLR1_2_STI...8,SET,189,-0.05851,-0.005903,0.062791,0.82428,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP,1
GOBP_POSITIVE_REGULATION_OF_...741,SET,153,-0.067461,-0.0061296,0.072388,0.82431,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,1
GOBP_REGULATION_OF_PROTEIN_C...4,SET,375,-0.040687,-0.0057524,0.043647,0.82437,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,1
GSE35685_CD34POS_CD38NEG_VS_...1,SET,189,-0.057974,-0.0058489,0.062161,0.82449,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN,1
BUSSLINGER_GASTRIC_IMMATURE_...,SET,156,-0.069158,-0.0063446,0.074138,0.82454,BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS,1
HP_HOMOCYSTINURIA,SET,9,-0.30544,-0.0067576,0.32741,0.82456,HP_HOMOCYSTINURIA,1
MIR586,SET,255,-0.050659,-0.0059257,0.054294,0.82459,MIR586,1
GSE14308_INDUCED_VS_NATURAL_...2,SET,178,-0.057128,-0.005595,0.061223,0.82461,GSE14308_INDUCED_VS_NATURAL_TREG_UP,1
GOBP_INTRACELLULAR_ZINC_ION_...,SET,34,-0.1442,-0.0061965,0.15453,0.82462,GOBP_INTRACELLULAR_ZINC_ION_HOMEOSTASIS,1
GSE42021_CD24INT_VS_CD24LOW_...2,SET,182,-0.060404,-0.0059812,0.064723,0.82465,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP,1
MIR4264,SET,97,-0.081319,-0.0058922,0.087127,0.82467,MIR4264,1
HP_CYSTATHIONINEMIA,SET,5,-0.47786,-0.0078809,0.51199,0.82467,HP_CYSTATHIONINEMIA,1
GOBP_REGULATION_OF_FIBROBLAS...1,SET,18,-0.18462,-0.005775,0.1978,0.82468,GOBP_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
GOBP_COMMISSURAL_NEURON_AXON...,SET,13,-0.23949,-0.0063673,0.25657,0.8247,GOBP_COMMISSURAL_NEURON_AXON_GUIDANCE,1
MIR4731_3P,SET,203,-0.059815,-0.0062517,0.064076,0.82471,MIR4731_3P,1
MIR2355_3P,SET,97,-0.083844,-0.0060752,0.089797,0.82477,MIR2355_3P,1
GOBP_NEGATIVE_REGULATION_OF_...473,SET,25,-0.14848,-0.0054726,0.15901,0.82478,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...5,SET,26,-0.18006,-0.0067679,0.19283,0.82479,GOBP_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY,1
DESCARTES_FETAL_EYE_VASCULAR...,SET,81,-0.096358,-0.006383,0.10319,0.82479,DESCARTES_FETAL_EYE_VASCULAR_ENDOTHELIAL_CELLS,1
GOCC_INO80_TYPE_COMPLEX,SET,27,-0.13658,-0.0052311,0.14624,0.82482,GOCC_INO80_TYPE_COMPLEX,1
HP_INTELLECTUAL_DISABILITY_P...1,SET,87,-0.081829,-0.0056168,0.087605,0.82486,HP_INTELLECTUAL_DISABILITY_PROFOUND,1
WACKER_HYPOXIA_TARGETS_OF_VHL,SET,11,-0.25634,-0.0062696,0.27441,0.82489,WACKER_HYPOXIA_TARGETS_OF_VHL,1
BRACHAT_RESPONSE_TO_CISPLATIN,SET,20,-0.18334,-0.006045,0.19625,0.8249,BRACHAT_RESPONSE_TO_CISPLATIN,1
REACTOME_NUCLEOTIDE_LIKE_PUR...,SET,13,-0.23706,-0.0063027,0.25374,0.82491,REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,1
GOBP_RESCUE_OF_STALLED_RIBOS...,SET,25,-0.14538,-0.0053584,0.15561,0.82492,GOBP_RESCUE_OF_STALLED_RIBOSOME,1
HP_APLASIA_INVOLVING_BONES_O...3,SET,15,-0.19512,-0.0055722,0.20885,0.82492,HP_APLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,1
HP_HYPOLIPOPROTEINEMIA,SET,58,-0.10705,-0.0060044,0.11458,0.82492,HP_HYPOLIPOPROTEINEMIA,1
GOBP_REGULATION_OF_CYSTEINE_...1,SET,176,-0.062031,-0.0060412,0.066386,0.82495,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
REACTOME_MITOCHONDRIAL_PROTE...2,SET,54,-0.10084,-0.0054581,0.1079,0.82498,REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,1
GOBP_NEGATIVE_REGULATION_OF_...701,SET,85,-0.094737,-0.006428,0.10137,0.82498,GOBP_NEGATIVE_REGULATION_OF_VIRAL_PROCESS,1
GOCC_MATRIX_SIDE_OF_MITOCHON...,SET,5,-0.35392,-0.0058369,0.37866,0.82501,GOCC_MATRIX_SIDE_OF_MITOCHONDRIAL_INNER_MEMBRANE,1
HP_THICK_UPPER_LIP_VERMILION,SET,20,-0.18873,-0.0062226,0.20182,0.82514,HP_THICK_UPPER_LIP_VERMILION,1
HP_MUSCLE_SPASM,SET,148,-0.065987,-0.0058977,0.070554,0.82517,HP_MUSCLE_SPASM,1
GOBP_ATP_BIOSYNTHETIC_PROCESS,SET,62,-0.090362,-0.0052396,0.096597,0.82521,GOBP_ATP_BIOSYNTHETIC_PROCESS,1
OUILLETTE_CLL_13Q14_DELETION...2,SET,70,-0.086262,-0.0053136,0.0922,0.82525,OUILLETTE_CLL_13Q14_DELETION_UP,1
GSE25890_CTRL_VS_IL33_IL7_TR...2,SET,179,-0.059031,-0.0057974,0.063097,0.82525,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP,1
GOBP_POSITIVE_REGULATION_OF_...434,SET,15,-0.20613,-0.0058866,0.22027,0.82531,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,1
GOBP_DETERMINATION_OF_PANCRE...,SET,4,-0.39893,-0.0058849,0.42628,0.82532,GOBP_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY,1
GSE31082_DN_VS_DP_THYMOCYTE_...2,SET,174,-0.056084,-0.0054312,0.059921,0.82535,GSE31082_DN_VS_DP_THYMOCYTE_UP,1
GSE46606_IRF4MID_VS_WT_CD40L...1,SET,185,-0.063872,-0.006376,0.06824,0.82535,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,1
GSE45365_NK_CELL_VS_CD11B_DC...4,SET,176,-0.060149,-0.005858,0.064244,0.82542,GSE45365_NK_CELL_VS_CD11B_DC_UP,1
HP_MACULAR_DEGENERATION,SET,88,-0.086422,-0.0059659,0.092303,0.82543,HP_MACULAR_DEGENERATION,1
PID_PI3KCI_PATHWAY,SET,47,-0.11953,-0.0060369,0.12766,0.82544,PID_PI3KCI_PATHWAY,1
MODULE_166,SET,48,-0.11192,-0.0057125,0.11949,0.82554,MODULE_166,1
HP_ABNORMAL_T_CELL_PROLIFERA...,SET,14,-0.20247,-0.005586,0.21612,0.82557,HP_ABNORMAL_T_CELL_PROLIFERATION,1
DBP_Q6,SET,224,-0.055202,-0.0060571,0.058919,0.82559,DBP_Q6,1
GOBP_INTRACELLULAR_MAGNESIUM...,SET,3,-0.47252,-0.0060367,0.50432,0.8256,GOBP_INTRACELLULAR_MAGNESIUM_ION_HOMEOSTASIS,1
JAK2_DN.V1_UP,SET,158,-0.069689,-0.0064338,0.074361,0.82566,JAK2_DN.V1_UP,1
GOBP_CATECHOLAMINE_UPTAKE,SET,17,-0.20595,-0.0062608,0.21961,0.82581,GOBP_CATECHOLAMINE_UPTAKE,1
ZSCAN18_TARGET_GENES,SET,33,-0.14104,-0.0059714,0.15035,0.8259,ZSCAN18_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...645,SET,81,-0.088293,-0.0058487,0.094113,0.82591,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,1
MIR7848_3P,SET,26,-0.15973,-0.0060037,0.17025,0.82593,MIR7848_3P,1
GOBP_CELLULAR_RESPONSE_TO_HY...2,SET,9,-0.29975,-0.0066317,0.31944,0.82596,GOBP_CELLULAR_RESPONSE_TO_HYDROPEROXIDE,1
HP_METABOLIC_ACIDOSIS,SET,149,-0.063548,-0.0056987,0.067724,0.82596,HP_METABOLIC_ACIDOSIS,1
MIR6758_5P,SET,99,-0.079719,-0.0058352,0.084954,0.82597,MIR6758_5P,1
WP_MICRORNA_NETWORK_ASSOCIAT...,SET,4,-0.43507,-0.0064179,0.46359,0.826,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,1
GOBP_HEPOXILIN_METABOLIC_PRO...,SET,7,-0.3532,-0.0068918,0.37633,0.82601,GOBP_HEPOXILIN_METABOLIC_PROCESS,1
HP_CEREBRAL_BERRY_ANEURYSM,SET,6,-0.33274,-0.0060113,0.35443,0.82608,HP_CEREBRAL_BERRY_ANEURYSM,1
GOMF_LIGASE_ACTIVITY_FORMING...1,SET,7,-0.30693,-0.005989,0.32687,0.82613,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS,1
REACTOME_ACTIVATION_OF_THE_A...,SET,10,-0.27669,-0.0064525,0.29463,0.82616,REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS,1
LINDGREN_BLADDER_CANCER_CLUS...2,SET,104,-0.081087,-0.0060825,0.086338,0.82617,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_GHR...2,SET,376,-0.043124,-0.0061048,0.045914,0.82619,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL,1
GOCC_IRON_SULFUR_CLUSTER_ASS...,SET,8,-0.29108,-0.0060717,0.30986,0.82623,GOCC_IRON_SULFUR_CLUSTER_ASSEMBLY_COMPLEX,1
RICKMAN_HEAD_AND_NECK_CANCER...6,SET,50,-0.12352,-0.0064343,0.13149,0.82624,RICKMAN_HEAD_AND_NECK_CANCER_F,1
GSE37301_COMMON_LYMPHOID_PRO...5,SET,177,-0.058081,-0.0056725,0.061825,0.82624,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN,1
WP_IRONSULFUR_CLUSTER_BIOGEN...,SET,13,-0.22376,-0.0059492,0.23818,0.82625,WP_IRONSULFUR_CLUSTER_BIOGENESIS,1
HP_FRAGMENTED_ELASTIC_FIBERS...,SET,9,-0.23335,-0.0051626,0.24838,0.82625,HP_FRAGMENTED_ELASTIC_FIBERS_IN_THE_DERMIS,1
HP_INTESTINAL_HYPOPLASIA,SET,19,-0.17792,-0.0057178,0.18938,0.82625,HP_INTESTINAL_HYPOPLASIA,1
GOBP_REGULATION_OF_RECEPTOR_...6,SET,107,-0.077194,-0.0058729,0.082156,0.82628,GOBP_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
GOBP_ADENOHYPOPHYSIS_DEVELOP...,SET,16,-0.21994,-0.0064868,0.23407,0.8263,GOBP_ADENOHYPOPHYSIS_DEVELOPMENT,1
DESCARTES_MAIN_FETAL_ASTROCY...,SET,33,-0.14955,-0.0063315,0.15912,0.82635,DESCARTES_MAIN_FETAL_ASTROCYTES,1
MIR205_5P,SET,201,-0.057751,-0.0060065,0.061439,0.82638,MIR205_5P,1
WP_GLYCOLYSIS_IN_SENESCENCE,SET,9,-0.24135,-0.0053397,0.25669,0.82645,WP_GLYCOLYSIS_IN_SENESCENCE,1
GSE40273_GATA1_KO_VS_WT_TREG...1,SET,185,-0.058266,-0.0058164,0.061945,0.82654,GSE40273_GATA1_KO_VS_WT_TREG_DN,1
GOBP_REGULATION_OF_SYSTEMIC_...5,SET,6,-0.40326,-0.0072852,0.42867,0.82657,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE,1
GOBP_REGULATION_OF_ANGIOTENS...,SET,8,-0.3101,-0.0064685,0.3296,0.8266,GOBP_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD,1
GOBP_REGULATION_OF_CELL_KILL...,SET,106,-0.087135,-0.0065985,0.092608,0.82662,GOBP_REGULATION_OF_CELL_KILLING,1
HP_DECREASED_PALMAR_CREASES,SET,5,-0.39343,-0.0064884,0.41793,0.82674,HP_DECREASED_PALMAR_CREASES,1
CEBPB_02,SET,237,-0.053982,-0.0060905,0.057325,0.82681,CEBPB_02,1
GOBP_LACTATE_METABOLIC_PROCE...,SET,16,-0.20184,-0.005953,0.21432,0.82684,GOBP_LACTATE_METABOLIC_PROCESS,1
GOMF_THIOESTERASE_BINDING,SET,9,-0.2567,-0.0056792,0.27253,0.82687,GOMF_THIOESTERASE_BINDING,1
BLANCO_MELO_BRONCHIAL_EPITHE...3,SET,69,-0.10092,-0.0061719,0.10713,0.82689,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN,1
MIR7161_5P,SET,177,-0.063585,-0.00621,0.067503,0.82689,MIR7161_5P,1
BIOCARTA_NKCELLS_PATHWAY,SET,18,-0.19859,-0.0062121,0.21082,0.8269,BIOCARTA_NKCELLS_PATHWAY,1
GOBP_METANEPHRIC_NEPHRON_MOR...,SET,24,-0.1886,-0.006811,0.20016,0.82695,GOBP_METANEPHRIC_NEPHRON_MORPHOGENESIS,1
HP_APLASIA_HYPOPLASIA_OF_THE...38,SET,10,-0.25366,-0.0059155,0.26922,0.82695,HP_APLASIA_HYPOPLASIA_OF_THE_INNER_EAR,1
HP_IMPAIRED_OROPHARYNGEAL_SW...,SET,12,-0.24233,-0.0061902,0.25717,0.82697,HP_IMPAIRED_OROPHARYNGEAL_SWALLOW_RESPONSE,1
GOBP_VIRAL_GENE_EXPRESSION,SET,98,-0.078332,-0.0057048,0.083119,0.827,GOBP_VIRAL_GENE_EXPRESSION,1
KEGG_MEDICUS_REFERENCE_CD80_...1,SET,10,-0.2597,-0.0060563,0.27545,0.8271,KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY,1
HP_UPSLANTED_PALPEBRAL_FISSU...,SET,270,-0.047581,-0.0057247,0.050467,0.8271,HP_UPSLANTED_PALPEBRAL_FISSURE,1
WP_KREBS_CYCLE_DISORDERS,SET,13,-0.23402,-0.006222,0.24821,0.82711,WP_KREBS_CYCLE_DISORDERS,1
FORTSCHEGGER_PHF8_TARGETS_DN,SET,685,-0.031231,-0.0059162,0.033121,0.82714,FORTSCHEGGER_PHF8_TARGETS_DN,1
NIKOLSKY_BREAST_CANCER_8Q12_...,SET,124,-0.1256,-0.010282,0.1332,0.82714,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,1
MIR4525,SET,32,-0.13825,-0.0057638,0.14656,0.82722,MIR4525,1
GOBP_REGULATION_OF_ENDOTHELI...2,SET,18,-0.19126,-0.0059827,0.20275,0.82724,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,1
REACTOME_PI5P_REGULATES_TP53...,SET,8,-0.29589,-0.006172,0.31364,0.82726,REACTOME_PI5P_REGULATES_TP53_ACETYLATION,1
GOBP_REGULATION_OF_SYNAPTIC_...14,SET,3,-0.48551,-0.0062026,0.51455,0.8273,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT,1
REACTOME_PTK6_REGULATES_RHO_...,SET,14,-0.20451,-0.0056424,0.21673,0.82732,REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,1
BILANGES_SERUM_SENSITIVE_GEN...,SET,72,-0.093674,-0.0058517,0.099251,0.82736,BILANGES_SERUM_SENSITIVE_GENES,1
GSE2770_IL12_AND_TGFB_VS_IL4...6,SET,178,-0.058758,-0.0057546,0.062254,0.82737,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
GOCC_PLATELET_DENSE_GRANULE_...1,SET,13,-0.21541,-0.005727,0.22816,0.82743,GOCC_PLATELET_DENSE_GRANULE_LUMEN,1
MIR9986,SET,148,-0.068025,-0.0060799,0.072051,0.82744,MIR9986,1
GAUSSMANN_MLL_AF4_FUSION_TAR...12,SET,166,-0.066317,-0.0062743,0.070234,0.82747,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1
KEGG_MEDICUS_REFERENCE_EREG_...1,SET,11,-0.25126,-0.0061453,0.2661,0.82747,KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY,1
GOMF_PYRIMIDINE_NUCLEOSIDE_T...,SET,8,-0.31053,-0.0064775,0.32887,0.82747,GOMF_PYRIMIDINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
CHANDRAN_METASTASIS_UP,SET,176,-0.060539,-0.005896,0.064105,0.82751,CHANDRAN_METASTASIS_UP,1
GSE17721_CTRL_VS_PAM3CSK4_24...1,SET,180,-0.059814,-0.0058905,0.063336,0.82751,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN,1
BIOCARTA_CERAMIDE_PATHWAY,SET,20,-0.18828,-0.0062076,0.19935,0.82752,BIOCARTA_CERAMIDE_PATHWAY,1
HP_RENAL_FIBROSIS,SET,15,-0.20176,-0.0057617,0.21361,0.82754,HP_RENAL_FIBROSIS,1
GOMF_ATPASE_COUPLED_INTRAMEM...,SET,26,-0.16518,-0.0062084,0.17486,0.82757,GOMF_ATPASE_COUPLED_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,1
GSE36826_WT_VS_IL1R_KO_SKIN_...4,SET,181,-0.0617,-0.0060929,0.065308,0.8276,GSE36826_WT_VS_IL1R_KO_SKIN_UP,1
GOBP_NEPHRIC_DUCT_FORMATION,SET,5,-0.41426,-0.006832,0.43841,0.82764,GOBP_NEPHRIC_DUCT_FORMATION,1
GSE27786_CD4_TCELL_VS_ERYTHT...1,SET,180,-0.05831,-0.0057424,0.061709,0.82765,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN,1
MIR6809_5P,SET,125,-0.073255,-0.0060209,0.077522,0.82766,MIR6809_5P,1
GOBP_POSITIVE_REGULATION_OF_...189,SET,15,-0.19719,-0.0056313,0.20864,0.8277,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
GOCC_SMOOTH_ENDOPLASMIC_RETI...2,SET,7,-0.35325,-0.0068928,0.37374,0.82771,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE,1
IRITANI_MAD1_TARGETS_UP,SET,12,-0.25325,-0.0064692,0.26786,0.82778,IRITANI_MAD1_TARGETS_UP,1
HP_THYROID_CARCINOMA,SET,57,-0.11067,-0.0061536,0.11705,0.82778,HP_THYROID_CARCINOMA,1
MIR5186,SET,31,-0.14562,-0.0059759,0.15401,0.82781,MIR5186,1
REACTOME_SYNTHESIS_OF_VERY_L...,SET,23,-0.19196,-0.0067865,0.20297,0.82785,REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,1
GOMF_RIBOSOME_BINDING,SET,87,-0.082215,-0.0056433,0.086929,0.82786,GOMF_RIBOSOME_BINDING,1
GSE4748_LPS_VS_LPS_AND_CYANO...2,SET,170,-0.062308,-0.0059649,0.065842,0.828,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,1
HP_SMOOTH_PHILTRUM,SET,159,-0.063311,-0.0058633,0.066893,0.82803,HP_SMOOTH_PHILTRUM,1
GOBP_GRANULOCYTE_ACTIVATION,SET,45,-0.121,-0.0059801,0.12784,0.82804,GOBP_GRANULOCYTE_ACTIVATION,1
GOBP_INOSITOL_PHOSPHATE_META...,SET,38,-0.12873,-0.0058476,0.136,0.82806,GOBP_INOSITOL_PHOSPHATE_METABOLIC_PROCESS,1
HP_DEVELOPMENTAL_STAGNATION,SET,16,-0.22121,-0.0065243,0.23367,0.82809,HP_DEVELOPMENTAL_STAGNATION,1
GSE42088_2H_VS_24H_LEISHMANI...1,SET,173,-0.061312,-0.0059206,0.064754,0.82813,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN,1
REACTOME_COOPERATION_OF_PREF...,SET,30,-0.13823,-0.0055805,0.14598,0.82815,REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,1
GSE21546_UNSTIM_VS_ANTI_CD3_...5,SET,135,-0.074217,-0.0063375,0.078379,0.82815,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
FAN_OVARY_CL18_B_LYMPHOCYTE,SET,383,-0.041015,-0.005859,0.043302,0.82822,FAN_OVARY_CL18_B_LYMPHOCYTE,1
GOBP_REGULATION_OF_CATECHOLA...2,SET,8,-0.29975,-0.0062526,0.31644,0.82824,GOBP_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,1
GSE18791_CTRL_VS_NEWCASTLE_V...15,SET,167,-0.064795,-0.0061485,0.068368,0.82836,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN,1
HP_BROAD_FEMORAL_NECK,SET,16,-0.19593,-0.0057787,0.20673,0.82838,HP_BROAD_FEMORAL_NECK,1
GSE27786_CD4_TCELL_VS_NEUTRO...2,SET,178,-0.059695,-0.0058464,0.062983,0.82838,GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP,1
HP_ECTOPIC_ANUS,SET,72,-0.098355,-0.0061442,0.10376,0.82841,HP_ECTOPIC_ANUS,1
GSE36476_YOUNG_VS_OLD_DONOR_...6,SET,173,-0.063061,-0.0060895,0.066523,0.82842,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP,1
MIR7109_3P,SET,60,-0.10107,-0.0057654,0.10661,0.82843,MIR7109_3P,1
GOBP_MONONUCLEAR_CELL_MIGRAT...,SET,203,-0.060589,-0.0063326,0.063889,0.82852,GOBP_MONONUCLEAR_CELL_MIGRATION,1
GOBP_T_CELL_ANTIGEN_PROCESSI...,SET,4,-0.44967,-0.0066333,0.47416,0.82852,GOBP_T_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_ABNORMAL_CSF_LACTATE_CONC...,SET,82,-0.084347,-0.0056216,0.088936,0.82853,HP_ABNORMAL_CSF_LACTATE_CONCENTRATION,1
GOBP_GROWTH_PLATE_CARTILAGE_...3,SET,19,-0.19024,-0.0061139,0.20059,0.82854,GOBP_GROWTH_PLATE_CARTILAGE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...718,SET,28,-0.16862,-0.0065767,0.17776,0.82858,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...451,SET,26,-0.16249,-0.0061074,0.17127,0.82861,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
DESCARTES_FETAL_SPLEEN_LYMPH...,SET,93,-0.092083,-0.0065339,0.097053,0.82863,DESCARTES_FETAL_SPLEEN_LYMPHOID_CELLS,1
MONNIER_POSTRADIATION_TUMOR_...2,SET,374,-0.040175,-0.0056725,0.042337,0.82866,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,1
IIZUKA_LIVER_CANCER_PROGRESS...2,SET,12,-0.2397,-0.0061229,0.25257,0.82869,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,1
ASH1L_TARGET_GENES,SET,1138,-0.025101,-0.0060498,0.026446,0.82873,ASH1L_TARGET_GENES,1
chr5q33,SET,63,-0.18009,-0.010526,0.18971,0.82875,chr5q33,1
GOMF_ISOMERASE_ACTIVITY,SET,158,-0.061098,-0.0056406,0.064358,0.82877,GOMF_ISOMERASE_ACTIVITY,1
GSE360_L_DONOVANI_VS_L_MAJOR...2,SET,181,-0.061138,-0.0060374,0.064399,0.82877,GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP,1
HP_HYPOVENTILATION,SET,46,-0.11829,-0.0059105,0.12458,0.8288,HP_HYPOVENTILATION,1
KORKOLA_CHORIOCARCINOMA_DN,SET,8,-0.33467,-0.0069809,0.35246,0.82881,KORKOLA_CHORIOCARCINOMA_DN,1
GOMF_TRANSFORMING_GROWTH_FAC...1,SET,23,-0.1823,-0.006445,0.19199,0.82881,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING,1
GSE15750_WT_VS_TRAF6KO_DAY6_...1,SET,185,-0.059529,-0.0059425,0.062684,0.82885,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN,1
GOBP_REGULATION_OF_ATPASE_CO...,SET,5,-0.30348,-0.0050051,0.31948,0.82892,GOBP_REGULATION_OF_ATPASE_COUPLED_CALCIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_FLIPPASE_ACTIVITY,SET,15,-0.21675,-0.0061899,0.22817,0.82893,GOMF_FLIPPASE_ACTIVITY,1
GSE360_CTRL_VS_L_MAJOR_DC_DN,SET,181,-0.062947,-0.0062161,0.066255,0.82896,GSE360_CTRL_VS_L_MAJOR_DC_DN,1
TRAVAGLINI_LUNG_TREM2_DENDRI...,SET,518,-0.036643,-0.0060646,0.038558,0.82902,TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL,1
GOBP_HYPOTHALAMUS_DEVELOPMENT,SET,25,-0.17901,-0.0065978,0.18833,0.82907,GOBP_HYPOTHALAMUS_DEVELOPMENT,1
HP_SPEECH_APRAXIA,SET,28,-0.14773,-0.005762,0.15537,0.82915,HP_SPEECH_APRAXIA,1
GOBP_POSITIVE_REGULATION_OF_...227,SET,80,-0.090879,-0.0059829,0.095571,0.82917,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,1
DESCARTES_MAIN_FETAL_MESOTHE...,SET,22,-0.18993,-0.0065675,0.19973,0.82917,DESCARTES_MAIN_FETAL_MESOTHELIAL_CELLS,1
HP_LONG_THUMB,SET,7,-0.32106,-0.0062647,0.3376,0.82919,HP_LONG_THUMB,1
GSE14413_UNSTIM_VS_IFNB_STIM...2,SET,110,-0.079021,-0.0060952,0.083088,0.82921,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP,1
AACATTC_MIR4093P,SET,137,-0.071308,-0.0061338,0.07497,0.82923,AACATTC_MIR4093P,1
GOBP_RESPIRATORY_BURST_INVOL...2,SET,9,-0.27794,-0.0061491,0.29221,0.82923,GOBP_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GOBP_DNA_PROTECTION,SET,5,-0.35366,-0.0058327,0.37181,0.82924,GOBP_DNA_PROTECTION,1
GOBP_REGULATION_OF_STEM_CELL...4,SET,79,-0.096938,-0.0063419,0.10191,0.82925,GOBP_REGULATION_OF_STEM_CELL_PROLIFERATION,1
OUELLET_CULTURED_OVARIAN_CAN...1,SET,30,-0.15177,-0.006127,0.15954,0.82927,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1
GOBP_HEART_PROCESS,SET,240,-0.057015,-0.0064728,0.059926,0.8293,GOBP_HEART_PROCESS,1
MIR5739,SET,6,-0.38642,-0.0069809,0.40605,0.82935,MIR5739,1
DAUER_STAT3_TARGETS_UP,SET,42,-0.1372,-0.0065514,0.14416,0.82938,DAUER_STAT3_TARGETS_UP,1
LAKE_ADULT_KIDNEY_C16_COLLEC...,SET,124,-0.081227,-0.0066496,0.085341,0.82939,LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX,1
GOBP_NEGATIVE_REGULATION_OF_...630,SET,31,-0.13357,-0.005481,0.14032,0.8294,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE,1
chr3p13,SET,10,-0.38021,-0.0088665,0.39944,0.82941,chr3p13,1
GOBP_NEGATIVE_REGULATION_OF_...291,SET,10,-0.25588,-0.0059671,0.26876,0.82946,GOBP_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,1
HP_MITRAL_VALVE_CALCIFICATION,SET,7,-0.33327,-0.006503,0.35005,0.82946,HP_MITRAL_VALVE_CALCIFICATION,1
GOBP_INOSITOL_TRISPHOSPHATE_...1,SET,6,-0.34247,-0.006187,0.35967,0.82949,GOBP_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_RETINAL_DEGENERATION,SET,261,-0.049877,-0.0059016,0.052376,0.82952,HP_RETINAL_DEGENERATION,1
GSE3920_IFNA_VS_IFNB_TREATED...2,SET,159,-0.065742,-0.0060885,0.069028,0.82955,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,1
VECCHI_GASTRIC_CANCER_ADVANC...1,SET,132,-0.070193,-0.0059274,0.073692,0.82958,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,1
GOBP_POSITIVE_REGULATION_OF_...283,SET,9,-0.30726,-0.0067978,0.32257,0.82958,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
GOBP_TYROSINE_CATABOLIC_PROC...,SET,6,-0.35519,-0.0064167,0.37284,0.82961,GOBP_TYROSINE_CATABOLIC_PROCESS,1
ZHENG_RESPONSE_TO_ARSENITE_DN,SET,11,-0.23226,-0.0056807,0.24368,0.82973,ZHENG_RESPONSE_TO_ARSENITE_DN,1
ID2_TARGET_GENES,SET,873,-0.028243,-0.0060077,0.02963,0.82975,ID2_TARGET_GENES,1
GOBP_RETROGRADE_TRANSPORT_VE...,SET,9,-0.30323,-0.0067087,0.31808,0.82978,GOBP_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI,1
MODULE_331,SET,69,-0.094619,-0.0057868,0.099229,0.82983,MODULE_331,1
HP_BLOODY_DIARRHEA,SET,45,-0.12595,-0.0062247,0.13207,0.82986,HP_BLOODY_DIARRHEA,1
GOBP_MEMORY,SET,118,-0.076325,-0.0060962,0.080023,0.8299,GOBP_MEMORY,1
GOCC_CLATHRIN_COATED_ENDOCYT...2,SET,67,-0.10818,-0.0065196,0.1134,0.82993,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE,1
GSE7831_UNSTIM_VS_INFLUENZA_...3,SET,181,-0.060407,-0.0059652,0.063319,0.82995,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN,1
DAZARD_UV_RESPONSE_CLUSTER_G5,SET,8,-0.21985,-0.004586,0.23039,0.83002,DAZARD_UV_RESPONSE_CLUSTER_G5,1
GSE40274_IRF4_VS_FOXP3_AND_I...2,SET,157,-0.06145,-0.0056554,0.064362,0.83014,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
WP_FRAGILE_X_SYNDROME,SET,117,-0.076261,-0.0060654,0.079866,0.83017,WP_FRAGILE_X_SYNDROME,1
HP_CARDIAC_SHUNT,SET,14,-0.23871,-0.0065859,0.24997,0.83019,HP_CARDIAC_SHUNT,1
chr6p25,SET,31,-0.23915,-0.0098136,0.2504,0.83021,chr6p25,1
MIR539_3P,SET,207,-0.060681,-0.0064037,0.063528,0.83025,MIR539_3P,1
MIR6718_5P,SET,63,-0.10317,-0.0060305,0.108,0.83029,MIR6718_5P,1
WP_BMP_SIGNALING_IN_EYELID_D...,SET,19,-0.2211,-0.0071056,0.23142,0.83031,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,1
HP_ULNAR_DEVIATION_OF_THE_HA...1,SET,27,-0.16465,-0.0063062,0.17233,0.83031,HP_ULNAR_DEVIATION_OF_THE_HAND,1
HP_ABNORMALITY_OF_PRENATAL_D...,SET,881,-0.028083,-0.0059995,0.029389,0.83034,HP_ABNORMALITY_OF_PRENATAL_DEVELOPMENT_OR_BIRTH,1
BIOCARTA_TEL_PATHWAY,SET,17,-0.18846,-0.0057291,0.19716,0.83043,BIOCARTA_TEL_PATHWAY,1
DESCARTES_FETAL_CEREBRUM_LIM...,SET,22,-0.1935,-0.0066908,0.20241,0.83045,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,1
GOCC_INNER_MITOCHONDRIAL_MEM...,SET,113,-0.071059,-0.0055548,0.074308,0.83053,GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,1
MIR1237_5P_MIR4488,SET,12,-0.25421,-0.0064937,0.26582,0.83054,MIR1237_5P_MIR4488,1
GOCC_CUL2_RING_UBIQUITIN_LIG...,SET,20,-0.1829,-0.0060303,0.19122,0.83058,GOCC_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX,1
GSE36888_STAT5_AB_KNOCKIN_VS...5,SET,181,-0.060214,-0.0059462,0.062953,0.83058,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN,1
GOBP_DICARBOXYLIC_ACID_METAB...,SET,89,-0.08523,-0.0059167,0.089082,0.83065,GOBP_DICARBOXYLIC_ACID_METABOLIC_PROCESS,1
MIR1294,SET,150,-0.068588,-0.0061711,0.071679,0.83068,MIR1294,1
GOBP_NEGATIVE_REGULATION_OF_...466,SET,22,-0.18608,-0.0064343,0.19446,0.83069,GOBP_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
GOBP_SEROTONERGIC_NEURON_AXO...,SET,5,-0.35285,-0.0058193,0.36865,0.83075,GOBP_SEROTONERGIC_NEURON_AXON_GUIDANCE,1
IL21_UP.V1_UP,SET,166,-0.064926,-0.0061427,0.067826,0.83077,IL21_UP.V1_UP,1
HP_ABNORMALLY_LAX_OR_HYPEREX...,SET,150,-0.066955,-0.0060242,0.069942,0.83078,HP_ABNORMALLY_LAX_OR_HYPEREXTENSIBLE_SKIN,1
GOBP_FOREBRAIN_DEVELOPMENT,SET,380,-0.044593,-0.0063456,0.046578,0.83081,GOBP_FOREBRAIN_DEVELOPMENT,1
MIR6882_3P,SET,106,-0.080569,-0.0061012,0.084122,0.8309,MIR6882_3P,1
HP_CONGENITAL_NONBULLOUS_ICH...,SET,20,-0.18724,-0.0061735,0.1955,0.8309,HP_CONGENITAL_NONBULLOUS_ICHTHYOSIFORM_ERYTHRODERMA,1
HP_BRANCHIAL_FISTULA,SET,9,-0.29701,-0.006571,0.30999,0.83099,HP_BRANCHIAL_FISTULA,1
GOBP_CORTICOSTERONE_SECRETION,SET,5,-0.39503,-0.0065148,0.41221,0.83104,GOBP_CORTICOSTERONE_SECRETION,1
HP_MACROCYTIC_ANEMIA,SET,63,-0.10501,-0.0061378,0.10958,0.83105,HP_MACROCYTIC_ANEMIA,1
GOMF_CALMODULIN_DEPENDENT_PR...1,SET,24,-0.15703,-0.0056709,0.16385,0.83106,GOMF_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_DISTAL...1,SET,22,-0.17975,-0.0062155,0.18749,0.83114,HP_ABNORMALITY_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,1
HP_BICONCAVE_VERTEBRAL_BODIES,SET,21,-0.17945,-0.0060625,0.18718,0.83114,HP_BICONCAVE_VERTEBRAL_BODIES,1
GSE21927_UNTREATED_VS_GMCSF_...1,SET,163,-0.065743,-0.0061639,0.068569,0.83116,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,1
BIOCARTA_NKT_PATHWAY,SET,24,-0.18116,-0.0065424,0.18893,0.83118,BIOCARTA_NKT_PATHWAY,1
MYOD_Q6_01,SET,237,-0.054029,-0.0060958,0.056337,0.83122,MYOD_Q6_01,1
GSE22611_NOD2_VS_CTRL_TRANSD...1,SET,185,-0.058496,-0.0058394,0.060996,0.83122,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,1
GOBP_GLIOGENESIS,SET,325,-0.04797,-0.0063225,0.050018,0.83123,GOBP_GLIOGENESIS,1
GOBP_INTRA_GOLGI_VESICLE_MED...,SET,32,-0.13387,-0.0055811,0.13958,0.83123,GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT,1
GSE1791_CTRL_VS_NEUROMEDINU_...5,SET,168,-0.061252,-0.0058295,0.063858,0.83126,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN,1
WP_RAS_AND_BRADYKININ_PATHWA...,SET,27,-0.1817,-0.0069593,0.18941,0.83128,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,1
HP_ULNAR_DEVIATION_OF_THE_HA...2,SET,58,-0.11289,-0.0063319,0.11765,0.83135,HP_ULNAR_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
TONKS_TARGETS_OF_RUNX1_RUNX1...13,SET,21,-0.19609,-0.0066247,0.20432,0.83139,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,1
GOMF_POLY_A_RNA_POLYMERASE_A...,SET,5,-0.39302,-0.0064817,0.4095,0.8314,GOMF_POLY_A_RNA_POLYMERASE_ACTIVITY,1
GOBP_AMMONIUM_TRANSMEMBRANE_...,SET,13,-0.24384,-0.0064829,0.25397,0.8315,GOBP_AMMONIUM_TRANSMEMBRANE_TRANSPORT,1
GOMF_INOSITOL_1_3_4_5_6_PENT...,SET,5,-0.29731,-0.0049032,0.30955,0.83158,GOMF_INOSITOL_1_3_4_5_6_PENTAKISPHOSPHATE_KINASE_ACTIVITY,1
HP_BROAD_FOOT,SET,26,-0.1704,-0.0064048,0.17741,0.83159,HP_BROAD_FOOT,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...2,SET,188,-0.058425,-0.0058789,0.060824,0.8316,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP,1
GSE19401_PAM2CSK4_VS_RETINOI...2,SET,170,-0.062257,-0.00596,0.064813,0.83161,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
WP_RENINANGIOTENSINALDOSTERO...,SET,43,-0.12739,-0.0061548,0.13259,0.83167,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,1
HP_PATHOLOGIC_FRACTURE,SET,57,-0.10959,-0.006094,0.11406,0.83167,HP_PATHOLOGIC_FRACTURE,1
GSE3982_MAC_VS_TH1_UP,SET,181,-0.06294,-0.0062154,0.065505,0.83168,GSE3982_MAC_VS_TH1_UP,1
MIR4504,SET,142,-0.071533,-0.0062635,0.074415,0.83178,MIR4504,1
WANG_LMO4_TARGETS_DN,SET,320,-0.044208,-0.0057824,0.045988,0.83179,WANG_LMO4_TARGETS_DN,1
MIR10A_5P_MIR10B_5P,SET,99,-0.085685,-0.0062719,0.089111,0.83186,MIR10A_5P_MIR10B_5P,1
MIR130A_3P,SET,356,-0.043993,-0.0060633,0.045746,0.83189,MIR130A_3P,1
HP_ENLARGED_VESTIBULAR_AQUED...,SET,7,-0.3199,-0.0062421,0.33264,0.83189,HP_ENLARGED_VESTIBULAR_AQUEDUCT,1
GOBP_MRNA_EXPORT_FROM_NUCLEUS,SET,60,-0.095431,-0.0054439,0.099216,0.83193,GOBP_MRNA_EXPORT_FROM_NUCLEUS,1
HP_DEATH_IN_INFANCY,SET,221,-0.054139,-0.0059011,0.056276,0.83198,HP_DEATH_IN_INFANCY,1
KHETCHOUMIAN_TRIM24_TARGETS_...2,SET,44,-0.1314,-0.0064217,0.13658,0.83199,KHETCHOUMIAN_TRIM24_TARGETS_UP,1
HP_SHORT_NOSE,SET,276,-0.049919,-0.0060714,0.051887,0.83199,HP_SHORT_NOSE,1
MIR5582_3P,SET,601,-0.034789,-0.0061874,0.03615,0.83205,MIR5582_3P,1
GOBP_MODIFICATION_OF_POSTSYN...1,SET,10,-0.25684,-0.0059895,0.26683,0.8321,GOBP_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,1
GSE21670_IL6_VS_TGFB_AND_IL6...4,SET,187,-0.055139,-0.0055336,0.057265,0.83219,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
HP_ETHYLMALONIC_ACIDURIA,SET,9,-0.23336,-0.0051628,0.24233,0.83221,HP_ETHYLMALONIC_ACIDURIA,1
HP_HITCHHIKER_THUMB,SET,6,-0.26015,-0.0046998,0.27013,0.83224,HP_HITCHHIKER_THUMB,1
MIR4657,SET,66,-0.10245,-0.0061283,0.10636,0.83227,MIR4657,1
HP_REDUCED_RENAL_CORTICOMEDU...,SET,14,-0.22677,-0.0062564,0.2354,0.83229,HP_REDUCED_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
DESCARTES_FETAL_MUSCLE_LYMPH...1,SET,56,-0.12121,-0.0066805,0.12582,0.83231,DESCARTES_FETAL_MUSCLE_LYMPHATIC_ENDOTHELIAL_CELLS,1
GSE7460_CTRL_VS_TGFB_TREATED...5,SET,186,-0.063178,-0.0063236,0.065578,0.83232,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN,1
REACTOME_APC_CDC20_MEDIATED_...,SET,24,-0.16867,-0.0060914,0.17505,0.83236,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,1
HP_ACEPHALIC_SPERMATOZOA,SET,7,-0.35298,-0.0068876,0.36633,0.83236,HP_ACEPHALIC_SPERMATOZOA,1
WP_NUCLEOTIDE_GPCRS,SET,9,-0.26296,-0.0058178,0.27288,0.83239,WP_NUCLEOTIDE_GPCRS,1
GSE36476_YOUNG_VS_OLD_DONOR_...2,SET,174,-0.062022,-0.0060063,0.06436,0.83239,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP,1
GOBP_TYPE_I_INTERFERON_PRODU...,SET,107,-0.077321,-0.0058827,0.080233,0.8324,GOBP_TYPE_I_INTERFERON_PRODUCTION,1
BOQUEST_STEM_CELL_UP,SET,233,-0.060178,-0.0067328,0.062437,0.83242,BOQUEST_STEM_CELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...253,SET,7,-0.29959,-0.0058458,0.31082,0.83244,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TUBE_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...670,SET,40,-0.12937,-0.006029,0.13422,0.83245,GOBP_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,1
HARALAMBIEVA_PBMC_M_M_R_II_A...2,SET,843,-0.031167,-0.0065203,0.032331,0.83247,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP,1
GOBP_RESPONSE_TO_ORGANOPHOSP...,SET,123,-0.077098,-0.0062862,0.079959,0.83253,GOBP_RESPONSE_TO_ORGANOPHOSPHORUS,1
MIR4637,SET,51,-0.11524,-0.0060624,0.11951,0.83255,MIR4637,1
GOBP_DENDRITE_EXTENSION,SET,32,-0.15107,-0.0062984,0.15664,0.83258,GOBP_DENDRITE_EXTENSION,1
DESCARTES_FETAL_MUSCLE_VASCU...,SET,63,-0.11436,-0.0066843,0.11857,0.83261,DESCARTES_FETAL_MUSCLE_VASCULAR_ENDOTHELIAL_CELLS,1
HP_LIP_TELANGIECTASIA,SET,5,-0.34499,-0.0056896,0.3576,0.83266,HP_LIP_TELANGIECTASIA,1
GOMF_TOLL_LIKE_RECEPTOR_4_BI...,SET,5,-0.34111,-0.0056256,0.35354,0.83268,GOMF_TOLL_LIKE_RECEPTOR_4_BINDING,1
GOBP_CARBOHYDRATE_DERIVATIVE...1,SET,569,-0.035112,-0.0060818,0.036388,0.8327,GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS,1
GOBP_MAST_CELL_CYTOKINE_PROD...,SET,6,-0.35635,-0.0064377,0.36928,0.83272,GOBP_MAST_CELL_CYTOKINE_PRODUCTION,1
NADELLA_PRKAR1A_TARGETS_DN,SET,7,-0.31981,-0.0062404,0.33139,0.83273,NADELLA_PRKAR1A_TARGETS_DN,1
GOMF_PROTEINASE_ACTIVATED_RE...,SET,5,-0.44532,-0.0073443,0.46147,0.83273,GOMF_PROTEINASE_ACTIVATED_RECEPTOR_ACTIVITY,1
GSE46606_IRF4MID_VS_WT_CD40L...4,SET,190,-0.059539,-0.0060224,0.061695,0.83273,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,1
MIR3940_5P,SET,33,-0.13321,-0.0056396,0.13803,0.83274,MIR3940_5P,1
BALLIF_DEVELOPMENTAL_DISABIL...,SET,13,-0.23908,-0.0063563,0.24771,0.83276,BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION,1
GOCC_CELL_TRAILING_EDGE,SET,14,-0.22684,-0.0062585,0.23502,0.83277,GOCC_CELL_TRAILING_EDGE,1
GOCC_TRANSPORTER_COMPLEX,SET,428,-0.042069,-0.0063448,0.043586,0.83277,GOCC_TRANSPORTER_COMPLEX,1
WP_MOLYBDENUM_COFACTOR_MOCO_...,SET,6,-0.36529,-0.0065992,0.37843,0.83279,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,1
HP_OPSOCLONUS,SET,14,-0.25255,-0.0069678,0.26162,0.8328,HP_OPSOCLONUS,1
GOBP_POSITIVE_REGULATION_OF_...74,SET,20,-0.1747,-0.0057598,0.18094,0.83285,GOBP_POSITIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...330,SET,6,-0.30336,-0.0054804,0.31415,0.83289,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
LIANG_SILENCED_BY_METHYLATIO...3,SET,26,-0.18495,-0.0069517,0.19139,0.83306,LIANG_SILENCED_BY_METHYLATION_UP,1
HP_ANTERIOR_PLAGIOCEPHALY,SET,5,-0.4144,-0.0068343,0.4287,0.83313,HP_ANTERIOR_PLAGIOCEPHALY,1
WEBER_METHYLATED_ICP_IN_SPER...2,SET,8,-0.3138,-0.0065457,0.32441,0.8333,WEBER_METHYLATED_ICP_IN_SPERM_UP,1
MORF_PTPN9,SET,51,-0.1091,-0.0057391,0.11276,0.83334,MORF_PTPN9,1
HP_SHORT_LONG_BONE,SET,238,-0.053512,-0.0060501,0.055308,0.83335,HP_SHORT_LONG_BONE,1
GOCC_CYTOLYTIC_GRANULE,SET,14,-0.25879,-0.0071401,0.26745,0.83338,GOCC_CYTOLYTIC_GRANULE,1
KEGG_MEDICUS_REFERENCE_DOUBL...1,SET,4,-0.37468,-0.005527,0.38718,0.83339,KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION,1
HP_DECREASED_ABSENT_ANKLE_RE...,SET,37,-0.12556,-0.0056283,0.12976,0.83339,HP_DECREASED_ABSENT_ANKLE_REFLEXES,1
PID_IL12_STAT4_PATHWAY,SET,32,-0.15259,-0.0063619,0.15767,0.83342,PID_IL12_STAT4_PATHWAY,1
HAY_BONE_MARROW_NK_CELLS,SET,323,-0.047147,-0.0061952,0.048712,0.83344,HAY_BONE_MARROW_NK_CELLS,1
XU_RESPONSE_TO_TRETINOIN_AND...1,SET,13,-0.23003,-0.0061157,0.23764,0.83346,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,1
GOBP_RENAL_SYSTEM_VASCULATUR...2,SET,8,-0.34031,-0.0070986,0.35152,0.8335,GOBP_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS,1
AGCACTT_MIR93_MIR302A_MIR302...,SET,318,-0.046683,-0.0060874,0.048216,0.83352,AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D,1
GOBP_SYNAPTIC_SIGNALING_VIA_...,SET,6,-0.40887,-0.0073865,0.42227,0.83353,GOBP_SYNAPTIC_SIGNALING_VIA_NEUROPEPTIDE,1
GOBP_MONOATOMIC_ION_HOMEOSTA...,SET,561,-0.036904,-0.0063485,0.038112,0.83355,GOBP_MONOATOMIC_ION_HOMEOSTASIS,1
GSE41867_LCMV_ARMSTRONG_VS_C...5,SET,178,-0.060033,-0.0058795,0.06198,0.83362,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN,1
GSE37301_HEMATOPOIETIC_STEM_...2,SET,167,-0.065452,-0.0062108,0.067565,0.83365,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP,1
GSE41867_NAIVE_VS_DAY15_LCMV...6,SET,183,-0.05921,-0.005879,0.06111,0.8337,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP,1
GOBP_CHONDROITIN_SULFATE_MET...,SET,24,-0.171,-0.0061756,0.17645,0.83375,GOBP_CHONDROITIN_SULFATE_METABOLIC_PROCESS,1
GOCC_KINOCILIUM,SET,10,-0.27699,-0.0064596,0.28582,0.83375,GOCC_KINOCILIUM,1
CHEBOTAEV_GR_TARGETS_UP,SET,76,-0.10154,-0.006516,0.10476,0.83378,CHEBOTAEV_GR_TARGETS_UP,1
HP_YELLOW_BROWN_DISCOLORATIO...,SET,14,-0.22559,-0.006224,0.23272,0.83381,HP_YELLOW_BROWN_DISCOLORATION_OF_THE_TEETH,1
GSE15930_NAIVE_VS_72H_IN_VIT...6,SET,185,-0.058861,-0.0058758,0.060705,0.83388,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
ZHANG_ADIPOGENESIS_BY_BMP7,SET,14,-0.22027,-0.0060773,0.22708,0.83398,ZHANG_ADIPOGENESIS_BY_BMP7,1
HP_FINGER_SYMPHALANGISM,SET,11,-0.2747,-0.0067186,0.28315,0.83401,HP_FINGER_SYMPHALANGISM,1
GOBP_REGULATION_OF_LIPID_KIN...,SET,8,-0.2618,-0.0054611,0.26964,0.8342,GOBP_REGULATION_OF_LIPID_KINASE_ACTIVITY,1
HOWARD_MONOCYTE_INACT_MONOV_...2,SET,203,-0.062998,-0.0065844,0.064884,0.83421,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
REACTOME_SARS_COV_1_TARGETS_...,SET,16,-0.21841,-0.0064417,0.22486,0.8343,REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,1
LAKE_ADULT_KIDNEY_C8_DECENDI...,SET,253,-0.052543,-0.0061223,0.054094,0.8343,LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB,1
BIOCARTA_ERBB3_PATHWAY,SET,5,-0.43567,-0.0071851,0.44818,0.83449,BIOCARTA_ERBB3_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...57,SET,37,-0.1206,-0.0054057,0.12405,0.8345,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
SMCHD1_TARGET_GENES,SET,30,-0.15792,-0.0063751,0.16244,0.83451,SMCHD1_TARGET_GENES,1
GSE40666_STAT1_KO_VS_STAT4_K...1,SET,139,-0.072957,-0.0063209,0.075044,0.83451,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN,1
GOBP_REGULATION_OF_CHROMOSOM...2,SET,225,-0.052899,-0.0058172,0.054406,0.83454,GOBP_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
WP_CHROMOSOMAL_AND_MICROSATE...,SET,72,-0.099098,-0.0061906,0.10192,0.83455,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,1
HO_LIVER_CANCER_VASCULAR_INV...,SET,12,-0.2581,-0.0065932,0.26543,0.83457,HO_LIVER_CANCER_VASCULAR_INVASION,1
GOBP_REGULATION_OF_MICROTUBU...4,SET,148,-0.063848,-0.0057066,0.065657,0.83458,GOBP_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION,1
DESCARTES_FETAL_EYE_SMOOTH_M...,SET,53,-0.11546,-0.0061917,0.11873,0.8346,DESCARTES_FETAL_EYE_SMOOTH_MUSCLE_CELLS,1
SENESE_HDAC1_TARGETS_DN,SET,221,-0.058885,-0.0064184,0.060544,0.83462,SENESE_HDAC1_TARGETS_DN,1
GOBP_REACTIVE_OXYGEN_SPECIES...2,SET,201,-0.061082,-0.006353,0.062775,0.83473,GOBP_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
REACTOME_MET_INTERACTS_WITH_...,SET,5,-0.43852,-0.0072322,0.45053,0.8348,REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS,1
GOBP_REGULATION_OF_PROTEIN_L...10,SET,4,-0.40638,-0.0059947,0.4175,0.83481,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_LYSOSOME,1
RAMASWAMY_METASTASIS_UP,SET,60,-0.10513,-0.0059973,0.108,0.83482,RAMASWAMY_METASTASIS_UP,1
GOMF_ACETYLATION_DEPENDENT_P...,SET,25,-0.16558,-0.0061028,0.17005,0.83489,GOMF_ACETYLATION_DEPENDENT_PROTEIN_BINDING,1
GOMF_LIPID_KINASE_ACTIVITY,SET,39,-0.13362,-0.0061488,0.13721,0.83492,GOMF_LIPID_KINASE_ACTIVITY,1
HP_APLASTIC_CLAVICLE,SET,16,-0.18919,-0.0055798,0.19428,0.83492,HP_APLASTIC_CLAVICLE,1
GOBP_NEGATIVE_REGULATION_OF_...671,SET,10,-0.28736,-0.0067012,0.29503,0.83496,GOBP_NEGATIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,1
MAHAJAN_RESPONSE_TO_IL1A_DN,SET,63,-0.10645,-0.006222,0.10926,0.83504,MAHAJAN_RESPONSE_TO_IL1A_DN,1
GOBP_LONG_CHAIN_FATTY_ACYL_C...1,SET,18,-0.21862,-0.0068387,0.22434,0.8351,GOBP_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,1
GOZGIT_ESR1_TARGETS_UP,SET,130,-0.076364,-0.0063998,0.078346,0.83514,GOZGIT_ESR1_TARGETS_UP,1
GOBP_REGULATION_OF_SKELETAL_...5,SET,16,-0.20607,-0.0060778,0.21142,0.83514,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION,1
HP_DYSOSTOSIS_MULTIPLEX,SET,21,-0.1745,-0.0058953,0.17903,0.83514,HP_DYSOSTOSIS_MULTIPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...187,SET,107,-0.077421,-0.0058903,0.079429,0.83515,GOBP_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,1
GOCC_VESICLE_LUMEN,SET,301,-0.049427,-0.0062735,0.050708,0.83515,GOCC_VESICLE_LUMEN,1
ZHAN_MULTIPLE_MYELOMA_CD1_DN,SET,40,-0.13606,-0.0063409,0.13958,0.83516,ZHAN_MULTIPLE_MYELOMA_CD1_DN,1
MIR210_3P,SET,10,-0.25736,-0.0060017,0.264,0.83517,MIR210_3P,1
LIU_OVARIAN_CANCER_TUMORS_AN...1,SET,33,-0.16575,-0.0070174,0.17002,0.83519,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN,1
MIR8063,SET,362,-0.044117,-0.0061305,0.045251,0.8352,MIR8063,1
HP_ABNORMAL_TONGUE_MORPHOLOGY,SET,333,-0.04665,-0.0062223,0.047849,0.8352,HP_ABNORMAL_TONGUE_MORPHOLOGY,1
GSE37533_UNTREATED_VS_PIOGLI...1,SET,149,-0.067402,-0.0060443,0.069122,0.83524,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...586,SET,12,-0.23052,-0.0058886,0.23637,0.83527,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,1
GOCC_NUCLEOLAR_RIBONUCLEASE_...,SET,7,-0.29722,-0.0057996,0.30477,0.83527,GOCC_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX,1
GSE6259_FLT3L_INDUCED_DEC205...2,SET,139,-0.071687,-0.0062108,0.073477,0.83537,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP,1
KEGG_MEDICUS_REFERENCE_BMP_S...1,SET,20,-0.19853,-0.0065455,0.20346,0.8354,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY,1
GSE3982_BASOPHIL_VS_TH2_UP,SET,172,-0.064554,-0.0062157,0.066156,0.83541,GSE3982_BASOPHIL_VS_TH2_UP,1
GOBP_CORTICOTROPIN_SECRETION,SET,6,-0.37128,-0.0067075,0.38046,0.83543,GOBP_CORTICOTROPIN_SECRETION,1
DBP_TARGET_GENES,SET,1183,-0.025016,-0.0061392,0.025627,0.8355,DBP_TARGET_GENES,1
MIR433_3P,SET,127,-0.075636,-0.0062657,0.077468,0.83555,MIR433_3P,1
GSE36078_UNTREATED_VS_AD5_T4...1,SET,181,-0.06298,-0.0062194,0.064502,0.83556,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN,1
MIR4452,SET,148,-0.068679,-0.0061383,0.070323,0.83561,MIR4452,1
GOBP_CD40_SIGNALING_PATHWAY,SET,13,-0.20672,-0.005496,0.21162,0.83566,GOBP_CD40_SIGNALING_PATHWAY,1
GOBP_VITAMIN_D_RECEPTOR_SIGN...,SET,12,-0.23566,-0.0060197,0.24124,0.83567,GOBP_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
GOCC_ORGANELLE_MEMBRANE_CONT...,SET,40,-0.12684,-0.0059109,0.12983,0.8357,GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE,1
HP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,8,-0.28274,-0.0058977,0.2893,0.83578,HP_MULTIPLE_EPIPHYSEAL_DYSPLASIA,1
HP_ABNORMAL_SPERMATOGENESIS,SET,134,-0.070653,-0.0060109,0.072284,0.83582,HP_ABNORMAL_SPERMATOGENESIS,1
GCM_BNIP1,SET,67,-0.09616,-0.0057955,0.098358,0.83587,GCM_BNIP1,1
GOBP_PURINE_CONTAINING_COMPO...2,SET,484,-0.038256,-0.006126,0.039119,0.83594,GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOCC_CIS_GOLGI_NETWORK_MEMBR...,SET,10,-0.25577,-0.0059645,0.26153,0.83594,GOCC_CIS_GOLGI_NETWORK_MEMBRANE,1
HP_CHOLESTATIC_LIVER_DISEASE,SET,16,-0.22227,-0.0065554,0.22726,0.83596,HP_CHOLESTATIC_LIVER_DISEASE,1
DESCARTES_MAIN_FETAL_LYMPHOI...,SET,116,-0.084116,-0.0066617,0.086008,0.83596,DESCARTES_MAIN_FETAL_LYMPHOID_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...646,SET,13,-0.23368,-0.0062129,0.2389,0.836,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...2,SET,6,-0.37873,-0.0068421,0.38709,0.83605,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,1
GSE27786_LIN_NEG_VS_NEUTROPH...2,SET,172,-0.061169,-0.0058899,0.062521,0.83605,GSE27786_LIN_NEG_VS_NEUTROPHIL_UP,1
GOBP_AMINO_ACID_METABOLIC_PR...,SET,255,-0.052865,-0.0061838,0.054025,0.83608,GOBP_AMINO_ACID_METABOLIC_PROCESS,1
MIR8087,SET,125,-0.074749,-0.0061437,0.076387,0.83609,MIR8087,1
GOBP_BLOOD_VESSEL_REMODELING,SET,40,-0.13446,-0.006266,0.13741,0.83609,GOBP_BLOOD_VESSEL_REMODELING,1
GOCC_MICROBODY_MEMBRANE,SET,57,-0.11054,-0.0061467,0.11297,0.83609,GOCC_MICROBODY_MEMBRANE,1
GOBP_EXTRACELLULAR_TRANSPORT,SET,38,-0.1247,-0.0056644,0.12742,0.83611,GOBP_EXTRACELLULAR_TRANSPORT,1
MIR374A_5P,SET,396,-0.044195,-0.0064172,0.045149,0.83617,MIR374A_5P,1
chr6q22,SET,54,-0.21264,-0.011509,0.21721,0.83619,chr6q22,1
HASINA_NOL7_TARGETS_UP,SET,10,-0.27936,-0.0065146,0.28522,0.83631,HASINA_NOL7_TARGETS_UP,1
chr9q32,SET,31,-0.25814,-0.010593,0.26355,0.83633,chr9q32,1
AREB6_02,SET,237,-0.055524,-0.0062645,0.056683,0.83634,AREB6_02,1
GOBP_PHOSPHOLIPID_CATABOLIC_...,SET,54,-0.1155,-0.0062518,0.11791,0.83634,GOBP_PHOSPHOLIPID_CATABOLIC_PROCESS,1
MIR331_5P,SET,66,-0.1013,-0.0060599,0.10341,0.83636,MIR331_5P,1
GOBP_POSITIVE_REGULATION_OF_...630,SET,70,-0.09937,-0.0061211,0.10143,0.83636,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
GOBP_RIBONUCLEOSIDE_MONOPHOS...2,SET,14,-0.24786,-0.0068385,0.25297,0.8364,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
GOUYER_TATI_TARGETS_DN,SET,17,-0.20249,-0.0061556,0.20664,0.83642,GOUYER_TATI_TARGETS_DN,1
HP_ABNORMAL_CIRCULATING_LACT...,SET,90,-0.090734,-0.006334,0.092586,0.83645,HP_ABNORMAL_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,1
THAKAR_PBMC_INACTIVATED_INFL...8,SET,582,-0.033595,-0.005883,0.034279,0.83646,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP,1
HP_ABNORMALITY_OF_CORNEAL_SI...,SET,145,-0.072667,-0.0064291,0.074145,0.83647,HP_ABNORMALITY_OF_CORNEAL_SIZE,1
HP_VERTEBRAL_ARCH_ANOMALY,SET,16,-0.1935,-0.005707,0.19742,0.83649,HP_VERTEBRAL_ARCH_ANOMALY,1
HP_DYNEIN_ARM_DEFECT_OF_RESP...,SET,14,-0.20573,-0.0056759,0.20984,0.83654,HP_DYNEIN_ARM_DEFECT_OF_RESPIRATORY_MOTILE_CILIA,1
GOCC_CKM_COMPLEX,SET,4,-0.31357,-0.0046256,0.31981,0.83657,GOCC_CKM_COMPLEX,1
GOBP_CGMP_MEDIATED_SIGNALING,SET,26,-0.17382,-0.0065332,0.17724,0.83662,GOBP_CGMP_MEDIATED_SIGNALING,1
GOBP_TRNA_SURVEILLANCE,SET,8,-0.27627,-0.0057627,0.2817,0.83663,GOBP_TRNA_SURVEILLANCE,1
GOBP_HEART_TRABECULA_FORMATI...,SET,15,-0.24013,-0.0068574,0.24479,0.83668,GOBP_HEART_TRABECULA_FORMATION,1
GOBP_PORE_COMPLEX_ASSEMBLY,SET,18,-0.1937,-0.0060591,0.19747,0.83668,GOBP_PORE_COMPLEX_ASSEMBLY,1
GSE6875_WT_VS_FOXP3_KO_TREG_...2,SET,177,-0.063735,-0.0062246,0.064974,0.83668,GSE6875_WT_VS_FOXP3_KO_TREG_UP,1
GOBP_PROTEIN_O_LINKED_GLYCOS...3,SET,10,-0.30616,-0.0071398,0.31208,0.83671,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_THREONINE,1
HP_SPARSE_AXILLARY_HAIR,SET,42,-0.1369,-0.0065371,0.13953,0.83674,HP_SPARSE_AXILLARY_HAIR,1
GOBP_NEGATIVE_REGULATION_OF_...274,SET,7,-0.28466,-0.0055544,0.29008,0.83677,GOBP_NEGATIVE_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,1
MORF_CDC10,SET,140,-0.067192,-0.0058422,0.06847,0.83678,MORF_CDC10,1
HP_CONCAVE_NASAL_RIDGE,SET,21,-0.20182,-0.0068184,0.20561,0.83684,HP_CONCAVE_NASAL_RIDGE,1
MIR3136_5P,SET,69,-0.10801,-0.0066057,0.11002,0.83687,MIR3136_5P,1
HE_LIM_SUN_FETAL_LUNG_C0_LAT...2,SET,632,-0.035161,-0.0064073,0.035813,0.83689,HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL,1
GOBP_CYTOSKELETON_DEPENDENT_...2,SET,180,-0.06252,-0.006157,0.06367,0.83693,GOBP_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT,1
GSE41867_NAIVE_VS_EFFECTOR_C...2,SET,187,-0.057309,-0.0057514,0.058359,0.83695,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,1
MIR4762_5P,SET,128,-0.074294,-0.0061786,0.075643,0.83699,MIR4762_5P,1
MIR7856_5P,SET,363,-0.045043,-0.0062675,0.045849,0.83705,MIR7856_5P,1
MIR655_3P,SET,382,-0.044803,-0.0063918,0.045603,0.83706,MIR655_3P,1
HP_PROMINENT_COCCYX,SET,5,-0.43369,-0.0071525,0.4414,0.83708,HP_PROMINENT_COCCYX,1
REACTOME_HS_GAG_BIOSYNTHESIS,SET,28,-0.18074,-0.0070496,0.18394,0.8371,REACTOME_HS_GAG_BIOSYNTHESIS,1
GOBP_REGULATION_OF_ER_TO_GOL...,SET,10,-0.261,-0.0060866,0.26559,0.83712,GOBP_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,1
DAZARD_UV_RESPONSE_CLUSTER_G2,SET,25,-0.18477,-0.0068101,0.18796,0.8372,DAZARD_UV_RESPONSE_CLUSTER_G2,1
KEGG_MEDICUS_VARIANT_MUTATIO...38,SET,35,-0.12667,-0.0055228,0.12882,0.83727,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_MULTICELLULAR_ORGANISMA...7,SET,91,-0.095249,-0.0066858,0.09684,0.83733,GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS,1
HP_BOWED_HUMERUS,SET,7,-0.31194,-0.0060867,0.31714,0.83734,HP_BOWED_HUMERUS,1
HP_ABNORMAL_CIRCULATING_CHOL...,SET,140,-0.073664,-0.0064049,0.074884,0.83736,HP_ABNORMAL_CIRCULATING_CHOLESTEROL_CONCENTRATION,1
GSE36888_UNTREATED_VS_IL2_TR...1,SET,181,-0.062958,-0.0062172,0.063986,0.83742,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN,1
ELVIDGE_HIF1A_TARGETS_UP,SET,62,-0.10173,-0.0058986,0.10337,0.83747,ELVIDGE_HIF1A_TARGETS_UP,1
HP_PALMAR_HYPERLINEARITY,SET,6,-0.35529,-0.0064186,0.36095,0.83752,HP_PALMAR_HYPERLINEARITY,1
GSE37416_CTRL_VS_0H_F_TULARE...1,SET,133,-0.074615,-0.0063245,0.075779,0.83759,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
SASSON_RESPONSE_TO_FORSKOLIN...1,SET,84,-0.090393,-0.0060972,0.091801,0.8376,SASSON_RESPONSE_TO_FORSKOLIN_DN,1
REACTOME_SIGNALING_BY_RETINO...,SET,40,-0.14139,-0.0065893,0.1436,0.8376,REACTOME_SIGNALING_BY_RETINOIC_ACID,1
GSE17721_0.5H_VS_8H_GARDIQUI...2,SET,175,-0.059501,-0.0057785,0.060419,0.83763,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP,1
HP_DEFICIENT_EXCISION_OF_UV_...,SET,5,-0.29066,-0.0047936,0.29511,0.83766,HP_DEFICIENT_EXCISION_OF_UV_INDUCED_PYRIMIDINE_DIMERS_IN_DNA,1
GSE6269_FLU_VS_STAPH_AUREUS_...1,SET,146,-0.070748,-0.0062807,0.071829,0.83767,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN,1
HP_FEBRILE_SEIZURE_WITHIN_TH...,SET,123,-0.078274,-0.0063821,0.079467,0.83768,HP_FEBRILE_SEIZURE_WITHIN_THE_AGE_RANGE_OF_3_MONTHS_TO_6_YEARS,1
MIR4289,SET,63,-0.10895,-0.0063681,0.11059,0.83774,MIR4289,1
MIKKELSEN_NPC_HCP_WITH_H3K27...,SET,330,-0.052523,-0.0069746,0.053304,0.83776,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,1
MIR583,SET,156,-0.067463,-0.0061891,0.068456,0.8378,MIR583,1
GOCC_OXIDOREDUCTASE_COMPLEX,SET,102,-0.07647,-0.0056811,0.077597,0.8378,GOCC_OXIDOREDUCTASE_COMPLEX,1
REACTOME_CARGO_RECOGNITION_F...,SET,95,-0.088671,-0.0063587,0.089972,0.83781,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1
STK33_SKM_DN,SET,239,-0.056454,-0.0063959,0.057281,0.83782,STK33_SKM_DN,1
GOBP_DEOXYRIBONUCLEOTIDE_MET...,SET,42,-0.13306,-0.0063536,0.13499,0.83786,GOBP_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
REACTOME_FORMATION_OF_SENESC...,SET,11,-0.22573,-0.0055208,0.22898,0.83788,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,1
TTANWNANTGGM_UNKNOWN,SET,54,-0.12472,-0.0067509,0.12649,0.83794,TTANWNANTGGM_UNKNOWN,1
GSE6674_CPG_VS_CPG_AND_ANTI_...1,SET,172,-0.067766,-0.0065251,0.068721,0.83795,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN,1
MIR383_3P,SET,122,-0.077133,-0.0062636,0.078212,0.83798,MIR383_3P,1
MORF_ANP32B,SET,178,-0.059251,-0.0058028,0.060079,0.83798,MORF_ANP32B,1
HP_ABNORMAL_CIRCULATING_PROG...,SET,6,-0.3259,-0.0058876,0.33046,0.83798,HP_ABNORMAL_CIRCULATING_PROGESTERONE_LEVEL,1
NELSON_RESPONSE_TO_ANDROGEN_...2,SET,75,-0.10202,-0.006504,0.10344,0.838,NELSON_RESPONSE_TO_ANDROGEN_UP,1
PRC2_EED_DN.V1_DN,SET,177,-0.059487,-0.0058098,0.06031,0.83801,PRC2_EED_DN.V1_DN,1
HP_PERIPHERAL_HYPOMYELINATION,SET,9,-0.24523,-0.0054255,0.24862,0.83802,HP_PERIPHERAL_HYPOMYELINATION,1
KEGG_MEDICUS_VARIANT_TGFA_OV...,SET,8,-0.3015,-0.0062892,0.30565,0.83803,KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
GOMF_TRANSLATION_REGULATOR_A...1,SET,115,-0.073162,-0.0057693,0.074163,0.83805,GOMF_TRANSLATION_REGULATOR_ACTIVITY,1
MCMURRAY_TP53_HRAS_COOPERATI...2,SET,26,-0.18497,-0.0069523,0.18748,0.83808,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,1
GOBP_MUSCLE_ATROPHY,SET,11,-0.24727,-0.0060476,0.25052,0.83818,GOBP_MUSCLE_ATROPHY,1
GOBP_NEGATIVE_REGULATION_OF_...624,SET,8,-0.34308,-0.0071564,0.34759,0.83818,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
HP_PERIPAPILLARY_CHORIORETIN...,SET,5,-0.42043,-0.0069339,0.42587,0.83823,HP_PERIPAPILLARY_CHORIORETINAL_ATROPHY,1
HP_HYPOPLASIA_OF_THE_FEMORAL...,SET,5,-0.41747,-0.006885,0.42284,0.83825,HP_HYPOPLASIA_OF_THE_FEMORAL_HEAD,1
GOBP_CELL_PROJECTION_ORGANIZ...,SET,1457,-0.023327,-0.0063023,0.023621,0.83831,GOBP_CELL_PROJECTION_ORGANIZATION,1
REACTOME_RUNX1_REGULATES_TRA...5,SET,5,-0.39313,-0.0064835,0.39801,0.83835,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING,1
HP_GASTROSTOMY_TUBE_FEEDING_...,SET,93,-0.085195,-0.0060451,0.086254,0.83835,HP_GASTROSTOMY_TUBE_FEEDING_IN_INFANCY,1
MIR3129_3P,SET,94,-0.089261,-0.0063674,0.090363,0.83837,MIR3129_3P,1
HP_IRREGULAR_MENSTRUATION,SET,58,-0.10946,-0.0061396,0.1108,0.83841,HP_IRREGULAR_MENSTRUATION,1
KEGG_PARKINSONS_DISEASE,SET,92,-0.079603,-0.0056181,0.08057,0.83842,KEGG_PARKINSONS_DISEASE,1
REACTOME_RAP1_SIGNALLING,SET,16,-0.20809,-0.0061371,0.21059,0.83844,REACTOME_RAP1_SIGNALLING,1
HOEK_NK_CELL_2011_2012_TIV_A...2,SET,12,-0.24068,-0.0061481,0.24357,0.83845,HOEK_NK_CELL_2011_2012_TIV_ADULT_3DY_UP,1
GSE37301_HEMATOPOIETIC_STEM_...4,SET,174,-0.06414,-0.0062114,0.064879,0.83857,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP,1
DIERICK_SEROTONIN_FUNCTION_G...,SET,7,-0.29732,-0.0058016,0.30073,0.83858,DIERICK_SEROTONIN_FUNCTION_GENES,1
HP_HAMARTOMATOUS_POLYPOSIS,SET,14,-0.20877,-0.0057599,0.21114,0.83861,HP_HAMARTOMATOUS_POLYPOSIS,1
GOBP_REGULATION_OF_CILIUM_BE...1,SET,15,-0.21816,-0.00623,0.22061,0.83863,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY,1
HALLMARK_NOTCH_SIGNALING,SET,31,-0.15033,-0.0061691,0.15203,0.83863,HALLMARK_NOTCH_SIGNALING,1
HP_PROLONGED_PR_INTERVAL,SET,10,-0.30509,-0.0071148,0.30851,0.83864,HP_PROLONGED_PR_INTERVAL,1
GSE6259_BCELL_VS_CD8_TCELL_DN,SET,168,-0.067286,-0.0064038,0.068028,0.83869,GSE6259_BCELL_VS_CD8_TCELL_DN,1
HOEGERKORP_CD44_TARGETS_DIRE...2,SET,24,-0.17803,-0.0064293,0.17997,0.83872,HOEGERKORP_CD44_TARGETS_DIRECT_UP,1
PID_ARF6_DOWNSTREAM_PATHWAY,SET,15,-0.23922,-0.0068314,0.24181,0.83873,PID_ARF6_DOWNSTREAM_PATHWAY,1
VALK_AML_CLUSTER_9,SET,32,-0.16279,-0.0067868,0.16452,0.83877,VALK_AML_CLUSTER_9,1
GOBP_GLUTAMATE_REUPTAKE,SET,6,-0.40149,-0.0072532,0.40564,0.83885,GOBP_GLUTAMATE_REUPTAKE,1
GOBP_LEYDIG_CELL_DIFFERENTIA...,SET,9,-0.29799,-0.0065929,0.30107,0.83885,GOBP_LEYDIG_CELL_DIFFERENTIATION,1
HE_LIM_SUN_FETAL_LUNG_C2_ADC...1,SET,152,-0.07239,-0.0065561,0.073132,0.83887,HE_LIM_SUN_FETAL_LUNG_C2_ADC_1_CELL,1
GOBP_HEMATOPOIETIC_STEM_CELL...2,SET,19,-0.20735,-0.0066635,0.20939,0.83897,GOBP_HEMATOPOIETIC_STEM_CELL_HOMEOSTASIS,1
MODULE_223,SET,132,-0.083112,-0.0070184,0.083926,0.83898,MODULE_223,1
MIR548AO_5P_MIR548AX,SET,152,-0.070181,-0.0063561,0.07085,0.83905,MIR548AO_5P_MIR548AX,1
GOBP_HEPATIC_STELLATE_CELL_A...,SET,9,-0.31856,-0.0070479,0.32159,0.83905,GOBP_HEPATIC_STELLATE_CELL_ACTIVATION,1
GOBP_REGULATION_OF_LUTEINIZI...,SET,7,-0.36053,-0.007035,0.36393,0.83907,GOBP_REGULATION_OF_LUTEINIZING_HORMONE_SECRETION,1
HP_HEMORRHAGE_OF_THE_EYE,SET,46,-0.12683,-0.0063375,0.12803,0.83907,HP_HEMORRHAGE_OF_THE_EYE,1
HP_ABNORMALITY_OF_THE_STAPES,SET,13,-0.26339,-0.0070026,0.26582,0.83911,HP_ABNORMALITY_OF_THE_STAPES,1
GSE3982_CENT_MEMORY_CD4_TCEL...5,SET,184,-0.059893,-0.0059629,0.060445,0.83912,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN,1
GOCC_CLATHRIN_SCULPTED_VESIC...,SET,12,-0.27212,-0.0069513,0.27457,0.83917,GOCC_CLATHRIN_SCULPTED_VESICLE,1
GOBP_POSITIVE_REGULATION_OF_...838,SET,3,-0.44993,-0.0057481,0.45396,0.83918,GOBP_POSITIVE_REGULATION_OF_VESICLE_TRANSPORT_ALONG_MICROTUBULE,1
GNF2_MSN,SET,20,-0.18708,-0.0061682,0.18873,0.83921,GNF2_MSN,1
GOBP_DETERMINATION_OF_ADULT_...,SET,31,-0.15317,-0.0062855,0.15451,0.83922,GOBP_DETERMINATION_OF_ADULT_LIFESPAN,1
GOMF_MHC_PROTEIN_BINDING,SET,26,-0.16742,-0.0062927,0.16889,0.83922,GOMF_MHC_PROTEIN_BINDING,1
GOBP_EMBRYONIC_CRANIAL_SKELE...,SET,42,-0.13925,-0.0066495,0.14047,0.83923,GOBP_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...500,SET,46,-0.13068,-0.0065299,0.13183,0.83923,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION,1
GSE10422_WT_VS_BAFF_TRANSGEN...2,SET,157,-0.065391,-0.0060181,0.065964,0.83923,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP,1
GSE26928_NAIVE_VS_CXCR5_POS_...1,SET,166,-0.061889,-0.0058553,0.062431,0.83923,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN,1
HE_LIM_SUN_FETAL_LUNG_C3_DEF...2,SET,23,-0.18103,-0.0064,0.1826,0.83924,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROCYTE,1
GOBP_GLOSSOPHARYNGEAL_NERVE_...,SET,5,-0.31712,-0.0052299,0.31984,0.83927,GOBP_GLOSSOPHARYNGEAL_NERVE_DEVELOPMENT,1
HP_ABNORMAL_CIRCULATING_OSTE...,SET,8,-0.31544,-0.00658,0.31801,0.83938,HP_ABNORMAL_CIRCULATING_OSTEOCALCIN_LEVEL,1
KEGG_MEDICUS_REFERENCE_MITOC...,SET,52,-0.10172,-0.0054032,0.10254,0.83941,KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS,1
GOBP_MATURATION_OF_LSU_RRNA,SET,23,-0.15038,-0.0053166,0.15158,0.83941,GOBP_MATURATION_OF_LSU_RRNA,1
GSE34515_CD16_POS_MONOCYTE_V...1,SET,183,-0.061954,-0.0061514,0.062441,0.83944,GSE34515_CD16_POS_MONOCYTE_VS_DC_DN,1
MIR7159_5P,SET,323,-0.049367,-0.0064869,0.049753,0.83945,MIR7159_5P,1
GOBP_TRNA_DECAY,SET,16,-0.21628,-0.0063789,0.21798,0.83945,GOBP_TRNA_DECAY,1
MIR3666,SET,353,-0.045566,-0.0062542,0.045918,0.83948,MIR3666,1
GOBP_RIBONUCLEOSIDE_METABOLI...,SET,32,-0.17709,-0.0073832,0.17844,0.83951,GOBP_RIBONUCLEOSIDE_METABOLIC_PROCESS,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...1,SET,6,-0.39601,-0.0071543,0.39884,0.83962,GOBP_GAMMA_AMINOBUTYRIC_ACID_BIOSYNTHETIC_PROCESS,1
REACTOME_MITOCHONDRIAL_IRON_...,SET,12,-0.23072,-0.0058935,0.23233,0.83965,REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS,1
HP_IMPAIRED_RENAL_CONCENTRAT...,SET,6,-0.33919,-0.0061276,0.34155,0.83966,HP_IMPAIRED_RENAL_CONCENTRATING_ABILITY,1
GSE11864_CSF1_VS_CSF1_IFNG_I...1,SET,168,-0.065082,-0.006194,0.065532,0.83967,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN,1
GOBP_GLOMERULAR_EPITHELIAL_C...,SET,12,-0.26569,-0.0067869,0.2675,0.83969,GOBP_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT,1
BIOCARTA_PLCD_PATHWAY,SET,5,-0.4565,-0.0075287,0.45953,0.83974,BIOCARTA_PLCD_PATHWAY,1
ZHOU_INFLAMMATORY_RESPONSE_L...3,SET,337,-0.049117,-0.0065899,0.049427,0.83982,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,1
REACTOME_BRANCHED_CHAIN_AMIN...,SET,20,-0.1842,-0.0060731,0.18536,0.83982,REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,1
GOCC_GOLGI_STACK,SET,125,-0.07522,-0.0061824,0.075682,0.83986,GOCC_GOLGI_STACK,1
IZADPANAH_STEM_CELL_ADIPOSE_...1,SET,97,-0.089703,-0.0064998,0.09023,0.83992,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,1
HP_ANENCEPHALY,SET,37,-0.12926,-0.0057938,0.13001,0.83994,HP_ANENCEPHALY,1
GSE13484_UNSTIM_VS_12H_YF17D...1,SET,177,-0.062195,-0.0060742,0.062523,0.84006,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN,1
MIR3927_5P,SET,35,-0.14124,-0.0061577,0.14198,0.84007,MIR3927_5P,1
HE_LIM_SUN_FETAL_LUNG_C2_NON...,SET,16,-0.20653,-0.0060913,0.2075,0.84021,HE_LIM_SUN_FETAL_LUNG_C2_NON_CLASSICAL_MONOCYTE,1
GOBP_IMP_METABOLIC_PROCESS,SET,15,-0.22426,-0.0064043,0.22529,0.84022,GOBP_IMP_METABOLIC_PROCESS,1
GOBP_ACETATE_ESTER_TRANSPORT,SET,9,-0.28189,-0.0062365,0.28314,0.84027,GOBP_ACETATE_ESTER_TRANSPORT,1
GOMF_GAMMA_AMINOBUTYRIC_ACID...1,SET,5,-0.4629,-0.0076342,0.46495,0.84027,GOMF_GAMMA_AMINOBUTYRIC_ACID_SODIUM_CHLORIDE_SYMPORTER_ACTIVITY,1
GSE37301_PRO_BCELL_VS_GRANUL...2,SET,132,-0.076267,-0.0064404,0.076603,0.84028,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
HP_ABNORMAL_CIRCULATING_HOMO...,SET,15,-0.23462,-0.0067002,0.23558,0.84035,HP_ABNORMAL_CIRCULATING_HOMOCYSTEINE_CONCENTRATION,1
GSE21774_CD62L_POS_CD56_DIM_...1,SET,181,-0.06339,-0.0062598,0.063643,0.84037,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,1
SHEPARD_BMYB_MORPHOLINO_UP,SET,198,-0.05949,-0.0061415,0.059714,0.84043,SHEPARD_BMYB_MORPHOLINO_UP,1
MIR508_3P,SET,94,-0.087501,-0.0062418,0.087823,0.84045,MIR508_3P,1
GSE24102_GRANULOCYSTIC_MDSC_...1,SET,181,-0.061998,-0.0061224,0.062225,0.84046,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN,1
GAUTAM_EYE_IRIS_CILIARY_BODY...1,SET,104,-0.08052,-0.00604,0.080809,0.84047,GAUTAM_EYE_IRIS_CILIARY_BODY_ACTIVATED_T_CELLS,1
DESCARTES_MAIN_FETAL_VISCERA...,SET,43,-0.13445,-0.0064957,0.13492,0.84048,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,1
HP_ABNORMALITY_OF_THE_PARATH...,SET,68,-0.10907,-0.0066225,0.10946,0.84049,HP_ABNORMALITY_OF_THE_PARATHYROID_GLAND,1
KEGG_MEDICUS_REFERENCE_CXCR4...2,SET,12,-0.25173,-0.0064304,0.25261,0.8405,KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,1
HP_DELAYED_CLOSURE_OF_THE_AN...,SET,29,-0.14692,-0.0058314,0.14742,0.8405,HP_DELAYED_CLOSURE_OF_THE_ANTERIOR_FONTANELLE,1
GSE11884_WT_VS_FURIN_KO_NAIV...2,SET,121,-0.078132,-0.0063189,0.078404,0.8405,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP,1
DURANTE_ADULT_OLFACTORY_NEUR...7,SET,31,-0.16785,-0.0068879,0.16842,0.84052,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_GLOBOSE_BASAL_CELLS,1
GOMF_ANDROGEN_BINDING,SET,4,-0.35418,-0.0052247,0.35533,0.84056,GOMF_ANDROGEN_BINDING,1
GSE21927_HEALTHY_VS_TUMOROUS...2,SET,167,-0.064968,-0.0061649,0.06517,0.84059,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP,1
GSE10325_CD4_TCELL_VS_LUPUS_...2,SET,183,-0.062295,-0.0061853,0.062483,0.84061,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP,1
GSE6259_CD4_TCELL_VS_CD8_TCE...1,SET,165,-0.06432,-0.0060671,0.064485,0.84072,GSE6259_CD4_TCELL_VS_CD8_TCELL_DN,1
GSE46606_UNSTIM_VS_CD40L_IL2...10,SET,187,-0.060036,-0.0060251,0.060187,0.84073,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,1
HP_ABNORMAL_UPPER_LIMB_BONE_...,SET,398,-0.043862,-0.0063845,0.043967,0.84076,HP_ABNORMAL_UPPER_LIMB_BONE_MORPHOLOGY,1
HP_TYPE_II_LISSENCEPHALY,SET,12,-0.23596,-0.0060275,0.23651,0.84078,HP_TYPE_II_LISSENCEPHALY,1
GOMF_UBIQUITIN_LIKE_LIGASE_S...,SET,53,-0.11972,-0.0064198,0.11994,0.84089,GOMF_UBIQUITIN_LIKE_LIGASE_SUBSTRATE_ADAPTOR_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_A...4,SET,4,-0.44275,-0.0065312,0.44356,0.8409,GOBP_REGULATION_OF_PROTEIN_AUTOUBIQUITINATION,1
HP_MITOCHONDRIAL_MYOPATHY,SET,37,-0.13021,-0.0058366,0.13045,0.8409,HP_MITOCHONDRIAL_MYOPATHY,1
TONKS_TARGETS_OF_RUNX1_RUNX1...1,SET,16,-0.21718,-0.0064053,0.2175,0.84098,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,1
PID_IGF1_PATHWAY,SET,28,-0.16894,-0.0065894,0.16919,0.84098,PID_IGF1_PATHWAY,1
MIR557,SET,204,-0.05965,-0.0062496,0.059725,0.84103,MIR557,1
GOCC_TRNA_METHYLTRANSFERASE_...,SET,6,-0.28059,-0.0050691,0.28094,0.84104,GOCC_TRNA_METHYLTRANSFERASE_COMPLEX,1
MIR196A_3P,SET,115,-0.078834,-0.0062166,0.078929,0.84105,MIR196A_3P,1
GOBP_TROPHOBLAST_GIANT_CELL_...,SET,12,-0.2638,-0.0067387,0.26407,0.84109,GOBP_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION,1
HP_SEGMENTAL_PERIPHERAL_DEMY...,SET,10,-0.29529,-0.0068863,0.29559,0.8411,HP_SEGMENTAL_PERIPHERAL_DEMYELINATION_REMYELINATION,1
KEGG_RNA_DEGRADATION,SET,49,-0.11807,-0.0060884,0.11817,0.84112,KEGG_RNA_DEGRADATION,1
GOBP_RESPONSE_TO_HEAT,SET,94,-0.08561,-0.006107,0.085686,0.84112,GOBP_RESPONSE_TO_HEAT,1
HP_ADENOCARCINOMA_OF_THE_SMA...,SET,9,-0.2798,-0.0061903,0.28003,0.84114,HP_ADENOCARCINOMA_OF_THE_SMALL_INTESTINE,1
KEGG_MEDICUS_REFERENCE_ANGIO...,SET,28,-0.16342,-0.0063739,0.1635,0.84122,KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
GOBP_ENERGY_RESERVE_METABOLI...,SET,85,-0.092277,-0.0062611,0.092308,0.84126,GOBP_ENERGY_RESERVE_METABOLIC_PROCESS,1
MCRS1_TARGET_GENES,SET,33,-0.14805,-0.006268,0.14806,0.84132,MCRS1_TARGET_GENES,1
ZNF134_TARGET_GENES,SET,843,-0.029662,-0.0062055,0.029662,0.84134,ZNF134_TARGET_GENES,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...5,SET,6,-0.3818,-0.0068975,0.38178,0.84135,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_DN,1
GSE17721_CPG_VS_GARDIQUIMOD_...5,SET,181,-0.062704,-0.0061921,0.062698,0.84136,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN,1
GOCC_UBIQUINONE_BIOSYNTHESIS...,SET,6,-0.28958,-0.0052314,0.28952,0.84138,GOCC_UBIQUINONE_BIOSYNTHESIS_COMPLEX,1
GOCC_FEMALE_PRONUCLEUS,SET,8,-0.26551,-0.0055385,0.26536,0.84148,GOCC_FEMALE_PRONUCLEUS,1
GOBP_REGULATION_OF_SYNAPSE_M...,SET,21,-0.19453,-0.006572,0.1944,0.8415,GOBP_REGULATION_OF_SYNAPSE_MATURATION,1
GSE4142_NAIVE_VS_MEMORY_BCEL...2,SET,184,-0.065762,-0.0065471,0.065704,0.84155,GSE4142_NAIVE_VS_MEMORY_BCELL_UP,1
GOMF_CASPASE_BINDING,SET,12,-0.22588,-0.00577,0.22567,0.84156,GOMF_CASPASE_BINDING,1
GOBP_GROWTH_PLATE_CARTILAGE_...1,SET,5,-0.44749,-0.0073801,0.44707,0.84157,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DEVELOPMENT,1
GNF2_RPA1,SET,25,-0.16823,-0.0062006,0.16805,0.84159,GNF2_RPA1,1
GOBP_ENDODERMAL_CELL_FATE_SP...,SET,7,-0.3914,-0.0076373,0.39099,0.84159,GOBP_ENDODERMAL_CELL_FATE_SPECIFICATION,1
GOBP_REGULATION_OF_ANTIGEN_P...1,SET,18,-0.2041,-0.0063844,0.20385,0.84163,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GSE23505_IL6_IL1_IL23_VS_IL6...1,SET,179,-0.062158,-0.0061045,0.062083,0.84163,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,1
GOBP_INTESTINAL_LIPID_ABSORP...,SET,21,-0.19836,-0.0067016,0.1981,0.84166,GOBP_INTESTINAL_LIPID_ABSORPTION,1
GSE557_WT_VS_CIITA_KO_DC_DN,SET,186,-0.065154,-0.0065214,0.065065,0.84167,GSE557_WT_VS_CIITA_KO_DC_DN,1
GOBP_RESPONSE_TO_DISACCHARIDE,SET,8,-0.27714,-0.0057809,0.27669,0.84173,GOBP_RESPONSE_TO_DISACCHARIDE,1
MIR1271_3P,SET,65,-0.11298,-0.0067072,0.11279,0.84174,MIR1271_3P,1
AP1_Q4,SET,251,-0.055797,-0.006476,0.055691,0.84179,AP1_Q4,1
GOMF_SUMO_POLYMER_BINDING,SET,5,-0.35296,-0.0058211,0.35225,0.84182,GOMF_SUMO_POLYMER_BINDING,1
HP_POSTERIOR_PITUITARY_DYSGE...,SET,22,-0.19001,-0.0065701,0.18956,0.84191,HP_POSTERIOR_PITUITARY_DYSGENESIS,1
HP_SHORT_CHIN,SET,56,-0.11601,-0.0063939,0.11569,0.84199,HP_SHORT_CHIN,1
GOBP_REGULATION_OF_LONG_TERM...2,SET,12,-0.29619,-0.0075661,0.29534,0.84203,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,1
ZNF584_TARGET_GENES,SET,284,-0.051063,-0.0062984,0.050914,0.84204,ZNF584_TARGET_GENES,1
GSE41867_NAIVE_VS_DAY15_LCMV...3,SET,164,-0.064148,-0.0060326,0.063959,0.84205,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN,1
KEGG_MEDICUS_ENV_FACTOR_NICO...1,SET,11,-0.26059,-0.0063735,0.25981,0.84206,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY,1
GAVISH_3CA_METAPROGRAM_MACRO...10,SET,48,-0.12385,-0.0063213,0.12347,0.84209,GAVISH_3CA_METAPROGRAM_MACROPHAGES_PROTEASOMAL_DEGRADATION,1
WP_GLIAL_CELL_DIFFERENTIATION,SET,5,-0.38074,-0.0062793,0.37955,0.8421,WP_GLIAL_CELL_DIFFERENTIATION,1
HP_PROXIMAL_HYPERREFLEXIA,SET,36,-0.13424,-0.0059353,0.13378,0.84216,HP_PROXIMAL_HYPERREFLEXIA,1
HP_FLAT_ACETABULAR_ROOF,SET,26,-0.16126,-0.0060613,0.16069,0.8422,HP_FLAT_ACETABULAR_ROOF,1
GOBP_NEGATIVE_REGULATION_OF_...16,SET,25,-0.1838,-0.0067745,0.18314,0.84222,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOBP_FOLIC_ACID_CONTAINING_C...3,SET,27,-0.15864,-0.0060759,0.15805,0.84224,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_RECURRENT_TONSILLITIS,SET,12,-0.26873,-0.0068646,0.26757,0.84238,HP_RECURRENT_TONSILLITIS,1
HE_LIM_SUN_FETAL_LUNG_C2_MEG...,SET,615,-0.036058,-0.0064848,0.035901,0.84239,HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE,1
HOLLEMAN_ASPARAGINASE_RESIST...4,SET,24,-0.16021,-0.0057859,0.15951,0.8424,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,1
GOCC_ARYL_HYDROCARBON_RECEPT...,SET,6,-0.29659,-0.0053581,0.29522,0.84246,GOCC_ARYL_HYDROCARBON_RECEPTOR_COMPLEX,1
GSE14000_TRANSLATED_RNA_VS_M...4,SET,174,-0.061358,-0.005942,0.061059,0.84252,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP,1
MODULE_91,SET,35,-0.13155,-0.0057353,0.13089,0.84255,MODULE_91,1
UNTERMAN_PROGRESSIVE_VS_STAB...5,SET,8,-0.34481,-0.0071925,0.34291,0.84268,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...401,SET,257,-0.058529,-0.0068728,0.0582,0.8427,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,1
HP_SHORT_4TH_METACARPAL,SET,10,-0.29089,-0.0067835,0.28922,0.84273,HP_SHORT_4TH_METACARPAL,1
PPARA_02,SET,124,-0.074788,-0.0061225,0.074349,0.84276,PPARA_02,1
GOBP_NEGATIVE_REGULATION_OF_...52,SET,15,-0.22897,-0.0065389,0.22761,0.84278,GOBP_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION,1
GOCC_GOLGI_CISTERNA,SET,96,-0.089257,-0.0064341,0.088712,0.84282,GOCC_GOLGI_CISTERNA,1
MIR3928_5P,SET,93,-0.089568,-0.0063554,0.089018,0.84283,MIR3928_5P,1
GOBP_REGULATION_OF_ENDOTHELI...5,SET,5,-0.44732,-0.0073772,0.44456,0.84283,GOBP_REGULATION_OF_ENDOTHELIAL_TUBE_MORPHOGENESIS,1
REACTOME_SYNTHESIS_SECRETION...1,SET,18,-0.21053,-0.0065855,0.20918,0.84289,REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,1
GOBP_THYMOCYTE_APOPTOTIC_PRO...,SET,19,-0.20363,-0.006544,0.2023,0.84292,GOBP_THYMOCYTE_APOPTOTIC_PROCESS,1
HP_DEEP_PALMAR_CREASE,SET,28,-0.1577,-0.0061508,0.15667,0.84293,HP_DEEP_PALMAR_CREASE,1
GOBP_NEGATIVE_REGULATION_OF_...662,SET,26,-0.16863,-0.0063381,0.16751,0.84295,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
SRSF9_TARGET_GENES,SET,613,-0.035746,-0.0064185,0.035502,0.84299,SRSF9_TARGET_GENES,1
GSE25088_CTRL_VS_IL4_AND_ROS...1,SET,170,-0.065533,-0.0062736,0.065083,0.843,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
MIR6772_3P,SET,66,-0.10369,-0.0062027,0.10297,0.84302,MIR6772_3P,1
GSE22886_UNSTIM_VS_IL2_STIM_...2,SET,169,-0.064119,-0.0061203,0.063666,0.84305,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP,1
WRNIP1_TARGET_GENES,SET,967,-0.02786,-0.0062202,0.027661,0.84307,WRNIP1_TARGET_GENES,1
HP_ABNORMAL_SACRUM_MORPHOLOGY,SET,139,-0.078618,-0.0068113,0.078058,0.84307,HP_ABNORMAL_SACRUM_MORPHOLOGY,1
GOMF_PLUS_END_DIRECTED_MICRO...,SET,17,-0.20549,-0.0062468,0.20396,0.84314,GOMF_PLUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,1
HP_HYPOPLASTIC_CERVICAL_VERT...,SET,6,-0.405,-0.0073166,0.40193,0.84318,HP_HYPOPLASTIC_CERVICAL_VERTEBRAE,1
GOBP_NEGATIVE_REGULATION_OF_...633,SET,9,-0.28472,-0.0062992,0.28249,0.84324,GOBP_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,1
HP_ABNORMAL_PENIS_MORPHOLOGY,SET,559,-0.036437,-0.0062573,0.036151,0.84324,HP_ABNORMAL_PENIS_MORPHOLOGY,1
GOBP_AMINO_ACID_CATABOLIC_PR...,SET,94,-0.089792,-0.0064053,0.089085,0.84325,GOBP_AMINO_ACID_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_SYSTEM_PR...,SET,510,-0.041223,-0.0067712,0.040888,0.84331,GOBP_REGULATION_OF_SYSTEM_PROCESS,1
BLALOCK_ALZHEIMERS_DISEASE_I...1,SET,149,-0.067917,-0.0060906,0.067363,0.84332,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,1
HARALAMBIEVA_PBMC_M_M_R_II_A...3,SET,10,-0.29939,-0.0069819,0.29695,0.84332,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_HIGH_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,1
GOBP_REGULATION_OF_MEGAKARYO...,SET,22,-0.19224,-0.0066474,0.19067,0.84333,GOBP_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
GSE19923_E2A_KO_VS_E2A_AND_H...1,SET,182,-0.066668,-0.0066015,0.066116,0.84335,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN,1
GSE3982_DC_VS_BASOPHIL_DN,SET,172,-0.064902,-0.0062493,0.064359,0.84337,GSE3982_DC_VS_BASOPHIL_DN,1
HP_AORTIC_ANEURYSM,SET,152,-0.071579,-0.0064827,0.070977,0.84338,HP_AORTIC_ANEURYSM,1
GOMF_GTP_DEPENDENT_PROTEIN_B...,SET,20,-0.21445,-0.0070705,0.21263,0.84339,GOMF_GTP_DEPENDENT_PROTEIN_BINDING,1
GSE3982_NEUTROPHIL_VS_TH1_UP,SET,171,-0.067533,-0.0064839,0.066906,0.84359,GSE3982_NEUTROPHIL_VS_TH1_UP,1
SOX5_01,SET,236,-0.059203,-0.0066657,0.058648,0.84362,SOX5_01,1
HP_FIBULAR_BOWING,SET,9,-0.31129,-0.0068869,0.30835,0.84363,HP_FIBULAR_BOWING,1
OZEN_MIR125B1_TARGETS,SET,22,-0.18867,-0.0065239,0.18686,0.84366,OZEN_MIR125B1_TARGETS,1
SHAFFER_IRF4_TARGETS_IN_ACTI...1,SET,73,-0.10086,-0.0063443,0.099891,0.84368,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1
WP_ASPIRIN_AND_MIRNAS,SET,9,-0.33067,-0.0073157,0.32748,0.84369,WP_ASPIRIN_AND_MIRNAS,1
CUI_DEVELOPING_HEART_C5_VALV...,SET,184,-0.06833,-0.0068028,0.067662,0.84372,CUI_DEVELOPING_HEART_C5_VALVAR_CELL,1
REACTOME_PCP_CE_PATHWAY,SET,88,-0.088461,-0.0061066,0.087578,0.84376,REACTOME_PCP_CE_PATHWAY,1
GSE40666_NAIVE_VS_EFFECTOR_C...4,SET,187,-0.06482,-0.0065052,0.06417,0.84378,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,1
GSE17721_POLYIC_VS_PAM3CSK4_...7,SET,175,-0.067984,-0.0066024,0.067292,0.84381,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN,1
MORF_TERF2IP,SET,109,-0.075406,-0.00579,0.074605,0.84392,MORF_TERF2IP,1
HE_LIM_SUN_FETAL_LUNG_C0_PER...,SET,186,-0.069079,-0.0069142,0.068345,0.84392,HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE,1
GOBP_POSITIVE_REGULATION_OF_...790,SET,20,-0.18452,-0.0060837,0.18255,0.84393,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,1
GSE40274_CTRL_VS_FOXP3_AND_S...2,SET,150,-0.068435,-0.0061574,0.067693,0.84398,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
JECHLINGER_EPITHELIAL_TO_MES...1,SET,59,-0.1157,-0.006545,0.11441,0.84406,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1
MIR4716_3P,SET,77,-0.099179,-0.0064063,0.098017,0.84419,MIR4716_3P,1
HP_DECREASED_CALVARIAL_OSSIF...,SET,17,-0.21686,-0.0065924,0.21429,0.84422,HP_DECREASED_CALVARIAL_OSSIFICATION,1
GOMF_PHOSPHATIDYLSERINE_FLIP...,SET,4,-0.43655,-0.0064397,0.43131,0.84426,GOMF_PHOSPHATIDYLSERINE_FLIPPASE_ACTIVITY,1
MARTINEZ_RESPONSE_TO_TRABECT...3,SET,65,-0.10786,-0.0064033,0.10656,0.84427,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,1
KEGG_VALINE_LEUCINE_AND_ISOL...1,SET,6,-0.34394,-0.0062135,0.3398,0.84427,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,1
RAFFEL_VEGFA_TARGETS_DN,SET,5,-0.39536,-0.0065204,0.39051,0.84432,RAFFEL_VEGFA_TARGETS_DN,1
HP_ABNORMALITY_OF_FOLATE_MET...,SET,13,-0.24549,-0.0065268,0.24242,0.84438,HP_ABNORMALITY_OF_FOLATE_METABOLISM,1
HP_MILD_MICROCEPHALY,SET,17,-0.21263,-0.0064639,0.20992,0.84444,HP_MILD_MICROCEPHALY,1
GSE14000_UNSTIM_VS_4H_LPS_DC...3,SET,180,-0.062217,-0.0061272,0.061425,0.84444,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP,1
HP_RADIAL_HEAD_SUBLUXATION,SET,7,-0.35483,-0.0069237,0.35028,0.84446,HP_RADIAL_HEAD_SUBLUXATION,1
GOBP_PROTEIN_MATURATION_BY_I...,SET,11,-0.26557,-0.0064954,0.26206,0.84456,GOBP_PROTEIN_MATURATION_BY_IRON_SULFUR_CLUSTER_TRANSFER,1
HP_ABNORMAL_HAIR_PATTERN,SET,308,-0.049288,-0.006327,0.048615,0.84466,HP_ABNORMAL_HAIR_PATTERN,1
MIR301A_3P,SET,352,-0.046662,-0.0063956,0.046003,0.84478,MIR301A_3P,1
GSE15930_STIM_VS_STIM_AND_TR...3,SET,190,-0.062556,-0.0063276,0.061659,0.84483,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN,1
GOBP_INTRACELLULAR_SPHINGOLI...,SET,5,-0.32983,-0.0054395,0.32507,0.84485,GOBP_INTRACELLULAR_SPHINGOLIPID_HOMEOSTASIS,1
GOBP_ESTABLISHMENT_OF_EPITHE...1,SET,16,-0.21668,-0.0063906,0.21354,0.84487,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY,1
HP_CHOROID_PLEXUS_CYST,SET,10,-0.31063,-0.007244,0.30604,0.84494,HP_CHOROID_PLEXUS_CYST,1
GSE3982_DC_VS_BCELL_DN,SET,163,-0.067285,-0.0063086,0.06629,0.84494,GSE3982_DC_VS_BCELL_DN,1
REACTOME_WNT5A_DEPENDENT_INT...1,SET,13,-0.23187,-0.0061647,0.2284,0.84498,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,1
HP_WORMIAN_BONES,SET,53,-0.11584,-0.0062116,0.1141,0.84499,HP_WORMIAN_BONES,1
GNF2_UBE2I,SET,36,-0.14056,-0.0062148,0.13845,0.845,GNF2_UBE2I,1
GOCC_MAIN_AXON,SET,67,-0.1174,-0.0070756,0.11564,0.845,GOCC_MAIN_AXON,1
HP_ABNORMALITY_OF_THE_INNER_...,SET,79,-0.098856,-0.0064674,0.097362,0.84502,HP_ABNORMALITY_OF_THE_INNER_EAR,1
GOBP_ADENINE_TRANSPORT,SET,5,-0.40148,-0.0066212,0.39527,0.8451,GOBP_ADENINE_TRANSPORT,1
GSE22935_UNSTIM_VS_12H_MBOVI...3,SET,181,-0.06252,-0.0061739,0.061557,0.8451,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
GOBP_ACYLGLYCEROL_TRANSPORT,SET,6,-0.32966,-0.0059555,0.32451,0.84515,GOBP_ACYLGLYCEROL_TRANSPORT,1
GSE18893_CTRL_VS_TNF_TREATED...8,SET,179,-0.064923,-0.006376,0.063896,0.84519,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP,1
REACTOME_SIGNALING_BY_THE_B_...,SET,103,-0.080258,-0.0059915,0.078982,0.84522,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1
HFH1_01,SET,217,-0.061827,-0.0066785,0.060843,0.84522,HFH1_01,1
WP_EFFECTS_OF_NITRIC_OXIDE,SET,6,-0.40217,-0.0072654,0.39574,0.84523,WP_EFFECTS_OF_NITRIC_OXIDE,1
GOCC_SITE_OF_DNA_DAMAGE,SET,110,-0.076578,-0.0059068,0.075357,0.84523,GOCC_SITE_OF_DNA_DAMAGE,1
BIOCARTA_SKP2E2F_PATHWAY,SET,10,-0.25437,-0.0059319,0.2503,0.84524,BIOCARTA_SKP2E2F_PATHWAY,1
GOBP_REGULATION_OF_MEMBRANE_...6,SET,16,-0.19486,-0.0057471,0.19172,0.84528,GOBP_REGULATION_OF_MEMBRANE_LIPID_METABOLIC_PROCESS,1
REACTOME_MISMATCH_REPAIR,SET,15,-0.19842,-0.0056663,0.19516,0.84534,REACTOME_MISMATCH_REPAIR,1
GOBP_NEGATIVE_REGULATION_OF_...145,SET,4,-0.44692,-0.0065927,0.43953,0.84537,GOBP_NEGATIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...275,SET,4,-0.44692,-0.0065927,0.43953,0.84537,GOBP_NEGATIVE_REGULATION_OF_HETEROCHROMATIN_FORMATION,1
GOCC_GLYCOPROTEIN_IB_IX_V_CO...,SET,4,-0.51606,-0.0076126,0.50753,0.84537,GOCC_GLYCOPROTEIN_IB_IX_V_COMPLEX,1
WP_ROBO4_AND_VEGF_SIGNALING_...,SET,6,-0.40381,-0.0072952,0.39712,0.84538,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,1
GSE27786_CD8_TCELL_VS_MONO_M...1,SET,179,-0.063636,-0.0062497,0.062581,0.84538,GSE27786_CD8_TCELL_VS_MONO_MAC_DN,1
PID_TELOMERASE_PATHWAY,SET,64,-0.11213,-0.0066054,0.11023,0.84546,PID_TELOMERASE_PATHWAY,1
MODULE_93,SET,173,-0.067274,-0.0064964,0.066136,0.84547,MODULE_93,1
GOBP_POSITIVE_REGULATION_OF_...513,SET,21,-0.20793,-0.0070249,0.20437,0.84552,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
HP_CHILDHOOD_ONSET_SENSORINE...,SET,18,-0.21525,-0.0067332,0.21155,0.84554,HP_CHILDHOOD_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,1
RHODES_CANCER_META_SIGNATURE,SET,58,-0.10848,-0.0060843,0.10658,0.8456,RHODES_CANCER_META_SIGNATURE,1
GOMF_POLYUBIQUITIN_MODIFICAT...,SET,45,-0.11497,-0.0056823,0.11295,0.84563,GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
ZHONG_PFC_MAJOR_TYPES_NPCS,SET,126,-0.076862,-0.0063424,0.075502,0.84566,ZHONG_PFC_MAJOR_TYPES_NPCS,1
GSE41867_DAY6_VS_DAY15_LCMV_...1,SET,169,-0.065052,-0.0062094,0.063899,0.84567,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
HP_BOWING_OF_THE_LEGS,SET,217,-0.060933,-0.006582,0.05985,0.84568,HP_BOWING_OF_THE_LEGS,1
GOMF_OLIGOPEPTIDE_BINDING,SET,10,-0.2996,-0.0069867,0.2941,0.84582,GOMF_OLIGOPEPTIDE_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...256,SET,177,-0.068179,-0.0066587,0.066922,0.84584,GOBP_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,1
GOMF_INOSITOL_PHOSPHATE_KINA...,SET,11,-0.23186,-0.0056707,0.22758,0.84584,GOMF_INOSITOL_PHOSPHATE_KINASE_ACTIVITY,1
REACTOME_ELECTRIC_TRANSMISSI...,SET,4,-0.47789,-0.0070495,0.469,0.84588,REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS,1
GOBP_AMMONIUM_HOMEOSTASIS,SET,5,-0.48556,-0.0080079,0.47648,0.84591,GOBP_AMMONIUM_HOMEOSTASIS,1
HP_HAND_CLENCHING,SET,27,-0.1619,-0.006201,0.15886,0.84592,HP_HAND_CLENCHING,1
GSE22886_NAIVE_CD4_TCELL_VS_...17,SET,185,-0.059037,-0.0058934,0.05793,0.84592,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN,1
GOBP_MESENCHYMAL_STEM_CELL_D...,SET,11,-0.28786,-0.0070405,0.28245,0.84593,GOBP_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,1
GOBP_PROTEIN_CONTAINING_COMP...2,SET,231,-0.05449,-0.0060706,0.053465,0.84593,GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,1
HP_HANDGRIP_MYOTONIA,SET,6,-0.39638,-0.0071608,0.38889,0.84595,HP_HANDGRIP_MYOTONIA,1
SANA_TNF_SIGNALING_UP,SET,79,-0.10406,-0.0068077,0.10209,0.84596,SANA_TNF_SIGNALING_UP,1
FARMER_BREAST_CANCER_CLUSTER...7,SET,19,-0.19793,-0.0063607,0.19416,0.84598,FARMER_BREAST_CANCER_CLUSTER_7,1
HP_EEG_WITH_FRONTAL_FOCAL_SP...,SET,4,-0.5334,-0.0078684,0.523,0.8461,HP_EEG_WITH_FRONTAL_FOCAL_SPIKES,1
GSE20727_CTRL_VS_ROS_INHIBIT...2,SET,176,-0.063247,-0.0061597,0.062014,0.8461,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP,1
LHX3_01,SET,211,-0.065054,-0.0069304,0.063771,0.84616,LHX3_01,1
GOMF_S_ADENOSYL_L_METHIONINE...,SET,16,-0.21057,-0.0062103,0.20635,0.84623,GOMF_S_ADENOSYL_L_METHIONINE_BINDING,1
MIR7153_5P,SET,103,-0.085271,-0.0063657,0.083551,0.84627,MIR7153_5P,1
DING_LUNG_CANCER_MUTATED_REC...,SET,6,-0.3466,-0.0062616,0.33954,0.84632,DING_LUNG_CANCER_MUTATED_RECURRENTLY,1
GOCC_CLATHRIN_SCULPTED_MONOA...,SET,5,-0.40503,-0.0066797,0.39678,0.84632,GOCC_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE,1
GOCC_BCL_2_FAMILY_PROTEIN_CO...,SET,10,-0.30183,-0.0070387,0.29565,0.84634,GOCC_BCL_2_FAMILY_PROTEIN_COMPLEX,1
YIH_RESPONSE_TO_ARSENITE_C5,SET,10,-0.35138,-0.0081943,0.34416,0.84636,YIH_RESPONSE_TO_ARSENITE_C5,1
KIM_RESPONSE_TO_TSA_AND_DECI...2,SET,108,-0.08207,-0.0062729,0.080378,0.84638,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1
HP_ATROPHIC_SCARS,SET,33,-0.15718,-0.0066547,0.15392,0.84641,HP_ATROPHIC_SCARS,1
WP_HEREDITARY_LEIOMYOMATOSIS...,SET,18,-0.2002,-0.0062622,0.19604,0.84642,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,1
ODONNELL_METASTASIS_UP,SET,70,-0.11408,-0.0070274,0.1117,0.84644,ODONNELL_METASTASIS_UP,1
GOBP_IRON_ION_TRANSMEMBRANE_...,SET,18,-0.19763,-0.0061819,0.19349,0.84646,GOBP_IRON_ION_TRANSMEMBRANE_TRANSPORT,1
MIR12117,SET,84,-0.089806,-0.0060576,0.087916,0.84648,MIR12117,1
S8_01,SET,230,-0.062011,-0.0068936,0.060704,0.84649,S8_01,1
WP_AMPLIFICATION_AND_EXPANSI...,SET,17,-0.23645,-0.0071882,0.23144,0.84652,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,1
GOBP_DOPAMINERGIC_NEURON_AXO...,SET,6,-0.36549,-0.0066028,0.35765,0.84659,GOBP_DOPAMINERGIC_NEURON_AXON_GUIDANCE,1
DESCARTES_FETAL_MUSCLE_SCHWA...,SET,101,-0.097036,-0.0071738,0.094952,0.84659,DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS,1
HP_LOWER_LIMB_SPASTICITY,SET,189,-0.062191,-0.0062743,0.060851,0.84661,HP_LOWER_LIMB_SPASTICITY,1
MIR5583_5P,SET,93,-0.092715,-0.0065787,0.090707,0.84664,MIR5583_5P,1
GOBP_FIBROBLAST_APOPTOTIC_PR...,SET,24,-0.17782,-0.0064217,0.17396,0.84665,GOBP_FIBROBLAST_APOPTOTIC_PROCESS,1
MIR1199_5P,SET,72,-0.10249,-0.0064024,0.10026,0.84666,MIR1199_5P,1
MIR301B_3P,SET,351,-0.047078,-0.0064437,0.046054,0.84666,MIR301B_3P,1
MIR3128,SET,114,-0.081028,-0.0063619,0.079253,0.84669,MIR3128,1
MIR8053,SET,5,-0.26081,-0.0043012,0.25506,0.84673,MIR8053,1
GOBP_PROTEIN_METHYLATION,SET,40,-0.12833,-0.0059805,0.12545,0.84682,GOBP_PROTEIN_METHYLATION,1
HP_ABNORMAL_NASAL_MUCOSA_MOR...,SET,69,-0.10467,-0.0064016,0.10232,0.84684,HP_ABNORMAL_NASAL_MUCOSA_MORPHOLOGY,1
ZNF260_TARGET_GENES,SET,668,-0.034932,-0.0065376,0.034137,0.8469,ZNF260_TARGET_GENES,1
GOBP_SPHINGOLIPID_METABOLIC_...,SET,158,-0.073943,-0.0068266,0.072248,0.84695,GOBP_SPHINGOLIPID_METABOLIC_PROCESS,1
GOBP_LUNG_SACCULE_DEVELOPMENT,SET,10,-0.28825,-0.006722,0.28162,0.84696,GOBP_LUNG_SACCULE_DEVELOPMENT,1
GOCC_SYNAPTOBREVIN_2_SNAP_25...,SET,5,-0.29759,-0.0049079,0.29072,0.84698,GOCC_SYNAPTOBREVIN_2_SNAP_25_SYNTAXIN_1A_COMPLEX,1
MANNE_COVID19_NONICU_VS_HEAL...1,SET,179,-0.071732,-0.0070448,0.070053,0.84707,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1
GOBP_POSITIVE_REGULATION_OF_...291,SET,9,-0.31805,-0.0070366,0.31059,0.84708,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,1
GOBP_EPINEPHRINE_SECRETION,SET,7,-0.37325,-0.0072832,0.36442,0.84713,GOBP_EPINEPHRINE_SECRETION,1
GSE1432_CTRL_VS_IFNG_6H_MICR...1,SET,183,-0.067424,-0.0066945,0.065828,0.84713,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,1
GSE4748_CTRL_VS_LPS_AND_CYAN...1,SET,189,-0.065207,-0.0065785,0.063656,0.84716,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
GSE5099_UNSTIM_VS_MCSF_TREAT...1,SET,186,-0.062195,-0.0062252,0.060715,0.84716,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN,1
GSE4748_CTRL_VS_CYANOBACTERI...2,SET,181,-0.063739,-0.0062943,0.062201,0.84725,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP,1
CTTTGTA_MIR524,SET,397,-0.045169,-0.0065666,0.044073,0.84728,CTTTGTA_MIR524,1
GSE20715_WT_VS_TLR4_KO_24H_O...2,SET,179,-0.065803,-0.0064624,0.064198,0.84731,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP,1
CHEMELLO_SOLEUS_VS_EDL_MYOFI...1,SET,5,-0.4061,-0.0066975,0.39613,0.84735,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN,1
GOCC_SPINDLE_MIDZONE,SET,35,-0.14542,-0.00634,0.14185,0.84735,GOCC_SPINDLE_MIDZONE,1
JNK_DN.V1_UP,SET,161,-0.073033,-0.0068057,0.071222,0.84741,JNK_DN.V1_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...16,SET,14,-0.22922,-0.0063243,0.22351,0.84744,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_G_PROTEIN_COUPLED_RECEP...4,SET,9,-0.29535,-0.0065344,0.288,0.84744,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS,1
GSE19198_CTRL_VS_IL21_TREATE...5,SET,176,-0.067626,-0.0065861,0.065941,0.84744,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN,1
HOLLEMAN_PREDNISOLONE_RESIST...2,SET,16,-0.18575,-0.0054783,0.18111,0.84745,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP,1
BOYLAN_MULTIPLE_MYELOMA_PCA1...2,SET,98,-0.094718,-0.0068982,0.09233,0.84751,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1
GOBP_ERK5_CASCADE,SET,3,-0.48167,-0.0061535,0.46954,0.84751,GOBP_ERK5_CASCADE,1
CLIMENT_BREAST_CANCER_COPY_N...2,SET,23,-0.20087,-0.0071015,0.19572,0.84762,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,1
REACTOME_SEROTONIN_RECEPTORS,SET,11,-0.27862,-0.0068144,0.27145,0.84764,REACTOME_SEROTONIN_RECEPTORS,1
CHNG_MULTIPLE_MYELOMA_HYPERP...1,SET,28,-0.15377,-0.0059974,0.14979,0.84768,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,1
HP_REDUCED_SYSTOLIC_FUNCTION,SET,21,-0.20259,-0.0068443,0.19734,0.84769,HP_REDUCED_SYSTOLIC_FUNCTION,1
ZSCAN30_TARGET_GENES,SET,1381,-0.025093,-0.0066151,0.02444,0.84771,ZSCAN30_TARGET_GENES,1
GOBP_PROTEIN_EXIT_FROM_ENDOP...,SET,45,-0.11485,-0.0056762,0.11185,0.84774,GOBP_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
KEGG_PROSTATE_CANCER,SET,86,-0.095214,-0.006498,0.092717,0.84777,KEGG_PROSTATE_CANCER,1
GOBP_POSITIVE_REGULATION_OF_...794,SET,18,-0.22324,-0.0069832,0.21738,0.84777,GOBP_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,1
GSE557_WT_VS_I_AB_KO_DC_UP,SET,178,-0.062635,-0.0061343,0.060986,0.84779,GSE557_WT_VS_I_AB_KO_DC_UP,1
GOBP_ORGANIC_HYDROXY_COMPOUN...1,SET,225,-0.060728,-0.0066782,0.059113,0.84786,GOBP_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS,1
GSE369_SOCS3_KO_VS_IFNG_KO_L...1,SET,181,-0.066836,-0.0066002,0.065045,0.84791,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN,1
PEDERSEN_METASTASIS_BY_ERBB2...1,SET,44,-0.13356,-0.0065271,0.12995,0.84796,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,1
MORF_PTPRB,SET,222,-0.06062,-0.0066223,0.058973,0.848,MORF_PTPRB,1
GOBP_RESPONSE_TO_GLUCAGON,SET,21,-0.19665,-0.0066437,0.19124,0.84809,GOBP_RESPONSE_TO_GLUCAGON,1
GOBP_REGULATION_OF_COLLAGEN_...1,SET,8,-0.28369,-0.0059175,0.27585,0.84811,GOBP_REGULATION_OF_COLLAGEN_FIBRIL_ORGANIZATION,1
GOBP_G_PROTEIN_COUPLED_SEROT...,SET,22,-0.1943,-0.0067187,0.18893,0.84812,GOBP_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
PID_CIRCADIAN_PATHWAY,SET,13,-0.25415,-0.006757,0.24711,0.84813,PID_CIRCADIAN_PATHWAY,1
GSE17322_CD103_POS_VS_CD11B_...2,SET,176,-0.065894,-0.0064174,0.064049,0.84821,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP,1
GSE17721_LPS_VS_GARDIQUIMOD_...6,SET,186,-0.064289,-0.0064348,0.062476,0.84826,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP,1
GOBP_RRNA_BASE_METHYLATION,SET,6,-0.32939,-0.0059507,0.32007,0.84828,GOBP_RRNA_BASE_METHYLATION,1
WEBER_METHYLATED_ICP_IN_SPER...1,SET,8,-0.34008,-0.0070938,0.33043,0.8483,WEBER_METHYLATED_ICP_IN_SPERM_DN,1
GOBP_MESODERMAL_CELL_FATE_CO...,SET,17,-0.22078,-0.0067117,0.21447,0.84835,GOBP_MESODERMAL_CELL_FATE_COMMITMENT,1
GOBP_POSITIVE_REGULATION_OF_...438,SET,5,-0.44144,-0.0072802,0.4288,0.84837,GOBP_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
MIR4517,SET,189,-0.066395,-0.0066985,0.064491,0.84838,MIR4517,1
HP_MANDIBULAR_PROGNATHIA,SET,174,-0.065663,-0.0063589,0.063732,0.84856,HP_MANDIBULAR_PROGNATHIA,1
HP_RECURRENT_HAND_FLAPPING,SET,24,-0.17072,-0.0061654,0.16569,0.84858,HP_RECURRENT_HAND_FLAPPING,1
HP_BCGOSIS,SET,7,-0.39765,-0.0077593,0.38589,0.8486,HP_BCGOSIS,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...1,SET,5,-0.47707,-0.0078679,0.46294,0.84861,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY,1
HP_MIDDLE_AGE_ONSET,SET,220,-0.060184,-0.0065453,0.058402,0.84861,HP_MIDDLE_AGE_ONSET,1
HP_POSTAXIAL_POLYDACTYLY,SET,123,-0.07766,-0.006332,0.075357,0.84862,HP_POSTAXIAL_POLYDACTYLY,1
DUAN_PRDM5_TARGETS,SET,65,-0.11901,-0.0070649,0.11545,0.84867,DUAN_PRDM5_TARGETS,1
GOBP_MICROTUBULE_BUNDLE_FORM...,SET,99,-0.083509,-0.0061126,0.081015,0.84867,GOBP_MICROTUBULE_BUNDLE_FORMATION,1
MODULE_62,SET,67,-0.094198,-0.0056772,0.091369,0.84871,MODULE_62,1
GSE1791_CTRL_VS_NEUROMEDINU_...1,SET,162,-0.070793,-0.0066172,0.068649,0.84877,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN,1
GNF2_ATM,SET,25,-0.16337,-0.0060214,0.15842,0.84878,GNF2_ATM,1
GOBP_FOLIC_ACID_CONTAINING_C...2,SET,5,-0.34291,-0.0056553,0.3325,0.84879,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOBP_CELL_SUBSTRATE_ADHESION,SET,333,-0.050435,-0.0067272,0.048898,0.84882,GOBP_CELL_SUBSTRATE_ADHESION,1
MIR3686,SET,295,-0.05276,-0.0066306,0.051152,0.84883,MIR3686,1
GSE22611_NOD2_VS_CTRL_TRANSD...2,SET,174,-0.064724,-0.0062679,0.062742,0.84886,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,1
HP_DEFICIT_IN_PHONOLOGIC_SHO...,SET,5,-0.47922,-0.0079033,0.46448,0.84889,HP_DEFICIT_IN_PHONOLOGIC_SHORT_TERM_MEMORY,1
ZHAN_LATE_DIFFERENTIATION_GE...1,SET,14,-0.21298,-0.005876,0.20641,0.84891,ZHAN_LATE_DIFFERENTIATION_GENES_DN,1
chr2q31,SET,73,-0.19667,-0.01237,0.19059,0.84893,chr2q31,1
THUM_MIR21_TARGETS_HEART_DIS...1,SET,7,-0.41617,-0.0081206,0.40327,0.84895,THUM_MIR21_TARGETS_HEART_DISEASE_DN,1
HAY_BONE_MARROW_PRE_DENDRITIC,SET,5,-0.42713,-0.0070443,0.41389,0.84895,HAY_BONE_MARROW_PRE_DENDRITIC,1
JOHNSTONE_PARVB_TARGETS_3_UP,SET,385,-0.047246,-0.0067663,0.045782,0.84896,JOHNSTONE_PARVB_TARGETS_3_UP,1
HP_PATENT_DUCTUS_ARTERIOSUS,SET,334,-0.048649,-0.0064986,0.047137,0.84897,HP_PATENT_DUCTUS_ARTERIOSUS,1
GOBP_REGULATION_OF_NATURAL_K...2,SET,8,-0.35677,-0.0074419,0.34559,0.84904,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,1
GOBP_MODULATION_OF_EXCITATOR...,SET,46,-0.13553,-0.0067721,0.13127,0.84907,GOBP_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
HP_SACROCOCCYGEAL_TERATOMA,SET,5,-0.37758,-0.0062271,0.36553,0.84918,HP_SACROCOCCYGEAL_TERATOMA,1
GOBP_NATURAL_KILLER_CELL_DIF...,SET,24,-0.19124,-0.0069064,0.18507,0.84926,GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION,1
chr18q11,SET,27,-0.35612,-0.01364,0.3446,0.84929,chr18q11,1
HP_BROAD_THUMB,SET,75,-0.10399,-0.0066299,0.10061,0.84935,HP_BROAD_THUMB,1
HP_KYPHOSIS,SET,380,-0.045109,-0.006419,0.043635,0.84937,HP_KYPHOSIS,1
HP_PARIETAL_CORTICAL_ATROPHY,SET,8,-0.30432,-0.0063479,0.29437,0.84938,HP_PARIETAL_CORTICAL_ATROPHY,1
REACTOME_DECTIN_1_MEDIATED_N...,SET,59,-0.10633,-0.0060148,0.10284,0.8494,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,1
CRGAARNNNNCGA_UNKNOWN,SET,39,-0.14216,-0.0065417,0.1375,0.8494,CRGAARNNNNCGA_UNKNOWN,1
GSE5542_UNTREATED_VS_IFNG_TR...4,SET,171,-0.067292,-0.0064607,0.065085,0.8494,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
MIR373_3P,SET,295,-0.051298,-0.0064468,0.049609,0.84943,MIR373_3P,1
HP_DECREASED_CIRCULATING_IGG...2,SET,9,-0.28118,-0.0062208,0.27192,0.84944,HP_DECREASED_CIRCULATING_IGG_SUBCLASS_LEVEL,1
GOBP_REGULATION_OF_HEPATOCYT...1,SET,8,-0.28718,-0.0059905,0.27768,0.84948,GOBP_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,1
chr20p12,SET,39,-0.23405,-0.01077,0.22626,0.84952,chr20p12,1
GSE3203_HEALTHY_VS_INFLUENZA...1,SET,179,-0.067696,-0.0066483,0.065443,0.84952,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN,1
HP_COMPENSATED_HYPOTHYROIDISM,SET,9,-0.30573,-0.006764,0.29554,0.84953,HP_COMPENSATED_HYPOTHYROIDISM,1
HP_APLASIA_HYPOPLASIA_INVOLV...11,SET,98,-0.088501,-0.0064454,0.085549,0.84954,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_NOSE,1
GOMF_METAL_CATION_PROTON_ANT...,SET,23,-0.18548,-0.0065576,0.17928,0.84956,GOMF_METAL_CATION_PROTON_ANTIPORTER_ACTIVITY,1
HP_HEAT_INTOLERANCE,SET,19,-0.195,-0.0062667,0.18846,0.84959,HP_HEAT_INTOLERANCE,1
GSE22886_NAIVE_BCELL_VS_MONO...2,SET,161,-0.072516,-0.0067575,0.070072,0.84963,GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP,1
KEGG_MEDICUS_REFERENCE_TSC1_...,SET,11,-0.25986,-0.0063557,0.25107,0.84967,KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY,1
MIR622,SET,74,-0.10307,-0.006527,0.099563,0.84971,MIR622,1
HP_ABNORMALITY_OF_THE_VOICE,SET,386,-0.045766,-0.0065626,0.04421,0.84971,HP_ABNORMALITY_OF_THE_VOICE,1
GSE7219_WT_VS_NIK_NFKB2_KO_D...2,SET,175,-0.068726,-0.0066744,0.066359,0.84981,GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP,1
GOBP_RESPONSE_TO_PH,SET,38,-0.148,-0.0067228,0.1429,0.84982,GOBP_RESPONSE_TO_PH,1
BLANCO_MELO_COVID19_SARS_COV...12,SET,139,-0.079747,-0.0069092,0.076995,0.84983,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,1
DASU_IL6_SIGNALING_DN,SET,6,-0.39563,-0.0071474,0.38194,0.84985,DASU_IL6_SIGNALING_DN,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...3,SET,7,-0.34279,-0.0066887,0.3309,0.84987,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP,1
HP_THICKENED_EARS,SET,11,-0.28168,-0.0068892,0.27191,0.84987,HP_THICKENED_EARS,1
MIR29B_2_5P,SET,199,-0.06345,-0.0065667,0.061245,0.84989,MIR29B_2_5P,1
GOBP_NEGATIVE_REGULATION_OF_...498,SET,11,-0.28587,-0.0069918,0.27594,0.84989,GOBP_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION,1
GOBP_ORGANOPHOSPHATE_CATABOL...,SET,222,-0.05902,-0.0064474,0.056947,0.84999,GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS,1
KEGG_GLYCINE_SERINE_AND_THRE...,SET,27,-0.17183,-0.0065812,0.16578,0.85,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,1
HP_ABNORMAL_BLOOD_GAS_LEVEL,SET,44,-0.13973,-0.0068288,0.13482,0.85,HP_ABNORMAL_BLOOD_GAS_LEVEL,1
GSE15930_NAIVE_VS_24H_IN_VIT...2,SET,187,-0.065432,-0.0065667,0.063127,0.85001,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP,1
GSE36826_WT_VS_IL1R_KO_SKIN_...3,SET,179,-0.062323,-0.0061207,0.060117,0.85006,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP,1
PASTURAL_RIZ1_TARGETS_UP,SET,8,-0.27263,-0.0056869,0.26295,0.85009,PASTURAL_RIZ1_TARGETS_UP,1
ZNF597_TARGET_GENES,SET,607,-0.036814,-0.0065791,0.035479,0.85027,ZNF597_TARGET_GENES,1
HP_HYPOPLASTIC_NASAL_BRIDGE,SET,5,-0.36148,-0.0059616,0.34832,0.85031,HP_HYPOPLASTIC_NASAL_BRIDGE,1
MIR1197,SET,84,-0.094893,-0.0064007,0.091424,0.85034,MIR1197,1
LU_TUMOR_VASCULATURE_UP,SET,27,-0.18069,-0.0069208,0.17408,0.85036,LU_TUMOR_VASCULATURE_UP,1
GOBP_REGULATION_OF_STEM_CELL...2,SET,10,-0.29637,-0.0069114,0.28541,0.85045,GOBP_REGULATION_OF_STEM_CELL_DIVISION,1
WP_GABA_METABOLISM_AKA_GHB,SET,10,-0.31063,-0.0072439,0.29911,0.85047,WP_GABA_METABOLISM_AKA_GHB,1
HP_ABNORMAL_ALVEOLAR_RIDGE_M...,SET,38,-0.13843,-0.0062881,0.1333,0.85047,HP_ABNORMAL_ALVEOLAR_RIDGE_MORPHOLOGY,1
GSE17974_IL4_AND_ANTI_IL12_V...12,SET,158,-0.074529,-0.0068806,0.07176,0.85049,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...418,SET,8,-0.31215,-0.0065112,0.3005,0.85053,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
HP_CUTIS_MARMORATA,SET,60,-0.11905,-0.0067911,0.11459,0.85057,HP_CUTIS_MARMORATA,1
GOBP_DENTATE_GYRUS_DEVELOPME...,SET,23,-0.19401,-0.0068591,0.1867,0.85063,GOBP_DENTATE_GYRUS_DEVELOPMENT,1
ZNF660_TARGET_GENES,SET,598,-0.037194,-0.0065992,0.03579,0.85064,ZNF660_TARGET_GENES,1
GOCC_NUCLEAR_REPLICATION_FORK,SET,39,-0.13786,-0.0063441,0.13265,0.85066,GOCC_NUCLEAR_REPLICATION_FORK,1
BIOCARTA_PARKIN_PATHWAY,SET,7,-0.32982,-0.0064358,0.31729,0.85071,BIOCARTA_PARKIN_PATHWAY,1
ZHONG_RESPONSE_TO_AZACITIDIN...2,SET,150,-0.071812,-0.0064612,0.069071,0.85075,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1
GSE5589_UNSTIM_VS_180MIN_LPS...3,SET,182,-0.064949,-0.0064313,0.062469,0.85075,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN,1
BUCKANOVICH_T_LYMPHOCYTE_HOM...1,SET,19,-0.18045,-0.0057992,0.17355,0.85077,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,1
MEISSNER_NPC_HCP_WITH_H3K4ME...1,SET,330,-0.055159,-0.0073247,0.053023,0.85089,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,1
HP_AUTOIMMUNE_HEMOLYTIC_ANEM...,SET,39,-0.15245,-0.0070152,0.14654,0.85089,HP_AUTOIMMUNE_HEMOLYTIC_ANEMIA,1
REACTOME_GOLGI_TO_ER_RETROGR...,SET,129,-0.072138,-0.0060226,0.069341,0.8509,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,1
MIR4757_5P,SET,55,-0.12144,-0.0066336,0.11673,0.85091,MIR4757_5P,1
GOBP_NEGATIVE_REGULATION_OF_...149,SET,11,-0.2874,-0.0070293,0.27625,0.85091,GOBP_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM,1
GOCC_ASTROCYTE_PROJECTION,SET,21,-0.21604,-0.0072987,0.20761,0.85097,GOCC_ASTROCYTE_PROJECTION,1
GOBP_NEGATIVE_REGULATION_OF_...487,SET,53,-0.12061,-0.0064677,0.11589,0.851,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
MIKKELSEN_ES_ICP_WITH_H3K4ME...,SET,126,-0.0856,-0.0070634,0.082206,0.85112,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
HP_CENTROCECAL_SCOTOMA,SET,3,-0.45263,-0.0057826,0.43467,0.85113,HP_CENTROCECAL_SCOTOMA,1
GOBP_BLASTOCYST_DEVELOPMENT,SET,110,-0.083248,-0.0064212,0.079935,0.85116,GOBP_BLASTOCYST_DEVELOPMENT,1
GOCC_SEX_CHROMATIN,SET,4,-0.39556,-0.0058351,0.37972,0.85122,GOCC_SEX_CHROMATIN,1
GOCC_ALVEOLAR_LAMELLAR_BODY,SET,8,-0.32187,-0.0067139,0.30897,0.85123,GOCC_ALVEOLAR_LAMELLAR_BODY,1
HP_SHORT_FACE,SET,17,-0.23158,-0.0070401,0.2223,0.85123,HP_SHORT_FACE,1
HP_RENAL_AMYLOIDOSIS,SET,11,-0.2723,-0.00666,0.26136,0.85125,HP_RENAL_AMYLOIDOSIS,1
GOBP_RESPONSE_TO_AMPHETAMINE,SET,34,-0.16743,-0.0071946,0.16068,0.85128,GOBP_RESPONSE_TO_AMPHETAMINE,1
MIR3929,SET,73,-0.10563,-0.0066441,0.10135,0.85134,MIR3929,1
HP_WOLFF_PARKINSON_WHITE_SYN...,SET,15,-0.21558,-0.0061565,0.20684,0.85136,HP_WOLFF_PARKINSON_WHITE_SYNDROME,1
GOBP_UTERINE_SMOOTH_MUSCLE_C...,SET,10,-0.27622,-0.0064414,0.26488,0.85147,GOBP_UTERINE_SMOOTH_MUSCLE_CONTRACTION,1
GAUTAM_EYE_CORNEA_CYTOTOXIC_...,SET,124,-0.078276,-0.0064079,0.075063,0.85147,GAUTAM_EYE_CORNEA_CYTOTOXIC_T_CELLS,1
HP_RECURRENT_BACTERIAL_SKIN_...,SET,23,-0.1894,-0.0066961,0.1816,0.8515,HP_RECURRENT_BACTERIAL_SKIN_INFECTIONS,1
GOBP_RUFFLE_ASSEMBLY,SET,42,-0.14436,-0.0068934,0.1384,0.85154,GOBP_RUFFLE_ASSEMBLY,1
GOBP_REGULATION_OF_STRESS_GR...,SET,11,-0.20731,-0.0050705,0.19873,0.85156,GOBP_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,1
GOMF_S_ADENOSYLMETHIONINE_DE...,SET,133,-0.073262,-0.0062098,0.070194,0.85168,GOMF_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY,1
MIR3663_3P,SET,134,-0.075099,-0.0063892,0.071953,0.85169,MIR3663_3P,1
KEGG_MEDICUS_REFERENCE_FGF_F...2,SET,33,-0.16658,-0.0070526,0.15957,0.85174,KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_PURINE_DEOXYRIBONUCLEOS...3,SET,11,-0.27692,-0.0067727,0.26522,0.85177,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
HUANG_GATA2_TARGETS_UP,SET,141,-0.077659,-0.0067761,0.074377,0.85178,HUANG_GATA2_TARGETS_UP,1
REACTOME_RUNX3_REGULATES_BCL...,SET,5,-0.44233,-0.007295,0.42361,0.8518,REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION,1
HP_ABNORMALITY_OF_THE_BILIAR...,SET,355,-0.048126,-0.0066238,0.046089,0.8518,HP_ABNORMALITY_OF_THE_BILIARY_SYSTEM,1
MIR629_5P,SET,102,-0.093164,-0.0069214,0.089204,0.85184,MIR629_5P,1
HP_ABNORMAL_PATTERN_OF_RESPI...,SET,677,-0.035377,-0.0066637,0.033873,0.85184,HP_ABNORMAL_PATTERN_OF_RESPIRATION,1
ANDERSON_BLOOD_CN54GP140_ADJ...1,SET,77,-0.092889,-0.006,0.088942,0.85184,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN,1
BOYAULT_LIVER_CANCER_SUBCLAS...15,SET,19,-0.21385,-0.0068725,0.20475,0.85185,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,1
MIR1910_3P,SET,165,-0.071044,-0.0067014,0.068013,0.85188,MIR1910_3P,1
HP_DIMINISHED_ABILITY_TO_CON...,SET,9,-0.27321,-0.0060445,0.26155,0.85189,HP_DIMINISHED_ABILITY_TO_CONCENTRATE,1
MODULE_190,SET,8,-0.39986,-0.0083408,0.38277,0.8519,MODULE_190,1
CAIRO_HEPATOBLASTOMA_DN,SET,243,-0.060897,-0.006956,0.058281,0.85195,CAIRO_HEPATOBLASTOMA_DN,1
BURTON_ADIPOGENESIS_7,SET,41,-0.15012,-0.0070827,0.14364,0.85202,BURTON_ADIPOGENESIS_7,1
KEGG_MEDICUS_VARIANT_DUPLICA...2,SET,13,-0.24127,-0.0064146,0.23083,0.85203,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY,1
AP4_01,SET,235,-0.060723,-0.0068225,0.058093,0.85205,AP4_01,1
GOMF_CARBON_NITROGEN_LIGASE_...,SET,10,-0.26002,-0.0060637,0.24874,0.85206,GOMF_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR,1
HP_PROGRESSIVE_FLEXION_CONTR...,SET,6,-0.42934,-0.0077563,0.41073,0.85206,HP_PROGRESSIVE_FLEXION_CONTRACTURES,1
GOBP_NEGATIVE_REGULATION_OF_...85,SET,13,-0.2675,-0.0071119,0.25588,0.85207,GOBP_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,1
HP_AGYRIA,SET,15,-0.2006,-0.0057287,0.1919,0.85207,HP_AGYRIA,1
MIR1267,SET,70,-0.10341,-0.0063696,0.09887,0.85218,MIR1267,1
HP_HYPERACTIVE_DEEP_TENDON_R...,SET,22,-0.18856,-0.0065201,0.18028,0.8522,HP_HYPERACTIVE_DEEP_TENDON_REFLEXES,1
GAVISH_3CA_METAPROGRAM_EPITH...4,SET,35,-0.14546,-0.0063419,0.13905,0.85224,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CILIA,1
GSE37336_LY6C_POS_VS_NEG_NAI...2,SET,132,-0.080852,-0.0068275,0.077265,0.85231,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP,1
GOBP_REGULATION_OF_MONOATOMI...2,SET,13,-0.2517,-0.0066919,0.24048,0.85236,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSPORT,1
TRAVAGLINI_LUNG_CAPILLARY_CE...,SET,14,-0.26472,-0.0073036,0.25284,0.85244,TRAVAGLINI_LUNG_CAPILLARY_CELL,1
LET_7E_3P,SET,4,-0.49077,-0.0072396,0.46857,0.85253,LET_7E_3P,1
HP_APLASIA_HYPOPLASIA_OF_THE...23,SET,6,-0.42712,-0.0077163,0.40778,0.85254,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,1
GSE5589_IL6_KO_VS_IL10_KO_LP...7,SET,184,-0.066846,-0.006655,0.063814,0.85256,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,1
DER_IFN_GAMMA_RESPONSE_DN,SET,10,-0.31107,-0.0072542,0.29693,0.85258,DER_IFN_GAMMA_RESPONSE_DN,1
GSE7831_1H_VS_4H_INFLUENZA_S...1,SET,186,-0.066942,-0.0067003,0.063895,0.8526,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...3,SET,431,-0.044576,-0.0067459,0.042538,0.85266,FAN_EMBRYONIC_CTX_BIG_GROUPS_CAJAL_RETZIUS,1
REACTOME_AEROBIC_RESPIRATION...,SET,209,-0.057574,-0.0061047,0.054917,0.85276,REACTOME_AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1
REACTOME_PASSIVE_TRANSPORT_B...,SET,12,-0.31569,-0.0080643,0.3011,0.85278,REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS,1
MIR6879_3P,SET,41,-0.14493,-0.0068377,0.1382,0.85283,MIR6879_3P,1
ZNF22_TARGET_GENES,SET,819,-0.030914,-0.0063789,0.029476,0.85285,ZNF22_TARGET_GENES,1
HP_NEMALINE_BODIES,SET,19,-0.20243,-0.0065056,0.19302,0.85285,HP_NEMALINE_BODIES,1
GOMF_DEHYDROASCORBIC_ACID_TR...,SET,6,-0.33939,-0.0061313,0.32355,0.85289,GOMF_DEHYDROASCORBIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_RHO_GTPASES_ACTIVAT...5,SET,21,-0.20996,-0.0070931,0.2001,0.85296,REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES,1
GOBP_NEGATIVE_REGULATION_OF_...612,SET,27,-0.18591,-0.0071205,0.17718,0.85296,GOBP_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
HP_MICROCORNEA,SET,111,-0.085673,-0.006638,0.081651,0.85296,HP_MICROCORNEA,1
HP_DECREASED_CD4_CD8_RATIO,SET,8,-0.31283,-0.0065254,0.29808,0.85301,HP_DECREASED_CD4_CD8_RATIO,1
GSE25123_CTRL_VS_IL4_STIM_PP...2,SET,179,-0.064674,-0.0063516,0.061623,0.85302,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...708,SET,69,-0.11184,-0.0068399,0.10656,0.85303,GOBP_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
GSE24972_WT_VS_IRF8_KO_SPLEE...2,SET,180,-0.068554,-0.0067513,0.065319,0.85303,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP,1
HP_SICK_SINUS_SYNDROME,SET,27,-0.18377,-0.0070387,0.17509,0.85304,HP_SICK_SINUS_SYNDROME,1
GOBP_CELLULAR_LIPID_METABOLI...,SET,924,-0.030871,-0.0067458,0.029405,0.8531,GOBP_CELLULAR_LIPID_METABOLIC_PROCESS,1
REACTOME_SUMO_IS_TRANSFERRED...,SET,7,-0.32591,-0.0063593,0.31042,0.85311,REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9,1
DESCARTES_MAIN_FETAL_PARIETA...,SET,93,-0.091061,-0.0064613,0.086725,0.85313,DESCARTES_MAIN_FETAL_PARIETAL_AND_CHIEF_CELLS,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...3,SET,117,-0.086066,-0.0068452,0.081965,0.85314,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN,1
GOBP_CELL_MIGRATION_INVOLVED...3,SET,6,-0.45351,-0.0081931,0.43186,0.85317,GOBP_CELL_MIGRATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
MIR6816_3P,SET,31,-0.14488,-0.0059452,0.13794,0.85321,MIR6816_3P,1
GOBP_VESICLE_TRANSPORT_ALONG...2,SET,43,-0.13396,-0.0064723,0.12752,0.85325,GOBP_VESICLE_TRANSPORT_ALONG_MICROTUBULE,1
MIR7160_3P,SET,27,-0.17536,-0.0067166,0.16682,0.8534,MIR7160_3P,1
GOBP_LYMPHOCYTE_MIGRATION_IN...,SET,9,-0.33163,-0.0073371,0.31547,0.85342,GOBP_LYMPHOCYTE_MIGRATION_INTO_LYMPHOID_ORGANS,1
GSE9960_GRAM_NEG_VS_GRAM_POS...1,SET,179,-0.06506,-0.0063894,0.061889,0.85342,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN,1
MIR6742_5P,SET,40,-0.1375,-0.0064079,0.13076,0.85349,MIR6742_5P,1
WP_NEURODEGENERATION_WITH_BR...,SET,41,-0.1364,-0.0064353,0.12971,0.8535,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,1
GOBP_NEURONAL_ACTION_POTENTI...2,SET,10,-0.2891,-0.0067418,0.27489,0.85352,GOBP_NEURONAL_ACTION_POTENTIAL_PROPAGATION,1
HP_BONE_PAIN,SET,82,-0.10518,-0.0070098,0.10001,0.85353,HP_BONE_PAIN,1
HP_INTESTINAL_MALROTATION,SET,126,-0.081486,-0.0067239,0.077477,0.85353,HP_INTESTINAL_MALROTATION,1
HP_LARGE_FOREHEAD,SET,21,-0.20271,-0.0068483,0.19273,0.85354,HP_LARGE_FOREHEAD,1
HP_PHOTORECEPTOR_LAYER_LOSS_...,SET,5,-0.40104,-0.0066141,0.38131,0.85354,HP_PHOTORECEPTOR_LAYER_LOSS_ON_MACULAR_OCT,1
RELA_DN.V1_DN,SET,119,-0.087966,-0.0070555,0.083628,0.85357,RELA_DN.V1_DN,1
HP_SHORT_STERNUM,SET,10,-0.29813,-0.0069523,0.28338,0.8536,HP_SHORT_STERNUM,1
HOEK_MYELOID_DENDRITIC_CELL_...6,SET,20,-0.22734,-0.0074956,0.21608,0.85362,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_UP,1
GAUTAM_EYE_CHOROID_SCLERA_AC...,SET,104,-0.085635,-0.0064237,0.081393,0.85362,GAUTAM_EYE_CHOROID_SCLERA_ACTIVATED_T_CELLS,1
KORKOLA_TERATOMA_UP,SET,13,-0.28498,-0.0075767,0.27079,0.85368,KORKOLA_TERATOMA_UP,1
GSE41867_NAIVE_VS_DAY15_LCMV...4,SET,145,-0.076459,-0.0067646,0.072638,0.85373,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP,1
UNTERMAN_PROGRESSIVE_VS_STAB...6,SET,8,-0.36002,-0.0075098,0.342,0.85375,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...11,SET,13,-0.24364,-0.0064778,0.23134,0.85386,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE17721_LPS_VS_CPG_12H_BMDC...1,SET,177,-0.068184,-0.0066592,0.064743,0.85386,GSE17721_LPS_VS_CPG_12H_BMDC_DN,1
WP_PHOSPHATIDYL_INOSITOL_PHO...,SET,40,-0.13799,-0.0064307,0.13101,0.85389,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,1
GOBP_STEM_CELL_FATE_SPECIFIC...,SET,6,-0.44496,-0.0080385,0.42242,0.8539,GOBP_STEM_CELL_FATE_SPECIFICATION,1
GSE3982_CTRL_VS_LPS_1H_NEUTR...2,SET,170,-0.067446,-0.0064568,0.064028,0.85391,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP,1
GOBP_POSITIVE_REGULATION_OF_...539,SET,127,-0.080673,-0.0066831,0.076577,0.85393,GOBP_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,1
KEGG_ADIPOCYTOKINE_SIGNALING...,SET,63,-0.1164,-0.0068037,0.11048,0.85396,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1
HP_WIDE_CRANIAL_SUTURES,SET,27,-0.16958,-0.006495,0.16095,0.85396,HP_WIDE_CRANIAL_SUTURES,1
GOBP_SYNOVIOCYTE_PROLIFERATI...,SET,2,-0.62242,-0.0064927,0.59072,0.85397,GOBP_SYNOVIOCYTE_PROLIFERATION,1
GSE9006_HEALTHY_VS_TYPE_2_DI...2,SET,176,-0.063386,-0.0061732,0.060155,0.85398,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,1
GOCC_APICAL_PART_OF_CELL,SET,434,-0.045875,-0.006966,0.043531,0.85402,GOCC_APICAL_PART_OF_CELL,1
GOBP_CRANIAL_SKELETAL_SYSTEM...,SET,67,-0.11957,-0.0072067,0.11345,0.85405,GOBP_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT,1
ANDERSON_BLOOD_CN54GP140_ADJ...6,SET,31,-0.16242,-0.006665,0.1541,0.85405,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_UP,1
GSE13411_NAIVE_VS_SWITCHED_M...1,SET,178,-0.0668,-0.0065422,0.063376,0.85406,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN,1
REACTOME_RHOBTB_GTPASE_CYCLE,SET,34,-0.1431,-0.0061493,0.13572,0.85413,REACTOME_RHOBTB_GTPASE_CYCLE,1
GOMF_AMINO_ACID_TRANSMEMBRAN...,SET,91,-0.10085,-0.0070789,0.095644,0.85415,GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMALITY_OF_SKULL_OSSI...,SET,46,-0.13124,-0.006558,0.12446,0.85416,HP_ABNORMALITY_OF_SKULL_OSSIFICATION,1
GOBP_PROTEIN_IMPORT_INTO_PER...1,SET,13,-0.23283,-0.0061901,0.22078,0.85418,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX,1
WP_NPHP1_DELETION_SYNDROME,SET,10,-0.31535,-0.007354,0.29897,0.85423,WP_NPHP1_DELETION_SYNDROME,1
GSE10325_LUPUS_BCELL_VS_LUPU...1,SET,188,-0.069762,-0.0070197,0.066137,0.85424,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN,1
VALK_AML_CLUSTER_10,SET,28,-0.18323,-0.0071466,0.1737,0.85425,VALK_AML_CLUSTER_10,1
GSE17721_PAM3CSK4_VS_CPG_2H_...1,SET,181,-0.064757,-0.0063949,0.061382,0.85428,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN,1
GSE3920_UNTREATED_VS_IFNA_TR...3,SET,179,-0.065379,-0.0064208,0.061966,0.8543,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN,1
NFY_01,SET,230,-0.061782,-0.0068682,0.058542,0.85436,NFY_01,1
GOBP_ASTROCYTE_DIFFERENTIATI...,SET,79,-0.10817,-0.0070767,0.1025,0.85436,GOBP_ASTROCYTE_DIFFERENTIATION,1
BASSO_HAIRY_CELL_LEUKEMIA_DN,SET,4,-0.48546,-0.0071613,0.45979,0.85447,BASSO_HAIRY_CELL_LEUKEMIA_DN,1
GOMF_G_RICH_STRAND_TELOMERIC...,SET,10,-0.26798,-0.0062493,0.25379,0.85449,GOMF_G_RICH_STRAND_TELOMERIC_DNA_BINDING,1
HP_ALLERGY,SET,35,-0.1571,-0.0068495,0.14872,0.85459,HP_ALLERGY,1
GOBP_MUSCULAR_SEPTUM_MORPHOG...,SET,5,-0.49949,-0.0082377,0.47273,0.85465,GOBP_MUSCULAR_SEPTUM_MORPHOGENESIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...28,SET,43,-0.12465,-0.0060222,0.11795,0.85468,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GOBP_POSITIVE_REGULATION_OF_...791,SET,7,-0.33877,-0.0066104,0.32053,0.85472,GOBP_POSITIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,1
KEGG_ENDOMETRIAL_CANCER,SET,50,-0.13027,-0.0067856,0.12324,0.85474,KEGG_ENDOMETRIAL_CANCER,1
IL21_UP.V1_DN,SET,157,-0.076349,-0.0070266,0.072226,0.85476,IL21_UP.V1_DN,1
GSE21670_IL6_VS_TGFB_AND_IL6...1,SET,188,-0.065615,-0.0066024,0.062062,0.85479,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,1
HP_MALFORMATION_OF_THE_HEPAT...,SET,8,-0.27084,-0.0056495,0.25612,0.85485,HP_MALFORMATION_OF_THE_HEPATIC_DUCTAL_PLATE,1
HALLMARK_OXIDATIVE_PHOSPHORY...,SET,169,-0.065826,-0.0062833,0.062238,0.85488,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1
LAKE_ADULT_KIDNEY_C30_IMMUNE...,SET,9,-0.32958,-0.0072917,0.3116,0.8549,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,1
GOBP_REGULATION_OF_OSTEOCLAS...1,SET,11,-0.29514,-0.0072184,0.27901,0.85492,GOBP_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,1
GOBP_REGULATION_OF_MUSCLE_SY...,SET,215,-0.065095,-0.0069994,0.061532,0.85494,GOBP_REGULATION_OF_MUSCLE_SYSTEM_PROCESS,1
PID_HIF2PATHWAY,SET,30,-0.16213,-0.0065451,0.15321,0.85501,PID_HIF2PATHWAY,1
HP_LOW_SET_EARS,SET,768,-0.03303,-0.0066096,0.031212,0.85503,HP_LOW_SET_EARS,1
GOBP_NEGATIVE_REGULATION_OF_...409,SET,7,-0.37509,-0.0073189,0.35439,0.85506,GOBP_NEGATIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
GOBP_REGULATION_OF_MITOCHOND...5,SET,27,-0.18194,-0.0069687,0.17189,0.85507,GOBP_REGULATION_OF_MITOCHONDRIAL_FISSION,1
GOBP_MAINTENANCE_OF_LENS_TRA...,SET,7,-0.41068,-0.0080136,0.38799,0.85508,GOBP_MAINTENANCE_OF_LENS_TRANSPARENCY,1
HP_APLASIA_HYPOPLASIA_OF_THE...50,SET,85,-0.096822,-0.0065694,0.091472,0.85508,HP_APLASIA_HYPOPLASIA_OF_THE_OVARY,1
HP_BABINSKI_SIGN,SET,255,-0.055642,-0.0065087,0.052564,0.85509,HP_BABINSKI_SIGN,1
KEGG_MEDICUS_REFERENCE_EGF_E...1,SET,21,-0.18974,-0.0064103,0.17924,0.8551,KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY,1
GOBP_POLYOL_METABOLIC_PROCESS,SET,95,-0.093829,-0.0067286,0.088636,0.8551,GOBP_POLYOL_METABOLIC_PROCESS,1
ZSCAN23_TARGET_GENES,SET,63,-0.11493,-0.0067175,0.10853,0.85518,ZSCAN23_TARGET_GENES,1
WP_TRYPTOPHAN_METABOLISM,SET,29,-0.18345,-0.0072814,0.17319,0.85524,WP_TRYPTOPHAN_METABOLISM,1
TGCACTT_MIR519C_MIR519B_MIR5...,SET,409,-0.04529,-0.0066808,0.042745,0.85532,TGCACTT_MIR519C_MIR519B_MIR519A,1
GOBP_NEGATIVE_REGULATION_OF_...437,SET,11,-0.29553,-0.007228,0.27891,0.85533,GOBP_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
PID_LKB1_PATHWAY,SET,45,-0.13734,-0.0067877,0.12961,0.85534,PID_LKB1_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...8,SET,10,-0.31213,-0.0072788,0.29453,0.85536,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,1
GOBP_REGULATION_OF_RESPONSE_...11,SET,1249,-0.026469,-0.0066617,0.024977,0.85536,GOBP_REGULATION_OF_RESPONSE_TO_STRESS,1
GOBP_EMBRYONIC_BODY_MORPHOGE...,SET,10,-0.25026,-0.0058361,0.23612,0.8554,GOBP_EMBRYONIC_BODY_MORPHOGENESIS,1
WP_OSTEOBLAST_SIGNALING,SET,13,-0.28186,-0.0074937,0.26584,0.85547,WP_OSTEOBLAST_SIGNALING,1
HP_APLASIA_HYPOPLASIA_OF_THE...15,SET,459,-0.04142,-0.0064637,0.039059,0.85553,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLUM,1
HESS_TARGETS_OF_HOXA9_AND_ME...2,SET,67,-0.11272,-0.0067934,0.10626,0.85559,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1
HP_RECURRENT_INFECTION_OF_TH...,SET,35,-0.1491,-0.0065005,0.14056,0.85559,HP_RECURRENT_INFECTION_OF_THE_GASTROINTESTINAL_TRACT,1
GOBP_STOMACH_DEVELOPMENT,SET,5,-0.44544,-0.0073462,0.41987,0.85562,GOBP_STOMACH_DEVELOPMENT,1
REACTOME_SIGNALING_BY_NOTCH1...1,SET,14,-0.24788,-0.0068389,0.2336,0.85567,REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER,1
chr11p14,SET,21,-0.33134,-0.011194,0.31223,0.85569,chr11p14,1
HP_GONADOTROPIN_DEFICIENCY,SET,8,-0.3569,-0.0074447,0.33632,0.85569,HP_GONADOTROPIN_DEFICIENCY,1
HP_POSTTERM_PREGNANCY,SET,5,-0.49668,-0.0081912,0.46802,0.8557,HP_POSTTERM_PREGNANCY,1
MODULE_69,SET,480,-0.040832,-0.0065122,0.038469,0.85575,MODULE_69,1
KEGG_MEDICUS_VARIANT_MET_OVE...,SET,13,-0.24493,-0.0065119,0.23068,0.85582,KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOMF_DNA_ENDONUCLEASE_ACTIVI...1,SET,38,-0.13937,-0.0063308,0.13126,0.85583,GOMF_DNA_ENDONUCLEASE_ACTIVITY,1
GOMF_LONG_CHAIN_FATTY_ACID_T...,SET,15,-0.22683,-0.0064777,0.21363,0.85583,GOMF_LONG_CHAIN_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_TRP_CHANNELS,SET,27,-0.19169,-0.0073421,0.18051,0.85586,REACTOME_TRP_CHANNELS,1
NIKOLSKY_BREAST_CANCER_5P15_...,SET,25,-0.32914,-0.012131,0.30992,0.85588,NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,1
GOMF_DINUCLEOTIDE_PHOSPHATAS...,SET,7,-0.34011,-0.0066364,0.32023,0.85589,GOMF_DINUCLEOTIDE_PHOSPHATASE_ACTIVITY,1
GSE2706_UNSTIM_VS_2H_R848_DC...2,SET,172,-0.064987,-0.0062575,0.06119,0.85589,GSE2706_UNSTIM_VS_2H_R848_DC_UP,1
MIR302D_5P,SET,183,-0.067857,-0.0067375,0.06388,0.85593,MIR302D_5P,1
HP_TOXEMIA_OF_PREGNANCY,SET,24,-0.20036,-0.0072358,0.1886,0.85595,HP_TOXEMIA_OF_PREGNANCY,1
GOBP_AMP_METABOLIC_PROCESS,SET,20,-0.20617,-0.0067976,0.19405,0.85597,GOBP_AMP_METABOLIC_PROCESS,1
FAN_OVARY_CL1_GPRC5A_TNFRS12...,SET,343,-0.048263,-0.0065317,0.045417,0.85602,FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL,1
WP_NAD_METABOLISM,SET,15,-0.23034,-0.006578,0.21675,0.85603,WP_NAD_METABOLISM,1
GOBP_KETONE_BODY_METABOLIC_P...,SET,10,-0.30681,-0.0071548,0.2887,0.85603,GOBP_KETONE_BODY_METABOLIC_PROCESS,1
GOMF_RAGE_RECEPTOR_BINDING,SET,10,-0.3212,-0.0074904,0.30213,0.85613,GOMF_RAGE_RECEPTOR_BINDING,1
GOBP_ESTABLISHMENT_OF_MEIOTI...,SET,6,-0.41619,-0.0075187,0.39136,0.8562,GOBP_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION,1
GOMF_CYTOSKELETAL_PROTEIN_BI...,SET,910,-0.030765,-0.0066742,0.028924,0.85625,GOMF_CYTOSKELETAL_PROTEIN_BINDING,1
HP_INFLEXIBLE_ADHERENCE_TO_R...,SET,2,-0.71695,-0.0074787,0.6738,0.85634,HP_INFLEXIBLE_ADHERENCE_TO_ROUTINES,1
GSE21063_WT_VS_NFATC1_KO_BCE...2,SET,186,-0.066215,-0.0066276,0.062229,0.85634,GSE21063_WT_VS_NFATC1_KO_BCELL_UP,1
PID_TCR_JNK_PATHWAY,SET,14,-0.25317,-0.0069848,0.23789,0.85638,PID_TCR_JNK_PATHWAY,1
PRMT5_TARGET_GENES,SET,64,-0.11092,-0.0065339,0.10422,0.85638,PRMT5_TARGET_GENES,1
GOBP_REGULATION_OF_BLOOD_CIR...,SET,240,-0.064049,-0.0072713,0.060181,0.85639,GOBP_REGULATION_OF_BLOOD_CIRCULATION,1
GOBP_PHOSPHATE_ION_TRANSPORT,SET,27,-0.1951,-0.0074728,0.1833,0.85641,GOBP_PHOSPHATE_ION_TRANSPORT,1
WAMUNYOKOLI_OVARIAN_CANCER_G...2,SET,125,-0.085142,-0.0069979,0.079986,0.85643,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,1
DESCARTES_MAIN_FETAL_SYNCYTI...,SET,64,-0.12066,-0.007108,0.11335,0.85644,DESCARTES_MAIN_FETAL_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,1
HP_SPASTIC_PARAPARESIS,SET,49,-0.12383,-0.0063853,0.11631,0.85647,HP_SPASTIC_PARAPARESIS,1
GOBP_POSITIVE_REGULATION_OF_...725,SET,44,-0.14018,-0.0068506,0.13165,0.85649,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,1
GSE16385_IL4_VS_ROSIGLITAZON...2,SET,174,-0.065973,-0.0063889,0.061959,0.8565,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
SNIP1_TARGET_GENES,SET,593,-0.03746,-0.0066196,0.035178,0.85653,SNIP1_TARGET_GENES,1
GOMF_CUPRIC_ION_BINDING,SET,5,-0.40889,-0.0067435,0.38398,0.85653,GOMF_CUPRIC_ION_BINDING,1
GAVISH_3CA_MALIGNANT_METAPRO...5,SET,46,-0.14245,-0.0071179,0.13376,0.85655,GAVISH_3CA_MALIGNANT_METAPROGRAM_14_EMT_3,1
KEGG_MEDICUS_VARIANT_MUTATIO...75,SET,11,-0.27081,-0.0066235,0.25427,0.85657,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
HP_IRIS_TRANSILLUMINATION_DE...,SET,12,-0.29439,-0.00752,0.2764,0.85657,HP_IRIS_TRANSILLUMINATION_DEFECT,1
KEGG_MEDICUS_REFERENCE_CHRNA...,SET,6,-0.33794,-0.006105,0.31726,0.85659,KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY,1
GOBP_LOCOMOTION_INVOLVED_IN_...,SET,11,-0.28386,-0.0069427,0.26649,0.8566,GOBP_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,1
GOBP_FOAM_CELL_DIFFERENTIATI...,SET,37,-0.15995,-0.0071698,0.15016,0.85661,GOBP_FOAM_CELL_DIFFERENTIATION,1
MIR381_5P,SET,7,-0.32948,-0.0064291,0.30927,0.85664,MIR381_5P,1
GOCC_DNA_RECOMBINASE_MEDIATO...,SET,7,-0.32794,-0.0063989,0.30776,0.85668,GOCC_DNA_RECOMBINASE_MEDIATOR_COMPLEX,1
WALLACE_PROSTATE_CANCER_UP,SET,18,-0.22401,-0.0070072,0.21022,0.85669,WALLACE_PROSTATE_CANCER_UP,1
HP_ABNORMAL_CIRCULATING_ALPH...,SET,30,-0.17914,-0.007232,0.16804,0.85679,HP_ABNORMAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,1
HP_UNUSUAL_SKIN_INFECTION,SET,7,-0.30851,-0.0060199,0.28929,0.85688,HP_UNUSUAL_SKIN_INFECTION,1
chr5q14,SET,46,-0.22256,-0.011121,0.20867,0.8569,chr5q14,1
GSE25087_FETAL_VS_ADULT_TCON...1,SET,155,-0.070181,-0.006418,0.0658,0.85691,GSE25087_FETAL_VS_ADULT_TCONV_DN,1
GOBP_SUBSTRATE_ADHESION_DEPE...,SET,97,-0.094083,-0.0068171,0.088198,0.85694,GOBP_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
GOBP_CELL_PROLIFERATION_IN_F...,SET,25,-0.19348,-0.007131,0.18134,0.85698,GOBP_CELL_PROLIFERATION_IN_FOREBRAIN,1
HP_PROGRESSIVE_ENCEPHALOPATHY,SET,10,-0.26532,-0.0061873,0.24867,0.85699,HP_PROGRESSIVE_ENCEPHALOPATHY,1
MIR372_3P,SET,304,-0.052366,-0.0066791,0.049077,0.85701,MIR372_3P,1
GOCC_CHOLINERGIC_SYNAPSE,SET,10,-0.33402,-0.0077893,0.31301,0.85703,GOCC_CHOLINERGIC_SYNAPSE,1
HP_RECURRENT_UPPER_AND_LOWER...,SET,14,-0.26634,-0.0073483,0.24956,0.85706,HP_RECURRENT_UPPER_AND_LOWER_RESPIRATORY_TRACT_INFECTIONS,1
GSE17721_POLYIC_VS_GARDIQUIM...12,SET,177,-0.067847,-0.0066262,0.063554,0.85713,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP,1
JI_METASTASIS_REPRESSED_BY_S...,SET,24,-0.21397,-0.0077274,0.20043,0.85714,JI_METASTASIS_REPRESSED_BY_STK11,1
GOCC_TRANS_GOLGI_NETWORK_TRA...1,SET,35,-0.1522,-0.0066355,0.14254,0.85718,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE,1
LIU_IL13_MEMORY_MODEL_UP,SET,17,-0.21893,-0.0066555,0.20503,0.85719,LIU_IL13_MEMORY_MODEL_UP,1
GSE18791_UNSTIM_VS_NEWCATSLE...9,SET,172,-0.072688,-0.006999,0.068059,0.85724,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN,1
MIR196A_5P_MIR196B_5P,SET,85,-0.098608,-0.0066906,0.092308,0.85729,MIR196A_5P_MIR196B_5P,1
PID_MYC_PATHWAY,SET,25,-0.18428,-0.0067922,0.17249,0.85731,PID_MYC_PATHWAY,1
KLF14_TARGET_GENES,SET,204,-0.064125,-0.0067185,0.060008,0.85737,KLF14_TARGET_GENES,1
LEIN_MIDBRAIN_MARKERS,SET,68,-0.11703,-0.0071053,0.10949,0.85741,LEIN_MIDBRAIN_MARKERS,1
MODULE_453,SET,40,-0.13415,-0.0062516,0.1255,0.85743,MODULE_453,1
GOMF_PROTEIN_TYROSINE_KINASE...1,SET,29,-0.19122,-0.0075901,0.1789,0.85743,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
HP_GINGIVAL_OVERGROWTH,SET,110,-0.094388,-0.0072805,0.088307,0.85743,HP_GINGIVAL_OVERGROWTH,1
GSE37532_VISCERAL_ADIPOSE_TI...5,SET,85,-0.10579,-0.0071782,0.098976,0.85743,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN,1
REACTOME_TP53_REGULATES_TRAN...10,SET,13,-0.25775,-0.0068527,0.24113,0.85744,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,1
GOBP_NITRIC_OXIDE_TRANSPORT,SET,3,-0.64736,-0.0082703,0.60552,0.85748,GOBP_NITRIC_OXIDE_TRANSPORT,1
WP_MONOAMINE_GPCRS,SET,32,-0.17852,-0.0074428,0.16691,0.85758,WP_MONOAMINE_GPCRS,1
GSE26669_CD4_VS_CD8_TCELL_IN...4,SET,184,-0.067417,-0.0067119,0.063033,0.85758,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP,1
GOBP_REGULATION_OF_CARDIAC_M...9,SET,23,-0.18911,-0.0066859,0.1768,0.8576,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,1
DESCARTES_FETAL_INTESTINE_SM...,SET,41,-0.14983,-0.0070692,0.14007,0.85762,DESCARTES_FETAL_INTESTINE_SMOOTH_MUSCLE_CELLS,1
GOBP_URATE_TRANSPORT,SET,11,-0.27901,-0.0068239,0.26081,0.85763,GOBP_URATE_TRANSPORT,1
GOMF_MRF_BINDING,SET,5,-0.42546,-0.0070168,0.3977,0.85764,GOMF_MRF_BINDING,1
GOMF_TELOMERASE_ACTIVITY,SET,5,-0.37277,-0.0061478,0.3484,0.85767,GOMF_TELOMERASE_ACTIVITY,1
GSE5503_MLN_DC_VS_PLN_DC_ACT...1,SET,184,-0.068192,-0.006789,0.063721,0.85772,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
MIR146A_5P,SET,103,-0.089117,-0.0066529,0.08327,0.85773,MIR146A_5P,1
HP_ABNORMAL_CIRCULATING_FREE...3,SET,7,-0.30903,-0.00603,0.28876,0.85773,HP_ABNORMAL_CIRCULATING_FREE_T4_CONCENTRATION,1
HP_AUTISM,SET,216,-0.064603,-0.0069624,0.06036,0.85775,HP_AUTISM,1
HP_HYPOPLASTIC_FIFTH_TOENAIL,SET,16,-0.25315,-0.0074663,0.23651,0.85776,HP_HYPOPLASTIC_FIFTH_TOENAIL,1
ZHENG_CORD_BLOOD_C1_PUTATIVE...,SET,92,-0.10116,-0.0071394,0.094508,0.85777,ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR,1
HP_DEEPLY_SET_EYE,SET,216,-0.062268,-0.0067108,0.058172,0.85778,HP_DEEPLY_SET_EYE,1
GCACTTT_MIR175P_MIR20A_MIR10...,SET,545,-0.040057,-0.006795,0.03741,0.85785,GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D,1
GSE22229_UNTREATED_VS_IMMUNO...2,SET,171,-0.071787,-0.0068923,0.067044,0.85785,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP,1
HP_ANKYLOGLOSSIA,SET,23,-0.1846,-0.0065263,0.1724,0.85786,HP_ANKYLOGLOSSIA,1
BIOCARTA_SUMO_PATHWAY,SET,6,-0.35613,-0.0064337,0.33255,0.85788,BIOCARTA_SUMO_PATHWAY,1
HP_EYELID_MYOCLONIA_SEIZURE,SET,7,-0.3043,-0.0059377,0.28414,0.8579,HP_EYELID_MYOCLONIA_SEIZURE,1
MORF_DCC,SET,99,-0.09672,-0.0070796,0.090302,0.85792,MORF_DCC,1
HP_RICKETS,SET,37,-0.16254,-0.0072856,0.15175,0.85792,HP_RICKETS,1
BHAT_ESR1_TARGETS_VIA_AKT1_DN,SET,79,-0.11061,-0.0072363,0.10326,0.85794,BHAT_ESR1_TARGETS_VIA_AKT1_DN,1
HP_RHINORRHEA,SET,7,-0.31189,-0.0060859,0.29109,0.85801,HP_RHINORRHEA,1
MIR135A_3P,SET,33,-0.15981,-0.0067658,0.14915,0.85802,MIR135A_3P,1
GOBP_CRANIOFACIAL_SUTURE_MOR...,SET,19,-0.22925,-0.0073675,0.21392,0.85806,GOBP_CRANIOFACIAL_SUTURE_MORPHOGENESIS,1
GOBP_DEMETHYLATION,SET,37,-0.15455,-0.0069275,0.14421,0.85807,GOBP_DEMETHYLATION,1
GOBP_REGULATION_OF_ALPHA_BET...2,SET,70,-0.11748,-0.0072365,0.10961,0.85808,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
SRC_UP.V1_DN,SET,147,-0.076085,-0.0067774,0.070981,0.85811,SRC_UP.V1_DN,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_...1,SET,44,-0.14067,-0.0068747,0.13122,0.85814,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,1
MIR6088,SET,152,-0.073892,-0.0066922,0.068922,0.85816,MIR6088,1
GOMF_STRUCTURAL_CONSTITUENT_...10,SET,36,-0.18916,-0.0083637,0.17641,0.85819,GOMF_STRUCTURAL_CONSTITUENT_OF_SKIN_EPIDERMIS,1
GOBP_PHASIC_SMOOTH_MUSCLE_CO...,SET,24,-0.20461,-0.0073892,0.19077,0.85825,GOBP_PHASIC_SMOOTH_MUSCLE_CONTRACTION,1
GOBP_GLYCEROLIPID_CATABOLIC_...,SET,64,-0.11904,-0.0070125,0.11098,0.85828,GOBP_GLYCEROLIPID_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_FEAR_RESP...,SET,9,-0.34847,-0.0077095,0.32471,0.85839,GOBP_REGULATION_OF_FEAR_RESPONSE,1
GSE34156_TLR1_TLR2_LIGAND_VS...1,SET,176,-0.068788,-0.0066993,0.064091,0.85842,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,1
GOBP_GLIAL_CELL_DIFFERENTIAT...,SET,247,-0.061263,-0.0070544,0.057074,0.85845,GOBP_GLIAL_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_HEAT_GENE...,SET,13,-0.29048,-0.007723,0.2706,0.85846,GOBP_REGULATION_OF_HEAT_GENERATION,1
GSE16385_ROSIGLITAZONE_IL4_V...2,SET,184,-0.065491,-0.0065201,0.061008,0.85847,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP,1
GOBP_ERBB2_SIGNALING_PATHWAY,SET,23,-0.19627,-0.0069389,0.18278,0.85853,GOBP_ERBB2_SIGNALING_PATHWAY,1
GSE2770_IL12_AND_TGFB_ACT_VS...1,SET,167,-0.072366,-0.0068669,0.067392,0.85854,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN,1
THUM_MIR21_TARGETS_HEART_DIS...2,SET,16,-0.2649,-0.0078129,0.24668,0.85855,THUM_MIR21_TARGETS_HEART_DISEASE_UP,1
ZBED5_TARGET_GENES,SET,1307,-0.026481,-0.0068063,0.02466,0.85855,ZBED5_TARGET_GENES,1
BIOCARTA_INSULIN_PATHWAY,SET,20,-0.20441,-0.0067396,0.19034,0.85857,BIOCARTA_INSULIN_PATHWAY,1
GOCC_ER_MEMBRANE_INSERTION_C...,SET,12,-0.27047,-0.006909,0.25177,0.85864,GOCC_ER_MEMBRANE_INSERTION_COMPLEX,1
GOCC_EXTRINSIC_COMPONENT_OF_...6,SET,7,-0.29262,-0.0057097,0.27236,0.85867,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_MEMBRANE,1
MIR491_5P,SET,97,-0.091188,-0.0066073,0.084865,0.85869,MIR491_5P,1
HP_IRREGULAR_CAPITAL_FEMORAL...,SET,4,-0.41865,-0.0061757,0.38962,0.85869,HP_IRREGULAR_CAPITAL_FEMORAL_EPIPHYSIS,1
AGTCTAG_MIR151,SET,20,-0.20875,-0.0068825,0.19423,0.85874,AGTCTAG_MIR151,1
GOBP_NEGATIVE_REGULATION_OF_...363,SET,54,-0.13386,-0.0072453,0.12456,0.85874,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,1
GSE14308_TH17_VS_NAIVE_CD4_T...2,SET,179,-0.066784,-0.0065588,0.062138,0.85875,GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP,1
BUSSLINGER_GASTRIC_MATURE_PI...,SET,208,-0.068108,-0.0072046,0.06337,0.85875,BUSSLINGER_GASTRIC_MATURE_PIT_CELLS,1
KEGG_MEDICUS_REFERENCE_TRANS...1,SET,11,-0.26836,-0.0065636,0.24968,0.85876,KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27,1
MODULE_240,SET,14,-0.24031,-0.00663,0.22359,0.85876,MODULE_240,1
GOBP_CUT_METABOLIC_PROCESS,SET,5,-0.37206,-0.006136,0.34615,0.85877,GOBP_CUT_METABOLIC_PROCESS,1
YRCCAKNNGNCGC_UNKNOWN,SET,60,-0.12442,-0.0070978,0.11574,0.85881,YRCCAKNNGNCGC_UNKNOWN,1
GAO_SMALL_INTESTINE_24W_C4_E...,SET,87,-0.10233,-0.0070239,0.095186,0.85881,GAO_SMALL_INTESTINE_24W_C4_ENTEROCYTE_PROGENITOR_SUBTYPE_2,1
GOMF_AMINE_TRANSMEMBRANE_TRA...,SET,6,-0.43094,-0.0077853,0.40083,0.85884,GOMF_AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_HEMATOPOI...2,SET,17,-0.20798,-0.0063226,0.19344,0.85885,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
GOCC_ARP2_3_PROTEIN_COMPLEX,SET,9,-0.2873,-0.0063564,0.26709,0.85895,GOCC_ARP2_3_PROTEIN_COMPLEX,1
HP_APLASIA_HYPOPLASIA_OF_THE...44,SET,5,-0.3325,-0.0054836,0.30911,0.85895,HP_APLASIA_HYPOPLASIA_OF_THE_MUSCULATURE_OF_THE_PELVIS,1
HP_BRUXISM,SET,29,-0.1723,-0.006839,0.16016,0.85898,HP_BRUXISM,1
chr8q13,SET,31,-0.37572,-0.015418,0.34917,0.85904,chr8q13,1
GOMF_STEROID_DEHYDROGENASE_A...1,SET,36,-0.16006,-0.0070771,0.14872,0.85909,GOMF_STEROID_DEHYDROGENASE_ACTIVITY,1
GOBP_PHOTOPERIODISM,SET,26,-0.17854,-0.0067106,0.16586,0.85912,GOBP_PHOTOPERIODISM,1
GAVISH_3CA_METAPROGRAM_ENDOT...15,SET,49,-0.13917,-0.0071764,0.12928,0.85914,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS,1
GSE17186_MEMORY_VS_CD21LOW_T...1,SET,179,-0.06715,-0.0065947,0.062374,0.85916,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN,1
HP_REGIONAL_ABNORMALITY_OF_S...,SET,469,-0.043502,-0.0068602,0.040402,0.8592,HP_REGIONAL_ABNORMALITY_OF_SKIN,1
REACTOME_SIGNALING_BY_TGF_BE...1,SET,91,-0.091421,-0.0064171,0.084896,0.85922,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1
GOBP_REGULATION_OF_ASYMMETRI...,SET,5,-0.48807,-0.0080492,0.45323,0.85922,GOBP_REGULATION_OF_ASYMMETRIC_CELL_DIVISION,1
GSE7764_IL15_NK_CELL_24H_VS_...2,SET,171,-0.067299,-0.0064614,0.062491,0.85924,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP,1
HP_MULTIPLE_ENCHONDROMATOSIS,SET,10,-0.29544,-0.0068896,0.2743,0.85927,HP_MULTIPLE_ENCHONDROMATOSIS,1
HP_SELF_INJURIOUS_BEHAVIOR,SET,166,-0.07363,-0.0069661,0.068359,0.85928,HP_SELF_INJURIOUS_BEHAVIOR,1
LINDGREN_BLADDER_CANCER_WITH...,SET,103,-0.094247,-0.0070358,0.087474,0.85935,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1
GOMF_GABA_RECEPTOR_BINDING,SET,17,-0.21224,-0.006452,0.19698,0.85935,GOMF_GABA_RECEPTOR_BINDING,1
GOMF_NADPLUS_PROTEIN_CYSTEIN...,SET,6,-0.38289,-0.0069171,0.35536,0.85936,GOMF_NADPLUS_PROTEIN_CYSTEINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...3,SET,17,-0.20494,-0.0062302,0.19019,0.85938,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,1
SP1_Q4_01,SET,231,-0.059987,-0.0066829,0.055647,0.85947,SP1_Q4_01,1
MIR190B_3P,SET,124,-0.081517,-0.0066733,0.075598,0.85954,MIR190B_3P,1
chr3q12,SET,22,-0.31393,-0.010855,0.29107,0.8596,chr3q12,1
GSE32986_UNSTIM_VS_GMCSF_AND...4,SET,180,-0.064265,-0.0063288,0.059584,0.8596,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,1
LINDGREN_BLADDER_CANCER_HIGH...,SET,47,-0.13992,-0.0070669,0.12973,0.85961,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,1
GSE6875_TCONV_VS_FOXP3_KO_TR...2,SET,180,-0.069324,-0.0068271,0.06427,0.85962,GSE6875_TCONV_VS_FOXP3_KO_TREG_UP,1
GSE17580_TREG_VS_TEFF_S_MANS...1,SET,176,-0.071598,-0.006973,0.066373,0.85964,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN,1
MORF_MAGEA8,SET,226,-0.06364,-0.0070138,0.058993,0.85965,MORF_MAGEA8,1
HP_ABNORMAL_SHOULDER_PHYSIOL...,SET,12,-0.29579,-0.0075559,0.27418,0.85966,HP_ABNORMAL_SHOULDER_PHYSIOLOGY,1
MIR1275,SET,258,-0.058984,-0.0069395,0.054672,0.85967,MIR1275,1
MIR507,SET,241,-0.059526,-0.0067718,0.055171,0.85969,MIR507,1
GOCC_G_PROTEIN_COUPLED_RECEP...1,SET,11,-0.30574,-0.0074776,0.28333,0.85972,GOCC_G_PROTEIN_COUPLED_RECEPTOR_COMPLEX,1
GNF2_TTN,SET,26,-0.1698,-0.006382,0.15734,0.85973,GNF2_TTN,1
GOMF_SINGLE_STRANDED_RNA_BIN...,SET,75,-0.10719,-0.0068336,0.099329,0.85973,GOMF_SINGLE_STRANDED_RNA_BINDING,1
MIR643,SET,58,-0.11991,-0.0067259,0.11109,0.85979,MIR643,1
MIR4804_3P,SET,79,-0.10407,-0.0068088,0.0964,0.85984,MIR4804_3P,1
REACTOME_PROTEIN_LOCALIZATION,SET,144,-0.074559,-0.0065739,0.069042,0.8599,REACTOME_PROTEIN_LOCALIZATION,1
LEE_INTRATHYMIC_T_PROGENITOR,SET,17,-0.2356,-0.0071624,0.2181,0.85998,LEE_INTRATHYMIC_T_PROGENITOR,1
GOMF_LIGASE_ACTIVITY_FORMING...5,SET,5,-0.37047,-0.0061098,0.3429,0.86001,GOMF_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS,1
GOBP_MYELOID_LEUKOCYTE_ACTIV...,SET,224,-0.066131,-0.0072563,0.061194,0.86007,GOBP_MYELOID_LEUKOCYTE_ACTIVATION,1
HP_SUBARACHNOID_HEMORRHAGE,SET,36,-0.16668,-0.00737,0.15418,0.86017,HP_SUBARACHNOID_HEMORRHAGE,1
MIR10396A_3P_MIR10396B_3P,SET,4,-0.56352,-0.0083127,0.52121,0.86018,MIR10396A_3P_MIR10396B_3P,1
KEGG_MEDICUS_VARIANT_MUTATIO...55,SET,35,-0.13958,-0.0060856,0.12909,0.8602,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
MIR5585_5P,SET,115,-0.085836,-0.0067687,0.079386,0.8602,MIR5585_5P,1
GOCC_SMAD_PROTEIN_COMPLEX,SET,9,-0.33426,-0.0073952,0.30908,0.86025,GOCC_SMAD_PROTEIN_COMPLEX,1
MIR6798_3P,SET,35,-0.15436,-0.00673,0.14272,0.86027,MIR6798_3P,1
GOMF_PROTEIN_SERINE_THREONIN...4,SET,36,-0.15836,-0.0070018,0.14639,0.8603,GOMF_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,1
GSE17721_CPG_VS_GARDIQUIMOD_...1,SET,186,-0.067842,-0.0067904,0.062717,0.8603,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
chr6p11,SET,2,-0.68533,-0.007149,0.63336,0.86038,chr6p11,1
GOBP_POSITIVE_REGULATION_OF_...67,SET,19,-0.22554,-0.007248,0.20843,0.86038,GOBP_POSITIVE_REGULATION_OF_BONE_RESORPTION,1
GOBP_POSITIVE_REGULATION_OF_...246,SET,57,-0.137,-0.0076181,0.12661,0.86039,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,1
REACTOME_METABOLISM_OF_WATER...,SET,120,-0.084748,-0.0068257,0.07831,0.86041,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1
GSE14000_TRANSLATED_RNA_VS_M...5,SET,161,-0.071363,-0.0066501,0.065944,0.86041,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN,1
GSE5503_LIVER_DC_VS_MLN_DC_A...2,SET,179,-0.069153,-0.0067915,0.063899,0.86042,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GOBP_CALCIUM_ION_HOMEOSTASIS,SET,303,-0.057038,-0.0072632,0.052692,0.86047,GOBP_CALCIUM_ION_HOMEOSTASIS,1
HP_ABNORMAL_B_CELL_SUBSET_DI...,SET,26,-0.1952,-0.007337,0.18033,0.86047,HP_ABNORMAL_B_CELL_SUBSET_DISTRIBUTION,1
MIR520F_3P,SET,184,-0.06809,-0.0067789,0.062898,0.86049,MIR520F_3P,1
GOMF_GLYCOGEN_BINDING,SET,7,-0.37776,-0.007371,0.34894,0.8605,GOMF_GLYCOGEN_BINDING,1
GOMF_INSULIN_LIKE_GROWTH_FAC...3,SET,13,-0.30164,-0.0080197,0.27863,0.8605,GOMF_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING,1
DESCARTES_MAIN_FETAL_BIPOLAR...,SET,48,-0.15052,-0.0076826,0.13903,0.86051,DESCARTES_MAIN_FETAL_BIPOLAR_CELLS,1
GOBP_CELLULAR_RESPONSE_TO_CH...1,SET,287,-0.055756,-0.006913,0.051493,0.86054,GOBP_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1
GOBP_POSITIVE_REGULATION_OF_...181,SET,14,-0.2369,-0.0065361,0.21876,0.86057,GOBP_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
GOBP_GLIAL_CELL_DEVELOPMENT,SET,126,-0.085081,-0.0070206,0.078564,0.86058,GOBP_GLIAL_CELL_DEVELOPMENT,1
MODULE_373,SET,20,-0.23097,-0.0076153,0.21323,0.86063,MODULE_373,1
HP_PRIMARY_MICROCEPHALY,SET,67,-0.1063,-0.0064069,0.098131,0.86065,HP_PRIMARY_MICROCEPHALY,1
HP_DUODENAL_ULCER,SET,12,-0.27126,-0.0069293,0.25035,0.8607,HP_DUODENAL_ULCER,1
GSE22103_LPS_VS_GMCSF_AND_IF...1,SET,188,-0.065927,-0.0066338,0.060842,0.86072,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,1
WP_BIOTIN_METABOLISM_INCLUDI...,SET,9,-0.31614,-0.0069943,0.29174,0.86073,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,1
GOBP_REGULATION_OF_TYPE_2_IM...,SET,34,-0.16979,-0.0072963,0.15668,0.86074,GOBP_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,1
MIR7977,SET,207,-0.064847,-0.0068433,0.059833,0.86077,MIR7977,1
GOBP_CYTOKINE_PRODUCTION,SET,722,-0.036423,-0.0070761,0.033599,0.86082,GOBP_CYTOKINE_PRODUCTION,1
HP_LACTIC_ACIDOSIS,SET,149,-0.072436,-0.0064958,0.066809,0.86086,HP_LACTIC_ACIDOSIS,1
HP_ENLARGED_OVARIES,SET,16,-0.22319,-0.0065825,0.20581,0.8609,HP_ENLARGED_OVARIES,1
HP_3_4_FINGER_SYNDACTYLY,SET,10,-0.32749,-0.0076372,0.30191,0.86097,HP_3_4_FINGER_SYNDACTYLY,1
WP_GPCRS_CLASS_B_SECRETINLIKE,SET,22,-0.22026,-0.0076162,0.20303,0.86099,WP_GPCRS_CLASS_B_SECRETINLIKE,1
REACTOME_PHOSPHATE_BOND_HYDR...1,SET,8,-0.30519,-0.0063661,0.2812,0.8611,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS,1
GOMF_FOUR_WAY_JUNCTION_DNA_B...,SET,16,-0.22372,-0.0065982,0.20605,0.8612,GOMF_FOUR_WAY_JUNCTION_DNA_BINDING,1
WP_NETRINUNC5B_SIGNALING,SET,48,-0.14038,-0.0071649,0.12929,0.86121,WP_NETRINUNC5B_SIGNALING,1
GSE27786_CD4_TCELL_VS_NEUTRO...1,SET,181,-0.071234,-0.0070344,0.065605,0.86121,GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN,1
GOBP_POSITIVE_REGULATION_OF_...364,SET,42,-0.15584,-0.0074414,0.14351,0.86123,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,1
GOMF_MHC_CLASS_I_PROTEIN_BIN...,SET,15,-0.23272,-0.0066458,0.2143,0.86123,GOMF_MHC_CLASS_I_PROTEIN_BINDING,1
HP_ABNORMAL_NASAL_BRIDGE_MOR...,SET,882,-0.031722,-0.0067806,0.029211,0.86125,HP_ABNORMAL_NASAL_BRIDGE_MORPHOLOGY,1
REACTOME_EXTENSION_OF_TELOME...,SET,48,-0.12495,-0.0063776,0.11503,0.86131,REACTOME_EXTENSION_OF_TELOMERES,1
KEGG_ALZHEIMERS_DISEASE,SET,139,-0.07325,-0.0063462,0.067428,0.86133,KEGG_ALZHEIMERS_DISEASE,1
HP_ABNORMAL_CALVARIA_MORPHOL...,SET,859,-0.032138,-0.0067838,0.029582,0.86134,HP_ABNORMAL_CALVARIA_MORPHOLOGY,1
GOBP_ANTIGEN_PROCESSING_AND_...8,SET,27,-0.20732,-0.0079406,0.19082,0.86136,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II,1
HP_MICRODONTIA,SET,157,-0.07605,-0.006999,0.06998,0.86142,HP_MICRODONTIA,1
GSE13485_CTRL_VS_DAY21_YF17D...1,SET,129,-0.08333,-0.0069569,0.076659,0.86148,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
LEIN_CEREBELLUM_MARKERS,SET,76,-0.11278,-0.0072374,0.10375,0.86149,LEIN_CEREBELLUM_MARKERS,1
GSE27786_CD4_TCELL_VS_NKTCEL...1,SET,184,-0.067333,-0.0067035,0.061932,0.86152,GSE27786_CD4_TCELL_VS_NKTCELL_DN,1
GSE14308_TH17_VS_NAIVE_CD4_T...1,SET,182,-0.069432,-0.0068752,0.063861,0.86153,GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN,1
ZNF426_TARGET_GENES,SET,121,-0.080867,-0.00654,0.074369,0.86156,ZNF426_TARGET_GENES,1
HP_DYSESTHESIA,SET,16,-0.24532,-0.0072353,0.22557,0.86159,HP_DYSESTHESIA,1
MORF_SKP1A,SET,179,-0.063166,-0.0062035,0.058072,0.86163,MORF_SKP1A,1
GSE17721_CTRL_VS_PAM3CSK4_12...2,SET,181,-0.068165,-0.0067314,0.06267,0.86163,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP,1
PID_ENDOTHELIN_PATHWAY,SET,62,-0.12455,-0.0072217,0.1145,0.86164,PID_ENDOTHELIN_PATHWAY,1
GOBP_HORMONE_BIOSYNTHETIC_PR...,SET,64,-0.12044,-0.0070953,0.11072,0.86166,GOBP_HORMONE_BIOSYNTHETIC_PROCESS,1
HP_WEAKNESS_DUE_TO_UPPER_MOT...,SET,427,-0.045387,-0.0068374,0.041712,0.86172,HP_WEAKNESS_DUE_TO_UPPER_MOTOR_NEURON_DYSFUNCTION,1
GOBP_NEGATIVE_REGULATION_OF_...441,SET,9,-0.34456,-0.007623,0.31662,0.86175,GOBP_NEGATIVE_REGULATION_OF_NEURON_MIGRATION,1
HP_PARACENTRAL_SCOTOMA,SET,7,-0.37527,-0.0073226,0.34484,0.86175,HP_PARACENTRAL_SCOTOMA,1
MIR6715A_3P,SET,148,-0.078435,-0.0070103,0.072073,0.86176,MIR6715A_3P,1
GOBP_POSITIVE_REGULATION_OF_...202,SET,17,-0.21829,-0.006636,0.20055,0.86179,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,1
ALX4_TARGET_GENES,SET,23,-0.21047,-0.0074409,0.19334,0.86182,ALX4_TARGET_GENES,1
GCM_IL6ST,SET,52,-0.12551,-0.006667,0.1153,0.86183,GCM_IL6ST,1
HP_BROAD_PHALANGES_OF_THE_HA...,SET,94,-0.097749,-0.0069729,0.089772,0.86188,HP_BROAD_PHALANGES_OF_THE_HAND,1
DESCARTES_FETAL_PANCREAS_ERY...,SET,107,-0.091771,-0.006982,0.084283,0.86188,DESCARTES_FETAL_PANCREAS_ERYTHROBLASTS,1
MIR4720_3P,SET,106,-0.093256,-0.007062,0.085642,0.8619,MIR4720_3P,1
GOBP_RESPONSE_TO_INTERLEUKIN...6,SET,12,-0.30649,-0.0078291,0.28143,0.86192,GOBP_RESPONSE_TO_INTERLEUKIN_18,1
GNF2_HDAC1,SET,99,-0.087787,-0.0064258,0.080609,0.86193,GNF2_HDAC1,1
LI_AMPLIFIED_IN_LUNG_CANCER,SET,165,-0.074378,-0.0070158,0.06829,0.86195,LI_AMPLIFIED_IN_LUNG_CANCER,1
MIR4286,SET,79,-0.10095,-0.0066043,0.092671,0.86198,MIR4286,1
REACTOME_FANCONI_ANEMIA_PATH...,SET,30,-0.14522,-0.0058624,0.1333,0.86201,REACTOME_FANCONI_ANEMIA_PATHWAY,1
GOBP_ADENYLATE_CYCLASE_INHIB...1,SET,5,-0.48293,-0.0079646,0.44329,0.86201,GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
BUCASAS_PBMC_FLUARIX_FLUVIRI...2,SET,18,-0.19689,-0.0061588,0.18073,0.86201,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_TOP_FUNCTIONAL_NETWORK_POSITIVE,1
GSE41867_NAIVE_VS_DAY8_LCMV_...1,SET,180,-0.067998,-0.0066965,0.062412,0.86203,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
chr8q24,SET,152,-0.16038,-0.014525,0.1472,0.86204,chr8q24,1
GOBP_GLUTAMINE_FAMILY_AMINO_...3,SET,66,-0.12016,-0.0071878,0.11027,0.86206,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GOMF_MIRNA_BINDING,SET,28,-0.15802,-0.0061632,0.14498,0.86211,GOMF_MIRNA_BINDING,1
GSE17721_LPS_VS_POLYIC_4H_BM...2,SET,184,-0.067068,-0.0066771,0.061528,0.86214,GSE17721_LPS_VS_POLYIC_4H_BMDC_UP,1
MASRI_RESISTANCE_TO_TAMOXIFE...1,SET,16,-0.25911,-0.007642,0.23763,0.86222,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,1
GOBP_POSITIVE_REGULATION_OF_...801,SET,10,-0.31722,-0.0073977,0.2909,0.86224,GOBP_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,1
GSE11961_PLASMA_CELL_DAY7_VS...2,SET,179,-0.069209,-0.0067969,0.063463,0.86225,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
HP_OPTIC_DISC_HYPOPLASIA,SET,16,-0.24398,-0.0071957,0.22372,0.86226,HP_OPTIC_DISC_HYPOPLASIA,1
GSE19888_ADENOSINE_A3R_INH_V...7,SET,177,-0.070155,-0.0068516,0.064323,0.86228,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...11,SET,52,-0.12182,-0.006471,0.11168,0.86232,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,1
REACTOME_SODIUM_PROTON_EXCHA...,SET,7,-0.35794,-0.0069844,0.32813,0.86233,REACTOME_SODIUM_PROTON_EXCHANGERS,1
GSE37534_UNTREATED_VS_PIOGLI...1,SET,185,-0.068652,-0.0068532,0.062932,0.86233,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,1
GOBP_NEGATIVE_REGULATION_OF_...269,SET,10,-0.28109,-0.0065551,0.25762,0.86238,GOBP_NEGATIVE_REGULATION_OF_HEART_RATE,1
GOMF_TRANSFERASE_ACTIVITY_TR...3,SET,178,-0.066435,-0.0065065,0.060887,0.86238,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS,1
GOMF_SUPERCOILED_DNA_BINDING,SET,6,-0.3702,-0.0066879,0.3391,0.86251,GOMF_SUPERCOILED_DNA_BINDING,1
REACTOME_INTERLEUKIN_4_AND_I...,SET,101,-0.10493,-0.0077574,0.096113,0.86252,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1
HP_ABNORMAL_2ND_FINGER_MORPH...,SET,37,-0.15546,-0.0069686,0.14238,0.86255,HP_ABNORMAL_2ND_FINGER_MORPHOLOGY,1
GOBP_GLYCOPROTEIN_BIOSYNTHET...,SET,289,-0.05674,-0.0070591,0.051962,0.86257,GOBP_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS,1
GOMF_NADH_DEHYDROGENASE_UBIQ...,SET,33,-0.14108,-0.0059728,0.12919,0.86257,GOMF_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY,1
GOBP_DOUBLE_STRAND_BREAK_REP...6,SET,58,-0.11094,-0.0062227,0.10159,0.86258,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
GOMF_ACROSIN_BINDING,SET,5,-0.38403,-0.0063334,0.35164,0.8626,GOMF_ACROSIN_BINDING,1
FULLER_PBMC_F_TULARENSIS_VAC...3,SET,37,-0.1476,-0.006616,0.13512,0.86265,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN,1
GOMF_PATTERN_RECOGNITION_REC...,SET,28,-0.18077,-0.0070504,0.16548,0.86266,GOMF_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY,1
GSE2706_2H_VS_8H_R848_AND_LP...2,SET,174,-0.06852,-0.0066356,0.062722,0.86267,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP,1
REACTOME_CLEC7A_DECTIN_1_SIG...,SET,94,-0.091095,-0.0064982,0.083383,0.86268,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1
CAFFAREL_RESPONSE_TO_THC_24H...2,SET,8,-0.30319,-0.0063244,0.27747,0.86273,CAFFAREL_RESPONSE_TO_THC_24HR_3_UP,1
GOBP_PARKIN_MEDIATED_STIMULA...,SET,4,-0.50265,-0.0074149,0.45994,0.86277,GOBP_PARKIN_MEDIATED_STIMULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
GOBP_REGULATION_OF_GERM_CELL...,SET,7,-0.30625,-0.0059758,0.28021,0.86278,GOBP_REGULATION_OF_GERM_CELL_PROLIFERATION,1
GOBP_SYNAPTIC_VESICLE_PRIMING,SET,19,-0.18798,-0.006041,0.17199,0.86278,GOBP_SYNAPTIC_VESICLE_PRIMING,1
GOMF_TOLL_LIKE_RECEPTOR_BIND...,SET,14,-0.27063,-0.0074667,0.24761,0.86279,GOMF_TOLL_LIKE_RECEPTOR_BINDING,1
KEGG_MEDICUS_VARIANT_MLL_ENL...,SET,11,-0.3241,-0.0079269,0.29652,0.8628,KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
GOBP_GLUCOCORTICOID_SECRETION,SET,11,-0.28577,-0.0069892,0.26145,0.8628,GOBP_GLUCOCORTICOID_SECRETION,1
GOMF_PHOSPHOLIPASE_A1_ACTIVI...,SET,13,-0.26259,-0.0069814,0.24021,0.86283,GOMF_PHOSPHOLIPASE_A1_ACTIVITY,1
MIR597_5P,SET,72,-0.11048,-0.0069017,0.10105,0.86288,MIR597_5P,1
REACTOME_TYPE_I_HEMIDESMOSOM...,SET,11,-0.28504,-0.0069714,0.26064,0.86293,REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,1
REACTOME_PURINERGIC_SIGNALIN...,SET,23,-0.1865,-0.0065937,0.17051,0.86296,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,1
REACTOME_ASSOCIATION_OF_TRIC...,SET,36,-0.13944,-0.0061655,0.12749,0.86297,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,1
GSE13306_TREG_VS_TCONV_DN,SET,186,-0.065719,-0.0065779,0.060079,0.86299,GSE13306_TREG_VS_TCONV_DN,1
GOBP_NEGATIVE_REGULATION_OF_...655,SET,377,-0.049553,-0.0070241,0.045275,0.86312,GOBP_NEGATIVE_REGULATION_OF_TRANSPORT,1
GSE27786_LIN_NEG_VS_NKCELL_UP,SET,174,-0.068328,-0.0066169,0.062424,0.86314,GSE27786_LIN_NEG_VS_NKCELL_UP,1
GOBP_MACROPHAGE_ACTIVATION_I...,SET,19,-0.2312,-0.0074301,0.21121,0.86316,GOBP_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOBP_PROTEIN_KINASE_C_SIGNAL...,SET,35,-0.16255,-0.0070871,0.1485,0.86316,GOBP_PROTEIN_KINASE_C_SIGNALING,1
HOEK_B_CELL_2011_2012_TIV_AD...4,SET,6,-0.43381,-0.0078371,0.39628,0.86317,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_DN,1
GOMF_ATPASE_REGULATOR_ACTIVI...,SET,45,-0.13125,-0.0064868,0.11989,0.86318,GOMF_ATPASE_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_NEUTROPHI...3,SET,8,-0.31595,-0.0065906,0.28857,0.86321,GOBP_REGULATION_OF_NEUTROPHIL_DEGRANULATION,1
GOBP_POSITIVE_REGULATION_OF_...492,SET,125,-0.081425,-0.0066924,0.074358,0.86324,GOBP_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,1
GOBP_NON_CANONICAL_NF_KAPPAB...,SET,114,-0.088926,-0.006982,0.081202,0.86326,GOBP_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GSE11961_FOLLICULAR_BCELL_VS...8,SET,180,-0.069858,-0.0068797,0.063781,0.8633,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP,1
TCTGATA_MIR361,SET,79,-0.10703,-0.0070025,0.097709,0.86333,TCTGATA_MIR361,1
GOBP_MICROVILLUS_ASSEMBLY,SET,19,-0.23961,-0.0077003,0.21872,0.86335,GOBP_MICROVILLUS_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...10,SET,60,-0.13288,-0.0075803,0.1213,0.86335,GOBP_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,1
KEGG_MEDICUS_REFERENCE_MANNO...2,SET,5,-0.37016,-0.0061048,0.33784,0.86338,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK,1
GSE14308_TH2_VS_TH17_UP,SET,184,-0.068441,-0.0068138,0.062466,0.86338,GSE14308_TH2_VS_TH17_UP,1
GSE17721_LPS_VS_POLYIC_4H_BM...1,SET,175,-0.067069,-0.0065135,0.061212,0.86339,GSE17721_LPS_VS_POLYIC_4H_BMDC_DN,1
GOBP_REGULATION_OF_NMDA_RECE...,SET,14,-0.25363,-0.0069975,0.23147,0.8634,GOBP_REGULATION_OF_NMDA_RECEPTOR_ACTIVITY,1
MIR1289,SET,52,-0.13845,-0.0073542,0.12634,0.86342,MIR1289,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...8,SET,32,-0.18668,-0.0077829,0.17033,0.86346,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP,1
GSE1112_OT1_CD8AB_VS_HY_CD8A...1,SET,153,-0.07361,-0.0066883,0.067157,0.86347,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,1
HP_FEEDING_DIFFICULTIES_IN_I...,SET,509,-0.04152,-0.0068134,0.037879,0.86348,HP_FEEDING_DIFFICULTIES_IN_INFANCY,1
GAVISH_3CA_METAPROGRAM_B_CEL...8,SET,44,-0.15005,-0.0073331,0.13688,0.8635,GAVISH_3CA_METAPROGRAM_B_CELLS_MHC_II,1
VANDESLUIS_COMMD1_TARGETS_GR...4,SET,17,-0.25397,-0.0077208,0.23167,0.86351,VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,1
HP_BROAD_ALVEOLAR_RIDGES,SET,12,-0.28129,-0.0071856,0.25655,0.86355,HP_BROAD_ALVEOLAR_RIDGES,1
GSE21670_UNTREATED_VS_TGFB_T...2,SET,180,-0.073231,-0.0072118,0.066782,0.86358,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP,1
GOBP_TOOTH_ERUPTION,SET,5,-0.4516,-0.0074479,0.41181,0.86359,GOBP_TOOTH_ERUPTION,1
GSE8685_IL2_STARVED_VS_IL15_...1,SET,178,-0.069491,-0.0068057,0.063366,0.86359,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,1
GSE13229_MATURE_VS_INTMATURE...1,SET,176,-0.068278,-0.0066497,0.062259,0.8636,GSE13229_MATURE_VS_INTMATURE_NKCELL_DN,1
HP_BIPARIETAL_NARROWING,SET,60,-0.10481,-0.0059791,0.095557,0.86364,HP_BIPARIETAL_NARROWING,1
HP_LANGUAGE_IMPAIRMENT,SET,988,-0.030255,-0.0068239,0.027584,0.86364,HP_LANGUAGE_IMPAIRMENT,1
HALLMARK_INTERFERON_GAMMA_RE...,SET,190,-0.071054,-0.0071872,0.06478,0.86364,HALLMARK_INTERFERON_GAMMA_RESPONSE,1
GOBP_TETRAHYDROFOLATE_METABO...,SET,17,-0.21606,-0.0065683,0.19698,0.86365,GOBP_TETRAHYDROFOLATE_METABOLIC_PROCESS,1
GOMF_CALCIUM_DEPENDENT_PHOSP...1,SET,17,-0.25833,-0.0078532,0.2355,0.86365,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...409,SET,79,-0.10631,-0.0069549,0.096903,0.86368,GOBP_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...665,SET,6,-0.45479,-0.0082162,0.41447,0.86373,GOBP_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,1
HP_TIP_TOE_GAIT,SET,75,-0.10646,-0.0067868,0.096989,0.86381,HP_TIP_TOE_GAIT,1
GOBP_NEGATIVE_REGULATION_OF_...666,SET,38,-0.17298,-0.0078574,0.15758,0.86383,GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,1
LEE_LIVER_CANCER_HEPATOBLAST,SET,15,-0.26683,-0.0076201,0.24307,0.86384,LEE_LIVER_CANCER_HEPATOBLAST,1
MIR519E_5P,SET,285,-0.056097,-0.0069314,0.051097,0.86386,MIR519E_5P,1
GOBP_REGULATION_OF_LEUKOCYTE...8,SET,213,-0.068109,-0.0072898,0.062038,0.86386,GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION,1
MODY_HIPPOCAMPUS_PRENATAL,SET,42,-0.13718,-0.0065503,0.12488,0.864,MODY_HIPPOCAMPUS_PRENATAL,1
GOBP_STEROID_HORMONE_SECRETI...,SET,26,-0.20192,-0.0075894,0.18377,0.86406,GOBP_STEROID_HORMONE_SECRETION,1
GSE4984_UNTREATED_VS_VEHICLE...1,SET,154,-0.074014,-0.0067468,0.067358,0.86407,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN,1
MODULE_337,SET,58,-0.1167,-0.0065454,0.10616,0.86415,MODULE_337,1
GOBP_CYCLIC_GMP_AMP_TRANSMEM...,SET,8,-0.37787,-0.007882,0.34373,0.86418,GOBP_CYCLIC_GMP_AMP_TRANSMEMBRANE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
DASU_IL6_SIGNALING_SCAR_DN,SET,13,-0.2823,-0.0075054,0.25677,0.8642,DASU_IL6_SIGNALING_SCAR_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...10,SET,16,-0.2387,-0.00704,0.21711,0.8642,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,1
MIKKELSEN_ES_HCP_WITH_H3_UNM...,SET,55,-0.13738,-0.0075042,0.12492,0.86428,MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,1
GSE20366_CD103_KLRG1_DP_VS_D...1,SET,173,-0.071087,-0.0068645,0.06463,0.8643,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN,1
CREB_02,SET,232,-0.06211,-0.0069342,0.056468,0.86431,CREB_02,1
GOMF_PHOSPHATIDYLGLYCEROL_BI...,SET,14,-0.26748,-0.0073798,0.24318,0.86431,GOMF_PHOSPHATIDYLGLYCEROL_BINDING,1
CRX_DN.V1_UP,SET,120,-0.086398,-0.0069586,0.078537,0.86435,CRX_DN.V1_UP,1
KEGG_MEDICUS_REFERENCE_ELECT...1,SET,36,-0.13765,-0.0060862,0.12511,0.86438,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GOBP_PURINE_NUCLEOSIDE_METAB...,SET,24,-0.21003,-0.0075848,0.19089,0.86438,GOBP_PURINE_NUCLEOSIDE_METABOLIC_PROCESS,1
ZNF165_TARGET_GENES,SET,67,-0.11335,-0.0068317,0.10302,0.8644,ZNF165_TARGET_GENES,1
MIR488_3P,SET,168,-0.071244,-0.0067805,0.06474,0.86443,MIR488_3P,1
HP_SEVERE_CYTOMEGALOVIRUS_IN...,SET,10,-0.30008,-0.0069978,0.27267,0.86444,HP_SEVERE_CYTOMEGALOVIRUS_INFECTION,1
REACTOME_GRB2_EVENTS_IN_ERBB...,SET,16,-0.22449,-0.0066209,0.20397,0.86446,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,1
HP_APLASIA_HYPOPLASIA_OF_THE...51,SET,17,-0.2305,-0.0070073,0.20943,0.86447,HP_APLASIA_HYPOPLASIA_OF_THE_PALMAR_CREASES,1
GOBP_POSITIVE_REGULATION_OF_...489,SET,23,-0.19009,-0.0067204,0.17269,0.86449,GOBP_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
chr12q15,SET,23,-0.34496,-0.012196,0.31333,0.86453,chr12q15,1
HOSHIDA_LIVER_CANCER_LATE_RE...2,SET,56,-0.13037,-0.0071858,0.1184,0.86457,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,1
GSE37301_CD4_TCELL_VS_GRANUL...2,SET,148,-0.080378,-0.007184,0.072989,0.8646,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
MIR4442,SET,4,-0.48,-0.0070807,0.43578,0.86465,MIR4442,1
HP_HYPOPLASTIC_ACETABULAE,SET,5,-0.47023,-0.0077551,0.42674,0.86475,HP_HYPOPLASTIC_ACETABULAE,1
HP_MYOGLOBINURIA,SET,23,-0.1666,-0.0058899,0.15117,0.86476,HP_MYOGLOBINURIA,1
IL15_UP.V1_DN,SET,157,-0.0771,-0.0070957,0.069947,0.86482,IL15_UP.V1_DN,1
GSE22229_UNTREATED_VS_IMMUNO...1,SET,180,-0.073047,-0.0071937,0.066249,0.86489,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN,1
GOMF_U2_SNRNA_BINDING,SET,5,-0.39333,-0.0064869,0.35672,0.8649,GOMF_U2_SNRNA_BINDING,1
HP_IMPAIRED_COLLAGEN_INDUCED...,SET,16,-0.21899,-0.0064588,0.19861,0.8649,HP_IMPAIRED_COLLAGEN_INDUCED_PLATELET_AGGREGATION,1
HP_SMALL_NAIL,SET,157,-0.0763,-0.007022,0.069192,0.86492,HP_SMALL_NAIL,1
chr4q22,SET,31,-0.30395,-0.012473,0.27562,0.86493,chr4q22,1
GOBP_CIRCADIAN_RHYTHM,SET,193,-0.07087,-0.0072243,0.064259,0.86495,GOBP_CIRCADIAN_RHYTHM,1
GOBP_PHOSPHOLIPID_METABOLIC_...,SET,342,-0.050701,-0.0068517,0.045972,0.86495,GOBP_PHOSPHOLIPID_METABOLIC_PROCESS,1
KENNEDY_PBMC_DRYVAX_AGE_18_4...,SET,32,-0.16582,-0.0069135,0.15036,0.86495,KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_DN,1
HP_DEMYELINATING_MOTOR_NEURO...,SET,5,-0.46439,-0.0076588,0.42102,0.86498,HP_DEMYELINATING_MOTOR_NEUROPATHY,1
MANNO_MIDBRAIN_NEUROTYPES_HP...2,SET,263,-0.058701,-0.0069718,0.05322,0.86498,MANNO_MIDBRAIN_NEUROTYPES_HPROGBP,1
GOBP_REGULATION_OF_LIPID_CAT...,SET,59,-0.12918,-0.0073074,0.11709,0.86503,GOBP_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
HP_HIGH_FREQUENCY_SENSORINEU...,SET,6,-0.35799,-0.0064673,0.32443,0.86508,HP_HIGH_FREQUENCY_SENSORINEURAL_HEARING_IMPAIRMENT,1
GSE1432_CTRL_VS_IFNG_6H_MICR...2,SET,183,-0.067464,-0.0066985,0.06112,0.86515,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,1
GSE17301_ACD3_ACD28_VS_ACD3_...4,SET,176,-0.069545,-0.006773,0.062991,0.86521,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...77,SET,37,-0.13651,-0.0061192,0.12363,0.86525,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GOBP_INDOLE_CONTAINING_COMPO...1,SET,5,-0.40321,-0.0066498,0.36514,0.86525,GOBP_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
MIR515_5P,SET,282,-0.056814,-0.0069835,0.051445,0.86528,MIR515_5P,1
GOBP_NEGATIVE_REGULATION_OF_...340,SET,20,-0.2194,-0.0072337,0.19866,0.86528,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,1
KEGG_MEDICUS_REFERENCE_KITLG...2,SET,14,-0.24936,-0.0068797,0.22576,0.8653,KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY,1
GSE22886_TH1_VS_TH2_12H_ACT_...1,SET,178,-0.07105,-0.0069585,0.064324,0.86532,GSE22886_TH1_VS_TH2_12H_ACT_DN,1
GOBP_REGULATION_OF_SULFUR_ME...,SET,12,-0.30589,-0.0078138,0.27692,0.86533,GOBP_REGULATION_OF_SULFUR_METABOLIC_PROCESS,1
HP_SUBSARCOLEMMAL_ACCUMULATI...,SET,5,-0.32142,-0.005301,0.29096,0.86535,HP_SUBSARCOLEMMAL_ACCUMULATIONS_OF_ABNORMALLY_SHAPED_MITOCHONDRIA,1
GOBP_REGULATION_OF_CARDIAC_M...5,SET,7,-0.33756,-0.0065868,0.30555,0.86536,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL,1
GOBP_CHONDROCYTE_DIFFERENTIA...2,SET,14,-0.26493,-0.0073092,0.23979,0.86537,GOBP_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_MELANOSOME_ASSEMBLY,SET,18,-0.22383,-0.0070016,0.20256,0.86541,GOBP_MELANOSOME_ASSEMBLY,1
KEGG_MEDICUS_REFERENCE_REGUL...6,SET,7,-0.30046,-0.0058627,0.27188,0.86544,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE,1
GOBP_POSITIVE_REGULATION_OF_...461,SET,6,-0.32304,-0.005836,0.2923,0.86545,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_NUCLEATION,1
WP_MODULATION_OF_PI3KAKTMTOR...,SET,14,-0.28396,-0.0078344,0.25692,0.86547,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,1
HP_ABNORMAL_CHOROID_MORPHOLO...,SET,170,-0.073851,-0.0070699,0.066813,0.86549,HP_ABNORMAL_CHOROID_MORPHOLOGY,1
BRUNEAU_HEART_GREAT_VESSELS_...,SET,8,-0.35957,-0.0075003,0.32528,0.8655,BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS,1
MYLLYKANGAS_AMPLIFICATION_HO...5,SET,5,-0.43941,-0.0072468,0.39751,0.8655,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18,1
WP_ETHER_LIPID_BIOSYNTHESIS,SET,19,-0.21567,-0.0069309,0.1951,0.8655,WP_ETHER_LIPID_BIOSYNTHESIS,1
HP_HYPOPLASTIC_NIPPLES,SET,31,-0.15479,-0.0063518,0.14003,0.8655,HP_HYPOPLASTIC_NIPPLES,1
GSE25088_CTRL_VS_IL4_AND_ROS...2,SET,160,-0.077154,-0.0071676,0.069796,0.8655,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
MIR4297,SET,161,-0.076056,-0.0070874,0.068795,0.86553,MIR4297,1
KEGG_MEDICUS_REFERENCE_P27_C...,SET,14,-0.22906,-0.0063196,0.20713,0.86559,KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S,1
GOBP_REGULATION_OF_GLUTAMATE...3,SET,19,-0.24324,-0.0078169,0.21995,0.8656,GOBP_REGULATION_OF_GLUTAMATE_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...230,SET,8,-0.36498,-0.0076133,0.32998,0.86565,GOBP_POSITIVE_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,1
MODULE_455,SET,36,-0.15193,-0.0067178,0.13735,0.86567,MODULE_455,1
MIR5571_3P,SET,39,-0.147,-0.0067645,0.13288,0.86569,MIR5571_3P,1
GSE38696_LIGHT_ZONE_VS_DARK_...1,SET,122,-0.08629,-0.0070072,0.077996,0.8657,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,1
MORI_PRE_BI_LYMPHOCYTE_DN,SET,71,-0.11429,-0.0070902,0.10327,0.86578,MORI_PRE_BI_LYMPHOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...636,SET,5,-0.46731,-0.007707,0.42219,0.86582,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,1
GOMF_CALCIUM_ION_TRANSMEMBRA...,SET,135,-0.0848,-0.0072412,0.076609,0.86583,GOMF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR548F_5P,SET,446,-0.046495,-0.0071546,0.042002,0.86584,MIR548F_5P,1
GOBP_CELLULAR_RESPONSE_TO_LU...,SET,5,-0.45679,-0.0075335,0.4126,0.86587,GOBP_CELLULAR_RESPONSE_TO_LUTEINIZING_HORMONE_STIMULUS,1
GOMF_HYDROLASE_ACTIVITY_ACTI...3,SET,15,-0.25013,-0.007143,0.22588,0.86592,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES,1
MCBRYAN_PUBERTAL_BREAST_3_4W...1,SET,32,-0.1643,-0.0068498,0.14835,0.86595,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1
MIR6776_5P,SET,83,-0.1021,-0.0068462,0.092194,0.86595,MIR6776_5P,1
GOBP_ENTRAINMENT_OF_CIRCADIA...,SET,27,-0.18603,-0.0071251,0.16797,0.86596,GOBP_ENTRAINMENT_OF_CIRCADIAN_CLOCK,1
HP_EXERCISE_INDUCED_MUSCLE_F...,SET,9,-0.31588,-0.0069886,0.28518,0.86598,HP_EXERCISE_INDUCED_MUSCLE_FATIGUE,1
HP_ABNORMAL_BLOOD_FOLATE_CON...,SET,10,-0.29657,-0.0069161,0.26774,0.86599,HP_ABNORMAL_BLOOD_FOLATE_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...508,SET,19,-0.20238,-0.0065037,0.18268,0.86602,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,1
HP_VESTIBULAR_HYPOFUNCTION,SET,15,-0.2705,-0.0077248,0.24418,0.86602,HP_VESTIBULAR_HYPOFUNCTION,1
GOBP_NEGATIVE_REGULATION_OF_...221,SET,9,-0.32431,-0.0071751,0.29271,0.86605,GOBP_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
KALMA_E2F1_TARGETS,SET,11,-0.25047,-0.0061259,0.22605,0.86607,KALMA_E2F1_TARGETS,1
MIR5100,SET,84,-0.10669,-0.0071966,0.096271,0.86612,MIR5100,1
HP_CORTICAL_CATARACT,SET,10,-0.31449,-0.007334,0.28372,0.86616,HP_CORTICAL_CATARACT,1
HP_ABNORMAL_RIGHT_VENTRICLE_...,SET,61,-0.12367,-0.0071128,0.11155,0.86618,HP_ABNORMAL_RIGHT_VENTRICLE_MORPHOLOGY,1
MIR8084,SET,213,-0.067652,-0.0072408,0.061022,0.8662,MIR8084,1
HALLMARK_ANGIOGENESIS,SET,35,-0.17198,-0.0074979,0.15512,0.86621,HALLMARK_ANGIOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...218,SET,8,-0.31586,-0.0065887,0.28486,0.86624,GOBP_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,1
GSE40274_LEF1_VS_FOXP3_AND_L...1,SET,173,-0.072771,-0.0070272,0.065625,0.86626,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_LENS_DEVELOPMENT_IN_CAM...,SET,79,-0.11746,-0.0076848,0.10589,0.86635,GOBP_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
REACTOME_RHO_GTPASES_ACTIVAT...10,SET,33,-0.15786,-0.0066833,0.14222,0.86648,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,1
GOBP_POSITIVE_REGULATION_OF_...570,SET,34,-0.16287,-0.0069989,0.14672,0.86652,GOBP_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
REACTOME_REPLACEMENT_OF_PROT...,SET,6,-0.41072,-0.00742,0.36992,0.86656,REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS,1
GOBP_REGULATION_OF_VOLTAGE_G...1,SET,21,-0.21975,-0.007424,0.19788,0.8666,GOBP_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GSE7852_THYMUS_VS_FAT_TREG_UP,SET,188,-0.066052,-0.0066464,0.059478,0.86661,GSE7852_THYMUS_VS_FAT_TREG_UP,1
WP_10Q22Q23_COPY_NUMBER_VARI...,SET,55,-0.14288,-0.0078046,0.12865,0.86662,WP_10Q22Q23_COPY_NUMBER_VARIATION,1
GSE16450_IMMATURE_VS_MATURE_...4,SET,182,-0.069402,-0.0068722,0.062492,0.86662,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,1
FARDIN_HYPOXIA_11,SET,28,-0.17866,-0.0069684,0.16075,0.86679,FARDIN_HYPOXIA_11,1
KEGG_MEDICUS_VARIANT_AMPLIFI...6,SET,9,-0.32067,-0.0070945,0.28851,0.8668,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY,1
HP_RENAL_INTERSTITIAL_FIBROS...,SET,6,-0.35077,-0.0063368,0.31549,0.86689,HP_RENAL_INTERSTITIAL_FIBROSIS,1
GSE39820_CTRL_VS_TGFBETA1_IL...1,SET,183,-0.070445,-0.0069944,0.063359,0.86689,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN,1
REACTOME_ATTENUATION_PHASE,SET,26,-0.19006,-0.0071437,0.17091,0.86693,REACTOME_ATTENUATION_PHASE,1
GOMF_K48_LINKED_POLYUBIQUITI...,SET,7,-0.36142,-0.0070522,0.32483,0.86706,GOMF_K48_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
GOBP_CELLULAR_RESPONSE_TO_CO...1,SET,10,-0.32281,-0.0075281,0.2901,0.86709,GOBP_CELLULAR_RESPONSE_TO_COCAINE,1
GSE43863_NAIVE_VS_MEMORY_TFH...2,SET,179,-0.072527,-0.0071228,0.065175,0.8671,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP,1
HESS_TARGETS_OF_HOXA9_AND_ME...1,SET,79,-0.11319,-0.0074053,0.10171,0.86711,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,1
HUMMERICH_SKIN_CANCER_PROGRE...2,SET,84,-0.11062,-0.0074619,0.099393,0.86714,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,1
GOBP_REGULATION_OF_MAINTENAN...,SET,4,-0.64397,-0.0094995,0.5785,0.86717,GOBP_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
GOBP_FRUCTOSE_1_6_BISPHOSPHA...,SET,9,-0.27829,-0.0061569,0.24995,0.86722,GOBP_FRUCTOSE_1_6_BISPHOSPHATE_METABOLIC_PROCESS,1
DESCARTES_FETAL_SPLEEN_MEGAK...,SET,88,-0.10593,-0.0073124,0.095142,0.86722,DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES,1
LUI_THYROID_CANCER_PAX8_PPAR...1,SET,44,-0.13854,-0.0067707,0.1244,0.86728,LUI_THYROID_CANCER_PAX8_PPARG_DN,1
PEDERSEN_METASTASIS_BY_ERBB2...5,SET,25,-0.21798,-0.0080342,0.19569,0.86733,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,1
SOUCEK_MYC_TARGETS,SET,10,-0.32957,-0.0076857,0.29582,0.86737,SOUCEK_MYC_TARGETS,1
GSE339_EX_VIVO_VS_IN_CULTURE...3,SET,180,-0.071453,-0.0070367,0.064131,0.86739,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN,1
ATF5_TARGET_GENES,SET,349,-0.05036,-0.0068736,0.04519,0.86744,ATF5_TARGET_GENES,1
GOCC_CLATHRIN_COATED_VESICLE,SET,201,-0.070078,-0.0072885,0.062873,0.86748,GOCC_CLATHRIN_COATED_VESICLE,1
KEGG_MEDICUS_REFERENCE_NRG_E...,SET,11,-0.27349,-0.0066889,0.24535,0.8675,KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_THE_KNEE,SET,371,-0.050951,-0.0071657,0.045701,0.86754,HP_ABNORMALITY_OF_THE_KNEE,1
HP_THORACOLUMBAR_SCOLIOSIS,SET,37,-0.14463,-0.0064832,0.12971,0.86757,HP_THORACOLUMBAR_SCOLIOSIS,1
GOBP_POSITIVE_REGULATION_OF_...494,SET,6,-0.46142,-0.008336,0.4138,0.86759,GOBP_POSITIVE_REGULATION_OF_MUCUS_SECRETION,1
MIR143_3P_MIR4770,SET,187,-0.070285,-0.0070536,0.063026,0.8676,MIR143_3P_MIR4770,1
HP_ANTENATAL_ONSET,SET,215,-0.064473,-0.0069325,0.057811,0.86762,HP_ANTENATAL_ONSET,1
GOBP_REGULATION_OF_NON_CANON...1,SET,88,-0.10241,-0.0070692,0.091811,0.86765,GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GOCC_EUKARYOTIC_TRANSLATION_...4,SET,7,-0.33858,-0.0066065,0.30354,0.86766,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M,1
HP_PARTIAL_ABSENCE_OF_THUMB,SET,9,-0.28456,-0.0062956,0.2551,0.86767,HP_PARTIAL_ABSENCE_OF_THUMB,1
HP_APPENDICULAR_SPASTICITY,SET,335,-0.051674,-0.0069128,0.04632,0.8677,HP_APPENDICULAR_SPASTICITY,1
CHUNG_BLISTER_CYTOTOXICITY_DN,SET,40,-0.15256,-0.0071098,0.13673,0.86775,CHUNG_BLISTER_CYTOTOXICITY_DN,1
MAZ_Q6,SET,179,-0.072567,-0.0071268,0.065028,0.86777,MAZ_Q6,1
HP_ENLARGED_TONSILS,SET,5,-0.40169,-0.0066247,0.35992,0.86779,HP_ENLARGED_TONSILS,1
KEGG_MEDICUS_REFERENCE_PDGF_...3,SET,16,-0.2422,-0.0071432,0.217,0.86781,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY,1
GOMF_HISTONE_DEUBIQUITINASE_...,SET,7,-0.27658,-0.0053967,0.2478,0.86781,GOMF_HISTONE_DEUBIQUITINASE_ACTIVITY,1
GSE17721_CTRL_VS_GARDIQUIMOD...9,SET,188,-0.070374,-0.0070812,0.063051,0.86781,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,SET,290,-0.055928,-0.0069699,0.050105,0.86783,MULLIGHAN_NPM1_SIGNATURE_3_UP,1
WAKABAYASHI_ADIPOGENESIS_PPA...5,SET,132,-0.082253,-0.0069458,0.073686,0.86784,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,1
GOCC_ENDODEOXYRIBONUCLEASE_C...,SET,5,-0.40137,-0.0066195,0.3595,0.86788,GOCC_ENDODEOXYRIBONUCLEASE_COMPLEX,1
KEGG_MEDICUS_REFERENCE_REGUL...13,SET,4,-0.5279,-0.0077872,0.47282,0.86789,KEGG_MEDICUS_REFERENCE_REGULATION_OF_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY_NLRP3_INHIBITION,1
MIR4766_5P,SET,293,-0.056603,-0.0070898,0.050696,0.86789,MIR4766_5P,1
GOBP_MEMBRANE_TO_MEMBRANE_DO...,SET,4,-0.53285,-0.0078603,0.47722,0.8679,GOBP_MEMBRANE_TO_MEMBRANE_DOCKING,1
REACTOME_REGULATION_OF_GENE_...1,SET,11,-0.28954,-0.0070814,0.2593,0.86791,REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,1
ZFHX3_TARGET_GENES,SET,1386,-0.026566,-0.0070151,0.023782,0.86801,ZFHX3_TARGET_GENES,1
HP_ABSENT_PUBIC_HAIR,SET,8,-0.35781,-0.0074637,0.32032,0.86801,HP_ABSENT_PUBIC_HAIR,1
HP_OCCIPITAL_CORTICAL_ATROPHY,SET,5,-0.5796,-0.0095588,0.51886,0.86801,HP_OCCIPITAL_CORTICAL_ATROPHY,1
GOBP_POSITIVE_REGULATION_OF_...196,SET,14,-0.2824,-0.0077913,0.25279,0.86802,GOBP_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,1
HP_RECURRENT_FRACTURES,SET,124,-0.087209,-0.0071393,0.078067,0.86802,HP_RECURRENT_FRACTURES,1
GSE17721_CTRL_VS_PAM3CSK4_24...2,SET,186,-0.070545,-0.007061,0.06315,0.86802,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP,1
GOBP_REGULATION_OF_OXIDOREDU...,SET,53,-0.13056,-0.007001,0.11686,0.86803,GOBP_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
GSE10325_LUPUS_BCELL_VS_LUPU...2,SET,161,-0.074605,-0.0069522,0.066763,0.86809,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP,1
GOBP_REGULATION_OF_LONG_TERM...3,SET,46,-0.14695,-0.0073425,0.13145,0.86818,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
HP_VITRITIS,SET,2,-0.52218,-0.005447,0.46706,0.86821,HP_VITRITIS,1
BRUNEAU_SEPTATION_VENTRICULAR,SET,10,-0.28111,-0.0065555,0.25142,0.86823,BRUNEAU_SEPTATION_VENTRICULAR,1
GSE11864_CSF1_PAM3CYS_VS_CSF...1,SET,173,-0.073828,-0.0071292,0.066004,0.86832,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
KEGG_MELANOMA,SET,68,-0.12404,-0.0075314,0.11089,0.86835,KEGG_MELANOMA,1
GOBP_CEMENTUM_MINERALIZATION,SET,5,-0.46332,-0.0076411,0.41409,0.8684,GOBP_CEMENTUM_MINERALIZATION,1
MIR3191_5P,SET,147,-0.080808,-0.0071981,0.072219,0.86841,MIR3191_5P,1
MODULE_279,SET,123,-0.086223,-0.0070302,0.07705,0.86843,MODULE_279,1
GSE3039_CD4_TCELL_VS_ALPHABE...1,SET,183,-0.069404,-0.0068911,0.062006,0.86849,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN,1
GOBP_NEUTROPHIL_DEGRANULATION,SET,13,-0.26074,-0.0069322,0.23287,0.86856,GOBP_NEUTROPHIL_DEGRANULATION,1
GSE22886_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.067384,-0.0066724,0.060183,0.86856,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN,1
GOCC_CYCLIN_CDK_POSITIVE_TRA...,SET,8,-0.2521,-0.0052586,0.22513,0.86859,GOCC_CYCLIN_CDK_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,1
GOCC_CIA_COMPLEX,SET,2,-0.53636,-0.005595,0.47891,0.86863,GOCC_CIA_COMPLEX,1
HP_ABNORMALITY_OF_BONE_MINER...,SET,572,-0.041005,-0.0071206,0.036613,0.86863,HP_ABNORMALITY_OF_BONE_MINERAL_DENSITY,1
GSE19825_IL2RALOW_VS_IL2RAHI...1,SET,182,-0.069271,-0.0068593,0.061833,0.8687,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,1
GOBP_REGULATION_OF_MIRNA_CAT...,SET,4,-0.3989,-0.0058843,0.35605,0.86871,GOBP_REGULATION_OF_MIRNA_CATABOLIC_PROCESS,1
GSE16450_CTRL_VS_IFNA_12H_ST...4,SET,180,-0.071548,-0.0070461,0.063861,0.86871,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,1
WANG_RESPONSE_TO_ANDROGEN_UP,SET,28,-0.1771,-0.0069075,0.15807,0.86872,WANG_RESPONSE_TO_ANDROGEN_UP,1
GOBP_RESPONSE_TO_THYROGLOBUL...,SET,5,-0.48382,-0.0079792,0.43183,0.86872,GOBP_RESPONSE_TO_THYROGLOBULIN_TRIIODOTHYRONINE,1
MIR7113_3P,SET,84,-0.10049,-0.0067781,0.089684,0.86874,MIR7113_3P,1
MIR3685,SET,166,-0.073726,-0.0069752,0.065771,0.86884,MIR3685,1
GOMF_METAL_CATION_MONOATOMIC...,SET,39,-0.15606,-0.0071814,0.1392,0.86886,GOMF_METAL_CATION_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,1
SU_THYMUS,SET,19,-0.25694,-0.0082573,0.22915,0.86891,SU_THYMUS,1
GOBP_REGULATION_OF_LYMPHOCYT...6,SET,63,-0.12559,-0.0073404,0.11199,0.86893,GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION,1
MIR3064_3P,SET,154,-0.07891,-0.0071931,0.070363,0.86895,MIR3064_3P,1
CASTELLANO_HRAS_AND_NRAS_TAR...2,SET,5,-0.39497,-0.006514,0.35215,0.86898,CASTELLANO_HRAS_AND_NRAS_TARGETS_UP,1
GOBP_REGULATION_OF_GLUTAMATE...2,SET,6,-0.41813,-0.0075539,0.37273,0.86902,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMAL_MUSCULOSKELETAL_...,SET,1455,-0.026085,-0.0070432,0.023253,0.86902,HP_ABNORMAL_MUSCULOSKELETAL_PHYSIOLOGY,1
HP_STIFF_SKIN,SET,6,-0.41474,-0.0074926,0.36969,0.86903,HP_STIFF_SKIN,1
HP_PITUITARY_PROLACTIN_CELL_...,SET,7,-0.34282,-0.0066893,0.3055,0.86909,HP_PITUITARY_PROLACTIN_CELL_ADENOMA,1
REACTOME_SIGNALING_BY_NOTCH,SET,168,-0.07001,-0.006663,0.062385,0.86911,REACTOME_SIGNALING_BY_NOTCH,1
REACTOME_ERBB2_ACTIVATES_PTK...,SET,13,-0.27011,-0.0071815,0.24065,0.86916,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,1
WINNEPENNINCKX_MELANOMA_META...2,SET,151,-0.073421,-0.0066278,0.065391,0.86923,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,1
HP_DIFFUSE_CEREBRAL_ATROPHY,SET,45,-0.14192,-0.0070139,0.12637,0.86927,HP_DIFFUSE_CEREBRAL_ATROPHY,1
MODULE_361,SET,127,-0.085762,-0.0071047,0.076363,0.86929,MODULE_361,1
MOOTHA_HUMAN_MITODB_6_2002,SET,382,-0.048296,-0.0068902,0.043001,0.8693,MOOTHA_HUMAN_MITODB_6_2002,1
ZHAN_MULTIPLE_MYELOMA_HP_DN,SET,38,-0.15467,-0.0070257,0.1377,0.86932,ZHAN_MULTIPLE_MYELOMA_HP_DN,1
MIR5699_5P,SET,98,-0.094816,-0.0069053,0.084416,0.86932,MIR5699_5P,1
GOBP_THYMIC_T_CELL_SELECTION,SET,24,-0.20412,-0.0073717,0.1817,0.86936,GOBP_THYMIC_T_CELL_SELECTION,1
GOBP_LEUKOCYTE_MEDIATED_CYTO...,SET,133,-0.093276,-0.0079062,0.083027,0.86937,GOBP_LEUKOCYTE_MEDIATED_CYTOTOXICITY,1
GOBP_PROTEIN_K11_LINKED_UBIQ...,SET,31,-0.16427,-0.006741,0.14621,0.86938,GOBP_PROTEIN_K11_LINKED_UBIQUITINATION,1
HP_ABNORMAL_CRY,SET,54,-0.12762,-0.0069075,0.11358,0.8694,HP_ABNORMAL_CRY,1
MIR203A_5P,SET,51,-0.12921,-0.0067971,0.11499,0.86941,MIR203A_5P,1
GTGCCAA_MIR96,SET,276,-0.059316,-0.0072143,0.052787,0.86942,GTGCCAA_MIR96,1
GOBP_METANEPHRIC_TUBULE_MORP...,SET,10,-0.33034,-0.0077037,0.29396,0.86944,GOBP_METANEPHRIC_TUBULE_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...666,SET,25,-0.20913,-0.0077081,0.18606,0.86949,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
CAGGTA_AREB6_01,SET,683,-0.038378,-0.0072597,0.034139,0.86952,CAGGTA_AREB6_01,1
ANDERSON_BLOOD_CN54GP140_ADJ...7,SET,6,-0.37308,-0.0067399,0.33181,0.86956,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_DN,1
GOBP_REGULATION_OF_HORMONE_L...,SET,511,-0.045864,-0.0075406,0.040784,0.8696,GOBP_REGULATION_OF_HORMONE_LEVELS,1
MIR6090,SET,9,-0.35138,-0.0077739,0.31245,0.86961,MIR6090,1
HP_FOCAL_CLONIC_SEIZURE,SET,39,-0.15338,-0.0070581,0.13638,0.86963,HP_FOCAL_CLONIC_SEIZURE,1
GSE17721_CTRL_VS_CPG_0.5H_BM...2,SET,184,-0.069893,-0.0069584,0.062137,0.86966,GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP,1
GSE11057_CD4_EFF_MEM_VS_PBMC...1,SET,183,-0.074536,-0.0074006,0.066255,0.86969,GSE11057_CD4_EFF_MEM_VS_PBMC_DN,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...3,SET,28,-0.18876,-0.0073621,0.16779,0.86969,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE,1
GOBP_VERY_LONG_CHAIN_FATTY_A...2,SET,6,-0.32179,-0.0058135,0.28601,0.86972,GOBP_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,1
HP_RECURRENT_ASPIRATION_PNEU...,SET,23,-0.19404,-0.00686,0.17246,0.86972,HP_RECURRENT_ASPIRATION_PNEUMONIA,1
REACTOME_KEAP1_NFE2L2_PATHWAY,SET,119,-0.086766,-0.0069592,0.077091,0.8698,REACTOME_KEAP1_NFE2L2_PATHWAY,1
HP_CONVULSIVE_STATUS_EPILEPT...,SET,6,-0.36939,-0.0066734,0.32819,0.86981,HP_CONVULSIVE_STATUS_EPILEPTICUS,1
GSE21927_EL4_VS_MCA203_TUMOR...2,SET,149,-0.083553,-0.0074927,0.074224,0.86984,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP,1
HP_ABNORMALITY_OF_THE_NAIL,SET,449,-0.046873,-0.0072364,0.041638,0.86985,HP_ABNORMALITY_OF_THE_NAIL,1
HP_PROLONGED_BLEEDING_AFTER_...2,SET,16,-0.26731,-0.0078837,0.23745,0.86986,HP_PROLONGED_BLEEDING_AFTER_SURGERY,1
chr13q21,SET,11,-0.45896,-0.011225,0.40764,0.86989,chr13q21,1
GOMF_CYCLOHYDROLASE_ACTIVITY,SET,5,-0.43869,-0.0072349,0.38962,0.8699,GOMF_CYCLOHYDROLASE_ACTIVITY,1
HP_PRIMARY_GONADAL_INSUFFICI...,SET,15,-0.25272,-0.0072169,0.22442,0.86993,HP_PRIMARY_GONADAL_INSUFFICIENCY,1
REACTOME_PROCESSING_AND_ACTI...,SET,10,-0.28343,-0.0066097,0.25168,0.86994,REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO,1
GOBP_CEREBRAL_CORTEX_GABAERG...3,SET,4,-0.54126,-0.0079843,0.4806,0.86995,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_MIGRATION,1
HP_DECREASED_MEAN_CORPUSCULA...1,SET,5,-0.50613,-0.0083472,0.44932,0.87,HP_DECREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,1
MIR3646,SET,771,-0.03594,-0.0072054,0.031905,0.87001,MIR3646,1
KEGG_ANTIGEN_PROCESSING_AND_...,SET,72,-0.13326,-0.0083245,0.11827,0.87006,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_SYNOSTOSIS_INVOLVING_BONE...1,SET,26,-0.21623,-0.0081274,0.1919,0.87007,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_FEET,1
GOBP_REGULATION_OF_SYSTEMIC_...7,SET,4,-0.56542,-0.0083407,0.50176,0.87009,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN,1
HP_INTRAUTERINE_GROWTH_RETAR...,SET,547,-0.040608,-0.0069007,0.036032,0.87012,HP_INTRAUTERINE_GROWTH_RETARDATION,1
HAY_BONE_MARROW_CD34_POS_HSC,SET,96,-0.10617,-0.0076531,0.094199,0.87013,HAY_BONE_MARROW_CD34_POS_HSC,1
GSE33292_DN3_THYMOCYTE_VS_TC...4,SET,184,-0.071797,-0.0071479,0.063698,0.87015,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP,1
GOBP_RAC_PROTEIN_SIGNAL_TRAN...,SET,44,-0.1426,-0.0069693,0.1265,0.87019,GOBP_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
KEGG_MEDICUS_VARIANT_AMPLIFI...14,SET,8,-0.35012,-0.0073034,0.31053,0.87023,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY,1
WP_UREA_CYCLE_AND_ASSOCIATED...,SET,23,-0.19841,-0.0070146,0.17594,0.87027,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,1
GSE16451_IMMATURE_VS_MATURE_...1,SET,181,-0.069266,-0.0068401,0.061422,0.87027,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,1
GOBP_TELENCEPHALON_GLIAL_CEL...,SET,25,-0.21053,-0.0077596,0.18668,0.87028,GOBP_TELENCEPHALON_GLIAL_CELL_MIGRATION,1
BIOCARTA_GHRELIN_PATHWAY,SET,13,-0.32303,-0.0085883,0.28642,0.87029,BIOCARTA_GHRELIN_PATHWAY,1
KEGG_MEDICUS_REFERENCE_TGFA_...1,SET,9,-0.33461,-0.0074029,0.29666,0.87032,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY,1
GOMF_ORGANIC_ACID_TRANSMEMBR...,SET,174,-0.076491,-0.0074075,0.067801,0.87037,GOMF_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE13485_DAY1_VS_DAY3_YF17D_...1,SET,182,-0.067984,-0.0067318,0.060261,0.87037,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN,1
MIR485_3P,SET,207,-0.071725,-0.0075691,0.063573,0.87038,MIR485_3P,1
HP_ULNAR_DEVIATION_OF_THE_WR...,SET,19,-0.25802,-0.0082919,0.22867,0.8704,HP_ULNAR_DEVIATION_OF_THE_WRIST,1
WENG_POR_TARGETS_LIVER_UP,SET,41,-0.15519,-0.0073219,0.13754,0.87041,WENG_POR_TARGETS_LIVER_UP,1
HP_BLEEDING_WITH_MINOR_OR_NO...,SET,7,-0.36951,-0.0072102,0.32746,0.87042,HP_BLEEDING_WITH_MINOR_OR_NO_TRAUMA,1
GOBP_POSITIVE_REGULATION_OF_...272,SET,9,-0.32097,-0.0071012,0.28444,0.87043,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,1
GOBP_POSITIVE_REGULATION_OF_...23,SET,38,-0.16803,-0.007633,0.14888,0.87047,GOBP_POSITIVE_REGULATION_OF_AMINE_TRANSPORT,1
GSE16385_UNTREATED_VS_12H_IL...2,SET,180,-0.07205,-0.0070955,0.063829,0.8705,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP,1
GOBP_PRO_B_CELL_DIFFERENTIAT...,SET,12,-0.28108,-0.0071801,0.24897,0.87054,GOBP_PRO_B_CELL_DIFFERENTIATION,1
HP_HYPOMETHIONINEMIA,SET,8,-0.38985,-0.0081321,0.3452,0.87062,HP_HYPOMETHIONINEMIA,1
GOMF_3_HYDROXYACYL_COA_DEHYD...1,SET,7,-0.47195,-0.009209,0.41784,0.87065,GOMF_3_HYDROXYACYL_COA_DEHYDRATASE_ACTIVITY,1
GSE35543_IN_VIVO_NTREG_VS_IN...1,SET,144,-0.082226,-0.0072499,0.072798,0.87065,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN,1
MSX1_01,SET,158,-0.081939,-0.0075647,0.072541,0.87066,MSX1_01,1
GOBP_RESPONSE_TO_MOLECULE_OF...2,SET,4,-0.51527,-0.007601,0.45618,0.87066,GOBP_RESPONSE_TO_MOLECULE_OF_FUNGAL_ORIGIN,1
MODULE_211,SET,11,-0.37192,-0.0090962,0.32925,0.87067,MODULE_211,1
GOMF_VASCULAR_ENDOTHELIAL_GR...1,SET,4,-0.60918,-0.0089863,0.5393,0.87067,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_BINDING,1
GOBP_DIPEPTIDE_TRANSMEMBRANE...,SET,8,-0.32988,-0.0068811,0.29201,0.87069,GOBP_DIPEPTIDE_TRANSMEMBRANE_TRANSPORT,1
GSE42021_TCONV_PLN_VS_CD24IN...1,SET,183,-0.069438,-0.0068945,0.061466,0.87069,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN,1
GSE1460_CD4_THYMOCYTE_VS_NAI...1,SET,174,-0.074506,-0.0072152,0.065944,0.87072,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,1
REACTOME_SYNTHESIS_OF_GLYCOS...,SET,17,-0.2219,-0.0067456,0.19638,0.87074,REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI,1
REACTOME_G1_S_DNA_DAMAGE_CHE...,SET,64,-0.11082,-0.0065283,0.098065,0.87077,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1
DAVICIONI_RHABDOMYOSARCOMA_P...2,SET,56,-0.1399,-0.0077107,0.12379,0.87079,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,1
GOCC_MALE_PRONUCLEUS,SET,6,-0.32693,-0.0059063,0.28928,0.87079,GOCC_MALE_PRONUCLEUS,1
HP_HAMARTOMA,SET,61,-0.11769,-0.0067692,0.10414,0.87079,HP_HAMARTOMA,1
KEGG_MEDICUS_VARIANT_MUTATIO...24,SET,35,-0.14618,-0.0063731,0.12933,0.8708,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GSE27786_CD8_TCELL_VS_ERYTHR...2,SET,182,-0.06691,-0.0066255,0.059195,0.87082,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP,1
GSE45365_WT_VS_IFNAR_KO_CD11...3,SET,167,-0.07305,-0.0069318,0.064626,0.87083,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP,1
HP_PROGRESSIVE_MICROCEPHALY,SET,82,-0.10144,-0.0067608,0.089737,0.87084,HP_PROGRESSIVE_MICROCEPHALY,1
GSE16385_MONOCYTE_VS_12H_ROS...5,SET,169,-0.069023,-0.0065885,0.061061,0.87084,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,1
GAVISH_3CA_METAPROGRAM_MACRO...6,SET,43,-0.16046,-0.0077525,0.14194,0.87085,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3,1
HP_FLATTENED_FEMORAL_EPIPHYS...,SET,12,-0.27478,-0.0070191,0.24307,0.87085,HP_FLATTENED_FEMORAL_EPIPHYSIS,1
BAFNA_MUC4_TARGETS_UP,SET,3,-0.58884,-0.0075227,0.52084,0.87087,BAFNA_MUC4_TARGETS_UP,1
MIR6732_3P,SET,87,-0.098919,-0.0067899,0.087481,0.87091,MIR6732_3P,1
GOBP_REGULATION_OF_CARBOHYDR...3,SET,163,-0.075873,-0.0071137,0.067098,0.87092,GOBP_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
GSE40666_UNTREATED_VS_IFNA_S...5,SET,181,-0.072694,-0.0071786,0.06428,0.87094,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN,1
REACTOME_NOTCH4_INTRACELLULA...,SET,19,-0.21587,-0.0069375,0.19082,0.87103,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
GSE16385_IL4_VS_ROSIGLITAZON...1,SET,157,-0.075205,-0.0069212,0.066469,0.87106,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
GOBP_ELASTIN_METABOLIC_PROCE...,SET,7,-0.43401,-0.0084687,0.38357,0.87107,GOBP_ELASTIN_METABOLIC_PROCESS,1
WP_CATALYTIC_CYCLE_OF_MAMMAL...,SET,5,-0.54926,-0.0090585,0.48522,0.87117,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,1
GOMF_N_N_DIMETHYLANILINE_MON...,SET,5,-0.54926,-0.0090585,0.48522,0.87117,GOMF_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY,1
CARRILLOREIXACH_HEPATOBLASTO...2,SET,18,-0.2343,-0.007329,0.20696,0.8712,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN,1
KEGG_ASTHMA,SET,25,-0.22063,-0.0081319,0.19487,0.87122,KEGG_ASTHMA,1
HP_LOWER_LIMB_JOINT_CONTRACT...,SET,197,-0.06962,-0.0071693,0.061488,0.87123,HP_LOWER_LIMB_JOINT_CONTRACTURE,1
GSE17721_CTRL_VS_PAM3CSK4_4H...2,SET,183,-0.069972,-0.0069475,0.061788,0.87127,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP,1
GOBP_ORGANIC_CYCLIC_COMPOUND...,SET,559,-0.041345,-0.0071002,0.036508,0.87128,GOBP_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS,1
HP_ABNORMAL_URINE_CARBOXYLIC...,SET,117,-0.0921,-0.0073251,0.081297,0.87136,HP_ABNORMAL_URINE_CARBOXYLIC_ACID_LEVEL,1
MODULE_367,SET,28,-0.19187,-0.0074835,0.16935,0.87138,MODULE_367,1
GSE1740_UNSTIM_VS_IFNA_STIMU...4,SET,165,-0.078699,-0.0074235,0.069459,0.87139,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP,1
GOMF_INTRACELLULARLY_CGMP_AC...,SET,6,-0.40489,-0.0073146,0.35732,0.87141,GOMF_INTRACELLULARLY_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,1
GSE16385_MONOCYTE_VS_12H_IFN...1,SET,174,-0.075433,-0.007305,0.066568,0.87142,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,1
GOBP_RETROGRADE_AXONAL_TRANS...,SET,21,-0.20915,-0.0070659,0.18455,0.87145,GOBP_RETROGRADE_AXONAL_TRANSPORT,1
HP_HETEROCHROMIA_IRIDIS,SET,23,-0.21738,-0.0076854,0.19181,0.87145,HP_HETEROCHROMIA_IRIDIS,1
REACTOME_NPAS4_REGULATES_EXP...,SET,20,-0.23451,-0.007732,0.20692,0.87146,REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES,1
HP_ABNORMALITY_OF_THE_PINEAL...,SET,14,-0.26107,-0.0072028,0.23024,0.87158,HP_ABNORMALITY_OF_THE_PINEAL_GLAND,1
MASSARWEH_RESPONSE_TO_ESTRAD...,SET,59,-0.13763,-0.0077858,0.12134,0.87165,MASSARWEH_RESPONSE_TO_ESTRADIOL,1
GSE32533_WT_VS_MIR17_OVEREXP...1,SET,174,-0.077836,-0.0075377,0.068619,0.87166,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,1
BIOCARTA_UCALPAIN_PATHWAY,SET,14,-0.27139,-0.0074877,0.23923,0.87169,BIOCARTA_UCALPAIN_PATHWAY,1
MIR1206,SET,105,-0.0948,-0.0071451,0.083563,0.87169,MIR1206,1
DUNNE_TARGETS_OF_AML1_MTG8_F...2,SET,49,-0.14837,-0.0076508,0.13078,0.8717,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,1
HP_RETINOPATHY_OF_PREMATURITY,SET,4,-0.45773,-0.0067522,0.40346,0.8717,HP_RETINOPATHY_OF_PREMATURITY,1
GOBP_PURINE_NUCLEOTIDE_TRANS...,SET,38,-0.17423,-0.0079142,0.15354,0.87175,GOBP_PURINE_NUCLEOTIDE_TRANSPORT,1
GSE6092_UNSTIM_VS_IFNG_STIM_...1,SET,177,-0.074331,-0.0072595,0.065489,0.87181,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,1
GSE22886_NAIVE_CD4_TCELL_VS_...12,SET,171,-0.074771,-0.0071788,0.065873,0.87182,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP,1
GOBP_REGULATION_OF_MOTOR_NEU...,SET,15,-0.2422,-0.0069166,0.21337,0.87183,GOBP_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GSE40277_GATA1_AND_SATB1_TRA...2,SET,181,-0.07181,-0.0070913,0.063261,0.87184,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,1
GSE9650_NAIVE_VS_EFF_CD8_TCE...2,SET,182,-0.071125,-0.0070429,0.062655,0.87184,GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP,1
GSE26343_UNSTIM_VS_LPS_STIM_...2,SET,191,-0.072027,-0.0073046,0.063442,0.87187,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,1
GOBP_RESPONSE_TO_NITRIC_OXIDE,SET,17,-0.24156,-0.0073436,0.21276,0.87189,GOBP_RESPONSE_TO_NITRIC_OXIDE,1
GOBP_T_CELL_EXTRAVASATION,SET,11,-0.31017,-0.007586,0.27315,0.87191,GOBP_T_CELL_EXTRAVASATION,1
GOBP_ENDOPLASMIC_RETICULUM_T...1,SET,25,-0.16964,-0.0062524,0.14939,0.87192,GOBP_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT,1
GOBP_RESPIRATORY_SYSTEM_DEVE...,SET,209,-0.071186,-0.0075481,0.062685,0.87194,GOBP_RESPIRATORY_SYSTEM_DEVELOPMENT,1
MIR6745,SET,85,-0.10793,-0.0073228,0.095031,0.87195,MIR6745,1
HP_ABNORMAL_ST_SEGMENT,SET,38,-0.16407,-0.0074527,0.14445,0.87197,HP_ABNORMAL_ST_SEGMENT,1
COATES_MACROPHAGE_M1_VS_M2_UP,SET,80,-0.11401,-0.0075055,0.10037,0.87198,COATES_MACROPHAGE_M1_VS_M2_UP,1
REACTOME_COPI_MEDIATED_ANTER...,SET,99,-0.091585,-0.0067038,0.080621,0.87201,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1
HSF2_TARGET_GENES,SET,196,-0.066698,-0.0068511,0.058711,0.87202,HSF2_TARGET_GENES,1
MIR127_3P,SET,5,-0.4861,-0.0080168,0.42783,0.87205,MIR127_3P,1
MAYBURD_RESPONSE_TO_L663536_...1,SET,51,-0.12697,-0.0066793,0.11174,0.87208,MAYBURD_RESPONSE_TO_L663536_DN,1
MIR223_5P,SET,138,-0.082748,-0.0071435,0.07281,0.87212,MIR223_5P,1
NIKOLSKY_BREAST_CANCER_15Q26...,SET,17,-0.36323,-0.011042,0.31959,0.87213,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,1
PIEPOLI_LGI1_TARGETS_DN,SET,12,-0.28612,-0.0073088,0.25174,0.87213,PIEPOLI_LGI1_TARGETS_DN,1
REACTOME_ABACAVIR_TRANSMEMBR...,SET,5,-0.51391,-0.0084755,0.45217,0.87213,REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT,1
REACTOME_RUNX1_REGULATES_TRA...4,SET,7,-0.35624,-0.0069512,0.31343,0.87213,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS,1
GOBP_REGULATION_OF_BRANCHING...5,SET,5,-0.47884,-0.0078971,0.42131,0.87213,GOBP_REGULATION_OF_BRANCHING_MORPHOGENESIS_OF_A_NERVE,1
MORF_SOD1,SET,243,-0.058419,-0.006673,0.051396,0.87215,MORF_SOD1,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...3,SET,220,-0.062822,-0.0068322,0.055266,0.87217,GOBP_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GCM_CSNK1A1,SET,35,-0.14642,-0.0063835,0.12878,0.8722,GCM_CSNK1A1,1
HP_SEVERE_GLOBAL_DEVELOPMENT...,SET,197,-0.067713,-0.0069729,0.059554,0.87222,HP_SEVERE_GLOBAL_DEVELOPMENTAL_DELAY,1
GOBP_DEOXYRIBONUCLEOSIDE_MET...,SET,10,-0.33202,-0.0077428,0.29201,0.87223,GOBP_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
HP_SHORT_UMBILICAL_CORD,SET,6,-0.42645,-0.0077041,0.37501,0.87226,HP_SHORT_UMBILICAL_CORD,1
MIR655_5P,SET,75,-0.12016,-0.0076606,0.10566,0.87228,MIR655_5P,1
BENPORATH_PRC2_TARGETS,SET,575,-0.047419,-0.0082553,0.041694,0.87229,BENPORATH_PRC2_TARGETS,1
chr7q36,SET,76,-0.22643,-0.014531,0.19907,0.87231,chr7q36,1
GOBP_ESTABLISHMENT_OF_PROTEI...8,SET,18,-0.21621,-0.0067631,0.19009,0.87231,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME,1
BILBAN_B_CLL_LPL_UP,SET,55,-0.13143,-0.0071789,0.11554,0.87232,BILBAN_B_CLL_LPL_UP,1
TRIP13_TARGET_GENES,SET,69,-0.118,-0.0072164,0.10374,0.87232,TRIP13_TARGET_GENES,1
GOBP_REGULATION_OF_LYMPHOCYT...5,SET,170,-0.08081,-0.0077361,0.071044,0.87232,GOBP_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,1
GSE36476_YOUNG_VS_OLD_DONOR_...8,SET,167,-0.0752,-0.0071359,0.066113,0.87232,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP,1
GSE5142_HTERT_TRANSDUCED_VS_...1,SET,178,-0.073026,-0.0071519,0.064201,0.87232,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN,1
GOBP_REGULATION_OF_NITRIC_OX...3,SET,20,-0.21911,-0.0072241,0.19261,0.87234,GOBP_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
GOBP_MONOATOMIC_CATION_TRANS...1,SET,750,-0.03762,-0.0074431,0.033066,0.87237,GOBP_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORT,1
MANNE_COVID19_ICU_VS_HEALTHY...1,SET,134,-0.091465,-0.0077816,0.080339,0.87253,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,1
GOBP_XMP_METABOLIC_PROCESS,SET,7,-0.35741,-0.0069741,0.31393,0.87254,GOBP_XMP_METABOLIC_PROCESS,1
MIR4715_3P,SET,67,-0.12331,-0.0074316,0.10828,0.87259,MIR4715_3P,1
GOBP_REGULATION_OF_EXCRETION,SET,9,-0.35182,-0.0077837,0.30887,0.87265,GOBP_REGULATION_OF_EXCRETION,1
GSE17721_CPG_VS_GARDIQUIMOD_...16,SET,180,-0.073915,-0.0072792,0.064885,0.87268,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP,1
BIOCARTA_NO1_PATHWAY,SET,28,-0.20698,-0.0080729,0.18165,0.87274,BIOCARTA_NO1_PATHWAY,1
HP_INCREASED_VERTEBRAL_HEIGHT,SET,10,-0.28142,-0.0065628,0.24694,0.87278,HP_INCREASED_VERTEBRAL_HEIGHT,1
HP_ABNORMAL_ELASTICITY_OF_SK...,SET,204,-0.069074,-0.007237,0.060603,0.8728,HP_ABNORMAL_ELASTICITY_OF_SKIN,1
HP_APLASIA_HYPOPLASIA_OF_FAC...,SET,50,-0.14873,-0.0077473,0.1305,0.8728,HP_APLASIA_HYPOPLASIA_OF_FACIAL_BONES,1
HP_ABNORMALITY_OF_DENTAL_COL...,SET,31,-0.17431,-0.0071528,0.15292,0.87282,HP_ABNORMALITY_OF_DENTAL_COLOR,1
KEGG_MEDICUS_PATHOGEN_SALMON...9,SET,5,-0.35993,-0.0059361,0.31575,0.87283,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SPVD_TO_TNF_NFKB_SIGNALING_PATHWAY,1
REACTOME_DOWNSTREAM_SIGNALIN...1,SET,77,-0.10189,-0.0065813,0.089369,0.87287,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1
HP_COMPLEX_FEBRILE_SEIZURE,SET,15,-0.24341,-0.0069512,0.21348,0.87289,HP_COMPLEX_FEBRILE_SEIZURE,1
HP_INTERSTITIAL_PNEUMONITIS,SET,15,-0.26829,-0.0076617,0.23529,0.87291,HP_INTERSTITIAL_PNEUMONITIS,1
KRAS.BREAST_UP.V1_DN,SET,124,-0.092667,-0.0075861,0.081265,0.87292,KRAS.BREAST_UP.V1_DN,1
REACTOME_RUNX1_REGULATES_TRA...1,SET,6,-0.38832,-0.0070152,0.34051,0.87293,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING,1
LINDGREN_BLADDER_CANCER_CLUS...4,SET,8,-0.33812,-0.0070529,0.29642,0.87299,LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP,1
HP_AXONAL_DEGENERATION_REGEN...,SET,9,-0.33011,-0.0073035,0.28939,0.873,HP_AXONAL_DEGENERATION_REGENERATION,1
HALLMARK_SPERMATOGENESIS,SET,126,-0.089671,-0.0073994,0.078608,0.873,HALLMARK_SPERMATOGENESIS,1
GSE35543_IN_VIVO_NTREG_VS_CO...1,SET,179,-0.075419,-0.0074068,0.066113,0.87301,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN,1
GOMF_SUMO_BINDING,SET,16,-0.23637,-0.0069713,0.20718,0.87304,GOMF_SUMO_BINDING,1
REACTOME_CHONDROITIN_SULFATE...2,SET,45,-0.14589,-0.0072103,0.12787,0.87305,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,1
MIR4737,SET,4,-0.52074,-0.0076816,0.45636,0.87307,MIR4737,1
GOMF_MONOATOMIC_CATION_TRANS...,SET,580,-0.042062,-0.0073534,0.036862,0.87307,GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...1,SET,159,-0.079638,-0.0073753,0.069793,0.87307,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN,1
GOCC_CLATHRIN_COATED_PIT,SET,73,-0.11227,-0.0070615,0.098358,0.87314,GOCC_CLATHRIN_COATED_PIT,1
BAKKER_FOXO3_TARGETS_DN,SET,157,-0.076325,-0.0070243,0.066862,0.87317,BAKKER_FOXO3_TARGETS_DN,1
HP_SLENDER_BUILD,SET,23,-0.18512,-0.0065447,0.16216,0.87317,HP_SLENDER_BUILD,1
GOBP_POSITIVE_REGULATION_OF_...309,SET,11,-0.32695,-0.0079964,0.28639,0.87318,GOBP_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION,1
GOBP_L_ALPHA_AMINO_ACID_TRAN...,SET,66,-0.1258,-0.0075255,0.11014,0.87332,GOBP_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_GLYCOGEN_...1,SET,25,-0.19976,-0.0073627,0.17489,0.87332,GOBP_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_L...3,SET,128,-0.083947,-0.0069814,0.073489,0.87333,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
GSE14308_NAIVE_CD4_TCELL_VS_...2,SET,178,-0.074423,-0.0072888,0.065149,0.87334,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP,1
PLASARI_NFIC_TARGETS_BASAL_DN,SET,20,-0.25124,-0.0082835,0.21992,0.87335,PLASARI_NFIC_TARGETS_BASAL_DN,1
REACTOME_CROSSLINKING_OF_COL...,SET,16,-0.27835,-0.0082093,0.24363,0.87337,REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,1
MIR3928_3P,SET,84,-0.10163,-0.006855,0.088952,0.87337,MIR3928_3P,1
NIKOLSKY_BREAST_CANCER_6P24_...,SET,21,-0.33173,-0.011207,0.29034,0.87338,NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON,1
HP_DELIRIUM,SET,8,-0.34555,-0.0072079,0.30238,0.87342,HP_DELIRIUM,1
GUILLAUMOND_KLF10_TARGETS_DN,SET,27,-0.19263,-0.0073781,0.16856,0.87343,GUILLAUMOND_KLF10_TARGETS_DN,1
GSE26928_NAIVE_VS_CXCR5_POS_...2,SET,155,-0.075782,-0.0069302,0.066312,0.87343,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP,1
GSE27786_LIN_NEG_VS_NKTCELL_...1,SET,184,-0.068452,-0.006815,0.059886,0.87348,GSE27786_LIN_NEG_VS_NKTCELL_DN,1
ENK_UV_RESPONSE_KERATINOCYTE...2,SET,470,-0.044995,-0.007103,0.039362,0.8735,ENK_UV_RESPONSE_KERATINOCYTE_UP,1
GOCC_9PLUS0_NON_MOTILE_CILIUM,SET,114,-0.090697,-0.0071211,0.079337,0.87351,GOCC_9PLUS0_NON_MOTILE_CILIUM,1
GNF2_PA2G4,SET,75,-0.10384,-0.0066199,0.09083,0.87352,GNF2_PA2G4,1
GOBP_CALCIUM_MEDIATED_SIGNAL...,SET,214,-0.070481,-0.0075611,0.061648,0.87353,GOBP_CALCIUM_MEDIATED_SIGNALING,1
GOBP_NEUROMUSCULAR_SYNAPTIC_...,SET,26,-0.19409,-0.007295,0.16977,0.87353,GOBP_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION,1
GOBP_PROTEIN_HISTIDYL_MODIFI...,SET,7,-0.32473,-0.0063364,0.284,0.87356,GOBP_PROTEIN_HISTIDYL_MODIFICATION_TO_DIPHTHAMIDE,1
HP_DISTAL_RENAL_TUBULAR_ACID...,SET,6,-0.41082,-0.0074218,0.35929,0.87356,HP_DISTAL_RENAL_TUBULAR_ACIDOSIS,1
HP_DYSGENESIS_OF_THE_CEREBEL...,SET,7,-0.30354,-0.0059228,0.26539,0.87363,HP_DYSGENESIS_OF_THE_CEREBELLAR_VERMIS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...20,SET,6,-0.40753,-0.0073624,0.35624,0.87368,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_ANOTHER_COMPOUND_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
REACTOME_REGULATION_OF_PYRUV...1,SET,12,-0.30419,-0.0077704,0.26585,0.87373,REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX,1
REACTOME_UCH_PROTEINASES,SET,80,-0.10497,-0.0069108,0.091739,0.87373,REACTOME_UCH_PROTEINASES,1
GSE360_DC_VS_MAC_DN,SET,171,-0.076347,-0.0073301,0.066722,0.87373,GSE360_DC_VS_MAC_DN,1
HP_ANEMIA_OF_INADEQUATE_PROD...,SET,174,-0.07188,-0.0069609,0.062804,0.87379,HP_ANEMIA_OF_INADEQUATE_PRODUCTION,1
GSE18791_UNSTIM_VS_NEWCATSLE...10,SET,179,-0.069614,-0.0068367,0.060823,0.87379,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP,1
GOMF_PLATELET_DERIVED_GROWTH...1,SET,11,-0.35276,-0.0086277,0.3082,0.8738,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_BINDING,1
HP_ERYTHEMA_NODOSUM,SET,7,-0.4135,-0.0080685,0.36117,0.87387,HP_ERYTHEMA_NODOSUM,1
KEGG_MEDICUS_VARIANT_MUTATIO...73,SET,14,-0.25564,-0.007053,0.22324,0.87391,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY,1
DESCARTES_FETAL_SPLEEN_AFP_A...,SET,172,-0.080282,-0.0077302,0.070107,0.87391,DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS,1
GSE17721_LPS_VS_PAM3CSK4_16H...2,SET,189,-0.069893,-0.0070513,0.061032,0.87393,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP,1
GSE19941_UNSTIM_VS_LPS_AND_I...2,SET,185,-0.074876,-0.0074745,0.065375,0.87396,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,1
GSE17580_UNINFECTED_VS_S_MAN...3,SET,175,-0.075446,-0.007327,0.06587,0.87397,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN,1
GSE21546_UNSTIM_VS_ANTI_CD3_...3,SET,145,-0.084906,-0.007512,0.074119,0.874,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN,1
GSE2770_UNTREATED_VS_IL4_TRE...4,SET,188,-0.069777,-0.0070212,0.060903,0.87404,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GOBP_ESTROGEN_BIOSYNTHETIC_P...,SET,11,-0.28963,-0.0070837,0.2527,0.87413,GOBP_ESTROGEN_BIOSYNTHETIC_PROCESS,1
HP_HIP_SUBLUXATION,SET,19,-0.22737,-0.0073071,0.19826,0.87427,HP_HIP_SUBLUXATION,1
HP_FATIGABLE_WEAKNESS_OF_DIS...,SET,8,-0.31356,-0.0065406,0.2734,0.87428,HP_FATIGABLE_WEAKNESS_OF_DISTAL_LIMB_MUSCLES,1
GOBP_LIPID_OXIDATION,SET,107,-0.09479,-0.0072117,0.082639,0.87431,GOBP_LIPID_OXIDATION,1
HP_EPICANTHUS_INVERSUS,SET,13,-0.29787,-0.0079194,0.25963,0.87436,HP_EPICANTHUS_INVERSUS,1
GOCC_CELL_CORTEX_REGION,SET,34,-0.16592,-0.0071298,0.14461,0.87437,GOCC_CELL_CORTEX_REGION,1
REACTOME_FCGAMMA_RECEPTOR_FC...,SET,81,-0.10873,-0.0072027,0.094767,0.87438,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1
HP_HAIR_FOLLICLE_NEOPLASM,SET,5,-0.54373,-0.0089673,0.47382,0.87441,HP_HAIR_FOLLICLE_NEOPLASM,1
GOMF_METALLOAMINOPEPTIDASE_A...,SET,23,-0.2237,-0.0079088,0.1949,0.87447,GOMF_METALLOAMINOPEPTIDASE_ACTIVITY,1
HP_ABNORMAL_P_WAVE,SET,5,-0.51462,-0.0084872,0.44831,0.87449,HP_ABNORMAL_P_WAVE,1
HP_PEDAL_EDEMA,SET,48,-0.14583,-0.0074429,0.12704,0.87449,HP_PEDAL_EDEMA,1
REACTOME_MAPK6_MAPK4_SIGNALI...,SET,86,-0.1031,-0.007036,0.089806,0.87451,REACTOME_MAPK6_MAPK4_SIGNALING,1
LEIN_OLIGODENDROCYTE_MARKERS,SET,72,-0.12066,-0.0075373,0.10509,0.87453,LEIN_OLIGODENDROCYTE_MARKERS,1
WIEMANN_TELOMERE_SHORTENING_...1,SET,5,-0.36371,-0.0059984,0.31678,0.87454,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN,1
GOBP_FEMALE_MEIOTIC_NUCLEAR_...,SET,32,-0.18414,-0.007677,0.16034,0.87459,GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION,1
KEGG_MEDICUS_VARIANT_MUTATIO...64,SET,10,-0.28448,-0.0066342,0.24771,0.8746,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
MIR875_5P,SET,49,-0.1476,-0.0076111,0.12849,0.87465,MIR875_5P,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...4,SET,28,-0.20856,-0.0081345,0.18154,0.87468,HE_LIM_SUN_FETAL_LUNG_C1_LATE_TIP_CELL,1
GOCC_VOLTAGE_GATED_SODIUM_CH...,SET,14,-0.31671,-0.008738,0.27567,0.87469,GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX,1
GOBP_D_AMINO_ACID_TRANSPORT,SET,6,-0.41729,-0.0075386,0.36305,0.8748,GOBP_D_AMINO_ACID_TRANSPORT,1
GOMF_TUMOR_NECROSIS_FACTOR_R...2,SET,28,-0.20489,-0.0079913,0.17825,0.87481,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING,1
GOBP_RESPONSE_TO_CELL_CYCLE_...,SET,7,-0.36449,-0.0071122,0.31701,0.87487,GOBP_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING,1
GOBP_REGULATION_OF_VITAMIN_D...1,SET,7,-0.39278,-0.0076642,0.3416,0.87488,GOBP_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
GOBP_RESPONSE_TO_CAMP,SET,83,-0.1109,-0.0074362,0.096432,0.87493,GOBP_RESPONSE_TO_CAMP,1
HP_FACIAL_HYPEROSTOSIS,SET,4,-0.54314,-0.0080121,0.47225,0.87495,HP_FACIAL_HYPEROSTOSIS,1
BIOCARTA_SALMONELLA_PATHWAY,SET,5,-0.3618,-0.0059668,0.31456,0.87496,BIOCARTA_SALMONELLA_PATHWAY,1
GOMF_PHOSPHOLIPASE_ACTIVITY,SET,101,-0.098438,-0.0072774,0.085582,0.87497,GOMF_PHOSPHOLIPASE_ACTIVITY,1
MIR6732_5P,SET,25,-0.19605,-0.0072258,0.17043,0.87499,MIR6732_5P,1
HP_VISUAL_HALLUCINATION,SET,21,-0.20915,-0.007066,0.18182,0.87499,HP_VISUAL_HALLUCINATION,1
GOBP_HYPOTONIC_RESPONSE,SET,13,-0.29147,-0.0077492,0.25329,0.87507,GOBP_HYPOTONIC_RESPONSE,1
GSE17721_POLYIC_VS_GARDIQUIM...7,SET,181,-0.072318,-0.0071414,0.062845,0.87507,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN,1
GOBP_MEMBRANE_PROTEIN_INTRAC...,SET,12,-0.25441,-0.0064988,0.22103,0.87513,GOBP_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS,1
chr8p12,SET,22,-0.3298,-0.011404,0.28649,0.87516,chr8p12,1
UNTERMAN_IPF_VS_CTRL_CD4T_DN,SET,9,-0.39403,-0.0087176,0.34228,0.87517,UNTERMAN_IPF_VS_CTRL_CD4T_DN,1
GOBP_DEOXYRIBONUCLEOSIDE_CAT...,SET,6,-0.47994,-0.0086705,0.41686,0.87519,GOBP_DEOXYRIBONUCLEOSIDE_CATABOLIC_PROCESS,1
GOMF_WIDE_PORE_CHANNEL_ACTIV...,SET,31,-0.19916,-0.0081727,0.17297,0.8752,GOMF_WIDE_PORE_CHANNEL_ACTIVITY,1
MORF_IFNA1,SET,175,-0.07722,-0.0074994,0.06706,0.87523,MORF_IFNA1,1
GOBP_RESPONSE_TO_INTERLEUKIN...3,SET,5,-0.47329,-0.0078055,0.411,0.87524,GOBP_RESPONSE_TO_INTERLEUKIN_13,1
GSE20727_ROS_INH_VS_ROS_INH_...1,SET,149,-0.084002,-0.0075329,0.072947,0.87524,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,1
MIR28_5P,SET,43,-0.15002,-0.0072481,0.13026,0.87526,MIR28_5P,1
GOBP_POSITIVE_REGULATION_OF_...597,SET,10,-0.31394,-0.0073213,0.2726,0.87526,GOBP_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY,1
ZNF197_TARGET_GENES,SET,504,-0.044065,-0.0071965,0.03826,0.87527,ZNF197_TARGET_GENES,1
GSE20715_0H_VS_6H_OZONE_LUNG...2,SET,182,-0.075786,-0.0075044,0.065803,0.87527,GSE20715_0H_VS_6H_OZONE_LUNG_UP,1
GSE19941_UNSTIM_VS_LPS_STIM_...1,SET,177,-0.074888,-0.0073139,0.065016,0.8753,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN,1
GAVISH_3CA_MALIGNANT_METAPRO...19,SET,45,-0.15603,-0.0077112,0.13543,0.87534,GAVISH_3CA_MALIGNANT_METAPROGRAM_28_OLIGO_NORMAL,1
GSE21546_UNSTIM_VS_ANTI_CD3_...2,SET,163,-0.078537,-0.0073635,0.068168,0.87535,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
MIR8067,SET,250,-0.062133,-0.0071973,0.053929,0.87536,MIR8067,1
GSE40274_CTRL_VS_FOXP3_AND_E...2,SET,157,-0.08015,-0.0073764,0.069549,0.87542,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
PURWIN_A375_SOX10_TARGETS,SET,43,-0.15492,-0.0074848,0.13441,0.87546,PURWIN_A375_SOX10_TARGETS,1
MIKKELSEN_IPS_ICP_WITH_H3K27...,SET,54,-0.13753,-0.0074439,0.11927,0.87555,MIKKELSEN_IPS_ICP_WITH_H3K27ME3,1
GOBP_PHOSPHATIDIC_ACID_METAB...,SET,35,-0.17548,-0.0076506,0.15217,0.87557,GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS,1
GOBP_CRANIAL_GANGLION_DEVELO...,SET,4,-0.54005,-0.0079665,0.46824,0.87561,GOBP_CRANIAL_GANGLION_DEVELOPMENT,1
HP_FETAL_AKINESIA_SEQUENCE,SET,32,-0.17167,-0.0071572,0.14884,0.87562,HP_FETAL_AKINESIA_SEQUENCE,1
HP_ABNORMAL_COAGULATION_FACT...,SET,5,-0.50517,-0.0083313,0.43791,0.87566,HP_ABNORMAL_COAGULATION_FACTOR_V_ACTIVITY,1
HP_OPEN_MOUTH,SET,98,-0.10156,-0.0073965,0.08803,0.87568,HP_OPEN_MOUTH,1
HP_BIFID_SCROTUM,SET,30,-0.19936,-0.0080479,0.17278,0.8757,HP_BIFID_SCROTUM,1
HP_ABNORMAL_RIB_MORPHOLOGY,SET,290,-0.05904,-0.0073577,0.051168,0.87571,HP_ABNORMAL_RIB_MORPHOLOGY,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...1,SET,12,-0.35103,-0.008967,0.3042,0.87573,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_II_PROTEIN_COMPLEX,1
MIR3662,SET,850,-0.035416,-0.0074383,0.030688,0.87575,MIR3662,1
GOBP_GOLGI_TO_ENDOSOME_TRANS...,SET,15,-0.23642,-0.0067515,0.20485,0.87576,GOBP_GOLGI_TO_ENDOSOME_TRANSPORT,1
MIR5007_3P,SET,109,-0.098286,-0.0075468,0.08516,0.87577,MIR5007_3P,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS...2,SET,60,-0.13714,-0.0078233,0.11879,0.87584,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,1
MIR146B_5P,SET,102,-0.096544,-0.0071725,0.083621,0.87585,MIR146B_5P,1
REACTOME_UB_SPECIFIC_PROCESS...,SET,148,-0.07735,-0.0069134,0.066982,0.87591,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1
GOBP_NEGATIVE_REGULATION_OF_...138,SET,21,-0.23938,-0.0080872,0.20726,0.87594,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,1
HP_TRIGONOCEPHALY,SET,40,-0.15422,-0.0071872,0.13352,0.87595,HP_TRIGONOCEPHALY,1
GOBP_POST_EMBRYONIC_DEVELOPM...,SET,80,-0.1115,-0.0073406,0.096492,0.87606,GOBP_POST_EMBRYONIC_DEVELOPMENT,1
MIR4513,SET,46,-0.1441,-0.0072005,0.1247,0.87607,MIR4513,1
KAECH_DAY8_EFF_VS_DAY15_EFF_...2,SET,177,-0.069986,-0.0068351,0.060551,0.87611,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP,1
GOBP_ATTACHMENT_OF_MITOTIC_S...,SET,25,-0.18959,-0.0069878,0.16399,0.87617,GOBP_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
HP_MUCOPOLYSACCHARIDURIA,SET,19,-0.21717,-0.0069792,0.18777,0.87628,HP_MUCOPOLYSACCHARIDURIA,1
GOBP_MATURATION_OF_LSU_RRNA_...,SET,16,-0.20639,-0.0060872,0.1784,0.87634,GOBP_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
GOBP_REGULATION_OF_CARDIAC_M...10,SET,18,-0.23228,-0.0072658,0.20077,0.87635,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION,1
MIR6881_3P,SET,160,-0.079103,-0.0073486,0.068355,0.8764,MIR6881_3P,1
GSE7548_NAIVE_VS_DAY28_PCC_I...2,SET,186,-0.068012,-0.0068074,0.058763,0.87643,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,1
ZHONG_RESPONSE_TO_AZACITIDIN...1,SET,58,-0.11674,-0.0065476,0.10086,0.87644,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,1
KIM_MYCL1_AMPLIFICATION_TARG...1,SET,18,-0.24788,-0.0077539,0.21416,0.87645,KIM_MYCL1_AMPLIFICATION_TARGETS_DN,1
HP_ABNORMAL_RESPIRATORY_EPIT...,SET,23,-0.18724,-0.0066199,0.16175,0.87648,HP_ABNORMAL_RESPIRATORY_EPITHELIUM_MORPHOLOGY,1
GOBP_HORMONE_METABOLIC_PROCE...,SET,228,-0.072121,-0.0079831,0.062294,0.87651,GOBP_HORMONE_METABOLIC_PROCESS,1
GSE9037_WT_VS_IRAK4_KO_BMDM_...1,SET,179,-0.073967,-0.0072643,0.06389,0.87651,GSE9037_WT_VS_IRAK4_KO_BMDM_DN,1
CIZ_01,SET,216,-0.070513,-0.0075994,0.060901,0.87653,CIZ_01,1
GSE29164_UNTREATED_VS_CD8_TC...6,SET,175,-0.072499,-0.0070408,0.062615,0.87653,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP,1
CTIP_DN.V1_UP,SET,116,-0.09563,-0.0075735,0.08259,0.87654,CTIP_DN.V1_UP,1
MIR5700,SET,269,-0.06115,-0.0073439,0.052806,0.87656,MIR5700,1
GSE41867_DAY6_VS_DAY8_LCMV_C...1,SET,183,-0.069894,-0.0069398,0.060329,0.87667,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
GOMF_U1_SNRNP_BINDING,SET,6,-0.40916,-0.0073917,0.35314,0.87669,GOMF_U1_SNRNP_BINDING,1
LU_AGING_BRAIN_DN,SET,139,-0.084561,-0.0073262,0.072974,0.87672,LU_AGING_BRAIN_DN,1
WP_AGERAGE_PATHWAY,SET,63,-0.12781,-0.0074705,0.11018,0.87697,WP_AGERAGE_PATHWAY,1
KEGG_MEDICUS_REFERENCE_GLYCO...4,SET,21,-0.19755,-0.006674,0.17028,0.87699,KEGG_MEDICUS_REFERENCE_GLYCOLYSIS,1
GSE20484_MCSG_VS_CXCL4_MONOC...2,SET,159,-0.078822,-0.0072998,0.067916,0.87708,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP,1
VISALA_RESPONSE_TO_HEAT_SHOC...1,SET,12,-0.28704,-0.0073323,0.24732,0.87709,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,1
HP_THORACIC_AORTIC_ANEURYSM,SET,108,-0.10014,-0.0076543,0.086279,0.87711,HP_THORACIC_AORTIC_ANEURYSM,1
NME2_TARGET_GENES,SET,53,-0.13991,-0.0075028,0.12054,0.87712,NME2_TARGET_GENES,1
HP_LARYNGOTRACHEOMALACIA,SET,7,-0.38695,-0.0075504,0.33335,0.87713,HP_LARYNGOTRACHEOMALACIA,1
GOBP_METHYLATION,SET,180,-0.0698,-0.006874,0.060129,0.87714,GOBP_METHYLATION,1
BOYAULT_LIVER_CANCER_SUBCLAS...8,SET,10,-0.32986,-0.0076924,0.28414,0.87715,BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,1
GOMF_PROTEIN_DISULFIDE_ISOME...,SET,21,-0.22659,-0.0076552,0.19517,0.87717,GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_ARSENI...,SET,6,-0.3358,-0.0060665,0.28918,0.87722,KEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,1
GOBP_PURINE_NUCLEOSIDE_MONOP...3,SET,38,-0.16482,-0.0074871,0.14192,0.87725,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GSE25123_ROSIGLITAZONE_VS_IL...2,SET,177,-0.074431,-0.0072693,0.064088,0.87725,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
chr16q11,SET,7,-0.80051,-0.01562,0.68919,0.87727,chr16q11,1
GSE17721_LPS_VS_GARDIQUIMOD_...18,SET,181,-0.075855,-0.0074907,0.065291,0.87733,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP,1
GSE22886_NAIVE_CD8_TCELL_VS_...5,SET,186,-0.078025,-0.0078097,0.067155,0.87735,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN,1
MORF_EIF4A2,SET,128,-0.082896,-0.006894,0.071337,0.87738,MORF_EIF4A2,1
REACTOME_PROCESSIVE_SYNTHESI...2,SET,14,-0.23563,-0.0065011,0.20277,0.87739,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,1
HP_ABNORMAL_CIRCULATING_ALDO...2,SET,10,-0.33391,-0.007787,0.28734,0.8774,HP_ABNORMAL_CIRCULATING_ALDOSTERONE,1
GOBP_REGULATION_OF_AEROBIC_R...,SET,27,-0.17673,-0.006769,0.15206,0.87743,GOBP_REGULATION_OF_AEROBIC_RESPIRATION,1
DER_IFN_BETA_RESPONSE_DN,SET,6,-0.42247,-0.0076323,0.36341,0.87748,DER_IFN_BETA_RESPONSE_DN,1
HP_EXTRAPYRAMIDAL_DYSKINESIA,SET,6,-0.44742,-0.008083,0.38484,0.8775,HP_EXTRAPYRAMIDAL_DYSKINESIA,1
GOBP_MALE_SEX_DETERMINATION,SET,11,-0.33293,-0.0081427,0.28634,0.87752,GOBP_MALE_SEX_DETERMINATION,1
PIONTEK_PKD1_TARGETS_DN,SET,15,-0.24194,-0.0069092,0.20807,0.87753,PIONTEK_PKD1_TARGETS_DN,1
HP_PULP_CALCIFICATION,SET,7,-0.44592,-0.008701,0.38348,0.87754,HP_PULP_CALCIFICATION,1
HP_CARDIAC_CONDUCTION_ABNORM...,SET,127,-0.089411,-0.007407,0.076873,0.8776,HP_CARDIAC_CONDUCTION_ABNORMALITY,1
MODULE_85,SET,47,-0.16132,-0.0081477,0.13869,0.87762,MODULE_85,1
HP_MULTIPLE_LENTIGINES,SET,15,-0.24114,-0.0068863,0.20729,0.87764,HP_MULTIPLE_LENTIGINES,1
HP_ABNORMAL_4TH_FINGER_MORPH...,SET,20,-0.24294,-0.0080098,0.20882,0.87765,HP_ABNORMAL_4TH_FINGER_MORPHOLOGY,1
GSE46606_UNSTIM_VS_CD40L_IL2...1,SET,185,-0.073975,-0.0073846,0.063587,0.87765,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,1
MIR3185,SET,188,-0.073566,-0.0074024,0.063233,0.87766,MIR3185,1
SESTO_RESPONSE_TO_UV_C6,SET,36,-0.17368,-0.0076793,0.14927,0.87768,SESTO_RESPONSE_TO_UV_C6,1
GOBP_POSITIVE_REGULATION_OF_...575,SET,6,-0.35224,-0.0063634,0.30274,0.87768,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,1
GOBP_VIRAL_RELEASE_FROM_HOST...,SET,28,-0.1783,-0.0069543,0.15321,0.87773,GOBP_VIRAL_RELEASE_FROM_HOST_CELL,1
GSE3982_EOSINOPHIL_VS_NKCELL...1,SET,171,-0.077486,-0.0074395,0.066581,0.87774,GSE3982_EOSINOPHIL_VS_NKCELL_DN,1
MIKKELSEN_MEF_ICP_WITH_H3K4M...,SET,37,-0.17529,-0.0078571,0.15054,0.87785,MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
GOBP_CELLULAR_RESPONSE_TO_PH,SET,25,-0.20056,-0.007392,0.17224,0.87786,GOBP_CELLULAR_RESPONSE_TO_PH,1
GOMF_HEPARAN_SULFATE_SULFOTR...,SET,14,-0.30112,-0.008308,0.25861,0.87786,GOMF_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY,1
GSE6674_CPG_VS_CPG_AND_ANTI_...2,SET,176,-0.071139,-0.0069283,0.061086,0.8779,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP,1
GOBP_CELLULAR_RESPONSE_TO_PR...3,SET,20,-0.27032,-0.0089125,0.23207,0.87794,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS,1
GSE42021_TREG_PLN_VS_TREG_PR...1,SET,188,-0.076794,-0.0077273,0.065927,0.87795,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN,1
GSE23308_CTRL_VS_CORTICOSTER...2,SET,173,-0.074587,-0.0072025,0.064025,0.87798,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN,1
GOBP_PROTEIN_HETEROTETRAMERI...,SET,15,-0.2284,-0.0065225,0.196,0.87804,GOBP_PROTEIN_HETEROTETRAMERIZATION,1
MEK_UP.V1_DN,SET,162,-0.081232,-0.007593,0.06971,0.87804,MEK_UP.V1_DN,1
HP_ABNORMAL_FULL_FIELD_ELECT...,SET,55,-0.1457,-0.0079586,0.125,0.8781,HP_ABNORMAL_FULL_FIELD_ELECTRORETINOGRAM,1
MIR28_3P,SET,46,-0.13631,-0.0068108,0.11694,0.87811,MIR28_3P,1
GOCC_NUCLEAR_CYCLIN_DEPENDEN...,SET,13,-0.21307,-0.0056648,0.18279,0.87811,GOCC_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,1
KEGG_MEDICUS_VARIANT_MUTATIO...65,SET,37,-0.14383,-0.0064469,0.12334,0.87821,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GOBP_SPERMIDINE_TRANSPORT,SET,5,-0.53735,-0.008862,0.46044,0.87839,GOBP_SPERMIDINE_TRANSPORT,1
REACTOME_SIGNALING_BY_LEPTIN,SET,11,-0.37937,-0.0092784,0.32499,0.87845,REACTOME_SIGNALING_BY_LEPTIN,1
GOCC_FIBRILLAR_COLLAGEN_TRIM...,SET,12,-0.3209,-0.0081972,0.2749,0.87845,GOCC_FIBRILLAR_COLLAGEN_TRIMER,1
REACTOME_C_TYPE_LECTIN_RECEP...,SET,126,-0.085344,-0.0070424,0.073106,0.87847,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1
HP_BRADYKINESIA,SET,95,-0.1006,-0.0072143,0.086149,0.87854,HP_BRADYKINESIA,1
GOBP_REGULATION_OF_CHEMOTAXIS,SET,193,-0.076209,-0.0077686,0.065247,0.87859,GOBP_REGULATION_OF_CHEMOTAXIS,1
GOCC_RIBOSOMAL_SUBUNIT,SET,167,-0.072748,-0.0069031,0.062282,0.8786,GOCC_RIBOSOMAL_SUBUNIT,1
MIR1912_3P,SET,80,-0.1112,-0.0073206,0.095195,0.87861,MIR1912_3P,1
GOMF_POTASSIUM_CHANNEL_ACTIV...1,SET,5,-0.50275,-0.0082915,0.43032,0.87865,GOMF_POTASSIUM_CHANNEL_ACTIVATOR_ACTIVITY,1
WP_INTERLEUKIN1_INDUCED_ACTI...,SET,9,-0.32442,-0.0071775,0.27763,0.8787,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,1
MIR891B,SET,115,-0.091401,-0.0072076,0.078215,0.87871,MIR891B,1
GOMF_OXIDOREDUCTASE_ACTIVITY...35,SET,17,-0.27407,-0.0083318,0.23449,0.87875,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS,1
GOBP_LEUKOTRIENE_BIOSYNTHETI...,SET,16,-0.27127,-0.0080007,0.23208,0.87877,GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS,1
REACTOME_APC_C_CDC20_MEDIATE...,SET,22,-0.20441,-0.0070682,0.17483,0.87883,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,1
GOBP_FOREBRAIN_RADIAL_GLIAL_...,SET,7,-0.38981,-0.0076062,0.3334,0.87883,GOBP_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION,1
GSE37301_HEMATOPOIETIC_STEM_...9,SET,152,-0.079427,-0.0071935,0.067924,0.87886,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN,1
LEIN_NEURON_MARKERS,SET,57,-0.13458,-0.0074836,0.11507,0.8789,LEIN_NEURON_MARKERS,1
HP_ABNORMAL_VERTEBRAL_SEGMEN...,SET,8,-0.39835,-0.0083094,0.34057,0.87893,HP_ABNORMAL_VERTEBRAL_SEGMENTATION_AND_FUSION,1
HP_ABNORMAL_HEART_MORPHOLOGY,SET,1338,-0.028221,-0.0073323,0.024121,0.87899,HP_ABNORMAL_HEART_MORPHOLOGY,1
GOBP_TROPHECTODERMAL_CELL_DI...,SET,19,-0.22447,-0.0072138,0.19183,0.87903,GOBP_TROPHECTODERMAL_CELL_DIFFERENTIATION,1
GOCC_U4_SNRNP,SET,10,-0.31525,-0.0073517,0.26937,0.87906,GOCC_U4_SNRNP,1
GSE32423_MEMORY_VS_NAIVE_CD8...5,SET,182,-0.072516,-0.0071806,0.061943,0.87913,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP,1
GOBP_POSITIVE_REGULATION_OF_...436,SET,3,-0.80319,-0.010261,0.68603,0.87915,GOBP_POSITIVE_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
REACTOME_STABILIZATION_OF_P53,SET,53,-0.12714,-0.0068177,0.10855,0.87925,REACTOME_STABILIZATION_OF_P53,1
GOBP_FATTY_ACID_TRANSMEMBRAN...,SET,19,-0.2228,-0.00716,0.1902,0.87927,GOBP_FATTY_ACID_TRANSMEMBRANE_TRANSPORT,1
GOMF_HSP90_PROTEIN_BINDING,SET,38,-0.1594,-0.0072407,0.13605,0.87932,GOMF_HSP90_PROTEIN_BINDING,1
MIR454_3P,SET,386,-0.051485,-0.0073828,0.043936,0.87936,MIR454_3P,1
GSE24142_DN2_VS_DN3_THYMOCYT...5,SET,180,-0.076385,-0.0075225,0.065183,0.87937,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP,1
PU1_Q6,SET,221,-0.07058,-0.0076931,0.060225,0.87938,PU1_Q6,1
GNF2_MATK,SET,23,-0.20245,-0.0071576,0.17275,0.87938,GNF2_MATK,1
GOMF_OXYGEN_BINDING,SET,28,-0.22025,-0.0085903,0.18793,0.87939,GOMF_OXYGEN_BINDING,1
GOBP_DEHYDROASCORBIC_ACID_TR...,SET,7,-0.3518,-0.0068647,0.30014,0.87942,GOBP_DEHYDROASCORBIC_ACID_TRANSPORT,1
HP_NARROW_NARIS,SET,8,-0.30059,-0.0062701,0.25644,0.87942,HP_NARROW_NARIS,1
HP_ABNORMAL_FETAL_GASTROINTE...,SET,17,-0.2525,-0.007676,0.21541,0.87943,HP_ABNORMAL_FETAL_GASTROINTESTINAL_SYSTEM_MORPHOLOGY,1
GOMF_TRANSFERASE_ACTIVITY_TR...2,SET,25,-0.21578,-0.0079532,0.18407,0.87945,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS,1
DESCARTES_MAIN_FETAL_RETINAL...2,SET,43,-0.15855,-0.0076603,0.13524,0.87947,DESCARTES_MAIN_FETAL_RETINAL_PROGENITORS_AND_MULLER_GLIA,1
HP_ABNORMALITY_OF_THE_DISTAL...2,SET,5,-0.41383,-0.006825,0.35292,0.87951,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_2ND_FINGER,1
KDM1B_TARGET_GENES,SET,110,-0.095488,-0.0073654,0.081423,0.87954,KDM1B_TARGET_GENES,1
MORF_LCAT,SET,118,-0.096733,-0.0077262,0.08248,0.87956,MORF_LCAT,1
HP_ABNORMAL_BONE_STRUCTURE,SET,737,-0.037758,-0.0074081,0.032192,0.87957,HP_ABNORMAL_BONE_STRUCTURE,1
GSE42724_MEMORY_BCELL_VS_PLA...2,SET,189,-0.072832,-0.0073479,0.062095,0.87958,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP,1
HP_OPTIC_NERVE_MISROUTING,SET,5,-0.50342,-0.0083025,0.42911,0.87963,HP_OPTIC_NERVE_MISROUTING,1
GOBP_NEGATIVE_REGULATION_OF_...421,SET,12,-0.30667,-0.0078337,0.26134,0.87968,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
GOMF_G_PROTEIN_COUPLED_SEROT...,SET,21,-0.23602,-0.0079736,0.20113,0.87969,GOMF_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_ACTIVITY,1
REACTOME_FLT3_SIGNALING,SET,37,-0.16307,-0.0073094,0.13896,0.8797,REACTOME_FLT3_SIGNALING,1
GOMF_VOLUME_SENSITIVE_ANION_...,SET,9,-0.38116,-0.0084328,0.32478,0.87971,GOMF_VOLUME_SENSITIVE_ANION_CHANNEL_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...2,SET,7,-0.37345,-0.007287,0.3182,0.87972,KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION,1
GOBP_REGULATION_OF_NUCLEAR_T...3,SET,13,-0.26487,-0.007042,0.22568,0.87972,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,1
LYF1_01,SET,238,-0.067549,-0.0076371,0.057545,0.87976,LYF1_01,1
GOBP_PROTEIN_LOCALIZATION_TO...10,SET,62,-0.12783,-0.0074121,0.10888,0.87979,GOBP_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
HP_NEONATAL_DEATH,SET,82,-0.10742,-0.0071591,0.0915,0.87979,HP_NEONATAL_DEATH,1
GSE22886_NAIVE_CD4_TCELL_VS_...6,SET,179,-0.07349,-0.0072173,0.062592,0.87982,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP,1
GOCC_NEURON_PROJECTION_MEMBR...,SET,56,-0.1407,-0.0077548,0.11982,0.87984,GOCC_NEURON_PROJECTION_MEMBRANE,1
HP_ABNORMALITY_OF_ACID_BASE_...,SET,378,-0.049711,-0.0070557,0.042335,0.87984,HP_ABNORMALITY_OF_ACID_BASE_HOMEOSTASIS,1
GOBP_MODULATION_BY_HOST_OF_V...3,SET,3,-0.60172,-0.0076873,0.51229,0.87991,GOBP_MODULATION_BY_HOST_OF_VIRAL_RNA_GENOME_REPLICATION,1
GOBP_GRANULOCYTE_CHEMOTAXIS,SET,118,-0.10535,-0.0084148,0.089686,0.87993,GOBP_GRANULOCYTE_CHEMOTAXIS,1
ZNF512_TARGET_GENES,SET,327,-0.057256,-0.0075691,0.048741,0.87994,ZNF512_TARGET_GENES,1
GOMF_ACETYLCHOLINE_RECEPTOR_...3,SET,7,-0.45778,-0.0089326,0.38968,0.87995,GOMF_ACETYLCHOLINE_RECEPTOR_INHIBITOR_ACTIVITY,1
GOBP_TERPENOID_BIOSYNTHETIC_...,SET,16,-0.25284,-0.007457,0.21521,0.87996,GOBP_TERPENOID_BIOSYNTHETIC_PROCESS,1
GAUTAM_EYE_IRIS_CILIARY_BODY...11,SET,112,-0.10175,-0.0079188,0.086609,0.87996,GAUTAM_EYE_IRIS_CILIARY_BODY_MONOCYTES,1
HIPC_SIGNATURES_PROJECT_PBMC...2,SET,9,-0.34053,-0.0075339,0.28984,0.87997,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_UP,1
GSE13547_CTRL_VS_ANTI_IGM_ST...6,SET,126,-0.091137,-0.0075203,0.077559,0.88001,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP,1
FAN_OVARY_CL10_PUTATIVE_EARL...,SET,225,-0.063816,-0.0070178,0.054306,0.88002,FAN_OVARY_CL10_PUTATIVE_EARLY_ATRESIA_GRANULOSA_CELL,1
GOBP_POSITIVE_REGULATION_OF_...701,SET,6,-0.50387,-0.0091028,0.42868,0.88008,GOBP_POSITIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,1
HP_DIFFUSE_OPTIC_DISC_PALLOR,SET,14,-0.28112,-0.0077561,0.23917,0.88008,HP_DIFFUSE_OPTIC_DISC_PALLOR,1
MIR4527,SET,64,-0.12605,-0.0074257,0.10724,0.88009,MIR4527,1
GOBP_POSITIVE_REGULATION_OF_...32,SET,8,-0.34507,-0.0071979,0.29353,0.88011,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_STEROETYPIC_MOVEMENTS_OF_...,SET,50,-0.13928,-0.0072547,0.11846,0.88013,HP_STEROETYPIC_MOVEMENTS_OF_FACE_AND_HEAD,1
HP_APLASIA_HYPOPLASIA_INVOLV...9,SET,119,-0.093606,-0.0075079,0.079598,0.88019,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_METACARPAL_BONES,1
HP_NORMAL_PRESSURE_HYDROCEPH...,SET,5,-0.50611,-0.0083469,0.43035,0.8802,HP_NORMAL_PRESSURE_HYDROCEPHALUS,1
GOMF_NUCLEOSIDE_TRANSMEMBRAN...,SET,10,-0.34794,-0.0081141,0.29579,0.88026,GOMF_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_FLARED_ILIAC_WING,SET,16,-0.24517,-0.0072307,0.20842,0.88026,HP_FLARED_ILIAC_WING,1
GOCC_CONDENSED_CHROMOSOME_CE...,SET,164,-0.075006,-0.0070538,0.063757,0.88028,GOCC_CONDENSED_CHROMOSOME_CENTROMERIC_REGION,1
HP_POINTED_CHIN,SET,118,-0.096246,-0.0076873,0.081801,0.88031,HP_POINTED_CHIN,1
GOCC_CILIARY_BASAL_BODY,SET,144,-0.082889,-0.0073084,0.070445,0.88032,GOCC_CILIARY_BASAL_BODY,1
GSE17721_CTRL_VS_GARDIQUIMOD...2,SET,184,-0.073466,-0.0073141,0.06242,0.88039,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
MIR148B_5P,SET,70,-0.11904,-0.0073328,0.10114,0.88041,MIR148B_5P,1
GOBP_LEUKOCYTE_MEDIATED_IMMU...,SET,364,-0.056622,-0.0078894,0.048093,0.88046,GOBP_LEUKOCYTE_MEDIATED_IMMUNITY,1
MODULE_51,SET,36,-0.19212,-0.0084948,0.16317,0.88049,MODULE_51,1
HP_PREMATURE_OSTEOARTHRITIS,SET,9,-0.35333,-0.0078171,0.30008,0.88049,HP_PREMATURE_OSTEOARTHRITIS,1
GOBP_POLYOL_BIOSYNTHETIC_PRO...,SET,58,-0.13108,-0.0073519,0.11131,0.8805,GOBP_POLYOL_BIOSYNTHETIC_PROCESS,1
GOMF_G_QUADRUPLEX_RNA_BINDING,SET,6,-0.40112,-0.0072465,0.34063,0.88051,GOMF_G_QUADRUPLEX_RNA_BINDING,1
HP_DECREASED_CIRCULATING_IGG...1,SET,7,-0.35922,-0.0070094,0.30504,0.88052,HP_DECREASED_CIRCULATING_IGG2_LEVEL,1
KEGG_MEDICUS_REFERENCE_METHI...,SET,10,-0.36018,-0.0083996,0.30583,0.88054,KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION,1
GSE8685_IL2_ACT_IL2_STARVED_...2,SET,181,-0.072268,-0.0071365,0.061361,0.88054,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,1
CTAGGAA_MIR384,SET,56,-0.132,-0.0072754,0.11206,0.88058,CTAGGAA_MIR384,1
GOBP_T_CELL_SELECTION,SET,57,-0.14528,-0.0080784,0.12333,0.8806,GOBP_T_CELL_SELECTION,1
GSE29618_PRE_VS_DAY7_POST_TI...5,SET,172,-0.070126,-0.0067524,0.059526,0.88061,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN,1
GOMF_LEUKOTRIENE_C4_GAMMA_GL...,SET,4,-0.50373,-0.0074307,0.42752,0.88065,GOMF_LEUKOTRIENE_C4_GAMMA_GLUTAMYL_TRANSFERASE_ACTIVITY,1
HP_ABSENT_INNER_DYNEIN_ARMS,SET,7,-0.35898,-0.0070047,0.30466,0.88066,HP_ABSENT_INNER_DYNEIN_ARMS,1
MIR202_3P,SET,229,-0.068326,-0.0075794,0.057975,0.8807,MIR202_3P,1
GOMF_ENDONUCLEASE_ACTIVITY,SET,111,-0.092447,-0.0071629,0.078415,0.88078,GOMF_ENDONUCLEASE_ACTIVITY,1
GSE9006_TYPE_1_DIABETES_AT_D...4,SET,184,-0.073623,-0.0073297,0.062448,0.88078,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP,1
GSE6259_FLT3L_INDUCED_33D1_P...1,SET,176,-0.073101,-0.0071194,0.061992,0.88083,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN,1
GOCC_EKC_KEOPS_COMPLEX,SET,3,-0.55089,-0.0070378,0.4671,0.88087,GOCC_EKC_KEOPS_COMPLEX,1
GOBP_HEPARAN_SULFATE_PROTEOG...5,SET,15,-0.29605,-0.0084545,0.25087,0.88101,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...342,SET,136,-0.091387,-0.0078324,0.077439,0.88102,GOBP_POSITIVE_REGULATION_OF_HORMONE_SECRETION,1
GSE17721_LPS_VS_PAM3CSK4_4H_...2,SET,189,-0.073939,-0.0074595,0.062647,0.88104,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP,1
HP_ABNORMALITY_OF_CANINE,SET,16,-0.26669,-0.0078657,0.22593,0.88107,HP_ABNORMALITY_OF_CANINE,1
MIR551A_MIR551B_3P,SET,5,-0.51572,-0.0085053,0.43688,0.88108,MIR551A_MIR551B_3P,1
KEGG_MEDICUS_REFERENCE_RAD51...,SET,10,-0.30266,-0.0070581,0.25639,0.88109,KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION,1
GSE22103_UNSTIM_VS_LPS_STIM_...2,SET,189,-0.07287,-0.0073517,0.061729,0.88109,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP,1
MIR4469,SET,104,-0.098741,-0.0074068,0.083632,0.88112,MIR4469,1
MORF_BCL2L11,SET,161,-0.082212,-0.007661,0.069623,0.88115,MORF_BCL2L11,1
YIH_RESPONSE_TO_ARSENITE_C3,SET,26,-0.20482,-0.0076986,0.17339,0.88124,YIH_RESPONSE_TO_ARSENITE_C3,1
STOSSI_RESPONSE_TO_ESTRADIOL,SET,37,-0.18248,-0.0081794,0.15446,0.88127,STOSSI_RESPONSE_TO_ESTRADIOL,1
WANG_THOC1_TARGETS_UP,SET,5,-0.48023,-0.0079201,0.40627,0.8814,WANG_THOC1_TARGETS_UP,1
HP_ABNORMAL_LACRIMAL_PUNCTUM...,SET,8,-0.36284,-0.0075686,0.30696,0.8814,HP_ABNORMAL_LACRIMAL_PUNCTUM_MORPHOLOGY,1
HP_HYPERMETHIONINEMIA,SET,7,-0.43903,-0.0085666,0.3714,0.88141,HP_HYPERMETHIONINEMIA,1
GOMF_NAD_P_H_OXIDASE_H2O2_FO...,SET,8,-0.32972,-0.0068777,0.27889,0.88144,GOMF_NAD_P_H_OXIDASE_H2O2_FORMING_ACTIVITY,1
HP_PULVERULENT_CATARACT,SET,11,-0.32932,-0.0080544,0.27852,0.88147,HP_PULVERULENT_CATARACT,1
MOREAUX_MULTIPLE_MYELOMA_BY_...2,SET,326,-0.059099,-0.0078011,0.049974,0.88151,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1
HP_ABNORMALITY_OF_SUBCUTANEO...,SET,60,-0.13215,-0.0075382,0.11174,0.88152,HP_ABNORMALITY_OF_SUBCUTANEOUS_FAT_TISSUE,1
MIR543,SET,295,-0.060121,-0.0075557,0.050832,0.88153,MIR543,1
GOCC_MULTIMERIC_RIBONUCLEASE...,SET,9,-0.32491,-0.0071884,0.27471,0.88154,GOCC_MULTIMERIC_RIBONUCLEASE_P_COMPLEX,1
GOMF_RIBONUCLEASE_P_ACTIVITY,SET,9,-0.32491,-0.0071884,0.27471,0.88154,GOMF_RIBONUCLEASE_P_ACTIVITY,1
GOMF_RIBONUCLEASE_P_RNA_BIND...,SET,9,-0.32491,-0.0071884,0.27471,0.88154,GOMF_RIBONUCLEASE_P_RNA_BINDING,1
PARK_OSTEOBLAST_DIFFERENTIAT...1,SET,6,-0.51937,-0.0093827,0.43909,0.88155,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN,1
GOBP_POSITIVE_REGULATION_OF_...209,SET,33,-0.18782,-0.0079517,0.15879,0.88155,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING,1
HP_PATELLAR_HYPOPLASIA,SET,14,-0.29365,-0.0081017,0.24822,0.88159,HP_PATELLAR_HYPOPLASIA,1
DESCARTES_FETAL_MUSCLE_SMOOT...,SET,67,-0.13253,-0.0079873,0.11201,0.88161,DESCARTES_FETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,1
GOBP_TYPE_I_PNEUMOCYTE_DIFFE...,SET,8,-0.3942,-0.0082227,0.33313,0.88165,GOBP_TYPE_I_PNEUMOCYTE_DIFFERENTIATION,1
HP_ABNORMAL_CSF_HOMOVANILLIC...,SET,9,-0.35167,-0.0077803,0.29715,0.88168,HP_ABNORMAL_CSF_HOMOVANILLIC_ACID_CONCENTRATION,1
GOBP_REGULATION_OF_SODIUM_IO...2,SET,42,-0.17583,-0.0083959,0.14855,0.88171,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE17721_PAM3CSK4_VS_CPG_6H_...2,SET,177,-0.07157,-0.0069899,0.060466,0.88172,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP,1
GOBP_REGULATION_OF_DEFENSE_R...1,SET,728,-0.039114,-0.0076291,0.033041,0.88175,GOBP_REGULATION_OF_DEFENSE_RESPONSE,1
HP_POSTERIOR_BLEPHARITIS,SET,5,-0.41304,-0.006812,0.34891,0.88175,HP_POSTERIOR_BLEPHARITIS,1
HP_ABNORMAL_SKIN_ADNEXA_MORP...,SET,1293,-0.028879,-0.0073856,0.024393,0.88176,HP_ABNORMAL_SKIN_ADNEXA_MORPHOLOGY,1
HP_FEEDING_DIFFICULTIES,SET,1009,-0.031831,-0.0072508,0.026881,0.88182,HP_FEEDING_DIFFICULTIES,1
HP_ATYPICAL_SCARRING_OF_SKIN,SET,64,-0.13221,-0.0077882,0.1116,0.88191,HP_ATYPICAL_SCARRING_OF_SKIN,1
GOBP_HISTAMINE_METABOLIC_PRO...,SET,6,-0.50706,-0.0091604,0.42801,0.88192,GOBP_HISTAMINE_METABOLIC_PROCESS,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...2,SET,7,-0.36682,-0.0071576,0.30961,0.88194,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_UP,1
AIZARANI_LIVER_C39_EPCAM_POS...,SET,177,-0.082226,-0.0080306,0.069393,0.88197,AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4,1
MIR128_1_5P,SET,12,-0.31759,-0.0081127,0.26794,0.88204,MIR128_1_5P,1
HP_CELIAC_DISEASE,SET,52,-0.14792,-0.007857,0.12476,0.8821,HP_CELIAC_DISEASE,1
REACTOME_FOXO_MEDIATED_TRANS...3,SET,15,-0.26878,-0.0076755,0.22668,0.88212,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,1
HP_UROGENITAL_FISTULA,SET,46,-0.14828,-0.0074089,0.12505,0.88212,HP_UROGENITAL_FISTULA,1
GOBP_CONNECTIVE_TISSUE_DEVEL...,SET,260,-0.065949,-0.0077885,0.055612,0.88215,GOBP_CONNECTIVE_TISSUE_DEVELOPMENT,1
HP_DIALEPTIC_SEIZURE,SET,221,-0.069236,-0.0075467,0.058373,0.8822,HP_DIALEPTIC_SEIZURE,1
GSE23114_WT_VS_SLE2C1_MOUSE_...4,SET,191,-0.07154,-0.0072552,0.060316,0.8822,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP,1
DESCARTES_MAIN_FETAL_LYMPHAT...,SET,64,-0.13492,-0.0079478,0.1137,0.8823,DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...165,SET,9,-0.33302,-0.0073678,0.28061,0.88233,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
GOBP_MAMMARY_GLAND_EPITHELIA...2,SET,25,-0.22842,-0.008419,0.19247,0.88234,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
HP_ABNORMALITY_OF_THE_UPPER_...2,SET,1520,-0.027135,-0.007474,0.022862,0.88235,HP_ABNORMALITY_OF_THE_UPPER_LIMB,1
GSE19888_ADENOSINE_A3R_INH_P...1,SET,181,-0.073714,-0.0072794,0.062107,0.88236,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN,1
HP_NARROW_MOUTH,SET,208,-0.071881,-0.0076037,0.060558,0.88238,HP_NARROW_MOUTH,1
MIR150_5P,SET,160,-0.077684,-0.0072168,0.065421,0.88246,MIR150_5P,1
HE_LIM_SUN_FETAL_LUNG_C2_CXC...,SET,118,-0.10038,-0.0080172,0.084532,0.88246,HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL,1
BUSSLINGER_GASTRIC_CHIEF_CEL...,SET,51,-0.15125,-0.0079564,0.12734,0.88252,BUSSLINGER_GASTRIC_CHIEF_CELLS,1
HP_ABNORMAL_HAND_MORPHOLOGY,SET,920,-0.034097,-0.0074356,0.028707,0.88253,HP_ABNORMAL_HAND_MORPHOLOGY,1
GOBP_DNA_TOPOLOGICAL_CHANGE,SET,9,-0.28974,-0.0064103,0.24389,0.88257,GOBP_DNA_TOPOLOGICAL_CHANGE,1
GSE37533_PPARG1_FOXP3_VS_FOX...4,SET,184,-0.074246,-0.0073917,0.062492,0.88259,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
NIKOLSKY_BREAST_CANCER_8Q23_...,SET,144,-0.16288,-0.014361,0.13708,0.88261,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1
GOBP_SPHINGOMYELIN_METABOLIC...,SET,20,-0.22635,-0.0074629,0.1905,0.88262,GOBP_SPHINGOMYELIN_METABOLIC_PROCESS,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...3,SET,273,-0.067292,-0.0081404,0.056625,0.88265,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL,1
MANALO_HYPOXIA_DN,SET,263,-0.059426,-0.0070579,0.05,0.88268,MANALO_HYPOXIA_DN,1
KEGG_MEDICUS_ENV_FACTOR_TCDD...,SET,19,-0.28141,-0.0090435,0.23676,0.88269,KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY,1
HP_HYPERGASTRINEMIA,SET,6,-0.4196,-0.0075803,0.35298,0.88272,HP_HYPERGASTRINEMIA,1
REACTOME_GAMMA_CARBOXYLATION...1,SET,51,-0.13777,-0.0072476,0.11588,0.88276,REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION,1
ATAGGAA_MIR202,SET,95,-0.1087,-0.0077952,0.091429,0.88276,ATAGGAA_MIR202,1
REACTOME_NOTCH3_ACTIVATION_A...,SET,23,-0.20368,-0.0072008,0.17128,0.8828,REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1
MIKKELSEN_MEF_ICP_WITH_H3K27...,SET,187,-0.077505,-0.0077782,0.065173,0.88281,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,1
MIR3191_3P,SET,21,-0.21824,-0.0073731,0.18352,0.88282,MIR3191_3P,1
HP_PAROXYSMAL_DYSTONIA,SET,20,-0.23324,-0.00769,0.19607,0.88288,HP_PAROXYSMAL_DYSTONIA,1
GOBP_LAYER_FORMATION_IN_CERE...,SET,13,-0.31208,-0.0082972,0.26234,0.88289,GOBP_LAYER_FORMATION_IN_CEREBRAL_CORTEX,1
YAO_TEMPORAL_RESPONSE_TO_PRO...6,SET,146,-0.077643,-0.0068928,0.065262,0.88291,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,1
GSE14350_TREG_VS_TEFF_UP,SET,181,-0.074685,-0.0073752,0.062767,0.88295,GSE14350_TREG_VS_TEFF_UP,1
GOBP_POSITIVE_REGULATION_OF_...716,SET,15,-0.28771,-0.0082162,0.24171,0.88303,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_T_HELPER_...5,SET,31,-0.20573,-0.0084422,0.17283,0.88304,GOBP_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
GOMF_PROTEIN_METHYLTRANSFERA...,SET,80,-0.1096,-0.0072151,0.092053,0.88308,GOMF_PROTEIN_METHYLTRANSFERASE_ACTIVITY,1
ODONNELL_TARGETS_OF_MYC_AND_...2,SET,68,-0.12459,-0.0075644,0.10464,0.88309,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1
GOBP_REGULATION_OF_MACROPHAG...4,SET,31,-0.19629,-0.008055,0.16485,0.8831,GOBP_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
GOMF_TRANSITION_METAL_ION_TR...,SET,41,-0.14429,-0.0068077,0.12118,0.88311,GOMF_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_METANEPHRIC_NEPHRON_TUB...1,SET,6,-0.49512,-0.0089447,0.41574,0.88315,GOBP_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,1
GOMF_PHOSPHOTRANSFERASE_ACTI...1,SET,21,-0.21521,-0.0072708,0.1807,0.88316,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS,1
MODULE_169,SET,89,-0.11677,-0.0081065,0.098018,0.88323,MODULE_169,1
GOCC_CELL_SUBSTRATE_JUNCTION,SET,411,-0.051001,-0.0075412,0.042806,0.88326,GOCC_CELL_SUBSTRATE_JUNCTION,1
GSE13485_DAY3_VS_DAY21_YF17D...2,SET,176,-0.076065,-0.007408,0.06383,0.8833,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
GOMF_NUCLEASE_INHIBITOR_ACTI...,SET,6,-0.38057,-0.0068752,0.31928,0.88335,GOMF_NUCLEASE_INHIBITOR_ACTIVITY,1
GREENBAUM_E2A_TARGETS_UP,SET,27,-0.19082,-0.0073087,0.16009,0.88336,GREENBAUM_E2A_TARGETS_UP,1
HP_GLUCAGONOMA,SET,6,-0.42401,-0.00766,0.35572,0.88336,HP_GLUCAGONOMA,1
HP_CONTINUOUS_SPIKE_AND_WAVE...,SET,8,-0.38384,-0.0080066,0.32188,0.88346,HP_CONTINUOUS_SPIKE_AND_WAVES_DURING_SLOW_SLEEP,1
GOBP_ENDOCARDIAL_CUSHION_TO_...,SET,6,-0.4519,-0.0081639,0.37885,0.88352,GOBP_ENDOCARDIAL_CUSHION_TO_MESENCHYMAL_TRANSITION,1
HP_ABNORMALITY_OF_PROTHROMBIN,SET,47,-0.16014,-0.0080879,0.13425,0.88352,HP_ABNORMALITY_OF_PROTHROMBIN,1
GSE21927_SPLEEN_C57BL6_VS_EL...2,SET,178,-0.073403,-0.0071889,0.061538,0.88352,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP,1
HP_EMG_POSITIVE_SHARP_WAVES,SET,9,-0.3785,-0.0083739,0.3173,0.88353,HP_EMG_POSITIVE_SHARP_WAVES,1
HP_HEMIPLEGIA,SET,33,-0.19667,-0.0083262,0.16486,0.88354,HP_HEMIPLEGIA,1
HP_HIGH_HYPERMETROPIA,SET,70,-0.13255,-0.008165,0.11104,0.88371,HP_HIGH_HYPERMETROPIA,1
HP_MYOTONIA,SET,28,-0.20196,-0.0078772,0.16918,0.88371,HP_MYOTONIA,1
HP_ABNORMAL_STERNUM_MORPHOLO...,SET,402,-0.050845,-0.0074372,0.042581,0.88377,HP_ABNORMAL_STERNUM_MORPHOLOGY,1
GOBP_TYPE_II_INTERFERON_PROD...,SET,108,-0.1087,-0.0083085,0.091021,0.8838,GOBP_TYPE_II_INTERFERON_PRODUCTION,1
TAF9B_TARGET_GENES,SET,397,-0.050318,-0.0073152,0.042125,0.88385,TAF9B_TARGET_GENES,1
KEGG_MEDICUS_PATHOGEN_ESCHER...4,SET,5,-0.51454,-0.0084859,0.4307,0.88388,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY,1
GSE17721_POLYIC_VS_GARDIQUIM...1,SET,181,-0.074656,-0.0073724,0.06247,0.88396,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
GOBP_LONG_TERM_MEMORY,SET,37,-0.17167,-0.0076948,0.14363,0.88398,GOBP_LONG_TERM_MEMORY,1
GOBP_REGULATION_OF_SHORT_TER...,SET,14,-0.28812,-0.0079492,0.24108,0.88398,GOBP_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY,1
GOBP_AMIDE_CATABOLIC_PROCESS,SET,16,-0.2516,-0.0074206,0.21047,0.88403,GOBP_AMIDE_CATABOLIC_PROCESS,1
GOCC_MICROTUBULE_BUNDLE,SET,6,-0.381,-0.0068831,0.31863,0.88409,GOCC_MICROTUBULE_BUNDLE,1
GSE8384_CTRL_VS_B_ABORTUS_4H...2,SET,174,-0.075932,-0.0073534,0.06347,0.88421,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP,1
HP_INCREASED_CIRCULATING_THY...,SET,8,-0.40452,-0.008438,0.33811,0.88422,HP_INCREASED_CIRCULATING_THYROGLOBULIN_CONCENTRATION,1
MIR4719,SET,456,-0.0493,-0.0076687,0.041201,0.88425,MIR4719,1
GOCC_SPECIFIC_GRANULE_MEMBRA...,SET,84,-0.11031,-0.0074408,0.092172,0.8843,GOCC_SPECIFIC_GRANULE_MEMBRANE,1
GOBP_REGULATION_OF_ACROSOME_...,SET,18,-0.25341,-0.0079267,0.21159,0.88446,GOBP_REGULATION_OF_ACROSOME_REACTION,1
HP_CHONDROSARCOMA,SET,7,-0.45441,-0.0088668,0.37941,0.88447,HP_CHONDROSARCOMA,1
GOBP_ALPHA_BETA_T_CELL_DIFFE...,SET,120,-0.1,-0.0080544,0.083477,0.88453,GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
ZNF623_TARGET_GENES,SET,335,-0.055938,-0.0074831,0.046681,0.88459,ZNF623_TARGET_GENES,1
GOMF_VOLTAGE_GATED_SODIUM_CH...2,SET,5,-0.54045,-0.0089132,0.45101,0.88459,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GSE360_L_DONOVANI_VS_B_MALAY...3,SET,187,-0.073582,-0.0073845,0.061406,0.88459,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
FLECHNER_BIOPSY_KIDNEY_TRANS...2,SET,509,-0.045334,-0.0074394,0.037823,0.88465,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1
GOBP_RESPIRATORY_BURST_INVOL...1,SET,14,-0.28954,-0.0079884,0.24157,0.88465,GOBP_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE,1
GOBP_LACTATION,SET,37,-0.1775,-0.0079565,0.14808,0.88467,GOBP_LACTATION,1
WP_KININKALLIKREIN_PATHWAY,SET,7,-0.47511,-0.0092708,0.39635,0.88468,WP_KININKALLIKREIN_PATHWAY,1
HP_JOINT_CONTRACTURE_OF_THE_...1,SET,7,-0.40292,-0.0078621,0.33612,0.88468,HP_JOINT_CONTRACTURE_OF_THE_4TH_FINGER,1
HP_INFANTILE_ENCEPHALOPATHY,SET,8,-0.36753,-0.0076664,0.30654,0.88472,HP_INFANTILE_ENCEPHALOPATHY,1
HP_LEFT_VENTRICULAR_HYPERTRO...,SET,87,-0.10433,-0.0071614,0.087003,0.88476,HP_LEFT_VENTRICULAR_HYPERTROPHY,1
GOBP_FILOPODIUM_ASSEMBLY,SET,60,-0.14425,-0.0082286,0.12027,0.8848,GOBP_FILOPODIUM_ASSEMBLY,1
GOBP_PROTEIN_LOCALIZATION_TO...24,SET,25,-0.1998,-0.0073642,0.16655,0.88486,GOBP_PROTEIN_LOCALIZATION_TO_ENDOSOME,1
GOBP_DEDIFFERENTIATION,SET,8,-0.43395,-0.009052,0.3617,0.88488,GOBP_DEDIFFERENTIATION,1
LEE_AGING_MUSCLE_DN,SET,38,-0.16345,-0.0074248,0.13622,0.88491,LEE_AGING_MUSCLE_DN,1
GOBP_CELL_AGGREGATION,SET,22,-0.24342,-0.008417,0.20286,0.88491,GOBP_CELL_AGGREGATION,1
GOBP_MOTOR_BEHAVIOR,SET,20,-0.22121,-0.0072935,0.18436,0.88491,GOBP_MOTOR_BEHAVIOR,1
HP_ABNORMAL_METABOLIC_BRAIN_...,SET,46,-0.14489,-0.0072396,0.12074,0.88493,HP_ABNORMAL_METABOLIC_BRAIN_IMAGING_BY_MRS,1
GOMF_COLLAGEN_BINDING_INVOLV...,SET,4,-0.58415,-0.0086171,0.48673,0.88495,GOMF_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,1
GSE4590_LARGE_PRE_BCELL_VS_V...2,SET,160,-0.08625,-0.0080126,0.071861,0.88497,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,1
HP_DEVIATION_OF_THE_4TH_FING...,SET,8,-0.41209,-0.0085959,0.34333,0.88498,HP_DEVIATION_OF_THE_4TH_FINGER,1
MIR892B,SET,71,-0.12428,-0.00771,0.10352,0.88503,MIR892B,1
GOBP_SUBSTRATE_INDEPENDENT_T...,SET,9,-0.3223,-0.0071305,0.2684,0.88508,GOBP_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION,1
HP_SLENDER_LONG_BONE,SET,46,-0.13923,-0.0069567,0.11594,0.88508,HP_SLENDER_LONG_BONE,1
GSE18791_UNSTIM_VS_NEWCATSLE...2,SET,186,-0.073151,-0.0073218,0.060913,0.8851,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP,1
MIR4659A_5P,SET,73,-0.11716,-0.0073694,0.097557,0.88511,MIR4659A_5P,1
MIR95_5P,SET,606,-0.042469,-0.0075837,0.035361,0.88512,MIR95_5P,1
GOBP_DEVELOPMENT_OF_SECONDAR...1,SET,6,-0.46652,-0.008428,0.38836,0.88516,GOBP_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS,1
MIR93_3P,SET,106,-0.096281,-0.0072911,0.080142,0.88519,MIR93_3P,1
WP_ELECTRON_TRANSPORT_CHAIN_...,SET,69,-0.10879,-0.0066535,0.090545,0.88522,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,1
GSE3982_DC_VS_MAC_LPS_STIM_UP,SET,173,-0.075068,-0.0072489,0.062447,0.88533,GSE3982_DC_VS_MAC_LPS_STIM_UP,1
WP_DUAL_HIJACK_MODEL_OF_VIF_...,SET,5,-0.46224,-0.0076233,0.3845,0.88534,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,1
GSE40068_BCL6_POS_VS_NEG_CXC...1,SET,178,-0.078703,-0.0077079,0.065461,0.88536,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN,1
GOBP_RUFFLE_ORGANIZATION,SET,53,-0.14769,-0.0079195,0.12283,0.88537,GOBP_RUFFLE_ORGANIZATION,1
HP_DECREASED_DLCO,SET,22,-0.22203,-0.0076776,0.18458,0.88549,HP_DECREASED_DLCO,1
HP_GLOBOZOOSPERMIA,SET,6,-0.46343,-0.0083722,0.38507,0.8856,HP_GLOBOZOOSPERMIA,1
GOCC_APICOLATERAL_PLASMA_MEM...,SET,23,-0.23471,-0.0082981,0.19499,0.88564,GOCC_APICOLATERAL_PLASMA_MEMBRANE,1
GOMF_DOUBLE_STRANDED_DNA_3_5...,SET,4,-0.5194,-0.0076619,0.43151,0.88564,GOMF_DOUBLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,1
HP_ABSENCE_OF_RENAL_CORTICOM...,SET,6,-0.50383,-0.0091021,0.4185,0.88568,HP_ABSENCE_OF_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...167,SET,13,-0.30497,-0.0081082,0.2533,0.8857,GOBP_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
GSE29618_PRE_VS_DAY7_FLU_VAC...5,SET,180,-0.072123,-0.0071027,0.05987,0.88582,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN,1
RANKIN_ANGIOGENIC_TARGETS_OF...1,SET,8,-0.43254,-0.0090225,0.35902,0.88585,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN,1
GOBP_GLUCOSE_IMPORT_IN_RESPO...,SET,5,-0.33255,-0.0054844,0.27589,0.88596,GOBP_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS,1
GOBP_POSITIVE_REGULATION_OF_...541,SET,13,-0.27022,-0.0071843,0.22417,0.88597,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
BROWNE_HCMV_INFECTION_2HR_DN,SET,47,-0.1569,-0.0079242,0.13015,0.88599,BROWNE_HCMV_INFECTION_2HR_DN,1
MIR140_3P,SET,129,-0.09025,-0.0075347,0.074862,0.886,MIR140_3P,1
HP_THIN_CORPUS_CALLOSUM,SET,735,-0.0377,-0.0073871,0.031269,0.88602,HP_THIN_CORPUS_CALLOSUM,1
MIR615_5P,SET,37,-0.18202,-0.008159,0.15096,0.88603,MIR615_5P,1
AGGGCCA_MIR328,SET,68,-0.12386,-0.0075201,0.10272,0.88604,AGGGCCA_MIR328,1
MIR5586_3P,SET,48,-0.1519,-0.0077529,0.12596,0.88607,MIR5586_3P,1
HP_ABNORMAL_EYELID_PHYSIOLOGY,SET,36,-0.16897,-0.007471,0.14011,0.88607,HP_ABNORMAL_EYELID_PHYSIOLOGY,1
GOBP_CARDIAC_CHAMBER_MORPHOG...,SET,121,-0.10601,-0.0085736,0.087874,0.88616,GOBP_CARDIAC_CHAMBER_MORPHOGENESIS,1
GSE28737_WT_VS_BCL6_HET_MARG...1,SET,180,-0.074281,-0.0073153,0.06157,0.88617,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN,1
MIR520E_5P,SET,146,-0.088431,-0.0078505,0.073273,0.88625,MIR520E_5P,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...3,SET,13,-0.27823,-0.0073972,0.23049,0.88629,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE15330_MEGAKARYOCYTE_ERYTH...5,SET,178,-0.072645,-0.0071147,0.060174,0.88632,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
GSE23502_BM_VS_COLON_TUMOR_M...1,SET,181,-0.075214,-0.0074275,0.062299,0.88634,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,1
HP_TESTICULAR_ATROPHY,SET,9,-0.31873,-0.0070516,0.26398,0.88635,HP_TESTICULAR_ATROPHY,1
BLANCO_MELO_BRONCHIAL_EPITHE...2,SET,579,-0.046244,-0.0080778,0.038291,0.88641,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP,1
HP_ABNORMALITY_OF_CARTILAGE_...,SET,14,-0.29324,-0.0080905,0.24281,0.88641,HP_ABNORMALITY_OF_CARTILAGE_OF_EXTERNAL_EAR,1
GSE37301_LYMPHOID_PRIMED_MPP...3,SET,189,-0.077404,-0.0078091,0.064088,0.88643,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN,1
GSE24292_WT_VS_PPARG_KO_MACR...2,SET,185,-0.076938,-0.0076803,0.063693,0.88646,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP,1
MIR3132,SET,62,-0.13077,-0.0075825,0.10824,0.88649,MIR3132,1
GSE14699_NAIVE_VS_DELETIONAL...2,SET,133,-0.091237,-0.0077334,0.0755,0.88655,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,1
DESCARTES_FETAL_STOMACH_SQUA...,SET,60,-0.14499,-0.0082708,0.11998,0.88656,DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS,1
chr3p22,SET,78,-0.23782,-0.015461,0.19678,0.88658,chr3p22,1
HP_HYPERPHENYLALANINEMIA,SET,6,-0.44526,-0.008044,0.36841,0.88658,HP_HYPERPHENYLALANINEMIA,1
DESCARTES_FETAL_PLACENTA_MYE...,SET,125,-0.099609,-0.008187,0.082418,0.88658,DESCARTES_FETAL_PLACENTA_MYELOID_CELLS,1
GOMF_G_PROTEIN_COUPLED_AMINE...,SET,38,-0.19126,-0.008688,0.15824,0.8866,GOMF_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY,1
GSE22886_IGM_MEMORY_BCELL_VS...2,SET,175,-0.078027,-0.0075777,0.064555,0.8866,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...548,SET,36,-0.16994,-0.0075141,0.14057,0.88664,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
GOBP_OXALATE_TRANSPORT,SET,11,-0.31055,-0.0075954,0.25689,0.88664,GOBP_OXALATE_TRANSPORT,1
GOBP_GUANINE_METABOLIC_PROCE...,SET,4,-0.50777,-0.0074904,0.41991,0.88671,GOBP_GUANINE_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_PUBIC_...,SET,52,-0.14296,-0.0075936,0.1182,0.88675,HP_ABNORMALITY_OF_THE_PUBIC_HAIR,1
GOMF_SNAP_RECEPTOR_ACTIVITY,SET,35,-0.16604,-0.007239,0.13726,0.88679,GOMF_SNAP_RECEPTOR_ACTIVITY,1
GSE3203_WT_VS_IFNAR1_KO_INFL...2,SET,179,-0.07852,-0.0077114,0.064903,0.88682,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP,1
REACTOME_CONSTITUTIVE_SIGNAL...1,SET,82,-0.12503,-0.0083327,0.10333,0.88684,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1
GSE31082_DP_VS_CD4_SP_THYMOC...1,SET,176,-0.077671,-0.0075645,0.064194,0.88684,GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN,1
HP_INCREASED_SULFUR_AMINO_AC...,SET,15,-0.32617,-0.0093145,0.2695,0.8869,HP_INCREASED_SULFUR_AMINO_ACID_LEVEL_IN_URINE,1
GSE22935_UNSTIM_VS_24H_MBOVI...1,SET,180,-0.08016,-0.0078942,0.06621,0.88698,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN,1
GSE9988_ANTI_TREM1_VS_LOW_LP...1,SET,174,-0.082805,-0.008019,0.068397,0.88698,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN,1
KEGG_METABOLISM_OF_XENOBIOTI...,SET,65,-0.17769,-0.010549,0.14676,0.88699,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,1
SCHERER_PBMC_APSV_WETVAX_AGE...6,SET,263,-0.068322,-0.0081145,0.056431,0.88699,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP,1
GOCC_SPERM_PLASMA_MEMBRANE,SET,14,-0.27537,-0.0075974,0.22728,0.88715,GOCC_SPERM_PLASMA_MEMBRANE,1
HP_DOWNBEAT_NYSTAGMUS,SET,7,-0.39164,-0.007642,0.32326,0.88715,HP_DOWNBEAT_NYSTAGMUS,1
CHANDRAN_METASTASIS_TOP50_UP,SET,29,-0.17414,-0.0069121,0.14372,0.88718,CHANDRAN_METASTASIS_TOP50_UP,1
WP_REGULATION_OF_APOPTOSIS_B...,SET,24,-0.20828,-0.0075218,0.17186,0.88722,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,1
GOBP_CELL_SUBSTRATE_JUNCTION...2,SET,100,-0.10555,-0.0077648,0.087096,0.88722,GOBP_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
GOMF_DOUBLE_STRANDED_DNA_EXO...,SET,6,-0.44144,-0.007975,0.36421,0.88725,GOMF_DOUBLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,1
HP_ABNORMAL_CEREBRAL_VEIN_MO...,SET,8,-0.37638,-0.0078511,0.31053,0.88725,HP_ABNORMAL_CEREBRAL_VEIN_MORPHOLOGY,1
GSE3982_DC_VS_NKCELL_DN,SET,166,-0.080811,-0.0076455,0.066659,0.8873,GSE3982_DC_VS_NKCELL_DN,1
GOMF_SNARE_BINDING,SET,102,-0.099744,-0.0074102,0.082257,0.88735,GOMF_SNARE_BINDING,1
PARK_HSC_VS_MULTIPOTENT_PROG...2,SET,16,-0.24144,-0.0071208,0.19901,0.88746,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,1
GOBP_ATP_METABOLIC_PROCESS,SET,176,-0.073635,-0.0071714,0.060687,0.88749,GOBP_ATP_METABOLIC_PROCESS,1
HP_CONTRACTURE_OF_THE_PROXIM...1,SET,6,-0.44342,-0.0080107,0.36545,0.88749,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_3RD_FINGER,1
GOBP_NEGATIVE_REGULATION_OF_...703,SET,5,-0.49879,-0.0082262,0.41104,0.88752,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
COATES_MACROPHAGE_M1_VS_M2_DN,SET,75,-0.12481,-0.0079568,0.10284,0.88755,COATES_MACROPHAGE_M1_VS_M2_DN,1
MIR151A_3P,SET,30,-0.2025,-0.0081748,0.16678,0.88765,MIR151A_3P,1
GSE17721_LPS_VS_CPG_24H_BMDC...2,SET,179,-0.076893,-0.0075516,0.063318,0.88769,GSE17721_LPS_VS_CPG_24H_BMDC_UP,1
ZNF224_TARGET_GENES,SET,1077,-0.032496,-0.0076327,0.026758,0.8877,ZNF224_TARGET_GENES,1
GSE24142_ADULT_VS_FETAL_EARL...2,SET,183,-0.078788,-0.0078228,0.06487,0.88772,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP,1
GSE42724_MEMORY_VS_B1_BCELL_...2,SET,185,-0.073521,-0.0073393,0.060532,0.88773,GSE42724_MEMORY_VS_B1_BCELL_UP,1
HP_LARYNGEAL_CLEFT,SET,6,-0.53392,-0.0096457,0.43958,0.88774,HP_LARYNGEAL_CLEFT,1
ERWIN_COHEN_PBMC_TC_83_AGE_1...3,SET,16,-0.27944,-0.0082416,0.23006,0.88774,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,1
GSE22432_MULTIPOTENT_PROGENI...1,SET,183,-0.074876,-0.0074344,0.061639,0.88776,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...412,SET,111,-0.10201,-0.0079039,0.083971,0.88778,GOBP_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,1
HP_LOWER_LIMB_HYPERREFLEXIA,SET,72,-0.11822,-0.0073853,0.09731,0.88779,HP_LOWER_LIMB_HYPERREFLEXIA,1
GOBP_PURINE_NUCLEOSIDE_CATAB...,SET,7,-0.386,-0.0075318,0.3177,0.8878,GOBP_PURINE_NUCLEOSIDE_CATABOLIC_PROCESS,1
GOMF_STEROID_HYDROXYLASE_ACT...,SET,26,-0.23216,-0.0087262,0.19108,0.88781,GOMF_STEROID_HYDROXYLASE_ACTIVITY,1
GOBP_AMINO_ACID_TRANSMEMBRAN...,SET,94,-0.11347,-0.008094,0.093381,0.88782,GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
MIR7110_3P,SET,366,-0.056695,-0.0079208,0.046658,0.88783,MIR7110_3P,1
FAN_OVARY_CL15_SMALL_ANTRAL_...,SET,552,-0.044957,-0.0076736,0.036995,0.88785,FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL,1
JAZAG_TGFB1_SIGNALING_VIA_SM...1,SET,59,-0.13452,-0.0076098,0.1107,0.88786,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,1
REACTOME_ALPHA_PROTEIN_KINAS...,SET,9,-0.38262,-0.0084651,0.3148,0.88789,REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY,1
HP_SKELETAL_DYSPLASIA,SET,169,-0.080122,-0.0076479,0.065899,0.88797,HP_SKELETAL_DYSPLASIA,1
REACTOME_SYNTHESIS_OF_PROSTA...,SET,14,-0.26716,-0.0073708,0.2197,0.888,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,1
HP_EPIGASTRIC_PAIN,SET,11,-0.33052,-0.0080838,0.27179,0.88801,HP_EPIGASTRIC_PAIN,1
GOBP_DNA_BIOSYNTHETIC_PROCESS,SET,177,-0.072507,-0.0070813,0.059608,0.88808,GOBP_DNA_BIOSYNTHETIC_PROCESS,1
GOMF_TRNA_SPECIFIC_RIBONUCLE...,SET,13,-0.28291,-0.0075218,0.23258,0.88808,GOMF_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY,1
DESCARTES_FETAL_EYE_LENS_FIB...,SET,58,-0.15333,-0.0086001,0.12604,0.88809,DESCARTES_FETAL_EYE_LENS_FIBRE_CELLS,1
GSE2585_AIRE_KO_VS_WT_CD80_L...2,SET,165,-0.083307,-0.0078581,0.06848,0.8881,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP,1
HP_FAILURE_TO_THRIVE,SET,957,-0.034888,-0.0077512,0.028676,0.88812,HP_FAILURE_TO_THRIVE,1
MIR12121,SET,27,-0.2165,-0.0082923,0.17793,0.88815,MIR12121,1
MIR708_5P,SET,44,-0.15679,-0.0076624,0.12885,0.88816,MIR708_5P,1
HP_THIN_UPPER_LIP_VERMILION,SET,263,-0.06441,-0.0076498,0.052926,0.88818,HP_THIN_UPPER_LIP_VERMILION,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...1,SET,63,-0.13122,-0.0076698,0.1078,0.88824,GOMF_RNA_ENDONUCLEASE_ACTIVITY,1
MTOR_UP.V1_UP,SET,155,-0.082829,-0.0075746,0.068033,0.88828,MTOR_UP.V1_UP,1
GSE21670_STAT3_KO_VS_WT_CD4_...2,SET,175,-0.084237,-0.0081808,0.069177,0.88832,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN,1
MATSUMIYA_PBMC_MODIFIED_VACC...2,SET,9,-0.34995,-0.0077423,0.28736,0.88834,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_HIGH_RESPONDERS_VS_LOW_RESPONDERS_0DY_UP,1
UNTERMAN_IPF_VS_CTRL_DC_DN,SET,6,-0.42019,-0.007591,0.345,0.88837,UNTERMAN_IPF_VS_CTRL_DC_DN,1
HP_SHORT_MANDIBULAR_RAMI,SET,6,-0.44379,-0.0080174,0.36426,0.88844,HP_SHORT_MANDIBULAR_RAMI,1
BURTON_ADIPOGENESIS_5,SET,101,-0.098979,-0.0073174,0.081235,0.88846,BURTON_ADIPOGENESIS_5,1
MIR6806_3P,SET,93,-0.10827,-0.0076823,0.088845,0.8885,MIR6806_3P,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...5,SET,183,-0.079204,-0.0078641,0.064992,0.88851,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN,1
GOBP_REPLACEMENT_OSSIFICATION,SET,28,-0.21849,-0.0085217,0.17924,0.88857,GOBP_REPLACEMENT_OSSIFICATION,1
GOMF_PROTEIN_ANTIGEN_BINDING,SET,7,-0.41689,-0.0081346,0.34196,0.88859,GOMF_PROTEIN_ANTIGEN_BINDING,1
AIZARANI_LIVER_C4_EPCAM_POS_...,SET,178,-0.083762,-0.0082034,0.068703,0.88861,AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1,1
GOMF_ANAPHASE_PROMOTING_COMP...,SET,9,-0.29818,-0.006597,0.24455,0.88863,GOMF_ANAPHASE_PROMOTING_COMPLEX_BINDING,1
GOBP_FACIAL_NERVE_STRUCTURAL...,SET,8,-0.41936,-0.0087477,0.34386,0.88868,GOBP_FACIAL_NERVE_STRUCTURAL_ORGANIZATION,1
HP_SCLERODACTYLY,SET,5,-0.48931,-0.0080697,0.40119,0.88869,HP_SCLERODACTYLY,1
GOBP_MAMMARY_GLAND_ALVEOLUS_...,SET,18,-0.27442,-0.008584,0.22498,0.88871,GOBP_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT,1
GOMF_HEAT_SHOCK_PROTEIN_BIND...,SET,119,-0.094552,-0.0075837,0.0775,0.88876,GOMF_HEAT_SHOCK_PROTEIN_BINDING,1
REACTOME_GASTRIN_CREB_SIGNAL...,SET,17,-0.26194,-0.0079631,0.21469,0.88878,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,1
HP_IMPAIRED_MYOCARDIAL_CONTR...,SET,8,-0.41394,-0.0086345,0.33926,0.88878,HP_IMPAIRED_MYOCARDIAL_CONTRACTILITY,1
GOBP_REGULATION_OF_ORGANELLE...3,SET,8,-0.37961,-0.0079185,0.31102,0.88886,GOBP_REGULATION_OF_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
GSE27786_LIN_NEG_VS_NKCELL_DN,SET,180,-0.07525,-0.0074106,0.061653,0.88886,GSE27786_LIN_NEG_VS_NKCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...162,SET,33,-0.19861,-0.0084086,0.16271,0.88888,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOBP_MINERALOCORTICOID_SECRE...,SET,7,-0.45294,-0.0088381,0.37095,0.88896,GOBP_MINERALOCORTICOID_SECRETION,1
KORKOLA_EMBRYONAL_CARCINOMA_...2,SET,28,-0.22875,-0.0089219,0.18732,0.88898,KORKOLA_EMBRYONAL_CARCINOMA_UP,1
GOBP_REGULATION_OF_TRIGLYCER...2,SET,13,-0.29958,-0.0079648,0.24531,0.88899,GOBP_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,1
GTTTGTT_MIR495,SET,228,-0.071466,-0.0079106,0.058494,0.88909,GTTTGTT_MIR495,1
WP_STEROL_REGULATORY_ELEMENT...,SET,67,-0.12159,-0.0073284,0.099492,0.88917,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1
GOMF_MACROLIDE_BINDING,SET,12,-0.2657,-0.0067871,0.21736,0.88921,GOMF_MACROLIDE_BINDING,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...5,SET,13,-0.31415,-0.0083522,0.25699,0.88921,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_DN,1
GOBP_MITRAL_VALVE_DEVELOPMENT,SET,14,-0.30918,-0.0085302,0.25291,0.88923,GOBP_MITRAL_VALVE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...813,SET,18,-0.26531,-0.0082991,0.21702,0.88924,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
HP_ABNORMAL_CONJUNCTIVA_MORP...,SET,150,-0.084322,-0.0075868,0.068974,0.88924,HP_ABNORMAL_CONJUNCTIVA_MORPHOLOGY,1
GOBP_IRON_IMPORT_INTO_CELL,SET,9,-0.33173,-0.0073392,0.27124,0.88932,GOBP_IRON_IMPORT_INTO_CELL,1
GSE19888_ADENOSINE_A3R_ACT_V...4,SET,164,-0.079105,-0.0074393,0.06468,0.88933,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...160,SET,20,-0.25616,-0.0084457,0.20943,0.88935,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
GOBP_PROLINE_METABOLIC_PROCE...,SET,9,-0.37079,-0.0082035,0.30314,0.88936,GOBP_PROLINE_METABOLIC_PROCESS,1
REACTOME_JNK_C_JUN_KINASES_P...,SET,18,-0.26296,-0.0082255,0.21496,0.88938,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,1
KEGG_MEDICUS_VARIANT_MUTATIO...60,SET,39,-0.15307,-0.0070438,0.12512,0.88939,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
KEGG_MEDICUS_REFERENCE_REGUL...2,SET,9,-0.35874,-0.0079367,0.29322,0.88941,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION,1
GSE16522_ANTI_CD3CD28_STIM_V...2,SET,186,-0.076119,-0.0076189,0.062212,0.88943,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP,1
WP_INSULIN_SIGNALING,SET,156,-0.084689,-0.0077694,0.0692,0.88948,WP_INSULIN_SIGNALING,1
GSE34006_A2AR_KO_VS_A2AR_AGO...2,SET,190,-0.079582,-0.0080498,0.065026,0.88949,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP,1
ZFP36L1_TARGET_GENES,SET,47,-0.14903,-0.0075267,0.12175,0.88952,ZFP36L1_TARGET_GENES,1
MEBARKI_HCC_PROGENITOR_WNT_DN,SET,72,-0.12855,-0.0080304,0.105,0.88958,MEBARKI_HCC_PROGENITOR_WNT_DN,1
TRAVAGLINI_LUNG_AIRWAY_SMOOT...,SET,157,-0.085811,-0.0078974,0.070088,0.88958,TRAVAGLINI_LUNG_AIRWAY_SMOOTH_MUSCLE_CELL,1
GOBP_POSITIVE_REGULATION_OF_...578,SET,147,-0.091205,-0.0081242,0.07449,0.88959,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,1
GOMF_CXCR_CHEMOKINE_RECEPTOR...,SET,17,-0.31486,-0.0095718,0.25716,0.88959,GOMF_CXCR_CHEMOKINE_RECEPTOR_BINDING,1
GSE45837_WT_VS_GFI1_KO_PDC_UP,SET,164,-0.080265,-0.0075483,0.065554,0.88959,GSE45837_WT_VS_GFI1_KO_PDC_UP,1
GOBP_INTERLEUKIN_1_ALPHA_PRO...,SET,8,-0.45542,-0.0094998,0.37192,0.88961,GOBP_INTERLEUKIN_1_ALPHA_PRODUCTION,1
HP_EMG_MYOTONIC_DISCHARGES,SET,8,-0.37539,-0.0078303,0.30651,0.88965,HP_EMG_MYOTONIC_DISCHARGES,1
GSE22886_NAIVE_TCELL_VS_NEUT...2,SET,175,-0.075561,-0.0073382,0.061693,0.88966,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP,1
GSE36826_NORMAL_VS_STAPH_AUR...4,SET,175,-0.076504,-0.0074298,0.062462,0.88967,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP,1
GSE26928_CENTR_MEMORY_VS_CXC...2,SET,159,-0.0842,-0.0077979,0.068734,0.88971,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,1
GOMF_C3HC4_TYPE_RING_FINGER_...,SET,6,-0.41519,-0.0075008,0.33887,0.88975,GOMF_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING,1
GOMF_OXIDOREDUCTASE_ACTIVITY...5,SET,9,-0.31894,-0.0070564,0.26026,0.88979,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,1
HP_ELEVATED_CIRCULATING_FOLL...,SET,46,-0.14889,-0.0074394,0.12149,0.88979,HP_ELEVATED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_LEVEL,1
KEGG_MEDICUS_VARIANT_MUTATIO...6,SET,15,-0.27104,-0.0077402,0.22109,0.88988,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY,1
GSE17721_CPG_VS_GARDIQUIMOD_...6,SET,185,-0.078756,-0.0078619,0.064243,0.88988,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP,1
REACTOME_APOPTOSIS,SET,163,-0.081752,-0.007665,0.066683,0.88989,REACTOME_APOPTOSIS,1
GOBP_REGULATION_OF_TRANSCRIP...5,SET,29,-0.19728,-0.0078306,0.16091,0.8899,GOBP_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
REACTOME_SYNTHESIS_OF_GDP_MA...,SET,5,-0.39978,-0.0065933,0.32607,0.88991,REACTOME_SYNTHESIS_OF_GDP_MANNOSE,1
SEIDEN_MET_SIGNALING,SET,18,-0.21764,-0.0068078,0.17747,0.88995,SEIDEN_MET_SIGNALING,1
HP_PRIMARY_CONGENITAL_GLAUCO...,SET,6,-0.45195,-0.0081649,0.36855,0.88995,HP_PRIMARY_CONGENITAL_GLAUCOMA,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...5,SET,10,-0.39192,-0.0091398,0.31958,0.88996,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_DN,1
NAKAMURA_LUNG_CANCER,SET,8,-0.42392,-0.0088427,0.34561,0.89,NAKAMURA_LUNG_CANCER,1
MIR323A_3P,SET,206,-0.074188,-0.0078103,0.060468,0.89006,MIR323A_3P,1
GSE37301_MULTIPOTENT_PROGENI...8,SET,146,-0.084589,-0.0075095,0.068947,0.89006,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP,1
HP_IMPAIRED_NEUTROPHIL_CHEMO...,SET,7,-0.41659,-0.0081288,0.33954,0.89007,HP_IMPAIRED_NEUTROPHIL_CHEMOTAXIS,1
KEGG_OLFACTORY_TRANSDUCTION,SET,320,-0.081144,-0.010614,0.066132,0.89008,KEGG_OLFACTORY_TRANSDUCTION,1
WP_CALCIUM_REGULATION_IN_CAR...,SET,149,-0.091535,-0.0082085,0.074597,0.89009,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,1
GOCC_APOLIPOPROTEIN_B_MRNA_E...,SET,4,-0.55522,-0.0081903,0.45246,0.8901,GOCC_APOLIPOPROTEIN_B_MRNA_EDITING_ENZYME_COMPLEX,1
KOBAYASHI_RESPONSE_TO_ROMIDE...,SET,19,-0.26469,-0.0085065,0.21569,0.89012,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,1
GOBP_REGULATION_OF_DENDRITIC...1,SET,11,-0.31775,-0.0077714,0.25889,0.89014,GOBP_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
MIR4464,SET,62,-0.13079,-0.0075836,0.10656,0.89015,MIR4464,1
REACTOME_LINOLEIC_ACID_LA_ME...,SET,7,-0.43588,-0.0085052,0.35507,0.89019,REACTOME_LINOLEIC_ACID_LA_METABOLISM,1
GSE360_T_GONDII_VS_B_MALAYI_...2,SET,176,-0.082862,-0.00807,0.067497,0.8902,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...30,SET,17,-0.21515,-0.0065405,0.17521,0.89025,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE,1
GSE5589_UNSTIM_VS_180MIN_LPS...1,SET,185,-0.074319,-0.0074189,0.060526,0.89025,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,1
FARMER_BREAST_CANCER_APOCRIN...2,SET,289,-0.063652,-0.007919,0.051822,0.89032,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1
MIR3925_3P,SET,161,-0.08393,-0.0078212,0.068328,0.89033,MIR3925_3P,1
MIR4536_5P,SET,41,-0.16062,-0.0075781,0.13076,0.89033,MIR4536_5P,1
HOEK_NEUTROPHIL_2011_2012_TI...1,SET,50,-0.14991,-0.0078087,0.12202,0.89037,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_DN,1
GOBP_NEGATIVE_REGULATION_OF_...46,SET,24,-0.22785,-0.0082286,0.18543,0.89042,GOBP_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,1
PHB2_TARGET_GENES,SET,149,-0.082781,-0.0074235,0.067358,0.89045,PHB2_TARGET_GENES,1
HP_HYPERURICEMIA,SET,23,-0.20695,-0.0073166,0.16837,0.89049,HP_HYPERURICEMIA,1
GOMF_NITRIC_OXIDE_SYNTHASE_R...,SET,7,-0.4158,-0.0081133,0.33817,0.89056,GOMF_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY,1
REACTOME_GPVI_MEDIATED_ACTIV...,SET,33,-0.19534,-0.0082699,0.15885,0.89059,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1
GOBP_RESPONSE_TO_CADMIUM_ION,SET,55,-0.15356,-0.0083882,0.12487,0.8906,GOBP_RESPONSE_TO_CADMIUM_ION,1
HP_NEONATAL_HYPOTONIA,SET,169,-0.080473,-0.0076813,0.065426,0.89064,HP_NEONATAL_HYPOTONIA,1
REACTOME_RUNX3_REGULATES_YAP...,SET,7,-0.44032,-0.0085918,0.35796,0.89066,REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION,1
GOBP_POSITIVE_REGULATION_OF_...19,SET,50,-0.15963,-0.0083152,0.12977,0.89067,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOBP_LEARNING,SET,143,-0.090402,-0.0079433,0.073459,0.89076,GOBP_LEARNING,1
HP_ABNORMAL_FEAR_INDUCED_BEH...,SET,7,-0.34559,-0.0067435,0.28083,0.89076,HP_ABNORMAL_FEAR_INDUCED_BEHAVIOR,1
HP_ENLARGED_POSTERIOR_FOSSA,SET,163,-0.07906,-0.0074125,0.064228,0.89081,HP_ENLARGED_POSTERIOR_FOSSA,1
WP_NANOPARTICLE_TRIGGERED_RE...,SET,12,-0.33421,-0.0085374,0.27148,0.89084,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...4,SET,636,-0.042616,-0.0077895,0.034618,0.89084,HP_ABNORMAL_MORPHOLOGY_OF_THE_GREAT_VESSELS,1
HP_ABNORMAL_THIRD_TOE_MORPHO...,SET,7,-0.45519,-0.008882,0.3697,0.89088,HP_ABNORMAL_THIRD_TOE_MORPHOLOGY,1
SHANK_TAL1_TARGETS_DN,SET,10,-0.34986,-0.0081587,0.28408,0.89093,SHANK_TAL1_TARGETS_DN,1
ZMYND11_TARGET_GENES,SET,34,-0.18213,-0.0078268,0.14789,0.89094,ZMYND11_TARGET_GENES,1
GSE20727_H2O2_VS_ROS_INHIBIT...2,SET,173,-0.079059,-0.0076344,0.064189,0.89095,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP,1
HP_HYPERTELORISM,SET,721,-0.039627,-0.0076934,0.032173,0.89096,HP_HYPERTELORISM,1
GOBP_NEGATIVE_REGULATION_OF_...433,SET,21,-0.23379,-0.0078983,0.18978,0.891,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
HP_DECREASED_SERUM_CREATININE,SET,4,-0.55863,-0.0082406,0.45345,0.89101,HP_DECREASED_SERUM_CREATININE,1
NAKAYA_MONOCYTE_FLUARIX_FLUV...1,SET,86,-0.11446,-0.0078116,0.092906,0.89102,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
REACTOME_NITRIC_OXIDE_STIMUL...,SET,19,-0.26433,-0.0084948,0.21452,0.89105,REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,1
HP_FLAT_FOREHEAD,SET,15,-0.27343,-0.0078084,0.2219,0.89106,HP_FLAT_FOREHEAD,1
GSE21360_NAIVE_VS_TERTIARY_M...2,SET,169,-0.080788,-0.0077114,0.065558,0.89107,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
GOBP_REGULATION_OF_PLASMA_ME...1,SET,16,-0.25977,-0.0076614,0.21077,0.8911,GOBP_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION,1
GOBP_RIBOSOME_DISASSEMBLY,SET,32,-0.17084,-0.0071226,0.13861,0.89111,GOBP_RIBOSOME_DISASSEMBLY,1
REACTOME_RSK_ACTIVATION,SET,5,-0.51977,-0.0085722,0.42168,0.89113,REACTOME_RSK_ACTIVATION,1
HP_ABNORMAL_T_WAVE,SET,35,-0.18876,-0.0082296,0.15311,0.89118,HP_ABNORMAL_T_WAVE,1
REACTOME_METABOLISM_OF_VITAM...,SET,185,-0.079056,-0.0078918,0.064121,0.89119,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1
GOBP_CYSTEINE_METABOLIC_PROC...,SET,10,-0.36226,-0.0084481,0.2938,0.89121,GOBP_CYSTEINE_METABOLIC_PROCESS,1
GOBP_MICROTUBULE_BASED_PROTE...,SET,14,-0.28792,-0.0079436,0.23351,0.89121,GOBP_MICROTUBULE_BASED_PROTEIN_TRANSPORT,1
REACTOME_SODIUM_COUPLED_SULP...,SET,5,-0.53736,-0.0088622,0.43579,0.89122,REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS,1
HP_LIMBAL_STEM_CELL_DEFICIEN...,SET,8,-0.44837,-0.0093527,0.36357,0.89125,HP_LIMBAL_STEM_CELL_DEFICIENCY,1
HP_HIGHLY_ARCHED_EYEBROW,SET,177,-0.075054,-0.0073301,0.060845,0.8913,HP_HIGHLY_ARCHED_EYEBROW,1
HP_SLENDER_TOE,SET,4,-0.51724,-0.00763,0.41916,0.89139,HP_SLENDER_TOE,1
GSE15930_NAIVE_VS_48H_IN_VIT...6,SET,187,-0.078741,-0.0079023,0.0638,0.89142,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
FOSTER_TOLERANT_MACROPHAGE_UP,SET,151,-0.09111,-0.0082246,0.073814,0.89145,FOSTER_TOLERANT_MACROPHAGE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...54,SET,4,-0.56455,-0.0083279,0.45733,0.89147,GOBP_NEGATIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,1
GOCC_MESSENGER_RIBONUCLEOPRO...,SET,6,-0.38283,-0.0069162,0.31007,0.89151,GOCC_MESSENGER_RIBONUCLEOPROTEIN_COMPLEX,1
GOCC_SODIUM_CHANNEL_COMPLEX,SET,24,-0.24856,-0.0089765,0.20132,0.89151,GOCC_SODIUM_CHANNEL_COMPLEX,1
GOMF_1_4_ALPHA_OLIGOGLUCAN_P...,SET,5,-0.36432,-0.0060085,0.29498,0.89159,GOMF_1_4_ALPHA_OLIGOGLUCAN_PHOSPHORYLASE_ACTIVITY,1
COWLING_MYCN_TARGETS,SET,38,-0.17639,-0.0080123,0.1428,0.89161,COWLING_MYCN_TARGETS,1
REACTOME_ORC1_REMOVAL_FROM_C...,SET,68,-0.11943,-0.0072514,0.09669,0.89162,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,1
HP_SCALING_SKIN,SET,42,-0.16347,-0.0078057,0.13232,0.89164,HP_SCALING_SKIN,1
ERWIN_COHEN_BLOOD_VACCINE_TC...2,SET,26,-0.21749,-0.0081747,0.17603,0.89168,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN,1
GOMF_NEUROPEPTIDE_Y_RECEPTOR...,SET,8,-0.46453,-0.0096898,0.37593,0.8917,GOMF_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_FA...,SET,32,-0.20297,-0.008462,0.16424,0.89172,GOBP_CELLULAR_RESPONSE_TO_FATTY_ACID,1
GOBP_T_HELPER_2_CELL_DIFFERE...,SET,18,-0.26758,-0.0083701,0.21652,0.89173,GOBP_T_HELPER_2_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_REFERENCE_HEPAR...1,SET,11,-0.33595,-0.0082166,0.27182,0.89175,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS,1
GOCC_PARANODE_REGION_OF_AXON,SET,12,-0.32125,-0.0082061,0.2599,0.89177,GOCC_PARANODE_REGION_OF_AXON,1
HOEK_PBMC_INACTIVATED_INFLUE...6,SET,14,-0.28474,-0.007856,0.23036,0.89177,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP,1
BERTUCCI_MEDULLARY_VS_DUCTAL...1,SET,153,-0.089442,-0.0081269,0.072348,0.89181,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,1
GOMF_NUCLEOSIDE_DIPHOSPHATE_...2,SET,17,-0.2504,-0.0076123,0.20251,0.89185,GOMF_NUCLEOSIDE_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,1
GSE33425_CD161_HIGH_VS_INT_C...2,SET,186,-0.076739,-0.007681,0.062049,0.8919,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_26S_P...,SET,37,-0.15794,-0.0070794,0.12766,0.89198,KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...90,SET,37,-0.15794,-0.0070794,0.12766,0.89198,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
HP_HYPERLIPIDEMIA,SET,138,-0.094341,-0.0081443,0.076247,0.892,HP_HYPERLIPIDEMIA,1
MIR675_3P,SET,56,-0.15008,-0.0082719,0.12129,0.89201,MIR675_3P,1
GOBP_PROTEIN_MATURATION_BY_P...,SET,6,-0.40056,-0.0072364,0.32368,0.89204,GOBP_PROTEIN_MATURATION_BY_PROTEIN_FOLDING,1
GSE10325_BCELL_VS_MYELOID_UP,SET,170,-0.082504,-0.0078983,0.066669,0.89205,GSE10325_BCELL_VS_MYELOID_UP,1
SUZUKI_RESPONSE_TO_TSA,SET,15,-0.2858,-0.0081618,0.23093,0.89207,SUZUKI_RESPONSE_TO_TSA,1
HP_MICROTIA_FIRST_DEGREE,SET,4,-0.62927,-0.0092826,0.50821,0.89217,HP_MICROTIA_FIRST_DEGREE,1
GOMF_C_ACETYLTRANSFERASE_ACT...,SET,7,-0.35623,-0.0069511,0.28767,0.8922,GOMF_C_ACETYLTRANSFERASE_ACTIVITY,1
GSE5589_LPS_VS_LPS_AND_IL10_...12,SET,183,-0.079652,-0.0079086,0.064314,0.89223,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
FOXO4_TARGET_GENES,SET,293,-0.059072,-0.007399,0.047672,0.89234,FOXO4_TARGET_GENES,1
HP_AGGRESSIVE_BEHAVIOR,SET,242,-0.068308,-0.0077866,0.055121,0.89236,HP_AGGRESSIVE_BEHAVIOR,1
GSE24142_ADULT_VS_FETAL_DN2_...2,SET,186,-0.080809,-0.0080883,0.065209,0.89236,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP,1
GSE14769_UNSTIM_VS_20MIN_LPS...1,SET,183,-0.078559,-0.0078001,0.063391,0.89237,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN,1
MIR4316,SET,131,-0.092946,-0.0078192,0.074947,0.89253,MIR4316,1
GOMF_ARRESTIN_FAMILY_PROTEIN...,SET,9,-0.30581,-0.0067659,0.24655,0.89257,GOMF_ARRESTIN_FAMILY_PROTEIN_BINDING,1
HP_HEPATOBLASTOMA,SET,21,-0.25416,-0.0085866,0.20489,0.8926,HP_HEPATOBLASTOMA,1
GOBP_MUSCLE_CELL_APOPTOTIC_P...,SET,76,-0.12135,-0.0077877,0.097814,0.89263,GOBP_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOMF_METHYLATION_DEPENDENT_P...,SET,66,-0.12264,-0.0073363,0.098836,0.89266,GOMF_METHYLATION_DEPENDENT_PROTEIN_BINDING,1
HP_ABNORMAL_ADIPOSE_TISSUE_M...,SET,214,-0.073409,-0.0078753,0.059157,0.89267,HP_ABNORMAL_ADIPOSE_TISSUE_MORPHOLOGY,1
GSE37534_PIOGLITAZONE_VS_ROS...1,SET,145,-0.093637,-0.0082845,0.075428,0.89277,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
GSE27786_NKCELL_VS_NEUTROPHI...2,SET,184,-0.076765,-0.0076426,0.061832,0.89278,GSE27786_NKCELL_VS_NEUTROPHIL_UP,1
REACTOME_MET_PROMOTES_CELL_M...,SET,41,-0.1832,-0.0086432,0.14755,0.8928,REACTOME_MET_PROMOTES_CELL_MOTILITY,1
HP_ABNORMAL_MIDFACE_MORPHOLO...,SET,533,-0.046023,-0.0077232,0.037064,0.89282,HP_ABNORMAL_MIDFACE_MORPHOLOGY,1
GOBP_CALCIUM_IMPORT_INTO_THE...,SET,14,-0.29197,-0.0080554,0.2351,0.89286,GOBP_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,1
KEGG_MEDICUS_VARIANT_AMPLIFI...7,SET,14,-0.27587,-0.0076113,0.22212,0.89287,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
NAKAYA_MYELOID_DENDRITIC_CEL...3,SET,247,-0.065287,-0.0075177,0.052567,0.89287,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,1
ZWANG_EGF_INTERVAL_UP,SET,76,-0.12526,-0.0080382,0.10082,0.89295,ZWANG_EGF_INTERVAL_UP,1
HP_ABNORMAL_2ND_METACARPAL_M...,SET,6,-0.48741,-0.0088055,0.39231,0.89295,HP_ABNORMAL_2ND_METACARPAL_MORPHOLOGY,1
GOBP_RESPONSE_TO_FUNGUS,SET,54,-0.15614,-0.0084514,0.12566,0.89298,GOBP_RESPONSE_TO_FUNGUS,1
TRAVAGLINI_LUNG_CLASSICAL_MO...,SET,248,-0.070498,-0.008134,0.056726,0.89302,TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL,1
KEGG_MEDICUS_VARIANT_MUTATIO...3,SET,8,-0.38145,-0.0079569,0.30684,0.89309,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY,1
GSE14308_TH2_VS_NAIVE_CD4_TC...2,SET,175,-0.076807,-0.0074592,0.061754,0.8932,GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP,1
BIOCARTA_IGF1_PATHWAY,SET,20,-0.23982,-0.0079069,0.19278,0.89324,BIOCARTA_IGF1_PATHWAY,1
WP_SILDENAFIL_TREATMENT,SET,19,-0.25982,-0.0083496,0.20884,0.89326,WP_SILDENAFIL_TREATMENT,1
HP_ABNORMAL_CIRCULATING_PROT...2,SET,58,-0.13734,-0.0077031,0.11039,0.89326,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_CONCENTRATION,1
HP_SHORT_TERM_MEMORY_IMPAIRM...,SET,6,-0.51937,-0.0093827,0.41746,0.89326,HP_SHORT_TERM_MEMORY_IMPAIRMENT,1
KEGG_MEDICUS_VARIANT_AMPLIFI...16,SET,13,-0.28833,-0.0076657,0.23172,0.8933,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_DELAYED_ABILITY_TO_STAND,SET,14,-0.28902,-0.007974,0.23225,0.89332,HP_DELAYED_ABILITY_TO_STAND,1
KIM_LIVER_CANCER_POOR_SURVIV...2,SET,21,-0.23976,-0.0081002,0.19266,0.89333,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,1
chr2q24,SET,48,-0.3003,-0.015327,0.24129,0.89335,chr2q24,1
PPARGC1A_TARGET_GENES,SET,79,-0.11844,-0.0077485,0.095149,0.89338,PPARGC1A_TARGET_GENES,1
HP_MILD_GLOBAL_DEVELOPMENTAL...,SET,70,-0.12568,-0.0077414,0.10091,0.8935,HP_MILD_GLOBAL_DEVELOPMENTAL_DELAY,1
WP_RELATIONSHIP_BETWEEN_INFL...,SET,25,-0.22092,-0.0081427,0.17738,0.89352,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,1
GSE3982_BASOPHIL_VS_EFF_MEMO...2,SET,184,-0.079514,-0.0079162,0.063836,0.89353,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
HP_PSEUDOBULBAR_SIGNS,SET,28,-0.19539,-0.0076208,0.15686,0.89354,HP_PSEUDOBULBAR_SIGNS,1
BERENJENO_TRANSFORMED_BY_RHO...5,SET,8,-0.44209,-0.0092217,0.35487,0.89357,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,1
PYEON_HPV_POSITIVE_TUMORS_DN,SET,8,-0.43504,-0.0090746,0.34913,0.89362,PYEON_HPV_POSITIVE_TUMORS_DN,1
TAKEDA_TARGETS_OF_NUP98_HOXA...2,SET,171,-0.090633,-0.0087018,0.072726,0.89365,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,1
GSE45881_CXCR6HI_VS_CXCR1LO_...2,SET,168,-0.078965,-0.0075153,0.063357,0.89367,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP,1
MEL18_DN.V1_UP,SET,133,-0.099946,-0.0084716,0.080179,0.89371,MEL18_DN.V1_UP,1
GOBP_POSITIVE_REGULATION_OF_...403,SET,21,-0.22942,-0.0077506,0.18399,0.89377,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,1
GOMF_MOLYBDOPTERIN_COFACTOR_...,SET,4,-0.56445,-0.0083264,0.4527,0.89377,GOMF_MOLYBDOPTERIN_COFACTOR_BINDING,1
GOBP_REGULATION_OF_MUSCLE_CO...,SET,154,-0.088934,-0.0081069,0.071319,0.89379,GOBP_REGULATION_OF_MUSCLE_CONTRACTION,1
HP_2_4_FINGER_SYNDACTYLY,SET,4,-0.50576,-0.0074606,0.40559,0.89379,HP_2_4_FINGER_SYNDACTYLY,1
GSE28737_BCL6_HET_VS_BCL6_KO...4,SET,184,-0.080934,-0.0080576,0.064903,0.89379,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,1
MIR654_3P,SET,71,-0.12786,-0.0079315,0.10253,0.8938,MIR654_3P,1
HP_PAROXYSMAL_INVOLUNTARY_EY...,SET,30,-0.18464,-0.0074539,0.14806,0.8938,HP_PAROXYSMAL_INVOLUNTARY_EYE_MOVEMENTS,1
GOBP_REGULATION_OF_THYMOCYTE...,SET,13,-0.29719,-0.0079014,0.23825,0.89386,GOBP_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,1
GOCC_INNER_ACROSOMAL_MEMBRANE,SET,5,-0.55115,-0.0090896,0.44183,0.89387,GOCC_INNER_ACROSOMAL_MEMBRANE,1
GOBP_SKELETAL_SYSTEM_DEVELOP...,SET,483,-0.052996,-0.0084778,0.042478,0.8939,GOBP_SKELETAL_SYSTEM_DEVELOPMENT,1
MIR328_3P,SET,39,-0.18222,-0.0083853,0.14605,0.89391,MIR328_3P,1
GSE21670_STAT3_KO_VS_WT_CD4_...5,SET,173,-0.077645,-0.0074978,0.062233,0.89391,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP,1
HILLION_HMGA1_TARGETS,SET,75,-0.12646,-0.0080621,0.10136,0.89392,HILLION_HMGA1_TARGETS,1
GSE22589_HEALTHY_VS_HIV_INFE...1,SET,183,-0.080412,-0.0079841,0.064435,0.89397,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN,1
REACTOME_SURFACTANT_METABOLI...,SET,26,-0.23087,-0.0086774,0.18499,0.89398,REACTOME_SURFACTANT_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...379,SET,953,-0.036636,-0.0081235,0.029345,0.89406,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
GOCC_IKAPPAB_KINASE_COMPLEX,SET,6,-0.37141,-0.0067097,0.29748,0.89407,GOCC_IKAPPAB_KINASE_COMPLEX,1
ZHANG_RESPONSE_TO_IKK_INHIBI...1,SET,96,-0.11472,-0.0082694,0.091875,0.89409,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,1
MODULE_397,SET,110,-0.098812,-0.0076217,0.079139,0.89409,MODULE_397,1
GOBP_RNA_SECONDARY_STRUCTURE...,SET,8,-0.37343,-0.0077894,0.29901,0.89414,GOBP_RNA_SECONDARY_STRUCTURE_UNWINDING,1
HP_POLYHYDRAMNIOS,SET,263,-0.066515,-0.0078998,0.053258,0.89414,HP_POLYHYDRAMNIOS,1
HP_HYPOPLASTIC_FIFTH_FINGERN...,SET,14,-0.29722,-0.0082003,0.23796,0.89417,HP_HYPOPLASTIC_FIFTH_FINGERNAIL,1
HP_PRIMARY_HYPOTHYROIDISM,SET,6,-0.36784,-0.0066452,0.29445,0.8942,HP_PRIMARY_HYPOTHYROIDISM,1
GOCC_MICROTUBULE_PLUS_END,SET,24,-0.20629,-0.0074499,0.16513,0.89421,GOCC_MICROTUBULE_PLUS_END,1
GOBP_LONG_CHAIN_FATTY_ACID_B...,SET,25,-0.22555,-0.0083131,0.1805,0.89426,GOBP_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
HP_BRONCHITIS,SET,62,-0.13815,-0.0080104,0.11056,0.89426,HP_BRONCHITIS,1
HP_FOCAL_NON_MOTOR_SEIZURE,SET,37,-0.18059,-0.0080947,0.14451,0.89427,HP_FOCAL_NON_MOTOR_SEIZURE,1
CACTGCC_MIR34A_MIR34C_MIR449,SET,258,-0.064523,-0.0075912,0.05163,0.89429,CACTGCC_MIR34A_MIR34C_MIR449,1
GOBP_SULFATE_TRANSPORT,SET,16,-0.2689,-0.0079307,0.21511,0.89436,GOBP_SULFATE_TRANSPORT,1
GSE13173_UNTREATED_VS_IL12_T...1,SET,117,-0.098947,-0.0078697,0.079148,0.89437,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN,1
GSE43955_1H_VS_60H_ACT_CD4_T...3,SET,185,-0.082024,-0.0081881,0.065611,0.89437,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
REACTOME_REGULATION_OF_PYRUV...2,SET,29,-0.20486,-0.0081313,0.16383,0.89443,REACTOME_REGULATION_OF_PYRUVATE_METABOLISM,1
PTTG1_TARGET_GENES,SET,55,-0.14449,-0.0078925,0.11554,0.89443,PTTG1_TARGET_GENES,1
GOBP_DETERMINATION_OF_DIGEST...,SET,6,-0.37008,-0.0066858,0.29594,0.89444,GOBP_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY,1
PID_ARF_3PATHWAY,SET,19,-0.25063,-0.0080544,0.2004,0.89445,PID_ARF_3PATHWAY,1
BIOCARTA_DICER_PATHWAY,SET,5,-0.51792,-0.0085415,0.41408,0.89448,BIOCARTA_DICER_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...93,SET,29,-0.22263,-0.0088367,0.17798,0.8945,GOBP_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,1
GOBP_REGULATION_OF_KERATINOC...2,SET,14,-0.3359,-0.0092675,0.2685,0.89453,GOBP_REGULATION_OF_KERATINOCYTE_MIGRATION,1
KEGG_MEDICUS_REFERENCE_TGFA_...3,SET,14,-0.28246,-0.0077931,0.22578,0.89454,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
MIR6855_3P,SET,45,-0.15705,-0.0077617,0.1255,0.8946,MIR6855_3P,1
GOMF_BIS_5_ADENOSYL_PENTAPHO...,SET,3,-0.774,-0.0098881,0.61847,0.89461,GOMF_BIS_5_ADENOSYL_PENTAPHOSPHATASE_ACTIVITY,1
GOBP_LIPID_IMPORT_INTO_CELL,SET,19,-0.24171,-0.0077679,0.19313,0.89462,GOBP_LIPID_IMPORT_INTO_CELL,1
GOBP_GASTRO_INTESTINAL_SYSTE...,SET,12,-0.29706,-0.0075883,0.23727,0.8947,GOBP_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,1
KEGG_BUTANOATE_METABOLISM,SET,31,-0.20342,-0.0083474,0.16247,0.89471,KEGG_BUTANOATE_METABOLISM,1
REACTOME_RHOBTB2_GTPASE_CYCLE,SET,22,-0.21243,-0.0073453,0.16967,0.89471,REACTOME_RHOBTB2_GTPASE_CYCLE,1
E2F1_Q3_01,SET,222,-0.071553,-0.0078166,0.057149,0.89471,E2F1_Q3_01,1
GSE21927_SPLEEN_MONOCYTE_VS_...2,SET,151,-0.081028,-0.0073145,0.064718,0.89471,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP,1
HP_DELAYED_OSSIFICATION_OF_C...,SET,15,-0.25242,-0.0072084,0.2016,0.89472,HP_DELAYED_OSSIFICATION_OF_CARPAL_BONES,1
MEBARKI_HCC_PROGENITOR_WNT_U...3,SET,39,-0.19775,-0.0091,0.15793,0.89474,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1
GOBP_REGULATION_OF_SKELETAL_...6,SET,7,-0.40205,-0.007845,0.32103,0.89478,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,1
GOMF_LIPOPROTEIN_PARTICLE_RE...1,SET,18,-0.27333,-0.0085498,0.2182,0.89483,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,1
CAGNYGKNAAA_UNKNOWN,SET,70,-0.13236,-0.0081532,0.10565,0.89486,CAGNYGKNAAA_UNKNOWN,1
MODULE_470,SET,15,-0.32018,-0.0091436,0.25549,0.89492,MODULE_470,1
GSE17721_CTRL_VS_GARDIQUIMOD...5,SET,183,-0.081372,-0.0080794,0.064927,0.89494,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN,1
DESCARTES_FETAL_THYMUS_THYMO...,SET,19,-0.26419,-0.0084904,0.21078,0.89497,DESCARTES_FETAL_THYMUS_THYMOCYTES,1
HP_APLASIA_HYPOPLASIA_OF_THE...39,SET,14,-0.29739,-0.008205,0.23724,0.89499,HP_APLASIA_HYPOPLASIA_OF_THE_LENS,1
ZNF490_TARGET_GENES,SET,335,-0.058987,-0.007891,0.04705,0.89502,ZNF490_TARGET_GENES,1
HP_ABNORMALITY_OF_PULMONARY_...,SET,168,-0.083063,-0.0079053,0.066244,0.89505,HP_ABNORMALITY_OF_PULMONARY_CIRCULATION,1
GOCC_TELOMERASE_HOLOENZYME_C...,SET,19,-0.22772,-0.0073182,0.18158,0.89509,GOCC_TELOMERASE_HOLOENZYME_COMPLEX,1
GSE44649_WT_VS_MIR155_KO_ACT...1,SET,182,-0.077341,-0.0076583,0.061664,0.89511,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN,1
GSE25088_IL4_VS_IL4_AND_ROSI...4,SET,177,-0.083613,-0.008166,0.066664,0.89512,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,1
MIR4748,SET,61,-0.134,-0.0077072,0.10682,0.89514,MIR4748,1
BIOCARTA_NFKB_PATHWAY,SET,20,-0.25092,-0.008273,0.20003,0.89515,BIOCARTA_NFKB_PATHWAY,1
MIR548AO_3P,SET,17,-0.25983,-0.0078987,0.20712,0.89515,MIR548AO_3P,1
HE_LIM_SUN_FETAL_LUNG_C3_VEN...,SET,76,-0.12943,-0.0083063,0.10316,0.8952,HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL,1
GOMF_INTRAMOLECULAR_OXIDORED...1,SET,51,-0.14813,-0.0077922,0.11803,0.89525,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY,1
chr21q21,SET,25,-0.35425,-0.013057,0.28226,0.89526,chr21q21,1
GOMF_ELECTRON_TRANSFER_ACTIV...,SET,96,-0.10168,-0.0073297,0.081009,0.89528,GOMF_ELECTRON_TRANSFER_ACTIVITY,1
GOBP_ENERGY_DERIVATION_BY_OX...,SET,277,-0.062102,-0.0075666,0.049476,0.89529,GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS,1
GOBP_DENDRITIC_CELL_MIGRATION,SET,31,-0.20701,-0.0084948,0.16491,0.89531,GOBP_DENDRITIC_CELL_MIGRATION,1
GOMF_DYNEIN_COMPLEX_BINDING,SET,19,-0.24397,-0.0078404,0.19431,0.89536,GOMF_DYNEIN_COMPLEX_BINDING,1
HP_ABNORMALITY_OF_THE_OUTER_...,SET,1117,-0.032732,-0.0078204,0.026069,0.89536,HP_ABNORMALITY_OF_THE_OUTER_EAR,1
HP_ABNORMALITY_OF_THE_MITOCH...,SET,190,-0.072333,-0.0073166,0.057575,0.8955,HP_ABNORMALITY_OF_THE_MITOCHONDRION,1
HP_ABNORMAL_CIRCULATING_NUCL...,SET,42,-0.16048,-0.0076629,0.12773,0.8955,HP_ABNORMAL_CIRCULATING_NUCLEOBASE_CONCENTRATION,1
GSE13547_WT_VS_ZFX_KO_BCELL_...6,SET,156,-0.092165,-0.0084553,0.073359,0.8955,GSE13547_WT_VS_ZFX_KO_BCELL_UP,1
TRAVAGLINI_LUNG_NONCLASSICAL...,SET,171,-0.087081,-0.0083607,0.069308,0.89551,TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL,1
GOCC_CORVET_COMPLEX,SET,7,-0.36741,-0.0071691,0.2923,0.8956,GOCC_CORVET_COMPLEX,1
HP_PROGRESSIVE_HEARING_IMPAI...,SET,35,-0.17225,-0.0075097,0.13691,0.89582,HP_PROGRESSIVE_HEARING_IMPAIRMENT,1
GSE27241_WT_VS_RORGT_KO_TH17...2,SET,164,-0.084913,-0.0079854,0.067491,0.89582,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN,1
WP_NANOPARTICLEMEDIATED_ACTI...,SET,28,-0.2169,-0.0084599,0.17239,0.89583,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,1
GOBP_IMP_CATABOLIC_PROCESS,SET,5,-0.51396,-0.0084763,0.40847,0.89584,GOBP_IMP_CATABOLIC_PROCESS,1
MIR6874_3P,SET,70,-0.1279,-0.0078784,0.10163,0.89588,MIR6874_3P,1
GOBP_REGULATION_OF_HYDROGEN_...3,SET,17,-0.26656,-0.0081036,0.21175,0.89595,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
HP_J_SHAPED_SELLA_TURCICA,SET,12,-0.29877,-0.007632,0.2373,0.89599,HP_J_SHAPED_SELLA_TURCICA,1
HP_THICK_HAIR,SET,19,-0.22402,-0.0071994,0.17792,0.896,HP_THICK_HAIR,1
WP_MICRORNA_FOR_TARGETING_CA...,SET,7,-0.39298,-0.0076682,0.31197,0.8961,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,1
HP_SEVERE_INTRAUTERINE_GROWT...,SET,13,-0.32766,-0.0087114,0.26007,0.89613,HP_SEVERE_INTRAUTERINE_GROWTH_RETARDATION,1
GSE43863_TFH_VS_LY6C_INT_CXC...2,SET,183,-0.078897,-0.0078337,0.062617,0.89616,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,1
REACTOME_SENSORY_PERCEPTION_...1,SET,6,-0.51475,-0.0092994,0.4085,0.89618,REACTOME_SENSORY_PERCEPTION_OF_SALTY_TASTE,1
HEBERT_MATRISOME_TNBC_LUNG_M...1,SET,20,-0.25022,-0.00825,0.19854,0.89621,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS,1
REACTOME_DEPOSITION_OF_NEW_C...,SET,23,-0.22163,-0.0078355,0.17585,0.89621,REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,1
GOBP_REELIN_MEDIATED_SIGNALI...,SET,8,-0.38329,-0.0079951,0.30411,0.89622,GOBP_REELIN_MEDIATED_SIGNALING_PATHWAY,1
GOMF_MRNA_REGULATORY_ELEMENT...,SET,15,-0.2419,-0.0069081,0.19189,0.89627,GOMF_MRNA_REGULATORY_ELEMENT_BINDING_TRANSLATION_REPRESSOR_ACTIVITY,1
MIR3690,SET,52,-0.1489,-0.0079094,0.1181,0.8963,MIR3690,1
MODULE_313,SET,13,-0.28855,-0.0076717,0.22881,0.89635,MODULE_313,1
DELPUECH_FOXO3_TARGETS_DN,SET,34,-0.20447,-0.0087864,0.16208,0.89643,DELPUECH_FOXO3_TARGETS_DN,1
MODULE_199,SET,52,-0.16449,-0.0087373,0.13036,0.89649,MODULE_199,1
HP_REDUCED_NATURAL_KILLER_CE...1,SET,11,-0.34986,-0.0085569,0.27725,0.8965,HP_REDUCED_NATURAL_KILLER_CELL_ACTIVITY,1
GOBP_PURINE_DEOXYRIBONUCLEOS...2,SET,6,-0.47395,-0.0085623,0.37557,0.89651,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...715,SET,30,-0.20994,-0.0084754,0.16634,0.89654,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
REACTOME_HSF1_ACTIVATION,SET,28,-0.20206,-0.0078808,0.16008,0.89655,REACTOME_HSF1_ACTIVATION,1
BIOCARTA_PRION_PATHWAY,SET,12,-0.29764,-0.0076031,0.23579,0.89657,BIOCARTA_PRION_PATHWAY,1
TGFB_UP.V1_DN,SET,172,-0.085693,-0.0082512,0.067851,0.89669,TGFB_UP.V1_DN,1
HP_ABNORMALITY_OF_THE_ANTERI...2,SET,110,-0.1013,-0.0078139,0.080156,0.89685,HP_ABNORMALITY_OF_THE_ANTERIOR_FONTANELLE,1
GNF2_PECAM1,SET,48,-0.16689,-0.0085178,0.13204,0.89686,GNF2_PECAM1,1
HP_MUSCLE_ABNORMALITY_RELATE...,SET,63,-0.12477,-0.0072928,0.098701,0.8969,HP_MUSCLE_ABNORMALITY_RELATED_TO_MITOCHONDRIAL_DYSFUNCTION,1
MODULE_119,SET,130,-0.091029,-0.0076288,0.071979,0.89699,MODULE_119,1
HP_RECURRENT_EAR_INFECTIONS,SET,16,-0.27804,-0.0082002,0.21982,0.89702,HP_RECURRENT_EAR_INFECTIONS,1
REACTOME_PURINE_RIBONUCLEOSI...,SET,9,-0.35762,-0.007912,0.28273,0.89703,REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS,1
REACTOME_BETA_CATENIN_INDEPE...,SET,142,-0.088614,-0.0077591,0.070045,0.89707,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1
SKIL_TARGET_GENES,SET,1479,-0.029913,-0.0081371,0.023644,0.89708,SKIL_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C0_MYL...,SET,110,-0.1131,-0.0087236,0.089358,0.89718,HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL,1
APRELIKOVA_BRCA1_TARGETS,SET,42,-0.163,-0.0077834,0.12876,0.89721,APRELIKOVA_BRCA1_TARGETS,1
MIR6511A_5P,SET,175,-0.08325,-0.0080849,0.065761,0.89723,MIR6511A_5P,1
HP_INVOLUNTARY_MOVEMENTS,SET,910,-0.036026,-0.0078155,0.028454,0.89725,HP_INVOLUNTARY_MOVEMENTS,1
GSE3982_NEUTROPHIL_VS_TH2_UP,SET,181,-0.082423,-0.0081394,0.065099,0.89725,GSE3982_NEUTROPHIL_VS_TH2_UP,1
HP_DISPROPORTIONATE_SHORT_LI...,SET,96,-0.1139,-0.0082104,0.089944,0.89729,HP_DISPROPORTIONATE_SHORT_LIMB_SHORT_STATURE,1
OCT1_B,SET,225,-0.078122,-0.0085909,0.061689,0.8973,OCT1_B,1
GOCC_LEADING_EDGE_MEMBRANE,SET,170,-0.084875,-0.0081253,0.06702,0.89731,GOCC_LEADING_EDGE_MEMBRANE,1
KEGG_PHOSPHATIDYLINOSITOL_SI...,SET,75,-0.1241,-0.0079119,0.097983,0.89734,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,1
GOBP_PRESYNAPTIC_ACTIVE_ZONE...,SET,7,-0.46672,-0.009107,0.36847,0.89735,GOBP_PRESYNAPTIC_ACTIVE_ZONE_ORGANIZATION,1
GOBP_REGULATION_OF_LUNG_BLOO...,SET,3,-0.65725,-0.0083966,0.51864,0.89746,GOBP_REGULATION_OF_LUNG_BLOOD_PRESSURE,1
GOCC_CLOCK_BMAL_TRANSCRIPTIO...,SET,2,-1.0721,-0.011184,0.8459,0.89749,GOCC_CLOCK_BMAL_TRANSCRIPTION_COMPLEX,1
GCM_MAPK10,SET,73,-0.13174,-0.0082861,0.10393,0.8975,GCM_MAPK10,1
GOBP_NEGATIVE_REGULATION_OF_...196,SET,5,-0.47562,-0.0078439,0.37514,0.89756,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
GSE18281_SUBCAPSULAR_VS_CENT...1,SET,188,-0.079658,-0.0080154,0.062828,0.89757,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN,1
GOMF_G_PROTEIN_COUPLED_GLUTA...2,SET,8,-0.40156,-0.0083762,0.31659,0.89766,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING,1
REACTOME_CYCLIN_A_CDK2_ASSOC...,SET,82,-0.10814,-0.0072071,0.085247,0.89768,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1
GSE9988_LOW_LPS_VS_CTRL_TREA...2,SET,165,-0.091501,-0.008631,0.072127,0.8977,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP,1
GOCC_CLATHRIN_COATED_VESICLE...,SET,124,-0.10182,-0.0083357,0.080245,0.89775,GOCC_CLATHRIN_COATED_VESICLE_MEMBRANE,1
REACTOME_CALCITONIN_LIKE_LIG...,SET,9,-0.42376,-0.0093754,0.33384,0.89784,REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS,1
GOBP_NEGATIVE_REGULATION_OF_...15,SET,42,-0.17866,-0.008531,0.14074,0.89785,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,1
DESCARTES_FETAL_HEART_LYMPHO...,SET,86,-0.12706,-0.0086715,0.10008,0.89788,DESCARTES_FETAL_HEART_LYMPHOID_CELLS,1
GENTILE_UV_RESPONSE_CLUSTER_...2,SET,37,-0.19352,-0.0086743,0.15242,0.89789,GENTILE_UV_RESPONSE_CLUSTER_D2,1
MIR26A_1_3P,SET,66,-0.12946,-0.0077444,0.10197,0.89789,MIR26A_1_3P,1
GOBP_REGULATION_OF_TRANSLATI...3,SET,13,-0.2595,-0.0068993,0.20436,0.89792,GOBP_REGULATION_OF_TRANSLATIONAL_FIDELITY,1
GSE37416_0H_VS_48H_F_TULAREN...1,SET,168,-0.080263,-0.0076388,0.063192,0.89797,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
HP_NOCTURNAL_SEIZURES,SET,18,-0.28178,-0.0088141,0.22184,0.89798,HP_NOCTURNAL_SEIZURES,1
CIC_TARGET_GENES,SET,376,-0.056229,-0.0079601,0.04426,0.89803,CIC_TARGET_GENES,1
GSE20500_RETINOIC_ACID_VS_RA...1,SET,175,-0.084657,-0.0082216,0.06663,0.89805,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,1
GOMF_PROTEIN_PHOSPHATASE_2B_...,SET,6,-0.39848,-0.0071988,0.31354,0.89811,GOMF_PROTEIN_PHOSPHATASE_2B_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...549,SET,59,-0.15016,-0.0084946,0.11815,0.89812,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION,1
HP_CONGENITAL_ICHTHYOSIFORM_...,SET,27,-0.22181,-0.0084954,0.17449,0.89816,HP_CONGENITAL_ICHTHYOSIFORM_ERYTHRODERMA,1
HP_ABNORMAL_T_CELL_ACTIVATION,SET,5,-0.48682,-0.0080287,0.38295,0.89817,HP_ABNORMAL_T_CELL_ACTIVATION,1
HP_DEVIATION_OF_TOES,SET,103,-0.11521,-0.0086009,0.090617,0.8982,HP_DEVIATION_OF_TOES,1
GOBP_REGULATION_OF_T_HELPER_...7,SET,42,-0.17681,-0.008443,0.13905,0.89823,GOBP_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...208,SET,13,-0.28496,-0.0075762,0.22407,0.89826,GOBP_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
HP_THORACIC_SCOLIOSIS,SET,54,-0.13903,-0.0075252,0.10932,0.89827,HP_THORACIC_SCOLIOSIS,1
GSE19825_NAIVE_VS_DAY3_EFF_C...2,SET,177,-0.085798,-0.0083794,0.067446,0.89832,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP,1
GSE22935_WT_VS_MYD88_KO_MACR...7,SET,180,-0.085577,-0.0084276,0.067259,0.89837,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN,1
HP_LIPOMA,SET,22,-0.23304,-0.008058,0.18309,0.89845,HP_LIPOMA,1
KEGG_MEDICUS_VARIANT_SCRAPIE...1,SET,35,-0.16466,-0.007179,0.12936,0.89846,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_RNA_STABILIZATION,SET,60,-0.13757,-0.0078474,0.10807,0.89848,GOBP_RNA_STABILIZATION,1
GSE17721_CPG_VS_GARDIQUIMOD_...14,SET,189,-0.079221,-0.0079924,0.062225,0.8985,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP,1
GOBP_BIOLOGICAL_PROCESS_INVO...1,SET,190,-0.082149,-0.0083095,0.064522,0.89852,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_HOST,1
AAGCACA_MIR218,SET,372,-0.059655,-0.008401,0.046852,0.89853,AAGCACA_MIR218,1
GSE2770_UNTREATED_VS_IL4_TRE...1,SET,179,-0.076665,-0.0075292,0.060211,0.89853,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
KYNG_ENVIRONMENTAL_STRESS_RE...7,SET,12,-0.32417,-0.0082808,0.2545,0.89862,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1
GOMF_G_PROTEIN_COUPLED_ADENO...,SET,5,-0.50606,-0.0083459,0.39729,0.89862,GOMF_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY,1
GSE19401_PAM2CSK4_VS_RETINOI...3,SET,175,-0.08133,-0.0078985,0.063848,0.89863,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...194,SET,5,-0.47951,-0.0079081,0.37641,0.89864,GOBP_NEGATIVE_REGULATION_OF_DOPAMINE_SECRETION,1
HP_MUCOSAL_TELANGIECTASIAE,SET,36,-0.16635,-0.0073551,0.13055,0.89869,HP_MUCOSAL_TELANGIECTASIAE,1
HP_PERIVENTRICULAR_LEUKOMALA...,SET,38,-0.16777,-0.0076211,0.13168,0.89869,HP_PERIVENTRICULAR_LEUKOMALACIA,1
GNF2_PPP6C,SET,35,-0.16887,-0.0073626,0.13253,0.8987,GNF2_PPP6C,1
HP_PINEAL_CYST,SET,8,-0.37005,-0.0077191,0.29041,0.8987,HP_PINEAL_CYST,1
HP_ABNORMAL_CIRCULATING_PROT...1,SET,101,-0.10768,-0.0079606,0.084487,0.89875,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,1
GSE17974_0H_VS_12H_IN_VITRO_...1,SET,176,-0.08004,-0.0077952,0.0628,0.89875,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN,1
HP_ELEVATED_MEAN_ARTERIAL_PR...,SET,10,-0.35511,-0.0082813,0.2786,0.89877,HP_ELEVATED_MEAN_ARTERIAL_PRESSURE,1
FRANCO_BLOOD_SANOFI_PASTEUR_...1,SET,14,-0.28508,-0.0078654,0.22366,0.89877,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_NEGATIVE,1
REACTOME_REGULATION_OF_HMOX1...,SET,5,-0.46481,-0.0076657,0.3646,0.89881,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,1
HP_BASAL_GANGLIA_CALCIFICATI...,SET,36,-0.19597,-0.008665,0.15372,0.89882,HP_BASAL_GANGLIA_CALCIFICATION,1
REACTOME_CGMP_EFFECTS,SET,15,-0.29959,-0.0085554,0.23496,0.89885,REACTOME_CGMP_EFFECTS,1
GSE3720_LPS_VS_PMA_STIM_VD2_...2,SET,118,-0.098666,-0.0078806,0.077372,0.89887,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,1
GOMF_SULFATE_TRANSMEMBRANE_T...,SET,15,-0.28141,-0.0080362,0.22064,0.89891,GOMF_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_G_PROTEIN_COUPLED_RECEP...1,SET,9,-0.34381,-0.0076066,0.26956,0.89892,GOBP_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION,1
GOBP_DENDRITIC_TRANSPORT,SET,12,-0.31752,-0.008111,0.24889,0.89897,GOBP_DENDRITIC_TRANSPORT,1
HP_KYPHOSCOLIOSIS,SET,164,-0.084127,-0.0079116,0.065929,0.89902,HP_KYPHOSCOLIOSIS,1
GOMF_REGULATORY_RNA_BINDING,SET,38,-0.16564,-0.0075239,0.12979,0.89904,GOMF_REGULATORY_RNA_BINDING,1
REACTOME_MULTIFUNCTIONAL_ANI...,SET,9,-0.36318,-0.008035,0.28454,0.89908,REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS,1
GOCC_CCR4_NOT_COMPLEX,SET,15,-0.27547,-0.0078666,0.21582,0.89908,GOCC_CCR4_NOT_COMPLEX,1
MIR2114_5P,SET,31,-0.19475,-0.0079916,0.15257,0.8991,MIR2114_5P,1
MIR335_5P,SET,105,-0.10895,-0.0082119,0.085342,0.89913,MIR335_5P,1
GAUCHER_PBMC_YF_VAX_STAMARIL...2,SET,183,-0.083244,-0.0082653,0.06517,0.89925,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP,1
GAVISH_3CA_METAPROGRAM_EPITH...24,SET,44,-0.17101,-0.0083575,0.13387,0.89927,GAVISH_3CA_METAPROGRAM_EPITHELIAL_V_ATPASE,1
REACTOME_FCGR_ACTIVATION,SET,12,-0.32906,-0.0084058,0.25748,0.89937,REACTOME_FCGR_ACTIVATION,1
GOBP_SPHINGOLIPID_BIOSYNTHET...,SET,107,-0.11266,-0.0085716,0.088147,0.89939,GOBP_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
HP_CHOLESTEATOMA,SET,10,-0.34866,-0.0081307,0.27276,0.89941,HP_CHOLESTEATOMA,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...2,SET,130,-0.099546,-0.0083427,0.077856,0.89947,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,1
HP_SENSORY_SEEKING,SET,24,-0.22386,-0.0080845,0.17507,0.89949,HP_SENSORY_SEEKING,1
KONDO_EZH2_TARGETS,SET,203,-0.081149,-0.0084815,0.063456,0.89951,KONDO_EZH2_TARGETS,1
REACTOME_SCAVENGING_OF_HEME_...,SET,10,-0.37317,-0.0087025,0.2917,0.89959,REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,1
KEGG_MEDICUS_PATHOGEN_HCV_CO...1,SET,12,-0.34412,-0.0087903,0.26894,0.89964,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY,1
REACTOME_REGULATION_OF_TBK1_...2,SET,10,-0.40443,-0.0094313,0.31607,0.89964,REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION,1
GAUTAM_EYE_IRIS_CILIARY_BODY...13,SET,256,-0.069366,-0.0081297,0.054206,0.89966,GAUTAM_EYE_IRIS_CILIARY_BODY_PUTATIVE_STEM_CELLS,1
GOBP_FLAVONOID_GLUCURONIDATI...,SET,5,-0.75692,-0.012483,0.59124,0.89976,GOBP_FLAVONOID_GLUCURONIDATION,1
GSE22140_GERMFREE_VS_SPF_ART...2,SET,186,-0.080051,-0.0080125,0.062528,0.89976,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP,1
RASHI_RESPONSE_TO_IONIZING_R...5,SET,126,-0.099186,-0.0081845,0.077407,0.89996,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1
HP_LONG_NASAL_BRIDGE,SET,4,-0.53758,-0.0079301,0.41949,0.89998,HP_LONG_NASAL_BRIDGE,1
GOBP_REGULATION_OF_RELEASE_O...3,SET,27,-0.21919,-0.0083951,0.17104,0.89999,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM,1
HP_BULBAR_SIGNS,SET,32,-0.18007,-0.0075073,0.1405,0.90001,HP_BULBAR_SIGNS,1
FLORIO_HUMAN_NEOCORTEX,SET,28,-0.22631,-0.0088269,0.17653,0.90007,FLORIO_HUMAN_NEOCORTEX,1
GSE17721_POLYIC_VS_GARDIQUIM...17,SET,180,-0.07908,-0.0077879,0.061679,0.90009,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN,1
HP_ABNORMALITY_OF_THE_GINGIVA,SET,211,-0.079069,-0.0084235,0.061653,0.90016,HP_ABNORMALITY_OF_THE_GINGIVA,1
KEGG_MEDICUS_VARIANT_DUPLICA...3,SET,14,-0.28174,-0.0077733,0.21963,0.90021,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMAL_CIRCULATING_FREE...2,SET,7,-0.38306,-0.0074746,0.2986,0.90022,HP_ABNORMAL_CIRCULATING_FREE_T3_CONCENTRATION,1
GOBP_REGULATION_OF_DNA_BIOSY...,SET,111,-0.10168,-0.0078787,0.079246,0.90027,GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,1
chr2p11,SET,44,-0.36959,-0.018062,0.28799,0.9003,chr2p11,1
CERVERA_SDHB_TARGETS_2,SET,102,-0.11879,-0.0088248,0.092557,0.90031,CERVERA_SDHB_TARGETS_2,1
MIR6735_3P,SET,33,-0.18309,-0.0077515,0.14267,0.90031,MIR6735_3P,1
DESCARTES_FETAL_HEART_MEGAKA...,SET,80,-0.13165,-0.0086672,0.10258,0.90032,DESCARTES_FETAL_HEART_MEGAKARYOCYTES,1
MIR3664_3P,SET,141,-0.089359,-0.0077969,0.069621,0.90033,MIR3664_3P,1
GOBP_ATRIOVENTRICULAR_VALVE_...2,SET,8,-0.424,-0.0088444,0.33033,0.90034,GOBP_ATRIOVENTRICULAR_VALVE_FORMATION,1
REACTOME_GLYCINE_DEGRADATION,SET,7,-0.34675,-0.0067661,0.27013,0.90036,REACTOME_GLYCINE_DEGRADATION,1
GOBP_NEGATIVE_REGULATION_OF_...43,SET,11,-0.37353,-0.0091357,0.29099,0.90036,GOBP_NEGATIVE_REGULATION_OF_BEHAVIOR,1
GOBP_ACYL_COA_METABOLIC_PROC...,SET,85,-0.12256,-0.0083158,0.095461,0.9004,GOBP_ACYL_COA_METABOLIC_PROCESS,1
WEBER_METHYLATED_HCP_IN_SPER...1,SET,28,-0.21059,-0.0082136,0.164,0.90043,WEBER_METHYLATED_HCP_IN_SPERM_DN,1
REACTOME_REELIN_SIGNALLING_P...,SET,4,-0.60148,-0.0088727,0.46841,0.90044,REACTOME_REELIN_SIGNALLING_PATHWAY,1
HP_ST_SEGMENT_ELEVATION,SET,24,-0.22643,-0.0081771,0.1763,0.90048,HP_ST_SEGMENT_ELEVATION,1
GOBP_SHORT_TERM_MEMORY,SET,10,-0.34595,-0.0080677,0.26932,0.90051,GOBP_SHORT_TERM_MEMORY,1
MODULE_514,SET,10,-0.31647,-0.0073801,0.24633,0.90055,MODULE_514,1
GSE3337_4H_VS_16H_IFNG_IN_CD...2,SET,187,-0.079228,-0.0079511,0.061651,0.90061,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP,1
HP_HYPERMOBILITY_OF_INTERPHA...,SET,5,-0.5276,-0.0087012,0.41048,0.90065,HP_HYPERMOBILITY_OF_INTERPHALANGEAL_JOINTS,1
GOBP_PURINE_NUCLEOBASE_BIOSY...,SET,8,-0.37031,-0.0077245,0.28807,0.90068,GOBP_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
FULLER_PBMC_F_TULARENSIS_VAC...4,SET,14,-0.27837,-0.0076802,0.21655,0.90068,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_UP,1
ACCATTT_MIR522,SET,144,-0.091143,-0.0080362,0.070896,0.9007,ACCATTT_MIR522,1
GOBP_NEGATIVE_REGULATION_OF_...271,SET,5,-0.49259,-0.0081239,0.38316,0.9007,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
GOBP_DENDRITIC_CELL_ANTIGEN_...,SET,13,-0.29582,-0.0078649,0.23005,0.90075,GOBP_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_PSORIASIFORM_LESION,SET,3,-0.75061,-0.0095893,0.58367,0.90077,HP_PSORIASIFORM_LESION,1
GOBP_TRNA_METHYLATION,SET,36,-0.1601,-0.007079,0.12449,0.90078,GOBP_TRNA_METHYLATION,1
GOBP_POSITIVE_REGULATION_OF_...153,SET,11,-0.34139,-0.0083497,0.26541,0.90082,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
GSE12392_CD8A_POS_VS_NEG_SPL...3,SET,188,-0.078475,-0.0078964,0.061007,0.90083,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN,1
GOBP_GLUTAMINE_METABOLIC_PRO...,SET,25,-0.2192,-0.0080791,0.1704,0.90084,GOBP_GLUTAMINE_METABOLIC_PROCESS,1
PANAPASA_BLOOD_FLUENZ_AGE_03...1,SET,6,-0.40661,-0.0073458,0.31608,0.90084,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_3DY_4DY_DN,1
KORKOLA_YOLK_SAC_TUMOR_UP,SET,13,-0.3651,-0.0097068,0.28377,0.90087,KORKOLA_YOLK_SAC_TUMOR_UP,1
MIR564,SET,14,-0.31165,-0.0085984,0.2422,0.9009,MIR564,1
GSE27291_0H_VS_7D_STIM_GAMMA...2,SET,154,-0.084259,-0.0076807,0.065459,0.90098,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP,1
GSE17721_CTRL_VS_POLYIC_2H_B...2,SET,177,-0.080566,-0.0078684,0.062575,0.90103,GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP,1
HP_EQUINUS_CALCANEUS,SET,8,-0.45487,-0.0094882,0.35327,0.90105,HP_EQUINUS_CALCANEUS,1
GSE16385_IFNG_TNF_VS_IL4_STI...1,SET,150,-0.087059,-0.007833,0.067602,0.90109,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,1
GSE5542_UNTREATED_VS_IFNA_TR...1,SET,168,-0.081982,-0.0078024,0.063637,0.90117,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,1
GOBP_LIPID_EXPORT_FROM_CELL,SET,49,-0.16949,-0.00874,0.13155,0.90118,GOBP_LIPID_EXPORT_FROM_CELL,1
GOBP_LONG_CHAIN_FATTY_ACID_I...,SET,10,-0.35032,-0.0081696,0.2719,0.90119,GOBP_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_MYELIN_ASSEMBLY,SET,23,-0.23441,-0.0082873,0.18191,0.90122,GOBP_MYELIN_ASSEMBLY,1
GOBP_REGULATION_OF_CALCIUM_I...9,SET,18,-0.27666,-0.008654,0.2147,0.90122,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
PID_INTEGRIN4_PATHWAY,SET,11,-0.35363,-0.0086491,0.27438,0.90127,PID_INTEGRIN4_PATHWAY,1
HP_SPASTIC_GAIT,SET,69,-0.13366,-0.0081745,0.10369,0.90129,HP_SPASTIC_GAIT,1
KEGG_MEDICUS_VARIANT_IGF2_OV...,SET,14,-0.29407,-0.0081134,0.22813,0.90131,KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
HP_POLYMICROGYRIA,SET,179,-0.080385,-0.0078945,0.062351,0.90133,HP_POLYMICROGYRIA,1
HP_DESQUAMATION_OF_SKIN_SOON...,SET,11,-0.31628,-0.0077356,0.2453,0.90136,HP_DESQUAMATION_OF_SKIN_SOON_AFTER_BIRTH,1
GOBP_RNA_5_END_PROCESSING,SET,32,-0.17375,-0.007244,0.13472,0.90143,GOBP_RNA_5_END_PROCESSING,1
GOBP_POSITIVE_REGULATION_OF_...819,SET,17,-0.24643,-0.0074916,0.19105,0.90145,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,1
GOMF_ARYL_HYDROCARBON_RECEPT...,SET,7,-0.31704,-0.0061863,0.24578,0.90145,GOMF_ARYL_HYDROCARBON_RECEPTOR_BINDING,1
MIR6750_3P,SET,62,-0.14552,-0.0084378,0.1128,0.90147,MIR6750_3P,1
PID_ERBB_NETWORK_PATHWAY,SET,15,-0.29114,-0.0083142,0.22556,0.9016,PID_ERBB_NETWORK_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...547,SET,12,-0.29785,-0.0076085,0.23072,0.90163,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
FURUKAWA_DUSP6_TARGETS_PCI35...2,SET,61,-0.1506,-0.0086623,0.11662,0.90172,FURUKAWA_DUSP6_TARGETS_PCI35_UP,1
HP_INCREASED_INTRAMYOCELLULA...,SET,18,-0.26244,-0.0082093,0.20319,0.90174,HP_INCREASED_INTRAMYOCELLULAR_LIPID_DROPLETS,1
GSE45365_CD8A_DC_VS_CD11B_DC...5,SET,149,-0.093336,-0.00837,0.072253,0.90178,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP,1
REACTOME_DEFECTIVE_F9_ACTIVA...,SET,5,-0.59299,-0.0097796,0.45902,0.90179,REACTOME_DEFECTIVE_F9_ACTIVATION,1
WP_BASE_EXCISION_REPAIR,SET,30,-0.17986,-0.0072608,0.13922,0.90179,WP_BASE_EXCISION_REPAIR,1
BIOCARTA_ETC_PATHWAY,SET,7,-0.36159,-0.0070556,0.27989,0.9018,BIOCARTA_ETC_PATHWAY,1
REACTOME_METHYLATION,SET,14,-0.3096,-0.0085419,0.23964,0.9018,REACTOME_METHYLATION,1
HU_FETAL_RETINA_PHOTORECEPTOR,SET,65,-0.14669,-0.0087084,0.11353,0.90182,HU_FETAL_RETINA_PHOTORECEPTOR,1
MODULE_200,SET,27,-0.24687,-0.0094553,0.19106,0.90183,MODULE_200,1
GOBP_REGULATION_OF_TRANS_SYN...,SET,447,-0.054688,-0.0084246,0.042322,0.90184,GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING,1
HP_REDUCED_VITAL_CAPACITY,SET,26,-0.19635,-0.0073803,0.15195,0.90186,HP_REDUCED_VITAL_CAPACITY,1
ADA2_TARGET_GENES,SET,755,-0.041181,-0.0081735,0.031862,0.90189,ADA2_TARGET_GENES,1
PRC1_BMI_UP.V1_DN,SET,154,-0.0883,-0.0080491,0.068321,0.90189,PRC1_BMI_UP.V1_DN,1
GOMF_PROTEIN_KINASE_C_BINDING,SET,48,-0.17001,-0.0086771,0.13153,0.9019,GOMF_PROTEIN_KINASE_C_BINDING,1
GOBP_TOXIN_METABOLIC_PROCESS,SET,15,-0.29867,-0.0085293,0.23107,0.90191,GOBP_TOXIN_METABOLIC_PROCESS,1
GSE29618_LAIV_VS_TIV_FLU_VAC...1,SET,172,-0.081356,-0.0078337,0.062937,0.90193,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN,1
REACTOME_EARLY_PHASE_OF_HIV_...,SET,14,-0.26762,-0.0073837,0.207,0.90196,REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE,1
MIR6506_3P,SET,5,-0.41924,-0.0069142,0.32424,0.90198,MIR6506_3P,1
HP_ABNORMAL_CIRCULATING_LYSI...,SET,5,-0.60569,-0.009989,0.46841,0.902,HP_ABNORMAL_CIRCULATING_LYSINE_CONCENTRATION,1
GSE41867_NAIVE_VS_EFFECTOR_C...1,SET,182,-0.076048,-0.0075303,0.058803,0.90203,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,1
PID_EPHRINB_REV_PATHWAY,SET,29,-0.22865,-0.0090757,0.17678,0.90206,PID_EPHRINB_REV_PATHWAY,1
GOBP_ISOPRENOID_BIOSYNTHETIC...,SET,28,-0.20883,-0.0081451,0.16143,0.90209,GOBP_ISOPRENOID_BIOSYNTHETIC_PROCESS,1
REACTOME_MITOCHONDRIAL_FATTY...1,SET,35,-0.18269,-0.0079649,0.14121,0.90211,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,1
FRIDMAN_IMMORTALIZATION_DN,SET,31,-0.20973,-0.0086066,0.16209,0.90214,FRIDMAN_IMMORTALIZATION_DN,1
GOBP_NUCLEOSIDE_TRANSPORT,SET,10,-0.37245,-0.0086857,0.28778,0.9022,GOBP_NUCLEOSIDE_TRANSPORT,1
HP_ABNORMAL_ILIUM_MORPHOLOGY,SET,85,-0.11845,-0.0080366,0.091515,0.90221,HP_ABNORMAL_ILIUM_MORPHOLOGY,1
GOMF_MOLECULAR_ADAPTOR_ACTIV...,SET,1032,-0.034302,-0.0078969,0.02649,0.90231,GOMF_MOLECULAR_ADAPTOR_ACTIVITY,1
MORF_MYST2,SET,60,-0.13137,-0.0074941,0.10145,0.90232,MORF_MYST2,1
HP_CORNEAL_STROMAL_EDEMA,SET,11,-0.3725,-0.0091106,0.28766,0.90232,HP_CORNEAL_STROMAL_EDEMA,1
GOBP_TRANSLATIONAL_ELONGATION,SET,59,-0.13203,-0.0074686,0.10193,0.90237,GOBP_TRANSLATIONAL_ELONGATION,1
GSE5099_CLASSICAL_M1_VS_ALTE...1,SET,146,-0.092073,-0.0081739,0.071083,0.90238,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN,1
GOBP_REGULATION_OF_SKELETAL_...7,SET,4,-0.59882,-0.0088334,0.4622,0.90243,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION,1
GOBP_BONE_GROWTH,SET,31,-0.20659,-0.0084777,0.1594,0.90251,GOBP_BONE_GROWTH,1
GOBP_DIOL_METABOLIC_PROCESS,SET,26,-0.21808,-0.0081969,0.16825,0.90254,GOBP_DIOL_METABOLIC_PROCESS,1
LAKE_ADULT_KIDNEY_C11_THIN_A...,SET,158,-0.091803,-0.0084754,0.070825,0.90254,LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB,1
GOBP_OPTIC_NERVE_MORPHOGENES...,SET,6,-0.50555,-0.0091331,0.39,0.90255,GOBP_OPTIC_NERVE_MORPHOGENESIS,1
AIZARANI_LIVER_C20_LSECS_3,SET,271,-0.072321,-0.0087171,0.055768,0.90264,AIZARANI_LIVER_C20_LSECS_3,1
GOBP_NEGATIVE_REGULATION_OF_...88,SET,20,-0.26708,-0.0088058,0.20588,0.90272,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOBP_MITOCHONDRIAL_RNA_MODIF...,SET,8,-0.37841,-0.0078934,0.29169,0.90273,GOBP_MITOCHONDRIAL_RNA_MODIFICATION,1
GSE7460_TCONV_VS_TREG_LN_UP,SET,184,-0.087225,-0.008684,0.067225,0.90276,GSE7460_TCONV_VS_TREG_LN_UP,1
HP_THORACOLUMBAR_KYPHOSIS,SET,18,-0.27969,-0.008749,0.21556,0.90277,HP_THORACOLUMBAR_KYPHOSIS,1
ABBUD_LIF_SIGNALING_2_UP,SET,13,-0.33456,-0.0088949,0.25781,0.90279,ABBUD_LIF_SIGNALING_2_UP,1
GOCC_RIPOPTOSOME,SET,6,-0.54111,-0.0097756,0.41699,0.90279,GOCC_RIPOPTOSOME,1
DESCARTES_MAIN_FETAL_MEGAKAR...,SET,155,-0.091435,-0.0083616,0.070456,0.90281,DESCARTES_MAIN_FETAL_MEGAKARYOCYTES,1
GOBP_TRNA_MODIFICATION,SET,83,-0.10828,-0.00726,0.083422,0.90284,GOBP_TRNA_MODIFICATION,1
GSE27859_CD11C_INT_F480_HI_M...2,SET,159,-0.086788,-0.0080375,0.066864,0.90285,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...473,SET,14,-0.271,-0.0074768,0.20876,0.90287,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,1
HP_LIMITED_ELBOW_FLEXION,SET,10,-0.39462,-0.0092027,0.30399,0.90287,HP_LIMITED_ELBOW_FLEXION,1
CASORELLI_ACUTE_PROMYELOCYTI...2,SET,143,-0.094961,-0.0083438,0.07315,0.90288,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1
GOCC_MICROTUBULE_ASSOCIATED_...,SET,139,-0.08836,-0.0076554,0.068063,0.90288,GOCC_MICROTUBULE_ASSOCIATED_COMPLEX,1
GOMF_LOW_DENSITY_LIPOPROTEIN...1,SET,16,-0.29079,-0.0085765,0.22396,0.90292,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,1
GOBP_ERBB2_EGFR_SIGNALING_PA...,SET,8,-0.44585,-0.0093002,0.34336,0.90293,GOBP_ERBB2_EGFR_SIGNALING_PATHWAY,1
GOBP_VENTRICULAR_SEPTUM_MORP...,SET,40,-0.20515,-0.0095603,0.15796,0.90297,GOBP_VENTRICULAR_SEPTUM_MORPHOGENESIS,1
MOOTHA_MITOCHONDRIA,SET,397,-0.054963,-0.0079905,0.042313,0.90301,MOOTHA_MITOCHONDRIA,1
CHEN_METABOLIC_SYNDROM_NETWO...,SET,1123,-0.035192,-0.0084292,0.027091,0.90302,CHEN_METABOLIC_SYNDROM_NETWORK,1
GACAGGG_MIR339,SET,63,-0.13617,-0.007959,0.10482,0.90303,GACAGGG_MIR339,1
MIR22_5P,SET,127,-0.097815,-0.0081031,0.075292,0.90304,MIR22_5P,1
DESCARTES_MAIN_FETAL_MESANGI...,SET,16,-0.30399,-0.0089657,0.23399,0.90305,DESCARTES_MAIN_FETAL_MESANGIAL_CELLS,1
GOBP_ANTIGEN_PROCESSING_AND_...7,SET,8,-0.34736,-0.0072458,0.26736,0.90306,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,1
GOMF_TRNA_GUANINE_METHYLTRAN...,SET,11,-0.32126,-0.0078573,0.24723,0.9031,GOMF_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY,1
GOBP_OTIC_VESICLE_FORMATION,SET,8,-0.36228,-0.007557,0.27879,0.90311,GOBP_OTIC_VESICLE_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...370,SET,66,-0.14267,-0.0085346,0.10979,0.90311,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,1
GOMF_UREA_TRANSMEMBRANE_TRAN...,SET,7,-0.51096,-0.0099701,0.39315,0.90313,GOMF_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_DEGRADATION_OF_DVL,SET,54,-0.13935,-0.0075424,0.10721,0.90315,REACTOME_DEGRADATION_OF_DVL,1
HP_CORNEAL_NEOVASCULARIZATION,SET,23,-0.26123,-0.0092355,0.20098,0.90315,HP_CORNEAL_NEOVASCULARIZATION,1
GOBP_REGULATION_OF_CALCIUM_M...,SET,92,-0.1198,-0.0084549,0.092162,0.90317,GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
GSE2585_CD80_HIGH_VS_LOW_MTE...2,SET,179,-0.085481,-0.0083951,0.065761,0.90317,GSE2585_CD80_HIGH_VS_LOW_MTEC_UP,1
REACTOME_REGULATION_OF_RUNX2...,SET,69,-0.12404,-0.0075859,0.095411,0.9032,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1
GOBP_UREA_TRANSMEMBRANE_TRAN...,SET,8,-0.48001,-0.010013,0.36912,0.90326,GOBP_UREA_TRANSMEMBRANE_TRANSPORT,1
KEGG_MEDICUS_REFERENCE_NUCLE...2,SET,11,-0.35557,-0.0086966,0.27336,0.90332,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,1
GOBP_MICROTUBULE_BASED_TRANS...,SET,187,-0.08017,-0.0080456,0.061629,0.90334,GOBP_MICROTUBULE_BASED_TRANSPORT,1
GSE12003_4D_VS_8D_CULTURE_BM...1,SET,127,-0.093268,-0.0077265,0.071692,0.90335,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN,1
PASQUALUCCI_LYMPHOMA_BY_GC_S...1,SET,156,-0.093298,-0.0085592,0.071709,0.90337,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,1
HP_WEAKNESS_OF_FACIAL_MUSCUL...,SET,210,-0.076198,-0.0080986,0.058566,0.90337,HP_WEAKNESS_OF_FACIAL_MUSCULATURE,1
BIOCARTA_HIF_PATHWAY,SET,15,-0.27657,-0.0078981,0.21257,0.90338,BIOCARTA_HIF_PATHWAY,1
HP_THICK_CEREBRAL_CORTEX,SET,9,-0.34166,-0.0075589,0.26257,0.90339,HP_THICK_CEREBRAL_CORTEX,1
CHESLER_BRAIN_D6MIT150_QTL_T...,SET,9,-0.40103,-0.0088725,0.30819,0.90341,CHESLER_BRAIN_D6MIT150_QTL_TRANS,1
HP_ABNORMAL_LUMBAR_SPINE_MOR...,SET,26,-0.22957,-0.0086286,0.17641,0.90342,HP_ABNORMAL_LUMBAR_SPINE_MORPHOLOGY,1
DNMT3A_TARGET_GENES,SET,489,-0.050745,-0.0081667,0.03899,0.90345,DNMT3A_TARGET_GENES,1
PID_HIF1A_PATHWAY,SET,15,-0.2573,-0.0073478,0.19768,0.90346,PID_HIF1A_PATHWAY,1
GTTATAT_MIR410,SET,80,-0.12641,-0.0083223,0.097106,0.9035,GTTATAT_MIR410,1
GSE17721_PAM3CSK4_VS_GADIQUI...4,SET,176,-0.076897,-0.0074891,0.059052,0.90356,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP,1
REACTOME_NICOTINAMIDE_SALVAG...,SET,17,-0.27433,-0.0083398,0.21067,0.90357,REACTOME_NICOTINAMIDE_SALVAGING,1
GOBP_POSITIVE_REGULATION_OF_...130,SET,137,-0.098415,-0.0084654,0.075577,0.90357,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH,1
GOBP_PROTEIN_FOLDING,SET,200,-0.074148,-0.0076929,0.056934,0.90359,GOBP_PROTEIN_FOLDING,1
GOBP_TELOMERE_MAINTENANCE_IN...,SET,30,-0.1836,-0.007412,0.14098,0.90359,GOBP_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,1
GSE25085_FETAL_LIVER_VS_FETA...1,SET,183,-0.086111,-0.00855,0.066117,0.9036,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN,1
GOBP_SMALL_MOLECULE_METABOLI...,SET,1631,-0.029184,-0.0082993,0.022396,0.90372,GOBP_SMALL_MOLECULE_METABOLIC_PROCESS,1
GOCC_DYNEIN_COMPLEX,SET,43,-0.1663,-0.0080345,0.12761,0.90373,GOCC_DYNEIN_COMPLEX,1
HP_RIGIDITY,SET,185,-0.080014,-0.0079874,0.061392,0.90376,HP_RIGIDITY,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...5,SET,125,-0.10476,-0.0086103,0.080368,0.90379,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP,1
SILIGAN_BOUND_BY_EWS_FLT1_FU...,SET,43,-0.18003,-0.0086978,0.1381,0.9038,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,1
REACTOME_ESTROGEN_STIMULATED...,SET,6,-0.41857,-0.0075618,0.3211,0.9038,REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ,1
MIR934,SET,73,-0.13301,-0.0083664,0.10204,0.9038,MIR934,1
WU_HBX_TARGETS_2_DN,SET,14,-0.3331,-0.0091901,0.25551,0.90381,WU_HBX_TARGETS_2_DN,1
GOBP_REGULATION_OF_DEFENSE_R...4,SET,52,-0.15974,-0.0084848,0.12253,0.90381,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,1
GSE17721_CTRL_VS_CPG_4H_BMDC...1,SET,179,-0.083391,-0.0081898,0.063967,0.90382,GSE17721_CTRL_VS_CPG_4H_BMDC_DN,1
MIR3145_3P,SET,206,-0.078109,-0.0082231,0.059897,0.90388,MIR3145_3P,1
HP_HYPERGLYCINURIA,SET,14,-0.31739,-0.0087567,0.24338,0.90389,HP_HYPERGLYCINURIA,1
MANNO_MIDBRAIN_NEUROTYPES_HR...3,SET,385,-0.061088,-0.0087486,0.046832,0.90395,MANNO_MIDBRAIN_NEUROTYPES_HRGL2B,1
HP_BROAD_PHILTRUM,SET,42,-0.16901,-0.0080705,0.12956,0.90396,HP_BROAD_PHILTRUM,1
KEGG_MEDICUS_REFERENCE_EGF_E...12,SET,15,-0.28079,-0.0080185,0.21518,0.90403,KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY,1
GOCC_NADH_DEHYDROGENASE_COMP...,SET,40,-0.15522,-0.0072336,0.11894,0.90405,GOCC_NADH_DEHYDROGENASE_COMPLEX,1
GOCC_INTRACELLULAR_CYCLIC_NU...,SET,5,-0.49768,-0.0082078,0.38134,0.90406,GOCC_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_COMPLEX,1
GOMF_UNFOLDED_PROTEIN_BINDING,SET,107,-0.097023,-0.0073816,0.074344,0.90406,GOMF_UNFOLDED_PROTEIN_BINDING,1
KEGG_MEDICUS_REFERENCE_CA2_P...1,SET,6,-0.46335,-0.0083707,0.35499,0.90409,KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY,1
GSE34156_UNTREATED_VS_6H_NOD...2,SET,149,-0.092714,-0.0083143,0.071014,0.90414,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
FIGUEROA_AML_METHYLATION_CLU...3,SET,8,-0.41554,-0.008668,0.31826,0.90416,FIGUEROA_AML_METHYLATION_CLUSTER_2_DN,1
GSE40666_UNTREATED_VS_IFNA_S...6,SET,153,-0.091138,-0.008281,0.069798,0.90417,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP,1
MIR5591_3P,SET,41,-0.17351,-0.008186,0.13284,0.90424,MIR5591_3P,1
HP_SPARSE_HAIR,SET,332,-0.060681,-0.0080819,0.046449,0.90428,HP_SPARSE_HAIR,1
REACTOME_DRUG_ADME,SET,101,-0.12771,-0.0094414,0.097749,0.9043,REACTOME_DRUG_ADME,1
GAVISH_3CA_METAPROGRAM_FIBRO...3,SET,48,-0.18507,-0.009446,0.14165,0.90432,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2,1
MORF_THPO,SET,109,-0.11173,-0.0085794,0.08551,0.90433,MORF_THPO,1
HP_HYPOSMIA,SET,49,-0.1624,-0.0083743,0.12426,0.90437,HP_HYPOSMIA,1
KORKOLA_SEMINOMA_DN,SET,8,-0.47915,-0.0099948,0.36656,0.90441,KORKOLA_SEMINOMA_DN,1
WP_GLYCOLYSIS_AND_GLUCONEOGE...,SET,38,-0.17533,-0.0079643,0.13413,0.90442,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,1
MIR29A_3P,SET,396,-0.059219,-0.0085987,0.045302,0.90442,MIR29A_3P,1
MIR3125,SET,220,-0.074407,-0.0080921,0.056913,0.90445,MIR3125,1
GOBP_REGULATION_OF_CALCIUM_I...7,SET,57,-0.15672,-0.0087144,0.11987,0.90445,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE2770_IL12_ACT_VS_ACT_CD4_...2,SET,167,-0.08798,-0.0083486,0.067267,0.90454,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP,1
HAY_BONE_MARROW_CD34_POS_MKP,SET,54,-0.16913,-0.0091547,0.12931,0.90455,HAY_BONE_MARROW_CD34_POS_MKP,1
HP_RETINAL_EXUDATE,SET,8,-0.39257,-0.0081889,0.30001,0.90464,HP_RETINAL_EXUDATE,1
GOBP_EOSINOPHIL_ACTIVATION,SET,8,-0.37171,-0.0077536,0.28405,0.90466,GOBP_EOSINOPHIL_ACTIVATION,1
GOBP_NEGATIVE_REGULATION_OF_...272,SET,3,-0.82731,-0.010569,0.63219,0.90466,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
GSE20715_WT_VS_TLR4_KO_24H_O...1,SET,181,-0.080686,-0.0079679,0.061648,0.9047,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN,1
GSE25123_CTRL_VS_IL4_AND_ROS...2,SET,186,-0.081413,-0.0081487,0.062202,0.9047,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...807,SET,17,-0.28195,-0.0085714,0.21541,0.90471,GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_GPCR_...2,SET,47,-0.17872,-0.0090262,0.13653,0.90472,KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY,1
GSE6259_33D1_POS_VS_DEC205_P...4,SET,174,-0.087534,-0.0084769,0.066872,0.90472,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP,1
GOMF_INITIATOR_METHIONYL_AMI...,SET,4,-0.58674,-0.0086552,0.44795,0.90486,GOMF_INITIATOR_METHIONYL_AMINOPEPTIDASE_ACTIVITY,1
HP_HYPERTRIGLYCERIDEMIA,SET,112,-0.11011,-0.0085695,0.084067,0.90486,HP_HYPERTRIGLYCERIDEMIA,1
GCM_USP6,SET,67,-0.12248,-0.007382,0.093497,0.9049,GCM_USP6,1
GOMF_HYDROLASE_ACTIVITY_ACTI...5,SET,69,-0.13512,-0.0082635,0.10314,0.90491,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES,1
GOBP_RESPONSE_TO_OXYGEN_LEVE...,SET,302,-0.065577,-0.0083369,0.050048,0.90494,GOBP_RESPONSE_TO_OXYGEN_LEVELS,1
HP_HYPERPLASIA_OF_THE_MAXILLA,SET,9,-0.44131,-0.0097636,0.33682,0.90494,HP_HYPERPLASIA_OF_THE_MAXILLA,1
ZNF211_TARGET_GENES,SET,2,-0.57265,-0.0059735,0.43688,0.90503,ZNF211_TARGET_GENES,1
HP_BROAD_ISCHIA,SET,5,-0.49473,-0.0081591,0.37728,0.90512,HP_BROAD_ISCHIA,1
GLI1_UP.V1_UP,SET,21,-0.2342,-0.0079124,0.17854,0.90519,GLI1_UP.V1_UP,1
KEGG_INSULIN_SIGNALING_PATHW...,SET,130,-0.098739,-0.008275,0.075263,0.90522,KEGG_INSULIN_SIGNALING_PATHWAY,1
GOBP_CALCIUM_ION_TRANSPORT_I...,SET,28,-0.23107,-0.0090123,0.17612,0.90523,GOBP_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
HP_PERINEAL_FISTULA,SET,12,-0.31705,-0.0080989,0.24164,0.90525,HP_PERINEAL_FISTULA,1
GNF2_PTPN4,SET,45,-0.17157,-0.0084792,0.13074,0.90527,GNF2_PTPN4,1
SCHUETZ_BREAST_CANCER_DUCTAL...2,SET,322,-0.067095,-0.008803,0.051128,0.90528,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,1
GSE339_CD8POS_VS_CD4CD8DN_DC...2,SET,182,-0.08254,-0.0081732,0.062894,0.90529,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,1
MODULE_345,SET,110,-0.10937,-0.0084363,0.083339,0.9053,MODULE_345,1
GOBP_POSITIVE_REGULATION_OF_...774,SET,17,-0.27571,-0.0083815,0.21007,0.90531,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
HP_FOCAL_SENSORY_SEIZURE,SET,15,-0.2901,-0.0082844,0.22102,0.90532,HP_FOCAL_SENSORY_SEIZURE,1
GOBP_POSITIVE_REGULATION_OF_...654,SET,5,-0.53105,-0.0087582,0.40452,0.90536,GOBP_POSITIVE_REGULATION_OF_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
NIKOLSKY_BREAST_CANCER_17Q11...,SET,119,-0.17891,-0.01435,0.13626,0.9054,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,1
GUO_HEX_TARGETS_DN,SET,60,-0.14129,-0.0080598,0.1076,0.90541,GUO_HEX_TARGETS_DN,1
GSE3203_WT_VS_IFNAR1_KO_INFL...1,SET,186,-0.083973,-0.008405,0.063949,0.90542,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN,1
HP_ABNORMAL_MUSCLE_FIBER_ALP...,SET,9,-0.37355,-0.0082645,0.28436,0.90551,HP_ABNORMAL_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,1
REACTOME_DOWNREGULATION_OF_E...2,SET,27,-0.21126,-0.0080914,0.16079,0.90555,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,1
FOURATI_BLOOD_TWINRIX_AGE_65...2,SET,5,-0.49929,-0.0082343,0.37997,0.90557,FOURATI_BLOOD_TWINRIX_AGE_65_81YO_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_DN,1
GOBP_POSITIVE_REGULATION_OF_...536,SET,5,-0.54531,-0.0089933,0.41493,0.9056,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,1
GOBP_AGGRESOME_ASSEMBLY,SET,4,-0.5436,-0.0080189,0.41359,0.90563,GOBP_AGGRESOME_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...277,SET,13,-0.34133,-0.0090749,0.25967,0.90565,GOBP_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
MIR4661_3P,SET,29,-0.20814,-0.0082614,0.15832,0.90568,MIR4661_3P,1
GSE18791_CTRL_VS_NEWCASTLE_V...20,SET,181,-0.079544,-0.007855,0.060503,0.90569,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP,1
GOBP_NEURON_PROJECTION_REGEN...,SET,55,-0.16005,-0.0087427,0.12172,0.90573,GOBP_NEURON_PROJECTION_REGENERATION,1
HP_ALTERNATING_ESOTROPIA,SET,10,-0.41514,-0.0096811,0.31566,0.90576,HP_ALTERNATING_ESOTROPIA,1
PID_TOLL_ENDOGENOUS_PATHWAY,SET,21,-0.22653,-0.0076531,0.17221,0.90581,PID_TOLL_ENDOGENOUS_PATHWAY,1
HP_BLOCK_VERTEBRAE,SET,5,-0.53745,-0.0088638,0.40856,0.90582,HP_BLOCK_VERTEBRAE,1
GOCC_RNAI_EFFECTOR_COMPLEX,SET,15,-0.31079,-0.0088755,0.23621,0.90586,GOCC_RNAI_EFFECTOR_COMPLEX,1
HP_TREMOR_BY_ANATOMICAL_SITE,SET,86,-0.12434,-0.0084858,0.094494,0.90588,HP_TREMOR_BY_ANATOMICAL_SITE,1
GOBP_NEGATIVE_REGULATION_OF_...33,SET,3,-0.70181,-0.0089659,0.53329,0.9059,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_ACTIVATION,1
GSE27786_LSK_VS_NKCELL_UP,SET,177,-0.080633,-0.007875,0.061269,0.90591,GSE27786_LSK_VS_NKCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...170,SET,15,-0.29069,-0.0083013,0.22085,0.90594,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,1
GOBP_REGULATION_OF_MESENCHYM...2,SET,10,-0.38523,-0.0089837,0.29263,0.90598,GOBP_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,1
HP_SCOTOMA,SET,69,-0.14093,-0.0086188,0.10704,0.906,HP_SCOTOMA,1
SCHOEN_NFKB_SIGNALING,SET,32,-0.23891,-0.0099607,0.18146,0.90601,SCHOEN_NFKB_SIGNALING,1
MIR302E,SET,444,-0.054133,-0.0083117,0.041102,0.90607,MIR302E,1
HP_PROMINENT_METOPIC_RIDGE,SET,57,-0.15163,-0.0084316,0.11511,0.90613,HP_PROMINENT_METOPIC_RIDGE,1
GOMF_OXALATE_TRANSMEMBRANE_T...,SET,9,-0.36918,-0.0081677,0.28022,0.90615,GOMF_OXALATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KEGG_MEDICUS_VARIANT_AMPLIFI...4,SET,8,-0.40795,-0.0085095,0.30961,0.90617,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY,1
MIR6505_5P,SET,187,-0.084231,-0.0084532,0.063929,0.90617,MIR6505_5P,1
GOBP_ENDOPLASMIC_RETICULUM_C...,SET,23,-0.23671,-0.0083687,0.17963,0.9062,GOBP_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS,1
HP_SEVERE_PHOTOSENSITIVITY,SET,5,-0.4158,-0.0068575,0.31551,0.90622,HP_SEVERE_PHOTOSENSITIVITY,1
REACTOME_TERMINAL_PATHWAY_OF...,SET,8,-0.4357,-0.0090885,0.3305,0.90629,REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT,1
GSE7460_CD8_TCELL_VS_CD4_TCE...1,SET,191,-0.085006,-0.0086209,0.064479,0.9063,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN,1
GOBP_REGULATION_OF_AUTOPHAGY...2,SET,10,-0.39035,-0.0091031,0.29604,0.90634,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
MIR3152_3P,SET,76,-0.13375,-0.0085834,0.10143,0.90635,MIR3152_3P,1
REACTOME_MITF_M_REGULATED_ME...,SET,124,-0.10284,-0.0084188,0.077972,0.90639,REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1
DESCARTES_FETAL_PLACENTA_EXT...,SET,60,-0.15644,-0.0089241,0.11862,0.90639,DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS,1
AUTS2_TARGET_GENES,SET,486,-0.051757,-0.0083046,0.039239,0.90641,AUTS2_TARGET_GENES,1
HP_EASY_FATIGABILITY,SET,85,-0.114,-0.0077348,0.086409,0.90645,HP_EASY_FATIGABILITY,1
GOMF_THREONINE_TYPE_PEPTIDAS...,SET,16,-0.28351,-0.0083616,0.21489,0.90646,GOMF_THREONINE_TYPE_PEPTIDASE_ACTIVITY,1
GRAHAM_NORMAL_QUIESCENT_VS_N...2,SET,54,-0.16736,-0.0090587,0.12684,0.90648,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,1
MOLENAAR_TARGETS_OF_CCND1_AN...1,SET,50,-0.16131,-0.0084026,0.12226,0.90648,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,1
HP_IRIS_COLOBOMA,SET,150,-0.089746,-0.0080748,0.068009,0.90651,HP_IRIS_COLOBOMA,1
REACTOME_G_ALPHA_Q_SIGNALLIN...,SET,203,-0.085081,-0.0088924,0.064471,0.90652,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1
GSE17721_0.5H_VS_24H_GARDIQU...1,SET,184,-0.07862,-0.0078273,0.059576,0.90652,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...56,SET,200,-0.081099,-0.0084141,0.061448,0.90654,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HAND,1
HP_PROGRESSIVE_NEUROLOGIC_DE...,SET,62,-0.13865,-0.0080393,0.10505,0.90655,HP_PROGRESSIVE_NEUROLOGIC_DETERIORATION,1
GSE9946_MATURE_STIMULATORY_V...1,SET,114,-0.1101,-0.0086442,0.083411,0.90656,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN,1
GOBP_CHEMOKINE_PRODUCTION,SET,90,-0.12808,-0.008941,0.097031,0.90657,GOBP_CHEMOKINE_PRODUCTION,1
WP_MYOMETRIAL_RELAXATION_AND...,SET,153,-0.095996,-0.0087224,0.072717,0.9066,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1
HP_INFERIOR_CEREBELLAR_VERMI...,SET,13,-0.3033,-0.0080637,0.22972,0.90663,HP_INFERIOR_CEREBELLAR_VERMIS_HYPOPLASIA,1
HP_VISUAL_FIXATION_INSTABILI...,SET,12,-0.29901,-0.007638,0.22647,0.90663,HP_VISUAL_FIXATION_INSTABILITY,1
KIM_ALL_DISORDERS_OLIGODENDR...2,SET,678,-0.042164,-0.0079479,0.031932,0.90665,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP,1
HP_ERYTHROID_DYSPLASIA,SET,4,-0.58689,-0.0086575,0.44443,0.90667,HP_ERYTHROID_DYSPLASIA,1
GOMF_COLLAGEN_BINDING,SET,67,-0.14686,-0.0088508,0.11116,0.90675,GOMF_COLLAGEN_BINDING,1
GSE36888_UNTREATED_VS_IL2_TR...4,SET,182,-0.08502,-0.0084187,0.064351,0.90677,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP,1
HP_ABNORMALITY_OF_THE_FOREHE...,SET,1026,-0.03568,-0.0081918,0.027005,0.90678,HP_ABNORMALITY_OF_THE_FOREHEAD,1
GOBP_AMIDE_METABOLIC_PROCESS,SET,399,-0.058906,-0.0085849,0.044578,0.90681,GOBP_AMIDE_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_PAIN_SENSA...,SET,90,-0.12037,-0.0084029,0.091061,0.90689,HP_ABNORMALITY_OF_PAIN_SENSATION,1
HP_INCREASED_CIRCULATING_GON...,SET,75,-0.12824,-0.0081755,0.096999,0.90692,HP_INCREASED_CIRCULATING_GONADOTROPIN_LEVEL,1
HP_PROMINENT_CRUS_OF_HELIX,SET,5,-0.56518,-0.009321,0.42738,0.90698,HP_PROMINENT_CRUS_OF_HELIX,1
GSE20715_WT_VS_TLR4_KO_48H_O...1,SET,176,-0.081433,-0.0079308,0.061578,0.90698,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN,1
HP_NEONATAL_BREATHING_DYSREG...,SET,5,-0.41376,-0.0068238,0.31287,0.90699,HP_NEONATAL_BREATHING_DYSREGULATION,1
GOBP_POSITIVE_REGULATION_OF_...717,SET,11,-0.36824,-0.0090063,0.27842,0.90701,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIKKELSEN_MCV6_ICP_WITH_H3K4...,SET,30,-0.224,-0.009043,0.16935,0.90704,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
MYOGENIN_Q6,SET,245,-0.073352,-0.0084127,0.055453,0.90704,MYOGENIN_Q6,1
GARGALOVIC_RESPONSE_TO_OXIDI...21,SET,48,-0.15781,-0.0080545,0.11928,0.90708,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,1
KEGG_MEDICUS_REFERENCE_EXTRI...,SET,10,-0.35584,-0.0082982,0.26892,0.90711,KEGG_MEDICUS_REFERENCE_EXTRINSIC_APOPTOTIC_PATHWAY,1
MIR6829_3P,SET,77,-0.13289,-0.0085835,0.10043,0.90711,MIR6829_3P,1
GOMF_PROTEASOME_ACTIVATING_A...,SET,6,-0.39528,-0.007141,0.29872,0.90711,GOMF_PROTEASOME_ACTIVATING_ACTIVITY,1
REACTOME_DEFECTIVE_RIPK1_MED...,SET,7,-0.41855,-0.0081671,0.31627,0.90714,REACTOME_DEFECTIVE_RIPK1_MEDIATED_REGULATED_NECROSIS,1
GOBP_REGULATION_OF_CD4_POSIT...2,SET,53,-0.16601,-0.0089023,0.12545,0.90714,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOCC_BOX_C_D_RNP_COMPLEX,SET,4,-0.5133,-0.0075719,0.38782,0.90717,GOCC_BOX_C_D_RNP_COMPLEX,1
MIR188_5P,SET,65,-0.14487,-0.0086001,0.10944,0.90719,MIR188_5P,1
GOBP_DERMATAN_SULFATE_BIOSYN...,SET,5,-0.55021,-0.0090742,0.41563,0.90721,GOBP_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_CORPUS_STRIATUM_...,SET,35,-0.18373,-0.0080102,0.13875,0.90727,HP_ABNORMAL_CORPUS_STRIATUM_MORPHOLOGY,1
HP_MODERATELY_SHORT_STATURE,SET,4,-0.53336,-0.0078677,0.40274,0.90729,HP_MODERATELY_SHORT_STATURE,1
WP_S1P_RECEPTOR_SIGNAL_TRANS...,SET,25,-0.22664,-0.0083535,0.17113,0.9073,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,1
GSE41978_KLRG1_HIGH_VS_LOW_E...1,SET,179,-0.082328,-0.0080854,0.062166,0.9073,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN,1
ZHENG_IL22_SIGNALING_DN,SET,34,-0.19546,-0.0083992,0.14757,0.90732,ZHENG_IL22_SIGNALING_DN,1
AIYAR_COBRA1_TARGETS_UP,SET,36,-0.19629,-0.0086791,0.14819,0.90733,AIYAR_COBRA1_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_RELN_...,SET,15,-0.30738,-0.0087779,0.23201,0.90738,KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY,1
HP_SEVERE_MUSCULAR_HYPOTONIA,SET,58,-0.14076,-0.0078952,0.10621,0.90746,HP_SEVERE_MUSCULAR_HYPOTONIA,1
GOBP_PEPTIDYL_LYSINE_TRIMETH...,SET,5,-0.43779,-0.00722,0.33028,0.90749,GOBP_PEPTIDYL_LYSINE_TRIMETHYLATION,1
HP_PARAPLEGIA,SET,126,-0.102,-0.0084171,0.076954,0.90749,HP_PARAPLEGIA,1
GOBP_SARCOPLASMIC_RETICULUM_...,SET,38,-0.18276,-0.0083017,0.13787,0.90751,GOBP_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT,1
GAVISH_3CA_METAPROGRAM_EPITH...20,SET,48,-0.16723,-0.0085351,0.12614,0.90753,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3,1
HP_CENTRAL_NERVOUS_SYSTEM_CY...,SET,180,-0.082251,-0.0081001,0.062037,0.90755,HP_CENTRAL_NERVOUS_SYSTEM_CYST,1
GOBP_REGULATION_OF_EXTRACELL...1,SET,20,-0.25046,-0.008258,0.18887,0.90759,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,1
GOBP_MITOCHONDRIAL_RNA_PROCE...,SET,20,-0.23971,-0.0079034,0.18072,0.90764,GOBP_MITOCHONDRIAL_RNA_PROCESSING,1
ZIRN_TRETINOIN_RESPONSE_WT1_...2,SET,23,-0.26016,-0.009198,0.19614,0.90765,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1
GOBP_POSITIVE_REGULATION_OF_...491,SET,98,-0.11309,-0.0082365,0.085226,0.90774,GOBP_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS,1
TAVAZOIE_METASTASIS,SET,87,-0.1251,-0.0085866,0.094251,0.90778,TAVAZOIE_METASTASIS,1
PLASARI_TGFB1_SIGNALING_VIA_...1,SET,29,-0.24504,-0.0097262,0.18461,0.90779,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,1
GCM_TEC,SET,29,-0.20646,-0.0081949,0.15555,0.90779,GCM_TEC,1
GOBP_G_PROTEIN_COUPLED_PURIN...1,SET,10,-0.45448,-0.010599,0.34239,0.9078,GOBP_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_G_PROTEIN_COUPLED_PURIN...,SET,10,-0.45448,-0.010599,0.34239,0.9078,GOMF_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...195,SET,23,-0.25212,-0.0089136,0.1899,0.90784,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,1
GOBP_LEUKOCYTE_CHEMOTAXIS_IN...,SET,8,-0.44874,-0.0093604,0.33787,0.90792,GOBP_LEUKOCYTE_CHEMOTAXIS_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GSE27786_LIN_NEG_VS_BCELL_DN,SET,182,-0.078827,-0.0078055,0.059338,0.90797,GSE27786_LIN_NEG_VS_BCELL_DN,1
GOBP_POSITIVE_REGULATION_BY_...3,SET,17,-0.25082,-0.0076248,0.18879,0.90799,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,1
KEGG_MEDICUS_REFERENCE_EGF_E...11,SET,11,-0.3212,-0.0078559,0.24174,0.90802,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY,1
DAVICIONI_PAX_FOXO1_SIGNATUR...1,SET,19,-0.29184,-0.0093788,0.21962,0.90804,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,1
GOCC_RIBONUCLEASE_MRP_COMPLEX,SET,8,-0.37209,-0.0077615,0.28001,0.90804,GOCC_RIBONUCLEASE_MRP_COMPLEX,1
GOCC_ENDOCYTIC_VESICLE,SET,315,-0.067544,-0.0087667,0.050827,0.90805,GOCC_ENDOCYTIC_VESICLE,1
GOCC_PYRUVATE_DEHYDROGENASE_...,SET,5,-0.58324,-0.0096189,0.43877,0.90811,GOCC_PYRUVATE_DEHYDROGENASE_COMPLEX,1
GSE42088_UNINF_VS_LEISHMANIA...2,SET,183,-0.085061,-0.0084456,0.063991,0.90811,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP,1
GARGALOVIC_RESPONSE_TO_OXIDI...8,SET,25,-0.2586,-0.0095314,0.19454,0.90812,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,1
GSE17974_0H_VS_6H_IN_VITRO_A...2,SET,162,-0.091959,-0.0085956,0.069176,0.90812,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP,1
NAKAMURA_ADIPOGENESIS_EARLY_...2,SET,57,-0.16444,-0.0091437,0.1237,0.90813,NAKAMURA_ADIPOGENESIS_EARLY_UP,1
GSE14000_UNSTIM_VS_4H_LPS_DC...4,SET,173,-0.080299,-0.0077541,0.060401,0.90814,GSE14000_UNSTIM_VS_4H_LPS_DC_UP,1
MIKKELSEN_NPC_LCP_WITH_H3K4M...,SET,55,-0.15317,-0.0083665,0.11519,0.90817,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,1
GOBP_GLUCAN_METABOLIC_PROCESS,SET,74,-0.1284,-0.0081313,0.096559,0.90819,GOBP_GLUCAN_METABOLIC_PROCESS,1
GOBP_ETHER_METABOLIC_PROCESS,SET,24,-0.24731,-0.0089313,0.18596,0.90822,GOBP_ETHER_METABOLIC_PROCESS,1
HP_VISCERAL_ANGIOMATOSIS,SET,15,-0.30332,-0.0086621,0.22799,0.9083,HP_VISCERAL_ANGIOMATOSIS,1
GOBP_CHONDROCYTE_PROLIFERATI...,SET,23,-0.24539,-0.0086757,0.18444,0.90831,GOBP_CHONDROCYTE_PROLIFERATION,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,SET,190,-0.082734,-0.0083687,0.062176,0.90834,DAZARD_RESPONSE_TO_UV_NHEK_UP,1
GOBP_CHONDROITIN_SULFATE_PRO...2,SET,29,-0.21345,-0.0084722,0.16039,0.90836,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,1
GOBP_LYMPHOCYTE_HOMEOSTASIS,SET,71,-0.13971,-0.0086667,0.10498,0.90837,GOBP_LYMPHOCYTE_HOMEOSTASIS,1
MIR3196,SET,19,-0.27318,-0.0087791,0.20525,0.90839,MIR3196,1
KEGG_MEDICUS_REFERENCE_CA2_C...1,SET,19,-0.25392,-0.0081603,0.19077,0.9084,KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY,1
GOBP_PEPTIDYL_METHIONINE_MOD...,SET,11,-0.33866,-0.0082828,0.25443,0.90841,GOBP_PEPTIDYL_METHIONINE_MODIFICATION,1
GOBP_REGULATION_OF_RELAXATIO...1,SET,6,-0.48063,-0.0086829,0.36104,0.90844,GOBP_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE,1
ACEVEDO_NORMAL_TISSUE_ADJACE...2,SET,154,-0.087661,-0.0079908,0.065821,0.90853,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...1,SET,17,-0.27825,-0.0084588,0.2089,0.90856,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,1
GRAESSMANN_APOPTOSIS_BY_DOXO...2,SET,1057,-0.036131,-0.0084122,0.027115,0.90865,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP,1
AIZARANI_LIVER_C7_EPCAM_POS_...,SET,206,-0.086188,-0.0090737,0.064679,0.90865,AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2,1
GCM_VAV1,SET,40,-0.161,-0.0075031,0.12082,0.90866,GCM_VAV1,1
SATO_SILENCED_BY_METHYLATION...1,SET,369,-0.063042,-0.0088427,0.047293,0.90873,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,1
MIR664A_5P,SET,65,-0.14909,-0.008851,0.11184,0.90875,MIR664A_5P,1
HP_APLASIA_HYPOPLASIA_OF_THE...25,SET,7,-0.48502,-0.009464,0.3638,0.90876,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,1
GOBP_REGULATION_OF_MRNA_CATA...,SET,170,-0.086676,-0.0082977,0.064984,0.90886,GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS,1
GOCC_EGG_COAT,SET,5,-0.44766,-0.0073828,0.33559,0.90888,GOCC_EGG_COAT,1
HP_LARYNGOTRACHEAL_STENOSIS,SET,5,-0.54515,-0.0089907,0.40867,0.90888,HP_LARYNGOTRACHEAL_STENOSIS,1
KEGG_HOMOLOGOUS_RECOMBINATION,SET,25,-0.20822,-0.0076743,0.15607,0.90891,KEGG_HOMOLOGOUS_RECOMBINATION,1
GOBP_POSITIVE_REGULATION_OF_...225,SET,5,-0.65599,-0.010819,0.49168,0.90892,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_ANTERIOR_COMMISSURE_MOR...,SET,7,-0.49885,-0.009734,0.37383,0.90896,GOBP_ANTERIOR_COMMISSURE_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...232,SET,13,-0.35025,-0.009312,0.26245,0.90897,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION,1
GOBP_PLATELET_DEGRANULATION,SET,7,-0.49022,-0.0095654,0.36732,0.90899,GOBP_PLATELET_DEGRANULATION,1
HP_DECREASED_MEAN_CORPUSCULA...2,SET,11,-0.30411,-0.0074378,0.22783,0.90902,HP_DECREASED_MEAN_CORPUSCULAR_VOLUME,1
GOBP_INTRACELLULAR_CORTICOST...,SET,12,-0.35138,-0.0089759,0.26324,0.90903,GOBP_INTRACELLULAR_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY,1
GSE28449_WT_VS_LRF_KO_GERMIN...2,SET,174,-0.090711,-0.0087845,0.067953,0.90904,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP,1
HP_LIVER_ABSCESS,SET,7,-0.45427,-0.0088641,0.34023,0.90908,HP_LIVER_ABSCESS,1
HP_PROMINENT_EYELASHES,SET,14,-0.30948,-0.0085386,0.23179,0.90908,HP_PROMINENT_EYELASHES,1
HP_INCREASED_URINARY_NON_PRO...,SET,31,-0.22547,-0.0092522,0.16884,0.90912,HP_INCREASED_URINARY_NON_PROTEINOGENIC_AMINO_ACID_LEVEL,1
GOBP_CELL_DIFFERENTIATION_IN...2,SET,53,-0.17926,-0.0096126,0.13421,0.90915,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
SCHAEFFER_PROSTATE_DEVELOPME...5,SET,428,-0.053923,-0.0081327,0.040373,0.90916,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1
GOBP_REGULATION_OF_GLYCOGEN_...3,SET,31,-0.20619,-0.0084612,0.15437,0.90916,GOBP_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
HP_NEUROGENIC_BLADDER,SET,65,-0.14014,-0.0083198,0.10492,0.90918,HP_NEUROGENIC_BLADDER,1
HP_ABNORMALITY_OF_THE_LOWER_...,SET,739,-0.042584,-0.0083658,0.031868,0.90926,HP_ABNORMALITY_OF_THE_LOWER_URINARY_TRACT,1
HP_MACULAR_COLOBOMA,SET,10,-0.38855,-0.009061,0.2907,0.90932,HP_MACULAR_COLOBOMA,1
HP_ONION_BULB_FORMATION,SET,27,-0.22498,-0.0086172,0.16832,0.90932,HP_ONION_BULB_FORMATION,1
HP_RENAL_TUBULAR_ACIDOSIS,SET,39,-0.18571,-0.008546,0.13892,0.90936,HP_RENAL_TUBULAR_ACIDOSIS,1
GSE17721_CTRL_VS_PAM3CSK4_0....2,SET,179,-0.083546,-0.0082049,0.062486,0.90938,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP,1
GOMF_BENZODIAZEPINE_RECEPTOR...,SET,9,-0.47997,-0.010619,0.35897,0.90939,GOMF_BENZODIAZEPINE_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_SKIN_MORPHOLOGY_...,SET,361,-0.060892,-0.00845,0.04554,0.9094,HP_ABNORMAL_SKIN_MORPHOLOGY_OF_THE_PALM,1
GSE16450_CTRL_VS_IFNA_6H_STI...3,SET,176,-0.082247,-0.0080101,0.061511,0.9094,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,1
GSE22886_IGM_MEMORY_BCELL_VS...3,SET,178,-0.085148,-0.0083391,0.063666,0.90945,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,1
GSE3994_WT_VS_PAC1_KO_ACTIVA...2,SET,187,-0.087068,-0.0087379,0.06509,0.90949,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP,1
REACTOME_DNA_REPLICATION,SET,122,-0.095337,-0.0077419,0.071247,0.90956,REACTOME_DNA_REPLICATION,1
WOTTON_RUNX_TARGETS_UP,SET,18,-0.26517,-0.0082947,0.19815,0.90959,WOTTON_RUNX_TARGETS_UP,1
GSE21670_TGFB_VS_IL6_TREATED...2,SET,177,-0.085391,-0.0083397,0.063805,0.9096,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP,1
GSE22935_UNSTIM_VS_12H_MBOVI...4,SET,187,-0.086732,-0.0087042,0.064797,0.90963,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
GACTGTT_MIR212_MIR132,SET,144,-0.094987,-0.0083751,0.070955,0.90966,GACTGTT_MIR212_MIR132,1
GAVISH_3CA_METAPROGRAM_FIBRO...8,SET,45,-0.2042,-0.010092,0.1525,0.90971,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_7,1
DESCARTES_FETAL_ADRENAL_SLC2...,SET,33,-0.20575,-0.008711,0.15366,0.90972,DESCARTES_FETAL_ADRENAL_SLC26A4_PAEP_POSITIVE_CELLS,1
GSE22443_IL2_VS_IL12_TREATED...2,SET,185,-0.085696,-0.0085546,0.063989,0.90974,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP,1
GSE6269_HEALTHY_VS_E_COLI_IN...1,SET,145,-0.098142,-0.008683,0.073282,0.90974,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN,1
GOBP_POSITIVE_REGULATION_BY_...1,SET,10,-0.37773,-0.0088086,0.28204,0.90975,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
HP_LONG_PENIS,SET,11,-0.36469,-0.0089194,0.27227,0.90978,HP_LONG_PENIS,1
GSE6674_CPG_VS_PL2_3_STIM_BC...1,SET,175,-0.086042,-0.0083561,0.064211,0.90987,GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...5,SET,14,-0.30035,-0.0082866,0.22411,0.9099,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_LATERAL_MESODERM_MORPHO...,SET,5,-0.57505,-0.0094838,0.42894,0.90997,GOBP_LATERAL_MESODERM_MORPHOGENESIS,1
GOBP_REGULATION_OF_CHONDROCY...2,SET,47,-0.18625,-0.0094065,0.1389,0.91,GOBP_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
GOCC_NON_MOTILE_CILIUM,SET,146,-0.093408,-0.0082924,0.069651,0.91004,GOCC_NON_MOTILE_CILIUM,1
REACTOME_TRANSCRIPTIONAL_REG...13,SET,28,-0.24807,-0.0096755,0.18493,0.9101,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,1
GSE20152_HTNFA_OVERXPRESS_AN...1,SET,173,-0.0836,-0.0080729,0.062322,0.9101,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN,1
MIR6503_5P,SET,52,-0.1589,-0.0084406,0.11845,0.91012,MIR6503_5P,1
YAO_TEMPORAL_RESPONSE_TO_PRO...13,SET,15,-0.28426,-0.0081178,0.21188,0.91013,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,1
WIZ_TARGET_GENES,SET,14,-0.2828,-0.0078024,0.21074,0.91018,WIZ_TARGET_GENES,1
HP_AREFLEXIA,SET,271,-0.068606,-0.0082693,0.051121,0.9102,HP_AREFLEXIA,1
GOBP_NEGATIVE_REGULATION_OF_...531,SET,25,-0.22443,-0.0082721,0.16715,0.91031,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION,1
WP_OMEGA9_FATTY_ACID_SYNTHES...,SET,13,-0.36036,-0.0095808,0.26832,0.91036,WP_OMEGA9_FATTY_ACID_SYNTHESIS,1
GNF2_TDG,SET,33,-0.18615,-0.007881,0.1386,0.91037,GNF2_TDG,1
HP_ABNORMAL_CIRCULATING_LEUC...,SET,4,-0.56664,-0.0083588,0.42179,0.91042,HP_ABNORMAL_CIRCULATING_LEUCINE_CONCENTRATION,1
GOMF_P_TYPE_TRANSMEMBRANE_TR...,SET,22,-0.24084,-0.0083277,0.17926,0.91043,GOMF_P_TYPE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MORF_UBE2I,SET,216,-0.072923,-0.0078591,0.054268,0.91048,MORF_UBE2I,1
HP_AMBIGUOUS_GENITALIA_MALE,SET,11,-0.35794,-0.0087545,0.26632,0.91053,HP_AMBIGUOUS_GENITALIA_MALE,1
GSE11924_TFH_VS_TH17_CD4_TCE...1,SET,180,-0.083096,-0.0081833,0.061823,0.91053,GSE11924_TFH_VS_TH17_CD4_TCELL_DN,1
KEGG_RENAL_CELL_CARCINOMA,SET,64,-0.14843,-0.0087438,0.11042,0.91055,KEGG_RENAL_CELL_CARCINOMA,1
KEGG_MEDICUS_REFERENCE_REGUL...7,SET,10,-0.35161,-0.0081997,0.26151,0.91061,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS,1
HP_APLASIA_HYPOPLASIA_OF_THE...64,SET,16,-0.28643,-0.0084479,0.21303,0.91061,HP_APLASIA_HYPOPLASIA_OF_THE_SACRUM,1
HP_APLASIA_HYPOPLASIA_AFFECT...1,SET,814,-0.04121,-0.0084788,0.030647,0.91063,HP_APLASIA_HYPOPLASIA_AFFECTING_BONES_OF_THE_AXIAL_SKELETON,1
GOBP_NUCLEOLUS_ORGANIZATION,SET,14,-0.28402,-0.007836,0.21121,0.91064,GOBP_NUCLEOLUS_ORGANIZATION,1
GOBP_BRANCHING_INVOLVED_IN_S...,SET,22,-0.25356,-0.0087677,0.18853,0.91067,GOBP_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
HP_SLEEP_RELATED_BREATHING_D...,SET,148,-0.096983,-0.0086681,0.07211,0.91067,HP_SLEEP_RELATED_BREATHING_DISORDERS,1
GSE15624_3H_VS_6H_HALOFUGINO...1,SET,135,-0.10244,-0.0087479,0.076171,0.91067,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_BCR_B...,SET,14,-0.33692,-0.0092955,0.25046,0.91071,KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY,1
HP_DECREASED_CIRCULATING_FRE...1,SET,5,-0.44436,-0.0073284,0.33031,0.91073,HP_DECREASED_CIRCULATING_FREE_T3,1
HP_LYMPHEDEMA,SET,68,-0.13679,-0.0083055,0.10168,0.91073,HP_LYMPHEDEMA,1
HP_POOR_SPEECH,SET,167,-0.085816,-0.0081432,0.063782,0.91075,HP_POOR_SPEECH,1
GOCC_ORGANELLE_INNER_MEMBRANE,SET,467,-0.051081,-0.0080386,0.037962,0.91078,GOCC_ORGANELLE_INNER_MEMBRANE,1
MIR6509_3P,SET,123,-0.10302,-0.0083995,0.076542,0.91082,MIR6509_3P,1
GOMF_HEXOKINASE_ACTIVITY,SET,5,-0.58672,-0.0096763,0.43573,0.91092,GOMF_HEXOKINASE_ACTIVITY,1
HP_RECURRENT_OTITIS_MEDIA,SET,173,-0.091108,-0.0087979,0.067663,0.91092,HP_RECURRENT_OTITIS_MEDIA,1
GSE13762_CTRL_VS_125_VITAMIN...1,SET,120,-0.10228,-0.008238,0.075963,0.91092,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN,1
GSE43955_TH0_VS_TGFB_IL6_TH1...10,SET,181,-0.084985,-0.0083924,0.063116,0.91092,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP,1
GOBP_SKELETAL_SYSTEM_MORPHOG...,SET,217,-0.085183,-0.0092014,0.063253,0.91095,GOBP_SKELETAL_SYSTEM_MORPHOGENESIS,1
KEGG_MEDICUS_VARIANT_MLL_AF4...,SET,25,-0.24502,-0.0090307,0.18193,0.91096,KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
GSE5542_UNTREATED_VS_IFNA_TR...2,SET,186,-0.08522,-0.0085298,0.063252,0.91105,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,1
GOMF_CTPASE_ACTIVITY,SET,5,-0.50669,-0.0083564,0.37606,0.91106,GOMF_CTPASE_ACTIVITY,1
GOBP_RESPONSE_TO_ACIDIC_PH,SET,25,-0.23653,-0.0087179,0.17553,0.91108,GOBP_RESPONSE_TO_ACIDIC_PH,1
HE_LIM_SUN_FETAL_LUNG_C1_CLU...,SET,64,-0.16035,-0.0094463,0.11898,0.91113,HE_LIM_SUN_FETAL_LUNG_C1_CLUB_CELL,1
HP_NARROW_PALATE,SET,164,-0.087812,-0.0082581,0.065124,0.91122,HP_NARROW_PALATE,1
HP_ABNORMAL_PUPILLARY_FUNCTI...,SET,70,-0.14567,-0.0089729,0.108,0.91129,HP_ABNORMAL_PUPILLARY_FUNCTION,1
GOMF_VERY_LONG_CHAIN_FATTY_A...,SET,9,-0.35964,-0.0079568,0.26659,0.91133,GOMF_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_FIBRO...5,SET,43,-0.15783,-0.0076253,0.11699,0.91134,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4,1
GSE13547_CTRL_VS_ANTI_IGM_ST...1,SET,151,-0.091204,-0.0082331,0.067596,0.91136,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN,1
KORKOLA_CORRELATED_WITH_POU5...,SET,26,-0.24372,-0.0091605,0.18062,0.91138,KORKOLA_CORRELATED_WITH_POU5F1,1
HP_HYPEREXTENSIBILITY_OF_THE...2,SET,38,-0.18321,-0.0083221,0.13577,0.91139,HP_HYPEREXTENSIBILITY_OF_THE_KNEE,1
GOBP_NEUROTRANSMITTER_RECEPT...2,SET,22,-0.25662,-0.0088733,0.19013,0.91144,GOBP_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
HP_SOFT_SKIN,SET,40,-0.19175,-0.0089358,0.14204,0.91148,HP_SOFT_SKIN,1
GNF2_RFC3,SET,39,-0.1678,-0.0077217,0.12429,0.91149,GNF2_RFC3,1
MAHADEVAN_GIST_MORPHOLOGICAL...,SET,14,-0.34844,-0.0096133,0.25807,0.91151,MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH,1
GSE26290_CTRL_VS_AKT_INHIBIT...2,SET,174,-0.091399,-0.0088512,0.067693,0.91151,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,1
GSE13484_UNSTIM_VS_YF17D_VAC...1,SET,188,-0.087337,-0.0087881,0.064654,0.91161,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
KEGG_MEDICUS_REFERENCE_GNRH_...,SET,20,-0.26557,-0.0087562,0.19658,0.91163,KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY,1
GAVISH_3CA_MALIGNANT_METAPRO...32,SET,40,-0.16689,-0.0077775,0.12354,0.91163,GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH,1
WP_STEROID_BIOSYNTHESIS,SET,10,-0.37203,-0.0086759,0.27534,0.91168,WP_STEROID_BIOSYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...551,SET,30,-0.20226,-0.0081652,0.14968,0.91168,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
WP_METHIONINE_METABOLISM_LEA...,SET,10,-0.41375,-0.0096488,0.3062,0.91169,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,1
KEGG_MEDICUS_REFERENCE_ANTIG...1,SET,11,-0.41791,-0.010221,0.30907,0.91183,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES,1
GOBP_CEREBRAL_CORTEX_DEVELOP...,SET,112,-0.11581,-0.0090133,0.08564,0.91185,GOBP_CEREBRAL_CORTEX_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...454,SET,6,-0.50668,-0.0091536,0.37465,0.91187,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_STEM_CELL_PROLIFERATION,1
GSE3203_UNTREATED_VS_IFNB_TR...1,SET,186,-0.087658,-0.0087738,0.064804,0.91191,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN,1
HP_POSTERIOR_RIB_CUPPING,SET,4,-0.58811,-0.0086754,0.43472,0.91194,HP_POSTERIOR_RIB_CUPPING,1
GOBP_REGULATION_OF_PEPTIDYL_...5,SET,39,-0.19059,-0.0087705,0.14085,0.91199,GOBP_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
KEGG_MEDICUS_PATHOGEN_HIV_GP...1,SET,12,-0.33675,-0.0086022,0.24885,0.912,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...304,SET,7,-0.48176,-0.0094005,0.35596,0.91203,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,1
MIKKELSEN_IPS_LCP_WITH_H3K4M...1,SET,157,-0.093486,-0.0086036,0.069059,0.91208,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,1
WP_TYPE_II_DIABETES_MELLITUS,SET,20,-0.26642,-0.0087841,0.19679,0.9121,WP_TYPE_II_DIABETES_MELLITUS,1
TCGA_GLIOBLASTOMA_COPY_NUMBE...1,SET,28,-0.28941,-0.011288,0.21375,0.91211,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,1
HP_SKIN_DIMPLE,SET,102,-0.1263,-0.0093829,0.093279,0.91212,HP_SKIN_DIMPLE,1
GOCC_POSTSYNAPTIC_ENDOSOME,SET,13,-0.30533,-0.0081178,0.22536,0.91226,GOCC_POSTSYNAPTIC_ENDOSOME,1
GSE17721_LPS_VS_PAM3CSK4_24H...1,SET,178,-0.086143,-0.0084366,0.06358,0.91226,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN,1
ZNF711_TARGET_GENES,SET,1383,-0.03219,-0.0084917,0.023756,0.91228,ZNF711_TARGET_GENES,1
HP_FIFTH_FINGER_DISTAL_PHALA...,SET,27,-0.22201,-0.0085032,0.16382,0.91232,HP_FIFTH_FINGER_DISTAL_PHALANX_CLINODACTYLY,1
HP_DENTAL_CROWDING,SET,119,-0.10871,-0.0087191,0.080198,0.91236,HP_DENTAL_CROWDING,1
GSE36392_TYPE_2_MYELOID_VS_M...2,SET,183,-0.091691,-0.009104,0.067646,0.91236,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP,1
FAN_EMBRYONIC_CTX_BRAIN_ENDO...2,SET,277,-0.076297,-0.0092962,0.056287,0.91236,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2,1
GOBP_ENDOTHELIN_RECEPTOR_SIG...,SET,10,-0.40896,-0.0095371,0.30159,0.91244,GOBP_ENDOTHELIN_RECEPTOR_SIGNALING_PATHWAY,1
BIOCARTA_REELIN_PATHWAY,SET,7,-0.46051,-0.0089858,0.3396,0.91245,BIOCARTA_REELIN_PATHWAY,1
LI_INDUCED_T_TO_NATURAL_KILL...2,SET,288,-0.069911,-0.0086829,0.051551,0.91247,LI_INDUCED_T_TO_NATURAL_KILLER_UP,1
GOBP_POSITIVE_REGULATION_OF_...316,SET,24,-0.25964,-0.0093766,0.19142,0.9125,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,1
GOBP_FATTY_ACID_DERIVATIVE_B...,SET,43,-0.19138,-0.0092463,0.14109,0.91251,GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS,1
GSE21360_NAIVE_VS_SECONDARY_...1,SET,156,-0.094412,-0.0086615,0.069588,0.91256,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN,1
VANTVEER_BREAST_CANCER_BRCA1...1,SET,37,-0.19288,-0.0086456,0.14214,0.9126,VANTVEER_BREAST_CANCER_BRCA1_DN,1
MIR146A_3P,SET,197,-0.085853,-0.008841,0.063259,0.91263,MIR146A_3P,1
KYNG_ENVIRONMENTAL_STRESS_RE...2,SET,12,-0.3331,-0.0085088,0.24542,0.91264,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,1
GOBP_INTERLEUKIN_18_MEDIATED...,SET,10,-0.41172,-0.0096015,0.30332,0.91266,GOBP_INTERLEUKIN_18_MEDIATED_SIGNALING_PATHWAY,1
HP_INGUINAL_HERNIA,SET,265,-0.073046,-0.0087079,0.05381,0.91267,HP_INGUINAL_HERNIA,1
GSE2770_IL12_VS_TGFB_AND_IL1...2,SET,116,-0.10996,-0.0087086,0.081001,0.91269,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
KEGG_NEUROTROPHIN_SIGNALING_...,SET,120,-0.10893,-0.0087734,0.08023,0.91271,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1
UBE2I_TARGET_GENES,SET,70,-0.14126,-0.0087013,0.10404,0.91271,UBE2I_TARGET_GENES,1
GSE5589_WT_VS_IL6_KO_LPS_AND...6,SET,180,-0.088694,-0.0087346,0.065327,0.91271,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
KEGG_RETINOL_METABOLISM,SET,60,-0.19713,-0.011245,0.14517,0.91274,KEGG_RETINOL_METABOLISM,1
HP_ABNORMAL_FOOT_MORPHOLOGY,SET,1315,-0.033511,-0.0086374,0.024679,0.91274,HP_ABNORMAL_FOOT_MORPHOLOGY,1
MIR6724_5P,SET,18,-0.2504,-0.0078327,0.1844,0.91275,MIR6724_5P,1
MIR2116_3P,SET,68,-0.14628,-0.0088816,0.10772,0.91276,MIR2116_3P,1
GOBP_CONNECTIVE_TISSUE_REPLA...1,SET,11,-0.35675,-0.0087254,0.2627,0.91276,GOBP_CONNECTIVE_TISSUE_REPLACEMENT,1
HP_FOOT_ACROOSTEOLYSIS,SET,7,-0.45225,-0.0088246,0.33292,0.91283,HP_FOOT_ACROOSTEOLYSIS,1
GOMF_METALLODIPEPTIDASE_ACTI...,SET,8,-0.44383,-0.009258,0.32669,0.91285,GOMF_METALLODIPEPTIDASE_ACTIVITY,1
MIR6782_5P,SET,37,-0.18951,-0.0084948,0.13942,0.91297,MIR6782_5P,1
STAMBOLSKY_BOUND_BY_MUTATED_...,SET,13,-0.32947,-0.0087596,0.24224,0.91309,STAMBOLSKY_BOUND_BY_MUTATED_TP53,1
YAMANAKA_GLIOBLASTOMA_SURVIV...2,SET,9,-0.4289,-0.009489,0.31534,0.9131,YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,1
REACTOME_IRAK2_MEDIATED_ACTI...,SET,8,-0.47798,-0.0099703,0.35138,0.91312,REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX,1
HP_HYPOPLASTIC_FRONTAL_SINUS...,SET,6,-0.49636,-0.008967,0.36488,0.91313,HP_HYPOPLASTIC_FRONTAL_SINUSES,1
GOBP_POSITIVE_REGULATION_OF_...290,SET,43,-0.16977,-0.0082025,0.1248,0.91314,GOBP_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,1
WP_OXIDATIVE_PHOSPHORYLATION,SET,35,-0.17235,-0.0075144,0.12669,0.91315,WP_OXIDATIVE_PHOSPHORYLATION,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...7,SET,28,-0.21908,-0.0085446,0.16096,0.91325,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
HP_FINGER_SWELLING,SET,4,-0.76701,-0.011315,0.56342,0.91329,HP_FINGER_SWELLING,1
GOBP_BRANCHIOMOTOR_NEURON_AX...,SET,6,-0.50694,-0.0091583,0.37237,0.9133,GOBP_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE,1
GOBP_POST_EMBRYONIC_HEMOPOIE...,SET,5,-0.4679,-0.0077167,0.34365,0.91332,GOBP_POST_EMBRYONIC_HEMOPOIESIS,1
GOMF_ADP_RIBOSE_DIPHOSPHATAS...,SET,6,-0.48296,-0.008725,0.35471,0.91332,GOMF_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY,1
GARGALOVIC_RESPONSE_TO_OXIDI...19,SET,13,-0.3662,-0.0097361,0.2689,0.91337,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,1
GSE36078_WT_VS_IL1R_KO_LUNG_...1,SET,184,-0.090505,-0.0090104,0.06645,0.91339,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN,1
HP_ABNORMALITY_OF_THE_PALPEB...,SET,738,-0.043275,-0.0084961,0.031772,0.9134,HP_ABNORMALITY_OF_THE_PALPEBRAL_FISSURES,1
GOBP_NUCLEOBASE_TRANSPORT,SET,12,-0.32016,-0.0081784,0.23503,0.91342,GOBP_NUCLEOBASE_TRANSPORT,1
GOBP_REACTIVE_OXYGEN_SPECIES...1,SET,45,-0.17357,-0.0085783,0.12742,0.91343,GOBP_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
HP_SEVERELY_REDUCED_VISUAL_A...,SET,39,-0.19126,-0.0088015,0.14033,0.91355,HP_SEVERELY_REDUCED_VISUAL_ACUITY,1
HP_MULTIPLE_RENAL_CYSTS,SET,67,-0.15619,-0.0094133,0.11453,0.91366,HP_MULTIPLE_RENAL_CYSTS,1
LI_CYTIDINE_ANALOGS_CYCTOTOX...,SET,14,-0.30278,-0.0083537,0.222,0.91369,LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,1
HP_APLASIA_OF_THE_PROXIMAL_P...,SET,9,-0.35046,-0.0077536,0.25691,0.91373,HP_APLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
GOBP_MESENCHYMAL_CELL_DEVELO...,SET,6,-0.56397,-0.010189,0.41337,0.91376,GOBP_MESENCHYMAL_CELL_DEVELOPMENT,1
KEGG_MEDICUS_PATHOGEN_HCMV_G...1,SET,14,-0.30894,-0.0085237,0.22641,0.91379,KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY,1
GSE23398_WT_VS_IL2_KO_CD4_TC...2,SET,180,-0.08732,-0.0085993,0.06398,0.91383,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP,1
GOMF_STEROID_DEHYDROGENASE_A...2,SET,30,-0.22378,-0.009034,0.16395,0.91385,GOMF_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,1
MIR363_5P,SET,65,-0.14996,-0.0089027,0.10985,0.9139,MIR363_5P,1
GOBP_POSITIVE_REGULATION_OF_...375,SET,88,-0.12947,-0.0089373,0.094826,0.91391,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,1
GSE17974_CTRL_VS_ACT_IL4_AND...2,SET,131,-0.097393,-0.0081934,0.071335,0.91391,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_AREG_...1,SET,11,-0.36346,-0.0088894,0.26614,0.91397,KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY,1
MIR29B_3P_MIR29C_3P,SET,396,-0.061903,-0.0089883,0.045314,0.91404,MIR29B_3P_MIR29C_3P,1
WP_SEROTONIN_RECEPTOR_2_AND_...,SET,18,-0.26576,-0.0083131,0.19444,0.91415,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,1
ELF5_TARGET_GENES,SET,379,-0.060588,-0.0086106,0.044319,0.91419,ELF5_TARGET_GENES,1
HP_GENU_VALGUM,SET,139,-0.10239,-0.0088706,0.074895,0.91419,HP_GENU_VALGUM,1
GOBP_REGULATION_OF_NUCLEAR_T...1,SET,21,-0.24116,-0.0081474,0.17637,0.91424,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
GOBP_COMMON_MYELOID_PROGENIT...,SET,9,-0.37993,-0.0084057,0.2778,0.91428,GOBP_COMMON_MYELOID_PROGENITOR_CELL_PROLIFERATION,1
HOWARD_MONOCYTE_INACT_MONOV_...1,SET,35,-0.21424,-0.0093407,0.15665,0.91428,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,1
chr3p24,SET,30,-0.36588,-0.014771,0.26748,0.91432,chr3p24,1
MIR345_3P,SET,199,-0.084619,-0.0087575,0.061857,0.91433,MIR345_3P,1
GSE23308_CTRL_VS_CORTICOSTER...4,SET,188,-0.082814,-0.008333,0.060528,0.91437,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP,1
LUI_THYROID_CANCER_CLUSTER_1,SET,47,-0.16909,-0.0085402,0.12357,0.9144,LUI_THYROID_CANCER_CLUSTER_1,1
GOMF_SINGLE_STRANDED_DNA_5_3...,SET,5,-0.46808,-0.0077196,0.34205,0.9144,GOMF_SINGLE_STRANDED_DNA_5_3_DNA_EXONUCLEASE_ACTIVITY,1
UEDA_CENTRAL_CLOCK,SET,80,-0.13182,-0.008678,0.096314,0.91443,UEDA_CENTRAL_CLOCK,1
MIR6859_5P,SET,189,-0.083223,-0.0083962,0.060809,0.91443,MIR6859_5P,1
GSE1740_MCSF_VS_MCSF_AND_IFN...1,SET,172,-0.08551,-0.0082336,0.062473,0.91445,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN,1
GSE17721_12H_VS_24H_PAM3CSK4...2,SET,182,-0.085137,-0.0084303,0.062187,0.9145,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP,1
GOBP_PROTEIN_POLYGLUTAMYLATI...,SET,11,-0.38282,-0.009363,0.27959,0.91453,GOBP_PROTEIN_POLYGLUTAMYLATION,1
GSE13306_TREG_RA_VS_TCONV_RA...2,SET,192,-0.084485,-0.0085901,0.061695,0.91455,GSE13306_TREG_RA_VS_TCONV_RA_UP,1
GOBP_PEPTIDYL_LYSINE_OXIDATI...,SET,5,-0.58073,-0.0095775,0.42407,0.91456,GOBP_PEPTIDYL_LYSINE_OXIDATION,1
GOMF_PROTEIN_LYSINE_6_OXIDAS...,SET,5,-0.58073,-0.0095775,0.42407,0.91456,GOMF_PROTEIN_LYSINE_6_OXIDASE_ACTIVITY,1
MARIADASON_RESPONSE_TO_BUTYR...5,SET,40,-0.19661,-0.0091623,0.14356,0.91457,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,1
GSE21546_WT_VS_SAP1A_KO_DP_T...1,SET,156,-0.09491,-0.0087071,0.0693,0.91458,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN,1
HP_ABNORMAL_FUNDUS_MORPHOLOGY,SET,1215,-0.034381,-0.008543,0.025102,0.9146,HP_ABNORMAL_FUNDUS_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...288,SET,117,-0.11565,-0.0091985,0.084421,0.91464,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
CTACCTC_LET7A_LET7B_LET7C_LE...,SET,352,-0.064012,-0.0087737,0.046714,0.9147,CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I,1
TTAYRTAA_E4BP4_01,SET,236,-0.081405,-0.0091655,0.059406,0.9147,TTAYRTAA_E4BP4_01,1
HP_ABSENT_LACRIMAL_PUNCTUM,SET,6,-0.5076,-0.0091702,0.37036,0.91473,HP_ABSENT_LACRIMAL_PUNCTUM,1
MIR6740_5P,SET,58,-0.15433,-0.0086562,0.11258,0.91478,MIR6740_5P,1
HP_PERIAURICULAR_SKIN_PITS,SET,48,-0.18046,-0.0092103,0.13164,0.91478,HP_PERIAURICULAR_SKIN_PITS,1
GSE10239_NAIVE_VS_MEMORY_CD8...2,SET,184,-0.084069,-0.0083697,0.061325,0.91478,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
MODULE_562,SET,20,-0.30768,-0.010144,0.22442,0.91481,MODULE_562,1
GOBP_EPITHELIAL_CELL_PROLIFE...3,SET,10,-0.40119,-0.0093559,0.29262,0.91481,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,1
GSE32986_UNSTIM_VS_CURDLAN_H...2,SET,179,-0.085573,-0.008404,0.06241,0.91483,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,1
MIR6716_5P,SET,118,-0.10852,-0.0086677,0.079141,0.91484,MIR6716_5P,1
GOBP_ORGANOPHOSPHATE_METABOL...,SET,902,-0.039565,-0.0085475,0.028852,0.91485,GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS,1
MIR4472,SET,93,-0.12211,-0.0086645,0.089042,0.91486,MIR4472,1
BIOCARTA_BARR_MAPK_PATHWAY,SET,13,-0.368,-0.0097839,0.26832,0.91488,BIOCARTA_BARR_MAPK_PATHWAY,1
LIN_NPAS4_TARGETS_UP,SET,156,-0.090742,-0.0083247,0.066158,0.9149,LIN_NPAS4_TARGETS_UP,1
MODULE_381,SET,11,-0.35155,-0.0085981,0.25628,0.91492,MODULE_381,1
HP_SUPERNUMERARY_BONES_OF_TH...,SET,23,-0.23978,-0.0084774,0.17478,0.91494,HP_SUPERNUMERARY_BONES_OF_THE_AXIAL_SKELETON,1
TERAO_AOX4_TARGETS_SKIN_DN,SET,17,-0.29811,-0.0090626,0.21719,0.91505,TERAO_AOX4_TARGETS_SKIN_DN,1
TONG_INTERACT_WITH_PTTG1,SET,51,-0.15081,-0.0079336,0.10986,0.91508,TONG_INTERACT_WITH_PTTG1,1
GSE7852_LN_VS_THYMUS_TREG_DN,SET,179,-0.088717,-0.0087128,0.064626,0.91508,GSE7852_LN_VS_THYMUS_TREG_DN,1
HP_NONIMMUNE_HYDROPS_FETALIS,SET,58,-0.14792,-0.0082967,0.10774,0.9151,HP_NONIMMUNE_HYDROPS_FETALIS,1
REACTOME_EFFECTS_OF_PIP2_HYD...,SET,26,-0.21564,-0.0081052,0.15705,0.91513,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,1
GOMF_MODIFIED_AMINO_ACID_BIN...,SET,91,-0.13354,-0.0093733,0.097237,0.91516,GOMF_MODIFIED_AMINO_ACID_BINDING,1
HP_OBSTRUCTIVE_AZOOSPERMIA,SET,27,-0.21894,-0.0083858,0.15943,0.91516,HP_OBSTRUCTIVE_AZOOSPERMIA,1
REACTOME_COMPLEX_I_BIOGENESIS,SET,56,-0.14073,-0.0077567,0.10246,0.91521,REACTOME_COMPLEX_I_BIOGENESIS,1
GSE30962_PRIMARY_VS_SECONDAR...1,SET,180,-0.089294,-0.0087937,0.064988,0.91527,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN,1
HP_PRURITUS,SET,140,-0.10182,-0.0088532,0.074096,0.9153,HP_PRURITUS,1
GOBP_LONG_CHAIN_FATTY_ACYL_C...2,SET,24,-0.26336,-0.0095108,0.19159,0.91536,GOBP_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,1
GOBP_OTIC_VESICLE_MORPHOGENE...,SET,10,-0.34716,-0.0080959,0.25254,0.91537,GOBP_OTIC_VESICLE_MORPHOGENESIS,1
GOMF_UDP_XYLOSYLTRANSFERASE_...,SET,6,-0.40604,-0.0073354,0.29536,0.91538,GOMF_UDP_XYLOSYLTRANSFERASE_ACTIVITY,1
HP_HYPOPLASIA_OF_THE_ZYGOMAT...,SET,37,-0.21231,-0.0095168,0.15439,0.91545,HP_HYPOPLASIA_OF_THE_ZYGOMATIC_BONE,1
GSE22886_NAIVE_BCELL_VS_NEUT...2,SET,171,-0.092842,-0.0089138,0.0675,0.91549,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP,1
GOMF_SMALL_PROTEIN_ACTIVATIN...,SET,5,-0.49592,-0.0081787,0.36052,0.91551,GOMF_SMALL_PROTEIN_ACTIVATING_ENZYME_BINDING,1
GOBP_NAD_CATABOLIC_PROCESS,SET,16,-0.2758,-0.0081343,0.20046,0.91556,GOBP_NAD_CATABOLIC_PROCESS,1
HP_LENS_LUXATION,SET,6,-0.54307,-0.0098109,0.39471,0.91556,HP_LENS_LUXATION,1
GOBP_PURINE_NUCLEOBASE_METAB...,SET,17,-0.27679,-0.0084144,0.20115,0.91558,GOBP_PURINE_NUCLEOBASE_METABOLIC_PROCESS,1
REACTOME_MITOCHONDRIAL_PROTE...1,SET,78,-0.12355,-0.0080322,0.089787,0.91559,REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION,1
MIR600,SET,129,-0.10997,-0.0091811,0.079904,0.91562,MIR600,1
GOBP_MAGNESIUM_ION_TRANSPORT,SET,14,-0.31737,-0.0087563,0.23059,0.91564,GOBP_MAGNESIUM_ION_TRANSPORT,1
HP_ABNORMAL_NASAL_TIP_MORPHO...,SET,324,-0.064911,-0.0085423,0.047156,0.91566,HP_ABNORMAL_NASAL_TIP_MORPHOLOGY,1
WP_BARDETBIEDL_SYNDROME,SET,76,-0.12749,-0.0081817,0.09261,0.91568,WP_BARDETBIEDL_SYNDROME,1
HP_POOR_HEAD_CONTROL,SET,208,-0.078834,-0.0083392,0.057255,0.91572,HP_POOR_HEAD_CONTROL,1
MIR4673,SET,129,-0.10459,-0.0087318,0.075948,0.91575,MIR4673,1
WP_SCFA_AND_SKELETAL_MUSCLE_...,SET,6,-0.48363,-0.0087371,0.35114,0.91578,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,1
KEGG_MEDICUS_PATHOGEN_ESCHER...5,SET,14,-0.31212,-0.0086114,0.2266,0.9158,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY,1
ZHAN_MULTIPLE_MYELOMA_MS_UP,SET,41,-0.21597,-0.010189,0.15678,0.91581,ZHAN_MULTIPLE_MYELOMA_MS_UP,1
GSE3982_NEUTROPHIL_VS_BASOPH...1,SET,172,-0.086369,-0.0083163,0.062685,0.91586,GSE3982_NEUTROPHIL_VS_BASOPHIL_DN,1
GSE23114_WT_VS_SLE2C1_MOUSE_...1,SET,167,-0.093271,-0.0088506,0.06768,0.91591,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN,1
MCCLUNG_CREB1_TARGETS_DN,SET,51,-0.16724,-0.0087976,0.12134,0.91593,MCCLUNG_CREB1_TARGETS_DN,1
HP_REDUCED_MUSCLE_FIBER_ALPH...,SET,8,-0.40778,-0.0085059,0.29585,0.91594,HP_REDUCED_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,1
HP_TOE_JOINT_CONTRACTURE,SET,27,-0.23248,-0.0089045,0.16865,0.91596,HP_TOE_JOINT_CONTRACTURE,1
GNF2_HAT1,SET,45,-0.17395,-0.0085972,0.12619,0.91597,GNF2_HAT1,1
SENESE_HDAC3_TARGETS_UP,SET,437,-0.059013,-0.0089911,0.042794,0.91604,SENESE_HDAC3_TARGETS_UP,1
chr9q22,SET,72,-0.24163,-0.015094,0.17517,0.9161,chr9q22,1
WP_HEAD_AND_NECK_SQUAMOUS_CE...,SET,73,-0.14,-0.008806,0.10149,0.91612,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1
LEF1_Q2,SET,211,-0.087525,-0.0093244,0.063445,0.91613,LEF1_Q2,1
CUI_DEVELOPING_HEART_C8_MACR...,SET,248,-0.07999,-0.0092292,0.057982,0.91613,CUI_DEVELOPING_HEART_C8_MACROPHAGE,1
HOFFMANN_IMMATURE_TO_MATURE_...1,SET,43,-0.19085,-0.0092207,0.13833,0.91614,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,1
GSE24574_BCL6_HIGH_TFH_VS_TC...1,SET,188,-0.089891,-0.0090451,0.065157,0.91614,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN,1
GSE19198_CTRL_VS_IL21_TREATE...1,SET,183,-0.090926,-0.009028,0.065902,0.91616,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN,1
HP_INCREASED_CIRCULATING_FRE...,SET,5,-0.43179,-0.0071212,0.31292,0.91618,HP_INCREASED_CIRCULATING_FREE_FATTY_ACID_LEVEL,1
HOWLIN_PUBERTAL_MAMMARY_GLAND,SET,62,-0.1692,-0.009811,0.1226,0.91621,HOWLIN_PUBERTAL_MAMMARY_GLAND,1
GSE17301_CTRL_VS_48H_IFNA2_S...1,SET,163,-0.090039,-0.0084419,0.065235,0.91623,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN,1
GOBP_NUCLEOBASE_METABOLIC_PR...,SET,36,-0.19315,-0.0085403,0.13994,0.91624,GOBP_NUCLEOBASE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_LYSOSOME_...1,SET,12,-0.36279,-0.0092673,0.26281,0.91626,GOBP_REGULATION_OF_LYSOSOME_ORGANIZATION,1
GOBP_ACTIVATION_OF_CYSTEINE_...2,SET,68,-0.1482,-0.0089978,0.10735,0.91627,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
MORF_CSNK1D,SET,65,-0.13759,-0.0081684,0.099641,0.91634,MORF_CSNK1D,1
SRY_01,SET,210,-0.084174,-0.0089463,0.060953,0.91635,SRY_01,1
GSE17721_LPS_VS_CPG_6H_BMDC_...2,SET,174,-0.089719,-0.0086885,0.064965,0.91636,GSE17721_LPS_VS_CPG_6H_BMDC_UP,1
HP_DYSPLASTIC_CORPUS_CALLOSUM,SET,40,-0.18627,-0.0086805,0.13486,0.91639,HP_DYSPLASTIC_CORPUS_CALLOSUM,1
HP_PERIORBITAL_FULLNESS,SET,34,-0.18596,-0.0079909,0.13459,0.91645,HP_PERIORBITAL_FULLNESS,1
BROWNE_HCMV_INFECTION_6HR_DN,SET,147,-0.098464,-0.0087709,0.071262,0.91646,BROWNE_HCMV_INFECTION_6HR_DN,1
MIR6749_3P,SET,100,-0.12313,-0.0090581,0.089108,0.91648,MIR6749_3P,1
GOBP_REGULATION_OF_MICROTUBU...2,SET,235,-0.073501,-0.0082582,0.053187,0.9165,GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS,1
GSE39556_UNTREATED_VS_3H_POL...2,SET,180,-0.093813,-0.0092388,0.067876,0.91653,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...144,SET,3,-0.79988,-0.010219,0.57864,0.91656,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,1
HP_DELAYED_MYELINATION,SET,245,-0.073882,-0.0084734,0.053447,0.91656,HP_DELAYED_MYELINATION,1
GOBP_MICROGLIAL_CELL_MEDIATE...,SET,5,-0.53157,-0.0087667,0.38447,0.9166,GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY,1
HP_PUSTULE,SET,25,-0.24227,-0.0089294,0.17517,0.91667,HP_PUSTULE,1
GOBP_AORTA_SMOOTH_MUSCLE_TIS...,SET,4,-0.60698,-0.0089538,0.43877,0.91671,GOBP_AORTA_SMOOTH_MUSCLE_TISSUE_MORPHOGENESIS,1
MIR6790_3P,SET,4,-0.54401,-0.0080249,0.39323,0.91672,MIR6790_3P,1
GOBP_NEGATIVE_REGULATION_OF_...214,SET,35,-0.20354,-0.008874,0.14713,0.91673,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GNF2_CD1D,SET,38,-0.20106,-0.0091331,0.14532,0.91674,GNF2_CD1D,1
GOBP_REGULATION_OF_POLYSACCH...1,SET,33,-0.20983,-0.0088835,0.15165,0.91675,GOBP_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GSE15330_HSC_VS_LYMPHOID_PRI...3,SET,181,-0.089267,-0.0088152,0.064483,0.91686,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP,1
REACTOME_NUCLEAR_EVENTS_MEDI...,SET,92,-0.12233,-0.0086334,0.088353,0.91689,REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1
MIR449C_3P,SET,50,-0.16554,-0.008623,0.11957,0.91689,MIR449C_3P,1
MIR4790_5P,SET,13,-0.3235,-0.0086008,0.23356,0.91697,MIR4790_5P,1
HP_ABNORMAL_PULSE,SET,5,-0.49883,-0.0082267,0.36016,0.91697,HP_ABNORMAL_PULSE,1
GOBP_NEURONAL_DENSE_CORE_VES...,SET,7,-0.49687,-0.0096952,0.35872,0.91698,GOBP_NEURONAL_DENSE_CORE_VESICLE_EXOCYTOSIS,1
HP_ABNORMAL_CIRCULATING_FERR...,SET,47,-0.17963,-0.0090723,0.12968,0.91699,HP_ABNORMAL_CIRCULATING_FERRITIN_CONCENTRATION,1
ZHONG_PFC_C8_UNKNOWN_NEUROD2...,SET,80,-0.14057,-0.0092546,0.10148,0.917,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,1
GCM_CALM1,SET,98,-0.11651,-0.0084849,0.084089,0.91704,GCM_CALM1,1
GOBP_ENDOCRINE_PROCESS,SET,84,-0.14138,-0.0095364,0.10204,0.91706,GOBP_ENDOCRINE_PROCESS,1
MIR6839_3P,SET,146,-0.1013,-0.0089927,0.073075,0.91715,MIR6839_3P,1
GSE23984_CTRL_VS_HYPOCALEMIC...2,SET,176,-0.087837,-0.0085545,0.063364,0.91715,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP,1
DITTMER_PTHLH_TARGETS_UP,SET,104,-0.12119,-0.0090906,0.087412,0.91718,DITTMER_PTHLH_TARGETS_UP,1
HP_COMPENSATORY_HEAD_POSTURE,SET,21,-0.26581,-0.0089803,0.19172,0.91719,HP_COMPENSATORY_HEAD_POSTURE,1
GOBP_NEGATIVE_REGULATION_OF_...615,SET,25,-0.24198,-0.0089189,0.17451,0.91721,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
KEGG_MEDICUS_PATHOGEN_HPV_E5...2,SET,13,-0.32081,-0.0085293,0.23133,0.91723,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
JIANG_HYPOXIA_CANCER,SET,53,-0.16413,-0.0088012,0.11834,0.91725,JIANG_HYPOXIA_CANCER,1
MIR4727_3P,SET,31,-0.22252,-0.0091313,0.16043,0.91727,MIR4727_3P,1
GOCC_MHC_CLASS_II_PROTEIN_CO...,SET,13,-0.40337,-0.010724,0.29076,0.91731,GOCC_MHC_CLASS_II_PROTEIN_COMPLEX,1
MIR576_3P,SET,58,-0.1565,-0.0087782,0.11281,0.91732,MIR576_3P,1
HP_WIDENED_SUBARACHNOID_SPACE,SET,28,-0.21743,-0.0084803,0.15673,0.91732,HP_WIDENED_SUBARACHNOID_SPACE,1
GOBP_MORPHOGENESIS_OF_AN_EPI...3,SET,60,-0.14774,-0.0084276,0.10648,0.91734,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET,1
GSE14699_NAIVE_VS_DELETIONAL...1,SET,185,-0.089022,-0.0088866,0.06416,0.91735,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,1
MATZUK_CUMULUS_EXPANSION,SET,8,-0.49805,-0.010389,0.35879,0.91744,MATZUK_CUMULUS_EXPANSION,1
BIOCARTA_ACH_PATHWAY,SET,14,-0.32749,-0.0090353,0.23592,0.91744,BIOCARTA_ACH_PATHWAY,1
GOBP_CALCIUM_ION_EXPORT_ACRO...,SET,9,-0.44407,-0.0098246,0.31991,0.91744,GOBP_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
MIR4470,SET,226,-0.080242,-0.0088434,0.0578,0.91746,MIR4470,1
GSE4142_PLASMA_CELL_VS_GC_BC...1,SET,177,-0.088012,-0.0085957,0.063351,0.91762,GSE4142_PLASMA_CELL_VS_GC_BCELL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...74,SET,7,-0.45569,-0.0088918,0.32795,0.91765,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_OPTN_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
PID_HIF1_TFPATHWAY,SET,64,-0.15722,-0.0092618,0.11314,0.91766,PID_HIF1_TFPATHWAY,1
MATTIOLI_MGUS_VS_PCL,SET,91,-0.12857,-0.0090245,0.092514,0.91768,MATTIOLI_MGUS_VS_PCL,1
GOBP_ASSOCIATIVE_LEARNING,SET,82,-0.13759,-0.0091699,0.099005,0.91768,GOBP_ASSOCIATIVE_LEARNING,1
HP_HIGH_NARROW_PALATE,SET,128,-0.1018,-0.008466,0.073216,0.91778,HP_HIGH_NARROW_PALATE,1
MURATA_VIRULENCE_OF_H_PILORI,SET,20,-0.28507,-0.009399,0.20503,0.91779,MURATA_VIRULENCE_OF_H_PILORI,1
SHIPP_DLBCL_CURED_VS_FATAL_DN,SET,38,-0.18982,-0.0086227,0.1365,0.91783,SHIPP_DLBCL_CURED_VS_FATAL_DN,1
IYENGAR_RESPONSE_TO_ADIPOCYT...,SET,10,-0.42397,-0.009887,0.30482,0.91786,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,1
REACTOME_UPTAKE_AND_FUNCTION...2,SET,6,-0.48624,-0.0087843,0.34948,0.91793,REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN,1
DESCARTES_FETAL_PANCREAS_DUC...,SET,96,-0.13316,-0.0095986,0.095701,0.91794,DESCARTES_FETAL_PANCREAS_DUCTAL_CELLS,1
REACTOME_EGFR_TRANSACTIVATIO...,SET,9,-0.38278,-0.0084687,0.27507,0.91797,REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN,1
HP_ANEMIC_PALLOR,SET,14,-0.30142,-0.0083162,0.21653,0.91804,HP_ANEMIC_PALLOR,1
GOMF_CARBON_NITROGEN_LYASE_A...,SET,13,-0.36205,-0.0096258,0.26001,0.9181,GOMF_CARBON_NITROGEN_LYASE_ACTIVITY,1
DIRMEIER_LMP1_RESPONSE_EARLY,SET,59,-0.16333,-0.0092392,0.11726,0.91817,DIRMEIER_LMP1_RESPONSE_EARLY,1
HP_TALIPES_CALCANEOVALGUS,SET,13,-0.31221,-0.0083007,0.22414,0.91817,HP_TALIPES_CALCANEOVALGUS,1
HP_ABNORMAL_PINEAL_MORPHOLOGY,SET,10,-0.36856,-0.0085949,0.26459,0.91818,HP_ABNORMAL_PINEAL_MORPHOLOGY,1
GOMF_PROTEIN_CARBOXYL_O_METH...,SET,6,-0.45776,-0.0082697,0.3286,0.91819,GOMF_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY,1
GOBP_STEROID_BIOSYNTHETIC_PR...,SET,167,-0.094987,-0.0090135,0.068184,0.9182,GOBP_STEROID_BIOSYNTHETIC_PROCESS,1
PID_MYC_ACTIV_PATHWAY,SET,76,-0.1417,-0.0090936,0.1017,0.91823,PID_MYC_ACTIV_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...415,SET,9,-0.39426,-0.0087227,0.28284,0.91832,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ADAPTATION,1
MODULE_28,SET,31,-0.19015,-0.0078028,0.13641,0.91833,MODULE_28,1
HP_ABNORMAL_INTERVERTEBRAL_D...,SET,39,-0.18307,-0.0084244,0.13133,0.91833,HP_ABNORMAL_INTERVERTEBRAL_DISK_MORPHOLOGY,1
HP_HYPOPLASIA_OF_THE_CORPUS_...,SET,391,-0.058714,-0.0084724,0.042114,0.91836,HP_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,1
REACTOME_DEGRADATION_OF_GLI1...,SET,57,-0.14132,-0.0078581,0.10136,0.91837,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,1
GOBP_TRANSLATIONAL_READTHROU...,SET,8,-0.46244,-0.0096461,0.33167,0.91837,GOBP_TRANSLATIONAL_READTHROUGH,1
ZNF34_TARGET_GENES,SET,213,-0.080583,-0.0086249,0.05778,0.91843,ZNF34_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...505,SET,43,-0.19477,-0.0094101,0.13964,0.91846,GOBP_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,1
GOBP_MOTOR_NEURON_MIGRATION,SET,12,-0.41653,-0.01064,0.29852,0.91853,GOBP_MOTOR_NEURON_MIGRATION,1
HP_ABNORMAL_LONG_BONE_MORPHO...,SET,686,-0.045883,-0.0086976,0.032872,0.9186,HP_ABNORMAL_LONG_BONE_MORPHOLOGY,1
GSE9650_NAIVE_VS_MEMORY_CD8_...2,SET,184,-0.089002,-0.0088609,0.063749,0.91866,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
REACTOME_CHL1_INTERACTIONS,SET,8,-0.50914,-0.01062,0.36462,0.91869,REACTOME_CHL1_INTERACTIONS,1
HP_CHILDHOOD_ONSET,SET,774,-0.043775,-0.0087922,0.031342,0.91873,HP_CHILDHOOD_ONSET,1
GNF2_SERPINB5,SET,27,-0.24431,-0.0093572,0.17487,0.9188,GNF2_SERPINB5,1
GSE36392_EOSINOPHIL_VS_MAC_I...2,SET,176,-0.092644,-0.0090227,0.066296,0.91885,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP,1
KEGG_MEDICUS_VARIANT_EML4_AL...2,SET,8,-0.42586,-0.0088833,0.3046,0.91895,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_IN...7,SET,24,-0.26847,-0.0096956,0.192,0.91898,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_BETA,1
MCCLUNG_DELTA_FOSB_TARGETS_8...,SET,45,-0.17591,-0.0086937,0.12578,0.91902,MCCLUNG_DELTA_FOSB_TARGETS_8WK,1
GOMF_HISTONE_H4K20_METHYLTRA...,SET,6,-0.47721,-0.0086211,0.34108,0.9191,GOMF_HISTONE_H4K20_METHYLTRANSFERASE_ACTIVITY,1
GOBP_TRUNK_SEGMENTATION,SET,5,-0.55566,-0.009164,0.39712,0.91912,GOBP_TRUNK_SEGMENTATION,1
GOCC_SPECIFIC_GRANULE,SET,148,-0.099284,-0.0088737,0.070954,0.91913,GOCC_SPECIFIC_GRANULE,1
GOBP_MITOCHONDRIAL_CALCIUM_I...1,SET,21,-0.2712,-0.0091621,0.1938,0.91914,GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS,1
HP_APLASIA_HYPOPLASIA_INVOLV...15,SET,42,-0.19758,-0.0094345,0.14119,0.91914,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETAL_MUSCULATURE,1
GSE37533_PPARG1_FOXP3_VS_PPA...1,SET,183,-0.08675,-0.0086134,0.06199,0.91915,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN,1
GOMF_ESTROGEN_16_ALPHA_HYDRO...,SET,8,-0.51429,-0.010728,0.36749,0.91916,GOMF_ESTROGEN_16_ALPHA_HYDROXYLASE_ACTIVITY,1
TGCTTTG_MIR330,SET,296,-0.071022,-0.0089405,0.050738,0.9192,TGCTTTG_MIR330,1
MATTHEWS_SKIN_CARCINOGENESIS...,SET,17,-0.30174,-0.0091728,0.21555,0.91921,MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,1
HP_INFANTILE_ONSET,SET,1172,-0.035796,-0.0087466,0.02557,0.91922,HP_INFANTILE_ONSET,1
GOCC_PEPTIDASE_COMPLEX,SET,115,-0.10364,-0.0081726,0.074026,0.91924,GOCC_PEPTIDASE_COMPLEX,1
MYLLYKANGAS_AMPLIFICATION_HO...12,SET,10,-0.39417,-0.0091921,0.28151,0.91926,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,1
SNIJDERS_AMPLIFIED_IN_HEAD_A...,SET,37,-0.21999,-0.0098609,0.15707,0.91932,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,1
REACTOME_DISINHIBITION_OF_SN...,SET,5,-0.50008,-0.0082474,0.35705,0.91932,REACTOME_DISINHIBITION_OF_SNARE_FORMATION,1
GOBP_NEURAL_PRECURSOR_CELL_P...,SET,157,-0.099849,-0.0091893,0.071282,0.91935,GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
BIOCARTA_MITR_PATHWAY,SET,5,-0.57887,-0.0095467,0.41317,0.91939,BIOCARTA_MITR_PATHWAY,1
HP_ABNORMAL_AUDITORY_EVOKED_...,SET,22,-0.25973,-0.0089811,0.18538,0.9194,HP_ABNORMAL_AUDITORY_EVOKED_POTENTIALS,1
GOBP_ANTIGEN_PROCESSING_AND_...1,SET,105,-0.1294,-0.0097528,0.092347,0.91942,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION,1
REACTOME_PTK6_PROMOTES_HIF1A...,SET,6,-0.53356,-0.0096391,0.38061,0.91951,REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION,1
GOBP_CARBOHYDRATE_BIOSYNTHET...,SET,186,-0.088902,-0.0088984,0.063411,0.91953,GOBP_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,1
GOMF_UDP_GLYCOSYLTRANSFERASE...,SET,132,-0.11546,-0.0097503,0.08235,0.91955,GOMF_UDP_GLYCOSYLTRANSFERASE_ACTIVITY,1
GSE29618_MONOCYTE_VS_PDC_UP,SET,185,-0.094383,-0.0094218,0.067306,0.91958,GSE29618_MONOCYTE_VS_PDC_UP,1
TTGCACT_MIR130A_MIR301_MIR13...,SET,352,-0.063697,-0.0087305,0.045406,0.91966,TTGCACT_MIR130A_MIR301_MIR130B,1
GOBP_IMPORT_INTO_THE_MITOCHO...,SET,46,-0.16358,-0.0081737,0.1166,0.91967,GOBP_IMPORT_INTO_THE_MITOCHONDRION,1
GSE21927_BALBC_VS_C57BL6_MON...3,SET,160,-0.092185,-0.0085639,0.065702,0.91969,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN,1
SCHERER_PBMC_YF_VAX_AGE_18_4...1,SET,222,-0.07834,-0.008558,0.05581,0.91979,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN,1
GSE25088_WT_VS_STAT6_KO_MACR...5,SET,183,-0.084894,-0.0084291,0.060475,0.9198,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP,1
MIR302A_5P,SET,175,-0.092969,-0.0090288,0.066217,0.91983,MIR302A_5P,1
GNF2_FOS,SET,34,-0.21653,-0.0093046,0.15422,0.91984,GNF2_FOS,1
HP_COLPOCEPHALY,SET,28,-0.21984,-0.0085743,0.15656,0.91985,HP_COLPOCEPHALY,1
HP_RESPIRATORY_INSUFFICIENCY,SET,561,-0.050794,-0.008738,0.036164,0.91991,HP_RESPIRATORY_INSUFFICIENCY,1
HP_ABNORMAL_CIRCULATING_COPP...,SET,11,-0.37071,-0.0090667,0.26387,0.91996,HP_ABNORMAL_CIRCULATING_COPPER_CONCENTRATION,1
HP_ABNORMAL_5TH_FINGER_MORPH...,SET,435,-0.057501,-0.0087412,0.040924,0.91999,HP_ABNORMAL_5TH_FINGER_MORPHOLOGY,1
HEDVAT_ELF4_TARGETS_UP,SET,12,-0.40942,-0.010458,0.29138,0.92,HEDVAT_ELF4_TARGETS_UP,1
GSE17721_ALL_VS_24H_PAM3CSK4...2,SET,179,-0.090284,-0.0088667,0.064246,0.92002,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP,1
FRANCO_BLOOD_SANOFI_PASTEUR_...3,SET,24,-0.25167,-0.0090887,0.17907,0.92005,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_NEGATIVE,1
MIR6762_3P,SET,115,-0.10844,-0.0085508,0.077149,0.92006,MIR6762_3P,1
GOBP_REGULATION_OF_GLUCOCORT...4,SET,10,-0.38986,-0.0090916,0.27731,0.92011,GOBP_REGULATION_OF_GLUCOCORTICOID_SECRETION,1
KOINUMA_TARGETS_OF_SMAD2_OR_...,SET,773,-0.045136,-0.0090601,0.032103,0.92012,KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,1
GOCC_MICROBODY,SET,132,-0.1039,-0.0087742,0.07389,0.92016,GOCC_MICROBODY,1
WP_SEROTONIN_AND_ANXIETYRELA...,SET,12,-0.39907,-0.010194,0.28374,0.92019,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,1
MORF_IL9,SET,86,-0.13489,-0.0092061,0.09591,0.9202,MORF_IL9,1
GOBP_POSITIVE_REGULATION_OF_...306,SET,33,-0.22753,-0.0096328,0.16178,0.9202,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...4,SET,108,-0.12099,-0.0092479,0.086018,0.92022,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,1
GOBP_ATP_SYNTHESIS_COUPLED_E...,SET,81,-0.11825,-0.0078328,0.084062,0.92023,GOBP_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,1
GOBP_MITOCHONDRIAL_PROTEIN_C...,SET,9,-0.33062,-0.0073147,0.23503,0.92023,GOBP_MITOCHONDRIAL_PROTEIN_CATABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_CHIN,SET,336,-0.066285,-0.0088803,0.047122,0.92023,HP_ABNORMALITY_OF_THE_CHIN,1
HP_PERIPHERAL_PULMONARY_ARTE...,SET,30,-0.24651,-0.0099517,0.17511,0.92039,HP_PERIPHERAL_PULMONARY_ARTERY_STENOSIS,1
FLORIO_NEOCORTEX_BASAL_RADIA...2,SET,339,-0.07107,-0.009563,0.050482,0.9204,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,1
KEGG_MEDICUS_REFERENCE_ERK_R...,SET,4,-0.6538,-0.0096444,0.46439,0.92041,KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING,1
GSE36891_UNSTIM_VS_PAM_TLR2_...1,SET,143,-0.097551,-0.0085714,0.069282,0.92043,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,1
REACTOME_PEPTIDE_HORMONE_BIO...,SET,13,-0.35527,-0.0094456,0.25224,0.92049,REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS,1
HP_ABNORMALITY_OF_THE_PROXIM...2,SET,7,-0.43624,-0.0085123,0.30968,0.92053,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_THUMB,1
AIZARANI_LIVER_C13_LSECS_2,SET,255,-0.083439,-0.0097601,0.059204,0.92062,AIZARANI_LIVER_C13_LSECS_2,1
RBL1_TARGET_GENES,SET,36,-0.20375,-0.0090087,0.14456,0.92063,RBL1_TARGET_GENES,1
GOBP_REGULATION_OF_NEURONAL_...2,SET,53,-0.16742,-0.0089777,0.11877,0.92066,GOBP_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY,1
GSE31082_DN_VS_CD8_SP_THYMOC...2,SET,176,-0.085836,-0.0083596,0.060896,0.92066,GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP,1
GSE2770_UNTREATED_VS_IL12_TR...1,SET,172,-0.088594,-0.0085306,0.062832,0.92072,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
HP_STEATORRHEA,SET,61,-0.16564,-0.0095272,0.11747,0.92074,HP_STEATORRHEA,1
GOBP_REGULATION_OF_PROTEIN_P...2,SET,22,-0.26531,-0.0091741,0.18812,0.92077,GOBP_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,1
MIR4797_3P,SET,94,-0.12027,-0.0085796,0.08527,0.92079,MIR4797_3P,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...6,SET,19,-0.31868,-0.010241,0.22594,0.92079,GOBP_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT,1
BERENJENO_TRANSFORMED_BY_RHO...1,SET,354,-0.064632,-0.0088833,0.045819,0.92081,BERENJENO_TRANSFORMED_BY_RHOA_DN,1
GOCC_NASCENT_POLYPEPTIDE_ASS...,SET,4,-0.52078,-0.0076822,0.36909,0.92087,GOCC_NASCENT_POLYPEPTIDE_ASSOCIATED_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...677,SET,5,-0.6009,-0.0099101,0.4257,0.92095,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MIGRATION,1
HP_HYPERTRICHOSIS,SET,234,-0.078391,-0.0087891,0.055524,0.92099,HP_HYPERTRICHOSIS,1
GSE15930_NAIVE_VS_24H_IN_VIT...6,SET,187,-0.089649,-0.008997,0.063489,0.92102,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP,1
GOBP_ESTABLISHMENT_OR_MAINTE...4,SET,22,-0.25902,-0.0089565,0.18343,0.92103,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY,1
GOBP_STRIATED_MUSCLE_CELL_AP...,SET,42,-0.18589,-0.0088764,0.13163,0.92105,GOBP_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
MURAKAMI_UV_RESPONSE_6HR_UP,SET,31,-0.21869,-0.0089743,0.15485,0.92106,MURAKAMI_UV_RESPONSE_6HR_UP,1
STARK_HYPPOCAMPUS_22Q11_DELE...2,SET,46,-0.18841,-0.0094143,0.13338,0.9211,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,1
GOBP_POSITIVE_REGULATION_OF_...468,SET,19,-0.29638,-0.0095248,0.20982,0.9211,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION,1
MIR26A_2_3P,SET,66,-0.14458,-0.0086487,0.10235,0.92111,MIR26A_2_3P,1
GSE17721_CTRL_VS_CPG_12H_BMD...2,SET,183,-0.089844,-0.0089206,0.063599,0.92111,GSE17721_CTRL_VS_CPG_12H_BMDC_UP,1
HP_HEAD_TREMOR,SET,39,-0.19221,-0.0088449,0.13604,0.92114,HP_HEAD_TREMOR,1
HP_EXTRAPYRAMIDAL_MUSCULAR_R...,SET,13,-0.3471,-0.0092284,0.24558,0.92122,HP_EXTRAPYRAMIDAL_MUSCULAR_RIGIDITY,1
DURANTE_ADULT_OLFACTORY_NEUR...20,SET,27,-0.26227,-0.010045,0.18555,0.92124,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_COLUMNAR_CELLS,1
MEISSNER_NPC_HCP_WITH_H3K27M...,SET,76,-0.1561,-0.010017,0.11042,0.92126,MEISSNER_NPC_HCP_WITH_H3K27ME3,1
HE_LIM_SUN_FETAL_LUNG_C3_DEF...3,SET,102,-0.11958,-0.0088836,0.08457,0.9213,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_RETICULOCYTE,1
REACTOME_FREE_FATTY_ACIDS_RE...,SET,10,-0.42077,-0.0098126,0.29758,0.92131,REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...788,SET,8,-0.43745,-0.0091249,0.30938,0.92131,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,1
GOCC_SWR1_COMPLEX,SET,13,-0.29008,-0.0077122,0.20513,0.92133,GOCC_SWR1_COMPLEX,1
GOMF_MRNA_3_UTR_AU_RICH_REGI...,SET,28,-0.22465,-0.0087619,0.15885,0.92135,GOMF_MRNA_3_UTR_AU_RICH_REGION_BINDING,1
KEGG_MEDICUS_REFERENCE_LEWIS...,SET,5,-0.65028,-0.010725,0.45977,0.92136,KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS,1
HP_OPTIC_DISC_DRUSEN,SET,12,-0.37894,-0.0096799,0.26792,0.92137,HP_OPTIC_DISC_DRUSEN,1
GOBP_REGULATION_OF_HEART_CON...,SET,190,-0.0952,-0.0096296,0.067303,0.92138,GOBP_REGULATION_OF_HEART_CONTRACTION,1
DESCARTES_FETAL_KIDNEY_ERYTH...,SET,129,-0.109,-0.0091,0.077055,0.92139,DESCARTES_FETAL_KIDNEY_ERYTHROBLASTS,1
RUTELLA_RESPONSE_TO_HGF_DN,SET,217,-0.084049,-0.0090789,0.059408,0.92143,RUTELLA_RESPONSE_TO_HGF_DN,1
WP_GPR143_IN_MELANOCYTES_AND...,SET,29,-0.2364,-0.0093831,0.16708,0.92144,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,1
WTTGKCTG_UNKNOWN,SET,455,-0.059501,-0.0092457,0.042041,0.9215,WTTGKCTG_UNKNOWN,1
MIR1255B_2_3P,SET,78,-0.12972,-0.0084329,0.09165,0.92151,MIR1255B_2_3P,1
MIR194_5P,SET,179,-0.091501,-0.0089862,0.064639,0.92154,MIR194_5P,1
BIOCARTA_CTBP1_PATHWAY,SET,8,-0.42526,-0.0088707,0.30041,0.92155,BIOCARTA_CTBP1_PATHWAY,1
GOMF_SULFURIC_ESTER_HYDROLAS...,SET,11,-0.39859,-0.0097486,0.28154,0.92157,GOMF_SULFURIC_ESTER_HYDROLASE_ACTIVITY,1
HP_PULMONARY_INTERSTITIAL_TH...,SET,7,-0.51748,-0.010097,0.36551,0.92157,HP_PULMONARY_INTERSTITIAL_THICKENING,1
HP_HYPOPLASTIC_ANEMIA,SET,6,-0.43444,-0.0078485,0.30685,0.92158,HP_HYPOPLASTIC_ANEMIA,1
GOMF_SEMAPHORIN_RECEPTOR_ACT...,SET,10,-0.42271,-0.0098576,0.2985,0.92162,GOMF_SEMAPHORIN_RECEPTOR_ACTIVITY,1
REACTOME_LTC4_CYSLTR_MEDIATE...,SET,6,-0.50498,-0.0091228,0.35651,0.92167,REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION,1
MODULE_80,SET,32,-0.24427,-0.010184,0.17245,0.92168,MODULE_80,1
GOMF_MODIFICATION_DEPENDENT_...,SET,156,-0.09088,-0.0083374,0.064151,0.9217,GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
GOBP_MITOCHONDRIAL_FISSION,SET,37,-0.21005,-0.0094153,0.14826,0.92171,GOBP_MITOCHONDRIAL_FISSION,1
HP_PERIPHERAL_DEMYELINATION,SET,40,-0.19463,-0.0090704,0.13736,0.92175,HP_PERIPHERAL_DEMYELINATION,1
WEBER_METHYLATED_ICP_IN_FIBR...,SET,16,-0.32938,-0.0097144,0.23243,0.92176,WEBER_METHYLATED_ICP_IN_FIBROBLAST,1
MIR4697_5P,SET,14,-0.35349,-0.0097528,0.24946,0.92176,MIR4697_5P,1
WP_ARYL_HYDROCARBON_RECEPTOR...1,SET,46,-0.17804,-0.0088963,0.12563,0.92178,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1
MOREAUX_B_LYMPHOCYTE_MATURAT...2,SET,72,-0.15297,-0.0095556,0.10792,0.9218,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,1
HP_SKIN_TAGS,SET,72,-0.14049,-0.0087761,0.099117,0.92181,HP_SKIN_TAGS,1
GOBP_NEGATIVE_REGULATION_OF_...627,SET,20,-0.27293,-0.0089986,0.19251,0.92185,GOBP_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
BIOCARTA_LDL_PATHWAY,SET,6,-0.58655,-0.010596,0.41369,0.92187,BIOCARTA_LDL_PATHWAY,1
GOBP_LEUKOTRIENE_D4_BIOSYNTH...,SET,5,-0.56252,-0.0092772,0.39675,0.92187,GOBP_LEUKOTRIENE_D4_BIOSYNTHETIC_PROCESS,1
GOBP_PREASSEMBLY_OF_GPI_ANCH...,SET,7,-0.40665,-0.0079348,0.28681,0.92187,GOBP_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE,1
GOMF_GLUTATHIONE_HYDROLASE_A...,SET,5,-0.56252,-0.0092772,0.39675,0.92187,GOMF_GLUTATHIONE_HYDROLASE_ACTIVITY,1
HP_FACIAL_DIPLEGIA,SET,39,-0.186,-0.0085592,0.13116,0.92191,HP_FACIAL_DIPLEGIA,1
GSE3039_NKT_CELL_VS_ALPHABET...1,SET,174,-0.092723,-0.0089794,0.065381,0.92192,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN,1
GOMF_14_3_3_PROTEIN_BINDING,SET,29,-0.22768,-0.0090371,0.16053,0.92193,GOMF_14_3_3_PROTEIN_BINDING,1
GOBP_REGULATION_OF_T_CELL_CO...,SET,4,-0.66637,-0.0098299,0.46982,0.92195,GOBP_REGULATION_OF_T_CELL_COSTIMULATION,1
HP_CHRONIC_BRONCHITIS,SET,21,-0.24892,-0.0084094,0.17548,0.92197,HP_CHRONIC_BRONCHITIS,1
NABA_MATRISOME_MULTIPLE_MYEL...,SET,9,-0.47743,-0.010563,0.33654,0.92199,NABA_MATRISOME_MULTIPLE_MYELOMA,1
HP_ABNORMAL_CIRCULATING_AMIN...,SET,150,-0.099033,-0.0089104,0.069809,0.92199,HP_ABNORMAL_CIRCULATING_AMINO_ACID_CONCENTRATION,1
HP_FACIAL_HYPERTRICHOSIS,SET,174,-0.091462,-0.0088573,0.064458,0.92203,HP_FACIAL_HYPERTRICHOSIS,1
GSE14308_TH2_VS_NAIVE_CD4_TC...1,SET,178,-0.086313,-0.0084532,0.060818,0.92207,GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN,1
BUSSLINGER_DUODENAL_DIFFEREN...,SET,267,-0.073545,-0.0088,0.05182,0.92208,BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS,1
ZSCAN5C_TARGET_GENES,SET,111,-0.11975,-0.0092787,0.084375,0.92209,ZSCAN5C_TARGET_GENES,1
HP_DECREASED_ACTIVITY_OF_MIT...2,SET,86,-0.11797,-0.008051,0.083111,0.9221,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_I,1
GR_Q6,SET,234,-0.082381,-0.0092364,0.058032,0.92212,GR_Q6,1
GOMF_LONG_CHAIN_FATTY_ACID_C...,SET,14,-0.30375,-0.0083806,0.21398,0.92212,GOMF_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
FERRANDO_HOX11_NEIGHBORS,SET,22,-0.27612,-0.0095476,0.19448,0.92216,FERRANDO_HOX11_NEIGHBORS,1
GOBP_MITOCHONDRIAL_FRAGMENTA...,SET,10,-0.41534,-0.0096859,0.29254,0.92216,GOBP_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS,1
QUEREC_MODEL_PBMC_YF_17D_VAC...2,SET,35,-0.1981,-0.0086367,0.13952,0.92217,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45_7DY_PREDICTIVE,1
HP_ANNULAR_PANCREAS,SET,25,-0.25513,-0.0094033,0.17967,0.92218,HP_ANNULAR_PANCREAS,1
GOBP_PURINE_DEOXYRIBONUCLEOS...1,SET,5,-0.64863,-0.010697,0.45665,0.92225,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_UPPER_...1,SET,65,-0.15821,-0.0093922,0.11136,0.92229,HP_ABNORMALITY_OF_THE_UPPER_ARM,1
MIR6828_5P,SET,159,-0.097272,-0.0090085,0.068465,0.9223,MIR6828_5P,1
GOBP_NEURON_MIGRATION,SET,166,-0.10128,-0.0095823,0.071278,0.92233,GOBP_NEURON_MIGRATION,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...2,SET,36,-0.19186,-0.0084834,0.13502,0.92234,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY,1
HP_IRREGULAR_EPIPHYSES,SET,21,-0.26519,-0.0089593,0.18662,0.92234,HP_IRREGULAR_EPIPHYSES,1
GAVISH_3CA_METAPROGRAM_EPITH...12,SET,46,-0.18808,-0.009398,0.13234,0.92236,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_2,1
HOFT_CD4_POSITIVE_ALPHA_BETA...4,SET,37,-0.20089,-0.0090048,0.14133,0.9224,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_UP,1
MIR19B_3P,SET,594,-0.052111,-0.0092159,0.036657,0.92242,MIR19B_3P,1
REACTOME_ASYMMETRIC_LOCALIZA...,SET,61,-0.14805,-0.0085154,0.10414,0.92243,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1
chr4q31,SET,62,-0.28049,-0.016264,0.19726,0.92247,chr4q31,1
HP_ABNORMAL_CIRCULATING_THYR...2,SET,31,-0.22048,-0.0090478,0.15505,0.92248,HP_ABNORMAL_CIRCULATING_THYROID_HORMONE_CONCENTRATION,1
HP_ABNORMAL_FEMORAL_NECK_HEA...,SET,180,-0.090953,-0.0089571,0.063958,0.92249,HP_ABNORMAL_FEMORAL_NECK_HEAD_MORPHOLOGY,1
ZSCAN5B_TARGET_GENES,SET,48,-0.17792,-0.009081,0.12509,0.92253,ZSCAN5B_TARGET_GENES,1
GHANDHI_DIRECT_IRRADIATION_DN,SET,32,-0.23907,-0.009967,0.16804,0.92257,GHANDHI_DIRECT_IRRADIATION_DN,1
CHARAFE_BREAST_CANCER_LUMINA...3,SET,425,-0.063292,-0.009513,0.044486,0.92259,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,1
GOBP_CITRATE_METABOLIC_PROCE...,SET,5,-0.49446,-0.0081547,0.34747,0.92262,GOBP_CITRATE_METABOLIC_PROCESS,1
HP_EPISODIC_ATAXIA,SET,24,-0.26087,-0.0094209,0.18333,0.92262,HP_EPISODIC_ATAXIA,1
GSE19923_E2A_KO_VS_HEB_AND_E...1,SET,164,-0.10057,-0.0094581,0.070672,0.92264,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,1
HSF4_TARGET_GENES,SET,5,-0.59445,-0.0098038,0.41769,0.92265,HSF4_TARGET_GENES,1
MED16_TARGET_GENES,SET,19,-0.28881,-0.0092815,0.20294,0.92265,MED16_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C7_FGF...,SET,45,-0.18445,-0.0091158,0.1296,0.92265,HE_LIM_SUN_FETAL_LUNG_C7_FGFBP2_POS_NEURAL_PROGENITOR_CELL,1
KEGG_MEDICUS_REFERENCE_CA2_P...2,SET,14,-0.31684,-0.0087416,0.22261,0.92267,KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY,1
GSE360_T_GONDII_VS_M_TUBERCU...2,SET,178,-0.094108,-0.0092167,0.066098,0.92273,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP,1
KEGG_MEDICUS_REFERENCE_IGF_I...2,SET,15,-0.31655,-0.0090399,0.2223,0.92277,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...571,SET,26,-0.256,-0.0096221,0.17972,0.92283,GOBP_POSITIVE_REGULATION_OF_P38MAPK_CASCADE,1
HP_DRY_HAIR,SET,16,-0.30576,-0.0090179,0.21464,0.92284,HP_DRY_HAIR,1
GSE4142_GC_BCELL_VS_MEMORY_B...2,SET,182,-0.091758,-0.0090859,0.064412,0.92285,GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP,1
RUAN_RESPONSE_TO_TNF_TROGLIT...1,SET,36,-0.21933,-0.0096977,0.15393,0.92289,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1
HP_AGENESIS_OF_CORPUS_CALLOS...,SET,301,-0.068993,-0.0087569,0.048421,0.92289,HP_AGENESIS_OF_CORPUS_CALLOSUM,1
GOBP_CELL_SURFACE_RECEPTOR_P...2,SET,582,-0.053354,-0.0093432,0.037443,0.9229,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY,1
WP_COMPLEMENTMEDIATED_INFLAM...,SET,10,-0.40585,-0.0094646,0.28476,0.92295,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,1
GOMF_G_PROTEIN_COUPLED_OPIOI...,SET,7,-0.46839,-0.0091395,0.32861,0.92296,GOMF_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_ACTIVITY,1
REACTOME_ION_TRANSPORT_BY_P_...,SET,51,-0.17657,-0.0092884,0.12381,0.92307,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,1
GOBP_POSITIVE_REGULATION_OF_...262,SET,14,-0.36875,-0.010174,0.25853,0.9231,GOBP_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,1
ZNF561_TARGET_GENES,SET,689,-0.047407,-0.0090054,0.033236,0.92311,ZNF561_TARGET_GENES,1
GOBP_PEROXISOMAL_TRANSPORT,SET,19,-0.25513,-0.0081989,0.17883,0.92314,GOBP_PEROXISOMAL_TRANSPORT,1
GOBP_VITAMIN_D_BIOSYNTHETIC_...,SET,10,-0.40158,-0.0093649,0.28148,0.92316,GOBP_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
GSE2770_IL12_VS_IL4_TREATED_...4,SET,182,-0.088431,-0.0087565,0.061983,0.92316,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
MIR5187_5P,SET,98,-0.12081,-0.0087983,0.084663,0.92319,MIR5187_5P,1
HP_ABNORMAL_OVARIAN_PHYSIOLO...,SET,87,-0.12627,-0.0086675,0.088485,0.92321,HP_ABNORMAL_OVARIAN_PHYSIOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...392,SET,6,-0.53963,-0.0097488,0.37806,0.92325,GOBP_NEGATIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,1
MIR19A_3P,SET,592,-0.052413,-0.0092542,0.036707,0.92333,MIR19A_3P,1
MODULE_427,SET,100,-0.119,-0.0087541,0.083331,0.92335,MODULE_427,1
MODULE_160,SET,2,-0.77884,-0.0081244,0.54534,0.92337,MODULE_160,1
GOMF_AMINOPEPTIDASE_ACTIVITY,SET,36,-0.21155,-0.009354,0.14813,0.92337,GOMF_AMINOPEPTIDASE_ACTIVITY,1
GOBP_ION_CHANNEL_MODULATING_...,SET,8,-0.46545,-0.009709,0.3258,0.92343,GOBP_ION_CHANNEL_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GSE12845_IGD_POS_BLOOD_VS_NA...2,SET,160,-0.089449,-0.0083097,0.062612,0.92343,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,1
GSE21063_CTRL_VS_ANTI_IGM_ST...10,SET,185,-0.091807,-0.0091646,0.064264,0.92343,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP,1
HOEK_MONOCYTE_2011_2012_TIV_...5,SET,9,-0.48256,-0.010676,0.33777,0.92344,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_DN,1
CREB_Q3,SET,238,-0.080249,-0.0090729,0.056161,0.92347,CREB_Q3,1
GNF2_S100A4,SET,44,-0.18785,-0.0091806,0.13147,0.92347,GNF2_S100A4,1
GSE20715_0H_VS_48H_OZONE_TLR...2,SET,187,-0.091103,-0.0091429,0.063755,0.92348,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP,1
GOBP_AXO_DENDRITIC_PROTEIN_T...,SET,9,-0.4107,-0.0090864,0.28738,0.92351,GOBP_AXO_DENDRITIC_PROTEIN_TRANSPORT,1
WP_GLUCOSE_METABOLISM_IN_TRI...,SET,8,-0.44859,-0.0093573,0.31374,0.92361,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,1
REACTOME_PDH_COMPLEX_SYNTHES...,SET,4,-0.72708,-0.010725,0.50844,0.92363,REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR,1
GOMF_PYRUVATE_DEHYDROGENASE_...3,SET,4,-0.72708,-0.010725,0.50844,0.92363,GOMF_PYRUVATE_DEHYDROGENASE_ACTIVITY,1
GOBP_ONE_CARBON_METABOLIC_PR...,SET,36,-0.2098,-0.0092766,0.14668,0.92369,GOBP_ONE_CARBON_METABOLIC_PROCESS,1
GSE1791_CTRL_VS_NEUROMEDINU_...7,SET,175,-0.089746,-0.0087158,0.062734,0.92371,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN,1
HP_AKINESIA,SET,37,-0.19812,-0.0088805,0.13846,0.92376,HP_AKINESIA,1
HP_ABNORMALITIES_OF_PLACENTA...,SET,103,-0.12498,-0.0093298,0.087332,0.92378,HP_ABNORMALITIES_OF_PLACENTA_OR_UMBILICAL_CORD,1
GINESTIER_BREAST_CANCER_ZNF2...2,SET,63,-0.14702,-0.0085931,0.10273,0.92379,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,1
GOBP_UREA_TRANSPORT,SET,10,-0.48023,-0.011199,0.33556,0.92379,GOBP_UREA_TRANSPORT,1
MIR6791_3P,SET,76,-0.14481,-0.0092928,0.10118,0.92381,MIR6791_3P,1
MIR6866_3P,SET,66,-0.15449,-0.0092413,0.10793,0.92384,MIR6866_3P,1
GOMF_MAGNESIUM_ION_TRANSMEMB...,SET,13,-0.33782,-0.0089815,0.23594,0.92389,GOMF_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE17186_NAIVE_VS_CD21HIGH_T...2,SET,176,-0.08879,-0.0086473,0.062014,0.92389,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,1
HE_LIM_SUN_FETAL_LUNG_C0_RES...,SET,98,-0.13792,-0.010044,0.096308,0.92393,HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE,1
GOBP_NEGATIVE_REGULATION_OF_...672,SET,45,-0.19274,-0.0095257,0.13453,0.92402,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...691,SET,13,-0.33459,-0.0088957,0.23349,0.92406,GOBP_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY,1
GSE13306_TREG_VS_TCONV_SPLEE...2,SET,183,-0.096173,-0.0095489,0.067114,0.92406,GSE13306_TREG_VS_TCONV_SPLEEN_UP,1
MAINA_VHL_TARGETS_UP,SET,10,-0.43432,-0.010128,0.30304,0.92409,MAINA_VHL_TARGETS_UP,1
GSE17721_4_VS_24H_GARDIQUIMO...2,SET,179,-0.092511,-0.0090854,0.064549,0.92409,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP,1
MIR203A_3P,SET,334,-0.069722,-0.0093135,0.048639,0.92413,MIR203A_3P,1
GOBP_CARDIAC_SEPTUM_MORPHOGE...,SET,68,-0.17094,-0.010379,0.11923,0.92416,GOBP_CARDIAC_SEPTUM_MORPHOGENESIS,1
GOMF_ENDONUCLEASE_ACTIVITY_A...2,SET,33,-0.21202,-0.0089764,0.14788,0.92416,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,1
LAKE_ADULT_KIDNEY_C10_THIN_A...,SET,317,-0.069834,-0.0090922,0.048708,0.92417,LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB,1
REACTOME_PTEN_REGULATION,SET,130,-0.10247,-0.008588,0.071467,0.92418,REACTOME_PTEN_REGULATION,1
MIR6894_3P,SET,62,-0.15806,-0.0091649,0.11023,0.92418,MIR6894_3P,1
AMIT_EGF_RESPONSE_120_HELA,SET,63,-0.15555,-0.0090918,0.10848,0.9242,AMIT_EGF_RESPONSE_120_HELA,1
HP_FINGER_CLINODACTYLY,SET,387,-0.062974,-0.0090417,0.043916,0.9242,HP_FINGER_CLINODACTYLY,1
WP_MIRNA_BIOGENESIS,SET,6,-0.47698,-0.008617,0.33261,0.92421,WP_MIRNA_BIOGENESIS,1
GOBP_REGULATION_OF_GLUCOSYLC...,SET,2,-0.99038,-0.010331,0.69064,0.92421,GOBP_REGULATION_OF_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,1
HP_LOW_INSERTION_OF_COLUMELLA,SET,7,-0.39781,-0.0077623,0.2774,0.92421,HP_LOW_INSERTION_OF_COLUMELLA,1
SYATTGTG_UNKNOWN,SET,205,-0.089826,-0.0094339,0.062622,0.92426,SYATTGTG_UNKNOWN,1
GOBP_REGULATION_OF_RENAL_SOD...,SET,7,-0.49014,-0.009564,0.34163,0.92431,GOBP_REGULATION_OF_RENAL_SODIUM_EXCRETION,1
MIR888_5P,SET,220,-0.082882,-0.0090138,0.057764,0.92432,MIR888_5P,1
HP_JOINT_SUBLUXATION,SET,26,-0.2471,-0.0092877,0.17216,0.92439,HP_JOINT_SUBLUXATION,1
GSE16450_CTRL_VS_IFNA_6H_STI...4,SET,187,-0.092679,-0.0093011,0.064566,0.92441,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,1
REACTOME_ESTROGEN_BIOSYNTHES...,SET,6,-0.49115,-0.0088729,0.3421,0.92444,REACTOME_ESTROGEN_BIOSYNTHESIS,1
GOBP_RNA_METHYLATION,SET,66,-0.13461,-0.0080521,0.093756,0.92445,GOBP_RNA_METHYLATION,1
GOBP_MYELIN_MAINTENANCE,SET,15,-0.32094,-0.0091651,0.2235,0.92448,GOBP_MYELIN_MAINTENANCE,1
HP_PERIODIC_PARALYSIS,SET,9,-0.43869,-0.0097055,0.30549,0.92449,HP_PERIODIC_PARALYSIS,1
GSE17721_POLYIC_VS_PAM3CSK4_...12,SET,183,-0.087921,-0.0087296,0.061208,0.92455,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP,1
HE_LIM_SUN_FETAL_LUNG_C3_EAR...,SET,593,-0.049351,-0.0087207,0.034356,0.92455,HE_LIM_SUN_FETAL_LUNG_C3_EARLY_CAP_CELL,1
HP_NARROW_NASAL_RIDGE,SET,19,-0.28036,-0.0090099,0.19516,0.92457,HP_NARROW_NASAL_RIDGE,1
BROWN_MYELOID_CELL_DEVELOPME...1,SET,119,-0.11366,-0.0091164,0.079116,0.92458,BROWN_MYELOID_CELL_DEVELOPMENT_DN,1
MORF_UBE2N,SET,82,-0.12429,-0.0082836,0.086513,0.92458,MORF_UBE2N,1
PRC2_SUZ12_UP.V1_UP,SET,165,-0.09817,-0.00926,0.068328,0.9246,PRC2_SUZ12_UP.V1_UP,1
GOBP_CHAPERONE_MEDIATED_PROT...2,SET,72,-0.13523,-0.0084475,0.094113,0.92461,GOBP_CHAPERONE_MEDIATED_PROTEIN_FOLDING,1
HP_ANDROGEN_INSUFFICIENCY,SET,3,-0.67178,-0.0085822,0.46753,0.92461,HP_ANDROGEN_INSUFFICIENCY,1
HP_PRELINGUAL_SENSORINEURAL_...,SET,11,-0.40674,-0.0099479,0.28308,0.92461,HP_PRELINGUAL_SENSORINEURAL_HEARING_IMPAIRMENT,1
MIKKELSEN_ES_HCP_WITH_H3K27M...,SET,38,-0.2205,-0.010016,0.15339,0.92471,MIKKELSEN_ES_HCP_WITH_H3K27ME3,1
KEGG_CALCIUM_SIGNALING_PATHW...,SET,167,-0.098164,-0.0093149,0.068262,0.92478,KEGG_CALCIUM_SIGNALING_PATHWAY,1
GOBP_TRNA_5_LEADER_REMOVAL,SET,11,-0.33051,-0.0080835,0.22982,0.92479,GOBP_TRNA_5_LEADER_REMOVAL,1
MIR4691_3P,SET,90,-0.12983,-0.0090633,0.090264,0.92483,MIR4691_3P,1
GOBP_REGULATION_OF_EPITHELIA...7,SET,100,-0.13126,-0.0096559,0.091248,0.92484,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GOBP_LONG_TERM_SYNAPTIC_DEPR...,SET,30,-0.25223,-0.010182,0.17534,0.92485,GOBP_LONG_TERM_SYNAPTIC_DEPRESSION,1
GSE45365_BCELL_VS_CD8_TCELL_...2,SET,149,-0.10441,-0.0093634,0.072584,0.92485,GSE45365_BCELL_VS_CD8_TCELL_UP,1
WP_MALE_INFERTILITY,SET,132,-0.10871,-0.0091798,0.07556,0.92487,WP_MALE_INFERTILITY,1
GSE36078_WT_VS_IL1R_KO_LUNG_...5,SET,176,-0.090644,-0.0088279,0.062972,0.92498,GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN,1
GSE22611_UNSTIM_VS_6H_MDP_ST...1,SET,174,-0.093352,-0.0090403,0.064847,0.925,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...2,SET,12,-0.38729,-0.0098932,0.26901,0.92501,GOBP_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,1
GOCC_POSTSYNAPTIC_ENDOCYTIC_...,SET,5,-0.607,-0.010011,0.42149,0.92507,GOCC_POSTSYNAPTIC_ENDOCYTIC_ZONE,1
HP_PIGMENTARY_RETINOPATHY,SET,163,-0.094885,-0.0088963,0.065888,0.92507,HP_PIGMENTARY_RETINOPATHY,1
GOBP_G_PROTEIN_COUPLED_OPIOI...,SET,11,-0.39559,-0.0096753,0.27462,0.92513,GOBP_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...174,SET,9,-0.45514,-0.01007,0.31593,0.92515,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS,1
GOBP_CARTILAGE_CONDENSATION,SET,18,-0.32403,-0.010136,0.2249,0.92516,GOBP_CARTILAGE_CONDENSATION,1
MODULE_511,SET,34,-0.20758,-0.00892,0.14407,0.92517,MODULE_511,1
GOMF_DIPEPTIDASE_ACTIVITY,SET,17,-0.30138,-0.0091619,0.20913,0.92522,GOMF_DIPEPTIDASE_ACTIVITY,1
GTGCAAT_MIR25_MIR32_MIR92_MI...,SET,281,-0.075337,-0.0092442,0.052267,0.92525,GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367,1
HP_DELAYED_ABILITY_TO_SIT,SET,76,-0.1409,-0.0090422,0.097756,0.92525,HP_DELAYED_ABILITY_TO_SIT,1
WANG_METASTASIS_OF_BREAST_CA...1,SET,13,-0.33435,-0.0088893,0.23195,0.92527,WANG_METASTASIS_OF_BREAST_CANCER,1
GOCC_DENSE_CORE_GRANULE_MEMB...,SET,7,-0.47608,-0.0092896,0.3302,0.92531,GOCC_DENSE_CORE_GRANULE_MEMBRANE,1
NADLER_OBESITY_DN,SET,47,-0.17315,-0.0087452,0.12009,0.92533,NADLER_OBESITY_DN,1
HP_ANOSMIA,SET,47,-0.19432,-0.0098146,0.13475,0.92536,HP_ANOSMIA,1
GOBP_NEGATIVE_REGULATION_OF_...280,SET,64,-0.1673,-0.0098553,0.11599,0.92538,GOBP_NEGATIVE_REGULATION_OF_HORMONE_SECRETION,1
HP_HIGH_OUTPUT_CONGESTIVE_HE...,SET,6,-0.51635,-0.0093282,0.358,0.92538,HP_HIGH_OUTPUT_CONGESTIVE_HEART_FAILURE,1
GOBP_NEGATIVE_REGULATION_OF_...674,SET,10,-0.37187,-0.0086721,0.25783,0.92539,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,1
KEGG_MEDICUS_VARIANT_EGF_OVE...1,SET,8,-0.44122,-0.0092035,0.30585,0.92542,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_INORGANIC_ION_HOMEOSTAS...,SET,489,-0.059697,-0.0096073,0.041371,0.92548,GOBP_INORGANIC_ION_HOMEOSTASIS,1
chr18q22,SET,23,-0.43395,-0.015342,0.30063,0.92555,chr18q22,1
GOCC_SPERMATOPROTEASOME_COMP...,SET,5,-0.46239,-0.0076258,0.32029,0.92557,GOCC_SPERMATOPROTEASOME_COMPLEX,1
GSE9988_LPS_VS_CTRL_TREATED_...2,SET,163,-0.10457,-0.009804,0.072433,0.92557,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP,1
GOBP_CELLULAR_HYPOTONIC_RESP...,SET,11,-0.39661,-0.0097002,0.27472,0.92558,GOBP_CELLULAR_HYPOTONIC_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...102,SET,8,-0.45862,-0.0095664,0.31761,0.92561,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
TTGGAGA_MIR5155P_MIR519E,SET,123,-0.10935,-0.008916,0.075715,0.92566,TTGGAGA_MIR5155P_MIR519E,1
GOBP_GMP_BIOSYNTHETIC_PROCESS,SET,13,-0.33665,-0.0089506,0.2331,0.92566,GOBP_GMP_BIOSYNTHETIC_PROCESS,1
HP_ELEVATED_SYSTOLIC_BLOOD_P...,SET,13,-0.35042,-0.0093167,0.24251,0.92576,HP_ELEVATED_SYSTOLIC_BLOOD_PRESSURE,1
BAHD1_TARGET_GENES,SET,18,-0.28434,-0.0088943,0.19677,0.92577,BAHD1_TARGET_GENES,1
GSE11961_GERMINAL_CENTER_BCE...1,SET,178,-0.093026,-0.0091107,0.064369,0.92579,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GOMF_1_PHOSPHATIDYLINOSITOL_...5,SET,8,-0.44431,-0.009268,0.30733,0.92586,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_EREG_...2,SET,14,-0.32707,-0.0090238,0.22618,0.92591,KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
HP_EYELID_APRAXIA,SET,5,-0.52898,-0.008724,0.36577,0.92593,HP_EYELID_APRAXIA,1
GOBP_EPIBOLY,SET,39,-0.18346,-0.0084423,0.12682,0.92598,GOBP_EPIBOLY,1
GOBP_MITOCHONDRIAL_CALCIUM_I...2,SET,20,-0.30011,-0.009895,0.2074,0.92604,GOBP_MITOCHONDRIAL_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
HP_SWOLLEN_LIP,SET,6,-0.58854,-0.010632,0.40668,0.92607,HP_SWOLLEN_LIP,1
DESCARTES_FETAL_PANCREAS_STR...,SET,16,-0.33739,-0.0099508,0.23313,0.92607,DESCARTES_FETAL_PANCREAS_STROMAL_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...743,SET,15,-0.32789,-0.0093638,0.22656,0.92608,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
HOEK_PBMC_INACTIVATED_INFLUE...5,SET,16,-0.31125,-0.0091798,0.21506,0.92608,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_DN,1
GOBP_REGULATION_OF_SREBP_SIG...,SET,6,-0.49536,-0.008949,0.34213,0.92616,GOBP_REGULATION_OF_SREBP_SIGNALING_PATHWAY,1
HP_DEVIATION_OF_THE_5TH_TOE,SET,16,-0.31438,-0.0092721,0.21709,0.9262,HP_DEVIATION_OF_THE_5TH_TOE,1
KEGG_MEDICUS_PATHOGEN_SALMON...4,SET,29,-0.23033,-0.0091424,0.15892,0.92637,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
HP_ABNORMAL_PARIETAL_BONE_MO...,SET,28,-0.22039,-0.008596,0.15202,0.92643,HP_ABNORMAL_PARIETAL_BONE_MORPHOLOGY,1
RUVBL1_TARGET_GENES,SET,126,-0.1112,-0.0091755,0.076679,0.92648,RUVBL1_TARGET_GENES,1
MIR5692B_MIR5692C,SET,373,-0.067531,-0.0095227,0.046567,0.92649,MIR5692B_MIR5692C,1
GOCC_ACTOMYOSIN,SET,86,-0.13951,-0.009521,0.096194,0.9265,GOCC_ACTOMYOSIN,1
GOBP_ANAPHASE_PROMOTING_COMP...,SET,22,-0.24347,-0.0084187,0.16783,0.92656,GOBP_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,1
GOMF_NUCLEOTIDE_RECEPTOR_ACT...,SET,17,-0.35325,-0.010739,0.2435,0.92656,GOMF_NUCLEOTIDE_RECEPTOR_ACTIVITY,1
GOCC_MRNA_EDITING_COMPLEX,SET,5,-0.56436,-0.0093075,0.38893,0.92661,GOCC_MRNA_EDITING_COMPLEX,1
HP_ABNORMAL_LIVER_ENZYME_ACT...,SET,11,-0.34366,-0.0084051,0.23671,0.92671,HP_ABNORMAL_LIVER_ENZYME_ACTIVITY_OR_CONCENTRATION,1
PID_A6B1_A6B4_INTEGRIN_PATHW...,SET,46,-0.18855,-0.0094211,0.12984,0.92676,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1
MIR324_5P,SET,39,-0.19363,-0.0089103,0.13334,0.92676,MIR324_5P,1
HP_SIDEROBLASTIC_ANEMIA,SET,32,-0.19539,-0.0081462,0.13456,0.92676,HP_SIDEROBLASTIC_ANEMIA,1
HP_SHORT_GREATER_SCIATIC_NOT...,SET,3,-0.79314,-0.010133,0.54605,0.92681,HP_SHORT_GREATER_SCIATIC_NOTCH,1
GOBP_POSITIVE_REGULATION_OF_...334,SET,5,-0.5897,-0.0097254,0.40598,0.92682,GOBP_POSITIVE_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,1
GOBP_NEGATIVE_REGULATION_OF_...583,SET,153,-0.10708,-0.0097295,0.0737,0.92687,GOBP_NEGATIVE_REGULATION_OF_SECRETION,1
GOBP_G0_TO_G1_TRANSITION,SET,36,-0.20186,-0.0089252,0.13893,0.92688,GOBP_G0_TO_G1_TRANSITION,1
GSE25146_UNSTIM_VS_HELIOBACT...1,SET,149,-0.099325,-0.0089071,0.068339,0.92694,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...33,SET,25,-0.25264,-0.0093118,0.1738,0.92697,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
MODULE_292,SET,120,-0.11678,-0.0094056,0.080322,0.927,MODULE_292,1
HP_ARTERIOVENOUS_FISTULA,SET,10,-0.41264,-0.0096227,0.28382,0.927,HP_ARTERIOVENOUS_FISTULA,1
GCM_BMPR2,SET,78,-0.1372,-0.0089196,0.094363,0.92702,GCM_BMPR2,1
GOBP_POSITIVE_REGULATION_OF_...263,SET,4,-0.56069,-0.008271,0.38555,0.92705,GOBP_POSITIVE_REGULATION_OF_EXIT_FROM_MITOSIS,1
GOBP_LYMPHOCYTE_CHEMOTAXIS,SET,42,-0.20381,-0.0097319,0.14014,0.92706,GOBP_LYMPHOCYTE_CHEMOTAXIS,1
HP_KNEE_CONTRACTURE,SET,98,-0.12979,-0.0094525,0.089222,0.92711,HP_KNEE_CONTRACTURE,1
MIR4462,SET,13,-0.28346,-0.0075362,0.19484,0.92713,MIR4462,1
GOMF_C_X3_C_CHEMOKINE_BINDING,SET,5,-0.60172,-0.0099237,0.41358,0.92714,GOMF_C_X3_C_CHEMOKINE_BINDING,1
HP_PES_PLANUS,SET,310,-0.072108,-0.0092858,0.049562,0.92714,HP_PES_PLANUS,1
GOBP_CELLULAR_RESPONSE_TO_AC...1,SET,14,-0.33805,-0.0093268,0.23235,0.92715,GOBP_CELLULAR_RESPONSE_TO_ACIDIC_PH,1
HP_APLASIA_HYPOPLASIA_OF_THE...68,SET,16,-0.30582,-0.0090196,0.21016,0.92719,HP_APLASIA_HYPOPLASIA_OF_THE_STERNUM,1
GOCC_SUPER_ELONGATION_COMPLEX,SET,5,-0.4958,-0.0081768,0.34065,0.92722,GOCC_SUPER_ELONGATION_COMPLEX,1
HP_ABSENCE_OF_THE_SACRUM,SET,8,-0.4464,-0.0093115,0.3067,0.92722,HP_ABSENCE_OF_THE_SACRUM,1
GOBP_POSITIVE_REGULATION_OF_...820,SET,7,-0.49985,-0.0097533,0.34342,0.92723,GOBP_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
HP_NO_SOCIAL_INTERACTION,SET,5,-0.6908,-0.011393,0.47452,0.92726,HP_NO_SOCIAL_INTERACTION,1
ZNF785_TARGET_GENES,SET,55,-0.16655,-0.0090974,0.11438,0.9273,ZNF785_TARGET_GENES,1
GSE14908_ATOPIC_VS_NONATOPIC...4,SET,176,-0.092173,-0.0089768,0.063295,0.92733,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP,1
GSE13522_CTRL_VS_T_CRUZI_BRA...1,SET,181,-0.09613,-0.0094929,0.065997,0.92737,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN,1
MIR96_3P,SET,65,-0.14915,-0.0088545,0.1024,0.92738,MIR96_3P,1
HP_ABNORMALITY_OF_THE_ORBITA...,SET,1410,-0.034059,-0.0090649,0.02338,0.9274,HP_ABNORMALITY_OF_THE_ORBITAL_REGION,1
GOBP_REGULATION_OF_VITAMIN_D...2,SET,10,-0.37091,-0.0086497,0.25459,0.92742,GOBP_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_CONDENSATION_OF_PRO...2,SET,11,-0.32033,-0.0078345,0.2198,0.92748,REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES,1
HP_SHALLOW_ACETABULAR_FOSSAE,SET,10,-0.37584,-0.0087646,0.2579,0.92748,HP_SHALLOW_ACETABULAR_FOSSAE,1
GSE16522_ANTI_CD3CD28_STIM_V...1,SET,175,-0.09107,-0.0088444,0.062484,0.9275,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN,1
GOBP_REGULATION_OF_FEMALE_RE...,SET,8,-0.49742,-0.010376,0.34127,0.92751,GOBP_REGULATION_OF_FEMALE_RECEPTIVITY,1
MODULE_418,SET,56,-0.16493,-0.0090904,0.11314,0.92753,MODULE_418,1
GOMF_INTRAMOLECULAR_OXIDORED...3,SET,15,-0.31723,-0.0090592,0.21758,0.92756,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS,1
GOBP_MESENCHYMAL_STEM_CELL_P...,SET,7,-0.51775,-0.010103,0.35505,0.9276,GOBP_MESENCHYMAL_STEM_CELL_PROLIFERATION,1
MIR6837_3P,SET,101,-0.12344,-0.0091259,0.08464,0.92763,MIR6837_3P,1
MUELLER_METHYLATED_IN_GLIOBL...,SET,35,-0.20948,-0.009133,0.14363,0.92764,MUELLER_METHYLATED_IN_GLIOBLASTOMA,1
KEGG_MEDICUS_REFERENCE_SEROT...,SET,3,-0.79594,-0.010168,0.54556,0.9277,KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM,1
GOCC_TERTIARY_GRANULE_LUMEN,SET,50,-0.18677,-0.0097285,0.12799,0.92774,GOCC_TERTIARY_GRANULE_LUMEN,1
HP_PERIPHERAL_EDEMA,SET,12,-0.3822,-0.0097632,0.26192,0.92774,HP_PERIPHERAL_EDEMA,1
ATGTAGC_MIR221_MIR222,SET,130,-0.12014,-0.010069,0.082323,0.92776,ATGTAGC_MIR221_MIR222,1
HP_BLUE_SCLERAE,SET,97,-0.12198,-0.0088385,0.083582,0.92776,HP_BLUE_SCLERAE,1
MYBL1_TARGET_GENES,SET,354,-0.06471,-0.008894,0.044339,0.92777,MYBL1_TARGET_GENES,1
HP_ABNORMAL_CIRCULATING_ALDO...1,SET,21,-0.25171,-0.0085039,0.17246,0.92779,HP_ABNORMAL_CIRCULATING_ALDOLASE_CONCENTRATION,1
GOBP_REGULATION_OF_T_CELL_MI...,SET,44,-0.19559,-0.0095589,0.13397,0.92783,GOBP_REGULATION_OF_T_CELL_MIGRATION,1
GOMF_PHOSPHOLIPASE_BINDING,SET,18,-0.30176,-0.0094392,0.20669,0.92784,GOMF_PHOSPHOLIPASE_BINDING,1
GSE14415_INDUCED_TREG_VS_TCO...1,SET,146,-0.10468,-0.0092933,0.071697,0.92785,GSE14415_INDUCED_TREG_VS_TCONV_DN,1
MIR9_5P,SET,436,-0.061395,-0.0093435,0.042042,0.92789,MIR9_5P,1
GOBP_MICROTUBULE_DEPOLYMERIZ...,SET,41,-0.18076,-0.008528,0.12378,0.92789,GOBP_MICROTUBULE_DEPOLYMERIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...323,SET,19,-0.28457,-0.0091452,0.19484,0.92791,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
GOBP_DIOL_BIOSYNTHETIC_PROCE...,SET,20,-0.27429,-0.0090437,0.1878,0.92793,GOBP_DIOL_BIOSYNTHETIC_PROCESS,1
REACTOME_PROCESSIVE_SYNTHESI...1,SET,19,-0.26965,-0.0086657,0.18458,0.92796,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE,1
GSE27786_LIN_NEG_VS_CD8_TCEL...1,SET,185,-0.091011,-0.0090852,0.062297,0.92797,GSE27786_LIN_NEG_VS_CD8_TCELL_DN,1
HP_ABNORMAL_FETAL_PULMONARY_...,SET,8,-0.46389,-0.0096765,0.31746,0.92802,HP_ABNORMAL_FETAL_PULMONARY_MORPHOLOGY,1
GOBP_TOLL_LIKE_RECEPTOR_SIGN...,SET,68,-0.1479,-0.0089798,0.10119,0.92807,GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
LEE_DIFFERENTIATING_T_LYMPHO...,SET,170,-0.093731,-0.0089731,0.064124,0.92808,LEE_DIFFERENTIATING_T_LYMPHOCYTE,1
HP_ABNORMAL_CIRCULATING_SULF...,SET,23,-0.28262,-0.0099917,0.19334,0.92809,HP_ABNORMAL_CIRCULATING_SULFUR_AMINO_ACID_CONCENTRATION,1
GOBP_MITOCHONDRIAL_RNA_METAB...,SET,50,-0.16242,-0.0084602,0.1111,0.92811,GOBP_MITOCHONDRIAL_RNA_METABOLIC_PROCESS,1
GSE22886_NAIVE_CD8_TCELL_VS_...9,SET,184,-0.092056,-0.0091649,0.062971,0.92811,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN,1
MARTIN_NFKB_TARGETS_UP,SET,41,-0.21524,-0.010155,0.14722,0.92812,MARTIN_NFKB_TARGETS_UP,1
GOBP_MAINTENANCE_OF_CENTROSO...,SET,5,-0.4332,-0.0071444,0.29628,0.92814,GOBP_MAINTENANCE_OF_CENTROSOME_LOCATION,1
HP_ABNORMAL_CARDIAC_VENTRICU...,SET,142,-0.10839,-0.009491,0.074133,0.92814,HP_ABNORMAL_CARDIAC_VENTRICULAR_FUNCTION,1
GSE6674_UNSTIM_VS_PL2_3_STIM...2,SET,133,-0.11181,-0.0094774,0.076465,0.92816,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP,1
KEGG_MEDICUS_REFERENCE_LEUCI...,SET,7,-0.45677,-0.0089129,0.31223,0.92825,KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION,1
HP_FLATTENED_EPIPHYSIS,SET,22,-0.25919,-0.0089625,0.17717,0.92825,HP_FLATTENED_EPIPHYSIS,1
GOBP_PROTECTION_FROM_NON_HOM...,SET,9,-0.36399,-0.0080529,0.24873,0.92831,GOBP_PROTECTION_FROM_NON_HOMOLOGOUS_END_JOINING_AT_TELOMERE,1
GOMF_MICROTUBULE_PLUS_END_BI...,SET,21,-0.24993,-0.0084437,0.17076,0.92834,GOMF_MICROTUBULE_PLUS_END_BINDING,1
MALONEY_RESPONSE_TO_17AAG_DN,SET,66,-0.14835,-0.0088741,0.10131,0.92843,MALONEY_RESPONSE_TO_17AAG_DN,1
GOBP_NEGATIVE_REGULATION_OF_...411,SET,83,-0.13277,-0.0089021,0.090642,0.92849,GOBP_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,1
WP_SEROTONIN_AND_ANXIETY,SET,15,-0.36949,-0.010552,0.25222,0.92852,WP_SEROTONIN_AND_ANXIETY,1
GOBP_FATTY_ACID_DERIVATIVE_C...,SET,17,-0.29916,-0.0090946,0.20418,0.92855,GOBP_FATTY_ACID_DERIVATIVE_CATABOLIC_PROCESS,1
GSE19923_E2A_KO_VS_E2A_AND_H...2,SET,194,-0.088499,-0.0090446,0.060404,0.92855,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP,1
GSE6566_STRONG_VS_WEAK_DC_ST...1,SET,156,-0.09957,-0.0091346,0.067947,0.92859,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN,1
GOCC_GOLGI_TRANS_CISTERNA,SET,9,-0.46738,-0.01034,0.31886,0.92864,GOCC_GOLGI_TRANS_CISTERNA,1
HP_NON_MOTOR_SEIZURE,SET,174,-0.095606,-0.0092586,0.065222,0.92865,HP_NON_MOTOR_SEIZURE,1
GOBP_NEGATIVE_REGULATION_OF_...623,SET,6,-0.58452,-0.01056,0.39874,0.92866,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
HP_RETINAL_PIGMENT_EPITHELIA...2,SET,39,-0.20114,-0.0092561,0.13721,0.92866,HP_RETINAL_PIGMENT_EPITHELIAL_MOTTLING,1
REACTOME_METABOLISM_OF_STERO...1,SET,146,-0.10431,-0.0092598,0.071148,0.92867,REACTOME_METABOLISM_OF_STEROIDS,1
MODULE_22,SET,31,-0.19459,-0.0079852,0.13273,0.92867,MODULE_22,1
WP_INTERACTIONS_OF_NATURAL_K...,SET,27,-0.25966,-0.0099453,0.17705,0.92875,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,1
GOBP_SULFUR_COMPOUND_METABOL...,SET,291,-0.077738,-0.0097043,0.053003,0.92876,GOBP_SULFUR_COMPOUND_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_VERTEB...1,SET,1337,-0.034902,-0.009065,0.023796,0.92877,HP_ABNORMALITY_OF_THE_VERTEBRAL_COLUMN,1
GSE11961_GERMINAL_CENTER_BCE...3,SET,184,-0.096464,-0.0096037,0.06576,0.92879,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,1
GSE17721_LPS_VS_POLYIC_8H_BM...1,SET,177,-0.092551,-0.0090389,0.063076,0.92884,GSE17721_LPS_VS_POLYIC_8H_BMDC_DN,1
WP_LEUCINE_ISOLEUCINE_AND_VA...,SET,22,-0.27471,-0.009499,0.18717,0.9289,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,1
GSE3920_IFNA_VS_IFNG_TREATED...3,SET,172,-0.098112,-0.009447,0.066846,0.9289,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN,1
CREIGHTON_ENDOCRINE_THERAPY_...3,SET,650,-0.053195,-0.0098257,0.036237,0.92893,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,1
HP_DERMAL_TRANSLUCENCY,SET,25,-0.2618,-0.0096492,0.17835,0.92893,HP_DERMAL_TRANSLUCENCY,1
CACGTTT_MIR302A,SET,29,-0.23472,-0.0093165,0.15989,0.92894,CACGTTT_MIR302A,1
GSE28726_NAIVE_VS_ACTIVATED_...3,SET,187,-0.09171,-0.0092038,0.062468,0.92895,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN,1
HALLMARK_BILE_ACID_METABOLISM,SET,110,-0.12562,-0.0096896,0.085557,0.92897,HALLMARK_BILE_ACID_METABOLISM,1
HP_CONJUNCTIVAL_HAMARTOMA,SET,10,-0.34441,-0.0080318,0.2345,0.92903,HP_CONJUNCTIVAL_HAMARTOMA,1
HP_NEOPLASM_OF_THE_EAR,SET,22,-0.27197,-0.0094043,0.18517,0.92904,HP_NEOPLASM_OF_THE_EAR,1
KEGG_MEDICUS_VARIANT_MUTATIO...91,SET,38,-0.18435,-0.0083742,0.1255,0.92906,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_REGULATION_OF_T_CIRCLE_...,SET,5,-0.46206,-0.0076204,0.3145,0.9291,GOBP_REGULATION_OF_T_CIRCLE_FORMATION,1
FEKIR_HEPARG_SPHERE_VS_HEPAR...2,SET,95,-0.13451,-0.009646,0.091546,0.92912,FEKIR_HEPARG_SPHERE_VS_HEPARG_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...57,SET,38,-0.19625,-0.0089146,0.13353,0.92917,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_THUMB,1
GOMF_CARBON_OXYGEN_LYASE_ACT...,SET,69,-0.15255,-0.00933,0.10377,0.92922,GOMF_CARBON_OXYGEN_LYASE_ACTIVITY,1
GSE24142_EARLY_THYMIC_PROGEN...12,SET,185,-0.09736,-0.009719,0.06622,0.92924,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP,1
GOBP_NEUTROPHIL_MIGRATION,SET,96,-0.14352,-0.010346,0.097617,0.92925,GOBP_NEUTROPHIL_MIGRATION,1
MIR1226_5P,SET,40,-0.20485,-0.0095466,0.13931,0.92928,MIR1226_5P,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...3,SET,17,-0.34086,-0.010362,0.23179,0.92928,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX,1
HP_ABNORMAL_SECOND_TOE_MORPH...,SET,12,-0.38244,-0.0097692,0.26007,0.92928,HP_ABNORMAL_SECOND_TOE_MORPHOLOGY,1
HP_TRIANGULAR_FACE,SET,145,-0.10525,-0.009312,0.071538,0.92938,HP_TRIANGULAR_FACE,1
ZNF202_TARGET_GENES,SET,64,-0.15734,-0.0092686,0.10693,0.92939,ZNF202_TARGET_GENES,1
HP_INCREASED_PROTEINOGENIC_A...,SET,42,-0.20887,-0.0099736,0.14195,0.9294,HP_INCREASED_PROTEINOGENIC_AMINO_ACID_LEVEL_IN_URINE,1
GSE17721_POLYIC_VS_PAM3CSK4_...10,SET,185,-0.090345,-0.0090187,0.061399,0.92941,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP,1
HP_ABNORMAL_CIRCULATING_PHEN...,SET,9,-0.45294,-0.010021,0.30779,0.92942,HP_ABNORMAL_CIRCULATING_PHENYLALANINE_CONCENTRATION,1
REACTOME_CROSS_PRESENTATION_...1,SET,6,-0.55475,-0.010022,0.37677,0.92953,REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES,1
REACTOME_OVARIAN_TUMOR_DOMAI...,SET,34,-0.21465,-0.0092238,0.14575,0.92957,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1
HP_ABNORMALITY_OF_VON_WILLEB...,SET,12,-0.3482,-0.0088946,0.23639,0.92962,HP_ABNORMALITY_OF_VON_WILLEBRAND_FACTOR,1
HP_INCREASED_ASPARTATE_FAMIL...,SET,7,-0.4868,-0.0094988,0.33045,0.92963,HP_INCREASED_ASPARTATE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,1
CALVET_IRINOTECAN_SENSITIVE_...2,SET,5,-0.5922,-0.0097666,0.40198,0.92964,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN,1
HP_TRACHEAL_STENOSIS,SET,25,-0.24118,-0.0088894,0.16369,0.92967,HP_TRACHEAL_STENOSIS,1
KEGG_MEDICUS_REFERENCE_PROK_...,SET,9,-0.45416,-0.010048,0.30818,0.92971,KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
GSE4984_GALECTIN1_VS_LPS_STI...1,SET,156,-0.099335,-0.009113,0.067405,0.92971,GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN,1
TACAATC_MIR508,SET,57,-0.16655,-0.0092608,0.11299,0.92974,TACAATC_MIR508,1
GOMF_PEROXISOME_TARGETING_SE...,SET,3,-0.70239,-0.0089734,0.47639,0.92981,GOMF_PEROXISOME_TARGETING_SEQUENCE_BINDING,1
GOBP_EOSINOPHIL_MEDIATED_IMM...,SET,8,-0.4155,-0.0086671,0.28168,0.9299,GOBP_EOSINOPHIL_MEDIATED_IMMUNITY,1
BIOCARTA_RECK_PATHWAY,SET,8,-0.45424,-0.0094751,0.30782,0.92997,BIOCARTA_RECK_PATHWAY,1
GOMF_HEMOGLOBIN_ALPHA_BINDING,SET,4,-0.88705,-0.013085,0.60114,0.92997,GOMF_HEMOGLOBIN_ALPHA_BINDING,1
PODAR_RESPONSE_TO_ADAPHOSTIN...1,SET,17,-0.34822,-0.010586,0.23586,0.93007,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,1
HP_SPASTIC_TETRAPLEGIA,SET,109,-0.12027,-0.0092345,0.081448,0.9301,HP_SPASTIC_TETRAPLEGIA,1
GSE5542_UNTREATED_VS_IFNG_TR...2,SET,184,-0.094418,-0.0094,0.063941,0.93011,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,1
WILLIAMS_ESR2_TARGETS_UP,SET,25,-0.24352,-0.0089755,0.16487,0.93016,WILLIAMS_ESR2_TARGETS_UP,1
GOBP_REGULATION_OF_LOCOMOTIO...,SET,5,-0.76426,-0.012604,0.51741,0.93016,GOBP_REGULATION_OF_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,1
REACTOME_CREATINE_METABOLISM,SET,10,-0.40474,-0.0094386,0.27398,0.93019,REACTOME_CREATINE_METABOLISM,1
GNF2_IL2RB,SET,41,-0.21104,-0.0099568,0.14286,0.93019,GNF2_IL2RB,1
MIR1256,SET,64,-0.16385,-0.0096524,0.11091,0.9302,MIR1256,1
HP_ABNORMAL_TRAGUS_MORPHOLOGY,SET,11,-0.36195,-0.0088524,0.245,0.9302,HP_ABNORMAL_TRAGUS_MORPHOLOGY,1
HP_APLASIA_HYPOPLASIA_OF_THE...34,SET,26,-0.24325,-0.0091428,0.16465,0.9302,HP_APLASIA_HYPOPLASIA_OF_THE_FIBULA,1
REACTOME_SPECIFICATION_OF_PR...,SET,11,-0.43011,-0.01052,0.2911,0.93022,REACTOME_SPECIFICATION_OF_PRIMORDIAL_GERM_CELLS,1
GOCC_ANAPHASE_PROMOTING_COMP...,SET,21,-0.25406,-0.0085833,0.17195,0.93022,GOCC_ANAPHASE_PROMOTING_COMPLEX,1
GSE15330_LYMPHOID_MULTIPOTEN...4,SET,180,-0.09352,-0.0092099,0.063292,0.93023,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
HP_ANOPHTHALMIA,SET,59,-0.16084,-0.0090984,0.10884,0.93026,HP_ANOPHTHALMIA,1
CAFFAREL_RESPONSE_TO_THC_8HR...4,SET,13,-0.3432,-0.0091247,0.23223,0.93027,CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,1
GSE29949_CD8_POS_DC_SPLEEN_V...1,SET,173,-0.097503,-0.0094154,0.065976,0.93027,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN,1
GNF2_CD14,SET,32,-0.24636,-0.010271,0.1667,0.93028,GNF2_CD14,1
HP_CALCIFICATION_OF_CARTILAGE,SET,11,-0.42152,-0.01031,0.28511,0.93035,HP_CALCIFICATION_OF_CARTILAGE,1
GSE27786_LIN_NEG_VS_CD4_TCEL...2,SET,180,-0.089639,-0.0088277,0.060629,0.93035,GSE27786_LIN_NEG_VS_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...804,SET,63,-0.17707,-0.01035,0.11976,0.93037,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
GOBP_PROGESTERONE_BIOSYNTHET...,SET,5,-0.52984,-0.0087382,0.35823,0.93043,GOBP_PROGESTERONE_BIOSYNTHETIC_PROCESS,1
HP_SECOND_TRIMESTER_ONSET,SET,41,-0.20106,-0.009486,0.13593,0.93044,HP_SECOND_TRIMESTER_ONSET,1
REACTOME_SPHINGOLIPID_DE_NOV...,SET,36,-0.21755,-0.0096192,0.14708,0.93045,REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS,1
HP_CORTICAL_DYSPLASIA,SET,51,-0.18405,-0.0096823,0.12443,0.93045,HP_CORTICAL_DYSPLASIA,1
MIR182_3P,SET,61,-0.16514,-0.009498,0.11162,0.93049,MIR182_3P,1
KEGG_MEDICUS_REFERENCE_MICRO...2,SET,19,-0.29895,-0.0096074,0.20205,0.9305,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS,1
MODULE_486,SET,85,-0.13062,-0.0088625,0.088262,0.93054,MODULE_486,1
HP_PERIPHERAL_ARTERIOVENOUS_...,SET,7,-0.4825,-0.009415,0.32597,0.93058,HP_PERIPHERAL_ARTERIOVENOUS_FISTULA,1
REACTOME_REGULATION_OF_CDH11...2,SET,10,-0.45187,-0.010538,0.30524,0.9306,REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION,1
GOBP_REGULATION_OF_INSULIN_L...,SET,20,-0.33038,-0.010893,0.22318,0.9306,GOBP_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE2770_UNTREATED_VS_TGFB_AN...2,SET,184,-0.094199,-0.0093783,0.063629,0.93062,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
DESCARTES_FETAL_SPLEEN_VASCU...,SET,41,-0.22182,-0.010466,0.14979,0.93067,DESCARTES_FETAL_SPLEEN_VASCULAR_ENDOTHELIAL_CELLS,1
WP_TRYPTOPHAN_CATABOLISM_LEA...,SET,16,-0.33398,-0.00985,0.2255,0.93069,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,1
REACTOME_SHC1_EVENTS_IN_EGFR...,SET,14,-0.33644,-0.0092822,0.22716,0.9307,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,1
WP_ENDOTHELIN_PATHWAYS,SET,31,-0.24644,-0.010113,0.16639,0.9307,WP_ENDOTHELIN_PATHWAYS,1
GOBP_AMINE_TRANSPORT,SET,90,-0.14453,-0.010089,0.097547,0.93077,GOBP_AMINE_TRANSPORT,1
HP_OCULOMOTOR_APRAXIA,SET,103,-0.11174,-0.0083415,0.075411,0.93078,HP_OCULOMOTOR_APRAXIA,1
GSE15659_RESTING_VS_ACTIVATE...2,SET,154,-0.10257,-0.0093502,0.069222,0.93079,GSE15659_RESTING_VS_ACTIVATED_TREG_UP,1
HP_TRIANGULAR_SHAPED_PHALANG...,SET,7,-0.55389,-0.010808,0.37375,0.93082,HP_TRIANGULAR_SHAPED_PHALANGES_OF_THE_HAND,1
AKT_UP_MTOR_DN.V1_DN,SET,173,-0.09674,-0.0093417,0.065257,0.93088,AKT_UP_MTOR_DN.V1_DN,1
GSE32423_CTRL_VS_IL7_IL4_MEM...2,SET,182,-0.094404,-0.0093479,0.063683,0.93088,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,1
GOBP_ADENOSINE_TRANSPORT,SET,5,-0.59361,-0.0097899,0.40042,0.93089,GOBP_ADENOSINE_TRANSPORT,1
GSE17721_CTRL_VS_CPG_8H_BMDC...1,SET,187,-0.092291,-0.0092622,0.062239,0.93093,GSE17721_CTRL_VS_CPG_8H_BMDC_DN,1
MYLLYKANGAS_AMPLIFICATION_HO...3,SET,9,-0.46067,-0.010192,0.3106,0.93098,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16,1
GOBP_PYRIDINE_NUCLEOTIDE_BIO...,SET,27,-0.25417,-0.0097349,0.17132,0.93103,GOBP_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOBP_NEURONAL_STEM_CELL_POPU...,SET,25,-0.24064,-0.0088694,0.16213,0.93112,GOBP_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE,1
HP_SPLENIC_RUPTURE,SET,4,-0.85021,-0.012542,0.57228,0.93131,HP_SPLENIC_RUPTURE,1
HP_URETHRAL_FISTULA,SET,4,-0.51971,-0.0076664,0.34975,0.93134,HP_URETHRAL_FISTULA,1
HP_URETHROVAGINAL_FISTULA,SET,4,-0.51971,-0.0076664,0.34975,0.93134,HP_URETHROVAGINAL_FISTULA,1
REACTOME_SYNTHESIS_OF_DNA,SET,116,-0.10884,-0.00862,0.073236,0.93138,REACTOME_SYNTHESIS_OF_DNA,1
MODY_HIPPOCAMPUS_POSTNATAL,SET,52,-0.17067,-0.0090655,0.11479,0.93145,MODY_HIPPOCAMPUS_POSTNATAL,1
GSE21033_3H_VS_12H_POLYIC_ST...1,SET,122,-0.12059,-0.0097929,0.081107,0.93147,GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN,1
GSE17721_CTRL_VS_POLYIC_0.5H...2,SET,180,-0.095,-0.0093556,0.063879,0.93151,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP,1
GOBP_HEART_VALVE_DEVELOPMENT,SET,72,-0.16536,-0.01033,0.11117,0.93155,GOBP_HEART_VALVE_DEVELOPMENT,1
GOBP_CALCIUM_ION_TRANSMEMBRA...1,SET,172,-0.10202,-0.0098233,0.068563,0.93161,GOBP_CALCIUM_ION_TRANSMEMBRANE_IMPORT_INTO_CYTOSOL,1
HAY_BONE_MARROW_MONOCYTE,SET,195,-0.094982,-0.0097318,0.063812,0.93168,HAY_BONE_MARROW_MONOCYTE,1
HP_ONYCHOMYCOSIS,SET,20,-0.30924,-0.010196,0.20771,0.93172,HP_ONYCHOMYCOSIS,1
GOBP_PROTEIN_LOCALIZATION_TO...21,SET,12,-0.40314,-0.010298,0.27077,0.93173,GOBP_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,1
GSE29617_DAY3_VS_DAY7_TIV_FL...2,SET,168,-0.103,-0.0098024,0.069174,0.93174,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,1
GSE3982_NEUTROPHIL_VS_BCELL_...2,SET,169,-0.10393,-0.0099205,0.069796,0.93175,GSE3982_NEUTROPHIL_VS_BCELL_UP,1
GAUTAM_EYE_IRIS_CILIARY_BODY...12,SET,104,-0.12872,-0.0096553,0.086434,0.93177,GAUTAM_EYE_IRIS_CILIARY_BODY_PIGMENTED_CILIARY_BODY_CELLS,1
AAGGGAT_MIR188,SET,67,-0.15721,-0.0094746,0.10554,0.93182,AAGGGAT_MIR188,1
HP_URETEROPELVIC_JUNCTION_OB...,SET,20,-0.25902,-0.00854,0.17385,0.93187,HP_URETEROPELVIC_JUNCTION_OBSTRUCTION,1
GOBP_CEREBRAL_CORTEX_NEURON_...,SET,22,-0.30358,-0.010497,0.20375,0.93188,GOBP_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION,1
HP_ABNORMAL_PERIAURICULAR_RE...,SET,95,-0.13198,-0.0094643,0.088562,0.93191,HP_ABNORMAL_PERIAURICULAR_REGION_MORPHOLOGY,1
HP_PROGRESSIVE_LEUKOENCEPHAL...,SET,4,-0.65443,-0.0096538,0.43914,0.93191,HP_PROGRESSIVE_LEUKOENCEPHALOPATHY,1
GOCC_MEDIATOR_COMPLEX,SET,34,-0.19871,-0.0085388,0.13333,0.93192,GOCC_MEDIATOR_COMPLEX,1
HP_MACULAR_SCAR,SET,5,-0.61792,-0.010191,0.41459,0.93194,HP_MACULAR_SCAR,1
GOMF_CENTROMERIC_DNA_BINDING,SET,6,-0.48715,-0.0088007,0.3268,0.93197,GOMF_CENTROMERIC_DNA_BINDING,1
GSE41176_WT_VS_TAK1_KO_ANTI_...7,SET,183,-0.094478,-0.0093807,0.06338,0.93197,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN,1
WP_FACTORS_AND_PATHWAYS_AFFE...,SET,36,-0.21601,-0.0095509,0.14489,0.93199,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1
GOBP_CARBOHYDRATE_PHOSPHORYL...,SET,21,-0.24526,-0.0082858,0.16451,0.93199,GOBP_CARBOHYDRATE_PHOSPHORYLATION,1
GOMF_OLEATE_TRANSMEMBRANE_TR...,SET,6,-0.48594,-0.0087789,0.32588,0.93203,GOMF_OLEATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
ACAGGGT_MIR10A_MIR10B,SET,111,-0.11888,-0.0092112,0.079717,0.93205,ACAGGGT_MIR10A_MIR10B,1
ZNF555_TARGET_GENES,SET,91,-0.12678,-0.008899,0.085004,0.93207,ZNF555_TARGET_GENES,1
GSE42088_2H_VS_24H_LEISHMANI...2,SET,176,-0.098101,-0.0095541,0.065772,0.93208,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP,1
REACTOME_DEGRADATION_OF_AXIN,SET,52,-0.16302,-0.0086594,0.10929,0.93209,REACTOME_DEGRADATION_OF_AXIN,1
HP_ABNORMALITY_OF_REFRACTION,SET,600,-0.052882,-0.0093979,0.035447,0.93213,HP_ABNORMALITY_OF_REFRACTION,1
HP_PROLONGED_BLEEDING_FOLLOW...1,SET,11,-0.44516,-0.010888,0.29838,0.93213,HP_PROLONGED_BLEEDING_FOLLOWING_CIRCUMCISION,1
GOBP_HYPOTHALAMUS_GONADOTROP...,SET,6,-0.62131,-0.011224,0.41642,0.93214,GOBP_HYPOTHALAMUS_GONADOTROPHIN_RELEASING_HORMONE_NEURON_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...577,SET,26,-0.25682,-0.0096529,0.17208,0.9322,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
GOBP_POSITIVE_REGULATION_OF_...842,SET,6,-0.43654,-0.0078864,0.29241,0.93226,GOBP_POSITIVE_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
BIOCARTA_ION_PATHWAY,SET,5,-0.55942,-0.0092261,0.37468,0.93228,BIOCARTA_ION_PATHWAY,1
GOBP_SIRNA_PROCESSING,SET,8,-0.46643,-0.0097294,0.31218,0.93242,GOBP_SIRNA_PROCESSING,1
GOBP_NEUTRAL_LIPID_CATABOLIC...,SET,37,-0.21796,-0.00977,0.14587,0.93243,GOBP_NEUTRAL_LIPID_CATABOLIC_PROCESS,1
GSE7852_TREG_VS_TCONV_LN_DN,SET,182,-0.10118,-0.010019,0.06772,0.93243,GSE7852_TREG_VS_TCONV_LN_DN,1
REACTOME_MITOTIC_METAPHASE_A...,SET,217,-0.08342,-0.009011,0.055819,0.93247,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1
GOCC_RUFFLE,SET,172,-0.09759,-0.0093968,0.065291,0.93249,GOCC_RUFFLE,1
GSE34006_WT_VS_A2AR_KO_TREG_...1,SET,182,-0.097863,-0.0096905,0.065472,0.9325,GSE34006_WT_VS_A2AR_KO_TREG_DN,1
REACTOME_PROTEIN_METHYLATION,SET,14,-0.3572,-0.009855,0.23893,0.93253,REACTOME_PROTEIN_METHYLATION,1
GOBP_REGULATION_OF_BASEMENT_...,SET,11,-0.3547,-0.0086752,0.23725,0.93254,GOBP_REGULATION_OF_BASEMENT_MEMBRANE_ORGANIZATION,1
GSE3982_BCELL_VS_NKCELL_UP,SET,177,-0.094367,-0.0092163,0.063112,0.93256,GSE3982_BCELL_VS_NKCELL_UP,1
HP_ARTERIOSCLEROSIS,SET,86,-0.14901,-0.01017,0.099648,0.93259,HP_ARTERIOSCLEROSIS,1
HP_TYPICAL_ABSENCE_SEIZURE,SET,37,-0.21666,-0.0097115,0.14488,0.93259,HP_TYPICAL_ABSENCE_SEIZURE,1
MIR105_3P,SET,4,-0.80518,-0.011878,0.53813,0.9327,MIR105_3P,1
WP_SARSCOV2_ALTERING_ANGIOGE...,SET,4,-0.77188,-0.011386,0.51581,0.93272,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,1
GOBP_AMINO_SUGAR_CATABOLIC_P...,SET,14,-0.36904,-0.010182,0.2466,0.93273,GOBP_AMINO_SUGAR_CATABOLIC_PROCESS,1
MIR6505_3P,SET,87,-0.13468,-0.0092448,0.089993,0.93274,MIR6505_3P,1
GNF2_SELL,SET,44,-0.18906,-0.0092398,0.12633,0.93274,GNF2_SELL,1
GOBP_POSITIVE_REGULATION_OF_...305,SET,17,-0.29924,-0.009097,0.19995,0.93274,GOBP_POSITIVE_REGULATION_OF_GLUCONEOGENESIS,1
GOCC_CHROMATIN_SILENCING_COM...,SET,12,-0.34007,-0.0086869,0.22722,0.93274,GOCC_CHROMATIN_SILENCING_COMPLEX,1
MANN_RESPONSE_TO_AMIFOSTINE_...1,SET,9,-0.3672,-0.0081239,0.24534,0.93275,MANN_RESPONSE_TO_AMIFOSTINE_DN,1
BUSSLINGER_GASTRIC_ISTHMUS_C...,SET,428,-0.063295,-0.009546,0.042289,0.93276,BUSSLINGER_GASTRIC_ISTHMUS_CELLS,1
GOCC_INNER_DYNEIN_ARM,SET,4,-0.59761,-0.0088156,0.39926,0.93277,GOCC_INNER_DYNEIN_ARM,1
MODULE_440,SET,18,-0.30662,-0.0095912,0.20483,0.93279,MODULE_440,1
GSE36078_WT_VS_IL1R_KO_LUNG_...4,SET,181,-0.095502,-0.0094309,0.063784,0.93283,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP,1
HP_HEMANGIOMATOSIS,SET,19,-0.3033,-0.0097472,0.20256,0.93284,HP_HEMANGIOMATOSIS,1
GOBP_ETHER_BIOSYNTHETIC_PROC...,SET,11,-0.40278,-0.0098511,0.26895,0.93287,GOBP_ETHER_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_EGF_E...3,SET,9,-0.44091,-0.0097547,0.29439,0.93289,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY,1
GOBP_PTERIDINE_CONTAINING_CO...2,SET,33,-0.21605,-0.0091467,0.14424,0.9329,GOBP_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
DESCARTES_FETAL_INTESTINE_MY...,SET,187,-0.10424,-0.010462,0.069597,0.9329,DESCARTES_FETAL_INTESTINE_MYELOID_CELLS,1
MODULE_102,SET,16,-0.31238,-0.0092132,0.20852,0.93294,MODULE_102,1
GSE9988_ANTI_TREM1_VS_ANTI_T...1,SET,161,-0.10973,-0.010226,0.073231,0.93298,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,1
OUYANG_PROSTATE_CANCER_PROGR...1,SET,20,-0.28133,-0.0092757,0.18772,0.93301,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,1
GOBP_POSITIVE_REGULATION_OF_...388,SET,6,-0.55683,-0.01006,0.37154,0.93302,GOBP_POSITIVE_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,1
GOBP_NEGATIVE_REGULATION_OF_...569,SET,8,-0.49895,-0.010408,0.33289,0.93303,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
WP_SARSCOV2_AND_COVID19_PATH...,SET,8,-0.5276,-0.011005,0.35198,0.93305,WP_SARSCOV2_AND_COVID19_PATHWAY,1
GSE360_L_DONOVANI_VS_B_MALAY...2,SET,173,-0.1008,-0.0097341,0.067248,0.93305,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
TTTGCAG_MIR518A2,SET,188,-0.093478,-0.009406,0.062353,0.93308,TTTGCAG_MIR518A2,1
REACTOME_NCAM_SIGNALING_FOR_...,SET,62,-0.16863,-0.0097779,0.11247,0.9331,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1
GAVISH_3CA_METAPROGRAM_CD4_T...8,SET,49,-0.18627,-0.0096052,0.12421,0.93314,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...7,SET,90,-0.13683,-0.0095521,0.091229,0.93317,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN,1
GSE1925_3H_VS_24H_IFNG_STIM_...1,SET,187,-0.09173,-0.0092058,0.061135,0.93324,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,1
GSE33374_CD8_ALPHAALPHA_VS_A...1,SET,189,-0.09219,-0.0093008,0.06143,0.93328,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,1
LIM_MAMMARY_LUMINAL_PROGENIT...2,SET,57,-0.17782,-0.0098878,0.11848,0.93329,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,1
GOMF_TRANSLATION_REPRESSOR_A...,SET,30,-0.21874,-0.0088303,0.14575,0.93329,GOMF_TRANSLATION_REPRESSOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...340,SET,8,-0.46914,-0.009786,0.31251,0.93334,GOBP_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
GOBP_NADH_METABOLIC_PROCESS,SET,28,-0.22961,-0.0089555,0.15289,0.93342,GOBP_NADH_METABOLIC_PROCESS,1
GSE8921_UNSTIM_VS_TLR1_2_STI...6,SET,185,-0.091501,-0.0091341,0.060909,0.93348,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP,1
REACTOME_REGULATION_OF_MITF_...3,SET,15,-0.33543,-0.0095791,0.22327,0.93349,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_LYSOSOME_BIOGENESIS_AND_AUTOPHAGY,1
MIR4772_3P,SET,82,-0.14744,-0.0098265,0.098137,0.93349,MIR4772_3P,1
GOBP_POSITIVE_REGULATION_OF_...737,SET,5,-0.6304,-0.010397,0.41961,0.93349,GOBP_POSITIVE_REGULATION_OF_SULFUR_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...85,SET,95,-0.14144,-0.010143,0.094138,0.93351,GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,1
GSE3982_DC_VS_MAC_LPS_STIM_DN,SET,173,-0.099613,-0.0096191,0.066284,0.93355,GSE3982_DC_VS_MAC_LPS_STIM_DN,1
GOBP_GLUCAN_BIOSYNTHETIC_PRO...,SET,40,-0.19846,-0.0092485,0.13204,0.93357,GOBP_GLUCAN_BIOSYNTHETIC_PROCESS,1
HP_CERVICAL_NEOPLASM,SET,6,-0.60694,-0.010965,0.40383,0.93357,HP_CERVICAL_NEOPLASM,1
MIR562,SET,59,-0.16198,-0.0091629,0.10776,0.93359,MIR562,1
GSE6566_STRONG_VS_WEAK_DC_ST...2,SET,156,-0.1089,-0.0099908,0.072447,0.9336,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...4,SET,150,-0.097548,-0.0087768,0.064882,0.93363,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP,1
HP_SUPERNUMERARY_NIPPLE,SET,46,-0.18184,-0.009086,0.12088,0.93374,HP_SUPERNUMERARY_NIPPLE,1
RASHI_RESPONSE_TO_IONIZING_R...3,SET,43,-0.18433,-0.0089057,0.12253,0.93375,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,1
FAELT_B_CLL_WITH_VH_REARRANG...1,SET,43,-0.19093,-0.0092247,0.12685,0.93386,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,1
GSE41176_UNSTIM_VS_ANTI_IGM_...16,SET,161,-0.099605,-0.0092819,0.066173,0.93386,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP,1
GOBP_REGULATION_OF_LEUKOCYTE...7,SET,226,-0.092074,-0.010147,0.061154,0.93391,GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,1
GOBP_PERIPHERAL_NERVOUS_SYST...4,SET,8,-0.45667,-0.0095258,0.30318,0.93399,GOBP_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,1
MIR4520_3P,SET,81,-0.14634,-0.0096936,0.097142,0.93401,MIR4520_3P,1
GSE15330_LYMPHOID_MULTIPOTEN...3,SET,176,-0.095642,-0.0093147,0.063476,0.93405,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
GSE22589_SIV_VS_HIV_AND_SIV_...1,SET,181,-0.093521,-0.0092352,0.06206,0.93408,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...270,SET,14,-0.36267,-0.010006,0.24063,0.93411,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_CIRCADIAN...1,SET,105,-0.12923,-0.0097404,0.085746,0.93411,GOBP_REGULATION_OF_CIRCADIAN_RHYTHM,1
GOMF_G_PROTEIN_COUPLED_NEURO...,SET,12,-0.41714,-0.010656,0.27673,0.93414,GOMF_G_PROTEIN_COUPLED_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
TARTE_PLASMA_CELL_VS_B_LYMPH...1,SET,34,-0.23949,-0.010291,0.15885,0.93416,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...167,SET,28,-0.22296,-0.0086963,0.14789,0.93416,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEPARATION,1
GOBP_FATTY_ACID_DERIVATIVE_M...,SET,68,-0.16552,-0.01005,0.10977,0.9342,GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS,1
LU_EZH2_TARGETS_UP,SET,253,-0.07647,-0.0089102,0.050709,0.93421,LU_EZH2_TARGETS_UP,1
GSE21927_SPLEEN_VS_4T1_TUMOR...2,SET,162,-0.10342,-0.0096667,0.068579,0.93421,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,1
GOMF_FK506_BINDING,SET,10,-0.35629,-0.0083088,0.23619,0.93427,GOMF_FK506_BINDING,1
HP_HYPOPLASIA_OF_THE_ODONTOI...,SET,22,-0.26994,-0.0093339,0.17895,0.93427,HP_HYPOPLASIA_OF_THE_ODONTOID_PROCESS,1
HP_APLASIA_HYPOPLASIA_OF_THE...80,SET,33,-0.22495,-0.0095236,0.14912,0.93428,HP_APLASIA_HYPOPLASIA_OF_THE_VERTEBRAE,1
BROWNE_HCMV_INFECTION_20HR_UP,SET,214,-0.087574,-0.0093949,0.058038,0.93433,BROWNE_HCMV_INFECTION_20HR_UP,1
GOBP_POSITIVE_REGULATION_OF_...82,SET,56,-0.18087,-0.0099691,0.11985,0.93436,GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...576,SET,72,-0.14809,-0.0092511,0.098116,0.93439,GOBP_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS,1
GOBP_CALCIUM_ION_TRANSMEMBRA...2,SET,311,-0.076508,-0.0098681,0.050687,0.9344,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,1
KAECH_NAIVE_VS_DAY15_EFF_CD8...2,SET,177,-0.095331,-0.0093104,0.063152,0.93441,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP,1
TGGNNNNNNKCCAR_UNKNOWN,SET,382,-0.068418,-0.009761,0.045318,0.93444,TGGNNNNNNKCCAR_UNKNOWN,1
GOBP_CALCIUM_ION_TRANSPORT,SET,396,-0.068442,-0.0099378,0.045327,0.93447,GOBP_CALCIUM_ION_TRANSPORT,1
WP_COPPER_HOMEOSTASIS,SET,49,-0.19051,-0.0098242,0.12614,0.93451,WP_COPPER_HOMEOSTASIS,1
MIR3934_3P,SET,90,-0.13069,-0.0091229,0.086524,0.93452,MIR3934_3P,1
REACTOME_REGULATION_OF_CYTOS...,SET,7,-0.46255,-0.0090256,0.30623,0.93453,REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS,1
GSE26030_TH1_VS_TH17_DAY15_P...2,SET,181,-0.095336,-0.0094145,0.063117,0.93453,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP,1
YBX1_TARGET_GENES,SET,57,-0.16437,-0.0091396,0.1088,0.93457,YBX1_TARGET_GENES,1
HP_MIOSIS,SET,25,-0.28075,-0.010348,0.18582,0.93458,HP_MIOSIS,1
GCM_MAP1B,SET,62,-0.16307,-0.0094558,0.10792,0.9346,GCM_MAP1B,1
GOBP_ANGIOTENSIN_ACTIVATED_S...,SET,17,-0.34969,-0.010631,0.23141,0.93461,GOBP_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY,1
GOBP_NEUROTRANSMITTER_UPTAKE,SET,43,-0.20774,-0.010037,0.13745,0.93465,GOBP_NEUROTRANSMITTER_UPTAKE,1
GOBP_GLYCOLYTIC_PROCESS_THRO...2,SET,16,-0.29792,-0.0087867,0.1971,0.93466,GOBP_GLYCOLYTIC_PROCESS_THROUGH_GLUCOSE_6_PHOSPHATE,1
MIR1185_1_3P_MIR1185_2_3P,SET,376,-0.067837,-0.0096033,0.044879,0.93467,MIR1185_1_3P_MIR1185_2_3P,1
HP_OOCYTE_ARREST_AT_METAPHAS...,SET,5,-0.58571,-0.0096596,0.38746,0.93468,HP_OOCYTE_ARREST_AT_METAPHASE_I,1
GOMF_DYNEIN_INTERMEDIATE_CHA...,SET,31,-0.23874,-0.009797,0.15792,0.9347,GOMF_DYNEIN_INTERMEDIATE_CHAIN_BINDING,1
MIR6876_3P,SET,49,-0.19716,-0.010167,0.13033,0.93481,MIR6876_3P,1
GOBP_PEPTIDYL_THREONINE_MODI...,SET,100,-0.13326,-0.0098031,0.088055,0.9349,GOBP_PEPTIDYL_THREONINE_MODIFICATION,1
SABATES_COLORECTAL_ADENOMA_S...1,SET,11,-0.36299,-0.0088779,0.23976,0.93497,SABATES_COLORECTAL_ADENOMA_SIZE_DN,1
GOBP_MONOSACCHARIDE_CATABOLI...,SET,44,-0.18629,-0.0091045,0.12304,0.93499,GOBP_MONOSACCHARIDE_CATABOLIC_PROCESS,1
chr4q34,SET,19,-0.50976,-0.016382,0.33666,0.935,chr4q34,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...1,SET,85,-0.14382,-0.0097583,0.094969,0.93503,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...3,SET,913,-0.04541,-0.0098667,0.029976,0.93509,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP,1
ALKBH3_TARGET_GENES,SET,353,-0.067905,-0.0093202,0.044818,0.93512,ALKBH3_TARGET_GENES,1
GSE14769_UNSTIM_VS_240MIN_LP...1,SET,181,-0.095224,-0.0094035,0.062851,0.93512,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN,1
GOBP_TRANSLATION,SET,580,-0.052209,-0.0091273,0.034456,0.93513,GOBP_TRANSLATION,1
GOMF_PROTEIN_GLUTAMIC_ACID_L...,SET,9,-0.46121,-0.010204,0.30433,0.93517,GOMF_PROTEIN_GLUTAMIC_ACID_LIGASE_ACTIVITY,1
MIR3197,SET,5,-0.5066,-0.008355,0.33423,0.9352,MIR3197,1
HP_HYPERKINETIC_MOVEMENTS,SET,35,-0.22493,-0.0098068,0.14838,0.93523,HP_HYPERKINETIC_MOVEMENTS,1
GOBP_REGULATION_OF_MEMBRANE_...7,SET,61,-0.16163,-0.0092964,0.10661,0.93524,GOBP_REGULATION_OF_MEMBRANE_PERMEABILITY,1
HP_HYPSARRHYTHMIA,SET,159,-0.10423,-0.0096532,0.068751,0.93524,HP_HYPSARRHYTHMIA,1
GOBP_NEGATIVE_REGULATION_OF_...709,SET,5,-0.4728,-0.0077975,0.31185,0.93525,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
GOBP_REGULATION_OF_CD40_SIGN...,SET,6,-0.40883,-0.0073858,0.26965,0.93525,GOBP_REGULATION_OF_CD40_SIGNALING_PATHWAY,1
GOBP_NATURAL_KILLER_CELL_CHE...,SET,10,-0.47318,-0.011035,0.31206,0.93527,GOBP_NATURAL_KILLER_CELL_CHEMOTAXIS,1
HP_MORTALITY_AGING,SET,399,-0.064397,-0.009385,0.042471,0.93527,HP_MORTALITY_AGING,1
MIR382_3P,SET,91,-0.13615,-0.0095565,0.089777,0.93529,MIR382_3P,1
MIR4476,SET,203,-0.091967,-0.0096121,0.060645,0.93529,MIR4476,1
HP_APLASIA_HYPOPLASIA_OF_THE...37,SET,25,-0.27098,-0.0099876,0.17869,0.93529,HP_APLASIA_HYPOPLASIA_OF_THE_HUMERUS,1
HP_LEFT_TO_RIGHT_SHUNT,SET,10,-0.4547,-0.010604,0.29974,0.93535,HP_LEFT_TO_RIGHT_SHUNT,1
GSE40274_XBP1_VS_FOXP3_AND_X...2,SET,177,-0.097945,-0.0095658,0.064568,0.93535,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_CELLULAR_RESPONSE_TO_PR...2,SET,15,-0.39846,-0.011379,0.26264,0.93537,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS,1
AFFAR_YY1_TARGETS_UP,SET,178,-0.099941,-0.009788,0.065868,0.93539,AFFAR_YY1_TARGETS_UP,1
KEGG_LONG_TERM_DEPRESSION,SET,66,-0.16663,-0.0099678,0.10983,0.93539,KEGG_LONG_TERM_DEPRESSION,1
KEGG_MEDICUS_REFERENCE_CA2_C...3,SET,11,-0.43165,-0.010557,0.28435,0.93549,KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY,1
MODULE_371,SET,26,-0.25072,-0.0094236,0.16515,0.9355,MODULE_371,1
GOBP_SCHWANN_CELL_DIFFERENTI...,SET,47,-0.19251,-0.0097228,0.12681,0.9355,GOBP_SCHWANN_CELL_DIFFERENTIATION,1
GOBP_CHEMICAL_SYNAPTIC_TRANS...,SET,104,-0.1322,-0.0099166,0.087066,0.93553,GOBP_CHEMICAL_SYNAPTIC_TRANSMISSION_POSTSYNAPTIC,1
HP_NEOPLASM_OF_THE_THYMUS,SET,7,-0.49221,-0.0096043,0.32411,0.93556,HP_NEOPLASM_OF_THE_THYMUS,1
GOMF_SMALL_MOLECULE_SENSOR_A...,SET,44,-0.18071,-0.0088318,0.11897,0.93561,GOMF_SMALL_MOLECULE_SENSOR_ACTIVITY,1
HP_ABNORMAL_MEAN_CORPUSCULAR...2,SET,55,-0.16253,-0.008878,0.10698,0.93564,HP_ABNORMAL_MEAN_CORPUSCULAR_VOLUME,1
GSE24634_TEFF_VS_TCONV_DAY3_...2,SET,183,-0.094495,-0.0093824,0.062182,0.93569,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP,1
GSE24634_TREG_VS_TCONV_POST_...3,SET,180,-0.099084,-0.0097578,0.065188,0.93573,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN,1
GSE1112_OT1_VS_HY_CD8AB_THYM...1,SET,177,-0.092701,-0.0090536,0.060985,0.93574,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN,1
HP_WIDE_MOUTH,SET,188,-0.095346,-0.009594,0.062714,0.93578,HP_WIDE_MOUTH,1
GSE24142_DN2_VS_DN3_THYMOCYT...6,SET,184,-0.097592,-0.009716,0.064184,0.9358,GSE24142_DN2_VS_DN3_THYMOCYTE_UP,1
GSE19888_CTRL_VS_T_CELL_MEMB...1,SET,187,-0.094281,-0.0094618,0.061999,0.93582,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN,1
HP_ABNORMAL_HAIR_QUANTITY,SET,758,-0.047675,-0.0094805,0.031346,0.93585,HP_ABNORMAL_HAIR_QUANTITY,1
GOMF_CYTOSKELETAL_MOTOR_ACTI...,SET,112,-0.12539,-0.0097591,0.082425,0.9359,GOMF_CYTOSKELETAL_MOTOR_ACTIVITY,1
GSE46242_CTRL_VS_EGR2_DELETE...2,SET,169,-0.097752,-0.0093307,0.064251,0.93591,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP,1
HUTTMANN_B_CLL_POOR_SURVIVAL...1,SET,57,-0.17349,-0.0096467,0.11402,0.93594,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,1
GSE22886_DAY0_VS_DAY7_MONOCY...1,SET,183,-0.096818,-0.0096131,0.063613,0.93599,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN,1
GSE42088_UNINF_VS_LEISHMANIA...6,SET,183,-0.098639,-0.0097938,0.064804,0.936,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP,1
GOBP_TELOMERASE_HOLOENZYME_C...,SET,6,-0.44837,-0.0081001,0.29448,0.93605,GOBP_TELOMERASE_HOLOENZYME_COMPLEX_ASSEMBLY,1
DESCARTES_MAIN_FETAL_CSH1_CS...,SET,70,-0.13904,-0.0085647,0.091306,0.93609,DESCARTES_MAIN_FETAL_CSH1_CSH2_POSITIVE_CELLS,1
HP_ANGIOSARCOMA,SET,5,-0.58093,-0.0095808,0.38147,0.9361,HP_ANGIOSARCOMA,1
MODULE_286,SET,35,-0.22768,-0.0099264,0.1495,0.93611,MODULE_286,1
GOMF_CHONDROITIN_SULFATE_BIN...,SET,9,-0.47532,-0.010516,0.3121,0.93611,GOMF_CHONDROITIN_SULFATE_BINDING,1
AHRARNT_02,SET,14,-0.34522,-0.0095244,0.22663,0.93614,AHRARNT_02,1
HP_ABNORMALITY_OF_GLOBE_LOCA...,SET,965,-0.042467,-0.0094723,0.02788,0.93614,HP_ABNORMALITY_OF_GLOBE_LOCATION,1
REACTOME_DOPAMINE_RECEPTORS,SET,5,-0.67268,-0.011094,0.44135,0.93626,REACTOME_DOPAMINE_RECEPTORS,1
GOMF_DOPAMINE_NEUROTRANSMITT...,SET,5,-0.67268,-0.011094,0.44135,0.93626,GOMF_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
HP_DEFECTIVE_T_CELL_PROLIFER...,SET,7,-0.44803,-0.0087423,0.29395,0.93626,HP_DEFECTIVE_T_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_PRO_B_CEL...,SET,8,-0.47793,-0.0099694,0.31346,0.93632,GOBP_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION,1
ICSBP_Q6,SET,231,-0.089148,-0.0099317,0.058456,0.93637,ICSBP_Q6,1
GOMF_ESTRADIOL_17_BETA_DEHYD...,SET,18,-0.32462,-0.010154,0.21284,0.93638,GOMF_ESTRADIOL_17_BETA_DEHYDROGENASE_NAD_P_ACTIVITY,1
GOMF_CHONDROITIN_SULFOTRANSF...,SET,5,-0.55858,-0.0092122,0.36623,0.93639,GOMF_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY,1
HP_INCREASED_MEAN_PLATELET_V...,SET,21,-0.3117,-0.010531,0.20434,0.93642,HP_INCREASED_MEAN_PLATELET_VOLUME,1
GOBP_GLYCEROL_TRANSMEMBRANE_...,SET,7,-0.60776,-0.011859,0.39837,0.93644,GOBP_GLYCEROL_TRANSMEMBRANE_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...608,SET,26,-0.26226,-0.0098573,0.1719,0.93644,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,1
GOMF_GLYCEROL_TRANSMEMBRANE_...,SET,7,-0.60776,-0.011859,0.39837,0.93644,GOMF_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_SUPRAVENTRICULAR_TACHYCAR...,SET,51,-0.19934,-0.010487,0.13066,0.93644,HP_SUPRAVENTRICULAR_TACHYCARDIA,1
HP_OLIGOZOOSPERMIA,SET,43,-0.19202,-0.0092772,0.12585,0.93646,HP_OLIGOZOOSPERMIA,1
GOBP_NEGATIVE_REGULATION_OF_...552,SET,5,-0.59976,-0.0098912,0.39306,0.93647,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_RECYCLING,1
DELACROIX_RARG_BOUND_MEF,SET,345,-0.073083,-0.0099189,0.047894,0.93648,DELACROIX_RARG_BOUND_MEF,1
GSE21063_CTRL_VS_ANTI_IGM_ST...1,SET,183,-0.096766,-0.0096078,0.063407,0.9365,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...8,SET,8,-0.43104,-0.0089912,0.28242,0.93652,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_UP,1
GOBP_PYRIMIDINE_NUCLEOBASE_C...,SET,8,-0.47326,-0.0098719,0.30995,0.9366,GOBP_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS,1
HP_AORTOPULMONARY_COLLATERAL...,SET,14,-0.38829,-0.010713,0.25429,0.93661,HP_AORTOPULMONARY_COLLATERAL_ARTERIES,1
MORF_GSPT1,SET,44,-0.18216,-0.0089026,0.11925,0.93668,MORF_GSPT1,1
GOBP_CHAPERONE_COFACTOR_DEPE...,SET,30,-0.22143,-0.0089389,0.14495,0.93668,GOBP_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING,1
GOBP_HEPARAN_SULFATE_PROTEOG...3,SET,8,-0.49781,-0.010384,0.32588,0.93669,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_POLYSACCHARIDE_CHAIN_BIOSYNTHETIC_PROCESS,1
GOMF_HIGH_VOLTAGE_GATED_CALC...,SET,13,-0.39023,-0.010375,0.25543,0.9367,GOMF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
MIR8069,SET,57,-0.18309,-0.01018,0.11983,0.93671,MIR8069,1
HP_PARIETAL_BOSSING,SET,8,-0.39204,-0.0081777,0.25658,0.93672,HP_PARIETAL_BOSSING,1
HP_ABNORMALITY_OF_THE_SENSE_...,SET,119,-0.12013,-0.0096357,0.078606,0.93677,HP_ABNORMALITY_OF_THE_SENSE_OF_SMELL,1
GSE17721_CTRL_VS_LPS_0.5H_BM...2,SET,179,-0.098867,-0.0097096,0.064692,0.93677,GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP,1
MEBARKI_HCC_PROGENITOR_WNT_D...3,SET,18,-0.33708,-0.010544,0.22048,0.93684,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1
GOCC_PHOSPHOLIPID_TRANSLOCAT...,SET,13,-0.36914,-0.0098144,0.24146,0.93684,GOCC_PHOSPHOLIPID_TRANSLOCATING_ATPASE_COMPLEX,1
HP_GENERALIZED_EDEMA,SET,24,-0.25558,-0.00923,0.16716,0.93685,HP_GENERALIZED_EDEMA,1
LY_AGING_MIDDLE_DN,SET,15,-0.30274,-0.0086456,0.19797,0.93689,LY_AGING_MIDDLE_DN,1
GOBP_REGULATION_OF_NUCLEASE_...,SET,21,-0.29682,-0.010028,0.1941,0.93689,GOBP_REGULATION_OF_NUCLEASE_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_L...14,SET,102,-0.12702,-0.0094363,0.083048,0.93691,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
REACTOME_REGULATION_OF_MRNA_...,SET,83,-0.1401,-0.0093936,0.091593,0.93693,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1
REACTOME_MITOCHONDRIAL_UNCOU...,SET,6,-0.53139,-0.0095999,0.34739,0.93694,REACTOME_MITOCHONDRIAL_UNCOUPLING,1
GOCC_AXON_INITIAL_SEGMENT,SET,21,-0.30335,-0.010248,0.1983,0.93696,GOCC_AXON_INITIAL_SEGMENT,1
TRAVAGLINI_LUNG_NATURAL_KILL...2,SET,30,-0.27139,-0.010956,0.1774,0.93696,TRAVAGLINI_LUNG_NATURAL_KILLER_T_CELL,1
HP_NEOPLASM_OF_THE_SMALL_INT...,SET,18,-0.29436,-0.0092078,0.1924,0.93698,HP_NEOPLASM_OF_THE_SMALL_INTESTINE,1
GSE10240_IL22_VS_IL22_AND_IL...1,SET,187,-0.093508,-0.0093842,0.061118,0.93698,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
HP_ABNORMAL_URETER_PHYSIOLOGY,SET,213,-0.091867,-0.0098327,0.060034,0.93702,HP_ABNORMAL_URETER_PHYSIOLOGY,1
GOBP_N_ACETYLNEURAMINATE_CAT...,SET,6,-0.56252,-0.010162,0.36744,0.9371,GOBP_N_ACETYLNEURAMINATE_CATABOLIC_PROCESS,1
GOMF_MUTLALPHA_COMPLEX_BINDI...,SET,7,-0.47084,-0.0091873,0.30745,0.93716,GOMF_MUTLALPHA_COMPLEX_BINDING,1
GSE26351_UNSTIM_VS_BMP_PATHW...2,SET,174,-0.09827,-0.0095166,0.064159,0.93719,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,1
GOBP_POSITIVE_REGULATION_OF_...356,SET,10,-0.50039,-0.011669,0.32664,0.93722,GOBP_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE3920_UNTREATED_VS_IFNG_TR...3,SET,166,-0.10423,-0.0098614,0.068041,0.93722,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN,1
WP_IL19_SIGNALING,SET,28,-0.26369,-0.010285,0.17209,0.93726,WP_IL19_SIGNALING,1
GOMF_RNA_DIRECTED_DNA_POLYME...,SET,6,-0.50429,-0.0091103,0.32912,0.93726,GOMF_RNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_INVOLV...3,SET,164,-0.10014,-0.0094172,0.065319,0.93736,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_THORAX,1
HP_BLISTERING_BY_ANATOMICAL_...,SET,25,-0.26944,-0.009931,0.1757,0.93742,HP_BLISTERING_BY_ANATOMICAL_LOCATION,1
GSE42088_UNINF_VS_LEISHMANIA...7,SET,169,-0.10296,-0.0098281,0.067122,0.93747,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN,1
REACTOME_CLASS_I_PEROXISOMAL...,SET,18,-0.29897,-0.009352,0.19489,0.93748,REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT,1
HP_SHALLOW_ANTERIOR_CHAMBER,SET,17,-0.32465,-0.0098695,0.21163,0.93749,HP_SHALLOW_ANTERIOR_CHAMBER,1
GOBP_DICHOTOMOUS_SUBDIVISION...,SET,8,-0.52127,-0.010873,0.33976,0.9375,GOBP_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT,1
HP_ABNORMALITY_ON_PULMONARY_...,SET,167,-0.10093,-0.0095774,0.065773,0.93754,HP_ABNORMALITY_ON_PULMONARY_FUNCTION_TESTING,1
CASTELLANO_HRAS_TARGETS_UP,SET,5,-0.54079,-0.0089188,0.35227,0.93762,CASTELLANO_HRAS_TARGETS_UP,1
MORF_FSHR,SET,244,-0.087036,-0.009962,0.056686,0.93765,MORF_FSHR,1
MIR379_3P_MIR411_3P,SET,173,-0.1054,-0.010178,0.068645,0.93766,MIR379_3P_MIR411_3P,1
TERAMOTO_OPN_TARGETS_CLUSTER...7,SET,8,-0.44771,-0.0093389,0.29156,0.93767,TERAMOTO_OPN_TARGETS_CLUSTER_8,1
GOBP_FOCAL_ADHESION_ASSEMBLY,SET,82,-0.14423,-0.0096127,0.093921,0.93768,GOBP_FOCAL_ADHESION_ASSEMBLY,1
WALLACE_PROSTATE_CANCER_RACE...1,SET,74,-0.14514,-0.0091911,0.094508,0.93769,WALLACE_PROSTATE_CANCER_RACE_DN,1
HP_SHORTENING_OF_ALL_DISTAL_...,SET,12,-0.32734,-0.0083618,0.21315,0.93769,HP_SHORTENING_OF_ALL_DISTAL_PHALANGES_OF_THE_FINGERS,1
MA_RAT_AGING_DN,SET,144,-0.11736,-0.010348,0.076387,0.93777,MA_RAT_AGING_DN,1
GSE18203_CTRL_VS_INTRATUMORA...2,SET,187,-0.091845,-0.0092174,0.05977,0.9378,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP,1
GSE30971_2H_VS_4H_LPS_STIM_M...3,SET,176,-0.10066,-0.0098029,0.065488,0.93785,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN,1
HP_LIMITATION_OF_JOINT_MOBIL...,SET,370,-0.071053,-0.0099798,0.046225,0.93786,HP_LIMITATION_OF_JOINT_MOBILITY,1
KEGG_MEDICUS_REFERENCE_EGF_E...7,SET,15,-0.33686,-0.0096198,0.21911,0.93789,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
HP_SLEEP_ABNORMALITY,SET,505,-0.060617,-0.0099092,0.039429,0.93789,HP_SLEEP_ABNORMALITY,1
GSE11924_TH1_VS_TH2_CD4_TCEL...2,SET,192,-0.091468,-0.0093002,0.059491,0.93791,GSE11924_TH1_VS_TH2_CD4_TCELL_UP,1
HP_ABNORMALITY_OF_THE_RADIAL...,SET,46,-0.19573,-0.00978,0.12727,0.93795,HP_ABNORMALITY_OF_THE_RADIAL_HEAD,1
HP_MULTIPLE_PRENATAL_FRACTUR...,SET,16,-0.30167,-0.0088973,0.19614,0.93797,HP_MULTIPLE_PRENATAL_FRACTURES,1
LET_7F_2_3P,SET,371,-0.069486,-0.0097725,0.045172,0.938,LET_7F_2_3P,1
GOBP_ESTROUS_CYCLE,SET,16,-0.32627,-0.0096228,0.21205,0.93805,GOBP_ESTROUS_CYCLE,1
HP_ABNORMAL_FIBULA_MORPHOLOGY,SET,51,-0.18873,-0.0099282,0.12266,0.93805,HP_ABNORMAL_FIBULA_MORPHOLOGY,1
ASTON_MAJOR_DEPRESSIVE_DISOR...1,SET,146,-0.10774,-0.0095646,0.070018,0.93806,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,1
GOCC_DERLIN_1_RETROTRANSLOCA...,SET,7,-0.44729,-0.0087279,0.29066,0.93807,GOCC_DERLIN_1_RETROTRANSLOCATION_COMPLEX,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...5,SET,15,-0.35323,-0.010087,0.22944,0.93815,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,1
chr9q21,SET,57,-0.27397,-0.015234,0.17793,0.93818,chr9q21,1
GOBP_PEPTIDYL_LYSINE_METHYLA...,SET,14,-0.33197,-0.0091591,0.21557,0.93821,GOBP_PEPTIDYL_LYSINE_METHYLATION,1
GOBP_NEGATIVE_REGULATION_OF_...661,SET,5,-0.60216,-0.0099308,0.39095,0.93824,GOBP_NEGATIVE_REGULATION_OF_TUBULIN_DEACETYLATION,1
REACTOME_XENOBIOTICS,SET,23,-0.31283,-0.01106,0.20306,0.93828,REACTOME_XENOBIOTICS,1
BIOCARTA_TERC_PATHWAY,SET,6,-0.44373,-0.0080162,0.28802,0.93829,BIOCARTA_TERC_PATHWAY,1
ERWIN_COHEN_PBMC_TC_83_AGE_1...4,SET,31,-0.26772,-0.010986,0.17377,0.93829,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,1
HP_ECTOPIA_PUPILLAE,SET,21,-0.31755,-0.010728,0.2061,0.93831,HP_ECTOPIA_PUPILLAE,1
SENESE_HDAC3_TARGETS_DN,SET,467,-0.062624,-0.0098551,0.040641,0.93832,SENESE_HDAC3_TARGETS_DN,1
HP_APNEIC_EPISODES_IN_INFANCY,SET,9,-0.44987,-0.009953,0.29196,0.93832,HP_APNEIC_EPISODES_IN_INFANCY,1
HP_ABNORMAL_CIRCULATING_INHI...,SET,6,-0.66121,-0.011945,0.42909,0.93833,HP_ABNORMAL_CIRCULATING_INHIBIN_B_CONCENTRATION,1
MIR302A_3P_MIR302B_3P_MIR302...,SET,323,-0.073542,-0.0096636,0.047713,0.93837,MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P,1
VICENT_METASTASIS_UP,SET,13,-0.38506,-0.010238,0.24979,0.9384,VICENT_METASTASIS_UP,1
REACTOME_ABC_TRANSPORTER_DIS...,SET,74,-0.1461,-0.0092523,0.094674,0.9386,REACTOME_ABC_TRANSPORTER_DISORDERS,1
RAMASWAMY_METASTASIS_DN,SET,51,-0.18559,-0.009763,0.12024,0.93864,RAMASWAMY_METASTASIS_DN,1
HP_ABNORMAL_STERNAL_OSSIFICA...,SET,11,-0.3756,-0.0091862,0.24333,0.93864,HP_ABNORMAL_STERNAL_OSSIFICATION,1
MENON_FETAL_KIDNEY_8_CONNECT...,SET,223,-0.088959,-0.0097397,0.057633,0.93864,MENON_FETAL_KIDNEY_8_CONNECTING_TUBULE_CELLS,1
COLLER_MYC_TARGETS_UP,SET,23,-0.27839,-0.0098422,0.18022,0.93878,COLLER_MYC_TARGETS_UP,1
GSE22886_NAIVE_TCELL_VS_NKCE...1,SET,181,-0.094525,-0.0093345,0.061195,0.93878,GSE22886_NAIVE_TCELL_VS_NKCELL_DN,1
HP_CLUBBING,SET,128,-0.11204,-0.0093179,0.072517,0.93882,HP_CLUBBING,1
KRAS.PROSTATE_UP.V1_UP,SET,122,-0.12547,-0.010189,0.081209,0.93883,KRAS.PROSTATE_UP.V1_UP,1
HP_DUODENAL_ADENOCARCINOMA,SET,7,-0.47444,-0.0092576,0.30701,0.93886,HP_DUODENAL_ADENOCARCINOMA,1
HP_FIBULAR_HYPOPLASIA,SET,22,-0.27151,-0.0093882,0.17567,0.93888,HP_FIBULAR_HYPOPLASIA,1
MANNO_MIDBRAIN_NEUROTYPES_HP...4,SET,298,-0.077668,-0.0098096,0.050246,0.93891,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM,1
HP_EYE_POKING,SET,5,-0.6058,-0.0099909,0.39176,0.93898,HP_EYE_POKING,1
MIR3123,SET,229,-0.089979,-0.0099813,0.058183,0.939,MIR3123,1
MIR128_2_5P,SET,11,-0.43004,-0.010518,0.27796,0.93908,MIR128_2_5P,1
HP_ABNORMAL_CHORIORETINAL_MO...,SET,135,-0.11477,-0.0098007,0.074159,0.93914,HP_ABNORMAL_CHORIORETINAL_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C2_PRE...,SET,509,-0.05863,-0.0096212,0.037878,0.93916,HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL,1
REACTOME_SYNTHESIS_OF_KETONE...,SET,8,-0.50021,-0.010434,0.32313,0.93918,REACTOME_SYNTHESIS_OF_KETONE_BODIES,1
GSE27786_BCELL_VS_MONO_MAC_DN,SET,180,-0.097855,-0.0096368,0.063208,0.9392,GSE27786_BCELL_VS_MONO_MAC_DN,1
GOBP_REGULATION_OF_POLYSACCH...2,SET,39,-0.21318,-0.0098102,0.13769,0.93921,GOBP_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS,1
HP_ABNORMAL_ENZYME_CONCENTRA...,SET,638,-0.053388,-0.0097731,0.034447,0.9394,HP_ABNORMAL_ENZYME_CONCENTRATION_OR_ACTIVITY,1
GOBP_AMINOGLYCAN_BIOSYNTHETI...,SET,74,-0.15721,-0.0099554,0.10143,0.93941,GOBP_AMINOGLYCAN_BIOSYNTHETIC_PROCESS,1
HP_DECREASED_VIGILANCE,SET,9,-0.44117,-0.0097605,0.28465,0.93941,HP_DECREASED_VIGILANCE,1
GOBP_POSITIVE_REGULATION_OF_...7,SET,7,-0.56136,-0.010954,0.36214,0.93944,GOBP_POSITIVE_REGULATION_OF_ACTION_POTENTIAL,1
GSE11961_MARGINAL_ZONE_BCELL...1,SET,188,-0.10035,-0.010097,0.06472,0.93948,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GOBP_CARDIAC_RIGHT_VENTRICLE...,SET,19,-0.3432,-0.011029,0.22131,0.93951,GOBP_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS,1
MIR6827_5P,SET,75,-0.14495,-0.0092411,0.093458,0.93954,MIR6827_5P,1
GOBP_LIPID_MODIFICATION,SET,168,-0.10121,-0.009632,0.065222,0.93963,GOBP_LIPID_MODIFICATION,1
BIOCARTA_BARRESTIN_SRC_PATHW...,SET,16,-0.3677,-0.010845,0.2369,0.93968,BIOCARTA_BARRESTIN_SRC_PATHWAY,1
GNF2_CD33,SET,43,-0.20963,-0.010128,0.13506,0.93968,GNF2_CD33,1
REACTOME_INTERFERON_GAMMA_SI...,SET,90,-0.14955,-0.01044,0.096347,0.93969,REACTOME_INTERFERON_GAMMA_SIGNALING,1
GOCC_MITOCHONDRIAL_MATRIX,SET,449,-0.060631,-0.0093605,0.03906,0.93969,GOCC_MITOCHONDRIAL_MATRIX,1
GSE17721_CTRL_VS_POLYIC_4H_B...1,SET,184,-0.098671,-0.0098235,0.063562,0.9397,GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN,1
GRAESSMANN_RESPONSE_TO_MC_AN...2,SET,567,-0.056265,-0.0097292,0.036244,0.93971,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP,1
REACTOME_MITOCHONDRIAL_CALCI...,SET,19,-0.32004,-0.010285,0.20612,0.93974,REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,1
GOCC_ATPASE_COMPLEX,SET,117,-0.11508,-0.009153,0.07412,0.93974,GOCC_ATPASE_COMPLEX,1
GSE29164_DAY3_VS_DAY7_CD8_TC...2,SET,178,-0.097606,-0.0095593,0.062855,0.93977,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP,1
GOBP_ENDOSOME_TO_PLASMA_MEMB...,SET,14,-0.36438,-0.010053,0.2346,0.9398,GOBP_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
MIR1295B_5P,SET,69,-0.15652,-0.0095725,0.10073,0.93988,MIR1295B_5P,1
HP_PATENT_DUCTUS_ARTERIOSUS_...,SET,5,-0.56999,-0.0094003,0.36674,0.93992,HP_PATENT_DUCTUS_ARTERIOSUS_AFTER_BIRTH_AT_TERM,1
GSE19401_UNSTIM_VS_PAM2CSK4_...2,SET,175,-0.099412,-0.0096545,0.063949,0.93996,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
GOBP_ENDOCRINE_HORMONE_SECRE...,SET,54,-0.19757,-0.010694,0.12708,0.93999,GOBP_ENDOCRINE_HORMONE_SECRETION,1
PID_S1P_S1P3_PATHWAY,SET,29,-0.25928,-0.010291,0.1667,0.94007,PID_S1P_S1P3_PATHWAY,1
HP_FUSION_OF_THE_CEREBELLAR_...,SET,5,-0.51526,-0.0084977,0.33119,0.94011,HP_FUSION_OF_THE_CEREBELLAR_HEMISPHERES,1
GOMF_SECONDARY_ACTIVE_SULFAT...,SET,11,-0.40291,-0.0098544,0.25894,0.94014,GOMF_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MODULE_77,SET,27,-0.22565,-0.0086428,0.14501,0.94015,MODULE_77,1
MIR452_3P,SET,118,-0.13255,-0.010587,0.08517,0.94017,MIR452_3P,1
GOBP_HEPARIN_METABOLIC_PROCE...,SET,17,-0.34801,-0.01058,0.22362,0.94017,GOBP_HEPARIN_METABOLIC_PROCESS,1
HP_SHORTENING_OF_ALL_PHALANG...,SET,6,-0.47916,-0.0086564,0.3079,0.94017,HP_SHORTENING_OF_ALL_PHALANGES_OF_THE_TOES,1
GSE360_CTRL_VS_B_MALAYI_LOW_...2,SET,180,-0.10188,-0.010033,0.065465,0.94017,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP,1
chr13q33,SET,18,-0.48649,-0.015218,0.31257,0.94018,chr13q33,1
MIR548AN,SET,438,-0.065685,-0.010019,0.042205,0.94018,MIR548AN,1
HP_MACULAR_THICKENING,SET,38,-0.22469,-0.010207,0.14437,0.94018,HP_MACULAR_THICKENING,1
GOBP_NEURONAL_ION_CHANNEL_CL...,SET,12,-0.39104,-0.009989,0.25123,0.9402,GOBP_NEURONAL_ION_CHANNEL_CLUSTERING,1
YIH_RESPONSE_TO_ARSENITE_C4,SET,16,-0.31553,-0.0093061,0.20269,0.94022,YIH_RESPONSE_TO_ARSENITE_C4,1
KEGG_MEDICUS_VARIANT_BCR_ABL...2,SET,13,-0.3541,-0.0094146,0.22748,0.94022,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,1
MIR1273H_5P,SET,176,-0.098996,-0.0096413,0.063595,0.94022,MIR1273H_5P,1
GOBP_NEGATIVE_REGULATION_OF_...589,SET,27,-0.25405,-0.0097304,0.16319,0.94022,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
GOBP_POSITIVE_REGULATION_OF_...638,SET,58,-0.17475,-0.0098017,0.11223,0.94027,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
GOCC_AXONEMAL_DYNEIN_COMPLEX,SET,18,-0.30826,-0.0096426,0.19797,0.94027,GOCC_AXONEMAL_DYNEIN_COMPLEX,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...4,SET,13,-0.41322,-0.010986,0.26537,0.94028,GOBP_GAMMA_AMINOBUTYRIC_ACID_SECRETION,1
GOMF_ARYLESTERASE_ACTIVITY,SET,6,-0.6781,-0.01225,0.43533,0.94034,GOMF_ARYLESTERASE_ACTIVITY,1
FAN_OVARY_CL4_T_LYMPHOCYTE_N...,SET,212,-0.091424,-0.0097625,0.058692,0.94034,FAN_OVARY_CL4_T_LYMPHOCYTE_NK_CELL_1,1
GOBP_CELLULAR_RESPONSE_TO_IN...4,SET,8,-0.48996,-0.01022,0.3145,0.94036,GOBP_CELLULAR_RESPONSE_TO_INSULIN_LIKE_GROWTH_FACTOR_STIMULUS,1
GOBP_POSITIVE_REGULATION_OF_...327,SET,23,-0.30564,-0.010806,0.19616,0.94039,GOBP_POSITIVE_REGULATION_OF_HEART_RATE,1
GOBP_INTRACELLULAR_OXYGEN_HO...,SET,6,-0.56144,-0.010143,0.36019,0.94046,GOBP_INTRACELLULAR_OXYGEN_HOMEOSTASIS,1
HP_CHOANAL_STENOSIS,SET,25,-0.27088,-0.0099838,0.17376,0.94048,HP_CHOANAL_STENOSIS,1
GSE360_L_MAJOR_VS_M_TUBERCUL...3,SET,166,-0.10328,-0.0097709,0.066251,0.94048,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN,1
HP_2_3_TOE_SYNDACTYLY,SET,81,-0.15126,-0.01002,0.097025,0.9405,HP_2_3_TOE_SYNDACTYLY,1
HP_POLYDACTYLY,SET,228,-0.088048,-0.009746,0.056475,0.9405,HP_POLYDACTYLY,1
DESCARTES_FETAL_PANCREAS_MES...,SET,63,-0.17762,-0.010382,0.11392,0.94051,DESCARTES_FETAL_PANCREAS_MESOTHELIAL_CELLS,1
MIR499A_5P,SET,160,-0.10741,-0.0099785,0.068879,0.94055,MIR499A_5P,1
KEGG_MEDICUS_VARIANT_MUTATIO...22,SET,5,-0.63326,-0.010444,0.40602,0.94057,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_GF_RT...1,SET,81,-0.1671,-0.011069,0.10714,0.94058,KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY,1
GOMF_OXIDATIVE_PHOSPHORYLATI...,SET,4,-0.64339,-0.009491,0.41247,0.94059,GOMF_OXIDATIVE_PHOSPHORYLATION_UNCOUPLER_ACTIVITY,1
MIR651_3P,SET,728,-0.051171,-0.0099807,0.032799,0.94063,MIR651_3P,1
MIR4436B_5P,SET,121,-0.12693,-0.010266,0.081342,0.94067,MIR4436B_5P,1
GOBP_ALLANTOIN_METABOLIC_PRO...,SET,9,-0.49934,-0.011048,0.31998,0.94068,GOBP_ALLANTOIN_METABOLIC_PROCESS,1
REACTOME_MITOTIC_SPINDLE_CHE...,SET,104,-0.12465,-0.0093506,0.079853,0.94073,REACTOME_MITOTIC_SPINDLE_CHECKPOINT,1
GSE24634_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.09638,-0.0095436,0.061742,0.94073,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN,1
HP_SEESAW_NYSTAGMUS,SET,6,-0.5763,-0.010411,0.36902,0.94081,HP_SEESAW_NYSTAGMUS,1
MIR545_5P,SET,285,-0.08073,-0.009975,0.051678,0.94087,MIR545_5P,1
GSE32255_UNSTIM_VS_4H_LPS_ST...2,SET,172,-0.10512,-0.010122,0.067293,0.94087,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP,1
GSE24142_EARLY_THYMIC_PROGEN...2,SET,183,-0.10604,-0.010529,0.067865,0.94091,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP,1
HP_CONSTIPATION,SET,388,-0.07091,-0.010194,0.045377,0.94093,HP_CONSTIPATION,1
HP_ABNORMAL_MITOCHONDRIA_IN_...,SET,25,-0.24275,-0.008947,0.15532,0.94095,HP_ABNORMAL_MITOCHONDRIA_IN_MUSCLE_TISSUE,1
MATSUDA_NATURAL_KILLER_DIFFE...,SET,437,-0.06507,-0.0099139,0.041628,0.94098,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1
BASSO_CD40_SIGNALING_UP,SET,95,-0.14509,-0.010405,0.09282,0.94099,BASSO_CD40_SIGNALING_UP,1
HP_EVERTED_LOWER_LIP_VERMILI...,SET,117,-0.13196,-0.010495,0.084415,0.94099,HP_EVERTED_LOWER_LIP_VERMILION,1
GOMF_MHC_CLASS_II_PROTEIN_CO...,SET,23,-0.30609,-0.010822,0.19578,0.94101,GOMF_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING,1
HP_ABNORMAL_HEART_SOUND,SET,39,-0.2222,-0.010225,0.14209,0.94106,HP_ABNORMAL_HEART_SOUND,1
GSE11961_MEMORY_BCELL_DAY7_V...1,SET,174,-0.10036,-0.0097193,0.06417,0.94109,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GSE19941_IL10_KO_VS_IL10_KO_...1,SET,150,-0.10426,-0.0093804,0.066649,0.94111,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN,1
MIR4424,SET,109,-0.1263,-0.0096979,0.080736,0.94113,MIR4424,1
DESCARTES_FETAL_ADRENAL_MYEL...,SET,151,-0.11924,-0.010763,0.076157,0.94128,DESCARTES_FETAL_ADRENAL_MYELOID_CELLS,1
GOBP_RESPONSE_TO_SODIUM_PHOS...,SET,9,-0.51806,-0.011462,0.33076,0.94135,GOBP_RESPONSE_TO_SODIUM_PHOSPHATE,1
GSE24814_STAT5_KO_VS_WT_PRE_...1,SET,183,-0.095916,-0.0095234,0.061237,0.94135,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN,1
ZIRN_TRETINOIN_RESPONSE_DN,SET,5,-0.56823,-0.0093713,0.36276,0.94136,ZIRN_TRETINOIN_RESPONSE_DN,1
HOWARD_NEUTROPHIL_INACT_MONO...2,SET,358,-0.076265,-0.01054,0.048689,0.94136,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
MIR4794,SET,88,-0.14841,-0.010245,0.094733,0.94139,MIR4794,1
GOBP_ADENYLATE_CYCLASE_INHIB...2,SET,8,-0.51667,-0.010777,0.32978,0.9414,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,1
CGCTGCT_MIR503,SET,21,-0.27205,-0.0091909,0.17362,0.94142,CGCTGCT_MIR503,1
MODULE_155,SET,24,-0.26168,-0.0094501,0.16697,0.94145,MODULE_155,1
WP_LEPTININSULIN_SIGNALING_O...,SET,16,-0.38395,-0.011324,0.24494,0.9415,WP_LEPTININSULIN_SIGNALING_OVERLAP,1
GOMF_HYDROLASE_ACTIVITY_ACTI...2,SET,128,-0.12321,-0.010247,0.078598,0.9415,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS,1
HOLLEMAN_PREDNISOLONE_RESIST...4,SET,16,-0.30384,-0.0089612,0.1938,0.94153,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,1
GOBP_REGULATION_OF_CYTOPLASM...3,SET,32,-0.22116,-0.0092206,0.14107,0.94153,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
GSE41867_NAIVE_VS_DAY8_LCMV_...6,SET,182,-0.091767,-0.0090869,0.058531,0.94153,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,1
TRAVAGLINI_LUNG_PROXIMAL_CIL...,SET,1478,-0.035377,-0.0096208,0.022564,0.94154,TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...567,SET,9,-0.48721,-0.010779,0.31064,0.9416,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,1
HP_INCOMPREHENSIBLE_SPEECH,SET,8,-0.44723,-0.0093288,0.28507,0.94165,HP_INCOMPREHENSIBLE_SPEECH,1
CHOW_RASSF1_TARGETS_UP,SET,22,-0.26013,-0.0089949,0.16578,0.94168,CHOW_RASSF1_TARGETS_UP,1
HP_ABNORMAL_PLATELET_MEMBRAN...,SET,6,-0.57244,-0.010341,0.36482,0.94168,HP_ABNORMAL_PLATELET_MEMBRANE_PROTEIN_EXPRESSION,1
WP_ALPHA_6_BETA_4_SIGNALING,SET,33,-0.24091,-0.010199,0.15345,0.94178,WP_ALPHA_6_BETA_4_SIGNALING,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...3,SET,96,-0.1434,-0.010337,0.091338,0.94178,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP,1
RAF_UP.V1_UP,SET,176,-0.10969,-0.010682,0.069861,0.94179,RAF_UP.V1_UP,1
GOBP_N_ACYLETHANOLAMINE_META...,SET,5,-0.52918,-0.0087272,0.337,0.94181,GOBP_N_ACYLETHANOLAMINE_METABOLIC_PROCESS,1
SHEPARD_CRASH_AND_BURN_MUTAN...2,SET,187,-0.099699,-0.010006,0.063486,0.94183,SHEPARD_CRASH_AND_BURN_MUTANT_UP,1
CGGTGTG_MIR220,SET,5,-0.64927,-0.010708,0.41345,0.94183,CGGTGTG_MIR220,1
HP_ANTI_THYROID_ANTIBODY_POS...,SET,10,-0.42809,-0.0099831,0.27255,0.94186,HP_ANTI_THYROID_ANTIBODY_POSITIVITY,1
GOMF_MECHANOSENSITIVE_MONOAT...2,SET,16,-0.3529,-0.010408,0.22468,0.94187,GOMF_MECHANOSENSITIVE_MONOATOMIC_ION_CHANNEL_ACTIVITY,1
BIOCARTA_WNT_LRP6_PATHWAY,SET,6,-0.62236,-0.011243,0.39612,0.94191,BIOCARTA_WNT_LRP6_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...79,SET,28,-0.27421,-0.010695,0.17453,0.94191,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_HEPATIC_S...,SET,7,-0.58696,-0.011453,0.37349,0.94196,GOBP_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,1
GOBP_SEMI_LUNAR_VALVE_DEVELO...,SET,48,-0.21358,-0.010901,0.13591,0.94196,GOBP_SEMI_LUNAR_VALVE_DEVELOPMENT,1
HP_CEREBELLAR_CORTICAL_ATROP...,SET,5,-0.60626,-0.0099985,0.38572,0.94199,HP_CEREBELLAR_CORTICAL_ATROPHY,1
HP_PREDOMINANTLY_LOWER_LIMB_...,SET,8,-0.48421,-0.0101,0.30801,0.94203,HP_PREDOMINANTLY_LOWER_LIMB_LYMPHEDEMA,1
HP_CRANIAL_NERVE_COMPRESSION,SET,49,-0.18205,-0.0093875,0.11579,0.94204,HP_CRANIAL_NERVE_COMPRESSION,1
HP_VASCULITIS_BY_ANATOMICAL_...,SET,14,-0.36279,-0.010009,0.23076,0.94204,HP_VASCULITIS_BY_ANATOMICAL_SITE,1
GOMF_ARYLSULFATASE_ACTIVITY,SET,9,-0.48846,-0.010807,0.31066,0.94205,GOMF_ARYLSULFATASE_ACTIVITY,1
GOMF_NEUROTRANSMITTER_RECEPT...3,SET,12,-0.42263,-0.010796,0.26876,0.94207,GOMF_NEUROTRANSMITTER_RECEPTOR_REGULATOR_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_GLYCO...5,SET,5,-0.51894,-0.0085584,0.32998,0.94209,KEGG_MEDICUS_REFERENCE_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE,1
HP_TALIPES_EQUINOVARUS,SET,347,-0.073543,-0.01001,0.046765,0.94209,HP_TALIPES_EQUINOVARUS,1
GSE36476_YOUNG_VS_OLD_DONOR_...7,SET,166,-0.11145,-0.010544,0.070866,0.94209,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN,1
GSE14908_ATOPIC_VS_NONATOPIC...2,SET,178,-0.096988,-0.0094987,0.061665,0.94211,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP,1
GNF2_LYN,SET,23,-0.29288,-0.010354,0.18619,0.94213,GNF2_LYN,1
GSE27241_WT_VS_RORGT_KO_TH17...1,SET,152,-0.10409,-0.009427,0.06617,0.94214,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN,1
HP_DELAYED_ABILITY_TO_WALK,SET,253,-0.083111,-0.0096842,0.05282,0.94219,HP_DELAYED_ABILITY_TO_WALK,1
KEGG_MEDICUS_REFERENCE_OKAZA...,SET,11,-0.36501,-0.0089274,0.23189,0.94225,KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION,1
HP_PREMATURE_ADRENARCHE,SET,10,-0.47816,-0.011151,0.30366,0.94232,HP_PREMATURE_ADRENARCHE,1
GOBP_ORGANIC_ACID_METABOLIC_...,SET,857,-0.048234,-0.01017,0.030625,0.94236,GOBP_ORGANIC_ACID_METABOLIC_PROCESS,1
GSE3982_EOSINOPHIL_VS_NEUTRO...2,SET,179,-0.093182,-0.0091514,0.059164,0.94236,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP,1
RB_P130_DN.V1_DN,SET,119,-0.12277,-0.0098469,0.077938,0.94238,RB_P130_DN.V1_DN,1
GOBP_RADIAL_GLIAL_CELL_DIFFE...,SET,14,-0.39731,-0.010962,0.25218,0.94242,GOBP_RADIAL_GLIAL_CELL_DIFFERENTIATION,1
GSE46606_UNSTIM_VS_CD40L_IL2...2,SET,171,-0.1034,-0.0099274,0.065623,0.94244,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,1
chr1q21,SET,161,-0.23509,-0.021907,0.14915,0.9425,chr1q21,1
GOBP_REGULATION_OF_NUCLEOTID...5,SET,28,-0.26034,-0.010154,0.16515,0.94252,GOBP_REGULATION_OF_NUCLEOTIDE_EXCISION_REPAIR,1
REACTOME_SIGNAL_ATTENUATION,SET,10,-0.43093,-0.010049,0.27335,0.94253,REACTOME_SIGNAL_ATTENUATION,1
GOMF_THIOL_OXIDASE_ACTIVITY,SET,4,-0.55807,-0.0082323,0.35397,0.94255,GOMF_THIOL_OXIDASE_ACTIVITY,1
HP_ABNORMAL_FOURTH_TOE_MORPH...,SET,8,-0.54554,-0.01138,0.34601,0.94256,HP_ABNORMAL_FOURTH_TOE_MORPHOLOGY,1
GOMF_LACTATE_DEHYDROGENASE_A...,SET,6,-0.70899,-0.012808,0.44964,0.94257,GOMF_LACTATE_DEHYDROGENASE_ACTIVITY,1
HP_ABNORMAL_CARTILAGE_MORPHO...,SET,41,-0.22182,-0.010466,0.14067,0.94259,HP_ABNORMAL_CARTILAGE_MORPHOLOGY,1
HP_HORIZONTAL_EYEBROW,SET,32,-0.23798,-0.0099216,0.15089,0.94261,HP_HORIZONTAL_EYEBROW,1
GSE32986_UNSTIM_VS_GMCSF_STI...1,SET,180,-0.097094,-0.0095619,0.061561,0.94262,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN,1
GOMF_ATP_DEPENDENT_PROTEIN_D...,SET,6,-0.53486,-0.0096626,0.33908,0.94263,GOMF_ATP_DEPENDENT_PROTEIN_DISAGGREGASE_ACTIVITY,1
HP_CONJUGATED_HYPERBILIRUBIN...,SET,34,-0.25741,-0.011062,0.16319,0.94264,HP_CONJUGATED_HYPERBILIRUBINEMIA,1
GLASS_IGF2BP1_CLIP_TARGETS_K...,SET,105,-0.12685,-0.009561,0.080415,0.94265,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,1
MIR3189_5P,SET,47,-0.18955,-0.0095733,0.12013,0.94269,MIR3189_5P,1
MODULE_430,SET,52,-0.18429,-0.0097891,0.11678,0.94272,MODULE_430,1
GOBP_EPITHELIAL_CELL_MORPHOG...,SET,30,-0.26899,-0.010859,0.17046,0.94272,GOBP_EPITHELIAL_CELL_MORPHOGENESIS,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...2,SET,98,-0.14692,-0.0107,0.093093,0.94273,HE_LIM_SUN_FETAL_LUNG_C1_LATE_BASAL_CELL,1
HP_NARROW_FOREHEAD,SET,150,-0.10907,-0.009813,0.069095,0.94276,HP_NARROW_FOREHEAD,1
RICKMAN_METASTASIS_DN,SET,243,-0.087499,-0.0099947,0.055432,0.94277,RICKMAN_METASTASIS_DN,1
GAVISH_3CA_METAPROGRAM_CD8_T...3,SET,43,-0.23302,-0.011258,0.14759,0.94281,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CYTOTOXIC,1
GNF2_TM4SF2,SET,23,-0.30628,-0.010828,0.19399,0.94281,GNF2_TM4SF2,1
MIR4647_MIR4662B,SET,77,-0.15131,-0.0097738,0.095829,0.94282,MIR4647_MIR4662B,1
GSE41867_DAY6_VS_DAY8_LCMV_C...2,SET,179,-0.10047,-0.0098672,0.063612,0.94287,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
HP_FRONTAL_UPSWEEP_OF_HAIR,SET,20,-0.32758,-0.010801,0.20737,0.94291,HP_FRONTAL_UPSWEEP_OF_HAIR,1
GSE17721_LPS_VS_POLYIC_8H_BM...2,SET,179,-0.097909,-0.0096155,0.061972,0.94293,GSE17721_LPS_VS_POLYIC_8H_BMDC_UP,1
chr7q34,SET,50,-0.34763,-0.018108,0.22,0.94295,chr7q34,1
GOBP_BRANCH_ELONGATION_INVOL...,SET,5,-0.70065,-0.011555,0.44343,0.94295,GOBP_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING,1
HP_MYDRIASIS,SET,16,-0.33619,-0.0099154,0.21275,0.94296,HP_MYDRIASIS,1
HP_HEMIVERTEBRAE,SET,47,-0.18876,-0.0095333,0.11944,0.94297,HP_HEMIVERTEBRAE,1
BROWNE_HCMV_INFECTION_4HR_UP,SET,47,-0.20449,-0.010328,0.12939,0.94299,BROWNE_HCMV_INFECTION_4HR_UP,1
DESCARTES_FETAL_ADRENAL_MEGA...,SET,86,-0.14951,-0.010204,0.094596,0.943,DESCARTES_FETAL_ADRENAL_MEGAKARYOCYTES,1
MODULE_285,SET,41,-0.19979,-0.0094261,0.12639,0.94303,MODULE_285,1
HP_ABNORMAL_CURVATURE_OF_THE...,SET,1027,-0.042457,-0.0097521,0.026853,0.94306,HP_ABNORMAL_CURVATURE_OF_THE_VERTEBRAL_COLUMN,1
WP_PURINE_METABOLISM_AND_REL...,SET,20,-0.31411,-0.010356,0.19865,0.94308,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,1
GOBP_CELLULAR_LIPID_BIOSYNTH...,SET,11,-0.42551,-0.010407,0.26909,0.94309,GOBP_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS,1
BUSSLINGER_GASTRIC_PARIETAL_...,SET,221,-0.088175,-0.0096109,0.055758,0.9431,BUSSLINGER_GASTRIC_PARIETAL_CELLS,1
GOBP_POLYSACCHARIDE_CATABOLI...,SET,26,-0.25501,-0.0095849,0.16124,0.94312,GOBP_POLYSACCHARIDE_CATABOLIC_PROCESS,1
GOBP_CRANIAL_NERVE_STRUCTURA...,SET,10,-0.49319,-0.011501,0.31177,0.94315,GOBP_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION,1
HP_GENERALIZED_AMYLOID_DEPOS...,SET,6,-0.57429,-0.010375,0.36302,0.94317,HP_GENERALIZED_AMYLOID_DEPOSITION,1
PECE_MAMMARY_STEM_CELL_UP,SET,121,-0.11894,-0.0096193,0.075181,0.94318,PECE_MAMMARY_STEM_CELL_UP,1
GOCC_SWI_SNF_COMPLEX,SET,28,-0.24841,-0.0096889,0.15701,0.94318,GOCC_SWI_SNF_COMPLEX,1
HP_ABNORMAL_NASAL_MORPHOLOGY,SET,1289,-0.038613,-0.009861,0.024403,0.9432,HP_ABNORMAL_NASAL_MORPHOLOGY,1
MIR4460,SET,78,-0.15376,-0.0099956,0.09717,0.94321,MIR4460,1
HP_CRYPTOZOOSPERMIA,SET,6,-0.54049,-0.0097644,0.34154,0.94323,HP_CRYPTOZOOSPERMIA,1
HP_PES_CAVUS,SET,252,-0.085743,-0.0099713,0.05418,0.94323,HP_PES_CAVUS,1
LMO2COM_01,SET,241,-0.091047,-0.010358,0.057528,0.94324,LMO2COM_01,1
NKX6_1_TARGET_GENES,SET,23,-0.28032,-0.0099107,0.1771,0.94327,NKX6_1_TARGET_GENES,1
ACTWSNACTNY_UNKNOWN,SET,96,-0.13011,-0.0093788,0.082191,0.94328,ACTWSNACTNY_UNKNOWN,1
HP_LOW_ANTERIOR_HAIRLINE,SET,130,-0.11637,-0.0097527,0.073513,0.94328,HP_LOW_ANTERIOR_HAIRLINE,1
REACTOME_FREE_FATTY_ACID_REC...,SET,4,-0.80617,-0.011892,0.50921,0.9433,REACTOME_FREE_FATTY_ACID_RECEPTORS,1
GOMF_ARACHIDONATE_COA_LIGASE...,SET,10,-0.41068,-0.0095772,0.25937,0.94332,GOMF_ARACHIDONATE_COA_LIGASE_ACTIVITY,1
MIR3678_3P,SET,115,-0.13154,-0.010373,0.08306,0.94336,MIR3678_3P,1
GOMF_HIGH_DENSITY_LIPOPROTEI...,SET,11,-0.43897,-0.010736,0.27704,0.94345,GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,1
MIR367_3P,SET,386,-0.071168,-0.010205,0.044912,0.94346,MIR367_3P,1
GOBP_SENSORY_PERCEPTION_OF_T...3,SET,5,-0.60545,-0.0099852,0.38205,0.94348,GOBP_SENSORY_PERCEPTION_OF_TOUCH,1
KEGG_MEDICUS_PATHOGEN_KSHV_M...2,SET,6,-0.64257,-0.011609,0.40541,0.94351,KEGG_MEDICUS_PATHOGEN_KSHV_MIR2_TO_CELL_SURFACE_MOLECULE_ENDOCYTOSIS,1
MIR92B_3P,SET,432,-0.06738,-0.010208,0.04251,0.94351,MIR92B_3P,1
HP_EDEMA_OF_THE_DORSUM_OF_HA...,SET,14,-0.3499,-0.0096536,0.22067,0.94358,HP_EDEMA_OF_THE_DORSUM_OF_HANDS,1
GOMF_APOLIPOPROTEIN_A_I_BIND...,SET,5,-0.54953,-0.0090629,0.34649,0.94362,GOMF_APOLIPOPROTEIN_A_I_BINDING,1
GSE24972_MARGINAL_ZONE_BCELL...4,SET,171,-0.10474,-0.010056,0.066039,0.94362,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP,1
ZNF157_TARGET_GENES,SET,58,-0.17856,-0.010015,0.11255,0.94368,ZNF157_TARGET_GENES,1
GSE22601_DOUBLE_NEGATIVE_VS_...7,SET,164,-0.10542,-0.0099143,0.066446,0.94369,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN,1
MIR550B_2_5P,SET,46,-0.20604,-0.010295,0.12982,0.94375,MIR550B_2_5P,1
GOBP_POSITIVE_REGULATION_OF_...662,SET,66,-0.17943,-0.010733,0.11304,0.94377,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
HP_ABNORMAL_CIRCLE_OF_WILLIS...,SET,6,-0.58519,-0.010572,0.36859,0.9438,HP_ABNORMAL_CIRCLE_OF_WILLIS_MORPHOLOGY,1
TOMIDA_METASTASIS_UP,SET,23,-0.28882,-0.010211,0.18192,0.94381,TOMIDA_METASTASIS_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...83,SET,8,-0.51329,-0.010707,0.3233,0.94381,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
MODULE_110,SET,4,-0.55097,-0.0081276,0.34703,0.94381,MODULE_110,1
KEGG_MEDICUS_VARIANT_EGF_OVE...2,SET,14,-0.35864,-0.0098948,0.22585,0.94384,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
DESCARTES_MAIN_FETAL_LENS_FI...,SET,137,-0.11791,-0.010143,0.074238,0.94388,DESCARTES_MAIN_FETAL_LENS_FIBRE_CELLS,1
GSE15324_ELF4_KO_VS_WT_ACTIV...1,SET,180,-0.10016,-0.0098642,0.063057,0.9439,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN,1
GOMF_HISTONE_H3K4ME_H3K4ME2_...,SET,2,-1.0742,-0.011205,0.6762,0.94391,GOMF_HISTONE_H3K4ME_H3K4ME2_H3K4ME3_DEMETHYLASE_ACTIVITY,1
GSE45365_CD8A_DC_VS_CD11B_DC...2,SET,167,-0.10793,-0.010242,0.067943,0.94391,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN,1
MORF_ARAF1,SET,70,-0.15185,-0.0093536,0.095583,0.94392,MORF_ARAF1,1
HP_ABNORMAL_SARCOMERE_MORPHO...,SET,12,-0.40506,-0.010347,0.25482,0.94402,HP_ABNORMAL_SARCOMERE_MORPHOLOGY,1
GSE9006_TYPE_1_VS_TYPE_2_DIA...2,SET,181,-0.09284,-0.009168,0.058405,0.94403,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,1
HOXA13_TARGET_GENES,SET,39,-0.21893,-0.010075,0.13771,0.94406,HOXA13_TARGET_GENES,1
MODULE_105,SET,188,-0.095947,-0.0096545,0.060333,0.94411,MODULE_105,1
ATTACAT_MIR3803P,SET,86,-0.15417,-0.010522,0.096932,0.94413,ATTACAT_MIR3803P,1
GOCC_LARGE_RIBOSOMAL_SUBUNIT,SET,104,-0.12468,-0.0093528,0.078374,0.94417,GOCC_LARGE_RIBOSOMAL_SUBUNIT,1
REACTOME_GP1B_IX_V_ACTIVATIO...,SET,11,-0.45162,-0.011046,0.28386,0.94419,REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,1
IIZUKA_LIVER_CANCER_PROGRESS...7,SET,8,-0.46046,-0.009605,0.28939,0.9442,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...4,SET,13,-0.37565,-0.0099874,0.23606,0.94422,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY,1
GOBP_B_CELL_CHEMOTAXIS,SET,8,-0.56472,-0.01178,0.3548,0.94426,GOBP_B_CELL_CHEMOTAXIS,1
GOBP_EMBRYONIC_HEMOPOIESIS,SET,23,-0.29164,-0.010311,0.18317,0.94432,GOBP_EMBRYONIC_HEMOPOIESIS,1
MCBRYAN_TERMINAL_END_BUD_DN,SET,6,-0.62503,-0.011292,0.39251,0.94434,MCBRYAN_TERMINAL_END_BUD_DN,1
REACTOME_SYNTHESIS_OF_DIPHTH...,SET,8,-0.42988,-0.0089671,0.26994,0.94436,REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2,1
GSE12845_NAIVE_VS_PRE_GC_TON...2,SET,180,-0.10319,-0.010162,0.064769,0.94443,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP,1
HP_EEG_WITH_GENERALIZED_SHAR...,SET,8,-0.4888,-0.010196,0.30671,0.94449,HP_EEG_WITH_GENERALIZED_SHARP_SLOW_WAVES,1
HP_FLARED_METAPHYSIS,SET,49,-0.18399,-0.0094875,0.11545,0.94449,HP_FLARED_METAPHYSIS,1
HP_ENURESIS,SET,29,-0.26837,-0.010652,0.16838,0.9445,HP_ENURESIS,1
BAUS_TFF2_TARGETS_UP,SET,31,-0.24668,-0.010123,0.15475,0.94453,BAUS_TFF2_TARGETS_UP,1
HP_DIFFUSE_CEREBELLAR_ATROPHY,SET,15,-0.31018,-0.0088578,0.19457,0.94454,HP_DIFFUSE_CEREBELLAR_ATROPHY,1
GOBP_AMINO_ACID_NEUROTRANSMI...,SET,10,-0.50346,-0.011741,0.31576,0.94457,GOBP_AMINO_ACID_NEUROTRANSMITTER_REUPTAKE,1
GOMF_4_GALACTOSYL_N_ACETYLGL...,SET,6,-0.69158,-0.012494,0.43375,0.94457,GOMF_4_GALACTOSYL_N_ACETYLGLUCOSAMINIDE_3_ALPHA_L_FUCOSYLTRANSFERASE_ACTIVITY,1
HP_THORACIC_KYPHOSIS,SET,43,-0.19629,-0.0094837,0.1231,0.94458,HP_THORACIC_KYPHOSIS,1
PRDM5_TARGET_GENES,SET,79,-0.15424,-0.010091,0.096723,0.94459,PRDM5_TARGET_GENES,1
GOBP_HISTAMINE_TRANSPORT,SET,15,-0.35167,-0.010043,0.22053,0.94459,GOBP_HISTAMINE_TRANSPORT,1
HP_SLANTING_OF_THE_PALPEBRAL...,SET,622,-0.05472,-0.0098951,0.034315,0.94459,HP_SLANTING_OF_THE_PALPEBRAL_FISSURE,1
GAVISH_3CA_METAPROGRAM_ENDOT...10,SET,46,-0.21974,-0.01098,0.13779,0.94461,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1,1
GSE16385_UNTREATED_VS_12H_IF...1,SET,171,-0.10391,-0.0099766,0.065143,0.94465,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,1
KEGG_DRUG_METABOLISM_CYTOCHR...,SET,65,-0.22954,-0.013627,0.14389,0.94467,KEGG_DRUG_METABOLISM_CYTOCHROME_P450,1
UNTERMAN_IPF_VS_CTRL_NK_CELL...1,SET,8,-0.53741,-0.01121,0.33677,0.94472,UNTERMAN_IPF_VS_CTRL_NK_CELL_DN,1
GSE17721_CPG_VS_GARDIQUIMOD_...3,SET,181,-0.099106,-0.0097868,0.062107,0.94472,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN,1
GOMF_EUKARYOTIC_INITIATION_F...,SET,9,-0.39119,-0.0086547,0.24507,0.94477,GOMF_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING,1
GSE37416_0H_VS_48H_F_TULAREN...2,SET,177,-0.10345,-0.010104,0.064802,0.9448,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
MORF_GMPS,SET,40,-0.1959,-0.0091293,0.1227,0.94481,MORF_GMPS,1
HP_NEONATAL_ONSET,SET,427,-0.066286,-0.0099857,0.041514,0.94482,HP_NEONATAL_ONSET,1
DAWSON_METHYLATED_IN_LYMPHOM...,SET,55,-0.22016,-0.012026,0.13782,0.9449,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,1
MIR455_5P,SET,82,-0.15244,-0.01016,0.095431,0.9449,MIR455_5P,1
GNF2_MSH2,SET,26,-0.24084,-0.0090524,0.15075,0.94493,GNF2_MSH2,1
GSE46606_IRF4HIGH_VS_IRF4MID...1,SET,178,-0.10369,-0.010155,0.064904,0.94493,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...478,SET,43,-0.22286,-0.010767,0.13949,0.94494,GOBP_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,1
GOBP_SPHINGOMYELIN_BIOSYNTHE...,SET,11,-0.4022,-0.009837,0.25173,0.94494,GOBP_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS,1
HP_TITUBATION,SET,29,-0.25908,-0.010284,0.16215,0.94495,HP_TITUBATION,1
GSE411_100MIN_VS_400MIN_IL6_...3,SET,183,-0.096583,-0.0095897,0.060443,0.94496,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
HP_ABNORMAL_CIRCULATING_AROM...,SET,18,-0.34851,-0.010902,0.21803,0.94502,HP_ABNORMAL_CIRCULATING_AROMATIC_AMINO_ACID_CONCENTRATION,1
HP_CERVICAL_RIBS,SET,10,-0.40975,-0.0095555,0.25635,0.94502,HP_CERVICAL_RIBS,1
GOMF_MECHANOSENSITIVE_MONOAT...1,SET,5,-0.58569,-0.0096593,0.36635,0.94505,GOMF_MECHANOSENSITIVE_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
REACTOME_GLUTATHIONE_CONJUGA...,SET,32,-0.27375,-0.011413,0.17117,0.94511,REACTOME_GLUTATHIONE_CONJUGATION,1
REACTOME_RRNA_MODIFICATION_I...1,SET,4,-0.75014,-0.011066,0.469,0.94513,REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION,1
GSE25123_ROSIGLITAZONE_VS_IL...3,SET,175,-0.10535,-0.010231,0.065846,0.94519,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,1
MODULE_343,SET,24,-0.2676,-0.009664,0.16724,0.9452,MODULE_343,1
BLANCO_MELO_INFLUENZA_A_INFE...2,SET,37,-0.23503,-0.010535,0.14687,0.94522,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,1
GOBP_REGULATION_OF_GOLGI_ORG...,SET,15,-0.34906,-0.0099683,0.21813,0.94522,GOBP_REGULATION_OF_GOLGI_ORGANIZATION,1
GSE5142_CTRL_VS_HTERT_TRANSD...1,SET,176,-0.10206,-0.0099393,0.063761,0.94526,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN,1
GSE21033_CTRL_VS_POLYIC_STIM...7,SET,178,-0.096335,-0.0094348,0.060171,0.94531,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN,1
GOCC_RSC_TYPE_COMPLEX,SET,15,-0.34918,-0.0099716,0.21808,0.94532,GOCC_RSC_TYPE_COMPLEX,1
GOMF_PROTEIN_CONTAINING_COMP...2,SET,15,-0.35255,-0.010068,0.22018,0.94532,GOMF_PROTEIN_CONTAINING_COMPLEX_DESTABILIZING_ACTIVITY,1
HP_TOOTH_MALPOSITION,SET,349,-0.075014,-0.010239,0.046842,0.94535,HP_TOOTH_MALPOSITION,1
HP_ATLANTOAXIAL_ABNORMALITY,SET,12,-0.37788,-0.0096528,0.23596,0.94536,HP_ATLANTOAXIAL_ABNORMALITY,1
MIR486_3P,SET,152,-0.1119,-0.010135,0.06987,0.94537,MIR486_3P,1
MIR6765_5P,SET,7,-0.48474,-0.0094585,0.30252,0.94545,MIR6765_5P,1
HP_HEMIPLEGIA_HEMIPARESIS,SET,192,-0.10166,-0.010337,0.063406,0.94556,HP_HEMIPLEGIA_HEMIPARESIS,1
BIOCARTA_AT1R_PATHWAY,SET,26,-0.27674,-0.010402,0.17259,0.94557,BIOCARTA_AT1R_PATHWAY,1
KRIGE_RESPONSE_TO_TOSEDOSTAT...1,SET,913,-0.045077,-0.0097944,0.028111,0.94558,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN,1
WP_ULCERATIVE_COLITIS_SIGNAL...,SET,16,-0.35739,-0.010541,0.22287,0.94559,WP_ULCERATIVE_COLITIS_SIGNALING,1
GOBP_MACROPHAGE_INFLAMMATORY...,SET,6,-0.58551,-0.010578,0.36511,0.9456,GOBP_MACROPHAGE_INFLAMMATORY_PROTEIN_1_ALPHA_PRODUCTION,1
GSE21379_TFH_VS_NON_TFH_SAP_...1,SET,172,-0.10527,-0.010137,0.065636,0.94562,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_CREAT...,SET,7,-0.49599,-0.0096782,0.30921,0.94564,KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY,1
ZNF667_TARGET_GENES,SET,120,-0.12405,-0.009991,0.077328,0.94565,ZNF667_TARGET_GENES,1
SERVITJA_LIVER_HNF1A_TARGETS...1,SET,152,-0.11789,-0.010677,0.073471,0.9457,SERVITJA_LIVER_HNF1A_TARGETS_DN,1
GOBP_CORTICOSTEROID_HORMONE_...,SET,18,-0.34458,-0.010779,0.21474,0.94571,GOBP_CORTICOSTEROID_HORMONE_SECRETION,1
GSE11864_UNTREATED_VS_CSF1_I...3,SET,164,-0.10475,-0.0098507,0.065266,0.94574,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...343,SET,49,-0.20371,-0.010504,0.12692,0.94575,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,1
GSE21546_WT_VS_ELK1_KO_DP_TH...2,SET,183,-0.099756,-0.0099047,0.062142,0.94578,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP,1
KEGG_TYPE_II_DIABETES_MELLIT...,SET,46,-0.22122,-0.011054,0.13778,0.94581,KEGG_TYPE_II_DIABETES_MELLITUS,1
GSE4142_PLASMA_CELL_VS_MEMOR...2,SET,175,-0.10924,-0.010609,0.068035,0.94582,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP,1
WP_TRANSCRIPTION_FACTORS_REG...,SET,8,-0.44033,-0.0091851,0.27421,0.94584,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,1
GOBP_INHIBITORY_SYNAPSE_ASSE...,SET,23,-0.33713,-0.011919,0.20994,0.94584,GOBP_INHIBITORY_SYNAPSE_ASSEMBLY,1
HP_PULMONARY_ARTERY_DILATATI...,SET,12,-0.405,-0.010346,0.25217,0.94586,HP_PULMONARY_ARTERY_DILATATION,1
REACTOME_GAB1_SIGNALOSOME,SET,17,-0.35582,-0.010817,0.22151,0.94589,REACTOME_GAB1_SIGNALOSOME,1
TTGCCAA_MIR182,SET,298,-0.083925,-0.0106,0.052222,0.94597,TTGCCAA_MIR182,1
GOBP_HOMOSERINE_METABOLIC_PR...,SET,3,-0.84586,-0.010806,0.52635,0.94597,GOBP_HOMOSERINE_METABOLIC_PROCESS,1
GSE360_L_MAJOR_VS_T_GONDII_D...2,SET,178,-0.10843,-0.01062,0.067467,0.94599,GSE360_L_MAJOR_VS_T_GONDII_DC_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...30,SET,182,-0.099817,-0.0098839,0.062096,0.94601,HP_APLASIA_HYPOPLASIA_OF_THE_EYEBROW,1
GOCC_CALCIUM_AND_CALMODULIN_...,SET,5,-0.6632,-0.010938,0.41257,0.94602,GOCC_CALCIUM_AND_CALMODULIN_DEPENDENT_PROTEIN_KINASE_COMPLEX,1
DESCARTES_FETAL_THYMUS_THYMI...,SET,197,-0.10767,-0.011088,0.066978,0.94603,DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS,1
RUVBL2_TARGET_GENES,SET,29,-0.25249,-0.010022,0.15704,0.94606,RUVBL2_TARGET_GENES,1
HP_ULNAR_BOWING,SET,16,-0.36784,-0.010849,0.22873,0.94609,HP_ULNAR_BOWING,1
GSE21927_SPLENIC_C26GM_TUMOR...4,SET,135,-0.11842,-0.010112,0.073605,0.94616,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP,1
HP_HYPERPLASIA_OF_MIDFACE,SET,4,-0.87006,-0.012835,0.5408,0.94617,HP_HYPERPLASIA_OF_MIDFACE,1
MIR363_3P,SET,385,-0.072332,-0.010359,0.044955,0.94618,MIR363_3P,1
HP_ABNORMAL_LOWER_LIMB_BONE_...,SET,671,-0.053813,-0.010093,0.033444,0.94619,HP_ABNORMAL_LOWER_LIMB_BONE_MORPHOLOGY,1
GOBP_REGULATION_OF_SYNAPTIC_...2,SET,194,-0.10082,-0.010304,0.062646,0.94622,GOBP_REGULATION_OF_SYNAPTIC_PLASTICITY,1
MIR3529_3P,SET,493,-0.064348,-0.010397,0.039981,0.94623,MIR3529_3P,1
MIR3133,SET,447,-0.067078,-0.010333,0.041673,0.94625,MIR3133,1
HP_FIRST_DORSAL_INTEROSSEI_M...,SET,7,-0.5739,-0.011198,0.35654,0.94625,HP_FIRST_DORSAL_INTEROSSEI_MUSCLE_WEAKNESS,1
GOBP_TRIGLYCERIDE_CATABOLIC_...,SET,27,-0.293,-0.011222,0.18202,0.94626,GOBP_TRIGLYCERIDE_CATABOLIC_PROCESS,1
HP_BILATERAL_CHOANAL_ATRESIA,SET,9,-0.38828,-0.0085903,0.24122,0.94626,HP_BILATERAL_CHOANAL_ATRESIA,1
GOMF_LOW_DENSITY_LIPOPROTEIN...2,SET,15,-0.38526,-0.011002,0.23933,0.94627,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,1
KIM_ALL_DISORDERS_DURATION_C...2,SET,8,-0.4352,-0.0090779,0.27032,0.94629,KIM_ALL_DISORDERS_DURATION_CORR_UP,1
MODULE_42,SET,24,-0.23962,-0.0086536,0.14883,0.9463,MODULE_42,1
MIR330_3P,SET,306,-0.083887,-0.010734,0.052098,0.94631,MIR330_3P,1
GSE22589_HEALTHY_VS_HIV_AND_...2,SET,182,-0.096369,-0.0095425,0.059845,0.94632,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP,1
HP_POSTERIORLY_ROTATED_EARS,SET,397,-0.069876,-0.010159,0.043386,0.94635,HP_POSTERIORLY_ROTATED_EARS,1
GSE3920_UNTREATED_VS_IFNB_TR...2,SET,183,-0.10293,-0.010219,0.063907,0.94635,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,1
HP_ABNORMAL_FINGERTIP_MORPHO...,SET,76,-0.16384,-0.010515,0.10172,0.94637,HP_ABNORMAL_FINGERTIP_MORPHOLOGY,1
WP_TGFBETA_SIGNALING_IN_THYR...,SET,19,-0.32378,-0.010405,0.201,0.94639,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1
DESCARTES_FETAL_PLACENTA_AFP...,SET,156,-0.11869,-0.010889,0.073654,0.94645,DESCARTES_FETAL_PLACENTA_AFP_ALB_POSITIVE_CELLS,1
HP_ABNORMALITY_OF_THE_DISTAL...4,SET,34,-0.24247,-0.01042,0.15046,0.94646,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,1
GARGALOVIC_RESPONSE_TO_OXIDI...24,SET,27,-0.26558,-0.010172,0.16477,0.94649,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,1
GOBP_OXIDATIVE_PHOSPHORYLATI...,SET,105,-0.12052,-0.0090838,0.07476,0.94652,GOBP_OXIDATIVE_PHOSPHORYLATION,1
HP_DELAYED_ERUPTION_OF_TEETH,SET,153,-0.11538,-0.010484,0.071548,0.94658,HP_DELAYED_ERUPTION_OF_TEETH,1
ZHAN_VARIABLE_EARLY_DIFFEREN...1,SET,27,-0.24077,-0.0092217,0.14929,0.94659,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1
HP_RECURRENT_GASTROENTERITIS,SET,12,-0.37796,-0.009655,0.23433,0.94662,HP_RECURRENT_GASTROENTERITIS,1
GOBP_REGULATION_OF_ENDOCRINE...,SET,39,-0.2498,-0.011495,0.15485,0.94663,GOBP_REGULATION_OF_ENDOCRINE_PROCESS,1
REACTOME_EPITHELIAL_MESENCHY...,SET,6,-0.53323,-0.0096332,0.33053,0.94665,REACTOME_EPITHELIAL_MESENCHYMAL_TRANSITION_EMT_DURING_GASTRULATION,1
NAKAYA_PLASMACYTOID_DENDRITI...1,SET,168,-0.10085,-0.0095986,0.062514,0.94665,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
HP_ABNORMALITY_OF_THE_AMNIOT...,SET,418,-0.067082,-0.010001,0.041568,0.9467,HP_ABNORMALITY_OF_THE_AMNIOTIC_FLUID,1
HP_PROGRESSIVE_PROXIMAL_MUSC...,SET,21,-0.28454,-0.0096131,0.17632,0.9467,HP_PROGRESSIVE_PROXIMAL_MUSCLE_WEAKNESS,1
TRAVAGLINI_LUNG_CD4_MEMORY_E...,SET,63,-0.18738,-0.010952,0.1161,0.94673,TRAVAGLINI_LUNG_CD4_MEMORY_EFFECTOR_T_CELL,1
REACTOME_KETONE_BODY_METABOL...,SET,10,-0.47452,-0.011066,0.29398,0.94674,REACTOME_KETONE_BODY_METABOLISM,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...2,SET,6,-0.58094,-0.010495,0.35986,0.94677,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,1
HP_BRADYCARDIA,SET,90,-0.14938,-0.010428,0.092527,0.94677,HP_BRADYCARDIA,1
HTF_01,SET,65,-0.16458,-0.0097707,0.10194,0.94678,HTF_01,1
HP_PAROXYSMAL_DYSKINESIA,SET,15,-0.35388,-0.010106,0.21919,0.94678,HP_PAROXYSMAL_DYSKINESIA,1
HP_SOFT_DOUGHY_SKIN,SET,12,-0.4302,-0.010989,0.26645,0.94679,HP_SOFT_DOUGHY_SKIN,1
EBAUER_TARGETS_OF_PAX3_FOXO1...2,SET,172,-0.1092,-0.010514,0.067614,0.94683,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,1
MIR626,SET,51,-0.20558,-0.010815,0.1273,0.94684,MIR626,1
CHYLA_CBFA2T3_TARGETS_UP,SET,346,-0.078423,-0.010659,0.048556,0.94685,CHYLA_CBFA2T3_TARGETS_UP,1
MORF_SNRP70,SET,59,-0.15591,-0.0088197,0.09653,0.94685,MORF_SNRP70,1
GCM_GSTA4,SET,57,-0.17809,-0.0099027,0.11024,0.94689,GCM_GSTA4,1
GOBP_STRESS_GRANULE_ASSEMBLY,SET,32,-0.23534,-0.0098115,0.14565,0.94692,GOBP_STRESS_GRANULE_ASSEMBLY,1
GOBP_PROTEIN_LOCALIZATION_TO...27,SET,5,-0.51472,-0.0084888,0.31848,0.94696,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_MEMBRANE,1
CREBP1_01,SET,156,-0.11623,-0.010663,0.07191,0.94697,CREBP1_01,1
GOBP_PROTEIN_MATURATION,SET,489,-0.061763,-0.0099398,0.038211,0.94698,GOBP_PROTEIN_MATURATION,1
HP_ABNORMAL_FINGER_MORPHOLOGY,SET,1056,-0.043365,-0.010092,0.026829,0.94698,HP_ABNORMAL_FINGER_MORPHOLOGY,1
GOCC_PROTEASOME_REGULATORY_P...1,SET,11,-0.34168,-0.0083567,0.21138,0.94699,GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX,1
WANG_RECURRENT_LIVER_CANCER_...1,SET,16,-0.37453,-0.011046,0.23169,0.947,WANG_RECURRENT_LIVER_CANCER_DN,1
MIR6834_3P,SET,42,-0.21148,-0.010098,0.13082,0.94701,MIR6834_3P,1
GOBP_REGULATION_OF_NEUTROPHI...4,SET,4,-0.734,-0.010828,0.45401,0.94702,GOBP_REGULATION_OF_NEUTROPHIL_EXTRAVASATION,1
HP_CNS_DEMYELINATION,SET,45,-0.21331,-0.010542,0.13194,0.94702,HP_CNS_DEMYELINATION,1
GSE46242_TH1_VS_ANERGIC_TH1_...3,SET,169,-0.10589,-0.010107,0.065483,0.94705,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN,1
MIR874_5P,SET,55,-0.18163,-0.0099212,0.11231,0.94707,MIR874_5P,1
MIR365B_5P,SET,31,-0.26869,-0.011026,0.16613,0.94709,MIR365B_5P,1
CAHOY_ASTROCYTIC,SET,94,-0.14942,-0.010659,0.09237,0.94712,CAHOY_ASTROCYTIC,1
ZNF239_TARGET_GENES,SET,32,-0.25582,-0.010665,0.1581,0.94717,ZNF239_TARGET_GENES,1
GOBP_INTRACELLULAR_DISTRIBUT...,SET,7,-0.57284,-0.011178,0.354,0.94718,GOBP_INTRACELLULAR_DISTRIBUTION_OF_MITOCHONDRIA,1
GOBP_NEGATIVE_REGULATION_OF_...109,SET,71,-0.16647,-0.010327,0.10284,0.94724,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GSE24671_CTRL_VS_SENDAI_VIRU...2,SET,146,-0.11769,-0.010448,0.072708,0.94724,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,1
GOBP_CORNIFIED_ENVELOPE_ASSE...,SET,6,-0.53346,-0.0096374,0.32953,0.94725,GOBP_CORNIFIED_ENVELOPE_ASSEMBLY,1
GOBP_CRANIAL_NERVE_MORPHOGEN...,SET,29,-0.28294,-0.011231,0.17475,0.94728,GOBP_CRANIAL_NERVE_MORPHOGENESIS,1
GOCC_PHOTORECEPTOR_CONNECTIN...,SET,37,-0.21915,-0.0098233,0.13531,0.94734,GOCC_PHOTORECEPTOR_CONNECTING_CILIUM,1
GOBP_CRD_MEDIATED_MRNA_STABI...,SET,11,-0.40575,-0.0099237,0.25046,0.94737,GOBP_CRD_MEDIATED_MRNA_STABILIZATION,1
HP_HOARSE_VOICE,SET,91,-0.15086,-0.010589,0.093122,0.94738,HP_HOARSE_VOICE,1
HP_FOCAL_HEMICLONIC_SEIZURE,SET,23,-0.31436,-0.011114,0.19401,0.94742,HP_FOCAL_HEMICLONIC_SEIZURE,1
MIR4769_5P,SET,39,-0.22626,-0.010412,0.13961,0.94744,MIR4769_5P,1
LIAO_METASTASIS,SET,476,-0.062821,-0.0099784,0.038762,0.94745,LIAO_METASTASIS,1
RICKMAN_TUMOR_DIFFERENTIATED...2,SET,111,-0.12918,-0.010009,0.079708,0.94745,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,1
HE_LIM_SUN_FETAL_LUNG_C4_ILC...2,SET,68,-0.1816,-0.011026,0.11206,0.94745,HE_LIM_SUN_FETAL_LUNG_C4_ILC3_CELL,1
KEGG_GLIOMA,SET,64,-0.17776,-0.010472,0.10967,0.94747,KEGG_GLIOMA,1
REACTOME_THE_ROLE_OF_GTSE1_I...,SET,73,-0.1514,-0.009523,0.093358,0.94756,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1
ZNF512B_TARGET_GENES,SET,176,-0.11014,-0.010727,0.067913,0.94756,ZNF512B_TARGET_GENES,1
GOCC_SCAR_COMPLEX,SET,11,-0.41458,-0.01014,0.25564,0.94756,GOCC_SCAR_COMPLEX,1
HOSHIDA_LIVER_CANCER_SURVIVA...2,SET,71,-0.17564,-0.010896,0.10829,0.94758,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1
GSE24671_CTRL_VS_BAKIMULC_IN...1,SET,151,-0.12008,-0.01084,0.074037,0.94758,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN,1
MODULE_8,SET,395,-0.069571,-0.010089,0.042888,0.9476,MODULE_8,1
GOMF_ADENOSINE_RECEPTOR_BIND...,SET,7,-0.55967,-0.010921,0.34499,0.94762,GOMF_ADENOSINE_RECEPTOR_BINDING,1
GSE41978_ID2_KO_VS_BIM_KO_KL...1,SET,180,-0.10508,-0.010349,0.064776,0.94762,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
GOBP_PEPTIDYL_LYSINE_MONOMET...,SET,7,-0.45681,-0.0089135,0.28156,0.94763,GOBP_PEPTIDYL_LYSINE_MONOMETHYLATION,1
GSE37301_MULTIPOTENT_PROGENI...5,SET,188,-0.099994,-0.010062,0.061631,0.94764,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,1
GOBP_NEURON_NEURON_SYNAPTIC_...,SET,8,-0.53974,-0.011259,0.33262,0.94766,GOBP_NEURON_NEURON_SYNAPTIC_TRANSMISSION,1
GOMF_COLLAGEN_RECEPTOR_ACTIV...,SET,6,-0.54285,-0.009807,0.33451,0.94768,GOMF_COLLAGEN_RECEPTOR_ACTIVITY,1
DESCARTES_FETAL_STOMACH_LYMP...1,SET,19,-0.3669,-0.011791,0.22606,0.9477,DESCARTES_FETAL_STOMACH_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOBP_L_AMINO_ACID_METABOLIC_...,SET,161,-0.11033,-0.010281,0.067975,0.94771,GOBP_L_AMINO_ACID_METABOLIC_PROCESS,1
MIR3177_5P,SET,146,-0.11397,-0.010117,0.07021,0.94772,MIR3177_5P,1
GOBP_RESPONSE_TO_PURINE_CONT...,SET,136,-0.12266,-0.010512,0.075559,0.94773,GOBP_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,1
SU_TESTIS,SET,68,-0.16706,-0.010143,0.1029,0.94775,SU_TESTIS,1
CART1_01,SET,201,-0.10581,-0.011005,0.06517,0.94776,CART1_01,1
GOBP_INOSITOL_TRISPHOSPHATE_...2,SET,10,-0.49296,-0.011496,0.30363,0.94776,GOBP_INOSITOL_TRISPHOSPHATE_METABOLIC_PROCESS,1
MIR6856_5P,SET,93,-0.14228,-0.010096,0.087615,0.94779,MIR6856_5P,1
MIR6512_5P,SET,106,-0.13474,-0.010203,0.082964,0.94781,MIR6512_5P,1
GOBP_CLUSTERING_OF_VOLTAGE_G...,SET,6,-0.58954,-0.01065,0.36299,0.94781,GOBP_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS,1
GSE32128_INOS_DEPENDENT_VS_I...1,SET,181,-0.10325,-0.010196,0.063561,0.94785,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN,1
MIKKELSEN_MCV6_LCP_WITH_H3K4...,SET,146,-0.11941,-0.010601,0.073504,0.94786,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,1
GAO_SMALL_INTESTINE_24W_C1_T...,SET,8,-0.46491,-0.0096978,0.28618,0.94786,GAO_SMALL_INTESTINE_24W_C1_TUFT_PROGENITOR,1
GSE15930_NAIVE_VS_72H_IN_VIT...4,SET,187,-0.10002,-0.010037,0.061548,0.94791,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,1
KENNEDY_PBMC_DRYVAX_AGE_18_5...,SET,11,-0.44254,-0.010823,0.2723,0.94793,KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_UP,1
HP_SECRETORY_DIARRHEA,SET,12,-0.37681,-0.0096254,0.23174,0.94801,HP_SECRETORY_DIARRHEA,1
GOBP_FORMATION_OF_EXTRACHROM...,SET,13,-0.34891,-0.0092765,0.21458,0.94802,GOBP_FORMATION_OF_EXTRACHROMOSOMAL_CIRCULAR_DNA,1
GOBP_SYNAPTONEMAL_COMPLEX_OR...,SET,23,-0.25679,-0.0090787,0.15792,0.94803,GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION,1
PID_FOXO_PATHWAY,SET,47,-0.20766,-0.010488,0.12765,0.9481,PID_FOXO_PATHWAY,1
MIR6795_3P,SET,12,-0.42612,-0.010885,0.26191,0.94812,MIR6795_3P,1
GOMF_L_SERINE_TRANSMEMBRANE_...,SET,8,-0.48522,-0.010121,0.29824,0.94812,GOMF_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE39110_UNTREATED_VS_IL2_TR...3,SET,186,-0.10935,-0.010945,0.067214,0.94812,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN,1
MODULE_121,SET,94,-0.16325,-0.011645,0.1003,0.94819,MODULE_121,1
GSE3565_CTRL_VS_LPS_INJECTED...4,SET,160,-0.11805,-0.010967,0.072511,0.94823,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP,1
MIR203B_3P,SET,88,-0.15517,-0.010712,0.095305,0.94824,MIR203B_3P,1
MORF_SART1,SET,58,-0.16572,-0.009295,0.10178,0.94825,MORF_SART1,1
GOMF_UBIQUITIN_LIGASE_COMPLE...,SET,6,-0.51292,-0.0092662,0.315,0.94826,GOMF_UBIQUITIN_LIGASE_COMPLEX_SCAFFOLD_ACTIVITY,1
MIR876_5P,SET,123,-0.131,-0.010681,0.080448,0.94827,MIR876_5P,1
HP_LARGE_FACE,SET,225,-0.090667,-0.0099705,0.055678,0.94827,HP_LARGE_FACE,1
NAKAYA_MYELOID_DENDRITIC_CEL...2,SET,355,-0.072938,-0.010039,0.044789,0.94828,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,1
PLASARI_TGFB1_SIGNALING_VIA_...4,SET,27,-0.27562,-0.010557,0.16921,0.94832,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,1
MIR6789_5P,SET,20,-0.28819,-0.0095019,0.17691,0.94834,MIR6789_5P,1
HAND1_TARGET_GENES,SET,362,-0.074874,-0.010404,0.04595,0.94838,HAND1_TARGET_GENES,1
GOCC_MITOCHONDRIAL_PROTEIN_C...,SET,230,-0.085511,-0.0095061,0.052479,0.94838,GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX,1
HP_GENERALIZED_HIRSUTISM,SET,86,-0.15325,-0.010459,0.094052,0.94838,HP_GENERALIZED_HIRSUTISM,1
GOBP_DERMATAN_SULFATE_PROTEO...1,SET,8,-0.48368,-0.010089,0.29667,0.94848,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GOBP_LINOLEIC_ACID_METABOLIC...,SET,19,-0.32809,-0.010544,0.20121,0.9485,GOBP_LINOLEIC_ACID_METABOLIC_PROCESS,1
REACTOME_REGULATION_OF_BACH1...,SET,10,-0.43815,-0.010218,0.2687,0.94851,REACTOME_REGULATION_OF_BACH1_ACTIVITY,1
CDP_01,SET,88,-0.16573,-0.01144,0.10163,0.94851,CDP_01,1
HP_LATERAL_VENTRICLE_DILATAT...,SET,75,-0.15661,-0.0099843,0.096038,0.94852,HP_LATERAL_VENTRICLE_DILATATION,1
HP_DEVIATION_OF_THE_2ND_FING...,SET,19,-0.32478,-0.010438,0.19909,0.94858,HP_DEVIATION_OF_THE_2ND_FINGER,1
RAF_UP.V1_DN,SET,171,-0.11872,-0.011399,0.072772,0.94859,RAF_UP.V1_DN,1
MISSIAGLIA_REGULATED_BY_METH...1,SET,107,-0.12665,-0.0096355,0.077628,0.9486,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,1
HP_ABNORMAL_CIRCULATING_METH...,SET,15,-0.41266,-0.011785,0.25284,0.94866,HP_ABNORMAL_CIRCULATING_METHIONINE_CONCENTRATION,1
MIR32_5P,SET,434,-0.069256,-0.010516,0.042429,0.94868,MIR32_5P,1
FONTAINE_PAPILLARY_THYROID_C...1,SET,73,-0.17101,-0.010756,0.10476,0.94869,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,1
GOBP_DAMP_METABOLIC_PROCESS,SET,7,-0.5697,-0.011116,0.34896,0.94871,GOBP_DAMP_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...168,SET,235,-0.093851,-0.010545,0.05748,0.94873,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE,1
GOBP_TRNA_3_END_PROCESSING,SET,6,-0.463,-0.0083644,0.28356,0.94873,GOBP_TRNA_3_END_PROCESSING,1
DURANTE_ADULT_OLFACTORY_NEUR...6,SET,71,-0.18471,-0.011459,0.11311,0.94875,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS,1
MYC_UP.V1_DN,SET,145,-0.115,-0.010175,0.070423,0.94876,MYC_UP.V1_DN,1
REACTOME_HSP90_CHAPERONE_CYC...,SET,53,-0.19173,-0.010281,0.1174,0.94877,REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,1
GOMF_N_ACETYLGALACTOSAMINE_4...,SET,5,-0.58632,-0.0096696,0.35895,0.9488,GOMF_N_ACETYLGALACTOSAMINE_4_O_SULFOTRANSFERASE_ACTIVITY,1
GOBP_PEROXISOME_FISSION,SET,8,-0.50394,-0.010512,0.30839,0.94887,GOBP_PEROXISOME_FISSION,1
KEGG_SELENOAMINO_ACID_METABO...,SET,23,-0.3026,-0.010698,0.18515,0.94889,KEGG_SELENOAMINO_ACID_METABOLISM,1
GARY_CD5_TARGETS_UP,SET,417,-0.067403,-0.010037,0.041234,0.94893,GARY_CD5_TARGETS_UP,1
HP_MACULAR_EDEMA,SET,32,-0.25473,-0.01062,0.15583,0.94893,HP_MACULAR_EDEMA,1
HP_HYPERPARATHYROIDISM,SET,28,-0.27751,-0.010824,0.16974,0.94896,HP_HYPERPARATHYROIDISM,1
GOBP_MYELOID_CELL_ACTIVATION...,SET,91,-0.15277,-0.010723,0.093418,0.949,GOBP_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GSE22025_TGFB1_VS_TGFB1_AND_...2,SET,179,-0.10625,-0.010435,0.064961,0.94903,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,1
GOMF_N6_METHYLADENOSINE_CONT...,SET,11,-0.45897,-0.011225,0.28049,0.9491,GOMF_N6_METHYLADENOSINE_CONTAINING_RNA_READER_ACTIVITY,1
SESTO_RESPONSE_TO_UV_C3,SET,19,-0.3251,-0.010448,0.19867,0.94911,SESTO_RESPONSE_TO_UV_C3,1
HP_ABNORMAL_CARDIAC_SEPTUM_M...,SET,657,-0.054904,-0.010194,0.033553,0.94911,HP_ABNORMAL_CARDIAC_SEPTUM_MORPHOLOGY,1
HP_ABNORMAL_RIB_OSSIFICATION,SET,8,-0.52628,-0.010978,0.32154,0.94915,HP_ABNORMAL_RIB_OSSIFICATION,1
GOBP_POSITIVE_REGULATION_OF_...6,SET,13,-0.39076,-0.010389,0.2387,0.94917,GOBP_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION,1
ZNF830_TARGET_GENES,SET,235,-0.091673,-0.0103,0.055991,0.9492,ZNF830_TARGET_GENES,1
AMIT_EGF_RESPONSE_480_MCF10A,SET,42,-0.22404,-0.010698,0.13677,0.94928,AMIT_EGF_RESPONSE_480_MCF10A,1
HP_CYSTOID_MACULAR_EDEMA,SET,19,-0.32636,-0.010488,0.19924,0.94929,HP_CYSTOID_MACULAR_EDEMA,1
GOMF_MITOCHONDRIAL_RIBOSOME_...,SET,8,-0.47865,-0.0099843,0.29218,0.9493,GOMF_MITOCHONDRIAL_RIBOSOME_BINDING,1
DESCARTES_MAIN_FETAL_ENS_GLIA,SET,11,-0.43009,-0.010519,0.26254,0.9493,DESCARTES_MAIN_FETAL_ENS_GLIA,1
WP_INTRAFLAGELLAR_TRANSPORT_...,SET,22,-0.29517,-0.010206,0.18012,0.94935,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,1
MORI_SMALL_PRE_BII_LYMPHOCYT...2,SET,73,-0.16416,-0.010326,0.10017,0.94937,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...1,SET,5,-0.6606,-0.010895,0.40307,0.94938,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,1
GOMF_CARBOXYLIC_ESTER_HYDROL...,SET,138,-0.12211,-0.010541,0.074498,0.94939,GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY,1
GOBP_REGULATION_OF_POSTSYNAP...7,SET,134,-0.12984,-0.011047,0.079206,0.94942,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,1
GSE20198_UNTREATED_VS_IL12_T...1,SET,182,-0.10316,-0.010215,0.062909,0.94946,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN,1
WP_PHOTODYNAMIC_THERAPYINDUC...2,SET,34,-0.24418,-0.010493,0.1489,0.94948,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,1
GOBP_REGULATION_OF_INTESTINA...2,SET,9,-0.48205,-0.010665,0.29394,0.94949,GOBP_REGULATION_OF_INTESTINAL_LIPID_ABSORPTION,1
GAVISH_3CA_METAPROGRAM_MACRO...12,SET,48,-0.22703,-0.011588,0.13839,0.94954,GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP,1
ATF2_S_UP.V1_DN,SET,168,-0.11152,-0.010614,0.067973,0.94956,ATF2_S_UP.V1_DN,1
ESC_V6.5_UP_EARLY.V1_DN,SET,149,-0.1211,-0.01086,0.073809,0.94956,ESC_V6.5_UP_EARLY.V1_DN,1
MIR5000_3P,SET,89,-0.15326,-0.01064,0.093411,0.94957,MIR5000_3P,1
GOBP_POSITIVE_REGULATION_OF_...108,SET,5,-0.61122,-0.01008,0.37245,0.9496,GOBP_POSITIVE_REGULATION_OF_CELLULAR_PH_REDUCTION,1
UNTERMAN_IPF_VS_CTRL_TREG_CE...1,SET,16,-0.41167,-0.012141,0.25084,0.94961,UNTERMAN_IPF_VS_CTRL_TREG_CELL_DN,1
MIR92A_3P,SET,435,-0.069371,-0.010546,0.042264,0.94963,MIR92A_3P,1
GOMF_MYOSIN_BINDING,SET,69,-0.16976,-0.010382,0.10339,0.94969,GOMF_MYOSIN_BINDING,1
GSE35685_CD34POS_CD38NEG_VS_...2,SET,172,-0.10582,-0.010189,0.064446,0.94969,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP,1
GOCC_MULTIVESICULAR_BODY_INT...,SET,6,-0.66494,-0.012013,0.40492,0.94971,GOCC_MULTIVESICULAR_BODY_INTERNAL_VESICLE,1
REACTOME_CONVERSION_FROM_APC...,SET,19,-0.30378,-0.0097624,0.18496,0.94973,REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,1
CAGGTCC_MIR492,SET,54,-0.18255,-0.0098806,0.11113,0.94976,CAGGTCC_MIR492,1
GOBP_MODULATION_OF_PROCESS_O...,SET,14,-0.41157,-0.011355,0.25055,0.94977,GOBP_MODULATION_OF_PROCESS_OF_ANOTHER_ORGANISM,1
GOBP_NEGATIVE_REGULATION_OF_...87,SET,30,-0.27463,-0.011087,0.16711,0.94984,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
HP_FULL_CHEEKS,SET,132,-0.11637,-0.009827,0.07081,0.94985,HP_FULL_CHEEKS,1
HP_ABNORMAL_RETINAL_MORPHOLO...,SET,847,-0.049311,-0.010339,0.029987,0.94994,HP_ABNORMAL_RETINAL_MORPHOLOGY,1
chr12q21,SET,59,-0.3404,-0.019256,0.20699,0.94996,chr12q21,1
WP_INFLUENCE_OF_LAMINOPATHIE...,SET,33,-0.2468,-0.010449,0.15003,0.95001,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1
MIR3151_5P,SET,48,-0.18889,-0.009641,0.11482,0.95002,MIR3151_5P,1
HP_APLASIA_HYPOPLASIA_INVOLV...16,SET,1045,-0.045025,-0.010427,0.027369,0.95002,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETON,1
REACTOME_AZATHIOPRINE_ADME,SET,21,-0.33038,-0.011161,0.20078,0.95005,REACTOME_AZATHIOPRINE_ADME,1
MIR15A_3P,SET,32,-0.2505,-0.010444,0.15217,0.95013,MIR15A_3P,1
GOMF_MHC_CLASS_I_PROTEIN_COM...,SET,5,-0.5505,-0.0090789,0.33439,0.95014,GOMF_MHC_CLASS_I_PROTEIN_COMPLEX_BINDING,1
GSE25123_WT_VS_PPARG_KO_MACR...4,SET,182,-0.10903,-0.010796,0.066183,0.95026,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN,1
GOBP_REGULATION_OF_MICROTUBU...1,SET,47,-0.21106,-0.01066,0.1281,0.95027,GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT,1
GSE7400_CTRL_VS_CSF3_IN_VIVO...2,SET,176,-0.101,-0.0098369,0.0613,0.95028,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP,1
HP_FLEXION_CONTRACTURE_OF_DI...,SET,276,-0.086663,-0.01054,0.052594,0.95029,HP_FLEXION_CONTRACTURE_OF_DIGIT,1
GOBP_AMINOPHOSPHOLIPID_TRANS...1,SET,6,-0.53869,-0.0097318,0.32689,0.95031,GOBP_AMINOPHOSPHOLIPID_TRANSLOCATION,1
GOMF_AMINOPHOSPHOLIPID_FLIPP...,SET,6,-0.53869,-0.0097318,0.32689,0.95031,GOMF_AMINOPHOSPHOLIPID_FLIPPASE_ACTIVITY,1
SIG_INSULIN_RECEPTOR_PATHWAY...,SET,48,-0.21256,-0.010849,0.12897,0.95032,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,1
GSE2770_TGFB_AND_IL4_VS_IL12...3,SET,183,-0.1043,-0.010356,0.063272,0.95036,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
HP_URINARY_URGENCY,SET,43,-0.20576,-0.0099409,0.1248,0.95038,HP_URINARY_URGENCY,1
KEGG_MEDICUS_VARIANT_MUTATIO...84,SET,8,-0.5364,-0.011189,0.32528,0.95042,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,1
GSE27786_LSK_VS_NKTCELL_UP,SET,174,-0.10442,-0.010112,0.063315,0.95044,GSE27786_LSK_VS_NKTCELL_UP,1
GUO_HEX_TARGETS_UP,SET,72,-0.16915,-0.010567,0.10256,0.95045,GUO_HEX_TARGETS_UP,1
GOMF_ADENYLATE_CYCLASE_BINDI...,SET,12,-0.44472,-0.01136,0.26958,0.95049,GOMF_ADENYLATE_CYCLASE_BINDING,1
GOBP_MACROMOLECULE_METHYLATI...,SET,104,-0.12474,-0.0093573,0.075609,0.9505,GOBP_MACROMOLECULE_METHYLATION,1
GOBP_NEGATIVE_REGULATION_OF_...456,SET,10,-0.43277,-0.010092,0.26228,0.95052,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
GOBP_RESPONSE_TO_THYROID_HOR...,SET,22,-0.32598,-0.011272,0.19754,0.95054,GOBP_RESPONSE_TO_THYROID_HORMONE,1
HP_GLOSSOPTOSIS,SET,25,-0.27681,-0.010202,0.16774,0.95054,HP_GLOSSOPTOSIS,1
HP_PROMINENT_VEINS_ON_TRUNK,SET,5,-0.54967,-0.0090652,0.33308,0.95055,HP_PROMINENT_VEINS_ON_TRUNK,1
GOMF_SYNTAXIN_BINDING,SET,59,-0.17262,-0.009765,0.10459,0.95056,GOMF_SYNTAXIN_BINDING,1
REACTOME_IFNG_SIGNALING_ACTI...,SET,8,-0.53153,-0.011087,0.322,0.95059,REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS,1
MIR4665_5P,SET,137,-0.12696,-0.01092,0.076911,0.95059,MIR4665_5P,1
GSE13306_TREG_VS_TCONV_LAMIN...2,SET,182,-0.10872,-0.010765,0.065842,0.95064,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP,1
HP_RHINITIS,SET,97,-0.13951,-0.010108,0.084476,0.95067,HP_RHINITIS,1
KANNAN_BLOOD_2012_2013_TIV_A...2,SET,190,-0.10104,-0.01022,0.06118,0.95067,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP,1
MEIS1BHOXA9_01,SET,127,-0.13727,-0.011371,0.083077,0.95075,MEIS1BHOXA9_01,1
GSE45739_UNSTIM_VS_ACD3_ACD2...2,SET,171,-0.10367,-0.009953,0.06273,0.95078,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP,1
MYF6_TARGET_GENES,SET,13,-0.38392,-0.010207,0.23229,0.9508,MYF6_TARGET_GENES,1
HP_TAPERED_SPERM_HEAD,SET,7,-0.56373,-0.011,0.34105,0.95082,HP_TAPERED_SPERM_HEAD,1
GOBP_NEUTROPHIL_EXTRAVASATION,SET,9,-0.53928,-0.011931,0.32623,0.95083,GOBP_NEUTROPHIL_EXTRAVASATION,1
HP_ABNORMAL_DERMATOGLYPHICS,SET,270,-0.086188,-0.01037,0.052125,0.95087,HP_ABNORMAL_DERMATOGLYPHICS,1
MIR3065_5P,SET,414,-0.069603,-0.010328,0.042092,0.95089,MIR3065_5P,1
GSE36095_WT_VS_HDAC9_KO_TREG...1,SET,109,-0.13771,-0.010574,0.083223,0.951,GSE36095_WT_VS_HDAC9_KO_TREG_DN,1
MITSIADES_RESPONSE_TO_APLIDI...2,SET,386,-0.072308,-0.010369,0.043688,0.95104,MITSIADES_RESPONSE_TO_APLIDIN_UP,1
MIR6779_5P,SET,158,-0.11097,-0.010245,0.067042,0.95105,MIR6779_5P,1
KEGG_BASE_EXCISION_REPAIR,SET,32,-0.2263,-0.0094348,0.13671,0.95106,KEGG_BASE_EXCISION_REPAIR,1
GOBP_NEGATIVE_REGULATION_OF_...416,SET,41,-0.22478,-0.010605,0.13578,0.95107,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,1
HE_LIM_SUN_FETAL_LUNG_C6_MUC...,SET,49,-0.21648,-0.011163,0.13071,0.95115,HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL,1
HE_LIM_SUN_FETAL_LUNG_C4_ILC...3,SET,166,-0.11825,-0.011187,0.071389,0.95117,HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL,1
HP_OVERFOLDING_OF_THE_SUPERI...,SET,4,-0.75159,-0.011087,0.45372,0.95118,HP_OVERFOLDING_OF_THE_SUPERIOR_HELICES,1
GOBP_REGULATION_OF_DOUBLE_ST...1,SET,119,-0.12398,-0.0099442,0.074839,0.95119,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,1
REACTOME_ABACAVIR_ADME,SET,9,-0.55766,-0.012338,0.33646,0.95128,REACTOME_ABACAVIR_ADME,1
MIR4328,SET,518,-0.06465,-0.0107,0.038996,0.95132,MIR4328,1
REACTOME_TFAP2_AP_2_FAMILY_R...2,SET,14,-0.43197,-0.011918,0.2605,0.95136,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,1
MIR6839_5P,SET,88,-0.15821,-0.010922,0.095402,0.95137,MIR6839_5P,1
GOBP_BONE_MORPHOGENESIS,SET,96,-0.15529,-0.011194,0.093639,0.95137,GOBP_BONE_MORPHOGENESIS,1
REACTOME_SYNTHESIS_OF_PA,SET,35,-0.27022,-0.011781,0.16292,0.9514,REACTOME_SYNTHESIS_OF_PA,1
ZHONG_PFC_C3_HOPX_POS_OPC,SET,7,-0.52735,-0.01029,0.31795,0.9514,ZHONG_PFC_C3_HOPX_POS_OPC,1
DONATO_CELL_CYCLE_TRETINOIN,SET,6,-0.66686,-0.012047,0.402,0.95142,DONATO_CELL_CYCLE_TRETINOIN,1
HOEK_NEUTROPHIL_2011_2012_TI...2,SET,28,-0.31276,-0.012198,0.18852,0.95143,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_UP,1
DOANE_RESPONSE_TO_ANDROGEN_DN,SET,220,-0.097252,-0.010577,0.058598,0.9515,DOANE_RESPONSE_TO_ANDROGEN_DN,1
HP_RETINAL_TELANGIECTASIA,SET,14,-0.36166,-0.0099782,0.21783,0.95156,HP_RETINAL_TELANGIECTASIA,1
MIR30A_3P,SET,347,-0.075409,-0.010264,0.045408,0.95161,MIR30A_3P,1
GAVISH_3CA_METAPROGRAM_CD8_T...5,SET,48,-0.1927,-0.0098352,0.11603,0.95161,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_GLYCOLYSIS_MYC,1
GSE5455_EX_VIVO_VS_POST_24H_...2,SET,183,-0.10308,-0.010235,0.062066,0.95162,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP,1
WILENSKY_RESPONSE_TO_DARAPLA...,SET,25,-0.27385,-0.010093,0.16488,0.95163,WILENSKY_RESPONSE_TO_DARAPLADIB,1
HP_LARGE_SELLA_TURCICA,SET,14,-0.35806,-0.0098788,0.21555,0.95165,HP_LARGE_SELLA_TURCICA,1
GOMF_LIGASE_ACTIVITY,SET,123,-0.12317,-0.010042,0.074139,0.95167,GOMF_LIGASE_ACTIVITY,1
MYC_UP.V1_UP,SET,159,-0.1087,-0.010066,0.065425,0.95167,MYC_UP.V1_UP,1
HP_ESOPHAGEAL_ATRESIA,SET,25,-0.26364,-0.0097171,0.15864,0.95172,HP_ESOPHAGEAL_ATRESIA,1
WP_FBXL10_ENHANCEMENT_OF_MAP...,SET,10,-0.40986,-0.0095581,0.24662,0.95173,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,1
chr12p12,SET,49,-0.35644,-0.018381,0.21445,0.95175,chr12p12,1
GOBP_FOLIC_ACID_CONTAINING_C...1,SET,8,-0.44417,-0.0092652,0.26716,0.95179,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
HP_PARAPLEGIA_PARAPARESIS,SET,181,-0.10429,-0.010299,0.062712,0.95184,HP_PARAPLEGIA_PARAPARESIS,1
HP_URINARY_RETENTION,SET,24,-0.30706,-0.011089,0.18464,0.95184,HP_URINARY_RETENTION,1
LAKE_ADULT_KIDNEY_C14_DISTAL...,SET,179,-0.11624,-0.011416,0.069897,0.95184,LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE,1
GOCC_OUTER_KINETOCHORE,SET,19,-0.33385,-0.010729,0.20069,0.95188,GOCC_OUTER_KINETOCHORE,1
MIR6069,SET,26,-0.26679,-0.010028,0.16036,0.9519,MIR6069,1
GOMF_NOTCH_BINDING,SET,22,-0.28217,-0.009757,0.16958,0.95193,GOMF_NOTCH_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...800,SET,25,-0.29542,-0.010888,0.17753,0.95194,GOBP_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,1
GOBP_REGULATION_OF_INTRINSIC...4,SET,15,-0.33175,-0.0094738,0.19936,0.95194,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,1
HP_HERNIA,SET,500,-0.064995,-0.010574,0.039058,0.95194,HP_HERNIA,1
GSE40274_FOXP3_VS_FOXP3_AND_...15,SET,151,-0.11667,-0.010532,0.070103,0.95196,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_SERINE_FAMILY_AMINO_ACI...2,SET,11,-0.42189,-0.010319,0.25348,0.95197,GOBP_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
HP_MACULAR_ATROPHY,SET,39,-0.23357,-0.010748,0.14033,0.95198,HP_MACULAR_ATROPHY,1
GOMF_GLYCEROPHOSPHODIESTER_P...,SET,4,-0.68371,-0.010086,0.41074,0.95199,GOMF_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY,1
GOBP_ORGANONITROGEN_COMPOUND...1,SET,1504,-0.037933,-0.010398,0.022787,0.952,GOBP_ORGANONITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOMF_PROTEASOME_BINDING,SET,16,-0.30922,-0.00912,0.18575,0.95201,GOMF_PROTEASOME_BINDING,1
HP_ABNORMAL_TOE_MORPHOLOGY,SET,627,-0.057943,-0.010518,0.034804,0.95202,HP_ABNORMAL_TOE_MORPHOLOGY,1
HP_ABNORMAL_PROPORTION_OF_CL...,SET,17,-0.41142,-0.012507,0.24696,0.95213,HP_ABNORMAL_PROPORTION_OF_CLASS_SWITCHED_MEMORY_B_CELLS,1
GOBP_RESPONSE_TO_WATER_DEPRI...,SET,5,-0.56979,-0.009397,0.342,0.95214,GOBP_RESPONSE_TO_WATER_DEPRIVATION,1
MIR4645_5P,SET,103,-0.14127,-0.010546,0.08479,0.95215,MIR4645_5P,1
GOBP_ANTIFUNGAL_INNATE_IMMUN...,SET,14,-0.36302,-0.010016,0.21786,0.95216,GOBP_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,1
DESCARTES_FETAL_LUNG_VISCERA...,SET,168,-0.12038,-0.011457,0.07224,0.95217,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,1
LI_ESTROGENE_NON_MCF7_T47D_E...2,SET,15,-0.34426,-0.0098311,0.20657,0.95219,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_UP,1
GOMF_PROTEIN_FOLDING_CHAPERO...2,SET,125,-0.125,-0.010274,0.074999,0.9522,GOMF_PROTEIN_FOLDING_CHAPERONE_BINDING,1
GOCC_UNIPLEX_COMPLEX,SET,5,-0.78885,-0.01301,0.47322,0.95223,GOCC_UNIPLEX_COMPLEX,1
GOBP_DEFENSE_RESPONSE_TO_FUN...,SET,44,-0.2305,-0.011265,0.13824,0.95227,GOBP_DEFENSE_RESPONSE_TO_FUNGUS,1
HP_APLASIA_HYPOPLASIA_OF_THE...33,SET,62,-0.18716,-0.010852,0.11224,0.95228,HP_APLASIA_HYPOPLASIA_OF_THE_FEMUR,1
HP_BRACHYCEPHALY,SET,216,-0.099297,-0.010702,0.059551,0.95228,HP_BRACHYCEPHALY,1
WP_MELANOMA,SET,66,-0.17459,-0.010444,0.10468,0.95231,WP_MELANOMA,1
MIR548M,SET,172,-0.10655,-0.01026,0.063876,0.95235,MIR548M,1
GOBP_ICOSANOID_CATABOLIC_PRO...,SET,9,-0.46945,-0.010386,0.28139,0.95236,GOBP_ICOSANOID_CATABOLIC_PROCESS,1
MODULE_245,SET,25,-0.28264,-0.010417,0.16941,0.95237,MODULE_245,1
GOBP_NEGATIVE_REGULATION_OF_...136,SET,4,-0.74148,-0.010938,0.44435,0.9524,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
WP_CCL18_SIGNALING,SET,33,-0.27706,-0.01173,0.16602,0.95241,WP_CCL18_SIGNALING,1
GSE14000_UNSTIM_VS_16H_LPS_D...4,SET,169,-0.10525,-0.010047,0.063074,0.95241,GSE14000_UNSTIM_VS_16H_LPS_DC_UP,1
DURCHDEWALD_SKIN_CARCINOGENE...1,SET,242,-0.094476,-0.01077,0.056605,0.95243,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1
GOBP_HEART_VALVE_FORMATION,SET,15,-0.40183,-0.011475,0.24077,0.95243,GOBP_HEART_VALVE_FORMATION,1
GSE18893_CTRL_VS_TNF_TREATED...2,SET,179,-0.10554,-0.010365,0.063224,0.95246,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP,1
MIR4781_3P,SET,35,-0.23957,-0.010445,0.14351,0.95247,MIR4781_3P,1
REACTOME_REGULATION_OF_RAS_B...,SET,64,-0.16673,-0.0098222,0.099826,0.95256,REACTOME_REGULATION_OF_RAS_BY_GAPS,1
GSE4748_CYANOBACTERIUM_LPSLI...1,SET,159,-0.11723,-0.010856,0.07018,0.95257,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
MANNO_MIDBRAIN_NEUROTYPES_HO...2,SET,324,-0.087303,-0.011489,0.052255,0.9526,MANNO_MIDBRAIN_NEUROTYPES_HOPC,1
GOBP_TRNA_METABOLIC_PROCESS,SET,167,-0.10032,-0.0095191,0.060026,0.95265,GOBP_TRNA_METABOLIC_PROCESS,1
GSE43955_TGFB_IL6_VS_TGFB_IL...3,SET,180,-0.10928,-0.010762,0.065343,0.95277,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,1
GOBP_POSITIVE_REGULATION_OF_...53,SET,7,-0.55828,-0.010894,0.33379,0.95278,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,1
REACTOME_PRESYNAPTIC_DEPOLAR...,SET,11,-0.46818,-0.011451,0.27986,0.95282,REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING,1
HOELZEL_NF1_TARGETS_UP,SET,115,-0.1453,-0.011458,0.086846,0.95283,HOELZEL_NF1_TARGETS_UP,1
ASXL2_TARGET_GENES,SET,38,-0.23187,-0.010532,0.13857,0.95285,ASXL2_TARGET_GENES,1
GOBP_PROTEIN_TARGETING_TO_PE...,SET,9,-0.42696,-0.0094461,0.25506,0.95292,GOBP_PROTEIN_TARGETING_TO_PEROXISOME,1
GSE15659_TREG_VS_TCONV_DN,SET,150,-0.12071,-0.010861,0.072105,0.95294,GSE15659_TREG_VS_TCONV_DN,1
GOBP_CELL_PROJECTION_ASSEMBLY,SET,537,-0.062495,-0.010526,0.037316,0.953,GOBP_CELL_PROJECTION_ASSEMBLY,1
HP_ABNORMAL_UTERINE_CERVIX_M...,SET,11,-0.50722,-0.012405,0.30278,0.95305,HP_ABNORMAL_UTERINE_CERVIX_MORPHOLOGY,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...6,SET,171,-0.1101,-0.010571,0.065723,0.95305,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,1
HP_ABNORMAL_FINGER_PHALANX_M...,SET,578,-0.060308,-0.010526,0.035994,0.95307,HP_ABNORMAL_FINGER_PHALANX_MORPHOLOGY,1
GSE28737_WT_VS_BCL6_HET_MARG...2,SET,173,-0.10763,-0.010393,0.064232,0.95308,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP,1
KEGG_MEDICUS_REFERENCE_KINET...1,SET,22,-0.29961,-0.01036,0.17876,0.95312,KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION,1
ZNF92_TARGET_GENES,SET,1106,-0.045426,-0.010803,0.027103,0.95313,ZNF92_TARGET_GENES,1
ACTGCCT_MIR34B,SET,200,-0.10213,-0.010596,0.060926,0.95315,ACTGCCT_MIR34B,1
HP_MULTINODULAR_GOITER,SET,5,-0.65656,-0.010828,0.39167,0.95315,HP_MULTINODULAR_GOITER,1
GOBP_BONE_DEVELOPMENT,SET,196,-0.10843,-0.011137,0.064674,0.95317,GOBP_BONE_DEVELOPMENT,1
GNF2_CARD15,SET,62,-0.19149,-0.011104,0.11408,0.95337,GNF2_CARD15,1
HP_PROXIMAL_RENAL_TUBULAR_AC...,SET,10,-0.41764,-0.0097394,0.2488,0.95337,HP_PROXIMAL_RENAL_TUBULAR_ACIDOSIS,1
MIR12127,SET,74,-0.16545,-0.010477,0.098563,0.95338,MIR12127,1
GOMF_FOLIC_ACID_BINDING,SET,12,-0.41807,-0.010679,0.24901,0.95341,GOMF_FOLIC_ACID_BINDING,1
GENTILE_UV_LOW_DOSE_UP,SET,23,-0.30771,-0.010879,0.18326,0.95342,GENTILE_UV_LOW_DOSE_UP,1
GOMF_DOUBLE_STRANDED_RNA_BIN...,SET,69,-0.16333,-0.0099892,0.09728,0.95342,GOMF_DOUBLE_STRANDED_RNA_BINDING,1
HP_DOWNTURNED_CORNERS_OF_MOU...,SET,150,-0.11948,-0.01075,0.071154,0.95344,HP_DOWNTURNED_CORNERS_OF_MOUTH,1
HEY2_TARGET_GENES,SET,54,-0.1927,-0.01043,0.11471,0.9535,HEY2_TARGET_GENES,1
RUBENSTEIN_SKELETAL_MUSCLE_S...2,SET,377,-0.072223,-0.010238,0.042966,0.9536,RUBENSTEIN_SKELETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,1
HP_MASTOIDITIS,SET,7,-0.54978,-0.010728,0.32704,0.95362,HP_MASTOIDITIS,1
MIR1587,SET,55,-0.18263,-0.009976,0.10863,0.95363,MIR1587,1
MODULE_287,SET,47,-0.21859,-0.01104,0.12995,0.95372,MODULE_287,1
HP_DEVIATION_OF_THE_4TH_TOE,SET,4,-0.84428,-0.012454,0.50192,0.95372,HP_DEVIATION_OF_THE_4TH_TOE,1
ZBTB44_TARGET_GENES,SET,622,-0.059159,-0.010698,0.035162,0.95375,ZBTB44_TARGET_GENES,1
HP_ABNORMAL_CIRCULATING_T4_C...,SET,24,-0.29864,-0.010785,0.1775,0.95375,HP_ABNORMAL_CIRCULATING_T4_CONCENTRATION,1
HP_CURLY_HAIR,SET,30,-0.25207,-0.010176,0.14981,0.95376,HP_CURLY_HAIR,1
HP_DISPROPORTIONATE_SHORT_ST...,SET,119,-0.13355,-0.010712,0.079356,0.9538,HP_DISPROPORTIONATE_SHORT_STATURE,1
GSE24142_ADULT_VS_FETAL_DN3_...1,SET,182,-0.11056,-0.010947,0.065677,0.95383,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN,1
HP_SMALL_SCROTUM,SET,51,-0.21486,-0.011303,0.12763,0.95385,HP_SMALL_SCROTUM,1
KEGG_MEDICUS_VARIANT_MUTATIO...23,SET,16,-0.35765,-0.010548,0.21242,0.95387,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
HP_ABNORMAL_LIP_MORPHOLOGY,SET,1049,-0.045733,-0.01061,0.027159,0.95389,HP_ABNORMAL_LIP_MORPHOLOGY,1
GSE29617_CTRL_VS_DAY3_TIV_FL...2,SET,165,-0.11039,-0.010412,0.065533,0.95394,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP,1
GOBP_SERINE_TRANSPORT,SET,9,-0.45489,-0.010064,0.27003,0.95396,GOBP_SERINE_TRANSPORT,1
GOCC_U12_TYPE_SPLICEOSOMAL_C...,SET,24,-0.25883,-0.0093472,0.15363,0.95397,GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX,1
GSE18791_CTRL_VS_NEWCASTLE_V...2,SET,178,-0.10146,-0.0099366,0.06022,0.95398,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP,1
GOCC_MIGRASOME,SET,5,-0.54176,-0.0089348,0.32151,0.954,GOCC_MIGRASOME,1
GOBP_CHONDROCYTE_DEVELOPMENT...,SET,8,-0.58972,-0.012301,0.34968,0.95414,GOBP_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOMF_TUBULIN_BINDING,SET,346,-0.075946,-0.010322,0.04503,0.95415,GOMF_TUBULIN_BINDING,1
GOBP_GLIAL_CELL_DERIVED_NEUR...,SET,15,-0.37632,-0.010747,0.22311,0.95416,GOBP_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_HEDGEHOG_LIGAND_BIO...,SET,62,-0.16569,-0.0096074,0.098217,0.95419,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,1
HP_FREQUENT_FALLS,SET,117,-0.1334,-0.01061,0.079061,0.95422,HP_FREQUENT_FALLS,1
HP_SHALLOW_ORBITS,SET,32,-0.24814,-0.010345,0.14704,0.95425,HP_SHALLOW_ORBITS,1
GOBP_TERPENOID_METABOLIC_PRO...,SET,96,-0.16686,-0.012028,0.098862,0.95427,GOBP_TERPENOID_METABOLIC_PROCESS,1
BANDRES_RESPONSE_TO_CARMUSTI...3,SET,148,-0.12156,-0.010864,0.071998,0.95432,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1
GOBP_NEGATIVE_REGULATION_OF_...284,SET,5,-0.68121,-0.011235,0.40347,0.95432,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
GOCC_CORTICAL_ENDOPLASMIC_RE...,SET,5,-0.59604,-0.00983,0.35298,0.95434,GOCC_CORTICAL_ENDOPLASMIC_RETICULUM,1
GOBP_NEUROTRANSMITTER_REUPTA...,SET,33,-0.27388,-0.011595,0.16218,0.95436,GOBP_NEUROTRANSMITTER_REUPTAKE,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...1,SET,51,-0.21783,-0.011459,0.12893,0.95444,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,1
GSE5542_IFNG_VS_IFNA_AND_IFN...4,SET,167,-0.10866,-0.010311,0.064312,0.95444,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
HADDAD_T_LYMPHOCYTE_AND_NK_P...2,SET,73,-0.1853,-0.011656,0.10967,0.95445,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,1
GSE9509_LPS_VS_LPS_AND_IL10_...4,SET,168,-0.11567,-0.011009,0.068451,0.95447,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP,1
HP_DECREASED_CIRCULATING_MET...,SET,8,-0.54936,-0.011459,0.32506,0.95448,HP_DECREASED_CIRCULATING_METHYLCOBALAMIN_CONCENTRATION,1
KEGG_MEDICUS_REFERENCE_ARNO_...,SET,24,-0.29119,-0.010516,0.17225,0.95453,KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
GOBP_AEROBIC_RESPIRATION,SET,147,-0.10991,-0.0097908,0.065014,0.95454,GOBP_AEROBIC_RESPIRATION,1
HP_ABNORMAL_FACIAL_SHAPE,SET,937,-0.047738,-0.010501,0.028237,0.95454,HP_ABNORMAL_FACIAL_SHAPE,1
MIR25_3P,SET,380,-0.076453,-0.010879,0.045213,0.95457,MIR25_3P,1
GAVISH_3CA_METAPROGRAM_ENDOT...11,SET,50,-0.21215,-0.01105,0.12545,0.95458,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2,1
GSE6259_33D1_POS_DC_VS_CD4_T...1,SET,165,-0.11215,-0.010579,0.066319,0.95458,GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN,1
GOBP_GAMMA_DELTA_T_CELL_ACTI...,SET,23,-0.2987,-0.01056,0.17658,0.95463,GOBP_GAMMA_DELTA_T_CELL_ACTIVATION,1
KEGG_ALDOSTERONE_REGULATED_S...,SET,39,-0.2555,-0.011758,0.15102,0.95466,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,1
MIR4790_3P,SET,77,-0.1599,-0.010329,0.094495,0.95468,MIR4790_3P,1
MIR30E_3P,SET,348,-0.076778,-0.010465,0.045363,0.95472,MIR30E_3P,1
BLANCO_MELO_MERS_COV_INFECTI...2,SET,230,-0.097232,-0.010809,0.057445,0.95473,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,1
HP_NYCTALOPIA,SET,200,-0.1048,-0.010873,0.061897,0.95478,HP_NYCTALOPIA,1
chr3q26,SET,61,-0.36725,-0.021123,0.21689,0.95479,chr3q26,1
BIOCARTA_P27_PATHWAY,SET,13,-0.37347,-0.0099294,0.22054,0.95481,BIOCARTA_P27_PATHWAY,1
MIR634,SET,83,-0.15658,-0.010499,0.092459,0.95481,MIR634,1
CASTELLANO_HRAS_TARGETS_DN,SET,4,-0.68321,-0.010078,0.40332,0.95485,CASTELLANO_HRAS_TARGETS_DN,1
REACTOME_METABOLISM_OF_LIPIDS,SET,701,-0.056146,-0.010754,0.033145,0.95486,REACTOME_METABOLISM_OF_LIPIDS,1
HP_PROGEROID_FACIAL_APPEARAN...,SET,29,-0.26052,-0.01034,0.15372,0.95493,HP_PROGEROID_FACIAL_APPEARANCE,1
GOCC_PORE_COMPLEX,SET,23,-0.31901,-0.011278,0.18821,0.95495,GOCC_PORE_COMPLEX,1
HP_HALLUX_VARUS,SET,5,-0.71602,-0.011809,0.42237,0.95498,HP_HALLUX_VARUS,1
GSE7509_FCGRIIB_VS_TNFA_IL1B...2,SET,157,-0.1093,-0.010059,0.064471,0.95498,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,1
MALONEY_RESPONSE_TO_17AAG_UP,SET,37,-0.25067,-0.011236,0.14782,0.95503,MALONEY_RESPONSE_TO_17AAG_UP,1
GOBP_REGULATION_OF_STEROID_H...2,SET,22,-0.33786,-0.011683,0.19923,0.95503,GOBP_REGULATION_OF_STEROID_HORMONE_SECRETION,1
GOMF_OXIDOREDUCTASE_ACTIVITY,SET,653,-0.057879,-0.010714,0.034103,0.95516,GOMF_OXIDOREDUCTASE_ACTIVITY,1
HP_RENAL_ANGIOMYOLIPOMA,SET,5,-0.61119,-0.01008,0.35999,0.95522,HP_RENAL_ANGIOMYOLIPOMA,1
KEGG_MEDICUS_REFERENCE_REGUL...3,SET,4,-0.77875,-0.011488,0.45853,0.95527,KEGG_MEDICUS_REFERENCE_REGULATION_OF_EXTRINSIC_APOPTOTIC_PATHWAY_XIAP,1
REACTOME_DEFECTS_IN_BIOTIN_B...,SET,8,-0.52326,-0.010915,0.30804,0.9553,REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM,1
ZWANG_CLASS_1_TRANSIENTLY_IN...,SET,454,-0.071031,-0.011025,0.041813,0.95531,ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,1
HP_TRANSIENT_HYPERPHENYLALAN...,SET,5,-0.69432,-0.011451,0.40868,0.95533,HP_TRANSIENT_HYPERPHENYLALANINEMIA,1
DURANTE_ADULT_OLFACTORY_NEUR...26,SET,80,-0.17737,-0.011677,0.10438,0.95536,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS,1
HP_ABNORMALITY_OF_THE_HUMERO...,SET,51,-0.2053,-0.0108,0.1208,0.95538,HP_ABNORMALITY_OF_THE_HUMERORADIAL_JOINT,1
LTE2_UP.V1_DN,SET,172,-0.11989,-0.011544,0.070523,0.95542,LTE2_UP.V1_DN,1
GOBP_ESTABLISHMENT_OR_MAINTE...2,SET,211,-0.10369,-0.011046,0.060988,0.95544,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,1
WP_PARKINUBIQUITIN_PROTEASOM...,SET,64,-0.17039,-0.010038,0.10022,0.95545,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,1
GOBP_POLYSACCHARIDE_METABOLI...,SET,97,-0.14627,-0.010598,0.086022,0.95546,GOBP_POLYSACCHARIDE_METABOLIC_PROCESS,1
GOBP_PERIPHERAL_NERVOUS_SYST...1,SET,28,-0.28303,-0.011039,0.16643,0.95547,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT,1
GOBP_RESPONSE_TO_OXIDATIVE_S...,SET,357,-0.078621,-0.010851,0.046225,0.9555,GOBP_RESPONSE_TO_OXIDATIVE_STRESS,1
GSE8835_HEALTHY_VS_CLL_CD4_T...1,SET,174,-0.11092,-0.010741,0.065213,0.9555,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN,1
VALK_AML_CLUSTER_5,SET,28,-0.26557,-0.010358,0.15613,0.95552,VALK_AML_CLUSTER_5,1
GOMF_OXIDOREDUCTASE_ACTIVITY...26,SET,9,-0.54298,-0.012013,0.31918,0.95554,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER,1
MCBRYAN_PUBERTAL_BREAST_4_5W...1,SET,171,-0.11505,-0.011046,0.067617,0.95556,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1
KIM_BIPOLAR_DISORDER_OLIGODE...2,SET,597,-0.057463,-0.010187,0.033771,0.95557,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP,1
GAO_LARGE_INTESTINE_ADULT_CE...,SET,289,-0.087846,-0.010929,0.051618,0.9556,GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL,1
HE_LIM_SUN_FETAL_LUNG_C0_ACT...,SET,522,-0.066402,-0.011031,0.03901,0.95563,HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL,1
GSE22033_UNTREATED_VS_MRL24_...1,SET,176,-0.1115,-0.010859,0.065498,0.95565,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN,1
GOBP_MEGAKARYOCYTE_DIFFERENT...,SET,47,-0.22497,-0.011362,0.13214,0.95566,GOBP_MEGAKARYOCYTE_DIFFERENTIATION,1
GSE22886_TH1_VS_TH2_48H_ACT_...2,SET,177,-0.11588,-0.011317,0.068057,0.95568,GSE22886_TH1_VS_TH2_48H_ACT_UP,1
YU_MYC_TARGETS_UP,SET,41,-0.22606,-0.010665,0.13275,0.95569,YU_MYC_TARGETS_UP,1
GOBP_REGULATION_OF_NEUTROPHI...2,SET,29,-0.3012,-0.011955,0.17688,0.95569,GOBP_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS,1
YAMASHITA_LIVER_CANCER_STEM_...2,SET,46,-0.23592,-0.011788,0.13852,0.95572,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,1
HP_POSTERIOR_PLAGIOCEPHALY,SET,7,-0.59133,-0.011538,0.34717,0.95573,HP_POSTERIOR_PLAGIOCEPHALY,1
HP_MIGRAINE_WITH_AURA,SET,12,-0.46525,-0.011885,0.27315,0.95574,HP_MIGRAINE_WITH_AURA,1
HP_MESOAXIAL_HAND_POLYDACTYLY,SET,10,-0.48895,-0.011402,0.28703,0.95575,HP_MESOAXIAL_HAND_POLYDACTYLY,1
MIR3689A_3P_MIR3689B_3P_MIR3...,SET,153,-0.11527,-0.010474,0.067649,0.95579,MIR3689A_3P_MIR3689B_3P_MIR3689C,1
GOMF_NADP_BINDING,SET,50,-0.20355,-0.010602,0.11939,0.95588,GOMF_NADP_BINDING,1
LA_MEN1_TARGETS,SET,21,-0.34891,-0.011788,0.20463,0.9559,LA_MEN1_TARGETS,1
CAATGCA_MIR33,SET,88,-0.15328,-0.010581,0.089867,0.95595,CAATGCA_MIR33,1
MANNO_MIDBRAIN_NEUROTYPES_BA...,SET,64,-0.16529,-0.0097372,0.096894,0.95598,MANNO_MIDBRAIN_NEUROTYPES_BASAL,1
CAFFAREL_RESPONSE_TO_THC_DN,SET,29,-0.24815,-0.0098495,0.14536,0.95609,CAFFAREL_RESPONSE_TO_THC_DN,1
GOBP_THYMUS_DEVELOPMENT,SET,47,-0.21959,-0.01109,0.12861,0.95612,GOBP_THYMUS_DEVELOPMENT,1
WP_NSP1_FROM_SARSCOV2_INHIBI...,SET,12,-0.39747,-0.010153,0.23276,0.95614,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,1
GSE1925_CTRL_VS_3H_IFNG_STIM...2,SET,155,-0.11603,-0.01061,0.06794,0.95615,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,1
GOBP_DISRUPTION_OF_CELLULAR_...,SET,3,-1.1345,-0.014494,0.66429,0.95616,GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,1
HP_MENOMETRORRHAGIA,SET,5,-0.82741,-0.013646,0.48441,0.95618,HP_MENOMETRORRHAGIA,1
GSE25088_ROSIGLITAZONE_VS_IL...4,SET,165,-0.11434,-0.010785,0.066918,0.95623,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,1
MED25_TARGET_GENES,SET,76,-0.16822,-0.010795,0.098444,0.95624,MED25_TARGET_GENES,1
HP_IMPAIRED_ADP_INDUCED_PLAT...,SET,18,-0.3439,-0.010757,0.20125,0.95625,HP_IMPAIRED_ADP_INDUCED_PLATELET_AGGREGATION,1
GSE5542_UNTREATED_VS_IFNA_TR...4,SET,172,-0.1149,-0.011063,0.067237,0.95625,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,1
MIR4791,SET,58,-0.18826,-0.010559,0.11015,0.95627,MIR4791,1
GOLDRATH_NAIVE_VS_MEMORY_CD8...2,SET,190,-0.10784,-0.010908,0.063074,0.95633,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP,1
GSE19888_ADENOSINE_A3R_INH_P...4,SET,186,-0.11146,-0.011156,0.065189,0.95634,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,1
GSE2706_R848_VS_LPS_8H_STIM_...1,SET,158,-0.12283,-0.01134,0.071838,0.95634,GSE2706_R848_VS_LPS_8H_STIM_DC_DN,1
MIKKELSEN_ES_ICP_WITH_H3K27M...,SET,41,-0.24029,-0.011337,0.14051,0.95638,MIKKELSEN_ES_ICP_WITH_H3K27ME3,1
MIR607,SET,872,-0.051636,-0.010978,0.030191,0.95638,MIR607,1
GOBP_CANONICAL_NF_KAPPAB_SIG...,SET,281,-0.088876,-0.010905,0.051923,0.95651,GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
HP_CIGARETTE_PAPER_SCARS,SET,10,-0.51469,-0.012003,0.3007,0.95651,HP_CIGARETTE_PAPER_SCARS,1
TGCAAAC_MIR452,SET,86,-0.16668,-0.011376,0.09737,0.95653,TGCAAAC_MIR452,1
HP_SEVERE_DEMYELINATION_OF_T...,SET,6,-0.61936,-0.011189,0.36178,0.95654,HP_SEVERE_DEMYELINATION_OF_THE_WHITE_MATTER,1
GSE17721_CTRL_VS_POLYIC_1H_B...1,SET,180,-0.11266,-0.011094,0.065803,0.95654,GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN,1
CBX5_TARGET_GENES,SET,592,-0.061109,-0.01079,0.035689,0.95657,CBX5_TARGET_GENES,1
GOBP_PROTEIN_LOCALIZATION_TO...26,SET,29,-0.23485,-0.0093219,0.13714,0.95659,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS,1
REACTOME_MATURATION_OF_SARS_...1,SET,11,-0.39393,-0.0096345,0.23,0.95661,REACTOME_MATURATION_OF_SARS_COV_1_NUCLEOPROTEIN,1
GSE44649_WT_VS_MIR155_KO_NAI...2,SET,184,-0.10965,-0.010917,0.064021,0.95661,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP,1
GOMF_CARDIOLIPIN_BINDING,SET,10,-0.48877,-0.011398,0.28526,0.95668,GOMF_CARDIOLIPIN_BINDING,1
GOBP_PROTON_MOTIVE_FORCE_DRI...,SET,43,-0.1915,-0.0092523,0.11175,0.9567,GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS,1
GOBP_NEGATIVE_REGULATION_OF_...294,SET,150,-0.12602,-0.011339,0.073514,0.95675,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,1
HP_DELAYED_ERUPTION_OF_PRIMA...,SET,14,-0.37116,-0.01024,0.21647,0.95678,HP_DELAYED_ERUPTION_OF_PRIMARY_TEETH,1
FIGUEROA_AML_METHYLATION_CLU...1,SET,41,-0.23754,-0.011207,0.13852,0.9568,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,1
KEGG_MEDICUS_REFERENCE_TNF_R...,SET,7,-0.54073,-0.010551,0.31534,0.9568,KEGG_MEDICUS_REFERENCE_TNF_RIPK1_3_SIGNALING_PATHWAY,1
GSE23568_ID3_TRANSDUCED_VS_I...2,SET,187,-0.10663,-0.010701,0.062164,0.95684,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP,1
TGANTCA_AP1_C,SET,1018,-0.049226,-0.01126,0.028691,0.95689,TGANTCA_AP1_C,1
GSE32901_TH17_EMRICHED_VS_TH...2,SET,102,-0.15,-0.011144,0.087412,0.95691,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP,1
GSE10273_HIGH_VS_LOW_IL7_TRE...2,SET,171,-0.11008,-0.010569,0.064135,0.95694,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP,1
GSE6259_FLT3L_INDUCED_33D1_P...6,SET,134,-0.12936,-0.011006,0.075361,0.95696,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP,1
HP_HYPOCHROMIC_MICROCYTIC_AN...,SET,15,-0.39738,-0.011348,0.23147,0.95698,HP_HYPOCHROMIC_MICROCYTIC_ANEMIA,1
REACTOME_TICAM1_TRAF6_DEPEND...,SET,9,-0.5822,-0.012881,0.33912,0.95699,REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX,1
GOBP_COLLAGEN_ACTIVATED_TYRO...,SET,9,-0.50266,-0.011121,0.29278,0.95699,GOBP_COLLAGEN_ACTIVATED_TYROSINE_KINASE_RECEPTOR_SIGNALING_PATHWAY,1
EGFR_UP.V1_DN,SET,162,-0.11699,-0.010935,0.06813,0.95701,EGFR_UP.V1_DN,1
MODULE_295,SET,19,-0.33959,-0.010913,0.19775,0.95703,MODULE_295,1
GSE29617_CTRL_VS_TIV_FLU_VAC...2,SET,163,-0.11647,-0.01092,0.067814,0.95704,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP,1
HP_ABNORMAL_VERTEBRAL_MORPHO...,SET,421,-0.071302,-0.010667,0.041502,0.9571,HP_ABNORMAL_VERTEBRAL_MORPHOLOGY,1
GOMF_PROTEIN_RNA_ADAPTOR_ACT...,SET,18,-0.34677,-0.010847,0.2018,0.95713,GOMF_PROTEIN_RNA_ADAPTOR_ACTIVITY,1
HP_PROXIMAL_TUBULOPATHY,SET,35,-0.22959,-0.01001,0.13358,0.95716,HP_PROXIMAL_TUBULOPATHY,1
MIR323B_3P,SET,56,-0.19606,-0.010806,0.11401,0.95724,MIR323B_3P,1
HP_PERIODIC_HYPOKALEMIC_PARE...,SET,7,-0.59365,-0.011584,0.34519,0.95725,HP_PERIODIC_HYPOKALEMIC_PARESIS,1
GOBP_PRE_MIRNA_PROCESSING,SET,14,-0.3999,-0.011033,0.23244,0.95731,GOBP_PRE_MIRNA_PROCESSING,1
GOCC_PROTEASOME_ACCESSORY_CO...,SET,23,-0.27494,-0.0097203,0.1598,0.95732,GOCC_PROTEASOME_ACCESSORY_COMPLEX,1
GOBP_HEMATOPOIETIC_PROGENITO...,SET,128,-0.13262,-0.011029,0.077075,0.95733,GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
REACTOME_INTRINSIC_PATHWAY_F...,SET,52,-0.21344,-0.011338,0.12403,0.95736,REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1
ZNF7_TARGET_GENES,SET,680,-0.058609,-0.011063,0.034058,0.95736,ZNF7_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_STRAD...,SET,8,-0.52046,-0.010856,0.3024,0.95738,KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY,1
REACTOME_PARASITE_INFECTION,SET,56,-0.19563,-0.010783,0.11366,0.95739,REACTOME_PARASITE_INFECTION,1
GOBP_PURINE_NUCLEOSIDE_MONOP...2,SET,10,-0.50646,-0.011811,0.29415,0.95744,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
GOMF_DIHYDROPYRIMIDINASE_ACT...,SET,6,-0.62876,-0.011359,0.36511,0.95747,GOMF_DIHYDROPYRIMIDINASE_ACTIVITY,1
HP_DRY_SKIN,SET,163,-0.11336,-0.010628,0.065823,0.95747,HP_DRY_SKIN,1
GOBP_REGULATION_OF_INTRINSIC...2,SET,28,-0.27107,-0.010573,0.15739,0.95748,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,1
MIR4322,SET,35,-0.27409,-0.01195,0.15912,0.95751,MIR4322,1
YGACNNYACAR_UNKNOWN,SET,83,-0.162,-0.010862,0.094022,0.95754,YGACNNYACAR_UNKNOWN,1
GOMF_LIGASE_ACTIVITY_FORMING...2,SET,45,-0.21638,-0.010694,0.12558,0.95755,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS,1
GSE8868_SPLEEN_VS_INTESTINE_...2,SET,175,-0.10879,-0.010566,0.063104,0.95764,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP,1
HP_ABNORMAL_MESENTERY_MORPHO...,SET,4,-0.63495,-0.0093664,0.36825,0.95766,HP_ABNORMAL_MESENTERY_MORPHOLOGY,1
GSE41867_NAIVE_VS_DAY8_LCMV_...5,SET,179,-0.106,-0.01041,0.061474,0.95767,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,1
REACTOME_METABOLISM_OF_FOLAT...,SET,16,-0.35735,-0.010539,0.20719,0.95771,REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES,1
KEGG_VALINE_LEUCINE_AND_ISOL...2,SET,42,-0.22952,-0.01096,0.13304,0.95774,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,1
HP_BROAD_CLAVICLES,SET,10,-0.49657,-0.01158,0.28785,0.95774,HP_BROAD_CLAVICLES,1
HP_DECREASED_CIRCULATING_TER...,SET,6,-0.65313,-0.011799,0.3786,0.95774,HP_DECREASED_CIRCULATING_TERMINAL_COMPLEMENT_COMPONENT_CONCENTRATION,1
HP_PREMATURE_LOSS_OF_PRIMARY...,SET,19,-0.35663,-0.011461,0.20663,0.95781,HP_PREMATURE_LOSS_OF_PRIMARY_TEETH,1
OCT1_06,SET,223,-0.10563,-0.011565,0.061192,0.95784,OCT1_06,1
HOEK_T_CELL_2011_2012_TIV_AD...1,SET,4,-0.77435,-0.011423,0.44853,0.95785,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_DN,1
GSE7460_WT_VS_FOXP3_HET_ACT_...1,SET,182,-0.11024,-0.010916,0.063841,0.95789,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN,1
GOBP_T_CELL_PROLIFERATION_IN...,SET,5,-0.69577,-0.011475,0.40289,0.9579,GOBP_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,1
KEGG_MEDICUS_REFERENCE_TNF_J...,SET,16,-0.38813,-0.011447,0.22471,0.95793,KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY,1
GOBP_ACTIN_POLYMERIZATION_DE...,SET,7,-0.55114,-0.010754,0.31904,0.95795,GOBP_ACTIN_POLYMERIZATION_DEPENDENT_CELL_MOTILITY,1
GOBP_HYPOTHALAMUS_CELL_MIGRA...,SET,6,-0.72221,-0.013047,0.41806,0.95795,GOBP_HYPOTHALAMUS_CELL_MIGRATION,1
VRTN_TARGET_GENES,SET,9,-0.49194,-0.010884,0.28469,0.958,VRTN_TARGET_GENES,1
GOBP_SYNAPTIC_VESICLE_UNCOAT...,SET,7,-0.52904,-0.010323,0.30614,0.95801,GOBP_SYNAPTIC_VESICLE_UNCOATING,1
BROWNE_HCMV_INFECTION_18HR_DN,SET,167,-0.11625,-0.011032,0.067258,0.95804,BROWNE_HCMV_INFECTION_18HR_DN,1
MIR30B_3P,SET,154,-0.11671,-0.010639,0.06752,0.95804,MIR30B_3P,1
HP_SCARRING,SET,88,-0.16196,-0.011181,0.093653,0.95812,HP_SCARRING,1
REACTOME_EGFR_INTERACTS_WITH...,SET,9,-0.54703,-0.012103,0.3163,0.95813,REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA,1
BIOCARTA_LIS1_PATHWAY,SET,18,-0.34462,-0.01078,0.1992,0.95818,BIOCARTA_LIS1_PATHWAY,1
HP_ANGIOKERATOMA,SET,5,-0.63204,-0.010424,0.3653,0.95819,HP_ANGIOKERATOMA,1
MIR2116_5P,SET,133,-0.12671,-0.01074,0.073231,0.9582,MIR2116_5P,1
GOCC_CLATHRIN_SCULPTED_GAMMA...,SET,8,-0.58647,-0.012233,0.3387,0.95831,GOCC_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE,1
GOMF_G_PROTEIN_ALPHA_SUBUNIT...,SET,29,-0.28349,-0.011252,0.16371,0.95832,GOMF_G_PROTEIN_ALPHA_SUBUNIT_BINDING,1
E4BP4_01,SET,194,-0.11356,-0.011605,0.065567,0.95835,E4BP4_01,1
GOBP_G_PROTEIN_COUPLED_ACETY...,SET,20,-0.367,-0.0121,0.2119,0.95835,GOBP_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,1
HP_HORIZONTAL_NYSTAGMUS,SET,102,-0.14313,-0.010634,0.082643,0.95835,HP_HORIZONTAL_NYSTAGMUS,1
KEGG_PROGESTERONE_MEDIATED_O...,SET,79,-0.16554,-0.01083,0.095549,0.9584,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,1
GSE7852_THYMUS_VS_FAT_TCONV_...2,SET,178,-0.10957,-0.010731,0.06324,0.95841,GSE7852_THYMUS_VS_FAT_TCONV_UP,1
GOMF_PURINE_NUCLEOTIDE_BINDI...,SET,1797,-0.036552,-0.010857,0.021095,0.95842,GOMF_PURINE_NUCLEOTIDE_BINDING,1
MARTIN_VIRAL_GPCR_SIGNALING_...2,SET,82,-0.16726,-0.011148,0.096512,0.95845,MARTIN_VIRAL_GPCR_SIGNALING_UP,1
HOLLERN_MICROACINAR_BREAST_T...1,SET,14,-0.41525,-0.011457,0.23954,0.95849,HOLLERN_MICROACINAR_BREAST_TUMOR_DN,1
HP_DYSPNEA,SET,432,-0.073656,-0.011159,0.042486,0.9585,HP_DYSPNEA,1
GOCC_LATE_ENDOSOME,SET,279,-0.090627,-0.011081,0.052265,0.95853,GOCC_LATE_ENDOSOME,1
WP_INTRACELLULAR_TRAFFICKING...,SET,27,-0.29201,-0.011184,0.16838,0.95855,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,1
GOCC_SWI_SNF_SUPERFAMILY_TYP...,SET,88,-0.14399,-0.0099396,0.083025,0.95855,GOCC_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX,1
MIR943,SET,47,-0.22681,-0.011456,0.13074,0.95861,MIR943,1
HP_CLINODACTYLY,SET,492,-0.067154,-0.01084,0.038705,0.95862,HP_CLINODACTYLY,1
GOBP_L_LEUCINE_CATABOLIC_PRO...,SET,6,-0.58245,-0.010522,0.33564,0.95865,GOBP_L_LEUCINE_CATABOLIC_PROCESS,1
HP_MYELOMENINGOCELE,SET,20,-0.35697,-0.011769,0.20568,0.95867,HP_MYELOMENINGOCELE,1
GSE17721_12H_VS_24H_GARDIQUI...2,SET,178,-0.11326,-0.011093,0.065256,0.95868,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP,1
MIR4263,SET,240,-0.097625,-0.011083,0.056243,0.95869,MIR4263,1
HP_ABNORMALITY_OF_THE_DIAPHR...,SET,101,-0.14681,-0.010854,0.084531,0.95878,HP_ABNORMALITY_OF_THE_DIAPHRAGM,1
GOBP_SUPEROXIDE_ANION_GENERA...,SET,36,-0.26496,-0.011715,0.15255,0.95879,GOBP_SUPEROXIDE_ANION_GENERATION,1
AIZARANI_LIVER_C24_EPCAM_POS...,SET,174,-0.12254,-0.011867,0.070544,0.9588,AIZARANI_LIVER_C24_EPCAM_POS_BILE_DUCT_CELLS_3,1
HALLMARK_ANDROGEN_RESPONSE,SET,94,-0.15609,-0.011135,0.089821,0.95887,HALLMARK_ANDROGEN_RESPONSE,1
HP_ABSENT_STERNAL_OSSIFICATI...,SET,5,-0.5641,-0.0093032,0.32459,0.95888,HP_ABSENT_STERNAL_OSSIFICATION,1
HP_GYNECOMASTIA,SET,91,-0.15801,-0.011091,0.090895,0.95892,HP_GYNECOMASTIA,1
ZNF664_TARGET_GENES,SET,766,-0.054204,-0.010833,0.031178,0.95893,ZNF664_TARGET_GENES,1
GSE13522_WT_VS_IFNAR_KO_SKIN...4,SET,177,-0.11531,-0.011262,0.066303,0.95899,GSE13522_WT_VS_IFNAR_KO_SKIN_UP,1
GOBP_MIDBRAIN_HINDBRAIN_BOUN...,SET,5,-0.66469,-0.010962,0.38208,0.95903,GOBP_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT,1
HP_CONGENITAL_DIAPHRAGMATIC_...,SET,79,-0.17219,-0.011265,0.098869,0.9592,HP_CONGENITAL_DIAPHRAGMATIC_HERNIA,1
GOBP_MULTI_PASS_TRANSMEMBRAN...,SET,8,-0.64472,-0.013448,0.37017,0.95921,GOBP_MULTI_PASS_TRANSMEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
GOCC_MULTI_PASS_TRANSLOCON_C...,SET,8,-0.64472,-0.013448,0.37017,0.95921,GOCC_MULTI_PASS_TRANSLOCON_COMPLEX,1
GSE10422_WT_VS_BAFF_TRANSGEN...1,SET,120,-0.1405,-0.011316,0.080648,0.95925,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN,1
HP_PULMONARY_OPACITY,SET,22,-0.34011,-0.01176,0.1952,0.95927,HP_PULMONARY_OPACITY,1
GSE5960_TH1_VS_ANERGIC_TH1_UP,SET,183,-0.10984,-0.010906,0.063041,0.95927,GSE5960_TH1_VS_ANERGIC_TH1_UP,1
MODULE_259,SET,41,-0.25048,-0.011818,0.1437,0.95933,MODULE_259,1
HP_TRUNCAL_OBESITY,SET,71,-0.17512,-0.010864,0.10046,0.95933,HP_TRUNCAL_OBESITY,1
GSE17721_POLYIC_VS_CPG_4H_BM...1,SET,184,-0.10895,-0.010847,0.062503,0.95934,GSE17721_POLYIC_VS_CPG_4H_BMDC_DN,1
KAAB_FAILED_HEART_VENTRICLE_...,SET,37,-0.24863,-0.011145,0.14257,0.95941,KAAB_FAILED_HEART_VENTRICLE_DN,1
TAKEDA_TARGETS_OF_NUP98_HOXA...5,SET,28,-0.3021,-0.011783,0.17323,0.95941,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,1
MIR5584_3P,SET,124,-0.13896,-0.011376,0.079679,0.95941,MIR5584_3P,1
RIGGINS_TAMOXIFEN_RESISTANCE...1,SET,202,-0.11334,-0.011817,0.064983,0.95942,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1
GOCC_RIBONUCLEASE_P_COMPLEX,SET,10,-0.44796,-0.010447,0.25679,0.95945,GOCC_RIBONUCLEASE_P_COMPLEX,1
HP_GASTROESOPHAGEAL_REFLUX,SET,434,-0.073443,-0.011152,0.04209,0.95949,HP_GASTROESOPHAGEAL_REFLUX,1
GOBP_REGULATION_OF_BLOOD_VES...,SET,7,-0.51435,-0.010036,0.29476,0.9595,GOBP_REGULATION_OF_BLOOD_VESSEL_REMODELING,1
STARK_PREFRONTAL_CORTEX_22Q1...1,SET,449,-0.068613,-0.010593,0.039314,0.95952,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,1
HP_ABNORMALITY_OF_FONTANELLES,SET,180,-0.11039,-0.010872,0.063254,0.95952,HP_ABNORMALITY_OF_FONTANELLES,1
KEGG_GNRH_SIGNALING_PATHWAY,SET,98,-0.15895,-0.011576,0.09106,0.95954,KEGG_GNRH_SIGNALING_PATHWAY,1
GSE42021_CD24INT_TREG_VS_CD2...1,SET,179,-0.10743,-0.010551,0.061538,0.95957,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN,1
GOBP_CELLULAR_RESPONSE_TO_RE...2,SET,136,-0.13246,-0.011353,0.07585,0.95962,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
WP_CELLULAR_PROTEOSTASIS,SET,5,-0.53,-0.0087409,0.30347,0.95963,WP_CELLULAR_PROTEOSTASIS,1
GSE14699_NAIVE_VS_ACT_CD8_TC...2,SET,174,-0.11946,-0.011568,0.068395,0.95964,GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP,1
BROWN_MYELOID_CELL_DEVELOPME...2,SET,147,-0.13021,-0.011598,0.07454,0.95965,BROWN_MYELOID_CELL_DEVELOPMENT_UP,1
MIR4293,SET,99,-0.15215,-0.011137,0.087107,0.95965,MIR4293,1
GOBP_POSITIVE_REGULATION_OF_...368,SET,6,-0.75402,-0.013622,0.43158,0.95968,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,1
HP_HYPERMETROPIA,SET,240,-0.098953,-0.011234,0.056637,0.95968,HP_HYPERMETROPIA,1
AGTCAGC_MIR345,SET,55,-0.18661,-0.010193,0.1068,0.95969,AGTCAGC_MIR345,1
PID_TXA2PATHWAY,SET,52,-0.21641,-0.011495,0.12383,0.95972,PID_TXA2PATHWAY,1
HP_INCREASED_DENSITY_OF_LONG...,SET,11,-0.4995,-0.012217,0.28577,0.95975,HP_INCREASED_DENSITY_OF_LONG_BONES,1
SUPT16H_TARGET_GENES,SET,1360,-0.041818,-0.010947,0.023911,0.95984,SUPT16H_TARGET_GENES,1
MIR30D_3P,SET,350,-0.079124,-0.010815,0.045234,0.95986,MIR30D_3P,1
HP_ABNORMALITY_OF_LIPOPROTEI...,SET,82,-0.17011,-0.011337,0.097254,0.95986,HP_ABNORMALITY_OF_LIPOPROTEIN_CHOLESTEROL_CONCENTRATION,1
REACTOME_NEGATIVE_REGULATION...13,SET,116,-0.14729,-0.011664,0.084197,0.95987,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1
TCTGGAC_MIR198,SET,78,-0.17131,-0.011137,0.097914,0.9599,TCTGGAC_MIR198,1
CEBP_Q2_01,SET,239,-0.10201,-0.011557,0.058265,0.96,CEBP_Q2_01,1
BIOCARTA_ACETAMINOPHEN_PATHW...,SET,5,-0.73487,-0.01212,0.41965,0.96003,BIOCARTA_ACETAMINOPHEN_PATHWAY,1
MIR6818_3P,SET,108,-0.15283,-0.011682,0.087278,0.96003,MIR6818_3P,1
REACTOME_HEPARAN_SULFATE_HEP...,SET,52,-0.217,-0.011526,0.12389,0.96007,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,1
GOBP_TRANSPOSITION,SET,35,-0.24977,-0.01089,0.14255,0.96012,GOBP_TRANSPOSITION,1
MIR625_3P,SET,45,-0.23714,-0.01172,0.13533,0.96013,MIR625_3P,1
GOBP_ASCENDING_AORTA_DEVELOP...,SET,5,-0.77029,-0.012704,0.43958,0.96013,GOBP_ASCENDING_AORTA_DEVELOPMENT,1
IRF2_01,SET,118,-0.14205,-0.011346,0.081061,0.96014,IRF2_01,1
HP_PROMINENT_STERNUM,SET,12,-0.49098,-0.012542,0.28014,0.96016,HP_PROMINENT_STERNUM,1
CAGTCAC_MIR134,SET,48,-0.21875,-0.011165,0.1248,0.96018,CAGTCAC_MIR134,1
MIR4265,SET,36,-0.27507,-0.012163,0.15687,0.96023,MIR4265,1
GOBP_TETRAHYDROFOLATE_BIOSYN...,SET,6,-0.52861,-0.0095498,0.30128,0.96032,GOBP_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...404,SET,134,-0.13781,-0.011724,0.078535,0.96034,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,1
GSE22886_TCELL_VS_BCELL_NAIV...1,SET,167,-0.12207,-0.011583,0.069562,0.96035,GSE22886_TCELL_VS_BCELL_NAIVE_DN,1
MIR365A_5P,SET,30,-0.29406,-0.011871,0.1675,0.96041,MIR365A_5P,1
KEGG_MEDICUS_REFERENCE_CHOLE...,SET,11,-0.42442,-0.01038,0.2417,0.96045,KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS,1
HP_OLIVOPONTOCEREBELLAR_HYPO...,SET,12,-0.4064,-0.010381,0.23143,0.96045,HP_OLIVOPONTOCEREBELLAR_HYPOPLASIA,1
GSE46242_TH1_VS_ANERGIC_TH1_...1,SET,158,-0.11955,-0.011037,0.068058,0.9605,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN,1
GOBP_RESPONSE_TO_INTERFERON_...2,SET,30,-0.30924,-0.012484,0.17603,0.96051,GOBP_RESPONSE_TO_INTERFERON_BETA,1
KEGG_MEDICUS_REFERENCE_IGF_I...1,SET,13,-0.44299,-0.011778,0.2521,0.96055,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY,1
GSE24634_IL4_VS_CTRL_TREATED...7,SET,176,-0.11758,-0.011451,0.066899,0.96058,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN,1
GOMF_ACYL_COA_HYDROLASE_ACTI...,SET,22,-0.32901,-0.011376,0.18718,0.96059,GOMF_ACYL_COA_HYDROLASE_ACTIVITY,1
HP_MYOPIA,SET,364,-0.079842,-0.011125,0.04542,0.96061,HP_MYOPIA,1
GSE29164_UNTREATED_VS_CD8_TC...7,SET,178,-0.11479,-0.011242,0.065292,0.96062,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN,1
ATGTTTC_MIR494,SET,142,-0.12853,-0.011254,0.073101,0.96063,ATGTTTC_MIR494,1
GOBP_RESPONSE_TO_L_GLUTAMATE,SET,15,-0.3818,-0.010903,0.21713,0.96065,GOBP_RESPONSE_TO_L_GLUTAMATE,1
GSE11864_UNTREATED_VS_CSF1_I...5,SET,164,-0.11266,-0.010595,0.064069,0.96065,GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN,1
MIR8060,SET,91,-0.15879,-0.011146,0.090299,0.96066,MIR8060,1
GSE40274_CTRL_VS_FOXP3_AND_P...2,SET,152,-0.12396,-0.011227,0.070493,0.96066,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
REACTOME_METABOLISM_OF_COFAC...,SET,22,-0.29987,-0.010369,0.17052,0.96067,REACTOME_METABOLISM_OF_COFACTORS,1
MIR6876_5P,SET,205,-0.10576,-0.011108,0.06014,0.96067,MIR6876_5P,1
GOBP_REGULATION_OF_CALCIUM_I...3,SET,5,-0.78249,-0.012905,0.44482,0.96071,GOBP_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
IRF1_01,SET,225,-0.10644,-0.011705,0.060501,0.96073,IRF1_01,1
GOBP_POSITIVE_REGULATION_OF_...197,SET,7,-0.54934,-0.010719,0.31225,0.96073,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
KEGG_DORSO_VENTRAL_AXIS_FORM...,SET,24,-0.31423,-0.011348,0.17859,0.96075,KEGG_DORSO_VENTRAL_AXIS_FORMATION,1
GSE42724_NAIVE_VS_MEMORY_BCE...2,SET,184,-0.10739,-0.010692,0.06102,0.96078,GSE42724_NAIVE_VS_MEMORY_BCELL_UP,1
MIR33B_3P,SET,60,-0.19832,-0.011313,0.11268,0.96079,MIR33B_3P,1
REACTOME_MITF_M_DEPENDENT_GE...,SET,91,-0.15844,-0.011121,0.090015,0.9608,REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION,1
GSE22886_DC_VS_MONOCYTE_DN,SET,180,-0.1141,-0.011237,0.064767,0.96093,GSE22886_DC_VS_MONOCYTE_DN,1
GSE36888_UNTREATED_VS_IL2_TR...6,SET,171,-0.12094,-0.011611,0.068648,0.96093,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP,1
GSE17301_CTRL_VS_48H_ACD3_AC...5,SET,178,-0.11684,-0.011443,0.066313,0.96096,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN,1
HP_NEUROMUSCULAR_DYSPHAGIA,SET,11,-0.43373,-0.010608,0.24612,0.96098,HP_NEUROMUSCULAR_DYSPHAGIA,1
HALLMARK_CHOLESTEROL_HOMEOST...,SET,69,-0.17729,-0.010843,0.1006,0.96098,HALLMARK_CHOLESTEROL_HOMEOSTASIS,1
GOMF_CARBOHYDRATE_KINASE_ACT...,SET,20,-0.3057,-0.010079,0.17346,0.96099,GOMF_CARBOHYDRATE_KINASE_ACTIVITY,1
GOBP_CO_TRANSCRIPTIONAL_RNA_...,SET,10,-0.41621,-0.0097061,0.23613,0.96101,GOBP_CO_TRANSCRIPTIONAL_RNA_3_END_PROCESSING_CLEAVAGE_AND_POLYADENYLATION_PATHWAY,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...6,SET,29,-0.26736,-0.010612,0.15166,0.96104,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_UP,1
FOURNIER_ACINAR_DEVELOPMENT_...3,SET,264,-0.091182,-0.01085,0.051702,0.96109,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,1
TONKS_TARGETS_OF_RUNX1_RUNX1...3,SET,16,-0.36,-0.010617,0.20402,0.96117,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,1
GOBP_LEUKOCYTE_MIGRATION_INV...,SET,19,-0.35796,-0.011504,0.20284,0.96119,GOBP_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
REACTOME_AMINE_LIGAND_BINDIN...,SET,40,-0.27438,-0.012787,0.15544,0.96123,REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,1
GOBP_FEAR_RESPONSE,SET,45,-0.25337,-0.012522,0.14336,0.96141,GOBP_FEAR_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...312,SET,24,-0.30604,-0.011052,0.17308,0.96148,GOBP_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
GSE32423_MEMORY_VS_NAIVE_CD8...4,SET,178,-0.12243,-0.01199,0.069237,0.96148,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP,1
GSE11864_CSF1_VS_CSF1_PAM3CY...1,SET,166,-0.11876,-0.011236,0.06716,0.96149,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN,1
HP_ABNORMALITY_OF_LIMB_BONE,SET,1523,-0.040242,-0.011094,0.022755,0.9615,HP_ABNORMALITY_OF_LIMB_BONE,1
GOBP_REGULATION_OF_CELLULAR_...8,SET,7,-0.57262,-0.011173,0.32357,0.9616,GOBP_REGULATION_OF_CELLULAR_PH_REDUCTION,1
GSE37301_LYMPHOID_PRIMED_MPP...9,SET,170,-0.11752,-0.011251,0.066409,0.9616,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN,1
HP_HIRSUTISM,SET,195,-0.10767,-0.011032,0.060812,0.96167,HP_HIRSUTISM,1
GSE40273_XBP1_KO_VS_WT_TREG_...1,SET,184,-0.1132,-0.01127,0.063905,0.96174,GSE40273_XBP1_KO_VS_WT_TREG_DN,1
GSE5503_PLN_DC_VS_SPLEEN_DC_...2,SET,186,-0.10847,-0.010857,0.061225,0.96176,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
HP_RETINAL_DYSPLASIA,SET,18,-0.34589,-0.01082,0.19523,0.96177,HP_RETINAL_DYSPLASIA,1
GSE5589_UNSTIM_VS_45MIN_LPS_...6,SET,183,-0.11183,-0.011104,0.063113,0.96179,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP,1
GSE369_SOCS3_KO_VS_WT_LIVER_...3,SET,187,-0.10831,-0.010869,0.061116,0.96181,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP,1
GSE9650_EXHAUSTED_VS_MEMORY_...1,SET,187,-0.10987,-0.011026,0.061988,0.96183,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN,1
HDAC4_TARGET_GENES,SET,517,-0.069184,-0.011439,0.039016,0.96189,HDAC4_TARGET_GENES,1
HP_APLASIA_HYPOPLASIA_OF_TOE,SET,112,-0.14428,-0.011229,0.081369,0.96189,HP_APLASIA_HYPOPLASIA_OF_TOE,1
GAVIN_FOXP3_TARGETS_CLUSTER_...2,SET,147,-0.12822,-0.011422,0.072304,0.96191,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1
REACTOME_REGULATION_OF_TP53_...3,SET,14,-0.40652,-0.011216,0.22924,0.96191,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS,1
DESCARTES_FETAL_ADRENAL_SYMP...,SET,90,-0.181,-0.012635,0.10206,0.96192,DESCARTES_FETAL_ADRENAL_SYMPATHOBLASTS,1
GSE43863_NAIVE_VS_LY6C_INT_C...1,SET,146,-0.12983,-0.011526,0.073157,0.96202,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN,1
MIR6715B_5P,SET,200,-0.10866,-0.011273,0.061217,0.96204,MIR6715B_5P,1
HP_FINE_HAIR,SET,69,-0.17398,-0.01064,0.098005,0.96206,HP_FINE_HAIR,1
GOBP_B_CELL_HOMEOSTASIS,SET,30,-0.29222,-0.011797,0.16461,0.96207,GOBP_B_CELL_HOMEOSTASIS,1
GSE17721_LPS_VS_PAM3CSK4_12H...2,SET,187,-0.11157,-0.011197,0.062849,0.96207,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...286,SET,6,-0.53466,-0.009659,0.30092,0.96219,GOBP_NEGATIVE_REGULATION_OF_HYPOXIA_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GSE2405_0H_VS_12H_A_PHAGOCYT...2,SET,185,-0.11498,-0.011478,0.0647,0.96222,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
ZNF445_TARGET_GENES,SET,7,-0.61489,-0.011998,0.3459,0.96226,ZNF445_TARGET_GENES,1
WP_PILOCYTIC_ASTROCYTOMA,SET,6,-0.54029,-0.0097607,0.30385,0.9623,WP_PILOCYTIC_ASTROCYTOMA,1
GOBP_PROTEIN_DEPOLYMERIZATION,SET,108,-0.13825,-0.010567,0.077742,0.96232,GOBP_PROTEIN_DEPOLYMERIZATION,1
WP_LINOLEIC_ACID_METABOLISM_...,SET,5,-0.72137,-0.011897,0.40534,0.96243,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...4,SET,11,-0.52292,-0.01279,0.29378,0.96245,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION,1
GOBP_ADENYLATE_CYCLASE_INHIB...4,SET,77,-0.19197,-0.0124,0.1078,0.96253,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
KEGG_ALANINE_ASPARTATE_AND_G...,SET,29,-0.29367,-0.011657,0.16487,0.96255,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,1
HP_IMPAIRED_TANDEM_GAIT,SET,9,-0.59031,-0.01306,0.33139,0.96256,HP_IMPAIRED_TANDEM_GAIT,1
GOBP_UBIQUITIN_RECYCLING,SET,12,-0.44225,-0.011297,0.2482,0.9626,GOBP_UBIQUITIN_RECYCLING,1
HP_SPASTIC_PARAPLEGIA,SET,95,-0.15527,-0.011135,0.087147,0.9626,HP_SPASTIC_PARAPLEGIA,1
GSE29618_LAIV_VS_TIV_FLU_VAC...3,SET,170,-0.11937,-0.011428,0.066994,0.9626,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN,1
REACTOME_GLYCEROPHOSPHOLIPID...2,SET,7,-0.5801,-0.011319,0.32544,0.96266,REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM,1
HP_MEDIAL_FLARING_OF_THE_EYE...,SET,35,-0.25249,-0.011008,0.14165,0.96266,HP_MEDIAL_FLARING_OF_THE_EYEBROW,1
GOBP_REGULATION_OF_CELL_CYCL...2,SET,172,-0.11707,-0.011273,0.065671,0.96267,GOBP_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GOBP_T_CELL_MEDIATED_IMMUNITY,SET,121,-0.15587,-0.012606,0.087438,0.96267,GOBP_T_CELL_MEDIATED_IMMUNITY,1
HP_ABNORMAL_DISTAL_PHALANX_M...,SET,146,-0.1269,-0.011266,0.071166,0.96272,HP_ABNORMAL_DISTAL_PHALANX_MORPHOLOGY_OF_FINGER,1
UEDA_PERIFERAL_CLOCK,SET,157,-0.12685,-0.011674,0.071104,0.96278,UEDA_PERIFERAL_CLOCK,1
HP_ABNORMAL_CSF_PYRUVATE_FAM...,SET,5,-0.71021,-0.011713,0.39805,0.9628,HP_ABNORMAL_CSF_PYRUVATE_FAMILY_AMINO_ACID_CONCENTRATION,1
HP_CALF_MUSCLE_PSEUDOHYPERTR...,SET,15,-0.34792,-0.0099357,0.19491,0.96287,HP_CALF_MUSCLE_PSEUDOHYPERTROPHY,1
DESCARTES_FETAL_THYMUS_ANTIG...,SET,152,-0.13393,-0.01213,0.075019,0.96289,DESCARTES_FETAL_THYMUS_ANTIGEN_PRESENTING_CELLS,1
GOBP_GMP_METABOLIC_PROCESS,SET,25,-0.30636,-0.011292,0.17155,0.96292,GOBP_GMP_METABOLIC_PROCESS,1
GSE6259_DEC205_POS_DC_VS_CD8...1,SET,140,-0.12985,-0.01129,0.072709,0.96294,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN,1
GOMF_DIACYLGLYCEROL_DEPENDEN...,SET,16,-0.36684,-0.010819,0.20539,0.96295,GOMF_DIACYLGLYCEROL_DEPENDENT_SERINE_THREONINE_KINASE_ACTIVITY,1
GOMF_ADP_PHOSPHATASE_ACTIVITY,SET,6,-0.5501,-0.009938,0.30795,0.96297,GOMF_ADP_PHOSPHATASE_ACTIVITY,1
HP_FURROWED_TONGUE,SET,38,-0.22022,-0.010004,0.12328,0.96297,HP_FURROWED_TONGUE,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...3,SET,35,-0.2527,-0.011017,0.14142,0.96302,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,1
REACTOME_REGULATION_OF_RUNX3...,SET,52,-0.19786,-0.01051,0.11072,0.96302,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1
HP_BASILAR_IMPRESSION,SET,5,-0.75985,-0.012532,0.42523,0.96302,HP_BASILAR_IMPRESSION,1
IL15_UP.V1_UP,SET,164,-0.12164,-0.011439,0.06804,0.96309,IL15_UP.V1_UP,1
GSE5589_LPS_VS_LPS_AND_IL10_...1,SET,176,-0.11684,-0.011379,0.06535,0.96309,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN,1
chr5p15,SET,52,-0.36487,-0.019381,0.20405,0.96312,chr5p15,1
HP_GAZE_EVOKED_HORIZONTAL_NY...,SET,17,-0.36562,-0.011115,0.20443,0.96314,HP_GAZE_EVOKED_HORIZONTAL_NYSTAGMUS,1
GSE29164_DAY3_VS_DAY7_CD8_TC...1,SET,187,-0.11498,-0.011539,0.064279,0.96317,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN,1
GSE6674_PL2_3_VS_ANTI_IGM_AN...2,SET,178,-0.11085,-0.010857,0.061968,0.96317,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,1
GSE41867_DAY15_EFFECTOR_VS_D...2,SET,189,-0.10961,-0.011059,0.061248,0.96324,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,1
MIR4303,SET,212,-0.10746,-0.011475,0.060027,0.96328,MIR4303,1
HP_ABNORMAL_HUMERUS_MORPHOLO...,SET,14,-0.39157,-0.010803,0.2187,0.9633,HP_ABNORMAL_HUMERUS_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...5,SET,120,-0.15398,-0.012402,0.085974,0.96335,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_PROGENITORS_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...310,SET,35,-0.26298,-0.011465,0.14681,0.96337,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,1
GSE37301_GRANULOCYTE_MONOCYT...1,SET,184,-0.1081,-0.010762,0.060344,0.96337,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,1
GOMF_SYNTAXIN_1_BINDING,SET,19,-0.35248,-0.011328,0.19675,0.96339,GOMF_SYNTAXIN_1_BINDING,1
HP_ANTERIOR_SUBCAPSULAR_CATA...,SET,6,-0.69973,-0.012641,0.39035,0.96347,HP_ANTERIOR_SUBCAPSULAR_CATARACT,1
REACTOME_SCF_BETA_TRCP_MEDIA...,SET,52,-0.19363,-0.010285,0.10801,0.96348,REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,1
HP_TYPE_1_MUSCLE_FIBER_ATROP...,SET,14,-0.40691,-0.011227,0.22698,0.96348,HP_TYPE_1_MUSCLE_FIBER_ATROPHY,1
GSE21927_SPLEEN_VS_TUMOR_MON...1,SET,168,-0.12062,-0.01148,0.067284,0.96348,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN,1
REACTOME_ACYL_CHAIN_REMODELL...5,SET,20,-0.375,-0.012364,0.2091,0.96353,REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,1
GOBP_NEGATIVE_REGULATION_OF_...34,SET,12,-0.47155,-0.012046,0.26281,0.96361,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,1
GOMF_SULFURTRANSFERASE_ACTIV...,SET,11,-0.45596,-0.011152,0.2541,0.96362,GOMF_SULFURTRANSFERASE_ACTIVITY,1
IVANOVSKA_MIR106B_TARGETS,SET,82,-0.15664,-0.010439,0.087263,0.96366,IVANOVSKA_MIR106B_TARGETS,1
MASRI_RESISTANCE_TO_TAMOXIFE...2,SET,15,-0.43342,-0.012377,0.24147,0.96366,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,1
GSE21380_TFH_VS_GERMINAL_CEN...2,SET,184,-0.11771,-0.011719,0.065576,0.96367,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,1
HP_ABNORMAL_UPPER_LIP_MORPHO...,SET,814,-0.054999,-0.011316,0.030628,0.96372,HP_ABNORMAL_UPPER_LIP_MORPHOLOGY,1
HP_DECEREBRATE_RIGIDITY,SET,5,-0.69216,-0.011415,0.38541,0.96374,HP_DECEREBRATE_RIGIDITY,1
HP_ABNORMAL_FETAL_CARDIOVASC...,SET,46,-0.21687,-0.010836,0.12074,0.96376,HP_ABNORMAL_FETAL_CARDIOVASCULAR_MORPHOLOGY,1
MIR513B_5P,SET,254,-0.0981,-0.011453,0.054606,0.96378,MIR513B_5P,1
KEGG_MEDICUS_REFERENCE_EGF_E...9,SET,15,-0.38687,-0.011048,0.21533,0.96379,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY,1
GOCC_ATG12_ATG5_ATG16_COMPLEX,SET,6,-0.70059,-0.012657,0.3899,0.96381,GOCC_ATG12_ATG5_ATG16_COMPLEX,1
PELLICCIOTTA_HDAC_IN_ANTIGEN...1,SET,49,-0.21243,-0.010954,0.11814,0.96391,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,1
REACTOME_OAS_ANTIVIRAL_RESPO...,SET,7,-0.76184,-0.014866,0.42367,0.96392,REACTOME_OAS_ANTIVIRAL_RESPONSE,1
WANG_TUMOR_INVASIVENESS_DN,SET,192,-0.10999,-0.011183,0.061163,0.96393,WANG_TUMOR_INVASIVENESS_DN,1
GSE21546_WT_VS_SAP1A_KO_AND_...4,SET,185,-0.11344,-0.011324,0.063075,0.96394,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
MIR515_3P,SET,61,-0.20153,-0.011592,0.11204,0.96396,MIR515_3P,1
GOBP_REGULATION_OF_RESPONSE_...10,SET,10,-0.46438,-0.01083,0.25809,0.964,GOBP_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
HP_FACIAL_HEMANGIOMA,SET,19,-0.374,-0.012019,0.20785,0.96401,HP_FACIAL_HEMANGIOMA,1
HP_MORNING_GLORY_ANOMALY,SET,6,-0.73816,-0.013335,0.41015,0.96404,HP_MORNING_GLORY_ANOMALY,1
HP_JUVENILE_CATARACT,SET,10,-0.46537,-0.010852,0.25851,0.96408,HP_JUVENILE_CATARACT,1
GOBP_POSITIVE_REGULATION_OF_...681,SET,6,-0.63463,-0.011465,0.3525,0.96409,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
GOBP_NEGATIVE_REGULATION_OF_...700,SET,26,-0.33794,-0.012702,0.18768,0.96411,GOBP_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,1
GNF2_HCK,SET,86,-0.17619,-0.012025,0.097845,0.96412,GNF2_HCK,1
HP_OSTEOLYSIS,SET,72,-0.17945,-0.01121,0.099639,0.96414,HP_OSTEOLYSIS,1
XU_HGF_TARGETS_REPRESSED_BY_...1,SET,81,-0.16689,-0.011055,0.092653,0.96416,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,1
GOMF_DEATH_DOMAIN_BINDING,SET,10,-0.54374,-0.01268,0.30185,0.96417,GOMF_DEATH_DOMAIN_BINDING,1
HP_HYPERPIGMENTED_HYPOPIGMEN...,SET,5,-0.72542,-0.011964,0.40267,0.96418,HP_HYPERPIGMENTED_HYPOPIGMENTED_MACULES,1
GOBP_REGULATION_OF_CHLORIDE_...,SET,6,-0.56955,-0.010289,0.31612,0.96419,GOBP_REGULATION_OF_CHLORIDE_TRANSPORT,1
HP_METAPHYSEAL_WIDENING,SET,89,-0.15893,-0.011033,0.088199,0.96421,HP_METAPHYSEAL_WIDENING,1
GOBP_REGULATION_OF_I_KAPPAB_...,SET,7,-0.6377,-0.012443,0.35382,0.96424,GOBP_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,1
GOBP_THELARCHE,SET,4,-0.88487,-0.013053,0.49094,0.96425,GOBP_THELARCHE,1
GOBP_VESTIBULOCOCHLEAR_NERVE...2,SET,5,-0.85125,-0.014039,0.47227,0.96426,GOBP_VESTIBULOCOCHLEAR_NERVE_FORMATION,1
HP_PROGRESSIVE_SPASTIC_QUADR...,SET,11,-0.49318,-0.012062,0.27339,0.96437,HP_PROGRESSIVE_SPASTIC_QUADRIPLEGIA,1
GSE1740_MCSF_VS_MCSF_AND_IFN...3,SET,146,-0.1282,-0.011381,0.071068,0.96437,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN,1
REACTOME_LYSOSOME_VESICLE_BI...,SET,32,-0.25979,-0.010831,0.144,0.96439,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,1
KEGG_MEDICUS_REFERENCE_AREG_...2,SET,14,-0.40815,-0.011261,0.22621,0.9644,KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,1
GSE3982_BCELL_VS_BASOPHIL_DN,SET,176,-0.12097,-0.011781,0.067024,0.96444,GSE3982_BCELL_VS_BASOPHIL_DN,1
YAGI_AML_SURVIVAL,SET,108,-0.14883,-0.011375,0.08245,0.96446,YAGI_AML_SURVIVAL,1
GOBP_RESPONSE_TO_REDOX_STATE,SET,12,-0.44599,-0.011393,0.24704,0.96448,GOBP_RESPONSE_TO_REDOX_STATE,1
CHESLER_BRAIN_D6MIT150_QTL_C...,SET,3,-0.85426,-0.010914,0.47317,0.96449,CHESLER_BRAIN_D6MIT150_QTL_CIS,1
MIR4714_5P,SET,93,-0.16527,-0.011727,0.091514,0.96453,MIR4714_5P,1
LI_LUNG_CANCER,SET,40,-0.23877,-0.011127,0.13219,0.96455,LI_LUNG_CANCER,1
HP_COXA_VALGA,SET,82,-0.17796,-0.011861,0.098525,0.96455,HP_COXA_VALGA,1
GSE42021_TREG_VS_TCONV_PLN_DN,SET,179,-0.11519,-0.011312,0.063772,0.96455,GSE42021_TREG_VS_TCONV_PLN_DN,1
DESCARTES_FETAL_LIVER_MYELOI...,SET,170,-0.13186,-0.012623,0.072982,0.96459,DESCARTES_FETAL_LIVER_MYELOID_CELLS,1
MIR7150,SET,121,-0.13742,-0.011114,0.076045,0.96462,MIR7150,1
GOBP_GROWTH_PLATE_CARTILAGE_...2,SET,9,-0.54878,-0.012141,0.30365,0.96463,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION,1
RODRIGUES_THYROID_CARCINOMA_...4,SET,707,-0.058255,-0.011204,0.032233,0.96464,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN,1
KEGG_MEDICUS_REFERENCE_GF_RT...3,SET,87,-0.1834,-0.012589,0.10146,0.96465,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY,1
GSE17721_CTRL_VS_CPG_8H_BMDC...2,SET,178,-0.11432,-0.011196,0.063228,0.96469,GSE17721_CTRL_VS_CPG_8H_BMDC_UP,1
MIR4444,SET,5,-0.65748,-0.010843,0.36362,0.9647,MIR4444,1
GSE24142_EARLY_THYMIC_PROGEN...9,SET,186,-0.11329,-0.01134,0.062647,0.96472,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN,1
BCAT_GDS748_DN,SET,40,-0.23691,-0.01104,0.13096,0.96476,BCAT_GDS748_DN,1
FAN_OVARY_CL0_XBP1_SELK_HIGH...,SET,123,-0.13641,-0.011122,0.075408,0.96477,FAN_OVARY_CL0_XBP1_SELK_HIGH_STROMAL_CELL,1
WP_SPINA_BIFIDA,SET,12,-0.47237,-0.012066,0.26109,0.96478,WP_SPINA_BIFIDA,1
HP_DECREASED_CIRCULATING_CER...,SET,8,-0.56756,-0.011839,0.31371,0.96478,HP_DECREASED_CIRCULATING_CERULOPLASMIN_CONCENTRATION,1
DESCARTES_FETAL_THYMUS_VASCU...,SET,113,-0.15816,-0.012364,0.087417,0.96478,DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS,1
GOMF_FLAVIN_ADENINE_DINUCLEO...,SET,81,-0.17111,-0.011335,0.094537,0.96485,GOMF_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...7,SET,171,-0.11894,-0.011419,0.065708,0.96485,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN,1
GSE23502_WT_VS_HDC_KO_MYELOI...3,SET,172,-0.12522,-0.012057,0.069151,0.96491,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN,1
MIR3658,SET,734,-0.058962,-0.011546,0.032543,0.96498,MIR3658,1
MORF_EIF3S6,SET,113,-0.13735,-0.010737,0.075781,0.96504,MORF_EIF3S6,1
KEGG_MEDICUS_REFERENCE_LESIO...,SET,12,-0.34759,-0.0088791,0.19172,0.96508,KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION,1
GOBP_BASEMENT_MEMBRANE_ORGAN...,SET,37,-0.26563,-0.011907,0.1465,0.96509,GOBP_BASEMENT_MEMBRANE_ORGANIZATION,1
GOMF_PHOSPHORYLATION_DEPENDE...,SET,8,-0.60656,-0.012652,0.33452,0.96509,GOMF_PHOSPHORYLATION_DEPENDENT_PROTEIN_BINDING,1
FOXG1_TARGET_GENES,SET,476,-0.071169,-0.011304,0.039247,0.9651,FOXG1_TARGET_GENES,1
HP_MIGRAINE_WITHOUT_AURA,SET,7,-0.65912,-0.012861,0.36349,0.9651,HP_MIGRAINE_WITHOUT_AURA,1
GOBP_CHONDROITIN_SULFATE_BIO...,SET,18,-0.35986,-0.011257,0.19843,0.96511,GOBP_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS,1
GAO_LARGE_INTESTINE_24W_C10_...,SET,55,-0.20401,-0.011144,0.11248,0.96513,GAO_LARGE_INTESTINE_24W_C10_ENTEROCYTE,1
HP_AREFLEXIA_OF_UPPER_LIMBS,SET,7,-0.65718,-0.012823,0.36231,0.96514,HP_AREFLEXIA_OF_UPPER_LIMBS,1
GOBP_MUCUS_SECRETION,SET,19,-0.40152,-0.012903,0.22135,0.96515,GOBP_MUCUS_SECRETION,1
GOCC_ORGANELLAR_RIBOSOME,SET,86,-0.15269,-0.010421,0.084166,0.96517,GOCC_ORGANELLAR_RIBOSOME,1
GSE22886_DAY0_VS_DAY7_MONOCY...2,SET,176,-0.11742,-0.011435,0.064713,0.96518,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP,1
GSE22501_PERIPHERAL_BLOOD_VS...1,SET,175,-0.12012,-0.011665,0.066187,0.96521,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN,1
GOBP_REGULATION_OF_ENDOTHELI...3,SET,34,-0.27678,-0.011894,0.15251,0.96522,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GOMF_IRON_ION_TRANSMEMBRANE_...,SET,9,-0.50026,-0.011068,0.27564,0.96522,GOMF_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_CENTRAL_HETEROCHROMIA,SET,6,-0.71716,-0.012956,0.39516,0.96522,HP_CENTRAL_HETEROCHROMIA,1
MIR509_3P,SET,53,-0.21231,-0.011385,0.11693,0.96529,MIR509_3P,1
ABDULRAHMAN_KIDNEY_CANCER_VH...,SET,13,-0.43111,-0.011462,0.23736,0.96533,ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,1
DESCARTES_FETAL_SPLEEN_MYELO...,SET,110,-0.16531,-0.012751,0.090981,0.96538,DESCARTES_FETAL_SPLEEN_MYELOID_CELLS,1
YAO_TEMPORAL_RESPONSE_TO_PRO...18,SET,69,-0.18064,-0.011048,0.099377,0.96544,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,1
GOBP_PROTEIN_TRANSMEMBRANE_I...,SET,34,-0.24798,-0.010656,0.13643,0.96544,GOBP_PROTEIN_TRANSMEMBRANE_IMPORT_INTO_INTRACELLULAR_ORGANELLE,1
GOBP_ANATOMICAL_STRUCTURE_AR...,SET,16,-0.43128,-0.01272,0.23725,0.96545,GOBP_ANATOMICAL_STRUCTURE_ARRANGEMENT,1
REACTOME_SWITCHING_OF_ORIGIN...,SET,88,-0.15483,-0.010688,0.085161,0.96546,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1
MIR4684_5P,SET,156,-0.12289,-0.011274,0.067566,0.96552,MIR4684_5P,1
KIM_ALL_DISORDERS_OLIGODENDR...1,SET,30,-0.26594,-0.010736,0.14617,0.96556,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,1
SCHAEFFER_SOX9_TARGETS_IN_PR...1,SET,44,-0.25594,-0.012508,0.14067,0.96557,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1
GSE5589_WT_VS_IL6_KO_LPS_STI...3,SET,182,-0.118,-0.011685,0.064853,0.96557,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN,1
MIR138_1_3P,SET,79,-0.17136,-0.011211,0.094173,0.96558,MIR138_1_3P,1
GOBP_NEGATIVE_REGULATION_OF_...96,SET,10,-0.46215,-0.010777,0.25399,0.96558,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,1
GSE26669_CTRL_VS_COSTIM_BLOC...2,SET,186,-0.11046,-0.011056,0.060694,0.96561,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP,1
GSE27786_LSK_VS_CD4_TCELL_UP,SET,172,-0.11581,-0.011151,0.063611,0.96565,GSE27786_LSK_VS_CD4_TCELL_UP,1
GOMF_TYPE_5_METABOTROPIC_GLU...,SET,6,-0.69322,-0.012523,0.38073,0.96567,GOMF_TYPE_5_METABOTROPIC_GLUTAMATE_RECEPTOR_BINDING,1
GSE6259_FLT3L_INDUCED_33D1_P...5,SET,130,-0.13617,-0.011412,0.074778,0.96569,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN,1
HP_INCREASED_SERUM_PYRUVATE,SET,41,-0.22302,-0.010522,0.12246,0.9657,HP_INCREASED_SERUM_PYRUVATE,1
AIZARANI_LIVER_C9_LSECS_1,SET,280,-0.10024,-0.012278,0.055043,0.9657,AIZARANI_LIVER_C9_LSECS_1,1
MIR219B_5P,SET,41,-0.23645,-0.011155,0.12982,0.96571,MIR219B_5P,1
GSE11057_NAIVE_VS_MEMORY_CD4...1,SET,174,-0.11926,-0.01155,0.065483,0.96571,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN,1
MORF_CCNI,SET,82,-0.16406,-0.010934,0.090018,0.96581,MORF_CCNI,1
RAMALHO_STEMNESS_UP,SET,180,-0.11273,-0.011102,0.061842,0.96583,RAMALHO_STEMNESS_UP,1
KEGG_MEDICUS_REFERENCE_ICOSL...,SET,8,-0.58799,-0.012265,0.32256,0.96583,KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY,1
REACTOME_DEFECTIVE_CFTR_CAUS...,SET,58,-0.18701,-0.010489,0.10259,0.96583,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,1
ZNF791_TARGET_GENES,SET,41,-0.22842,-0.010777,0.12531,0.96583,ZNF791_TARGET_GENES,1
HP_THICK_LOWER_LIP_VERMILION,SET,115,-0.15026,-0.011849,0.082396,0.96589,HP_THICK_LOWER_LIP_VERMILION,1
HP_INTELLECTUAL_DISABILITY_M...2,SET,132,-0.13064,-0.011032,0.071632,0.9659,HP_INTELLECTUAL_DISABILITY_MODERATE,1
HP_APLASIA_OF_THE_LEFT_HEMID...,SET,5,-0.79532,-0.013116,0.43605,0.96591,HP_APLASIA_OF_THE_LEFT_HEMIDIAPHRAGM,1
ACTTTAT_MIR1425P,SET,268,-0.093797,-0.011244,0.051424,0.96592,ACTTTAT_MIR1425P,1
MIR6881_5P,SET,48,-0.2298,-0.011729,0.12596,0.96595,MIR6881_5P,1
HP_NASAL_DYSARTHRIA,SET,29,-0.29079,-0.011542,0.15936,0.96597,HP_NASAL_DYSARTHRIA,1
GSE15330_WT_VS_IKAROS_KO_LYM...1,SET,180,-0.11189,-0.011019,0.061312,0.96598,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN,1
HP_THIN_VERMILION_BORDER,SET,346,-0.084557,-0.011492,0.046312,0.96605,HP_THIN_VERMILION_BORDER,1
GOBP_SYNAPTIC_TRANSMISSION_G...1,SET,56,-0.22195,-0.012233,0.12154,0.96607,GOBP_SYNAPTIC_TRANSMISSION_GABAERGIC,1
HP_BUTTERFLY_VERTEBRAE,SET,16,-0.39021,-0.011508,0.21363,0.96611,HP_BUTTERFLY_VERTEBRAE,1
GSE37301_LYMPHOID_PRIMED_MPP...6,SET,180,-0.11435,-0.011261,0.062579,0.96616,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP,1
MIR1245B_3P,SET,129,-0.13572,-0.011331,0.07425,0.96621,MIR1245B_3P,1
HP_ABNORMAL_AMPLITUDE_OF_DAR...,SET,14,-0.42994,-0.011862,0.23517,0.96623,HP_ABNORMAL_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM,1
BIOCARTA_EDG1_PATHWAY,SET,22,-0.35719,-0.012351,0.19533,0.96626,BIOCARTA_EDG1_PATHWAY,1
WP_GASTRIC_CANCER_NETWORK_2,SET,30,-0.29695,-0.011988,0.16234,0.96631,WP_GASTRIC_CANCER_NETWORK_2,1
GSE37301_PRO_BCELL_VS_GRANUL...1,SET,161,-0.12371,-0.011528,0.067604,0.96636,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
NPM1_TARGET_GENES,SET,280,-0.091915,-0.011259,0.050215,0.9664,NPM1_TARGET_GENES,1
MIR3201,SET,74,-0.17797,-0.011271,0.097198,0.96644,MIR3201,1
GOBP_ALCOHOL_BIOSYNTHETIC_PR...,SET,126,-0.13906,-0.011475,0.075943,0.96645,GOBP_ALCOHOL_BIOSYNTHETIC_PROCESS,1
GOBP_MITOCHONDRIAL_TRANSLATI...1,SET,123,-0.12841,-0.01047,0.070105,0.96649,GOBP_MITOCHONDRIAL_TRANSLATION,1
HE_LIM_SUN_FETAL_LUNG_C6_DEU...,SET,190,-0.10855,-0.01098,0.059233,0.96656,HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL,1
HP_DECREASED_CIRCULATING_COP...,SET,6,-0.69486,-0.012553,0.37914,0.96657,HP_DECREASED_CIRCULATING_COPPER_CONCENTRATION,1
HP_NODULAR_REGENERATIVE_HYPE...,SET,5,-0.77185,-0.012729,0.42114,0.96657,HP_NODULAR_REGENERATIVE_HYPERPLASIA_OF_LIVER,1
GOBP_POSITIVE_REGULATION_OF_...680,SET,10,-0.53038,-0.012369,0.28935,0.96659,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...48,SET,45,-0.24397,-0.012057,0.13307,0.96662,GOBP_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE,1
BUSSLINGER_DUODENAL_MATURE_E...,SET,237,-0.10305,-0.011627,0.056204,0.96663,BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES,1
BDP1_TARGET_GENES,SET,1011,-0.049427,-0.01127,0.026949,0.96667,BDP1_TARGET_GENES,1
MORF_PPP2R4,SET,44,-0.21613,-0.010563,0.11782,0.9667,MORF_PPP2R4,1
MIR6810_3P,SET,69,-0.19167,-0.011722,0.10447,0.96671,MIR6810_3P,1
HP_GLOMERULAR_SUBEPITHELIAL_...,SET,11,-0.45053,-0.011019,0.24558,0.96671,HP_GLOMERULAR_SUBEPITHELIAL_DEPOSITS,1
CRX_Q4,SET,246,-0.10524,-0.012094,0.057352,0.96673,CRX_Q4,1
MODULE_235,SET,79,-0.18425,-0.012054,0.10041,0.96673,MODULE_235,1
GOBP_NEGATIVE_REGULATION_OF_...342,SET,67,-0.21069,-0.012698,0.1148,0.96675,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,1
HP_ABNORMAL_GAMMA_GLUTAMYLTR...,SET,41,-0.25017,-0.011803,0.13631,0.96676,HP_ABNORMAL_GAMMA_GLUTAMYLTRANSFERASE_LEVEL,1
GOMF_5_DEOXYRIBOSE_5_PHOSPHA...,SET,7,-0.4539,-0.0088568,0.24717,0.96684,GOMF_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY,1
HP_FACIAL_TICS,SET,14,-0.43374,-0.011967,0.23598,0.96696,HP_FACIAL_TICS,1
HP_SHORT_RIBS,SET,58,-0.19836,-0.011126,0.10789,0.967,HP_SHORT_RIBS,1
GSE2770_IL12_VS_TGFB_AND_IL1...6,SET,169,-0.1251,-0.011941,0.067995,0.96709,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
GOBP_SMOOTH_MUSCLE_CONTRACTI...,SET,104,-0.16317,-0.01224,0.088686,0.9671,GOBP_SMOOTH_MUSCLE_CONTRACTION,1
MIR100_3P,SET,67,-0.19507,-0.011757,0.10601,0.96711,MIR100_3P,1
HP_PULMONARY_INSUFFICIENCY,SET,24,-0.33329,-0.012036,0.1811,0.96713,HP_PULMONARY_INSUFFICIENCY,1
GSE11057_PBMC_VS_MEM_CD4_TCE...2,SET,178,-0.12587,-0.012328,0.068384,0.96716,GSE11057_PBMC_VS_MEM_CD4_TCELL_UP,1
KEGG_FOLATE_BIOSYNTHESIS,SET,10,-0.48549,-0.011322,0.26372,0.96718,KEGG_FOLATE_BIOSYNTHESIS,1
HP_ABNORMALITY_OF_THE_PHILTR...,SET,621,-0.063604,-0.011493,0.034549,0.96718,HP_ABNORMALITY_OF_THE_PHILTRUM,1
KEGG_MEDICUS_PATHOGEN_SALMON...8,SET,19,-0.35575,-0.011433,0.19319,0.96721,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...475,SET,14,-0.45884,-0.012659,0.24917,0.96722,GOBP_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...476,SET,116,-0.14262,-0.011295,0.077439,0.96723,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...256,SET,15,-0.42753,-0.012209,0.23213,0.96724,GOBP_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS,1
HP_DEVIATION_OF_THE_HAND_OR_...,SET,478,-0.073,-0.011619,0.039632,0.96725,HP_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
MODULE_350,SET,55,-0.20354,-0.011118,0.1105,0.96726,MODULE_350,1
GOMF_DNA_CLAMP_LOADER_ACTIVI...,SET,9,-0.51015,-0.011287,0.27691,0.96728,GOMF_DNA_CLAMP_LOADER_ACTIVITY,1
RODWELL_AGING_KIDNEY_NO_BLOO...1,SET,127,-0.14691,-0.012171,0.079735,0.96729,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,1
MIR548U,SET,142,-0.13989,-0.012249,0.075884,0.96736,MIR548U,1
JNK_DN.V1_DN,SET,167,-0.12982,-0.012319,0.070423,0.96736,JNK_DN.V1_DN,1
GSE36527_CD62L_HIGH_VS_CD62L...2,SET,179,-0.11757,-0.011547,0.063777,0.96736,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP,1
GUENTHER_GROWTH_SPHERICAL_VS...2,SET,20,-0.4017,-0.013244,0.21776,0.96745,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,1
GSE21546_UNSTIM_VS_ANTI_CD3_...8,SET,175,-0.12248,-0.011895,0.066379,0.96748,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP,1
HP_DEEP_PLANTAR_CREASES,SET,19,-0.36254,-0.011651,0.19641,0.96753,HP_DEEP_PLANTAR_CREASES,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...5,SET,7,-0.59312,-0.011573,0.32132,0.96754,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN,1
GOBP_CEREBRAL_CORTEX_REGIONA...,SET,7,-0.74526,-0.014542,0.40374,0.96754,GOBP_CEREBRAL_CORTEX_REGIONALIZATION,1
SANSOM_APC_TARGETS,SET,191,-0.11447,-0.011608,0.061995,0.96757,SANSOM_APC_TARGETS,1
GOMF_GLUCURONOSYLTRANSFERASE...,SET,31,-0.36547,-0.014998,0.19793,0.96758,GOMF_GLUCURONOSYLTRANSFERASE_ACTIVITY,1
KEGG_GLYCEROLIPID_METABOLISM,SET,41,-0.25696,-0.012123,0.13914,0.96761,KEGG_GLYCEROLIPID_METABOLISM,1
GOBP_NEUTROPHIL_CHEMOTAXIS,SET,78,-0.2013,-0.013086,0.10899,0.96762,GOBP_NEUTROPHIL_CHEMOTAXIS,1
HP_PROFOUND_SENSORINEURAL_HE...,SET,9,-0.55949,-0.012378,0.30286,0.96764,HP_PROFOUND_SENSORINEURAL_HEARING_IMPAIRMENT,1
REACTOME_WAX_AND_PLASMALOGEN...,SET,5,-0.75302,-0.012419,0.40751,0.96768,REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS,1
PETRETTO_CARDIAC_HYPERTROPHY,SET,32,-0.27631,-0.01152,0.14951,0.9677,PETRETTO_CARDIAC_HYPERTROPHY,1
HP_THORACIC_HYPOPLASIA,SET,130,-0.13879,-0.011632,0.075099,0.9677,HP_THORACIC_HYPOPLASIA,1
GOBP_POLAR_BODY_EXTRUSION_AF...,SET,4,-0.94809,-0.013986,0.51297,0.96771,GOBP_POLAR_BODY_EXTRUSION_AFTER_MEIOTIC_DIVISIONS,1
HP_ABNORMAL_EXTERNAL_NOSE_MO...,SET,789,-0.055844,-0.01132,0.030209,0.96773,HP_ABNORMAL_EXTERNAL_NOSE_MORPHOLOGY,1
DESCARTES_FETAL_EYE_GANGLION...,SET,33,-0.299,-0.012659,0.1617,0.96777,DESCARTES_FETAL_EYE_GANGLION_CELLS,1
GOBP_NUCLEOTIDE_TRANSMEMBRAN...,SET,28,-0.32868,-0.01282,0.17774,0.96778,GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT,1
HP_THIRD_DEGREE_ATRIOVENTRIC...,SET,9,-0.4932,-0.010912,0.26661,0.96783,HP_THIRD_DEGREE_ATRIOVENTRICULAR_BLOCK,1
GSE32034_LY6C_HIGH_VS_LOW_MO...1,SET,188,-0.11367,-0.011437,0.061425,0.96787,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN,1
GSE27786_LIN_NEG_VS_CD8_TCEL...2,SET,179,-0.11575,-0.011368,0.062523,0.96793,GSE27786_LIN_NEG_VS_CD8_TCELL_UP,1
UNTERMAN_IPF_VS_CTRL_MONOCYT...1,SET,19,-0.4206,-0.013517,0.22717,0.96794,UNTERMAN_IPF_VS_CTRL_MONOCYTE_DN,1
MIR4742_5P,SET,169,-0.12767,-0.012186,0.068934,0.96798,MIR4742_5P,1
MORF_BMPR2,SET,47,-0.2565,-0.012955,0.13849,0.96798,MORF_BMPR2,1
HP_ABNORMAL_CIRCULATING_CERU...,SET,10,-0.52687,-0.012287,0.28447,0.96799,HP_ABNORMAL_CIRCULATING_CERULOPLASMIN_CONCENTRATION,1
HP_INTERMITTENT_CLAUDICATION,SET,8,-0.55589,-0.011596,0.30012,0.96799,HP_INTERMITTENT_CLAUDICATION,1
MIR574_5P,SET,77,-0.17649,-0.0114,0.095279,0.968,MIR574_5P,1
GSE46606_UNSTIM_VS_CD40L_IL2...4,SET,178,-0.11625,-0.011385,0.06275,0.96802,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,1
MIR6774_3P,SET,5,-0.85843,-0.014157,0.4633,0.96804,MIR6774_3P,1
MORF_PTPRR,SET,83,-0.18012,-0.012078,0.097216,0.96804,MORF_PTPRR,1
HP_PSYCHOTIC_MENTATION,SET,15,-0.38748,-0.011065,0.20911,0.96805,HP_PSYCHOTIC_MENTATION,1
HP_CRUMPLED_EAR,SET,5,-0.68591,-0.011312,0.37011,0.96807,HP_CRUMPLED_EAR,1
GSE12198_NK_VS_NK_ACT_EXPANS...1,SET,184,-0.1148,-0.01143,0.061938,0.96809,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN,1
GOBP_REGULATION_OF_CD8_POSIT...2,SET,8,-0.57718,-0.01204,0.31133,0.96812,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
MARKEY_RB1_ACUTE_LOF_DN,SET,211,-0.11343,-0.012084,0.061172,0.96814,MARKEY_RB1_ACUTE_LOF_DN,1
REACTOME_MITOCHONDRIAL_TRANS...,SET,91,-0.15199,-0.010668,0.081956,0.96816,REACTOME_MITOCHONDRIAL_TRANSLATION,1
HP_ABNORMAL_CSF_PROTEIN_CONC...,SET,45,-0.24667,-0.012191,0.133,0.96817,HP_ABNORMAL_CSF_PROTEIN_CONCENTRATION,1
MIR548AJ_5P_MIR548G_5P_MIR54...,SET,446,-0.078319,-0.012052,0.042219,0.9682,MIR548AJ_5P_MIR548G_5P_MIR548X_5P,1
ANDERSON_BLOOD_CN54GP140_ADJ...3,SET,30,-0.25735,-0.010389,0.13872,0.9682,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN,1
REACTOME_SMALL_INTERFERING_R...,SET,9,-0.54917,-0.01215,0.29601,0.96821,REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS,1
GSE37416_12H_VS_48H_F_TULARE...2,SET,182,-0.11816,-0.0117,0.063689,0.96821,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOMF_OSMOSENSOR_ACTIVITY,SET,5,-0.78736,-0.012985,0.42434,0.96823,GOMF_OSMOSENSOR_ACTIVITY,1
HP_PROTUBERANT_ABDOMEN,SET,39,-0.25615,-0.011787,0.13804,0.96823,HP_PROTUBERANT_ABDOMEN,1
GSE27291_0H_VS_6H_STIM_GAMMA...2,SET,152,-0.12674,-0.011478,0.06827,0.96829,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP,1
MIR670_5P,SET,230,-0.1066,-0.011851,0.057391,0.96837,MIR670_5P,1
GOCC_KINESIN_COMPLEX,SET,47,-0.21324,-0.01077,0.11479,0.96838,GOCC_KINESIN_COMPLEX,1
GOBP_LEUKOTRIENE_D4_METABOLI...,SET,7,-0.59973,-0.011702,0.32281,0.9684,GOBP_LEUKOTRIENE_D4_METABOLIC_PROCESS,1
GOBP_VESICLE_UNCOATING,SET,9,-0.45691,-0.010109,0.24592,0.9684,GOBP_VESICLE_UNCOATING,1
HP_CONGESTIVE_HEART_FAILURE,SET,220,-0.10829,-0.011776,0.058283,0.9684,HP_CONGESTIVE_HEART_FAILURE,1
GNF2_MCL1,SET,49,-0.22551,-0.011629,0.12133,0.96845,GNF2_MCL1,1
GOBP_NAD_METABOLIC_PROCESS,SET,57,-0.20763,-0.011545,0.11169,0.96848,GOBP_NAD_METABOLIC_PROCESS,1
GOBP_COPPER_ION_TRANSPORT,SET,15,-0.41187,-0.011762,0.2215,0.96851,GOBP_COPPER_ION_TRANSPORT,1
GOBP_SMALL_MOLECULE_BIOSYNTH...,SET,539,-0.069811,-0.011779,0.037524,0.96858,GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,1
GOCC_PODOSOME,SET,33,-0.27289,-0.011553,0.14665,0.96861,GOCC_PODOSOME,1
GSE17721_CTRL_VS_CPG_6H_BMDC...1,SET,178,-0.1175,-0.011507,0.063084,0.96873,GSE17721_CTRL_VS_CPG_6H_BMDC_DN,1
MIR519E_3P,SET,60,-0.20992,-0.011975,0.11269,0.96875,MIR519E_3P,1
POU6F1_01,SET,211,-0.11944,-0.012724,0.064116,0.96875,POU6F1_01,1
GOMF_PHOSPHATIDYLSERINE_1_AC...,SET,6,-0.58802,-0.010623,0.31565,0.96875,GOMF_PHOSPHATIDYLSERINE_1_ACYLHYDROLASE_ACTIVITY,1
HP_EXERCISE_INDUCED_MUSCLE_S...,SET,7,-0.51949,-0.010137,0.27882,0.96877,HP_EXERCISE_INDUCED_MUSCLE_STIFFNESS,1
TGCACTG_MIR148A_MIR152_MIR14...,SET,270,-0.10013,-0.012047,0.053736,0.96878,TGCACTG_MIR148A_MIR152_MIR148B,1
HAY_BONE_MARROW_CD34_POS_CLP,SET,7,-0.70976,-0.013849,0.38087,0.9688,HAY_BONE_MARROW_CD34_POS_CLP,1
HP_SPONTANEOUS_PAIN_SENSATION,SET,5,-0.74682,-0.012317,0.40072,0.96881,HP_SPONTANEOUS_PAIN_SENSATION,1
SHIPP_DLBCL_CURED_VS_FATAL_UP,SET,36,-0.27352,-0.012094,0.14672,0.96884,SHIPP_DLBCL_CURED_VS_FATAL_UP,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...1,SET,378,-0.079674,-0.011308,0.042739,0.96884,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN,1
MODULE_40,SET,82,-0.18154,-0.012099,0.097354,0.96888,MODULE_40,1
REACTOME_POLYMERASE_SWITCHIN...,SET,24,-0.29808,-0.010765,0.15975,0.96896,REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE,1
TACTTGA_MIR26A_MIR26B,SET,273,-0.098905,-0.011965,0.053004,0.96897,TACTTGA_MIR26A_MIR26B,1
HP_PROGRESSIVE_EXTRAPYRAMIDA...,SET,8,-0.57114,-0.011914,0.30609,0.96897,HP_PROGRESSIVE_EXTRAPYRAMIDAL_MOVEMENT_DISORDER,1
RAGHAVACHARI_PLATELET_SPECIF...,SET,60,-0.21847,-0.012462,0.11706,0.969,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,1
SABATES_COLORECTAL_ADENOMA_DN,SET,260,-0.10759,-0.012706,0.057639,0.96901,SABATES_COLORECTAL_ADENOMA_DN,1
HAHTOLA_MYCOSIS_FUNGOIDES_UP,SET,14,-0.45345,-0.012511,0.2428,0.96908,HAHTOLA_MYCOSIS_FUNGOIDES_UP,1
MIR522_3P,SET,159,-0.12645,-0.011711,0.067702,0.9691,MIR522_3P,1
REACTOME_ZINC_EFFLUX_AND_COM...,SET,5,-0.73078,-0.012052,0.39109,0.96915,REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY,1
HOEK_PBMC_INACTIVATED_INFLUE...1,SET,8,-0.50581,-0.010551,0.27067,0.96916,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_DN,1
BURTON_ADIPOGENESIS_6,SET,176,-0.11767,-0.01146,0.062966,0.96917,BURTON_ADIPOGENESIS_6,1
GOBP_SENSORY_PERCEPTION_OF_L...,SET,201,-0.12136,-0.012622,0.064924,0.9692,GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS,1
HP_ABNORMAL_THORACIC_SPINE_M...,SET,94,-0.15621,-0.011143,0.083546,0.96923,HP_ABNORMAL_THORACIC_SPINE_MORPHOLOGY,1
HP_UPPER_LIMB_HYPERTONIA,SET,9,-0.54984,-0.012165,0.29408,0.96923,HP_UPPER_LIMB_HYPERTONIA,1
GOBP_CRANIAL_NERVE_FORMATION,SET,10,-0.61424,-0.014324,0.32845,0.96926,GOBP_CRANIAL_NERVE_FORMATION,1
HP_MENINGOCELE,SET,53,-0.22818,-0.012236,0.12201,0.96926,HP_MENINGOCELE,1
GENTILE_UV_HIGH_DOSE_UP,SET,17,-0.40566,-0.012332,0.21689,0.96928,GENTILE_UV_HIGH_DOSE_UP,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...1,SET,17,-0.40699,-0.012373,0.2176,0.96928,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,1
KEGG_MEDICUS_REFERENCE_EGF_E...8,SET,13,-0.44778,-0.011905,0.23938,0.96929,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_COLD,SET,42,-0.24606,-0.011749,0.13154,0.96929,GOBP_RESPONSE_TO_COLD,1
GOBP_PROTEIN_TRIMERIZATION,SET,17,-0.38601,-0.011735,0.20631,0.96932,GOBP_PROTEIN_TRIMERIZATION,1
GOBP_INTERNEURON_MIGRATION_F...,SET,6,-0.58114,-0.010499,0.31056,0.96934,GOBP_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX,1
MIR182_5P,SET,506,-0.073468,-0.012022,0.039254,0.96936,MIR182_5P,1
HP_INCREASED_MUSCLE_LIPID_CO...,SET,33,-0.27464,-0.011627,0.14669,0.96941,HP_INCREASED_MUSCLE_LIPID_CONTENT,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...1,SET,8,-0.6693,-0.013961,0.35739,0.96944,GOBP_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...266,SET,14,-0.41266,-0.011385,0.22033,0.96945,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,1
MIR6830_5P,SET,163,-0.12969,-0.012159,0.069227,0.96948,MIR6830_5P,1
GOBP_REGULATION_OF_GLUCOSE_M...,SET,88,-0.17718,-0.012231,0.094563,0.9695,GOBP_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,1
PAX2_01,SET,49,-0.22352,-0.011526,0.11929,0.96951,PAX2_01,1
ROZANOV_MMP14_TARGETS_UP,SET,242,-0.10975,-0.012511,0.058548,0.96957,ROZANOV_MMP14_TARGETS_UP,1
GOBP_BASE_EXCISION_REPAIR_GA...,SET,13,-0.34587,-0.0091955,0.18448,0.96958,GOBP_BASE_EXCISION_REPAIR_GAP_FILLING,1
MIR4687_5P,SET,40,-0.25949,-0.012093,0.13838,0.96961,MIR4687_5P,1
MIR6729_3P,SET,63,-0.19756,-0.011547,0.10532,0.96965,MIR6729_3P,1
HP_PULMONARY_INTERSTITIAL_HI...,SET,21,-0.37982,-0.012832,0.20243,0.96969,HP_PULMONARY_INTERSTITIAL_HIGH_RESOLUTION_COMPUTED_TOMOGRAPHY_ABNORMALITY,1
GSE9509_LPS_VS_LPS_AND_IL10_...2,SET,187,-0.12555,-0.0126,0.066898,0.96971,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP,1
GNF2_MAPT,SET,39,-0.29269,-0.013469,0.15594,0.96973,GNF2_MAPT,1
AAANWWTGC_UNKNOWN,SET,183,-0.12345,-0.012258,0.065763,0.96975,AAANWWTGC_UNKNOWN,1
GOBP_CELLULAR_RESPONSE_TO_OX...5,SET,21,-0.34821,-0.011764,0.18547,0.96976,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL,1
GSE22886_CD4_TCELL_VS_BCELL_...1,SET,170,-0.12562,-0.012026,0.066906,0.96977,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN,1
chr16q23,SET,51,-0.36791,-0.019354,0.1959,0.96981,chr16q23,1
WP_GLYOXYLATE_METABOLISM,SET,11,-0.50085,-0.01225,0.26668,0.96981,WP_GLYOXYLATE_METABOLISM,1
KASLER_HDAC7_TARGETS_2_DN,SET,31,-0.28924,-0.011869,0.15399,0.96982,KASLER_HDAC7_TARGETS_2_DN,1
GOBP_RISC_COMPLEX_ASSEMBLY,SET,10,-0.54812,-0.012782,0.29173,0.96986,GOBP_RISC_COMPLEX_ASSEMBLY,1
GOMF_LYSOZYME_ACTIVITY,SET,9,-0.56857,-0.012579,0.30239,0.96996,GOMF_LYSOZYME_ACTIVITY,1
TANG_SENESCENCE_TP53_TARGETS...2,SET,31,-0.30803,-0.01264,0.16378,0.96999,TANG_SENESCENCE_TP53_TARGETS_UP,1
REACTOME_CRMPS_IN_SEMA3A_SIG...,SET,15,-0.44211,-0.012625,0.23506,0.96999,REACTOME_CRMPS_IN_SEMA3A_SIGNALING,1
MIR625_5P,SET,190,-0.11737,-0.011872,0.062396,0.97001,MIR625_5P,1
GSE41867_DAY8_VS_DAY15_LCMV_...4,SET,182,-0.11663,-0.011549,0.061986,0.97004,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
ATF2_UP.V1_DN,SET,166,-0.13098,-0.012391,0.069606,0.97005,ATF2_UP.V1_DN,1
GOCC_PLATELET_DENSE_GRANULE,SET,19,-0.3623,-0.011643,0.19244,0.97012,GOCC_PLATELET_DENSE_GRANULE,1
REACTOME_REGULATION_OF_CHOLE...,SET,53,-0.20679,-0.011089,0.10983,0.97013,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1
HP_APLASIA_HYPOPLASIA_OF_THE...79,SET,43,-0.24949,-0.012054,0.13251,0.97013,HP_APLASIA_HYPOPLASIA_OF_THE_VAGINA,1
SNAI1_TARGET_GENES,SET,370,-0.083869,-0.01178,0.044542,0.97014,SNAI1_TARGET_GENES,1
GOBP_REGULATION_OF_MUCUS_SEC...,SET,9,-0.62039,-0.013726,0.32947,0.97014,GOBP_REGULATION_OF_MUCUS_SECRETION,1
KEGG_MEDICUS_REFERENCE_MAGI_...,SET,6,-0.65035,-0.011749,0.34535,0.97015,KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY,1
HP_CESSATION_OF_HEAD_GROWTH,SET,6,-0.6754,-0.012202,0.35864,0.97016,HP_CESSATION_OF_HEAD_GROWTH,1
MIR4269,SET,190,-0.11935,-0.012072,0.063367,0.97017,MIR4269,1
WP_ONCOSTATIN_M_SIGNALING,SET,63,-0.22215,-0.012985,0.11794,0.97018,WP_ONCOSTATIN_M_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...818,SET,9,-0.46182,-0.010217,0.24506,0.97024,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,1
STAT5A_04,SET,188,-0.12338,-0.012414,0.065465,0.97025,STAT5A_04,1
HIF1_Q3,SET,211,-0.11328,-0.012068,0.060099,0.97027,HIF1_Q3,1
GOBP_CHEMOKINE_C_X_C_MOTIF_L...3,SET,18,-0.39946,-0.012495,0.21192,0.97027,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
GSE25123_WT_VS_PPARG_KO_MACR...2,SET,164,-0.12666,-0.011912,0.067188,0.97029,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN,1
GOMF_DEUBIQUITINASE_ACTIVATO...,SET,7,-0.52561,-0.010256,0.27876,0.97031,GOMF_DEUBIQUITINASE_ACTIVATOR_ACTIVITY,1
IBRAHIM_NRF1_DOWN,SET,127,-0.1471,-0.012186,0.078001,0.97034,IBRAHIM_NRF1_DOWN,1
GOBP_INTRINSIC_APOPTOTIC_SIG...7,SET,9,-0.45654,-0.010101,0.242,0.97038,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYPOXIA,1
HP_CEREBRAL_PALSY,SET,157,-0.12975,-0.011941,0.068774,0.97039,HP_CEREBRAL_PALSY,1
GSE23925_LIGHT_ZONE_VS_NAIVE...1,SET,174,-0.11948,-0.01157,0.063274,0.9705,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN,1
RODWELL_AGING_KIDNEY_DN,SET,124,-0.1517,-0.012419,0.080318,0.97053,RODWELL_AGING_KIDNEY_DN,1
GOBP_NEGATIVE_REGULATION_OF_...364,SET,57,-0.23472,-0.013052,0.12427,0.97053,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,1
MIR4453,SET,24,-0.36662,-0.01324,0.19406,0.97056,MIR4453,1
HP_THICKENED_GLOMERULAR_BASE...,SET,9,-0.5193,-0.011489,0.27487,0.97056,HP_THICKENED_GLOMERULAR_BASEMENT_MEMBRANE,1
GOBP_NEGATIVE_REGULATION_OF_...185,SET,3,-0.93969,-0.012005,0.49737,0.97057,GOBP_NEGATIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,1
MIR4677_5P,SET,233,-0.10757,-0.012035,0.056934,0.97058,MIR4677_5P,1
GOMF_TESTOSTERONE_17_BETA_DE...,SET,9,-0.5365,-0.011869,0.28393,0.97058,GOMF_TESTOSTERONE_17_BETA_DEHYDROGENASE_NADPPLUS_ACTIVITY,1
HP_DECREASED_PROPORTION_OF_C...2,SET,8,-0.54906,-0.011453,0.29058,0.97058,HP_DECREASED_PROPORTION_OF_CD8_POSITIVE_T_CELLS,1
CHANGOLKAR_H2AFY_TARGETS_UP,SET,43,-0.26196,-0.012656,0.13862,0.9706,CHANGOLKAR_H2AFY_TARGETS_UP,1
KEGG_PROTEASOME,SET,43,-0.22554,-0.010897,0.11933,0.97061,KEGG_PROTEASOME,1
GOMF_ALPHA_2A_ADRENERGIC_REC...,SET,4,-0.92045,-0.013578,0.48691,0.97064,GOMF_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING,1
HP_PROGRESSIVE_SPASTICITY,SET,26,-0.30459,-0.011448,0.16112,0.97065,HP_PROGRESSIVE_SPASTICITY,1
chr5q35,SET,116,-0.3092,-0.024487,0.16353,0.97066,chr5q35,1
HP_ABNORMAL_CNS_MYELINATION,SET,360,-0.08193,-0.011354,0.043307,0.97074,HP_ABNORMAL_CNS_MYELINATION,1
HP_UVEAL_ECTROPION,SET,7,-0.63685,-0.012427,0.33652,0.97078,HP_UVEAL_ECTROPION,1
HP_CLUBBING_OF_FINGERS,SET,37,-0.28013,-0.012557,0.14791,0.97087,HP_CLUBBING_OF_FINGERS,1
GSE24492_LYVE_NEG_VS_POS_MAC...1,SET,177,-0.12343,-0.012055,0.065162,0.9709,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN,1
GSE17721_POLYIC_VS_PAM3CSK4_...8,SET,184,-0.11503,-0.011452,0.060686,0.97098,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP,1
GSE27786_LSK_VS_BCELL_UP,SET,175,-0.11872,-0.01153,0.062633,0.97098,GSE27786_LSK_VS_BCELL_UP,1
LAKE_ADULT_KIDNEY_C15_CONNEC...,SET,156,-0.14262,-0.013084,0.075199,0.97105,LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE,1
HP_ABNORMALITY_OF_MACULAR_PI...,SET,36,-0.3023,-0.013366,0.15936,0.97108,HP_ABNORMALITY_OF_MACULAR_PIGMENTATION,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...3,SET,27,-0.32117,-0.012301,0.16925,0.97112,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
LTE2_UP.V1_UP,SET,178,-0.12805,-0.012541,0.067468,0.97114,LTE2_UP.V1_UP,1
HP_ANODONTIA,SET,13,-0.44319,-0.011783,0.23338,0.97121,HP_ANODONTIA,1
REACTOME_REGULATION_OF_RUNX1...,SET,17,-0.40794,-0.012402,0.2148,0.97122,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,1
REACTOME_TRANSCRIPTIONAL_REG...5,SET,112,-0.14685,-0.011429,0.077297,0.97126,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1
GOBP_REGULATION_OF_SYNAPTIC_...5,SET,34,-0.2886,-0.012402,0.1519,0.97128,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
GSE23502_WT_VS_HDC_KO_MYELOI...2,SET,179,-0.11813,-0.011601,0.062172,0.97128,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP,1
GOBP_MYCOTOXIN_METABOLIC_PRO...,SET,7,-0.63775,-0.012444,0.33559,0.9713,GOBP_MYCOTOXIN_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_VASCULAR_...4,SET,29,-0.30544,-0.012124,0.16071,0.97131,GOBP_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_HYPERLYSINURIA,SET,5,-0.70795,-0.011676,0.37243,0.97134,HP_HYPERLYSINURIA,1
GOBP_NEGATIVE_REGULATION_OF_...454,SET,35,-0.27265,-0.011887,0.14332,0.97143,GOBP_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,1
HP_IMPAIRED_ARACHIDONIC_ACID...,SET,7,-0.60779,-0.01186,0.31938,0.97147,HP_IMPAIRED_ARACHIDONIC_ACID_INDUCED_PLATELET_AGGREGATION,1
GSE40685_TREG_VS_FOXP3_KO_TR...2,SET,172,-0.12922,-0.012442,0.067888,0.9715,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP,1
GSE41867_DAY6_EFFECTOR_VS_DA...2,SET,185,-0.11954,-0.011933,0.062804,0.9715,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,1
chr4p12,SET,15,-0.73262,-0.020922,0.38479,0.97153,chr4p12,1
GOBP_L_LEUCINE_METABOLIC_PRO...,SET,8,-0.56389,-0.011762,0.29606,0.97158,GOBP_L_LEUCINE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_EXTRACELL...4,SET,61,-0.2136,-0.012286,0.11215,0.97158,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,1
MURARO_PANCREAS_BETA_CELL,SET,858,-0.058132,-0.012264,0.030513,0.97161,MURARO_PANCREAS_BETA_CELL,1
GAVISH_3CA_METAPROGRAM_ENDOT...14,SET,46,-0.27144,-0.013563,0.14246,0.97162,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING,1
SCHLOSSER_MYC_TARGETS_AND_SE...1,SET,42,-0.22953,-0.01096,0.12046,0.97163,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...2,SET,8,-0.656,-0.013684,0.34428,0.97163,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_PHOSPHAGEN_METABOLIC_PR...,SET,5,-0.63615,-0.010491,0.33374,0.97167,GOBP_PHOSPHAGEN_METABOLIC_PROCESS,1
HP_ABNORMAL_SKULL_BASE_MORPH...,SET,205,-0.11244,-0.011809,0.058991,0.97167,HP_ABNORMAL_SKULL_BASE_MORPHOLOGY,1
HP_SHORT_FEMUR,SET,25,-0.34289,-0.012638,0.1799,0.97167,HP_SHORT_FEMUR,1
HP_PATELLAR_SUBLUXATION,SET,5,-0.86445,-0.014257,0.4535,0.97168,HP_PATELLAR_SUBLUXATION,1
GOBP_PROTEIN_REFOLDING,SET,24,-0.30948,-0.011177,0.16235,0.97169,GOBP_PROTEIN_REFOLDING,1
GOBP_TRNA_5_END_PROCESSING,SET,13,-0.40269,-0.010706,0.21123,0.97169,GOBP_TRNA_5_END_PROCESSING,1
GAO_ESOPHAGUS_25W_C1_CILIATE...,SET,375,-0.0832,-0.011763,0.043636,0.97171,GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS,1
LEF1_Q6,SET,240,-0.1126,-0.012784,0.059038,0.97175,LEF1_Q6,1
GOMF_RIBONUCLEOPROTEIN_COMPL...,SET,142,-0.129,-0.011296,0.067617,0.97179,GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING,1
DESCARTES_FETAL_PLACENTA_MEG...,SET,156,-0.13379,-0.012274,0.070124,0.97179,DESCARTES_FETAL_PLACENTA_MEGAKARYOCYTES,1
MIR361_5P,SET,152,-0.13367,-0.012106,0.070049,0.97181,MIR361_5P,1
GOCC_COSTAMERE,SET,16,-0.41976,-0.01238,0.21992,0.97184,GOCC_COSTAMERE,1
GSE360_DC_VS_MAC_L_DONOVANI_...2,SET,189,-0.12176,-0.012284,0.063761,0.9719,GSE360_DC_VS_MAC_L_DONOVANI_UP,1
GOCC_CTF18_RFC_LIKE_COMPLEX,SET,8,-0.55405,-0.011557,0.29002,0.97195,GOCC_CTF18_RFC_LIKE_COMPLEX,1
HP_HYDROMETROCOLPOS,SET,28,-0.30949,-0.012071,0.16193,0.97201,HP_HYDROMETROCOLPOS,1
HP_OSTEOLYSIS_INVOLVING_BONE...2,SET,20,-0.36596,-0.012066,0.19147,0.97201,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,1
VERRECCHIA_RESPONSE_TO_TGFB1...6,SET,5,-0.74159,-0.01223,0.3879,0.97204,VERRECCHIA_RESPONSE_TO_TGFB1_C6,1
GSE2770_IL12_ACT_VS_ACT_CD4_...5,SET,158,-0.12871,-0.011883,0.067322,0.97204,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...7,SET,423,-0.078277,-0.011738,0.04094,0.97205,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE,1
EIF4E_UP,SET,88,-0.16565,-0.011435,0.086632,0.97206,EIF4E_UP,1
GOBP_REGULATION_OF_NATURAL_K...3,SET,13,-0.47802,-0.012709,0.24993,0.97209,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,1
GSE40274_CTRL_VS_HELIOS_TRAN...1,SET,163,-0.12877,-0.012074,0.067315,0.97212,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
REACTOME_INTERACTION_BETWEEN...,SET,30,-0.33129,-0.013374,0.17307,0.97219,REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,1
GSE36476_CTRL_VS_TSST_ACT_40...2,SET,178,-0.12587,-0.012327,0.065719,0.97226,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP,1
GOCC_LATE_ENDOSOME_MEMBRANE,SET,153,-0.13094,-0.011897,0.068364,0.97227,GOCC_LATE_ENDOSOME_MEMBRANE,1
MIR2054,SET,148,-0.13954,-0.012472,0.072835,0.9723,MIR2054,1
MIR6787_5P,SET,24,-0.35439,-0.012798,0.18497,0.9723,MIR6787_5P,1
GSE17721_POLYIC_VS_CPG_6H_BM...1,SET,184,-0.117,-0.011649,0.061066,0.97231,GSE17721_POLYIC_VS_CPG_6H_BMDC_DN,1
GOBP_REGULATION_OF_GAMMA_AMI...,SET,8,-0.64641,-0.013484,0.33723,0.97236,GOBP_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION,1
HE_LIM_SUN_FETAL_LUNG_C0_EAR...2,SET,518,-0.076855,-0.01272,0.040096,0.97236,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL,1
BIOCARTA_SARS_PATHWAY,SET,7,-0.64022,-0.012492,0.33398,0.97237,BIOCARTA_SARS_PATHWAY,1
GOMF_DYNEIN_LIGHT_INTERMEDIA...,SET,28,-0.29988,-0.011696,0.15641,0.97239,GOMF_DYNEIN_LIGHT_INTERMEDIATE_CHAIN_BINDING,1
HP_LEUKODYSTROPHY,SET,83,-0.167,-0.011198,0.087102,0.97239,HP_LEUKODYSTROPHY,1
GOBP_PEPTIDYL_HISTIDINE_MODI...,SET,9,-0.45867,-0.010148,0.23921,0.9724,GOBP_PEPTIDYL_HISTIDINE_MODIFICATION,1
CP2_02,SET,220,-0.11321,-0.012312,0.059038,0.97241,CP2_02,1
GNF2_CASP1,SET,102,-0.16684,-0.012395,0.086982,0.97244,GNF2_CASP1,1
GSE25085_FETAL_BM_VS_ADULT_B...2,SET,187,-0.12349,-0.012393,0.064351,0.9725,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,1
CHIARADONNA_NEOPLASTIC_TRANS...5,SET,130,-0.14884,-0.012474,0.077551,0.97251,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,1
chr6p24,SET,31,-0.51123,-0.020979,0.26631,0.97254,chr6p24,1
GOBP_MONOCYTE_CHEMOTACTIC_PR...,SET,18,-0.45592,-0.014261,0.23748,0.97255,GOBP_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
GOMF_HISTAMINE_RECEPTOR_ACTI...,SET,6,-0.69904,-0.012629,0.36407,0.97257,GOMF_HISTAMINE_RECEPTOR_ACTIVITY,1
GOBP_CARTILAGE_MORPHOGENESIS,SET,9,-0.65006,-0.014382,0.33852,0.97258,GOBP_CARTILAGE_MORPHOGENESIS,1
HP_STEREOTYPICAL_HAND_WRINGI...,SET,20,-0.38914,-0.01283,0.20264,0.97259,HP_STEREOTYPICAL_HAND_WRINGING,1
REACTOME_SEROTONIN_AND_MELAT...,SET,4,-0.8307,-0.012254,0.43247,0.97261,REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS,1
GSE29618_PRE_VS_DAY7_POST_TI...4,SET,180,-0.12151,-0.011966,0.063253,0.97263,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP,1
GOBP_AMINOPHOSPHOLIPID_TRANS...2,SET,8,-0.56862,-0.011861,0.29597,0.97264,GOBP_AMINOPHOSPHOLIPID_TRANSPORT,1
HP_OPTIC_NERVE_COMPRESSION,SET,14,-0.45039,-0.012426,0.23442,0.97264,HP_OPTIC_NERVE_COMPRESSION,1
GOBP_NEGATIVE_REGULATION_OF_...98,SET,3,-1.1032,-0.014093,0.57413,0.97265,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
LET_7G_5P,SET,361,-0.089224,-0.012382,0.046433,0.97266,LET_7G_5P,1
GOBP_ADHESION_OF_SYMBIONT_TO...1,SET,12,-0.52714,-0.013466,0.27433,0.97266,GOBP_ADHESION_OF_SYMBIONT_TO_HOST,1
WP_2Q211_COPY_NUMBER_VARIATI...,SET,15,-0.5124,-0.014633,0.26663,0.97267,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,1
HP_ABNORMAL_CIRCULATING_ASPA...,SET,22,-0.4,-0.013831,0.20816,0.97267,HP_ABNORMAL_CIRCULATING_ASPARTATE_FAMILY_AMINO_ACID_CONCENTRATION,1
HP_CEREBELLAR_MALFORMATION,SET,219,-0.11171,-0.012122,0.05811,0.97272,HP_CEREBELLAR_MALFORMATION,1
VANDESLUIS_NORMAL_EMBRYOS_DN,SET,19,-0.43163,-0.013871,0.22446,0.97275,VANDESLUIS_NORMAL_EMBRYOS_DN,1
MIR224_3P,SET,160,-0.13014,-0.01209,0.067678,0.97275,MIR224_3P,1
GOMF_HISTONE_H4K20_MONOMETHY...,SET,3,-1.0953,-0.013992,0.5694,0.97278,GOMF_HISTONE_H4K20_MONOMETHYLTRANSFERASE_ACTIVITY,1
GOCC_ENDOPEPTIDASE_COMPLEX,SET,84,-0.16848,-0.011365,0.087575,0.97281,GOCC_ENDOPEPTIDASE_COMPLEX,1
HP_MITOCHONDRIAL_RESPIRATORY...,SET,10,-0.52222,-0.012178,0.27132,0.97286,HP_MITOCHONDRIAL_RESPIRATORY_CHAIN_DEFECTS,1
CREIGHTON_ENDOCRINE_THERAPY_...1,SET,445,-0.080879,-0.012432,0.041984,0.97297,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,1
MIR585_5P,SET,119,-0.15458,-0.012398,0.080183,0.97305,MIR585_5P,1
MODULE_411,SET,72,-0.19463,-0.012158,0.10093,0.97308,MODULE_411,1
GOBP_METALLO_SULFUR_CLUSTER_...,SET,21,-0.3489,-0.011787,0.18091,0.9731,GOBP_METALLO_SULFUR_CLUSTER_ASSEMBLY,1
MIR320A_5P,SET,98,-0.17053,-0.012419,0.088385,0.97315,MIR320A_5P,1
CHIANG_LIVER_CANCER_SUBCLASS...2,SET,154,-0.14348,-0.013079,0.07436,0.97316,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1
HP_ABNORMAL_ENZYME_ACTIVITY_...2,SET,7,-0.5455,-0.010644,0.28261,0.9732,HP_ABNORMAL_ENZYME_ACTIVITY_IN_MUSCLE_TISSUE,1
GOBP_REGULATION_OF_DEFENSE_R...3,SET,5,-0.65561,-0.010812,0.33961,0.97322,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_FUNGUS,1
MODULE_341,SET,74,-0.19226,-0.012175,0.099578,0.97323,MODULE_341,1
GOMF_MINUS_END_DIRECTED_MICR...,SET,17,-0.41586,-0.012642,0.21531,0.97328,GOMF_MINUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...480,SET,17,-0.3559,-0.010819,0.18422,0.97331,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION,1
GSE29618_PRE_VS_DAY7_FLU_VAC...6,SET,170,-0.13069,-0.012512,0.067611,0.97338,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP,1
MIR152_3P,SET,314,-0.096213,-0.012468,0.049768,0.97339,MIR152_3P,1
YOSHIMURA_MAPK8_TARGETS_DN,SET,350,-0.09108,-0.012449,0.047108,0.9734,YOSHIMURA_MAPK8_TARGETS_DN,1
GOBP_NEUTROPHIL_ACTIVATION_I...,SET,20,-0.36747,-0.012116,0.19007,0.9734,GOBP_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...1,SET,108,-0.15028,-0.011486,0.077697,0.97345,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_L...4,SET,38,-0.26603,-0.012084,0.13752,0.97346,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
HP_MALAR_PROMINENCE,SET,5,-0.71327,-0.011763,0.36873,0.97346,HP_MALAR_PROMINENCE,1
GOBP_PURINE_RIBONUCLEOSIDE_M...,SET,19,-0.41012,-0.01318,0.21197,0.97348,GOBP_PURINE_RIBONUCLEOSIDE_METABOLIC_PROCESS,1
REACTOME_SCF_SKP2_MEDIATED_D...,SET,57,-0.20151,-0.011205,0.10414,0.97349,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1
MIR5004_3P,SET,124,-0.14874,-0.012177,0.076863,0.97351,MIR5004_3P,1
DESCARTES_FETAL_HEART_SATB2_...,SET,84,-0.20805,-0.014033,0.10751,0.97351,DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS,1
MIR377_5P,SET,50,-0.22529,-0.011735,0.11636,0.97356,MIR377_5P,1
MIR4538,SET,25,-0.36658,-0.013511,0.18933,0.97357,MIR4538,1
MIR4746_5P,SET,8,-0.51479,-0.010738,0.26581,0.9736,MIR4746_5P,1
GOBP_CELLULAR_MODIFIED_AMINO...3,SET,175,-0.12671,-0.012306,0.065427,0.9736,GOBP_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS,1
CUI_DEVELOPING_HEART_C4_ENDO...,SET,135,-0.15546,-0.013275,0.080259,0.97362,CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL,1
HOFMANN_MYELODYSPLASTIC_SYND...5,SET,20,-0.34801,-0.011474,0.17959,0.97366,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,1
REACTOME_TELOMERE_C_STRAND_L...,SET,32,-0.27086,-0.011293,0.13979,0.97366,REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,1
BURTON_ADIPOGENESIS_10,SET,26,-0.31337,-0.011778,0.16169,0.97369,BURTON_ADIPOGENESIS_10,1
HP_ABNORMALITY_OF_MOUTH_SHAPE,SET,240,-0.1087,-0.012341,0.056087,0.97369,HP_ABNORMALITY_OF_MOUTH_SHAPE,1
WP_MITOCHONDRIAL_GENE_EXPRES...,SET,18,-0.4238,-0.013257,0.21854,0.97376,WP_MITOCHONDRIAL_GENE_EXPRESSION,1
LET_7A_5P_LET_7C_5P_LET_7E_5P,SET,360,-0.090238,-0.012505,0.046521,0.97378,LET_7A_5P_LET_7C_5P_LET_7E_5P,1
GOBP_PENTOSE_METABOLIC_PROCE...,SET,12,-0.48727,-0.012447,0.25116,0.9738,GOBP_PENTOSE_METABOLIC_PROCESS,1
CAIRO_PML_TARGETS_BOUND_BY_M...2,SET,22,-0.34823,-0.012041,0.17949,0.97381,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,1
GOBP_NUCLEOBASE_CATABOLIC_PR...,SET,10,-0.54796,-0.012779,0.28234,0.97385,GOBP_NUCLEOBASE_CATABOLIC_PROCESS,1
GOBP_T_CELL_MIGRATION,SET,63,-0.22002,-0.01286,0.11337,0.97385,GOBP_T_CELL_MIGRATION,1
ZBTB18_TARGET_GENES,SET,672,-0.06424,-0.012057,0.033096,0.97386,ZBTB18_TARGET_GENES,1
GOBP_POLYSACCHARIDE_BIOSYNTH...,SET,60,-0.21356,-0.012183,0.11003,0.97386,GOBP_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...279,SET,6,-0.79982,-0.014449,0.41208,0.97386,GOBP_POSITIVE_REGULATION_OF_FEAR_RESPONSE,1
GSE40274_CTRL_VS_SATB1_TRANS...2,SET,150,-0.13885,-0.012493,0.071533,0.97386,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
LI_CISPLATIN_RESISTANCE_UP,SET,24,-0.38307,-0.013834,0.1973,0.9739,LI_CISPLATIN_RESISTANCE_UP,1
TGAGATT_MIR216,SET,101,-0.16447,-0.012159,0.084702,0.97391,TGAGATT_MIR216,1
chr5q21,SET,14,-0.69573,-0.019195,0.35825,0.97393,chr5q21,1
HP_ABNORMAL_METAPHYSIS_MORPH...,SET,204,-0.11449,-0.011996,0.058939,0.97396,HP_ABNORMAL_METAPHYSIS_MORPHOLOGY,1
HP_SACCADIC_OSCILLATION,SET,20,-0.42411,-0.013983,0.21829,0.97397,HP_SACCADIC_OSCILLATION,1
HP_CHILDHOOD_ONSET_TRUNCAL_O...,SET,30,-0.30398,-0.012272,0.15645,0.97398,HP_CHILDHOOD_ONSET_TRUNCAL_OBESITY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...6,SET,127,-0.16327,-0.013526,0.084017,0.974,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS,1
HP_PREMATURE_OVARIAN_INSUFFI...,SET,61,-0.19904,-0.011448,0.10237,0.97406,HP_PREMATURE_OVARIAN_INSUFFICIENCY,1
GOBP_PTERIDINE_CONTAINING_CO...1,SET,13,-0.42633,-0.011335,0.21917,0.97412,GOBP_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
ACCTGTTG_UNKNOWN,SET,144,-0.14376,-0.012675,0.07388,0.97416,ACCTGTTG_UNKNOWN,1
MIR3187_3P,SET,63,-0.20757,-0.012132,0.10666,0.97417,MIR3187_3P,1
MIR98_5P,SET,361,-0.090556,-0.012567,0.046505,0.97424,MIR98_5P,1
MODULE_456,SET,102,-0.16599,-0.012332,0.085212,0.97429,MODULE_456,1
GSE40274_CTRL_VS_FOXP3_AND_G...2,SET,125,-0.15374,-0.012636,0.078903,0.97431,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOMF_L_LACTATE_DEHYDROGENASE...,SET,5,-0.98059,-0.016172,0.50322,0.97432,GOMF_L_LACTATE_DEHYDROGENASE_ACTIVITY,1
GOBP_L_AMINO_ACID_CATABOLIC_...,SET,60,-0.2195,-0.012522,0.11264,0.97433,GOBP_L_AMINO_ACID_CATABOLIC_PROCESS,1
HP_SINGLE_TRANSVERSE_PALMAR_...,SET,179,-0.12302,-0.012081,0.063103,0.97437,HP_SINGLE_TRANSVERSE_PALMAR_CREASE,1
DESCARTES_FETAL_STOMACH_MYEL...,SET,65,-0.22619,-0.013428,0.116,0.9744,DESCARTES_FETAL_STOMACH_MYELOID_CELLS,1
BAE_BRCA1_TARGETS_UP,SET,60,-0.21548,-0.012292,0.1105,0.97441,BAE_BRCA1_TARGETS_UP,1
GOBP_MITOCHONDRIAL_TRNA_PROC...,SET,12,-0.42899,-0.010958,0.21997,0.97442,GOBP_MITOCHONDRIAL_TRNA_PROCESSING,1
HP_BLURRED_VISION,SET,33,-0.30833,-0.013054,0.15806,0.97444,HP_BLURRED_VISION,1
MIR1227_5P,SET,97,-0.16493,-0.011951,0.084523,0.97448,MIR1227_5P,1
HP_FOCAL_AUTOMATISM_SEIZURE,SET,12,-0.46862,-0.011971,0.24006,0.97453,HP_FOCAL_AUTOMATISM_SEIZURE,1
LET_7I_5P,SET,362,-0.090544,-0.012582,0.046378,0.97454,LET_7I_5P,1
GSE17721_LPS_VS_PAM3CSK4_24H...2,SET,187,-0.11842,-0.011885,0.060658,0.97454,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP,1
MATSUMIYA_PBMC_MODIFIED_VACC...1,SET,60,-0.23113,-0.013185,0.11838,0.97455,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP,1
DESCARTES_MAIN_FETAL_METANEP...,SET,25,-0.3949,-0.014555,0.20227,0.97455,DESCARTES_MAIN_FETAL_METANEPHRIC_CELLS,1
HP_PUNCTATE_CATARACT,SET,14,-0.46671,-0.012876,0.239,0.97457,HP_PUNCTATE_CATARACT,1
GSE1460_DP_THYMOCYTE_VS_NAIV...4,SET,162,-0.12861,-0.012022,0.065859,0.97457,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,1
WP_CLEAR_CELL_RENAL_CELL_CAR...,SET,80,-0.18709,-0.012317,0.095784,0.9746,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,1
GOBP_REGULATION_OF_DEFENSE_R...5,SET,34,-0.31563,-0.013564,0.1616,0.9746,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,1
HP_RETINAL_COLOBOMA,SET,37,-0.27384,-0.012275,0.14017,0.97462,HP_RETINAL_COLOBOMA,1
GOBP_CD8_POSITIVE_ALPHA_BETA...1,SET,26,-0.35032,-0.013167,0.17915,0.97473,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
REACTOME_REGULATION_OF_PTEN_...4,SET,65,-0.1924,-0.011422,0.098383,0.97474,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,1
GOBP_PYRUVATE_FAMILY_AMINO_A...1,SET,10,-0.51323,-0.011969,0.26241,0.97475,GOBP_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_HUMERUS,SET,54,-0.23988,-0.012984,0.12265,0.97475,HP_ABNORMALITY_OF_THE_HUMERUS,1
GOMF_ACID_AMINO_ACID_LIGASE_...,SET,22,-0.35951,-0.012431,0.18378,0.97477,GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY,1
GOBP_RESPONSE_TO_TUMOR_CELL,SET,38,-0.2903,-0.013187,0.14834,0.97482,GOBP_RESPONSE_TO_TUMOR_CELL,1
HP_ABNORMALITY_OF_UPPER_LIP_...,SET,387,-0.085941,-0.012339,0.043914,0.97482,HP_ABNORMALITY_OF_UPPER_LIP_VERMILLION,1
GOBP_REGULATION_OF_T_HELPER_...6,SET,12,-0.5117,-0.013071,0.26145,0.97483,GOBP_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
GOBP_MITOCHONDRIAL_RNA_3_END...,SET,6,-0.64959,-0.011735,0.3318,0.97486,GOBP_MITOCHONDRIAL_RNA_3_END_PROCESSING,1
HP_ABNORMAL_CIRCULATING_APOL...,SET,9,-0.50377,-0.011145,0.25727,0.97488,HP_ABNORMAL_CIRCULATING_APOLIPOPROTEIN_CONCENTRATION,1
MIR4776_5P,SET,44,-0.2436,-0.011905,0.12439,0.97489,MIR4776_5P,1
MODULE_324,SET,126,-0.16785,-0.013851,0.085642,0.97499,MODULE_324,1
GOBP_FRUCTOSE_6_PHOSPHATE_ME...,SET,12,-0.47861,-0.012226,0.24416,0.97501,GOBP_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS,1
MIR205_3P,SET,359,-0.090078,-0.012466,0.045943,0.97503,MIR205_3P,1
GOCC_ISWI_TYPE_COMPLEX,SET,12,-0.42017,-0.010733,0.21428,0.97504,GOCC_ISWI_TYPE_COMPLEX,1
BILANGES_SERUM_RESPONSE_TRAN...,SET,29,-0.3094,-0.012281,0.15779,0.97505,BILANGES_SERUM_RESPONSE_TRANSLATION,1
GOBP_NEGATIVE_REGULATION_OF_...649,SET,118,-0.14854,-0.011864,0.07575,0.97505,GOBP_NEGATIVE_REGULATION_OF_TRANSLATION,1
GSE3982_NEUTROPHIL_VS_EFF_ME...1,SET,181,-0.11432,-0.011289,0.058292,0.97506,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,1
GOBP_RRNA_METHYLATION,SET,17,-0.35637,-0.010834,0.18167,0.97509,GOBP_RRNA_METHYLATION,1
GSE21927_SPLENIC_C26GM_TUMOR...3,SET,162,-0.13203,-0.012341,0.067304,0.97509,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN,1
GSE37605_C57BL6_VS_NOD_FOXP3...8,SET,107,-0.16526,-0.012573,0.084232,0.97511,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP,1
GOBP_COPI_COATED_VESICLE_BUD...,SET,6,-0.51085,-0.0092289,0.26029,0.97514,GOBP_COPI_COATED_VESICLE_BUDDING,1
HP_ABNORMALITY_OF_LYSOSOMAL_...,SET,8,-0.61357,-0.012799,0.31262,0.97515,HP_ABNORMALITY_OF_LYSOSOMAL_METABOLISM,1
HP_ABNORMAL_MUSCLE_GLYCOGEN_...,SET,10,-0.4678,-0.010909,0.23832,0.97517,HP_ABNORMAL_MUSCLE_GLYCOGEN_CONTENT,1
TTTGCAC_MIR19A_MIR19B,SET,467,-0.079496,-0.01251,0.040487,0.9752,TTTGCAC_MIR19A_MIR19B,1
GOBP_POSITIVE_REGULATION_OF_...657,SET,12,-0.49761,-0.012711,0.25343,0.9752,GOBP_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY,1
MIR563,SET,30,-0.3244,-0.013096,0.1652,0.97521,MIR563,1
GOBP_SEMINIFEROUS_TUBULE_DEV...,SET,13,-0.48295,-0.01284,0.24586,0.97524,GOBP_SEMINIFEROUS_TUBULE_DEVELOPMENT,1
REACTOME_TRNA_PROCESSING_IN_...1,SET,3,-0.92976,-0.011878,0.4733,0.97525,REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION,1
GSE13485_CTRL_VS_DAY7_YF17D_...2,SET,163,-0.1318,-0.012358,0.067096,0.97525,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP,1
GSE42021_TCONV_PLN_VS_CD24HI...2,SET,186,-0.12448,-0.01246,0.063354,0.97528,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP,1
HP_ABNORMAL_MYELINATION,SET,539,-0.070756,-0.011938,0.035998,0.97532,HP_ABNORMAL_MYELINATION,1
GOMF_FAD_BINDING,SET,36,-0.28971,-0.01281,0.14736,0.97534,GOMF_FAD_BINDING,1
BLANCO_MELO_COVID19_SARS_COV...8,SET,302,-0.10725,-0.013634,0.054546,0.97535,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,1
GSE17186_MEMORY_VS_CD21HIGH_...1,SET,187,-0.12918,-0.012964,0.065678,0.97539,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,1
GOCC_GROWTH_FACTOR_COMPLEX,SET,8,-0.71516,-0.014918,0.36354,0.97541,GOCC_GROWTH_FACTOR_COMPLEX,1
GSE43863_NAIVE_VS_MEMORY_TH1...2,SET,153,-0.13962,-0.012686,0.070977,0.97541,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP,1
GOBP_LIPID_HYDROXYLATION,SET,7,-0.78652,-0.015347,0.39975,0.97543,GOBP_LIPID_HYDROXYLATION,1
GOMF_POLY_G_BINDING,SET,7,-0.59863,-0.011681,0.30424,0.97544,GOMF_POLY_G_BINDING,1
GOBP_CARDIAC_NEURAL_CREST_CE...1,SET,12,-0.58138,-0.014851,0.29533,0.97549,GOBP_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,1
IL2_UP.V1_UP,SET,159,-0.13921,-0.012892,0.07064,0.97561,IL2_UP.V1_UP,1
GOBP_RESPONSE_TO_LECTIN,SET,20,-0.42456,-0.013998,0.2154,0.97563,GOBP_RESPONSE_TO_LECTIN,1
HP_RHIZOMELIA,SET,59,-0.22684,-0.012832,0.11506,0.97565,HP_RHIZOMELIA,1
HP_RETINAL_HEMORRHAGE,SET,26,-0.3473,-0.013054,0.17613,0.97568,HP_RETINAL_HEMORRHAGE,1
REACTOME_CELLULAR_RESPONSE_T...3,SET,70,-0.18834,-0.011602,0.095486,0.97571,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,1
HP_OSTEOLYSIS_INVOLVING_BONE...1,SET,11,-0.54769,-0.013395,0.27767,0.97571,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_LOWER_LIMBS,1
KEGG_PEROXISOME,SET,74,-0.19236,-0.012182,0.097511,0.97573,KEGG_PEROXISOME,1
GSE36888_UNTREATED_VS_IL2_TR...7,SET,179,-0.13435,-0.013194,0.068104,0.97573,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN,1
GOBP_ETHANOLAMINE_CONTAINING...,SET,7,-0.5987,-0.011682,0.30342,0.97575,GOBP_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_CARDIAC_NEURAL_CREST_CE...2,SET,15,-0.51316,-0.014655,0.25999,0.97579,GOBP_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT,1
TURASHVILI_BREAST_NORMAL_DUC...2,SET,57,-0.21657,-0.012042,0.10968,0.97584,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,1
MARSON_FOXP3_TARGETS_UP,SET,61,-0.22964,-0.013208,0.11626,0.97588,MARSON_FOXP3_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_GF_RT...2,SET,89,-0.19586,-0.013597,0.099154,0.97588,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY,1
GSE22935_UNSTIM_VS_24H_MBOVI...2,SET,189,-0.12437,-0.012548,0.062964,0.97588,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
HP_PULMONARY_ARTERY_HYPOPLAS...,SET,8,-0.66601,-0.013893,0.33712,0.97589,HP_PULMONARY_ARTERY_HYPOPLASIA,1
HP_ABNORMAL_CEREBROSPINAL_FL...,SET,531,-0.072315,-0.012113,0.036601,0.9759,HP_ABNORMAL_CEREBROSPINAL_FLUID_MORPHOLOGY,1
HP_SCLEROSIS_OF_SKULL_BASE,SET,13,-0.52784,-0.014034,0.26712,0.97592,HP_SCLEROSIS_OF_SKULL_BASE,1
HOXA7_TARGET_GENES,SET,95,-0.17475,-0.012531,0.088413,0.97594,HOXA7_TARGET_GENES,1
GOBP_SOMATIC_DIVERSIFICATION...2,SET,13,-0.40615,-0.010798,0.2055,0.97594,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION,1
LET_7B_5P,SET,362,-0.091618,-0.012731,0.046344,0.97597,LET_7B_5P,1
GOBP_LYMPHOCYTE_MIGRATION,SET,96,-0.18235,-0.013145,0.092224,0.97598,GOBP_LYMPHOCYTE_MIGRATION,1
BERNARD_PPAPDC1B_TARGETS_UP,SET,34,-0.2904,-0.012479,0.14685,0.976,BERNARD_PPAPDC1B_TARGETS_UP,1
GOBP_MEGAKARYOCYTE_DEVELOPME...,SET,20,-0.41302,-0.013618,0.20883,0.97602,GOBP_MEGAKARYOCYTE_DEVELOPMENT,1
GSE18791_CTRL_VS_NEWCASTLE_V...6,SET,176,-0.12297,-0.011976,0.062176,0.97602,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP,1
BIDUS_METASTASIS_UP,SET,186,-0.11912,-0.011922,0.06019,0.97608,BIDUS_METASTASIS_UP,1
GSE2128_CTRL_VS_MIMETOPE_NEG...1,SET,182,-0.12223,-0.012103,0.061766,0.97608,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN,1
KRCTCNNNNMANAGC_UNKNOWN,SET,14,-0.45982,-0.012686,0.23233,0.97609,KRCTCNNNNMANAGC_UNKNOWN,1
MIR3157_3P,SET,35,-0.29643,-0.012924,0.14971,0.97614,MIR3157_3P,1
GOBP_AMINO_SUGAR_BIOSYNTHETI...,SET,11,-0.51393,-0.01257,0.25942,0.9762,GOBP_AMINO_SUGAR_BIOSYNTHETIC_PROCESS,1
MIR196A_1_3P,SET,358,-0.094547,-0.013067,0.047678,0.97631,MIR196A_1_3P,1
YAATNRNNNYNATT_UNKNOWN,SET,97,-0.18438,-0.01336,0.092982,0.97631,YAATNRNNNYNATT_UNKNOWN,1
GSE3982_EOSINOPHIL_VS_BCELL_...1,SET,177,-0.1244,-0.012149,0.06269,0.97638,GSE3982_EOSINOPHIL_VS_BCELL_DN,1
GOMF_DEATH_RECEPTOR_BINDING,SET,19,-0.3704,-0.011904,0.18664,0.97639,GOMF_DEATH_RECEPTOR_BINDING,1
HP_3_METHYLGLUTACONIC_ACIDUR...,SET,17,-0.41867,-0.012728,0.21098,0.97639,HP_3_METHYLGLUTACONIC_ACIDURIA,1
LAKE_ADULT_KIDNEY_C18_COLLEC...,SET,295,-0.099775,-0.012539,0.050279,0.97639,LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA,1
GSE5589_WT_VS_IL10_KO_LPS_AN...6,SET,177,-0.12726,-0.012429,0.064094,0.97645,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOBP_RESPONSE_TO_REACTIVE_OX...,SET,180,-0.13149,-0.012949,0.066183,0.97652,GOBP_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
HP_DYSGYRIA,SET,7,-0.63133,-0.012319,0.3177,0.97654,HP_DYSGYRIA,1
MIR126_5P,SET,405,-0.086592,-0.012712,0.043569,0.97656,MIR126_5P,1
MIR4654,SET,51,-0.24226,-0.012744,0.12186,0.97659,MIR4654,1
GOMF_FILAMIN_BINDING,SET,12,-0.50019,-0.012777,0.25159,0.97659,GOMF_FILAMIN_BINDING,1
VANHARANTA_UTERINE_FIBROID_UP,SET,39,-0.2915,-0.013414,0.14655,0.97664,VANHARANTA_UTERINE_FIBROID_UP,1
MORF_WNT1,SET,93,-0.18125,-0.012861,0.091123,0.97664,MORF_WNT1,1
HP_ABNORMAL_COCCYX_MORPHOLOGY,SET,8,-0.70242,-0.014652,0.35311,0.97666,HP_ABNORMAL_COCCYX_MORPHOLOGY,1
HP_TAPERED_DISTAL_PHALANGES_...,SET,6,-0.84549,-0.015274,0.42489,0.97669,HP_TAPERED_DISTAL_PHALANGES_OF_FINGER,1
GSE42021_CD24INT_VS_CD24LOW_...4,SET,172,-0.12958,-0.012477,0.065103,0.97672,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP,1
HP_RECURRENT_FEVER,SET,85,-0.18816,-0.012767,0.094519,0.97674,HP_RECURRENT_FEVER,1
MIR595,SET,57,-0.21632,-0.012029,0.10865,0.97675,MIR595,1
GOBP_REGULATION_OF_PROTEIN_L...9,SET,12,-0.49658,-0.012685,0.24937,0.97677,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_ENDOSOME,1
HP_BROAD_RIBS,SET,24,-0.37122,-0.013406,0.1864,0.97678,HP_BROAD_RIBS,1
ZNF514_TARGET_GENES,SET,7,-0.67147,-0.013102,0.33704,0.97682,ZNF514_TARGET_GENES,1
KEGG_ONE_CARBON_POOL_BY_FOLA...,SET,17,-0.38397,-0.011673,0.19272,0.97683,KEGG_ONE_CARBON_POOL_BY_FOLATE,1
TRAVAGLINI_LUNG_CILIATED_CELL,SET,954,-0.055594,-0.012333,0.027891,0.97688,TRAVAGLINI_LUNG_CILIATED_CELL,1
GOBP_PROTEIN_DESUMOYLATION,SET,9,-0.49706,-0.010997,0.24932,0.9769,GOBP_PROTEIN_DESUMOYLATION,1
GOBP_PEPTIDE_METABOLIC_PROCE...,SET,72,-0.20868,-0.013036,0.10466,0.97691,GOBP_PEPTIDE_METABOLIC_PROCESS,1
MIR6086,SET,49,-0.23376,-0.012054,0.11723,0.97692,MIR6086,1
HP_ABNORMAL_FOURTH_VENTRICLE...,SET,132,-0.14074,-0.011885,0.070579,0.97692,HP_ABNORMAL_FOURTH_VENTRICLE_MORPHOLOGY,1
MIR204_5P,SET,347,-0.093741,-0.012759,0.047007,0.97693,MIR204_5P,1
HP_EEG_WITH_PARIETAL_EPILEPT...,SET,4,-1.0607,-0.015646,0.53165,0.97697,HP_EEG_WITH_PARIETAL_EPILEPTIFORM_DISCHARGES,1
GOMF_METAL_ION_SENSOR_ACTIVI...,SET,8,-0.72117,-0.015043,0.3614,0.977,GOMF_METAL_ION_SENSOR_ACTIVITY,1
DESCARTES_FETAL_EYE_AMACRINE...,SET,7,-0.67385,-0.013149,0.33766,0.97701,DESCARTES_FETAL_EYE_AMACRINE_CELLS,1
MIR432_3P,SET,57,-0.23279,-0.012944,0.11663,0.97703,MIR432_3P,1
GOBP_INDOLE_CONTAINING_COMPO...3,SET,22,-0.40179,-0.013893,0.20129,0.97703,GOBP_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
WP_CHOLESTEROL_BIOSYNTHESIS_...2,SET,106,-0.16615,-0.012582,0.083215,0.97706,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,1
HP_STEROETYPIC_UPPER_EXTREMI...,SET,43,-0.25809,-0.01247,0.12925,0.97707,HP_STEROETYPIC_UPPER_EXTREMITY_MOVEMENTS,1
HP_PNEUMOTHORAX,SET,72,-0.21271,-0.013288,0.10649,0.9771,HP_PNEUMOTHORAX,1
GOBP_TRICUSPID_VALVE_DEVELOP...,SET,7,-0.72873,-0.014219,0.36478,0.97712,GOBP_TRICUSPID_VALVE_DEVELOPMENT,1
HP_REDUCED_VISUAL_ACUITY,SET,518,-0.076253,-0.01262,0.038168,0.97712,HP_REDUCED_VISUAL_ACUITY,1
GSE6090_UNSTIM_VS_DC_SIGN_ST...2,SET,153,-0.12742,-0.011578,0.063778,0.97713,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP,1
GSE37605_TREG_VS_TCONV_NOD_F...1,SET,154,-0.14019,-0.012779,0.070161,0.97714,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN,1
DESCARTES_FETAL_LIVER_MEGAKA...,SET,113,-0.1674,-0.013086,0.083773,0.97715,DESCARTES_FETAL_LIVER_MEGAKARYOCYTES,1
ZHANG_GATA6_TARGETS_DN,SET,61,-0.22672,-0.01304,0.11345,0.97716,ZHANG_GATA6_TARGETS_DN,1
TRAVAGLINI_LUNG_VASCULAR_SMO...,SET,57,-0.24433,-0.013586,0.12226,0.97716,TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL,1
MIR7111_3P,SET,112,-0.16275,-0.012666,0.081426,0.97717,MIR7111_3P,1
GOBP_NEGATIVE_REGULATION_OF_...436,SET,24,-0.35731,-0.012904,0.17865,0.97724,GOBP_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
HP_POLLAKISURIA,SET,7,-0.61283,-0.011958,0.30634,0.97727,HP_POLLAKISURIA,1
HP_INTESTINAL_FISTULA,SET,29,-0.3119,-0.01238,0.15579,0.97735,HP_INTESTINAL_FISTULA,1
GSE13411_NAIVE_VS_MEMORY_BCE...2,SET,163,-0.1366,-0.012807,0.068214,0.97738,GSE13411_NAIVE_VS_MEMORY_BCELL_UP,1
REACTOME_TRANSCRIPTIONAL_REG...8,SET,36,-0.30325,-0.013408,0.1514,0.9774,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1
SHIRAISHI_PLZF_TARGETS_UP,SET,9,-0.55338,-0.012243,0.27619,0.97744,SHIRAISHI_PLZF_TARGETS_UP,1
GOMF_PHOSPHOFRUCTOKINASE_ACT...,SET,6,-0.58318,-0.010536,0.29103,0.97745,GOMF_PHOSPHOFRUCTOKINASE_ACTIVITY,1
GOCC_RIBOSOME,SET,211,-0.10981,-0.011699,0.054792,0.97747,GOCC_RIBOSOME,1
VANASSE_BCL2_TARGETS_UP,SET,29,-0.34398,-0.013653,0.17161,0.97748,VANASSE_BCL2_TARGETS_UP,1
GSE3982_EOSINOPHIL_VS_TH2_DN,SET,180,-0.1277,-0.012576,0.063694,0.97751,GSE3982_EOSINOPHIL_VS_TH2_DN,1
GOBP_SUPEROXIDE_METABOLIC_PR...,SET,62,-0.22979,-0.013324,0.11451,0.97761,GOBP_SUPEROXIDE_METABOLIC_PROCESS,1
HP_CEREBELLAR_CYST,SET,138,-0.14134,-0.012202,0.070429,0.97761,HP_CEREBELLAR_CYST,1
GSE11864_CSF1_VS_CSF1_PAM3CY...2,SET,166,-0.13072,-0.012367,0.065131,0.97762,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP,1
HP_HYPOHIDROSIS,SET,64,-0.22581,-0.013302,0.11246,0.97766,HP_HYPOHIDROSIS,1
GSE3720_UNSTIM_VS_LPS_STIM_V...3,SET,129,-0.15776,-0.013171,0.078571,0.97767,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN,1
GSE32423_IL7_VS_IL7_IL4_MEMO...2,SET,188,-0.12162,-0.012238,0.060567,0.97768,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,1
DESCARTES_FETAL_CEREBELLUM_U...,SET,19,-0.45776,-0.014711,0.2279,0.9777,DESCARTES_FETAL_CEREBELLUM_UNIPOLAR_BRUSH_CELLS,1
GOCC_MITOCHONDRIAL_LARGE_RIB...,SET,54,-0.21358,-0.01156,0.10632,0.97772,GOCC_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT,1
HP_ABNORMAL_CRANIAL_NERVE_MO...,SET,71,-0.20391,-0.01265,0.10149,0.97773,HP_ABNORMAL_CRANIAL_NERVE_MORPHOLOGY,1
GSE24671_CTRL_VS_BAKIMULC_IN...2,SET,181,-0.12691,-0.012533,0.063137,0.97778,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP,1
JOHANSSON_GLIOMAGENESIS_BY_P...1,SET,21,-0.38014,-0.012843,0.18907,0.97781,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,1
GOBP_INTERLEUKIN_1_PRODUCTION,SET,104,-0.17748,-0.013313,0.088257,0.97783,GOBP_INTERLEUKIN_1_PRODUCTION,1
REACTOME_CROSS_PRESENTATION_...2,SET,47,-0.22692,-0.011461,0.11282,0.97785,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,1
DURANTE_ADULT_OLFACTORY_NEUR...22,SET,32,-0.3299,-0.013754,0.16402,0.97785,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_HORIZONTAL_BASAL_CELLS,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...7,SET,129,-0.14619,-0.012204,0.072648,0.9779,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN,1
GOBP_NEGATIVE_REGULATION_OF_...313,SET,7,-0.70996,-0.013853,0.35267,0.97794,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,1
GOBP_ENDOCHONDRAL_BONE_MORPH...,SET,56,-0.2504,-0.013801,0.12434,0.97798,GOBP_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_PROLACTIN_SECRETION,SET,5,-0.86772,-0.014311,0.43078,0.978,GOBP_PROLACTIN_SECRETION,1
MIR187_5P,SET,163,-0.14028,-0.013153,0.069621,0.97804,MIR187_5P,1
HP_ABNORMAL_CARDIAC_ATRIUM_M...,SET,518,-0.076162,-0.012605,0.037797,0.97804,HP_ABNORMAL_CARDIAC_ATRIUM_MORPHOLOGY,1
HP_ABNORMAL_NOSTRIL_MORPHOLO...,SET,434,-0.081621,-0.012394,0.040489,0.97809,HP_ABNORMAL_NOSTRIL_MORPHOLOGY,1
MIR153_5P,SET,950,-0.059315,-0.013133,0.029418,0.97811,MIR153_5P,1
TST1_01,SET,221,-0.12402,-0.013518,0.06151,0.97811,TST1_01,1
ZNF585B_TARGET_GENES,SET,96,-0.18156,-0.013088,0.089999,0.97816,ZNF585B_TARGET_GENES,1
HP_RIGHT_VENTRICULAR_HYPERTR...,SET,25,-0.32126,-0.011841,0.15925,0.97816,HP_RIGHT_VENTRICULAR_HYPERTROPHY,1
HP_APLASIA_HYPOPLASIA_OF_THE...63,SET,116,-0.15553,-0.012317,0.077083,0.97818,HP_APLASIA_HYPOPLASIA_OF_THE_RIBS,1
HP_YELLOW_WHITE_LESIONS_OF_T...2,SET,56,-0.24367,-0.01343,0.12076,0.97819,HP_YELLOW_WHITE_LESIONS_OF_THE_RETINA,1
DCA_UP.V1_DN,SET,165,-0.13128,-0.012384,0.065059,0.97819,DCA_UP.V1_DN,1
GOBP_NEGATIVE_REGULATION_OF_...515,SET,5,-0.82934,-0.013678,0.41083,0.97823,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
LAKE_ADULT_KIDNEY_C12_THICK_...,SET,328,-0.096591,-0.012788,0.047849,0.97823,LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB,1
MIKKELSEN_MCV6_ICP_WITH_H3K2...,SET,74,-0.22037,-0.013956,0.10915,0.97825,MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,1
HP_OPISTHOTONUS,SET,47,-0.24735,-0.012493,0.1225,0.97826,HP_OPISTHOTONUS,1
GOMF_ACETYLGALACTOSAMINYLTRA...,SET,32,-0.33959,-0.014158,0.16813,0.97829,GOMF_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
GSE15330_GRANULOCYTE_MONOCYT...2,SET,178,-0.12235,-0.011982,0.060575,0.97829,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP,1
HP_3_METHYLGLUTARIC_ACIDURIA,SET,5,-0.7233,-0.011929,0.35803,0.97831,HP_3_METHYLGLUTARIC_ACIDURIA,1
HP_CUPPED_EAR,SET,57,-0.22498,-0.01251,0.11134,0.97834,HP_CUPPED_EAR,1
MIR148A_3P,SET,315,-0.10038,-0.013028,0.049647,0.97839,MIR148A_3P,1
GOBP_SODIUM_DEPENDENT_PHOSPH...,SET,12,-0.56415,-0.014411,0.27896,0.97842,GOBP_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,1
AIZARANI_LIVER_C23_KUPFFER_C...,SET,196,-0.13118,-0.013475,0.064863,0.97843,AIZARANI_LIVER_C23_KUPFFER_CELLS_3,1
WP_SLEEP_REGULATION,SET,38,-0.31685,-0.014393,0.15663,0.97845,WP_SLEEP_REGULATION,1
MIR148B_3P,SET,313,-0.1008,-0.013042,0.049823,0.97847,MIR148B_3P,1
HP_ANISOPOIKILOCYTOSIS,SET,9,-0.62341,-0.013792,0.30807,0.97849,HP_ANISOPOIKILOCYTOSIS,1
chr3p14,SET,47,-0.53211,-0.026875,0.26286,0.97852,chr3p14,1
GOBP_LIPID_PHOSPHORYLATION,SET,10,-0.51845,-0.01209,0.25604,0.97855,GOBP_LIPID_PHOSPHORYLATION,1
GOMF_ATP_DEPENDENT_DIACYLGLY...,SET,10,-0.51845,-0.01209,0.25604,0.97855,GOMF_ATP_DEPENDENT_DIACYLGLYCEROL_KINASE_ACTIVITY,1
MIR3189_3P,SET,69,-0.19995,-0.012229,0.098722,0.97858,MIR3189_3P,1
HP_LONG_PHILTRUM,SET,371,-0.09104,-0.012804,0.044917,0.97865,HP_LONG_PHILTRUM,1
GOBP_AUTOCRINE_SIGNALING,SET,7,-0.74882,-0.014611,0.36911,0.97875,GOBP_AUTOCRINE_SIGNALING,1
HP_CAUDAL_APPENDAGE,SET,6,-0.83616,-0.015106,0.4121,0.97876,HP_CAUDAL_APPENDAGE,1
SESTO_RESPONSE_TO_UV_C2,SET,50,-0.23302,-0.012138,0.11479,0.97881,SESTO_RESPONSE_TO_UV_C2,1
WP_CORI_CYCLE,SET,13,-0.43945,-0.011684,0.21617,0.97896,WP_CORI_CYCLE,1
PALOMERO_GSI_SENSITIVITY_UP,SET,6,-0.72105,-0.013026,0.35461,0.97898,PALOMERO_GSI_SENSITIVITY_UP,1
REACTOME_PHOSPHORYLATION_OF_...2,SET,19,-0.35741,-0.011486,0.17571,0.97902,REACTOME_PHOSPHORYLATION_OF_THE_APC_C,1
GOBP_POSITIVE_REGULATION_OF_...30,SET,4,-0.67957,-0.010025,0.33395,0.97906,GOBP_POSITIVE_REGULATION_OF_ANOIKIS,1
HP_HEAD_TITUBATION,SET,18,-0.40988,-0.012821,0.20137,0.97909,HP_HEAD_TITUBATION,1
WP_IL1_AND_MEGAKARYOCYTES_IN...,SET,22,-0.40188,-0.013896,0.19743,0.9791,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,1
MIR380_5P,SET,42,-0.29291,-0.013987,0.14387,0.97911,MIR380_5P,1
IIZUKA_LIVER_CANCER_PROGRESS...1,SET,23,-0.32502,-0.011491,0.15955,0.97917,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,1
GOBP_GLYCEROL_ETHER_METABOLI...,SET,19,-0.41955,-0.013483,0.2059,0.9792,GOBP_GLYCEROL_ETHER_METABOLIC_PROCESS,1
VALK_AML_CLUSTER_1,SET,25,-0.3894,-0.014352,0.19095,0.97928,VALK_AML_CLUSTER_1,1
ACATTCC_MIR1_MIR206,SET,279,-0.10415,-0.012735,0.051073,0.97928,ACATTCC_MIR1_MIR206,1
GOBP_REGULATION_OF_NEUTROPHI...6,SET,37,-0.31821,-0.014264,0.15604,0.97928,GOBP_REGULATION_OF_NEUTROPHIL_MIGRATION,1
GOBP_AORTIC_VALVE_MORPHOGENE...,SET,39,-0.30601,-0.014082,0.15005,0.97929,GOBP_AORTIC_VALVE_MORPHOGENESIS,1
WP_CHOLESTEROL_BIOSYNTHESIS_...3,SET,5,-0.68852,-0.011355,0.33742,0.97934,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,1
GOCC_LAMININ_COMPLEX,SET,9,-0.61581,-0.013624,0.30173,0.97936,GOCC_LAMININ_COMPLEX,1
GOMF_PROTEIN_SERINE_THREONIN...3,SET,10,-0.60435,-0.014094,0.296,0.9794,GOMF_PROTEIN_SERINE_THREONINE_KINASE_BINDING,1
GOBP_VOLUNTARY_MUSCULOSKELET...,SET,7,-0.60215,-0.01175,0.29477,0.97946,GOBP_VOLUNTARY_MUSCULOSKELETAL_MOVEMENT,1
GOMF_TFIID_CLASS_TRANSCRIPTI...,SET,10,-0.54765,-0.012771,0.26777,0.97957,GOMF_TFIID_CLASS_TRANSCRIPTION_FACTOR_COMPLEX_BINDING,1
ZHONG_PFC_C4_PTGDS_POS_OPC,SET,132,-0.15877,-0.013408,0.077611,0.9796,ZHONG_PFC_C4_PTGDS_POS_OPC,1
REACTOME_ACTIVATION_OF_BH3_O...,SET,30,-0.34171,-0.013795,0.16687,0.9797,REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,1
MIR4670_3P,SET,137,-0.15202,-0.013076,0.074231,0.97971,MIR4670_3P,1
GOCC_CRD_MEDIATED_MRNA_STABI...,SET,6,-0.63279,-0.011432,0.30893,0.97973,GOCC_CRD_MEDIATED_MRNA_STABILITY_COMPLEX,1
DESCARTES_MAIN_FETAL_GRANULE...,SET,14,-0.49728,-0.01372,0.24275,0.97974,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,1
MODULE_248,SET,117,-0.16722,-0.0133,0.081614,0.97976,MODULE_248,1
GOBP_POSITIVE_REGULATION_OF_...619,SET,4,-0.91022,-0.013427,0.44422,0.97976,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEUBIQUITINATION,1
ZNF354B_TARGET_GENES,SET,161,-0.13874,-0.012929,0.067662,0.97984,ZNF354B_TARGET_GENES,1
GOBP_ROSTROCAUDAL_NEURAL_TUB...,SET,7,-0.69925,-0.013644,0.34065,0.97994,GOBP_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING,1
APPIERTO_RESPONSE_TO_FENRETI...2,SET,37,-0.27065,-0.012132,0.13174,0.98002,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,1
GOBP_AMMONIUM_ION_METABOLIC_...,SET,22,-0.42547,-0.014712,0.2071,0.98002,GOBP_AMMONIUM_ION_METABOLIC_PROCESS,1
HP_ABNORMAL_DIAPHYSIS_MORPHO...,SET,296,-0.1033,-0.013003,0.050264,0.98006,HP_ABNORMAL_DIAPHYSIS_MORPHOLOGY,1
REACTOME_TRANS_GOLGI_NETWORK...,SET,65,-0.20634,-0.01225,0.10035,0.98011,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1
GSE41176_UNSTIM_VS_ANTI_IGM_...10,SET,170,-0.12716,-0.012173,0.061834,0.98012,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...213,SET,6,-0.72831,-0.013157,0.35408,0.98014,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,1
CUI_TCF21_TARGETS_2_DN,SET,761,-0.068041,-0.013556,0.033076,0.98015,CUI_TCF21_TARGETS_2_DN,1
ZNF8_TARGET_GENES,SET,786,-0.064723,-0.013096,0.031463,0.98015,ZNF8_TARGET_GENES,1
HP_CRANIOFACIAL_DISPROPORTION,SET,6,-0.66804,-0.012069,0.32472,0.98016,HP_CRANIOFACIAL_DISPROPORTION,1
HP_SEPTATE_VAGINA,SET,10,-0.59433,-0.01386,0.28891,0.98016,HP_SEPTATE_VAGINA,1
WP_ONECARBON_METABOLISM,SET,29,-0.32083,-0.012734,0.15594,0.98017,WP_ONECARBON_METABOLISM,1
GOBP_REGULATION_OF_CORTICOST...,SET,16,-0.4728,-0.013944,0.22978,0.98018,GOBP_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...268,SET,28,-0.31723,-0.012373,0.15411,0.98022,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...7,SET,496,-0.077676,-0.012588,0.037731,0.98023,HP_ABNORMAL_MORPHOLOGY_OF_THE_NASAL_ALAE,1
GOMF_3_KETO_STEROL_REDUCTASE...,SET,5,-0.81182,-0.013389,0.39429,0.98024,GOMF_3_KETO_STEROL_REDUCTASE_ACTIVITY,1
GOBP_REGULATION_OF_RESPONSE_...9,SET,27,-0.34588,-0.013248,0.16798,0.98025,GOBP_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...6,SET,112,-0.16557,-0.012886,0.080396,0.98027,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP,1
IIZUKA_LIVER_CANCER_EARLY_RE...,SET,11,-0.57505,-0.014065,0.27919,0.98028,IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,1
HP_ABNORMAL_CEREBELLAR_VERMI...,SET,317,-0.096057,-0.012506,0.046634,0.98028,HP_ABNORMAL_CEREBELLAR_VERMIS_MORPHOLOGY,1
HP_DRUSEN,SET,26,-0.374,-0.014057,0.18149,0.98033,HP_DRUSEN,1
HP_ABNORMAL_LOCALIZATION_OF_...,SET,202,-0.12482,-0.013014,0.060565,0.98034,HP_ABNORMAL_LOCALIZATION_OF_KIDNEY,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,SET,17,-0.44183,-0.013432,0.21429,0.98038,WP_PROTEOGLYCAN_BIOSYNTHESIS,1
HP_HYPOPLASIA_OF_THE_IRIS,SET,30,-0.35123,-0.014179,0.17035,0.98038,HP_HYPOPLASIA_OF_THE_IRIS,1
GSE21546_WT_VS_SAP1A_KO_AND_...2,SET,164,-0.14036,-0.0132,0.068077,0.98038,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
GOBP_PROTEIN_QUALITY_CONTROL...,SET,23,-0.32285,-0.011414,0.15654,0.98041,GOBP_PROTEIN_QUALITY_CONTROL_FOR_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEINS,1
GOBP_PURINE_CONTAINING_COMPO...4,SET,37,-0.31798,-0.014253,0.15414,0.98044,GOBP_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,1
GOCC_PREFOLDIN_COMPLEX,SET,6,-0.58173,-0.010509,0.28187,0.98048,GOCC_PREFOLDIN_COMPLEX,1
NEUROD2_TARGET_GENES,SET,5,-0.78043,-0.012871,0.378,0.98051,NEUROD2_TARGET_GENES,1
DURANTE_ADULT_OLFACTORY_NEUR...11,SET,163,-0.14025,-0.01315,0.067924,0.98052,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,1
MIR211_5P,SET,346,-0.097267,-0.01322,0.047091,0.98056,MIR211_5P,1
GSE43955_1H_VS_42H_ACT_CD4_T...3,SET,182,-0.13157,-0.013028,0.06367,0.9806,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
SIG_IL4RECEPTOR_IN_B_LYPHOCY...,SET,27,-0.34437,-0.01319,0.16662,0.98062,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,1
GSE19888_CTRL_VS_A3R_ACTIVAT...2,SET,179,-0.11943,-0.011729,0.05777,0.98064,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP,1
GSE29164_DAY3_VS_DAY7_UNTREA...2,SET,163,-0.1344,-0.012601,0.064998,0.98066,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP,1
HP_SHORT_FOOT,SET,111,-0.17863,-0.01384,0.086378,0.98067,HP_SHORT_FOOT,1
GSE40441_NRP1_POS_INDUCED_TR...1,SET,181,-0.12905,-0.012744,0.062369,0.98073,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN,1
REACTOME_IRS_ACTIVATION,SET,5,-0.95061,-0.015678,0.45934,0.98074,REACTOME_IRS_ACTIVATION,1
GOBP_PROTEIN_MATURATION_BY_4...,SET,4,-1.0918,-0.016106,0.52761,0.98074,GOBP_PROTEIN_MATURATION_BY_4FE_4S_CLUSTER_TRANSFER,1
HP_RETINAL_NONATTACHMENT,SET,7,-0.71586,-0.013968,0.34593,0.98074,HP_RETINAL_NONATTACHMENT,1
REACTOME_TLR3_MEDIATED_TICAM...,SET,6,-0.8015,-0.01448,0.38719,0.98077,REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH,1
MODULE_233,SET,21,-0.3589,-0.012125,0.17332,0.9808,MODULE_233,1
GSE25123_WT_VS_PPARG_KO_MACR...5,SET,178,-0.13387,-0.013111,0.064621,0.98084,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP,1
GOBP_POSITIVE_REGULATION_OF_...188,SET,6,-0.68842,-0.012437,0.33225,0.98086,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,1
GOBP_SEROTONIN_METABOLIC_PRO...,SET,10,-0.60765,-0.014171,0.29325,0.98087,GOBP_SEROTONIN_METABOLIC_PROCESS,1
MIR6509_5P,SET,88,-0.19601,-0.013531,0.094569,0.98089,MIR6509_5P,1
GOCC_CCAAT_BINDING_FACTOR_CO...,SET,5,-0.71833,-0.011847,0.34633,0.98096,GOCC_CCAAT_BINDING_FACTOR_COMPLEX,1
GOBP_MITOCHONDRIAL_TRANSCRIP...,SET,19,-0.36957,-0.011877,0.17815,0.98097,GOBP_MITOCHONDRIAL_TRANSCRIPTION,1
GSE32986_UNSTIM_VS_GMCSF_AND...1,SET,168,-0.13995,-0.013319,0.067432,0.98102,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,1
HP_HYPEREXTENSIBLE_SKIN,SET,60,-0.22683,-0.01294,0.10922,0.98108,HP_HYPEREXTENSIBLE_SKIN,1
MIR219A_2_3P,SET,65,-0.22024,-0.013075,0.10605,0.98109,MIR219A_2_3P,1
MIR12128,SET,129,-0.16003,-0.013361,0.077001,0.98115,MIR12128,1
GOMF_ATP_DEPENDENT_PROTEIN_B...,SET,6,-0.70281,-0.012697,0.33814,0.98116,GOMF_ATP_DEPENDENT_PROTEIN_BINDING,1
GSE26030_UNSTIM_VS_RESTIM_TH...2,SET,163,-0.14745,-0.013824,0.070943,0.98116,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP,1
GOMF_PHOSPHOTRANSFERASE_ACTI...2,SET,7,-0.62542,-0.012204,0.30086,0.98117,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR,1
HP_APLASIA_HYPOPLASIA_OF_THE...21,SET,108,-0.17298,-0.013221,0.08321,0.98117,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,1
REACTOME_ANTIGEN_PROCESSING_...1,SET,97,-0.17327,-0.012555,0.083342,0.98119,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1
GSE22229_RENAL_TRANSPLANT_IM...1,SET,183,-0.13467,-0.013371,0.064755,0.98122,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN,1
GOBP_POSITIVE_REGULATION_OF_...457,SET,14,-0.40944,-0.011296,0.19684,0.98123,GOBP_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE,1
MIR193A_5P,SET,36,-0.30474,-0.013474,0.14649,0.98124,MIR193A_5P,1
KEGG_MEDICUS_REFERENCE_SIALY...,SET,6,-0.77912,-0.014075,0.37432,0.9813,KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS,1
WP_EXRNA_MECHANISM_OF_ACTION...,SET,6,-0.65347,-0.011805,0.31387,0.98132,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,1
GSE17580_TREG_VS_TEFF_UP,SET,182,-0.13067,-0.012939,0.062754,0.98133,GSE17580_TREG_VS_TEFF_UP,1
WP_BIOSYNTHESIS_AND_REGENERA...,SET,12,-0.48983,-0.012513,0.23516,0.98136,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,1
HOWLIN_CITED1_TARGETS_2_UP,SET,16,-0.42983,-0.012677,0.20634,0.98137,HOWLIN_CITED1_TARGETS_2_UP,1
GOBP_NEGATIVE_REGULATION_OF_...101,SET,21,-0.36219,-0.012236,0.1738,0.98141,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE,1
GOCC_MITOCHONDRION,SET,1453,-0.047171,-0.012728,0.02263,0.98143,GOCC_MITOCHONDRION,1
HP_ABNORMAL_RENAL_PELVIS_MOR...,SET,244,-0.1144,-0.013094,0.054886,0.98143,HP_ABNORMAL_RENAL_PELVIS_MORPHOLOGY,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...2,SET,5,-0.96838,-0.015971,0.46451,0.98145,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,1
GSE21360_NAIVE_VS_PRIMARY_ME...2,SET,159,-0.14595,-0.013516,0.069995,0.98146,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...1,SET,180,-0.13772,-0.013563,0.06604,0.98148,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN,1
GSE43955_10H_VS_30H_ACT_CD4_...1,SET,185,-0.13083,-0.01306,0.062725,0.98149,GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...310,SET,15,-0.50094,-0.014305,0.24016,0.9815,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,1
MIR1233_3P,SET,71,-0.23498,-0.014577,0.11261,0.98153,MIR1233_3P,1
HP_INCREASED_GLUTAMINE_FAMIL...,SET,5,-0.71132,-0.011731,0.34086,0.98154,HP_INCREASED_GLUTAMINE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,1
REACTOME_L1CAM_INTERACTIONS,SET,108,-0.18433,-0.014089,0.088304,0.98157,REACTOME_L1CAM_INTERACTIONS,1
GOMF_WD40_REPEAT_DOMAIN_BIND...,SET,4,-0.79324,-0.011701,0.37989,0.9816,GOMF_WD40_REPEAT_DOMAIN_BINDING,1
GSE17721_PAM3CSK4_VS_CPG_12H...1,SET,187,-0.12977,-0.013023,0.062137,0.98161,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN,1
LET_7F_5P,SET,362,-0.096885,-0.013463,0.046389,0.98162,LET_7F_5P,1
HP_RESPIRATORY_DISTRESS,SET,192,-0.13057,-0.013276,0.062517,0.98162,HP_RESPIRATORY_DISTRESS,1
HP_ABNORMAL_LATERAL_VENTRICL...,SET,104,-0.17101,-0.012828,0.081841,0.98166,HP_ABNORMAL_LATERAL_VENTRICLE_MORPHOLOGY,1
GOBP_CELLULAR_RESPONSE_TO_OX...4,SET,145,-0.14525,-0.012851,0.069498,0.98168,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,1
GOBP_NEGATIVE_REGULATION_OF_...293,SET,16,-0.4537,-0.013381,0.21707,0.98169,GOBP_NEGATIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
HP_ABNORMAL_PELVIS_BONE_OSSI...,SET,15,-0.45066,-0.01287,0.21556,0.98171,HP_ABNORMAL_PELVIS_BONE_OSSIFICATION,1
HP_ANASARCA,SET,9,-0.5069,-0.011215,0.24248,0.98171,HP_ANASARCA,1
HP_PERSISTENT_PUPILLARY_MEMB...,SET,9,-0.65235,-0.014433,0.31201,0.98172,HP_PERSISTENT_PUPILLARY_MEMBRANE,1
HU_FETAL_RETINA_MULLER,SET,36,-0.32371,-0.014313,0.15482,0.98172,HU_FETAL_RETINA_MULLER,1
GOMF_GLYCEROL_CHANNEL_ACTIVI...,SET,5,-0.99236,-0.016366,0.47452,0.98174,GOMF_GLYCEROL_CHANNEL_ACTIVITY,1
GOMF_MYOSIN_HEAVY_CHAIN_BIND...,SET,13,-0.47643,-0.012667,0.22772,0.98178,GOMF_MYOSIN_HEAVY_CHAIN_BINDING,1
LI_ESTROGENE_LATE_E2_RESPONS...2,SET,52,-0.26841,-0.014257,0.12823,0.98183,LI_ESTROGENE_LATE_E2_RESPONSE_UP,1
chr16p13,SET,209,-0.25758,-0.027312,0.12302,0.98186,chr16p13,1
GOCC_MSL_COMPLEX,SET,3,-0.76844,-0.0098171,0.36684,0.9819,GOCC_MSL_COMPLEX,1
LENAOUR_DENDRITIC_CELL_MATUR...1,SET,115,-0.17203,-0.013566,0.082092,0.98193,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1
MODULE_117,SET,652,-0.077068,-0.014256,0.036775,0.98194,MODULE_117,1
HP_HYPERREFLEXIA_IN_UPPER_LI...,SET,25,-0.34406,-0.012681,0.16418,0.98194,HP_HYPERREFLEXIA_IN_UPPER_LIMBS,1
REACTOME_RUNX1_REGULATES_TRA...2,SET,66,-0.2053,-0.012281,0.097954,0.98195,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,1
GAVISH_3CA_METAPROGRAM_MACRO...9,SET,47,-0.24593,-0.012421,0.11733,0.98196,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MYC_MITOCHONDRIA,1
GOBP_POSITIVE_REGULATION_OF_...515,SET,8,-0.65128,-0.013585,0.31066,0.98197,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,1
GOBP_CD4_POSITIVE_ALPHA_BETA...2,SET,19,-0.42534,-0.013669,0.20284,0.98199,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_CYTOKINE_PRODUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...529,SET,5,-0.64384,-0.010618,0.30702,0.982,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MICROTUBULE,1
HP_CORONAL_CLEFT_VERTEBRAE,SET,17,-0.43297,-0.013162,0.20647,0.982,HP_CORONAL_CLEFT_VERTEBRAE,1
GSE41867_NAIVE_VS_DAY6_LCMV_...3,SET,179,-0.13352,-0.013113,0.063644,0.98204,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...103,SET,5,-0.82095,-0.013539,0.39126,0.98205,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GSE36476_CTRL_VS_TSST_ACT_72...2,SET,174,-0.13997,-0.013555,0.066708,0.98205,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP,1
CUX1_TARGET_GENES,SET,664,-0.070363,-0.013131,0.033529,0.98207,CUX1_TARGET_GENES,1
SHETH_LIVER_CANCER_VS_TXNIP_...3,SET,69,-0.21586,-0.013202,0.10283,0.98209,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,1
MIR3158_3P,SET,35,-0.29764,-0.012977,0.1418,0.98209,MIR3158_3P,1
REACTOME_LOSS_OF_FUNCTION_OF...2,SET,7,-0.71528,-0.013957,0.34061,0.98213,REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER,1
HP_RETINAL_DYSTROPHY,SET,310,-0.10196,-0.013129,0.048551,0.98213,HP_RETINAL_DYSTROPHY,1
HP_FACIAL_CAPILLARY_HEMANGIO...,SET,10,-0.62773,-0.014639,0.29877,0.98217,HP_FACIAL_CAPILLARY_HEMANGIOMA,1
GOMF_RRNA_ADENINE_METHYLTRAN...,SET,7,-0.61601,-0.01202,0.29302,0.98223,GOMF_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY,1
GOBP_BERGMANN_GLIAL_CELL_DIF...,SET,10,-0.57251,-0.013351,0.27225,0.98226,GOBP_BERGMANN_GLIAL_CELL_DIFFERENTIATION,1
GOBP_ASPARAGINE_METABOLIC_PR...,SET,5,-0.75888,-0.012516,0.36082,0.98227,GOBP_ASPARAGINE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_SMOOTH_MU...3,SET,56,-0.25226,-0.013904,0.11987,0.98232,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
BRF2_TARGET_GENES,SET,7,-0.60336,-0.011773,0.2867,0.98233,BRF2_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...622,SET,52,-0.27202,-0.014449,0.12919,0.98237,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,1
HP_PSEUDOARTHROSIS,SET,8,-0.64463,-0.013447,0.30614,0.98238,HP_PSEUDOARTHROSIS,1
MIR3620_5P,SET,49,-0.23772,-0.012259,0.11288,0.98239,MIR3620_5P,1
GOBP_COLLAGEN_ACTIVATED_SIGN...,SET,13,-0.53524,-0.01423,0.25417,0.98239,GOBP_COLLAGEN_ACTIVATED_SIGNALING_PATHWAY,1
GOBP_ZINC_ION_IMPORT_INTO_OR...,SET,11,-0.52084,-0.012739,0.24728,0.9824,GOBP_ZINC_ION_IMPORT_INTO_ORGANELLE,1
GOBP_CHONDROITIN_SULFATE_PRO...1,SET,23,-0.3715,-0.013134,0.17636,0.98241,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GOMF_DESUMOYLASE_ACTIVITY,SET,7,-0.57763,-0.011271,0.27423,0.98241,GOMF_DESUMOYLASE_ACTIVITY,1
MODULE_355,SET,29,-0.29979,-0.011899,0.14228,0.98243,MODULE_355,1
GOMF_LIPASE_ACTIVATOR_ACTIVI...,SET,19,-0.38943,-0.012515,0.18484,0.98243,GOMF_LIPASE_ACTIVATOR_ACTIVITY,1
HP_GIANT_PLATELETS,SET,10,-0.62489,-0.014572,0.29651,0.98246,HP_GIANT_PLATELETS,1
MIR663A,SET,17,-0.45919,-0.013959,0.21785,0.98247,MIR663A,1
HP_INCREASED_CIRCULATING_LAC...1,SET,180,-0.12269,-0.012082,0.058187,0.9825,HP_INCREASED_CIRCULATING_LACTATE_CONCENTRATION,1
GSE15330_HSC_VS_MEGAKARYOCYT...2,SET,176,-0.13705,-0.013347,0.064999,0.9825,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,1
HP_ABNORMAL_HEMIDIAPHRAGM_MO...,SET,7,-0.7735,-0.015093,0.36678,0.98252,HP_ABNORMAL_HEMIDIAPHRAGM_MORPHOLOGY,1
GOBP_BRUSH_BORDER_ASSEMBLY,SET,8,-0.57527,-0.012,0.27272,0.98254,GOBP_BRUSH_BORDER_ASSEMBLY,1
GOBP_PYRUVATE_FAMILY_AMINO_A...2,SET,12,-0.5111,-0.013056,0.24214,0.9826,GOBP_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GSE17186_MEMORY_VS_CD21HIGH_...2,SET,182,-0.13747,-0.013612,0.065107,0.98262,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,1
GOBP_REGULATION_OF_RECEPTOR_...4,SET,61,-0.23407,-0.013463,0.11085,0.98263,GOBP_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
HP_TOE_DEFORMITY,SET,112,-0.17232,-0.013411,0.081593,0.98265,HP_TOE_DEFORMITY,1
MODULE_334,SET,147,-0.14843,-0.013221,0.070204,0.98275,MODULE_334,1
GOBP_DNA_INTEGRATION,SET,7,-0.62493,-0.012194,0.29551,0.98277,GOBP_DNA_INTEGRATION,1
GSE40493_BCL6_KO_VS_WT_TREG_...2,SET,167,-0.13554,-0.012862,0.064074,0.98279,GSE40493_BCL6_KO_VS_WT_TREG_UP,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...5,SET,29,-0.33309,-0.013221,0.15736,0.98285,GOBP_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,1
YORDY_RECIPROCAL_REGULATION_...1,SET,63,-0.24398,-0.01426,0.11525,0.98286,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,1
GOBP_MYD88_DEPENDENT_TOLL_LI...,SET,18,-0.3857,-0.012065,0.18217,0.98287,GOBP_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...11,SET,6,-0.87964,-0.015891,0.41535,0.9829,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR,1
GOBP_DETECTION_OF_VIRUS,SET,5,-0.73616,-0.012141,0.34747,0.98293,GOBP_DETECTION_OF_VIRUS,1
GOBP_HEART_VALVE_MORPHOGENES...,SET,60,-0.25882,-0.014764,0.12214,0.98295,GOBP_HEART_VALVE_MORPHOGENESIS,1
HP_CHORIORETINAL_DYSPLASIA,SET,14,-0.48843,-0.013476,0.23045,0.98296,HP_CHORIORETINAL_DYSPLASIA,1
HP_INCREASED_MUSCLE_GLYCOGEN...,SET,8,-0.57401,-0.011974,0.27082,0.98297,HP_INCREASED_MUSCLE_GLYCOGEN_CONTENT,1
KAAB_HEART_ATRIUM_VS_VENTRIC...1,SET,240,-0.11713,-0.013297,0.055216,0.98304,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1
GOBP_REGULATION_OF_RIBONUCLE...,SET,9,-0.67832,-0.015007,0.31965,0.98308,GOBP_REGULATION_OF_RIBONUCLEASE_ACTIVITY,1
GSE11961_FOLLICULAR_BCELL_VS...5,SET,184,-0.13735,-0.013674,0.064724,0.98308,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN,1
MIR3960_MIR8072,SET,17,-0.8361,-0.025417,0.39374,0.98314,MIR3960_MIR8072,1
GOBP_NEGATIVE_REGULATION_OF_...354,SET,5,-0.86217,-0.014219,0.40594,0.98315,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,1
CAVIN1_TARGET_GENES,SET,62,-0.22675,-0.013148,0.10674,0.98317,CAVIN1_TARGET_GENES,1
GOMF_MICROTUBULE_MOTOR_ACTIV...,SET,68,-0.2186,-0.013273,0.1029,0.98317,GOMF_MICROTUBULE_MOTOR_ACTIVITY,1
WANG_RESPONSE_TO_FORSKOLIN_UP,SET,22,-0.39322,-0.013597,0.18504,0.9832,WANG_RESPONSE_TO_FORSKOLIN_UP,1
GSE16385_MONOCYTE_VS_12H_ROS...3,SET,187,-0.1291,-0.012956,0.060707,0.98327,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,1
HP_SHOULDER_GIRDLE_MUSCLE_AT...,SET,13,-0.46953,-0.012483,0.22069,0.98331,HP_SHOULDER_GIRDLE_MUSCLE_ATROPHY,1
GOBP_AMINOACYL_TRNA_METABOLI...,SET,8,-0.5741,-0.011975,0.26978,0.98332,GOBP_AMINOACYL_TRNA_METABOLISM_INVOLVED_IN_TRANSLATIONAL_FIDELITY,1
GOMF_AMINOACYL_TRNA_EDITING_...,SET,8,-0.5741,-0.011975,0.26978,0.98332,GOMF_AMINOACYL_TRNA_EDITING_ACTIVITY,1
GSE17721_12H_VS_24H_GARDIQUI...1,SET,176,-0.1288,-0.012544,0.060527,0.98332,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN,1
WP_REGUCALCIN_IN_PROXIMAL_TU...,SET,30,-0.32906,-0.013284,0.15451,0.98339,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,1
GSE40274_CTRL_VS_LEF1_TRANSD...2,SET,156,-0.14424,-0.013233,0.067709,0.98342,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_ACETYL_COA_METABOLIC_PR...,SET,30,-0.31515,-0.012723,0.1479,0.98344,GOBP_ACETYL_COA_METABOLIC_PROCESS,1
HP_AMBLYOPIA,SET,99,-0.18341,-0.013425,0.086077,0.98344,HP_AMBLYOPIA,1
GOMF_TOXIC_SUBSTANCE_BINDING,SET,10,-0.61798,-0.014411,0.28994,0.98347,GOMF_TOXIC_SUBSTANCE_BINDING,1
GSE40274_CTRL_VS_LEF1_TRANSD...1,SET,156,-0.13958,-0.012805,0.065479,0.98347,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_MODERATE_GLOBAL_DEVELOPME...,SET,22,-0.38164,-0.013196,0.179,0.98349,HP_MODERATE_GLOBAL_DEVELOPMENTAL_DELAY,1
CTATGCA_MIR153,SET,203,-0.13161,-0.013755,0.061722,0.9835,CTATGCA_MIR153,1
AMIT_EGF_RESPONSE_20_HELA,SET,10,-0.6088,-0.014197,0.28535,0.98355,AMIT_EGF_RESPONSE_20_HELA,1
HP_ABNORMAL_FEMUR_MORPHOLOGY,SET,270,-0.11043,-0.013286,0.05175,0.98357,HP_ABNORMAL_FEMUR_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...420,SET,22,-0.40408,-0.013972,0.1893,0.9836,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
TATA_01,SET,221,-0.1284,-0.013995,0.060142,0.98361,TATA_01,1
HP_DEVELOPMENTAL_GLAUCOMA,SET,64,-0.23169,-0.013649,0.10851,0.98362,HP_DEVELOPMENTAL_GLAUCOMA,1
HP_REDUCED_AMPLITUDE_OF_DARK...,SET,12,-0.53688,-0.013714,0.25142,0.98363,HP_REDUCED_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM_A_WAVE,1
GOBP_POSITIVE_REGULATION_OF_...551,SET,6,-0.76616,-0.013841,0.35863,0.98367,GOBP_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY,1
HP_HYPOPLASTIC_FINGERNAIL,SET,46,-0.2888,-0.01443,0.13517,0.98368,HP_HYPOPLASTIC_FINGERNAIL,1
NIKOLSKY_BREAST_CANCER_1Q21_...,SET,34,-0.46746,-0.020088,0.21859,0.98376,NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,1
GSE24142_DN2_VS_DN3_THYMOCYT...3,SET,186,-0.13701,-0.013713,0.064061,0.98376,GSE24142_DN2_VS_DN3_THYMOCYTE_DN,1
WP_ARYL_HYDROCARBON_RECEPTOR...2,SET,45,-0.27825,-0.013752,0.13008,0.98378,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,1
TGATTTRY_GFI1_01,SET,263,-0.12273,-0.014576,0.057373,0.98378,TGATTTRY_GFI1_01,1
HP_EPISCLERITIS,SET,4,-1.0529,-0.015532,0.49223,0.98378,HP_EPISCLERITIS,1
GOBP_PEROXISOME_ORGANIZATION,SET,30,-0.32411,-0.013084,0.1514,0.98384,GOBP_PEROXISOME_ORGANIZATION,1
GOBP_POSITIVE_REGULATION_OF_...815,SET,7,-0.69317,-0.013526,0.32384,0.98384,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
HP_IMPAIRED_RISTOCETIN_INDUC...,SET,8,-0.67645,-0.01411,0.31587,0.98388,HP_IMPAIRED_RISTOCETIN_INDUCED_PLATELET_AGGREGATION,1
GOBP_FOLIC_ACID_METABOLIC_PR...,SET,13,-0.44314,-0.011782,0.20688,0.9839,GOBP_FOLIC_ACID_METABOLIC_PROCESS,1
REACTOME_RUNX3_REGULATES_P14...,SET,10,-0.53725,-0.012529,0.25071,0.98393,REACTOME_RUNX3_REGULATES_P14_ARF,1
GSE18791_CTRL_VS_NEWCASTLE_V...4,SET,177,-0.12964,-0.012662,0.060483,0.98396,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP,1
HP_RENAL_TUBULAR_DYSFUNCTION,SET,90,-0.19103,-0.013336,0.089108,0.98397,HP_RENAL_TUBULAR_DYSFUNCTION,1
GOBP_LYMPHOID_PROGENITOR_CEL...,SET,24,-0.37096,-0.013397,0.173,0.98399,GOBP_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,1
GSE33374_CD8_ALPHAALPHA_VS_A...2,SET,188,-0.13591,-0.013676,0.063365,0.98401,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,1
GSE7509_UNSTIM_VS_IFNA_STIM_...2,SET,169,-0.13736,-0.013111,0.064027,0.98403,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP,1
MIR551B_5P,SET,451,-0.089981,-0.013922,0.041935,0.98405,MIR551B_5P,1
GOCC_HAPTOGLOBIN_HEMOGLOBIN_...,SET,7,-0.85995,-0.01678,0.40072,0.98406,GOCC_HAPTOGLOBIN_HEMOGLOBIN_COMPLEX,1
GGGNRMNNYCAT_UNKNOWN,SET,73,-0.20902,-0.013148,0.097368,0.98409,GGGNRMNNYCAT_UNKNOWN,1
GOBP_MITOCHONDRIAL_TRANSMEMB...,SET,90,-0.18754,-0.013092,0.087348,0.9841,GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT,1
GSE15330_HSC_VS_LYMPHOID_PRI...2,SET,177,-0.13384,-0.013071,0.062331,0.9841,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN,1
MCBRYAN_PUBERTAL_TGFB1_TARGE...2,SET,156,-0.15056,-0.013812,0.070085,0.98414,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...233,SET,7,-0.69907,-0.013641,0.32543,0.98414,GOBP_POSITIVE_REGULATION_OF_ENDOCYTIC_RECYCLING,1
HP_ABNORMAL_INVOLUNTARY_EYE_...,SET,961,-0.060333,-0.013431,0.028074,0.98418,HP_ABNORMAL_INVOLUNTARY_EYE_MOVEMENTS,1
GSE6674_UNSTIM_VS_CPG_STIM_B...2,SET,131,-0.15875,-0.013355,0.073866,0.98418,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP,1
HP_SECONDARY_MICROCEPHALY,SET,174,-0.13518,-0.013091,0.062892,0.98419,HP_SECONDARY_MICROCEPHALY,1
HP_ABSENCE_OF_LYMPH_NODE_GER...,SET,5,-0.93498,-0.01542,0.4349,0.98421,HP_ABSENCE_OF_LYMPH_NODE_GERMINAL_CENTER,1
GOBP_G_PROTEIN_COUPLED_PURIN...2,SET,10,-0.6155,-0.014354,0.28624,0.98423,GOBP_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY,1
GSE24634_NAIVE_CD4_TCELL_VS_...5,SET,187,-0.12606,-0.012651,0.058625,0.98423,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN,1
HP_MEGALOBLASTIC_ANEMIA,SET,17,-0.46219,-0.014051,0.21485,0.98426,HP_MEGALOBLASTIC_ANEMIA,1
REACTOME_SARS_COV_2_TARGETS_...1,SET,12,-0.5707,-0.014578,0.26527,0.98427,REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,1
KEGG_GLYCOSAMINOGLYCAN_BIOSY...2,SET,25,-0.38777,-0.014292,0.18015,0.98432,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...38,SET,15,-0.48257,-0.013781,0.22416,0.98433,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,1
NR1D1_TARGET_GENES,SET,88,-0.19439,-0.013419,0.090181,0.98443,NR1D1_TARGET_GENES,1
HP_ABNORMAL_DELIVERY,SET,87,-0.19482,-0.013372,0.090379,0.98443,HP_ABNORMAL_DELIVERY,1
HE_LIM_SUN_FETAL_LUNG_C3_PRI...,SET,100,-0.18799,-0.013829,0.087202,0.98444,HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE,1
HP_PARKINSONISM_WITH_FAVORAB...,SET,22,-0.38875,-0.013442,0.18031,0.98445,HP_PARKINSONISM_WITH_FAVORABLE_RESPONSE_TO_DOPAMINERGIC_MEDICATION,1
WP_ANGIOTENSIN_II_RECEPTOR_T...,SET,25,-0.3918,-0.014441,0.18171,0.98446,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,1
KEGG_MEDICUS_REFERENCE_EGF_E...10,SET,11,-0.56206,-0.013747,0.26057,0.98449,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY,1
REACTOME_SIGNALING_BY_TGF_BE...2,SET,8,-0.69767,-0.014553,0.32345,0.98449,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER,1
GOBP_PURINE_RIBONUCLEOSIDE_C...,SET,5,-0.78739,-0.012986,0.36498,0.9845,GOBP_PURINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS,1
MIR500A_5P,SET,140,-0.155,-0.013477,0.071833,0.98452,MIR500A_5P,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...2,SET,57,-0.23499,-0.013067,0.10891,0.98452,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
CTCTAGA_MIR526C_MIR518F_MIR5...,SET,48,-0.26657,-0.013606,0.12346,0.98457,CTCTAGA_MIR526C_MIR518F_MIR526A,1
GSE7460_CTRL_VS_FOXP3_OVEREX...2,SET,171,-0.13951,-0.013394,0.064588,0.98461,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP,1
HP_APLASIA_HYPOPLASIA_INVOLV...2,SET,317,-0.10701,-0.013933,0.049537,0.98462,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,1
GOBP_CELLULAR_RESPONSE_TO_OX...1,SET,225,-0.12503,-0.01375,0.057851,0.98466,GOBP_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
GOBP_REGULATION_OF_SYNAPSE_S...1,SET,7,-0.70198,-0.013698,0.32448,0.98474,GOBP_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY,1
WP_NAD_BIOSYNTHESIS_II_FROM_...,SET,8,-0.65459,-0.013654,0.30245,0.98477,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,1
HELLER_SILENCED_BY_METHYLATI...2,SET,239,-0.12594,-0.014268,0.058155,0.98482,HELLER_SILENCED_BY_METHYLATION_UP,1
ZNF548_TARGET_GENES,SET,45,-0.2942,-0.01454,0.13585,0.98482,ZNF548_TARGET_GENES,1
GSE22886_DAY1_VS_DAY7_MONOCY...2,SET,182,-0.14144,-0.014005,0.065309,0.98482,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP,1
MANNE_COVID19_COMBINED_COHOR...1,SET,196,-0.14631,-0.015029,0.067507,0.98489,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,1
REACTOME_THE_FATTY_ACID_CYCL...,SET,4,-0.87358,-0.012887,0.40296,0.98491,REACTOME_THE_FATTY_ACID_CYCLING_MODEL,1
MIR4663,SET,61,-0.24192,-0.013914,0.11155,0.98494,MIR4663,1
WATANABE_RECTAL_CANCER_RADIO...1,SET,89,-0.20254,-0.014061,0.093347,0.98498,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,1
WP_ALANINE_AND_ASPARTATE_MET...,SET,11,-0.54247,-0.013268,0.24998,0.98499,WP_ALANINE_AND_ASPARTATE_METABOLISM,1
HP_BROAD_NASAL_TIP,SET,133,-0.156,-0.013223,0.071863,0.98502,HP_BROAD_NASAL_TIP,1
MIR483_3P,SET,49,-0.27165,-0.014008,0.12513,0.98503,MIR483_3P,1
MIR329_5P,SET,124,-0.16334,-0.013372,0.075224,0.98504,MIR329_5P,1
MIR6736_5P,SET,42,-0.26941,-0.012864,0.12407,0.98504,MIR6736_5P,1
GSE7852_LN_VS_FAT_TREG_UP,SET,180,-0.13306,-0.013104,0.061278,0.98504,GSE7852_LN_VS_FAT_TREG_UP,1
GSE12366_NAIVE_VS_MEMORY_BCE...1,SET,174,-0.14854,-0.014385,0.068396,0.98506,GSE12366_NAIVE_VS_MEMORY_BCELL_DN,1
GNF2_TNFRSF1B,SET,58,-0.25152,-0.014108,0.11573,0.98512,GNF2_TNFRSF1B,1
GSE26669_CTRL_VS_COSTIM_BLOC...4,SET,184,-0.13401,-0.013342,0.061657,0.98512,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP,1
MIR6836_3P,SET,53,-0.25919,-0.013899,0.11924,0.98513,MIR6836_3P,1
MODULE_299,SET,34,-0.28651,-0.012312,0.13179,0.98514,MODULE_299,1
HP_LIPEMIA_RETINALIS,SET,4,-0.9238,-0.013627,0.42471,0.98518,HP_LIPEMIA_RETINALIS,1
REACTOME_AUF1_HNRNP_D0_BINDS...,SET,52,-0.24347,-0.012933,0.11188,0.98522,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,1
HP_OCULAR_ANTERIOR_SEGMENT_D...,SET,273,-0.11323,-0.013698,0.052036,0.98522,HP_OCULAR_ANTERIOR_SEGMENT_DYSGENESIS,1
GSE36078_UNTREATED_VS_AD5_T4...2,SET,179,-0.13935,-0.013685,0.064031,0.98523,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...484,SET,13,-0.60601,-0.016112,0.27842,0.98524,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
GOMF_GALACTOSIDASE_ACTIVITY,SET,6,-0.73557,-0.013289,0.33782,0.98527,GOMF_GALACTOSIDASE_ACTIVITY,1
GOMF_ENZYME_SUBSTRATE_ADAPTO...,SET,65,-0.23556,-0.013984,0.10814,0.9853,GOMF_ENZYME_SUBSTRATE_ADAPTOR_ACTIVITY,1
WP_AMPACTIVATED_PROTEIN_KINA...,SET,67,-0.23142,-0.013947,0.10623,0.98531,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,1
TIAN_BHLHA15_TARGETS,SET,15,-0.48262,-0.013783,0.22147,0.98533,TIAN_BHLHA15_TARGETS,1
GOCC_GLYCOGEN_GRANULE,SET,6,-0.72069,-0.01302,0.33062,0.98536,GOCC_GLYCOGEN_GRANULE,1
GOBP_DOUBLE_STRAND_BREAK_REP...3,SET,8,-0.54327,-0.011332,0.2492,0.98537,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_ALTERNATIVE_NONHOMOLOGOUS_END_JOINING,1
KEGG_MEDICUS_REFERENCE_MANNO...1,SET,3,-1.0807,-0.013806,0.49564,0.98538,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...1,SET,178,-0.13739,-0.013456,0.062989,0.98541,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN,1
WP_PKCGAMMA_CALCIUM_SIGNALIN...,SET,21,-0.42627,-0.014401,0.19535,0.98544,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,1
GSE13887_ACT_CD4_VS_NO_TREAT...1,SET,119,-0.17768,-0.014251,0.081414,0.98545,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN,1
GOBP_CEREBRAL_CORTEX_CELL_MI...,SET,42,-0.30126,-0.014385,0.138,0.98547,GOBP_CEREBRAL_CORTEX_CELL_MIGRATION,1
GOBP_INSULIN_LIKE_GROWTH_FAC...,SET,48,-0.28906,-0.014754,0.13237,0.98551,GOBP_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
WP_ACE_INHIBITOR_PATHWAY,SET,14,-0.60824,-0.016781,0.27848,0.98552,WP_ACE_INHIBITOR_PATHWAY,1
GOBP_FOREBRAIN_CELL_MIGRATION,SET,59,-0.25278,-0.0143,0.11565,0.98557,GOBP_FOREBRAIN_CELL_MIGRATION,1
GOCC_PLATELET_DENSE_GRANULE_...2,SET,5,-0.88853,-0.014654,0.40655,0.98557,GOCC_PLATELET_DENSE_GRANULE_MEMBRANE,1
MIR3134,SET,59,-0.23871,-0.013504,0.10921,0.98558,MIR3134,1
LI_ESTROGENE_T47D_E2_RESPONS...2,SET,56,-0.27368,-0.015084,0.12503,0.98569,LI_ESTROGENE_T47D_E2_RESPONSE_UP,1
GOCC_GOLGI_MEDIAL_CISTERNA,SET,11,-0.60885,-0.014891,0.27803,0.98573,GOCC_GOLGI_MEDIAL_CISTERNA,1
DESCARTES_FETAL_CEREBRUM_MEG...,SET,313,-0.10824,-0.014005,0.049423,0.98574,DESCARTES_FETAL_CEREBRUM_MEGAKARYOCYTES,1
GSE34156_NOD2_LIGAND_VS_NOD2...2,SET,155,-0.15458,-0.014136,0.070566,0.98575,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,1
GOBP_EPINEPHRINE_TRANSPORT,SET,11,-0.65424,-0.016001,0.29861,0.98577,GOBP_EPINEPHRINE_TRANSPORT,1
GSE17721_0.5H_VS_12H_CPG_BMD...2,SET,181,-0.13903,-0.013729,0.063445,0.98578,GSE17721_0.5H_VS_12H_CPG_BMDC_UP,1
CHIN_BREAST_CANCER_COPY_NUMB...1,SET,12,-0.47827,-0.012217,0.21812,0.98583,CHIN_BREAST_CANCER_COPY_NUMBER_DN,1
HP_ENURESIS_NOCTURNA,SET,10,-0.62416,-0.014556,0.28456,0.98585,HP_ENURESIS_NOCTURNA,1
GOMF_MHC_PROTEIN_COMPLEX_BIN...,SET,30,-0.35837,-0.014467,0.1633,0.9859,GOMF_MHC_PROTEIN_COMPLEX_BINDING,1
GOCC_POSTSYNAPTIC_RECYCLING_...,SET,7,-0.66169,-0.012911,0.30143,0.98592,GOCC_POSTSYNAPTIC_RECYCLING_ENDOSOME,1
MIR6778_5P,SET,97,-0.18117,-0.013128,0.082519,0.98593,MIR6778_5P,1
GOBP_RHYTHMIC_BEHAVIOR,SET,46,-0.29687,-0.014834,0.13514,0.98597,GOBP_RHYTHMIC_BEHAVIOR,1
REACTOME_GLYOXYLATE_METABOLI...,SET,19,-0.41936,-0.013477,0.19088,0.98598,REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,1
HP_ABNORMAL_HEAD_MOVEMENTS,SET,33,-0.33922,-0.014361,0.15437,0.986,HP_ABNORMAL_HEAD_MOVEMENTS,1
HORIUCHI_WTAP_TARGETS_UP,SET,269,-0.11988,-0.014397,0.054531,0.98603,HORIUCHI_WTAP_TARGETS_UP,1
GOMF_BETA_GALACTOSIDASE_ACTI...,SET,5,-0.91753,-0.015132,0.41711,0.98608,GOMF_BETA_GALACTOSIDASE_ACTIVITY,1
HP_INCREASED_FEMORAL_ANTEVER...,SET,4,-0.80085,-0.011814,0.36406,0.98608,HP_INCREASED_FEMORAL_ANTEVERSION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...7,SET,11,-0.571,-0.013965,0.25953,0.98609,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS,1
HP_ABNORMAL_EPIPHYSIS_MORPHO...1,SET,246,-0.12005,-0.013796,0.054567,0.98609,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY,1
ELVIDGE_HYPOXIA_BY_DMOG_DN,SET,52,-0.26435,-0.014042,0.12014,0.9861,ELVIDGE_HYPOXIA_BY_DMOG_DN,1
GOBP_TRNA_THREONYLCARBAMOYLA...2,SET,4,-0.68211,-0.010062,0.31002,0.9861,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_MODIFICATION,1
GCM_SMO,SET,58,-0.23515,-0.013189,0.10684,0.98612,GCM_SMO,1
REACTOME_ACTIVATION_OF_GENE_...,SET,41,-0.26547,-0.012525,0.12056,0.98616,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,1
GOMF_GALACTOSIDE_BINDING,SET,5,-0.98177,-0.016191,0.445,0.98631,GOMF_GALACTOSIDE_BINDING,1
HP_LACRIMAL_DUCT_STENOSIS,SET,13,-0.52262,-0.013895,0.23678,0.98634,HP_LACRIMAL_DUCT_STENOSIS,1
WP_CHOLESTEROL_METABOLISM,SET,69,-0.22995,-0.014063,0.10417,0.98635,WP_CHOLESTEROL_METABOLISM,1
MIR1262,SET,44,-0.26908,-0.01315,0.1219,0.98635,MIR1262,1
GOBP_NEGATIVE_REGULATION_OF_...550,SET,15,-0.45945,-0.013121,0.20814,0.98635,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...676,SET,30,-0.37546,-0.015157,0.1701,0.98635,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
KEGG_MEDICUS_PATHOGEN_ESCHER...8,SET,4,-0.97236,-0.014344,0.4403,0.98639,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_TIR_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_COMMO...,SET,7,-0.76847,-0.014995,0.34785,0.98641,KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION,1
REACTOME_TRNA_MODIFICATION_I...1,SET,7,-0.58058,-0.011329,0.26283,0.98641,REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION,1
GOCC_MEMBRANE_ATTACK_COMPLEX,SET,7,-0.76847,-0.014995,0.34785,0.98641,GOCC_MEMBRANE_ATTACK_COMPLEX,1
BREDEMEYER_RAG_SIGNALING_NOT...1,SET,57,-0.25397,-0.014122,0.11494,0.98643,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1
WCTCNATGGY_UNKNOWN,SET,69,-0.2244,-0.013724,0.10156,0.98643,WCTCNATGGY_UNKNOWN,1
GSE2770_IL12_AND_TGFB_VS_IL4...1,SET,173,-0.1396,-0.013481,0.063157,0.98645,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
GSE19888_CTRL_VS_TCELL_MEMBR...1,SET,185,-0.1415,-0.014126,0.063953,0.98653,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN,1
HP_BILATERAL_TALIPES_EQUINOV...,SET,43,-0.3035,-0.014664,0.13711,0.98657,HP_BILATERAL_TALIPES_EQUINOVARUS,1
GSE43955_1H_VS_20H_ACT_CD4_T...1,SET,183,-0.14516,-0.014413,0.065572,0.98657,GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN,1
WP_OREXIN_RECEPTOR_PATHWAY,SET,189,-0.15448,-0.015585,0.069771,0.98658,WP_OREXIN_RECEPTOR_PATHWAY,1
GOMF_ADENYLYLTRANSFERASE_ACT...,SET,21,-0.42879,-0.014486,0.19368,0.98658,GOMF_ADENYLYLTRANSFERASE_ACTIVITY,1
GSE17974_CTRL_VS_ACT_IL4_AND...4,SET,159,-0.15638,-0.014483,0.070523,0.9867,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP,1
GOBP_PROTEIN_LIPOYLATION,SET,5,-0.80803,-0.013326,0.36433,0.98671,GOBP_PROTEIN_LIPOYLATION,1
REACTOME_PYRUVATE_METABOLISM,SET,44,-0.30642,-0.014975,0.13814,0.98672,REACTOME_PYRUVATE_METABOLISM,1
MIR5586_5P,SET,74,-0.23665,-0.014986,0.10663,0.98676,MIR5586_5P,1
HP_NEPHRONOPHTHISIS,SET,35,-0.31005,-0.013518,0.13971,0.98676,HP_NEPHRONOPHTHISIS,1
HP_WIDELY_SPACED_TEETH,SET,103,-0.18408,-0.013742,0.082913,0.98679,HP_WIDELY_SPACED_TEETH,1
MIR4500,SET,465,-0.092233,-0.014484,0.041538,0.9868,MIR4500,1
GOMF_CATALYTIC_ACTIVITY_ACTI...3,SET,16,-0.42301,-0.012476,0.19051,0.9868,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_RRNA,1
GSE29949_CD8_NEG_DC_SPLEEN_V...1,SET,175,-0.14499,-0.014081,0.065303,0.9868,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN,1
MIR6801_3P,SET,48,-0.28264,-0.014426,0.12728,0.98681,MIR6801_3P,1
GOBP_AMYLOID_PRECURSOR_PROTE...1,SET,13,-0.48517,-0.012899,0.21844,0.98682,GOBP_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_INVOLV...17,SET,62,-0.23835,-0.01382,0.1073,0.98683,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_VERTEBRAL_COLUMN,1
MIR4782_5P,SET,150,-0.16148,-0.014529,0.072662,0.98686,MIR4782_5P,1
FIGUEROA_AML_METHYLATION_CLU...7,SET,14,-0.55534,-0.015322,0.24978,0.9869,FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,1
MIR4480,SET,49,-0.26946,-0.013895,0.12116,0.98692,MIR4480,1
HP_FETAL_PLEURAL_EFFUSION,SET,5,-0.84661,-0.013962,0.38066,0.98692,HP_FETAL_PLEURAL_EFFUSION,1
GSE17721_0.5H_VS_8H_PAM3CSK4...2,SET,181,-0.13663,-0.013492,0.061418,0.98694,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP,1
GSE37533_PPARG1_FOXP3_VS_PPA...3,SET,173,-0.14184,-0.013696,0.063761,0.98694,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,1
KEGG_MEDICUS_VARIANT_LOSS_OF...2,SET,5,-0.85469,-0.014096,0.38415,0.98695,KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY,1
GSE27896_HDAC6_KO_VS_WT_TREG...2,SET,164,-0.14789,-0.013908,0.066463,0.98696,GSE27896_HDAC6_KO_VS_WT_TREG_UP,1
GOCC_MYELIN_SHEATH_ADAXONAL_...,SET,5,-0.74954,-0.012362,0.33662,0.98701,GOCC_MYELIN_SHEATH_ADAXONAL_REGION,1
HP_INTUSSUSCEPTION,SET,10,-0.62049,-0.01447,0.27861,0.98702,HP_INTUSSUSCEPTION,1
HP_ABNORMAL_Z_DISK_MORPHOLOGY,SET,8,-0.66463,-0.013864,0.29839,0.98703,HP_ABNORMAL_Z_DISK_MORPHOLOGY,1
HP_THYMUS_HYPERPLASIA,SET,6,-0.91485,-0.016528,0.41066,0.98705,HP_THYMUS_HYPERPLASIA,1
GSE3039_B2_VS_B1_BCELL_UP,SET,186,-0.1362,-0.013633,0.061132,0.98705,GSE3039_B2_VS_B1_BCELL_UP,1
GSE14908_ATOPIC_VS_NONATOPIC...1,SET,174,-0.1404,-0.013596,0.062981,0.98709,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN,1
GSE40274_FOXP3_VS_FOXP3_AND_...14,SET,117,-0.1881,-0.01496,0.08438,0.98709,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
LAKE_ADULT_KIDNEY_C20_COLLEC...,SET,139,-0.16876,-0.014621,0.075708,0.98709,LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX,1
GOBP_PSEUDOPODIUM_ORGANIZATI...,SET,15,-0.50015,-0.014283,0.22432,0.98711,GOBP_PSEUDOPODIUM_ORGANIZATION,1
HP_SPONDYLOEPIPHYSEAL_DYSPLA...,SET,9,-0.65005,-0.014382,0.29154,0.98711,HP_SPONDYLOEPIPHYSEAL_DYSPLASIA,1
KIM_GLIS2_TARGETS_UP,SET,81,-0.23261,-0.015409,0.10425,0.98716,KIM_GLIS2_TARGETS_UP,1
RPA1_TARGET_GENES,SET,39,-0.31751,-0.014611,0.14231,0.98716,RPA1_TARGET_GENES,1
GOMF_AMIDINE_LYASE_ACTIVITY,SET,7,-0.72884,-0.014222,0.32664,0.98716,GOMF_AMIDINE_LYASE_ACTIVITY,1
SCHAEFFER_PROSTATE_DEVELOPME...13,SET,10,-0.61936,-0.014444,0.27752,0.98718,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP,1
GOBP_POSITIVE_REGULATION_OF_...410,SET,25,-0.39968,-0.014731,0.17898,0.98722,GOBP_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
MORF_FRK,SET,98,-0.20096,-0.014636,0.089981,0.98723,MORF_FRK,1
TAATGTG_MIR323,SET,148,-0.1571,-0.014041,0.070289,0.98729,TAATGTG_MIR323,1
GSE27859_MACROPHAGE_VS_DC_UP,SET,154,-0.15164,-0.013823,0.06784,0.98729,GSE27859_MACROPHAGE_VS_DC_UP,1
REACTOME_SEPARATION_OF_SISTE...,SET,174,-0.13893,-0.013454,0.062087,0.98737,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,1
GSE27786_LSK_VS_NEUTROPHIL_UP,SET,172,-0.14003,-0.013483,0.06251,0.98745,GSE27786_LSK_VS_NEUTROPHIL_UP,1
HP_NOCTURNAL_HYPOVENTILATION,SET,15,-0.44181,-0.012617,0.19719,0.98746,HP_NOCTURNAL_HYPOVENTILATION,1
chr15q21,SET,78,-0.39573,-0.025726,0.17662,0.98747,chr15q21,1
HP_ABNORMAL_CHEEK_MORPHOLOGY,SET,231,-0.12357,-0.013766,0.055139,0.98748,HP_ABNORMAL_CHEEK_MORPHOLOGY,1
LAKE_ADULT_KIDNEY_C13_THICK_...,SET,113,-0.19303,-0.015089,0.086121,0.98749,LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB,1
GSE37532_TREG_VS_TCONV_PPARG...1,SET,181,-0.13464,-0.013296,0.060045,0.98753,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN,1
HP_CEREBELLAR_DYSPLASIA,SET,18,-0.47287,-0.014792,0.2108,0.98755,HP_CEREBELLAR_DYSPLASIA,1
REACTOME_NICOTINATE_METABOLI...,SET,29,-0.36352,-0.014429,0.162,0.98758,REACTOME_NICOTINATE_METABOLISM,1
NIKOLSKY_BREAST_CANCER_16P13...,SET,101,-0.33397,-0.02469,0.14878,0.9876,NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,1
GSE5679_RARA_AGONIST_AM580_V...1,SET,181,-0.14627,-0.014444,0.065163,0.9876,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN,1
GOBP_PEPTIDOGLYCAN_METABOLIC...,SET,6,-0.84568,-0.015278,0.37631,0.98768,GOBP_PEPTIDOGLYCAN_METABOLIC_PROCESS,1
MIR5706,SET,150,-0.16421,-0.014774,0.073031,0.98772,MIR5706,1
GOMF_MYOSIN_V_BINDING,SET,16,-0.49249,-0.014525,0.21897,0.98774,GOMF_MYOSIN_V_BINDING,1
MODULE_447,SET,35,-0.32532,-0.014183,0.14439,0.98787,MODULE_447,1
GOCC_POSTSYNAPTIC_ENDOSOME_M...,SET,4,-0.90931,-0.013414,0.40354,0.98788,GOCC_POSTSYNAPTIC_ENDOSOME_MEMBRANE,1
LIU_CMYB_TARGETS_DN,SET,6,-0.65292,-0.011795,0.28967,0.9879,LIU_CMYB_TARGETS_DN,1
chr11q24,SET,81,-0.41705,-0.027626,0.18493,0.98793,chr11q24,1
GOBP_POSITIVE_REGULATION_OF_...84,SET,193,-0.14123,-0.014397,0.062626,0.98793,GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GSE11973_MIR223_KOVS_WT_BONE...1,SET,154,-0.1537,-0.014011,0.068151,0.98794,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN,1
MIR3143,SET,412,-0.096867,-0.01434,0.042941,0.98795,MIR3143,1
LET_7D_5P,SET,316,-0.11226,-0.014593,0.049742,0.98798,LET_7D_5P,1
REACTOME_RRNA_PROCESSING_IN_...,SET,6,-0.8324,-0.015038,0.36837,0.98807,REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION,1
LIU_CDX2_TARGETS_DN,SET,8,-0.762,-0.015895,0.33718,0.98808,LIU_CDX2_TARGETS_DN,1
GOBP_HYPOTHALAMUS_CELL_DIFFE...,SET,11,-0.69248,-0.016937,0.30634,0.9881,GOBP_HYPOTHALAMUS_CELL_DIFFERENTIATION,1
GSE14769_UNSTIM_VS_80MIN_LPS...2,SET,182,-0.13731,-0.013596,0.060727,0.98812,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP,1
HP_SQUARED_ILIAC_BONES,SET,11,-0.56671,-0.01386,0.25059,0.98813,HP_SQUARED_ILIAC_BONES,1
HP_DEPRESSED_NASAL_BRIDGE,SET,527,-0.084824,-0.014157,0.037493,0.98816,HP_DEPRESSED_NASAL_BRIDGE,1
REACTOME_SIGNALING_BY_NOTCH4,SET,77,-0.20552,-0.013275,0.090828,0.98817,REACTOME_SIGNALING_BY_NOTCH4,1
GOBP_POSITIVE_REGULATION_OF_...203,SET,5,-0.88147,-0.014537,0.38946,0.98819,GOBP_POSITIVE_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,1
GOBP_CEREBRAL_CORTEX_RADIALL...,SET,33,-0.35656,-0.015095,0.15748,0.98821,GOBP_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION,1
HOLLERN_ADENOMYOEPITHELIAL_B...,SET,17,-0.45739,-0.013905,0.20199,0.98822,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,1
REACTOME_NEGATIVE_REGULATION...10,SET,51,-0.24699,-0.012993,0.10907,0.98822,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,1
GOBP_REGULATION_OF_DENDRITIC...2,SET,10,-0.65991,-0.015389,0.29135,0.98824,GOBP_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS,1
GSE45365_WT_VS_IFNAR_KO_CD11...4,SET,161,-0.14819,-0.01381,0.065393,0.98827,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP,1
REACTOME_REGULATION_OF_LOCAL...,SET,11,-0.59786,-0.014622,0.26341,0.98838,REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,1
GOBP_HEPARIN_BIOSYNTHETIC_PR...,SET,11,-0.59863,-0.014641,0.26364,0.98841,GOBP_HEPARIN_BIOSYNTHETIC_PROCESS,1
REACTOME_ACTIVATION_OF_BAD_A...,SET,15,-0.50127,-0.014315,0.22071,0.98842,REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA,1
GAVISH_3CA_MALIGNANT_METAPRO...2,SET,38,-0.30386,-0.013803,0.13375,0.98845,GAVISH_3CA_MALIGNANT_METAPROGRAM_11_TRANSLATION_INITIATION,1
GNF2_DNM1,SET,68,-0.25274,-0.015345,0.11119,0.98848,GNF2_DNM1,1
MIR1271_5P,SET,355,-0.10794,-0.014856,0.047467,0.98851,MIR1271_5P,1
HP_CONGENITAL_STATIONARY_NIG...,SET,18,-0.47261,-0.014784,0.20772,0.98855,HP_CONGENITAL_STATIONARY_NIGHT_BLINDNESS,1
WP_ROLES_OF_CERAMIDES_IN_DEV...,SET,23,-0.42756,-0.015116,0.18779,0.98859,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,1
GSE13547_CTRL_VS_ANTI_IGM_ST...5,SET,141,-0.17191,-0.015,0.075462,0.98863,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN,1
HP_CHORIORETINAL_COLOBOMA,SET,40,-0.312,-0.01454,0.13693,0.98865,HP_CHORIORETINAL_COLOBOMA,1
HP_GENERALIZED_HYPOTONIA,SET,580,-0.080629,-0.014096,0.035378,0.98866,HP_GENERALIZED_HYPOTONIA,1
HP_CLONUS,SET,98,-0.19338,-0.014083,0.084751,0.98874,HP_CLONUS,1
HP_WIDENED_CEREBELLAR_SUBARA...,SET,6,-0.82338,-0.014875,0.36085,0.98874,HP_WIDENED_CEREBELLAR_SUBARACHNOID_SPACE,1
GOBP_REGULATION_OF_PODOSOME_...,SET,13,-0.53131,-0.014126,0.23282,0.98875,GOBP_REGULATION_OF_PODOSOME_ASSEMBLY,1
HP_LIMB_HYPERTONIA,SET,143,-0.1583,-0.013909,0.069354,0.98876,HP_LIMB_HYPERTONIA,1
GSE9878_CTRL_VS_EBF_TRANSDUC...1,SET,180,-0.13547,-0.013341,0.059352,0.98876,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN,1
MEINHOLD_OVARIAN_CANCER_LOW_...2,SET,10,-0.6908,-0.01611,0.30254,0.98879,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,1
HP_INCREASED_INTERVERTEBRAL_...,SET,6,-0.78021,-0.014095,0.34169,0.98879,HP_INCREASED_INTERVERTEBRAL_SPACE,1
AMIT_EGF_RESPONSE_20_MCF10A,SET,11,-0.57751,-0.014125,0.25289,0.9888,AMIT_EGF_RESPONSE_20_MCF10A,1
GOBP_REGULATION_OF_ANTIFUNGA...,SET,4,-0.8652,-0.012763,0.37887,0.9888,GOBP_REGULATION_OF_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,1
HP_AORTIC_ROOT_ANEURYSM,SET,64,-0.24521,-0.014445,0.10737,0.9888,HP_AORTIC_ROOT_ANEURYSM,1
DAZARD_UV_RESPONSE_CLUSTER_G...1,SET,21,-0.46051,-0.015558,0.20145,0.98887,DAZARD_UV_RESPONSE_CLUSTER_G24,1
GOMF_DIPEPTIDYL_PEPTIDASE_AC...,SET,12,-0.56307,-0.014383,0.24631,0.98887,GOMF_DIPEPTIDYL_PEPTIDASE_ACTIVITY,1
GOMF_PROTEIN_KINASE_A_BINDING,SET,49,-0.27361,-0.014109,0.11963,0.9889,GOMF_PROTEIN_KINASE_A_BINDING,1
GSE17721_LPS_VS_POLYIC_0.5H_...1,SET,182,-0.14124,-0.013985,0.061733,0.98892,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN,1
GSE22886_CD8_TCELL_VS_BCELL_...1,SET,170,-0.15161,-0.014514,0.066217,0.98897,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN,1
HP_DIAPHYSEAL_SCLEROSIS,SET,9,-0.7161,-0.015843,0.31234,0.98906,HP_DIAPHYSEAL_SCLEROSIS,1
HP_ORAL_AVERSION,SET,16,-0.50808,-0.014985,0.22159,0.98907,HP_ORAL_AVERSION,1
KEGG_MEDICUS_REFERENCE_BMP15...,SET,6,-0.87918,-0.015883,0.38306,0.98913,KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_LYMPHOID_...,SET,12,-0.53868,-0.01376,0.23465,0.98915,GOBP_REGULATION_OF_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,1
HP_PROMINENT_FOREHEAD,SET,221,-0.12895,-0.014056,0.056172,0.98915,HP_PROMINENT_FOREHEAD,1
MIR1304_5P,SET,121,-0.17859,-0.014443,0.077725,0.9892,MIR1304_5P,1
GOMF_OXIDOREDUCTASE_ACTIVITY...37,SET,25,-0.42143,-0.015533,0.18341,0.98921,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS,1
KEGG_LINOLEIC_ACID_METABOLISM,SET,29,-0.43131,-0.01712,0.18759,0.98925,KEGG_LINOLEIC_ACID_METABOLISM,1
GSE21927_GMCSF_IL6_VS_GMCSF_...2,SET,144,-0.15874,-0.013996,0.06902,0.98927,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...1,SET,8,-0.64979,-0.013554,0.28243,0.98929,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_DN,1
GOBP_RRNA_MODIFICATION,SET,25,-0.3427,-0.012631,0.1489,0.98931,GOBP_RRNA_MODIFICATION,1
MIR4458,SET,318,-0.11433,-0.014908,0.049663,0.98933,MIR4458,1
DURAND_STROMA_S_UP,SET,261,-0.13114,-0.015517,0.056928,0.98937,DURAND_STROMA_S_UP,1
GOCC_INSULIN_LIKE_GROWTH_FAC...,SET,5,-1.0312,-0.017007,0.4475,0.98939,GOCC_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEIN_COMPLEX,1
KOYAMA_SEMA3B_TARGETS_DN,SET,319,-0.11312,-0.014773,0.04908,0.98941,KOYAMA_SEMA3B_TARGETS_DN,1
KEGG_MEDICUS_REFERENCE_NAD_B...,SET,12,-0.60847,-0.015543,0.26399,0.98941,KEGG_MEDICUS_REFERENCE_NAD_BIOSYNTHESIS,1
MIR3122,SET,59,-0.24613,-0.013924,0.10677,0.98942,MIR3122,1
MIR12133,SET,352,-0.10985,-0.015056,0.047627,0.98945,MIR12133,1
HP_ABNORMAL_CONJUGATE_EYE_MO...,SET,1020,-0.06267,-0.014349,0.027171,0.98945,HP_ABNORMAL_CONJUGATE_EYE_MOVEMENT,1
GOBP_PROTEOGLYCAN_METABOLIC_...,SET,83,-0.22677,-0.015205,0.098303,0.98946,GOBP_PROTEOGLYCAN_METABOLIC_PROCESS,1
MIR1908_5P,SET,16,-0.51506,-0.015191,0.223,0.98954,MIR1908_5P,1
MORF_RAB3A,SET,77,-0.23105,-0.014924,0.10004,0.98954,MORF_RAB3A,1
CHEN_LUNG_CANCER_SURVIVAL,SET,24,-0.39152,-0.014139,0.16946,0.98956,CHEN_LUNG_CANCER_SURVIVAL,1
GOBP_VESTIBULOCOCHLEAR_NERVE...1,SET,11,-0.69163,-0.016916,0.29936,0.98956,GOBP_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT,1
MIR609,SET,30,-0.35665,-0.014398,0.15435,0.98957,MIR609,1
HP_ABNORMAL_CEREBRAL_VENTRIC...,SET,816,-0.070393,-0.0145,0.030463,0.98957,HP_ABNORMAL_CEREBRAL_VENTRICLE_MORPHOLOGY,1
MIKKELSEN_MEF_HCP_WITH_H3_UN...,SET,185,-0.15301,-0.015274,0.066173,0.98961,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,1
GOBP_REGULATION_OF_HEMATOPOI...1,SET,41,-0.29319,-0.013833,0.12677,0.98962,GOBP_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GCAAGAC_MIR431,SET,43,-0.3162,-0.015277,0.13668,0.98965,GCAAGAC_MIR431,1
GOBP_PROTEIN_KINASE_C_ACTIVA...,SET,24,-0.40244,-0.014533,0.17394,0.98965,GOBP_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GSE36527_CD62L_HIGH_CD69_NEG...2,SET,180,-0.14393,-0.014174,0.062197,0.98966,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP,1
HP_ABNORMAL_NASAL_BASE_NORPH...,SET,24,-0.40423,-0.014598,0.17461,0.98969,HP_ABNORMAL_NASAL_BASE_NORPHOLOGY,1
GOBP_MITOCHONDRIAL_TRANSPORT,SET,164,-0.15093,-0.014194,0.065164,0.98972,GOBP_MITOCHONDRIAL_TRANSPORT,1
GSE2585_THYMIC_DC_VS_MTEC_DN,SET,177,-0.14861,-0.014514,0.064144,0.98974,GSE2585_THYMIC_DC_VS_MTEC_DN,1
GOMF_EXTRACELLULAR_MATRIX_BI...,SET,61,-0.27327,-0.015717,0.11789,0.98977,GOMF_EXTRACELLULAR_MATRIX_BINDING,1
PER1_TARGET_GENES,SET,21,-0.43558,-0.014716,0.18786,0.98979,PER1_TARGET_GENES,1
CTCTGGA_MIR520A_MIR525,SET,141,-0.16287,-0.014211,0.070199,0.98983,CTCTGGA_MIR520A_MIR525,1
REACTOME_FLT3_SIGNALING_THRO...,SET,6,-0.74553,-0.013469,0.32118,0.98986,REACTOME_FLT3_SIGNALING_THROUGH_SRC_FAMILY_KINASES,1
GOMF_PEPTIDOGLYCAN_MURALYTIC...,SET,13,-0.61317,-0.016302,0.26414,0.98986,GOMF_PEPTIDOGLYCAN_MURALYTIC_ACTIVITY,1
ZFP82_TARGET_GENES,SET,25,-0.37437,-0.013798,0.16119,0.98989,ZFP82_TARGET_GENES,1
MIR4701_3P,SET,46,-0.27879,-0.01393,0.11998,0.98992,MIR4701_3P,1
PID_ILK_PATHWAY,SET,44,-0.29383,-0.01436,0.12642,0.98994,PID_ILK_PATHWAY,1
KEGG_MEDICUS_REFERENCE_FLT3L...1,SET,14,-0.48949,-0.013505,0.21054,0.98996,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY,1
MODULE_509,SET,12,-0.54632,-0.013955,0.2349,0.98998,MODULE_509,1
GOBP_CARTILAGE_DEVELOPMENT,SET,187,-0.15294,-0.015348,0.065755,0.98998,GOBP_CARTILAGE_DEVELOPMENT,1
GSE20715_WT_VS_TLR4_KO_48H_O...2,SET,178,-0.15145,-0.014832,0.06511,0.98998,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP,1
MARIADASON_RESPONSE_TO_BUTYR...3,SET,9,-0.68336,-0.015119,0.29366,0.99001,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8,1
GOBP_PURINERGIC_NUCLEOTIDE_R...,SET,27,-0.43369,-0.016611,0.18636,0.99001,GOBP_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,1
GSE37301_MULTIPOTENT_PROGENI...3,SET,187,-0.1425,-0.014301,0.061209,0.99004,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN,1
GOBP_RELEASE_OF_SEQUESTERED_...,SET,34,-0.34474,-0.014814,0.14806,0.99005,GOBP_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_ENDOPLASMIC_RETICULUM,1
HP_VEIN_OF_GALEN_ANEURYSMAL_...,SET,5,-0.89675,-0.014789,0.38508,0.99006,HP_VEIN_OF_GALEN_ANEURYSMAL_MALFORMATION,1
GOBP_REGULATION_OF_CELLULAR_...16,SET,17,-0.50168,-0.015251,0.21531,0.99009,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
MORI_PLASMA_CELL_DN,SET,34,-0.35513,-0.015261,0.15221,0.99017,MORI_PLASMA_CELL_DN,1
LAKE_ADULT_KIDNEY_C19_COLLEC...,SET,288,-0.11551,-0.014347,0.049515,0.99017,LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA,1
WP_BENZENE_METABOLISM,SET,5,-0.90213,-0.014878,0.38646,0.9902,WP_BENZENE_METABOLISM,1
GOBP_PARALLEL_ACTIN_FILAMENT...,SET,7,-0.79006,-0.015416,0.3385,0.9902,GOBP_PARALLEL_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
TRAVAGLINI_LUNG_ARTERY_CELL,SET,124,-0.19575,-0.016025,0.083798,0.99025,TRAVAGLINI_LUNG_ARTERY_CELL,1
HP_COLOBOMA,SET,207,-0.13692,-0.014449,0.058588,0.99027,HP_COLOBOMA,1
REACTOME_GLUTATHIONE_SYNTHES...,SET,12,-0.57532,-0.014696,0.24612,0.99029,REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING,1
FLETCHER_PBMC_BCG_10W_INFANT...2,SET,119,-0.21043,-0.016878,0.090021,0.99029,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP,1
GOCC_NEURONAL_RIBONUCLEOPROT...,SET,3,-1.1177,-0.014279,0.47753,0.99037,GOCC_NEURONAL_RIBONUCLEOPROTEIN_GRANULE,1
HOWARD_PBMC_INACT_MONOV_INFL...2,SET,334,-0.1203,-0.01607,0.051324,0.99046,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP,1
GOBP_TRNA_PROCESSING,SET,119,-0.16588,-0.013305,0.070723,0.99049,GOBP_TRNA_PROCESSING,1
HP_OVERLAPPING_TOE,SET,60,-0.25838,-0.014739,0.11015,0.9905,HP_OVERLAPPING_TOE,1
HP_ABNORMAL_OSSIFICATION_OF_...,SET,10,-0.63563,-0.014823,0.27079,0.99054,HP_ABNORMAL_OSSIFICATION_OF_THE_PUBIC_BONE,1
MIR1261,SET,76,-0.22954,-0.014731,0.097595,0.99066,MIR1261,1
GOBP_RESPONSE_TO_OXYGEN_RADI...,SET,25,-0.40941,-0.01509,0.17398,0.99069,GOBP_RESPONSE_TO_OXYGEN_RADICAL,1
GOBP_REGULATION_OF_T_CELL_ME...3,SET,94,-0.22974,-0.016389,0.097616,0.9907,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
HP_ABNORMAL_ODONTOID_PROCESS...,SET,28,-0.36978,-0.014423,0.1571,0.9907,HP_ABNORMAL_ODONTOID_PROCESS_MORPHOLOGY,1
REACTOME_TRANSCRIPTIONAL_REG...6,SET,91,-0.20207,-0.014184,0.085847,0.99071,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1
MIR376C_3P,SET,138,-0.17431,-0.015048,0.074044,0.99071,MIR376C_3P,1
GOBP_POSITIVE_REGULATION_OF_...86,SET,72,-0.24603,-0.015369,0.10448,0.99073,GOBP_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
GOMF_TUMOR_NECROSIS_FACTOR_R...3,SET,46,-0.30613,-0.015297,0.13,0.99073,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING,1
MIR1322,SET,68,-0.27823,-0.016893,0.11808,0.99076,MIR1322,1
HP_GINGIVAL_RECESSION,SET,5,-0.8444,-0.013926,0.35841,0.99076,HP_GINGIVAL_RECESSION,1
HP_PULMONARY_ARTERIAL_HYPERT...,SET,130,-0.1754,-0.014699,0.074426,0.99077,HP_PULMONARY_ARTERIAL_HYPERTENSION,1
GSE4748_CTRL_VS_LPS_STIM_DC_...1,SET,182,-0.15097,-0.014949,0.064068,0.99077,GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...2,SET,96,-0.23076,-0.016634,0.097876,0.9908,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL,1
GCM_DDX11,SET,44,-0.26769,-0.013083,0.11349,0.99083,GCM_DDX11,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...1,SET,22,-0.4721,-0.016324,0.20013,0.99083,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE,1
MIR4428,SET,114,-0.18245,-0.014325,0.077336,0.99084,MIR4428,1
SHIPP_DLBCL_VS_FOLLICULAR_LY...2,SET,44,-0.31307,-0.0153,0.13268,0.99085,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,1
REACTOME_ABERRANT_REGULATION...1,SET,19,-0.41911,-0.013469,0.17759,0.99086,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS,1
GSE2585_THYMIC_MACROPHAGE_VS...1,SET,165,-0.15742,-0.014849,0.066689,0.99087,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN,1
IWANAGA_E2F1_TARGETS_NOT_IND...,SET,6,-0.73674,-0.01331,0.31207,0.99088,IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM,1
MODULE_272,SET,12,-0.54224,-0.013851,0.2296,0.9909,MODULE_272,1
BOYLAN_MULTIPLE_MYELOMA_C_CL...2,SET,35,-0.33971,-0.014811,0.14379,0.99092,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,1
MIR7702,SET,50,-0.282,-0.014689,0.11935,0.99093,MIR7702,1
GOBP_STEROL_BIOSYNTHETIC_PRO...,SET,54,-0.26649,-0.014424,0.11268,0.99098,GOBP_STEROL_BIOSYNTHETIC_PROCESS,1
GOBP_COPPER_ION_IMPORT,SET,6,-0.82155,-0.014842,0.3471,0.99103,GOBP_COPPER_ION_IMPORT,1
HP_BREECH_PRESENTATION,SET,49,-0.28088,-0.014484,0.11862,0.99105,HP_BREECH_PRESENTATION,1
ILK_TARGET_GENES,SET,15,-0.49761,-0.01421,0.21012,0.99106,ILK_TARGET_GENES,1
HP_LIPOMATOUS_TUMOR,SET,42,-0.31825,-0.015197,0.13437,0.99106,HP_LIPOMATOUS_TUMOR,1
HP_MACULAR_HYPOPIGMENTATION,SET,5,-1.0138,-0.01672,0.42785,0.99109,HP_MACULAR_HYPOPIGMENTATION,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...3,SET,16,-0.54476,-0.016067,0.22988,0.9911,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP,1
WP_AFLATOXIN_B1_METABOLISM,SET,6,-0.8821,-0.015936,0.37205,0.99112,WP_AFLATOXIN_B1_METABOLISM,1
GSE411_WT_VS_SOCS3_KO_MACROP...5,SET,183,-0.15888,-0.015775,0.067,0.99113,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP,1
GOCC_GABA_ERGIC_SYNAPSE,SET,69,-0.27318,-0.016707,0.11514,0.99116,GOCC_GABA_ERGIC_SYNAPSE,1
HP_WIDELY_SPACED_PRIMARY_TEE...,SET,5,-0.96662,-0.015942,0.40727,0.99118,HP_WIDELY_SPACED_PRIMARY_TEETH,1
HP_HBS_HEMOGLOBIN,SET,5,-0.98383,-0.016225,0.41444,0.99119,HP_HBS_HEMOGLOBIN,1
GOCC_ENDOPLASMIC_RETICULUM_P...2,SET,9,-0.63661,-0.014085,0.26815,0.9912,GOCC_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_CONTACT_SITE,1
GSE1925_CTRL_VS_24H_IFNG_STI...3,SET,174,-0.14614,-0.014153,0.061536,0.99122,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN,1
GOBP_RESPONSE_TO_INTERLEUKIN...11,SET,14,-0.48425,-0.01336,0.20382,0.99124,GOBP_RESPONSE_TO_INTERLEUKIN_7,1
PANGAS_TUMOR_SUPPRESSION_BY_...1,SET,128,-0.17929,-0.01491,0.075448,0.99125,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,1
HP_APLASIA_HYPOPLASIA_INVOLV...1,SET,236,-0.13563,-0.015271,0.057008,0.99132,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_FEET,1
TGCACGA_MIR517A_MIR517C,SET,17,-0.48226,-0.014661,0.20243,0.99139,TGCACGA_MIR517A_MIR517C,1
COMP1_01,SET,103,-0.22811,-0.017029,0.095753,0.99139,COMP1_01,1
GNF2_FGR,SET,30,-0.36934,-0.01491,0.15504,0.99139,GNF2_FGR,1
HP_HORSESHOE_KIDNEY,SET,122,-0.181,-0.014699,0.075955,0.99141,HP_HORSESHOE_KIDNEY,1
MODULE_67,SET,199,-0.14386,-0.014888,0.060351,0.99143,MODULE_67,1
HP_THORACOLUMBAR_KYPHOSCOLIO...,SET,6,-0.85833,-0.015506,0.36006,0.99143,HP_THORACOLUMBAR_KYPHOSCOLIOSIS,1
GOMF_PHOSPHOLIPASE_ACTIVATOR...,SET,15,-0.47615,-0.013598,0.19965,0.99145,GOMF_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY,1
GOBP_REGULATION_OF_RESPONSE_...12,SET,20,-0.4975,-0.016403,0.20844,0.9915,GOBP_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
MIR6079,SET,135,-0.18024,-0.015391,0.075498,0.99151,MIR6079,1
MIR764,SET,46,-0.27168,-0.013575,0.11379,0.99152,MIR764,1
GOBP_REGULATION_OF_REACTIVE_...2,SET,130,-0.18072,-0.015146,0.075655,0.99154,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
GOMF_ADENYL_NUCLEOTIDE_BINDI...,SET,1501,-0.054811,-0.015011,0.022921,0.9916,GOMF_ADENYL_NUCLEOTIDE_BINDING,1
KUMAR_TARGETS_OF_MLL_AF9_FUS...,SET,367,-0.11158,-0.015609,0.046641,0.99162,KUMAR_TARGETS_OF_MLL_AF9_FUSION,1
GSE13306_RA_VS_UNTREATED_MEM...2,SET,189,-0.15119,-0.015253,0.063082,0.99172,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP,1
NOURUZI_NEPC_ASCL1_TARGETS,SET,124,-0.20119,-0.01647,0.08391,0.99174,NOURUZI_NEPC_ASCL1_TARGETS,1
HP_LIMITED_WRIST_MOVEMENT,SET,12,-0.60404,-0.01543,0.2519,0.99175,HP_LIMITED_WRIST_MOVEMENT,1
GOMF_SIRNA_BINDING,SET,7,-0.80715,-0.01575,0.33648,0.99177,GOMF_SIRNA_BINDING,1
MIR1178_3P,SET,83,-0.23802,-0.015959,0.099149,0.99181,MIR1178_3P,1
HP_SHORT_TOE,SET,89,-0.21768,-0.015112,0.090633,0.99184,HP_SHORT_TOE,1
HP_EXAGGERATED_CUPID_S_BOW,SET,31,-0.36389,-0.014933,0.15146,0.99185,HP_EXAGGERATED_CUPID_S_BOW,1
MIR1252_3P,SET,270,-0.13003,-0.015645,0.054115,0.99186,MIR1252_3P,1
DESCARTES_MAIN_FETAL_ANTIGEN...,SET,91,-0.22815,-0.016014,0.094937,0.99187,DESCARTES_MAIN_FETAL_ANTIGEN_PRESENTING_CELLS,1
GSE33425_CD161_HIGH_VS_NEG_C...2,SET,184,-0.15426,-0.015358,0.064175,0.99188,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP,1
GOBP_CELL_DIFFERENTIATION_IN...1,SET,24,-0.44464,-0.016058,0.18478,0.99194,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT,1
GSE13485_PRE_VS_POST_YF17D_V...1,SET,179,-0.15558,-0.01528,0.064627,0.99196,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN,1
GOCC_SPECTRIN,SET,9,-0.65559,-0.014504,0.27218,0.99199,GOCC_SPECTRIN,1
GOCC_PROTEASOME_COMPLEX,SET,60,-0.24168,-0.013786,0.10022,0.99205,GOCC_PROTEASOME_COMPLEX,1
GOBP_PHOSPHATIDYLSERINE_ACYL...,SET,8,-0.81001,-0.016896,0.33581,0.99206,GOBP_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING,1
CHOI_ATL_CHRONIC_VS_ACUTE_DN,SET,17,-0.4868,-0.014799,0.20181,0.99207,CHOI_ATL_CHRONIC_VS_ACUTE_DN,1
MIR6743_5P,SET,35,-0.33709,-0.014697,0.13968,0.99209,MIR6743_5P,1
GAVISH_3CA_METAPROGRAM_FIBRO...20,SET,48,-0.31338,-0.015995,0.12985,0.99209,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE,1
GOBP_NEGATIVE_REGULATION_OF_...698,SET,22,-0.47719,-0.0165,0.19775,0.99209,GOBP_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,1
GSE360_L_DONOVANI_VS_T_GONDI...3,SET,184,-0.14802,-0.014736,0.061332,0.99209,GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN,1
GOBP_POSITIVE_REGULATION_OF_...538,SET,27,-0.44415,-0.017011,0.18396,0.99211,GOBP_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,1
HP_ABNORMAL_FEMORAL_NECK_MOR...,SET,139,-0.17596,-0.015245,0.072876,0.99212,HP_ABNORMAL_FEMORAL_NECK_MORPHOLOGY,1
HP_SEVERE_HEARING_IMPAIRMENT,SET,14,-0.53126,-0.014657,0.21998,0.99213,HP_SEVERE_HEARING_IMPAIRMENT,1
GOBP_REGULATION_OF_GLUCONEOG...,SET,43,-0.31934,-0.015429,0.13207,0.99219,GOBP_REGULATION_OF_GLUCONEOGENESIS,1
LOPEZ_MESOTELIOMA_SURVIVAL_T...1,SET,7,-0.77074,-0.015039,0.31845,0.99224,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN,1
GOBP_PHOSPHATIDYLSERINE_META...,SET,22,-0.43048,-0.014885,0.17788,0.99224,GOBP_PHOSPHATIDYLSERINE_METABOLIC_PROCESS,1
SENESE_HDAC1_AND_HDAC2_TARGE...1,SET,203,-0.15203,-0.01589,0.062685,0.99235,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,1
HP_RETINAL_ATROPHY,SET,92,-0.21508,-0.01518,0.088682,0.99235,HP_RETINAL_ATROPHY,1
GOBP_MYOBLAST_FATE_COMMITMENT,SET,6,-0.97841,-0.017676,0.40324,0.99237,GOBP_MYOBLAST_FATE_COMMITMENT,1
HP_ATLANTOAXIAL_DISLOCATION,SET,6,-0.81047,-0.014642,0.33368,0.99242,HP_ATLANTOAXIAL_DISLOCATION,1
HIF1_Q5,SET,227,-0.14058,-0.015526,0.057851,0.99244,HIF1_Q5,1
GAUSSMANN_MLL_AF4_FUSION_TAR...1,SET,90,-0.23384,-0.016324,0.09623,0.99245,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1
MTOR_UP.N4.V1_UP,SET,175,-0.1558,-0.015131,0.064113,0.99245,MTOR_UP.N4.V1_UP,1
MIR132_5P,SET,8,-0.74061,-0.015449,0.30457,0.99248,MIR132_5P,1
VOIGT_PBMC_FLUARIX_AGE_50_74...,SET,18,-0.53329,-0.016682,0.21928,0.99249,VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP,1
REACTOME_RUNX2_REGULATES_BON...,SET,28,-0.41141,-0.016046,0.16909,0.99251,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,1
WU_ALZHEIMER_DISEASE_UP,SET,9,-0.69074,-0.015282,0.28383,0.99252,WU_ALZHEIMER_DISEASE_UP,1
HP_ZONULAR_CATARACT,SET,47,-0.31508,-0.015913,0.12947,0.99252,HP_ZONULAR_CATARACT,1
HP_ABNORMALITY_OF_MOUTH_SIZE,SET,373,-0.11056,-0.01559,0.045425,0.99253,HP_ABNORMALITY_OF_MOUTH_SIZE,1
WP_DISORDERS_IN_KETOLYSIS,SET,5,-0.82786,-0.013653,0.33976,0.99258,WP_DISORDERS_IN_KETOLYSIS,1
GOBP_AMIDE_BIOSYNTHETIC_PROC...,SET,144,-0.18017,-0.015886,0.073943,0.99258,GOBP_AMIDE_BIOSYNTHETIC_PROCESS,1
GOBP_MITOCHONDRIAL_ELECTRON_...2,SET,42,-0.27899,-0.013322,0.11451,0.99258,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,1
GSE17721_POLYIC_VS_CPG_12H_B...2,SET,178,-0.16128,-0.015795,0.066142,0.99262,GSE17721_POLYIC_VS_CPG_12H_BMDC_UP,1
HP_ABNORMAL_OOCYTE_MORPHOLOGY,SET,6,-0.83367,-0.015061,0.34147,0.99268,HP_ABNORMAL_OOCYTE_MORPHOLOGY,1
GSE29618_MONOCYTE_VS_PDC_DAY...2,SET,186,-0.15931,-0.015945,0.065248,0.99268,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP,1
GSE27859_DC_VS_CD11C_INT_F48...2,SET,182,-0.1473,-0.014586,0.060317,0.99269,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,1
GOBP_REGULATION_OF_NAD_P_H_O...,SET,5,-0.94407,-0.01557,0.38622,0.99274,GOBP_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY,1
GSE33425_CD161_INT_VS_NEG_CD...2,SET,187,-0.15485,-0.01554,0.063348,0.99274,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP,1
GOBP_REGULATION_OF_SUPEROXID...1,SET,20,-0.49812,-0.016424,0.20373,0.99275,GOBP_REGULATION_OF_SUPEROXIDE_ANION_GENERATION,1
LUI_THYROID_CANCER_PAX8_PPAR...2,SET,44,-0.30066,-0.014694,0.12296,0.99276,LUI_THYROID_CANCER_PAX8_PPARG_UP,1
MIR3167,SET,96,-0.22106,-0.015936,0.090374,0.99277,MIR3167,1
GSE9988_LPS_VS_LOW_LPS_MONOC...1,SET,147,-0.17456,-0.01555,0.071358,0.99278,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...1,SET,7,-0.8736,-0.017046,0.35674,0.99283,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,1
GSE5589_LPS_AND_IL10_VS_LPS_...4,SET,182,-0.15498,-0.015347,0.063265,0.99285,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,1
GOBP_TRNA_THREONYLCARBAMOYLA...1,SET,13,-0.51155,-0.013601,0.20878,0.99286,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS,1
GOMF_PROTEIN_LIPID_COMPLEX_B...,SET,28,-0.43081,-0.016803,0.17571,0.99289,GOMF_PROTEIN_LIPID_COMPLEX_BINDING,1
REACTOME_STAT5_ACTIVATION,SET,7,-0.73778,-0.014396,0.30063,0.99293,REACTOME_STAT5_ACTIVATION,1
GNF2_RAB3A,SET,34,-0.38626,-0.016598,0.15739,0.99294,GNF2_RAB3A,1
GOBP_REGULATION_OF_CELLULAR_...12,SET,17,-0.4736,-0.014397,0.19272,0.993,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,1
HP_PATENT_FORAMEN_OVALE,SET,112,-0.19119,-0.01488,0.077746,0.99303,HP_PATENT_FORAMEN_OVALE,1
GSE19888_ADENOSINE_A3R_INH_V...4,SET,184,-0.16245,-0.016174,0.066061,0.99303,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...203,SET,7,-0.87323,-0.017039,0.35478,0.99307,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
FLECHNER_BIOPSY_KIDNEY_TRANS...3,SET,504,-0.09695,-0.015833,0.039387,0.99308,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1
GOBP_POSITIVE_REGULATION_OF_...830,SET,14,-0.5914,-0.016317,0.24022,0.99309,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_CLINODACTYLY_OF_THE_2ND_F...,SET,8,-0.85076,-0.017746,0.34545,0.9931,HP_CLINODACTYLY_OF_THE_2ND_FINGER,1
GOCC_RISC_LOADING_COMPLEX,SET,8,-0.78968,-0.016472,0.32044,0.99313,GOCC_RISC_LOADING_COMPLEX,1
MORF_MAP3K14,SET,106,-0.21323,-0.016147,0.086507,0.99314,MORF_MAP3K14,1
GOBP_T_HELPER_1_CELL_CYTOKIN...,SET,8,-0.73227,-0.015275,0.2968,0.99319,GOBP_T_HELPER_1_CELL_CYTOKINE_PRODUCTION,1
HP_TRACHEAL_CALCIFICATION,SET,3,-1.3071,-0.016699,0.5294,0.99322,HP_TRACHEAL_CALCIFICATION,1
REACTOME_PROTEIN_LIPOYLATION,SET,10,-0.60137,-0.014024,0.24342,0.99325,REACTOME_PROTEIN_LIPOYLATION,1
GOBP_PEPTIDE_BIOSYNTHETIC_PR...,SET,25,-0.45072,-0.016612,0.18237,0.99327,GOBP_PEPTIDE_BIOSYNTHETIC_PROCESS,1
HP_NARROW_INTERNAL_AUDITORY_...,SET,15,-0.57919,-0.01654,0.23432,0.99327,HP_NARROW_INTERNAL_AUDITORY_CANAL,1
MIR4638_5P,SET,5,-0.85234,-0.014057,0.34469,0.99329,MIR4638_5P,1
WP_CANONICAL_AND_NONCANONICA...2,SET,17,-0.56058,-0.017042,0.22666,0.9933,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1
HP_APLASIA_HYPOPLASIA_AFFECT...4,SET,140,-0.18049,-0.015693,0.072885,0.99336,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_FUNDUS,1
MIR4445_5P,SET,85,-0.22979,-0.015592,0.092754,0.99338,MIR4445_5P,1
GSE6092_UNSTIM_VS_IFNG_STIM_...4,SET,179,-0.14912,-0.014645,0.060132,0.99342,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP,1
PID_CERAMIDE_PATHWAY,SET,43,-0.33021,-0.015954,0.13311,0.99344,PID_CERAMIDE_PATHWAY,1
GSE5589_LPS_VS_LPS_AND_IL6_S...1,SET,180,-0.15277,-0.015045,0.061584,0.99344,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
HP_ABNORMALITY_OF_PRIMARY_TE...,SET,70,-0.25214,-0.015532,0.10163,0.99345,HP_ABNORMALITY_OF_PRIMARY_TEETH,1
HP_ABNORMAL_RENAL_MEDULLA_MO...,SET,57,-0.2789,-0.015508,0.11234,0.99347,HP_ABNORMAL_RENAL_MEDULLA_MORPHOLOGY,1
GOMF_E_BOX_BINDING,SET,52,-0.34372,-0.018258,0.13843,0.99348,GOMF_E_BOX_BINDING,1
REACTOME_APC_C_MEDIATED_DEGR...,SET,84,-0.21379,-0.014421,0.08607,0.9935,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1
GOBP_SULFUR_COMPOUND_BIOSYNT...,SET,155,-0.18053,-0.016509,0.072644,0.99352,GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS,1
GSE17721_LPS_VS_GARDIQUIMOD_...3,SET,180,-0.15239,-0.015008,0.061305,0.99353,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN,1
DESCARTES_FETAL_ADRENAL_VASC...,SET,110,-0.2169,-0.01673,0.087249,0.99354,DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS,1
chr20q12,SET,7,-1.408,-0.027473,0.56604,0.99356,chr20q12,1
MIR451B,SET,150,-0.18038,-0.016229,0.072518,0.99356,MIR451B,1
GOBP_NEGATIVE_REGULATION_OF_...702,SET,14,-0.57882,-0.01597,0.2325,0.9936,GOBP_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION,1
GOMF_HEMOGLOBIN_BINDING,SET,8,-0.89852,-0.018742,0.36059,0.99364,GOMF_HEMOGLOBIN_BINDING,1
HP_ABNORMAL_CEREBRAL_SUBCORT...,SET,1030,-0.067247,-0.015468,0.026937,0.99372,HP_ABNORMAL_CEREBRAL_SUBCORTEX_MORPHOLOGY,1
GSE27786_CD8_TCELL_VS_NKCELL...2,SET,187,-0.15135,-0.015189,0.060535,0.99379,GSE27786_CD8_TCELL_VS_NKCELL_UP,1
GOCC_EUKARYOTIC_TRANSLATION_...3,SET,13,-0.52241,-0.013889,0.20889,0.9938,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX,1
HP_ABNORMAL_MUSCLE_TISSUE_ME...,SET,45,-0.30059,-0.014856,0.12012,0.99383,HP_ABNORMAL_MUSCLE_TISSUE_METABOLITE_CONCENTRATION,1
MIR4797_5P,SET,105,-0.19998,-0.015073,0.079869,0.99385,MIR4797_5P,1
MIR96_5P,SET,414,-0.10909,-0.016188,0.043565,0.99386,MIR96_5P,1
HP_SHORT_4TH_TOE,SET,5,-0.82121,-0.013543,0.32788,0.99387,HP_SHORT_4TH_TOE,1
HP_ABNORMAL_PALMAR_DERMATOGL...,SET,226,-0.14083,-0.015521,0.056207,0.99388,HP_ABNORMAL_PALMAR_DERMATOGLYPHICS,1
HP_ABNORMAL_FORM_OF_THE_VERT...,SET,307,-0.12167,-0.015594,0.048536,0.9939,HP_ABNORMAL_FORM_OF_THE_VERTEBRAL_BODIES,1
BLALOCK_ALZHEIMERS_DISEASE_DN,SET,1103,-0.06573,-0.015612,0.0262,0.99394,BLALOCK_ALZHEIMERS_DISEASE_DN,1
GSE34205_HEALTHY_VS_RSV_INF_...2,SET,168,-0.15943,-0.015173,0.06353,0.99395,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP,1
GOBP_ESTABLISHMENT_OR_MAINTE...3,SET,7,-0.72259,-0.0141,0.28782,0.99397,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY,1
MIR4680_5P,SET,58,-0.27783,-0.015583,0.1106,0.99399,MIR4680_5P,1
GSE7509_UNSTIM_VS_TNFA_IL1B_...1,SET,80,-0.23292,-0.015334,0.092663,0.99402,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,1
GOMF_2_IRON_2_SULFUR_CLUSTER...,SET,23,-0.38856,-0.013737,0.15456,0.99403,GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING,1
HP_SUBDURAL_HEMORRHAGE,SET,12,-0.70349,-0.01797,0.27974,0.99404,HP_SUBDURAL_HEMORRHAGE,1
GSE3994_WT_VS_PAC1_KO_ACTIVA...1,SET,189,-0.15867,-0.016008,0.063001,0.9941,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN,1
GOBP_REGULATION_OF_CARBOHYDR...1,SET,88,-0.23518,-0.016235,0.093373,0.99411,GOBP_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,1
KEGG_CIRCADIAN_RHYTHM_MAMMAL,SET,12,-0.71918,-0.018371,0.28547,0.99412,KEGG_CIRCADIAN_RHYTHM_MAMMAL,1
GOBP_NEGATIVE_REGULATION_OF_...308,SET,29,-0.40279,-0.015988,0.15987,0.99412,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,1
HP_ABNORMAL_PERIVENTRICULAR_...,SET,116,-0.19561,-0.015491,0.077483,0.9942,HP_ABNORMAL_PERIVENTRICULAR_WHITE_MATTER_MORPHOLOGY,1
GSE6259_33D1_POS_DC_VS_BCELL...2,SET,136,-0.18871,-0.016174,0.074753,0.9942,GSE6259_33D1_POS_DC_VS_BCELL_UP,1
GOMF_ATP_DEPENDENT_PEPTIDASE...,SET,7,-0.65981,-0.012875,0.26121,0.99423,GOMF_ATP_DEPENDENT_PEPTIDASE_ACTIVITY,1
REACTOME_TGF_BETA_RECEPTOR_S...2,SET,15,-0.61214,-0.017481,0.24183,0.99431,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GOMF_MICROTUBULE_BINDING,SET,255,-0.13355,-0.015621,0.052669,0.99438,GOMF_MICROTUBULE_BINDING,1
GSE45365_HEALTHY_VS_MCMV_INF...5,SET,160,-0.17244,-0.016019,0.067873,0.99446,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP,1
GOBP_VESTIBULOCOCHLEAR_NERVE...3,SET,7,-1.0048,-0.019606,0.39546,0.99447,GOBP_VESTIBULOCOCHLEAR_NERVE_MORPHOGENESIS,1
GSE5589_WT_VS_IL6_KO_LPS_STI...4,SET,172,-0.159,-0.015309,0.062553,0.99448,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
GOBP_NAD_TRANSMEMBRANE_TRANS...,SET,4,-1.165,-0.017186,0.45817,0.9945,GOBP_NAD_TRANSMEMBRANE_TRANSPORT,1
GOMF_NAD_TRANSMEMBRANE_TRANS...,SET,4,-1.165,-0.017186,0.45817,0.9945,GOMF_NAD_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_NEPHROPATHY,SET,82,-0.24308,-0.0162,0.095457,0.99455,HP_NEPHROPATHY,1
KEGG_MEDICUS_REFERENCE_FLT3L...2,SET,15,-0.51701,-0.014764,0.20288,0.99458,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY,1
GOBP_HEPARAN_SULFATE_PROTEOG...1,SET,32,-0.40901,-0.017052,0.16043,0.9946,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
MIR1266_3P,SET,48,-0.30142,-0.015384,0.1181,0.99464,MIR1266_3P,1
GOBP_AMP_CATABOLIC_PROCESS,SET,5,-1.0639,-0.017546,0.41668,0.99466,GOBP_AMP_CATABOLIC_PROCESS,1
PASINI_SUZ12_TARGETS_DN,SET,289,-0.13671,-0.017008,0.053521,0.99468,PASINI_SUZ12_TARGETS_DN,1
HP_CHOREA,SET,202,-0.15284,-0.015936,0.059725,0.99475,HP_CHOREA,1
GOBP_NAD_TRANSPORT,SET,5,-1.0612,-0.017501,0.41457,0.99476,GOBP_NAD_TRANSPORT,1
GSE40274_CTRL_VS_FOXP3_AND_P...1,SET,147,-0.17681,-0.015749,0.068943,0.99483,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_ANAL_FISTULA,SET,7,-0.77147,-0.015053,0.30061,0.99486,HP_ANAL_FISTULA,1
HP_MACROTIA,SET,219,-0.14802,-0.016062,0.057661,0.99487,HP_MACROTIA,1
GOCC_AXON_HILLOCK,SET,7,-0.84938,-0.016574,0.32994,0.99497,GOCC_AXON_HILLOCK,1
GOBP_CELL_FATE_DETERMINATION,SET,40,-0.39218,-0.018276,0.15229,0.99499,GOBP_CELL_FATE_DETERMINATION,1
GOBP_APICAL_PROTEIN_LOCALIZA...,SET,14,-0.55506,-0.015314,0.21549,0.995,GOBP_APICAL_PROTEIN_LOCALIZATION,1
GSE29618_BCELL_VS_MONOCYTE_D...1,SET,185,-0.17319,-0.017289,0.067224,0.995,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN,1
WP_GLYCOSAMINOGLYCAN_SYNTHES...,SET,39,-0.36365,-0.016734,0.14113,0.99501,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,1
MIR378J,SET,70,-0.27204,-0.016757,0.10559,0.99501,MIR378J,1
LEI_HOXC8_TARGETS_DN,SET,17,-0.53309,-0.016206,0.20674,0.99504,LEI_HOXC8_TARGETS_DN,1
HP_ABNORMAL_TISSUE_ENZYME_CO...,SET,55,-0.28609,-0.015627,0.11088,0.99506,HP_ABNORMAL_TISSUE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
MEBARKI_HCC_PROGENITOR_WNT_D...2,SET,25,-0.50037,-0.018442,0.1938,0.99508,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT,1
PID_ERBB1_DOWNSTREAM_PATHWAY,SET,102,-0.22694,-0.01686,0.08788,0.99509,PID_ERBB1_DOWNSTREAM_PATHWAY,1
HP_ABNORMAL_SCLERA_MORPHOLOGY,SET,127,-0.18993,-0.015734,0.073548,0.99509,HP_ABNORMAL_SCLERA_MORPHOLOGY,1
GSE27786_NKTCELL_VS_ERYTHROB...1,SET,186,-0.16316,-0.016331,0.063103,0.99513,GSE27786_NKTCELL_VS_ERYTHROBLAST_DN,1
WRN_TARGET_GENES,SET,10,-0.68345,-0.015938,0.26424,0.99515,WRN_TARGET_GENES,1
GOBP_DE_NOVO_PROTEIN_FOLDING,SET,39,-0.33162,-0.01526,0.12809,0.99518,GOBP_DE_NOVO_PROTEIN_FOLDING,1
HP_DELAYED_PUBIC_BONE_OSSIFI...,SET,7,-0.91729,-0.017899,0.35408,0.99521,HP_DELAYED_PUBIC_BONE_OSSIFICATION,1
HP_FACIAL_PARALYSIS,SET,10,-0.77794,-0.018142,0.30024,0.99521,HP_FACIAL_PARALYSIS,1
GSE15330_WT_VS_IKAROS_KO_GRA...2,SET,187,-0.16182,-0.01624,0.062455,0.99521,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
GOBP_PODOSOME_ASSEMBLY,SET,21,-0.48117,-0.016256,0.18564,0.99522,GOBP_PODOSOME_ASSEMBLY,1
GOMF_TRANSMEMBRANE_RECEPTOR_...5,SET,16,-0.66481,-0.019607,0.25652,0.99522,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
WP_GALANIN_RECEPTOR_PATHWAY,SET,21,-0.51337,-0.017344,0.19806,0.99523,WP_GALANIN_RECEPTOR_PATHWAY,1
REACTOME_ASSEMBLY_OF_ACTIVE_...,SET,17,-0.5831,-0.017726,0.22487,0.99524,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,1
GOBP_RESPONSE_TO_STIMULUS_IN...,SET,13,-0.63937,-0.016999,0.2462,0.99529,GOBP_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION,1
GOBP_MITOCHONDRIAL_GENE_EXPR...,SET,155,-0.16333,-0.014937,0.062874,0.9953,GOBP_MITOCHONDRIAL_GENE_EXPRESSION,1
MIR10226,SET,69,-0.27276,-0.016682,0.10499,0.99531,MIR10226,1
GSE40274_SATB1_VS_FOXP3_AND_...1,SET,105,-0.22067,-0.016632,0.084924,0.99531,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_NONRIBOSOMAL_PEPTIDE_BI...,SET,17,-0.55455,-0.016858,0.2132,0.99535,GOBP_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS,1
GOBP_RESPONSE_TO_PROSTAGLAND...1,SET,31,-0.47223,-0.019379,0.1814,0.99538,GOBP_RESPONSE_TO_PROSTAGLANDIN,1
GOMF_PROTEIN_KINASE_A_REGULA...,SET,24,-0.42717,-0.015427,0.16402,0.99539,GOMF_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING,1
GSE17721_0.5H_VS_24H_PAM3CSK...1,SET,186,-0.15685,-0.015699,0.060159,0.99543,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...307,SET,39,-0.36219,-0.016667,0.13883,0.99545,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,1
MIR1233_5P,SET,94,-0.21993,-0.015689,0.084279,0.99546,MIR1233_5P,1
ZNF33A_TARGET_GENES,SET,175,-0.16601,-0.016122,0.06355,0.9955,ZNF33A_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...421,SET,5,-0.94764,-0.015629,0.36264,0.99551,GOBP_POSITIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,1
HP_IRIDODONESIS,SET,4,-1.2676,-0.018699,0.48448,0.99555,HP_IRIDODONESIS,1
GOMF_INTERLEUKIN_2_RECEPTOR_...,SET,5,-0.96083,-0.015846,0.36707,0.99557,GOMF_INTERLEUKIN_2_RECEPTOR_BINDING,1
HP_DEVELOPMENTAL_CATARACT,SET,109,-0.21089,-0.016193,0.080539,0.99558,HP_DEVELOPMENTAL_CATARACT,1
HP_ABNORMAL_EYEBROW_MORPHOLO...,SET,580,-0.092666,-0.0162,0.035371,0.9956,HP_ABNORMAL_EYEBROW_MORPHOLOGY,1
GOBP_BEHAVIORAL_RESPONSE_TO_...2,SET,9,-0.82572,-0.018268,0.3151,0.99561,GOBP_BEHAVIORAL_RESPONSE_TO_ETHANOL,1
GOCC_NURF_COMPLEX,SET,5,-0.87608,-0.014448,0.33425,0.99561,GOCC_NURF_COMPLEX,1
MORF_THRA,SET,46,-0.35123,-0.01755,0.13398,0.99562,MORF_THRA,1
FIGUEROA_AML_METHYLATION_CLU...11,SET,29,-0.42437,-0.016844,0.16178,0.99564,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,1
HP_MULTIPLE_LIPOMAS,SET,31,-0.41605,-0.017073,0.15852,0.99566,HP_MULTIPLE_LIPOMAS,1
GOBP_POSITIVE_REGULATION_OF_...311,SET,17,-0.59246,-0.018011,0.2253,0.99572,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_INTERN...,SET,19,-0.56369,-0.018115,0.2144,0.99572,HP_ABNORMALITY_OF_THE_INTERNAL_AUDITORY_CANAL,1
GSE18893_CTRL_VS_TNF_TREATED...6,SET,182,-0.16319,-0.016159,0.062054,0.99572,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP,1
GOBP_N_ACETYLNEURAMINATE_MET...,SET,11,-0.68897,-0.016851,0.2618,0.99575,GOBP_N_ACETYLNEURAMINATE_METABOLIC_PROCESS,1
HP_ABNORMALLY_LARGE_GLOBE,SET,39,-0.37344,-0.017185,0.1417,0.99579,HP_ABNORMALLY_LARGE_GLOBE,1
GOBP_REGULATION_OF_DNA_DIREC...,SET,9,-0.70902,-0.015687,0.26891,0.99581,GOBP_REGULATION_OF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,1
LAKE_ADULT_KIDNEY_C27_VASCUL...,SET,145,-0.20566,-0.018196,0.078001,0.99581,LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES,1
GOBP_REGULATION_OF_BIOLOGICA...,SET,59,-0.31768,-0.017971,0.1204,0.99583,GOBP_REGULATION_OF_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,1
KEGG_GLYOXYLATE_AND_DICARBOX...,SET,16,-0.5261,-0.015516,0.19925,0.99586,KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM,1
IVANOVA_HEMATOPOIESIS_STEM_C...1,SET,179,-0.17558,-0.017244,0.066461,0.99587,IVANOVA_HEMATOPOIESIS_STEM_CELL,1
HP_COARSE_FACIAL_FEATURES,SET,191,-0.16326,-0.016557,0.061744,0.9959,HP_COARSE_FACIAL_FEATURES,1
NOUZOVA_TRETINOIN_AND_H4_ACE...,SET,123,-0.19112,-0.015583,0.072136,0.99596,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,1
HP_DUPLICATED_COLLECTING_SYS...,SET,19,-0.47197,-0.015168,0.1778,0.99602,HP_DUPLICATED_COLLECTING_SYSTEM,1
GSE9037_WT_VS_IRAK4_KO_LPS_1...1,SET,172,-0.17853,-0.01719,0.067198,0.99605,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN,1
GSE1460_INTRATHYMIC_T_PROGEN...5,SET,171,-0.17945,-0.017229,0.067528,0.99606,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,1
MIR455_3P,SET,84,-0.24979,-0.016849,0.093951,0.99607,MIR455_3P,1
REACTOME_APC_C_CDH1_MEDIATED...,SET,70,-0.24826,-0.015293,0.093345,0.99609,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1
THUM_SYSTOLIC_HEART_FAILURE_...1,SET,190,-0.16472,-0.016661,0.061904,0.9961,THUM_SYSTOLIC_HEART_FAILURE_DN,1
GOBP_POSITIVE_REGULATION_OF_...631,SET,18,-0.51105,-0.015986,0.19187,0.99613,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
HP_PROFOUND_HEARING_IMPAIRME...,SET,10,-0.76336,-0.017802,0.28663,0.99613,HP_PROFOUND_HEARING_IMPAIRMENT,1
HP_CONE_CONE_ROD_DYSTROPHY,SET,52,-0.31616,-0.016794,0.11866,0.99614,HP_CONE_CONE_ROD_DYSTROPHY,1
GOBP_VIRAL_TRANSCRIPTION,SET,50,-0.30103,-0.01568,0.11294,0.99615,GOBP_VIRAL_TRANSCRIPTION,1
DODD_NASOPHARYNGEAL_CARCINOM...1,SET,1481,-0.063315,-0.017234,0.023743,0.99617,DODD_NASOPHARYNGEAL_CARCINOMA_DN,1
GOBP_POSITIVE_REGULATION_OF_...433,SET,18,-0.59945,-0.018751,0.22479,0.99617,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
GOCC_TRANSLATION_PREINITIATI...,SET,15,-0.54682,-0.015616,0.20497,0.99618,GOCC_TRANSLATION_PREINITIATION_COMPLEX,1
SESTO_RESPONSE_TO_UV_C5,SET,46,-0.34355,-0.017166,0.12873,0.99619,SESTO_RESPONSE_TO_UV_C5,1
LEIN_LOCALIZED_TO_PROXIMAL_D...,SET,31,-0.42821,-0.017572,0.16038,0.9962,LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,1
GSE17721_0.5H_VS_12H_PAM3CSK...1,SET,184,-0.16079,-0.016007,0.060206,0.99621,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN,1
REACTOME_TETRAHYDROBIOPTERIN...,SET,10,-0.66555,-0.015521,0.24869,0.99627,REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION,1
GSE13762_CTRL_VS_125_VITAMIN...3,SET,119,-0.21413,-0.017175,0.079909,0.99631,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN,1
GOMF_ATP_DEPENDENT_PROTEIN_F...,SET,31,-0.37768,-0.015498,0.14077,0.99635,GOMF_ATP_DEPENDENT_PROTEIN_FOLDING_CHAPERONE,1
HP_VENTRICULOMEGALY,SET,641,-0.091539,-0.016795,0.03405,0.99641,HP_VENTRICULOMEGALY,1
LUI_TARGETS_OF_PAX8_PPARG_FU...,SET,32,-0.38803,-0.016177,0.14409,0.99646,LUI_TARGETS_OF_PAX8_PPARG_FUSION,1
KEGG_GLYCOSAMINOGLYCAN_BIOSY...1,SET,21,-0.48725,-0.016461,0.18053,0.99652,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,1
REACTOME_RUNX2_REGULATES_GEN...,SET,8,-0.84304,-0.017585,0.31231,0.99652,REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION,1
HP_KERATAN_SULFATE_EXCRETION...,SET,5,-1.0183,-0.016793,0.37702,0.99654,HP_KERATAN_SULFATE_EXCRETION_IN_URINE,1
HP_METATARSUS_VALGUS,SET,19,-0.54831,-0.017621,0.20291,0.99655,HP_METATARSUS_VALGUS,1
GNF2_ANP32B,SET,34,-0.38867,-0.016702,0.14382,0.99656,GNF2_ANP32B,1
FAN_OVARY_CL11_MURAL_GRANULO...,SET,387,-0.12257,-0.017599,0.045314,0.99658,FAN_OVARY_CL11_MURAL_GRANULOSA_CELL,1
HP_SUBCORTICAL_WHITE_MATTER_...,SET,3,-1.3372,-0.017083,0.49385,0.99661,HP_SUBCORTICAL_WHITE_MATTER_CALCIFICATIONS,1
GOBP_FARNESYL_DIPHOSPHATE_ME...,SET,5,-0.90761,-0.014968,0.33471,0.99665,GOBP_FARNESYL_DIPHOSPHATE_METABOLIC_PROCESS,1
GOBP_CELLULAR_MODIFIED_AMINO...1,SET,42,-0.35463,-0.016934,0.13072,0.99666,GOBP_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
KIM_ALL_DISORDERS_CALB1_CORR...2,SET,497,-0.10485,-0.017007,0.038636,0.99667,KIM_ALL_DISORDERS_CALB1_CORR_UP,1
HASLINGER_B_CLL_WITH_13Q14_D...,SET,23,-0.4931,-0.017433,0.18157,0.99669,HASLINGER_B_CLL_WITH_13Q14_DELETION,1
GOMF_PROTEIN_FOLDING_CHAPERO...1,SET,62,-0.28639,-0.016606,0.10547,0.99669,GOMF_PROTEIN_FOLDING_CHAPERONE,1
MIR3691_5P,SET,40,-0.36391,-0.016959,0.13358,0.99677,MIR3691_5P,1
DESCARTES_MAIN_FETAL_EXCITAT...,SET,5,-1.1809,-0.019476,0.43316,0.99679,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,1
HP_AGENESIS_OF_CEREBELLAR_VE...,SET,16,-0.51817,-0.015282,0.18991,0.99682,HP_AGENESIS_OF_CEREBELLAR_VERMIS,1
GOBP_REGULATION_OF_CELLULAR_...20,SET,41,-0.34405,-0.016232,0.12599,0.99684,GOBP_REGULATION_OF_CELLULAR_SENESCENCE,1
HP_ABNORMAL_CSF_GLYCINE_CONC...,SET,8,-0.75722,-0.015795,0.27721,0.99685,HP_ABNORMAL_CSF_GLYCINE_CONCENTRATION,1
HOLLERN_PAPILLARY_BREAST_TUM...,SET,15,-0.63401,-0.018106,0.23164,0.9969,HOLLERN_PAPILLARY_BREAST_TUMOR,1
MODY_HIPPOCAMPUS_NEONATAL,SET,30,-0.44559,-0.017988,0.16272,0.99691,MODY_HIPPOCAMPUS_NEONATAL,1
REACTOME_ESTROGEN_DEPENDENT_...2,SET,23,-0.54678,-0.019331,0.19968,0.99691,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,1
PID_INSULIN_GLUCOSE_PATHWAY,SET,26,-0.45126,-0.016961,0.16471,0.99692,PID_INSULIN_GLUCOSE_PATHWAY,1
GOBP_P_BODY_ASSEMBLY,SET,21,-0.48942,-0.016535,0.17866,0.99692,GOBP_P_BODY_ASSEMBLY,1
ELLWOOD_MYC_TARGETS_DN,SET,40,-0.37317,-0.01739,0.13617,0.99693,ELLWOOD_MYC_TARGETS_DN,1
HP_THIN_BONY_CORTEX,SET,18,-0.56891,-0.017796,0.20756,0.99693,HP_THIN_BONY_CORTEX,1
HP_EYELID_MYOCLONUS,SET,9,-0.78225,-0.017307,0.28525,0.99695,HP_EYELID_MYOCLONUS,1
HP_VERTEBRAL_CLEFTING,SET,35,-0.39621,-0.017274,0.14434,0.99697,HP_VERTEBRAL_CLEFTING,1
GSE36476_YOUNG_VS_OLD_DONOR_...4,SET,176,-0.1839,-0.01791,0.066973,0.99698,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP,1
GSE7568_IL4_VS_IL4_AND_TGFB_...2,SET,151,-0.19027,-0.017176,0.069225,0.997,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP,1
MIR6503_3P,SET,28,-0.42588,-0.016611,0.15491,0.99701,MIR6503_3P,1
HP_EVERSION_OF_LATERAL_THIRD...,SET,4,-0.89005,-0.013129,0.32319,0.99705,HP_EVERSION_OF_LATERAL_THIRD_OF_LOWER_EYELIDS,1
HP_KNUCKLE_PAD,SET,7,-0.89488,-0.017462,0.32444,0.99709,HP_KNUCKLE_PAD,1
HP_ABNORMAL_CSF_METABOLITE_C...,SET,128,-0.19503,-0.016219,0.07064,0.99711,HP_ABNORMAL_CSF_METABOLITE_CONCENTRATION,1
HP_INTESTINAL_BLEEDING,SET,6,-0.97294,-0.017577,0.35154,0.99717,HP_INTESTINAL_BLEEDING,1
GOBP_FORMATION_OF_CYTOPLASMI...,SET,13,-0.60303,-0.016033,0.2177,0.99719,GOBP_FORMATION_OF_CYTOPLASMIC_TRANSLATION_INITIATION_COMPLEX,1
DESCARTES_FETAL_LIVER_VASCUL...,SET,102,-0.25425,-0.018888,0.091812,0.99719,DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS,1
NKX2_3_TARGET_GENES,SET,436,-0.11415,-0.017372,0.041113,0.99725,NKX2_3_TARGET_GENES,1
HP_CONJUNCTIVAL_ICTERUS,SET,6,-0.97538,-0.017621,0.35133,0.99725,HP_CONJUNCTIVAL_ICTERUS,1
HP_SPLENIC_INFARCTION,SET,6,-1.0513,-0.018992,0.37864,0.99725,HP_SPLENIC_INFARCTION,1
HP_RETINAL_THINNING,SET,28,-0.48395,-0.018876,0.17425,0.99726,HP_RETINAL_THINNING,1
HP_LIMBAL_DERMOID,SET,8,-0.82467,-0.017202,0.29657,0.99728,HP_LIMBAL_DERMOID,1
MODULE_122,SET,129,-0.22705,-0.018956,0.081555,0.99731,MODULE_122,1
GOBP_SLEEP,SET,21,-0.56151,-0.01897,0.20172,0.99731,GOBP_SLEEP,1
RORA_TARGET_GENES,SET,214,-0.15888,-0.017045,0.057016,0.99733,RORA_TARGET_GENES,1
GSE37416_12H_VS_24H_F_TULARE...2,SET,181,-0.17908,-0.017684,0.064229,0.99735,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
MIR10396B_5P,SET,19,-0.57296,-0.018413,0.20514,0.99739,MIR10396B_5P,1
chr3q29,SET,43,-0.6951,-0.033583,0.24867,0.9974,chr3q29,1
DESCARTES_FETAL_KIDNEY_VASCU...,SET,79,-0.28581,-0.018699,0.10222,0.99741,DESCARTES_FETAL_KIDNEY_VASCULAR_ENDOTHELIAL_CELLS,1
GOBP_NEURON_PROJECTION_MAINT...,SET,10,-0.67549,-0.015753,0.2415,0.99742,GOBP_NEURON_PROJECTION_MAINTENANCE,1
HP_ASYMMETRY_OF_SPINAL_FACET...,SET,4,-1.3142,-0.019387,0.4696,0.99743,HP_ASYMMETRY_OF_SPINAL_FACET_JOINTS,1
GSE18148_CBFB_KO_VS_WT_TREG_...2,SET,173,-0.18533,-0.017896,0.066223,0.99743,GSE18148_CBFB_KO_VS_WT_TREG_UP,1
GOBP_REGULATION_OF_GLYCOPROT...,SET,44,-0.35988,-0.017588,0.12856,0.99744,GOBP_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
MIR6847_5P,SET,136,-0.2067,-0.017716,0.073719,0.99747,MIR6847_5P,1
TCATCTC_MIR143,SET,131,-0.20711,-0.017423,0.073847,0.99748,TCATCTC_MIR143,1
GOBP_COMMON_BILE_DUCT_DEVELO...,SET,5,-1.1277,-0.018598,0.40096,0.99754,GOBP_COMMON_BILE_DUCT_DEVELOPMENT,1
HP_ABNORMALITY_OF_HAIR_TEXTU...,SET,157,-0.18863,-0.01736,0.067037,0.99755,HP_ABNORMALITY_OF_HAIR_TEXTURE,1
MIR4656,SET,98,-0.24691,-0.017982,0.087539,0.9976,MIR4656,1
HP_DEATH_IN_CHILDHOOD,SET,111,-0.22299,-0.017278,0.078972,0.99762,HP_DEATH_IN_CHILDHOOD,1
HP_APLASIA_HYPOPLASIA_OF_THE...14,SET,269,-0.14168,-0.017015,0.050132,0.99764,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLAR_VERMIS,1
CDX2_Q5,SET,231,-0.17512,-0.01951,0.061932,0.99765,CDX2_Q5,1
GSE21380_NON_TFH_VS_GERMINAL...1,SET,184,-0.17315,-0.017238,0.061165,0.99768,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,1
MIR3664_5P,SET,69,-0.29127,-0.017814,0.10271,0.99771,MIR3664_5P,1
WP_PROLINE_AND_HYDROXYPROLIN...,SET,5,-1.3077,-0.021568,0.46074,0.99773,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,1
GOMF_MHC_CLASS_IB_RECEPTOR_A...,SET,6,-1.1414,-0.020621,0.40223,0.99773,GOMF_MHC_CLASS_IB_RECEPTOR_ACTIVITY,1
GSE3720_UNSTIM_VS_PMA_STIM_V...1,SET,112,-0.23496,-0.018286,0.082744,0.99774,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,1
HP_ABNORMAL_RENAL_COLLECTING...,SET,24,-0.4648,-0.016786,0.16347,0.99776,HP_ABNORMAL_RENAL_COLLECTING_SYSTEM_MORPHOLOGY,1
GSE15733_BM_VS_SPLEEN_MEMORY...2,SET,176,-0.18658,-0.018172,0.06565,0.99776,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP,1
GOBP_RESPONSE_TO_PROSTAGLAND...3,SET,23,-0.58581,-0.020711,0.20601,0.99777,GOBP_RESPONSE_TO_PROSTAGLANDIN_E,1
HP_LEUKOENCEPHALOPATHY,SET,190,-0.17002,-0.017198,0.05978,0.99777,HP_LEUKOENCEPHALOPATHY,1
HP_HYPOCHROMIA,SET,13,-0.67875,-0.018046,0.23836,0.9978,HP_HYPOCHROMIA,1
MIR4659A_3P_MIR4659B_3P,SET,609,-0.10128,-0.018129,0.035528,0.99782,MIR4659A_3P_MIR4659B_3P,1
HP_ENTRAPMENT_NEUROPATHY,SET,10,-0.7709,-0.017978,0.2704,0.99782,HP_ENTRAPMENT_NEUROPATHY,1
HP_NUCLEAR_CATARACT,SET,25,-0.49802,-0.018356,0.17458,0.99783,HP_NUCLEAR_CATARACT,1
HP_SPERMATOGENESIS_MATURATIO...,SET,11,-0.63116,-0.015437,0.221,0.99785,HP_SPERMATOGENESIS_MATURATION_ARREST,1
IKEDA_MIR1_TARGETS_DN,SET,6,-0.992,-0.017921,0.34697,0.99787,IKEDA_MIR1_TARGETS_DN,1
GSE8835_CD4_VS_CD8_TCELL_CLL...2,SET,189,-0.18629,-0.018794,0.06517,0.99787,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP,1
DESCARTES_FETAL_KIDNEY_STROM...,SET,123,-0.24137,-0.01968,0.084425,0.99787,DESCARTES_FETAL_KIDNEY_STROMAL_CELLS,1
MIR4688,SET,44,-0.35633,-0.017414,0.12455,0.99789,MIR4688,1
GOBP_CARBON_DIOXIDE_TRANSPORT,SET,12,-0.85282,-0.021785,0.29755,0.99792,GOBP_CARBON_DIOXIDE_TRANSPORT,1
HP_OCULAR_FLUTTER,SET,5,-1.2247,-0.020198,0.42716,0.99793,HP_OCULAR_FLUTTER,1
HP_POSITIONAL_FOOT_DEFORMITY,SET,414,-0.12322,-0.018285,0.042948,0.99794,HP_POSITIONAL_FOOT_DEFORMITY,1
GSE17186_NAIVE_VS_CD21HIGH_T...4,SET,178,-0.18523,-0.018141,0.064471,0.99797,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,1
GSE17721_POLYIC_VS_CPG_0.5H_...1,SET,178,-0.18203,-0.017828,0.063333,0.99797,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN,1
GOBP_TETRAHYDROBIOPTERIN_MET...,SET,8,-0.78912,-0.01646,0.27451,0.99798,GOBP_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS,1
HP_BRANCHIAL_ANOMALY,SET,16,-0.56422,-0.016641,0.19576,0.99802,HP_BRANCHIAL_ANOMALY,1
HP_WIDE_NASAL_RIDGE,SET,8,-0.71621,-0.01494,0.24811,0.99805,HP_WIDE_NASAL_RIDGE,1
GOBP_REGULATION_OF_CYTOPLASM...1,SET,7,-0.89234,-0.017412,0.30829,0.9981,GOBP_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,1
DAZARD_UV_RESPONSE_CLUSTER_G3,SET,13,-0.69314,-0.018428,0.23918,0.99812,DAZARD_UV_RESPONSE_CLUSTER_G3,1
GOMF_DNA_POLYMERASE_BINDING,SET,19,-0.45311,-0.014562,0.15611,0.99815,GOMF_DNA_POLYMERASE_BINDING,1
MORF_EPHA7,SET,125,-0.23166,-0.01904,0.079743,0.99816,MORF_EPHA7,1
GOBP_IMMUNE_RESPONSE_TO_TUMO...,SET,24,-0.55873,-0.020178,0.19238,0.99816,GOBP_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
HP_ANTERIOR_PITUITARY_HYPOPL...,SET,32,-0.46886,-0.019547,0.16142,0.99816,HP_ANTERIOR_PITUITARY_HYPOPLASIA,1
GOBP_MODULATION_BY_SYMBIONT_...,SET,53,-0.36723,-0.019693,0.12628,0.99818,GOBP_MODULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,1
GOBP_CELLULAR_MODIFIED_AMINO...2,SET,29,-0.44626,-0.017713,0.15329,0.9982,GOBP_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS,1
HP_POSTURAL_INSTABILITY,SET,74,-0.2903,-0.018384,0.099723,0.9982,HP_POSTURAL_INSTABILITY,1
HP_SAGITTAL_CRANIOSYNOSTOSIS,SET,23,-0.46853,-0.016565,0.16092,0.9982,HP_SAGITTAL_CRANIOSYNOSTOSIS,1
GSE8621_LPS_STIM_VS_LPS_PRIM...2,SET,185,-0.18716,-0.018683,0.064288,0.9982,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,1
GSE27786_NKTCELL_VS_NEUTROPH...2,SET,176,-0.18039,-0.017568,0.061831,0.99823,GSE27786_NKTCELL_VS_NEUTROPHIL_UP,1
GOMF_POLYAMINE_TRANSMEMBRANE...,SET,10,-0.89184,-0.020798,0.30558,0.99824,GOMF_POLYAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOCC_PSEUDOPODIUM,SET,16,-0.61908,-0.018259,0.21174,0.99827,GOCC_PSEUDOPODIUM,1
GOMF_INSULIN_BINDING,SET,5,-1.0651,-0.017566,0.36312,0.99832,GOMF_INSULIN_BINDING,1
KEGG_MTOR_SIGNALING_PATHWAY,SET,49,-0.38744,-0.019979,0.13194,0.99834,KEGG_MTOR_SIGNALING_PATHWAY,1
DESCARTES_MAIN_FETAL_SATB2_L...,SET,77,-0.29892,-0.019308,0.10173,0.99835,DESCARTES_MAIN_FETAL_SATB2_LRRC7_POSITIVE_CELLS,1
MODULE_78,SET,20,-0.57501,-0.018958,0.19552,0.99836,MODULE_78,1
GOBP_PROTEIN_K27_LINKED_UBIQ...,SET,11,-0.72293,-0.017681,0.24585,0.99836,GOBP_PROTEIN_K27_LINKED_UBIQUITINATION,1
HP_ABNORMALITY_OF_SPINAL_FAC...,SET,5,-1.2228,-0.020167,0.41564,0.99837,HP_ABNORMALITY_OF_SPINAL_FACET_JOINT,1
HP_ABNORMAL_LOWER_LIP_MORPHO...,SET,208,-0.18203,-0.019256,0.061837,0.99838,HP_ABNORMAL_LOWER_LIP_MORPHOLOGY,1
GOBP_REGULATION_OF_REMOVAL_O...,SET,6,-0.96911,-0.017508,0.32887,0.99839,GOBP_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS,1
HP_ABNORMAL_ENZYME_ACTIVITY_...1,SET,21,-0.56022,-0.018927,0.19009,0.99839,HP_ABNORMAL_ENZYME_ACTIVITY_IN_CULTURED_FIBROBLASTS,1
MIR4502,SET,68,-0.29924,-0.018169,0.1014,0.99841,MIR4502,1
KMT2D_TARGET_GENES,SET,585,-0.10686,-0.018759,0.036189,0.99842,KMT2D_TARGET_GENES,1
GOBP_GLUTATHIONE_CATABOLIC_P...,SET,7,-0.96808,-0.01889,0.32771,0.99843,GOBP_GLUTATHIONE_CATABOLIC_PROCESS,1
GOBP_PROTEOGLYCAN_BIOSYNTHET...,SET,63,-0.33225,-0.019419,0.11228,0.99845,GOBP_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GOCC_EUKARYOTIC_48S_PREINITI...,SET,13,-0.64613,-0.017179,0.21824,0.99846,GOCC_EUKARYOTIC_48S_PREINITIATION_COMPLEX,1
chr11q25,SET,13,-1.2399,-0.032965,0.4182,0.99848,chr11q25,1
GOBP_CD8_POSITIVE_ALPHA_BETA...2,SET,15,-0.68685,-0.019615,0.23067,0.99855,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
HP_ABNORMAL_SUBCUTANEOUS_FAT...,SET,8,-0.82088,-0.017123,0.27496,0.99858,HP_ABNORMAL_SUBCUTANEOUS_FAT_TISSUE_DISTRIBUTION,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...3,SET,107,-0.27099,-0.020617,0.090367,0.99864,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
AIZARANI_LIVER_C18_NK_NKT_CE...,SET,110,-0.2632,-0.020302,0.087776,0.99864,AIZARANI_LIVER_C18_NK_NKT_CELLS_5,1
TAATAAT_MIR126,SET,201,-0.19626,-0.020412,0.065308,0.99867,TAATAAT_MIR126,1
GSE34006_A2AR_KO_VS_A2AR_AGO...1,SET,188,-0.18241,-0.018354,0.060691,0.99867,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN,1
GSE3982_MAC_VS_NEUTROPHIL_LP...1,SET,167,-0.20368,-0.019327,0.067471,0.99873,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN,1
MIR1243,SET,56,-0.34224,-0.018863,0.11321,0.99875,MIR1243,1
MIKKELSEN_IPS_ICP_WITH_H3K4M...,SET,116,-0.25881,-0.020497,0.085512,0.99876,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1
ZNF436_TARGET_GENES,SET,409,-0.13102,-0.019327,0.043296,0.99876,ZNF436_TARGET_GENES,1
LUI_THYROID_CANCER_CLUSTER_3,SET,26,-0.48054,-0.018062,0.15873,0.99877,LUI_THYROID_CANCER_CLUSTER_3,1
GSE17721_LPS_VS_PAM3CSK4_1H_...2,SET,175,-0.18445,-0.017913,0.060875,0.99878,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP,1
GSE37605_TREG_VS_TCONV_C57BL...1,SET,158,-0.21264,-0.019631,0.070151,0.99878,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN,1
GSE17721_PAM3CSK4_VS_CPG_0.5...1,SET,181,-0.18619,-0.018387,0.061335,0.9988,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN,1
HP_COLOR_VISION_DEFECT,SET,133,-0.23288,-0.019739,0.076646,0.99881,HP_COLOR_VISION_DEFECT,1
GOBP_ZYMOGEN_INHIBITION,SET,7,-0.85873,-0.016756,0.28191,0.99884,GOBP_ZYMOGEN_INHIBITION,1
MIR487B_3P,SET,9,-0.94808,-0.020975,0.31085,0.99885,MIR487B_3P,1
HP_MYELOPATHY,SET,13,-0.73937,-0.019658,0.2412,0.99891,HP_MYELOPATHY,1
BREDEMEYER_RAG_SIGNALING_NOT...2,SET,59,-0.34097,-0.019288,0.11111,0.99892,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,1
GOBP_REGULATION_OF_GLYCOGEN_...2,SET,6,-1.0808,-0.019526,0.35045,0.99898,GOBP_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS,1
REACTOME_ARYL_HYDROCARBON_RE...,SET,6,-0.85661,-0.015475,0.27665,0.99902,REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING,1
MXD1_TARGET_GENES,SET,504,-0.11849,-0.019351,0.038255,0.99902,MXD1_TARGET_GENES,1
GOBP_ONE_CARBON_COMPOUND_TRA...,SET,22,-0.6904,-0.023873,0.22287,0.99902,GOBP_ONE_CARBON_COMPOUND_TRANSPORT,1
HP_OPTIC_NERVE_DYSPLASIA,SET,6,-1.174,-0.02121,0.37796,0.99905,HP_OPTIC_NERVE_DYSPLASIA,1
WP_HYPERTROPHY_MODEL,SET,19,-0.65393,-0.021015,0.20922,0.99911,WP_HYPERTROPHY_MODEL,1
HP_THIN_LOWER_LIP_VERMILION,SET,5,-1.3391,-0.022085,0.42867,0.99911,HP_THIN_LOWER_LIP_VERMILION,1
REACTOME_RUNX2_REGULATES_OST...,SET,21,-0.60778,-0.020533,0.19437,0.99912,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,1
MIR4301,SET,34,-0.43736,-0.018794,0.13953,0.99914,MIR4301,1
GOMF_STRUCTURAL_CONSTITUENT_...3,SET,20,-0.66327,-0.021869,0.21101,0.99916,GOMF_STRUCTURAL_CONSTITUENT_OF_EYE_LENS,1
HP_ABNORMALITY_OF_RETINAL_PI...,SET,283,-0.15876,-0.019548,0.050395,0.99918,HP_ABNORMALITY_OF_RETINAL_PIGMENTATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...49,SET,100,-0.26388,-0.019412,0.083677,0.99919,HP_APLASIA_HYPOPLASIA_OF_THE_OPTIC_NERVE,1
GSE26928_NAIVE_VS_EFF_MEMORY...2,SET,156,-0.2157,-0.019788,0.068385,0.99919,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,1
GSE17721_4_VS_24H_CPG_BMDC_UP,SET,177,-0.20774,-0.020289,0.065733,0.99921,GSE17721_4_VS_24H_CPG_BMDC_UP,1
GOBP_REGULATION_OF_ENDOSOME_...3,SET,3,-1.4067,-0.017971,0.44489,0.99922,GOBP_REGULATION_OF_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
HP_THIRD_TRIMESTER_ONSET,SET,41,-0.41547,-0.019602,0.13122,0.99923,HP_THIRD_TRIMESTER_ONSET,1
GSE3720_UNSTIM_VS_LPS_STIM_V...1,SET,130,-0.24743,-0.020736,0.078104,0.99923,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN,1
GOCC_ENDONUCLEASE_COMPLEX,SET,35,-0.45325,-0.019761,0.14219,0.99928,GOCC_ENDONUCLEASE_COMPLEX,1
HP_BUPHTHALMOS,SET,24,-0.615,-0.02221,0.19265,0.99929,HP_BUPHTHALMOS,1
HP_HYPOPLASIA_OF_THE_PRIMARY...,SET,7,-1.032,-0.020137,0.3227,0.99931,HP_HYPOPLASIA_OF_THE_PRIMARY_TEETH,1
GOBP_REGULATION_OF_T_CELL_ME...2,SET,10,-0.98008,-0.022856,0.306,0.99932,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
HP_SKEWFOOT,SET,6,-1.2145,-0.021941,0.37877,0.99933,HP_SKEWFOOT,1
HP_CHOREOATHETOSIS,SET,101,-0.2735,-0.02022,0.085042,0.99935,HP_CHOREOATHETOSIS,1
GSE17721_LPS_VS_CPG_2H_BMDC_...1,SET,181,-0.20518,-0.020261,0.063784,0.99935,GSE17721_LPS_VS_CPG_2H_BMDC_DN,1
HP_GASTROPARESIS,SET,30,-0.46997,-0.018973,0.14591,0.99936,HP_GASTROPARESIS,1
HP_CERVICAL_MYELOPATHY,SET,7,-1.1159,-0.021774,0.34563,0.99938,HP_CERVICAL_MYELOPATHY,1
HP_EEG_WITH_FOCAL_SHARP_WAVES,SET,10,-0.87033,-0.020296,0.26896,0.99939,HP_EEG_WITH_FOCAL_SHARP_WAVES,1
HORTON_SREBF_TARGETS,SET,24,-0.52598,-0.018995,0.16231,0.9994,HORTON_SREBF_TARGETS,1
GGCAGAC_MIR346,SET,40,-0.44569,-0.02077,0.13757,0.9994,GGCAGAC_MIR346,1
HP_CLOSED_NEURAL_TUBE_DEFECT,SET,67,-0.35269,-0.021256,0.10891,0.9994,HP_CLOSED_NEURAL_TUBE_DEFECT,1
HP_ATHETOSIS,SET,139,-0.23303,-0.02019,0.071676,0.99942,HP_ATHETOSIS,1
GSE29618_BCELL_VS_MONOCYTE_DN,SET,179,-0.21831,-0.021441,0.066888,0.99945,GSE29618_BCELL_VS_MONOCYTE_DN,1
HP_LOWER_LIMB_HYPERTONIA,SET,32,-0.46739,-0.019486,0.14278,0.99947,HP_LOWER_LIMB_HYPERTONIA,1
YANG_BREAST_CANCER_ESR1_LASE...1,SET,42,-0.43885,-0.020955,0.13349,0.99949,YANG_BREAST_CANCER_ESR1_LASER_DN,1
MODULE_278,SET,32,-0.48277,-0.020128,0.14671,0.9995,MODULE_278,1
HP_SUTURAL_CATARACT,SET,7,-1.045,-0.020391,0.31743,0.9995,HP_SUTURAL_CATARACT,1
WP_GLYCINE_METABOLISM_INCLUD...,SET,15,-0.67759,-0.01935,0.20543,0.99951,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,1
GSE46606_IRF4HIGH_VS_IRF4MID...2,SET,185,-0.20451,-0.020415,0.062037,0.99951,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,1
HP_IRREGULAR_DENTITION,SET,7,-1.0889,-0.021248,0.32995,0.99952,HP_IRREGULAR_DENTITION,1
REACTOME_AFLATOXIN_ACTIVATIO...,SET,18,-0.68818,-0.021527,0.20782,0.99953,REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION,1
HP_PLAGIOCEPHALY,SET,134,-0.24609,-0.020937,0.074202,0.99954,HP_PLAGIOCEPHALY,1
DESCARTES_FETAL_KIDNEY_MEGAK...,SET,103,-0.30059,-0.02244,0.090491,0.99955,DESCARTES_FETAL_KIDNEY_MEGAKARYOCYTES,1
HP_ABNORMAL_CSF_CARBOXYLIC_A...,SET,24,-0.54252,-0.019592,0.16317,0.99956,HP_ABNORMAL_CSF_CARBOXYLIC_ACID_CONCENTRATION,1
GOBP_ISOPENTENYL_DIPHOSPHATE...,SET,5,-1.1884,-0.019599,0.35617,0.99957,GOBP_ISOPENTENYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_T_CELL_MEDIATED_IMMUNE_...,SET,11,-0.97786,-0.023916,0.29273,0.99958,GOBP_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
MODULE_35,SET,4,-1.2649,-0.018658,0.37733,0.9996,MODULE_35,1
GOBP_CHAPERONE_MEDIATED_PROT...1,SET,22,-0.54369,-0.0188,0.16118,0.99963,GOBP_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY,1
REACTOME_TFAP2A_ACTS_AS_A_TR...,SET,5,-1.2438,-0.020512,0.36781,0.99964,REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION,1
WAKABAYASHI_ADIPOGENESIS_PPA...2,SET,600,-0.12297,-0.021853,0.035765,0.99971,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D,1
GOBP_CHONDROCYTE_DEVELOPMENT,SET,29,-0.62417,-0.024775,0.18091,0.99972,GOBP_CHONDROCYTE_DEVELOPMENT,1
KEGG_TERPENOID_BACKBONE_BIOS...,SET,15,-0.67758,-0.01935,0.19515,0.99974,KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS,1
GOBP_INOSINE_METABOLIC_PROCE...,SET,4,-1.7884,-0.026382,0.51205,0.99976,GOBP_INOSINE_METABOLIC_PROCESS,1
MIR637,SET,78,-0.33403,-0.021715,0.093696,0.99982,MIR637,1
GOBP_CHONDROCYTE_DIFFERENTIA...1,SET,107,-0.31521,-0.023982,0.088168,0.99982,GOBP_CHONDROCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_SUPEROXID...2,SET,27,-0.61031,-0.023376,0.1703,0.99983,GOBP_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS,1
GSE5099_MONOCYTE_VS_CLASSICA...2,SET,174,-0.22647,-0.021932,0.06261,0.99985,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP,1
WP_ENTEROCYTE_CHOLESTEROL_ME...,SET,34,-0.4992,-0.021452,0.13629,0.99987,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,1
MIR3135A,SET,30,-0.52487,-0.021189,0.14365,0.99987,MIR3135A,1
GOBP_REGULATION_OF_VIRAL_TRA...,SET,18,-0.72508,-0.022681,0.19897,0.99987,GOBP_REGULATION_OF_VIRAL_TRANSCRIPTION,1
HP_ABNORMAL_LIVER_PHYSIOLOGY,SET,24,-0.68166,-0.024617,0.18408,0.99989,HP_ABNORMAL_LIVER_PHYSIOLOGY,1
WP_CHOLESTEROL_METABOLISM_WI...,SET,44,-0.45363,-0.022169,0.12172,0.9999,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,1
MIR5571_5P,SET,149,-0.27697,-0.024838,0.072979,0.99993,MIR5571_5P,1
AGTTCTC_MIR146A_MIR146B,SET,50,-0.46815,-0.024385,0.1217,0.99994,AGTTCTC_MIR146A_MIR146B,1
GOBP_ADENOSINE_METABOLIC_PRO...,SET,9,-1.309,-0.028961,0.34055,0.99994,GOBP_ADENOSINE_METABOLIC_PROCESS,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS...1,SET,48,-0.53005,-0.027053,0.13376,0.99996,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,1
SCHMIDT_POR_TARGETS_IN_LIMB_...2,SET,26,-0.60451,-0.022721,0.15157,0.99997,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,1
REACTOME_CHOLESTEROL_BIOSYNT...,SET,24,-0.63569,-0.022957,0.15344,0.99998,REACTOME_CHOLESTEROL_BIOSYNTHESIS,1
WP_CHOLESTEROL_BIOSYNTHESIS_...1,SET,14,-0.82575,-0.022782,0.20293,0.99998,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...803,SET,4,-1.7624,-0.025997,0.43224,0.99998,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
DESCARTES_FETAL_LUNG_LYMPHAT...,SET,48,-0.54931,-0.028036,0.1324,0.99998,DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS,1
WP_CHOLESTEROL_SYNTHESIS_DIS...,SET,17,-0.83845,-0.025489,0.19088,0.99999,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,1
HP_POROKERATOSIS,SET,7,-1.3657,-0.026649,0.31224,0.99999,HP_POROKERATOSIS,1
GSE18791_CTRL_VS_NEWCASTLE_V...18,SET,178,-0.25802,-0.02527,0.061601,0.99999,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP,1
KEGG_MEDICUS_REFERENCE_MEVAL...,SET,12,-0.98805,-0.025239,0.21334,1,KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY,1
WP_MEVALONATE_ARM_OF_CHOLEST...,SET,13,-0.93056,-0.024741,0.20021,1,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,1
WP_MEVALONATE_PATHWAY,SET,7,-1.3114,-0.025589,0.25983,1,WP_MEVALONATE_PATHWAY,1
MODULE_432,SET,13,-1,-0.026588,0.22132,1,MODULE_432,1
HP_FETAL_PERICARDIAL_EFFUSION,SET,6,-1.3783,-0.0249,0.31041,1,HP_FETAL_PERICARDIAL_EFFUSION,1
